PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Tenopir, C; Allard, S; Douglass, K; Aydinoglu, AU; Wu, L; Read, E; Manoff, M; Frame, M				Tenopir, Carol; Allard, Suzie; Douglass, Kimberly; Aydinoglu, Arsev Umur; Wu, Lei; Read, Eleanor; Manoff, Maribeth; Frame, Mike			Data Sharing by Scientists: Practices and Perceptions	PLOS ONE			English	Article								Background: Scientific research in the 21st century is more data intensive and collaborative than in the past. It is important to study the data practices of researchers - data accessibility, discovery, re-use, preservation and, particularly, data sharing. Data sharing is a valuable part of the scientific method allowing for verification of results and extending research from prior results. Methodology/Principal Findings: A total of 1329 scientists participated in this survey exploring current data sharing practices and perceptions of the barriers and enablers of data sharing. Scientists do not make their data electronically available to others for various reasons, including insufficient time and lack of funding. Most respondents are satisfied with their current processes for the initial and short-term parts of the data or research lifecycle (collecting their research data; searching for, describing or cataloging, analyzing, and short-term storage of their data) but are not satisfied with long-term data preservation. Many organizations do not provide support to their researchers for data management both in the short- and long-term. If certain conditions are met (such as formal citation and sharing reprints) respondents agree they are willing to share their data. There are also significant differences and approaches in data management practices based on primary funding agency, subject discipline, age, work focus, and world region. Conclusions/Significance: Barriers to effective data sharing and preservation are deeply rooted in the practices and culture of the research process as well as the researchers themselves. New mandates for data management plans from NSF and other federal agencies and world-wide attention to the need to share and preserve data could lead to changes. Large scale programs, such as the NSF-sponsored DataNET (including projects like DataONE) will both bring attention and resources to the issue and make it easier for scientists to apply sound data management principles.	[Tenopir, Carol; Allard, Suzie; Douglass, Kimberly; Aydinoglu, Arsev Umur; Wu, Lei] Univ Tennessee, Sch Informat Sci, Knoxville, TN 37996 USA; [Read, Eleanor; Manoff, Maribeth] Univ Tennessee, Univ Tennessee Lib, Knoxville, TN USA; [Frame, Mike] US Geol Survey, Ctr Informat Biol, Oak Ridge, TN USA	University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville; United States Department of the Interior; United States Geological Survey	Tenopir, C (corresponding author), Univ Tennessee, Sch Informat Sci, Knoxville, TN 37996 USA.	ctenopir@utk.edu	Aydinoglu, Arsev Umur/A-5455-2016	Aydinoglu, Arsev Umur/0000-0001-8857-6001; Tenopir, Carol/0000-0002-9056-8251; Allard, Suzie/0000-0001-9421-3848	National Science Foundation, Division of Cyberinfrastructure, Data Observation Network for Earth (DataONE) NSF [0830944]; Direct For Computer & Info Scie & Enginr [0830944] Funding Source: National Science Foundation	National Science Foundation, Division of Cyberinfrastructure, Data Observation Network for Earth (DataONE) NSF(National Science Foundation (NSF)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	The project was funded as part of the National Science Foundation, Division of Cyberinfrastructure, Data Observation Network for Earth (DataONE) NSF award #0830944 under a Cooperative Agreement. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arzberger P., 2004, DATA SCI J, V3, P135, DOI DOI 10.2481/DSJ.3.135; Campbell EG, 2002, JAMA-J AM MED ASSOC, V287, P473, DOI 10.1001/jama.287.4.473; Campbell Eric G, 2003, J Health Care Law Policy, V6, P241; DRYAD, 2010, DRYAD SUSTAINABILITY; European Science Foundation, 2007, SHAR RESP SHAR RES D; Hey T., 2009, 4 PARADIGM DATA INTE; *INT CONS POL SOC, 2009, GUID SOC SCI DAT PRE; *JOINT INF SYST CO, 2010, JISC HELP RES; *NAT SCI FDN, 2007, 0728 NSF; *NAT SCI FDN OFF C, 2008, SUST DIG DAT PRES AC; National Academy of Sciences Committee on Ensuring the Utility and Integrity of Research Data in a Digital Age, 2009, ENS INT ACC STEW RES; Nelson B, 2009, NATURE, V461, P160, DOI 10.1038/461160a; *PARSE, 2009, PARSE INSIGHT; Paton NW, 2008, BIOCHEM SOC T, V36, P33, DOI 10.1042/BST0360033; *PUBL RES CONS, 2010, ACC VS IMP; Savage CJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007078; Sieber Joan E, 1991, ETHICS BEHAV, V1, P69, DOI DOI 10.1207/S15327019EB0102_1; Smit E, 2011, LEARN PUBL, V24, P35, DOI 10.1087/20110107	18	576	591	7	191	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21101	10.1371/journal.pone.0021101	http://dx.doi.org/10.1371/journal.pone.0021101			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21738610	Green Published, gold			2022-12-27	WOS:000292290100013
J	Reed, TE; Schindler, DE; Hague, MJ; Patterson, DA; Meir, E; Waples, RS; Hinch, SG				Reed, Thomas E.; Schindler, Daniel E.; Hague, Merran J.; Patterson, David A.; Meir, Eli; Waples, Robin S.; Hinch, Scott G.			Time to Evolve? Potential Evolutionary Responses of Fraser River Sockeye Salmon to Climate Change and Effects on Persistence	PLOS ONE			English	Article							FRESH-WATER; LIFE-HISTORY; CONTEMPORARY EVOLUTION; MIGRATION MORTALITY; ONCORHYNCHUS-NERKA; EXTINCTION RISK; TEMPERATURE; ADAPTATION; PHYSIOLOGY; MODELS	Evolutionary adaptation affects demographic resilience to climate change but few studies have attempted to project changes in selective pressures or quantify impacts of trait responses on population dynamics and extinction risk. We used a novel individual-based model to explore potential evolutionary changes in migration timing and the consequences for population persistence in sockeye salmon Oncorhynchus nerka in the Fraser River, Canada, under scenarios of future climate warming. Adult sockeye salmon are highly sensitive to increases in water temperature during their arduous upriver migration, raising concerns about the fate of these ecologically, culturally, and commercially important fish in a warmer future. Our results suggest that evolution of upriver migration timing could allow these salmon to avoid increasingly frequent stressful temperatures, with the odds of population persistence increasing in proportion to the trait heritability and phenotypic variance. With a simulated 2 degrees C increase in average summer river temperatures by 2100, adult migration timing from the ocean to the river advanced by similar to 10 days when the heritability was 0.5, while the risk of quasi-extinction was only 17% of that faced by populations with zero evolutionary potential (i.e., heritability fixed at zero). The rates of evolution required to maintain persistence under simulated scenarios of moderate to rapid warming are plausible based on estimated heritabilities and rates of microevolution of timing traits in salmon and related species, although further empirical work is required to assess potential genetic and ecophysiological constraints on phenological adaptation. These results highlight the benefits to salmon management of maintaining evolutionary potential within populations, in addition to conserving key habitats and minimizing additional stressors where possible, as a means to build resilience to ongoing climate change. More generally, they demonstrate the importance and feasibility of considering evolutionary processes, in addition to ecology and demography, when projecting population responses to environmental change.	[Reed, Thomas E.; Schindler, Daniel E.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Reed, Thomas E.; Waples, Robin S.] NOAA, Natl Marine Fisheries Serv, NW Fisheries Sci Ctr, Seattle, WA 98112 USA; [Hague, Merran J.; Patterson, David A.] Simon Fraser Univ, Sch Resource & Environm Management, Fisheries & Oceans Canada, Sci Branch, Burnaby, BC V5A 1S6, Canada; [Meir, Eli] SimBiot Software, Ithaca, NY USA; [Hinch, Scott G.] Univ British Columbia, Dept Forest Sci, Vancouver, BC V6T 1W5, Canada; [Hinch, Scott G.] Univ British Columbia, Inst Resources Environm & Sustainabil, Vancouver, BC V5Z 1M9, Canada	University of Washington; University of Washington Seattle; National Oceanic Atmospheric Admin (NOAA) - USA; Fisheries & Oceans Canada; Simon Fraser University; University of British Columbia; University of British Columbia	Reed, TE (corresponding author), Netherlands Inst Ecol, Wageningen, Netherlands.	t.reed@nioo.knaw.nl	Waples, Robin S/K-1126-2016; Reed, Thomas E/A-5788-2012	Reed, Thomas E/0000-0002-2993-0477; Meir, Eli/0000-0002-1874-1750	Gordon and Betty Moore Foundation; Fisheries and Oceans Canada	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Fisheries and Oceans Canada	This work was supported by grants from the Gordon and Betty Moore Foundation (Synthesis of climate effects on salmon; http://www.moore.org/grants-awarded.aspx) and from the Fisheries and Oceans Canada, Environmental Watch Program (http://www.pac.dfo-mpo.gc.ca/science/habitat/frw-rfo/intro-eng.htm). The funders had no direct role in study design, data analysis, decision to publish, or preparation of the manuscript. Temperature data were provided by Fisheries and Oceans Canada's Environmental Watch Program.	[Anonymous], 2005, MILLENNIUM ECOSYSTEM; BARTON NH, 1986, GENET RES, V47, P209, DOI 10.1017/S0016672300023156; Betts RA, 2011, PHILOS T R SOC A, V369, P67, DOI 10.1098/rsta.2010.0292; Blackbourn D.J., 1987, Canadian Special Publication of Fisheries and Aquatic Sciences, V96, P296; BRETT JR, 1971, AM ZOOL, V11, P99; Bryant MD, 2009, CLIMATIC CHANGE, V95, P169, DOI 10.1007/s10584-008-9530-x; BURGER R, 1995, EVOLUTION, V49, P151, DOI 10.1111/j.1558-5646.1995.tb05967.x; Burgner R. L., 1991, PACIFIC SALMON LIFE; Canadell JG, 2007, P NATL ACAD SCI USA, V104, P18866, DOI 10.1073/pnas.0702737104; Carlson SM, 2008, EVOL APPL, V1, P222, DOI 10.1111/j.1752-4571.2008.00025.x; Chevin LM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000357; Cooke SJ, 2004, FISHERIES, V29, P22, DOI 10.1577/1548-8446(2004)29[22:AMTAHE]2.0.CO;2; Cooke SJ, 2008, BEHAV ECOL, V19, P747, DOI 10.1093/beheco/arn006; Crossin GT, 2008, CAN J ZOOL, V86, P127, DOI 10.1139/Z07-122; Crozier LG, 2008, EVOL APPL, V1, P252, DOI 10.1111/j.1752-4571.2008.00033.x; Eliason EJ, 2011, SCIENCE, V332, P109, DOI 10.1126/science.1199158; Falconer D. S., 1996, INTRO QUANTITATIVE G; Farrell AP, 2008, PHYSIOL BIOCHEM ZOOL, V81, P697, DOI 10.1086/592057; Ferrari MR, 2007, J HYDROL, V342, P336, DOI 10.1016/j.jhydrol.2007.06.002; Fleming I.A., 2002, ENCY GLOBAL ENV CHAN, P309; Fraser DJ, 2008, EVOL APPL, V1, P535, DOI 10.1111/j.1752-4571.2008.00036.x; GABLE JG, 1993, 5 PAC SALM COMM, P36; Gienapp P, 2008, MOL ECOL, V17, P167, DOI 10.1111/j.1365-294X.2007.03413.x; GILHOUSEN P, 1990, INT PACIFIC SALMON C, V26; HAGUE M, 2007, CANADIAN TECHNICAL R, V2776, P55; Hague MJ, 2011, GLOBAL CHANGE BIOL, V17, P87, DOI 10.1111/j.1365-2486.2010.02225.x; Hard JJ, 2008, EVOL APPL, V1, P388, DOI 10.1111/j.1752-4571.2008.00020.x; Healey M, 2011, CAN J FISH AQUAT SCI, V68, P718, DOI [10.1139/F11-010, 10.1139/f2011-010]; Hellmann JJ, 2007, BIOL CONSERV, V137, P599, DOI 10.1016/j.biocon.2007.03.018; Hendry AP, 2008, MOL ECOL, V17, P20, DOI 10.1111/j.1365-294X.2007.03428.x; HINCH S, 2009, P C EARL MIGR PREM M, P8; Hinch Scott G., 2006, Fish Physiology, V24, P239; Hodgson S, 2002, CAN J ZOOL, V80, P542, DOI 10.1139/Z02-030; Hodgson S, 2006, FISH OCEANOGR, V15, P1, DOI 10.1111/j.1365-2419.2005.00354.x; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Isaac Joanne L., 2009, Endangered Species Research, V7, P115, DOI 10.3354/esr00093; Jenouvrier S, 2009, P NATL ACAD SCI USA, V106, P1844, DOI 10.1073/pnas.0806638106; Keefer ML, 2008, ECOL FRESHW FISH, V17, P136, DOI 10.1111/j.1600-0633.2007.00267.x; Keith DA, 2008, BIOL LETTERS, V4, P560, DOI 10.1098/rsbl.2008.0049; Kinnison MT, 2008, MOL ECOL, V17, P405, DOI 10.1111/j.1365-294X.2007.03495.x; Kinnison MT, 2007, FUNCT ECOL, V21, P444, DOI 10.1111/j.1365-2435.2007.01278.x; Kinnison MT, 2001, GENETICA, V112, P145, DOI 10.1023/A:1013375419520; Lovejoy Thomas E., 2005, pi; LYNCH M, 1993, BIOTIC INTERACTIONS AND GLOBAL CHANGE, P234; Macdonald J.S., 2000, Canadian Technical Report of Fisheries and Aquatic Sciences, V2315, pi; Macdonald JS, 2010, T AM FISH SOC, V139, P768, DOI 10.1577/T08-223.1; Martins EG, 2011, GLOBAL CHANGE BIOL, V17, P99, DOI 10.1111/j.1365-2486.2010.02241.x; MCDANIELS T, 2010, J ENVIRON MANAGE, P2771; Morrison J, 2002, J HYDROL, V263, P230, DOI 10.1016/S0022-1694(02)00065-3; Mote PW, 2003, CLIMATIC CHANGE, V61, P45, DOI 10.1023/A:1026302914358; MOUSSALLI E, 1986, CAN J FISH AQUAT SCI, V43, P135, DOI 10.1139/f86-014; Naughton GP, 2005, CAN J FISH AQUAT SCI, V62, P30, DOI 10.1139/F04-147; Patterson DA, 2007, CANADIAN TECHNICAL R, V2724; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Quinn T. P, 2018, BEHAV ECOLOGY PACIFI; Quinn TP, 2009, AM FISH S S, V69, P23; Quinn TP, 1996, ECOLOGY, V77, P1151, DOI 10.2307/2265584; Quinn TP, 2000, EVOLUTION, V54, P1372, DOI 10.1111/j.0014-3820.2000.tb00569.x; Rand PS, 2006, T AM FISH SOC, V135, P655, DOI 10.1577/T05-023.1; Reed TE, 2011, CONSERV BIOL, V25, P56, DOI 10.1111/j.1523-1739.2010.01552.x; Reed TE, 2010, P ROY SOC B-BIOL SCI, V277, P3391, DOI 10.1098/rspb.2010.0771; Schindler DE, 2008, FISHERIES, V33, P502, DOI 10.1577/1548-8446-33.10.502; Sinervo B, 2010, SCIENCE, V328, P894, DOI 10.1126/science.1184695; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stockwell CA, 2003, TRENDS ECOL EVOL, V18, P94, DOI 10.1016/S0169-5347(02)00044-7; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Visser ME, 2008, P ROY SOC B-BIOL SCI, V275, P649, DOI 10.1098/rspb.2007.0997	67	81	81	0	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e20380	10.1371/journal.pone.0020380	http://dx.doi.org/10.1371/journal.pone.0020380			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738573	Green Submitted, Green Published, gold			2022-12-27	WOS:000292142800002
J	Straetemans, M; Glaziou, P; Bierrenbach, AL; Sismanidis, C; van der Werf, MJ				Straetemans, Masja; Glaziou, Philippe; Bierrenbach, Ana L.; Sismanidis, Charalambos; van der Werf, Marieke J.			Assessing Tuberculosis Case Fatality Ratio: A Meta-Analysis	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SHORT-COURSE CHEMOTHERAPY; HIV-INFECTED PERSONS; NEGATIVE PULMONARY TUBERCULOSIS; DRUG-RESISTANT TUBERCULOSIS; HIGH MORTALITY-RATES; HEALTH-CARE WORKERS; RURAL SOUTH-AFRICA; SUB-SAHARAN AFRICA; RISK-FACTORS	Background: Recently, the tuberculosis (TB) Task Force Impact Measurement acknowledged the need to review the assumptions underlying the TB mortality estimates published annually by the World Health Organization (WHO). TB mortality is indirectly measured by multiplying estimated TB incidence with estimated case fatality ratio (CFR). We conducted a meta-analysis to estimate the TB case fatality ratio in TB patients having initiated TB treatment. Methods: We searched for eligible studies in the PubMed and Embase databases through March 4(th) 2011 and by reference listing of relevant review articles. Main analyses included the estimation of the pooled percentages of: a) TB patients dying due to TB after having initiated TB treatment and b) TB patients dying during TB treatment. Pooled percentages were estimated using random effects regression models on the combined patient population from all studies. Main Results: We identified 69 relevant studies of which 22 provided data on mortality due to TB and 59 provided data on mortality during TB treatment. Among HIV infected persons the pooled percentage of TB patients dying due to TB was 9.2% (95% Confidence Interval (CI): 3.7%-14.7%) and among HIV uninfected persons 3.0% (95% CI: 21.2%-7.4%) based on the results of eight and three studies respectively providing data for this analyses. The pooled percentage of TB patients dying during TB treatment was 18.8% (95% CI: 14.8%-22.8%) among HIV infected patients and 3.5% (95% CI: 2.0%-4.92%) among HIV uninfected patients based on the results of 27 and 19 studies respectively. Conclusion: The results of the literature review are useful in generating prior distributions of CFR in countries with vital registration systems and have contributed towards revised estimates of TB mortality This literature review did not provide us with all data needed for a valid estimation of TB CFR in TB patients initiating TB treatment.	[Straetemans, Masja; van der Werf, Marieke J.] KNCV TB Fdn, Unit Knowledge Res & Policy, The Hague, Netherlands; [Straetemans, Masja; van der Werf, Marieke J.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, Ctr Infect & Immun Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands; [Glaziou, Philippe; Bierrenbach, Ana L.; Sismanidis, Charalambos] World Hlth Org, Stop TB Dept, Geneva, Switzerland	KNCV Tuberculosis Foundation; University of Amsterdam; Academic Medical Center Amsterdam; World Health Organization	Straetemans, M (corresponding author), Royal Trop Inst, KIT Biomed Res, NL-1105 AZ Amsterdam, Netherlands.	m.straetemans@kit.nl	Bierrenbach, Ana L/F-3185-2014	Bierrenbach, Ana L/0000-0002-6837-0636; van der Werf, Marieke J./0000-0001-8021-1358; Glaziou, Philippe/0000-0002-0649-1272	Dutch Ministry of Foreign Affairs	Dutch Ministry of Foreign Affairs	This study has been funded by the Dutch Ministry of Foreign Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKAH AN, 1995, LANCET, V345, P607, DOI 10.1016/S0140-6736(95)90519-7; Adatu F, 2003, INT J TUBERC LUNG D, V7, pS63; Agutu WO, 1997, E AFR MED J, V74, P348; Alavi S. M., 2009, Acta Medica Iranica, V47, P89; Banerjee A, 1997, T ROY SOC TROP MED H, V91, P707, DOI 10.1016/S0035-9203(97)90533-2; Boeree MJ, 2005, TROP MED INT HEALTH, V10, P723, DOI 10.1111/j.1365-3156.2005.01433.x; Borgdorff MW, 1998, EUR RESPIR J, V11, P816, DOI 10.1183/09031936.98.11040816; BUSILLO CP, 1992, CHEST, V102, P797, DOI 10.1378/chest.102.3.797; Cain KP, 2009, EMERG INFECT DIS, V15, P258, DOI 10.3201/eid1502.080942; Cayla JA, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-121; Ciglenecki I, 2007, INT J TUBERC LUNG D, V11, P1121; Connolly C, 1998, INT J TUBERC LUNG D, V2, P919; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Crofts JR, 2008, INT J TUBERC LUNG D, V12, P308; CULLINAN P, 1991, THORAX, V46, P347, DOI 10.1136/thx.46.5.347; Davies GR, 1999, AIDS, V13, P811, DOI 10.1097/00002030-199905070-00010; Dean GL, 2002, AIDS, V16, P75, DOI 10.1097/00002030-200201040-00010; DeRiemer K, 2005, LANCET, V365, P1239, DOI 10.1016/S0140-6736(05)74812-1; Dewan PK, 2004, INT J TUBERC LUNG D, V8, P598; Dye C, 2005, JAMA-J AM MED ASSOC, V293, P2767, DOI 10.1001/jama.293.22.2767; Dye C, 2008, LANCET INFECT DIS, V8, P233, DOI 10.1016/S1473-3099(07)70291-8; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Egger E, 1997, LANCET, V350, P326, DOI 10.1016/S0140-6736(97)02419-7; El-Sony AI, 2002, INT J TUBERC LUNG D, V6, P1058; ELLIOTT AM, 1995, T ROY SOC TROP MED H, V89, P78, DOI 10.1016/0035-9203(95)90668-1; Eng B, 2009, SE ASIAN J TROP MED, V40, P89; Erbes R, 2006, EUR RESPIR J, V27, P1223, DOI 10.1183/09031936.06.00088105; Espinal MA, 2000, JAMA-J AM MED ASSOC, V283, P2537, DOI 10.1001/jama.283.19.2537; Faustini A, 2006, THORAX, V61, P158, DOI 10.1136/thx.2005.045963; Fielder JF, 2002, INT J TUBERC LUNG D, V6, P1114; Garcia-Garcia MD, 2002, EMERG INFECT DIS, V8, P1327; Garin B, 1997, LANCET, V350, P1298, DOI 10.1016/S0140-6736(05)62475-0; Glaziou P, 2009, CLIN CHEST MED, V30, P621, DOI 10.1016/j.ccm.2009.08.017; Glynn JR, 1998, B WORLD HEALTH ORGAN, V76, P295; Gustafson P, 2007, INFECTION, V35, P69, DOI 10.1007/s15010-007-6090-3; Hargreaves NJ, 2001, INT J TUBERC LUNG D, V5, P847; Harries AD, 2009, INT J TUBERC LUNG D, V13, P6; Harries AD, 1999, INT J TUBERC LUNG D, V3, P402; Harries AD, 1998, T ROY SOC TROP MED H, V92, P343, DOI 10.1016/S0035-9203(98)91036-7; Harries AD, 2002, T ROY SOC TROP MED H, V96, P34, DOI 10.1016/S0035-9203(02)90231-2; Harries AD, 2001, INT J TUBERC LUNG D, V5, P1000; Harries AD, 1999, T ROY SOC TROP MED H, V93, P32, DOI 10.1016/S0035-9203(99)90170-0; Horne DJ, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-258; HUSSEY G, 1991, PEDIATR INFECT DIS J, V10, P832, DOI 10.1097/00006454-199111000-00008; Jochem K, 1997, INT J TUBERC LUNG D, V1, P502; Jones KDJ, 2008, T ROY SOC TROP MED H, V102, P219, DOI 10.1016/j.trstmh.2007.11.014; Kang'ombe C, 2000, T ROY SOC TROP MED H, V94, P305, DOI 10.1016/S0035-9203(00)90335-3; Kang'ombe CT, 2004, INT J TUBERC LUNG D, V8, P829; Karim SSA, 2010, NEW ENGL J MED, V362, P697, DOI 10.1056/NEJMoa0905848; KASSIM S, 1995, AIDS, V9, P1185, DOI 10.1097/00002030-199510000-00011; Kelly PM, 1999, T ROY SOC TROP MED H, V93, P287, DOI 10.1016/S0035-9203(99)90025-1; Kim HJ, 2001, INT J TUBERC LUNG D, V5, P1129; Kolappan C, 2008, INT J TUBERC LUNG D, V12, P81; Korenromp EL, 2009, INT J TUBERC LUNG D, V13, P283; Lau KK, 2005, INT J TUBERC LUNG D, V9, P1391; Lawn SD, 2008, AM J RESP CRIT CARE, V177, P680, DOI 10.1164/rccm.200709-1311PP; Leroy V, 1997, AM J EPIDEMIOL, V145, P293; Lillebaek T, 1999, INT J TUBERC LUNG D, V3, P603; Low S, 2009, INT J TUBERC LUNG D, V13, P328; MAHER D, 2008, TUBERCULOSIS DEATHS; Malkin JE, 1997, INT J TUBERC LUNG D, V1, P68; Mathew TA, 2006, INT J TUBERC LUNG D, V10, P857; Moorman J, 1999, INT J TUBERC LUNG D, V3, P786; Mukadi YD, 2001, AIDS, V15, P143, DOI 10.1097/00002030-200101260-00002; Mwaungulu FBD, 2004, B WORLD HEALTH ORGAN, V82, P354; Najera-Ortiz JC, 2008, INT J EPIDEMIOL, V37, P786, DOI 10.1093/ije/dyn089; Noeske J, 2002, T ROY SOC TROP MED H, V96, P429, DOI 10.1016/S0035-9203(02)90383-4; Norval PY, 1998, INT J TUBERC LUNG D, V2, P44; NUNN P, 1992, AM REV RESPIR DIS, V146, P849, DOI 10.1164/ajrccm/146.4.849; OKWERA A, 1994, LANCET, V344, P1323, DOI 10.1016/S0140-6736(94)90693-9; Pai M, 2004, NATL MED J INDIA, V17, P86; Pardeshi Geeta, 2009, Indian J Med Sci, V63, P180, DOI 10.4103/0019-5359.53163; Park MM, 1996, AM J RESP CRIT CARE, V153, P317, DOI 10.1164/ajrccm.153.1.8542137; PERRIENS JH, 1995, NEW ENGL J MED, V332, P779, DOI 10.1056/NEJM199503233321204; PERRIENS JH, 1991, AM REV RESPIR DIS, V144, P750, DOI 10.1164/ajrccm/144.4.750; POLLOCK NR, 2009, INFECT CONTROL HOSP; Rothman KJ., 2008, MODERN EPIDEMIOLOGY; Sadacharam K, 2007, Indian J Tuberc, V54, P199; SAKURAI R, 1989, JPN J MED, V28, P471; SELBY C, 1995, RESP MED, V89, P369, DOI 10.1016/0954-6111(95)90010-1; Shen X, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-95; SMALL PM, 1991, NEW ENGL J MED, V324, P289, DOI 10.1056/NEJM199101313240503; Sophia Vijay, 2004, Indian Journal of Tuberculosis, V51, P199; Straetemans M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015241; Thomas A, 2005, INT J TUBERC LUNG D, V9, P556; Thulstrup AM, 2000, EPIDEMIOL INFECT, V124, P221, DOI 10.1017/S0950268899003593; Tiemersma EW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017601; UNAIDS, 2010, UNAIDS REP GLOB HIV; van den Broek J, 1998, INT J TUBERC LUNG D, V2, P547; Vree M, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-210; Walker E, 2008, CLEV CLIN J MED, V75, P431, DOI 10.3949/ccjm.75.6.431; Walpola HC, 2003, INT J TUBERC LUNG D, V7, P742; Wang G J, 2009, J Infect Public Health, V2, P112, DOI 10.1016/j.jiph.2009.07.003; Wang Jann-Tay, 2002, Journal of Microbiology Immunology and Infection, V35, P215; *WHO, 2009, GLOB TB CONTR 2009 E; *WHO, 2009, GLOB TUB CONTR SHORT; *WHO, 2011, GLOB TASK FORC TB IM; WHO, 1997, TREATM TUB GUID NAT, V2; Wilkinson D, 1996, S AFR MED J, V86, P64; Wilkinson D, 1998, J TROP PEDIATRICS, V44, P266, DOI 10.1093/tropej/44.5.266; Wood R, 2007, J INFECT DIS, V196, pS497, DOI 10.1086/521118; World Health Organization, 2003, TREATM TUB GUID NAT, DOI DOI 10.1016/S0035-9203(99)90185-2; World Health organization (WHO), 2008, GLOB TUB CONTR; XIE HJ, 1992, TUBERCLE LUNG DIS, V73, P77, DOI 10.1016/0962-8479(92)90059-S; Zachariah R, 2007, INT J TUBERC LUNG D, V11, P848	105	55	55	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e20755	10.1371/journal.pone.0020755	http://dx.doi.org/10.1371/journal.pone.0020755			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738585	gold, Green Published, Green Submitted			2022-12-27	WOS:000292092600008
J	Raida, MK; Nylen, J; Holten-Andersen, L; Buchmann, K				Raida, Martin K.; Nylen, Jorgen; Holten-Andersen, Lars; Buchmann, Kurt			Association between Plasma Antibody Response and Protection in Rainbow Trout Oncorhynchus mykiss Immersion Vaccinated against Yersinia ruckeri	PLOS ONE			English	Article							SALMO-GAIRDNERI RICHARDSON; VIBRIO-ANGUILLARUM; BACTERINS; IMMUNIZATION; IMMUNITY; WALBAUM; INFECTIONS; EFFICACY; DISEASE; FISH	A key hallmark of the vertebrate adaptive immune system is the generation of antigen-specific antibodies from B cells. Fish are the most primitive gnathostomes (jawed vertebrates) possessing an adaptive immune system. Vaccination of rainbow trout against enteric redmouth disease (ERM) by immersion in Yersinia ruckeri bacterin confers a high degree of protection to the fish. The immune mechanisms responsible for protection may comprise both cellular and humoral elements but the role of specific immunoglobulins in this system has been questioned and not previously described. The present study demonstrates significant increase in plasma antibody titers following immersion vaccination and significantly reduced mortality during Y. ruckeri challenge. Rainbow trout were immersion-vaccinated, using either a commercial ERM vaccine (AquaVac (TM) ERM vet) or an experimental Y. ruckeri bacterin. Half of the trout vaccinated with AquaVac (TM) ERM vet received an oral booster (AquaVac (TM) ERM Oral vet). Sub-groups of the fish from each group were subsequently exposed to 1x10(9) CFU Y. ruckeri/ml either eight or twenty-six weeks post vaccination (wpv). All vaccinated groups showed 0% mortality when challenged, which was highly significant compared to the non-vaccinated controls (40 and 28% mortality eight and twenty-six weeks post vaccination (wpv), respectively) (P < 0.0001). Plasma samples from all groups of vaccinated fish were taken 0, 4, 8, 12, 16 and 26 wpv. and Y. ruckeri specific IgM antibody levels were measured with ELISA. A significant increase in titers was recorded in vaccinated fish, which also showed a reduced bacteremia during challenge. In vitro plasma studies showed a significantly increased bactericidal effect of fresh plasma from vaccinated fish indicating that plasma proteins may play a role in protection of vaccinated rainbow trout.	[Raida, Martin K.; Holten-Andersen, Lars; Buchmann, Kurt] Univ Copenhagen, Dept Vet Dis Biol, Fac Life Sci, Frederiksberg, Denmark; [Nylen, Jorgen] Intervet Schering Plough Anim Hlth, Ballerup, Denmark	University of Copenhagen; Merck & Company; Schering Plough Corporation	Raida, MK (corresponding author), Univ Copenhagen, Dept Vet Dis Biol, Fac Life Sci, Frederiksberg, Denmark.	mkr@life.ku.dk		Buchmann, Kurt/0000-0002-2747-237X	Danish Agency for Science Technology and Innovation [274-07-0354]	Danish Agency for Science Technology and Innovation	This work was supported by the Danish Agency for Science Technology and Innovation Grant 274-07-0354. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMEND DF, 1983, J FISH DIS, V6, P337, DOI 10.1111/j.1365-2761.1983.tb00085.x; ANDERSON DP, 1985, AM ZOOL, V25, P75; CIPRIANO RC, 1987, J WILDLIFE DIS, V23, P545, DOI 10.7589/0090-3558-23.4.545; COSSARINIDUNIER M, 1986, J FISH DIS, V9, P27, DOI 10.1111/j.1365-2761.1986.tb00976.x; Fernandez L, 2007, VET MICROBIOL, V125, P1, DOI 10.1016/j.vetmic.2007.06.013; Fouz B, 2006, J FISH DIS, V29, P339, DOI 10.1111/j.1365-2761.2006.00723.x; HORNE MT, 1999, FISH DIS DISORDERS, V3, P455; HUNTER VA, 1980, J FISH DIS, V3, P467, DOI 10.1111/j.1365-2761.1980.tb00433.x; JOHNSON KA, 1983, J FISH DIS, V6, P331, DOI 10.1111/j.1365-2761.1983.tb00084.x; JOHNSON KA, 1982, J FISH DIS, V5, P207, DOI 10.1111/j.1365-2761.1982.tb00475.x; JOHNSON KA, 1983, J FISH DIS, V6, P473, DOI 10.1111/j.1365-2761.1983.tb00101.x; Larsen JL, 1997, DEV BIOLOGICALS, V90, P391; OLESEN NJ, 1991, J APPL ICHTHYOL, V7, P36, DOI 10.1111/j.1439-0426.1991.tb00592.x; Raida MK, 2008, VACCINE, V26, P1050, DOI 10.1016/j.vaccine.2007.12.029; Raida MK, 2008, FISH SHELLFISH IMMUN, V25, P533, DOI 10.1016/j.fsi.2008.07.008; Raida MK, 2009, DEV COMP IMMUNOL, V33, P35, DOI 10.1016/j.dci.2008.07.001; Ryckaert J, 2010, FISH SHELLFISH IMMUN, V29, P648, DOI 10.1016/j.fsi.2010.06.009; Stevenson RMW, 1997, DEV BIOLOGICALS, V90, P117; TATNER MF, 1987, AQUACULTURE, V62, P173, DOI 10.1016/0044-8486(87)90164-5; Tobback E, 2007, J FISH DIS, V30, P257, DOI 10.1111/j.1365-2761.2007.00816.x; Tobback E, 2009, DIS AQUAT ORGAN, V84, P219, DOI 10.3354/dao02057; TORROBA M, 1993, HISTOL HISTOPATHOL, V8, P363	22	51	51	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e18832	10.1371/journal.pone.0018832	http://dx.doi.org/10.1371/journal.pone.0018832			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21731605	Green Published, Green Submitted, gold			2022-12-27	WOS:000292036900001
J	Willett, CS				Willett, Christopher S.			Complex Deleterious Interactions Associated with Malic Enzyme May Contribute to Reproductive Isolation in the Copepod Tigriopus californicus	PLOS ONE			English	Article							DOBZHANSKY-MULLER INCOMPATIBILITIES; ELECTRON-TRANSPORT SYSTEM; CYTOCHROME-C GENOTYPES; HYBRID STERILITY; POPULATION DIFFERENTIATION; DROSOPHILA-MELANOGASTER; OUTBREEDING DEPRESSION; EPISTATIC INTERACTIONS; GENE CAUSES; EVOLUTION	Dobzhansky-Muller incompatibilities can result from the interactions of more than a single pair of interacting genes and there are several different models of how such complex interactions can be structured. Previous empirical work has identified complex conspecific epistasis as a form of complex interaction that has contributed to postzygotic reproductive isolation between taxa, but other forms of complexity are also possible. Here, I probe the genetic basis of reproductive isolation in crosses of the intertidal copepod Tigriopus californicus by looking at the impact of markers in genes encoding metabolic enzymes in F-2 hybrids. The region of the genome associated with the locus ME2 is shown to have strong, repeatable impacts on the fitness of hybrids in crosses and epistatic interactions with another chromosomal region marked by the GOT2 locus in one set of crosses. In a cross between one of these populations and a third population, these two regions do not appear to interact despite the continuation of a large effect of the ME2 region itself in both crosses. The combined results suggest that the ME2 chromosomal region is involved in incompatibilities with several unique partners. If these deleterious interactions all stem from the same factor in this region, that would suggest a different form of complexity from complex conspecific epistasis, namely, multiple independent deleterious interactions stemming from the same factor. Confirmation of this idea will require more fine-scale mapping of the interactions of the ME2 region of the genome.	Univ N Carolina, Dept Biol, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill	Willett, CS (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27515 USA.	willett4@email.unc.edu	Willett, Christopher/F-9443-2011	Willett, Christopher/0000-0002-9094-9265	National Science Foundation [DEB-0516139, DEB-0821003]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation grants DEB-0516139 and DEB-0821003 to CSW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbash DA, 2000, GENETICS, V154, P1747; Bordenstein SR, 2001, J EVOLUTION BIOL, V14, P490, DOI 10.1046/j.1420-9101.2001.00289.x; Brideau NJ, 2006, SCIENCE, V314, P1292, DOI 10.1126/science.1133953; Burton RS, 1998, EVOLUTION, V52, P734, DOI 10.1111/j.1558-5646.1998.tb03698.x; BURTON RS, 1987, EVOLUTION, V41, P504, DOI 10.1111/j.1558-5646.1987.tb05821.x; Burton RS, 1997, EVOLUTION, V51, P993, DOI 10.1111/j.1558-5646.1997.tb03681.x; BURTON RS, 1985, MAR BIOL, V86, P247, DOI 10.1007/BF00397511; CABOT EL, 1994, GENETICS, V137, P175; Chang AS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015377; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Coyne J.A., 2004, SPECIATION; Coyne JA, 1998, GENETICS, V150, P1091; Davis AW, 1996, GENETICS, V143, P1287; DAVIS AW, 1994, GENETICS, V137, P191; Demuth JP, 2007, EVOLUTION, V61, P494, DOI 10.1111/j.1558-5646.2007.00048.x; DILL MM, 1984, BIOCHEM GENET, V22, P339, DOI 10.1007/BF00484232; Edmands S, 1999, EVOLUTION, V53, P1757, DOI 10.1111/j.1558-5646.1999.tb04560.x; Edmands S, 2004, J EXP MAR BIOL ECOL, V303, P183, DOI 10.1016/j.jembe.2003.11.012; Edmands S, 2001, MOL ECOL, V10, P1743, DOI 10.1046/j.0962-1083.2001.01306.x; Edmands S, 2009, EVOLUTION, V63, P2184, DOI 10.1111/j.1558-5646.2009.00689.x; Fay JC, 2000, GENETICS, V155, P1405; FU YX, 1993, GENETICS, V133, P693; GANZ HH, 1995, MAR BIOL, V123, P821, DOI 10.1007/BF00349126; HALDANE JBS, 1964, J GENET, V59, P29, DOI 10.1007/BF02984134; Harrison JS, 2006, J EVOLUTION BIOL, V19, P2040, DOI 10.1111/j.1420-9101.2006.01145.x; Hoelzel A.R., 1992, P159; Johnson NA, 2010, TRENDS GENET, V26, P317, DOI 10.1016/j.tig.2010.04.005; Kondrashov AS, 2003, EVOLUTION, V57, P151; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Maside XR, 1998, GENETICS, V150, P745; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Moyle LC, 2009, GENETICS, V181, P347, DOI 10.1534/genetics.108.095679; Neff MM, 2002, TRENDS GENET, V18, P613, DOI 10.1016/S0168-9525(02)02820-2; ORR HA, 1995, GENETICS, V139, P1805; Orr HA, 2001, GENETICS, V158, P1089; Palmer CA, 2000, MAR BIOL, V136, P693, DOI 10.1007/s002270050729; PEREZ DE, 1995, GENETICS, V140, P201; Phadnis N, 2009, SCIENCE, V323, P376, DOI 10.1126/science.1163934; Presgraves DC, 2010, NAT REV GENET, V11, P175, DOI 10.1038/nrg2718; TAJIMA F, 1989, GENETICS, V123, P585; Tang SW, 2009, SCIENCE, V323, P779, DOI 10.1126/science.1169123; Wade MJ, 1999, EVOLUTION, V53, P855, DOI [10.2307/2640725, 10.1111/j.1558-5646.1999.tb05379.x]; Welch JJ, 2004, EVOLUTION, V58, P1145; Willett CS, 2007, J EVOLUTION BIOL, V20, P1196, DOI 10.1111/j.1420-9101.2006.01281.x; Willett CS, 2008, GENETICA, V133, P129, DOI 10.1007/s10709-007-9191-0; Willett CS, 2008, J HERED, V99, P56, DOI 10.1093/jhered/esm088; Willett CS, 2006, GENETICS, V173, P1465, DOI 10.1534/genetics.105.051011; Willett CS, 2011, GENETICA, V139, P575, DOI 10.1007/s10709-010-9525-1; Willett CS, 2010, EVOLUTION, V64, P2521, DOI 10.1111/j.1558-5646.2010.01008.x; Willett CS, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-139; Willett CS, 2004, MOL BIOL EVOL, V21, P443, DOI 10.1093/molbev/msh031; Willett CS, 2003, EVOLUTION, V57, P2286; Willett CS, 2001, EVOLUTION, V55, P1592; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	54	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21177	10.1371/journal.pone.0021177	http://dx.doi.org/10.1371/journal.pone.0021177			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731664	Green Published, Green Submitted, gold			2022-12-27	WOS:000292033700043
J	Lopes-dos-Santos, V; Conde-Ocazionez, S; Nicolelis, MAL; Ribeiro, ST; Tort, ABL				Lopes-dos-Santos, Vitor; Conde-Ocazionez, Sergio; Nicolelis, Miguel A. L.; Ribeiro, Sidarta T.; Tort, Adriano B. L.			Neuronal Assembly Detection and Cell Membership Specification by Principal Component Analysis	PLOS ONE			English	Article							ENSEMBLE ACTIVITY; SURROGATE-DATA; CORTICAL ACTIVITY; FIRING PATTERNS; SINGLE NEURONS; NETWORK; CORTEX; NONLINEARITY; HIPPOCAMPUS; SYNCHRONIZATION	In 1949, Donald Hebb postulated that assemblies of synchronously activated neurons are the elementary units of information processing in the brain. Despite being one of the most influential theories in neuroscience, Hebb's cell assembly hypothesis only started to become testable in the past two decades due to technological advances. However, while the technology for the simultaneous recording of large neuronal populations undergoes fast development, there is still a paucity of analytical methods that can properly detect and track the activity of cell assemblies. Here we describe a principal component-based method that is able to (1) identify all cell assemblies present in the neuronal population investigated, (2) determine the number of neurons involved in ensemble activity, (3) specify the precise identity of the neurons pertaining to each cell assembly, and (4) unravel the time course of the individual activity of multiple assemblies. Application of the method to multielectrode recordings of awake and behaving rats revealed that assemblies detected in the cerebral cortex and hippocampus typically contain overlapping neurons. The results indicate that the PCA method presented here is able to properly detect, track and specify neuronal assemblies, irrespective of overlapping membership.	[Lopes-dos-Santos, Vitor; Conde-Ocazionez, Sergio; Ribeiro, Sidarta T.; Tort, Adriano B. L.] Univ Fed Rio Grande do Norte, Inst Brain, BR-59072970 Natal, RN, Brazil; [Lopes-dos-Santos, Vitor; Conde-Ocazionez, Sergio; Nicolelis, Miguel A. L.; Ribeiro, Sidarta T.; Tort, Adriano B. L.] Edmond & Lily Safra Int Inst Neurosci Natal, Natal, RN, Brazil; [Nicolelis, Miguel A. L.] Duke Univ, Ctr Neuroengn, Durham, NC USA; [Nicolelis, Miguel A. L.] Duke Univ, Dept Neurobiol, Durham, NC USA	Universidade Federal do Rio Grande do Norte; Duke University; Duke University	Lopes-dos-Santos, V (corresponding author), Univ Fed Rio Grande do Norte, Inst Brain, BR-59072970 Natal, RN, Brazil.	vtlsantos@gmail.com; tort@neuro.ufrn.br	Tort, Adriano/A-9945-2009; Lopes-dos-Santos, Vítor/C-3541-2014; Ribeiro, Sidarta/C-5794-2016	Tort, Adriano/0000-0002-9877-7816; Lopes-dos-Santos, Vitor/0000-0002-1858-0125; Ribeiro, Sidarta/0000-0001-9325-9545; Conde-Ocazionez, Sergio/0000-0002-8290-5502	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Associacao Alberto Santos Dumont para Apoio a Pesquisa	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Associacao Alberto Santos Dumont para Apoio a Pesquisa	This work was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, and Associacao Alberto Santos Dumont para Apoio a Pesquisa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELES M, 1988, J NEUROPHYSIOL, V60, P909, DOI 10.1152/jn.1988.60.3.909; Abeles M, 2001, J NEUROSCI METH, V107, P141, DOI 10.1016/S0165-0270(01)00364-8; Abeles M, 1991, CORTICONICS NEURAL C; Benchenane K, 2010, NEURON, V66, P921, DOI 10.1016/j.neuron.2010.05.013; BERGER D, 2010, COMPUTATIONAL INTELL, DOI DOI 10.1155/2010/439648).HINDAWI; Berger D, 2007, NEUROCOMPUTING, V70, P2112, DOI 10.1016/j.neucom.2006.10.141; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Bowers JS, 2009, PSYCHOL REV, V116, P220, DOI 10.1037/a0014462; Brown EN, 2004, NAT NEUROSCI, V7, P456, DOI 10.1038/nn1228; Buzsaki G, 2004, NAT NEUROSCI, V7, P446, DOI 10.1038/nn1233; Buzsaki G, 2010, NEURON, V68, P362, DOI 10.1016/j.neuron.2010.09.023; Carmena Jose M, 2003, PLoS Biol, V1, pE42; Chapin JK, 1999, J NEUROSCI METH, V94, P121, DOI 10.1016/S0165-0270(99)00130-2; Freiwald W A, 2001, Prog Brain Res, V130, P111; Fries P, 2007, TRENDS NEUROSCI, V30, P309, DOI 10.1016/j.tins.2007.05.005; Gelbard-Sagiv H, 2008, SCIENCE, V322, P96, DOI 10.1126/science.1164685; Grun S, 2009, J NEUROPHYSIOL, V101, P1126, DOI 10.1152/jn.00093.2008; Grun S, 2002, NEURAL COMPUT, V14, P43, DOI 10.1162/089976602753284455; Harris KD, 2005, NAT REV NEUROSCI, V6, P399, DOI 10.1038/nrn1669; Harris KD, 2003, NATURE, V424, P552, DOI 10.1038/nature01834; Hebb Donald O., 1949, ORG BEHAV; Humphries MD, 2011, J NEUROSCI, V31, P2321, DOI 10.1523/JNEUROSCI.2853-10.2011; Hung CP, 2005, SCIENCE, V310, P863, DOI 10.1126/science.1117593; Ikegaya Y, 2004, SCIENCE, V304, P559, DOI 10.1126/science.1093173; KELEMEN E, 2010, PLOS BIOL, V8; Khoa TQD, 2008, J PHYSIOL SCI, V58, P47, DOI 10.2170/physiolsci.RP012707; Koch C, 1996, CEREB CORTEX, V6, P93, DOI 10.1093/cercor/6.2.93; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Leger JF, 2005, J NEUROPHYSIOL, V93, P281, DOI 10.1152/jn.00067.2003; LEVY WB, 1983, NEUROSCIENCE, V8, P791, DOI 10.1016/0306-4522(83)90010-6; LLOYD SP, 1982, IEEE T INFORM THEORY, V28, P129, DOI 10.1109/TIT.1982.1056489; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; Louis S, 2010, NEURAL NETWORKS, V23, P705, DOI 10.1016/j.neunet.2010.05.004; Maldonado P, 2008, J NEUROPHYSIOL, V100, P1523, DOI 10.1152/jn.00076.2008; Marcenko V. A., 1967, MATH USSR SB, V1, P457, DOI [10.1070/SM1967v001n04ABEH001994, DOI 10.1070/SM1967V001N04ABEH001994]; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; Mokeichev A, 2007, NEURON, V53, P413, DOI 10.1016/j.neuron.2007.01.017; Nicolelis MAL, 1997, NEURON, V19, P219, DOI 10.1016/S0896-6273(00)80932-0; Nicolelis MAL, 1998, NAT NEUROSCI, V1, P621, DOI 10.1038/2855; NICOLELIS MAL, 1995, SCIENCE, V268, P1353, DOI 10.1126/science.7761855; Nicolelis MAL, 1999, J NEUROSCI METH, V94, P3; Pastalkova E, 2008, SCIENCE, V321, P1322, DOI 10.1126/science.1159775; Perc M, 2008, BIOPHYS CHEM, V132, P33, DOI 10.1016/j.bpc.2007.10.002; Peyrache A, 2010, J COMPUT NEUROSCI, V29, P309, DOI 10.1007/s10827-009-0154-6; Peyrache A, 2009, NAT NEUROSCI, V12, P919, DOI 10.1038/nn.2337; Pikovsky A., 2001, SYNCHRONIZATION UNIV; Pipa G, 2008, J COMPUT NEUROSCI, V25, P64, DOI 10.1007/s10827-007-0065-3; Plerou V, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.066126; Pradhan N, 1996, PHYS REV E, V53, P2684, DOI 10.1103/PhysRevE.53.2684; Prut Y, 1998, J NEUROPHYSIOL, V79, P2857, DOI 10.1152/jn.1998.79.6.2857; Quiroga RQ, 2008, TRENDS COGN SCI, V12, P87, DOI 10.1016/j.tics.2007.12.003; Quiroga RQ, 2005, NATURE, V435, P1102, DOI 10.1038/nature03687; Ribeiro S, 2004, PLOS BIOL, V2, P126, DOI 10.1371/journal.pbio.0020024; Ribeiro S, 2007, FRONT NEUROSCI-SWITZ, V1, P43, DOI 10.3389/neuro.01.1.1.003.2007; Schneidman E, 2006, NATURE, V440, P1007, DOI 10.1038/nature04701; Schreiber T, 1999, PHYS REP, V308, P2, DOI 10.1016/S0370-1573(98)00035-0; Schreiber T, 1996, PHYS REV LETT, V77, P635, DOI 10.1103/PhysRevLett.77.635; Shmiel T, 2006, J NEUROPHYSIOL, V96, P2645, DOI 10.1152/jn.00798.2005; SINGER W, 1993, ANNU REV PHYSIOL, V55, P349, DOI 10.1146/annurev.physiol.55.1.349; Staude B, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00016; Staude B, 2010, J COMPUT NEUROSCI, V29, P327, DOI 10.1007/s10827-009-0195-x; Stevenson IH, 2011, NAT NEUROSCI, V14, P139, DOI 10.1038/nn.2731; Tetko IV, 2001, J NEUROSCI METH, V105, P1, DOI 10.1016/S0165-0270(00)00336-8; THEILER J, 1992, PHYSICA D, V58, P77, DOI 10.1016/0167-2789(92)90102-S; Volman V, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/4/043013; Wallenstein GV, 1998, TRENDS NEUROSCI, V21, P317, DOI 10.1016/S0166-2236(97)01220-4; Wang QY, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0015851, 10.1371/journal.pone.0021006]; Wang QY, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.026206; Waydo S, 2006, J NEUROSCI, V26, P10232, DOI 10.1523/JNEUROSCI.2101-06.2006; Wessberg J, 2000, NATURE, V408, P361, DOI 10.1038/35042582; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520	75	57	58	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e20996	10.1371/journal.pone.0020996	http://dx.doi.org/10.1371/journal.pone.0020996			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698248	gold, Green Published			2022-12-27	WOS:000291730000037
J	Nityananda, V; Bee, MA				Nityananda, Vivek; Bee, Mark A.			Finding Your Mate at a Cocktail Party: Frequency Separation Promotes Auditory Stream Segregation of Concurrent Voices in Multi-Species Frog Choruses	PLOS ONE			English	Article							HYLA-VERSICOLOR; TONE SEQUENCES; SONGBIRD FOREBRAIN; GREY TREEFROGS; PERCEPTUAL ORGANIZATION; BEHAVIORAL MEASURES; SCENE ANALYSIS; CALL DURATION; RECOGNITION; PREFERENCES	Vocal communication in crowded social environments is a difficult problem for both humans and nonhuman animals. Yet many important social behaviors require listeners to detect, recognize, and discriminate among signals in a complex acoustic milieu comprising the overlapping signals of multiple individuals, often of multiple species. Humans exploit a relatively small number of acoustic cues to segregate overlapping voices (as well as other mixtures of concurrent sounds, like polyphonic music). By comparison, we know little about how nonhuman animals are adapted to solve similar communication problems. One important cue enabling source segregation in human speech communication is that of frequency separation between concurrent voices: differences in frequency promote perceptual segregation of overlapping voices into separate "auditory streams" that can be followed through time. In this study, we show that frequency separation (Delta F) also enables frogs to segregate concurrent vocalizations, such as those routinely encountered in mixed-species breeding choruses. We presented female gray treefrogs (Hyla chrysoscelis) with a pulsed target signal (simulating an attractive conspecific call) in the presence of a continuous stream of distractor pulses (simulating an overlapping, unattractive heterospecific call). When the Delta F between target and distractor was small (e.g., <= 3 semitones), females exhibited low levels of responsiveness, indicating a failure to recognize the target as an attractive signal when the distractor had a similar frequency. Subjects became increasingly more responsive to the target, as indicated by shorter latencies for phonotaxis, as the Delta F between target and distractor increased (e.g., Delta F = 6-12 semitones). These results support the conclusion that gray treefrogs, like humans, can exploit frequency separation as a perceptual cue to segregate concurrent voices in noisy social environments. The ability of these frogs to segregate concurrent voices based on frequency separation may involve ancient hearing mechanisms for source segregation shared with humans and other vertebrates.	[Nityananda, Vivek; Bee, Mark A.] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Nityananda, V (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, London, England.	mbee@umn.edu	Bee, Mark A/A-9410-2013	Bee, Mark A/0000-0002-6770-9730; Nityananda, Vivek/0000-0002-2878-2425	NIDCD [DC009582]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009582] Funding Source: NIH RePORTER	NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by NIDCD DC009582 (http://www.nidcd.nih.gov/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alder TB, 1998, NAT NEUROSCI, V1, P519, DOI 10.1038/2237; ASSMANN PF, 1999, P 14 INT C PHON SCI, P179; Bee MA, 2005, BRAIN BEHAV EVOLUT, V66, P197, DOI 10.1159/000087854; Bee MA, 2004, J NEUROPHYSIOL, V92, P1088, DOI 10.1152/jn.00884.2003; Bee MA, 2008, ANIM BEHAV, V76, P845, DOI 10.1016/j.anbehav.2008.01.029; Bee MA, 2008, J COMP PSYCHOL, V122, P235, DOI 10.1037/0735-7036.122.3.235; Bee MA, 2008, ANIM BEHAV, V75, P1781, DOI 10.1016/j.anbehav.2007.10.032; Bee MA, 2010, J COMP PHYSIOL A, V196, P543, DOI 10.1007/s00359-010-0542-4; Bee MA, 2010, ETHOLOGY, V116, P564, DOI 10.1111/j.1439-0310.2010.01773.x; Bee MA, 2009, J ACOUST SOC AM, V126, P2788, DOI 10.1121/1.3224707; Bird J., 1998, PSYCHOPHYSICAL PHYSL, P263; Bregman A.S., 1990, AUDITORY SCENE ANAL; BROKX JPL, 1982, J PHONETICS, V10, P23, DOI 10.1016/S0095-4470(19)30909-X; Bush SL, 2002, ANIM BEHAV, V63, P7, DOI 10.1006/anbe.2001.1880; Capranica RR, 1983, ADV VERTEBRATE NEURO, P701, DOI DOI 10.1007/978-1-4684-4412-4_36; Carlyon RP, 2004, TRENDS COGN SCI, V8, P465, DOI 10.1016/j.tics.2004.08.008; CHERRY EC, 1953, J ACOUST SOC AM, V25, P975, DOI 10.1121/1.1907229; COCROFT RB, 1995, ANIM BEHAV, V49, P283, DOI 10.1006/anbe.1995.0043; Darwin CJ, 1997, TRENDS COGN SCI, V1, P327, DOI 10.1016/S1364-6613(97)01097-8; Edwards CJ, 2002, NAT NEUROSCI, V5, P934, DOI 10.1038/nn916; Elliott L., 2009, FROGS TOADS N AM COM; Endepols H, 2003, BEHAV BRAIN RES, V145, P63, DOI 10.1016/S0166-4328(03)00098-6; Fay Richard R., 2008, V29, P307; Fay RR, 2000, HEARING RES, V149, P1, DOI 10.1016/S0378-5955(00)00168-4; Fay RR, 1998, HEARING RES, V120, P69, DOI 10.1016/S0378-5955(98)00058-6; Fishman YI, 2004, J ACOUST SOC AM, V116, P1656, DOI 10.1121/1.1778903; Fishman YI, 2001, HEARING RES, V151, P167, DOI 10.1016/S0378-5955(00)00224-0; Gerhardt HC, 2005, ANIM BEHAV, V70, P39, DOI 10.1016/j.anbehav.2004.09.021; Gerhardt HC, 2000, BEHAV ECOL, V11, P663, DOI 10.1093/beheco/11.6.663; Gerhardt HC., 2002, ACOUSTIC COMMUNICATI; HILLERY CM, 1984, COPEIA, P844; HILLERY CM, 1982, J COMP PHYSIOL, V146, P435, DOI 10.1007/BF00609440; HILLERY CM, 1984, HEARING RES, V14, P129, DOI 10.1016/0378-5955(84)90012-1; Howard RD, 1998, ANIM BEHAV, V55, P1165, DOI 10.1006/anbe.1997.0683; Hulse SH, 2002, ADV STUD BEHAV, V31, P163, DOI 10.1016/S0065-3454(02)80008-0; Izumi A, 2002, COGNITION, V82, pB113, DOI 10.1016/S0010-0277(01)00161-5; Larson KA, 2004, COPEIA, P676; Ma L, 2010, J COMP PSYCHOL, V124, P317, DOI 10.1037/a0018273; MacDougall-Shackleton SA, 1998, J ACOUST SOC AM, V103, P3581, DOI 10.1121/1.423063; Marshall VT, 2006, ANIM BEHAV, V72, P449, DOI 10.1016/j.anbehav.2006.02.001; McDermott JH, 2009, CURR BIOL, V19, pR1024, DOI 10.1016/j.cub.2009.09.005; MEGELA AL, 1983, J COMP PHYSIOL, V151, P423, DOI 10.1007/BF00605458; Micheyl C, 2005, NEURON, V48, P139, DOI 10.1016/j.neuron.2005.08.039; Moore BCJ, 2002, ACTA ACUST UNITED AC, V88, P320; NARINS PM, 1995, SCI AM, V273, P78, DOI 10.1038/scientificamerican0895-78; Narins PM, 2007, HEARING SOUND COMMUN; Popper AN, 1997, BRAIN BEHAV EVOLUT, V50, P213; Pressnitzer D, 2008, CURR BIOL, V18, P1124, DOI 10.1016/j.cub.2008.06.053; PTACEK MB, 1994, EVOLUTION, V48, P898, DOI 10.1111/j.1558-5646.1994.tb01370.x; Schul J, 2002, P ROY SOC B-BIOL SCI, V269, P1847, DOI 10.1098/rspb.2002.2092; Schwartz JJ, 2001, BEHAV ECOL SOCIOBIOL, V49, P443, DOI 10.1007/s002650100317; Shamma SA, 2010, CURR OPIN NEUROBIOL, V20, P361, DOI 10.1016/j.conb.2010.03.009; Swanson EM, 2007, CAN J ZOOL, V85, P921, DOI 10.1139/Z07-074; Yost W. A., 2008, AUDITORY PERCEPTION; Zakon H.H., 1988, P125	55	33	33	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e21191	10.1371/journal.pone.0021191	http://dx.doi.org/10.1371/journal.pone.0021191			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	778TS	21698268	Green Published, gold			2022-12-27	WOS:000291730000059
J	Ye, L; Mayberry, R; Lo, CY; Britt, KL; Stanley, EG; Elefanty, AG; Gargett, CE				Ye, Louie; Mayberry, Robyn; Lo, Camden Y.; Britt, Kara L.; Stanley, Edouard G.; Elefanty, Andrew G.; Gargett, Caroline E.			Generation of Human Female Reproductive Tract Epithelium from Human Embryonic Stem Cells	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; HUMAN ENDOMETRIUM; DIRECTED DIFFERENTIATION; PROGESTERONE-RECEPTOR; MULLERIAN DUCT; GROWTH-FACTOR; IN-VITRO; EXPRESSION; MOUSE; MICE	Background: Recent studies have identified stem/progenitor cells in human and mouse uterine epithelium, which are postulated to be responsible for tissue regeneration and proliferative disorders of human endometrium. These progenitor cells are thought to be derived from Mullerian duct (MD), the primordial female reproductive tract (FRT). Methodology/Principal Findings: We have developed a model of human reproductive tract development in which inductive neonatal mouse uterine mesenchyme (nMUM) is recombined with green fluorescent protein (GFP)-tagged human embryonic stem cells (hESCs); GFP-hESC (ENVY). We demonstrate for the first time that hESCs can be differentiated into cells with a human FRT epithelial cell phenotype. hESC derived FRT epithelial cells emerged from cultures containing MIXL1(+) mesendodermal precursors, paralleling events occurring during normal organogenesis. Following transplantation, nMUM treated embryoid bodies (EBs) generated epithelial structures with a typical MD phenotype that expressed the MD markers PAX2, HOXA10. Functionally, the hESCs derived FRT epithelium responded to exogenous estrogen by proliferating and secreting uterine-specific glycodelin A (GdA). Conclusions/Significance: These data show nMUM can induce differentiation of hESC to form the FRT epithelium. This may provide a model to study early developmental events of the human FRT.	[Ye, Louie; Gargett, Caroline E.] Monash Univ, Ritchie Ctr, Monash Inst Med Res, Melbourne, Vic 3004, Australia; [Ye, Louie; Gargett, Caroline E.] Monash Univ, Dept Obstet & Gynecol, Melbourne, Vic 3004, Australia; [Mayberry, Robyn; Stanley, Edouard G.; Elefanty, Andrew G.] Monash Univ, Monash Immunol & Stem Cell Labs, Melbourne, Vic 3004, Australia	Monash University; Monash University; Monash University	Ye, L (corresponding author), Monash Univ, Ritchie Ctr, Monash Inst Med Res, Melbourne, Vic 3004, Australia.	caroline.gargett@monash.edu	Gargett, Caroline Eve/I-4895-2019; Britt, Kara/A-5568-2009; Stanley, Ed G/A-2985-2013; Britt, Kara/B-2437-2013; Gargett, Caroline E/Q-7911-2019; Elefanty, Andrew G/A-6066-2008	Stanley, Ed G/0000-0002-6389-3665; Britt, Kara/0000-0001-6069-7856; Gargett, Caroline E/0000-0002-3590-2077; Lo, Camden/0000-0002-6215-2363; Elefanty, Andrew/0000-0001-6448-8314				Barberini F, 2007, ARCH HISTOL CYTOL, V70, P21, DOI 10.1679/aohc.70.21; Batchelder CA, 2009, DIFFERENTIATION, V78, P45, DOI 10.1016/j.diff.2009.05.001; BIGSBY RM, 1986, AM J PHYSIOL, V251, pE630, DOI 10.1152/ajpendo.1986.251.5.E630; BISCHOF P, 1993, EUR J OBSTET GYN R B, V49, P93, DOI 10.1016/0028-2243(93)90131-U; Chan RWS, 2006, STEM CELLS, V24, P1529, DOI 10.1634/stemcells.2005-0411; Chan RWS, 2004, BIOL REPROD, V70, P1738, DOI 10.1095/biolreprod.103.024109; Couse JF, 2001, ANN NY ACAD SCI, V948, P1; Cunha G R, 1987, Prog Clin Biol Res, V239, P273; CUNHA GR, 1976, J EXP ZOOL, V196, P361, DOI 10.1002/jez.1401960310; Daftary GS, 2007, FERTIL STERIL, V87, P367, DOI 10.1016/j.fertnstert.2006.06.041; Dai W, 2007, J MOL CELL CARDIOL, V43, P504, DOI 10.1016/j.yjmcc.2007.07.001; Funayama N, 1999, DEVELOPMENT, V126, P4129; Gadue P, 2006, P NATL ACAD SCI USA, V103, P16806, DOI 10.1073/pnas.0603916103; Gargett CE, 2007, HUM REPROD UPDATE, V13, P87, DOI 10.1093/humupd/dml045; Gargett CE, 2008, MOL CELL ENDOCRINOL, V288, P22, DOI 10.1016/j.mce.2008.02.026; GARGETT CE, 2009, BIOL REPROD; Hatzistavrou T, 2009, NAT METHODS, V6, P659, DOI [10.1038/nmeth.1364, 10.1038/NMETH.1364]; Hu JB, 2004, BIOL REPROD, V70, P1870, DOI 10.1095/biolreprod.103.026336; HUBBARD SA, REPRODUCTION, V140, P23; KAITUULINO TJ, ENDOCRINOLOGY, V151, P3386; Kishi Y, 2008, CELL TRANSPLANT, V17, P1095, DOI 10.3727/096368908786991560; Klattig J, 2007, SEX DEV, V1, P271, DOI 10.1159/000108929; Kobayashi A, 2003, NAT REV GENET, V4, P969, DOI 10.1038/nrg1225; Kurita T, 2005, DIFFERENTIATION, V73, P313, DOI 10.1111/j.1432-0436.2005.00033.x; Kurita T, 2000, BIOL REPROD, V62, P821, DOI 10.1095/biolreprod62.4.831; Kurita T, 2001, DEV BIOL, V240, P194, DOI 10.1006/dbio.2001.0458; LAIRD SM, 1995, HUM REPROD, V10, P1346, DOI 10.1093/HUMREP/10.6.1346; LYDON JP, 1995, GENE DEV, V9, P2266, DOI 10.1101/gad.9.18.2266; MASUDA H, PLOS ONE, V5; Mazal PR, 2005, MODERN PATHOL, V18, P535, DOI 10.1038/modpathol.3800320; Merjava S, 2009, EXP EYE RES, V89, P426, DOI 10.1016/j.exer.2009.04.009; MOSER FG, 1975, J CELL BIOL, V66, P676, DOI 10.1083/jcb.66.3.676; Mummery C, 2003, CIRCULATION, V107, P2733, DOI 10.1161/01.CIR.0000068356.38592.68; Ng ES, 2008, NAT PROTOC, V3, P768, DOI 10.1038/nprot.2008.42; Ng ES, 2005, BLOOD, V106, P1601, DOI 10.1182/blood-2005-03-0987; Nicholas CR, 2009, HUM MOL GENET, V18, P4376, DOI 10.1093/hmg/ddp393; Okada A, 2004, J MOL ENDOCRINOL, V32, P615, DOI 10.1677/jme.0.0320615; Okada Akinobu, 2005, Journal of Toxicological Sciences, V30, P75, DOI 10.2131/jts.30.75; Oottamasathien S, 2007, DEV BIOL, V304, P556, DOI 10.1016/j.ydbio.2007.01.010; Orvis GD, 2007, DEV BIOL, V306, P493, DOI 10.1016/j.ydbio.2007.03.027; Pick M, 2007, STEM CELLS, V25, P2206, DOI 10.1634/stemcells.2006-0713; Przyborski SA, 2005, STEM CELLS, V23, P1242, DOI 10.1634/stemcells.2005-0014; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Seppala M, 2002, ENDOCR REV, V23, P401, DOI 10.1210/er.2001-0026; Simon L, 2009, STEM CELLS, V27, P1666, DOI 10.1002/stem.93; Stoikos CJ, 2008, HUM REPROD, V23, P1447, DOI 10.1093/humrep/den110; Takeyama J, 2001, J CLIN ENDOCR METAB, V86, P2258, DOI 10.1210/jc.86.5.2258; Taylor RA, 2006, NAT METHODS, V3, P179, DOI 10.1038/nmeth855; ten Berge D, 2008, CELL STEM CELL, V3, P508, DOI 10.1016/j.stem.2008.09.013; Tong GX, 2007, MODERN PATHOL, V20, P856, DOI 10.1038/modpathol.3800827; Torres M, 1995, DEVELOPMENT, V121, P4057; Tulac S, 2003, J CLIN ENDOCR METAB, V88, P3860, DOI 10.1210/jc.2003-030494; WANG T, 1989, ARCH GYNECOL OBSTET, V246, P169, DOI 10.1007/BF00934078; Wang Y, 2008, DIFFERENTIATION, V76, P1081, DOI 10.1111/j.1432-0436.2008.00295.x; Wei QX, 2009, FERTIL STERIL, V91, P1686, DOI 10.1016/j.fertnstert.2008.02.121; Wiles MV, 1999, EXP CELL RES, V247, P241, DOI 10.1006/excr.1998.4353; ZABAGLO L, J CLIN PATHOL, V63, P800; Zhang Y, 2007, AM J RESP CELL MOL, V36, P515, DOI 10.1165/rcmb.2006-0475RC	58	32	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e21136	10.1371/journal.pone.0021136	http://dx.doi.org/10.1371/journal.pone.0021136			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698266	Green Published, gold			2022-12-27	WOS:000291730000055
J	Ke, L; Meijering, RAM; Hoogstra-Berends, F; Mackovicova, K; Vos, MJ; Van Gelder, IC; Henning, RH; Kampinga, HH; Brundel, BJJM				Ke, Lei; Meijering, Roelien A. M.; Hoogstra-Berends, Femke; Mackovicova, Katarina; Vos, Michel J.; Van Gelder, Isabelle C.; Henning, Robert H.; Kampinga, Harm H.; Brundel, Bianca J. J. M.			HSPB1, HSPB6, HSPB7 and HSPB8 Protect against RhoA GTPase-Induced Remodeling in Tachypaced Atrial Myocytes	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; ALPHA-B-CRYSTALLIN; PHOSPHORYLATION; ACTIN; CYTOSKELETON; STRESS; HSP25; OVEREXPRESSION; LOCALIZATION; DYSFUNCTION	Background: We previously demonstrated the small heat shock protein, HSPB1, to prevent tachycardia remodeling in in vitro and in vivo models for Atrial Fibrillation (AF). To gain insight into its mechanism of action, we examined the protective effect of all 10 members of the HSPB family on tachycardia remodeling. Furthermore, modulating effects of HSPB on RhoA GTPase activity and F-actin stress fiber formation were examined, as this pathway was found of prime importance in tachycardia remodeling events and the initiation of AF. Methods and Results: Tachypacing (4 Hz) of HL-1 atrial myocytes significantly and progressively reduced the amplitude of Ca2+ transients (CaT). In addition to HSPB1, also overexpression of HSPB6, HSPB7 and HSPB8 protected against tachypacinginduced CaT reduction. The protective effect was independent of HSPB1. Moreover, tachypacing induced RhoA GTPase activity and caused F-actin stress fiber formation. The ROCK inhibitor Y27632 significantly prevented tachypacing-induced Factin formation and CaT reductions, showing that RhoA activation is required for remodeling. Although all protective HSPB members prevented the formation of F-actin stress fibers, their mode of action differs. Whilst HSPB1, HSPB6 and HSPB7 acted via direct prevention of F-actin formation, HSPB8-protection was mediated via inhibition of RhoA GTPase activity. Conclusion: Overexpression of HSPB1, as well as HSPB6, HSPB7 and HSPB8 independently protect against tachycardia remodeling by attenuation of the RhoA GTPase pathway at different levels. The cardioprotective role for multiple HSPB members indicate a possible therapeutic benefit of compounds able to boost the expression of single or multiple members of the HSPB family.	[Ke, Lei; Vos, Michel J.; Kampinga, Harm H.] Univ Groningen, Dept Radiat & Stress Cell Biol, Univ Inst Drug Explorat GUIDE, Univ Med Ctr Groningen, Groningen, Netherlands; [Meijering, Roelien A. M.; Hoogstra-Berends, Femke; Mackovicova, Katarina; Henning, Robert H.; Brundel, Bianca J. J. M.] Univ Groningen, Dept Clin Pharmacol, GUIDE, Univ Med Ctr Groningen, Groningen, Netherlands; [Hoogstra-Berends, Femke] Nyken BV, Groningen, Netherlands; [Van Gelder, Isabelle C.] Univ Groningen, Dept Cardiol, GUIDE, Univ Med Ctr Groningen, Utrecht, Netherlands; [Van Gelder, Isabelle C.] Interuniv Cardiol Inst Netherlands, Utrecht, Netherlands	University of Groningen; University of Groningen; University of Groningen; Interuniversity Cardiology Institute of the Netherlands; Utrecht University	Ke, L (corresponding author), Univ Groningen, Dept Radiat & Stress Cell Biol, Univ Inst Drug Explorat GUIDE, Univ Med Ctr Groningen, Groningen, Netherlands.	B.J.J.M.Brundel@med.umcg.nl	Henning, Robert H/AAY-5222-2020	Vos, Michel/0000-0001-9379-2219; Kampinga, Harm/0000-0002-8966-8466; Henning, Robert/0000-0002-5135-4621	Dutch Organization for Scientific Research (NWO) [916.46.043]; Dutch Heart Foundation [2007B217]; EFRO; Ubbo Emmius Bursaal grant [800403]	Dutch Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Dutch Heart Foundation(Netherlands Heart Foundation); EFRO; Ubbo Emmius Bursaal grant	This study was supported by the Dutch Organization for Scientific Research (NWO program grant 916.46.043), Dutch Heart Foundation (2007B217), EFRO grant (Operationeel Programma Noord-Nederland 2007-2013 (OP-EFRO), Drug delivery en targeting cluster) and Ubbo Emmius Bursaal grant (UMCG Number 800403). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Femke Hoogstra-Berends, a technician employed by Nyken BV, helped with execution of experiments. The funder Nyken BV played a role in this study as an employer of Femke Hoogstra-Berends.	Adam O, 2007, J AM COLL CARDIOL, V50, P359, DOI 10.1016/j.jacc.2007.03.041; Brown JH, 2006, CIRC RES, V98, P730, DOI 10.1161/01.RES.0000216039.75913.9e; Brundel BJJM, 2006, CIRC RES, V99, P1394, DOI 10.1161/01.RES.0000252323.83137.fe; Brundel BJJM, 2006, J MOL CELL CARDIOL, V41, P555, DOI 10.1016/j.yjmcc.2006.06.068; Brundel BJJM, 2004, CARDIOVASC RES, V62, P521, DOI 10.1016/j.cardiores.2004.02.007; Bryantsev AL, 2002, CELL STRESS CHAPERON, V7, P146, DOI 10.1379/1466-1268(2002)007<0146:DPAAOH>2.0.CO;2; Carra S, 2008, J BIOL CHEM, V283, P1437, DOI 10.1074/jbc.M706304200; Carra S, 2010, J BIOL CHEM, V285, P37811, DOI 10.1074/jbc.M110.127498; Carra S, 2009, J BIOL CHEM, V284, P5523, DOI 10.1074/jbc.M807440200; Dobrev D, 2010, LANCET, V375, P1212, DOI 10.1016/S0140-6736(10)60096-7; Fan GC, 2004, CIRC RES, V94, P1474, DOI 10.1161/01.RES.0000129179.66631.00; FAN GC, 2010, J MOL CELL IN PRESS; Golenhofen N, 2004, HISTOCHEM CELL BIOL, V122, P415, DOI 10.1007/s00418-004-0711-z; Hoch B, 1996, MOL CELL BIOCHEM, V161, P231, DOI 10.1007/BF00240054; Janmey PA, 1998, PHYSIOL REV, V78, P763, DOI 10.1152/physrev.1998.78.3.763; Johnson BD, 2005, P NATL ACAD SCI USA, V102, P4191, DOI 10.1073/pnas.0409695102; Kampinga HH, 2009, CELL STRESS CHAPERON, V14, P105, DOI 10.1007/s12192-008-0068-7; Kappe G, 2003, CELL STRESS CHAPERON, V8, P53, DOI 10.1379/1466-1268(2003)8<53:THGECS>2.0.CO;2; Kerfant BG, 2001, CIRC RES, V88, pE59, DOI 10.1161/hh0701.090462; Krief S, 1999, J BIOL CHEM, V274, P36592, DOI 10.1074/jbc.274.51.36592; Landry J, 1995, BIOCHEM CELL BIOL, V73, P703, DOI 10.1139/o95-078; LAVOIE JN, 1995, MOL CELL BIOL, V15, P505, DOI 10.1128/MCB.15.1.505; Leach RN, 2005, CELL CALCIUM, V38, P515, DOI 10.1016/j.ceca.2005.07.006; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Ogata T, 2008, MOL CELL BIOL, V28, P3424, DOI 10.1128/MCB.02186-07; Paredes RM, 2008, METHODS, V46, P143, DOI 10.1016/j.ymeth.2008.09.025; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Reil JC, 2010, CARDIOVASC RES, V87, P485, DOI 10.1093/cvr/cvq079; Sah VP, 1999, J CLIN INVEST, V103, P1627, DOI 10.1172/JCI6842; Sanbe A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005351; Simon S, 2007, J BIOL CHEM, V282, P34276, DOI 10.1074/jbc.M703267200; Sui XZ, 2009, CIRC RES, V104, P887, DOI 10.1161/CIRCRESAHA.108.192328; Sun XK, 2004, J BIOL CHEM, V279, P2394, DOI 10.1074/jbc.M311324200; Vos MJ, 2008, BIOCHEMISTRY-US, V47, P7001, DOI 10.1021/bi800639z; Vos MJ, 2011, AUTOPHAGY, V7, P101, DOI 10.4161/auto.7.1.13935; Vos MJ, 2010, HUM MOL GENET, V19, P4677, DOI 10.1093/hmg/ddq398; VOS MJ, 2009, THESIS; VOS MJ, 2010, AUTOPHAGY, V7, P1	38	65	66	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e20395	10.1371/journal.pone.0020395	http://dx.doi.org/10.1371/journal.pone.0020395			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21731611	Green Published, gold, Green Submitted			2022-12-27	WOS:000292036900003
J	Rigden, DJ; Woodhead, DD; Wong, PWH; Galperin, MY				Rigden, Daniel J.; Woodhead, Duncan D.; Wong, Prudence W. H.; Galperin, Michael Y.			New Structural and Functional Contexts of the Dx[DN]xDG Linear Motif: Insights into Evolution of Calcium-Binding Proteins	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; ACTIN-ASSOCIATED PROTEIN; BIEDL-SYNDROME PROTEINS; CRYSTAL-STRUCTURE; EF-HAND; PHOSPHOLIPASE-D; SITES; RECOGNITION; SUBTILISIN; DOMAIN	Binding of calcium ions (Ca2+) to proteins can have profound effects on their structure and function. Common roles of calcium binding include structure stabilization and regulation of activity. It is known that diverse families - EF-hands being one of at least twelve - use a Dx[DN]xDG linear motif to bind calcium in near-identical fashion. Here, four novel structural contexts for the motif are described. Existing experimental data for one of them, a thermophilic archaeal subtilisin, demonstrate for the first time a role for Dx[DN]xDG-bound calcium in protein folding. An integrin-like embedding of the motif in the blade of a beta-propeller fold - here named the calcium blade - is discovered in structures of bacterial and fungal proteins. Furthermore, sensitive database searches suggest a common origin for the calcium blade in b-propeller structures of different sizes and a pan-kingdom distribution of these proteins. Factors favouring the multiple convergent evolution of the motif appear to include its general Asp-richness, the regular spacing of the Asp residues and the fact that change of Asp into Gly and vice versa can occur though a single nucleotide change. Among the known structural contexts for the Dx[DN] xDG motif, only the calcium blade and the EF-hand are currently found intracellularly in large numbers, perhaps because the higher extracellular concentration of Ca2+ allows for easier fixing of newly evolved motifs that have acquired useful functions. The analysis presented here will inform ongoing efforts toward prediction of similar calcium-binding motifs from sequence information alone.	[Rigden, Daniel J.; Woodhead, Duncan D.] Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England; [Wong, Prudence W. H.] Univ Liverpool, Dept Comp Sci, Liverpool, Merseyside, England; [Galperin, Michael Y.] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20892 USA	University of Liverpool; University of Liverpool; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Rigden, DJ (corresponding author), Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England.	drigden@liv.ac.uk	Galperin, Michael Y./B-5859-2013	Galperin, Michael Y./0000-0002-2265-5572; Rigden, Daniel/0000-0002-7565-8937; Wong, Prudence W.H./0000-0001-7935-7245	Biotechnology and Biological Sciences Research Council; National Institutes of Health at the National Library of Medicine	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institutes of Health at the National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	Biotechnology and Biological Sciences Research Council studentship (DDW); National Institutes of Health Intramural Research Program at the National Library of Medicine (MYG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adany R, 2003, CELL MOL LIFE SCI, V60, P1049, DOI 10.1007/s00018-003-2178-9; Alba MM, 1999, J MOL EVOL, V49, P789, DOI 10.1007/PL00006601; Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; Andreini C, 2008, J BIOL INORG CHEM, V13, P1205, DOI 10.1007/s00775-008-0404-5; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; BAUMANN U, 1993, EMBO J, V12, P3357, DOI 10.1002/j.1460-2075.1993.tb06009.x; BEARER EL, 1992, J NEUROSCI, V12, P750; Bearer EL, 2000, ANN HUM GENET, V64, P189, DOI 10.1046/j.1469-1809.2000.6430189.x; Bearer EL, 1999, EUR J CELL BIOL, V78, P117, DOI 10.1016/S0171-9335(99)80013-2; Beurg M, 2009, NAT NEUROSCI, V12, P553, DOI 10.1038/nn.2295; BORDO D, 1991, J MOL BIOL, V217, P721, DOI 10.1016/0022-2836(91)90528-E; Brakoulias A, 2004, PROTEINS, V56, P250, DOI 10.1002/prot.20123; Bronner F, 2001, ScientificWorldJournal, V1, P919; Caines MEC, 2008, J BIOL CHEM, V283, P31279, DOI 10.1074/jbc.C800150200; Carafoli E, 2002, P NATL ACAD SCI USA, V99, P1115, DOI 10.1073/pnas.032427999; CARAFOLI E, CALCIUM CELLULAR REG; Chaudhuri I, 2008, PROTEINS, V71, P795, DOI 10.1002/prot.21764; Cioci G, 2006, J MOL BIOL, V357, P1575, DOI 10.1016/j.jmb.2006.01.066; Dragani B, 1999, ARCH BIOCHEM BIOPHYS, V368, P211, DOI 10.1006/abbi.1999.1312; Dutta A, 2010, STRUCTURE, V18, P1140, DOI 10.1016/j.str.2010.06.013; Eddy Sean R, 2009, Genome Inform, V23, P205; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edwards RJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000967; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Fiscella M, 2003, NAT BIOTECHNOL, V21, P302, DOI 10.1038/nbt797; Gahmberg CG, 2009, BBA-GEN SUBJECTS, V1790, P431, DOI 10.1016/j.bbagen.2009.03.007; GANGOLA P, 1987, J BIOL CHEM, V262, P12570; Gattiker Alexandre, 2002, Appl Bioinformatics, V1, P107; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; Gould CM, 2010, NUCLEIC ACIDS RES, V38, pD167, DOI 10.1093/nar/gkp1016; Grabarek Z, 2006, J MOL BIOL, V359, P509, DOI 10.1016/j.jmb.2006.03.066; Graveley BR, 2000, RNA, V6, P1197, DOI 10.1017/S1355838200000960; Harding MM, 2006, ACTA CRYSTALLOGR D, V62, P678, DOI 10.1107/S0907444906014594; Harris TW, 2010, NUCLEIC ACIDS RES, V38, pD463, DOI 10.1093/nar/gkp952; Heinig M, 2004, NUCLEIC ACIDS RES, V32, pW500, DOI 10.1093/nar/gkh429; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hoskins BE, 2003, HUM MUTAT, V22, P151, DOI 10.1002/humu.10241; Johnson LS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-431; Kawasaki H, 1998, BIOMETALS, V11, P277, DOI 10.1023/A:1009282307967; Kleywegt GJ, 1999, J MOL BIOL, V285, P1887, DOI 10.1006/jmbi.1998.2393; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P842, DOI 10.1107/S0907444995016477; KRETSINGER RH, 1976, ANNU REV BIOCHEM, V45, P239, DOI 10.1146/annurev.bi.45.070176.001323; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Kurakata Y, 2008, J MOL BIOL, V381, P116, DOI 10.1016/j.jmb.2008.05.061; Kvansakul M, 2004, EMBO J, V23, P1223, DOI 10.1038/sj.emboj.7600166; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Li JY, 1999, ARCH BIOCHEM BIOPHYS, V361, P142, DOI 10.1006/abbi.1998.0969; LI JY, 1994, J BIOL CHEM, V269, P28963; Li N, 2010, MOL MICROBIOL, V76, P861, DOI 10.1111/j.1365-2958.2010.07123.x; Liu OW, 2008, CELL, V135, P174, DOI 10.1016/j.cell.2008.07.046; MCPHALEN CA, 1991, ADV PROTEIN CHEM, V42, P77; Mykytyn K, 2004, TRENDS MOL MED, V10, P106, DOI 10.1016/j.molmed.2004.01.003; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Neduva V, 2005, PLOS BIOL, V3, P2090, DOI 10.1371/journal.pbio.0030405; Nitz M, 2004, ANGEW CHEM INT EDIT, V43, P3682, DOI 10.1002/anie.200460028; Ochiai A, 2007, J BIOL CHEM, V282, P37134, DOI 10.1074/jbc.M704663200; Orans J, 2010, P NATL ACAD SCI USA, V107, P1065, DOI 10.1073/pnas.0911616107; Petosa C, 1997, NATURE, V385, P833, DOI 10.1038/385833a0; Pidcock E, 2001, J BIOL INORG CHEM, V6, P479, DOI 10.1007/s007750100214; Praetorius HA, 2001, J MEMBRANE BIOL, V184, P71, DOI 10.1007/s00232-001-0075-4; Redruello B, 2010, GENE, V456, P1, DOI 10.1016/j.gene.2010.02.003; Richard GF, 2000, EMBO REP, V1, P122, DOI 10.1093/embo-reports/kvd031; Rigden DJ, 2004, J MOL BIOL, V343, P971, DOI 10.1016/j.jmb.2004.08.077; Rigden DJ, 2003, TRENDS MICROBIOL, V11, P295, DOI 10.1016/S0966-842X(03)00153-7; Rigden DJ, 2003, FEMS MICROBIOL LETT, V221, P103, DOI 10.1016/S0378-1097(03)00160-5; Rose PW, 2011, NUCLEIC ACIDS RES, V39, pD392, DOI 10.1093/nar/gkq1021; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Seo SJ, 2009, HUM MOL GENET, V18, P1323, DOI 10.1093/hmg/ddp031; Shah AS, 2008, P NATL ACAD SCI USA, V105, P3380, DOI 10.1073/pnas.0712327105; Shinde U, 1996, ADV EXP MED BIOL, V379, P147; Smith R J, 1995, Adv Microb Physiol, V37, P83, DOI 10.1016/S0065-2911(08)60144-7; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Sprangers R, 2003, J MOL BIOL, V327, P507, DOI 10.1016/S0022-2836(03)00148-7; STRYNADKA NCJ, 1989, ANNU REV BIOCHEM, V58, P951, DOI 10.1146/annurev.bi.58.070189.004511; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; Suzuki R, 2009, J BIOCHEM, V146, P389, DOI 10.1093/jb/mvp086; Takeuchi Y, 2009, BIOCHEMISTRY-US, V48, P10637, DOI 10.1021/bi901334b; Tanaka SI, 2007, J MOL BIOL, V372, P1055, DOI 10.1016/j.jmb.2007.07.027; Tanaka SI, 2007, J BIOL CHEM, V282, P8246, DOI 10.1074/jbc.M610137200; Torrance JW, 2008, PROTEINS, V71, P813, DOI 10.1002/prot.21741; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wells RD, 1996, J BIOL CHEM, V271, P2875, DOI 10.1074/jbc.271.6.2875; Wheeler DL, 2007, NUCLEIC ACIDS RES, V35, pD5, DOI 10.1093/nar/gkl1031; Wilson MA, 2000, J MOL BIOL, V301, P1237, DOI 10.1006/jmbi.2000.4029; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Yadid I, 2010, P NATL ACAD SCI USA, V107, P7287, DOI 10.1073/pnas.0912616107; Ye YM, 2003, PROTEIN ENG, V16, P429, DOI 10.1093/protein/gzg051; Ye YM, 2001, PROTEIN ENG, V14, P1001, DOI 10.1093/protein/14.12.1001; Yuan P, 2010, SCIENCE, V329, P182, DOI 10.1126/science.1190414	92	42	43	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21507	10.1371/journal.pone.0021507	http://dx.doi.org/10.1371/journal.pone.0021507			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21720552	gold, Green Submitted, Green Published			2022-12-27	WOS:000292036900046
J	Takagi, T; Ishii, K; Shibata, S; Yasuda, A; Sato, M; Nagoshi, N; Saito, H; Okano, HJ; Toyama, Y; Okano, H; Nakamura, M				Takagi, Takehiko; Ishii, Ken; Shibata, Shinsuke; Yasuda, Akimasa; Sato, Momoka; Nagoshi, Narihito; Saito, Harukazu; Okano, Hirotaka J.; Toyama, Yoshiaki; Okano, Hideyuki; Nakamura, Masaya			Schwann-Spheres Derived from Injured Peripheral Nerves in Adult Mice - Their In Vitro Characterization and Therapeutic Potential	PLOS ONE			English	Article							SPINAL-CORD-INJURY; PLURIPOTENT STEM-CELLS; FUNCTIONAL RECOVERY; LOCOMOTOR RECOVERY; PROGENITOR CELLS; NERVOUS-SYSTEM; AXONAL GROWTH; SELF-RENEWAL; GLIAL-CELLS; TRANSPLANTATION	Multipotent somatic stem cells have been identified in various adult tissues. However, the stem/progenitor cells of the peripheral nerves have been isolated only from fetal tissues. Here, we isolated Schwann-cell precursors/immature Schwann cells from the injured peripheral nerves of adult mice using a floating culture technique that we call "Schwann-spheres." The Schwann-spheres were derived from de-differentiated mature Schwann cells harvested 24 hours to 6 weeks after peripheral nerve injury. They had extensive self-renewal and differentiation capabilities. They strongly expressed the immature-Schwann- cell marker p75, and differentiated only into the Schwann-cell lineage. The spheres showed enhanced myelin formation and neurite growth compared to mature Schwann cells in vitro. Mature Schwann cells have been considered a promising candidate for cell-transplantation therapies to repair the damaged nervous system, whereas these "Schwann-spheres" would provide a more potential autologous cell source for such transplantation.	[Takagi, Takehiko; Ishii, Ken; Yasuda, Akimasa; Sato, Momoka; Toyama, Yoshiaki; Nakamura, Masaya] Keio Univ, Sch Med, Dept Orthopaed Surg, Tokyo, Japan; [Takagi, Takehiko; Shibata, Shinsuke; Yasuda, Akimasa; Sato, Momoka; Okano, Hirotaka J.; Okano, Hideyuki] Keio Univ, Sch Med, Dept Physiol, Tokyo 160, Japan; [Sato, Momoka] Keio Univ, Ctr Integrated Med Res, Tokyo, Japan; [Nagoshi, Narihito; Saito, Harukazu] Natl Hosp Org, Murayama Med Ctr, Dept Orthopaed Surg, Tokyo, Japan	Keio University; Keio University; Keio University	Takagi, T (corresponding author), Keio Univ, Sch Med, Dept Orthopaed Surg, Tokyo, Japan.	hidokano@sc.itc.keio.ac.jp; masa@sc.itc.keio.ac.jp	Shibata, Shinsuke/AAM-6620-2020; Nakamura, Masaya/K-4111-2013; Okano, Hideyuki/I-7584-2019; Toyama, Yoshiaki/K-5743-2013	ISHII, KEN/0000-0003-0094-7918; Okano, Hirotaka James/0000-0003-4611-7098	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Japan Science and Technology Corporation (JST); General Insurance Association of Japan; Keio University; Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Corporation (JST)(Japan Science & Technology Agency (JST)); General Insurance Association of Japan; Keio University; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by grants from the Leading Project for Realization of Regenerative Medicine from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, from the Japan Science and Technology Corporation (JST), and from the General Insurance Association of Japan. This work was also supported by a Keio University grant-in-aid for the encouragement of young medical scientists, by grants-in-aid for scientific research from MEXT, Japan, by a grant-in-aid for research fellowship for young scientists from the Japan Society for the Promotion of Science, and by a grant-in-aid from the Global COE Program of MEXT, Japan to Keio University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUAYO AJ, 1981, J EXP BIOL, V95, P231; Agudo M, 2008, GLIA, V56, P1263, DOI 10.1002/glia.20695; Amoh Y, 2005, P NATL ACAD SCI USA, V102, P5530, DOI 10.1073/pnas.0501263102; Amoh Y, 2005, P NATL ACAD SCI USA, V102, P17734, DOI 10.1073/pnas.0508440102; Amoh Y, 2008, CELL CYCLE, V7, P1865, DOI 10.4161/cc.7.12.6056; Amoh Y, 2009, J CELL BIOCHEM, V107, P1016, DOI 10.1002/jcb.22204; Biernaskie J, 2007, J NEUROSCI, V27, P9545, DOI 10.1523/JNEUROSCI.1930-07.2007; Casella CTB, 1996, GLIA, V17, P327, DOI 10.1002/(SICI)1098-1136(199608)17:4<327::AID-GLIA7>3.0.CO;2-W; Chau CH, 2004, FASEB J, V18, P194, DOI 10.1096/fj.03-0196fje; Cummings BJ, 2005, P NATL ACAD SCI USA, V102, P14069, DOI 10.1073/pnas.0507063102; Fernandes KJL, 2004, NAT CELL BIOL, V6, P1082, DOI 10.1038/ncb1181; Fortun J, 2009, NEUROSCI LETT, V456, P124, DOI 10.1016/j.neulet.2008.08.092; Fouad K, 2005, J NEUROSCI, V25, P1169, DOI 10.1523/JNEUROSCI.3562-04.2005; Golden KL, 2007, EXP NEUROL, V207, P203, DOI 10.1016/j.expneurol.2007.06.023; Grimpe B, 2005, MOL CELL NEUROSCI, V28, P18, DOI 10.1016/j.mcn.2004.06.010; Haastert K, 2007, NAT PROTOC, V2, P99, DOI 10.1038/nprot.2006.486; Hill CE, 2006, GLIA, V53, P338, DOI 10.1002/glia.20287; Hisahara S, 2000, EMBO J, V19, P341, DOI 10.1093/emboj/19.3.341; Hood B, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/FOC.2009.26.2.E4; Hoshikawa S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003464; Iwanami A, 2005, J NEUROSCI RES, V80, P182, DOI 10.1002/jnr.20436; Iwashita Y, 2000, EXP NEUROL, V164, P292, DOI 10.1006/exnr.2000.7440; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; Jones LL, 2001, J PHYSIOL-LONDON, V533, P83, DOI 10.1111/j.1469-7793.2001.0083b.x; Kawaguchi A, 2001, MOL CELL NEUROSCI, V17, P259, DOI 10.1006/mcne.2000.0925; Kawamoto S, 2000, FEBS LETT, V470, P263, DOI 10.1016/S0014-5793(00)01338-7; Kohyama J, 2008, P NATL ACAD SCI USA, V105, P18012, DOI 10.1073/pnas.0808417105; Kuhlbrodt K, 1998, J NEUROSCI, V18, P237, DOI 10.1523/jneurosci.18-01-00237.1998; Kulbatski I, 2008, PROG HISTOCHEM CYTO, V43, P123, DOI 10.1016/j.proghi.2008.04.001; Kumagai G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007706; Li LN, 2003, P NATL ACAD SCI USA, V100, P9958, DOI 10.1073/pnas.1733025100; Liu F, 2011, CELL CYCLE, V10, P830, DOI 10.4161/cc.10.5.14969; McKenzie IA, 2006, J NEUROSCI, V26, P6651, DOI 10.1523/JNEUROSCI.1007-06.2006; Mirsky R, 2002, J PHYSIOL-PARIS, V96, P17, DOI 10.1016/S0928-4257(01)00076-6; Miura K, 2009, NAT BIOTECHNOL, V27, P743, DOI 10.1038/nbt.1554; Molteni R, 2004, P NATL ACAD SCI USA, V101, P8473, DOI 10.1073/pnas.0401443101; Morrison SJ, 1999, CELL, V96, P737, DOI 10.1016/S0092-8674(00)80583-8; Nagoshi N, 2008, CELL STEM CELL, V2, P392, DOI 10.1016/j.stem.2008.03.005; Nakamura M, 2005, J NEUROSCI RES, V81, P457, DOI 10.1002/jnr.20580; Ogawa Y, 2002, J NEUROSCI RES, V69, P925, DOI 10.1002/jnr.10341; Pearse DD, 2004, NAT MED, V10, P610, DOI 10.1038/nm1056; Plant GW, 2001, MOL CELL NEUROSCI, V17, P471, DOI 10.1006/mcne.2000.0948; Stolt CC, 2004, DEVELOPMENT, V131, P2349, DOI 10.1242/dev.01114; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takami T, 2002, J NEUROSCI, V22, P6670; Toma JG, 2001, NAT CELL BIOL, V3, P778, DOI 10.1038/ncb0901-778; Tsuji O, 2010, P NATL ACAD SCI USA, V107, P12704, DOI 10.1073/pnas.0910106107; Vukojevic K, 2010, GENE EXPR PATTERNS, V10, P144, DOI 10.1016/j.gep.2009.12.001; Weidner N, 1999, J COMP NEUROL, V413, P495, DOI 10.1002/(SICI)1096-9861(19991101)413:4<495::AID-CNE1>3.0.CO;2-Z; Wernig M, 2008, P NATL ACAD SCI USA, V105, P5856, DOI 10.1073/pnas.0801677105; WIDERA D, 2011, STEM CELLS IN PRESS; Wong CE, 2006, J CELL BIOL, V175, P1005, DOI 10.1083/jcb.200606062; Xu XM, 1999, EUR J NEUROSCI, V11, P1723, DOI 10.1046/j.1460-9568.1999.00591.x; Yoshida S, 2006, STEM CELLS, V24, P2714, DOI 10.1634/stemcells.2006-0156	54	8	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21497	10.1371/journal.pone.0021497	http://dx.doi.org/10.1371/journal.pone.0021497			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21720551	Green Published, Green Submitted, gold			2022-12-27	WOS:000292036900044
J	Wang, WH; Liu, YF; Su, CC; Su, MC; Li, SY; Yang, JJ				Wang, Wen-Hung; Liu, Yu-Fan; Su, Ching-Chyuan; Su, Mao-Chang; Li, Shuan-Yow; Yang, Jiann-Jou			A Novel Missense Mutation in the Connexin30 Causes Nonsyndromic Hearing Loss	PLOS ONE			English	Article							GAP-JUNCTION CONNEXINS; ENCODING CONNEXIN-26; LARGE DELETION; GENE MUTATION; DEAFNESS; GJB2; EXPRESSION; MOUSE; PHOSPHORYLATION; IDENTIFICATION	Dysfunctional gap junctions caused by GJB2 (CX26) and GJB6 (CX30) mutations are implicated in nearly half of nonsyndromic hearing loss cases. A recent study identified a heterozygous mutation, c.119C>T (p.A40V), in the GJB6 gene of patients with nonsyndromic hearing loss. However, the functional role of the mutation in hearing loss remains unclear. In this study, analyses of cell biology indicated that a p.A40V missense mutation of CX30 causes CX30 protein accumulation in the Golgi body rather than in the cytoplasmic membrane. The tet-on protein expression system was used for further study of mutant proteins in CX30 and CX30A40V co-expressions and in CX26 and CX30A40V co-expressions. The p.A40V missense mutation exerted a dominant negative effect on both normal CX30 and CX26, which impaired gap junction formation. Moreover, computer-assisted modeling suggested that this p.A40V mutation affects the intra molecular interaction in the hydrophobic core of Trp44, which significantly alters the efficiency of gap junction formation. These findings suggest that the p.A40V mutation in CX30 causes autosomal-dominant nonsyndromic hearing loss. These data provide a novel molecular explanation for the role of GJB6 in hearing loss.	[Wang, Wen-Hung] Chang Gung Univ, Coll Med, Dept Otolaryngol, Chang Gung Mem Hosp Chiayi, Gueishan, Taoyuan County, Taiwan; [Liu, Yu-Fan; Li, Shuan-Yow; Yang, Jiann-Jou] Chung Shan Med Univ, Dept Biomed Sci, Taichung, Taiwan; [Liu, Yu-Fan; Li, Shuan-Yow; Yang, Jiann-Jou] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Su, Ching-Chyuan] Tian Sheng Mem Hosp, Dept Cardiovasc Surg, Tong Kang, Pin Tong, Taiwan; [Su, Mao-Chang] Chung Shan Med Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Taichung, Taiwan; [Su, Mao-Chang] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Su, Mao-Chang] Chung Shan Med Univ, Dept Speech Language Pathol & Audiol, Taichung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University	Wang, WH (corresponding author), Chang Gung Univ, Coll Med, Dept Otolaryngol, Chang Gung Mem Hosp Chiayi, Gueishan, Taoyuan County, Taiwan.	syl@csmu.edu.tw; jiannjou@csmu.edu.tw	Yang, Jiann-Jou/E-9502-2011	Yang, Jiann-Jou/0000-0002-9019-2178	National Science Council, Republic of China [NSC 98-2320-B-040-012-MY3, NSC 98-2320-B-040-016-MY3]; National Science Council; Ministry of Education; Chung Shan Medical University	National Science Council, Republic of China(Ministry of Science and Technology, Taiwan); National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Education; Chung Shan Medical University	This work is supported by National Science Council, Republic of China (NSC 98-2320-B-040-012-MY3; NSC 98-2320-B-040-016-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Wei-Chi Chen for his technical assistance, and Ted Knoy is acknowledged for his editorial assistance. Fluorescence microscope was performed in the Instrument Center of Chung Shan Medical University, which is supported by National Science Council, Ministry of Education, and Chung Shan Medical University.	Ahmad S, 2003, BIOCHEM BIOPH RES CO, V307, P362, DOI 10.1016/S0006-291X(03)01166-5; Apps SA, 2007, INT J AUDIOL, V46, P75, DOI 10.1080/14992020600582190; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Beyer Eric C., 2009, P3, DOI 10.1007/978-1-59745-489-6_1; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Bruzzone R, 1996, EUR J BIOCHEM, V238, P1, DOI 10.1111/j.1432-1033.1996.0001q.x; del Castillo FJ, 2005, J MED GENET, V42, P588, DOI 10.1136/jmg.2004.028324; del Castillo I, 2002, NEW ENGL J MED, V346, P243, DOI 10.1056/NEJMoa012052; del Castillo I, 2003, AM J HUM GENET, V73, P1452, DOI 10.1086/380205; Dinh EH, 2009, BRAIN RES, V1277, P52, DOI 10.1016/j.brainres.2009.02.008; EVANS WH, 1994, BIOCHEM SOC T, V22, P788, DOI 10.1042/bst0220788; Falk MM, 1997, EMBO J, V16, P2703, DOI 10.1093/emboj/16.10.2703; FALK MM, 1994, J CELL BIOL, V127, P343, DOI 10.1083/jcb.127.2.343; Feldmann D, 2004, AM J MED GENET A, V127A, P263, DOI 10.1002/ajmg.a.20588; Forge A, 2003, J COMP NEUROL, V467, P207, DOI 10.1002/cne.10916; GILULA NB, 1972, NATURE, V235, P262, DOI 10.1038/235262a0; Grifa A, 1999, NAT GENET, V23, P16, DOI 10.1038/12612; Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269; Hong HM, 2010, HUM GENET, V127, P191, DOI 10.1007/s00439-009-0758-y; Junne T, 2006, MOL BIOL CELL, V17, P4063, DOI 10.1091/mbc.E06-03-0200; Kelsell DP, 1997, NATURE, V387, P80, DOI 10.1038/387080a0; KIKUCHI T, 1994, ACTA OTO-LARYNGOL, V114, P520, DOI 10.3109/00016489409126097; KIKUCHI T, 1995, ANAT EMBRYOL, V191, P101, DOI 10.1007/BF00186783; Kleopa KA, 2002, J NEUROSCI RES, V68, P522, DOI 10.1002/jnr.10255; Kumar NM, 1996, CELL, V84, P381, DOI 10.1016/S0092-8674(00)81282-9; Laird DW, 2006, BIOCHEM J, V394, P527, DOI 10.1042/BJ20051922; LAIRD DW, 1995, J CELL BIOL, V131, P1193, DOI 10.1083/jcb.131.5.1193; Lamartine J, 2000, NAT GENET, V26, P142, DOI 10.1038/79851; Lautermann J, 1999, DEV GENET, V25, P306, DOI 10.1002/(SICI)1520-6408(1999)25:4<306::AID-DVG4>3.0.CO;2-R; Lautermann J, 1998, CELL TISSUE RES, V294, P415, DOI 10.1007/s004410051192; LEUBE RE, 1995, J CELL SCI, V108, P883; Maeda S, 2009, NATURE, V458, P597, DOI 10.1038/nature07869; MAKOWSKI L, 1977, J CELL BIOL, V74, P629, DOI 10.1083/jcb.74.2.629; Martin PEM, 2000, CURR TOP MEMBR, V49, P461; Marziano NK, 2003, HUM MOL GENET, V12, P805, DOI 10.1093/hmg/ddg076; Melo F, 1998, J MOL BIOL, V277, P1141, DOI 10.1006/jmbi.1998.1665; Montgomery JR, 2004, J AM ACAD DERMATOL, V51, P377, DOI 10.1016/j.jaad.2003.12.042; MORTON NE, 1991, ANN NY ACAD SCI, V630, P16, DOI 10.1111/j.1749-6632.1991.tb19572.x; MUSIL LS, 1991, J CELL BIOL, V115, P1357, DOI 10.1083/jcb.115.5.1357; Nickel Regina, 2009, P419, DOI 10.1007/978-1-59745-489-6_20; Pallares-Ruiz N, 2002, EUR J HUM GENET, V10, P72, DOI 10.1038/sj.ejhg.5200762; Peitsch MC, 2002, BIOINFORMATICS, V18, P934, DOI 10.1093/bioinformatics/18.7.934; Petit C, 1996, NAT GENET, V14, P385, DOI 10.1038/ng1296-385; Qu CY, 2009, EXP CELL RES, V315, P1683, DOI 10.1016/j.yexcr.2009.03.001; Richard G, 2002, AM J HUM GENET, V70, P1341, DOI 10.1086/339986; Sanchez HA, 2010, J GEN PHYSIOL, V136, P47, DOI 10.1085/jgp.201010433; Sasin JM, 2004, NUCLEIC ACIDS RES, V32, pW586, DOI 10.1093/nar/gkh440; SCHULTE BA, 1994, HEARING RES, V78, P65, DOI 10.1016/0378-5955(94)90045-0; Spicer SS, 1998, HEARING RES, V118, P1, DOI 10.1016/S0378-5955(98)00006-9; Tang HY, 2006, AM J MED GENET A, V140A, P2401, DOI 10.1002/ajmg.a.31525; White TW, 1996, J BIOENERG BIOMEMBR, V28, P339, DOI 10.1007/BF02110110; Willecke K, 2002, BIOL CHEM, V383, P725, DOI 10.1515/BC.2002.076; Yang JJ, 2007, AUDIOL NEURO-OTOL, V12, P198, DOI 10.1159/000099024; Yang JJ, 2010, HUM GENET, V128, P303, DOI 10.1007/s00439-010-0856-x; Yum SW, 2002, NEUROBIOL DIS, V11, P43, DOI 10.1006/nbdi.2002.0545; Zhou XW, 1997, BIOPHYS J, V72, P1946, DOI 10.1016/S0006-3495(97)78840-4	56	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21473	10.1371/journal.pone.0021473	http://dx.doi.org/10.1371/journal.pone.0021473			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21731760	gold, Green Published, Green Submitted			2022-12-27	WOS:000292036900036
J	De Angelis, G; Moschioni, M; Muzzi, A; Pezzicoli, A; Censini, S; Delany, I; Lo Sapio, M; Sinisi, A; Donati, C; Masignani, V; Barocchi, MA				De Angelis, Gabriella; Moschioni, Monica; Muzzi, Alessandro; Pezzicoli, Alfredo; Censini, Stefano; Delany, Isabel; Lo Sapio, Morena; Sinisi, Antonia; Donati, Claudio; Masignani, Vega; Barocchi, Michele A.			The Streptococcus pneumoniae Pilus-1 Displays a Biphasic Expression Pattern	PLOS ONE			English	Article							RLRA PATHOGENICITY ISLET; PHASE VARIATION; PNEUMOCOCCAL PILUS; HAEMOPHILUS-INFLUENZAE; ANTIGENIC VARIATION; VIRULENCE FACTORS; SEQUENCE REPEATS; NASOPHARYNGEAL; CARRIAGE; PROTEIN	The Streptococcus pneumoniae pilus-1 is encoded by pilus islet 1 (PI-1), which has three clonal variants (clade I, II and III) and is present in about 30% of clinical pneumococcal isolates. In vitro and in vivo assays have demonstrated that pilus-1 is involved in attachment to epithelial cells and virulence, as well as protection in mouse models of infection. Several reports suggest that pilus-1 expression is tightly regulated and involves the interplay of numerous genetic regulators, including the PI-1 positive regulator RlrA. In this report we provide evidence that pilus expression, when analyzed at the single-cell level in PI-1 positive strains, is biphasic. In fact, the strains present two phenotypically different sub-populations of bacteria, one that expresses the pilus, while the other does not. The proportions of these two phenotypes are variable among the strains tested and are not influenced by genotype, serotype, growth conditions, colony morphology or by the presence of antibodies directed toward the pilus components. Two sub-populations, enriched in pilus expressing or not expressing bacteria were obtained by means of colony selection and immuno-detection methods for five strains. PI-1 sequencing in the two sub-populations revealed the absence of mutations, thus indicating that the biphasic expression observed is not due to a genetic modification within PI-1. Microarray expression profile and western blot analyses on whole bacterial lysates performed comparing the two enriched sub-populations, revealed that pilus expression is regulated at the transcriptional level (on/off regulation), and that there are no other genes, in addition to those encoded by PI-1, concurrently regulated across the strains tested. Finally, we provide evidence that the over-expression of the RrlA positive regulator is sufficient to induce pilus expression in pilus-1 negative bacteria. Overall, the data presented here suggest that the observed biphasic pilus expression phenotype could be an example of bistability in pneumococcus.	[De Angelis, Gabriella; Moschioni, Monica; Muzzi, Alessandro; Pezzicoli, Alfredo; Censini, Stefano; Delany, Isabel; Lo Sapio, Morena; Sinisi, Antonia; Donati, Claudio; Masignani, Vega; Barocchi, Michele A.] Novartis Vaccines & Diagnost, Siena, Italy	Novartis	De Angelis, G (corresponding author), Novartis Vaccines & Diagnost, Siena, Italy.	michele.barocchi@novartis.com	Donati, Claudio/J-5180-2012; Muzzi, Alessandro/J-6200-2012; Donati, Claudio/AAF-1246-2020	Donati, Claudio/0000-0001-8688-1651	Novartis Vaccines and Diagnostics	Novartis Vaccines and Diagnostics	The study was completely funded by Novartis Vaccines and Diagnostics. No other external funding was used for this study. The funder had a role in deciding the topic (S. pneumoniae) but had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHEN MG, 1986, GENE, V45, P45, DOI 10.1016/0378-1119(86)90130-7; Aguiar SI, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-41; Arai J, 2011, J CLIN MICROBIOL, V49, P1646, DOI 10.1128/JCM.01990-10; Auranen K, 2010, AM J EPIDEMIOL, V171, P169, DOI 10.1093/aje/kwp351; Bagnoli F, 2008, J BACTERIOL, V190, P5480, DOI 10.1128/JB.00384-08; Barocchi MA, 2006, P NATL ACAD SCI USA, V103, P2857, DOI 10.1073/pnas.0511017103; Basset A, 2007, J CLIN MICROBIOL, V45, P1684, DOI 10.1128/JCM.00265-07; Dave S, 2001, INFECT IMMUN, V69, P3435, DOI 10.1128/IAI.69.5.3435-3437.2001; Dubnau D, 2006, MOL MICROBIOL, V61, P564, DOI 10.1111/j.1365-2958.2006.05249.x; El Mortaji L, 2010, J BIOL CHEM, V285, P12405, DOI 10.1074/jbc.M109.082776; Falker S, 2008, MOL MICROBIOL, V70, P595, DOI 10.1111/j.1365-2958.2008.06396.x; Fletcher MA, 2007, VACCINE, V25, P2507, DOI 10.1016/j.vaccine.2006.09.027; Garcia-Suarez MDM, 2006, ENFERM INFEC MICR CL, V24, P512, DOI 10.1157/13092469; Gianfaldoni C, 2007, INFECT IMMUN, V75, P1059, DOI 10.1128/IAI.01400-06; Givon-Lavi N, 1999, CLIN INFECT DIS, V29, P1274, DOI 10.1086/313465; Greenberg D, 2004, J CLIN MICROBIOL, V42, P4604, DOI 10.1128/JCM.42.10.4604-4609.2004; Hava DL, 2003, J BACTERIOL, V185, P413, DOI 10.1128/JB.185.2.413-421.2003; Hemsley C, 2003, J BACTERIOL, V185, P6640, DOI 10.1128/JB.185.22.6640-6647.2003; Hilleringmann M, 2009, EMBO J, V28, P3921, DOI 10.1038/emboj.2009.360; Izore T, 2010, STRUCTURE, V18, P106, DOI 10.1016/j.str.2009.10.019; Janulczyk R, 2010, J BACTERIOL, V192, P3990, DOI 10.1128/JB.01465-09; Jedrzejas MJ, 2001, MICROBIOL MOL BIOL R, V65, P187, DOI 10.1128/MMBR.65.2.187-207.2001; Kim KS, 2010, LANCET INFECT DIS, V10, P32, DOI 10.1016/S1473-3099(09)70306-8; Kloosterman TG, 2006, MICROBIOL-SGM, V152, P351, DOI 10.1099/mic.0.28521-0; LeMieux J, 2006, INFECT IMMUN, V74, P2453, DOI 10.1128/IAI.74.4.2453-2456.2006; LeMieux J, 2008, J BACTERIOL, V190, P6002, DOI 10.1128/JB.00379-08; Lipsitch M, 2007, J INFECT DIS, V196, P1221, DOI 10.1086/521831; Manzano C, 2008, STRUCTURE, V16, P1838, DOI 10.1016/j.str.2008.10.007; Melchiorre S, 2009, CLIN MICROBIOL INFEC; Moschioni M, 2008, J INFECT DIS, V197, P888, DOI 10.1086/528375; Muzzi A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003660; Nakata M, 2009, INFECT IMMUN, V77, P32, DOI 10.1128/IAI.00772-08; Neiers F, 2009, J MOL BIOL, V393, P704, DOI 10.1016/j.jmb.2009.08.058; Nelson AL, 2007, MOL MICROBIOL, V66, P329, DOI 10.1111/j.1365-2958.2007.05908.x; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Overweg K, 2000, INFECT IMMUN, V68, P4604, DOI 10.1128/IAI.68.8.4604-4610.2000; Pelton SI, 2009, PEDIATR INFECT DIS J, V28, pS133, DOI 10.1097/INF.0b013e3181b6d81a; Polissi A, 1998, INFECT IMMUN, V66, P5620, DOI 10.1128/IAI.66.12.5620-5629.1998; Puopolo KM, 2003, MOL MICROBIOL, V50, P977, DOI 10.1046/j.1365-2958.2003.03745.x; Rioux S, 2011, MICROBIOL-SGM, V157, P336, DOI 10.1099/mic.0.042184-0; Rosch JW, 2008, INFECT IMMUN, V76, P3187, DOI 10.1128/IAI.00054-08; Rosch JW, 2009, MOL MICROBIOL, V72, P12, DOI 10.1111/j.1365-2958.2009.06638.x; Rozen S, 2000, Methods Mol Biol, V132, P365; Ryan MW, 2000, LARYNGOSCOPE, V110, P961, DOI 10.1097/00005537-200006000-00014; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Serrano I, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-67; Sjostrom K, 2007, P NATL ACAD SCI USA, V104, P12907, DOI 10.1073/pnas.0705589104; Smits WK, 2006, NAT REV MICROBIOL, V4, P259, DOI 10.1038/nrmicro1381; Song XM, 2009, MICROB PATHOGENESIS, V46, P28, DOI 10.1016/j.micpath.2008.10.006; Spraggon G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010919; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Ton-That H, 2004, TRENDS MICROBIOL, V12, P228, DOI 10.1016/j.tim.2004.03.004; Turner KH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000779; Vallon-Christersson J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-330; van der Poll T, 2009, LANCET, V374, P1543, DOI 10.1016/S0140-6736(09)61114-4; van der Woude MW, 2004, CLIN MICROBIOL REV, V17, P581, DOI 10.1128/CMR.17.3.581-611.2004; VANHAM SM, 1993, CELL, V73, P1187, DOI 10.1016/0092-8674(93)90647-9; Weiser JN, 2010, J MOL MED, V88, P97, DOI 10.1007/s00109-009-0557-x; Weiser JN, 1998, MICROB DRUG RESIST, V4, P129, DOI 10.1089/mdr.1998.4.129; Weiser JN, 1996, INFECT IMMUN, V64, P2240, DOI 10.1128/IAI.64.6.2240-2245.1996; WEISER JN, 1994, INFECT IMMUN, V62, P2582, DOI 10.1128/IAI.62.6.2582-2589.1994; Wisniewski-Dye F, 2008, ANTON LEEUW INT J G, V94, P493, DOI 10.1007/s10482-008-9267-6; Zahner D, 2000, J BACTERIOL, V182, P5919, DOI 10.1128/JB.182.20.5919-5921.2000	64	39	39	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21269	10.1371/journal.pone.0021269	http://dx.doi.org/10.1371/journal.pone.0021269			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731688	Green Published, gold, Green Submitted			2022-12-27	WOS:000292033700054
J	Ekdale, EG; Berta, A; Demere, TA				Ekdale, Eric G.; Berta, Annalisa; Demere, Thomas A.			The Comparative Osteology of the Petrotympanic Complex (Ear Region) of Extant Baleen Whales (Cetacea: Mysticeti)	PLOS ONE			English	Article							SEMICIRCULAR CANAL SIZE; INNER-EAR; TOOTHED MYSTICETE; PHYLOGENETIC-RELATIONSHIPS; EARLY-PLIOCENE; EVOLUTION; MORPHOLOGY; HEARING; PETROSAL; MAMMALIA	Background: Anatomical comparisons of the ear region of baleen whales (Mysticeti) are provided through detailed osteological descriptions and high-resolution photographs of the petrotympanic complex (tympanic bulla and petrosal bone) of all extant species of mysticete cetaceans. Salient morphological features are illustrated and identified, including overall shape of the bulla, size of the conical process of the bulla, morphology of the promontorium, and the size and shape of the anterior process of the petrosal. We place our comparative osteological observations into a phylogenetic context in order to initiate an exploration into petrotympanic evolution within Mysticeti. Principal Findings: The morphology of the petrotympanic complex is diagnostic for individual species of baleen whale (e. g., sigmoid and conical processes positioned at midline of bulla in Balaenoptera musculus; confluence of fenestra cochleae and perilymphatic foramen in Eschrichtius robustus), and several mysticete clades are united by derived characteristics. Balaenids and neobalaenids share derived features of the bulla, such as a rhomboid shape and a reduced anterior lobe (swelling) in ventral aspect, and eschrichtiids share derived morphologies of the petrosal with balaenopterids, including loss of a medial promontory groove and dorsomedial elongation of the promontorium. Monophyly of Balaenoidea (Balaenidae and Neobalaenidae) and Balaenopteroidea (Balaenopteridae and Eschrichtiidae) was recovered in phylogenetic analyses utilizing data exclusively from the petrotympanic complex. Significance: This study fills a major gap in our knowledge of the complex structures of the mysticete petrotympanic complex, which is an important anatomical region for the interpretation of the evolutionary history of mammals. In addition, we introduce a novel body of phylogenetically informative characters from the ear region of mysticetes. Our detailed anatomical descriptions, illustrations, and comparisons provide valuable data for current and future studies on the phylogenetic relationships, evolution, and auditory physiology of mysticetes and other cetaceans throughout Earth's history.	[Ekdale, Eric G.; Demere, Thomas A.] San Diego Nat Hist Museum, Dept Palaeontol, San Diego, CA USA; [Berta, Annalisa] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA	California State University System; San Diego State University	Ekdale, EG (corresponding author), San Diego Nat Hist Museum, Dept Palaeontol, San Diego, CA USA.	eekdale@sdnhm.org		Demere, Thomas/0000-0001-5464-3528	NSF [DEB-0743869, DEB-0743861]; Direct For Biological Sciences [0743861] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Research was supported by NSF grant DEB-0743869 to AB and grant DEB-0743861 to TAD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnason U, 2004, GENE, V333, P27, DOI 10.1016/j.gene.2004.02.010; Asher RJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-108; Atalgin SH, 2009, ANAT HISTOL EMBRYOL, V38, P23, DOI 10.1111/j.1439-0264.2008.00887.x; Au WWL, 2000, SPR HDB AUD, V12, P1; Bisconti M, 2005, PALAEONTOLOGY, V48, P793, DOI 10.1111/j.1475-4983.2005.00488.x; Bisconti M, 2001, ITAL J ZOOL, V68, P87, DOI 10.1080/11250000109356390; Bisconti M, 2008, ZOOL J LINN SOC-LOND, V153, P161, DOI 10.1111/j.1096-3642.2008.00374.x; Bouetel V, 2006, GEODIVERSITAS, V28, P319; BURDA H, 1989, HEARING RES, V39, P225, DOI 10.1016/0378-5955(89)90042-7; CLARK CT, 1993, J MORPHOL, V215, P119, DOI 10.1002/jmor.1052150203; Colbert EH, 1944, B AM MUS NAT HIST, V83, P196; CURTHOYS IS, 1982, EXP BRAIN RES, V47, P295; Demere TA, 2008, ZOOL J LINN SOC-LOND, V154, P308, DOI 10.1111/j.1096-3642.2008.00414.x; Demere TA, 2008, SYST BIOL, V57, P15, DOI 10.1080/10635150701884632; Demere Thomas A., 2005, Journal of Mammalian Evolution, V12, P99, DOI 10.1007/s10914-005-6944-3; Dooley AC, 2004, J VERTEBR PALEONTOL, V24, P453, DOI 10.1671/2401; Ekdale EG, 2004, ACTA PALAEONTOL POL, V49, P161; EKDALE EG, 2009, THESIS U TEXAS AUSTI, P439; Fitzgerald EMG, 2006, P ROY SOC B-BIOL SCI, V273, P2955, DOI 10.1098/rspb.2006.3664; Fitzgerald EMG, 2010, ZOOL J LINN SOC-LOND, V158, P367, DOI 10.1111/j.1096-3642.2009.00572.x; FLEISCHER G, 1976, J PALEONTOL, V50, P133; Fordyce R. Ewan, 1994, Proceedings of the San Diego Society of Natural History, V29, P147; Fordyce RE, 2002, SM C PALEOB, P185; FRASER F. C., 1960, BULL BRIT MUS [NAT HIST] ZOOL, V7, P1; FRASER FC, 1954, B BRIT MUS NAT HIST, V2, P103; FRITZSCH B, 1988, ZOOMORPHOLOGY, V108, P201, DOI 10.1007/BF00312221; Geisler JH, 1998, ADV VERT PALEOBIOL, P163; Geisler JH, 1996, J PALEONTOL, V70, P1045, DOI 10.1017/S0022336000038749; Geisler Jonathan H., 2003, Journal of Mammalian Evolution, V10, P23, DOI 10.1023/A:1025552007291; Gray A.A., 1908, LABYRINTH ANIMALS IN, VII; Gray AA, 1907, LABYRINTH ANIMALS IN, V1; GRAY O, 1955, J Laryngol Otol, V69, P151, DOI 10.1017/S0022215100050556; Hyrtl J., 1845, VERLEICHENDE ANATOMI; Junge G. C. A., 1950, Zool Verh Leiden 1950, VNo. 9, P1; Kandel BM, 2010, J EXP BIOL, V213, P1175, DOI 10.1242/jeb.040105; Kasuya T., 1973, Scientific Rep Whales Res Inst Tokyo, VNo. 25, P1; Kato H, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P158; Kellogg R, 1928, Q REV BIOL, V3, P29, DOI 10.1086/394293; Kellogg R., 1965, Bulletin United States National Museum, VNo. 247, P1; KELLOGG R, 1969, US NATL MUSEUM B, V294, P1; KELLOGG R, 1936, CARN I WASH PUBL, V482, P366; Kesteven HL, 1929, J ANAT, V63, P447; Ketten Darlene R., 1997, Bioacoustics, V8, P103; KETTEN DR, 1992, EVOLUTIONARY BIOLOGY OF HEARING, P717; Ketten DR, 2000, SPR HDB AUD, V12, P43; KETTEN DR, 1993, MARINE MAMMAL SENSOR, P53; Kimura T, 2002, J VERTEBR PALEONTOL, V22, P684, DOI 10.1671/0272-4634(2002)022[0684:ANCCMF]2.0.CO;2; Kimura T, 2010, J VERTEBR PALEONTOL, V30, P577, DOI 10.1080/02724631003621912; Lasker DM, 2008, JARO-J ASSOC RES OTO, V9, P334, DOI 10.1007/s10162-008-0120-4; Lee MS, 2000, ZOOL SCR, V29, P101, DOI 10.1046/j.1463-6409.2000.00035.x; LILLIE DG, 1910, P ZOOL SOC LOND, P769; LINDOW BEK, 2002, BARDHVALERNES INDBYR, P12; Luo Z., 1999, U MICHIGAN PAPERS PA, V31, P1; Luo ZX, 1998, ADV VERT PALEOBIOL, P269; LUO ZX, 1995, J VERTEBR PALEONTOL, V15, P431, DOI 10.1080/02724634.1995.10011239; Luo ZX, 1996, J VERTEBR PALEONTOL, V16, P328, DOI 10.1080/02724634.1996.10011320; MacIntyre GT., 1972, EVOLUTIONARY BIOL, P275, DOI [10.1007/978-1-4684-9063-3_9, DOI 10.1007/978-1-4684-9063-3_9]; MACPHEE RDE, 1981, CONTRIB PRIMATOL, V8, P1; Maisey JG, 2001, J MORPHOL, V250, P236, DOI 10.1002/jmor.1068; Marx FG, 2011, J MAMM EVOL, V18, P77, DOI 10.1007/s10914-010-9148-4; McGowen MR, 2009, MOL PHYLOGENET EVOL, V53, P891, DOI 10.1016/j.ympev.2009.08.018; MCLEOD SA, 1993, BOWHEAD WHALE, P45; MEAD JG, 2009, CONTRIBUTIONS ZOOLOG, V627, P1; Nikaido M, 2006, MOL BIOL EVOL, V23, P866, DOI 10.1093/molbev/msj071; NORRIS CA, 1994, ZOOL J LINN SOC-LOND, V111, P73, DOI 10.1006/zjls.1994.1018; Nummela S, 2008, SENSORY EVOLUTION ON THE THRESHOLD: ADAPTATIONS IN SECONDARILY AQUATIC VERTEBRATES, P211; O'Leary M.A., 2007, MORPHOBANK 2 5 WEB A; O'Leary M. A., 2010, B AM MUS NAT HIST, V355, P1; OELSCHLAGER HA, 1986, AM J ANAT, V177, P353, DOI 10.1002/aja.1001770306; Oishi Masayuki, 1994, Island Arc, V3, P436, DOI 10.1111/j.1440-1738.1994.tb00124.x; Parks SE, 2007, ANAT REC, V290, P734, DOI 10.1002/ar.20527; PETERHANS JCK, 1995, ZOOL J LINN SOC-LOND, V113, P329, DOI 10.1111/j.1096-3642.1995.tb00937.x; PICK TP, 1977, ANATOMY DESCRIPTIVE, P1257; Purves P.E., 1966, WHALES DOLPHINS PORP, P320; REILLY SB, 2008, IUCN 2010; Ridewood WG, 1923, PHILOS T R SOC LON B, V211, P209, DOI 10.1098/rstb.1923.0005; Rychel AL, 2004, MOL PHYLOGENET EVOL, V32, P892, DOI 10.1016/j.ympev.2004.02.020; Sanders AE, 2002, SM C PALEOB, P313; Sasaki T, 2005, SYST BIOL, V54, P77, DOI 10.1080/10635150590905939; Sasaki T, 2006, MOL PHYLOGENET EVOL, V41, P40, DOI 10.1016/j.ympev.2006.03.032; SEGALL W, 1970, Fieldiana Zoology, V51, P169; Spoor F, 2002, NATURE, V417, P163, DOI 10.1038/417163a; Steeman ME, 2009, SYST BIOL, V58, P573, DOI 10.1093/sysbio/syp060; Steeman ME, 2007, ZOOL J LINN SOC-LOND, V150, P875, DOI 10.1111/j.1096-3642.2007.00313.x; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Wada S, 2003, NATURE, V426, P278, DOI 10.1038/nature02103; Whitfield TT, 2002, DEV DYNAM, V223, P427, DOI 10.1002/dvdy.10073; Wible J.R., 1990, Journal of Vertebrate Paleontology, V10, P183; Wible JR, 2004, B AM MUS NAT HIST, P1, DOI 10.1206/0003-0090(2004)281<0001:NDOTSA>2.0.CO;2; Yamada M., 1953, Scientific Reports of the Whales Research Institute Tokyo, V8, P1; Yang AZ, 2007, J NEUROPHYSIOL, V98, P3197, DOI 10.1152/jn.00798.2007	91	72	74	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21311	10.1371/journal.pone.0021311	http://dx.doi.org/10.1371/journal.pone.0021311			42	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731700	gold, Green Submitted, Green Published			2022-12-27	WOS:000292033700061
J	Lilliebridge, RA; Tong, SYC; Giffard, PM; Holt, DC				Lilliebridge, Rachael A.; Tong, Steven Y. C.; Giffard, Philip M.; Holt, Deborah C.			The Utility of High-Resolution Melting Analysis of SNP Nucleated PCR Amplicons-An MLST Based Staphylococcus aureus Typing Scheme	PLOS ONE			English	Article							METHICILLIN-RESISTANT; CLONAL COMPLEX; SMALL SET; BACTERIAL; DNA; IDENTIFICATION; ASSIGNMENT	High resolution melting (HRM) analysis is gaining prominence as a method for discriminating DNA sequence variants. Its advantage is that it is performed in a real-time PCR device, and the PCR amplification and HRM analysis are closed tube, and effectively single step. We have developed an HRM-based method for Staphylococcus aureus genotyping. Eight single nucleotide polymorphisms (SNPs) were derived from the S. aureus multi-locus sequence typing (MLST) database on the basis of maximized Simpson's Index of Diversity. Only G <-> A, G <-> T, C <-> A, C <-> T SNPs were considered for inclusion, to facilitate allele discrimination by HRM. In silico experiments revealed that DNA fragments incorporating the SNPs give much higher resolving power than randomly selected fragments. It was shown that the predicted optimum fragment size for HRM analysis was 200 bp, and that other SNPs within the fragments contribute to the resolving power. Six DNA fragments ranging from 83 bp to 219 bp, incorporating the resolution optimized SNPs were designed. HRM analysis of these fragments using 94 diverse S. aureus isolates of known sequence type or clonal complex (CC) revealed that sequence variants are resolved largely in accordance with G+C content. A combination of experimental results and in silico prediction indicates that HRM analysis resolves S. aureus into 268 "melt types" (MelTs), and provides a Simpson's Index of Diversity of 0.978 with respect to MLST. There is a high concordance between HRM analysis and the MLST defined CCs. We have generated a Microsoft Excel key which facilitates data interpretation and translation between MelT and MLST data. The potential of this approach for genotyping other bacterial pathogens was investigated using a computerized approach to estimate the densities of SNPs with unlinked allelic states. The MLST databases for all species tested contained abundant unlinked SNPs, thus suggesting that high resolving power is not dependent upon large numbers of SNPs.	[Lilliebridge, Rachael A.; Tong, Steven Y. C.; Giffard, Philip M.; Holt, Deborah C.] Charles Darwin Univ, Menzies Sch Hlth Res, Trop & Emerging Infect Dis Div, Darwin, NT 0909, Australia	Charles Darwin University; Menzies School of Health Research	Lilliebridge, RA (corresponding author), Charles Darwin Univ, Menzies Sch Hlth Res, Trop & Emerging Infect Dis Div, Darwin, NT 0909, Australia.	deborah.holt@menzies.edu.au	Giffard, Philip/N-2293-2013; Tong, Steven/N-2353-2013; Holt, Deborah/A-8002-2012	Tong, Steven/0000-0002-1368-8356; Giffard, Phil/0000-0002-3030-9127; Holt, Deborah/0000-0003-4951-1891	Australian National Health and Medical Research Council [508829]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	SYCT is supported by an Australian National Health and Medical Research Council Postdoctoral Training Fellowship (508829). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carrico JA, 2006, J CLIN MICROBIOL, V44, P2524, DOI 10.1128/JCM.02536-05; Coombs GW, 2010, ANTIMICROB AGENTS CH, V54, P1914, DOI 10.1128/AAC.01287-09; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Filliol I, 2006, J BACTERIOL, V188, P759, DOI 10.1128/JB.188.2.759-772.2006; Hall TA, 2009, J CLIN MICROBIOL, V47, P1733, DOI 10.1128/JCM.02175-08; Honsa E, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-140; Huygens F, 2006, J CLIN MICROBIOL, V44, P3712, DOI 10.1128/JCM.00843-06; Keim P, 2004, INFECT GENET EVOL, V4, P205, DOI 10.1016/j.meegid.2004.02.005; Kibbe WA, 2007, NUCLEIC ACIDS RES, V35, pW43, DOI 10.1093/nar/gkm234; Ng JWS, 2009, J CLIN MICROBIOL, V47, P2295, DOI 10.1128/JCM.00122-09; Pearson T, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-78; Price EP, 2006, J MED MICROBIOL, V55, P1061, DOI 10.1099/jmm.0.46460-0; Price EP, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-278; Richardson LJ, 2011, CLIN MICROBIOL INFEC, V17, P1426, DOI 10.1111/j.1469-0691.2010.03433.x; Robertson GA, 2004, J MED MICROBIOL, V53, P35, DOI 10.1099/jmm.0.05365-0; SCHILDKRAUT C, 1965, BIOPOLYMERS, V3, P195, DOI 10.1002/bip.360030207; Shopsin B, 1999, J CLIN MICROBIOL, V37, P3556, DOI 10.1128/JCM.37.11.3556-3563.1999; Stephens AJ, 2006, J MED MICROBIOL, V55, P43, DOI 10.1099/jmm.0.46157-0; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tong SYC, 2009, CLIN MICROBIOL INFEC, V15, P1126, DOI 10.1111/j.1469-0691.2009.02732.x; Tong SYC, 2010, J INFECT DIS, V202, P760, DOI 10.1086/655396; Tong SYC, 2009, J INFECT DIS, V199, P1461, DOI 10.1086/598218	23	39	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e19749	10.1371/journal.pone.0019749	http://dx.doi.org/10.1371/journal.pone.0019749			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731606	gold, Green Published			2022-12-27	WOS:000292033700003
J	Lyons, L; ELBeltagy, M; Bennett, G; Wigmore, P				Lyons, Laura; ELBeltagy, Maha; Bennett, Geoffrey; Wigmore, Peter			The Effects of Cyclophosphamide on Hippocampal Cell Proliferation and Spatial Working Memory in Rat	PLOS ONE			English	Article							COGNITIVE FUNCTION; ADJUVANT CHEMOTHERAPY; CANCER-CHEMOTHERAPY; NEUROGENESIS; METHOTREXATE; DEFICITS; IMPAIRMENT; PLASTICITY; NEURONS; AGENT	Cyclophosphamide (CP) is a chemotherapy used in combinations that are associated with cognitive impairment. In the present study male Lister-hooded rats (n = 12) were used to investigate the effects of chronic administration of CP (30mg/kg, 7 i.v. doses, or an equivalent volume of saline) on performance in the novel location recognition (NLR) task and on the proliferation and survival of hippocampal cells. The survival of hippocampal cells dividing at the beginning of treatment was significantly reduced by CP. However, no difference was seen between CP treated and control groups for the number of cells proliferating 7 days after the final injection and both groups performed equally well in the NLR task. These results indicate that the given dose of CP acutely reduces the survival of newly born hippocampal cells. However, it does not have a longer term effect on spatial working memory or hippocampal proliferation, suggesting that CP is less neurotoxic than other chemotherapies with which it is used in combination.	[Lyons, Laura; Bennett, Geoffrey; Wigmore, Peter] Univ Nottingham, Sch Biomed Sci, Queens Med Ctr, Nottingham NG7 2RD, England; [ELBeltagy, Maha] Menoufiya Univ, Dept Anat, Shibin Al Kawm, Egypt	University of Nottingham; Egyptian Knowledge Bank (EKB); Menofia University	Lyons, L (corresponding author), Univ Nottingham, Sch Biomed Sci, Queens Med Ctr, Nottingham NG7 2RD, England.	mbxll@nottingham.ac.uk	Elbeltagy, Maha/Y-1139-2019	Elbeltagy, Maha/0000-0002-4777-2388	Cancer Research UK	Cancer Research UK(Cancer Research UK)	This project was funded by Cancer Research UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahles Tim A, 2002, Clin Breast Cancer, V3 Suppl 3, pS84, DOI 10.3816/CBC.2002.s.018; Branda RF, 2002, J LAB CLIN MED, V140, P358, DOI 10.1067/mlc.2002.128648; Bruel-Jungerman E, 2005, EUR J NEUROSCI, V21, P513, DOI 10.1111/j.1460-9568.2005.03875.x; Bunting KD, 1996, J BIOL CHEM, V271, P11891, DOI 10.1074/jbc.271.20.11891; Dix SL, 1999, BEHAV BRAIN RES, V99, P191, DOI 10.1016/S0166-4328(98)00079-5; Ehninger D, 2008, CELL TISSUE RES, V331, P243, DOI 10.1007/s00441-007-0478-3; ELBeltagy M, 2010, BEHAV BRAIN RES, V208, P112, DOI 10.1016/j.bbr.2009.11.017; FOLEY J, 2008, PSYCHOPHARMACOLOGY B, V208, P112; Gandal MJ, 2008, NEUROSCIENCE, V157, P95, DOI 10.1016/j.neuroscience.2008.08.060; Goldhirsch A, 1998, ANN ONCOL, V9, P489, DOI 10.1023/A:1008236502420; Huang GJ, 2006, BIOL PSYCHIAT, V59, P619, DOI 10.1016/j.biopsych.2005.09.016; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Janelsins MC, 2010, CANCER INVEST, V28, P544, DOI 10.3109/07357900903405942; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Ko HG, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-1; Konat GW, 2008, METAB BRAIN DIS, V23, P325, DOI 10.1007/s11011-008-9100-y; Kreukels BPC, 2008, CLIN BREAST CANCER, V8, P80, DOI 10.3816/CBC.2008.n.006; Lee GD, 2006, CLIN CANCER RES, V12, P198, DOI 10.1158/1078-0432.CCR-05-1286; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Lyons L, 2011, PSYCHOPHARMACOLOGY, V215, P105, DOI 10.1007/s00213-010-2122-2; MacLeod JE, 2007, BEHAV BRAIN RES, V181, P168, DOI 10.1016/j.bbr.2007.04.003; Matalon ST, 2004, REPROD TOXICOL, V18, P219, DOI 10.1016/j.reprotox.2003.10.014; Matsuda Tomohiro, 2005, Breast Cancer, V12, P279, DOI 10.2325/jbcs.12.279; MAYHEW TM, 1988, PLACENTA, V9, P565, DOI 10.1016/0143-4004(88)90001-X; McGregor A, 2004, BEHAV NEUROSCI, V118, P1011, DOI 10.1037/0735-7044.118.5.1011; Mondie CM, 2010, BEHAV BRAIN RES, V209, P66, DOI 10.1016/j.bbr.2010.01.016; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Mumby DG, 2002, LEARN MEMORY, V9, P49, DOI 10.1101/lm.41302; MUSTAFA S, 2008, EUROPEAN J NEUROSCIE, V10, P1460; PEREZLOPEZ F, 1984, REV ESPANOLA ONCOLOG; Reiriz AB, 2006, CLIN CANCER RES, V12, P5000, DOI 10.1158/1078-0432.CCR-06-0138; Schagen SB, 2002, ANN ONCOL, V13, P1387, DOI 10.1093/annonc/mdf241; Schagen SB, 1999, CANCER, V85, P640, DOI 10.1002/(SICI)1097-0142(19990201)85:3<640::AID-CNCR14>3.0.CO;2-G; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Seigers R, 2008, BEHAV BRAIN RES, V186, P168, DOI 10.1016/j.bbr.2007.08.004; Seigers R, 2011, NEUROSCI BIOBEHAV R, V35, P729, DOI 10.1016/j.neubiorev.2010.09.006; Seigers R, 2010, BRAIN RES BULL, V81, P472, DOI 10.1016/j.brainresbull.2009.10.006; Snyder JS, 2009, J NEUROSCI, V29, P14484, DOI 10.1523/JNEUROSCI.1768-09.2009; Taillibert S, 2007, CURR OPIN ONCOL, V19, P623, DOI 10.1097/CCO.0b013e3282f0e224; Wantuch C, 2007, NEUROSCI LETT, V421, P250, DOI 10.1016/j.neulet.2007.05.043; Winocur G, 2006, PHARMACOL BIOCHEM BE, V85, P66, DOI 10.1016/j.pbb.2006.07.010; Wojtowicz JM, 2006, HIPPOCAMPUS, V16, P261, DOI 10.1002/hipo.20158; Yang M, 2010, NEUROBIOL LEARN MEM, V93, P487, DOI 10.1016/j.nlm.2010.01.006; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	44	46	46	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21445	10.1371/journal.pone.0021445	http://dx.doi.org/10.1371/journal.pone.0021445			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731752	Green Submitted, Green Published, gold			2022-12-27	WOS:000292033700087
J	Oka, T; Tagawa, K; Ito, H; Okazawa, H				Oka, Tsutomu; Tagawa, Kazuhiko; Ito, Hikaru; Okazawa, Hitoshi			Dynamic Changes of the Phosphoproteome in Postmortem Mouse Brains	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; PAIRED HELICAL FILAMENTS; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; ALPHA-SYNUCLEIN; TYROSINE PHOSPHORYLATION; HUNTINGTONS-DISEASE; GAMMA-SECRETASE; TAU; MUTATIONS	Protein phosphorylation is deeply involved in the pathological mechanism of various neurodegenerative disorders. However, in human pathological samples, phosphorylation can be modified during preservation by postmortem factors such as time and temperature. Postmortem changes may also differ among proteins. Unfortunately, there is no comprehensive database that could support the analysis of protein phosphorylation in human brain samples from the standpoint of postmortem changes. As a first step toward addressing the issue, we performed phosphoproteome analysis with brain tissue dissected from mouse bodies preserved under different conditions. Quantitative whole proteome mass analysis showed surprisingly diverse postmortem changes in phosphoproteins that were dependent on temperature, time and protein species. Twelve hrs postmortem was a critical time point for preservation at room temperature. At 4 degrees C, after the body was cooled down, most phosphoproteins were stable for 72 hrs. At either temperature, increase greater than 2-fold was exceptional during this interval. We found several standard proteins by which we can calculate the postmortem time at room temperature. The information obtained in this study will be indispensable for evaluating experimental data with human as well as mouse brain samples.	[Oka, Tsutomu; Tagawa, Kazuhiko; Ito, Hikaru; Okazawa, Hitoshi] Tokyo Med & Dent Univ, Med Res Inst, Dept Neuropathol, Tokyo, Japan	Tokyo Medical & Dental University (TMDU)	Oka, T (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Neuropathol, Tokyo, Japan.	okazawa-tky@umin.ac.jp	Ito, Hikaru/GRR-6595-2022	Ito, Hikaru/0000-0002-4693-2482	Ministry of Education, Culture, Sports, Science and Technology (MEXT)	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by the Strategic Research Program for Brain Sciences (SRPBS) to H.O. from the Ministry of Education, Culture, Sports, Science and Technology (MEXT). The funders had a role in the decision of study direction but no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson FI, 2011, J MOL BIOL, V407, P261, DOI 10.1016/j.jmb.2010.12.029; Anggono V, 2006, NAT NEUROSCI, V9, P752, DOI 10.1038/nn1695; Arai T, 2009, ACTA NEUROPATHOL, V117, P125, DOI 10.1007/s00401-008-0480-1; Chang KH, 2010, J NEUROCHEM, V113, P1221, DOI 10.1111/j.1471-4159.2010.06687.x; Chen L, 2005, NAT NEUROSCI, V8, P657, DOI 10.1038/nn1443; Chen L, 2009, J CLIN INVEST, V119, P3257, DOI 10.1172/JCI39088; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Greggio E, 2009, BIOCHEM BIOPH RES CO, V389, P449, DOI 10.1016/j.bbrc.2009.08.163; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Gu XF, 2009, NEURON, V64, P828, DOI 10.1016/j.neuron.2009.11.020; Hanger DP, 2007, J BIOL CHEM, V282, P23645, DOI 10.1074/jbc.M703269200; Humbert S, 2002, DEV CELL, V2, P831, DOI 10.1016/S1534-5807(02)00188-0; Imam SZ, 2011, J NEUROSCI, V31, P157, DOI 10.1523/JNEUROSCI.1833-10.2011; IQBAL K, 1989, P NATL ACAD SCI USA, V86, P5646, DOI 10.1073/pnas.86.14.5646; Kang DE, 2002, CELL, V110, P751, DOI 10.1016/S0092-8674(02)00970-4; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Katashima R, 1998, BBA-GENE STRUCT EXPR, V1396, P245, DOI 10.1016/S0167-4781(97)00217-0; Kim Y, 2008, BIOCHEM BIOPH RES CO, V377, P975, DOI 10.1016/j.bbrc.2008.10.104; Kuo LH, 2008, MOL BIOL CELL, V19, P4201, DOI 10.1091/mbc.E07-09-0987; Lautier C, 2008, AM J HUM GENET, V82, P822, DOI 10.1016/j.ajhg.2008.01.015; MASLIAH E, 1992, AM J PATHOL, V140, P263; Modregger J, 2000, J CELL SCI, V113, P4511; Modregger J, 2002, HUM MOL GENET, V11, P2547, DOI 10.1093/hmg/11.21.2547; Mortiboys H, 2010, NEUROLOGY, V75, P2017, DOI 10.1212/WNL.0b013e3181ff9685; Noble W, 2005, P NATL ACAD SCI USA, V102, P6990, DOI 10.1073/pnas.0500466102; NUKINA N, 1985, J BIOCHEM-TOKYO, V98, P1715, DOI 10.1093/oxfordjournals.jbchem.a135443; Okochi M, 2000, J BIOL CHEM, V275, P390, DOI 10.1074/jbc.275.1.390; PALAIOLOGOS G, 1988, J NEUROCHEM, V51, P317, DOI 10.1111/j.1471-4159.1988.tb04872.x; PETERS HI, 1995, EUR J BIOCHEM, V234, P550, DOI 10.1111/j.1432-1033.1995.550_b.x; Piedrahita D, 2010, J NEUROSCI, V30, P13966, DOI 10.1523/JNEUROSCI.3637-10.2010; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Russo C, 2002, J BIOL CHEM, V277, P35282, DOI 10.1074/jbc.M110785200; SANG LJ, 2002, BIOCHEM BIOPH RES CO, V291, P158; Sorensen JB, 2006, EMBO J, V25, P955, DOI 10.1038/sj.emboj.7601003; Stanley CA, 1998, NEW ENGL J MED, V338, P1352, DOI 10.1056/NEJM199805073381904; Strauss KM, 2005, HUM MOL GENET, V14, P2099, DOI 10.1093/hmg/ddi215; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Takahashi K, 2008, BIOCHEM BIOPH RES CO, V377, P544, DOI 10.1016/j.bbrc.2008.10.013; Tarr PE, 2002, BIOCHEM BIOPH RES CO, V295, P324, DOI 10.1016/S0006-291X(02)00678-2; Tarr PE, 2002, J BIOL CHEM, V277, P16798, DOI 10.1074/jbc.M110286200; VANDAMME HTF, 1990, BIOCHIM BIOPHYS ACTA, V1050, P241, DOI 10.1016/0167-4781(90)90174-Z; Verderio C, 2004, NEURON, V41, P599, DOI 10.1016/S0896-6273(04)00077-7; Wang JZ, 2007, EUR J NEUROSCI, V25, P59, DOI 10.1111/j.1460-9568.2006.05226.x	44	29	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21405	10.1371/journal.pone.0021405	http://dx.doi.org/10.1371/journal.pone.0021405			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731734	Green Submitted, gold, Green Published			2022-12-27	WOS:000292033700078
J	Thalappilly, S; Feng, XL; Pastyryeva, S; Suzuki, K; Muruve, D; Larocque, D; Richard, S; Truss, M; von Deimling, A; Riabowol, K; Tallen, G				Thalappilly, Subhash; Feng, Xiaolan; Pastyryeva, Svitlana; Suzuki, Keiko; Muruve, Daniel; Larocque, Daniel; Richard, Stephane; Truss, Matthias; von Deimling, Andreas; Riabowol, Karl; Tallen, Gesche			The p53 Tumor Suppressor Is Stabilized by Inhibitor of Growth 1 (ING1) by Blocking Polyubiquitination	PLOS ONE			English	Article							PHD FINGER; CELL-PROLIFERATION; PLANT HOMEODOMAIN; PROTEIN-DEGRADATION; DNA-DAMAGE; BINDING; EXPRESSION; P33(ING1); APOPTOSIS; UBIQUITINATION	The INhibitor of Growth tumor suppressors (ING1-ING5) affect aging, apoptosis, DNA repair and tumorigenesis. Plant homeodomains (PHD) of ING proteins bind histones in a methylation-sensitive manner to regulate chromatin structure. ING1 and ING2 contain a polybasic region (PBR) adjacent to their PHDs that binds stress-inducible phosphatidylinositol monophosphate (PtIn-MP) signaling lipids to activate these INGs. ING1 induces apoptosis independently of p53 but other studies suggest proapoptotic interdependence of ING1 and p53 leaving their functional relationship unclear. Here we identify a novel ubiquitin-binding domain (UBD) that overlaps with the PBR of ING1 and shows similarity to previously described UBDs involved in DNA damage responses. The ING1 UBD binds ubiquitin with high affinity (K-d similar to 100 nM) and ubiquitin competes with PtIn-MPs for ING1 binding. ING1 expression stabilized wild-type, but not mutant p53 in an MDM2-independent manner and knockdown of endogenous ING1 depressed p53 levels in a transcription-independent manner. ING1 stabilized unmodified and six multimonoubiquitinated forms of wild-type p53 that were also seen upon DNA damage, but not p53 mutants lacking the six known sites of ubiquitination. We also find that ING1 physically interacts with herpesvirus-associated ubiquitin-specific protease (HAUSP), a p53 and MDM2 deubiquitinase (DUB), and knockdown of HAUSP blocks the ability of ING1 to stabilize p53. These data link lipid stress signaling to ubiquitin-mediated proteasomal degradation through the PBR/UBD of ING1 and further indicate that ING1 stabilizes p53 by inhibiting polyubiquitination of multimonoubiquitinated forms via interaction with and colocalization of the HAUSP-deubiquitinase with p53.	[Thalappilly, Subhash; Feng, Xiaolan; Pastyryeva, Svitlana; Suzuki, Keiko; Riabowol, Karl] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada; [Thalappilly, Subhash; Feng, Xiaolan; Pastyryeva, Svitlana; Suzuki, Keiko; Riabowol, Karl] Univ Calgary, Dept Oncol, Calgary, AB, Canada; [Muruve, Daniel] Univ Calgary, Dept Med, Calgary, AB, Canada; [Larocque, Daniel] GlaxoSmithKline Biol N Amer, Chron Disorders DAP, Preclin Res Team Neurodegenerat Dis, Laval, PQ, Canada; [Richard, Stephane] McGill Univ, Dept Med & Oncol, Lady Davis Inst, Montreal, PQ, Canada; [Truss, Matthias] Charite, Dept Pediat, Mol Biol Lab, D-13353 Berlin, Germany; [von Deimling, Andreas] Heidelberg Univ, Inst Pathol, Dept Neuropathol, D-6900 Heidelberg, Germany; [von Deimling, Andreas] Clin Cooperat Unit Neuropathol, Heidelberg, Germany; [Tallen, Gesche] Charite, Dept Pediat Oncol Haematol, D-13353 Berlin, Germany	University of Calgary; University of Calgary; University of Calgary; GlaxoSmithKline; Lady Davis Institute; McGill University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Ruprecht Karls University Heidelberg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Thalappilly, S (corresponding author), Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada.	gesche.tallen@charite.de	von Deimling, Andreas/F-7774-2013; Feng, Xiaolan/J-9997-2019	von Deimling, Andreas/0000-0002-5863-540X; Feng, Xiaolan/0000-0002-7333-8198; Thalappilly, Subhash/0000-0003-1766-3057	Canadian Institutes for Health Research (CIHR); German Federal Ministry for Research and Education (BMBF) [NGFN KR-S01T06, 01GS04363]; Kind Philipp-Leukamie-Stiftung and Charite-Universitatsmedizin Berlin	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); German Federal Ministry for Research and Education (BMBF)(Federal Ministry of Education & Research (BMBF)); Kind Philipp-Leukamie-Stiftung and Charite-Universitatsmedizin Berlin	D.L. was supported by a Canadian Institutes for Health Research (CIHR) studentship and X.F. held AHFMR and CIHR studentships. K.R. is an AHFMR Scientist. This work was supported by grants to K.R. from the CIHR, to A.v.D. and M.T. from the German Federal Ministry for Research and Education (BMBF) (NGFN KR-S01T06, 01GS04363), and to G.T. from the Kind Philipp-Leukamie-Stiftung and Charite-Universitatsmedizin Berlin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravind L, 2003, CELL CYCLE, V2, P123, DOI 10.4161/cc.2.2.335; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Champagne KS, 2008, PROTEINS, V72, P1371, DOI 10.1002/prot.22140; Cheung KJJ, 2000, BRIT J CANCER, V83, P1468, DOI 10.1054/bjoc.2000.1464; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Coles AH, 2008, CANCER RES, V68, P8705, DOI 10.1158/0008-5472.CAN-08-0923; Coles AH, 2007, CANCER RES, V67, P2054, DOI 10.1158/0008-5472.CAN-06-3558; Coscoy L, 2003, TRENDS CELL BIOL, V13, P7, DOI 10.1016/S0962-8924(02)00005-3; Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007; Erster S, 2004, MOL CELL BIOL, V24, P6728, DOI 10.1128/MCB.24.15.6728-6741.2004; Fang S, 2003, SEMIN CANCER BIOL, V13, P5, DOI 10.1016/S1044-579X(02)00095-0; FRIEDMAN PN, 1993, P NATL ACAD SCI USA, V90, P3319, DOI 10.1073/pnas.90.8.3319; Garkavtsev I, 1996, NAT GENET, V14, P415, DOI 10.1038/ng1296-415; Garkavtsev I, 1998, NATURE, V391, P295, DOI 10.1038/34675; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Gong W, 2006, MOL CELL BIOL, V26, P2947, DOI 10.1128/MCB.26.8.2947-2954.2006; Gordon PMK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-426; Gozani O, 2003, CELL, V114, P99, DOI 10.1016/S0092-8674(03)00480-X; Grossman SR, 2003, SCIENCE, V300, P342, DOI 10.1126/science.1080386; Han XJ, 2008, NAT CELL BIOL, V10, P1333, DOI 10.1038/ncb1792; He GHY, 2005, MOL BIOL EVOL, V22, P104, DOI 10.1093/molbev/msh256; Helbing CC, 1997, CANCER RES, V57, P1255; Hofmann K, 2009, DNA REPAIR, V8, P544, DOI 10.1016/j.dnarep.2009.01.003; Jones DR, 2006, MOL CELL, V23, P685, DOI 10.1016/j.molcel.2006.07.014; Kaadige MR, 2006, J BIOL CHEM, V281, P28831, DOI 10.1074/jbc.M605624200; Kataoka H, 2003, CANCER RES, V63, P5785; Kuo WHW, 2007, EXP CELL RES, V313, P1628, DOI 10.1016/j.yexcr.2007.02.010; Leung KM, 2002, CANCER RES, V62, P4890; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Luo JJ, 2009, GENETICS, V181, P473, DOI 10.1534/genetics.107.080515; Marchenko ND, 2007, CELL CYCLE, V6, P1718, DOI 10.4161/cc.6.14.4503; Marchenko ND, 2007, EMBO J, V26, P923, DOI 10.1038/sj.emboj.7601560; Martin DGE, 2006, MOL CELL BIOL, V26, P7871, DOI 10.1128/MCB.00573-06; Nagashima M, 2001, P NATL ACAD SCI USA, V98, P9671, DOI 10.1073/pnas.161151798; Nakamura S, 2000, MOL CELL BIOL, V20, P9391, DOI 10.1128/MCB.20.24.9391-9398.2000; Nencioni A, 2007, LEUKEMIA, V21, P30, DOI 10.1038/sj.leu.2404444; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Russell MW, 2008, BIOCHEM BIOPH RES CO, V374, P490, DOI 10.1016/j.bbrc.2008.07.076; Scott M, 2001, J CELL SCI, V114, P3455; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Soliman MA, 2007, TRENDS BIOCHEM SCI, V32, P509, DOI 10.1016/j.tibs.2007.08.006; Soliman MA, 2008, AGING CELL, V7, P783, DOI 10.1111/j.1474-9726.2008.00427.x; SUZUKI K, 2011, HYBRIDOMA IN PRESS; Taverna SD, 2006, MOL CELL, V24, P785, DOI 10.1016/j.molcel.2006.10.026; Terrell J, 1998, MOL CELL, V1, P193, DOI 10.1016/S1097-2765(00)80020-9; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Vieyra D, 2002, CANCER RES, V62, P4445; Vieyra D, 2002, J BIOL CHEM, V277, P29832, DOI 10.1074/jbc.M200197200; Yang YL, 2009, CANCER SCI, V100, P24, DOI 10.1111/j.1349-7006.2008.01013.x; Yen HCS, 2008, SCIENCE, V322, P918, DOI 10.1126/science.1160489; Ythier D, 2008, INT J CANCER, V123, P1483, DOI 10.1002/ijc.23790	51	32	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21065	10.1371/journal.pone.0021065	http://dx.doi.org/10.1371/journal.pone.0021065			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731648	Green Submitted, gold, Green Published			2022-12-27	WOS:000292033700033
J	Wu, L; Wang, JX; Tang, P; Chen, HJ; Gao, HC				Wu, Lin; Wang, Jixuan; Tang, Peng; Chen, Haijiang; Gao, Haichun			Genetic and Molecular Characterization of Flagellar Assembly in Shewanella oneidensis	PLOS ONE			English	Article							HELICOBACTER-PYLORI; POLAR FLAGELLUM; FUNCTIONAL-CHARACTERIZATION; CAULOBACTER-CRESCENTUS; EXPORT CHAPERONES; PSEUDAMINIC ACID; CELL MOTILITY; CAMPYLOBACTER; PROTEIN; FILAMENT	Shewanella oneidensis is a highly motile organism by virtue of a polar flagellum. Unlike most flagellated bacteria, it contains only one major chromosome segment encoding the components of the flagellum with the exception of the motor proteins. In this region, three genes encode flagellinsaccording to the original genome annotation. However, we find that only flaA and flaB encode functional filament subunits. Although these two genesare under the control of different promoters, they are actively transcribed and subsequently translated, producing a considerable number of flagellin proteins. Additionally, both flagellins are able to interact with their chaperon FliS and are subjected to feedback regulation. Furthermore, FlaA and FlaB are glycosylated by a pathwayinvolving a major glycosylating enzyme, PseB, in spite of the lack of the majority of theconsensus glycosylation sites. In conclusion, flagellar assembly in S. oneidensis has novel features despite the conservation of homologous genes across taxa.	[Wu, Lin] Zhejiang Univ, Inst Microbiol, Hangzhou 310003, Zhejiang, Peoples R China; Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Wu, L (corresponding author), Zhejiang Univ, Inst Microbiol, Hangzhou 310003, Zhejiang, Peoples R China.	haichung@zju.edu.cn	Gao, Haichun/A-2160-2014; Gao, Haichun/AFU-4588-2022; Chen, Haijiang/D-1893-2009	Gao, Haichun/0000-0002-2647-6563; Gao, Haichun/0000-0002-2647-6563; 	Major State Basic Research Development Program [2010CB833803]; Fundamental Research Funds for the Central Universities	Major State Basic Research Development Program(National Basic Research Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research was supported by Major State Basic Research Development Program (973 Progam: 2010CB833803) and by the Fundamental Research Funds for the Central Universities to HG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge P, 2002, CURR OPIN MICROBIOL, V5, P160, DOI 10.1016/S1369-5274(02)00302-8; Anderson PE, 2000, MOL MICROBIOL, V38, P41, DOI 10.1046/j.1365-2958.2000.02108.x; Bardy SL, 2003, MICROBIOL-SGM, V149, P295, DOI 10.1099/mic.0.25948-0; Bennett JCQ, 2001, MOL MICROBIOL, V39, P781, DOI 10.1046/j.1365-2958.2001.02268.x; BOUHENNI RA, ELECTROANALYSIS, V22, P856; Bresolin G, 2008, MICROBIOL-SGM, V154, P196, DOI 10.1099/mic.0.2007/008458-0; Brown JD, 2008, MOL MICROBIOL, V70, P924, DOI 10.1111/j.1365-2958.2008.06455.x; Caccavo F, 2002, GEOMICROBIOL J, V19, P161, DOI 10.1080/01490450252864262; Cameron DE, 2008, P NATL ACAD SCI USA, V105, P8736, DOI 10.1073/pnas.0803281105; Canals R, 2006, J BACTERIOL, V188, P542, DOI 10.1128/JB.188.2.542-555.2006; Capdevila S, 2004, MICROBIOL-SGM, V150, P3889, DOI 10.1099/mic.0.27362-0; Chevance FFV, 2008, NAT REV MICROBIOL, V6, P455, DOI 10.1038/nrmicro1887; Childers SE, 2002, NATURE, V416, P767, DOI 10.1038/416767a; Douillard FP, 2008, J BACTERIOL, V190, P7975, DOI 10.1128/JB.00879-08; Evdokimov AG, 2003, NAT STRUCT BIOL, V10, P789, DOI 10.1038/nsb982; Ewing CP, 2009, J BACTERIOL, V191, P7086, DOI 10.1128/JB.00378-09; Fredrickson JK, 2008, NAT REV MICROBIOL, V6, P592, DOI 10.1038/nrmicro1947; Gao HC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-42; Gao HC, 2010, MICROB BIOTECHNOL, V3, P455, DOI 10.1111/j.1751-7915.2010.00181.x; Gao HC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015295; Gao HC, 2009, ISME J, V3, P966, DOI 10.1038/ismej.2009.40; Gao WM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-76; GUERRY P, 1991, J BACTERIOL, V173, P4757, DOI 10.1128/jb.173.15.4757-4764.1991; Guerry P, 2008, TRENDS MICROBIOL, V16, P428, DOI 10.1016/j.tim.2008.07.002; Heidelberg JF, 2002, NAT BIOTECHNOL, V20, P1118, DOI 10.1038/nbt749; Imada K, 2010, P NATL ACAD SCI USA, V107, P8812, DOI 10.1073/pnas.1001866107; Karpinets TV, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq012; Kearns DB, 2010, NAT REV MICROBIOL, V8, P634, DOI 10.1038/nrmicro2405; Kim J, 2007, MOL MICROBIOL, V64, P165, DOI 10.1111/j.1365-2958.2007.05646.x; Kim JS, 1999, J BACTERIOL, V181, P6969; Klose KE, 1998, J BACTERIOL, V180, P303, DOI 10.1128/JB.180.2.303-316.1998; Koerdt A, 2009, J BACTERIOL, V191, P5085, DOI 10.1128/JB.00206-09; KOSTRZYNSKA M, 1991, J BACTERIOL, V173, P937, DOI 10.1128/jb.173.3.937-946.1991; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; KUTSUKAKE K, 1990, J BACTERIOL, V172, P741, DOI 10.1128/jb.172.2.741-747.1990; KUWAJIMA G, 1988, J BACTERIOL, V170, P3305, DOI 10.1128/jb.170.7.3305-3309.1988; Lambert C, 2006, MOL MICROBIOL, V60, P274, DOI 10.1111/j.1365-2958.2006.05081.x; Li J, 2007, FEMS MICROBIOL LETT, V273, P180, DOI 10.1111/j.1574-6968.2007.00810.x; Liang YL, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-291; Liu RY, 2007, P NATL ACAD SCI USA, V104, P7116, DOI 10.1073/pnas.0700266104; Logan SM, 2006, MICROBIOL-SGM, V152, P1249, DOI 10.1099/mic.0.28735-0; Macnab RM, 2003, ANNU REV MICROBIOL, V57, P77, DOI 10.1146/annurev.micro.57.030502.090832; Martinez RM, 2010, J BACTERIOL, V192, P2085, DOI 10.1128/JB.01562-09; Martinez RM, 2009, J BACTERIOL, V191, P5669, DOI 10.1128/JB.00632-09; McCarter LL, 2006, CURR OPIN MICROBIOL, V9, P180, DOI 10.1016/j.mib.2006.02.001; McCarter LL, 2001, MICROBIOL MOL BIOL R, V65, P445, DOI 10.1128/MMBR.65.3.445-462.2001; Merino S, 2006, FEMS MICROBIOL LETT, V263, P127, DOI 10.1111/j.1574-6968.2006.00403.x; MINNICH SA, 1988, J BACTERIOL, V170, P3953, DOI 10.1128/jb.170.9.3953-3960.1988; Moens S, 1996, CRIT REV MICROBIOL, V22, P67, DOI 10.3109/10408419609106456; Neal-McKinney JM, 2010, MOL MICROBIOL, V76, P918, DOI 10.1111/j.1365-2958.2010.07144.x; Nealson K. H., 2006, PROKARYOTES; Nothaft H, 2010, NAT REV MICROBIOL, V8, P765, DOI 10.1038/nrmicro2383; NUIJTEN PJM, 1990, J BIOL CHEM, V265, P17798; Ozin AJ, 2003, FEMS MICROBIOL LETT, V219, P219, DOI 10.1016/S0378-1097(02)01208-9; Pallen MJ, 2006, NAT REV MICROBIOL, V4, P784, DOI 10.1038/nrmicro1493; Paulick A, 2009, MOL MICROBIOL, V71, P836, DOI 10.1111/j.1365-2958.2008.06570.x; Pratt LA, 1998, MOL MICROBIOL, V30, P285, DOI 10.1046/j.1365-2958.1998.01061.x; Prouty MG, 2001, MOL MICROBIOL, V39, P1595, DOI 10.1046/j.1365-2958.2001.02348.x; Saltikov CW, 2003, P NATL ACAD SCI USA, V100, P10983, DOI 10.1073/pnas.1834303100; Samatey FA, 2001, NATURE, V410, P331, DOI 10.1038/35066504; Schoenhofen IC, 2006, GLYCOBIOLOGY, V16, p8C, DOI 10.1093/glycob/cwl010; Schoenhofen IC, 2009, GLYCOBIOLOGY, V19, P715, DOI 10.1093/glycob/cwp039; Schoenhofen IC, 2006, J BIOL CHEM, V281, P8907, DOI 10.1074/jbc.M512987200; Schoenhofen IC, 2006, J BIOL CHEM, V281, P723, DOI 10.1074/jbc.M511021200; Song WJ, 2007, FEMS MICROBIOL LETT, V271, P222, DOI 10.1111/j.1574-6968.2007.00720.x; Soutourina OA, 2003, FEMS MICROBIOL REV, V27, P505, DOI 10.1016/S0168-6445(03)00064-0; Stewart BJ, 2003, J BACTERIOL, V185, P4508, DOI 10.1128/JB.185.15.4508-4518.2003; Syed MH, 2009, BIOINFORMATION, V4, P169, DOI 10.6026/97320630004169; Terashima H, 2010, J BACTERIOL, V192, P5609, DOI 10.1128/JB.00720-10; Thibault P, 2001, J BIOL CHEM, V276, P34862, DOI 10.1074/jbc.M104529200; Thormann KM, 2006, J BACTERIOL, V188, P2681, DOI 10.1128/JB.188.7.2681-2691.2006; Turatsinze JV, 2008, NAT PROTOC, V3, P1578, DOI 10.1038/nprot.2008.97; Vegh BM, 2006, BIOCHEM BIOPH RES CO, V345, P93, DOI 10.1016/j.bbrc.2006.04.055; Wang SY, 2006, J MOL BIOL, V355, P798, DOI 10.1016/j.jmb.2005.11.020; WASSENAAR TM, 1991, EMBO J, V10, P2055, DOI 10.1002/j.1460-2075.1991.tb07736.x; Yamamoto S, 2006, J BACTERIOL, V188, P958, DOI 10.1128/JB.188.3.958-967.2006; Yamamoto S, 2006, J BACTERIOL, V188, P6703, DOI 10.1128/JB.00799-06; Yang C, 2006, J BIOL CHEM, V281, P29872, DOI 10.1074/jbc.M605052200; YOKOSEKI T, 1995, MICROBIOL-SGM, V141, P1715, DOI 10.1099/13500872-141-7-1715; Yonekura K, 2003, NATURE, V424, P643, DOI 10.1038/nature01830; YOSHIOKA K, 1995, J BACTERIOL, V177, P1090, DOI 10.1128/jb.177.4.1090-1093.1995; Young GM, 1999, P NATL ACAD SCI USA, V96, P6456, DOI 10.1073/pnas.96.11.6456	82	76	77	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21479	10.1371/journal.pone.0021479	http://dx.doi.org/10.1371/journal.pone.0021479			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731763	Green Published, Green Submitted, gold			2022-12-27	WOS:000292033700089
J	Dye, C; Trunz, BB; Lonnroth, K; Roglic, G; Williams, BG				Dye, Christopher; Trunz, Bernadette Bourdin; Loennroth, Knut; Roglic, Gojka; Williams, Brian G.			Nutrition, Diabetes and Tuberculosis in the Epidemiological Transition	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; PREVALENCE; INDIA; URBAN; KOREA; RISK; MELLITUS; CRITERIA; BURDEN; TRENDS	Background: Diabetes prevalence and body mass index reflect the nutritional profile of populations but have opposing effects on tuberculosis risk. Interactions between diabetes and BMI could help or hinder TB control in growing, aging, urbanizing populations. Methods and Findings: We compiled data describing temporal changes in BMI, diabetes prevalence and population age structure in rural and urban areas for men and women in countries with high (India) and low (Rep. Korea) TB burdens. Using published data on the risks of TB associated with these factors, we calculated expected changes in TB incidence between 1998 and 2008. In India, TB incidence cases would have increased (28% from 1.7 m to 2.1 m) faster than population size (22%) because of adverse effects of aging, urbanization, changing BMI and rising diabetes prevalence, generating an increase in TB incidence per capita of 5.5% in 10 years. In India, general nutritional improvements were offset by a fall in BMI among the majority of men who live in rural areas. The growing prevalence of diabetes in India increased the annual number of TB cases in people with diabetes by 46% between 1998 and 2008. In Korea, by contrast, the number of TB cases increased more slowly (6.1% from 40,200 to 42,800) than population size (14%) because of positive effects of urbanization, increasing BMI and falling diabetes prevalence. Consequently, TB incidence per capita fell by 7.8% in 10 years. Rapid population aging was the most significant adverse effect in Korea. Conclusions: Nutritional and demographic changes had stronger adverse effects on TB in high-incidence India than in lower-incidence Korea. The unfavourable effects in both countries can be overcome by early drug treatment but, if left unchecked, could lead to an accelerating rise in TB incidence. The prevention and management of risk factors for TB would reinforce TB control by chemotherapy.	[Dye, Christopher; Loennroth, Knut] World Hlth Org, Stop TB Dept, Geneva, Switzerland; [Trunz, Bernadette Bourdin] Petit Lancy, Geneva, Switzerland; [Williams, Brian G.] SACEMA, Stellenbosch, South Africa	World Health Organization	Dye, C (corresponding author), World Hlth Org, Stop TB Dept, Geneva, Switzerland.	dyec@who.int	Dye, Christopher/AIC-4659-2022; Lönnroth, Knut/L-2339-2014; Lonnroth, Knut/H-5470-2017	Lönnroth, Knut/0000-0001-5054-8240; Lonnroth, Knut/0000-0001-6944-0256; Dye, Christopher/0000-0002-2957-1793; Williams, Brian/0000-0002-3174-4876; Roglic, Gojka/0000-0003-0872-0689	World Health Organization	World Health Organization(World Health Organization)	The work was funded by the World Health Organization, and done as part of the routine work of the authors who are WHO staff (except BBT, who was a consultant to the WHO at the time of the study). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, GLOB TUB CONTR; Chadha VK, 2005, INT J TUBERC LUNG D, V9, P116; Choi YJ, 2009, DIABETES CARE, V32, P2016, DOI 10.2337/dc08-2228; Dooley KE, 2009, LANCET INFECT DIS, V9, P737, DOI 10.1016/S1473-3099(09)70282-8; Dowdy DW, 2009, B WORLD HEALTH ORGAN, V87, P296, DOI 10.2471/BLT.08.054510; Dye C, 1998, LANCET, V352, P1886, DOI 10.1016/S0140-6736(98)03199-7; Dye C, 2009, B WORLD HEALTH ORGAN, V87, P683, DOI 10.2471/BLT.08.058453; GOLDHABERFIEBER.JD, 2011, INT J EPIDEMIOLOGY; Hong YP, 1998, INT J TUBERC LUNG D, V2, P27; IIPS & ORC Macro, 2000, NATL FAMILY HLTH SUR; International Institute for Population Sciences (IIPS) and Macro International, 2007, NAT FAM HLTH SURV NF; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; Khan M., 2006, DUAL BURDEN OVERWEIG; Kim SJ, 1995, TUBERCLE LUNG DIS, V76, P529, DOI 10.1016/0962-8479(95)90529-4; Kim WY, 2008, ASIA PAC J CLIN NUTR, V17, P47; Kim Y, 2004, OBES RES, V12, P445, DOI 10.1038/oby.2004.50; Lee HY, 2010, J KOREAN MED SCI, V25, P1777, DOI 10.3346/jkms.2010.25.12.1777; Lonnroth K, 2010, LANCET, V375, P1814, DOI 10.1016/S0140-6736(10)60483-7; Lonnroth K, 2010, INT J EPIDEMIOL, V39, P149, DOI 10.1093/ije/dyp308; Mbanya JCN, 2010, LANCET, V375, P2254, DOI 10.1016/S0140-6736(10)60550-8; Mohan V, 2006, DIABETOLOGIA, V49, P1175, DOI 10.1007/s00125-006-0219-2; Mohan V, 2008, DIABETES RES CLIN PR, V80, P159, DOI 10.1016/j.diabres.2007.11.018; Nyamdorj R, 2008, OBESITY, V16, P1622, DOI 10.1038/oby.2008.73; Ramachandran A, 2001, DIABETOLOGIA, V44, P1094, DOI 10.1007/s001250100627; Ruslami R, 2010, TROP MED INT HEALTH, V15, P1289, DOI 10.1111/j.1365-3156.2010.02625.x; Sadikot SM, 2004, DIABETES RES CLIN PR, V66, P293, DOI 10.1016/j.diabres.2004.04.007; Sadikot SM, 2004, DIABETES RES CLIN PR, V66, P301, DOI 10.1016/j.diabres.2004.04.008; Stevenson CR, 2007, CHRONIC ILLN, V3, P228, DOI 10.1177/1742395307081502; Stevenson CR, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-234; Styblo K, 1991, EPIDEMIOLOGY TUBERCU; Tuei Vivian C, 2010, Diabetes Metab Res Rev, V26, P433, DOI 10.1002/dmrr.1106; *UN DOEASA POP DIV, 2009, WORLD PROSP 2008 REV; *UN DOEASA POP DIV, 2010, WORLD URB PROSP 2009; Vynnycky E, 2008, EPIDEMIOL INFECT, V136, P943, DOI 10.1017/S0950268807008552; *WHO, 2009, GLOB TUB CONTR SHORT; WHO, 2010, GLOB TUB CONTR 2010	37	62	69	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2011	6	6							e21161	10.1371/journal.pone.0021161	http://dx.doi.org/10.1371/journal.pone.0021161			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782CL	21712992	Green Published, gold			2022-12-27	WOS:000291985100014
J	Tan, SJ; Rudd, JA; Yew, DT				Tan, Sijie; Rudd, John A.; Yew, David T.			Gene Expression Changes in GABA(A) Receptors and Cognition Following Chronic Ketamine Administration in Mice	PLOS ONE			English	Article							NEUROTROPHIC FACTOR; RECENT TRENDS; RAT-BRAIN; MEMORY; SUBUNITS; ALPHA-5; POTENTIATION; HIPPOCAMPUS; ANESTHETICS; NEURONS	Ketamine is a well-known anesthetic agent and a drug of abuse. Despite its widespread use and abuse, little is known about its long-term effects on the central nervous system. The present study was designed to evaluate the effect of long-term (1- and 3-month) ketamine administration on learning and memory and associated gene expression levels in the brain. The Morris water maze was used to assess spatial memory and gene expression changes were assayed using Affymetrix Genechips; a focus on the expression of GABA(A) receptors that mediate a tonic inhibition in the brain, was confirmed by quantitative real-time PCR and western blot. Compared with saline controls, there was a decline in learning and memory performance in the ketamine-treated mice. Genechip results showed that 110 genes were up-regulated and 136 genes were down-regulated. An ontology analysis revealed the most significant effects of ketamine were on GABAA receptors. In particular, there was a significant up-regulation of both mRNA and protein levels of the alpha 5 subunit (Gabra5) of the GABAA receptors in the prefrontal cortex. In conclusion, chronic exposure to ketamine impairs working memory in mice, which may be explained at least partly by up-regulation of Gabra5 subunits in the prefrontal cortex.	[Tan, Sijie; Yew, David T.] Chinese Univ Hong Kong, Fac Med, Brain Res Ctr, Shatin, Hong Kong, Peoples R China; [Rudd, John A.] Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong	Yew, DT (corresponding author), Chinese Univ Hong Kong, Fac Med, Brain Res Ctr, Shatin, Hong Kong, Peoples R China.	david-yew@cuhk.edu.hk	Tan, Sijie/W-6260-2019; Rudd, John A./R-6603-2018; McAlonan, Grainne/G-1541-2011	Rudd, John A./0000-0002-8316-0792; tan, Sijie/0000-0002-8389-7372; McAlonan, Grainne/0000-0002-4466-2343	Beat Drugs Fund Association, Hong Kong Government [080048, 100052]	Beat Drugs Fund Association, Hong Kong Government	This work was supported by the Beat Drugs Fund Association, Hong Kong Government, Grant Numbers: 080048 and 100052. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Bergman S A, 1999, Anesth Prog, V46, P10; Chambers MS, 2003, J MED CHEM, V46, P2227, DOI 10.1021/jm020582q; Chapouthier Georges, 2002, Current Topics in Medicinal Chemistry, V2, P841, DOI 10.2174/1568026023393552; Collinson N, 2002, J NEUROSCI, V22, P5572; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; Curran HV, 2000, ADDICTION, V95, P575, DOI 10.1046/j.1360-0443.2000.9545759.x; Degenhardt L, 2005, SUBST USE MISUSE, V40, P1241, DOI 10.1081/JA-200066777; Dingledine R, 1999, PHARMACOL REV, V51, P7; Fang YX, 2006, ACTA PHARMACOL SIN, V27, P140, DOI 10.1111/j.1745-7254.2006.00270.x; Hijazi Y, 2002, DRUG METAB DISPOS, V30, P853, DOI 10.1124/dmd.30.7.853; Hirota K, 1999, J Anesth, V13, P107, DOI 10.1007/s005400050035; Honey GD, 2005, CEREB CORTEX, V15, P749, DOI 10.1093/cercor/bhh176; Ibla JC, 2009, CURR DRUG SAF, V4, P11, DOI 10.2174/157488609787354495; Irifune M, 2000, ANESTH ANALG, V91, P230, DOI 10.1097/00000539-200007000-00043; JONES EG, 1993, CEREB CORTEX, V3, P361, DOI 10.1093/cercor/3.5.361-a; KLEINSCHMIDT A, 1987, SCIENCE, V238, P355, DOI 10.1126/science.2443978; Li F, 2009, NEW ENGL J MED, V361, P302, DOI 10.1056/NEJMcibr0902052; Li Q, 2007, NEUROCHEM INT, V50, P848, DOI 10.1016/j.neuint.2007.02.005; LIN LH, 1992, J PHARMACOL EXP THER, V263, P569; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mak YT, 2010, MICROSC RES TECHNIQ, V73, P195, DOI 10.1002/jemt.20774; Martin LJ, 2010, J NEUROSCI, V30, P5269, DOI 10.1523/JNEUROSCI.4209-09.2010; Maxwell JC, 2005, SUBST USE MISUSE, V40, P1203, DOI 10.1081/JA-200066736; MHATRE MC, 1992, MOL BRAIN RES, V14, P71, DOI 10.1016/0169-328X(92)90012-Z; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Mizoguchi Y, 2003, J BIOL CHEM, V278, P44097, DOI 10.1074/jbc.M305872200; Mizukami K, 1997, EXP NEUROL, V147, P333, DOI 10.1006/exnr.1997.6591; Morgan CJA, 2010, ADDICTION, V105, P121, DOI 10.1111/j.1360-0443.2009.02761.x; Morgan CJA, 2004, NEUROPSYCHOPHARMACOL, V29, P208, DOI 10.1038/sj.npp.1300342; Narita M, 2001, ADDICT BIOL, V6, P373, DOI 10.1080/13556210020077091; OLIVERIO ALBERTO, 1966, LIFE SCI, V5, P1317, DOI 10.1016/0024-3205(66)90033-6; OLSEN RW, 1990, FASEB J, V4, P1469, DOI 10.1096/fasebj.4.5.2155149; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Perry JL, 2011, BRAIN RES REV, V65, P124, DOI 10.1016/j.brainresrev.2010.09.001; Ricaurte GA, 2005, LANCET, V365, P2137, DOI 10.1016/S0140-6736(05)66737-2; Ricci V, 2011, PSYCHOPHARMACOLOGY, V215, P143, DOI 10.1007/s00213-010-2121-3; Rissman RA, 2003, NEUROSCIENCE, V120, P695, DOI 10.1016/S0306-4522(03)00030-7; Rissman RA, 2007, J NEUROCHEM, V103, P1285, DOI 10.1111/j.1471-4159.2007.04832.x; Rowland LM, 2005, NEUROPSYCHOPHARMACOL, V30, P633, DOI 10.1038/sj.npp.1300642; SCHOLFIELD CN, 1980, PFLUG ARCH EUR J PHY, V383, P249, DOI 10.1007/BF00587527; Shi Q, 2010, NEUROSCIENCE, V166, P852, DOI 10.1016/j.neuroscience.2010.01.007; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Watanabe M, 2002, INT REV CYTOL, V213, P1; WISDEN W, 1992, J NEUROSCI, V12, P1040; Wolff K, 2006, CNS DRUGS, V20, P199, DOI 10.2165/00023210-200620030-00003; Wu Y, 2005, NEUROCHEM INT, V46, P565, DOI 10.1016/j.neuint.2005.01.002; Xu Q, 2007, CLIN EXP PHARMACOL P, V34, P499, DOI 10.1111/j.1440-1681.2007.04601.x; Yeung LY, 2010, TOXICOL LETT, V193, P189, DOI 10.1016/j.toxlet.2010.01.008; Yoshiike Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003029	50	40	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2011	6	6							e21328	10.1371/journal.pone.0021328	http://dx.doi.org/10.1371/journal.pone.0021328			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782CL	21712993	gold, Green Submitted, Green Published			2022-12-27	WOS:000291985100030
J	Zeh, C; Amornkul, PN; Inzaule, S; Ondoa, P; Oyaro, B; Mwaengo, DM; Vandenhoudt, H; Gichangi, A; Williamson, J; Thomas, T; DeCock, KM; Hart, C; Nkengasong, J; Laserson, K				Zeh, Clement; Amornkul, Pauli N.; Inzaule, Seth; Ondoa, Pascale; Oyaro, Boaz; Mwaengo, Dufton M.; Vandenhoudt, Hilde; Gichangi, Anthony; Williamson, John; Thomas, Timothy; DeCock, Kevin M.; Hart, Clyde; Nkengasong, John; Laserson, Kayla			Population-Based Biochemistry, Immunologic and Hematological Reference Values for Adolescents and Young Adults in a Rural Population in Western Kenya	PLOS ONE			English	Article							IMMUNOHEMATOLOGICAL REFERENCE RANGES; ANTIRETROVIRAL THERAPY; REFERENCE INTERVALS; LYMPHOCYTE COUNTS; PLATELET COUNT; HEALTHY-ADULTS; RISK-FACTORS; CELL COUNT; TANZANIA; HIV-1	Background: There is need for locally-derived age-specific clinical laboratory reference ranges of healthy Africans in sub-Saharan Africa. Reference values from North American and European populations are being used for African subjects despite previous studies showing significant differences. Our aim was to establish clinical laboratory reference values for African adolescents and young adults that can be used in clinical trials and for patient management. Methods and Findings: A panel of 298, HIV-seronegative individuals aged 13-34 years was randomly selected from participants in two population-based cross-sectional surveys assessing HIV prevalence and other sexually transmitted infections in western Kenya. The adolescent (<18 years)-to-adults (>= 18 years) ratio and the male-to-female ratio was 1:1. Median and 95% reference ranges were calculated for immunohematological and biochemistry values. Compared with U. S-derived reference ranges, we detected lower hemoglobin (HB), hematocrit (HCT), red blood cells (RBC), mean corpuscular volume (MCV), neutrophil, glucose, and blood urea nitrogen values but elevated eosinophil and total bilirubin values. Significant gender variation was observed in hematological parameters in addition to T-bilirubin and creatinine indices in all age groups, AST in the younger and neutrophil, platelet and CD4 indices among the older age group. Age variation was also observed, mainly in hematological parameters among males. Applying U. S. NIH Division of AIDS (DAIDS) toxicity grading to our results, 40% of otherwise healthy study participants were classified as having an abnormal laboratory parameter (grade 1-4) which would exclude them from participating in clinical trials. Conclusion: Hematological and biochemistry reference values from African population differ from those derived from a North American population, showing the need to develop region-specific reference values. Our data also show variations in hematological indices between adolescent and adult males which should be considered when developing reference ranges. This study provides the first locally-derived clinical laboratory reference ranges for adolescents and young adults in western Kenya.	[Zeh, Clement; Amornkul, Pauli N.; Mwaengo, Dufton M.; Gichangi, Anthony; Williamson, John; Thomas, Timothy; DeCock, Kevin M.; Laserson, Kayla] US Ctr Dis Control & Prevent CDC Kenya, Kisumu, Kenya; [Inzaule, Seth; Oyaro, Boaz] Kenya Med Res Inst US CDC Res & Publ Hlth, Ctr Global Hlth Res, Kisumu, Kenya; [Ondoa, Pascale] Univ Amsterdam, Acad Med Ctr,Ctr Poverty Related Communicable Dis, Amsterdam Inst Global Hlth & Dev AIGHD, Dept Internal Med,Ctr Infect & Immun CINIMA, NL-1105 AZ Amsterdam, Netherlands; [Vandenhoudt, Hilde] Inst Trop Med ITM, Antwerp, Belgium; [Hart, Clyde; Nkengasong, John] US Ctr Dis Control & Prevent, Global AIDS Program, Natl Ctr HIV Viral Hepatitis STD & TB Prevent, Atlanta, GA USA	Kenya Medical Research Institute; University of Amsterdam; Academic Medical Center Amsterdam; Institute of Tropical Medicine (ITM); Centers for Disease Control & Prevention - USA	Zeh, C (corresponding author), US Ctr Dis Control & Prevent CDC Kenya, Kisumu, Kenya.	czeh@ke.cdc.gov			Kenya Medical Research Institute; U.S. Centers for Disease Control and Prevention (CDC), Division of HIV/AIDS Prevention-Surveillance and Epidemiology [5U19C1000323-04]	Kenya Medical Research Institute; U.S. Centers for Disease Control and Prevention (CDC), Division of HIV/AIDS Prevention-Surveillance and Epidemiology(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported by the Kenya Medical Research Institute through a cooperative agreement with the U.S. Centers for Disease Control and Prevention (CDC), Division of HIV/AIDS Prevention-Surveillance and Epidemiology, grant award number-5U19C1000323-04. The study design, data collection instruments, data analysis, decision to publish, and preparation of manuscript was led by scientists at the CDC and stationed in Kenya. Data collection was done by Kenyan staff working for a CDC-funded research station in Kisumu, Kenya. The findings and conclusions in this article are those of the authors and do not necessarily represent the views of the U. S. Centers for Disease Control and Prevention. Use of trade names is for identification purposes only and does not constitute endorsement by the U. S. Centers for Disease Control and Prevention or the Department of Health and Human Services.	Abdulkadir J, 1979, Ethiop Med J, V17, P5; Adazu K, 2005, AM J TROP MED HYG, V73, P1151, DOI 10.4269/ajtmh.2005.73.1151; Amornkul PN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006470; AZIKIWE AN, 1984, E AFR MED J, V61, P482; BADENHORST CJ, 1995, E AFR MED J, V72, P19; Bain BJ, 1996, J CLIN PATHOL, V49, P664, DOI 10.1136/jcp.49.8.664; Cengiz Cem, 2005, Clin Liver Dis, V9, P647, DOI 10.1016/j.cld.2005.07.009; CHOONG ML, 1995, ANN CLIN BIOCHEM, V32, P532, DOI 10.1177/000456329503200603; COZZI LA, 1998, EPIDEMIOL INFECT, V121, P369; DAIDS, 2004, DIV AIDS TABL GRAD S; EFRON B, 1987, J AM STAT ASSOC, V82, P171, DOI 10.2307/2289144; Eller LA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003919; Esparza J, 2003, CURR MOL MED, V3, P183, DOI 10.2174/1566524033479825; Ezeilo G C, 1974, East Afr Med J, V51, P936; GILL GV, 1979, T ROY SOC TROP MED H, V73, P111, DOI 10.1016/0035-9203(79)90142-1; GORDON AS, 1968, ANN NY ACAD SCI, V149, P318, DOI 10.1111/j.1749-6632.1968.tb15167.x; Handzel T, 2003, AM J TROP MED HYG, V69, P318, DOI 10.4269/ajtmh.2003.69.318; HAWKINS WW, 1954, BLOOD, V9, P999, DOI 10.1182/blood.V9.10.999.999; Jaoko W, 2008, VACCINE, V26, P2788, DOI 10.1016/j.vaccine.2008.02.071; Karita E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004401; *KEN MOH, 2001, NAT GUID VOL COUNS T; Kibaya RS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003327; KINOTI G K, 1971, East African Medical Journal, V48, P490; KRABBE S, 1978, ACTA PAEDIATR SCAND, V67, P655, DOI 10.1111/j.1651-2227.1978.tb17818.x; Kratz A, 2004, NEW ENGL J MED, V351, P1548, DOI 10.1056/NEJMcpc049016; Lee BW, 1996, CYTOMETRY, V26, P8, DOI 10.1002/(SICI)1097-0320(19960315)26:1<8::AID-CYTO2>3.0.CO;2-E; Lugada ES, 2004, CLIN DIAGN LAB IMMUN, V11, P29, DOI 10.1128/CDLI.11.1.29-34.2004; MASABA SC, 1983, J TROP MED HYG, V86, P65; Menard D, 2003, CLIN DIAGN LAB IMMUN, V10, P443, DOI 10.1128/CDLI.10.3.443-445.2003; Miller V, 1999, J INFECT DIS, V180, P530, DOI 10.1086/314890; *NAT COMM CLIN LAB, 2000, C28A2 NCCLS, V20; National AIDS and STI Control Programme, 2008, KEN AIDS IND SURV 20; Ng'ayo MO, 2007, SEX TRANSM INFECT, V84, P62, DOI 10.1136/sti.2007.027508; Ngowi BJ, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-1; OBrien WA, 1996, NEW ENGL J MED, V334, P426, DOI 10.1056/NEJM199602153340703; OBrien WA, 1997, ANN INTERN MED, V126, P939, DOI 10.7326/0003-4819-126-12-199706150-00002; Olsen A, 2001, J BIOSOC SCI, V33, P569, DOI 10.1017/S0021932001005697; Phillips AN, 2001, JAMA-J AM MED ASSOC, V286, P2560, DOI 10.1001/jama.286.20.2560; Romeo J, 2009, EUR J HAEMATOL, V83, P586, DOI 10.1111/j.1600-0609.2009.01326.x; Saathoff E, 2008, TROP MED INT HEALTH, V13, P612, DOI 10.1111/j.1365-3156.2008.02047.x; Schnabl Kareena, 2008, Clin Biochem Rev, V29, P89; SHAHABUDDIN S, 1995, CLIN IMMUNOL IMMUNOP, V75, P168, DOI 10.1006/clin.1995.1067; SHAPER AG, 1971, LANCET, V2, P1021; Tsegaye A, 1999, CLIN DIAGN LAB IMMUN, V6, P410, DOI 10.1128/CDLI.6.3.410-414.1999; TUGUME SB, 1995, CLIN DIAGN LAB IMMUN, V2, P233, DOI 10.1128/CDLI.2.2.233-235.1995; *UNAIDS, 2008, AIDS EP UPD GEN; Urassa WK, 2003, J IMMUNOL METHODS, V277, P65, DOI 10.1016/S0022-1759(03)00174-1; World Health Organization, 2008, GLOB TUB CONTR SURV	48	56	57	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2011	6	6							e21040	10.1371/journal.pone.0021040	http://dx.doi.org/10.1371/journal.pone.0021040			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782CL	21713038	Green Published, Green Submitted, gold			2022-12-27	WOS:000291985100008
J	Kitchen, CMR; Yeghiazarian, L; Hoh, R; McCune, JM; Sinclair, E; Martin, JN; Deeks, SG				Kitchen, Christina M. R.; Yeghiazarian, Lilit; Hoh, Rebecca; McCune, Joseph M.; Sinclair, Elizabeth; Martin, Jeffrey N.; Deeks, Steven G.			Immune Activation, Cd4+T Cell Counts, and Viremia Exhibit Oscillatory Patterns over Time in Patients with Highly Resistant HIV Infection	PLOS ONE			English	Article							T-LYMPHOCYTE ACTIVATION; MULTIPLE IMPUTATION; VIROLOGICAL FAILURE; ANTIRETROVIRAL THERAPY; PREDICTIVE-VALUE; SIV INFECTION; EL-NINO; DYNAMICS; RNA; INDIVIDUALS	The rates of immunologic and clinical progression are lower in patients with drug-resistant HIV compared to wild-type HIV. This difference is not fully explained by viral load. It has been argued that reductions in T cell activation and/or viral fitness might result in preserved target cells and an altered relationship between the level of viremia and the rate of CD4+ T cell loss. We tested this hypothesis over time in a cohort of patients with highly resistant HIV. Fifty-four antiretroviral-treated patients with multi-drug resistant HIV and detectable plasma HIV RNA were followed longitudinally. CD4+ T cell counts and HIV RNA levels were measured every 4 weeks and T cell activation (CD38/HLA-DR) was measured every 16 weeks. We found that the levels of CD4+ T cell activation over time were a strong independent predictor of CD4+ T cell counts while CD8+ T cell activation was more strongly associated with viremia. Using spectral analysis, we found strong evidence for oscillatory (or cyclic) behavior in CD4+ T cell counts, HIV RNA levels, and T cell activation. Each of the cell populations exhibited an oscillatory behavior with similar frequencies. Collectively, these data suggest that there may be a mechanistic link between T cell activation, CD4+ T cell counts, and viremia and lends support for the hypothesis of altered predator-prey dynamics as a possible explanation of the stability of CD4+ T cell counts in the presence of sustained multi-drug resistant viremia.	[Kitchen, Christina M. R.; Yeghiazarian, Lilit] Univ Calif Los Angeles, Dept Biostat, Los Angeles, CA 90024 USA; [Yeghiazarian, Lilit] Univ Cincinnati, Sch Energy Biol & Med Engn, Environm Engn Program, Cincinnati, OH USA; [Hoh, Rebecca; Deeks, Steven G.] Univ Calif San Francisco, Dept Med, HIV AIDS Program, San Francisco, CA USA; [McCune, Joseph M.; Sinclair, Elizabeth] Univ Calif San Francisco, Dept Med, Div Expt Med, San Francisco, CA USA; [Martin, Jeffrey N.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	University of California System; University of California Los Angeles; University System of Ohio; University of Cincinnati; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Kitchen, CMR (corresponding author), Univ Calif Los Angeles, Dept Biostat, Los Angeles, CA 90024 USA.	cr@ucla.edu	Ramirez, Christina/AAT-5088-2021	Ramirez, Christina/0000-0002-8435-0416	University of California Los Angeles Center for AIDS Research (CMRK); National Institutes of Health [AI055273, AI44595, AI069994, DPI OD00329]; University of California San Francisco (UCSF) CFAR [P30 MH59037]; UCSF Clinical and Translational Research Institute Clinical Research Center [UL1 RR024131]; Center for AIDS Prevention Studies [P30 MH62246]; Burroughs Wellcome Fund; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044595, K24AI069994] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH059037, P30MH062246] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000329] Funding Source: NIH RePORTER	University of California Los Angeles Center for AIDS Research (CMRK); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California San Francisco (UCSF) CFAR; UCSF Clinical and Translational Research Institute Clinical Research Center; Center for AIDS Prevention Studies; Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the University of California Los Angeles Center for AIDS Research (CMRK) AIDS Training Grant (LY), the National Institutes of Health (AI055273, AI44595, AI069994), University of California San Francisco (UCSF) CFAR (P30 MH59037); the UCSF Clinical and Translational Research Institute Clinical Research Center (UL1 RR024131); and the Center for AIDS Prevention Studies (P30 MH62246). JMM is a recipient of the Burroughs Wellcome Fund Clinical Scientist Award in Translational Research and the NIH Director's Pioneer Award Program, part of the NIH Roadmap for Medical Research, through grant number DPI OD00329. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RM, INFECT DIS HUMANS DY; BEAL SL, 1982, CRIT REV BIOMED ENG, V8, P195; Bloomfield P., 2000, FOURIER ANAL TIME SE, P261; Bonhoeffer S, 1997, J VIROL, V71, P3275, DOI 10.1128/JVI.71.4.3275-3278.1997; Bouma MJ, 1996, TROP MED INT HEALTH, V1, P86, DOI 10.1046/j.1365-3156.1996.d01-7.x; Broersen PMT, 2004, AUTOMATICA, V40, P1495, DOI 10.1016/j.automatica.2004.04.011; Catalfamo M, 2008, P NATL ACAD SCI USA, V105, P19851, DOI 10.1073/pnas.0810032105; Deeks SG, 2004, BLOOD, V104, P942, DOI 10.1182/blood-2003-09-3333; Deeks SG, 2000, J INFECT DIS, V181, P946, DOI 10.1086/315334; Emu B, 2005, J VIROL, V79, P14169, DOI 10.1128/JVI.79.22.14169-14178.2005; Giorgi JV, 2002, J ACQ IMMUN DEF SYND, V29, P346, DOI 10.1097/00126334-200204010-00004; Giorgi JV, 1999, J INFECT DIS, V179, P859, DOI 10.1086/314660; Graham JW, 2007, PREV SCI, V8, P206, DOI 10.1007/s11121-007-0070-9; Grossman Z, 1998, P NATL ACAD SCI USA, V95, P6314, DOI 10.1073/pnas.95.11.6314; Hales S, 1999, ENVIRON HEALTH PERSP, V107, P99, DOI 10.2307/3434364; Havlir DV, 1998, NEW ENGL J MED, V339, P1261, DOI 10.1056/NEJM199810293391801; Hazenberg MD, 2003, AIDS, V17, P1881, DOI 10.1097/00002030-200309050-00006; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Hopke PK, 2001, BIOMETRICS, V57, P22, DOI 10.1111/j.0006-341X.2001.00022.x; Hunt PW, 2006, AIDS, V20, P691, DOI 10.1097/01.aids.0000216369.30948.18; Hunt PW, 2003, J INFECT DIS, V187, P1534, DOI 10.1086/374786; Ledergerber B, 2004, LANCET, V364, P51, DOI 10.1016/S0140-6736(04)16589-6; LEE H, 2011, ASTROPHYSIC IN PRESS; Lindblade KA, 1999, T ROY SOC TROP MED H, V93, P480, DOI 10.1016/S0035-9203(99)90344-9; Liu Z, 1998, J ACQ IMMUN DEF SYND, V18, P332, DOI 10.1097/00042560-199808010-00004; Mellors JW, 2007, JAMA-J AM MED ASSOC, V297, P2349, DOI 10.1001/jama.297.21.2349; Nowak MA, 1996, SCIENCE, V272, P74, DOI 10.1126/science.272.5258.74; Penn ML, 2001, AIDS RES HUM RETROV, V17, P517, DOI 10.1089/08892220151126580; PERELSON AS, 1993, MATH BIOSCI, V114, P81, DOI 10.1016/0025-5564(93)90043-A; Petersen ML, 2008, AIDS, V22, P2097, DOI 10.1097/QAD.0b013e32830f97e2; Phillips AN, 1997, J MED VIROL, V53, P261, DOI 10.1002/(SICI)1096-9071(199711)53:3<261::AID-JMV14>3.0.CO;2-K; PRESS WH, NUMERICAL RECIPES C; Reuman DC, 2006, P NATL ACAD SCI USA, V103, P18860, DOI 10.1073/pnas.0608571103; Robbins GK, 2009, CLIN INFECT DIS, V48, P350, DOI 10.1086/595888; Rodriguez B, 2006, JAMA-J AM MED ASSOC, V296, P1498, DOI 10.1001/jama.296.12.1498; Rubin DB, 1996, J AM STAT ASSOC, V91, P473, DOI 10.1080/01621459.1996.10476908; Silvestri G, 2003, IMMUNITY, V18, P441, DOI 10.1016/S1074-7613(03)00060-8; Silvestri G, 2007, J CLIN INVEST, V117, P3148, DOI 10.1172/JCI33034; Spouge JL, 1996, MATH BIOSCI, V138, P1, DOI 10.1016/S0025-5564(96)00064-8; Spratt M, 2010, AM J EPIDEMIOL, V172, P478, DOI 10.1093/aje/kwq137; Sterne Jonathan A C, 2009, BMJ, V338, pb2393, DOI 10.1136/bmj.b2393; Suntharalingam G, 2006, NEW ENGL J MED, V355, P1018, DOI 10.1056/NEJMoa063842; Tesselaar K, 2003, NAT IMMUNOL, V4, P49, DOI 10.1038/ni869; Vaidya NK, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001012; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; White IR, 2010, STAT MED, V29, P2920, DOI 10.1002/sim.3944	46	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e21190	10.1371/journal.pone.0021190	http://dx.doi.org/10.1371/journal.pone.0021190			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	21701594	Green Published, Green Submitted, gold			2022-12-27	WOS:000291983800030
J	Stolovicki, E; Braun, E				Stolovicki, Elad; Braun, Erez			Collective Dynamics of Gene Expression in Cell Populations	PLOS ONE			English	Article							ADAPTATION; YEAST; NOISE; INHERITANCE; RESPONSES; CYCLE	The phenotypic state of the cell is commonly thought to be determined by the set of expressed genes. However, given the apparent complexity of genetic networks, it remains open what processes stabilize a particular phenotypic state. Moreover, it is not clear how unique is the mapping between the vector of expressed genes and the cell's phenotypic state. To gain insight on these issues, we study here the expression dynamics of metabolically essential genes in twin cell populations. We show that two yeast cell populations derived from a single steady-state mother population and exhibiting a similar growth phenotype in response to an environmental challenge, displayed diverse expression patterns of essential genes. The observed diversity in the mean expression between populations could not result from stochastic cell-to-cell variability, which would be averaged out in our large cell populations. Remarkably, within a population, sets of expressed genes exhibited coherent dynamics over many generations. Thus, the emerging gene expression patterns resulted from collective population dynamics. It suggests that in a wide range of biological contexts, gene expression reflects a self-organization process coupled to population-environment dynamics.	[Stolovicki, Elad] Technion Israel Inst Technol, Dept Phys, IL-32000 Haifa, Israel; Technion Israel Inst Technol, Network Biol Res Labs, IL-32000 Haifa, Israel	Technion Israel Institute of Technology; Technion Israel Institute of Technology	Stolovicki, E (corresponding author), Technion Israel Inst Technol, Dept Phys, IL-32000 Haifa, Israel.	erez@physics.technion.ac.il	Stolovicki, Elad/AAT-1742-2021		Israel Science Foundation [95/08, 496/10]; US-Israel Binational Foundation	Israel Science Foundation(Israel Science Foundation); US-Israel Binational Foundation(US-Israel Binational Science Foundation)	This work was supported by the Israel Science Foundation (grants 95/08, 496/10), and the US-Israel Binational Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi EM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000257; Avery SV, 2006, NAT REV MICROBIOL, V4, P577, DOI 10.1038/nrmicro1460; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Booth IR, 2002, INT J FOOD MICROBIOL, V78, P19, DOI 10.1016/S0168-1605(02)00239-8; Braun E, 2004, PHYS BIOL, V1, P67, DOI 10.1088/1478-3967/1/2/003; Brenner N, 2006, PHYS BIOL, V3, P172, DOI 10.1088/1478-3975/3/3/002; Carroll S. B., 2001, DNA DIVERSITY MOL GE; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; David L, 2010, HFSP J, V4, P131, DOI 10.2976/1.3353782; Davidson E.H., 2006, REGULATORY GENOME; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Furusawa C, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040003; Furusawa C, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-17; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; GEVAZATORSKY N, 2006, MOL SYSTEMS BIOL, V10, P1; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Huang S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.128701; Huang S, 2009, BIOESSAYS, V31, P546, DOI 10.1002/bies.200800189; Jablonka E, 2009, Q REV BIOL, V84, P131, DOI 10.1086/598822; Johnston M, 1999, TRENDS GENET, V15, P29, DOI 10.1016/S0168-9525(98)01637-0; Kaneko K., 2006, INTRO COMPLEX SYSTEM; Kauffman S.A., 1993, ORIGINS ORDER; Kaufmann BB, 2007, PLOS BIOL, V5, P1973, DOI 10.1371/journal.pbio.0050239; Klevecz RR, 2008, FEBS J, V275, P2372, DOI 10.1111/j.1742-4658.2008.06399.x; Lachmann M, 1996, J THEOR BIOL, V181, P1, DOI 10.1006/jtbi.1996.0109; Lashkari DA, 1997, P NATL ACAD SCI USA, V94, P13057, DOI 10.1073/pnas.94.24.13057; Levin BR, 2006, NAT REV MICROBIOL, V4, P556, DOI 10.1038/nrmicro1445; LEWONTIN RC, 2001, LIFE MIND, P59; Lopez-Maury L, 2008, NAT REV GENET, V9, P583, DOI 10.1038/nrg2398; Moss Lenny, 2003, WHAT GENES CANT DO; Murray DB, 2007, P NATL ACAD SCI USA, V104, P2241, DOI 10.1073/pnas.0606677104; Odling-Smee FJ, 2003, NICHE CONSTRUCTION N; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Ribeiro AS, 2007, J THEOR BIOL, V247, P743, DOI 10.1016/j.jtbi.2007.04.020; Stern S, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100147; Stolovicki E, 2006, GENETICS, V173, P75, DOI 10.1534/genetics.106.055442; Tsuchyia M, 2007, FEBS J, V274, P2878, DOI 10.1111/j.1742-4658.2007.05822.x; Tu BP, 2005, SCIENCE, V310, P1152, DOI 10.1126/science.1120499; Waddington C.H., 1957, STRATEGY GENE	41	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e20530	10.1371/journal.pone.0020530	http://dx.doi.org/10.1371/journal.pone.0020530			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698278	Green Published, gold, Green Submitted			2022-12-27	WOS:000291730000012
J	Caspers, BA; Schroeder, FC; Franke, S; Voigt, CC				Caspers, Barbara A.; Schroeder, Frank C.; Franke, Stephan; Voigt, Christian C.			Scents of Adolescence: The Maturation of the Olfactory Phenotype in a Free-Ranging Mammal	PLOS ONE			English	Article							SACCOPTERYX-BILINEATA CHIROPTERA; SEXUAL SELECTION; POTENTIAL USE; BAT; EMBALLONURIDAE; ODOR; RECOGNITION; PUBERTY	Olfaction is an important sensory modality for mate recognition in many mammal species. Odorants provide information about the health status, genotype, dominance status and/or reproductive status. How and when odor profiles change during sexual maturation is, however often unclear, particularly in free-ranging mammals. Here, we investigated whether the wing sac odorant of male greater sac-winged bats (Saccopteryx bilineata, Emballonuridae) differs between young and adults, and thus offers information about sexual maturity to potential mating partners. Using gas chromatography - mass spectrometry, we found differences in the odorants of young and adult males prior and during, but not after the mating period. The wing sac odorant of adult males consists of several substances, such as Pyrocoll, 2,6,10-trimethyl-3-oxo-6,10-dodecadienolide, and a so far unidentified substance; all being absent in the odor profiles of juveniles prior to the mating season. During the mating season, these substances are present in most of the juvenile odorants, but still at lower quantities compared to the wing sac odorants of adults. These results suggest that the wing sac odorant of males encodes information about age and/or sexual maturity. Although female S. bilineata start to reproduce at the age of half a year, most males of the same age postpone the sexual maturation of their olfactory phenotype until after the first mating season.	[Caspers, Barbara A.] Univ Bielefeld, Dept Anim Behaviour, Bielefeld, Germany; [Schroeder, Frank C.] Boyce Thompson Inst Plant Res, Ithaca, NY USA; [Schroeder, Frank C.] Cornell Univ, Ithaca, NY USA; [Franke, Stephan] Univ Hamburg, Inst Organ Chem, D-2000 Hamburg, Germany; [Voigt, Christian C.] Leibniz Inst Zoo & Wildlife Res, Evolutionary Ecol Res Grp, Berlin, Germany	University of Bielefeld; Cornell University; Boyce Thompson Institute for Plant Research; Cornell University; University of Hamburg; Leibniz Institut fur Zoo und Wildtierforschung	Caspers, BA (corresponding author), Univ Bielefeld, Dept Anim Behaviour, Bielefeld, Germany.	barbara.caspers@uni-bielefeld.de	Schroeder, Frank/H-5026-2012; Caspers, Barbara/C-5573-2011	Caspers, Barbara/0000-0002-4380-0476; Schroeder, Frank/0000-0002-4420-0237	German National Science Council [Vo 890/9]; National Institutes of Health [GM 53830]; Boyce-Thompson Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053830] Funding Source: NIH RePORTER	German National Science Council; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boyce-Thompson Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported in part by a grant from the German National Science Council (to CCV: DFG; Vo 890/9), the National Institutes of Health (GM 53830), and the Boyce-Thompson Institute (to FCS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Publication fee was supported by the Open Access Publication Fund of Bielefeld University.	Bloss J, 2002, J CHEM ECOL, V28, P819, DOI 10.1023/A:1015296928423; Burger BV, 2005, TOP CURR CHEM, V240, P231, DOI 10.1007/b98318; Caspers B, 2008, CHEM SIGNAL, V11, P151, DOI 10.1007/978-0-387-73945-8_14; Caspers B, 2009, ZOOMORPHOLOGY, V128, P37, DOI 10.1007/s00435-008-0072-6; Caspers BA, 2009, ETHOLOGY, V115, P713, DOI 10.1111/j.1439-0310.2009.01651.x; Caspers BA, 2009, BEHAV ECOL SOCIOBIOL, V63, P741, DOI 10.1007/s00265-009-0708-7; Clarke KR, 2006, J EXP MAR BIOL ECOL, V330, P55, DOI 10.1016/j.jembe.2005.12.017; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Dechmann Dina K. N., 2005, COGNITION BRAIN BEHA, V9, P479; Ebling F.J., 1977, P17; EBLING FJ, 1972, GEN COMP ENDOCR S, V3, P223; Greene E, 2000, NATURE, V407, P1000, DOI 10.1038/35039500; Greiner S, 2011, J TROP ECOL, V27, P121, DOI 10.1017/S0266467410000696; Johansson BG, 2007, BIOL REV, V82, P265, DOI 10.1111/j.1469-185X.2007.00009.x; Muehter VR, 1997, BEHAV ECOL SOCIOBIOL, V41, P281, DOI 10.1007/s002650050389; MYER JS, 1964, J COMP PHYSIOL PSYCH, V58, P112, DOI 10.1037/h0045533; MYKYTOWYCZ R, 1972, NATURWISSENSCHAFTEN, V59, P133, DOI 10.1007/BF00637350; Nagy M, 2007, P ROY SOC B-BIOL SCI, V274, P3019, DOI 10.1098/rspb.2007.1008; Osada K, 2009, CHEM SENSES, V34, P713, DOI 10.1093/chemse/bjp058; Pusey A, 1996, TRENDS ECOL EVOL, V11, P201, DOI 10.1016/0169-5347(96)10028-8; Quay W., 1970, BIOL BATS, P2; Rasmussen LEL, 2002, NATURE, V415, P975, DOI 10.1038/415975a; Schaffer J., 1940, HAUTDRUSENORGANE SAU; Setchell JM, 2010, CHEM SENSES, V35, P205, DOI 10.1093/chemse/bjp105; Sisk CL, 2004, NAT NEUROSCI, V7, P1040, DOI 10.1038/nn1326; Starck D., 1958, Gegenbaurs Jahrbuch, V99, P3; STEARNS SC, 1986, EVOLUTION, V40, P893, DOI 10.1111/j.1558-5646.1986.tb00560.x; STEARNS SC, 1976, Q REV BIOL, V51, P3, DOI 10.1086/409052; Stevenson IR, 1995, P ROY SOC B-BIOL SCI, V262, P267, DOI 10.1098/rspb.1995.0205; TANNENBAUM R, 1975, THESIS CORNELL U; Trillmich F, 2009, PHYSIOL BEHAV, V96, P476, DOI 10.1016/j.physbeh.2008.11.014; Voigt CC, 1999, BEHAV ECOL SOCIOBIOL, V47, P29, DOI 10.1007/s002650050646; Voigt CC, 2008, J MAMMAL, V89, P50, DOI 10.1644/06-MAMM-A-432.1; Voigt CC, 2007, ACTA CHIROPTEROL, V9, P463, DOI 10.3161/1733-5329(2007)9[463:AOFTMA]2.0.CO;2; Voigt CC, 2008, J MAMMAL, V89, P1401, DOI 10.1644/08-MAMM-S-060.1; Zhang JX, 2001, PHYSIOL BEHAV, V74, P415, DOI 10.1016/S0031-9384(01)00506-6	36	14	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21162	10.1371/journal.pone.0021162	http://dx.doi.org/10.1371/journal.pone.0021162			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738615	gold, Green Submitted, Green Published			2022-12-27	WOS:000292092600015
J	Hu, ZZ; Kagan, BL; Ariazi, EA; Rosenthal, DS; Zhang, LH; Li, JV; Huang, HZ; Wu, C; Jordan, VC; Riegel, AT; Wellstein, A				Hu, Zhang-Zhi; Kagan, Benjamin L.; Ariazi, Eric A.; Rosenthal, Dean S.; Zhang, Lihua; Li, Jordan V.; Huang, Hongzhan; Wu, Cathy; Jordan, V. Craig; Riegel, Anna T.; Wellstein, Anton			Proteomic Analysis of Pathways Involved in Estrogen-Induced Growth and Apoptosis of Breast Cancer Cells	PLOS ONE			English	Article							NUCLEAR RECEPTOR COACTIVATOR; TYROSINE PHOSPHORYLATION; ANTIHORMONAL THERAPY; TAMOXIFEN RESISTANCE; ENDOCRINE THERAPY; AIB1; KINASE; SRC-3; PROLIFERATION; MODULATION	Background: Estrogen is a known growth promoter for estrogen receptor (ER)-positive breast cancer cells. Paradoxically, in breast cancer cells that have been chronically deprived of estrogen stimulation, re-introduction of the hormone can induce apoptosis. Methodology/Principal Findings: Here, we sought to identify signaling networks that are triggered by estradiol (E2) in isogenic MCF-7 breast cancer cells that undergo apoptosis (MCF-7: 5C) versus cells that proliferate upon exposure to E2 (MCF-7). The nuclear receptor co-activator AIB1 (Amplified in Breast Cancer-1) is known to be rate-limiting for E2-induced cell survival responses in MCF-7 cells and was found here to also be required for the induction of apoptosis by E2 in the MCF-7: 5C cells. Proteins that interact with AIB1 as well as complexes that contain tyrosine phosphorylated proteins were isolated by immunoprecipitation and identified by mass spectrometry (MS) at baseline and after a brief exposure to E2 for two hours. Bioinformatic network analyses of the identified protein interactions were then used to analyze E2 signaling pathways that trigger apoptosis versus survival. Comparison of MS data with a computationally-predicted AIB1 interaction network showed that 26 proteins identified in this study are within this network, and are involved in signal transduction, transcription, cell cycle regulation and protein degradation. Conclusions: G-protein-coupled receptors, PI3 kinase, Wnt and Notch signaling pathways were most strongly associated with E2-induced proliferation or apoptosis and are integrated here into a global AIB1 signaling network that controls qualitatively distinct responses to estrogen.	[Hu, Zhang-Zhi; Kagan, Benjamin L.; Rosenthal, Dean S.; Zhang, Lihua; Li, Jordan V.; Jordan, V. Craig; Riegel, Anna T.; Wellstein, Anton] Georgetown Univ, Lombardi Canc Ctr, Washington, DC USA; [Ariazi, Eric A.] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA	Georgetown University; Fox Chase Cancer Center	Hu, ZZ (corresponding author), Georgetown Univ, Lombardi Canc Ctr, Washington, DC USA.	wellstea@georgetown.edu	Rosenthal, Dean S/J-2360-2014; Jordan, V. Craig/H-4491-2011; JORDAN, V.Craig/AAX-3562-2020	Rosenthal, Dean/0000-0002-7624-0209; Wellstein, Anton/0000-0002-0570-4950; Wu, Cathy/0000-0001-6379-8601	Department of Defense, Center of Excellence [W81XWH-06-10590]; National Institutes of Health/National Cancer Institute [R01 CA113477, P30 CA051008]; NATIONAL CANCER INSTITUTE [P50CA058185, P30CA051008, R01CA113477] Funding Source: NIH RePORTER	Department of Defense, Center of Excellence(United States Department of Defense); National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Department of Defense Breast Program W81XWH-06-10590 Center of Excellence Grant (V.C.J., A.W., A.T.R.), National Institutes of Health/National Cancer Institute R01 CA113477 (A.T.R.) and P30 CA051008. Views and opinions of, and endorsements by the author(s) do not reflect those of the U.S. Army or the Department of Defense. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Aebersold R, 2009, NAT METHODS, V6, P411, DOI [10.1038/NMETH.F.255, 10.1038/nmeth.f.255]; Ahn J, 2009, J BIOL CHEM, V284, P13812, DOI 10.1074/jbc.M808821200; Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Ariazi EA, 2006, J STEROID BIOCHEM, V102, P128, DOI 10.1016/j.jsbmb.2006.09.003; Ariazi EA, 2010, CANCER RES, V70, P1184, DOI 10.1158/0008-5472.CAN-09-3068; Arpino G, 2008, ENDOCR REV, V29, P217, DOI 10.1210/er.2006-0045; Bell AW, 2009, NAT METHODS, V6, P423, DOI [10.1038/NMETH.1333, 10.1038/nmeth.1333]; Brauch H, 2009, EUR J CANCER, V45, P2274, DOI 10.1016/j.ejca.2009.05.032; Brinkmeier ML, 2003, MOL ENDOCRINOL, V17, P2152, DOI 10.1210/me.2003-0225; Bundy DL, 1997, J BIOL CHEM, V272, P33132, DOI 10.1074/jbc.272.52.33132; CARTER AC, 1977, JAMA-J AM MED ASSOC, V237, P2079, DOI 10.1001/jama.237.19.2079; Castellano L, 2009, P NATL ACAD SCI USA, V106, P15732, DOI 10.1073/pnas.0906947106; Coste A, 2008, P NATL ACAD SCI USA, V105, P17187, DOI 10.1073/pnas.0808207105; Coste A, 2006, EMBO J, V25, P2453, DOI 10.1038/sj.emboj.7601106; Cuevas IC, 2005, CANCER RES, V65, P5070, DOI 10.1158/0008-5472.CAN-05-0240; de Mora JF, 2000, MOL CELL BIOL, V20, P5041, DOI 10.1128/MCB.20.14.5041-5047.2000; Deng QD, 2004, ONCOGENE, V23, P4903, DOI 10.1038/sj.onc.1207615; Dodds EC, 1938, NATURE, V141, P247, DOI 10.1038/141247b0; Ellis MJ, 2009, JAMA-J AM MED ASSOC, V302, P774, DOI 10.1001/jama.2009.1204; Engelmann A, 2008, ONCOGENE, V27, P1429, DOI 10.1038/sj.onc.1210772; Fereshteh MP, 2008, CANCER RES, V68, P3697, DOI 10.1158/0008-5472.CAN-07-6702; Fernando RI, 2004, MOL BIOL CELL, V15, P3266, DOI 10.1091/mbc.E03-11-0823; Fichtner I, 2004, EUR J CANCER, V40, P845, DOI 10.1016/j.ejca.2003.11.030; Haddow A, 1944, BMJ-BRIT MED J, V1944, P393; Han Sang Jun, 2006, Nucl Recept Signal, V4, pe014; Hiraike H, 2010, BRIT J CANCER, V102, P1061, DOI 10.1038/sj.bjc.6605577; Hoffman BG, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-81; Howell A, 2005, LANCET, V365, P60, DOI 10.1016/s0140-6736(04)17666-6; Hu ZZ, 2011, METHODS MOL BIOL, V719, P547, DOI 10.1007/978-1-61779-027-0_26; Hu Zhang-Zhi, 2008, J Proteomics Bioinform, V1, P47; JIANG SY, 1992, MOL CELL ENDOCRINOL, V90, P77, DOI 10.1016/0303-7207(92)90104-E; Jordan JD, 1999, J BIOL CHEM, V274, P21507, DOI 10.1074/jbc.274.31.21507; Jordan VC, 2007, BREAST, V16, pS105, DOI 10.1016/j.breast.2007.07.020; Jordan VC, 2005, BREAST, V14, P624, DOI 10.1016/j.breast.2005.08.022; JORDAN VC, 2011, CANC PREVENTION RES; Kerrien S, 2007, NUCLEIC ACIDS RES, V35, pD561, DOI 10.1093/nar/gkl958; Klumpp S, 2002, CURR OPIN PHARMACOL, V2, P458, DOI 10.1016/S1471-4892(02)00176-5; Konecny GE, 2006, CANCER RES, V66, P1630, DOI 10.1158/0008-5472.CAN-05-1182; Lahusen T, 2007, CANCER RES, V67, P7256, DOI 10.1158/0008-5472.CAN-07-1013; Lahusen T, 2009, BREAST CANCER RES TR, V116, P225, DOI 10.1007/s10549-009-0405-2; Lanz RB, 2010, MOL ENDOCRINOL, V24, P859, DOI 10.1210/me.2009-0499; Lewis JS, 2005, J STEROID BIOCHEM, V94, P131, DOI 10.1016/j.jsbmb.2004.12.032; Lewis JS, 2005, JNCI-J NATL CANCER I, V97, P1746, DOI 10.1093/jnci/dji400; Lewis-Wambi JS, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2255; LIPPMAN ME, 1975, NATURE, V256, P592, DOI 10.1038/256592a0; List HJ, 2001, J BIOL CHEM, V276, P23763, DOI 10.1074/jbc.M102397200; Liu YL, 1996, GENOMICS, V31, P58, DOI 10.1006/geno.1996.0009; Liu ZJ, 2008, CANCER INVEST, V26, P878, DOI 10.1080/07357900801965042; Long WW, 2010, MOL CELL, V37, P321, DOI 10.1016/j.molcel.2010.01.004; Lonning PE, 2001, BREAST CANCER RES TR, V67, P111, DOI 10.1023/A:1010619225209; Louet JF, 2006, P NATL ACAD SCI USA, V103, P17868, DOI 10.1073/pnas.0608711103; Macedo LF, 2009, ANN NY ACAD SCI, V1155, P162, DOI 10.1111/j.1749-6632.2008.03689.x; Mathas S, 2005, BLOOD, V106, P4287, DOI 10.1182/blood-2004-09-3620; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; Nagahama Y, 2008, CANCER SCI, V99, P23, DOI 10.1111/j.1349-7006.2007.00650.x; Nicholson RI, 2005, BREAST CANCER RES TR, V93, pS3, DOI 10.1007/s10549-005-9036-4; Oh A, 2004, CANCER RES, V64, P8299, DOI 10.1158/0008-5472.CAN-04-0354; Oh AS, 2008, MOL CELL BIOL, V28, P6580, DOI 10.1128/MCB.00118-08; Osborne CK, 2003, J NATL CANCER I, V95, P353, DOI 10.1093/jnci/95.5.353; Papa S, 2004, NAT CELL BIOL, V6, P146, DOI 10.1038/ncb1093; Roux PP, 2003, MOL CELL BIOL, V23, P4796, DOI 10.1128/MCB.23.14.4796-4804.2003; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schiff R, 2003, CLIN CANCER RES, V9, p447S; Song RXD, 2001, J NATL CANCER I, V93, P1714, DOI 10.1093/jnci/93.22.1714; Sullivan A, 2007, BRIT J CANCER, V96, P196, DOI 10.1038/sj.bjc.6603525; Tilli MT, 2005, MOL ENDOCRINOL, V19, P644, DOI 10.1210/me.2004-0106; Tong DD, 2009, PATHOBIOLOGY, V76, P163, DOI 10.1159/000218332; Torres-Arzayus MI, 2006, CANCER RES, V66, P11381, DOI 10.1158/0008-5472.CAN-06-2316; Torres-Arzayus MI, 2004, CANCER CELL, V6, P263, DOI 10.1016/j.ccr.2004.06.027; van Agthoven T, 2009, J CLIN ONCOL, V27, P542, DOI 10.1200/JCO.2008.17.1462; Xu JM, 2009, NAT REV CANCER, V9, P615, DOI 10.1038/nrc2695; Xu JM, 2000, P NATL ACAD SCI USA, V97, P6379, DOI 10.1073/pnas.120166297; Zhang JY, 2005, CANCER RES, V65, P8372, DOI 10.1158/0008-5472.CAN-05-0576; Zhao WH, 2009, BIOCHEM BIOPH RES CO, V380, P699, DOI 10.1016/j.bbrc.2009.01.155; Zhao Y, 2002, J BIOL CHEM, V277, P30031, DOI 10.1074/jbc.M203811200; Zhou G, 2003, MOL CELL BIOL, V23, P7742, DOI 10.1128/MCB.23.21.7742-7755.2003; ZIMMER A, 1994, BIOCHEM BIOPH RES CO, V201, P943, DOI 10.1006/bbrc.1994.1793	78	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e20410	10.1371/journal.pone.0020410	http://dx.doi.org/10.1371/journal.pone.0020410			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738574	Green Submitted, Green Published, gold			2022-12-27	WOS:000292092600002
J	Ma, KU; Liu, Y; Zhu, Q; Liu, CH; Duan, JL; Tan, BKH; Zhu, YZ				Ma, Kaium; Liu, Yan; Zhu, Qing; Liu, Chun-hua; Duan, Jun-Li; Tan, Benny K-H; Zhu, Yi Zhun			H2S Donor, S-Propargyl-Cysteine, Increases CSE in SGC-7901 and Cancer-Induced Mice: Evidence for a Novel Anti-Cancer Effect of Endogenous H2S?	PLOS ONE			English	Article							ACINAR-CELL APOPTOSIS; DIALLYL TRISULFIDE; HYDROGEN-SULFIDE; PROSTATE-CANCER; E-CADHERIN; CYCLE ARREST; IN-VITRO; CARCINOMA; GROWTH; RAT	Background: S-propargyl-cysteine (SPRC), an H2S donor, is a structural analogue of S-allycysteine (SAC). It was investigated for its potential anti-cancer effect on SGC-7901 gastric cancer cells and the possible mechanisms that may be involved. Methods and Findings: SPRC treatment significantly decreased cell viability, suppressed the proliferation and migration of SPRC-7901 gastric cancer cells, was pro-apoptotic as well as caused cell cycle arrest at the G(1)/S phase. In an in vivo study, intra-peritoneal injection of 50 mg/kg and 100 mg/kg of SPRC significantly reduced tumor weights and tumor volumes of gastric cancer implants in nude mice, with a tumor growth inhibition rate of 40-75%. SPRC also induced a pro-apoptotic effect in cancer tissues and elevated the expressions of p53 and Bax in tumors and cells. SPRC treatment also increased protein expression of cystathione-gamma-lyase (CSE) in cells and tumors, and elevated H2S levels in cell culture media, plasma and tumoral CSE activity of gastric cancer-induced nude mice by 2, 2.3 and 1.4 fold, respectively. Most of the anti-cancer functions of SPRC on cells and tumors were significantly suppressed by PAG, an inhibitor of CSE activity. Conclusions: Taken together, the results of our study provide insights into a novel anti-cancer effect of H2S as well as of SPRC on gastric cancer through inducing the activity of a new target, CSE.	[Ma, Kaium; Zhu, Qing; Liu, Chun-hua; Zhu, Yi Zhun] Fudan Univ, Sch Pharm, Dept Pharmacol, Shanghai 200433, Peoples R China; [Ma, Kaium; Zhu, Qing; Liu, Chun-hua; Zhu, Yi Zhun] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Liu, Yan] Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Cardiovasc Med, Shanghai 200030, Peoples R China; [Duan, Jun-Li] Shanghai Jiao Tong Univ, Xinhua Hosp, Dept Gerontol, Shanghai 200030, Peoples R China; [Tan, Benny K-H; Zhu, Yi Zhun] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore 117595, Singapore	Fudan University; Fudan University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; National University of Singapore	Ma, KU (corresponding author), Fudan Univ, Sch Pharm, Dept Pharmacol, Shanghai 200433, Peoples R China.	zhuyz@fudan.edu.cn	Zhu, Yi Zhun/ABG-8449-2021; Zhu, Qing/G-4522-2018	Zhu, Yi Zhun/0000-0001-7700-8041; Zhu, Qing/0000-0002-9411-9517	National Distinguished Young Scientists Grant in China [385 (30888002)]; National 973 Project [2007CB512006, 2010CB912600]; Shanghai-Unilever Research & Development Fund [08540750400]	National Distinguished Young Scientists Grant in China; National 973 Project(National Basic Research Program of China); Shanghai-Unilever Research & Development Fund	We acknowledge the financial assistance provided by a grant from the National Distinguished Young Scientists Grant 385 (No. 30888002) in China, the National 973 Project (2007CB512006 and 2010CB912600) and Shanghai-Unilever Research & Development Fund (08540750400).	Adhikari S, 2008, J CELL MOL MED, V12, P1374, DOI 10.1111/j.1582-4934.2008.00318.x; Arunkumar A, 2006, MOL CELL BIOCHEM, V288, P107, DOI 10.1007/s11010-006-9126-6; Baskar R, 2007, FASEB J, V21, P247, DOI 10.1096/fj.06-6255com; BRESLOW N, 1977, INT J CANCER, V20, P680, DOI 10.1002/ijc.2910200506; Cao Y, 2006, AM J PHYSIOL-CELL PH, V291, pC503, DOI 10.1152/ajpcell.00547.2005; Chu QJ, 2006, CARCINOGENESIS, V27, P2180, DOI 10.1093/carcin/bgl054; Davis SR, 2005, MYCOSES, V48, P95, DOI 10.1111/j.1439-0507.2004.01076.x; Dong CN, 2009, BIOORGAN MED CHEM, V17, P3499, DOI 10.1016/j.bmc.2009.02.065; Geng B, 2004, BIOCHEM BIOPH RES CO, V313, P362, DOI 10.1016/j.bbrc.2003.11.130; GIROLDI LA, 1993, CANCER METAST REV, V12, P29, DOI 10.1007/BF00689788; Harada K, 2005, CANCER LETT, V226, P161, DOI 10.1016/j.canlet.2004.12.048; Herman-Antosiewicz A, 2004, MUTAT RES-FUND MOL M, V555, P121, DOI 10.1016/j.mrfmmm.2004.04.016; Hong YS, 2000, EXP MOL MED, V32, P127, DOI 10.1038/emm.2000.22; Jacob C, 2008, PLANTA MED, V74, P1580, DOI 10.1055/s-0028-1088299; Jemal A, 2002, CA-CANCER J CLIN, V52, P23, DOI 10.3322/canjclin.52.1.23; Liu XH, 2009, CLIN EXP PHARMACOL P, V36, P696, DOI 10.1111/j.1440-1681.2008.05135.x; Loh KP, 2009, J ETHNOPHARMACOL, V125, P337, DOI 10.1016/j.jep.2009.05.025; MARCOTTE P, 1975, BIOCHEM BIOPH RES CO, V62, P677, DOI 10.1016/0006-291X(75)90452-0; Miyake H, 1999, BRIT J CANCER, V79, P1651, DOI 10.1038/sj.bjc.6690264; Mok YYP, 2004, BRIT J PHARMACOL, V143, P881, DOI 10.1038/sj.bjp.0706014; Nakagawa H, 2001, CARCINOGENESIS, V22, P891, DOI 10.1093/carcin/22.6.891; Shen JK, 1996, PLANTA MED, V62, P415, DOI 10.1055/s-2006-957929; St Croix B, 1998, J CELL BIOL, V142, P557, DOI 10.1083/jcb.142.2.557; Sundaram SG, 1996, J NUTR, V126, P1355, DOI 10.1093/jn/126.5.1355; Wang Q, 2009, J CARDIOVASC PHARM, V54, P139, DOI 10.1097/FJC.0b013e3181ac8e12; Wang XH, 2003, ONCOGENE, V22, P109, DOI 10.1038/sj.onc.1206069; Wang XT, 1998, BIOCHEM J, V333, P291, DOI 10.1042/bj3330291; Xiao D, 2004, ONCOGENE, V23, P5594, DOI 10.1038/sj.onc.1207747; Xiao DH, 2003, CANCER RES, V63, P6825; Yang GD, 2007, J BIOL CHEM, V282, P16567, DOI 10.1074/jbc.M700605200; Yoshiji H, 1998, INT J CANCER, V75, P81, DOI 10.1002/(SICI)1097-0215(19980105)75:1<81::AID-IJC13>3.3.CO;2-J; Zhang ZM, 2007, CHINESE MED J-PEKING, V120, P1336, DOI 10.1097/00029330-200708010-00008	32	77	79	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e20525	10.1371/journal.pone.0020525	http://dx.doi.org/10.1371/journal.pone.0020525			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738579	Green Submitted, Green Published, gold			2022-12-27	WOS:000292092600004
J	Arora, S; Bhardwaj, A; Srivastava, SK; Singh, S; McClellan, S; Wang, B; Singh, AP				Arora, Sumit; Bhardwaj, Arun; Srivastava, Sanjeev K.; Singh, Seema; McClellan, Steven; Wang, Bin; Singh, Ajay P.			Honokiol Arrests Cell Cycle, Induces Apoptosis, and Potentiates the Cytotoxic Effect of Gemcitabine in Human Pancreatic Cancer Cells	PLOS ONE			English	Article							NF-KAPPA-B; DOWN-REGULATION; CHEMOTHERAPY; INHIBITION; ACTIVATION; INDUCTION; PATHWAYS; ANGIOGENESIS; MODULATION; RESISTANCE	Survival rates for patients with pancreatic cancer are extremely poor due to its asymptomatic progression to advanced and metastatic stage for which current therapies remain largely ineffective. Therefore, novel therapeutic agents and treatment approaches are desired to improve the clinical outcome. In this study, we determined the effects of honokiol, a biologically active constituent of oriental medicinal herb Magnolia officinalis/grandiflora, on two pancreatic cancer cell lines, MiaPaCa and Panc1, alone and in combination with the standard chemotherapeutic drug, gemcitabine. Honokiol exerted growth inhibitory effects on both the pancreatic cancer cell lines by causing cell cycle arrest at G(1) phase and induction of apoptosis. At the molecular level, honokiol markedly decreased the expression of cyclins (D1 and E) and cyclin-dependent kinases (Cdk2 and Cdk4), and caused an increase in Cdk inhibitors, p21 and p27. Furthermore, honokiol treatment led to augmentation of Bax/Bcl-2 and Bax/Bcl-xL ratios to favor apoptosis in pancreatic cancer cells. These changes were accompanied by enhanced cytoplasmic accumulation of NF-kappa B with a concomitant decrease in nuclear fraction and reduced transcriptional activity of NF-kappa B responsive promoter. This was associated with decreased phosphorylation of inhibitor of kappa B alpha (IkB-alpha) causing its stabilization and thus increased cellular levels. Importantly, honokiol also potentiated the cytotoxic effects of gemcitabine, in part, by restricting the gemcitabine-induced nuclear accumulation of NF-kappa B in the treated pancreatic cancer cell lines. Altogether, these findings demonstrate, for the first time, the growth inhibitory effects of honokiol in pancreatic cancer and indicate its potential usefulness as a novel natural agent in prevention and therapy.	[Arora, Sumit; Bhardwaj, Arun; Srivastava, Sanjeev K.; Singh, Seema; McClellan, Steven; Singh, Ajay P.] Univ S Alabama, Dept Oncol Sci, Mitchell Canc Inst, Mobile, AL 36688 USA; [Wang, Bin] Univ S Alabama, Dept Math & Stat, Coll Arts & Sci, Mobile, AL 36688 USA; [Singh, Ajay P.] Univ S Alabama, Coll Med, Dept Biochem & Mol Biol, Mobile, AL USA	University of South Alabama; University of South Alabama; University of South Alabama	Arora, S (corresponding author), Univ S Alabama, Dept Oncol Sci, Mitchell Canc Inst, Mobile, AL 36688 USA.	asingh@usouthal.edu	Singh, Ajay/AAF-4414-2020	Singh, Ajay/0000-0003-3492-6330; Wang, Bin/0000-0002-3689-6932	National Institutes of Health/National Cancer Institute (NIH/NCI) [CA137513]; USAMCI; NATIONAL CANCER INSTITUTE [R03CA137513] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute (NIH/NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); USAMCI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grant support from National Institutes of Health/National Cancer Institute (NIH/NCI) (CA137513) and USAMCI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abukhdeir Abde M., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000744; Basseres DS, 2006, ONCOGENE, V25, P6817, DOI 10.1038/sj.onc.1209942; Call JA, 2008, LANCET ONCOL, V9, P1002, DOI 10.1016/S1470-2045(08)70209-2; Cappella P, 2001, INT J CANCER, V93, P401, DOI 10.1002/ijc.1351.abs; Chen CY, 2007, EUR J PHARMACOL, V574, P94, DOI 10.1016/j.ejphar.2007.07.028; Chen F, 2004, WORLD J GASTROENTERO, V10, P3459; Chen YJ, 2010, CANCER LETT, V291, P20, DOI 10.1016/j.canlet.2009.08.032; Chilampalli S, 2010, ANTICANCER RES, V30, P777; Dahlman JM, 2009, J CELL BIOCHEM, V106, P42, DOI 10.1002/jcb.21976; DHAYAT S, 2011, INT J CANC, V10; Fong WF, 2005, INT J BIOCHEM CELL B, V37, P427, DOI 10.1016/j.biocel.2004.05.021; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Giovannetti E, 2010, CANCER RES, V70, P4528, DOI 10.1158/0008-5472.CAN-09-4467; Gupta SC, 2010, CANCER METAST REV, V29, P405, DOI 10.1007/s10555-010-9235-2; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HUANG P, 1995, CANCER CHEMOTH PHARM, V36, P181, DOI 10.1007/BF00685844; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kamat AM, 2007, MOL CANCER THER, V6, P1022, DOI 10.1158/1535-7163.MCT-06-0545; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Lee SY, 2008, EUR J PHARMACOL, V582, P17, DOI 10.1016/j.ejphar.2007.12.027; Li DH, 2004, LANCET, V363, P1049, DOI 10.1016/S0140-6736(04)15841-8; Li ZY, 2008, EUR J OBSTET GYN R B, V140, P95, DOI 10.1016/j.ejogrb.2008.02.023; Liptay S, 2003, INT J CANCER, V105, P735, DOI 10.1002/ijc.11081; Newman DJ, 2003, J NAT PROD, V66, P1022, DOI 10.1021/np030096l; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Park EJ, 2009, CANCER LETT, V277, P133, DOI 10.1016/j.canlet.2008.11.029; Perkins ND, 2000, TRENDS BIOCHEM SCI, V25, P434, DOI 10.1016/S0968-0004(00)01617-0; Satyanarayana A, 2009, ONCOGENE, V28, P2925, DOI 10.1038/onc.2009.170; Singh AP, 2004, CANCER RES, V64, P622, DOI 10.1158/0008-5472.CAN-03-2636; Singh S, 2010, BRIT J CANCER, V103, P1671, DOI 10.1038/sj.bjc.6605968; Srivastava SK, 2004, CARCINOGENESIS, V25, P1701, DOI 10.1093/carcin/bgh179; Uwagawa T, 2009, ANTICANCER RES, V29, P3173; Vermeulen K, 2003, CELL PROLIFERAT, V36, P131, DOI 10.1046/j.1365-2184.2003.00266.x; Wharry CE, 2009, CANCER BIOL THER, V8, P1567, DOI 10.4161/cbt.8.16.8961; Wong HH, 2009, NAT REV GASTRO HEPAT, V6, P412, DOI 10.1038/nrgastro.2009.89; Yang SE, 2002, BIOCHEM PHARMACOL, V63, P1641, DOI 10.1016/S0006-2952(02)00894-8; Yokoi K, 2004, CLIN CANCER RES, V10, P2299, DOI 10.1158/1078-0432.CCR-03-0488	40	108	111	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21573	10.1371/journal.pone.0021573	http://dx.doi.org/10.1371/journal.pone.0021573			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21720559	Green Published, gold, Green Submitted			2022-12-27	WOS:000292036900055
J	Caselli, L; Chelazzi, L				Caselli, Luana; Chelazzi, Leonardo			Does the Macaque Monkey Provide a Good Model for Studying Human Executive Control? A Comparative Behavioral Study of Task Switching	PLOS ONE			English	Article							PREFRONTAL CORTEX; COGNITIVE CONTROL; CATEGORIZATION; COSTS	The ability to swiftly and smoothly switch from one task set to another is central to intelligent behavior, because it allows an organism to flexibly adapt to ever changing environmental conditions and internal needs. For this reason, researchers interested in executive control processes have often relied on task-switching paradigms as powerful tools to uncover the underlying cognitive and brain architecture. In order to gather fundamental information at the single-cell level, it would be greatly helpful to demonstrate that non-human primates, especially the macaque monkey, share with us similar behavioral manifestations of task-switching and therefore, in all likelihood, similar underlying brain mechanisms. Unfortunately, prior attempts have provided negative results (e.g., Stoet & Snyder, 2003b), in that it was reported that macaques do not show the typical signature of task-switching operations at the behavioral level, represented by switch costs. If confirmed, this would indicate that the macaque cannot be used as a model approach to explore human executive control mechanisms by means of task-switching paradigms. We have therefore decided to re-explore this issue, by conducting a comparative experiment on a group of human participants and two macaque monkeys, whereby we measured and compared performance costs linked to task switching and resistance to interference across the two species. Contrary to what previously reported, we found that both species display robust task switching costs, thus supporting the claim that macaque monkeys provide an exquisitely suitable model to study the brain mechanisms responsible for maintaining and switching task sets.	[Caselli, Luana; Chelazzi, Leonardo] Univ Verona, Sect Physiol & Psychol, Dept Neurol Neuropsychol Morphol & Motor Sci, I-37100 Verona, Italy; [Caselli, Luana] Univ Parma, Physiol Sect, Dept Neurosci, I-43100 Parma, Italy; [Chelazzi, Leonardo] Italian Inst Neurosci, Verona, Italy	University of Verona; University of Parma	Caselli, L (corresponding author), Univ Verona, Sect Physiol & Psychol, Dept Neurol Neuropsychol Morphol & Motor Sci, I-37100 Verona, Italy.	leonardo.chelazzi@univr.it	Chelazzi, Leonardo/B-6084-2011; Caselli, Luana/AGA-7498-2022	Chelazzi, Leonardo/0000-0001-8566-0611; Caselli, Luana/0000-0001-7058-7570	Human Frontier Science Program; Italian Government	Human Frontier Science Program(Human Frontier Science Program); Italian Government	Human Frontier Science Program and Italian Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLPORT A, 1994, ATTENTION PERFORM, V15, P421; Asaad WF, 2000, J NEUROPHYSIOL, V84, P451, DOI 10.1152/jn.2000.84.1.451; Baddeley A, 1996, Q J EXP PSYCHOL-A, V49, P5, DOI 10.1080/713755608; Braver TS, 2003, NEURON, V39, P713, DOI 10.1016/S0896-6273(03)00466-5; Bunge SA, 2002, NEUROIMAGE, V17, P1562, DOI 10.1006/nimg.2002.1252; Dias R, 1996, NATURE, V380, P69, DOI 10.1038/380069a0; Dreher JC, 2002, P NATL ACAD SCI USA, V99, P14595, DOI 10.1073/pnas.222193299; Duncan J, 2001, NAT REV NEUROSCI, V2, P820, DOI 10.1038/35097575; Fagot C., 1994, THESIS U CALIFORNIA; Freedman DJ, 2002, J NEUROPHYSIOL, V88, P929, DOI 10.1152/jn.2002.88.2.929; JERSILD AT, 1927, ARCH PSYCHOL, V89, P1; Kray J, 2000, PSYCHOL AGING, V15, P126, DOI 10.1037//0882-7974.15.1.126; Los SA, 1996, ACTA PSYCHOL, V94, P145, DOI 10.1016/0001-6918(95)00050-X; Luria A.R., 1966, HIGHER CORTICAL FUNC, P3; Meiran N, 2001, EUR J COGN PSYCHOL, V13, P165, DOI 10.1080/09541440042000269; Meiran N, 1996, J EXP PSYCHOL LEARN, V22, P1423, DOI 10.1037/0278-7393.22.6.1423; Meiran N, 2000, PSYCHOL RES-PSYCH FO, V63, P234, DOI 10.1007/s004269900004; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; Monsell S, 2003, TRENDS COGN SCI, V7, P134, DOI 10.1016/S1364-6613(03)00028-7; Nakahara K, 2002, SCIENCE, V295, P1532, DOI 10.1126/science.1067653; Pashler H, 2000, CONTROL OF COGNITIVE PROCESSES: ATTENTION AND PERFORMANCE XVIII, P277; PASSINGHAM RE, 1972, NEUROPSYCHOLOGIA, V10, P41, DOI 10.1016/0028-3932(72)90041-3; ROGERS RD, 1995, J EXP PSYCHOL GEN, V124, P207, DOI 10.1037/0096-3445.124.2.207; Rubinstein JS, 2001, J EXP PSYCHOL HUMAN, V27, P763, DOI 10.1037//0096-1523.27.4.763; Rushworth MFS, 2002, J NEUROPHYSIOL, V87, P2577, DOI 10.1152/jn.2002.87.5.2577; Shallice T., 1988, NEUROPSYCHOLOGY MENT, DOI DOI 10.1017/IPM.2020.45; Sohn MH, 2000, P NATL ACAD SCI USA, V97, P13448, DOI 10.1073/pnas.240460497; SPECTOR A, 1976, AM J PSYCHOL, V89, P669, DOI 10.2307/1421465; Stoet G, 2003, ANIM COGN, V6, P121, DOI 10.1007/s10071-003-0170-2; Stoet G, 2003, NEUROPSYCHOLOGIA, V41, P1357, DOI 10.1016/S0028-3932(03)00048-4; Stoet G, 2009, TRENDS COGN SCI, V13, P228, DOI 10.1016/j.tics.2009.02.002; Stoet G, 2007, COGN AFFECT BEHAV NE, V7, P192, DOI 10.3758/CABN.7.3.192; Umilta C., 1988, CONSCIOUSNESS CONT S; Vogels R, 1999, EUR J NEUROSCI, V11, P1223, DOI 10.1046/j.1460-9568.1999.00530.x; Wallis JD, 2001, NATURE, V411, P953, DOI 10.1038/35082081; WATANABE M, 1990, EXP BRAIN RES, V80, P296; West RL, 1996, PSYCHOL BULL, V120, P272, DOI 10.1037/0033-2909.120.2.272	37	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21489	10.1371/journal.pone.0021489	http://dx.doi.org/10.1371/journal.pone.0021489			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21720549	Green Published, Green Submitted, gold			2022-12-27	WOS:000292036900041
J	Wells, S; Nornes, S; Lardelli, M				Wells, Simon; Nornes, Svanhild; Lardelli, Michael			Transgenic Zebrafish Recapitulating tbx16 Gene Early Developmental Expression	PLOS ONE			English	Article							FLUORESCENT PROTEIN EXPRESSION; SPINAL NEURONS; PROMOTER; VERTEBRATES; EVOLUTION; MUTATION; ELEMENTS; EMBRYOS; MARKS	We describe the creation of a transgenic zebrafish expressing GFP driven by a 7.5 kb promoter region of the tbx16 gene. This promoter segment is sufficient to recapitulate early embryonic expression of endogenous tbx16 in the presomitic mesoderm, the polster and, subsequently, in the hatching gland. Expression of GFP in the transgenic lines later in development diverges to some extent from endogenous tbx16 expression with the serendipitous result that one line expresses GFP specifically in commissural primary ascending (CoPA) interneurons of the developing spinal cord. Using this line we demonstrate that the gene mafba (valentino) is expressed in CoPA interneurons.	[Wells, Simon; Nornes, Svanhild; Lardelli, Michael] Univ Adelaide, Dept Mol Biosci, Special Res Ctr Mol Genet Dev, Adelaide, SA, Australia	University of Adelaide	Wells, S (corresponding author), Univ Adelaide, Dept Mol Biosci, Special Res Ctr Mol Genet Dev, Adelaide, SA, Australia.	simon.wells@adelaide.edu.au		Lardelli, Michael/0000-0002-4289-444X	Australian Research Council via its Special Research Centre for the Molecular Genetics of Development [S00001531]	Australian Research Council via its Special Research Centre for the Molecular Genetics of Development(Australian Research Council)	This work was supported by funds from the Australian Research Council via its Special Research Centre for the Molecular Genetics of Development (S00001531). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHEN JY, 2010, FISH PHYSIOL BIOCHEM, P5; Ellingsen S, 2005, DEVELOPMENT, V132, P3799, DOI 10.1242/dev.01951; Gong ZY, 2002, DEV DYNAM, V223, P204, DOI 10.1002/dvdy.10051; Griffin KJP, 1998, DEVELOPMENT, V125, P3379; Higashijima S, 2004, J NEUROSCI, V24, P5827, DOI 10.1523/JNEUROSCI.5342-03.2004; HO RK, 1990, NATURE, V348, P728, DOI 10.1038/348728a0; Jowett T., 1997, TISSUE IN SITU HYBRI; Ju BS, 2003, DEV DYNAM, V227, P14, DOI 10.1002/dvdy.10273; Kikuta H, 2007, GENOME RES, V17, P545, DOI 10.1101/gr.6086307; KIMMEL CB, 1989, NATURE, V337, P358, DOI 10.1038/337358a0; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kimura Y, 2006, J NEUROSCI, V26, P5684, DOI 10.1523/JNEUROSCI.4993-05.2006; KUWADA JY, 1990, J COMP NEUROL, V302, P617, DOI 10.1002/cne.903020316; Mione M, 2008, DEV NEUROSCI-BASEL, V30, P65, DOI 10.1159/000109853; MOLVEN A, 1990, DEVELOPMENT, V109, P279; Park HC, 2000, DEV BIOL, V227, P279, DOI 10.1006/dbio.2000.9898; Roberts A, 2000, BRAIN RES BULL, V53, P585, DOI 10.1016/S0361-9230(00)00392-0; Ruvinsky I, 1998, DEV GENES EVOL, V208, P94, DOI 10.1007/s004270050158; STREISINGER G, 1981, NATURE, V291, P293, DOI 10.1038/291293a0; Tamme Richard, 2002, BMC Dev Biol, V2, P9, DOI 10.1186/1471-213X-2-9; WELLS S, 2010, EXP CELL RES, P1; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Yeo SY, 2007, DEV BIOL, V301, P555, DOI 10.1016/j.ydbio.2006.10.020	23	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21559	10.1371/journal.pone.0021559	http://dx.doi.org/10.1371/journal.pone.0021559			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21720556	Green Published, gold, Green Submitted			2022-12-27	WOS:000292036900052
J	Bengestrate, L; Virtue, S; Campbell, M; Vidal-Puig, A; Hadaschik, D; Hahn, P; Bielke, W				Bengestrate, Lena; Virtue, Sam; Campbell, Mark; Vidal-Puig, Antonio; Hadaschik, Dirk; Hahn, Peter; Bielke, Wolfgang			Genome-Wide Profiling of MicroRNAs in Adipose Mesenchymal Stem Cell Differentiation and Mouse Models of Obesity	PLOS ONE			English	Article							GENE-EXPRESSION; ADIPOGENESIS; MICROARRAY; ADIPOCYTES; PROTEIN; TISSUE	In recent years, there has been accumulating evidence that microRNAs are key regulator molecules of gene expression. The cellular processes that are regulated by microRNAs include e. g. cell proliferation, programmed cell death and cell differentiation. Adipocyte differentiation is a highly regulated cellular process for which several important regulating factors have been discovered, but still not all are known to fully understand the underlying mechanisms. In the present study, we analyzed the expression of 597 microRNAs during the differentiation of mouse mesenchymal stem cells into terminally differentiated adipocytes by real-time RT-PCR. In total, 66 miRNAs were differentially expressed in mesenchymal stem cell-derived adipocytes compared to the undifferentiated progenitor cells. To further study the regulation of these 66 miRNAs in white adipose tissue in vivo and their dependence on PPAR gamma activity, mouse models of genetically or diet induced obesity as well as a mouse line expressing a dominant negative PPAR gamma mutant were employed.	[Bengestrate, Lena; Hadaschik, Dirk; Hahn, Peter; Bielke, Wolfgang] QIAGEN GmbH, Dept Epigenet, Hilden, Germany; [Virtue, Sam; Campbell, Mark; Vidal-Puig, Antonio] Univ Cambridge, Addenbrookes Hosp, Inst Metab Sci, Metab Res Labs, Cambridge CB2 2QQ, England	QIAGEN GmbH; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Bengestrate, L (corresponding author), Univ Cologne, Inst Biochem 2, Cologne, Germany.	wolfgang.bielke@qiagen.com	Virtue, SAm/B-7578-2013; Xie, Huangming/B-2260-2012	Virtue, SAm/0000-0002-9545-5432; Vidal-Puig, Antonio/0000-0003-4220-9577	MRC [14133]; BBSRC [20485]; R&D department of QIAGEN GmbH; MRC [G0802051] Funding Source: UKRI; Medical Research Council [G0802051] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); R&D department of QIAGEN GmbH; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work for this project was funded in part by MRC Programme grant number 14133 (www.mrc.ac.uk/index.htm) and BBSRC grant number 20485 (www.bbsrc.ac.uk) to Antonio Vidal-Puig. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors DH, PH, and WB are currently employees within the R&D department of QIAGEN GmbH and declare potential competing financial interests, including personal ownership of QIAGEN stocks and/or stock options. Several commercially available products, marketed by QIAGEN, were employed for this study. These products include kits and items for nucleic acid isolation and amplification, as well as the miScript system for microRNA detection. QIAGEN holds several issued and pending patents related to these products. The above said does not alter the authors' adherence to all the PloS ONE policies on sharing data and materials.	Almind K, 2004, DIABETES, V53, P3274, DOI 10.2337/diabetes.53.12.3274; Baksh D, 2004, J CELL MOL MED, V8, P301, DOI 10.1111/j.1582-4934.2004.tb00320.x; Barry FP, 2004, INT J BIOCHEM CELL B, V36, P568, DOI 10.1016/j.biocel.2003.11.001; BAXA CA, 1989, BIOCHEMISTRY-US, V28, P8683, DOI 10.1021/bi00448a003; Billon N, 2008, BIOL CELL, V100, P563, DOI 10.1042/BC20080011; Caballero B, 2007, EPIDEMIOL REV, V29, P1, DOI 10.1093/epirev/mxm012; Canales RD, 2006, NAT BIOTECHNOL, V24, P1115, DOI 10.1038/nbt1236; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Heneghan HM, 2010, OBES REV, V11, P354, DOI 10.1111/j.1467-789X.2009.00659.x; Hurst DR, 2009, CANCER RES, V69, P1279, DOI 10.1158/0008-5472.CAN-08-3559; Hwang HW, 2006, BRIT J CANCER, V94, P776, DOI 10.1038/sj.bjc.6603023; Janderova L, 2003, OBES RES, V11, P65, DOI 10.1038/oby.2003.11; Kumar P, 2011, RNA, V17, P365, DOI 10.1261/rna.2490111; Leski TA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006569; MacDougald OA, 2002, TRENDS ENDOCRIN MET, V13, P5, DOI 10.1016/S1043-2760(01)00517-3; McPherson R, 2007, CAN J CARDIOL, V23, p23A, DOI 10.1016/S0828-282X(07)71002-4; Moraes RC, 2003, ENDOCRINOLOGY, V144, P4773, DOI 10.1210/en.2003-0456; Nadler ST, 2000, P NATL ACAD SCI USA, V97, P11371, DOI 10.1073/pnas.97.21.11371; Ogden CL, 2007, GASTROENTEROLOGY, V132, P2087, DOI 10.1053/j.gastro.2007.03.052; Ortega FJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009022; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rosen ED, 2002, ANN NY ACAD SCI, V979, P143, DOI 10.1111/j.1749-6632.2002.tb04875.x; Ruan H, 2002, DIABETES, V51, P1319, DOI 10.2337/diabetes.51.5.1319; Schickel R, 2008, ONCOGENE, V27, P5959, DOI 10.1038/onc.2008.274; Soukas A, 2000, GENE DEV, V14, P963; Vaananen HK, 2005, ANN MED, V37, P469, DOI 10.1080/07853890500371957; Wilfred BR, 2007, MOL GENET METAB, V91, P209, DOI 10.1016/j.ymgme.2007.03.011; Wixler V, 2007, J CELL BIOL, V177, P163, DOI 10.1083/jcb.200606043; Xie HM, 2009, DIABETES, V58, P1050, DOI 10.2337/db08-1299; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	33	39	43	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21305	10.1371/journal.pone.0021305	http://dx.doi.org/10.1371/journal.pone.0021305			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731698	gold, Green Submitted, Green Published			2022-12-27	WOS:000292035400020
J	Ivashuta, S; Banks, IR; Wiggins, BE; Zhang, YJ; Ziegler, TE; Roberts, JK; Heck, GR				Ivashuta, Sergey; Banks, Isaac R.; Wiggins, B. Elizabeth; Zhang, Yuanji; Ziegler, Todd E.; Roberts, James K.; Heck, Gregory R.			Regulation of Gene Expression in Plants through miRNA Inactivation	PLOS ONE			English	Article							MICRORNA TARGETS; SIRNA BIOGENESIS; SMALL RNAS; PREDICTION; SPONGES	Eukaryotic organisms possess a complex RNA-directed gene expression regulatory network allowing the production of unique gene expression patterns. A recent addition to the repertoire of RNA-based gene regulation is miRNA target decoys, endogenous RNA that can negatively regulate miRNA activity. miRNA decoys have been shown to be a valuable tool for understanding the function of several miRNA families in plants and invertebrates. Engineering and precise manipulation of an endogenous RNA regulatory network through modification of miRNA activity also affords a significant opportunity to achieve a desired outcome of enhanced plant development or response to environmental stresses. Here we report that expression of miRNA decoys as single or heteromeric non-cleavable microRNA (miRNA) sites embedded in either non-protein-coding or within the 3' untranslated region of protein-coding transcripts can regulate the expression of one or more miRNA targets. By altering the sequence of the miRNA decoy sites, we were able to attenuate miRNA inactivation, which allowed for fine regulation of native miRNA targets and the production of a desirable range of plant phenotypes. Thus, our results demonstrate miRNA decoys are a flexible and robust tool, not only for studying miRNA function, but also for targeted engineering of gene expression in plants. Computational analysis of the Arabidopsis transcriptome revealed a number of potential miRNA decoys, suggesting that endogenous decoys may have an important role in natural modulation of expression in plants.	[Ivashuta, Sergey; Banks, Isaac R.; Wiggins, B. Elizabeth; Zhang, Yuanji; Ziegler, Todd E.; Roberts, James K.; Heck, Gregory R.] Monsanto Co, Chesterfield, MO USA	Monsanto	Ivashuta, S (corresponding author), Monsanto Co, Chesterfield, MO USA.	sergey.i.ivashuta@monsanto.com		Ziegler, Todd/0000-0001-8947-5763				Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Alves L, 2009, NUCLEIC ACIDS RES, V37, P4010, DOI 10.1093/nar/gkp272; Axtell MJ, 2006, CELL, V127, P565, DOI 10.1016/j.cell.2006.09.032; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Conlon Helen E, 2007, Methods Mol Biol, V362, P379; DUNNETT CW, 1955, J AM STAT ASSOC, V50, P1096, DOI 10.2307/2281208; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Ebert MS, 2010, RNA, V16, P2043, DOI 10.1261/rna.2414110; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Franco-Zorrilla JM, 2007, NAT GENET, V39, P1033, DOI 10.1038/ng2079; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Gu S, 2009, NAT STRUCT MOL BIOL, V16, P144, DOI 10.1038/nsmb.1552; Hinkelmann K., 1994, DESIGN ANAL EXPT, V1; James C, 2003, CURR SCI INDIA, V84, P303; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Mullen JL, 2006, PLANT CELL ENVIRON, V29, P1099, DOI 10.1111/j.1365-3040.2005.01484.x; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Pearson W R, 2000, Methods Mol Biol, V132, P185; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Sambrook J., 2001, MOL CLONING; Shukla LI, 2008, BBA-GENE REGUL MECH, V1779, P743, DOI 10.1016/j.bbagrm.2008.04.004; Sire C, 2009, FEBS LETT, V583, P1039, DOI 10.1016/j.febslet.2009.02.024; Todesco M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001031; Towbin H, 1992, Biotechnology, V24, P145; Vandenbussche F, 2003, PLANT PHYSIOL, V133, P517, DOI 10.1104/pp.103.022665	29	61	63	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21330	10.1371/journal.pone.0021330	http://dx.doi.org/10.1371/journal.pone.0021330			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731706	gold, Green Published, Green Submitted			2022-12-27	WOS:000292035400023
J	Bish, LT; Yarchoan, M; Sleeper, MM; Gazzara, JA; Morine, KJ; Acosta, P; Barton, ER; Sweeney, HL				Bish, Lawrence T.; Yarchoan, Mark; Sleeper, Meg M.; Gazzara, Jeffrey A.; Morine, Kevin J.; Acosta, Pedro; Barton, Elisabeth R.; Sweeney, H. Lee			Chronic Losartan Administration Reduces Mortality and Preserves Cardiac but Not Skeletal Muscle Function in Dystrophic Mice	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; MDX-MICE; HEART-FAILURE; TGF-BETA; HYPERTROPHIC CARDIOMYOPATHY; FIBROSIS; TGF-BETA-1; MODEL	Duchenne muscular dystrophy (DMD) is a degenerative disorder affecting skeletal and cardiac muscle for which there is no effective therapy. Angiotension receptor blockade (ARB) has excellent therapeutic potential in DMD based on recent data demonstrating attenuation of skeletal muscle disease progression during 6-9 months of therapy in the mdx mouse model of DMD. Since cardiac-related death is major cause of mortality in DMD, it is important to evaluate the effect of any novel treatment on the heart. Therefore, we evaluated the long-term impact of ARB on both the skeletal muscle and cardiac phenotype of the mdx mouse. Mdx mice received either losartan (0.6 g/L) (n = 8) or standard drinking water (n = 9) for two years, after which echocardiography was performed to assess cardiac function. Skeletal muscle weight, morphology, and function were assessed. Fibrosis was evaluated in the diaphragm and heart by Trichrome stain and by determination of tissue hydroxyproline content. By the study endpoint, 88% of treated mice were alive compared to only 44% of untreated (p = 0.05). No difference in skeletal muscle morphology, function, or fibrosis was noted in losartan-treated animals. Cardiac function was significantly preserved with losartan treatment, with a trend towards reduction in cardiac fibrosis. We saw no impact on the skeletal muscle disease progression, suggesting that other pathways that trigger fibrosis dominate over angiotensin II in skeletal muscle long term, unlike the situation in the heart. Our study suggests that ARB may be an important prophylactic treatment for DMD-associated cardiomyopathy, but will not impact skeletal muscle disease.	[Bish, Lawrence T.; Yarchoan, Mark; Gazzara, Jeffrey A.; Morine, Kevin J.; Acosta, Pedro; Sweeney, H. Lee] Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA; [Sleeper, Meg M.] Univ Penn, Vet Hosp, Dept Clin Studies, Div Cardiol, Philadelphia, PA 19104 USA; [Barton, Elisabeth R.] Univ Penn, Sch Dent Med, Dept Anat & Cell Biol, Philadelphia, PA 19104 USA; [Barton, Elisabeth R.] Univ Penn, Penn Muscle Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Bish, LT (corresponding author), Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA.	bish@mail.med.upenn.edu	Sweeney, H Lee/F-1862-2010	Yarchoan, Mark/0000-0003-4401-0748	National Institutes of Health [P01-HL059407, U54-AR052646, T32-HL-007748]; Parent Project Muscular Dystrophy; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007748, P01HL059407] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U54AR052646] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parent Project Muscular Dystrophy; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health (P01-HL059407 to HLS, U54-AR052646 to HLS, T32-HL-007748 to LTB) and the Parent Project Muscular Dystrophy to HLS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton ER, 2006, AM J PHYSIOL-CELL PH, V290, pC411, DOI 10.1152/ajpcell.00192.2005; Baxter P, 2006, DEV MED CHILD NEUROL, V48, P163, DOI 10.1017/S0012162206000351; Bostick B, 2009, MOL THER, V17, P253, DOI 10.1038/mt.2008.264; Campistol JM, 1999, KIDNEY INT, V56, P714, DOI 10.1046/j.1523-1755.1999.00597.x; Cohn RD, 2007, NAT MED, V13, P204, DOI 10.1038/nm1536; Colussi C, 2010, CARDIOVASC RES, V87, P73, DOI 10.1093/cvr/cvq035; Dupont E, 2001, CIRCULATION, V103, P842, DOI 10.1161/01.CIR.103.6.842; Esmatjes E, 2001, NEPHROL DIAL TRANSPL, V16, P90, DOI 10.1093/ndt/16.suppl_1.90; Ferreira JCB, 2011, LIFE SCI, V88, P578, DOI 10.1016/j.lfs.2011.01.009; Gregorevic P, 2008, MOL THER, V16, P657, DOI 10.1038/mt.2008.28; Gunther S, 2010, N-S ARCH PHARMACOL, V382, P265, DOI 10.1007/s00210-010-0544-3; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Kaye DM, 2008, ANNU REV MED, V59, P13, DOI 10.1146/annurev.med.59.052407.103237; Kuehn BM, 2007, JAMA-J AM MED ASSOC, V298, P1385, DOI 10.1001/jama.298.12.1385; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Lim DS, 2001, CIRCULATION, V103, P789, DOI 10.1161/01.CIR.103.6.789; Mouisel E, 2010, MUSCLE NERVE, V41, P809, DOI 10.1002/mus.21624; Nowak KJ, 2004, EMBO REP, V5, P872, DOI 10.1038/sj.embor.7400221; Passerini L, 2002, NEUROMUSCULAR DISORD, V12, P828, DOI 10.1016/S0960-8966(02)00071-8; PICKERING JG, 1990, CIRCULATION, V81, P949, DOI 10.1161/01.CIR.81.3.949; Silcocks PB, 1997, HEART, V78, P237, DOI 10.1136/hrt.78.3.237; Spurney CF, 2011, J CARDIOVASC PHARM T, V16, P87, DOI 10.1177/1074248410381757; Teekakirikul P, 2010, J CLIN INVEST, V120, P3520, DOI 10.1172/JCI42028; Van Erp C, 2010, MUSCLE NERVE, V42, P504, DOI 10.1002/mus.21716; Vinge LE, 2008, CIRC RES, V102, P1458, DOI 10.1161/CIRCRESAHA.108.173195; Wagner KR, 2008, NEUROTHERAPEUTICS, V5, P583, DOI 10.1016/j.nurt.2008.08.013	26	45	45	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e20856	10.1371/journal.pone.0020856	http://dx.doi.org/10.1371/journal.pone.0020856			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731628	Green Published, gold			2022-12-27	WOS:000292033700017
J	Eilers, EJ; Kremen, C; Greenleaf, SS; Garber, AK; Klein, AM				Eilers, Elisabeth J.; Kremen, Claire; Greenleaf, Sarah Smith; Garber, Andrea K.; Klein, Alexandra-Maria			Contribution of Pollinator-Mediated Crops to Nutrients in the Human Food Supply	PLOS ONE			English	Article							WORLD AGRICULTURE; NORTH-AMERICAN; ECONOMIC VALUE; HUMAN HEALTH; PLANTS; CONSERVATION; DECLINES; LYCOPENE; TRENDS; YIELD	The contribution of nutrients from animal pollinated world crops has not previously been evaluated as a biophysical measure for the value of pollination services. This study evaluates the nutritional composition of animal-pollinated world crops. We calculated pollinator dependent and independent proportions of different nutrients of world crops, employing FAO data for crop production, USDA data for nutritional composition, and pollinator dependency data according to Klein et al. (2007). Crop plants that depend fully or partially on animal pollinators contain more than 90% of vitamin C, the whole quantity of Lycopene and almost the full quantity of the antioxidants beta-cryptoxanthin and beta-tocopherol, the majority of the lipid, vitamin A and related carotenoids, calcium and fluoride, and a large portion of folic acid. Ongoing pollinator decline may thus exacerbate current difficulties of providing a nutritionally adequate diet for the global human population.	[Eilers, Elisabeth J.] Free Univ Berlin, Dept Appl Zool Anim Ecol, D-1000 Berlin, Germany; [Eilers, Elisabeth J.] Max Planck Inst Chem Ecol, Dept Evolutionary Neuroethol, Jena, Germany; [Kremen, Claire] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Greenleaf, Sarah Smith] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA; [Garber, Andrea K.] Univ Calif San Francisco, Div Adolescent Med, San Francisco, CA 94143 USA; [Klein, Alexandra-Maria] Leuphana Univ Luneburg, Inst Ecol, Sect Ecosyst Funct, Luneburg, Germany	Free University of Berlin; Max Planck Society; University of California System; University of California Berkeley; University of California System; University of California Davis; University of California System; University of California San Francisco; Leuphana University Luneburg	Eilers, EJ (corresponding author), Free Univ Berlin, Dept Appl Zool Anim Ecol, D-1000 Berlin, Germany.	eeilers@ice.mpg.de	Klein, Alexandra-Maria/J-5871-2016	Klein, Alexandra-Maria/0000-0003-2139-8575	German Science Foundation [KL 1849/4-1]; NSF [BEB-00-72909]; European Commission [244090 - STEP - CP - FP]	German Science Foundation(German Research Foundation (DFG)); NSF(National Science Foundation (NSF)); European Commission(European CommissionEuropean Commission Joint Research Centre)	The German Science Foundation provided funding to AMK (KL 1849/4-1). This work is part of the National Center for Ecological Analysis and Synthesis Restoring Pollination Services Working Group (led by C. Kremen and N. M. Williams, and supported by the Center's NSF grant no. BEB-00-72909) and part of the STEP (Status and Trends of European Pollinators) project of the European Commission under the 7th Framework Program for Research and Technological Development (grant no. 244090 - STEP - CP - FP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizen MA, 2008, CURR BIOL, V18, P1572, DOI 10.1016/j.cub.2008.08.066; BAWA KS, 1990, ANNU REV ECOL SYST, V21, P399, DOI 10.1146/annurev.es.21.110190.002151; Bazzano LA, 2006, JAMA-J AM MED ASSOC, V296, P2720, DOI 10.1001/jama.296.22.2720; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Daily GC, 1997, NATURES SERVICES SOC, DOI DOI 10.12987/9780300188479-039; DellaPenna D, 1999, SCIENCE, V285, P375, DOI 10.1126/science.285.5426.375; Food and Nutrition Board IOM, 1997, DIET REF INT CALC MA; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Ghazoul J, 2005, TRENDS ECOL EVOL, V20, P367, DOI 10.1016/j.tree.2005.04.026; Gilland B, 2002, FOOD POLICY, V27, P47, DOI 10.1016/S0306-9192(02)00002-7; GROSS BJ, 2010, THESIS U CALIFORNIA; Heaney RP, 2000, J AM COLL NUTR, V19, p83S, DOI 10.1080/07315724.2000.10718088; Kearns CA, 2001, CONSERV ECOL, V5; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Kremen C, 2000, SCIENCE, V288, P1828, DOI 10.1126/science.288.5472.1828; Kris-Etherton PM, 2004, CIRCULATION, V110, P637, DOI 10.1161/01.CIR.0000137822.39831.F1; Losey JE, 2006, BIOSCIENCE, V56, P311, DOI 10.1641/0006-3568(2006)56[311:TEVOES]2.0.CO;2; Maberly G, 2008, TRENDS WHEAT FLOUR F; Pinstrup-Andersen P., 1999, WORLD FOOD PROSPECTS; Poletti S, 2004, CURR OPIN BIOTECH, V15, P162, DOI 10.1016/j.copbio.2004.03.002; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; PRESCOTTALLEN R, 1990, CONSERV BIOL, V4, P365, DOI 10.1111/j.1523-1739.1990.tb00310.x; Raskin I, 2002, TRENDS BIOTECHNOL, V20, P522, DOI 10.1016/S0167-7799(02)02080-2; Richards AJ, 2001, ANN BOT-LONDON, V88, P165, DOI 10.1006/anbo.2001.1463; SOUTHWICK EE, 1992, J ECON ENTOMOL, V85, P621, DOI 10.1093/jee/85.3.621; Stahl W, 1998, FEBS LETT, V427, P305, DOI 10.1016/S0014-5793(98)00434-7; Stahl W, 1996, ARCH BIOCHEM BIOPHYS, V336, P1, DOI 10.1006/abbi.1996.0525; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Trumbo P, 2001, J AM DIET ASSOC, V101, P294, DOI 10.1016/S0002-8223(01)00078-5; *US FAO, 2011, INT FOOD COMP TABL; *US FAO, 2008, PROD DAT; *USDA, 2002, US ALM IND SIT; WEAVER CM, 1994, AM J CLIN NUTR, V59, p1238S, DOI 10.1093/ajcn/59.5.1238S; Welch RM, 1999, FIELD CROP RES, V60, P1, DOI 10.1016/S0378-4290(98)00129-4	35	177	184	4	128	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21363	10.1371/journal.pone.0021363	http://dx.doi.org/10.1371/journal.pone.0021363			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731717	Green Published, gold, Green Submitted			2022-12-27	WOS:000292033700067
J	Kromrey, S; Bart, E; Hegde, J				Kromrey, Sarah; Bart, Evgeniy; Hegde, Jay			What the 'Moonwalk' Illusion Reveals about the Perception of Relative Depth from Motion	PLOS ONE			English	Article							DYNAMIC OCCLUSION; STIMULI; ORDER	When one visual object moves behind another, the object farther from the viewer is progressively occluded and/or disoccluded by the nearer object. For nearly half a century, this dynamic occlusion cue has beenthought to be sufficient by itself for determining the relative depth of the two objects. This view is consistent with the self-evident geometric fact that the surface undergoing dynamic occlusion is always farther from the viewer than the occluding surface. Here we use a contextual manipulation of a previously known motion illusion, which we refer to as the 'Moonwalk' illusion, to demonstrate that the visual system cannot determine relative depth from dynamic occlusion alone. Indeed, in the Moonwalk illusion, human observers perceive a relative depth contrary to the dynamic occlusion cue. However, the perception of the expected relative depth is restored by contextual manipulations unrelated to dynamic occlusion. On the other hand, we show that an Ideal Observer can determine using dynamic occlusion alone in the same Moonwalk stimuli, indicating that the dynamic occlusion cue is, in principle, sufficient for determining relative depth. Our results indicate that in order to correctly perceive relative depth from dynamic occlusion, the human brain, unlike the Ideal Observer, needs additionalsegmentation information that delineate the occluder from the occluded object. Thus, neural mechanisms of object segmentation must, in addition to motion mechanisms that extract information about relative depth, play a crucial role in the perception of relative depth from motion.	[Kromrey, Sarah; Hegde, Jay] Georgia Hlth Sci Univ, Brain & Behav Discovery Inst, Augusta, GA USA; [Kromrey, Sarah; Hegde, Jay] Georgia Hlth Sci Univ, Vis Discovery Inst, Augusta, GA USA; [Bart, Evgeniy] Xerox Corp, Palo Alto Res Ctr, Palo Alto, CA 94304 USA; [Hegde, Jay] Georgia Hlth Sci Univ, Dept Ophthalmol, Augusta, GA USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; Xerox; University System of Georgia; Augusta University	Kromrey, S (corresponding author), Georgia Hlth Sci Univ, Brain & Behav Discovery Inst, Augusta, GA USA.	jhegde@mcg.edu			Brain and Behavior Discovery Institute; Vision Discovery Institute of the Georgia Health Sciences University	Brain and Behavior Discovery Institute; Vision Discovery Institute of the Georgia Health Sciences University	This study was supported in part by the Brain and Behavior Discovery Institute and by the Vision Discovery Institute of the Georgia Health Sciences University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; ALBRIGHT TD, 1992, SCIENCE, V255, P1141, DOI 10.1126/science.1546317; ANDERSEN GJ, 1989, PERCEPT PSYCHOPHYS, V46, P49, DOI 10.3758/BF03208073; ANSTIS SM, 1989, P 2 RET RES FDN C, P247; Baker CL, 2001, PROG BRAIN RES, V134, P171; Beck C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003807; BRUNO N, 1990, PERCEPT PSYCHOPHYS, V48, P331, DOI 10.3758/BF03206684; CAVANAGH P, 1989, Spatial Vision, V4, P103, DOI 10.1163/156856889X00077; CHUBB C, 1988, J OPT SOC AM A, V5, P1986, DOI 10.1364/JOSAA.5.001986; CRATON LG, 1990, PERCEPT PSYCHOPHYS, V47, P169, DOI 10.3758/BF03205981; FLEET DJ, 1994, VISION RES, V34, P3057, DOI 10.1016/0042-6989(94)90278-X; FLEET DJ, 2005, MATH MODELS COMPUTER, P1; FLEET DJ, 2002, EXPLORING ARTIFICIAL, P139; GIBSON JJ, 1969, PERCEPT PSYCHOPHYS, V5, P113, DOI 10.3758/BF03210533; Hegde J, 2004, J VISION, V4, P838, DOI 10.1167/4.10.1; HORN BKP, 1981, ARTIF INTELL, V17, P185, DOI 10.1016/0004-3702(81)90024-2; Howard I. P., 2002, SEEING DEPTH, V2; KAPLAN GA, 1969, PERCEPT PSYCHOPHYS, V6, P193, DOI 10.3758/BF03207015; Kersten D, 2004, ANNU REV PSYCHOL, V55, P271, DOI 10.1146/annurev.psych.55.090902.142005; MICHOTTE A, 1964, STUDIA PSYCHOLOGIA; MUTCH KM, 1988, NATURAL COMPUTATION, P44; NIYOGI SA, 1995, DETECTING KINETIC OC, P1044; ONO H, 1988, PERCEPTION, V17, P255, DOI 10.1068/p170255; PEARL J., 1988, PROBABILISTIC REASON, DOI 10.1016/B978-0-08-051489-5.50008-4; RAMACHANDRAN VS, 1990, PERCEPTION, V19, P611, DOI 10.1068/p190611; ROYDEN CS, 1988, PERCEPTION, V17, P289, DOI 10.1068/p170289; THOMPSON WB, 1985, IEEE T PATTERN ANAL, V7, P374, DOI 10.1109/TPAMI.1985.4767677; Vaina LM, 2003, PROG BRAIN RES, V144, P197, DOI 10.1016/S0079-6123(03)14401-4; YONAS A, 1987, PERCEPT PSYCHOPHYS, V41, P53, DOI 10.3758/BF03208213	29	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e20951	10.1371/journal.pone.0020951	http://dx.doi.org/10.1371/journal.pone.0020951			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	782TF	21731635	Green Published, Green Submitted, gold			2022-12-27	WOS:000292033700022
J	Tyagi, AM; Srivastava, K; Sharan, K; Yadav, D; Maurya, R; Singh, D				Tyagi, Abdul Malik; Srivastava, Kamini; Sharan, Kunal; Yadav, Dinesh; Maurya, Rakesh; Singh, Divya			Daidzein Prevents the Increase in CD4(+)CD28null T Cells and B Lymphopoesis in Ovariectomized Mice: A Key Mechanism for Anti-Osteoclastogenic Effect	PLOS ONE			English	Article							BONE-MINERAL DENSITY; CD28 EXPRESSION; PHYTOESTROGEN GENISTEIN; SOYBEAN ISOFLAVONE; PANCREATIC-ISLETS; OXIDATIVE STRESS; LYMPHOPOIESIS; POSTMENOPAUSAL; SENESCENCE; MARROW	Estrogen deficiency leads to an upregulation of TNF-alpha producing T cells and B-lymphopoesis which augments osteoclastogenesis. Estrogen deficiency also increases the population of premature senescent CD4(+)CD28null T cells which secrete a higher amount of TNF-alpha thus leading to enhanced osteoclastogenesis. Isoflavonoids like daidzein and genistein are found mostly in soybeans, legumes, and peas. These share structural similarity with 17 beta-stradiol (E2) and have osteoprotective role. This study explores the effect of daidzein (Daid) on the proliferation of TNF-alpha producing T cells, premature senescent T cells and B cell lymphopoesis under estrogen deficient conditions. For this study adult Balb/c mice were treated with Daid at 10 mg/kg body weight dose by oral gavage daily post ovariectomy (Ovx). After six weeks animals were autopsied and bone marrow and spleen cells were collected for FACS analysis. Blood serum was collected for ELISA. It was observed that Ovx mice treated with Daid for six weeks show reduction in Ovx induced expansion of CD4(+) T cells in bone marrow and spleen when analysed by flow cytometry. Estrogen deficiency led to increased prevalence of TNF-alpha secreting CD4(+)CD28null T cells, however, treatment with Daid increased the percentage of CD4(+)CD28(+) T cells. Co-culture of CD4(+)CD28null T cells and bone marrow resulted in enhanced osteoclastogenesis as evident by increased tartarate resistant acid phosphatase (TRAP) expression, an osteoclast marker. However, treatment with Daid resulted in reduced osteoclastogenesis in CD4(+)CD28null T cells and bone marrow cell co-culture. Daid also regulated B lymphopoesis and decreased mRNA levels of RANKL in B220(+) cells. Taken together, we propose that one of the mechanisms by which Daid prevents bone loss is by reversing the detrimental immune changes as a result of estrogen deficiency.	[Tyagi, Abdul Malik; Srivastava, Kamini; Sharan, Kunal; Singh, Divya] CSIR, Cent Drug Res Inst, Div Endocrinol, Lucknow, Uttar Pradesh, India; [Yadav, Dinesh; Maurya, Rakesh] CSIR, Cent Drug Res Inst, Div Med & Proc Chem, Lucknow, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Tyagi, AM (corresponding author), CSIR, Cent Drug Res Inst, Div Endocrinol, Lucknow, Uttar Pradesh, India.	divya_singh@cdri.res.in	Malik, Abdul/AAX-5715-2020	Malik, Abdul/0000-0001-9012-5779; SRIVASTAVA, KAMINI/0000-0002-3928-0885; Sharan, Kunal/0000-0003-2139-2544	Ministry of Health and Family Welfare, Department of Science and Technology, Department of Biotechnology and Council of Scientific and Industrial Research, Government of India	Ministry of Health and Family Welfare, Department of Science and Technology, Department of Biotechnology and Council of Scientific and Industrial Research, Government of India	Generous funding was provided by the Ministry of Health and Family Welfare, Department of Science and Technology, Department of Biotechnology and Council of Scientific and Industrial Research, Government of India. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubin JE, 2000, OSTEOPOROSIS INT, V11, P905, DOI 10.1007/s001980070028; Baker PJ, 1999, INFECT IMMUN, V67, P2804, DOI 10.1128/IAI.67.6.2804-2809.1999; Banfi G, 2008, CLIN CHEM LAB MED, V46, P1550, DOI 10.1515/CCLM.2008.302; BIANCHI F, 1993, TISSUE CELL, V25, P817, DOI 10.1016/0040-8166(93)90030-O; Bitto A, 2009, J ENDOCRINOL, V201, P321, DOI 10.1677/JOE-08-0552; Bryl E, 2005, ARTHRITIS RHEUM-US, V52, P2996, DOI 10.1002/art.21353; Bryl E, 2001, J IMMUNOL, V167, P3231, DOI 10.4049/jimmunol.167.6.3231; Cenci S, 2003, P NATL ACAD SCI USA, V100, P10405, DOI 10.1073/pnas.1533207100; D'Amelio P, 2008, BONE, V43, P92, DOI 10.1016/j.bone.2008.02.017; Effros RB, 1997, DEV COMP IMMUNOL, V21, P471, DOI 10.1016/S0145-305X(97)00027-X; EFFROS RB, 1994, EXP GERONTOL, V29, P601, DOI 10.1016/0531-5565(94)90073-6; Effros RB, 1998, AGING-CLIN EXP RES, V10, P152; Erlandsson MC, 2000, CELL IMMUNOL, V205, P103, DOI 10.1006/cimm.2000.1719; Grassi F, 2007, P NATL ACAD SCI USA, V104, P15087, DOI 10.1073/pnas.0703610104; Hertrampf T, 2007, BONE, V40, P1529, DOI 10.1016/j.bone.2007.02.006; Horowitz MC, 2005, IMMUNOL REV, V208, P141, DOI 10.1111/j.0105-2896.2005.00328.x; Imanishi T, 2005, HYPERTENS RES, V28, P263, DOI 10.1291/hypres.28.263; Ishimi Y, 2002, BONE, V31, P180, DOI 10.1016/S8756-3282(02)00780-9; Ishimi Y, 1999, ENDOCRINOLOGY, V140, P1893, DOI 10.1210/en.140.4.1893; KALU DN, 1993, BONE MINER, V23, P145, DOI 10.1016/S0169-6009(08)80050-5; Kawai T, 2006, AM J PATHOL, V169, P987, DOI 10.2353/ajpath.2006.060180; Kozlowska E, 2007, IMMUNOLOGY, V122, P445, DOI 10.1111/j.1365-2567.2007.02667.x; Kritz-Silverstein D, 2002, J WOMEN HEALTH GEN-B, V11, P69, DOI 10.1089/152460902753473480; Lean JM, 2003, J CLIN INVEST, V112, P915, DOI 10.1172/JCI200318859; Li R, 2002, CANCER-AM CANCER SOC, V95, P960, DOI 10.1002/cncr.10791; Li Y, 2007, J CELL BIOCHEM, V100, P1370, DOI 10.1002/jcb.21121; MARCHETTI P, 1994, TRANSPLANTATION, V57, P1532; MASUZAWA T, 1994, J CLIN INVEST, V94, P1090, DOI 10.1172/JCI117424; Mei J, 2001, J CLIN ENDOCR METAB, V86, P5217, DOI 10.1210/jc.86.11.5217; Miyamoto M, 1998, PLANTA MED, V64, P516, DOI 10.1055/s-2006-957505; Miyaura C, 1997, P NATL ACAD SCI USA, V94, P9360, DOI 10.1073/pnas.94.17.9360; Morito K, 2002, BIOL PHARM BULL, V25, P48, DOI 10.1248/bpb.25.48; Pacifici R, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2126; Pandey R, 2010, MENOPAUSE, V17, P602, DOI 10.1097/gme.0b013e3181d0f7f0; Picherit C, 2000, J NUTR, V130, P1675, DOI 10.1093/jn/130.7.1675; Puel C, 2006, CLIN NUTR, V25, P859, DOI 10.1016/j.clnu.2006.03.009; Rapaport FT, 1997, TRANSPL P, V29, P1261, DOI 10.1016/S0041-1345(96)00489-7; Roggia C, 2001, P NATL ACAD SCI USA, V98, P13960, DOI 10.1073/pnas.251534698; ROSEN CJ, 1990, J BONE MINER RES, V5, P851; Sakai T, 2010, J NUTR SCI VITAMINOL, V56, P72, DOI 10.3177/jnsv.56.72; Sakai T, 2008, J MED INVESTIG, V55, P167, DOI 10.2152/jmi.55.167; Setchell KDR, 2003, AM J CLIN NUTR, V78, p593S, DOI 10.1093/ajcn/78.3.593S; Somekawa Y, 2001, OBSTET GYNECOL, V97, P109, DOI 10.1016/S0029-7844(00)01080-2; Sun DX, 2003, J BONE MINER RES, V18, P1206, DOI 10.1359/jbmr.2003.18.7.1206; Tarjanyi Oktavia, 2009, Immun Ageing, V6, P8, DOI 10.1186/1742-4933-6-8; TYAGI AM, 2011, OSTEOPOROS IN PRESS; Vallejo AN, 1999, J IMMUNOL, V162, P6572; Vallejo AN, 2004, TRENDS MOL MED, V10, P119, DOI 10.1016/j.molmed.2004.01.002; Vallejo AN, 2002, J BIOL CHEM, V277, P46940, DOI 10.1074/jbc.M207352200; Weitzmann MN, 2005, IMMUNOL REV, V208, P154, DOI 10.1111/j.0105-2896.2005.00324.x; Yellayi S, 2002, P NATL ACAD SCI USA, V99, P7616, DOI 10.1073/pnas.102650199	51	52	52	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21216	10.1371/journal.pone.0021216	http://dx.doi.org/10.1371/journal.pone.0021216			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731677	gold, Green Published, Green Submitted			2022-12-27	WOS:000292033700048
J	Wang, DC; Wang, HY; Zhou, YY; Zhang, QX; Zhang, FF; Du, PC; Wang, SJ; Chen, C; Kan, BA				Wang, Duochun; Wang, Haiyin; Zhou, Yanyan; Zhang, Qiuxiang; Zhang, Fanfei; Du, Pengcheng; Wang, Shujing; Chen, Chen; Kan, Biao			Genome Sequencing Reveals Unique Mutations in Characteristic Metabolic Pathways and the Transfer of Virulence Genes between V. mimicus and V. cholerae	PLOS ONE			English	Article							VIBRIO PATHOGENICITY ISLAND; LYSOGENIC CONVERSION; CTX-PHI; TOXIN; STRAINS; IDENTIFICATION; HEMOLYSIN; PROPHAGE; EXPRESSION; EPIDEMIC	Vibrio mimicus, the species most similar to V. cholerae, is a microbe present in the natural environmental and sometimes causes diarrhea and internal infections in humans. It shows similar phenotypes to V. cholerae but differs in some biochemical characteristics. The molecular mechanisms underlying the differences in biochemical metabolism between V. mimicus and V. cholerae are currently unclear. Several V. mimicus isolates have been found that carry cholera toxin genes (ctxAB) and cause cholera-like diarrhea in humans. Here, the genome of the V. mimicus isolate SX-4, which carries an intact CTX element, was sequenced and annotated. Analysis of its genome, together with those of other Vibrio species, revealed extensive differences within the Vibrionaceae. Common mutations in gene clusters involved in three biochemical metabolism pathways that are used for discrimination between V. mimicus and V. cholerae were found in V. mimicus strains. We also constructed detailed genomic structures and evolution maps for the general types of genomic drift associated with pathogenic characters in polysaccharides, CTX elements and toxin co-regulated pilus (TCP) gene clusters. Overall, the whole-genome sequencing of the V. mimicus strain carrying the cholera toxin gene provides detailed information for understanding genomic differences among Vibrio spp. V. mimicus has a large number of diverse gene and nucleotide differences from its nearest neighbor, V. cholerae. The observed mutations in the characteristic metabolism pathways may indicate different adaptations to different niches for these species and may be caused by ancient events in evolution before the divergence of V. cholerae and V. mimicus. Horizontal transfers of virulence-related genes from an uncommon clone of V. cholerae, rather than the seventh pandemic strains, have generated the pathogenic V. mimicus strain carrying cholera toxin genes.	[Wang, Duochun; Wang, Haiyin; Zhou, Yanyan; Du, Pengcheng; Wang, Shujing; Chen, Chen; Kan, Biao] Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Zhang, Qiuxiang; Zhang, Fanfei] Ctr Dis Control & Prevent Shanxi Prov, Taiyuan, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Wang, DC (corresponding author), Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	chenchen@icdc.cn; kanbiao@icdc.cn	CHEN, CHEN/HDM-6657-2022; chen, chen/AAQ-1805-2021	chen, chen/0000-0003-1765-8899	National Basic Research Priorities Program [2009CB522604]; National High Technology Research and Development Program of China (863 Program) [2006AA02Z425]; National Natural Science Foundation of China [30872260]; special grant for Prevention and Treatment of Infectious Diseases [2008ZX10004-012]	National Basic Research Priorities Program(National Basic Research Program of China); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); special grant for Prevention and Treatment of Infectious Diseases	This work was supported by grants from the National Basic Research Priorities Program (2009CB522604), the National High Technology Research and Development Program of China (863 Program) (2006AA02Z425), the National Natural Science Foundation of China (No. 30872260) and a special grant for Prevention and Treatment of Infectious Diseases (2008ZX10004-012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna MT, 1999, APPL ENVIRON MICROB, V65, P336; ALBERT MJ, 1993, LANCET, V341, P704; Boyd EF, 2000, INFECT IMMUN, V68, P1507, DOI 10.1128/IAI.68.3.1507-1513.2000; DAVIS BR, 1981, J CLIN MICROBIOL, V14, P631, DOI 10.1128/JCM.14.6.631-639.1981; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Faruque SM, 2003, INFECT IMMUN, V71, P1020, DOI 10.1128/IAI.71.2.1020-1025.2003; Faruque SM, 1998, MICROBIOL MOL BIOL R, V62, P1301, DOI 10.1128/MMBR.62.4.1301-1314.1998; Faruque SM, 1999, INFECT IMMUN, V67, P5723, DOI 10.1128/IAI.67.11.5723-5729.1999; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hasan NA, 2010, P NATL ACAD SCI USA, V107, P21134, DOI 10.1073/pnas.1013825107; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; Karaolis DKR, 1998, P NATL ACAD SCI USA, V95, P3134, DOI 10.1073/pnas.95.6.3134; Kim GT, 1997, BBA-MOL BASIS DIS, V1360, P102, DOI 10.1016/S0925-4439(97)00008-2; Kumar P, 2009, J MED MICROBIOL, V58, P234, DOI 10.1099/jmm.0.002089-0; Lee SH, 1999, CELL, V99, P625, DOI 10.1016/S0092-8674(00)81551-2; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Li MR, 2003, APPL ENVIRON MICROB, V69, P1728, DOI 10.1128/AEM.69.3.1728-1738.2003; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Lin W, 1999, P NATL ACAD SCI USA, V96, P1071, DOI 10.1073/pnas.96.3.1071; Liu Guang-wen, 2006, Zhonghua Weishengwuxue He Mianyixue Zazhi, V26, P379; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Maiti D, 2006, MICROBIOL-SGM, V152, P3633, DOI 10.1099/mic.0.2006/000117-0; Mukhopadhyay AK, 2001, J BACTERIOL, V183, P4737, DOI 10.1128/JB.183.16.4737-4746.2001; Nair GB, 2006, J CLIN MICROBIOL, V44, P4211, DOI 10.1128/JCM.01304-06; RAMAMURTHY T, 1993, LANCET, V341, P703, DOI 10.1016/0140-6736(93)90480-5; Rubin EJ, 1998, MOL MICROBIOL, V28, P1247, DOI 10.1046/j.1365-2958.1998.00889.x; Sack DA, 2004, LANCET, V363, P223, DOI 10.1016/S0140-6736(03)15328-7; Saunders J, 2004, NAT REV MICROBIOL, V2, P86, DOI 10.1038/nrmicro830; SHANDERA WX, 1983, ANN INTERN MED, V99, P169, DOI 10.7326/0003-4819-99-2-169; Shi L, 1998, MICROBIOL IMMUNOL, V42, P823, DOI 10.1111/j.1348-0421.1998.tb02357.x; Shi L, 2000, J HEALTH SCI, V46, P63; Shinoda S, 2004, MICROBIOL IMMUNOL, V48, P547, DOI 10.1111/j.1348-0421.2004.tb03551.x; SPIRA WM, 1983, APPL ENVIRON MICROB, V46, P704, DOI 10.1128/AEM.46.3.704-709.1983; Srividhya KV, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001193; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Thompson CC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-258; UCHIMURA M, 1993, EPIDEMIOL INFECT, V111, P49, DOI 10.1017/S0950268800056661; Vicente ACP, 1997, J MED MICROBIOL, V46, P398, DOI 10.1099/00222615-46-5-398; WALDOR MK, 1994, P NATL ACAD SCI USA, V91, P11388, DOI 10.1073/pnas.91.24.11388; Waldor MK, 1996, SCIENCE, V272, P1910, DOI 10.1126/science.272.5270.1910	40	26	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21299	10.1371/journal.pone.0021299	http://dx.doi.org/10.1371/journal.pone.0021299			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731695	Green Submitted, Green Published, gold			2022-12-27	WOS:000292033700057
J	Calvi, CL; Podowski, M; D'Alessio, FR; Metzger, SL; Misono, K; Poonyagariyagorn, H; Lopez-Mercado, A; Ku, T; Lauer, T; Cheadle, C; Talbot, CC; Jie, CF; McGrath-Morrow, S; King, LS; Walston, J; Neptune, ER				Calvi, Carla L.; Podowski, Megan; D'Alessio, Franco R.; Metzger, Shana L.; Misono, Kaori; Poonyagariyagorn, Hataya; Lopez-Mercado, Armando; Ku, Therese; Lauer, Thomas; Cheadle, Christopher; Talbot, C. Conover, Jr.; Jie, Chunfa; McGrath-Morrow, Sharon; King, Landon S.; Walston, Jeremy; Neptune, Enid R.			Critical Transition in Tissue Homeostasis Accompanies Murine Lung Senescence	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; OXIDATIVE STRESS; B-CELL; MATRIX METALLOPROTEINASE-1; AUTOIMMUNITY; OLD; IMMUNOSENESCENCE; INFLAMMATION; EMPHYSEMA; C57BL/6J	Background: Respiratory dysfunction is a major contributor to morbidity and mortality in aged populations. The susceptibility to pulmonary insults is attributed to "low pulmonary reserve'', ostensibly reflecting a combination of age-related musculoskeletal, immunologic and intrinsic pulmonary dysfunction. Methods/Principal Findings: Using a murine model of the aging lung, senescent DBA/2 mice, we correlated a longitudinal survey of airspace size and injury measures with a transcriptome from the aging lung at 2, 4, 8, 12, 16 and 20 months of age. Morphometric analysis demonstrated a nonlinear pattern of airspace caliber enlargement with a critical transition occurring between 8 and 12 months of age marked by an initial increase in oxidative stress, cell death and elastase activation which is soon followed by inflammatory cell infiltration, immune complex deposition and the onset of airspace enlargement. The temporally correlative transcriptome showed exuberant induction of immunoglobulin genes coincident with airspace enlargement. Immunohistochemistry, ELISA analysis and flow cytometry demonstrated increased immunoglobulin deposition in the lung associated with a contemporaneous increase in activated B-cells expressing high levels of TLR4 (toll receptor 4) and CD86 and macrophages during midlife. These midlife changes culminate in progressive airspace enlargement during late life stages. Conclusion/Significance: Our findings establish that a tissue-specific aging program is evident during a presenescent interval which involves early oxidative stress, cell death and elastase activation, followed by B lymphocyte and macrophage expansion/activation. This sequence heralds the progression to overt airspace enlargement in the aged lung. These signature events, during middle age, indicate that early stages of the aging immune system may have important correlates in the maintenance of tissue morphology. We further show that time-course analyses of aging models, when informed by structural surveys, can reveal nonintuitive signatures of organ-specific aging pathology.	[Calvi, Carla L.; Podowski, Megan; D'Alessio, Franco R.; Metzger, Shana L.; Misono, Kaori; Poonyagariyagorn, Hataya; Lopez-Mercado, Armando; Ku, Therese; King, Landon S.; Neptune, Enid R.] Johns Hopkins Univ, Sch Med, Div Pulm & Crit Care Med, Baltimore, MD 21218 USA; [Cheadle, Christopher] Johns Hopkins Univ, Sch Med, Div Allergy & Clin Immunol, Baltimore, MD USA; [Talbot, C. Conover, Jr.; Jie, Chunfa] Johns Hopkins Univ, Sch Med, JHMI Microarray Core, Baltimore, MD USA; [Walston, Jeremy] Johns Hopkins Univ, Sch Med, Div Geriatr, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Calvi, CL (corresponding author), Johns Hopkins Univ, Sch Med, Div Pulm & Crit Care Med, Baltimore, MD 21218 USA.	eneptune@jhmi.edu	Ku, Therese/Q-4857-2019	Ku, Therese/0000-0002-8353-4985	National Institutes of Health [RO1-HL085312]; National Institute on Aging (NIA) through the Johns Hopkins Older Americans Independence Center (OAIC) [P30 AG021334]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085312] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG021334] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging (NIA) through the Johns Hopkins Older Americans Independence Center (OAIC)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by the National Institutes of Health (grants RO1-HL085312 to E.R.N.). This work has also been supported by the National Institute on Aging (NIA) through the Johns Hopkins Older Americans Independence Center (OAIC), P30 AG021334 (to E.R.N. and J.D.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benz CC, 2008, NAT REV CANCER, V8, P875, DOI 10.1038/nrc2522; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Boren E, 2004, AUTOIMMUN REV, V3, P401, DOI 10.1016/j.autrev.2004.03.004; Chung HY, 2006, ANTIOXID REDOX SIGN, V8, P572, DOI 10.1089/ars.2006.8.572; D'Alessio FR, 2009, J CLIN INVEST, V119, P2898, DOI 10.1172/JCI36498; Dasgupta J, 2010, J CELL PHYSIOL, V225, P52, DOI 10.1002/jcp.22193; Dorshkind K, 2009, NAT REV IMMUNOL, V9, P57, DOI 10.1038/nri2471; Feghali-Bostwick CA, 2008, AM J RESP CRIT CARE, V177, P156, DOI 10.1164/rccm.200701-014OC; Fisher GJ, 2009, AM J PATHOL, V174, P101, DOI 10.2353/ajpath.2009.080599; Gibson KL, 2009, AGING CELL, V8, P18, DOI 10.1111/j.1474-9726.2008.00443.x; Guerrettaz LM, 2008, P NATL ACAD SCI USA, V105, P11898, DOI 10.1073/pnas.0805498105; Hasler P, 2005, CELL IMMUNOL, V233, P102, DOI 10.1016/j.cellimm.2005.04.012; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Huang KW, 2007, J APPL PHYSIOL, V102, P1632, DOI 10.1152/japplphysiol.00833.2006; Huang KW, 2007, J APPL PHYSIOL, V102, P200, DOI 10.1152/japplphysiol.00400.2006; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Larbi A, 2008, ADV EXP MED BIOL, V640, P312, DOI 10.1007/978-0-387-09789-3_21; Listi F, 2006, ANN NY ACAD SCI, V1089, P487, DOI 10.1196/annals.1386.013; McElhaney JE, 2009, CURR OPIN IMMUNOL, V21, P418, DOI 10.1016/j.coi.2009.05.023; Misra V, 2007, PHYSIOL GENOMICS, V31, P429, DOI 10.1152/physiolgenomics.00060.2007; Pawelec G, 1999, MECH AGEING DEV, V108, P1; Podowski M, 2009, AM J PATHOL, V175, P84, DOI 10.2353/ajpath.2009.080870; RICHARDS D W, 1956, Bull N Y Acad Med, V32, P407; Sato T, 2006, AM J RESP CRIT CARE, V174, P530, DOI 10.1164/rccm.200511-1816OC; Speziali E, 2009, CELL IMMUNOL, V256, P1, DOI 10.1016/j.cellimm.2009.01.010; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; van der Strate BWA, 2006, AM J RESP CRIT CARE, V173, P751, DOI 10.1164/rccm.200504-594OC; VERBEKEN EK, 1992, CHEST, V101, P793, DOI 10.1378/chest.101.3.793; Zahn JM, 2007, PLOS GENET, V3, P2326, DOI 10.1371/journal.pgen.0030201	30	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2011	6	6							e20712	10.1371/journal.pone.0020712	http://dx.doi.org/10.1371/journal.pone.0020712			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782CL	21713037	Green Published, Green Submitted, gold			2022-12-27	WOS:000291985100004
J	Jiang, Q; Ho, YY; Hao, L; Berrios, CN; Chakravarti, A				Jiang, Qian; Ho, Yen-Yi; Hao, Li; Berrios, Courtney Nichols; Chakravarti, Aravinda			Copy Number Variants in Candidate Genes Are Genetic Modifiers of Hirschsprung Disease	PLOS ONE			English	Article							DEPENDENT PROBE AMPLIFICATION; STRUCTURAL VARIATION; RET ENHANCER; HUMAN GENOME; COMMON; EXPRESSION; CHROMOSOME-10; MALFORMATIONS; DUPLICATIONS; ASSOCIATION	Hirschsprung disease (HSCR) is a neurocristopathy characterized by absence of intramural ganglion cells along variable lengths of the gastrointestinal tract. The HSCR phenotype is highly variable with respect to gender, length of aganglionosis, familiality and the presence of additional anomalies. By molecular genetic analysis, a minimum of 11 neuro-developmental genes (RET, GDNF, NRTN, SOX10, EDNRB, EDN3, ECE1, ZFHX1B, PHOX2B, KIAA1279, TCF4) are known to harbor rare, high-penetrance mutations that confer a large risk to the bearer. In addition, two other genes (RET, NRG1) harbor common, low-penetrance polymorphisms that contribute only partially to risk and can act as genetic modifiers. To broaden this search, we examined whether a set of 67 proven and candidate HSCR genes harbored additional modifier alleles. In this pilot study, we utilized a custom-designed array CGH with similar to 33,000 test probes at an average resolution of similar to 185 bp to detect gene-sized or smaller copy number variants (CNVs) within these 67 genes in 18 heterogeneous HSCR patients. Using stringent criteria, we identified CNVs at three loci (MAPK10, ZFHX1B, SOX2) that are novel, involve regulatory and coding sequences of neuro-developmental genes, and show association with HSCR in combination with other congenital anomalies. Additional CNVs are observed under relaxed criteria. Our research suggests a role for CNVs in HSCR and, importantly, emphasizes the role of variation in regulatory sequences. A much larger study will be necessary both for replication and for identifying the full spectrum of small CNV effects.	[Jiang, Qian; Ho, Yen-Yi; Hao, Li; Berrios, Courtney Nichols; Chakravarti, Aravinda] Johns Hopkins Univ, Sch Med, Ctr Complex Dis Genom, McKusick Nathans Inst Genet Med, Baltimore, MD 21218 USA	Johns Hopkins University	Jiang, Q (corresponding author), Johns Hopkins Univ, Sch Med, Ctr Complex Dis Genom, McKusick Nathans Inst Genet Med, Baltimore, MD 21218 USA.	aravinda@jhmi.edu	Jiang, Qian/ABG-8183-2020	Jiang, Qian/0000-0001-6023-2290; Berrios, Courtney/0000-0001-5170-070X	U.S. National Institutes of Health [R37 HD28088]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD028088] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by the U.S. National Institutes of Health for funding (R37 HD28088). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Amiel J, 2008, J MED GENET, V45, P1, DOI 10.1136/jmg.2007.053959; Arnold S, 2009, HUM MUTAT, V30, P771, DOI 10.1002/humu.20944; Bolk S, 2000, P NATL ACAD SCI USA, V97, P268, DOI 10.1073/pnas.97.1.268; Brabletz S, 2010, EMBO REP, V11, P670, DOI 10.1038/embor.2010.117; Brewer C, 1999, AM J HUM GENET, V64, P1702, DOI 10.1086/302410; Brewer C, 1998, AM J HUM GENET, V63, P1153, DOI 10.1086/302041; Bylund M, 2003, NAT NEUROSCI, V6, P1162, DOI 10.1038/nn1131; Chaignat E, 2011, GENOME RES, V21, P106, DOI 10.1101/gr.112748.110; CHAKRAVARTI A, 2001, METABOLIC MOL BASES, P6231; CLEVELAND WS, 1981, AM STAT, V35, P54, DOI 10.2307/2683591; Cox JJ, 2011, NEW ENGL J MED, V364, P91, DOI 10.1056/NEJMc1010311; Dathe K, 2009, AM J HUM GENET, V84, P483, DOI 10.1016/j.ajhg.2009.03.001; de Pontual L, 2007, HUM MUTAT, V28, P790, DOI 10.1002/humu.20517; Delabar Jean-Maurice, 1993, European Journal of Human Genetics, V1, P114; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Emison ES, 2010, AM J HUM GENET, V87, P60, DOI 10.1016/j.ajhg.2010.06.007; Emison ES, 2005, NATURE, V434, P857, DOI 10.1038/nature03467; Episkopou V, 2005, TRENDS NEUROSCI, V28, P219, DOI 10.1016/j.tins.2005.03.003; Fanciulli M, 2010, CLIN GENET, V77, P201, DOI 10.1111/j.1399-0004.2009.01342.x; Garcia-Barcelo MM, 2009, P NATL ACAD SCI USA, V106, P2694, DOI 10.1073/pnas.0809630105; Girirajan S, 2010, NAT GENET, V42, P203, DOI 10.1038/ng.534; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Haldane JBS, 1941, J GENET, V41, P149, DOI 10.1007/BF02983018; Heanue TA, 2006, P NATL ACAD SCI USA, V103, P6919, DOI 10.1073/pnas.0602152103; Hinds DA, 2006, NAT GENET, V38, P82, DOI 10.1038/ng1695; Huber W, 2002, BIOINFORMATICS, V18, pS96; Kurth I, 2009, NAT GENET, V41, P862, DOI 10.1038/ng0809-862; Lower KM, 2009, P NATL ACAD SCI USA, V106, P21771, DOI 10.1073/pnas.0909331106; LYONNET S, 1993, NAT GENET, V4, P346, DOI 10.1038/ng0893-346; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Matsuzaki H, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r125; Neidhart S, 2001, FEBS LETT, V508, P259, DOI 10.1016/S0014-5793(01)03090-3; Nunez-Torres R, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-119; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; PUFFENBERGER EG, 1994, CELL, V79, P1257, DOI 10.1016/0092-8674(94)90016-7; Serra A, 2009, ANN HUM GENET, V73, P147, DOI 10.1111/j.1469-1809.2008.00503.x; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; Thomas DJ, 2007, NUCLEIC ACIDS RES, V35, pD663, DOI 10.1093/nar/gkl1017; Wakamatsu N, 2001, NAT GENET, V27, P369, DOI 10.1038/86860	41	48	50	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2011	6	6							e21219	10.1371/journal.pone.0021219	http://dx.doi.org/10.1371/journal.pone.0021219			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782CL	21712996	Green Submitted, gold, Green Published			2022-12-27	WOS:000291985100017
J	Cinnamon, J; Schuurman, N; Hameed, SM				Cinnamon, Jonathan; Schuurman, Nadine; Hameed, S. Morad			Pedestrian Injury and Human Behaviour: Observing Road-Rule Violations at High-Incident Intersections	PLOS ONE			English	Article							SIGNALIZED INTERSECTIONS; DRIVER BEHAVIOR; SAFETY; CRASHES; PREVENTION; COLLISIONS; PATTERNS	Background: Human behaviour is an obvious, yet under-studied factor in pedestrian injury. Behavioural interventions that address rule violations by pedestrians and motorists could potentially reduce the frequency of pedestrian injury. In this study, a method was developed to examine road-rule non-compliance by pedestrians and motorists. The purpose of the study was to examine the potential association between violations made by pedestrians and motorists at signalized intersections, and collisions between pedestrians and motor-vehicles. The underlying hypothesis is that high-incident pedestrian intersections are likely to vary with respect to their aetiology, and thus are likely to require individualized interventions - based on the type and rate of pedestrian and motorist violation. Methods: High-incident pedestrian injury intersections in Vancouver, Canada were identified using geographic information systems. Road-rule violations by pedestrians and motorists were documented at each incident hotspot by a team of observers at several different time periods during the day. Results: Approximately 9,000 pedestrians and 18,000 vehicles were observed in total. In total for all observed intersections, over 2000 (21%) pedestrians committed one of the observed pedestrian road-crossing violations, while approximately 1000 (5.9%) drivers committed one of the observed motorist violations. Great variability in road-rule violations was observed between intersections, and also within intersections at different observation periods. Conclusions: Both motorists and pedestrians were frequently observed committing road-rule violations at signalized intersections, suggesting a potential human behavioural contribution to pedestrian injury at the study sites. These results suggest that each intersection may have unique mechanisms that contribute to pedestrian injury, and may require targeted behavioural interventions. The method described in this study provides the basis for understanding the relationship between violations and pedestrian injury risk at urban intersections. Findings could be applied to targeted prevention campaigns designed to reduce the number of pedestrian injuries at signalized intersections.	[Cinnamon, Jonathan; Schuurman, Nadine] Simon Fraser Univ, Dept Geog, Burnaby, BC V5A 1S6, Canada; [Hameed, S. Morad] Vancouver Gen Hosp, Trauma Serv, Vancouver, BC, Canada	Simon Fraser University; University of British Columbia	Cinnamon, J (corresponding author), Simon Fraser Univ, Dept Geog, Burnaby, BC V5A 1S6, Canada.	jca80@sfu.ca	Cinnamon, Jonathan/ABB-8331-2021	Cinnamon, Jonathan/0000-0001-7383-6886	SSHRC; Canadian Institutes of Health Research (CIHR); Michael Smith Foundation for Health Research (MSFHR)	SSHRC(Social Sciences and Humanities Research Council of Canada (SSHRC)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research)	A Mathematics of Information Technology and Computing Science (MITACS) Accelerate internship held by JC provided funding for this project, which was carried out in conjunction with Trauma Services at Vancouver General Hospital (VGH). Additional research support for JC was provided by a SSHRC doctoral scholarship. NS is supported by career awards from the Canadian Institutes of Health Research (CIHR) and Michael Smith Foundation for Health Research (MSFHR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ghamdi AS, 2002, ACCIDENT ANAL PREV, V34, P205, DOI 10.1016/S0001-4575(01)00015-X; Anderson RWG, 1997, ACCIDENT ANAL PREV, V29, P667, DOI 10.1016/S0001-4575(97)00036-5; Boyce TE, 2000, ENVIRON BEHAV, V32, P502, DOI 10.1177/00139160021972630; Chakravarthy B, 2007, ANN EMERG MED, V50, pS99, DOI 10.1016/j.annemergmed.2007.06.378; Clifton KJ, 2007, ACCIDENT ANAL PREV, V39, P708, DOI 10.1016/j.aap.2006.11.003; Cusimano M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008669; de Lavalette BC, 2009, SAFETY SCI, V47, P1248, DOI 10.1016/j.ssci.2009.03.016; Duperrex O, 2002, BRIT MED J, V324, P1129, DOI 10.1136/bmj.324.7346.1129; ESRI, 2006, ARCGIS 9 2; Geyer J., 2005, CONTINUING DEBATE SA; Guo F, 2010, ACCIDENT ANAL PREV, V42, P84, DOI 10.1016/j.aap.2009.07.005; HARBLUK JL, 2002, IMPACT COGNITIVE DIS, P1; Harre N, 2004, TRANSPORT RES F-TRAF, V7, P167, DOI 10.1016/j.trf.2004.07.002; HARWOOD DW, 2008, PEDESTRIAN SAFETY PR, DOI DOI 10.1016/J.AAP.2005.03.019; Hatfield J, 2007, ACCIDENT ANAL PREV, V39, P833, DOI 10.1016/j.aap.2006.12.005; HEINONEN JA, 2007, PEDESTRIAN INJURIES; Holland CA, 2009, HEALTH EDUC RES, V24, P674, DOI 10.1093/her/cyp003; Jacobsen PL, 2003, INJURY PREV, V9, P205, DOI 10.1136/ip.9.3.205rep; Kim K, 2008, ACCIDENT ANAL PREV, V40, P894, DOI 10.1016/j.aap.2007.10.004; Kim K, 2008, ACCIDENT ANAL PREV, V40, P2043, DOI 10.1016/j.aap.2008.08.021; King MJ, 2009, ACCIDENT ANAL PREV, V41, P485, DOI 10.1016/j.aap.2009.01.008; LaScala EA, 2000, ACCIDENT ANAL PREV, V32, P651, DOI 10.1016/S0001-4575(99)00100-1; Leden L, 2002, ACCIDENT ANAL PREV, V34, P457, DOI 10.1016/S0001-4575(01)00043-4; Lee C, 2005, ACCIDENT ANAL PREV, V37, P775, DOI 10.1016/j.aap.2005.03.019; Li Y, 2010, ACCIDENT ANAL PREV, V42, P1156, DOI 10.1016/j.aap.2010.01.004; Lyons RA, 2006, INJURY PREV, V12, P312, DOI 10.1136/ip.2006.011916; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Nasar J.L., 2003, TRANSPORT RES F-TRAF, V6, P175, DOI [DOI 10.1016/J.TRF.2004.07.002, DOI 10.1016/S1369-8478(03)00024-X]; Nasar J, 2008, ACCIDENT ANAL PREV, V40, P69, DOI 10.1016/j.aap.2007.04.005; National Highway Traffic Safety Administration, 2010, TRAFF SAF FACTS 2009; Nilsen P, 2004, INJURY PREV, V10, P268, DOI 10.1136/ip.2004.005744; Nilsen Per, 2007, Int J Inj Contr Saf Promot, V14, P241, DOI 10.1080/17457300701736726; Papaioannou P, 2007, ACCIDENT ANAL PREV, V39, P147, DOI 10.1016/j.aap.2006.06.014; Preusser DF, 2002, ACCIDENT ANAL PREV, V34, P703, DOI 10.1016/S0001-4575(01)00070-7; Pulugurtha SS, 2011, ACCIDENT ANAL PREV, V43, P439, DOI 10.1016/j.aap.2010.09.014; Retting RA, 2001, ACCIDENT ANAL PREV, V33, P723, DOI 10.1016/S0001-4575(00)00086-5; Rosen E, 2009, ACCIDENT ANAL PREV, V41, P536, DOI 10.1016/j.aap.2009.02.002; RUSSWURM L, 2010, WERE ALL PEDESTRIAN, DOI DOI 10.1016/J.JSR.2007.01.008; RUSSWURM L, 2010, VANCOUVER AREA NETWO; Schuurman N, 2008, CAN J SURG, V51, P389; Schuurman N, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-233; Sciortino S, 2005, ACCIDENT ANAL PREV, V37, P1102, DOI 10.1016/j.aap.2005.06.010; Stevenson M, 2006, INJURY PREV, V12, P1, DOI 10.1136/ip.2005.010413; STEVENSON MR, 1995, INT J EPIDEMIOL, V24, P957, DOI 10.1093/ije/24.5.957; Stutts J. C., 1996, TRANSPORT RES REC, V1538, P68, DOI [DOI 10.1177/0361198196153800109, 10.1177/0361198196153800109]; *TRANSP CAN, 2004, CAN MOT VEH COLL STA; *TRANSP CAN, 2008, QUICK LOOK INT CRASH; Transport Canada, 2008, QUICK LOOK SPEED CRA; Transport Canada, 2010, CAN MOT VEH COLL STA; Ulfarsson GF, 2010, ACCIDENT ANAL PREV, V42, P1805, DOI 10.1016/j.aap.2010.05.001; Wier M, 2009, ACCIDENT ANAL PREV, V41, P137, DOI 10.1016/j.aap.2008.10.001; Winston FK, 2010, INJURY PREV, V16, P107, DOI 10.1136/ip.2009.021972; World Health Organization, 2009, GLOB STAT REP ROAD S; Yang CYD, 2007, J SAFETY RES, V38, P311, DOI 10.1016/j.jsr.2007.01.008; Young K., 2003, DRIVER DISTRACTION R, P1	55	47	47	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e21063	10.1371/journal.pone.0021063	http://dx.doi.org/10.1371/journal.pone.0021063			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	778TS	21698258	Green Published, gold, Green Submitted			2022-12-27	WOS:000291730000047
J	Gershenson, C				Gershenson, Carlos			Self-Organization Leads to Supraoptimal Performance in Public Transportation Systems	PLOS ONE			English	Article							INSTABILITY	The performance of public transportation systems affects a large part of the population. Current theory assumes that passengers are served optimally when vehicles arrive at stations with regular intervals. In this paper, it is shown that self-organization can improve the performance of public transportation systems beyond the theoretical optimum by responding adaptively to local conditions. This is possible because of a "slower-is-faster" effect, where passengers wait more time at stations but total travel times are reduced. The proposed self-organizing method uses "antipheromones" to regulate headways, which are inspired by the stigmergy (communication via environment) of some ant colonies.	[Gershenson, Carlos] Univ Nacl Autonoma Mexico, Inst Invest Matemat Aplicadas & Sistemas, Dept Ciencias Computac, Mexico City 04510, DF, Mexico; [Gershenson, Carlos] Univ Nacl Autonoma Mexico, Ctr Ciencias Complejidad, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Gershenson, C (corresponding author), Univ Nacl Autonoma Mexico, Inst Invest Matemat Aplicadas & Sistemas, Dept Ciencias Computac, Mexico City 04510, DF, Mexico.	cgg@unam.mx	Gershenson, Carlos/F-2241-2010	Gershenson, Carlos/0000-0003-0193-3067	CONACyT, Mexico [47907]	CONACyT, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by SNI membership 47907 of CONACyT, Mexico http://www.conacyt.gob.mx. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1980, TRANSP RES REC; Ashby W. R., 1956, INTRO CYBERNETICS; Bar-Yam Y, 2005, LECT NOTES COMPUT SC, V3464, P16; Bonabeau E DdRDF, 1999, SWARM INTELLIGENCE N; Cohen JE, 2003, SCIENCE, V302, P1172, DOI 10.1126/science.1088665; Cools S.-B., 2007, SELF ORGANIZING TRAF, P41; Gershenson C, 2003, LECT NOTES ARTIF INT, V2801, P606; Gershenson C., 2007, DESIGN CONTROL SELF; Gershenson C, 2010, PALADYN J BEHAV ROBO, V1, P147, DOI DOI 10.2478/S13230-010-0015-Z]; Gershenson C, 2005, COMPLEX SYST, V16, P29; Gershenson C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007292; Helbing D, 2000, NATURE, V407, P487, DOI 10.1038/35035023; Helbing D, 2009, EUR PHYS J B, V70, P257, DOI 10.1140/epjb/e2009-00213-5; Theraulaz G, 1999, ARTIF LIFE, V5, P97, DOI 10.1162/106454699568700; WELDING PI, 1957, OPER RES QUART, V8, P133, DOI 10.2307/3007157; 2011, WORLD METRODATABASE	16	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e21469	10.1371/journal.pone.0021469	http://dx.doi.org/10.1371/journal.pone.0021469			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738674	Green Published, Green Submitted, gold			2022-12-27	WOS:000292291800015
J	Noinaj, N; Bhasin, SK; Song, ES; Scoggin, KE; Juliano, MA; Juliano, L; Hersh, LB; Rodgers, DW				Noinaj, Nicholas; Bhasin, Sonia K.; Song, Eun Suk; Scoggin, Kirsten E.; Juliano, Maria A.; Juliano, Luiz; Hersh, Louis B.; Rodgers, David W.			Identification of the Allosteric Regulatory Site of Insulysin	PLOS ONE			English	Article							INSULIN-DEGRADING ENZYME; AMYLOID-BETA-PEPTIDE; ALZHEIMERS-DISEASE; PROTEIN; IDE; ATP; SOFTWARE; BINDING; GENE; RECOGNITION	Background: Insulin degrading enzyme (IDE) is responsible for the metabolism of insulin and plays a role in clearance of the Ab peptide associated with Alzheimer's disease. Unlike most proteolytic enzymes, IDE, which consists of four structurally related domains and exists primarily as a dimer, exhibits allosteric kinetics, being activated by both small substrate peptides and polyphosphates such as ATP. Principal Findings: The crystal structure of a catalytically compromised mutant of IDE has electron density for peptide ligands bound at the active site in domain 1 and a distal site in domain 2. Mutating residues in the distal site eliminates allosteric kinetics and activation by a small peptide, as well as greatly reducing activation by ATP, demonstrating that this site plays a key role in allostery. Comparison of the peptide bound IDE structure (using a low activity E111F IDE mutant) with unliganded wild type IDE shows a change in the interface between two halves of the clamshell-like molecule, which may enhance enzyme activity by altering the equilibrium between closed and open conformations. In addition, changes in the dimer interface suggest a basis for communication between subunits. Conclusions/Significance: Our findings indicate that a region remote from the active site mediates allosteric activation of insulysin by peptides. Activation may involve a small conformational change that weakens the interface between two halves of the enzyme.	[Noinaj, Nicholas; Bhasin, Sonia K.; Song, Eun Suk; Scoggin, Kirsten E.; Hersh, Louis B.; Rodgers, David W.] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA; [Noinaj, Nicholas; Bhasin, Sonia K.; Song, Eun Suk; Scoggin, Kirsten E.; Hersh, Louis B.; Rodgers, David W.] Univ Kentucky, Struct Biol Ctr, Lexington, KY USA; [Juliano, Maria A.; Juliano, Luiz] Univ Fed Sao Paulo, Dept Biophys, Escola Paulista Med, Sao Paulo, Brazil	University of Kentucky; University of Kentucky; Universidade Federal de Sao Paulo (UNIFESP)	Noinaj, N (corresponding author), Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA.	david.rodgers@uky.edu	Juliano, Luiz/D-7204-2012; Complexos, INCT Fluidos/H-9172-2013	Juliano, Luiz/0000-0002-5589-2822; Scoggin, Kirsten/0000-0003-1348-641X	United States Public Health Services [NS38041, DA02243, DA016176, P20 RR20171, T32 DA016176]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS038041, R01NS038041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA016176, R01DA002243] Funding Source: NIH RePORTER	United States Public Health Services(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by United States Public Health Services grants NS38041, DA02243, DA016176, and P20 RR20171. N.N. was supported by a United States Public Health Services training grant (T32 DA016176). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adams PD, 2004, J SYNCHROTRON RADIAT, V11, P53, DOI 10.1107/S0909049503024130; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Authier F, 1996, CLIN INVEST MED, V19, P149; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barrett AJ, 2003, HDB PROTEOLYTIC ENZY; BAUMEISTER H, 1993, FEBS LETT, V317, P250, DOI 10.1016/0014-5793(93)81286-9; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Camberos MC, 2001, EXP BIOL MED, V226, P334, DOI 10.1177/153537020122600411; Chalkley RJ, 2005, MOL CELL PROTEOMICS, V4, P1194, DOI 10.1074/mcp.D500002-MCP200; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Duckworth WC, 1998, ENDOCR REV, V19, P608, DOI 10.1210/er.19.5.608; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fakhrai-Rad H, 2000, HUM MOL GENET, V9, P2149, DOI 10.1093/hmg/9.14.2149; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; GOMISRUTH FX, 1994, J BIOL CHEM, V269, P17111; Guo Q, 2010, J MOL BIOL, V395, P430, DOI 10.1016/j.jmb.2009.10.072; Gutfreund H., 1995, KINETICS LIFE SCI RE; Heras B, 2005, ACTA CRYSTALLOGR D, V61, P1173, DOI 10.1107/S0907444905019451; Hersh LB, 2003, CURR PHARM DESIGN, V9, P449, DOI 10.2174/1381612033391676; Im H, 2007, J BIOL CHEM, V282, P25453, DOI 10.1074/jbc.M701590200; Karamohamed S, 2003, DIABETES, V52, P1562, DOI 10.2337/diabetes.52.6.1562; Kim M, 2007, J BIOL CHEM, V282, P7825, DOI 10.1074/jbc.M609168200; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Malito E, 2008, BIOCHEMISTRY-US, V47, P12822, DOI 10.1021/bi801192h; Manolopoulou M, 2009, J BIOL CHEM, V284, P14177, DOI 10.1074/jbc.M900068200; MATTHEWS BW, 1988, ACCOUNTS CHEM RES, V21, P333, DOI 10.1021/ar00153a003; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miller BC, 2003, P NATL ACAD SCI USA, V100, P6221, DOI 10.1073/pnas.1031520100; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ogino T, 2004, J VIROL, V78, P11766, DOI 10.1128/JVI.78.21.11766-11777.2004; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Qiu WQ, 2006, NEUROBIOL AGING, V27, P190, DOI 10.1016/j.neurobiolaging.2005.01.004; Qiu WQ, 1998, J BIOL CHEM, V273, P32730, DOI 10.1074/jbc.273.49.32730; Safavi A, 1996, BIOCHEMISTRY-US, V35, P14318, DOI 10.1021/bi960582q; Shen YQ, 2006, NATURE, V443, P870, DOI 10.1038/nature05143; Song ES, 2005, J MOL NEUROSCI, V25, P201, DOI 10.1385/JMN:25:3:201; Song ES, 2004, J BIOL CHEM, V279, P54216, DOI 10.1074/jbc.M411177200; Song ES, 2003, J BIOL CHEM, V278, P49789, DOI 10.1074/jbc.M308983200; Song ES, 2001, J BIOL CHEM, V276, P1152, DOI 10.1074/jbc.M008702200; Song ES, 2005, J BIOL CHEM, V280, P17701, DOI 10.1074/jbc.M501896200; Song ES, 2006, BIOCHEMISTRY-US, V45, P15085, DOI 10.1021/bi061298u; Song ES, 2011, J BIOL CHEM, V286, P13852, DOI 10.1074/jbc.M110.191668; Song ES, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009719; Vepsalainen S, 2009, J NEUROL NEUROSUR PS, V80, P1268, DOI 10.1136/jnnp.2008.160002; Vepsalainen S, 2007, J MED GENET, V44, DOI 10.1136/jmg.2006.048470; Yao HB, 2006, ARCH BIOCHEM BIOPHYS, V451, P175, DOI 10.1016/j.abb.2006.04.011; Zuo XM, 2009, BRAIN RES, V1249, P1, DOI 10.1016/j.brainres.2008.10.034	51	31	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e20864	10.1371/journal.pone.0020864	http://dx.doi.org/10.1371/journal.pone.0020864			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21731629	gold, Green Published, Green Submitted			2022-12-27	WOS:000292036900008
J	Xie, ZG; Bi, CL; Cheong, LL; Liu, SC; Huang, GF; Zhou, JB; Yu, Q; Chen, CS; Chng, WJ				Xie, Zhigang; Bi, Chonglei; Cheong, Lip Lee; Liu, Shaw Cheng; Huang, Gaofeng; Zhou, Jianbiao; Yu, Qiang; Chen, Chien-Shing; Chng, Wee Joo			Determinants of Sensitivity to DZNep Induced Apoptosis in Multiple Myeloma Cells	PLOS ONE			English	Article							BCL-2 FAMILY PROTEINS; PROSTATE-CANCER; HISTONE METHYLTRANSFERASE; CD44 EXPRESSION; CARCINOMA-CELLS; INHIBITOR; 5-LIPOXYGENASE; GENE; ABT-737; LEUKEMIA	The 3-Deazaneplanocin A (DZNep), one of S-adenosylhomocysteine (AdoHcy) hydrolase inhibitors, has shown antitumor activities in a broad range of solid tumors and acute myeloid leukemia. Here, we examined its effects on multiple myeloma (MM) cells and found that, at 500 nM, it potently inhibited growth and induced apoptosis in 2 of 8 MM cell lines. RNA from un-treated and DZNep treated cells was profiled by Affymetrix HG-U133 Plus 2.0 microarray and genes with a significant change in gene expression were determined by significance analysis of microarray (SAM) testing. ALOX5 was the most down-regulated gene (5.8-fold) in sensitive cells and was expressed at low level in resistant cells. The results were corroborated by quantitative RT-PCR. Western-blot analysis indicated ALOX5 was highly expressed only in sensitive cell line H929 and greatly decreased upon DZNep treatment. Ectopic expression of ALOX5 reduced sensitivity to DZNep in H929 cells. Furthermore, down- regulation of ALOX5 by RNA interference could also induce apoptosis in H929. Gene expression analysis on MM patient dataset indicated ALOX5 expression was significantly higher in MM patients compared to normal plasma cells. We also found that Bcl-2 was overexpressed in DZNep insensitive cells, and cotreatment with DZNep and ABT-737, a Bcl-2 family inhibitor, synergistically inhibited growth and induced apoptosis of DZNep insensitive MM cells. Taken together, this study shows one of mechanisms of the DZNep efficacy on MM correlates with its ability to down- regulate the ALOX5 levels. In addition, DZNep insensitivity might be associated with overexpression of Bcl-2, and the combination of ABT-737 and DZNep could synergistically induced apoptosis. These results suggest that DZNep may be exploited therapeutically for a subset of MM.	[Xie, Zhigang; Bi, Chonglei; Liu, Shaw Cheng; Zhou, Jianbiao; Chng, Wee Joo] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore; [Cheong, Lip Lee; Chen, Chien-Shing; Chng, Wee Joo] Natl Univ Hlth Syst, Dept Med, Singapore, Singapore; [Huang, Gaofeng; Chng, Wee Joo] Natl Univ Hlth Syst, Dept Haematol & Oncol, Singapore, Singapore; [Yu, Qiang] Genome Inst Singapore, Singapore, Singapore; [Chen, Chien-Shing] Loma Linda Univ, Sch Med, Div Hematol & Oncol, Loma Linda, CA USA	National University of Singapore; National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Loma Linda University	Xie, ZG (corresponding author), Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore.	mdccwj@nus.edu.sg	Xie, Zhigang/AAF-6102-2019; Bi, Chonglei/D-2158-2011	Xie, Zhigang/0000-0003-2974-1825; Bi, Chonglei/0000-0002-9597-3985; Yu, Qiang/0000-0003-2132-8278	National Medical Research Council of Singapore [NMRC/CG/NCIS/2010]	National Medical Research Council of Singapore(National Medical Research Council, Singapore)	This project is funded by the National Medical Research Council of Singapore (http://www.nmrc.gov.sg/) grant NMRC/CG/NCIS/2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belfiore MC, 2007, CANCER LETT, V254, P236, DOI 10.1016/j.canlet.2007.03.010; Bergsagel PL, 2005, J CLIN ONCOL, V23, P6333, DOI 10.1200/JCO.2005.05.021; Bergsagel PL, 1996, P NATL ACAD SCI USA, V93, P13931, DOI 10.1073/pnas.93.24.13931; Bray M, 2000, ANTIVIR RES, V45, P135, DOI 10.1016/S0166-3542(00)00066-8; Chang H, 2004, BRIT J HAEMATOL, V125, P64, DOI 10.1111/j.1365-2141.2004.04867.x; Chauhan D, 2007, ONCOGENE, V26, P2374, DOI 10.1038/sj.onc.1210028; Chen YY, 2009, NAT GENET, V41, P783, DOI 10.1038/ng.389; Cheng EHY, 1997, SCIENCE, V278, P1966, DOI 10.1126/science.278.5345.1966; Chesi M, 1998, BLOOD, V92, P3025, DOI 10.1182/blood.V92.9.3025.421k53_3025_3034; DECLERCQ E, 1989, ANTIMICROB AGENTS CH, V33, P1291, DOI 10.1128/AAC.33.8.1291; Dillon SC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-227; Feinman R, 1999, BLOOD, V93, P3044; Fiskus W, 2009, BLOOD, V114, P2733, DOI 10.1182/blood-2009-03-213496; Ghosh J, 1998, P NATL ACAD SCI USA, V95, P13182, DOI 10.1073/pnas.95.22.13182; Ghosh J, 2003, BIOCHEM BIOPH RES CO, V307, P342, DOI 10.1016/S0006-291X(03)01201-4; GLAZER RI, 1986, BIOCHEM BIOPH RES CO, V135, P688, DOI 10.1016/0006-291X(86)90048-3; GLAZER RI, 1986, BIOCHEM PHARMACOL, V35, P4523, DOI 10.1016/0006-2952(86)90774-4; Godar S, 2008, CELL, V134, P62, DOI 10.1016/j.cell.2008.06.006; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Keats JJ, 2003, BLOOD, V101, P1520, DOI 10.1182/blood-2002-06-1675; Keats JJ, 2006, LEUKEMIA LYMPHOMA, V47, P2289, DOI 10.1080/10428190600822128; Kho PS, 2004, J BIOL CHEM, V279, P21183, DOI 10.1074/jbc.M311912200; Kirsch DG, 1999, J BIOL CHEM, V274, P21155, DOI 10.1074/jbc.274.30.21155; Kline MP, 2007, LEUKEMIA, V21, P1549, DOI 10.1038/sj.leu.2404719; Marango J, 2008, BLOOD, V111, P3145, DOI 10.1182/blood-2007-06-092122; Mason KD, 2009, LEUKEMIA, V23, P2034, DOI 10.1038/leu.2009.151; MAYERS DL, 1995, P NATL ACAD SCI USA, V92, P215, DOI 10.1073/pnas.92.1.215; Melstrom LG, 2008, CLIN CANCER RES, V14, P6525, DOI 10.1158/1078-0432.CCR-07-4631; Mi HY, 2005, NUCLEIC ACIDS RES, V33, pD284, DOI 10.1093/nar/gki078; Miranda TB, 2009, MOL CANCER THER, V8, P1579, DOI 10.1158/1535-7163.MCT-09-0013; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Ozvaran MK, 2004, MOL CANCER THER, V3, P545; Pandit B, 2010, PROSTATE, V70, P825, DOI 10.1002/pros.21116; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Peters-Golden M, 1998, AM J RESP CRIT CARE, V157, pS227, DOI 10.1164/ajrccm.157.6.mar4; Puthier D, 1999, BRIT J HAEMATOL, V107, P392, DOI 10.1046/j.1365-2141.1999.01705.x; Raab MS, 2009, LANCET, V374, P324, DOI 10.1016/S0140-6736(09)60221-X; Riccardi C, 2006, NAT PROTOC, V1, P1458, DOI 10.1038/nprot.2006.238; SANGFELT O, 1995, INT J CANCER, V63, P190, DOI 10.1002/ijc.2910630207; Tan J, 2007, GENE DEV, V21, P1050, DOI 10.1101/gad.1524107; Tu YP, 1996, BLOOD, V88, P1805, DOI 10.1182/blood.V88.5.1805.bloodjournal8851805; Xie ZG, 2008, CANCER CHEMOTH PHARM, V62, P949, DOI 10.1007/s00280-008-0684-z; Zhou GX, 2007, BBA-GEN SUBJECTS, V1770, P1021, DOI 10.1016/j.bbagen.2007.03.002; Zhou J, 2008, LEUKEMIA, V22, P138, DOI 10.1038/sj.leu.2404960	44	28	30	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21583	10.1371/journal.pone.0021583	http://dx.doi.org/10.1371/journal.pone.0021583			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21720561	Green Published, Green Submitted, gold			2022-12-27	WOS:000292036900057
J	Zajdowicz, SLW; Jones-Carson, J; Vazquez-Torres, A; Jobling, MG; Gill, RE; Holmes, RK				Zajdowicz, Sheryl L. W.; Jones-Carson, Jessica; Vazquez-Torres, Andres; Jobling, Michael G.; Gill, Ronald E.; Holmes, Randall K.			Alanine Racemase Mutants of Burkholderia pseudomallei and Burkholderia mallei and Use of Alanine Racemase as a Non-Antibiotic-Based Selectable Marker	PLOS ONE			English	Article							THYMIDYLATE SYNTHASE GENE; COMPLETE GENOME SEQUENCE; FREE D-SERINE; PSEUDOMONAS-AERUGINOSA; ESCHERICHIA-COLI; SALMONELLA-TYPHIMURIUM; MOLECULAR CHARACTERIZATION; ENZYME-PURIFICATION; LACTOCOCCUS-LACTIS; BACILLUS-SUBTILIS	Burkholderia pseudomallei and Burkholderia mallei are category B select agents and must be studied under BSL3 containment in the United States. They are typically resistant to multiple antibiotics, and the antibiotics used to treat B. pseudomallei or B. mallei infections may not be used as selective agents with the corresponding Burkholderia species. Here, we investigated alanine racemase deficient mutants of B. pseudomallei and B. mallei for development of non-antibiotic-based genetic selection methods and for attenuation of virulence. The genome of B. pseudomallei K96243 has two annotated alanine racemase genes (bpsl2179 and bpss0711), and B. mallei ATCC 23344 has one (bma1575). Each of these genes encodes a functional enzyme that can complement the alanine racemase deficiency of Escherichia coli strain ALA1. Herein, we show that B. pseudomallei with in-frame deletions in both bpsl2179 and bpss0711, or B. mallei with an in-frame deletion in bma1575, requires exogenous D-alanine for growth. Introduction of bpsl2179 on a multicopy plasmid into alanine racemase deficient variants of either Burkholderia species eliminated the requirement for D-alanine. During log phase growth without D-alanine, the viable counts of alanine racemase deficient mutants of B. pseudomallei and B. mallei decreased within 2 hours by about 1000-fold and 10-fold, respectively, and no viable bacteria were present at 24 hours. We constructed several genetic tools with bpsl2179 as a selectable genetic marker, and we used them without any antibiotic selection to construct an in-frame Delta flgK mutant in the alanine racemase deficient variant of B. pseudomallei K96243. In murine peritoneal macrophages, wild type B. mallei ATCC 23344 was killed much more rapidly than wild type B. pseudomallei K96243. In addition, the alanine racemase deficient mutant of B. pseudomallei K96243 exhibited attenuation versus its isogenic parental strain with respect to growth and survival in murine peritoneal macrophages.	[Zajdowicz, Sheryl L. W.; Jones-Carson, Jessica; Vazquez-Torres, Andres; Jobling, Michael G.; Gill, Ronald E.; Holmes, Randall K.] Univ Colorado, Sch Med, Dept Microbiol, Aurora, CO 80011 USA; [Zajdowicz, Sheryl L. W.] Metropolitan State Coll, Dept Biol, Denver, CO 80204 USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Zajdowicz, SLW (corresponding author), Univ Colorado, Sch Med, Dept Microbiol, Aurora, CO 80011 USA.	randall.holmes@ucdenver.edu	Jobling, Michael G/AAJ-3814-2021	Jobling, Michael/0000-0001-7689-3093	NIH/NIAID [R21 AI074606, U54 AI065357, G-7819]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI065357, R21AI074606] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by NIH/NIAID grant R21 AI074606 (to RKH) and NIH/NIAID grant U54 AI065357 subaward #G-7819 (to AVT). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Ausubel F. M., 2002, SHORT PROTOCOLS MOL; Bron PA, 2002, APPL ENVIRON MICROB, V68, P5663, DOI 10.1128/AEM.68.11.5663-5670.2002; Cheng AC, 2005, CLIN MICROBIOL REV, V18, P383, DOI 10.1128/CMR.18.2.383-416.2005; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Choi KH, 2005, NAT METHODS, V2, P443, DOI 10.1038/NMETH765; Choi KH, 2008, APPL ENVIRON MICROB, V74, P1064, DOI 10.1128/AEM.02430-07; Choi KH, 2006, NAT PROTOC, V1, P162, DOI 10.1038/nprot.2006.25; Dance DAB, 2000, ACTA TROP, V74, P159, DOI 10.1016/S0001-706X(99)00066-2; DeShazer D, 1997, J BACTERIOL, V179, P2116, DOI 10.1128/jb.179.7.2116-2125.1997; Durfee T, 2008, J BACTERIOL, V190, P2597, DOI 10.1128/JB.01695-07; FERRARI E, 1985, BIO-TECHNOL, V3, P1003, DOI 10.1038/nbt1185-1003; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Fischer W., 1990, HDB LIPID RES, P123; GALAN JE, 1990, GENE, V94, P29, DOI 10.1016/0378-1119(90)90464-3; Gilad Jacob, 2007, Recent Pat Antiinfect Drug Discov, V2, P233, DOI 10.2174/157489107782497335; Hamad MA, 2009, GENE, V430, P123, DOI 10.1016/j.gene.2008.10.011; Hamase K, 1997, BBA-GEN SUBJECTS, V1334, P214, DOI 10.1016/S0304-4165(96)00095-5; Hamase K, 1999, AMINO ACIDS, V17, P277, DOI 10.1007/BF01366926; Handfield M, 1998, BIOTECHNIQUES, V24, P261, DOI 10.2144/98242st02; HASHIMOTO A, 1993, NEUROSCI LETT, V152, P33, DOI 10.1016/0304-3940(93)90476-2; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P14240, DOI 10.1073/pnas.0403302101; Hols P, 1997, J BACTERIOL, V179, P3804, DOI 10.1128/jb.179.11.3804-3807.1997; INAGAKI K, 1986, BIOCHEMISTRY-US, V25, P3268, DOI 10.1021/bi00359a028; Jones AL, 1996, INFECT IMMUN, V64, P782, DOI 10.1128/IAI.64.3.782-790.1996; Kim HS, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-174; Leelarasmee Amorn, 1998, Southeast Asian Journal of Tropical Medicine and Public Health, V29, P410; Lenz LL, 2008, CLIN VACCINE IMMUNOL, V15, P1414, DOI 10.1128/CVI.00208-08; Limmathurotsakul D, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000327; McCollister BD, 2005, J EXP MED, V202, P625, DOI 10.1084/jem.20050246; Milligan DL, 2007, J BACTERIOL, V189, P8381, DOI 10.1128/JB.01201-07; NAGATA Y, 1992, BIOCHIM BIOPHYS ACTA, V1115, P208, DOI 10.1016/0304-4165(92)90055-Y; NAGATA Y, 1992, EXPERIENTIA, V48, P986, DOI 10.1007/BF01919147; Neubauer H, 2005, J VET MED B, V52, P201, DOI 10.1111/j.1439-0450.2005.00855.x; Nierman WC, 2004, P NATL ACAD SCI USA, V101, P14246, DOI 10.1073/pnas.0403306101; Oikawa T, 2006, J BIOTECHNOL, V125, P503, DOI 10.1016/j.jbiotec.2006.04.002; PRESTON RA, 1984, J GEN MICROBIOL, V130, P3123; Propst KL, 2010, INFECT IMMUN, V78, P3136, DOI 10.1128/IAI.01313-09; Reitzer L.J., 1996, ESCHERICHIA COLI SAL, P391; ROSS P, 1990, APPL ENVIRON MICROB, V56, P2156, DOI 10.1128/AEM.56.7.2156-2163.1990; ROSS P, 1990, APPL ENVIRON MICROB, V56, P2164, DOI 10.1128/AEM.56.7.2164-2169.1990; ROSSO G, 1969, BIOCHEM BIOPH RES CO, V34, P134, DOI 10.1016/0006-291X(69)90539-7; RUHLAND GJ, 1987, SYST APPL MICROBIOL, V9, P40, DOI 10.1016/S0723-2020(87)80054-1; Stevens JM, 2005, J BACTERIOL, V187, P7857, DOI 10.1128/JB.187.22.7857-7862.2005; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Strych U, 2002, J BACTERIOL, V184, P4321, DOI 10.1128/JB.184.15.4321-4325.2002; Strych U, 2001, FEMS MICROBIOL LETT, V196, P93, DOI 10.1016/S0378-1097(01)00045-3; Strych U, 2000, CURR MICROBIOL, V41, P290, DOI 10.1007/s002840010136; Strych U, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-40; Tauch A, 2002, J BIOTECHNOL, V99, P79, DOI 10.1016/S0168-1656(02)00159-1; Thompson RJ, 1998, INFECT IMMUN, V66, P3552, DOI 10.1128/IAI.66.8.3552-3561.1998; Thongdee M, 2008, APPL ENVIRON MICROB, V74, P2985, DOI 10.1128/AEM.00030-08; Vazquez-Torres A, 2000, J EXP MED, V192, P227, DOI 10.1084/jem.192.2.227; Verch T, 2004, INFECT IMMUN, V72, P6418, DOI 10.1128/IAI.72.11.6418-6425.2004; Waag DM., 2004, BIOL WEAPONS DEFENSE, P209; WALSH CT, 1989, J BIOL CHEM, V264, P2393; WASSERMAN SA, 1983, J BACTERIOL, V153, P1439, DOI 10.1128/JB.153.3.1439-1450.1983; WASSERMAN SA, 1984, BIOCHEMISTRY-US, V23, P5182, DOI 10.1021/bi00317a015; Whitlock GC, 2007, FEMS MICROBIOL LETT, V277, P115, DOI 10.1111/j.1574-6968.2007.00949.x; WIJSMAN HJW, 1972, GENET RES, V20, P269, DOI 10.1017/S001667230001380X; WILD J, 1985, MOL GEN GENET, V198, P315, DOI 10.1007/BF00383013; YABUUCHI E, 1992, MICROBIOL IMMUNOL, V36, P1251, DOI 10.1111/j.1348-0421.1992.tb02129.x; YONAHA K, 1975, J FERMENT TECHNOL, V53, P579	62	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21523	10.1371/journal.pone.0021523	http://dx.doi.org/10.1371/journal.pone.0021523			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21720554	Green Submitted, gold, Green Published			2022-12-27	WOS:000292036900048
J	Zhang, CL; Li, AM; Gao, SL; Zhang, XC; Xiao, H				Zhang, Chengliang; Li, Aimin; Gao, Shenglan; Zhang, Xinchun; Xiao, Hua			The TIP30 Protein Complex, Arachidonic Acid and Coenzyme A Are Required for Vesicle Membrane Fusion	PLOS ONE			English	Article							TRANSPORT VESICLES; GOLGI CISTERNAE; PHOSPHOLIPASE-D; SNARE COMPLEX; LIPIDS; ENDOSOMES; RAB; MECHANISMS; EXOCYTOSIS; CURVATURE	Efficient membrane fusion has been successfully mimicked in vitro using artificial membranes and a number of cellular proteins that are currently known to participate in membrane fusion. However, these proteins are not sufficient to promote efficient fusion between biological membranes, indicating that critical fusogenic factors remain unidentified. We have recently identified a TIP30 protein complex containing TIP30, acyl-CoA synthetase long-chain family member 4 (ACSL4) and Endophilin B1 (Endo B1) that promotes the fusion of endocytic vesicles with Rab5a vesicles, which transport endosomal acidification enzymes vacuolar (H(+))-ATPases (V-ATPases) to the early endosomes in vivo. Here, we demonstrate that the TIP30 protein complex facilitates the fusion of endocytic vesicles with Rab5a vesicles in vitro. Fusion of the two vesicles also depends on arachidonic acid, coenzyme A and the synthesis of arachidonyl-CoA by ACSL4. Moreover, the TIP30 complex is able to transfer arachidonyl groups onto phosphatidic acid (PA), producing a new lipid species that is capable of inducing close contact between membranes. Together, our data suggest that the TIP30 complex facilitates biological membrane fusion through modification of PA on membranes.	[Zhang, Chengliang; Li, Aimin; Gao, Shenglan; Xiao, Hua] Michigan State Univ, Dept Biomed & Integrat Physiol, E Lansing, MI 48824 USA; [Zhang, Chengliang; Zhang, Xinchun] Michigan State Univ, Genet Program, E Lansing, MI 48824 USA; [Li, Aimin] So Med Univ, Nanfang Hosp, Dept Oncol, Guangzhou, Guangdong, Peoples R China	Michigan State University; Michigan State University; Southern Medical University - China	Zhang, CL (corresponding author), Michigan State Univ, Dept Biomed & Integrat Physiol, E Lansing, MI 48824 USA.	xiaoh@msu.edu	Zhang, Chengliang/E-6943-2016	Zhang, Chengliang/0000-0003-3798-4157; Zhang, Chengliang/0000-0001-6999-4670	NIDDK [RO1 DK066110-01]; Department of Defense [W81XWH-08-1-0377]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066110] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The study was funded by RO1 DK066110-01 from the NIDDK, http://www2.niddk.nih.gov/, and W81XWH-08-1-0377 (to H.X.) from the Department of Defense, www.defense.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bethani I, 2009, TRAFFIC, V10, P1543, DOI 10.1111/j.1600-0854.2009.00959.x; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brandhorst D, 2006, P NATL ACAD SCI USA, V103, P2701, DOI 10.1073/pnas.0511138103; Cao Y, 1998, GENOMICS, V49, P327, DOI 10.1006/geno.1998.5268; Chattopadhyay S, 2003, J BIOL CHEM, V278, P39675, DOI 10.1074/jbc.M212594200; Connell E, 2007, EMBO REP, V8, P414, DOI 10.1038/sj.embor.7400935; CREUTZ CE, 1981, J CELL BIOL, V91, P247, DOI 10.1083/jcb.91.1.247; DOWLER S, 2002, SCI STKE, pPL6, DOI DOI 10.1126/STKE.2002.129.PL6; FAHEY DA, 1986, BIOCHEMISTRY-US, V25, P4468, DOI 10.1021/bi00363a045; FUCHS R, 2002, CURR PROTOC CELL BIO, pCH3; GORVEL JP, 1995, J BIOL CHEM, V270, P2741, DOI 10.1074/jbc.270.6.2741; Haucke V, 2007, CURR OPIN CELL BIOL, V19, P426, DOI 10.1016/j.ceb.2007.06.003; Jenkins GM, 2005, CELL MOL LIFE SCI, V62, P2305, DOI 10.1007/s00018-005-5195-z; Jones D, 1999, BBA-MOL CELL BIOL L, V1439, P229, DOI 10.1016/S1388-1981(99)00097-9; Jun Y, 2004, J BIOL CHEM, V279, P53186, DOI 10.1074/jbc.M411363200; KINNUNEN PKJ, 1992, CHEM PHYS LIPIDS, V63, P251, DOI 10.1016/0009-3084(92)90041-M; Kinnunen PKJ, 2000, BIOSCIENCE REP, V20, P465, DOI 10.1023/A:1010402819509; Latham CF, 2007, J NEUROCHEM, V100, P1543, DOI 10.1111/j.1471-4159.2006.04286.x; Lee YC, 1996, BIOCHEMISTRY-US, V35, P3677, DOI 10.1021/bi9517502; Martens S, 2008, NAT REV MOL CELL BIO, V9, P543, DOI 10.1038/nrm2417; MAYORGA LS, 1993, P NATL ACAD SCI USA, V90, P10255, DOI 10.1073/pnas.90.21.10255; McMahon HT, 2010, CELL, V140, P601, DOI 10.1016/j.cell.2010.02.017; Mima J, 2008, EMBO J, V27, P2031, DOI 10.1038/emboj.2008.139; Ohya T, 2009, NATURE, V459, P1091, DOI 10.1038/nature08107; PFANNER N, 1990, J CELL BIOL, V110, P955, DOI 10.1083/jcb.110.4.955; PFANNER N, 1989, CELL, V59, P95, DOI 10.1016/0092-8674(89)90872-6; PRYER NK, 1992, ANNU REV BIOCHEM, V61, P471; Rickman C, 2005, CHEM BIOL, V12, P545, DOI 10.1016/j.chembiol.2005.03.004; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Wickner W, 2008, NAT STRUCT MOL BIOL, V15, P658, DOI 10.1038/nsmb.1451; Xiao H, 2000, EMBO J, V19, P956, DOI 10.1093/emboj/19.5.956; Zhang CL, 2011, J BIOL CHEM, V286, P9373, DOI 10.1074/jbc.M110.207720	32	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21233	10.1371/journal.pone.0021233	http://dx.doi.org/10.1371/journal.pone.0021233			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21731680	Green Published, Green Submitted, gold			2022-12-27	WOS:000292036900016
J	Aly, HH; Oshiumi, H; Shime, H; Matsumoto, M; Wakita, T; Shimotohno, K; Seya, T				Aly, Hussein Hassan; Oshiumi, Hiroyuki; Shime, Hiroaki; Matsumoto, Misako; Wakita, Taka; Shimotohno, Kunitada; Seya, Tsukasa			Development of Mouse Hepatocyte Lines Permissive for Hepatitis C Virus (HCV)	PLOS ONE			English	Article							APOPTOSIS; ALPHA; LIVER; REPLICATION; SUPPRESSION; EXPRESSION; INFECTION; PROTEIN	The lack of a suitable small animal model for the analysis of hepatitis C virus (HCV) infection has hampered elucidation of the HCV life cycle and the development of both protective and therapeutic strategies against HCV infection. Human and mouse harbor a comparable system for antiviral type I interferon (IFN) induction and amplification, which regulates viral infection and replication. Using hepatocytes from knockout (ko) mice, we determined the critical step of the IFN-inducing/ amplification pathways regulating HCV replication in mouse. The results infer that interferon-beta promoter stimulator (IPS1) or interferon A receptor (IFNAR) were a crucial barrier to HCV replication in mouse hepatocytes. Although both IFNARko and IPS-1ko hepatocytes showed a reduced induction of type I interferons in response to viral infection, only IPS-1-/- cells circumvented cell death from HCV cytopathic effect and significantly improved J6JFH1 replication, suggesting IPS-1 to be a key player regulating HCV replication in mouse hepatocytes. We then established mouse hepatocyte lines lacking IPS-1 or IFNAR through immortalization with SV40T antigen. Expression of human (h)CD81 on these hepatocyte lines rendered both lines HCVcc-permissive. We also found that the chimeric J6JFH1 construct, having the structure region from J6 isolate enhanced HCV replication in mouse hepatocytes rather than the full length original JFH1 construct, a new finding that suggests the possible role of the HCV structural region in HCV replication. This is the first report on the entry and replication of HCV infectious particles in mouse hepatocytes. These mouse hepatocyte lines will facilitate establishing a mouse HCV infection model with multifarious applications.	[Aly, Hussein Hassan; Oshiumi, Hiroyuki; Shime, Hiroaki; Matsumoto, Misako; Seya, Tsukasa] Hokkaido Univ, Grad Sch Med, Dept Microbiol & Immunol, Sapporo, Hokkaido, Japan; [Wakita, Taka] Natl Inst Infect Dis, Dept Virol 2, Shinjuku Ku, Tokyo 1628640, Japan; [Shimotohno, Kunitada] Chiba Inst Technol, Res Inst, Chiba, Japan	Hokkaido University; National Institute of Infectious Diseases (NIID); Chiba Institute of Technology	Aly, HH (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Microbiol & Immunol, Sapporo, Hokkaido, Japan.	seya-tu@pop.med.hokudai.ac.jp	美佐子, 松本/A-4497-2012; Shime, Hiroaki/P-6454-2019; Seya, Tsukasa/A-4336-2012; Oshiumi, Hiroyuki/G-1645-2012; Shime, Hiroaki/D-8721-2012; Aly, Hussein Hassan/GWV-0669-2022	Shime, Hiroaki/0000-0003-0209-5034; Aly, Hussein H/0000-0002-2455-0694; Oshiumi, Hiroyuki/0000-0003-1567-8722	Ministry of Education, Science, and Culture; Ministry of Health, Labor, and Welfare of Japan; Hokkaido University Leader Development System in the Basic Interdisciplinary Research Areas (L station); Mitsubishi Foundation; Mochida Foundation; NorthTec Foundation Waxman Foundation; Yakult Foundation; Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [23590558, 22114008, 22790371, 22790450] Funding Source: KAKEN	Ministry of Education, Science, and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Hokkaido University Leader Development System in the Basic Interdisciplinary Research Areas (L station); Mitsubishi Foundation; Mochida Foundation; NorthTec Foundation Waxman Foundation; Yakult Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid from the Ministry of Education, Science, and Culture (Specified Project for Advanced Research), the Ministry of Health, Labor, and Welfare of Japan, and the Hokkaido University Leader Development System in the Basic Interdisciplinary Research Areas (L station). Supports from Mitsubishi Foundation, Mochida Foundation, NorthTec Foundation Waxman Foundation and Yakult Foundation are gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We want to thank Dr. Michinori Kohara (Tokyo Metropolitan Institute for Medical Science, Tokyo, Japan); Dr. Tadatsugu Taniguchi (University of Tokyo, Yokyo, Japan); Dr. Thomas Pietschmann (Division of Experimental Virology, TWINCORE, Hannover, Germany); and Dr. Makoto Hijikata (The Institute for Virus Research, Kyoto University, Japan) for their generous supply of research material. Dr. Hussein H. Aly was supported by a JSPS postdoctoral fellowship from the Japan Society for the Promotion of Science.	Akazawa T, 2007, P NATL ACAD SCI USA, V104, P252, DOI 10.1073/pnas.0605978104; Aly HH, 2007, J HEPATOL, V46, P26, DOI 10.1016/j.jhep.2006.08.018; Aly HH, 2009, HEPATOLOGY, V50, P689, DOI 10.1002/hep.23034; Aly HH, 2009, BIOCHEM BIOPH RES CO, V379, P330, DOI 10.1016/j.bbrc.2008.12.054; Berg CP, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-213; Bitzegeio J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000978; Deng L, 2008, J VIROL, V82, P10375, DOI 10.1128/JVI.00395-08; Diamond MS, 2009, J INTERF CYTOK RES, V29, P521, DOI 10.1089/jir.2009.0069; Ebihara T, 2008, HEPATOLOGY, V48, P48, DOI 10.1002/hep.22337; Ebihara T, 2010, J EXP MED, V207, P2675, DOI 10.1084/jem.20091573; Foy E, 2005, P NATL ACAD SCI USA, V102, P2986, DOI 10.1073/pnas.0408707102; Haid S, 2010, J VIROL, V84, P964, DOI 10.1128/JVI.01504-09; Ishigami A, 2002, AM J PATHOL, V161, P1273, DOI 10.1016/S0002-9440(10)64404-5; Ishiyama T, 2003, CANCER SCI, V94, P757, DOI 10.1111/j.1349-7006.2003.tb01515.x; Ladu S, 2008, GASTROENTEROLOGY, V135, P1322, DOI 10.1053/j.gastro.2008.07.012; Lin LT, 2010, J VIROL, V84, P9170, DOI 10.1128/JVI.00559-10; Lowe SW, 2000, CARCINOGENESIS, V21, P485, DOI 10.1093/carcin/21.3.485; Mankouri J, 2009, P NATL ACAD SCI USA, V106, P15903, DOI 10.1073/pnas.0906798106; Mateu G, 2008, VIROLOGY, V376, P397, DOI 10.1016/j.virol.2008.03.027; O'Neill LAJ, 2010, CURR BIOL, V20, pR328, DOI 10.1016/j.cub.2010.01.044; Oshiumi H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014258; Oshiumi H, 2010, CELL HOST MICROBE, V8, P496, DOI 10.1016/j.chom.2010.11.008; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684; Ray RB, 1996, VIROLOGY, V226, P176, DOI 10.1006/viro.1996.0644; Schulze-Bergkamen H, 2004, SEMIN ONCOL, V31, P90, DOI 10.1053/j.seminoncol.2003.11.006; Seto W.K., 2010, J HEPATOL; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thompson AJ, 2010, GASTROENTEROLOGY, V139, P120, DOI 10.1053/j.gastro.2010.04.013; Uprichard SL, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-89; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Zhu HZ, 2007, GASTROENTEROLOGY, V133, P1649, DOI 10.1053/j.gastro.2007.09.017	33	20	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21284	10.1371/journal.pone.0021284	http://dx.doi.org/10.1371/journal.pone.0021284			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731692	Green Published, Green Submitted, gold			2022-12-27	WOS:000292033700055
J	de Jong, MA; Wahlberg, N; van Eijk, M; Brakefield, PM; Zwaan, BJ				de Jong, Maaike A.; Wahlberg, Niklas; van Eijk, Marleen; Brakefield, Paul M.; Zwaan, Bas J.			Mitochondrial DNA Signature for Range-Wide Populations of Bicyclus anynana Suggests a Rapid Expansion from Recent Refugia	PLOS ONE			English	Article							PLASTICITY; LEPIDOPTERA; BUTTERFLIES; HAPLOTYPES; NEUTRALITY; EVOLUTION; BIOLOGY; MARKERS; TESTS; GENE	This study investigates the genetic diversity, population structure and demographic history of the afrotropical butterfly Bicyclus anynana using mitochondrial DNA (mtDNA). Samples from six wild populations covering most of the species range from Uganda to South Africa were compared for the cytochrome c oxidase subunit gene (COI). Molecular diversity indices show overall high mtDNA diversity for the populations, but low nucleotide divergence between haplotypes. Our results indicate relatively little geographic population structure among the southern populations, especially given the extensive distributional range and an expectation of limited gene flow between populations. We implemented neutrality tests to assess signatures of recent historical demographic events. Tajima's D test and Fu's FS test both suggested recent population growth for the populations. The results were only significant for the southernmost populations when applying Tajima's D, but Fu's FS indicated significant deviations from neutrality for all populations except the one closest to the equator. Based on our own findings and those from pollen and vegetation studies, we hypothesize that the species range of B. anynana was reduced to equatorial refugia during the last glacial period, and that the species expanded southwards during the past 10.000 years. These results provide crucial background information for studies of phenotypic and molecular adaptation in wild populations of B. anynana.	[de Jong, Maaike A.; van Eijk, Marleen; Brakefield, Paul M.; Zwaan, Bas J.] Leiden Univ, Inst Biol, Leiden, Netherlands; [de Jong, Maaike A.] Univ Helsinki, Dept Biosci, Helsinki, Finland; [Wahlberg, Niklas] Univ Turku, Dept Biol, SF-20500 Turku, Finland; [Brakefield, Paul M.] Univ Cambridge, Dept Zool, Cambridge, England; [Zwaan, Bas J.] Wageningen Univ, Genet Lab, Wageningen, Netherlands	Leiden University; Leiden University - Excl LUMC; University of Helsinki; University of Turku; University of Cambridge; Wageningen University & Research	de Jong, MA (corresponding author), Leiden Univ, Inst Biol, Leiden, Netherlands.	maaike.dejong@helsinki.fi	Zwaan, Bas J/D-8721-2015; Wahlberg, Niklas/B-7765-2008; de Jong, Maaike/D-6978-2014	Zwaan, Bas J/0000-0002-8221-4998; Wahlberg, Niklas/0000-0002-1259-3363; de Jong, Maaike/0000-0003-4803-7411	Netherlands Organization for Scientific Research [814.01.012]; EU [FP6 036894]; Royal Netherlands Academy of Arts and Sciences (KNAW); Treub Foundation; Uyttenboogaart-Eliasen Foundation	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); EU(European Commission); Royal Netherlands Academy of Arts and Sciences (KNAW); Treub Foundation; Uyttenboogaart-Eliasen Foundation	Sources of funding: Earth and Life Sciences program of the Netherlands Organization for Scientific Research (Grant no. 814.01.012) www.nwo.nl; EU-funded Network of Excellence LifeSpan (FP6 036894) http://www.lifespannetwork.nl/; the Royal Netherlands Academy of Arts and Sciences (KNAW) www.knaw.nl; the Treub Foundation and the Uyttenboogaart-Eliasen Foundation, http://www.ue-stichting.nl/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Brakefield PM, 2010, AM NAT, V176, pS77, DOI 10.1086/657059; BRAKEFIELD PM, 1991, ECOL ENTOMOL, V16, P291, DOI 10.1111/j.1365-2311.1991.tb00220.x; Brakefield PM, 1996, NATURE, V384, P236, DOI 10.1038/384236a0; BROWER AVZ, 1991, EVOLUTION, V45, P1281, DOI 10.1111/j.1558-5646.1991.tb04393.x; Caterino MS, 2000, ANNU REV ENTOMOL, V45, P1, DOI 10.1146/annurev.ento.45.1.1; Condamin M., 1973, Memoires Inst fond Afr noire, VNo. 88, P1; de Jong MA, 2010, CLIM RES, V43, P91, DOI 10.3354/cr00881; Douglass John F., 2003, Bulletin of the Allyn Museum, V143, P1; Elenga H, 2000, J BIOGEOGR, V27, P621, DOI 10.1046/j.1365-2699.2000.00430.x; Estoup A, 1996, MOL ECOL, V5, P19, DOI 10.1111/j.1365-294X.1996.tb00288.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Flenley JR, 1998, CLIMATIC CHANGE, V39, P177, DOI 10.1023/A:1005367822750; Freeland JR, 2003, ECOL ENTOMOL, V28, P413, DOI 10.1046/j.1365-2311.2003.00521.x; Fu YX, 1997, GENETICS, V147, P915; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HAMILTON A, 2001, AFRICAN RAIN FOREST, P183; HARRISON RG, 1989, TRENDS ECOL EVOL, V4, P6, DOI 10.1016/0169-5347(89)90006-2; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; MORITZ C, 1987, ANNU REV ECOL SYST, V18, P269, DOI 10.1146/annurev.ecolsys.18.1.269; Nei M., 1987, MOL EVOLUTIONARY GEN; Oostra V, 2011, P ROY SOC B-BIOL SCI, V278, P789, DOI 10.1098/rspb.2010.1560; Prentice IC, 2000, J BIOGEOGR, V27, P507, DOI 10.1046/j.1365-2699.2000.00425.x; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; TAJIMA F, 1989, GENETICS, V123, P585; Valade R, 2009, MOL ECOL, V18, P3458, DOI 10.1111/j.1365-294X.2009.04290.x; Vandewoestijne S, 2004, MOL PHYLOGENET EVOL, V31, P630, DOI 10.1016/j.ympev.2003.09.007; Wahlberg N, 2008, SYST BIOL, V57, P231, DOI 10.1080/10635150802033006	31	51	54	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21385	10.1371/journal.pone.0021385	http://dx.doi.org/10.1371/journal.pone.0021385			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731725	Green Published, gold, Green Submitted			2022-12-27	WOS:000292033700072
J	Frauer, C; Hoffmann, T; Bultmann, S; Casa, V; Cardoso, MC; Antes, I; Leonhardt, H				Frauer, Carina; Hoffmann, Thomas; Bultmann, Sebastian; Casa, Valentina; Cardoso, M. Cristina; Antes, Iris; Leonhardt, Heinrich			Recognition of 5-Hydroxymethylcytosine by the Uhrf1 SRA Domain	PLOS ONE			English	Article							HEMI-METHYLATED DNA; MOLECULAR-DYNAMICS; METHYLTRANSFERASE; BINDING; 5-METHYLCYTOSINE; PROTEINS; CONVERSION; MUTATION; DNMT3A; DAMAGE	Recent discovery of 5-hydroxymethylcytosine (5hmC) in genomic DNA raises the question how this sixth base is recognized by cellular proteins. In contrast to the methyl-CpG binding domain (MBD) of MeCP2, we found that the SRA domain of Uhrf1, an essential factor in DNA maintenance methylation, binds 5hmC and 5-methylcytosine containing substrates with similar affinity. Based on the co-crystal structure, we performed molecular dynamics simulations of the SRA: DNA complex with the flipped cytosine base carrying either of these epigenetic modifications. Our data indicate that the SRA binding pocket can accommodate 5hmC and stabilizes the flipped base by hydrogen bond formation with the hydroxyl group.	[Frauer, Carina; Bultmann, Sebastian; Leonhardt, Heinrich] Univ Munich, Dept Biol 2, Planegg Martinsried, Germany; [Hoffmann, Thomas; Antes, Iris] Tech Univ Munich, Dept Life Sci, D-8050 Freising Weihenstephan, Germany; [Casa, Valentina; Cardoso, M. Cristina] Tech Univ Darmstadt, Dept Biol, Darmstadt, Germany; [Frauer, Carina; Hoffmann, Thomas; Bultmann, Sebastian; Antes, Iris; Leonhardt, Heinrich] Ctr Integrated Prot Sci Munich CIPSM, Munich, Germany	University of Munich; Technical University of Munich; Technical University of Darmstadt	Frauer, C (corresponding author), Univ Munich, Dept Biol 2, Planegg Martinsried, Germany.	antes@wzw.tum.de; h.leonhardt@lmu.de	Leonhardt, Heinrich/B-2791-2014; Bultmann, Sebastian/AAC-7729-2020; Cardoso, M. Cristina/F-5215-2011	Hoffmann, Thomas/0000-0002-2980-8324	Nanosystems Initiative Munich (NIM); Center for NanoSciences (CeNS) Munich; Deutsche Forschungsgemeinschaft (DFG) [SFB TR5]; Elite Network of Bavaria; International Max Planck Research School for Molecular and Cellular Life Sciences (IMPRS-LS); Graduate School for Life Sciences Munich (LSM)	Nanosystems Initiative Munich (NIM); Center for NanoSciences (CeNS) Munich; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Elite Network of Bavaria; International Max Planck Research School for Molecular and Cellular Life Sciences (IMPRS-LS); Graduate School for Life Sciences Munich (LSM)	This work was supported by grants from the Nanosystems Initiative Munich (NIM, http://www.nano-initiative-munich.de), the Center for NanoSciences (CeNS, http://www.cens.de) Munich, and by grants from the Deutsche Forschungsgemeinschaft (DFG, SFB TR5, http://www.dfg.de) to HL. CF gratefully acknowledges support by the Elite Network of Bavaria (International Doctorate Program NanoBioTechnology, IDK-NBT, http://www.cens.de/doctorate-program) and the International Max Planck Research School for Molecular and Cellular Life Sciences (IMPRS-LS, http://www.imprs-ls.de). SB was supported by the Graduate School for Life Sciences Munich (LSM, http://www.lsm.bio.lmu.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achour M, 2008, ONCOGENE, V27, P2187, DOI 10.1038/sj.onc.1210855; Aqvist J, 2002, ACCOUNTS CHEM RES, V35, P358, DOI 10.1021/ar010014p; Arita K, 2008, NATURE, V455, P818, DOI 10.1038/nature07249; Avvakumov GV, 2008, NATURE, V455, P822, DOI 10.1038/nature07273; BECKER PB, 1987, CELL, V51, P435, DOI 10.1016/0092-8674(87)90639-8; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Brero A, 2005, J CELL BIOL, V169, P733, DOI 10.1083/jcb.200502062; Chuang LSH, 1997, SCIENCE, V277, P1996, DOI 10.1126/science.277.5334.1996; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Frauer C, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1029; Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Hashimoto H, 2008, NATURE, V455, P826, DOI 10.1038/nature07280; Ho KL, 2008, MOL CELL, V29, P525, DOI 10.1016/j.molcel.2007.12.028; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Kim JK, 2009, NUCLEIC ACIDS RES, V37, P493, DOI 10.1093/nar/gkn961; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Lei H, 1996, DEVELOPMENT, V122, P3195; LEONHARDT H, 1992, CELL, V71, P865, DOI 10.1016/0092-8674(92)90561-P; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; MacKerell AD, 2001, BIOPOLYMERS, V56, P257; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Meilinger D, 2009, EMBO REP, V10, P1259, DOI 10.1038/embor.2009.201; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rottach A, 2010, NUCLEIC ACIDS RES, V38, P1796, DOI 10.1093/nar/gkp1152; Rottach A, 2009, J CELL BIOCHEM, V108, P43, DOI 10.1002/jcb.22253; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sasai N, 2009, INT J DEV BIOL, V53, P323, DOI 10.1387/ijdb.082652ns; SHARIF J, 2007, NATURE; Szwagierczak A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq684; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Valinluck V, 2004, NUCLEIC ACIDS RES, V32, P4100, DOI 10.1093/nar/gkh739; Valinluck V, 2007, CANCER RES, V67, P946, DOI 10.1158/0008-5472.CAN-06-3123; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240	42	138	146	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21306	10.1371/journal.pone.0021306	http://dx.doi.org/10.1371/journal.pone.0021306			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731699	Green Published, gold, Green Submitted			2022-12-27	WOS:000292033700060
J	Windahl, SH; Andersson, N; Borjesson, AE; Swanson, C; Svensson, J; Moverare-Skrtic, S; Sjogren, K; Shao, RJ; Lagerquist, MK; Ohlsson, C				Windahl, Sara H.; Andersson, Niklas; Borjesson, Anna E.; Swanson, Charlotte; Svensson, Johan; Moverare-Skrtic, Sofia; Sjogren, Klara; Shao, Ruijin; Lagerquist, Marie K.; Ohlsson, Claes			Reduced Bone Mass and Muscle Strength in Male 5 alpha-Reductase Type 1 Inactivated Mice	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-BETA; ANDROGEN RECEPTOR; STEROID 5-ALPHA-REDUCTASE; TESTOSTERONE-RECEPTOR; TRABECULAR BONE; CORTICAL BONE; GROWTH-PLATE; ALPHA; EXPRESSION; SRD5A3	Androgens are important regulators of bone mass but the relative importance of testosterone (T) versus dihydrotestosterone (DHT) for the activation of the androgen receptor (AR) in bone is unknown. 5 alpha-reductase is responsible for the irreversible conversion of T to the more potent AR activator DHT. There are two well established isoenzymes of 5 alpha-reductase (type 1 and type 2), encoded by separate genes (Srd5a1 and Srd5a2). 5 alpha-reductase type 2 is predominantly expressed in male reproductive tissues whereas 5 alpha-reductase type 1 is highly expressed in liver and moderately expressed in several other tissues including bone. The aim of the present study was to investigate the role of 5 alpha-areductase type 1 for bone mass using Srd5a1(-/-) mice. Four-month-old male Srd5a1(-/-) mice had reduced trabecular bone mineral density (-36%, p<0.05) and cortical bone mineral content (-15%, p<0.05) but unchanged serum androgen levels compared with wild type (WT) mice. The cortical bone dimensions were reduced in the male Srd5a1(-/-) mice as a result of a reduced cortical periosteal circumference compared with WT mice. T treatment increased the cortical periosteal circumference (p<0.05) in orchidectomized WT mice but not in orchidectomized Srd5a1(-/-) mice. Male Srd5a1(-/-) mice demonstrated a reduced forelimb muscle grip strength compared with WT mice (p<0.05). Female Srd5a1(-/-) mice had slightly increased cortical bone mass associated with elevated circulating levels of androgens. In conclusion, 5 alpha-reductase type 1 inactivated male mice have reduced bone mass and forelimb muscle grip strength and we propose that these effects are due to lack of 5 alpha-reductase type 1 expression in bone and muscle. In contrast, the increased cortical bone mass in female Srd5a1(-/-) mice, is an indirect effect mediated by elevated circulating androgen levels.	[Windahl, Sara H.; Andersson, Niklas; Borjesson, Anna E.; Swanson, Charlotte; Svensson, Johan; Moverare-Skrtic, Sofia; Sjogren, Klara; Lagerquist, Marie K.; Ohlsson, Claes] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Ctr Bone & Arthrit Res, Gothenburg, Sweden; [Shao, Ruijin] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg	Windahl, SH (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Med, Ctr Bone & Arthrit Res, Gothenburg, Sweden.	claes.ohlsson@medic.gu.se	Skrtic, Sofia/AAQ-1585-2020; Shao, Linus R/M-3059-2019; Lagerquist, Marie/A-9531-2010; Shao, Linus R/M-3134-2019; Ohlsson, Claes/AGP-3544-2022	Shao, Linus R/0000-0002-1339-9570; Lagerquist, Marie/0000-0002-9089-8605; Shao, Linus R/0000-0002-1339-9570; Ohlsson, Claes/0000-0002-9633-2805; Svensson, Johan/0000-0002-4487-6405; Tornqvist, Anna/0000-0003-2621-9038; Windahl, Sara/0000-0002-6611-6001; Andersson, Niklas/0000-0002-3493-7358; Sjogren, Klara/0000-0001-5776-7278	Swedish Research Council; Swedish Foundation for Strategic Research; COMBINE; Avtal om Lakarutbildning och Forskning /Lakarutbildningsavtalet research grant in Gothenburg; Lundberg Foundation; Torsten and Ragnar Soderberg's Foundation; Novo Nordisk Foundation; Reumatikerforbundet; Gustav V 80-ars fond; Ake Wiberg Foundation; Magnus Bergvall foundation; Tore Nilson Foundation; NIH (NIDDK) [DK071122]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071122, R56DK071122] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); COMBINE; Avtal om Lakarutbildning och Forskning /Lakarutbildningsavtalet research grant in Gothenburg; Lundberg Foundation(European Commission); Torsten and Ragnar Soderberg's Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Reumatikerforbundet; Gustav V 80-ars fond; Ake Wiberg Foundation; Magnus Bergvall foundation; Tore Nilson Foundation; NIH (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the Swedish Research Council, the Swedish Foundation for Strategic Research, COMBINE, the Avtal om Lakarutbildning och Forskning /Lakarutbildningsavtalet research grant in Gothenburg, the Lundberg Foundation, the Torsten and Ragnar Soderberg's Foundation, the Novo Nordisk Foundation, Reumatikerforbundet, Gustav V 80-ars fond, Ake Wiberg Foundation, The Magnus Bergvall foundation, The Tore Nilson Foundation and the NIH (NIDDK grant DK071122). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arts J, 1997, ENDOCRINOLOGY, V138, P5067, DOI 10.1210/en.138.11.5067; BHASIN S, J CLIN ENDOCRINOL ME, V95, P2536; Callewaert F, 2009, FASEB J, V23, P232, DOI 10.1096/fj.08-113456; Cantagrel V, 2010, CELL, V142, P203, DOI 10.1016/j.cell.2010.06.001; DESLYPERE JP, 1992, MOL CELL ENDOCRINOL, V88, P15, DOI 10.1016/0303-7207(92)90004-P; Goodarzi MO, 2006, J CLIN ENDOCR METAB, V91, P4085, DOI 10.1210/jc.2006-0227; Issa S, 2002, J CLIN ENDOCR METAB, V87, P5401, DOI 10.1210/jc.2001-011902; Jablonka-Shariff A, 1999, BIOL REPROD, V61, P171, DOI 10.1095/biolreprod61.1.171; KAUFMAN M, 1983, J STEROID BIOCHEM, V18, P121, DOI 10.1016/0022-4731(83)90077-8; KAUFMAN M, 1993, J STEROID BIOCHEM, V45, P467, DOI 10.1016/0960-0760(93)90161-O; KOVACS WJ, 1984, J CLIN INVEST, V73, P1095, DOI 10.1172/JCI111295; Langlois VS, 2010, GEN COMP ENDOCR, V166, P489, DOI 10.1016/j.ygcen.2009.08.004; Mahendroo MS, 1999, MOL ENDOCRINOL, V13, P981, DOI 10.1210/me.13.6.981; Mahendroo MS, 1997, MOL ENDOCRINOL, V11, P917, DOI 10.1210/me.11.7.917; Mahendroo MS, 2001, ENDOCRINOLOGY, V142, P4652, DOI 10.1210/en.142.11.4652; Mahendroo MS, 1996, MOL ENDOCRINOL, V10, P380, DOI 10.1210/me.10.4.380; Mahendroo MS, 1999, REV REPROD, V4, P179, DOI 10.1530/ror.0.0040179; Mellstrom D, 2008, J BONE MINER RES, V23, P1552, DOI 10.1359/JBMR.080518; Moverare S, 2003, P NATL ACAD SCI USA, V100, P13573, DOI 10.1073/pnas.2233084100; Nilsson LO, 1999, J CLIN ENDOCR METAB, V84, P370, DOI 10.1210/jc.84.1.370; Ohlsson C, 2009, ENDOCR REV, V30, P494, DOI 10.1210/er.2009-0010; Olsen NJ, 2001, ENDOCRINOLOGY, V142, P1278, DOI 10.1210/en.142.3.1278; Onoe Y, 1997, ENDOCRINOLOGY, V138, P4509, DOI 10.1210/en.138.10.4509; Riggs BL, 2002, ENDOCR REV, V23, P279, DOI 10.1210/er.23.3.279; RUSSELL DW, 1994, ANNU REV BIOCHEM, V63, P25, DOI 10.1146/annurev.bi.63.070194.000325; SCHWEIKERT HU, 1980, ACTA ENDOCRINOL-COP, V95, P258, DOI 10.1530/acta.0.0950258; Sims NA, 2003, J CLIN INVEST, V111, P1319, DOI 10.1172/JCI200317246; Stiles AR, 2010, CELL, V142, P196, DOI 10.1016/j.cell.2010.07.003; Storer TW, 2008, J AM GERIATR SOC, V56, DOI 10.1111/j.1532-5415.2008.01927.x; Tivesten A, 2004, J BONE MINER RES, V19, P1833, DOI 10.1359/JBMR.040819; Uemura M, 2008, CANCER SCI, V99, P81, DOI 10.1111/j.1349-7006.2007.00656.x; van der Eerden BCJ, 2002, ENDOCRINOLOGY, V143, P4048, DOI 10.1210/en.2002-220093; Vandenput L, 2009, NAT REV ENDOCRINOL, V5, P437, DOI 10.1038/nrendo.2009.112; Vanderschueren D, 2004, ENDOCR REV, V25, P389, DOI 10.1210/er.2003-0003; Venken K, 2006, J BONE MINER RES, V21, P576, DOI 10.1359/JBMR.060103; Vidal O, 2000, P NATL ACAD SCI USA, V97, P5474, DOI 10.1073/pnas.97.10.5474; Vidal O, 1999, J BONE MINER RES, V14, P923, DOI 10.1359/jbmr.1999.14.6.923; WILSON EM, 1976, J BIOL CHEM, V251, P5620; Windahl SH, 2000, BONE, V26, P117, DOI 10.1016/S8756-3282(99)00248-3; Windahl SH, 1999, J CLIN INVEST, V104, P895, DOI 10.1172/JCI6730	40	35	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21402	10.1371/journal.pone.0021402	http://dx.doi.org/10.1371/journal.pone.0021402			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731732	gold, Green Published, Green Submitted			2022-12-27	WOS:000292033700076
J	Cuijpers, P; Donker, T; Johansson, R; Mohr, DC; van Straten, A; Andersson, G				Cuijpers, Pim; Donker, Tara; Johansson, Robert; Mohr, David C.; van Straten, Annemieke; Andersson, Gerhard			Self-Guided Psychological Treatment for Depressive Symptoms: A Meta-Analysis	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; COGNITIVE-BEHAVIORAL THERAPY; PRIMARY-CARE; STEPPED-CARE; OVERCOMING DEPRESSION; HELP INTERVENTIONS; INTERNET ODIN; HEALTH-CARE; ANXIETY; PROGRAM	Background: A number of trials have examined the effects of self-guided psychological intervention, without any contact between the participants and a therapist or coach. The results and sizes of these trials have been mixed. This is the first quantitative meta-analysis, aimed at organizing and evaluating the literature, and estimating effect size. Method: We conducted systematic literature searches in PubMed, PsycINFO and Embase up to January 2010, and identified additional studies through earlier meta-analyses, and the references of included studies. We identified seven randomized controlled trials that met our inclusion criteria, with a total of 1,362 respondents. The overall quality of the studies was high. A post-hoc power calculation showed that the studies had sufficient statistical power to detect an effect size of d = 0.19. Results: The overall mean effect size indicating the difference between self-guided psychological treatment and control groups at post-test was d = 0.28 (p<0.001), which corresponds to a NNT of 6.41. At 4 to 12 months follow-up the effect size was d = 0.23. There was no indication for significant publication bias. Conclusions: We found evidence that self-guided psychological treatment has a small but significant effect on participants with increased levels of depressive symptomatology.	[Cuijpers, Pim; Donker, Tara; van Straten, Annemieke] Vrije Univ Amsterdam, Dept Clin Psychol, Amsterdam, Netherlands; [Johansson, Robert; Andersson, Gerhard] Linkoping Univ, Dept Behav Sci & Learning, Swedish Inst Disabil Res, Linkoping, Sweden; [Mohr, David C.] Northwestern Univ, Dept Prevent Med, Chicago, IL 60611 USA; [Andersson, Gerhard] Karolinska Inst, Psychiat Sect, Dept Clin Neurosci, Stockholm, Sweden	Vrije Universiteit Amsterdam; Linkoping University; Northwestern University; Karolinska Institutet	Cuijpers, P (corresponding author), Vrije Univ Amsterdam, Dept Clin Psychol, Amsterdam, Netherlands.	p.cuijpers@psy.vu.nl	Andersson, Gerhard/J-8529-2012; Cuijpers, Pim/G-1703-2013; van Straten, Annemieke/P-8495-2019	Andersson, Gerhard/0000-0003-4753-6745; van Straten, Annemieke/0000-0001-6875-2215; Donker, Tara/0000-0002-7470-8234; Cuijpers, Pim/0000-0001-5497-2743; Mohr, David/0000-0002-5443-7596; Johansson, Robert/0000-0001-5547-3866	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [RL1HD058295] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025741] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Andersson Gerhard, 2009, Cognitive Behaviour Therapy, V38, P196, DOI 10.1080/16506070903318960; Borenstein M., 2009, INTRO METAANALYSIS; Christensen H, 2006, PSYCHOL MED, V36, P1737, DOI 10.1017/S0033291706008695; Christensen H, 2004, BRIT MED J, V328, P265, DOI 10.1136/bmj.37945.566632.EE; Clarke G, 2005, J MED INTERNET RES, V7, DOI 10.2196/jmir.7.2.e16; Clarke G, 2002, J MED INTERNET RES, V4, DOI 10.2196/jmir.4.3.e14; Clarke Greg, 2009, Cognitive Behaviour Therapy, V38, P222, DOI 10.1080/16506070802675353; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cuijpers P, 1997, J BEHAV THER EXP PSY, V28, P139, DOI 10.1016/S0005-7916(97)00005-0; Cuijpers P, 2010, PSYCHOL MED, V40, P1943, DOI 10.1017/S0033291710000772; Cuijpers P, 2010, PSYCHOL MED, V40, P211, DOI 10.1017/S0033291709006114; Cuijpers P, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-36; de Graaf LE, 2009, BRIT J PSYCHIAT, V195, P73, DOI 10.1192/bjp.bp.108.054429; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Fletcher J, 2005, BEHAV COGN PSYCHOTH, V33, P319, DOI 10.1017/S1352465805002079; Gellatly J, 2007, PSYCHOL MED, V37, P1217, DOI 10.1017/S0033291707000062; Gregory RJ, 2004, PROF PSYCHOL-RES PR, V35, P275, DOI 10.1037/0735-7028.35.3.275; Grime PR, 2004, OCCUP MED-OXFORD, V54, P353, DOI 10.1093/occmed/kqh077; Haddock CK, 1997, CEPHALALGIA, V17, P113, DOI 10.1046/j.1468-2982.1997.1702113.x; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hirai M, 2006, BEHAV THER, V37, P99, DOI 10.1016/j.beth.2005.05.002; Holdsworth N, 1996, J MENTAL HLTH, V5, P195, DOI DOI 10.1080/09638239650037081; Kraemer HC, 2006, BIOL PSYCHIAT, V59, P990, DOI 10.1016/j.biopsych.2005.09.014; LITTLE P, BMJ, V328, P441; Marrs RW, 1995, AM J COMMUN PSYCHOL, V23, P843, DOI 10.1007/BF02507018; Menchola M, 2007, PROF PSYCHOL-RES PR, V38, P421, DOI 10.1037/0735-7028.38.4.421; Meyer B, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1151; Patten SB, 2003, PSYCHIAT SERV, V54, P396, DOI 10.1176/appi.ps.54.3.396; Rahe RH, 2002, PSYCHOSOM MED, V64, P278, DOI 10.1097/00006842-200203000-00011; Sackett DL, 2000, EVIDENCE BASED MED P, DOI DOI 10.1016/S1031-170X(97)80036-0; Salkovskis P, 2006, PSYCHOL MED, V36, P325, DOI 10.1017/S0033291705006422; Scogin F, 1996, J CONSULT CLIN PSYCH, V64, P1086, DOI 10.1037/0022-006X.64.5.1086; Seekles W, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-90; Spek V, 2007, PSYCHOL MED, V37, P1797, DOI 10.1017/S0033291707000542; Spek V, 2007, PSYCHOL MED, V37, P319, DOI 10.1017/S0033291706008944; van Straten A, 2010, MED J AUSTRALIA, V192, pS36, DOI 10.5694/j.1326-5377.2010.tb03691.x; van Straten A, 2009, SLEEP MED REV, V13, P61, DOI 10.1016/j.smrv.2008.04.006; van't Veer-Tazelaar PJ, 2009, ARCH GEN PSYCHIAT, V66, P297, DOI 10.1001/archgenpsychiatry.2008.555; Webster J, 2003, BJOG-INT J OBSTET GY, V110, P842, DOI 10.1016/S1470-0328(03)02977-X; Zetterqvist Kristofer, 2003, Cognitive Behaviour Therapy, V32, P151, DOI 10.1080/16506070302316	41	177	180	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2011	6	6							e21274	10.1371/journal.pone.0021274	http://dx.doi.org/10.1371/journal.pone.0021274			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	782CL	21712998	Green Published, Green Submitted, gold			2022-12-27	WOS:000291985100023
J	Parikh, RY; Ramanathan, R; Coloe, PJ; Bhargava, SK; Patole, MS; Shouche, YS; Bansal, V				Parikh, Rasesh Y.; Ramanathan, Rajesh; Coloe, Peter J.; Bhargava, Suresh K.; Patole, Milind S.; Shouche, Yogesh S.; Bansal, Vipul			Genus-Wide Physicochemical Evidence of Extracellular Crystalline Silver Nanoparticles Biosynthesis by Morganella spp.	PLOS ONE			English	Article							FUNGUS FUSARIUM-OXYSPORUM; BIOLOGICAL SYNTHESIS; GOLD NANOPARTICLES; SILICA; PROVIDENCIA; RESISTANCE; PROTEUS; OXIDE; SAND; AG	This study was performed to determine whether extracellular silver nanoparticles (AgNPs) production is a genus-wide phenotype associated with all the members of genus Morganella, or only Morganella morganii RP-42 isolate is able to synthesize extracellular Ag nanoparticles. To undertake this study, all the available Morganella isolates were exposed to Ag+ ions, and the obtained nanoproducts were thoroughly analyzed using physico-chemical characterization tools such as transmission electron microscopy (TEM), UV-visible spectrophotometry (UV-vis), and X-ray diffraction (XRD) analysis. It was identified that extracellular biosynthesis of crystalline silver nanoparticles is a unique biochemical character of all the members of genus Morganella, which was found independent of environmental changes. Significantly, the inability of other closely related members of the family Enterobacteriaceae towards AgNPs synthesis strongly suggests that AgNPs synthesis in the presence of Ag+ ions is a phenotypic character that is uniquely associated with genus Morganella.	[Parikh, Rasesh Y.; Patole, Milind S.; Shouche, Yogesh S.] Natl Ctr Cell Sci, Pune, Maharashtra, India; [Ramanathan, Rajesh; Coloe, Peter J.; Bhargava, Suresh K.; Bansal, Vipul] RMIT Univ, Sch Appl Sci, Melbourne, Vic, Australia	Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS); Royal Melbourne Institute of Technology (RMIT)	Shouche, YS (corresponding author), Natl Ctr Cell Sci, Pune Univ Campus, Pune, Maharashtra, India.	yogesh@nccs.res.in; vipul.bansal@rmit.edu.au	Ramanathan, Rajesh/H-1617-2011; Bhargava, Suresh K./AAQ-2675-2020; Bhargava, Suresh K./C-5783-2011; Bansal, Vipul/B-2485-2008	Bhargava, Suresh K./0000-0002-3127-8166; Bhargava, Suresh K./0000-0002-3127-8166; Bansal, Vipul/0000-0002-3354-4317; Ramanathan, Rajesh/0000-0002-8500-9148	Australian Research Council (ARC); APD [DP0988099]; Department of Education, Employment and Workplace Relations (DEEWR), Commonwealth of Australia	Australian Research Council (ARC)(Australian Research Council); APD; Department of Education, Employment and Workplace Relations (DEEWR), Commonwealth of Australia(Australian Government)	This work was supported in part by the Australian Research Council (ARC) Discovery grant and an APD Fellowship to V. B. (DP0988099), and an Endeavour Research Award to R.Y.P. from the Department of Education, Employment and Workplace Relations (DEEWR), Commonwealth of Australia to pursue this work at RMIT University, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2003, LANGMUIR, V19, P3550, DOI 10.1021/la026772l; Ahmad A, 2003, COLLOID SURFACE B, V28, P313, DOI 10.1016/S0927-7765(02)00174-1; Bansal V, 2005, J MATER CHEM, V15, P2583, DOI 10.1039/b503008k; Bansal V, 2005, ADV MATER, V17, P889, DOI 10.1002/adma.200401176; Bansal V, 2004, J MATER CHEM, V14, P3303, DOI 10.1039/b407904c; Bansal V, 2006, J AM CHEM SOC, V128, P11958, DOI 10.1021/ja063011m; Bansal V, 2007, LANGMUIR, V23, P4993, DOI 10.1021/la062535x; Bansal V, 2006, J AM CHEM SOC, V128, P14059, DOI 10.1021/ja062113+; Bansal V, 2011, AUST J CHEM, V64, P279, DOI 10.1071/CH10343; Bansal V, 2010, CRYSTENGCOMM, V12, P4280, DOI 10.1039/c0ce00215a; Bansal V, 2009, ELECTROCHEM COMMUN, V11, P1639, DOI 10.1016/j.elecom.2009.06.018; Bharde A, 2006, SMALL, V2, P135, DOI 10.1002/smll.200500180; Bharde AA, 2008, LANGMUIR, V24, P5787, DOI 10.1021/la704019p; BRENNER DJ, 1978, INT J SYST BACTERIOL, V28, P269, DOI 10.1099/00207713-28-2-269; Egger S, 2009, APPL ENVIRON MICROB, V75, P2973, DOI 10.1128/AEM.01658-08; Emborg J, 2006, INT J SYST EVOL MICR, V56, P2473, DOI 10.1099/ijs.0.64357-0; Fulton M, 1943, J BACTERIOL, V46, P79, DOI 10.1128/JB.46.1.79-82.1943; Galeano B, 2003, APPL ENVIRON MICROB, V69, P4329, DOI 10.1128/AEM.69.7.4329-4331.2003; Gupta A, 1999, NAT MED, V5, P183, DOI 10.1038/5545; JENSEN KT, 1992, INT J SYST BACTERIOL, V42, P613; KLAUS JT, 2001, TRENDS BIOTECHNOL, V19, P15; Klaus T, 1999, P NATL ACAD SCI USA, V96, P13611, DOI 10.1073/pnas.96.24.13611; Nangia Y, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-39; Niemeyer C.M., 2005, NANOBIOTECHNOLOGY CO; O'Hara CM, 2000, CLIN MICROBIOL REV, V13, P534, DOI 10.1128/CMR.13.4.534-546.2000; Parikh RY, 2008, CHEMBIOCHEM, V9, P1415, DOI 10.1002/cbic.200700592; Pearson A, 2010, CHEM COMMUN, V46, P731, DOI 10.1039/b918866e; Ramanathan R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017707; Ramanathan R, 2011, LANGMUIR, V27, P714, DOI 10.1021/la1036162; Schultz S, 2000, P NATL ACAD SCI USA, V97, P996, DOI 10.1073/pnas.97.3.996; Selvakannan PR, 2004, LANGMUIR, V20, P7825, DOI 10.1021/la049258j; Shankar SS, 2004, NAT MATER, V3, P482, DOI 10.1038/nmat1152; Song JY, 2010, BIOPROC BIOSYST ENG, V33, P159, DOI 10.1007/s00449-009-0373-2; Song JY, 2009, BIOPROC BIOSYST ENG, V32, P79, DOI 10.1007/s00449-008-0224-6; Sweeney RY, 2004, CHEM BIOL, V11, P1553, DOI 10.1016/j.chembiol.2004.08.022; Thakkar KN, 2010, NANOMED-NANOTECHNOL, V6, P257, DOI 10.1016/j.nano.2009.07.002; Yang HL, 2009, WATER RES, V43, P3777, DOI 10.1016/j.watres.2009.06.002	37	47	49	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2011	6	6							e21401	10.1371/journal.pone.0021401	http://dx.doi.org/10.1371/journal.pone.0021401			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782CL	21713008	gold, Green Submitted, Green Published			2022-12-27	WOS:000291985100039
J	Ankeny, RF; Thourani, VH; Weiss, D; Vega, JD; Taylor, WR; Nerem, RM; Jo, H				Ankeny, Randall F.; Thourani, Vinod H.; Weiss, Daiana; Vega, J. David; Taylor, W. Robert; Nerem, Robert M.; Jo, Hanjoong			Preferential Activation of SMAD1/5/8 on the Fibrosa Endothelium in Calcified Human Aortic Valves - Association with Low BMP Antagonists and SMAD6	PLOS ONE			English	Article							BONE MORPHOGENIC PROTEIN-4; SPEMANN ORGANIZER; CAROTID BIFURCATION; EARLY LESION; STENOSIS; CELLS; FLOW; ATHEROSCLEROSIS; CALCIFICATION; NOGGIN	Background: Aortic valve (AV) calcification preferentially occurs on the fibrosa side while the ventricularis side remains relatively unaffected. Here, we tested the hypothesis that side-dependent activation of bone morphogenic protein (BMP) pathway in the endothelium of the ventricularis and fibrosa is associated with human AV calcification. Methods and Results: Human calcified AVs obtained from AV replacement surgeries and non-calcified AVs from heart transplantations were used for immunohistochemical studies. We found SMAD-1/5/8 phosphorylation (a canonical BMP pathway) was higher in the calcified fibrosa than the non-calcified fibrosa while SMAD-2/3 phosphorylation (a canonical TGF beta pathway) did not show any difference. Interestingly, we found that BMP-2/4/6 expression was significantly higher on the ventricularis endothelium compared to the fibrosa in both calcified and non-calcified AV cusps; however, BMP antagonists (crossvienless-2/BMPER and noggin) expression was significantly higher on the ventricularis endothelium compared to the fibrosa in both disease states. Moreover, significant expression of inhibitory SMAD-6 expression was found only in the non-calcified ventricularis endothelium. Conclusions: SMAD-1/5/8 is preferentially activated in the calcified fibrosa endothelium of human AVs and it correlates with low expression of BMP antagonists and inhibitory SMAD6. These results suggest a dominant role of BMP antagonists in the side-dependent calcification of human AVs.	[Ankeny, Randall F.; Taylor, W. Robert; Jo, Hanjoong] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Thourani, Vinod H.; Vega, J. David] Emory Univ, Div Cardiothorac Surg, Atlanta, GA 30322 USA; [Weiss, Daiana; Taylor, W. Robert; Jo, Hanjoong] Emory Univ, Div Cardiol, Atlanta, GA 30322 USA; [Nerem, Robert M.] Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA; [Jo, Hanjoong] Ewha Womans Univ, Dept Bioinspired Sci, Seoul, South Korea	University System of Georgia; Georgia Institute of Technology; Emory University; Emory University; University System of Georgia; Georgia Institute of Technology; Ewha Womans University	Ankeny, RF (corresponding author), Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.	hjo@bme.gatech.edu	Jo, Hanjoong/L-6216-2019; thourani, vinod/AAP-5968-2020	Jo, Hanjoong/0000-0003-1833-372X; 	National Institutes of Health [HL75209, HL87012, HL80711, PO1 HL05800, PO1 HL075209]; WCU [R31-2008-000-10010-0]; American Heart Association [0715417B]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070531, R01HL087012, P01HL075209, U01HL080711] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); WCU; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by funding from National Institutes of Health grants HL75209, HL87012, and HL80711, and WCU Program (R31-2008-000-10010-0) (HJ), as well as an American Heart Association pre-doctoral fellowship 0715417B (RFA). Imaging studies were performed in part through the use of the Emory Internal Medicine Imaging Core, (supported by NIH grants PO1 HL05800 and PO1 HL075209). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREW LC, 2004, J ORTHOPAED RES, V22, P1188; BOSTROM K, 1993, J CLIN INVEST, V91, P1800, DOI 10.1172/JCI116391; BUTCHER JT, 2005, ARTERIOSCLER THROMB; Chang K, 2007, CIRCULATION, V116, P1258, DOI 10.1161/CIRCULATIONAHA.106.683227; Galvin KM, 2000, NAT GENET, V24, P171, DOI 10.1038/72835; Guerraty MA, 2010, ARTERIOSCL THROM VAS, V30, P225, DOI 10.1161/ATVBAHA.109.198549; HEMMATIBRIVANLOU A, 1994, CELL, V77, P283, DOI 10.1016/0092-8674(94)90320-4; Hogan BLM, 1996, CURR OPIN GENET DEV, V6, P432, DOI 10.1016/S0959-437X(96)80064-5; Hsu SY, 2005, INT J CLIN PRACT, V59, P72, DOI 10.1111/j.1368-5031.2004.00219.x; Jian B, 2003, ANN THORAC SURG, V75, P457, DOI 10.1016/S0003-4975(02)04312-6; Jian B, 2001, AM J PATHOL, V159, P321, DOI 10.1016/S0002-9440(10)61698-7; Koos R, 2009, THROMB HAEMOSTASIS, V101, P706, DOI 10.1160/TH08-09-0611; KU DN, 1985, ARTERIOSCLEROSIS, V5, P293, DOI 10.1161/01.ATV.5.3.293; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Miriyala S, 2006, CIRCULATION, V113, P2818, DOI 10.1161/CIRCULATIONAHA.106.611822; Miyazono K, 1999, BONE, V25, P91, DOI 10.1016/S8756-3282(99)00113-1; Mohler ER, 2000, LANCET, V356, P524, DOI 10.1016/S0140-6736(00)02572-1; Mohler ER, 2004, AM J CARDIOL, V94, P1396, DOI 10.1016/j.amjcard.2004.08.013; MOHLER ER, 1991, CLIN CARDIOL, V14, P995, DOI 10.1002/clc.4960141210; Mohler ER, 2001, CIRCULATION, V103, P1522, DOI 10.1161/01.cir.103.11.1522; NAKAMURA T, 1990, SCIENCE, V247, P836, DOI 10.1126/science.2106159; OBrien KD, 1996, ARTERIOSCL THROM VAS, V16, P523, DOI 10.1161/01.ATV.16.4.523; OTTO CM, 1994, CIRCULATION, V90, P844, DOI 10.1161/01.CIR.90.2.844; Otto CM, 1999, NEW ENGL J MED, V341, P142, DOI 10.1056/NEJM199907153410302; Parolari A, 2009, EUR J CARDIO-THORAC, V35, P493, DOI 10.1016/j.ejcts.2008.11.033; Piccolo S, 1996, CELL, V86, P589, DOI 10.1016/S0092-8674(00)80132-4; Rajamannan NM, 2003, CIRCULATION, V107, P2181, DOI 10.1161/01.CIR.0000070591.21548.69; Sacks MS, 2007, PHILOS T R SOC B, V362, P1369, DOI 10.1098/rstb.2007.2122; Simmons CA, 2005, CIRC RES, V96, P792, DOI 10.1161/01.RES.0000161998.92009.64; SMITH WC, 1992, CELL, V70, P829, DOI 10.1016/0092-8674(92)90316-5; Sorescu GP, 2004, CIRC RES, V95, P773, DOI 10.1161/01.RES.0000145728.22878.45; Sorescu GP, 2003, J BIOL CHEM, V278, P31128, DOI 10.1074/jbc.M300703200; Sucosky P, 2009, ARTERIOSCL THROM VAS, V29, P254, DOI 10.1161/ATVBAHA.108.176347; Sudo S, 2004, J BIOL CHEM, V279, P23134, DOI 10.1074/jbc.M402376200; Thourani VH, 2008, ANN THORAC SURG, V86, P1458, DOI 10.1016/j.athoracsur.2008.06.036; Topper JN, 1997, P NATL ACAD SCI USA, V94, P9314, DOI 10.1073/pnas.94.17.9314; Weiss RM, 2006, CIRCULATION, V114, P2065, DOI 10.1161/CIRCULATIONAHA.106.634139; Yetkin E, 2009, INT J CARDIOL, V135, P4, DOI 10.1016/j.ijcard.2009.03.108; ZARINS CK, 1983, CIRC RES, V53, P502, DOI 10.1161/01.RES.53.4.502; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6	41	54	59	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e20969	10.1371/journal.pone.0020969	http://dx.doi.org/10.1371/journal.pone.0020969			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698246	Green Published, gold, Green Submitted			2022-12-27	WOS:000291730000033
J	Colzato, LS; Ruiz, MJ; van den Wildenberg, WPM; Hommel, B				Colzato, Lorenza S.; Ruiz, Manuel J.; van den Wildenberg, Wery P. M.; Hommel, Bernhard			Khat Use Is Associated with Impaired Working Memory and Cognitive Flexibility	PLOS ONE			English	Article							CATHA-EDULIS; INDIVIDUAL-DIFFERENCES; EXECUTIVE FUNCTIONS; PREFRONTAL CORTEX; DOPAMINE; ECSTASY; TASK; INTELLIGENCE; INVOLVEMENT; PERCEPTION	Rationale: Khat consumption has increased during the last decades in Eastern Africa and has become a global phenomenon spreading to ethnic communities in the rest of the world, such as The Netherlands, United Kingdom, Canada, and the United States. Very little is known, however, about the relation between khat use and cognitive control functions in khat users. Objective: We studied whether khat use is associated with changes in working memory (WM) and cognitive flexibility, two central cognitive control functions. Methods: Khat users and khat-free controls were matched in terms of sex, ethnicity, age, alcohol and cannabis consumption, and IQ (Raven's progressive matrices). Groups were tested on cognitive flexibility, as measured by a Global-Local task, and on WM using an N-back task. Result: Khat users performed significantly worse than controls on tasks tapping into cognitive flexibility as well as monitoring of information in WM. Conclusions: The present findings suggest that khat use impairs both cognitive flexibility and the updating of information in WM. The inability to monitor information in WM and to adjust behavior rapidly and flexibly may have repercussions for daily life activities.	[Colzato, Lorenza S.; Ruiz, Manuel J.; Hommel, Bernhard] Leiden Univ, Inst Psychol Res, Leiden, Netherlands; [Colzato, Lorenza S.; Ruiz, Manuel J.; Hommel, Bernhard] Leiden Univ, Leiden Inst Brain & Cognit, Leiden, Netherlands; [van den Wildenberg, Wery P. M.] Univ Amsterdam, Dept Psychol, Amsterdam Ctr Study Adapt Control Brain & Behav A, Amsterdam, Netherlands	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Amsterdam	Colzato, LS (corresponding author), Leiden Univ, Inst Psychol Res, Leiden, Netherlands.	colzato@fsw.leidenuniv.nl	Hommel, Bernhard/F-8173-2010; Colzato, Lorenza S/H-6296-2013; Ruiz, Manuel J./M-7894-2014	Hommel, Bernhard/0000-0003-4731-5125; Ruiz, Manuel J./0000-0002-1286-6624; Ruiz, Manuel J/0000-0002-2926-702X; Colzato, Lorenza/0000-0003-1735-1280	NWO (Netherlands Organisation for Scientific Research)	NWO (Netherlands Organisation for Scientific Research)(Netherlands Organization for Scientific Research (NWO))	The research of LSC, WVDW and BH is supported by NWO (Netherlands Organisation for Scientific Research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman PL, 2005, PSYCHOL BULL, V131, P30, DOI 10.1037/0033-2909.131.1.30; Al-Habori Molham, 2005, Expert Opin Drug Saf, V4, P1145, DOI 10.1517/14740338.4.6.1145; Baicy K, 2007, ADDICTION, V102, P5, DOI 10.1111/j.1360-0443.2006.01777.x; Balint EE, 2009, WIEN KLIN WOCHENSCHR, V121, P604, DOI 10.1007/s00508-009-1259-7; Banjaw MY, 2005, BEHAV BRAIN RES, V156, P181, DOI 10.1016/j.bbr.2004.05.020; Beckerleg S, 2008, SUBST USE MISUSE, V43, P749, DOI 10.1080/10826080701739057; Berman S, 2008, ANN NY ACAD SCI, V1141, P195, DOI 10.1196/annals.1441.031; Braver TS, 2000, CONTROL OF COGNITIVE PROCESSES: ATTENTION AND PERFORMANCE XVIII, P713; BRENNEISEN R, 1990, BRIT J CLIN PHARMACO, V30, P825, DOI 10.1111/j.1365-2125.1990.tb05447.x; Carrier N, 2008, SUBST USE MISUSE, V43, P803, DOI 10.1080/10826080701739016; Chappell JS, 2010, FORENSIC SCI INT, V195, P108, DOI 10.1016/j.forsciint.2009.12.002; Colzato LS, 2010, NEUROSCIENCE, V170, P782, DOI 10.1016/j.neuroscience.2010.07.050; Colzato LS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001143; Colzato LS, 2006, PSYCHON B REV, V13, P1043, DOI 10.3758/BF03213923; Colzato LS, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2010.00219; Colzato LS, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00008; Colzato LS, 2010, NEUROPSYCHOLOGIA, V48, P2764, DOI 10.1016/j.neuropsychologia.2010.04.023; Colzato LS, 2009, PSYCHOPHARMACOLOGY, V207, P225, DOI 10.1007/s00213-009-1650-0; Colzato LS, 2004, NEUROSCI LETT, V360, P103, DOI 10.1016/j.neulet.2004.01.054; Cools R, 2006, NEUROSCI BIOBEHAV R, V30, P1, DOI 10.1016/j.neubiorev.2005.03.024; Cools R, 2008, J NEUROSCI, V28, P1208, DOI 10.1523/JNEUROSCI.4475-07.2008; Cox G, 2003, ADV PSYCHIAT TREAT, V9, P456, DOI [10.1192/apt.9.6.456, DOI 10.1192/APT.9.6.456]; Daumann J, 2004, BIOL PSYCHIAT, V56, P349, DOI 10.1016/j.biopsych.2004.06.011; Daumann J, 2003, NEUROREPORT, V14, P1983, DOI 10.1097/00001756-200310270-00021; Feyissa AM, 2008, PROG NEURO-PSYCHOPH, V32, P1147, DOI 10.1016/j.pnpbp.2007.12.033; Friedman NP, 2006, PSYCHOL SCI, V17, P172, DOI 10.1111/j.1467-9280.2006.01681.x; Friedman NP, 2004, J EXP PSYCHOL GEN, V133, P101, DOI 10.1037/0096-3445.133.1.101; Hartman M, 2005, PSYCHOL AGING, V20, P645, DOI 10.1037/0882-7974.20.4.645; Hassan N. A. G. M., 2007, Eastern Mediterranean Health Journal, V13, P706; Hoffman R, 2010, J ETHNOPHARMACOL, V132, P554, DOI 10.1016/j.jep.2010.05.033; Kalix P, 1996, PHARM WORLD SCI, V18, P69, DOI 10.1007/BF00579708; KALIX P, 1985, PHARMACOL REV, V37, P149; Kane MJ, 2007, J EXP PSYCHOL LEARN, V33, P615, DOI 10.1037/0278-7393.33.3.615; Kray J, 2002, BRAIN COGNITION, V49, P363, DOI 10.1006/brcg.2001.1505; KRIKORIAN AD, 1984, J ETHNOPHARMACOL, V12, P115, DOI 10.1016/0378-8741(84)90047-3; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Monsell S., 1996, UNSOLVED MYSTERIES M, P93; Moustafa AA, 2008, NEUROPSYCHOLOGIA, V46, P3144, DOI 10.1016/j.neuropsychologia.2008.07.011; NAVON D, 1977, COGNITIVE PSYCHOL, V9, P353, DOI 10.1016/0010-0285(77)90012-3; Nordahl TE, 2003, J NEUROPSYCH CLIN N, V15, P317, DOI 10.1176/appi.neuropsych.15.3.317; Odenwald M, 2007, SUCHT, V53, P9, DOI DOI 10.1024/2007.01.03; PANTELIS C, 1989, PSYCHOL MED, V19, P657, DOI 10.1017/S0033291700024259; Patel NB, 2000, E AFR MED J, V77, P329; Pennings EJM, 2008, REGUL TOXICOL PHARM, V52, P199, DOI 10.1016/j.yrtph.2008.08.005; Raven JohnC., 1988, ADV PROGRESSIVE MATR; SAWAGUCHI T, 1991, SCIENCE, V251, P947, DOI 10.1126/science.1825731; Siessmeier T, 2006, EUR J NEUROSCI, V24, P305, DOI 10.1111/j.1460-9568.2006.04903.x; *UNODC, WORLD DRUG REP 2010; van der Plas EAA, 2009, J CLIN EXP NEUROPSYC, V31, P706, DOI 10.1080/13803390802484797; Vogel EK, 2005, NATURE, V438, P500, DOI 10.1038/nature04171; von Geusau NA, 2004, PSYCHOPHARMACOLOGY, V175, P331, DOI 10.1007/s00213-004-1832-8; WAGNER GC, 1982, DRUG ALCOHOL DEPEN, V9, P279, DOI 10.1016/0376-8716(82)90067-9; ZELGER JL, 1981, NEUROPHARMACOLOGY, V20, P839, DOI 10.1016/0028-3908(81)90076-9	54	55	55	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e20602	10.1371/journal.pone.0020602	http://dx.doi.org/10.1371/journal.pone.0020602			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	778TS	21698275	Green Published, Green Submitted, gold			2022-12-27	WOS:000291730000016
J	Floegel, A; Drogan, D; Wang-Sattler, R; Prehn, C; Illig, T; Adamski, J; Joost, HG; Boeing, H; Pischon, T				Floegel, Anna; Drogan, Dagmar; Wang-Sattler, Rui; Prehn, Cornelia; Illig, Thomas; Adamski, Jerzy; Joost, Hans-Georg; Boeing, Heiner; Pischon, Tobias			Reliability of Serum Metabolite Concentrations over a 4-Month Period Using a Targeted Metabolomic Approach	PLOS ONE			English	Article							EPIC-GERMANY; PLASMA; BIOMARKERS; STABILITY; WOMEN; REPRODUCIBILITY; DISEASES; 1-YEAR	Metabolomics is a promising tool for discovery of novel biomarkers of chronic disease risk in prospective epidemiologic studies. We investigated the between- and within-person variation of the concentrations of 163 serum metabolites over a period of 4 months to evaluate the metabolite reliability expressed by the intraclass-correlation coefficient (ICC: the ratio of between-person variance and total variance). The analyses were performed with the BIOCRATES AbsoluteIDQ (TM) targeted metabolomics technology, including acylcarnitines, amino acids, glycerophospholipids, sphingolipids and hexose in 100 healthy individuals from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam study who had provided two fasting blood samples 4 months apart. Overall, serum reliability of metabolites over a 4-month period was good. The median ICC of the 163 metabolites was 0.57. The highest ICC was observed for hydroxysphingomyelin C14:1 (ICC = 0.85) and the lowest was found for acylcarnitine C3:1 (ICC = 0). Reliability was high for hexose (ICC = 0.76), sphingolipids (median ICC = 0.66; range: 0.24-0.85), amino acids (median ICC = 0.58; range: 0.41-0.72) and glycerophospholipids (median ICC = 0.58; range: 0.03-0.81). Among acylcarnitines, reliability of short and medium chain saturated compounds was good to excellent (ICC range: 0.50-0.81). Serum reliability was lower for most hydroxyacylcarnitines and monounsaturated acylcarnitines (ICC range: 0.11-0.45 and 0.00-0.63, respectively). For most of the metabolites a single measurement may be sufficient for risk assessment in epidemiologic studies with healthy subjects.	[Floegel, Anna; Drogan, Dagmar; Boeing, Heiner; Pischon, Tobias] German Inst Human Nutr Potsdam Rehbrucke, Dept Epidemiol, Nuthetal, Germany; [Wang-Sattler, Rui; Illig, Thomas] German Res Ctr Environm Hlth, Inst Epidemiol, Helmholtz Zentrum Munchen, Neuherberg, Germany; [Prehn, Cornelia; Adamski, Jerzy] German Res Ctr Environm Hlth, Inst Expt Genet, Helmholtz Zentrum Munchen, Genome Anal Ctr, Neuherberg, Germany; [Joost, Hans-Georg] German Inst Human Nutr Potsdam Rehbrucke, Dept Pharmacol, Nuthetal, Germany; [Pischon, Tobias] Max Delbruck Ctr Mol Med MDC, Mol Epidemiol Grp, Berlin, Germany	Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Helmholtz Association; Max Delbruck Center for Molecular Medicine	Floegel, A (corresponding author), German Inst Human Nutr Potsdam Rehbrucke, Dept Epidemiol, Nuthetal, Germany.	anna.floegel@dife.de	Floegel, Anna/F-4854-2013; Joost, Hans-Georg/J-4462-2013; Pischon, Tobias/HGE-8577-2022; Wang-Sattler, Rui/B-5354-2014	Joost, Hans-Georg/0000-0002-5860-606X; Pischon, Tobias/0000-0003-1568-767X; Wang-Sattler, Rui/0000-0002-8794-8229; Adamski, Jerzy/0000-0001-9259-0199; Prehn, Cornelia/0000-0002-1274-4715; Floegel, Anna/0000-0001-9806-4288	Federal Ministry of Education and Research, Germany (Bundesministerium fur Bildung und Forschung, Forderkennzeichen) [01GI0922]	Federal Ministry of Education and Research, Germany (Bundesministerium fur Bildung und Forschung, Forderkennzeichen)(Federal Ministry of Education & Research (BMBF))	This work was supported by a grant from the Federal Ministry of Education and Research, Germany (Bundesministerium fur Bildung und Forschung, Forderkennzeichen 01GI0922). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SH, 2009, J NUTR, V139, P1073, DOI 10.3945/jn.108.103754; Bergmann MM, 1999, ANN NUTR METAB, V43, P225, DOI 10.1159/000012789; Boeing H, 1999, ANN NUTR METAB, V43, P205, DOI 10.1159/000012787; Boeing H, 1999, ANN NUTR METAB, V43, P195, DOI 10.1159/000012786; BOULAT O, 1993, EUR J CLIN CHEM CLIN, V31, P585; Crews B, 2009, ANAL CHEM, V81, P8538, DOI 10.1021/ac9014947; Fleiss JL., 1986, DESIGN ANAL CLIN EXP, DOI [10.1002/9781118032923.ch1, DOI 10.1002/9781118032923.CH1, DOI 10.1002/9781118032923]; Gowda GAN, 2008, EXPERT REV MOL DIAGN, V8, P617, DOI 10.1586/14737159.8.5.617; HARTUNG J, 1981, ANN STAT, V9, P278, DOI 10.1214/aos/1176345394; Illig T, 2010, NAT GENET, V42, P137, DOI 10.1038/ng.507; Kaplan RC, 2007, CANCER EPIDEM BIOMAR, V16, P1291, DOI 10.1158/1055-9965.EPI-06-1089; Koeberl DD, 2003, PEDIATR RES, V54, P219, DOI 10.1203/01.PDR.0000074972.36356.89; Kotsopoulos J, 2010, CANCER EPIDEM BIOMAR, V19, P938, DOI 10.1158/1055-9965.EPI-09-1318; Lewis GD, 2008, J AM COLL CARDIOL, V52, P117, DOI 10.1016/j.jacc.2008.03.043; Lin D, 2009, CAN J CARDIOL, V25, p9A, DOI 10.1016/S0828-282X(09)71048-7; McBride KL, 2007, MOL GENET METAB, V90, P217, DOI 10.1016/j.ymgme.2006.08.010; MIHALIK SJ, 2010, OBESITY SILVER SPRIN; Oresic M, 2009, NUTR METAB CARDIOVAS, V19, P816, DOI 10.1016/j.numecd.2009.04.018; Pavoine C, 2009, CARDIOVASC RES, V82, P175, DOI 10.1093/cvr/cvp030; Pischon T, 2003, CLIN CHEM, V49, P650, DOI 10.1373/49.4.650; Romisch-Margl W, 2011, METABOLOMICS; ROSNER B, 2006, FUNDAMENTALS BIOSTAT, P606; Rosner B, 2006, FUNDAMENTALS BIOSTAT, P613; Soares JC, 1999, PSYCHIAT RES, V86, P107, DOI 10.1016/S0165-1781(99)00028-1; Strnadova KA, 2007, CLIN CHEM, V53, P717, DOI 10.1373/clinchem.2006.076679; Vinayavekhin N, 2010, ACS CHEM BIOL, V5, P91, DOI 10.1021/cb900271r; Wang-Sattler R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003863; Weikert C, 2007, CLIN CHEM LAB MED, V45, P899, DOI 10.1515/CCLM.2007.148; Weinberger Klaus M, 2008, Ther Umsch, V65, P487, DOI 10.1024/0040-5930.65.9.487; Zelena E, 2009, ANAL CHEM, V81, P1357, DOI 10.1021/ac8019366; Zhang P, 1997, J BIOL CHEM, V272, P9609; Zhao XJ, 2009, AM J PHYSIOL-ENDOC M, V296, pE384, DOI 10.1152/ajpendo.90748.2008; Zivkovic AM, 2009, METABOLOMICS, V5, P507, DOI 10.1007/s11306-009-0174-2	33	100	102	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e21103	10.1371/journal.pone.0021103	http://dx.doi.org/10.1371/journal.pone.0021103			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698256	Green Accepted, gold, Green Published			2022-12-27	WOS:000291730000053
J	Maestre, AM; Garzon, A; Rodriguez, D				Maestre, Ana M.; Garzon, Ana; Rodriguez, Dolores			Equine Torovirus (BEV) Induces Caspase-Mediated Apoptosis in Infected Cells	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; ACTIVATED PROTEIN-KINASE; 28S RIBOSOMAL-RNA; VIRUS-INDUCED APOPTOSIS; CYTOCHROME-C RELEASE; DEPENDENT APOPTOSIS; DIFFERENTIAL REQUIREMENTS; CULTURED-CELLS; SARS-COV; IN-VITRO	Toroviruses are gastroenteritis causing agents that infect different animal species and humans. To date, very little is known about how toroviruses cause disease. Here, we describe for the first time that the prototype member of this genus, the equine torovirus Berne virus (BEV), induces apoptosis in infected cells at late times postinfection. Observation of BEV infected cells by electron microscopy revealed that by 24 hours postinfection some cells exhibited morphological characteristics of apoptotic cells. Based on this finding, we analyzed several apoptotic markers, and observed protein synthesis inhibition, rRNA and DNA degradation, nuclear fragmentation, caspase-mediated cleavage of PARP and eIF4GI, and PKR and eIF2 alpha phosphorylation, all these processes taking place after peak virus production. We also determined that both cell death receptor and mitochondrial pathways are involved in the apoptosis process induced by BEV. BEV-induced apoptosis at late times postinfection, once viral progeny are produced, could facilitate viral dissemination in vivo and contribute to viral pathogenesis.	[Maestre, Ana M.; Garzon, Ana; Rodriguez, Dolores] CSIC, Ctr Nacl Biotecnol, Dept Mol & Cellular Biol, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Maestre, AM (corresponding author), Mt Sinai Sch Med, Dept Microbiol, New York, NY 10029 USA.	drodrig@cnb.csic.es	Merens, Ana Maestre/I-2445-2019; Rodriguez, Dolores/ABF-9855-2020	Merens, Ana Maestre/0000-0002-2494-0879; Rodriguez, Dolores/0000-0001-6365-4501	Spanish Ministry of Science and Education (MEC) [BIO2002-03739, BIO2005-08449, BIO2006-10988, CONSOLIDER CSD2006-00007]; MEC [AP2002-1806]	Spanish Ministry of Science and Education (MEC)(Spanish Government); MEC(European Commission)	This work was supported by grants BIO2002-03739, BIO2005-08449, BIO2006-10988 and CONSOLIDER CSD2006-00007, all financed by the Spanish Ministry of Science and Education (MEC). A.M.M. was recipient of a predoctoral scholarship "Formacion del Profesorado Universitario" (FPU) AP2002-1806 from the MEC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An SW, 1999, J VIROL, V73, P7853, DOI 10.1128/JVI.73.9.7853-7859.1999; Balachandran S, 2000, J VIROL, V74, P1513, DOI 10.1128/JVI.74.3.1513-1523.2000; Balachandran S, 1998, EMBO J, V17, P6888, DOI 10.1093/emboj/17.23.6888; Banerjee S, 2000, J VIROL, V74, P8793, DOI 10.1128/JVI.74.19.8793-8802.2000; Belyavskyi M, 1998, VIROLOGY, V250, P41, DOI 10.1006/viro.1998.9356; Benedict CA, 2003, CURR OPIN IMMUNOL, V15, P59, DOI 10.1016/S0952-7915(02)00018-3; Berlanga JJ, 2006, EMBO J, V25, P1730, DOI 10.1038/sj.emboj.7601073; Best SM, 2004, VIROLOGY, V320, P191, DOI 10.1016/j.virol.2003.11.025; Bisbal C, 2007, BIOCHIMIE, V89, P789, DOI 10.1016/j.biochi.2007.02.006; Bordi L, 2006, ARCH VIROL, V151, P369, DOI 10.1007/s00705-005-0632-8; Bossy-Wetzel E, 1998, EMBO J, V17, P37, DOI 10.1093/emboj/17.1.37; Castelli JC, 1998, CELL DEATH DIFFER, V5, P313, DOI 10.1038/sj.cdd.4400352; Castello A, 2006, J BIOL CHEM, V281, P33206, DOI 10.1074/jbc.M604340200; CAVANAGH D, 1994, ARCH VIROL, V135, P227, DOI 10.1007/BF01309782; Chen CJ, 2002, VIROLOGY, V302, P321, DOI 10.1006/viro.2002.1626; Clemens MJ, 2000, CELL DEATH DIFFER, V7, P603, DOI 10.1038/sj.cdd.4400695; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Collins AR, 2002, CLIN DIAGN LAB IMMUN, V9, P1392, DOI 10.1128/CDLI.9.6.1392-1395.2002; *COR STUD GROUP, 2008, 11 INT S NID OXF UK; DARZYNKIEWICZ Z, 1992, CYTOMETRY, V13, P795, DOI 10.1002/cyto.990130802; De Martino L, 2010, VET MICROBIOL, V141, P36, DOI 10.1016/j.vetmic.2009.09.001; DeDiego ML, 2007, J VIROL, V81, P1701, DOI 10.1128/JVI.01467-06; DELIC J, 1993, INT J RADIAT BIOL, V64, P39, DOI 10.1080/09553009314551091; DENBOON JA, 1991, VIROLOGY, V182, P655, DOI 10.1016/0042-6822(91)90606-C; Der SD, 1997, P NATL ACAD SCI USA, V94, P3279, DOI 10.1073/pnas.94.7.3279; DiazGuerra M, 1997, VIROLOGY, V236, P354, DOI 10.1006/viro.1997.8719; Donze O, 1999, VIROLOGY, V256, P322, DOI 10.1006/viro.1999.9618; Eleouet JF, 1998, J VIROL, V72, P4918, DOI 10.1128/JVI.72.6.4918-4924.1998; Eleouet JF, 2000, J VIROL, V74, P3975, DOI 10.1128/JVI.74.9.3975-3983.2000; FLOYDSMITH G, 1981, SCIENCE, V212, P1030, DOI 10.1126/science.6165080; Gaddy DF, 2007, J VIROL, V81, P2792, DOI 10.1128/JVI.01760-06; Garzon A, 2006, ADV EXP MED BIOL, V581, P175; Germain M, 1999, J BIOL CHEM, V274, P28379, DOI 10.1074/jbc.274.40.28379; Haagmans BL, 1996, J VIROL, V70, P8977, DOI 10.1128/JVI.70.12.8977-8983.1996; Hay S, 2002, J GEN VIROL, V83, P1547, DOI 10.1099/0022-1317-83-7-1547; He B, 2006, CELL DEATH DIFFER, V13, P393, DOI 10.1038/sj.cdd.4401833; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hirata H, 1998, J EXP MED, V187, P587, DOI 10.1084/jem.187.4.587; Hoet Armando E., 2004, Animal Health Research Reviews, V5, P157, DOI 10.1079/AHR200498; HORZINEK MC, 1985, J GEN VIROL, V66, P1287, DOI 10.1099/0022-1317-66-6-1287; HOUGE G, 1995, MOL CELL BIOL, V15, P2051; HOUGE G, 1993, FEBS LETT, V315, P16, DOI 10.1016/0014-5793(93)81123-H; Ito T, 2010, J CLIN MICROBIOL, V48, P1795, DOI 10.1128/JCM.02339-09; Jacomy H, 2003, VIROLOGY, V315, P20, DOI 10.1016/S0042-6822(03)00323-4; Jeffrey IW, 2002, CANCER RES, V62, P2272; Kaufman RJ, 1999, P NATL ACAD SCI USA, V96, P11693, DOI 10.1073/pnas.96.21.11693; KAUFMAN RJ, 2000, DOUBLE STRANDED RNA; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kim B, 2000, J COMP PATHOL, V123, P64, DOI 10.1053/jcpa.2000.0386; Koyama AH, 2000, MICROBES INFECT, V2, P1111, DOI 10.1016/S1286-4579(00)01265-X; Krahling V, 2009, J VIROL, V83, P2298, DOI 10.1128/JVI.01245-08; Kuwabara M, 2007, CLIN VACCINE IMMUNOL, V14, P998, DOI 10.1128/CVI.00475-06; LEE SB, 1994, VIROLOGY, V199, P491, DOI 10.1006/viro.1994.1151; LEE SK, 1994, J VET MED SCI, V56, P879, DOI 10.1292/jvms.56.879; LEVIN D, 1978, P NATL ACAD SCI USA, V75, P1121, DOI 10.1073/pnas.75.3.1121; Li FQ, 2007, VIROLOGY, V365, P435, DOI 10.1016/j.virol.2007.04.015; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Liu C, 2001, J VIROL, V75, P6402, DOI 10.1128/JVI.75.14.6402-6409.2001; Liu Y, 2007, VIROLOGY, V360, P364, DOI 10.1016/j.virol.2006.10.044; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Marissen WE, 1998, MOL CELL BIOL, V18, P7565, DOI 10.1128/MCB.18.12.7565; Mizutani T, 2004, VIROLOGY, V327, P169, DOI 10.1016/j.virol.2004.07.005; Morley SJ, 2000, FEBS LETT, V477, P229, DOI 10.1016/S0014-5793(00)01805-6; Nadano D, 2000, J BIOL CHEM, V275, P13967, DOI 10.1074/jbc.275.18.13967; Pignatelli J, 2009, VIRUS RES, V143, P33, DOI 10.1016/j.virusres.2009.02.019; POHLENZ JFL, 1984, VET PATHOL, V21, P407, DOI 10.1177/030098588402100407; Ren LL, 2005, DNA CELL BIOL, V24, P496, DOI 10.1089/dna.2005.24.496; Ruggieri A, 2007, VET MICROBIOL, V121, P64, DOI 10.1016/j.vetmic.2006.12.016; Rusch L, 2000, J INTERF CYTOK RES, V20, P1091, DOI 10.1089/107999000750053762; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Slee EA, 1996, BIOCHEM J, V315, P21, DOI 10.1042/bj3150021; Slee EA, 2001, J BIOL CHEM, V276, P7320, DOI 10.1074/jbc.M008363200; SNIJDER EJ, 1993, J GEN VIROL, V74, P2305, DOI 10.1099/0022-1317-74-11-2305; SNIJDER EJ, 1989, J GEN VIROL, V70, P3363, DOI 10.1099/0022-1317-70-12-3363; SNIJDER EJ, 1990, VIROLOGY, V178, P355, DOI 10.1016/0042-6822(90)90332-L; Soldani C, 2002, APOPTOSIS, V7, P321, DOI 10.1023/A:1016119328968; Spriggs KA, 2010, MOL CELL, V40, P228, DOI 10.1016/j.molcel.2010.09.028; Srivastava SP, 1998, J BIOL CHEM, V273, P2416, DOI 10.1074/jbc.273.4.2416; Suzuki K, 2008, VET MICROBIOL, V129, P390, DOI 10.1016/j.vetmic.2007.11.034; TAKIZAWA T, 1995, VIROLOGY, V209, P288, DOI 10.1006/viro.1995.1260; Takizawa T, 1996, J VIROL, V70, P8128, DOI 10.1128/JVI.70.11.8128-8132.1996; Teodoro JG, 1997, J VIROL, V71, P1739, DOI 10.1128/JVI.71.3.1739-1746.1997; Thomson BJ, 2001, INT J EXP PATHOL, V82, P65, DOI 10.1111/j.1365-2613.2001.iep195.x; van Vliet ALW, 2002, EMBO J, V21, P6571, DOI 10.1093/emboj/cdf635; WEISS M, 1983, J GEN VIROL, V64, P1849, DOI 10.1099/0022-1317-64-9-1849; WEISS M, 1986, J GEN VIROL, V67, P1305, DOI 10.1099/0022-1317-67-7-1305; Woo M, 1998, GENE DEV, V12, P806, DOI 10.1101/gad.12.6.806; WOODE GN, 1984, J CLIN MICROBIOL, V19, P623, DOI 10.1128/JCM.19.5.623-630.1984; WOODE GN, 1982, VET MICROBIOL, V7, P221, DOI 10.1016/0378-1135(82)90036-0; Yan HM, 2004, J MED VIROL, V73, P323, DOI 10.1002/jmv.20094; Yi XL, 2003, J BIOL CHEM, V278, P16992, DOI 10.1074/jbc.M300039200; ZHOU AM, 1993, CELL, V72, P753, DOI 10.1016/0092-8674(93)90403-D	92	9	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e20972	10.1371/journal.pone.0020972	http://dx.doi.org/10.1371/journal.pone.0020972			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698249	Green Published, gold			2022-12-27	WOS:000291730000035
J	Sueur, J; Mackie, D; Windmill, JFC				Sueur, Jerome; Mackie, David; Windmill, James F. C.			So Small, So Loud: Extremely High Sound Pressure Level from a Pygmy Aquatic Insect (Corixidae, Micronectinae)	PLOS ONE			English	Article							STRIDULATION; HETEROPTERA; GENERATION; EFFICIENCY; PREDATORS; SIGNALS; STICK; SLIP	To communicate at long range, animals have to produce intense but intelligible signals. This task might be difficult to achieve due to mechanical constraints, in particular relating to body size. Whilst the acoustic behaviour of large marine and terrestrial animals has been thoroughly studied, very little is known about the sound produced by small arthropods living in freshwater habitats. Here we analyse for the first time the calling song produced by the male of a small insect, the water boatman Micronecta scholtzi. The song is made of three distinct parts differing in their temporal and amplitude parameters, but not in their frequency content. Sound is produced at 78.9 (63.6-82.2) SPL rms re 2.10(-5) Pa with a peak at 99.2 (85.7-104.6) SPL re 2.10(-5) Pa estimated at a distance of one metre. This energy output is significant considering the small size of the insect. When scaled to body length and compared to 227 other acoustic species, the acoustic energy produced by M. scholtzi appears as an extreme value, outperforming marine and terrestrial mammal vocalisations. Such an extreme display may be interpreted as an exaggerated secondary sexual trait resulting from a runaway sexual selection without predation pressure.	[Sueur, Jerome] Museum Natl Hist Nat, Dept Syst & Evolut, UMR CNRS Origine Struct & Evolut Biodiversite 720, Paris, France; [Mackie, David; Windmill, James F. C.] Univ Strathclyde, Dept Elect & Elect Engn, Ctr Ultrason Engn, Glasgow G1 1XW, Lanark, Scotland	Museum National d'Histoire Naturelle (MNHN); University of Strathclyde	Sueur, J (corresponding author), Museum Natl Hist Nat, Dept Syst & Evolut, UMR CNRS Origine Struct & Evolut Biodiversite 720, Paris, France.	sueur@mnhn.fr	Sueur, Jerome/G-5364-2011; Windmill, James F C/I-1117-2019	Windmill, James F C/0000-0003-4878-349X	Royal Society (London) [JP080761]; BBSRC [BB/H004637/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H004637/1] Funding Source: researchfish	Royal Society (London)(Royal Society of London); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Royal Society (London) International Joint Project grant (JP080761). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIKEN RB, 1982, ANIM BEHAV, V30, P54, DOI 10.1016/S0003-3472(82)80237-6; Aiken RB, 1985, BIOL REV, V65, P163; Alexander Richard D., 1997, P4, DOI 10.1017/CBO9780511721946.002; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 1998, PRINCIPLES ANIMAL CO; [Anonymous], 1994, SEXUAL SELECTION; Au W. W., 1993, SONAR DOLPHINS; Bennet-Clark HC, 1999, J EXP BIOL, V202, P3347; Bennet-Clark HC, 1998, PHILOS T ROY SOC B, V353, P407, DOI 10.1098/rstb.1998.0219; Brumm H, 2005, ADV STUD BEHAV, V35, P151, DOI 10.1016/S0065-3454(05)35004-2; DAMBACH M, 1995, J EXP BIOL, V198, P721; Duellman W. E., 1986, BIOL AMPHIBIANS; Fisher RA, 1930, GENETICAL THEORY NAT; Fletcher N. H., 1992, ACOUSTIC SYSTEMS BIO; Fletcher NH, 2004, J ACOUST SOC AM, V115, P2334, DOI 10.1121/1.1694997; FORREST TG, 1991, BEHAV ECOL, V2, P327, DOI 10.1093/beheco/2.4.327; Gerhardt HC., 2002, ACOUSTIC COMMUNICATI; Greenfield MD, 2002, SIGNALERS RECEIVERS; Hartmann WH., 1998, SIGNALS SOUND SENSAT; Hill Stephanie A., 2007, Journal of Orthoptera Research, V16, P35, DOI 10.1665/1082-6467(2007)16[35:SGIMRM]2.0.CO;2; JANSSON A, 1989, ANN ENTOMOL FENN, V55, P161; JANSSON A, 1973, BEHAVIOUR, V46, P1, DOI 10.1163/156853973X00157; King I. M., 1999, Bioacoustics, V10, P115; King Ian M., 1999, Bioacoustics, V10, P19; King Ian M., 1999, Bioacoustics, V9, P297; Lardner B, 2002, NATURE, V420, P475, DOI 10.1038/420475a; LEACH M, 2003, INTRO ELECTROACOUSTI; Limousin D, 2009, J EXP BIOL, V212, P4091, DOI 10.1242/jeb.035345; PARSONS M C, 1976, Psyche (Cambridge), V83, P132, DOI 10.1155/1976/95167; Patek SN, 2007, J EXP BIOL, V210, P3538, DOI 10.1242/jeb.009084; Patek SN, 2001, NATURE, V411, P153, DOI 10.1038/35075656; Poole JH, 1999, ANIM BEHAV, V58, P185, DOI 10.1006/anbe.1999.1117; PRAGER J, 1982, J COMP PHYSIOL, V148, P323, DOI 10.1007/BF00679017; Renaud O, 2010, J STAT PLAN INFER, V140, P1852, DOI 10.1016/j.jspi.2010.01.008; Specht R., 2004, AVISOFT SAS LAB PRO; Sueur J, 2008, BIOACOUSTICS, V18, P213, DOI 10.1080/09524622.2008.9753600; THEISS J, 1982, BEHAV ECOL SOCIOBIOL, V10, P225, DOI 10.1007/BF00299689; Windmill JFC, 2006, CURR BIOL, V16, P2418, DOI 10.1016/j.cub.2006.09.066; YOHAI VJ, 1987, ANN STAT, V15, P642, DOI 10.1214/aos/1176350366; Zuk M, 1998, Q REV BIOL, V73, P415, DOI 10.1086/420412; Zuk M, 2006, BIOL LETTERS, V2, P521, DOI 10.1098/rsbl.2006.0539; [No title captured]; [No title captured]; [No title captured]; [No title captured]	45	30	30	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e21089	10.1371/journal.pone.0021089	http://dx.doi.org/10.1371/journal.pone.0021089			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698252	Green Accepted, Green Published, gold			2022-12-27	WOS:000291730000051
J	Kumar, PS; Brooker, MR; Dowd, SE; Camerlengo, T				Kumar, Purnima S.; Brooker, Michael R.; Dowd, Scot E.; Camerlengo, Terry			Target Region Selection Is a Critical Determinant of Community Fingerprints Generated by 16S Pyrosequencing	PLOS ONE			English	Article							RIBOSOMAL-RNA GENES; BACTERIAL DIVERSITY; ORAL MICROFLORA; IDENTIFICATION; BIAS; PHYLOTYPES; FRAGMENTS	Pyrosequencing of 16S rRNA genes allows for in-depth characterization of complex microbial communities. Although it is known that primer selection can influence the profile of a community generated by sequencing, the extent and severity of this bias on deep-sequencing methodologies is not well elucidated. We tested the hypothesis that the hypervariable region targeted for sequencing and primer degeneracy play important roles in influencing the composition of 16S pyrotag communities. Subgingival plaque from deep sites of current smokers with chronic periodontitis was analyzed using Sanger sequencing and pyrosequencing using 4 primer pairs. Greater numbers of species were detected by pyrosequencing than by Sanger sequencing. Rare taxa constituted nearly 6% of each pyrotag community and less than 1% of the Sanger sequencing community. However, the different target regions selected for pyrosequencing did not demonstrate a significant difference in the number of rare and abundant taxa detected. The genera Prevotella, Fusobacterium, Streptococcus, Granulicatella, Bacteroides, Porphyromonas and Treponema were abundant when the V1-V3 region was targeted, while Streptococcus, Treponema, Prevotella, Eubacterium, Porphyromonas, Campylobacer and Enterococcus predominated in the community generated by V4-V6 primers, and the most numerous genera in the V7-V9 community were Veillonella, Streptococcus, Eubacterium, Enterococcus, Treponema, Catonella and Selenomonas. Targeting the V4-V6 region failed to detect the genus Fusobacterium, while the taxa Selenomonas, TM7 and Mycoplasma were not detected by the V7-V9 primer pairs. The communities generated by degenerate and non-degenerate primers did not demonstrate significant differences. Averaging the community fingerprints generated by V1-V3 and V7-V9 primers providesd results similar to Sanger sequencing, while allowing a significantly greater depth of coverage than is possible with Sanger sequencing. It is therefore important to use primers targeted to these two regions of the 16S rRNA gene in all deep-sequencing efforts to obtain representational characterization of complex microbial communities.	[Kumar, Purnima S.; Brooker, Michael R.] Ohio State Univ, Coll Dent, Div Periodontol, Columbus, OH 43210 USA; [Dowd, Scot E.] Res Testing Lab, Lubbock, TX USA; [Camerlengo, Terry] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Kumar, PS (corresponding author), Ohio State Univ, Coll Dent, Div Periodontol, Columbus, OH 43210 USA.	kumar.83@osu.edu	Dowd, Scot E/M-5386-2017; Kumar, Purnima/S-6312-2019; Kumar, Purnima/F-6363-2013	Dowd, Scot E/0000-0002-6296-1427; Kumar, Purnima/0000-0001-5844-1341; Kumar, Purnima/0000-0001-5844-1341; , Michael/0000-0003-4988-7952	NIH [1R03DE018734-01A1]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R03DE018734] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The research was supported by NIH grant 1R03DE018734-01A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Anton AI, 2001, CLIN MICROBIOL INFEC, V7, P345, DOI 10.1046/j.1198-743x.2001.00260.x; Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chakravorty S, 2007, J MICROBIOL METH, V69, P330, DOI 10.1016/j.mimet.2007.02.005; CLAESSON MJ, NUCL ACIDS RES, V38, pE200; Clarridge JE, 2004, CLIN MICROBIOL REV, V17, P840, DOI 10.1128/CMR.17.4.840-862.2004; de Lillo A, 2006, ORAL MICROBIOL IMMUN, V21, P61, DOI 10.1111/j.1399-302X.2005.00255.x; Delima SL, 2010, J CLIN MICROBIOL, V48, P2344, DOI 10.1128/JCM.01821-09; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Diaz PI, 2006, APPL ENVIRON MICROB, V72, P2837, DOI 10.1128/AEM.72.4.2837-2848.2006; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Dowd SF, 2008, FOODBORNE PATHOG DIS, V5, P459, DOI 10.1089/fpd.2008.0107; Gomes SC, 2006, J PERIODONTOL, V77, P1483, DOI 10.1902/jop.2006.060026; Huber JA, 2009, ENVIRON MICROBIOL, V11, P1292, DOI 10.1111/j.1462-2920.2008.01857.x; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Hutter G, 2003, MICROBIOL-SGM, V149, P67, DOI 10.1099/mic.0.25791-0; Keijser BJF, 2008, J DENT RES, V87, P1016, DOI 10.1177/154405910808701104; Kleter B, 1998, AM J PATHOL, V153, P1731, DOI 10.1016/S0002-9440(10)65688-X; Kroes I, 1999, P NATL ACAD SCI USA, V96, P14547, DOI 10.1073/pnas.96.25.14547; Kumar PS, 2005, J CLIN MICROBIOL, V43, P3944, DOI 10.1128/JCM.43.8.3944-3955.2005; Kumar PS, 2006, J CLIN MICROBIOL, V44, P3665, DOI 10.1128/JCM.00317-06; KUNIN V, ENV MICROBIOL, V12, P118; LI L, J DENT RES; Martinez-Murcia AJ, 1999, INT J SYST BACTERIOL, V49, P601, DOI 10.1099/00207713-49-2-601; Nossa CW, 2010, WORLD J GASTROENTERO, V16, P4135, DOI 10.3748/wjg.v16.i33.4135; Osborne Jason, 2002, PRACTICAL ASSESSMENT; Paster BJ, 2001, J BACTERIOL, V183, P3770, DOI 10.1128/JB.183.12.3770-3783.2001; Polz MF, 1998, APPL ENVIRON MICROB, V64, P3724; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Riggio MP, 2008, ORAL DIS, V14, P251, DOI 10.1111/j.1601-0825.2007.01371.x; Shannon CE, 1997, M D COMPUT, V14, P306; Shchipkova AY, 2010, J DENT RES; Suzuki M, 1998, APPL ENVIRON MICROB, V64, P4522; Suzuki MT, 1996, APPL ENVIRON MICROB, V62, P625, DOI 10.1128/AEM.62.2.625-630.1996; Trotha R, 2001, INFECTION, V29, P12, DOI 10.1007/s15010-001-0064-7; Wang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007401; Youssef N, 2009, APPL ENVIRON MICROB, V75, P5227, DOI 10.1128/AEM.00592-09; Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259	40	187	194	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e20956	10.1371/journal.pone.0020956	http://dx.doi.org/10.1371/journal.pone.0020956			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21738596	gold, Green Published, Green Submitted			2022-12-27	WOS:000292290100010
J	Wich, SA; Vogel, ER; Larsen, MD; Fredriksson, G; Leighton, M; Yeager, CP; Brearley, FQ; van Schaik, CP; Marshall, AJ				Wich, Serge A.; Vogel, Erin R.; Larsen, Michael D.; Fredriksson, Gabriella; Leighton, Mark; Yeager, Carey P.; Brearley, Francis Q.; van Schaik, Carel P.; Marshall, Andrew J.			Forest Fruit Production Is Higher on Sumatra Than on Borneo	PLOS ONE			English	Article							RAIN-FOREST; REPRODUCTIVE PHENOLOGY; NEOTROPICAL FORESTS; TROPICAL FORESTS; SOIL NUTRIENTS; NATIONAL-PARK; TREE GROWTH; BODY-SIZE; EL-NINO; LITTERFALL	Background: Various studies have shown that the population densities of a number of forest vertebrates, such as orangutans, are higher on Sumatra than Borneo, and that several species exhibit smaller body sizes on Borneo than Sumatra and mainland Southeast Asia. It has been suggested that differences in forest fruit productivity between the islands can explain these patterns. Here we present a large-scale comparison of forest fruit production between the islands to test this hypothesis. Methodology/Principal Findings: Data on fruit production were collated from Sumatran and Bornean sites. At six sites we assessed fruit production in three forest types: riverine, peat swamp and dryland forests. We compared fruit production using time-series models during different periods of overall fruit production and in different tree size classes. We examined overall island differences and differences specifically for fruiting period and tree size class. The results of these analyses indicate that overall the Sumatran forests are more productive than those on Borneo. This difference remains when each of the three forest types (dryland, riverine, and peat) are examined separately. The difference also holds over most tree sizes and fruiting periods. Conclusions/Significance: Our results provide strong support for the hypothesis that forest fruit productivity is higher on Sumatra than Borneo. This difference is most likely the result of the overall younger and more volcanic soils on Sumatra than Borneo. These results contribute to our understanding of the determinants of faunal density and the evolution of body size on both islands.	[Wich, Serge A.; van Schaik, Carel P.] Univ Zurich, Inst Anthropol, Zurich, Switzerland; [Wich, Serge A.] Sumatran Orangutan Conservat Programme PanEco YEL, Medan, Sumatra, Indonesia; [Vogel, Erin R.] George Washington Univ, Ctr Adv Study Hominid Paleobiol, Washington, DC USA; [Larsen, Michael D.] George Washington Univ, Dept Stat, Washington, DC 20052 USA; [Fredriksson, Gabriella] Univ Amsterdam, Zool Museum, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands; [Leighton, Mark] Great Ape World Heritage Species Project, Babson Pk, MA USA; [Yeager, Carey P.] Univ Florida, Dept Zool, Gainesville, FL 32611 USA; [Brearley, Francis Q.] Manchester Metropolitan Univ, Sch Sci & Environm, Manchester M15 6BH, Lancs, England; [Marshall, Andrew J.] Univ Calif Davis, Dept Anthropol, Grad Grp Ecol, Davis, CA 95616 USA; [Marshall, Andrew J.] Univ Calif Davis, Dept Anthropol, Anim Behav Grad Grp, Davis, CA 95616 USA	University of Zurich; George Washington University; George Washington University; University of Amsterdam; State University System of Florida; University of Florida; Manchester Metropolitan University; University of California System; University of California Davis; University of California System; University of California Davis	Wich, SA (corresponding author), Univ Zurich, Inst Anthropol, Zurich, Switzerland.	sergealexander.wich@uzh.ch		Wich, Serge/0000-0003-3954-5174	Netherlands Foundation for the Advancement of Tropical Research (WOTRO); Netherlands Organisation for Scientific Research (NWO); Wildlife Conservation Society (WCS); Tropenbos Foundation; Borneo Orangutan Foundation; American Zoo and Aquarium Association; Conservation International and The Arnold Arboretum of Harvard University; European Commission; Government of Indonesia; National Geographic Society; Erb Foundation; Douroucoulli Foundation; Crystal Channel Foundation; Margot Marsh Biodiversity Foundation; Center For Field Research; International Scientific Support Trust; American Primatological Association; Page Yeager; Clare Booth Luce Professorship for Women in Science	Netherlands Foundation for the Advancement of Tropical Research (WOTRO); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Wildlife Conservation Society (WCS); Tropenbos Foundation; Borneo Orangutan Foundation; American Zoo and Aquarium Association; Conservation International and The Arnold Arboretum of Harvard University; European Commission(European CommissionEuropean Commission Joint Research Centre); Government of Indonesia(Ministry of Research and Technology of the Republic of Indonesia (RISTEK)); National Geographic Society(National Geographic Society); Erb Foundation; Douroucoulli Foundation; Crystal Channel Foundation; Margot Marsh Biodiversity Foundation; Center For Field Research; International Scientific Support Trust; American Primatological Association; Page Yeager; Clare Booth Luce Professorship for Women in Science	Financial support was provided by the Netherlands Foundation for the Advancement of Tropical Research (WOTRO), the Netherlands Organisation for Scientific Research (NWO), the Wildlife Conservation Society (WCS), the Tropenbos Foundation, the Borneo Orangutan Foundation, the Conservation Endowment Fund of the American Zoo and Aquarium Association, Conservation International and The Arnold Arboretum of Harvard University, the European Commission and the Government of Indonesia as the funding agencies for the Leuser Development Programme, The National Geographic Society, the Erb Foundation, the Douroucoulli Foundation, the Crystal Channel Foundation, the Margot Marsh Biodiversity Foundation, the Center For Field Research, the International Scientific Support Trust, the American Primatological Association, Page Yeager, and a Clare Booth Luce Professorship for Women in Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, LIFE LOGGING; APPANAH S, 1985, MALAY FOR, V4, P37; ASHTON PS, 1988, AM NAT, V132, P44, DOI 10.1086/284837; Baker TR, 2003, J TROP ECOL, V19, P109, DOI 10.1017/S0266467403003146; Brearley FQ, 2004, FOREST ECOL MANAG, V195, P385, DOI 10.1016/j.foreco.2004.02.048; Brearley FQ, 2007, J ECOL, V95, P828, DOI 10.1111/j.1365-2745.2007.01258.x; BROWN JH, 1981, AM ZOOL, V21, P877; Cannon CH, 2004, J VEG SCI, V15, P257, DOI 10.1111/j.1654-1103.2004.tb02260.x; Cannon CH, 2007, ECOL LETT, V10, P956, DOI 10.1111/j.1461-0248.2007.01089.x; Cannon CH, 2009, P NATL ACAD SCI USA, V106, P11188, DOI 10.1073/pnas.0809865106; Chave J, 2010, BIOGEOSCIENCES, V7, P43, DOI 10.5194/bg-7-43-2010; Clark DA, 2001, ECOL APPL, V11, P371, DOI 10.1890/1051-0761(2001)011[0371:NPPITF]2.0.CO;2; Cowpertwait PSP, 2009, USE R, P1, DOI 10.1007/978-0-387-88698-5_1; Curran LM, 2000, ECOL MONOGR, V70, P129, DOI 10.1890/0012-9615(2000)070[0129:ETOTSS]2.0.CO;2; Curran LM, 2000, ECOL MONOGR, V70, P101, DOI 10.1890/0012-9615(2000)070[0101:VRTSVI]2.0.CO;2; Delgado RA, 2000, EVOL ANTHROPOL, V9, P201; Fredriksson GM, 2006, BIOL J LINN SOC, V89, P489, DOI 10.1111/j.1095-8312.2006.00688.x; Galdikas BMF, 1978, THESIS U CALIFORNIA; GENTRY AH, 1987, BIOTROPICA, V19, P216, DOI 10.2307/2388339; HEANEY LR, 1978, EVOLUTION, V32, P29, DOI 10.1111/j.1558-5646.1978.tb01096.x; Janson Charles H., 1999, P237, DOI 10.1017/CBO9780511542381.015; JANZEN D H, 1974, Biotropica, V6, P69, DOI 10.2307/2989823; Kay RF, 1997, P NATL ACAD SCI USA, V94, P13023, DOI 10.1073/pnas.94.24.13023; LaDeau SL, 2001, SCIENCE, V292, P95, DOI 10.1126/science.1057547; Lloyd J, 2008, PHILOS T R SOC B, V363, P1811, DOI 10.1098/rstb.2007.0032; LONSDALE WM, 1988, ANN BOT-LONDON, V61, P319, DOI 10.1093/oxfordjournals.aob.a087560; MacKinnon K., 1996, ECOLOGY KALIMANTAN, V3; MARSHALL AJ, 2004, THESIS HARVARD U US; Marshall Andrew J., 2006, P313; Marshall Andrew J., 2009, P97; MEDWAY L, 1972, Biological Journal of the Linnean Society, V4, P117, DOI 10.1111/j.1095-8312.1972.tb00692.x; Meijaard E, 2004, RAFFLES B ZOOL, V52, P665; Meijaard E, 2004, J ZOOL, V263, P179, DOI 10.1017/S0952836904005011; Meijaard E, 2004, ZOOL J LINN SOC-LOND, V140, P63, DOI 10.1111/j.1096-3642.2004.00091.x; Meiri S, 2004, AM NAT, V163, P469, DOI 10.1086/382229; Meiri S, 2008, J BIOGEOGR, V35, P1087, DOI 10.1111/j.1365-2699.2008.01897.x; Mirmanto E, 1999, PHILOS T ROY SOC B, V354, P1825, DOI 10.1098/rstb.1999.0524; Neter J., 1996, APPL LINEAR STAT MOD, V4th, P720; Numata S, 2003, AM J BOT, V90, P1025, DOI 10.3732/ajb.90.7.1025; OATES JF, 1990, ECOLOGY, V71, P328, DOI 10.2307/1940272; Paoli GD, 2007, ECOSYSTEMS, V10, P503, DOI 10.1007/s10021-007-9042-y; Paoli GD, 2006, J ECOL, V94, P157, DOI 10.1111/j.1365-2745.2005.01077.x; Peres CA, 1997, FOLIA PRIMATOL, V68, P199, DOI 10.1159/000157247; PROCTOR J, 1988, J ECOL, V76, P320, DOI 10.2307/2260596; PROCTOR J, 1983, J ECOL, V71, P261, DOI 10.2307/2259976; Proctor J., 1983, Malaysian Forester, V46, P60; R Core Team, 2020, R LANG ENV STAT COMP; Reich PB, 1997, ECOLOGY, V78, P335, DOI 10.1890/0012-9658(1997)078[0335:NMAPIH]2.0.CO;2; Rice J., 1995, MATH STAT DATA ANAL; Rijksen H. D., 1978, FIELDSTUDY SUMATRAN; Sakai S, 1999, AM J BOT, V86, P1414, DOI 10.2307/2656924; SATTERTHWAITE FE, 1946, BIOMETRICS BULL, V2, P110, DOI 10.2307/3002019; Schuur EAG, 2003, ECOLOGY, V84, P1165, DOI 10.1890/0012-9658(2003)084[1165:PAGCRT]2.0.CO;2; SOKAL RR, 1994, BIOMETRY; Stevenson PR, 2001, BIOL J LINN SOC, V72, P161, DOI 10.1006/bijl.2000.0497; Terborgh J., 1987, P205; Van Schaik C, 2004, ORANGUTANS RED APES; Van Schaik C. P., 1986, J TROP ECOL, V2, P327, DOI DOI 10.1017/S0266467400000973; VANSCHAIK CP, 1985, BIOTROPICA, V17, P196, DOI 10.2307/2388217; VANSCHAIK CP, 1993, ANNU REV ECOL SYST, V24, P353, DOI 10.1146/annurev.es.24.110193.002033; VITOUSEK PM, 1986, ANNU REV ECOL SYST, V17, P137, DOI 10.1146/annurev.es.17.110186.001033; VITOUSEK PM, 1984, ECOLOGY, V65, P285, DOI 10.2307/1939481; WEBB CO, 1998, SEEDLING ECOLOGY TRE; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510; Whitmore T.C., 1984, pi; WHITMORE TC, 1998, INTRO TROPICAL RAIN; Wich S, 2004, PRIMATES, V45, P177, DOI 10.1007/s10329-004-0080-1; Wich SA, 2006, INT J PRIMATOL, V27, P1535, DOI 10.1007/s10764-006-9093-5; Wich SA, 2000, J TROP ECOL, V16, P563, DOI 10.1017/S0266467400001577; Wich SA, 2004, J HUM EVOL, V47, P385, DOI 10.1016/j.jhevol.2004.08.006; WICH SA, 2009, ORANGUTANS GEOGRAHIC; Wich SA, 2006, FEEDING ECOLOGY APES, P335; WRIGHT SJ, 1994, AM NAT, V143, P192, DOI 10.1086/285600; YEAGER CP, 1989, INT J PRIMATOL, V10, P497, DOI 10.1007/BF02739363; Zimmerman JK, 2007, J TROP ECOL, V23, P231, DOI 10.1017/S0266467406003890	75	43	43	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21278	10.1371/journal.pone.0021278	http://dx.doi.org/10.1371/journal.pone.0021278			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738627	gold, Green Published, Green Accepted			2022-12-27	WOS:000292142800015
J	Ciufo, LF; Murray, PA; Thompson, A; Rigden, DJ; Rees, HH				Ciufo, Leonora F.; Murray, Patricia A.; Thompson, Anu; Rigden, Daniel J.; Rees, Huw H.			Characterisation of a Desmosterol Reductase Involved in Phytosterol Dealkylation in the Silkworm, Bombyx mori	PLOS ONE			English	Article							STEROL COMPOSITION; JUVENILE-HORMONE; DIETARY STEROLS; METABOLISM; NEMATODE; PLANT; CHOLESTEROL; DROSOPHILA; SEQUENCE; INSIGHTS	Most species of invertebrate animals cannot synthesise sterols de novo and many that feed on plants dealkylate phytosterols (mostly C-29 and C-28) yielding cholesterol (C-27). The final step of this dealkylation pathway involves desmosterol reductase (DHCR24)-catalysed reduction of desmosterol to cholesterol. We now report the molecular characterisation in the silkworm, Bombyx mori, of such a desmosterol reductase involved in production of cholesterol from phytosterol, rather than in de novo synthesis of cholesterol. Phylogenomic analysis of putative desmosterol reductases revealed the occurrence of various clades that allowed for the identification of a strong reductase candidate gene in Bombyx mori (BGIBMGA 005735). Following PCR-based cloning of the cDNA (1.6 kb) and its heterologous expression in Saccharomyces cerevisae, the recombinant protein catalysed reduction of desmosterol to cholesterol in an NADH- and FAD- dependent reaction. Conceptual translation of the cDNA, that encodes a 58.9 kDa protein, and database searching, revealed that the enzyme belongs to an FAD- dependent oxidoreductase family. Western blotting revealed reductase protein expression exclusively in the microsomal subcellular fraction and primarily in the gut. The protein is peripherally associated with microsomal membranes. 2D-native gel and PAGE analysis revealed that the reductase is part of a large complex with molecular weight approximately 250kDa. The protein occurs in midgut microsomes at a fairly constant level throughout development in the last two instars, but is drastically reduced during the wandering stage in preparation for metamorphosis. Putative Broad Complex transcription factor-binding sites detectable upstream of the DHCR24 gene may play a role in this down-regulation.	[Ciufo, Leonora F.; Murray, Patricia A.; Rigden, Daniel J.; Rees, Huw H.] Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England; [Thompson, Anu] Univ Liverpool, Sch Environm Sci, Liverpool L69 3BX, Merseyside, England	University of Liverpool; University of Liverpool	Ciufo, LF (corresponding author), Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England.	reeshh@liv.ac.uk		Murray, Patricia/0000-0003-1316-148X; Rigden, Daniel/0000-0002-7565-8937	Leverhulme Trust [F/00025/AB]	Leverhulme Trust(Leverhulme Trust)	This research was supported by the Leverhulme Trust, Grant Number: F/00025/AB (URL: http://www.leverhulme.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad P, 2008, NAT BIOTECHNOL, V26, P909, DOI 10.1038/nbt.1482; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; AWATA N, 1975, BIOCHEM BIOPH RES CO, V64, P157, DOI 10.1016/0006-291X(75)90232-6; BROOKS CJW, 1968, LIPIDS, V3, P391, DOI 10.1007/BF02531277; Brown MR, 2009, ANNU REV ENTOMOL, V54, P105, DOI 10.1146/annurev.ento.53.103106.093334; Cappellozza L, 2005, APPL ENTOMOL ZOOL, V40, P405, DOI 10.1303/aez.2005.405; CHITWOOD DJ, 1987, J NEMATOL, V19, P352; CHITWOOD DJ, 1985, J NEMATOL, V17, P64; Chitwood DJ, 1999, CRIT REV BIOCHEM MOL, V34, P273, DOI 10.1080/10409239991209309; CHITWOOD DJ, 1984, LIPIDS, V19, P500, DOI 10.1007/BF02534482; CHITWOOD DJ, 1991, LIPIDS, V26, P619, DOI 10.1007/BF02536426; CLARKE GS, 1981, THESIS U LIVERPOOL; COLE RJ, 1968, LIFE SCI PT 1 PHYSI, V7, P713, DOI 10.1016/0024-3205(68)90315-9; COLE RJ, 1967, EXP PARASITOL, V21, P232, DOI 10.1016/0014-4894(67)90085-9; Desmond E, 2009, GENOME BIOL EVOL, V1, P364, DOI 10.1093/gbe/evp036; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; FUJIMOTO Y, 1980, BIOCHEMISTRY-US, V19, P1065, DOI 10.1021/bi00547a003; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Goad L.J., 1978, MARINE NATURAL PRODU, V2, P75; GOAD LJ, 1981, PURE APPL CHEM, V53, P837, DOI 10.1351/pac198153040837; Greeve I, 2000, J NEUROSCI, V20, P7345; HIEB WF, 1968, SCIENCE, V160, P778, DOI 10.1126/science.160.3829.778; Hiruma K, 2010, J INSECT PHYSIOL, V56, P1390, DOI 10.1016/j.jinsphys.2010.03.029; Ijiro T, 2004, INSECT BIOCHEM MOLEC, V34, P963, DOI 10.1016/j.ibmb.2004.06.005; Klahre U, 1998, PLANT CELL, V10, P1677, DOI 10.1105/tpc.10.10.1677; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Lafont R., 2005, COMPREHENSIVE MOL IN, V3, P125, DOI DOI 10.1016/B0-44-451924-6/00035-1; LOZANO R, 1987, LIPIDS, V22, P84, DOI 10.1007/BF02534858; LOZANO R, 1985, LIPIDS, V20, P102, DOI 10.1007/BF02534215; Madoui MA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-471; Madoui MA, 2009, NEW PHYTOL, V183, P291, DOI 10.1111/j.1469-8137.2009.02895.x; MALLORY FB, 1971, LIPIDS, V6, P149, DOI 10.1007/BF02533028; Martin-Creuzburg D, 2004, J CHEM ECOL, V30, P483, DOI 10.1023/B:JOEC.0000018624.94689.95; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Muramatsu D, 2008, MECH DEVELOP, V125, P411, DOI 10.1016/j.mod.2008.02.001; Nei M., 2000, MOL EVOLUTION PHYLOG; Opperman CH, 2008, P NATL ACAD SCI USA, V105, P14802, DOI 10.1073/pnas.0805946105; PENNOCK JF, 1977, INT REV BIOCHEM, V14, P153; Rawson RB, 2003, NAT REV MOL CELL BIO, V4, P631, DOI 10.1038/nrm1174; Reed BD, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000133; Rees H.H., 1984, Nova Acta Leopoldina, V56, P267; REES HH, 1972, BIOSYNTHESIS, V1, P59; Riddiford LM, 2003, INSECT BIOCHEM MOLEC, V33, P1327, DOI 10.1016/j.ibmb.2003.06.001; RZHETSKY A, 1992, MOL BIOL EVOL, V9, P945; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; SVOBODA JA, 1982, LIPIDS, V17, P220, DOI 10.1007/BF02535107; Svoboda JA, 1999, CRIT REV BIOCHEM MOL, V34, P49, DOI 10.1080/10409239991209183; SVOBODA JA, 1977, J NEMATOL, V9, P286; THOMPSON MJ, 1972, PROC R SOC SER B-BIO, V180, P203, DOI 10.1098/rspb.1972.0015; VONKALM L, 1994, EMBO J, V13, P3505, DOI 10.1002/j.1460-2075.1994.tb06657.x; Waterham HR, 2006, FEBS LETT, V580, P5442, DOI 10.1016/j.febslet.2006.07.027; Waterham HR, 2001, AM J HUM GENET, V69, P685, DOI 10.1086/323473; Wheeler DL, 2007, NUCLEIC ACIDS RES, V35, pD5, DOI 10.1093/nar/gkl1031; Xia QY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r162; Zhou XF, 2002, DEVELOPMENT, V129, P2259; [No title captured]	61	20	23	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21316	10.1371/journal.pone.0021316	http://dx.doi.org/10.1371/journal.pone.0021316			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738635	gold, Green Submitted, Green Published			2022-12-27	WOS:000292092600028
J	Curioni-Fontecedro, A; Nuber, N; Mihic-Probst, D; Seifert, B; Soldini, D; Dummer, R; Knuth, A; van den Broek, M; Moch, H				Curioni-Fontecedro, Alessandra; Nuber, Natko; Mihic-Probst, Daniela; Seifert, Burkhardt; Soldini, Davide; Dummer, Reinhard; Knuth, Alexander; van den Broek, Maries; Moch, Holger			Expression of MAGE-C1/CT7 and MAGE-C2/CT10 Predicts Lymph Node Metastasis in Melanoma Patients	PLOS ONE			English	Article							CANCER-TESTIS ANTIGENS; REPRESENTATIONAL-DIFFERENCE ANALYSIS; CANCER/TESTIS CT ANTIGENS; CYTOLYTIC T-LYMPHOCYTES; MULTIPLE-MYELOMA; HEPATOCELLULAR-CARCINOMA; CUTANEOUS MELANOMA; CELL PROLIFERATION; IMPROVED SURVIVAL; IMMUNE-RESPONSES	MAGE-C1/CT7 and MAGE-C2/CT10 are members of the large MAGE family of cancer-testis (CT) antigens. CT antigens are promising targets for immunotherapy in cancer because their expression is restricted to cancer and germ line cells and a proportion of cancer patients presents with immune responses against CT antigens, which clearly demonstrates their immunogenicity. This study investigates the expression of MAGE-C1/CT7 and MAGE-C2/CT10 in primary and metastatic melanoma. Immunohistochemical staining of tissue microarrays that consisted of 59 primary malignant melanomas of the skin, 163 lymph node and distant melanoma metastases and 68 melanoma cell lines was performed. We found MAGE-C1/CT7 expression in 15 out of 50 (24%) primary melanomas and 15 out of 50 (24%) cell lines, whereas MAGE-C2/CT10 was detected in 17 out of 51 (33%) primary melanomas and 14 out of 68 (17%) cell lines. MAGE-C1/CT7 and MAGE-C2/CT10 were both detected in 40% of melanoma metastases. Patients with MAGE-C1/CT7 or MAGE-C2/CT10 positive primary melanoma had significantly more lymph node metastases (p = 0.005 and p<0.001, resp.). Prediction of lymph node metastasis by MAGE-C1/CT7 and MAGE-C2/CT10 was independent of tumor cell proliferation rate (Ki67 labeling index) in a multivariate analysis (p = 0.01). Our results suggest that the expression of MAGE-C1/CT7 and MAGE-C2/CT10 in primary melanoma is a potent predictor of sentinel lymph node metastasis.	[Curioni-Fontecedro, Alessandra; Nuber, Natko; Knuth, Alexander; van den Broek, Maries] Univ Zurich Hosp, Div Internal Med, CH-8091 Zurich, Switzerland; [Curioni-Fontecedro, Alessandra; Nuber, Natko; Knuth, Alexander; van den Broek, Maries] Univ Zurich Hosp, Clin Oncol, CH-8091 Zurich, Switzerland; [Mihic-Probst, Daniela; Soldini, Davide; Moch, Holger] Univ Zurich Hosp, Inst Surg Pathol, CH-8091 Zurich, Switzerland; [Seifert, Burkhardt] Univ Zurich, Inst Social & Prevent Med, Biostat Unit, CH-8006 Zurich, Switzerland; [Dummer, Reinhard] Univ Zurich Hosp, Dermatol Clin, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University of Zurich; University Zurich Hospital	Curioni-Fontecedro, A (corresponding author), Univ Zurich Hosp, Div Internal Med, CH-8091 Zurich, Switzerland.	alessandra.curioni@usz.ch	knuth, alexander/H-2608-2014; van den Broek, Maries/L-6532-2019; Curioni-Fontecedro, Alessandra/R-4950-2018; Mihic-Probst, Daniela/AAB-6374-2021; van den Broek, Maries/G-4128-2016	knuth, alexander/0000-0002-9318-2784; Curioni-Fontecedro, Alessandra/0000-0002-5778-5270; Seifert, Burkhardt/0000-0002-5829-2478; van den Broek, Maries/0000-0002-9489-3692	Krebsliga Zurich; Cancer Research Institute/Ludwig Institute for Cancer Research/Cancer Vaccine Collaborative/Atlantic Philantropies; Terry Fox Foundation; Hanne Liebermann Foundation; Hartmann Muller Foundation; Ellinger Foundation	Krebsliga Zurich; Cancer Research Institute/Ludwig Institute for Cancer Research/Cancer Vaccine Collaborative/Atlantic Philantropies; Terry Fox Foundation; Hanne Liebermann Foundation; Hartmann Muller Foundation; Ellinger Foundation	The funding for materials and researchers involved in this study was kindly donated from the following charity organisations: Krebsliga Zurich (www.krebsliga-zh.ch), Cancer Research Institute/Ludwig Institute for Cancer Research/Cancer Vaccine Collaborative/Atlantic Philantropies (www.cancerresearch.org, www.licr.org), the Terry Fox Foundation (www.terryfox.org), the Hanne Liebermann Foundation, the Hartmann Muller Foundation (http://www.hms.uzh.ch/), and the Ellinger Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade MA, 2001, J STRUCT BIOL, V134, P117, DOI 10.1006/jsbi.2001.4392; Atanackovic D, 2007, BLOOD, V109, P1103, DOI 10.1182/blood-2006-04-014480; Atanackovic D, 2010, HAEMATOL-HEMATOL J, V95, P785, DOI 10.3324/haematol.2009.014464; Bajetta E, 2002, SEMIN ONCOL, V29, P427, DOI 10.1053/sonc.2002.35238; Barrow C, 2006, CLIN CANCER RES, V12, P764, DOI 10.1158/1078-0432.CCR-05-1544; Chen YT, 1998, P NATL ACAD SCI USA, V95, P6919, DOI 10.1073/pnas.95.12.6919; Curioni-Fontecedro A, 2008, LEUKEMIA, V22, P1646, DOI 10.1038/leu.2008.43; Dhodapkar Madhav V, 2003, Cancer Immun, V3, P9; Dummer R, 2010, ANN ONCOL, V21, pv194, DOI 10.1093/annonc/mdq188; Dummer R, 2001, DERMATOLOGY, V203, P75, DOI 10.1159/000051710; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Gimotty PA, 2005, J CLIN ONCOL, V23, P8048, DOI 10.1200/JCO.2005.02.0735; Godelaine D, 2007, CANCER IMMUNOL IMMUN, V56, P753, DOI 10.1007/s00262-006-0244-5; Goodyear O, 2010, BLOOD, V116, P1908, DOI 10.1182/blood-2009-11-249474; Gure AO, 2000, INT J CANCER, V85, P726, DOI 10.1002/(SICI)1097-0215(20000301)85:5<726::AID-IJC21>3.0.CO;2-F; Hu SS, 2009, ARCH DERMATOL, V145, P1369, DOI 10.1001/archdermatol.2009.302; Jungbluth AA, 2002, INT J CANCER, V99, P839, DOI 10.1002/ijc.10416; Jungbluth AA, 2005, BLOOD, V106, P167, DOI 10.1182/blood-2004-12-4931; Kirkwood JM, 2006, CLIN CANCER RES, V12, p2331S, DOI 10.1158/1078-0432.CCR-05-2538; Kirkwood JM, 2008, J CLIN ONCOL, V26, P3445, DOI 10.1200/JCO.2007.14.6423; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Lee CC, 2008, J CLIN ONCOL, V26, P535, DOI 10.1200/JCO.2007.14.0285; Lee CC, 2009, J CLIN ONCOL, V27, P3489, DOI 10.1200/JCO.2008.18.9845; Lucas S, 1998, CANCER RES, V58, P743; Luftl M, 2004, BRIT J DERMATOL, V151, P1213, DOI 10.1111/j.1365-2133.2004.06260.x; Ma WB, 2004, INT J CANCER, V109, P698, DOI 10.1002/ijc.20038; Mihic-Probst D, 2006, INT J CANCER, V118, P2262, DOI 10.1002/ijc.21608; Mihic-Probst D, 2007, INT J CANCER, V121, P1764, DOI 10.1002/ijc.22891; MORTON DL, 1991, ANN SURG, V214, P491, DOI 10.1097/00000658-199110000-00013; Moschos SJ, 2006, J CLIN ONCOL, V24, P3164, DOI 10.1200/JCO.2005.05.2498; Nuber N, 2010, P NATL ACAD SCI USA, V107, P15187, DOI 10.1073/pnas.1002155107; Ohsie SJ, 2008, J CUTAN PATHOL, V35, P433, DOI 10.1111/j.1600-0560.2007.00891.x; Parmiani G, 2003, SEMIN CANCER BIOL, V13, P391, DOI 10.1016/j.semcancer.2003.09.001; Peng JR, 2005, CANCER LETT, V219, P223, DOI 10.1016/j.canlet.2004.07.028; Riener MO, 2009, INT J CANCER, V124, P352, DOI 10.1002/ijc.23966; Rothberg BEG, 2009, JNCI-J NATL CANCER I, V101, P452, DOI 10.1093/jnci/djp038; Sahin U, 1998, INT J CANCER, V78, P387, DOI 10.1002/(SICI)1097-0215(19981029)78:3<387::AID-IJC22>3.0.CO;2-2; Scanlan Matthew J, 2004, Cancer Immun, V4, P1; Serrone L, 2000, J EXP CLIN CANC RES, V19, P21; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Straume O, 2000, CLIN CANCER RES, V6, P1845; Tinguely M, 2008, CANCER SCI, V99, P720, DOI 10.1111/j.1349-7006.2008.00738.x; Wang Y, 2002, J IMMUNOL, V169, P1102, DOI 10.4049/jimmunol.169.2.1102; Zhuang Ran, 2006, Cancer Immun, V6, P7	44	35	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21418	10.1371/journal.pone.0021418	http://dx.doi.org/10.1371/journal.pone.0021418			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738656	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000292092600038
J	Chen, YX; Wang, WH; Zhou, YY; Shields, R; Chanda, SK; Elston, RC; Li, J				Chen, Yixuan; Wang, Wenhui; Zhou, Yingyao; Shields, Robert; Chanda, Sumit K.; Elston, Robert C.; Li, Jing			In Silico Gene Prioritization by Integrating Multiple Data Sources	PLOS ONE			English	Article							DISEASE-GENES; FUNCTION PREDICTION; NETWORK; WALKING; MOUSE	Identifying disease genes is crucial to the understanding of disease pathogenesis, and to the improvement of disease diagnosis and treatment. In recent years, many researchers have proposed approaches to prioritize candidate genes by considering the relationship of candidate genes and existing known disease genes, reflected in other data sources. In this paper, we propose an expandable framework for gene prioritization that can integrate multiple heterogeneous data sources by taking advantage of a unified graphic representation. Gene-gene relationships and gene-disease relationships are then defined based on the overall topology of each network using a diffusion kernel measure. These relationship measures are in turn normalized to derive an overall measure across all networks, which is utilized to rank all candidate genes. Based on the informativeness of available data sources with respect to each specific disease, we also propose an adaptive threshold score to select a small subset of candidate genes for further validation studies. We performed large scale cross-validation analysis on 110 disease families using three data sources. Results have shown that our approach consistently outperforms other two state of the art programs. A case study using Parkinson disease (PD) has identified four candidate genes (UBB, SEPT5, GPR37 and TH) that ranked higher than our adaptive threshold, all of which are involved in the PD pathway. In particular, a very recent study has observed a deletion of TH in a patient with PD, which supports the importance of the TH gene in PD pathogenesis. A web tool has been implemented to assist scientists in their genetic studies.	[Chen, Yixuan; Wang, Wenhui; Shields, Robert; Li, Jing] Case Western Reserve Univ, Dept Elect Engn & Comp Sci, Cleveland, OH 44106 USA; [Zhou, Yingyao] Novartis Res Fdn, Genom Inst, San Diego, CA USA; [Chanda, Sumit K.] Burnham Inst Med Res, Infect & Inflammatory Dis Ctr, La Jolla, CA USA; [Elston, Robert C.; Li, Jing] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Li, Jing] Jilin Univ, Joint Inst Syst Biol, Coll Comp Sci & Technol, Changchun 130023, Peoples R China	Case Western Reserve University; Novartis; Sanford Burnham Prebys Medical Discovery Institute; Case Western Reserve University; Jilin University	Chen, YX (corresponding author), Case Western Reserve Univ, Dept Elect Engn & Comp Sci, Cleveland, OH 44106 USA.	jingli@case.edu	Wang, Wenhui/A-8066-2011	Li, Jing/0000-0003-1160-6959; Wang, Wenhui/0000-0001-6681-1373	National Institutes of Health/National Library of Medicine [LM008991]; National Institutes of Health/National Center for Research Resources [RR03655]; Case Western Reserve University; Genomics Institute of the Novartis Research Foundation	National Institutes of Health/National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); National Institutes of Health/National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Case Western Reserve University; Genomics Institute of the Novartis Research Foundation	This research was supported by National Institutes of Health/National Library of Medicine [grant LM008991], National Institutes of Health/National Center for Research Resources [grant RR03655], and a joint summer fellowship program from Case Western Reserve University and Genomics Institute of the Novartis Research Foundation to JL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adie EA, 2006, BIOINFORMATICS, V22, P773, DOI 10.1093/bioinformatics/btk031; Aerts S, 2006, NAT BIOTECHNOL, V24, P537, DOI 10.1038/nbt1203; Ala U, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000043; Alfarano C, 2005, NUCLEIC ACIDS RES, V33, pD418, DOI 10.1093/nar/gki051; Altshuler D, 2000, NAT GENET, V26, P135, DOI 10.1038/79839; Bademci G, 2010, HUM MUTAT, V31, pE1767, DOI 10.1002/humu.21351; Chatr-Aryamontri A, 2007, NUCLEIC ACIDS RES, V35, pD572, DOI 10.1093/nar/gkl950; Chen J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-392; Dennissen FJA, 2010, NEURODEGENER DIS, V7, P76, DOI 10.1159/000285510; Franke L, 2006, AM J HUM GENET, V78, P1011, DOI 10.1086/504300; Freudenberg J, 2002, BIOINFORMATICS, V18, pS110, DOI 10.1093/bioinformatics/18.suppl_2.S110; Hamosh A, 2002, NUCLEIC ACIDS RES, V30, P52, DOI 10.1093/nar/30.1.52; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Konig R, 2010, NATURE, V463, P813, DOI 10.1038/nature08699; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Li YJ, 2010, BIOINFORMATICS, V26, P1219, DOI 10.1093/bioinformatics/btq108; Marazziti D, 2009, FASEB J, V23, P1978, DOI 10.1096/fj.08-121210; Mishra GR, 2006, NUCLEIC ACIDS RES, V34, pD411, DOI 10.1093/nar/gkj141; Oti M, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.041376; Pattin KA, 2008, HUM GENET, V124, P19, DOI 10.1007/s00439-008-0522-8; Perez-Iratxeta C, 2002, NAT GENET, V31, P316, DOI 10.1038/ng895; Smedley D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-22; Strohman R, 2002, SCIENCE, V296, P701, DOI 10.1126/science.1070534; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tranchevent LC, 2008, NUCLEIC ACIDS RES, V36, pW377, DOI 10.1093/nar/gkn325; Troyanskaya OG, 2003, P NATL ACAD SCI USA, V100, P8348, DOI 10.1073/pnas.0832373100; Turner FS, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-11-r75; van Driel MA, 2006, EUR J HUM GENET, V14, P535, DOI 10.1038/sj.ejhg.5201585; Vanunu O, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000641; Vastrik I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r39; Wu XB, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.27; Xu JZ, 2006, BIOINFORMATICS, V22, P2800, DOI 10.1093/bioinformatics/btl467; Zhou YY, 2005, BIOINFORMATICS, V21, P1237, DOI 10.1093/bioinformatics/bti111	34	40	41	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21137	10.1371/journal.pone.0021137	http://dx.doi.org/10.1371/journal.pone.0021137			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21731658	Green Published, gold			2022-12-27	WOS:000292036900012
J	Jansa, SA; Voss, RS				Jansa, Sharon A.; Voss, Robert S.			Adaptive Evolution of the Venom-Targeted vWF Protein in Opossums that Eat Pitvipers	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; SNAKE BOTHROPS-ASPER; WARM-BLOODED ANIMALS; LECTIN-LIKE PROTEINS; POSITIVE SELECTION; ACETYLCHOLINE-RECEPTOR; PHYLOGENETIC ANALYSIS; VONWILLEBRAND-FACTOR; RAPID EVOLUTION; REPRODUCTIVE PROTEINS	The rapid evolution of venom toxin genes is often explained as the result of a biochemical arms race between venomous animals and their prey. However, it is not clear that an arms race analogy is appropriate in this context because there is no published evidence for rapid evolution in genes that might confer toxin resistance among routinely envenomed species. Here we report such evidence from an unusual predator-prey relationship between opossums (Marsupialia: Didelphidae) and pitvipers (Serpentes: Crotalinae). In particular, we found high ratios of replacement to silent substitutions in the gene encoding von Willebrand Factor (vWF), a venom-targeted hemostatic blood protein, in a clade of opossums known to eat pitvipers and to be resistant to their hemorrhagic venom. Observed amino-acid substitutions in venom-resistant opossums include changes in net charge and hydrophobicity that are hypothesized to weaken the bond between vWF and one of its toxic snake-venom ligands, the C-type lectin-like protein botrocetin. Our results provide the first example of rapid adaptive evolution in any venom-targeted molecule, and they support the notion that an evolutionary arms race might be driving the rapid evolution of snake venoms. However, in the arms race implied by our results, venomous snakes are prey, and their venom has a correspondingly defensive function in addition to its usual trophic role.	[Jansa, Sharon A.] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; [Jansa, Sharon A.] Univ Minnesota, JF Bell Museum Nat Hist, St Paul, MN 55108 USA; [Voss, Robert S.] Amer Museum Nat Hist, Dept Mammal, New York, NY 10024 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; American Museum of Natural History (AMNH)	Jansa, SA (corresponding author), Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA.	jansa003@umn.edu		Jansa, Sharon/0000-0002-8073-1262	National Science Foundation [DEB-0211952, DEB-0322253, DEB-0743062]; Division Of Environmental Biology [0743062] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation grants DEB-0211952, DEB-0322253, and DEB-0743062 (www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS PA, 1986, TRENDS ECOL EVOL, V1, P108, DOI 10.1016/0169-5347(86)90037-6; Almeida-Santos Selma Maria, 2000, Current Herpetology, V19, P1; Angulo Y, 2009, TOXICON, V54, P949, DOI 10.1016/j.toxicon.2008.12.014; Azara F., 1802, APUNTAMIENTOS HIST N; BARCHAN D, 1995, BIOCHEMISTRY-US, V34, P9172, DOI 10.1021/bi00028a029; BARCHAN D, 1992, P NATL ACAD SCI USA, V89, P7717, DOI 10.1073/pnas.89.16.7717; Barlow A, 2009, P ROY SOC B-BIOL SCI, V276, P2443, DOI 10.1098/rspb.2009.0048; Barreiro LB, 2010, NAT REV GENET, V11, P17, DOI 10.1038/nrg2698; Bdolah A, 1997, TOXICON, V35, P1251, DOI 10.1016/S0041-0101(97)00019-6; Biardi J.E., 2008, BIOL RATTLESNAKES, P557; Biardi JE, 2000, TOXICON, V38, P713, DOI 10.1016/S0041-0101(99)00179-8; Braud S, 2000, BIOCHIMIE, V82, P851, DOI 10.1016/S0300-9084(00)01178-0; Brodie ED, 1999, BIOSCIENCE, V49, P557, DOI 10.2307/1313476; Cundall David, 2002, P149; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; DAWKINS R, 1979, PROC R SOC SER B-BIO, V205, P489, DOI 10.1098/rspb.1979.0081; DOMONT GB, 1991, TOXICON, V29, P1183, DOI 10.1016/0041-0101(91)90191-S; Drummond A., 2011, GENEIOUS V5 5; Du Xiao-Yan, 2010, P359; Duda TF, 1999, P NATL ACAD SCI USA, V96, P6820, DOI 10.1073/pnas.96.12.6820; Fry BG, 2005, GENOME RES, V15, P403, DOI 10.1101/gr.3228405; Fry BG, 2004, MOL BIOL EVOL, V21, P870, DOI 10.1093/molbev/msh091; Fry BG, 2008, MOL CELL PROTEOMICS, V7, P215, DOI 10.1074/mcp.M700094-MCP200; Fukuda K, 2005, NAT STRUCT MOL BIOL, V12, P152, DOI 10.1038/nsmb892; Fukuda K, 2002, STRUCTURE, V10, P943, DOI 10.1016/S0969-2126(02)00787-6; Gibbs HL, 2008, J MOL EVOL, V66, P151, DOI 10.1007/s00239-008-9067-7; Greene Harry W., 1992, P107; GREENE HW, 1988, BIOL REPTILIA, P16; Gutierrez Jose Maria, 2010, P115; Hanifin CT, 2008, PLOS BIOL, V6, P471, DOI 10.1371/journal.pbio.0060060; Hughes AL, 2007, HEREDITY, V99, P364, DOI 10.1038/sj.hdy.6801031; HUGHES AL, 1994, PHILOS T ROY SOC B, V346, P359, DOI 10.1098/rstb.1994.0153; Jackson K, 2003, ZOOL J LINN SOC-LOND, V137, P337, DOI 10.1046/j.1096-3642.2003.00052.x; Juarez P, 2008, MOL BIOL EVOL, V25, P2391, DOI 10.1093/molbev/msn179; KACHALSKY SG, 1995, P NATL ACAD SCI USA, V92, P10801, DOI 10.1073/pnas.92.23.10801; KILMON JA, 1976, TOXICON, V14, P337, DOI 10.1016/0041-0101(76)90032-5; KLAUBER L. M., 1972, RATTLESNAKES THEIR H, V2nd; KOCHVA E, 1987, TOXICON, V25, P65, DOI 10.1016/0041-0101(87)90150-4; Kordis D, 2000, GENE, V261, P43, DOI 10.1016/S0378-1119(00)00490-X; Kozminsky-Atias A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-333; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lu QM, 2005, TOXICON, V45, P1089, DOI 10.1016/j.toxicon.2005.02.022; Mackessy SP, 2010, HDB VENOMS TOXINS RE, P3; Mackessy SP, 2006, ZOOL ANZ, V245, P147, DOI 10.1016/j.jcz.2006.01.003; Gutierrez JM, 2009, TOXICON, V54, P976, DOI 10.1016/j.toxicon.2009.01.039; Markland FS, 1998, TOXICON, V36, P1749, DOI 10.1016/S0041-0101(98)00126-3; Matsui T, 2005, TOXICON, V45, P1075, DOI 10.1016/j.toxicon.2005.02.023; Mebs D, 1996, TOXICON, V34, P1313, DOI 10.1016/S0041-0101(96)00104-3; Morita T, 2005, TOXICON, V45, P1099, DOI 10.1016/j.toxicon.2005.02.021; MOUSSATCHE H, 1989, MEM I OSWALDO CRUZ, V84, P391, DOI 10.1590/S0074-02761989000800070; NEVESFERREIRA AGC, 2010, HDB VENOMS TOXINS RE, P259; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; Ogawa T, 2005, TOXICON, V45, P1, DOI 10.1016/j.toxicon.2004.07.028; Oliveira ME, 1999, STUD NEOTROP FAUNA E, V34, P72, DOI 10.1076/snfe.34.2.72.2105; Ota R, 2000, MOL BIOL EVOL, V17, P798, DOI 10.1093/oxfordjournals.molbev.a026358; Perales J, 2005, TOXICON, V45, P1013, DOI 10.1016/j.toxicon.2005.02.028; PERALES J, 1994, TOXICON, V32, P1237, DOI 10.1016/0041-0101(94)90353-0; PEREZ JC, 1978, TOXICON, V16, P375, DOI 10.1016/0041-0101(78)90158-7; PEREZ JC, 1979, TOXICON, V17, P601, DOI 10.1016/0041-0101(79)90234-4; Perez JC, 1999, TOXICON, V37, P703, DOI 10.1016/S0041-0101(98)00205-0; READ MS, 1989, BLOOD, V74, P1031; Rucavado A, 2001, THROMB HAEMOSTASIS, V85, P710; Sadler JE, 1998, ANNU REV BIOCHEM, V67, P395, DOI 10.1146/annurev.biochem.67.1.395; SANDERS WE, 1988, LAB INVEST, V59, P443; Swanson WJ, 2002, NAT REV GENET, V3, P137, DOI 10.1038/nrg733; Thwin MM, 1998, TOXICON, V36, P1471, DOI 10.1016/S0041-0101(98)00137-8; Turner LM, 2008, INT J DEV BIOL, V52, P769, DOI 10.1387/ijdb.082577lt; USAMI Y, 1993, P NATL ACAD SCI USA, V90, P928, DOI 10.1073/pnas.90.3.928; VELLARD J., 1949, PUBL MUS HIST NAT JAVIER PRADO" SER A ZOOL, V1, P1; VERMEIJ GJ, 1994, ANNU REV ECOL SYST, V25, P219, DOI 10.1146/annurev.es.25.110194.001251; Voss RS, 2009, B AM MUS NAT HIST, P1; Weinberger H, 2010, MOL BIOL EVOL, V27, P1025, DOI 10.1093/molbev/msp310; WERNER RM, 1977, TOXICON, V15, P29, DOI 10.1016/0041-0101(77)90066-6; Yang Z., 2006, COMPUTATIONAL MOL EV, DOI DOI 10.1093/ACPROF:OSO/9780198567028.001.0001; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237	78	57	60	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e20997	10.1371/journal.pone.0020997	http://dx.doi.org/10.1371/journal.pone.0020997			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731638	Green Published, gold			2022-12-27	WOS:000292033700025
J	Li, Y; Zheng, HJ; Liu, Y; Jiang, YW; Xin, JQ; Chen, W; Song, ZQ				Li, Yuan; Zheng, Huajun; Liu, Yang; Jiang, Yanwei; Xin, Jiuqing; Chen, Wei; Song, Zhiqiang			The Complete Genome Sequence of Mycoplasma bovis Strain Hubei-1	PLOS ONE			English	Article							MULTIPLEX-PCR; CLPC ATPASE; BACTERIAL; PROTEIN; IDENTIFICATION; VIRULENCE; REPLICATION; PNEUMONIA; DATABASE; GENES	Infection by Mycoplasma bovis (M. bovis) can induce diseases, such as pneumonia and otitis media in young calves and mastitis and arthritis in older animals. Here, we report the finished and annotated genome sequence of M. bovis strain Hubei-1, a strain isolated in 2008 that caused calf pneumonia on a Chinese farm. The genome of M. bovis strain Hubei-1 contains a single circular chromosome of 953,114 bp with a 29.37% GC content. We identified 803 open reading frames (ORFs) that occupy 89.5% of the genome. While 34 ORFs were Hubei-1 specific, 662 ORFs had orthologs in the M. bovis type strain PG45 genome. Genome analysis validated lateral gene transfer between M. bovis and the Mycoplasma mycoides subspecies mycoides, while phylogenetic analysis found that the closest M. bovis neighbor is Mycoplasma agalactiae. Glycerol may be the main carbon and energy source of M. bovis, and most of the biosynthesis pathways were incomplete. We report that 47 lipoproteins, 12 extracellular proteins and 18 transmembrane proteins are phase-variable and may help M. bovis escape the immune response. Besides lipoproteins and phase-variable proteins, genomic analysis found two possible pathogenicity islands, which consist of four genes and 11 genes each, and several other virulence factors including hemolysin, lipoate protein ligase, dihydrolipoamide dehydrogenase, extracellular cysteine protease and 5'-nucleotidase.	[Li, Yuan; Liu, Yang; Xin, Jiuqing; Chen, Wei; Song, Zhiqiang] Chinese Acad Agr Sci, Harbin Vet Res Inst, Div Bacterial Dis,State Key Lab Vet Biotechnol, Natl Contagious Bovine Pleuropneumonia Reference, Harbin, Peoples R China; [Zheng, Huajun; Jiang, Yanwei] Chinese Natl Human Genome Ctr Shanghai, Shanghai MOST Key Lab Hlth & Dis Genom, Shanghai, Peoples R China	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS	Li, Y (corresponding author), Chinese Acad Agr Sci, Harbin Vet Res Inst, Div Bacterial Dis,State Key Lab Vet Biotechnol, Natl Contagious Bovine Pleuropneumonia Reference, Harbin, Peoples R China.	xinjiuqing2001@126.com		Zheng, Huajun/0000-0002-9242-4040	National Natural Science Foundations of China; Harbin Science and Technology Program, China	National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); Harbin Science and Technology Program, China	Funding: National Natural Science Foundations of China and Harbin Science and Technology Program, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adegboye DS, 1996, J AM VET MED ASSOC, V209, P647; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BHUGRA B, 1993, MOL MICROBIOL, V7, P577, DOI 10.1111/j.1365-2958.1993.tb01148.x; Borukhov S, 2005, MOL MICROBIOL, V55, P1315, DOI 10.1111/j.1365-2958.2004.04481.x; Burns EH, 1996, INFECT IMMUN, V64, P4744, DOI 10.1128/IAI.64.11.4744-4750.1996; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Caswell Jeff L., 2007, Animal Health Research Reviews, V8, P161, DOI 10.1017/S1466252307001351; Chambaud I, 2001, NUCLEIC ACIDS RES, V29, P2145, DOI 10.1093/nar/29.10.2145; Chang LJ, 2008, BIOCHEM BIOPH RES CO, V367, P213, DOI 10.1016/j.bbrc.2007.12.124; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Dybvig K, 2008, INFECT IMMUN, V76, P4000, DOI 10.1128/IAI.00516-08; Foddai A, 2005, MOL CELL PROBE, V19, P207, DOI 10.1016/j.mcp.2004.11.007; Fujikawa N, 2003, NUCLEIC ACIDS RES, V31, P2077, DOI 10.1093/nar/gkg309; Gardy JL, 2005, BIOINFORMATICS, V21, P617, DOI 10.1093/bioinformatics/bti057; Gates AE, 2008, VACCINE, V26, P2010, DOI 10.1016/j.vaccine.2008.02.010; Ghai R, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-198; GOEBEL W, 1988, A VAN LEEUW J MICROB, V54, P453, DOI 10.1007/BF00461864; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guo FB, 2003, NUCLEIC ACIDS RES, V31, P1780, DOI 10.1093/nar/gkg254; Himmelreich R, 1996, NUCLEIC ACIDS RES, V24, P4420, DOI 10.1093/nar/24.22.4420; Hotzel H, 1996, J APPL BACTERIOL, V80, P505, DOI 10.1111/j.1365-2672.1996.tb03249.x; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; KIRILLICHEVA GB, 1987, ZH MIKROBIOL EPIDEMI, V5, P76; Langille MGI, 2009, BIOINFORMATICS, V25, P664, DOI 10.1093/bioinformatics/btp030; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lysnyansky I, 1999, J BACTERIOL, V181, P5734, DOI 10.1128/JB.181.18.5734-5741.1999; Lysnyansky I, 2008, FEMS MICROBIOL LETT, V279, P234, DOI 10.1111/j.1574-6968.2007.01040.x; Mackiewicz P, 2004, NUCLEIC ACIDS RES, V32, P3781, DOI 10.1093/nar/gkh699; Marchler-Bauer A, 2007, NUCLEIC ACIDS RES, V35, pD237, DOI 10.1093/nar/gkl951; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Maunsell FP, 2009, VET CLIN N AM-FOOD A, V25, P139, DOI 10.1016/j.cvfa.2008.10.011; Maunsell FP, 2009, VACCINE, V27, P2781, DOI 10.1016/j.vaccine.2009.02.100; MILES H, 1992, J DAIRY SCI, V75, P596, DOI 10.3168/jds.S0022-0302(92)77797-2; Nair S, 2000, INFECT IMMUN, V68, P7061, DOI 10.1128/IAI.68.12.7061-7068.2000; Neyrolles O, 1999, INFECT IMMUN, V67, P1569; O'Riordan M, 2003, SCIENCE, V302, P462, DOI 10.1126/science.1088170; Pfutzner H, 1996, REV SCI TECH OIE, V15, P1477, DOI 10.20506/rst.15.4.987; Picardeau M, 1999, MOL MICROBIOL, V32, P437, DOI 10.1046/j.1365-2958.1999.01368.x; Pilo P, 2005, J BACTERIOL, V187, P6824, DOI 10.1128/JB.187.19.6824-6831.2005; POUMARAT F, 1991, VET MICROBIOL, V29, P329, DOI 10.1016/0378-1135(91)90140-B; Robino P, 2005, VET MICROBIOL, V109, P201, DOI 10.1016/j.vetmic.2005.05.007; ROTTEM S, 1964, J GEN MICROBIOL, V37, P123, DOI 10.1099/00221287-37-1-123; Rouquette C, 1998, MOL MICROBIOL, V27, P1235, DOI 10.1046/j.1365-2958.1998.00775.x; SANDERS JD, 1994, INFECT IMMUN, V62, P4515, DOI 10.1128/IAI.62.10.4515-4525.1994; Schmidt H, 2004, CLIN MICROBIOL REV, V17, P14, DOI 10.1128/CMR.17.1.14-56.2004; Tettelin H, 1999, GENOMICS, V62, P500, DOI 10.1006/geno.1999.6048; Thomas A, 2004, VET MICROBIOL, V104, P213, DOI 10.1016/j.vetmic.2004.09.009; Thomas A, 2002, VET REC, V151, P472, DOI 10.1136/vr.151.16.472; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Uchiyama I, 2003, NUCLEIC ACIDS RES, V31, P58, DOI 10.1093/nar/gkg109; van der Merwe J, 2010, INFECT IMMUN, V78, P4570, DOI 10.1128/IAI.00707-10; Walz PH, 1997, J VET DIAGN INVEST, V9, P250, DOI 10.1177/104063879700900305; Westberg J, 2004, GENOME RES, V14, P221, DOI 10.1101/gr.1673304	55	80	92	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e20999	10.1371/journal.pone.0020999	http://dx.doi.org/10.1371/journal.pone.0020999			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731639	gold, Green Submitted, Green Published			2022-12-27	WOS:000292033700026
J	Linkner, J; Witte, G; Stradal, T; Curth, U; Faix, J				Linkner, Joern; Witte, Gregor; Stradal, Theresia; Curth, Ute; Faix, Jan			High-Resolution X-Ray Structure of the Trimeric Scar/WAVE-Complex Precursor Brk1	PLOS ONE			English	Article							ARP2/3 COMPLEX; WAVE-COMPLEX; CELLULAR CONTROL; REGULATES ACTIN; N-WASP; SCAR; PROTEIN; ULTRACENTRIFUGATION; BRICK1/HSPC300; ACTIVATION	The Scar/WAVE-complex links upstream Rho-GTPase signaling to the activation of the conserved Arp2/3-complex. Scar/WAVE-induced and Arp2/3-complex-mediated actin nucleation is crucial for actin assembly in protruding lamellipodia to drive cell migration. The heteropentameric Scar/WAVE-complex is composed of Scar/WAVE, Abi, Nap, Pir and a small polypeptide Brk1/HSPC300, and recent work suggested that free Brk1 serves as a homooligomeric precursor in the assembly of this complex. Here we characterized the Brk1 trimer from Dictyostelium by analytical ultracentrifugation and gelfiltration. We show for the first time its dissociation at concentrations in the nanomolar range as well as an exchange of subunits within different DdBrk1 containing complexes. Moreover, we determined the three-dimensional structure of DdBrk1 at 1.5 angstrom resolution by X-ray crystallography. Three chains of DdBrk1 are associated with each other forming a parallel triple coiled-coil bundle. Notably, this structure is highly similar to the heterotrimeric alpha-helical bundle of HSPC300/WAVE1/Abi2 within the human Scar/WAVE-complex. This finding, together with the fact that Brk1 is collectively sandwiched by the remaining subunits and also constitutes the main subunit connecting the triple-coil domain of the HSPC300/WAVE1/Abi2/heterotrimer to Sra1( Pir1), implies a critical function of this subunit in the assembly process of the entire Scar/WAVE-complex.	[Linkner, Joern; Curth, Ute; Faix, Jan] Hannover Med Sch, Inst Biophys Chem, D-3000 Hannover, Germany; [Witte, Gregor] Univ Munich, Gene Ctr, Munich, Germany; [Witte, Gregor] Univ Munich, Munich Ctr Adv Photon MAP, Dept Biochem, Munich, Germany; [Witte, Gregor] Univ Munich, Ctr Integrated Prot Sci Munich CIPSM, Munich, Germany; [Stradal, Theresia] Univ Munster, Inst Mol Cell Biol, Munster, Germany; [Stradal, Theresia] Helmholtz Ctr Infect Res HZI, Signaling & Motil Grp, Braunschweig, Germany	Hannover Medical School; University of Munich; University of Munich; University of Munich; University of Munster; Helmholtz Association; Helmholtz-Center for Infection Research	Linkner, J (corresponding author), Hannover Med Sch, Inst Biophys Chem, D-3000 Hannover, Germany.	witte@genzentrum.lmu.de; faix.jan@mh-hannover.de	Witte, Gregor/B-4635-2011	Witte, Gregor/0000-0003-0313-0962; Stradal, Theresia/0000-0002-0352-9474	Deutsche Forschungsgemeinschaft (DFG) [330/5-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by a grant to J.F. (330/5-1) from the Deutsche Forschungsgemeinschaft. The article processing charges are funded by the Deutsche Forschungsgemeinschaft (DFG) "Open Access Publizieren" The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Basu D, 2005, PLANT CELL, V17, P502, DOI 10.1105/tpc.104.027987; Bear JE, 1998, J CELL BIOL, V142, P1325, DOI 10.1083/jcb.142.5.1325; Blagg SL, 2004, BIOCHEM SOC T, V32, P1113, DOI 10.1042/BST0321113; Brown Patrick H, 2008, Curr Protoc Immunol, VChapter 18, DOI 10.1002/0471142735.im1815s81; Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Chen ZC, 2010, NATURE, V468, P533, DOI 10.1038/nature09623; DeLano WL., 2020, PYMOL MOL GRAPHICS S; Derivery E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002462; Derivery E, 2010, BIOESSAYS, V32, P119, DOI 10.1002/bies.200900123; Derivery E, 2009, CELL MOTIL CYTOSKEL, V66, P777, DOI 10.1002/cm.20342; Djakovic S, 2006, DEVELOPMENT, V133, P1091, DOI 10.1242/dev.02280; Eden S, 2002, NATURE, V418, P790, DOI 10.1038/nature00859; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gautreau A, 2004, P NATL ACAD SCI USA, V101, P4379, DOI 10.1073/pnas.0400628101; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Ibarra N, 2006, CURR BIOL, V16, P717, DOI 10.1016/j.cub.2006.02.068; Innocenti M, 2005, NAT CELL BIOL, V7, P969, DOI 10.1038/ncb1304; Innocenti M, 2004, NAT CELL BIOL, V6, P319, DOI 10.1038/ncb1105; Insall RH, 2009, DEV CELL, V17, P310, DOI 10.1016/j.devcel.2009.08.012; Ismail AM, 2009, NAT STRUCT MOL BIOL, V16, P561, DOI 10.1038/nsmb.1587; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kammerer RA, 2005, P NATL ACAD SCI USA, V102, P13891, DOI 10.1073/pnas.0502390102; Kim Y, 2006, NATURE, V442, P814, DOI 10.1038/nature04976; Koestler SA, 2008, NAT CELL BIOL, V10, P306, DOI 10.1038/ncb1692; Lai FP, 2008, EMBO J, V27, P982, DOI 10.1038/emboj.2008.34; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Le J, 2006, CURR BIOL, V16, P895, DOI 10.1016/j.cub.2006.03.061; Lebensohn AM, 2009, MOL CELL, V36, P512, DOI 10.1016/j.molcel.2009.10.024; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Mullins RD, 1999, CURR OPIN STRUC BIOL, V9, P244; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Parida, 1998, Genome Inform Ser Workshop Genome Inform, V9, P112; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Pollitt AY, 2008, CURR BIOL, V18, P203, DOI 10.1016/j.cub.2008.01.026; Pollitt AY, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-13; Qurashi A, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-18; Rhodes DG, 2009, METHOD ENZYMOL, V463, P691, DOI 10.1016/S0076-6879(09)63039-1; Rottner K, 2010, TRENDS CELL BIOL, V20, P650, DOI 10.1016/j.tcb.2010.08.014; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Steffen A, 2004, EMBO J, V23, P749, DOI 10.1038/sj.emboj.7600084; Steffen A, 2006, MOL BIOL CELL, V17, P2581, DOI 10.1091/mbc.E05-11-1088; Stradal TEB, 2006, CURR OPIN CELL BIOL, V18, P4, DOI 10.1016/j.ceb.2005.12.003; Veltman DM, 2010, MOL BIOL CELL, V21, P2880, DOI 10.1091/mbc.E10-04-0372; Walshaw J, 2003, J STRUCT BIOL, V144, P349, DOI 10.1016/j.jsb.2003.10.014; Welch MD, 2002, ANNU REV CELL DEV BI, V18, P247, DOI 10.1146/annurev.cellbio.18.040202.112133; Westphal M, 1997, CURR BIOL, V7, P176, DOI 10.1016/S0960-9822(97)70088-5; Winkler I, 2011, J BIOL CHEM, V286, P17326, DOI 10.1074/jbc.M110.187641; Witte G, 2005, NUCLEIC ACIDS RES, V33, P1662, DOI 10.1093/nar/gki310; Yamazaki D, 2003, NATURE, V424, P452, DOI 10.1038/nature01770; Yan C, 2003, EMBO J, V22, P3602, DOI 10.1093/emboj/cdg350; Zhang XG, 2005, PLANT CELL, V17, P2314, DOI 10.1105/tpc.104.028670	57	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e21327	10.1371/journal.pone.0021327	http://dx.doi.org/10.1371/journal.pone.0021327			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	21701600	Green Published, gold, Green Submitted			2022-12-27	WOS:000291983800042
J	Baine, M; Sahak, F; Lin, C; Chakraborty, S; Lyden, E; Batra, SK				Baine, Michael; Sahak, Freshta; Lin, Chi; Chakraborty, Subhankar; Lyden, Elizabeth; Batra, Surinder K.			Marital Status and Survival in Pancreatic Cancer Patients: A SEER Based Analysis	PLOS ONE			English	Article							BREAST-CANCER; MORTALITY; DIAGNOSIS; DISEASE; HEALTH; IMPACT; WOMEN	Background: Recent findings suggest that marital status affects survival in patients with different types of cancer. However, its role in the survival of patients with pancreatic ductal adenocarcinoma is unknown. In this study, we investigated whether there was an association between marital status and overall survival (OS) in patients with pancreatic ductal adenocarcinoma (PDAC). Methods: Adult patients diagnosed with PDAC between 1998 and 2003 with known marital statuses were identified from the Surveillance, Epidemiology, and End Results registry of the National Cancer Institute. OS for these patients was plotted using the Kaplan-Meier method. Comparative risks of mortality were evaluated by using univariate and multivariate-adjusted Cox regression models. Results: Using Kaplan-Meier analysis, we found that the median overall survival of patients was 4 months and 3 months (p<0.001) for married and unmarried patients, respectively. Subgroup analysis on patients with cancer-directed surgery showed that the median survival was 16 months and 13 months (P<0.0005) for married and unmarried groups, respectively. Multivariate analysis adjusting for age, race, sex, stage, year of diagnosis, radiation therapy and cancer-directed surgery showed that patients who were married at the time of diagnosis had a significantly decreased risk of death at both 2 months (15% risk reduction) and 3 years (13% risk reduction) post diagnosis. Conclusions: Marital status is an independent prognostic factor of both perioperative and long-term survival in patients with PDAC. This observation may suggest a suboptimally met psychosocial need among PDAC patients that is partially fulfilled by the support system provided by marriage.	[Baine, Michael; Batra, Surinder K.] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Sahak, Freshta; Chakraborty, Subhankar; Batra, Surinder K.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE USA; [Lin, Chi] Univ Nebraska Med Ctr, Dept Radiat Oncol, Omaha, NE USA; [Lyden, Elizabeth] Univ Nebraska Med Ctr, Coll Publ Hlth, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Baine, M (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA.	sbatra@unmc.edu	Lin, Chi/AAE-2495-2019		Department of Defense [BC074639, BC083295, BC09742]; National Institutes of Health [RO1 CA78590, EDRNUO1 CA111294, RO1 CA133774, RO1 CA131944, SPORE50 CA127297]; NATIONAL CANCER INSTITUTE [R01CA133774, U01CA111294, P50CA127297, R01CA078590, R01CA131944] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors on this work are supported, in part, by grants from the Department of Defense (BC074639, BC083295, and BC09742) and the National Institutes of Health (RO1 CA78590, EDRNUO1 CA111294, RO1 CA133774, RO1 CA131944, and SPORE50 CA127297). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, CANC FACTS FIG 2009; Antoni MH, 2007, CURR DIR PSYCHOL SCI, V16, P42, DOI 10.1111/j.1467-8721.2007.00472.x; Cohen S, 2004, AM PSYCHOL, V59, P676, DOI 10.1037/0003-066X.59.8.676; Institute of Medicine (IOM, 2008, CANC CAR WHOL PAT M; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KAPLAN GA, 1988, AM J EPIDEMIOL, V128, P370, DOI 10.1093/oxfordjournals.aje.a114977; Kiecolt-Glaser JK, 2002, ANNU REV PSYCHOL, V53, P83, DOI 10.1146/annurev.psych.53.100901.135217; Kravdal O, 2001, SOC SCI MED, V52, P357, DOI 10.1016/S0277-9536(00)00139-8; Kroenke CH, 2006, J CLIN ONCOL, V24, P1105, DOI 10.1200/JCO.2005.04.2846; National Cancer Institute, SURV EP END RES CANC; Osborne C, 2005, BREAST CANCER RES TR, V93, P41, DOI 10.1007/s10549-005-3702-4; Patel MK, 2010, J LOW GENIT TRACT DI, V14, P329, DOI 10.1097/LGT.0b013e3181ddfa68; RYAN DP, 2010, CHEMOTHERAPY ADV PAN; Stack S, 1998, J MARRIAGE FAM, V60, P527, DOI 10.2307/353867; Wills TA, 2001, HANDBOOK OF HEALTH PSYCHOLOGY, P209; Yarcheski A, 2004, J NURS SCHOLARSHIP, V36, P102, DOI 10.1111/j.1547-5069.2004.04021.x	16	76	76	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e21052	10.1371/journal.pone.0021052	http://dx.doi.org/10.1371/journal.pone.0021052			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	778TS	21698253	Green Submitted, Green Published, gold			2022-12-27	WOS:000291730000045
J	Kistler, AD; Siwy, J; Breunig, F; Jeevaratnam, P; Scherl, A; Mullen, W; Warnock, DG; Wanner, C; Hughes, DA; Mischak, H; Wuthrich, RP; Serra, AL				Kistler, Andreas D.; Siwy, Justyna; Breunig, Frank; Jeevaratnam, Praveen; Scherl, Alexander; Mullen, William; Warnock, David G.; Wanner, Christoph; Hughes, Derralynn A.; Mischak, Harald; Wuethrich, Rudolf P.; Serra, Andreas L.			A Distinct Urinary Biomarker Pattern Characteristic of Female Fabry Patients That Mirrors Response to Enzyme Replacement Therapy	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; ONSET HYPERTROPHIC CARDIOMYOPATHY; MASS-SPECTROMETRY; ALPHA-GALACTOSIDASE; HEMODIALYSIS-PATIENTS; CLINICAL PROTEOMICS; YOUNG-PATIENTS; DISCOVERY; GLOBOTRIAOSYLCERAMIDE; PREVALENCE	Female patients affected by Fabry disease, an X-linked lysosomal storage disorder, exhibit a wide spectrum of symptoms, which renders diagnosis, and treatment decisions challenging. No diagnostic test, other than sequencing of the alpha-galactosidase A gene, is available and no biomarker has been proven useful to screen for the disease, predict disease course and monitor response to enzyme replacement therapy. Here, we used urine proteomic analysis based on capillary electrophoresis coupled to mass spectrometry and identified a biomarker profile in adult female Fabry patients. Urine samples were taken from 35 treatment-naive female Fabry patients and were compared to 89 age-matched healthy controls. We found a diagnostic biomarker pattern that exhibited 88.2% sensitivity and 97.8% specificity when tested in an independent validation cohort consisting of 17 treatment-naive Fabry patients and 45 controls. The model remained highly specific when applied to additional control patients with a variety of other renal, metabolic and cardiovascular diseases. Several of the 64 identified diagnostic biomarkers showed correlations with measures of disease severity. Notably, most biomarkers responded to enzyme replacement therapy, and 8 of 11 treated patients scored negative for Fabry disease in the diagnostic model. In conclusion, we defined a urinary biomarker model that seems to be of diagnostic use for Fabry disease in female patients and may be used to monitor response to enzyme replacement therapy.	[Kistler, Andreas D.; Wuethrich, Rudolf P.; Serra, Andreas L.] Univ Zurich Hosp, Div Nephrol, CH-8091 Zurich, Switzerland; [Kistler, Andreas D.] Univ Miami, Miller Sch Med, Div Nephrol & Hypertens, Miami, FL 33136 USA; [Siwy, Justyna; Mischak, Harald] Mosaiques Diagnost & Therapeut AG, Hannover, Germany; [Breunig, Frank; Wanner, Christoph] Univ Hosp, Div Nephrol, Wurzburg, Germany; [Jeevaratnam, Praveen; Hughes, Derralynn A.] UCL, Sch Med, Dept Haematol, London W1N 8AA, England; [Scherl, Alexander] Univ Geneva, Fac Med, Prote Core Facil, Geneva, Switzerland; [Mullen, William] Univ Glasgow, Sch Life Sci, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Warnock, David G.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Mischak, Harald] Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland	University of Zurich; University Zurich Hospital; University of Miami; University of Wurzburg; University of London; University College London; UCL Medical School; University of Geneva; University of Glasgow; University of Alabama System; University of Alabama Birmingham; University of Glasgow	Kistler, AD (corresponding author), Univ Zurich Hosp, Div Nephrol, CH-8091 Zurich, Switzerland.	akistler@med.miami.edu	Mullen, William/GWC-8078-2022; Scherl, Alexander/B-8910-2012; Mischak, Harald/E-8685-2011; Hughes, Derralynn/J-8012-2013	Hughes, Derralynn/0000-0003-4531-9173; Kistler, Andreas/0000-0002-4114-9560; Mullen, William/0000-0002-5685-1563; Siwy, Justyna/0000-0003-1407-2534; Mischak, Harald/0000-0003-0323-0306	Genzyme; Shire; Amgen; European Community [HEALTH-F2-2009-241544]; Genzyme Inc.; Shire HGT; Amicus therapeutics; Genzyme Corporation	Genzyme(Sanofi-AventisGenzyme Corporation); Shire; Amgen(Amgen); European Community(European Commission); Genzyme Inc.(Sanofi-AventisGenzyme Corporation); Shire HGT; Amicus therapeutics; Genzyme Corporation(Sanofi-AventisGenzyme Corporation)	Funding for this study was supported by unrestricted research grants provided by Genzyme (to ADK, RPW and ALS), Shire (to ADK, RPW and ALS) and Amgen (to RPW) and a European Community's 7th Framework Programme grant (to HM; grant agreement HEALTH-F2-2009-241544 (SysKID)). The funders had no role in study design, data collection and analysis, or preparation of the manuscript.; ADK has received travel grants from Shire HGT and honoraria from Genzyme Inc. HM is the founder and co-owner of Mosaiques Diagnostics, who developed the CE-MS technology. JS is an employee of Mosaiques Diagnostics. DAH has received research support, travel grants and honoraria for meetings and advisory boards from Genzyme Inc, Shire HGT and Amicus therapeutics. DGW is a consultant for Genzyme Corporation on Fabry disease, and has received research support from Genzyme Corporation and Amicus therapeutics. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Andrade J, 2008, CLIN J AM SOC NEPHRO, V3, P139, DOI 10.2215/CJN.02490607; Auray-Blais C, 2010, CLIN CHIM ACTA, V411, P1906, DOI 10.1016/j.cca.2010.07.038; Baptista MV, 2010, STROKE, V41, P431, DOI 10.1161/STROKEAHA.109.570499; Brouns R, 2010, STROKE, V41, P863, DOI 10.1161/STROKEAHA.110.579409; Chimenti C, 2004, CIRCULATION, V110, P1047, DOI 10.1161/01.CIR.0000139847.74101.03; Coon JJ, 2008, PROTEOM CLIN APPL, V2, P964, DOI 10.1002/prca.200800024; Decramer S, 2006, NAT MED, V12, P398, DOI 10.1038/nm1384; DeLeo J. M., 1993, RECEIVER OPERATING C, P318; Delles C, 2010, J HYPERTENS, V28, P2316, DOI 10.1097/HJH.0b013e32833d81b7; Desnick RJ, 2003, ANN INTERN MED, V138, P338, DOI 10.7326/0003-4819-138-4-200302180-00014; Dobyns WB, 2004, AM J MED GENET A, V129A, P136, DOI 10.1002/ajmg.20004.a.30123; El Dib R.P., 2010, COCHRANE DB SYST REV, V5; Eng CM, 2001, NEW ENGL J MED, V345, P9, DOI 10.1056/NEJM200107053450102; Gaspar P, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-19; Good DM, 2010, MOL CELL PROTEOMICS, V9, P2424, DOI 10.1074/mcp.M110.001917; Guffon N, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.4.e38; Haubitz M, 2009, MOL CELL PROTEOMICS, V8, P2296, DOI 10.1074/mcp.M800529-MCP200; Jantos-Siwy J, 2009, J PROTEOME RES, V8, P268, DOI 10.1021/pr800401m; Kistler AD, 2009, KIDNEY INT, V76, P89, DOI 10.1038/ki.2009.93; Kitagawa T, 2005, MOL GENET METAB, V85, P196, DOI 10.1016/j.ymgme.2005.01.007; Kotanko P, 2004, J AM SOC NEPHROL, V15, P1323, DOI 10.1097/01.ASN.0000124671.61963.1E; Linthorst GE, 2005, CLIN CHIM ACTA, V353, P201, DOI 10.1016/j.cccn.2004.10.019; Mehta A, 2004, EUR J CLIN INVEST, V34, P236, DOI 10.1111/j.1365-2362.2004.01309.x; Merta M, 2007, NEPHROL DIAL TRANSPL, V22, P179, DOI 10.1093/ndt/gfl528; Metzger J, 2009, CRIT REV CL LAB SCI, V46, P129, DOI 10.1080/10408360902805261; Mischak H, 2007, PROTEOM CLIN APPL, V1, P148, DOI 10.1002/prca.200600771; Mischak H, 2009, MASS SPECTROM REV, V28, P703, DOI 10.1002/mas.20205; Moore DF, 2007, P NATL ACAD SCI USA, V104, P2873, DOI 10.1073/pnas.0611315104; NAKAO S, 1995, NEW ENGL J MED, V333, P288, DOI 10.1056/NEJM199508033330504; Neuhoff NV, 2004, RAPID COMMUN MASS SP, V18, P149, DOI 10.1002/rcm.1294; PASCHKE E, 2010, AM J KIDNEY DIS; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Rolfs A, 2005, LANCET, V366, P1794, DOI 10.1016/S0140-6736(05)67635-0; Rossing K, 2008, J AM SOC NEPHROL, V19, P1283, DOI 10.1681/ASN.2007091025; Rozenfeld PA, 2009, CLIN CHIM ACTA, V403, P194, DOI 10.1016/j.cca.2009.02.016; Sachdev B, 2002, CIRCULATION, V105, P1407, DOI 10.1161/01.CIR.0000012626.81324.38; Schiffer E, 2009, CLIN CANCER RES, V15, P4935, DOI 10.1158/1078-0432.CCR-09-0226; Schiffmann R, 2001, JAMA-J AM MED ASSOC, V285, P2743, DOI 10.1001/jama.285.21.2743; Tanaka M, 2005, CLIN NEPHROL, V64, P281; Theodorescu D, 2006, LANCET ONCOL, V7, P230, DOI 10.1016/S1470-2045(06)70584-8; Theodorescu D, 2005, ELECTROPHORESIS, V26, P2797, DOI 10.1002/elps.200400208; Thongboonkerd V, 2007, J PROTEOME RES, V6, P3881, DOI 10.1021/pr070328s; Vojtova L, 2010, RENAL FAILURE, V32, P1202, DOI 10.3109/0886022X.2010.516859; Vylet'al P, 2008, J INHERIT METAB DIS, V31, P508, DOI 10.1007/s10545-008-0900-3; Whitfield PD, 2005, J INHERIT METAB DIS, V28, P21, DOI 10.1007/s10545-005-4415-x; Whybra C, 2004, CLIN GENET, V65, P299, DOI 10.1111/j.1399-0004.2004.00219.x; Wilcox WR, 2008, MOL GENET METAB, V93, P112, DOI 10.1016/j.ymgme.2007.09.013; Wittke S, 2005, ELECTROPHORESIS, V26, P1476, DOI 10.1002/elps.200410140; Young E, 2005, ACTA PAEDIATR, V94, P51, DOI 10.1080/08035320510028111; Zurbig P, 2006, ELECTROPHORESIS, V27, P2111, DOI 10.1002/elps.200500827	50	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e20534	10.1371/journal.pone.0020534	http://dx.doi.org/10.1371/journal.pone.0020534			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698285	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000291730000013
J	Pinc, L; Bartos, L; Reslova, A; Kotrba, R				Pinc, Ludvik; Bartos, Ludek; Reslova, Alice; Kotrba, Radim			Dogs Discriminate Identical Twins	PLOS ONE			English	Article							ODOR	Earlier studies have shown variation among experimental attempts to establish whether human monozygotic twins that are genetically identical also have identical individual scents. In none of the cases were the dogs able to distinguish all the individual scents of monozygotic twins living in the same environment if the scents were presented to them separately. Ten specially trained police German Shepherd dogs of three Czech Republic Police Regional Headquarters were used for scent identification in our study. The dogs were supposed to match scents of two monozygotic pairs (5 and 7 years old) and two dizygotic twin pairs (8 and 13 years old). Scents were collected on cotton squares stored in glass jars. Dog handlers were blind to the experiment details. In each trial (line-up), one scent was used as a starting scent and the dog was then sent to determine if any of the 7 presented glass jars contained a matching scent. Scents of children of similar ages were used as distractors. In the matching procedure, the dogs matched correctly the scent of one twin with the other, as well as two scents collected from every single identical and non-identical twin to prove their efficacy and likewise, the presence of the matching twin scent in any given glass jar. All dogs in all trials distinguished correctly the scents of identical as well as non-identical twins. All dogs similarly matched positively two scents collected from the same individuals. Our findings indicated that specially trained German Shepherd dogs are able to distinguish individual scents of identical twins despite the fact that they live in the same environment, eat the same food and even if the scents are not presented to them simultaneously.	[Pinc, Ludvik; Bartos, Ludek] Czech Univ Life Sci, Canine Behav Res Ctr, Dept Anim Sci & Ethol, Prague, Czech Republic; [Bartos, Ludek; Kotrba, Radim] Inst Anim Sci, Dept Ethol, Prague, Czech Republic; [Reslova, Alice] Inst Criminalist, Prague, Czech Republic; [Kotrba, Radim] Czech Univ Life Sci, Inst Trop & Subtrop, Dept Anim Sci & Food Proc, Prague, Czech Republic	Czech University of Life Sciences Prague; Czech Research Institute of Animal Science; Institute of Criminalistics Prague - Police of the Czech Republic; Czech University of Life Sciences Prague	Pinc, L (corresponding author), Czech Univ Life Sci, Canine Behav Res Ctr, Dept Anim Sci & Ethol, Prague, Czech Republic.	bartos@vuzv.cz	, Ludvik/AAX-9114-2021	Kotrba, Radim/0000-0001-5009-8454	Ministry of Agriculture [MZe 0002701404]; Ministry of Interior [MV c. VF20102015011]; Ministry of Education, Youth and Sports of the Czech Republic [MSMT 1321/213206]	Ministry of Agriculture(Gida Tarim Ve Hayvancilik Bakanligi); Ministry of Interior; Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	The Ministry of Agriculture (MZe 0002701404), the Ministry of Interior (MV c. VF20102015011), and the Ministry of Education, Youth and Sports (MSMT 1321/213206) of the Czech Republic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Curran AM, 2005, FORENSIC SCI COMMUN, V7, P1; Eggert F, 1998, GENETICA, V104, P191, DOI 10.1023/A:1026402531196; Ferstl R, 1998, NEPHROL DIAL TRANSPL, V13, P1117, DOI 10.1093/ndt/13.5.1117; Harvey LM, 2006, J FORENSIC SCI, V51, P1109, DOI 10.1111/j.1556-4029.2006.00231.x; HEPPER PG, 1988, PERCEPTION, V17, P549, DOI 10.1068/p170549; Kaldenbach J., 1998, K9 SCENT DETECTION M; KALMUS H., 1955, BRIT JOUR ANIMAL BEHAVIOUR, V3, P25, DOI 10.1016/S0950-5601(55)80072-X; KLOUBEK M, 2008, AKTUALNI STAV UNPUB; KLOUBEK M, 2003, KRIMINALISTICKY SBOR, V10; Santos PSC, 2005, HORM BEHAV, V47, P384, DOI 10.1016/j.yhbeh.2004.11.005; Schoon A., 2002, K9 SUSPECT DISCRIMIN; SETTLE RH, 1994, ANIM BEHAV, V48, P1443, DOI 10.1006/anbe.1994.1380; SOMMERVILLE BA, 1990, CHEM SIGNAL, V5, P634; STOCKHAM RA, 2004, FOREN SCI COMM, V6; STRAUS J, KRIMINALISTICKA ODOR, P192; Teryngel J., 2002, TRESTNI PRAVO, V11, P9; Thom MD, 2005, CHEM SIGNAL, V10, P173, DOI 10.1007/0-387-25160-X_22; Thornhill R, 2003, BEHAV ECOL, V14, P668, DOI 10.1093/beheco/arg043; Tomaszewski T, 2006, FORENSIC SCI INT, V162, P191, DOI 10.1016/j.forsciint.2006.06.017	19	29	29	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e20704	10.1371/journal.pone.0020704	http://dx.doi.org/10.1371/journal.pone.0020704			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698282	gold, Green Published, Green Submitted			2022-12-27	WOS:000291730000020
J	Hodge, JM; Collier, FM; Pavlos, NJ; Kirkland, MA; Nicholson, GC				Hodge, Jason M.; Collier, Fiona M.; Pavlos, Nathan J.; Kirkland, Mark A.; Nicholson, Geoffrey C.			M-CSF Potently Augments RANKL-Induced Resorption Activation in Mature Human Osteoclasts	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; BLOOD MONONUCLEAR-CELLS; FACTOR-KAPPA-B; BONE-RESORPTION; RECEPTOR ACTIVATOR; C-SRC; DIFFERENTIATION; OSTEOPETROSIS; FACTOR-1; EXPRESSION	Macrophage-CSF (M-CSF) is critical for osteoclast (OC) differentiation and is reported to enhance mature OC survival and motility. However, its role in the regulation of bone resorption, the main function of OCs, has not been well characterised. To address this we analysed short-term cultures of fully differentiated OCs derived from human colony forming unit-granulocyte macrophages (CFU-GM). When cultured on dentine, OC survival was enhanced by M-CSF but more effectively by receptor activator of NFkB ligand (RANKL). Resorption was entirely dependent on the presence of RANKL. Co-treatment with M-CSF augmented RANKL-induced resorption in a concentration-dependent manner with a (200-300%) stimulation at 25 ng/mL, an effect observed within 4-6 h. M-CSF co-treatment also increased number of resorption pits and F-actin sealing zones, but not the number of OCs or pit size, indicating stimulation of the proportion of OCs activated. M-CSF facilitated RANKL-induced activation of c-fos and extracellular signal-regulated kinase (ERK) 1/2 phosphorylation, but not NFkB nor nuclear factor of activated T-cells, cytoplasmic-1 (NFATc1). The mitogen-activated protein kinase kinase (MEK) 1 inhibitor PD98059 partially blocked augmentation of resorption by M-CSF. Our results reveal a previously unidentified role of M-CSF as a potent stimulator of mature OC resorbing activity, possibly mediated via ERK upstream of c-fos.	[Hodge, Jason M.; Kirkland, Mark A.] Univ Melbourne, Dept Clin & Biomed Sci, Geelong, Vic, Australia; [Hodge, Jason M.; Collier, Fiona M.; Kirkland, Mark A.] Barwon Hlth, Barwon Biomed Res, Geelong, Vic, Australia; [Pavlos, Nathan J.] Univ Western Australia, Sch Surg, Ctr Orthopaed Res, Nedlands, WA 6009, Australia; [Nicholson, Geoffrey C.] Univ Queensland, Sch Med, Rural Clin Sch, Toowoomba, Qld, Australia	University of Melbourne; University of Western Australia; University of Queensland	Hodge, JM (corresponding author), Univ Melbourne, Dept Clin & Biomed Sci, Geelong, Vic, Australia.	jhodge@unimelb.edu.au	Nicholson, Geoffrey C/F-1901-2010	Nicholson, Geoffrey C/0000-0002-0152-1153; Pavlos, Nathan/0000-0001-7003-188X				Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Bradley EW, 2008, J CELL BIOCHEM, V104, P1439, DOI 10.1002/jcb.21719; Bradley Elizabeth W., 2008, V455, P19, DOI 10.1007/978-1-59745-104-8_2; Bruzzaniti A, 2006, REV ENDOCR METAB DIS, V7, P123, DOI 10.1007/s11154-006-9009-x; CANO E, 1995, TRENDS BIOCHEM SCI, V20, P117, DOI 10.1016/S0968-0004(00)88978-1; Dai XM, 2004, BLOOD, V103, P1114, DOI 10.1182/blood-2003-08-2739; Desai MP, 2007, J CLIN LAB ANAL, V21, P55, DOI 10.1002/jcla.20166; Dey A, 2000, MOL BIOL CELL, V11, P3835, DOI 10.1091/mbc.11.11.3835; Edwards M, 1998, BONE, V22, P325, DOI 10.1016/S8756-3282(97)00284-6; Fuller K, 2006, ENDOCRINOLOGY, V147, P1979, DOI 10.1210/en.2005-1340; FULLER K, 1993, J EXP MED, V178, P1733, DOI 10.1084/jem.178.5.1733; Fuller K, 1998, J EXP MED, V188, P997, DOI 10.1084/jem.188.5.997; Grey A, 2000, ENDOCRINOLOGY, V141, P2129, DOI 10.1210/en.141.6.2129; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; HATTERSLEY G, 1991, BIOCHEM BIOPH RES CO, V177, P526, DOI 10.1016/0006-291X(91)92015-C; Hodge JM, 2007, J CELL BIOCHEM, V102, P759, DOI 10.1002/jcb.21331; Hodge JM, 2004, J BONE MINER RES, V19, P190, DOI 10.1359/JBMR.0301232; Holmes SG, 2004, BONE, V35, P471, DOI 10.1016/j.bone.2004.02.028; Karsdal MA, 2007, J BONE MINER RES, V22, P487, DOI 10.1359/JBMR.070109; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; LAKKAKORPI PT, 1991, J BONE MINER RES, V6, P817; Lee SK, 2006, BONE, V38, P678, DOI 10.1016/j.bone.2005.10.011; Lee SK, 2006, CURR OPIN RHEUMATOL, V18, P411, DOI 10.1097/01.bor.0000231911.42666.78; Lee ZH, 2003, BIOCHEM BIOPH RES CO, V305, P211, DOI 10.1016/S0006-291X(03)00695-8; LORENZO JA, 1987, ENDOCRINOLOGY, V121, P1164, DOI 10.1210/endo-121-3-1164; MARKS SC, 1976, J HERED, V67, P11, DOI 10.1093/oxfordjournals.jhered.a108657; Miyazaki T, 2000, J CELL BIOL, V148, P333, DOI 10.1083/jcb.148.2.333; Miyazaki T, 2004, J BIOL CHEM, V279, P17660, DOI 10.1074/jbc.M311032200; Myers DE, 1999, FEBS LETT, V463, P295, DOI 10.1016/S0014-5793(99)01650-6; Nicholson GC, 2000, CLIN SCI, V99, P133, DOI 10.1042/CS19990355; Owens JM, 1999, J CELL PHYSIOL, V179, P170, DOI 10.1002/(SICI)1097-4652(199905)179:2<170::AID-JCP7>3.0.CO;2-K; Pavlos NJ, 2005, MOL CELL BIOL, V25, P5253, DOI 10.1128/MCB.25.12.5253-5269.2005; Pederson L, 2008, P NATL ACAD SCI USA, V105, P20764, DOI 10.1073/pnas.0805133106; Ryan GR, 2001, BLOOD, V98, P74, DOI 10.1182/blood.V98.1.74; Sarma U, 1996, BLOOD, V88, P2531, DOI 10.1182/blood.V88.7.2531.bloodjournal8872531; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; Suehiro A, 1999, ARCH GERONTOL GERIAT, V29, P13, DOI 10.1016/S0167-4943(99)00015-1; TANAKA S, 1993, J CLIN INVEST, V91, P257, DOI 10.1172/JCI116179; Wei S, 2005, IMMUNOBIOLOGY, V210, P109, DOI 10.1016/j.imbio.2005.05.005; WIKTORJEDRZEJCZAK W, 1990, P NATL ACAD SCI USA, V87, P4828, DOI 10.1073/pnas.87.12.4828; Yao GQ, 2005, CALCIFIED TISSUE INT, V76, P371, DOI 10.1007/s00223-004-0099-8; YOSHIDA H, 1990, NATURE, V345, P442, DOI 10.1038/345442a0	42	54	62	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21462	10.1371/journal.pone.0021462	http://dx.doi.org/10.1371/journal.pone.0021462			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21738673	Green Published, Green Submitted, gold			2022-12-27	WOS:000292290100026
J	Lu, LY; Zhang, YC; Yeung, CH; Zhou, T				Lue, Linyuan; Zhang, Yi-Cheng; Yeung, Chi Ho; Zhou, Tao			Leaders in Social Networks, the Delicious Case	PLOS ONE			English	Article							COMPLEX NETWORKS; DYNAMICS	Finding pertinent information is not limited to search engines. Online communities can amplify the influence of a small number of power users for the benefit of all other users. Users' information foraging in depth and breadth can be greatly enhanced by choosing suitable leaders. For instance in delicious. com, users subscribe to leaders' collection which lead to a deeper and wider reach not achievable with search engines. To consolidate such collective search, it is essential to utilize the leadership topology and identify influential users. Google's PageRank, as a successful search algorithm in the World Wide Web, turns out to be less effective in networks of people. We thus devise an adaptive and parameter-free algorithm, the LeaderRank, to quantify user influence. We show that LeaderRank outperforms PageRank in terms of ranking effectiveness, as well as robustness against manipulations and noisy data. These results suggest that leaders who are aware of their clout may reinforce the development of social networks, and thus the power of collective search.	[Lue, Linyuan; Zhang, Yi-Cheng; Yeung, Chi Ho; Zhou, Tao] Univ Shanghai Sci & Technol, Res Ctr Complex Syst Sci, Shanghai, Peoples R China; [Lue, Linyuan; Zhang, Yi-Cheng; Yeung, Chi Ho; Zhou, Tao] Univ Elect Sci & Technol China, Web Sci Ctr, Chengdu 610054, Peoples R China; [Lue, Linyuan; Zhang, Yi-Cheng; Yeung, Chi Ho; Zhou, Tao] Univ Fribourg, Dept Phys, CH-1700 Fribourg, Switzerland	University of Shanghai for Science & Technology; University of Electronic Science & Technology of China; University of Fribourg	Lu, LY (corresponding author), Univ Shanghai Sci & Technol, Res Ctr Complex Syst Sci, Shanghai, Peoples R China.	yi-cheng.zhang@unifr.ch	Zhou, Tao/D-5849-2012; zhou, tao/GQA-3572-2022; Yeung, Chi Ho/H-9673-2013	Yeung, Chi Ho/0000-0001-6207-7597; Zhou, Tao/0000-0003-0561-2316	Shanghai Leading Academic Discipline Project [S30501]; EU [213360, 231200]; National Natural Science Foundation of China [10635040, 90924011]; Swiss National Science Foundation [200020-132253]	Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); EU(European Commission); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work is supported by the Shanghai Leading Academic Discipline Project (under grant S30501), QLectives projects (EU FET-Open Grants 213360 and 231200), National Natural Science Foundation of China under Grant Nos. 10635040 and 90924011 and the Swiss National Science Foundation (200020-132253). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allesina S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000494; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Chen J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-73; Chen P, 2007, J INFORMETR, V1, P8, DOI 10.1016/j.joi.2006.06.001; Douceur JR, 2002, LECT NOTES COMPUT SC, V2429, P251, DOI 10.1007/3-540-45748-8_24; Easley D, 2010, NETWORKS CROWDS MARK; Galam S, 2002, EUR PHYS J B, V25, P403, DOI 10.1140/epjb/e20020045; GAYOAVELLO D, 2010, ARXIVORG10040816; Guimera R, 2009, P NATL ACAD SCI USA, V106, P22073, DOI 10.1073/pnas.0908366106; Kleinberg JM, 1999, J ACM, V46, P604, DOI 10.1145/324133.324140; Lampe C., 2006, P 2006 20 ANN C COMP, P167, DOI [DOI 10.1145/1180875.1180901, 10.1145/1180875.1180901]; Legrain P, 2001, TRENDS GENET, V17, P346, DOI 10.1016/S0168-9525(01)02323-X; Levine Brian Neil, 2006, 2006052 U MASS AMH; Lu LY, 2011, PHYSICA A, V390, P1150, DOI 10.1016/j.physa.2010.11.027; MARSDEN PV, 1990, ANNU REV SOCIOL, V16, P435, DOI 10.1146/annurev.so.16.080190.002251; Masum H, 2004, 1 MONDAY, V9, P7; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Page L., 1999, 199966 STANF INFOLAB; Park J, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/10/P10014; Pastor-Satorras R, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.036104; Radicchi F, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056103; VIEIRA MV, 2007, P 16 ACM C INF KNOWL, P563; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Yang R, 2007, PHYS LETT A, V364, P189, DOI 10.1016/j.physleta.2006.12.021	25	463	512	11	165	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21202	10.1371/journal.pone.0021202	http://dx.doi.org/10.1371/journal.pone.0021202			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738620	Green Published, Green Submitted, gold			2022-12-27	WOS:000292092600018
J	Fleishman, SJ; Leaver-Fay, A; Corn, JE; Strauch, EM; Khare, SD; Koga, N; Ashworth, J; Murphy, P; Richter, F; Lemmon, G; Meiler, J; Baker, D				Fleishman, Sarel J.; Leaver-Fay, Andrew; Corn, Jacob E.; Strauch, Eva-Maria; Khare, Sagar D.; Koga, Nobuyasu; Ashworth, Justin; Murphy, Paul; Richter, Florian; Lemmon, Gordon; Meiler, Jens; Baker, David			RosettaScripts: A Scripting Language Interface to the Rosetta Macromolecular Modeling Suite	PLOS ONE			English	Article							COMPUTATIONAL REDESIGN; PROTEIN; DESIGN; PREDICTION; ALGORITHMS; PACKING; BINDING	Macromolecular modeling and design are increasingly useful in basic research, biotechnology, and teaching. However, the absence of a user-friendly modeling framework that provides access to a wide range of modeling capabilities is hampering the wider adoption of computational methods by non-experts. RosettaScripts is an XML-like language for specifying modeling tasks in the Rosetta framework. RosettaScripts provides access to protocol-level functionalities, such as rigid-body docking and sequence redesign, and allows fast testing and deployment of complex protocols without need for modifying or recompiling the underlying C++ code. We illustrate these capabilities with RosettaScripts protocols for the stabilization of proteins, the generation of computationally constrained libraries for experimental selection of higher-affinity binding proteins, loop remodeling, small-molecule ligand docking, design of ligand-binding proteins, and specificity redesign in DNA-binding proteins.	[Fleishman, Sarel J.; Corn, Jacob E.; Strauch, Eva-Maria; Khare, Sagar D.; Koga, Nobuyasu; Ashworth, Justin; Murphy, Paul; Richter, Florian; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Leaver-Fay, Andrew] Univ N Carolina, Dept Biochem, Chapel Hill, NC 27599 USA; [Lemmon, Gordon; Meiler, Jens] Vanderbilt Univ, Struct Biol Ctr, Nashville, TN USA; [Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of North Carolina; University of North Carolina Chapel Hill; Vanderbilt University; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Fleishman, SJ (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	sarelf@uw.edu	Lemmon, Gordon H/O-2199-2015; Baker, David/K-8941-2012	Lemmon, Gordon H/0000-0002-8381-205X; Baker, David/0000-0001-7896-6217; Meiler, Jens/0000-0001-8945-193X; Ashworth, Justin/0000-0003-4835-6551; Fleishman, Sarel/0000-0003-3177-7560; Corn, Jacob/0000-0002-7798-5309; Koga, Nobuyasu/0000-0001-8457-0809	Howard Hughes Medical Institute; Defense Advanced Research Agency; Defense Threat Reduction Agency; Human Frontier Science Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008320] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Defense Advanced Research Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Human Frontier Science Program(Human Frontier Science Program); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by the Howard Hughes Medical Institute, Defense Advanced Research Agency, and Defense Threat Reduction Agency. SJF was supported by a long-term fellowship from the Human Frontier Science Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashworth J, 2006, NATURE, V441, P656, DOI 10.1038/nature04818; Ashworth J, 2010, NUCLEIC ACIDS RES, V38, P5601, DOI 10.1093/nar/gkq283; Canutescu AA, 2003, PROTEIN SCI, V12, P963, DOI 10.1110/ps.0242703; Chaudhury S, 2010, BIOINFORMATICS, V26, P689, DOI 10.1093/bioinformatics/btq007; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; Davis IW, 2009, J MOL BIOL, V385, P381, DOI 10.1016/j.jmb.2008.11.010; Davis IW, 2006, STRUCTURE, V14, P265, DOI 10.1016/j.str.2005.10.007; Fleishman SJ, 2011, SCIENCE, V332, P816, DOI 10.1126/science.1202617; Guntas G, 2010, P NATL ACAD SCI USA, V107, P19296, DOI 10.1073/pnas.1006528107; Havranek JJ, 2009, PROTEIN SCI, V18, P1293, DOI 10.1002/pro.142; Havranek JJ, 2004, J MOL BIOL, V344, P59, DOI 10.1016/j.jmb.2004.09.029; Jiang L, 2008, SCIENCE, V319, P1387, DOI 10.1126/science.1152692; Korkegian A, 2005, SCIENCE, V308, P857, DOI 10.1126/science.1107387; Kortemme T, 2004, NAT STRUCT MOL BIOL, V11, P371, DOI 10.1038/nsmb749; Kuhlman B, 2000, P NATL ACAD SCI USA, V97, P10383, DOI 10.1073/pnas.97.19.10383; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Leaver-Fay A, 2005, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2005, P16; Leaver-Fay A., 2010, METHOD ENZYMOL, V487, P545; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Lerner RA, 2006, ANGEW CHEM INT EDIT, V45, P8106, DOI 10.1002/anie.200603381; Mandell DJ, 2009, NAT METHODS, V6, P551, DOI 10.1038/nmeth0809-551; Meiler J, 2006, PROTEINS, V65, P538, DOI 10.1002/prot.21086; MEYERS S, 2005, EFFECTIVE C; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; SANDBERG WS, 1989, SCIENCE, V245, P54, DOI 10.1126/science.2787053; Sheffler W, 2009, PROTEIN SCI, V18, P229, DOI 10.1002/pro.8; Smith CA, 2008, J MOL BIOL, V380, P742, DOI 10.1016/j.jmb.2008.05.023; Thyme SB, 2009, NATURE, V461, P1300, DOI 10.1038/nature08508; Tyka MD, 2011, J MOL BIOL, V405, P607, DOI 10.1016/j.jmb.2010.11.008; Zanghellini A, 2006, PROTEIN SCI, V15, P2785, DOI 10.1110/ps.062353106	30	307	324	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e20161	10.1371/journal.pone.0020161	http://dx.doi.org/10.1371/journal.pone.0020161			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21731610	Green Submitted, Green Published, gold			2022-12-27	WOS:000292036900002
J	Kenyon, EJ; McEwen, GK; Callaway, H; Elgar, G				Kenyon, Emma J.; McEwen, Gayle K.; Callaway, Heather; Elgar, Greg			Functional Analysis of Conserved Non-Coding Regions Around the Short Stature hox Gene (shox) in Whole Zebrafish Embryos	PLOS ONE			English	Article							HOMEOBOX GENE; POLARIZING ACTIVITY; EXPRESSION; LIMB; PATTERN; MECHANISMS; PHENOTYPES; DELETIONS; MUTATION; ELEMENTS	Background: Mutations in the SHOX gene are responsible for Leri-Weill Dyschondrosteosis, a disorder characterised by mesomelic limb shortening. Recent investigations into regulatory elements surrounding SHOX have shown that deletions of conserved non-coding elements (CNEs) downstream of the SHOX gene produce a phenotype indistinguishable from Leri-Weill Dyschondrosteosis. As this gene is not found in rodents, we used zebrafish as a model to characterise the expression pattern of the shox gene across the whole embryo and characterise the enhancer domains of different CNEs associated with this gene. Methodology/Principal Findings: Expression of the shox gene in zebrafish was identified using in situ hybridization, with embryos showing expression in the blood, putative heart, hatching gland, brain pharyngeal arch, olfactory epithelium, and fin bud apical ectodermal ridge. By identifying sequences showing 65% identity over at least 40 nucleotides between Fugu, human, dog and opossum we uncovered 35 CNEs around the shox gene. These CNEs were compared with CNEs previously discovered by Sabherwal et al., resulting in the identification of smaller more deeply conserved sub-sequence. Sabherwal et al.'s CNEs were assayed for regulatory function in whole zebrafish embryos resulting in the identification of additional tissues under the regulatory control of these CNEs. Conclusion/Significance: Our results using whole zebrafish embryos have provided a more comprehensive picture of the expression pattern of the shox gene, and a better understanding of its regulation via deeply conserved noncoding elements. In particular, we identify additional tissues under the regulatory control of previously identified SHOX CNEs. We also demonstrate the importance of these CNEs in evolution by identifying duplicated shox CNEs and more deeply conserved sub-sequences within already identified CNEs.	[Kenyon, Emma J.] Wellcome Trust Sanger Inst, Cambridge, Cambs, England; [McEwen, Gayle K.] Max Planck Inst Mol Genet, Berlin, Germany; [Callaway, Heather] UCL, London, Greater London, England; [Elgar, Greg] Natl Inst Med Res, MRC, London NW7 1AA, Greater London, England	Wellcome Trust Sanger Institute; Max Planck Society; University of London; University College London; MRC National Institute for Medical Research	Kenyon, EJ (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge, Cambs, England.	ek1@sanger.ac.uk		Elgar, Greg/0000-0001-7323-1596; McEwen, Gayle/0000-0001-5134-1380	MRC National Institute for Medical Research [G0401138]; Medical Research Council [MC_U117597141, G0401138] Funding Source: researchfish; MRC [MC_U117597141, G0401138] Funding Source: UKRI	MRC National Institute for Medical Research; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by a grant from the MRC National Institute for Medical Research grant number G0401138. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIMENKO MA, 1995, DEV BIOL, V170, P243, DOI 10.1006/dbio.1995.1211; AVARON F, 2007, SHH GLI SIGNALLING D, DOI DOI 10.1007/978-0-387-39957-7; Blaschke RJ, 1998, P NATL ACAD SCI USA, V95, P2406, DOI 10.1073/pnas.95.5.2406; Blaschke RJ, 2007, CIRCULATION, V115, P1830, DOI 10.1161/CIRCULATIONAHA.106.637819; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; Clement-Jones M, 2000, HUM MOL GENET, V9, P695, DOI 10.1093/hmg/9.5.695; DANE PJ, 1985, J EMBRYOL EXP MORPH, V87, P145; Durand C, 2010, EUR J HUM GENET, V18, P527, DOI 10.1038/ejhg.2009.216; Ellison JW, 1997, HUM MOL GENET, V6, P1341, DOI 10.1093/hmg/6.8.1341; Freitas R, 2006, NATURE, V442, P1033, DOI 10.1038/nature04984; Fried C, 2003, J EXP ZOOL PART B, V299B, P18, DOI 10.1002/jez.b.00037; Gillis JA, 2009, P NATL ACAD SCI USA, V106, P5720, DOI 10.1073/pnas.0810959106; Goode DK, 2011, DEVELOPMENT, V138, P879, DOI 10.1242/dev.055996; Grandel H, 1998, MECH DEVELOP, V79, P99, DOI 10.1016/S0925-4773(98)00176-2; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kozak M, 2001, NUCLEIC ACIDS RES, V29, P5226, DOI 10.1093/nar/29.24.5226; KRAUSS S, 1993, CELL, V75, P1431, DOI 10.1016/0092-8674(93)90628-4; Loomis CA, 1996, NATURE, V382, P360, DOI 10.1038/382360a0; LOSSON R, 1979, P NATL ACAD SCI USA, V76, P5134, DOI 10.1073/pnas.76.10.5134; McEwen GK, 2006, GENOME RES, V16, P451, DOI 10.1101/gr.4143406; Muller F, 1997, MOL REPROD DEV, V47, P404, DOI 10.1002/(SICI)1098-2795(199708)47:4&lt;404::AID-MRD6&gt;3.0.CO;2-O; Ogata T, 2001, J CLIN ENDOCR METAB, V86, P5498, DOI 10.1210/jc.86.11.5498; Rao E, 1997, NAT GENET, V16, P54, DOI 10.1038/ng0597-54; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; RIDDLE RD, 1995, CELL, V83, P631, DOI 10.1016/0092-8674(95)90103-5; Robertson SP, 2000, J MED GENET, V37, P959, DOI 10.1136/jmg.37.12.959; Ross JL, 2001, J CLIN ENDOCR METAB, V86, P5674, DOI 10.1210/jc.86.12.5674; Sabherwal N, 2007, HUM MOL GENET, V16, P210, DOI 10.1093/hmg/ddl470; Shears DJ, 1998, NAT GENET, V19, P70, DOI 10.1038/ng0198-70; Spranger S, 1999, AM J MED GENET, V83, P367, DOI 10.1002/(SICI)1096-8628(19990423)83:5<367::AID-AJMG5>3.0.CO;2-K; Thisse B, 2004, ZFIN DIRECT DATA SUB; Tiecke E, 2006, DEV BIOL, V298, P585, DOI 10.1016/j.ydbio.2006.07.008; Vickerman L, 2011, DEV BIOL, V350, P323, DOI 10.1016/j.ydbio.2010.11.031; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; Woolfe A, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-100; Zinn AR, 2002, AM J MED GENET, V110, P158, DOI 10.1002/ajmg.10422	37	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21498	10.1371/journal.pone.0021498	http://dx.doi.org/10.1371/journal.pone.0021498			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21731768	Green Published, gold, Green Submitted			2022-12-27	WOS:000292036900045
J	Brandstaetter, AS; Rossler, W; Kleineidam, CJ				Brandstaetter, Andreas Simon; Roessler, Wolfgang; Kleineidam, Christoph Johannes			Friends and Foes from an Ant Brain's Point of View - Neuronal Correlates of Colony Odors in a Social Insect	PLOS ONE			English	Article							NESTMATE-RECOGNITION CUES; CUTICULAR HYDROCARBON COMPOSITION; DIRECT BEHAVIORAL EVIDENCE; ANTENNAL LOBE; KIN RECOGNITION; ENSEMBLE REPRESENTATIONS; OLFACTORY PATHWAY; HARVESTER ANTS; CAMPONOTUS; SYSTEM	Background: Successful cooperation depends on reliable identification of friends and foes. Social insects discriminate colony members (nestmates/friends) from foreign workers (non-nestmates/foes) by colony-specific, multi-component colony odors. Traditionally, complex processing in the brain has been regarded as crucial for colony recognition. Odor information is represented as spatial patterns of activity and processed in the primary olfactory neuropile, the antennal lobe (AL) of insects, which is analogous to the vertebrate olfactory bulb. Correlative evidence indicates that the spatial activity patterns reflect odor-quality, i.e., how an odor is perceived. For colony odors, alternatively, a sensory filter in the peripheral nervous system was suggested, causing specific anosmia to nestmate colony odors. Here, we investigate neuronal correlates of colony odors in the brain of a social insect to directly test whether they are anosmic to nestmate colony odors and whether spatial activity patterns in the AL can predict how odor qualities like "friend'' and "foe'' are attributed to colony odors. Methodology/Principal Findings: Using ant dummies that mimic natural conditions, we presented colony odors and investigated their neuronal representation in the ant Camponotus floridanus. Nestmate and non-nestmate colony odors elicited neuronal activity: In the periphery, we recorded sensory responses of olfactory receptor neurons (electroantennography), and in the brain, we measured colony odor specific spatial activity patterns in the AL (calcium imaging). Surprisingly, upon repeated stimulation with the same colony odor, spatial activity patterns were variable, and as variable as activity patterns elicited by different colony odors. Conclusions: Ants are not anosmic to nestmate colony odors. However, spatial activity patterns in the AL alone do not provide sufficient information for colony odor discrimination and this finding challenges the current notion of how odor quality is coded. Our result illustrates the enormous challenge for the nervous system to classify multi-component odors and indicates that other neuronal parameters, e. g., precise timing of neuronal activity, are likely necessary for attribution of odor quality to multi-component odors.	[Brandstaetter, Andreas Simon; Roessler, Wolfgang; Kleineidam, Christoph Johannes] Univ Wurzburg, Biozentrum, Dept Behav Physiol & Sociobiol Zool 2, Wurzburg, Germany; [Kleineidam, Christoph Johannes] Univ Konstanz, Dept Biol, Constance, Germany	University of Wurzburg; University of Konstanz	Brandstaetter, AS (corresponding author), CNRS, UPR 9034, LEGS, Bat 13,BP 1, Gif Sur Yvette, France.	Andreas.Brandstaetter@legs.cnrs-gif.fr	Rössler, Wolfgang/E-9526-2019; Kleineidam, Christoph J/A-6529-2009; Brandstaetter, Andreas/C-1605-2009	Rössler, Wolfgang/0000-0002-5195-8214; Kleineidam, Christoph J/0000-0003-0671-1455; 	German Research Foundation (DFG) [SFB 554/A6]; German Excellence Initiative to the Graduate School of Life Sciences, University of Wurzburg; University of Wurzburg	German Research Foundation (DFG)(German Research Foundation (DFG)); German Excellence Initiative to the Graduate School of Life Sciences, University of Wurzburg; University of Wurzburg	This research was supported by the German Research Foundation (DFG; SFB 554/A6). A.S.B. was supported by a grant of the German Excellence Initiative to the Graduate School of Life Sciences, University of Wurzburg. This publication was funded by the German Research Foundation ( DFG) and the University of Wurzburg in the funding program: Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akino T, 2004, APPL ENTOMOL ZOOL, V39, P381, DOI 10.1303/aez.2004.381; ARNOLD G, 1985, CELL TISSUE RES, V242, P593, DOI 10.1007/BF00225425; BAGNERES AG, 1991, EXPERIENTIA, V47, P106, DOI 10.1007/BF02041269; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BHATKAR A, 1970, Florida Entomologist, V53, P229, DOI 10.2307/3493193; Boulay R, 2000, ANIM BEHAV, V59, P1127, DOI 10.1006/anbe.2000.1408; Brandstaetter AS, 2008, NATURWISSENSCHAFTEN, V95, P601, DOI 10.1007/s00114-008-0360-5; Brandstaetter AS, 2010, CHEM SENSES, V35, P323, DOI 10.1093/chemse/bjq022; BUCKNER JS, 1993, INSECT LIPIDS: CHEMISTRY, BIOCHEMISTRY AND BIOLOGY, P227; Buczkowski G, 2005, J CHEM ECOL, V31, P829, DOI 10.1007/s10886-005-3547-7; CARLIN NF, 1983, SCIENCE, V222, P1027, DOI 10.1126/science.222.4627.1027; CARLIN NF, 1986, BEHAV ECOL SOCIOBIOL, V19, P123, DOI 10.1007/BF00299947; CARLIN NF, 1987, BEHAV ECOL SOCIOBIOL, V20, P219, DOI 10.1007/BF00299736; CARLIN NF, 1987, BEHAV ECOL SOCIOBIOL, V20, P209, DOI 10.1007/BF00299735; D'Ettorre P, 2004, J EXP BIOL, V207, P1085, DOI 10.1242/jeb.00865; d'Ettorre P, 2010, ANT ECOLOGY, P194; Daly KC, 2004, P NATL ACAD SCI USA, V101, P10476, DOI 10.1073/pnas.0401902101; Deisig N, 2010, J NEUROPHYSIOL, V103, P2185, DOI 10.1152/jn.00342.2009; Dietemann V, 2003, P NATL ACAD SCI USA, V100, P10341, DOI 10.1073/pnas.1834281100; Dupuy F, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-28; Endler A, 2006, BEHAV ECOL SOCIOBIOL, V59, P490, DOI 10.1007/s00265-005-0073-0; Endler A, 2004, P NATL ACAD SCI USA, V101, P2945, DOI 10.1073/pnas.0308447101; Faber T, 1999, NAT NEUROSCI, V2, P74, DOI 10.1038/4576; Fernandez PC, 2009, J NEUROSCI, V29, P10191, DOI 10.1523/JNEUROSCI.1874-09.2009; Gadau J, 1996, MOL ECOL, V5, P785, DOI 10.1111/j.1365-294X.1996.tb00374.x; Galizia CG, 2008, ENTOMOL EXP APPL, V128, P81, DOI 10.1111/j.1570-7458.2007.00661.x; Galizia CG, 2010, ANNU REV ENTOMOL, V55, P399, DOI 10.1146/annurev-ento-112408-085442; Galizia CG, 1999, NATURWISSENSCHAFTEN, V86, P533, DOI 10.1007/s001140050669; Greene MJ, 2003, NATURE, V423, P32, DOI 10.1038/423032a; Guerrieri F, 2005, PLOS BIOL, V3, P718, DOI 10.1371/journal.pbio.0030060; Guerrieri FJ, 2008, J EXP BIOL, V211, P1109, DOI 10.1242/jeb.008508; Guerrieri FJ, 2009, P ROY SOC B-BIOL SCI, V276, P2461, DOI 10.1098/rspb.2008.1860; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Heinze J, 2002, BEHAV ECOL SOCIOBIOL, V52, P59, DOI 10.1007/s00265-002-0491-1; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; Holldobler B., 1990, pi; Holldobler B., 2009, SUPERORGANISM, P522; Hourcade B, 2010, J NEUROSCI, V30, P6461, DOI 10.1523/JNEUROSCI.0841-10.2010; Hourcade B, 2009, LEARN MEMORY, V16, P607, DOI 10.1101/lm.1445609; Howard RW, 2005, ANNU REV ENTOMOL, V50, P371, DOI 10.1146/annurev.ento.50.071803.130359; Hughes WOH, 2008, SCIENCE, V320, P1213, DOI 10.1126/science.1156108; Kaib M, 2000, J COMP PHYSIOL A, V186, P939, DOI 10.1007/s003590000146; Katzerke A, 2006, BEHAV ECOL SOCIOBIOL, V61, P143, DOI 10.1007/s00265-006-0245-6; Kirschner S, 2006, J COMP NEUROL, V499, P933, DOI 10.1002/cne.21158; Kleineidam Christoph J., 2009, P195; Krofczik S, 2009, FRONT COMPUT NEUROSC, V2, DOI 10.3389/neuro.10.009.2008; Kuebler LS, 2010, J COMP NEUROL, V518, P352, DOI 10.1002/cne.22217; Lahav S, 2001, J CHEM ECOL, V27, P927, DOI 10.1023/A:1010382919227; Lahav S, 1999, NATURWISSENSCHAFTEN, V86, P246, DOI 10.1007/s001140050609; Lei H, 2004, J NEUROSCI, V24, P11108, DOI 10.1523/JNEUROSCI.3677-04.2004; Lei H, 2008, J CHEM ECOL, V34, P915, DOI 10.1007/s10886-008-9487-2; Leonhardt SD, 2007, J COMP PHYSIOL A, V193, P993, DOI 10.1007/s00359-007-0252-8; LOCKEY KH, 1988, COMP BIOCHEM PHYS B, V89, P595, DOI 10.1016/0305-0491(88)90305-7; Martin JP, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00159; MICHENER CD, 1969, ANNU REV ENTOMOL, V14, P299, DOI 10.1146/annurev.en.14.010169.001503; MOREL L, 1988, BEHAV ECOL SOCIOBIOL, V22, P175, DOI 10.1007/BF00300567; Najar-Rodriguez AJ, 2010, J EXP BIOL, V213, P3388, DOI 10.1242/jeb.046284; Nakanishi A, 2010, J COMP NEUROL, V518, P2186, DOI 10.1002/cne.22326; Nielsen J, 1999, INSECT SOC, V46, P58, DOI 10.1007/s000400050113; Ozaki M, 2005, SCIENCE, V309, P311, DOI 10.1126/science.1105244; Perisse E, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-30; PROVOST E, 1993, INSECT BIOCHEM MOLEC, V23, P945, DOI 10.1016/0965-1748(93)90112-6; Riffell Jeffrey A, 2009, Proc Natl Acad Sci U S A, V106, P19219, DOI 10.1073/pnas.0910592106; Riffell JA, 2009, CURR BIOL, V19, P335, DOI 10.1016/j.cub.2009.01.041; Ruchty M, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00174; Silbering AF, 2008, J NEUROSCI, V28, P13075, DOI 10.1523/JNEUROSCI.2973-08.2008; Singer TL, 1998, AM ZOOL, V38, P394; SOROKER V, 1994, NATURWISSENSCHAFTEN, V81, P510; Stroeymeyt N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012377; Thomas ML, 1999, NATURWISSENSCHAFTEN, V86, P87, DOI 10.1007/s001140050578; Thum AS, 2007, J NEUROSCI, V27, P11132, DOI 10.1523/JNEUROSCI.2712-07.2007; Vander Meer Robert K., 1998, P79; VANDERMEER RK, 1989, J CHEM ECOL, V15, P2115, DOI 10.1007/BF01207442; Wagner D, 2000, J CHEM ECOL, V26, P2245, DOI 10.1023/A:1005529224856; Wagner D, 2001, J CHEM ECOL, V27, P1805, DOI 10.1023/A:1010408725464; Wagner D, 1998, J CHEM ECOL, V24, P2021, DOI 10.1023/A:1020781508889; WALLIS D. L., 1963, ANIMAL BEHAVIOUR, V11, P164, DOI 10.1016/0003-3472(63)90025-3; Zube C, 2008, J COMP NEUROL, V506, P425, DOI 10.1002/cne.21548	78	36	36	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21383	10.1371/journal.pone.0021383	http://dx.doi.org/10.1371/journal.pone.0021383			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731724	gold, Green Published, Green Submitted			2022-12-27	WOS:000292035400032
J	Campbell-Smith, G; Campbell-Smith, M; Singleton, I; Linkie, M				Campbell-Smith, Gail; Campbell-Smith, Miran; Singleton, Ian; Linkie, Matthew			Raiders of the Lost Bark: Orangutan Foraging Strategies in a Degraded Landscape	PLOS ONE			English	Article							PONGO-PYGMAEUS; NATIONAL-PARK; TEMPORAL PATTERNS; VERVET MONKEYS; BEHAVIOR; ECOLOGY; AVAILABILITY; PERCEPTIONS; CONFLICT; WILDLIFE	Deforestation is rapidly transforming primary forests across the tropics into human-dominated landscapes. Consequently, conservationists need to understand how different taxa respond and adapt to these changes in order to develop appropriate management strategies. Our two year study seeks to determine how wild Sumatran orangutans (Pongo abelii) adapt to living in an isolated agroforest landscape by investigating the sex of crop-raiders related to population demographics, and their temporal variations in feeding behaviour and dietary composition. From focal animal sampling we found that nine identified females raided cultivated fruits more than the four males. Seasonal adaptations were shown through orangutan feeding habits that shifted from being predominantly fruit-based (56% of the total feeding time, then 22% on bark) to the fallback food of bark (44%, then 35% on fruits), when key cultivated resources such as jackfruit (Artocarpus integer), were unavailable. Cultivated fruits were mostly consumed in the afternoon and evening, when farmers had returned home. The finding that females take greater crop-raiding risks than males differs from previous human-primate conflict studies, probably because of the low risks associated (as farmers rarely retaliated) and low intraspecific competition between males. Thus, the behavioral ecology of orangutans living in this human-dominated landscape differs markedly from that in primary forest, where orangutans have a strictly wild food diet, even where primary rainforests directly borders farmland. The importance of wild food availability was clearly illustrated in this study with 21% of the total orangutan feeding time being allocated to feeding on cultivated fruits. As forests are increasingly converted to cultivation, humans and orangutans are predicted to come into conflict more frequently. This study reveals orangutan adaptations for coexisting with humans, e. g. changes in temporal foraging patterns, which should be used for guiding the development of specific human-wildlife conflict mitigation strategies to lessen future crop-raiding and conflicts.	[Campbell-Smith, Gail; Linkie, Matthew] Univ Kent, Durrell Inst Conservat & Ecol, Canterbury, Kent, England; [Campbell-Smith, Miran] Orangutan Informat Ctr, Human Orangutan Conflict & Mitigat Programme, Medan, North Sumatra, Indonesia; [Singleton, Ian] PanEco Fdn, Sumatran Orangutan Conservat Programme, Medan, North Sumatra, Indonesia; [Linkie, Matthew] Fauna & Flora Int, Cambridge, England	University of Kent	Campbell-Smith, G (corresponding author), Univ Kent, Durrell Inst Conservat & Ecol, Canterbury, Kent, England.	primatelass@gmail.com			United States Fish and Wildlife Service [31221208, 31221435]; SeaWorld and Bush Gardens Conservation Fund; Born Free Foundation; Humane Society International; People's Trust for Endangered Species; PanEco; Orangutan Foundation; Primate Society of Great Britain; Orangutan Republik Education Initiative; Borneo Orangutan Society-Canada	United States Fish and Wildlife Service(US Fish & Wildlife Service); SeaWorld and Bush Gardens Conservation Fund; Born Free Foundation; Humane Society International; People's Trust for Endangered Species; PanEco; Orangutan Foundation; Primate Society of Great Britain; Orangutan Republik Education Initiative; Borneo Orangutan Society-Canada	This study was financially supported by the United States Fish and Wildlife Service Great Ape Conservation Fund (http://www.fws.gov/international/index.html) through grants #31221208 and #31221435 held by N. Leader-Williams at the Durrell Institute of Conservation and Ecology, University of Kent, and by funds awarded to G. Campbell-Smith by SeaWorld and Bush Gardens Conservation Fund (http://www.swbg-conservationfund.org), Born Free Foundation (http://www.bornfree.org.uk), Humane Society International (http://www.hsi.org), People's Trust for Endangered Species (http://www.ptes.org), PanEco (http://www.paneco.ch/content-n67-r-sD.html), Orangutan Foundation (http://www.orangutan.org.uk), Primate Society of Great Britain (http://www.psgb.org), Orangutan Republik Education Initiative (http://www.orangutanrepublik.org/ourei/), and Borneo Orangutan Society-Canada (http://www.orangutan.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard F, 2002, SCIENCE, V297, P999, DOI 10.1126/science.1070656; ALTMANN J, 1988, AM J PRIMATOL, V15, P213, DOI 10.1002/ajp.1350150304; Ancrenaz M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011510; BARTON RA, 1992, ANIM BEHAV, V43, P831, DOI 10.1016/S0003-3472(05)80206-4; BRENNAN EJ, 1985, AFR J ECOL, V23, P35, DOI 10.1111/j.1365-2028.1985.tb00710.x; Campbell-Smith G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017210; Campbell-Smith G, 2010, AM J PRIMATOL, V72, P866, DOI 10.1002/ajp.20822; CANT JGH, 1987, AM J PRIMATOL, V12, P71, DOI 10.1002/ajp.1350120104; Chiyo PI, 2005, AFR J ECOL, V43, P48, DOI 10.1111/j.1365-2028.2004.00544.x; Creel S, 2007, SCIENCE, V315, P960, DOI 10.1126/science.1135918; Delgado RA, 2000, EVOL ANTHROPOL, V9, P201; Doran D, 1997, INT J PRIMATOL, V18, P183, DOI 10.1023/A:1026368518431; Fox EA, 2004, AM J PHYS ANTHROPOL, V125, P162, DOI 10.1002/ajpa.10386; GALDIKAS BMF, 1988, INT J PRIMATOL, V9, P1, DOI 10.1007/BF02740195; HARRISON ME, 2008, AM J PRIMATOL, V70, P1; HARRISON MJS, 1983, ANIM BEHAV, V31, P969, DOI 10.1016/S0003-3472(83)80001-3; Hill CM, 1997, INT J PEST MANAGE, V43, P77, DOI 10.1080/096708797229022; Hoare, 1999, STANDARDISED DATA CO; Hockings K., 2009, BEST PRACTICE GUIDEL; Hockings KJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000886; Hockings KJ, 2009, AM J PRIMATOL, V71, P636, DOI 10.1002/ajp.20698; Kanamori T, 2010, AM J PRIMATOL, V72, P820, DOI 10.1002/ajp.20848; Knott CD, 1998, INT J PRIMATOL, V19, P1061, DOI 10.1023/A:1020330404983; KNOTT CD, 1999, THESIS U HARVARD CAM; Leighton M., 1983, TROPICAL RAIN FOREST, P181; Linkie M, 2007, ANIM CONSERV, V10, P127, DOI 10.1111/j.1469-1795.2006.00083.x; MACKINNON J, 1974, ANIM BEHAV, V22, P3, DOI 10.1016/S0003-3472(74)80054-0; Meijaard E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012813; MITANI JC, 1989, AM J PRIMATOL, V18, P87, DOI 10.1002/ajp.1350180203; Morrogh-Bernard H., 2002, LSB LEAK FDN OR CULT; Morrogh-Bernard Helen C., 2009, P119; Naughton-Treves L, 1998, J APPL ECOL, V35, P596, DOI 10.1046/j.1365-2664.1998.3540596.x; Naughton-Treves L, 1998, CONSERV BIOL, V12, P156, DOI 10.1046/j.1523-1739.1998.96346.x; PRISTON N, 2005, THESIS U CAMBRIDGE E; Priston NEC, 2009, INT J PEST MANAGE, V55, P243, DOI 10.1080/09670870902769955; Russon Anne E., 2009, P135; Saj T, 1999, INT J PRIMATOL, V20, P977, DOI 10.1023/A:1020886820759; Saj TL, 2001, AFR J ECOL, V39, P195, DOI 10.1046/j.0141-6707.2000.00299.x; Sha JCM, 2009, AM J PRIMATOL, V71, P825, DOI 10.1002/ajp.20710; Stephens D.W., 1986, pi; Wich SA, 2006, INT J PRIMATOL, V27, P1535, DOI 10.1007/s10764-006-9093-5; Yihune M, 2009, AFR J ECOL, V47, P276, DOI 10.1111/j.1365-2028.2007.00917.x; 2009, NATL NUTR DATABASE	43	60	62	2	157	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e20962	10.1371/journal.pone.0020962	http://dx.doi.org/10.1371/journal.pone.0020962			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731636	Green Published, gold, Green Submitted			2022-12-27	WOS:000292033700023
J	Cortes-Avizanda, A; Almaraz, P; Carrete, M; Sanchez-Zapata, JA; Delgado, A; Hiraldo, F; Donazar, JA				Cortes-Avizanda, Ainara; Almaraz, Pablo; Carrete, Martina; Sanchez-Zapata, Jose A.; Delgado, Antonio; Hiraldo, Fernando; Donazar, Jose A.			Spatial Heterogeneity in Resource Distribution Promotes Facultative Sociality in Two Trans-Saharan Migratory Birds	PLOS ONE			English	Article							KITES MILVUS-MILVUS; GEOGRAPHICAL VARIATION; MOVEMENT PATTERNS; BRAIN SIZE; RED KITES; POPULATION; EVOLUTION; FOOD; SURVIVAL; AVAILABILITY	Background: Migrant populations must cope not only with environmental changes in different biomes, but also with the continuous constraints imposed by human-induced changes through landscape transformation and resource patchiness. Theoretical studies suggest that changes in food distribution can promote changes in the social arrangement of individuals without apparent adaptive value. Empirical research on this subject has only been performed at reduced geographical scales and/or for single species. However, the relative contribution of food patchiness and predictability, both in space and time, to abundance and sociality can vary among species, depending on their degree of flexibility. Methodology/Principal Findings: By means of constrained zero-inflated Generalized Additive Models we analysed the spatial distribution of two trans-Saharan avian scavengers that breed (Europe) and winter (Africa) sympatrically, in relation to food availability. In the summering grounds, the probability of finding large numbers of both species increases close to predictable feeding sources, whereas in the wintering grounds, where food resources are widespread, we did not find such aggregation patterns, except for the black kite, which aggregated at desert locust outbreaks. The comparison of diets in both species through stable isotopes revealed that their diets overlapped during summering, but not during wintering. Conclusions/Significance: Our results suggest that bird sociality at feeding grounds is closely linked to the pattern of spatial distribution and predictability of trophic resources, which are ultimately induced by human activities. Migrant species can show adaptive foraging strategies to face changing distribution of food availability in both wintering and summering quarters. Understanding these effects is a key aspect for predicting the fitness costs and population consequences of habitat transformations on the viability of endangered migratory species.	[Cortes-Avizanda, Ainara; Carrete, Martina; Hiraldo, Fernando; Donazar, Jose A.] CSIC, Estn Biol Donana, Dept Conservat Biol, E-41080 Seville, Spain; [Almaraz, Pablo; Sanchez-Zapata, Jose A.] Univ Miguel Hernandez, Dept Appl Biol, Alicante, Spain; [Carrete, Martina] Univ Pablo de Olavide, Dept Phys Chem & Nat Syst, Seville, Spain; [Delgado, Antonio] CSIC, Estn Expt Zaidin, Lab Biogeoquim Isotopos Estables, Granada, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Universidad Miguel Hernandez de Elche; Universidad Pablo de Olavide; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ)	Cortes-Avizanda, A (corresponding author), CSIC, Estn Biol Donana, Dept Conservat Biol, E-41080 Seville, Spain.	ainara@ebd.csic.es	Carrete, Martina/A-6376-2009; Cortés-Avizanda, Ainara/C-6634-2013; Carrete, Martina/D-2618-2017; Almaraz, Pablo/A-3683-2014; Hiraldo, Fernando/AAA-8314-2019; CORTES-AVIZANDA, AINARA/O-3248-2019; Sanchez-Zapata, Jose Antonio/H-1413-2015; Huertas, Antonio Delgado/F-6866-2011	Carrete, Martina/0000-0002-0491-2950; Cortés-Avizanda, Ainara/0000-0002-9674-6434; Almaraz, Pablo/0000-0003-1416-2695; CORTES-AVIZANDA, AINARA/0000-0002-9674-6434; Sanchez-Zapata, Jose Antonio/0000-0001-8230-4953; Huertas, Antonio Delgado/0000-0002-7240-1570; Donazar, Jose Antonio/0000-0002-9433-9755	Spanish Government [CGL2004-00270]	Spanish Government(Spanish GovernmentEuropean Commission)	This work was supported by the project CGL2004-00270 of Spanish Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal DK, 2002, ENVIRON ECOL STAT, V9, P341, DOI 10.1023/A:1020910605990; Anadon JD, 2010, ANIM CONSERV, V13, P495, DOI 10.1111/j.1469-1795.2010.00369.x; [Anonymous], 2010, R LANG ENV STAT COMP; Barry SC, 2002, ECOL MODEL, V157, P179, DOI 10.1016/S0304-3800(02)00194-1; Bjornstad ON, 2001, ENVIRON ECOL STAT, V8, P53, DOI 10.1023/A:1009601932481; BLANCO G, 1994, J RAPTOR RES, V28, P242; Blanco G, 1999, ANIM BEHAV, V57, P1219, DOI 10.1006/anbe.1999.1103; Blanco G, 2007, ENVIRON MICROBIOL, V9, P1738, DOI 10.1111/j.1462-2920.2007.01291.x; Bolnick DI, 2010, P ROY SOC B-BIOL SCI, V277, P1789, DOI 10.1098/rspb.2010.0018; Bowlin MS, 2010, INTEGR COMP BIOL, V50, P261, DOI 10.1093/icb/icq013; Burnham K. P., 1998, MODEL SELECTION INFE; Carrete M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018859; Carrete M, 2009, ECOL APPL, V19, P840, DOI 10.1890/07-2134.1; Chesser RT, 1998, AM NAT, V152, P311, DOI 10.1086/286171; Chiogna M, 2007, ENVIRONMETRICS, V18, P303, DOI 10.1002/env.830; Cortes-Avizanda A, 2010, BIOL CONSERV, V143, P1707, DOI 10.1016/j.biocon.2010.04.016; Cotton PA, 2003, P NATL ACAD SCI USA, V100, P12219, DOI 10.1073/pnas.1930548100; COX GW, 1985, AM NAT, V126, P451, DOI 10.1086/284432; Cramp S., 1980, HDB BIRDS EUROPE MID; Delibes-Mateos M, 2008, CONSERV BIOL, V22, P1106, DOI 10.1111/j.1523-1739.2008.00993.x; Donazar JA, 2009, SCIENCE, V326, P664, DOI 10.1126/science.326_664a; Donazar Jose Antonio, 1992, Ardeola, V39, P29; Donazar Sancho J.A., 1988, Ardeola, V35, P3; Eide NE, 2004, J ANIM ECOL, V73, P1056, DOI 10.1111/j.0021-8790.2004.00885.x; Forsman D., 2007, RAPTORS EUROPE MIDDL; Garcia-Ripolles C, 2010, BIRD STUDY, V57, P261, DOI 10.1080/00063650903505762; Grande JM, 2009, OIKOS, V118, P580, DOI 10.1111/j.1600-0706.2009.17218.x; Grimm V, 2005, CONSERV BIOL, V19, P578, DOI 10.1111/j.1523-1739.2005.000163.x; HIRALDO F, 1993, ETHOLOGY, V93, P117; Houston D. C., 1979, SERENGETI DYNAMICS E, P236; Inger R, 2008, IBIS, V150, P447, DOI 10.1111/j.1474-919X.2008.00839.x; Jenness J., 2004, NEAREST FEATURES NEA; Johnson DDP, 2002, TRENDS ECOL EVOL, V17, P563, DOI 10.1016/S0169-5347(02)02619-8; Krause J, 2002, LIVING GROUPS; Lefebvre L, 2004, BRAIN BEHAV EVOLUT, V63, P233, DOI 10.1159/000076784; Lemus JA, 2009, P ROY SOC B-BIOL SCI, V276, P2307, DOI 10.1098/rspb.2009.0071; Lemus JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001444; LEVEY DJ, 1992, AM NAT, V140, P447, DOI 10.1086/285421; Liu H, 2010, J STAT SOFTW, V35, P1; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; MACDONALD DW, 1983, NATURE, V301, P379, DOI 10.1038/301379a0; Martin TG, 2005, ECOL LETT, V8, P1235, DOI 10.1111/j.1461-0248.2005.00826.x; Marzluff JM, 1996, ANIM BEHAV, V51, P89, DOI 10.1006/anbe.1996.0008; Michener R, 2007, ECOL METHOD CONCEPT, pXVII; Mihoub JB, 2010, BIOL CONSERV, V143, P839, DOI 10.1016/j.biocon.2009.12.026; Monkkonen M, 2004, ECOGRAPHY, V27, P112, DOI 10.1111/j.0906-7590.2004.03705.x; Mooney HA, 2001, P NATL ACAD SCI USA, V98, P5446, DOI 10.1073/pnas.091093398; Newton I, 2004, IBIS, V146, P197, DOI 10.1111/j.1474-919X.2004.00293.x; Overington SE, 2008, BEHAV ECOL, V19, P836, DOI 10.1093/beheco/arn037; Perez-Tris J, 2002, J ANIM ECOL, V71, P211, DOI 10.1046/j.1365-2656.2002.00590.x; Piersma T, 2003, TRENDS ECOL EVOL, V18, P228, DOI 10.1016/S0169-5347(03)00036-3; Popa-Lisseanu AG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000205; Revilla E, 2002, J ANIM ECOL, V71, P497, DOI 10.1046/j.1365-2656.2002.00617.x; Robb GN, 2008, FRONT ECOL ENVIRON, V6, P476, DOI 10.1890/060152; Rubenstein DR, 2004, TRENDS ECOL EVOL, V19, P256, DOI 10.1016/j.tree.2004.03.017; Sanderson FJ, 2006, BIOL CONSERV, V131, P93, DOI 10.1016/j.biocon.2006.02.008; Schaub M, 2005, J ANIM ECOL, V74, P656, DOI 10.1111/j.1365-2656.2005.00961.x; SCHOENER TW, 1974, SCIENCE, V185, P27, DOI 10.1126/science.185.4145.27; Sillett TS, 2000, SCIENCE, V288, P2040, DOI 10.1126/science.288.5473.2040; Sol D, 2005, P ROY SOC B-BIOL SCI, V272, P1433, DOI 10.1098/rspb.2005.3099; Sol D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009617; Tokeshi M., 1999, SPECIES COEXISTENCE; VEIGA JP, 1990, HOLARCTIC ECOL, V13, P62; Villafuerte R, 1998, BIOL CONSERV, V84, P181, DOI 10.1016/S0006-3207(97)00094-3; WARD P, 1973, IBIS, V115, P517, DOI 10.1111/j.1474-919X.1973.tb01990.x; Wenger SJ, 2008, ECOLOGY, V89, P2953, DOI 10.1890/07-1127.1; Wichmann MC, 2005, GLOBAL PLANET CHANGE, V47, P273, DOI 10.1016/j.gloplacha.2004.10.016; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	74	30	30	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21016	10.1371/journal.pone.0021016	http://dx.doi.org/10.1371/journal.pone.0021016			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731640	Green Published, gold, Green Submitted			2022-12-27	WOS:000292033700027
J	Glotzbach, JP; Januszyk, M; Vial, IN; Wong, VW; Gelbard, A; Kalisky, T; Thangarajah, H; Longaker, MT; Quake, SR; Chu, G; Gurtner, GC				Glotzbach, Jason P.; Januszyk, Michael; Vial, Ivan N.; Wong, Victor W.; Gelbard, Alexander; Kalisky, Tomer; Thangarajah, Hariharan; Longaker, Michael T.; Quake, Stephen R.; Chu, Gilbert; Gurtner, Geoffrey C.			An Information Theoretic, Microfluidic-Based Single Cell Analysis Permits Identification of Subpopulations among Putatively Homogeneous Stem Cells	PLOS ONE			English	Article							STOCHASTIC GENE-EXPRESSION; HEMATOPOIETIC STEM; CLUSTER-ANALYSIS; NOISE; HETEROGENEITY; ARCHITECTURE; EVOLUTION	An incomplete understanding of the nature of heterogeneity within stem cell populations remains a major impediment to the development of clinically effective cell-based therapies. Transcriptional events within a single cell are inherently stochastic and can produce tremendous variability, even among genetically identical cells. It remains unclear how mammalian cellular systems overcome this intrinsic noisiness of gene expression to produce consequential variations in function, and what impact this has on the biologic and clinical relevance of highly 'purified' cell subgroups. To address these questions, we have developed a novel method combining microfluidic-based single cell analysis and information theory to characterize and predict transcriptional programs across hundreds of individual cells. Using this technique, we demonstrate that multiple subpopulations exist within a well-studied and putatively homogeneous stem cell population, murine long-term hematopoietic stem cells (LT-HSCs). These subgroups are defined by nonrandom patterns that are distinguishable from noise and are consistent with known functional properties of these cells. We anticipate that this analytic framework can also be applied to other cell types to elucidate the relationship between transcriptional and phenotypic variation.	[Glotzbach, Jason P.; Januszyk, Michael; Vial, Ivan N.; Wong, Victor W.; Gelbard, Alexander; Thangarajah, Hariharan; Longaker, Michael T.; Gurtner, Geoffrey C.] Stanford Univ, Sch Med, Dept Surg, Stanford, CA 94305 USA; [Kalisky, Tomer; Quake, Stephen R.] Stanford Univ, Sch Med, Dept Bioengn, Stanford, CA 94305 USA; [Chu, Gilbert] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Chu, Gilbert] Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University	Glotzbach, JP (corresponding author), Stanford Univ, Sch Med, Dept Surg, Stanford, CA 94305 USA.	ggurtner@stanford.edu	Glotzbach, Jason P./O-4394-2019; Gelbard, Alexander/K-1976-2014	Glotzbach, Jason P./0000-0002-8002-9422; Gelbard, Alexander/0000-0003-0078-1305	National Institutes of Health, National Institute of Diabetes, Digestive Disease Kidney Disease [2 RO1 DK074095-07]; Oak Foundation; Hagey Laboratory for Pediatric Regenerative Medicine; National Institutes of Health [NRSA F32DK088448-01]; American Heart Association [09POST2220348]; Hagey individual fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074095] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007033] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Diabetes, Digestive Disease Kidney Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Oak Foundation; Hagey Laboratory for Pediatric Regenerative Medicine; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Hagey individual fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This study was supported by National Institutes of Health, National Institute of Diabetes, Digestive Disease Kidney Disease Grant 2 RO1 DK074095-07 to GCG and the Oak Foundation and Hagey Laboratory for Pediatric Regenerative Medicine grants to GCG and MTL. JPG was supported by National Institutes of Health NRSA F32DK088448-01. MJ was supported by American Heart Association Individual Fellowship #09POST2220348 and INV was supported by a Hagey individual fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; BOZDOGAN H, 1984, ANN I STAT MATH, V36, P163, DOI 10.1007/BF02481962; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cagatay T, 2009, CELL, V139, P512, DOI 10.1016/j.cell.2009.07.046; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Glauche I, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000447; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Graf T, 2008, CELL STEM CELL, V3, P480, DOI 10.1016/j.stem.2008.10.007; Guo GJ, 2010, DEV CELL, V18, P675, DOI 10.1016/j.devcel.2010.02.012; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Ince RAA, 2010, NEURAL NETWORKS, V23, P713, DOI 10.1016/j.neunet.2010.05.008; Kerr G, 2008, COMPUT BIOL MED, V38, P283, DOI 10.1016/j.compbiomed.2007.11.001; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; LANDAUER R, 1961, IBM J RES DEV, V5, P183, DOI 10.1147/rd.53.0183; Levsky JM, 2002, SCIENCE, V297, P836, DOI 10.1126/science.1072241; Levsky JM, 2003, TRENDS CELL BIOL, V13, P4, DOI 10.1016/S0962-8924(02)00002-8; Li XJ, 2011, LAB CHIP, V11, P1378, DOI 10.1039/c0lc00626b; Maheshri N, 2007, ANNU REV BIOPH BIOM, V36, P413, DOI 10.1146/annurev.biophys.36.040306.132705; Matsuzaki Y, 2004, IMMUNITY, V20, P87, DOI 10.1016/S1074-7613(03)00354-6; Melin J, 2007, ANNU REV BIOPH BIOM, V36, P213, DOI 10.1146/annurev.biophys.36.040306.132646; Metcalf D, 2007, IMMUNITY, V26, P669, DOI 10.1016/j.immuni.2007.05.012; Nakauchi H, 1999, ANN NY ACAD SCI, V872, P57, DOI 10.1111/j.1749-6632.1999.tb08453.x; Narsinh KH, 2011, J CLIN INVEST, V121, P1217, DOI 10.1172/JCI44635; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Raaijmakers MHGP, 2008, CELL, V135, P1006, DOI 10.1016/j.cell.2008.11.034; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Ramos CA, 2006, PLOS GENET, V2, P1487, DOI 10.1371/journal.pgen.0020159; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Rosenfeld S, 2009, GENE REGUL SYST BIO, V3, P1; Scherrer K, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100123; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Thorsen T, 2002, SCIENCE, V298, P580, DOI 10.1126/science.1076996; Tibshirani R, 2005, J COMPUT GRAPH STAT, V14, P511, DOI 10.1198/106186005X59243; VANVALEN L, 1974, J THEOR BIOL, V45, P235, DOI 10.1016/0022-5193(74)90053-8; Warren L, 2006, P NATL ACAD SCI USA, V103, P17807, DOI 10.1073/pnas.0608512103; Warren LA, 2007, AGING CELL, V6, P775, DOI 10.1111/j.1474-9726.2007.00337.x; Weissman IL, 2008, BLOOD, V112, P3543, DOI 10.1182/blood-2008-08-078220; Wheeler AR, 2003, ANAL CHEM, V75, P3581, DOI 10.1021/ac0340758; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048	50	51	52	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21211	10.1371/journal.pone.0021211	http://dx.doi.org/10.1371/journal.pone.0021211			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731674	Green Published, Green Submitted, gold			2022-12-27	WOS:000292033700046
J	Katiyar, SK; Mantena, SK; Meeran, SM				Katiyar, Santosh K.; Mantena, Sudheer K.; Meeran, Syed M.			Silymarin Protects Epidermal Keratinocytes from Ultraviolet Radiation-Induced Apoptosis and DNA Damage by Nucleotide Excision Repair Mechanism	PLOS ONE			English	Article							GREEN TEA POLYPHENOLS; INDUCED IMMUNOSUPPRESSION; SKIN-CANCER; ACTIVATION; PHOTOCARCINOGENESIS; INTERLEUKIN-12; ENHANCEMENT; CONTRIBUTE	Solar ultraviolet (UV) radiation is a well recognized epidemiologic risk factor for melanoma and non-melanoma skin cancers. This observation has been linked to the accumulation of UVB radiation-induced DNA lesions in cells, and that finally lead to the development of skin cancers. Earlier, we have shown that topical treatment of skin with silymarin, a plant flavanoid from milk thistle (Silybum marianum), inhibits photocarcinogenesis in mice; however it is less understood whether chemopreventive effect of silymarin is mediated through the repair of DNA lesions in skin cells and that protect the cells from apoptosis. Here, we show that treatment of normal human epidermal keratinocytes (NHEK) with silymarin blocks UVB-induced apoptosis of NHEK in vitro. Silymarin reduces the amount of UVB radiation-induced DNA damage as demonstrated by reduced amounts of cyclobutane pyrimidine dimers (CPDs) and as measured by comet assay, and that ultimately may lead to reduced apoptosis of NHEK. The reduction of UV radiation-induced DNA damage by silymarin appears to be related with induction of nucleotide excision repair (NER) genes, because UV radiation-induced apoptosis was not blocked by silymarin in NER-deficient human fibroblasts. Cytostaining and dot-blot analysis revealed that silymarin repaired UV-induced CPDs in NER-proficient fibroblasts from a healthy individual but did not repair UV-induced CPD-positive cells in NER-deficient fibroblasts from patients suffering from xeroderma pigmentosum complementation-A disease. Similarly, immunohistochemical analysis revealed that silymarin did not reduce the number of UVB-induced sunburn/apoptotic cells in the skin of NER-deficient mice, but reduced the number of sunburn cells in their wild-type counterparts. Together, these results suggest that silymarin exert the capacity to reduce UV radiation-induced DNA damage and, thus, prevent the harmful effects of UV radiation on the genomic stability of epidermal cells.	[Katiyar, Santosh K.; Mantena, Sudheer K.; Meeran, Syed M.] Univ Alabama Birmingham, Dept Dermatol, Birmingham, AL 35294 USA; [Katiyar, Santosh K.] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA; [Katiyar, Santosh K.] Univ Alabama Birmingham, Nutr Obes Res Ctr, Birmingham, AL 35294 USA; [Katiyar, Santosh K.] Univ Alabama Birmingham, Ctr Aging, Birmingham, AL 35294 USA; [Katiyar, Santosh K.] Birmingham Vet Affairs Med Ctr, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham	Katiyar, SK (corresponding author), Univ Alabama Birmingham, Dept Dermatol, Birmingham, AL 35294 USA.	skatiyar@uab.edu	Meeran, Syed Musthapa/AAG-2157-2020	Meeran, Syed Musthapa/0000-0003-3859-146X	National Cancer Institute [RO1 CA140197]; Veterans Administration Merit Review Award; NATIONAL CANCER INSTITUTE [R01CA140197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR050948] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Administration Merit Review Award(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	RO1 CA140197 by National Cancer Institute (http//www.cancer.gov) and the Veterans Administration Merit Review Award *SKK). The human keratinocytes were obtained from the UAB Skin Diseases Research Center (AR050948). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragane Y, 1998, J CELL BIOL, V140, P171, DOI 10.1083/jcb.140.1.171; Camenisch U, 2006, NAT STRUCT MOL BIOL, V13, P278, DOI 10.1038/nsmb1061; DEVRIES A, 1995, NATURE, V377, P169, DOI 10.1038/377169a0; Dong L, 2010, CANCER RES, V70, P3547, DOI 10.1158/0008-5472.CAN-09-4596; Housman TS, 2003, J AM ACAD DERMATOL, V48, P425, DOI 10.1067/mjd.2003.186; Katiyar SK, 2010, CANCER PREV RES, V3, P179, DOI 10.1158/1940-6207.CAPR-09-0044; Katiyar SK, 2005, INT J ONCOL, V26, P169; Katiyar SK, 2005, MOL CANCER THER, V4, P207; Katiyar SK, 1997, JNCI-J NATL CANCER I, V89, P556, DOI 10.1093/jnci/89.8.556; Katyar SK, 2008, PHOTOCHEM PHOTOBIOL, V84, P266, DOI 10.1111/j.1751-1097.2007.00241.x; Kolgen W, 2003, J INVEST DERMATOL, V121, P751, DOI 10.1046/j.1523-1747.2003.12476.x; Kulms D, 2002, ONCOGENE, V21, P5844, DOI 10.1038/sj.onc.1205743; Kulms D, 1999, P NATL ACAD SCI USA, V96, P7974, DOI 10.1073/pnas.96.14.7974; Mantena SK, 2006, MOL CANCER THER, V5, P296, DOI 10.1158/1535-7163.MCT-05-0448; Mantena SK, 2006, FREE RADICAL BIO MED, V40, P1603, DOI 10.1016/j.freeradbiomed.2005.12.032; Meeran SM, 2006, MOL CANCER THER, V5, P1660, DOI 10.1158/1535-7163.MCT-06-0095; Meeran SM, 2009, J INVEST DERMATOL, V129, P1258, DOI 10.1038/jid.2008.354; Murphy G, 2001, EXP DERMATOL, V10, P155, DOI 10.1034/j.1600-0625.2001.010003155.x; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Schwarz A, 2002, NAT CELL BIOL, V4, P26, DOI 10.1038/ncb717; Stege H, 2000, P NATL ACAD SCI USA, V97, P1790, DOI 10.1073/pnas.030528897; Vaid M, 2010, CANCER PREV RES, V3, P1621, DOI 10.1158/1940-6207.CAPR-10-0137	22	68	70	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21410	10.1371/journal.pone.0021410	http://dx.doi.org/10.1371/journal.pone.0021410			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731736	Green Published, Green Submitted, gold			2022-12-27	WOS:000292033700079
J	Demeyer, M; De Graef, P; Verfaillie, K; Wagemans, J				Demeyer, Maarten; De Graef, Peter; Verfaillie, Karl; Wagemans, Johan			Perceptual Grouping of Object Contours Survives Saccades	PLOS ONE			English	Article							TRANSSACCADIC MEMORY; VISUAL MEMORY; EYE-MOVEMENTS; INFORMATION; REPRESENTATION; WORLD; ORGANIZATION; COMPRESSION; INTEGRATION; PROXIMITY	Human observers explore scenes by shifting their gaze from object to object. Before each eye movement, a peripheral glimpse of the next object to be fixated has however already been caught. Here we investigate whether the perceptual organization extracted from such a preview could guide the perceptual analysis of the same object during the next fixation. We observed that participants were indeed significantly faster at grouping together spatially separate elements into an object contour, when the same contour elements had also been grouped together in the peripheral preview display. Importantly, this facilitation occurred despite a change in the grouping cue defining the object contour (similarity versus collinearity). We conclude that an intermediate-level description of object shape persists in the visual system across gaze shifts, providing it with a robust basis for balancing efficiency and continuity during scene exploration.	[Demeyer, Maarten; De Graef, Peter; Verfaillie, Karl; Wagemans, Johan] Univ Leuven KU Leuven, Expt Psychol Lab, Leuven, Belgium	KU Leuven	Demeyer, M (corresponding author), Univ Leuven KU Leuven, Expt Psychol Lab, Leuven, Belgium.	maarten.demeyer@psy.kuleuven.be	Wagemans, Johan/M-3878-2019	Wagemans, Johan/0000-0002-7970-1541	Research Fund K.U. Leuven [GOA/2005/03-TBA]; European Community [IST-C-033816]; Methusalem grant [METH/08/02]	Research Fund K.U. Leuven(KU Leuven); European Community(European Commission); Methusalem grant	This research was supported by the Concerted Research Effort Convention GOA of the Research Fund K.U. Leuven (GOA/2005/03-TBA) granted to Gery d'Ydewalle, Karl Verfaillie, and Johan Wagemans; by the European Community through GazeCom project IST-C-033816 to Karl Verfaillie and Peter De Graef; and by a Methusalem grant to Johan Wagemans (METH/08/02). Maarten Demeyer is a postdoctoral research fellow of the Research Fund K. U. Leuven (PDMK/10/061). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CARLSONRADVANSKY LA, 1995, J EXP PSYCHOL LEARN, V21, P1441, DOI 10.1037/0278-7393.21.6.1441; Claessens PME, 2008, J VISION, V8, DOI 10.1167/8.7.33; De Graef P, 2002, PROG BRAIN RES, V140, P181; De Graef Peter, 2007, P165, DOI 10.1016/B978-008044980-7/50010-0; Demeyer M, 2010, VISION RES, V50, P1225, DOI 10.1016/j.visres.2010.04.008; Demeyer M, 2009, J VISION, V9, DOI 10.1167/9.4.28; Deubel H, 2002, PROG BRAIN RES, V140, P165; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; Dumoulin SO, 2006, J NEUROPHYSIOL, V95, P3654, DOI 10.1152/jn.01156.2005; Einhauser W, 2008, J VISION, V8, DOI 10.1167/8.2.2; Fang F, 2008, J VISION, V8, DOI 10.1167/8.7.2; Germeys F, 2010, J VISION, V10, DOI 10.1167/10.10.9; Grill-Spector K, 2001, VISION RES, V41, P1409, DOI 10.1016/S0042-6989(01)00073-6; Hamker FH, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040031; Henderson JM, 2003, TRENDS COGN SCI, V7, P498, DOI 10.1016/j.tics.2003.09.006; Henderson JM, 2003, PERCEPT PSYCHOPHYS, V65, P58, DOI 10.3758/BF03194783; Henderson JM, 1997, PSYCHOL SCI, V8, P51, DOI 10.1111/j.1467-9280.1997.tb00543.x; Henderson JM, 2008, VISION RES, V48, P16, DOI 10.1016/j.visres.2007.10.008; HOFFMAN JE, 1995, PERCEPT PSYCHOPHYS, V57, P787, DOI 10.3758/BF03206794; IRWIN DE, 1990, PERCEPT PSYCHOPHYS, V47, P35, DOI 10.3758/BF03208162; IRWIN DE, 1992, J EXP PSYCHOL LEARN, V18, P307, DOI 10.1037/0278-7393.18.2.307; JONIDES J, 1983, SCIENCE, V222, P188, DOI 10.1126/science.6623072; Kimchi R, 2008, PSYCHOL SCI, V19, P660, DOI 10.1111/j.1467-9280.2008.02140.x; KOWLER E, 1995, VISION RES, V35, P1741, DOI 10.1016/0042-6989(94)00255-K; KUBOVY M, 1995, PSYCHOL SCI, V6, P225, DOI 10.1111/j.1467-9280.1995.tb00597.x; Landman R, 2004, PSYCHON B REV, V11, P254, DOI 10.3758/BF03196567; Landman R, 2003, VISION RES, V43, P149, DOI 10.1016/S0042-6989(02)00402-9; LEDERMAN SJ, 1972, PERCEPT PSYCHOPHYS, V12, P401, DOI 10.3758/BF03205850; Machilsen B, 2009, J VISION, V9, DOI 10.1167/9.12.11; Mathot S, 2010, PSYCHOL SCI, V21, P1793, DOI 10.1177/0956797610388813; Melcher D, 2005, CURR BIOL, V15, P1745, DOI 10.1016/j.cub.2005.08.044; Melcher D, 2007, NAT NEUROSCI, V10, P903, DOI 10.1038/nn1917; Melcher D, 2008, TRENDS COGN SCI, V12, P466, DOI 10.1016/j.tics.2008.09.003; Morrone MC, 2005, NAT NEUROSCI, V8, P950, DOI 10.1038/nn1488; Nakamura K, 2002, P NATL ACAD SCI USA, V99, P4026, DOI 10.1073/pnas.052379899; Op de Beeck HP, 2008, J NEUROSCI, V28, P10111, DOI 10.1523/JNEUROSCI.2511-08.2008; OREGAN JK, 1992, CAN J PSYCHOL, V46, P461, DOI 10.1037/h0084327; Panis S, 2009, J EXP PSYCHOL HUMAN, V35, P661, DOI 10.1037/a0013547; POLLATSEK A, 1984, J EXP PSYCHOL GEN, V113, P426, DOI 10.1037/0096-3445.113.3.426; Prime SL, 2007, EXP BRAIN RES, V180, P609, DOI 10.1007/s00221-007-0885-4; Ross J, 1997, NATURE, V386, P598, DOI 10.1038/386598a0; Scholte HS, 2006, BRAIN RES, V1076, P106, DOI 10.1016/j.brainres.2005.10.051; Singer J.D., 2003, APPL LONGITUDINAL DA, DOI 10.1093/acprof:oso/9780195152968.001.0001; Sligte IG, 2009, J NEUROSCI, V29, P7432, DOI 10.1523/JNEUROSCI.0784-09.2009; Van Eccelpoel C, 2008, J VISION, V8, DOI 10.1167/8.14.29; Wertheimer M, 1923, PSYCHOL FORSCH, V4, P301, DOI 10.1007/BF00410640; Wilkinson F, 1998, VISION RES, V38, P3555, DOI 10.1016/S0042-6989(98)00039-X; Wolf W, 1997, SPATIAL VISION, V10, P323, DOI 10.1163/156856897X00249	48	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2011	6	6							e21257	10.1371/journal.pone.0021257	http://dx.doi.org/10.1371/journal.pone.0021257			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	782CL	21713007	gold, Green Submitted, Green Published			2022-12-27	WOS:000291985100021
J	van Hal, SJ; Jones, M; Gosbell, IB; Paterson, DL				van Hal, Sebastiaan J.; Jones, Mark; Gosbell, Iain B.; Paterson, David L.			Vancomycin Heteroresistance Is Associated with Reduced Mortality in ST239 Methicillin-Resistant Staphylococcus aureus Blood Stream Infections	PLOS ONE			English	Article							MINIMUM INHIBITORY CONCENTRATION; BACTERICIDAL ACTIVITY; CLINICAL-FEATURES; BACTEREMIA; SUSCEPTIBILITY; INTERMEDIATE; EFFICACY; STRAINS	Background: Despite hVISA infections being associated with vancomycin treatment failure, no previous study has been able to detect a mortality difference between heteroresistant vancomycin intermediate Staphylococcus aureus (hVISA) and vancomycin susceptible Staphylococcus aureus (VSSA) bloodstream infections (BSI). Methodology: Consecutive methicillin-resistant S. aureus (MRSA) BSI episodes between 1996 and 2008 were reviewed. Patient demographics, clinical presentation, treatment and overall mortality at 30 days were extracted from the medical records. All isolates underwent vancomycin minimum inhibitory concentration (VMIC) testing by broth microdilution and Etest. hVISA was confirmed by population analysis profiling using the area under the curve method (PAP-AUC). Principal Findings: 401 evaluable MRSA BSI episodes were identified over the 12 years. Of these, 46 (11.5%) and 2 (0.5%) were confirmed as hVISA and VISA by PAP-AUC respectively. hVISA predominantly occurred in ST239-like MRSA isolates with high VMIC (2 mg/L). Compared to VSSA, hVISA was associated with chronic renal failure (p<0.001), device related infections (haemodialysis access) (p<0.001) and previous vancomycin usage (p = 0.004). On multivariate analysis, independent predictors of mortality included age, presence of multiple co-morbidities, principal diagnosis, transit to ICU and severity of illness while infection related surgery and hVISA phenotype were associated with increased survival. Conclusions/Significance: The presence of hVISA is dependent on the appropriate interplay between host and pathogen factors. hVISA in ST239 MRSA is an independent predictor of survival. Whether these findings would be replicated across all MRSA clones is unknown and warrants further study.	[van Hal, Sebastiaan J.; Gosbell, Iain B.] Liverpool Hosp, Dept Microbiol & Infect Dis, Sydney S W Pathol Serv, Sydney, NSW, Australia; [van Hal, Sebastiaan J.; Gosbell, Iain B.] Univ Western Sydney, Sch Med, Microbiol & Infect Dis Unit, Penrith, NSW, Australia; [Jones, Mark] Univ Queensland, Ctr Healthcare Related Infect Surveillance & Prev, Queensland Hlth, Brisbane, Qld, Australia; [Jones, Mark] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; [Paterson, David L.] Univ Queensland, Ctr Clin Res UQCCR, Brisbane, Qld, Australia	Liverpool Hospital; Western Sydney University; Queensland Health; University of Queensland; University of Queensland; University of Queensland	van Hal, SJ (corresponding author), Liverpool Hosp, Dept Microbiol & Infect Dis, Sydney S W Pathol Serv, Sydney, NSW, Australia.	Sebastian.vanHal@sswahs.nsw.gov.au	Paterson, David L/A-9258-2010; Jones, Mark/I-2720-2016	Gosbell, Iain/0000-0001-5245-5152; van Hal, Sebastiaan/0000-0001-5852-4155; Jones, Mark/0000-0001-6858-9710; Paterson, David/0000-0003-2079-4437				Bae IG, 2009, J INFECT DIS, V200, P1355, DOI 10.1086/606027; Charles PGP, 2004, CLIN INFECT DIS, V38, P448, DOI 10.1086/381093; Chua K, 2009, CURR OPIN INFECT DIS, V22, P525, DOI 10.1097/QCO.0b013e328331fbcd; *CLIN LAB STAND I, 2011, M100S21 CLSI; Corey GR, 2009, CLIN INFECT DIS, V48, pS254, DOI 10.1086/598186; Hidayat LK, 2006, ARCH INTERN MED, V166, P2138, DOI 10.1001/archinte.166.19.2138; Hiramatsu K, 1997, LANCET, V350, P1670, DOI 10.1016/S0140-6736(97)07324-8; Hiramatsu K, 1997, J ANTIMICROB CHEMOTH, V40, P135, DOI 10.1093/jac/40.1.135; HOLMES N, 2010, INCREASED MORTALITY; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Horne KC, 2009, ANTIMICROB AGENTS CH, V53, P3447, DOI 10.1128/AAC.01365-08; Howden BP, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-39; Howden BP, 2010, CLIN MICROBIOL REV, V23, P99, DOI 10.1128/CMR.00042-09; Jones RN, 2006, CLIN INFECT DIS, V42, pS13, DOI 10.1086/491710; Lesens O, 2003, INFECT CONT HOSP EP, V24, P890, DOI 10.1086/502156; Maor Y, 2009, J INFECT DIS, V199, P619, DOI 10.1086/596629; McCallum N, 2006, ANTIMICROB AGENTS CH, V50, P2352, DOI 10.1128/AAC.00073-06; Moise PA, 2007, ANTIMICROB AGENTS CH, V51, P2582, DOI 10.1128/AAC.00939-06; Musta AC, 2009, J CLIN MICROBIOL, V47, P1640, DOI 10.1128/JCM.02135-08; Neoh Hui-min, 2007, Ann Clin Microbiol Antimicrob, V6, P13, DOI 10.1186/1476-0711-6-13; Patel N, 2011, CLIN INFECT DIS, V52, P969, DOI 10.1093/cid/cir078; Peleg AY, 2009, J INFECT DIS, V199, P532, DOI 10.1086/596511; Rybak MJ, 2008, J CLIN MICROBIOL, V46, P2950, DOI 10.1128/JCM.00582-08; Sakoulas G, 2004, J CLIN MICROBIOL, V42, P2398, DOI 10.1128/JCM.42.6.2398-2402.2004; Sakoulas G, 2005, ANTIMICROB AGENTS CH, V49, P2687, DOI 10.1128/AAC.49.7.2687-2692.2005; Sakoulas G, 2002, ANTIMICROB AGENTS CH, V46, P1492, DOI 10.1128/AAC.46.5.1492-1502.2002; Soriano A, 2008, CLIN INFECT DIS, V46, P193, DOI 10.1086/524667; TAKESUE Y, 2010, J INFECT CHEMOTHER; Turnidge JD, 2009, MED J AUSTRALIA, V191, P368, DOI 10.5694/j.1326-5377.2009.tb02841.x; van Hal SJ, 2011, ANTIMICROB AGENTS CH, V55, P405, DOI 10.1128/AAC.01133-10; van Hal SJ, 2011, J CLIN MICROBIOL, V49, P1489, DOI 10.1128/JCM.02302-10; VANHAL SJ, 2010, 50 INT C ANT AG CHEM; Vikram HR, 2003, JAMA-J AM MED ASSOC, V290, P3207, DOI 10.1001/jama.290.24.3207; Walsh TR, 2001, J ANTIMICROB CHEMOTH, V47, P357, DOI 10.1093/jac/47.3.357; Walsh TR, 2001, J CLIN MICROBIOL, V39, P2439, DOI 10.1128/JCM.39.7.2439-2444.2001	35	56	56	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2011	6	6							e21217	10.1371/journal.pone.0021217	http://dx.doi.org/10.1371/journal.pone.0021217			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782CL	21713004	gold, Green Published, Green Submitted			2022-12-27	WOS:000291985100016
J	Ochala, J; Renaud, G; Diez, ML; Banduseela, VC; Aare, S; Ahlbeck, K; Radell, PJ; Eriksson, LI; Larsson, L				Ochala, Julien; Renaud, Guillaume; Diez, Monica Llano; Banduseela, Varuna C.; Aare, Sudhakar; Ahlbeck, Karsten; Radell, Peter J.; Eriksson, Lars I.; Larsson, Lars			Diaphragm Muscle Weakness in an Experimental Porcine Intensive Care Unit Model	PLOS ONE			English	Article							CONTROLLED MECHANICAL VENTILATION; SKELETAL-MUSCLE; RAT DIAPHRAGM; NEUROMUSCULAR-TRANSMISSION; PROTEIN-TURNOVER; CRITICAL ILLNESS; FIBERS; FORCE; CONTRACTILE; DYSFUNCTION	In critically ill patients, mechanisms underlying diaphragm muscle remodeling and resultant dysfunction contributing to weaning failure remain unclear. Ventilator-induced modifications as well as sepsis and administration of pharmacological agents such as corticosteroids and neuromuscular blocking agents may be involved. Thus, the objective of the present study was to examine how sepsis, systemic corticosteroid treatment (CS) and neuromuscular blocking agent administration (NMBA) aggravate ventilator-related diaphragm cell and molecular dysfunction in the intensive care unit. Piglets were exposed to different combinations of mechanical ventilation and sedation, endotoxin-induced sepsis, CS and NMBA for five days and compared with sham-operated control animals. On day 5, diaphragm muscle fibre structure (myosin heavy chain isoform proportion, cross-sectional area and contractile protein content) did not differ from controls in any of the mechanically ventilated animals. However, a decrease in single fibre maximal force normalized to cross-sectional area (specific force) was observed in all experimental piglets. Therefore, exposure to mechanical ventilation and sedation for five days has a key negative impact on diaphragm contractile function despite a preservation of muscle structure. Post-translational modifications of contractile proteins are forwarded as one probable underlying mechanism. Unexpectedly, sepsis, CS or NMBA have no significant additive effects, suggesting that mechanical ventilation and sedation are the triggering factors leading to diaphragm weakness in the intensive care unit.	[Ochala, Julien; Renaud, Guillaume; Diez, Monica Llano; Banduseela, Varuna C.; Aare, Sudhakar; Larsson, Lars] Uppsala Univ, Dept Neurosci, Uppsala, Sweden; [Larsson, Lars] Penn State Univ, Dept Biobehav Hlth, University Pk, PA 16802 USA; [Ahlbeck, Karsten; Radell, Peter J.; Eriksson, Lars I.] Karolinska Inst, Sect Anesthesiol & Intens Care Med, Stockholm, Sweden	Uppsala University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Karolinska Institutet	Ochala, J (corresponding author), Uppsala Univ, Dept Neurosci, Uppsala, Sweden.	julien.ochala@neuro.uu.se	Ochala, Julien/K-4120-2017; Larsson, Lars/AAY-1347-2021	Ochala, Julien/0000-0002-6358-2920; Larsson, Lars/0000-0003-3722-035X	Swedish Research Council, Swedish Institute and Association Francaise contre les Myopathies; Swedish Research Council, Association Francaise contre les Myopathies, Swedish Cancer Foundation; European Commission [EC Fp7CT-223756]	Swedish Research Council, Swedish Institute and Association Francaise contre les Myopathies(Swedish Research Council); Swedish Research Council, Association Francaise contre les Myopathies, Swedish Cancer Foundation(Association Francaise contre les MyopathiesSwedish Research Council); European Commission(European CommissionEuropean Commission Joint Research Centre)	This study was supported by grants from the Swedish Research Council, Swedish Institute and Association Francaise contre les Myopathies to J.O., and from the Swedish Research Council, Association Francaise contre les Myopathies, Swedish Cancer Foundation and European Commission (MyoAge, EC Fp7CT&-223756) to L.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anzueto A, 1997, CRIT CARE MED, V25, P1187, DOI 10.1097/00003246-199707000-00021; BANDUSEELA VC, 2009, PHYSL GENOMICS; Bolton CF, 1996, INTENS CARE MED, V22, P841; BRENNER B, 1986, P NATL ACAD SCI USA, V83, P3542, DOI 10.1073/pnas.83.10.3542; Cooney RN, 1997, SHOCK, V7, P1, DOI 10.1097/00024382-199701000-00001; DEKHUIJZEN PNR, 1992, EUR RESPIR J, V5, P997; Ebihara S, 2002, AM J RESP CRIT CARE, V165, P221, DOI 10.1164/ajrccm.165.2.2108041; ESTEBAN A, 1995, NEW ENGL J MED, V332, P345, DOI 10.1056/NEJM199502093320601; Esteban A, 2000, AM J RESP CRIT CARE, V161, P1450, DOI 10.1164/ajrccm.161.5.9902018; FABIATO A, 1988, METHOD ENZYMOL, V157, P378; Friedrich O, 2006, CURR OPIN CLIN NUTR, V9, P403, DOI 10.1097/01.mco.0000232900.59168.a0; Frontera WR, 1997, MUSCLE NERVE, V20, P948, DOI 10.1002/(SICI)1097-4598(199708)20:8<948::AID-MUS3>3.0.CO;2-6; Gayan-Ramirez G, 1999, AM J RESP CRIT CARE, V159, P283, DOI 10.1164/ajrccm.159.1.9803021; Horinouchi H, 2005, PATHOBIOLOGY, V72, P108, DOI 10.1159/000084113; Hudson LD, 2003, NEW ENGL J MED, V348, P745, DOI 10.1056/NEJMe020180; HUSSAIN SNA, 1985, J APPL PHYSIOL, V59, P365, DOI 10.1152/jappl.1985.59.2.365; LARSSON L, 1993, J PHYSIOL-LONDON, V472, P595, DOI 10.1113/jphysiol.1993.sp019964; LEBOURDELLES G, 1994, AM J RESP CRIT CARE, V149, P1539, DOI 10.1164/ajrccm.149.6.8004310; Levine S, 2008, NEW ENGL J MED, V358, P1327, DOI 10.1056/NEJMoa070447; Mantilla CB, 2009, RESP PHYSIOL NEUROBI, V169, P133, DOI 10.1016/j.resp.2009.09.002; MARTIN AF, 1981, J BIOL CHEM, V256, P964; Martyn DA, 2007, BIOPHYS J, V92, P4379, DOI 10.1529/biophysj.106.096768; MCDONALD KS, 1995, J APPL PHYSIOL, V79, P1796, DOI 10.1152/jappl.1995.79.5.1796; MOSS RL, 1979, J PHYSIOL-LONDON, V292, P177, DOI 10.1113/jphysiol.1979.sp012845; Nordquist J, 2007, MOL MED, V13, P461, DOI 10.2119/2006-00066.Nordquist; Norman H, 2006, PFLUG ARCH EUR J PHY, V453, P53, DOI 10.1007/s00424-006-0110-5; Norman H, 2006, ACTA ANAESTH SCAND, V50, P1058, DOI 10.1111/j.1399-6576.2006.01105.x; OCHALA J, 2009, PFLUGERS ARCH; Polla B, 2004, THORAX, V59, P808, DOI 10.1136/thx.2003.009894; Powers SK, 2002, J APPL PHYSIOL, V92, P1851, DOI 10.1152/japplphysiol.00881.2001; Radell PJ, 2002, INTENS CARE MED, V28, P358, DOI 10.1007/s00134-002-1207-8; Regnier M, 1998, BIOPHYS J, V74, P2005, DOI 10.1016/S0006-3495(98)77907-X; REID MB, 1993, J APPL PHYSIOL, V75, P1081, DOI 10.1152/jappl.1993.75.3.1081; Sassoon CSH, 2009, CRIT CARE, V13, DOI 10.1186/cc7971; Sassoon CSH, 2004, AM J RESP CRIT CARE, V170, P626, DOI 10.1164/rccm.200401-042OC; Shanely RA, 2004, AM J RESP CRIT CARE, V170, P994, DOI 10.1164/rccm.200304-575OC; Shanely RA, 2002, AM J RESP CRIT CARE, V166, P1369, DOI 10.1164/rccm.200202-088OC; SHINDOH C, 1994, TOHOKU J EXP MED, V173, P291, DOI 10.1620/tjem.173.291; Supinski G, 2000, AM J PHYSIOL-REG I, V278, pR891, DOI 10.1152/ajpregu.2000.278.4.R891; Testelmans D, 2006, CRIT CARE MED, V34, P3018, DOI 10.1097/01.CCM.0000245783.28478.AD; Yang LY, 2002, AM J RESP CRIT CARE, V166, P1135, DOI 10.1164/rccm.2202020; ZAK R, 1979, PHYSIOL REV, V59, P407, DOI 10.1152/physrev.1979.59.2.407; Zergeroglu MA, 2003, J APPL PHYSIOL, V95, P1116, DOI 10.1152/japplphysiol.00824.2002	43	35	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e20558	10.1371/journal.pone.0020558	http://dx.doi.org/10.1371/journal.pone.0020558			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698290	Green Published, Green Submitted, gold			2022-12-27	WOS:000291730000014
J	Yang, JH; Baskar, S; Kwong, KY; Kennedy, MG; Wiestner, A; Rader, C				Yang, Jiahui; Baskar, Sivasubramanian; Kwong, Ka Yin; Kennedy, Michael G.; Wiestner, Adrian; Rader, Christoph			Therapeutic Potential and Challenges of Targeting Receptor Tyrosine Kinase ROR1 with Monoclonal Antibodies in B-Cell Malignancies	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; CHIMERIC RABBIT/HUMAN FAB; PHAGE DISPLAY; MOUSE DEVELOPMENT; EXPRESSION; GENERATION; RITUXIMAB; FAMILY; INFECTIONS; PHENOTYPE	Background: Based on its selective cell surface expression in chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL), receptor tyrosine kinase ROR1 has recently emerged as a promising target for therapeutic monoclonal antibodies (mAbs). To further assess the suitability of ROR1 for targeted therapy of CLL and MCL, a panel of mAbs was generated and its therapeutic utility was investigated. Methodology and Principal Findings: A chimeric rabbit/human Fab library was generated from immunized rabbits and selected by phage display. Chimeric rabbit/human Fab and IgG1 were investigated for their capability to bind to human and mouse ROR1, to mediate antibody-dependent cellular cytotoxicity (ADCC), complement-dependent cytotoxicity (CDC), and internalization, and to agonize or antagonize apoptosis using primary CLL cells from untreated patients as well as MCL cell lines. A panel of mAbs demonstrated high affinity and specificity for a diverse set of epitopes that involve all three extracellular domains of ROR1, are accessible on the cell surface, and mediate internalization. The mAb with the highest affinity and slowest rate of internalization was found to be the only mAb that mediated significant, albeit weak, ADCC. None of the mAbs mediated CDC. Alone, they did not enhance or inhibit apoptosis. Conclusions and Significance: Owing to its relatively low cell surface density, ROR1 may be a preferred target for armed rather than naked mAbs. Provided is a panel of fully sequenced and thoroughly characterized anti-ROR1 mAbs suitable for conversion to antibody-drug conjugates, immunotoxins, chimeric antigen receptors, and other armed mAb entities for preclinical and clinical studies.	[Yang, Jiahui; Baskar, Sivasubramanian; Kwong, Ka Yin; Kennedy, Michael G.; Rader, Christoph] NCI, Expt Transplantat & Immunol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Wiestner, Adrian] NHLBI, Hematol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Yang, JH (corresponding author), NCI, Expt Transplantat & Immunol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	raderc@mail.nih.gov		Rader, Christoph/0000-0001-9955-3454	Center for Cancer Research, National Cancer Institute, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC010648] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006070] Funding Source: NIH RePORTER	Center for Cancer Research, National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was funded by the Intramural Research Program of the Center for Cancer Research, National Cancer Institute, National Institutes of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shawi R, 2001, DEV GENES EVOL, V211, P161, DOI 10.1007/s004270100140; Baskar S, 2008, CLIN CANCER RES, V14, P396, DOI 10.1158/1078-0432.CCR-07-1823; Baskar S, 2009, BLOOD, V114, P4494, DOI 10.1182/blood-2009-05-222786; Borras L, 2010, J BIOL CHEM, V285, P9054, DOI 10.1074/jbc.M109.072876; Byrd JC, 2002, BLOOD, V99, P1038, DOI 10.1182/blood.V99.3.1038; Cheson BD, 2008, NEW ENGL J MED, V359, P613, DOI 10.1056/NEJMra0708875; Chiorazzi N, 2005, NEW ENGL J MED, V352, P804, DOI 10.1056/NEJMra041720; D'Arena G, 2000, AM J HEMATOL, V64, P275; DaneshManesh AH, 2008, INT J CANCER, V123, P1190, DOI 10.1002/ijc.23587; Dornan D, 2010, BLOOD, V116, P4212, DOI 10.1182/blood-2010-03-272765; Dreyling Martin, 2009, Hematology Am Soc Hematol Educ Program, P542, DOI 10.1182/asheducation-2009.1.542; Elter T, 2009, ANN HEMATOL, V88, P121, DOI 10.1007/s00277-008-0566-9; Farag SS, 2004, BLOOD, V103, P1472, DOI 10.1182/blood-2003-07-2548; Fukuda T, 2008, P NATL ACAD SCI USA, V105, P3047, DOI 10.1073/pnas.0712148105; Gea-Banacloche JC, 2010, SEMIN HEMATOL, V47, P187, DOI 10.1053/j.seminhematol.2010.01.002; Green JL, 2008, TRENDS CELL BIOL, V18, P536, DOI 10.1016/j.tcb.2008.08.006; Hallek M, 2008, BLOOD, V111, P5446, DOI 10.1182/blood-2007-06-093906; Hallek M, 2011, BLOOD REV, V25, P1, DOI 10.1016/j.blre.2010.09.001; Hofer T, 2008, P NATL ACAD SCI USA, V105, P12451, DOI 10.1073/pnas.0800800105; Hofer T, 2007, J IMMUNOL METHODS, V318, P75, DOI 10.1016/j.jim.2006.10.007; Hudecek M, 2010, BLOOD, V116, P4532, DOI 10.1182/blood-2010-05-283309; Jaglowski SM, 2010, BLOOD, V116, P3705, DOI 10.1182/blood-2010-04-001230; Jin HK, 2008, CANCER RES, V68, P4360, DOI 10.1158/0008-5472.CAN-07-5960; Kabat EA, 1991, SEQUENCES PROTEINS I; Klein U, 2001, J EXP MED, V194, P1625, DOI 10.1084/jem.194.11.1625; Kwong KY, 2008, J MOL BIOL, V384, P1143, DOI 10.1016/j.jmb.2008.09.008; Kwong KY, 2009, CURR PROTOC PROTEIN; Lapalombella R, 2010, BLOOD, V115, P2619, DOI 10.1182/blood-2009-09-242438; Levesque MC, 2001, LEUKEMIA, V15, P1305, DOI 10.1038/sj.leu.2402192; MASIAKOWSKI P, 1992, J BIOL CHEM, V267, P26181; Minami Y, 2010, DEV DYNAM, V239, P1, DOI 10.1002/dvdy.21991; Oishi I, 1999, GENES CELLS, V4, P41, DOI 10.1046/j.1365-2443.1999.00234.x; Pedersen MW, 2010, CANCER RES, V70, P588, DOI 10.1158/0008-5472.CAN-09-1417; PEREZGALAN P, 2010, BLOOD; Popkov M, 2004, J IMMUNOL METHODS, V288, P149, DOI 10.1016/j.jim.2004.03.005; Popkov M, 2003, J MOL BIOL, V325, P325, DOI 10.1016/S0022-2836(02)01232-9; Prat M, 1998, J CELL SCI, V111, P237; Rader C, 2000, J BIOL CHEM, V275, P13668, DOI 10.1074/jbc.275.18.13668; Rader C, 2009, METHOD MOL BIOL, V525, pxiv; Rader C, 2011, EXPERIMENTAL AND APPLIED IMMUNOTHERAPY, P59, DOI 10.1007/978-1-60761-980-2_3; Rader Christoph, 2009, V525, P101, DOI 10.1007/978-1-59745-554-1_5; Rosenwald A, 2001, J EXP MED, V194, P1639, DOI 10.1084/jem.194.11.1639; Smith MR, 2008, CURR OPIN HEMATOL, V15, P415, DOI 10.1097/MOH.0b013e328302c9c5; Stahl SJ, 2010, J MOL BIOL, V397, P697, DOI 10.1016/j.jmb.2010.01.061; Stein R, 2004, BLOOD, V104, P3705, DOI 10.1182/blood-2004-03-0890; Steinberger P, 2000, J BIOL CHEM, V275, P36073, DOI 10.1074/jbc.M002765200; Wiestner A, 2003, BLOOD, V101, P4944, DOI 10.1182/blood-2002-10-3306	47	51	71	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e21018	10.1371/journal.pone.0021018	http://dx.doi.org/10.1371/journal.pone.0021018			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698301	Green Submitted, Green Published, gold			2022-12-27	WOS:000291730000039
J	Zhou, JM; Eksioglu, EA; Fortenbery, NR; Chen, XH; Wang, HQ; Epling-Burnette, PK; Djeu, JY; Wei, S				Zhou, Junmin; Eksioglu, Erika A.; Fortenbery, Nicole R.; Chen, Xianghong; Wang, Huaquan; Epling-Burnette, Pearlie K.; Djeu, Julie Y.; Wei, Sheng			Bone Marrow Mononuclear Cells Up-Regulate Toll-Like Receptor Expression and Produce Inflammatory Mediators in Response to Cigarette Smoke Extract	PLOS ONE			English	Article							NF-KAPPA-B; OBSTRUCTIVE PULMONARY-DISEASE; BRONCHIAL EPITHELIAL-CELLS; SIGNALING PATHWAYS; INNATE IMMUNITY; CANCER-CELLS; IN-VITRO; ACTIVATION; LIPOPOLYSACCHARIDE; KINASE	Several reports link cigarette smoking with leukemia. However, the effects of cigarette smoke extract (CSE) on bone marrow hematopoiesis remain unknown. The objective of this study was to elucidate the direct effects of cigarette smoke on human bone marrow hematopoiesis and characterize the inflammatory process known to result from cigarette smoking. Bone marrow mononuclear cells (BMCs) from healthy individuals when exposed to CSE had significantly diminished CFU-E, BFU-E and CFU-GM. We found increased nuclear translocation of the NF-kappa B p65 subunit and, independently, enhanced activation of AKT and ERK1/2. Exposure of BMCs to CSE induced IL-8 and TGF-beta 1 production, which was dependent on NF-kappa B and ERK1/2, but not on AKT. CSE treatment had no effect on the release of TNF-alpha, IL-10, or VEGF. Finally, CSE also had a significant induction of TLR2, TLR3 and TLR4, out of which, the up-regulation of TLR2 and TLR3 was found to be dependent on ERK1/2 and NF-kappa B activation, but not AKT. These results indicate that CSE profoundly inhibits the growth of erythroid and granulocyte-macrophage progenitors in the bone marrow. Further, CSE modulates NF-kappa B- and ERK1/2-dependent responses, suggesting that cigarette smoking may impair bone marrow hematopoiesis in vivo as well as induce inflammation, two processes that proceed malignant transformation.	[Zhou, Junmin; Eksioglu, Erika A.; Fortenbery, Nicole R.; Chen, Xianghong; Epling-Burnette, Pearlie K.; Djeu, Julie Y.; Wei, Sheng] H Lee Moffitt Canc Ctr & Res Inst, Dept Immunol, Tampa, FL USA; [Wang, Huaquan] Tianjin Med Univ, Gen Hosp, Dept Hematol, Tianjin, Peoples R China	H Lee Moffitt Cancer Center & Research Institute; Tianjin Medical University	Zhou, JM (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Immunol, Tampa, FL USA.	Sheng.wei@moffitt.org	Wang, Huaquan/AAN-6917-2021; Eksioglu, Erika/E-6315-2015	Eksioglu, Erika/0000-0003-4458-7192	National Institutes of Health [AI056213]; State of Florida/Department of Health [09KT-01]; NATIONAL CANCER INSTITUTE [P30CA076292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056213] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); State of Florida/Department of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant [AI056213] and a grant from the State of Florida/Department of Health fund [09KT-01]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797; Baeuerle PA, 1997, ADV IMMUNOL, V65, P111, DOI 10.1016/S0065-2776(08)60742-7; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Barnes PJ, 2008, NAT REV IMMUNOL, V8, P183, DOI 10.1038/nri2254; Birrell MA, 2008, J CELL PHYSIOL, V214, P27, DOI 10.1002/jcp.21158; Chen ZH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003316; Didierlaurent A, 2006, MOL CELL BIOL, V26, P735, DOI 10.1128/MCB.26.3.735-742.2006; Ehlers SL, 2011, BONE MARROW TRANSPL, V46, P285, DOI 10.1038/bmt.2010.113; Fong YC, 2008, J BONE MINER RES, V23, P961, DOI 10.1359/JBMR.080206; Francois S, 2005, J IMMUNOL, V174, P3633, DOI 10.4049/jimmunol.174.6.3633; Fromer L, 2008, INT J CLIN PRACT, V62, P1219, DOI 10.1111/j.1742-1241.2008.01807.x; Fukao T, 2003, TRENDS IMMUNOL, V24, P358, DOI 10.1016/S1471-4906(03)00139-X; Garbin U, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008225; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Gribaldo L, 1999, EXP HEMATOL, V27, P1593, DOI 10.1016/S0301-472X(99)00107-1; Guillot L, 2005, J BIOL CHEM, V280, P5571, DOI 10.1074/jbc.M410592200; Haura EB, 2006, MED HYPOTHESES, V67, P951, DOI 10.1016/j.mehy.2005.12.050; Imler JL, 2001, TRENDS CELL BIOL, V11, P304, DOI 10.1016/S0962-8924(01)02004-9; Ishii M, 2008, EUR J IMMUNOL, V38, P2290, DOI 10.1002/eji.200838360; Khaldoyanidi S, 2001, BLOOD, V98, P303, DOI 10.1182/blood.V98.2.303; Kumar A, 2003, FASEB J, V17, P386, DOI 10.1096/fj.02-0542com; Laan M, 2004, J IMMUNOL, V173, P4164, DOI 10.4049/jimmunol.173.6.4164; Larsson J, 2003, BLOOD, V102, P3129, DOI 10.1182/blood-2003-04-1300; Lichtman MA, 2007, LEUKEMIA, V21, P1137, DOI 10.1038/sj.leu.2404698; Liu XD, 2003, OSTEOPOROSIS INT, V14, P235, DOI 10.1007/s00198-002-1350-7; Liu XD, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-66; Mockenhaupt FP, 2006, P NATL ACAD SCI USA, V103, P177, DOI 10.1073/pnas.0506803102; Mortaz E, 2008, J LEUKOCYTE BIOL, V83, P575, DOI 10.1189/jlb.0907625; Ojaniemi M, 2003, EUR J IMMUNOL, V33, P597, DOI 10.1002/eji.200323376; Ozes ON, 1999, NATURE, V401, P82; Pace E, 2008, IMMUNOLOGY, V124, P401, DOI 10.1111/j.1365-2567.2007.02788.x; Parent-Massin D, 2010, TOXICOLOGY, V267, P112, DOI 10.1016/j.tox.2009.10.031; Philip S, 2003, J BIOL CHEM, V278, P14487, DOI 10.1074/jbc.M207309200; Podar K, 2009, LEUKEMIA, V23, P10, DOI 10.1038/leu.2008.259; Rakoff-Nahoum S, 2009, NAT REV CANCER, V9, P57, DOI 10.1038/nrc2541; Robbins CS, 2006, AM J RESP CRIT CARE, V174, P1342, DOI 10.1164/rccm.200604-561OC; Romashkova JA, 1999, NATURE, V401, P86, DOI 10.1038/43474; Ruse M, 2006, IMMUNOL RES, V34, P33, DOI 10.1385/IR:34:1:33; Lu S, 2006, PROSTATE, V66, P996, DOI 10.1002/pros.20424; Staron M, 2010, BLOOD, V115, P2380, DOI 10.1182/blood-2009-07-233031; Takada Y, 2005, J BIOL CHEM, V280, P17203, DOI 10.1074/jbc.M500077200; Testa U, 2004, LEUKEMIA, V18, P1176, DOI 10.1038/sj.leu.2403383; van Eeden SF, 2000, EUR RESPIR J, V15, P915, DOI 10.1034/j.1399-3003.2000.15e18.x; Wang DH, 2009, J IMMUNOL, V182, P5757, DOI 10.4049/jimmunol.0803861; Wang JH, 2009, AM J RHINOL ALLERGY, V23, pE5, DOI 10.2500/ajra.2009.23.3407; Wang ZQ, 2006, CANCER RES, V66, P8870, DOI 10.1158/0008-5472.CAN-06-1280	46	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21173	10.1371/journal.pone.0021173	http://dx.doi.org/10.1371/journal.pone.0021173			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21738617	Green Published, Green Submitted, gold			2022-12-27	WOS:000292290100014
J	Munoz-Abellan, C; Rabasa, C; Daviu, N; Nadal, R; Armario, A				Munoz-Abellan, Cristina; Rabasa, Cristina; Daviu, Nuria; Nadal, Roser; Armario, Antonio			Behavioral and Endocrine Consequences of Simultaneous Exposure to Two Different Stressors in Rats: Interaction or Independence?	PLOS ONE			English	Article							PITUITARY-ADRENAL RESPONSIVENESS; ANXIETY-RELATED BEHAVIOR; ELEVATED PLUS-MAZE; CAT ODOR; SINGLE EXPOSURE; MARKED DISSOCIATION; DEFENSIVE BEHAVIORS; ADRENOCORTICAL AXIS; PREDATOR EXPOSURE; LASTING INCREASES	Although behavioral and endocrine consequences of acute exposure to stressors have been extensively studied, little is known about how simultaneous exposure to two different stressors interacts to induce short-and long-term effects. In the present experiment we studied this interaction in adult male rats exposed to cat fur odor (impregnated cloth) or immobilization on boards either separately or simultaneously. We reasoned that exposure to the odor of a potential predator while immobilized, may potentiate its negative consequences as compared to exposure to only one of the stressors. Exposure to cat odor elicited the expected reduction of activity and avoidance of the area where the impregnated cloth was located. The endocrine response (plasma levels of ACTH and corticosterone, as a measure of the hypothalamic-pituitary-adrenal axis, HPA) was markedly greater after immobilization than after cat fur odor and no additive effects were found by simultaneous exposure to both stressors. Cat odor, but not immobilization, increased anxiety-like behavior as evaluated in the elevated plus-maze 7 days after the stressors, with no evidence of enhanced HPA activation. In addition, cat odor exposure resulted in long-lasting (8 days later) fear conditioning to the box containing a clean cloth, which was reflected by hypoactivity, avoidance of the cloth area and enhanced HPA activation. All these effects were similarly observed in rats exposed simultaneously to cat odor and immobilization. In rats only exposed to immobilization, only some weak behavioral signs of fear conditioning were found, but HPA activation in response to the context paired to immobilization was enhanced to the same extent as in cat odor-exposed animals, supporting a certain degree of endocrine conditioning. The present results did not reveal important behavioral interactions between the two stressors when animals experienced both simultaneously, whereas some interactions were found regarding HPA activation. Theoretical implications are discussed.	[Munoz-Abellan, Cristina; Rabasa, Cristina; Daviu, Nuria; Nadal, Roser; Armario, Antonio] Univ Autonoma Barcelona, Inst Neurociencies, E-08193 Barcelona, Spain; [Munoz-Abellan, Cristina; Rabasa, Cristina; Daviu, Nuria; Armario, Antonio] Univ Autonoma Barcelona, Fac Biociencies, Unitat Fisiol Anim, E-08193 Barcelona, Spain; [Nadal, Roser] Univ Autonoma Barcelona, Fac Psicol, Unitat Psicobiol, E-08193 Barcelona, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; Autonomous University of Barcelona	Munoz-Abellan, C (corresponding author), Univ Autonoma Barcelona, Inst Neurociencies, E-08193 Barcelona, Spain.	Antonio.armario@uab.es	Armario, Antonio/C-9267-2011; Nadal, Roser/C-7977-2011; Daviu, Nuria/C-9528-2011	Armario, Antonio/0000-0001-9524-3635; Nadal, Roser/0000-0001-8972-2525; Daviu, Nuria/0000-0002-9843-2981	Ministerio de Ciencia e Innovacion [SAF2008-01175]; Instituto de Salud Carlos III (Redes Tematicas de Investigacion Cooperativa en Salud, Ministerio de Sanidad y Consumo) [RD06/0001/0015]; Plan Nacional sobre Drogas and Generalitat de Catalunya, Spain [SGR2009-16]; Ministerio de Educacion y Ciencia, Spain	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Instituto de Salud Carlos III (Redes Tematicas de Investigacion Cooperativa en Salud, Ministerio de Sanidad y Consumo)(Instituto de Salud Carlos III); Plan Nacional sobre Drogas and Generalitat de Catalunya, Spain; Ministerio de Educacion y Ciencia, Spain(Spanish Government)	This work was supported by grants from Ministerio de Ciencia e Innovacion (SAF2008-01175), Instituto de Salud Carlos III (RD06/0001/0015, Redes Tematicas de Investigacion Cooperativa en Salud, Ministerio de Sanidad y Consumo), Plan Nacional sobre Drogas and Generalitat de Catalunya (SGR2009-16), Spain. CMA, ND and CR are recipients of fellowships from Ministerio de Educacion y Ciencia, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL EL, 1991, PHYSIOL BEHAV, V50, P151, DOI 10.1016/0031-9384(91)90513-N; Adamec R, 1998, NEUROSCI BIOBEHAV R, V23, P301, DOI 10.1016/S0149-7634(98)00032-3; Adamec R, 2004, PHYSIOL BEHAV, V83, P401, DOI 10.1016/j.physbeh.2004.08.029; Adamec RE, 1999, PHYSIOL BEHAV, V65, P723; ADAMEC RE, 1993, PHYSIOL BEHAV, V54, P101, DOI 10.1016/0031-9384(93)90050-P; Adamec RE, 1997, BEHAV NEUROSCI, V111, P435; ANDERO R, 2010, HIPPOCAMPUS IN PRESS; Andero R, 2011, AM J PSYCHIAT, V168, P163, DOI 10.1176/appi.ajp.2010.10030326; [Anonymous], 2007, LEARNING BEHAV CONT; Armario Antonio, 2006, CNS & Neurological Disorders-Drug Targets, V5, P485, DOI 10.2174/187152706778559336; Belda X, 2004, BEHAV BRAIN RES, V154, P399, DOI 10.1016/j.bbr.2004.03.011; Belda X, 2008, HORM BEHAV, V54, P654, DOI 10.1016/j.yhbeh.2008.07.003; Blanchard RJ, 2001, NEUROSCI BIOBEHAV R, V25, P587, DOI 10.1016/S0149-7634(01)00043-4; BRUSH FR, 1991, BEHAV GENET, V21, P35, DOI 10.1007/BF01067665; Cohen H, 2004, NEUROPSYCHOPHARMACOL, V29, P1962, DOI 10.1038/sj.npp.1300523; Cohen H, 2003, BIOL PSYCHIAT, V53, P463, DOI 10.1016/S0006-3223(02)01909-1; Cohen H, 2000, EUR NEUROPSYCHOPHARM, V10, P429, DOI 10.1016/S0924-977X(00)00105-X; Cohen H, 1999, DEPRESS ANXIETY, V10, P8, DOI 10.1002/(SICI)1520-6394(1999)10:1<8::AID-DA2>3.0.CO;2-#; Daviu N, 2010, NEUROBIOL LEARN MEM, V94, P183, DOI 10.1016/j.nlm.2010.05.005; Dielenberg RA, 1999, PHARMACOL BIOCHEM BE, V62, P197, DOI 10.1016/S0091-3057(98)00064-1; Dielenberg RA, 1999, J COMP PSYCHOL, V113, P376, DOI 10.1037/0735-7036.113.4.376; Dielenberg RA, 2001, BRAIN RES, V897, P228, DOI 10.1016/S0006-8993(01)02227-2; ENGELAND WC, 1989, ENDOCRINOLOGY, V124, P2978, DOI 10.1210/endo-124-6-2978; FANSELOW MS, 1990, ANIM LEARN BEHAV, V18, P264, DOI 10.3758/BF03205285; Figueiredo HF, 2003, ENDOCRINOLOGY, V144, P5249, DOI 10.1210/en.2003-0713; FILE SE, 1993, PHYSIOL BEHAV, V54, P1109, DOI 10.1016/0031-9384(93)90333-B; FILE SE, 1994, PSYCHOPHARMACOLOGY, V113, P543, DOI 10.1007/BF02245237; Gagliano H, 2008, BEHAV BRAIN RES, V187, P239, DOI 10.1016/j.bbr.2007.09.006; Goswami S, 2010, LEARN MEMORY, V17, P494, DOI 10.1101/lm.1948910; Hardin JW, 2012, GEN ESTIMATING EQUAT; Johnson JD, 2002, BRAIN BEHAV IMMUN, V16, P461, DOI 10.1006/brbi.2001.0638; Koks S, 2002, NEUROSCI LETT, V322, P116, DOI 10.1016/S0304-3940(02)00110-6; Landgraf R, 1999, J NEUROENDOCRINOL, V11, P405; LEMEVEL JC, 1979, ENDOCRINOLOGY, V105, P812; Li CI, 2004, BEHAV NEUROSCI, V118, P324, DOI 10.1037/0735-7044.118.2.324; Liebsch G, 1998, NEUROPSYCHOPHARMACOL, V19, P381, DOI 10.1016/S0893-133X(98)00042-6; Mackenzie L, 2010, NEUROSCIENCE, V169, P733, DOI 10.1016/j.neuroscience.2010.05.005; Marquez C, 2006, BEHAV BRAIN RES, V168, P13, DOI 10.1016/j.bbr.2005.10.004; Marquez C, 2002, BRAIN RES, V926, P181, DOI 10.1016/S0006-8993(01)03112-2; Mazur J.E., 2006, LEARN BEHAV; McCulloch C. E., 2001, GEN LINEAR MIXED MOD; McGregor IS, 1999, PSYCHOPHARMACOLOGY, V147, P174, DOI 10.1007/s002130051158; Mesches M H, 1999, J Neurosci, V19, pRC18; Munoz-Abellan C, 2010, PHYSIOL BEHAV, V99, P388, DOI 10.1016/j.physbeh.2009.12.008; Munoz-Abellan C, 2009, HORM BEHAV, V56, P465, DOI 10.1016/j.yhbeh.2009.08.002; Munoz-Abellan C, 2008, PSYCHONEUROENDOCRINO, V33, P1139, DOI 10.1016/j.psyneuen.2008.06.002; O'Connor KA, 2003, PSYCHONEUROENDOCRINO, V28, P481, DOI 10.1016/S0306-4530(02)00035-5; Papes F, 2010, CELL, V141, P692, DOI 10.1016/j.cell.2010.03.037; PELLOW S, 1986, PHARMACOL BIOCHEM BE, V24, P525, DOI 10.1016/0091-3057(86)90552-6; Rotllant D, 2007, DEV NEUROBIOL, V67, P702, DOI 10.1002/dneu.20345; Siviy SM, 2006, BEHAV NEUROSCI, V120, P49, DOI 10.1037/0735-7044.120.1.49; Staples LG, 2010, NEUROBIOL LEARN MEM, V94, P435, DOI 10.1016/j.nlm.2010.09.009; Takahashi LK, 2005, NEUROSCI BIOBEHAV R, V29, P1157, DOI 10.1016/j.neubiorev.2005.04.008; Vahl TP, 2005, AM J PHYSIOL-ENDOC M, V289, pE823, DOI 10.1152/ajpendo.00122.2005; Valles A, 2000, AM J PHYSIOL-REG I, V279, pR1138, DOI 10.1152/ajpregu.2000.279.3.R1138; Zelena D, 2003, AM J PHYSIOL-ENDOC M, V285, pE1110, DOI 10.1152/ajpendo.00219.2003	56	27	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21426	10.1371/journal.pone.0021426	http://dx.doi.org/10.1371/journal.pone.0021426			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21731743	Green Published, gold, Green Submitted			2022-12-27	WOS:000292036900030
J	Bella, SD; Palmer, C				Bella, Simone Dalla; Palmer, Caroline			Rate Effects on Timing, Key Velocity, and Finger Kinematics in Piano Performance	PLOS ONE			English	Article							PERSON IDENTIFICATION; STRING VIBRATIONS; FORCE PRODUCTION; MOTION; ACCURACY; TOUCH; HAND; FEEDBACK; GAIT	We examined the effect of rate on finger kinematics in goal-directed actions of pianists. In addition, we evaluated whether movement kinematics can be treated as an indicator of personal identity. Pianists' finger movements were recorded with a motion capture system while they performed melodies from memory at different rates. Pianists' peak finger heights above the keys preceding keystrokes increased as tempo increased, and were attained about one tone before keypress. These rate effects were not simply due to a strategy to increase key velocity (associated with tone intensity) of the corresponding keystroke. Greater finger heights may compensate via greater tactile feedback for a speed-accuracy tradeoff that underlies the tendency toward larger temporal variability at faster tempi. This would allow pianists to maintain high temporal accuracy when playing at fast rates. In addition, finger velocity and accelerations as pianists' fingers approached keys were sufficiently unique to allow pianists' identification with a neural-network classifier. Classification success was higher in pianists with more extensive musical training. Pianists' movement "signatures'' may reflect unique goal-directed movement kinematic patterns, leading to individualistic sound.	[Bella, Simone Dalla] Univ Finance & Management, Dept Cognit Psychol, Warsaw, Poland; [Palmer, Caroline] McGill Univ, Dept Psychol, Montreal, PQ, Canada	University of Finance & Management Warsaw; McGill University	Bella, SD (corresponding author), Univ Finance & Management, Dept Cognit Psychol, Warsaw, Poland.	sdallabella@vizja.pl		Palmer, Caroline/0000-0003-4816-8067	European Commission [14847]; Canada Research Chair; NSERC [298173]	European Commission(European CommissionEuropean Commission Joint Research Centre); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was supported by an International Reintegration Grant 14847 from the European Commission to the first author and by a Canada Research Chair and NSERC Grant 298173 to the second author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASKENFELT A, 1991, J ACOUST SOC AM, V90, P2383, DOI 10.1121/1.402043; ASKENFELT A, 1990, J ACOUST SOC AM, V88, P52, DOI 10.1121/1.399933; Balasubramaniam R, 2004, EXP BRAIN RES, V159, P129, DOI 10.1007/s00221-004-2066-z; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/bf00058655; CUTTING JE, 1977, B PSYCHONOMIC SOC, V9, P353, DOI 10.3758/BF03337021; DEMUTH H, 2005, NEURONAL NETWORK TOO; Drake C, 2000, COGNITION, V74, P1, DOI 10.1016/S0010-0277(99)00061-X; Dryden IL, 1998, STAT SHAPE ANAL, DOI DOI 10.5555/1046920.1088707; Engel KC, 1997, EXP BRAIN RES, V113, P189, DOI 10.1007/BF02450317; Gabrielsson A., 1996, PSYCHOL MUSIC, V24, P68, DOI DOI 10.1177/0305735696241007; Gabrielsson A., 1999, PSYCHOL MUSIC, P501, DOI [10.1016/B978-012213564-4/50015-9, DOI 10.1016/B978-012213564-4/50015-9]; Goebl W, 2005, J ACOUST SOC AM, V118, P1154, DOI 10.1121/1.1944648; Goebl W, 2008, EXP BRAIN RES, V186, P471, DOI 10.1007/s00221-007-1252-1; Goebl W, 2009, MUSIC PERCEPT, V26, P427, DOI 10.1525/MP.2009.26.5.427; HAKEN H, 1985, BIOL CYBERN, V51, P347, DOI 10.1007/BF00336922; Hardcastle W. J., 1999, COARTICULATION THEOR; Jackson PL, 2004, CURR OPIN NEUROBIOL, V14, P259, DOI 10.1016/j.conb.2004.01.020; Latash ML, 1998, EXP BRAIN RES, V122, P131, DOI 10.1007/s002210050500; Li ZN, 1998, EXP BRAIN RES, V122, P71, DOI 10.1007/s002210050492; Loehr JD, 2007, EXP BRAIN RES, V178, P518, DOI 10.1007/s00221-006-0760-8; Loehr JD, 2009, J MOTOR BEHAV, V41, P128, DOI 10.3200/JMBR.41.2.128-136; MACKENZIE CL, 1990, ATTENTION PERFORM, V8, P375; PALMER C, 1993, J EXP PSYCHOL LEARN, V19, P457, DOI 10.1037/0278-7393.19.2.457; Palmer C, 1996, MUSIC PERCEPT, V13, P433; Palmer C, 2003, PSYCHOL REV, V110, P683, DOI 10.1037/0033-295X.110.4.683; Palmer C., 2007, P INT C MUS COMM SCI, P119; Palmer C., 2006, MUSIC MOTOR CONTROL, P39, DOI [10.1093/acprof:oso/9780199298723.003.0003, DOI 10.1093/ACPROF:OSO/9780199298723.003.0003]; Palmer C, 2009, MUSIC PERCEPT, V26, P439, DOI 10.1525/MP.2009.26.5.439; Pfordresher PQ, 2007, COGNITIVE SCI, V31, P63, DOI 10.1080/03640210709336985; Ramsay JO, 2000, J AM STAT ASSOC, V95, P9; RAMSEY J. O., 2005, FUNCTIONAL DATA ANAL; RAMSEY JO, 2002, APPL FUNCTIONAL DATA; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Rosenbaum DA, 2006, MOTOR CONTROL AND LEARNING, P9, DOI 10.1007/0-387-28287-4_2; Rosenbaum David A., 1996, P169, DOI 10.1016/B978-012759440-8/50013-X; RUSSIANOFF L, 1982, CLARINET METHOD BOOK, V2; Santello M, 2002, J NEUROSCI, V22, P1426, DOI 10.1523/JNEUROSCI.22-04-01426.2002; Santello M, 1998, J NEUROPHYSIOL, V79, P1307, DOI 10.1152/jn.1998.79.3.1307; Schmidt RA, 2005, MOTOR CONTROL LEARNI; Slobounov S, 2002, BRAIN RES, V954, P212, DOI 10.1016/S0006-8993(02)03288-2; Stevenage SV, 1999, APPL COGNITIVE PSYCH, V13, P513, DOI 10.1002/(SICI)1099-0720(199912)13:6<513::AID-ACP616>3.0.CO;2-8; TAYLOR K, 1983, PRINCIPLES PIANO TEC; Teal L., 1963, ART SAXOPHONE PLAYIN; Troje NF, 2005, PERCEPT PSYCHOPHYS, V67, P667, DOI 10.3758/BF03193523; Tsakiris M, 2005, COGN NEUROPSYCHOL, V22, P387, DOI 10.1080/02643290442000158; Westhoff C, 2007, PERCEPT PSYCHOPHYS, V69, P241, DOI 10.3758/BF03193746	46	28	28	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e20518	10.1371/journal.pone.0020518	http://dx.doi.org/10.1371/journal.pone.0020518			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	782TT	21731615	Green Published, gold, Green Submitted			2022-12-27	WOS:000292035400003
J	Borodina, I; Jensen, BM; Wagner, T; Hachem, MA; Sondergaard, I; Poulsen, LK				Borodina, Irina; Jensen, Bettina M.; Wagner, Tim; Hachem, Maher A.; Sondergaard, Ib; Poulsen, Lars K.			Expression of Enzymatically Inactive Wasp Venom Phospholipase A1 in Pichia pastoris	PLOS ONE			English	Article							REACTIVE CARBOHYDRATE DETERMINANTS; ALLERGEN-SPECIFIC IMMUNOTHERAPY; VES V 2; VESPULA-VULGARIS; N-GLYCANS; ANTIGEN 5; RECOMBINANT; PROTEINS; VACCINE; HYALURONIDASE	Wasp venom allergy is the most common insect venom allergy in Europe. It is manifested by large local reaction or anaphylactic shock occurring after a wasp sting. The allergy can be treated by specific immunotherapy with whole venom extracts. Wasp venom is difficult and costly to obtain and is a subject to composition variation, therefore it can be advantageous to substitute it with a cocktail of recombinant allergens. One of the major venom allergens is phospholipase A1, which so far has been expressed in Escherichia coli and in insect cells. Our aim was to produce the protein in secreted form in yeast Pichia pastoris, which can give high yields of correctly folded protein on defined minimal medium and secretes relatively few native proteins simplifying purification. Residual amounts of enzymatically active phospholipase A1 could be expressed, but the venom protein had a deleterious effect on growth of the yeast cells. To overcome the problem we introduced three different point mutations at the critical points of the active site, where serine137, aspartate165 or histidine229 were replaced by alanine (S137A, D165A and H229A). All the three mutated forms could be expressed in P. pastoris. The H229A mutant did not have any detectable phospholipase A1 activity and was secreted at the level of several mg/L in shake flask culture. The protein was purified by nickel-affinity chromatography and its identity was confirmed by MALDI-TOF mass spectrometry. The protein could bind IgE antibodies from wasp venom allergic patients and could inhibit the binding of wasp venom to IgE antibodies specific for phospholipase A1 as shown by Enzyme Allergo-Sorbent Test (EAST). Moreover, the recombinant protein was allergenic in a biological assay as demonstrated by its capability to induce histamine release of wasp venom-sensitive basophils. The recombinant phospholipase A1 presents a good candidate for wasp venom immunotherapy.	[Borodina, Irina; Wagner, Tim; Sondergaard, Ib] Tech Univ Denmark, Inst Syst Biol, Ctr Microbial Biotechnol, DK-2800 Lyngby, Denmark; [Jensen, Bettina M.; Poulsen, Lars K.] Rigshosp, Dept 7551, CUH Gentofte, Allergy Clin,Dermato Allergol Dept K, Copenhagen O, Denmark; [Hachem, Maher A.] Tech Univ Denmark, Inst Syst Biol, Enzyme & Prot Ctr, DK-2800 Lyngby, Denmark	Technical University of Denmark; Rigshospitalet; Technical University of Denmark	Borodina, I (corresponding author), Tech Univ Denmark, Inst Syst Biol, Ctr Microbial Biotechnol, DK-2800 Lyngby, Denmark.	lkpallgy@mail.dk	Poulsen, Lars K/J-3065-2019; Borodina, Irina/G-5587-2013; Abou Hachem, Maher/M-4772-2019	Poulsen, Lars K/0000-0002-1730-847X; Abou Hachem, Maher/0000-0001-8250-1842; Borodina, Irina/0000-0002-8452-1393	Danish Research Council [274-07-0148]	Danish Research Council(Det Frie Forskningsrad (DFF))	This work was funded by Grant 274-07-0148 from the Danish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARKHOLT V, 1989, ANAL BIOCHEM, V177, P318, DOI 10.1016/0003-2697(89)90059-6; Blank S, 2010, J IMMUNOL, V184, P5403, DOI 10.4049/jimmunol.0803709; Borodina I, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-74; CHARPIN D, 1992, J ALLERGY CLIN IMMUN, V90, P331, DOI 10.1016/S0091-6749(05)80011-9; Combet C, 2002, BIOINFORMATICS, V18, P213, DOI 10.1093/bioinformatics/18.1.213; Crameri R, 2006, CURR OPIN IMMUNOL, V18, P761, DOI 10.1016/j.coi.2006.09.001; Golden DBK, 2005, J ALLERGY CLIN IMMUN, V115, P439, DOI 10.1016/j.jaci.2005.01.005; Jappe U, 2006, ALLERGY, V61, P1220, DOI 10.1111/j.1398-9995.2006.01232.x; Jin C, 2008, J ALLERGY CLIN IMMUN, V121, P185, DOI 10.1016/j.jaci.2007.07.047; Jutel M, 2005, J ALLERGY CLIN IMMUN, V116, P608, DOI 10.1016/j.jaci.2005.06.004; Karamloo F, 2005, EUR J IMMUNOL, V35, P3268, DOI 10.1002/eji.200425522; KING TP, 1983, MOL IMMUNOL, V20, P297, DOI 10.1016/0161-5890(83)90069-X; King TP, 1996, J ALLERGY CLIN IMMUN, V98, P588, DOI 10.1016/S0091-6749(96)70093-3; Kolarich D, 2005, FEBS J, V272, P5182, DOI 10.1111/j.1742-4658.2005.04841.x; Kolarich D, 2007, PROTEOMICS, V7, P1615, DOI 10.1002/pmic.200600800; Laino P, 2010, PROTEOMICS, V10, P2359, DOI 10.1002/pmic.200900803; Malkin EM, 2005, INFECT IMMUN, V73, P3677, DOI 10.1128/IAI.73.6.3677-3685.2005; Mayer A, 2006, CLIN CANCER RES, V12, P6509, DOI 10.1158/1078-0432.CCR-06-0769; Mittermann I, 2010, J ALLERGY CLIN IMMUN, V125, P1300, DOI 10.1016/j.jaci.2010.03.017; Monsalve RI, 1999, PROTEIN EXPRES PURIF, V16, P410, DOI 10.1006/prep.1999.1082; MOSBECH H, 2004, NOVART FDN SYMP, V257, P207; MOSBECH H, 2004, NOVART FDN SYMP, V257, P188; MOSBECH H, 2004, NOVART FDN SYMP, V257, P276; Mosbech Holger, 2004, Novartis Found Symp, V257, P177; Pauli G, 2008, J ALLERGY CLIN IMMUN, V122, P951, DOI 10.1016/j.jaci.2008.09.017; Seismann Henning, 2010, Clin Mol Allergy, V8, P7, DOI 10.1186/1476-7961-8-7; Seismann H, 2010, MOL IMMUNOL, V47, P799, DOI 10.1016/j.molimm.2009.10.005; Seppala U, 2009, MOL IMMUNOL, V46, P2014, DOI 10.1016/j.molimm.2009.03.005; Skov LK, 2006, ACTA CRYSTALLOGR D, V62, P595, DOI 10.1107/S0907444906010687; SKOV PS, 1984, AGENTS ACTIONS, V14, P414, DOI 10.1007/BF01973840; Suck R, 2000, INT ARCH ALLERGY IMM, V121, P284, DOI 10.1159/000024341; vanWandelen C, 1997, J CHROMATOGR A, V763, P11, DOI 10.1016/S0021-9673(96)00891-6; Walsh G, 2010, NAT BIOTECHNOL, V28, P917, DOI 10.1038/nbt0910-917; Winkler B, 2003, IMMUNOLOGY, V110, P376, DOI 10.1046/j.1365-2567.2003.01751.x; Wu SX, 2004, BIOTECHNIQUES, V36, P152, DOI 10.2144/04361DD02	35	13	14	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21267	10.1371/journal.pone.0021267	http://dx.doi.org/10.1371/journal.pone.0021267			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731687	Green Published, Green Submitted, gold			2022-12-27	WOS:000292035400017
J	Larios, OE; Coleman, BL; Drews, SJ; Mazzulli, T; Borgundvaag, B; Green, K; McGeer, AJ				Larios, Oscar E.; Coleman, Brenda L.; Drews, Steven J.; Mazzulli, Tony; Borgundvaag, Bjug; Green, Karen; McGeer, Allison J.		STOP-Flu Study	Self-Collected Mid-Turbinate Swabs for the Detection of Respiratory Viruses in Adults with Acute Respiratory Illnesses	PLOS ONE			English	Article							FLOCKED SWABS; VIRAL LOAD; INFLUENZA; CHILDREN	Background: The gold standard for respiratory virus testing is a nasopharyngeal (NP) swab, which is collected by a healthcare worker. Midturbinate (MT) swabs are an alternative due to their ease of collection and possible self-collection by patients. The objective of this study was to compare the respiratory virus isolation of flocked MT swabs compared to flocked NP swabs. Methods: Beginning in October 2008, healthy adults aged 18 to 69 years were recruited into a cohort and followed up for symptoms of influenza. They were asked to have NP and MT swabs taken as soon as possible after the onset of a fever or two or more respiratory symptoms with an acute onset. The swabs were tested for viral respiratory infections using Seeplex (R) RV12 multiplex PCR detection kit. Seventy six pairs of simultaneous NP and MT swabs were collected from 38 symptomatic subjects. Twenty nine (38%) of these pairs were positive by either NP or MT swabs or both. Sixty nine (91%) of the pair results were concordant. Two samples (3%) for hCV OC43/HKU1 and 1 sample (1%) for rhinovirus A/B were positive by NP but negative by MT. One sample each for hCV 229E/NL63, hCV OC43/HKU1, respiratory syncytial virus A, and influenza B were positive by MT but negative by NP. Conclusions: Flocked MT swabs are sensitive for the diagnosis of multiple respiratory viruses. Given the ease of MT collection and similar results between the two swabs, it is likely that MT swabs should be the preferred method of respiratory cell collection for outpatient studies. In light of this data, larger studies should be performed to ensure that this still holds true and data should also be collected on the patient preference of collection methods.	[Larios, Oscar E.] Royal Univ Hosp, Dept Med, Saskatoon, SK S7N 0W8, Canada; [Larios, Oscar E.] Royal Univ Hosp, Dept Lab Med, Saskatoon, SK S7N 0W8, Canada; [Larios, Oscar E.] Univ Saskatchewan, Fac Med, Saskatoon, SK, Canada; [Coleman, Brenda L.; Mazzulli, Tony; Green, Karen; McGeer, Allison J.] Mt Sinai Hosp, Dept Microbiol, Toronto, ON M5G 1X5, Canada; [Coleman, Brenda L.; Mazzulli, Tony; Borgundvaag, Bjug; McGeer, Allison J.] Univ Toronto, Fac Med, Toronto, ON, Canada; [Drews, Steven J.] Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB, Canada; [Drews, Steven J.] Prov Lab Publ Hlth, Dept Microbiol, Calgary, AB, Canada; [Borgundvaag, Bjug] Mt Sinai Hosp, Dept Emergency Med, Toronto, ON M5G 1X5, Canada	University of Saskatchewan; University of Saskatchewan; University of Saskatchewan; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Calgary; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Larios, OE (corresponding author), Royal Univ Hosp, Dept Med, Saskatoon, SK S7N 0W8, Canada.	bcoleman@mtsinai.on.ca	Borgundvaag, Bjug/AAE-8228-2020; Borgundvaag, Bjug/AAH-4446-2020; Larios, Oscar E/D-1794-2010; McGeer, Allison/AAB-6885-2020; mcgeer, allison/H-7747-2014	McGeer, Allison/0000-0001-5647-6137; mcgeer, allison/0000-0001-5647-6137; McNeil, Shelly/0000-0001-5444-4166; Tripp, Ralph/0000-0002-2924-9956; Coleman, Brenda L./0000-0002-7144-4827	GlaxoSmithKline Inc; GSK	GlaxoSmithKline Inc(GlaxoSmithKline); GSK(GlaxoSmithKline)	This work was funded, in part, by an investigator-initiated research contract with GlaxoSmithKline Inc (http://www.gsk.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.; OEL received travel support from Copan Diagnostics Inc. (http://www.copanusa.com) to present this research. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. AJM has read the journal's policy and wishes to disclose the follow: receipt of funding from GSK for the pilot study from which this sub-study sprang. The results of the sub-study are not directly applicable to GSK and this does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. No other authors have competing interests to declare.	Abu-Diab A, 2008, J CLIN MICROBIOL, V46, P2414, DOI 10.1128/JCM.00369-08; Chan KH, 2008, J CLIN VIROL, V42, P65, DOI 10.1016/j.jcv.2007.12.003; Daley P, 2006, J CLIN MICROBIOL, V44, P2265, DOI 10.1128/JCM.02055-05; DeVincenzo JP, 2010, AM J RESP CRIT CARE, V182, P1305, DOI 10.1164/rccm.201002-0221OC; Esposito S, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-85; Forman MS, 2007, MANUAL OF CLINICAL MICROBIOLOGY, 9TH ED, P1284; Ginocchio CC, 2007, J CLIN VIROL, V40, pS11, DOI 10.1016/S1386-6532(07)70004-5; GREENBERG SB, 1986, CUMITECH, V21; Heikkinen T, 2002, J CLIN MICROBIOL, V40, P4337, DOI 10.1128/JCM.40.11.4337-4339.2002; Lambert SB, 2008, PEDIATRICS, V122, pE615, DOI 10.1542/peds.2008-0691; Lee N, 2009, J INFECT DIS, V200, P492, DOI 10.1086/600383; Mahony JB, 2008, CLIN MICROBIOL REV, V21, P716, DOI 10.1128/CMR.00037-07; Smieja M, 2010, J CLIN MICROBIOL, V48, P3340, DOI 10.1128/JCM.02235-09; Sung Rita Y T, 2009, Hong Kong Med J, V15, P24; To KKW, 2010, J MED VIROL, V82, P1, DOI 10.1002/jmv.21664; Yoo SJ, 2007, KOREAN J LAB MED, V27, P420, DOI 10.3343/kjlm.2007.27.6.420	17	54	55	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21335	10.1371/journal.pone.0021335	http://dx.doi.org/10.1371/journal.pone.0021335			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731708	Green Published, gold, Green Submitted			2022-12-27	WOS:000292035400025
J	Zhang, JC; Wu, J; Toyohara, J; Fujita, Y; Chen, HX; Hashimoto, K				Zhang, Jichun; Wu, Jin; Toyohara, Jun; Fujita, Yuko; Chen, Hongxian; Hashimoto, Kenji			Pharmacological Characterization of [H-3]CHIBA-3007 Binding to Glycine Transporter 1 in the Rat Brain	PLOS ONE			English	Article							D-SERINE; SCHIZOPHRENIA; INHIBITORS; GLYT1; LOCALIZATION; EXPRESSION; TYPE-1; GENE; CNS; NEUROTRANSMISSION	Glycine transporter-1 (GlyT-1) in glial cells regulates extracellular levels of glycine, which acts as an obligatory co-agonist at the N-methyl-D-aspartate (NMDA) receptors in the brain. In the present study, we developed a novel radioligand, [H-3]3-chloro-N-((S)-((R)-1-methylpiperidin-2-yl)(thiophen- 3-yl)methyl)-4- (trifluoromethyl) picolinamide ([H-3]CHIBA-3007), for studying GlyT-1 in the brain. The presence of a single saturable high-affinity binding component for [H-3]CHIBA-3007 binding to the rat brain membranes was detected. Scatchard analysis revealed an apparent equilibrium dissociation constant (K-d) of 1.61 +/- 0.16 nM and a maximal number of binding sites (B-max) of 692.8 +/- 22.8 fmol/mg protein (mean +/- SEM, n = 3). The specific binding of [H-3]CHIBA-3007 was inhibited by a number of GlyT-1 inhibitors, such as CHIBA-3007, desmethyl-CHIBA-3007, CHIBA-3008, SSR504734, NFPS/ALX5407, LY2365109 and Org24598, consistent with the pharmacological profiles of GlyT-1 inhibitors. Interestingly, the potency of eight GlyT-1 inhibitors (CHIBA-3007, desmethyl-CHIBA-3007, NFPS/ALX5407, LY2365109, Org24598, SSR504734, sarcosine, and glycine) for blocking in vitro specific binding of [H-3]CHIBA-3007 was significantly correlated with the potency of these inhibitors for inhibiting [C-14]glycine uptake in the rat brain membranes. In contrast, the GlyT-2 inhibitor ALX1393 exhibited very weak for [H-3]CHIBA-3007 binding. Furthermore, the regional distribution of [H-3]CHIBA-3007 binding in the rat brain was similar to the previously reported distribution of GlyT-1. The present findings suggest that [H-3]CHIBA-3007 would be a useful new radioligand for studying GlyT-1 in the brain.	[Zhang, Jichun; Wu, Jin; Toyohara, Jun; Fujita, Yuko; Chen, Hongxian; Hashimoto, Kenji] Chiba Univ, Ctr Forens Mental Hlth, Div Clin Neurosci, Chiba, Japan	Chiba University	Zhang, JC (corresponding author), Chiba Univ, Ctr Forens Mental Hlth, Div Clin Neurosci, Chiba, Japan.	hashimoto@faculty.chiba-u.jp	Toyohara, Jun/C-4461-2011; Hashimoto, Kenji/I-5800-2015	Toyohara, Jun/0000-0003-4721-405X; Hashimoto, Kenji/0000-0002-8892-0439	Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation of Japan [06-46]	Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation of Japan(National Institute of Biomedical Innovation)	This work was supported by a grant from the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation of Japan (Grant ID 06-46, to Dr. Kenji Hashimoto). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APRISON M. H., 1965, LIFE SCI, V4, P2075, DOI 10.1016/0024-3205(65)90325-5; Aragon C, 2005, TRENDS PHARMACOL SCI, V26, P283, DOI 10.1016/j.tips.2005.04.007; BOROWSKY B, 1993, NEURON, V10, P851, DOI 10.1016/0896-6273(93)90201-2; Burnet PWJ, 2008, SCHIZOPHR RES, V102, P283, DOI 10.1016/j.schres.2008.02.009; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Cubelos B, 2005, CEREB CORTEX, V15, P448, DOI 10.1093/cercor/bhh147; Danysz W, 1998, PHARMACOL REV, V50, P597; Dargazanli G, 2005, [No title captured], Patent No. [WO2005037781A3, 2005037781]; Depoortere R, 2005, NEUROPSYCHOPHARMACOL, V30, P1963, DOI 10.1038/sj.npp.1300772; Eulenburg V, 2005, TRENDS BIOCHEM SCI, V30, P325, DOI 10.1016/j.tibs.2005.04.004; GLOWINSKI J, 1966, J NEUROCHEM, V13, P655, DOI 10.1111/j.1471-4159.1966.tb09873.x; Goff DC, 2001, AM J PSYCHIAT, V158, P1367, DOI 10.1176/appi.ajp.158.9.1367; Hashimoto K, 2003, ARCH GEN PSYCHIAT, V60, P572, DOI 10.1001/archpsyc.60.6.572; Hashimoto Kenji, 2007, Central Nervous System Agents in Medicinal Chemistry, V7, P177, DOI 10.2174/187152407781669161; Hashimoto K, 2008, EUR NEUROPSYCHOPHARM, V18, P414, DOI 10.1016/j.euroneuro.2007.07.009; Hashimoto Kenji, 2006, Recent Pat CNS Drug Discov, V1, P43, DOI 10.2174/157488906775245336; Hashimoto K, 2005, CURR PSYCHIATRY REV, V1, P151, DOI 10.2174/1573400054065569; Hashimoto Kenji, 2004, Current Medicinal Chemistry - Central Nervous System Agents, V4, P147, DOI 10.2174/1568015043357011; Hashimoto K, 2011, CURR PHARM DESIGN, V17, P112, DOI 10.2174/138161211795049598; Hashimoto Kenji, 2010, Open Med Chem J, V4, P10, DOI 10.2174/1874104501004010010; Herdon HJ, 2010, NEUROPHARMACOLOGY, V59, P558, DOI 10.1016/j.neuropharm.2010.07.023; Javitt DC, 2008, BIOL PSYCHIAT, V63, P6, DOI 10.1016/j.biopsych.2007.09.017; Javitt DC, 2009, CURR OPIN DRUG DISC, V12, P468; JAVITT DC, 1991, AM J PSYCHIAT, V148, P1301; KIM KM, 1994, MOL PHARMACOL, V45, P608; Kinney Gene G., 2005, Current Neuropharmacology, V3, P35, DOI 10.2174/1570159052773387; Lindsley CW, 2006, CURR TOP MED CHEM, V6, P1883, DOI 10.2174/156802606778249784; LIU QR, 1993, J BIOL CHEM, V268, P2106; Lowe JA, 2003, BIOORG MED CHEM LETT, V13, P1291, DOI 10.1016/S0960-894X(03)00126-4; Mallorga PJ, 2003, NEUROPHARMACOLOGY, V45, P585, DOI 10.1016/S0028-3908(03)00227-2; Mezler M, 2008, MOL PHARMACOL, V74, P1705, DOI 10.1124/mol.108.049312; Sekiguchi Y., 2008, PCT Int. Appl., Patent No. 2008018639; SMITH KE, 1992, NEURON, V8, P927, DOI 10.1016/0896-6273(92)90207-T; Sur C, 2004, EXPERT OPIN INV DRUG, V13, P515, DOI 10.1517/13543784.13.5.515; VANDENBERG RJ, 2001, EXPER OPIN THER TAR, V5, P507, DOI DOI 10.1517/14728222.5.4.507; ZAFRA F, 1995, EUR J NEUROSCI, V7, P1342, DOI 10.1111/j.1460-9568.1995.tb01125.x; Zafra F, 1997, MOL NEUROBIOL, V14, P117, DOI 10.1007/BF02740653; ZAFRA F, 1995, J NEUROSCI, V15, P3952; Zeng Z, 2008, NUCL MED BIOL, V35, P315, DOI 10.1016/j.nucmedbio.2007.12.002; 갠지하시모토, 2006, Clinical Psychopharmacology and Neuroscience, V4, P3	40	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21322	10.1371/journal.pone.0021322	http://dx.doi.org/10.1371/journal.pone.0021322			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731704	Green Published, Green Submitted, gold			2022-12-27	WOS:000292035400021
J	Jesse, R; Vela, E; Pfenninger, M				Jesse, Ruth; Vela, Errol; Pfenninger, Markus			Phylogeography of a Land Snail Suggests TransMediterranean Neolithic Transport	PLOS ONE			English	Article							LAST GLACIAL MAXIMUM; DISPERSAL; MIGRATION; BIOGEOGRAPHY; INFERENCE; ECOLOGY; OPTIMUM; REFUGIA; EUROPE; MATRIX	Background: Fragmented distribution ranges of species with little active dispersal capacity raise the question about their place of origin and the processes and timing of either range fragmentation or dispersal. The peculiar distribution of the land snail Tudorella sulcata s.str. in Southern France, Sardinia and Algeria is such a challenging case. Methodology: Statistical phylogeographic analyses with mitochondrial COI and nuclear hsp70 haplotypes were used to answer the questions of the species' origin, sequence and timing of dispersal. The origin of the species was on Sardinia. Starting from there, a first expansion to Algeria and then to France took place. Abiotic and zoochorous dispersal could be excluded by considering the species' life style, leaving only anthropogenic translocation as parsimonious explanation. The geographic expansion could be dated to approximately 8,000 years before present with a 95% confidence interval of 10,000 to 3,000 years before present. Conclusions: This period coincides with the Neolithic expansion in the Western Mediterranean, suggesting a role of these settlers as vectors. Our findings thus propose that non-domesticated animals and plants may give hints on the direction and timing of early human expansion routes.	[Jesse, Ruth] Goethe Univ Frankfurt, Inst Ecol Evolut & Divers, Frankfurt, Germany; [Vela, Errol] Univ Montpellier 2, UMR AMAP, TA A51 PS2, Montpellier, France; [Jesse, Ruth; Pfenninger, Markus] Biodivers & Climate Res Ctr, Mol Ecol Grp, Frankfurt, Germany	Goethe University Frankfurt; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Jesse, R (corresponding author), Goethe Univ Frankfurt, Inst Ecol Evolut & Divers, Frankfurt, Germany.	Pfenninger@bio.uni-frankfurt.de	Pfenninger, Markus/A-8230-2012		Hessen's Ministry of Higher Education, Research, and the Arts	Hessen's Ministry of Higher Education, Research, and the Arts	The study was supported by the research funding programme "LOEWE - Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz'' of Hessen's Ministry of Higher Education, Research, and the Arts. (http://www.hessen.de/irj/HMWK_Internet?uid=fa560c0b-ed11-9311-1010-43bf5aa60dfa). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhami J, 1998, J AM MOSQUITO CONTR, V14, P340; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Bilton DT, 2001, ANNU REV ECOL SYST, V32, P159, DOI 10.1146/annurev.ecolsys.32.081501.114016; BOAG DA, 1986, CAN J ZOOL, V64, P904, DOI 10.1139/z86-136; Broodbank C, 2006, J MEDITERR ARCHAEOL, V19, P199, DOI DOI 10.1558//JMEA.2006.V19I2.199; Calo C., 2008, INT J MODERN ANTHR, V1, P39; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cordellier M, 2009, MOL ECOL, V18, P534, DOI 10.1111/j.1365-294X.2008.04042.x; Davison K, 2006, J ARCHAEOL SCI, V33, P641, DOI 10.1016/j.jas.2005.09.017; Depraz A, 2008, MOL ECOL, V17, P2449, DOI 10.1111/j.1365-294X.2008.03760.x; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Emerson BC, 2001, TRENDS ECOL EVOL, V16, P707, DOI 10.1016/S0169-5347(01)02305-9; Fleming K, 1998, EARTH PLANET SC LETT, V163, P327, DOI 10.1016/S0012-821X(98)00198-8; Ho SYW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001615; Jesse R, 2009, BIOL INVASIONS, V11, P2209, DOI 10.1007/s10530-008-9377-0; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Kalis AJ, 2003, QUATERNARY SCI REV, V22, P33, DOI 10.1016/S0277-3791(02)00181-6; Krijgsman W, 1999, NATURE, V400, P652, DOI 10.1038/23231; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Millot C, 1999, J MARINE SYST, V20, P423, DOI 10.1016/S0924-7963(98)00078-5; Nathan R, 2008, TRENDS ECOL EVOL, V23, P638, DOI 10.1016/j.tree.2008.08.003; Olson SL, 2003, P BIOL SOC WASH, V116, P732; Pfenninger M, 2002, EVOLUTION, V56, P1776, DOI 10.1111/j.0014-3820.2002.tb00191.x; Pfenninger M, 2010, MOL PHYLOGENET EVOL, V54, P427, DOI 10.1016/j.ympev.2009.09.024; Pinceel J, 2005, MOL ECOL, V14, P1133, DOI 10.1111/j.1365-294X.2005.02479.x; Pregill GK, 2009, DIVERS DISTRIB, V15, P983, DOI 10.1111/j.1472-4642.2009.00603.x; Pringle A, 2006, BIOL INVASIONS, V8, P1131, DOI 10.1007/s10530-005-3804-2; Ricciardi A, 1998, J ANIM ECOL, V67, P613, DOI 10.1046/j.1365-2656.1998.00220.x; Rohling EJ, 1999, MAR GEOL, V153, P57, DOI 10.1016/S0025-3227(98)00020-6; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens PA, 2007, TRENDS ECOL EVOL, V22, P192, DOI 10.1016/j.tree.2006.12.003; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tobias Phillip V., 2002, Human Evolution, V17, P157, DOI 10.1007/BF02436368; Turney CSM, 2007, QUATERNARY SCI REV, V26, P2036, DOI 10.1016/j.quascirev.2007.07.003; Tykot RH, 2002, ACCOUNTS CHEM RES, V35, P618, DOI 10.1021/ar000208p; Vela E, 2008, GEODIVERSITAS, V30, P233; Welter-Schultes FW, 2008, J MOLLUS STUD, V74, P79, DOI 10.1093/mollus/eym047; Wilson JRU, 2009, TRENDS ECOL EVOL, V24, P136, DOI 10.1016/j.tree.2008.10.007; Zeder MA, 2008, P NATL ACAD SCI USA, V105, P11597, DOI 10.1073/pnas.0801317105	41	21	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e20734	10.1371/journal.pone.0020734	http://dx.doi.org/10.1371/journal.pone.0020734			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731622	Green Published, gold, Green Submitted			2022-12-27	WOS:000292033700014
J	Juhila, J; Sipila, T; Icay, K; Nicorici, D; Ellonen, P; Kallio, A; Korpelainen, E; Greco, D; Hovatta, I				Juhila, Juuso; Sipila, Tessa; Icay, Katherine; Nicorici, Daniel; Ellonen, Pekka; Kallio, Aleksi; Korpelainen, Eija; Greco, Dario; Hovatta, Iiris			MicroRNA Expression Profiling Reveals MiRNA Families Regulating Specific Biological Pathways in Mouse Frontal Cortex and Hippocampus	PLOS ONE			English	Article							DIGITAL GENE-EXPRESSION; CENTRAL-NERVOUS-SYSTEM; DIFFERENTIAL EXPRESSION; ALZHEIMERS-DISEASE; PROBE LEVEL; ADULT; BRAIN; RNA; PATTERNS; MIRBASE	MicroRNAs (miRNAs) are small regulatory molecules that cause post-transcriptional gene silencing. Although some miRNAs are known to have region-specific expression patterns in the adult brain, the functional consequences of the region-specificity to the gene regulatory networks of the brain nuclei are not clear. Therefore, we studied miRNA expression patterns by miRNA-Seq and microarrays in two brain regions, frontal cortex (FCx) and hippocampus (HP), which have separate biological functions. We identified 354 miRNAs from FCx and 408 from HP using miRNA-Seq, and 245 from FCx and 238 from HP with microarrays. Several miRNA families and clusters were differentially expressed between FCx and HP, including the miR-8 family, miR-182 vertical bar miR-96 vertical bar miR-183 cluster, and miR-212 vertical bar miR-312 cluster overexpressed in FCx and miR-34 family overexpressed in HP. To visualize the clusters, we developed support for viewing genomic alignments of miRNA-Seq reads in the Chipster genome browser. We carried out pathway analysis of the predicted target genes of differentially expressed miRNA families and clusters to assess their putative biological functions. Interestingly, several miRNAs from the same family/cluster were predicted to regulate specific biological pathways. We have developed a miRNA-Seq approach with a bioinformatic analysis workflow that is suitable for studying miRNA expression patterns from specific brain nuclei. FCx and HP were shown to have distinct miRNA expression patterns which were reflected in the predicted gene regulatory pathways. This methodology can be applied for the identification of brain region-specific and phenotype-specific miRNA-mRNA-regulatory networks from the adult and developing rodent brain.	[Juhila, Juuso; Nicorici, Daniel; Ellonen, Pekka; Hovatta, Iiris] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland; [Juhila, Juuso; Sipila, Tessa; Icay, Katherine; Hovatta, Iiris] Univ Helsinki, Res Programs Unit, Biomedicum Helsinki, Helsinki, Finland; [Juhila, Juuso; Sipila, Tessa; Icay, Katherine; Hovatta, Iiris] Univ Helsinki, Dept Med Genet, Haartman Inst, Helsinki, Finland; [Sipila, Tessa; Hovatta, Iiris] Natl Inst Hlth & Welf, Dept Mental Hlth & Subst Abuse Serv, Helsinki, Finland; [Kallio, Aleksi; Korpelainen, Eija] IT Ctr Sci, CSC, Espoo, Finland; [Greco, Dario] Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden	University of Helsinki; University of Helsinki; University of Helsinki; Finland National Institute for Health & Welfare; Karolinska Institutet	Juhila, J (corresponding author), Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland.	iiris.hovatta@helsinki.fi	Hovatta, Iiris/D-6871-2012; Greco, Dario/T-7113-2019	Hovatta, Iiris/0000-0002-5990-7892; Greco, Dario/0000-0001-9195-9003; Ellonen, Pekka/0000-0001-6072-0489; Nicorici, Daniel/0000-0002-0278-8263; Korpelainen, Eija/0000-0002-4406-5602	Institute for Molecular Medicine (FIMM) of the University of Helsinki; Academy of Finland; Peter and Patricia Gruber Foundation; Helsinki Biomedical Graduate School; European Science Foundation	Institute for Molecular Medicine (FIMM) of the University of Helsinki; Academy of Finland(Academy of Finland); Peter and Patricia Gruber Foundation; Helsinki Biomedical Graduate School; European Science Foundation(European Science Foundation (ESF)European Commission)	This work was supported by the Institute for Molecular Medicine (FIMM) of the University of Helsinki http://www.fimm.fi (IH), Academy of Finland http://www.aka.fi (IH), Rosalind Franklin Young Investigator Award from the Peter and Patricia Gruber Foundation http://www.gruberprizes.org/GruberPrizes/YoungScientists_RosalindFranklin.php (IH), the Helsinki Biomedical Graduate School http://www.hbgs.helsinki.fi (TS), and the European Science Foundation http://www.esf.org/ (TS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altuvia Y, 2005, NUCLEIC ACIDS RES, V33, P2697, DOI 10.1093/nar/gki567; Ason B, 2006, P NATL ACAD SCI USA, V103, P14385, DOI 10.1073/pnas.0603529103; Bak M, 2008, RNA, V14, P432, DOI 10.1261/rna.783108; Baracskay KL, 2006, SYNAPSE, V60, P271, DOI 10.1002/syn.20292; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Benjamini Y, 2001, ANN STAT, V29, P1165; Brugg B, 1996, J NEUROCHEM, V66, P733; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Clinton SM, 2005, AM J PSYCHIAT, V162, P1859, DOI 10.1176/appi.ajp.162.10.1859; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Fahlgren N, 2009, RNA, V15, P992, DOI 10.1261/rna.1473809; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fiore R, 2007, EXPERT OPIN BIOL TH, V7, P1823, DOI 10.1517/14712598.7.12.1823; Fiore Roberto, 2007, ScientificWorldJournal, V7, P167; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Git A, 2010, RNA, V16, P991, DOI 10.1261/rna.1947110; Glazov EA, 2008, GENOME RES, V18, P957, DOI 10.1101/gr.074740.107; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Haughey NJ, 2010, BBA-MOL CELL BIOL L, V1801, P878, DOI 10.1016/j.bbalip.2010.05.003; Hollander JA, 2010, NATURE, V466, P197, DOI 10.1038/nature09202; HOLM S, 1979, SCAND J STAT, V6, P65; Hovatta I, 2005, NATURE, V438, P662, DOI 10.1038/nature04250; Hovatta I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r25; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jensen KP, 2009, MOL PSYCHIATR, V14, P381, DOI 10.1038/mp.2008.15; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kapsimali M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r173; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kuchenbauer F, 2008, GENOME RES, V18, P1787, DOI 10.1101/gr.077578.108; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Laurin N, 2005, MOL PSYCHIATR, V10, P1117, DOI 10.1038/sj.mp.4001737; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lukiw WJ, 2007, NEUROREPORT, V18, P297, DOI 10.1097/WNR.0b013e3280148e8b; Megraw M, 2007, NUCLEIC ACIDS RES, V35, pD149, DOI 10.1093/nar/gkl904; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Muinos-Gimeno M, 2011, BIOL PSYCHIAT, V69, P526, DOI 10.1016/j.biopsych.2010.10.010; Muinos-Gimeno M, 2009, HUM MUTAT, V30, P1062, DOI 10.1002/humu.21005; Olsen L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007225; Perkins DO, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r27; Pradervand S, 2010, BIOTECHNIQUES, V48, P219, DOI 10.2144/000113367; Presutti C, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-S1-S5; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Rinaldi A, 2010, BEHAV BRAIN RES, V208, P265, DOI 10.1016/j.bbr.2009.11.012; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Saus E, 2010, HUM MOL GENET, V19, P4017, DOI 10.1093/hmg/ddq316; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Trantham-Davidson H, 2008, BEHAV BRAIN RES, V189, P244, DOI 10.1016/j.bbr.2007.12.031; Wang WX, 2008, J NEUROSCI, V28, P1213, DOI 10.1523/JNEUROSCI.5065-07.2008; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Xu JZ, 2008, RNA, V14, P1276, DOI 10.1261/rna.997708; Yang Xinan, 2006, Journal of Bioinformatics and Computational Biology, V4, P693, DOI 10.1142/S0219720006002120; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Yu ZF, 2000, J MOL NEUROSCI, V15, P85, DOI 10.1385/JMN:15:2:85; Zapala MA, 2005, P NATL ACAD SCI USA, V102, P10357, DOI 10.1073/pnas.0503357102; ZHANG Y, 2010, J INTEGR BIOINFORM, V7, DOI DOI 10.2390/BIECOLL-JIB-2010-2127	64	60	61	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21495	10.1371/journal.pone.0021495	http://dx.doi.org/10.1371/journal.pone.0021495			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731767	Green Submitted, Green Published, gold			2022-12-27	WOS:000292033700090
J	Yan, JQ; Xu, YQ; Zhu, CS; Zhang, LM; Wu, AM; Yang, Y; Xiong, ZJ; Deng, C; Huang, XF; Yenari, MA; Yang, YG; Ying, WH; Wang, Q				Yan, Junqiang; Xu, Yunqi; Zhu, Cansheng; Zhang, Limin; Wu, Aimin; Yang, Yu; Xiong, Zhaojun; Deng, Chao; Huang, Xu-Feng; Yenari, Midori A.; Yang, Yuan-Guo; Ying, Weihai; Wang, Qing			Simvastatin Prevents Dopaminergic Neurodegeneration in Experimental Parkinsonian Models: The Association with Anti-Inflammatory Responses	PLOS ONE			English	Article							NMDA RECEPTOR ANTAGONISTS; D-ASPARTATE RECEPTORS; ALZHEIMERS-DISEASE; GLUTAMATE RECEPTORS; PREFRONTAL CORTEX; CORTICAL-NEURONS; RAT-BRAIN; SYNAPTIC PLASTICITY; MESSENGER-RNA; BASAL GANGLIA	Background: In addition to their original applications to lowering cholesterol, statins display multiple neuroprotective effects. N-methyl-D-aspartate (NMDA) receptors interact closely with the dopaminergic system and are strongly implicated in therapeutic paradigms of Parkinson's disease (PD). This study aims to investigate how simvastatin impacts on experimental parkinsonian models via regulating NMDA receptors. Methodology/Principal Findings: Regional changes in NMDA receptors in the rat brain and anxiolytic-like activity were examined after unilateral medial forebrain bundle lesion by 6-hydroxydopamine via a 3-week administration of simvastatin. NMDA receptor alterations in the post-mortem rat brain were detected by [H-3]MK-801(Dizocilpine) binding autoradiography. 6-hydroxydopamine treated PC12 was applied to investigate the neuroprotection of simvastatin, the association with NMDA receptors, and the anti-inflammation. 6-hydroxydopamine induced anxiety and the downregulation of NMDA receptors in the hippocampus, CA1(Cornu Ammonis 1 Area), amygdala and caudate putamen was observed in 6-OHDA(6-hydroxydopamine) lesioned rats whereas simvastatin significantly ameliorated the anxiety-like activity and restored the expression of NMDA receptors in examined brain regions. Significant positive correlations were identified between anxiolytic-like activity and the restoration of expression of NMDA receptors in the hippocampus, amygdala and CA1 following simvastatin administration. Simvastatin exerted neuroprotection in 6-hydroxydopamine-lesioned rat brain and 6-hydroxydopamine treated PC12, partially by regulating NMDA receptors, MMP9 (matrix metalloproteinase-9), and TNF-a (tumour necrosis factor-alpha). Conclusions/Significance: Our results provide strong evidence that NMDA receptor modulation after simvastatin treatment could partially explain its anxiolytic-like activity and anti-inflammatory mechanisms in experimental parkinsonian models. These findings contribute to a better understanding of the critical roles of simvastatin in treating PD via NMDA receptors.	[Yan, Junqiang; Xu, Yunqi; Zhu, Cansheng; Zhang, Limin; Wu, Aimin; Yang, Yu; Wang, Qing] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Neurol, Guangzhou 510275, Guangdong, Peoples R China; [Deng, Chao; Huang, Xu-Feng; Wang, Qing] Univ Wollongong, Sch Hlth Sci, Ctr Translat Neurosci, Wollongong, NSW 2522, Australia; [Xiong, Zhaojun] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Cardiol, Guangzhou 510275, Guangdong, Peoples R China; [Yenari, Midori A.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Yenari, Midori A.] San Francisco VA Med Ctr, San Francisco, CA USA; [Yang, Yuan-Guo; Ying, Weihai] Shanghai Jiao Tong Univ, Med X Res Inst, Shanghai 200030, Peoples R China	Sun Yat Sen University; University of Wollongong; Sun Yat Sen University; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; Shanghai Jiao Tong University	Yan, JQ (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Dept Neurol, Guangzhou 510275, Guangdong, Peoples R China.	denniswq@yahoo.com	Huang, Xu-Feng/H-7408-2015; Deng, Chao/F-4417-2016; Huang, Xu-Feng/D-6053-2013	Huang, Xu-Feng/0000-0002-5895-2253; Deng, Chao/0000-0003-1147-5741; Huang, Xu-Feng/0000-0002-5895-2253; Wang, Qing/0000-0002-3882-6540	Third Affiliated Hospital of Sun Yat-Sen University; Fundamental Research Funds for the Central Universities [A77, 10ykzd08]; Program for New Century Excellent Talents in University (NCET2010, P.R. China); National Natural Science Foundation of China [81071031]; Australia National Health and Medical Research Council [NHMRC 514640]	Third Affiliated Hospital of Sun Yat-Sen University; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Program for New Century Excellent Talents in University (NCET2010, P.R. China)(Program for New Century Excellent Talents in University (NCET)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Australia National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Grant-In-Aid from the Third Affiliated Hospital of Sun Yat-Sen University, Fundamental Research Funds for the Central Universities (Grant No. A77 and 10ykzd08), Program for New Century Excellent Talents in University (NCET2010, P.R. China), National Natural Science Foundation of China (81071031), and Australia National Health and Medical Research Council Grant (NHMRC 514640) to Q.W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloisi F, 2001, GLIA, V36, P165, DOI 10.1002/glia.1106; Araki T, 2000, EUR NEUROPSYCHOPHARM, V10, P365, DOI 10.1016/S0924-977X(00)00094-8; Armentero MT, 2006, NEUROBIOL DIS, V22, P1, DOI 10.1016/j.nbd.2005.09.010; Becker C, 2008, DRUG SAFETY, V31, P399, DOI 10.2165/00002018-200831050-00004; Betarbet R, 2004, EXP NEUROL, V187, P76, DOI 10.1016/j.expneurol.2003.12.012; Bi H, 2002, J NEUROL SCI, V200, P11, DOI 10.1016/S0022-510X(02)00087-4; Bibbiani F, 2005, EXP NEUROL, V196, P422, DOI 10.1016/j.expneurol.2005.08.017; Blundell J, 2007, BRAIN RES, V1136, P59, DOI 10.1016/j.brainres.2006.09.078; Byrnes EM, 2006, PSYCHONEUROENDOCRINO, V31, P988, DOI 10.1016/j.psyneuen.2006.05.008; Carlsson CM, 2008, J ALZHEIMERS DIS, V13, P187; Cramer C, 2008, NEUROLOGY, V71, P344, DOI 10.1212/01.wnl.0000319647.15752.7b; de Bartolomeis A, 2005, CURR PHARM DESIGN, V11, P3561, DOI 10.2174/138161205774414538; Dunah AW, 2000, MOL PHARMACOL, V57, P342; Espejo EF, 1997, BRAIN RES, V762, P281, DOI 10.1016/S0006-8993(97)00593-3; Fiorentini C, 2006, MOL PHARMACOL, V69, P805, DOI 10.1124/mol.105.016667; Fox SH, 2008, LANCET NEUROL, V7, P927, DOI 10.1016/S1474-4422(08)70214-X; Galic MA, 2009, NEUROBIOL DIS, V36, P343, DOI 10.1016/j.nbd.2009.07.025; Ghosh A, 2009, J NEUROSCI, V29, P13543, DOI 10.1523/JNEUROSCI.4144-09.2009; GREENAMYRE JT, 1991, ARCH NEUROL-CHICAGO, V48, P977, DOI 10.1001/archneur.1991.00530210109030; Hallett PJ, 2006, J NEUROSCI, V26, P4690, DOI 10.1523/JNEUROSCI.0792-06.2006; Hallett PJ, 2004, PHARMACOL THERAPEUT, V102, P155, DOI 10.1016/j.pharmthera.2004.04.001; Harre EM, 2008, EUR J NEUROSCI, V27, P644, DOI 10.1111/j.1460-9568.2008.06031.x; Hemandez-Romero MD, 2008, J NEUROCHEM, V105, P445, DOI 10.1111/j.1471-4159.2007.05148.x; Hirsch EC, 1998, ANN NEUROL, V44, pS115, DOI 10.1002/ana.410440717; Hu NW, 2009, P NATL ACAD SCI USA, V106, P20504, DOI 10.1073/pnas.0908083106; Iida J, 2007, MOL CELL BIOL, V27, P4388, DOI 10.1128/MCB.01901-06; Janssen WGM, 2005, EXP NEUROL, V191, pS28, DOI 10.1016/j.expneurol.2004.08.020; Johnson PL, 2006, J NEUROSCI, V26, P7093, DOI 10.1523/JNEUROSCI.0408-06.2006; Leentjens AFG, 2008, MOVEMENT DISORD, V23, P2015, DOI 10.1002/mds.22233; Michaluk P, 2009, J NEUROSCI, V29, P6007, DOI 10.1523/JNEUROSCI.5346-08.2009; Mishizen-Eberz AJ, 2004, NEUROBIOL DIS, V15, P80, DOI 10.1016/j.nbd.2003.09.016; Mogi M, 2007, NEUROSCI LETT, V414, P94, DOI 10.1016/j.neulet.2006.12.003; Niemann S, 2007, EUR J NEUROSCI, V26, P1407, DOI 10.1111/j.1460-9568.2007.05774.x; Nilsson A, 2007, BRAIN RES, V1186, P102, DOI 10.1016/j.brainres.2007.09.008; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Pickel VM, 2006, NEUROSCIENCE, V142, P671, DOI 10.1016/j.neuroscience.2006.06.059; Rodriguez-Blanco J, 2008, J NEUROCHEM, V107, P127, DOI 10.1111/j.1471-4159.2008.05588.x; Sasaki J, 2010, NATURE, V465, P497, DOI 10.1038/nature09023; Selley ML, 2005, BRAIN RES, V1037, P1, DOI 10.1016/j.brainres.2004.02.083; Starr JM, 2004, INT J GERIATR PSYCH, V19, P327, DOI 10.1002/gps.1093; STARR MS, 1995, SYNAPSE, V19, P264, DOI 10.1002/syn.890190405; Stoll G, 1999, PROG NEUROBIOL, V58, P233, DOI 10.1016/S0301-0082(98)00083-5; Tadaiesky MT, 2008, NEUROSCIENCE, V156, P830, DOI 10.1016/j.neuroscience.2008.08.035; Tian L, 2007, J CELL BIOL, V178, P687, DOI 10.1083/jcb.200612097; Tsang SWY, 2008, NEUROBIOL AGING, V29, P1524, DOI 10.1016/j.neurobiolaging.2007.03.014; Wang C, 2006, TOXICOL SCI, V91, P192, DOI 10.1093/toxsci/kfj144; Wang C, 2004, NEUROSCIENCE, V125, P473, DOI 10.1016/j.neuroscience.2004.02.003; Wang Q, 2005, BRAIN RES, V1045, P229, DOI 10.1016/j.brainres.2005.03.016; Wang Q, 2005, BRIT J PHARMACOL, V144, P933, DOI 10.1038/sj.bjp.0706106; WANG Q, 2010, EXP NEUROL IN PRESS; Wang Q, 2009, EXP NEUROL, V216, P132, DOI 10.1016/j.expneurol.2008.11.016; Wheeler D, 2009, J NEUROCHEM, V109, P1237, DOI 10.1111/j.1471-4159.2009.06038.x; Xia P, 2010, J NEUROSCI, V30, P11246, DOI 10.1523/JNEUROSCI.2488-10.2010; Yang CR, 2005, NEUROSCIENTIST, V11, P452, DOI 10.1177/1073858405279692; Yeh SH, 2008, J NEUROSCI, V28, P14259, DOI 10.1523/JNEUROSCI.4258-08.2008; Young-Xu Y, 2003, J AM COLL CARDIOL, V42, P690, DOI 10.1016/S0735-1097(03)00785-X; Yu SP, 1997, J PHYSIOL-LONDON, V499, P721, DOI 10.1113/jphysiol.1997.sp021964; Yu SP, 1999, SCIENCE, V284, P336, DOI 10.1126/science.284.5412.336; Yuan H, 2005, J NEUROSCI METH, V144, P35, DOI 10.1016/j.jneumeth.2004.10.004	59	77	80	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e20945	10.1371/journal.pone.0020945	http://dx.doi.org/10.1371/journal.pone.0020945			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731633	Green Published, Green Submitted, gold			2022-12-27	WOS:000292033700020
J	Gao, L; Dai, H; Zhang, TL; Chou, KC				Gao, Lei; Dai, Hua; Zhang, Tong-Liang; Chou, Kuo-Chen			Remote Data Retrieval for Bioinformatics Applications: An Agent Migration Approach	PLOS ONE			English	Article							MOBILE AGENTS; SUBCELLULAR-LOCALIZATION; GRID MIDDLEWARE; INTEGRATION; DATABASES; PROTEINS; SERVICE	Some of the approaches have been developed to retrieve data automatically from one or multiple remote biological data sources. However, most of them require researchers to remain online and wait for returned results. The latter not only requires highly available network connection, but also may cause the network overload. Moreover, so far none of the existing approaches has been designed to address the following problems when retrieving the remote data in a mobile network environment: (1) the resources of mobile devices are limited; (2) network connection is relatively of low quality; and (3) mobile users are not always online. To address the aforementioned problems, we integrate an agent migration approach with a multi-agent system to overcome the high latency or limited bandwidth problem by moving their computations to the required resources or services. More importantly, the approach is fit for the mobile computing environments. Presented in this paper are also the system architecture, the migration strategy, as well as the security authentication of agent migration. As a demonstration, the remote data retrieval from GenBank was used to illustrate the feasibility of the proposed approach.	[Gao, Lei] Donghua Univ, Coll Informat Sci & Technol, Shanghai, Peoples R China; [Dai, Hua] Tellabs, Shanghai Res & Dev Ctr, Shanghai, Peoples R China; [Zhang, Tong-Liang] Minist Transport China, Res Inst Highway, Beijing, Peoples R China; [Chou, Kuo-Chen] Gordon Life Sci Inst, San Diego, CA USA	Donghua University; Ministry of Transport of the People's Republic of China	Gao, L (corresponding author), Donghua Univ, Coll Informat Sci & Technol, Shanghai, Peoples R China.	dr.leigao@gmail.com	Gao, Lei/F-9698-2010; Chou, Kuo-Chen/A-8340-2009	Gao, Lei/0000-0003-4272-9417; 				Abosamra A, 2011, EGYPT INFORM J, V12, P29, DOI 10.1016/j.eij.2011.02.003; Baek JW, 2006, INFORM SCIENCES, V176, P3347, DOI 10.1016/j.ins.2006.01.005; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Buttler D, 2002, INFORM SOFTWARE TECH, V44, P237, DOI 10.1016/S0950-5849(02)00013-7; Cadag E, 2010, J BIOMED INFORM, V43, P873, DOI 10.1016/j.jbi.2010.07.005; Carreras I, 2010, IEEE T SYST MAN CY A, V40, P815, DOI 10.1109/TSMCA.2010.2048025; Cheng CB, 2008, COMPUT IND ENG, V55, P406, DOI 10.1016/j.cie.2008.01.003; Chou K.-C., 2010, NAT SCI IRVINE, V2, P1090, DOI [10.4236/ns.2010.210136, DOI 10.4236/NS.2010.210136]; CHOU KC, 2009, NAT SCI, V2, P63, DOI DOI 10.4236/NS.2009.12011; Chou KC, 2008, NAT PROTOC, V3, P153, DOI 10.1038/nprot.2007.494; Chou KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018258; Chou KC, 2011, J THEOR BIOL, V273, P236, DOI 10.1016/j.jtbi.2010.12.024; Chou KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011335; Chou KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009931; Chung YF, 2009, COMPUT STAND INTER, V31, P1061, DOI 10.1016/j.csi.2008.09.039; Crasso M, 2011, EXPERT SYST APPL, V38, P1723, DOI 10.1016/j.eswa.2010.07.098; Ding YS, 2007, INFORM SCIENCES, V177, P722, DOI 10.1016/j.ins.2006.08.005; Ding YS, 2011, IEEE T SYST MAN CY A, V41, P1032, DOI 10.1109/TSMCA.2011.2109377; Du TC, 2005, DECIS SUPPORT SYST, V39, P371, DOI 10.1016/j.dss.2004.01.003; Gao L, 2006, J PHARMACEUT BIOMED, V41, P246, DOI 10.1016/j.jpba.2005.09.031; Gao L, 2004, INT J INTELL SYST, V19, P859, DOI 10.1002/int.20028; GAO L, 2011, ECOLOGICAL IN PRESS, DOI DOI 10.1016/J.ECOLECON.2011.04.014; GAO L, 2005, LECT NOTES COMPUTER, V3482, P175; Gao L, 2006, INT J INTELL SYST, V21, P1269, DOI 10.1002/int.20183; Goble C, 2008, J BIOMED INFORM, V41, P687, DOI 10.1016/j.jbi.2008.01.008; Gouy M, 2008, BIOCHIMIE, V90, P555, DOI 10.1016/j.biochi.2007.07.003; Jennings NR, 2001, COMMUN ACM, V44, P35, DOI 10.1145/367211.367250; Karasavvas KA, 2004, J BIOMED INFORM, V37, P205, DOI 10.1016/j.jbi.2004.04.003; Lacroix Z, 2003, DATA KNOWL ENG, V44, P347, DOI 10.1016/S0169-023X(02)00143-X; Ma L, 2008, IEEE T SYST MAN CY A, V38, P180, DOI 10.1109/TSMCA.2007.909552; Macauley J, 1998, BIOINFORMATICS, V14, P575, DOI 10.1093/bioinformatics/14.7.575; Manzoor U, 2010, J NETW COMPUT APPL, V35, P696, DOI 10.1016/j.jnca.2010.03.015; O'Grady MJ, 2005, INTERACT COMPUT, V17, P343, DOI 10.1016/j.intcom.2005.01.003; Stein LD, 1998, GENE, V209, pGC39, DOI 10.1016/S0378-1119(97)00672-0; Thireou Trias, 2007, Genomics Proteomics & Bioinformatics, V5, P70, DOI 10.1016/S1672-0229(07)60017-5; Urrea E, 2009, AD HOC NETW, V7, P677, DOI 10.1016/j.adhoc.2008.03.005; Wang C, 2010, IEEE T COMPUT, V59, P721, DOI 10.1109/TC.2010.39; Wei R, 2010, PROTEIN PEPTIDE LETT, V17, P1215, DOI 10.2174/092986610792231429	38	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e20949	10.1371/journal.pone.0020949	http://dx.doi.org/10.1371/journal.pone.0020949			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	21701677	Green Published, gold			2022-12-27	WOS:000291983800014
J	Poon, AFY; Aldous, JL; Mathews, WC; Kitahata, M; Kahn, JS; Saag, MS; Rodriguez, B; Boswell, SL; Frost, SDW; Haubrich, RH				Poon, Art F. Y.; Aldous, Jeannette L.; Mathews, W. Christopher; Kitahata, Mari; Kahn, James S.; Saag, Michael S.; Rodriguez, Benigno; Boswell, Stephen L.; Frost, Simon D. W.; Haubrich, Richard H.			Transmitted Drug Resistance in the CFAR Network of Integrated Clinical Systems Cohort: Prevalence and Effects on Pre-Therapy CD4 and Viral Load	PLOS ONE			English	Article							MARGINAL STRUCTURAL MODELS; REVERSE-TRANSCRIPTASE; ANTIRETROVIRAL TREATMENT; GENOTYPIC-RESISTANCE; REPLICATIVE FITNESS; M184V MUTATION; HIV-1 VARIANTS; VIRUS; INDIVIDUALS; POPULATIONS	Human immunodeficiency virus type 1 (HIV-1) genomes often carry one or more mutations associated with drug resistance upon transmission into a therapy-naive individual. We assessed the prevalence and clinical significance of transmitted drug resistance (TDR) in chronically-infected therapy-naive patients enrolled in a multi-center cohort in North America. Pre-therapy clinical significance was quantified by plasma viral load (pVL) and CD4+ cell count (CD4) at baseline. Naive bulk sequences of HIV-1 protease and reverse transcriptase (RT) were screened for resistance mutations as defined by the World Health Organization surveillance list. The overall prevalence of TDR was 14.2%. We used a Bayesian network to identify co-transmission of TDR mutations in clusters associated with specific drugs or drug classes. Aggregate effects of mutations by drug class were estimated by fitting linear models of pVL and CD4 on weighted sums over TDR mutations according to the Stanford HIV Database algorithm. Transmitted resistance to both classes of reverse transcriptase inhibitors was significantly associated with lower CD4, but had opposing effects on pVL. In contrast, position-specific analyses of TDR mutations revealed substantial effects on CD4 and pVL at several residue positions that were being masked in the aggregate analyses, and significant interaction effects as well. Residue positions in RT with predominant effects on CD4 or pVL (D67 and M184) were re-evaluated in causal models using an inverse probability-weighting scheme to address the problem of confounding by other mutations and demographic or risk factors. We found that causal effect estimates of mutations M184V/I (-1.7 log(10) pVL) and D67N/G (-2.1 3 root CD4 and +0.4 log(10) pVL) were compensated by K103N/S and K219Q/E/N/R. As TDR becomes an increasing dilemma in this modern era of highly-active antiretroviral therapy, these results have immediate significance for the clinical management of HIV-1 infections and our understanding of the ongoing adaptation of HIV-1 to human populations.	[Poon, Art F. Y.] BC Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Aldous, Jeannette L.; Mathews, W. Christopher; Haubrich, Richard H.] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA; [Kitahata, Mari] Univ Washington, Seattle, WA 98195 USA; [Kahn, James S.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Saag, Michael S.] Univ Alabama, Birmingham, CA USA; [Rodriguez, Benigno] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Boswell, Stephen L.] Harvard Univ, Sch Med, Boston, MA USA; [Frost, Simon D. W.] Univ Cambridge, Cambridge, England	B.C. Centre for Excellence in HIV/AIDS; University of California System; University of California San Diego; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco; University of Alabama System; University of Alabama Birmingham; Case Western Reserve University; Harvard University; Harvard Medical School; University of Cambridge	Poon, AFY (corresponding author), BC Ctr Excellence HIV AIDS, Vancouver, BC, Canada.	rhaubrich@ucsd.edu	Rodriguez, Benigno/C-3365-2009; Frost, Simon/F-3648-2010; Mathews, William C/E-4451-2010; Poon, Art/W-9811-2019	Rodriguez, Benigno/0000-0001-9736-7957; Frost, Simon/0000-0002-5207-9879; Mathews, William C/0000-0002-2352-0725; Poon, Art/0000-0003-3779-154X	National Institutes of Health (NIH) [R21 AI080397, AI064086 (K24), CNICS R24 AI067039, AI43638, AI47745, AI57167]; UCSD Center for AIDS Research (CFAR) [AI36214, AI027767]; San Diego ACTG CTU [AI69432]; NIH/National Center for Research Resources (NCRR) [RR024369]; NIH/National Institute of Allergy and Infectious Diseases (NIAID) [AI027763]; NIH Broad Agency [BAA-RM-04-23]; Royal Society Wolfson Research; Canadian Institutes of Health Research (CIHR) [200802HFE]; NATIONAL CENTER FOR RESEARCH RESOURCES [K24RR024369] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036214, R21AI047745, R01AI047745, U01AI043638, R21AI080397, R56AI047745, K24AI064086, R24AI067039, UM1AI069432, R01AI057167, P30AI027767, P30AI027763, U01AI069432] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSD Center for AIDS Research (CFAR); San Diego ACTG CTU; NIH/National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH/National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH Broad Agency; Royal Society Wolfson Research(Royal Society of London); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) Exploratory/Development Grant R21 AI080397 to RH; AI064086 (K24 to RH); CNICS R24 AI067039; UCSD Center for AIDS Research (CFAR) AI36214 and the San Diego ACTG CTU AI69432. Additionally, MSS was supported by CFAR grant (AI027767). JSK was supported by grants K24 NIH/National Center for Research Resources (NCRR) grant RR024369, NIH/National Institute of Allergy and Infectious Diseases (NIAID) grant AI027763, and NIH Broad Agency Announcement grant BAA-RM-04-23. SDWF was supported by NIH grants AI43638, AI47745, and AI57167, and also in part by a Royal Society Wolfson Research Merit Award. AFYP was supported by a Canadian Institutes of Health Research (CIHR) Fellowships Award (200802HFE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balotta C, 2000, ANTIVIR THER, V5, P7; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Bezemer D, 2006, ANTIVIR THER, V11, P173; Booth CL, 2007, J ANTIMICROB CHEMOTH, V59, P1047, DOI 10.1093/jac/dkm082; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Castagna A, 2006, AIDS, V20, P795, DOI 10.1097/01.aids.0000218542.08845.b2; Collins JA, 2004, J VIROL, V78, P603, DOI 10.1128/JVI.78.2.603-611.2004; CONG M, 2007, J VIROL, V81; Devereux HL, 2001, J MED VIROL, V65, P218, DOI 10.1002/jmv.2023; Frost SDW, 2000, J VIROL, V74, P6262, DOI 10.1128/JVI.74.14.6262-6268.2000; Garcia-Lerma JG, 2004, J VIROL, V78, P7545, DOI 10.1128/JVI.78.14.7545-7552.2004; GOTOH O, 1982, J MOL BIOL, V162, P705, DOI 10.1016/0022-2836(82)90398-9; Gotte M, 2000, J VIROL, V74, P3579, DOI 10.1128/JVI.74.8.3579-3585.2000; Grant RM, 2002, JAMA-J AM MED ASSOC, V288, P181, DOI 10.1001/jama.288.2.181; Halvas EK, 2010, J INFECT DIS, V201, P672, DOI 10.1086/650542; Harrison L, 2010, AIDS, V24, P1917, DOI 10.1097/QAD.0b013e32833c1d93; Hernan MA, 2000, EPIDEMIOLOGY, V11, P561, DOI 10.1097/00001648-200009000-00012; Hogg RS, 2006, PLOS MED, V3, P1570, DOI 10.1371/journal.pmed.0030356; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Johnson JA, 2008, PLOS MED, V5, P1112, DOI 10.1371/journal.pmed.0050158; Kitahata MM, 2008, INT J EPIDEMIOL, V37, P948, DOI 10.1093/ije/dym231; Lecossier D, 2005, JAIDS-J ACQ IMM DEF, V38, P37, DOI 10.1097/00126334-200501010-00007; Little SJ, 2008, J VIROL, V82, P5510, DOI 10.1128/JVI.02579-07; Liu TF, 2006, CLIN INFECT DIS, V42, P1608, DOI 10.1086/503914; Lumley T., 2004, J STAT SOFTW, V9, P1, DOI [10.18637/jss.v009.i08, DOI 10.18637/JSS.V009.I08]; Mammano F, 2000, J VIROL, V74, P8524, DOI 10.1128/JVI.74.18.8524-8531.2000; Pao D, 2004, JAIDS-J ACQ IMM DEF, V37, P1570, DOI 10.1097/00126334-200412150-00006; Paredes R, 2009, J VIROL, V83, P2038, DOI 10.1128/JVI.02154-08; PEARL J., 1988, PROBABILISTIC REASON, DOI 10.1016/B978-0-08-051489-5.50008-4; Pillay D, 2006, AIDS, V20, P21, DOI 10.1097/01.aids.0000196172.35056.b7; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Poon AFY, 2007, J VIROL, V81, P13598, DOI 10.1128/JVI.01570-07; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Shet A, 2006, JAIDS-J ACQ IMM DEF, V41, P439, DOI 10.1097/01.qai.0000219290.49152.6a; Simen BB, 2009, J INFECT DIS, V199, P693, DOI 10.1086/596736; Taylor JMG, 2000, J ACQ IMMUN DEF SYND, V23, P160; Thompson MA, 2010, JAMA-J AM MED ASSOC, V304, P321, DOI 10.1001/jama.2010.1004; VENABLES WN, MODERN APPL STAT S S; von Wyl V, 2010, J INFECT DIS, V201, P1054, DOI 10.1086/651168; Wainberg MA, 1996, SCIENCE, V271, P1282, DOI 10.1126/science.271.5253.1282; Wei X, 2003, VIROLOGY, V311, P202, DOI 10.1016/S0042-6822(03)00173-9; Wensing AMJ, 2005, J INFECT DIS, V192, P958, DOI 10.1086/432916; Wheeler WH, 2010, AIDS, V24, P1203, DOI 10.1097/QAD.0b013e3283388742; Wilkin TJ, 2008, CLIN INFECT DIS, V47, P1580, DOI 10.1086/593311; Yerly S, 2007, AIDS, V21, P2223, DOI 10.1097/QAD.0b013e3282f0b685	45	25	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e21189	10.1371/journal.pone.0021189	http://dx.doi.org/10.1371/journal.pone.0021189			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	21701595	Green Published, Green Submitted, gold			2022-12-27	WOS:000291983800029
J	Wu, H; Zeng, H; Lam, R; Tempel, W; Amaya, MF; Xu, C; Dombrovski, L; Qiu, W; Wang, YM; Min, JR				Wu, Hong; Zeng, Hong; Lam, Robert; Tempel, Wolfram; Amaya, Maria F.; Xu, Chao; Dombrovski, Ludmila; Qiu, Wei; Wang, Yanming; Min, Jinrong			Structural and Histone Binding Ability Characterizations of Human PWWP Domains	PLOS ONE			English	Article							STATE-SPECIFIC RECOGNITION; MOLECULAR-BASIS; DNA METHYLTRANSFERASES; CHROMO DOMAIN; TUDOR DOMAIN; ICF SYNDROME; H3 TAIL; METHYLATION; PROTEINS; DNMT3A	Background: The PWWP domain was first identified as a structural motif of 100-130 amino acids in the WHSC1 protein and predicted to be a protein-protein interaction domain. It belongs to the Tudor domain 'Royal Family', which consists of Tudor, chromodomain, MBT and PWWP domains. While Tudor, chromodomain and MBT domains have long been known to bind methylated histones, PWWP was shown to exhibit histone binding ability only until recently. Methodology/Principal Findings: The PWWP domain has been shown to be a DNA binding domain, but sequence analysis and previous structural studies show that the PWWP domain exhibits significant similarity to other 'Royal Family' members, implying that the PWWP domain has the potential to bind histones. In order to further explore the function of the PWWP domain, we used the protein family approach to determine the crystal structures of the PWWP domains from seven different human proteins. Our fluorescence polarization binding studies show that PWWP domains have weak histone binding ability, which is also confirmed by our NMR titration experiments. Furthermore, we determined the crystal structures of the BRPF1 PWWP domain in complex with H3K36me3, and HDGF2 PWWP domain in complex with H3K79me3 and H4K20me3. Conclusions: PWWP proteins constitute a new family of methyl lysine histone binders. The PWWP domain consists of three motifs: a canonical beta-barrel core, an insertion motif between the second and third beta-strands and a C-terminal alpha-helix bundle. Both the canonical beta-barrel core and the insertion motif are directly involved in histone binding. The PWWP domain has been previously shown to be a DNA binding domain. Therefore, the PWWP domain exhibits dual functions: binding both DNA and methyllysine histones.	[Wu, Hong; Zeng, Hong; Lam, Robert; Tempel, Wolfram; Amaya, Maria F.; Xu, Chao; Dombrovski, Ludmila; Qiu, Wei; Min, Jinrong] Univ Toronto, Struct Genom Consortium, Toronto, ON, Canada; [Wang, Yanming] Penn State Univ, Dept Biochem & Mol Biol, Ctr Gene Regulat, University Pk, PA 16802 USA; [Min, Jinrong] Univ Toronto, Dept Physiol, Toronto, ON, Canada	University of Toronto; Structural Genomics Consortium; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Toronto	Wu, H (corresponding author), Univ Toronto, Struct Genom Consortium, Toronto, ON, Canada.	jr.min@utoronto.ca	Min, Jinrong/G-3449-2011; Xu, Chao/G-3885-2010	Min, Jinrong/0000-0001-5210-3130; Xu, Chao/0000-0003-0444-7080; Wang, Yanming/0000-0002-0710-043X	Structural Genomics Consortium, a registered charity [1097737]; Canadian Institutes for Health Research; Canadian Foundation for Innovation; Genome Canada through the Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institute; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co., Inc.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust; National Center for Research Resources [RR-15301]; United States Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; National Science Foundation [DMR-0936384]; National Institutes of Health; United States Department of Energy's Office of Science; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER	Structural Genomics Consortium, a registered charity(University of Toronto); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Genome Canada through the Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institute(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co., Inc.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); United States Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy's Office of Science(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research was supported by the Structural Genomics Consortium, a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institute, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research and the Wellcome Trust. Results shown in this report are derived from work performed at Structural Biology Center and Northeastern Collaborative Access Team beamlines at the Advanced Photon Source, Argonne National Laboratory, with support from the National Center for Research Resources (RR-15301). Argonne National Laboratory is operated by UChicago Argonne, LLC, for the United States Department of Energy, Office of Biological and Environmental Research, under contract DE-AC02-06CH11357. Research was also conducted at the Cornell High Energy Synchrotron Source (CHESS), which is supported by the National Science Foundation (DMR-0936384) and the National Institutes of Health, and also at the National Synchrotron Light Source at Brookhaven National Laboratory, funded by the United States Department of Energy's Office of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams-Cioaba MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013559; Adams-Cioaba MA, 2009, BIOCHEM CELL BIOL, V87, P93, DOI 10.1139/O08-129; Bjarkam CR, 2009, BRAIN STRUCT FUNCT, V214, P37, DOI 10.1007/s00429-009-0219-3; Botbol YR, 2008, NUCLEIC ACIDS RES, V36, P1237, DOI 10.1093/nar/gkm1127; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Chen TP, 2004, MOL CELL BIOL, V24, P9048, DOI 10.1128/MCB.24.20.9048-9058.2004; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; Dhayalan A, 2010, J BIOL CHEM, V285, P26114, DOI 10.1074/jbc.M109.089433; El-Tahir HM, 2009, J BIOL CHEM, V284, P11637, DOI 10.1074/jbc.M901101200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eryilmaz J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007274; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Flanagan JF, 2005, NATURE, V438, P1181, DOI 10.1038/nature04290; Ge YZ, 2004, J BIOL CHEM, V279, P25447, DOI 10.1074/jbc.M312296200; Guo YH, 2009, NUCLEIC ACIDS RES, V37, P2204, DOI 10.1093/nar/gkp086; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Laguri C, 2008, BIOCHEMISTRY-US, V47, P6199, DOI 10.1021/bi7024639; Lepourcelet M, 2005, DEVELOPMENT, V132, P415, DOI 10.1242/dev.01579; Li H, 2007, MOL CELL, V28, P677, DOI 10.1016/j.molcel.2007.10.023; Liu H, 2010, GENES DEV; Liu K, 2010, P NATL ACAD SCI USA, V107, P18398, DOI 10.1073/pnas.1013106107; Lukasik SM, 2006, PROTEIN SCI, V15, P314, DOI 10.1110/ps.051751706; Maurer-Stroh S, 2003, TRENDS BIOCHEM SCI, V28, P69, DOI 10.1016/S0968-0004(03)00004-5; Min JR, 2007, NAT STRUCT MOL BIOL, V14, P1229, DOI 10.1038/nsmb1340; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Nielsen PR, 2002, NATURE, V416, P103, DOI 10.1038/nature722; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; OTWINOWSKI Z, PROCESSING XRAY DIFF, P307; Park J, 2008, J MOL MED, V86, P1269, DOI 10.1007/s00109-008-0392-5; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Qiu C, 2002, NAT STRUCT BIOL, V9, P217, DOI 10.1038/nsb759; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schuetz A, 2006, EMBO J, V25, P4245, DOI 10.1038/sj.emboj.7601316; Shikauchi Y, 2009, MOL CELL BIOL, V29, P1944, DOI 10.1128/MCB.00840-08; Shun MC, 2008, J VIROL, V82, P11555, DOI 10.1128/JVI.01561-08; Stec I, 1998, HUM MOL GENET, V7, P1071, DOI 10.1093/hmg/7.7.1071; Stec I, 2000, FEBS LETT, V473, P1, DOI 10.1016/S0014-5793(00)01449-6; Sun BF, 2008, J BIOL CHEM, V283, P36504, DOI 10.1074/jbc.M806564200; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vermeulen M, 2010, CELL, V142, P967, DOI 10.1016/j.cell.2010.08.020; Vezzoli A, 2010, NAT STRUCT MOL BIOL, V17, P617, DOI 10.1038/nsmb.1797; WANG BC, 1985, METHOD ENZYMOL, V115, P90; Wang Y, 2009, MOL CELL, V33, P428, DOI 10.1016/j.molcel.2009.02.002; Watanabe Y, 2010, ADV CLIN CHEM, V52, P145, DOI 10.1016/S0065-2423(10)52006-7; Wijmenga C, 1998, AM J HUM GENET, V63, P803, DOI 10.1086/302021; Xu C, 2008, STRUCTURE, V16, P1740, DOI 10.1016/j.str.2008.08.008; Xu C, 2010, P NATL ACAD SCI USA, V107, P19266, DOI 10.1073/pnas.1008937107; Yang J, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-101; Yokoyama A, 2008, CANCER CELL, V14, P36, DOI 10.1016/j.ccr.2008.05.003; Zhang P, 2006, NUCLEIC ACIDS RES, V34, P6621, DOI 10.1093/nar/gkl989	52	112	124	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e18919	10.1371/journal.pone.0018919	http://dx.doi.org/10.1371/journal.pone.0018919			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	21720545	gold, Green Published			2022-12-27	WOS:000291983800001
J	Fowler, DW; Woodward, HN; Freedman, EA; Larson, PL; Horner, JR				Fowler, Denver W.; Woodward, Holly N.; Freedman, Elizabeth A.; Larson, Peter L.; Horner, John R.			Reanalysis of "Raptorex kriegsteini": A Juvenile Tyrannosaurid Dinosaur from Mongolia	PLOS ONE			English	Article							LONG-BONE HISTOLOGY; THEROPOD DINOSAUR; PARK FORMATION; NORTH-AMERICA; MAIASAURA-PEEBLESORUM; CRANIOFACIAL ONTOGENY; TARBOSAURUS-BATAAR; GROWTH DYNAMICS; BUGIN-TSAV; ALBERTA	The carnivorous Tyrannosauridae are among the most iconic dinosaurs: typified by large body size, tiny forelimbs, and massive robust skulls with laterally thickened teeth. The recently described small-bodied tyrannosaurid Raptorex kreigsteini is exceptional as its discovery proposes that many of the distinctive anatomical traits of derived tyrannosaurids were acquired in the Early Cretaceous, before the evolution of large body size. This inference depends on two core interpretations: that the holotype (LH PV18) derives from the Lower Cretaceous of China, and that despite its small size, it is a subadult or young adult. Here we show that the published data is equivocal regarding stratigraphic position and that ontogenetic reanalysis shows there is no reason to conclude that LH PV18 has reached this level of maturity. The probable juvenile status of LH PV18 makes its use as a holotype unreliable, since diagnostic features of Raptorex may be symptomatic of its immature status, rather than its actual phylogenetic position. These findings are consistent with the original sale description of LH PV18 as a juvenile Tarbosaurus from the Upper Cretaceous of Mongolia. Consequently, we suggest that there is currently no evidence to support the conclusion that tyrannosaurid skeletal design first evolved in the Early Cretaceous at small body size.	[Fowler, Denver W.; Woodward, Holly N.; Freedman, Elizabeth A.; Horner, John R.] Montana State Univ, Museum Rockies, Bozeman, MT 59717 USA; [Fowler, Denver W.; Woodward, Holly N.; Freedman, Elizabeth A.; Horner, John R.] Montana State Univ, Dept Earth Sci, Bozeman, MT 59717 USA; [Larson, Peter L.] Black Hills Inst Geol Res Inc, Hill City, SD USA; [Larson, Peter L.] Univ Manchester, Sch Earth Atmospher & Environm Sci, Manchester, Lancs, England	Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman; University of Manchester	Fowler, DW (corresponding author), Montana State Univ, Museum Rockies, Bozeman, MT 59717 USA.	df9465@yahoo.co.uk	Freedman, Elizabeth/J-1752-2012; Ballard, HollyNoelle/AED-7676-2022	Freedman, Elizabeth/0000-0002-5763-5272; Ballard, HollyNoelle/0000-0003-0413-0681; Fowler, Denver/0000-0001-9188-4371	Damaris Waggoner; David Sands	Damaris Waggoner; David Sands	Funding for the Museum of the Rockies graduate student fund was provided by Damaris Waggoner and David Sands. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHENBACH J, 2009, WASHINGTON POST 0918; BAGILS RZ, 2004, MESOZOIC FISHES, V3, P391; Benson RBJ, 2008, J VERTEBR PALEONTOL, V28, P732, DOI 10.1671/0272-4634(2008)28[732:NIOSAT]2.0.CO;2; Benson RBJ, 2010, SCIENCE, V327, P1613, DOI 10.1126/science.1187456; BOYLE A, 2009, MSNBC NEWS; Brinkman DB, 2002, J PALEONTOL, V76, P138, DOI 10.1666/0022-3360(2002)076<0138:TCFUJR>2.0.CO;2; Brochu CA, 1996, J VERTEBR PALEONTOL, V16, P49, DOI 10.1080/02724634.1996.10011283; Brochu CA, 2003, J VERTEBR PALEONTOL, V22, P1, DOI [10.1080/02724634.2003.10010947, DOI 10.1080/02724634.2003.10010947, 10.2307/3889334, DOI 10.2307/3889334]; Brown B., 1940, Annals of the New York Academy of Sciences, V40, P133; Brown CM, 2009, J VERTEBR PALEONTOL, V29, P132, DOI 10.1671/039.029.0119; Brusatte SL, 2009, P NATL ACAD SCI USA, V106, P17261, DOI 10.1073/pnas.0906911106; Bybee PJ, 2006, J MORPHOL, V267, P347, DOI 10.1002/jmor.10406; Carpenter K, 2005, LIFE O PAST, P23; Carr TD, 2005, J VERTEBR PALEONTOL, V25, P119, DOI 10.1671/0272-4634(2005)025[0119:ANGASO]2.0.CO;2; Carr TD, 2004, ZOOL J LINN SOC-LOND, V142, P479, DOI 10.1111/j.1096-3642.2004.00130.x; Carr TD, 1999, J VERTEBR PALEONTOL, V19, P497, DOI 10.1080/02724634.1999.10011161; CASE TJ, 1978, PALEOBIOLOGY, V4, P320, DOI 10.1017/S0094837300006023; Clark J, 2009, SCIENCE, V326, P373, DOI 10.1126/science.1181276; Csiki Z, 2010, P NATL ACAD SCI USA, V107, P15357, DOI 10.1073/pnas.1006970107; Currie PJ, 2005, LIFE O PAST, P537; Currie Philip J., 2008, P1; Currie PJ, 2003, ACTA PALAEONTOL POL, V48, P191; Currie PJ, 2003, CAN J EARTH SCI, V40, P651, DOI 10.1139/E02-083; Currie PJ, 2001, CAN J EARTH SCI, V38, P1729, DOI 10.1139/e01-042; CURRIE PJ, 1993, CRETACEOUS RES, V14, P127, DOI 10.1006/cres.1993.1011; de Ricqles Armand J., 2003, Annales de Paleontologie, V89, P67, DOI 10.1016/S0753-3969(03)00005-3; Dilkes DW, 2001, CAN J EARTH SCI, V38, P1205, DOI 10.1139/e01-016; DODSON P, 1988, CAN J EARTH SCI, V25, P926, DOI 10.1139/e88-090; DODSON P, 1975, SYST ZOOL, V24, P37, DOI 10.2307/2412696; DODSON P, 1976, J PALEONTOL, V50, P929; DONG ZM, 1977, VERTEBRAT PALASIATIC, V15, P307; Erickson GM, 2004, NATURE, V430, P772, DOI 10.1038/nature02699; Evans DC, 2007, J VERTEBR PALEONTOL, V27, P642, DOI 10.1671/0272-4634(2007)27[642:AJPOHB]2.0.CO;2; Evans DC, 2005, LIFE O PAST, P349; Everhart Michael J., 2011, Transactions of the Kansas Academy of Science, V114, P59, DOI 10.1660/062.114.0105; Francillon-Vieillot H., 1990, P471; Herne MC, 2010, SCIENCE, V329, DOI 10.1126/science.1190100; Holmes RB, 2001, CAN J EARTH SCI, V38, P1423, DOI 10.1139/e01-036; Holtz TR, 2004, DINOSAURIA, 2ND EDITION, P111; Holtz Thomas R. Jr, 2001, P64; Hone DWE, 2011, CRETACEOUS RES, V32, P495, DOI 10.1016/j.cretres.2011.03.005; Horner J.R., 1983, J VERTEBR PALEONTOL, V3, P29, DOI [DOI 10.1080/02724634.1983.10011954, 10.1080/02724634.1983.10011954]; Horner JR, 2008, J VERTEBR PALEONTOL, V28, P134, DOI 10.1671/0272-4634(2008)28[134:OOCEIT]2.0.CO;2; Horner JR, 2006, P ROY SOC B-BIOL SCI, V273, P2757, DOI 10.1098/rspb.2006.3643; Horner JR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007626; Horner John R., 1994, P312; Horner JR, 2004, P ROY SOC B-BIOL SCI, V271, P1875, DOI 10.1098/rspb.2004.2829; Horner JR, 2000, J VERTEBR PALEONTOL, V20, P115, DOI 10.1671/0272-4634(2000)020[0115:LBHOTH]2.0.CO;2; Horner JR, 2001, PALEOBIOLOGY, V27, P39, DOI 10.1666/0094-8373(2001)027<0039:COOSEA>2.0.CO;2; Hurum JH, 2003, ACTA PALAEONTOL POL, V48, P161; Hutt S, 2001, CRETACEOUS RES, V22, P227, DOI 10.1006/cres.2001.0252; HUTTON JM, 1986, COPEIA, P332, DOI 10.2307/1444994; Klein N, 2008, PALEOBIOLOGY, V34, P247, DOI 10.1666/0094-8373(2008)034[0247:OSITLB]2.0.CO;2; Knoll F, 2010, GONDWANA RES, V17, P171, DOI 10.1016/j.gr.2009.03.010; LI PX, 1994, ACTA GEOL SINICA, V7, P329; MA FZ, 1987, VERTEBRAT PALASIATIC, V25, P8; MADSEN JH, 1974, J PALEONTOL, V48, P27; MALEEV EA, 1955, DOKL AKAD NAUK SSSR+, V104, P634; Margottini L, 2011, SCIENCE, V332, P782, DOI 10.1126/science.332.6031.782; MARYANSKA T, 1979, LETHAIA, V12, P265, DOI 10.1111/j.1502-3931.1979.tb01006.x; MULLEN W, 2009, CHICAGO TRIBUNE 0918; Newbrey MG, 2010, CAN J EARTH SCI, V47, P1183, DOI 10.1139/E10-041; Osborn HF, 1905, B AM MUS NAT HIST, V21, P259; Padian K, 2004, J VERTEBR PALEONTOL, V24, P555, DOI 10.1671/0272-4634(2004)024[0555:GISDAP]2.0.CO;2; Padian K, 2001, NATURE, V412, P405, DOI 10.1038/35086500; Rauhut OWM, 2003, PALAEONTOLOGY, V46, P903, DOI 10.1111/1475-4983.00325; Reisz RR, 2005, SCIENCE, V309, P761, DOI 10.1126/science.1114942; Rozhdestvensky AK, 1965, PALEONTOL ZH, V3, P95; RUSSELL DA, 1970, NATL MUS NAT HIST PU, V1, P1; Ryan MJ, 2005, LIFE O PAST, P312; Ryan MJ, 2005, CAN J EARTH SCI, V42, P1369, DOI 10.1139/E05-029; Ryan MJ, 2001, PALAIOS, V16, P482, DOI 10.2307/3515564; Sampson SD, 1997, ZOOL J LINN SOC-LOND, V121, P293, DOI 10.1111/j.1096-3642.1997.tb00340.x; Sampson SD, 1995, J VERTEBR PALEONTOL, V15, P743, DOI 10.1080/02724634.1995.10011259; Scannella J.B., 2009, CINCINNATI MUSEUM CT, V3, P148; Scannella JB, 2010, J VERTEBR PALEONTOL, V30, P1157, DOI 10.1080/02724634.2010.483632; Sereno PC, 2009, SCIENCE, V326, P418, DOI 10.1126/science.1177428; Tanks DH, 2005, LIFE O PAST, P34; Trueman CN, 2006, GEOCHIM COSMOCHIM AC, V70, P4343, DOI 10.1016/j.gca.2006.06.1556; Trueman CN, 1997, GEOLOGY, V25, P263, DOI 10.1130/0091-7613(1997)025<0263:AGMTTT>2.3.CO;2; Tsuihiji T, 2011, J VERTEBR PALEONTOL, V31, P497, DOI 10.1080/02724634.2011.557116; Tucker AD, 1997, MAR FRESHWATER RES, V48, P343, DOI 10.1071/MF96113; Wedel MJ, 2003, J VERTEBR PALEONTOL, V23, P344, DOI 10.1671/0272-4634(2003)023[0344:TEOVPI]2.0.CO;2; Weishampel DB, 2008, J VERTEBR PALEONTOL, V28, P1110, DOI 10.1671/0272-4634-28.4.1110; Whitlock JA, 2010, J VERTEBR PALEONTOL, V30, P442, DOI 10.1080/02724631003617647; Xu X, 2006, NATURE, V439, P715, DOI 10.1038/nature04511; Xu X, 2004, NATURE, V431, P680, DOI 10.1038/nature02855; Zhang Jiang-Yong, 2002, Vertebrata Palasiatica, V40, P257	88	46	47	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21376	10.1371/journal.pone.0021376	http://dx.doi.org/10.1371/journal.pone.0021376			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21738646	Green Published, Green Submitted, gold			2022-12-27	WOS:000292290100021
J	Chang, CH; Toh, S; Lin, JW; Chen, ST; Kuo, CW; Chuang, LM; Lai, MS				Chang, Chia-Hsuin; Toh, Sengwee; Lin, Jou-Wei; Chen, Shu-Ting; Kuo, Chuei-Wen; Chuang, Lee-Ming; Lai, Mei-Shu			Cancer Risk Associated with Insulin Glargine among Adult Type 2 Diabetes Patients - A Nationwide Cohort Study	PLOS ONE			English	Article							ANALOGS; MALIGNANCIES	Background: Preclinical and observational studies raise the concern about the safety of insulin glargine in terms of cancer initiation and promotion. This study is designed to examine cancer incidence associated with use of insulin glargine vs. intermediate/long-acting human insulin (HI). Methodology: A retrospective cohort study using the Taiwan National Health Insurance claims database was conducted to identify adult patients with type 2 diabetes mellitus and without a history of cancer who initiated insulin glargine (n = 10,190) or intermediate/long-acting HI (n = 49,253) during 2004-2007. Exclusive users were followed from the date of insulin initiation to the earliest of cancer diagnosis, death, disenrollment, or December 31 2007. We estimated adjusted hazard ratios and 95% confidence intervals (CIs) with Cox proportional hazards models adjusting for baseline propensity score. Findings: The incidence rate of all cancer per 1,000 person-years was 13.8 for insulin glargine initiators (179 cases) and 16.0 for intermediate/long-acting HI initiators (1,445 cases) during an average follow-up of 2 years. No significant difference in overall cancer risk between insulin glargine initiators and HI initiators was found. For men, however, the adjusted hazard ratio of insulin glargine use as compared with intermediate/long-acting HI was 2.15 (95% CI 1.01-4.59) for pancreatic cancer, and 2.42 (95% CI 1.50-8.40) for prostate cancer. The increased risk was not observed among women. Conclusions: Insulin glargine use did not increase the risk of overall cancer incidence as compared with HI. The positive associations with pancreatic and prostate cancer need further evaluation and validation.	[Chang, Chia-Hsuin; Chen, Shu-Ting; Chuang, Lee-Ming; Lai, Mei-Shu] Natl Taiwan Univ, Coll Publ Hlth, Inst Prevent Med, Taipei 10764, Taiwan; [Chang, Chia-Hsuin; Chuang, Lee-Ming] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Toh, Sengwee] Harvard Univ, Sch Med, Dept Populat Med, Harvard Pilgrim Hlth Care Inst, Boston, MA USA; [Lin, Jou-Wei] Natl Taiwan Univ Hosp, Yun Lin Branch, Ctr Cardiovasc, Dou Liou City, Yun Lin, Taiwan; [Kuo, Chuei-Wen] Natl Hlth Insurance Mediat Comm, Dept Hlth, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; Harvard Pilgrim Health Care; Harvard University; Harvard Medical School; National Taiwan University; National Taiwan University Hospital	Chang, CH (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Inst Prevent Med, Taipei 10764, Taiwan.	leeming@ntu.edu.tw; mslai@ntu.edu.tw	Toh, Sengwee/D-7567-2017; Chuang, Lee-Ming/AAF-3324-2019	Toh, Sengwee/0000-0002-5160-0810; CHANG, CHIA-HSUIN/0000-0003-0024-6177; Lai, Mei-shu/0000-0001-6130-3468; CHUANG, LEE-MING/0000-0003-0978-2662	Department of Health [DOH098-TD-D-113-098016]	Department of Health	This study was supported by Department of Health grant DOH098-TD-D-113-098016. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Colhoun HM, 2009, DIABETOLOGIA, V52, P1755, DOI 10.1007/s00125-009-1453-1; Currie CJ, 2009, DIABETOLOGIA, V52, P1766, DOI 10.1007/s00125-009-1440-6; Erbel S, 2008, DIABETES CARE, V31, P1105, DOI 10.2337/dc07-2015; Giovannucci E, 2010, CA-CANCER J CLIN, V60, P207, DOI 10.3322/caac.20078; Grote VA, 2010, EXP CLIN ENDOCR DIAB, V118, P4, DOI 10.1055/s-0029-1243193; Hemkens LG, 2009, DIABETOLOGIA, V52, P1732, DOI 10.1007/s00125-009-1418-4; Hernandez-Diaz S, 2010, DIABETOLOGIA, V53, P802, DOI 10.1007/s00125-010-1675-2; Home PD, 2009, DIABETOLOGIA, V52, P2499, DOI 10.1007/s00125-009-1530-5; Jonasson JM, 2009, DIABETOLOGIA, V52, P1745, DOI 10.1007/s00125-009-1444-2; Mannucci E, 2010, DIABETES CARE, V33, P1997, DOI 10.2337/dc10-0476; Pocock SJ, 2009, LANCET, V374, P511, DOI 10.1016/S0140-6736(09)61307-6; Pollak M, 2010, INT J CLIN PRACT, V64, P628, DOI 10.1111/j.1742-1241.2010.02354.x; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Rosenstock J, 2009, DIABETOLOGIA, V52, P1778, DOI 10.1007/s00125-009-1415-7; Schneeweiss S, 2010, PHARMACOEPIDEM DR S, V19, P858, DOI 10.1002/pds.1926; Smith U, 2009, DIABETOLOGIA, V52, P1699, DOI 10.1007/s00125-009-1441-5; Weinstein D, 2009, DIABETES-METAB RES, V25, P41, DOI 10.1002/dmrr.912; Who collaborating centre for drug statistics methodology, DEF DAIL DOS DEF GEN	19	32	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21368	10.1371/journal.pone.0021368	http://dx.doi.org/10.1371/journal.pone.0021368			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738645	Green Published, gold, Green Submitted			2022-12-27	WOS:000292092600032
J	Khan, JA; Kudgus, RA; Szabolcs, A; Dutta, S; Wang, EF; Cao, S; Curran, GL; Shah, V; Curley, S; Mukhopadhyay, D; Robertson, JD; Bhattacharya, R; Mukherjee, P				Khan, Jameel Ahmad; Kudgus, Rachel A.; Szabolcs, Annamaria; Dutta, Shamit; Wang, Enfeng; Cao, Sheng; Curran, Geoffry L.; Shah, Vijay; Curley, Steven; Mukhopadhyay, Debabrata; Robertson, J. David; Bhattacharya, Resham; Mukherjee, Priyabrata			Designing Nanoconjugates to Effectively Target Pancreatic Cancer Cells In Vitro and In Vivo	PLOS ONE			English	Article							GROWTH-FACTOR-RECEPTOR; FUNCTIONALIZED GOLD NANOPARTICLES; MONOCLONAL-ANTIBODY CETUXIMAB; PARTICLE-SIZE; MECHANISM; CHEMISTRY; DELIVERY; BIODISTRIBUTION; NANOTECHNOLOGY; TRAFFICKING	Background: Pancreatic cancer is the fourth leading cause of cancer related deaths in America. Monoclonal antibodies are a viable treatment option for inhibiting cancer growth. Tumor specific drug delivery could be achieved utilizing these monoclonal antibodies as targeting agents. This type of designer therapeutic is evolving and with the use of gold nanoparticles it is a promising approach to selectively deliver chemotherapeutics to malignant cells. Gold nanoparticles (GNPs) are showing extreme promise in current medicinal research. GNPs have been shown to non-invasively kill tumor cells by hyperthermia using radiofrequency. They have also been implemented as early detection agents due to their unique X-ray contrast properties; success was revealed with clear delineation of blood capillaries in a preclinical model by CT (computer tomography). The fundamental parameters for intelligent design of nanoconjugates are on the forefront. The goal of this study is to define the necessary design parameters to successfully target pancreatic cancer cells. Methodology/Principal Findings: The nanoconjugates described in this study were characterized with various physicochemical techniques. We demonstrate that the number of cetuximab molecules (targeting agent) on a GNP, the hydrodynamic size of the nanoconjugates, available reactive surface area and the ability of the nanoconjugates to sequester EGFR (epidermal growth factor receptor), all play critical roles in effectively targeting tumor cells in vitro and in vivo in an orthotopic model of pancreatic cancer. Conclusion: Our results suggest the specific targeting of tumor cells depends on a number of crucial components 1) targeting agent to nanoparticle ratio 2) availability of reactive surface area on the nanoparticle 3) ability of the nanoconjugate to bind the target and 4) hydrodynamic diameter of the nanoconjugate. We believe this study will help define the design parameters for formulating better strategies for specifically targeting tumors with nanoparticle conjugates.	[Khan, Jameel Ahmad; Kudgus, Rachel A.; Szabolcs, Annamaria; Dutta, Shamit; Wang, Enfeng; Mukhopadhyay, Debabrata; Bhattacharya, Resham; Mukherjee, Priyabrata] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Cao, Sheng; Shah, Vijay] Mayo Clin, Coll Med, Dept Med & Physiol, Rochester, MN USA; [Curley, Steven] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; [Mukhopadhyay, Debabrata; Mukherjee, Priyabrata] Mayo Clin, Coll Med, Ctr Canc, Rochester, MN USA; [Robertson, J. David] Univ Missouri, Dept Chem, Columbia, MO 65211 USA; [Robertson, J. David] Univ Missouri, Univ Missouri Res Reactor, Columbia, MO USA; [Mukhopadhyay, Debabrata; Mukherjee, Priyabrata] Coll Med, Dept Biomed Engn, Rochester, MN USA	Mayo Clinic; Mayo Clinic; University of Texas System; UTMD Anderson Cancer Center; Mayo Clinic; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Khan, JA (corresponding author), Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA.	Mukherjee.priyabrata@mayo.edu		Robertson, John/0000-0002-6675-8469	National Institutes of Health [CA135011, CA136494, CA150190]; MD Anderson Cancer Center Developmental Grant (UTMD); NATIONAL CANCER INSTITUTE [R01CA136494, R01CA135011, R01CA150190] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MD Anderson Cancer Center Developmental Grant (UTMD); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by National Institutes of Health CA135011, CA136494, CA150190 and an MD Anderson Cancer Center Developmental Grant (UTMD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartlett DW, 2007, P NATL ACAD SCI USA, V104, P15549, DOI 10.1073/pnas.0707461104; Bhattacharya R, 2008, ADV DRUG DELIVER REV, V60, P1289, DOI 10.1016/j.addr.2008.03.013; Bhattacharya R, 2007, NANOMED-NANOTECHNOL, V3, P224, DOI 10.1016/j.nano.2007.07.001; Bhattacharya R, 2007, ADV MATER, V19, P711, DOI 10.1002/adma.200602098; Bhattacharyya S, 2010, P NATL ACAD SCI USA, V107, P14541, DOI 10.1073/pnas.1006507107; Biesso A, 2009, J AM CHEM SOC, V131, P2442, DOI 10.1021/ja8088873; Burda C, 2005, CHEM REV, V105, P1025, DOI 10.1021/cr030063a; Chanda N, 2010, P NATL ACAD SCI USA, V107, P8760, DOI 10.1073/pnas.1002143107; Choi CHJ, 2010, P NATL ACAD SCI USA, V107, P1235, DOI 10.1073/pnas.0914140107; Choi HS, 2010, NAT NANOTECHNOL, V5, P42, DOI [10.1038/NNANO.2009.314, 10.1038/nnano.2009.314]; Daniel MC, 2004, CHEM REV, V104, P293, DOI 10.1021/cr030698+; De Jong WH, 2008, BIOMATERIALS, V29, P1912, DOI 10.1016/j.biomaterials.2007.12.037; Ehrenberg MS, 2009, BIOMATERIALS, V30, P603, DOI 10.1016/j.biomaterials.2008.09.050; Ferrari M, 2005, NAT REV CANCER, V5, P161, DOI 10.1038/nrc1566; Gannon Christopher J., 2008, Journal of Nanobiotechnology, V6, P2, DOI 10.1186/1477-3155-6-2; Hainfeld JF, 2006, BRIT J RADIOL, V79, P248, DOI 10.1259/bjr/13169882; Han G, 2007, NANOMEDICINE-UK, V2, P113, DOI 10.2217/17435889.2.1.113; Hirsch LR, 2003, P NATL ACAD SCI USA, V100, P13549, DOI 10.1073/pnas.2232479100; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Jans H, 2009, ANAL CHEM, V81, P9425, DOI 10.1021/ac901822w; Kang B, 2010, J AM CHEM SOC, V132, P1517, DOI 10.1021/ja9102698; Khan JA, 2007, CHEMBIOCHEM, V8, P1237, DOI 10.1002/cbic.200700165; Li SQ, 2005, CANCER CELL, V7, P301, DOI 10.1016/j.ccr.2005.03.003; Liao HJ, 2009, CANCER RES, V69, P6179, DOI 10.1158/0008-5472.CAN-09-0049; Lu Y, 2007, CANCER RES, V67, P8240, DOI 10.1158/0008-5472.CAN-07-0589; Luwor RB, 2005, ONCOGENE, V24, P4433, DOI 10.1038/sj.onc.1208625; Mangeney C, 2002, J AM CHEM SOC, V124, P5811, DOI 10.1021/ja010796h; Mirkin CA, 2000, NATURE, V405, P626, DOI 10.1038/35015190; Mukherjee P, 2005, CLIN CANCER RES, V11, P3530, DOI 10.1158/1078-0432.CCR-04-2482; Mukherjee Priyabrata, 2007, Journal of Nanobiotechnology, V5, P4, DOI 10.1186/1477-3155-5-4; Orth JD, 2006, CANCER RES, V66, P3603, DOI 10.1158/0008-5472.CAN-05-2916; Park JW, 2002, CLIN CANCER RES, V8, P1172; Patra CR, 2008, CANCER RES, V68, P1970, DOI 10.1158/0008-5472.CAN-07-6102; Patra CR, 2010, ADV DRUG DELIVER REV, V62, P346, DOI 10.1016/j.addr.2009.11.007; Perrault SD, 2009, NANO LETT, V9, P1909, DOI 10.1021/nl900031y; Rocha-Lima Caio M, 2007, Cancer Control, V14, P295; SCHREIBER AB, 1983, J BIOL CHEM, V258, P846; Slovin SF, 2009, CLIN GENITOURIN CANC, V7, pE77, DOI 10.3816/CGC.2009.n.028; Sonavane G, 2008, COLLOID SURFACE B, V66, P274, DOI 10.1016/j.colsurfb.2008.07.004; Stephan S, 2004, CLIN CANCER RES, V10, P6993, DOI 10.1158/1078-0432.CCR-04-0808; Whitesides GM, 2003, NAT BIOTECHNOL, V21, P1161, DOI 10.1038/nbt872; Xie H, 2003, ANAL CHEM, V75, P5797, DOI 10.1021/ac034578d; Yen CW, 2009, J PHYS CHEM A, V113, P4340, DOI 10.1021/jp811014u	43	54	55	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e20347	10.1371/journal.pone.0020347	http://dx.doi.org/10.1371/journal.pone.0020347			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738572	Green Published, gold, Green Submitted			2022-12-27	WOS:000292092600001
J	Thomas, F; Cosse, A; Goulitquer, S; Raimund, S; Morin, P; Valero, M; Leblanc, C; Potin, P				Thomas, Francois; Cosse, Audrey; Goulitquer, Sophie; Raimund, Stefan; Morin, Pascal; Valero, Myriam; Leblanc, Catherine; Potin, Philippe			Waterborne Signaling Primes the Expression of Elicitor-Induced Genes and Buffers the Oxidative the Brown Alga Laminaria digitata	PLOS ONE			English	Article							INDUCED RESISTANCE; MOLECULAR-MECHANISMS; PLANT INTERACTIONS; TALKING TREES; GETTING READY; DEFENSE; COMMUNICATION; VOLATILES; COSTS; BURST	As marine sessile organisms, seaweeds must respond efficiently to biotic and abiotic challenges in their natural environment to reduce the fitness consequences of wounds and oxidative stress. This study explores the early steps of the defense responses of a large marine brown alga (the tangle kelp Laminaria digitata) and investigates its ability to transmit a warning message to neighboring conspecifics. We compared the early responses to elicitation with oligoguluronates in laboratory-grown and harvested wild individuals of L. digitata. We followed the release of H2O2 and the concomitant production of volatile organic compounds. We also monitored the kinetics of expression of defense-related genes following the oxidative burst. Laboratory-grown algae were transplanted in kelp habitats to further evaluate their responses to elicitation after a transient immersion in natural seawater. In addition, a novel conditioning procedure was established to mimic field conditions in the laboratory. Our experiments showed that L. digitata integrates waterborne cues present in the kelp bed and/or released from elicited neighboring plants. Indeed, the exposure to elicited conspecifics changes the patterns of oxidative burst and volatile emissions and potentiates this kelp for faster induction of genes specifically regulated in response to oligoguluronates. Thus, waterborne signals shape the elicitor-induced responses of kelps through a yet unknown mechanism reminiscent of priming in land plants.	[Thomas, Francois; Cosse, Audrey; Leblanc, Catherine; Potin, Philippe] Univ Paris 06, Marine Plants & Biomol Lab, Stn Biol Roscoff, Unite Mixte Rech 7139, Roscoff, France; [Thomas, Francois; Cosse, Audrey; Leblanc, Catherine; Potin, Philippe] CNRS, Stn Biol, Unite Mixte Rech 7139, Roscoff, France; [Goulitquer, Sophie] Univ Bretagne Occidentale, Fac Med, Inst Natl Sante & Rech Med,U613, Lab Biochim Epissage Canc Lipides & Apoptose, Brest, France; [Raimund, Stefan; Morin, Pascal; Valero, Myriam] Univ Paris 06, Stn Biol, Unite Mixte Rech 7144, Roscoff, France; [Raimund, Stefan; Morin, Pascal; Valero, Myriam] CNRS, Stn Biol, Unite Mixte Rech 7144, Roscoff, France	UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bretagne Occidentale; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Thomas, F (corresponding author), Univ Paris 06, Marine Plants & Biomol Lab, Stn Biol Roscoff, Unite Mixte Rech 7139, Roscoff, France.	potin@sb-roscoff.fr	Morin, Pascal/A-1112-2016; Valero, Myriam/C-7550-2011; Valero, Myriam/M-6052-2019	Morin, Pascal/0000-0003-2766-1821; Valero, Myriam/0000-0002-9000-1423; Valero, Myriam/0000-0002-9000-1423; Thomas, Francois/0000-0003-1896-0774; POTIN, Philippe/0000-0001-7358-6282	French National Research Agency (ANR) [ANR 06 BDIV 012]; Ministry of Higher Education and Research; Brittany Regional Council; ECOKELP; European Community (ESTeam) [MESTCT 2005-020737]	French National Research Agency (ANR)(French National Research Agency (ANR)); Ministry of Higher Education and Research(Ministry of Higher Education & Scientific Research (MHESR)); Brittany Regional Council(Region Bretagne); ECOKELP; European Community (ESTeam)(European Commission)	This work was partially funded by the ECOKELP program of the French National Research Agency (ANR) (ANR 06 BDIV 012). Ph.D. fellowships to F. T. and S. G were awarded by the Ministry of Higher Education and Research. A. C. was supported by a Ph.D. fellowship from the Brittany Regional Council and a postdoctoral fellowship from ECOKELP. S. R. received funding from the European Community Sixth Framework Programme (ESTeam MESTCT 2005-020737). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	APT KE, 1995, MOL GEN GENET, V246, P455, DOI 10.1007/BF00290449; BALDWIN IT, 1983, SCIENCE, V221, P277, DOI 10.1126/science.221.4607.277; Baldwin IT, 2006, SCIENCE, V311, P812, DOI 10.1126/science.1118446; Borell EM, 2004, OECOLOGIA, V140, P328, DOI 10.1007/s00442-004-1589-0; Broadgate WJ, 2004, MAR CHEM, V88, P61, DOI 10.1016/j.marchem.2004.03.002; Bruce TJA, 2007, PLANT SCI, V173, P603, DOI 10.1016/j.plantsci.2007.09.002; BRUIN J, 1995, TRENDS ECOL EVOL, V10, P167, DOI 10.1016/S0169-5347(00)89033-3; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Coleman RA, 2007, OECOLOGIA, V151, P454, DOI 10.1007/s00442-006-0601-2; Conrath U, 2002, TRENDS PLANT SCI, V7, P210, DOI 10.1016/S1360-1385(02)02244-6; Conrath U, 2006, MOL PLANT MICROBE IN, V19, P1062, DOI 10.1094/MPMI-19-1062; Cosse A., 2007, ADV BOT RES, V46, P221, DOI DOI 10.1016/S0065-2296(07)46006-2; Cosse A, 2009, NEW PHYTOL, V182, P239, DOI 10.1111/j.1469-8137.2008.02745.x; Dring MJ, 2006, ADV BOT RES, V43, P175, DOI 10.1016/S0065-2296(05)43004-9; FOWLER SV, 1985, AM NAT, V126, P181, DOI 10.1086/284408; Frost CJ, 2008, NEW PHYTOL, V180, P722, DOI 10.1111/j.1469-8137.2008.02599.x; Frost CJ, 2008, PLANT PHYSIOL, V146, P818, DOI 10.1104/pp.107.113027; Frost CJ, 2007, ECOL LETT, V10, P490, DOI 10.1111/j.1461-0248.2007.01043.x; Galis I, 2009, PLANT CELL ENVIRON, V32, P617, DOI 10.1111/j.1365-3040.2008.01862.x; Goulitquer S, 2009, CHEMBIOCHEM, V10, P977, DOI 10.1002/cbic.200900004; Haavisto F, 2010, OECOLOGIA, V162, P685, DOI 10.1007/s00442-009-1494-7; HAUG A, 1974, CARBOHYD RES, V32, P217, DOI 10.1016/S0008-6215(00)82100-X; Hay ME, 2009, ANNU REV MAR SCI, V1, P193, DOI 10.1146/annurev.marine.010908.163708; HAYES MP, 1995, CYTOKINE, V7, P427, DOI 10.1006/cyto.1995.0058; Heil M, 2008, TRENDS PLANT SCI, V13, P264, DOI 10.1016/j.tplants.2008.03.005; Heil M, 2007, P NATL ACAD SCI USA, V104, P5467, DOI 10.1073/pnas.0610266104; Heyraud A, 1996, CARBOHYD RES, V289, P11, DOI 10.1016/0008-6215(96)00060-2; Jones CE, 2009, ATMOS CHEM PHYS, V9, P8757, DOI 10.5194/acp-9-8757-2009; Karban R, 2000, OECOLOGIA, V125, P66, DOI 10.1007/PL00008892; Karban R, 2006, ECOLOGY, V87, P922, DOI 10.1890/0012-9658(2006)87[922:DRISVA]2.0.CO;2; Karban R., 1997, INDUCED RESPONSES HE, DOI 10.7208/chicago/9780226424972.001.0001; Kupper FC, 2006, J EXP BOT, V57, P1991, DOI 10.1093/jxb/erj146; Kupper FC, 2009, PLANT CELL PHYSIOL, V50, P789, DOI 10.1093/pcp/pcp023; Kupper FC, 2002, J CHEM ECOL, V28, P2057, DOI 10.1023/A:1020706129624; Kupper FC, 2001, PLANT PHYSIOL, V125, P278, DOI 10.1104/pp.125.1.278; Lane A. L., 2008, P229, DOI 10.1007/978-3-540-74181-7_11; Palmer CJ, 2005, ENVIRON CHEM, V2, P282, DOI 10.1071/EN05078; Pelletreau K. N., 2008, P121, DOI 10.1007/978-3-540-74181-7_6; Pieterse CMJ, 2007, TRENDS PLANT SCI, V12, P564, DOI 10.1016/j.tplants.2007.09.004; Pohnert G, 2002, NAT PROD REP, V19, P108, DOI 10.1039/a806888g; POTIN P, 2008, ALGAL CHEM ECOLOGY, V18, P245; Pruvost J, 1999, ANALYST, V124, P1389, DOI 10.1039/a904597j; RHOADES DF, 1983, ACS SYM SER, V208, P55; Rohde S, 2004, J ECOL, V92, P1011, DOI 10.1111/j.0022-0477.2004.00936.x; SHONLE I, 1995, ECOLOGY, V76, P2660, DOI 10.2307/2265837; Ton J, 2007, PLANT J, V49, P16, DOI 10.1111/j.1365-313X.2006.02935.x; Toth GB, 2000, P NATL ACAD SCI USA, V97, P14418, DOI 10.1073/pnas.250226997; Van Donk E, 2007, ECOL INFORM, V2, P112, DOI 10.1016/j.ecoinf.2007.03.002; van Hulten M, 2006, P NATL ACAD SCI USA, V103, P5602, DOI 10.1073/pnas.0510213103; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vardi A, 2006, PLOS BIOL, V4, P411, DOI 10.1371/journal.pbio.0040060; VOS M, 2006, ANN BOT-LONDON, V97, P779; Walters D, 2007, PHYSIOL MOL PLANT P, V71, P3, DOI 10.1016/j.pmpp.2007.09.008; Yi HS, 2009, PLANT PHYSIOL, V151, P2152, DOI 10.1104/pp.109.144782; Yoon HS, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-14	55	24	24	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21475	10.1371/journal.pone.0021475	http://dx.doi.org/10.1371/journal.pone.0021475			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21731761	Green Published, gold			2022-12-27	WOS:000292036900037
J	Kramer, PA; Sylvester, AD				Kramer, Patricia Ann; Sylvester, Adam D.			The Energetic Cost of Walking: A Comparison of Predictive Methods	PLOS ONE			English	Article							LEVEL WALKING; LIMB LENGTH; AUSTRALOPITHECUS-AFARENSIS; BIPEDAL WALKING; LOCOMOTOR COST; BODY-SIZE; MECHANICS; WORK; EXPENDITURE; FERTILITY	Background: The energy that animals devote to locomotion has been of intense interest to biologists for decades and two basic methodologies have emerged to predict locomotor energy expenditure: those based on metabolic and those based on mechanical energy. Metabolic energy approaches share the perspective that prediction of locomotor energy expenditure should be based on statistically significant proxies of metabolic function, while mechanical energy approaches, which derive from many different perspectives, focus on quantifying the energy of movement. Some controversy exists as to which mechanical perspective is "best", but from first principles all mechanical methods should be equivalent if the inputs to the simulation are of similar quality. Our goals in this paper are 1) to establish the degree to which the various methods of calculating mechanical energy are correlated, and 2) to investigate to what degree the prediction methods explain the variation in energy expenditure. Methodology/Principal Findings: We use modern humans as the model organism in this experiment because their data are readily attainable, but the methodology is appropriate for use in other species. Volumetric oxygen consumption and kinematic and kinetic data were collected on 8 adults while walking at their self-selected slow, normal and fast velocities. Using hierarchical statistical modeling via ordinary least squares and maximum likelihood techniques, the predictive ability of several metabolic and mechanical approaches were assessed. We found that all approaches are correlated and that the mechanical approaches explain similar amounts of the variation in metabolic energy expenditure. Most methods predict the variation within an individual well, but are poor at accounting for variation between individuals. Conclusion: Our results indicate that the choice of predictive method is dependent on the question(s) of interest and the data available for use as inputs. Although we used modern humans as our model organism, these results can be extended to other species.	[Kramer, Patricia Ann] Univ Washington, Dept Anthropol, Seattle, WA 98195 USA; [Kramer, Patricia Ann] Univ Washington, Dept Orthopaed & Sports Med, Seattle, WA 98195 USA; [Sylvester, Adam D.] Max Planck Inst Evolutionary Anthropol, Leipzig, Germany	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Max Planck Society	Kramer, PA (corresponding author), Univ Washington, Dept Anthropol, Seattle, WA 98195 USA.	pakramer@u.washington.edu		Kramer, Patricia Ann/0000-0002-6435-9130				ALEXANDER RM, 1983, J ZOOL, V201, P135, DOI 10.1111/j.1469-7998.1983.tb04266.x; Bereket S, 2005, J SPORT MED PHYS FIT, V45, P152; Bertram JEA, 2001, AM J PHYS ANTHROPOL, V115, P319, DOI 10.1002/ajpa.1088; CAVAGNA GA, 1975, J APPL PHYSIOL, V39, P174, DOI 10.1152/jappl.1975.39.1.174; CAVAGNA GA, 1976, J PHYSIOL-LONDON, V262, P639, DOI 10.1113/jphysiol.1976.sp011613; CAVAGNA GA, 1966, J APPL PHYSIOL, V21, P271, DOI 10.1152/jappl.1966.21.1.271; CAVAGNA GA, 1977, J PHYSIOL-LONDON, V268, P467, DOI 10.1113/jphysiol.1977.sp011866; Chumanov ES, 2008, CLIN BIOMECH, V23, P1260, DOI 10.1016/j.clinbiomech.2008.07.011; Crompton RH, 1998, J HUM EVOL, V35, P55, DOI 10.1006/jhev.1998.0222; Crompton RH, 2010, PHILOS T R SOC B, V365, P3301, DOI 10.1098/rstb.2010.0035; DAWSON TJ, 1973, NATURE, V246, P313, DOI 10.1038/246313a0; ELLISON P, 2008, ENERGETICS REPROD EC, P172; *FAO WHO UNU, 1985, TECHN REP SER N WHO; FARLEY CT, 1991, SCIENCE, V253, P306, DOI 10.1126/science.1857965; FULL RJ, 1991, J EXP BIOL, V156, P215; Glass S., 2007, ACSMS METABOLIC CALC; Gordon CC, 1988, 1988 ANTHROPOMETRIC; Griffin TM, 2004, J EXP BIOL, V207, P4215, DOI 10.1242/jeb.01277; HANAVAN E P Jr, 1964, AMRL TR, P1; Jasienska G, 1998, P ROY SOC B-BIOL SCI, V265, P1847, DOI 10.1098/rspb.1998.0511; Jones JH, 2010, J ANIM ECOL, V79, P1262, DOI 10.1111/j.1365-2656.2010.01687.x; Jungers WL, 2009, NATURE, V459, P81, DOI 10.1038/nature07989; Kaplan H, 1996, YEARB PHYS ANTHROPOL, V39, P91; KRAM R, 1990, NATURE, V346, P265, DOI 10.1038/346265a0; Kramer PA, 1999, J EXP BIOL, V202, P2807; KRAMER PA, 1998, THESIS U WASHINGTON; Kramer PA, 2008, GAIT POSTURE, V27, P209, DOI 10.1016/j.gaitpost.2007.03.009; Kramer PA, 2010, AM J HUM BIOL, V22, P497, DOI 10.1002/ajhb.21027; LANGMAN VA, 1995, J EXP BIOL, V198, P629; Lovejoy CO, 2010, PHILOS T R SOC B, V365, P3289, DOI 10.1098/rstb.2010.0112; Lovejoy CO, 2009, SCIENCE, V326, P100, DOI 10.1126/science.1175833; LOVEJOY CO, 2009, SCIENCE, V326; Marsh RL, 2004, SCIENCE, V303, P80, DOI 10.1126/science.1090704; Nagano A, 2005, AM J PHYS ANTHROPOL, V126, P2, DOI 10.1002/ajpa.10408; Nakatsukasa M, 2004, AM J PHYS ANTHROPOL, V124, P248, DOI 10.1002/ajpa.10352; Nakatsukasa M, 2002, AM J PHYS ANTHROPOL, P117; Pfau T, 2006, J EXP BIOL, V209, P3742, DOI 10.1242/jeb.02439; PIMENTAL NA, 1979, ERGONOMICS, V22, P963, DOI 10.1080/00140137908924670; Pontzer H, 2005, J EXP BIOL, V208, P1513, DOI 10.1242/jeb.01549; Pontzer H, 2007, J EXP BIOL, V210, P1752, DOI 10.1242/jeb.002246; Pontzer H, 2009, J HUM EVOL, V56, P43, DOI 10.1016/j.jhevol.2008.09.001; Rabe-Hesketh S.S.A., 2005, MULTILEVEL LONGITUDI; Reilly SM, 2006, P ROY SOC B-BIOL SCI, V273, P1563, DOI 10.1098/rspb.2006.3489; Richard AF, 2000, J HUM EVOL, V39, P381, DOI 10.1006/jhev.2000.0427; Sarton-Miller I, 2006, AM J HUM BIOL, V18, P600, DOI 10.1002/ajhb.20529; Sellers WI, 2005, J R SOC INTERFACE, V2, P431, DOI 10.1098/rsif.2005.0060; Sellers WI, 2004, J ANAT, V204, P343, DOI 10.1111/j.0021-8782.2004.00294.x; Sellers WI, 2003, J EXP BIOL, V206, P1127, DOI 10.1242/jeb.00205; Sellers WI, 2007, P ROY SOC B-BIOL SCI, V274, P2711, DOI 10.1098/rspb.2007.0846; SMITH EA, 1984, EVOLUTIONARY ECOLOGY, P25; Starr Cecie, 2006, BIOL HUMAN EMPHASIS; Steudel-Numbers KL, 2006, J HUM EVOL, V51, P445, DOI 10.1016/j.jhevol.2006.05.001; Steudel-Numbers KL, 2009, J HUM EVOL, V56, P355, DOI 10.1016/j.jhevol.2008.11.002; Steudel-Numbers KL, 2004, J HUM EVOL, V47, P95, DOI 10.1016/j.jhevol.2004.06.002; Tardif S, 2004, BRIT J NUTR, V92, P841, DOI 10.1079/BJN20041269; TAYLOR CR, 1994, ADV VET SCI COMP MED, V38, P181; TAYLOR CR, 1982, ANNU REV PHYSIOL, V44, P97, DOI 10.1146/annurev.ph.44.030182.000525; TAYLOR CR, 1970, AM J PHYSIOL, V219, P1104, DOI 10.1152/ajplegacy.1970.219.4.1104; TAYLOR CR, 1982, J EXP BIOL, V97, P1; Tracer DP, 1996, HUM BIOL, V68, P277; Umberger BR, 2007, J EXP BIOL, V210, P3255, DOI 10.1242/jeb.000950; Valeggia C, 2004, J BIOSOC SCI, V36, P573, DOI 10.1017/S0021932003006382; Valeggia C, 2009, AM J HUM BIOL, V21, P559, DOI 10.1002/ajhb.20907; Wall-Scheffler C, 2010, AM J PHYS ANTHROPOL, P238; Weaver TD, 2005, EVOL ANTHROPOL, V14, P218, DOI 10.1002/evan.20069; WILLEMS PA, 1995, J EXP BIOL, V198, P379; Winter David A., 2009, BIOMECHANICS MOTOR C, V4th, P75; YAMAZAKI N, 1979, J HUM EVOL, V8, P337, DOI 10.1016/0047-2484(79)90057-5; Zelik KE, 2010, J EXP BIOL, V213, P4257, DOI 10.1242/jeb.044297; ZUNTZ N, 1886, EUR J APPL PHYSL, V38, P337	70	12	12	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21290	10.1371/journal.pone.0021290	http://dx.doi.org/10.1371/journal.pone.0021290			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	782TF	21731693	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000292033700056
J	Chang, H; Jackson, DG; Kayne, PS; Ross-Macdonald, PB; Ryseck, RP; Siemers, NO				Chang, Han; Jackson, Donald G.; Kayne, Paul S.; Ross-Macdonald, Petra B.; Ryseck, Rolf-Peter; Siemers, Nathan O.			Exome Sequencing Reveals Comprehensive Genomic Alterations across Eight Cancer Cell Lines	PLOS ONE			English	Article							KINASE GENE FAMILY; SOMATIC MUTATIONS; BREAST-CANCER; LUNG-CANCER; COLORECTAL CANCERS; GEFITINIB; CETUXIMAB; PATTERNS; THERAPY	It is well established that genomic alterations play an essential role in oncogenesis, disease progression, and response of tumors to therapeutic intervention. The advances of next-generation sequencing technologies (NGS) provide unprecedented capabilities to scan genomes for changes such as mutations, deletions, and alterations of chromosomal copy number. However, the cost of full-genome sequencing still prevents the routine application of NGS in many areas. Capturing and sequencing the coding exons of genes (the "exome") can be a cost-effective approach for identifying changes that result in alteration of protein sequences. We applied an exome-sequencing technology (Roche Nimblegen capture paired with 454 sequencing) to identify sequence variation and mutations in eight commonly used cancer cell lines from a variety of tissue origins (A2780, A549, Colo205, GTL16, NCI-H661, MDA-MB468, PC3, and RD). We showed that this technology can accurately identify sequence variation, providing similar to 95% concordance with Affymetrix SNP Array 6.0 performed on the same cell lines. Furthermore, we detected 19 of the 21 mutations reported in Sanger COSMIC database for these cell lines. We identified an average of 2,779 potential novel sequence variations/mutations per cell line, of which 1,904 were non-synonymous. Many non-synonymous changes were identified in kinases and known cancer-related genes. In addition we confirmed that the read-depth of exome sequence data can be used to estimate high-level gene amplifications and identify homologous deletions. In summary, we demonstrate that exome sequencing can be a reliable and cost-effective way for identifying alterations in cancer genomes, and we have generated a comprehensive catalogue of genomic alterations in coding regions of eight cancer cell lines. These findings could provide important insights into cancer pathways and mechanisms of resistance to anti-cancer therapies.	[Chang, Han; Jackson, Donald G.; Kayne, Paul S.; Ross-Macdonald, Petra B.; Ryseck, Rolf-Peter; Siemers, Nathan O.] Bristol Myers Squibb Co, Res & Dev, Princeton, NJ 08540 USA	Bristol-Myers Squibb	Chang, H (corresponding author), Bristol Myers Squibb Co, Res & Dev, Princeton, NJ 08540 USA.	Han.Chang@bms.com		Jackson, Donald/0000-0002-0863-9031	Bristol-Myers Squibb Co.	Bristol-Myers Squibb Co.(Bristol-Myers Squibb)	This work was supported by Bristol-Myers Squibb Co. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agelopoulos K, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-78; Bardelli A, 2003, SCIENCE, V300, P949, DOI 10.1126/science.1082596; Bengtsson H, 2009, BIOINFORMATICS, V25, P2149, DOI 10.1093/bioinformatics/btp371; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; Davies H, 2005, CANCER RES, V65, P7591, DOI 10.1158/0008-5472.CAN-05-1855; Forbes SA, 2010, NUCLEIC ACIDS RES, V38, pD652, DOI 10.1093/nar/gkp995; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hedges D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008232; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Khambata-Ford S, 2007, J CLIN ONCOL, V25, P3230, DOI 10.1200/JCO.2006.10.5437; Kimura T, 2006, ONCOL REP, V15, P1205; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Meyerson M, 2010, NAT REV GENET, V11, P685, DOI 10.1038/nrg2841; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; REGECAMBRIN G, 1992, CANCER GENET CYTOGEN, V64, P170, DOI 10.1016/0165-4608(92)90350-H; Robison K, 2010, BRIEF BIOINFORM, V11, P524, DOI 10.1093/bib/bbq013; Stephens P, 2005, NAT GENET, V37, P590, DOI 10.1038/ng1571; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720	27	22	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e21097	10.1371/journal.pone.0021097	http://dx.doi.org/10.1371/journal.pone.0021097			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	21701589	Green Submitted, Green Published, gold			2022-12-27	WOS:000291983800023
J	Cardoen, D; Ernst, UR; Van Vaerenbergh, M; Boerjan, B; de Graaf, DC; Wenseleers, T; Schoofs, L; Verleyen, P				Cardoen, Dries; Ernst, Ulrich R.; Van Vaerenbergh, Matthias; Boerjan, Bart; de Graaf, Dirk C.; Wenseleers, Tom; Schoofs, Liliane; Verleyen, Peter			Differential Proteomics in Dequeened Honeybee Colonies Reveals Lower Viral Load in Hemolymph of Fertile Worker Bees	PLOS ONE			English	Article							APIS-MELLIFERA L.; GENOME-WIDE ANALYSIS; BRAIN GENE-EXPRESSION; DEFORMED-WING-VIRUS; PICORNA-LIKE VIRUS; JUVENILE-HORMONE; OVARY DEVELOPMENT; THIOREDOXIN PEROXIDASE; VARROA DESTRUCTOR; INSECT SOCIETIES	The eusocial societies of honeybees, where the queen is the only fertile female among tens of thousands sterile worker bees, have intrigued scientists for centuries. The proximate factors, which cause the inhibition of worker bee ovaries, remain largely unknown; as are the factors which cause the activation of worker ovaries upon the loss of queen and brood in the colony. In an attempt to reveal key players in the regulatory network, we made a proteomic comparison of hemolymph profiles of workers with completely activated ovaries vs. rudimentary ovaries. An unexpected finding of this study is the correlation between age matched worker sterility and the enrichment of Picorna-like virus proteins. Fertile workers, on the other hand, show the upregulation of potential components of the immune system. It remains to be investigated whether viral infections contribute to worker sterility directly or are the result of a weaker immune system of sterile workers.	[Cardoen, Dries; Ernst, Ulrich R.; Boerjan, Bart; Schoofs, Liliane; Verleyen, Peter] Katholieke Univ Leuven, Res Grp Funct Genom & Prote, Leuven, Belgium; [Ernst, Ulrich R.; Wenseleers, Tom] Katholieke Univ Leuven, Entomol Lab, Leuven, Belgium; [Van Vaerenbergh, Matthias; de Graaf, Dirk C.] Univ Ghent, Lab Zoophysiol, B-9000 Ghent, Belgium	KU Leuven; KU Leuven; Ghent University	Cardoen, D (corresponding author), Katholieke Univ Leuven, Res Grp Funct Genom & Prote, Leuven, Belgium.	dries.cardoen@bio.kuleuven.be	Ernst, Uli/AAJ-6768-2020; schoofs, liliane/ABD-2943-2020; Wenseleers, Tom/J-3960-2013; de Graaf, Dirk C./HGD-4017-2022; Ernst, Ulrich R/C-2575-2011; Schoofs, Liliane/F-2815-2010	Ernst, Uli/0000-0002-6330-5341; Wenseleers, Tom/0000-0002-1434-861X; Ernst, Ulrich R/0000-0002-6330-5341; Schoofs, Liliane/0000-0002-1673-432X	Research Foundation of Flanders (FWO-Flanders) [G041708N, GO62811N]; K.U.Leuven Research Foundation [GOA 2010/14]; Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen)	Research Foundation of Flanders (FWO-Flanders)(FWO); K.U.Leuven Research Foundation; Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	The authors gratefully acknowledge the Research Foundation of Flanders (FWO-Flanders G041708N and GO62811N) and the K.U.Leuven Research Foundation (GOA 2010/14) for financial support. DC, UE and MVV are funded by the Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen). BB is an FWO fellow and PV an FWO postdoc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaux C, 2009, GENES BRAIN BEHAV, V8, P309, DOI 10.1111/j.1601-183X.2009.00480.x; Amdam GV, 2005, EXP GERONTOL, V40, P939, DOI 10.1016/j.exger.2005.08.004; Baer B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r67; Barchuk AR, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-70; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bogaerts A, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-11; Bogaerts A, 2009, PROTEOMICS, V9, P3201, DOI 10.1002/pmic.200800604; Briand L, 2001, EUR J BIOCHEM, V268, P752, DOI 10.1046/j.1432-1327.2001.01927.x; Capella ICS, 1998, J INSECT PHYSIOL, V44, P385, DOI 10.1016/S0022-1910(98)00027-4; Chan QWT, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r156; Chan QWT, 2006, MOL CELL PROTEOMICS, V5, P2252, DOI 10.1074/mcp.M600197-MCP200; Chen TH, 2011, VIROLOGY, V410, P410, DOI 10.1016/j.virol.2010.12.013; Collins AM, 2006, INSECT MOL BIOL, V15, P541, DOI 10.1111/j.1365-2583.2006.00674.x; Corona M, 2007, P NATL ACAD SCI USA, V104, P7128, DOI 10.1073/pnas.0701909104; Cristino AS, 2006, INSECT MOL BIOL, V15, P703, DOI 10.1111/j.1365-2583.2006.00696.x; Danty E, 1999, J NEUROSCI, V19, P7468, DOI 10.1523/JNEUROSCI.19-17-07468.1999; de Miranda JR, 2010, J INVERTEBR PATHOL, V103, pS48, DOI 10.1016/j.jip.2009.06.012; Foret S, 2006, GENOME RES, V16, P1404, DOI 10.1101/gr.5075706; Fujiyuki T, 2004, J VIROL, V78, P1093, DOI 10.1128/JVI.78.3.1093-1100.2004; Fujiyuki T, 2009, J VIROL, V83, P11560, DOI 10.1128/JVI.00519-09; Furlong EEM, 2001, SCIENCE, V293, P1629, DOI 10.1126/science.1062660; Gauthier L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016217; Gilbert LI, 2000, INSECT BIOCHEM MOLEC, V30, P617, DOI 10.1016/S0965-1748(00)00034-5; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grozinger CM, 2007, MOL ECOL, V16, P4837, DOI 10.1111/j.1365-294X.2007.03545.x; Grozinger CM, 2003, P NATL ACAD SCI USA, V100, P14519, DOI 10.1073/pnas.2335884100; Haenen S, 2010, J PROTEOME RES, V9, P5868, DOI 10.1021/pr100638m; Hartfelder K, 2000, BRAZ J MED BIOL RES, V33, P157, DOI 10.1590/S0100-879X2000000200003; Hartfelder K, 2002, INSECT BIOCHEM MOLEC, V32, P211, DOI 10.1016/S0965-1748(01)00100-X; HARTFELDER K, 1998, SOCIAL INSECT POLYMO; Hoover SER, 2003, NATURWISSENSCHAFTEN, V90, P477, DOI 10.1007/s00114-003-0462-z; Kocher SD, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-232; Lanzi G, 2006, J VIROL, V80, P4998, DOI 10.1128/JVI.80.10.4998-5009.2006; Lee KS, 2005, INSECT BIOCHEM MOLEC, V35, P73, DOI 10.1016/j.ibmb.2004.09.008; Maisonnasse A, 2009, APIDOLOGIE, V40, P562, DOI 10.1051/apido/2009024; Miller DG, 2001, INSECT SOC, V48, P178, DOI 10.1007/PL00001762; Mohammedi A, 1998, NATURWISSENSCHAFTEN, V85, P455, DOI 10.1007/s001140050531; Moore J, 2011, J GEN VIROL, V92, P156, DOI 10.1099/vir.0.025965-0; Ongus JR, 2004, J GEN VIROL, V85, P3747, DOI 10.1099/vir.0.80470-0; Peiren N, 2008, TOXICON, V52, P72, DOI 10.1016/j.toxicon.2008.05.003; Pelletier J, 2010, J CHEM ECOL, V36, P245, DOI 10.1007/s10886-010-9762-x; Pelosi P, 2005, CHEM SENSES, V30, pI291, DOI 10.1093/chemse/bjh229; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; RACHINSKY A, 1990, GEN COMP ENDOCR, V79, P31, DOI 10.1016/0016-6480(90)90085-Z; Randolt K, 2008, ARCH INSECT BIOCHEM, V69, P155, DOI 10.1002/arch.20269; RATNIEKS FLW, 1993, BEHAV ECOL SOCIOBIOL, V32, P191, DOI 10.1007/BF00173777; RATNIEKS FLW, 1989, NATURE, V342, P796, DOI 10.1038/342796a0; Ratnieks FLW, 2008, TRENDS ECOL EVOL, V23, P45, DOI 10.1016/j.tree.2007.09.013; Robinson GE, 1997, ARCH INSECT BIOCHEM, V35, P559, DOI 10.1002/(SICI)1520-6327(1997)35:4<559::AID-ARCH13>3.0.CO;2-9; Roossinck MJ, 1997, ANNU REV PHYTOPATHOL, V35, P191, DOI 10.1146/annurev.phyto.35.1.191; Schmid MR, 2008, J INSECT PHYSIOL, V54, P439, DOI 10.1016/j.jinsphys.2007.11.002; Slessor KN, 2005, J CHEM ECOL, V31, P2731, DOI 10.1007/s10886-005-7623-9; Sullivan DT, 2003, J EXP BIOL, V206, P2031, DOI 10.1242/jeb.00367; Thompson GJ, 2008, INSECT MOL BIOL, V17, P657, DOI 10.1111/j.1365-2583.2008.00838.x; Thompson GJ, 2006, INSECT MOL BIOL, V15, P637, DOI 10.1111/j.1365-2583.2006.00678.x; Vierstraete E, 2004, P NATL ACAD SCI USA, V101, P470, DOI 10.1073/pnas.0304567101; VISSCHER PK, 1989, BEHAV ECOL SOCIOBIOL, V25, P247, DOI 10.1007/BF00300050; Wang Y, 2001, FREE RADICAL BIO MED, V31, P1448, DOI 10.1016/S0891-5849(01)00728-6; Wang Y, 2010, J INSECT PHYSIOL, V56, P1816, DOI 10.1016/j.jinsphys.2010.07.013; Wenseleers T, 2006, NATURE, V444, P50, DOI 10.1038/444050a; WILSONRICH N, 2010, J INSECT PHYSL, V54, P1392; Wolschin F, 2007, PROTEOME SCI, V5, DOI 10.1186/1477-5956-5-10; Xu PX, 2005, NEURON, V45, P193, DOI 10.1016/j.neuron.2004.12.031; Zhang P, 1997, J BIOL CHEM, V272, P30615, DOI 10.1074/jbc.272.49.30615; Zou Z, 2006, INSECT MOL BIOL, V15, P603, DOI 10.1111/j.1365-2583.2006.00684.x	65	17	17	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e20043	10.1371/journal.pone.0020043	http://dx.doi.org/10.1371/journal.pone.0020043			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698281	gold, Green Published, Green Submitted			2022-12-27	WOS:000291730000007
J	Maccani, MA; Padbury, JF; Marsit, CJ				Maccani, Matthew A.; Padbury, James F.; Marsit, Carmen J.			miR-16 and miR-21 Expression in the Placenta Is Associated with Fetal Growth	PLOS ONE			English	Article							CIGARETTE-SMOKING; CELL; MICRORNAS; PTEN; PREGNANCY; OVARIAN; GENE	Background: Novel research has suggested that altered miRNA expression in the placenta is associated with adverse pregnancy outcomes and with potentially harmful xenobiotic exposures. We hypothesized that aberrant expression of miRNA in the placenta is associated with fetal growth, a measurable phenotype resulting from a number of intrauterine factors, and one which is significantly predictive of later life outcomes. Methodology/Principal Findings: We analyzed 107 primary, term, human placentas for expression of 6 miRNA reported to be expressed in the placenta and to regulate cell growth and development pathways: miR-16, miR-21, miR-93, miR-135b, miR-146a, and miR-182. The expression of miR-16 and miR-21 was markedly reduced in infants with the lowest birthweights (p < 0.05). Logistic regression models suggested that low expression of miR-16 in the placenta predicts an over 4-fold increased odds of small for gestational age (SGA) status (p = 0.009, 95% CI = 1.42, 12.05). Moreover, having both low miR-16 and low miR-21 expression in the placenta predicts a greater increase in odds for SGA than having just low miR-16 or miR-21 expression (p < 0.02), suggesting an additive effect of both of these miRNA. Conclusions/Significance: Our study is one of the first to investigate placental miRNA expression profiles associated with birthweight and SGA status. Future research on miRNA whose expression is associated with in utero exposures and markers of fetal growth is essential for better understanding the epigenetic mechanisms underlying the developmental origins of health and disease.	[Maccani, Matthew A.; Marsit, Carmen J.] Brown Univ, Dept Pathol & Lab Med, Providence, RI 02912 USA; [Padbury, James F.] Brown Univ, Women & Infants Hosp, Dept Pediat, Providence, RI 02908 USA; [Marsit, Carmen J.] Brown Univ, Dept Community Hlth, Ctr Environm Hlth & Technol, Providence, RI 02912 USA	Brown University; Brown University; Women & Infants Hospital Rhode Island; Brown University	Maccani, MA (corresponding author), Brown Univ, Dept Pathol & Lab Med, Providence, RI 02912 USA.	Carmen_Marsit@brown.edu		Marsit, Carmen/0000-0003-4566-150X	NIEHS [P42ES013660, T32ES007272]; NCRR [P20 RR018728]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018728] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007272, P42ES013660] Funding Source: NIH RePORTER	NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded by National Institutes of Health grants from the NIEHS (P42ES013660 and T32ES007272 to MAM) and the NCRR (P20 RR018728). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL EL, 1984, J PSYCHOACTIVE DRUGS, V16, P327, DOI 10.1080/02791072.1984.10472303; Argente J, 2010, PEDIATR NEPHROL, V25, P679, DOI 10.1007/s00467-009-1432-2; Avila L, 2010, PLACENTA, V31, P1070, DOI 10.1016/j.placenta.2010.09.011; Avissar-Whiting M, 2010, REPROD TOXICOL, V29, P401, DOI 10.1016/j.reprotox.2010.04.004; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Bissels U, 2009, RNA, V15, P2375, DOI 10.1261/rna.1754109; Calin GA, 2008, P NATL ACAD SCI USA, V105, P5166, DOI 10.1073/pnas.0800121105; Chen RW, 2008, BLOOD, V112, P822, DOI 10.1182/blood-2008-03-142182; Chim SSC, 2008, CLIN CHEM, V54, P482, DOI 10.1373/clinchem.2007.097972; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Desai M, 2007, REPROD SCI, V14, P329, DOI 10.1177/1933719107303983; Du TT, 2007, CELL RES, V17, P661, DOI 10.1038/cr.2007.67; Esposito ER, 2008, TOXICOLOGY, V246, P193, DOI 10.1016/j.tox.2008.01.014; Fenton Tanis R, 2003, BMC Pediatr, V3, P13; HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248; Hou J, 2009, J IMMUNOL, V183, P2150, DOI 10.4049/jimmunol.0900707; Kaddar T, 2009, BIOL CELL, V101, P511, DOI 10.1042/BC20080213; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Linsley PS, 2007, MOL CELL BIOL, V27, P2240, DOI 10.1128/MCB.02005-06; Liu Q, 2008, NUCLEIC ACIDS RES, V36, P5391, DOI 10.1093/nar/gkn522; Lou YH, 2010, INT J MOL MED, V26, P819, DOI 10.3892/ijmm_00000530; MACCANI MA, 2010, EPIGENETICS, V5; Maccani MA, 2010, EPIGENETICS-US, V5, P583, DOI 10.4161/epi.5.7.12762; Maccani MA, 2009, AM J REPROD IMMUNOL, V62, P78, DOI 10.1111/j.1600-0897.2009.00716.x; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Miska EA, 2005, CURR OPIN GENET DEV, V15, P563, DOI 10.1016/j.gde.2005.08.005; Mouillet JF, 2010, PLACENTA, V31, P781, DOI 10.1016/j.placenta.2010.07.001; Mouillet JF, 2010, FASEB J, V24, P2030, DOI 10.1096/fj.09-149724; Pineles BL, 2007, AM J OBSTET GYNECOL, V196, P261, DOI 10.1016/j.ajog.2007.01.008; Shea AK, 2008, NICOTINE TOB RES, V10, P267, DOI 10.1080/14622200701825908; Shiverick KT, 1999, PLACENTA, V20, P265, DOI 10.1053/plac.1998.0377; Tamashiro KLK, 2010, PHYSIOL BEHAV, V100, P560, DOI 10.1016/j.physbeh.2010.04.008; Tokyol C, 2008, UPSALA J MED SCI, V113, P235, DOI 10.3109/2000-1967-231; Tran N, 2007, BIOCHEM BIOPH RES CO, V358, P12, DOI 10.1016/j.bbrc.2007.03.201; Wang P, 2009, CANCER RES, V69, P8157, DOI 10.1158/0008-5472.CAN-09-1996	35	112	119	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e21210	10.1371/journal.pone.0021210	http://dx.doi.org/10.1371/journal.pone.0021210			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698265	Green Submitted, gold, Green Published			2022-12-27	WOS:000291730000062
J	Lim, PH; Pisat, NP; Gadhia, N; Pandey, A; Donovan, FX; Stein, L; Salt, DE; Eide, DJ; MacDiarmid, CW				Lim, Phaik Har; Pisat, Nilambari P.; Gadhia, Nidhi; Pandey, Abhinav; Donovan, Frank X.; Stein, Lauren; Salt, David E.; Eide, David J.; MacDiarmid, Colin W.			Regulation of Alr1 Mg Transporter Activity by Intracellular Magnesium	PLOS ONE			English	Article							YEAST PLASMA-MEMBRANE; ACTIN CYTOSKELETON; GENE ENCODES; METAL-IONS; PROTEIN; UBIQUITIN; ENDOCYTOSIS; CORA; VACUOLAR; FAMILY	Mg homeostasis is critical to eukaryotic cells, but the contribution of Mg transporter activity to homeostasis is not fully understood. In yeast, Mg uptake is primarily mediated by the Alr1 transporter, which also allows low affinity uptake of other divalent cations such as Ni2+, Mn2+, Zn2+ and Co2+. Using Ni2+ uptake to assay Alr1 activity, we observed approximately ninefold more activity under Mg-deficient conditions. The mnr2 mutation, which is thought to block release of vacuolar Mg stores, was associated with increased Alr1 activity, suggesting Alr1 was regulated by intracellular Mg supply. Consistent with a previous report of the regulation of Alr1 expression by Mg supply, Mg deficiency and the mnr2 mutation both increased the accumulation of a carboxy-terminal epitope-tagged version of the Alr1 protein (Alr1-HA). However, Mg supply had little effect on ALR1 promoter activity or mRNA levels. In addition, while Mg deficiency caused a seven-fold increase in Alr1-HA accumulation, the N-terminally tagged and untagged Alr1 proteins increased less than two-fold. These observations argue that the Mg-dependent accumulation of the C-terminal epitope-tagged protein was primarily an artifact of its modification. Plasma membrane localization of YFP-tagged Alr1 was also unaffected by Mg supply, indicating that a change in Alr1 location did not explain the increased activity we observed. We conclude that variation in Alr1 protein accumulation or location does not make a substantial contribution to its regulation by Mg supply, suggesting Alr1 activity is directly regulated via as yet unknown mechanisms.	[Lim, Phaik Har] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Pisat, Nilambari P.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Gadhia, Nidhi] Regeneron Pharmaceut Inc, Dept Pharmacol & Pharmacokinet, Tarrytown, NY 10591 USA; [Pandey, Abhinav] Univ Utrecht, Fac Sci, Bijvoet Ctr Biomol Res, Utrecht, Netherlands; [Donovan, Frank X.] NHGRI, Canc Genet Branch, NIH, Bethesda, MD 20892 USA; [Stein, Lauren] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Wauwatosa, WI USA; [Salt, David E.] Univ Aberdeen, Sch Biol Sci, Aberdeen, Scotland; [Eide, David J.; MacDiarmid, Colin W.] Univ Wisconsin, Dept Nutr Sci, Madison, WI 53706 USA	Baylor College of Medicine; Washington University (WUSTL); Regeneron; Utrecht University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Medical College of Wisconsin; University of Aberdeen; University of Wisconsin System; University of Wisconsin Madison	Lim, PH (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	macdiarmid@nutrisci.wisc.edu	MacDiarmid, Colin/AAV-5920-2021	MacDiarmid, Colin/0000-0001-8578-5756; Donovan, Frank X./0000-0002-7712-2335	National Institutes of Health [GM056285]; University of Missouri Research Board; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056285] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Missouri Research Board; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (grant # GM056285 to DE) and the University of Missouri Research Board. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amighi J, 2004, STROKE, V35, P22, DOI 10.1161/01.STR.0000105928.95124.1F; Andreini C, 2008, J BIOL INORG CHEM, V13, P1205, DOI 10.1007/s00775-008-0404-5; Beeler T, 1997, BBA-BIOMEMBRANES, V1323, P310, DOI 10.1016/S0005-2736(96)00199-X; Belgareh-Touze N, 2008, BIOCHEM SOC T, V36, P791, DOI 10.1042/BST0360791; BENEDETTI H, 1994, MOL BIOL CELL, V5, P1023, DOI 10.1091/mbc.5.9.1023; Bodenmiller B, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100182; BONNEAUD N, 1991, YEAST, V7, P609, DOI 10.1002/yea.320070609; Burke D., 2000, METHODS YEAST GENETI; CHANG A, 1995, J CELL BIOL, V128, P39, DOI 10.1083/jcb.128.1.39; Chen J, 2009, CELL RES, V19, P887, DOI 10.1038/cr.2009.58; Chen XZ, 1999, J BIOL CHEM, V274, P35089, DOI 10.1074/jbc.274.49.35089; CHERNOW B, 1989, CHEST, V95, P391, DOI 10.1378/chest.95.2.391; Cohen A, 2000, J BIOL CHEM, V275, P33388, DOI 10.1074/jbc.M004611200; Cowan J. A., 1995, P1; Cromie MJ, 2010, J BACTERIOL, V192, P604, DOI 10.1128/JB.01239-09; Cromie MJ, 2006, CELL, V125, P71, DOI 10.1016/j.cell.2006.01.043; Dai LJ, 2001, PHYSIOL REV, V81, P51, DOI 10.1152/physrev.2001.81.1.51; Drummond RSM, 2006, PLANT SCI, V170, P78, DOI 10.1016/j.plantsci.2005.08.018; Dupre S, 2001, MOL CELL BIOL, V21, P4482, DOI 10.1128/MCB.21.14.4482-4494.2001; Eguez L, 2004, GENETICS, V167, P107, DOI 10.1534/genetics.167.1.107; Eide DJ, 1998, ANNU REV NUTR, V18, P441, DOI 10.1146/annurev.nutr.18.1.441; ELIN RJ, 1994, AM J CLIN PATHOL, V102, P616, DOI 10.1093/ajcp/102.5.616; Felice MR, 2005, J BIOL CHEM, V280, P22181, DOI 10.1074/jbc.M414663200; FLATMAN PW, 1984, J MEMBRANE BIOL, V80, P1, DOI 10.1007/BF01868686; Galan JM, 1996, J BIOL CHEM, V271, P10946, DOI 10.1074/jbc.271.18.10946; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Gitan RS, 1998, J BIOL CHEM, V273, P28617, DOI 10.1074/jbc.273.44.28617; Gitan RS, 2000, BIOCHEM J, V346, P329, DOI 10.1042/0264-6021:3460329; Graschopf A, 2001, J BIOL CHEM, V276, P16216, DOI 10.1074/jbc.M101504200; Groisman EA, 2001, J BACTERIOL, V183, P1835, DOI 10.1128/JB.183.6.1835-1842.2001; Grubbs RD, 2002, BIOMETALS, V15, P251, DOI 10.1023/A:1016026831789; GUARENTE L, 1983, METHOD ENZYMOL, V101, P181; HEIN C, 1995, MOL MICROBIOL, V18, P77, DOI 10.1111/j.1365-2958.1995.mmi_18010077.x; Helliwell SB, 2001, J CELL BIOL, V153, P649, DOI 10.1083/jcb.153.4.649; Hicke L, 1997, FASEB J, V11, P1215, DOI 10.1096/fasebj.11.14.9409540; Hu J, 2009, J BIOL CHEM, V284, P15619, DOI 10.1074/jbc.M901581200; Jenness DD, 1997, MOL CELL BIOL, V17, P6236, DOI 10.1128/MCB.17.11.6236; Johansson MJO, 2010, GENE DEV, V24, P1491, DOI 10.1101/gad.1930710; Kaminska J, 2002, MOL CELL BIOL, V22, P6946, DOI 10.1128/MCB.22.20.6946-6958.2002; Kim D, 2004, PLANT J, V39, P237, DOI 10.1111/j.1365-313X.2004.02126.x; Kucharski LM, 2000, J BIOL CHEM, V275, P16767, DOI 10.1074/jbc.M001507200; Lee JM, 2006, CURR GENET, V49, P7, DOI 10.1007/s00294-005-0037-y; Li LG, 2001, PLANT CELL, V13, P2761, DOI 10.1105/tpc.13.12.2761; Liu XF, 1999, J BIOL CHEM, V274, P4863, DOI 10.1074/jbc.274.8.4863; Lopez-Ridaura R, 2004, DIABETES CARE, V27, P134, DOI 10.2337/diacare.27.1.134; Lunin VV, 2006, NATURE, V440, P833, DOI 10.1038/nature04642; Luo WJ, 2000, MOL BIOL CELL, V11, P579, DOI 10.1091/mbc.11.2.579; MacDiarmid CW, 1996, PLANT PHYSIOL, V112, P1101, DOI 10.1104/pp.112.3.1101; MacDiarmid CW, 1998, J BIOL CHEM, V273, P1727, DOI 10.1074/jbc.273.3.1727; Magasanik B, 2002, GENE, V290, P1, DOI 10.1016/S0378-1119(02)00558-9; Maguire ME, 2006, CURR OPIN STRUC BIOL, V16, P432, DOI 10.1016/j.sbi.2006.06.006; Mao DD, 2008, J INTEGR PLANT BIOL, V50, P1530, DOI 10.1111/j.1744-7909.2008.00770.x; MARUYAMA T, 1994, BBA-BIOMEMBRANES, V1194, P289, DOI 10.1016/0005-2736(94)90311-5; Moncrief MBC, 1999, J BIOL INORG CHEM, V4, P523, DOI 10.1007/s007750050374; Moomaw AS, 2008, PHYSIOLOGY, V23, P275, DOI 10.1152/physiol.00019.2008; MUHLRAD D, 1992, YEAST, V8, P79, DOI 10.1002/yea.320080202; MYERS AM, 1986, GENE, V45, P299, DOI 10.1016/0378-1119(86)90028-4; Nikko E, 2007, TRAFFIC, V8, P566, DOI 10.1111/j.1600-0854.2007.00553.x; Papp-Wallace KM, 2008, J BACTERIOL, V190, P6509, DOI 10.1128/JB.00144-08; Papp-Wallace KM, 2007, MOL MEMBR BIOL, V24, P351, DOI 10.1080/09687680701441883; Payandeh J, 2008, J BIOL CHEM, V283, P11721, DOI 10.1074/jbc.M707889200; Payandeh J, 2006, EMBO J, V25, P3762, DOI 10.1038/sj.emboj.7601269; PIPER RC, 1995, J CELL BIOL, V131, P603, DOI 10.1083/jcb.131.3.603; Pisat NP, 2009, GENETICS, V183, P873, DOI 10.1534/genetics.109.106419; PISKACEK M, 2008, J CELL MOL MED; Pizzirusso M, 2004, MOL BIOL CELL, V15, P2401, DOI 10.1091/mbc.E03-10-0727; RATHS S, 1993, J CELL BIOL, V120, P55, DOI 10.1083/jcb.120.1.55; ROTHMAN JH, 1989, EMBO J, V8, P2057, DOI 10.1002/j.1460-2075.1989.tb03614.x; Sambrook J., 2001, MOL CLONING LAB MANU; Sarikaya AT, 2006, MOL BIOTECHNOL, V32, P139, DOI 10.1385/MB:32:2:139; Schindl R, 2007, BIOPHYS J, V93, P3872, DOI 10.1529/biophysj.107.112318; Sheff MA, 2004, YEAST, V21, P661, DOI 10.1002/yea.1130; Soetens O, 2001, J BIOL CHEM, V276, P43949, DOI 10.1074/jbc.M102945200; Springael JY, 2002, FEBS LETT, V517, P103, DOI 10.1016/S0014-5793(02)02586-3; Springael JY, 1998, MOL BIOL CELL, V9, P1253, DOI 10.1091/mbc.9.6.1253; Stimpson HEM, 2006, EMBO J, V25, P662, DOI 10.1038/sj.emboj.7600984; Supek F, 1996, P NATL ACAD SCI USA, V93, P5105, DOI 10.1073/pnas.93.10.5105; Touyz R. M., 2003, Molecular Aspects of Medicine, V24, P107, DOI 10.1016/S0098-2997(02)00094-8; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Wachek M, 2006, FEBS J, V273, P4236, DOI 10.1111/j.1742-4658.2006.05424.x; Wendland B, 1996, J CELL BIOL, V135, P1485, DOI 10.1083/jcb.135.6.1485; WILLIAMS RJP, 1993, MAGNESIUM CELL, P15; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wolf FI, 2008, CLIN SCI, V114, P27, DOI 10.1042/CS20070129; Zhao H, 1996, P NATL ACAD SCI USA, V93, P2454, DOI 10.1073/pnas.93.6.2454; Zsurka G, 2001, GENOMICS, V72, P158, DOI 10.1006/geno.2000.6407; ZUBENKO GS, 1983, P NATL ACAD SCI-BIOL, V80, P510, DOI 10.1073/pnas.80.2.510	87	13	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e20896	10.1371/journal.pone.0020896	http://dx.doi.org/10.1371/journal.pone.0020896			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738593	Green Published, Green Submitted, gold			2022-12-27	WOS:000292142800006
J	Lightfoot, YL; Chen, J; Mathews, CE				Lightfoot, Yaima L.; Chen, Jing; Mathews, Clayton E.			Role of the Mitochondria in Immune-Mediated Apoptotic Death of the Human Pancreatic beta Cell Line beta Lox5	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; DEPENDENT DIABETES-MELLITUS; CYTOKINE-INDUCED INHIBITION; IFN-GAMMA; HUMAN ISLETS; INDEPENDENT PATHWAYS; INSULINOMA CELLS; CYTOCHROME-C; FACTOR AIF; TNF-ALPHA	Mitochondria are indispensable in the life and death of many types of eukaryotic cells. In pancreatic beta cells, mitochondria play an essential role in the secretion of insulin, a hormone that regulates blood glucose levels. Unregulated blood glucose is a hallmark symptom of diabetes. The onset of Type 1 diabetes is preceded by autoimmune-mediated destruction of beta cells. However, the exact role of mitochondria has not been assessed in beta cell death. In this study, we examine the role of mitochondria in both Fas- and proinflammatory cytokine-mediated destruction of the human beta cell line, beta Lox5. IFN gamma primed beta Lox5 cells for apoptosis by elevating cell surface Fas. Consequently, beta Lox5 cells were killed by caspase-dependent apoptosis by agonistic activation of Fas, but only after priming with IFN gamma. This beta cell line undergoes both apoptotic and necrotic cell death after incubation with the combination of the proinflammatory cytokines IFN gamma and TNF alpha. Additionally, both caspase-dependent and -independent mechanisms that require proper mitochondrial function are involved. Mitochondrial contributions to beta Lox5 cell death were analyzed using mitochondrial DNA (mtDNA) depleted beta Lox5 cells, or beta Lox5 rho(0) cells. beta Lox5 rho(0) cells are not sensitive to IFN gamma and TNF alpha killing, indicating a direct role for the mitochondria in cytokine-induced cell death of the parental cell line. However, beta Lox5 rho(0) cells are susceptible to Fas killing, implicating caspase-dependent extrinsic apoptotic death is the mechanism by which these human beta cells die after Fas ligation. These data support the hypothesis that immune mediators kill beta Lox5 cells by both mitochondrial-dependent intrinsic and caspase-dependent extrinsic pathways.	[Lightfoot, Yaima L.; Chen, Jing; Mathews, Clayton E.] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USA	State University System of Florida; University of Florida	Lightfoot, YL (corresponding author), Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USA.	clayton.mathews@pathology.ufl.edu			University of Florida; National Institutes of Health [DK074656]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK074656, R01DK074656] Funding Source: NIH RePORTER	University of Florida(University of Florida); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a University of Florida Experimental Pathology Innovative Grant Award (JC) and a grant from the National Institutes of Health [DK074656 (CEM)]. YL was funded by a supplement for diversity from the National Institutes of Health to DK074656. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amrani A, 2000, J CLIN INVEST, V105, P459, DOI 10.1172/JCI8185; Anderson B, 1999, P NATL ACAD SCI USA, V96, P9311, DOI 10.1073/pnas.96.16.9311; Andersson AK, 2001, BIOCHEM BIOPH RES CO, V281, P396, DOI 10.1006/bbrc.2001.4361; Augstein P, 2004, J AUTOIMMUN, V23, P301, DOI 10.1016/j.jaut.2004.09.006; Augstein P, 2008, DIABETES VASC DIS RE, V5, P198, DOI 10.3132/dvdr.2008.032; Ball AJ, 2007, BIOCHEM BIOPH RES CO, V355, P331, DOI 10.1016/j.bbrc.2007.01.153; Barnhart BC, 2003, SEMIN IMMUNOL, V15, P185, DOI 10.1016/S1044-5323(03)00031-9; Baroni MG, 1999, J ENDOCRINOL, V161, P59, DOI 10.1677/joe.0.1610059; BELLMANN K, 1995, J CLIN INVEST, V95, P2840, DOI 10.1172/JCI117989; Bellmann K, 1996, FEBS LETT, V391, P185, DOI 10.1016/0014-5793(96)00730-2; Bottino R, 2004, DIABETES, V53, P2559, DOI 10.2337/diabetes.53.10.2559; Bottino R, 2002, DIABETES, V51, P2561, DOI 10.2337/diabetes.51.8.2561; Burkart V, 2000, J BIOL CHEM, V275, P19521, DOI 10.1074/jbc.M002265200; Cai JY, 1998, BBA-BIOENERGETICS, V1366, P139, DOI 10.1016/S0005-2728(98)00109-1; Cande C, 2004, CELL DEATH DIFFER, V11, P591, DOI 10.1038/sj.cdd.4401400; Cande C, 2002, J CELL SCI, V115, P4727, DOI 10.1242/jcs.00210; Cavallo MG, 1996, J ENDOCRINOL, V150, P113, DOI 10.1677/joe.0.1500113; CETKOVICCVRLJE M, 1994, CYTOKINE, V6, P399, DOI 10.1016/1043-4666(94)90064-7; Chambers KT, 2008, DIABETES, V57, P124, DOI 10.2337/db07-0944; Chen J, 2006, DIABETES RES CLIN PR, V74, P148, DOI 10.1016/j.diabres.2006.03.024; Chervonsky AV, 1997, CELL, V89, P17, DOI 10.1016/S0092-8674(00)80178-6; CORBETT JA, 1993, P NATL ACAD SCI USA, V90, P1731, DOI 10.1073/pnas.90.5.1731; CORBETT JA, 1993, BIOCHEMISTRY-US, V32, P13767, DOI 10.1021/bi00213a002; Cunha-Oliveira T, 2006, BRAIN RES, V1089, P44, DOI 10.1016/j.brainres.2006.03.061; Dai T, 2009, ENDOCRINOLOGY, V150, P3031, DOI 10.1210/en.2008-0732; Demeterco C, 2002, J CLIN ENDOCR METAB, V87, P3475, DOI 10.1210/jc.87.7.3475; Domingues AF, 2008, NEUROTOX RES, V13, P31, DOI 10.1007/BF03033365; Dorff G, 2002, BIOL CHEM, V383, P1357, DOI 10.1515/BC.2002.154; Eizirik DL, 2009, NAT REV ENDOCRINOL, V5, P219, DOI 10.1038/nrendo.2009.21; Eizirik DL, 2001, DIABETOLOGIA, V44, P2115, DOI 10.1007/s001250100021; EIZIRIK DL, 1994, J CLIN INVEST, V93, P1968, DOI 10.1172/JCI117188; Foulis AK, 2008, NOVART FDN SYMP, V292, P202; Foulis AK, 2008, NOVART FDN SYMP, V292, P13; Foulis AK, 2008, NOVART FDN SYMP, V292, P122; Foulis Alan K, 2008, Novartis Found Symp, V292, P2; Grunnet LG, 2009, DIABETES, V58, P1807, DOI 10.2337/db08-0178; Gysemans C, 2008, BIOCHEM SOC T, V36, P328, DOI 10.1042/BST0360328; Halvorsen TL, 1999, MOL CELL BIOL, V19, P1864; Hanafusa T, 2008, ANN NY ACAD SCI, V1150, P297, DOI 10.1196/annals.1447.052; Holcik M, 2001, NAT REV MOL CELL BIO, V2, P550, DOI 10.1038/35080103; Imagawa A, 2001, DIABETES, V50, P1269, DOI 10.2337/diabetes.50.6.1269; Itkin-Ansari P, 2000, MOL ENDOCRINOL, V14, P814, DOI 10.1210/me.14.6.814; Itkin-Ansari P, 2003, ANN NY ACAD SCI, V1005, P138, DOI 10.1196/annals.1288.015; Jitrapakdee S, 2010, DIABETOLOGIA, V53, P1019, DOI 10.1007/s00125-010-1685-0; Johannesen J, 2003, AUTOIMMUNITY, V36, P167, DOI 10.1080/0891693031000101288; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Li JH, 2005, J IMMUNOL, V175, P1858, DOI 10.4049/jimmunol.175.3.1858; Liu DB, 2000, DIABETES, V49, P1116, DOI 10.2337/diabetes.49.7.1116; Macfarlane WM, 1997, FEBS LETT, V413, P304, DOI 10.1016/S0014-5793(97)00874-0; Mathews CE, 2005, J IMMUNOL, V175, P1248, DOI 10.4049/jimmunol.175.2.1248; Mathews CE, 2005, PEDIATR DIABETES, V6, P165, DOI 10.1111/j.1399-543X.2005.00123.x; Monetini L, 1999, AUTOIMMUNITY, V29, P171, DOI 10.3109/08916939908998532; Moriwaki M, 1999, DIABETOLOGIA, V42, P1332, DOI 10.1007/s001250051446; Narushima M, 2005, NAT BIOTECHNOL, V23, P1274, DOI 10.1038/nbt1145; Ou D, 2005, HUM IMMUNOL, V66, P799, DOI 10.1016/j.humimm.2005.03.009; Ou D, 2002, DIABETOLOGIA, V45, P1678, DOI 10.1007/s00125-002-0926-2; Ou DW, 2006, CELL TRANSPLANT, V15, P399, DOI 10.3727/000000006783981837; Ou DW, 2005, HUM IMMUNOL, V66, P274, DOI 10.1016/j.humimm.2004.12.002; Ou DW, 2002, HUM IMMUNOL, V63, P256, DOI 10.1016/S0198-8859(02)00372-5; RABINOVITCH A, 1994, J CLIN ENDOCR METAB, V79, P1058, DOI 10.1210/jc.79.4.1058; Rabinovitch A, 1998, DIABETES METAB REV, V14, P129, DOI 10.1002/(SICI)1099-0895(199806)14:2<129::AID-DMR208>3.3.CO;2-M; RABINOVITCH A, 1990, J CLIN ENDOCR METAB, V71, P152, DOI 10.1210/jcem-71-1-152; Rabinovitch A, 1998, BIOCHEM PHARMACOL, V55, P1139, DOI 10.1016/S0006-2952(97)00492-9; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Scarim AL, 1998, ENDOCRINOLOGY, V139, P5050, DOI 10.1210/en.139.12.5050; SOLDEVILA G, 1991, J AUTOIMMUN, V4, P291, DOI 10.1016/0896-8411(91)90025-8; Steer SA, 2006, PLOS MED, V3, P253, DOI 10.1371/journal.pmed.0030017; Stephens LA, 1997, J AUTOIMMUN, V10, P293, DOI 10.1006/jaut.1997.0133; Stephens LA, 1999, ENDOCRINOLOGY, V140, P3219, DOI 10.1210/en.140.7.3219; Su X, 2000, J IMMUNOL, V164, P2523, DOI 10.4049/jimmunol.164.5.2523; Suarez-Pinzon WL, 2000, DIABETOLOGIA, V43, P1149, DOI 10.1007/s001250051506; Suk K, 2001, J IMMUNOL, V166, P4481, DOI 10.4049/jimmunol.166.7.4481; Thomas HE, 2004, DIABETES, V53, P113, DOI 10.2337/diabetes.53.1.113; Thomas HE, 2009, APOPTOSIS, V14, P1389, DOI 10.1007/s10495-009-0339-5; Wang S, 1997, TRANSPLANT P, V29, P2219, DOI 10.1016/S0041-1345(97)00306-0; Zong WX, 2004, GENE DEV, V18, P1272, DOI 10.1101/gad.1199904; Zumsteg U, 2000, DIABETES, V49, P39, DOI 10.2337/diabetes.49.1.39	77	18	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e20617	10.1371/journal.pone.0020617	http://dx.doi.org/10.1371/journal.pone.0020617			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738580	Green Published, gold, Green Submitted			2022-12-27	WOS:000292092600005
J	Bayle, DJ; Schoendorff, B; Henaff, MA; Krolak-Salmon, P				Bayle, Dimitri J.; Schoendorff, Benjamin; Henaff, Marie-Anne; Krolak-Salmon, Pierre			Emotional Facial Expression Detection in the Peripheral Visual Field	PLOS ONE			English	Article							SPATIAL-FREQUENCY; FACE PERCEPTION; RECOGNITION; AMYGDALA; SYSTEM; FEAR; IMAGES; IDENTIFICATION; COMPONENT; CONTRAST	Background: In everyday life, signals of danger, such as aversive facial expressions, usually appear in the peripheral visual field. Although facial expression processing in central vision has been extensively studied, this processing in peripheral vision has been poorly studied. Methodology/Principal Findings: Using behavioral measures, we explored the human ability to detect fear and disgust vs. neutral expressions and compared it to the ability to discriminate between genders at eccentricities up to 40 degrees. Responses were faster for the detection of emotion compared to gender. Emotion was detected from fearful faces up to 40 degrees of eccentricity. Conclusions: Our results demonstrate the human ability to detect facial expressions presented in the far periphery up to 40 degrees of eccentricity. The increasing advantage of emotion compared to gender processing with increasing eccentricity might reflect a major implication of the magnocellular visual pathway in facial expression processing. This advantage may suggest that emotion detection, relative to gender identification, is less impacted by visual acuity and within-face crowding in the periphery. These results are consistent with specific and automatic processing of danger-related information, which may drive attention to those messages and allow for a fast behavioral reaction.	[Bayle, Dimitri J.; Henaff, Marie-Anne; Krolak-Salmon, Pierre] CNRS UMR5292, INSERM U1028, Lyon Neurosci Res Ctr, Brain Dynam & Cognit Team, Lyon, France; [Bayle, Dimitri J.; Schoendorff, Benjamin; Henaff, Marie-Anne; Krolak-Salmon, Pierre] Univ Lyon 1, F-69365 Lyon, France; [Bayle, Dimitri J.] Hosp Sick Children, Res Inst, Toronto, ON M5G 1X8, Canada; [Krolak-Salmon, Pierre] Hosp Civils Lyon, Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); CHU Lyon	Bayle, DJ (corresponding author), CNRS UMR5292, INSERM U1028, Lyon Neurosci Res Ctr, Brain Dynam & Cognit Team, Lyon, France.	dimitri.bayle@inserm.fr	krolak-salmon, pierre/AAV-2152-2020	bayle, dimitri/0000-0003-1867-2721	French National Institute for Health and Medical Research	French National Institute for Health and Medical Research(Institut National de la Sante et de la Recherche Medicale (Inserm))	The research was supported by the French National Institute for Health and Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2005, NATURE, V433, P68, DOI 10.1038/nature03086; BALABAN MT, 1994, BIOL PSYCHOL, V38, P117, DOI 10.1016/0301-0511(94)90033-7; Baudouin JY, 2006, PERCEPTION, V35, P531, DOI 10.1068/p3403; Bayle DJ, 2010, BRAIN RES, V1313, P113, DOI 10.1016/j.brainres.2009.11.060; Bayle DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008207; Bex PJ, 2002, J OPT SOC AM A, V19, P1096, DOI 10.1364/JOSAA.19.001096; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; Calvo MG, 2008, J EXP PSYCHOL GEN, V137, P471, DOI 10.1037/a0012771; Calvo MG, 2008, EXP PSYCHOL, V55, P359, DOI 10.1027/1618-3169.55.6.359; de Gelder B, 1999, NEUROREPORT, V10, P3759, DOI 10.1097/00001756-199912160-00007; Dolan RJ, 2003, ANN NY ACAD SCI, V985, P348, DOI 10.1111/j.1749-6632.2003.tb07093.x; Ekman P., 1976, PICTURES FACIAL AFFE; EKMAN P, 1971, DARWIN FACIAL EXPRES; Fridlund A.J., 1994, HUMAN FACIAL EXPRESS; Goren D, 2006, VISION RES, V46, P1253, DOI 10.1016/j.visres.2005.10.028; Hare TA, 2005, BIOL PSYCHIAT, V57, P624, DOI 10.1016/j.biopsych.2004.12.038; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Holmes A, 2003, COGNITIVE BRAIN RES, V16, P174, DOI 10.1016/S0926-6410(02)00268-9; Kanwisher N, 1997, J NEUROSCI, V17, P4302; KAPLAN E, 1986, P NATL ACAD SCI USA, V83, P2755, DOI 10.1073/pnas.83.8.2755; LeDoux J, 1996, PROG BRAIN RES, V107, P437; Liddell BJ, 2005, NEUROIMAGE, V24, P235, DOI 10.1016/j.neuroimage.2004.08.016; Makela P, 2001, VISION RES, V41, P599, DOI 10.1016/S0042-6989(00)00259-5; Martelli M, 2005, J VISION, V5, P58, DOI 10.1167/5.1.6; McKone E, 2004, J EXP PSYCHOL LEARN, V30, P181, DOI 10.1037/0278-7393.30.1.181; Meissirel C, 1997, P NATL ACAD SCI USA, V94, P5900, DOI 10.1073/pnas.94.11.5900; Morris JS, 1999, P NATL ACAD SCI USA, V96, P1680, DOI 10.1073/pnas.96.4.1680; Morris JS, 1998, NATURE, V393, P467, DOI 10.1038/30976; Palermo R, 2004, BEHAV RES METH INS C, V36, P634, DOI 10.3758/BF03206544; SCHILLER PH, 1979, J NEUROPHYSIOL, V42, P1124, DOI 10.1152/jn.1979.42.4.1124; Sere B, 2000, PERCEPTION, V29, P1403, DOI 10.1068/p2991; Vuilleumier P, 2003, NAT NEUROSCI, V6, P624, DOI 10.1038/nn1057	32	45	45	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21584	10.1371/journal.pone.0021584	http://dx.doi.org/10.1371/journal.pone.0021584			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	782UF	21720562	Green Published, Green Submitted, gold			2022-12-27	WOS:000292036900058
J	Guo, SC; Gonzalez-Perez, RR				Guo, Shanchun; Gonzalez-Perez, Ruben R.			Notch, IL-1 and Leptin Crosstalk Outcome (NILCO) Is Critical for Leptin-Induced Proliferation, Migration and VEGF/VEGFR-2 Expression in Breast Cancer	PLOS ONE			English	Article							GROWTH-FACTOR; ESTROGEN-RECEPTOR; SIGNALING PATHWAY; MAMMARY-TUMORS; ENDOTHELIAL-CELLS; FEMALE MICE; KAPPA-B; TRANSACTIVATION; ANGIOGENESIS; INVASIVENESS	High levels of pro-angiogenic factors, leptin, IL-1, Notch and VEGF (ligands and receptors), are found in breast cancer, which is commonly correlated with metastasis and lower survival of patients. We have previously reported that leptin induces the growth of breast cancer and the expression of VEGF/VEGFR-2 and IL-1 system. We hypothesized that Notch, IL-1 and leptin crosstalk outcome (NILCO) plays an essential role in the regulation of leptin-mediated induction of proliferation/migration and expression of pro-angiogenic molecules in breast cancer. To test this hypothesis, leptin's effects on the expression and activation of Notch signaling pathway and VEGF/VEGFR-2/IL-1 were determined in mouse (4T1, EMT6 and MMT) breast cancer cells. Remarkably, leptin up-regulated Notch1-4/JAG1/Dll-4, Notch target genes: Hey2 and survivin, together with IL1 and VEGF/VEGFR-2. RNA knockdown and pharmacological inhibitors of leptin signaling significantly abrogated activity of reporter gene-luciferase CSL (RBP-Jk) promoter, showing that it was linked to leptin-activated JAK2/STAT3, MAPK, PI-3K/mTOR, p38 and JNK signaling pathways. Interestingly, leptin upregulatory effects on cell proliferation/migration and c factors Notch, IL-1 and VEGF/VEGFR-2 were abrogated by a gamma-secretase inhibitor, DAPT, as well as siRNA against CSL. In addition, blockade of IL-1R tI inhibited leptin-induced Notch, Hey2 and survivin as well as VEGF/VEGFR-2 expression. These data suggest leptin is an inducer of Notch (expression/activation) and IL-1 signaling modulates leptin effects on Notch and VEGF/VEGFR-2. We show for the first time that a novel unveiled crosstalk between Notch, IL-1 and leptin (NILCO) occurs in breast cancer. Leptin induction of proliferation/migration and upregulation of VEGF/VEGFR-2 in breast cancer cells were related to an intact Notch signaling axis. NILCO could represent the integration of developmental, pro-inflammatory and proangiogenic signals critical for leptin-induced cell proliferation/migration and regulation of VEGF/VEGFR-2 in breast cancer. Targeting NILCO might help to design new pharmacological strategies aimed at controlling breast cancer growth and angiogenesis.	[Guo, Shanchun; Gonzalez-Perez, Ruben R.] Morehouse Sch Med, Dept Microbiol Biochem & Immunol, Atlanta, GA 30310 USA	Morehouse School of Medicine	Guo, SC (corresponding author), Morehouse Sch Med, Dept Microbiol Biochem & Immunol, Atlanta, GA 30310 USA.	rgonzalez@msm.edu			National Institutes of Health/National Cancer Institute [1SC1CA138658-03]; Georgia Cancer Coalition Distinguished Cancer Scholar Award; Morehouse School of Medicine [NIH RR03034, 1C06 RR18386]; NATIONAL CANCER INSTITUTE [SC1CA138658] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018386] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Georgia Cancer Coalition Distinguished Cancer Scholar Award; Morehouse School of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This investigation was partially funded by grants from the National Institutes of Health/National Cancer Institute 1SC1CA138658-03; the Georgia Cancer Coalition Distinguished Cancer Scholar Award to RRG-P, and facilities and support services at Morehouse School of Medicine (NIH RR03034 and 1C06 RR18386). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altieri DC, 2008, ONCOGENE, V27, P6276, DOI 10.1038/onc.2008.303; Apte RN, 2006, CANCER METAST REV, V25, P387, DOI 10.1007/s10555-006-9004-4; Artwohl M, 2002, INT J OBESITY, V26, P577, DOI 10.1038/sj.ijo.0801947; Bartella V, 2008, CANCER RES, V68, P4919, DOI 10.1158/0008-5472.CAN-08-0642; Bash J, 1999, EMBO J, V18, P2803, DOI 10.1093/emboj/18.10.2803; Carino C, 2008, INT J CANCER, V123, P2782, DOI 10.1002/ijc.23887; Catalano S, 2004, J BIOL CHEM, V279, P19908, DOI 10.1074/jbc.M313191200; Cirillo D, 2008, J CELL BIOCHEM, V105, P956, DOI 10.1002/jcb.21911; Cleary MP, 2004, EXP BIOL MED, V229, P182, DOI 10.1177/153537020422900207; Cleary MP, 2003, BREAST CANCER RES TR, V77, P205, DOI 10.1023/A:1021891825399; Cordle J, 2008, NAT STRUCT MOL BIOL, V15, P849, DOI 10.1038/nsmb.1457; D'Souza B, 2008, ONCOGENE, V27, P5148, DOI 10.1038/onc.2008.229; Eisenberg A, 2004, FEBS LETT, V565, P139, DOI 10.1016/j.febslet.2004.03.089; Garofalo C, 2004, CLIN CANCER RES, V10, P6466, DOI 10.1158/1078-0432.CCR-04-0203; Garonna E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018823; Gonzalez RR, 2006, J BIOL CHEM, V281, P26320, DOI 10.1074/jbc.M601991200; Gonzalez RR, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2321; Gonzalez-Perez RR, 2010, CELL SIGNAL, V22, P1350, DOI 10.1016/j.cellsig.2010.05.003; Guo SC, 2011, BBA-REV CANCER, V1815, P197, DOI 10.1016/j.bbcan.2010.12.002; Guo SC, 2010, BBA-REV CANCER, V1806, P108, DOI 10.1016/j.bbcan.2010.04.004; Hainaud P, 2006, CANCER RES, V66, P8501, DOI 10.1158/0008-5472.CAN-05-4226; Hu X, 2002, J NATL CANCER I, V94, P1704, DOI 10.1093/jnci/94.22.1704; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Laud K, 2002, MOL CELL ENDOCRINOL, V188, P219, DOI 10.1016/S0303-7207(01)00678-5; MEHTA RS, 1993, CARCINOGENESIS, V14, P1693, DOI 10.1093/carcin/14.8.1693; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Miyoshi Y, 2006, INT J CANCER, V118, P1414, DOI 10.1002/ijc.21543; Nakopoulou L, 2002, HUM PATHOL, V33, P863, DOI 10.1053/hupa.2002.126879; O'Neill L A, 2000, Sci STKE, V2000, pre1; Okumura M, 2002, BBA-MOL CELL RES, V1592, P107, DOI 10.1016/S0167-4889(02)00276-8; Osipo C, 2008, LAB INVEST, V88, P11, DOI 10.1038/labinvest.3700700; Ray A, 2007, INT J ONCOL, V30, P1499; Ray A, 2010, EXPERT OPIN THER TAR, V14, P443, DOI 10.1517/14728221003716466; Rehman AO, 2006, TRENDS CELL BIOL, V16, P293, DOI 10.1016/j.tcb.2006.04.003; Rizzo P, 2008, CANCER RES, V68, P5226, DOI 10.1158/0008-5472.CAN-07-5744; Ryan BM, 2009, CANCER TREAT REV, V35, P553, DOI 10.1016/j.ctrv.2009.05.003; Saxena NK, 2008, CANCER RES, V68, P9712, DOI 10.1158/0008-5472.CAN-08-1952; Soares R, 2004, MOL ENDOCRINOL, V18, P2333, DOI 10.1210/me.2003-0362; Soares R, 2003, ULTRASTRUCT PATHOL, V27, P33, DOI 10.1080/01913120309946; Soares Raquel, 2003, Angiogenesis, V6, P271, DOI 10.1023/B:AGEN.0000029413.32882.dd; Styer AK, 2008, ENDOCRINOLOGY, V149, P506, DOI 10.1210/en.2007-1225; Sweeney G, 2002, CELL SIGNAL, V14, P655, DOI 10.1016/S0898-6568(02)00006-2; Voronov E, 2003, P NATL ACAD SCI USA, V100, P2645, DOI 10.1073/pnas.0437939100; Whiteman MK, 2005, CANCER EPIDEM BIOMAR, V14, P2009, DOI 10.1158/1055-9965.EPI-05-0106; Zhou W, 2011, BRIT J CANCER, V104, P128, DOI 10.1038/sj.bjc.6606013	45	84	88	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21467	10.1371/journal.pone.0021467	http://dx.doi.org/10.1371/journal.pone.0021467			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731759	Green Published, Green Submitted, gold			2022-12-27	WOS:000292035400041
J	Ogura, T				Ogura, Toshihiko			Three-Dimensional X-ray Observation of Atmospheric Biological Samples by Linear-Array Scanning-Electron Generation X-ray Microscope System	PLOS ONE			English	Article							CT IMAGE-RECONSTRUCTION; RHODOBACTER-CAPSULATUS; RESOLUTION; TOMOGRAPHY; PROJECTIONS; NANOSCALE; MOLECULES; CELLS	Recently, we developed a soft X-ray microscope called the scanning-electron generation X-ray microscope (SGXM), which consists of a simple X-ray detection system that detects X-rays emitted from the interaction between a scanning electron beam (EB) and the thin film of the sample mount. We present herein a three-dimensional (3D) X-ray detection system that is based on the SGXM technology and designed for studying atmospheric biological samples. This 3D X-ray detection system contains a linear X-ray photodiode (PD) array. The specimens are placed under a CuZn-coated Si(3)N(4) thin film, which is attached to an atmospheric sample holder. Multiple tilt X-ray images of the samples are detected simultaneously by the linear array of X-ray PDs, and the 3D structure is calculated by a new 3D reconstruction method that uses a simulated-annealing algorithm. The resulting 3D models clearly reveal the inner structure of the bacterium. In addition, the proposed method can easily be used for diverse samples in a broad range of scientific fields.	Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Tsukuba, Ibaraki, Japan	National Institute of Advanced Industrial Science & Technology (AIST)	Ogura, T (corresponding author), Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Tsukuba, Ibaraki, Japan.	t-ogura@aist.go.jp	Ogura, Toshihiko/M-4089-2018		Japan Society for the Promotion of Science [20300107]; Canon foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Canon foundation(Canon Foundation)	This study was supported by KAKENHI Grant-in-Aid for Scientific Research (B) (No. 20300107) of the Japan Society for the Promotion of Science, and the Canon foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali FEF, 1999, FUZZY SET SYST, V103, P295, DOI 10.1016/S0165-0114(98)00229-2; Chao W, 2009, OPT EXPRESS, V17, P17669, DOI 10.1364/OE.17.017669; Chao WL, 2005, NATURE, V435, P1210, DOI 10.1038/nature03719; COSSLETT VE, 1953, J APPL PHYS, V24, P616, DOI 10.1063/1.1721338; de Smit E, 2008, NATURE, V456, P222, DOI 10.1038/nature07516; Dierolf M, 2010, NATURE, V467, P436, DOI 10.1038/nature09419; Drouin D, 2007, SCANNING, V29, P92, DOI 10.1002/sca.20000; GILBERT P, 1972, J THEOR BIOL, V36, P105, DOI 10.1016/0022-5193(72)90180-4; GORDON R, 1970, J THEOR BIOL, V29, P471, DOI 10.1016/0022-5193(70)90109-8; HANEISHI H, 1990, APPL OPTICS, V29, P259, DOI 10.1364/AO.29.000259; Jacobsen C, 1999, TRENDS CELL BIOL, V9, P44, DOI 10.1016/S0962-8924(98)01424-X; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; KIRZ J, 1995, Q REV BIOPHYS, V28, P33, DOI 10.1017/S0033583500003139; Koshino M, 2007, SCIENCE, V316, P853, DOI 10.1126/science.1138690; Larabell CA, 2004, MOL BIOL CELL, V15, P957, DOI 10.1091/mbc.E03-07-0522; LILBURN TG, 1992, BIOCHIM BIOPHYS ACTA, V1100, P160; Meyer JC, 2008, NATURE, V454, P319, DOI 10.1038/nature07094; Nishino Y, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.018101; Ogura T, 2006, J STRUCT BIOL, V156, P371, DOI 10.1016/j.jsb.2006.05.016; Ogura T, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/29/295501; Ogura T, 2010, BIOCHEM BIOPH RES CO, V391, P198, DOI 10.1016/j.bbrc.2009.11.031; Ogura T, 2009, BIOCHEM BIOPH RES CO, V385, P624, DOI 10.1016/j.bbrc.2009.05.107; Parkinson DY, 2008, J STRUCT BIOL, V162, P380, DOI 10.1016/j.jsb.2008.02.003; Sali A, 2003, NATURE, V422, P216, DOI 10.1038/nature01513; Shelswell KJ, 2005, J BACTERIOL, V187, P5040, DOI 10.1128/JB.187.14.5040-5043.2005; SMITH WE, 1983, OPT LETT, V8, P199, DOI 10.1364/OL.8.000199; Takahashi Y, 2010, NANO LETT, V10, P1922, DOI 10.1021/nl100891n; TOMIE T, 1991, SCIENCE, V252, P691, DOI 10.1126/science.2024121	29	2	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21516	10.1371/journal.pone.0021516	http://dx.doi.org/10.1371/journal.pone.0021516			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731770	gold, Green Submitted, Green Published			2022-12-27	WOS:000292035400045
J	Xiao, F; Weng, JW; Fan, KN; Wang, WN				Xiao, Fei; Weng, Jingwei; Fan, Kangnian; Wang, Wenning			Detailed Regulatory Mechanism of the Interaction between ZO-1 PDZ2 and Connexin43 Revealed by MD Simulations	PLOS ONE			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; GAP-JUNCTION PROTEIN; TUMOR-SUPPRESSOR PROTEIN; ZONULA OCCLUDENS-1; MOLECULAR-DYNAMICS; DOMAIN PROTEINS; CHANNEL; BINDING; SITES; IDENTIFICATION	The gap junction protein connexin43 (Cx43) binds to the second PDZ domain of Zonula occludens-1 (ZO-1) through its C-terminal tail, mediating the regulation of gap junction plaque size and dynamics. Biochemical study demonstrated that the very C-terminal 12 residues of Cx43 are necessary and sufficient for ZO-1 PDZ2 binding and phosphorylation at residues Ser (-9) and Ser (-10) of the peptide can disrupt the association. However, only a crystal structure of ZO-1 PDZ2 in complex with a shorter 9 aa peptide of connexin43 was solved experimentally. Here, the interactions between ZO-1 PDZ2 and the short, long and phosphorylated Cx43 peptides were studied using molecular dynamics (MD) simulations and free energy calculation. The short peptide bound to PDZ2 exhibits large structural variations, while the extension of three upstream residues stabilizes the peptide conformation and enhanced the interaction. Phosphorylation at Ser(-9) significantly weakens the binding and results in conformational flexibility of the peptide. Glu210 of ZO-1 PDZ2 was found to be a key regulatory point in Cx43 binding and phosphorylation induced dissociation.	[Xiao, Fei; Fan, Kangnian; Wang, Wenning] Fudan Univ, Dept Chem, Shanghai Key Lab Mol Catalysis & Innovat Mat, Shanghai 200433, Peoples R China; [Weng, Jingwei; Wang, Wenning] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Xiao, F (corresponding author), Fudan Univ, Dept Chem, Shanghai Key Lab Mol Catalysis & Innovat Mat, Shanghai 200433, Peoples R China.	wnwang@fudan.edu.cn	Fan, K/GXH-3734-2022		National High Technology Research Program of China [2006AA02A320]; National Major Basic Research Program of China [2009CB918600, 2011CB808505]; National Science Foundation of China [20973040, 31070642]; Science & Technology Commission of Shanghai Municipality [08DZ2270500]; Shanghai Leading Academic Discipline Project [B108]	National High Technology Research Program of China(National High Technology Research and Development Program of China); National Major Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science & Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This work was supported by National High Technology Research Program of China (2006AA02A320), National Major Basic Research Program of China (2009CB918600, 2011CB808505), National Science Foundation of China (20973040, 31070642), Science & Technology Commission of Shanghai Municipality (08DZ2270500), and Shanghai Leading Academic Discipline Project (B108). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akoyev V, 2007, CELL SIGNAL, V19, P958, DOI 10.1016/j.cellsig.2006.11.007; Basdevant N, 2006, J AM CHEM SOC, V128, P12766, DOI 10.1021/ja060830y; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Chen J, 2008, EMBO J, V27, P2113, DOI 10.1038/emboj.2008.138; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Colledge M, 1998, CURR OPIN NEUROBIOL, V8, P357, DOI 10.1016/S0959-4388(98)80061-5; Craven SE, 1998, CELL, V93, P495, DOI 10.1016/S0092-8674(00)81179-4; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Daura X, 1999, ANGEW CHEM INT EDIT, V38, P236, DOI 10.1002/(SICI)1521-3773(19990115)38:1/2<236::AID-ANIE236>3.3.CO;2-D; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Fanning AS, 1996, CURR BIOL, V6, P1385, DOI 10.1016/S0960-9822(96)00737-3; FANNING AS, 1998, PROTEIN MODULES SIGN, P209; Gerek ZN, 2009, PROTEINS, V77, P796, DOI 10.1002/prot.22492; Giepmans BNG, 1998, CURR BIOL, V8, P931, DOI 10.1016/S0960-9822(07)00375-2; Hansson T, 1997, J MOL BIOL, V265, P118, DOI 10.1006/jmbi.1996.0716; HEMMING NJ, 1995, J BIOL CHEM, V270, P5360, DOI 10.1074/jbc.270.10.5360; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hunter AW, 2005, MOL BIOL CELL, V16, P5686, DOI 10.1091/mbc.E05-08-0737; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Kornau HC, 1997, CURR OPIN NEUROBIOL, V7, P368, DOI 10.1016/S0959-4388(97)80064-5; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; O'Brien RJ, 1998, CURR OPIN NEUROBIOL, V8, P364, DOI 10.1016/S0959-4388(98)80062-7; Park DJ, 2007, CELL COMMUN ADHES, V14, P211, DOI 10.1080/15419060701755958; PEARLMAN DA, 1994, J PHYS CHEM-US, V98, P1487, DOI 10.1021/j100056a020; Ponting CP, 1997, BIOESSAYS, V19, P469, DOI 10.1002/bies.950190606; Saras J, 1996, TRENDS BIOCHEM SCI, V21, P455, DOI 10.1016/S0968-0004(96)30044-3; Saras J, 1997, J BIOL CHEM, V272, P24333, DOI 10.1074/jbc.272.39.24333; SATO T, 1995, SCIENCE, V268, P411, DOI 10.1126/science.7536343; Sheng M, 1996, NEURON, V17, P575, DOI 10.1016/S0896-6273(00)80190-7; Shieh BH, 1996, NEURON, V16, P991, DOI 10.1016/S0896-6273(00)80122-1; Simske JS, 1996, CELL, V85, P195, DOI 10.1016/S0092-8674(00)81096-X; Solan JL, 2005, BBA-BIOMEMBRANES, V1711, P154, DOI 10.1016/j.bbamem.2004.09.013; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Sorgen PL, 2004, J BIOL CHEM, V279, P54695, DOI 10.1074/jbc.M409552200; Staneva I, 2009, J MOL BIOL, V393, P1118, DOI 10.1016/j.jmb.2009.08.063; Toyofuku T, 1998, J BIOL CHEM, V273, P12725, DOI 10.1074/jbc.273.21.12725; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT; van Ham M, 2003, MOL BIOL REP, V30, P69, DOI 10.1023/A:1023941703493; van Zeijl L, 2007, J CELL BIOL, V177, P881, DOI 10.1083/jcb.200610144; WILLOTT E, 1993, P NATL ACAD SCI USA, V90, P7834, DOI 10.1073/pnas.90.16.7834; WOODS DF, 1993, MECH DEVELOP, V44, P85, DOI 10.1016/0925-4773(93)90059-7; Yogo K, 2002, FEBS LETT, V531, P132, DOI 10.1016/S0014-5793(02)03441-5; Zhang MJ, 2003, ACCOUNTS CHEM RES, V36, P530, DOI 10.1021/ar020210b; ZWANZIG RW, 1954, J CHEM PHYS, V22, P1420, DOI 10.1063/1.1740409	48	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21527	10.1371/journal.pone.0021527	http://dx.doi.org/10.1371/journal.pone.0021527			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731774	Green Published, Green Submitted, gold			2022-12-27	WOS:000292035400049
J	Huang, H; Shen, JK; Vinores, SA				Huang, Hu; Shen, Jikui; Vinores, Stanley A.			Blockade of VEGFR1 and 2 Suppresses Pathological Angiogenesis and Vascular Leakage in the Eye	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; OXYGEN-INDUCED RETINOPATHY; CHOROIDAL NEOVASCULARIZATION; MACULAR DEGENERATION; PERMEABILITY FACTOR; TUMOR ANGIOGENESIS; MOUSE MODEL; EXPRESSION; HYPOXIA; INHIBITION	Objective: VEGFR1 and 2 signaling have both been increasingly shown to mediate complications of ischemic retinopathies, including retinopathy of prematurity (ROP), age-related macular degeneration (AMD), and diabetic retinopathy (DR). This study evaluates the effects of blocking VEGFR1 and 2 on pathological angiogenesis and vascular leakage in ischemic retinopathy in a model of ROP and in choroidal neovascularization (CNV) in a model of AMD. Materials and Methods: Neutralizing antibodies specific for mouse VEGFR1 (MF1) and VEGFR2 (DC101) were administrated systemically. CNV was induced by laser photocoagulation and assessed 14d after laser treatment. Retinal NV was generated in oxygen-induced ischemic retinopathy (OIR) and assessed at p17. NV quantification was determined by measuring NV tufts and vascular leakage was quantified by measuring [H-3]-mannitol leakage from blood vessels into the retina. Gene expression was measured by real-time quantitative (Q) PCR. Results: VEGFR1 and VEGFR2 expressions were up-regulated during CNV pathogenesis. Both MF1 and DC101 significantly suppressed CNV at 50 mg/kg: DC101 suppressed CNV by 73 +/- 5% (p<0.0001) and MF1 by 64 +/- 6% (p = 0.0002) in a dosage-dependent manner. The combination of MF1 and DC101 enhanced the inhibitory efficacy and resulted in an accumulation of retinal microglia at the CNV lesion. Similarly, both MF1 and DC101 significantly suppressed retinal NV in OIR at 50 mg/kg: DC101 suppressed retinal NV by 54 +/- 8% (p = 0.013) and MF1 by 50 +/- 7% (p<0.0002). MF1 was even more effective at inhibiting ischemia-induced BRB breakdown than DC101: the retina/lung leakage ratio for MF1 was reduced by 73 +/- 24%, p = 0.001 and for DC101 by 12 +/- 4%, p = 0.003. The retina/renal leakage ratio for MF1 was reduced by 52 +/- 28%, p = 0.009 and for DC101 by 13 +/- 4%, p = 0.001. Conclusion: Our study provides further evidence that both VEGFR1 and 2 mediate pathological angiogenesis and vascular leakage in these models of ocular disease and suggests that antagonist antibodies to these receptor tyrosine kinases (RTKs) are potential therapeutic agents.	[Huang, Hu; Shen, Jikui; Vinores, Stanley A.] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine	Huang, H (corresponding author), Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21205 USA.	svinores@jhmi.edu			National Eye Institute [EY017164]; Lilly/ImClone; Wilmer Eye Institute; NIH [P30EY1765]; NATIONAL EYE INSTITUTE [R01EY017164, P30EY001765] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Lilly/ImClone(Eli Lilly); Wilmer Eye Institute(Johns Hopkins University); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The study was supported by NIH grant EY017164 from the National Eye Institute and a stipend from Lilly/ImClone (S. A. V.), The Louise L. Sloan Research Grant Award from Wilmer Eye Institute (H. H.), ARVO Travel Grant from the National Eye Institute (H. H.), and NIH core grant P30EY1765. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have the following competing interest. A stipend was received from Lilly/ImClone as part of a Sponsored Research Agreement to partially support this study. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	ADAMIS AP, 1994, AM J OPHTHALMOL, V118, P445, DOI 10.1016/S0002-9394(14)75794-0; AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; Ambati J, 2003, NAT MED, V9, P1390, DOI 10.1038/nm950; Brown JL, 2010, MOL CANCER THER, V9, P145, DOI 10.1158/1535-7163.MCT-09-0554; Caicedo A, 2005, EXP EYE RES, V81, P38, DOI 10.1016/j.exer.2005.01.013; Carmeliet P, 2001, NAT MED, V7, P575, DOI 10.1038/87904; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Chang KH, 2007, P NATL ACAD SCI USA, V104, P10595, DOI 10.1073/pnas.0702072104; Chappelow AV, 2008, DRUGS, V68, P1029, DOI 10.2165/00003495-200868080-00002; Chen J, 2009, INVEST OPHTH VIS SCI, V50, P1329, DOI 10.1167/iovs.08-2521; Chen L, 2002, OCUL IMMUNOL INFLAMM, V10, P27, DOI 10.1076/ocii.10.1.27.10328; COLTON CA, 1992, J HISTOCHEM CYTOCHEM, V40, P505, DOI 10.1177/40.4.1372634; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; Derevjanik NL, 2002, INVEST OPHTH VIS SCI, V43, P2462; Dias S, 2001, P NATL ACAD SCI USA, V98, P10857, DOI 10.1073/pnas.191117498; Dixon JA, 2009, EXPERT OPIN INV DRUG, V18, P1573, DOI 10.1517/13543780903201684; DOR Y, 2000, TRENDS CARDIOVAS MED, V7, P289; Dorrell MI, 2007, P NATL ACAD SCI USA, V104, P967, DOI 10.1073/pnas.0607542104; Ferrara N, 2010, CYTOKINE GROWTH F R, V21, P21, DOI 10.1016/j.cytogfr.2009.11.003; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Fu YL, 2007, INVEST OPHTH VIS SCI, V48, P5184, DOI 10.1167/iovs.07-0469; Guerin E, 2008, MICROVASC RES, V75, P302, DOI 10.1016/j.mvr.2007.12.001; Hackett SF, 2000, J CELL PHYSIOL, V184, P275, DOI 10.1002/1097-4652(200009)184:3<275::AID-JCP1>3.3.CO;2-Z; Hiratsuka S, 1998, P NATL ACAD SCI USA, V95, P9349, DOI 10.1073/pnas.95.16.9349; Huang H, 2005, EXP EYE RES, V80, P727, DOI 10.1016/j.exer.2004.11.019; Huang H, 2008, DEV DYNAM, V237, P286, DOI 10.1002/dvdy.21408; Huang H, 2010, INVEST OPHTH VIS SCI, V51, P5825, DOI 10.1167/iovs.10-5576; Kumar A, 2010, J BIOL CHEM, V285, P15500, DOI 10.1074/jbc.M110.113787; Luhmann UFO, 2009, INVEST OPHTH VIS SCI, V50, P5934, DOI 10.1167/iovs.09-3462; Luttun A, 2002, NAT MED, V8, P831, DOI 10.1038/nm731; Ma WX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007945; Maiti D, 2008, INVEST OPHTH VIS SCI, V49, P3640, DOI 10.1167/iovs.08-1760; MALECAZE F, 1994, ARCH OPHTHALMOL-CHIC, V112, P1476, DOI 10.1001/archopht.1994.01090230090028; Meyer M, 1999, EMBO J, V18, P363, DOI 10.1093/emboj/18.2.363; MILLER JW, 1994, AM J PATHOL, V145, P574; Ogawa S, 1998, J BIOL CHEM, V273, P31273, DOI 10.1074/jbc.273.47.31273; Okamoto N, 1997, AM J PATHOL, V151, P281; PEER J, 1995, LAB INVEST, V72, P638; PIERCE EA, 1995, P NATL ACAD SCI USA, V92, P905, DOI 10.1073/pnas.92.3.905; Prewett M, 1999, CANCER RES, V59, P5209; Rakic JM, 2003, INVEST OPHTH VIS SCI, V44, P3186, DOI 10.1167/iovs.02-1092; Robinson GS, 2001, FASEB J, V15, P1215, DOI 10.1096/fj.00-0598fje; Rockwell Patricia, 1995, Molecular and Cellular Differentiation, V3, P315; ROQUE RS, 1993, CURR EYE RES, V12, P285, DOI 10.3109/02713689308999475; Sainson RCA, 2008, ANGIOGENESIS, V11, P41, DOI 10.1007/s10456-008-9098-0; Schlingemann RO, 2009, PROG BRAIN RES, V175, P253, DOI 10.1016/S0079-6123(09)17517-9; Semenza GL, 2000, BIOCHEM PHARMACOL, V59, P47, DOI 10.1016/S0006-2952(99)00292-0; Semenza GL, 1998, CHEST, V114, p40S, DOI 10.1378/chest.114.1_Supplement.40S; SEMKOVA I, 2010, INVEST OPHT IN PRESS; Sengupta N, 2010, INVEST OPHTH VIS SCI, V51, P2697, DOI 10.1167/iovs.09-4137; Shen JK, 2007, INVEST OPHTH VIS SCI, V48, P4335, DOI 10.1167/iovs.07-0113; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Tobe T, 1998, INVEST OPHTH VIS SCI, V39, P180; Tunon J, 2009, SURV OPHTHALMOL, V54, P339, DOI 10.1016/j.survophthal.2009.02.003; Van de Veire S, 2010, CELL, V141, P178, DOI 10.1016/j.cell.2010.02.039; Verbeke G., 2000, LINEAR MIXED MODELS, P568; Vinores SA, 2006, J CELL PHYSIOL, V206, P749, DOI 10.1002/jcp.20525; VINORES SA, 2007, ANGIOGENESIS BASIC S, P467; VINORES SA, 2002, GEN PHARMACOL, V35, P233; Wang ES, 2004, BLOOD, V104, P2893, DOI 10.1182/blood-2004-01-0226; Wang JJ, 2010, DIABETES, V59, P2297, DOI 10.2337/db09-1420; Witmer AN, 2002, INVEST OPHTH VIS SCI, V43, P849; Wu Y, 2006, CLIN CANCER RES, V12, P6573, DOI 10.1158/1078-0432.CCR-06-0831; Yoshida T, 2010, FASEB J, V24, P1759, DOI 10.1096/fj.09-145664; Zhong XF, 2011, MOL VIS, V17, P492	67	76	85	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21411	10.1371/journal.pone.0021411	http://dx.doi.org/10.1371/journal.pone.0021411			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731737	Green Published, Green Submitted, gold			2022-12-27	WOS:000292033700080
J	Ray, B; Long, JM; Sokol, DK; Lahiri, DK				Ray, Balmiki; Long, Justin M.; Sokol, Deborah K.; Lahiri, Debomoy K.			Increased Secreted Amyloid Precursor Protein-alpha (sAPP alpha) in Severe Autism: Proposal of a Specific, Anabolic Pathway and Putative Biomarker	PLOS ONE			English	Article							FRAGILE-X-SYNDROME; AMINO-TERMINAL REGION; NEUROTROPHIC FACTOR; DIAGNOSTIC INTERVIEW; NEURITE OUTGROWTH; PROMOTER ACTIVITY; MESSENGER-RNA; APP GENE; 5'-UNTRANSLATED REGION; MENTAL-RETARDATION	Autism is a neurodevelopmental disorder characterized by deficits in verbal communication, social interactions, and the presence of repetitive, stereotyped and compulsive behaviors. Excessive early brain growth is found commonly in some patients and may contribute to disease phenotype. Reports of increased levels of brain-derived neurotrophic factor (BDNF) and other neurotrophic-like factors in autistic neonates suggest that enhanced anabolic activity in CNS mediates this overgrowth effect. We have shown previously that in a subset of patients with severe autism and aggression, plasma levels of the secreted amyloid-beta (A beta) precursor protein-alpha form (sAPP alpha) were significantly elevated relative to controls and patients with mild-to-moderate autism. Here we further tested the hypothesis that levels of sAPP alpha and sAPP beta (proteolytic cleavage products of APP by alpha-and beta-secretase, respectively) are deranged in autism and may contribute to an anabolic environment leading to brain overgrowth. We measured plasma levels of sAPP alpha, sAPP beta, A beta peptides and BDNF by corresponding ELISA in a well characterized set of subjects. We included for analysis 18 control, 6 mild-to-moderate, and 15 severely autistic patient plasma samples. We have observed that sAPPa levels are increased and BDNF levels decreased in the plasma of patients with severe autism as compared to controls. Further, we show that A beta 1-40, A beta 1-42, and sAPP beta levels are significantly decreased in the plasma of patients with severe autism. These findings do not extend to patients with mild-to-moderate autism, providing a biochemical correlate of phenotypic severity. Taken together, this study provides evidence that sAPP alpha levels are generally elevated in severe autism and suggests that these patients may have aberrant non-amyloidogenic processing of APP.	[Ray, Balmiki; Long, Justin M.; Lahiri, Debomoy K.] Indiana Univ Sch Med, Inst Psychiat Res, Dept Psychiat, Indianapolis, IN USA; [Sokol, Deborah K.] Indiana Univ Sch Med, Dept Neurol, Indianapolis, IN USA; [Lahiri, Debomoy K.] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Ray, B (corresponding author), Indiana Univ Sch Med, Inst Psychiat Res, Dept Psychiat, Indianapolis, IN USA.	dlahiri@iupui.edu	Lahiri, Debomoy/AAZ-3322-2020	Long, Justin/0000-0003-0769-604X	National Institutes of Health [AG18379, AG18884]; NATIONAL INSTITUTE ON AGING [R01AG018379, R01AG018884] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by grant support from the National Institutes of Health (AG18379 and AG18884) to DKL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; ALAYAHDI L, 2011, COMMUNICATION; Alley GM, 2010, J NEUROSCI RES, V88, P143, DOI 10.1002/jnr.22172; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; ARAKI W, 1991, BIOCHEM BIOPH RES CO, V181, P265, DOI 10.1016/S0006-291X(05)81412-3; Badcock C, 2008, NATURE, V454, P1054, DOI 10.1038/4541054a; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Bailey AR, 2008, INT J CLIN EXP MED, V1, P338; Bauman M.L, 1994, NEUROBIOLOGY AUTISM, P119; Bell KFS, 2008, NEUROBIOL AGING, V29, P554, DOI 10.1016/j.neurobiolaging.2006.11.004; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Caille I, 2004, DEVELOPMENT, V131, P2173, DOI 10.1242/dev.01103; *CDCP, 2006, MMWR SURVEILL SUMM, V58, P1; Chen Chun-Wei David, 2006, Current Alzheimer Research, V3, P63, DOI 10.2174/156720506775697205; Conti E, 2010, ALZ DIS ASSOC DIS, V24, P96, DOI 10.1097/WAD.0b013e3181aba63a; Correia CT, 2010, GENES BRAIN BEHAV, V9, P841, DOI 10.1111/j.1601-183X.2010.00627.x; Courchesne E, 2004, CURR OPIN NEUROL, V17, P489, DOI 10.1097/01.wco.0000137542.14610.b4; Courchesne E, 2003, JAMA-J AM MED ASSOC, V290, P337, DOI 10.1001/jama.290.3.337; Courchesne E, 2001, NEUROLOGY, V57, P245, DOI 10.1212/WNL.57.2.245; Crespi B, 2008, BEHAV BRAIN SCI, V31, P241, DOI 10.1017/S0140525X08004214; Croen LA, 2008, AUTISM RES, V1, P130, DOI 10.1002/aur.14; Dolen G, 2008, J PHYSIOL-LONDON, V586, P1503, DOI 10.1113/jphysiol.2008.150722; Dolen G, 2007, NEURON, V56, P955, DOI 10.1016/j.neuron.2007.12.001; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; Friedman SD, 2003, NEUROLOGY, V60, P100, DOI 10.1212/WNL.60.1.100; Furukawa K, 1996, J NEUROCHEM, V67, P1882, DOI 10.1046/j.1471-4159.1996.67051882.x; Gakhar-Koppole N, 2008, EUR J NEUROSCI, V28, P871, DOI 10.1111/j.1460-9568.2008.06398.x; Ge YW, 2002, ANN NY ACAD SCI, V973, P463, DOI 10.1111/j.1749-6632.2002.tb04684.x; Geschwind DH, 2007, CURR OPIN NEUROBIOL, V17, P103, DOI 10.1016/j.conb.2007.01.009; GOODMAN Y, 1994, EXP NEUROL, V128, P1, DOI 10.1006/exnr.1994.1107; Greenough WT, 2001, P NATL ACAD SCI USA, V98, P7101, DOI 10.1073/pnas.141145998; Hashimoto K, 2006, PROG NEURO-PSYCHOPH, V30, P1529, DOI 10.1016/j.pnpbp.2006.06.018; HAYASHI Y, 1994, BIOCHEM BIOPH RES CO, V205, P936, DOI 10.1006/bbrc.1994.2755; Hazlett HC, 2005, ARCH GEN PSYCHIAT, V62, P1366, DOI 10.1001/archpsyc.62.12.1366; HILBICH C, 1993, J BIOL CHEM, V268, P26571; Hu VW, 2009, AUTISM RES, V2, P67, DOI 10.1002/aur.72; Ishida A, 1997, NEUROREPORT, V8, P2133, DOI 10.1097/00001756-199707070-00009; JIN LW, 1994, J NEUROSCI, V14, P5461; Just MA, 2007, CEREB CORTEX, V17, P951, DOI 10.1093/cercor/bhl006; Kanner L, 1943, NERV CHILD, V2, P217; Karege F, 2002, NEUROSCI LETT, V328, P261, DOI 10.1016/S0304-3940(02)00529-3; Katoh-Semba R, 2007, INT J DEV NEUROSCI, V25, P367, DOI 10.1016/j.ijdevneu.2007.07.002; Kogan MD, 2009, PEDIATRICS, V124, P1395, DOI 10.1542/peds.2009-1522; Kwak YD, 2006, STEM CELLS DEV, V15, P381, DOI 10.1089/scd.2006.15.381; Lahiri DK, 2009, MOL PSYCHIATR, V14, P992, DOI 10.1038/mp.2009.82; Lahiri DK, 2003, CURR DRUG TARGETS, V4, P97, DOI 10.2174/1389450033346957; Lahiri DK, 2005, NEUROBIOL AGING, V26, P1329, DOI 10.1016/j.neurobiolaging.2004.11.005; LAHIRI DK, 1995, MOL BRAIN RES, V32, P233, DOI 10.1016/0169-328X(95)00078-7; Long JM, 2011, BIOCHEM BIOPH RES CO, V404, P889, DOI 10.1016/j.bbrc.2010.12.053; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Maenner MJ, 2010, PEDIATRICS, V126, pE1018, DOI 10.1542/peds.2010-1023; Maloney B, 2004, FASEB J, V18, P1288, DOI 10.1096/fj.03-1703fje; MATTSON MP, 1993, NEURON, V10, P243, DOI 10.1016/0896-6273(93)90315-I; Mattson MP, 1997, PHYSIOL REV, V77, P1081, DOI 10.1152/physrev.1997.77.4.1081; Miyazaki K, 2004, BRAIN DEV-JPN, V26, P292, DOI 10.1016/S0387-7604(03)00168-2; Morimoto T, 1998, J NEUROSCI RES, V51, P185, DOI 10.1002/(SICI)1097-4547(19980115)51:2<185::AID-JNR7>3.0.CO;2-9; Mullen E. M., 1992, MULLEN SCALES EARLY; Napoli I, 2008, CELL, V134, P1042, DOI 10.1016/j.cell.2008.07.031; Nelson KB, 2001, ANN NEUROL, V49, P597, DOI 10.1002/ana.1024.abs; Nelson PG, 2006, INT J DEV NEUROSCI, V24, P73, DOI 10.1016/j.ijdevneu.2005.10.003; Ohsawa I, 1999, EUR J NEUROSCI, V11, P1907, DOI 10.1046/j.1460-9568.1999.00601.x; OHSAWA I, 1995, BIOCHEM BIOPH RES CO, V213, P52, DOI 10.1006/bbrc.1995.2097; Ohsawa I, 1997, BIOCHEM BIOPH RES CO, V236, P59, DOI 10.1006/bbrc.1997.6903; Ray B, 2010, NEUROSCI LETT, V470, P1, DOI 10.1016/j.neulet.2009.11.016; ROCH JM, 1994, P NATL ACAD SCI USA, V91, P7450, DOI 10.1073/pnas.91.16.7450; Rogers JT, 2002, J BIOL CHEM, V277, P45518, DOI 10.1074/jbc.M207435200; Rogers JT, 1999, J BIOL CHEM, V274, P6421, DOI 10.1074/jbc.274.10.6421; Ruiz-Leon Y, 2001, J NEUROCHEM, V79, P278, DOI 10.1046/j.1471-4159.2001.00547.x; SAITOH T, 1989, CELL, V58, P615, DOI 10.1016/0092-8674(89)90096-2; Schopler E., 1988, CHILDHOOD AUTISM RAT; SCHUBERT D, 1989, NEURON, V3, P689, DOI 10.1016/0896-6273(89)90237-7; Schumann CM, 2010, J NEUROSCI, V30, P4419, DOI 10.1523/JNEUROSCI.5714-09.2010; SEUBERT P, 1993, NATURE, V361, P260, DOI 10.1038/361260a0; Sheikh AM, 2010, J NEUROSCI RES, V88, P2641, DOI 10.1002/jnr.22416; Singh KK, 2008, NAT NEUROSCI, V11, P649, DOI 10.1038/nn.2114; SMITHSWINTOSKY VL, 1994, J NEUROCHEM, V63, P781, DOI 10.1046/j.1471-4159.1994.63020781.x; Sokol DK, 2006, J CHILD NEUROL, V21, P444, DOI 10.1177/08830738060210062201; Song WH, 1998, GENE, V217, P165, DOI 10.1016/S0378-1119(98)00340-0; Tadevosyan-Leyfer O, 2003, J AM ACAD CHILD PSY, V42, P864, DOI 10.1097/01.CHI.0000046870.56865.90; Taylor CJ, 2008, NEUROBIOL DIS, V31, P250, DOI 10.1016/j.nbd.2008.04.011; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Toro R, 2010, TRENDS GENET, V26, P363, DOI 10.1016/j.tig.2010.05.007; Tsai SJ, 2005, MED HYPOTHESES, V65, P79, DOI 10.1016/j.mehy.2005.01.034; Turner PR, 2003, PROG NEUROBIOL, V70, P1, DOI 10.1016/S0301-0082(03)00089-3; Verhoeven JS, 2010, NEURORADIOLOGY, V52, P3, DOI 10.1007/s00234-009-0583-y; Vilardo E, 2010, J BIOL CHEM, V285, P18344, DOI 10.1074/jbc.M110.112664; Villa A, 2001, J NEUROCHEM, V77, P1077, DOI 10.1046/j.1471-4159.2001.00315.x; Wechsler D, 1974, WECHSLER INTELLIGENC; Weiler IJ, 2004, P NATL ACAD SCI USA, V101, P17504, DOI 10.1073/pnas.0407533101; Westmark CJ, 2007, PLOS BIOL, V5, P629, DOI 10.1371/journal.pbio.0050052; Westmark PR, 2006, NEUROBIOL AGING, V27, P787, DOI 10.1016/j.neurobiolaging.2006.03.003; Young-Pearse TL, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-15; ZAIDI SHE, 1994, J BIOL CHEM, V269, P24000; ZAIDI SHE, 1994, J BIOL CHEM, V269, P24007; Zalfa F, 2003, CELL, V112, P317, DOI 10.1016/S0092-8674(03)00079-5	95	86	90	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e20405	10.1371/journal.pone.0020405	http://dx.doi.org/10.1371/journal.pone.0020405			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731612	gold, Green Published, Green Submitted			2022-12-27	WOS:000292033700007
J	Sena, G; Frentz, Z; Birnbaum, KD; Leibler, S				Sena, Giovanni; Frentz, Zak; Birnbaum, Kenneth D.; Leibler, Stanislas			Quantitation of Cellular Dynamics in Growing Arabidopsis Roots with Light Sheet Microscopy	PLOS ONE			English	Article							RECONSTRUCTION; TRACKING	To understand dynamic developmental processes, living tissues have to be imaged frequently and for extended periods of time. Root development is extensively studied at cellular resolution to understand basic mechanisms underlying pattern formation and maintenance in plants. Unfortunately, ensuring continuous specimen access, while preserving physiological conditions and preventing photo-damage, poses major barriers to measurements of cellular dynamics in growing organs such as plant roots. We present a system that integrates optical sectioning through light sheet fluorescence microscopy with hydroponic culture that enables us to image, at cellular resolution, a vertically growing Arabidopsis root every few minutes and for several consecutive days. We describe novel automated routines to track the root tip as it grows, to track cellular nuclei and to identify cell divisions. We demonstrate the system's capabilities by collecting data on divisions and nuclear dynamics.	[Sena, Giovanni; Birnbaum, Kenneth D.] NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA; [Frentz, Zak; Leibler, Stanislas] Rockefeller Univ, Lab Living Matter, New York, NY 10021 USA; [Leibler, Stanislas] Inst Adv Study, Simons Ctr Syst Biol, Princeton, NJ 08540 USA; [Leibler, Stanislas] Inst Adv Study, Sch Nat Sci, Princeton, NJ 08540 USA	New York University; Rockefeller University; Institute for Advanced Study - USA; Institute for Advanced Study - USA	Sena, G (corresponding author), NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA.	senag@nyu.edu	Sena, Giovanni/C-3297-2012	Sena, Giovanni/0000-0003-3626-5038	National Institutes of Health [R01 GM078279]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078279] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	K.D.B. is supported by a grant from the National Institutes of Health (R01 GM078279; http://grants.nih.gov/grants/oer.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baskin TI, 2000, PLANT MOL BIOL, V43, P545, DOI 10.1023/A:1006383921517; Boisnard-Lorig C, 2001, PLANT CELL, V13, P495, DOI 10.1105/tpc.13.3.495; Campilho A, 2006, PLANT J, V48, P619, DOI 10.1111/j.1365-313X.2006.02892.x; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chickarmane V, 2010, ANNU REV PLANT BIOL, V61, P65, DOI 10.1146/annurev-arplant-042809-112213; Dzyubachyk O, 2007, I S BIOMED IMAGING, P97, DOI 10.1109/ISBI.2007.356797; Fernandez R, 2010, NAT METHODS, V7, P547, DOI [10.1038/nmeth.1472, 10.1038/NMETH.1472]; Frigo M, 2005, P IEEE, V93, P216, DOI 10.1109/JPROC.2004.840301; Fuchs E, 2002, OPT EXPRESS, V10, P145, DOI 10.1364/OE.10.000145; GOR V, 2005, IEEE COMP SOC C COMP; Holekamp TF, 2008, NEURON, V57, P661, DOI 10.1016/j.neuron.2008.01.011; HOLMES TJ, 1988, J OPT SOC AM A, V5, P666, DOI 10.1364/JOSAA.5.000666; Huisken J, 2004, SCIENCE, V305, P1007, DOI 10.1126/science.1100035; Karp R.M., 1972, REDUCIBILITY COMBINA, P85, DOI DOI 10.1007/978-1-4684-2001-29; Keller PJ, 2008, SCIENCE, V322, P1065, DOI 10.1126/science.1162493; Keller PJ, 2010, NAT METHODS, V7, P637, DOI [10.1038/NMETH.1476, 10.1038/nmeth.1476]; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Li K, 2008, MED IMAGE ANAL, V12, P546, DOI 10.1016/j.media.2008.06.001; Liu M, 2010, PLANT J, V62, P135, DOI 10.1111/j.1365-313X.2009.04117.x; Lucas Bruce D, 1981, P 7 INT JOINT C ART, DOI DOI 10.1042/CS0730285; Malamy JE, 1997, DEVELOPMENT, V124, P33; Marshall WF, 1997, CURR BIOL, V7, P930, DOI 10.1016/S0960-9822(06)00412-X; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; PAWLEY JB, 2006, HDB BIOL CONFOCAL MI, P985; Pawley JB, 2006, HDB BIOL CONFOCAL MI, p[xxviii, 985]; Petricka JJ, 2008, CURR OPIN GENET DEV, V18, P354, DOI 10.1016/j.gde.2008.05.001; Sena G, 2009, NATURE, V457, P1150, DOI 10.1038/nature07597; Verveer PJ, 2007, NAT METHODS, V4, P311, DOI 10.1038/NMETH1017	28	60	60	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21303	10.1371/journal.pone.0021303	http://dx.doi.org/10.1371/journal.pone.0021303			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731697	Green Published, Green Submitted, gold			2022-12-27	WOS:000292033700059
J	Shoji, M; Sato, K; Yukitake, H; Kondo, Y; Narita, Y; Kadowaki, T; Naito, M; Nakayama, K				Shoji, Mikio; Sato, Keiko; Yukitake, Hideharu; Kondo, Yoshio; Narita, Yuka; Kadowaki, Tomoko; Naito, Mariko; Nakayama, Koji			Por Secretion System-Dependent Secretion and Glycosylation of Porphyromonas gingivalis Hemin-Binding Protein 35	PLOS ONE			English	Article							POLYCYSTIC KIDNEY-DISEASE; GRAM-NEGATIVE BACTERIA; OUTER-MEMBRANE PROTEIN; C-TERMINAL-DOMAIN; ESCHERICHIA-COLI; STRUCTURAL-ANALYSIS; BIOFILM FORMATION; LIPOPOLYSACCHARIDE; GINGIPAINS; MUTANTS	The anaerobic Gram-negative bacterium Porphyromonas gingivalis is a major pathogen in severe forms of periodontal disease and refractory periapical perodontitis. We have recently found that P. gingivalis has a novel secretion system named the Por secretion system (PorSS), which is responsible for secretion of major extracellular proteinases, Arg-gingipains (Rgps) and Lys-gingipain. These proteinases contain conserved C-terminal domains (CTDs) in their C-termini. Hemin-binding protein 35 (HBP35), which is one of the outer membrane proteins of P. gingivalis and contributes to its haem utilization, also contains a CTD, suggesting that HBP35 is translocated to the cell surface via the PorSS. In this study, immunoblot analysis of P. gingivalis mutants deficient in the PorSS or in the biosynthesis of anionic polysaccharide-lipopolysaccharide (A-LPS) revealed that HBP35 is translocated to the cell surface via the PorSS and is glycosylated with A-LPS. From deletion analysis with a GFP-CTD[ HBP35] green fluorescent protein fusion, the C-terminal 22 amino acid residues of CTD[HBP35] were found to be required for cell surface translocation and glycosylation. The GFP-CTD fusion study also revealed that the CTDs of CPG70, peptidylarginine deiminase, P27 and RgpB play roles in PorSS-dependent translocation and glycosylation. However, CTD-region peptides were not found in samples of glycosylated HBP35 protein by peptide map fingerprinting analysis, and antibodies against CTD-regions peptides did not react with glycosylated HBP35 protein. These results suggest both that the CTD region functions as a recognition signal for the PorSS and that glycosylation of CTD proteins occurs after removal of the CTD region. Rabbits were used for making antisera against bacterial proteins in this study.	[Shoji, Mikio; Sato, Keiko; Yukitake, Hideharu; Narita, Yuka; Kadowaki, Tomoko; Naito, Mariko; Nakayama, Koji] Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Microbiol & Immunol, Div Microbiol & Oral Infect, Nagasaki 852, Japan; [Kondo, Yoshio] Nagasaki Univ, Grad Sch Biomed Sci, Dept Pediat Dent, Nagasaki 852, Japan; [Nakayama, Koji] Nagasaki Univ, Global COE Program, Nagasaki 852, Japan	Nagasaki University; Nagasaki University; Nagasaki University	Shoji, M (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Microbiol & Immunol, Div Microbiol & Oral Infect, Nagasaki 852, Japan.	knak@nagasaki-u.ac.jp	Shoji, Mikio/J-8283-2018	Shoji, Mikio/0000-0002-7605-4721; NAITO, Mariko/0000-0003-0769-7747	Ministry of Education, Science, Sports, Culture, and Technology, Japan [20249073, 20791341]; Nagasaki University; Nagasaki University, Japan; Grants-in-Aid for Scientific Research [21592364] Funding Source: KAKEN	Ministry of Education, Science, Sports, Culture, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Nagasaki University; Nagasaki University, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid (20249073 and 20791341 to KN and MS, respectively) for scientific research from the Ministry of Education, Science, Sports, Culture, and Technology, Japan; by the Global COE Program at Nagasaki University to KN; and in part by the president's discretionary fund of Nagasaki University, Japan to MS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABIKO Y, 1990, ARCH ORAL BIOL, V35, P689, DOI 10.1016/0003-9969(90)90091-N; Aduse-Opoku J, 2006, INFECT IMMUN, V74, P449, DOI 10.1128/IAI.74.1.449-460.2006; Chen YY, 2011, MOL MICROBIOL, V79, P1380, DOI 10.1111/j.1365-2958.2010.07530.x; Chen YY, 2002, J BIOL CHEM, V277, P23433, DOI 10.1074/jbc.M200811200; Curtis MA, 1999, INFECT IMMUN, V67, P3816, DOI 10.1128/IAI.67.8.3816-3823.1999; Delgado-Partin VM, 1998, J BIOL CHEM, V273, P9927, DOI 10.1074/jbc.273.16.9927; Demmer RT, 2006, J AM DENT ASSOC, V137, p14S, DOI 10.14219/jada.archive.2006.0402; Feldman MF, 2005, P NATL ACAD SCI USA, V102, P3016, DOI 10.1073/pnas.0500044102; Fletcher CM, 2009, CELL, V137, P321, DOI 10.1016/j.cell.2009.02.041; Genco CA, 1999, CLIN INFECT DIS, V28, P456, DOI 10.1086/515156; GLUCKSMANNKUIS MA, 1995, CELL, V81, P289; Hug I, 2011, GLYCOBIOLOGY, V21, P138, DOI 10.1093/glycob/cwq148; Ishiguro I, 2009, FEMS MICROBIOL LETT, V292, P261, DOI 10.1111/j.1574-6968.2009.01489.x; Ito K, 2006, J MOL BIOL, V362, P228, DOI 10.1016/j.jmb.2006.06.083; Kondo Y, 2010, INFECT IMMUN, V78, P2846, DOI 10.1128/IAI.01448-09; Lepine G, 1996, INFECT IMMUN, V64, P1467; LEPINE G, 1995, ORAL MICROBIOL IMMUN, V10, P1, DOI 10.1111/j.1399-302X.1995.tb00110.x; Lundberg K, 2010, NAT REV RHEUMATOL, V6, P727, DOI 10.1038/nrrheum.2010.139; MULVEY MR, 1988, GENE, V73, P337, DOI 10.1016/0378-1119(88)90498-2; Nagano K, 2007, J MED MICROBIOL, V56, P1536, DOI 10.1099/jmm.0.47289-0; Nakao R, 2008, BIOCHEM BIOPH RES CO, V365, P784, DOI 10.1016/j.bbrc.2007.11.035; Nguyen KA, 2007, J BACTERIOL, V189, P833, DOI 10.1128/JB.01530-06; Paramonov N, 2005, MOL MICROBIOL, V58, P847, DOI 10.1111/j.1365-2958.2005.04871.x; Paramonov NA, 2009, J BACTERIOL, V191, P5272, DOI 10.1128/JB.00019-09; Rangarajan M, 2008, J BACTERIOL, V190, P2920, DOI 10.1128/JB.01868-07; Saiki K, 2007, MICROBIOL IMMUNOL, V51, P483, DOI 10.1111/j.1348-0421.2007.tb03936.x; Saito S, 1997, GEN PHARMACOL, V28, P675, DOI 10.1016/S0306-3623(96)00366-7; Sato K, 2005, J BIOL CHEM, V280, P8668, DOI 10.1074/jbc.M413544200; Sato K, 2010, P NATL ACAD SCI USA, V107, P276, DOI 10.1073/pnas.0912010107; Sato K, 2009, MICROBIOL-SGM, V155, P1282, DOI 10.1099/mic.0.025163-0; Seers CA, 2006, J BACTERIOL, V188, P6376, DOI 10.1128/JB.00731-06; Shi Y, 1999, J BIOL CHEM, V274, P17955, DOI 10.1074/jbc.274.25.17955; Shoji M, 2004, MOL MICROBIOL, V52, P1513, DOI 10.1111/j.1365-2958.2004.04105.x; Shoji M, 2002, MICROBIOL-SGM, V148, P1183, DOI 10.1099/00221287-148-4-1183; Shoji M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-152; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Slakeski N, 2011, J BACTERIOL, V193, P132, DOI 10.1128/JB.00773-10; Slaney JM, 2006, INFECT IMMUN, V74, P5352, DOI 10.1128/IAI.00304-06; Vanterpool E, 2005, INFECT IMMUN, V73, P3971, DOI 10.1128/IAI.73.7.3971-3982.2005; Vanterpool E, 2005, INFECT IMMUN, V73, P1357, DOI 10.1128/IAI.73.3.1357-1366.2005; Veith PD, 2009, J PROTEOME RES, V8, P4279, DOI 10.1021/pr900372c; Veith PD, 2002, BIOCHEM J, V363, P105, DOI 10.1042/0264-6021:3630105; Wegner N, 2010, ARTHRITIS RHEUM-US, V62, P2662, DOI 10.1002/art.27552; Yamaguchi M, 2010, INFECT IMMUN, V78, P3801, DOI 10.1128/IAI.00071-10; Zeituni AE, 2010, J BACTERIOL, V192, P4103, DOI 10.1128/JB.00275-10	45	108	110	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21372	10.1371/journal.pone.0021372	http://dx.doi.org/10.1371/journal.pone.0021372			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731719	gold, Green Published, Green Submitted			2022-12-27	WOS:000292033700068
J	Schmutz, I; Wendt, S; Schnell, A; Kramer, A; Mansuy, IM; Albrecht, U				Schmutz, Isabelle; Wendt, Sabrina; Schnell, Anna; Kramer, Achim; Mansuy, Isabelle M.; Albrecht, Urs			Protein Phosphatase 1 (PP1) Is a Post-Translational Regulator of the Mammalian Circadian Clock	PLOS ONE			English	Article							SUPRACHIASMATIC NUCLEUS; GENE-EXPRESSION; PHASE-SHIFTS; MPER2; LIGHT; PHOSPHORYLATION; COMPONENT; CREB; TRANSCRIPTION; MUTATION	Circadian clocks coordinate the timing of important biological processes. Interconnected transcriptional and post-translational feedback loops based on a set of clock genes generate and maintain these rhythms with a period of about 24 hours. Many clock proteins undergo circadian cycles of post-translational modifications. Among these modifications, protein phosphorylation plays an important role in regulating activity, stability and intracellular localization of clock components. Several protein kinases were characterized as regulators of the circadian clock. However, the function of protein phosphatases, which balance phosphorylation events, in the mammalian clock mechanism is less well understood. Here, we identify protein phosphatase 1 (PP1) as regulator of period and light-induced resetting of the mammalian circadian clock. Down-regulation of PP1 activity in cells by RNA interference and in vivo by expression of a specific inhibitor in the brain of mice tended to lengthen circadian period. Moreover, reduction of PP1 activity in the brain altered light-mediated clock resetting behavior in mice, enhancing the phase shifts in either direction. At the molecular level, diminished PP1 activity increased nuclear accumulation of the clock component PER2 in neurons. Hence, PP1, may reduce PER2 phosphorylation thereby influencing nuclear localization of this protein. This may at least partially influence period and phase shifting properties of the mammalian circadian clock.	[Schmutz, Isabelle; Schnell, Anna; Albrecht, Urs] Univ Fribourg, Biochem Unit, Dept Biol, CH-1700 Fribourg, Switzerland; [Wendt, Sabrina; Kramer, Achim] Charite, Lab Chronobiol, D-13353 Berlin, Germany; [Mansuy, Isabelle M.] Univ Zurich, Fac Med, Brain Res Inst, Zurich, Switzerland; [Mansuy, Isabelle M.] Swiss Fed Inst Technol, Dept Biol, Zurich, Switzerland	University of Fribourg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Geneva; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Schmutz, I (corresponding author), Univ Fribourg, Biochem Unit, Dept Biol, CH-1700 Fribourg, Switzerland.	urs.albrecht@unifr.ch	Albrecht, Urs/A-9831-2011; Mansuy, Isabelle M/N-3042-2015	Albrecht, Urs/0000-0002-0663-8676; Mansuy, Isabelle M/0000-0001-7785-5371; Kramer, Achim/0000-0001-9671-6078; Schnell, Anna/0000-0002-3943-598X	Swiss National Science Foundation; Japanese-Swiss ST programme; European Union; Deutsche Forschungsgemeinschaft [SFB740/D2]; states of Fribourg and Zurich (Switzerland)	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Japanese-Swiss ST programme; European Union(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); states of Fribourg and Zurich (Switzerland)	This work was supported by the Swiss National Science Foundation, the Japanese-Swiss S&T programme, the European Union FP6 Integrated Project EUCLOCK, the Deutsche Forschungsgemeinschaft (SFB740/D2) and the states of Fribourg and Zurich (Switzerland). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama M, 2001, J NEUROCHEM, V78, P499, DOI 10.1046/j.1471-4159.2001.00452.x; ALBERTS AS, 1994, MOL CELL BIOL, V14, P4398, DOI 10.1128/MCB.14.7.4398; Albrecht U, 2001, J BIOL RHYTHM, V16, P100, DOI 10.1177/074873001129001791; Albrecht U, 2007, COLD SPRING HARB SYM, V72, P95, DOI 10.1101/sqb.2007.72.001; Albrecht U, 1997, CELL, V91, P1055, DOI 10.1016/S0092-8674(00)80495-X; ALVAREZSAAVEDRA M, 2010, HUM MOL GENET; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Camacho F, 2001, FEBS LETT, V489, P159, DOI 10.1016/S0014-5793(00)02434-0; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Cohen PTW, 2002, J CELL SCI, V115, P241; Comolli J, 1996, PLANT PHYSIOL, V111, P285, DOI 10.1104/pp.111.1.285; DeBruyne JP, 2007, NAT NEUROSCI, V10, P543, DOI 10.1038/nn1884; Eide EJ, 2005, MOL CELL BIOL, V25, P2795, DOI 10.1128/MCB.25.7.2795-2807.2005; Fang YS, 2007, GENE DEV, V21, P1506, DOI 10.1101/gad.1541607; FOULKES JG, 1983, EUR J BIOCHEM, V132, P309, DOI 10.1111/j.1432-1033.1983.tb07363.x; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Gallego M, 2006, BIOCHEM J, V399, P169, DOI 10.1042/BJ20060678; Gau D, 2002, NEURON, V34, P245, DOI 10.1016/S0896-6273(02)00656-6; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Genoux D, 2002, NATURE, V418, P970, DOI 10.1038/nature00928; GINTY DD, 1993, SCIENCE, V260, P238, DOI 10.1126/science.8097062; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Hirota T, 2004, ZOOL SCI, V21, P359, DOI 10.2108/zsj.21.359; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; JAINCHIL.JL, 1969, J VIROL, V4, P549, DOI 10.1128/JVI.4.5.549-553.1969; Jakubcakova V, 2007, NEURON, V54, P831, DOI 10.1016/j.neuron.2007.04.031; Jud C, 2005, BIOL PROCED ONLINE, V7, P101, DOI 10.1251/bpo109; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; KLEE WA, 1974, P NATL ACAD SCI USA, V71, P3474, DOI 10.1073/pnas.71.9.3474; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Koshibu K, 2009, J NEUROSCI, V29, P13079, DOI 10.1523/JNEUROSCI.3610-09.2009; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; LAVERY DJ, 1993, GENE DEV, V7, P1871, DOI 10.1101/gad.7.10.1871; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maier B, 2009, GENE DEV, V23, P708, DOI 10.1101/gad.512209; Masubuchi S, 2010, P NATL ACAD SCI USA, V107, P1642, DOI 10.1073/pnas.0910292107; Meng QJ, 2008, NEURON, V58, P78, DOI 10.1016/j.neuron.2008.01.019; Michalon A, 2005, GENESIS, V43, P205, DOI 10.1002/gene.20175; Motzkus D, 2000, FEBS LETT, V486, P315, DOI 10.1016/S0014-5793(00)02315-2; Oster H, 2003, CURR BIOL, V13, P725, DOI 10.1016/S0960-9822(03)00252-5; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Reick M, 2001, SCIENCE, V293, P506, DOI 10.1126/science.1060699; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Ripperger JA, 2000, GENE DEV, V14, P679; Ripperger JA, 2010, PROTEIN REV, V12, P37, DOI 10.1007/978-1-4419-1262-6_2; Sathyanarayanan S, 2004, CELL, V116, P603, DOI 10.1016/S0092-8674(04)00128-X; Schmutz I, 2010, GENE DEV, V24, P345, DOI 10.1101/gad.564110; Tischkau SA, 2003, J BIOL CHEM, V278, P718, DOI 10.1074/jbc.M209241200; Toh KL, 2001, SCIENCE, V291, P1040, DOI 10.1126/science.1057499; Travnickova-Bendova Z, 2002, P NATL ACAD SCI USA, V99, P7728, DOI 10.1073/pnas.102075599; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; VANSELOW JT, 2010, CIRCADIAN CLOCK; Vanselow K, 2006, GENE DEV, V20, P2660, DOI 10.1101/gad.397006; Vielhaber E, 2000, MOL CELL BIOL, V20, P4888, DOI 10.1128/MCB.20.13.4888-4899.2000; Wakamatsu H, 2001, NEUROREPORT, V12, P127, DOI 10.1097/00001756-200101220-00033; Xu Y, 2007, CELL, V128, P59, DOI 10.1016/j.cell.2006.11.043; Yagita K, 2002, EMBO J, V21, P1301, DOI 10.1093/emboj/21.6.1301; Yan L, 2006, J NEUROSCI, V26, P9434, DOI 10.1523/JNEUROSCI.2538-06.2006; Yang YH, 2004, GENE DEV, V18, P255, DOI 10.1101/gad.1152604; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118	63	28	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2011	6	6							e21325	10.1371/journal.pone.0021325	http://dx.doi.org/10.1371/journal.pone.0021325			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782CL	21712997	gold, Green Published, Green Accepted			2022-12-27	WOS:000291985100029
J	Breen, L; Philp, A; Shaw, CS; Jeukendrup, AE; Baar, K; Tipton, KD				Breen, Leigh; Philp, Andrew; Shaw, Christopher S.; Jeukendrup, Asker E.; Baar, Keith; Tipton, Kevin D.			Beneficial Effects of Resistance Exercise on Glycemic Control Are Not Further Improved by Protein Ingestion	PLOS ONE			English	Article							MUSCLE GLYCOGEN-SYNTHESIS; PLASMA-INSULIN RESPONSES; SKELETAL-MUSCLE; GLUCOSE-TOLERANCE; AMINO-ACID; AS160 PHOSPHORYLATION; CO-INGESTION; SENSITIVITY; CARBOHYDRATE; INCREASES	Purpose: To investigate the mechanisms underpinning modifications in glucose homeostasis and insulin sensitivity 24 h after a bout of resistance exercise (RE) with or without protein ingestion. Methods: Twenty-four healthy males were assigned to a control (CON; n = 8), exercise (EX; n = 8) or exercise plus protein condition (EX+PRO; n = 8). Muscle biopsy and blood samples were obtained at rest for all groups and immediately post-RE (75% 1RM, 8610 repetitions of leg-press and extension exercise) for EX and EX+PRO only. At 24 h post-RE (or post-resting biopsy for CON), a further muscle biopsy was obtained. Participants then consumed an oral glucose load (OGTT) containing 2 g of [U-C-13] glucose during an infusion of 6, 6-[H-2(2)] glucose. Blood samples were obtained every 10 min for 2 h to determine glucose kinetics. EX+PRO ingested an additional 25 g of intact whey protein with the OGTT. A final biopsy sample was obtained at the end of the OGTT. Results: Fasted plasma glucose and insulin were similar for all groups and were not different immediately post- and 24 h post-RE. Following RE, muscle glycogen was 266 +/- 8 and 19 +/- 6% lower in EX and EX+PRO, respectively. During OGTT, plasma glucose AUC was lower for EX and EX+PRO (75.1 +/- 2.7 and 75.3 +/- 2.8 mmol.L-1:120 min, respectively) compared with CON (90.6 +/- 4.1 mmol.L-1:120 min). Plasma insulin response was 13 +/- 2 and 21 +/- 4% lower for EX and CON, respectively, compared with EX+PRO. Glucose disappearance from the circulation was similar to 12% greater in EX and EX+PRO compared with CON. Basal 24 h post-RE and insulin-stimulated PAS-AS160/TBC1D4 phosphorylation was greater for EX and EX+PRO. Conclusions: Prior RE improves glycemic control and insulin sensitivity through an increase in the rate at which glucose is disposed from the circulation. However, co-ingesting protein during a high-glucose load does not augment this response at 24 h post-exercise in healthy, insulin-sensitive individuals.	[Breen, Leigh; Shaw, Christopher S.; Jeukendrup, Asker E.; Tipton, Kevin D.] Univ Birmingham, Sch Sport & Exercise Sci, Birmingham, W Midlands, England; [Breen, Leigh] McMaster Univ, Dept Kinesiol, Hamilton, ON, Canada; [Philp, Andrew; Baar, Keith] Univ Calif Davis, Funct Mol Biol Lab, Davis, CA 95616 USA; [Tipton, Kevin D.] Univ Stirling, Dept Sports Studies, Stirling FK9 4LA, Scotland	University of Birmingham; McMaster University; University of California System; University of California Davis; University of Stirling	Breen, L (corresponding author), Univ Birmingham, Sch Sport & Exercise Sci, Birmingham, W Midlands, England.	k.d.tipton@stir.ac.uk	Breen, Leigh/AAO-7302-2021	Breen, Leigh/0000-0001-6669-4816; Shaw, Christopher/0000-0003-1499-0220; Philp, Andrew/0000-0003-3860-4136; Tipton, Kevin/0000-0002-6545-8122	The Insulin Dependent Diabetes Trust, UK	The Insulin Dependent Diabetes Trust, UK	Funding was provided by The Insulin Dependent Diabetes Trust, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias EB, 2007, AM J PHYSIOL-ENDOC M, V292, pE1191, DOI 10.1152/ajpendo.00602.2006; Beeson M, 2003, DIABETES, V52, P1926, DOI 10.2337/diabetes.52.8.1926; Black LE, 2010, J STRENGTH COND RES, V24, P1109, DOI 10.1519/JSC.0b013e3181cbab6d; Bouskila M, 2008, AM J PHYSIOL-ENDOC M, V294, pE28, DOI 10.1152/ajpendo.00481.2007; Chapman J, 2002, MED SCI SPORT EXER, V34, P936, DOI 10.1097/00005768-200206000-00005; Colberg SR, 2010, MED SCI SPORT EXER, V42, P2282, DOI 10.1249/MSS.0b013e3181eeb61c; Cusi K, 2000, J CLIN INVEST, V105, P311, DOI 10.1172/JCI7535; DeFronzo R A, 1983, Am J Med, V74, P52, DOI 10.1016/0002-9343(83)90654-X; DEFRONZO RA, 1981, DIABETES, V30, P1000, DOI 10.2337/diab.30.12.1000; DeFronzo RA, 2009, DIABETES, V58, P773, DOI 10.2337/db09-9028; DEVLIN JT, 1985, DIABETES, V34, P973, DOI 10.2337/diabetes.34.10.973; DEVLIN JT, 1987, DIABETES, V36, P434, DOI 10.2337/diabetes.36.4.434; Dreyer HC, 2008, J APPL PHYSIOL, V105, P1967, DOI 10.1152/japplphysiol.90562.2008; Eriksson KF, 1996, DIABETOLOGIA, V39, P573, DOI 10.1007/BF00403304; Fenicchia LM, 2004, METABOLISM, V53, P284, DOI 10.1016/j.metabol.2003.10.007; FLUCKEY JD, 1994, J APPL PHYSIOL, V77, P1087, DOI 10.1152/jappl.1994.77.3.1087; Funai K, 2009, AM J PHYSIOL-ENDOC M, V297, pE242, DOI 10.1152/ajpendo.00194.2009; Goodyear LJ, 1998, ANNU REV MED, V49, P235, DOI 10.1146/annurev.med.49.1.235; Hamada T, 2006, J APPL PHYSIOL, V101, P1368, DOI 10.1152/japplphysiol.00416.2006; Howlett KF, 2008, AM J PHYSIOL-ENDOC M, V294, pE401, DOI 10.1152/ajpendo.00542.2007; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; Jeukendrup AE, 1999, J PHYSIOL-LONDON, V515, P579, DOI 10.1111/j.1469-7793.1999.579ac.x; Jonsson B, 2002, DIABETOLOGIA, V45, pS5, DOI 10.1007/s00125-002-0858-x; Kennedy JW, 1999, DIABETES, V48, P1192, DOI 10.2337/diabetes.48.5.1192; Kim YB, 2003, DIABETES, V52, P1935, DOI 10.2337/diabetes.52.8.1935; Koopman R, 2005, EUR J APPL PHYSIOL, V94, P180, DOI 10.1007/s00421-004-1307-y; Kramer HF, 2006, DIABETES, V55, P2067, DOI 10.2337/db06-0150; Luebbers PE, 2008, J STRENGTH COND RES, V22, P1094, DOI 10.1519/JSC.0b013e31816d456f; Manders RJ, 2006, J NUTR, V136, P1294, DOI 10.1093/jn/136.5.1294; Manders RJF, 2005, AM J CLIN NUTR, V82, P76, DOI 10.1093/ajcn/82.1.76; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; MAYHEW JL, 1995, J SPORT MED PHYS FIT, V35, P108; MIKINES KJ, 1988, AM J PHYSIOL, V254, pE248, DOI 10.1152/ajpendo.1988.254.3.E248; Mokdad AH, 2001, JAMA-J AM MED ASSOC, V286, P1195, DOI 10.1001/jama.286.10.1195; Moore DR, 2009, J PHYSIOL-LONDON, V587, P897, DOI 10.1113/jphysiol.2008.164087; NUTTALL FQ, 1991, DIABETES CARE, V14, P824, DOI 10.2337/diacare.14.9.824; NUTTALL FQ, 1984, DIABETES CARE, V7, P465, DOI 10.2337/diacare.7.5.465; PALLOTTA JA, 1968, METABOLISM, V17, P901, DOI 10.1016/0026-0495(68)90156-X; Perseghin G, 1996, NEW ENGL J MED, V335, P1357, DOI 10.1056/NEJM199610313351804; Proietto J, 1990, Horm Metab Res Suppl, V24, P25; SHULMAN GI, 1990, NEW ENGL J MED, V322, P223, DOI 10.1056/NEJM199001253220403; STEELE R, 1959, ANN NY ACAD SCI, V82, P420, DOI 10.1111/j.1749-6632.1959.tb44923.x; Taylor EB, 2008, J BIOL CHEM, V283, P9787, DOI 10.1074/jbc.M708839200; Tipton KD, 1999, AM J PHYSIOL-ENDOC M, V276, pE628, DOI 10.1152/ajpendo.1999.276.4.E628; van Loon LJC, 2000, J NUTR, V130, P2508, DOI 10.1093/jn/130.10.2508; van Loon LJC, 2000, AM J CLIN NUTR, V72, P96; van Loon LJC, 2003, DIABETES CARE, V26, P625, DOI 10.2337/diacare.26.3.625; Venables MC, 2007, EUR J APPL PHYSIOL, V100, P711, DOI 10.1007/s00421-007-0464-1; Vind BF, 2011, DIABETOLOGIA, V54, P157, DOI 10.1007/s00125-010-1924-4; Wolfe RR, 1992, RADIOACTIVE STABLE I; ZAWADZKI KM, 1992, J APPL PHYSIOL, V72, P1854, DOI 10.1152/jappl.1992.72.5.1854; Zierath JR, 1996, DIABETOLOGIA, V39, P1180, DOI 10.1007/BF02658504	53	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e20613	10.1371/journal.pone.0020613	http://dx.doi.org/10.1371/journal.pone.0020613			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	21701685	Green Published, gold, Green Accepted			2022-12-27	WOS:000291983800007
J	Iguchi, A; Shinzato, C; Foret, S; Miller, DJ				Iguchi, Akira; Shinzato, Chuya; Foret, Sylvain; Miller, David J.			Identification of Fast-Evolving Genes in the Scleractinian Coral Acropora Using Comparative EST Analysis	PLOS ONE			English	Article							POSITIVE SELECTION; EVOLUTIONARY HISTORY; ADAPTIVE EVOLUTION; BINDING LECTIN; RECOGNITION; PATHOGENS; ALIGNMENT; IMMUNITY; PATTERN	To identify fast-evolving genes in reef-building corals, we performed direct comparative sequence analysis with expressed sequence tag (EST) datasets from two acroporid species: Acropora palmata from the Caribbean Sea and A. millepora from the Great Barrier Reef in Australia. Comparison of 589 independent sequences from 1,421 A. palmata contigs, with 10,247 A. millepora contigs resulted in the identification of 196 putative homologues. Most of the homologous pairs demonstrated high amino acid similarities (over 90%). Comparisons of putative homologues showing low amino acid similarities (under 90%) among the Acropora species to the near complete datasets from two other cnidarians (Hydra magnipapillata and Nematostella vectensis) implied that some were non-orthologous. Within 86 homologous pairs, 39 exhibited dN/dS ratios significantly less than 1, suggesting that these genes are under purifying selection associated with functional constraints. Eight independent genes showed dN/dS ratios exceeding 1, while three deviated significantly from 1, suggesting that these genes may play important roles in the adaptive evolution of Acropora. Our results also indicated that CEL-III lectin was under positive selection, consistent with a possible role in immunity or symbiont recognition. Further studies are needed to clarify the possible functions of the genes under positive selection to provide insight into the evolutionary process of corals.	[Iguchi, Akira] Univ Ryukyus, Trop Biosphere Res Ctr, Sesoko Stn, Okinawa, Japan; [Shinzato, Chuya] Okinawa Inst Sci & Technol, Okinawa, Japan; [Foret, Sylvain; Miller, David J.] James Cook Univ, Sch Pharm & Mol Sci, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Foret, Sylvain; Miller, David J.] James Cook Univ, Sch Pharm & Mol Sci, Coral Genom Grp, Townsville, Qld 4811, Australia	University of the Ryukyus; Okinawa Institute of Science & Technology Graduate University; James Cook University; James Cook University	Iguchi, A (corresponding author), Univ Ryukyus, Trop Biosphere Res Ctr, Sesoko Stn, Okinawa, Japan.	iguchi.a0218@gmail.com	Iguchi, Akira/I-3180-2016; Shinzato, Chuya/G-2958-2015; FORET, Sylvain/B-9207-2012	Iguchi, Akira/0000-0002-8894-1977; 	Australian Research Council (ARC) via the Centre of Excellence for Coral Reef Studies; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [20121002, 21121505]; KAKENHI [21710199]; Japan Society for the Promotion of Science (JSPS); Okinawa International Exchange and Human Resources Development Foundation	Australian Research Council (ARC) via the Centre of Excellence for Coral Reef Studies(Australian Research Council); Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Okinawa International Exchange and Human Resources Development Foundation	This study was supported by the Australian Research Council (ARC) directly to DJM via the Centre of Excellence for Coral Reef Studies, Grant-in-Aid for Scientific Research on Innovative Areas "Coral reef science for symbiosis and coexistence of human and ecosystem under combined stresses" (No. 20121002, No. 21121505 to CS) of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, KAKENHI (21710199 to CS), and the Japan Society for the Promotion of Science (JSPS). AI and CS gratefully acknowledge the receipt of a scholarship from the Okinawa International Exchange and Human Resources Development Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Biswas S, 2006, TRENDS GENET, V22, P437, DOI 10.1016/j.tig.2006.06.005; Feder ME, 2003, NAT REV GENET, V4, P651, DOI 10.1038/nrg1128; Field SF, 2006, J MOL EVOL, V62, P332, DOI 10.1007/s00239-005-0129-9; Foret S, 2007, CORAL REEFS, V26, P475, DOI 10.1007/s00338-007-0206-1; Foret S, 2010, TRENDS GENET, V26, P154, DOI 10.1016/j.tig.2010.01.003; Fujita T, 2004, IMMUNOL REV, V198, P185, DOI 10.1111/j.0105-2896.2004.0123.x; Grasso LC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-540; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; HATAKEYAMA T, 1994, J BIOCHEM, V116, P209, DOI 10.1093/oxfordjournals.jbchem.a124495; Hatta M, 1999, MOL BIOL EVOL, V16, P1607, DOI 10.1093/oxfordjournals.molbev.a026073; Hayes ML, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-150; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hughes AL, 2007, HEREDITY, V99, P364, DOI 10.1038/sj.hdy.6801031; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; Jimbo M, 2000, COMP BIOCHEM PHYS B, V125, P227, DOI 10.1016/S0305-0491(99)00173-X; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Khalturin K, 2009, TRENDS GENET, V25, P404, DOI 10.1016/j.tig.2009.07.006; Kortschak RD, 2003, CURR BIOL, V13, P2190, DOI 10.1016/j.cub.2003.11.030; Kvennefors ECE, 2008, DEV COMP IMMUNOL, V32, P1582, DOI 10.1016/j.dci.2008.05.010; Kvennefors ECE, 2010, DEV COMP IMMUNOL, V34, P1219, DOI 10.1016/j.dci.2010.06.016; Lee CE, 2006, MOL ECOL, V15, P1193, DOI 10.1111/j.1365-294X.2006.02945.x; Marquez LM, 2002, MOL ECOL, V11, P1339, DOI 10.1046/j.1365-294X.2002.01526.x; Metz EC, 1996, MOL BIOL EVOL, V13, P397, DOI 10.1093/oxfordjournals.molbev.a025598; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; Palumbi SR, 2009, HEREDITY, V102, P66, DOI 10.1038/hdy.2008.104; Schwarz JA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-97; Swanson WJ, 2003, MOL BIOL EVOL, V20, P18, DOI 10.1093/oxfordjournals.molbev.a004233; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Turner TL, 2005, PLOS BIOL, V3, P1572, DOI 10.1371/journal.pbio.0030285; Uchida T, 2004, J BIOL CHEM, V279, P37133, DOI 10.1074/jbc.M404065200; van Oppen MJH, 2001, MOL BIOL EVOL, V18, P1315, DOI 10.1093/oxfordjournals.molbev.a003916; Veron J.E.N, 2000, CORALS WORLD; Wallace Carden C., 1999, pi; Willis BL, 2006, ANNU REV ECOL EVOL S, V37, P489, DOI 10.1146/annurev.ecolsys.37.091305.110136; Wood-Charlson EM, 2006, CELL MICROBIOL, V8, P1985, DOI 10.1111/j.1462-5822.2006.00765.x; Woolhouse MEJ, 2002, NAT GENET, V32, P569, DOI 10.1038/ng1202-569; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	41	20	20	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e20140	10.1371/journal.pone.0020140	http://dx.doi.org/10.1371/journal.pone.0020140			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	21701682	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000291983800004
J	Pei, NC; Lian, JY; Erickson, DL; Swenson, NG; Kress, WJ; Ye, WH; Ge, XJ				Pei, Nancai; Lian, Ju-Yu; Erickson, David L.; Swenson, Nathan G.; Kress, W. John; Ye, Wan-Hui; Ge, Xue-Jun			Exploring Tree-Habitat Associations in a Chinese Subtropical Forest Plot Using a Molecular Phylogeny Generated from DNA Barcode Loci	PLOS ONE			English	Article							SPATIAL DISTRIBUTIONS; OVERDISPERSION; BIODIVERSITY; COMMUNITIES; DIVERSITY; PATTERNS; SCALE; TRAIT; SIZE	Elucidating the ecological mechanisms underlying community assembly in subtropical forests remains a central challenge for ecologists. The assembly of species into communities can be due to interspecific differences in habitat associations, and there is increasing evidence that these associations may have an underlying phylogenetic structure in contemporary terrestrial communities. In other words, by examining the degree to which closely related species prefer similar habitats and the degree to which they co-occur, ecologists are able to infer the mechanisms underlying community assembly. Here we implement this approach in a diverse subtropical tree community in China using a long-term forest dynamics plot and a molecular phylogeny generated from three DNA barcode loci. We find that there is phylogenetic signal in plant-habitat associations (i.e. closely related species tend to prefer similar habitats) and that patterns of co-occurrence within habitats are typically non-random with respect to phylogeny. In particular, we found phylogenetic clustering in valley and low-slope habitats in this forest, indicating a filtering of lineages plays a dominant role in structuring communities in these habitats and we found evidence of phylogenetic overdispersion in high-slope, ridge-top and high-gully habitats, indicating that distantly related species tended to co-occur in these high elevation habitats and that lineage filtering is less important in structuring these communities. Thus we infer that non-neutral niche-based processes acting upon evolutionarily conserved habitat preferences explain the assembly of local scale communities in the forest studied.	[Pei, Nancai; Lian, Ju-Yu; Ye, Wan-Hui; Ge, Xue-Jun] Chinese Acad Sci, S China Bot Garden, Key Lab Plant Resource Conservat & Sustainable Ut, Guangzhou, Guangdong, Peoples R China; [Pei, Nancai] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Erickson, David L.; Kress, W. John] Smithsonian Inst, Natl Museum Nat Hist, Dept Bot, Washington, DC 20560 USA; [Swenson, Nathan G.] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Smithsonian Institution; Smithsonian National Museum of Natural History; Michigan State University	Pei, NC (corresponding author), Chinese Acad Sci, S China Bot Garden, Key Lab Plant Resource Conservat & Sustainable Ut, Guangzhou, Guangdong, Peoples R China.	why@scbg.ac.cn; xjge@scbg.ac.cn	Swenson, Nathan/A-3514-2012; Ge, Xue-Jun/AAP-5967-2020	Swenson, Nathan/0000-0003-3819-9767; Ge, Xue-Jun/0000-0002-5008-9475	National Basic Research Program of China (973 Program) [2007CB411600]; China National Program for R & D Infrastructure and Facility Development [2008BAC39B02]; Chinese Academy of Sciences [2009-LSF-GBOWS-01, KSCX2-YW-N-0807, KZCX2-YW-430]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); China National Program for R & D Infrastructure and Facility Development; Chinese Academy of Sciences(Chinese Academy of Sciences)	This study was financially supported by National Basic Research Program of China (973 Program) (2007CB411600), China National Program for R & D Infrastructure and Facility Development (2008BAC39B02), the Research Fund for the Large-Scale Scientific Facilities of the Chinese Academy of Sciences (2009-LSF-GBOWS-01), Major Innovation Program of CAS (KSCX2-YW-N-0807) and Key Innovation Project of CAS (KZCX2-YW-430). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Caley MJ, 1997, ECOLOGY, V78, P70; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Diamond J.M., 1975, P342; Doyle J. J., 1987, PHYTOCHEM B, P11; Fazekas AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002802; Gotelli NJ, 2001, OECOLOGIA, V129, P281, DOI 10.1007/s004420100717; Harms KE, 2001, J ECOL, V89, P947, DOI 10.1111/j.1365-2745.2001.00615.x; Horner-Devine MC, 2006, ECOLOGY, V87, pS100, DOI 10.1890/0012-9658(2006)87[100:PCAOIB]2.0.CO;2; Hubbell S.P., 1983, TROPICAL RAIN FOREST, P25; Hubbell Stephen P., 2001, V32, pi; Jabot F, 2009, ECOL LETT, V12, P239, DOI 10.1111/j.1461-0248.2008.01280.x; John R, 2007, P NATL ACAD SCI USA, V104, P864, DOI 10.1073/pnas.0604666104; KALUZNY SP, 1998, S SPATIALSTATS USERS; Kelly CK, 2008, ECOLOGY, V89, P962, DOI 10.1890/07-0322.1; Kembel SW, 2006, ECOLOGY, V87, pS86, DOI 10.1890/0012-9658(2006)87[86:TPSOAN]2.0.CO;2; Kress WJ, 2009, P NATL ACAD SCI USA, V106, P18621, DOI 10.1073/pnas.0909820106; Li L, 2009, OIKOS, V118, P495, DOI 10.1111/j.1600-0706.2009.16753.x; Miller M. A., 2010, CIPRES PORTALS; PARADIS E, 2010, ANAL PHYLOGENETICS E; R Core Team, 2018, R LANG ENV STAT COMP; Rabosky DL, 2007, OECOLOGIA, V154, P561, DOI 10.1007/s00442-007-0849-1; RICKLEFS RE, 1987, SCIENCE, V235, P167, DOI 10.1126/science.235.4785.167; Schreeg LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013685; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Swenson NG, 2007, ECOLOGY, V88, P1770, DOI 10.1890/06-1499.1; Swenson NG, 2007, AM J BOT, V94, P451, DOI 10.3732/ajb.94.3.451; Swenson NG, 2006, ECOLOGY, V87, P2418, DOI 10.1890/0012-9658(2006)87[2418:TPAPOS]2.0.CO;2; Swenson NG, 2011, AM J BOT, V98, P472, DOI 10.3732/ajb.1000289; Swenson NG, 2009, ECOLOGY, V90, P2161, DOI 10.1890/08-1025.1; Swenson NG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004390; Tilman D., 1982, Monographs in Population Biology, pi; Tilman David, 1993, P13; Vamosi SM, 2009, MOL ECOL, V18, P572, DOI 10.1111/j.1365-294X.2008.04001.x; WANG ZG, 2007, THESIS CHINESE ACAD; Wang Z, 2009, BASIC APPL ECOL, V10, P648, DOI 10.1016/j.baae.2009.03.002; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Webb CO, 2000, AM NAT, V156, P145, DOI 10.1086/303378; Weiher E., 1999, ECOLOGICAL ASSEMBLY, DOI DOI 10.1017/CBO9780511542237	41	60	77	3	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e21273	10.1371/journal.pone.0021273	http://dx.doi.org/10.1371/journal.pone.0021273			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	21701680	gold, Green Published, Green Submitted			2022-12-27	WOS:000291983800037
J	Liu, QY; Yao, YM; Yu, Y; Dong, N; Sheng, ZY				Liu, Qing-yang; Yao, Yong-ming; Yu, Yan; Dong, Ning; Sheng, Zhi-yong			Astragalus Polysaccharides Attenuate Postburn Sepsis via Inhibiting Negative Immunoregulation of CD4(+)CD25(high) T Cells	PLOS ONE			English	Article							MEMBRANACEUS; SUPPRESSION; INJURY; MECHANISMS; RECEPTORS; INDUCTION; TREGS	Backgroud: Astragalus polysaccharides (APS) isolated from one of the Chinese herbs, Astragalus mongholicus, are known to have a variety of immunomodulatory activities. However, it is not yet clear whether APS can exert an effect on the immune functions of regulatory T cells (Tregs). This study was carried out to investigate the effect of APS on the immune function of peripheral blood Tregs in postburn sepsis. Methodology/Principal Findings: BalB/c mice were randomly divided into six groups as follows: sham burn group, burn control(burn without infection animals) group, burn plus P. aeruginosa group, burn plus P. aeruginosa with APS (50 mg/kg) treatment group, burn plus P. aeruginosa with APS (100 mg/kg) treatment group, and burn plus P. aeruginosa with APS (200 mg/kg) treatment group, and they were sacrificed on postburn day 1, 3, 5, and 7, respectively, with seven animals at each time point. Magnetic microbeads were used to isolate peripheral blood Tregs and CD4(+) T cells. Phenotypes were analyzed by flow cytometry, and cytokine levels were determined with ELISA. In the burn plus P. aeruginosa group, forkhead/winged helix transcription factor p3 (Foxp3) expression on CD4(+)CD25(+)Tregs were strongly enhanced in comparison to the sham group, and the capacity of CD4(+)CD25(+)Tregs to produce interleukin (IL)-10 was markedly increased. Administration of APS to inhibit CD4(+)CD25(+)Tregs could significantly decrease expression of Foxp3 on CD4(+)CD25(+)Tregs, and IL-10 production in burned mice with P. aeruginosa infection. At the same time, proliferative activity and expression of IL-2 and IL-2R alpha on CD4(+) T cells were restored. In contrast, anti-Toll-like receptor 4 (TLR4) antibody could block the effect of APS on Tregs immune function. Conclusion: APS might suppress CD4(+)CD25(+)Treg activity, at least in part, via binding TLR4 on Tregs and trigger a shift of Th2 to Th1 with activation of CD4(+) T cells in burned mice with P. aeruginosa infection.	[Liu, Qing-yang; Yao, Yong-ming; Yu, Yan; Dong, Ning; Sheng, Zhi-yong] Chinese Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Burns Inst, Dept Microbiol & Immunol, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital	Liu, QY (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Burns Inst, Dept Microbiol & Immunol, Beijing, Peoples R China.	llqq2003yy@yahoo.com.cn			National Natural Science Foundation of China [81000847, 81071545]; National Basic Research Program of China [2005CB522602]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This study was supported, in part, by grants from the National Natural Science Foundation of China (http://www.nsfc.gov.cn/Portal0/default124.htm) (grant no. 81000847 to Q-yL; 81071545 to Yan Yu), and the National Basic Research Program of China (http://www.973.gov.cn/) (grant no. 2005CB522602 to Yan Yu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arazi A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008447; Bacchetta R, 2005, AUTOIMMUN REV, V4, P491, DOI 10.1016/j.autrev.2005.04.005; Belkaid Y, 2005, NAT IMMUNOL, V6, P353, DOI 10.1038/ni1181; Chatila TA, 2005, J ALLERGY CLIN IMMUN, V116, P949, DOI 10.1016/j.jaci.2005.08.047; Chen W, 2010, J DIABETES COMPLICAT, V24, P199, DOI 10.1016/j.jdiacomp.2008.12.003; Cho WCS, 2007, J ETHNOPHARMACOL, V113, P132, DOI 10.1016/j.jep.2007.05.020; CHOILEAIN NN, 2006, J SURG RES, V130, P124; Coffer PJ, 2004, NAT REV IMMUNOL, V4, P889, DOI 10.1038/nri1488; Das G, 2001, J IMMUNOL, V167, P2004, DOI 10.4049/jimmunol.167.4.2004; Efron P, 2003, SHOCK, V20, P386, DOI 10.1097/01.SHK.0000092698.10326.6f; Goleva E, 2005, J ALLERGY CLIN IMMUN, V116, P1094, DOI 10.1016/j.jaci.2005.08.051; Jonuleit H, 2003, J IMMUNOL, V171, P6323, DOI 10.4049/jimmunol.171.12.6323; Kim S W, 2008, J Anim Sci, V86, pE138; Kuo YH, 2009, J ETHNOPHARMACOL, V122, P28, DOI 10.1016/j.jep.2008.11.025; Liu QY, 2011, J ETHNOPHARMACOL, V136, P457, DOI 10.1016/j.jep.2010.06.041; Liu QY, 2011, IMMUNOBIOLOGY, V216, P47, DOI 10.1016/j.imbio.2010.03.005; Ma XQ, 2002, J AGR FOOD CHEM, V50, P4861, DOI 10.1021/jf0202279; Mills KHG, 2004, NAT REV IMMUNOL, V4, P841, DOI 10.1038/nri1485; Miyara M, 2007, TRENDS MOL MED, V13, P108, DOI 10.1016/j.molmed.2007.01.003; Murphy TJ, 2005, J IMMUNOL, V174, P2957, DOI 10.4049/jimmunol.174.5.2957; O'Garra A, 2004, J CLIN INVEST, V114, P1372, DOI 10.1172/JCI200423215; Patenaude J, 2005, J LEUKOCYTE BIOL, V77, P141, DOI 10.1189/jlb.0703314; Pestka S, 2004, ANNU REV IMMUNOL, V22, P929, DOI 10.1146/annurev.immunol.22.012703.104622; Purcell EM, 2006, SHOCK, V25, P135, DOI 10.1097/01.shk.0000190824.51653.32; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Shao BM, 2004, BIOCHEM BIOPH RES CO, V320, P1103, DOI 10.1016/j.bbrc.2004.06.065; Sunden-Cullberg J, 2006, CURR OPIN INFECT DIS, V19, P231, DOI 10.1097/01.qco.0000224816.96986.67; Thompson C, 2004, CURR OPIN PHARMACOL, V4, P408, DOI 10.1016/j.coph.2004.05.001; Tin MMY, 2007, CARCINOGENESIS, V28, P1347, DOI 10.1093/carcin/bgl238; TU WW, 1995, CHIN J IMMUNOL, V11, P34; Wisnoski N, 2007, SHOCK, V27, P251, DOI 10.1097/01.shk.0000239780.33398.e4; Yagi H, 2004, INT IMMUNOL, V16, P1643, DOI 10.1093/intimm/dxh165; Zheng SG, 2006, INT IMMUNOL, V18, P279, DOI 10.1093/intimm/dxh368	33	79	94	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e19811	10.1371/journal.pone.0019811	http://dx.doi.org/10.1371/journal.pone.0019811			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698274	gold, Green Published, Green Submitted			2022-12-27	WOS:000291730000003
J	Olivera-Bravo, S; Fernandez, A; Sarlabos, MN; Rosillo, JC; Casanova, G; Jimenez, M; Barbeito, L				Olivera-Bravo, Silvia; Fernandez, Anabel; Noel Sarlabos, Maria; Carlos Rosillo, Juan; Casanova, Gabriela; Jimenez, Marcie; Barbeito, Luis			Neonatal Astrocyte Damage Is Sufficient to Trigger Progressive Striatal Degeneration in a Rat Model of Glutaric Acidemia-I	PLOS ONE			English	Article							WHITE-MATTER ASTROCYTES; MITOCHONDRIAL DYSFUNCTION; EXPRESSION; PROLIFERATION; PREVENTION; SURVIVAL; NEURONS; DISEASE; STRESS; CORTEX	Background: We have investigated whether an acute metabolic damage to astrocytes during the neonatal period may critically disrupt subsequent brain development, leading to neurodevelopmental disorders. Astrocytes are vulnerable to glutaric acid (GA), a dicarboxylic acid that accumulates in millimolar concentrations in Glutaric Acidemia I (GA-I), an inherited neurometabolic childhood disease characterized by degeneration of striatal neurons. While GA induces astrocyte mitochondrial dysfunction, oxidative stress and subsequent increased proliferation, it is presently unknown whether such astrocytic dysfunction is sufficient to trigger striatal neuronal loss. Methodology/Principal Findings: A single intracerebroventricular dose of GA was administered to rat pups at postnatal day 0 (P0) to induce an acute, transient rise of GA levels in the central nervous system (CNS). GA administration potently elicited proliferation of astrocytes expressing S100 beta followed by GFAP astrocytosis and nitrotyrosine staining lasting until P45. Remarkably, GA did not induce acute neuronal loss assessed by FluoroJade C and NeuN cell count. Instead, neuronal death appeared several days after GA treatment and progressively increased until P45, suggesting a delayed onset of striatal degeneration. The axonal bundles perforating the striatum were disorganized following GA administration. In cell cultures, GA did not affect survival of either striatal astrocytes or neurons, even at high concentrations. However, astrocytes activated by a short exposure to GA caused neuronal death through the production of soluble factors. Iron porphyrin antioxidants prevented GA-induced astrocyte proliferation and striatal degeneration in vivo, as well as astrocyte-mediated neuronal loss in vitro. Conclusions/Significance: Taken together, these results indicate that a transient metabolic insult with GA induces long lasting phenotypic changes in astrocytes that cause them to promote striatal neuronal death. Pharmacological protection of astrocytes with antioxidants during encephalopatic crisis may prevent astrocyte dysfunction and the ineluctable progression of disease in children with GA-I.	[Olivera-Bravo, Silvia; Noel Sarlabos, Maria; Jimenez, Marcie; Barbeito, Luis] Inst Clemente Estable, Cellular & Mol Neurobiol Dept, Montevideo, Uruguay; [Fernandez, Anabel; Carlos Rosillo, Juan] Univ Republica, Inst Clemente Estable, Cellular & Mol Neurophysiol Dept, Comparat Neuroanat Associated Unit,Sch Sci, Montevideo, Uruguay; [Casanova, Gabriela; Jimenez, Marcie] Univ Republica, Comparat Neuroanat Associated Unit, Electron Microscopy Unit, Sch Sci, Montevideo, Uruguay; [Barbeito, Luis] Inst Pasteur Montevideo, Montevideo, Uruguay	Instituto de Investigaciones Biologicas Clemente Estable Uruguay; Instituto de Investigaciones Biologicas Clemente Estable Uruguay; Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur de Montevideo	Olivera-Bravo, S (corresponding author), Inst Clemente Estable, Cellular & Mol Neurobiol Dept, Montevideo, Uruguay.	barbeito@pasteur.edu.uy		Barbeito, Luis/0000-0002-3047-232X	Consejo Nacional de Ciencia y Tecnologia [76/23]; Programa para el Desarrollo de las Ciencias Basicas, Biology option	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Programa para el Desarrollo de las Ciencias Basicas, Biology option	This work was funded by the Programa de Desarrollo Tecnologico Salud No 76/23 of the Consejo Nacional de Ciencia y Tecnologia to S.O.B., and the Programa para el Desarrollo de las Ciencias Basicas, Biology option. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Abramov AY, 2005, PHILOS T R SOC B, V360, P2309, DOI 10.1098/rstb.2005.1766; Bain JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009567; Barbeito LH, 2004, BRAIN RES REV, V47, P263, DOI 10.1016/j.brainresrev.2004.05.003; Barres BA, 2008, NEURON, V60, P430, DOI 10.1016/j.neuron.2008.10.013; Brozzi F, 2009, J BIOL CHEM, V284, P8788, DOI 10.1074/jbc.M805897200; Cassina P, 2002, J NEUROSCI RES, V67, P21, DOI 10.1002/jnr.10107; Cassina P, 2008, J NEUROSCI, V28, P4115, DOI 10.1523/JNEUROSCI.5308-07.2008; Chatterjee S, 1999, GLIA, V27, P152; Crow JP, 2005, ANN NEUROL, V58, P258, DOI 10.1002/ana.20552; De Keyser J, 2008, J NEUROL SCI, V267, P3, DOI 10.1016/j.jns.2007.08.044; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Donato R, 2009, BBA-MOL CELL RES, V1793, P1008, DOI 10.1016/j.bbamcr.2008.11.009; Eroglu C, 2010, NATURE, V468, P223, DOI 10.1038/nature09612; Ferreira GD, 2005, NEUROCHEM RES, V30, P1123, DOI 10.1007/s11064-005-7711-9; Funk CBR, 2005, BRAIN, V128, P711, DOI 10.1093/brain/awh401; GOODMAN SI, 1995, HUM MOL GENET, V4, P1493; Haynes RL, 2009, ACTA NEUROPATHOL, V118, P391, DOI 10.1007/s00401-009-0540-1; Hoffmann GF, 1996, NEUROPEDIATRICS, V27, P115, DOI 10.1055/s-2007-973761; Kolker S, 2000, AMINO ACIDS, V18, P31, DOI 10.1007/s007260050003; KOLKER S, 2008, J INHERIT METAB DIS; LAMP J, 2011, J BIOL CHEM; Latini A, 2007, CELL MOL NEUROBIOL, V27, P423, DOI 10.1007/s10571-006-9134-9; LEIBEL RL, 1980, NEUROLOGY, V30, P1163, DOI 10.1212/WNL.30.11.1163; Olivera S, 2008, NEUROBIOL DIS, V32, P528, DOI 10.1016/j.nbd.2008.09.011; Paxinos G., 2004, J CHEM INF MODEL, V5th; Paxinos G., 1991, ATLAS DEV RAT BRAIN; Powell EM, 1999, GLIA, V26, P73, DOI 10.1002/(SICI)1098-1136(199903)26:1<73::AID-GLIA8>3.0.CO;2-S; Rosa RB, 2007, LIFE SCI, V81, P1668, DOI 10.1016/j.lfs.2007.09.021; SANETO RP, 1987, J NEUROSCI RES, V18, P147, DOI 10.1002/jnr.490180122; Sauer SW, 2006, J NEUROCHEM, V97, P899, DOI 10.1111/j.1471-4159.2006.03813.x; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; Sharma R, 2010, ACTA NEUROPATHOL, V120, P223, DOI 10.1007/s00401-010-0704-z; SOFFER D, 1992, J NEUROL SCI, V107, P199, DOI 10.1016/0022-510X(92)90289-W; Stolp HB, 2009, NEUROSCI LETT, V451, P232, DOI 10.1016/j.neulet.2009.01.021; Strauss KA, 2003, AM J MED GENET C, V121C, P38, DOI 10.1002/ajmg.c.20007; Sullivan SM, 2010, BRAIN RES, V1319, P164, DOI 10.1016/j.brainres.2010.01.010; Vargas MR, 2008, J NEUROSCI RES, V86, P3515, DOI 10.1002/jnr.21797; VENTIMIGLIA R, 1995, EUR J NEUROSCI, V7, P213, DOI 10.1111/j.1460-9568.1995.tb01057.x; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; Zacharaki T, 2010, BRAIN RES, V1344, P62, DOI 10.1016/j.brainres.2010.05.021; Zhu CL, 2009, J CEREBR BLOOD F MET, V29, P342, DOI 10.1038/jcbfm.2008.124; Zinnanti WJ, 2007, J CLIN INVEST, V117, P3258, DOI 10.1172/JCI31617	43	47	48	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e20831	10.1371/journal.pone.0020831	http://dx.doi.org/10.1371/journal.pone.0020831			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698251	Green Submitted, Green Published, gold			2022-12-27	WOS:000291730000026
J	Steele, KT; Steenhoff, AP; Newcomb, CW; Rantleru, T; Nthobatsang, R; Lesetedi, G; Bellamy, SL; Nachega, JB; Gross, R; Bisson, GP				Steele, Katherine T.; Steenhoff, Andrew P.; Newcomb, Craig W.; Rantleru, Tumelo; Nthobatsang, Rudo; Lesetedi, Gloria; Bellamy, Scarlett L.; Nachega, Jean B.; Gross, Robert; Bisson, Gregory P.			Early Mortality and AIDS Progression Despite High Initial Antiretroviral Therapy Adherence and Virologic Suppression in Botswana	PLOS ONE			English	Article							RECONSTITUTION INFLAMMATORY SYNDROME; SUB-SAHARAN AFRICA; FOLLOW-UP; RISK-FACTORS; HIV-1-INFECTED PATIENTS; COMBINATION THERAPY; TREATMENT PROGRAMS; IMMUNOLOGICAL OUTCOMES; RURAL DISTRICT; NORTH-AMERICA	Background: Adverse outcomes occurring early after antiretroviral therapy (ART) initiation are common in sub-Saharan Africa, despite reports of high levels of ART adherence in this setting. We sought to determine the relationship between very early ART adherence and early adverse outcomes in HIV-infected adults in Botswana. Methods: This prospective cohort study of 402 ART-naive, HIV-infected adults initiating ART at a public HIV clinic in Gaborone, Botswana evaluated the relationship between suboptimal early ART adherence and HIV treatment outcomes in the initial months after ART initiation. Early adherence during the interval between initial ART dispensation and first ART refill was calculated using pill counts. In the primary analysis patients not returning to refill and those with adherence <0.95 were considered to have suboptimal early adherence. The primary outcome was death or loss to follow-up during the first 6 months of ART; a secondary composite outcome included the primary outcome plus incident opportunistic illness (OIs) and virologic failure. We also calculated the percent of early adverse outcomes theoretically attributable to suboptimal early adherence using the population attributable risk percent (PAR%). Results: Suboptimal early adherence was independently associated with loss to follow-up and death (adjusted OR 2.3, 95% CI 1.1-4.8) and with the secondary composite outcome including incident OIs and virologic failure (adjusted OR 2.6, 95% CI 1.4-4.7). However, of those with early adverse outcomes, less than one-third had suboptimal adherence and approximately two-thirds achieved virologic suppression. The PAR% relating suboptimal early adherence and primary and secondary outcomes were 14.7% and 17.7%, respectively. Conclusions: Suboptimal early adherence was associated with poor outcomes, but most early adverse outcomes occurred in patients with optimal early adherence. Clinical care and research efforts should focus on understanding early adverse outcomes that occur despite optimal adherence.	[Steele, Katherine T.; Steenhoff, Andrew P.; Rantleru, Tumelo; Nthobatsang, Rudo; Lesetedi, Gloria; Gross, Robert; Bisson, Gregory P.] Botswana Univ Pennsylvania Partnership, Gaborone, Botswana; [Steele, Katherine T.] Univ Penn, Sch Med, Philadelphia, PA 19104 USA; [Steenhoff, Andrew P.] Childrens Hosp Philadelphia, Div Infect Dis, Philadelphia, PA 19104 USA; [Steenhoff, Andrew P.] Univ Penn, Ctr AIDS Res, Philadelphia, PA 19104 USA; [Newcomb, Craig W.; Bellamy, Scarlett L.; Gross, Robert; Bisson, Gregory P.] Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Nachega, Jean B.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Nachega, Jean B.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Gross, Robert; Bisson, Gregory P.] Univ Penn, Sch Med, Div Infect Dis, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Pennsylvania	Steele, KT (corresponding author), Botswana Univ Pennsylvania Partnership, Gaborone, Botswana.	bisson@mail.med.upenn.edu		Nachega, Jean/0000-0002-2862-4443; Bellamy, Scarlett/0000-0002-2906-4046	Doris Duke Charitable Foundation, New York, NY; University of Pennsylvania Center for AIDS Research (CFAR), NIH [P30 AI 045008]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI045008] Funding Source: NIH RePORTER	Doris Duke Charitable Foundation, New York, NY(Doris Duke Charitable Foundation (DDCF)); University of Pennsylvania Center for AIDS Research (CFAR), NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by an Operations Research on AIDS Care in Africa grant from the Doris Duke Charitable Foundation, New York, NY (GB), as well as core services and support from the University of Pennsylvania Center for AIDS Research (CFAR), an NIH-funded program (P30 AI 045008). The funding sources had no influence on study design, data collection and analysis, interpretation of the data, manuscript preparation or decision to submit for publication.	Barth RE, 2010, LANCET INFECT DIS, V10, P155, DOI 10.1016/S1473-3099(09)70328-7; Bisson GP, 2008, JAIDS-J ACQ IMM DEF, V49, P107, DOI 10.1097/QAI.0b013e3181820141; Bisson GP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001725; Bourgarit A, 2006, AIDS, V20, pF1, DOI 10.1097/01.aids.0000202648.18526.bf; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Castelnuovo B, 2009, CLIN INFECT DIS, V49, P965, DOI 10.1086/605500; Chene G, 2003, LANCET, V362, P679, DOI 10.1016/S0140-6736(03)14229-8; Djomand G, 2003, AIDS, V17, pS5, DOI 10.1097/00002030-200317003-00002; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Ferradini L, 2006, LANCET, V367, P1335, DOI 10.1016/S0140-6736(06)68580-2; Haddow LJ, 2009, CLIN INFECT DIS, V49, P1424, DOI 10.1086/630208; Hester EK, 1998, AIDS, V12, P439; Hogg RS, 2002, AIDS, V16, P1051, DOI 10.1097/00002030-200205030-00012; Karcher H, 2007, TROP MED INT HEALTH, V12, P687, DOI 10.1111/j.1365-3156.2007.01830.x; Laurent C, 2002, AIDS, V16, P1363, DOI 10.1097/00002030-200207050-00008; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Lawn SD, 2010, AIDS, V24, P1323, DOI 10.1097/QAD.0b013e3283390dd1; Leng K, 2008, INT J STD AIDS, V19, P642, DOI 10.1258/ijsa.2008.008062; Marazzi MC, 2008, AIDS RES HUM RETROV, V24, P555, DOI 10.1089/aid.2007.0217; Markowitz M, 2007, JAIDS-J ACQ IMM DEF, V46, P125, DOI 10.1097/QAI.0b013e318157131c; May MT, 2006, LANCET, V368, P451, DOI 10.1016/S0140-6736(06)69152-6; McMahon JH, 2011, CLIN INFECT DIS, V52, P493, DOI 10.1093/cid/ciq167; Meintjes G, 2008, LANCET INFECT DIS, V8, P516, DOI 10.1016/S1473-3099(08)70184-1; Mills EJ, 2006, JAMA-J AM MED ASSOC, V296, P679, DOI 10.1001/jama.296.6.679; Murdoch DA, 2008, AIDS, V22, P601, DOI 10.1097/QAD.0b013e3282f4a607; Muyingo SK, 2008, JAIDS-J ACQ IMM DEF, V48, P468, DOI 10.1097/QAI.0b013e31817dc3fd; Nachega JB, 2006, JAIDS-J ACQ IMM DEF, V43, P78, DOI 10.1097/01.qai.0000225015.43266.46; Nachega JB, 2009, JAIDS-J ACQ IMM DEF, V51, P65, DOI 10.1097/QAI.0b013e318199072e; Nakanjako Damalie, 2008, AIDS Res Ther, V5, P23, DOI 10.1186/1742-6405-5-23; Park WB, 2007, J INTERN MED, V261, P268, DOI 10.1111/j.1365-2796.2006.01762.x; Rockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Spire B, 2008, ANTIVIR THER, V13, P697; Ssali F, 2006, ANTIVIR THER, V11, P741; Wester CW, 2007, JAIDS-J ACQ IMM DEF, V46, P318, DOI 10.1097/QAI.0b013e3181568e3f; Wester CW, 2005, CLIN INFECT DIS, V40, P1041, DOI 10.1086/428352; Westreich D, 2009, AIDS, V23, P707, DOI 10.1097/QAD.0b013e328325d115; WHO, 2010, ANT THER HIV INF AD; World Health Organization, 2005, INT WHO CLIN STAG HI; Zachariah R, 2006, AIDS, V20, P2355, DOI 10.1097/QAD.0b013e32801086b0	42	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e20010	10.1371/journal.pone.0020010	http://dx.doi.org/10.1371/journal.pone.0020010			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698283	Green Published, Green Submitted, gold			2022-12-27	WOS:000291730000005
J	Ishida, Y; Oleksyk, TK; Georgiadis, NJ; David, VA; Zhao, K; Stephens, RM; Kolokotronis, SO; Roca, AL				Ishida, Yasuko; Oleksyk, Taras K.; Georgiadis, Nicholas J.; David, Victor A.; Zhao, Kai; Stephens, Robert M.; Kolokotronis, Sergios-Orestis; Roca, Alfred L.			Reconciling Apparent Conflicts between Mitochondrial and Nuclear Phylogenies in African Elephants	PLOS ONE			English	Article							TETRANUCLEOTIDE MICROSATELLITE LOCI; CYTONUCLEAR GENOMIC DISSOCIATION; CONTROL REGION SEQUENCES; SEX-BIASED DISPERSAL; POPULATION-STRUCTURE; WEST-AFRICA; INBREEDING AVOIDANCE; LOXODONTA-AFRICANA; GENETIC DIVERSITY; FOREST ELEPHANTS	Conservation strategies for African elephants would be advanced by resolution of conflicting claims that they comprise one, two, three or four taxonomic groups, and by development of genetic markers that establish more incisively the provenance of confiscated ivory. We addressed these related issues by genotyping 555 elephants from across Africa with microsatellite markers, developing a method to identify those loci most effective at geographic assignment of elephants (or their ivory), and conducting novel analyses of continent-wide datasets of mitochondrial DNA. Results showed that nuclear genetic diversity was partitioned into two clusters, corresponding to African forest elephants (99.5% Cluster-1) and African savanna elephants (99.4% Cluster-2). Hybrid individuals were rare. In a comparison of basal forest "F" and savanna "S" mtDNA clade distributions to nuclear DNA partitions, forest elephant nuclear genotypes occurred only in populations in which S clade mtDNA was absent, suggesting that nuclear partitioning corresponds to the presence or absence of S clade mtDNA. We reanalyzed African elephant mtDNA sequences from 81 locales spanning the continent and discovered that S clade mtDNA was completely absent among elephants at all 30 sampled tropical forest locales. The distribution of savanna nuclear DNA and S clade mtDNA corresponded closely to range boundaries traditionally ascribed to the savanna elephant species based on habitat and morphology. Further, a reanalysis of nuclear genetic assignment results suggested that West African elephants do not comprise a distinct third species. Finally, we show that some DNA markers will be more useful than others for determining the geographic origins of illegal ivory. These findings resolve the apparent incongruence between mtDNA and nuclear genetic patterns that has confounded the taxonomy of African elephants, affirm the limitations of using mtDNA patterns to infer elephant systematics or population structure, and strongly support the existence of two elephant species in Africa.	[Ishida, Yasuko; Zhao, Kai; Roca, Alfred L.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Oleksyk, Taras K.] Univ Puerto Rico, Dept Biol, Mayaguez, PR USA; [Georgiadis, Nicholas J.] Bole & Klingenstein Fdn, Cody, WY USA; [David, Victor A.] NCI, Lab Genom Divers, Frederick, MD 21701 USA; [Stephens, Robert M.] NCI, SAIC Frederick Inc, Adv Biomed Comp Ctr, Frederick, MD 21701 USA; [Kolokotronis, Sergios-Orestis] Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA; [Roca, Alfred L.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Puerto Rico; University of Puerto Rico Mayaguez; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; American Museum of Natural History (AMNH); University of Illinois System; University of Illinois Urbana-Champaign	Ishida, Y (corresponding author), Univ Illinois, Dept Anim Sci, 328 Mumford Hall, Urbana, IL 61801 USA.	taras.oleksyk@upr.edu; roca@illinois.edu	Kolokotronis, Sergios-Orestis/GWM-5773-2022; Taras, Oleksyk/J-8805-2013; Kolokotronis, Sergios-Orestis/A-1910-2009	Kolokotronis, Sergios-Orestis/0000-0003-3309-8465; Taras, Oleksyk/0000-0002-8148-3918; Kolokotronis, Sergios-Orestis/0000-0003-3309-8465; Roca, Alfred/0000-0001-9217-5593	U. S. Fish and Wildlife Service African Elephant Conservation Fund [AFE-0458-98210-8-G743]	U. S. Fish and Wildlife Service African Elephant Conservation Fund(US Fish & Wildlife Service)	Funding was provided by the U. S. Fish and Wildlife Service African Elephant Conservation Fund Grant no. AFE-0458-98210-8-G743. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archie EA, 2003, MOL ECOL NOTES, V3, P244, DOI 10.1046/j.1471-8286.2003.00412.x; Archie EA, 2007, MOL ECOL, V16, P4138, DOI 10.1111/j.1365-294X.2007.03483.x; Backhaus D., 1958, Saugetierkundliche Mitteilungen, V6, P166; Barker PA, 2001, SCIENCE, V292, P2307, DOI 10.1126/science.1059612; Barnes RFW, 1999, MAMMAL REV, V29, P175, DOI 10.1046/j.1365-2907.1999.00044.x; Barriel V, 1999, CR ACAD SCI III-VIE, V322, P447, DOI 10.1016/S0764-4469(99)80093-6; Belkhir K, 2004, GENETIX 4 05; Blanc Julian J., 2007, AFRICAN ELEPHANT STA; Boutin-Ganache I, 2001, BIOTECHNIQUES, V31, P24, DOI 10.2144/01311bm02; Buggs RJA, 2007, HEREDITY, V99, P301, DOI 10.1038/sj.hdy.6800997; Capelli C, 2006, MOL PHYLOGENET EVOL, V40, P620, DOI 10.1016/j.ympev.2006.03.015; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; Comstock KE, 2003, CONSERV BIOL, V17, P1840, DOI 10.1111/j.1523-1739.2003.00358.x; Comstock KE, 2002, MOL ECOL, V11, P2489, DOI 10.1046/j.1365-294X.2002.01615.x; Coyne J.A., 2004, SPECIATION; Debruyne R, 2005, CLADISTICS, V21, P31, DOI 10.1111/j.1096-0031.2004.00044.x; Debruyne R, 2003, CR BIOL, V326, P687, DOI 10.1016/S1631-0691(03)00158-6; deMenocal P, 2000, SCIENCE, V288, P2198, DOI 10.1126/science.288.5474.2198; DESAEGER H, 1954, EXPLORATION PARC NAT, V1; DOUGLAS-HAMILTON I, 1987, Oryx, V21, P11; Eggert LS, 2003, MOL ECOL, V12, P1389, DOI 10.1046/j.1365-294X.2003.01822.x; Eggert LS, 2002, P ROY SOC B-BIOL SCI, V269, P1993, DOI 10.1098/rspb.2002.2070; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fernando PJ, 2001, MOL ECOL NOTES, V1, P232, DOI 10.1046/j.1471-8278.2001.00082.x; Frade F., 1934, B SOC PORT SCI NAT, V11, P135; GEORGIADIS N, 1994, J HERED, V85, P100, DOI 10.1093/oxfordjournals.jhered.a111405; Good JM, 2008, MOL ECOL, V17, P1313, DOI 10.1111/j.1365-294X.2007.03640.x; Groves Colin P., 2000, Elephant, V2, P7; Groves Colin P., 2000, Elephant, V2, P4; Grubb Peter, 2000, Elephant, V2, P1; Haldane JBS, 1922, J GENET, V12, P101, DOI 10.1007/BF02983075; Handley LJL, 2007, MOL ECOL, V16, P1559, DOI 10.1111/j.1365-294X.2006.03152.x; HAUF J, 2000, ZOOLOGY, V102, P184; Hedrick PW, 2007, EVOLUTION, V61, P2750, DOI 10.1111/j.1558-5646.2007.00250.x; Hoelzer GA, 1997, EVOLUTION, V51, P622, DOI 10.1111/j.1558-5646.1997.tb02451.x; Hollister-Smith JA, 2007, ANIM BEHAV, V74, P287, DOI 10.1016/j.anbehav.2006.12.008; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Johnson MB, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-244; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Karesh W., 1989, CONSERV BIOL, V1, P261; Kopp JB, 2008, NAT GENET, V40, P1175, DOI 10.1038/ng.226; Kuntner M, 2011, ZOOL SCR, V40, P1, DOI 10.1111/j.1463-6409.2010.00452.x; Lei R, 2008, J ZOOL, V275, P252, DOI 10.1111/j.1469-7998.2008.00437.x; Lei RH, 2009, J HERED, V100, P675, DOI 10.1093/jhered/esp069; Mailand C, 2007, NAT PROTOC, V2, P2228, DOI 10.1038/nprot.2007.318; Matschie P., 1900, SITZUNGSBERICHTE GES, V8, P189; Mayr W., 1969, PRINCIPLES SYSTEMATI; Meirmans PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/j.1471-8286.2004.00770.x; Menotti-Raymond MA, 2005, J FORENSIC SCI, V50, P1061, DOI 10.1520/JFS2004317; Morin PA, 2009, MOL ECOL RESOUR, V9, P1451, DOI 10.1111/j.1755-0998.2009.02672.x; Nyakaana S, 2002, HEREDITY, V89, P90, DOI 10.1038/sj.hdy.6800110; Petit RJ, 2009, TRENDS ECOL EVOL, V24, P386, DOI 10.1016/j.tree.2009.02.011; Pfeffer P., 1989, VIE MORT GEANT ELEPH; Pritchard JK, 2000, GENETICS, V155, P945; PUSEY AE, 1987, TRENDS ECOL EVOL, V2, P295, DOI 10.1016/0169-5347(87)90081-4; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Roca A. L., 2002, PACHYDERM, V33, P93; Roca AL, 2001, SCIENCE, V293, P1473, DOI 10.1126/science.1059936; Roca AL, 2005, CURR OPIN GENET DEV, V15, P652, DOI 10.1016/j.gde.2005.09.014; Roca AL, 2005, NAT GENET, V37, P96, DOI 10.1038/ng1485; Roca AL, 2008, TRENDS GENET, V24, P49, DOI 10.1016/j.tig.2007.11.005; Roca AL, 2007, QUATERN INT, V169, P4, DOI 10.1016/j.quaint.2006.08.008; Rohland N, 2007, PLOS BIOL, V5, P1663, DOI 10.1371/journal.pbio.0050207; Rohland N, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000564; Rosenberg NA, 2003, AM J HUM GENET, V73, P1402, DOI 10.1086/380416; ROTH HH, 1991, MAMMALIA, V55, P489, DOI 10.1515/mamm.1991.55.4.489; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Salzmann U, 2005, HOLOCENE, V15, P190, DOI 10.1191/0959683605hl799rp; Sambrook J., 2002, MOL CLONING LAB MANU; Sarno RJ, 2000, MOL ECOL, V9, P1922, DOI 10.1046/j.1365-294x.2000.01077-3.x; Shannon C. E., 1949, MATH THEORY COMMUNIC; Shriver MD, 1997, AM J HUM GENET, V60, P957; Smith MW, 2005, NAT REV GENET, V6, P623, DOI 10.1038/nrg1657; Species Survival Network, 2006, IV UPD; Stokes S, 1997, NATURE, V388, P154, DOI 10.1038/40596; Sukumar R., 2003, LIVING ELEPHANTS EVO; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Thompson LG, 2002, SCIENCE, V298, P589, DOI 10.1126/science.1073198; Wasser SK, 2008, CONSERV BIOL, V22, P1065, DOI 10.1111/j.1523-1739.2008.01012.x; Wasser SK, 2007, P NATL ACAD SCI USA, V104, P4228, DOI 10.1073/pnas.0609714104; Wasser SK, 2009, SCI AM, V301, P68, DOI 10.1038/scientificamerican0709-68; Wasser SK, 2004, P NATL ACAD SCI USA, V101, P14847, DOI 10.1073/pnas.0403170101; WHITE F, 1983, VEGETATION AFRICA; Winkler CA, 2010, ANNU REV GENOM HUM G, V11, P65, DOI 10.1146/annurev-genom-082509-141523; Wu CI, 2001, J EVOLUTION BIOL, V14, P851, DOI 10.1046/j.1420-9101.2001.00335.x	85	35	37	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2011	6	6							e20642	10.1371/journal.pone.0020642	http://dx.doi.org/10.1371/journal.pone.0020642			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JJ	21701575	Green Submitted, Green Published, gold			2022-12-27	WOS:000291611500036
J	Ons, B; Verstraelen, L; Wagemans, J				Ons, Bart; Verstraelen, Leopold; Wagemans, Johan			A Computational Model of Visual Anisotropy	PLOS ONE			English	Article							ORIENTATION DISCRIMINATION; VERNIER ACUITY; OBLIQUE; PERCEPTION; STIMULI; SENSITIVITY; SELECTIVITY; SYMMETRY; CORTEX	Visual anisotropy has been demonstrated in multiple tasks where performance differs between vertical, horizontal, and oblique orientations of the stimuli. We explain some principles of visual anisotropy by anisotropic smoothing, which is based on a variation on Koenderink's approach in [1]. We tested the theory by presenting Gaussian elongated luminance profiles and measuring the perceived orientations by means of an adjustment task. Our framework is based on the smoothing of the image with elliptical Gaussian kernels and it correctly predicted an illusory orientation bias towards the vertical axis. We discuss the scope of the theory in the context of other anisotropies in perception.	[Ons, Bart; Wagemans, Johan] Univ Louvain, Expt Psychol Lab, Louvain, Belgium; [Verstraelen, Leopold] Univ Louvain, Dept Geometry, Louvain, Belgium		Ons, B (corresponding author), Univ Louvain, Expt Psychol Lab, Louvain, Belgium.	johan.wagemans@psy.kuleuven.be	Wagemans, Johan/M-3878-2019	Wagemans, Johan/0000-0002-7970-1541	Flemish Government [METH/08/02]	Flemish Government(European Commission)	This work was supported by the Methusalem grant by the Flemish Government awarded to JW (METH/08/02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPELLE S, 1972, PSYCHOL BULL, V78, P266, DOI 10.1037/h0033117; CAMISA JM, 1977, PERCEPTION, V6, P165, DOI 10.1068/p060165; CAMPBELL FW, 1966, J PHYSIOL-LONDON, V187, P437, DOI 10.1113/jphysiol.1966.sp008101; CORWIN TR, 1977, PERCEPT PSYCHOPHYS, V21, P445, DOI 10.3758/BF03199500; DAVIDOFF JB, 1974, PERCEPTION, V3, P47, DOI 10.1068/p030047; DEVALOIS RL, 1982, VISION RES, V22, P531, DOI 10.1016/0042-6989(82)90112-2; ESSOCK EA, 1990, VISION RES, V30, P1243, DOI 10.1016/0042-6989(90)90179-O; Essock EA, 2003, VISION RES, V43, P1329, DOI 10.1016/S0042-6989(03)00142-1; Essock EA, 1997, J EXP PSYCHOL HUMAN, V23, P515, DOI 10.1037/0096-1523.23.2.515; HEELEY DW, 1994, VISION RES, V34, P2059, DOI 10.1016/0042-6989(94)90317-4; HEELEY DW, 1988, VISION RES, V28, P337, DOI 10.1016/0042-6989(88)90162-9; KOENDERINK JJ, 1992, IMAGE VISION COMPUT, V10, P557, DOI 10.1016/0262-8856(92)90076-F; KOENDERINK JJ, 1984, BIOL CYBERN, V50, P363, DOI 10.1007/BF00336961; Koenderink JJ, 2002, LECT NOTES COMPUT SC, V2350, P158; Koenderink JJ, 1998, ADV IMAG ELECT PHYS, V103, P65, DOI 10.1016/S1076-5670(08)70015-6; Li BW, 2003, J NEUROPHYSIOL, V90, P204, DOI 10.1152/jn.00954.2002; Machilsen B, 2009, J VISION, V9, DOI 10.1167/9.12.11; Ons B, 2010, KRAGUJEV J MATH, V34, P5; Verstraelen L, 2005, KRAGUJEV J MATH, V28, P7; WAGEMANS J, 1993, J EXP PSYCHOL HUMAN, V19, P364, DOI 10.1037/0096-1523.19.2.364; WAGEMANS J, 1995, SPATIAL VISION, V9, P9, DOI 10.1163/156856895X00098; WENDEROTH P, 1994, PERCEPTION, V23, P221, DOI 10.1068/p230221; Westheimer G, 1998, VISION RES, V38, P1097, DOI 10.1016/S0042-6989(97)00248-4; ZLASKOVA M, 1993, VISION RES, V33, P2073; [No title captured]	25	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e21091	10.1371/journal.pone.0021091	http://dx.doi.org/10.1371/journal.pone.0021091			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	786GP	21738607	gold, Green Published, Green Submitted			2022-12-27	WOS:000292291800009
J	Firnhaber, C; Azzoni, L; Foulkes, AS; Gross, R; Yin, XF; Van Amsterdam, D; Schulze, D; Glencross, DK; Stevens, W; Hunt, G; Morris, L; Fox, L; Sanne, I; Montaner, LJ				Firnhaber, Cynthia; Azzoni, Livio; Foulkes, Andrea S.; Gross, Robert; Yin, Xiangfan; Van Amsterdam, Desiree; Schulze, Doreen; Glencross, Deborah K.; Stevens, Wendy; Hunt, Gillian; Morris, Lynn; Fox, Lawrence; Sanne, Ian; Montaner, Luis J.			Randomized Trial of Time-Limited Interruptions of Protease Inhibitor-Based Antiretroviral Therapy (ART) vs. Continuous Therapy for HIV-1 Infection	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; AFRICAN ADULTS; CELL COUNTS; ADHERENCE; INTERMITTENT; DETERMINANTS; PLASMA; NEVIRAPINE; INFERIOR; RISK	Background: The clinical outcomes of short interruptions of PI-based ART regimens remains undefined. Methods: A 2-arm non-inferiority trial was conducted on 53 HIV-1 infected South African participants with viral load <50 copies/ml and CD4 T cell count >450 cells/mu l on stavudine (or zidovudine), lamivudine and lopinavir/ritonavir. Subjects were randomized to a) sequential 2, 4 and 8-week ART interruptions or b) continuous ART (cART). Primary analysis was based on the proportion of CD4 count >350 cells(c)/ml over 72 weeks. Adherence, HIV-1 drug resistance, and CD4 count rise over time were analyzed as secondary endpoints. Results: The proportions of CD4 counts >350 cells/mu l were 82.12% for the intermittent arm and 93.73 for the cART arm; the difference of 11.95% was above the defined 10% threshold for non-inferiority (upper limit of 97.5% CI, 24.1%; 2-sided CI: -0.16, 23.1). No clinically significant differences in opportunistic infections, adverse events, adherence or viral resistance were noted; after randomization, long-term CD4 rise was observed only in the cART arm. Conclusion: We are unable to conclude that short PI-based ART interruptions are non-inferior to cART in retention of immune reconstitution; however, short interruptions did not lead to a greater rate of resistance mutations or adverse events than cART suggesting that this regimen may be more forgiving than NNRTIs if interruptions in therapy occur.	[Firnhaber, Cynthia; Van Amsterdam, Desiree; Schulze, Doreen; Sanne, Ian] Univ Witwatersrand, Dept Med, Fac Hlth Sci, Clin HIV Res Unit, ZA-2001 Johannesburg, South Africa; [Azzoni, Livio; Yin, Xiangfan; Montaner, Luis J.] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; [Foulkes, Andrea S.] Univ Massachusetts, Div Biostat, Amherst, MA 01003 USA; [Gross, Robert] Univ Penn, Dept Med Infect Dis, Philadelphia, PA 19104 USA; [Gross, Robert] Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Glencross, Deborah K.; Stevens, Wendy] Univ Witwatersrand, Dept Mol Med & Haematol, ZA-2001 Johannesburg, South Africa; [Glencross, Deborah K.; Stevens, Wendy] Univ Witwatersrand, Natl Hlth Lab Serv, ZA-2001 Johannesburg, South Africa; [Hunt, Gillian; Morris, Lynn] Natl Inst Communicable Dis, Johannesburg, South Africa; [Fox, Lawrence] NIAID, Div Aids, NIH, DHHS, Bethesda, MD 20892 USA	University of Witwatersrand; The Wistar Institute; University of Massachusetts System; University of Massachusetts Amherst; University of Pennsylvania; University of Pennsylvania; University of Witwatersrand; National Health Laboratory Service; University of Witwatersrand; National Institute for Communicable Diseases (NICD); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Firnhaber, C (corresponding author), Univ Witwatersrand, Dept Med, Fac Hlth Sci, Clin HIV Res Unit, ZA-2001 Johannesburg, South Africa.	montaner@wistar.org	Sanne, Ian/ABH-2231-2020; Morris, Lynn/V-3941-2018	Morris, Lynn/0000-0003-3961-7828; Glencross, Deborah/0000-0001-7106-769X	NIH/NIAID [UO1AI51986, RO1 AI056983]; Philadelphia Foundation; Stengel-Miller family; Commonwealth of Pennsylvania; Pennsylvania Department of Health; Cancer Center Grant [P30 CA10815]; NATIONAL CANCER INSTITUTE [P30CA010815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056983, U01AI051986] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Philadelphia Foundation; Stengel-Miller family; Commonwealth of Pennsylvania; Pennsylvania Department of Health; Cancer Center Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was partially supported by: NIH/NIAID grant UO1AI51986 to LJM; and NIH/NIAID grant RO1 AI056983 to ASF. Additional support was provided by The Philadelphia Foundation (Robert I. Jacobs Fund), The Stengel-Miller family, AIDS funds from the Commonwealth of Pennsylvania and from the Commonwealth Universal Research Enhancement Program, Pennsylvania Department of Health, as well as by a Cancer Center Grant (P30 CA10815). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananworanich J, 2007, AIDS, V21, P123, DOI 10.1097/01.aids.0000256414.91105.8e; Ananworanich J, 2006, LANCET, V368, P459, DOI 10.1016/S0140-6736(06)69153-8; Beyene KA, 2009, PHARMACOEPIDEM DR S, V18, P1007, DOI 10.1002/pds.1814; Cantrell RA, 2008, JAIDS-J ACQ IMM DEF, V49, P190, DOI 10.1097/QAI.0b013e31818455d2; Danel C, 2009, J INFECT DIS, V199, P66, DOI 10.1086/595298; Diabate S, 2007, AIDS, V21, P1799, DOI 10.1097/QAD.0b013e3282a5667b; *DIV AIDS N, 2004, TABL GRAD SEV ADV EV; Dybul M, 2003, J INFECT DIS, V188, P388, DOI 10.1086/376535; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; El-Sadr WM, 2008, NEW ENGL J MED, V359, P553, DOI 10.1056/NEJMp0803762; Gross R, 2001, AIDS, V15, P2109, DOI 10.1097/00002030-200111090-00006; Gross R, 2008, HIV CLIN TRIALS, V9, P202, DOI 10.1310/hct0903-202; Jacobson JM, 2006, J INFECT DIS, V194, P623, DOI 10.1086/506364; Kiguba R, 2007, JAIDS-J ACQ IMM DEF, V45, P218, DOI 10.1097/QAI.0b013e31805d8ae3; Kikaire B, 2007, AIDS, V21, P733, DOI 10.1097/QAD.0b013e3280121801; Kranzer K, 2010, JAIDS-J ACQ IMM DEF, V55, pE17, DOI 10.1097/QAI.0b013e3181f275fd; Leon A, 2009, J ANTIMICROB CHEMOTH, V63, P184, DOI 10.1093/jac/dkn461; Loubser S, 2006, AIDS, V20, P995, DOI 10.1097/01.aids.0000222071.60620.1d; Lundgren JD, 2008, J INFECT DIS, V197, P1145, DOI 10.1086/529523; Marcellin F, 2008, TROP MED INT HEALTH, V13, P1470, DOI 10.1111/j.1365-3156.2008.02170.x; Marchou B, 2007, AIDS, V21, P457, DOI 10.1097/QAD.0b013e328013d9eb; Mills EJ, 2006, JAMA-J AM MED ASSOC, V296, P679, DOI 10.1001/jama.296.6.679; OBRIEN DP, CONFL HLTH, V4, P12; Palmisano L, 2007, JAIDS-J ACQ IMM DEF, V46, P39; Papasavvas E, 2004, PLOS MED, V1, P218, DOI 10.1371/journal.pmed.0010064; Paton NI, 2008, CURR OPIN INFECT DIS, V21, P25, DOI 10.1097/QCO.0b013e3282f4069d; Posse M, 2009, AIDS PATIENT CARE ST, V23, P867, DOI 10.1089/apc.2009.0050; Rhee SY, 2003, NUCLEIC ACIDS RES, V31, P298, DOI 10.1093/nar/gkg100; Stephen Hobokela, 2009, Med Confl Surviv, V25, P134, DOI 10.1080/13623690902943412; Touloumi G, 2006, JAIDS-J ACQ IMM DEF, V42, P554, DOI 10.1097/01.qai.0000230321.85911.db; Tuller D, 2010, NY TIMES; Walker AS, 2008, AIDS, V22, P237, DOI 10.1097/QAD.0b013e3282f2d760; WEISER SD, PLOS ONE, V5	33	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21450	10.1371/journal.pone.0021450	http://dx.doi.org/10.1371/journal.pone.0021450			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738668	gold, Green Published, Green Submitted			2022-12-27	WOS:000292142800024
J	Whiteman, IT; Minamide, LS; Goh, DL; Bamburg, JR; Goldsbury, C				Whiteman, Ineka T.; Minamide, Laurie S.; Goh, De Lian; Bamburg, James R.; Goldsbury, Claire			Rapid Changes in Phospho-MAP/Tau Epitopes during Neuronal Stress: Cofilin-Actin Rods Primarily Recruit Microtubule Binding Domain Epitopes	PLOS ONE			English	Article							TAU-PROTEIN; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; NEUROPIL THREADS; NEUROFIBRILLARY PATHOLOGY; SENILE PLAQUES; PICKS-DISEASE; PHOSPHORYLATION; BRAIN; KINASE	Abnormal mitochondrial function is a widely reported contributor to neurodegenerative disease including Alzheimer's disease (AD), however, a mechanistic link between mitochondrial dysfunction and the initiation of neuropathology remains elusive. In AD, one of the earliest hallmark pathologies is neuropil threads comprising accumulated hyperphosphorylated microtubule-associated protein (MAP) tau in neurites. Rod-like aggregates of actin and its associated protein cofilin (AC rods) also occur in AD. Using a series of antibodies - AT270, AT8, AT100, S214, AT180, 12E8, S396, S404 and S422 - raised against different phosphoepitopes on tau, we characterize the pattern of expression and re-distribution in neurites of these phosphoepitope labels during mitochondrial inhibition. Employing chick primary neuron cultures, we demonstrate that epitopes recognized by the monoclonal antibody 12E8, are the only species rapidly recruited into AC rods. These results were recapitulated with the actin depolymerizing drug Latrunculin B, which induces AC rods and a concomitant increase in the 12E8 signal measured on Western blot. This suggests that AC rods may be one way in which MAP redistribution and phosphorylation is influenced in neurons during mitochondrial stress and potentially in the early pathogenesis of AD.	[Whiteman, Ineka T.; Goh, De Lian; Goldsbury, Claire] Univ Sydney, Brain & Mind Res Inst, Sydney, NSW 2006, Australia; [Whiteman, Ineka T.; Goh, De Lian; Goldsbury, Claire] Univ Sydney, Sch Med Sci, Bosch Inst, Sydney, NSW 2006, Australia; [Minamide, Laurie S.; Bamburg, James R.] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA	University of Sydney; University of Sydney; Colorado State University	Whiteman, IT (corresponding author), Univ Sydney, Brain & Mind Res Inst, Sydney, NSW 2006, Australia.	claire.goldsbury@sydney.edu.au		Whiteman, Ineka/0000-0002-3302-7416; Goldsbury, Claire/0000-0003-0647-1789	Sir Zelman Cowen University; Judith Jane Mason and Harold Stannett Williams Memorial Foundation; Rebecca Cooper Foundation; NHMRC; Sydney Medical School; National Institutes of Health [NS40371]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040371] Funding Source: NIH RePORTER	Sir Zelman Cowen University; Judith Jane Mason and Harold Stannett Williams Memorial Foundation; Rebecca Cooper Foundation; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Sydney Medical School; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The Sir Zelman Cowen Universities Fund, The Judith Jane Mason and Harold Stannett Williams Memorial Foundation, The Rebecca Cooper Foundation, The NHMRC, Sydney Medical School and the National Institutes of Health grant NS40371 (JRB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso AD, 2001, P NATL ACAD SCI USA, V98, P6923, DOI 10.1073/pnas.121119298; Augustinack JC, 2002, ACTA NEUROPATHOL, V103, P26, DOI 10.1007/s004010100423; Baas PW, 2005, TRENDS CELL BIOL, V15, P183, DOI 10.1016/j.tcb.2005.02.001; Bamburg JR, 2010, CURR ALZHEIMER RES, V7, P241, DOI 10.2174/156720510791050902; Bamburg JR, 2009, CELL MOTIL CYTOSKEL, V66, P635, DOI 10.1002/cm.20388; BIERNAT J, 1993, NEURON, V11, P153, DOI 10.1016/0896-6273(93)90279-Z; Blass JP, 2000, ANN NY ACAD SCI, V924, P170; BRAAK H, 1995, NEUROBIOL AGING, V16, P271, DOI 10.1016/0197-4580(95)00021-6; Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; CORREAS I, 1990, BIOCHEM J, V269, P61, DOI 10.1042/bj2690061; Cullen KM, 2006, NEUROBIOL AGING, V27, P1786, DOI 10.1016/j.neurobiolaging.2005.10.016; Davis RC, 2009, J ALZHEIMERS DIS, V18, DOI 10.3233/JAD-2009-1122; Dehmelt L, 2005, GENOME BIOL, V6; Dehmelt L, 2004, J NEUROBIOL, V58, P18, DOI 10.1002/neu.10284; Delacourte A, 1998, ANN NEUROL, V43, P193, DOI 10.1002/ana.410430209; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; Ebneth A, 1998, J CELL BIOL, V143, P777, DOI 10.1083/jcb.143.3.777; Escobar-Khondiker M, 2007, J NEUROSCI, V27, P7827, DOI 10.1523/JNEUROSCI.1644-07.2007; Fischer D, 2009, BIOCHEMISTRY-US, V48, P10047, DOI 10.1021/bi901090m; Fulga TA, 2007, NAT CELL BIOL, V9, P139, DOI 10.1038/ncb1528; Gallo G, 2007, NAT CELL BIOL, V9, P133, DOI 10.1038/ncb0207-133; Garcia ML, 2001, CURR OPIN CELL BIOL, V13, P41, DOI 10.1016/S0955-0674(00)00172-1; Gauthier-Kemper A, 2011, J CELL BIOL, V192, P647, DOI 10.1083/jcb.201007161; Giannakopoulos P, 2007, NEUROPATH APPL NEURO, V33, P334, DOI 10.1111/j.1365-2990.2007.00827.x; GOEDERT M, 1993, TRENDS NEUROSCI, V16, P460, DOI 10.1016/0166-2236(93)90078-Z; Goldsbury C, 2008, AGING CELL, V7, P771, DOI 10.1111/j.1474-9726.2008.00423.x; Gordon-Krajcer W, 2007, NEUROCHEM RES, V32, P729, DOI 10.1007/s11064-006-9199-3; GRIFFITH LM, 1982, J BIOL CHEM, V257, P9143; GRIFFITH LM, 1978, J CELL BIOL, V78, P958, DOI 10.1083/jcb.78.3.958; Hashiguchi M, 2000, J BIOL CHEM, V275, P25247, DOI 10.1074/jbc.M003738200; He HJ, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-81; Hernandez F, 2004, NEUROSCI LETT, V357, P143, DOI 10.1016/j.neulet.2003.12.049; Kapogiannis D, 2011, LANCET NEUROL, V10, P187, DOI 10.1016/S1474-4422(10)70277-5; LEWIS SA, 1988, SCIENCE, V242, P936, DOI 10.1126/science.3142041; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; LINDWALL G, 1984, J BIOL CHEM, V259, P5301; MANDELKOW EM, 1995, NEUROBIOL AGING, V16, P355, DOI 10.1016/0197-4580(95)00025-A; Mandelkow EM, 2004, J CELL BIOL, V167, P99, DOI 10.1083/jcb.200401085; Mattson MP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3114pe10; Melov S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000536; Minamide LS, 2010, J BIOL CHEM, V285, P5450, DOI 10.1074/jbc.M109.063768; Minamide LS, 2000, NAT CELL BIOL, V2, P628, DOI 10.1038/35023579; Mitchell TW, 2000, J HISTOCHEM CYTOCHEM, V48, P1627, DOI 10.1177/002215540004801206; MORAGA DM, 1993, J NEUROCHEM, V61, P979, DOI 10.1111/j.1471-4159.1993.tb03611.x; Nelson PT, 2010, J ALZHEIMERS DIS, V21, P75, DOI 10.3233/JAD-2010-091603; Nishimura I, 2004, CELL, V116, P671, DOI 10.1016/S0092-8674(04)00170-9; Ozer RS, 2000, MOL BIOL CELL, V11, P3573, DOI 10.1091/mbc.11.10.3573; Praprotnik D, 1996, ACTA NEUROPATHOL, V91, P226, DOI 10.1007/s004010050420; Probst A, 1996, ACTA NEUROPATHOL, V92, P588, DOI 10.1007/s004010050565; Schaar BT, 2004, NEURON, V41, P203, DOI 10.1016/S0896-6273(03)00843-2; SCHMIDT ML, 1993, MOL CHEM NEUROPATHOL, V18, P299, DOI 10.1007/BF03160121; SELDEN SC, 1983, J BIOL CHEM, V258, P7064; SEUBERT P, 1995, J BIOL CHEM, V270, P18917, DOI 10.1074/jbc.270.32.18917; Shaw AE, 2004, ELECTROPHORESIS, V25, P2611, DOI 10.1002/elps.200406017; Smith MA, 2005, NEUROBIOL AGING, V26, P579, DOI 10.1016/j.neurobiolaging.2004.09.021; Su B, 2010, BBA-MOL BASIS DIS, V1802, P135, DOI 10.1016/j.bbadis.2009.09.013; Timm T, 2003, EMBO J, V22, P5090, DOI 10.1093/emboj/cdg447; Umahara T, 2004, ACTA NEUROPATHOL, V108, P279, DOI 10.1007/s00401-004-0885-4; Velasco ME, 1998, BRAIN RES, V813, P329, DOI 10.1016/S0006-8993(98)01034-8; Wang WX, 2008, J NEUROSCI, V28, P1213, DOI 10.1523/JNEUROSCI.5065-07.2008; Wang XL, 2009, J NEUROCHEM, V109, P153, DOI 10.1111/j.1471-4159.2009.05867.x; Wen Y, 2004, BRAIN RES, V1022, P30, DOI 10.1016/j.brainres.2004.05.106; Whiteman IT, 2009, J NEUROSCI, V29, P12994, DOI 10.1523/JNEUROSCI.3531-09.2009; YAMAUCHI PS, 1993, BIOCHEM BIOPH RES CO, V190, P710, DOI 10.1006/bbrc.1993.1107; YAO J, 2011, PLOS ONE, V5; Yoshida H, 2002, BIOCHEMISTRY-US, V41, P15203, DOI 10.1021/bi026464m; Zempel H, 2010, J NEUROSCI, V30, P11938, DOI 10.1523/JNEUROSCI.2357-10.2010; Zhou LX, 2006, BIOCHEM BIOPH RES CO, V348, P637, DOI 10.1016/j.bbrc.2006.07.099	68	22	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e20878	10.1371/journal.pone.0020878	http://dx.doi.org/10.1371/journal.pone.0020878			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738590	Green Published, gold, Green Submitted			2022-12-27	WOS:000292142800004
J	Knorr, U; Vinberg, M; Hansen, A; Klose, M; Feldt-Rasmussen, U; Hilsted, L; Hasselstrom, J; Gether, U; Winkel, P; Gluud, C; Wetterslev, J; Kessing, LV				Knorr, Ulla; Vinberg, Maj; Hansen, Allan; Klose, Marianne; Feldt-Rasmussen, Ulla; Hilsted, Linda; Hasselstrom, Jorgen; Gether, Ulrik; Winkel, Per; Gluud, Christian; Wetterslev, Jorn; Kessing, Lars Vedel			Escitalopram and Neuroendocrine Response in Healthy First-Degree Relatives to Depressed Patients - A Randomized Placebo-Controlled Trial	PLOS ONE			English	Article							COMBINED DEXAMETHASONE/CRH TEST; SALIVARY CORTISOL; FAMILIAL RISK; HORMONE TEST; CRH TEST; CITALOPRAM; ENDOPHENOTYPES; INTERVENTION; MARKER	Introduction: The mechanisms by which selective serotonin re-uptake inhibitors (SSRI) act in depressed patients remain unknown. The serotonergic neurotransmitter system and the hypothalamic-pituitary-adrenal (HPA) system may interact. The aim of the AGENDA trial was to investigate whether long-term intervention with SSRI versus placebo affects the cortisol response in the dexamethasone corticotropin-releasing hormone (DEX-CRH) test in healthy first-degree relatives to patients with major depressive disorder (MDD). Methods: Eighty healthy first-degree relatives to patients with MDD were randomized to escitalopram 10 mg versus matching placebo daily for four weeks. The primary outcome measure was the intervention difference in the change of the total area under the curve (CorAUC(total)) for plasma cortisol in the DEX-CRH test at entry to after four weeks of intervention. Results: Change in CorAUCtotal showed no statistically significant difference between the escitalopram and the placebo group, p = 0.47. There were large intra-and inter-individual differences in the results of the DEX-CRH test. There was statistically significant negative correlation between the plasma escitalopram concentration and change in CorAUC(total), rho = -0.41, p = 0.01. Post-hoc analyses showed a statistically significant interaction between age and intervention group and change in log CorAUC(total). Conclusion: The present trial does not support an effect of escitalopram 10 mg daily compared with placebo on the HPA-axis in healthy first-degree relatives to patients with MDD. Increasing levels of escitalopram tended to decrease the HPA-response in the DEX-CRH test and this effect increased with age.	[Knorr, Ulla; Vinberg, Maj; Hansen, Allan; Kessing, Lars Vedel] Copenhagen Univ Hosp, Rigshosp, Dept Psychiat Copenhagen, Copenhagen, Denmark; [Klose, Marianne; Feldt-Rasmussen, Ulla] Copenhagen Univ Hosp, Rigshosp, Dept Med Endocrinol, Copenhagen, Denmark; [Hilsted, Linda] Copenhagen Univ Hosp, Rigshosp, Dept Clin Biochem, Copenhagen, Denmark; [Hasselstrom, Jorgen] Aarhus Univ Hosp, Ctr Psychiat Res, Dept Clin Biochem, DK-8000 Aarhus, Denmark; [Knorr, Ulla; Gether, Ulrik] Univ Copenhagen, Dept Neurosci & Pharmacol, Ctr Pharmacogenom, Copenhagen, Denmark; [Winkel, Per; Gluud, Christian; Wetterslev, Jorn] Copenhagen Univ Hosp, Rigshosp, Ctr Clin Intervent Res, Copenhagen Trial Unit, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Aarhus University; University of Copenhagen; Rigshospitalet; University of Copenhagen	Knorr, U (corresponding author), Copenhagen Univ Hosp, Rigshosp, Dept Psychiat Copenhagen, Copenhagen, Denmark.	ulla.knorr@regionh.dk	Wetterslev, Jørn/ABF-1251-2020; Feldt-Rasmussen, Ulla/AAB-9218-2021; Vinberg/ABC-7493-2021; Gluud, Christian/HGB-3191-2022; Gluud, Christian/AAY-1027-2021; Hilsted, Linda/AAC-5921-2022	Wetterslev, Jørn/0000-0001-7778-1771; Feldt-Rasmussen, Ulla/0000-0002-5903-3355; Vinberg/0000-0002-5982-1335; Gluud, Christian/0000-0002-8861-0799; Kessing, Lars/0000-0001-9377-9436; Gether, Ulrik/0000-0002-0020-3807; Knorr, Ulla/0000-0002-1222-1527	Center for Pharmacogenomics, University of Copenhagen; Danish Research Council; University of Copenhagen; Lundbeck Foundation; Lundbeck Foundation [R17-2007-1798] Funding Source: researchfish	Center for Pharmacogenomics, University of Copenhagen; Danish Research Council(Det Frie Forskningsrad (DFF)); University of Copenhagen; Lundbeck Foundation(Lundbeckfonden); Lundbeck Foundation(Lundbeckfonden)	Ulla Knorr was supported by a fellowship from the Center for Pharmacogenomics, University of Copenhagen. The Danish Research Council, University of Copenhagen and the Lundbeck Foundation supported the trial. H. Lundbeck A/S supplied the trial drug and placebo free of charge. The foundations of Eli Larsen, Jeppe Juhl, Geert Jorgensen, Ivan Nielsen, and Arvid Nilsson gave unrestricted economical support. Roche Diagnostics and Siemens Healthcare Diagnostics supplied the reagents for measurements of plasma cortisol and plasma ACTH, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1999, STAT MED, V18, P1905; [Anonymous], STRUCTURED CLIN INTE; Bech P, 2006, PHARMACOPSYCHIATRY, V39, P128, DOI 10.1055/s-2006-946702; BECH P, 1986, ACTA PSYCHIAT SCAND, V73, P1; Bhagwagar Z, 2002, PSYCHOPHARMACOLOGY, V163, P118, DOI 10.1007/s00213-002-1149-4; Bock Camilla, 2009, Clin Pract Epidemiol Ment Health, V5, P4, DOI 10.1186/1745-0179-5-4; Cipriani A, 2009, LANCET; FULLER RW, 1990, NEUROENDOCRINOLOGY, V52, P206, DOI 10.1159/000125586; Gluud C, 2006, J HEPATOL, V44, P607, DOI 10.1016/j.jhep.2005.12.006; Gluud LL, 2006, AM J EPIDEMIOL, V163, P493, DOI 10.1093/aje/kwj069; Gotzsche PC, 1996, CONTROL CLIN TRIALS, V17, P285, DOI 10.1016/0197-2456(95)00263-4; Gould TD, 2006, GENES BRAIN BEHAV, V5, P113, DOI 10.1111/j.1601-183X.2005.00186.x; Guyatt GH, 2008, PLOS MED, V5, P3, DOI 10.1371/journal.pmed.0050004; Halligan SL, 2004, BIOL PSYCHIAT, V55, P376, DOI 10.1016/j.biopsych.2003.09.013; Hasler G, 2004, NEUROPSYCHOPHARMACOL, V29, P1765, DOI 10.1038/sj.npp.1300506; Hasler G, 2006, BIOL PSYCHIAT, V60, P93, DOI 10.1016/j.biopsych.2005.11.006; HEUSER I, 1994, J PSYCHIAT RES, V28, P341, DOI 10.1016/0022-3956(94)90017-5; Ising M, 2005, PROG NEURO-PSYCHOPH, V29, P1085, DOI 10.1016/j.pnpbp.2005.03.014; Ising M, 2007, BIOL PSYCHIAT, V62, P47, DOI 10.1016/j.biopsych.2006.07.039; Jensen JB, 1999, J NEUROENDOCRINOL, V11, P465; Jongsma ME, 2005, PROG NEURO-PSYCHOPH, V29, P738, DOI 10.1016/j.pnpbp.2005.04.026; KENDELL RE, 1989, PSYCHOL MED, V19, P45, DOI 10.1017/S0033291700011016; Knorr U, 2010, NORD J PSYCHIAT; Knorr U, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-66; Kunugi H, 2006, NEUROPSYCHOPHARMACOL, V31, P212, DOI 10.1038/sj.npp.1300868; Lindstrom E, 2001, NORD J PSYCHIAT, V55, P5, DOI 10.1080/080394801317084428; Lotrich FE, 2005, PSYCHOPHARMACOLOGY, V178, P268, DOI 10.1007/s00213-004-2006-4; Mannie ZN, 2007, AM J PSYCHIAT, V164, P617, DOI 10.1176/appi.ajp.164.4.617; Modell S, 1998, NEUROPSYCHOPHARMACOL, V18, P253; Nadeem HS, 2004, NEUROPSYCHOPHARMACOL, V29, P1699, DOI 10.1038/sj.npp.1300475; Pariante CM, 2004, PSYCHOPHARMACOLOGY, V177, P200, DOI 10.1007/s00213-004-1925-4; ROBINS E, 1970, AM J PSYCHIAT, V126, P983, DOI 10.1176/ajp.126.7.983; Schule C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004324; Seifritz E, 1996, NEUROPSYCHOPHARMACOL, V14, P253, DOI 10.1016/0893-133X(95)00117-V; Sogaard B, 2005, J CLIN PHARMACOL, V45, P1400, DOI 10.1177/0091270005280860; Sullivan LM, 1999, STAT MED, V18, P855, DOI 10.1002/(SICI)1097-0258(19990415)18:7<855::AID-SIM117>3.0.CO;2-7; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779; Vinberg M, 2008, PSYCHIAT RES, V161, P292, DOI 10.1016/j.psychres.2007.08.001; WING JK, 1990, ARCH GEN PSYCHIAT, V47, P589; Winkel P, 2007, STAT DEV QUALITY MED	40	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21224	10.1371/journal.pone.0021224	http://dx.doi.org/10.1371/journal.pone.0021224			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738622	Green Published, gold, Green Submitted			2022-12-27	WOS:000292092600019
J	Mullins, JGL; Parker, JE; Cools, HJ; Togawa, RC; Lucas, JA; Fraaije, BA; Kelly, DE; Kelly, SL				Mullins, Jonathan G. L.; Parker, Josie E.; Cools, Hans J.; Togawa, Roberto C.; Lucas, John A.; Fraaije, Bart A.; Kelly, Diane E.; Kelly, Steven L.			Molecular Modelling of the Emergence of Azole Resistance in Mycosphaerella graminicola	PLOS ONE			English	Article							CANDIDA-ALBICANS; CYP51 GENE; 14-ALPHA-DEMETHYLASE CYP51; SENSITIVITY; FUNGICIDES; MUTATIONS; PROTEIN; SUBSTITUTION; INHIBITION; MECHANISMS	A structural rationale for recent emergence of azole (imidazole and triazole) resistance associated with CYP51 mutations in the wheat pathogen Mycosphaerella graminicola is presented, attained by homology modelling of the wild type protein and 13 variant proteins. The novel molecular models of M. graminicola CYP51 are based on multiple homologues, individually identified for each variant, rather than using a single structural scaffold, providing a robust structure-function rationale for the binding of azoles, including important fungal specific regions for which no structural information is available. The wild type binding pocket reveals specific residues in close proximity to the bound azole molecules that are subject to alteration in the variants. This implicates azole ligands as important agents exerting selection on specific regions bordering the pocket, that become the focus of genetic mutation events, leading to reduced sensitivity to that group of related compounds. Collectively, the models account for several observed functional effects of specific alterations, including loss of triadimenol sensitivity in the Y137F variant, lower sensitivity to tebuconazole of I381V variants and increased resistance to prochloraz of V136A variants. Deletion of Y459 and G460, which brings about removal of that entire section of beta turn from the vicinity of the binding pocket, confers resistance to tebuconazole and epoxiconazole, but sensitivity to prochloraz in variants carrying a combination of A379G I381V Delta Y459/G460. Measurements of binding pocket volume proved useful in assessment of scope for general resistance to azoles by virtue of their accommodation without bonding interaction, particularly when combined with analysis of change in positions of key amino acids. It is possible to predict the likely binding orientation of an azole molecule in any of the variant CYPs, providing potential for an in silico screening system and reliable predictive approach to assess the probability of particular variants exhibiting resistance to particular azole fungicides.	[Mullins, Jonathan G. L.; Parker, Josie E.; Kelly, Diane E.; Kelly, Steven L.] Swansea Univ, Inst Life Sci, Sch Med, Swansea, W Glam, Wales; [Cools, Hans J.; Lucas, John A.; Fraaije, Bart A.] Rothamsted Res, Dept Plant Pathol & Microbiol, Harpenden, Herts, England; [Togawa, Roberto C.] Embrapa Recursos Genet & Biotecnol, Lab Bioinformat, Brasilia, DF, Brazil	Swansea University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Mullins, JGL (corresponding author), Swansea Univ, Inst Life Sci, Sch Med, Swansea, W Glam, Wales.	j.g.l.mullins@swan.ac.uk	Fraaije, Bart/AAL-4604-2021; Lucas, John/D-9699-2013; Cools, Hans/B-5134-2008	Fraaije, Bart/0000-0001-8176-2258; Cools, Hans/0000-0003-2932-7130; Parker, Josie/0000-0002-3855-4194; Mullins, Jonathan/0000-0003-0144-2962; Togawa, Roberto/0000-0001-7179-3210	Biotechnology and Biological Sciences Research Council (BBSRC); Biotechnology and Biological Sciences Research Council [BB/E02257X/1] Funding Source: researchfish; BBSRC [BB/E02257X/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Part of this work was supported by a grant from the Biotechnology and Biological Sciences Research Council (BBSRC). Rothamsted Research is an Institute of the BBSRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bean TP, 2009, FEMS MICROBIOL LETT, V296, P266, DOI 10.1111/j.1574-6968.2009.01645.x; BOSCOTT PE, 1994, J MOL GRAPH MODEL, V12, P185, DOI 10.1016/0263-7855(94)80086-3; Brunner PC, 2008, MOL PLANT PATHOL, V9, P305, DOI 10.1111/J.1364-3703.2007.00464.X; Canas-Gutierrez GP, 2009, PEST MANAG SCI, V65, P892, DOI 10.1002/ps.1770; Cools HJ, 2006, BIOCHEM SOC T, V34, P1219, DOI 10.1042/BST0341219; Cools HJ, 2010, APPL ENVIRON MICROB, V76, P2866, DOI 10.1128/AEM.02158-09; Cools HJ, 2008, PEST MANAG SCI, V64, P681, DOI 10.1002/ps.1568; Delye C, 1998, CURR GENET, V34, P399, DOI 10.1007/s002940050413; Delye C, 1997, GENE, V195, P29, DOI 10.1016/S0378-1119(97)00141-8; Eswar N, 2003, NUCLEIC ACIDS RES, V31, P3375, DOI 10.1093/nar/gkg543; Ferreira MED, 2005, MED MYCOL, V43, pS313, DOI 10.1080/13693780400029114; Fraaije BA, 2007, MOL PLANT PATHOL, V8, P245, DOI [10.1111/j.1364-3703.2007.00388.x, 10.1111/j.1364-3703.2007.00388.X]; Grunberg R, 2007, BIOINFORMATICS, V23, P769, DOI 10.1093/bioinformatics/btl655; HARDWICK NV, 2001, FACTORS AFFECTING DI, P1989; Hendlich M, 1997, J MOL GRAPH MODEL, V15, P359, DOI 10.1016/S1093-3263(98)00002-3; JEFCOATE CR, 1978, BIOMEMBRANES C; Kelly SL, 1999, FEMS MICROBIOL LETT, V180, P171, DOI 10.1111/j.1574-6968.1999.tb08792.x; Lamb DC, 1997, FEMS MICROBIOL LETT, V149, P25, DOI 10.1111/j.1574-6968.1997.tb10303.x; LEROUX P, 2010, PEST MANAG SCI; Leroux P, 2007, PEST MANAG SCI, V63, P688, DOI 10.1002/ps.1390; Marichal P, 1999, MICROBIOL-SGM, V145, P2701, DOI 10.1099/00221287-145-10-2701; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Podust LM, 2001, P NATL ACAD SCI USA, V98, P3068, DOI 10.1073/pnas.061562898; Sanglard D, 1998, ANTIMICROB AGENTS CH, V42, P241, DOI 10.1093/jac/42.2.241; Stammler G, 2008, CROP PROT, V27, P1448, DOI 10.1016/j.cropro.2008.07.007; Stergiopoulos I, 2003, PEST MANAG SCI, V59, P1333, DOI 10.1002/ps.766; Strushkevich N, 2010, J MOL BIOL, V397, P1067, DOI 10.1016/j.jmb.2010.01.075; Wheeler DL, 2007, NUCLEIC ACIDS RES, V35, pD5, DOI 10.1093/nar/gkl1031; Wyand RA, 2005, FUNGAL GENET BIOL, V42, P726, DOI 10.1016/j.fgb.2005.04.007	31	68	71	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e20973	10.1371/journal.pone.0020973	http://dx.doi.org/10.1371/journal.pone.0020973			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738598	Green Published, gold, Green Submitted			2022-12-27	WOS:000292092600009
J	Shih, YL; Huang, KF; Lai, HM; Liao, JH; Lee, CS; Chang, CM; Mak, HM; Hsieh, CW; Lin, CC				Shih, Yu-Ling; Huang, Kai-Fa; Lai, Hsin-Mei; Liao, Jiahn-Haur; Lee, Chai-Siah; Chang, Chiao-Min; Mak, Huey-Ming; Hsieh, Cheng-Wei; Lin, Chu-Chi			The N-Terminal Amphipathic Helix of the Topological Specificity Factor MinE Is Associated with Shaping Membrane Curvature	PLOS ONE			English	Article							DIVISION SITE SELECTION; CELL-DIVISION; ESCHERICHIA-COLI; STRUCTURAL BASIS; HYDROPHOBIC RESIDUES; CRYSTAL-STRUCTURE; PROPER PLACEMENT; DYNAMIN; PHOSPHOLIPIDS; LOCALIZATION	Pole-to-pole oscillations of the Min proteins in Escherichia coli are required for the proper placement of the division septum. Direct interaction of MinE with the cell membrane is critical for the dynamic behavior of the Min system. In vitro, this MinE-membrane interaction led to membrane deformation; however, the underlying mechanism remained unclear. Here we report that MinE-induced membrane deformation involves the formation of an amphipathic helix of MinE 2-9, which, together with the adjacent basic residues, function as membrane anchors. Biochemical evidence suggested that the membrane association induces formation of the helix, with the helical face, consisting of A2, L3, and F6, inserted into the membrane. Insertion of this helix into the cell membrane can influence local membrane curvature and lead to drastic changes in membrane topology. Accordingly, MinE showed characteristic features of protein-induced membrane tubulation and lipid clustering in in vitro reconstituted systems. In conclusion, MinE shares common protein signatures with a group of membrane trafficking proteins in eukaryotic cells. These MinE signatures appear to affect membrane curvature.	[Shih, Yu-Ling; Huang, Kai-Fa; Liao, Jiahn-Haur; Lee, Chai-Siah; Chang, Chiao-Min; Mak, Huey-Ming; Hsieh, Cheng-Wei; Lin, Chu-Chi] Acad Sinica, Inst Biol Chem, Taipei, Taiwan; [Shih, Yu-Ling; Lai, Hsin-Mei] Natl Taiwan Univ, Inst Biochem Sci, Taipei, Taiwan	Academia Sinica - Taiwan; National Taiwan University	Shih, YL (corresponding author), Acad Sinica, Inst Biol Chem, Taipei, Taiwan.	ylshih10@gate.sinica.edu.tw	Shih, Yu-Ling/F-8396-2011	Shih, Yu-Ling/0000-0002-8232-2569; Lee, Chai Siah/0000-0002-7688-4469	Academia Sinica [AS97-FP-M02-2, AS98-CDA-L07]; National Science Council, Taiwan [NSC97-2311-B-001-010-MY3]	Academia Sinica(Academia Sinica - Taiwan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work is supported by Academia Sinica (AS97-FP-M02-2, AS98-CDA-L07) and the National Science Council (NSC97-2311-B-001-010-MY3), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DW, 2009, NAT REV MICROBIOL, V7, P642, DOI 10.1038/nrmicro2198; Antonny B, 1997, BIOCHEMISTRY-US, V36, P4675, DOI 10.1021/bi962252b; Barr FA, 2007, CELL, V131, P847, DOI 10.1016/j.cell.2007.11.011; Bigay J, 2005, EMBO J, V24, P2244, DOI 10.1038/sj.emboj.7600714; Campelo F, 2010, FEBS LETT, V584, P1830, DOI 10.1016/j.febslet.2009.10.023; Casamayor A, 2003, MOL CELL BIOL, V23, P2762, DOI 10.1128/MCB.23.8.2762-2777.2003; Cho W, 2005, PROTEIN-LIPID INTERACTIONS: FROM MEMBRANE DOMAINS TO CELLULAR NETWORKS, P369; DEBOER PAJ, 1989, CELL, V56, P641, DOI 10.1016/0092-8674(89)90586-2; DEBOER PAJ, 1988, J BACTERIOL, V170, P2106, DOI 10.1128/jb.170.5.2106-2112.1988; Feig Michael, 2008, V443, P181, DOI 10.1007/978-1-59745-177-2_10; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Frost A, 2008, CELL, V132, P807, DOI 10.1016/j.cell.2007.12.041; Fu XL, 2001, P NATL ACAD SCI USA, V98, P980, DOI 10.1073/pnas.031549298; Ghasriani H, 2010, P NATL ACAD SCI USA, V107, P18416, DOI 10.1073/pnas.1007141107; Goldberg J, 1998, CELL, V95, P237, DOI 10.1016/S0092-8674(00)81754-7; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Howard M, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.278102; Hsieh CW, 2010, MOL MICROBIOL, V75, P499, DOI 10.1111/j.1365-2958.2009.07006.x; Hu ZL, 1999, P NATL ACAD SCI USA, V96, P14819, DOI 10.1073/pnas.96.26.14819; Hu ZL, 2002, P NATL ACAD SCI USA, V99, P6761, DOI 10.1073/pnas.102059099; Huang KC, 2003, P NATL ACAD SCI USA, V100, P12724, DOI 10.1073/pnas.2135445100; Huang MD, 2001, J CELL BIOL, V155, P937, DOI 10.1083/jcb.200106039; Im W, 2005, P NATL ACAD SCI USA, V102, P6771, DOI 10.1073/pnas.0408135102; Kang GB, 2010, MOL MICROBIOL, V76, P1222, DOI 10.1111/j.1365-2958.2010.07160.x; King GF, 1999, MOL MICROBIOL, V31, P1161, DOI 10.1046/j.1365-2958.1999.01256.x; King GF, 2000, NAT STRUCT BIOL, V7, P1013, DOI 10.1038/80917; Kozlov MM, 2010, NATURE, V463, P439, DOI 10.1038/463439a; Kraft CA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.299pl4; Krauss M, 2008, J BIOL CHEM, V283, P27717, DOI 10.1074/jbc.M804528200; Lee MCS, 2005, CELL, V122, P605, DOI 10.1016/j.cell.2005.07.025; Li Z, 2007, EMBO J, V26, P4694, DOI 10.1038/sj.emboj.7601895; Lindas AC, 2008, P NATL ACAD SCI USA, V105, P18942, DOI 10.1073/pnas.0809467105; Lonhienne TGA, 2010, P NATL ACAD SCI USA, V107, P12883, DOI 10.1073/pnas.1001085107; Low HH, 2006, NATURE, V444, P766, DOI 10.1038/nature05312; Low HH, 2009, CELL, V139, P1342, DOI 10.1016/j.cell.2009.11.003; Lundmark R, 2008, BIOCHEM J, V414, P189, DOI 10.1042/BJ20081237; Martens S, 2007, SCIENCE, V316, P1205, DOI 10.1126/science.1142614; Mileykovskaya E, 2003, J BIOL CHEM, V278, P22193, DOI 10.1074/jbc.M302603200; Mileykovskaya E, 2009, BBA-BIOMEMBRANES, V1788, P2084, DOI 10.1016/j.bbamem.2009.04.003; Osawa M, 2009, EMBO J, V28, P3476, DOI 10.1038/emboj.2009.277; PICHOFF S, 1995, MOL MICROBIOL, V18, P321, DOI 10.1111/j.1365-2958.1995.mmi_18020321.x; Pucadyil TJ, 2009, SCIENCE, V325, P1217, DOI 10.1126/science.1171004; Raskin DM, 1999, P NATL ACAD SCI USA, V96, P4971, DOI 10.1073/pnas.96.9.4971; Roux A, 2006, NATURE, V441, P528, DOI 10.1038/nature04718; Samson RY, 2008, SCIENCE, V322, P1710, DOI 10.1126/science.1165322; Schwille P, 2009, CRIT REV BIOCHEM MOL, V44, P223, DOI 10.1080/10409230903074549; Shih YL, 2003, P NATL ACAD SCI USA, V100, P7865, DOI 10.1073/pnas.1232225100; Shih YL, 2002, EMBO J, V21, P3347, DOI 10.1093/emboj/cdf323; Suefuji K, 2002, P NATL ACAD SCI USA, V99, P16776, DOI 10.1073/pnas.262671699; Szeto TH, 2002, P NATL ACAD SCI USA, V99, P15693, DOI 10.1073/pnas.232590599; Tanaka-Takiguchi Y, 2009, CURR BIOL, V19, P140, DOI 10.1016/j.cub.2008.12.030; Vallis Y, 1999, CURR BIOL, V9, P257, DOI 10.1016/S0960-9822(99)80114-6; Zheng J, 1996, J MOL BIOL, V255, P14, DOI 10.1006/jmbi.1996.0002; Zhou H, 2003, J BACTERIOL, V185, P4326, DOI 10.1128/JB.185.15.4326-4335.2003	55	31	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21425	10.1371/journal.pone.0021425	http://dx.doi.org/10.1371/journal.pone.0021425			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738659	Green Published, Green Submitted, gold			2022-12-27	WOS:000292092600039
J	Eberle, KE; Sansing, HA; Szaniszlo, P; Resto, VA; Berrier, AL				Eberle, Karen E.; Sansing, Hope A.; Szaniszlo, Peter; Resto, Vicente A.; Berrier, Allison L.			Carcinoma Matrix Controls Resistance to Cisplatin through Talin Regulation of NF-kB	PLOS ONE			English	Article							FOCAL ADHESION KINASE; KAPPA-B KINASE; EXTRACELLULAR-MATRIX; DRUG-RESISTANCE; HUMAN HEAD; CANCER; ACTIVATION; SRC; INTEGRINS; PATHWAYS	Extracellular matrix factors within the tumor microenvironment that control resistance to chemotherapeutics are poorly understood. This study focused on understanding matrix adhesion pathways that control the oral carcinoma response to cisplatin. Our studies revealed that adhesion of HN12 and JHU012 oral carcinomas to carcinoma matrix supported tumor cell proliferation in response to treatment with cisplatin. Proliferation in response to 30 mu M cisplatin was not observed in HN12 cells adherent to other purified extracellular matrices such as Matrigel, collagen I, fibronectin or laminin I. Integrin beta(1) was important for adhesion to carcinoma matrix to trigger proliferation after treatment with cisplatin. Disruption of talin expression in HN12 cells adherent to carcinoma matrix increased cisplatin induced proliferation. Pharmacological inhibitors were used to determine signaling events required for talin deficiency to regulate cisplatin induced proliferation. Pharmacological inhibition of NF-kB reduced proliferation of talin-deficient HN12 cells treated with 30 mu M cisplatin. Nuclear NF-kB activity was assayed in HN12 cells using a luciferase reporter of NF-kB transcriptional activity. Nuclear NF-kB activity was similar in HN12 cells adherent to carcinoma matrix and collagen I when treated with vehicle DMSO. Following treatment with 30 mM cisplatin, NF-kB activity is maintained in cells adherent to carcinoma matrix whereas NF-kB activity is reduced in collagen I adherent cells. Expression of talin was sufficient to trigger proliferation of HN12 cells adherent to collagen I following treatment with 1 and 30 mu M cisplatin. Talin overexpression was sufficient to trigger NF-kB activity following treatment with cisplatin in carcinoma matrix adherent HN12 cells in a process disrupted by FAK siRNA. Thus, adhesions within the carcinoma matrix create a matrix environment in which exposure to cisplatin induces proliferation through the function of integrin beta(1), talin and FAK pathways that regulate NF-kB nuclear activity.	[Eberle, Karen E.; Sansing, Hope A.; Berrier, Allison L.] Louisiana State Univ, Hlth Sci Ctr New Orleans, Sch Dent, Dept Oral & Craniofacial Biol, New Orleans, LA 70112 USA; [Szaniszlo, Peter; Resto, Vicente A.] Univ Texas Med Branch Hlth, Univ Texas Med Branch, Ctr Canc, Dept Otolaryngol, Galveston, TX 77555 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University of Texas System; University of Texas Medical Branch Galveston	Eberle, KE (corresponding author), Louisiana State Univ, Hlth Sci Ctr New Orleans, Sch Dent, Dept Oral & Craniofacial Biol, New Orleans, LA 70112 USA.	allison.berrier@gmail.com	Resto, Vicente/D-9891-2014		LSUHSC-NO School of Dentistry; National Cancer Institute [1K08CA132988-01A2]; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [K08CA132988] Funding Source: NIH RePORTER	LSUHSC-NO School of Dentistry; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	ALB was supported by the LSUHSC-NO School of Dentistry and VAR by National Cancer Institute 1K08CA132988-01A2 and Howard Hughes Medical Institute Physician Scientist Early Career Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuzeid WM, 2009, J CLIN INVEST, V119, P1974, DOI 10.1172/JCI33816; Aleshin A, 2010, NEOPLASIA, V12, P599, DOI 10.1593/neo.10328; Aoki K, 2004, ONCOL REP, V11, P375; Benhar M, 2002, ONCOGENE, V21, P8723, DOI 10.1038/sj.onc.1205980; BENTON G, 2010, INT J CANC; Berrier A, 1998, J IMMUNOL, V161, P2267; Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237; Berrier Allison L., 2004, V294, P55; Bharti AC, 2002, BIOCHEM PHARMACOL, V64, P883, DOI 10.1016/S0006-2952(02)01154-1; CARDINALI M, 1995, INT J CANCER, V61, P98, DOI 10.1002/ijc.2910610117; Castello-Cros R, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-94; Castello-Cros Remedios, 2009, V522, P275, DOI 10.1007/978-1-59745-413-1_19; CHEN HC, 1995, J BIOL CHEM, V270, P16995, DOI 10.1074/jbc.270.28.16995; Chrenek MA, 2001, BREAST CANCER RES, V3, P224, DOI 10.1186/bcr300; Critchley DR, 2008, J CELL SCI, V121, P1345, DOI 10.1242/jcs.018085; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Defilippi P, 2006, TRENDS CELL BIOL, V16, P257, DOI 10.1016/j.tcb.2006.03.003; Egles C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010528; Franco SJ, 2004, NAT CELL BIOL, V6, P977, DOI 10.1038/ncb1175; Funk SD, 2010, CIRC RES, V106, P1394, DOI 10.1161/CIRCRESAHA.109.210286; Gabarra-Niecko V, 2003, CANCER METAST REV, V22, P359, DOI 10.1023/A:1023725029589; Green JA, 2009, J BIOL CHEM, V284, P8148, DOI 10.1074/jbc.M805934200; Hodkinson PS, 2007, INT J RADIAT BIOL, V83, P733, DOI 10.1080/09553000701570204; Kim HE, 2000, CLIN CANCER RES, V6, P4142; Kim W, 2004, J BIOL CHEM, V279, P8333, DOI 10.1074/jbc.M312026200; Kook S, 2000, MOL BIOL CELL, V11, P929, DOI 10.1091/mbc.11.3.929; Kruegel J, 2010, CELL MOL LIFE SCI, V67, P2879, DOI 10.1007/s00018-010-0367-x; LAI MT, 2011, J PATHOL; Lamar JM, 2008, CANCER RES, V68, P7371, DOI 10.1158/0008-5472.CAN-08-1080; Lee S, 2005, GYNECOL ONCOL, V97, P26, DOI 10.1016/j.ygyno.2004.11.051; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Li F, 2010, BBA-REV CANCER, V1805, P167, DOI 10.1016/j.bbcan.2010.01.002; Liu SC, 2000, J CELL SCI, V113, P3563; Masumoto N, 1999, INT J CANCER, V80, P731, DOI 10.1002/(SICI)1097-0215(19990301)80:5<731::AID-IJC17>3.0.CO;2-H; Maubant S, 2002, B CANCER, V89, P923; Morin PJ, 2003, DRUG RESIST UPDATE, V6, P169, DOI 10.1016/S1368-7646(03)00059-1; Parsons JT, 2008, CLIN CANCER RES, V14, P627, DOI 10.1158/1078-0432.CCR-07-2220; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Peng X, 2011, CURR PROTEIN PEPT SC, V12, P52, DOI 10.2174/138920311795659452; Pengetnze Y, 2003, BIOCHEM BIOPH RES CO, V309, P377, DOI 10.1016/j.bbrc.2003.08.012; Peterson-Roth E, 2009, CANCER RES, V69, P3619, DOI 10.1158/0008-5472.CAN-08-0985; Petzold T, 2009, AM J PHYSIOL-CELL PH, V297, pC814, DOI 10.1152/ajpcell.00226.2009; Puigvert JC, 2009, MOL PHARMACOL, V75, P947, DOI 10.1124/mol.108.051649; Sakamoto S, 2010, CANCER RES, V70, P1885, DOI 10.1158/0008-5472.CAN-09-2833; SANSING HA, 2011, BIOCH BIOPHYS RES CO; Schultze A, 2010, EXPERT OPIN INV DRUG, V19, P777, DOI 10.1517/13543784.2010.489548; Serebriiskii I, 2008, MATRIX BIOL, V27, P573, DOI 10.1016/j.matbio.2008.02.008; Shamimi-Noori S, 2008, CANCER GENE THER, V15, P356, DOI 10.1038/sj.cgt.7701120; Sherman-Baust CA, 2003, CANCER CELL, V3, P377, DOI 10.1016/S1535-6108(03)00058-8; Snider JL, 2008, J BIOL CHEM, V283, P13952, DOI 10.1074/jbc.M800289200; Specenier PM, 2007, CANCER LETT, V256, P166, DOI 10.1016/j.canlet.2007.06.015; Tamatani T, 2004, INT J CANCER, V108, P912, DOI 10.1002/ijc.11640; Tamatani T, 2001, CANCER LETT, V171, P165, DOI 10.1016/S0304-3835(01)00611-5; Tikhmyanova N, 2010, CELL MOL LIFE SCI, V67, P1025, DOI 10.1007/s00018-009-0213-1; Van Waes C, 2007, CLIN CANCER RES, V13, P4956, DOI 10.1158/1078-0432.CCR-07-1287; Vlodavsky I, 2001, Curr Protoc Cell Biol, VChapter 10, DOI 10.1002/0471143030.cb1004s01; Wang JH, 2003, J IMMUNOL, V170, P795, DOI 10.4049/jimmunol.170.2.795; Woessmann W, 2002, CANCER CHEMOTH PHARM, V50, P397, DOI 10.1007/s00280-002-0502-y; Zhang X, 2008, NAT CELL BIOL, V10, P1062, DOI 10.1038/ncb1765; Zhao J, 2009, CANCER METAST REV, V28, P35, DOI 10.1007/s10555-008-9165-4	61	33	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21496	10.1371/journal.pone.0021496	http://dx.doi.org/10.1371/journal.pone.0021496			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21720550	Green Published, gold, Green Submitted			2022-12-27	WOS:000292036900043
J	Libera, DD; Di Mitri, D; Bergami, A; Centonze, D; Gasperini, C; Grasso, MG; Galgani, S; Martinelli, V; Comi, G; Avolio, C; Martino, G; Borsellino, G; Sallusto, F; Battistini, L; Furlan, R				Libera, Dacia Dalla; Di Mitri, Diletta; Bergami, Alessandra; Centonze, Diego; Gasperini, Claudio; Grasso, Maria Grazia; Galgani, Simona; Martinelli, Vittorio; Comi, Giancarlo; Avolio, Carlo; Martino, Gianvito; Borsellino, Giovanna; Sallusto, Federica; Battistini, Luca; Furlan, Roberto			T Regulatory Cells Are Markers of Disease Activity in Multiple Sclerosis Patients	PLOS ONE			English	Article							DIAGNOSTIC-CRITERIA; IN-VITRO; FOXP3; EXPRESSION; CTLA4; INTERLEUKIN-2; AUTOIMMUNITY; INFLAMMATION; TOLERANCE; SECONDARY	FoxP3(+) Treg cells are believed to play a role in the occurrence of autoimmunity and in the determination of clinical recurrences. Contradictory reports are, however, available describing frequency and function of Treg cells during autoimmune diseases. We examined, by both polychromatic flow cytometry, and real-time RT-PCR, several Treg markers in peripheral blood mononuclear cells from patients with multiple sclerosis (MS), an autoimmune disease affecting the central nervous system. We found that Tregs, as defined by CD25, CD39, FoxP3, CTLA4, and GITR expression, were significantly decreased in stable MS patients as compared to healthy donors, but, surprisingly, restored to normal levels during an acute clinical attack. We conclude that Treg cells are not involved in causing clinical relapses, but rather react to inflammation in the attempt to restore homeostasis.	[Libera, Dacia Dalla; Bergami, Alessandra; Martinelli, Vittorio; Comi, Giancarlo; Martino, Gianvito; Furlan, Roberto] Ist Sci San Raffaele, Inst Expt Neurol, Div Neurosci, I-20132 Milan, Italy; [Di Mitri, Diletta; Centonze, Diego; Grasso, Maria Grazia; Borsellino, Giovanna; Battistini, Luca] Fdn Santa Lucia, Rome, Italy; [Centonze, Diego] Univ Roma Tor Vergata, Dipartimento Neurosci, Rome, Italy; [Gasperini, Claudio; Galgani, Simona] San Camillo Hosp, Lancisi Neurol Unit, Rome, Italy; [Avolio, Carlo] Univ Foggia, Dept Med & Occupat Sci, Foggia, Italy; [Sallusto, Federica] Inst Res Biomed, Bellinzona, Switzerland	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; IRCCS Santa Lucia; University of Rome Tor Vergata; University of Foggia; Universita della Svizzera Italiana	Libera, DD (corresponding author), Ist Sci San Raffaele, Inst Expt Neurol, Div Neurosci, I-20132 Milan, Italy.	furlan.roberto@hsr.it	Martinelli, Vittorio/AAN-7240-2020; martino, gianvito/AAL-2682-2020; Centonze, Diego/J-7767-2016; Furlan, Roberto/N-5224-2019; Borsellino, Giovanna/K-3074-2016; Furlan, Roberto/J-9177-2016; Di Mitri, Diletta/AAA-4273-2019; Battistini, luca/ABE-1882-2021; Battistini, Luca/D-6920-2014; gasperini, claudio/K-5093-2016	martino, gianvito/0000-0003-1295-9131; Centonze, Diego/0000-0002-8390-8545; Furlan, Roberto/0000-0001-7376-9425; Borsellino, Giovanna/0000-0002-4227-6481; Furlan, Roberto/0000-0001-7376-9425; Battistini, Luca/0000-0002-6488-4891; grasso, maria grazia/0000-0003-1582-5534; Dalla Libera, Dacia/0000-0001-5028-4177; DI MITRI, DILETTA/0000-0002-9626-4259; gasperini, claudio/0000-0002-3959-4067	FISM; Italian Ministry of Health; Italian Ministry of Research	FISM(Fondazione Italiana Sclerosi Multipla (FISM)); Italian Ministry of Health(Ministry of Health, Italy); Italian Ministry of Research(Ministry of Education, Universities and Research (MIUR))	This work has been supported by FISM (GB, LB, and RF), the Italian Ministry of Health (LB and RF), and the Italian Ministry of Research (RF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan SE, 2007, INT IMMUNOL, V19, P345, DOI 10.1093/intimm/dxm014; Bacchetta R, 2006, J CLIN INVEST, V116, P1713, DOI 10.1172/JCI25112; Borsellino G, 2007, BLOOD, V110, P1225, DOI 10.1182/blood-2006-12-064527; Carreno BM, 2002, ANNU REV IMMUNOL, V20, P29, DOI 10.1146/annurev.immunol.20.091101.091806; Curiel TJ, 2007, NAT MED, V13, P250, DOI 10.1038/nm0307-250; de Andres C, 2007, J NEUROIMMUNOL, V182, P204, DOI 10.1016/j.jneuroim.2006.09.012; de Kleer IM, 2004, J IMMUNOL, V172, P6435, DOI 10.4049/jimmunol.172.10.6435; de la Rosa M, 2004, EUR J IMMUNOL, V34, P2480, DOI 10.1002/eji.200425274; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Gambineri E, 2003, CURR OPIN RHEUMATOL, V15, P430, DOI 10.1097/00002281-200307000-00010; Gartner D, 2006, J NEUROIMMUNOL, V172, P73, DOI 10.1016/j.jneuroim.2005.11.003; Heggarty S, 2007, J NEUROIMMUNOL, V187, P187, DOI 10.1016/j.jneuroim.2007.04.017; Huan J, 2005, J NEUROSCI RES, V81, P45, DOI 10.1002/jnr.20522; Kasper LH, 2007, J NEUROL, V254, P10, DOI 10.1007/s00415-007-1003-z; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kobie JJ, 2006, J IMMUNOL, V177, P6780, DOI 10.4049/jimmunol.177.10.6780; Kohm AP, 2002, J IMMUNOL, V169, P4712, DOI 10.4049/jimmunol.169.9.4712; Kuniyasu Y, 2000, INT IMMUNOL, V12, P1145, DOI 10.1093/intimm/12.8.1145; Liu GZ, 2008, CLIN EXP IMMUNOL, V154, P22, DOI 10.1111/j.1365-2249.2008.03730.x; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Lublin FD, 1996, NEUROLOGY, V46, P907, DOI 10.1212/WNL.46.4.907; Malferrari G, 2005, EXP MOL PATHOL, V78, P55, DOI 10.1016/j.yexmp.2004.10.001; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Michel L, 2008, J CLIN INVEST, V118, P3411, DOI 10.1172/JCI35365; Oaks MK, 2000, CELL IMMUNOL, V201, P144, DOI 10.1006/cimm.2000.1649; Palacios R, 2008, J NEUROIMMUNOL, V203, P108, DOI 10.1016/j.jneuroim.2008.06.021; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Putheti P, 2004, J CLIN IMMUNOL, V24, P155, DOI 10.1023/B:JOCI.0000019780.93817.82; Read S, 2006, J IMMUNOL, V177, P4376, DOI 10.4049/jimmunol.177.7.4376; Reddy J, 2004, P NATL ACAD SCI USA, V101, P15434, DOI 10.1073/pnas.0404444101; Sakaguchi S, 2001, IMMUNOL REV, V182, P18, DOI 10.1034/j.1600-065X.2001.1820102.x; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Sansom DM, 2006, IMMUNOL REV, V212, P131, DOI 10.1111/j.0105-2896.2006.00419.x; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Venken K, 2006, J NEUROSCI RES, V83, P1432, DOI 10.1002/jnr.20852; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; Vukmanovic-Stejic M, 2008, J CLIN INVEST, V118, P3639, DOI 10.1172/JCI35834; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Zheng Y, 2007, NAT IMMUNOL, V8, P457, DOI 10.1038/ni1455; zur Wiesch JS, 2011, J VIROL, V85, P1287, DOI 10.1128/JVI.01758-10	44	34	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21386	10.1371/journal.pone.0021386	http://dx.doi.org/10.1371/journal.pone.0021386			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21731726	gold, Green Published, Green Submitted			2022-12-27	WOS:000292036900024
J	Yin, LH; Rao, P; Elson, P; Wang, JH; Ittmann, M; Heston, WDW				Yin, Lihong; Rao, Pravin; Elson, Paul; Wang, Jianghua; Ittmann, Michael; Heston, Warren D. W.			Role of TMPRSS2-ERG Gene Fusion in Negative Regulation of PSMA Expression	PLOS ONE			English	Article							MEMBRANE ANTIGEN PSMA; PROSTATE-CANCER PROGRESSION; ANDROGEN RECEPTOR; ERG; INTERNALIZATION; ANTIBODIES; PREDICTOR; CELLS; PTEN	Prostate specific membrane antigen (PSMA) is overexpressed in prostatic adenocarcinoma (CaP), and its expression is negatively regulated by androgen stimulation. However, it is still unclear which factors are involved in this downregulation. TMPRSS2-ERG fusion is the most common known gene rearrangement in prostate carcinoma. Androgen stimulation can increase expression of the TMPRSS2-ERG fusion in fusion positive prostate cancer cells. The purpose of this investigation is to determine whether PSMA expression can be regulated by the TMPRSS2-ERG gene fusion. We employed two PSMA positive cell lines: VCaP cells, which harbor TMPRSS2-ERG fusion, and LNCaP cells, which lack the fusion. After 24 hours of androgen treatment, TMPRSS2-ERG mRNA level was increased in VCaP cells. PSMA mRNA level was dramatically decreased in VCaP cells, while it only has moderate change in LNCaP cells. Treatment with the androgen antagonist flutamide partially restored PSMA expression in androgen-treated VCaP cells. Knocking down ERG by siRNA in VCaP cells enhances PSMA expression both in the presence and absence of synthetic androgen R1881. Overexpressing TMPRSS2-ERG fusions in LNCaP cells downregulated PSMA both in the presence or absence of R1881, while overexpressing wild type ERG did not. Using PSMA-based luciferase reporter assays, we found TMPRSS2-ERG fusion can inhibit PSMA activity at the transcriptional level. Our data indicated that downregulation of PSMA in androgen-treated VCaP cells appears partially mediated by TMPRSS2-ERG gene fusion.	[Yin, Lihong; Heston, Warren D. W.] Cleveland Clin, Dept Canc Biol, Cleveland, OH 44106 USA; [Rao, Pravin; Heston, Warren D. W.] Cleveland Clin, Glickman Urol & Kidney Inst, Cleveland, OH 44106 USA; [Elson, Paul] Cleveland Clin, Dept Quantitat Hlth Sci, Cleveland, OH 44106 USA; [Wang, Jianghua; Ittmann, Michael] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Ittmann, Michael] Michael E DeBakey Vet Affairs Med Ctr VAMC, Houston, TX USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Baylor College of Medicine	Yin, LH (corresponding author), Cleveland Clin, Dept Canc Biol, Cleveland, OH 44106 USA.	hestonw@ccf.org			NIH [CA101069]; WDWH; Department of Defense [DAMD-W81XWH-09-1-0385]; NATIONAL CANCER INSTITUTE [R01CA101069] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); WDWH; Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from NIH CA101069, WDWH and from the Department of Defense Prostate Cancer Research program DAMD-W81XWH-09-1-0385, MI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anilkumar G, 2003, CANCER RES, V63, P2645; Attard G, 2009, CANCER RES, V69, P2912, DOI 10.1158/0008-5472.CAN-08-3667; Bonaccorsi L, 2009, J ENDOCRINOL INVEST, V32, P590, DOI 10.1007/BF03346514; Cai CM, 2009, CANCER RES, V69, P6027, DOI 10.1158/0008-5472.CAN-09-0395; Carver BS, 2009, NAT GENET, V41, P619, DOI 10.1038/ng.370; Chang SS, 1999, CANCER RES, V59, P3192; Chinnaiyan AM, 2008, NEOPLASIA, V10, P177, DOI 10.1593/neo.07822; Demichelis F, 2007, ONCOGENE, V26, P4596, DOI 10.1038/sj.onc.1210237; Ghosh A, 2003, PROSTATE, V57, P140, DOI 10.1002/pros.10289; Haffner MC, 2009, HUM PATHOL, V40, P1754, DOI 10.1016/j.humpath.2009.06.003; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Hu R, 2009, CANCER RES, V69, P16, DOI 10.1158/0008-5472.CAN-08-2764; ISRAELI RS, 1994, CANCER RES, V54, P1807; King JC, 2009, NAT GENET, V41, P524, DOI 10.1038/ng.371; Liu H, 1997, CANCER RES, V57, P3629; Liu H, 1998, CANCER RES, V58, P4055; Makkonen H, 2011, MOL CELL ENDOCRINOL, V331, P57, DOI 10.1016/j.mce.2010.08.008; Minner S, 2011, PROSTATE, V71, P281, DOI 10.1002/pros.21241; Mitsiades C, 2004, CLIN EXP METASTAS, V21, P495, DOI 10.1007/s10585-004-3217-0; O'Keefe DS, 2004, PROSTATE, V58, P200, DOI 10.1002/pros.10319; Perner S, 2007, HUM PATHOL, V38, P696, DOI 10.1016/j.humpath.2006.11.012; Perner S, 2006, CANCER RES, V66, P8337, DOI 10.1158/0008-5472.CAN-06-1482; Ross JS, 2003, CLIN CANCER RES, V9, P6357; Sun C, 2008, ONCOGENE, V27, P5348, DOI 10.1038/onc.2008.183; Tasch J, 2001, CRIT REV IMMUNOL, V21, P249; Tomlins SA, 2006, CANCER RES, V66, P3396, DOI 10.1158/0008-5472.CAN-06-0168; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Waltering KK, 2009, CANCER RES, V69, P8141, DOI 10.1158/0008-5472.CAN-09-0919; Wang JH, 2008, CANCER RES, V68, P8516, DOI 10.1158/0008-5472.CAN-08-1147; Wright GL, 1996, UROLOGY, V48, P326, DOI 10.1016/S0090-4295(96)00184-7; Yu JD, 2010, CANCER CELL, V17, P443, DOI 10.1016/j.ccr.2010.03.018	31	15	15	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21319	10.1371/journal.pone.0021319	http://dx.doi.org/10.1371/journal.pone.0021319			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21731703	Green Published, Green Submitted, gold			2022-12-27	WOS:000292036900021
J	Ronchi, R; Revol, P; Katayama, M; Rossetti, Y; Farne, A				Ronchi, Roberta; Revol, Patrice; Katayama, Masahiro; Rossetti, Yves; Farne, Alessandro			Seeing Your Error Alters My Pointing: Observing Systematic Pointing Errors Induces Sensori-Motor After-Effects	PLOS ONE			English	Article							PRISM ADAPTATION; NEGLECT REHABILITATION; SPATIAL NEGLECT; VISION; COORDINATION; PROPRIOCEPTION; REPRESENTATION; CONSOLIDATION; INTERFERENCE; DISPLACEMENT	During the procedure of prism adaptation, subjects execute pointing movements to visual targets under a lateral optical displacement: As consequence of the discrepancy between visual and proprioceptive inputs, their visuo-motor activity is characterized by pointing errors. The perception of such final errors triggers error-correction processes that eventually result into sensori-motor compensation, opposite to the prismatic displacement (i.e., after-effects). Here we tested whether the mere observation of erroneous pointing movements, similar to those executed during prism adaptation, is sufficient to produce adaptation-like after-effects. Neurotypical participants observed, from a first-person perspective, the examiner's arm making incorrect pointing movements that systematically overshot visual targets location to the right, thus simulating a rightward optical deviation. Three classical after-effect measures (proprioceptive, visual and visual-proprioceptive shift) were recorded before and after first-person's perspective observation of pointing errors. Results showed that mere visual exposure to an arm that systematically points on the right-side of a target (i.e., without error correction) produces a leftward after-effect, which mostly affects the observer's proprioceptive estimation of her body midline. In addition, being exposed to such a constant visual error induced in the observer the illusion "to feel'' the seen movement. These findings indicate that it is possible to elicit sensori-motor after-effects by mere observation of movement errors.	[Ronchi, Roberta; Revol, Patrice; Rossetti, Yves; Farne, Alessandro] CNRS, INSERM, U1028, Lyon Neurosci Res Ctr,ImpAct Team,UMR5292, Lyon, France; [Ronchi, Roberta; Rossetti, Yves; Farne, Alessandro] Univ Lyon 1, F-69365 Lyon, France; [Revol, Patrice; Rossetti, Yves; Farne, Alessandro] Hop Neurol Mouvement & Handicap, Hosp Civils Lyon, Lyon, France; [Katayama, Masahiro] Senri Chuou Hosp, Dept Neurol, Toyonaka, Osaka, Japan; [Katayama, Masahiro] Kobe Univ, Grad Sch Med, Dept Community Med & Social Healthcare Sci, Chuo Ku, Kobe, Hyogo 657, Japan; [Ronchi, Roberta] Univ Milano Bicocca, Dept Psychol, Milan, Italy; [Ronchi, Roberta] IRCCS Ist Auxol Italiano, Osped S Luca, Neuropsychol Lab, Milan, Italy	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Kobe University; University of Milano-Bicocca; IRCCS Istituto Auxologico Italiano	Ronchi, R (corresponding author), CNRS, INSERM, U1028, Lyon Neurosci Res Ctr,ImpAct Team,UMR5292, Lyon, France.	r.ronchi@auxologico.it; yves.rossetti@inserm.fr	FARNE, ALESSANDRO/G-1238-2015; Rossetti, Yves/H-3693-2017	FARNE, ALESSANDRO/0000-0001-5769-3491; Rossetti, Yves/0000-0001-8867-4496	ANR [RPV08085CSA]; INSERM AVENIR [R05265CS]; Marie Curie RTN; Hospices Civiles de Lyon	ANR(French National Research Agency (ANR)); INSERM AVENIR(Institut National de la Sante et de la Recherche Medicale (Inserm)); Marie Curie RTN(European Commission); Hospices Civiles de Lyon	The study was supported by the ANR grant No. RPV08085CSA, the INSERM AVENIR grant No. R05265CS, the Marie Curie RTN grant Discos and the PHRC grant from the Hospices Civiles de Lyon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECKETT PA, 1980, J EXP PSYCHOL HUMAN, V6, P433, DOI 10.1037/0096-1523.6.3.433; Belopolsky AV, 2008, ACTA PSYCHOL, V128, P56, DOI 10.1016/j.actpsy.2007.09.012; Bird G, 2005, BRIT J PSYCHOL, V96, P371, DOI 10.1348/000712605X47440; BrashersKrug T, 1996, NATURE, V382, P252, DOI 10.1038/382252a0; Buccino G, 2007, NEUROIMAGE, V36, pT119, DOI 10.1016/j.neuroimage.2007.03.036; Cross ES, 2009, CEREB CORTEX, V19, P315, DOI 10.1093/cercor/bhn083; Desmurget M, 2000, TRENDS COGN SCI, V4, P423, DOI 10.1016/S1364-6613(00)01537-0; Diedrichsen J, 2005, J NEUROSCI, V25, P9919, DOI 10.1523/JNEUROSCI.1874-05.2005; Dijkerman HC, 2007, EXP BRAIN RES, V176, P387, DOI 10.1007/s00221-006-0627-z; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; Dupierrix E, 2008, BRAIN RES, V1214, P127, DOI 10.1016/j.brainres.2008.01.021; Dupierrix E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004465; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; Farne A, 2002, NEUROPSYCHOLOGIA, V40, P718, DOI 10.1016/S0028-3932(01)00186-5; Fernandez-Ruiz J, 2000, COGNITIVE BRAIN RES, V9, P223, DOI 10.1016/S0926-6410(99)00057-9; FINKE RA, 1979, COGNITIVE PSYCHOL, V11, P235, DOI 10.1016/0010-0285(79)90011-2; Fortis P, 2010, NEUROPSYCHOLOGY, V24, P681, DOI 10.1037/a0019476; Frassinetti F, 2002, BRAIN, V125, P608, DOI 10.1093/brain/awf056; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gianelli C, 2008, BRAIN RES, V1218, P166, DOI 10.1016/j.brainres.2008.04.046; Girardi M, 2004, NEUROPSYCHOLOGIA, V42, P1477, DOI 10.1016/j.neuropsychologia.2004.03.008; Gribble PL, 2002, NATURE, V417, P938, DOI 10.1038/nature00834; Hatada Y, 2006, EXP BRAIN RES, V169, P417, DOI 10.1007/s00221-005-0159-y; Hatada Y, 2006, EXP BRAIN RES, V173, P415, DOI 10.1007/s00221-006-0381-2; HELD R, 1963, SCIENCE, V142, P455, DOI 10.1126/science.142.3591.455; Heyes CM, 2002, Q J EXP PSYCHOL-A, V55, P593, DOI 10.1080/02724980143000389; Ingram HA, 2000, EXP BRAIN RES, V132, P114, DOI 10.1007/s002219900322; Jacquin-Courtois S, 2010, BRAIN, V133, P895, DOI 10.1093/brain/awp327; Jeannerod M, 1995, CURR OPIN NEUROBIOL, V5, P727, DOI 10.1016/0959-4388(95)80099-9; JEANNEROD M, 1993, BAILLIERE CLIN NEUR, V2, P439; Kilner JM, 2003, CURR BIOL, V13, P522, DOI 10.1016/S0960-9822(03)00165-9; KORNHEISER AS, 1976, PSYCHOL BULL, V83, P783, DOI 10.1037/0033-2909.83.5.783; Krakauer JW, 2006, TRENDS NEUROSCI, V29, P58, DOI 10.1016/j.tins.2005.10.003; Longo MR, 2008, COGNITION, V107, P978, DOI 10.1016/j.cognition.2007.12.004; Luaute J, 2006, NEUROLOGY, V66, P1859, DOI 10.1212/01.wnl.0000219614.33171.01; Luaute J, 2009, J NEUROSCI, V29, P169, DOI 10.1523/JNEUROSCI.3054-08.2009; Massen C, 2007, J EXP PSYCHOL LEARN, V33, P1118, DOI 10.1037/0278-7393.33.6.1118; Mattar AAG, 2005, NEURON, V46, P153, DOI 10.1016/j.neuron.2005.02.009; Milner AD, 2005, CURR OPIN NEUROL, V18, P748, DOI 10.1097/01.wco.0000191512.60368.ee; Newport R, 2010, EXP BRAIN RES, V204, P385, DOI 10.1007/s00221-009-2104-y; Nys GMS, 2008, RESTOR NEUROL NEUROS, V26, P1; PICK HL, 1965, PERCEPT MOTOR SKILL, V20, P1070, DOI 10.2466/pms.1965.20.3c.1070; Pisella L, 2006, CURR OPIN NEUROL, V19, P534, DOI 10.1097/WCO.0b013e328010924b; Raos V, 2007, J NEUROSCI, V27, P12675, DOI 10.1523/JNEUROSCI.2988-07.2007; Redding GA, 2006, NEUROPSYCHOLOGIA, V44, P1, DOI 10.1016/j.neuropsychologia.2005.04.009; Redding GM, 1996, J EXP PSYCHOL HUMAN, V22, P379, DOI 10.1037/0096-1523.22.2.379; REDDING GM, 1988, J MOTOR BEHAV, V20, P242, DOI 10.1080/00222895.1988.10735444; REDDING GM, 1993, J MOTOR BEHAV, V25, P75, DOI 10.1080/00222895.1993.9941642; Redding GM, 2005, NEUROSCI BIOBEHAV R, V29, P431, DOI 10.1016/j.neubiorev.2004.12.004; Redding GM, 1997, J MOTOR BEHAV, V29, P119, DOI 10.1080/00222899709600827; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; ROSSETTI Y, 1993, PERCEPT PSYCHOPHYS, V54, P355, DOI 10.3758/BF03205270; ROSSETTI Y, 1995, J NEUROPHYSIOL, V74, P457, DOI 10.1152/jn.1995.74.1.457; Rossetti Y, 1998, NATURE, V395, P166, DOI 10.1038/25988; Sarri M, 2008, NEUROPSYCHOLOGIA, V46, P1069, DOI 10.1016/j.neuropsychologia.2007.11.005; Serino A, 2009, STROKE, V40, P1392, DOI 10.1161/STROKEAHA.108.530485; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Shiraishi H, 2008, NEUROREHABILITATION, V23, P137; Tsakiris M, 2007, CONSCIOUS COGN, V16, P645, DOI 10.1016/j.concog.2007.05.012; van Schie HT, 2004, NAT NEUROSCI, V7, P549, DOI 10.1038/nn1239; WELCH RB, 1972, PERCEPT PSYCHOPHYS, V12, P453, DOI 10.3758/BF03210933	62	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21070	10.1371/journal.pone.0021070	http://dx.doi.org/10.1371/journal.pone.0021070			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	782TT	21731649	Green Published, Green Submitted, gold			2022-12-27	WOS:000292035400008
J	Florea, L; Souvorov, A; Kalbfleisch, TS; Salzberg, SL				Florea, Liliana; Souvorov, Alexander; Kalbfleisch, Theodore S.; Salzberg, Steven L.			Genome Assembly Has a Major Impact on Gene Content: A Comparison of Annotation in Two Bos Taurus Assemblies	PLOS ONE			English	Article							SEQUENCE; PROGRAM; NUMBER; BLAST	Gene and SNP annotation are among the first and most important steps in analyzing a genome. As the number of sequenced genomes continues to grow, a key question is: how does the quality of the assembled sequence affect the annotations? We compared the gene and SNP annotations for two different Bos taurus genome assemblies built from the same data but with significant improvements in the later assembly. The same annotation software was used for annotating both sequences. While some annotation differences are expected even between high-quality assemblies such as these, we found that a staggering 40% of the genes (>9,500) varied significantly between assemblies, due in part to the availability of new gene evidence but primarily to genome mis-assembly events and local sequence variations. For instance, although the later assembly is generally superior, 660 protein coding genes in the earlier assembly are entirely missing from the later genome's annotation, and approximately 3,600 (15%) of the genes have complex structural differences between the two assemblies. In addition, 12-20% of the predicted proteins in both assemblies have relatively large sequence differences when compared to their RefSeq models, and 6-15% of bovine dbSNP records are unrecoverable in the two assemblies. Our findings highlight the consequences of genome assembly quality on gene and SNP annotation and argue for continued improvements in any draft genome sequence. We also found that tracking a gene between different assemblies of the same genome is surprisingly difficult, due to the numerous changes, both small and large, that occur in some genes. As a side benefit, our analyses helped us identify many specific loci for improvement in the Bos taurus genome assembly.	[Florea, Liliana; Salzberg, Steven L.] Univ Maryland, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA; [Souvorov, Alexander] NIH, Natl Ctr Biotechnol Informat, Bethesda, MD 20892 USA; [Kalbfleisch, Theodore S.] Univ Louisville, Ctr Genet & Mol Med, Louisville, KY 40292 USA	University System of Maryland; University of Maryland College Park; National Institutes of Health (NIH) - USA; University of Louisville	Florea, L (corresponding author), Univ Maryland, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA.	florea@umiacs.umd.edu	Salzberg, Steven L/F-6162-2011; Salzberg, Steven/Q-6514-2019; Kalbfleisch, Theodore/AAN-5407-2021	Salzberg, Steven L/0000-0002-8859-7432; Salzberg, Steven/0000-0002-8859-7432; Kalbfleisch, Theodore/0000-0002-2370-8189	National Institutes of Health [R01-LM006845, 3P20RR016481-09S1, 1P30ES014443-01A1]; USDA National Institute of Food and Agriculture [2009-35205-05209]; U.S. Department of Energy [DE-EM0000197]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016481] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006102, R01HG006677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES014443] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083873] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM006845] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported in part by grant R01-LM006845 from the National Institutes of Health and by National Research Initiative Competitive Grant no. 2009-35205-05209 from the USDA National Institute of Food and Agriculture to SLS. TSK was supported in part by funding from the U.S. Department of Energy DE-EM0000197 and funding from the National Institutes of Health 3P20RR016481-09S1 and 1P30ES014443-01A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Clamp M, 2007, P NATL ACAD SCI USA, V104, P19428, DOI 10.1073/pnas.0709013104; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Eilbeck K, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-67; Florea L, 2005, GENOME RES, V15, P54, DOI 10.1101/gr.2889405; Florea L, 1998, GENOME RES, V8, P967, DOI 10.1101/gr.8.9.967; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gibbs RA, 2009, SCIENCE, V324, P528, DOI 10.1126/science.1167936; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Liolios K, 2008, NUCLEIC ACIDS RES, V36, pD475, DOI 10.1093/nar/gkm884; Nowrousian M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000891; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Pennisi E, 2003, SCIENCE, V300, P1484, DOI 10.1126/science.300.5625.1484b; Pertea M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-206; Salzberg Steven L, 2010, F1000 Biol Rep, V2, P64, DOI 10.3410/B2-64; Schatz MC, 2010, GENOME RES, V20, P1165, DOI 10.1101/gr.101360.109; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Wheeler DL, 2008, NUCLEIC ACIDS RES, V36, pD13, DOI 10.1093/nar/gkm1000; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	25	42	42	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21400	10.1371/journal.pone.0021400	http://dx.doi.org/10.1371/journal.pone.0021400			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731731	Green Submitted, Green Published, gold			2022-12-27	WOS:000292033700075
J	L'Abbate, C; Cipriano, I; Perez-Hurtado, EC; Leao, SC; Carneiro, CRW; Machado, J				L'Abbate, Carolina; Cipriano, Ivone; Perez-Hurtado, Elizabeth Cristina; Leao, Sylvia Cardoso; Whitaker Carneiro, Celia Regina; Machado, Joel, Jr.			TGF-beta-Mediated Sustained ERK1/2 Activity Promotes the Inhibition of Intracellular Growth of Mycobacterium avium in Epithelioid Cells Surrogates	PLOS ONE			English	Article							ALPHA TNF-ALPHA; NITRIC-OXIDE; LEISHMANIA-MEXICANA; MURINE MACROPHAGES; KINASE-ACTIVITY; MAP KINASE; PROTEIN; COMPLEX; EXPRESSION; ACTIVATION	Transforming growth factor beta (TGF-beta) has been implicated in the pathogenesis of several diseases including infection with intracellular pathogens such as the Mycobacterium avium complex. Infection of macrophages with M. avium induces TGF-beta production and neutralization of this cytokine has been associated with decreased intracellular bacterial growth. We have previously demonstrated that epithelioid cell surrogates (ECs) derived from primary murine peritoneal macrophages through a process of differentiation induced by IL-4 overlap several features of epithelioid cells found in granulomas. In contrast to undifferentiated macrophages, ECs produce larger amounts of TGF-beta and inhibit the intracellular growth of M. avium. Here we asked whether the levels of TGF-beta produced by ECs are sufficient to induce a self-sustaining autocrine TGF-beta signaling controlling mycobacterial replication in infected-cells. We showed that while exogenous addition of increased concentration of TGF-beta to infected-macrophages counteracted M. avium replication, pharmacological blockage of TGF-beta receptor kinase activity with SB-431542 augmented bacterial load in infected-ECs. Moreover, the levels of TGF-beta produced by ECs correlated with high and sustained levels of ERK1/2 activity. Inhibition of ERK1/2 activity with U0126 increased M. avium replication in infected-cells, suggesting that modulation of intracellular bacterial growth is dependent on the activation of ERK1/2. Interestingly, blockage of TGF-beta receptor kinase activity with SB-431542 in infected-ECs inhibited ERK1/2 activity, enhanced intracellular M. avium burden and these effects were followed by a severe decrease in TGF-beta production. In summary, our findings indicate that the amplitude of TGF-beta signaling coordinates the strength and duration of ERK1/2 activity that is determinant for the control of intracellular mycobacterial growth.	[L'Abbate, Carolina; Perez-Hurtado, Elizabeth Cristina; Whitaker Carneiro, Celia Regina] Univ Fed Sao Paulo, Dept Microbiol Imunol & Parasitol, Disciplina Imunol, Sao Paulo, Brazil; [Cipriano, Ivone] Univ Fed Sao Paulo, Dept Morfol & Genet, Disciplina Biol Desenvolvimento, Sao Paulo, Brazil; [Leao, Sylvia Cardoso] Univ Fed Sao Paulo, Dept Microbiol Imunol & Parasitol, Disciplina Microbiol, Sao Paulo, Brazil; [Machado, Joel, Jr.] Univ Fed Sao Paulo, Dept Ciencias Biol, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	L'Abbate, C (corresponding author), Univ Fed Sao Paulo, Dept Microbiol Imunol & Parasitol, Disciplina Imunol, Sao Paulo, Brazil.	joel.jr@unifesp.br	Leao, Sylvia/O-9637-2016; Cipriano, Ivone/D-4953-2014; Leao, Sylvia/F-4431-2012; Pérez, Elizabeth C/E-8057-2012; Machado, Joel/C-5117-2012	Leao, Sylvia/0000-0003-2083-0119; Leao, Sylvia/0000-0003-2083-0119; Pérez, Elizabeth C/0000-0003-3038-9902; MACHADO JUNIOR, JOEL/0000-0001-7907-3314	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [06/01533-9, 02/6935-7]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), grant numbers 06/01533-9 and 02/6935-7. CL was awarded a fellowship by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS DO, 1984, ANNU REV IMMUNOL, V2, P283, DOI 10.1146/annurev.immunol.2.1.283; Alvarez-Rueda N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007581; Atfi A, 1997, J BIOL CHEM, V272, P1429, DOI 10.1074/jbc.272.3.1429; BARRALNETTO M, 1987, AM J PATHOL, V127, P271; BERMUDEZ LE, 1993, INFECT IMMUN, V61, P4126, DOI 10.1128/IAI.61.10.4126-4130.1993; BERMUDEZ LE, 1993, J IMMUNOL, V150, P1838; Blumenthal A, 2002, INFECT IMMUN, V70, P4961, DOI 10.1128/IAI.70.9.4961-4967.2002; Borges-Walmsley MI, 2002, TRENDS MICROBIOL, V10, P80, DOI 10.1016/S0966-842X(01)02292-2; Bouley DM, 2001, INFECT IMMUN, V69, P7820, DOI 10.1128/IAI.69.12.7820-7831.2001; Cameron P, 2004, J IMMUNOL, V173, P3297, DOI 10.4049/jimmunol.173.5.3297; Chinen LTD, 2006, MICROBES INFECT, V8, P965, DOI 10.1016/j.micinf.2005.09.017; Chomarat P, 1998, Int Rev Immunol, V17, P1, DOI 10.3109/08830189809084486; Cipriano IM, 2003, INFLAMMATION, V27, P201, DOI 10.1023/A:1025084413767; Dahl KE, 1996, INFECT IMMUN, V64, P399, DOI 10.1128/IAI.64.2.399-405.1996; DANNENBERG AM, 1993, HOSP PRACT, V28, P51, DOI 10.1080/21548331.1993.11442738; Davis JM, 2002, IMMUNITY, V17, P693, DOI 10.1016/S1074-7613(02)00475-2; Dewas C, 2000, J IMMUNOL, V165, P5238, DOI 10.4049/jimmunol.165.9.5238; DING A, 1990, J IMMUNOL, V145, P940; DOI T, 1993, INFECT IMMUN, V61, P1980, DOI 10.1128/IAI.61.5.1980-1989.1993; Ebisuya M, 2005, J CELL SCI, V118, P2997, DOI 10.1242/jcs.02505; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Fujita J, 2002, MICROBIOL IMMUNOL, V46, P67, DOI 10.1111/j.1348-0421.2002.tb02660.x; Grosset J, 2003, ANTIMICROB AGENTS CH, V47, P833, DOI 10.1128/AAC.47.3.833-836.2003; Hanafusa H, 2002, NAT CELL BIOL, V4, P850, DOI 10.1038/ncb867; Hanak V, 2006, RESP MED, V100, P610, DOI 10.1016/j.rmed.2005.08.005; Hartsough MT, 1996, J BIOL CHEM, V271, P22368, DOI 10.1074/jbc.271.37.22368; HORSBURGH CR, 1992, AIDS, V6, P512; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Kelly-Welch AE, 2003, SCIENCE, V300, P1527, DOI 10.1126/science.1085458; Khanolkar-Young S, 1998, CLIN EXP IMMUNOL, V113, P438; Klug K, 2011, INNATE IMMUN-LONDON, V17, P470, DOI 10.1177/1753425910377799; Letterio JJ, 1998, ANNU REV IMMUNOL, V16, P137, DOI 10.1146/annurev.immunol.16.1.137; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Martiny A, 1999, MOL BIOCHEM PARASIT, V102, P1, DOI 10.1016/S0166-6851(99)00067-5; MULDER KM, 1992, J BIOL CHEM, V267, P5029; Nandan D, 2002, J BIOL CHEM, V277, P50190, DOI 10.1074/jbc.M209210200; Oliveira RS, 2000, J CLIN MICROBIOL, V38, P4643, DOI 10.1128/JCM.38.12.4643-4645.2000; Reed SG, 1999, MICROBES INFECT, V1, P1313, DOI 10.1016/S1286-4579(99)00252-X; Reilly AF, 2004, PEDIATR BLOOD CANCER, V43, P698, DOI 10.1002/pbc.20061; Rich JN, 2001, MICROSC RES TECHNIQ, V52, P363, DOI 10.1002/1097-0029(20010215)52:4<363::AID-JEMT1021>3.3.CO;2-6; Roach SK, 2002, INFECT IMMUN, V70, P3040, DOI 10.1128/IAI.70.6.3040-3052.2002; Sangari FJ, 2001, INFECT IMMUN, V69, P1515, DOI 10.1128/IAI.69.3.1515-1520.2001; Sano C, 1999, CLIN EXP IMMUNOL, V115, P435; Secott TE, 2002, INFECT IMMUN, V70, P2670, DOI 10.1128/IAI.70.5.2670-2675.2002; Seyler I, 1997, J LEUKOCYTE BIOL, V62, P374, DOI 10.1002/jlb.62.3.374; Shimizu T, 2002, INT J LEPROSY, V70, P250; Shiratsuchi H, 1996, J INFECT DIS, V173, P410, DOI 10.1093/infdis/173.2.410; Tomioka H, 1997, ANTIMICROB AGENTS CH, V41, P357, DOI 10.1128/AAC.41.2.357; Tomioka H, 2000, CLIN EXP IMMUNOL, V122, P335, DOI 10.1046/j.1365-2249.2000.01393.x; TOOSSI Z, 1995, J IMMUNOL, V154, P465; Ulrichs T, 2006, J PATHOL, V208, P261, DOI 10.1002/path.1906; Wang WF, 1997, J BIOL CHEM, V272, P22771, DOI 10.1074/jbc.272.36.22771; WARWICKDAVIES J, 1995, J IMMUNOL, V155, P3186; Wills-Karp M, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1.51.pe55; Wilson Mary E., 1996, Methods (Orlando), V9, P248, DOI 10.1006/meth.1996.0031; Xander P, 2007, MICROBES INFECT, V9, P1484, DOI 10.1016/j.micinf.2007.08.001; Xu Z, 2003, CELL RES, V13, P343, DOI 10.1038/sj.cr.7290179; Yadav M, 2004, J IMMUNOL, V172, P5588, DOI 10.4049/jimmunol.172.9.5588; YAJKO DM, 1995, J ACQ IMMUN DEF SYND, V9, P176; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008	60	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21465	10.1371/journal.pone.0021465	http://dx.doi.org/10.1371/journal.pone.0021465			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731758	Green Published, Green Submitted, gold			2022-12-27	WOS:000292033700088
J	Macotela, Y; Emanuelli, B; Bang, AM; Espinoza, DO; Boucher, J; Beebe, K; Gall, W; Kahn, CR				Macotela, Yazmin; Emanuelli, Brice; Bang, Anneli M.; Espinoza, Daniel O.; Boucher, Jeremie; Beebe, Kirk; Gall, Walter; Kahn, C. Ronald			Dietary Leucine - An Environmental Modifier of Insulin Resistance Acting on Multiple Levels of Metabolism	PLOS ONE			English	Article							AMINO-ACIDS; GLUCOSE-METABOLISM; SKELETAL-MUSCLE; INDUCED OBESITY; RECEPTOR SUBSTRATE-1; MAMMALIAN TARGET; PROTEIN INTAKE; BLOOD-GLUCOSE; WEIGHT-LOSS; PHOSPHORYLATION	Environmental factors, such as the macronutrient composition of the diet, can have a profound impact on risk of diabetes and metabolic syndrome. In the present study we demonstrate how a single, simple dietary factor-leucine-can modify insulin resistance by acting on multiple tissues and at multiple levels of metabolism. Mice were placed on a normal or high fat diet (HFD). Dietary leucine was doubled by addition to the drinking water. mRNA, protein and complete metabolomic profiles were assessed in the major insulin sensitive tissues and serum, and correlated with changes in glucose homeostasis and insulin signaling. After 8 weeks on HFD, mice developed obesity, fatty liver, inflammatory changes in adipose tissue and insulin resistance at the level of IRS-1 phosphorylation, as well as alterations in metabolomic profile of amino acid metabolites, TCA cycle intermediates, glucose and cholesterol metabolites, and fatty acids in liver, muscle, fat and serum. Doubling dietary leucine reversed many of the metabolite abnormalities and caused a marked improvement in glucose tolerance and insulin signaling without altering food intake or weight gain. Increased dietary leucine was also associated with a decrease in hepatic steatosis and a decrease in inflammation in adipose tissue. These changes occurred despite an increase in insulin-stimulated phosphorylation of p70S6 kinase indicating enhanced activation of mTOR, a phenomenon normally associated with insulin resistance. These data indicate that modest changes in a single environmental/nutrient factor can modify multiple metabolic and signaling pathways and modify HFD induced metabolic syndrome by acting at a systemic level on multiple tissues. These data also suggest that increasing dietary leucine may provide an adjunct in the management of obesity-related insulin resistance.	[Macotela, Yazmin; Emanuelli, Brice; Bang, Anneli M.; Espinoza, Daniel O.; Boucher, Jeremie; Kahn, C. Ronald] Joslin Diabet Ctr, Boston, MA 02215 USA; [Macotela, Yazmin; Emanuelli, Brice; Bang, Anneli M.; Espinoza, Daniel O.; Boucher, Jeremie; Kahn, C. Ronald] Harvard Univ, Sch Med, Boston, MA USA; [Beebe, Kirk; Gall, Walter] Metabolon Inc, Durham, NC USA	Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School; Metabolon	Macotela, Y (corresponding author), Joslin Diabet Ctr, Boston, MA 02215 USA.	c.ronald.kahn@joslin.harvard.edu	Emanuelli, Brice/M-2097-2016; Boucher, Jeremie/G-6602-2015; Kahn, Ronald/AAY-2435-2021	Emanuelli, Brice/0000-0001-5795-5666; Kahn, Ronald/0000-0002-7583-9228	Pew Latin American Fellows program; NIH [DK33201]; Loveman Foundation; Mary K. Iacocca Professorship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082659, P30DK036836, R01DK033201, R37DK031036] Funding Source: NIH RePORTER	Pew Latin American Fellows program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Loveman Foundation; Mary K. Iacocca Professorship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Pew Latin American Fellows program fellowship an ADA grant to YM, NIH grant DK33201 to CRK, the Loveman Foundation and the Mary K. Iacocca Professorship. Metabolon, Inc, acted as a funder only through employment of KB and WG. The role of Metabolon was performance of the metabolomic analysis reported in this study. Other than that, Metabolon had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreassi MG, 2009, MUTAT RES-FUND MOL M, V667, P35, DOI 10.1016/j.mrfmmm.2008.10.018; Anthony JC, 2002, DIABETES, V51, P928, DOI 10.2337/diabetes.51.4.928; Bae EJ, 2008, MOL PHARMACOL, V73, P1502, DOI 10.1124/mol.107.044347; Bortolotti M, 2009, AM J CLIN NUTR, V90, P1002, DOI 10.3945/ajcn.2008.27296; BRATUSCHMARRAIN PR, 1983, DIABETES, V32, P1028, DOI 10.2337/diabetes.32.11.1028; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Calder PC, 2006, J NUTR, V136, p288S, DOI 10.1093/jn/136.1.288S; Carlson CJ, 2004, BIOCHEM BIOPH RES CO, V316, P533, DOI 10.1016/j.bbrc.2004.02.082; Draznin B, 2006, DIABETES, V55, P2392, DOI 10.2337/db06-0391; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; GALL WE, 2010, PLOS ONE IN PRESS; Gannon MC, 2003, AM J CLIN NUTR, V78, P734, DOI 10.1093/ajcn/78.4.734; Gual P, 2003, J BIOL CHEM, V278, P26550, DOI 10.1074/jbc.M212273200; Halton TL, 2004, J AM COLL NUTR, V23, P373, DOI 10.1080/07315724.2004.10719381; Hinault C, 2006, DIABETOLOGIA, V49, P1017, DOI 10.1007/s00125-006-0201-z; Hinault C, 2004, FASEB J, V18, P1894, DOI 10.1096/fj.03-1409fje; Huang SL, 2003, CANCER BIOL THER, V2, P222, DOI 10.4161/cbt.2.3.360; Kalogeropoulo D, 2008, METABOLISM, V57, P1747, DOI 10.1016/j.metabol.2008.09.001; Kawaguchi T, 2008, INT J MOL MED, V22, P105; Kimball SR, 1999, J BIOL CHEM, V274, P11647, DOI 10.1074/jbc.274.17.11647; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Krieger JW, 2006, AM J CLIN NUTR, V83, P260; Layman DK, 2003, J NUTR, V133, p261S, DOI 10.1093/jn/133.1.261S; Layman DK, 2006, J NUTR, V136, p319S, DOI 10.1093/jn/136.1.319S; Lehmann R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011519; Linn T, 2000, DIABETOLOGIA, V43, P1257, DOI 10.1007/s001250051521; Linn T, 1996, J CLIN ENDOCR METAB, V81, P3938, DOI 10.1210/jc.81.11.3938; Lynch CJ, 2000, J CELL BIOCHEM, V77, P234, DOI 10.1002/(SICI)1097-4644(20000501)77:2<234::AID-JCB7>3.0.CO;2-I; Nairizi A, 2009, J NUTR, V139, P715, DOI 10.3945/jn.108.100081; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Patti ME, 1998, J CLIN INVEST, V101, P1519, DOI 10.1172/JCI1326; Petzke KJ, 2007, J NUTR BIOCHEM, V18, P400, DOI 10.1016/j.jnutbio.2006.07.005; Romao I, 2008, J AM DIET ASSOC, V108, pS24, DOI 10.1016/j.jada.2008.01.022; Ropelle ER, 2008, DIABETES, V57, P594, DOI 10.2337/db07-0573; Saemann MD, 2009, AM J TRANSPLANT, V9, P2655, DOI 10.1111/j.1600-6143.2009.02832.x; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Strissel KJ, 2007, DIABETES, V56, P2910, DOI 10.2337/db07-0767; Takano T, 2001, MOL CELL BIOL, V21, P5050, DOI 10.1128/MCB.21.15.5050-5062.2001; Tran TT, 2008, CELL METAB, V7, P410, DOI 10.1016/j.cmet.2008.04.004; Tremblay F, 2001, J BIOL CHEM, V276, P38052; Tremblay F, 2007, ANNU REV NUTR, V27, P293, DOI 10.1146/annurev.nutr.25.050304.092545; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Weichhart T, 2008, IMMUNITY, V29, P565, DOI 10.1016/j.immuni.2008.08.012; Zhang YY, 2007, DIABETES, V56, P1647, DOI 10.2337/db07-0123	44	203	233	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21187	10.1371/journal.pone.0021187	http://dx.doi.org/10.1371/journal.pone.0021187			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731668	gold, Green Published, Green Submitted			2022-12-27	WOS:000292033700045
J	Raichlen, DA; Gordon, AD				Raichlen, David A.; Gordon, Adam D.			Relationship between Exercise Capacity and Brain Size in Mammals	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; RUNNING PERFORMANCE; NEUROTROPHIC FACTOR; NEUROGENESIS; INCREASES; EVOLUTION; MICE; ENCEPHALIZATION; INTELLIGENCE; REGRESSION	Background: A great deal of experimental research supports strong associations between exercise, cognition, neurogenesis and neuroprotection in mammals. Much of this work has focused on neurogenesis in individual subjects in a limited number of species. However, no study to date has examined the relationship between exercise and neurobiology across a wide range of mammalian taxa. It is possible that exercise and neurobiology are related across evolutionary time. To test this hypothesis, this study examines the association between exercise and brain size across a wide range of mammals. Methodology/Principal Findings: Controlling for associations with body size, we examined the correlation between brain size and a proxy for exercise frequency and capacity, maximum metabolic rate (MMR; ml O-2 min(-1)). We collected brain sizes and MMRs from the literature and calculated residuals from the least-squares regression line describing the relationship between body mass and each variable of interest. We then analyzed the correlation between residual brain size and residual MMR both before and after controlling for phylogeny using phylogenetic independent contrasts. We found a significant positive correlation between maximum metabolic rate and brain size across a wide range of taxa. Conclusions: These results suggest a novel hypothesis that links brain size to the evolution of locomotor behaviors in a wide variety of mammalian species. In the end, we suggest that some portion of brain size in nonhuman mammals may have evolved in conjunction with increases in exercise capacity rather than solely in response to selection related to cognitive abilities.	[Raichlen, David A.] Univ Arizona, Sch Anthropol, Tucson, AZ 85721 USA; [Gordon, Adam D.] SUNY Albany, Dept Anthropol, Albany, NY 12222 USA	University of Arizona; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Raichlen, DA (corresponding author), Univ Arizona, Sch Anthropol, Tucson, AZ 85721 USA.	raichlen@email.arizona.edu	Gordon, Adam/AAB-9006-2019	Gordon, Adam/0000-0002-1807-4644	Wenner Gren Foundation	Wenner Gren Foundation	This project was supported by a Wenner Gren Foundation Hunt Fellowship to D.R. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral SL, 2001, AM J PHYSIOL-HEART C, V281, pH1163, DOI 10.1152/ajpheart.2001.281.3.H1163; Ashwell KWS, 2008, BRAIN BEHAV EVOLUT, V71, P181, DOI 10.1159/000114406; BENNETT AF, 1979, SCIENCE, V206, P649, DOI 10.1126/science.493968; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Bramble DM, 2004, NATURE, V432, P345, DOI 10.1038/nature03052; BRUMMELKAMP R, 1940, NEDERL AKAD WET VERH, V39, P1; BRUMMELKAMP R, 1937, NORMALE ABNORMALE HE; Burton RF, 2006, J ZOOL, V269, P225, DOI 10.1111/j.1469-7998.2006.00111.x; CAPPON J, 1994, J APPL PHYSIOL, V76, P2490, DOI 10.1152/jappl.1994.76.6.2490; CARRIER DR, 1984, CURR ANTHROPOL, V25, P483, DOI 10.1086/203165; Carro E, 2000, J NEUROSCI, V20, P2926; Chaddock L, 2010, BRAIN RES, V1358, P172, DOI 10.1016/j.brainres.2010.08.049; Chaddock L, 2010, DEV NEUROSCI-BASEL, V32, P249, DOI 10.1159/000316648; Chang QA, 2006, NEURON, V49, P341, DOI 10.1016/j.neuron.2005.12.027; Chappell MA, 2007, J EXP BIOL, V210, P4179, DOI 10.1242/jeb.006163; CLUTTONBROCK TH, 1980, J ZOOL, V190, P309; COSKUN Y, TURK J ZOOL, V28, P205; Cotman CW, 2007, TRENDS NEUROSCI, V30, P464, DOI 10.1016/j.tins.2007.06.011; Cotman CW, 2002, TRENDS NEUROSCI, V25, P295, DOI 10.1016/S0166-2236(02)02143-4; COUNT EW, 1947, ANN NY ACAD SCI, V46, P993, DOI 10.1111/j.1749-6632.1947.tb36165.x; CRILE GEORGE, 1940, OHIO JOUR SCI, V40, P219; DANIELS JT, 1978, EUR J APPL PHYSIOL O, V39, P249, DOI 10.1007/BF00421448; Deaner RO, 2007, BRAIN BEHAV EVOLUT, V70, P115, DOI 10.1159/000102973; Dunbar RIM, 2007, SCIENCE, V317, P1344, DOI 10.1126/science.1145463; EVANS DL, 1988, PFLUG ARCH EUR J PHY, V411, P316, DOI 10.1007/BF00585121; FABEL K, 2003, EUROPEAN J NEUROSCIE; Garland T, 2000, AM NAT, V155, P346, DOI 10.1086/303327; GARLAND T, 1992, SYST BIOL, V41, P18, DOI 10.2307/2992503; GITTLEMAN JL, 1986, J MAMMAL, V67, P23, DOI 10.2307/1380998; HAARMANN K, 1972, MITT HAMBURG ZOOL MU, V68, P231; Healy SD, 2007, P ROY SOC B-BIOL SCI, V274, P453, DOI 10.1098/rspb.2006.3748; Isler K, 2006, BIOL LETTERS, V2, P557, DOI 10.1098/rsbl.2006.0538; Jerison HJ., 1973, EVOLUTION BRAIN INTE; Johnson RA, 2003, NEUROSCIENCE, V121, P1, DOI 10.1016/S0306-4522(03)00422-6; Johnson RA, 2003, BRAIN RES, V983, P108, DOI 10.1016/S0006-8993(03)03039-7; KOLB E, COMMUNICATION; Kolb EM, 2010, NEUROBIOLOGICAL PHYS; Kraus RM, 2004, J APPL PHYSIOL, V96, P1445, DOI 10.1152/japplphysiol.01031.2003; KRUSKA D, 1970, Z ANAT ENTWICKLUNGS, V131, P291; Kruska D, 1975, J Hirnforsch, V16, P469; KRUSKA D, 1973, Zeitschrift fuer Zoologische Systematik und Evolutionsforschung, V11, P81; Lefebvre L, 2004, BRAIN BEHAV EVOLUT, V63, P233, DOI 10.1159/000076784; Lofqvist C, 2006, PEDIATRICS, V117, P1930, DOI 10.1542/peds.2005-1926; MACE GM, 1980, TRENDS NEUROSCI, V3, P193, DOI 10.1016/0166-2236(80)90071-5; MACE GM, 1982, BIOL J LINN SOC, V17, P243, DOI 10.1111/j.1095-8312.1982.tb02019.x; MACE GM, 1981, J ZOOL, V193, P333; Maddison W., 2018, MESQUITE MODULAR SYS; MIDFORD P, 2003, PDAP PDTREE TRANSLAT; NEEPER SA, 1995, NATURE, V373, P109, DOI 10.1038/373109a0; OBOUSSIER H, 1974, Mitteilungen aus dem Hamburgischen Zoologischen Museum und Institut, V71, P235; Oboussier H., 1966, Zeitschrift fuer Saugietierkunde, V31, P464; OBOUSSIER H, 1955, ARCH ENTW MECH, V147, P405; Oboussier H., 1972, MITTEILUNGEN HAMBURG, V68, P271; OLFERT MI, 2010, MED SCI SPORTS EX S2, V42, P5; Pereira AC, 2007, P NATL ACAD SCI USA, V104, P5638, DOI 10.1073/pnas.0611721104; PURVIS A, 1995, PHILOS T R SOC LON B, V104, P5638; Reader SM, 2002, P NATL ACAD SCI USA, V99, P4436, DOI 10.1073/pnas.062041299; Regal P.J., 1978, P183; Rezende EL, 2006, J EXP BIOL, V209, P115, DOI 10.1242/jeb.01883; Rhodes JS, 2003, BEHAV NEUROSCI, V117, P1006, DOI 10.1037/0735-7044.117.5.1006; RONNEFELD U, 1970, MORPHOL JB, V115, P163; SACHER GA, 1974, AM NAT, V108, P593, DOI 10.1086/282938; Savage VM, 2004, FUNCT ECOL, V18, P257, DOI 10.1111/j.0269-8463.2004.00856.x; Sentilhes L, 2010, J NEUROPATH EXP NEUR, V69, P111, DOI 10.1097/NEN.0b013e3181ccc9a9; SHULTZ S, 2006, P ROY SOC LOND B BIO, V272, P2305; SILVA M, 1995, CRC HDB MAMMALIAN BO; Sol D, 2005, P NATL ACAD SCI USA, V102, P5460, DOI 10.1073/pnas.0408145102; SWALLOW JG, 1991, J EXP BIOL, V202, P2513; Tang K, 2004, PHYSIOL GENOMICS, V18, P63, DOI 10.1152/physiolgenomics.00023.2004; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; van Praag H, 2008, NEUROMOL MED, V10, P128, DOI 10.1007/s12017-008-8028-z; von Tyszka H., 1966, Mitteilungen der Hamburgischen Zoologischen Museum und Institut, V63, P121; Warncke Paul, 1908, Journal fuer Psychologie Leipzig, V13; Weibel ER, 2004, RESP PHYSIOL NEUROBI, V140, P115, DOI 10.1016/j.resp.2004.01.006; WILLERMAN L, 1991, INTELLIGENCE, V15, P223, DOI 10.1016/0160-2896(91)90031-8; Wilson DE, 2009, HDB MAMMALS WORLD, V1; WIRZ K, 1950, ACTA ANAT BASEL, V9; Witelson SF, 2006, BRAIN, V129, P386, DOI 10.1093/brain/awh696; Ye P, 1996, DEV BRAIN RES, V95, P44; [No title captured]	80	30	30	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e20601	10.1371/journal.pone.0020601	http://dx.doi.org/10.1371/journal.pone.0020601			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731619	Green Submitted, Green Published, gold			2022-12-27	WOS:000292033700011
J	Schaer, DA; Li, YB; Merghoub, T; Rizzuto, GA; Shemesh, A; Cohen, AD; Li, YY; Avogadri, F; Toledo-Crow, R; Houghton, AN; Wolchok, JD				Schaer, David A.; Li, Yongbiao; Merghoub, Taha; Rizzuto, Gabrielle A.; Shemesh, Amos; Cohen, Adam D.; Li, Yanyun; Avogadri, Francesca; Toledo-Crow, Ricardo; Houghton, Alan N.; Wolchok, Jedd D.			Detection of Intra-Tumor Self Antigen Recognition during Melanoma Tumor Progression in Mice Using Advanced Multimode Confocal/Two Photon Microscope	PLOS ONE			English	Article							REGULATORY T-CELLS; CANCER IMMUNOSURVEILLANCE; SUPPRESSOR-CELLS; IMMUNE-RESPONSE; LYTIC FUNCTION; IMMUNOTHERAPY; LYMPHOCYTES; TOLERANCE; EFFECTOR; SYSTEM	Determining how tumor immunity is regulated requires understanding the extent to which the anti-tumor immune response "functions" in vivo without therapeutic intervention. To better understand this question, we developed advanced multimodal reflectance confocal/two photon fluorescence intra-vital imaging techniques to use in combination with traditional ex vivo analysis of tumor specific T cells. By transferring small numbers of melanoma-specific CD8+ T cells (Pmel-1), in an attempt to mimic physiologic conditions, we found that B16 tumor growth alone was sufficient to induce naive Pmel-1 T cell proliferation and acquisition of effector phenotype. Tumor-primed Pmel-1 T cells, are capable of killing target cells in the periphery and secrete IFN gamma, but are unable to mediate tumor regression. Within the tumor, Pmel-1 T cells have highly confined mobility, displaying long term interactions with tumor cells. In contrast, adoptively transferred non tumor-specific OT-I T cells show neither confined mobility, nor long term interaction with B16 tumor cells, suggesting that intra-tumor recognition of cognate self antigen by Pmel-1 T cells occurs during tumor growth. Together, these data indicate that lack of anti-tumor efficacy is not solely due to ignorance of self antigen in the tumor microenvironment but rather to active immunosuppressive influences preventing a protective immune response.	[Schaer, David A.; Merghoub, Taha; Rizzuto, Gabrielle A.; Shemesh, Amos; Li, Yanyun; Avogadri, Francesca; Houghton, Alan N.; Wolchok, Jedd D.] Sloan Kettering Inst Canc Res, Program Immunol, Swim Amer Lab, New York, NY USA; [Merghoub, Taha; Cohen, Adam D.; Houghton, Alan N.; Wolchok, Jedd D.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Li, Yongbiao; Toledo-Crow, Ricardo] Sloan Kettering Inst Canc Res, Res Engn Lab, New York, NY USA; [Rizzuto, Gabrielle A.; Houghton, Alan N.; Wolchok, Jedd D.] Cornell Univ, Weill Med Coll, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University	Schaer, DA (corresponding author), Sloan Kettering Inst Canc Res, Program Immunol, Swim Amer Lab, New York, NY USA.	wolchokj@mskcc.org	Rizzuto, Gabrielle/GWR-2224-2022; Cohen, Adam D/F-6729-2012; Merghoub, Taha/ABD-8362-2021	Cohen, Adam/0000-0003-0939-3843; Rizzuto, Gabrielle/0000-0003-3052-0253	NIH [R01CA56821, P01CA33049, P01CA59350, K12 CA120121-01]; NIH/NCI [T32 CA09149-30]; John D. Proctor Foundation; Mr. William H. Goodwin and Mrs. Alice Goodwin and the Commonwealth Cancer Foundation for Research and the Experimental Therapeutics Center of Memorial Sloan-Kettering Cancer Center; NATIONAL CANCER INSTITUTE [T32CA009149, P01CA033049, R01CA056821, P01CA059350, K12CA120121] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); John D. Proctor Foundation; Mr. William H. Goodwin and Mrs. Alice Goodwin and the Commonwealth Cancer Foundation for Research and the Experimental Therapeutics Center of Memorial Sloan-Kettering Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Grant support: This work was supported by NIH grants R01CA56821, P01CA33049, and P01CA59350 (to J.D.W. and A.N.H.), D.A.S. is supported by the NIH Clinical Training for Scholar Grant K12 CA120121-01, and received support from the NIH/NCI Immunology Training Grant T32 CA09149-30 and John D. Proctor Foundation: Margaret A. Cunningham Immune Mechanisms in Cancer Research Fellowship Award; Swim Across America (http://www.swimacrossamerica.org); the Mr. William H. Goodwin and Mrs. Alice Goodwin and the Commonwealth Cancer Foundation for Research and the Experimental Therapeutics Center of Memorial Sloan-Kettering Cancer Center (to J.D.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badovinac VP, 2007, IMMUNITY, V26, P827, DOI 10.1016/j.immuni.2007.04.013; Bajenoff M, 2007, TRENDS IMMUNOL, V28, P346, DOI 10.1016/j.it.2007.06.005; Boissonnas A, 2007, J EXP MED, V204, P345, DOI 10.1084/jem.20061890; Breart B, 2008, J CLIN INVEST, V118, P1390, DOI 10.1172/JCI34388; Cahalan MD, 2006, CURR OPIN IMMUNOL, V18, P476, DOI 10.1016/j.coi.2006.05.013; Chen ML, 2005, P NATL ACAD SCI USA, V102, P419, DOI 10.1073/pnas.0408197102; Dunn GP, 2004, IMMUNITY, V21, P137, DOI 10.1016/j.immuni.2004.07.017; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Germain RN, 2008, IMMUNOL REV, V221, P163, DOI 10.1111/j.1600-065X.2008.00591.x; Koneru M, 2005, J IMMUNOL, V174, P1830, DOI 10.4049/jimmunol.174.4.1830; Koneru M, 2006, J IMMUNOL, V176, P6103, DOI 10.4049/jimmunol.176.10.6103; Kowalczyk DW, 2001, J IMMUNOL METHODS, V253, P163, DOI 10.1016/S0022-1759(01)00356-8; Marigo I, 2008, IMMUNOL REV, V222, P162, DOI 10.1111/j.1600-065X.2008.00602.x; Mempel TR, 2006, IMMUNITY, V25, P129, DOI 10.1016/j.immuni.2006.04.015; Monu N, 2007, CANCER RES, V67, P11447, DOI 10.1158/0008-5472.CAN-07-1441; Mrass P, 2006, J EXP MED, V203, P2749, DOI 10.1084/jem.20060710; Overwijk WW, 2003, J EXP MED, V198, P569, DOI 10.1084/jem.20030590; Overwijk WW, 1998, J EXP MED, V188, P277, DOI 10.1084/jem.188.2.277; Quezada SA, 2006, J CLIN INVEST, V116, P1935, DOI 10.1172/JCI27745; Radoja S, 2001, J IMMUNOL, V167, P5042, DOI 10.4049/jimmunol.167.9.5042; Rizzuto GA, 2009, J EXP MED, V206, P849, DOI 10.1084/jem.20081382; Rodriguez PC, 2008, IMMUNOL REV, V222, P180, DOI 10.1111/j.1600-065X.2008.00608.x; Savage PA, 2008, SCIENCE, V319, P215, DOI 10.1126/science.1148886; Sitkovsky M, 2005, NAT REV IMMUNOL, V5, P712, DOI 10.1038/nri1685; Smyth MJ, 2006, ADV IMMUNOL, V90, P1, DOI 10.1016/S0065-2776(06)90001-7; Speiser DE, 1997, J EXP MED, V186, P645, DOI 10.1084/jem.186.5.645; Turk MJ, 2004, J EXP MED, V200, P771, DOI 10.1084/jem.20041130; Zipfel WR, 2003, P NATL ACAD SCI USA, V100, P7075, DOI 10.1073/pnas.0832308100	29	11	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21214	10.1371/journal.pone.0021214	http://dx.doi.org/10.1371/journal.pone.0021214			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731676	Green Published, Green Submitted, gold			2022-12-27	WOS:000292033700047
J	Svensson, E; Olsen, L; Morck, C; Brackmann, C; Enejder, A; Faergeman, NJ; Pilon, M				Svensson, Emma; Olsen, Louise; Morck, Catarina; Brackmann, Christian; Enejder, Annika; Faergeman, Nils J.; Pilon, Marc			The Adiponectin Receptor Homologs in C-elegans Promote Energy Utilization and Homeostasis	PLOS ONE			English	Article							ADIPOSE-SPECIFIC PROTEIN; FATTY-ACID-COMPOSITION; CAENORHABDITIS-ELEGANS; DAF-16; ACTIVATION; OXIDATION; DECREASE; STORAGE; CLONING; NHR-49	Adiponectin is an adipokine with insulin-sensitising actions in vertebrates. Its receptors, AdipoR1 and AdipoR2, are PAQR-type proteins with 7-transmembrane domains and topologies reversed that of GPCR's, i.e. their C-termini are extracellular. We identified three adiponectin receptor homologs in the nematode C. elegans, named paqr-1, paqr-2 and paqr-3. These are differently expressed in the intestine (the main fat-storing tissue), hypodermis, muscles, neurons and secretory tissues, from which they could exert systemic effects. Analysis of mutants revealed that paqr-1 and -2 are novel metabolic regulators in C. elegans and that they act redundantly but independently from paqr-3. paqr-2 is the most important of the three paqr genes: mutants grow poorly, fail to adapt to growth at low temperature, and have a very high fat content with an abnormal enrichment in long (C20) poly-unsaturated fatty acids when combined with the paqr-1 mutation. paqr-2 mutants are also synthetic lethal with mutations in nhr-49, sbp-1 and fat-6, which are C. elegans homologs of nuclear hormone receptors, SREBP and FAT-6 (a Delta 9 desaturase), respectively. Like paqr-2, paqr-1 is also synthetic lethal with sbp-1. Mutations in aak-2, the C. elegans homolog of AMPK, or nhr-80, another nuclear hormone receptor gene, suppress the growth phenotype of paqr-2 mutants, probably because they restore the balance between energy expenditure and storage. We conclude that paqr-1 and paqr-2 are receptors that regulate fatty acid metabolism and cold adaptation in C. elegans, that their main function is to promote energy utilization rather than storage, and that PAQR class proteins have regulated metabolism in metazoans for at least 700 million years.	[Svensson, Emma; Morck, Catarina; Pilon, Marc] Univ Gothenburg, Dept Cell & Mol Biol, Gothenburg, Sweden; [Olsen, Louise; Faergeman, Nils J.] Univ So Denmark, Dept Biochem & Mol Biol, Odense, Denmark; [Brackmann, Christian; Enejder, Annika] Chalmers Univ, Dept Chem & Biol Engn, Gothenburg, Sweden	University of Gothenburg; University of Southern Denmark; Chalmers University of Technology	Svensson, E (corresponding author), Univ Gothenburg, Dept Cell & Mol Biol, Gothenburg, Sweden.	marc.pilon@cmb.gu.se	Pilon, Marc/B-9955-2008; Enejder, Annika/J-1938-2012; Pilon, Marc/AAY-4082-2020	Pilon, Marc/0000-0003-3919-2882; Pilon, Marc/0000-0003-3919-2882; Brackmann, Christian/0000-0002-4816-9134; Faergeman, Nils/0000-0002-9281-5287	Ahlens Stiftelse; Swedish Research Council (Vetenskapradet); Cancerfonden; Magnus Bergvalls Stiftelse; Danish Research Council for Strategic Research	Ahlens Stiftelse; Swedish Research Council (Vetenskapradet)(Swedish Research Council); Cancerfonden(Swedish Cancer Society); Magnus Bergvalls Stiftelse; Danish Research Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	This work was funded by the Ahlens Stiftelse, the Swedish Research Council (Vetenskapradet), Cancerfonden, Magnus Bergvalls Stiftelse, and the Danish Research Council for Strategic Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Atherton HJ, 2008, FEBS LETT, V582, P1661, DOI 10.1016/j.febslet.2008.04.020; Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Bjursell M, 2007, DIABETES, V56, P583, DOI 10.2337/db06-1432; Brash AR, 2001, J CLIN INVEST, V107, P1339, DOI 10.1172/JCI13210; Brock TJ, 2006, PLOS GENET, V2, P997, DOI 10.1371/journal.pgen.0020108; Brooks KK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007545; Forrester WC, 1997, DEVELOPMENT, V124, P1831; Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798; GARWIN JL, 1980, J BACTERIOL, V141, P1457, DOI 10.1128/JB.141.3.1457-1459.1980; Hellerer T, 2007, P NATL ACAD SCI USA, V104, P14658, DOI 10.1073/pnas.0703594104; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Holland WL, 2011, NAT MED, V17, P55, DOI 10.1038/nm.2277; Holland WL, 2009, MOL PHARMACOL, V75, P740, DOI 10.1124/mol.109.054817; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697; Imai J, 2006, OBESITY, V14, P1132, DOI 10.1038/oby.2006.130; Imbeault P, 2009, METABOLISM, V58, P552, DOI 10.1016/j.metabol.2008.11.017; Iwabu M, 2010, NATURE, V464, P1313, DOI 10.1038/nature08991; Kadowaki T, 2008, FEBS LETT, V582, P74, DOI 10.1016/j.febslet.2007.11.070; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; Kubota N, 2007, CELL METAB, V6, P55, DOI 10.1016/j.cmet.2007.06.003; Kupchak BR, 2009, BIOCHEMISTRY-US, V48, P5504, DOI 10.1021/bi9006258; Lee RYN, 2001, CURR BIOL, V11, P1950, DOI 10.1016/S0960-9822(01)00595-4; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Lindsay RS, 2002, LANCET, V360, P57, DOI 10.1016/S0140-6736(02)09335-2; Maeda K, 1996, BIOCHEM BIOPH RES CO, V221, P286, DOI 10.1006/bbrc.1996.0587; MANSER J, 1990, DEV GENET, V11, P49, DOI 10.1002/dvg.1020110107; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Morck C, 2009, P NATL ACAD SCI USA, V106, P18285, DOI 10.1073/pnas.0907117106; Murray P, 2007, P NATL ACAD SCI USA, V104, P5489, DOI 10.1073/pnas.0609590104; Narbonne P, 2009, NATURE, V457, P210, DOI 10.1038/nature07536; Nomura T, 2010, GENES NUTR, V5, P17, DOI 10.1007/s12263-009-0157-y; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Pischon T, 2004, JAMA-J AM MED ASSOC, V291, P1730, DOI 10.1001/jama.291.14.1730; POLYZOS SA, 2010, METABOLISM; Qi Y, 2004, NAT MED, V10, P524, DOI 10.1038/nm1029; Savvidou S, 2009, J CLIN GASTROENTEROL, V43, P765, DOI 10.1097/MCG.0b013e31819e9048; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Shtonda BB, 2006, J EXP BIOL, V209, P89, DOI 10.1242/jeb.01955; Spranger J, 2003, LANCET, V361, P226, DOI 10.1016/S0140-6736(03)12255-6; Sulston J., 1988, NEMATODE CAENORHABDI, P587; Tanaka T, 1996, LIPIDS, V31, P1173, DOI 10.1007/BF02524292; Tang YT, 2005, J MOL EVOL, V61, P372, DOI 10.1007/s00239-004-0375-2; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Van Gilst MR, 2005, PLOS BIOL, V3, P301, DOI 10.1371/journal.pbio.0030053; Villa NY, 2009, MOL PHARMACOL, V75, P866, DOI 10.1124/mol.108.049809; Watts JL, 2009, TRENDS ENDOCRIN MET, V20, P58, DOI 10.1016/j.tem.2008.11.002; Watts JL, 2002, P NATL ACAD SCI USA, V99, P5854, DOI 10.1073/pnas.092064799; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yamauchi T, 2003, J BIOL CHEM, V278, P2461, DOI 10.1074/jbc.M209033200; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Yamauchi T, 2007, NAT MED, V13, P332, DOI 10.1038/nm1557; Yang FJ, 2006, NATURE, V442, P700, DOI 10.1038/nature04942; Yen K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012810; Zhang SBO, 2010, P NATL ACAD SCI USA, V107, P4640, DOI 10.1073/pnas.0912308107	59	37	46	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2011	6	6							e21343	10.1371/journal.pone.0021343	http://dx.doi.org/10.1371/journal.pone.0021343			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782CL	21712952	gold, Green Published, Green Submitted			2022-12-27	WOS:000291985100033
J	Takeuchi, H; Mizoguchi, H; Doi, Y; Jin, SJ; Noda, M; Liang, JF; Li, H; Zhou, Y; Mori, R; Yasuoka, S; Li, ED; Parajuli, B; Kawanokuchi, J; Sonobe, Y; Sato, J; Yamanaka, K; Sobue, G; Mizuno, T; Suzumura, A				Takeuchi, Hideyuki; Mizoguchi, Hiroyuki; Doi, Yukiko; Jin, Shijie; Noda, Mariko; Liang, Jianfeng; Li, Hua; Zhou, Yan; Mori, Rarami; Yasuoka, Satoko; Li, Endong; Parajuli, Bijay; Kawanokuchi, Jun; Sonobe, Yoshifumi; Sato, Jun; Yamanaka, Koji; Sobue, Gen; Mizuno, Tetsuya; Suzumura, Akio			Blockade of Gap Junction Hemichannel Suppresses Disease Progression in Mouse Models of Amyotrophic Lateral Sclerosis and Alzheimer's Disease	PLOS ONE			English	Article							MOTOR-NEURON DEGENERATION; GLUTAMATE RELEASE; ACTIVATED MICROGLIA; IN-VITRO; BETA; BRAIN; NEUROTOXICITY; GLIA; ALS; ACCUMULATION	Background: Glutamate released by activated microglia induces excitotoxic neuronal death, which likely contributes to non-cell autonomous neuronal death in neurodegenerative diseases, including amyotrophic lateral sclerosis and Alzheimer's disease. Although both blockade of glutamate receptors and inhibition of microglial activation are the therapeutic candidates for these neurodegenerative diseases, glutamate receptor blockers also perturbed physiological and essential glutamate signals, and inhibitors of microglial activation suppressed both neurotoxic/neuroprotective roles of microglia and hardly affected disease progression. We previously demonstrated that activated microglia release a large amount of glutamate specifically through gap junction hemichannel. Hence, blockade of gap junction hemichannel may be potentially beneficial in treatment of neurodegenerative diseases. Methods and Findings: In this study, we generated a novel blood-brain barrier permeable gap junction hemichannel blocker based on glycyrrhetinic acid. We found that pharmacologic blockade of gap junction hemichannel inhibited excessive glutamate release from activated microglia in vitro and in vivo without producing notable toxicity. Blocking gap junction hemichannel significantly suppressed neuronal loss of the spinal cord and extended survival in transgenic mice carrying human superoxide dismutase 1 with G93A or G37R mutation as an amyotrophic lateral sclerosis mouse model. Moreover, blockade of gap junction hemichannel also significantly improved memory impairments without altering amyloid beta deposition in double transgenic mice expressing human amyloid precursor protein with K595N and M596L mutations and presenilin 1 with A264E mutation as an Alzheimer's disease mouse model. Conclusions: Our results suggest that gap junction hemichannel blockers may represent a new therapeutic strategy to target neurotoxic microglia specifically and prevent microglia-mediated neuronal death in various neurodegenerative diseases.	[Takeuchi, Hideyuki; Doi, Yukiko; Jin, Shijie; Noda, Mariko; Liang, Jianfeng; Li, Hua; Zhou, Yan; Yasuoka, Satoko; Li, Endong; Parajuli, Bijay; Kawanokuchi, Jun; Sonobe, Yoshifumi; Mizuno, Tetsuya; Suzumura, Akio] Nagoya Univ, Environm Med Res Inst, Dept Neuroimmunol, Chikusa Ku, Nagoya, Aichi 464, Japan; [Mizoguchi, Hiroyuki; Mori, Rarami; Sato, Jun] Nagoya Univ, Futurist Environm Simulat Ctr, Environm Med Res Inst, Chikusa Ku, Nagoya, Aichi 464, Japan; [Yamanaka, Koji] RIKEN, Lab Motor Neuron Dis, Brain Sci Inst, Wako, Saitama, Japan; [Sobue, Gen] Nagoya Univ, Dept Neurol, Grad Sch Med, Showa Ku, Nagoya, Aichi 464, Japan	Nagoya University; Nagoya University; RIKEN; Nagoya University	Takeuchi, H (corresponding author), Nagoya Univ, Environm Med Res Inst, Dept Neuroimmunol, Chikusa Ku, Furo Cho, Nagoya, Aichi 464, Japan.	htake@riem.nagoya-u.ac.jp	Yamanaka, Koji/H-5806-2011; Yamanaka, Koji/ABD-1034-2020; Parajuli, Bijay/G-2961-2015; Li, Endong/J-4502-2013; Bijay, Parajuli/AAT-5590-2021	Yamanaka, Koji/0000-0003-4655-0035; Yamanaka, Koji/0000-0003-4655-0035; Parajuli, Bijay/0000-0003-3813-113X; Noda, Mariko/0000-0002-6066-1359; Takeuchi, Hideyuki/0000-0001-5912-7581; jin, shijie/0000-0001-5689-841X	National Institute of Biomedical Innovation; Uehara Memorial Foundation; Japan Research Foundation for Clinical Pharmacology; Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labour and Welfare of Japan; New Energy and Industrial Technology Development Organization	National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Uehara Memorial Foundation(Uehara Memorial Foundation); Japan Research Foundation for Clinical Pharmacology; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO))	This work was supported by the Program for Promotion of Fundamental Studies in Health Sciences from the National Institute of Biomedical Innovation; a grant from the Uehara Memorial Foundation; a grant from the Japan Research Foundation for Clinical Pharmacology; a Grant-in-Aid for the global Center of Excellence program from the Ministry of Education, Culture, Sports, Science and Technology of Japan; grants from the Ministry of Health, Labour and Welfare of Japan; and a grant from New Energy and Industrial Technology Development Organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barger SW, 2001, J NEUROCHEM, V76, P846, DOI 10.1046/j.1471-4159.2001.00075.x; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Chanson M, 2005, BBA-BIOMEMBRANES, V1711, P197, DOI 10.1016/j.bbamem.2004.10.005; Contreras JE, 2003, P NATL ACAD SCI USA, V100, P11388, DOI 10.1073/pnas.1434298100; Cotrina ML, 1998, J NEUROSCI, V18, P2520; De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200; DELISLE MB, 1984, J NEUROL SCI, V63, P241, DOI 10.1016/0022-510X(84)90199-0; Deshpande A, 2006, J NEUROSCI, V26, P6011, DOI 10.1523/JNEUROSCI.1189-06.2006; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Dickson TC, 1999, EXP NEUROL, V156, P100, DOI 10.1006/exnr.1998.7010; Doi Y, 2009, AM J PATHOL, V175, P2121, DOI 10.2353/ajpath.2009.090418; Eugenin EA, 2001, P NATL ACAD SCI USA, V98, P4190, DOI 10.1073/pnas.051634298; Frantseva MV, 2002, J CEREBR BLOOD F MET, V22, P453, DOI 10.1097/00004647-200204000-00009; Fujita K, 1998, NEUROCHEM INT, V33, P41, DOI 10.1016/S0197-0186(05)80007-5; Gilman S, 2005, NEUROLOGY, V64, P1553, DOI 10.1212/01.WNL.0000159740.16984.3C; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Haughey NJ, 2003, NEUROMOL MED, V3, P173, DOI 10.1385/NMM:3:3:173; Hayworth CR, 2009, NEUROSCIENCE, V164, P975, DOI 10.1016/j.neuroscience.2009.08.031; Holmes C, 2008, LANCET, V372, P216, DOI 10.1016/S0140-6736(08)61075-2; HORI N, 1994, EXP NEUROL, V129, P279, DOI 10.1006/exnr.1994.1170; Jin S, 2007, BRAIN RES, V1179, P140, DOI 10.1016/j.brainres.2007.08.055; Jin SJ, 2009, TOHOKU J EXP MED, V217, P87, DOI 10.1620/tjem.217.87; Juszczak GR, 2009, PROG NEURO-PSYCHOPH, V33, P181, DOI 10.1016/j.pnpbp.2008.12.014; Kempermann G, 2003, SCIENCE, V302, P1689, DOI 10.1126/science.1092864; Kipnis J, 2004, P NATL ACAD SCI USA, V101, P14663, DOI 10.1073/pnas.0404842101; Koenigsknecht J, 2004, J NEUROSCI, V24, P9838, DOI 10.1523/JNEUROSCI.2557-04.2004; LAIRD DW, 2009, TRENDS CELL BIOL; Leigh PN, 2004, AMYOTROPH LATERAL SC, V5, P84, DOI 10.1080/14660820410020187; Liang JF, 2008, BRAIN RES, V1210, P11, DOI 10.1016/j.brainres.2008.03.012; Lobsiger CS, 2007, NAT NEUROSCI, V10, P1355, DOI 10.1038/nn1988; McGeer PL, 2002, MUSCLE NERVE, V26, P459, DOI 10.1002/mus.10191; Mizoguchi H, 2007, J NEUROCHEM, V100, P1579, DOI 10.1111/j.1471-4159.2006.04288.x; Mouri A, 2007, FASEB J, V21, P2135, DOI 10.1096/fj.06-7685com; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Nelson PT, 2002, ANN MED, V34, P491, DOI 10.1080/078538902321117698; Newsholme EA, 1997, NUTRITION, V13, P728, DOI 10.1016/S0899-9007(97)83034-1; NEWSHOLME P, 1989, BIOCHEM J, V261, P211, DOI 10.1042/bj2610211; Nissim I, 1999, AM J PHYSIOL-RENAL, V277, pF493, DOI 10.1152/ajprenal.1999.277.4.F493; Orrell RW, 2010, BRIT MED BULL, V93, P145, DOI 10.1093/bmb/ldp049; Parsons CG, 2007, NEUROPHARMACOLOGY, V53, P699, DOI 10.1016/j.neuropharm.2007.07.013; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; PIANI D, 1992, EUR J IMMUNOL, V22, P2429, DOI 10.1002/eji.1830220936; Pop V, 2010, J NEUROSCI, V30, P9831, DOI 10.1523/JNEUROSCI.6194-09.2010; Prokai L, 2000, MED RES REV, V20, P367, DOI 10.1002/1098-1128(200009)20:5<367::AID-MED3>3.0.CO;2-P; Rawanduzy A, 1997, J NEUROSURG, V87, P916, DOI 10.3171/jns.1997.87.6.0916; Saito Y, 2003, J NEUROPATH EXP NEUR, V62, P644, DOI 10.1093/jnen/62.6.644; Schwab JM, 2004, CELL DEATH DIFFER, V11, P1245, DOI 10.1038/sj.cdd.4401487; SUZUMURA A, 1987, J NEUROIMMUNOL, V15, P263, DOI 10.1016/0165-5728(87)90121-4; Suzumura A, 2006, ANN NY ACAD SCI, V1088, P219, DOI 10.1196/annals.1366.012; Takahashi T, 1997, ACTA NEUROPATHOL, V94, P294, DOI 10.1007/s004010050707; Takeuchi H, 2005, J BIOL CHEM, V280, P10444, DOI 10.1074/jbc.M413863200; Takeuchi H, 2008, EXP NEUROL, V214, P144, DOI 10.1016/j.expneurol.2008.08.001; Takeuchi H, 2006, J BIOL CHEM, V281, P21362, DOI 10.1074/jbc.M600504200; Velazquez JLP, 2000, TRENDS NEUROSCI, V23, P68; Vernadakis A, 1996, PROG NEUROBIOL, V49, P185, DOI 10.1016/S0301-0082(96)00012-3; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Waza M, 2005, NAT MED, V11, P1088, DOI 10.1038/nm1298; Yamamoto M, 2008, EXPERT OPIN PHARMACO, V9, P1845, DOI 10.1517/14656566.9.11.1845 ; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; Yawata I, 2008, LIFE SCI, V82, P1111, DOI 10.1016/j.lfs.2008.03.010; Yudkoff M, 1997, GLIA, V21, P92, DOI 10.1002/(SICI)1098-1136(199709)21:1<92::AID-GLIA10>3.0.CO;2-W; Zietlow R, 1999, EUR J NEUROSCI, V11, P1657, DOI 10.1046/j.1460-9568.1999.00583.x	65	75	79	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2011	6	6							e21108	10.1371/journal.pone.0021108	http://dx.doi.org/10.1371/journal.pone.0021108			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782CL	21712989	Green Submitted, Green Published, gold			2022-12-27	WOS:000291985100011
J	Guerrero, R; Vernia, S; Sanz, R; Abreu-Rodriguez, I; Almaraz, C; Garcia-Hoyos, M; Michelucci, R; Tassinari, CA; Riguzzi, P; Nobile, C; Sanz, P; Serratosa, JM; Gomez-Garre, P				Guerrero, Rosa; Vernia, Santiago; Sanz, Raul; Abreu-Rodriguez, Irene; Almaraz, Carmen; Garcia-Hoyos, Maria; Michelucci, Roberto; Tassinari, Carlo Alberto; Riguzzi, Patrizia; Nobile, Carlo; Sanz, Pascual; Serratosa, Jose M.; Gomez-Garre, Pilar			A PTG Variant Contributes to a Milder Phenotype in Lafora Disease	PLOS ONE			English	Article							PROGRESSIVE MYOCLONUS EPILEPSY; E3 UBIQUITIN LIGASE; GLYCOGEN-SYNTHESIS; PROTEIN; MUTATIONS; MALIN; ACCUMULATION; GENE; DEGRADATION; METABOLISM	Lafora disease is an autosomal recessive form of progressive myoclonus epilepsy with no effective therapy. Although the outcome is always unfavorable, onset of symptoms and progression of the disease may vary. We aimed to identify modifier genes that may contribute to the clinical course of Lafora disease patients with EPM2A or EPM2B mutations. We established a list of 43 genes coding for proteins related to laforin/malin function and/or glycogen metabolism and tested common polymorphisms for possible associations with phenotypic differences using a collection of Lafora disease families. Genotype and haplotype analysis showed that PPP1R3C may be associated with a slow progression of the disease. The PPP1R3C gene encodes protein targeting to glycogen (PTG). Glycogen targeting subunits play a major role in recruiting type 1 protein phosphatase (PP1) to glycogen-enriched cell compartments and in increasing the specific activity of PP1 toward specific glycogenic substrates (glycogen synthase and glycogen phosphorylase). Here, we report a new mutation (c.746A>G, N249S) in the PPP1R3C gene that results in a decreased capacity to induce glycogen synthesis and a reduced interaction with glycogen phosphorylase and laforin, supporting a key role of this mutation in the glycogenic activity of PTG. This variant was found in one of two affected siblings of a Lafora disease family characterized by a remarkable mild course. Our findings suggest that variations in PTG may condition the course of Lafora disease and establish PTG as a potential target for pharmacogenetic and therapeutic approaches.	[Guerrero, Rosa; Sanz, Raul; Almaraz, Carmen; Serratosa, Jose M.; Gomez-Garre, Pilar] Inst Invest Sanitaria Fdn Jimenez Diaz, Lab Neurol, Unidad Epilepsia, Serv Neurol, Madrid, Spain; [Guerrero, Rosa; Sanz, Raul; Almaraz, Carmen; Serratosa, Jose M.; Gomez-Garre, Pilar] CIBERER, Madrid, Spain; [Vernia, Santiago; Garcia-Hoyos, Maria; Sanz, Pascual] CSIC, Inst Biomed Valencia, Valencia, Spain; [Vernia, Santiago; Garcia-Hoyos, Maria; Sanz, Pascual] CIBERER, Valencia, Spain; [Abreu-Rodriguez, Irene] Inst Biomed Sevilla IBiS, Lab Invest Biomed, Seville, Spain; [Michelucci, Roberto; Riguzzi, Patrizia] Bellaria Hosp, Dept Neurosci, Neurol Unit, Bologna, Italy; [Nobile, Carlo] CNR, Inst Neurosci, Sect Padua, Padua, Italy; [Gomez-Garre, Pilar] Inst Biomed Sevilla IBiS, Unidad Trastornos Movimiento, Serv Neurol & Neurofisiol Clin, Seville, Spain; [Tassinari, Carlo Alberto] Univ Bologna, Bologna, Italy	Fundacion Jimenez Diaz; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); AUSL di Bologna; Consiglio Nazionale delle Ricerche (CNR); Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); University of Bologna	Guerrero, R (corresponding author), Inst Invest Sanitaria Fdn Jimenez Diaz, Lab Neurol, Unidad Epilepsia, Serv Neurol, Madrid, Spain.	serratosa@telefonica.net; pggarre@telefonica.net	Vernia, Santiago/Q-7038-2017; Michelucci, Roberto/AAB-9074-2020; Gómez-Garre, Pilar/AAG-8048-2020; Sanz, Pascual/K-2751-2014	Vernia, Santiago/0000-0001-6728-5555; Gómez-Garre, Pilar/0000-0002-0437-6182; Sanz, Pascual/0000-0002-2399-4103; Nobile, Carlo/0000-0002-0634-2218; Almaraz Pro, Maria del Carmen/0000-0002-6714-4450; Serratosa, Jose/0000-0003-2239-8948; Michelucci, Roberto/0000-0002-9655-7940; Tassinari, Carlo Alberto/0000-0002-4183-5165; Guerrero, Rosa/0000-0002-4138-4667	Fundacion Mutua Madrilena; Spanish Ministry of Education and Science [SAF2008-01907, SAF2007-61003]; Generalitat Valenciana [Prometeo 2009/051]	Fundacion Mutua Madrilena(Instituto de Salud Carlos III); Spanish Ministry of Education and Science(Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission)	This work was supported by grants from the Fundacion Mutua Madrilena to PGG and RG, the Spanish Ministry of Education and Science (SAF2008-01907, SAF2007-61003) to PS and JMS and from the Generalitat Valenciana (Prometeo 2009/051) to PS. There are no current external funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguado C, 2010, HUM MOL GENET, V19, P2867, DOI 10.1093/hmg/ddq190; Baykan B, 2005, EPILEPSIA, V46, P1695, DOI 10.1111/j.1528-1167.2005.00272.x; Berman HK, 1998, J BIOL CHEM, V273, P26421, DOI 10.1074/jbc.273.41.26421; Solaz-Fuster MC, 2008, HUM MOL GENET, V17, P667, DOI 10.1093/hmg/ddm339; Chan EM, 2003, NAT GENET, V35, P125, DOI 10.1038/ng1238; DePaoli-Roach AA, 2010, J BIOL CHEM, V285, P25372, DOI 10.1074/jbc.M110.148668; Fernandez-Sanchez ME, 2003, HUM MOL GENET, V12, P3161, DOI 10.1093/hmg/ddg340; Fong NM, 2000, J BIOL CHEM, V275, P35034, DOI 10.1074/jbc.M005541200; Franceschetti S, 2006, EPILEPSIA, V47, P640, DOI 10.1111/j.1528-1167.2006.00479.x; Gentry MS, 2005, P NATL ACAD SCI USA, V102, P8501, DOI 10.1073/pnas.0503285102; Gomez-Abad C, 2005, NEUROLOGY, V64, P982, DOI 10.1212/01.WNL.0000154519.10805.F7; Gomez-Abad C, 2007, EPILEPSIA, V48, P1011, DOI 10.1111/j.1528-1167.2007.01004.x; Gomez-Garre P, 2007, NEUROLOGY, V68, P1369, DOI 10.1212/01.wnl.0000260061.37559.67; Gomez-Garre P, 2000, EUR J HUM GENET, V8, P946, DOI 10.1038/sj.ejhg.5200571; HARRIMAN DGF, 1955, BRAIN, V78, P325, DOI 10.1093/brain/78.3.325; Lafora GR, 1911, Z GESAMTE NEUROL PSY, V6, P1, DOI 10.1007/BF02863929; Minassian BA, 1998, NAT GENET, V20, P171, DOI 10.1038/2470; Printen JA, 1997, SCIENCE, V275, P1475, DOI 10.1126/science.275.5305.1475; Roach Peter J., 2002, Current Molecular Medicine (Hilversum), V2, P101, DOI 10.2174/1566524024605761; SAKAI M, 1970, NEUROLOGY, V20, P160, DOI 10.1212/WNL.20.2.160; Serratosa JM, 1999, HUM MOL GENET, V8, P345, DOI 10.1093/hmg/8.2.345; Singh S, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.039479; TASSINARI CA, 1978, REV EEG NEUROPHYSIOL, V8, P107, DOI 10.1016/S0370-4475(78)80126-9; Van Heycop Ten Ham MW., 1974, HDB CLIN NEUROLOGY, V15, P382; Vernia S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005907; Vernia S, 2009, J BIOL CHEM, V284, P8247, DOI 10.1074/jbc.M808492200; Vilchez D, 2007, NAT NEUROSCI, V10, P1407, DOI 10.1038/nn1998; WANG J, 2009, J BIOL CHEM, V277, P2377; Worby CA, 2008, J BIOL CHEM, V283, P4069, DOI 10.1074/jbc.M708712200; YOKOI S, 1968, ARCH NEUROL-CHICAGO, V19, P15, DOI 10.1001/archneur.1968.00480010033002	30	23	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e21294	10.1371/journal.pone.0021294	http://dx.doi.org/10.1371/journal.pone.0021294			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738631	Green Published, gold			2022-12-27	WOS:000292291800010
J	Rachow, A; Zumla, A; Heinrich, N; Rojas-Ponce, G; Mtafya, B; Reither, K; Ntinginya, EN; O'Grady, J; Huggett, J; Dheda, K; Boehme, C; Perkins, M; Saathoff, E; Hoelscher, M				Rachow, Andrea; Zumla, Alimuddin; Heinrich, Norbert; Rojas-Ponce, Gabriel; Mtafya, Bariki; Reither, Klaus; Ntinginya, Elias N.; O'Grady, Justin; Huggett, Jim; Dheda, Keertan; Boehme, Catharina; Perkins, Mark; Saathoff, Elmar; Hoelscher, Michael			Rapid and Accurate Detection of Mycobacterium tuberculosis in Sputum Samples by Cepheid Xpert MTB/RIF Assay-A Clinical Validation Study	PLOS ONE			English	Article							RIFAMPIN RESISTANCE; SMEAR MICROSCOPY; SUSCEPTIBILITY; PERFORMANCE; SPECIMENS; DIAGNOSIS; SETTINGS; SYSTEM; IMPACT	Background: A crucial impediment to global tuberculosis control is the lack of an accurate, rapid diagnostic test for detection of patients with active TB. A new, rapid diagnostic method, (Cepheid) Xpert MTB/RIF Assay, is an automated sample preparation and real-time PCR instrument, which was shown to have good potential as an alternative to current reference standard sputum microscopy and culture. Methods: We performed a clinical validation study on diagnostic accuracy of the Xpert MTB/RIF Assay in a TB and HIV endemic setting. Sputum samples from 292 consecutively enrolled adults from Mbeya, Tanzania, with suspected TB were subject to analysis by the Xpert MTB/RIF Assay. The diagnostic performance of Xpert MTB/RIF Assay was compared to standard sputum smear microscopy and culture. Confirmed Mycobacterium tuberculosis in a positive culture was used as a reference standard for TB diagnosis. Results: Xpert MTB/RIF Assay achieved 88.4% (95% CI = 78.4% to 94.9%) sensitivity among patients with a positive culture and 99% (95% CI = 94.7% to 100.0%) specificity in patients who had no TB. HIV status did not affect test performance in 172 HIV-infected patients (58.9% of all participants). Seven additional cases (9.1% of 77) were detected by Xpert MTB/RIF Assay among the group of patients with clinical TB who were culture negative. Within 45 sputum samples which grew non-tuberculous mycobacteria the assay's specificity was 97.8% (95% CI = 88.2% to 99.9%). Conclusions: The Xpert MTB/RIF Assay is a highly sensitive, specific and rapid method for diagnosing TB which has potential to complement the current reference standard of TB diagnostics and increase its overall sensitivity. Its usefulness in detecting sputum smear and culture negative patients needs further study. Further evaluation in high burden TB and HIV areas under programmatic health care settings to ascertain applicability, cost-effectiveness, robustness and local acceptance are required.	[Rachow, Andrea; Heinrich, Norbert; Reither, Klaus; Saathoff, Elmar; Hoelscher, Michael] Univ Munich LMU, Med Ctr, Div Infect Dis & Trop Med, Munich, Germany; [Rachow, Andrea; Rojas-Ponce, Gabriel; Mtafya, Bariki; Ntinginya, Elias N.] Natl Inst Med Res, Mbeya Med Res Programme, Mbeya, Tanzania; [Zumla, Alimuddin; O'Grady, Justin; Huggett, Jim; Dheda, Keertan] UCL, Sch Med, Windeyer Inst Med Sci, Dept Infect, London W1N 8AA, England; [Reither, Klaus] Swiss Trop & Publ Hlth Inst Swiss TPH, Basel, Switzerland; [Boehme, Catharina; Perkins, Mark] FIND, Geneva, Switzerland	University of Munich; University of London; University College London; UCL Medical School; University of Basel; Swiss Tropical & Public Health Institute; Foundation For Innovative New Diagnostics	Rachow, A (corresponding author), Univ Munich LMU, Med Ctr, Div Infect Dis & Trop Med, Munich, Germany.	arachow@mmrp.org	Hoelscher, Michael/D-3436-2012; N, Heinrich/B-3750-2014; O'Grady, Justin/I-2982-2012; ZUMLA, Alimuddin/ABA-8208-2020; Huggett, Jim/N-9316-2013	N, Heinrich/0000-0001-9252-7106; O'Grady, Justin/0000-0001-5412-7152; ZUMLA, Alimuddin/0000-0002-5111-5735; Reither, Klaus/0000-0001-6195-8237; Huggett, Jim/0000-0002-0945-1911	European Commission (E.C.); DG Research [LSHP-CT-2006-037785]; EC.AIDCO [ADAT SANTE/2006/129-931]; German Ministry for Education and Research (BmBF); EU; EDCTP; UK-MRC; NIHR; UCLH-CBRC	European Commission (E.C.)(European CommissionEuropean Commission Joint Research Centre); DG Research(European Commission); EC.AIDCO; German Ministry for Education and Research (BmBF)(Federal Ministry of Education & Research (BMBF)); EU(European Commission); EDCTP; UK-MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR(National Institute for Health Research (NIHR)); UCLH-CBRC	This study was funded by the European Commission (E.C.), DG Research, (LSHP-CT-2006-037785), EC.AIDCO, (ADAT SANTE/2006/129-931), and by the German Ministry for Education and Research (BmBF). MH, AZ, JH, JO and KD receive support from the EU-FW7, EDCTP, UK-MRC, and the EU FW7. AZ receives support from the NIHR, UCLH-CBRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blakemore R, 2010, J CLIN MICROBIOL, V48, P2495, DOI 10.1128/JCM.00128-10; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Buijtels PCAM, 2010, CLIN MICROBIOL INFEC, V16, P1142, DOI 10.1111/j.1469-0691.2009.03072.x; Chilima BZ, 2006, APPL ENVIRON MICROB, V72, P2343, DOI 10.1128/AEM.72.4.2343-2350.2006; Dowdy DW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004057; Harries AD, 2010, LANCET, V375, P1906, DOI 10.1016/S0140-6736(10)60409-6; Helb D, 2010, J CLIN MICROBIOL, V48, P229, DOI 10.1128/JCM.01463-09; HILLEMANN D, 2011, J CLIN MICROBIOL; Hillemann D, 2007, J CLIN MICROBIOL, V45, P2635, DOI 10.1128/JCM.00521-07; Ling DI, 2008, EUR RESPIR J, V32, P1165, DOI 10.1183/09031936.00061808; MARLOWE EM, 2011, J CLIN MICROBIOL; MOURE R, 2010, J CLIN MICROBIOL; Pai M, 2008, PLOS MED, V5, P1043, DOI 10.1371/journal.pmed.0050156; Richter Elvira, 2009, Expert Rev Respir Med, V3, P497, DOI 10.1586/ers.09.45; Scarparo C, 2004, J CLIN MICROBIOL, V42, P1109, DOI 10.1128/JCM.42.3.1109-1114.2004; Steingart KR, 2006, LANCET INFECT DIS, V6, P664, DOI 10.1016/S1473-3099(06)70602-8; Van Rie A, 2008, J CLIN MICROBIOL, V46, P897, DOI 10.1128/JCM.01553-07; Wallis RS, 2010, LANCET, V375, P1920, DOI 10.1016/S0140-6736(10)60359-5; Wang JY, 2004, J CLIN MICROBIOL, V42, P4599, DOI 10.1128/JCM.42.10.4599-4603.2004; WHO, 2010, M XDR TB SURV CONTR; World Health Organization (WHO), 2008, MOV RES FIND NEW WHO	21	123	128	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e20458	10.1371/journal.pone.0020458	http://dx.doi.org/10.1371/journal.pone.0020458			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21738575	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000292290100002
J	Rokholm, B; Silventoinen, K; Angquist, L; Skytthe, A; Kyvik, KO; Sorensen, TIA				Rokholm, Benjamin; Silventoinen, Karri; Angquist, Lars; Skytthe, Axel; Kyvik, Kirsten Ohm; Sorensen, Thorkild I. A.			Increased Genetic Variance of BMI with a Higher Prevalence of Obesity	PLOS ONE			English	Article							BODY-MASS INDEX; PHYSICAL-ACTIVITY; WAIST CIRCUMFERENCE; SEX-DIFFERENCES; HERITABILITY; EPIDEMIOLOGY; OVERWEIGHT; TWIN	Background and objectives: There is no doubt that the dramatic worldwide increase in obesity prevalence is due to changes in environmental factors. However, twin studies suggest that genetic differences are responsible for the major part of the variation in body mass index (BMI) and other measures of body fatness within populations. Several recent studies suggest that the genetic effects on adiposity may be stronger when combined with presumed risk factors for obesity. We tested the hypothesis that a higher prevalence of obesity and overweight and a higher BMI mean is associated with a larger genetic variation in BMI. Methods: The data consisted of self-reported height and weight from two Danish twin surveys in 1994 and 2002. A total of 15,017 monozygotic and dizygotic twin pairs were divided into subgroups by year of birth (from 1931 through 1982) and sex. The genetic and environmental variance components of BMI were calculated for each subgroup using the classical twin design. Likewise, the prevalence of obesity, prevalence of overweight and the mean of the BMI distribution was calculated for each subgroup and tested as explanatory variables in a random effects meta-regression model with the square root of the additive genetic variance (equal to the standard deviation) as the dependent variable. Results: The size of additive genetic variation was positively and significantly associated with obesity prevalence (p = 0.001) and the mean of the BMI distribution (p = 0.015). The association with prevalence of overweight was positive but not statistically significant (p = 0.177). Conclusion: The results suggest that the genetic variation in BMI increases as the prevalence of obesity, prevalence of overweight and the BMI mean increases. The findings suggest that the genes related to body fatness are expressed more aggressively under the influence of an obesity-promoting environment.	[Rokholm, Benjamin; Angquist, Lars; Sorensen, Thorkild I. A.] Copenhagen Univ Hosp, Ctr Hlth & Soc, Inst Prevent Med, Copenhagen, Denmark; [Silventoinen, Karri] Univ Helsinki, Dept Social Res, Populat Res Unit, Helsinki, Finland; [Skytthe, Axel; Kyvik, Kirsten Ohm] Univ So Denmark, Danish Twin Registry, Inst Publ Hlth, Odense, Denmark	University of Copenhagen; University of Helsinki; University of Southern Denmark	Rokholm, B (corresponding author), Copenhagen Univ Hosp, Ctr Hlth & Soc, Inst Prevent Med, Copenhagen, Denmark.	br@ipm.regionh.dk	Skytthe, Axel E/G-4820-2019; Kyvik, Kirsten O/K-5680-2016	Skytthe, Axel E/0000-0002-8629-4913; Kyvik, Kirsten O/0000-0003-2981-0245; Angquist, Lars/0000-0002-9516-4424; Silventoinen, Karri/0000-0003-1759-3079	Danish Research Council	Danish Research Council(Det Frie Forskningsrad (DFF))	The funder is The Danish Research Council (http://en.fi.dk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasen CH, 2008, DIABETES, V57, P95, DOI 10.2337/db07-0910; Andreasen CH, 2009, NUTRITION, V25, P998, DOI 10.1016/j.nut.2009.06.001; Bogardus C, 2009, OBESITY, V17, P209, DOI 10.1038/oby.2008.613; Christiansen L, 2003, TWIN RES, V6, P275, DOI 10.1375/136905203322296610; Clarke AJ, 2010, EUR J HUM GENET, V18, P859, DOI 10.1038/ejhg.2010.35; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Flegal KM, 2005, PHYSIOL BEHAV, V86, P599, DOI 10.1016/j.physbeh.2005.08.050; Ford ES, 2008, J CLIN ENDOCR METAB, V93, pS1, DOI 10.1210/jc.2008-1356; Heitmann BL, 1997, AM J CLIN NUTR, V66, P672, DOI 10.1093/ajcn/66.3.672; Karnehed N, 2006, PUBLIC HEALTH NUTR, V9, P851, DOI 10.1017/PHN2005926; Li SX, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000332; McCaffery JM, 2009, AM J CLIN NUTR, V89, P1011, DOI 10.3945/ajcn.2008.27170; Mustelin L, 2009, INT J OBESITY, V33, P29, DOI 10.1038/ijo.2008.258; Neale M. C, 2003, MX STAT MODELING, V6th; NEALE MC, 2006, METHODOLOGY GENETIC; Ogden CL, 2007, GASTROENTEROLOGY, V132, P2087, DOI 10.1053/j.gastro.2007.03.052; Olsen LW, 2006, EPIDEMIOLOGY, V17, P292, DOI 10.1097/01.ede.0000208349.16893.e0; Rampersaud E, 2008, ARCH INTERN MED, V168, P1791, DOI 10.1001/archinte.168.16.1791; Schousboe K, 2003, TWIN RES, V6, P409, DOI 10.1375/twin.6.5.409; SILVENTOINEN K, 2009, INT J OBES; Silventoinen K, 2009, AM J CLIN NUTR, V90, P1096, DOI 10.3945/ajcn.2009.27689; Skytthe A, 2006, TWIN RES HUM GENET, V9, P763; Sonestedt E, 2009, AM J CLIN NUTR, V90, P1418, DOI 10.3945/ajcn.2009.27958; Staub K, 2010, EUR J CLIN NUTR, V64, P335, DOI 10.1038/ejcn.2010.7; Sterne J, 2009, METAANALYSIS UPDATED; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; Vimaleswaran KS, 2009, AM J CLIN NUTR, V90, P425, DOI 10.3945/ajcn.2009.27652; World Health Organization, 2000, WHO TECHN REP SER, V894	29	35	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e20816	10.1371/journal.pone.0020816	http://dx.doi.org/10.1371/journal.pone.0020816			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21738588	gold, Green Submitted, Green Published			2022-12-27	WOS:000292290100008
J	Schelleman, H; Brensinger, CM; Bilker, WB; Hennessy, S				Schelleman, Hedi; Brensinger, Colleen M.; Bilker, Warren B.; Hennessy, Sean			Antidepressant-Warfarin Interaction and Associated Gastrointestinal Bleeding Risk in a Case-Control Study	PLOS ONE			English	Article							SEROTONIN REUPTAKE INHIBITORS; ATRIAL-FIBRILLATION; ELDERLY-PATIENTS; HEMORRHAGE; THERAPY; COHORT	Background: Bleeding is the most common and worrisome adverse effect of warfarin therapy. One of the factors that might increase bleeding risk is initiation of interacting drugs that potentiate warfarin. We sought to evaluate whether initiation of an antidepressant increases the risk of hospitalization for gastrointestinal bleeding in warfarin users. Methodology/Principal Findings: Medicaid claims data (1999-2005) were used to perform an observational case-control study nested within person-time exposed to warfarin in those >= 18 years. In total, 430,455 warfarin users contributed 407,370 person-years of warfarin use. The incidence rate of hospitalization for GI bleeding among warfarin users was 4.48 per 100 person-years (95% CI, 4.42-4.55). Each gastrointestinal bleeding cases was matched to 50 controls based on index date and state. Warfarin users had an increased odds ratio of gastrointestinal bleeding upon initiation of citalopram (OR = 1.73 [95% CI, 1.25-2.38]), fluoxetine (OR = 1.63 [95% CI, 1.11-2.38]), paroxetine (OR = 1.64 [95% CI, 1.27-2.12]), amitriptyline (OR = 1.47 [95% CI, 1.02-2.11]). Also mirtazapine, which is not believed to interact with warfarin, increased the risk of GI bleeding (OR = 1.75 [95% CI, 1.30-2.35]). Conclusions/Significance: Warfarin users who initiated citalopram, fluoxetine, paroxetine, amitriptyline, or mirtazapine had an increased risk of hospitalization for gastrointestinal bleeding. However, the elevated risk with mirtazapine suggests that a drug-drug interaction may not have been responsible for all of the observed increased risk.	[Schelleman, Hedi; Brensinger, Colleen M.; Bilker, Warren B.; Hennessy, Sean] Univ Penn, Sch Med, Dept Biostat & Epidemiol, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Bilker, Warren B.; Hennessy, Sean] Univ Penn, Sch Med, Ctr Educ & Res Therapeut, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Schelleman, H (corresponding author), Univ Penn, Sch Med, Dept Biostat & Epidemiol, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA.	hschelle@mail.med.upenn.edu	Bilker, Warren/AAS-3515-2021		National Institute on Aging [R01AG025152]; Clinical and Translational Science Award [5KL2RR024132]; Abbott; Amgen; Berlex; Merck; Novartis; Pfizer; Roche; Sanofi-aventis en Wyeth; Shire; Tekeda; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024132] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025152] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Clinical and Translational Science Award; Abbott(Abbott Laboratories); Amgen(Amgen); Berlex; Merck(Merck & Company); Novartis(Novartis); Pfizer(Pfizer); Roche(Roche Holding); Sanofi-aventis en Wyeth; Shire; Tekeda; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This project was funded by National Institute on Aging grant R01AG025152. Apart from suggestions from reviewers during the grant peer review process, this funder had no role in the design and conduct of the study, collection, management, analysis, and interpretation of the data, or preparation, review, or approval of the manuscript. Part of the infrastructure for this study was funded by the Clinical and Translational Science Award 5KL2RR024132. This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr. Schelleman has had travel to scientific conferences paid for by pharmacoepidemiology training funds contributed by pharmaceutical manufacturers (Abbott, Amgen, Berlex, Merck, Novartis, Pfizer, Roche, Sanofi-aventis en Wyeth). Ms. Brensinger has consulted for a law firm (Kaye Scholer LLP) representing Pfizer, unrelated to warfarin and antidepressants. Dr. Bilker has consulted for Johnson & Johnson and Astra Zeneca, unrelated to warfarin and antidepressants. Dr. Hennessy has received research funding from Shire and Tekeda, and consulted for Bayer, Teva, Wyeth, Astra-Zeneca, Endo and Amgen, all unrelated to warfarin and antidepressants. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Chen Y, 2009, PHARMACOEPIDEM DR S, V18, P196, DOI 10.1002/pds.1699; Dalton SO, 2003, ARCH INTERN MED, V163, P59, DOI 10.1001/archinte.163.1.59; de Abajo FJ, 1999, BRIT MED J, V319, P1106, DOI 10.1136/bmj.319.7217.1106; Dunn NR, 2000, BRIT MED J, V320, P1405; FLANDERS WD, 1986, AM J EPIDEMIOL, V124, P684, DOI 10.1093/oxfordjournals.aje.a114442; Hansen ML, 2010, ARCH INTERN MED, V170, P1433, DOI 10.1001/archinternmed.2010.271; Hansten PD, 2010, DRUG INTERACTIONS AN; Hennessy S, 2007, MED CARE, V45, P1216, DOI 10.1097/MLR.0b013e318148435a; Hennessy S, 2005, PHARMACOEPIDEMIOLOGY, 4TH EDITION, P281; Hylek EM, 2007, CIRCULATION, V115, P2689, DOI 10.1161/CIRCULATIONAHA.106.653048; Kurdyak PA, 2005, J CLIN PSYCHOPHARM, V25, P561, DOI 10.1097/01.jcp.0000186869.67418.bc; Meijer WEE, 2004, ARCH INTERN MED, V164, P2367, DOI 10.1001/archinte.164.21.2367; MICKEY RM, 1989, AM J EPIDEMIOL, V129, P125, DOI 10.1093/oxfordjournals.aje.a115101; Opatrny L, 2008, BRIT J CLIN PHARMACO, V66, P76, DOI 10.1111/j.1365-2125.2008.03154.x; Schalekamp T, 2008, ARCH INTERN MED, V168, P180, DOI 10.1001/archinternmed.2007.32; Schelleman H, 2010, AM J MED, V123, P151, DOI 10.1016/j.amjmed.2009.07.020; Schmider J, 1997, BRIT J CLIN PHARMACO, V44, P495, DOI 10.1046/j.1365-2125.1997.00601.x; Tatsumi M, 1997, EUR J PHARMACOL, V340, P249, DOI 10.1016/S0014-2999(97)01393-9; Tournier M, 2008, J POPUL THER CLIN PH, V15, pE22; van Walraven C, 2001, BMJ-BRIT MED J, V323, P655, DOI 10.1136/bmj.323.7314.655; Wallerstedt SM, 2009, PHARMACOEPIDEM DR S, V18, P412, DOI 10.1002/pds.1737; 2010, MICROMEDEX 2 0; 2010, DRUG FACTS COMP ANSW	23	65	65	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21447	10.1371/journal.pone.0021447	http://dx.doi.org/10.1371/journal.pone.0021447			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21731754	Green Submitted, gold, Green Published			2022-12-27	WOS:000292036900032
J	Walia, G; Surolia, A				Walia, Guneet; Surolia, Avadhesha			Insights into the Regulatory Characteristics of the Mycobacterial Dephosphocoenzyme A Kinase: Implications for the Universal CoA Biosynthesis Pathway	PLOS ONE			English	Article							COENZYME-A BIOSYNTHESIS; ESCHERICHIA-COLI K-12; PHOSPHOPANTETHEINE ADENYLYLTRANSFERASE; PANTOTHENATE KINASE; CRYSTAL-STRUCTURE; TUBERCULOSIS; THIOESTERS; AUXOTROPH	Being vastly different from the human counterpart, we suggest that the last enzyme of the Mycobacterium tuberculosis Coenzyme A biosynthetic pathway, dephosphocoenzyme A kinase (CoaE) could be a good anti-tubercular target. Here we describe detailed investigations into the regulatory features of the enzyme, affected via two mechanisms. Enzymatic activity is regulated by CTP which strongly binds the enzyme at a site overlapping that of the leading substrate, dephosphocoenzyme A (DCoA), thereby obscuring the binding site and limiting catalysis. The organism has evolved a second layer of regulation by employing a dynamic equilibrium between the trimeric and monomeric forms of CoaE as a means of regulating the effective concentration of active enzyme. We show that the monomer is the active form of the enzyme and the interplay between the regulator, CTP and the substrate, DCoA, affects enzymatic activity. Detailed kinetic data have been corroborated by size exclusion chromatography, dynamic light scattering, glutaraldehyde crosslinking, limited proteolysis and fluorescence investigations on the enzyme all of which corroborate the effects of the ligands on the enzyme oligomeric status and activity. Cysteine mutagenesis and the effects of reducing agents on mycobacterial CoaE oligomerization further validate that the latter is not cysteine-mediated or reduction-sensitive. These studies thus shed light on the novel regulatory features employed to regulate metabolite flow through the last step of a critical biosynthetic pathway by keeping the latter catalytically dormant till the need arises, the transition to the active form affected by a delicate crosstalk between an essential cellular metabolite (CTP) and the precursor to the pathway end-product (DCoA).	[Walia, Guneet; Surolia, Avadhesha] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India; [Surolia, Avadhesha] Natl Inst Immunol, New Delhi 110067, India	Indian Institute of Science (IISC) - Bangalore; Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Walia, G (corresponding author), Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India.	surolia@nii.res.in			Department of Science and Technology (DST), Government of India; DST	Department of Science and Technology (DST), Government of India(Department of Science & Technology (India)); DST(Department of Science & Technology (India))	This work was supported by a grant from the Department of Science and Technology (DST), Government of India. AS holds a JC Bose Fellowship of DST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Begley TP, 2001, VITAM HORM, V61, P157; Chohnan S, 1998, BIOSCI BIOTECH BIOCH, V62, P1122, DOI 10.1271/bbb.62.1122; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Fadoulogiou VE, 2008, ANAL BIOCHEM, V373, P404, DOI 10.1016/j.ab.2007.10.027; Geerlof A, 1999, J BIOL CHEM, V274, P27105, DOI 10.1074/jbc.274.38.27105; Genschel U, 2004, MOL BIOL EVOL, V21, P1242, DOI 10.1093/molbev/msh119; Ghaderi D, 2007, J MOL BIOL, V369, P746, DOI 10.1016/j.jmb.2007.03.037; Glickman MS, 2001, CELL, V104, P477, DOI 10.1016/S0092-8674(01)00236-7; GOTTSCHALK G, 1979, BACTERIAL METABOLISM, P35; JACKOWSKI S, 1981, J BACTERIOL, V148, P926, DOI 10.1128/JB.148.3.926-932.1981; Manabe YC, 2000, NAT MED, V6, P1327, DOI 10.1038/82139; Mishra PK, 2001, J BACTERIOL, V183, P2774, DOI 10.1128/JB.183.9.2774-2778.2001; O'Toole N, 2003, PROTEIN SCI, V12, P327, DOI 10.1110/ps.0227803; Obmolova G, 2001, J STRUCT BIOL, V136, P119, DOI 10.1006/jsbi.2001.4428; Rubio S, 2008, PLANT PHYSIOL, V148, P546, DOI 10.1104/pp.108.124057; Sambandamurthy VK, 2005, INFECT IMMUN, V73, P1196, DOI 10.1128/IAI.73.2.1196-1203.2005; Sambandamurthy VK, 2002, NAT MED, V8, P1171, DOI 10.1038/nm765; SERINA L, 1995, BIOCHEMISTRY-US, V34, P5066, DOI 10.1021/bi00015a018; Seto A, 2005, PROTEINS, V58, P235, DOI 10.1002/prot.20276; SONG WJ, 1994, J BIOL CHEM, V269, P27051; Spry C, 2008, FEMS MICROBIOL REV, V32, P56, DOI 10.1111/j.1574-6976.2007.00093.x; TAHILIANI AG, 1991, VITAM HORM, V46, P165; TRAUT TW, 1994, CRIT REV BIOCHEM MOL, V29, P125, DOI 10.3109/10409239409086799; VALLARI DS, 1987, J BIOL CHEM, V262, P2468; Walia G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015228; Walia G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007645; Yun M, 2000, J BIOL CHEM, V275, P28093; Zhao LH, 2003, EUR J MED CHEM, V38, P345, DOI 10.1016/S0223-5234(03)00047-3	28	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21390	10.1371/journal.pone.0021390	http://dx.doi.org/10.1371/journal.pone.0021390			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21731728	Green Submitted, Green Published, gold			2022-12-27	WOS:000292036900026
J	Zhao, JS; Li, WJ; Ge, D; Zhang, PJ; Li, JJ; Lu, CL; Ji, XD; Guan, DX; Gao, H; Xu, LY; Li, EM; Soukiasian, H; Koeffler, HP; Wang, XF; Xie, D				Zhao, Jiang-Sha; Li, Wen-Jie; Ge, Di; Zhang, Pei-Jing; Li, Jing-Jing; Lu, Chun-Lai; Ji, Xiao-Dan; Guan, Dong-Xian; Gao, Hong; Xu, Li-Yan; Li, Eng-Ming; Soukiasian, Harmik; Koeffler, H. Phillip; Wang, Xiao-Fan; Xie, Dong			Tumor Initiating Cells in Esophageal Squamous Cell Carcinomas Express High Levels of CD44	PLOS ONE			English	Article							CANCER STEM-CELLS; ACUTE PROMYELOCYTIC LEUKEMIA; TRANS-RETINOIC ACID; PROSPECTIVE IDENTIFICATION; DIFFERENTIATION THERAPY; SUBPOPULATION; GROWTH	Background: Esophageal Squamous Cell Carcinoma (ESCC) is a major subtype of esophageal cancer causing significant morbility and mortality in Asia. Mechanism of initiation and progression of this disease is unclear. Tumor initiating cells (TICs) are the subpopulation of cells which have the ability to self-renew, as well as, to drive initiation and progression of cancer. Increasing evidence has shown that TICs exist in a variety of tumors. However, the identification and characterization of TICs in esophageal carcinoma has remained elusive. Methodology/Principal Findings: to identify TICs in ESCC, ESCC cell lines including two primary cells were used for screening suitable surface marker. Then colony formation assay, drug resistant assay and tumorigenicity assay in immune deficient mice were used to characterize TICs in ESCC. We found that just the CD44 expression correlated with tumorigenicity in ESCC cell lines. And then induced differentiation of ESCC cells by all-trans retinoic acid treatment led to decreased expression of CD44. The FACS isolated cell subpopulations with high CD44 expression showed increased colony formation and drug resistance in vitro, as well as significantly enhanced tumorigenicity in NOD/SICD mice, as compared to the low expressing CD44 ESCC cells. Conclusions/Significance: our study has discovered a novel TIC surface marker, CD44, which can be utilized to enrich efficiently the TICs in ESCC. These findings will be useful for further studies of these cells and exploring therapeutic approaches.	[Zhao, Jiang-Sha; Zhang, Pei-Jing; Li, Jing-Jing; Ji, Xiao-Dan; Guan, Dong-Xian; Gao, Hong; Xie, Dong] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Mol Oncol Lab, Shanghai, Peoples R China; [Zhao, Jiang-Sha; Zhang, Pei-Jing; Li, Jing-Jing; Ji, Xiao-Dan; Guan, Dong-Xian; Gao, Hong; Xie, Dong] Chinese Acad Sci, Grad Sch, Shanghai, Peoples R China; [Li, Wen-Jie] Zhengzhou Univ, Coll Publ Hlth, Zhengzhou, Peoples R China; [Ge, Di; Lu, Chun-Lai] Fudan Univ, Shanghai Med Coll, Dept Thorac Surg, Zhongshan Hosp, Shanghai 200433, Peoples R China; [Xu, Li-Yan; Li, Eng-Ming] Shantou Univ, Coll Med, Dept Biochem & Mol Biol, Shantou, Peoples R China; [Soukiasian, Harmik] Univ Calif Los Angeles, Sch Med, Dept Surg, Cedars Sinai Med Ctr, Los Angeles, CA 90024 USA; [Koeffler, H. Phillip] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore; [Wang, Xiao-Fan] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Zhengzhou University; Fudan University; Shantou University; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; National University of Singapore; Duke University	Zhao, JS (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Mol Oncol Lab, Shanghai, Peoples R China.	dxie@sibs.ac.cn	xu, li/GNH-3667-2022	Xie, Dong/0000-0003-2804-8578; Zhang, Peijing/0000-0003-1586-8710; Xie, Dong/0000-0002-1150-8657	Ministry of Science and Technology [2008ZX10002-017]; 863 Program [2007AA02Z4]; 973 Program [2007CB914704]; National Natural Science Funds for Distinguished Young Scholar [30725010]; National Natural Science Foundation of China [90813023, 30528003]; Chinese Academy of Sciences [KSCX2-YW-R-152, KSCX-YW-R-73]; Science and Technology Commission of Shanghai Municipality [08140902300]; NSFC [U0932001]; SIBS [2009KIP510]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); 863 Program(National High Technology Research and Development Program of China); 973 Program(National Basic Research Program of China); National Natural Science Funds for Distinguished Young Scholar(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); NSFC(National Natural Science Foundation of China (NSFC)); SIBS	This work was supported by Ministry of Science and Technology Key program (2008ZX10002-017), 863 Program (2007AA02Z4), and 973 Program (2007CB914704), National Natural Science Funds for Distinguished Young Scholar (30725010), National Natural Science Foundation of China (90813023 and 30528003). Chinese Academy of Sciences Grant (KSCX2-YW-R-152 and KSCX-YW-R-73), and Science and Technology Commission of Shanghai Municipality (08140902300), NSFC-Guangdong Joint Fund (U0932001), and SIBS Fund (2009KIP510). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Burkert J, 2008, J PATHOL, V214, P564, DOI 10.1002/path.2307; CASTAIGNE S, 1990, BLOOD, V76, P1704; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Cooke G, 2008, DIGEST DIS SCI, V53, P2851, DOI 10.1007/s10620-008-0240-z; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Du L, 2008, CLIN CANCER RES, V14, P6751, DOI 10.1158/1078-0432.CCR-08-1034; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; Frank NY, 2010, J CLIN INVEST, V120, P41, DOI 10.1172/JCI41004; Gotoda T, 2000, GUT, V46, P14, DOI 10.1136/gut.46.1.14; Huang DZ, 2009, STEM CELLS DEV, V18, P465, DOI 10.1089/scd.2008.0033; HUANG ME, 1988, BLOOD, V72, P567, DOI 10.1182/blood.V72.2.567.567; Huang SD, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-9; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Li K, 2002, INT J CANCER, V102, P271, DOI [10.1002/ijc.10706, 10.1002/jhc.10706]; Lichtenauer UD, 2008, ENDOCRINOLOGY, V149, P1314, DOI 10.1210/en.2007-1001; Liu WK, 2009, ONKOLOGIE, V32, P574, DOI 10.1159/000232346; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Muller A, 1997, CANCER LETT, V113, P95, DOI 10.1016/S0304-3835(97)04601-6; Nozoe T, 2004, J CANCER RES CLIN, V130, P334, DOI 10.1007/s00432-004-0542-2; Patrawala L, 2006, ONCOGENE, V25, P1696, DOI 10.1038/sj.onc.1209327; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Reim F, 2009, CANCER RES, V69, P8058, DOI 10.1158/0008-5472.CAN-09-0834; Roye GD, 1996, INT J CANCER, V69, P254, DOI 10.1002/(SICI)1097-0215(19960822)69:4<254::AID-IJC2>3.0.CO;2-W; Shimizu M, 2004, CLIN CANCER RES, V10, P1130, DOI 10.1158/1078-0432.CCR-0714-3; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Soprano DR, 2007, VITAM HORM, V75, P69, DOI 10.1016/S0083-6729(06)75003-8; Takaishi S, 2009, STEM CELLS, V27, P1006, DOI 10.1002/stem.30; Vizcaino AP, 2002, INT J CANCER, V99, P860, DOI 10.1002/ijc.10427; WARRELL RP, 1991, NEW ENGL J MED, V324, P1385, DOI 10.1056/NEJM199105163242002; Wong FH, 2009, INT J ONCOL, V34, P117, DOI 10.3892/ijo_00000135; Xu XC, 1999, CANCER RES, V59, P2477; Yamashita T, 2009, GASTROENTEROLOGY, V136, P1012, DOI 10.1053/j.gastro.2008.12.004; Yang ZF, 2008, CANCER CELL, V13, P153, DOI 10.1016/j.ccr.2008.01.013; Zhou ZQ, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-291	40	111	116	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21419	10.1371/journal.pone.0021419	http://dx.doi.org/10.1371/journal.pone.0021419			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21731740	Green Published, Green Submitted, gold			2022-12-27	WOS:000292036900029
J	Ngamphiw, C; Assawamakin, A; Xu, SH; Shaw, PJ; Yang, JO; Ghang, H; Bhak, J; Liu, E; Tongsima, S				Ngamphiw, Chumpol; Assawamakin, Anunchai; Xu, Shuhua; Shaw, Philip J.; Yang, Jin Ok; Ghang, Ho; Bhak, Jong; Liu, Edison; Tongsima, Sissades		HUGO Pan-Asian SNP Consortium	PanSNPdb: The Pan-Asian SNP Genotyping Database	PLOS ONE			English	Article							COPY-NUMBER; GENOME-WIDE; GENETIC DIVERSITY; HAPLOTYPE; POPULATION; BLOCK; MODEL; MAP	The HUGO Pan-Asian SNP consortium conducted the largest survey to date of human genetic diversity among Asians by sampling 1,719 unrelated individuals among 71 populations from China, India, Indonesia, Japan, Malaysia, the Philippines, Singapore, South Korea, Taiwan, and Thailand. We have constructed a database (PanSNPdb), which contains these data and various new analyses of them. PanSNPdb is a research resource in the analysis of the population structure of Asian peoples, including linkage disequilibrium patterns, haplotype distributions, and copy number variations. Furthermore, PanSNPdb provides an interactive comparison with other SNP and CNV databases, including HapMap3, JSNP, dbSNP and DGV and thus provides a comprehensive resource of human genetic diversity. The information is accessible via a widely accepted graphical interface used in many genetic variation databases. Unrestricted access to PanSNPdb and any associated files is available at: http://www4a.biotec.or.th/PASNP.	[Ngamphiw, Chumpol; Assawamakin, Anunchai; Shaw, Philip J.; Tongsima, Sissades] Natl Ctr Genet Engn & Biotechnol BIOTEC, Klongluang, Pathumthani, Thailand; [Ngamphiw, Chumpol] Chulalongkorn Univ, Fac Grad Sch, Interdept Program BioMed Sci, Bangkok, Thailand; [Xu, Shuhua] Chinese Acad Sci, Shanghai Inst Biol Sci, CAS MPG Partner Inst Computat Biol, Shanghai, Peoples R China; [Yang, Jin Ok] KRIBB, KOBIC, Taejon, South Korea; [Ghang, Ho; Bhak, Jong] Genome Res Fdn, Personal Genom Inst, Suwon, South Korea; [Bhak, Jong] TheragenEtex, Theragen BiO Inst, Suwon, South Korea; [Liu, Edison] Genome Inst Singapore, Singapore, Singapore	National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Chulalongkorn University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	Ngamphiw, C (corresponding author), Natl Ctr Genet Engn & Biotechnol BIOTEC, Klongluang, Pathumthani, Thailand.	sissades@biotec.or.th	Hoh, Boon-Peng/H-8682-2016; Ngamphiw, Chumpol/ABB-6488-2021; XU, SHUHUA/D-5345-2009; Xu, Shuhua/AAH-7620-2020; Tongsima, Sissades/F-4891-2011; Ahmed, Ikhlak/Q-2494-2019	Hoh, Boon-Peng/0000-0001-9249-4965; Ngamphiw, Chumpol/0000-0002-8581-397X; XU, SHUHUA/0000-0002-1975-1002; Xu, Shuhua/0000-0002-1975-1002; Tongsima, Sissades/0000-0002-1491-1839; Ahmed, Ikhlak/0000-0002-5753-9627	National Center for Genetic Engineering and Biotechnology; National Science and Technology Development Agency (NSTDA) through the National Center for Genetic Engineering and Biotechnology (BIOTEC); National Science Foundation of China [30971577]; Science and Technology Commission of Shanghai Municipality [09ZR1436400, 11QA1407600]; Bill and Melinda Gates Foundation under the Grand Challenges Explorations Initiative; KRIBB Research Initiative; Korean Ministry of Education, Science and Technology (MEST) [2010-0029345]; MOST; KRIBB internal fund of South Korea; Thailand Research Fund (TRF); Center of Excellence in Molecular Genetics of Cancer and Human Diseases, Chulalongkorn University	National Center for Genetic Engineering and Biotechnology; National Science and Technology Development Agency (NSTDA) through the National Center for Genetic Engineering and Biotechnology (BIOTEC); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Bill and Melinda Gates Foundation under the Grand Challenges Explorations Initiative; KRIBB Research Initiative; Korean Ministry of Education, Science and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea); MOST; KRIBB internal fund of South Korea; Thailand Research Fund (TRF)(Thailand Research Fund (TRF)); Center of Excellence in Molecular Genetics of Cancer and Human Diseases, Chulalongkorn University(Chulalongkorn University)	The authors wish to thank the National Center for Genetic Engineering and Biotechnology for financial support. Anunchai Assawamakin was supported by the National Science and Technology Development Agency (NSTDA) Postdoctoral Fellowship offered through the National Center for Genetic Engineering and Biotechnology (BIOTEC). Shuhua Xu was supported by the National Science Foundation of China (30971577) and the Science and Technology Commission of Shanghai Municipality (09ZR1436400, 11QA1407600). Philip J. Shaw is supported by a grant from the Bill and Melinda Gates Foundation under the Grand Challenges Explorations Initiative. Jin Ok Yang was supported by KRIBB Research Initiative Program and the Korean Ministry of Education, Science and Technology (MEST) under grant number (2010-0029345). Ho Ghang and Jong Bhak were supported by MOST and KRIBB internal fund of South Korea. Sissades Tongsima was supported by the Thailand Research Fund (TRF), and also in part by the Center of Excellence in Molecular Genetics of Cancer and Human Diseases, Chulalongkorn University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla MA, 2009, SCIENCE, V326, P1541, DOI 10.1126/science.1177074; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Friedlaender JS, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040019; Hirakawa M, 2002, NUCLEIC ACIDS RES, V30, P158, DOI 10.1093/nar/30.1.158; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jacobs S, 2007, CANCER RES, V67, P2544, DOI 10.1158/0008-5472.CAN-06-3597; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; Kayser M, 2008, AM J HUM GENET, V82, P194, DOI 10.1016/j.ajhg.2007.09.010; Komura D, 2006, GENOME RES, V16, P1575, DOI 10.1101/gr.5629106; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Pennisi E, 2010, SCIENCE, V330, P574, DOI 10.1126/science.330.6004.574; Sayers EW, 2011, NUCLEIC ACIDS RES, V39, pD38, DOI 10.1093/nar/gkq1172; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Stein LD, 2002, GENOME RES, V12, P1599, DOI 10.1101/gr.403602; Zhang K, 2003, BIOINFORMATICS, V19, P1300, DOI 10.1093/bioinformatics/btg142	16	36	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21451	10.1371/journal.pone.0021451	http://dx.doi.org/10.1371/journal.pone.0021451			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731755	gold, Green Submitted, Green Published			2022-12-27	WOS:000292035400040
J	Smith, B; Chen, ZG; Reimers, L; van Doorslaer, K; Schiffman, M; DeSalle, R; Herrero, R; Yu, K; Wacholder, S; Wang, T; Burk, RD				Smith, Benjamin; Chen, Zigui; Reimers, Laura; van Doorslaer, Koenraad; Schiffman, Mark; DeSalle, Rob; Herrero, Rolando; Yu, Kai; Wacholder, Sholom; Wang, Tao; Burk, Robert D.			Sequence Imputation of HPV16 Genomes for Genetic Association Studies	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; CERVICAL-CANCER; GENOTYPE IMPUTATION; HUMAN-POPULATIONS; NEOPLASIA; VARIANTS; PCR; CARCINOGENICITY; CLASSIFICATION; INFECTIONS	Background: Human Papillomavirus type 16 (HPV16) causes over half of all cervical cancer and some HPV16 variants are more oncogenic than others. The genetic basis for the extraordinary oncogenic properties of HPV16 compared to other HPVs is unknown. In addition, we neither know which nucleotides vary across and within HPV types and lineages, nor which of the single nucleotide polymorphisms (SNPs) determine oncogenicity. Methods: A reference set of 62 HPV16 complete genome sequences was established and used to examine patterns of evolutionary relatedness amongst variants using a pairwise identity heatmap and HPV16 phylogeny. A BLAST-based algorithm was developed to impute complete genome data from partial sequence information using the reference database. To interrogate the oncogenic risk of determined and imputed HPV16 SNPs, odds-ratios for each SNP were calculated in a case-control viral genome-wide association study (VWAS) using biopsy confirmed high-grade cervix neoplasia and self-limited HPV16 infections from Guanacaste, Costa Rica. Results: HPV16 variants display evolutionarily stable lineages that contain conserved diagnostic SNPs. The imputation algorithm indicated that an average of 97.5 +/- 1.03% of SNPs could be accurately imputed. The VWAS revealed specific HPV16 viral SNPs associated with variant lineages and elevated odds ratios; however, individual causal SNPs could not be distinguished with certainty due to the nature of HPV evolution. Conclusions: Conserved and lineage-specific SNPs can be imputed with a high degree of accuracy from limited viral polymorphic data due to the lack of recombination and the stochastic mechanism of variation accumulation in the HPV genome. However, to determine the role of novel variants or non-lineage-specific SNPs by VWAS will require direct sequence analysis. The investigation of patterns of genetic variation and the identification of diagnostic SNPs for lineages of HPV16 variants provides a valuable resource for future studies of HPV16 pathogenicity.	[Smith, Benjamin; Chen, Zigui; Burk, Robert D.] Albert Einstein Coll Med, Dept Pediat, Bronx, NY 10467 USA; [Chen, Zigui; van Doorslaer, Koenraad; Burk, Robert D.] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA; [Reimers, Laura; Burk, Robert D.] Albert Einstein Coll Med, Dept Obstet Gynecol & Womens Hlth, Bronx, NY 10467 USA; [Schiffman, Mark; Yu, Kai; Wacholder, Sholom] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [DeSalle, Rob] Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA; [Herrero, Rolando] Fdn INCIENSA, San Jose, Costa Rica; [Wang, Tao; Burk, Robert D.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); American Museum of Natural History (AMNH); Yeshiva University; Albert Einstein College of Medicine	Smith, B (corresponding author), Albert Einstein Coll Med, Dept Pediat, Bronx, NY 10467 USA.	robert.burk@einstein.yu.edu	Schiffman, Mark/B-9766-2015; Chen, Zigui/E-8490-2017; Iadeluca, Laura/V-2811-2017	Chen, Zigui/0000-0002-8577-1298; Iadeluca, Laura/0000-0002-2379-6094; Van Doorslaer, Koenraad/0000-0002-2985-0733	Public Health Service, National Cancer Institute [CA78527]; Center Grants to the Einstein Cancer Research Center; Center for AIDS Research (CFAR); American Museum of Natural History; National Cancer Institute, National Institutes of Health; Department of Health and Human Services; National Institutes of Health [N01-CP-21081, N01-CP-33061, N01-CP-40542, N01-CP-50535, N01-CP-81023]; DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS [N01CP081023, N01CP033061, N01CP040542, N01CP050535, N01CP021081] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA078527, U01CA078527] Funding Source: NIH RePORTER	Public Health Service, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)United States Public Health Service); Center Grants to the Einstein Cancer Research Center; Center for AIDS Research (CFAR); American Museum of Natural History; National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Health and Human Services; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	R.D.B. is supported in part by Public Health Service award CA78527 from the National Cancer Institute and uses facilities supported by Center Grants to the Einstein Cancer Research Center and the Center for AIDS Research (CFAR). R.D. thanks the Louis and Dorothy Cullman Program in Molecular Systematics at the American Museum of Natural History for support. The Guanacaste cohort (design and conduct of the study, sample collection, management, analysis and interpretation of the data) for the enrollment and follow-up phases was supported by the National Cancer Institute, National Institutes of Health, Department of Health and Human Services. National Institutes of Health (N01-CP-21081, N01-CP-33061, N01-CP-40542, N01-CP-50535, N01-CP-81023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. However, some of the investigators are intramural NCI investigators, the agency funding the majority of this study.	Allen CT, 2010, LARYNGOSCOPE, V120, P1756, DOI 10.1002/lary.20936; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; Bernard HU, 2006, INT J CANCER, V118, P1071, DOI 10.1002/ijc.21655; Berumen J, 2001, JNCI-J NATL CANCER I, V93, P1325, DOI 10.1093/jnci/93.17.1325; Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; Bruni L, 2010, J INFECT DIS, V202, P1789, DOI 10.1086/657321; Burk RD, 2003, CANCER RES, V63, P7215; Burk RD, 2009, PUBLIC HEALTH GENOM, V12, P281, DOI 10.1159/000214919; Calleja-Macias IE, 2005, J VIROL, V79, P6565, DOI 10.1128/JVI.79.10.6565-6569.2005; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Castle PE, 2002, J MED VIROL, V68, P417, DOI 10.1002/jmv.10220; Chen ZG, 2005, J VIROL, V79, P7014, DOI 10.1128/JVI.79.11.7014-7023.2005; Chen ZG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020183; Chen Z, 2009, J VIROL, V83, P1443, DOI 10.1128/JVI.02068-08; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; GHEIT T, 2011, CANC EPIDEMIOL  0428; Herrero R, 2000, JNCI-J NATL CANCER I, V92, P464, DOI 10.1093/jnci/92.6.464; Herrero R, 1997, Rev Panam Salud Publica, V1, P362, DOI 10.1590/S1020-49891997000500005; HO L, 1993, J VIROL, V67, P6413, DOI 10.1128/JVI.67.11.6413-6423.1993; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kang HM, 2010, J COMPUT BIOL, V17, P547, DOI 10.1089/cmb.2009.0199; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li N, 2010, INT J CANC; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Molijn A, 2005, J CLIN VIROL, V32, pS43, DOI 10.1016/j.jcv.2004.12.004; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Neale BM, 2010, COLD SPRING HARB PRO, V2010; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qu WM, 1997, J CLIN MICROBIOL, V35, P1304, DOI 10.1128/JCM.35.6.1304-1310.1997; Rector A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r57; REEVES WC, 1989, NEW ENGL J MED, V320, P1437, DOI 10.1056/NEJM198906013202201; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Schiffman M, 2005, VIROLOGY, V337, P76, DOI 10.1016/j.virol.2005.04.002; Schiffman M, 2010, CANCER RES, V70, P3159, DOI 10.1158/0008-5472.CAN-09-4179; SEEDORF K, 1985, VIROLOGY, V145, P181, DOI 10.1016/0042-6822(85)90214-4; Terai M, 2002, J INFECT DIS, V185, P1794, DOI 10.1086/340824; Terai M, 2001, J GEN VIROL, V82, P2035, DOI 10.1099/0022-1317-82-9-2035; Xi LF, 2007, J INFECT DIS, V195, P1340, DOI 10.1086/513441; Xi LF, 2010, J INFECT DIS, V202, P1667, DOI 10.1086/657083; Yamada T, 1997, J VIROL, V71, P2463, DOI 10.1128/JVI.71.3.2463-2472.1997	45	61	65	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21375	10.1371/journal.pone.0021375	http://dx.doi.org/10.1371/journal.pone.0021375			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731721	Green Submitted, gold, Green Published			2022-12-27	WOS:000292035400031
J	Bocklandt, S; Lin, W; Sehl, ME; Sanchez, FJ; Sinsheimer, JS; Horvath, S; Vilain, E				Bocklandt, Sven; Lin, Wen; Sehl, Mary E.; Sanchez, Francisco J.; Sinsheimer, Janet S.; Horvath, Steve; Vilain, Eric			Epigenetic Predictor of Age	PLOS ONE			English	Article							DNA METHYLATION; NETWORK ANALYSIS; HYPERMETHYLATION; DISEASE; CANCER; GENES; TWINS; MICE	From themoment of conception, we begin to age. A decay of cellular structures, gene regulation, and DNA sequence ages cells and organisms. DNA methylation patterns change with increasing age and contribute to age related disease. Here we identify 88 sites in or near 80 genes for which the degree of cytosine methylation is significantly correlated with age in saliva of 34 male identical twin pairs between 21 and 55 years of age. Furthermore, we validated sites in the promoters of three genes and replicated our results in a general population sample of 31 males and 29 females between 18 and 70 years of age. The methylation of three sites-in the promoters of the EDARADD, TOM1L1, and NPTX2 genes-is linear with age over a range of five decades. Using just two cytosines from these loci, we built a regression model that explained 73% of the variance in age, and is able to predict the age of an individual with an average accuracy of 5.2 years. In forensic science, such a model could estimate the age of a person, based on a biological sample alone. Furthermore, a measurement of relevant sites in the genome could be a tool in routine medical screening to predict the risk of age-related diseases and to tailor interventions based on the epigenetic bio-age instead of the chronological age.	[Bocklandt, Sven; Sanchez, Francisco J.; Sinsheimer, Janet S.; Horvath, Steve; Vilain, Eric] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90024 USA; [Lin, Wen; Sinsheimer, Janet S.; Horvath, Steve] Univ Calif Los Angeles, Dept Biostat, Los Angeles, CA USA; [Sehl, Mary E.] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA; [Sinsheimer, Janet S.] Univ Calif Los Angeles, Dept Biomath, Los Angeles, CA USA; [Sanchez, Francisco J.; Vilain, Eric] Univ Calif Los Angeles, Ctr Soc & Genet, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Bocklandt, S (corresponding author), Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90024 USA.	evilain@ucla.edu	Sánchez, Francisco J./B-4022-2009	Sánchez, Francisco J./0000-0001-9879-7019				Boks MP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006767; Bork S, 2010, AGING CELL, V9, P54, DOI 10.1111/j.1474-9726.2009.00535.x; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Goyns MH, 2002, MECH AGEING DEV, V123, P791, DOI 10.1016/S0047-6374(01)00424-9; Gronniger E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000971; Horvath S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000117; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langton AK, 2008, J INVEST DERMATOL, V128, P1311, DOI 10.1038/sj.jid.5701178; Maegawa S, 2010, GENOME RES, V20, P332, DOI 10.1101/gr.096826.109; Marks PA, 2007, NAT BIOTECHNOL, V25, P84, DOI 10.1038/nbt1272; Moran LB, 2008, ACTA NEUROPATHOL, V115, P471, DOI 10.1007/s00401-007-0309-3; Park JK, 2007, PANCREAS, V35, pE9, DOI 10.1097/MPA.0b013e318153fa42; R Development Core Team, 2005, R LANG ENV STAT COMP; Rakyan VK, 2010, GENOME RES, V20, P434, DOI 10.1101/gr.103101.109; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Teschendorff AE, 2010, GENOME RES, V20, P440, DOI 10.1101/gr.103606.109; Thiede C, 2000, BONE MARROW TRANSPL, V25, P575, DOI 10.1038/sj.bmt.1702170; Tibshirani R, 1997, STAT MED, V16, P385, DOI 10.1002/(SICI)1097-0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3; Wang SC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002698; Wu TT, 2009, BIOINFORMATICS, V25, P714, DOI 10.1093/bioinformatics/btp041; Yan MH, 2002, CURR BIOL, V12, P409, DOI 10.1016/S0960-9822(02)00687-5; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128	23	522	543	5	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e14821	10.1371/journal.pone.0014821	http://dx.doi.org/10.1371/journal.pone.0014821			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731603	gold, Green Published			2022-12-27	WOS:000292033700001
J	Bohmann, K; Monadjem, A; Noer, CL; Rasmussen, M; Zeale, MRK; Clare, E; Jones, G; Willerslev, E; Gilbert, MTP				Bohmann, Kristine; Monadjem, Ara; Noer, Christina Lehmkuhl; Rasmussen, Morten; Zeale, Matt R. K.; Clare, Elizabeth; Jones, Gareth; Willerslev, Eske; Gilbert, M. Thomas P.			Molecular Diet Analysis of Two African Free-Tailed Bats (Molossidae) Using High Throughput Sequencing	PLOS ONE			English	Article							DNA; PREY; PCR; IDENTIFICATION; PREDATOR	Given the diversity of prey consumed by insectivorous bats, it is difficult to discern the composition of their diet using morphological or conventional PCR-based analyses of their faeces. We demonstrate the use of a powerful alternate tool, the use of the Roche FLX sequencing platform to deep-sequence uniquely 59 tagged insect-generic barcode cytochrome c oxidase I (COI) fragments, that were PCR amplified from faecal pellets of two free-tailed bat species Chaerephon pumilus and Mops condylurus (family: Molossidae). Although the analyses were challenged by the paucity of southern African insect COI sequences in the GenBank and BOLD databases, similarity to existing collections allowed the preliminary identification of 25 prey families from six orders of insects within the diet of C. pumilus, and 24 families from seven orders within the diet of M. condylurus. Insects identified to families within the orders Lepidoptera and Diptera were widely present among the faecal samples analysed. The two families that were observed most frequently were Noctuidae and Nymphalidae (Lepidoptera). Species-level analysis of the data was accomplished using novel bioinformatics techniques for the identification of molecular operational taxonomic units (MOTU). Based on these analyses, our data provide little evidence of resource partitioning between sympatric M. condylurus and C. pumilus in the Simunye region of Swaziland at the time of year when the samples were collected, although as more complete databases against which to compare the sequences are generated this may have to be re-evaluated.	[Bohmann, Kristine; Noer, Christina Lehmkuhl; Rasmussen, Morten; Willerslev, Eske; Gilbert, M. Thomas P.] Nat Hist Museum Denmark, Ctr GeoGenet, Copenhagen, Denmark; [Monadjem, Ara] Univ Swaziland, Dept Biol Sci, All Out Africa Res Unit, Kwaluseni, Eswatini; [Zeale, Matt R. K.; Clare, Elizabeth; Jones, Gareth] Univ Bristol, Sch Biol Sci, Bristol, Avon, England	University of Bristol	Bohmann, K (corresponding author), Nat Hist Museum Denmark, Ctr GeoGenet, Copenhagen, Denmark.	mtpgilbert@gmail.com	Willerslev, Eske/A-9619-2011; Gilbert, Marcus TP/A-8936-2013; Monadjem, Ara/K-7279-2014; Willerslev, Eske/AAA-5686-2019; Bohmann, Kristine/B-9617-2015	Willerslev, Eske/0000-0002-7081-6748; Gilbert, Marcus TP/0000-0002-5805-7195; Monadjem, Ara/0000-0003-1906-4023; Jones, Gareth/0000-0002-1904-3735; Zeale, Matt/0000-0002-4997-9577; Bohmann, Kristine/0000-0001-7907-064X; Lehmkuhl Noer, Christina/0000-0001-8303-5759	Bat Conservation International; Etatsraad Georg Bestle og Hustrus Mindelegat; Oticon Fonden; Danish Council for Independent Research Natural Sciences; Natural Sciences and Engineering Research Council of Canada; Royal Swaziland Sugar Corporation	Bat Conservation International; Etatsraad Georg Bestle og Hustrus Mindelegat; Oticon Fonden; Danish Council for Independent Research Natural Sciences(Det Frie Forskningsrad (DFF)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Royal Swaziland Sugar Corporation	This study was supported by Bat Conservation International, Etatsraad Georg Bestle og Hustrus Mindelegat and the Oticon Fonden (KB and CN), the Danish Council for Independent Research Natural Sciences 'Skou' award (MTPG), and a Natural Sciences and Engineering Research Council of Canada postdoctoral fellowship (ELC). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study was also supported by the Royal Swaziland Sugar Corporation, who provided field assistance and therefore had a role in data collection.	Aspetsberger F, 2003, AFR ZOOL, V38, P245; Binladen J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000197; Bouchard Sylvie, 1998, Mammalian Species, V574, P1; CLARE EL, MOL ECOL IN PRESS; Clare EL, 2009, MOL ECOL, V18, P2532, DOI 10.1111/j.1365-294X.2009.04184.x; Colwell RK, 2013, ESTIMATES STAT ESTIM; Deagle Bruce E, 2006, Front Zool, V3, P11, DOI 10.1186/1742-9994-3-11; Deagle BE, 2009, MOL ECOL, V18, P2022, DOI 10.1111/j.1365-294X.2009.04158.x; Faure PA, 2009, J MAMMAL, V90, P1148, DOI 10.1644/08-MAMM-A-332.1; Floyd R, 2002, MOL ECOL, V11, P839, DOI 10.1046/j.1365-294X.2002.01485.x; FULLARD JH, 1981, J COMP PHYSIOL, V143, P363, DOI 10.1007/BF00611174; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Gilbert MTP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000272; Goerlitz HR, 2010, CURR BIOL, V20, P1568, DOI 10.1016/j.cub.2010.07.046; Gonzalez JM, 2005, BIOINFORMATICS, V21, P333, DOI 10.1093/bioinformatics/bti008; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; HAPPOLD DCD, 1989, J REPROD FERTIL, V85, P133; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Jones G., 2004, ECHOLOCATION BATS DO, P345; Kingston T, 2001, P ROY SOC B-BIOL SCI, V268, P1381, DOI 10.1098/rspb.2001.1630; Kohn MH, 1997, TRENDS ECOL EVOL, V12, P223, DOI 10.1016/S0169-5347(97)01050-1; Meusnier I, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-214; Meyer M, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1095; Monadjem A, 2008, ACTA CHIROPTEROL, V10, P339, DOI 10.3161/150811008X414917; Nsubuga AM, 2004, MOL ECOL, V13, P2089, DOI 10.1111/j.1365-294X.2004.02207.x; Pegard A, 2009, J AGR FOOD CHEM, V57, P5700, DOI 10.1021/jf803680c; Poinar H, 2009, SCIENCE, V325, DOI [10.1126/science.1167531, 10.1126/science.1168182]; Roques KG, 2001, J APPL ECOL, V38, P268, DOI 10.1046/j.1365-2664.2001.00567.x; Rozen S, 2000, Methods Mol Biol, V132, P365; Schoeman MC, 2003, OECOLOGIA, V134, P154, DOI 10.1007/s00442-002-1107-1; Soininen EM, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-16; Svensson AM, 2003, OIKOS, V101, P239, DOI 10.1034/j.1600-0706.2003.12156.x; Symondson WOC, 2002, MOL ECOL, V11, P627, DOI 10.1046/j.1365-294X.2002.01471.x; TAYLOR P. J., 2010, BATS SO CENTRAL AFRI; Valentini A, 2009, MOL ECOL RESOUR, V9, P51, DOI 10.1111/j.1755-0998.2008.02352.x; Zeale MRK, 2011, MOL ECOL RESOUR, V11, P236, DOI 10.1111/j.1755-0998.2010.02920.x	37	154	162	0	135	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21441	10.1371/journal.pone.0021441	http://dx.doi.org/10.1371/journal.pone.0021441			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731749	Green Published, gold, Green Submitted			2022-12-27	WOS:000292033700086
J	Jonasson, KA; Willis, CKR				Jonasson, Kristin A.; Willis, Craig K. R.			Changes in Body Condition of Hibernating Bats Support the Thrifty Female Hypothesis and Predict Consequences for Populations with White-Nose Syndrome	PLOS ONE			English	Article							GROUND-SQUIRRELS SLEEP; EVAPORATIVE WATER-LOSS; MYOTIS-LUCIFUGUS; BROWN BATS; MAMMALIAN HIBERNATION; ENERGY AVAILABILITY; ELECTRICAL-CONDUCTIVITY; PIPISTRELLE BATS; METABOLIC-RATE; LIFE-HISTORY	White-nose syndrome (WNS) is a new disease of bats that has devastated populations in eastern North America. Infection with the fungus, Geomyces destructans, is thought to increase the time bats spend out of torpor during hibernation, leading to starvation. Little is known about hibernation in healthy, free-ranging bats and more data are needed to help predict consequences of WNS. Trade-offs presumably exist between the energetic benefits and physiological/ecological costs of torpor, leading to the prediction that the relative importance of spring energy reserves should affect an individual's use of torpor and depletion of energy reserves during winter. Myotis lucifugus mate during fall and winter but females do not become pregnant until after spring emergence. Thus, female reproductive success depends on spring fat reserves while male reproductive success does not. Consequently, females should be "thrifty" in their use of fat compared to males. We measured body condition index (BCI; mass/forearm length) of 432 M. lucifugus in Manitoba, Canada during the winter of 2009/2010. Bats were captured during the fall mating period (n = 200), early hibernation (n = 125), and late hibernation (n = 128). Adult females entered hibernation with greater fat reserves and consumed those reserves more slowly than adult males and young of the year. Consequently, adult females may be more likely than males or young of the year to survive the disruption of energy balance associated with WNS, although surviving females may not have sufficient reserves to support reproduction.	[Jonasson, Kristin A.; Willis, Craig K. R.] Univ Winnipeg, Dept Biol, Ctr Forest Interdisciplinary Res, Winnipeg, MB R3B 2E9, Canada	University of Winnipeg	Jonasson, KA (corresponding author), Univ Winnipeg, Dept Biol, Ctr Forest Interdisciplinary Res, Winnipeg, MB R3B 2E9, Canada.	c.willis@uwinnipeg.ca	Willis, Craig K.R./F-5218-2013	Willis, Craig/0000-0002-0985-8607	Natural Sciences and Engineering Research Council (NSERC, Canada); Canada Foundation for Innovation (CFI); Manitoba Research and Innovation Fund; NSERC; Manitoba Graduate Scholarship; Bat Conservation International Student Research Scholarship	Natural Sciences and Engineering Research Council (NSERC, Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); Manitoba Research and Innovation Fund; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Manitoba Graduate Scholarship; Bat Conservation International Student Research Scholarship	This work was supported by the Natural Sciences and Engineering Research Council (NSERC, Canada) Discovery Grant to CKRW; the Canada Foundation for Innovation (CFI) Leader's Opportunity Fund Grand to CKRW; the Manitoba Research and Innovation Fund Grant to CKRW; the NSERC Canada Graduate Scholarship to KAJ; the Manitoba Graduate Scholarship to KAJ; and the Bat Conservation International Student Research Scholarship to KAJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG RB, 1977, J COMP PHYSIOL, V119, P141, DOI 10.1007/BF00686562; ARNOLD W, 1990, BEHAV ECOL SOCIOBIOL, V27, P239; BEER JAMES R., 1956, JOUR MAMMAL, V37, P31, DOI 10.2307/1375523; BILECKI L, 2003, THESIS U MANITOBA WI; Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; Boyles JG, 2007, J EXP BIOL, V210, P4345, DOI 10.1242/jeb.007294; Boyles JG, 2010, ECOL MODEL, V221, P1644, DOI 10.1016/j.ecolmodel.2010.03.018; Boyles JG, 2010, FRONT ECOL ENVIRON, V8, P92, DOI 10.1890/080187; Boyles JG, 2009, J MAMMAL, V90, P9, DOI 10.1644/08-MAMM-A-205.1; Brock Fenton M. B., 1970, Contr. Life Sci. Div. R. Ont. Mus., V77, P1; BUCHANAN GD, 1987, AM J ANAT, V178, P335, DOI 10.1002/aja.1001780405; Burton RS, 1999, FUNCT ECOL, V13, P232, DOI 10.1046/j.1365-2435.1999.00302.x; Choi IH, 1998, PHYSIOL ZOOL, V71, P257, DOI 10.1086/515915; DAAN S, 1991, NEUROSCI LETT, V128, P265, DOI 10.1016/0304-3940(91)90276-Y; Davis W. H., 1965, Journal of Mammalogy, V46, P296, DOI 10.2307/1377850; DAVIS WH, 1966, J MAMMAL, V47, P383, DOI 10.2307/1377679; Dunbar MB, 2006, J MAMMAL, V87, P1096, DOI 10.1644/05-MAMM-A-254R3.1; EWING WG, 1970, COMP BIOCHEM PHYSIOL, V36, P119, DOI 10.1016/0010-406X(70)90658-4; FENTON BM, 1980, MAMMALIAN SPECIES, V142, P1; FENTON MB, 1969, CAN J ZOOLOG, V47, P597, DOI 10.1139/z69-103; Frank CL, 2000, LIFE IN THE COLD, P207; FRENCH AR, 1985, J COMP PHYSIOL B, V156, P13, DOI 10.1007/BF00692921; FRENCH AR, 1982, J APPL PHYSIOL, V52, P216, DOI 10.1152/jappl.1982.52.1.216; Frick WF, 2010, SCIENCE, V329, P679, DOI 10.1126/science.1188594; Frick WF, 2010, J ANIM ECOL, V79, P128, DOI 10.1111/j.1365-2656.2009.01615.x; Gargas A, 2009, MYCOTAXON, V108, P147, DOI 10.5248/108.147; Geiser F, 2004, ANNU REV PHYSIOL, V66, P239, DOI 10.1146/annurev.physiol.66.032102.115105; Green AJ, 2001, ECOLOGY, V82, P1473, DOI 10.2307/2680003; Grigg G, 2000, LIFE IN THE COLD, P5; GRINDAL SD, 1992, AM MIDL NAT, V128, P339, DOI 10.2307/2426468; GUSTAFSON AW, 1976, BIOL REPROD, V15, P9, DOI 10.1093/biolreprod/15.1.9; HOCK RJ, 1951, BIOL BULL-US, V101, P289, DOI 10.2307/1538547; HOLROYD SL, 1993, INFLUENCES SOME EXTR, P126; Humphries MM, 2003, PHYSIOL BIOCHEM ZOOL, V76, P165, DOI 10.1086/367950; Humphries MM, 2003, PHYSIOL BIOCHEM ZOOL, V76, P180, DOI 10.1086/367949; KING WJ, 1991, OECOLOGIA, V86, P528, DOI 10.1007/BF00318319; Kortner G, 1998, OECOLOGIA, V113, P170, DOI 10.1007/s004420050365; Kunz TH, 1998, ECOSCIENCE, V5, P8, DOI 10.1080/11956860.1998.11682443; Luis AD, 2006, FUNCT ECOL, V20, P471, DOI 10.1111/j.1365-2435.2006.01119.x; Lyman C.P., 1982, P54; MCMANUS JJ, 1974, J MAMMAL, V55, P844, DOI 10.2307/1379416; McNab B.K, 2002, PHYSL ECOLOGY VERTEB, DOI DOI 10.1643/0045-8511(2002)002[1170:]2.0.CO;2; Meteyer CU, 2009, J VET DIAGN INVEST, V21, P411, DOI 10.1177/104063870902100401; MICHENER GR, 1990, J MAMMAL, V71, P489, DOI 10.2307/1381787; Millesi E, 2001, J BIOL RHYTHM, V16, P264, DOI 10.1177/074873001129001971; Munro D, 2005, J ANIM ECOL, V74, P692, DOI 10.1111/j.1365-2656.2005.00968.x; MYERS P, 1978, AM NAT, V112, P701, DOI 10.1086/283312; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; Pearce RD, 2008, ACTA CHIROPTEROL, V10, P153, DOI 10.3161/150811008X331171; PLOSKEY G R, 1979, Southwestern Naturalist, V24, P71, DOI 10.2307/3670626; POPOV VI, 1992, NEUROSCIENCE, V48, P45, DOI 10.1016/0306-4522(92)90336-Z; Prendergast BJ, 2002, AM J PHYSIOL-REG I, V282, pR1054, DOI 10.1152/ajpregu.00562.2001; RACEY PA, 1974, J ZOOL, V173, P264, DOI 10.1111/j.1469-7998.1974.tb03136.x; RACEY PA, 1981, J REPROD FERTIL, V61, P123; Randall D., 2001, ECKERT ANIMAL PHYSL; RANSOME RD, 1989, BIOL J LINN SOC, V38, P71, DOI 10.1111/j.1095-8312.1989.tb01564.x; REEDER DM, 2009, ALTERED AROUSAL PATT; Reynolds DS, 2009, J WILDLIFE MANAGE, V73, P1197, DOI 10.2193/2008-151; Ruczynski I, 2011, BIOL LETTERS, V7, P153, DOI 10.1098/rsbl.2010.0585; Ruediger J, 2007, SYNAPSE, V61, P343, DOI 10.1002/syn.20380; SCHOWALTER DB, 1980, J MAMMAL, V61, P350, DOI 10.2307/1380065; SCHOWALTER DB, 1979, CAN FIELD NAT, V93, P243; Sendor T, 2003, J ANIM ECOL, V72, P308, DOI 10.1046/j.1365-2656.2003.00702.x; SHAW WILLIAM T., 1926, JOUR MAMMAL, V7, P91, DOI 10.2307/1373674; SPEAKMAN JR, 1991, J APPL ECOL, V28, P1087, DOI 10.2307/2404227; Stawski C, 2010, NATURWISSENSCHAFTEN, V97, P29, DOI 10.1007/s00114-009-0606-x; Tannerfeldt M, 1998, OIKOS, V83, P545, DOI 10.2307/3546681; THOMAS DW, 1992, PHYSIOL ZOOL, V65, P443, DOI 10.1086/physzool.65.2.30158262; Thomas DW, 1997, FUNCT ECOL, V11, P585, DOI 10.1046/j.1365-2435.1997.00129.x; THOMAS DW, 1990, J MAMMAL, V71, P475, DOI 10.2307/1381967; THOMAS DW, 1979, BEHAV ECOL SOCIOBIOL, V6, P129, DOI 10.1007/BF00292559; TRACHSEL L, 1991, AM J PHYSIOL, V260, pR1123, DOI 10.1152/ajpregu.1991.260.6.R1123; TUTTLE MD, 2009, WHIT NOS SYNDR SCI S, V2; Wang LCH, 1978, STRATEGIES COLD NATU, P109; Watkins M. W., 2003, EFFECT SIZE CALCULAT; WHITAKER JO, 1993, AM MIDL NAT, V129, P200, DOI 10.2307/2426448; Wilkinson GS, 2002, AGING CELL, V1, P124, DOI 10.1046/j.1474-9728.2002.00020.x; WILLIAMS DF, 1979, AM MIDL NAT, V102, P113, DOI 10.2307/2425072; Willis CKR, 2009, J COMP PHYSIOL B, V179, P867, DOI 10.1007/s00360-009-0366-0; Wimsatt WA, 1944, ANAT REC, V88, P193, DOI 10.1002/ar.1090880206; WIMSATT WA, 1945, J MAMMAL, V26, P23, DOI 10.2307/1375029; WIMSATT WA, 1957, ANAT REC, V129, P115, DOI 10.1002/ar.1091290110	82	98	101	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21061	10.1371/journal.pone.0021061	http://dx.doi.org/10.1371/journal.pone.0021061			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731647	Green Published, Green Submitted, gold			2022-12-27	WOS:000292033700032
J	Tian, Z; Shen, J; Wang, FF; Xiao, PG; Yang, JS; Lei, HT; Kazlauskas, A; Kohane, IS; Wu, EX				Tian, Ze; Shen, Jie; Wang, Fengfei; Xiao, Peigen; Yang, Junshan; Lei, Hetian; Kazlauskas, Andrius; Kohane, Isaac S.; Wu, Erxi			Cambogin Is Preferentially Cytotoxic to Cells Expressing PDGFR	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTORS; MULTIPLE-MYELOMA; TYROSINE KINASE; CYCLE ARREST; IN-VITRO; INHIBITOR; MEDULLOBLASTOMA; TUMORS; APOPTOSIS; EFFICACY	Platelet-derived growth factor receptors (PDGFRs) have been implicated in a wide array of human malignancies, including medulloblastoma (MB), the most common brain tumor of childhood. Although significant progress in MB biology and therapeutics has been achieved during the past decades, MB remains a horrible challenge to the physicians and researchers. Therefore, novel inhibitors targeting PDGFR signaling pathway may offer great promise for the treatment of MB. In the present study, we investigated the cytotoxicity and mechanisms of cambogin in Daoy MB cells. Our results show that cambogin triggers significant S phase cell cycle arrest and apoptosis via down regulation of cyclin A and E, and activation of caspases. More importantly, further mechanistic studies demonstrated that cambogin inhibits PDGFR signaling in Daoy and genetically defined mouse embryo fibroblast (MEF) cell lines. These results suggest that cambogin is preferentially cytotoxic to cells expressing PDGFR. Our findings may provide a novel approach by targeting PDGFR signaling against MB.	[Tian, Ze; Shen, Jie; Xiao, Peigen; Yang, Junshan; Lei, Hetian] Chinese Acad Med Sci, Inst Med Plant Dev, Peking Union Med Coll, Beijing 100730, Peoples R China; [Wang, Fengfei; Wu, Erxi] N Dakota State Univ, Dept Pharmaceut Sci, Fargo, ND 58105 USA; [Lei, Hetian; Kazlauskas, Andrius] Harvard Univ, Sch Med, Schepens Eye Res Inst, Dept Ophthalmol, Boston, MA USA; [Tian, Ze; Kohane, Isaac S.] Harvard Univ, Childrens Hosp Boston, Sch Med, Informat Program, Boston, MA USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Peking Union Medical College; North Dakota State University Fargo; Harvard University; Harvard Medical School; Schepens Eye Research Institute; Harvard University; Boston Children's Hospital; Harvard Medical School	Tian, Z (corresponding author), Chinese Acad Med Sci, Inst Med Plant Dev, Peking Union Med Coll, Beijing 100730, Peoples R China.	ze_tian@dfci.harvard.edu; erxi.wu@ndsu.edu	Kohane, Isaac Kohane/K-3716-2012; tian, ze/HDM-4308-2022	Kohane, Isaac Kohane/0000-0003-2192-5160; Lei, Hetian/0000-0003-4091-1936; Wu, Erxi/0000-0002-1680-3639	Nancy Lurie Marks' foundation; ND EPSCoR; North Dakota State University; National Center for Research Resources (NCRR) [NIH P20 RR020151]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103505] Funding Source: NIH RePORTER	Nancy Lurie Marks' foundation; ND EPSCoR; North Dakota State University; National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the Nancy Lurie Marks' foundation (ISK), ND EPSCoR (EW), North Dakota State University faculty funds (EW), and Pilot Project Grant (EW) from the Centers of Biomedical Research Excellence (COBRE) grant NIH P20 RR020151 from the National Center for Research Resources (NCRR). NCRR is a component of the National Institutes of Health (NIH). The contents of this report are solely the responsibility of the authors and do not necessarily reflect the official views of the NIH or NCRR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOUANTOUN TJ, 2009, MOL CANC THER; Buchdunger E, 2000, J PHARMACOL EXP THER, V295, P139; CATENA R, CANC RES, V71, P164; Coluccia AML, 2008, BLOOD, V112, P1346, DOI 10.1182/blood-2007-10-116590; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; El-Sheikh A, 2010, PEDIATR BLOOD CANCER, V55, P35, DOI 10.1002/pbc.22465; ESSAT M, INT J CANC, V128, P2202; FLEMING TP, 1992, CANCER RES, V52, P4550; Gilbertson RJ, 2003, NAT GENET, V35, P197, DOI 10.1038/ng1103-197; GOOSKENS SL, PEDIAT BLOOD CANC, V55, P369; KINOSHITA K, INT J ONCOL, V37, P869; Kumar S, 2007, PLANTA MED, V73, P1452, DOI 10.1055/s-2007-990255; LANNANG AM, PLANTA MED, V76, P708; Li XR, 2010, ONCOTARGET, V1, P309, DOI 10.18632/oncotarget.141; MacDonald TJ, 2001, NAT GENET, V29, P143, DOI 10.1038/ng731; Perrone F, EUR J CANC, V46, P2837; Podar K, 2007, BLOOD, V109, P1669, DOI 10.1182/blood-2006-08-042747; Shen J, 2007, PHARMAZIE, V62, P549, DOI 10.1691/ph.2007.7.6580; Smits A, 1996, LAB INVEST, V74, P188; Tian Z, 2008, INT J CANCER, V122, P31, DOI 10.1002/ijc.23048; Tian Z, 2009, CANCER CHEMOTH PHARM, V63, P1131, DOI 10.1007/s00280-008-0832-5; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Weinstein IB, 2008, CANCER RES, V68, P3077, DOI 10.1158/0008-5472.CAN-07-3293; Wu EX, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003794; XU G, J NAT PROD, V73, P104; Yang JL, 2008, CANCER, V113, P1532, DOI 10.1002/cncr.23778; Zuzak TJ, 2002, EUR J CANCER, V38, P83, DOI 10.1016/S0959-8049(01)00355-0	27	10	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2011	6	6							e21370	10.1371/journal.pone.0021370	http://dx.doi.org/10.1371/journal.pone.0021370			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782CL	21712951	Green Published, gold, Green Submitted			2022-12-27	WOS:000291985100035
J	Collin, A; Archambault, P; Long, B				Collin, Antoine; Archambault, Phillippe; Long, Bernard			Predicting Species Diversity of Benthic Communities within Turbid Nearshore Using Full-Waveform Bathymetric LiDAR and Machine Learners	PLOS ONE			English	Article							DISTRIBUTION MODELS; ECOLOGICAL THEORY; HABITAT; FISH; ASSEMBLAGES; VEGETATION; ABUNDANCE; RICHNESS; PATTERNS; REEFS	Epi-macrobenthic species richness, abundance and composition are linked with type, assemblage and structural complexity of seabed habitat within coastal ecosystems. However, the evaluation of these habitats is highly hindered by limitations related to both waterborne surveys (slow acquisition, shallow water and low reactivity) and water clarity (turbid for most coastal areas). Substratum type/diversity and bathymetric features were elucidated using a supervised method applied to airborne bathymetric LiDAR waveforms over Saint-Simeon-Bonaventure's nearshore area (Gulf of Saint-Lawrence, Quebec, Canada). High-resolution underwater photographs were taken at three hundred stations across an 8-km(2) study area. Seven models based upon state-of-the-art machine learning techniques such as Naive Bayes, Regression Tree, Classification Tree, C 4.5, Random Forest, Support Vector Machine, and CN2 learners were tested for predicting eight epi-macrobenthic species diversity metrics as a function of the class number. The Random Forest outperformed other models with a three-discretized Simpson index applied to epi-macrobenthic communities, explaining 69% (Classification Accuracy) of its variability by mean bathymetry, time range and skewness derived from the LiDAR waveform. Corroborating marine ecological theory, areas with low Simpson epi-macrobenthic diversity responded to low water depths, high skewness and time range, whereas higher Simpson diversity relied upon deeper bottoms (correlated with stronger hydrodynamics) and low skewness and time range. The degree of species heterogeneity was therefore positively linked with the degree of the structural complexity of the benthic cover. This work underpins that fully exploited bathymetric LiDAR (not only bathymetrically derived by-products), coupled with proficient machine learner, is able to rapidly predict habitat characteristics at a spatial resolution relevant to epi-macrobenthos diversity, ranging from clear to turbid waters. This method might serve both to nurture marine ecological theory and to manage areas with high species heterogeneity where navigation is hazardous and water clarity opaque to passive optical sensors.	[Collin, Antoine; Long, Bernard] Univ Quebec, INRS, ETE, Dept Geosci, Quebec City, PQ, Canada; [Archambault, Phillippe] Univ Quebec, Inst Sci Mer, Rimouski, PQ G5L 3A1, Canada	University of Quebec; Institut national de la recherche scientifique (INRS); University of Quebec	Collin, A (corresponding author), Univ Quebec, INRS, ETE, Dept Geosci, Quebec City, PQ, Canada.	antoinecollin1@gmail.com	Rogers, King/G-5482-2010; Collin, Antoine/L-1169-2013; Collin, Antoine/AAL-4560-2021	Collin, Antoine/0000-0001-9559-7572; Collin, Antoine/0000-0001-9559-7572; Archambault, Philippe/0000-0001-5986-6149	network of excellence GEOIDE (Canada); Fisheries and Oceans Canada; US Naval Hydrographic Service; Optech Int.	network of excellence GEOIDE (Canada); Fisheries and Oceans Canada; US Naval Hydrographic Service; Optech Int.	This study was supported by the network of excellence GEOIDE (Canada), Fisheries and Oceans Canada, US Naval Hydrographic Service, and Optech Int. The funders had no role in study design, decision to publish, or preparation of the manuscript. Optech Int. was involved in data collection and analysis.	Adjeroud M, 1997, MAR ECOL PROG SER, V159, P105, DOI 10.3354/meps159105; Anselin L., 2003, GEODA 0 9 USERS GUID; Archambault P, 2001, MAR ECOL PROG SER, V222, P51, DOI 10.3354/meps222051; Austin M, 2007, ECOL MODEL, V200, P1, DOI 10.1016/j.ecolmodel.2006.07.005; Austin MP, 1996, AUST J ECOL, V21, P154, DOI 10.1111/j.1442-9993.1996.tb00596.x; Austin MP, 2002, ECOL MODEL, V157, P101, DOI 10.1016/S0304-3800(02)00205-3; AUSTIN MP, 1989, BIOL CONSERV, V50, P13, DOI 10.1016/0006-3207(89)90003-7; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brier G. W., 1950, MONTHLY WEATHER REVI, V78, P1, DOI DOI 10.1175/1520-0493(1950)078<0001:VOFEIT>2.0.CO;2; Brock JC, 2006, REMOTE SENS ENVIRON, V104, P31, DOI 10.1016/j.rse.2006.04.017; Clark P., 1989, Machine Learning, V3, P261, DOI 10.1007/BF00116835; COLLIN A, 2011, REMOTE SENS EN UNPUB; Collin A, 2008, IEEE T GEOSCI REMOTE, V46, P2947, DOI 10.1109/TGRS.2008.920020; Collin A, 2010, REMOTE SENS ENVIRON, V114, P520, DOI 10.1016/j.rse.2009.10.011; Demsar J, 2004, LECT NOTES ARTIF INT, V3202, P537; ELITH J, 2009, DO THEY DO THEY WHY; Friedman JH, 2002, COMPUT STAT DATA AN, V38, P367, DOI 10.1016/S0167-9473(01)00065-2; Galparsoro I, 2009, ECOL MODEL, V220, P556, DOI 10.1016/j.ecolmodel.2008.11.003; Gray J.S., 1974, Oceanography mar Biol, V12, P223; GUENTHER GC, 2000, EARSEL DRESD; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Harborne AR, 2006, ECOLOGY, V87, P2871, DOI 10.1890/0012-9658(2006)87[2871:MTBDOC]2.0.CO;2; Hewitt JE, 2005, ECOLOGY, V86, P1619, DOI 10.1890/04-1099; Hsu C.-W., 2010, PRACTICAL GUIDE SUPP; Irish J.L., 2000, B INT NAVIGATION ASS, V43-53, DOI [10.1016/S0924-2716(99)00003-9, DOI 10.1016/S0924-2716(99)00003-9]; Kobler A, 2006, ECOL MODEL, V191, P83, DOI 10.1016/j.ecolmodel.2005.08.002; KONONENKO I, 1991, MACH LEARN, V6, P67, DOI 10.1007/BF00153760; Leathwick JR, 1998, ECOGRAPHY, V21, P235, DOI 10.1111/j.1600-0587.1998.tb00561.x; Levesque Melanie, 2010, Canadian Technical Report of Fisheries and Aquatic Sciences, V2893, P1; LONG B, 2006, ETUDE HYDRODYNAMIQUE; LONG BF, 2009, P 2 FUDOTERAM WORKSH; MAC ARTHUR ROBERT H., 1967; MALANSON GP, 1992, ECOL MODEL, V64, P261, DOI 10.1016/0304-3800(92)90026-B; Maxwell DL, 2009, J SEA RES, V61, P258, DOI 10.1016/j.seares.2008.11.008; MINCHIN PR, 1989, VEGETATIO, V83, P97, DOI 10.1007/BF00031683; MITCHELL T, 1989, ANNU REV COMPUT SCI, V4, P417; Mumby PJ, 2001, OECOLOGIA, V128, P274, DOI 10.1007/s004420100643; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Petersen C.G.J., 1913, REP DAN BIOL ANN REV, V16, P229; Pittman SJ, 2007, ECOL MODEL, V204, P9, DOI 10.1016/j.ecolmodel.2006.12.017; Pittman SJ, 2009, J COASTAL RES, V25, P27, DOI [10.2112/SI53-004.1, 10.2112/S153-004.1]; Purkis SJ, 2008, CORAL REEFS, V27, P167, DOI 10.1007/s00338-007-0306-y; Quinlan J.R., 1993, C4 5 PROGRAMS MACHIN; *RES SYST, 2005, ENVI US GUID ENVI VE; Ridgeway G., 2006, GEN BOOSTED REGRESSI; Rigby R., 2001, NEW TRENDS STAT MODE; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Rydgren K, 2003, J VEG SCI, V14, P869, DOI 10.1111/j.1654-1103.2003.tb02220.x; *SAS I INC, 2009, JMP 8 US GUID; THORSON G, 1957, GEOL SOC AM MEM, V67, P461; Turner MG, 2001, LANDSCAPE ECOLOGY TH, DOI DOI 10.1007/B97434; Ward TJ, 1999, ECOL APPL, V9, P691; Wedding LM, 2008, REMOTE SENS ENVIRON, V112, P4159, DOI 10.1016/j.rse.2008.01.025; Wei CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015323; WOOD JD, 1996, THESIS U LEICESTER L	55	34	34	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e21265	10.1371/journal.pone.0021265	http://dx.doi.org/10.1371/journal.pone.0021265			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	21701576	Green Published, gold, Green Accepted			2022-12-27	WOS:000291983800036
J	Fukushi, M; Ito, T; Oka, T; Kitazawa, T; Miyoshi-Akiyama, T; Kirikae, T; Yamashita, M; Kudo, K				Fukushi, Masaya; Ito, Tateki; Oka, Teruaki; Kitazawa, Toshio; Miyoshi-Akiyama, Tohru; Kirikae, Teruo; Yamashita, Makoto; Kudo, Koichiro			Serial Histopathological Examination of the Lungs of Mice Infected with Influenza A Virus PR8 Strain	PLOS ONE			English	Article							ACUTE RESPIRATORY-DISTRESS; H1N1; H5N1; SURFACTANT; PATHOLOGY; DISEASE; HUMANS; MODELS; SERUM	Avian influenza H5N1 and pandemic (H1N1) 2009 viruses are known to induce viral pneumonia and subsequent acute respiratory distress syndrome (ARDS) with diffuse alveolar damage (DAD). The mortality rate of ARDS/DAD is extremely high, at approximately 60%, and no effective treatment for ARDS/DAD has been established. We examined serial pathological changes in the lungs of mice infected with influenza virus to determine the progress from viral pneumonia to ARDS/DAD. Mice were intranasally infected with influenza A/Puerto Rico/8/34 (PR8) virus, and their lungs were examined both macro- and micro-pathologically every 2 days. We also evaluated general condition, survival rate, body weight, viral loads in lung, and surfactant proteins in serum. As a result, all infected mice died within 9 days postinfection. At 2 days postinfection, inflammation in alveolar septa, i.e., interstitial pneumonia, was observed around bronchioles. From 4 to 6 days postinfection, interstitial pneumonia with alveolar collapse expanded throughout the lungs. From 6 to 9 days postinfection, DAD with severe alveolar collapse was observed in the lungs of all of dying and dead mice. In contrast, DAD was not observed in the live infected-mice from 2 to 6 days postinfection, despite their poor general condition. In addition, histopathological analysis was performed in mice infected with a dose of PR8 virus which was 50% of the lethal dose for mice in the 20-day observation period. DAD with alveolar collapse was observed in all dead mice. However, in the surviving mice, instead of DAD, glandular metaplasia was broadly observed in their lungs. The present study indicates that DAD with severe alveolar collapse is associated with death in this mouse infection model of influenza virus. Inhibition of the development of DAD with alveolar collapse may decrease the mortality rate in severe viral pneumonia caused by influenza virus infection.	[Fukushi, Masaya; Oka, Teruaki; Kudo, Koichiro] Ctr Dis Control & Prevent, Natl Ctr Global Hlth & Med, Tokyo, Japan; [Fukushi, Masaya; Miyoshi-Akiyama, Tohru; Kirikae, Teruo] Natl Ctr Global Hlth & Med, Res Inst, Dept Infect Dis, Tokyo, Japan; [Ito, Tateki; Kitazawa, Toshio] Natl Ctr Global Hlth & Med, Dept Diagnost Pathol, Tokyo, Japan; [Oka, Teruaki] Kanto Cent Hosp, Dept Pathol, Tokyo, Japan; [Yamashita, Makoto] Daiichi Sankyo Co Ltd, Biol Res Labs, Tokyo, Japan	National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan; Daiichi Sankyo Company Limited	Fukushi, M (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Global Hlth & Med, Tokyo, Japan.	mfukushi@ri.ncgm.go.jp			Founding Research Centers for Emerging and Reemerging Infectious Diseases; Ministry of Education, Culture, Sports, Science and Technology of Japan	Founding Research Centers for Emerging and Reemerging Infectious Diseases(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by The Program of Founding Research Centers for Emerging and Reemerging Infectious Diseases from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHBAUGH DG, 1967, LANCET, V2, P319; Barnard DL, 2009, ANTIVIR RES, V82, pA110, DOI 10.1016/j.antiviral.2008.12.014; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Centers for Disease Control and Prevention, 2009, MMWR-MORBID MORTAL W, V58, P435, DOI DOI 10.1007/S00134-010-2021-3; Chotpitayasunondh T, 2005, EMERG INFECT DIS, V11, P201, DOI 10.3201/eid1102.041061; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Deng GC, 2010, ARCH VIROL, V155, P187, DOI 10.1007/s00705-009-0560-0; Esteban A, 2004, ANN INTERN MED, V141, P440, DOI 10.7326/0003-4819-141-6-200409210-00009; Garigliany MM, 2010, EMERG INFECT DIS, V16, P595, DOI 10.3201/eid1604.091061; Gingrich JR, 1996, CANCER RES, V56, P4096; Gold WM, 2000, TXB RESP MED, P781; Greene KE, 1999, AM J RESP CRIT CARE, V160, P1843, DOI 10.1164/ajrccm.160.6.9901117; Griese M, 1999, EUR RESPIR J, V13, P1455, DOI 10.1034/j.1399-3003.1999.13f36.x; Hien TT, 2004, NEW ENGL J MED, V350, P1179, DOI 10.1056/NEJMoa040419; Ichinohe T, 2005, J VIROL, V79, P2910, DOI 10.1128/JVI.79.5.2910-2919.2005; Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Katzenstein A., 2006, SURG PATHOLOGY NONNE; Kubo S, 2010, ANTIMICROB AGENTS CH, V54, P1256, DOI 10.1128/AAC.01311-09; Liem NT, 2008, JPN J INFECT DIS, V61, P157; Lucattelli M, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-83; Maines TR, 2005, J VIROL, V79, P11788, DOI 10.1128/JVI.79.18.11788-11800.2005; Mauad T, 2010, AM J RESP CRIT CARE, V181, P72, DOI 10.1164/rccm.200909-1420OC; NORTHWAY WH, 1967, NEW ENGL J MED, V276, P357, DOI 10.1056/NEJM196702162760701; OKUNO Y, 1994, J VIROL, V68, P517, DOI 10.1128/JVI.68.1.517-520.1994; Pan TL, 2002, AM J PHYSIOL-LUNG C, V282, pL824, DOI 10.1152/ajplung.00421.2000; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; Shieh WJ, 2010, AM J PATHOL, V177, P166, DOI 10.2353/ajpath.2010.100115; Taubenberger JK, 2008, ANNU REV PATHOL-MECH, V3, P499, DOI 10.1146/annurev.pathmechdis.3.121806.154316; Tomashefski JF, 2000, CLIN CHEST MED, V21, P435, DOI 10.1016/S0272-5231(05)70158-1; Tumpey TM, 2005, SCIENCE, V310, P77, DOI 10.1126/science.1119392; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; *WHO, WHO PAN H1N1 2009 UP; *WHO, WHO AV INFL REP; Xu T, 2006, AM J RESP CRIT CARE, V174, P1011, DOI 10.1164/rccm.200511-1751OC	35	59	60	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e21207	10.1371/journal.pone.0021207	http://dx.doi.org/10.1371/journal.pone.0021207			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	21701593	Green Submitted, Green Published, gold			2022-12-27	WOS:000291983800032
J	Ferreira, ME; Flaherty, K; Prochasson, P				Ferreira, Monica E.; Flaherty, Kacie; Prochasson, Philippe			The Saccharomyces cerevisiae Histone Chaperone Rtt106 Mediates the Cell Cycle Recruitment of SWI/SNF and RSC to the HIR-Dependent Histone Genes	PLOS ONE			English	Article							IN-VIVO; TRANSCRIPTIONAL REPRESSORS; REMODELING COMPLEX; CHROMATIN; YEAST; IDENTIFICATION; PROMOTERS; SUBUNITS; REVEALS; DOMAINS	Background: In Saccharomyces cerevisiae, three out of the four histone gene pairs (HTA1-HTB1, HHT1-HHF1, and HHT2-HHF2) are regulated by the HIR co-repressor complex. The histone chaperone Rtt106 has recently been shown to be present at these histone gene loci throughout the cell cycle in a HIR- and Asf1-dependent manner and involved in their transcriptional repression. The SWI/SNF and RSC chromatin remodeling complexes are both recruited to the HIR-dependent histone genes; SWI/SNF is required for their activation in S phase, whereas RSC is implicated in their repression outside of S phase. Even though their presence at the histone genes is dependent on the HIR complex, their specific recruitment has not been well characterized. In this study we focused on characterizing the role played by the histone chaperone Rtt106 in the cell cycle-dependent recruitment of SWI/SNF and RSC complexes to the histone genes. Methodology/Principal Findings: Using GST pull-down and co-immunoprecipitation assays, we showed that Rtt106 physically interacts with both the SWI/SNF and RSC complexes in vitro and in vivo. We then investigated the function of this interaction with respect to the recruitment of these complexes to HIR-dependent histone genes. Using chromatin immunoprecipitation assays (ChIP), we found that Rtt106 is important for the recruitment of both SWI/SNF and RSC complexes to the HIR-dependent histone genes. Furthermore, using synchronized cell cultures, we showed by ChIP assays that the Rtt106-dependent SWI/SNF recruitment to these histone gene loci is cell cycle regulated and restricted to late G1 phase just before the peak of histone gene expression in S phase. Conclusions/Significance: Overall, these data strongly suggest that the interaction between the histone chaperone Rtt106 and both the SWI/SNF and RSC chromatin remodeling complexes is important for the cell cycle regulated recruitment of these two complexes to the HIR-dependent histone genes.	[Ferreira, Monica E.; Flaherty, Kacie; Prochasson, Philippe] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66103 USA	University of Kansas; University of Kansas Medical Center	Ferreira, ME (corresponding author), Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66103 USA.	pprochasson@kumc.edu			K-INBRE [P20 RR016475]; Kansas Bioscience Authority (KBA); Kansas Medical Center Research Institute (KMCRI); Leukemia and Lymphoma Society; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016475] Funding Source: NIH RePORTER	K-INBRE; Kansas Bioscience Authority (KBA); Kansas Medical Center Research Institute (KMCRI); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by a K-INBRE grant (P20 RR016475), the Kansas Bioscience Authority (KBA), the Kansas Medical Center Research Institute (KMCRI), and the Leukemia and Lymphoma Society Special Fellowship to PP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; Anderson HE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013488; Angus-Hill ML, 2001, MOL CELL, V7, P741, DOI 10.1016/S1097-2765(01)00219-2; Balaji S, 2009, MOL BIOSYST, V5, P269, DOI 10.1039/b816424j; Banumathy G, 2009, MOL CELL BIOL, V29, P758, DOI 10.1128/MCB.01047-08; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Dimova D, 1999, MOL CELL, V4, P75, DOI 10.1016/S1097-2765(00)80189-6; ERIKSSON PR, 2010, MOL CELL BIOL; Ferreira ME, 2009, FEBS J, V276, P2557, DOI 10.1111/j.1742-4658.2009.06979.x; Feser J, 2010, MOL CELL, V39, P724, DOI 10.1016/j.molcel.2010.08.015; Fillingham J, 2009, MOL CELL, V35, P340, DOI 10.1016/j.molcel.2009.06.023; FREEMAN KB, 1992, MOL CELL BIOL, V12, P5455, DOI 10.1128/MCB.12.12.5455; Govind CK, 2005, MOL CELL BIOL, V25, P5626, DOI 10.1128/MCB.25.13.5626-5638.2005; Graumann J, 2004, MOL CELL PROTEOMICS, V3, P226, DOI 10.1074/mcp.M300099-MCP200; Green EM, 2005, CURR BIOL, V15, P2044, DOI 10.1016/j.cub.2005.10.053; Gunjan A, 2005, BIOCHIMIE, V87, P625, DOI 10.1016/j.biochi.2005.02.008; Huang SB, 2005, P NATL ACAD SCI USA, V102, P13410, DOI 10.1073/pnas.0506176102; Imbeault D, 2008, J BIOL CHEM, V283, P27350, DOI 10.1074/jbc.C800147200; LAMOUR V, 1995, HUM MOL GENET, V4, P791, DOI 10.1093/hmg/4.5.791; Lee KK, 2004, BIOCHEM SOC T, V32, P899, DOI 10.1042/BST0320899; Li Q, 2008, CELL, V134, P244, DOI 10.1016/j.cell.2008.06.018; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; MORAN L, 1994, FACTORS INVOLVED TEM; Neely KE, 2002, MOL CELL BIOL, V22, P1615, DOI 10.1128/MCB.22.6.1615-1625.2002; Ng HH, 2002, GENE DEV, V16, P806, DOI 10.1101/gad.978902; OSLEY MA, 1986, CELL, V45, P537, DOI 10.1016/0092-8674(86)90285-0; OSLEY MA, 1991, ANNU REV BIOCHEM, V60, P827, DOI 10.1146/annurev.biochem.60.1.827; OSLEY MA, 1987, MOL CELL BIOL, V7, P4204, DOI 10.1128/MCB.7.12.4204; Prochasson P, 2005, GENE DEV, V19, P2534, DOI 10.1101/gad.1341105; Prochasson P, 2003, MOL CELL, V12, P983, DOI 10.1016/S1097-2765(03)00366-6; Sharma VM, 2003, GENE DEV, V17, P502, DOI 10.1101/gad.1039503; Spector MS, 1997, MOL CELL BIOL, V17, P545, DOI 10.1128/MCB.17.2.545; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Sutton A, 2001, GENETICS, V158, P587; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Xu F, 2005, CELL, V121, P375, DOI 10.1016/j.cell.2005.03.011; XU HX, 1992, MOL CELL BIOL, V12, P5249, DOI 10.1128/MCB.12.11.5249	37	15	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e21113	10.1371/journal.pone.0021113	http://dx.doi.org/10.1371/journal.pone.0021113			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698254	Green Published, gold, Green Submitted			2022-12-27	WOS:000291730000054
J	Essex, BG; Lejuez, CW; Qian, RY; Bernstein, K; Zald, DH				Essex, Brian G.; Lejuez, Carl W.; Qian, Rebecca Y.; Bernstein, Katherine; Zald, David H.			The Balloon Analog Insurance Task (BAIT): A Behavioral Measure of Protective Risk Management	PLOS ONE			English	Article							PREFRONTAL CORTEX; DECISION-MAKING; CONSTRUCT-VALIDITY; PROSPECT-THEORY; INTOLERANCE; UNCERTAINTY; WORRY; BART; SOMATIZATION; VALIDATION	Prior methods used to assess individual differences related to risk have not focused on an important component of risk management: how willing individuals are to pay for or take actions to insure what they already have. It is not clear whether this type of protective risk management taps into the same individual differences as does risk taking propensity measured by existing risk taking tasks. We developed a novel task to assess protective risk management, the Balloon Analog Insurance Task (BAIT), which is modeled after the Balloon Analog Risk Task (BART). In the BAIT, individuals are forced to decide how much money they are willing to pay in order to insure a specific fraction of their prior winnings given changing but imprecise levels of risk of monetary loss. Participants completed the BART and BAIT for real monetary rewards, and completed six self report questionnaires. The amount of insurance purchased on the BAIT was positively correlated with scores on the Intolerance of Uncertainty Scale and on the Checking scale of the revised Obsessive Compulsive Inventory. Conversely, the amount of insurance purchased was negatively correlated with scores on the Domain Specific Risk Taking Questionnaire, and on the Psychopathic Personality Inventory (PPI). Furthermore, relationships between insurance purchased and these scales remained significant after controlling for the BART in linear regression analyses, and the BART was only a significant predictor for measures on one scale - the PPI. Our results reveal that behavior on the BAIT taps into a number of individual differences that are not related to behavior on another measure of risk taking. We propose that the BAIT may provide a useful complement to the BART in the assessment of risk management style.	[Essex, Brian G.; Qian, Rebecca Y.; Bernstein, Katherine; Zald, David H.] Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA; [Lejuez, Carl W.] Univ Maryland, Dept Psychol, College Pk, MD 20742 USA; [Zald, David H.] Vanderbilt Univ, Dept Psychiat, Nashville, TN USA	Vanderbilt University; University System of Maryland; University of Maryland College Park; Vanderbilt University	Essex, BG (corresponding author), Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA.	Brian.essex@vanderbilt.edu		Lejuez, Carl/0000-0003-2772-7835	National Science Foundation; National Institutes of Health [5R01MH074567-04]; Vanderbilt University; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH074567] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt University; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This project was funded by a graduate research fellowship from the National Science Foundation (http://www.nsfgrfp.org/) to the first author, a grant from the National Institutes of Health (#5R01MH074567-04) (http://grants.nih.gov/grants/oer.htm), and Vanderbilt University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Buelow MT, 2009, NEUROPSYCHOL REV, V19, P102, DOI 10.1007/s11065-009-9083-4; Buhr K, 2002, BEHAV RES THER, V40, P931, DOI 10.1016/S0005-7967(01)00092-4; De Martino B, 2006, SCIENCE, V313, P684, DOI 10.1126/science.1128356; Foa EB, 2002, PSYCHOL ASSESSMENT, V14, P485, DOI 10.1037//1040-3590.14.4.485; FREESTON MH, 1994, PERS INDIV DIFFER, V17, P791, DOI 10.1016/0191-8869(94)90048-5; Hunt MK, 2005, ASSESSMENT, V12, P416, DOI 10.1177/1073191105278740; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Ladouceur R, 1997, BEHAV MODIF, V21, P355, DOI 10.1177/01454455970213006; Lejuez C, 2003, J ADOLESCENCE, V26, P475, DOI 10.1016/S0140-1971(03)00036-8; Lejuez CW, 2002, J EXP PSYCHOL-APPL, V8, P75, DOI 10.1037//1076-898X.8.2.75; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Lilienfeld SO, 2001, J PSYCHOPATHOL BEHAV, V23, P11, DOI 10.1023/A:1011035306061; MEYER TJ, 1990, BEHAV RES THER, V28, P487, DOI 10.1016/0005-7967(90)90135-6; Rogers RD, 1999, NEUROPSYCHOPHARMACOL, V20, P322, DOI 10.1016/S0893-133X(98)00091-8; Rogers RD, 1999, J NEUROSCI, V19, P9029, DOI 10.1523/JNEUROSCI.19-20-09029.1999; Schmidt NB, 2006, J ANXIETY DISORD, V20, P263, DOI 10.1016/j.janxdis.2005.02.002; Tom SM, 2007, SCIENCE, V315, P515, DOI 10.1126/science.1134239; TVERSKY A, 1992, J RISK UNCERTAINTY, V5, P297, DOI 10.1007/BF00122574; Weber E. U, 2002, J BEHAV DECISION MAK, V15; Wilson DL, 1999, J PSYCHOPATHOL BEHAV, V21, P221, DOI 10.1023/A:1022825415137	21	3	4	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21448	10.1371/journal.pone.0021448	http://dx.doi.org/10.1371/journal.pone.0021448			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	784FW	21738666	gold, Green Published, Green Submitted			2022-12-27	WOS:000292142800023
J	Maher, P; Dargusch, R; Ehren, JL; Okada, S; Sharma, K; Schubert, D				Maher, Pamela; Dargusch, Richard; Ehren, Jennifer L.; Okada, Shinichi; Sharma, Kumar; Schubert, David			Fisetin Lowers Methylglyoxal Dependent Protein Glycation and Limits the Complications of Diabetes	PLOS ONE			English	Article							C-REACTIVE PROTEIN; OXIDATIVE STRESS; ALZHEIMERS-DISEASE; FLAVONOID FISETIN; END-PRODUCTS; MICE; NEPHROPATHY; ACTIVATION; INFLAMMATION; OSTEOPONTIN	The elevated glycation of macromolecules by the reactive dicarbonyl and alpha-oxoaldehyde methylglyoxal (MG) has been associated with diabetes and its complications. We have identified a rare flavone, fisetin, which increases the level and activity of glyoxalase 1, the enzyme required for the removal of MG, as well as the synthesis of its essential co-factor, glutathione. It is shown that fisetin reduces two major complications of diabetes in Akita mice, a model of type 1 diabetes. Although fisetin had no effect on the elevation of blood sugar, it reduced kidney hypertrophy and albuminuria and maintained normal levels of locomotion in the open field test. This correlated with a reduction in proteins glycated by MG in the blood, kidney and brain of fisetin-treated animals along with an increase in glyoxalase 1 enzyme activity and an elevation in the expression of the rate-limiting enzyme for the synthesis of glutathione, a co-factor for glyoxalase 1. The expression of the receptor for advanced glycation end products (RAGE), serum amyloid A and serum C-reactive protein, markers of protein oxidation, glycation and inflammation, were also increased in diabetic Akita mice and reduced by fisetin. It is concluded that fisetin lowers the elevation of MG-protein glycation that is associated with diabetes and ameliorates multiple complications of the disease. Therefore, fisetin or a synthetic derivative may have potential therapeutic use for the treatment of diabetic complications.	[Maher, Pamela; Dargusch, Richard; Ehren, Jennifer L.; Schubert, David] Salk Inst Biol Studies, Cellular Neurobiol Lab, La Jolla, CA 92037 USA; [Okada, Shinichi; Sharma, Kumar] Univ Calif San Diego, Dept Med, Ctr Renal Translat Med, La Jolla, CA 92093 USA	Salk Institute; University of California System; University of California San Diego	Maher, P (corresponding author), Salk Inst Biol Studies, Cellular Neurobiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	pmaher@salk.edu			not-for-profit Fritz B. Burns Foundation; Juvenile Diabetes Research Foundation; Hewitt Foundation; National Institutes of Health [DK063491]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491] Funding Source: NIH RePORTER	not-for-profit Fritz B. Burns Foundation; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Hewitt Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the not-for-profit Fritz B. Burns Foundation (PM, DS), the Juvenile Diabetes Research Foundation (DS), the Hewitt Foundation (JLE) and National Institutes of Health grant DK063491 (PM, DS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai Y, 2000, J NUTR, V130, P2243; Asakawa A, 2007, INT J MOL MED, V19, P649; Barber AJ, 2005, INVEST OPHTH VIS SCI, V46, P2210, DOI 10.1167/iovs.04-1340; Bierhaus A, 2009, DIABETOLOGIA, V52, P2251, DOI 10.1007/s00125-009-1458-9; Biessels GJ, 2008, LANCET NEUROL, V7, P184, DOI 10.1016/S1474-4422(08)70021-8; Brouwers O, 2011, J BIOL CHEM, V286, P1374, DOI 10.1074/jbc.M110.144097; Brownlee M, 2000, METABOLISM, V49, P9, DOI 10.1016/S0026-0495(00)80078-5; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Burdo JR, 2009, NEUROBIOL AGING, V30, P1910, DOI 10.1016/j.neurobiolaging.2008.02.010; Calcutt NA, 2009, NAT REV DRUG DISCOV, V8, P417, DOI 10.1038/nrd2476; Choeiri C, 2005, BEHAV BRAIN RES, V157, P31, DOI 10.1016/j.bbr.2004.06.005; Closhen D, 2010, CYTOKINE, V50, P117, DOI 10.1016/j.cyto.2010.02.011; Cumming RC, 2005, FASEB J, V19, P2060, DOI 10.1096/fj.05-4195fje; DAVIS JB, 1994, BRAIN RES, V652, P169, DOI 10.1016/0006-8993(94)90334-4; Gamcsik MP, 2002, BIOCHEM PHARMACOL, V63, P843, DOI 10.1016/S0006-2952(01)00931-5; Gao L, 2009, CARDIOVASC RES, V82, P9, DOI 10.1093/cvr/cvp031; Geraets L, 2009, BIOCHEM BIOPH RES CO, V382, P598, DOI 10.1016/j.bbrc.2009.03.071; Goh SY, 2008, J CLIN ENDOCR METAB, V93, P1143, DOI 10.1210/jc.2007-1817; Goshen I, 2009, FRONT NEUROENDOCRIN, V30, P30, DOI 10.1016/j.yfrne.2008.10.001; Gurley SB, 2006, AM J PHYSIOL-RENAL, V290, pF214, DOI 10.1152/ajprenal.00204.2005; Jacobson AM, 2011, DIABETOLOGIA, V54, P245, DOI 10.1007/s00125-010-1883-9; Jolivalt CG, 2008, J NEUROSCI RES, V86, P3265, DOI 10.1002/jnr.21787; King GL, 2008, J PERIODONTOL, V79, P1527, DOI 10.1902/jop.2008.080246; MACKAY K, 1988, KIDNEY INT, V33, P677, DOI 10.1038/ki.1988.53; Maher P., 2010, MICRONUTRIENTS BRAIN, P189; Maher P, 2007, BRAIN RES, V1173, P117, DOI 10.1016/j.brainres.2007.07.061; Maher P, 2006, P NATL ACAD SCI USA, V103, P16568, DOI 10.1073/pnas.0607822103; Maziere C, 2010, FREE RADICAL BIO MED, V48, P1382, DOI 10.1016/j.freeradbiomed.2010.02.022; Meerwaldt R, 2008, CARDIOVASC DIABETOL, V7, DOI 10.1186/1475-2840-7-29; Miyata T, 2010, NAT REV NEPHROL, V6, P83, DOI 10.1038/nrneph.2009.211; Nicholas SB, 2010, KIDNEY INT, V77, P588, DOI 10.1038/ki.2009.518; Ochrietor JD, 2000, CYTOKINE, V12, P888, DOI 10.1006/cyto.2000.0668; Prasain JK, 2007, MOL PHARMACEUT, V4, P846, DOI 10.1021/mp700116u; Queisser MA, 2010, DIABETES, V59, P670, DOI 10.2337/db08-1565; RamachandraRao SP, 2009, J AM SOC NEPHROL, V20, P1765, DOI 10.1681/ASN.2008090931; Reagan LP, 2008, EUR J PHARMACOL, V585, P64, DOI 10.1016/j.ejphar.2008.02.050; Sagara Y, 2004, J NEUROCHEM, V90, P1144, DOI 10.1111/j.1471-4159.2004.02563.x; Santel T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003508; Scatena M, 2007, ARTERIOSCL THROM VAS, V27, P2302, DOI 10.1161/ATVBAHA.107.144824; Seiler A, 2008, CELL METAB, V8, P237, DOI 10.1016/j.cmet.2008.07.005; Shia CS, 2009, J AGR FOOD CHEM, V57, P83, DOI 10.1021/jf802378q; Stirban A, 2008, MT SINAI J MED, V75, P328, DOI 10.1002/msj.20057; Susztak K, 2004, DIABETES, V53, P784, DOI 10.2337/diabetes.53.3.784; Takasawa R, 2008, BIOORGAN MED CHEM, V16, P3969, DOI 10.1016/j.bmc.2008.01.031; Tan Shirlee, 2001, Current Topics in Medicinal Chemistry, V1, P497, DOI 10.2174/1568026013394741; Thornalley PJ, 1996, GEN PHARMACOL-VASC S, V27, P565, DOI 10.1016/0306-3623(95)02054-3; Wersching H, 2010, NEUROLOGY, V74, P1022, DOI 10.1212/WNL.0b013e3181d7b45b; Williamson G, 2005, AM J CLIN NUTR, V81, p243S, DOI [10.1093/ajcn/81.1.243S, 10.1093/ajcn/81.1.230S]; Wu L, 2002, ENDOTHELIUM-J ENDOTH, V9, P273, DOI 10.1080/10623320214734; Yan SF, 2009, ANN MED, V41, P408, DOI 10.1080/07853890902806576; Yao DC, 2010, DIABETES, V59, P249, DOI 10.2337/db09-0801; Yoshioka M, 1997, DIABETES, V46, P887, DOI 10.2337/diabetes.46.5.887; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040; Zheng LT, 2008, INT IMMUNOPHARMACOL, V8, P484, DOI 10.1016/j.intimp.2007.12.012; Zhu YQ, 2007, SEMIN NEPHROL, V27, P153, DOI 10.1016/j.semnephrol.2007.01.008	55	115	117	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21226	10.1371/journal.pone.0021226	http://dx.doi.org/10.1371/journal.pone.0021226			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738623	Green Published, gold, Green Submitted			2022-12-27	WOS:000292092600020
J	Gandhi, J; Cashman, SM; Kumar-Singh, R				Gandhi, Jarel; Cashman, Siobhan M.; Kumar-Singh, Rajendra			Soluble CD59 Expressed from an Adenovirus In Vivo Is a Potent Inhibitor of Complement Deposition on Murine Liver Vascular Endothelium	PLOS ONE			English	Article							MEMBRANE ATTACK COMPLEX; MACULAR DEGENERATION; REGULATOR CD59; TARGETED FORM; FACTOR-H; RECOMBINANT; DEFICIENCY; ACTIVATION; DISEASE; SYSTEM	Inappropriate activation of complement on the vascular endothelium of specific organs, or systemically, underlies the etiology of a number of diseases. These disorders include atypical hemolytic uremic syndrome, membranoproliferative glomerulonephritis, atherosclerosis, age-related macular degeneration, diabetic retinopathy, and transplant rejection. Inhibition of the terminal step of complement activation, i.e. formation of the membrane attack complex, using CD59 has the advantage of retaining the upstream processes of the complement cascade necessary for fighting pathogens and retaining complement's crucial role in tissue homeostasis. Previous studies have shown the necessity of membrane targeting of soluble CD59 in order for it to prove an effective inhibitor of complement deposition both in vitro and in vivo. In this study we have generated an in vivo model of human complement activation on murine liver vascular endothelium. This model should prove useful for the development of anti-complement therapies for complement-induced pathologies of vascular endothelium. Using this model, we have demonstrated the viability of a non membrane-targeted soluble CD59 to significantly inhibit complement deposition on the endothelium of murine liver vasculature when expressed in vivo from an adenovirus. This result, unanticipated based on prior studies, suggests that the use of non membrane-targeted sCD59 as an anti-complement therapy be re-visited.	[Gandhi, Jarel; Cashman, Siobhan M.; Kumar-Singh, Rajendra] Tufts Univ, Sch Med, Dept Ophthalmol, Boston, MA 02111 USA	Tufts University	Gandhi, J (corresponding author), Tufts Univ, Sch Med, Dept Ophthalmol, Boston, MA 02111 USA.	rajendra.kumar-singh@tufts.edu		Kumar-Singh, Rajendra/0000-0002-7754-0713	The Ellison Foundation; Virginia B. Smith Trust; NIH/NEI [EY014991, EY013887]; Lions Eye Foundation; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY014991] Funding Source: NIH RePORTER	The Ellison Foundation(Lawrence Ellison Foundation); Virginia B. Smith Trust; NIH/NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Lions Eye Foundation; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by grants to R.K.-S. from The Ellison Foundation, The Virginia B. Smith Trust, NIH/NEI (EY014991 and EY013887) and grants to the Department of Ophthalmology at Tufts University from the Lions Eye Foundation and Research to Prevent Blindness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DH, 2002, AM J OPHTHALMOL, V134, P411, DOI 10.1016/S0002-9394(02)01624-0; Anderson DH, 2010, PROG RETIN EYE RES, V29, P95, DOI 10.1016/j.preteyeres.2009.11.003; Banz Y., 2011, ANN MED; BOGEN SA, 1992, AM J PATHOL, V141, P843; Bora NS, 2010, J BIOL CHEM, V285, P33826, DOI 10.1074/jbc.M110.153130; Cashman SM, 2007, MOL THER, V15, P1640, DOI 10.1038/sj.mt.6300203; Cashman SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019078; DAVIES A, 1989, J EXP MED, V170, P637, DOI 10.1084/jem.170.3.637; De Simoni MG, 2003, J CEREBR BLOOD F MET, V23, P232, DOI 10.1097/01.WCB.0000046146.31247.A1; Emlen W, 2010, SEMIN THROMB HEMOST, V36, P660, DOI 10.1055/s-0030-1262888; Fallaux FJ, 1996, HUM GENE THER, V7, P215, DOI 10.1089/hum.1996.7.2-215; Fijen CAP, 1999, CLIN INFECT DIS, V28, P98, DOI 10.1086/515075; Fijen CAP, 1998, J CLIN MICROBIOL, V36, P2342, DOI 10.1128/JCM.36.8.2342-2345.1998; Fraser DA, 2003, J BIOL CHEM, V278, P48921, DOI 10.1074/jbc.M302598200; Gerl VB, 2002, INVEST OPHTH VIS SCI, V43, P1104; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Homann C, 1997, GUT, V40, P544, DOI 10.1136/gut.40.4.544; Johnson M, 2006, HUM GENE THER, V17, P1262, DOI 10.1089/hum.2006.17.1262; Kim IH, 2001, P NATL ACAD SCI USA, V98, P13282, DOI 10.1073/pnas.241506298; Klos A, 2009, MOL IMMUNOL, V46, P2753, DOI 10.1016/j.molimm.2009.04.027; Licht C, 2009, THROMB HAEMOSTASIS, V101, P271, DOI 10.1160/TH08-09-0575; Ma KN, 2010, INVEST OPHTH VIS SCI, V51, P6776, DOI 10.1167/iovs.10-5887; Markiewski MM, 2007, AM J PATHOL, V171, P715, DOI 10.2353/ajpath.2007.070166; MERI S, 1990, IMMUNOLOGY, V71, P1; Mizuno M, 2001, ARTHRITIS RHEUM-US, V44, P2425, DOI 10.1002/1529-0131(200110)44:10<2425::AID-ART407>3.0.CO;2-4; Pascher A, 1996, TRANSPLANT P, V28, P754; Pickering MC, 2008, CLIN EXP IMMUNOL, V151, P210, DOI 10.1111/j.1365-2249.2007.03574.x; Powell MB, 1997, J IMMUNOL, V158, P1692; Qin XB, 2009, AM J HEMATOL, V84, P65, DOI 10.1002/ajh.21319; Ramo K, 2008, INVEST OPHTH VIS SCI, V49, P4126, DOI 10.1167/iovs.08-2025; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; ROLLINS SA, 1990, J IMMUNOL, V144, P3478; Satoh S, 1997, TRANSPLANTATION, V64, P1117, DOI 10.1097/00007890-199710270-00006; Song HB, 2003, J CLIN INVEST, V111, P1875, DOI 10.1172/JCI200317348; SUGITA Y, 1994, IMMUNOLOGY, V82, P34; SWEIGARD JH, 2011, GENE THER IN PRESS; Tian J, 2009, J VIROL, V83, P5648, DOI 10.1128/JVI.00082-09; Wu GX, 2009, CIRC RES, V104, P550, DOI 10.1161/CIRCRESAHA.108.191361; Zhang HF, 1999, J CLIN INVEST, V103, P55, DOI 10.1172/JCI4607; Zipfel PF, 2001, TRENDS IMMUNOL, V22, P345, DOI 10.1016/S1471-4906(01)01972-X	40	9	11	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21621	10.1371/journal.pone.0021621	http://dx.doi.org/10.1371/journal.pone.0021621			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21720565	Green Submitted, gold, Green Published			2022-12-27	WOS:000292036900061
J	Waldie, PA; Blomberg, SP; Cheney, KL; Goldizen, AW; Grutter, AS				Waldie, Peter A.; Blomberg, Simon P.; Cheney, Karen L.; Goldizen, Anne W.; Grutter, Alexandra S.			Long-Term Effects of the Cleaner Fish Labroides dimidiatus on Coral Reef Fish Communities	PLOS ONE			English	Article							ANILOCRA-APOGONAE; HOST FISH; DIVERSITY; REMOVAL; WRASSE; ECTOPARASITES; FACILITATION; DAMSELFISH; ABUNDANCE; BEHAVIOR	Cleaning behaviour is deemed a mutualism, however the benefit of cleaning interactions to client individuals is unknown. Furthermore, mechanisms that may shift fish community structure in the presence of cleaning organisms are unclear. Here we show that on patch reefs (61-285 m(2)) which had all cleaner wrasse Labroides dimidiatus (Labridae) experimentally removed (1-5 adults reef(-1)) and which were then maintained cleaner-fish free over 8.5 years, individuals of two site-attached (resident) client damselfishes (Pomacentridae) were smaller compared to those on control reefs. Furthermore, resident fishes were 37% less abundant and 23% less species rich per reef, compared to control reefs. Such changes in site-attached fish may reflect lower fish growth rates and/or survivorship. Additionally, juveniles of visitors (fish likely to move between reefs) were 65% less abundant on removal reefs suggesting cleaners may also affect recruitment. This may, in part, explain the 23% lower abundance and 33% lower species richness of visitor fishes, and 66% lower abundance of visitor herbivores (Acanthuridae) on removal reefs that we also observed. This is the first study to demonstrate a benefit of cleaning behaviour to client individuals, in the form of increased size, and to elucidate potential mechanisms leading to community-wide effects on the fish population. Many of the fish groups affected may also indirectly affect other reef organisms, thus further impacting the reef community. The large-scale effect of the presence of the relatively small and uncommon fish, Labroides dimidiadus, on other fishes is unparalleled on coral reefs.	[Waldie, Peter A.; Blomberg, Simon P.; Cheney, Karen L.; Goldizen, Anne W.; Grutter, Alexandra S.] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia	University of Queensland	Waldie, PA (corresponding author), Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia.	a.grutter@uq.edu.au	Blomberg, Simone P/B-7613-2008; Cheney, Karen/L-3427-2018; Goldizen, Anne/G-7366-2012; Waldie, Peter/J-3896-2019; Cheney, Karen L/A-6827-2013; Grutter, Alexandra S/J-2737-2013	Blomberg, Simone P/0000-0003-1062-0839; Cheney, Karen/0000-0001-5622-9494; Goldizen, Anne/0000-0003-0101-4108; Waldie, Peter/0000-0002-9153-5638; Cheney, Karen L/0000-0001-5622-9494; Grutter, Alexandra S/0000-0003-1688-2821	Australian Research Council [RnumZL00/ARCFEL010600, A00105175, DP0557058]; University of Queensland [00/ARCCS251]	Australian Research Council(Australian Research Council); University of Queensland(University of Queensland)	This research was funded by the Australian Research Council (www.arc.gov.au) (grant numbers: RnumZL00/ARCFEL010600, A00105175, DP0557058) and The University of Queensland (www.uq.edu.au) (00/ARCCS251). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitchison J., 2003, STAT ANAL COMPOSITIO; Babak O, 2007, J APPL STAT, V34, P985, DOI 10.1080/02664760701590376; Bansemer C, 2002, ETHOLOGY, V108, P353, DOI 10.1046/j.1439-0310.2002.00777.x; Barber I, 2000, REV FISH BIOL FISHER, V10, P131, DOI 10.1023/A:1016658224470; BELL JD, 1985, CORAL REEFS, V4, P41, DOI 10.1007/BF00302203; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bshary R, 2003, J ANIM ECOL, V72, P169, DOI 10.1046/j.1365-2656.2003.00683.x; Cheney KL, 2008, BEHAV ECOL, V19, P1063, DOI 10.1093/beheco/arn067; Cheney KL, 2001, ANIM BEHAV, V62, P927, DOI 10.1006/anbe.2001.1832; CLAGUE G, BIOL LETT IN PRESS; Cole AJ, 2009, CORAL REEFS, V28, P965, DOI 10.1007/s00338-009-0519-3; Dulvy NK, 2004, ECOL LETT, V7, P410, DOI 10.1111/j.1461-0248.2004.00593.x; Finley RJ, 2003, MAR ECOL PROG SER, V248, P305, DOI 10.3354/meps248305; Fogelman RM, 2009, INT J PARASITOL, V39, P577, DOI 10.1016/j.ijpara.2008.10.013; Forrester GE, 2006, ECOLOGY, V87, P1110, DOI 10.1890/0012-9658(2006)87[1110:PAASOR]2.0.CO;2; GORLICK DL, 1987, COPEIA, P41, DOI 10.2307/1446035; Graham NAJ, 2003, ENVIRON CONSERV, V30, P200, DOI 10.1017/S0376892903000195; Green A.L., 2009, MONITORING FUNCTIONA; Green BS, 2008, ADV MAR BIOL, V54, P1, DOI 10.1016/S0065-2881(08)00001-1; Grutter A, 1996, MAR ECOL PROG SER, V130, P61, DOI 10.3354/meps130061; Grutter Alexandra S., 2007, P110; Grutter AS, 2011, FUNCT ECOL, V25, P586, DOI 10.1111/j.1365-2435.2010.01798.x; Grutter AS, 2002, PARASITOLOGY, V124, pS65, DOI 10.1017/S0031182002001488; GRUTTER AS, 1995, MAR ECOL PROG SER, V118, P51, DOI 10.3354/meps118051; Grutter AS, 2003, CURR BIOL, V13, P64, DOI 10.1016/S0960-9822(02)01393-3; Grutter AS, 2002, MAR ECOL PROG SER, V234, P247, DOI 10.3354/meps234247; GRUTTER AS, 1994, MAR ECOL PROG SER, V115, P21, DOI 10.3354/meps115021; Grutter AS, 1997, OECOLOGIA, V111, P137, DOI 10.1007/s004420050217; Grutter AS, 1999, NATURE, V398, P672, DOI 10.1038/19443; Grutter AS, 1996, J EXP MAR BIOL ECOL, V196, P285, DOI 10.1016/0022-0981(95)00135-2; Holbrook SJ, 2000, OECOLOGIA, V122, P109, DOI 10.1007/PL00008826; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jobling Malcolm, 2002, P97, DOI 10.1002/9780470693803.ch5; Krebs C.J., 1999, ECOLOGICAL METHODOLO; Kulbicki M, 2005, AQUAT LIVING RESOUR, V18, P231, DOI 10.1051/alr:2005029; Lewis AR, 1997, CORAL REEFS, V16, P139, DOI 10.1007/s003380050068; LOSEY GS, 1972, COPEIA, P820, DOI 10.2307/1442741; LOSEY GS, 1995, ETHOLOGY, V100, P277; Marini L, 2010, BIOL CONSERV, V143, P2164, DOI 10.1016/j.biocon.2010.05.029; McCormick MI, 2007, ECOLOGY, V88, P1562, DOI 10.1890/06-0830; Ostlund-Nilsson S, 2005, MAR ECOL PROG SER, V287, P209, DOI 10.3354/meps287209; Quinn GP, 2002, EXPERIMENTAL DESIGN; R Development Core Team, 2010, LANG ENV STAT COMP; Raihani NJ, 2010, SCIENCE, V327, P171, DOI 10.1126/science.1183068; Randall J E, 1997, FISHES GREAT BARRIER, VSecond, P557; ROBERTS CM, 1995, CONSERV BIOL, V9, P988, DOI 10.1046/j.1523-1739.1995.9051332.x-i1; Rohde K, 2005, MARINE PARASITOLOGY, P1; Scheffer M, 2005, TRENDS ECOL EVOL, V20, P579, DOI 10.1016/j.tree.2005.08.018; SWEATMAN HPA, 1985, ECOL MONOGR, V55, P469, DOI 10.2307/2937132; Wabnitz Colette, 2003, P1; WICKSTEN MK, 1995, COPEIA, P477; Youngbluth M. J., 1968, Zeitschrift fuer Tierpsychologie, V25, P915	54	82	83	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21201	10.1371/journal.pone.0021201	http://dx.doi.org/10.1371/journal.pone.0021201			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21731670	Green Published, Green Submitted, gold			2022-12-27	WOS:000292036900014
J	Zahuczky, G; Kristof, E; Majai, G; Fesus, L				Zahuczky, Gabor; Kristof, Endre; Majai, Gyoengyike; Fesues, Laszlo			Differentiation and Glucocorticoid Regulated Apopto-Phagocytic Gene Expression Patterns in Human Macrophages. Role of Mertk in Enhanced Phagocytosis	PLOS ONE			English	Article							THP-1 CELLS; CLEARANCE; RECEPTORS; MONOCYTE; INFLAMMATION; NEUTROPHILS; COMPLEMENT; SYSTEM	The daily clearance of physiologically dying cells is performed safely mainly by cells in the mononuclear phagocyte system. They can recognize and engulf dying cells utilizing several cooperative mechanisms. In our study we show that the expression of a broad range of apopto-phagocytic genes is strongly up-regulated during differentiation of human monocytes to macrophages with different donor variability. The glucocorticoid dexamethasone has a profound effect on this process by selectively up-regulating six genes and down-regulating several others. The key role of the up-regulated mer tyrosine kinase (Mertk) in dexamethasone induced enhancement of phagocytosis could be demonstrated in human monocyte derived macrophages by gene silencing as well as blocking antibodies, and also in a monocyte-macrophage like cell line. However, the additional role of other glucocorticoid induced elements must be also considered since the presence of autologous serum during phagocytosis could almost completely compensate for the blocked function of Mertk.	[Zahuczky, Gabor; Kristof, Endre; Majai, Gyoengyike; Fesues, Laszlo] Univ Debrecen, Hungarian Acad Sci, Apoptosis & Genom Res Grp, Dept Biochem & Mol Biol, Debrecen, Hungary; [Majai, Gyoengyike] Univ Debrecen, Dept Internal Med 3, Debrecen, Hungary	Hungarian Academy of Sciences; University of Debrecen; University of Debrecen	Zahuczky, G (corresponding author), Univ Debrecen, Hungarian Acad Sci, Apoptosis & Genom Res Grp, Dept Biochem & Mol Biol, Debrecen, Hungary.	fesus@med.unideb.hu	Kristóf, Endre/AGB-5046-2022	Kristóf, Endre/0000-0002-2215-6984	Hungarian Scientific Research Fund [OTKA NI 67877]; Hungarian Ministry of Health; EU [MRTN-CT-2006-036032, MRTN-CT 2006-035624, LSHB-CT-2007-037730]; TAMOP [4.2.1./B-09/1/KONV-2010-0007]; European Social Fund	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Ministry of Health; EU(European Commission); TAMOP; European Social Fund(European Social Fund (ESF))	The study has been funded by grants from the Hungarian Scientific Research Fund (OTKA NI 67877), the Hungarian Ministry of Health and EU (MRTN-CT-2006-036032, MRTN-CT 2006-035624, LSHB-CT-2007-037730) as well as the TAMOP 4.2.1./B-09/1/KONV-2010-0007 project implemented through the New Hungary Development Plan, co-financed by the European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baschant U, 2010, J STEROID BIOCHEM, V120, P69, DOI 10.1016/j.jsbmb.2010.03.058; Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668; de Almeida CJG, 2005, CELL MOL LIFE SCI, V62, P1532, DOI 10.1007/s00018-005-4511-y; Ehrchen J, 2007, BLOOD, V109, P1265, DOI 10.1182/blood-2006-02-001115; Elliott MR, 2010, J CELL BIOL, V189, P1059, DOI 10.1083/jcb.201004096; Erwig LP, 2008, CELL DEATH DIFFER, V15, P243, DOI 10.1038/sj.cdd.4402184; Erwig LP, 2007, AM J PATHOL, V171, P2, DOI 10.2353/ajpath.2007.070135; Gardai SJ, 2006, J LEUKOCYTE BIOL, V79, P896, DOI 10.1189/jlb.1005550; Giles KM, 2001, J IMMUNOL, V167, P976, DOI 10.4049/jimmunol.167.2.976; Hart SP, 2004, CLIN EXP IMMUNOL, V135, P181, DOI 10.1111/j.1365-2249.2003.02330.x; Hasko G, 2007, PHARMACOL THERAPEUT, V113, P264, DOI 10.1016/j.pharmthera.2006.08.003; Henson PM, 2006, TRENDS IMMUNOL, V27, P244, DOI 10.1016/j.it.2006.03.005; Hume DA, 2006, CURR OPIN IMMUNOL, V18, P49, DOI 10.1016/j.coi.2005.11.008; Kohro Takahide, 2004, J Atheroscler Thromb, V11, P88; Lauber K, 2004, MOL CELL, V14, P277, DOI 10.1016/S1097-2765(04)00237-0; Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303; Lim HY, 2007, IMMUNOLOGY, V122, P47, DOI 10.1111/j.1365-2567.2007.02611.x; Liu YQ, 1999, J IMMUNOL, V162, P3639; Majai G, 2006, IMMUNOL LETT, V104, P94, DOI 10.1016/j.imlet.2005.11.016; Majai G, 2007, EUR J IMMUNOL, V37, P1343, DOI 10.1002/eji.200636398; McColl A, 2009, J IMMUNOL, V183, P2167, DOI 10.4049/jimmunol.0803503; MEAGHER LC, 1992, J LEUKOCYTE BIOL, V52, P269, DOI 10.1002/jlb.52.3.269; Mevorach D, 1998, J EXP MED, V188, P2313, DOI 10.1084/jem.188.12.2313; Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325; Petrovski G, 2007, CELL DEATH DIFFER, V14, P1117, DOI 10.1038/sj.cdd.4402112; Sather S, 2007, BLOOD, V109, P1026, DOI 10.1182/blood-2006-05-021634; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Schwende H, 1996, J LEUKOCYTE BIOL, V59, P555, DOI 10.1002/jlb.59.4.555; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Stahn C, 2007, MOL CELL ENDOCRINOL, V275, P71, DOI 10.1016/j.mce.2007.05.019; Stuart LM, 2005, IMMUNITY, V22, P539, DOI 10.1016/j.immuni.2005.05.002; Tasker JG, 2006, ENDOCRINOLOGY, V147, P5549, DOI 10.1210/en.2006-0981; VANFURTH R, 1979, BLOOD, V54, P485; Yona S, 2007, IMMUNOL CELL BIOL, V85, P81, DOI 10.1038/sj.icb.7100034; ZIEGLERHEITBROCK HWL, 1994, J LEUKOCYTE BIOL, V55, P73, DOI 10.1002/jlb.55.1.73	35	40	41	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21349	10.1371/journal.pone.0021349	http://dx.doi.org/10.1371/journal.pone.0021349			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21731712	Green Submitted, gold, Green Published			2022-12-27	WOS:000292036900022
J	Chen, YC; Wu, JC; Haschler, I; Majeed, A; Chen, TJ; Wetter, T				Chen, Yu-Chun; Wu, Jau-Ching; Haschler, Ingo; Majeed, Azeem; Chen, Tzeng-Ji; Wetter, Thomas			Academic Impact of a Public Electronic Health Database: Bibliometric Analysis of Studies Using the General Practice Research Database	PLOS ONE			English	Article							CARE UTILIZATION DATABASES; EPIDEMIOLOGIC RESEARCH; INSURANCE RESEARCH; DRUG SAFETY; CLAIMS DATA; GROWTH	Background: Studies that use electronic health databases as research material are getting popular but the influence of a single electronic health database had not been well investigated yet. The United Kingdom's General Practice Research Database (GPRD) is one of the few electronic health databases publicly available to academic researchers. This study analyzed studies that used GPRD to demonstrate the scientific production and academic impact by a single public health database. Methodology and Findings: A total of 749 studies published between 1995 and 2009 with 'General Practice Research Database' as their topics, defined as GPRD studies, were extracted from Web of Science. By the end of 2009, the GPRD had attracted 1251 authors from 22 countries and been used extensively in 749 studies published in 193 journals across 58 study fields. Each GPRD study was cited 2.7 times by successive studies. Moreover, the total number of GPRD studies increased rapidly, and it is expected to reach 1500 by 2015, twice the number accumulated till the end of 2009. Since 17 of the most prolific authors (1.4% of all authors) contributed nearly half (47.9%) of GPRD studies, success in conducting GPRD studies may accumulate. The GPRD was used mainly in, but not limited to, the three study fields of "Pharmacology and Pharmacy", "General and Internal Medicine', and "Public, Environmental and Occupational Health". The UK and United States were the two most active regions of GPRD studies. One-third of GRPD studies were internationally co-authored. Conclusions: A public electronic health database such as the GPRD will promote scientific production in many ways. Data owners of electronic health databases at a national level should consider how to reduce access barriers and to make data more available for research.	[Chen, Yu-Chun; Haschler, Ingo; Wetter, Thomas] Heidelberg Univ, Dept Med Informat, Heidelberg, Germany; [Chen, Yu-Chun; Wu, Jau-Ching] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Wu, Jau-Ching] Natl Yang Ming Univ, Inst Pharmacol, Taipei 112, Taiwan; [Wu, Jau-Ching] Taipei Vet Gen Hosp, Dept Neurosurg, Taipei, Taiwan; [Majeed, Azeem] Univ London Imperial Coll Sci Technol & Med, Dept Publ Hlth & Primary Care, London, England; [Chen, Tzeng-Ji] Natl Yang Ming Univ, Inst Hosp & Hlth Care Adm, Taipei 112, Taiwan; [Chen, Tzeng-Ji] Taipei Vet Gen Hosp, Dept Family Med, Taipei, Taiwan	Ruprecht Karls University Heidelberg; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Imperial College London; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital	Chen, YC (corresponding author), Heidelberg Univ, Dept Med Informat, Heidelberg, Germany.	Yu-Chun.Chen@stud.uni-heidelberg.de	Wu, Jau-Ching/AAU-4009-2021; Chen, Yu-Chun/B-1227-2012; Chen, YuChun/L-1052-2019; Chen, Yu Chun/K-6635-2019; Chen, TJ/AAH-8430-2021	Wu, Jau-Ching/0000-0002-6996-3409; Chen, Yu-Chun/0000-0002-4124-1949; Chen, YuChun/0000-0002-4124-1949; Majeed, Azeem/0000-0002-2357-9858				Bornmann L, 2009, EMBO REP, V10, P2, DOI 10.1038/embor.2008.233; Central Intelligence Agency, WORLD FACTB 2009; Cepeda MS, 2010, NAT REV DRUG DISCOV, V9, P84, DOI 10.1038/nrd2988-c1; Chen YC, 2011, BRIT MED J, V342, P297; Chen YC, 2011, SCIENTOMETRICS, V86, P365, DOI 10.1007/s11192-010-0289-2; Crystal S, 2007, MED CARE, V45, pS58, DOI 10.1097/MLR.0b013e31805371bf; Egbring M, 2010, PHARMACOEPIDEM DR S, V19, P38, DOI 10.1002/pds.1860; EGGHE L, 1992, SCIENTOMETRICS, V25, P5, DOI 10.1007/BF02016845; Egghe L, 2005, LIBR INFORM SCI SER, P1; Fernandez-Cano A, 2004, SCIENTOMETRICS, V61, P301, DOI 10.1023/B:SCIE.0000045112.11562.11; Gnani S, 2006, USERS GUIDE DATA COL; Gould L, 2009, PHARMACOEPIDEM DR S, V18, pS205; *GPRD GROUP, 2010, GPRD BIBL; Herrett E, 2010, BRIT J CLIN PHARMACO, V69, P4, DOI 10.1111/j.1365-2125.2009.03537.x; Hoffmann F, 2009, PHARMACOEPIDEM DR S, V18, P349, DOI 10.1002/pds.1721; Hsiao FY, 2007, J FOOD DRUG ANAL, V15, P99; Johansson S, 2010, DRUG SAFETY, V33, P223, DOI 10.2165/11319010-000000000-00000; Khan NF, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X483562; Larsen PO, 2010, SCIENTOMETRICS, V84, P575, DOI 10.1007/s11192-010-0202-z; LLOYD DCEF, 1995, BRIT MED J, V311, P991; Majeed Azeem, 2004, Health Stat Q, P5; Martin-Latry K, 2010, PHARMACOEPIDEM DR S, V19, P256, DOI 10.1002/pds.1912; Rodriguez LAG, 1998, BRIT J CLIN PHARMACO, V45, P419; Schneeweiss S, 2005, J CLIN EPIDEMIOL, V58, P323, DOI 10.1016/j.jclinepi.2004.10.012; Schneeweiss S, 2007, MED CARE, V45, pS131, DOI 10.1097/MLR.0b013e318070c08e; Tricco AC, 2008, J CLIN EPIDEMIOL, V61, P192, DOI 10.1016/j.jclinepi.2007.03.009; van Staa TP, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000194; Zhou P, 2010, SCIENTOMETRICS, V82, P597, DOI 10.1007/s11192-010-0174-z	28	26	32	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21404	10.1371/journal.pone.0021404	http://dx.doi.org/10.1371/journal.pone.0021404			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	782TF	21731733	Green Published, gold, Green Submitted			2022-12-27	WOS:000292033700077
J	Liaw, H; Lee, D; Myung, K				Liaw, Hungjiun; Lee, Deokjae; Myung, Kyungjae			DNA-PK-Dependent RPA2 Hyperphosphorylation Facilitates DNA Repair and Suppresses Sister Chromatid Exchange	PLOS ONE			English	Article							REPLICATION PROTEIN-A; RADIATION-INDUCED PHOSPHORYLATION; S-PHASE CHECKPOINT; ATAXIA-TELANGIECTASIA; BINDING PROTEIN; P34 SUBUNIT; POLYMERASE-ETA; HUMAN-CELLS; HELA-CELLS; KINASE	Hyperphosphorylation of RPA2 at serine 4 and serine 8 (S4, S8) has been used as a marker for activation of the DNA damage response. What types of DNA lesions cause RPA2 hyperphosphorylation, which kinase(s) are responsible for them, and what is the biological outcome of these phosphorylations, however, have not been fully investigated. In this study we demonstrate that RPA2 hyperphosphorylation occurs primarily in response to genotoxic stresses that cause high levels of DNA double-strand breaks (DSBs) and that the DNA-dependent protein kinase complex (DNA-PK) is responsible for the modifications in vivo. Alteration of S4, S8 of RPA2 to alanines, which prevent phosphorylations at these sites, caused increased mitotic entry with concomitant increases in RAD51 foci and homologous recombination. Taken together, our results demonstrate that RPA2 hyperphosphorylation by DNA-PK in response to DSBs blocks unscheduled homologous recombination and delays mitotic entry. This pathway thus permits cells to repair DNA damage properly and increase cell viability.	[Liaw, Hungjiun; Lee, Deokjae; Myung, Kyungjae] NHGRI, Genome Instabil Sect, Genet & Mol Biol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Liaw, H (corresponding author), Natl Cheng Kung Univ, Dept Life Sci, Tainan 70101, Taiwan.	kmyung@mail.nih.gov	Liaw, Hungjiun/G-7034-2014	Liaw, Hungjiun/0000-0002-3481-709X	National Human Genome Research Institute, National Institutes of Health [HG012003-09]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG012003, ZIAHG012003] Funding Source: NIH RePORTER	National Human Genome Research Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by National Human Genome Research Institute, National Institutes of Health (HG012003-09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anantha RW, 2007, J BIOL CHEM, V282, P35910, DOI 10.1074/jbc.M704645200; Anantha RW, 2008, P NATL ACAD SCI USA, V105, P12903, DOI 10.1073/pnas.0803001105; Block WD, 2004, NUCLEIC ACIDS RES, V32, P997, DOI 10.1093/nar/gkh265; BOUBNOV NV, 1995, MOL CELL BIOL, V15, P5700; Branzei D, 2010, NAT REV MOL CELL BIO, V11, P208, DOI 10.1038/nrm2852; Branzei D, 2009, DNA REPAIR, V8, P1038, DOI 10.1016/j.dnarep.2009.04.014; Brown EJ, 2003, GENE DEV, V17, P615, DOI 10.1101/gad.1067403; BRUSH GS, 1994, P NATL ACAD SCI USA, V91, P12520, DOI 10.1073/pnas.91.26.12520; CARTY MP, 1994, EMBO J, V13, P2114, DOI 10.1002/j.1460-2075.1994.tb06487.x; Cheng XB, 1996, RADIOTHER ONCOL, V39, P43, DOI 10.1016/0167-8140(96)01712-4; Cruet-Hennequart S, 2008, DNA REPAIR, V7, P582, DOI 10.1016/j.dnarep.2007.12.012; Fernandez-Capetillo O, 2002, NAT CELL BIOL, V4, P993, DOI 10.1038/ncb884; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Gately DP, 1998, MOL BIOL CELL, V9, P2361, DOI 10.1091/mbc.9.9.2361; Kannouche P, 2001, GENE DEV, V15, P158, DOI 10.1101/gad.187501; Lee DH, 2010, NAT STRUCT MOL BIOL, V17, P365, DOI 10.1038/nsmb.1769; Lee KY, 2008, MOL CELLS, V26, P5; LIU VF, 1993, MOL CELL BIOL, V13, P7222, DOI 10.1128/MCB.13.12.7222; Manthey KC, 2007, J CELL SCI, V120, P4221, DOI 10.1242/jcs.004580; Morgan SE, 1997, CANCER RES, V57, P3386; Motegi A, 2008, P NATL ACAD SCI USA, V105, P12411, DOI 10.1073/pnas.0805685105; Nakanishi K, 2005, P NATL ACAD SCI USA, V102, P1110, DOI 10.1073/pnas.0407796102; Niu HW, 1997, J BIOL CHEM, V272, P12634, DOI 10.1074/jbc.272.19.12634; Oakley GG, 2003, BIOCHEMISTRY-US, V42, P3255, DOI 10.1021/bi026377u; Olson E, 2006, J BIOL CHEM, V281, P39517, DOI 10.1074/jbc.M605121200; PAN ZQ, 1994, P NATL ACAD SCI USA, V91, P8343, DOI 10.1073/pnas.91.18.8343; Ruis BL, 2008, MOL CELL BIOL, V28, P6182, DOI 10.1128/MCB.00355-08; SALAHUDDIN, 1990, GENE DEV, V4, P968, DOI 10.1101/gad.4.6.968; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Shao RG, 1999, EMBO J, V18, P1397, DOI 10.1093/emboj/18.5.1397; Sogo JM, 2002, SCIENCE, V297, P599, DOI 10.1126/science.1074023; Solomon DA, 2004, J CELL BIOL, V166, P455, DOI 10.1083/jcb.200312048; Stephan H, 2009, NUCLEIC ACIDS RES, V37, P6028, DOI 10.1093/nar/gkp605; Syljuasen RG, 2005, MOL CELL BIOL, V25, P3553, DOI 10.1128/MCB.25.9.3553-3562.2005; Wang HY, 2001, CANCER RES, V61, P8554; ZernikKobak M, 1997, J BIOL CHEM, V272, P23896, DOI 10.1074/jbc.272.38.23896	36	50	52	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21424	10.1371/journal.pone.0021424	http://dx.doi.org/10.1371/journal.pone.0021424			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731742	Green Published, Green Submitted, gold			2022-12-27	WOS:000292033700082
J	Momose, F; Sekimoto, T; Ohkura, T; Jo, S; Kawaguchi, A; Nagata, K; Morikawa, Y				Momose, Fumitaka; Sekimoto, Tetsuya; Ohkura, Takashi; Jo, Shuichi; Kawaguchi, Atsushi; Nagata, Kyosuke; Morikawa, Yuko			Apical Transport of Influenza A Virus Ribonucleoprotein Requires Rab11-positive Recycling Endosome	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; MICROTUBULE-MEDIATED TRANSPORT; NUCLEAR IMPORT; MEMBRANE TRAFFICKING; STRUCTURAL BASIS; MATRIX PROTEIN; RNA SEGMENTS; RAB GTPASES; POLYMERASE; INFECTION	Influenza A virus RNA genome exists as eight-segmented ribonucleoprotein complexes containing viral RNA polymerase and nucleoprotein (vRNPs). Packaging of vRNPs and virus budding take place at the apical plasma membrane (APM). However, little is known about the molecular mechanisms of apical transport of newly synthesized vRNP. Transfection of fluorescent-labeled antibody and subsequent live cell imaging revealed that punctate vRNP signals moved along microtubules rapidly but intermittently in both directions, suggestive of vesicle trafficking. Using a series of Rab family protein, we demonstrated that progeny vRNP localized to recycling endosome (RE) in an active/GTP-bound Rab11-dependent manner. The vRNP interacted with Rab11 through viral RNA polymerase. The localization of vRNP to RE and subsequent accumulation to the APM were impaired by overexpression of Rab binding domains (RBD) of Rab11 family interacting proteins (Rab11-FIPs). Similarly, no APM accumulation was observed by overexpression of class II Rab11-FIP mutants lacking RBD. These results suggest that the progeny vRNP makes use of Rab11-dependent RE machinery for APM trafficking.	[Momose, Fumitaka; Sekimoto, Tetsuya; Ohkura, Takashi; Kawaguchi, Atsushi; Morikawa, Yuko] Kitasato Univ, Kitasato Inst Life Sci, Tokyo, Japan; [Jo, Shuichi; Kawaguchi, Atsushi; Nagata, Kyosuke] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki, Japan	Kitasato University; University of Tsukuba	Momose, F (corresponding author), Kitasato Univ, Kitasato Inst Life Sci, Tokyo, Japan.	fmomose@lisci.kitasato-u.ac.jp		Kawaguchi, Atsushi/0000-0002-5485-1578	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japanese Society for the Promotion of Science (JSPS); Kitasato University	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Kitasato University	This work was supported in part by a grant-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (FM KN YM), Research Fellowship of the Japanese Society for the Promotion of Science (JSPS) (AK), and by a Kitasato University Research Grant for Young Researchers (FM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Amorim MJ, 2011, J VIROL, V85, P4143, DOI 10.1128/JVI.02606-10; Babbey CM, 2006, MOL BIOL CELL, V17, P3156, DOI 10.1091/mbc.E05-08-0799; BLACK BC, 1979, NUCLEIC ACIDS RES, V6, P2339, DOI 10.1093/nar/6.6.2339; Brock SC, 2003, P NATL ACAD SCI USA, V100, P15143, DOI 10.1073/pnas.2434327100; BROWN DT, 1975, J VIROL, V16, P366, DOI 10.1128/JVI.16.2.366-387.1975; Bruce EA, 2010, J VIROL, V84, P5848, DOI 10.1128/JVI.00307-10; Bruce EA, 2009, VIROLOGY, V390, P268, DOI 10.1016/j.virol.2009.05.016; Bukrinskaya A, 1998, J EXP MED, V188, P2113, DOI 10.1084/jem.188.11.2113; Casanova JE, 1999, MOL BIOL CELL, V10, P47, DOI 10.1091/mbc.10.1.47; Chambers R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010994; Chen BJ, 2008, VIROLOGY, V372, P221, DOI 10.1016/j.virol.2007.11.008; Chen BJ, 2007, J VIROL, V81, P7111, DOI 10.1128/JVI.00361-07; Coloma R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000491; COMPANS RW, 1972, J VIROL, V10, P795, DOI 10.1128/JVI.10.4.795-800.1972; Cresawn KO, 2007, EMBO J, V26, P3737, DOI 10.1038/sj.emboj.7601813; Cui ZQ, 2005, NUCLEIC ACIDS RES, V33, P3245, DOI 10.1093/nar/gki629; Deng T, 2006, J VIROL, V80, P11911, DOI 10.1128/JVI.01565-06; DESSELBERGER U, 1980, GENE, V8, P315, DOI 10.1016/0378-1119(80)90007-4; DRIVAS GT, 1991, ONCOGENE, V6, P3; Duhaut SD, 2002, J GEN VIROL, V83, P403, DOI 10.1099/0022-1317-83-2-403; Duhaut SD, 1996, VIROLOGY, V216, P326, DOI 10.1006/viro.1996.0068; Eathiraj S, 2006, J MOL BIOL, V364, P121, DOI 10.1016/j.jmb.2006.08.064; Elster C, 1997, J GEN VIROL, V78, P1589, DOI 10.1099/0022-1317-78-7-1589; Elton D, 2001, J VIROL, V75, P408, DOI 10.1128/JVI.75.1.408-419.2001; Fujii Y, 2003, P NATL ACAD SCI USA, V100, P2002, DOI 10.1073/pnas.0437772100; FULLER S, 1984, CELL, V38, P65, DOI 10.1016/0092-8674(84)90527-0; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; Greber UF, 2006, CELL, V124, P741, DOI 10.1016/j.cell.2006.02.018; Gromov PS, 1998, FEBS LETT, V429, P359, DOI 10.1016/S0014-5793(98)00607-3; Hales CM, 2001, J BIOL CHEM, V276, P39067, DOI 10.1074/jbc.M104831200; Harris A, 2006, P NATL ACAD SCI USA, V103, P19123, DOI 10.1073/pnas.0607614103; Hollinshead M, 2001, J CELL BIOL, V154, P389, DOI 10.1083/jcb.200104124; Horgan CP, 2007, TRAFFIC, V8, P414, DOI 10.1111/j.1600-0854.2007.00543.x; Horgan CP, 2009, BIOCHEM SOC T, V37, P1032, DOI 10.1042/BST0371032; HSU MT, 1987, P NATL ACAD SCI USA, V84, P8140, DOI 10.1073/pnas.84.22.8140; Huet S, 2010, J VIROL, V84, P1254, DOI 10.1128/JVI.01533-09; Hunziker W, 1998, J BIOL CHEM, V273, P15734, DOI 10.1074/jbc.273.25.15734; Hutchinson EC, 2010, J GEN VIROL, V91, P313, DOI 10.1099/vir.0.017608-0; Inoue H, 2008, MOL BIOL CELL, V19, P4224, DOI 10.1091/mbc.E08-03-0290; Jagoe WN, 2006, STRUCTURE, V14, P1273, DOI 10.1016/j.str.2006.06.010; Jin M, 2006, BBA-GENE STRUCT EXPR, V1759, P281, DOI 10.1016/j.bbaexp.2006.06.001; Jing J, 2009, HISTOL HISTOPATHOL, V24, P1171, DOI 10.14670/HH-24.1171; Jo S, 2010, MICROBES INFECT, V12, P1079, DOI 10.1016/j.micinf.2010.06.011; Klumpp K, 1997, EMBO J, V16, P1248, DOI 10.1093/emboj/16.6.1248; Krzyzaniak MA, 2009, TRAFFIC, V10, P1439, DOI 10.1111/j.1600-0854.2009.00967.x; Lakadamyali M, 2003, P NATL ACAD SCI USA, V100, P9280, DOI 10.1073/pnas.0832269100; Lee GE, 2006, J VIROL, V80, P4264, DOI 10.1128/JVI.80.9.4264-4275.2006; Lee JR, 2003, J BIOL CHEM, V278, P2624, DOI 10.1074/jbc.M211152200; Li E, 1998, J VIROL, V72, P8806, DOI 10.1128/JVI.72.11.8806-8812.1998; Lindsay AJ, 2002, J BIOL CHEM, V277, P12190, DOI 10.1074/jbc.M108665200; Marsh M, 1997, J CELL SCI, V110, P95; MATLIN KS, 1981, J CELL BIOL, V91, P601, DOI 10.1083/jcb.91.3.601; Mettenleiter TC, 2009, VIRUS RES, V143, P222, DOI 10.1016/j.virusres.2009.03.018; Momose F, 2007, MICROBES INFECT, V9, P1422, DOI 10.1016/j.micinf.2007.07.007; MURTI KG, 1988, VIROLOGY, V164, P562, DOI 10.1016/0042-6822(88)90574-0; Naito T, 2007, J VIROL, V81, P1339, DOI 10.1128/JVI.01917-06; NAKAJIMA K, 1979, J VIROL, V29, P1142, DOI 10.1128/JVI.29.3.1142-1148.1979; Nayak DP, 2004, VIRUS RES, V106, P147, DOI 10.1016/j.virusres.2004.08.012; Noda T, 2006, NATURE, V439, P490, DOI 10.1038/nature04378; Odagiri T, 1997, J VIROL, V71, P2138, DOI 10.1128/JVI.71.3.2138-2145.1997; ONEILL RE, 1995, J BIOL CHEM, V270, P22701, DOI 10.1074/jbc.270.39.22701; Patton GS, 2005, J VIROL, V79, P6392, DOI 10.1128/JVI.79.10.6392-6399.2005; PENFOLD MET, 1994, P NATL ACAD SCI USA, V91, P6529, DOI 10.1073/pnas.91.14.6529; Portela A, 2002, J GEN VIROL, V83, P723, DOI 10.1099/0022-1317-83-4-723; Prekeris R, 2000, MOL CELL, V6, P1437, DOI 10.1016/S1097-2765(00)00140-4; Radtke K, 2006, CELL MICROBIOL, V8, P387, DOI 10.1111/j.1462-5822.2005.00679.x; Ren MD, 1998, P NATL ACAD SCI USA, V95, P6187, DOI 10.1073/pnas.95.11.6187; RESAINFANTE P, 2010, J VIROL, P11; Rietdorf J, 2001, NAT CELL BIOL, V3, P992, DOI 10.1038/ncb1101-992; ROBERTS SR, 1995, J VIROL, V69, P2667, DOI 10.1128/JVI.69.4.2667-2673.1995; RODRIGUEZBOULAN E, 1978, P NATL ACAD SCI USA, V75, P5071, DOI 10.1073/pnas.75.10.5071; Rossman JS, 2010, CELL, V142, P902, DOI 10.1016/j.cell.2010.08.029; Rowe RK, 2008, VIROLOGY, V382, P239, DOI 10.1016/j.virol.2008.09.021; Santangelo PJ, 2007, NUCLEIC ACIDS RES, V35, P3602, DOI 10.1093/nar/gkm246; Schmitt AP, 2005, J VIROL, V79, P2988, DOI 10.1128/JVI.79.5.2988-2997.2005; Schwartz SL, 2007, J CELL SCI, V120, P3905, DOI 10.1242/jcs.015909; SHAPIRO GI, 1987, J VIROL, V61, P764, DOI 10.1128/JVI.61.3.764-773.1987; Shiba T, 2006, P NATL ACAD SCI USA, V103, P15416, DOI 10.1073/pnas.0605357103; Sodeik B, 2000, TRENDS MICROBIOL, V8, P465, DOI 10.1016/S0966-842X(00)01824-2; Sodeik B, 1997, J CELL BIOL, V136, P1007, DOI 10.1083/jcb.136.5.1007; Stange A, 2005, J VIROL, V79, P5466, DOI 10.1128/JVI.79.9.5466-5476.2005; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Tchatalbachev S, 2001, RNA, V7, P979, DOI 10.1017/S1355838201002424; Thomas JA, 2008, VIRUS RES, V134, P39, DOI 10.1016/j.virusres.2007.12.006; Torreira E, 2007, NUCLEIC ACIDS RES, V35, P3774, DOI 10.1093/nar/gkm336; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Utley TJ, 2008, P NATL ACAD SCI USA, V105, P10209, DOI 10.1073/pnas.0712144105; Wallace DME, 2002, BIOCHEM BIOPH RES CO, V299, P770, DOI 10.1016/S0006-291X(02)02720-1; Wang KN, 1998, J VIROL, V72, P3455, DOI 10.1128/JVI.72.4.3455-3458.1998; Wang XY, 2000, J BIOL CHEM, V275, P29138, DOI 10.1074/jbc.M004410200; Ward BM, 2001, J VIROL, V75, P11651, DOI 10.1128/JVI.75.23.11651-11663.2001; Watanabe K, 1996, J VIROL, V70, P241, DOI 10.1128/JVI.70.1.241-247.1996; Wilcke M, 2000, J CELL BIOL, V151, P1207, DOI 10.1083/jcb.151.6.1207; Ye ZP, 1999, J VIROL, V73, P7467, DOI 10.1128/JVI.73.9.7467-7473.1999; Zacchi P, 1998, J CELL BIOL, V140, P1039, DOI 10.1083/jcb.140.5.1039	96	85	89	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21123	10.1371/journal.pone.0021123	http://dx.doi.org/10.1371/journal.pone.0021123			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731653	gold, Green Published, Green Submitted			2022-12-27	WOS:000292033700037
J	Al Saleh, S; Al Mulla, F; Luqmani, YA				Al Saleh, Sanaa; Al Mulla, Fahd; Luqmani, Yunus A.			Estrogen Receptor Silencing Induces Epithelial to Mesenchymal Transition in Human Breast Cancer Cells	PLOS ONE			English	Article							ENDOCRINE THERAPY RESISTANCE; TGF-BETA; IN-VITRO; PROMOTES METASTASIS; SIGNALING PATHWAYS; TUMOR PROGRESSION; SLUG EXPRESSION; LUNG METASTASIS; CADHERIN; INVASION	We propose the hypothesis that loss of estrogen receptor function which leads to endocrine resistance in breast cancer, also results in trans-differentiation from an epithelial to a mesenchymal phenotype that is responsible for increased aggressiveness and metastatic propensity. siRNA mediated silencing of the estrogen receptor in MCF7 breast cancer cells resulted in estrogen/tamoxifen resistant cells (pII) with altered morphology, increased motility with rearrangement and switch from a keratin/actin to a vimentin based cytoskeleton, and ability to invade simulated components of the extracellular matrix. Phenotypic profiling using an Affymetrix Human Genome U133 plus 2.0 GeneChip indicated geometric fold changes >= 3 in approximately 2500 identifiable unique sequences, with about 1270 of these being up-regulated in pII cells. Changes were associated with genes whose products are involved in cell motility, loss of cellular adhesion and interaction with the extracellular matrix. Selective analysis of the data also showed a shift from luminal to basal cell markers and increased expression of a wide spectrum of genes normally associated with mesenchymal characteristics, with consequent loss of epithelial specific markers. Over-expression of several peptide growth factors and their receptors are indicative of an increased contribution to the higher proliferative rates of pII cells as well as aiding their potential for metastatic activity. Signalling molecules that have been identified as key transcriptional drivers of epithelial to mesenchymal transition were also found to be elevated in pII cells. These data support our hypothesis that induced loss of estrogen receptor in previously estrogen/antiestrogen sensitive cells is a trigger for the concomitant loss of endocrine dependence and onset of a series of possibly parallel events that changes the cell from an epithelial to a mesenchymal type. Inhibition of this transition through targeting of specific mediators may offer a useful supplementary strategy to circumvent the effects of loss of endocrine sensitivity.	[Al Saleh, Sanaa; Luqmani, Yunus A.] Kuwait Univ, Fac Pharm, Safat, Kuwait; [Al Saleh, Sanaa] Kuwait Univ, Coll Grad Studies, Safat, Kuwait; [Al Mulla, Fahd] Kuwait Univ, Fac Med, Safat, Kuwait	Kuwait University; Kuwait University; Kuwait University	Al Saleh, S (corresponding author), Kuwait Univ, Fac Pharm, Safat, Kuwait.	yunus@hsc.edu.kw	Al-Mulla, Fahd/E-2068-2015	Al-Mulla, Fahd/0000-0001-5409-3829	Kuwait University Research Administration [YM08/09, GM01/01, GM01/05]	Kuwait University Research Administration	This work was supported by grants YM08/09, GM01/01, and GM01/05 from the Kuwait University Research Administration (http://www.ovpr.kuniv.edu/research/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Saleh S, 2011, INT J ONCOL, V38, P1197, DOI 10.3892/ijo.2011.942; al-Mulla F, 2011, MOL BIOSYST, V7, P928, DOI 10.1039/c0mb00208a; ALAZMI A, 2006, THESIS KUWAIT U; Ali S, 2002, NAT REV CANCER, V2, P101, DOI 10.1038/nrc721; Arpino G, 2008, ENDOCR REV, V29, P217, DOI 10.1210/er.2006-0045; Berx G, 2001, BREAST CANCER RES, V3, P289, DOI 10.1186/bcr309; Berx G, 2007, CLIN EXP METASTAS, V24, P587, DOI 10.1007/s10585-007-9114-6; Bindels S, 2006, ONCOGENE, V25, P4975, DOI 10.1038/sj.onc.1209511; Care A, 1998, ONCOGENE, V16, P3285, DOI 10.1038/sj.onc.1201875; Care A, 2001, CANCER RES, V61, P6532; Charafe-Jauffret E, 2006, ONCOGENE, V25, P2273, DOI 10.1038/sj.onc.1209254; Choi J, 2007, INVEST OPHTH VIS SCI, V48, P2708, DOI 10.1167/iovs.06-0639; Dandachi N, 2001, J PATHOL, V193, P181, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH752>3.0.CO;2-V; de Graauw M, 2010, P NATL ACAD SCI USA, V107, P6340, DOI 10.1073/pnas.0913360107; Deng BQ, 2010, MOL CELL BIOCHEM, V340, P21, DOI 10.1007/s11010-010-0396-7; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Fujita N, 2003, CELL, V113, P207, DOI 10.1016/S0092-8674(03)00234-4; GILLES C, 1996, BREAST J, V2, P83; Gjerdrum C, 2010, P NATL ACAD SCI USA, V107, P1124, DOI 10.1073/pnas.0909333107; Hayashida T, 2010, P NATL ACAD SCI USA, V107, P1100, DOI 10.1073/pnas.0912710107; Hazan RB, 2004, ANN NY ACAD SCI, V1014, P155, DOI 10.1196/annals.1294.016; Hollier BG, 2009, J MAMMARY GLAND BIOL, V14, P29, DOI 10.1007/s10911-009-9110-3; Howell A, 2008, ADV EXP MED BIOL, V617, P201, DOI 10.1007/978-0-387-69080-3_19; Huang HD, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r29; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Hurtado A, 2008, NATURE, V456, P663, DOI 10.1038/nature07483; ISERI OD, 2010, DRUG RESISTANT MCF 7, DOI DOI 10.1016/J.BIOPHA.2010.10.004; Kim S, 2010, CARCINOGENESIS, V31, P597, DOI 10.1093/carcin/bgq024; Knowlden JM, 2005, ENDOCRINOLOGY, V146, P4609, DOI 10.1210/en.2005-0247; Kokkinos MI, 2007, CELLS TISSUES ORGANS, V185, P191, DOI 10.1159/000101320; Kun Y, 2003, HUM MOL GENET, V12, P3245, DOI 10.1093/hmg/ddg347; Landemaine T, 2008, CANCER RES, V68, P6092, DOI 10.1158/0008-5472.CAN-08-0436; Linger RMA, 2008, ADV CANCER RES, V100, P35, DOI 10.1016/S0065-230X(08)00002-X; Lonning PE, 2001, ENDOCR-RELAT CANCER, V8, P259, DOI 10.1677/erc.0.0080259; Luqmani YA, 2009, INT J ONCOL, V34, P231, DOI 10.3892/ijo_00000145; Miller TE, 2008, J BIOL CHEM, V283, P29897, DOI 10.1074/jbc.M804612200; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; Navarro A, 2004, FASEB J, V18, P1801, DOI 10.1096/fj.04-2516rev; Nicholson RI, 2005, J STEROID BIOCHEM, V93, P257, DOI 10.1016/j.jsbmb.2004.12.006; Normanno N, 2005, ENDOCR-RELAT CANCER, V12, P721, DOI 10.1677/erc.1.00857; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Orlichenko LS, 2008, CLIN EXP METASTAS, V25, P593, DOI 10.1007/s10585-008-9143-9; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Sabbah M, 2008, DRUG RESIST UPDATE, V11, P123, DOI 10.1016/j.drup.2008.07.001; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Sarrio D, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-74; Schiff R, 2004, CLIN CANCER RES, V10, p331S, DOI 10.1158/1078-0432.CCR-031212; Sheridan C, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1610; Sphyris N, 2009, CURR BREAST CANCER R, V1, P229, DOI 10.1007/s12609-009-0032-2; Thompson EW, 2005, CANCER RES, V65, P5991, DOI 10.1158/0008-5472.CAN-05-0616; Tse JC, 2007, J CELL BIOCHEM, V101, P816, DOI 10.1002/jcb.21215; Turner N, 2010, CANCER RES, V70, P2085, DOI 10.1158/0008-5472.CAN-09-3746; van den Abbeele A, 2007, CANCER LETT, V255, P57, DOI 10.1016/j.canlet.2007.03.023; Vincent T, 2009, NAT CELL BIOL, V11, P943, DOI 10.1038/ncb1905; Wheelock MJ, 2008, J CELL SCI, V121, P727, DOI 10.1242/jcs.000455; Wiggins HL, 2010, BIOTECHNIQUES, V48, P120, DOI 10.2144/000113353; Yan W, 2010, J BIOL CHEM, V285, P14042, DOI 10.1074/jbc.M110.105262; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang J, 2009, P NATL ACAD SCI USA, V106, P3913, DOI 10.1073/pnas.0810617106; Ye Y, 2008, BIOCHEM J, V416, P179, DOI 10.1042/BJ20080328; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927	62	95	95	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2011	6	6							e20610	10.1371/journal.pone.0020610	http://dx.doi.org/10.1371/journal.pone.0020610			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782CL	21713035	Green Submitted, gold, Green Published			2022-12-27	WOS:000291985100002
J	Camm, EJ; Tijsseling, D; Richter, HG; Adler, A; Hansell, JA; Derks, JB; Cross, CM; Giussani, DA				Camm, Emily J.; Tijsseling, Deodata; Richter, Hans G.; Adler, Alexandra; Hansell, Jeremy A.; Derks, Jan B.; Cross, Christine M.; Giussani, Dino A.			Oxidative Stress in the Developing Brain: Effects of Postnatal Glucocorticoid Therapy and Antioxidants in the Rat	PLOS ONE			English	Article							NITRIC-OXIDE; VITAMIN-C; DEXAMETHASONE TREATMENT; NEONATAL DEXAMETHASONE; CORTICOSTEROID-THERAPY; ENDOTHELIAL-CELLS; CONTROLLED-TRIAL; LUNG-DISEASE; FETAL SHEEP; GROWTH	In premature infants, glucocorticoids ameliorate chronic lung disease, but have adverse effects on long-term neurological function. Glucocorticoid excess promotes free radical overproduction. We hypothesised that the adverse effects of postnatal glucocorticoid therapy on the developing brain are secondary to oxidative stress and that antioxidant treatment would diminish unwanted effects. Male rat pups received a clinically-relevant tapering course of dexamethasone (DEX; 0.5, 0.3, and 0.1 mg. kg(-1). day(-1)), with or without antioxidant vitamins C and E (DEXCE; 200 mg. kg(-1). day(-1) and 100 mg. kg(-1). day(-1), respectively), on postnatal days 1-6 (P1-6). Controls received saline or saline with vitamins. At weaning, relative to controls, DEX decreased total brain volume (704.4 +/- 34.7 mm(3) vs. 564.0 +/- 20.0 mm(3)), the soma volume of neurons in the CA1 (1172.6 +/- 30.4 mu m(3) vs. 1002.4 +/- 11.8 mu m(3)) and in the dentate gyrus (525.9 +/- 27.2 mu m(3) vs. 421.5 +/- 24.6 mu m(3)) of the hippocampus, and induced oxidative stress in the cortex (protein expression: heat shock protein 70 [Hsp70]: +68%; 4-hydroxynonenal [4-HNE]: +118% and nitrotyrosine [NT]: +20%). Dexamethasone in combination with vitamins resulted in improvements in total brain volume (637.5 +/- 43.1 mm(3)), and soma volume of neurons in the CA1 (1157.5 +/- 42.4 mu m(3)) and the dentate gyrus (536.1 +/- 27.2 mu m(3)). Hsp70 protein expression was unaltered in the cortex (+9%), however, 4-HNE (+95%) and NT (+24%) protein expression remained upregulated. Treatment of neonates with vitamins alone induced oxidative stress in the cortex (Hsp70: +67%; 4-HNE: +73%; NT: +22%) and in the hippocampus (NT: +35%). Combined glucocorticoid and antioxidant therapy in premature infants may be safer for the developing brain than glucocorticoids alone in the treatment of chronic lung disease. However, antioxidant therapy in healthy offspring is not recommended.	[Camm, Emily J.; Richter, Hans G.; Adler, Alexandra; Hansell, Jeremy A.; Cross, Christine M.; Giussani, Dino A.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England; [Tijsseling, Deodata; Derks, Jan B.] Univ Med Ctr, Dept Obstet, Utrecht, Netherlands	University of Cambridge; Utrecht University; Utrecht University Medical Center	Camm, EJ (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England.	dag26@cam.ac.uk	; Richter, Hans/D-6273-2013	Giussani, Dino/0000-0002-1308-1204; Richter, Hans/0000-0002-7224-9388	British Heart Foundation (BHF); Biotechnology and Biological Sciences Research Council (BBSRC); Fonds Internationalisering, University Medical Center, Utrecht	British Heart Foundation (BHF)(British Heart Foundation); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Fonds Internationalisering, University Medical Center, Utrecht	This study was supported by the British Heart Foundation (BHF), the Biotechnology and Biological Sciences Research Council (BBSRC) and the Fonds Internationalisering, University Medical Center, Utrecht. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler A, 2010, NEONATOLOGY, V98, P73, DOI 10.1159/000275561; Ahlbom E, 2000, P NATL ACAD SCI USA, V97, P14726, DOI 10.1073/pnas.260501697; Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Antonow-Schlorke I, 2003, J PHYSIOL-LONDON, V547, P117, DOI 10.1113/jphysiol.2002.025700; BADEN M, 1972, PEDIATRICS, V50, P526; Bal MP, 2005, PEDIATR RES, V58, P46, DOI 10.1203/01.PDR.0000163617.01673.9A; Behl C, 1997, ENDOCRINOLOGY, V138, P101, DOI 10.1210/en.138.1.101; Behl C, 1997, CELL TISSUE RES, V290, P471, DOI 10.1007/s004410050955; BURTON GW, 1994, P NUTR SOC, V53, P251, DOI 10.1079/PNS19940030; Cai S, 2002, CARDIOVASC RES, V55, P838, DOI 10.1016/S0008-6363(02)00460-1; Carr AC, 2000, CIRC RES, V87, P349, DOI 10.1161/01.RES.87.5.349; Chen K, 2004, ENDOTHELIUM-J ENDOTH, V11, P109, DOI 10.1080/10623320490482655; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; CUMMINGS JJ, 1989, NEW ENGL J MED, V320, P1505, DOI 10.1056/NEJM198906083202301; Daghini E, 2006, AM J PHYSIOL-REG I, V290, pR609, DOI 10.1152/ajpregu.00436.2005; DANIELS VG, 1973, J PHYSIOL-LONDON, V229, P681, DOI 10.1113/jphysiol.1973.sp010160; de la Monte SM, 2000, CELL MOL LIFE SCI, V57, P1471, DOI 10.1007/PL00000630; De Vries WB, 2002, PEDIATR RES, V52, P900, DOI 10.1203/01.PDR.0000036281.74804.27; Derks JB, 1997, J PHYSIOL-LONDON, V499, P217, DOI 10.1113/jphysiol.1997.sp021922; Duksal F, 2009, BRAIN RES, V1250, P75, DOI 10.1016/j.brainres.2008.10.051; EVANS PH, 1993, BRIT MED BULL, V49, P577, DOI 10.1093/oxfordjournals.bmb.a072632; EYSEL UT, 1984, J COMP NEUROL, V229, P301, DOI 10.1002/cne.902290214; Flagel SB, 2002, AM J PHYSIOL-REG I, V282, pR55, DOI 10.1152/ajpregu.2002.282.1.R55; Fletcher AJW, 2002, J PHYSIOL-LONDON, V545, P649, DOI 10.1113/jphysiol.2001.015693; Fowden AL, 2004, REPRODUCTION, V127, P515, DOI 10.1530/rep.1.00033; FREI B, 1989, P NATL ACAD SCI USA, V86, P6377, DOI 10.1073/pnas.86.16.6377; French NP, 1999, AM J OBSTET GYNECOL, V180, P114, DOI 10.1016/S0002-9378(99)70160-2; GEETHA A, 1989, Indian Journal of Physiology and Pharmacology, V33, P53; Grier DG, 2005, DRUGS, V65, P15, DOI 10.2165/00003495-200565010-00002; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Halliday HL, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001145.pub2, 10.1002/14651858.CD001146.pub2]; Halliday HL, 2001, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD001145, 10.1002/14651858.CD001145]; Halliday HL, 2003, COCHRANE DB SYST REV; Halliday HL, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001144; Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nu.16.070196.000341; He J, 2004, AM J PHYSIOL-REG I, V287, pR198, DOI 10.1152/ajpregu.00349.2003; Heller R, 1999, J BIOL CHEM, V274, P8254, DOI 10.1074/jbc.274.12.8254; Huang WL, 1999, OBSTET GYNECOL, V94, P213, DOI 10.1016/S0029-7844(99)00265-3; Iuchi T, 2003, CIRC RES, V92, P81, DOI 10.1161/01.RES.0000050588.35034.3C; Jackson TS, 1998, CIRC RES, V83, P916; Johns DG, 2001, EXP BIOL MED, V226, P27, DOI 10.1177/153537020122600104; Kanagawa T, 2006, AM J OBSTET GYNECOL, V194, P231, DOI 10.1016/j.ajog.2005.06.015; Khassaf M, 2003, J PHYSIOL-LONDON, V549, P645, DOI 10.1113/jphysiol.2003.040303; KIERNAN JA, 1991, BRAIN, V114, P843, DOI 10.1093/brain/114.2.843; Lohle M, 2005, J PHYSIOL-LONDON, V564, P575, DOI 10.1113/jphysiol.2004.077537; McIntosh LJ, 1996, EXP NEUROL, V141, P201, DOI 10.1006/exnr.1996.0154; McIntosh LJ, 1998, BRAIN RES, V791, P209, DOI 10.1016/S0006-8993(98)00115-2; Mitsui T, 2002, ACTA NEUROPATHOL, V104, P260, DOI 10.1007/s00401-002-0553-5; MOUNTJOY CQ, 1983, NEUROBIOL AGING, V4, P1, DOI 10.1016/0197-4580(83)90048-9; MUNCK A, 1971, PERSPECT BIOL MED, V14, P265; Neal CR, 2004, AM J PHYSIOL-REG I, V287, pR375, DOI 10.1152/ajpregu.00012.2004; OLANOW CW, 1993, TRENDS NEUROSCI, V16, P439, DOI 10.1016/0166-2236(93)90070-3; Oncu M, 2002, HUM EXP TOXICOL, V21, P223, DOI 10.1191/0960327102ht225oa; Papile LA, 1998, NEW ENGL J MED, V338, P1112, DOI 10.1056/NEJM199804163381604; *PED AAO, 2002, PEDIATRICS, V109, P330; Radernaker KJ, 2008, ARCH DIS CHILD-FETAL, V93, pF58, DOI 10.1136/adc.2007.119545; Rajashree S, 1998, MOL CELL BIOCHEM, V181, P77, DOI 10.1023/A:1006833824163; Sahin N, 2009, BRIT POULTRY SCI, V50, P259, DOI 10.1080/00071660902758981; Schafer SC, 2005, AM J PHYSIOL-HEART C, V288, pH436, DOI 10.1152/ajpheart.00587.2004; Scheepens A, 2003, J PHYSIOL-LONDON, V552, P163, DOI 10.1113/jphysiol.2003.043414; Shinwell ES, 2000, ARCH DIS CHILD-FETAL, V83, pF177, DOI 10.1136/fn.83.3.F177; SICARD RE, 1992, PEDIATR RES, V31, P359, DOI 10.1203/00006450-199204000-00011; THIBEAULT DW, 1993, PEDIATR PULM, V16, P81, DOI 10.1002/ppul.1950160202; Thorp JA, 2002, OBSTET GYNECOL, V99, P109, DOI 10.1016/S0029-7844(01)01657-X; UNO H, 1994, HORM BEHAV, V28, P336, DOI 10.1006/hbeh.1994.1030; Versari D, 2006, HYPERTENSION, V47, P475, DOI 10.1161/01.HYP.0000201445.77125.26; Wagner JP, 1999, J NEUROSCI, V19, P6006, DOI 10.1523/JNEUROSCI.19-14-06006.1999; Wallerath T, 1999, P NATL ACAD SCI USA, V96, P13357, DOI 10.1073/pnas.96.23.13357; WEICHSEL ME, 1977, ANN NEUROL, V2, P364, DOI 10.1002/ana.410020503; Weiler HA, 1997, BIOL NEONATE, V71, P53, DOI 10.1159/000244397; Whitworth JA, 2002, J HYPERTENS, V20, P1035, DOI 10.1097/00004872-200206000-00003; Wilson JX, 2009, BIOFACTORS, V35, P5, DOI 10.1002/biof.7; Yeh TF, 2004, NEW ENGL J MED, V350, P1304, DOI 10.1056/NEJMoa032089; Zhang Y, 2004, AM J HYPERTENS, V17, P260, DOI 10.1016/j.amjhyper.2003.11.004	74	26	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e21142	10.1371/journal.pone.0021142	http://dx.doi.org/10.1371/journal.pone.0021142			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698270	Green Published, Green Submitted, gold			2022-12-27	WOS:000291730000056
J	Elyazar, IRF; Gething, PW; Patil, AP; Rogayah, H; Kusriastuti, R; Wismarini, DM; Tarmizi, SN; Baird, JK; Hay, SI				Elyazar, Iqbal R. F.; Gething, Peter W.; Patil, Anand P.; Rogayah, Hanifah; Kusriastuti, Rita; Wismarini, Desak M.; Tarmizi, Siti N.; Baird, J. Kevin; Hay, Simon I.			Plasmodium falciparum Malaria Endemicity in Indonesia in 2010	PLOS ONE			English	Article							RISK; POPULATION; PREVALENCE; INFECTION; PROGRAM; MAPS; PREDICTION; SPACE; TOOLS; MODEL	Background: Malaria control programs require a detailed understanding of the contemporary spatial distribution of infection risk to efficiently allocate resources. We used model based geostatistics (MBG) techniques to generate a contemporary map of Plasmodium falciparum malaria risk in Indonesia in 2010. Methods: Plasmodium falciparum Annual Parasite Incidence (PfAPI) data (2006-2008) were used to map limits of P. falciparum transmission. A total of 2,581 community blood surveys of P. falciparum parasite rate (PfPR) were identified (1985-2009). After quality control, 2,516 were included into a national database of age-standardized 2-10 year old PfPR data (PfPR(2-10)) for endemicity mapping. A Bayesian MBG procedure was used to create a predicted surface of PfPR2-10 endemicity with uncertainty estimates. Population at risk estimates were derived with reference to a 2010 human population count surface. Results: We estimate 132.8 million people in Indonesia, lived at risk of P. falciparum transmission in 2010. Of these, 70.3% inhabited areas of unstable transmission and 29.7% in stable transmission. Among those exposed to stable risk, the vast majority were at low risk (93.39%) with the reminder at intermediate (6.6%) and high risk (0.01%). More people in western Indonesia lived in unstable rather than stable transmission zones. In contrast, fewer people in eastern Indonesia lived in unstable versus stable transmission areas. Conclusion: While further feasibility assessments will be required, the immediate prospects for sustained control are good across much of the archipelago and medium term plans to transition to the pre-elimination phase are not unrealistic for P. falciparum. Endemicity in areas of Papua will clearly present the greatest challenge. This P. falciparum endemicity map allows malaria control agencies and their partners to comprehensively assess the region-specific prospects for reaching pre-elimination, monitor and evaluate the effectiveness of future strategies against this 2010 baseline and ultimately improve their evidence-based malaria control strategies.	[Elyazar, Iqbal R. F.; Baird, J. Kevin] Eijkman Oxford Clin Res Unit, Jakarta, Indonesia; [Gething, Peter W.; Patil, Anand P.; Hay, Simon I.] Univ Oxford, Dept Zool, Spatial Ecol & Epidemiol Grp, Oxford OX1 3PS, England; [Rogayah, Hanifah; Kusriastuti, Rita; Wismarini, Desak M.; Tarmizi, Siti N.] Indonesian Minist Hlth, Directorate Vector Borne Dis, Jakarta, Indonesia; [Baird, J. Kevin] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford, England	Eijkman Institute; University of Oxford; Ministry of Health - Indonesia; University of Oxford	Elyazar, IRF (corresponding author), Eijkman Oxford Clin Res Unit, Jakarta, Indonesia.	iqbal.elyazar@gmail.com; simon.hay@zoo.ox.ac.uk	Gething, Peter/GQR-1884-2022; Hay, Simon Iain/F-8967-2015; Gething, Peter/ABD-2110-2020	Gething, Peter/0000-0001-6759-5449; Hay, Simon Iain/0000-0002-0611-7272; 	University of Oxford-Li Ka Shing Foundation; Oxford Tropical Network; Wellcome Trust [079091, 091835, B9RJIXO]; Science and Technology Directorate, Department of Homeland Security; Fogarty International Center, National Institutes of Health; Indonesian Ministry of Health; Wellcome Trust, U.K.; Eijkman Institute of Molecular Biology, Jakarta	University of Oxford-Li Ka Shing Foundation; Oxford Tropical Network; Wellcome Trust(Wellcome Trust); Science and Technology Directorate, Department of Homeland Security(United States Department of Homeland Security (DHS)); Fogarty International Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Indonesian Ministry of Health; Wellcome Trust, U.K.(Wellcome Trust); Eijkman Institute of Molecular Biology, Jakarta	IE is funded by grants from the University of Oxford-Li Ka Shing Foundation Global Health Program and the Oxford Tropical Network. SIH is funded by a Senior Research Fellowship from the Wellcome Trust (#079091), which also supports PWG. SIH also acknowledges funding support from the RAPIDD program of the Science and Technology Directorate, Department of Homeland Security, and the Fogarty International Center, National Institutes of Health. APP is funded by a grant from the Wellcome Trust (#091835). HR, RK, DMW, SNT are funded by the Indonesian Ministry of Health. JKB is funded by a grant from the Wellcome Trust (#B9RJIXO). This work forms part of the output of the Malaria Atlas Project (MAP, http://www.map.ox.ac.uk), principally funded by the Wellcome Trust, U.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The national assembly of parasite prevalence surveys was dependent on the generous contributions of data by a large number of people in the malaria research and control communities, and these individuals are listed on the MAP website (http://www.map.ac.uk/acknowledgements.html). We thank Catherine Moyes for comments and Jennie Charlton for proofreading this paper. The authors additionally acknowledge the support of the colleagues from the Sub-Directorate of Indonesian Malaria Control including Achmad Farchanny, Adhi Sambodo, Ali Romzan, Aris Munanto, Bangkit Hutajulu, Budi Pramono, Charles Tobing, Elvieda Samoedro, Niken W. Palupi, Nur Asni and Saktiyono. The authors also thank the support of the Eijkman Institute of Molecular Biology, Jakarta.	[Anonymous], 2009, MAL MICR QUAL ASS MA; Badan Pusat Statistik, 2010, HAS SENS PEND 2010 D; Balk DL, 2006, ADV PARASIT, V62, P119, DOI 10.1016/S0065-308X(05)62004-0; Bicheron P., 2010, GLOBCOVER PRODUCTS D; Brooker S, 2002, TRENDS PARASITOL, V18, P70, DOI 10.1016/S1471-4922(01)02223-1; Brooker S, 2006, EMERG INFECT DIS, V12, P1600, DOI 10.3201/eid1210.060051; Clements ACA, 2006, TROP MED INT HEALTH, V11, P490, DOI 10.1111/j.1365-3156.2006.01594.x; *DEP KES, 2009, KEP MENT KES REP IND; Diggle PJ, 2007, ANN TROP MED PARASIT, V101, P499, DOI [10.1179/136485913X13789813917463, 10.1179/136485907X229121]; Diggle PJ, 1998, J R STAT SOC C-APPL, V47, P299, DOI 10.1111/1467-9876.00113; Elyazar IRF, 2011, ADV PARASIT, V74, P41, DOI 10.1016/B978-0-12-385897-9.00002-1; Feachem RGA, 2009, SHRINKING MALARIA MA; Gething PW, 2006, PLOS MED, V3, P825, DOI 10.1371/journal.pmed.0030271; Global Malaria Programme, 2007, MAL EL FIELD MAN LOW; Gosoniu L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009322; Greiner M, 2000, PREV VET MED, V45, P23, DOI 10.1016/S0167-5877(00)00115-X; Guerra CA, 2010, PLOS NEGLECT TROP D, V4, P8; Guerra CA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-17; Guerra CA, 2008, PLOS MED, V5, P300, DOI 10.1371/journal.pmed.0050038; Hay SI, 2006, ADV PARASIT, V62, P37, DOI 10.1016/S0065-308X(05)62002-7; Hay SI, 2005, TROP MED INT HEALTH, V10, P1073, DOI 10.1111/j.1365-3156.2005.01487.x; Hay SI, 2004, LANCET INFECT DIS, V4, P327, DOI 10.1016/S1473-3099(04)01043-6; Hay SI, 2010, PLOS MED, V7, P6; Hay SI, 2008, LANCET INFECT DIS, V8, P369, DOI 10.1016/S1473-3099(08)70069-0; Hay SI, 2006, PLOS MED, V3, P2204, DOI 10.1371/journal.pmed.0030473; Hay SI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000209; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Kazembe Lawrence N, 2006, Int J Health Geogr, V5, P41, DOI 10.1186/1476-072X-5-41; Manh BH, 2011, INT J PARASITOL, V41, P109, DOI 10.1016/j.ijpara.2010.08.005; Noor AM, 2010, AM J TROP MED HYG, V83, P854, DOI 10.4269/ajtmh.2010.10-0331; Noor AM, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-180; Noor AM, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-159; Patil AP, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-186; PULL JH, 1974, B WORLD HEALTH ORGAN, V51, P507; Reid H, 2010, AM J TROP MED HYG, V83, P861, DOI 10.4269/ajtmh.2010.10-0154; Reid H, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-150; Scharlemann JPW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001408; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sinka ME, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-72; Smith DL, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-131; Smith DL, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-87; SMITH DL, 2009, MEASURING MALARIA EL, P00108; Snow RW, 1996, PARASITOL TODAY, V12, P455, DOI 10.1016/S0169-4758(96)30032-X; Stein ML, 2005, J AM STAT ASSOC, V100, P310, DOI 10.1198/016214504000000854; Stevens W, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-22; Takken W., 1990, ENV MEASURES MALARIA; Wallace A. R., 1863, J ROYAL GEOGRAPHICAL, V33, P217, DOI DOI 10.2307/1798448; Zanzibar Malaria Control Program, 2009, MAL EL ZANZ FEAS ASS; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	57	41	42	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21315	10.1371/journal.pone.0021315	http://dx.doi.org/10.1371/journal.pone.0021315			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21738634	Green Published, gold			2022-12-27	WOS:000292290100017
J	Chuang, LY; Huang, HC; Lin, MC; Yang, CH				Chuang, Li-Yeh; Huang, Hsiu-Chen; Lin, Ming-Cheng; Yang, Cheng-Hong			Particle Swarm Optimization with Reinforcement Learning for the Prediction of CpG Islands in the Human Genome	PLOS ONE			English	Article							METHYLATION; CLUSTERS	Background: Regions with abundant GC nucleotides, a high CpG number, and a length greater than 200 bp in a genome are often referred to as CpG islands. These islands are usually located in the 59 end of genes. Recently, several algorithms for the prediction of CpG islands have been proposed. Methodology/Principal Findings: We propose here a new method called CPSORL to predict CpG islands, which consists of a complement particle swarm optimization algorithm combined with reinforcement learning to predict CpG islands more reliably. Several CpG island prediction tools equipped with the sliding window technique have been developed previously. However, the quality of the results seems to rely too much on the choices that are made for the window sizes, and thus these methods leave room for improvement. Conclusions/Significance: Experimental results indicate that CPSORL provides results of a higher sensitivity and a higher correlation coefficient in all selected experimental contigs than the other methods it was compared to (CpGIS, CpGcluster, CpGProd and CpGPlot). A higher number of CpG islands were identified in chromosomes 21 and 22 of the human genome than with the other methods from the literature. CPSORL also achieved the highest coverage rate (3.4%). CPSORL is an application for identifying promoter and TSS regions associated with CpG islands in entire human genomic. When compared to CpGcluster, the islands predicted by CPSORL covered a larger region in the TSS (12.2%) and promoter (26.1%) region. If Alu sequences are considered, the islands predicted by CPSORL (Alu) covered a larger TSS (40.5%) and promoter (67.8%) region than CpGIS. Furthermore, CPSORL was used to verify that the average methylation density was 5.33% for CpG islands in the entire human genome.	[Chuang, Li-Yeh] I Shou Univ, Inst Biotechnol & Chem Engn, Kaohsiung, Taiwan; [Huang, Hsiu-Chen] Natl Cheng Kung Univ, Inst Biomed Engn, Tainan 70101, Taiwan; [Huang, Hsiu-Chen] Chia Yi Christian Hosp, Dept Phys Med & Rehabil, Chiayi, Taiwan; [Lin, Ming-Cheng; Yang, Cheng-Hong] Natl Kaohsiung Univ Appl Sci, Dept Elect Engn, Kaohsiung 807, Taiwan; [Yang, Cheng-Hong] Toko Univ, Dept Network Syst, Chiayi, Taiwan	I Shou University; National Cheng Kung University; National Kaohsiung University of Science & Technology	Chuang, LY (corresponding author), I Shou Univ, Inst Biotechnol & Chem Engn, Kaohsiung, Taiwan.	03281@cych.org.tw; chyang@cc.kuas.edu.tw	Yang, Cheng-Hong/M-7984-2013; Yang, Cheng-Hong/K-2438-2019; Chuang, Li-Yeh/E-5005-2011	Yang, Cheng-Hong/0000-0002-2741-0072; 	National Science Council in Taiwan [NSC96-2221-E-214-050-MY3, NSC98-2221-E-151-040-, NSC 98-2622-E-151-001-CC2, 98-2622-E-151-024-CC3]	National Science Council in Taiwan(Ministry of Science and Technology, Taiwan)	This work is partly supported by the National Science Council in Taiwan under grants NSC96-2221-E-214-050-MY3, NSC98-2221-E-151-040-, NSC 98-2622-E-151-001-CC2 and 98-2622-E-151-024-CC3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Barto A.G., 1997, ADV PSYCHOL, V121, P358; Chuang LY, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq204; Davis CD, 2004, EXP BIOL MED, V229, P988, DOI 10.1177/153537020422901002; Egan J.P., 1975, SIGNAL DETECTION THE; Fang F, 2006, BIOINFORMATICS, V22, P2204, DOI 10.1093/bioinformatics/btl377; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; GUDISE VG, 2003, EVOLVING DIGITAL CIR, V461, P468; Hackenberg M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-446; Hackenberg M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-327; Han L, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-65; Hancock JM, 2001, MOL BIOL EVOL, V18, P1014, DOI 10.1093/oxfordjournals.molbev.a003873; Hanson R.K., 1997, DEV BRIEF ACTUARIAL; Illingworth RS, 2009, FEBS LETT, V583, P1713, DOI 10.1016/j.febslet.2009.04.012; Jiang CZ, 2007, MOL BIOL EVOL, V24, P1991, DOI 10.1093/molbev/msm128; Kane MF, 1997, CANCER RES, V57, P808; Kennedy J., 1995, 1995 IEEE International Conference on Neural Networks Proceedings (Cat. No.95CH35828), P1942, DOI 10.1109/ICNN.1995.488968; Kennedy J, 1995, 1995 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS PROCEEDINGS, VOLS 1-6, P1942, DOI 10.1109/icnn.1995.488968; Lai HM, 2008, J MED BIOL ENG, V28, P23; Lin YC, 2008, MOL BIOL EVOL, V25, P2189, DOI 10.1093/molbev/msn165; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Ponger L, 2002, BIOINFORMATICS, V18, P631, DOI 10.1093/bioinformatics/18.4.631; Ressom HW, 2005, BIOINFORMATICS, V21, P4039, DOI 10.1093/bioinformatics/bti670; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Takai Daiya, 2003, In Silico Biology, V3, P235; TYKOCINSKI ML, 1984, NUCLEIC ACIDS RES, V12, P4385, DOI 10.1093/nar/12.10.4385; Whitehead S. D., 1990, Proceedings. 5th IEEE International Symposium on Intelligent Control 1990 (Cat. No.90TH0333-5), P1289, DOI 10.1109/ISIC.1990.128621; Ye SJ, 2008, BIOINFORMATION, V2, P335, DOI 10.6026/97320630002335; Yegnasubramanian S, 2008, CANCER RES, V68, P8954, DOI 10.1158/0008-5472.CAN-07-6088	28	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21036	10.1371/journal.pone.0021036	http://dx.doi.org/10.1371/journal.pone.0021036			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738602	Green Published, Green Submitted, gold			2022-12-27	WOS:000292142800010
J	Congreve, CR; Lieberman, BS				Congreve, Curtis R.; Lieberman, Bruce S.			Phylogenetic and Biogeographic Analysis of Sphaerexochine Trilobites	PLOS ONE			English	Article							EVOLUTION; PALEOBIOGEOGRAPHY; EXTINCTION; VICARIANCE; PATTERNS; FAUNAS	Background: Sphaerexochinae is a speciose and widely distributed group of cheirurid trilobites. Their temporal range extends from the earliest Ordovician through the Silurian, and they survived the end Ordovician mass extinction event (the second largest mass extinction in Earth history). Prior to this study, the individual evolutionary relationships within the group had yet to be determined utilizing rigorous phylogenetic methods. Understanding these evolutionary relationships is important for producing a stable classification of the group, and will be useful in elucidating the effects the end Ordovician mass extinction had on the evolutionary and biogeographic history of the group. Methodology/Principal Findings: Cladistic parsimony analysis of cheirurid trilobites assigned to the subfamily Sphaerexochinae was conducted to evaluate phylogenetic patterns and produce a hypothesis of relationship for the group. This study utilized the program TNT, and the analysis included thirty-one taxa and thirty-nine characters. The results of this analysis were then used in a Lieberman-modified Brooks Parsimony Analysis to analyze biogeographic patterns during the Ordovician-Silurian. Conclusions/Significance: The genus Sphaerexochus was found to be monophyletic, consisting of two smaller clades (one composed entirely of Ordovician species and another composed of Silurian and Ordovician species). By contrast, the genus Kawina was found to be paraphyletic. It is a basal grade that also contains taxa formerly assigned to Cydonocephalus. Phylogenetic patterns suggest Sphaerexochinae is a relatively distinctive trilobite clade because it appears to have been largely unaffected by the end Ordovician mass extinction. Finally, the biogeographic analysis yields two major conclusions about Sphaerexochus biogeography: Bohemia and Avalonia were close enough during the Silurian to exchange taxa; and during the Ordovician there was dispersal between Eastern Laurentia and the Yangtze block (South China) and between Eastern Laurentia and Avalonia.	[Congreve, Curtis R.] Univ Kansas, Dept Geol, Lawrence, KS 66045 USA; Univ Kansas, Biodivers Inst, Lawrence, KS 66045 USA	University of Kansas; University of Kansas	Congreve, CR (corresponding author), Univ Kansas, Dept Geol, Lawrence, KS 66045 USA.	oldjack327@yahoo.com		Congreve, Curtis/0000-0003-3476-1257	NSF [DEB-0716162]	NSF(National Science Foundation (NSF))	Support for this research was provided by NSF DEB-0716162. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrain JM, 1998, J PALEONTOL, V72, P698, DOI 10.1017/S0022336000040403; Adrain JM, 1998, SCIENCE, V280, P1922, DOI 10.1126/science.280.5371.1922; Adrain Jonathan M., 1997, Bulletin of the Natural History Museum Geology Series, V53, P79; Armstrong HA, 2001, J GEOL SOC LONDON, V158, P475, DOI 10.1144/jgs.158.3.475; BARTON DC, 1916, ST LOUIS WASHINGTON, V3, P101; BERRY WBN, 1973, GEOL SOC AM BULL, V84, P275, DOI 10.1130/0016-7606(1973)84<275:GCOLOS>2.0.CO;2; Beyrich E, 1845, UEBER EINIGE BOHMISC; BILLINGS E, 1861, PALAEZOIC FOSSILS CA; BREMER K, 1994, CLADISTICS, V10, P295, DOI 10.1006/clad.1994.1019; CHATTERTON BDE, 1989, PALEOBIOLOGY, V15, P118, DOI 10.1017/S0094837300009313; Cocks LRM, 2002, J GEOL SOC LONDON, V159, P631, DOI 10.1144/0016-764901-118; Congreve CR, 2010, J PALEONTOL, V84, P128, DOI 10.1666/09-026.1; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; FORTEY RA, 1992, TECTONOPHYSICS, V206, P147, DOI 10.1016/0040-1951(92)90373-E; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; GOULD SJ, 1980, PALEOBIOLOGY, V6, P119, DOI 10.1017/S0094837300012549; HARPER DAT, 1992, TERRA NOVA, V4, P204, DOI 10.1111/j.1365-3121.1992.tb00473.x; Hembree DI, 2006, PALAEOGEOGR PALAEOCL, V235, P340, DOI 10.1016/j.palaeo.2005.11.006; HILLIS DM, 1991, PHYLOGENETIC ANALYSIS OF DNA SEQUENCES, P278; HOLLOWAY D J, 1980, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V170, P1; Jell P. A., 2003, Memoirs of the Queensland Museum, V48, P331; KOBAYASHI T, 1976, P JPN ACAD, V52, P367, DOI 10.2183/pjab1945.52.367; Lane PD, 1971, BRIT CHEIRURIDAE TRI; Lee SB, 2008, PALAEOGEOGR PALAEOCL, V260, P315, DOI 10.1016/j.palaeo.2007.11.008; Lieberman, 2000, PALEOBIOGEOGRAPHY US; Lieberman BS, 2003, SPEC PAP PALAEONTOL, P59; Lieberman BS, 1996, PALEOBIOLOGY, V22, P66, DOI 10.1017/S009483730001602X; Maddison D.R., 2007, MESQUITE 2 MODULAR S; Maguire KC, 2008, PALAEOGEOGR PALAEOCL, V267, P175, DOI 10.1016/j.palaeo.2008.06.014; Pribyl A., 1985, Acta Universitatis Palackianae Olomucensis Facultatis Medicae, V83, P107; Rambaut A., 2008, FIGTREE; RAMSKOLD L, 1983, PALAEONTOLOGY, V26, P175; RIEDL R, 1978, ORDER LIVING ORGANIS, P1; Rode AL, 2005, J PALEONTOL, V79, P267, DOI 10.1666/0022-3360(2005)079<0267:IEABAC>2.0.CO;2; ROSS RJ, 1951, PEABODY MUSEUM NATUR, V6, P1; SCOTESE CR, 2007, PALEOGIS; SCOTESE CR, 1991, 909 GEOL SURV CAN, P271; Sheehan PM, 2001, ANNU REV EARTH PL SC, V29, P331, DOI 10.1146/annurev.earth.29.1.331; SHEEHAN PM, 1973, LETHAIA, V6, P147, DOI 10.1111/j.1502-3931.1973.tb01188.x; Speyer S.E., 1989, Historical Biology, V3, P27; SWOFFORD DL, 1998, PAUP; Thomas A.T., 1981, Palaeontographical Society Monographs (London), V134, P57; Torsvik TH, 1996, EARTH-SCI REV, V40, P229, DOI 10.1016/0012-8252(96)00008-6; TORSVIK TH, 1995, J GEOL SOC LONDON, V152, P279, DOI 10.1144/gsjgs.152.2.0279; WARBURG E, 1925, B GEOLOGICAL I U UPP, V17; WHITTINGTON H. B., 1963, BULL MUS COMP ZOOL HARVARD UNIV, V129, P1; WHITTINGTON H. B., 1965, BULL MUS COMP ZOOL HARVARD UNIV, V132, P275; Whittington H. B., 1997, TREATISE INVERTEBR O, V1; WILEY EO, 1979, SYST ZOOL, V28, P308; Zhou ZY., 2008, P LINNEAN SOC NEW S, V129, P183	50	12	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21304	10.1371/journal.pone.0021304	http://dx.doi.org/10.1371/journal.pone.0021304			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738632	Green Published, gold, Green Submitted			2022-12-27	WOS:000292092600027
J	Hu, Y; Wang, JF; Li, XH; Ren, D; Zhu, J				Hu, Yi; Wang, Jinfeng; Li, Xiaohong; Ren, Dan; Zhu, Jun			Geographical Detector-Based Risk Assessment of the Under-Five Mortality in the 2008 Wenchuan Earthquake, China	PLOS ONE			English	Article							HETEROGENEITY; INJURIES; ERROR	On 12 May, 2008, a devastating earthquake registering 8.0 on the Richter scale occurred in Sichuan Province, China, taking tens of thousands of lives and destroying the homes of millions of people. Many of the deceased were children, particular children less than five years old who were more vulnerable to such a huge disaster than the adult. In order to obtain information specifically relevant to further researches and future preventive measures, potential risk factors associated with earthquake-related child mortality need to be identified. We used four geographical detectors (risk detector, factor detector, ecological detector, and interaction detector) based on spatial variation analysis of some potential factors to assess their effects on the under-five mortality. It was found that three factors are responsible for child mortality: earthquake intensity, collapsed house, and slope. The study, despite some limitations, has important implications for both researchers and policy makers.	[Hu, Yi] China Univ Geosci, Sch Earth & Mineral Resource, Beijing, Peoples R China; [Hu, Yi; Wang, Jinfeng] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, State Key Lab Resources & Environm Informat Syst, Beijing, Peoples R China; [Li, Xiaohong; Ren, Dan; Zhu, Jun] Sichuan Univ, W China Hosp 2, Natl Off Maternal & Child Hlth Surveillance, Chengdu 610064, Sichuan, Peoples R China	China University of Geosciences; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Sichuan University	Hu, Y (corresponding author), China Univ Geosci, Sch Earth & Mineral Resource, Beijing, Peoples R China.	wangjf@lreis.ac.cn; zhujun028@163.com		Wang, Jinfeng/0000-0002-6687-9420; Li, Xiaohong/0000-0003-0336-7302	NSFC [41023010]; MOST, China [2009ZX10004-201, 2008BAI56B02, 2007DFC20180, 2007AA12Z233, 2006BAK01A13]; CAS, China [KZCX2-YW-308]	NSFC(National Natural Science Foundation of China (NSFC)); MOST, China(Ministry of Science and Technology, China); CAS, China(Chinese Academy of Sciences)	This study was supported by the NSFC (41023010), MOST, China (2009ZX10004-201, 2008BAI56B02, 2007DFC20180, 2007AA12Z233, 2006BAK01A13) and the CAS, China (KZCX2-YW-308). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen M.P., 1997, REGRESSION ANAL DUMM; [Anonymous], J GEOGR GEOL; [Anonymous], 1986, PRINCIPLES GEOGRAPHI; Armenian HK, 1997, INT J EPIDEMIOL, V26, P806, DOI 10.1093/ije/26.4.806; Brus DJ, 1997, GEODERMA, V80, P1, DOI 10.1016/S0016-7061(97)00072-4; Chen CT, 2009, GEOPH RES ABSTR, V11, P5615; Clark J. S, 2007, MODELS ECOLOGICAL DA; DEBRUYCKER M, 1985, INT J EPIDEMIOL, V14, P113, DOI 10.1093/ije/14.1.113; Ellidokuz H, 2005, CROAT MED J, V46, P613; FAN J, 2009, OVERVIEW EVALUATION, P19; Fisher N. I., 1987, STAT ANAL SPHERICAL; GRIFFITH DA, 1994, GEOGR ANAL, V26, P300; GRIMMETT RR, 1994, PROBABILITY RANDOM P; Gutierrez E, 2005, AM J EPIDEMIOL, V161, P1151, DOI 10.1093/aje/kwi149; Haining R.P., 1988, COMMUNICATIONS STAT, V17, P537; Hu YF, 2011, 2011 AASRI CONFERENCE ON APPLIED INFORMATION TECHNOLOGY (AASRI-AIT 2011), VOL 1, P1; Li LF, 2008, STOCH ENV RES RISK A, V22, P689, DOI 10.1007/s00477-007-0179-1; Liao YL, 2010, INT J GEOGR INF SCI, V24, P47, DOI 10.1080/13658810802186874; LIEPING Y, 2008, 14 WORLD C EARTHQ EN; Pai CH, 2007, NAT HAZARDS, V42, P19, DOI 10.1007/s11069-006-9043-8; Peek-Asa C, 2003, INJ PREV, V9, P62, DOI 10.1136/ip.9.1.62; Peek-Asa C, 2000, ANN EPIDEMIOL, V10, P5, DOI 10.1016/S1047-2797(99)00058-7; PEEKASA C, 1998, INT J EPIDEMIOL, P456; Press W. H., 1992, ART SCI COMPUTING; SPENCE RJS, 1990, REDUCING HUMAN CASUA, P1; TIEDEMANN H, 1989, P INT WORKSH EARTHQ, P420; Wang JF, 2010, INT J GEOGR INF SCI, V24, P107, DOI 10.1080/13658810802443457; Wang JF, 2010, INT J GEOGR INF SCI, V24, P523, DOI 10.1080/13658810902873512; WATTS J, 2008, CHINESE QUAKE FORCED, P2008; Wood H. O., 1931, B SEISMOL SOC AM, V21, P277	30	79	103	6	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21427	10.1371/journal.pone.0021427	http://dx.doi.org/10.1371/journal.pone.0021427			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738660	gold, Green Published			2022-12-27	WOS:000292092600040
J	Peyron, MA; Gierczynski, I; Hartmann, C; Loret, C; Dardevet, D; Martin, N; Woda, A				Peyron, Marie-Agnes; Gierczynski, Isabelle; Hartmann, Christoph; Loret, Chrystel; Dardevet, Dominique; Martin, Nathalie; Woda, Alain			Role of Physical Bolus Properties as Sensory Inputs in the Trigger of Swallowing	PLOS ONE			English	Article							PARTICLE-SIZE DISTRIBUTION; NUTRITIONAL-STATUS; FOOD TRANSPORT; NATURAL FOODS; MASTICATION; VOLUME; CONSISTENCY; ACCOMMODATION; INITIATION; THRESHOLD	Background: Swallowing is triggered when a food bolus being prepared by mastication has reached a defined state. However, although this view is consensual and well supported, the physical properties of the swallowable bolus have been under-researched. We tested the hypothesis that measuring bolus physical changes during the masticatory sequence to deglutition would reveal the bolus properties potentially involved in swallowing initiation. Methods: Twenty normo-dentate young adults were instructed to chew portions of cereal and spit out the boluses at different times in the masticatory sequence. The mechanical properties of the collected boluses were measured by a texture profile analysis test currently used in food science. The median particle size of the boluses was evaluated by sieving. In a simultaneous sensory study, twenty-five other subjects expressed their perception of bolus texture dominating at any mastication time. Findings: Several physical changes appeared in the food bolus as it was formed during mastication: (1) in rheological terms, bolus hardness rapidly decreased as the masticatory sequence progressed, (2) by contrast, adhesiveness, springiness and cohesiveness regularly increased until the time of swallowing, (3) median particle size, indicating the bolus particle size distribution, decreased mostly during the first third of the masticatory sequence, (4) except for hardness, the rheological changes still appeared in the boluses collected just before swallowing, and (5) physical changes occurred, with sensory stickiness being described by the subjects as a dominant perception of the bolus at the end of mastication. Conclusions: Although these physical and sensory changes progressed in the course of mastication, those observed just before swallowing seem to be involved in swallowing initiation. They can be considered as strong candidates for sensory inputs from the bolus that are probably crucially involved in the triggering of swallowing, since they appeared in boluses prepared in various mastication strategies by different subjects.	[Peyron, Marie-Agnes; Gierczynski, Isabelle; Dardevet, Dominique] Univ Auvergne, CRNH Auvergne, INRA, Unite Nutr Humaine UMR 1019, Clermont Ferrand, France; [Hartmann, Christoph; Loret, Chrystel; Martin, Nathalie] Nestle Res Ctr, CH-1000 Lausanne, Switzerland; [Woda, Alain] Univ Auvergne, Ctr Rech Odontol Clin CROC, EA 3847, Clermont Ferrand, France; [Woda, Alain] CHU, Serv Odontol, Clermont Ferrand, France	INRAE; Universite Clermont Auvergne (UCA); Nestle SA; Universite Clermont Auvergne (UCA); CHU Clermont Ferrand	Peyron, MA (corresponding author), Univ Auvergne, CRNH Auvergne, INRA, Unite Nutr Humaine UMR 1019, Clermont Ferrand, France.	marie-agnes.peyron@clermont.inra.fr		Dardevet, Dominique/0000-0001-7320-9970; Hartmann, Christoph/0000-0002-2199-6842; martin, nathalie/0000-0002-2086-3773				Alexander R. McN., 1999, Science Progress, V82, P171; ANDERSON DL, 1977, INT DENT J, V27, P349; Bhattacharyya N, 2003, OTOLARYNG HEAD NECK, V129, P632, DOI 10.1016/S0194-5998(03)00633-8; BREENE W M, 1975, Journal of Texture Studies, V6, P53, DOI 10.1111/j.1745-4603.1975.tb01118.x; Chen JS, 2011, FOOD HYDROCOLLOID, V25, P325, DOI 10.1016/j.foodhyd.2010.06.010; Coster S.T., 1987, DYSPHAGIA, V1, P113, DOI DOI 10.1007/BF02412327; DANTAS RO, 1990, AM J PHYSIOL, V258, pG675, DOI 10.1152/ajpgi.1990.258.5.G675; Engelen L, 2005, ARCH ORAL BIOL, V50, P739, DOI 10.1016/j.archoralbio.2005.01.004; FELDMAN RS, 1980, J AM GERIATR SOC, V28, P97, DOI 10.1111/j.1532-5415.1980.tb00240.x; Fontijn-Tekamp FA, 2000, J DENT RES, V79, P1519, DOI 10.1177/00220345000790071501; Gaviao MBD, 2004, EUR J ORAL SCI, V112, P19, DOI 10.1111/j.0909-8836.2004.00105.x; Hiiemae KM, 1999, DYSPHAGIA, V14, P31, DOI 10.1007/PL00009582; HOLLSHWANDNER CH, 1975, J DENT RES, V54, P83, DOI 10.1177/00220345750540014201; HUTCHINGS JB, 1988, J TEXTURE STUD, V19, P103, DOI 10.1111/j.1745-4603.1988.tb00928.x; Ishihara S, 2011, FOOD HYDROCOLLOID, V25, P1016, DOI 10.1016/j.foodhyd.2010.09.022; Jalabert-Malbos ML, 2007, FOOD QUAL PREFER, V18, P803, DOI 10.1016/j.foodqual.2007.01.010; JEAN A, 1984, J AUTONOM NERV SYST, V10, P225, DOI 10.1016/0165-1838(84)90017-1; Jean A., 1990, NEUROPHYSIOLOGY JAWS, P294; KAHRILAS PJ, 1993, GASTROENTEROLOGY, V104, P152, DOI 10.1016/0016-5085(93)90847-6; Kahrilas PJ, 1996, GASTROENTEROLOGY, V111, P297, DOI 10.1053/gast.1996.v111.pm8690194; Labbe D, 2009, FOOD QUAL PREFER, V20, P216, DOI 10.1016/j.foodqual.2008.10.001; Lassauzay C, 2000, EUR J ORAL SCI, V108, P484, DOI 10.1034/j.1600-0722.2000.00866.x; Lowell SY, 2008, NEUROIMAGE, V42, P285, DOI 10.1016/j.neuroimage.2008.04.234; LUCAS PW, 1986, J ORAL REHABIL, V13, P127, DOI 10.1111/j.1365-2842.1986.tb00645.x; LUND J P, 1991, Critical Reviews in Oral Biology and Medicine, V2, P33; Miller JL, 1996, DYSPHAGIA, V11, P117, DOI 10.1007/BF00417901; Mishellany A, 2006, DYSPHAGIA, V21, P87, DOI 10.1007/s00455-006-9014-y; Mishellany-Dutour A, 2008, BRIT J NUTR, V99, P121, DOI 10.1017/S0007114507795284; NELSEN RJ, 1979, JAMA-J AM MED ASSOC, V241, P238, DOI 10.1001/jama.1979.03290290012005; Nicosia MA, 2001, J BIOMECH, V34, P1537, DOI 10.1016/S0021-9290(01)00147-6; Nowjack-Raymer RE, 2007, J DENT RES, V86, P1171, DOI 10.1177/154405910708601206; Palmer JB, 2007, PHYSIOL BEHAV, V91, P66, DOI 10.1016/j.physbeh.2007.01.018; Peyron MA, 2004, J DENT RES, V83, P578, DOI 10.1177/154405910408300713; Pineau N, 2009, FOOD QUAL PREFER, V20, P450, DOI 10.1016/j.foodqual.2009.04.005; POUDEROUX P, 1995, GASTROENTEROLOGY, V108, P1418, DOI 10.1016/0016-5085(95)90690-8; Prinz JF, 1997, P ROY SOC B-BIOL SCI, V264, P1715, DOI 10.1098/rspb.1997.0238; PRINZ JF, 1995, ARCH ORAL BIOL, V40, P401, DOI 10.1016/0003-9969(94)00185-E; Rosenholm JB, 2008, ADV COLLOID INTERFAC, V141, P48, DOI 10.1016/j.cis.2008.03.001; Sheiham A, 2001, J DENT RES, V80, P408, DOI 10.1177/00220345010800020201; Shimazaki Y, 2001, J DENT RES, V80, P340, DOI 10.1177/00220345010800010801; Sonies BC, 2009, AM J PHYS MED REHAB, V88, P464, DOI 10.1097/PHM.0b013e3181a5abad; Steele CM, 2010, DYSPHAGIA, V25, P323, DOI 10.1007/s00455-010-9301-5; Steele CM, 2004, DYSPHAGIA, V19, P192, DOI 10.1007/s00455-004-0006-5; Szczesniak AS, 2002, FOOD QUAL PREFER, V13, P215, DOI 10.1016/S0950-3293(01)00039-8; SZCZESNIAK AS, 1963, J FOOD SCI, V28, P385, DOI 10.1111/j.1365-2621.1963.tb00219.x; Takahashi T, 2007, NEUROSCIENCE, V145, P791, DOI 10.1016/j.neuroscience.2006.12.044; Trulsson M, 1997, J NEUROPHYSIOL, V77, P737, DOI 10.1152/jn.1997.77.2.737; Woda A, 2010, J DENT RES, V89, P281, DOI 10.1177/0022034509357022; YURKSTAS A, 1951, Br Dent J, V91, P261	49	97	98	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21167	10.1371/journal.pone.0021167	http://dx.doi.org/10.1371/journal.pone.0021167			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738616	Green Published, gold, Green Submitted			2022-12-27	WOS:000292092600016
J	Nyirandutiye, DH; Iknane, AA; Fofana, A; Brown, KH				Nyirandutiye, Daniele H.; Iknane, Akory Ag; Fofana, Amadou; Brown, Kenneth H.			Screening for Acute Childhood Malnutrition during the National Nutrition Week in Mali Increases Treatment Referrals	PLOS ONE			English	Article							CHILDREN	Objective: To evaluate a pilot intervention designed to integrate mid-upper arm circumference (MUAC) screening for acute malnutrition into the semi-annual Child Nutrition Week (Semaine d'Intensification des Activites de Nutrition, or "SIAN'') activities carried out in June 2008. Design: A cross-sectional survey was conducted in Kolokani and Nara, two health districts in the Koulikoro region of Mali, 4-5 months after the SIAN, using a population-proportionate, multi-stage random sample of: 1) health centers, and 2) households in communities linked to each of the selected health centers. Caregivers of 1543 children who were 6-59 months of age at the time of the SIAN, 17 community-based volunteers and 45 health center staff members were interviewed. Results: A total of 1278 children 6-59 months (83% of those studied) reportedly participated in SIAN. Of the participating children, 1258 received vitamin A (98% of SIAN participants; 82% of all eligible children), 945 received anti-helminth tablets (84% of participants; 71% of eligibles), and 669 were screened for acute malnutrition (52% of participants; 43% of eligibles). 186 of the children screened (27%) were reportedly identified as acutely malnourished. SIAN screening covered a significantly greater proportion of children than were examined in both community-based (22% of children) and health center-based screening activities (5% of children) combined during the 4-5 months after the SIAN (P<0.0001). In general, community volunteers and health personnel positively evaluated their experience adding MUAC screening to SIAN. Conclusion: Integrating MUAC screening for acute malnutrition in SIAN permits the assessment of a large number of children for acute malnutrition, and should be continued.	[Nyirandutiye, Daniele H.] US Congress, Hunger Ctr, Washington, DC USA; [Nyirandutiye, Daniele H.; Brown, Kenneth H.] Helen Keller Int, Reg Off Afr, Dakar, Senegal; [Iknane, Akory Ag] Inst Natl Rech Sante Publ, Bamako, Mali; [Fofana, Amadou] Cellule Planificat & Stat Sante, Bamako, Mali		Nyirandutiye, DH (corresponding author), US Congress, Hunger Ctr, Washington, DC USA.	kbrown@hki.org			The United States Agency for International Development/Office for Foreign Disaster Assistance [DFD-G-00-06-00203-01]; Richard and Rhoda Goldman Fund	The United States Agency for International Development/Office for Foreign Disaster Assistance(United States Agency for International Development (USAID)); Richard and Rhoda Goldman Fund	The study was supported by grants from The United States Agency for International Development/Office for Foreign Disaster Assistance under grant number DFD-G-00-06-00203-01, and the Richard and Rhoda Goldman Fund (http://www.goldmanfund.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayoya MA, 2007, PUBLIC HEALTH NUTR, V10, P1241, DOI 10.1017/S1368980007687138; Berger SG, 2007, J NUTR, V137, P1328, DOI 10.1093/jn/137.5.1328; BOUARE M, 2008, SEMAINE INTENSIFICAT; CIA, 2009, CIA WORLD FACTBOOK; Cogill B, 2003, ANTHROPOMETRIC INDIC; Fiedler JL, 2008, HEALTH POLICY PLANN, V23, P222, DOI 10.1093/heapol/czn015; *H KELL INT, 2008, INT SURV TREATM PREV; *MACR, 2006, DEM HLTH SURV MAL 20; *MICR IN H KELL IN, 2006, INT VIT A SUPPL CDTI; *MIN SANT DIV NUTR, 2008, RES SIAN; Standardized Monitoring Assessment of Relief Transitions (SMART), 2006, MEAS MORT NUTR STAT; *UNDP, 2008, UNDP HUM DEV IND UPD; Valid International, 2006, COMM BAS THER CAR CT; Wallace A, 2009, TROP MED INT HEALTH, V14, P11, DOI 10.1111/j.1365-3156.2008.02196.x	14	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e14818	10.1371/journal.pone.0014818	http://dx.doi.org/10.1371/journal.pone.0014818			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731602	Green Submitted, Green Published, gold			2022-12-27	WOS:000292035400002
J	Xin, ZT; Carroll, KA; Kumar, N; Song, K; Ly, H				Xin, Zhong-Tao; Carroll, Kathryn A.; Kumar, Naveen; Song, Kui; Ly, Hinh			Transcriptional Activation of TINF2, a Gene Encoding the Telomere-Associated Protein TIN2, by Sp1 and NF-kappa B Factors	PLOS ONE			English	Article							BINDING; TRF1; EXPRESSION; GROWTH; LENGTH; TRANSACTIVATION; DYSFUNCTION; METASTASIS; INHIBITORS; SHELTERIN	The expression of the telomere-associated protein TIN2 has been shown to be essential for early embryonic development in mice and for development of a variety of human malignancies. Recently, germ-line mutations in TINF2, which encodes for the TIN2 protein, have been identified in a number of patients with bone-marrow failure syndromes. Yet, the molecular mechanisms that regulate TINF2 expression are largely unknown. To elucidate the mechanisms involved in human TINF2 regulation, we cloned a 2.7 kb genomic DNA fragment containing the putative promoter region and, through deletion analysis, identified a 406 bp region that functions as a minimal promoter. This promoter proximal region is predicted to contain several putative Sp1 and NF-kappa B binding sites based on bioinformatic analysis. Direct binding of the Sp1 and NF-kappa B transcription factors to the TIN2 promoter sequence was demonstrated by electrophoretic mobility shift assay (EMSA) and/or chromatin immunoprecipitation (ChIP) assays. Transfection of a plasmid carrying the Sp1 transcription factor into Sp-deficient SL2 cells strongly activated TIN2 promoter-driven luciferase reporter expression. Similarly, the NF-kappa B molecules p50 and p65 were found to strongly activate luciferase expression in NF-kappa B knockout MEFs. Mutating the predicted transcription factor binding sites effectively reduced TIN2 promoter activity. Various known chemical inhibitors of Sp1 and NF-kappa B could also strongly inhibit TIN2 transcriptional activity. Collectively, our results demonstrate the important roles that Sp1 and NF-kappa B play in regulating the expression of the human telomere-binding protein TIN2, which can shed important light on its possible role in causing various forms of human diseases and cancers.	[Xin, Zhong-Tao; Carroll, Kathryn A.; Kumar, Naveen; Song, Kui; Ly, Hinh] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA	Emory University	Xin, ZT (corresponding author), Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA.	hly@emory.edu			NIH [T32 GM008490]; American Cancer Society [RSG-06-162-01-GMC]; Emory Winship Cancer Institute [NCI-P30CA138292]; Atlanta Clinical and Translational Science Institute and Emory University Research Committee (ACTSI-URC) [UL1RR025008]; NATIONAL CANCER INSTITUTE [P30CA138292] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008490] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Emory Winship Cancer Institute; Atlanta Clinical and Translational Science Institute and Emory University Research Committee (ACTSI-URC); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	K. A. C was supported in part by the NIH pre-doctoral training grant (T32 GM008490). This work was funded in part by a research scholar grant from the American Cancer Society (RSG-06-162-01-GMC) and seed grants from the Emory Winship Cancer Institute (NCI-P30CA138292) and the Atlanta Clinical and Translational Science Institute and Emory University Research Committee (ACTSI-URC) (UL1RR025008) to H. L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artandi SE, 2010, CARCINOGENESIS, V31, P9, DOI 10.1093/carcin/bgp268; Basseres DS, 2006, ONCOGENE, V25, P6817, DOI 10.1038/sj.onc.1209942; Baumann P, 2001, SCIENCE, V292, P1171, DOI 10.1126/science.1060036; Bellon M, 2006, INT J CANCER, V119, P2090, DOI 10.1002/ijc.22026; Bilaud T, 1997, NAT GENET, V17, P236, DOI 10.1038/ng1097-236; Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; Broccoli D, 1997, NAT GENET, V17, P231, DOI 10.1038/ng1097-231; Carroll KA, 2009, INT J CLIN EXP PATHO, V2, P528; Chan SS, 2010, FEBS LETT, V584, P3773, DOI 10.1016/j.febslet.2010.06.016; Chiang YJ, 2004, MOL CELL BIOL, V24, P6631, DOI 10.1128/mcb.24.15.6631-6634.2004; CHONG L, 1995, SCIENCE, V270, P1663, DOI 10.1126/science.270.5242.1663; Cong YS, 2000, J BIOL CHEM, V275, P35665, DOI 10.1074/jbc.C000637200; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Dittmer J, 1997, J BIOL CHEM, V272, P4953, DOI 10.1074/jbc.272.8.4953; DU HY, 2008, PEDIAT BLOOD CANC; EMILI A, 1994, MOL CELL BIOL, V14, P1582, DOI 10.1128/MCB.14.3.1582; HOEY T, 1993, CELL, V72, P247, DOI 10.1016/0092-8674(93)90664-C; Houghtaling BR, 2004, CURR BIOL, V14, P1621, DOI 10.1016/j.cub.2004.08.052; HU H, 2010, J CANC RES CLIN ONCO; Huang SY, 2002, AM J PATHOL, V161, P125, DOI 10.1016/S0002-9440(10)64164-8; Kaminker P, 2005, J CELL SCI, V118, P1321, DOI 10.1242/jcs.01709; Kaminker PG, 2009, CELL CYCLE, V8, P931, DOI 10.4161/cc.8.6.7941; Keith W Nicol, 2004, BMC Blood Disord, V4, P3, DOI 10.1186/1471-2326-4-3; Kim SH, 2008, J CELL BIOL, V181, P447, DOI 10.1083/jcb.200710028; Kim SH, 1999, NAT GENET, V23, P405, DOI 10.1038/70508; Kumar AP, 1999, CANCER LETT, V137, P159, DOI 10.1016/S0304-3835(98)00351-6; Kyo S, 2000, NUCLEIC ACIDS RES, V28, P669, DOI 10.1093/nar/28.3.669; Li BB, 2000, CELL, V101, P471, DOI 10.1016/S0092-8674(00)80858-2; MILLER DM, 1987, AM J MED SCI, V294, P388, DOI 10.1097/00000441-198711000-00015; Oh BK, 2005, AM J PATHOL, V166, P73, DOI 10.1016/S0002-9440(10)62233-X; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; Pore N, 2004, MOL BIOL CELL, V15, P4841, DOI 10.1091/mbc.E04-05-0374; PUGH BF, 1991, GENE DEV, V5, P1935, DOI 10.1101/gad.5.11.1935; RAY R, 1989, J CLIN INVEST, V83, P2003, DOI 10.1172/JCI114110; Savage SA, 2008, AM J HUM GENET, V82, P501, DOI 10.1016/j.ajhg.2007.10.004; SCHRECK R, 1992, J EXP MED, V175, P1181, DOI 10.1084/jem.175.5.1181; Sinha-Datta U, 2004, BLOOD, V104, P2523, DOI 10.1182/blood-2003-12-4251; Sovak MA, 1997, J CLIN INVEST, V100, P2952, DOI 10.1172/JCI119848; Teo HL, 2010, NAT CELL BIOL, V12, P758, DOI 10.1038/ncb2080; Trejo SR, 1997, J BIOL CHEM, V272, P27411, DOI 10.1074/jbc.272.43.27411; Tsangaris E, 2008, HUM GENET, V124, P507, DOI 10.1007/s00439-008-0576-7; Walne AJ, 2008, BLOOD, V112, P3594, DOI 10.1182/blood-2008-05-153445; Weaver VM, 2002, CANCER CELL, V2, P205, DOI 10.1016/S1535-6108(02)00125-3; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Yamada K, 2002, ANTICANCER RES, V22, P1315; Yamada M, 2002, ANTICANCER RES, V22, P3303; Ye JZS, 2004, NAT GENET, V36, P618, DOI 10.1038/ng1360; ZHONG Z, 1992, MOL CELL BIOL, V12, P4834, DOI 10.1128/MCB.12.11.4834	48	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21333	10.1371/journal.pone.0021333	http://dx.doi.org/10.1371/journal.pone.0021333			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731707	Green Published, gold, Green Submitted			2022-12-27	WOS:000292035400024
J	Telldahl, Y; Svensson, E; Gotherstrom, A; Stora, J				Telldahl, Ylva; Svensson, Emma; Gotherstrom, Anders; Stora, Jan			Typing Late Prehistoric Cows and Bulls-Osteology and Genetics of Cattle at the Eketorp Ringfort on the Oland Island in Sweden	PLOS ONE			English	Article							POPULATION-STRUCTURE; NEAR-EAST; GENOME	Human management of livestock and the presence of different breeds have been discussed in archaeozoology and animal breeding. Traditionally osteometrics has been the main tool in addressing these questions. We combine osteometrics with molecular sex identifications of 104 of 340 morphometrically analysed bones in order to investigate the use of cattle at the Eketorp ringfort on the Oland island in Sweden. The fort is dated to 300-1220/50 A. D., revealing three different building phases. In order to investigate specific patterns and shifts through time in the use of cattle the genetic data is evaluated in relation to osteometric patterns and occurrence of pathologies on cattle metapodia. Males were genotyped for a Y-chromosomal SNP in UTY19 that separates the two major haplogroups, Y1 and Y2, in taurine cattle. A subset of the samples were also genotyped for one SNP involved in coat coloration (MC1R), one SNP putatively involved in resistance to cattle plague (TLR4), and one SNP in intron 5 of the IGF-1 gene that has been associated to size and reproduction. The results of the molecular analyses confirm that the skeletal assemblage from Eketorp is dominated by skeletal elements from females, which implies that dairying was important. Pathological lesions on the metapodia were classified into two groups; those associated with the use as draught animals and those lesions without a similar aetiology. The results show that while bulls both exhibit draught related lesions and other types of lesions, cows exhibit other types of lesions. Interestingly, a few elements from females exhibit draught related lesions. We conclude that this reflects the different use of adult female and male cattle. Although we note some variation in the use of cattle at Eketorp between Iron Age and Medieval time we have found little evidence for the use of different types of animals for specific purposes. The use of specific (genetic) breeds seems to be a phenomenon that developed later than the Eketorp settlement.	[Telldahl, Ylva; Stora, Jan] Stockholm Univ, Dept Archaeol & Class Studies, Osteoarchaeol Res Lab, S-10691 Stockholm, Sweden; [Svensson, Emma; Gotherstrom, Anders] Uppsala Univ, Dept Evolutionary Biol, Uppsala, Sweden	Stockholm University; Uppsala University	Telldahl, Y (corresponding author), Stockholm Univ, Dept Archaeol & Class Studies, Osteoarchaeol Res Lab, S-10691 Stockholm, Sweden.	ylva.telldahl@ofl.su.se		Gotherstrom, Anders/0000-0001-8579-1304; Svensson, Emma/0000-0002-4349-849X	Birgit Gad Rausing; Helge Ax:son Johnsson stiftelsen, P o Lundells, Lars Hiertas Minne; Berit Wallenbergs Stiftelse; Birgit and Gad Rausings stiftelse; Royal Swedish Academy of Science	Birgit Gad Rausing; Helge Ax:son Johnsson stiftelsen, P o Lundells, Lars Hiertas Minne; Berit Wallenbergs Stiftelse; Birgit and Gad Rausings stiftelse; Royal Swedish Academy of Science	Financial support to Emma Svensson from Birgit & Gad Rausing and Helge Ax:son Johnsson stiftelsen, P o Lundells, Lars Hiertas Minne. Financial support was received from Berit Wallenbergs Stiftelse and Birgit and Gad Rausings stiftelse to Ylva Telldahl. Anders Gotherstrom was supported by the Royal Swedish Academy of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBARELLA U, 1999, MEDIEVAL SETTLEMENT, V9, P16; Albarella U, 2008, J ARCHAEOL SCI, V35, P1828, DOI 10.1016/j.jas.2007.11.016; AXELSSON M, 2000, BONE SPAVIN CLIN EPI; BARTOSIEWICZ L, 1997, ANN MUSEE ROYAL PAFR; Beg MA, 2002, BIOL REPROD, V66, P120, DOI 10.1095/biolreprod66.1.120; BENECKE N, 1994, OZOOLOGISCHE STUDIEN; Boessneck J., 1979, EKETORP BEFESTIGUNG; BORG K, 2000, MEDELTIDSARKEOLOGISK; BORG K, 1976, EKETORP FORTIFICATIO; Bunter KL, 2005, AUST J EXP AGR, V45, P783, DOI 10.1071/EA05048; CSERHALMI N, 1998, FARAD MARK HDB TOLKN; Davis ME, 2006, J ANIM SCI, V84, P2299, DOI 10.2527/jas.2005-567; De Cupere B, 2000, INT J OSTEOARCHAEOL, V10, P254, DOI 10.1002/1099-1212(200007/08)10:4<254::AID-OA528>3.0.CO;2-#; Flori L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006595; Gagneux P, 1997, MOL ECOL, V6, P861, DOI 10.1111/j.1365-294X.1997.tb00140.x; Ginther OJ, 2004, BIOL REPROD, V70, P99, DOI 10.1095/biolreprod.103.021949; Gotherstrom A, 2005, P ROY SOC B-BIOL SCI, V272, P2345, DOI 10.1098/rspb.2005.3243; HABERMEHL KH, 1961, ALTERSBESTIMMUNG BEI; Herschend F., 2009, EARLY IRON AGE S SCA; Hoerr NL., 1956, BLAKISTONS NEW GOULD; Kantanen J, 2000, J HERED, V91, P446, DOI 10.1093/jhered/91.6.446; KLUNGLAND H, 1995, MAMM GENOME, V6, P636, DOI 10.1007/BF00352371; Lien S, 2000, MAMM GENOME, V11, P877, DOI 10.1007/s003350010180; Mckay SD, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-37; MENNERICH G, 1968, ROMERZEITLICHE TIERK; Meuwissen THE, 2002, GENETICS, V161, P373; MYRDAL J, 1985, MEDELTIDENS KERBRUK; Myrdal J., 1999, JORDBRUKET FEODALISM; NASMAN U, 1981, BORGENES O SKAL, V1, P19; NASMAN U, 1976, EKETORP FORTIFICATIO; NORKJAER NJ, 2006, ENV ARCHAEOLOGY, V11, P35; Olausson, 1999, SPIRALENS OGA TJUGO, P291; PEDERSEN EA, 1998, SVENSKA JORDBRUKETS, P239; Pellecchia M, 2007, P R SOC B, V274, P1175, DOI 10.1098/rspb.2006.0258; Qanbari S, 2010, ANIM GENET, V41, P377, DOI 10.1111/j.1365-2052.2009.02016.x; Roberts C., 1997, ARCHAEOLOGY DIS; Schlumbaum A, 2006, ANIM GENET, V37, P373, DOI 10.1111/j.1365-2052.2006.01435.x; Schlumbaum A, 2003, ANTIQUITY, V77, P298; SCHMID E, 1972, ATLAS ANIMAL BONES F; Silver I.A, 1969, SCI ARCHAEOLOGY SURV, V2nd, P283; Svensson EM, 2007, ANIM GENET, V38, P378, DOI 10.1111/j.1365-2052.2007.01620.x; Svensson E, 2008, BIOL LETTERS, V4, P752, DOI 10.1098/rsbl.2008.0342; Svensson EM, 2008, J ARCHAEOL SCI, V35, P942, DOI 10.1016/j.jas.2007.06.021; SWEENEY Del, 1995, AGR MIDDLE AGES TECH; Telldahl Y, 2005, Diet and Health in Past Animal Populations: Current Research and Future Directions, P63; Von Den Driesch A., 1976, GUIDE MEASUREMENT AN; White SN, 2003, MAMM GENOME, V14, P149, DOI 10.1007/s00335-002-2213-4; Wiener P, 2004, HEREDITY, V93, P597, DOI 10.1038/sj.hdy.6800566; ZIMMERMANN W, 1988, SETTL LANDSC P C ARH	49	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e20748	10.1371/journal.pone.0020748	http://dx.doi.org/10.1371/journal.pone.0020748			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731623	Green Published, gold, Green Submitted			2022-12-27	WOS:000292033700015
J	Allard, M; Oger, R; Vignard, V; Percier, JM; Fregni, G; Perier, A; Caignard, A; Charreau, B; Bernardeau, K; Khammari, A; Dreno, B; Gervois, N				Allard, Mathilde; Oger, Romain; Vignard, Virginie; Percier, Jean-Michel; Fregni, Giulia; Perier, Aurelie; Caignard, Anne; Charreau, Beatrice; Bernardeau, Karine; Khammari, Amir; Dreno, Brigitte; Gervois, Nadine			Serum Soluble HLA-E in Melanoma: A New Potential Immune-Related Marker in Cancer	PLOS ONE			English	Article							PROVIDE TUMOR-CELLS; LEUKOCYTE ANTIGEN-G; CLASS-I MOLECULES; T-LYMPHOCYTES; MALIGNANT DISEASES; COLORECTAL-CANCER; ESCAPE MECHANISMS; IFN-GAMMA; NK CELLS; EXPRESSION	Background: Tumor-derived soluble factors, including soluble HLA molecules, can contribute to cancer immune escape and therefore impact on clinical course of malignant diseases. We previously reported that melanoma cells produce, in vitro, soluble forms of the non-classical MHC class I molecule HLA-E (sHLA-E). In order to investigate sHLA-E production by various tumors and to address its potential value as a tumor-associated marker, we developed a specific ELISA for the quantification of sHLA-E in biological fluids. Methodology/Principal Findings: We developed a sHLA-E specific and sensitive ELISA and we showed that serum sHLA-E levels were significantly elevated (P<0.01) in melanoma patients (n=127), compared with healthy donors (n=94). sHLA-E was also detected in the culture supernatants of a wide variety of tumor cell lines (n=98) including melanomas, kidney, colorectal and breast cancers. Cytokines regulation of sHLA-E production by tumor cells was also carried out. IFN-gamma, IFN-alpha and TNF-alpha were found to upregulate sHLA-E production by tumor cells. Conclusions/Significance: In view of the broad tumor tissue release of HLA-E and its up-regulation by inflammatory cytokines, sHLA-E should be studied for its involvement in immune responses against tumors. Interestingly, our results demonstrated a positive association between the presence of serum sHLA-E and melanoma. Therefore, the determination of sHLA-E levels, using ELISA approach, may be investigated as a clinical marker in cancer patients.	[Allard, Mathilde; Oger, Romain; Vignard, Virginie; Percier, Jean-Michel; Khammari, Amir; Dreno, Brigitte; Gervois, Nadine] INSERM, UMR, U892, Nantes, France; [Allard, Mathilde; Oger, Romain; Gervois, Nadine] Univ Nantes, Fac Sci, Nantes, France; [Fregni, Giulia; Perier, Aurelie; Caignard, Anne] Univ Paris 05, Inst Cochin, INSERM, CNRS,UMR 8104,U1016, Paris, France; [Charreau, Beatrice] INSERM, UMR, U643, Nantes, France; [Bernardeau, Karine] Recombinant Prot Prod Facil IFR 26, Nantes, France; [Khammari, Amir; Dreno, Brigitte] Ctr Hosp Univ Nantes, Unit Skin Canc, Nantes, France; [Khammari, Amir; Dreno, Brigitte] Ctr Hosp Univ Nantes, GMP Unit Cellular Therapy, Nantes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes	Allard, M (corresponding author), INSERM, UMR, U892, Nantes, France.	ngervois@nantes.inserm.fr	CHARREAU, Beatrice/AAK-8186-2020; OGER, Romain/K-7423-2015; Gervois, Nadine/K-6658-2015; Vignard, Virginie/K-7540-2015; Caignard, Anne/F-8159-2013; allard, mathilde/C-9577-2018	CHARREAU, Beatrice/0000-0001-5870-4615; Gervois, Nadine/0000-0002-0092-3919; Vignard, Virginie/0000-0002-6702-2824; Caignard, Anne/0000-0001-9923-6045; allard, mathilde/0000-0002-2217-1295; OGER, Romain/0000-0001-5012-6099	Ligue Nationale contre le Cancer	Ligue Nationale contre le Cancer(Ligue nationale contre le cancer)	This work was supported by grants awarded by the "Ligue Nationale contre le Cancer'' (labellisation 2007). The funder has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algarra I, 2004, CANCER IMMUNOL IMMUN, V53, P904, DOI 10.1007/s00262-004-0517-9; Arreygue-Garcia NA, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-16; Bahri R, 2006, J IMMUNOL, V176, P1331, DOI 10.4049/jimmunol.176.3.1331; Bainbridge DRJ, 2000, J REPROD IMMUNOL, V48, P17, DOI 10.1016/S0165-0378(00)00070-X; Bangia N, 2006, IMMUNOL INVEST, V35, P485, DOI 10.1080/08820130600808246; Bracarda S, 2011, BJU INT, V107, P214, DOI 10.1111/j.1464-410X.2010.09707.x; Campoli M, 2008, ONCOGENE, V27, P5869, DOI 10.1038/onc.2008.273; Campoli M, 2008, TISSUE ANTIGENS, V72, P321, DOI 10.1111/j.1399-0039.2008.01106.x; Contini P, 2003, EUR J IMMUNOL, V33, P125, DOI 10.1002/immu.200390015; Coupel S, 2007, BLOOD, V109, P2806, DOI 10.1182/blood-2006-06-030213; Derre L, 2002, J IMMUNOL, V168, P4864, DOI 10.4049/jimmunol.168.10.4864; Derre L, 2006, J IMMUNOL, V177, P3100, DOI 10.4049/jimmunol.177.5.3100; Fournel S, 2000, J IMMUNOL, V164, P6100, DOI 10.4049/jimmunol.164.12.6100; Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112; Gros F, 2008, EUR J IMMUNOL, V38, P742, DOI 10.1002/eji.200736918; Holdenrieder S, 2006, INT J CANCER, V118, P684, DOI 10.1002/ijc.21382; Holdenrieder S, 2006, CANCER IMMUNOL IMMUN, V55, P1584, DOI 10.1007/s00262-006-0167-1; Kholmanskikh O, 2010, INT J CANCER, V127, P1625, DOI 10.1002/ijc.25182; Kim R, 2007, IMMUNOLOGY, V121, P1, DOI 10.1111/j.1365-2567.2007.02587.x; Le Drean E, 1998, EUR J IMMUNOL, V28, P264, DOI 10.1002/(SICI)1521-4141(199801)28:01<264::AID-IMMU264>3.0.CO;2-O; Levy EM, 2008, INT J ONCOL, V32, P633, DOI 10.3892/ijo.32.3.633; Malmberg KJ, 2002, J CLIN INVEST, V110, P1515, DOI 10.1172/JC1200215564; Marin R, 2003, IMMUNOGENETICS, V54, P767, DOI 10.1007/s00251-002-0526-9; Michelin S, 2009, HUM IMMUNOL, V70, P1010, DOI 10.1016/j.humimm.2009.07.030; PERIER A, 2011, ONCOGENE; Rebmann V, 2003, SEMIN CANCER BIOL, V13, P371, DOI 10.1016/S1044-579X(03)00028-2; Rebmann V, 2007, SEMIN CANCER BIOL, V17, P430, DOI 10.1016/j.semcancer.2007.06.011; Rebmann V, 2007, SEMIN CANCER BIOL, V17, P422, DOI 10.1016/j.semcancer.2007.06.010; Rouas-Freiss N, 2005, CANCER RES, V65, P10139, DOI 10.1158/0008-5472.CAN-05-0097; RouasFreiss N, 1997, P NATL ACAD SCI USA, V94, P11520, DOI 10.1073/pnas.94.21.11520; Schutt P, 2010, HUM IMMUNOL, V71, P489, DOI 10.1016/j.humimm.2010.02.015; Sebti Y, 2003, HUM IMMUNOL, V64, P1093, DOI 10.1016/j.humimm.2003.08.345; Seliger B, 2003, TRENDS IMMUNOL, V24, P82, DOI 10.1016/S1471-4906(02)00039-X; Singer G, 2003, CLIN CANCER RES, V9, P4460; Speiser DE, 1999, J EXP MED, V190, P775, DOI 10.1084/jem.190.6.775; Sprague AH, 2009, BIOCHEM PHARMACOL, V78, P539, DOI 10.1016/j.bcp.2009.04.029; Tabayoyong WB, 2007, LEUKEMIA RES, V31, P121, DOI 10.1016/j.leukres.2006.06.008; Ugurel S, 2001, CANCER, V92, P369, DOI 10.1002/1097-0142(20010715)92:2<369::AID-CNCR1332>3.0.CO;2-U; Yeruva S, 2008, INT J COLORECTAL DIS, V23, P305, DOI 10.1007/s00384-007-0396-6; Zhang MH, 2009, TRANSPLANTATION, V87, P8, DOI 10.1097/TP.0b013e31818b6141; Zhu CB, 2011, INT J CANCER, V128, P617, DOI 10.1002/ijc.25372	41	39	44	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2011	6	6							e21118	10.1371/journal.pone.0021118	http://dx.doi.org/10.1371/journal.pone.0021118			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782CL	21712991	Green Published, Green Submitted, gold			2022-12-27	WOS:000291985100012
J	Gonzaga, VE; Ramos, M; Maves, RC; Freeman, R; Montgomery, JM				Gonzaga, Victor E.; Ramos, Mariana; Maves, Ryan C.; Freeman, Randal; Montgomery, Joel M.			Concurrent Outbreak of Norovirus Genotype I and Enterotoxigenic Escherichia coli on a US Navy Ship following a Visit to Lima, Peru	PLOS ONE			English	Article							VIRUS-INFECTION; UNITED-STATES; GASTROENTERITIS; TRAVELERS; DIARRHEA; DISEASE; PCR	An outbreak of norovirus (NoV) genotype I and Enterotoxigenic Escherichia coli (ETEC) occurred among US Navy Ship personnel following a visit to Lima, Peru, in June 2008. Visiting a specific area in Lima was significantly associated with illness. While ETEC and NoV are commonly recognized as causative agents of outbreaks, co-circulation of both pathogens has been rarely observed in shipboard outbreaks.	[Gonzaga, Victor E.; Ramos, Mariana; Maves, Ryan C.; Montgomery, Joel M.] United States Naval Med Res Unit Six NAMRU 6, Lima, Peru; [Freeman, Randal] USA, El Paso, TX USA		Gonzaga, VE (corresponding author), United States Naval Med Res Unit Six NAMRU 6, Lima, Peru.	jmontgomery@ke.cdc.gov	Maves, Ryan C/AGG-3988-2022	Maves, Ryan C/0000-0001-6234-6160	AFHSC-GEIS [847705 82000 25GB B0016]	AFHSC-GEIS	This study was supported by grant AFHSC-GEIS, work unit number 847705 82000 25GB B0016. The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the Department of the Navy, Department of Defense, nor the U. S. Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apelt N, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-131; Castilho JG, 2006, J CLIN MICROBIOL, V44, P3947, DOI 10.1128/JCM.00279-06; CDC, 2010, NOR TECHN FACT SHEET; Ferreira MSR, 2008, J MED VIROL, V80, P338, DOI 10.1002/jmv.21059; GALENO H, GASTROINTESTINAL DIS; Guion CE, 2008, J CLIN MICROBIOL, V46, P1752, DOI 10.1128/JCM.02341-07; Ko GP, 2005, J CLIN MICROBIOL, V43, P6126, DOI 10.1128/JCM.43.12.6126-6129.2005; LEVINE MM, 1980, AM J EPIDEMIOL, V111, P347, DOI 10.1093/oxfordjournals.aje.a112906; McCarthy M, 2000, J INFECT DIS, V181, pS387, DOI 10.1086/315582; Olsen K.E., 2010, EURO SURVEILL    JAN; Thornton S, 2002, MIL MED, V167, P826, DOI 10.1093/milmed/167.10.826; Trujillo AA, 2006, J CLIN MICROBIOL, V44, P1405, DOI 10.1128/JCM.44.4.1405-1412.2006; Vidal R, 2005, EMERG INFECT DIS, V11, P1134, DOI 10.3201/eid1107.041062; Widdowson MA, 2005, EMERG INFECT DIS, V11, P95, DOI 10.3201/eid1101.040426	14	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2011	6	6							e20822	10.1371/journal.pone.0020822	http://dx.doi.org/10.1371/journal.pone.0020822			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782CL	21713034	Green Submitted, Green Published, gold			2022-12-27	WOS:000291985100005
J	Bhattacharya, S; Zhang, Q; Carmichael, PL; Boekelheide, K; Andersen, ME				Bhattacharya, Sudin; Zhang, Qiang; Carmichael, Paul L.; Boekelheide, Kim; Andersen, Melvin E.			Toxicity Testing in the 21(st) Century: Defining New Risk Assessment Approaches Based on Perturbation of Intracellular Toxicity Pathways	PLOS ONE			English	Article							DISCRIMINATE RODENT CARCINOGENS; INCOHERENT FEEDFORWARD LOOP; VITRO GENOTOXICITY TESTS; CELL-CYCLE ARREST; IN-VITRO; DOSE-RESPONSE; REGULATORY NETWORKS; GENE-EXPRESSION; DNA-DAMAGE; STEM-CELLS	The approaches to quantitatively assessing the health risks of chemical exposure have not changed appreciably in the past 50 to 80 years, the focus remaining on high-dose studies that measure adverse outcomes in homogeneous animal populations. This expensive, low-throughput approach relies on conservative extrapolations to relate animal studies to much lower-dose human exposures and is of questionable relevance to predicting risks to humans at their typical low exposures. It makes little use of a mechanistic understanding of the mode of action by which chemicals perturb biological processes in human cells and tissues. An alternative vision, proposed by the U.S. National Research Council (NRC) report Toxicity Testing in the 21(st) Century: A Vision and a Strategy, called for moving away from traditional high-dose animal studies to an approach based on perturbation of cellular responses using well-designed in vitro assays. Central to this vision are (a) "toxicity pathways" (the innate cellular pathways that may be perturbed by chemicals) and (b) the determination of chemical concentration ranges where those perturbations are likely to be excessive, thereby leading to adverse health effects if present for a prolonged duration in an intact organism. In this paper we briefly review the original NRC report and responses to that report over the past 3 years, and discuss how the change in testing might be achieved in the U.S. and in the European Union (EU). EU initiatives in developing alternatives to animal testing of cosmetic ingredients have run very much in parallel with the NRC report. Moving from current practice to the NRC vision would require using prototype toxicity pathways to develop case studies showing the new vision in action. In this vein, we also discuss how the proposed strategy for toxicity testing might be applied to the toxicity pathways associated with DNA damage and repair.	[Bhattacharya, Sudin; Zhang, Qiang; Andersen, Melvin E.] Hamner Inst Hlth Sci, Program Chem Safety Sci, Res Triangle Pk, NC 27709 USA; [Carmichael, Paul L.] Unilever, Safety & Environm Assurance Ctr, Bedford, England; [Boekelheide, Kim] Brown Univ, Dept Pathol & Lab Med, Providence, RI 02912 USA	The Hamner Institutes for Health Sciences; Unilever; Brown University	Bhattacharya, S (corresponding author), Hamner Inst Hlth Sci, Program Chem Safety Sci, Res Triangle Pk, NC 27709 USA.	MAndersen@thehamner.org	Andersen, Melvin/S-6646-2019; Andersen, Melvin E/K-5179-2012; Bhattacharya, Sudin/AAA-2454-2022	Andersen, Melvin/0000-0002-3894-4811; Andersen, Melvin E/0000-0002-3894-4811; Bhattacharya, Sudin/0000-0002-2360-1672; Carmichael, Paul/0000-0003-1353-9032	Long-Range Research Initiative of the American Chemistry Council (ACC-LRI); Exxon-Mobil Research Foundation, Unilever; Superfund Research Program [P42ES04911, P42ES013660]; U.S. National Institute of Environmental Health Sciences; Exxon-Mobil Research Foundation; American Chemistry Council; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES004911, P42ES013660] Funding Source: NIH RePORTER	Long-Range Research Initiative of the American Chemistry Council (ACC-LRI); Exxon-Mobil Research Foundation, Unilever; Superfund Research Program; U.S. National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Exxon-Mobil Research Foundation; American Chemistry Council; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded by The Long-Range Research Initiative of the American Chemistry Council (ACC-LRI), the Exxon-Mobil Research Foundation, Unilever, and the Superfund Research Program grants P42ES04911 (SB, QZ and MEA) and P42ES013660 (KB). With the exception of Unilever who employ Paul Carmichael, the funders had no role in the focus of this review, the decision of examples to emphasize, the decision to publish, or in preparation of the manuscript.; We gratefully acknowledge support from the Superfund Research Program of the U.S. National Institute of Environmental Health Sciences, the Exxon-Mobil Research Foundation, and the American Chemistry Council.	Agami R, 2000, CELL, V102, P55, DOI 10.1016/S0092-8674(00)00010-6; Ahn J, 2002, J BIOL CHEM, V277, P48418, DOI 10.1074/jbc.M208321200; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Andersen ME, 2010, TOXICOL SCI, V117, P17, DOI 10.1093/toxsci/kfq188; Andersen ME, 2010, J TOXICOL ENV HEAL B, V13, P163, DOI 10.1080/10937404.2010.483933; Andersen ME, 2009, TOXICOL SCI, V107, P324, DOI 10.1093/toxsci/kfn255; Araujo RP, 2007, NAT REV DRUG DISCOV, V6, P871, DOI 10.1038/nrd2381; Batchelor E, 2008, MOL CELL, V30, P277, DOI 10.1016/j.molcel.2008.03.016; Batchelor E, 2009, NAT REV CANCER, V9, P371, DOI 10.1038/nrc2604; Beerenwinkel N, 2007, PLOS COMPUT BIOL, V3, P2239, DOI 10.1371/journal.pcbi.0030225; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; Blaauboer BJ, 2010, J TOXICOL ENV HEAL B, V13, P242, DOI 10.1080/10937404.2010.483940; Boekelheide K, 2010, TOXICOL SCI, V114, P20, DOI 10.1093/toxsci/kfp307; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Bus JS, 2009, TOXICOL SCI, V112, P297, DOI 10.1093/toxsci/kfp234; Chapin RE, 2009, TOXICOL SCI, V112, P17, DOI 10.1093/toxsci/kfp202; Chipuk JE, 2006, CELL DEATH DIFFER, V13, P994, DOI 10.1038/sj.cdd.4401908; Clewell HJ, 2008, TOXICOL APPL PHARM, V231, P122, DOI 10.1016/j.taap.2008.04.021; Collins FS, 2008, SCIENCE, V319, P906, DOI 10.1126/science.1154619; Danna EA, 2006, CURR OPIN CHEM BIOL, V10, P20, DOI 10.1016/j.cbpa.2005.12.021; Dellarco V, 2010, J TOXICOL ENV HEAL B, V13, P347, DOI 10.1080/10937404.2010.483950; Doak SH, 2007, CANCER RES, V67, P3904, DOI 10.1158/0008-5472.CAN-06-4061; ENOCH T, 1995, TRENDS BIOCHEM SCI, V20, P426, DOI 10.1016/S0968-0004(00)89093-3; Fentem J, 2004, ATLA-ALTERN LAB ANIM, V32, P617, DOI 10.1177/026119290403200612; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Firestone M, 2010, J TOXICOL ENV HEAL B, V13, P139, DOI 10.1080/10937404.2010.483178; Geva-Zatorsky N, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100068; Giono LE, 2006, J CELL PHYSIOL, V209, P13, DOI 10.1002/jcp.20689; Hartung T, 2010, J TOXICOL ENV HEAL B, V13, P277, DOI 10.1080/10937404.2010.483945; Hartung T, 2009, TOXICOL SCI, V109, P18, DOI 10.1093/toxsci/kfp059; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Holsapple MP, 2009, TOXICOL SCI, V107, P307, DOI 10.1093/toxsci/kfn258; Hubal EAC, 2010, J TOXICOL ENV HEAL B, V13, P299, DOI 10.1080/10937404.2010.483947; Judson R, 2010, J TOXICOL ENV HEAL B, V13, P218, DOI 10.1080/10937404.2010.483937; Kaplan S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.43; Kavlock R, 2010, J TOXICOL ENV HEAL B, V13, P197, DOI 10.1080/10937404.2010.483935; Kirkland D, 2005, MUTAT RES-GEN TOX EN, V584, P1, DOI 10.1016/j.mrgentox.2005.02.004; Kirkland D, 2007, MUTAT RES-GEN TOX EN, V628, P31, DOI 10.1016/j.mrgentox.2006.11.008; Kirkland D, 2006, MUTAT RES-GEN TOX EN, V608, P29, DOI 10.1016/j.mrgentox.2006.04.017; Krewski D, 2010, J TOXICOL ENV HEAL B, V13, P51, DOI 10.1080/10937404.2010.483176; Kultz D, 2005, ANNU REV PHYSIOL, V67, P225, DOI 10.1146/annurev.physiol.67.040403.103635; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Locke PA, 2010, J TOXICOL ENV HEAL B, V13, P376, DOI 10.1080/10937404.2010.483952; Loewer A, 2010, CELL, V142, P89, DOI 10.1016/j.cell.2010.05.031; Ma WZ, 2009, CELL, V138, P760, DOI 10.1016/j.cell.2009.06.013; MacDonald JS, 2009, TOXICOL SCI, V110, P40, DOI 10.1093/toxsci/kfp088; Mangan S, 2006, J MOL BIOL, V356, P1073, DOI 10.1016/j.jmb.2005.12.003; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Mangan S, 2003, J MOL BIOL, V334, P197, DOI 10.1016/j.jmb.2003.09.049; Meek B, 2009, TOXICOL SCI, V108, P19, DOI 10.1093/toxsci/kfp008; National Research Council, 2007, TOXICITY TESTING 21; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Pauwels M, 2004, TOXICOL LETT, V151, P7, DOI 10.1016/j.toxlet.2004.01.026; REIF D, 2010, ENV HLTH PERSPECT; Rhomberg LR, 2010, J TOXICOL ENV HEAL B, V13, P361, DOI 10.1080/10937404.2010.483951; Rietjens IMCM, 2005, MUTAT RES-FUND MOL M, V574, P124, DOI 10.1016/j.mrfmmm.2005.01.028; Rosenfeld N, 2002, J MOL BIOL, V323, P785, DOI 10.1016/S0022-2836(02)00994-4; Rothenberg EV, 2007, NAT IMMUNOL, V8, P441, DOI 10.1038/ni1461; Rotroff DM, 2010, J TOXICOL ENV HEAL B, V13, P329, DOI 10.1080/10937404.2010.483949; Schoeters G, 2010, J TOXICOL ENV HEAL B, V13, P232, DOI 10.1080/10937404.2010.483938; Seo YR, 2004, EXP MOL MED, V36, P505, DOI 10.1038/emm.2004.64; Shah I, 2010, J TOXICOL ENV HEAL B, V13, P314, DOI 10.1080/10937404.2010.483948; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Simmons SO, 2009, TOXICOL SCI, V111, P202, DOI 10.1093/toxsci/kfp140; Singh SV, 2004, J BIOL CHEM, V279, P25813, DOI 10.1074/jbc.M313538200; Stephens ML, 2010, J TOXICOL ENV HEAL B, V13, P291, DOI 10.1080/10937404.2010.483946; SWENBERG JA, 1987, ENVIRON HEALTH PERSP, V76, P57, DOI 10.2307/3430465; Swiers G, 2006, DEV BIOL, V294, P525, DOI 10.1016/j.ydbio.2006.02.051; Tan YM, 2007, J EXPO SCI ENV EPID, V17, P591, DOI 10.1038/sj.jes.7500540; Tweats DJ, 2007, MUTAGENESIS, V22, P5, DOI 10.1093/mutage/gel052; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; U.S.EPA, 2009, EPA100K09001; Utesch D, 2008, MUTAT RES-GEN TOX EN, V654, P38, DOI 10.1016/j.mrgentox.2008.04.008; Walker NJ, 2009, TOXICOL SCI, V110, P251, DOI 10.1093/toxsci/kfp106; Williams GM, 2001, TOXICOLOGY, V166, P3, DOI 10.1016/S0300-483X(01)00442-5; Zhang Q, 2007, PLOS COMPUT BIOL, V3, P345, DOI 10.1371/journal.pcbi.0030024; Zhang QA, 2010, J TOXICOL ENV HEAL B, V13, P253, DOI 10.1080/10937404.2010.483943	78	137	142	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e20887	10.1371/journal.pone.0020887	http://dx.doi.org/10.1371/journal.pone.0020887			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	21701582	Green Published, Green Submitted, gold			2022-12-27	WOS:000291983800013
J	Guillemaud, T; Blin, A; Simon, S; Morel, K; Franck, P				Guillemaud, Thomas; Blin, Aurelie; Simon, Sylvaine; Morel, Karine; Franck, Pierre			Weak Spatial and Temporal Population Genetic Structure in the Rosy Apple Aphid, Dysaphis plantaginea, in French Apple Orchards	PLOS ONE			English	Article							CROSS-SPECIES AMPLIFICATION; PEACH-POTATO APHID; INSECTICIDE RESISTANCE; MICROSATELLITE LOCI; AUTUMN KAOLIN; HOST RACES; CULTIVARS; HOMOPTERA; PASSERINI; SOFTWARE	We used eight microsatellite loci and a set of 20 aphid samples to investigate the spatial and temporal genetic structure of rosy apple aphid populations from 13 apple orchards situated in four different regions in France. Genetic variability was very similar between orchard populations and between winged populations collected before sexual reproduction in the fall and populations collected from colonies in the spring. A very small proportion of individuals (similar to 2%) had identical multilocus genotypes. Genetic differentiation between orchards was low (F-ST<0.026), with significant differentiation observed only between orchards from different regions, but no isolation by distance was detected. These results are consistent with high levels of genetic mixing in holocyclic Dysaphis plantaginae populations (host alternation through migration and sexual reproduction). These findings concerning the adaptation of the rosy apple aphid have potential consequences for pest management.	[Guillemaud, Thomas; Blin, Aurelie] IBSV INRA UNSA CNRS, Equipe Biol Populat Interact, UMR 1301, Sophia Antipolis, France; [Franck, Pierre] INRA, Plantes & Syst Culture Horticoles UR1115, Avignon, France; [Simon, Sylvaine; Morel, Karine] INRA, Rech Integree UE695, Domaine De Gotheron, St Marcel Valen, France	Centre National de la Recherche Scientifique (CNRS); INRAE; INRAE; INRAE	Guillemaud, T (corresponding author), IBSV INRA UNSA CNRS, Equipe Biol Populat Interact, UMR 1301, Sophia Antipolis, France.	guillem@sophia.inra.fr	guillemaud, thomas/B-4899-2012	guillemaud, thomas/0000-0003-0451-1644; Franck, Pierre/0000-0002-1904-8325	French Program ECOGER [AO 2005]	French Program ECOGER	This work was funded by the French Program ECOGER AO 2005. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeli G, 2006, J PEST SCI, V79, P175, DOI 10.1007/s10340-006-0129-6; Arnaud-Haond S, 2007, MOL ECOL NOTES, V7, P15, DOI 10.1111/j.1471-8286.2006.01522.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blackman R.L., 1981, P75; Blommers LHM, 2004, J PEST SCI, V77, P155, DOI 10.1007/s10340-004-0046-5; Bonnemaison L., 1959, Annales des Epiphyties Paris (C), V10, P257; BONNEMAISON L, 1961, ENNEMIS ANNIMAUX PLA, P1; Brown MW, 2007, ENVIRON ENTOMOL, V36, P1131, DOI 10.1603/0046-225X(2007)36[1131:CBCORA]2.0.CO;2; Burgel K, 2005, J APPL ENTOMOL, V129, P311, DOI 10.1111/j.1439-0418.2005.00968.x; Butault J.P., 2010, SYNTHESE RAPPORT ET; Carletto J, 2009, MOL ECOL, V18, P2198, DOI 10.1111/j.1365-294X.2009.04190.x; Carletto J, 2010, PEST MANAG SCI, V66, P301, DOI 10.1002/ps.1874; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Cross JV, 2007, CROP PROT, V26, P1140, DOI 10.1016/j.cropro.2006.10.007; DeBarro PJ, 1995, P ROY SOC B-BIOL SCI, V262, P321, DOI 10.1098/rspb.1995.0212; Delmotte F, 2002, MOL ECOL, V11, P711, DOI 10.1046/j.1365-294X.2002.01478.x; DELORME R, 1999, PUCERON CENDRE POMMI; DELORME R, 1999, ANPP, P89; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; FORREST JMS, 1975, ANN APPL BIOL, V81, P281, DOI 10.1111/j.1744-7348.1975.tb01643.x; Gauffre B, 2006, MOL ECOL NOTES, V6, P440, DOI 10.1111/j.1471-8286.2006.01264.x; Gomez A, 2000, MOL ECOL, V9, P203, DOI 10.1046/j.1365-294x.2000.00849.x; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Guillemaud T, 2003, HEREDITY, V91, P143, DOI 10.1038/sj.hdy.6800292; Halkett F, 2005, TRENDS ECOL EVOL, V20, P194, DOI 10.1016/j.tree.2005.01.001; Hartl D.L., 1997, PRINCIPLES POPULATIO, V3rd ed.; Harvey NG, 2003, MOL ECOL NOTES, V3, P111, DOI 10.1046/j.1471-8286.2003.00369.x; Hill D.S, 1987, AGR INSECT PESTS TEM; HULL LA, 1983, J ECON ENTOMOL, V76, P594, DOI 10.1093/jee/76.3.594; Jensen AB, 2008, AGR FOREST ENTOMOL, V10, P279, DOI 10.1111/j.1461-9563.2008.00383.x; LATHROP FRANK H., 1928, OHIO JOUR SCI, V28, P177; Lenormand T, 1998, P ROY SOC B-BIOL SCI, V265, P1985, DOI 10.1098/rspb.1998.0529; LOXDALE HD, 1993, BIOL REV, V68, P291, DOI 10.1111/j.1469-185X.1993.tb00998.x; LOXDALE HD, 1990, J ANIM ECOL, V59, P497, DOI 10.2307/4877; LYTH M, 1985, ANN APPL BIOL, V107, P155, DOI 10.1111/j.1744-7348.1985.tb01559.x; Marko V, 2008, J APPL ENTOMOL, V132, P26, DOI 10.1111/j.1439-0418.2007.01233.x; MartinezTorres D, 1997, J EVOLUTION BIOL, V10, P459, DOI 10.1007/s000360050036; Massonnet B, 2004, HEREDITY, V93, P577, DOI 10.1038/sj.hdy.6800559; Minarro M, 2007, ENVIRON ENTOMOL, V36, P1206, DOI 10.1603/0046-225X(2007)36[1206:ROACTD]2.0.CO;2; Minarro M, 2005, BIOCONTROL, V50, P403, DOI 10.1007/s10526-004-5527-1; Minarro M, 2008, CROP PROT, V27, P391, DOI 10.1016/j.cropro.2007.07.003; Papura D, 2003, HEREDITY, V90, P397, DOI 10.1038/sj.hdy.6800262; Peccoud J, 2009, P NATL ACAD SCI USA, V106, P7495, DOI 10.1073/pnas.0811117106; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; Pritchard JK, 2000, GENETICS, V155, P945; Qubbaj T, 2005, ENTOMOL EXP APPL, V115, P145, DOI 10.1111/j.1570-7458.2005.00255.x; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Roughgarden J., 1996, THEORY POPULATION GE; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Simon JC, 2003, P ROY SOC B-BIOL SCI, V270, P1703, DOI 10.1098/rspb.2003.2430; Simon JC, 2002, TRENDS ECOL EVOL, V17, P34, DOI 10.1016/S0169-5347(01)02331-X; Simon JC, 1999, MOL ECOL, V8, P531, DOI 10.1046/j.1365-294x.1999.00583.x; Sokal R.R., 2012, BIOMETRY; SOLOMON MG, 2003, 10 14 MARCH 2002, P79; Sunnucks P, 1997, MOL ECOL, V6, P1059, DOI 10.1046/j.1365-294X.1997.00280.x; Sunnucks P, 1996, GENETICS, V144, P747; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vorburger C, 2006, J EVOLUTION BIOL, V19, P97, DOI 10.1111/j.1420-9101.2005.00985.x; Wilson ACC, 2004, MOL ECOL NOTES, V4, P104, DOI 10.1046/j.1471-8286.2004.00584.x; Wilson ACC, 2002, HEREDITY, V88, P258, DOI [10.1038/sj.hdy.6800037, 10.1038/sj/hdy/6800037]; Wright S., 1969, THEORY GENE FREQUENC; Wyss E, 2004, J APPL ENTOMOL, V128, P147, DOI 10.1111/j.1439-0418.2004.00825.x; Wyss E, 1999, ENTOMOL EXP APPL, V90, P167, DOI 10.1023/A:1003564714363; Zamoum T, 2005, HEREDITY, V94, P630, DOI 10.1038/sj.hdy.6800673	64	10	10	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e21263	10.1371/journal.pone.0021263	http://dx.doi.org/10.1371/journal.pone.0021263			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	21701679	Green Submitted, gold, Green Published			2022-12-27	WOS:000291983800035
J	Li, XH; Johnson, KR; Bryant, M; Elkahloun, AG; Amar, M; Remaley, AT; De Silva, R; Hallenbeck, JM; Quandt, JA				Li, Xinhui; Johnson, Kory R.; Bryant, Mark; Elkahloun, Abdel G.; Amar, Marcelo; Remaley, Alan T.; De Silva, Ranil; Hallenbeck, John M.; Quandt, Jacqueline A.			Intranasal Delivery of E-Selectin Reduces Atherosclerosis in ApoE-/- Mice	PLOS ONE			English	Article							RECEPTOR-DEFICIENT MICE; CORONARY-ARTERY-DISEASE; REGULATORY T-CELLS; SOLUBLE E-SELECTIN; MUCOSAL TOLERANCE; ORAL TOLERANCE; SUBARACHNOID HEMORRHAGE; ADHESION MOLECULES; LYMPHOID-TISSUE; CEREBROSPINAL-FLUID	Mucosal tolerance to E-selectin prevents stroke and protects against ischemic brain damage in experimental models of stroke studying healthy animals or spontaneously hypertensive stroke-prone rats. A reduction in inflammation and neural damage was associated with immunomodulatory or "tolerogenic" responses to E-selectin. The purpose of the current study on ApoE deficient mice is to assess the capacity of this stroke prevention innovation to influence atherosclerosis, a major underlying cause for ischemic strokes; human E-selectin is being translated as a potential clinical prevention strategy for secondary stroke. Female ApoE-/- mice received intranasal delivery of E-selectin prior to ( pre-tolerization) or simultaneously with initiation of a high-fat diet. After 7 weeks on the high-fat diet, lipid lesions in the aorta, serum triglycerides, and total cholesterol were assessed as markers of atherosclerosis development. We also assessed E-selectin-specific antibodies and cytokine responses, in addition to inflammatory responses that included macrophage infiltration of the aorta and altered gene expression profiles of aortic mRNA. Intranasal delivery of E-selectin prior to initiation of high-fat chow decreased atherosclerosis, serum total cholesterol, and expression of the leucocyte chemoattractant CCL21 that is typically upregulated in atherosclerotic lesions of ApoE-/- mice. This response was associated with the induction of E-selectin specific cells producing the immunomodulatory cytokine IL-10 and immunosuppressive antibody isotypes. Intranasal administration of E-selectin generates E-selectin specific immune responses that are immunosuppressive in nature and can ameliorate atherosclerosis, a major risk factor for ischemic stroke. These results provide additional preclinical support for the potential of induction of mucosal tolerance to E-selectin to prevent stroke.	[Li, Xinhui; Hallenbeck, John M.] NINDS, Stroke Branch, NIH, Bethesda, MD 20892 USA; [Johnson, Kory R.] NINDS, Bioinformat Sect, NIH, Bethesda, MD 20892 USA; [Bryant, Mark] NIH, Div Vet Resources, Off Res Support, Bethesda, MD 20892 USA; [Elkahloun, Abdel G.] NIH, Div Intramural Res Programs, Microarray Core Facil, Bethesda, MD 20892 USA; [Amar, Marcelo; Remaley, Alan T.; De Silva, Ranil] NHLBI, NIH, Bethesda, MD 20892 USA; [Quandt, Jacqueline A.] NINDS, Neuroimmunol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Li, XH (corresponding author), NINDS, Stroke Branch, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	hallenbj@ninds.nih.gov; jquandt@pathology.ubc.ca	Amar, Marcelo/AAD-5599-2019; Quandt, Jacqueline Alice/AHE-4020-2022	Quandt, Jacqueline Alice/0000-0003-1320-2819	National Institute of Neurological Disorders and Stroke; National Heart, Lung and Blood Institute, NIH, Bethesda, MD; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZICHG200365] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002924] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Heart, Lung and Blood Institute, NIH, Bethesda, MD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by the Stroke and Neuroimmunology Branches, Intramural Research Program of the National Institute of Neurological Disorders and Stroke and also a Bench to Bedside Award from the National Heart, Lung and Blood Institute, NIH, Bethesda, MD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbari O, 2003, INT ARCH ALLERGY IMM, V130, P108, DOI 10.1159/000069012; Arumugam TV, 2004, SHOCK, V21, P401, DOI 10.1097/00024382-200405000-00002; BAMFORD J, 1990, J NEUROL NEUROSUR PS, V53, P16, DOI 10.1136/jnnp.53.1.16; Biber K, 2001, GLIA, V34, P121, DOI 10.1002/glia.1047; Bjorkbacka H, 2004, NAT MED, V10, P416, DOI 10.1038/nm1008; Bogavac-Stanojevic N, 2003, CLIN CHEM LAB MED, V41, P893, DOI 10.1515/CCLM.2003.135; Broere F, 2008, J IMMUNOL, V181, P899, DOI 10.4049/jimmunol.181.2.899; Burchill MA, 2007, IMMUNOL LETT, V114, P1, DOI 10.1016/j.imlet.2007.08.005; Cao WX, 2005, EUR J IMMUNOL, V35, P2709, DOI 10.1002/eji.200425957; Chen SC, 2002, J IMMUNOL, V168, P1009, DOI 10.4049/jimmunol.168.3.1009; Chen Y, 2003, P NATL ACAD SCI USA, V100, P15107, DOI 10.1073/pnas.2436538100; Clark-Greuel JN, 2007, ANN THORAC SURG, V83, P946, DOI 10.1016/j.athoracsur.2006.10.026; Damas JK, 2007, ARTERIOSCL THROM VAS, V27, P614, DOI 10.1161/01.ATV.0000255581.38523.7c; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Engelhardt B, 2006, J NEURAL TRANSM, V113, P477, DOI 10.1007/s00702-005-0409-y; Faria AMC, 1999, ADV IMMUNOL, V73, P153, DOI 10.1016/S0065-2776(08)60787-7; Feinberg MW, 2004, J BIOL CHEM, V279, P16388, DOI 10.1074/jbc.M309664200; Frangogiannis NG, 2006, CURR MED CHEM, V13, P1877, DOI 10.2174/092986706777585086; George J, 2004, CARDIOVASC RES, V62, P603, DOI 10.1016/j.cardiores.2004.01.028; Gu L, 1998, MOL CELL, V2, P275, DOI 10.1016/S1097-2765(00)80139-2; Han XB, 2009, J BIOL CHEM, V284, P32950, DOI 10.1074/jbc.M109.040899; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Hansson GK, 2009, ATHEROSCLEROSIS, V202, P2, DOI 10.1016/j.atherosclerosis.2008.08.039; Hjelmstrom P, 2000, AM J PATHOL, V156, P1133, DOI 10.1016/S0002-9440(10)64981-4; Huehn J, 2005, TRENDS IMMUNOL, V26, P632, DOI 10.1016/j.it.2005.10.001; Hwang SJ, 1997, CIRCULATION, V96, P4219; Illoh K, 2006, J CEREBR BLOOD F MET, V26, P1538, DOI 10.1038/sj.jcbfm.9600308; Ishibashi S, 2009, J CEREBR BLOOD F MET, V29, P606, DOI 10.1038/jcbfm.2008.153; Kansas GS, 1996, BLOOD, V88, P3259, DOI 10.1182/blood.V88.9.3259.bloodjournal8893259; KLINGENBERG R, 2010, ARTERIOSCLER THROMB; Kozuka K, 2002, ATHEROSCLEROSIS, V161, P161, DOI 10.1016/S0021-9150(01)00635-9; Lan RY, 2008, J AUTOIMMUN, V31, P7, DOI 10.1016/j.jaut.2008.03.002; Liu Y, 2006, ATHEROSCLEROSIS, V188, P19, DOI 10.1016/j.atherosclerosis.2005.10.029; Lo JC, 2007, SCIENCE, V316, P285, DOI 10.1126/science.1137221; Malatino LS, 2007, J INTERN MED, V262, P479, DOI 10.1111/j.1365-2796.2007.01841.x; Maron R, 2002, CIRCULATION, V106, P1708, DOI 10.1161/01.CIR.0000029750.99462.30; Mayer L, 2004, NAT REV IMMUNOL, V4, P407, DOI 10.1038/nri1370; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Nakayama T, 2007, BRAIN RES, V1132, P177, DOI 10.1016/j.brainres.2006.09.116; Oh IY, 2007, BLOOD, V110, P3891, DOI 10.1182/blood-2006-10-048991; Oksjoki R, 2007, FRONT BIOSCI-LANDMRK, V12, P4696, DOI 10.2741/2419; Peranteau WH, 2008, J INVEST DERMATOL, V128, P1852, DOI 10.1038/sj.jid.5701232; Polin RS, 1998, J NEUROSURG, V89, P559, DOI 10.3171/jns.1998.89.4.0559; Potteaux S, 2004, ARTERIOSCL THROM VAS, V24, P1474, DOI 10.1161/01.ATV.0000134378.86443.cd; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Samsom JN, 2004, CRIT REV IMMUNOL, V24, P157, DOI 10.1615/CritRevImmunol.v24.i3.10; Schonbeck U, 2000, P NATL ACAD SCI USA, V97, P7458, DOI 10.1073/pnas.97.13.7458; Shechter R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000113; Shevach EM, 2006, IMMUNITY, V25, P195, DOI 10.1016/j.immuni.2006.08.003; SMITH KA, 1988, SCIENCE, V240, P1169, DOI 10.1126/science.3131876; Takeda H, 2002, STROKE, V33, P2156, DOI 10.1161/01.STR.0000029821.82531.8B; TSUKADA N, 1995, NEUROLOGY, V45, P1914, DOI 10.1212/WNL.45.10.1914; van Puijvelde GHM, 2006, CIRCULATION, V114, P1968, DOI 10.1161/CIRCULATIONAHA.106.615609; Wakita H, 2008, J CEREBR BLOOD F MET, V28, P341, DOI 10.1038/sj.jcbfm.9600528; Wang XL, 1997, CARDIOVASC RES, V34, P404, DOI 10.1016/S0008-6363(97)00033-3; Weiner HL, 2004, ANN NY ACAD SCI, V1029, P211, DOI 10.1196/annals.1309.053; *WHO, 2004, ATL HEART DIS STROK; XU S, 2009, CARDIOVASC PATHOL; Yoneyama H, 2001, J EXP MED, V193, P35, DOI 10.1084/jem.193.1.35; Yoshioka T, 2004, GENE THER, V11, P1772, DOI 10.1038/sj.gt.3302348	61	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e20620	10.1371/journal.pone.0020620	http://dx.doi.org/10.1371/journal.pone.0020620			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	21701687	gold, Green Published, Green Submitted			2022-12-27	WOS:000291983800008
J	Abramson, G; Soto, CAT; Ona, L				Abramson, Guillermo; Trejo Soto, Claudia A.; Ona, Leonardo			The Role of Asymmetric Interactions on the Effect of Habitat Destruction in Mutualistic Networks	PLOS ONE			English	Article							REPRODUCTIVE SUSCEPTIBILITY; SPECIALIZATION; POLLINATOR; FRAGMENTATION; SYSTEMS	Plant-pollinator mutualistic networks are asymmetric in their interactions: specialist plants are pollinated by generalist animals, while generalist plants are pollinated by a broad range involving specialists and generalists. It has been suggested that this asymmetric -or disassortative- assemblage could play an important role in determining the observed equal susceptibility of specialist and generalist plants under habitat destruction. At the core of the analysis of the phenomenon lies the observation that specialist plants, otherwise candidates to extinction, could cope with the disruption thanks to their interaction with a few generalist pollinators. We present a theoretical framework that supports this thesis. We analyze a dynamical model of a system of mutualistic plants and pollinators, subject to the destruction of their habitat. We analyze and compare two families of interaction topologies, ranging from highly assortative to highly disassortative ones, as well as real pollination networks. We found that several features observed in natural systems are predicted by the mathematical model. First, there is a tendency to increase the asymmetry of the network as a result of the extinctions. Second, an entropy measure of the differential susceptibility to extinction of specialist and generalist species show that they tend to balance when the network is disassortative. Finally, the disappearance of links in the network, as a result of extinctions, shows that specialist plants preserve more connections than the corresponding plants in an assortative system, enabling them to resist the disruption.	[Abramson, Guillermo] Ctr Atom Bariloche, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina; [Abramson, Guillermo] Consejo Nacl Invest Cient & Tecn, San Carlos De Bariloche, Rio Negro, Argentina; [Abramson, Guillermo; Trejo Soto, Claudia A.] Inst Balseiro, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina; [Ona, Leonardo] Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, Leipzig, Germany	Comision Nacional de Energia Atomica (CNEA); Centro Atomico Bariloche; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Comision Nacional de Energia Atomica (CNEA); University Nacional Cuyo Mendoza; Instituto Balseiro; Max Planck Society	Abramson, G (corresponding author), Ctr Atom Bariloche, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina.	abramson@cab.cnea.gov.ar	Trejo-Soto, Claudia Andrea/G-8551-2016	Trejo-Soto, Claudia Andrea/0000-0003-0267-3359; Ona, Leonardo/0000-0002-0883-7134	CONICET [PIP 112-200801-00076]; Universidad Nacional de Cuyo [06/C304]	CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad Nacional de Cuyo	This work has been funded by CONICET through PIP 112-200801-00076 and by Universidad Nacional de Cuyo (06/C304). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar R, 2006, ECOL LETT, V9, P968, DOI 10.1111/j.1461-0248.2006.00927.x; Aizen MA, 2002, J VEG SCI, V13, P885, DOI 10.1111/j.1654-1103.2002.tb02118.x; Ashworth L, 2004, J ECOL, V92, P717, DOI 10.1111/j.0022-0477.2004.00910.x; Bascompte J, 2006, SCIENCE, V312, P431, DOI 10.1126/science.1123412; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bascompte J, 1996, J ANIM ECOL, V65, P465, DOI 10.2307/5781; BASCOMPTE J, 2006, ASYMMETRIC COEVOLUTI; Bascompte J, 2010, SCIENCE, V329, P765, DOI 10.1126/science.1194255; BOND WJ, 1994, PHILOS T R SOC B, V344, P83, DOI 10.1098/rstb.1994.0055; Ehrlich A.H., 1981, EXTINCTION; Fenster CB, 2001, ECOLOGY, V82, P844, DOI 10.2307/2680202; Fortuna MA, 2006, ECOL LETT, V9, P278, DOI 10.1111/j.1461-0248.2005.00868.x; Fortuna MA, 2008, ECOL LETT, V11, P490, DOI 10.1111/j.1461-0248.2008.01167.x; Herrera Carlos M., 1996, P65; Kaiser-Bunbury CN, 2010, ECOL LETT, V13, P442, DOI 10.1111/j.1461-0248.2009.01437.x; LEVINS R, 1971, P NATL ACAD SCI USA, V68, P1246, DOI 10.1073/pnas.68.6.1246; Morris William F., 2003, P260; Newman M., 2010, NETWORKS INTRO, DOI [10.1162/artl_r_00062, 10.1093/acprof:oso/9780199206650.001.0001, DOI 10.1093/ACPROF:OSO/9780199206650.001.0001]; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; OLSEN JM, 2009, ECOLOGY, V86, P1573; Perrings C. A., 1995, BIODIVERSITY LOSS EC; RENNER SS, 1999, DYNAMICS TROPICAL CO, P339; TILMAN D, 1994, NATURE, V371, P65, DOI 10.1038/371065a0; TILMAN D, 1997, SPATIAL ECOLOGY ROLE, P3; Vazquez DP, 2004, ECOLOGY, V85, P1251, DOI 10.1890/03-3112; Vazquez DP, 2002, AM NAT, V159, P606, DOI 10.1086/339991; Waser NM, 1996, ECOLOGY, V77, P1043, DOI 10.2307/2265575; Wilson E.O., 1988, P3	28	14	14	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e21028	10.1371/journal.pone.0021028	http://dx.doi.org/10.1371/journal.pone.0021028			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698298	Green Published, Green Submitted, gold			2022-12-27	WOS:000291730000041
J	Balduini, A; Badalucco, S; Pugliano, MT; Baev, D; De Silvestri, A; Cattaneo, M; Rosti, V; Barosi, G				Balduini, Alessandra; Badalucco, Stefania; Pugliano, Maria Teresa; Baev, Denis; De Silvestri, Annalisa; Cattaneo, Marco; Rosti, Vittorio; Barosi, Giovanni			In Vitro Megakaryocyte Differentiation and Proplatelet Formation in Ph-Negative Classical Myeloproliferative Neoplasms: Distinct Patterns in the Different Clinical Phenotypes	PLOS ONE			English	Article							MOBILIZED PERIPHERAL-BLOOD; BONE-MARROW; ESSENTIAL THROMBOCYTHEMIA; IDIOPATHIC MYELOFIBROSIS; GROWTH; MUTATION; CELLS; JAK2; CLASSIFICATION; MECHANISMS	Background: Ph-negative myeloproliferative neoplasms (MPNs) are clonal disorders that include primary myelofibrosis (PMF), polycythemia vera (PV) and essential thrombocythemia (ET). Although the pathogenesis of MPNs is still incompletely understood, an involvement of the megakaryocyte lineage is a distinctive feature. Methodology/Principal Findings: We analyzed the in vitro megakaryocyte differentiation and proplatelet formation in 30 PMF, 8 ET, 8 PV patients, and 17 healthy controls (CTRL). Megakaryocytes were differentiated from peripheral blood CD34(+) or CD45(+) cells in the presence of thrombopoietin. Megakaryocyte output was higher in MPN patients than in CTRL with no correlation with the JAK2 V617F mutation. PMF-derived megakaryocytes displayed nuclei with a bulbous appearance, were smaller than ET- or PV-derived megakaryocytes and formed proplatelets that presented several structural alterations. In contrast, ET- and PV-derived megakaryocytes produced more proplatelets with a striking increase in bifurcations and tips compared to both control and PMF. Proplatelets formation was correlated with platelet counts in patient peripheral blood. Patients with pre-fibrotic PMF had a pattern of megakaryocyte proliferation and proplatelet formation that was similar to that of fibrotic PMF and different from that of ET. Conclusions/Significance: In conclusion, MPNs are associated with high megakaryocyte proliferative potential. Profound differences in megakaryocyte morphology and proplatelet formation distinguish PMF, both fibrotic and prefibrotic, from ET and PV.	[Balduini, Alessandra; Badalucco, Stefania] Univ Pavia, Dept Biochem, I-27100 Pavia, Italy; [Balduini, Alessandra] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA; [Pugliano, Maria Teresa; Cattaneo, Marco] Univ Milan, Dipartimento Med Chirurg & Odontoiatria, Unita Med 3, Azienda Osped San Paolo, Milan, Italy; [Baev, Denis] ViroStatics, Sassari, Italy; [De Silvestri, Annalisa] IRCCS Policlin S Matteo Fdn, Biometr Unit, Pavia, Italy; [Rosti, Vittorio; Barosi, Giovanni] IRCCS Policlin S Matteo Fdn, Clin Epidemiol Unit, Pavia, Italy; [Rosti, Vittorio; Barosi, Giovanni] IRCCS Policlin S Matteo Fdn, Ctr Study Myelofibrosis, Pavia, Italy	University of Pavia; Tufts University; University of Milan; IRCCS Fondazione San Matteo; IRCCS Fondazione San Matteo; IRCCS Fondazione San Matteo	Balduini, A (corresponding author), Univ Pavia, Dept Biochem, Via Palestro 3, I-27100 Pavia, Italy.	alessandra.balduini@unipv.it	Rosti, Vittorio/K-1743-2018; BALDUINI, ALESSANDRA/AAC-3363-2022; Barosi, Giovanni/AAI-1714-2019; De Silvestri, Annalisa/I-6024-2014; Balduini, Alessandra/K-6802-2016; Cattaneo, Marco/AAT-4080-2020	Rosti, Vittorio/0000-0003-4195-2289; BALDUINI, ALESSANDRA/0000-0003-3145-1245; De Silvestri, Annalisa/0000-0003-3128-8441; Balduini, Alessandra/0000-0003-3145-1245; Pugliano, Mariateresa/0000-0003-0749-0172; Cattaneo, Marco/0000-0002-7343-4534	Cariplo Foundation [2006.0596/10.8485]; Associazione Italiana per la Ricerca sul Cancro (AIRC, Milano)	Cariplo Foundation(Fondazione Cariplo); Associazione Italiana per la Ricerca sul Cancro (AIRC, Milano)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by Cariplo Foundation (2006.0596/10.8485) and was funded (in part) by a grant from Associazione Italiana per la Ricerca sul Cancro (AIRC, Milano) "Special Program Molecular Clinical Oncology 5x1000" to AGIMM (AIRC-Gruppo Italiano Malattie Mieloproliferative). A detailed description of the AGIMM project is available at http://www.progettoagimm.it. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avecilla ST, 2004, NAT MED, V10, P64, DOI 10.1038/nm973; Balduini A, 2008, J THROMB HAEMOST, V6, P1900, DOI 10.1111/j.1538-7836.2008.03132.x; Balduini A, 2009, J THROMB HAEMOST, V7, P478, DOI 10.1111/j.1538-7836.2008.03255.x; Barosi G, 1999, J CLIN ONCOL, V17, P2954, DOI 10.1200/JCO.1999.17.9.2954; Barosi G, 2005, SEMIN HEMATOL, V42, P248, DOI 10.1053/j.seminhematol.2005.05.018; Barosi G, 2001, BLOOD, V98, P3249, DOI 10.1182/blood.V98.12.3249; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; BECKER RP, 1976, AM J ANAT, V145, P183, DOI 10.1002/aja.1001450204; Besancenot R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000476; Boveri E, 2008, BRIT J HAEMATOL, V140, P162, DOI 10.1111/j.1365-2141.2007.06885.x; Chaligne R, 2009, LEUKEMIA, V23, P1186, DOI 10.1038/leu.2009.22; Chang Q, 1997, EXP HEMATOL, V25, P423; Ciurea SO, 2007, BLOOD, V110, P986, DOI 10.1182/blood-2006-12-064626; Giraudier S, 2002, BLOOD, V100, P2932, DOI 10.1182/blood-2002-02-0485; Hartwig J, 2003, J THROMB HAEMOST, V1, P1580, DOI 10.1046/j.1538-7836.2003.00331.x; HAYLOCK DN, 1992, BLOOD, V80, P1405; Hoffman R, 2007, BIOL BLOOD MARROW TR, V13, P64, DOI 10.1016/j.bbmt.2006.11.003; Italiano JE, 2003, J THROMB HAEMOST, V1, P1174, DOI 10.1046/j.1538-7836.2003.00290.x; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Junt T, 2007, SCIENCE, V317, P1767, DOI 10.1126/science.1146304; Kaushansky K, 2005, J CLIN INVEST, V115, P3339, DOI 10.1172/JCI26674; Kaushansky K, 2006, CYTOKINE GROWTH F R, V17, P423, DOI 10.1016/j.cytogfr.2006.09.005; Kilpivaara O, 2009, NAT GENET, V41, P455, DOI 10.1038/ng.342; Larson MK, 2006, BLOOD, V108, P1509, DOI 10.1182/blood-2005-11-011957; Lataillade JJ, 2008, BLOOD, V112, P3026, DOI 10.1182/blood-2008-06-158386; LEVINE R, 2006, AM SOC HEMATOL ED BO, P233; LEVINE RL, 2006, AM SOC HEMATOL ED PR, P510; LI J, BLOOD, V116, P1528; Muth M, 2010, LEUKEMIA RES, V34, P1424, DOI 10.1016/j.leukres.2010.03.040; Patel SR, 2005, J CLIN INVEST, V115, P3348, DOI 10.1172/JCI26891; Schulze H, 2005, J THROMB HAEMOST, V3, P1717, DOI 10.1111/j.1538-7836.2005.01426.x; Swerdlow SH, 2008, WHO CLASSIFICATION T; Taksin AL, 1999, BLOOD, V93, P125, DOI 10.1182/blood.V93.1.125.401k32_125_139; Tefferi A, 2006, BLOOD, V108, P2493, DOI 10.1182/blood-2006-05-025544; THIELE J, 1982, VIRCHOWS ARCH B, V41, P67, DOI 10.1007/BF02890272; THIELE J, 2001, WHO CLASSIFICATION T, P35; Thiele J, 2005, HAEMATOLOGICA, V90, P1128; Thon JN, 2010, J CELL BIOL, V191, P861, DOI 10.1083/jcb.201006102; Vannucchi AM, 2005, BLOOD, V105, P3493, DOI 10.1182/blood-2004-04-1320; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Weisdorf DJ, 1997, AM J HEMATOL, V54, P202, DOI 10.1002/(SICI)1096-8652(199703)54:3<202::AID-AJH5>3.0.CO;2-#; WILLIAMS N, 1982, BRIT J HAEMATOL, V52, P173, DOI 10.1111/j.1365-2141.1982.tb03878.x	42	43	45	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e21015	10.1371/journal.pone.0021015	http://dx.doi.org/10.1371/journal.pone.0021015			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698292	Green Published, gold, Green Submitted			2022-12-27	WOS:000291730000038
J	Tchanturia, K; Harrison, A; Davies, H; Roberts, M; Oldershaw, A; Nakazato, M; Stahl, D; Morris, R; Schmidt, U; Treasure, J				Tchanturia, Kate; Harrison, Amy; Davies, Helen; Roberts, Marion; Oldershaw, Anna; Nakazato, Michiko; Stahl, Daniel; Morris, Robin; Schmidt, Ulrike; Treasure, Janet			Cognitive Flexibility and Clinical Severity in Eating Disorders	PLOS ONE			English	Article							ANOREXIA-NERVOSA; CENTRAL COHERENCE; RECOVERY	Objectives: The aim of this study was to explore cognitive flexibility in a large dataset of people with Eating Disorders and Healthy Controls (HC) and to see how patient characteristics (body mass index [BMI] and length of illness) are related to this thinking style. Methods: A dataset was constructed from our previous studies using a conceptual shift test - the Brixton Spatial Anticipation Test. 601 participants were included, 215 patients with Anorexia Nervosa (AN) (96 inpatients; 119 outpatients), 69 patients with Bulimia Nervosa (BN), 29 Eating Disorder Not Otherwise Specified (EDNOS), 72 in long-term recovery from AN (Rec AN) and a comparison group of 216 HC. Results: The AN and EDNOS groups had significantly more errors than the other groups on the Brixton Test. In comparison to the HC group, the effect size decrement was large for AN patients receiving inpatient treatment and moderate for AN outpatients. Conclusions: These findings confirm that patients with AN have poor cognitive flexibility. Severity of illness measured by length of illness does not fully explain the lack of flexibility and supports the trait nature of inflexibility in people with AN.	[Tchanturia, Kate; Stahl, Daniel] Kings Coll London, Inst Psychiat, Dept Biostat, London WC2R 2LS, England; [Morris, Robin] Kings Coll London, Inst Psychiat, Dept Psychol, London WC2R 2LS, England	University of London; King's College London; University of London; King's College London	Tchanturia, K (corresponding author), Kings Coll London, Inst Psychiat, Dept Biostat, London WC2R 2LS, England.	kate.tchanturia@kcl.ac.uk	Tchanturia, Kate/H-1474-2011; Stahl, Daniel/B-9713-2011	Tchanturia, Kate/0000-0001-8988-3265; Stahl, Daniel/0000-0001-7987-6619; Harrison, Amy/0000-0002-3771-9735; Treasure, Janet/0000-0003-0871-4596; Roberts, Marion/0000-0001-6824-4413	Psychiatry Research Trust; NIHR Biomedical Research Centre for Mental Health, South London; Maudsley NHS Foundation Trust; Institute of Psychiatry, King's College London; National Institutes of Health Research (NIHR) [RP-PG-0606-1043]; Psychiatry Research Trust [284286]; Nina Jackson Research into Eating Disorders Studentship	Psychiatry Research Trust; NIHR Biomedical Research Centre for Mental Health, South London(National Institute for Health Research (NIHR)); Maudsley NHS Foundation Trust; Institute of Psychiatry, King's College London(General Electric); National Institutes of Health Research (NIHR)(National Institute for Health Research (NIHR)); Psychiatry Research Trust; Nina Jackson Research into Eating Disorders Studentship	This work was supported by the Psychiatry Research Trust, by the NIHR Biomedical Research Centre for Mental Health, South London and Maudsley NHS Foundation Trust and Institute of Psychiatry, King's College London and by National Institutes of Health Research (NIHR) Programme Grant for Applied Research (Reference number RP-PG-0606-1043). The views expressed herein are not necessarily those of the NHS, NIHR or the Department of Health. AH, MR, AO were supported by a Nina Jackson Research into Eating Disorders Studentship in collaboration with the Psychiatry Research Trust registered charity no. 284286. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], NATL ADULT READING T; Bardone-Cone AM, 2010, BEHAV RES THER, V48, P194, DOI 10.1016/j.brat.2009.11.001; Burgess P.W., 1997, HAYLING BRIXTON TEST; Cohen J.E., 1988, STAT POWER ANAL BEHA; Crawford JR, 2001, PSYCHOL MED, V31, P451, DOI 10.1017/S0033291701003634; Genders R, 2010, EAT WEIGHT DISORD-ST, V15, pE234, DOI 10.1007/BF03325304; Holliday J, 2005, AM J PSYCHIAT, V162, P2269, DOI 10.1176/appi.ajp.162.12.2269; Lopez C, 2008, PSYCHOL MED, V38, P1393, DOI 10.1017/S0033291708003486; Lopez C, 2010, ANN GEN PSYCHIATR, V9, DOI 10.1186/1744-859X-9-40; McAnarney ER, 2011, J ADOLESCENT HEALTH, V49, P99, DOI 10.1016/j.jadohealth.2010.11.259; Nakazato M, 2009, PSYCHOL MED, V39, P1029, DOI 10.1017/S0033291708004108; Roberts ME, 2007, PSYCHOL MED, V37, P1075, DOI 10.1017/S0033291707009877; Roberts ME, 2010, J PSYCHIATR RES, V44, P964, DOI 10.1016/j.jpsychires.2010.03.001; Schmidt U, 2006, BRIT J CLIN PSYCHOL, V45, P343, DOI 10.1348/014466505X53902; Tchanturia K, 2004, J PSYCHIATR RES, V38, P545, DOI 10.1016/j.jpsychires.2004.03.001; Tchanturia K, 2004, J INT NEUROPSYCH SOC, V10, P513, DOI 10.1017/S1355617704104086; Tchanturia K, 2008, PSYCHOL MED, V38, P1371, DOI 10.1017/S0033291708003796; Tenconi E, 2010, WORLD J BIOL PSYCHIA, V11, P813, DOI 10.3109/15622975.2010.483250; Thomas JJ, 2010, PSYCHIAT RES, V178, P511, DOI 10.1016/j.psychres.2010.05.021; VANDENEYNDE F, 2011, ACTA PSYCHIAT SCAND, DOI DOI 10.1111/J.1600-0447.2011.01701; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th ed; Zakzanis KK, 2010, J NEUROPSYCHOL, V4, P89, DOI 10.1348/174866409X459674	22	154	157	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e20462	10.1371/journal.pone.0020462	http://dx.doi.org/10.1371/journal.pone.0020462			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	778TS	21698277	gold, Green Published, Green Submitted			2022-12-27	WOS:000291730000011
J	Borkar, AN; Rout, MK; Hosur, RV				Borkar, Aditi Narendra; Rout, Manoj Kumar; Hosur, Ramakrishna V.			Visualization of Early Events in Acetic Acid Denaturation of HIV-1 Protease: A Molecular Dynamics Study	PLOS ONE			English	Article							DRUG-RESISTANCE; SH3 DOMAIN; SIMULATIONS; PROTEINS; MONOMER; INHIBITORS; STABILITY; COMPLEXES; HIERARCHY; SUBSTRATE	Protein denaturation plays a crucial role in cellular processes. In this study, denaturation of HIV-1 Protease (PR) was investigated by all-atom MD simulations in explicit solvent. The PR dimer and monomer were simulated separately in 9 M acetic acid (9 M AcOH) solution and water to study the denaturation process of PR in acetic acid environment. Direct visualization of the denaturation dynamics that is readily available from such simulations has been presented. Our simulations in 9 M AcOH reveal that the PR denaturation begins by separation of dimer into intact monomers and it is only after this separation that the monomer units start denaturing. The denaturation of the monomers is flagged off by the loss of crucial interactions between the alpha-helix at C-terminal and surrounding beta-strands. This causes the structure to transit from the equilibrium dynamics to random non-equilibrating dynamics. Residence time calculations indicate that denaturation occurs via direct interaction of the acetic acid molecules with certain regions of the protein in 9 M AcOH. All these observations have helped to decipher a picture of the early events in acetic acid denaturation of PR and have illustrated that the alpha-helix and the beta-sheet at the C-terminus of a native and functional PR dimer should maintain both the stability and the function of the enzyme and thus present newer targets for blocking PR function.	[Borkar, Aditi Narendra] Univ Pune, Inst Bioinformat & Biotechnol, Pune, Maharashtra, India; [Borkar, Aditi Narendra; Rout, Manoj Kumar; Hosur, Ramakrishna V.] Tata Inst Fundamental Res, Dept Chem Sci, Mumbai 400005, Maharashtra, India; [Hosur, Ramakrishna V.] Mumbai Univ Campus, UM DAE Ctr Excellence Basic Sci, Kalina, Santa Cruz Mumb, India	Savitribai Phule Pune University; Tata Institute of Fundamental Research (TIFR); UM-DAE Centre for Excellence in Basic Sciences	Borkar, AN (corresponding author), Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England.	hosur@tifr.res.in		Borkar, Aditi Narendra/0000-0003-4361-6561; Borkar, Aditi/0000-0001-9278-1438	Department of Atomic Energy (DAE); Department of Science and Technology (DST), Government of India	Department of Atomic Energy (DAE)(Department of Atomic Energy (DAE)); Department of Science and Technology (DST), Government of India(Department of Science & Technology (India))	Department of Atomic Energy (DAE) and Department of Science and Technology (DST), Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Bhavesh NS, 2003, J BIOL CHEM, V278, P19980, DOI 10.1074/jbc.M301615200; Bhavesh NS, 2001, FEBS LETT, V509, P218, DOI 10.1016/S0014-5793(01)03066-6; Broglia RA, 2005, PROTEIN SCI, V14, P2668, DOI 10.1110/ps.051670905; Broglia RA, 2001, J CHEM PHYS, V114, P7267, DOI 10.1063/1.1361076; Broglia RA, 2001, PROTEINS, V45, P421, DOI 10.1002/prot.1158; Chatterjee A, 2005, J BIOL CHEM, V280, P11369, DOI 10.1074/jbc.M412603200; Chen XF, 2004, J MOL MODEL, V10, P373, DOI 10.1007/s00894-004-0205-x; COLLINS JR, 1995, NAT STRUCT BIOL, V2, P334, DOI 10.1038/nsb0495-334; HARRISON RW, 1994, PROTEIN ENG, V7, P1353, DOI 10.1093/protein/7.11.1353; Hornak V, 2006, P NATL ACAD SCI USA, V103, P915, DOI 10.1073/pnas.0508452103; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ishima R, 2003, J BIOL CHEM, V278, P43311, DOI 10.1074/jbc.M307549200; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Levy Y, 2004, J MOL BIOL, V340, P67, DOI 10.1016/j.jmb.2004.04.028; Levy Y, 2003, J PHYS CHEM B, V107, P3068, DOI 10.1021/jp0219956; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Mok YK, 1999, J MOL BIOL, V289, P619, DOI 10.1006/jmbi.1999.2769; Navon A, 2001, BIOCHEMISTRY-US, V40, P105, DOI 10.1021/bi001946o; Pedretti A, 2004, J COMPUT AID MOL DES, V18, P167, DOI 10.1023/B:JCAM.0000035186.90683.f2; Perryman AL, 2004, PROTEIN SCI, V13, P1108, DOI 10.1110/ps.03468904; Pillai B, 2001, PROTEINS, V43, P57, DOI 10.1002/1097-0134(20010401)43:1<57::AID-PROT1017>3.0.CO;2-D; Rout MK, 2009, ARCH BIOCHEM BIOPHYS, V482, P33, DOI 10.1016/j.abb.2008.11.022; Schuler LD, 2001, J COMPUT CHEM, V22, P1205, DOI 10.1002/jcc.1078; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Tiana G, 2002, PROTEINS, V49, P82, DOI 10.1002/prot.10196; Trylska J, 2007, BIOPHYS J, V92, P4179, DOI 10.1529/biophysj.106.100560; Wallqvist A, 1998, PROTEIN ENG, V11, P999, DOI 10.1093/protein/11.11.999; Wartha F, 2005, J CHEM THEORY COMPUT, V1, P315, DOI 10.1021/ct049869o; Yan MC, 2008, PROTEINS, V70, P731, DOI 10.1002/prot.21539; Yi Q, 2000, J MOL BIOL, V299, P1341, DOI 10.1006/jmbi.2000.3816; ZHANG O, 1995, BIOCHEMISTRY-US, V34, P6784, DOI 10.1021/bi00020a025; Zhu ZW, 2003, BIOCHEMISTRY-US, V42, P1326, DOI 10.1021/bi020496s	34	7	7	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e19830	10.1371/journal.pone.0019830	http://dx.doi.org/10.1371/journal.pone.0019830			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21738569	Green Published, gold, Green Submitted			2022-12-27	WOS:000292290100001
J	Jagadeesan, B; Littlejohn, AEF; Amalaradjou, MAR; Singh, AK; Mishra, KK; La, D; Kihara, D; Bhunia, AK				Jagadeesan, Balamurugan; Littlejohn, Amy E. Fleishman; Amalaradjou, Mary Anne Roshni; Singh, Atul K.; Mishra, Krishna K.; La, David; Kihara, Daisuke; Bhunia, Arun K.			N-Terminal Gly(224)-Gly(411) Domain in Listeria Adhesion Protein Interacts with Host Receptor Hsp60	PLOS ONE			English	Article							MONOCYTOGENES VIRULENCE FACTOR; ACID-RICH PROTEIN; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; SURFACE PROTEIN; ENTAMOEBA-HISTOLYTICA; STREPTOCOCCUS-PNEUMONIAE; BACTERIAL ADHESION; ESCHERICHIA-COLI; INVASION PROTEIN; ALPHA-ENOLASE	Background: Listeria adhesion protein (LAP) is a housekeeping bifunctional enzyme consisting of N-terminal acetaldehyde dehydrogenase (ALDH) and C-terminal alcohol dehydrogenase (ADH). It aids Listeria monocytogenes in crossing the epithelial barrier through a paracellular route by interacting with its host receptor, heat shock protein 60 (Hsp60). To gain insight into the binding interaction between LAP and Hsp60, LAP subdomain(s) participating in the Hsp60 interaction were investigated. Methods: Using a ModBase structural model, LAP was divided into 4 putative subdomains: the ALDH region contains N1 (Met(1)-Pro(223)) and N2 (Gly(224)-Gly(411)), and the ADH region contains C1 (Gly(412)-Val(648)) and C2 (Pro(649)-Val(866)). Each subdomain was cloned and overexpressed in Escherichia coli and purified. Purified subdomains were used in ligand overlay, immunofluorescence, and bead-based epithelial cell adhesion assays to analyze each domain's affinity toward Hsp60 protein or human ileocecal epithelial HCT-8 cells. Results: The N2 subdomain exhibited the greatest affinity for Hsp60 with a K-D of 9.50 +/- 2.6 nM. The K-D of full-length LAP (7.2 +/- 0.5 nM) to Hsp60 was comparable to the N2 value. Microspheres (1 mu m diameter) coated with N2 subdomain showed significantly (P<0.05) higher binding to HCT-8 cells than beads coated with other subdomains and this binding was inhibited when HCT-8 cells were pretreated with anti-Hsp60 antibody to specifically block epithelial Hsp60. Furthermore, HCT-8 cells pretreated with purified N2 subdomain also reduced L. monocytogenes adhesion by about 4 log confirming its involvement in interaction with epithelial cells. Conclusion: These data indicate that the N2 subdomain in the LAP ALDH domain is critical in initiating interaction with mammalian cell receptor Hsp60 providing insight into the molecular mechanism of pathogenesis for the development of potential anti-listerial control strategies.	[Jagadeesan, Balamurugan; Littlejohn, Amy E. Fleishman; Amalaradjou, Mary Anne Roshni; Singh, Atul K.; Mishra, Krishna K.; Bhunia, Arun K.] Purdue Univ, Dept Food Sci, Mol Food Microbiol Lab, W Lafayette, IN 47907 USA; [Littlejohn, Amy E. Fleishman; Kihara, Daisuke; Bhunia, Arun K.] Purdue Univ, Purdue Univ Interdisciplinary Life Sci Program, W Lafayette, IN 47907 USA; [La, David; Kihara, Daisuke] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Kihara, Daisuke] Purdue Univ, Dept Comp Sci, W Lafayette, IN 47907 USA; [Bhunia, Arun K.] Purdue Univ, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Jagadeesan, B (corresponding author), Purdue Univ, Dept Food Sci, Mol Food Microbiol Lab, Smith Hall, W Lafayette, IN 47907 USA.	bhunia@purdue.edu	amalaradjou, mary anne roshni/D-2004-2012; Bhunia, Arun K./K-7639-2012; Singh, Atul Kumar/H-6629-2019	Bhunia, Arun K./0000-0003-3640-1554; Singh, Atul Kumar/0000-0001-7343-3577; Amalaradjou, Mary Anne Roshni/0000-0001-7411-2206; Jagadeesan, Balamurugan/0000-0002-2471-8290	U.S. Department of Agriculture [1935-42000-035, 2009-35603-05059]; Purdue Faculty; National Institute of General Medical Sciences of the National Institutes of Health [R01 GM075004]; National Science Foundation [DMS800568, IIS0915801, EF0850009]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075004] Funding Source: NIH RePORTER	U.S. Department of Agriculture(United States Department of Agriculture (USDA)); Purdue Faculty; National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	AKB, AFL, MARA, AKS, KKM are supported by U.S. Department of Agriculture Grant # 1935-42000-035, and 2009-35603-05059, and Purdue Faculty Scholar Funding. DL and DK were supported by National Institute of General Medical Sciences of the National Institutes of Health (R01 GM075004) and National Science Foundation DMS800568, IIS0915801, and EF0850009. The funders had no role in study design, data collection, and data analysis, decision to publish, or preparation of the manuscript.	Abachin E, 2002, MOL MICROBIOL, V43, P1, DOI 10.1046/j.1365-2958.2002.02723.x; Ainscough SL, 2009, EXP EYE RES, V89, P629, DOI 10.1016/j.exer.2009.06.005; Alvarez-Dominguez C, 2008, TRAFFIC, V9, P325, DOI 10.1111/j.1600-0854.2007.00683.x; Bergmann S, 2004, INFECT IMMUN, V72, P2416, DOI 10.1128/IAI.72.4.2416-2419.2004; Bergmann S, 2001, MOL MICROBIOL, V40, P1273, DOI 10.1046/j.1365-2958.2001.02448.x; Bierne H, 2007, MICROBIOL MOL BIOL R, V71, P377, DOI 10.1128/MMBR.00039-06; Braun L, 2000, EMBO J, V19, P1458, DOI 10.1093/emboj/19.7.1458; Burkholder KM, 2010, INFECT IMMUN, V78, P5062, DOI 10.1128/IAI.00516-10; Burkholder KM, 2009, MICROBES INFECT, V11, P859, DOI 10.1016/j.micinf.2009.05.006; Cabanes D, 2005, EMBO J, V24, P2827, DOI 10.1038/sj.emboj.7600750; Cossart P, 2003, TRENDS CELL BIOL, V13, P23, DOI 10.1016/S0962-8924(02)00006-5; Disson O, 2008, NATURE, V455, P1114, DOI 10.1038/nature07303; Dramsi S, 2004, MOL MICROBIOL, V53, P639, DOI 10.1111/j.1365-2958.2004.04138.x; Dziewanowska K, 2000, INFECT IMMUN, V68, P6321, DOI 10.1128/IAI.68.11.6321-6328.2000; Egea L, 2007, INT J BIOCHEM CELL B, V39, P1190, DOI 10.1016/j.biocel.2007.03.008; Gilot P, 1999, INFECT IMMUN, V67, P6698; Henderson B, 2006, INFECT IMMUN, V74, P3693, DOI 10.1128/IAI.01882-05; Ireton K, 2007, CELL MICROBIOL, V9, P1365, DOI 10.1111/j.1462-5822.2007.00933.x; Jagadeesan B, 2010, MICROBIOL-SGM, V156, P2782, DOI 10.1099/mic.0.036509-0; Jaradat ZW, 2003, MED MICROBIOL IMMUN, V192, P85, DOI 10.1007/S00430-002-0150-1; Kim KP, 2006, FEMS MICROBIOL LETT, V256, P324, DOI 10.1111/j.1574-6968.2006.00140.x; Kinhikar AG, 2006, MOL MICROBIOL, V60, P999, DOI 10.1111/j.1365-2958.2006.05151.x; Koba H, 2009, ORAL MICROBIOL IMMUN, V24, P162, DOI 10.1111/j.1399-302X.2008.00490.x; KOHLER S, 1990, INFECT IMMUN, V58, P1943; KUMARAN D, 2011, CRYSTAL STRUCTURE LA; Lahteenmaki K, 2005, TRENDS MICROBIOL, V13, P79, DOI 10.1016/j.tim.2004.12.003; Lebrun M, 1996, MOL MICROBIOL, V21, P579, DOI 10.1111/j.1365-2958.1996.tb02566.x; Lecuit M, 2001, SCIENCE, V292, P1722, DOI 10.1126/science.1059852; Lecuit M, 1997, INFECT IMMUN, V65, P5309, DOI 10.1128/IAI.65.12.5309-5319.1997; Mengaud J, 1996, CELL, V84, P923, DOI 10.1016/S0092-8674(00)81070-3; Milohanic E, 2004, INFECT IMMUN, V72, P4401, DOI 10.1128/IAI.72.8.4401-4409.2004; Nelson D, 2001, J DENT RES, V80, P371, DOI 10.1177/00220345010800011301; Pancholi V, 2003, INT J MED MICROBIOL, V293, P391, DOI 10.1078/1438-4221-00283; PANCHOLI V, 1992, J EXP MED, V176, P415, DOI 10.1084/jem.176.2.415; Pancholi V, 2003, MICROB PATHOGENESIS, V35, P293, DOI 10.1016/j.micpath.2003.08.004; Pandiripally VK, 1999, J MED MICROBIOL, V48, P117, DOI 10.1099/00222615-48-2-117; Pentecost M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000900; Pieper U, 2004, NUCLEIC ACIDS RES, V32, pD217, DOI 10.1093/nar/gkh095; Pizarro-Cerda J, 2006, CELL, V124, P715, DOI 10.1016/j.cell.2006.02.012; Pizarro-Cerda J, 2006, J PATHOL, V208, P215, DOI 10.1002/path.1888; Pohl E, 2002, J BIOL CHEM, V277, P19938, DOI 10.1074/jbc.M112244200; Ranford J C, 2000, Expert Rev Mol Med, V2, P1, DOI 10.1017/S1462399400002015; Reis O, 2010, J INFECT DIS, V202, P551, DOI 10.1086/654880; Romero-Steiner S, 2006, VACCINE, V24, P3224, DOI 10.1016/j.vaccine.2006.01.042; Sabet C, 2008, INFECT IMMUN, V76, P1368, DOI 10.1128/IAI.01519-07; Santi-Rocca J, 2008, CELL MICROBIOL, V10, P202, DOI 10.1111/j.1462-5822.2007.01030.x; Schubert WD, 2002, CELL, V111, P825, DOI 10.1016/S0092-8674(02)01136-4; Seigneur M, 2005, CELL MICROBIOL, V7, P569, DOI 10.1111/j.1462-5822.2005.00487.x; Shen Y, 2000, CELL, V103, P501, DOI 10.1016/S0092-8674(00)00141-0; Stie J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005780; Vazquez-Boland JA, 2001, CLIN MICROBIOL REV, V14, P584, DOI 10.1128/CMR.14.3.584-640.2001; Wampler JL, 2004, INFECT IMMUN, V72, P931, DOI 10.1128/IAI.72.2.931-936.2004; WUENSCHER MD, 1993, J BACTERIOL, V175, P3491, DOI 10.1128/jb.175.11.3491-3501.1993; Xayarath B, 2009, MOL MICROBIOL, V74, P956, DOI 10.1111/j.1365-2958.2009.06910.x; YANG WG, 1994, MOL BIOCHEM PARASIT, V64, P253, DOI 10.1016/0166-6851(93)00020-A; Yavlovich A, 2007, INFECT IMMUN, V75, P5716, DOI 10.1128/IAI.01049-07	56	24	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e20694	10.1371/journal.pone.0020694	http://dx.doi.org/10.1371/journal.pone.0020694			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21738582	gold, Green Submitted, Green Published			2022-12-27	WOS:000292290100005
J	Kornysheva, K; Schubotz, RI				Kornysheva, Katja; Schubotz, Ricarda I.			Impairment of Auditory-Motor Timing and Compensatory Reorganization after Ventral Premotor Cortex Stimulation	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; EVENT-RELATED FMRI; PARKINSONS-DISEASE; ARCUATE FASCICULUS; SENSORIMOTOR SYNCHRONIZATION; SUBCORTICAL STROKE; HUMAN CEREBELLUM; MUSICAL RHYTHMS; FRONTAL-LOBE; HUMAN BRAIN	Integrating auditory and motor information often requires precise timing as in speech and music. In humans, the position of the ventral premotor cortex (PMv) in the dorsal auditory stream renders this area a node for auditory-motor integration. Yet, it remains unknown whether the PMv is critical for auditory-motor timing and which activity increases help to preserve task performance following its disruption. 16 healthy volunteers participated in two sessions with fMRI measured at baseline and following rTMS (rTMS) of either the left PMv or a control region. Subjects synchronized left or right finger tapping to sub-second beat rates of auditory rhythms in the experimental task, and produced self-paced tapping during spectrally matched auditory stimuli in the control task. Left PMv rTMS impaired auditory-motor synchronization accuracy in the first sub-block following stimulation (p<0.01, Bonferroni corrected), but spared motor timing and attention to task. Task-related activity increased in the homologue right PMv, but did not predict the behavioral effect of rTMS. In contrast, anterior midline cerebellum revealed most pronounced activity increase in less impaired subjects. The present findings suggest a critical role of the left PMv in feed-forward computations enabling accurate auditory-motor timing, which can be compensated by activity modulations in the cerebellum, but not in the homologue region contralateral to stimulation.	[Kornysheva, Katja] UCL, Motor Control Grp, Inst Cognit Neurosci, London, England; [Kornysheva, Katja; Schubotz, Ricarda I.] Max Planck Inst Neurol Res, Motor Cognit Grp, Cologne, Germany; [Schubotz, Ricarda I.] Univ Munster, Inst Psychol, Munster, Germany	University of London; University College London; Max Planck Society; University of Munster	Kornysheva, K (corresponding author), UCL, Motor Control Grp, Inst Cognit Neurosci, London, England.	k.kornysheva@ucl.ac.uk	Kornysheva, Katja/AAP-7062-2020; Schubotz, Ricarda/B-2871-2013	Kornysheva, Katja/0000-0002-1562-7880; Schubotz, Ricarda/0000-0001-5802-6869	Max Planck Society	Max Planck Society(Max Planck Society)	This study has been funded by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen EA, 2007, SCIENCE, V317, P1918, DOI 10.1126/science.1146426; ASCHERSLEBEN G, 1995, PERCEPT PSYCHOPHYS, V57, P305, DOI 10.3758/BF03213056; Awiszus F, 2003, SUPPL CLIN NEUROPHYS, V56, P13; Awiszus F, 1999, EXP BRAIN RES, V129, P317, DOI 10.1007/s002210050901; Baker K, 2008, PARKINSONISM RELAT D, V14, P314, DOI 10.1016/j.parkreldis.2007.09.008; Bernal B, 2009, BRAIN, V132, P2309, DOI 10.1093/brain/awp206; Bloom JS, 2005, NEUROPSYCHOL REV, V15, P59, DOI 10.1007/s11065-005-6252-y; Catani M, 2008, CORTEX, V44, P953, DOI 10.1016/j.cortex.2008.04.002; CHEN JL, 2008, CEREB CORTEX; Chen JL, 2006, NEUROIMAGE, V32, P1771, DOI 10.1016/j.neuroimage.2006.04.207; Chen JL, 2009, ANN NY ACAD SCI, V1169, P15, DOI 10.1111/j.1749-6632.2009.04556.x; CHOLLET F, 1991, ANN NEUROL, V29, P63, DOI 10.1002/ana.410290112; Coull JT, 2008, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.010.2008; Dancause N, 2007, J COMP NEUROL, V505, P701, DOI 10.1002/cne.21531; Doumas M, 2005, EXP BRAIN RES, V167, P238, DOI 10.1007/s00221-005-0029-7; DUM RP, 1991, J NEUROSCI, V11, P667; Dum RP, 2002, PHYSIOL BEHAV, V77, P677, DOI 10.1016/S0031-9384(02)00929-0; FERBERT A, 1992, J PHYSIOL-LONDON, V453, P525, DOI 10.1113/jphysiol.1992.sp019243; Del Olmo MF, 2007, J NEUROPHYSIOL, V98, P145, DOI 10.1152/jn.01088.2006; Fitzgerald PB, 2006, CLIN NEUROPHYSIOL, V117, P2584, DOI 10.1016/j.clinph.2006.06.712; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Friston KJ., 1994, FUNCTIONAL NEUROIMAG, P79; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; GOLDBERG G, 1985, BEHAV BRAIN SCI, V8, P567, DOI 10.1017/S0140525X00045167; Grefkes C, 2008, ANN NEUROL, V63, P236, DOI 10.1002/ana.21228; Habas C, 2009, J NEUROSCI, V29, P8586, DOI 10.1523/JNEUROSCI.1868-09.2009; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Innocenti GM., 1986, GEN ORG CALLOSAL CON, P291, DOI [10.1007/978-1-4613-2149-1_9, DOI 10.1007/978-1-4613-2149-1_9]; Jancke L, 2000, COGNITIVE BRAIN RES, V10, P51, DOI 10.1016/S0926-6410(00)00022-7; Josephs O, 1997, HUM BRAIN MAPP, V5, P243, DOI 10.1002/(SICI)1097-0193(1997)5:4<243::AID-HBM7>3.0.CO;2-3; Kavounoudias A, 2008, NEUROPSYCHOLOGIA, V46, P567, DOI 10.1016/j.neuropsychologia.2007.10.002; Kawashima R, 2000, J NEUROPHYSIOL, V83, P1079, DOI 10.1152/jn.2000.83.2.1079; Kell CA, 2009, BRAIN, V132, P2747, DOI 10.1093/brain/awp185; Kelly RM, 2003, J NEUROSCI, V23, P8432; Kleber B, 2007, NEUROIMAGE, V36, P889, DOI 10.1016/j.neuroimage.2007.02.053; KORNYSHEVA K, 2010, HUM BRAIN MAPP; Kornysheva K, 2010, HUM BRAIN MAPP, V31, P48, DOI 10.1002/hbm.20844; Liepert J, 2007, RESTOR NEUROL NEUROS, V25, P461; Lohmann G, 2001, COMPUT MED IMAG GRAP, V25, P449, DOI 10.1016/S0895-6111(01)00008-8; Malcolm MP, 2008, NEUROSCI LETT, V435, P240, DOI 10.1016/j.neulet.2008.02.055; McIntosh GC, 1997, J NEUROL NEUROSUR PS, V62, P22, DOI 10.1136/jnnp.62.1.22; Mills KR, 1997, MUSCLE NERVE, V20, P570, DOI 10.1002/(SICI)1097-4598(199705)20:5<570::AID-MUS5>3.3.CO;2-F; Mishory A, 2004, J ECT, V20, P160, DOI 10.1097/00124509-200409000-00007; Mori S, 2004, PROG BRAIN RES, V143, P341, DOI 10.1016/S0079-6123(03)43033-1; Murase N, 2004, ANN NEUROL, V55, P400, DOI 10.1002/ana.10848; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; Norris DG, 2000, JMRI-J MAGN RESON IM, V11, P445, DOI 10.1002/(SICI)1522-2586(200004)11:4<445::AID-JMRI13>3.0.CO;2-T; Nowak DA, 2008, ARCH NEUROL-CHICAGO, V65, P741, DOI 10.1001/archneur.65.6.741; O'Reilly JX, 2008, J NEUROSCI, V28, P2252, DOI 10.1523/JNEUROSCI.2742-07.2008; O'Shea J, 2007, NEURON, V54, P479, DOI 10.1016/j.neuron.2007.04.021; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Peretz I, 2003, ANN NY ACAD SCI, V999, P58, DOI 10.1196/annals.1284.006; Pollok B, 2008, EUR J NEUROSCI, V27, P757, DOI 10.1111/j.1460-9568.2008.06044.x; Rao SM, 1997, J NEUROSCI, V17, P5528; Rauschecker JP, 2009, NAT NEUROSCI, V12, P718, DOI 10.1038/nn.2331; Repp BH, 2005, PSYCHON B REV, V12, P969, DOI 10.3758/BF03206433; Riecker A, 2000, NEUROREPORT, V11, P1997, DOI 10.1097/00001756-200006260-00038; Rilling JK, 2008, NAT NEUROSCI, V11, P426, DOI 10.1038/nn2072; RIZZOLATTI G, 1987, EXP BRAIN RES, V67, P220, DOI 10.1007/BF00269468; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Rothwell J C, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P97; Ruspantini I, 2011, BEHAV BRAIN RES, V220, P325, DOI 10.1016/j.bbr.2011.02.017; Schmahmann J.D., 2000, MRI ATLAS HUMAN CERE; Schubotz RI, 2003, NEUROIMAGE, V20, pS120, DOI 10.1016/j.neuroimage.2003.09.014; Schubotz RI, 2003, NEUROIMAGE, V20, P173, DOI 10.1016/S1053-8119(03)00218-0; Schubotz RI, 2000, NEUROIMAGE, V11, P1, DOI 10.1006/nimg.1999.0514; Schubotz RI, 2001, CEREB CORTEX, V11, P210, DOI 10.1093/cercor/11.3.210; Schubotz RI, 2007, TRENDS COGN SCI, V11, P211, DOI 10.1016/j.tics.2007.02.006; Schubotz RI, 2010, NEUROIMAGE, V50, P396, DOI 10.1016/j.neuroimage.2009.12.069; Simmonds DJ, 2007, NEUROPSYCHOLOGIA, V45, P2147, DOI 10.1016/j.neuropsychologia.2007.01.013; Spencer RMC, 2007, NEUROIMAGE, V36, P378, DOI 10.1016/j.neuroimage.2007.03.009; Stinear CM, 2007, BRAIN, V130, P170, DOI 10.1093/brain/awl333; Stoodley CJ, 2009, NEUROIMAGE, V44, P489, DOI 10.1016/j.neuroimage.2008.08.039; Strick PL, 2009, ANNU REV NEUROSCI, V32, P413, DOI 10.1146/annurev.neuro.31.060407.125606; Talairach J., 1988, COPLANAR STEREOTAXIC; Tesche CD, 2000, HUM BRAIN MAPP, V9, P119, DOI 10.1002/(SICI)1097-0193(200003)9:3<119::AID-HBM2>3.0.CO;2-R; Thaut MH, 2003, ANN NY ACAD SCI, V999, P364, DOI 10.1196/annals.1284.044; Thaut MH, 2001, FUNCT NEUROL, V16, P163; Thaut MH, 1999, IEEE ENG MED BIOL, V18, P101, DOI 10.1109/51.752991; Theoret H, 2001, NEUROSCI LETT, V306, P29, DOI 10.1016/S0304-3940(01)01860-2; Thobois S, 2000, NEUROLOGY, V55, P996, DOI 10.1212/WNL.55.7.996; Toma K, 2003, NEUROSCI LETT, V344, P177, DOI 10.1016/S0304-3940(03)00417-8; van Wegen E, 2006, PARKINSONISM RELAT D, V12, P21, DOI 10.1016/j.parkreldis.2005.06.009; Wassermann EM, 1998, EVOKED POTENTIAL, V108, P1, DOI 10.1016/S0168-5597(97)00096-8; Willems AM, 2007, MOVEMENT DISORD, V22, P1871, DOI 10.1002/mds.21445; Witt ST, 2008, NEUROIMAGE, V42, P343, DOI 10.1016/j.neuroimage.2008.04.025; Wolfensteller U, 2007, NEUROIMAGE, V36, pT33, DOI 10.1016/j.neuroimage.2007.03.040; WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023; Xu D, 2006, J NEUROSCI, V26, P5990, DOI 10.1523/JNEUROSCI.0038-06.2006; Zatorre RJ, 2007, NAT REV NEUROSCI, V8, P547, DOI 10.1038/nrn2152	92	22	22	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21421	10.1371/journal.pone.0021421	http://dx.doi.org/10.1371/journal.pone.0021421			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21738657	Green Published, gold			2022-12-27	WOS:000292290100022
J	Wang, N; Chang, C; Yao, Q; Li, GH; Qin, LG; Chen, L; Chen, KP				Wang, Nan; Chang, Cheng; Yao, Qin; Li, Guohui; Qin, Lvgao; Chen, Liang; Chen, Keping			Display of Bombyx mori Alcohol Dehydrogenases on the Bacillus subtilis Spore Surface to Enhance Enzymatic Activity under Adverse Conditions	PLOS ONE			English	Article							COAT; PURIFICATION; ANTIGENS; DELIVERY; PROTEINS; YEAST; COTC	Alcohol dehydrogenases (ADHs) are oxidoreductases catalyzing the reversible oxidation of alcohols to corresponding aldehydes or ketones accompanied by nicotinamide adenine dinucleotide (NAD) or nicotinamide adenine dinucleotide phosphate (NADP) as coenzyme. ADHs attract major scientific and industrial interest for the evolutionary perspectives, afforded by their wide occurrence in nature, and for their use in industrial synthesis. However, the low activity of ADHs under extremes of pH and temperature often limits their application. To obtain ADH with high activity, in this study, we used Bombyx mori alcohol dehydrogenases (BmADH) as foreign gene and constructed a recombinant integrative plasmid pJS700-BmADH. This pJS700-BmADH was transformed into Bacillus subtilis by double cross-over and produced an amylase inactivated mutant. The fusion protein containing BmADH was expressed on the spore surface and recognized by BmADH-specific antibody. We also assayed the alcohol dehydrogenase activity of the fusion protein together with the native BmADH at different pH and temperature levels, which indicated the recombinant enzyme exhibits activity over wider ranges of temperature and pH than its native form, perhaps due to the resistance properties of B. subtilis spores against adverse conditions.	[Wang, Nan; Chang, Cheng; Yao, Qin; Li, Guohui; Qin, Lvgao; Chen, Liang; Chen, Keping] Jiangsu Univ, Inst Life Sci, Zhenjiang, Jiangsu Prov, Peoples R China	Jiangsu University	Wang, N (corresponding author), Jiangsu Univ, Inst Life Sci, Zhenjiang, Jiangsu Prov, Peoples R China.	kpchen@ujs.edu.cn		Chen, Liang/0000-0001-7371-3130	Jiangsu Sci-Tech Support Project-Agriculture [BE2008379]; National Program of High-Tech Research and Development (863 High-Tech Program) [2008AA10Z145]; National Natural Science Foundation [30871826]	Jiangsu Sci-Tech Support Project-Agriculture; National Program of High-Tech Research and Development (863 High-Tech Program)(National High Technology Research and Development Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Jiangsu Sci-Tech Support Project-Agriculture (No. BE2008379), the National Program of High-Tech Research and Development (863 High-Tech Program, No. 2008AA10Z145), and the National Natural Science Foundation (No. 30871826). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barak I, 2005, MOL MICROBIOL, V55, P330, DOI 10.1111/j.1365-2958.2004.04445.x; Branden C.-I., 1975, ENZYMES, V11, P103; Chen W, 2002, BIOTECHNOL BIOENG, V79, P496, DOI 10.1002/bit.10407; Cutting S., 1990, MOL BIOL METHODS BAC; Dolega A, 2010, COORDIN CHEM REV, V254, P916, DOI 10.1016/j.ccr.2009.12.039; DONOVAN W, 1987, J MOL BIOL, V196, P1, DOI 10.1016/0022-2836(87)90506-7; Henriques AO, 2000, METHODS, V20, P95, DOI 10.1006/meth.1999.0909; Hirakawa H, 2004, J BIOSCI BIOENG, V97, P202, DOI 10.1263/jbb.97.202; Huang JM, 2008, VACCINE, V26, P6043, DOI 10.1016/j.vaccine.2008.09.024; Huo J, 2010, PROTEIN EXPRES PURIF, V72, P95, DOI 10.1016/j.pep.2010.01.014; Isticato R, 2004, J BACTERIOL, V186, P1129, DOI 10.1128/JB.186.4.1129-1135.2004; Isticato R, 2001, J BACTERIOL, V183, P6294, DOI 10.1128/JB.183.21.6294-6301.2001; Jung HC, 1998, NAT BIOTECHNOL, V16, P576, DOI 10.1038/nbt0698-576; Kim JH, 2005, BIOCHEM BIOPH RES CO, V331, P210, DOI 10.1016/j.bbrc.2005.03.144; Kim JH, 2007, J MICROBIOL BIOTECHN, V17, P677; LI Q, 2010, CHINESE J BIOTECHNOL, V26, P264; Mauriello EMF, 2004, VACCINE, V22, P1177, DOI 10.1016/j.vaccine.2003.09.031; Mazza P, 1994, Boll Chim Farm, V133, P3; Nicholson WL., 1990, MOL BIOL METHODS BAC, P391, DOI DOI 10.1111/J.1751-1097.1991.TB02087.X; Oggioni MR, 2003, VACCINE, V21, pS96, DOI 10.1016/S0264-410X(03)00207-X; OKUMA Y, 1991, J FERMENT BIOENG, V71, P309, DOI 10.1016/0922-338X(91)90341-D; OUDMAN L, 1991, HEREDITY, V67, P103, DOI 10.1038/hdy.1991.69; RACKER E, 1955, METHOD ENZYMOL, V1, P500, DOI 10.1016/0076-6879(55)01084-7; REID MF, 1994, CRIT REV MICROBIOL, V20, P13, DOI 10.3109/10408419409113545; RELLA R, 1987, EUR J BIOCHEM, V167, P475, DOI 10.1111/j.1432-1033.1987.tb13361.x; Sambrook J., 2001, MOL CLONING LAB MANU; VONWARTBURG JP, 1964, BIOCHEMISTRY-US, V3, P1775, DOI 10.1021/bi00899a033; Wernerus H, 2004, BIOTECHNOL APPL BIOC, V40, P209; Zhang ZH, 2006, HYPERTENSION, V48, P127, DOI 10.1161/01.HYP.0000224296.96235.dd	29	22	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21454	10.1371/journal.pone.0021454	http://dx.doi.org/10.1371/journal.pone.0021454			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21738670	Green Published, Green Submitted, gold			2022-12-27	WOS:000292290100025
J	Mas-Munoz, J; Komen, H; Schneider, O; Visch, SW; Schrama, JW				Mas-Munoz, Julia; Komen, Hans; Schneider, Oliver; Visch, Sander W.; Schrama, Johan W.			Feeding Behaviour, Swimming Activity and Boldness Explain Variation in Feed Intake and Growth of Sole (Solea solea) Reared in Captivity	PLOS ONE			English	Article							PLAICE PLEURONECTES-PLATESSA; TROUT SALMO-TRUTTA; FOOD-CONSUMPTION; ARCTIC CHARR; BROWN TROUT; ATLANTIC SALMON; DOVER SOLE; MACROPODUS-OPERCULARIS; INDIVIDUAL-DIFFERENCES; ANTIPREDATOR BEHAVIOR	The major economic constraint for culturing sole (Solea solea) is its slow and variable growth. The objective was to study the relationship between feed intake/efficiency, growth, and (non-) feeding behaviour of sole. Sixteen juveniles with an average (SD) growth of 2.7 (1.9) g/kg(0.8)/d were selected on their growth during a 4-week period in which they were housed communally with 84 other fish. Selected fish were housed individually during a second 4-week period to measure individual feed intake, growth, and behaviour. Fish were hand-fed three times a day during the dark phase of the day until apparent satiation. During six different days, behaviour was recorded twice daily during 3 minutes by direct observations. Total swimming activity, frequency of burying and of escapes were recorded. At the beginning and end of the growth period, two sequential behavioural tests were performed: "Novel Environment" and "Light Avoidance". Fish housed individually still exhibited pronounced variation in feed intake (CV = 23%), growth (CV = 25%) and behavior (CV = 100%). Differences in feed intake account for 79% of the observed individual differences in growth of sole. Fish with higher variation in feed intake between days and between meals within days had significantly a lower total feed intake (r = -0.65 and r = -0.77) and growth. Active fish showed significantly higher feed intake (r = 0.66) and growth (r = 0.58). Boldness during both challenge tests was related to fast growth: (1) fish which reacted with a lower latency time to swim in a novel environment had significantly higher feed intake (r = -0.55) and growth (r = -0.66); (2) fish escaping during the light avoidance test tended to show higher feed intake (P<0.1) and had higher growth (P<0.05). In conclusion, feeding consistency, swimming activity in the tank, and boldness during behavioral tests are related to feed intake and growth of sole in captivity.	[Mas-Munoz, Julia; Visch, Sander W.; Schrama, Johan W.] Wageningen Univ, Aquaculture & Fisheries Grp, Wageningen, Netherlands; [Komen, Hans; Schneider, Oliver] Wageningen Univ, Anim Breeding & Genet Grp, Wageningen, Netherlands; [Mas-Munoz, Julia; Schneider, Oliver] Wageningen IMARES, Yerseke, Netherlands	Wageningen University & Research; Wageningen University & Research; Wageningen University & Research	Mas-Munoz, J (corresponding author), Wageningen Univ, Aquaculture & Fisheries Grp, Wageningen, Netherlands.	julia.mas@wur.nl	Komen, Hans/D-8876-2012	Schrama, Johan/0000-0001-7156-8806	Wageningen University; IMARES institute in The Netherlands; Zeeuwse Tong Project; European Fisheries	Wageningen University(European Commission); IMARES institute in The Netherlands; Zeeuwse Tong Project; European Fisheries	This research project has been funded by Wageningen University and IMARES institute in The Netherlands, which together are integrated in a project theme on development and production in sea and coastal areas. Moreover this research is supported by the Zeeuwse Tong Project (Zeeland Sole Project), co-funded by the European Fisheries Fund. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of manuscript.	Aragao C, 2008, AMINO ACIDS, V34, P143, DOI 10.1007/s00726-007-0495-2; Armstrong JD, 1997, J ANIM ECOL, V66, P203, DOI 10.2307/6022; Berghahn R, 1995, NETH J SEA RES, V34, P131, DOI 10.1016/0077-7579(95)90021-7; Biro PA, 2008, TRENDS ECOL EVOL, V23, P361, DOI 10.1016/j.tree.2008.04.003; Biro PA, 2006, J ANIM ECOL, V75, P1165, DOI 10.1111/j.1365-2656.2006.01137.x; Blonk RJW, 2010, AQUACULTURE, V300, P43, DOI 10.1016/j.aquaculture.2009.12.028; Bridcut EE, 1995, CAN J FISH AQUAT SCI, V52, P2543, DOI 10.1139/f95-845; BURROWS MT, 1995, ANIM BEHAV, V50, P41, DOI 10.1006/anbe.1995.0219; CARO TM, 1986, ANIM BEHAV, V34, P1483, DOI 10.1016/S0003-3472(86)80219-6; CARTER CG, 1991, J FISH BIOL, V39, P873, DOI 10.1111/j.1095-8649.1991.tb04416.x; Carter CG, 1992, AQUAT LIVING RESOUR, V5, P225, DOI 10.1051/alr:1992022; CUI Y, 1988, J FISH BIOL, V32, P749, DOI 10.1111/j.1095-8649.1988.tb05414.x; CUI YB, 1990, COMP BIOCHEM PHYS A, V97, P551, DOI 10.1016/0300-9629(90)90126-D; Cutts CJ, 1998, J FISH BIOL, V52, P1026, DOI 10.1111/j.1095-8649.1998.tb00601.x; Dingemanse NJ, 2005, BEHAVIOUR, V142, P1159, DOI 10.1163/156853905774539445; Dinis MT, 1999, AQUACULTURE, V176, P27, DOI 10.1016/S0044-8486(99)00047-2; Duarte S, 2009, AQUACULT ENG, V41, P22, DOI 10.1016/j.aquaeng.2009.06.001; Ellis T, 1997, J FISH BIOL, V51, P389; Exadactylos A, 1998, J SEA RES, V40, P117, DOI 10.1016/S1385-1101(98)00015-X; FONDS M, 1992, NETH J SEA RES, V29, P127, DOI 10.1016/0077-7579(92)90014-6; FONDS M, 1989, AQUACULTURE BIOTECHN; Fraser DF, 2001, AM NAT, V158, P124, DOI 10.1086/321307; GERLAI R, 1990, BEHAV GENET, V20, P487, DOI 10.1007/BF01067715; GERVAI J, 1985, BEHAV GENET, V15, P503, DOI 10.1007/BF01065447; Gjedrem T, 2000, AQUAC RES, V31, P25, DOI 10.1046/j.1365-2109.2000.00389.x; GOTCEITAS V, 1990, OECOLOGIA, V83, P346, DOI 10.1007/BF00317558; Grima L, 2010, AQUACULTURE, V302, P169, DOI 10.1016/j.aquaculture.2010.02.016; Hepher B., 1988, NUTR POND FISHES; Howell B., 2009, AQUACULTURE EUROPE, V34, P24; Howell BR, 1997, AQUACULTURE, V155, P355, DOI 10.1016/S0044-8486(97)00103-8; Huntingford F, 2005, BEHAVIOUR, V142, P1207, DOI 10.1163/156853905774539382; Huntingford FA, 2004, J FISH BIOL, V65, P122, DOI 10.1111/j.0022-1112.2004.00562.x; Imsland AK, 2003, REV FISH BIOL FISHER, V13, P379, DOI 10.1007/s11160-004-1632-6; JOBLING M, 1989, AQUACULTURE, V81, P367, DOI 10.1016/0044-8486(89)90160-9; JOBLING M, 1985, AQUACULTURE, V44, P83, DOI 10.1016/0044-8486(85)90011-0; JOBLING M, 1983, J FISH BIOL, V22, P577, DOI 10.1111/j.1095-8649.1983.tb04217.x; JOBLING M, 1994, J FISH BIOL, V44, P1069, DOI 10.1111/j.1095-8649.1994.tb01277.x; Johnsson JI, 1996, CAN J FISH AQUAT SCI, V53, P1546, DOI 10.1139/cjfas-53-7-1546; Kadri S, 1997, J FISH BIOL, V50, P273, DOI 10.1006/jfbi.1996.0290; KOEBELE BP, 1985, ENVIRON BIOL FISH, V12, P181, DOI 10.1007/BF00005149; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; Kristiansen TS, 2007, APPL ANIM BEHAV SCI, V104, P236, DOI 10.1016/j.applanim.2006.09.007; Kristiansen TS, 2004, AQUACULTURE, V230, P137, DOI 10.1016/S0044-8486(03)00436-8; LAGARDERE JP, 1987, J FISH BIOL, V30, P91, DOI 10.1111/j.1095-8649.1987.tb05735.x; Lahti K, 2001, ANIM BEHAV, V62, P935, DOI 10.1006/anbe.2001.1821; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; LUITING P, 1991, LIVEST PROD SCI, V27, P321, DOI 10.1016/0301-6226(91)90127-C; Martins CIM, 2011, AQUACULTURE, V312, P192, DOI 10.1016/j.aquaculture.2010.12.035; Martins CIM, 2005, AQUAC RES, V36, P1509, DOI 10.1111/j.1365-2109.2005.01372.x; MCCARTHY ID, 1992, J FISH BIOL, V41, P257, DOI 10.1111/j.1095-8649.1992.tb02655.x; MCCARTHY ID, 1994, P ROY SOC B-BIOL SCI, V257, P141, DOI 10.1098/rspb.1994.0107; METCALFE NB, 1986, J FISH BIOL, V28, P525, DOI 10.1111/j.1095-8649.1986.tb05190.x; Overton JL, 2010, AQUAC RES, V42, P31, DOI 10.1111/j.1365-2109.2010.02502.x; QUIAN X, 2002, APPL ICHTHYOLOGY, V18, P695; Ragland GJ, 2004, HEREDITY, V92, P569, DOI 10.1038/sj.hdy.6800462; Ryer CH, 1996, J FISH BIOL, V48, P686, DOI 10.1111/j.1095-8649.1996.tb01464.x; Ryer CH, 2008, J EXP MAR BIOL ECOL, V359, P62, DOI 10.1016/j.jembe.2008.02.017; *SAS I INC, 2002, SASOONLINEDOC VERS 9; Schram E, 2006, AQUACULTURE, V252, P339, DOI 10.1016/j.aquaculture.2005.07.011; Sih A, 2003, ANIM BEHAV, V65, P29, DOI 10.1006/anbe.2002.2025; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; SMAGULA CM, 1982, T AM FISH SOC, V111, P543, DOI 10.1577/1548-8659(1982)111<543:DVIFCB>2.0.CO;2; Sundstrom LF, 2004, BEHAV ECOL, V15, P192, DOI 10.1093/beheco/arg089; Wang N, 1998, AQUACULTURE, V167, P43, DOI 10.1016/S0044-8486(98)00299-3; WERNER EE, 1993, AM NAT, V142, P242, DOI 10.1086/285537; WILSON DS, 1993, J COMP PSYCHOL, V107, P250, DOI 10.1037/0735-7036.107.3.250	67	35	37	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21393	10.1371/journal.pone.0021393	http://dx.doi.org/10.1371/journal.pone.0021393			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738651	Green Submitted, gold, Green Published			2022-12-27	WOS:000292092600036
J	Kuck, P; Garcia, FH; Misof, B; Meusemann, K				Kueck, Patrick; Garcia, Francisco Hita; Misof, Bernhard; Meusemann, Karen			Improved Phylogenetic Analyses Corroborate a Plausible Position of Martialis heureka in the Ant Tree of Life	PLOS ONE			English	Article							SEQUENCE ALIGNMENTS; BAYESIAN-INFERENCE; EARLY EVOLUTION; NEIGHBOR-NET; HYMENOPTERA; DIVERSIFICATION; RANDOMNESS; MRBAYES; AGE	Martialinae are pale, eyeless and probably hypogaeic predatory ants. Morphological character sets suggest a close relationship to the ant subfamily Leptanillinae. Recent analyses based on molecular sequence data suggest that Martialinae are the sister group to all extant ants. However, by comparing molecular studies and different reconstruction methods, the position of Martialinae remains ambiguous. While this sister group relationship was well supported by Bayesian partitioned analyses, Maximum Likelihood approaches could not unequivocally resolve the position of Martialinae. By re-analysing a previous published molecular data set, we show that the Maximum Likelihood approach is highly appropriate to resolve deep ant relationships, especially between Leptanillinae, Martialinae and the remaining ant subfamilies. Based on improved alignments, alignment masking, and tree reconstructions with a sufficient number of bootstrap replicates, our results strongly reject a placement of Martialinae at the first split within the ant tree of life. Instead, we suggest that Leptanillinae are a sister group to all other extant ant subfamilies, whereas Martialinae branch off as a second lineage. This assumption is backed by approximately unbiased (AU) tests, additional Bayesian analyses and split networks. Our results demonstrate clear effects of improved alignment approaches, alignment masking and data partitioning. We hope that our study illustrates the importance of thorough, comprehensible phylogenetic analyses using the example of ant relationships.	[Kueck, Patrick; Misof, Bernhard; Meusemann, Karen] Zool Forsch Museum Alexander Koenig ZFMK, Bonn, Germany; [Garcia, Francisco Hita] Calif Acad Sci, Dept Entomol, San Francisco, CA 94118 USA	Zoologisches Forschungsmuseum Alexander Koenig (ZFMK); California Academy of Sciences	Kuck, P (corresponding author), Zool Forsch Museum Alexander Koenig ZFMK, Bonn, Germany.	patrick_kueck@web.de	Meusemann, Karen/J-4027-2013; Garcia, Francisco Hita/C-9636-2015	Garcia, Francisco Hita/0000-0003-4709-3083	DFG [MI649/6-2, SPP 1174 (WA530/33)]	DFG(German Research Foundation (DFG))	The work of BM has been supported by the DFG (www.dfg.de) grant MI649/6-2, and PK is supported by a doctoral fellowship financed by the DFG, SPP 1174 (WA530/33), which is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOLTON B, 1990, SYST ENTOMOL, V15, P267, DOI 10.1111/j.1365-3113.1990.tb00063.x; Brady SG, 2006, P NATL ACAD SCI USA, V103, P18172, DOI 10.1073/pnas.0605858103; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Bryant D, 2007, ALGORITHM MOL BIOL, V2, DOI 10.1186/1748-7188-2-8; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Dinapoli A, 2011, J MOLLUS STUD, V77, P1, DOI 10.1093/mollus/eyq027; Douady CJ, 2003, MOL BIOL EVOL, V20, P248, DOI 10.1093/molbev/msg042; Dress AWM, 2008, ALGORITHM MOL BIOL, V3, DOI 10.1186/1748-7188-3-7; Erixon P, 2003, SYST BIOL, V52, P665, DOI 10.1080/10635150390235485; Golubchik T, 2007, MOL BIOL EVOL, V24, P2433, DOI 10.1093/molbev/msm176; Grimaldi D, 2000, P NATL ACAD SCI USA, V97, P13678, DOI 10.1073/pnas.240452097; Grimaldi David, 1997, American Museum Novitates, V3208, P1; Hartmann S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-95; Huelsenbeck JP, 2002, SYST BIOL, V51, P673, DOI 10.1080/10635150290102366; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kuck P., 2009, ALICUT PERLSCRIPT WH; Kuck P, 2010, MOL PHYLOGENET EVOL, V56, P1115, DOI 10.1016/j.ympev.2010.04.024; Kuck P, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-10; Meusemann K, 2010, MOL BIOL EVOL, V27, P2451, DOI 10.1093/molbev/msq130; Misof B, 2009, SYST BIOL, V58, P21, DOI 10.1093/sysbio/syp006; Moreau CS, 2009, MYRMECOL NEWS, V12, P201; Moreau CS, 2006, SCIENCE, V312, P101, DOI 10.1126/science.1124891; Murienne J, 2010, MOL PHYLOGENET EVOL, V57, P301, DOI 10.1016/j.ympev.2010.06.022; Nuin PAS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-471; Ott M, 2007, P ACM IEEE SUP C 200; Ouellette GD, 2006, MOL PHYLOGENET EVOL, V40, P359, DOI 10.1016/j.ympev.2006.03.017; Pattengale ND, 2010, J COMPUT BIOL, V17, P337, DOI 10.1089/cmb.2009.0179; PRATAS F, 2009, P ICPP 2009 VIENN AU; Rabeling C, 2008, P NATL ACAD SCI USA, V105, P14913, DOI 10.1073/pnas.0806187105; RAMBAUT A, J DA TRACER; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schwarzer J, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-186; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Simon S, 2009, MOL BIOL EVOL, V26, P2719, DOI 10.1093/molbev/msp191; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stover BC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-7; Suzuki Y, 2002, P NATL ACAD SCI USA, V99, P16138, DOI 10.1073/pnas.212646199; URBANI CB, 1992, SYST ENTOMOL, V17, P301, DOI 10.1111/j.1365-3113.1992.tb00553.x; Ward PS, 2010, ANT ECOLOGY, P3; Wilson EO, 2005, P NATL ACAD SCI USA, V102, P7411, DOI 10.1073/pnas.0502264102	43	27	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21031	10.1371/journal.pone.0021031	http://dx.doi.org/10.1371/journal.pone.0021031			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21731644	Green Submitted, Green Published, gold			2022-12-27	WOS:000292036900009
J	Landrieu, I; Smet-Nocca, C; Amniai, L; Louis, JV; Wieruszeski, JM; Goris, J; Janssens, V; Lippens, G				Landrieu, Isabelle; Smet-Nocca, Caroline; Amniai, Laziza; Louis, Justin Vijay; Wieruszeski, Jean-Michel; Goris, Jozef; Janssens, Veerle; Lippens, Guy			Molecular Implication of PP2A and Pin1 in the Alzheimer's Disease Specific Hyperphosphorylation of Tau	PLOS ONE			English	Article							PROTEIN PHOSPHATASE 2A; PAIRED HELICAL FILAMENTS; PROLYL ISOMERASE PIN1; DEVELOPMENTAL REGULATION; PHOSPHORYLATION SITES; DEPHOSPHORYLATION; BINDING; RECOGNIZES; HOLOENZYME; EXPRESSION	Background: Tau phosphorylation and dephosphorylation regulate in a poorly understood manner its physiological role of microtubule stabilization, and equally its integration in Alzheimer disease (AD) related fibrils. A specific phospho-pattern will result from the balance between kinases and phosphatases. The heterotrimeric Protein Phosphatase type 2A encompassing regulatory subunit PR55/Ba (PP2A(T55 alpha)) is a major Tau phosphatase in vivo, which contributes to its final phosphorylation state. We use NMR spectroscopy to determine the dephosphorylation rates of phospho-Tau by this major brain phosphatase, and present site-specific and kinetic data for the individual sites including the pS202/pT205 AT8 and pT231 AT180 phospho-epitopes. Methodology/Principal Findings: We demonstrate the importance of the PR55/B alpha regulatory subunit of PP2A within this enzymatic process, and show that, unexpectedly, phosphorylation at the pT231 AT180 site negatively interferes with the dephosphorylation of the pS202/pT205 AT8 site. This inhibitory effect can be released by the phosphorylation dependent prolyl cis/trans isomerase Pin1. Because the stimulatory effect is lost with the dimeric PP2A core enzyme (PP2A(D)) or with a phospho-Tau T231A mutant, we propose that Pin1 regulates the interaction between the PR55/B alpha subunit and the AT180 phospho-epitope on Tau. Conclusions/Significance: Our results show that phosphorylation of T231 (AT180) can negatively influence the dephosphorylation of the pS202/pT205 AT8 epitope, even without an altered PP2A pool. Thus, a priming dephosphorylation of pT231 AT180 is required for efficient PP2A(T55 alpha)-mediated dephosphorylation of pS202/pT205 AT8. The sophisticated interplay between priming mechanisms reported for certain Tau kinases and the one described here for Tau phosphatase PP2A(T55 alpha) may contribute to the hyperphosphorylation of Tau observed in AD neurons.	[Landrieu, Isabelle; Smet-Nocca, Caroline; Amniai, Laziza; Wieruszeski, Jean-Michel; Lippens, Guy] Univ Lille N France, IFR 147, CNRS, UMR 8576, Villeneuve Dascq, France; [Louis, Justin Vijay; Goris, Jozef; Janssens, Veerle] Univ Louvain, Fac Med, Dept Mol Cell Biol, Prot Phosphorylat & Prote Grp, Louvain, Belgium	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille	Landrieu, I (corresponding author), Univ Lille N France, IFR 147, CNRS, UMR 8576, Villeneuve Dascq, France.	isabelle.landrieu@univ-lille1.fr	Janssens, Veerle/I-7059-2016; Smet-Nocca, Caroline/U-3427-2019; Smet-Nocca, Caroline/G-2868-2012; Landrieu, Isabelle/AAF-8495-2019	Janssens, Veerle/0000-0002-6772-8448; Smet-Nocca, Caroline/0000-0002-9793-0882; Smet-Nocca, Caroline/0000-0002-9793-0882; Landrieu, Isabelle/0000-0002-4883-2637; Lippens, Guy/0000-0002-8236-0901	Region Nord; CNRS; Pasteur Institute of Lille; European Community (FEDER); French Research Ministry; University of Sciences and Technologies of Lille I; TGE RMN THC [Fr3050]; CNRS/Region Nord-Pas de Calais (France); 'Geconcerteerde OnderzoeksActies' of the Flemish government; 'Interuniversitary Attraction Poles' of the Belgian Science Policy [P6/28]; 'Fonds voor Wetenschappelijk Onderzoek-Vlaanderen';  [ANR-05-blanc-6320-01]	Region Nord(Region Hauts-de-France); CNRS(Centre National de la Recherche Scientifique (CNRS)); Pasteur Institute of Lille; European Community (FEDER)(European Commission); French Research Ministry(Ministry of Research, France); University of Sciences and Technologies of Lille I; TGE RMN THC; CNRS/Region Nord-Pas de Calais (France)(Centre National de la Recherche Scientifique (CNRS)Region Hauts-de-France); 'Geconcerteerde OnderzoeksActies' of the Flemish government; 'Interuniversitary Attraction Poles' of the Belgian Science Policy; 'Fonds voor Wetenschappelijk Onderzoek-Vlaanderen'(FWO); 	This work was supported by ANR-05-blanc-6320-01 grant. The NMR facilities were funded by the Region Nord, CNRS, Pasteur Institute of Lille, European Community (FEDER), French Research Ministry and the University of Sciences and Technologies of Lille I. Financial support from the TGE RMN THC Fr3050 for conducting the research is gratefully acknowledged. L.A. was supported by a pre-doctoral fellowship of the CNRS/Region Nord-Pas de Calais (France). J.V.L., J.G. and V.J. are supported by grants of the 'Geconcerteerde OnderzoeksActies' of the Flemish government, the 'Interuniversitary Attraction Poles' of the Belgian Science Policy P6/28 and the 'Fonds voor Wetenschappelijk Onderzoek-Vlaanderen'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amniai L, 2009, FASEB J, V23, P1146, DOI 10.1096/fj.08-121590; Augustinack JC, 2002, ACTA NEUROPATHOL, V103, P26, DOI 10.1007/s004010100423; Bertrand J, 2010, NEUROSCIENCE, V168, P323, DOI 10.1016/j.neuroscience.2010.04.009; Bodart JF, 2008, J MAGN RESON, V192, P252, DOI 10.1016/j.jmr.2008.03.006; Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; Cheng Q, 1996, BIOCHEMISTRY-US, V35, P15593, DOI 10.1021/bi960709b; Cho JH, 2004, J NEUROCHEM, V88, P349, DOI 10.1046/j.1471-4159.2003.02155.x; DREWES G, 1993, FEBS LETT, V336, P425, DOI 10.1016/0014-5793(93)80850-T; Gauthier A, 2010, BIOL CHEM, V391, P639, DOI 10.1515/BC.2010.060; Gharbi-Ayachi A, 2010, SCIENCE, V330, P1673, DOI 10.1126/science.1197048; GOEDERT M, 1995, J NEUROCHEM, V65, P2804; GOEDERT M, 1995, NEUROSCI LETT, V189, P167, DOI 10.1016/0304-3940(95)11484-E; GOEDERT M, 1994, BIOCHEM J, V301, P871, DOI 10.1042/bj3010871; GONG CX, 1994, NEUROSCIENCE, V61, P765, DOI 10.1016/0306-4522(94)90400-6; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Janssens V, 2008, TRENDS BIOCHEM SCI, V33, P113, DOI 10.1016/j.tibs.2007.12.004; Kins S, 2001, J BIOL CHEM, V276, P38193; Landrieu I, 2006, J AM CHEM SOC, V128, P3575, DOI 10.1021/ja054656+; Landrieu I, 2010, BIOCHEM SOC T, V38, P1006, DOI 10.1042/BST0381006; Lin YT, 2007, J NEUROCHEM, V103, P802, DOI 10.1111/j.1471-4159.2007.04792.x; Liou YC, 2003, NATURE, V424, P556, DOI 10.1038/nature01832; Lippens G, 2008, CHEM BIOL, V15, P311, DOI 10.1016/j.chembiol.2008.03.008; Louis JV, 2011, P NATL ACAD SCI USA, V108, P6957, DOI 10.1073/pnas.1018777108; Lu PJ, 1999, NATURE, V399, P784; Lu PJ, 1999, SCIENCE, V283, P1325, DOI 10.1126/science.283.5406.1325; Luna-Munoz J, 2005, J ALZHEIMERS DIS, V8, P29; Luna-Munoz J, 2007, J ALZHEIMERS DIS, V12, P365; Martens E, 2004, J MOL BIOL, V336, P971, DOI 10.1016/j.jmb.2003.12.047; Mochida S, 2010, SCIENCE, V330, P1670, DOI 10.1126/science.1195689; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Peterson DW, 2010, P NATL ACAD SCI USA, V107, P2884, DOI 10.1073/pnas.0912718107; Plattner F, 2006, J BIOL CHEM, V281, P25457, DOI 10.1074/jbc.M603469200; Schmidt K, 2002, EUR J NEUROSCI, V16, P2039, DOI 10.1046/j.1460-9568.2002.02274.x; Sillen A, 2007, BIOCHEMISTRY-US, V46, P3055, DOI 10.1021/bi061920i; Smet C, 2004, BIOCHEMISTRY-US, V43, P2032, DOI 10.1021/bi035479x; Smet C, 2004, CHEMBIOCHEM, V5, P1639, DOI 10.1002/cbic.200400145; Sontag E, 1999, J BIOL CHEM, V274, P25490, DOI 10.1074/jbc.274.36.25490; Sontag E, 1996, NEURON, V17, P1201, DOI 10.1016/S0896-6273(00)80250-0; Sontag E, 2004, J NEUROPATH EXP NEUR, V63, P287, DOI 10.1093/jnen/63.4.287; Thomson M, 2009, NATURE, V460, P274, DOI 10.1038/nature08102; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Vogelsberg-Ragaglia V, 2001, EXP NEUROL, V168, P402, DOI 10.1006/exnr.2001.7630; WAELKENS E, 1987, J BIOL CHEM, V262, P1049; Welburn Julie, 2004, V296, P219; Xu YH, 2008, MOL CELL, V31, P873, DOI 10.1016/j.molcel.2008.08.006; YAMAMOTO H, 1995, J BIOCHEM-TOKYO, V118, P1224, DOI 10.1093/oxfordjournals.jbchem.a125011; Zhou XZ, 2000, MOL CELL, V6, P873, DOI 10.1016/S1097-2765(00)00085-X	48	54	56	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21521	10.1371/journal.pone.0021521	http://dx.doi.org/10.1371/journal.pone.0021521			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731772	Green Published, Green Submitted, gold			2022-12-27	WOS:000292035400047
J	Sparkman, AM; Waits, LP; Murray, DL				Sparkman, Amanda M.; Waits, Lisette P.; Murray, Dennis L.			Social and Demographic Effects of Anthropogenic Mortality: A Test of the Compensatory Mortality Hypothesis in the Red Wolf	PLOS ONE			English	Article							SURVIVAL; HARVEST; POPULATIONS; MANAGEMENT; WOLVES; RATES	Whether anthropogenic mortality is additive or compensatory to natural mortality in animal populations has long been a question of theoretical and practical importance. Theoretically, under density-dependent conditions populations compensate for anthropogenic mortality through decreases in natural mortality and/or increases in productivity, but recent studies of large carnivores suggest that anthropogenic mortality can be fully additive to natural mortality and thereby constrain annual survival and population growth rate. Nevertheless, mechanisms underlying either compensatory or additive effects continue to be poorly understood. Using long-term data on a reintroduced population of the red wolf, we tested for evidence of additive vs. compensatory effects of anthropogenic mortality on annual survival and population growth rates, and the preservation and reproductive success of breeding pairs. We found that anthropogenic mortality had a strong additive effect on annual survival and population growth rate at low population density, though there was evidence for compensation in population growth at high density. When involving the death of a breeder, anthropogenic mortality was also additive to natural rates of breeding pair dissolution, resulting in a net decrease in the annual preservation of existing breeding pairs. However, though the disbanding of a pack following death of a breeder resulted in fewer recruits per litter relative to stable packs, there was no relationship between natural rates of pair dissolution and population growth rate at either high or low density. Thus we propose that short-term additive effects of anthropogenic mortality on population growth in the red wolf population at low density were primarily a result of direct mortality of adults rather than indirect socially-mediated effects resulting in reduced recruitment. Finally, we also demonstrate that per capita recruitment and the proportion of adults that became reproductive declined steeply with increasing population density, suggesting that there is potential for density-dependent compensation of anthropogenically-mediated population regulation.	[Sparkman, Amanda M.; Murray, Dennis L.] Trent Univ, Dept Biol, Peterborough, ON K9J 7B8, Canada; [Waits, Lisette P.] Univ Idaho, Dept Fish & Wildlife Resources, Moscow, ID USA	Trent University; Idaho; University of Idaho	Sparkman, AM (corresponding author), Trent Univ, Dept Biol, Peterborough, ON K9J 7B8, Canada.	asparkma@gmail.com		Waits, Lisette/0000-0002-1323-0812	U.S. Fish and Wildlife Service (USFWS); Canada Research Chairs program	U.S. Fish and Wildlife Service (USFWS)(US Fish & Wildlife Service); Canada Research Chairs program(Canada Research Chairs)	The fieldwork was funded by the U.S. Fish and Wildlife Service (USFWS) and grants to DLM from the Canada Research Chairs program and the Natural Sciences and Engineering Research Council (Canada) supported data analysis and write-up. With the exception of the long-term fieldwork conducted by the USFWS upon which this manuscript is based, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JR, 2006, MULTIFACETED MOL APP; Adams LG, 2008, WILDLIFE MONOGR, P1, DOI 10.2193/2008-012; ANDERSON DR, 1976, US FISH WILDLIFE SER, V128, P1; BARTMANN RM, 1992, WILDLIFE MONOGR, P1; Brainerd SM, 2008, J WILDLIFE MANAGE, V72, P89, DOI 10.2193/2006-305; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; BURNHAM KP, 1984, J WILDLIFE MANAGE, V48, P350, DOI 10.2307/3801166; Cooley HS, 2009, ECOLOGY, V90, P2913, DOI 10.1890/08-1805.1; Cote SD, 2001, WILDLIFE SOC B, V29, P726; Creel S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012918; FULLER TK, 1989, WILDLIFE MONOGR, P1; Fuller Todd K., 2003, P161; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; HARRINGTON FH, 1983, BEHAV ECOL SOCIOBIOL, V13, P19, DOI 10.1007/BF00295072; HEISEY DM, 1985, J WILDLIFE MANAGE, V49, P668, DOI 10.2307/3801692; KNOWLTON FF, 1972, J WILDLIFE MANAGE, V36, P369, DOI 10.2307/3799066; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; MCCARLEY H, 1979, RECENT CHANGES DISTR; Mech LD., 1970, WOLF ECOLOGY BEHAV E; Murray DL, 2006, J WILDLIFE MANAGE, V70, P1530, DOI 10.2193/0022-541X(2006)70[1530:OITSE]2.0.CO;2; Murray DL, 2010, BIOL CONSERV, V143, P2514, DOI 10.1016/j.biocon.2010.06.018; Pedersen HC, 2004, P ROY SOC B-BIOL SCI, V271, P381, DOI 10.1098/rspb.2003.2599; PHILLIPS MK, 2003, WOLVES BEHAV ECOLOGY; Robinson HS, 2008, ECOL APPL, V18, P1028, DOI 10.1890/07-0352.1; Rutledge LY, 2010, BIOL CONSERV, V143, P332, DOI 10.1016/j.biocon.2009.10.017; Sandercock BK, 2011, J ANIM ECOL, V80, P244, DOI 10.1111/j.1365-2656.2010.01769.x; Sedinger JS, 2010, J WILDLIFE MANAGE, V74, P326, DOI 10.2193/2009-071; Smith DW, 2010, J WILDLIFE MANAGE, V74, P620, DOI 10.2193/2008-584; Sparkman AM, 2011, P ROY SOC B-BIOL SCI, V278, P1381, DOI 10.1098/rspb.2010.1921; Sparkman AM, 2011, BEHAV ECOL, V22, P199, DOI 10.1093/beheco/arq194; *US FISH WILDL SER, 2007, 5 YEAR STAT REV SUMM; *US FISH WILDL SER, 1984, RED WOLF REC PLAN; Wallach AD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006861; [No title captured]	34	25	26	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e20868	10.1371/journal.pone.0020868	http://dx.doi.org/10.1371/journal.pone.0020868			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21738589	Green Published, gold			2022-12-27	WOS:000292035400005
J	Limana, F; Esposito, G; D'Arcangelo, D; Di Carlo, A; Romani, S; Melillo, G; Mangoni, A; Bertolami, C; Pompilio, G; Germani, A; Capogrossi, MC				Limana, Federica; Esposito, Grazia; D'Arcangelo, Daniela; Di Carlo, Anna; Romani, Sveva; Melillo, Guido; Mangoni, Antonella; Bertolami, Chiara; Pompilio, Giulio; Germani, Antonia; Capogrossi, Maurizio C.			HMGB1 Attenuates Cardiac Remodelling in the Failing Heart via Enhanced Cardiac Regeneration and miR-206-Mediated Inhibition of TIMP-3	PLOS ONE			English	Article							MOBILITY GROUP BOX-1; ISCHEMIA-REPERFUSION INJURY; MYOCARDIAL-INFARCTION; TISSUE INHIBITORS; PROTEIN; EXPRESSION; MICRORNAS; RECEPTOR; METALLOPROTEINASES; ACTIVATION	Aims: HMGB1 injection into the mouse heart, acutely after myocardial infarction (MI), improves left ventricular (LV) function and prevents remodeling. Here, we examined the effect of HMGB1 in chronically failing hearts. Methods and Results: Adult C57 BL16 female mice underwent coronary artery ligation; three weeks later 200 ng HMGB1 or denatured HMGB1 (control) were injected in the peri-infarcted region of mouse failing hearts. Four weeks after treatment, both echocardiography and hemodynamics demonstrated a significant improvement in LV function in HMGB1-treated mice. Further, HMGB1-treated mice exhibited a similar to 23% reduction in LV volume, a similar to 48% increase in infarcted wall thickness and a similar to 14% reduction in collagen deposition. HMGB1 induced cardiac regeneration and, within the infarcted region, it was found a similar to 2-fold increase in c-kit(+) cell number, a similar to 13-fold increase in newly formed myocytes and a similar to 2-fold increase in arteriole length density. HMGB1 also enhanced MMP2 and MMP9 activity and decreased TIMP-3 levels. Importantly, miR-206 expression 3 days after HMGB1 treatment was 4-5-fold higher than in control hearts and 20-25 fold higher that in sham operated hearts. HMGB1 ability to increase miR-206 was confirmed in vitro, in cardiac fibroblasts. TIMP3 was identified as a potential miR-206 target by TargetScan prediction analysis; further, in cultured cardiac fibroblasts, miR-206 gain- and loss-of-function studies and luciferase reporter assays showed that TIMP3 is a direct target of miR-206. Conclusions: HMGB1 injected into chronically failing hearts enhanced LV function and attenuated LV remodelling; these effects were associated with cardiac regeneration, increased collagenolytic activity, miR-206 overexpression and miR-206 mediated inhibition of TIMP-3.	[Limana, Federica; Pompilio, Giulio] IRCCS, Ctr Cardiol Monzino, Lab Biol Vasc & Med Rigenerat, Milan, Italy; [Esposito, Grazia; D'Arcangelo, Daniela; Di Carlo, Anna; Melillo, Guido; Mangoni, Antonella; Bertolami, Chiara; Capogrossi, Maurizio C.] IRCCS, Ist Dermopat Immacolata, Lab Patol Vasc, Milan, Italy; [Romani, Sveva] Casa Sollievo Sofferenza IRCCS, Mendel Lab, San Giovanni Rotondo, Italy; [Germani, Antonia] Fdn Livio Patrizi, Rome, Italy	IRCCS Centro Cardiologico Monzino; IRCCS Istituto Dermopatico dell'Immacolata (IDI); IRCCS Casa Sollievo Della Sofferenza; Istituto CSS Mendel	Limana, F (corresponding author), IRCCS, Ctr Cardiol Monzino, Lab Biol Vasc & Med Rigenerat, Milan, Italy.	capogrossi@idi.it	D'Arcangelo, Daniela/K-6533-2016; Limana, Federica/AAB-2989-2021; Pompilio, Giulio/J-6701-2014; Melillo, Guido/K-6341-2016; Di Carlo, Anna/AAY-4368-2021	D'Arcangelo, Daniela/0000-0002-7862-3289; Pompilio, Giulio/0000-0003-2581-5735; Melillo, Guido/0000-0002-2379-9471; Di Carlo, Anna/0000-0002-6037-6160	Italian Ministry of Health	Italian Ministry of Health(Ministry of Health, Italy)	This research was supported by a grant from Italian Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarbanell AM, 2011, SURGERY, V149, P329, DOI 10.1016/j.surg.2010.07.002; Andrassy M, 2008, CIRCULATION, V117, P3216, DOI 10.1161/CIRCULATIONAHA.108.769331; ANVERSA P, 2002, CARDIOVASCULAR SYSTE, P75; Barringhaus KG, 2009, CIRCULATION, V119, P2217, DOI 10.1161/CIRCULATIONAHA.107.715839; Bearzi C, 2007, P NATL ACAD SCI USA, V104, P14068, DOI 10.1073/pnas.0706760104; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Chavakis E, 2007, CIRC RES, V100, P204, DOI 10.1161/01.RES.0000257774.55970.f4; Creemers EEJM, 2001, CIRC RES, V89, P201, DOI 10.1161/hh1501.094396; De Mori R, 2007, ARTERIOSCL THROM VAS, V27, P2377, DOI 10.1161/ATVBAHA.107.153429; Ding HS, 2010, SAUDI MED J, V31, P486; Germani A, 2007, J LEUKOCYTE BIOL, V81, P41, DOI 10.1189/jlb.0306165; Greco S, 2009, FASEB J, V23, P3335, DOI 10.1096/fj.08-128579; Ikeda S, 2009, MOL CELL BIOL, V29, P2193, DOI 10.1128/MCB.01222-08; Kang KH, 2008, CARDIOVASC RES, V79, P150, DOI 10.1093/cvr/cvn072; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Kitahara T, 2008, CARDIOVASC RES, V80, P40, DOI 10.1093/cvr/cvn163; Kohno T, 2009, CARDIOVASC RES, V81, P565, DOI 10.1093/cvr/cvn291; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krum H, 2009, LANCET, V374, P1808, DOI 10.1016/S0140-6736(09)61992-9; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li YY, 1998, CIRCULATION, V98, P1728, DOI 10.1161/01.CIR.98.17.1728; Limana F, 2005, CIRC RES, V97, pE73, DOI 10.1161/01.RES.0000186276.06104.04; Liu HJ, 2010, J CELL SCI, V123, P2914, DOI 10.1242/jcs.057620; Liu PL, 2010, AM J RESP CELL MOL, V43, P530, DOI 10.1165/rcmb.2009-0269OC; Lovelock JD, 2005, AM J PHYSIOL-HEART C, V288, pH461, DOI 10.1152/ajpheart.00402.2004; Mitola S, 2006, J IMMUNOL, V176, P12, DOI 10.4049/jimmunol.176.1.12; Oozawa S, 2008, CIRC J, V72, P1178, DOI 10.1253/circj.72.1178; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Palumbo R, 2004, J CELL BIOL, V164, P441, DOI 10.1083/jcb.200304135; Palumbo R, 2007, J CELL BIOL, V179, P33, DOI 10.1083/jcb.200704015; Qi JH, 2003, NAT MED, V9, P407, DOI 10.1038/nm846; Qiu JH, 2010, STROKE, V41, P2077, DOI 10.1161/STROKEAHA.110.590463; Rossini A, 2008, J MOL CELL CARDIOL, V44, P683, DOI 10.1016/j.yjmcc.2008.01.009; Rota M, 2008, CIRC RES, V103, P107, DOI 10.1161/CIRCRESAHA.108.178525; Satoh M, 2010, J CARD FAIL, V16, P404, DOI 10.1016/j.cardfail.2010.01.002; Schlueter C, 2005, AM J PATHOL, V166, P1259, DOI 10.1016/S0002-9440(10)62344-9; Schlueter J, 2006, DEV BIOL, V295, P546, DOI 10.1016/j.ydbio.2006.03.036; Shan ZX, 2009, BIOCHEM BIOPH RES CO, V381, P597, DOI 10.1016/j.bbrc.2009.02.097; Small EM, 2010, CIRCULATION, V121, P1022, DOI 10.1161/CIRCULATIONAHA.109.889048; Takahashi K, 2008, CIRCULATION, V118, pS106, DOI 10.1161/CIRCULATIONAHA.107.757443; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Tian H, 2007, J MOL CELL CARDIOL, V43, P733, DOI 10.1016/j.yjmcc.2007.09.003; Ulloa L, 2006, CYTOKINE GROWTH F R, V17, P189, DOI 10.1016/j.cytogfr.2006.01.003; Urbanek K, 2005, CIRC RES, V97, P663, DOI 10.1161/01.RES.0000183733.53101.11; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; Vanhoutte D, 2010, J MOL CELL CARDIOL, V48, P445, DOI 10.1016/j.yjmcc.2009.09.013; Volz HC, 2010, BASIC RES CARDIOL, V105, P805, DOI 10.1007/s00395-010-0114-3	49	96	103	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e19845	10.1371/journal.pone.0019845	http://dx.doi.org/10.1371/journal.pone.0019845			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731608	gold, Green Published			2022-12-27	WOS:000292033700005
J	Liu, YL; Chiang, YH; Liu, GY; Hung, HC				Liu, Yi-Liang; Chiang, Yu-Hsiu; Liu, Guang-Yaw; Hung, Hui-Chih			Functional Role of Dimerization of Human Peptidylarginine Deiminase 4 (PAD4)	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; HISTONE DEIMINATION; MULTIPLE-SCLEROSIS; MOLECULAR-CLONING; GENE ORGANIZATION; STRUCTURAL BASIS; PROTEIN; CITRULLINATION; SEQUENCE; TARGET	Peptidylarginine deiminase 4 (PAD4) is a homodimeric enzyme that catalyzes Ca2+-dependent protein citrullination, which results in the conversion of arginine to citrulline. This paper demonstrates the functional role of dimerization in the regulation of PAD4 activity. To address this question, we created a series of dimer interface mutants of PAD4. The residues Arg8, Tyr237, Asp273, Glu281, Tyr435, Arg544 and Asp547, which are located at the dimer interface, were mutated to disturb the dimer organization of PAD4. Sedimentation velocity experiments were performed to investigate the changes in the quaternary structures and the dissociation constants (K-d) between wild-type and mutant PAD4 monomers and dimers. The kinetic data indicated that disrupting the dimer interface of the enzyme decreases its enzymatic activity and calcium-binding cooperativity. The K-d values of some PAD4 mutants were much higher than that of the wild-type (WT) protein (0.45 mu M) and were concomitant with lower k(cat) values than that of WT (13.4 s(-1)). The K-d values of the monomeric PAD4 mutants ranged from 16.8 to 45.6 mu M, and the k(cat) values of the monomeric mutants ranged from 3.3 to 7.3 s(-1). The k(cat) values of these interface mutants decreased as the K-d values increased, which suggests that the dissociation of dimers to monomers considerably influences the activity of the enzyme. Although dissociation of the enzyme reduces the activity of the enzyme, monomeric PAD4 is still active but does not display cooperative calcium binding. The ionic interaction between Arg8 and Asp547 and the Tyr435-mediated hydrophobic interaction are determinants of PAD4 dimer formation.	[Liu, Yi-Liang; Chiang, Yu-Hsiu; Hung, Hui-Chih] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan; [Liu, Yi-Liang; Chiang, Yu-Hsiu; Hung, Hui-Chih] Natl Chung Hsing Univ, Inst Genom & Bioinformat, Taichung 40227, Taiwan; [Liu, Yi-Liang; Liu, Guang-Yaw] Chung Shan Med Univ, Inst Microbiol & Immunol, Taichung, Taiwan; [Liu, Yi-Liang; Liu, Guang-Yaw] Chung Shan Med Univ Hosp, Div Rheumatol Allergy & Immunol, Taichung, Taiwan	National Chung Hsing University; National Chung Hsing University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital	Liu, YL (corresponding author), Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan.	liugy@csmu.edu.tw; hchung@dragon.nchu.edu.tw	Hung, Hui-Chih/L-8061-2019; Hung, Hui-Chih/G-4485-2013	Hung, Hui-Chih/0000-0003-0180-1822; Hung, Hui-Chih/0000-0003-0180-1822	National Science Council, Republic of China [NSC-99-2113-M-005-010, NSC-99-2314-B-040-002-MY3]; Ministry of Education, Taiwan, Republic of China	National Science Council, Republic of China(Ministry of Science and Technology, Taiwan); Ministry of Education, Taiwan, Republic of China(Ministry of Education, Taiwan)	This work was supported by the National Science Council, Republic of China (NSC-99-2113-M-005-010 and NSC-99-2314-B-040-002-MY3) and in part, by the Ministry of Education, Taiwan, Republic of China under the ATU plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	ALTSCHUL SF, 1994, NAT GENET, V6, P119, DOI 10.1038/ng0294-119; Andrade F, 2010, ARTHRITIS RHEUM-US, V62, P1630, DOI 10.1002/art.27439; Anzilotti C, 2010, AUTOIMMUN REV, V9, P158, DOI 10.1016/j.autrev.2009.06.002; Arita K, 2006, P NATL ACAD SCI USA, V103, P5291, DOI 10.1073/pnas.0509639103; Arita K, 2004, NAT STRUCT MOL BIOL, V11, P777, DOI 10.1038/nsmb799; Asaga H, 1998, BIOCHEM BIOPH RES CO, V243, P641, DOI 10.1006/bbrc.1998.8148; Barton A, 2004, ARTHRITIS RHEUM, V50, P1117, DOI 10.1002/art.20169; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chavanas S, 2004, GENE, V330, P19, DOI 10.1016/j.gene.2003.12.038; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cuthbert GL, 2004, CELL, V118, P545, DOI 10.1016/j.cell.2004.08.020; Guerrin M, 2003, BIOCHEM J, V370, P167, DOI 10.1042/BJ20020870; Gyorgy B, 2006, INT J BIOCHEM CELL B, V38, P1662, DOI 10.1016/j.biocel.2006.03.008; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hung HC, 2007, APOPTOSIS, V12, P475, DOI 10.1007/s10495-006-0005-0; Ishigami A, 2002, ARCH BIOCHEM BIOPHYS, V407, P25, DOI 10.1016/S0003-9861(02)00516-7; Ishigami A, 2010, GERIATR GERONTOL INT, V10, pS53, DOI 10.1111/j.1447-0594.2010.00593.x; Jones JE, 2009, CURR OPIN DRUG DISC, V12, P616; Kang CP, 2006, ARTHRITIS RHEUM-US, V54, P90, DOI 10.1002/art.21536; Kanno T, 2000, J INVEST DERMATOL, V115, P813, DOI 10.1046/j.1523-1747.2000.00131.x; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Knuckley B, 2010, BIOCHEMISTRY-US, V49, P4852, DOI 10.1021/bi100363t; Laue T.M., 1992, ANAL ULTRACENTRIFUGA; Li P, 2010, ONCOGENE, V29, P3153, DOI 10.1038/onc.2010.51; Li PX, 2008, MOL CELL BIOL, V28, P4745, DOI 10.1128/MCB.01747-07; Liao YF, 2005, ANAL BIOCHEM, V347, P176, DOI 10.1016/j.ab.2005.09.027; Liu GY, 2006, APOPTOSIS, V11, P183, DOI 10.1007/s10495-006-3715-4; Masson-Bessiere C, 2001, J IMMUNOL, V166, P4177, DOI 10.4049/jimmunol.166.6.4177; Mizoguchi M, 1998, J HISTOCHEM CYTOCHEM, V46, P1303, DOI 10.1177/002215549804601110; MOSCARELLO MA, 1994, J CLIN INVEST, V94, P146, DOI 10.1172/JCI117300; Nakashima K, 1999, J BIOL CHEM, V274, P27786, DOI 10.1074/jbc.274.39.27786; Nakashima K, 2002, J BIOL CHEM, V277, P49562, DOI 10.1074/jbc.M208795200; Reparon-Schuijt CC, 2001, ARTHRITIS RHEUM, V44, P41, DOI 10.1002/1529-0131(200101)44:1<41::AID-ANR6>3.0.CO;2-0; ROGERS GE, 1977, BIOCHIM BIOPHYS ACTA, V495, P159, DOI 10.1016/0005-2795(77)90250-1; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2010, BIOPHYS J, V98, P2005, DOI 10.1016/j.bpj.2009.12.4336; Senshu T, 1999, J DERMATOL SCI, V21, P113, DOI 10.1016/S0923-1811(99)00026-2; Slack JL, 2011, CELL MOL LIFE SCI, V68, P709, DOI 10.1007/s00018-010-0480-x; SLACK JL, 2011, BIOCHEMISTR IN PRESS; Suzuki A, 2005, BIOCHEM BIOPH RES CO, V333, P418, DOI 10.1016/j.bbrc.2005.05.137; Suzuki A, 2003, NAT GENET, V34, P395, DOI 10.1038/ng1206; Tarcsa E, 1996, J BIOL CHEM, V271, P30709, DOI 10.1074/jbc.271.48.30709; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van Boekel MAM, 2002, ARTHRITIS RES, V4, P87, DOI 10.1186/ar395; Vossenaar ER, 2003, ARTHRITIS RHEUM-US, V48, P2489, DOI 10.1002/art.11229; Vossenaar ER, 2004, ARTHRITIS RES THER, V6, P1, DOI 10.1186/ar1027; Vossenaar ER, 2003, BIOESSAYS, V25, P1106, DOI 10.1002/bies.10357; Vossenaar ER, 2004, ARTHRITIS RES THER, V6, pR142, DOI 10.1186/ar1149; Wang Y, 2004, SCIENCE, V306, P279, DOI 10.1126/science.1101400; Wood DD, 1996, ANN NEUROL, V40, P18, DOI 10.1002/ana.410400106; Wright PW, 2003, DEV BIOL, V256, P73, DOI 10.1016/S0012-1606(02)00126-4	51	39	40	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21314	10.1371/journal.pone.0021314	http://dx.doi.org/10.1371/journal.pone.0021314			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731701	Green Published, gold, Green Submitted			2022-12-27	WOS:000292033700062
J	Nowak, MD; Davis, AP; Anthony, F; Yoder, AD				Nowak, Michael D.; Davis, Aaron P.; Anthony, Francois; Yoder, Anne D.			Expression and Trans-Specific Polymorphism of Self-Incompatibility RNases in Coffea (Rubiaceae)	PLOS ONE			English	Article							F-BOX GENE; INBREEDING DEPRESSION; RECENT SPECIATION; POLLEN; EVOLUTION; RIBONUCLEASES; PHYLOGENY; ALLELES; LOCUS; COMPATIBILITY	Self-incompatibility (SI) is widespread in the angiosperms, but identifying the biochemical components of SI mechanisms has proven to be difficult in most lineages. Coffea (coffee; Rubiaceae) is a genus of old-world tropical understory trees in which the vast majority of diploid species utilize a mechanism of gametophytic self-incompatibility (GSI). The S-RNase GSI system was one of the first SI mechanisms to be biochemically characterized, and likely represents the ancestral Eudicot condition as evidenced by its functional characterization in both asterid (Solanaceae, Plantaginaceae) and rosid (Rosaceae) lineages. The S-RNase GSI mechanism employs the activity of class III RNase T2 proteins to terminate the growth of "self" pollen tubes. Here, we investigate the mechanism of Coffea GSI and specifically examine the potential for homology to S-RNase GSI by sequencing class III RNase T2 genes in populations of 14 African and Madagascan Coffea species and the closely related self-compatible species Psilanthus ebracteolatus. Phylogenetic analyses of these sequences aligned to a diverse sample of plant RNase T2 genes show that the Coffea genome contains at least three class III RNase T2 genes. Patterns of tissue-specific gene expression identify one of these RNase T2 genes as the putative Coffea S-RNase gene. We show that populations of SI Coffea are remarkably polymorphic for putative S-RNase alleles, and exhibit a persistent pattern of trans-specific polymorphism characteristic of all S-RNase genes previously isolated from GSI Eudicot lineages. We thus conclude that Coffea GSI is most likely homologous to the classic Eudicot S-RNase system, which was retained since the divergence of the Rubiaceae lineage from an ancient SI Eudicot ancestor, nearly 90 million years ago.	[Nowak, Michael D.; Yoder, Anne D.] Duke Univ, Dept Biol, Durham, NC USA; [Davis, Aaron P.] Royal Bot Gardens, Surrey, England; [Anthony, Francois] Ctr Montpellier, Inst Rech Dev, Unite Mixte Rech Resistance Plantes Bioagresseurs, Montpellier, France	Duke University; Royal Botanic Gardens, Kew; Institut de Recherche pour le Developpement (IRD)	Nowak, MD (corresponding author), Univ Algarve, Ctr Ciencias Mar Algarve, Campus Gambelas, Faro, Portugal.	michael.nowak@duke.edu	Nowak, Michael/M-3747-2017; Anthony, Francois F/A-9341-2008	Nowak, Michael/0000-0001-8924-6506; 	United States National Science Foundation [0849186]; Society of Systematic Biologists; American Society of Plant Taxonomists; Duke University Graduate School	United States National Science Foundation(National Science Foundation (NSF)); Society of Systematic Biologists; American Society of Plant Taxonomists; Duke University Graduate School	This work was supported by the United States National Science Foundation (www.nsf.gov; 0849186 to ADY), and graduate student research grants to MDN from the Society of Systematic Biologists (www.systbiol.org), American Society of Plant Taxonomists (www.aspt.net), and Duke University Graduate School (www.gradschool.duke.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; ALEXANDER MP, 1987, STAIN TECHNOL, V62, P107, DOI 10.3109/10520298709107976; Allen A. M., 2008, P73, DOI 10.1007/978-3-540-68486-2_4; Anderson CL, 2005, AM J BOT, V92, P1737, DOI 10.3732/ajb.92.10.1737; ANDERSON MA, 1989, PLANT CELL, V1, P483, DOI 10.1105/tpc.1.5.483; ANDERSON MA, 1986, NATURE, V321, P38, DOI 10.1038/321038a0; ANDERSON W R, 1973, Taxon, V22, P537, DOI 10.2307/1218628; [Anonymous], 2014, TRACER V1 6; Anthony F, 2010, PLANT SYST EVOL, V285, P51, DOI 10.1007/s00606-009-0255-8; BATEMAN AJ, 1952, HEREDITY, V6, P285, DOI 10.1038/hdy.1952.40; BERTHAUD J, 1980, CAFE CACAO THE, V24, P267; BERTHOU F, 1983, THEOR APPL GENET, V65, P77, DOI 10.1007/BF00276268; Bosch M, 2008, J EXP BOT, V59, P481, DOI 10.1093/jxb/erm195; Brandvain Y, 2005, AM NAT, V166, P330, DOI 10.1086/432036; Carvalho A, 1969, OUTLINES PERENNIAL C, V4, P189; Charlesworth D, 2005, NEW PHYTOL, V168, P61, DOI 10.1111/j.1469-8137.2005.01443.x; CHARLESWORTH D, 1987, ANNU REV ECOL SYST, V18, P237, DOI 10.1146/annurev.es.18.110187.001321; CHARLESWORTH D, 1995, BIOESSAYS, V17, P31, DOI 10.1002/bies.950170108; CHARRIER A, 1985, P13; CHARRIER A, 1979, MEMOIRES ORSTOM, V87; Chawla B, 1997, THEOR APPL GENET, V95, P992, DOI 10.1007/s001220050652; CLARK AG, 1993, MECHANISMS OF MOLECULAR EVOLUTION, P79; Coulibaly I, 2002, THEOR APPL GENET, V105, P994, DOI 10.1007/s00122-002-1008-z; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Davis AP, 2007, AM J BOT, V94, P313, DOI 10.3732/ajb.94.3.313; Davis AP, 2006, BOT J LINN SOC, V152, P465, DOI 10.1111/j.1095-8339.2006.00584.x; deNettancourt D, 1997, SEX PLANT REPROD, V10, P185, DOI 10.1007/s004970050087; Devier B, 2009, GENETICS, V181, P209, DOI 10.1534/genetics.108.093708; FIGUEROA F, 1988, NATURE, V335, P265, DOI 10.1038/335265a0; Foxe JP, 2009, P NATL ACAD SCI USA, V106, P5241, DOI 10.1073/pnas.0807679106; Franklin-Tong N, 2003, TRENDS PLANT SCI, V8, P598, DOI 10.1016/j.tplants.2003.10.008; Franklin-Tong VE, 2007, J INTEGR PLANT BIOL, V49, P1219, DOI 10.1111/j.1672-9072.2007.00516.x; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Goldberg EE, 2010, SCIENCE, V330, P493, DOI 10.1126/science.1194513; Govaerts R., 2010, WORLD CHECKLIST RUBI; GREEN PJ, 1994, ANNU REV PLANT PHYS, V45, P421, DOI 10.1146/annurev.pp.45.060194.002225; Guo YL, 2009, P NATL ACAD SCI USA, V106, P5246, DOI 10.1073/pnas.0808012106; Husband BC, 1996, EVOLUTION, V50, P54, DOI [10.2307/2410780, 10.1111/j.1558-5646.1996.tb04472.x]; Igic B, 2004, NEW PHYTOL, V161, P97, DOI 10.1046/j.1469-8137.2003.00952.x; Igic B, 2001, P NATL ACAD SCI USA, V98, P13167, DOI 10.1073/pnas.231386798; Igic B, 2008, INT J PLANT SCI, V169, P93, DOI 10.1086/523362; IOERGER TR, 1990, P NATL ACAD SCI USA, V87, P9732, DOI 10.1073/pnas.87.24.9732; Irie M, 1999, PHARMACOL THERAPEUT, V81, P77, DOI 10.1016/S0163-7258(98)00035-7; Itagaki T, 2006, BIOL PHARM BULL, V29, P875, DOI 10.1248/bpb.29.875; Kao TH, 2004, PLANT CELL, V16, pS72, DOI 10.1105/tpc.016154; Kaothien-Nakayama P, 2010, PLANT DEVELOPMENTAL BIOLOGY - BIOTECHNOLOGICAL PERSPECTIVES, VOL 1, P459, DOI 10.1007/978-3-642-02301-9_22; Klein DE, 2009, SEX PLANT REPROD, V22, P121, DOI 10.1007/s00497-009-0097-0; Lai Z, 2002, PLANT MOL BIOL, V50, P29, DOI 10.1023/A:1016050018779; Lashermes P, 1999, MOL GEN GENET, V261, P259, DOI 10.1007/s004380050965; Lashermes P, 2001, GENOME, V44, P589, DOI 10.1139/gen-44-4-589; LEE HS, 1994, NATURE, V367, P560, DOI 10.1038/367560a0; Luhtala N, 2010, TRENDS BIOCHEM SCI, V35, P253, DOI 10.1016/j.tibs.2010.02.002; MacIntosh GC, 2010, MOL GENET GENOMICS, V283, P381, DOI 10.1007/s00438-010-0524-9; Magallon S, 2009, AM J BOT, V96, P349, DOI 10.3732/ajb.0800060; Matton DP, 1997, PLANT CELL, V9, P1757, DOI 10.1105/tpc.9.10.1757; Maurin O, 2007, ANN BOT-LONDON, V100, P1565, DOI 10.1093/aob/mcm257; McClure BA, 2006, PLANTA, V224, P233, DOI 10.1007/s00425-006-0284-2; Miller JS, 2008, EVOLUTION, V62, P1052, DOI 10.1111/j.1558-5646.2008.00358.x; Miller JS, 2000, SCIENCE, V289, P2335, DOI 10.1126/science.289.5488.2335; Nasrallah JB, 2007, GENETICS, V175, P1965, DOI 10.1534/genetics.106.069393; Nylander J. A. A., 2004, MRMODELTEST V2; Paetsch M, 2010, EVOLUTION IN ACTION: CASE STUDIES IN ADAPTIVE RADIATION, SPECIATION AND THE ORIGIN OF BIODIVERSITY, P77, DOI 10.1007/978-3-642-12425-9_5; Plechakova O, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-123; Richman AD, 1999, P NATL ACAD SCI USA, V96, P168, DOI 10.1073/pnas.96.1.168; RIVEROS GM, 1995, PLANT SYST EVOL, V194, P1, DOI 10.1007/BF00983212; ROBERTSON K, 2010, COMP EVIDENCE CORREL; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sassa H, 1996, MOL GEN GENET, V250, P547; SCHEMSKE DW, 1985, EVOLUTION, V39, P41, DOI [10.2307/2408515, 10.1111/j.1558-5646.1985.tb04078.x]; Sherman-Broyles S., 2008, P123, DOI 10.1007/978-3-540-68486-2_6; Sloop CM, 2009, BIOL INVASIONS, V11, P1131, DOI 10.1007/s10530-008-9385-0; Stebbins G. L., 1970, ANNU REV ECOL SYST, V1, P307, DOI DOI 10.1146/ANNUREV.ES.01.110170.001515; Steinbachs JE, 2002, MOL BIOL EVOL, V19, P825, DOI 10.1093/oxfordjournals.molbev.a004139; Stoffelen P, 2009, TAXON, V58, P133, DOI 10.1002/tax.581014; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Tosh J, 2009, ANN MO BOT GARD, V96, P194, DOI 10.3417/2006202; Ushijima K, 2003, PLANT CELL, V15, P771, DOI 10.1105/tpc.009290; Uyenoyama MK, 2003, THEOR POPUL BIOL, V63, P281, DOI 10.1016/S0040-5809(03)00020-0; Vega FE, 2003, NATURE, V425, P343, DOI 10.1038/425343a; VEKEMANS X, 1994, GENETICS, V137, P1157; Vieira CP, 2002, HEREDITY, V88, P172, DOI 10.1038/sj.hdy.6800024; Vieira J, 2008, J MOL EVOL, V67, P179, DOI 10.1007/s00239-008-9137-x; Vieira J, 2007, J MOL EVOL, V65, P175, DOI 10.1007/s00239-006-0285-6; Watanabe M., 2008, P151, DOI 10.1007/978-3-540-68486-2_7; Wheeler D, 2007, GENETICS, V177, P2171, DOI 10.1534/genetics.107.076885; WHITEHOUSE HLK, 1950, ANN BOT-LONDON, V14, P199, DOI 10.1093/oxfordjournals.aob.a083243; Wu X, 2010, PLANT BIOLOGY, V12, P484, DOI 10.1111/j.1438-8677.2009.00242.x; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yeung K, 2005, EVOLUTION, V59, P2048; Zhang Y., 2008, P193, DOI 10.1007/978-3-540-68486-2_9	91	45	46	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21019	10.1371/journal.pone.0021019	http://dx.doi.org/10.1371/journal.pone.0021019			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731641	Green Published, gold			2022-12-27	WOS:000292033700028
J	Gasnault, J; Costagliola, D; Hendel-Chavez, H; Dulioust, A; Pakianather, S; Mazet, AA; de Herve, MGD; Lancar, R; Lascaux, AS; Porte, L; Delfraissy, JF; Taoufik, Y				Gasnault, Jacques; Costagliola, Dominique; Hendel-Chavez, Houria; Dulioust, Anne; Pakianather, Sophie; Mazet, Anne-Aurelie; de Herve, Marie-Ghislaine de Goer; Lancar, Remi; Lascaux, Anne-Sophie; Porte, Lydie; Delfraissy, Jean-Francois; Taoufik, Yassine		ANRS 125 Trial Team	Improved Survival of HIV-1-Infected Patients with Progressive Multifocal Leukoencephalopathy Receiving Early 5-Drug Combination Antiretroviral Therapy	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; T-LYMPHOCYTES; CEREBROSPINAL-FLUID; PROLONGED SURVIVAL; CELL RESPONSES; HIV; HAART; ENFUVIRTIDE; ASSOCIATION; INFECTION	Background: Progressive multifocal leukoencephalopathy (PML), a rare devastating demyelinating disease caused by the polyomavirus JC (JCV), occurs in severely immunocompromised patients, most of whom have advanced-stage HIV infection. Despite combination antiretroviral therapy (cART), 50% of patients die within 6 months of PML onset. We conducted a multicenter, open-label pilot trial evaluating the survival benefit of a five-drug cART designed to accelerate HIV replication decay and JCV-specific immune recovery. Methods and Findings: All the patients received an optimized cART with three or more drugs for 12 months, plus the fusion inhibitor enfuvirtide during the first 6 months. The main endpoint was the one-year survival rate. A total of 28 patients were enrolled. At entry, median CD4+ T-cell count was 53 per microliter and 86% of patients had detectable plasma HIV RNA and CSF JCV DNA levels. Seven patients died, all before month 4. The one-year survival estimate was 0.75 (95% confidence interval, 0.61 to 0.93). At month 6, JCV DNA was undetectable in the CSF of 81% of survivors. At month 12, 81% of patients had undetectable plasma HIV RNA, and the median CD4+ T-cell increment was 105 per microliter. In univariate analysis, higher total and naive CD4+ T-cell counts and lower CSF JCV DNA level at baseline were associated with better survival. JCV-specific functional memory CD4+ T-cell responses, based on a proliferation assay, were detected in 4% of patients at baseline and 43% at M12 (P = 0.008). Conclusions: The early use of five-drug cART after PML diagnosis appears to improve survival. This is associated with recovery of anti-JCV T-cell responses and JCV clearance from CSF. A low CD4+ T-cell count (particularly naive subset) and high JCV DNA copies in CSF at PML diagnosis appear to be risk factors for death.	[Gasnault, Jacques; Dulioust, Anne; Delfraissy, Jean-Francois] Hop Univ Bicetre, Serv Med Interne & Malad Infect, AP HP, Le Kremlin Bicetre, France; [Gasnault, Jacques; Hendel-Chavez, Houria; de Herve, Marie-Ghislaine de Goer; Delfraissy, Jean-Francois; Taoufik, Yassine] INSERM, U1012, F-94275 Le Kremlin Bicetre, France; [Costagliola, Dominique] Grp Hosp Pitie Salpetriere, Serv Malad Infect & Trop, AP HP, F-75634 Paris, France; [Costagliola, Dominique; Pakianather, Sophie; Lancar, Remi] INSERM, U943, Paris, France; [Costagliola, Dominique] UPMC Univ Paris 06, UMR S 943, Paris, France; [Hendel-Chavez, Houria; Taoufik, Yassine] Hop Univ Bicetre, Immunol Lab, AP HP, Le Kremlin Bicetre, France; [Mazet, Anne-Aurelie] Hop Univ Bicetre, Virol Lab, AP HP, Le Kremlin Bicetre, France; [Lascaux, Anne-Sophie] Hop Henri Mondor, Serv Immunol Clin, AP HP, F-94010 Creteil, France; [Porte, Lydie] Hop Purpan, Serv Malad Infect, Toulouse, France; [Delfraissy, Jean-Francois; Taoufik, Yassine] UPS Univ Paris 11, Fac Med Bicetre, Le Kremlin Bicetre, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; CHU de Toulouse	Gasnault, J (corresponding author), Hop Univ Bicetre, Serv Med Interne & Malad Infect, AP HP, Le Kremlin Bicetre, France.	jacques.gasnault@bct.aphp.fr	Costagliola, Dominique/H-5849-2011	Costagliola, Dominique/0000-0003-0765-0869; MOULIGNIER, Antoine/0000-0001-7566-0175	The French National Agency for Research on AIDS and Viral Hepatitis (ANRS, Paris)	The French National Agency for Research on AIDS and Viral Hepatitis (ANRS, Paris)(ANRS)	The French National Agency for Research on AIDS and Viral Hepatitis (ANRS, 101 rue de Tolbiac, 75013 Paris) sponsored the trial and was involved in the study design. After approval of the protocol, the sponsor was not involved in the collection, analysis or interpretation of the data, writing of the report, or the decision to submit the paper for publication. Roche provided Fuzeon (enfuvirtide) and Gilead provided Truvada (tenofovir plus emtricitabine).	Antinori A, 2003, J NEUROVIROL, V9, P47, DOI 10.1080/13550280390195388; Berger JR, 2001, J NEUROVIROL, V7, P329; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Cinque P, 2003, J NEUROVIROL, V9, P88, DOI 10.1080/13550280390195298; Cinque P, 1998, NEW ENGL J MED, V339, P848, DOI 10.1056/NEJM199809173391216; Cinque P, 2001, J NEUROVIROL, V7, P358; Clifford DB, 1999, NEUROLOGY, V52, P623, DOI 10.1212/WNL.52.3.623; Day CL, 2003, J EXP MED, V198, P1773, DOI 10.1084/jem.20031947; de Herve MGD, 2008, J IMMUNOL, V181, P5974, DOI 10.4049/jimmunol.181.9.5974; De Luca A, 2000, J INFECT DIS, V182, P1077, DOI 10.1086/315817; De Luca A, 2008, AIDS, V22, P1759, DOI 10.1097/QAD.0b013e32830a5043; Du Pasquier RA, 2004, BRAIN, V127, P1970, DOI 10.1093/brain/awh215; Engsig FN, 2009, J INFECT DIS, V199, P77, DOI 10.1086/595299; Falco V, 2008, JAIDS-J ACQ IMM DEF, V49, P26, DOI 10.1097/QAI.0b013e31817bec64; Gasnault J, 2006, REV NEUROL-FRANCE, V162, P43, DOI 10.1016/S0035-3787(06)74981-5; Gasnault J, 1999, J NEUROVIROL, V5, P421, DOI 10.3109/13550289909029483; Gasnault J, 2003, AIDS, V17, P1443, DOI 10.1097/00002030-200307040-00004; Grabar S, 2008, HIV MED, V9, P246, DOI 10.1111/j.1468-1293.2008.00554.x; Herman J, 2004, PEDIATR TRANSPLANT, V8, P485, DOI 10.1111/j.1399-3046.2004.00211.x; Koralnik IJ, 2002, J IMMUNOL, V168, P499, DOI 10.4049/jimmunol.168.1.499; Letendre Scott L, 2010, Top HIV Med, V18, P45; Levy Y, 2009, J CLIN INVEST, V119, P997, DOI 10.1172/JCI38052; Lima MA, 2007, J VIROL, V81, P3361, DOI 10.1128/JVI.01809-06; Mocroft A, 2009, CLIN INFECT DIS, V48, P1138, DOI 10.1086/597468; Molto J, 2006, ANTIVIR THER, V11, P47; Monforte AD, 2004, ANN NEUROL, V55, P320, DOI 10.1002/ana.10827; Raffi F, 2006, CLIN INFECT DIS, V42, P870, DOI 10.1086/500206; Reynes J, 2007, AIDS PATIENT CARE ST, V21, P533, DOI 10.1089/apc.2006.0174; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; TADA H, 1990, P NATL ACAD SCI USA, V87, P3479, DOI 10.1073/pnas.87.9.3479; Tan K, 2009, NEUROLOGY, V72, P1458, DOI 10.1212/01.wnl.0000343510.08643.74; Taoufik Y, 1998, J INFECT DIS, V178, P1816, DOI 10.1086/314496; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Vendrely A, 2005, ACTA NEUROPATHOL, V109, P449, DOI 10.1007/s00401-005-0983-y; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Younes SA, 2003, J EXP MED, V198, P1909, DOI 10.1084/jem.20031598	36	43	46	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e20967	10.1371/journal.pone.0020967	http://dx.doi.org/10.1371/journal.pone.0020967			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738597	gold, Green Published, Green Submitted			2022-12-27	WOS:000292291800007
J	Lladser, ME; Gouet, R; Reeder, J				Lladser, Manuel E.; Gouet, Raul; Reeder, Jens			Extrapolation of Urn Models via Poissonization: Accurate Measurements of the Microbial Unknown	PLOS ONE			English	Article							NONPARAMETRIC-ESTIMATION; PROBABILITY; NUMBER; POPULATION; DIVERSITY; COVERAGE	The availability of high-throughput parallel methods for sequencing microbial communities is increasing our knowledge of the microbial world at an unprecedented rate. Though most attention has focused on determining lower-bounds on the a-diversity i.e. the total number of different species present in the environment, tight bounds on this quantity may be highly uncertain because a small fraction of the environment could be composed of a vast number of different species. To better assess what remains unknown, we propose instead to predict the fraction of the environment that belongs to unsampled classes. Modeling samples as draws with replacement of colored balls from an urn with an unknown composition, and under the sole assumption that there are still undiscovered species, we show that conditionally unbiased predictors and exact prediction intervals (of constant length in logarithmic scale) are possible for the fraction of the environment that belongs to unsampled classes. Our predictions are based on a Poissonization argument, which we have implemented in what we call the Embedding algorithm. In fixed i.e. non-randomized sample sizes, the algorithm leads to very accurate predictions on a sub-sample of the original sample. We quantify the effect of fixed sample sizes on our prediction intervals and test our methods and others found in the literature against simulated environments, which we devise taking into account datasets from a human-gut and -hand microbiota. Our methodology applies to any dataset that can be conceptualized as a sample with replacement from an urn. In particular, it could be applied, for example, to quantify the proportion of all the unseen solutions to a binding site problem in a random RNA pool, or to reassess the surveillance of a certain terrorist group, predicting the conditional probability that it deploys a new tactic in a next attack.	[Lladser, Manuel E.] Univ Colorado, Dept Appl Math, Boulder, CO 80309 USA; [Gouet, Raul] Univ Chile, Ctr Modelamiento Matemat CNRS UMI 2807, Santiago, Chile; [Reeder, Jens] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); Universidad de Chile; University of Colorado System; University of Colorado Boulder	Lladser, ME (corresponding author), Univ Colorado, Dept Appl Math, Boulder, CO 80309 USA.	manuel.lladser@colorado.edu	Gouet, Raul/I-6302-2016; Lladser, Manuel/O-7557-2019	Gouet, Raul/0000-0003-3125-6773; Lladser, Manuel/0000-0001-6843-6845	NASA [ROSES NNX08AP60G]; NIH [R01 HG004872]; FONDAP; BASAL-CMM; Fondecyt [1090216]; German Academic Exchange Service (DAAD); NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004872] Funding Source: NIH RePORTER	NASA(National Aeronautics & Space Administration (NASA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FONDAP; BASAL-CMM(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/BASAL); Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	M. Lladser was partially supported by NASA ROSES NNX08AP60G and NIH R01 HG004872. R. Gouet was supported by FONDAP, BASAL-CMM and Fondecyt 1090216. J. Reeder was supported by a post-doctoral scholarship from the German Academic Exchange Service (DAAD). M. Lladser and R. Gouet are thankful to the project Nucleo Milenio Informacion y Aleatoriedad, which facilitated a research visit to collaborate in person. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramowitz M., 1964, HDB MATH FUNCTIONS F; Aldous D. J., 1988, PROBABILITY APPROXIM; BUNGE J, 1993, J AM STAT ASSOC, V88, P364, DOI 10.2307/2290733; BURNHAM KP, 1978, BIOMETRIKA, V65, P625, DOI 10.2307/2335915; CHAO A, 1984, SCAND J STAT, V11, P265; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; CLAYTON MK, 1987, J AM STAT ASSOC, V82, P305, DOI 10.2307/2289168; Curtis TP, 2006, PHILOS T R SOC B, V361, P2023, DOI 10.1098/rstb.2006.1921; Durrett R., 1999, ESSENTIALS STOCHASTI; ESTY WW, 1983, ANN STAT, V11, P905, DOI 10.1214/aos/1176346256; Fierer N, 2010, P NATL ACAD SCI USA, V107, P6477, DOI 10.1073/pnas.1000162107; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Hinsley F.H, 1993, CODEBREAKERS INSIDE; Hong SH, 2006, P NATL ACAD SCI USA, V103, P117, DOI 10.1073/pnas.0507245102; Hughes JB, 2001, APPL ENVIRON MICROB, V67, P4399, DOI 10.1128/AEM.67.10.4399-4406.2001; Hwang HK, 2008, ANN PROBAB, V36, P992, DOI 10.1214/07-AOP350; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; MAHMOUD HM, 2000, WIL INT S D, pR11; Mao CX, 2007, ANN STAT, V35, P917, DOI 10.1214/009053606000001280; Mao CX, 2002, BIOMETRIKA, V89, P669, DOI 10.1093/biomet/89.3.669; Quince C, 2008, ISME J, V2, P997, DOI 10.1038/ismej.2008.69; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Schloss PD, 2004, MICROBIOL MOL BIOL R, V68, P686, DOI 10.1128/MMBR.68.4.686-691.2004; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; STARR N, 1979, ANN STAT, V7, P644, DOI 10.1214/aos/1176344684; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322	30	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21105	10.1371/journal.pone.0021105	http://dx.doi.org/10.1371/journal.pone.0021105			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738613	Green Submitted, gold, Green Published			2022-12-27	WOS:000292142800013
J	Downs, LM; Wallin-Hakansson, B; Boursnell, M; Marklund, S; Hedhammar, A; Truve, K; Hubinette, L; Lindblad-Toh, K; Bergstrom, T; Mellersh, CS				Downs, Louise M.; Wallin-Hakansson, Berit; Boursnell, Mike; Marklund, Stefan; Hedhammar, Ake; Truve, Katarina; Hubinette, Louise; Lindblad-Toh, Kerstin; Bergstrom, Tomas; Mellersh, Cathryn S.			A Frameshift Mutation in Golden Retriever Dogs with Progressive Retinal Atrophy Endorses SLC4A3 as a Candidate Gene for Human Retinal Degenerations	PLOS ONE			English	Article							CONE-ROD DYSTROPHY; RETINITIS-PIGMENTOSA; CARBONIC-ANHYDRASE; CONGENITAL AMAUROSIS; BICARBONATE; TRANSPORT; DYSPLASIA; EXCHANGER; BLINDNESS; AE1	Progressive retinal atrophy (PRA) in dogs, the canine equivalent of retinitis pigmentosa (RP) in humans, is characterised by vision loss due to degeneration of the photoreceptor cells in the retina, eventually leading to complete blindness. It affects more than 100 dog breeds, and is caused by numerous mutations. RP affects 1 in 4000 people in the Western world and 70% of causal mutations remain unknown. Canine diseases are natural models for the study of human diseases and are becoming increasingly useful for the development of therapies in humans. One variant, prcd-PRA, only accounts for a small proportion of PRA cases in the Golden Retriever (GR) breed. Using genome-wide association with 27 cases and 19 controls we identified a novel PRA locus on CFA37 (p(raw) = 1.94x10(-10), p(genome) = 1.0x10(-5)), where a 644 kb region was homozygous within cases. A frameshift mutation was identified in a solute carrier anion exchanger gene (SLC4A3) located within this region. This variant was present in 56% of PRA cases and 87% of obligate carriers, and displayed a recessive mode of inheritance with full penetrance within those lineages in which it segregated. Allele frequencies are approximately 4% in the UK, 6% in Sweden and 2% in France, but the variant has not been found in GRs from the US. A large proportion of cases (approximately 44%) remain unexplained, indicating that PRA in this breed is genetically heterogeneous and caused by at least three mutations. SLC4A3 is important for retinal function and has not previously been associated with spontaneously occurring retinal degenerations in any other species, including humans.	[Downs, Louise M.; Boursnell, Mike; Mellersh, Cathryn S.] Anim Hlth Trust, Canine Genet, Newmarket, Suffolk, England; [Wallin-Hakansson, Berit] Swedish Kennel Club SKK, Stockholm, Sweden; [Hedhammar, Ake] Swedish Univ Agr Sci SLU, Dept Clin Sci, Uppsala, Sweden; [Marklund, Stefan; Truve, Katarina; Hubinette, Louise; Bergstrom, Tomas] Swedish Univ Agr Sci SLU, Dept Anim Breeding & Genet, Uppsala, Sweden; [Lindblad-Toh, Kerstin] Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab, Uppsala, Sweden; [Lindblad-Toh, Kerstin] Broad Inst Harvard Univ & Massachusetts Inst Tech, Cambridge, MA USA	Animal Health Trust; Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences; Uppsala University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Downs, LM (corresponding author), Anim Hlth Trust, Canine Genet, Newmarket, Suffolk, England.	louise.downs@aht.org.uk	; Bergstrom, Tomas/B-4681-2017	Truve, Katarina/0000-0002-2449-8283; Hedhammar, Ake/0000-0001-7048-3851; Burmeister, Louise/0000-0002-6551-055X; Bergstrom, Tomas/0000-0002-7480-2669; Boursnell, Mike/0000-0002-2554-8190	Kennel Club Charitable Trust; European Commission [GA-201370]; Swedish Kennel Club; European Science Foundation; Guide Dogs for the Blind Association	Kennel Club Charitable Trust; European Commission(European CommissionEuropean Commission Joint Research Centre); Swedish Kennel Club; European Science Foundation(European Science Foundation (ESF)European Commission); Guide Dogs for the Blind Association	Supported by funding from the Kennel Club Charitable Trust, the European Commission (FP7-LUPA, GA-201370), the Research Fund of the Swedish Kennel Club, the European Science Foundation, the Guide Dogs for the Blind Association and donations from dog owners. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acland GM, 2001, NAT GENET, V28, P92, DOI 10.1038/88327; Aguirre G D, 1998, Mol Vis, V4, P23; Alper SL, 2009, J EXP BIOL, V212, P1672, DOI 10.1242/jeb.029454; Alper SL, 2002, J NEPHROL, V15, pS41; Alvarez BV, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000839; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Beggs AH, 2010, P NATL ACAD SCI USA, V107, P14697, DOI 10.1073/pnas.1003677107; Bonfield JK, 1995, NUCLEIC ACIDS RES, V23, P4992, DOI 10.1093/nar/23.24.4992; Dahl NK, 2003, J BIOL CHEM, V278, P44949, DOI 10.1074/jbc.M308660200; Daiger SP, 2007, ARCH OPHTHALMOL-CHIC, V125, P151, DOI 10.1001/archopht.125.2.151; Dekomien G, 2000, CYTOGENET CELL GENET, V90, P261, DOI 10.1159/000056785; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; GRONDAHL J, 1987, CLIN GENET, V31, P255; HAIM M, 1992, ACTA OPHTHALMOL, V70, P178; KANNER BI, 1993, SOC GEN PHY, V48, P243; Kijas JW, 2002, P NATL ACAD SCI USA, V99, P6328, DOI 10.1073/pnas.082714499; KOBAYASHI S, 1994, J NEUROSCI, V14, P6266; Kopito R R, 1990, Int Rev Cytol, V123, P177, DOI 10.1016/S0074-7696(08)60674-9; Kukekova AV, 2009, MAMM GENOME, V20, P109, DOI 10.1007/s00335-008-9163-4; Mellersh CS, 2006, GENOMICS, V88, P293, DOI 10.1016/j.ygeno.2006.05.004; Morgan PE, 2007, AM J PHYSIOL-CELL PH, V293, pC738, DOI 10.1152/ajpcell.00157.2007; NEWMAN EA, 1991, GLIA, V4, P424, DOI 10.1002/glia.440040411; *OPTIGEN, 2008, PRA GOLD RETR; PAGON RA, 1988, SURV OPHTHALMOL, V33, P137, DOI 10.1016/0039-6257(88)90085-9; PARRY HB, 1953, BRIT J OPHTHALMOL, V37, P487, DOI 10.1136/bjo.37.8.487; PATTERSON DF, 1993, AM J HUM GENET, V52, P388; Petersen-Jones S, 2005, J SMALL ANIM PRACT, V46, P371, DOI 10.1111/j.1748-5827.2005.tb00333.x; Petersen-Jones SM, 1999, INVEST OPHTH VIS SCI, V40, P1637; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rozen S, 2000, Methods Mol Biol, V132, P365; Seddon JM, 2006, ANIM GENET, V37, P407, DOI 10.1111/j.1365-2052.2006.01484.x; Sidjanin DJ, 2002, HUM MOL GENET, V11, P1823, DOI 10.1093/hmg/11.16.1823; Sterling D, 1999, BIOCHEM J, V344, P221, DOI 10.1042/0264-6021:3440221; Sterling D, 2002, J BIOL CHEM, V277, P25239, DOI 10.1074/jbc.M202562200; Sterling D, 2001, JOP, V2, P165; SUBER ML, 1993, P NATL ACAD SCI USA, V90, P3968, DOI 10.1073/pnas.90.9.3968; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vince JW, 2000, BIOCHEMISTRY-US, V39, P5527, DOI 10.1021/bi992564p; Wiik AC, 2008, GENOME RES, V18, P1415, DOI 10.1101/gr.074302.107; WINKLER BS, 1977, INVEST OPHTH VIS SCI, V16, P766; Zangerl B, 2006, GENOMICS, V88, P551, DOI 10.1016/j.ygeno.2006.07.007; Zhang Q, 2002, HUM MOL GENET, V11, P993, DOI 10.1093/hmg/11.9.993; Zhang Q, 1998, GENE, V215, P231, DOI 10.1016/S0378-1119(98)00310-2	43	40	40	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21452	10.1371/journal.pone.0021452	http://dx.doi.org/10.1371/journal.pone.0021452			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738669	Green Submitted, Green Published, gold			2022-12-27	WOS:000292092600042
J	Fritz, H; Kennedy, D; Fergusson, D; Fernandes, R; Doucette, S; Cooley, K; Seely, A; Sagar, S; Wong, R; Seely, D				Fritz, Heidi; Kennedy, Deborah; Fergusson, Dean; Fernandes, Rochelle; Doucette, Steve; Cooley, Kieran; Seely, Andrew; Sagar, Stephen; Wong, Raimond; Seely, Dugald			Vitamin A and Retinoid Derivatives for Lung Cancer: A Systematic Review and Meta Analysis	PLOS ONE			English	Article							BETA-CAROTENE SUPPLEMENTATION; SQUAMOUS-CELL CARCINOMA; CHEMOTHERAPY-NAIVE PATIENTS; BASE-LINE CHARACTERISTICS; GROWTH-FACTOR RECEPTOR; 2ND PRIMARY TUMORS; 13-CIS-RETINOIC ACID; ALPHA-TOCOPHEROL; EFFICACY TRIAL; HIGH-RISK	Background: Despite reported antiproliferative activity of vitamin A and its common use for cancer, there is no comprehensive synthesis of its safety and efficacy in lung cancers. To address this issue we conducted a systematic review of the safety and efficacy of vitamin A for the treatment and prevention of lung cancers. Methods and Findings: Two independent reviewers searched six electronic databases from inception to July 2009 for clinical, observational, and preclinical evidence pertaining to the safety and efficacy of vitamin A and related retinoids for lung cancers. 248 studies were included for full review and analysis. Five RCTs assessed treatment of lung cancers, three assessed primary prevention, and three looked at secondary prevention of lung cancers. Five surrogate studies, 26 phase I/II, 32 observational, and 67 preclinical studies were also included. 107 studies were included for interactions between vitamin A and chemo- or radiation-therapy. Although some studies demonstrated benefits, there was insufficient evidence overall to support the use of vitamin A or related retinoids for the treatment or prevention of lung cancers. Retinyl palmitate combined with beta carotene increased risk of lung cancer in smokers in the large CARET trial. Pooling of three studies pertaining to treatment and three studies on secondary prevention revealed no significant effects on response rate, second primary tumor, recurrence, 5-year survival, and mortality. There was a small improvement in event free survival associated with vitamin A compared to controls, RR 1.24 (95% CI 1.13-1.35). The synthetic rexinoid bexarotene increased survival significantly among a subset of patients in two RCTs (p<0.014, <0.087). Conclusions: There is a lack of evidence to support the use of naturally occuring retinoids for the treatment and prevention of lung cancers. The rexinoid bexarotene may hold promise for use among a subset of patients, and deserves further study.	[Fritz, Heidi; Kennedy, Deborah; Fernandes, Rochelle; Cooley, Kieran; Seely, Dugald] Canadian Coll Naturopath Med, Dept Res & Epidemiol, Toronto, ON, Canada; [Kennedy, Deborah; Cooley, Kieran] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada; [Fernandes, Rochelle] Univ Toronto, Lab Med & Pathobiol LMP, Toronto, ON, Canada; [Seely, Andrew] Ottawa Hosp Res Inst, Dept Surg, Ottawa, ON, Canada; [Sagar, Stephen; Wong, Raimond] McMaster Univ, Dept Med, Juravinski Canc Ctr, Hamilton, ON, Canada	University of Toronto; University of Toronto; University of Ottawa; Ottawa Hospital Research Institute; McMaster University	Fritz, H (corresponding author), Canadian Coll Naturopath Med, Dept Res & Epidemiol, Toronto, ON, Canada.	dseely@ccnm.edu	Cooley, Kieran/L-3080-2019	Cooley, Kieran/0000-0001-7960-6504; Fergusson, Dean/0000-0002-3389-2485	Canadian Institutes of Health Research (CIHR); SickKids Foundation	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); SickKids Foundation	This project was supported by a knowledge synthesis grant from the Canadian Institutes of Health Research (CIHR). Deborah Kennedy is supported by a career development grant from the SickKids Foundation. No additional sources of funding were accessed. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acin-Perez R, 2010, FASEB J, V24, P627, DOI 10.1096/fj.09-142281; Albanes D, 1996, J NATL CANCER I, V88, P1560, DOI 10.1093/jnci/88.21.1560; Albanes D, 1997, AM J CLIN NUTR, V66, P366, DOI 10.1093/ajcn/66.2.366; Alberg AJ, 2005, J CLIN ONCOL, V23, P3175, DOI 10.1200/JCO.2005.10.462; Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; *AM CANC SOC, 2010, CANC REF INF WHAT AR; [Anonymous], 2005, CLIN LUNG CANCER, V7, P17, DOI 10.1016/S1525-7304(11)70385-0; [Anonymous], 1982, EUR J BIOCHEM, V129, P1; Ayoub J, 1999, J CLIN ONCOL, V17, P3546, DOI 10.1200/JCO.1999.17.11.3546; Becker-Witt C, 2003, J ALTERN COMPLEM MED, V9, P113, DOI 10.1089/107555303321222991; Bertram JS, 2005, BBA-MOL BASIS DIS, V1740, P170, DOI 10.1016/j.bbadis.2005.01.003; Black HS, 2004, PHOTOCH PHOTOBIO SCI, V3, P753, DOI 10.1039/b316438a; Blumenschein GR, 2008, J CLIN ONCOL, V26, P1879, DOI 10.1200/JCO.2007.12.2689; BOLLAG W, 1992, ANN ONCOL, V3, P513, DOI 10.1093/oxfordjournals.annonc.a058252; Buntzel J, 1998, Auris Nasus Larynx, V25, P413, DOI 10.1016/S0385-8146(98)00040-6; Clarke Nicole, 2004, Expert Reviews in Molecular Medicine, V6, P1, DOI 10.1017/S1462399404008488; COLDITZ GA, 1987, ARCH INTERN MED, V147, P157, DOI 10.1001/archinte.147.1.157; Cook NR, 2000, CANCER CAUSE CONTROL, V11, P617, DOI 10.1023/A:1008995430664; Danby F William, 2003, Dermatol Online J, V9, P30; de Klerk NH, 1998, INT J CANCER, V75, P362, DOI 10.1002/(SICI)1097-0215(19980130)75:3&lt;362::AID-IJC6&gt;3.0.CO;2-0; DiPaolo RS, 1999, J CLIN ONCOL, V17, P2213, DOI 10.1200/JCO.1999.17.7.2213; Dragnev KH, 2005, J CLIN ONCOL, V23, P8757, DOI 10.1200/JCO.2005.01.9521; Dragnev KH, 2003, CANCER BIOL THER, V2, pS150; Dragnev KH, 2007, CLIN CANCER RES, V13, P1794, DOI 10.1158/1078-0432.CCR-06-1836; *EIS INC, TARGR BEX; Freemantle SJ, 2006, J NATL CANCER I, V98, P426, DOI 10.1093/jnci/djj116; Freemantle SJ, 2003, ONCOGENE, V22, P7305, DOI 10.1038/sj.onc.1206936; FRITSCH PO, 1992, J AM ACAD DERMATOL, V27, pS8, DOI 10.1016/S0190-9622(08)80253-8; Fu JJ, 2007, CANCER LETT, V248, P153, DOI 10.1016/j.canlet.2006.06.012; Gackowski D, 2005, INT J CANCER, V114, P153, DOI 10.1002/ijc.20700; Gagnier JJ, 2006, J CLIN EPIDEMIOL, V59, P1134, DOI 10.1016/j.jclinepi.2005.12.020; Gallicchio L, 2008, AM J CLIN NUTR, V88, P372, DOI 10.1093/ajcn/88.2.372; Goodman GE, 2008, J CLIN ONCOL, V26, P5495, DOI 10.1200/JCO.2008.19.0884; Goodman GE, 2004, J NATL CANCER I, V96, P1743, DOI 10.1093/jnci/djh320; GOODMAN GE, 1993, CANCER EPIDEM BIOMAR, V2, P389; Gregory J, 2009, CURR ONCOL REP, V11, P439, DOI 10.1007/s11912-009-0060-0; Guarise A, 2008, CANCER IMAGING, V8, P220, DOI 10.1102/1470-7330.2008.0028; HIGDON J, 2009, CAROTENOIDS ALPHA CA; HIGDON J, 2009, VITAMIN A; HONG WK, 1986, NEW ENGL J MED, V315, P1501, DOI 10.1056/NEJM198612113152401; HONG WK, 1990, NEW ENGL J MED, V323, P795, DOI 10.1056/NEJM199009203231205; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Kalemkerian GP, 1998, CANCER-AM CANCER SOC, V83, P1102, DOI 10.1002/(SICI)1097-0142(19980915)83:6<1102::AID-CNCR8>3.0.CO;2-9; Kamangar F, 2006, CANCER EPIDEM BIOMAR, V15, P1562, DOI 10.1158/1055-9965.EPI-06-0316; Khuri FR, 2001, J CLIN ONCOL, V19, P2626, DOI 10.1200/JCO.2001.19.10.2626; Kurie JM, 2000, CLIN CANCER RES, V6, P2973; Lee IM, 1999, J NATL CANCER I, V91, P2102, DOI 10.1093/jnci/91.24.2102; LIPPMAN SM, 1993, NEW ENGL J MED, V328, P15, DOI 10.1056/NEJM199301073280103; Lippman SM, 2001, JNCI-J NATL CANCER I, V93, P605, DOI 10.1093/jnci/93.8.605; Lonardo F, 1999, CANCER RES, V59, P2470; Maeno T, 2002, AM J RESP CELL MOL, V26, P246, DOI 10.1165/ajrcmb.26.2.4509; Matthay KK, 2009, J CLIN ONCOL, V27, P1007, DOI 10.1200/JCO.2007.13.8925; MCLARTY JW, 1995, AM J CLIN NUTR, V62, P1431; Meyskens FL, 2005, CANCER EPIDEM BIOMAR, V14, P1366, DOI 10.1158/1055-9965.EPI-04-0666; MEYSKENS JFL, 1981, P AM ASSOC CANC RES, V22, pC151; Micke O, 2010, FRONT RADIAT THER ON, V42, P198, DOI 10.1159/000262477; MICKSCHE M, 1977, ONCOLOGY, V34, P234, DOI 10.1159/000225231; Mitsudomi T, 2010, FEBS J, V277, P301, DOI 10.1111/j.1742-4658.2009.07448.x; NEELY SM, 1987, ARCH INTERN MED, V147, P529, DOI 10.1001/archinte.147.3.529; NETTESHEIM P, 1976, CANCER RES, V36, P996; NETTESHEIM P, 1976, INT J CANCER, V17, P351, DOI 10.1002/ijc.2910170311; O'Neil C, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006751.pub2; OLSSON L, 1985, INT J CANCER, V35, P189, DOI 10.1002/ijc.2910350209; Omenn GS, 2007, EUR J CANCER PREV, V16, P184, DOI 10.1097/01.cej.0000215612.98132.18; Omenn GS, 1996, J NATL CANCER I, V88, P1550, DOI 10.1093/jnci/88.21.1550; Omenn GS, 1998, ANNU REV PUBL HEALTH, V19, P73, DOI 10.1146/annurev.publhealth.19.1.73; Omenn GS, 1996, NEW ENGL J MED, V334, P1150, DOI 10.1056/NEJM199605023341802; Ozpolat B, 2003, J PHARM PHARM SCI, V6, P292; Parker RS, 1996, FASEB J, V10, P542, DOI 10.1096/fasebj.10.5.8621054; Pasquali D, 2006, CURR PHARM DESIGN, V12, P1923, DOI 10.2174/138161206776873554; PASTORINO U, 1993, J CLIN ONCOL, V11, P1216, DOI 10.1200/JCO.1993.11.7.1216; Patrick L, 2000, Altern Med Rev, V5, P530; PILKINGTON T, 1992, DRUGS, V43, P597, DOI 10.2165/00003495-199243040-00010; Ramlau R, 2008, J CLIN ONCOL, V26, P1886, DOI 10.1200/JCO.2007.12.2614; RAY A, 2005, INDIAN J CANCER, V42, P15; Recchia F, 2005, ANTICANCER RES, V25, P3149; Redlich CA, 1998, CANCER EPIDEM BIOMAR, V7, P211; Rigas JR, 2005, ONCOLOGIST, V10, P22, DOI 10.1634/theoncologist.10-1-22; Rizvi N, 2001, Clin Lung Cancer, V2, P210, DOI 10.3816/CLC.2001.n.005; Roehrs M, 2009, NEPHROL DIAL TRANSPL, V24, P2212, DOI 10.1093/ndt/gfp001; Ruotsalainen T, 2000, ANTI-CANCER DRUG, V11, P101, DOI 10.1097/00001813-200002000-00006; RUSCH V, 1995, CANCER RES, V55, P1365; Siems W, 2002, FASEB J, V16, P1289, DOI 10.1096/fj.01-0765fje; Smith W, 2005, CRIT REV ONCOL HEMAT, V55, P143, DOI 10.1016/j.critrevonc.2005.02.003; SMITH WE, 1972, ENVIRON RES, V5, P152, DOI 10.1016/0013-9351(72)90030-8; Soria JC, 2001, JNCI-J NATL CANCER I, V93, P1257, DOI 10.1093/jnci/93.16.1257; Stahl W, 2005, BBA-MOL BASIS DIS, V1740, P101, DOI 10.1016/j.bbadis.2004.12.006; Tang GW, 2010, AM J CLIN NUTR, V91, p1468S, DOI 10.3945/ajcn.2010.28674G; VAN DE, 2002, COCHRANE DB SYST REV; van Helden YGJ, 2009, CARCINOGENESIS, V30, P2070, DOI 10.1093/carcin/bgp186; van Zandwijk N, 2000, JNCI-J NATL CANCER I, V92, P977, DOI 10.1093/jnci/92.12.977; Virtamo J, 2003, JAMA-J AM MED ASSOC, V290, P476, DOI 10.1001/jama.290.4.476; Waladkhani AR, 1997, INT J CANCER, V70, P494, DOI 10.1002/(SICI)1097-0215(19970207)70:4<494::AID-IJC24>3.0.CO;2-E; Wang XD, 1999, J NATL CANCER I, V91, P60, DOI 10.1093/jnci/91.1.60; Wildi JD, 2008, CHEMOTHERAPY, V54, P125, DOI 10.1159/000119706; WILKOFF LJ, 1980, P SOC EXP BIOL MED, V163, P233; Witschi H, 2000, EXP LUNG RES, V26, P743, DOI 10.1080/01902140150216792; Witschi H, 2000, CARCINOGENESIS, V21, P977, DOI 10.1093/carcin/21.5.977; Wolf G, 1996, FASEB J, V10, P1102, DOI 10.1096/fasebj.10.9.8801174	99	46	46	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21107	10.1371/journal.pone.0021107	http://dx.doi.org/10.1371/journal.pone.0021107			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738614	Green Published, Green Submitted, gold			2022-12-27	WOS:000292092600014
J	Sjodin, P; Francois, O				Sjodin, Per; Francois, Olivier			Wave-of-Advance Models of the Diffusion of the Y Chromosome Haplogroup R1b1b2 in Europe	PLOS ONE			English	Article							GENE POOL; MUTATION-RATE; MTDNA; DIVERSITY; FARMERS; DNA; EXPANSION; ADMIXTURE; LINEAGES; HISTORY	Whether or not the spread of agriculture in Europe was accompanied by movements of people is a long-standing question in archeology and anthropology, which has been frequently addressed with the help of population genetic data. Estimates on dates of expansion and geographic origins obtained from genetic data are however sensitive to the calibration of mutation rates and to the mathematical models used to perform inference. For instance, recent data on the Y chromosome haplogroup R1b1b2 (M269) have either suggested a Neolithic origin for European paternal lineages or a more ancient Paleolithic origin depending on the calibration of Y-STR mutation rates. Here we examine the date of expansion and the geographic origin of hgR1b1b2 considering two current estimates of mutation rates in a total of fourteen realistic wave-of-advance models. We report that a range expansion dating to the Paleolithic is unlikely to explain the observed geographical distribution of microsatellite diversity, and that whether the data is informative with respect to the spread of agriculture in Europe depends on the mutation rate assumption in a critical way.	[Sjodin, Per] Uppsala Univ, Evolutionary Biol Ctr, Dept Evolutionary Biol, Uppsala, Sweden; [Francois, Olivier] Univ Grenoble 1, CNRS, TIMC IMAG UMR 5525, Grenoble, France	Uppsala University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA)	Sjodin, P (corresponding author), Uppsala Univ, Evolutionary Biol Ctr, Dept Evolutionary Biol, Uppsala, Sweden.	per.sjodins@ebc.uu.se	Francois, Olivier/AAQ-3137-2020; Francois, Olivier/A-6051-2012	Francois, Olivier/0000-0003-2402-2442; Francois, Olivier/0000-0003-2402-2442	Institute of Complex Systems (IXXI); STINT (The Swedish Foundation for International Cooperation in Research and Higher Education)	Institute of Complex Systems (IXXI); STINT (The Swedish Foundation for International Cooperation in Research and Higher Education)	OF received support from the Institute of Complex Systems (IXXI, www.ixxi.fr). PS was supported by an Institutional Grant for Younger Researchers from STINT (The Swedish Foundation for International Cooperation in Research and Higher Education, www.stint.se) to Mattias Jakobsson and Michael Blum. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; AMMERMAN AJ, 1971, MAN, V6, P674, DOI 10.2307/2799190; AMMERMAN AJ, 1984, NEOLITHIC TRANSITION; Balaresque P, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000285; Barbujani G, 1998, AM J HUM GENET, V62, P488, DOI 10.1086/301719; Barker G., 2006, AGR REVOLUTION PREHI; Bramanti B, 2009, SCIENCE, V326, P137, DOI 10.1126/science.1176869; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Chiaroni J, 2009, P NATL ACAD SCI USA, V106, P20174, DOI 10.1073/pnas.0910803106; Chikhi L, 1998, P NATL ACAD SCI USA, V95, P9053, DOI 10.1073/pnas.95.15.9053; Chikhi L, 2002, P NATL ACAD SCI USA, V99, P11008, DOI 10.1073/pnas.162158799; Cruciani F, 2011, FORENSIC SCI INT-GEN, V5, pE49, DOI 10.1016/j.fsigen.2010.07.006; Currat M, 2005, P ROY SOC B-BIOL SCI, V272, P679, DOI 10.1098/rspb.2004.2999; Di Giacomo F, 2004, HUM GENET, V115, P357, DOI 10.1007/s00439-004-1168-9; Diamond J, 2003, SCIENCE, V300, P597, DOI 10.1126/science.1078208; Dupanloup I, 2004, MOL BIOL EVOL, V21, P1361, DOI 10.1093/molbev/msh135; Francois O, 2010, MOL BIOL EVOL, V27, P1257, DOI 10.1093/molbev/msq010; Francois O, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000075; Haak W, 2005, SCIENCE, V310, P1016, DOI 10.1126/science.1118725; Haak W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000536; JOBLING M, 2004, HUMAN EVOLUTIONARY G, P15253; Liu H, 2006, AM J HUM GENET, V79, P230, DOI 10.1086/505436; MARTIN TR, 1992, ANCIENT GREECE PREHI; MENOZZI P, 1978, SCIENCE, V201, P786, DOI 10.1126/science.356262; Morelli L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010419; Myres NM, 2011, EUR J HUM GENET, V19, P95, DOI 10.1038/ejhg.2010.146; Ray N, 2010, BIOINFORMATICS, V26, P2993, DOI 10.1093/bioinformatics/btq579; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Richards M, 1996, AM J HUM GENET, V59, P185; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; Shi WT, 2010, MOL BIOL EVOL, V27, P385, DOI 10.1093/molbev/msp243; Simoni L, 2000, AM J HUM GENET, V66, P262, DOI 10.1086/302706; Soares P, 2010, CURR BIOL, V20, pR174, DOI 10.1016/j.cub.2009.11.054; Torroni A, 2001, AM J HUM GENET, V69, P844, DOI 10.1086/323485; Whittle A, 2007, P BRIT ACAD, V144; Wilson IJ, 2003, J R STAT SOC A STAT, V166, P155, DOI 10.1111/1467-985X.00264; Zhivotovsky LA, 2004, AM J HUM GENET, V74, P50, DOI 10.1086/380911; Zhivotovsky LA, 2006, MOL BIOL EVOL, V23, P2268, DOI 10.1093/molbev/msl105	38	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21592	10.1371/journal.pone.0021592	http://dx.doi.org/10.1371/journal.pone.0021592			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21720564	Green Submitted, Green Published, gold			2022-12-27	WOS:000292036900060
J	Chartier, L; Leng, C; Sire, JM; Le Minor, O; Saman, M; Bercion, R; Rahalison, L; Fontanet, A; Germany, Y; L'Her, P; Mayaud, C; Vray, M				Chartier, Loic; Leng, Chanthy; Sire, Jean-Marie; Le Minor, Odile; Saman, Manil; Bercion, Raymond; Rahalison, Lila; Fontanet, Arnaud; Germany, Yves; L'Her, Pierre; Mayaud, Charles; Vray, Muriel			Factors Associated with Negative Direct Sputum Examination in Asian and African HIV-Infected Patients with Tuberculosis (ANRS 1260)	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; IMMUNODEFICIENCY; DIAGNOSIS; COINFECTION; PREVALENCE; PREDICTORS; PROGRAM; RISK	Objective: To identify factors associated with negative direct sputum examination among African and Cambodian patients co-infected by Mycobacterium tuberculosis and HIV. Design: Prospective multicenter study (ANRS1260) conducted in Cambodia, Senegal and Central African Republic. Methods: Univariate and multivariate analyses (logistic regression) were used to identify clinical and radiological features associated with negative direct sputum examination in HIV-infected patients with positive M. tuberculosis culture on Lowenstein-Jensen medium. Results: Between September 2002 and December 2005, 175 co-infected patients were hospitalized with at least one respiratory symptom and pulmonary radiographic anomaly. Acid-fast bacillus (AFB) examination was positive in sputum samples from 110 subjects (63%) and negative in 65 patients (37%). Most patients were at an advanced stage of HIV disease (92% at stage III or IV of the WHO classification) with a median CD4 cell count of 36/mm(3). In this context, we found that sputum AFB negativity was more frequent in co-infected subjects with associated respiratory tract infections (OR = 2.8 [95%CI:1.1-7.0]), dyspnea (OR = 2.5 [95% CI:1.1-5.6]), and localized interstitial opacities (OR = 3.1 [95%CI:1.3-7.6]), but was less frequent with CD4 <= 50/mm(3) (OR = 0.4 [95%CI:0.2-0.90), adenopathies (OR = 0.4 [95%CI:0.2-0.93]) and cavitation (OR = 0.1 [95%CI:0.03-0.6]). Conclusions: One novel finding of this study is the association between concomitant respiratory tract infection and negative sputum AFB, particularly in Cambodia. This finding suggests that repeating AFB testing in AFB-negative patients should be conducted when broad spectrum antibiotic treatment does not lead to complete recovery from respiratory symptoms. In HIV-infected patients with a CD4 cell count below 50/mm3 without an identified cause of pneumonia, systematic AFB direct sputum examination is justified because of atypical clinical features (without cavitation) and high pulmonary mycobacterial burden.	[Chartier, Loic; Le Minor, Odile; Fontanet, Arnaud; Vray, Muriel] Inst Pasteur, Paris, France; [Leng, Chanthy; Saman, Manil] Inst Pasteur, Phnom Penh, Cambodia; [Sire, Jean-Marie] Inst Pasteur, Dakar, Senegal; [Bercion, Raymond] Hop Principal, Dakar, Senegal; [Rahalison, Lila] Inst Pasteur, Antananarivo, Madagascar; [Fontanet, Arnaud] Conservatoire Natl Arts & Metiers, Paris, France; [Germany, Yves] Int Network Inst Pasteur, Paris, France; [L'Her, Pierre] Hop Mil, Percy, France; [Mayaud, Charles] Hop Tenon, F-75970 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar; heSam Universite; Conservatoire National Arts & Metiers (CNAM); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite	Chartier, L (corresponding author), Inst Pasteur, Paris, France.	chartier@pasteur.fr	Vray, Muriel/M-7947-2018	, arnaud/0000-0002-5239-6110	Agence Nationale de Recherche sur le SIDA et Les Hepatites Virales (ANRS)	Agence Nationale de Recherche sur le SIDA et Les Hepatites Virales (ANRS)(ANRSFrench National Research Agency (ANR))	This work was supported by a grant from the Agence Nationale de Recherche sur le SIDA et Les Hepatites Virales (ANRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderaye G, 2007, SCAND J INFECT DIS, V39, P1045, DOI 10.1080/00365540701474508; Behr MA, 1999, LANCET, V353, P444, DOI 10.1016/S0140-6736(98)03406-0; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Cattamanchi A, 2008, J CLIN MICROBIOL, V46, P3325, DOI 10.1128/JCM.01175-08; Grant AD, 1997, AIDS, V11, P1357, DOI 10.1097/00002030-199711000-00010; Hargreaves NJ, 2001, INT J TUBERC LUNG D, V5, P847; Iliyasu Z, 2009, J EPIDEMIOL, V19, P81, DOI 10.2188/jea.JE20080026; JONES BE, 1993, AM REV RESPIR DIS, V148, P1292, DOI 10.1164/ajrccm/148.5.1292; Kimerling ME, 2002, INT J TUBERC LUNG D, V6, P988; Lawn SD, 2011, INT J TUBERC LUNG D, V15, P287; Le Minor O, 2008, JAIDS-J ACQ IMM DEF, V48, P620, DOI 10.1097/QAI.0b013e31817efb3c; Maher D, 2005, TROP MED INT HEALTH, V10, P734, DOI 10.1111/j.1365-3156.2005.01456.x; Manosuthi W, 2006, JAIDS-J ACQ IMM DEF, V43, P42, DOI 10.1097/01.qai.0000230521.86964.86; Mayaud C, 1999, THORAX, V54, P567, DOI 10.1136/thx.54.7.567; Mwandumba HC, 2008, TUBERCULOSIS, V88, P58, DOI 10.1016/j.tube.2007.06.003; Palmieri F, 2002, INFECTION, V30, P68, DOI 10.1007/s15010-002-2062-9; Porskrog A, 2011, INT J TUBERC LUNG D, V15, P459, DOI 10.5588/ijtld.10.0353; Samb B, 1997, INT J TUBERC LUNG D, V1, P25; Shafer RW, 1996, CLIN INFECT DIS, V22, P683, DOI 10.1093/clinids/22.4.683; Sharma SK, 2005, INDIAN J MED RES, V121, P550; Siddiqi K, 2003, LANCET INFECT DIS, V3, P288, DOI 10.1016/S1473-3099(03)00609-1; Vray M, 2008, AIDS, V22, P1323, DOI 10.1097/QAD.0b013e3282fdf8bf; *WHO, 1998, GLOB TUB PROGR; World Health Organization, 2004, TB HIV CLIN MAN, V2nd; Zhou JL, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-46	25	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21212	10.1371/journal.pone.0021212	http://dx.doi.org/10.1371/journal.pone.0021212			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731675	Green Published, Green Submitted, gold			2022-12-27	WOS:000292035400015
J	Lecomte, N; Ahlstrom, O; Ehrich, D; Fuglei, E; Ims, RA; Yoccoz, NG				Lecomte, Nicolas; Ahlstrom, Oystein; Ehrich, Dorothee; Fuglei, Eva; Ims, Rolf A.; Yoccoz, Nigel G.			Intrapopulation Variability Shaping Isotope Discrimination and Turnover: Experimental Evidence in Arctic Foxes	PLOS ONE			English	Article							STABLE-CARBON ISOTOPES; LABORATORY EXPERIMENTS; FACTORS DELTA-N-15; ANIMAL-TISSUES; MIXING MODELS; CONSUMER-DIET; AVIAN BLOOD; FRACTIONATION; DELTA-C-13; NITROGEN	Background: Tissue-specific stable isotope signatures can provide insights into the trophic ecology of consumers and their roles in food webs. Two parameters are central for making valid inferences based on stable isotopes, isotopic discrimination difference in isotopic ratio between consumer and its diet) and turnover time (renewal process of molecules in a given tissue usually measured when half of the tissue composition has changed). We investigated simultaneously the effects of age, sex, and diet types on the variation of discrimination and half-life in nitrogen and carbon stable isotopes (delta(15)N and delta(13)C, respectively) in five tissues (blood cells, plasma, muscle, liver, nail, and hair) of a top predator, the arctic fox Vulpes lagopus. Methodology/Principal Findings: We fed 40 farmed foxes (equal numbers of adults and yearlings of both sexes) with diet capturing the range of resources used by their wild counterparts. We found that, for a single species, six tissues, and three diet types, the range of discrimination values can be almost as large as what is known at the scale of the whole mammalian or avian class. Discrimination varied depending on sex, age, tissue, and diet types, ranging from 0.3 parts per thousand to 5.3 parts per thousand (mean = 2.6%) for delta(15)N and from 0.2 parts per thousand to 2.9 parts per thousand (mean = 0.9%) for delta(13)C. We also found an impact of population structure on delta(15)N half-life in blood cells. Varying across individuals, delta(15)N half-life in plasma (6 to 10 days) was also shorter than for delta(13)C (14 to 22 days), though delta(15)N and delta(13)C half-lives are usually considered as equal. Conclusion/Significane: Overall, our multi-factorial experiment revealed that at least six levels of isotopic variations could co-occur in the same population. Our experimental analysis provides a framework for quantifying multiple sources of variation in isotopic discrimination and half-life that needs to be taken into account when designing and analysing ecological field studies.	[Lecomte, Nicolas; Ehrich, Dorothee; Ims, Rolf A.; Yoccoz, Nigel G.] Univ Tromso, Dept Arctic & Marine Biol, Tromso, Norway; [Ahlstrom, Oystein] Norwegian Univ Life Sci, Dept Anim & Aquacultural Sci, As, Norway; [Fuglei, Eva] Norwegian Polar Res Inst, Fram Ctr, Tromso, Norway	UiT The Arctic University of Tromso; Norwegian University of Life Sciences; Norwegian Polar Institute	Lecomte, N (corresponding author), Univ Tromso, Dept Arctic & Marine Biol, Tromso, Norway.	nicolas.lecomte@uit.no	Yoccoz, Nigel/C-8561-2014; Ehrich, Dorothee/F-6492-2015	Yoccoz, Nigel/0000-0003-2192-1039; Ehrich, Dorothee/0000-0002-3028-9488; Lecomte, Nicolas/0000-0002-8473-5375	Norwegian Polar Institute; Norwegian Research Council; Norwegian University of Life Science; University of Tromso	Norwegian Polar Institute; Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian University of Life Science; University of Tromso	This work was supported by (alphabetical order): Norwegian Polar Institute, Norwegian Research Council through the International Polar Year project "Arctic Predators" (http://www.arctic-predators.uit.no), Norwegian University of Life Science, and University of Tromso. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHLSTROM O, 1995, ACTA AGR SCAND A-AN, V45, P74, DOI 10.1080/09064709509410916; Auerswald K, 2010, J APPL ECOL, V47, P936, DOI 10.1111/j.1365-2664.2009.01764.x; Ayliffe LK, 2004, OECOLOGIA, V139, P11, DOI 10.1007/s00442-003-1479-x; Bearhop S, 2000, AUK, V117, P504, DOI 10.1642/0004-8038(2000)117[0504:IOLAUA]2.0.CO;2; Bearhop S, 2002, PHYSIOL BIOCHEM ZOOL, V75, P451, DOI 10.1086/342800; Ben-David M, 2001, OECOLOGIA, V127, P180, DOI 10.1007/s004420000570; Bond AL, 2011, ECOL APPL, V21, P1017, DOI 10.1890/09-2409.1; Burnham K. P., 1998, MODEL SELECTION INFE; Carleton SA, 2008, RAPID COMMUN MASS SP, V22, P3008, DOI 10.1002/rcm.3691; Carleton SA, 2010, FUNCT ECOL, V24, P805, DOI 10.1111/j.1365-2435.2010.01700.x; Caut S, 2008, CAN J ZOOL, V86, P438, DOI 10.1139/Z08-012; Caut S, 2008, FUNCT ECOL, V22, P255, DOI 10.1111/j.1365-2435.2007.01360.x; Caut S, 2010, J APPL ECOL, V47, P948, DOI 10.1111/j.1365-2664.2010.01832.x; Caut S, 2009, J APPL ECOL, V46, P443, DOI 10.1111/j.1365-2664.2009.01620.x; Cerling TE, 2007, OECOLOGIA, V151, P175, DOI 10.1007/s00442-006-0571-4; Cherel Y, 2005, ECOLOGY, V86, P2881, DOI 10.1890/05-0562; Cherel Y, 2005, PHYSIOL BIOCHEM ZOOL, V78, P106, DOI 10.1086/425202; Cherry SG, 2011, J APPL ECOL, V48, P373, DOI 10.1111/j.1365-2664.2010.01908.x; Dalerum F, 2005, OECOLOGIA, V144, P647, DOI 10.1007/s00442-005-0118-0; del Rio CM, 2008, OECOLOGIA, V156, P765, DOI 10.1007/s00442-008-1040-z; del Rio CM, 2009, BIOL REV, V84, P91, DOI 10.1111/j.1469-185X.2008.00064.x; Elsdon TS, 2010, MAR ECOL PROG SER, V408, P195, DOI 10.3354/meps08518; Felicetti LA, 2003, CAN J ZOOL, V81, P763, DOI [10.1139/z03-054, 10.1139/Z03-054]; Gannes LZ, 1997, ECOLOGY, V78, P1271, DOI 10.1890/0012-9658(1997)078[1271:SIIAEA]2.0.CO;2; GARDNER MJ, 1986, BMJ-BRIT MED J, V292, P746, DOI 10.1136/bmj.292.6522.746; Haramis GM, 2001, AUK, V118, P1008, DOI 10.1642/0004-8038(2001)118[1008:SIAOCW]2.0.CO;2; Henden JA, 2008, J APPL ECOL, V45, P1086, DOI 10.1111/j.1365-2664.2008.01515.x; Hilderbrand GV, 1996, CAN J ZOOL, V74, P2080, DOI 10.1139/z96-236; HOBSON KA, 1992, CONDOR, V94, P181, DOI 10.2307/1368807; HOBSON KA, 1992, CONDOR, V94, P189, DOI 10.2307/1368808; Hobson KA, 2003, CAN J ZOOL, V81, P1630, DOI 10.1139/Z03-140; Hobson KA, 1996, CAN J FISH AQUAT SCI, V53, P528, DOI 10.1139/cjfas-53-3-528; Kery M., 2010, INTRO WINBUGS ECOLOG; Klaassen M, 2010, FUNCT ECOL, V24, P796, DOI 10.1111/j.1365-2435.2010.01689.x; Matthews B, 2008, FRESHWATER BIOL, V53, P1942, DOI 10.1111/j.1365-2427.2008.02018.x; McCulloch C. E., 2001, GEN LINEAR MIXED MOD; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; Newsome SD, 2010, ECOL APPL, V20, P1744, DOI 10.1890/09-1502.1; Overman NC, 2001, CAN J FISH AQUAT SCI, V58, P1253, DOI 10.1139/cjfas-58-6-1253; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Pinheiro J, 2001, MIXED EFFECTS MODELS; PINHEIRO JC, 2006, IME LINEAR NONLINEAR; Podlesak DW, 2006, PHYSIOL BIOCHEM ZOOL, V79, P534, DOI 10.1086/502813; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; R Development Core Team, 2010, LANG ENV STAT COMP V; Reichlin TS, 2010, DIVERS DISTRIB, V16, P643, DOI 10.1111/j.1472-4642.2010.00664.x; Robbins CT, 2010, OECOLOGIA, V162, P571, DOI 10.1007/s00442-009-1485-8; Roth JD, 2000, CAN J ZOOL, V78, P848, DOI 10.1139/cjz-78-5-848; Roth JD, 2002, OECOLOGIA, V133, P70, DOI 10.1007/s00442-002-1004-7; Sakano H, 2005, ENVIRON BIOL FISH, V72, P13, DOI 10.1007/s10641-004-4187-4; SCHWARCZ HP, 1991, J ARCHAEOL SCI, V18, P261, DOI 10.1016/0305-4403(91)90065-W; Spence KO, 2005, OECOLOGIA, V146, P89, DOI 10.1007/s00442-005-0170-9; SPRINSON DB, 1949, J BIOL CHEM, V180, P715; SUTOH M, 1987, RADIOISOTOPES; Tarroux A, 2010, METHODS ECOL EVOL, V1, P231, DOI 10.1111/j.2041-210X.2010.00033.x; TIESZEN LL, 1983, OECOLOGIA, V57, P32, DOI 10.1007/BF00379558; Trueman CN, 2005, RAPID COMMUN MASS SP, V19, P3239, DOI 10.1002/rcm.2199; Vanderklift MA, 2003, OECOLOGIA, V136, P169, DOI 10.1007/s00442-003-1270-z; Yoccoz N.G., 1991, B ECOL SOC AM, V72, P106; Zilversmit DB, 1943, J GEN PHYSIOL, V26, P325, DOI 10.1085/jgp.26.3.325	61	50	50	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21357	10.1371/journal.pone.0021357	http://dx.doi.org/10.1371/journal.pone.0021357			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731715	Green Submitted, Green Published, gold			2022-12-27	WOS:000292035400028
J	Oshansky, CM; Pickens, JA; Bradley, KC; Jones, LP; Saavedra-Ebner, GM; Barber, JP; Crabtree, JM; Steinhauer, DA; Tompkins, SM; Tripp, RA				Oshansky, Christine M.; Pickens, Jennifer A.; Bradley, Konrad C.; Jones, Les P.; Saavedra-Ebner, Geraldine M.; Barber, James P.; Crabtree, Jackelyn M.; Steinhauer, David A.; Tompkins, S. Mark; Tripp, Ralph A.			Avian Influenza Viruses Infect Primary Human Bronchial Epithelial Cells Unconstrained by Sialic Acid alpha 2,3 Residues	PLOS ONE			English	Article							RECEPTOR-BINDING SPECIFICITY; HUMAN AIRWAY EPITHELIUM; I INTERFERON RESPONSE; A H5N1 VIRUSES; MAACKIA-AMURENSIS; CYTOKINE RESPONSES; GENE-EXPRESSION; HUMAN ALVEOLAR; HOST-RANGE; H1N1	Avian influenza viruses (AIV) are an important emerging threat to public health. It is thought that sialic acid (sia) receptors are barriers in cross-species transmission where the binding preferences of AIV and human influenza viruses are sias alpha 2,3 versus alpha 2,6, respectively. In this study, we show that a normal fully differentiated, primary human bronchial epithelial cell model is readily infected by low pathogenic H5N1, H5N2 and H5N3 AIV, which primarily bind to sia alpha 2,3 moieties, and replicate in these cells independent of specific sias on the cell surface. NHBE cells treated with neuraminidase prior to infection are infected by AIV despite removal of sia alpha 2,3 moieties. Following AIV infection, higher levels of IP-10 and RANTES are secreted compared to human influenza virus infection, indicating differential chemokine expression patterns, a feature that may contribute to differences in disease pathogenesis between avian and human influenza virus infections in humans.	[Oshansky, Christine M.; Pickens, Jennifer A.; Jones, Les P.; Saavedra-Ebner, Geraldine M.; Barber, James P.; Crabtree, Jackelyn M.; Tompkins, S. Mark; Tripp, Ralph A.] Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA 30602 USA; [Bradley, Konrad C.; Steinhauer, David A.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA	University System of Georgia; University of Georgia; Emory University	Oshansky, CM (corresponding author), Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA 30602 USA.	ratripp@uga.edu	Tompkins, Stephen/A-3317-2008; Tripp, Ralph/F-5218-2011	Tompkins, Stephen/0000-0002-1523-5588; Tripp, Ralph/0000-0002-2924-9956; Barber, James/0000-0003-3108-1002; Bradley, Konrad/0000-0001-8761-6219	Center of Excellence for Influenza Research and Surveillance (CEIRS) [HHSN266200700006C]; Georgia Research Alliance	Center of Excellence for Influenza Research and Surveillance (CEIRS); Georgia Research Alliance	This work was funded by the Center of Excellence for Influenza Research and Surveillance (CEIRS) contract HHSN266200700006C and the Georgia Research Alliance (http://www.gra.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angata T, 2002, CHEM REV, V102, P439, DOI 10.1021/cr000407m; Basler CF, 2008, ANTIVIR RES, V79, P166, DOI 10.1016/j.antiviral.2008.04.006; BAUM LG, 1990, ACTA HISTOCHEM, P35; Chan MCW, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-135; Chan MCW, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-102; Chan RWY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008713; Cheung CY, 2002, LANCET, V360, P1831, DOI 10.1016/S0140-6736(02)11772-7; Conenello GM, 2007, PLOS PATHOG, V3, P1414, DOI 10.1371/journal.ppat.0030141; CONNOR RJ, 1994, VIROLOGY, V205, P17, DOI 10.1006/viro.1994.1615; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Dushoff J, 2006, AM J EPIDEMIOL, V163, P181, DOI 10.1093/aje/kwj024; Fritz RS, 1999, J INFECT DIS, V180, P586, DOI 10.1086/314938; Glaser L, 2005, J VIROL, V79, P11533, DOI 10.1128/JVI.79.17.11533-11536.2005; Glaser L, 2007, VIRUS RES, V126, P9, DOI 10.1016/j.virusres.2007.01.011; Hayden FG, 1998, J CLIN INVEST, V101, P643, DOI 10.1172/JCI1355; Ilyushina NA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000043; Imberty A, 2000, J BIOL CHEM, V275, P17541, DOI 10.1074/jbc.M000560200; Ito T, 1998, J VIROL, V72, P7367, DOI 10.1128/JVI.72.9.7367-7373.1998; KNIBBS RN, 1991, J BIOL CHEM, V266, P83; Kogure T, 2006, GLYCOCONJUGATE J, V23, P101, DOI 10.1007/s10719-006-5442-z; KONAMI Y, 1994, FEBS LETT, V342, P334, DOI 10.1016/0014-5793(94)80527-X; Krunkosky TM, 2000, AM J RESP CELL MOL, V22, P685, DOI 10.1165/ajrcmb.22.6.3925; Malakhov MP, 2006, ANTIMICROB AGENTS CH, V50, P1470, DOI 10.1128/AAC.50.4.1470-1479.2006; Malavia NK, 2009, AM J RESP CELL MOL, V41, P297, DOI 10.1165/rcmb.2008-0358OC; Matrosovich M, 2000, J VIROL, V74, P8502, DOI 10.1128/JVI.74.18.8502-8512.2000; Matrosovich M, 2009, REV SCI TECH OIE, V28, P203, DOI 10.20506/rst.28.1.1870; Matrosovich MN, 2004, P NATL ACAD SCI USA, V101, P4620, DOI 10.1073/pnas.0308001101; McAuley JL, 2007, CELL HOST MICROBE, V2, P240, DOI 10.1016/j.chom.2007.09.001; NELSON J, 1993, VIRUS RES, V29, P155, DOI 10.1016/0168-1702(93)90056-S; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Nicholls JM, 2007, NAT MED, V13, P147, DOI 10.1038/nm1529; Nicholls JM, 2008, TRENDS MICROBIOL, V16, P149, DOI 10.1016/j.tim.2008.01.008; Olsen CW, 2002, VIRUS RES, V85, P199, DOI 10.1016/S0168-1702(02)00027-8; Oshansky CM, 2009, VIRAL IMMUNOL, V22, P147, DOI 10.1089/vim.2008.0098; Pappaioanou M, 2009, COMP IMMUNOL MICROB, V32, P287, DOI 10.1016/j.cimid.2008.01.003; Peiris JSM, 2004, LANCET, V363, P617, DOI 10.1016/S0140-6736(04)15595-5; Ramos I, 2011, J VIROL, V85, P4421, DOI 10.1128/JVI.02356-10; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rose MC, 2000, J AEROSOL MED, V13, P245, DOI 10.1089/jam.2000.13.245; Schauer R, 2000, GLYCOCONJUGATE J, V17, P485, DOI 10.1023/A:1011062223612; SCHNITZLER SU, 2009, VIRUS GENES; Shelton H, 2011, J VIROL, V85, P1875, DOI 10.1128/JVI.01822-10; SHIBUYA N, 1987, J BIOL CHEM, V262, P1596; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Simonsen L, 1998, J INFECT DIS, V178, P53, DOI 10.1086/515616; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; SPRINGER GF, 1969, P NATL ACAD SCI USA, V64, P634, DOI 10.1073/pnas.64.2.634; Stray SJ, 2000, GLYCOBIOLOGY, V10, P649, DOI 10.1093/glycob/10.7.649; SUZUKI Y, 1985, VACCINE, V3, P201, DOI 10.1016/0264-410X(85)90104-5; Suzuki Y, 2000, J VIROL, V74, P11825, DOI 10.1128/JVI.74.24.11825-11831.2000; SUZUKI Y, 1985, J BIOL CHEM, V260, P1362; SUZUKI Y, 1986, J BIOL CHEM, V261, P7057; TATENO I, 1966, NEW ENGL J MED, V274, P237, DOI 10.1056/NEJM196602032740502; Thompson CI, 2006, J VIROL, V80, P8060, DOI 10.1128/JVI.00384-06; To KF, 2001, J MED VIROL, V63, P242, DOI 10.1002/1096-9071(200103)63:3&lt;242::AID-JMV1007&gt;3.0.CO;2-N; Varki A, 2008, TRENDS MOL MED, V14, P351, DOI 10.1016/j.molmed.2008.06.002; Varki A, 2007, NATURE, V446, P1023, DOI 10.1038/nature05816; Wang CC, 2009, P NATL ACAD SCI USA, V106, P18137, DOI 10.1073/pnas.0909696106; WANG WC, 1988, J BIOL CHEM, V263, P4576; Webby R, 2004, NAT MED, V10, pS77, DOI 10.1038/nm1151; WHO, 2010, CUM NUMB CONF HUM CA; *WHO, 2009, CUM NUMB CONF HUM CA; Xu Q, 2010, J VIROL, V84, P4936, DOI 10.1128/JVI.02489-09; Zeng H, 2007, J VIROL, V81, P12439, DOI 10.1128/JVI.01134-07	64	39	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21183	10.1371/journal.pone.0021183	http://dx.doi.org/10.1371/journal.pone.0021183			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731666	Green Submitted, Green Published, gold			2022-12-27	WOS:000292035400012
J	Vestergaard, P; Stoen, OG; Swenson, JE; Mosekilde, L; Heickendorff, L; Frobert, O				Vestergaard, Peter; Stoen, Ole-Gunnar; Swenson, Jon E.; Mosekilde, Leif; Heickendorff, Lene; Frobert, Ole			Vitamin D Status and Bone and Connective Tissue Turnover in Brown Bears (Ursus arctos) during Hibernation and the Active State	PLOS ONE			English	Article							SPINAL-CORD-INJURY; DISUSE OSTEOPOROSIS; MAMMALIAN HIBERNATION; PARATHYROID-HORMONE; METABOLISM; FRACTURES; OSTEOCALCIN; AMERICANUS; CALCIUM; SKIN	Background: Extended physical inactivity causes disuse osteoporosis in humans. In contrast, brown bears (Ursus arctos) are highly immobilised for half of the year during hibernation without signs of bone loss and therefore may serve as a model for prevention of osteoporosis. Aim: To study 25-hydroxy-vitamin D (25OHD) levels and bone turnover markers in brown bears during the hibernating state in winter and during the active state in summer. We measured vitamin D subtypes (D(2) and D(3)), calcitropic hormones (parathyroid hormone [PTH], 1,25-dihydroxy-vitamin D [1,25(OH)(2)D]) and bone turnover parameters (osteocalcin, ICTP, CTX-I), PTH, serum calcium and PIIINP. Material and Methods: We drew blood from seven immobilised wild brown bears during hibernation in February and in the same bears while active in June. Results: Serum 25-hydroxy-cholecalciferol (25OHD(3)) was significantly higher in the summer than in the winter (22.8 +/- 4.6 vs. 8.8 +/- 2.1 nmol/l, two tailed p - 2p = 0.02), whereas 25-hydroxy-ergocalciferol (25OHD(2)) was higher in winter (54.2 +/- 8.3 vs. 18.7 +/- 1.7 nmol/l, 2p < 0.01). Total serum calcium and PTH levels did not differ between winter and summer. Activated 1,25(OH)(2)D demonstrated a statistically insignificant trend towards higher summer levels. Osteocalcin levels were higher in summer than winter, whereas other markers of bone turnover (ICTP and CTX-I) were unchanged. Serum PIIINP, which is a marker of connective tissue and to some degree muscle turnover, was significantly higher during summer than during winter. Conclusions: Dramatic changes were documented in the vitamin D(3)/D(2) ratio and in markers of bone and connective tissue turnover in brown bears between hibernation and the active state. Because hibernating brown bears do not develop disuse osteoporosis, despite extensive physical inactivity we suggest that they may serve as a model for the prevention of this disease.	[Vestergaard, Peter] Aarhus Univ Hosp, Osteoporosis Clin, DK-8000 Aarhus, Denmark; [Stoen, Ole-Gunnar; Swenson, Jon E.] Norwegian Univ Life Sci, Dept Ecol & Nat Resource Management, As, Norway; [Swenson, Jon E.] Norwegian Inst Nat Res, N-7004 Trondheim, Norway; [Mosekilde, Leif] Aarhus Univ Hosp THG, Dept Endocrinol & Internal Med, Aarhus, Denmark; [Heickendorff, Lene] Aarhus Univ Hosp, Dept Clin Biochem, DK-8000 Aarhus, Denmark; [Frobert, Ole] Orebro Univ Hosp, Dept Cardiol, Orebro, Sweden	Aarhus University; Norwegian University of Life Sciences; Norwegian Institute Nature Research; Aarhus University; Aarhus University; Orebro University	Vestergaard, P (corresponding author), Aarhus Univ Hosp, Osteoporosis Clin, DK-8000 Aarhus, Denmark.	p-vest@post4.tele.dk	Swenson, Jon/E-2883-2013; Swenson, Jon/AAE-2890-2019; Støen, Ole-Gunnar/AAY-6457-2020	Frobert, Ole/0000-0002-5846-345X	Swedish Environmental Protection Agency; Norwegian Directorate for Nature Management; Swedish Association for Hunting and Wildlife Management, WWF Sweden; Research Council of Norway; Norwegian Institute for Nature Research	Swedish Environmental Protection Agency; Norwegian Directorate for Nature Management; Swedish Association for Hunting and Wildlife Management, WWF Sweden; Research Council of Norway(Research Council of Norway); Norwegian Institute for Nature Research(Bioforsk)	The Scandinavian Brown Bear Research Project was funded by the Swedish Environmental Protection Agency, the Norwegian Directorate for Nature Management, the Swedish Association for Hunting and Wildlife Management, WWF Sweden, the Research Council of Norway and the Norwegian Institute for Nature Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMSON A S, 1961, Arch Phys Med Rehabil, V42, P147; [Anonymous], 2007, HDB WILDLIFE CHEM IM; Camacho PM, 2008, CLIN CHEM LAB MED, V46, P1345, DOI 10.1515/CCLM.2008.310; Carey HV, 2003, PHYSIOL REV, V83, P1153, DOI 10.1152/physrev.00008.2003; Confavreux CB, 2009, MOL CELL ENDOCRINOL, V310, P21, DOI 10.1016/j.mce.2009.04.004; Crissey S, 2001, COMP BIOCHEM PHYS A, V128, P155, DOI 10.1016/S1095-6433(00)00289-0; Dahle B, 1998, WILDLIFE BIOL, V4, P147, DOI 10.2981/wlb.1998.017; Donahue SW, 2006, J EXP BIOL, V209, P1630, DOI 10.1242/jeb.02185; Fan L, 2008, J FOOD SCI, V73, pM292, DOI 10.1111/j.1750-3841.2008.00838.x; Ferron M, 2008, P NATL ACAD SCI USA, V105, P5266, DOI 10.1073/pnas.0711119105; FLOYD T, 1990, CLIN ORTHOP RELAT R, P301; Friebe A, 2001, URSUS-SERIES, V12, P37; Frobert O, 2010, THROMB J, V8, DOI 10.1186/1477-9560-8-11; FROST HM, 1987, ANAT RECORD, V219, P1, DOI 10.1002/ar.1092190104; Harcourt-Brown F, 2002, TXB RABBIT MED; Heaney RP, 2011, J CLIN ENDOCR METAB, V96, pE447, DOI 10.1210/jc.2010-2230; HERMINGHUYSEN D, 1995, PHYSIOL BEHAV, V57, P271, DOI 10.1016/0031-9384(94)00246-2; Hojskov CS, 2010, CLIN CHIM ACTA, V411, P114, DOI 10.1016/j.cca.2009.10.010; Holick MF, 2003, J CELL BIOCHEM, V88, P296, DOI 10.1002/jcb.10338; HORST RL, 1984, ARCH BIOCHEM BIOPHYS, V231, P67, DOI 10.1016/0003-9861(84)90363-1; Hymoller L, 2010, J DAIRY SCI, V93, P2025, DOI 10.3168/jds.2009-2991; Imel EA, 2010, J CLIN ENDOCR METAB, V95, P1846, DOI 10.1210/jc.2009-1671; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Leventis P, 2009, SCAND J RHEUMATOL, V38, P149, DOI 10.1080/03009740802419081; Lin RC, 2005, VET SURG, V34, P358, DOI 10.1111/j.1532-950X.2005.00055.x; Manchi S, 2005, WILDLIFE BIOL, V11, P123, DOI 10.2981/0909-6396(2005)11[123:DBOSBB]2.0.CO;2; Mcgee ME, 2008, BONE, V42, P396, DOI 10.1016/j.bone.2007.10.010; McGee ME, 2007, J ANAT, V210, P160, DOI 10.1111/j.1469-7580.2006.00681.x; McGee-Lawrence ME, 2009, BONE, V45, P1186, DOI 10.1016/j.bone.2009.08.011; McGee-Lawrence ME, 2009, J BIOMECH, V42, P1378, DOI 10.1016/j.jbiomech.2008.11.039; McGee-Lawrence ME, 2008, AM J PHYSIOL-REG I, V295, pR1999, DOI 10.1152/ajpregu.90648.2008; MCGRAW RL, 1994, CALCIFIED TISSUE INT, V55, P87, DOI 10.1007/BF00297180; Mechanick JI, 1997, ARCH PHYS MED REHAB, V78, P692, DOI 10.1016/S0003-9993(97)90075-7; NEWLANDER JA, 1952, J ANIM SCI, V11, P419, DOI 10.2527/jas1952.112419x; NIELSEN HK, 1991, J BONE MINER RES, V6, P435; PATTERSON G, 1999, PHYSL BIOCH STEROLS, V1; Persson IL, 2001, WILDLIFE BIOL, V7, P27, DOI 10.2981/wlb.2001.006; SCHNEIDER VS, 1993, ACTA ASTRONAUT, V29, P139, DOI 10.1016/0094-5765(93)90031-Q; SCHWARZ P, 1994, EUR J CLIN INVEST, V24, P553, DOI 10.1111/j.1365-2362.1994.tb01106.x; Sondergaard K, 1997, BRIT J DERMATOL, V136, P47, DOI 10.1046/j.1365-2133.1997.d01-1141.x; SORENSEN FB, 1990, EUR J CLIN INVEST, V20, P330; Vestergaard P, 1998, SPINAL CORD, V36, P790, DOI 10.1038/sj.sc.3100648	42	28	29	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21483	10.1371/journal.pone.0021483	http://dx.doi.org/10.1371/journal.pone.0021483			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731765	Green Published, gold			2022-12-27	WOS:000292035400043
J	Cavassani, KA; Tristao, FSM; Oliveira, LL; Rocha, FA; Vancim, JO; Moreira, AP; Campanelli, AP; Panagio, LA; Milanezi, CM; Martinez, R; Rossi, MA; Silva, JS				Cavassani, Karen A.; Tristao, Fabrine S. M.; Oliveira, Leandro L.; Rocha, Fernanda A.; Vancim, Jaqueline O.; Moreira, Ana Paula; Campanelli, Ana Paula; Panagio, Luciano A.; Milanezi, Cristiane M.; Martinez, Roberto; Rossi, Marcos A.; Silva, Joao S.			Cell-Free Antigens from Paracoccidioides brasiliensis Drive IL-4 Production and Increase the Severity of Paracoccidioidomycosis	PLOS ONE			English	Article							RADIOATTENUATED YEAST-CELLS; PULMONARY PARACOCCIDIOIDOMYCOSIS; BALB/C MICE; IMMUNE-RESPONSE; IFN-GAMMA; INFECTION; MACROPHAGES; GLYCOPROTEIN; IMMUNIZATION; CYTOKINES	The thermally dimorphic fungus Paracoccidioides brasiliensis (Pb) is the causative agent of paracoccidioidomycosis (PCM), one of the most frequent systemic mycosis that affects the rural population in Latin America. PCM is characterized by a chronic inflammatory granulomatous reaction, which is consequence of a Th1-mediated adaptive immune response. In the present study we investigated the mechanisms involved in the immunoregulation triggered after a prior contact with cell-free antigens (CFA) during a murine model of PCM. The results showed that the inoculation of CFA prior to the infection resulted in disorganized granulomatous lesions and increased fungal replication in the lungs, liver and spleen, that paralleled with the higher levels of IL-4 when compared with the control group. The role of IL-4 in facilitating the fungal growth was demonstrated in IL-4-deficient- and neutralizing anti-IL-4 mAb-treated mice. The injection of CFA did not affect the fungal growth in these mice, which, in fact, exhibited a significant diminished amount of fungus in the tissues and smaller granulomas. Considering that in vivo anti-IL-4-application started one week after the CFA-inoculum, it implicates that IL-4-CFA-induced is responsible by the mediation of the observed unresponsiveness. Further, the characterization of CFA indicated that a proteic fraction is required for triggering the immunosuppressive mechanisms, while glycosylation or glycosphingolipids moieties are not. Taken together, our data suggest that the prior contact with soluble Pb antigens leads to severe PCM in an IL-4 dependent manner.	[Cavassani, Karen A.; Tristao, Fabrine S. M.; Rocha, Fernanda A.; Vancim, Jaqueline O.; Moreira, Ana Paula; Panagio, Luciano A.; Milanezi, Cristiane M.; Martinez, Roberto; Rossi, Marcos A.; Silva, Joao S.] Univ Sao Paulo, Sch Med Ribeirao Preto, Sao Paulo, Brazil; [Oliveira, Leandro L.] Univ Sao Paulo, Sch Pharmaceut Sci Ribeirao Preto, Sao Paulo, Brazil; [Campanelli, Ana Paula] Univ Sao Paulo, Sch Dent Bauru, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Cavassani, KA (corresponding author), Univ Sao Paulo, Sch Med Ribeirao Preto, Sao Paulo, Brazil.	jsdsilva@fmrp.usp.br	Tristao, Fabrine/K-6590-2013; Campanelli, Ana Paula/B-9144-2012; Panagio, Luciano Aparecido/V-3027-2019; de Oliveira, Leandro Licursi/D-3616-2009; Silva, Joao/A-4484-2008	Panagio, Luciano Aparecido/0000-0002-2484-3147; de Oliveira, Leandro Licursi/0000-0003-4353-7011; Silva, Joao/0000-0002-3410-3927; Campanelli, Ana Paula/0000-0002-0536-5469	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); National Counsel of Technological and Scientific Development (CNPq)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Counsel of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) and National Counsel of Technological and Scientific Development (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida SR, 1998, MED MYCOL, V36, P405, DOI 10.1080/02681219880000641; Arruda C, 2004, INFECT IMMUN, V72, P3932, DOI 10.1128/IAI.72.7.3932-3940.2004; Soares RDA, 2008, INFECT IMMUN, V76, P4214, DOI 10.1128/IAI.00753-07; Benard G, 1997, J INFECT DIS, V175, P1263, DOI 10.1086/593694; Benard G, 2001, CYTOKINE, V13, P248, DOI 10.1006/cyto.2000.0824; Bertini S, 2007, CLIN VACCINE IMMUNOL, V14, P150, DOI 10.1128/CVI.00285-06; Borges-Walmsley MI, 2002, TRENDS MICROBIOL, V10, P80, DOI 10.1016/S0966-842X(01)02292-2; BRUMMER E, 1993, CLIN MICROBIOL REV, V6, P89, DOI 10.1128/CMR.6.2.89-117.1993; Calich VLG, 1998, BRAZ J MED BIOL RES, V31, P615, DOI 10.1590/S0100-879X1998000500003; CALICH VLG, 1979, CLIN IMMUNOL IMMUNOP, V12, P20, DOI 10.1016/0090-1229(79)90108-9; CAMARGO ZP, 1991, J MED VET MYCOL, V29, P31; Campanelli AP, 2003, J INFECT DIS, V187, P1496, DOI 10.1086/374646; Cano LE, 1998, INFECT IMMUN, V66, P800, DOI 10.1128/IAI.66.2.800-806.1998; CASOTTO M, 1990, J CLIN MICROBIOL, V28, P1188, DOI 10.1128/JCM.28.6.1188-1193.1990; Cenci E, 1999, J INFECT DIS, V180, P1957, DOI 10.1086/315142; Coltri KC, 2006, MICROBES INFECT, V8, P704, DOI 10.1016/j.micinf.2005.09.008; Commins S, 2008, J ALLERGY CLIN IMMUN, V121, P1108, DOI 10.1016/j.jaci.2008.02.026; COSTA TA, 2005, 9 INT M PAR AG DE LI, P29; Coutinho Ziadir Francisco, 2002, Cad. Saúde Pública, V18, P1441, DOI 10.1590/S0102-311X2002000500037; Martins EMD, 2009, MYCOPATHOLOGIA, V168, P51, DOI 10.1007/s11046-009-9197-5; Ferreira KS, 2006, IMMUNOL LETT, V103, P121, DOI 10.1016/j.imlet.2005.10.014; Ferreira KS, 2003, SCAND J IMMUNOL, V58, P290, DOI 10.1046/j.1365-3083.2003.01291.x; FIGUEROA JI, 1994, J CLIN MICROBIOL, V32, P1566, DOI 10.1128/JCM.32.6.1566-1574.1994; Franco MF., 1989, BAILLIERE CLIN TROP, V4, P185, DOI DOI 10.1590/S0036-46651994000100017; JIMENEZFINKEL BE, 1988, INFECT IMMUN, V56, P734, DOI 10.1128/IAI.56.4.734-743.1988; Karhawi ASK, 2000, MED MYCOL, V38, P225, DOI 10.1080/714030939; Kopf M, 1996, J EXP MED, V184, P1127, DOI 10.1084/jem.184.3.1127; Livonesi MC, 2008, MED MYCOL, V46, P637, DOI 10.1080/13693780801982762; Livonesi MC, 2009, MICROBES INFECT, V11, P123, DOI 10.1016/j.micinf.2008.10.015; Martins EMDN, 2007, VACCINE, V25, P7893, DOI 10.1016/j.vaccine.2007.09.011; MCEWEN JG, 1987, J MED VET MYCOL, V25, P165; Moreira AP, 2010, CELL IMMUNOL, V263, P196, DOI 10.1016/j.cellimm.2010.03.016; MOSCARDIBACCHI M, 1994, J MED MICROBIOL, V40, P159, DOI 10.1099/00222615-40-3-159; Noel W, 2004, TRENDS PARASITOL, V20, P126, DOI 10.1016/j.pt.2004.01.004; Peracoli MTS, 2003, MICROBES INFECT, V5, P413, DOI 10.1016/S1286-4579(03)00040-6; Pina A, 2004, INFECT IMMUN, V72, P2369, DOI 10.1128/IAI.72.4.2369-2378.2004; Popi AF, 2002, CELL IMMUNOL, V218, P87, DOI 10.1016/S0008-8749(02)00576-2; PUCCIA R, 1986, INFECT IMMUN, V53, P199, DOI 10.1128/IAI.53.1.199-206.1986; Restrepo A, 2001, MED MYCOL, V39, P233, DOI 10.1080/714031028; RESTREPO A, 1985, SABOURAUDIA, V23, P323; Restrepo-Moreno Angela, 1993, P251; RODRIGUES EG, 1994, J MED VET MYCOL, V32, P77; Saraiva ECO, 1996, J MED VET MYCOL, V34, P155; Souto JT, 2000, AM J PATHOL, V156, P1811, DOI 10.1016/S0002-9440(10)65053-5; Taborda CP, 1998, INFECT IMMUN, V66, P786, DOI 10.1128/IAI.66.2.786-793.1998; Wang WX, 2002, PLANT PHYSIOL, V130, P865, DOI 10.1104/pp.002436; Zhu Z, 2004, SCIENCE, V304, P1678, DOI 10.1126/science.1095336	47	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21423	10.1371/journal.pone.0021423	http://dx.doi.org/10.1371/journal.pone.0021423			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731741	gold, Green Submitted, Green Published			2022-12-27	WOS:000292033700081
J	Farmer, S; San-Segundo, PA; Aragon, L				Farmer, Sarah; San-Segundo, Pedro A.; Aragon, Luis			The Smc5-Smc6 Complex Is Required to Remove Chromosome Junctions in Meiosis	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; DAMAGED REPLICATION FORKS; MEIOTIC CROSSING-OVER; SACCHAROMYCES-CEREVISIAE; DNA-REPAIR; SUMO LIGASE; HOMOLOGOUS RECOMBINATION; PACHYTENE CHECKPOINT; HOLLIDAY JUNCTIONS; JOINT MOLECULES	Meiosis, a specialized cell division with a single cycle of DNA replication round and two consecutive rounds of nuclear segregation, allows for the exchange of genetic material between parental chromosomes and the formation of haploid gametes. The structural maintenance of chromosome (SMC) proteins aid manipulation of chromosome structures inside cells. Eukaryotic SMC complexes include cohesin, condensin and the Smc5-Smc6 complex. Meiotic roles have been discovered for cohesin and condensin. However, although Smc5-Smc6 is known to be required for successful meiotic divisions, the meiotic functions of the complex are not well understood. Here we show that the Smc5-Smc6 complex localizes to specific chromosome regions during meiotic prophase I. We report that meiotic cells lacking Smc5-Smc6 undergo catastrophic meiotic divisions as a consequence of unresolved linkages between chromosomes. Surprisingly, meiotic segregation defects are not rescued by abrogation of Spo11-induced meiotic recombination, indicating that at least some chromosome linkages in smc5-smc6 mutants originate from other cellular processes. These results demonstrate that, as in mitosis, Smc5-Smc6 is required to ensure proper chromosome segregation during meiosis by preventing aberrant recombination intermediates between homologous chromosomes.	[Farmer, Sarah; Aragon, Luis] Univ London Imperial Coll Sci Technol & Med, Ctr Clin Sci, MRC, Cell Cycle Grp, London, England; [San-Segundo, Pedro A.] Univ Salamanca, CSIC, Inst Biol Func & Genom, E-37008 Salamanca, Spain	Imperial College London; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Funcional y Genomica (IBFG); University of Salamanca	Farmer, S (corresponding author), Univ London Imperial Coll Sci Technol & Med, Ctr Clin Sci, MRC, Cell Cycle Grp, London, England.	luis.aragon@csc.mrc.ac.uk	San-Segundo, Pedro A/L-4539-2014	San-Segundo, Pedro A/0000-0002-5616-574X	Medical Research Council United Kingdom; Spanish Ministry of Education [BFU2009-07159]; Fundacion Ramon Areces; Medical Research Council [MC_U120074328] Funding Source: researchfish; MRC [MC_U120074328] Funding Source: UKRI	Medical Research Council United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Spanish Ministry of Education(Spanish Government); Fundacion Ramon Areces; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the Medical Research Council United Kingdom Intramural Grant Programme to LA and grant BFU2009-07159 from the Spanish Ministry of Education and Fundacion Ramon Areces to PS-S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews EA, 2005, MOL CELL BIOL, V25, P185, DOI 10.1128/MCB.25.1.185-196.2005; Argueso JL, 2004, GENETICS, V168, P1805, DOI 10.1534/genetics.104.032912; ATCHESON CL, 1987, P NATL ACAD SCI USA, V84, P8035, DOI 10.1073/pnas.84.22.8035; Baudat F, 2007, CHROMOSOME RES, V15, P565, DOI 10.1007/s10577-007-1140-3; Boddy MN, 2001, CELL, V107, P537, DOI 10.1016/S0092-8674(01)00536-0; Branzei D, 2006, CELL, V127, P509, DOI 10.1016/j.cell.2006.08.050; CAO L, 1990, CELL, V61, P1089, DOI 10.1016/0092-8674(90)90072-M; Cha RS, 2000, GENE DEV, V14, P493; Cost GJ, 2006, GENETICS, V172, P2185, DOI 10.1534/genetics.105.053876; Cromie GA, 2006, CELL, V127, P1167, DOI 10.1016/j.cell.2006.09.050; de los Santos T, 2001, GENETICS, V159, P1511; De Piccoli G, 2006, NAT CELL BIOL, V8, P1032, DOI 10.1038/ncb1466; Franklin AE, 1999, PLANT CELL, V11, P809, DOI 10.1105/tpc.11.5.809; Goldfarb T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000520; Hazbun TR, 2003, MOL CELL, V12, P1353, DOI 10.1016/S1097-2765(03)00476-3; Hochwagen A, 2006, CURR BIOL, V16, pR217, DOI 10.1016/j.cub.2006.03.009; Hong EJE, 2002, GENE DEV, V16, P363, DOI 10.1101/gad.938102; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; Interthal H, 2000, MOL GEN GENET, V263, P812, DOI 10.1007/s004380000241; Jessop L, 2008, MOL CELL, V31, P313, DOI 10.1016/j.molcel.2008.05.021; Jessop L, 2006, PLOS GENET, V2, P1402, DOI 10.1371/journal.pgen.0020155; Kaliraman V, 2001, GENE DEV, V15, P2730, DOI 10.1101/gad.932201; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; KLAPHOLZ S, 1980, GENETICS, V96, P567; KLAPHOLZ S, 1985, GENETICS, V110, P187; Lamb NE, 2005, CYTOGENET GENOME RES, V111, P250, DOI 10.1159/000086896; Lee B, 2001, CURR OPIN CELL BIOL, V13, P770, DOI 10.1016/S0955-0674(00)00282-9; LEHMANN AR, 1995, MOL CELL BIOL, V15, P7067; Liberi G, 2005, GENE DEV, V19, P339, DOI 10.1101/gad.322605; Lindroos HB, 2006, MOL CELL, V22, P755, DOI 10.1016/j.molcel.2006.05.014; Lynn A, 2007, CHROMOSOME RES, V15, P591, DOI 10.1007/s10577-007-1150-1; Martinez-Perez E, 2009, CURR OPIN GENET DEV, V19, P105, DOI 10.1016/j.gde.2009.02.005; Oh SD, 2008, MOL CELL, V31, P324, DOI 10.1016/j.molcel.2008.07.006; Oh SD, 2007, CELL, V130, P259, DOI 10.1016/j.cell.2007.05.035; Pebernard S, 2006, MOL CELL BIOL, V26, P1617, DOI 10.1128/MCB.26.5.1617-1630.2006; Pebernard S, 2004, MOL BIOL CELL, V15, P4866, DOI 10.1091/mbc.E04-05-0436; Potts PR, 2006, EMBO J, V25, P3377, DOI 10.1038/sj.emboj.7601218; Potts PR, 2005, MOL CELL BIOL, V25, P7021, DOI 10.1128/MCB.25.16.7021-7032.2005; Rockmill B, 2003, CURR BIOL, V13, P1954, DOI 10.1016/j.cub.2003.10.059; Roeder GS, 2000, TRENDS GENET, V16, P395, DOI 10.1016/S0168-9525(00)02080-1; Roeder GS, 1997, GENE DEV, V11, P2600, DOI 10.1101/gad.11.20.2600; San-Segundo PA, 1999, CELL, V97, P313, DOI 10.1016/S0092-8674(00)80741-2; SCHWACHA A, 1995, CELL, V83, P783, DOI 10.1016/0092-8674(95)90191-4; Sergeant J, 2005, MOL CELL BIOL, V25, P172, DOI 10.1128/MCB.25.1.172-184.2005; Shinohara M, 2000, P NATL ACAD SCI USA, V97, P10814, DOI 10.1073/pnas.97.20.10814; Shonn MA, 2000, SCIENCE, V289, P300, DOI 10.1126/science.289.5477.300; Smith AV, 1997, J CELL BIOL, V136, P957, DOI 10.1083/jcb.136.5.957; Smith GR, 2003, GENETICS, V165, P2289; Sollier J, 2009, MOL BIOL CELL, V20, P1671, DOI 10.1091/mbc.E08-08-0875; SYM M, 1993, CELL, V72, P365, DOI 10.1016/0092-8674(93)90114-6; Torres-Rosell J, 2005, NAT CELL BIOL, V7, P412, DOI 10.1038/ncb1239; Torres-Rosell J, 2007, SCIENCE, V315, P1411, DOI 10.1126/science.1134025; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253; XU LZ, 1995, MOL CELL BIOL, V15, P6572; Zhao XL, 2005, P NATL ACAD SCI USA, V102, P4777, DOI 10.1073/pnas.0500537102	55	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e20948	10.1371/journal.pone.0020948	http://dx.doi.org/10.1371/journal.pone.0020948			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731634	Green Published, Green Submitted, gold			2022-12-27	WOS:000292033700021
J	Hao, DC; Ge, GB; Xiao, PG; Zhang, YY; Yang, L				Hao, Da Cheng; Ge, GuangBo; Xiao, PeiGen; Zhang, YanYan; Yang, Ling			The First Insight into the Tissue Specific Taxus Transcriptome via Illumina Second Generation Sequencing	PLOS ONE			English	Article							TAXOL BIOSYNTHESIS; RNA-SEQ; DNA; IDENTIFICATION; VISUALIZATION; CHLOROPLAST; DISCOVERY; GENOMICS; NEEDLES; TOOL	Background: Illumina second generation sequencing is now an efficient route for generating enormous sequence collections that represent expressed genes and quantitate expression level. Taxus is a world-wide endangered gymnosperm genus and forms an important anti-cancer medicinal resource, but the large and complex genomes of Taxus have hindered the development of genomic resources. The research of its tissue-specific transcriptome is absent. There is also no study concerning the association between the plant transcriptome and metabolome with respect to the plant tissue type. Methodology/Principal Findings: We performed the de novo assembly of Taxus mairei transcriptome using Illumina paired-end sequencing technology. In a single run, we produced 13,737,528 sequencing reads corresponding to 2.03 Gb total nucleotides. These reads were assembled into 36,493 unique sequences. Based on similarity search with known proteins, 23,515 Unigenes were identified to have the Blast hit with a cut-off E-value above 10(-5). Furthermore, we investigated the transcriptome difference of three Taxus tissues using a tag-based digital gene expression system. We obtained a sequencing depth of over 3.15 million tags per sample and identified a large number of genes associated with tissue specific functions and taxane biosynthetic pathway. The expression of the taxane biosynthetic genes is significantly higher in the root than in the leaf and the stem, while high activity of taxane-producing pathway in the root was also revealed via metabolomic analyses. Moreover, many antisense transcripts and novel transcripts were found; clusters with similar differential expression patterns, enriched GO terms and enriched metabolic pathways with regard to the differentially expressed genes were revealed for the first time. Conclusions/Significance: Our data provides the most comprehensive sequence resource available for Taxus study and will help define mechanisms of tissue specific functions and secondary metabolism in non-model plant organisms.	[Hao, Da Cheng] Dalian Jiaotong Univ, Inst Biotechnol, Dalian, Peoples R China; [Ge, GuangBo; Zhang, YanYan; Yang, Ling] Chinese Acad Sci, Dalian Inst Chem Phys, Dalian, Peoples R China; [Xiao, PeiGen] Chinese Acad Med Sci, Inst Med Plant Dev, Beijing 100730, Peoples R China	Dalian Jiaotong University; Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS	Hao, DC (corresponding author), Dalian Jiaotong Univ, Inst Biotechnol, Dalian, Peoples R China.	hao@djtu.edu.cn; yling@dicp.ac.cn	Yang, Ling/F-5472-2012	ling, yang/0000-0001-7093-5926	Ministry of Science and Technology of China [2009AA02Z205]; Chinese Academy of Sciences [KSCX2-YW-G-050]; National Natural Science Foundation of China [30973590]; National Key Technology R&D Program in the 11th Five Year Plan of China [2008ZX10208]; China Postdoctoral Science Foundation [20080440019, 200902069]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology R&D Program in the 11th Five Year Plan of China(National Key Technology R&D Program); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work is supported by the 863 program (2009AA02Z205) of the Ministry of Science and Technology of China, the Key Direction Program (KSCX2-YW-G-050) of the Chinese Academy of Sciences, the National Natural Science Foundation of China (30973590), the National Key Technology R&D Program in the 11th Five Year Plan of China (2008ZX10208), and the China Postdoctoral Science Foundation (20080440019 and 200902069). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Benjamini Y, 2001, ANN STAT, V29, P1165; Collins LJ, 2008, GENOME INFORM SER, V21, P3; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Croteau Rodney, 2006, Phytochemistry Reviews, V5, P75, DOI 10.1007/s11101-005-3748-2; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fu CH, 2011, PLANT CELL PHYSIOL, V52, P238, DOI 10.1093/pcp/pcq201; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; Ge GB, 2008, PLANTA MED, V74, P773, DOI 10.1055/s-2008-1074531; Ge GB, 2008, RAPID COMMUN MASS SP, V22, P2315, DOI 10.1002/rcm.3616; Hall N, 2007, J EXP BIOL, V210, P1518, DOI 10.1242/jeb.001370; Hampel D, 2009, ARCH BIOCHEM BIOPHYS, V487, P91, DOI 10.1016/j.abb.2009.05.018; Hao DC, 2008, PLANT SYST EVOL, V276, P89, DOI 10.1007/s00606-008-0069-0; Hao DC, 2008, BIOL PHARM BULL, V31, P260, DOI 10.1248/bpb.31.260; Hao DC, 2011, MOL GENET GENOMICS, V285, P197, DOI 10.1007/s00438-010-0598-4; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Jennewein S, 2004, P NATL ACAD SCI USA, V101, P9149, DOI 10.1073/pnas.0403009101; Jennewein S, 2003, ARCH BIOCHEM BIOPHYS, V413, P262, DOI 10.1016/S0003-9861(03)00090-0; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kaspera Rudiger, 2006, Phytochemistry Reviews, V5, P433, DOI 10.1007/s11101-006-9006-4; Ketchum REB, 2003, PHYTOCHEMISTRY, V62, P901, DOI 10.1016/S0031-9422(02)00711-2; Kingston DGI, 2001, CHEM COMMUN, P867, DOI 10.1039/b100070p; Lee EK, 2010, NAT BIOTECHNOL, V28, P1213, DOI 10.1038/nbt.1693; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Long RM, 2005, BIOCHEM BIOPH RES CO, V338, P410, DOI 10.1016/j.bbrc.2005.08.119; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Mizrachi E, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-681; Morrissy AS, 2009, GENOME RES, V19, P1825, DOI 10.1101/gr.094482.109; Morrissy S., 2010, CURR PROTOC HUM GENE; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Rodriguez-Concepcion M, 2002, PLANT PHYSIOL, V130, P1079, DOI 10.1104/pp.007138; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schuster SC, 2008, NAT METHODS, V5, P16, DOI [10.1038/nmeth1156, 10.1038/NMETH1156]; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; van Rozendaal ELM, 2000, PHYTOCHEMISTRY, V53, P383, DOI 10.1016/S0031-9422(99)00094-1; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; Wu Q, 2011, PLANTA MED, V77, P394, DOI 10.1055/s-0030-1250331; Xu Q, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-540; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031	40	134	164	3	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21220	10.1371/journal.pone.0021220	http://dx.doi.org/10.1371/journal.pone.0021220			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731678	gold, Green Submitted, Green Published			2022-12-27	WOS:000292033700049
J	Zimmermann, HW; Seidler, S; Gassler, N; Nattermann, J; Luedde, T; Trautwein, C; Tacke, F				Zimmermann, Henning W.; Seidler, Sebastian; Gassler, Nikolaus; Nattermann, Jacob; Luedde, Tom; Trautwein, Christian; Tacke, Frank			Interleukin-8 Is Activated in Patients with Chronic Liver Diseases and Associated with Hepatic Macrophage Accumulation in Human Liver Fibrosis	PLOS ONE			English	Article							ALCOHOLIC HEPATITIS; NEUTROPHILIC INFILTRATION; MONOCYTE SUBSETS; CXC CHEMOKINES; EXPRESSION; INJURY; RECEPTORS; CIRRHOSIS; CELLS; RECRUITMENT	Background: Interleukin-8 (IL-8, CXCL8) is a potent chemoattractant for neutrophils and contributes to acute liver inflammation. Much less is known about IL-8 in chronic liver diseases (CLD), but elevated levels were reported from alcoholic and hepatitis C-related CLD. We investigated the regulation of IL-8, its receptors CXCR1 and CXCR2 and possible IL-8 responding cells in CLD patients. Methodology: Serum IL-8 levels were measured in CLD patients (n = 200) and healthy controls (n = 141). Intrahepatic IL-8, CXCR1 and CXCR2 gene expression was quantified from liver samples (n = 41), alongside immunohistochemical neutrophil (MPO) and macrophage (CD68) stainings. CXCR1 and CXCR2 expression was analyzed on purified monocytes from patients (n = 111) and controls (n = 31). In vitro analyses explored IL-8 secretion by different leukocyte subsets. Principal Findings: IL-8 serum levels were significantly increased in CLD patients, especially in end-stage cirrhosis. Interestingly, patients with cholestatic diseases exhibited highest IL-8 serum concentrations. IL-8 correlated with liver function, inflammatory cytokines and non-invasive fibrosis markers. Intrahepatically, IL-8 and CXCR1 expression were strongly up-regulated. However, intrahepatic IL-8 could only be associated to neutrophil infiltration in patients with primary biliary cirrhosis (PBC). In non-cholestatic cirrhosis, increased IL-8 and CXCR1 levels were associated with hepatic macrophage accumulation. In line, CXCR1, but not CXCR2 or CXCR3, expression was increased on circulating monocytes from cirrhotic patients. Moreover, monocyte-derived macrophages from CLD patients, especially the non-classical CD16(+) subtype, displayed enhanced IL-8 secretion in vitro. Conclusions: IL-8 is strongly activated in CLD, thus likely contributing to hepatic inflammation. Our study suggests a novel role of IL-8 for recruitment and activation of hepatic macrophages via CXCR1 in human liver cirrhosis.	[Zimmermann, Henning W.; Seidler, Sebastian; Luedde, Tom; Trautwein, Christian; Tacke, Frank] Univ Hosp, Dept Med 3, Aachen, Germany; [Gassler, Nikolaus] Univ Hosp, Inst Pathol, Aachen, Germany; [Nattermann, Jacob] Univ Bonn, Dept Med 1, D-5300 Bonn, Germany	RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital; University of Bonn	Zimmermann, HW (corresponding author), Univ Hosp, Dept Med 3, Aachen, Germany.	frank.tacke@gmx.net	Luedde, Tom/AAE-9135-2022; Tacke, Frank/ABF-2212-2020	Luedde, Tom/0000-0002-6288-8821; 	German Research Foundation [DFG Ta434/2-1, DFG SFB/TRR 57]; RWTH-Aachen University	German Research Foundation(German Research Foundation (DFG)); RWTH-Aachen University	This work was supported by the German Research Foundation (DFG Ta434/2-1, DFG SFB/TRR 57), and by the Start-Program for Young Investigators and Interdisciplinary Centre for Clinical Research (IZKF) at RWTH-Aachen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afford SC, 1998, J PATHOL, V186, P82, DOI 10.1002/(SICI)1096-9896(199809)186:1<82::AID-PATH151>3.0.CO;2-D; Ahuja SK, 1996, J BIOL CHEM, V271, P20545, DOI 10.1074/jbc.271.34.20545; BAGGIOLINI M, 1989, J CLIN INVEST, V84, P1045, DOI 10.1172/JCI114265; Bautista AP, 2002, ALCOHOL, V27, P17, DOI 10.1016/S0741-8329(02)00206-9; Bonecchi R, 2000, J IMMUNOL, V164, P3862, DOI 10.4049/jimmunol.164.7.3862; CARRE PC, 1991, J CLIN INVEST, V88, P1802, DOI 10.1172/JCI115501; Clement S, 2010, J HEPATOL, V52, P635, DOI 10.1016/j.jhep.2009.10.035; Dominguez M, 2009, GASTROENTEROLOGY, V136, P1639, DOI 10.1053/j.gastro.2009.01.056; Emadi S, 2005, BLOOD, V105, P464, DOI 10.1182/blood-2003-12-4415; French SW, 2002, ALCOHOL, V27, P43, DOI 10.1016/S0741-8329(02)00205-7; Hammerich L, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/345803; Hashimoto S, 1996, EXP HEMATOL, V24, P123; Heymann Felix, 2009, Inflammation & Allergy Drug Targets, V8, P307; HILL DB, 1993, HEPATOLOGY, V18, P576, DOI 10.1016/0270-9139(93)90358-T; Huang YS, 1996, J HEPATOL, V24, P377, DOI 10.1016/S0168-8278(96)80156-5; Ingersoll MA, 2010, BLOOD, V115, pE10, DOI 10.1182/blood-2009-07-235028; Iredale JP, 2007, J CLIN INVEST, V117, P539, DOI 10.1172/JCI30542; Isse K, 2007, LIVER INT, V27, P672, DOI 10.1111/j.1478-3231.2007.01465.x; Jaeschke H, 2002, ALCOHOL, V27, P23, DOI 10.1016/S0741-8329(02)00200-8; Jaeschke H, 2006, LIVER INT, V26, P912, DOI 10.1111/j.1478-3231.2006.01327.x; Jaeschke H, 2006, AM J PHYSIOL-GASTR L, V290, pG1083, DOI 10.1152/ajpgi.00568.2005; KAPLANSKI G, 1994, BLOOD, V84, P4242, DOI 10.1182/blood.V84.12.4242.bloodjournal84124242; Karlmark KR, 2010, HEPATOLOGY, V52, P1769, DOI 10.1002/hep.23894; Karlmark KR, 2009, HEPATOLOGY, V50, P261, DOI 10.1002/hep.22950; Karlmark Karlin Raja, 2008, Expert Rev Gastroenterol Hepatol, V2, P233, DOI 10.1586/17474124.2.2.233; Kirsch R, 2000, J GASTROEN HEPATOL, V15, P1298, DOI 10.1046/j.1440-1746.2000.02232.x; Kobayashi Y, 2008, FRONT BIOSCI-LANDMRK, V13, P2400, DOI 10.2741/2853; Marra F, 2009, SEMIN IMMUNOPATHOL, V31, P345, DOI 10.1007/s00281-009-0169-0; MATSUSHIMA K, 1989, CYTOKINE, V1, P1; MOROHASHI H, 1995, J LEUKOCYTE BIOL, V57, P180, DOI 10.1002/jlb.57.1.180; Motoo Yoshiharu, 2004, JOP, V5, P138; Murphy PM, 1997, SEMIN HEMATOL, V34, P311; Neugebauer H, 2008, LIVER INT, V28, P1149, DOI 10.1111/j.1478-3231.2008.01829.x; Nolan JP, 2010, HEPATOLOGY, V52, P1829, DOI 10.1002/hep.23917; Polyak SJ, 2001, J VIROL, V75, P6209, DOI 10.1128/JVI.75.13.6209-6211.2001; Sallusto F, 2008, NAT IMMUNOL, V9, P949, DOI 10.1038/ni.f.214; Schauer IG, 2008, UROLOGY, V72, P205, DOI 10.1016/j.urology.2007.11.083; Schuppan D, 2008, LANCET, V371, P838, DOI 10.1016/S0140-6736(08)60383-9; Seidler S, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-30; Shawcross DI, 2008, HEPATOLOGY, V48, P1202, DOI 10.1002/hep.22474; TACKE F, 2011, LIVER INT IN PRESS; Tacke F, 2011, J GASTROEN HEPATOL, V26, P523, DOI 10.1111/j.1440-1746.2010.06436.x; TRITTO G, 2011, J HEPATOL IN PRESS; Wasmuth HE, 2010, SEMIN LIVER DIS, V30, P215, DOI 10.1055/s-0030-1255351; Zimmermann HW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011049	45	180	200	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21381	10.1371/journal.pone.0021381	http://dx.doi.org/10.1371/journal.pone.0021381			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731723	Green Published, Green Submitted, gold			2022-12-27	WOS:000292033700071
J	Osthoff, M; Katan, M; Fluri, F; Schuetz, P; Bingisser, R; Kappos, L; Steck, AJ; Engelter, ST; Mueller, B; Christ-Crain, M; Trendelenburg, M				Osthoff, Michael; Katan, Mira; Fluri, Felix; Schuetz, Philipp; Bingisser, Roland; Kappos, Ludwig; Steck, Andreas J.; Engelter, Stefan T.; Mueller, Beat; Christ-Crain, Mirjam; Trendelenburg, Marten			Mannose-Binding Lectin Deficiency Is Associated With Smaller Infarction Size and Favorable Outcome in Ischemic Stroke Patients	PLOS ONE			English	Article							C-REACTIVE PROTEIN; REPERFUSION INJURY; COMPLEMENT ACTIVATION; MYOCARDIAL-INFARCTION; ADMISSION C; PATHWAY; THROMBOLYSIS; SEVERITY; TRANSPLANTATION; INFECTION	Background: The Mannose-binding lectin (MBL) pathway of complement plays a pivotal role in the pathogenesis of ischemia/reperfusion (I/R) injury after experimental ischemic stroke. As comparable data in human ischemic stroke are limited, we investigated in more detail the association of MBL deficiency with infarction volume and functional outcome in a large cohort of patients receiving intravenous thrombolysis or conservative treatment. Methodology/Principal Findings: In a post hoc analysis of a prospective cohort study, admission MBL concentrations were determined in 353 consecutive patients with an acute ischemic stroke of whom 287 and 66 patients received conservative and thrombolytic treatment, respectively. Stroke severity, infarction volume, and functional outcome were studied in relation to MBL concentrations at presentation to the emergency department. MBL levels on admission were not influenced by the time from symptom onset to presentation (p = 0.53). In the conservative treatment group patients with mild strokes at presentation, small infarction volumes or favorable outcomes after three months demonstrated 1.5 to 2.6-fold lower median MBL levels (p = 0.025, p = 0.0027 and p = 0.046, respectively) compared to patients with more severe strokes. Moreover, MBL deficient patients (<100 ng/ml) were subject to a considerably decreased risk of an unfavorable outcome three months after ischemic stroke (adjusted odds ratio 0.38, p<0.05) and showed smaller lesion volumes (mean size 0.6 vs. 18.4 ml, p = 0.0025). In contrast, no association of MBL concentration with infarction volume or functional outcome was found in the thrombolysis group. However, the small sample size limits the significance of this observation. Conclusions: MBL deficiency is associated with smaller cerebral infarcts and favorable outcome in patients receiving conservative treatment. Our data suggest an important role of the lectin pathway in the pathophysiology of cerebral I/R injury and might pave the way for new therapeutic interventions.	[Osthoff, Michael; Trendelenburg, Marten] Univ Basel Hosp, Dept Biomed, Clin Immunol Lab, CH-4031 Basel, Switzerland; [Osthoff, Michael; Trendelenburg, Marten] Univ Basel Hosp, Clin Internal Med, CH-4031 Basel, Switzerland; [Katan, Mira; Christ-Crain, Mirjam] Univ Basel Hosp, Dept Endocrinol, CH-4031 Basel, Switzerland; [Katan, Mira; Fluri, Felix; Kappos, Ludwig; Steck, Andreas J.; Engelter, Stefan T.] Univ Basel Hosp, Dept Neurol, CH-4031 Basel, Switzerland; [Bingisser, Roland] Univ Basel Hosp, Dept Emergency Med, CH-4031 Basel, Switzerland; [Mueller, Beat] Kantonsspital, Med Univ Clin, Aarau, Switzerland; [Schuetz, Philipp] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	University of Basel; University of Basel; University of Basel; University of Basel; University of Basel; Kantonsspital Aarau AG (KSA); Harvard University; Harvard T.H. Chan School of Public Health	Osthoff, M (corresponding author), Univ Basel Hosp, Dept Biomed, Clin Immunol Lab, CH-4031 Basel, Switzerland.	mosthoff@uhbs.ch	Mueller, Beat/G-2662-2012; schuetz, philipp/C-8475-2013; Trendelenburg, Marten/AAM-1626-2020	schuetz, philipp/0000-0001-6400-4949; Trendelenburg, Marten/0000-0001-7036-8386; Katan, Mira/0000-0002-9265-8066; Bingisser, Roland/0000-0001-8223-9792; Osthoff, Michael/0000-0001-5439-957X; Christ-Crain, Mirjam/0000-0002-6336-0965; Engelter, Stefan/0000-0003-3855-6234	Swiss National Science Foundation [3232B0-107248/2, 324730-132955, PP00P3-12346]; University of Basel	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Basel	This work was supported by a SCORE fellowship form the Swiss National Science Foundation to MT (Nr. 3232B0-107248/2 and 324730-132955), a grant to young researchers from the University of Basel to MK as well as a grant of the Swiss National Science Foundation to MCC (Nr. PP00P3-12346). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; AGOSTONI A, 1994, CIRCULATION, V90, P2666, DOI 10.1161/01.CIR.90.6.2666; Appelros P, 2003, STROKE, V34, P122, DOI 10.1161/01.STR.0000047852.05842.3C; Arumugam TV, 2004, SHOCK, V21, P401, DOI 10.1097/00024382-200405000-00002; Audebert HJ, 2004, STROKE, V35, P2128, DOI 10.1161/01.STR.0000137607.61697.77; Bouwman LH, 2006, HUM IMMUNOL, V67, P247, DOI 10.1016/j.humimm.2006.02.030; Busche MN, 2009, AM J PHYSIOL-HEART C, V297, pH1853, DOI 10.1152/ajpheart.00049.2009; Cervera A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008433; Chan RK, 2006, J IMMUNOL, V177, P8080, DOI 10.4049/jimmunol.177.11.8080; de Vries B, 2004, AM J PATHOL, V165, P1677, DOI 10.1016/S0002-9440(10)63424-4; DeGraba TJ, 1999, STROKE, V30, P1208, DOI 10.1161/01.STR.30.6.1208; den Hertog H.M., 2009, J NEUROL; Elkind MSV, 2006, ARCH INTERN MED, V166, P2073, DOI 10.1001/archinte.166.19.2073; Fidler KJ, 2004, INTENS CARE MED, V30, P1438, DOI 10.1007/s00134-004-2303-8; Gadjeva M, 2004, MOL IMMUNOL, V41, P113, DOI 10.1016/j.molimm.2004.03.015; Garred P, 2006, GENES IMMUN, V7, P85, DOI 10.1038/sj.gene.6364283; Garred P, 2003, MOL IMMUNOL, V40, P73, DOI 10.1016/S0161-5890(03)00104-4; Gesuete R, 2009, ANN NEUROL, V66, P332, DOI 10.1002/ana.21740; Hart ML, 2005, J IMMUNOL, V174, P6373, DOI 10.4049/jimmunol.174.10.6373; Herpers BL, 2009, CLIN EXP IMMUNOL, V156, P488, DOI 10.1111/j.1365-2249.2009.03929.x; Idicula TT, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-18; Jordan JE, 2001, CIRCULATION, V104, P1413, DOI 10.1161/hc3601.095578; Katan M, 2009, ANN NEUROL, V66, P799, DOI 10.1002/ana.21783; LU J, 1990, J IMMUNOL, V144, P2287; Manuel O, 2007, TRANSPLANTATION, V83, P359, DOI 10.1097/01.tp.0000251721.90688.c2; Matthijsen RA, 2009, MOL IMMUNOL, V46, P2244, DOI 10.1016/j.molimm.2009.04.010; Mocco J, 2006, NEUROSURGERY, V59, P28, DOI [10.1227/01.NEU.0000219221.14280.65, 10.1227/01.neu.0000243280.75920.f4]; Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781; Pedersen ED, 2004, CLIN EXP IMMUNOL, V137, P117, DOI 10.1111/j.1365-2249.2004.02489.x; Petersen SV, 2001, J IMMUNOL METHODS, V257, P107, DOI 10.1016/S0022-1759(01)00453-7; Potlukova E, 2010, CLIN IMMUNOL, V136, P123, DOI 10.1016/j.clim.2010.02.015; Rahpeymai Y, 2006, EMBO J, V25, P1364, DOI 10.1038/sj.emboj.7601004; Szeplaki G, 2009, ATHEROSCLEROSIS, V204, P315, DOI 10.1016/j.atherosclerosis.2008.07.044; Topakian R, 2008, J NEUROL, V255, P1190, DOI 10.1007/s00415-008-0866-y; Trendelenburg M, 2010, EUR HEART J, V31, P1181, DOI 10.1093/eurheartj/ehp597; Wahlgren N, 2007, LANCET, V369, P275, DOI 10.1016/S0140-6736(07)60149-4; Walsh MC, 2005, J IMMUNOL, V175, P541, DOI 10.4049/jimmunol.175.1.541; Whiteley W, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000145; 2008, CEREBROVASC DIS, V25, P457	39	74	79	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2011	6	6							e21338	10.1371/journal.pone.0021338	http://dx.doi.org/10.1371/journal.pone.0021338			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782CL	21712986	Green Published, Green Submitted, gold			2022-12-27	WOS:000291985100032
J	Li, W; Wang, Z; Li, J; Yang, HC; Cui, SJ; Wang, XX; Ma, LG				Li, Wei; Wang, Zheng; Li, Jian; Yang, Hongchun; Cui, Sujuan; Wang, Xiaoxue; Ma, Ligeng			Overexpression of AtBMI1C, a Polycomb Group Protein Gene, Accelerates Flowering in Arabidopsis	PLOS ONE			English	Article							LOCUS-C; HISTONE H2A; EXPRESSION; CHROMATIN; COMPLEX; FLC; VERNALIZATION; UBIQUITYLATION; REPRESSION; PATTERNS	Polycomb group protein (PcG)-mediated gene silencing is emerging as an essential developmental regulatory mechanism in eukaryotic organisms. PcGs inactivate or maintain the silenced state of their target chromatin by forming complexes, including Polycomb Repressive Complex 1 (PRC1) and 2 (PRC2). Three PRC2 complexes have been identified and characterized in Arabidopsis; of these, the EMF and VRN complexes suppress flowering by catalyzing the trimethylation of lysine 27 on histone H3 of FLOWER LOCUS T (FT) and FLOWER LOCUS C (FLC). However, little is known about the role of PRC1 in regulating the floral transition, although AtRING1A, AtRING1B, AtBMI1A, and AtBMI1B are believed to regulate shoot apical meristem and embryonic development as components of PRC1. Moreover, among the five RING finger PcGs in the Arabidopsis genome, four have been characterized. Here, we report that the fifth, AtBMI1C, is a novel, ubiquitously expressed nuclear PcG protein and part of PRC1, which is evolutionarily conserved with Psc and BMI1. Overexpression of AtBMI1C caused increased H2A monoubiquitination and flowering defects in Arabidopsis. Both the suppression of FLC and activation of FT were observed in AtBMI1C-overexpressing lines, resulting in early flowering. No change in the H3K27me3 level in FLC chromatin was detected in an AtBMI1C-overexpressing line. Our results suggest that AtBMI1C participates in flowering time control by regulating the expression of FLC; moreover, the repression of FLC by AtBMI1C is not due to the activity of PRC2. Instead, it is likely the result of PRC1 activity, into which AtBMI1C is integrated.	[Li, Wei; Wang, Zheng; Li, Jian; Cui, Sujuan; Ma, Ligeng] Hebei Normal Univ, Coll Biol Sci, Hebei Key Lab Mol Cell Biol, Shijiazhuang, Hebei, Peoples R China; [Wang, Zheng; Li, Jian; Yang, Hongchun; Wang, Xiaoxue] Natl Inst Biol Sci, Beijing, Peoples R China	Hebei Normal University; National Institute of Biological Sciences, Beijing	Li, W (corresponding author), Hebei Normal Univ, Coll Biol Sci, Hebei Key Lab Mol Cell Biol, Shijiazhuang, Hebei, Peoples R China.	xiaoxuewang6@163.com; ligeng.ma@mail.hebtu.edu.cn		Yang, Hongchun/0000-0002-8265-3958	China MOST [2008105]; Hebei Province Key Laboratory [109960121D]	China MOST(Ministry of Science and Technology, China); Hebei Province Key Laboratory	This work was supported by grants from the China MOST 863 Project (to LM, 2008105) and the Hebei Province Key Laboratory Program (to LM, 109960121D). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baurle I, 2006, CELL, V125, P655, DOI 10.1016/j.cell.2006.05.005; Bratzel F, 2010, CURR BIOL, V20, P1853, DOI 10.1016/j.cub.2010.09.046; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Cao Y, 2008, PLANT CELL, V20, P2586, DOI 10.1105/tpc.108.062760; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; De Lucia F, 2008, P NATL ACAD SCI USA, V105, P16831, DOI 10.1073/pnas.0808687105; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Francis NJ, 2001, MOL CELL, V8, P545, DOI 10.1016/S1097-2765(01)00316-1; Gendrel AV, 2005, NAT METHODS, V2, P213, DOI 10.1038/nmeth0305-213; Gendrel AV, 2002, SCIENCE, V297, P1871, DOI 10.1126/science.1074950; Goodrich J, 1997, NATURE, V386, P44, DOI 10.1038/386044a0; He YH, 2005, TRENDS PLANT SCI, V10, P30, DOI 10.1016/j.tplants.2004.11.003; Hennig L, 2009, TRENDS GENET, V25, P414, DOI 10.1016/j.tig.2009.07.002; Jiang DH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003404; JURGENS G, 1985, NATURE, V316, P153, DOI 10.1038/316153a0; Kim DH, 2009, ANNU REV CELL DEV BI, V25, P277, DOI 10.1146/annurev.cellbio.042308.113411; Kohler C, 2005, NAT GENET, V37, P28, DOI 10.1038/ng1495; Kohler C, 2003, EMBO J, V22, P4804, DOI 10.1093/emboj/cdg444; LINCOLN C, 1994, PLANT CELL, V6, P1859, DOI 10.1105/tpc.6.12.1859; Liu FQ, 2010, SCIENCE, V327, P94, DOI 10.1126/science.1180278; Luo M, 2000, P NATL ACAD SCI USA, V97, P10637, DOI 10.1073/pnas.170292997; Makarevich G, 2006, EMBO REP, V7, P947, DOI 10.1038/sj.embor.7400760; MANDEL MA, 1992, NATURE, V360, P273, DOI 10.1038/360273a0; Michaels SD, 2005, PLANT PHYSIOL, V137, P149, DOI 10.1104/pp.104.052811; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Qin F, 2008, PLANT CELL, V20, P1693, DOI 10.1105/tpc.107.057380; Sanchez-Pulido L, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-308; Sawarkar R, 2010, DEV CELL, V19, P651, DOI 10.1016/j.devcel.2010.10.012; Schonrock N, 2006, GENE DEV, V20, P1667, DOI 10.1101/gad.377206; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Searle I, 2006, GENE DEV, V20, P898, DOI 10.1101/gad.373506; Shao ZH, 1999, CELL, V98, P37, DOI 10.1016/S0092-8674(00)80604-2; Sheldon CC, 2008, P NATL ACAD SCI USA, V105, P2214, DOI 10.1073/pnas.0711453105; Spillane C, 2000, CURR BIOL, V10, P1535, DOI 10.1016/S0960-9822(00)00839-3; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TRUERNIT E, 1995, PLANTA, V196, P564, DOI 10.1007/BF00203657; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Xu L, 2008, CURR BIOL, V18, P1966, DOI 10.1016/j.cub.2008.11.019; Yoshida N, 2001, PLANT CELL, V13, P2471, DOI 10.1105/tpc.13.11.2471; Zhang X, 2007, NAT STRUCT MOL BIOL, V14, P869, DOI 10.1038/nsmb1283	43	29	30	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e21364	10.1371/journal.pone.0021364	http://dx.doi.org/10.1371/journal.pone.0021364			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	21701597	Green Published, Green Submitted, gold			2022-12-27	WOS:000291983800044
J	Rao, JU; Shah, KB; Puttaiah, J; Rudraiah, M				Rao, Jyotsna U.; Shah, Kunal B.; Puttaiah, Jayaram; Rudraiah, Medhamurthy			Gene Expression Profiling of Preovulatory Follicle in the Buffalo Cow: Effects of Increased IGF-I Concentration on Periovulatory Events	PLOS ONE			English	Article							GROWTH-FACTOR-I; BOVINE GRANULOSA-CELLS; MESSENGER-RIBONUCLEIC-ACID; VASCULAR ENDOTHELIAL-CELLS; FACTOR BINDING PROTEIN-4; INDUCED UP-REGULATION; GONADOTROPIN SURGE; STIMULATING-HORMONE; DOMINANT FOLLICLE; LUTEINIZING-HORMONE	The preovulatory follicle in response to gonadotropin surge undergoes dramatic biochemical, and morphological changes orchestrated by expression changes in hundreds of genes. Employing well characterized bovine preovulatory follicle model, granulosa cells (GCs) and follicle wall were collected from the preovulatory follicle before, 1, 10 and 22 h post peak LH surge. Microarray analysis performed on GCs revealed that 450 and 111 genes were differentially expressed at 1 and 22 h post peak LH surge, respectively. For validation, qPCR and immunocytochemistry analyses were carried out for some of the differentially expressed genes. Expression analysis of many of these genes showed distinct expression patterns in GCs and the follicle wall. To study molecular functions and genetic networks, microarray data was analyzed using Ingenuity Pathway Analysis which revealed majority of the differentially expressed genes to cluster within processes like steroidogenesis, cell survival and cell differentiation. In the ovarian follicle, IGF-I is established to be an important regulator of the above mentioned molecular functions. Thus, further experiments were conducted to verify the effects of increased intrafollicular IGF-I levels on the expression of genes associated with the above mentioned processes. For this purpose, buffalo cows were administered with exogenous bGH to transiently increase circulating and intrafollicular concentrations of IGF-I. The results indicated that increased intrafollicular concentrations of IGF-I caused changes in expression of genes associated with steroidogenesis (StAR, SRF) and apoptosis (BCL-2, FKHR, PAWR). These results taken together suggest that onset of gonadotropin surge triggers activation of various biological pathways and that the effects of growth factors and peptides on gonadotropin actions could be examined during preovulatory follicle development.	[Rao, Jyotsna U.; Shah, Kunal B.; Puttaiah, Jayaram; Rudraiah, Medhamurthy] Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Rao, JU (corresponding author), Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India.	rmm@mrdg.iisc.ernet.in			NAIP-ICAR [NAIP/C4/C1056]; DBT [BT/PR5362/AAQ/01/208/2004]	NAIP-ICAR(Indian Council of Agricultural Research (ICAR)); DBT(Department of Biotechnology (DBT) India)	This work was supported by NAIP-ICAR (NAIP/C4/C1056) (http://www.naip.icar.org.in/project.html) and DBT (BT/PR5362/AAQ/01/208/2004) (http://dbtindia.nic.in/uniquepage.asp?id_pk=68). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong DT, 1996, BIOL REPROD, V54, P331, DOI 10.1095/biolreprod54.2.331; Austin EJ, 2001, BIOL REPROD, V64, P839, DOI 10.1095/biolreprod64.3.839; Babic AM, 1999, MOL CELL BIOL, V19, P2958; Bakke LJ, 2004, BIOL REPROD, V71, P605, DOI 10.1095/biolreprod.104.027185; Bakke LJ, 2002, BIOL REPROD, V66, P1627, DOI 10.1095/biolreprod66.6.1627; Bedard J, 2003, MOL REPROD DEV, V64, P152, DOI 10.1002/mrd.10239; Beg MA, 2003, REPRODUCTION, V125, P847, DOI 10.1530/reprod/125.6.847; Beg MA, 2001, BIOL REPROD, V64, P432, DOI 10.1095/biolreprod64.2.432; Bridges PJ, 2007, MOL CELL ENDOCRINOL, V263, P1, DOI 10.1016/j.mce.2006.08.002; Brigstock DR, 1999, ENDOCR REV, V20, P189, DOI 10.1210/er.20.2.189; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Cao MJ, 2006, REPRODUCTION, V131, P125, DOI 10.1530/rep.1.00849; Chrysis D, 2001, J NEUROSCI, V21, P1481, DOI 10.1523/JNEUROSCI.21-05-01481.2001; Claussen M, 1997, ENDOCRINOLOGY, V138, P3797, DOI 10.1210/en.138.9.3797; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; DeClerck YA, 1996, ENZYME PROTEIN, V49, P72, DOI 10.1159/000468617; delaSota RL, 1996, BIOL REPROD, V55, P803, DOI 10.1095/biolreprod55.4.803; Dow MPD, 2002, REPRODUCTION, V123, P711, DOI 10.1530/reprod/123.5.711; Dow MPD, 2002, BIOL REPROD, V66, P1413, DOI 10.1095/biolreprod66.5.1413; ECHTERNKAMP SE, 1994, BIOL REPROD, V51, P971, DOI 10.1095/biolreprod51.5.971; Eerola I, 2003, AM J HUM GENET, V73, P1240, DOI 10.1086/379793; ENGELHARDT H, 1991, MOL CELL ENDOCRINOL, V75, P237, DOI 10.1016/0303-7207(91)90166-P; Evans ACO, 2004, BIOL REPROD, V70, P1475, DOI 10.1095/biolreprod.103.025114; Fan HY, 2010, MOL ENDOCRINOL, V24, P1529, DOI 10.1210/me.2010-0141; Fayad T, 2004, BIOL REPROD, V70, P523, DOI 10.1095/biolreprod.103.021709; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Forde N, 2008, PHYSIOL GENOMICS, V33, P193, DOI 10.1152/physiolgenomics.00274.2007; Fortune JE, 2001, BIOL REPROD, V65, P112, DOI 10.1095/biolreprod65.1.112; Funston RN, 1996, BIOL REPROD, V55, P1390, DOI 10.1095/biolreprod55.6.1390; Ginther OJ, 2004, BIOL REPROD, V70, P99, DOI 10.1095/biolreprod.103.021949; GONG JG, 1993, J ENDOCRINOL, V139, P67, DOI 10.1677/joe.0.1390067; Gonzalez IH, 2007, APOPTOSIS, V12, P769, DOI 10.1007/s10495-006-0019-7; Grado-Ahuir JA, 2009, J ANIM SCI, V87, P1921, DOI 10.2527/jas.2008-1222; Harlow CR, 2002, MOL CELL ENDOCRINOL, V187, P23, DOI 10.1016/S0303-7207(01)00702-X; Henry SP, 2001, J BIOL CHEM, V276, P12212, DOI 10.1074/jbc.M011290200; Hilmi C, 2008, J INVEST DERMATOL, V128, P1499, DOI 10.1038/sj.jid.5701185; HOLTORF AP, 1989, ENDOCRINOLOGY, V125, P2612, DOI 10.1210/endo-125-5-2612; HSIEH CL, 1989, SOMAT CELL MOLEC GEN, V15, P579, DOI 10.1007/BF01534919; Hsieh M, 2002, ENDOCRINOLOGY, V143, P898, DOI 10.1210/en.143.3.898; Hu CL, 2004, MOL ENDOCRINOL, V18, P326, DOI 10.1210/me.2003-0178; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Iwashita M, 1998, MOL HUM REPROD, V4, P401, DOI 10.1093/molehr/4.4.401; Jainudeen M. R., 1993, P315; Ji W, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh084; Jo M, 2002, BIOL REPROD, V67, P1981, DOI 10.1095/biolreprod.102.004366; Jyotsna UR, 2009, ANIM REPROD SCI, V113, P71, DOI 10.1016/j.anireprosci.2008.08.001; KEEL BA, 1995, ENDOCRINOLOGY, V136, P1197, DOI 10.1210/en.136.3.1197; Kirby CJ, 1996, BIOL REPROD, V55, P996, DOI 10.1095/biolreprod55.5.996; Klipper E, 2009, ENDOCRINOLOGY, V150, P413, DOI 10.1210/en.2008-0697; Kolle S, 1998, BIOL REPROD, V59, P836, DOI 10.1095/biolreprod59.4.836; Komar CM, 2001, BIOL REPROD, V64, P1797, DOI 10.1095/biolreprod64.6.1797; Li QL, 2009, REPRODUCTION, V137, P297, DOI 10.1530/REP-08-0308; Li QL, 2004, REPRODUCTION, V128, P555, DOI 10.1530/rep.1.00282; Lijnen HR, 1998, ARTERIOSCL THROM VAS, V18, P1035, DOI 10.1161/01.ATV.18.7.1035; Liu HF, 2007, BIOINFORMATICS, V23, P2385, DOI 10.1093/bioinformatics/btm360; Lorenzo P, 2001, J BIOL CHEM, V276, P12201, DOI 10.1074/jbc.M010932200; LORENZO PL, 1994, J REPROD FERTIL, V101, P697, DOI 10.1530/jrf.0.1010697; Madan P, 2003, BIOL REPROD, V69, P1506, DOI 10.1095/biolreprod.102.013714; Makowski GS, 1998, INFLAMMATION, V22, P287, DOI 10.1023/A:1022300216202; Manna PR, 2006, MOL ENDOCRINOL, V20, P362, DOI 10.1210/me.2004-0526; Mazzieri R, 1997, EMBO J, V16, P2319, DOI 10.1093/emboj/16.9.2319; MCARDLE CA, 1991, MOL CELL ENDOCRINOL, V78, P211, DOI 10.1016/0303-7207(91)90125-C; McLean PG, 2002, CIRC RES, V90, P465, DOI 10.1161/hh0402.105372; MEIDAN R, 1992, BIOL REPROD, V46, P715, DOI 10.1095/biolreprod46.4.715; Mihm M, 2008, REPRODUCTION, V135, P253, DOI 10.1530/REP-06-0193; Mihm M, 1997, BIOL REPROD, V57, P1328, DOI 10.1095/biolreprod57.6.1328; Miller JR, 1999, ONCOGENE, V18, P7860, DOI 10.1038/sj.onc.1203245; Mirza H, 1996, J CLIN INVEST, V97, P1705, DOI 10.1172/JCI118597; Nagyova E, 1999, BIOL REPROD, V61, P569, DOI 10.1095/biolreprod61.3.569; Nakajima M, 2007, J BIOL CHEM, V282, P32185, DOI 10.1074/jbc.M700522200; Natesampillai S, 2008, AM J PHYSIOL-ENDOC M, V294, pE385, DOI 10.1152/ajpendo.00480.2007; Nazar RN, 2010, MOL BIOTECHNOL, V44, P8, DOI 10.1007/s12033-009-9212-6; Ndiaye K, 2005, BIOL REPROD, V73, P324, DOI 10.1095/biolreprod.104.038026; Nemcova L, 2007, BIOL REPROD, V76, P1016, DOI 10.1095/biolreprod.106.057927; Oshlack A, 2007, BIOINFORMATICS, V23, P1235, DOI 10.1093/bioinformatics/btm111; Park Y, 2005, J BIOL CHEM, V280, P9135, DOI 10.1074/jbc.M409486200; Porter DA, 2001, REPRODUCTION, V121, P561, DOI 10.1530/rep.0.1210561; Priyanka S, 2009, ENDOCRINOLOGY, V150, P1473, DOI 10.1210/en.2008-0840; Pru JK, 2001, MOL ENDOCRINOL, V15, P845, DOI 10.1210/me.15.6.845; Quirk S M, 2004, J Anim Sci, V82 E-Suppl, pE40; Quirk SM, 2004, ENDOCRINOLOGY, V145, P5033, DOI 10.1210/en.2004-0140; Quirk SM, 2006, J ENDOCRINOL, V189, P441, DOI 10.1677/joe.1.06549; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Rhoads ML, 2008, J DAIRY SCI, V91, P1802, DOI 10.3168/jds.2007-0664; Rhodes FM, 2001, REPRODUCTION, V122, P561, DOI 10.1530/rep.0.1220561; Richards JS, 2002, MOL ENDOCRINOL, V16, P580, DOI 10.1210/me.16.3.580; Rieger D, 1998, J REPROD FERTIL, V112, P123, DOI 10.1530/jrf.0.1120123; Rivera GM, 2003, ENDOCRINOLOGY, V144, P2977, DOI 10.1210/en.2002-0077; Rivera GM, 2003, ENDOCRINOLOGY, V144, P437, DOI 10.1210/en.2002-220657; Rivera GM, 2001, BIOL REPROD, V65, P102, DOI 10.1095/biolreprod65.1.102; Robinson RS, 2009, REPRODUCTION, V138, P869, DOI 10.1530/REP-09-0283; SCHAMS D, 1988, J ENDOCRINOL, V116, P97, DOI 10.1677/joe.0.1160097; Schuur ER, 2001, J BIOL CHEM, V276, P33554, DOI 10.1074/jbc.M105555200; Sekar N, 2000, MOL CELL ENDOCRINOL, V159, P25, DOI 10.1016/S0303-7207(99)00203-8; Sekar N, 2000, ENDOCRINOLOGY, V141, P3983, DOI 10.1210/en.141.11.3983; Sharma SC, 2000, J BIOL CHEM, V275, P33718, DOI 10.1074/jbc.M003555200; Shi F, 2003, J ENDOCRINOL, V179, P195, DOI 10.1677/joe.0.1790195; Shimo T, 1999, J BIOCHEM-TOKYO, V126, P137, DOI 10.1093/oxfordjournals.jbchem.a022414; Singh B, 1997, BIOL REPROD, V56, P1370, DOI 10.1095/biolreprod56.6.1370; SIROIS J, 1994, ENDOCRINOLOGY, V135, P841, DOI 10.1210/en.135.3.841; Souza AH, 2009, THERIOGENOLOGY, V72, P271, DOI 10.1016/j.theriogenology.2009.02.016; Spicer LJ, 2007, BIOL REPROD, V77, P18, DOI 10.1095/biolreprod.106.058230; Spicer LJ, 1997, BIOL REPROD, V56, P1458, DOI 10.1095/biolreprod56.6.1458; SPICER LJ, 1988, BIOL REPROD, V39, P573, DOI 10.1095/biolreprod39.3.573; Steinhoff M, 2000, NAT MED, V6, P151, DOI 10.1038/72247; Stewart RE, 1995, J ANIM SCI, V73, P3719; Sudo N, 2007, MOL CELL ENDOCRINOL, V264, P197, DOI 10.1016/j.mce.2006.10.011; Tajima K, 2005, ENDOCRINOLOGY, V146, P2903, DOI 10.1210/en.2005-0093; TILLY JL, 1995, ENDOCRINOLOGY, V136, P232, DOI 10.1210/en.136.1.232; Tomoeda M, 2008, BIOCHEM BIOPH RES CO, V371, P191, DOI 10.1016/j.bbrc.2008.03.158; Vainio S, 1999, NATURE, V397, P405, DOI 10.1038/17068; Yadav VK, 2002, BIOL REPROD, V67, P752, DOI 10.1095/biolreprod.102.004077; Yang MY, 2000, BIOL REPROD, V62, P1209, DOI 10.1095/biolreprod62.5.1209; Zhao HH, 2001, J BIOL CHEM, V276, P27907, DOI 10.1074/jbc.M104278200; Zheng XF, 2009, REPRODUCTION, V137, P969, DOI 10.1530/REP-08-0365	115	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e20754	10.1371/journal.pone.0020754	http://dx.doi.org/10.1371/journal.pone.0020754			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	21701678	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000291983800012
J	Sueyoshi, T; Green, WD; Vinal, K; Woodrum, TS; Moore, R; Negishi, M				Sueyoshi, Tatsuya; Green, William D.; Vinal, Kellie; Woodrum, Tyler S.; Moore, Rick; Negishi, Masahiko			Garlic Extract Diallyl Sulfide (DAS) Activates Nuclear Receptor CAR to Induce the Sult1e1 Gene in Mouse Liver	PLOS ONE			English	Article							CONSTITUTIVE ANDROSTANE RECEPTOR; DRUG-METABOLIZING-ENZYMES; ORGANOSULFUR COMPOUNDS; ESTROGEN SULFOTRANSFERASE; ENHANCER MODULE; 1E1 EXPRESSION; CANCER; RISK; POLYMORPHISMS; CYP1A1	Constituent chemicals in garlic extract are known to induce phase I and phase II enzymes in rodent livers. Here we have utilized Car(+/+) and Car(-/-) mice to demonstrate that the nuclear xenobiotic receptor CAR regulated the induction of the estrogen sulfotransferase Sult1e1 gene by diallyl sulfide (DAS) treatment in mouse liver. DAS treatment caused CAR accumulation in the nucleus, resulting in a remarkable increase of SULT1E1 mRNA (3,200 fold) and protein in the livers of Car(+/+) females but not of Car(-/-) female mice. DAS also induced other CAR-regulated genes such as Cyp2b10, Cyp3a11 and Gadd45 beta. Compared with the rapid increase of these mRNA levels, which began as early as 6 hourrs after DAS treatment, the levels of SULT1E1 mRNA began increasing after 24 hours. This slow response to DAS suggested that CAR required an additional factor to activate the Sult1e1 gene or that this activation was indirect. Despite the remarkable induction of SULT1E1, there was no decrease in the serum levels of endogenous E2 or increase of estrone sulfate while the clearance of exogenously administrated E2 was accelerated in DAS treated mice.	[Sueyoshi, Tatsuya; Green, William D.; Vinal, Kellie; Woodrum, Tyler S.; Moore, Rick; Negishi, Masahiko] Natl Inst Environm Hlth Sci, Pharmacogenet Sect, Reprod & Dev Toxicol Lab, NIH, Res Triangle Pk, NC USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Sueyoshi, T (corresponding author), Natl Inst Environm Hlth Sci, Pharmacogenet Sect, Reprod & Dev Toxicol Lab, NIH, Res Triangle Pk, NC USA.	sueyoshi@niehs.nih.gov	Negishi, Masahiko/F-7805-2019	Negishi, Masahiko/0000-0002-2076-8928; Green, William/0000-0001-7472-8756	NIH, National Institute of Environmental Health Sciences (NIEHS) [Zo1Es71005-01]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES080040] Funding Source: NIH RePORTER	NIH, National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by the Intramural Research Program of the NIH, National Institute of Environmental Health Sciences (NIEHS), Zo1Es71005-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alnouti Y, 2008, J PHARMACOL EXP THER, V324, P612, DOI 10.1124/jpet.107.129650; Berges R, 2004, CARCINOGENESIS, V25, P1953, DOI 10.1093/carcin/bgh200; Bianchini F, 2001, ENVIRON HEALTH PERSP, V109, P893; Chang TKH, 2009, AAPS J, V11, P590, DOI 10.1208/s12248-009-9135-y; Choi JY, 2005, CANCER EPIDEM BIOMAR, V14, P1090, DOI 10.1158/1055-9965.EPI-04-0688; di Masi A, 2009, MOL ASPECTS MED, V30, P297, DOI 10.1016/j.mam.2009.04.002; Dong B, 2009, P NATL ACAD SCI USA, V106, P18831, DOI 10.1073/pnas.0909731106; Falany CN, 2009, J STEROID BIOCHEM, V114, P113, DOI 10.1016/j.jsbmb.2009.02.009; FALANY CN, 1995, J STEROID BIOCHEM, V52, P529, DOI 10.1016/0960-0760(95)00015-R; Falany CN, 2005, METHOD PHARMACOL TOX, P341; Fisher CD, 2007, DRUG METAB DISPOS, V35, P995, DOI 10.1124/dmd.106.014340; Fleischauer AT, 2001, J NUTR, V131, p1032S, DOI 10.1093/jn/131.3.1032S; Gong H, 2008, CANCER RES, V68, P7386, DOI 10.1158/0008-5472.CAN-08-1545; Guyonnet D, 2002, CARCINOGENESIS, V23, P1335, DOI 10.1093/carcin/23.8.1335; Guyonnet D, 2001, MUTAT RES-GEN TOX EN, V495, P135, DOI 10.1016/S1383-5718(01)00205-4; He D, 2008, BBA-MOL CELL RES, V1783, P2391, DOI 10.1016/j.bbamcr.2008.08.012; Hirata H, 2008, CANCER-AM CANCER SOC, V112, P1964, DOI 10.1002/cncr.23392; Honkakoski P, 2003, ANN MED, V35, P172, DOI 10.1080/07853890310008224; Honkakoski P, 1998, MOL CELL BIOL, V18, P5652, DOI 10.1128/MCB.18.10.5652; Huang WD, 2005, MOL ENDOCRINOL, V19, P1646, DOI 10.1210/me.2004-0520; Kakizaki S, 2008, CURR DRUG METAB, V9, P614, DOI 10.2174/138920008785821666; Kakuta Y, 1997, NAT STRUCT BIOL, V4, P904, DOI 10.1038/nsb1197-904; Kang HS, 2007, PHYSIOL GENOMICS, V31, P281, DOI 10.1152/physiolgenomics.00098.2007; Kawamoto T, 2000, MOL ENDOCRINOL, V14, P1897, DOI 10.1210/me.14.11.1897; Kawamoto T, 1999, MOL CELL BIOL, V19, P6318; Kodama S, 2004, MOL CELL BIOL, V24, P7931, DOI 10.1128/MCB.24.18.7931-7940.2004; Konno Y, 2008, DRUG METAB PHARMACOK, V23, P8, DOI 10.2133/dmpk.23.8; Ngo SNT, 2007, J NUTR, V137, P2264, DOI 10.1093/jn/137.10.2264; Petrotchenko EV, 1999, J BIOL CHEM, V274, P30019, DOI 10.1074/jbc.274.42.30019; Qatanani M, 2005, CURR DRUG METAB, V6, P329, DOI 10.2174/1389200054633899; Rebbeck TR, 2006, J NATL CANCER I, V98, P1311, DOI 10.1093/jnci/djj360; Song WC, 2001, ANN NY ACAD SCI, V948, P43; SONG WC, 1995, ENDOCRINOLOGY, V136, P2477, DOI 10.1210/en.136.6.2477; Sueyoshi T, 1999, J BIOL CHEM, V274, P6043, DOI 10.1074/jbc.274.10.6043; Sugatani J, 2001, HEPATOLOGY, V33, P1232, DOI 10.1053/jhep.2001.24172; Swales K, 2004, MOL ENDOCRINOL, V18, P1589, DOI 10.1210/me.2003-0397; Tong MH, 2005, NAT MED, V11, P153, DOI 10.1038/nm1184; Ueda A, 2002, MOL PHARMACOL, V61, P1, DOI 10.1124/mol.61.1.1; Urquhart BL, 2007, J CLIN PHARMACOL, V47, P566, DOI 10.1177/0091270007299930; Wada T, 2009, TRENDS ENDOCRIN MET, V20, P273, DOI 10.1016/j.tem.2009.03.003; Wang HB, 2004, J BIOL CHEM, V279, P29295, DOI 10.1074/jbc.M400580200; Wei P, 2000, NATURE, V407, P920, DOI 10.1038/35038112; Yamamoto Y, 2004, CANCER RES, V64, P7197, DOI 10.1158/0008-5472.CAN-04-1459; Yamazaki Y, 2007, GUT, V56, P565, DOI 10.1136/gut.2006.093260; Yoshinari K, 2003, FEBS LETT, V548, P17, DOI 10.1016/S0014-5793(03)00720-8; Yoshinari K, 2010, BIOCHEM PHARMACOL, V79, P261, DOI 10.1016/j.bcp.2009.08.008; Zhang P, 2006, CARCINOGENESIS, V27, P2090, DOI 10.1093/carcin/bgl064	47	28	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e21229	10.1371/journal.pone.0021229	http://dx.doi.org/10.1371/journal.pone.0021229			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698271	Green Published, gold			2022-12-27	WOS:000291730000064
J	Klaus, A; Yu, S; Plenz, D				Klaus, Andreas; Yu, Shan; Plenz, Dietmar			Statistical Analyses Support Power Law Distributions Found in Neuronal Avalanches	PLOS ONE			English	Article							FLIGHT SEARCH PATTERNS; GIBRATS LAW; CORTICAL NETWORKS; LEVY; LIKELIHOOD; RANGE	The size distribution of neuronal avalanches in cortical networks has been reported to follow a power law distribution with exponent close to -1.5, which is a reflection of long-range spatial correlations in spontaneous neuronal activity. However, identifying power law scaling in empirical data can be difficult and sometimes controversial. In the present study, we tested the power law hypothesis for neuronal avalanches by using more stringent statistical analyses. In particular, we performed the following steps: (i) analysis of finite-size scaling to identify scale-free dynamics in neuronal avalanches, (ii) model parameter estimation to determine the specific exponent of the power law, and (iii) comparison of the power law to alternative model distributions. Consistent with critical state dynamics, avalanche size distributions exhibited robust scaling behavior in which the maximum avalanche size was limited only by the spatial extent of sampling ("finite size" effect). This scale-free dynamics suggests the power law as a model for the distribution of avalanche sizes. Using both the Kolmogorov-Smirnov statistic and a maximum likelihood approach, we found the slope to be close to -1.5, which is in line with previous reports. Finally, the power law model for neuronal avalanches was compared to the exponential and to various heavy-tail distributions based on the Kolmogorov-Smirnov distance and by using a log-likelihood ratio test. Both the power law distribution without and with exponential cut-off provided significantly better fits to the cluster size distributions in neuronal avalanches than the exponential, the lognormal and the gamma distribution. In summary, our findings strongly support the power law scaling in neuronal avalanches, providing further evidence for critical state dynamics in superficial layers of cortex.	[Klaus, Andreas; Yu, Shan; Plenz, Dietmar] NIMH, Sect Crit Brain Dynam, Bethesda, MD 20892 USA; [Klaus, Andreas] Karolinska Inst, Nobel Inst Neurophysiol, Dept Neurosci, S-10401 Stockholm, Sweden; [Klaus, Andreas] Stockholm Brain Inst, Stockholm, Sweden	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Karolinska Institutet	Klaus, A (corresponding author), NIMH, Sect Crit Brain Dynam, Bethesda, MD 20892 USA.	Andreas.Klaus@frontiersin.org	Yu, Shan/S-3123-2017; Klaus, Andreas/B-3392-2009	Klaus, Andreas/0000-0002-4133-351X; yu, shan/0000-0002-4385-6306	NIMH; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002797] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the NIMH Division of Intramural Research Programs. AK was in addition supported by the NIH-Karolinska Institute joint PhD program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 1999, NATURE, V401, P130, DOI 10.1038/43601; BAK P, 1988, PHYS REV A, V38, P364, DOI 10.1103/PhysRevA.38.364; Beggs JM, 2004, J NEUROSCI, V24, P5216, DOI 10.1523/JNEUROSCI.0540-04.2004; Beggs JM, 2003, J NEUROSCI, V23, P11167; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Edwards AM, 2007, NATURE, V449, P1044, DOI 10.1038/nature06199; Eeckhout J, 2004, AM ECON REV, V94, P1429, DOI 10.1257/0002828043052303; Eeckhout J, 2009, AM ECON REV, V99, P1676, DOI 10.1257/aer.99.4.1676; Gireesh ED, 2008, P NATL ACAD SCI USA, V105, P7576, DOI 10.1073/pnas.0800537105; Goldstein ML, 2004, EUR PHYS J B, V41, P255, DOI 10.1140/epjb/e2004-00316-5; Hald A, 1999, STAT SCI, V14, P214, DOI 10.1214/ss/1009212248; Humphries NE, 2010, NATURE, V465, P1066, DOI 10.1038/nature09116; JENSEN HJ, 1998, SELF ORG CRITICALITY, P1; Jones JH, 2003, P ROY SOC B-BIOL SCI, V270, P1123, DOI 10.1098/rspb.2003.2369; Kinouchi O, 2006, NAT PHYS, V2, P348, DOI 10.1038/nphys289; Levy M, 2009, AM ECON REV, V99, P1672, DOI 10.1257/aer.99.4.1672; Liljeros F, 2001, NATURE, V411, P907, DOI 10.1038/35082140; MALEVERGNE Y, 2009, ARXIV09091281; Mitzenmacher M., 2003, INTERNET MATH, V2, P226, DOI [10.1080/15427951.2004.10129088, DOI 10.1080/15427951.2004.10129088]; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; PAWITAN Y, 2001, ALL LIKELIHOOD STAT, P231; Petermann T, 2009, P NATL ACAD SCI USA, V106, P15921, DOI 10.1073/pnas.0904089106; Plenz D., 2009, ARXIV09125369; Plenz D, 2007, TRENDS NEUROSCI, V30, P101, DOI 10.1016/j.tins.2007.01.005; PRESS WH, 2007, NUMERICAL RECIPES AR, P502; Shew WL, 2011, J NEUROSCI, V31, P55, DOI 10.1523/JNEUROSCI.4637-10.2011; Shew WL, 2009, J NEUROSCI, V29, P15595, DOI 10.1523/JNEUROSCI.3864-09.2009; Stewart CV, 2006, J NEUROSCI, V26, P8148, DOI 10.1523/JNEUROSCI.0723-06.2006; Tkaik G., 2009, ARXIV09125409; Touboul J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008982; Viswanathan GM, 1996, NATURE, V381, P413, DOI 10.1038/381413a0; VUONG QH, 1989, ECONOMETRICA, V57, P307, DOI 10.2307/1912557	32	145	145	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e19779	10.1371/journal.pone.0019779	http://dx.doi.org/10.1371/journal.pone.0019779			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21720544	Green Submitted, gold, Green Published			2022-12-27	WOS:000291052200015
J	Henssge, U; Do, T; Gilbert, SC; Cox, S; Clark, D; Wickstrom, C; Ligtenberg, AJM; Radford, DR; Beighton, D				Henssge, Uta; Thuy Do; Gilbert, Steven C.; Cox, Steven; Clark, Douglas; Wickstroem, Claes; Ligtenberg, A. J. M.; Radford, David R.; Beighton, David			Application of MLST and Pilus Gene Sequence Comparisons to Investigate the Population Structures of Actinomyces naeslundii and Actinomyces oris	PLOS ONE			English	Article							BETA-D-GALACTOSAMINE; GENOSPECIES 1; SALIVARY PROTEINS; TYPE-1 FIMBRIAE; ROOT SURFACES; SP-NOV; VISCOSUS; IDENTIFICATION; BINDING; RECEPTORS	Actinomyces naeslundii and Actinomyces oris are members of the oral biofilm. Their identification using 16S rRNA sequencing is problematic and better achieved by comparison of metG partial sequences. A. oris is more abundant and more frequently isolated than A. naeslundii. We used a multi-locus sequence typing approach to investigate the genotypic diversity of these species and assigned A. naeslundii (n = 37) and A. oris (n = 68) isolates to 32 and 68 sequence types (ST), respectively. Neighbor-joining and ClonalFrame dendrograms derived from the concatenated partial sequences of 7 house-keeping genes identified at least 4 significant subclusters within A. oris and 3 within A. naeslundii. The strain collection we had investigated was an under-representation of the total population since at least 3 STs composed of single strains may represent discrete clusters of strains not well represented in the collection. The integrity of these sub-clusters was supported by the sequence analysis of fimP and fimA, genes coding for the type 1 and 2 fimbriae, respectively. An A. naeslundii subcluster was identified with both fimA and fimP genes and these strains were able to bind to MUC7 and statherin while all other A. naeslundii strains possessed only fimA and did not bind to statherin. An A. oris subcluster harboured a fimA gene similar to that of Actinomyces odontolyticus but no detectable fimP failed to bind significantly to either MUC7 or statherin. These data are evidence of extensive genotypic and phenotypic diversity within the species A. oris and A. naeslundii but the status of the subclusters identified here will require genome comparisons before their phylogenic position can be unequivocally established.	[Henssge, Uta; Thuy Do; Gilbert, Steven C.; Cox, Steven; Clark, Douglas; Radford, David R.; Beighton, David] Kings Coll London, Inst Dent, Dept Microbiol, Henry Wellcome Labs Microbiol & Salivary Res, London WC2R 2LS, England; [Wickstroem, Claes] Malmo Univ, Fac Odontol, Dept Oral Biol, Malmo, Sweden; [Ligtenberg, A. J. M.] ACTA, Dept Oral Biochem, Amsterdam, Netherlands	University of London; King's College London; Malmo University; Academic Center for Dentistry Amsterdam; Vrije Universiteit Amsterdam	Henssge, U (corresponding author), Kings Coll London, Inst Dent, Dept Microbiol, Henry Wellcome Labs Microbiol & Salivary Res, London WC2R 2LS, England.	david.beighton@kcl.ac.uk	Wickstrom, Claes/B-6338-2008; Radford, David R/E-9935-2011	Wickstrom, Claes/0000-0002-8183-8846; Radford, David R/0000-0001-8668-0358	Dental Institute, King's College London; Department of Health via the National Institute for Health Research (NIHR)	Dental Institute, King's College London; Department of Health via the National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR))	The authors acknowledge support from the Dental Institute, King's College London, and from the Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's & St Thomas' NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Bosch JA, 2003, J MICROBIOL METH, V53, P51, DOI 10.1016/S0167-7012(02)00220-8; BOWDEN G, 1993, J DENT RES, V72, P1171, DOI 10.1177/00220345930720080201; Bowden GHW, 1999, J DENT RES, V78, P1800, DOI 10.1177/00220345990780120601; Brailsford SR, 1998, CARIES RES, V32, P100, DOI 10.1159/000016438; BRENNAN MJ, 1984, INFECT IMMUN, V46, P459, DOI 10.1128/IAI.46.2.459-464.1984; CISAR JO, 1984, INFECT IMMUN, V46, P453, DOI 10.1128/IAI.46.2.453-458.1984; CISAR JO, 1984, J DENT RES, V63, P393, DOI 10.1177/00220345840630030701; CLARK WB, 1989, INFECT IMMUN, V57, P3003, DOI 10.1128/IAI.57.10.3003-3008.1989; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Do T, 2008, FEMS MICROBIOL LETT, V288, P156, DOI 10.1111/j.1574-6968.2008.01336.x; Drobni Mirva, 2006, BMC Microbiol, V6, P43; ELLEN RP, 1976, INFECT IMMUN, V14, P1119, DOI 10.1128/IAI.14.5.1119-1124.1976; Flora B, 2001, PROTEIN EXPRES PURIF, V23, P198, DOI 10.1006/prep.2001.1493; GIBBONS RJ, 1988, INFECT IMMUN, V56, P2990, DOI 10.1128/IAI.56.11.2990-2993.1988; GIBBONS RJ, 1989, J DENT RES, V68, P750, DOI 10.1177/00220345890680050101; GIBBONS RJ, 1988, INFECT IMMUN, V56, P439, DOI 10.1128/IAI.56.2.439-445.1988; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hall V, 1999, J CLIN MICROBIOL, V37, P2255, DOI 10.1128/JCM.37.7.2255-2261.1999; Hall V, 2001, J CLIN MICROBIOL, V39, P3555, DOI 10.1128/JCM.39.10.3555-3562.2001; Hallberg K, 1998, ORAL MICROBIOL IMMUN, V13, P188, DOI 10.1111/j.1399-302X.1998.tb00731.x; Hallberg K, 1998, ORAL MICROBIOL IMMUN, V13, P327, DOI 10.1111/j.1399-302X.1998.tb00687.x; Henssge U, 2009, INT J SYST EVOL MICR, V59, P509, DOI 10.1099/ijs.0.000950-0; JELANI T, 2009, FEMS YEAST RES, V9, P1102; JENSEN JL, 1992, J DENT RES, V71, P1569, DOI 10.1177/00220345920710090501; JOHNSON JL, 1990, INT J SYST BACTERIOL, V40, P273, DOI 10.1099/00207713-40-3-273; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI [DOI 10.4135/9781446279281.N7, DOI 10.1271/BBB.67.1048]; LEVINE MJ, 1987, J DENT RES, V66, P436, DOI 10.1177/00220345870660020901; Li J, 2004, J APPL MICROBIOL, V97, P1311, DOI 10.1111/j.1365-2672.2004.02420.x; Li T, 1999, INFECT IMMUN, V67, P2053, DOI 10.1128/IAI.67.5.2053-2059.1999; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Proctor GB, 2005, J DENT RES, V84, P73, DOI 10.1177/154405910508400113; PUTNINS EE, 1993, J DENT RES, V72, P1374, DOI 10.1177/00220345930720100601; QURESHI JV, 1981, INFECT IMMUN, V31, P261, DOI 10.1128/IAI.31.1.261-266.1981; STROMBERG N, 1990, J BIOL CHEM, V265, P11251; STROMBERG N, 1992, INFECT IMMUN, V60, P3278; STROMBERG N, 1992, INFECT IMMUN, V60, P3268; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Wickstrom C, 2000, BIOCHEM J, V351, P421, DOI 10.1042/0264-6021:3510421; Wickstrom C, 2009, MICROBIOL-SGM, V155, P53, DOI 10.1099/mic.0.022111-0; Ximenez-Fyvie LA, 1999, ORAL MICROBIOL IMMUN, V14, P257, DOI 10.1034/j.1399-302X.1999.140410.x	42	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e21430	10.1371/journal.pone.0021430	http://dx.doi.org/10.1371/journal.pone.0021430			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738661	gold, Green Published, Green Submitted			2022-12-27	WOS:000292291800014
J	McMahon, DP; Hayward, A; Kathirithamby, J				McMahon, Dino P.; Hayward, Alexander; Kathirithamby, Jeyaraney			The First Molecular Phylogeny of Strepsiptera (Insecta) Reveals an Early Burst of Molecular Evolution Correlated with the Transition to Endoparasitism	PLOS ONE			English	Article							AMINO-ACID REPLACEMENT; SUBSTITUTION RATE VARIATION; SUBUNIT RIBOSOMAL-RNA; MITOCHONDRIAL GENOME; DIVERSIFICATION; RATES; MODELS; SEQUENCES; ALIGNMENT; PARASITE	A comprehensive model of evolution requires an understanding of the relationship between selection at the molecular and phenotypic level. We investigate this in Strepsiptera, an order of endoparasitic insects whose evolutionary biology is poorly studied. We present the first molecular phylogeny of Strepsiptera, and use this as a framework to investigate the association between parasitism and molecular evolution. We find evidence of a significant burst in the rate of molecular evolution in the early history of Strepsiptera. The evolution of morphological traits linked to parasitism is significantly correlated with the pattern in molecular rate. The correlated burst in genotypic-phenotypic evolution precedes the main phase of strepsipteran diversification, which is characterised by the return to a low and even molecular rate, and a period of relative morphological stability. These findings suggest that the transition to endoparasitism led to relaxation of selective constraint in the strepsipteran genome. Our results indicate that a parasitic lifestyle can affect the rate of molecular evolution, although other causal life-history traits correlated with parasitism may also play an important role.	[McMahon, Dino P.; Hayward, Alexander; Kathirithamby, Jeyaraney] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Oxford	McMahon, DP (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	dino.mcmahon@googlemail.com; jeyaraney.kathirithamby@zoo.ox.ac.uk	McMahon, Dino/S-2620-2019; McMahon, Dino P/F-7006-2012	McMahon, Dino/0000-0003-1119-5299; McMahon, Dino P/0000-0003-1119-5299; Hayward, Alexander/0000-0001-7413-718X	Leverhulme Trust [F/08502/G]; Elizabeth Hannah Jenkinson Fund	Leverhulme Trust(Leverhulme Trust); Elizabeth Hannah Jenkinson Fund	This work was supported by The Leverhulme Trust (F/08502/G). DPM was supported by an Elizabeth Hannah Jenkinson Fund for laboratory funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Abascal F, 2007, MOL BIOL EVOL, V24, P1; Adachi J, 1996, J MOL EVOL, V42, P459; Ahrens D, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-234; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Bravo F, 2009, CLADISTICS, V25, P614, DOI 10.1111/j.1096-0031.2009.00264.x; Bromham L, 2002, EVOLUTION, V56, P1921; Bromham L, 2009, BIOL LETTERS, V5, P401, DOI 10.1098/rsbl.2009.0136; BROWER AVZ, 1994, P NATL ACAD SCI USA, V91, P6491, DOI 10.1073/pnas.91.14.6491; Castro LR, 2005, MOL PHYLOGENET EVOL, V34, P469, DOI 10.1016/j.ympev.2004.11.005; Castro LR, 2007, SYST ENTOMOL, V32, P60, DOI 10.1111/j.1365-3113.2006.00356.x; Chan KMA, 2005, BIOINFORMATICS, V21, P1709, DOI 10.1093/bioinformatics/bti175; CROWSON RA, 1960, ANNU REV ENTOMOL, V5, P111, DOI 10.1146/annurev.en.05.010160.000551; Dorus S, 2004, NAT GENET, V36, P1326, DOI 10.1038/ng1471; Dowton M, 1995, J MOL EVOL, V41, P958, DOI 10.1007/BF00173176; Drummond A, 2001, BIOINFORMATICS, V17, P662, DOI 10.1093/bioinformatics/17.7.662; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Duff RJ, 1997, J MOL EVOL, V45, P631, DOI 10.1007/PL00006267; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EGGLETON P, 1992, PHILOS T R SOC B, V337, P1, DOI 10.1098/rstb.1992.0079; Ekman S, 2008, SYST BIOL, V57, P141, DOI 10.1080/10635150801910451; Farrell BD, 2001, MOL PHYLOGENET EVOL, V18, P467, DOI 10.1006/mpev.2000.0888; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Gillespie JJ, 2005, INSECT MOL BIOL, V14, P625, DOI 10.1111/j.1365-2583.2005.00591.x; Gillespie JJ, 2004, MOL PHYLOGENET EVOL, V33, P936, DOI 10.1016/j.ympev.2004.08.004; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hardman M, 2008, SYST BIOL, V57, P116, DOI 10.1080/10635150801902193; Hayward A, 2011, MOL ECOL, V20, P1508, DOI 10.1111/j.1365-294X.2011.05010.x; Ho SYW, 2009, BIOL LETTERS, V5, P421, DOI 10.1098/rsbl.2008.0729; Huelsenbeck John P., 2001, Tijdschrift voor Entomologie, V144, P165; Huelsenbeck JP, 1998, SYST BIOL, V47, P519; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hunter MS, 2001, ANNU REV ENTOMOL, V46, P251, DOI 10.1146/annurev.ento.46.1.251; Ishiwata K, 2011, MOL PHYLOGENET EVOL, V58, P169, DOI 10.1016/j.ympev.2010.11.001; Kathirithamby J, 2003, P NATL ACAD SCI USA, V100, P7655, DOI 10.1073/pnas.1131999100; KATHIRITHAMBY J, 1989, SYST ENTOMOL, V14, P41, DOI 10.1111/j.1365-3113.1989.tb00265.x; Kathirithamby J, 2009, ANNU REV ENTOMOL, V54, P227, DOI 10.1146/annurev.ento.54.110807.090525; Kathirithamby J, 2010, SYST ENTOMOL, V35, P234, DOI 10.1111/j.1365-3113.2009.00507.x; Kim H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011608; Kinzelbach RK, 1978, TIERWELT DEUTSCHLAND, V65, P166; KJER KM, 1994, BBA-GENE STRUCT EXPR, V1217, P147, DOI 10.1016/0167-4781(94)90028-0; Lanfear R, 2010, TRENDS ECOL EVOL, V25, P495, DOI 10.1016/j.tree.2010.06.007; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Longhorn SJ, 2010, MOL PHYLOGENET EVOL, V55, P846, DOI 10.1016/j.ympev.2010.03.024; MADDISON WP, 2006, MESQUITE MODULAR SYS; McKenna DD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011887; McMahon DP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-603; Moore BR, 2007, AM NAT, V170, pS28, DOI 10.1086/519460; NADEAU NJ, 2007, P ROY SOC B-BIOL SCI, V255, P37; Nee Sean, 1996, P230; Nylander JAA., 2004, BIOINFORMATICS; O'Connor TD, 2009, BIOINFORMATICS, V25, pI94, DOI 10.1093/bioinformatics/btp231; Omland KE, 1997, EVOLUTION, V51, P1381, DOI [10.1111/j.1558-5646.1997.tb01461.x, 10.2307/2411190]; Pagel M, 2004, SYST BIOL, V53, P673, DOI 10.1080/10635150490522232; Pohl H, 2005, CLADISTICS, V21, P328, DOI 10.1111/j.1096-0031.2005.00074.x; Pohl H, 2004, ARTHROPOD STRUCT DEV, V33, P31, DOI 10.1016/j.asd.2003.10.001; Pohl H, 2001, INSECT SYST EVOL, V32, P143, DOI 10.1163/187631201X00092; Pohl H, 2008, ZOOLOGY, V111, P318, DOI 10.1016/j.zool.2007.06.008; Poulin R., 2004, PARASITE BIODIVERSIT; Poulin R, 2008, TRENDS PARASITOL, V24, P24, DOI 10.1016/j.pt.2007.10.002; Rabosky DL, 2006, EVOLUTION, V60, P1152; Rambaut A, 1997, COMPUT APPL BIOSCI, V13, P303; RAMBAUT A, 2007, AJ TRACER V1 4; Rambaut A, 2007, FIGTREE V1 0; Ramm SA, 2008, MOL BIOL EVOL, V25, P207, DOI 10.1093/molbev/msm242; Ricklefs RE, 2007, J EVOLUTION BIOL, V20, P1751, DOI 10.1111/j.1420-9101.2007.01388.x; Robinson-Rechavi M, 2000, BIOINFORMATICS, V16, P296, DOI 10.1093/bioinformatics/16.3.296; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schmid-Hempel P, 2008, TRENDS ECOL EVOL, V23, P318, DOI 10.1016/j.tree.2008.02.011; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021; Silvestri F., 1943, B LAB ZOOLOGIA GEN A, V32, P197; Soria-Carrasco V, 2007, BIOINFORMATICS, V23, P2954, DOI 10.1093/bioinformatics/btm466; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Venditti C, 2010, NATURE, V463, P349, DOI 10.1038/nature08630; Welch JJ, 2005, TRENDS ECOL EVOL, V20, P320, DOI 10.1016/j.tree.2005.02.007; Welch JJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-53; Whiting MF, 1997, SYST BIOL, V46, P1, DOI 10.1093/sysbio/46.1.1; Wiegmann BM, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-34; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	88	39	41	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21206	10.1371/journal.pone.0021206	http://dx.doi.org/10.1371/journal.pone.0021206			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738621	Green Published, Green Submitted, gold			2022-12-27	WOS:000292142800014
J	Polgar, G; Malavasi, S; Cipolato, G; Georgalas, V; Clack, JA; Torricelli, P				Polgar, Gianluca; Malavasi, Stefano; Cipolato, Giacomo; Georgalas, Vyron; Clack, Jennifer A.; Torricelli, Patrizia			Acoustic Communication at the Water's Edge: Evolutionary Insights from a Mudskipper	PLOS ONE			English	Article							PERIOPHTALMUS-SOBRINUS EGGERT; SOUND PRODUCTION; AUDITORY-SENSITIVITY; MOLECULAR PHYLOGENY; AGONISTIC BEHAVIOR; QUANTITATIVE-ANALYSIS; ONTOGENIC DEVELOPMENT; COURTSHIP SOUNDS; GOBIIDS PISCES; FISH	Coupled behavioural observations and acoustical recordings of aggressive dyadic contests showed that the mudskipper Periophthalmodon septemradiatus communicates acoustically while out of water. An analysis of intraspecific variability showed that specific acoustic components may act as tags for individual recognition, further supporting the sounds' communicative value. A correlative analysis amongst acoustical properties and video-acoustical recordings in slow-motion supported first hypotheses on the emission mechanism. Acoustic transmission through the wet exposed substrate was also discussed. These observations were used to support an "exaptation hypothesis", i.e. the maintenance of key adaptations during the first stages of water-to-land vertebrate eco-evolutionary transitions (based on eco-evolutionary and palaeontological considerations), through a comparative bioacoustic analysis of aquatic and semiterrestrial gobiid taxa. In fact, a remarkable similarity was found between mudskipper vocalisations and those emitted by gobioids and other soniferous benthonic fishes.	[Polgar, Gianluca] Univ Malaya, Inst Ocean & Earth Sci, Inst Biol Sci, Kuala Lumpur, Malaysia; [Malavasi, Stefano; Cipolato, Giacomo; Georgalas, Vyron; Torricelli, Patrizia] Univ Ca Foscari Venezia, Dept Environm Sci Informat & Stat, Venice, Italy; [Clack, Jennifer A.] Univ Museum Zool, Cambridge, England	Universiti Malaya; Universita Ca Foscari Venezia; University of Cambridge	Polgar, G (corresponding author), Univ Malaya, Inst Ocean & Earth Sci, Inst Biol Sci, Kuala Lumpur, Malaysia.	gianluca.polgar@gmail.com	Georgalas, Vyron/G-5845-2011; Polgar, Gianluca/D-1450-2010; Malavasi, Stefano/F-6419-2014	Polgar, Gianluca/0000-0002-4901-6287; 	MIUR (Italian Ministry of Public Instructions, University and Scientific Research)	MIUR (Italian Ministry of Public Instructions, University and Scientific Research)(Ministry of Education, Universities and Research (MIUR))	This research was funded by the MIUR (Italian Ministry of Public Instructions, University and Scientific Research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFZELIUS BA, 1956, Z ANAT ENTWICKLUNGS, V119, P470; Ahlberg PE, 2005, NATURE, V437, P137, DOI 10.1038/nature03893; Ahnelt Harald, 2004, Proceedings of the California Academy of Sciences, V55, P358; Akamatsu T, 2002, J ACOUST SOC AM, V112, P3073, DOI 10.1121/1.1515799; Akihito, 2000, GENE, V259, P5, DOI 10.1016/S0378-1119(00)00488-1; ALEKSEEV AA, 1994, P GEOLOGIST ASSOC, V105, P41, DOI 10.1016/S0016-7878(08)80137-X; Algeo T.J., 2001, PLANTS INVADE LAND, P213, DOI DOI 10.7312/GENS11160-013; Amorim MCP, 2007, J MAR BIOL ASSOC UK, V87, P1017, DOI 10.1017/S0025315407056822; Amorim Maria Clara P., 2006, P71; Amorim MCP, 2005, ETHOLOGY, V111, P255, DOI 10.1111/j.1439-0310.2004.01061.x; AMORIM MCP, 2008, BEHAV, V165, P1065; [Anonymous], TERRESTRIAL ENV ORIG; [Anonymous], 2004, ACTA U LATVIENSIS; [Anonymous], 1981, HEARING SOUND COMMUN; BRILLET C, 1981, BIOL BEHAV, V6, P35; BRILLET C, 1975, Zeitschrift fuer Tierpsychologie, V39, P283; BRILLET C, 1983, BIOL BEHAV, V8, P49; BRILLET C, 1980, TERRE VIE-REV ECOL A, V34, P427; BRILLET C, 1980, BIOL BEHAV, V5, P297; BRILLET C, 1984, C R HEBD SEANCES A D, V198, P347; Buckingham MJ, 2000, J ACOUST SOC AM, V108, P2796, DOI 10.1121/1.1322018; Clack JA, 2006, PALAEOGEOGR PALAEOCL, V232, P167, DOI 10.1016/j.palaeo.2005.07.019; Clack JA, 2003, NATURE, V425, P65, DOI 10.1038/nature01904; Clack JA., 2012, GAINING GROUND ORIGI; Clack JA, 2007, INTEGR COMP BIOL, V47, P510, DOI 10.1093/icb/icm055; CLAYTON DA, 1982, COPEIA, P232; CLAYTON DA, 1988, J U KUWAIT-SCI, V15, P115; CLAYTON DA, 1986, J ZOOL, V209, P501, DOI 10.1111/j.1469-7998.1986.tb03607.x; Crawford JD, 1997, MAR FRESHW BEHAV PHY, V29, P65, DOI 10.1080/10236249709379001; Daeschler EB, 2006, NATURE, V440, P757, DOI 10.1038/nature04639; De Jong K, 2007, ANIM BEHAV, V74, P1285, DOI 10.1016/j.anbehav.2007.02.023; DIESSELHORST G, 1938, WEBERSCHEN APPARAT Z, V25, P748; GERHARDT HC, 1991, ANIM BEHAV, V42, P615, DOI 10.1016/S0003-3472(05)80245-3; GORDON MS, 1969, J EXP BIOL, V50, P141; Graham JB, 1997, AIR BREATHING FISHES, DOI DOI 10.1016/B978-012294860-2/50006-4; Hill PSM, 2001, AM ZOOL, V41, P1135, DOI 10.1668/0003-1569(2001)041[1135:VAACAR]2.0.CO;2; HOESE DF, 1984, SPEC PUBL AM SOC ICH, V1, P588; Ishimatsu A, 1998, NATURE, V391, P237, DOI 10.1038/34560; Kihslinger RL, 2002, J COMP PSYCHOL, V116, P210, DOI 10.1037//0735-7036.116.2.210; Kobayashi T., 1972, Bulletin Fac Fish Nagasaki Univ, VNo. 33, P49; LADICH F, 1990, ETHOLOGY, V84, P193; LADICH F, 1989, ZOOL JAHRB ALLG ZOOL, V93, P501; Ladich Friedrich, 2006, P3; Lechner W, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-10; Lema SC, 2002, J COMP PSYCHOL, V116, P145, DOI 10.1037//0735-7036.116.2.145; LINDEMANN MA, 2004, 27 ANN MIDW RES M AS; Lindstrom K, 2000, ENVIRON BIOL FISH, V58, P411, DOI 10.1023/A:1007695526177; Lugli A, 2004, ETHOL ECOL EVOL, V16, P55; Lugli M, 1999, J FISH BIOL, V54, P691, DOI 10.1006/jfbi.1998.0898; Lugli M, 1997, MAR FRESHW BEHAV PHY, V29, P109, DOI 10.1080/10236249709379003; Lugli M, 1996, J FISH BIOL, V49, P648; LUGLI M, 1995, ENVIRON BIOL FISH, V43, P219, DOI 10.1007/BF00005853; Lugli M, 2007, J ACOUST SOC AM, V122, P2881, DOI 10.1121/1.2783113; Malavasi S, 2003, ENVIRON BIOL FISH, V66, P231, DOI 10.1023/A:1023923403180; Malavasi S, 2009, J FISH BIOL, V75, P1883, DOI 10.1111/j.1095-8649.2009.02430.x; Malavasi S, 2008, BIOL J LINN SOC, V93, P763, DOI 10.1111/j.1095-8312.2008.00947.x; Murdy E. O., 1989, REC AUSTR MUS S, V11, P1, DOI [DOI 10.3853/J.0812-7387.11.1989.93, 10.3853/j.0812-7387.11.1989.93]; MYRBERG AA, 2006, COMMUNICATION FISHES, V1, P149; Niedzwiedzki G, 2010, NATURE, V463, P43, DOI 10.1038/nature08623; NURSALL JR, 1974, AM ZOOL, V14, P1099; NURSALL JR, 1981, B MAR SCI, V31, P730; Pace CM, 2009, J EXP BIOL, V212, P2279, DOI 10.1242/jeb.029041; Parmentier E, 2009, J EXP BIOL, V212, P2022, DOI 10.1242/jeb.030270; Polgar G, 2010, J FISH BIOL, V77, P1645, DOI 10.1111/j.1095-8649.2010.02807.x; Polgar G, 2010, MAR ECOL PROG SER, V409, P199, DOI 10.3354/meps08597; Retallack GJ, 1997, SCIENCE, V276, P583, DOI 10.1126/science.276.5312.583; Rice AN, 2009, J EXP BIOL, V212, P1377, DOI 10.1242/jeb.028506; Rollo A, 2007, BEHAVIOUR, V144, P1, DOI 10.1163/156853907779947391; SABATIER JM, 1986, J ACOUST SOC AM, V80, P646, DOI 10.1121/1.394058; Schultze Hans-Peter, 1999, P373, DOI 10.1016/B978-012356040-7/50018-4; Simpson HJ, 2000, J ACOUST SOC AM, V107, P2329, DOI 10.1121/1.428618; Stadler John H., 2002, Bioacoustics, V13, P145; STEBBINS RC, 1961, COPEIA, P18; TAKEMURA A, 1984, B JPN SOC SCI FISH, V50, P561; TAVOLGA WILLIAM N., 1956, ZOOLOGICA [NEW YORK], V41, P49; Thacker CE, 2005, MOL PHYLOGENET EVOL, V37, P858, DOI 10.1016/j.ympev.2005.05.004; Thacker CE, 2003, MOL PHYLOGENET EVOL, V26, P354, DOI 10.1016/S1055-7903(02)00361-5; Thacker CE, 2009, COPEIA, P93, DOI 10.1643/CI-08-004; Thorson RF, 2002, ENVIRON BIOL FISH, V63, P321, DOI 10.1023/A:1014334425821; TORRICELLI P, 1990, Bioacoustics, V2, P261; Townsend Kathy A., 2005, Proceedings of the Royal Society of Queensland, V112, P53; Vasconcelos RO, 2008, J EXP BIOL, V211, P502, DOI 10.1242/jeb.008474; Wang HY, 2001, MOL PHYLOGENET EVOL, V20, P390, DOI 10.1006/mpev.2001.0957; WHANG A, 1994, ENVIRON BIOL FISH, V40, P141, DOI 10.1007/BF00002540; Wysocki LE, 2001, J COMP PHYSIOL A, V187, P177, DOI 10.1007/s003590100186; Zhang G, 1989, B FAC FISH NAGASAKI, V66, P21	86	15	16	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21434	10.1371/journal.pone.0021434	http://dx.doi.org/10.1371/journal.pone.0021434			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738663	gold, Green Published			2022-12-27	WOS:000292142800020
J	McLachlan, SM; Aliesky, HA; Chen, CR; Williams, RW; Rapoport, B				McLachlan, Sandra M.; Aliesky, Holly A.; Chen, Chun-Rong; Williams, Robert W.; Rapoport, Basil			Exceptional Hyperthyroidism and a Role for both Major Histocompatibility Class I and Class II Genes in a Murine Model of Graves' Disease	PLOS ONE			English	Article							THYROTROPIN RECEPTOR ECTODOMAIN; MONOCLONAL-ANTIBODY; MICE; AUTOANTIBODIES; SUSCEPTIBILITY; EXPRESSION; IDIOTYPES; INSIGHT; PROTEIN; CELLS	Autoimmune hyperthyroidism, Graves' disease, can be induced by immunizing susceptible strains of mice with adenovirus encoding the human thyrotropin receptor (TSHR) or its A-subunit. Studies in two small families of recombinant inbred strains showed that susceptibility to developing TSHR antibodies (measured by TSH binding inhibition, TBI) was linked to the MHC region whereas genes on different chromosomes contributed to hyperthyroidism. We have now investigated TSHR antibody production and hyperthyroidism induced by TSHR A-subunit adenovirus immunization of a larger family of strains (26 of the AXB and BXA strains). Analysis of the combined AXB and BXA families provided unexpected insight into several aspects of Graves' disease. First, extreme thyroid hyperplasia and hyperthyroidism in one remarkable strain, BXA13, reflected an inability to generate non-functional TSHR antibodies measured by ELISA. Although neutral TSHR antibodies have been detected in Graves' sera, pathogenic, functional TSHR antibodies in Graves' patients are undetectable by ELISA. Therefore, this strain immunized with A-subunit-adenovirus that generates only functional TSHR antibodies may provide an improved model for studies of induced Graves' disease. Second, our combined analysis of linkage data from this and previous work strengthens the evidence that gene variants in the immunoglobulin heavy chain V region contribute to generating thyroid stimulating antibodies. Third, a broad region that encompasses the MHC region on mouse chomosome 17 is linked to the development of TSHR antibodies (measured by TBI). Most importantly, unlike other strains, TBI linkage in the AXB and BXA families to MHC class I and class II genes provides an explanation for the unresolved class I/class II difference in humans.	[McLachlan, Sandra M.; Aliesky, Holly A.; Chen, Chun-Rong; Rapoport, Basil] Cedars Sinai Res Inst, Thyroid Autoimmun Unit, Los Angeles, CA USA; [McLachlan, Sandra M.; Aliesky, Holly A.; Chen, Chun-Rong; Rapoport, Basil] Univ Calif Los Angeles, Sch Med, Los Angeles, CA USA; [Williams, Robert W.] Univ Tennessee, Dept Anat & Neurobiol, Hlth Sci Ctr, Memphis, TN USA	Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Tennessee System; University of Tennessee Health Science Center	McLachlan, SM (corresponding author), Cedars Sinai Res Inst, Thyroid Autoimmun Unit, Los Angeles, CA USA.	mclachlans@cshs.org	Williams, Robert W./H-8789-2016	Williams, Robert W./0000-0001-8924-4447	National Institutes of Health [DK54684, DK19289, U01AA13499, U24AA13513, P20-DA-21131, U01CA105417, U24RR021760]; NATIONAL CANCER INSTITUTE [U01CA105417] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U24RR021760] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK019289, R01DK082390, R01DK054684] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA013499] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P20DA021131] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institutes of Health Grants DK54684 (SMM), DK19289 (BR), U01AA13499, U24AA13513, P20-DA-21131, U01CA105417 and U24RR021760 (RWW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliesky HA, 2006, ENDOCRINOLOGY, V147, P2789, DOI 10.1210/en.2006-0160; Chazenbalk GD, 1997, J BIOL CHEM, V272, P18959, DOI 10.1074/jbc.272.30.18959; Chazenbalk GD, 1999, J CLIN ENDOCR METAB, V84, P702, DOI 10.1210/jc.84.2.702; Chen CR, 2006, THYROID, V16, P427, DOI 10.1089/thy.2006.16.427; Chen CR, 2004, ENDOCRINOLOGY, V145, P4927, DOI 10.1210/en.2004-0716; Chen CR, 2003, J CLIN INVEST, V111, P1897, DOI 10.1172/JCI200317069; CHURCHILL GA, 1994, GENETICS, V138, P963; HEUFELDER AE, 1992, J CLIN ENDOCR METAB, V74, P724, DOI 10.1210/jc.74.4.724; Jacobson EM, 2007, THYROID, V17, P949, DOI 10.1089/thy.2007.0153; Jacobson EM, 2009, J BIOL CHEM, V284, P34231, DOI 10.1074/jbc.M109.041574; Joshi MB, 2001, INFECT IMMUN, V69, P4884, DOI 10.1128/IAI.69.8.4884-4890.2001; Lozier JN, 2005, BLOOD, V105, P1029, DOI 10.1182/blood-2004-03-1126; Mallya M, 2006, PROTEIN SCI, V15, P2244, DOI 10.1110/ps.062242606; Mayfield JA, 2007, GENES IMMUN, V8, P468, DOI 10.1038/sj.gene.6364411; MCGREGOR AM, 1992, J CLIN ENDOCR METAB, V74, P720, DOI 10.1210/jc.74.4.720; McLachlan SM, 2008, ENDOCRINOLOGY, V149, P2001, DOI 10.1210/en.2007-1517; McLachlan SM, 2011, ENDOCRINOLOGY, V152, P1172, DOI 10.1210/en.2010-1138; McLachlan SM, 2005, ENDOCR REV, V26, P800, DOI 10.1210/er.2004-0023; Metcalfe R, 2002, J CLIN ENDOCR METAB, V87, P1754, DOI 10.1210/jc.87.4.1754; Misharin AV, 2009, ENDOCRINOLOGY, V150, P3944, DOI 10.1210/en.2009-0181; Mittereder N, 1996, J VIROL, V70, P7498, DOI 10.1128/JVI.70.11.7498-7509.1996; Morshed SA, 2010, ENDOCRINOLOGY, V151, P5537, DOI 10.1210/en.2010-0424; Nagayama Y, 2003, THYROID, V13, P233, DOI 10.1089/105072503321582024; Nagayama Y, 2002, J IMMUNOL, V168, P2789, DOI 10.4049/jimmunol.168.6.2789; Nagayama Y, 2007, THYROID, V17, P981, DOI 10.1089/thy.2007.0161; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; PISETSKY DS, 1977, J EXP MED, V146, P1603, DOI 10.1084/jem.146.6.1603; Rapoport B, 2010, GENES IMMUN, V11, P254, DOI 10.1038/gene.2010.8; Rapoport B, 2007, THYROID, V17, P911, DOI 10.1089/thy.2007.0170; RATANACHAIYAVONG S, 1991, CLIN EXP IMMUNOL, V84, P48; RUDIKOFF S, 1976, J EXP MED, V144, P1294, DOI 10.1084/jem.144.5.1294; Sanders J, 2005, THYROID, V15, P672, DOI 10.1089/thy.2005.15.672; Schwarz-Lauer L, 2003, ENDOCRINOLOGY, V144, P1718, DOI 10.1210/en.2002-0069; SEMMA M, 1981, IMMUNOLOGY, V42, P45; Shifman S, 2006, PLOS BIOL, V4, P2227, DOI 10.1371/journal.pbio.0040395; Simmonds MJ, 2007, HUM MOL GENET, V16, P2149, DOI 10.1093/hmg/ddm165; Spindler KR, 2010, J IMMUNOL, V184, P3055, DOI 10.4049/jimmunol.0903363; STENSZKY V, 1985, J CLIN ENDOCR METAB, V61, P735, DOI 10.1210/jcem-61-4-735; TODD JA, 1988, SCIENCE, V240, P1003, DOI 10.1126/science.3368786; TRAYSTMAN MD, 1991, CLIN EXP IMMUNOL, V86, P291, DOI 10.1111/j.1365-2249.1991.tb05812.x; Williams RW, 2001, GENOME BIOL, V2; Williams RW, 1998, J NEUROSCI, V18, P138	42	8	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21378	10.1371/journal.pone.0021378	http://dx.doi.org/10.1371/journal.pone.0021378			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738647	Green Published, gold, Green Submitted			2022-12-27	WOS:000292092600033
J	Liu, B; Wang, GS; Yang, J; Pan, XD; Yang, ZC; Zang, LQ				Liu, Bing; Wang, Genshu; Yang, Jie; Pan, Xuediao; Yang, Zhicheng; Zang, Linquan			Berberine Inhibits Human Hepatoma Cell Invasion without Cytotoxicity in Healthy Hepatocytes	PLOS ONE			English	Article							NF-KAPPA-B; HEPATOCELLULAR-CARCINOMA; MATRIX METALLOPROTEINASES; CANCER CELLS; APOPTOSIS; EXPRESSION; MIGRATION; PATHWAY; ACTIVATION; ADHESION	Conventional chemotherapy fails to cure metastatic hepatoma mainly due to its high hepatotoxicity. Many plant-derived agents have been accepted to effectively inhibit hepatoma cell invasion. However, the investigation that whether effectual plant-derived agents against invasive hepatoma cells exert unexpected cytotoxicity in healthy hepatocytes has been ignored. This study demonstrated that berberine exhibited significant cytotoxicity in HepG2 cells mainly through upregulation of reactive oxygen species (ROS) production but was ineffective in normal Chang liver cells. Berberine exerted anti-invasive effect on HepG2 cells through suppression of matrix metalloproteinase-9 (MMP-9) expression. Moreover, berberine could significantly inhibit the activity of PI3K-AKT and ERK pathways. Combination treatment of ERK pathway inhibitor PD98059 or AKT pathway inhibitor LY294002 and berberine could result in a synergistic reduction on MMP-9 expression along with an inhibition of cell invasion. Enhancement of ROS production by berberine had no influence on its suppressive effects on the activity of PI3K-AKT and ERK pathways, as well as MMP-9 expression and HepG2 cell invasion. In conclusion, our results suggest that berberine may be a potential alternative against invasive hepatoma cells through PI3K-AKT and ERK pathways-dependent downregulation of MMP-9 expression. This study also provides a previously neglected insight into the investigation of plant-derived agents-based therapy against tumor invasion with the consideration of damage to healthy cells.	[Liu, Bing; Pan, Xuediao; Yang, Zhicheng; Zang, Linquan] Guangdong Pharmaceut Univ, Sch Pharm, Dept Pharmacol, Guangzhou, Guangdong, Peoples R China; [Wang, Genshu] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Liver Surg, Guangzhou 510275, Guangdong, Peoples R China; [Yang, Jie] Guangxi Med Univ, Sch Pharm, Dept Pharmacol, Nanning, Peoples R China	Guangdong Pharmaceutical University; Sun Yat Sen University; Guangxi Medical University	Liu, B (corresponding author), Guangdong Pharmaceut Univ, Sch Pharm, Dept Pharmacol, Guangzhou, Guangdong, Peoples R China.	gdpuhepatology@163.com						Abiru S, 2002, HEPATOLOGY, V35, P1117, DOI 10.1053/jhep.2002.32676; Arii S, 1996, HEPATOLOGY, V24, P316; Bahassi EM, 2004, CLIN EXP METASTAS, V21, P293, DOI 10.1023/B:CLIN.0000046132.46946.dd; Cheng JCH, 2006, ONCOGENE, V25, P7009, DOI 10.1038/sj.onc.1209706; Chung TW, 2004, FASEB J, V18, P1123, DOI 10.1096/fj.03-1429fje; Deem TL, 2004, BLOOD, V104, P2385, DOI 10.1182/blood-2004-02-0665; Deryugina EI, 2005, CANCER RES, V65, P10959, DOI 10.1158/0008-5472.CAN-05-2228; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Groth S, 2005, J BIOL CHEM, V280, P33190, DOI 10.1074/jbc.M504249200; Gui SY, 2008, PHARMAZIE, V63, P516, DOI 10.1691/ph.2008.8018; He B, 2009, CLIN CANCER RES, V15, P5803, DOI 10.1158/1078-0432.CCR-09-0811; Ho YT, 2009, CANCER LETT, V279, P155, DOI 10.1016/j.canlet.2009.01.033; Hwang JM, 2006, ARCH TOXICOL, V80, P62, DOI 10.1007/s00204-005-0014-8; Ito Y, 1998, HEPATOLOGY, V27, P951, DOI 10.1002/hep.510270409; Itoh Y, 2002, ESSAYS BIOCHEM, V38, P21, DOI 10.1042/bse0380021; Jantova S, 2003, J PHARM PHARMACOL, V55, P1143, DOI 10.1211/002235703322277186; Kamata H, 1999, CELL SIGNAL, V11, P1, DOI 10.1016/S0898-6568(98)00037-0; Kim JH, 2004, ONCOL REP, V12, P1233; Kim S, 2008, MOLECULES, V13, P2975, DOI 10.3390/molecules13122975; Kim Won Ho, 1993, Yonsei Medical Journal, V34, P45; KOHN EC, 1995, CANCER RES, V55, P1856; Kozuki Y, 2000, CANCER LETT, V151, P111, DOI 10.1016/S0304-3835(99)00418-8; Kozuki Y, 2001, CANCER LETT, V167, P151, DOI 10.1016/S0304-3835(01)00476-1; Lin TH, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-58; Meeran SM, 2008, TOXICOL APPL PHARM, V229, P33, DOI 10.1016/j.taap.2007.12.027; Monvoisin A, 1999, J HEPATOL, V30, P511, DOI 10.1016/S0168-8278(99)80113-5; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; Oh SH, 2006, TOXICOL APPL PHARM, V212, P212, DOI 10.1016/j.taap.2005.07.018; Peng PL, 2006, TOXICOL APPL PHARM, V214, P8, DOI 10.1016/j.taap.2005.11.010; Pervaiz S, 2002, CURR PHARM DESIGN, V8, P1723, DOI 10.2174/1381612023394025; Sanceau J, 2003, J BIOL CHEM, V278, P36537, DOI 10.1074/jbc.M304300200; Scheving LA, 2007, AM J PHYSIOL-GASTR L, V293, pG552, DOI 10.1152/ajpgi.00140.2007; Sener SF, 2005, J SURG ONCOL, V92, P1, DOI 10.1002/jso.20335; Singh T, 2011, CARCINOGENESIS, V32, P86, DOI 10.1093/carcin/bgq215; Takahra T, 2004, INT J BIOCHEM CELL B, V36, P353, DOI 10.1016/S1357-2725(03)00260-7; Tang FQ, 2009, J BIOL CHEM, V284, P27456, DOI 10.1074/jbc.M109.033795; Thant AA, 2001, CLIN EXP METASTAS, V18, P423, DOI 10.1023/A:1010921730952; Thomas MB, 2008, ANN SURG ONCOL, V15, P1008, DOI 10.1245/s10434-007-9705-0; Tsai PL, 2004, DRUG METAB DISPOS, V32, P405, DOI 10.1124/dmd.32.4.405; Tsang CM, 2009, INT J MOL MED, V24, P131, DOI 10.3892/ijmm_00000216; van Waveren C, 2006, CARCINOGENESIS, V27, P409, DOI 10.1093/carcin/bgi242; Weng CJ, 2008, CARCINOGENESIS, V29, P147, DOI 10.1093/carcin/bgm261; Wu WS, 2006, CANCER METAST REV, V25, P695, DOI 10.1007/s10555-006-9037-8; Xu G, 2004, INT J ONCOL, V24, P893; Yagasaki K, 2000, CYTOTECHNOLOGY, V33, P229, DOI 10.1023/A:1008141918852; Ye MZ, 2009, J PHARM PHARMACOL, V61, P831, DOI [10.1211/jpp.61.07.0001, 10.1211/jpp/61.07.0001]; Zhang GY, 2000, CANCER LETT, V159, P169, DOI 10.1016/S0304-3835(00)00545-0; 2004, INT J CANC, V111, P174	48	92	101	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21416	10.1371/journal.pone.0021416	http://dx.doi.org/10.1371/journal.pone.0021416			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21738655	Green Published, gold, Green Submitted			2022-12-27	WOS:000292036900028
J	Slater, SC; Beachley, V; Hayes, T; Zhang, DM; Welsh, GI; Saleem, MA; Mathieson, PW; Wen, XJ; Su, B; Satchell, SC				Slater, Sadie C.; Beachley, Vince; Hayes, Thomas; Zhang, Daming; Welsh, Gavin I.; Saleem, Moin A.; Mathieson, Peter W.; Wen, Xuejun; Su, Bo; Satchell, Simon C.			An In Vitro Model of the Glomerular Capillary Wall Using Electrospun Collagen Nanofibres in a Bioartificial Composite Basement Membrane	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; BLOOD-BRAIN-BARRIER; CELLS; EXPRESSION; VEGF; PROTEINURIA; COCULTURE; SCAFFOLDS; CULTURE; MATRIX	The filtering unit of the kidney, the glomerulus, contains capillaries whose walls function as a biological sieve, the glomerular filtration barrier. This comprises layers of two specialised cells, glomerular endothelial cells (GEnC) and podocytes, separated by a basement membrane. Glomerular filtration barrier function, and dysfunction in disease, remains incompletely understood, partly due to difficulties in studying the relevant cell types in vitro. We have addressed this by generation of unique conditionally immortalised human GEnC and podocytes. However, because the glomerular filtration barrier functions as a whole, it is necessary to develop three dimensional co-culture models to maximise the benefit of the availability of these cells. Here we have developed the first two tri-layer models of the glomerular capillary wall. The first is based on tissue culture inserts and provides evidence of cell-cell interaction via soluble mediators. In the second model the synthetic support of the tissue culture insert is replaced with a novel composite bioartificial membrane. This consists of a nanofibre membrane containing collagen I, electrospun directly onto a micro-photoelectroformed fine nickel supporting mesh. GEnC and podocytes grew in monolayers on either side of the insert support or the novel membrane to form a tri-layer model recapitulating the human glomerular capillary in vitro. These models will advance the study of both the physiology of normal glomerular filtration and of its disruption in glomerular disease.	[Slater, Sadie C.; Welsh, Gavin I.; Saleem, Moin A.; Mathieson, Peter W.; Satchell, Simon C.] Univ Bristol, Acad Renal Unit, Bristol, Avon, England; [Beachley, Vince; Wen, Xuejun] Clemson Univ, Dept Bioengn, Charleston, SC USA; [Hayes, Thomas; Zhang, Daming; Su, Bo] Univ Bristol, Dept Oral & Dent Sci, Bristol, Avon, England	University of Bristol; Clemson University; University of Bristol	Slater, SC (corresponding author), Univ Bristol, Acad Renal Unit, Bristol, Avon, England.	S.C.Satchell@bristol.ac.uk		Saleem, Moin/0000-0002-9808-4518; Su, Bo/0000-0003-1063-8182; Welsh, Gavin Iain/0000-0002-2148-6658	Wellcome Trust [075731]; Medical Research Council [G0500053]; Biotechnology and Biological Sciences Research Council [BB/G000077/1]; Biotechnology and Biological Sciences Research Council [BB/G012776/1] Funding Source: researchfish; Medical Research Council [G0800200, G0701836] Funding Source: researchfish; BBSRC [BB/G000077/1, BB/G012776/1] Funding Source: UKRI; MRC [G0701836, G0800200, G0500053] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by a Wellcome Trust Fellowship to Dr. SC Satchell (075731), the Medical Research Council (G0500053) and the Biotechnology and Biological Sciences Research Council (BB/G000077/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT NJ, 1992, J CELL SCI, V103, P23; Bakunts K, 2008, BIOTECHNIQUES, V44, P341, DOI 10.2144/000112682; Barnes CP, 2007, ADV DRUG DELIVER REV, V59, P1413, DOI 10.1016/j.addr.2007.04.022; Bevan HS, 2008, NEPHRON PHYSIOL, V110, P57, DOI 10.1159/000177614; BIEGEL D, 1994, IN VITRO CELL DEV-AN, V30A, P581; Cui TG, 2004, AM J PHYSIOL-RENAL, V286, pF767, DOI 10.1152/ajprenal.00337.2003; Dai NT, 2005, BIOCHEM BIOPH RES CO, V329, P905, DOI 10.1016/j.bbrc.2005.02.059; Daley WP, 2008, J CELL SCI, V121, P255, DOI 10.1242/jcs.006064; Davis B, 2007, J AM SOC NEPHROL, V18, P2320, DOI 10.1681/ASN.2006101093; Durbeej M, 1996, MATRIX BIOL, V15, P397, DOI 10.1016/S0945-053X(96)90159-6; Eremina V, 2003, J CLIN INVEST, V111, P707, DOI 10.1172/JCI200317423; Eremina V, 2008, NEW ENGL J MED, V358, P1129, DOI 10.1056/NEJMoa0707330; Foster RR, 2008, AM J PATHOL, V173, P938, DOI 10.2353/ajpath.2008.070416; HALL V, 1957, AM HEART J, V54, P1, DOI 10.1016/0002-8703(57)90073-X; Haraldsson B, 2008, PHYSIOL REV, V88, P451, DOI 10.1152/physrev.00055.2006; He W, 2005, TISSUE ENG, V11, P1574, DOI 10.1089/ten.2005.11.1574; Hermanns MI, 2004, LAB INVEST, V84, P736, DOI 10.1038/labinvest.3700081; Hirschberg R, 2008, CELL TISSUE RES, V331, P485, DOI 10.1007/s00441-007-0526-z; Kefalides N A, 1973, Int Rev Connect Tissue Res, V6, P63; Kitahara T, 2005, NEPHROL DIAL TRANSPL, V20, P42, DOI 10.1093/ndt/gfh572; Lopez-Heredia MA, 2008, BIOMATERIALS, V29, P2608, DOI 10.1016/j.biomaterials.2008.02.021; Ma SH, 2005, LAB CHIP, V5, P74, DOI 10.1039/b405713a; MACARAK EJ, 1983, J CELL PHYSIOL, V116, P76, DOI 10.1002/jcp.1041160112; Matthews JA, 2002, BIOMACROMOLECULES, V3, P232, DOI 10.1021/bm015533u; Rho KS, 2006, BIOMATERIALS, V27, P1452, DOI 10.1016/j.biomaterials.2005.08.004; SAEKI T, 1991, AM J PATHOL, V139, P949; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Satchell SC, 2006, KIDNEY INT, V69, P1633, DOI 10.1038/sj.ki.5000277; Satchell SC, 2004, J AM SOC NEPHROL, V15, P566, DOI 10.1097/01.ASN.0000115397.22519.03; Satchell SC, 2007, J AM SOC NEPHROL, V18, P2875, DOI 10.1681/ASN.2006101104; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Tillman BW, 2009, BIOMATERIALS, V30, P583, DOI 10.1016/j.biomaterials.2008.10.006; Wang PC, 2005, J BIOSCI BIOENG, V99, P529, DOI 10.1263/jbb.99.529; Wang S, 2008, TISSUE ENG PT A, V14, P227, DOI 10.1089/tea.2007.0143; Williamson MR, 2006, BIOMATERIALS, V27, P3608, DOI 10.1016/j.biomaterials.2006.02.025; Zhang YZ, 2008, BIOMATERIALS, V29, P4314, DOI 10.1016/j.biomaterials.2008.07.038; Zhong SP, 2005, BIOMACROMOLECULES, V6, P2998, DOI 10.1021/bm050318p	37	41	42	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e20802	10.1371/journal.pone.0020802	http://dx.doi.org/10.1371/journal.pone.0020802			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21731625	Green Published, gold, Green Submitted			2022-12-27	WOS:000292036900006
J	Magico, AC; Bell, JB				Magico, Adam C.; Bell, John B.			Identification of a Classical Bipartite Nuclear Localization Signal in the Drosophila TEA/ATTS Protein Scalloped	PLOS ONE			English	Article							DNA-BINDING DOMAIN; CELL-PROLIFERATION; EXPORT SIGNALS; TRANSCRIPTION FACTORS; GENE-EXPRESSION; SUBCELLULAR-LOCALIZATION; IMPORTIN ALPHA-1; TEAD/TEF FAMILY; WING FORMATION; VIRUS TYPE-1	Drosophila melanogaster wing development has been shown to rely on the activity of a complex of two proteins, Scalloped (Sd) and Vestigial (Vg). Within this complex, Sd is known to provide DNA binding though its TEA/ATTS domain, while Vg modulates this binding and provides transcriptional activation through N- and C-terminal activation domains. There is also evidence that Sd is required for the nuclear translocation of Vg. Indeed, a candidate sequence which shows consensus to the bipartite family of nuclear localization signals (NLSs) has been identified within Sd previously, though it is not known if it is functional, or if additional unpredicted signals that mediate nuclear transport exist within the protein. By expressing various enhanced green fluorescent protein (eGFP) tagged constructs within Drosophila S2 cells, we demonstrate that this NLS is indeed functional and necessary for the proper nuclear localization of Sd. Additionally, the region containing the NLS is critical for the wildtype function of ectopically expressed Sd, in the context of wing development. Using site-directed mutagenesis, we have identified a group of five amino acids within this NLS which is critical for its function, as well as another group of two which is of lesser importance. Together with data that suggests that this sequence mediates interactions with Importin-alpha 3, we conclude that the identified NLS is likely a classical bipartite signal. Further dissection of Sd has also revealed that a large portion of the C-terminal domain of the protein is required its proper nuclear localization. Finally, a Leptomycin B (LB) sensitive signal which appears to facilitate nuclear export is identified, raising the possibility that Sd also contains a nuclear export signal (NES).	[Magico, Adam C.; Bell, John B.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	University of Alberta	Magico, AC (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	jbell@ualberta.ca			Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was funded by a Natural Sciences and Engineering Research Council of Canada (NSERC) grant (http://www.nserc-crsng.gc.ca/index_eng.asp) to JB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; ADRIANOPOULOS A, 1991, PLANT CELL, V3, P747, DOI 10.1105/tpc.3.8.747; Bogerd HP, 1996, MOL CELL BIOL, V16, P4207; Bogerd HP, 1998, J VIROL, V72, P8627, DOI 10.1128/JVI.72.11.8627-8635.1998; BURGLIN TR, 1991, CELL, V66, P11, DOI 10.1016/0092-8674(91)90132-I; CAMPBELL S, 1992, GENE DEV, V6, P367, DOI 10.1101/gad.6.3.367; Chan WM, 2007, FLY, V1, P340, DOI 10.4161/fly.5320; Chen HH, 2004, J BIOL CHEM, V279, P30800, DOI 10.1074/jbc.M400154200; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Chow L, 2004, GENOME, V47, P849, DOI 10.1139/G04-060; Cressman DE, 2001, J IMMUNOL, V167, P3626, DOI 10.4049/jimmunol.167.7.3626; DAVIDSON I, 1988, CELL, V54, P931, DOI 10.1016/0092-8674(88)90108-0; Delanoue R, 2004, CELL DEATH DIFFER, V11, P110, DOI 10.1038/sj.cdd.4401321; Deng H, 2009, MOL BIOL CELL, V20, P256, DOI 10.1091/mbc.E08-03-0288; Fisher CL, 1997, BIOTECHNIQUES, V23, P570, DOI 10.2144/97234bm01; Garg A, 2007, GENETICS, V175, P659, DOI 10.1534/genetics.106.063966; Gassman NR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017907; Gorjanacz M, 2002, DEV BIOL, V251, P271, DOI 10.1006/dbio.2002.0827; Goulev Y, 2008, CURR BIOL, V18, P435, DOI 10.1016/j.cub.2008.02.034; Halder G, 1998, GENE DEV, V12, P3900, DOI 10.1101/gad.12.24.3900; Halder G, 2001, DEVELOPMENT, V128, P3295; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; HWANG JJ, 1993, EMBO J, V12, P2337, DOI 10.1002/j.1460-2075.1993.tb05888.x; Jacquemin P, 1996, J BIOL CHEM, V271, P21775, DOI 10.1074/jbc.271.36.21775; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Knapp AA, 2009, VIROLOGY, V383, P60, DOI 10.1016/j.virol.2008.09.037; Kosugi S, 2008, TRAFFIC, V9, P2053, DOI 10.1111/j.1600-0854.2008.00825.x; Kosugi S, 2009, J BIOL CHEM, V284, P478, DOI 10.1074/jbc.M807017200; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; KUSSEL P, 1995, J CELL BIOL, V129, P1491, DOI 10.1083/jcb.129.6.1491; la Cour T, 2003, NUCLEIC ACIDS RES, V31, P393, DOI 10.1093/nar/gkg101; LALOUX I, 1990, MOL CELL BIOL, V10, P3541, DOI 10.1128/MCB.10.7.3541; LANFORD RE, 1984, CELL, V37, P801, DOI 10.1016/0092-8674(84)90415-X; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; MacKay JO, 2003, GENETICS, V163, P1365; Maeda T, 2002, J BIOL CHEM, V277, P48889, DOI 10.1074/jbc.M206858200; Markossian KA, 2004, BIOCHEMISTRY-MOSCOW+, V69, P971, DOI 10.1023/B:BIRY.0000043539.07961.4c; Mason DA, 2002, GENETICS, V161, P157; Mathe E, 2000, DEV BIOL, V223, P307, DOI 10.1006/dbio.2000.9743; McCabe JB, 1999, MOL BIOL CELL, V10, P3771, DOI 10.1091/mbc.10.11.3771; Meyer BE, 1996, J VIROL, V70, P2350, DOI 10.1128/JVI.70.4.2350-2359.1996; North AJ, 2006, J CELL BIOL, V172, P9, DOI 10.1083/jcb.200507103; Oh H, 2008, DEVELOPMENT, V135, P1081, DOI 10.1242/dev.015255; Ota M, 2008, DEVELOPMENT, V135, P4059, DOI 10.1242/dev.027151; Ratan R, 2008, GENETICS, V178, P839, DOI 10.1534/genetics.107.081778; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; RUBIN GM, 1983, NUCLEIC ACIDS RES, V11, P6341, DOI 10.1093/nar/11.18.6341; Simmonds AJ, 1998, GENE DEV, V12, P3815, DOI 10.1101/gad.12.24.3815; Sorokin AV, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1439, DOI 10.1134/S0006297907130032; Srivastava A, 2004, GENETICS, V166, P1833, DOI 10.1534/genetics.166.4.1833; Srivastava A, 2002, GENESIS, V33, P40, DOI 10.1002/gene.10086; TOROK I, 1995, J CELL BIOL, V129, P1473, DOI 10.1083/jcb.129.6.1473; Tran EJ, 2006, CELL, V125, P1041, DOI 10.1016/j.cell.2006.05.027; Vassilev A, 2001, GENE DEV, V15, P1229, DOI 10.1101/gad.888601; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weber F, 1998, VIROLOGY, V250, P9, DOI 10.1006/viro.1998.9329; WILLIAMS JA, 1994, NATURE, V368, P299, DOI 10.1038/368299a0; Wu S, 2008, DEV CELL, V14, P388, DOI 10.1016/j.devcel.2008.01.007; XIAO JH, 1991, CELL, V65, P551, DOI 10.1016/0092-8674(91)90088-G; YLIKOMI T, 1992, EMBO J, V11, P3681, DOI 10.1002/j.1460-2075.1992.tb05453.x; Zhang L, 2008, DEV CELL, V14, P377, DOI 10.1016/j.devcel.2008.01.006; Zheng C, 2005, J VIROL, V79, P11864, DOI 10.1128/JVI.79.18.11864-11872.2005	62	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21431	10.1371/journal.pone.0021431	http://dx.doi.org/10.1371/journal.pone.0021431			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731746	Green Submitted, Green Published, gold			2022-12-27	WOS:000292035400037
J	Belbin, O; Crump, M; Bisceglio, GD; Carrasquillo, MM; Morgan, K; Younkin, SG				Belbin, Olivia; Crump, Michael; Bisceglio, Gina D.; Carrasquillo, Minerva M.; Morgan, Kevin; Younkin, Steven G.			Multiple Insulin Degrading Enzyme Variants Alter In Vitro Reporter Gene Expression	PLOS ONE			English	Article							AMYLOID BETA-PROTEIN; BLOCK SPANNING IDE; ALZHEIMERS-DISEASE; A-BETA; PEPTIDE; BRAIN; DEGRADATION; DEPOSITION; NEURONS	The insulin degrading enzyme (IDE) variant, v311 (rs6583817), is associated with increased post-mortem cerebellar IDE mRNA, decreased plasma beta-amyloid (A beta), decreased risk for Alzheimer's disease (AD) and increased reporter gene expression, suggesting that it is a functional variant driving increased IDE expression. To identify other functional IDE variants, we have tested v685, rs11187061 (associated with decreased cerebellar IDE mRNA) and variants on H6, the haplotype tagged by v311 (v10; rs4646958, v315; rs7895832, v687; rs17107734 and v154; rs4646957), for altered in vitro reporter gene expression. The reporter gene expression levels associated with the second most common haplotype (H2) successfully replicated the post-mortem findings in hepatocytoma (0.89 fold-change, p = 0.04) but not neuroblastoma cells. Successful in vitro replication was achieved for H6 in neuroblastoma cells when the sequence was cloned 5' to the promoter (1.18 fold-change, p = 0.006) and 3' to the reporter gene (1.29 fold change, p = 0.003), an effect contributed to by four variants (v10, v315, v154 and v311). Since IDE mediates A beta degradation, variants that regulate IDE expression could represent good therapeutic targets for AD.	[Belbin, Olivia; Crump, Michael; Bisceglio, Gina D.; Carrasquillo, Minerva M.; Younkin, Steven G.] Mayo Clin, Coll Med, Dept Neurosci, Jacksonville, FL 32224 USA; [Belbin, Olivia; Morgan, Kevin] Univ Nottingham, Queens Med Ctr, Inst Genet, Sch Mol Med Sci, Nottingham NG7 2RD, England	Mayo Clinic; University of Nottingham	Belbin, O (corresponding author), Mayo Clin, Coll Med, Dept Neurosci, Jacksonville, FL 32224 USA.	kevin.morgan@nottingham.ac.uk		Belbin, Olivia/0000-0002-9805-8408; Morgan, Kevin/0000-0002-8217-2396; Belbin, Olivia/0000-0002-6109-6371	Alzheimer's Research Trust; Big Lottery Fund; US National Institutes of Health; NIA [R01 AG18023]; Robert and Clarice Smith Postdoctoral Fellowship; Robert and Clarice Smith and Abigail Van Buren Alzheimer's Disease Research Program; Palumbo Professorship in Alzheimer's Disease Research; NATIONAL INSTITUTE ON AGING [R01AG018023] Funding Source: NIH RePORTER; Alzheimers Research UK [ART-BIG2009-1, ART-PPG2008A-3, ART-SB2010A-1] Funding Source: researchfish	Alzheimer's Research Trust; Big Lottery Fund; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Robert and Clarice Smith Postdoctoral Fellowship; Robert and Clarice Smith and Abigail Van Buren Alzheimer's Disease Research Program; Palumbo Professorship in Alzheimer's Disease Research; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK))	Support for this research was provided by grants from the Alzheimer's Research Trust (OB and KM) and the Big Lottery Fund (KM), US National Institutes of Health, NIA (R01 AG18023, SGY), Robert and Clarice Smith Postdoctoral Fellowship (MMC), Robert and Clarice Smith and Abigail Van Buren Alzheimer's Disease Research Program (SGY) and by the Palumbo Professorship in Alzheimer's Disease Research (SGY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backstrom JR, 1996, J NEUROSCI, V16, P7910; Bernstein HG, 1999, NEUROSCI LETT, V263, P161, DOI 10.1016/S0304-3940(99)00135-4; Bertram L, 2000, SCIENCE, V290, P2302, DOI 10.1126/science.290.5500.2302; Blacker D, 2003, HUM MOL GENET, V12, P23, DOI 10.1093/hmg/ddg007; Carrasquillo MM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008764; Ertekin-Taner N, 2004, HUM MUTAT, V23, P334, DOI 10.1002/humu.20016; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Hu JG, 2001, J BIOL CHEM, V276, P47863, DOI 10.1074/jbc.M104068200; Iwata N, 2000, NAT MED, V6, P143, DOI 10.1038/72237; Kehoe P, 1999, HUM MOL GENET, V8, P237, DOI 10.1093/hmg/8.2.237; KUROCHKIN IV, 1994, FEBS LETT, V345, P33, DOI 10.1016/0014-5793(94)00387-4; McDermott JR, 1997, NEUROCHEM RES, V22, P49, DOI 10.1023/A:1027325304203; Prince JA, 2003, HUM MUTAT, V22, P363, DOI 10.1002/humu.10282; Qiu WQ, 1998, J BIOL CHEM, V273, P32730, DOI 10.1074/jbc.273.49.32730; Rockman MV, 2002, MOL BIOL EVOL, V19, P1991, DOI 10.1093/oxfordjournals.molbev.a004023; ROHER AE, 1994, BIOCHEM BIOPH RES CO, V205, P1755, DOI 10.1006/bbrc.1994.2872	16	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21429	10.1371/journal.pone.0021429	http://dx.doi.org/10.1371/journal.pone.0021429			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731745	Green Published, gold, Green Submitted			2022-12-27	WOS:000292033700083
J	Bouche, P; Douglas-Hamilton, I; Wittemyer, G; Nianogo, AJ; Doucet, JL; Lejeune, P; Vermeulen, C				Bouche, Philippe; Douglas-Hamilton, Iain; Wittemyer, George; Nianogo, Aime J.; Doucet, Jean-Louis; Lejeune, Philippe; Vermeulen, Cedric			Will Elephants Soon Disappear from West African Savannahs?	PLOS ONE			English	Article							WAZA-NATIONAL-PARK; LARGE MAMMALS; BURKINA-FASO; TRENDS; POPULATIONS; OSTRICHES; CAMEROON	Precipitous declines in Africa's native fauna and flora are recognized, but few comprehensive records of these changes have been compiled. Here, we present population trends for African elephants in the 6,213,000 km 2 Sudano-Sahelian range of West and Central Africa assessed through the analysis of aerial and ground surveys conducted over the past 4 decades. These surveys are focused on the best protected areas in the region, and therefore represent the best case scenario for the northern savanna elephants. A minimum of 7,745 elephants currently inhabit the entire region, representing a minimum decline of 50% from estimates four decades ago for these protected areas. Most of the historic range is now devoid of elephants and, therefore, was not surveyed. Of the 23 surveyed elephant populations, half are estimated to number less than 200 individuals. Historically, most populations numbering less than 200 individuals in the region were extirpated within a few decades. Declines differed by region, with Central African populations experiencing much higher declines (-76%) than those in West Africa (-33%). As a result, elephants in West Africa now account for 86% of the total surveyed. Range wide, two refuge zones retain elephants, one in West and the other in Central Africa. These zones are separated by a large distance (similar to 900 km) of high density human land use, suggesting connectivity between the regions is permanently cut. Within each zone, however, sporadic contacts between populations remain. Retaining such connectivity should be a high priority for conservation of elephants in this region. Specific corridors designed to reduce the isolation of the surveyed populations are proposed. The strong commitment of governments, effective law enforcement to control the illegal ivory trade and the involvement of local communities and private partners are all critical to securing the future of elephants inhabiting Africa's northern savannas.	[Bouche, Philippe; Doucet, Jean-Louis; Lejeune, Philippe; Vermeulen, Cedric] Univ Liege Gembloux Agrobio Tech, Unite Gest Ressources Forestieres & Milieux Nat, Gembloux, Belgium; [Douglas-Hamilton, Iain; Wittemyer, George] Save Elephants, Nairobi, Kenya; [Wittemyer, George] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA; [Nianogo, Aime J.] IUCN, PACO, Ouagadougou, Burkina Faso; [Douglas-Hamilton, Iain] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Liege; Colorado State University; University of Oxford	Bouche, P (corresponding author), Univ Liege Gembloux Agrobio Tech, Unite Gest Ressources Forestieres & Milieux Nat, Gembloux, Belgium.	ph_bouche@yahoo.com	Wittemyer, George/AFQ-1840-2022		African Development Bank; Agence Francaise de Developpement; Conservation International; European Union; Kingdom of Belgium; World Bank	African Development Bank(CGIAR); Agence Francaise de Developpement; Conservation International; European Union(European Commission); Kingdom of Belgium; World Bank(The World Bank India)	These surveys were funds by African Development Bank (www.afdb.org), Agence Francaise de Developpement (www.afd.fr), Conservation International (www.conservation.org), European Union (www.europa.eu), Kingdom of Belgium (www.belgium.be), World Bank (www.worldbank.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, STAT METHODS BIOL; Barnes RFW, 1999, MAMMAL REV, V29, P175, DOI 10.1046/j.1365-2907.1999.00044.x; BARNES RFW, 1998, AFRICAN ELEPHANT DAT; Beier P, 1998, CONSERV BIOL, V12, P1241, DOI 10.1046/j.1523-1739.1998.98036.x; Blake S, 2007, PLOS BIOL, V5, P945, DOI 10.1371/journal.pbio.0050111; Blanc J.J., 2003, AFRICAN ELEPHANT STA; Blanc Julian J., 2007, AFRICAN ELEPHANT STA; Bouche P, 2004, PACHYDERM, V37, P85; Bouche P., 2009, PACHYDERM, V45, P47; Bouche Ph., 2002, Pachyderm, V32, P49; Bouche Ph., 2007, NAZINGA, P259; Bouche P, 2010, AFR J ECOL, V48, P994, DOI 10.1111/j.1365-2028.2009.01202.x; Bouche P, 2007, PACHYDERM, P58; Bouche P, 2007, PACHYDERM, P33; Buckland S. T., 1993, Distance sampling: estimating abundance of biological populations.; Calix M., 2018, EUROPEAN RED LIST SA; Chardonnet Bertrand, 2000, Pachyderm, V28, P16; Chardonnet Ph, 2008, BOIS FOR TROP, V295, P91; Clerici N, 2007, J NAT CONSERV, V15, P26, DOI 10.1016/j.jnc.2006.08.003; Dejace P, 2000, REV ECOL-TERRE VIE, V55, P305; DOUGLAS-HAMILTON I, 1987, Oryx, V21, P11; Douglas-Hamilton I., 2009, PACHYDERM, V45, P154; Douglas -Hamilton I, 1981, ILCA MONOGRAPH; DOUGLASHAMILTON I, 1996, SERIE MANUELS TECHNI, V7, P31; DUPUY AR, 1971, B I FRANCAIS AFRIQ A, V33, P253; Eggert LS, 2002, P ROY SOC B-BIOL SCI, V269, P1993, DOI 10.1098/rspb.2002.2070; ESSER JD, 1979, TERRE VIE-REV ECOL A, V33, P3; Fischer Frauke, 2005, Pachyderm, V38, P64; Foguekem D, 2009, SCI RES ESSAYS, V4, P1423; HAESSLER C, 2003, SAVANES AFRICAINES E; JACHMANN H, 1991, AFR J ECOL, V29, P188, DOI 10.1111/j.1365-2028.1991.tb01001.x; Jeannin A., 1936, MAMMIFERES SAUVAGES; Milliken T., 2009, ELEPHANT TRADE INFOR; Nakande A, 2007, PACHYDERM, P81; NORTONGRIFFITHS M, 1978, HDB COUNTING ANIMALS, V1; Okoumassou K., 1998, Pachyderm, V26, P52; *PNUE, 2002, ET ENV MOND 2002; Poilecot P, 2010, BOIS FOR TROP, P93; PRINS HHT, 1992, ENVIRON CONSERV, V19, P117, DOI 10.1017/S0376892900030587; ROTH HH, 1991, MAMMALIA, V55, P489, DOI 10.1515/mamm.1991.55.4.489; SAID MY, 1995, AFRICAN ELEPHANT DAT; Sam M.K., 1998, Pachyderm, V26, P61; Sam Moses Kofi, 2002, Pachyderm, V33, P39; Sinclair ARE, 2006, WILDLIFE ECOLOGY CON; Tchamba MN, 1995, AFR J ECOL, V33, P366, DOI 10.1111/j.1365-2028.1995.tb01046.x; *UNEP, 2006, SUD POST CONFL ENV A; VERMEULEN C, 2004, BURKINA FASO PARES R, V59, P20; Western D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006140; White F., 1983, VEGETATION AFRICA DE	49	79	80	3	103	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e20619	10.1371/journal.pone.0020619	http://dx.doi.org/10.1371/journal.pone.0020619			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731620	Green Published, gold, Green Submitted			2022-12-27	WOS:000292033700012
J	Pan, YF; Robinett, CC; Baker, BS				Pan, Yufeng; Robinett, Carmen C.; Baker, Bruce S.			Turning Males On: Activation of Male Courtship Behavior in Drosophila melanogaster	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; SEX-DETERMINATION GENE; REPRODUCTIVE-BEHAVIOR; NEURAL CIRCUITRY; DOUBLESEX GENE; VISUAL-SYSTEM; BIBIONIDAE DIPTERA; FEMALE DROSOPHILA; SENSORY NEURONS; FRUITLESS GENE	The innate sexual behaviors of Drosophila melanogaster males are an attractive system for elucidating how complex behavior patterns are generated. The potential for male sexual behavior in D. melanogaster is specified by the fruitless (fru) and doublesex (dsx) sex regulatory genes. We used the temperature-sensitive activator dTRPA1 to probe the roles of fru(M)- and dsx-expressing neurons in male courtship behaviors. Almost all steps of courtship, from courtship song to ejaculation, can be induced at very high levels through activation of either all fru(M) or all dsx neurons in solitary males. Detailed characterizations reveal different roles for fru(M) and dsx in male courtship. Surprisingly, the system for mate discrimination still works well when all dsx neurons are activated, but is impaired when all fru(M) neurons are activated. Most strikingly, we provide evidence for a fru(M)-independent courtship pathway that is primarily vision dependent.	[Pan, Yufeng; Robinett, Carmen C.; Baker, Bruce S.] Howard Hughes Med Inst, Ashburn, VA USA	Howard Hughes Medical Institute	Pan, YF (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus, Ashburn, VA USA.	bakerb@janelia.hhmi.org	Pan, Yufeng/V-2376-2017; Robinett, Carmen/AAH-3177-2019	Pan, Yufeng/0000-0002-1535-9716; 	Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This research was funded by Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand A, 2001, GENETICS, V158, P1569; Baker BS, 2001, CELL, V105, P13, DOI 10.1016/S0092-8674(01)00293-8; BAKER BS, 1988, GENE DEV, V2, P477, DOI 10.1101/gad.2.4.477; BENNETCL.HC, 1967, NATURE, V215, P669, DOI 10.1038/215669a0; BERNSTEIN AS, 1992, J INSECT BEHAV, V5, P15, DOI 10.1007/BF01049155; Billeter JC, 2006, CURR BIOL, V16, pR766, DOI 10.1016/j.cub.2006.08.025; BURTIS KC, 1989, CELL, V56, P997, DOI 10.1016/0092-8674(89)90633-8; Cachero S, 2010, CURR BIOL, V20, P1589, DOI 10.1016/j.cub.2010.07.045; Chan YB, 2007, P NATL ACAD SCI USA, V104, P19577, DOI 10.1073/pnas.0709803104; Clyne JD, 2008, CELL, V133, P354, DOI 10.1016/j.cell.2008.01.050; Demir E, 2005, CELL, V121, P785, DOI 10.1016/j.cell.2005.04.027; Dickson BJ, 2008, SCIENCE, V322, P904, DOI 10.1126/science.1159276; Ditch LM, 2005, DEVELOPMENT, V132, P155, DOI 10.1242/dev.01568; DOWNES JA, 1969, ANNU REV ENTOMOL, V14, P271, DOI 10.1146/annurev.en.14.010169.001415; Ferveur J F, 1998, J Neurogenet, V12, P205; Gailey DA, 2006, MOL BIOL EVOL, V23, P633, DOI 10.1093/molbev/msj070; Gong WJ, 2003, P NATL ACAD SCI USA, V100, P2556, DOI 10.1073/pnas.0535280100; Greenspan RJ, 2000, ANNU REV GENET, V34, P205, DOI 10.1146/annurev.genet.34.1.205; Hasemeyer M, 2009, NEURON, V61, P511, DOI 10.1016/j.neuron.2009.01.009; HALL JC, 1977, BEHAV GENET, V7, P291, DOI 10.1007/BF01066800; HALL JC, 1979, GENETICS, V92, P437; HALL JC, 1994, SCIENCE, V264, P1702, DOI 10.1126/science.8209251; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; HAUSEN K, 1980, PROC R SOC SER B-BIO, V208, P57, DOI 10.1098/rspb.1980.0042; Kimura K, 2008, NEURON, V59, P759, DOI 10.1016/j.neuron.2008.06.007; Koganezawa M, 2010, CURR BIOL, V20, P1, DOI 10.1016/j.cub.2009.11.038; Kohatsu S, 2011, NEURON, V69, P498, DOI 10.1016/j.neuron.2010.12.017; Kvitsiani D, 2006, CURR BIOL, V16, pR355, DOI 10.1016/j.cub.2006.04.025; Lee G, 2002, J NEUROGENET, V16, P229, DOI 10.1080/01677060216292; Lee G, 2000, J NEUROBIOL, V43, P404, DOI 10.1002/1097-4695(20000615)43:4<404::AID-NEU8>3.0.CO;2-D; Manoli DS, 2006, TRENDS NEUROSCI, V29, P444, DOI 10.1016/j.tins.2006.06.006; Manoli DS, 2005, NATURE, V436, P395, DOI 10.1038/nature03859; Manoli DS, 2004, NATURE, V430, P564, DOI 10.1038/nature02713; Mellert DJ, 2010, DEVELOPMENT, V137, P323, DOI 10.1242/dev.045047; Nilsen SP, 2004, P NATL ACAD SCI USA, V101, P12342, DOI 10.1073/pnas.0404693101; Pulver SR, 2009, J NEUROPHYSIOL, V101, P3075, DOI 10.1152/jn.00071.2009; Rideout EJ, 2007, CURR BIOL, V17, P1473, DOI 10.1016/j.cub.2007.07.047; Rideout EJ, 2010, NAT NEUROSCI, V13, P458, DOI 10.1038/nn.2515; Robinett CC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000365; Ryner LC, 1996, CELL, V87, P1079, DOI 10.1016/S0092-8674(00)81802-4; Sanders LE, 2008, DEV BIOL, V320, P378, DOI 10.1016/j.ydbio.2008.05.543; Santel A, 1997, MECH DEVELOP, V64, P19, DOI 10.1016/S0925-4773(97)00031-2; Shirangi TR, 2006, NAT GENET, V38, P1435, DOI 10.1038/ng1908; SHOREY HH, 1962, SCIENCE, V137, P677, DOI 10.1126/science.137.3531.677; Siwicki KK, 2009, CURR OPIN NEUROBIOL, V19, P200, DOI 10.1016/j.conb.2009.04.001; SPIETH HT, 1974, ANNU REV ENTOMOL, V19, P385, DOI 10.1146/annurev.en.19.010174.002125; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; STRAUSFELD NJ, 1991, J COMP PHYSIOL A, V169, P379, DOI 10.1007/BF00197652; Usui-Aoki K, 2000, NAT CELL BIOL, V2, P500, DOI 10.1038/35019537; Villella A, 1996, GENETICS, V143, P331; Villella A, 2008, ADV GENET, V62, P67, DOI 10.1016/S0065-2660(08)00603-2; von Philipsborn AC, 2011, NEURON, V69, P509, DOI 10.1016/j.neuron.2011.01.011; Vrontou E, 2006, NAT NEUROSCI, V9, P1469, DOI 10.1038/nn1809; Yamamoto D, 2007, ADV GENET, V59, P39, DOI 10.1016/S0065-2660(07)59002-4; Yang CH, 2009, NEURON, V61, P519, DOI 10.1016/j.neuron.2008.12.021; Yapici N, 2008, NATURE, V451, P33, DOI 10.1038/nature06483; Yu JY, 2010, CURR BIOL, V20, P1602, DOI 10.1016/j.cub.2010.08.025; ZEIL J, 1983, J COMP PHYSIOL, V150, P379, DOI 10.1007/BF00605027; ZEIL J, 1983, CELL TISSUE RES, V229, P591	59	61	62	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21144	10.1371/journal.pone.0021144	http://dx.doi.org/10.1371/journal.pone.0021144			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731661	Green Published, Green Submitted, gold			2022-12-27	WOS:000292033700040
J	Vasquez, KO; Casavant, C; Peterson, JD				Vasquez, Kristine O.; Casavant, Chelsea; Peterson, Jeffrey D.			Quantitative Whole Body Biodistribution of Fluorescent-Labeled Agents by Non-Invasive Tomographic Imaging	PLOS ONE			English	Article							VIVO; QUANTIFICATION; ARTHRITIS	When small molecules or proteins are injected into live animals, their physical and chemical properties will significantly affect pharmacokinetics, tissue penetration, and the ultimate routes of metabolism and clearance. Fluorescence molecular tomography (FMT) offers the ability to non-invasively image and quantify temporal changes in fluorescence throughout the major organ systems of living animals, in a manner analogous to traditional approaches with radiolabeled agents. This approach is best used with biotherapeutics (therapeutic antibodies, or other large proteins) or large-scaffold drug-delivery vectors, that are minimally affected by low-level fluorophore conjugation. Application to small molecule drugs should take into account the significant impact of fluorophore labeling on size and physicochemical properties, however, the presents studies show that this technique is readily applied to small molecule agents developed for far-red (FR) or near infrared (NIR) imaging. Quantification by non-invasive FMT correlated well with both fluorescence from tissue homogenates as well as with planar (2D) fluorescence reflectance imaging of excised intact organs (r(2) = 0.996 and 0.969, respectively). Dynamic FMT imaging (multiple times from 0 to 24 h) performed in live mice after the injection of four different FR/NIR-labeled agents, including immunoglobulin, 20-50 nm nanoparticles, a large vascular imaging agent, and a small molecule integrin antagonist, showed clear differences in the percentage of injected dose per gram of tissue (%ID/g) in liver, kidney, and bladder signal. Nanoparticles and IgG1 favored liver over kidney signal, the small molecule integrin-binding agent favored rapid kidney and bladder clearance, and the vascular agent, showed both liver and kidney clearance. Further assessment of the volume of distribution of these agents by fluorescent volume added information regarding their biodistribution and highlighted the relatively poor extravasation into tissue by IgG1. These studies demonstrate the ability of quantitative FMT imaging of FR/NIR agents to non-invasively visualize and quantify the biodistribution of different agents over time.	[Vasquez, Kristine O.; Casavant, Chelsea; Peterson, Jeffrey D.] PerkinElmer Inc, Dept Appl Biol, Boston, MA USA		Vasquez, KO (corresponding author), PerkinElmer Inc, Dept Appl Biol, Boston, MA USA.	jeff.peterson@perkinelmer.com			PerkinElmer	PerkinElmer	Research was supported by internal funding from PerkinElmer, and there are no current external funding sources for this study. Because all authors are employed by the funder, the funder played a role in the decision to perform studies and in approval of the manuscript.	Ackerman ME, 2008, MOL CANCER THER, V7, P2233, DOI 10.1158/1535-7163.MCT-08-0067; Banzato A, 2009, NUCL MED BIOL, V36, P525, DOI 10.1016/j.nucmedbio.2009.02.005; Boss DS, 2008, ONCOLOGIST, V13, P25, DOI 10.1634/theoncologist.2007-0097; Buono C, 2009, J CLIN INVEST, V119, P1373, DOI 10.1172/JCI35548; Grimm J, 2005, P NATL ACAD SCI USA, V102, P14404, DOI 10.1073/pnas.0503920102; Hoyt R., 2007, MOUSE BIOMEDICAL RES, V2nd, P23; Kenanova V, 2005, CANCER RES, V65, P622; Korideck H, 2009, J PHARMACOL EXP THER, V329, P882, DOI 10.1124/jpet.108.147579; Kossodo S, 2010, MOL IMAGING BIOL, V12, P488, DOI 10.1007/s11307-009-0279-z; Kozloff KM, 2007, J BONE MINER RES, V22, P1208, DOI 10.1359/JBMR.070504; Mahmood U, 2003, MOL CANCER THER, V2, P489; Mohajerani P, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3149855; Montet X, 2007, RADIOLOGY, V242, P751, DOI 10.1148/radiol.2423052065; NAHRENDORF M, 2009, ARTERIOSCLER THROMB; Ntziachristos V, 2003, EUR RADIOL, V13, P195, DOI 10.1007/s00330-002-1524-x; Ntziachristos V, 2002, MOL IMAGING, V1, P82, DOI 10.1162/153535002320162732; Peterson JD, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3038; Priyadarshani A, 2010, J OVARIAN RES, V3, DOI 10.1186/1757-2215-3-10; Robe A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-111; Seo Y, 2008, CURR RADIOPHARM, V1, P17, DOI 10.2174/1874471010801010017; Stangenberg L, 2009, ARTHRITIS RHEUM-US, V60, P2314, DOI 10.1002/art.24704; Tabrizi M, 2010, AAPS J, V12, P33, DOI 10.1208/s12248-009-9157-5; Takakura Y, 1996, PHARMACEUT RES, V13, P820, DOI 10.1023/A:1016084508097; Wunder A, 2004, ARTHRITIS RHEUM-US, V50, P2459, DOI 10.1002/art.20379; Yang Z, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/16/165101; Yaseen MA, 2009, MOL PHARMACEUT, V6, P1321, DOI 10.1021/mp800270t; Zhang ZR, 2005, BIOCONJUGATE CHEM, V16, P1232, DOI 10.1021/bc050136s; Zilberman Y, 2008, J ORTHOP RES, V26, P522, DOI 10.1002/jor.20518	28	98	100	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e20594	10.1371/journal.pone.0020594	http://dx.doi.org/10.1371/journal.pone.0020594			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731618	Green Published, Green Submitted, gold			2022-12-27	WOS:000292033700010
J	Sonah, H; Deshmukh, RK; Sharma, A; Singh, VP; Gupta, DK; Gacche, RN; Rana, JC; Singh, NK; Sharma, TR				Sonah, Humira; Deshmukh, Rupesh K.; Sharma, Anshul; Singh, Vinay P.; Gupta, Deepak K.; Gacche, Raju N.; Rana, Jai C.; Singh, Nagendra K.; Sharma, Tilak R.			Genome-Wide Distribution and Organization of Microsatellites in Plants: An Insight into Marker Development in Brachypodium	PLOS ONE			English	Article							ORYZA-SATIVA L.; AGROBACTERIUM-MEDIATED TRANSFORMATION; EST-SSR MARKERS; MISMATCH REPAIR; DRAFT SEQUENCE; MODEL SYSTEM; DISTACHYON; DIVERSITY; MUTATION; DUPLICATIONS	Plant genomes are complex and contain large amounts of repetitive DNA including microsatellites that are distributed across entire genomes. Whole genome sequences of several monocot and dicot plants that are available in the public domain provide an opportunity to study the origin, distribution and evolution of microsatellites, and also facilitate the development of new molecular markers. In the present investigation, a genome-wide analysis of microsatellite distribution in monocots (Brachypodium, sorghum and rice) and dicots (Arabidopsis, Medicago and Populus) was performed. A total of 797,863 simple sequence repeats (SSRs) were identified in the whole genome sequences of six plant species. Characterization of these SSRs revealed that mono-nucleotide repeats were the most abundant repeats, and that the frequency of repeats decreased with increase in motif length both in monocots and dicots. However, the frequency of SSRs was higher in dicots than in monocots both for nuclear and chloroplast genomes. Interestingly, GC-rich repeats were the dominant repeats only in monocots, with the majority of them being present in the coding region. These coding GC-rich repeats were found to be involved in different biological processes, predominantly binding activities. In addition, a set of 22,879 SSR markers that were validated by e-PCR were developed and mapped on different chromosomes in Brachypodium for the first time, with a frequency of 101 SSR markers per Mb. Experimental validation of 55 markers showed successful amplification of 80% SSR markers in 16 Brachypodium accessions. An online database 'BraMi' (Brachypodium microsatellite markers) of these genome-wide SSR markers was developed and made available in the public domain. The observed differential patterns of SSR marker distribution would be useful for studying microsatellite evolution in a monocot-dicot system. SSR markers developed in this study would be helpful for genomic studies in Brachypodium and related grass species, especially for the map based cloning of the candidate gene(s).	[Sonah, Humira; Deshmukh, Rupesh K.; Sharma, Anshul; Singh, Vinay P.; Gupta, Deepak K.; Singh, Nagendra K.; Sharma, Tilak R.] Indian Agr Res Inst, Natl Res Ctr Plant Biotechnol, New Delhi 110012, India; [Rana, Jai C.] Natl Bur Plant Genet Resources, Reg Stn, Shimla, HP, India; [Deshmukh, Rupesh K.; Gacche, Raju N.] Swami Ramanand Teerth Marathwada Univ, Nanded, Maharashtra, India	Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; ICAR - National Institute For Plant Biotechnology (NIPB); Indian Council of Agricultural Research (ICAR); ICAR - National Bureau of Plant Genetics Resources; Swami Ramanand Teerth Marathwada University	Sonah, H (corresponding author), Indian Agr Res Inst, Natl Res Ctr Plant Biotechnol, New Delhi 110012, India.	trsharma@nrcpb.org	Deshmukh, Rupesh Kailasrao/C-6479-2012; Singh, Nouratan/N-9377-2017	Deshmukh, Rupesh Kailasrao/0000-0003-4167-6552; Singh, Nouratan/0000-0002-8063-8375; Sonah, Humira/0000-0003-4796-6120; /0000-0001-9732-7533	ICAR-NPTC [2049-3004]	ICAR-NPTC	ICAR-NPTC has funded this work with grant number 2049-3004, URL www.nrcpb.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves SC, 2009, NAT PROTOC, V4, P638, DOI 10.1038/nprot.2009.30; Anderson TJC, 2000, MOL ECOL, V9, P1599, DOI 10.1046/j.1365-294x.2000.01057.x; Asp T, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-36; Blanc G, 2003, GENOME RES, V13, P137, DOI 10.1101/gr.751803; Chabane K, 2005, GENET RESOUR CROP EV, V52, P903, DOI 10.1007/s10722-003-6112-7; Chakraborty R, 1997, P NATL ACAD SCI USA, V94, P1041, DOI 10.1073/pnas.94.3.1041; Cho YG, 2000, THEOR APPL GENET, V100, P713, DOI 10.1007/s001220051343; Draper J, 2001, PLANT PHYSIOL, V127, P1539, DOI 10.1104/pp.010196; Garvin DF, 2008, CROP SCI, V48, pS69, DOI 10.2135/cropsci2007.06.0332tpg; Garvin DF, 2010, GENOME, V53, P1, DOI [10.1139/G09-079, 10.1139/g09-079]; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Gupta PK, 2003, MOL GENET GENOMICS, V270, P315, DOI 10.1007/s00438-003-0921-4; Hancock J.M., 1997, MICROSATELLITES EVOL, P1; Harr B, 2002, MOL CELL, V10, P199, DOI 10.1016/S1097-2765(02)00575-0; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; LEVINSON G, 1987, MOL BIOL EVOL, V4, P203; Li SX, 2011, MOL BREEDING, V27, P59, DOI 10.1007/s11032-010-9413-5; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; McCouch SR, 2002, DNA RES, V9, P199, DOI 10.1093/dnares/9.6.199; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; Parida SK, 2006, THEOR APPL GENET, V112, P808, DOI 10.1007/s00122-005-0182-1; Parida SK, 2010, GENOME, V53, P55, DOI [10.1139/G09-084, 10.1139/g09-084]; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Powell W, 1996, TRENDS PLANT SCI, V1, P215, DOI 10.1016/1360-1385(96)86898-1; Riley DE, 2007, BIOCHEM BIOPH RES CO, V355, P619, DOI 10.1016/j.bbrc.2007.01.200; Saha MC, 2004, THEOR APPL GENET, V109, P783, DOI 10.1007/s00122-004-1681-1; SCHLOTTERER C, 1992, NUCLEIC ACIDS RES, V20, P211, DOI 10.1093/nar/20.2.211; Schuler GD, 1997, GENOME RES, V7, P541, DOI 10.1101/gr.7.5.541; Singh H, 2010, MOL BREEDING, V25, P359, DOI 10.1007/s11032-009-9328-1; Sonah H, 2011, BIOTECHNOL ADV, V29, P199, DOI 10.1016/j.biotechadv.2010.11.002; Temnykh S, 2001, GENOME RES, V11, P1441, DOI 10.1101/gr.184001; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Vision TJ, 2000, SCIENCE, V290, P2114, DOI 10.1126/science.290.5499.2114; Vogel J, 2008, PLANT CELL REP, V27, P471, DOI 10.1007/s00299-007-0472-y; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Vogel JP, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-88; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; Whittaker JC, 2003, GENETICS, V164, P781; WOLFE KH, 1989, P NATL ACAD SCI USA, V86, P6201, DOI 10.1073/pnas.86.16.6201; Xu X, 2000, NAT GENET, V24, P396, DOI 10.1038/74238; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037	41	157	171	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2011	6	6							e21298	10.1371/journal.pone.0021298	http://dx.doi.org/10.1371/journal.pone.0021298			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782CL	21713003	Green Submitted, Green Published, gold			2022-12-27	WOS:000291985100028
J	Vasan, SK; Neville, MJ; Antonisamy, B; Samuel, P; Fall, CH; Geethanjali, FS; Thomas, N; Raghupathy, P; Brismar, K; Karpe, F				Vasan, Senthil K.; Neville, Matt J.; Antonisamy, Belavendra; Samuel, Prasanna; Fall, Caroline H.; Geethanjali, Finney S.; Thomas, Nihal; Raghupathy, Palany; Brismar, Kerstin; Karpe, Fredrik			Absence of Birth-Weight Lowering Effect of ADCY5 and Near CCNL, but Association of Impaired Glucose-Insulin Homeostasis with ADCY5 in Asian Indians	PLOS ONE			English	Article							TYPE-2 DIABETES RISK; FASTING GLUCOSE; FETAL-GROWTH; GENE; POPULATION; MUTATIONS; COHORT; POLYMORPHISM; VARIANTS; ALLELES	Background: A feature of the Asian Indian phenotype is low birth weight with increased adult type 2 diabetes risk. Most populations show consistent associations between low birth weight and adult type 2 diabetes. Recently, two birth weight-lowering loci on chromosome 3 (near CCNL1 and ADCY5) were identified in a genome-wide association study, the latter of which is also a type 2 diabetes locus. We therefore tested the impact of these genetic variants on birth weight and adult glucose/insulin homeostasis in a large Indian birth cohort. Methodology/Principal Findings: Adults (n = 2,151) enrolled in a birth cohort (established 1969-73) were genotyped for rs900400 (near CCNL1) and rs9883204 (ADCY5). Associations were tested for birth weight, anthropometry from infancy to adulthood, and type 2 diabetes related glycemic traits. The average birth weight in this population was 2.79 +/- 0.47 kg and was not associated with genetic variation in CCNL1 (p = 0.87) or ADCY5 (p = 0.54). Allele frequencies for the 'birth weight-lowering' variants were similar compared with Western populations. There were no significant associations with growth or adult weight. However, the 'birth weight-lowering' variant of ADCY5 was associated with modest increase in fasting glucose (beta 0.041, p = 0.027), 2-hours glucose (beta 0.127, p = 0.019), and reduced insulinogenic index (beta -0.106, p = 0.050) and 2-hour insulin (beta -0.058, p = 0.010). Conclusions: The low birth weight in Asian Indians is not even partly explained by genetic variants near CCNL1 and ADCY5 which implies that non-genetic factors may predominate. However, the 'birth-weight-lowering' variant of ADCY5 was associated with elevated glucose and decreased insulin response in early adulthood which argues for a common genetic cause of low birth weight and risk of type 2 diabetes.	[Vasan, Senthil K.; Brismar, Kerstin] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Vasan, Senthil K.; Thomas, Nihal; Karpe, Fredrik] Christian Med Coll & Hosp, Dept Diabet Endocrinol & Metab, Vellore, Tamil Nadu, India; [Neville, Matt J.; Karpe, Fredrik] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [Antonisamy, Belavendra; Samuel, Prasanna] Christian Med Coll & Hosp, Dept Biostat, Vellore, Tamil Nadu, India; [Fall, Caroline H.] MRC, Epidemiol Resource Ctr, Southampton, Hants, England; [Geethanjali, Finney S.] Christian Med Coll & Hosp, Dept Clin Biochem, Vellore, Tamil Nadu, India; [Raghupathy, Palany] Christian Med Coll & Hosp, Dept Child Hlth, Vellore, Tamil Nadu, India; [Karpe, Fredrik] Oxford Radcliffe Hosp ORH Trust, Oxford Biomed Res Ctr, NIHR, Oxford, England	Karolinska Institutet; Christian Medical College & Hospital (CMCH) Vellore; University of Oxford; Christian Medical College & Hospital (CMCH) Vellore; Christian Medical College & Hospital (CMCH) Vellore; Christian Medical College & Hospital (CMCH) Vellore; University of Oxford	Vasan, SK (corresponding author), Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden.	vaskan@ki.se; Fredrik.Karpe@ocdem.ox.ac.uk		Vasan, Senthil/0000-0002-3630-6568; Brismar, Kerstin/0000-0002-5241-514X; Fall, Caroline/0000-0003-4402-5552; Karpe, Fredrik/0000-0002-2751-1770	British Heart Foundation; Swedish Institutet, Stockholm, Sweden; Family Erling-Persson Foundation; Medical Research Council [G0400519, MC_UP_A620_1016, MR/J000094/1] Funding Source: researchfish; MRC [G0400519, MC_UP_A620_1016, MR/J000094/1] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Swedish Institutet, Stockholm, Sweden; Family Erling-Persson Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was supported by the British Heart Foundation. S.V. is on a scholarship from the Swedish Institutet, Stockholm, Sweden and also supported by Family Erling-Persson Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson EA, 2010, DIABETOLOGIA, V53, P1908, DOI 10.1007/s00125-010-1790-0; Antonisamy B, 2009, INT J EPIDEMIOL, V38, P663, DOI 10.1093/ije/dyn159; Babenko AP, 2006, NEW ENGL J MED, V355, P456, DOI 10.1056/NEJMoa055068; Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; Chauhan G, 2010, DIABETES, V59, P2068, DOI 10.2337/db09-1386; DHAWAN S, 1995, BRIT MED J, V311, P86, DOI 10.1136/bmj.311.6997.86; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; DURNIN JVGA, 1974, BRIT J NUTR, V32, P77, DOI 10.1079/BJN19740060; Edghill EL, 2006, DIABETIC MED, V23, P1301, DOI 10.1111/j.1464-5491.2006.01999.x; Freathy RM, 2007, AM J HUM GENET, V80, P1150, DOI 10.1086/518517; Freathy RM, 2010, NAT GENET, V42, P430, DOI 10.1038/ng.567; Freathy RM, 2009, DIABETES, V58, P1428, DOI 10.2337/db08-1739; Harding S, 2004, INT J EPIDEMIOL, V33, P1279, DOI 10.1093/ije/dyh186; Hattersley AT, 1999, LANCET, V353, P1789, DOI 10.1016/S0140-6736(98)07546-1; Kinare AS, 2010, J ULTRAS MED, V29, P215, DOI 10.7863/jum.2010.29.2.215; Kuriyan R, 1998, INDIAN J MED RES, V107, P37; Leary S, 2006, ACTA OBSTET GYN SCAN, V85, P1080, DOI 10.1080/00016340600697447; Lindsay RS, 2003, DIABETES, V52, P187, DOI 10.2337/diabetes.52.1.187; Raghupathy P, 2010, DIABETES RES CLIN PR, V87, P283, DOI 10.1016/j.diabres.2009.11.015; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; SACHDEV HPS, 1997, MALNUTRITION S ASIA, P23; Stoy J, 2007, P NATL ACAD SCI USA, V104, P15040, DOI 10.1073/pnas.0707291104; Vaessen N, 2002, LANCET, V359, P1036, DOI 10.1016/S0140-6736(02)08067-4; Weedon MN, 2005, DIABETES, V54, P576, DOI 10.2337/diabetes.54.2.576; Whincup PH, 2008, JAMA-J AM MED ASSOC, V300, P2886, DOI 10.1001/jama.2008.886	25	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2011	6	6							e21331	10.1371/journal.pone.0021331	http://dx.doi.org/10.1371/journal.pone.0021331			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782CL	21712988	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000291985100031
J	Zhang, W; Liu, GJ; Tang, F; Shao, J; Lu, Y; Bao, YL; Yao, HC; Lu, CP				Zhang, Wei; Liu, Guangjin; Tang, Fang; Shao, Jing; Lu, Yan; Bao, Yinli; Yao, Huochun; Lu, Chengping			Pre-Absorbed Immunoproteomics: A Novel Method for the Detection of Streptococcus suis Surface Proteins	PLOS ONE			English	Article							GRAM-POSITIVE BACTERIA; SUBCELLULAR-LOCALIZATION; PROTEOME ANALYSIS; NORTH-AMERICA; IN-VIVO; IDENTIFICATION; SEROTYPE-2; VIRULENCE; TYPE-2; MUTANOLYSIN	Streptococcus suis serotype 2 (SS2) is a zoonotic pathogen that can cause infections in pigs and humans. Bacterial surface proteins are often investigated as potential vaccine candidates and biomarkers of virulence. In this study, a novel method for identifying bacterial surface proteins is presented, which combines immunoproteomic and immunoserologic techniques. Critical to the success of this new method is an improved procedure for generating two-dimensional electrophoresis gel profiles of S. suis proteins. The S. suis surface proteins identified in this study include muramidase-released protein precursor (MRP) and an ABC transporter protein, while MRP is thought to be one of the main virulence factors in SS2 located on the bacterial surface. Herein, we demonstrate that the ABC transporter protein can bind to HEp-2 cells, which strongly suggests that this protein is located on the bacterial cell surface and may be involved in pathogenesis. An immunofluorescence assay confirmed that the ABC transporter is localized to the bacterial outer surface. This new method may prove to be a useful tool for identifying surface proteins, and aid in the development of new vaccine subunits and disease diagnostics.	[Zhang, Wei; Liu, Guangjin; Tang, Fang; Shao, Jing; Lu, Yan; Bao, Yinli; Yao, Huochun; Lu, Chengping] Nanjing Agr Univ, Key Lab Anim Dis Diagnost & Immunol, Minist Agr, Nanjing, Peoples R China	Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University	Lu, CP (corresponding author), Nanjing Agr Univ, Key Lab Anim Dis Diagnost & Immunol, Minist Agr, Nanjing, Peoples R China.	lucp@njau.edu.cn	Lu, Yan/AAX-7831-2020	Lu, Yan/0000-0002-5893-6114	Youth Foundation of National Natural Science Foundation of China [30800815]; Foundation of National Natural Science Foundation of China [30671558]; Cloning and Identification of the resistance genes of swine against major pathogenic microorganism [2009ZX08009-1546]; Chinese Ministry of Agriculture [200803016, 200903055]	Youth Foundation of National Natural Science Foundation of China; Foundation of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Cloning and Identification of the resistance genes of swine against major pathogenic microorganism; Chinese Ministry of Agriculture(Ministry of Agriculture & Rural Affairs)	This work was supported by the Youth Foundation of National Natural Science Foundation of China (No. 30800815), the Foundation of National Natural Science Foundation of China (No. 30671558), Cloning and Identification of the resistance genes of swine against major pathogenic microorganism (2009ZX08009-1546), the Special Fund for Public Welfare Industry of Chinese Ministry of Agriculture (200803016) and the Special Fund for Public Welfare Industry of Chinese Ministry of Agriculture (200903055). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARENDS JP, 1988, REV INFECT DIS, V10, P131; Bonafonte MA, 2000, FEMS MICROBIOL LETT, V191, P31, DOI 10.1016/S0378-1097(00)00366-9; Cahill DJ, 2001, J IMMUNOL METHODS, V250, P81, DOI 10.1016/S0022-1759(01)00325-8; Gardy JL, 2005, BIOINFORMATICS, V21, P617, DOI 10.1093/bioinformatics/bti057; Garmory HS, 2004, INFECT IMMUN, V72, P6757, DOI 10.1128/IAI.72.12.6757-6763.2004; Gottschalk M, 2000, VET MICROBIOL, V76, P259, DOI 10.1016/S0378-1135(00)00250-9; Gottschalk Marcelo, 2007, Animal Health Research Reviews, V8, P29, DOI 10.1017/S1466252307001247; Gu HW, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-201; Hamel J, 1997, MICROB PATHOGENESIS, V23, P11, DOI 10.1006/mpat.1996.0124; Hempel K, 2010, J PROTEOME RES, V9, P1579, DOI 10.1021/pr901143a; Jing HB, 2008, PROTEOMICS, V8, P333, DOI 10.1002/pmic.200600930; KAMPFER P, 1995, J MICROBIOL METH, V21, P55, DOI 10.1016/0167-7012(94)00033-4; Kim SW, 2007, MOL CELLS, V23, P239; KTIMPFER P, 1995, J MICROBIOLOGICAL ME, V21, P55; LINDENMAYER J, 1990, J CLIN MICROBIOL, V28, P92, DOI 10.1128/JCM.28.1.92-96.1990; MITTAL KR, 1982, J CLIN MICROBIOL, V15, P1019, DOI 10.1128/JCM.15.6.1019-1023.1982; Rodriguez-Ortega MJ, 2006, NAT BIOTECHNOL, V24, P191, DOI 10.1038/nbt1179; Shen HB, 2009, PROTEIN PEPTIDE LETT, V16, P1478, DOI 10.2174/092986609789839322; SIEGEL JL, 1981, INFECT IMMUN, V31, P808, DOI 10.1128/IAI.31.2.808-815.1981; Simpson RJ, 2003, PROTEINS PROTEOMICS; SMITH HE, 1992, INFECT IMMUN, V60, P2361, DOI 10.1128/IAI.60.6.2361-2367.1992; SPATAFORA G, 1995, INFECT IMMUN, V63, P2556, DOI 10.1128/IAI.63.7.2556-2563.1995; SUTCLIFFE IC, 1995, J BACTERIOL, V177, P1123, DOI 10.1128/jb.177.5.1123-1128.1995; Tjalsma H, 2008, PROTEOMICS, V8, P1415, DOI 10.1002/pmic.200700550; TROTTIER S, 1991, REV INFECT DIS, V13, P1251; VECHT U, 1989, AM J VET RES, V50, P1037; Vecht U, 1997, VET MICROBIOL, V58, P53, DOI 10.1016/S0378-1135(97)00131-4; Winterhoff N, 2002, J BACTERIOL, V184, P6768, DOI 10.1128/JB.184.24.6768-6776.2002; Wolters DA, 2001, ANAL CHEM, V73, P5683, DOI 10.1021/ac010617e; Wu ZF, 2008, FEMS IMMUNOL MED MIC, V53, P52, DOI 10.1111/j.1574-695X.2008.00401.x; Yao HuoChun, 1999, Journal of Nanjing Agricultural University, V22, P67; YOKOGAWA K, 1974, ANTIMICROB AGENTS CH, V6, P156, DOI 10.1128/AAC.6.2.156; Zhang AD, 2008, PROTEOMICS, V8, P3506, DOI 10.1002/pmic.200800007; Zhang AD, 2009, VACCINE, V27, P1348, DOI 10.1016/j.vaccine.2008.12.047; Zhang W, 2007, PROTEOMICS, V7, P4468, DOI 10.1002/pmic.200700294; Zhou M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-173; Zhu HN, 2002, RAPID COMMUN MASS SP, V16, P2115, DOI 10.1002/rcm.831	37	20	20	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2011	6	6							e21234	10.1371/journal.pone.0021234	http://dx.doi.org/10.1371/journal.pone.0021234			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782CL	21713002	Green Submitted, gold, Green Published			2022-12-27	WOS:000291985100019
J	Stahl, PL; Bjursell, MK; Mahdessian, H; Hober, S; Jirstrom, K; Lundeberg, J				Stahl, Patrik L.; Bjursell, Magnus K.; Mahdessian, Hovsep; Hober, Sophia; Jirstrom, Karin; Lundeberg, Joakim			Translational Database Selection and Multiplexed Sequence Capture for Up Front Filtering of Reliable Breast Cancer Biomarker Candidates	PLOS ONE			English	Article							GENE-EXPRESSION PROFILES; IDENTIFICATION; AMPLIFICATION; TECHNOLOGIES; MARKERS; GENOME	Biomarker identification is of utmost importance for the development of novel diagnostics and therapeutics. Here we make use of a translational database selection strategy, utilizing data from the Human Protein Atlas (HPA) on differentially expressed protein patterns in healthy and breast cancer tissues as a means to filter out potential biomarkers for underlying genetic causatives of the disease. DNA was isolated from ten breast cancer biopsies, and the protein coding and flanking non-coding genomic regions corresponding to the selected proteins were extracted in a multiplexed format from the samples using a single DNA sequence capture array. Deep sequencing revealed an even enrichment of the multiplexed samples and a great variation of genetic alterations in the tumors of the sampled individuals. Benefiting from the upstream filtering method, the final set of biomarker candidates could be completely verified through bidirectional Sanger sequencing, revealing a 40 percent false positive rate despite high read coverage. Of the variants encountered in translated regions, nine novel non-synonymous variations were identified and verified, two of which were present in more than one of the ten tumor samples.	[Stahl, Patrik L.; Mahdessian, Hovsep; Lundeberg, Joakim] Royal Inst Technol, Div Gene Technol, Sci Life Lab, Solna, Sweden; [Bjursell, Magnus K.] Karolinska Inst, Sci Life Lab, Dept Mol Med & Surg, Solna, Sweden; [Hober, Sophia] Royal Inst Technol, Div Prote, Sch Biotechnol, AlbaNova Univ Ctr, Stockholm, Sweden; [Jirstrom, Karin] Lund Univ, Div Pathol, Dept Clin Sci, Skane Univ Hosp, Lund, Sweden	Royal Institute of Technology; Karolinska Institutet; Royal Institute of Technology; Lund University; Skane University Hospital	Stahl, PL (corresponding author), Royal Inst Technol, Div Gene Technol, Sci Life Lab, Solna, Sweden.	patrik.stahl@scilifelab.se			Knut and Alice Wallenberg Foundation; Swedish Cancer Foundation; Swedish Scientific Council	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Cancer Foundation; Swedish Scientific Council	This work was supported by the Knut and Alice Wallenberg Foundation (www.wallenberg.com/kaw), the Swedish Cancer Foundation (www.cancerfonden.se) and the Swedish Scientific Council (www.vr.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert TJ, 2007, NAT METHODS, V4, P903, DOI 10.1038/NMETH1111; [Anonymous], HUMAN PROTEIN ATLAS; Bentley DR, 2006, CURR OPIN GENET DEV, V16, P545, DOI 10.1016/j.gde.2006.10.009; Binladen J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000197; Cirulli ET, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r57; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Han HJ, 2008, NATURE, V452, P187, DOI 10.1038/nature06781; Ilyin SE, 2004, TRENDS BIOTECHNOL, V22, P411, DOI 10.1016/j.tibtech.2004.06.005; Klevebring D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-684; Lundberg E, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.106; Lundin S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010029; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Margulies M, 2005, NATURE; Nathanson KN, 2001, NAT MED, V7, P552, DOI 10.1038/87876; Nishizuka S, 2003, CANCER RES, V63, P5243; PLEASANCE ED, 2009, NATURE; Porreca GJ, 2007, NAT METHODS, V4, P931, DOI 10.1038/NMETH1110; Shendure J, 2004, NAT REV GENET, V5, P335, DOI 10.1038/nrg1325; Shendure J, 2008, NAT METHODS, V5, P585, DOI 10.1038/nmeth0708-585; Staal FJT, 2003, LEUKEMIA, V17, P1324, DOI 10.1038/sj.leu.2402974; STAHL PL, 2010, J INVESTIGATIVE DERM; Uhlen M, 2005, MOL CELL PROTEOMICS, V4, P1920, DOI 10.1074/mcp.M500279-MCP200; Welsh JB, 2001, P NATL ACAD SCI USA, V98, P1176, DOI 10.1073/pnas.98.3.1176; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Xin W, 2003, AM J PATHOL, V162, P255, DOI 10.1016/S0002-9440(10)63816-3	26	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e20794	10.1371/journal.pone.0020794	http://dx.doi.org/10.1371/journal.pone.0020794			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698250	Green Published, gold, Green Submitted			2022-12-27	WOS:000291730000024
J	Strand, MF; Wilson, SR; Dembinski, JL; Holsworth, DD; Khvat, A; Okun, I; Petersen, D; Krauss, S				Strand, Martin F.; Wilson, Steven R.; Dembinski, Jennifer L.; Holsworth, Daniel D.; Khvat, Alexander; Okun, Ilya; Petersen, Dirk; Krauss, Stefan			A Novel Synthetic Smoothened Antagonist Transiently Inhibits Pancreatic Adenocarcinoma Xenografts in a Mouse Model	PLOS ONE			English	Article							HEDGEHOG SIGNALING PATHWAY; GLI-MEDIATED TRANSCRIPTION; TUMOR-SUPPRESSOR SUFU; BASAL-CELL CARCINOMAS; SONIC HEDGEHOG; PRIMARY CILIA; CANCER-CELLS; TUMORIGENESIS; CYCLOPAMINE; MECHANISMS	Background: Hedgehog (Hh) signaling is over-activated in several solid tumors where it plays a central role in cell growth, stroma recruitment and tumor progression. In the Hh signaling pathway, the Smoothened (SMO) receptor comprises a primary drug target with experimental small molecule SMO antagonists currently being evaluated in clinical trials. Principal Findings: Using Shh-Light II (Shh-L2) and alkaline phosphatase (AP) based screening formats on a "focused diversity" library we identified a novel small molecule inhibitor of the Hh pathway, MS-0022 (2-bromo-N-(4-(8-methylimidazo[1,2-a]pyridin-2-yl)phenyl)benzamide). MS-0022 showed effective Hh signaling pathway inhibition at the level of SMO in the low nM range, and Hh pathway inhibition downstream of Suppressor of fused (SUFU) in the low mu M range. MS-0022 reduced growth in the tumor cell lines PANC-1, SUIT-2, PC-3 and FEMX in vitro. MS-0022 treatment led to a transient delay of tumor growth that correlated with a reduction of stromal Gli1 levels in SUIT-2 xenografts in vivo. Significance: We document the in vitro and in vivo efficacy and bioavailability of a novel small molecule SMO antagonist, MS-0022. Although MS-0022 primarily interferes with Hh signaling at the level of SMO, it also has a downstream inhibitory effect and leads to a stronger reduction of growth in several tumor cell lines when compared to related SMO antagonists.	[Strand, Martin F.; Dembinski, Jennifer L.; Krauss, Stefan] Univ Oslo, Rikshosp, Oslo Univ Hosp, Inst Microbiol,Unit Cell Signalling, N-0027 Oslo, Norway; [Holsworth, Daniel D.; Khvat, Alexander; Okun, Ilya] ChemDiv Inc, San Diego, CA USA; [Wilson, Steven R.; Petersen, Dirk] Univ Oslo, Dept Chem, N-0027 Oslo, Norway	University of Oslo; National Hospital Norway; University of Oslo	Strand, MF (corresponding author), Univ Oslo, Rikshosp, Oslo Univ Hosp, Inst Microbiol,Unit Cell Signalling, N-0027 Oslo, Norway.	martin.frank.strand@rr-research.no; stefan.krauss@rr-research.no	Okun, Ilya/F-9889-2014; Strand, Martin/AAQ-3908-2021; wilson, steven/D-6614-2012	Okun, Ilya/0000-0002-8562-4044; Strand, Martin/0000-0002-2588-5488; wilson, steven/0000-0002-9755-1188; Dembinski, Jennifer/0000-0001-9259-9572; Krauss, Stefan/0000-0001-6992-8091	Research Council of Norway; ChemDiv Inc.	Research Council of Norway(Research Council of Norway); ChemDiv Inc.	This study was funded by the Research Council of Norway (http://www.forskningsradet.no/), and by ChemDiv Inc. (http://www.chemdiv.com/). The Research Council of Norway had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. As indicated under the competing interests section, Drs. Alex Khvat, Ilya Okun and Dan Holsworth are employed by ChemDiv Inc., and ChemDiv Inc. had a partial role in the study design, execution of the experiments, data analysis, and decision to publish and in reviewing the manuscript. The MS-0022 chemotype has been patented by ChemDiv Inc. (PCT/IB2008/055258; WO 2009/077956 A2 and WO 2009/077956 A3).	Alieva I B, 1999, Membr Cell Biol, V12, P895; Altaba ARI, 2008, CANCER CELL, V14, P281, DOI 10.1016/j.ccr.2008.09.007; Bailey JM, 2009, ONCOGENE, V28, P3513, DOI 10.1038/onc.2009.220; Bailey JM, 2008, CLIN CANCER RES, V14, P5995, DOI 10.1158/1078-0432.CCR-08-0291; Bailey JM, 2007, J CELL BIOCHEM, V102, P829, DOI 10.1002/jcb.21509; Barakat MT, 2009, CANCER CELL, V16, P276, DOI 10.1016/j.ccr.2009.09.019; Beachy PA, 2004, NATURE, V432, P324, DOI 10.1038/nature03100; Berman DM, 2003, NATURE, V425, P846, DOI 10.1038/nature01972; Birnbaum DJ, 2011, GENE CHROMOSOME CANC, V50, P456, DOI 10.1002/gcc.20870; Borzillo GV, 2005, CURR TOP MED CHEM, V5, P147, DOI 10.2174/1568026053507732; Butz J, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-11; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Cheng SY, 2008, ADV CANCER RES, V101, P29, DOI 10.1016/S0065-230X(08)00402-8; Cheng SY, 2002, P NATL ACAD SCI USA, V99, P5442, DOI 10.1073/pnas.082096999; Cooper MK, 1998, SCIENCE, V280, P1603, DOI 10.1126/science.280.5369.1603; Dembinski J. L., 2009, CLIN EXP METASTASIS; Dierks C, 2010, RECENT RESULTS CANC, V184, P235, DOI 10.1007/978-3-642-01222-8_17; Dijkgraaf GJP, 2011, CANCER RES, V71, P435, DOI 10.1158/0008-5472.CAN-10-2876; Dwyer JR, 2007, J BIOL CHEM, V282, P8959, DOI 10.1074/jbc.M611741200; Epstein EH, 2008, NAT REV CANCER, V8, P743, DOI 10.1038/nrc2503; FIETZ MJ, 1994, DEVELOPMENT, P43; Frank-Kamenetsky Maria, 2002, J Biol, V1, P10, DOI 10.1186/1475-4924-1-10; Han YG, 2008, NAT NEUROSCI, V11, P277, DOI 10.1038/nn2059; Hidaka H, 2005, J EXP CLIN CANC RES, V24, P127; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Hruban RH, 2006, CANCER RES, V66, P95, DOI 10.1158/0008-5472.CAN-05-2168; Hyman JM, 2009, P NATL ACAD SCI USA, V106, P14132, DOI 10.1073/pnas.0907134106; Incardona JP, 1998, DEVELOPMENT, V125, P3553; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Kainuma O, 1997, PANCREAS, V15, P379, DOI 10.1097/00006676-199711000-00008; Katoh Y, 2009, INT J ONCOL, V35, P187, DOI 10.3892/ijo_00000328; Kean S, 2009, SCIENCE, V325, P1188, DOI 10.1126/science.325_1188; Kiselyov AS, 2006, CHEM BIOL DRUG DES, V68, P67, DOI 10.1111/j.1747-0285.2006.00409.x; KRAUSS S, 1993, CELL, V75, P1431, DOI 10.1016/0092-8674(93)90628-4; Lauth M, 2007, CELL CYCLE, V6, P2458, DOI 10.4161/cc.6.20.4808; Lauth M, 2007, P NATL ACAD SCI USA, V104, P8455, DOI 10.1073/pnas.0609699104; Low JA, 2010, J CLIN ONCOL, V28, P5321, DOI 10.1200/JCO.2010.27.9943; NEESSE A, 2010, GUT             1021, DOI DOI 10.1136/GUT.2010.226092; Nolan-Stevaux O, 2009, GENE DEV, V23, P24, DOI 10.1101/gad.1753809; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Robarge KD, 2009, BIOORG MED CHEM LETT, V19, P5576, DOI 10.1016/j.bmcl.2009.08.049; Rohatgi R, 2007, NAT CELL BIOL, V9, P1005, DOI 10.1038/ncb435; Rubin LL, 2006, NAT REV DRUG DISCOV, V5, P1026, DOI 10.1038/nrd2086; Rudin CM, 2009, NEW ENGL J MED, V361, P1173, DOI 10.1056/NEJMoa0902903; Ruiz i Altaba A, 2007, TRENDS CELL BIOL, V17, P438, DOI 10.1016/j.tcb.2007.06.007; Sasaki H, 1997, DEVELOPMENT, V124, P1313; Sato N, 1998, FEBS LETT, V441, P318, DOI 10.1016/S0014-5793(98)01571-3; Scales SJ, 2009, TRENDS PHARMACOL SCI, V30, P303, DOI 10.1016/j.tips.2009.03.007; Seeley ES, 2010, J CELL SCI, V123, P511, DOI 10.1242/jcs.061093; So PL, 2010, EXPERT OPIN INV DRUG, V19, P1099, DOI 10.1517/13543784.2010.504714; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Taipale J, 2002, NATURE, V418, P892, DOI 10.1038/nature00989; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Theunissen JW, 2009, CANCER RES, V69, P6007, DOI 10.1158/0008-5472.CAN-09-0756; Tian H, 2009, P NATL ACAD SCI USA, V106, P4254, DOI 10.1073/pnas.0813203106; Toftgard R, 2009, NAT MED, V15, P994, DOI 10.1038/nm0909-994; Tremblay MR, 2009, J MED CHEM, V52, P4400, DOI 10.1021/jm900305z; Unden AB, 1996, CANCER RES, V56, P4562; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Von Hoff DD, 2009, NEW ENGL J MED, V361, P1164, DOI 10.1056/NEJMoa0905360; Walter K, 2010, CLIN CANCER RES, V16, P1781, DOI 10.1158/1078-0432.CCR-09-1913; Wilson CW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005182; Wilson SR, 2005, J SEP SCI, V28, P1751, DOI 10.1002/jssc.200500062; Wong SY, 2009, NAT MED, V15, P1055, DOI 10.1038/nm.2011; YAUCH RL, 2009, SCIENCE; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275; Yue S, 2009, ONCOGENE, V28, P492, DOI 10.1038/onc.2008.403; Zhao Y, 2007, NATURE, V450, P252, DOI 10.1038/nature06225	69	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e19904	10.1371/journal.pone.0019904	http://dx.doi.org/10.1371/journal.pone.0019904			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698280	Green Published, Green Submitted, gold			2022-12-27	WOS:000291730000004
J	Ginet, N; Pardoux, R; Adryanczyk, G; Garcia, D; Brutesco, C; Pignol, D				Ginet, Nicolas; Pardoux, Romain; Adryanczyk, Geraldine; Garcia, Daniel; Brutesco, Catherine; Pignol, David			Single-Step Production of a Recyclable Nanobiocatalyst for Organophosphate Pesticides Biodegradation Using Functionalized Bacterial Magnetosomes	PLOS ONE			English	Article							MAGNETOTACTIC BACTERIA; MAGNETIC PARTICLES; PROTEIN; GENE; NANOPARTICLES; SEPARATION	Enzymes are versatile catalysts in laboratories and on an industrial scale; improving their immobilization would be beneficial to broadening their applicability and ensuring their (re)use. Lipid-coated nano-magnets produced by magnetotactic bacteria are suitable for a universally applicable single-step method of enzyme immobilization. By genetically functionalizing the membrane surrounding these magnetite particles with a phosphohydrolase, we engineered an easy-to-purify, robust and recyclable biocatalyst to degrade ethyl-paraoxon, a commonly used pesticide. For this, we genetically fused the opd gene from Flavobacterium sp. ATCC 27551 encoding a paraoxonase to mamC, an abundant protein of the magnetosome membrane in Magnetospirillum magneticum AMB-1. The MamC protein acts as an anchor for the paraoxonase to the magnetosome surface, thus producing magnetic nanoparticles displaying phosphohydrolase activity. Magnetosomes functionalized with Opd were easily recovered from genetically modified AMB-1 cells: after cellular disruption with a French press, the magnetic nanoparticles are purified using a commercially available magnetic separation system. The catalytic properties of the immobilized Opd were measured on ethyl-paraoxon hydrolysis: they are comparable with the purified enzyme, with K(m) (and k(cat)) values of 58 mu M (and 178 s(-1)) and 43 mu M (and 314 s(-1)) for the immobilized and purified enzyme respectively. The Opd, a metalloenzyme requiring a zinc cofactor, is thus properly matured in AMB-1. The recycling of the functionalized magnetosomes was investigated and their catalytic activity proved to be stable over repeated use for pesticide degradation. In this study, we demonstrate the easy production of functionalized magnetic nanoparticles with suitably genetically modified magnetotactic bacteria that are efficient as a reusable nanobiocatalyst for pesticides bioremediation in contaminated effluents.	[Ginet, Nicolas; Adryanczyk, Geraldine; Garcia, Daniel; Brutesco, Catherine; Pignol, David] CEA, DSV, IBEB, Lab Bioenerget Cellulaire, St Paul Les Durance, France; [Pardoux, Romain] CEA, DSV, IBEB, Lab Interact Prot Met, St Paul Les Durance, France; [Ginet, Nicolas; Pardoux, Romain; Adryanczyk, Geraldine; Garcia, Daniel; Brutesco, Catherine; Pignol, David] CNRS, UMR Biol Vegetale & Microbiol Environm 6191, St Paul Les Durance, France; [Ginet, Nicolas; Pardoux, Romain; Adryanczyk, Geraldine; Garcia, Daniel; Brutesco, Catherine; Pignol, David] Aix Marseille Univ, St Paul Les Durance, France	CEA; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Ginet, N (corresponding author), CEA, DSV, IBEB, Lab Bioenerget Cellulaire, St Paul Les Durance, France.	nicolas.ginet@cea.fr	Ginet, Nicolas/AEB-2370-2022	Ginet, Nicolas/0000-0002-5544-4376; PIGNOL, David/0000-0002-8070-0319	Centre National de la Recherche Scientifique (CNRS); Commissariat a l'Energie Atomique (CEA)	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Commissariat a l'Energie Atomique (CEA)(French Atomic Energy Commission)	This work was supported by Centre National de la Recherche Scientifique (CNRS) and Commissariat a l'Energie Atomique (CEA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bazylinski DA, 2004, NAT REV MICROBIOL, V2, P217, DOI 10.1038/nrmicro842; Bellini S, 2009, CHIN J OCEANOL LIMN, V27, P3, DOI 10.1007/s00343-009-0003-5; Bellini S, 2009, CHIN J OCEANOL LIMN, V27, P6, DOI 10.1007/s00343-009-0006-2; BLAKEMORE R, 1975, SCIENCE, V190, P377, DOI 10.1126/science.170679; Elnashar M.M.M., 2010, J BIOMATER NANOBIOTE, V01, P61, DOI [10.4236/jbnb.2010.11008, DOI 10.4236/JBNB.2010.11008]; Jogler C, 2009, ENVIRON MICROBIOL, V11, P1267, DOI 10.1111/j.1462-2920.2009.01854.x; Kim JB, 2008, TRENDS BIOTECHNOL, V26, P639, DOI 10.1016/j.tibtech.2008.07.009; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Lang C, 2008, APPL ENVIRON MICROB, V74, P4944, DOI 10.1128/AEM.00231-08; Lang C, 2007, MACROMOL BIOSCI, V7, P144, DOI 10.1002/mabi.200600235; Lefevre CT, 2009, APPL ENVIRON MICROB, V75, P3835, DOI 10.1128/AEM.00165-09; Matsunaga T, 2005, DNA RES, V12, P157, DOI 10.1093/dnares/dsi002; MULBRY WW, 1989, J BACTERIOL, V171, P6740, DOI 10.1128/jb.171.12.6740-6746.1989; Murat D, 2010, P NATL ACAD SCI USA, V107, P5593, DOI 10.1073/pnas.0914439107; Petros RA, 2010, NAT REV DRUG DISCOV, V9, P615, DOI 10.1038/nrd2591; Takahashi M, 2009, BIOTECHNOL PROGR, V25, P219, DOI 10.1002/btpr.101; Van Dyk JS, 2011, CHEMOSPHERE, V82, P291, DOI 10.1016/j.chemosphere.2010.10.033; Yoshino T, 2008, BIOTECHNOL BIOENG, V101, P470, DOI 10.1002/bit.21912; Yoshino T, 2009, BIOTECHNOL BIOENG, V103, P130, DOI 10.1002/bit.22240	19	50	54	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21442	10.1371/journal.pone.0021442	http://dx.doi.org/10.1371/journal.pone.0021442			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738665	Green Published, gold, Green Submitted			2022-12-27	WOS:000292142800022
J	Schernhammer, ES; Giovannucci, E; Baba, Y; Fuchs, CS; Ogino, S				Schernhammer, Eva S.; Giovannucci, Edward; Baba, Yoshifumi; Fuchs, Charles S.; Ogino, Shuji			B Vitamins, Methionine and Alcohol Intake and Risk of Colon Cancer in Relation to BRAF Mutation and CpG Island Methylator Phenotype (CIMP)	PLOS ONE			English	Article							ONE-CARBON METABOLISM; POPULATION-BASED SAMPLE; METHYLENETETRAHYDROFOLATE REDUCTASE POLYMORPHISM; SPORADIC COLORECTAL-CANCER; MGMT PROMOTER METHYLATION; DNA METHYLATION; MICROSATELLITE INSTABILITY; MULTIVITAMIN USE; COMPETING RISKS; DIETARY-FOLATE	Background: One-carbon metabolism appears to play an important role in DNA methylation reaction. Evidence suggests that a low intake of B vitamins or high alcohol consumption increases colorectal cancer risk. How one-carbon nutrients affect the CpG island methylator phenotype (CIMP) or BRAF mutation status in colon cancer remains uncertain. Methods: Utilizing incident colon cancers in a large prospective cohort of women (the Nurses' Health Study), we determined BRAF status (N = 386) and CIMP status (N = 375) by 8 CIMP-specific markers [CACNA1G, CDKN2A (p16), CRABP1, IGF2, MLH1, NEUROG1, RUNX3, and SOCS1], and 8 other CpG islands (CHFR, HIC1, IGFBP3, MGMT, MINT-1, MINT-31, p14, and WRN). We examined the relationship between intake of one-carbon nutrients and alcohol and colon cancer risk, by BRAF mutation or CIMP status. Results: Higher folate intake was associated with a trend towards low risk of CIMP-low/0 tumors [ total folate intake >= 400 mg/day vs. <200 mu g/day; the multivariate relative risk = 0.73; 95% CI = 0.53-1.02], whereas total folate intake had no influence on CIMP-high tumor risks (P-heterogeneity = 0.73). Neither vitamin B-6, methionine or alcohol intake appeared to differentially influence risks for CIMP-high and CIMP-low/0 tumors. Using the 16-marker CIMP panel did not substantially alter our results. B vitamins, methionine or alcohol intake did not affect colon cancer risk differentially by BRAF status. Conclusions: This molecular pathological epidemiology study suggests that low level intake of folate may be associated with an increased risk of CIMP-low/0 colon tumors, but not that of CIMP-high tumors. However, the difference between CIMP-high and CIMP-low/0 cancer risks was not statistically significant, and additional studies are necessary to confirm these observations.	[Schernhammer, Eva S.; Fuchs, Charles S.] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA; [Schernhammer, Eva S.; Fuchs, Charles S.; Ogino, Shuji] Harvard Univ, Sch Med, Boston, MA USA; [Schernhammer, Eva S.] KFJ Spital, Ludwig Boltzmann Inst Appl Canc Res, Vienna, Austria; [Schernhammer, Eva S.] Appl Canc Res Inst Translat Res Vienna ACR ITR VI, Vienna, Austria; [Schernhammer, Eva S.; Giovannucci, Edward] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Giovannucci, Edward] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Baba, Yoshifumi; Fuchs, Charles S.; Ogino, Shuji] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Ogino, Shuji] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Ludwig Boltzmann Institute; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital	Schernhammer, ES (corresponding author), Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA.	eva.schernhammer@channing.harvard.edu	Schernhammer, Eva S/L-7898-2018	Schernhammer, Eva S/0000-0002-4337-9415; Ogino, Shuji/0000-0002-3909-2323	United States National Institutes of Health (NIH) [P01 CA87969, P01 CA55075, P50 CA127003, K07 CA122826, R01 CA151993]; Bennett Family Fund for Targeted Therapies Research; Entertainment Industry Foundation through National Colorectal Cancer Research Alliance; NATIONAL CANCER INSTITUTE [P01CA087969, R01CA151993, P50CA127003, K07CA122826, P01CA055075] Funding Source: NIH RePORTER	United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bennett Family Fund for Targeted Therapies Research; Entertainment Industry Foundation through National Colorectal Cancer Research Alliance; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the United States National Institutes of Health (NIH) [P01 CA87969 (to S. Hankinson), P01 CA55075 (to W. Willett), P50 CA127003 (to C.S.F.), K07 CA122826 (to S.O.), R01 CA151993 (to S.O.)], the Bennett Family Fund for Targeted Therapies Research; and the Entertainment Industry Foundation through National Colorectal Cancer Research Alliance. The content is solely the responsibility of the authors and does not necessarily represent the official views of NCI or NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barault L, 2008, CANCER RES, V68, P8541, DOI 10.1158/0008-5472.CAN-08-1171; Candiloro ILM, 2009, CANCER PREV RES, V2, P862, DOI 10.1158/1940-6207.CAPR-09-0056; Chan AT, 2007, NEW ENGL J MED, V356, P2131, DOI 10.1056/NEJMoa067208; Chen HP, 2007, INT J CANCER, V120, P1684, DOI 10.1002/ijc.22406; Chen J, 1998, CARCINOGENESIS, V19, P2129, DOI 10.1093/carcin/19.12.2129; Curtin K, 2007, CARCINOGENESIS, V28, P1672, DOI 10.1093/carcin/bgm089; Curtin K, 2011, NUTR CANCER, V63, P357, DOI 10.1080/01635581.2011.535965; de Vogel S, 2008, CARCINOGENESIS, V29, P1765, DOI 10.1093/carcin/bgn074; de Vogel S, 2011, CANCER CAUSE CONTROL, V22, P1, DOI 10.1007/s10552-010-9659-6; Eads CA, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.8.e32; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Fuchs CS, 2002, CANCER EPIDEM BIOMAR, V11, P227; GIOVANNUCCI E, 1995, JNCI-J NATL CANCER I, V87, P265, DOI 10.1093/jnci/87.4.265; GIOVANNUCCI E, 1993, J NATL CANCER I, V85, P875, DOI 10.1093/jnci/85.11.875; Giovannucci E, 1998, ANN INTERN MED, V129, P517, DOI 10.7326/0003-4819-129-7-199810010-00002; Giovannucci E, 2002, J NUTR, V132, p2350S, DOI 10.1093/jn/132.8.2350S; Glynn RJ, 2005, AM J EPIDEMIOL, V162, P975, DOI 10.1093/aje/kwi309; Gosden RG, 2007, NEW ENGL J MED, V356, P731, DOI 10.1056/NEJMe068284; Harnack L, 2002, NUTR CANCER, V43, P152, DOI 10.1207/S15327914NC432_5; Hawkins NJ, 2009, MODERN PATHOL, V22, P1588, DOI 10.1038/modpathol.2009.130; Hazra A, 2010, CANCER CAUSE CONTROL, V21, P331, DOI 10.1007/s10552-009-9464-2; Hinoue T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008357; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Karpinski P, 2010, CANCER EPIDEMIOL, V34, P338, DOI 10.1016/j.canep.2010.03.002; Kawakami K, 2008, BRIT J CANCER, V98, P1555, DOI 10.1038/sj.bjc.6604346; Kerkel K, 2008, NAT GENET, V40, P904, DOI 10.1038/ng.174; Kim YI, 2004, ENVIRON MOL MUTAGEN, V44, P10, DOI 10.1002/em.20025; Linhart HG, 2007, GENE DEV, V21, P3110, DOI 10.1101/gad.1594007; LUNN M, 1995, BIOMETRICS, V51, P524, DOI 10.2307/2532940; Ma J, 1997, CANCER RES, V57, P1098; Minoo P, 2007, J PATHOL, V212, P124, DOI 10.1002/path.2160; Nosho K, 2009, CLIN CANCER RES, V15, P3663, DOI 10.1158/1078-0432.CCR-08-2383; Nosho K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003698; Ogino S, 2006, GUT, V55, P1000, DOI 10.1136/gut.2005.082933; Ogino S, 2005, J MOL DIAGN, V7, P413, DOI 10.1016/S1525-1578(10)60571-5; Ogino S, 2008, J MOL DIAGN, V10, P13, DOI 10.2353/jmoldx.2008.070082; Ogino S, 2007, CARCINOGENESIS, V28, P1985, DOI 10.1093/carcin/bgm160; Ogino S, 2007, J MOL DIAGN, V9, P305, DOI 10.2353/jmoldx.2007.060170; Ogino S, 2006, J MOL DIAGN, V8, P582, DOI 10.2353/jmoldx.2006.060082; Ogino S, 2006, J MOL DIAGN, V8, P209, DOI 10.2353/jmoldx.2006.050135; Ogino S, 2011, GUT, V60, P397, DOI 10.1136/gut.2010.217182; Oyama K, 2004, ANTICANCER RES, V24, P649; Raptis S, 2007, JNCI-J NATL CANCER I, V99, P463, DOI 10.1093/jnci/djk095; Samowitz WS, 2008, GENE CHROMOSOME CANC, V47, P835, DOI 10.1002/gcc.20584; Samowitz WS, 2005, GASTROENTEROLOGY, V129, P837, DOI 10.1053/j.gastro.2005.06.020; Schemhammer ES, 2008, CANCER EPIDEM BIOMAR, V17, P2895, DOI 10.1158/1055-9965.EPI-08-0638; Schernhammer ES, 2008, GASTROENTEROLOGY, V135, P770, DOI 10.1053/j.gastro.2008.06.033; Schernhammer ES, 2010, GUT, V59, P794, DOI 10.1136/gut.2009.183707; Schilling E, 2009, GENOME RES, V19, P2028, DOI 10.1101/gr.095562.109; Slattery ML, 2007, INT J CANCER, V120, P656, DOI 10.1002/ijc.22342; Slattery ML, 2010, CANCER CAUSE CONTROL, V21, P1237, DOI 10.1007/s10552-010-9551-4; STAMPFER MJ, 1984, AM J EPIDEMIOL, V119, P837, DOI 10.1093/oxfordjournals.aje.a113804; Suzuki Hiromu, 2006, Asian Pac J Cancer Prev, V7, P177; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; van Engeland M, 2003, CANCER RES, V63, P3133; Van Guelpen B, 2010, CANCER CAUSE CONTROL, V21, P557, DOI 10.1007/s10552-009-9484-y; Wallace K, 2010, CANCER PREV RES, V3, P1552, DOI 10.1158/1940-6207.CAPR-10-0047; Wei EK, 2005, J NATL CANCER I, V97, P684, DOI 10.1093/jnci/dji116; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; WILLETT WC, 1988, AM J EPIDEMIOL, V127, P188, DOI 10.1093/oxfordjournals.aje.a114780; WILLETT WC, 1987, NEW ENGL J MED, V316, P1174, DOI 10.1056/NEJM198705073161902; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; Zhang YY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-r138; 1996, FED REG, P8797	64	39	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21102	10.1371/journal.pone.0021102	http://dx.doi.org/10.1371/journal.pone.0021102			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738611	Green Submitted, Green Published, gold			2022-12-27	WOS:000292092600012
J	Talavera, D; Robertson, DL; Lovell, SC				Talavera, David; Robertson, David L.; Lovell, Simon C.			Characterization of Protein-Protein Interaction Interfaces from a Single Species	PLOS ONE			English	Article							INTERACTION SITES; RECOGNITION SITES; QUATERNARY STRUCTURE; HOT-SPOTS; PREDICTION; COMPLEXES; SEQUENCE; CONTACTS; INFORMATION; EVOLUTION	Most proteins attain their biological functions through specific interactions with other proteins. Thus, the study of protein-protein interactions and the interfaces that mediate these interactions is of prime importance for the understanding of biological function. In particular the precise determinants of binding specificity and their contributions to binding energy within protein interfaces are not well understood. In order to better understand these determinants an appropriate description of the interaction surface is needed. Available data from the yeast Saccharomyces cerevisiae allow us to focus on a single species and to use all the available structures, correcting for redundancy, instead of using structural representatives. This allows us to control for potentially confounding factors that may affect sequence propensities. We find a significant contribution of main-chain atoms to protein-protein interactions. These include interactions both with other main-chain and side-chain atoms on the interacting chain. We find that the type of interaction depends on both amino acid and secondary structure type involved in the contact. For example, residues in a-helices and large amino acids are the most likely to be involved in interactions through their side-chain atoms. We find an intriguing homogeneity when calculating the average solvation energy of different areas of the protein surface. Unexpectedly, homo-and hetero-complexes have quite similar results for all analyses. Our findings demonstrate that the manner in which protein-protein interactions are formed is determined by the residue type and the secondary structure found in the interface. However the homogeneity of the desolvation energy despite heterogeneity of interface properties suggests a complex relationship between interface composition and binding energy.	[Talavera, David; Robertson, David L.; Lovell, Simon C.] Univ Manchester, Fac Life Sci, Manchester, NH USA		Talavera, D (corresponding author), Univ Manchester, Fac Life Sci, Manchester, NH USA.	simon.lovell@manchester.ac.uk	Talavera, David/AAD-2088-2021	Talavera, David/0000-0002-8820-3931; Lovell, Simon/0000-0002-4092-8458	BBSRC [BB/F013337/1]; Biotechnology and Biological Sciences Research Council [BB/F013337/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding was provided by BBSRC grant number BB/F013337/1 (www.bbsrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloy P, 2003, J MOL BIOL, V332, P989, DOI 10.1016/j.jmb.2003.07.006; Aloy P, 2002, P NATL ACAD SCI USA, V99, P5896, DOI 10.1073/pnas.092147999; Armon A, 2001, J MOL BIOL, V307, P447, DOI 10.1006/jmbi.2000.4474; Bahadur RP, 2008, CELL MOL LIFE SCI, V65, P1059, DOI 10.1007/s00018-007-7451-x; Bahadur RP, 2003, PROTEINS, V53, P708, DOI 10.1002/prot.10461; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Chakrabarti P, 2002, PROTEINS, V47, P334, DOI 10.1002/prot.10085; Chen HL, 2005, PROTEINS, V61, P21, DOI 10.1002/prot.20514; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; Crowley PB, 2005, PROTEINS, V59, P231, DOI 10.1002/prot.20417; de Vries SJ, 2008, CURR PROTEIN PEPT SC, V9, P394, DOI 10.2174/138920308785132712; de Vries SJ, 2006, BIOINFORMATICS, V22, P2094, DOI 10.1093/bioinformatics/btl275; DeLano WL, 2002, CURR OPIN STRUC BIOL, V12, P14, DOI 10.1016/S0959-440X(02)00283-X; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Hakes L, 2007, P NATL ACAD SCI USA, V104, P7999, DOI 10.1073/pnas.0609962104; Henrick K, 1998, TRENDS BIOCHEM SCI, V23, P358, DOI 10.1016/S0968-0004(98)01253-5; Hoskins J, 2006, PROTEIN SCI, V15, P1017, DOI 10.1110/ps.051589106; Janin J, 2008, Q REV BIOPHYS, V41, P133, DOI 10.1017/S0033583508004708; Jones S, 1997, J MOL BIOL, V272, P121, DOI 10.1006/jmbi.1997.1234; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Jones S, 1997, J MOL BIOL, V272, P133, DOI 10.1006/jmbi.1997.1233; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Kufareva I, 2007, PROTEINS, V67, P400, DOI 10.1002/prot.21233; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Lichtarge O, 1996, J MOL BIOL, V257, P342, DOI 10.1006/jmbi.1996.0167; Lo Conte L, 1999, J MOL BIOL, V285, P2177; LOVELL SC, MOL BIOL EVOL, V27, P2567; Mintseris J, 2005, P NATL ACAD SCI USA, V102, P10930, DOI 10.1073/pnas.0502667102; Nadassy K, 1999, BIOCHEMISTRY-US, V38, P1999, DOI 10.1021/bi982362d; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Neuvirth H, 2004, J MOL BIOL, V338, P181, DOI 10.1016/j.jmb.2004.02.040; Ofran Y, 2003, J MOL BIOL, V325, P377, DOI 10.1016/S0022-2836(02)01223-8; Pal C, 2006, NAT REV GENET, V7, P337, DOI 10.1038/nrg1838; PRESTA LG, 1988, SCIENCE, V240, P1632, DOI 10.1126/science.2837824; Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099; RICHARDSON JS, 1988, SCIENCE, V240, P1648, DOI 10.1126/science.3381086; Talavera D, 2006, PROTEIN SCI, V15, P2525, DOI 10.1110/ps.062406706; Word JM, 1999, J MOL BIOL, V285, P1735, DOI 10.1006/jmbi.1998.2401; Word JM, 1999, J MOL BIOL, V285, P1711, DOI 10.1006/jmbi.1998.2400; Zhou HX, 2007, BIOINFORMATICS, V23, P2203, DOI 10.1093/bioinformatics/btm323; Zhou HX, 2001, PROTEINS, V44, P336, DOI 10.1002/prot.1099	46	34	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21053	10.1371/journal.pone.0021053	http://dx.doi.org/10.1371/journal.pone.0021053			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738603	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000292092600010
J	Winters, M; Barta, JL; Monroe, C; Kemp, BM				Winters, Misa; Barta, Jodi Lynn; Monroe, Cara; Kemp, Brian M.			To Clone or Not To Clone: Method Analysis for Retrieving Consensus Sequences In Ancient DNA Samples	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; MOLECULAR ANALYSIS; GENETIC-ANALYSIS; NEANDERTHAL DNA; ORIGIN; REVEAL; DIVERSITY; REMAINS; BONES; CONTAMINATION	The challenges associated with the retrieval and authentication of ancient DNA (aDNA) evidence are principally due to postmortem damage which makes ancient samples particularly prone to contamination from "modern" DNA sources. The necessity for authentication of results has led many aDNA researchers to adopt methods considered to be "gold standards" in the field, including cloning aDNA amplicons as opposed to directly sequencing them. However, no standardized protocol has emerged regarding the necessary number of clones to sequence, how a consensus sequence is most appropriately derived, or how results should be reported in the literature. In addition, there has been no systematic demonstration of the degree to which direct sequences are affected by damage or whether direct sequencing would provide disparate results from a consensus of clones. To address this issue, a comparative study was designed to examine both cloned and direct sequences amplified from similar to 3,500 year-old ancient northern fur seal DNA extracts. Majority rules and the Consensus Confidence Program were used to generate consensus sequences for each individual from the cloned sequences, which exhibited damage at 31 of 139 base pairs across all clones. In no instance did the consensus of clones differ from the direct sequence. This study demonstrates that, when appropriate, cloning need not be the default method, but instead, should be used as a measure of authentication on a case-by-case basis, especially when this practice adds time and cost to studies where it may be superfluous.	[Winters, Misa; Barta, Jodi Lynn; Monroe, Cara; Kemp, Brian M.] Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA; [Barta, Jodi Lynn; Monroe, Cara; Kemp, Brian M.] Washington State Univ, Dept Anthropol, Pullman, WA 99164 USA; [Monroe, Cara] Univ Calif Santa Barbara, Dept Anthropol, Santa Barbara, CA 93106 USA	Washington State University; Washington State University; University of California System; University of California Santa Barbara	Winters, M (corresponding author), Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA.	bmkemp@wsu.edu			National Institute of Justice, Office of Justice Programs, U.S. Department of Justice [2008-DN-BX-K008]; Interdisciplinary Training for Undergraduates in Biological and Mathematical Sciences (UBM) [EF-0531870]	National Institute of Justice, Office of Justice Programs, U.S. Department of Justice; Interdisciplinary Training for Undergraduates in Biological and Mathematical Sciences (UBM)	This project was supported by Award No. 2008-DN-BX-K008 awarded by the National Institute of Justice, Office of Justice Programs, U.S. Department of Justice. The opinions, findings, and conclusions or recommendations expressed in this publication/program/exhibition are those of the author(s) and do not necessarily reflect those of the Department of Justice. Support for Misa Winters was provided by the Interdisciplinary Training for Undergraduates in Biological and Mathematical Sciences (UBM) grant EF-0531870. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso A, 2004, FORENSIC SCI INT, V139, P141, DOI 10.1016/j.forsciint.2003.10.008; Arnason U, 2006, MOL PHYLOGENET EVOL, V41, P345, DOI 10.1016/j.ympev.2006.05.022; Binladen J, 2006, GENETICS, V172, P733, DOI 10.1534/genetics.105.049718; Bouwman AS, 2005, J ARCHAEOL SCI, V32, P703, DOI 10.1016/j.jas.2004.11.014; Bower MA, 2005, NUCLEIC ACIDS RES, V33, P2549, DOI 10.1093/nar/gki550; Capelli C, 2003, FORENSIC SCI INT, V131, P59, DOI 10.1016/S0379-0738(02)00396-1; Caramelli D, 2003, P NATL ACAD SCI USA, V100, P6593, DOI 10.1073/pnas.1130343100; Collins MJ, 2009, P ROY SOC B-BIOL SCI, V276, P2971, DOI 10.1098/rspb.2009.0563; Cooper A, 2000, SCIENCE, V289, P1139; CROCKFORD SJ, 2004, UNL050 AL DEP TRANSP; Endicott P, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000081; Fernandez E, 2009, J ARCHAEOL SCI, V36, P965, DOI 10.1016/j.jas.2008.11.009; Gilbert MTP, 2008, SCIENCE, V320, P786, DOI 10.1126/science.1154116; Gilbert MTP, 2007, NUCLEIC ACIDS RES, V35, P1, DOI 10.1093/nar/gkl483; Gilbert MTP, 2004, CURR BIOL, V14, pR463, DOI 10.1016/j.cub.2004.06.008; Gilbert MTP, 2006, FORENSIC SCI INT, V156, P208, DOI 10.1016/j.forsciint.2005.02.021; Gilbert MTP, 2005, TRENDS ECOL EVOL, V20, P541, DOI 10.1016/j.tree.2005.07.005; Green RE, 2008, CELL, V134, P416, DOI 10.1016/j.cell.2008.06.021; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Haak W, 2005, SCIENCE, V310, P1016, DOI 10.1126/science.1118725; Handt O, 1996, AM J HUM GENET, V59, P368; HANDT O, 1994, SCIENCE, V264, P1775, DOI 10.1126/science.8209259; Hebsgaard MB, 2009, ANTIQUITY, V83, P430, DOI 10.1017/S0003598X00098537; Helgason A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000343; Hofreiter M, 2002, MOL BIOL EVOL, V19, P1244, DOI 10.1093/oxfordjournals.molbev.a004185; Hofreiter M, 2001, NUCLEIC ACIDS RES, V29, P4793, DOI 10.1093/nar/29.23.4793; Karanth KP, 2005, P NATL ACAD SCI USA, V102, P5090, DOI 10.1073/pnas.0408354102; Kemp BM, 2005, FORENSIC SCI INT, V154, P53, DOI 10.1016/j.forsciint.2004.11.017; Kemp BM, 2007, AM J PHYS ANTHROPOL, V132, P605, DOI 10.1002/ajpa.20543; Kemp BM, 2010, HUM BIOL, V82, P227, DOI 10.3378/027.082.0207; Kim JH, 2005, MOL CELLS, V20, P325; Krause J, 2007, NATURE, V449, P902, DOI 10.1038/nature06193; Krings M, 1997, CELL, V90, P19, DOI 10.1016/S0092-8674(00)80310-4; Krings M, 1999, P NATL ACAD SCI USA, V96, P5581, DOI 10.1073/pnas.96.10.5581; Kuch M, 2007, AM J PHYS ANTHROPOL, V132, P594, DOI 10.1002/ajpa.20536; Kuhn TS, 2010, MOL ECOL, V19, P1312, DOI 10.1111/j.1365-294X.2010.04565.x; Lambert DM, 2002, SCIENCE, V295, P2270, DOI 10.1126/science.1068105; Lari M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010648; Larson G, 2007, P NATL ACAD SCI USA, V104, P15276, DOI 10.1073/pnas.0703411104; Leonard JA, 2007, J ARCHAEOL SCI, V34, P1361, DOI 10.1016/j.jas.2006.10.023; Lindqvist C, 2010, P NATL ACAD SCI USA, V107, P5053, DOI 10.1073/pnas.0914266107; Loreille O, 2001, CURR BIOL, V11, P200, DOI 10.1016/S0960-9822(01)00046-X; Malmstrom H, 2005, MOL BIOL EVOL, V22, P2040, DOI 10.1093/molbev/msi195; Malmstrom H, 2007, MOL BIOL EVOL, V24, P998, DOI 10.1093/molbev/msm015; Monsalve MV, 2002, AM J PHYS ANTHROPOL, V119, P288, DOI 10.1002/ajpa.10116; Moss M. L., 2006, J ISL COAST ARCHAEOL, V1, P165, DOI DOI 10.1080/15564890600934129; Orlando L, 2003, MOL PHYLOGENET EVOL, V28, P485, DOI 10.1016/S1055-7903(03)00023-X; Orlando L, 2006, CURR BIOL, V16, pR400, DOI 10.1016/j.cub.2006.05.019; Ovchinnikov IV, 2000, NATURE, V404, P490, DOI 10.1038/35006625; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; PAABO S, 1988, NUCLEIC ACIDS RES, V16, P9775, DOI 10.1093/nar/16.20.9775; Poinar H, 2003, CURR BIOL, V13, P1150, DOI 10.1016/S0960-9822(03)00450-0; Poinar H, 2009, SCIENCE, V325, DOI [10.1126/science.1167531, 10.1126/science.1168182]; Poinar HN, 1998, SCIENCE, V281, P402, DOI 10.1126/science.281.5375.402; Poinar HN, 2001, P NATL ACAD SCI USA, V98, P4317, DOI 10.1073/pnas.061014798; Salamon M, 2005, P NATL ACAD SCI USA, V102, P13783, DOI 10.1073/pnas.0503718102; Shapiro B, 2004, SCIENCE, V306, P1561, DOI 10.1126/science.1101074; Speller CF, 2010, P NATL ACAD SCI USA, V107, P2807, DOI 10.1073/pnas.0909724107; Thomsen PF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005048; Willerslev E, 2005, P ROY SOC B-BIOL SCI, V272, P3, DOI 10.1098/rspb.2004.2813; Willerslev E, 2003, SCIENCE, V300, P791, DOI 10.1126/science.1084114; Willerslev E, 2007, SCIENCE, V317, P111, DOI 10.1126/science.1141758; Zeder MA, 2006, TRENDS GENET, V22, P139, DOI 10.1016/j.tig.2006.01.007	63	41	41	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21247	10.1371/journal.pone.0021247	http://dx.doi.org/10.1371/journal.pone.0021247			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	783OD	21738625	Green Published, gold			2022-12-27	WOS:000292092600022
J	Johnson, DDP; Weidmann, NB; Cederman, LE				Johnson, Dominic D. P.; Weidmann, Nils B.; Cederman, Lars-Erik			Fortune Favours the Bold: An Agent-Based Model Reveals Adaptive Advantages of Overconfidence in War	PLOS ONE			English	Article							COMPETITION; EVOLUTION	Overconfidence has long been considered a cause of war. Like other decision-making biases, overconfidence seems detrimental because it increases the frequency and costs of fighting. However, evolutionary biologists have proposed that overconfidence may also confer adaptive advantages: increasing ambition, resolve, persistence, bluffing opponents, and winning net payoffs from risky opportunities despite occasional failures. We report the results of an agent-based model of inter-state conflict, which allows us to evaluate the performance of different strategies in competition with each other. Counter-intuitively, we find that overconfident states predominate in the population at the expense of unbiased or underconfident states. Overconfident states win because: (1) they are more likely to accumulate resources from frequent attempts at conquest; (2) they are more likely to gang up on weak states, forcing victims to split their defences; and (3) when the decision threshold for attacking requires an overwhelming asymmetry of power, unbiased and underconfident states shirk many conflicts they are actually likely to win. These `` adaptive advantages'' of overconfidence may, via selection effects, learning, or evolved psychology, have spread and become entrenched among modern states, organizations and decision-makers. This would help to explain the frequent association of overconfidence and war, even if it no longer brings benefits today.	[Johnson, Dominic D. P.] Univ Edinburgh, Edinburgh, Midlothian, Scotland; [Weidmann, Nils B.] Yale Univ, Jackson Inst Global Affairs, New Haven, CT USA; [Weidmann, Nils B.] Int Peace Res Inst, Ctr Study Civil War, Oslo, Norway; [Cederman, Lars-Erik] ETH, Zurich, Switzerland	University of Edinburgh; Yale University; Peace Research Institute Oslo (PRIO); Swiss Federal Institutes of Technology Domain; ETH Zurich	Johnson, DDP (corresponding author), Univ Edinburgh, Edinburgh, Midlothian, Scotland.	dominic.johnson@ed.ac.uk	Weidmann, Nils B/P-8172-2016; Johnson, Dominic/GXH-1117-2022	Weidmann, Nils B/0000-0002-4791-4913; 	Society in Science Branco Weiss Fellowship; ETH Zurich	Society in Science Branco Weiss Fellowship; ETH Zurich(ETH Zurich)	This study was generously supported by a Society in Science Branco Weiss Fellowship to DJ (http://www.society-in-science.org/) and by ETH Zurich for NW and LC (http://www.ethz.ch/index_EN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, EMERGENT ACTORS WORL; Arreguin-Toft I., 2005, WEAK WIN WARS THEORY; Axelrod R., 1997, COMPLEXITY COOPERATI, DOI [10.1515/9781400822300, DOI 10.1515/9781400822300]; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; BAUMEISTER RF, 1989, J SOC CLIN PSYCHOL, V8, P176, DOI 10.1521/jscp.1989.8.2.176; Bazerman MH, 2000, ANNU REV PSYCHOL, V51, P279, DOI 10.1146/annurev.psych.51.1.279; BENDAVID I, 2006, 81 DUK U FUQ SCH BUS; Blainey G., 1973, CAUSES WAR; Bowles S, 2006, SCIENCE, V314, P1569, DOI 10.1126/science.1134829; Burt A, 2006, GENES CONFLICT BIOL; Cederman LE, 2002, P NATL ACAD SCI USA, V99, P7296, DOI 10.1073/pnas.082081099; CHRISTENSEN TJ, 1990, INT ORGAN, V44, P137, DOI 10.1017/S0020818300035232; FEARON JD, 1995, INT ORGAN, V49, P379, DOI 10.1017/S0020818300033324; Fiske SusanT., 1991, SOCIAL COGNITION 2; Ganguly Sumit, 2001, CONFLICT UNENDING IN; Gilbert N., 2007, AGENT BASED MODELS; Hammond RA, 2006, J CONFLICT RESOLUT, V50, P926, DOI 10.1177/0022002706293470; Haselton MG, 2006, PERS SOC PSYCHOL REV, V10, P47, DOI 10.1207/s15327957pspr1001_3; Helbing D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000758; Helbing D, 2009, P NATL ACAD SCI USA, V106, P3680, DOI 10.1073/pnas.0811503106; Hirshleifer J, 2001, DARK SIDE FORCE EC F; JAMES L, 2000, RAJ MAKING UNMAKING; Janis IL, 1972, VICTIMS GROUPTHINK P; Jervis Robert., 2017, PERCEPTION MISPERCEP; JOHNSON DDP, INT SECURIT IN PRESS; Johnson DDP., 2004, OVERCONFIDENCE WAR H; Johnson DDP, 2006, P ROY SOC B-BIOL SCI, V273, P2513, DOI 10.1098/rspb.2006.3606; Johnson DDP, 2008, NATURAL SECURITY: A DARWINIAN APPROACH TO A DANGEROUS WORLD, P209; Johnson Shawn., 2021, WIN REPUBLICANS WISC; KAHNEMAN D, 2006, FOREIGN POLICY, V158, P34; Liberman Peter., 1998, DOES CONQUEST PAY EX; LINDLEY D, 2006, PHIL PA AM POL SCI A; LOEWENSTEIN G, 1993, J LEGAL STUD, V22, P135, DOI 10.1086/468160; MACK A, 1975, WORLD POLIT, V27, P175, DOI 10.2307/2009880; MALMENDIER U, 2004, 10807 NAT BUR EC RES; May E.R., 1973, LESSONS USE MISUSE H; MEARSHEIMER JJ, 1989, INT SECURITY, V13, P54, DOI 10.2307/2538780; Mearsheimer JohnJ., 2014, TRAGEDY GREAT POWER; Mueller J., 2004, REMNANTS WAR; Nettle D., 2004, EMOTION EVOLUTION RA, P193, DOI 10.1093/acprof:oso/9780198528975.003.0010; Pakenham Thomas, 1992, SCRAMBLE AFRICA; PAUL TV, 1994, ASYMMETRIC CONFLICTS; Slantchev BL, 2003, AM POLIT SCI REV, V97, P621, DOI 10.1017/S0003055403000911; Smirnov O, 2007, J POLIT, V69, P927, DOI 10.1111/j.1468-2508.2007.00599.x; Szolnoki A, 2010, EPL-EUROPHYS LETT, V92, DOI 10.1209/0295-5075/92/38003; Taylor S. E., 1989, POSITIVE ILLUSIONS C; TAYLOR SE, 1994, PSYCHOL BULL, V116, P21, DOI 10.1037/0033-2909.116.1.21; Trivers R, 2000, ANN NY ACAD SCI, V907, P114; Trivers Robert, 2011, DECEIT SELF DECEPTIO; US EPA O, 2014, MODERN INSURGENCY CO; Van Den Steen E, 2004, AM ECON REV, V94, P1141, DOI 10.1257/0002828042002697; Van Evera S, 1998, INT SECURITY, V22, P5, DOI 10.2307/2539239; Van Evera S, 2003, PERSPECTIVES ON STRUCTURAL REALISM, P163; Van Evera Stephen., 1999, CAUSES WAR POWER ROO; VERNER J, 1977, AM NAT, V111, P769, DOI 10.1086/283204; Walt StephenM., 1987, ORIGINS ALLIANCES; Waltz KennethN., 1979, THEORY INT POLITICS; WANG K, 1994, INT STUD QUART, V38, P139, DOI 10.2307/2600875; Weidmann NB, 2008, SOC SCI COMPUT REV, V26, P510, DOI 10.1177/0894439307313516; Wrangham R, 1999, EVOL HUM BEHAV, V20, P3, DOI 10.1016/S1090-5138(98)00040-3	60	23	25	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e20851	10.1371/journal.pone.0020851	http://dx.doi.org/10.1371/journal.pone.0020851			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	782UF	21731627	Green Published, gold, Green Submitted			2022-12-27	WOS:000292036900007
J	Tong, SYC; Dakh, F; Hurt, AC; Deng, YM; Freeman, K; Fagan, PK; Barr, IG; Giffard, PM				Tong, Steven Y. C.; Dakh, Farshid; Hurt, Aeron C.; Deng, Yi-Mo; Freeman, Kevin; Fagan, Peter K.; Barr, Ian G.; Giffard, Philip M.			Rapid Detection of the H275Y Oseltamivir Resistance Mutation in Influenza A/H1N1 2009 by Single Base Pair RT-PCR and High-Resolution Melting	PLOS ONE			English	Article							VIRUS	Introduction: We aimed to design a real-time reverse-transcriptase-PCR (rRT-PCR), high-resolution melting (HRM) assay to detect the H275Y mutation that confers oseltamivir resistance in influenza A/H1N1 2009 viruses. Findings: A novel strategy of amplifying a single base pair, the relevant SNP at position 823 of the neuraminidase gene, was chosen to maintain specificity of the assay. Wildtype and mutant virus were differentiated when using known reference samples of cell-cultured virus. However, when dilutions of these reference samples were assayed, amplification of nonspecific primer-dimer was evident and affected the overall melting temperature (T-m) of the amplified products. Due to primer-dimer appearance at > 30 cycles we found that if the cycle threshold (C-T) for a dilution was > 30, the HRM assay did not consistently discriminate mutant from wildtype. Where the C-T was < 30 we noted an inverse relationship between C-T and T-m and fitted quadratic curves allowed the discrimination of wildtype, mutant and 30:70 mutant: wildtype virus mixtures. We compared the C-T values for a TaqMan H1N1 09 detection assay with those for the HRM assay using 59 clinical samples and demonstrated that samples with a TaqMan detection assay C-T > 32.98 would have an H275Y assay C-T > 30. Analysis of the TaqMan C-T values for 609 consecutive clinical samples predicted that 207 (34%) of the samples would result in an HRM assay C-T > 30 and therefore not be amenable to the HRM assay. Conclusions: The use of single base pair PCR and HRM can be useful for specifically interrogating SNPs. When applied to H1N1 09, the constraints this placed on primer design resulted in amplification of primer-dimer products. The impact primer-dimer had on HRM curves was adjusted for by plotting T-m against C-T. Although less sensitive than TaqMan assays, the HRM assay can rapidly, and at low cost, screen samples with moderate viral concentrations.	[Tong, Steven Y. C.; Dakh, Farshid; Giffard, Philip M.] Charles Darwin Univ, Menzies Sch Hlth Res, Darwin, NT 0909, Australia; [Tong, Steven Y. C.] Royal Darwin Hosp, Dept Infect Dis, Darwin, NT, Australia; [Hurt, Aeron C.; Deng, Yi-Mo; Barr, Ian G.] World Hlth Org Collaborating Ctr Reference & Res, Melbourne, Vic, Australia; [Freeman, Kevin; Fagan, Peter K.] Royal Darwin Hosp, No Terr Govt Pathol Serv Microbiol Lab, Darwin, NT, Australia	Charles Darwin University; Menzies School of Health Research; World Health Organization	Tong, SYC (corresponding author), Charles Darwin Univ, Menzies Sch Hlth Res, Darwin, NT 0909, Australia.	Steven.tong@menzies.edu.au	Tong, Steven/N-2353-2013; Giffard, Philip/N-2293-2013	Tong, Steven/0000-0002-1368-8356; Dakh, Farshid/0000-0003-4010-1722; Deng, Yi-Mo/0000-0003-2177-8308; Barr, Ian/0000-0002-7351-418X; FREEMAN, KEVIN/0000-0002-6959-8712; Hurt, Aeron/0000-0003-1826-4314; Giffard, Phil/0000-0002-3030-9127	Australian National Health and Research Council [605829]	Australian National Health and Research Council(Australian Research Council)	ST is supported by an Australian National Health and Research Council Post-doctoral training fellowship (605829). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, Wkly Epidemiol Rec, V84, P453; Baz M, 2009, NEW ENGL J MED, V361, P2296, DOI 10.1056/NEJMc0910060; Carr MJ, 2008, J VIROL METHODS, V153, P257, DOI 10.1016/j.jviromet.2008.07.011; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P969; Chidlow GR, 2010, J VIROL METHODS, V169, P47, DOI 10.1016/j.jviromet.2010.06.014; Deyde VM, 2009, EXPERT REV MOL DIAGN, V9, P493, DOI 10.1586/ERM.09.21; Englund J., 2009, Morbidity and Mortality Weekly Report, V58, P893; Guo LZ, 2009, ANTIVIR RES, V82, P29, DOI 10.1016/j.antiviral.2009.01.004; Hata M, 2010, J CLIN MICROBIOL, V48, P1983, DOI 10.1128/JCM.01862-09; Hindiyeh M, 2010, J CLIN MICROBIOL, V48, P1884, DOI 10.1128/JCM.02540-09; Hurt AC, 2004, ANTIVIR RES, V62, P37, DOI 10.1016/j.antiviral.2003.11.008; Mai LQ, 2010, NEW ENGL J MED, V362, P86, DOI 10.1056/NEJMc0910448; Medina RA, 2011, J CLIN MICROBIOL, V49, P335, DOI 10.1128/JCM.01142-10; Mehta T, 2010, J CLIN MICROBIOL, V48, P4326, DOI 10.1128/JCM.01190-10; Renaud C, 2010, J CLIN VIROL, V49, P21, DOI 10.1016/j.jcv.2010.06.019; Speers DJ, 2010, MED J AUSTRALIA, V192, P166, DOI 10.5694/j.1326-5377.2010.tb03459.x; STEAIN MC, 2009, ANTIVIRAL RES, V84; Suzuki Y, 2011, J CLIN MICROBIOL, V49, P125, DOI 10.1128/JCM.01401-10; van der Vries E, 2010, J CLIN VIROL, V47, P34, DOI 10.1016/j.jcv.2009.09.030; Varillas D, 2011, J VIROL METHODS, V171, P284, DOI 10.1016/j.jviromet.2010.10.003; Whiley DM, 2009, J CLIN VIROL, V45, P203, DOI 10.1016/j.jcv.2009.05.032	22	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21446	10.1371/journal.pone.0021446	http://dx.doi.org/10.1371/journal.pone.0021446			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21731753	Green Published, gold			2022-12-27	WOS:000292036900031
J	Kisby, GE; Fry, RC; Lasarev, MR; Bammler, TK; Beyer, RP; Churchwell, M; Doerge, DR; Meira, LB; Palmer, VS; Ramos-Crawford, AL; Ren, XF; Sullivan, RC; Kavanagh, TJ; Samson, LD; Zarbl, H; Spencer, PS				Kisby, Glen E.; Fry, Rebecca C.; Lasarev, Michael R.; Bammler, Theodor K.; Beyer, Richard P.; Churchwell, Mona; Doerge, Daniel R.; Meira, Lisiane B.; Palmer, Valerie S.; Ramos-Crawford, Ana-Luiza; Ren, Xuefeng; Sullivan, Robert C.; Kavanagh, Terrance J.; Samson, Leona D.; Zarbl, Helmut; Spencer, Peter S.			The Cycad Genotoxin MAM Modulates Brain Cellular Pathways Involved in Neurodegenerative Disease and Cancer in a DNA Damage-Linked Manner	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; PARKINSONISM-DEMENTIA COMPLEX; SPORADIC ALZHEIMERS-DISEASE; TRANSCRIPTION FACTORS; GENE-EXPRESSION; INDUCED COLON; P38 MAPK; O-6-METHYLGUANINE-DNA METHYLTRANSFERASE; 2 SIDES; TAU	Methylazoxymethanol (MAM), the genotoxic metabolite of the cycad azoxyglucoside cycasin, induces genetic alterations in bacteria, yeast, plants, insects and mammalian cells, but adult nerve cells are thought to be unaffected. We show that the brains of adult C57BL6 wild-type mice treated with a single systemic dose of MAM acetate display DNA damage (O-6-methyldeoxyguanosine lesions, O-6-mG) that remains constant up to 7 days post-treatment. By contrast, MAM-treated mice lacking a functional gene encoding the DNA repair enzyme O-6-mG DNA methyltransferase (MGMT) showed elevated O-6-mG DNA damage starting at 48 hours post-treatment. The DNA damage was linked to changes in the expression of genes in cell-signaling pathways associated with cancer, human neurodegenerative disease, and neurodevelopmental disorders. These data are consistent with the established developmental neurotoxic and carcinogenic properties of MAM in rodents. They also support the hypothesis that early-life exposure to MAM-glucoside (cycasin) has an etiological association with a declining, prototypical neurodegenerative disease seen in Guam, Japan, and New Guinea populations that formerly used the neurotoxic cycad plant for food or medicine, or both. These findings suggest environmental genotoxins, specifically MAM, target common pathways involved in neurodegeneration and cancer, the outcome depending on whether the cell can divide (cancer) or not (neurodegeneration). Exposure to MAM-related environmental genotoxins may have relevance to the etiology of related tauopathies, notably, Alzheimer's disease.	[Kisby, Glen E.; Lasarev, Michael R.; Palmer, Valerie S.; Ramos-Crawford, Ana-Luiza; Spencer, Peter S.] Oregon Hlth & Sci Univ, Ctr Res Occupat & Environm Toxicol, Portland, OR 97201 USA; [Fry, Rebecca C.; Meira, Lisiane B.; Samson, Leona D.] MIT, Ctr Environm Hlth Sci, Cambridge, MA 02139 USA; [Fry, Rebecca C.; Meira, Lisiane B.; Samson, Leona D.] MIT, Biol Engn Div, Cambridge, MA 02139 USA; [Bammler, Theodor K.; Beyer, Richard P.] Univ Washington, Dept Environm & Occupat Hlth Sci, Ctr Ecogenet & Environm Hlth, Seattle, WA 98195 USA; [Churchwell, Mona; Doerge, Daniel R.] US FDA, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA; [Palmer, Valerie S.; Spencer, Peter S.] Oregon Hlth & Sci Univ, Global Hlth Ctr, Portland, OR 97201 USA; [Sullivan, Robert C.; Zarbl, Helmut] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA	Oregon Health & Science University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of Washington; University of Washington Seattle; US Food & Drug Administration (FDA); Oregon Health & Science University; Fred Hutchinson Cancer Center	Kisby, GE (corresponding author), Western Univ Hlth Sci, Coll Osteopath Med Pacific NW, Lebanon, OR USA.	gkisby@westernu.edu; spencer@ohsu.edu	Meira, Lisiane/AAA-4326-2020	Lasarev, Michael R/0000-0002-1896-2705; Fry, Rebecca/0000-0003-0899-9018; Meira, Lisiane/0000-0003-4289-2986	National Institutes of Environmental Health Sciences [ES11384 (OHSU), ES11399 (MIT), ES011387 (FHCRC/UW), ES07033 (UW)]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005022, U19ES011384, U19ES011399, U19ES011387, P30ES007033, P30ES010126] Funding Source: NIH RePORTER	National Institutes of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded by the National Institutes of Environmental Health Sciences: ES11384 (OHSU), ES11399 (MIT), ES011387 (FHCRC/UW) and ES07033 (UW) (http://www.niehs.nih.gov/research/supported/centers/trc/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki W, 2009, BIOCHEM BIOPH RES CO, V380, P111, DOI 10.1016/j.bbrc.2009.01.044; Behrens MI, 2009, CURR ALZHEIMER RES, V6, P196, DOI 10.2174/156720509788486608; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bobola MS, 2007, DNA REPAIR, V6, P1127, DOI 10.1016/j.dnarep.2007.03.009; Bolos M, 2010, J BIOL CHEM, V285, P17693, DOI 10.1074/jbc.M109.096594; Bolotin E, 2010, HEPATOLOGY, V51, P642, DOI 10.1002/hep.23357; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; BONFANTI M, 1991, NUCLEIC ACIDS RES, V19, P5739, DOI 10.1093/nar/19.20.5739; Boonen RACM, 2009, AGEING RES REV, V8, P71, DOI 10.1016/j.arr.2008.11.003; Borenstein AR, 2007, NEUROLOGY, V68, P1764, DOI 10.1212/01.wnl.0000262027.31623.b2; Caricasole A, 2005, BIOSCIENCE REP, V25, P309, DOI 10.1007/s10540-005-2893-6; Chaparro-Huerta V, 2008, INT J DEV NEUROSCI, V26, P487, DOI 10.1016/j.ijdevneu.2008.02.008; Chen JZ, 2009, CANCER BIOL THER, V8, P1313, DOI 10.4161/cbt.8.14.8983; Chen Y, 2009, J CELL BIOCHEM, V106, P353, DOI 10.1002/jcb.22020; Churchwell MI, 2006, J CHROMATOGR B, V844, P60, DOI 10.1016/j.jchromb.2006.06.042; CORREA P, 1975, LANCET, V2, P58; de la Monte SM, 2009, J ALZHEIMERS DIS, V17, P817, DOI 10.3233/JAD-2009-1098; de la Monte SM, 2009, BMB REP, V42, P475, DOI 10.5483/BMBRep.2009.42.8.475; de la Monte SM, 2009, J ALZHEIMERS DIS, V17, P519, DOI 10.3233/JAD-2009-1070; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Elia L, 2009, CIRCULATION, V120, P2377, DOI 10.1161/CIRCULATIONAHA.109.879429; Esclaire F, 1999, EXP NEUROL, V155, P11, DOI 10.1006/exnr.1998.6962; Ganjam GK, 2009, J BIOL CHEM, V284, P30783, DOI 10.1074/jbc.M109.045260; GARRUTO RM, 1981, ANN NEUROL, V10, P341, DOI 10.1002/ana.410100405; GARRUTO RM, 1980, ANN NEUROL, V8, P612, DOI 10.1002/ana.410080612; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ghosh R, 1999, NUCLEIC ACIDS RES, V27, P3213, DOI 10.1093/nar/27.15.3213; Glassner BJ, 1999, MUTAGENESIS, V14, P339, DOI 10.1093/mutage/14.3.339; Haddock RL, 2009, ASIAN PAC J CANCER P, V10, P57; Hailer-Morrison MK, 2003, BIOCHEMISTRY-US, V42, P9761, DOI 10.1021/bi034546k; Hebert SS, 2010, HUM MOL GENET, V19, P3959, DOI 10.1093/hmg/ddq311; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; JONES MZ, 1976, J NEUROPATH EXP NEUR, V35, P413, DOI 10.1097/00005072-197607000-00004; Kihira T, 2009, NEUROPATHOLOGY, V29, P548, DOI 10.1111/j.1440-1789.2009.01010.x; Kisby GE, 2009, DNA REPAIR, V8, P400, DOI 10.1016/j.dnarep.2008.12.002; Kisby GE, 2005, NEUROBIOL DIS, V19, P108, DOI 10.1016/j.nbd.2004.11.014; KISBY GE, 1992, NEUROLOGY, V42, P1336, DOI 10.1212/WNL.42.7.1336; KURLAND LT, 1972, FED PROC, V31, P1540; Kuzuhara S, 2001, ANN NEUROL, V49, P501, DOI 10.1002/ana.100; LAQUEUR GL, 1967, JNCI-J NATL CANCER I, V39, P355; LAQUEUR GL, 1963, J NATL CANCER I, V31, P919; MCGEER PL, 2011, PROG NEUROBIOL   APR; McKean JW, 2004, STAT SCI, V19, P562, DOI 10.1214/088342304000000549; Michigami Toshimi, 2010, Clin Calcium, V20, P1196, DOI CliCa100811961202; Miklossy J, 2008, ACTA NEUROPATHOL, V116, P625, DOI 10.1007/s00401-008-0439-2; Morris LGT, 2010, ONCOGENE, V29, P3453, DOI 10.1038/onc.2010.127; Munoz L, 2010, NEUROPHARMACOLOGY, V58, P561, DOI 10.1016/j.neuropharm.2009.11.010; Muyllaert D, 2008, GENES BRAIN BEHAV, V7, P57, DOI 10.1111/j.1601-183X.2007.00376.x; Nigro N D, 1985, Prog Clin Biol Res, V186, P161; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Park EC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004284; Parsian AJ, 2002, MUTAT RES-FUND MOL M, V501, P105, DOI 10.1016/S0027-5107(02)00016-7; Plato CC, 2003, AM J EPIDEMIOL, V157, P149, DOI 10.1093/aje/kwf175; Reinhardt HC, 2007, CANCER CELL, V11, P175, DOI 10.1016/j.ccr.2006.11.024; ROBISON SH, 1984, J NEUROL SCI, V64, P11, DOI 10.1016/0022-510X(84)90051-0; ROMAN GC, 1995, ETIOLOGY PARKINSONS, P203; Romanowska M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005354; Rosenberg DW, 2009, CARCINOGENESIS, V30, P183, DOI 10.1093/carcin/bgn267; Roth U, 2004, J BIOL CHEM, V279, P2623, DOI 10.1074/jbc.M308391200; Ryffel GU, 2001, J MOL ENDOCRINOL, V27, P11, DOI 10.1677/jme.0.0270011; Salkovic-Petrisic M, 2009, J ALZHEIMERS DIS, V18, P729, DOI 10.3233/JAD-2009-1184; Sarver AL, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-401; Serrano J, 2010, ONCOGENE, V29, P2165, DOI 10.1038/onc.2009.503; SHIRAKE H, 1975, HDB CLIN NEUROLOGY 2, V22; Shors TJ, 2002, HIPPOCAMPUS, V12, P578, DOI 10.1002/hipo.10103; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Silber JR, 1996, P NATL ACAD SCI USA, V93, P6941, DOI 10.1073/pnas.93.14.6941; Souter S, 2010, CURR ALZHEIMER RES, V7, P697, DOI 10.2174/156720510793611637; Spencer PS, 2005, MOVEMENT DISORD, V20, pS119, DOI 10.1002/mds.20552; SPENCER PS, 1991, NEUROLOGY, V41, P62, DOI 10.1212/WNL.41.5_Suppl_2.62; SPENCER PS, 1987, CAN J NEUROL SCI, V14, P347, DOI 10.1017/S0317167100037732; Staropoli JF, 2008, BIOESSAYS, V30, P719, DOI 10.1002/bies.20784; Steen E, 2005, J ALZHEIMERS DIS, V7, P63, DOI 10.3233/jad-2005-7107; Suzui M, 2001, MOL CARCINOGEN, V32, P206, DOI 10.1002/mc.10014; Suzuki M, 2010, ACTA NEUROL SCAND, V122, P367, DOI 10.1111/j.1600-0404.2010.01321.x; Takahashi M, 2004, CANCER SCI, V95, P475, DOI 10.1111/j.1349-7006.2004.tb03235.x; Terpstra JT, 2005, J STAT SOFTW, V14; Vadigepalli Rajanikanth, 2003, OMICS A Journal of Integrative Biology, V7, P235, DOI 10.1089/153623103322452378; WHITING MG, 1988, TRANSCR 4 CYC C; Winton MJ, 2006, ACTA NEUROPATHOL, V111, P401, DOI 10.1007/s00401-006-0053-0; Yamini B, 2007, CANCER RES, V67, P6889, DOI 10.1158/0008-5472.CAN-06-4496; Zhang RY, 2010, NEUROBIOL DIS, V38, P68, DOI 10.1016/j.nbd.2009.12.028; Zhang ZX, 1996, ACTA NEUROL SCAND, V94, P51, DOI 10.1111/j.1600-0404.1996.tb00039.x; R CODE IMPLEMENT RLM	86	38	41	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e20911	10.1371/journal.pone.0020911	http://dx.doi.org/10.1371/journal.pone.0020911			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731631	Green Submitted, gold, Green Published			2022-12-27	WOS:000292035400006
J	Meng, E; Cai, TF; Li, WY; Zhang, H; Liu, YB; Peng, K; Liang, SP; Zhang, DY				Meng, Er; Cai, Tian-Fu; Li, Wen-Ying; Zhang, Hui; Liu, Yan-Bo; Peng, Kuan; Liang, Songping; Zhang, Dong-Yi			Functional Expression of Spider Neurotoxic Peptide Huwentoxin-I in E. coli	PLOS ONE			English	Article							DISULFIDE BOND FORMATION; SELENOCOSMIA-HUWENA; ESCHERICHIA-COLI; SCANNING MUTAGENESIS; CHANNEL BLOCKER; VENOM; TRANSLOCATION; PURIFICATION; CYTOPLASM; SEQUENCE	The coding sequence of huwentoxin-I, a neurotoxic peptide isolated from the venom of the Chinese spider Ornithoctonus huwena, was amplified by PCR using the cDNA library constructed from the spider venom glands. The cloned fragment was inserted into the expression vector pET-40b and transformed into the E. coli strain BL21 (DE3). The expression of a soluble fusion protein, disulfide interchange protein (DsbC)-huwentoxin-I, was auto-induced in the periplasm of E. coli in the absence of IPTG. After partial purification using a Ni-NTA column, the expressed fusion protein was digested using enterokinase to release heteroexpressed huwentoxin-I and was further purified using RP-HPLC. The resulting peptide was subjected to gel electrophoresis and mass spectrometry analysis. The molecular weight of the heteroexpressed huwentoxin-I was 3750.69, which is identical to that of the natural form of the peptide isolated from spider venom. The physiological properties of the heteroexpressed huwentoxin-I were further analyzed using a whole-cell patch clamp assay. The heteroexpressed huwentoxin-I was able to block currents generated by human Na-v1.7 at an IC50 of 640 nmole/L, similar to that of the natural huwentoxin-I, which is 630 nmole/L.	[Meng, Er; Cai, Tian-Fu; Zhang, Hui; Liu, Yan-Bo; Liang, Songping] Hunan Normal Univ, Coll Life Sci, Minist Educ, Key Lab Prot Chem & Dev Biol, Changsha, Hunan, Peoples R China; [Meng, Er; Li, Wen-Ying; Zhang, Dong-Yi] Natl Univ Def Technol, Coll Sci, Res Ctr Biol Informat, Changsha, Hunan, Peoples R China; [Peng, Kuan] Cent S Univ Forestry & Technol, Core Facil Biotechnol, Changsha, Hunan, Peoples R China	Hunan Normal University; National University of Defense Technology - China; Central South University of Forestry & Technology	Meng, E (corresponding author), Hunan Normal Univ, Coll Life Sci, Minist Educ, Key Lab Prot Chem & Dev Biol, Changsha, Hunan, Peoples R China.	liangsp@hunnu.edu.cn; dongyizhang@yahoo.cn			National Natural Science Foundation of China [30971432]; New Century Excellent Talents in University [NCET-05-0715]; Ministry of Science and Technology of China [2010CB529800]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by National Natural Science Foundation of China, No. 30971432 to Dr. D.Y. Zhang; New Century Excellent Talents in University, No. NCET-05-0715 to Dr. D.Y. Zhang; the Ministry of Science and Technology of China "973" Project, No. 2010CB529800 to Dr. S. P. Liang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarraberes FA, 2001, BBA-BIOMEMBRANES, V1513, P1, DOI 10.1016/S0304-4157(01)00005-3; Anangi R, 2007, TOXIN REV, V26, P169, DOI 10.1080/15569540701209815; Chen J, 1999, J BIOL CHEM, V274, P19601, DOI 10.1074/jbc.274.28.19601; Chen JQ, 2005, TOXICON, V45, P15, DOI 10.1016/j.toxicon.2004.08.018; Diao JB, 2003, TOXICON, V42, P715, DOI 10.1016/j.toxicon.2003.08.007; [刁建波 Diao Jianbo], 2003, [中国生物化学与分子生物学报, Chinese Journal of Biochemistry and Molecular Biology], V19, P195; Escoubas P, 2004, TOXICON, V43, P555, DOI 10.1016/j.toxicon.2004.02.007; Escoubas P, 2003, PROTEIN SCI, V12, P1332, DOI 10.1110/ps.0307003; Escoubas P, 2009, EXPERT REV PROTEOMIC, V6, P221, DOI 10.1586/EPR.09.45; Ji WJ, 2005, PROTEIN EXPRES PURIF, V41, P454, DOI 10.1016/j.pep.2005.02.012; Jiang LP, 2009, PEPTIDES, V30, P669, DOI 10.1016/j.peptides.2008.12.012; KANG Y, 1994, J BIOTECHNOL, V36, P45, DOI 10.1016/0168-1656(94)90022-1; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li M, 2000, TOXICON, V38, P153, DOI 10.1016/S0041-0101(99)00123-3; LIANG SP, 1993, TOXICON, V31, P969, DOI 10.1016/0041-0101(93)90256-I; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; [刘君梁 Liu Junliang], 2005, [中国生物化学与分子生物学报, Chinese Journal of Biochemistry and Molecular Biology], V21, P39; Maggio F, 2002, J BIOL CHEM, V277, P22806, DOI 10.1074/jbc.M202297200; Mergulhao FJM, 2005, BIOTECHNOL ADV, V23, P177, DOI 10.1016/j.biotechadv.2004.11.003; Miot M, 2004, MICROB CELL FACT, V3, DOI 10.1186/1475-2859-3-4; Nie Dong-Song, 2002, Sheng Wu Gong Cheng Xue Bao, V18, P172; PARK CS, 1991, P NATL ACAD SCI USA, V88, P2046, DOI 10.1073/pnas.88.6.2046; Peng K, 2001, TOXICON, V39, P491, DOI 10.1016/S0041-0101(00)00150-1; Prinz WA, 1997, J BIOL CHEM, V272, P15661, DOI 10.1074/jbc.272.25.15661; Qu YX, 1997, J PROTEIN CHEM, V16, P565, DOI 10.1023/A:1026314722607; Ren GP, 2007, J BACTERIOL, V189, P2777, DOI 10.1128/JB.01406-06; Saez NJ, 2010, TOXINS, V2, P2851, DOI 10.3390/toxins2122851; SMITH LA, 1993, BIOCHEMISTRY-US, V32, P5692, DOI 10.1021/bi00072a026; Stewart EJ, 1998, EMBO J, V17, P5543, DOI 10.1093/emboj/17.19.5543; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tedford HW, 2004, J BIOL CHEM, V279, P44133, DOI 10.1074/jbc.M404006200; Wang MC, 2007, BIOCHEM BIOPH RES CO, V357, P579, DOI 10.1016/j.bbrc.2007.02.168; Xiao YC, 2008, J BIOL CHEM, V283, P27300, DOI 10.1074/jbc.M708447200; ZAPUN A, 1995, BIOCHEMISTRY-US, V34, P5075, DOI 10.1021/bi00015a019; ZHANG DG, 1993, J PROTEIN CHEM, V12, P735, DOI 10.1007/BF01024931; Zhou PA, 1997, TOXICON, V35, P39, DOI 10.1016/S0041-0101(96)00072-4	36	21	24	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21608	10.1371/journal.pone.0021608	http://dx.doi.org/10.1371/journal.pone.0021608			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731778	gold, Green Published, Green Submitted			2022-12-27	WOS:000292035400051
J	Apic, G; Betts, MJ; Russell, RB				Apic, Gordana; Betts, Matthew J.; Russell, Robert B.			Content Disputes in Wikipedia Reflect Geopolitical Instability	PLOS ONE			English	Article								Indicators that rank countries according socioeconomic measurements are important tools for regional development and political reform. Those currently in widespread use are sometimes criticized for a lack of reproducibility or the inability to compare values over time, necessitating simple, fast and systematic measures. Here, we applied the 'guilt by association' principle often used in biological networks to the information network within the online encyclopedia Wikipedia to create an indicator quantifying the degree to which pages linked to a country are disputed by contributors. The indicator correlates with metrics of governance, political or economic stability about as well as they correlate with each other, and though faster and simpler, it is remarkably stable over time despite constant changes in the underlying disputes. For some countries, changes over a four year period appear to correlate with world events related to conflicts or economic problems.	[Apic, Gordana; Betts, Matthew J.; Russell, Robert B.] Heidelberg Univ, Cell Networks, Heidelberg, Germany; [Apic, Gordana] Cambridge Cell Networks Ltd, St Johns Innovat Ctr, Cambridge, England	Ruprecht Karls University Heidelberg; St Johns Innovation Centre - UK	Apic, G (corresponding author), Heidelberg Univ, Cell Networks, Heidelberg, Germany.	robert.russell@bioquant.uni-heidelberg.de	Russell, Rob/AAH-9145-2019; Russell, Robert/GWU-6389-2022	Russell, Rob/0000-0002-1905-4717; Russell, Robert/0000-0002-7213-1398	German Science Ministry (DFG)	German Science Ministry (DFG)(German Research Foundation (DFG))	We are supported in part by the Excellence Grant CellNetworks from the German Science Ministry (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Burns A., 2009, RECORD COMMUNICATION, P298; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Giles J, 2005, NATURE, V438, P900, DOI 10.1038/438900a; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; KAUFMANN D, 2009, 4978 WORLD BANK POLI; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Mastruzzi M., 2007, 4149 WORLD BANK POL; Oliver S, 2000, NATURE, V403, P601, DOI 10.1038/35001165; Palla G, 2007, NATURE, V446, P664, DOI 10.1038/nature05670; SARWAR B, 2000, P 2 ACM C EL COMM, P158, DOI DOI 10.1145/352871.352887; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; VINTON G, 2007, CERF DISRUPTIVE POWE; Yu HY, 2006, BIOINFORMATICS, V22, P823, DOI 10.1093/bioinformatics/btl014; Zhu XW, 2007, GENE DEV, V21, P1010, DOI 10.1101/gad.1528707	16	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e20902	10.1371/journal.pone.0020902	http://dx.doi.org/10.1371/journal.pone.0020902			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731630	Green Submitted, Green Published, gold			2022-12-27	WOS:000292033700018
J	Bowen, L; Ebrahim, S; De Stavola, B; Ness, A; Kinra, S; Bharathi, AV; Prabhakaran, D; Reddy, KS				Bowen, Liza; Ebrahim, Shah; De Stavola, Bianca; Ness, Andy; Kinra, Sanjay; Bharathi, A. V.; Prabhakaran, Dorairaj; Reddy, K. Srinath			Dietary Intake and Rural-Urban Migration in India: A Cross-Sectional Study	PLOS ONE			English	Article							FOOD FREQUENCY QUESTIONNAIRE; CORONARY-HEART-DISEASE; RISK-FACTORS; CARDIOVASCULAR-DISEASES; BLOOD-PRESSURE; CONSUMPTION; HABITS; FRUIT; REPRODUCIBILITY; TRANSITION	Background: Migration from rural areas of India contributes to urbanisation and lifestyle change, and dietary changes may increase the risk of obesity and chronic diseases. We tested the hypothesis that rural-to-urban migrants have different macronutrient and food group intake to rural non-migrants, and that migrants have a diet more similar to urban non-migrants. Methods and findings: The diets of migrants of rural origin, their rural dwelling sibs, and those of urban origin together with their urban dwelling sibs were assessed by an interviewer-administered semi-quantitative food frequency questionnaire. A total of 6,509 participants were included. Median energy intake in the rural, migrant and urban groups was 2731, 3078, and 3224 kcal respectively for men, and 2153, 2504, and 2644 kcal for women (p<0.001). A similar trend was seen for overall intake of fat, protein and carbohydrates (p<0.001), though differences in the proportion of energy from these nutrients were <2%. Migrant and urban participants reported up to 80% higher fruit and vegetable intake than rural participants (p<0.001), and up to 35% higher sugar intake (p<0.001). Meat and dairy intake were higher in migrant and urban participants than rural participants (p<0.001), but varied by region. Sibling-pair analyses confirmed these results. There was no evidence of associations with time in urban area. Conclusions: Rural to urban migration appears to be associated with both positive (higher fruit and vegetables intake) and negative (higher energy and fat intake) dietary changes. These changes may be of relevance to cardiovascular health and warrant public health interventions.	[Bowen, Liza; Ebrahim, Shah; De Stavola, Bianca; Kinra, Sanjay] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England; [Ebrahim, Shah; Prabhakaran, Dorairaj] Publ Hlth Fdn India, S Asia Network Chron Dis, New Delhi, India; [Ness, Andy] Univ Bristol, Sch Oral & Dent Sci, Bristol, Avon, England; [Bharathi, A. V.] Indira Gandhi Natl Open Univ, Dept Food Sci & Nutr, New Delhi, India; [Prabhakaran, Dorairaj] Ctr Chron Dis Control, New Delhi, India	University of London; London School of Hygiene & Tropical Medicine; Public Health Foundation of India; University of Bristol	Bowen, L (corresponding author), London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England.	lizabowen@gmail.com	Bowen, Liza/AAA-5502-2019; Berryman, Katie/J-4236-2014; Prabhakaran, Dorairaj/B-4147-2011; Ness, Andy R/M-7612-2013	Prabhakaran, Dorairaj/0000-0002-3172-834X; Ness, Andy R/0000-0003-3548-9523; Reddy, K Srinath/0000-0003-3416-3548; De Stavola, Bianca Lucia/0000-0001-7853-0528; Bowen, Liza/0000-0001-8318-8421	Wellcome Trust [GR070797MF]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work is funded by Wellcome Trust project grant GR070797MF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bansal D., 2010, PUBLIC HEALTH NUTR, P1; Bjerregaard P, 2002, INT J OBESITY, V26, P1503, DOI 10.1038/sj.ijo.0802082; Bjerregaard P, 2007, SCAND J PUBLIC HEALT, V35, P380, DOI 10.1080/14034940701195214; Ebrahim S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000268; Elwood PC, 2004, EUR J CLIN NUTR, V58, P718, DOI 10.1038/sj.ejcn.1601869; Enas Enas A, 2008, Indian Heart J, V60, P161; Fall CHD, 2001, BRIT MED BULL, V60, P33, DOI 10.1093/bmb/60.1.33; *FAOSTAT, 2006, COR CONS DAT; *FOOD STAND AG, 2003, NAT DIET NUTR SURV A; Food Standards Agency, 2006, FSA NUTR FOOD BAS GU; Ghaffar A, 2004, BMJ-BRIT MED J, V328, P807, DOI 10.1136/bmj.328.7443.807; Goplan C, 1971, NUTR VALUE INDIAN FO, P58; Hammar N, 2009, EUR J CLIN NUTR, V63, P312, DOI 10.1038/sj.ejcn.1602931; HARDING WR, 1986, ECOL FOOD NUTR, V19, P83, DOI 10.1080/03670244.1986.9990951; HE J, 1991, HYPERTENSION, V17, P378, DOI 10.1161/01.HYP.17.3.378; He J, 1996, AM J EPIDEMIOL, V144, P839, DOI 10.1093/oxfordjournals.aje.a009018; Hebert JR, 1999, PUBLIC HEALTH NUTR, V2, P39, DOI 10.1017/S1368980099000051; Hebert JR, 1998, PUBLIC HEALTH NUTR, V1, P123, DOI 10.1079/PHN19980019; *IIPS, 2006, KEY FIND NFHS 3; International Institute for Population Sciences (IIPS) and Macro International, 2007, NAT FAM HLTH SURV NF; Jonnalagadda SS, 2002, J AM COLL NUTR, V21, P372, DOI 10.1080/07315724.2002.10719238; Kakar A, 2003, J Assoc Physicians India, V51, P87; Katan MB, 2010, JAMA-J AM MED ASSOC, V303, P65, DOI 10.1001/jama.2009.1912; Kouris-Blazos A, 2002, ASIA PAC J CLIN NUTR, V11, pS569, DOI 10.1046/j.1440-6047.11.supp3.2.x; KUSHI LH, 1985, NEW ENGL J MED, V312, P811, DOI 10.1056/NEJM198503283121302; LEE MM, 1994, INT J EPIDEMIOL, V23, P984, DOI 10.1093/ije/23.5.984; MENSINK RP, 1992, ARTERIOSCLER THROMB, V12, P911, DOI 10.1161/01.ATV.12.8.911; Mente A, 2009, ARCH INTERN MED, V169, P659, DOI 10.1001/archinternmed.2009.38; Mohan V, 2004, J Assoc Physicians India, V52, P468; Mohan V, 2008, DIABETES RES CLIN PR, V80, P159, DOI 10.1016/j.diabres.2007.11.018; *NAT SAMP SURV ORG, 2007, NUTR INT IND 2004 20; Ness AR, 1999, J CARDIOVASC RISK, V6, P229; Ness AR, 1997, INT J EPIDEMIOL, V26, P1, DOI 10.1093/ije/26.1.1; Ounpuu S, 2000, EUR HEART J, V21, P880, DOI 10.1053/euhj.1999.1880; Pandey D, 2005, NATL MED J INDIA, V18, P230; Patel JV, 2006, ATHEROSCLEROSIS, V185, P297, DOI 10.1016/j.atherosclerosis.2005.06.005; POULTER NR, 1990, BMJ-BRIT MED J, V300, P967, DOI 10.1136/bmj.300.6730.967; POWLES JW, 1993, J HUM HYPERTENS, V7, P419; Radhika G, 2008, BRIT J NUTR, V99, P398, DOI 10.1017/S0007114507803965; Raj S, 1999, J AM DIET ASSOC, V99, P1106, DOI 10.1016/S0002-8223(99)00266-7; Reddy KS, 2006, B WORLD HEALTH ORGAN, V84, P461, DOI 10.2471/BLT.05.027037; Reddy KS, 2009, NESTLE NUTR WORKS SE, V63, P15, DOI 10.1159/000209969; Reddy KS, 2004, PUBLIC HEALTH NUTR, V7, P167, DOI 10.1079/PHN2003587; Ruxton CHS, 2010, CRIT REV FOOD SCI, V50, P1, DOI 10.1080/10408390802248569; Shetty PS, 2002, PUBLIC HEALTH NUTR, V5, P175, DOI 10.1079/PHN2001291; Speedy AW, 2003, J NUTR, V133, p4048S, DOI 10.1093/jn/133.11.4048S; Stamler J., 2005, CORONARY HEART DIS E, V2, P18; Sudha V, 2006, INT J FOOD SCI NUTR, V57, P481, DOI 10.1080/09637480600969220; TILLOTSON JL, 1973, AM J CLIN NUTR, V26, P177, DOI 10.1093/ajcn/26.2.177; Torun B, 2002, INT J EPIDEMIOL, V31, P218, DOI 10.1093/ije/31.1.218; *USDA, NUTR DAT LAB; van Baak MA, 2009, OBES REV, V10, P9, DOI 10.1111/j.1467-789X.2008.00561.x; Welch AU., 1995, MCCANCE WIDDOWSONS C; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487	55	83	85	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e14822	10.1371/journal.pone.0014822	http://dx.doi.org/10.1371/journal.pone.0014822			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731604	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000292033700002
J	DiMaio, F; Leaver-Fay, A; Bradley, P; Baker, D; Andre, I				DiMaio, Frank; Leaver-Fay, Andrew; Bradley, Phil; Baker, David; Andre, Ingemar			Modeling Symmetric Macromolecular Structures in Rosetta3	PLOS ONE			English	Article							PROTEIN-STRUCTURE PREDICTION; SEQUENCES	Symmetric protein assemblies play important roles in many biochemical processes. However, the large size of such systems is challenging for traditional structure modeling methods. This paper describes the implementation of a general framework for modeling arbitrary symmetric systems in Rosetta3. We describe the various types of symmetries relevant to the study of protein structure that may be modeled using Rosetta's symmetric framework. We then describe how this symmetric framework is efficiently implemented within Rosetta, which restricts the conformational search space by sampling only symmetric degrees of freedom, and explicitly simulates only a subset of the interacting monomers. Finally, we describe structure prediction and design applications that utilize the Rosetta3 symmetric modeling capabilities, and provide a guide to running simulations on symmetric systems.	[DiMaio, Frank; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Leaver-Fay, Andrew] Univ N Carolina, Dept Biochem, Chapel Hill, NC 27599 USA; [Bradley, Phil] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Andre, Ingemar] Lund Univ, Ctr Chem, Ctr Mol Prot Sci, Dept Biochem & Struct Biol, Lund, Sweden	University of Washington; University of Washington Seattle; University of North Carolina; University of North Carolina Chapel Hill; Fred Hutchinson Cancer Center; Lund University	DiMaio, F (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	dimaio@u.washington.edu	Baker, David/K-8941-2012; André, Ingemar/O-4777-2014	Baker, David/0000-0001-7896-6217; André, Ingemar/0000-0002-4753-8233	NIH [P41RR002250, R01GM092802]; HHMI; Knut and Alice Wallenberg Foundation; Crafoord foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092802] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Crafoord foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	FD and DB acknowledge the NIH (P41RR002250, R01GM092802) and HHMI. IA was supported by the Knut and Alice Wallenberg Foundation and the Crafoord foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE H, 1984, COMPUT CHEM, V8, P239, DOI 10.1016/0097-8485(84)85015-9; Andre I, 2007, P NATL ACAD SCI USA, V104, P17656, DOI 10.1073/pnas.0702626104; Bradley P, 2006, PROTEINS, V65, P922, DOI 10.1002/prot.21133; Das R, 2009, P NATL ACAD SCI USA, V106, P18978, DOI 10.1073/pnas.0904407106; Kuhlman B, 2000, P NATL ACAD SCI USA, V97, P10383, DOI 10.1073/pnas.97.19.10383; Leaver-Fay A, 2005, LECT NOTES COMPUT SC, V3692, P389; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; MOULT J, 1995, PROTEINS, V23, pR2, DOI 10.1002/prot.340230303; Pierce NA, 2002, PROTEIN ENG, V15, P779, DOI 10.1093/protein/15.10.779; PONDER JW, 1987, J MOL BIOL, V193, P775, DOI 10.1016/0022-2836(87)90358-5; Sgourakis NG, 2011, J AM CHEM SOC, V133, P6288, DOI 10.1021/ja111318m; Wang C, 2007, J MOL BIOL, V373, P503, DOI 10.1016/j.jmb.2007.07.050	12	136	140	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e20450	10.1371/journal.pone.0020450	http://dx.doi.org/10.1371/journal.pone.0020450			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731614	Green Published, Green Submitted, gold			2022-12-27	WOS:000292033700008
J	Ohira, T; Terada, M; Kawano, F; Nakai, N; Ogura, A; Ohira, Y				Ohira, Takashi; Terada, Masahiro; Kawano, Fuminori; Nakai, Naoya; Ogura, Akihiko; Ohira, Yoshinobu			Region-Specific Responses of Adductor Longus Muscle to Gravitational Load-Dependent Activity in Wistar Hannover Rats	PLOS ONE			English	Article							MYOSIN HEAVY-CHAIN; SKELETAL-MUSCLE; SOLEUS MUSCLE; HINDLIMB SUSPENSION; MECHANICAL-PROPERTIES; SPACEFLIGHT; RECOVERY; FIBER; SLOW; ACTIVATION	Response of adductor longus (AL) muscle to gravitational unloading and reloading was studied. Male Wistar Hannover rats (5-wk old) were hindlimb-unloaded for 16 days with or without 16-day ambulation recovery. The electromyogram (EMG) activity in AL decreased after acute unloading, but that in the rostral region was even elevated during continuous unloading. The EMG levels in the caudal region gradually increased up to 6th day, but decreased again. Approximately 97% of fibers in the caudal region were pure type I at the beginning of experiment. Mean percentage of type I fibers in the rostral region was 61% and that of type I+II and II fiber was 14 and 25%, respectively. The percent type I fibers decreased and de novo appearance of type I+II was noted after unloading. But the fiber phenotype in caudal, not rostral and middle, region was normalized after 16-day ambulation. Pronounced atrophy after unloading and re-growth following ambulation was noted in type I fibers of the caudal region. Sarcomere length in the caudal region was passively shortened during unloading, but that in the rostral region was unchanged or even stretched slightly. Growth-associated increase of myonuclear number seen in the caudal region of control rats was inhibited by unloading. Number of mitotic active satellite cells decreased after unloading only in the caudal region. It was indicated that the responses of fiber properties in AL to unloading and reloading were closely related to the region-specific neural and mechanical activities, being the caudal region more responsive.	[Ohira, Takashi; Terada, Masahiro; Ogura, Akihiko; Ohira, Yoshinobu] Osaka Univ, Grad Sch Frontier Biosci, Toyonaka, Osaka 560, Japan; [Kawano, Fuminori; Nakai, Naoya; Ohira, Yoshinobu] Osaka Univ, Grad Sch Med, Toyonaka, Osaka 560, Japan	Osaka University; Osaka University	Ohira, T (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, Toyonaka, Osaka 560, Japan.	ohira@space.hss.osaka-u.ac.jp			Japan Society for the Promotion of Science [19100009]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was carried out as a part of a Grant-in-Aid for Scientific Research (S, 19100009) from the Japan Society for the Promotion of Science (http://www.jsps.go.jp/j-grantsinaid/index.html). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALFORD EK, 1987, EXP NEUROL, V96, P635, DOI 10.1016/0014-4886(87)90225-1; Allen DL, 1996, J APPL PHYSIOL, V81, P145, DOI 10.1152/jappl.1996.81.1.145; CAIOZZO VJ, 1994, J APPL PHYSIOL, V76, P1764, DOI 10.1152/jappl.1994.76.4.1764; DAMELIO F, 1992, J NEUROPATH EXP NEUR, V51, P415, DOI 10.1097/00005072-199207000-00004; De-Doncker L, 2006, EXP NEUROL, V201, P368, DOI 10.1016/j.expneurol.2006.04.021; De-Doncker L, 2005, J EXP BIOL, V208, P4585, DOI 10.1242/jeb.01931; Desaphy JF, 2005, NEUROBIOL DIS, V18, P356, DOI 10.1016/j.nbd.2004.09.016; Edgerton VR, 1996, HDB PHYSL 4, P721; Enns DL, 2007, EUR J APPL PHYSIOL, V100, P445, DOI 10.1007/s00421-007-0445-4; Enns DL, 2006, CAN J PHYSIOL PHARM, V84, P601, DOI 10.1139/Y06-013; Ikemoto M, 2001, FASEB J, V15, P1279, DOI 10.1096/fj.00-0629fje; JIANG B, 1992, J APPL PHYSIOL, V73, pS58, DOI 10.1152/jappl.1992.73.2.S58; Kawano F, 2007, AM J PHYSIOL-CELL PH, V293, pC35, DOI 10.1152/ajpcell.00297.2006; Kawano F, 2004, JPN J PHYSIOL, V54, P229, DOI 10.2170/jjphysiol.54.229; Kawano F, 2004, AM J PHYSIOL-REG I, V287, pR76, DOI 10.1152/ajpregu.00694.2003; Kawano F, 2002, NEUROSCIENCE, V114, P1133, DOI 10.1016/S0306-4522(02)00304-4; MARTIN TP, 1988, J APPL PHYSIOL, V65, P2318, DOI 10.1152/jappl.1988.65.5.2318; MIU B, 1990, FASEB J, V4, P64, DOI 10.1096/fasebj.4.1.2136839; Ohira M, 2002, JPN J PHYSIOL, V52, P235, DOI 10.2170/jjphysiol.52.235; Ohira T., 2009, JPN J AEROSP ENV MED, V46, P21; Ohira Y, 2003, JPN J PHYSIOL, V53, P389, DOI 10.2170/jjphysiol.53.389; OHIRA Y, 1992, J APPL PHYSIOL, V73, pS51, DOI 10.1152/jappl.1992.73.2.S51; Ohira Y, 1997, ACTA ANAT, V159, P90; Ohira Y, 2001, AM J PHYSIOL-CELL PH, V280, pC1008, DOI 10.1152/ajpcell.2001.280.4.C1008; OHIRA Y, 1994, AM J PHYSIOL, V266, pC1257, DOI 10.1152/ajpcell.1994.266.5.C1257; Ohira Yoshinobu, 2002, J Gravit Physiol, V9, P49; RILEY DA, 1990, FASEB J, V4, P84, DOI 10.1096/fasebj.4.1.2153085; Riley DA, 1996, J APPL PHYSIOL, V81, P133, DOI 10.1152/jappl.1996.81.1.133; Riley DA, 2005, AM J PHYSIOL-CELL PH, V288, pC360, DOI 10.1152/ajpcell.00386.2004; RILEY DA, 1992, J APPL PHYSIOL, V73, pS33, DOI 10.1152/jappl.1992.73.2.S33; Sugiura T, 2005, AM J PHYSIOL-REG I, V288, pR1273, DOI 10.1152/ajpregu.00688.2004; THOMASON DB, 1987, J APPL PHYSIOL, V63, P138, DOI 10.1152/jappl.1987.63.1.138; THOMASON DB, 1987, J APPL PHYSIOL, V63, P130, DOI 10.1152/jappl.1987.63.1.130; Thompson JL, 1999, ANAT REC, V254, P39, DOI 10.1002/(SICI)1097-0185(19990101)254:1<39::AID-AR6>3.0.CO;2-K; Vermaelen M, 2007, AM J PHYSIOL-CELL PH, V292, pC1723, DOI 10.1152/ajpcell.00398.2006; Wang XD, 2006, AM J PHYSIOL-CELL PH, V290, pC981, DOI 10.1152/ajpcell.00298.2005; WINIARSKI AM, 1987, EXP NEUROL, V96, P650, DOI 10.1016/0014-4886(87)90226-3	37	21	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21044	10.1371/journal.pone.0021044	http://dx.doi.org/10.1371/journal.pone.0021044			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731645	Green Published, Green Submitted, gold			2022-12-27	WOS:000292033700031
J	Bueno, LL; Lobo, FP; Morais, CG; Mourao, LC; de Avila, RAM; Soares, IS; Fontes, CJ; Lacerda, MV; Olortegui, CC; Bartholomeu, DC; Fujiwara, RT; Braga, EM				Bueno, Lilian Lacerda; Lobo, Francisco Pereira; Morais, Cristiane Guimaraes; Mourao, Luiza Carvalho; Machado de Avila, Ricardo Andrez; Soares, Irene Silva; Fontes, Cor Jesus; Lacerda, Marcus Vinicius; Olortegui, Carlos Chavez; Bartholomeu, Daniella Castanheira; Fujiwara, Ricardo Toshio; Braga, Erika Martins			Identification of a Highly Antigenic Linear B Cell Epitope within Plasmodium vivax Apical Membrane Antigen 1 (AMA-1)	PLOS ONE			English	Article							MALARIA VACCINE CANDIDATE; ERYTHROCYTE INVASION; ANTIBODY-RESPONSE; CLINICAL-TRIAL; FULL-LENGTH; DOMAIN-II; FALCIPARUM; RECOMBINANT; PROTEIN; PROGRESS	Apical membrane antigen 1 (AMA-1) is considered to be a major candidate antigen for a malaria vaccine. Previous immunoepidemiological studies of naturally acquired immunity to Plasmodium vivax AMA-1 (PvAMA-1) have shown a higher prevalence of specific antibodies to domain II (DII) of AMA-1. In the present study, we confirmed that specific antibody responses from naturally infected individuals were highly reactive to both full-length AMA-1 and DII. Also, we demonstrated a strong association between AMA-1 and DII IgG and IgG subclass responses. We analyzed the primary sequence of PvAMA-1 for B cell linear epitopes co-occurring with intrinsically unstructured/ disordered regions (IURs). The B cell epitope comprising the amino acid sequence 290-307 of PvAMA-1 (SASDQPTQYEEEMTDYQK), with the highest prediction scores, was identified in domain II and further selected for chemical synthesis and immunological testing. The antigenicity of the synthetic peptide was identified by serological analysis using sera from P. vivax-infected individuals who were knowingly reactive to the PvAMA-1 ectodomain only, domain II only, or reactive to both antigens. Although the synthetic peptide was recognized by all serum samples specific to domain II, serum with reactivity only to the full-length protein presented 58.3% positivity. Moreover, IgG reactivity against PvAMA-1 and domain II after depletion of specific synthetic peptide antibodies was reduced by 18% and 33% (P = 0.0001 for both), respectively. These results suggest that the linear epitope SASDQPTQYEEEMTDYQK is highly antigenic during natural human infections and is an important antigenic region of the domain II of PvAMA-1, suggesting its possible future use in pre-clinical studies.	[Bueno, Lilian Lacerda; Lobo, Francisco Pereira; Morais, Cristiane Guimaraes; Mourao, Luiza Carvalho; Bartholomeu, Daniella Castanheira; Fujiwara, Ricardo Toshio; Braga, Erika Martins] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Belo Horizonte, MG, Brazil; [Machado de Avila, Ricardo Andrez; Olortegui, Carlos Chavez] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil; [Soares, Irene Silva] Univ Sao Paulo, Dept Anal Clin & Toxicol, Sao Paulo, Brazil; [Fontes, Cor Jesus] Univ Fed Mato Grosso, Dept Clin Med, Cuiaba, Brazil; [Lacerda, Marcus Vinicius] Fundacao Med Trop Dr Heitor Vieira Dourado, Manaus, Amazonas, Brazil; [Fujiwara, Ricardo Toshio] Fiocruz MS, Inst Rene Rachou, Lab Imunol Celular & Mol, Belo Horizonte, MG, Brazil; [Bartholomeu, Daniella Castanheira] INCTV, Belo Horizonte, MG, Brazil; [Fujiwara, Ricardo Toshio] INCT DT, Salvador, BA, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade de Sao Paulo; Universidade Federal de Mato Grosso; Fundacao Oswaldo Cruz	Bueno, LL (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Belo Horizonte, MG, Brazil.	embraga@icb.ufmg.br	Fontes, Cor JF/G-7331-2018; Soares, Irene Silva/C-5974-2012; Chavez-Olortegui, Carlos/F-9227-2019; de Ávila, Ricardo Andrez Machado/J-8224-2015; Braga, Erika Martins/A-6776-2008; Bartholomeu, Daniella C./J-4714-2015; Fujiwara, Ricardo Toshio/J-7579-2012; Bueno, Lilian/AAQ-1939-2020; Lobo, Francisco Pereira/AAG-3118-2021; Soares, Irene/GQF-1984-2022	Fontes, Cor JF/0000-0003-2756-0588; Soares, Irene Silva/0000-0002-3336-6856; Chavez-Olortegui, Carlos/0000-0001-9390-7207; de Ávila, Ricardo Andrez Machado/0000-0002-1303-0490; Braga, Erika Martins/0000-0001-5550-7157; Bartholomeu, Daniella C./0000-0003-0974-7357; Fujiwara, Ricardo Toshio/0000-0002-4713-575X; Bueno, Lilian/0000-0003-3510-4590; Lobo, Francisco Pereira/0000-0002-9671-9313; 	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais/FAPEMIG [CBB APQ-0997-4.01/07]; CNPq/Brazil; PNPD/CAPES; Brazilian National Research Council (CNPq); Pro-Reitoria de Pesquisa of the Universidade Federal de Minas Gerais	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais/FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq/Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); PNPD/CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Pro-Reitoria de Pesquisa of the Universidade Federal de Minas Gerais	This work was financially supported by Fundacao de Amparo a Pesquisa do Estado de Minas Gerais/FAPEMIG (Grant # CBB APQ-0997-4.01/07). Lilian Bueno is supported by a Doctoral degree fellowship from CNPq/Brazil. Francisco Lobo is supported by a Post-doctoral fellowship from PNPD/CAPES. Irene Soares, Daniella Bartholomeu, Marcus Vinicius Lacerda, Carlos Chavez Olortegui, Ricardo Fujiwara and Erika Braga are supported by Brazilian National Research Council (CNPq) fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors would also like to thank the financial support from Pro-Reitoria de Pesquisa of the Universidade Federal de Minas Gerais for English editing costs.	Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000406; Anders RF, 1998, VACCINE, V16, P240, DOI 10.1016/S0264-410X(97)88331-4; Angov E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002189; Anstey NM, 2009, TRENDS PARASITOL, V25, P220, DOI 10.1016/j.pt.2009.02.003; Arevalo-Herrera M, 2010, HUM VACCINES, V6, P124, DOI 10.4161/hv.6.1.9931; ARIAS AE, 1989, TROP MED PARASITOL, V40, P21; Baird JK, 2004, ANTIMICROB AGENTS CH, V48, P4075, DOI 10.1128/AAC.48.11.4075-4083.2004; Blythe MJ, 2005, PROTEIN SCI, V14, P246, DOI 10.1110/ps.041059505; Bozdech Z, 2008, P NATL ACAD SCI USA, V105, P16290, DOI 10.1073/pnas.0807404105; Carlton JM, 2008, NATURE, V455, P757, DOI 10.1038/nature07327; Chesne-Seck ML, 2005, MOL BIOCHEM PARASIT, V144, P55, DOI 10.1016/j.molbiopara.2005.07.007; COLLINS WE, 1994, AM J TROP MED HYG, V51, P711, DOI 10.4269/ajtmh.1994.51.711; DEANS JA, 1988, PARASITE IMMUNOL, V10, P535, DOI 10.1111/j.1365-3024.1988.tb00241.x; Donahue CG, 2000, MOL BIOCHEM PARASIT, V111, P15, DOI 10.1016/S0166-6851(00)00289-9; Doolan DL, 2011, INT J PARASITOL, V41, P3, DOI 10.1016/j.ijpara.2010.08.002; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; DRUILHE P, 1987, INFECT IMMUN, V55, P888, DOI 10.1128/IAI.55.4.888-891.1987; Feng ZP, 2005, J MOL BIOL, V350, P641, DOI 10.1016/j.jmb.2005.05.011; Fraser TS, 2001, MOL BIOCHEM PARASIT, V117, P49, DOI 10.1016/S0166-6851(01)00326-7; Gaffar FR, 2004, INFECT IMMUN, V72, P2947, DOI 10.1128/IAI.72.5.2947-2955.2004; GAUSEPOHL H, 1992, PEPTIDE RES, V5, P315; Gentil F, 2010, VACCINE, V28, P6183, DOI 10.1016/j.vaccine.2010.07.017; Good MF, 2005, TRENDS PARASITOL, V21, P29, DOI 10.1016/j.pt.2004.10.006; Good MF, 2010, IMMUNITY, V33, P555, DOI 10.1016/j.immuni.2010.10.005; Gunasekera AM, 2007, MOL BIOL EVOL, V24, P939, DOI 10.1093/molbev/msm013; Hehl AB, 2000, INFECT IMMUN, V68, P7078, DOI 10.1128/IAI.68.12.7078-7086.2000; Herrera S, 2007, TRENDS PARASITOL, V23, P122, DOI 10.1016/j.pt.2007.01.008; Hodder AN, 2001, INFECT IMMUN, V69, P3286, DOI 10.1128/IAI.69.5.3286-3294.2001; Howell SA, 2003, J BIOL CHEM, V278, P23890, DOI 10.1074/jbc.M302160200; Howell SA, 2001, J BIOL CHEM, V276, P31311, DOI 10.1074/jbc.M103076200; Kato K, 2005, P NATL ACAD SCI USA, V102, P5552, DOI 10.1073/pnas.0501594102; Kimura Masatsugu, 1997, Parasitology International, V46, P91, DOI 10.1016/S1383-5769(97)00013-5; Kocken CHM, 1999, INFECT IMMUN, V67, P43, DOI 10.1128/IAI.67.1.43-49.1999; Lalitha PV, 2004, INFECT IMMUN, V72, P4464, DOI 10.1128/IAI.72.8.4464-4470.2004; Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2; Li F, 2002, J BIOL CHEM, V277, P50303, DOI 10.1074/jbc.M207985200; List C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000771; Mahanty S, 2003, J EXP BIOL, V206, P3781, DOI 10.1242/jeb.00646; Malkin EM, 2005, INFECT IMMUN, V73, P3677, DOI 10.1128/IAI.73.6.3677-3685.2005; Mitchell GH, 2004, INFECT IMMUN, V72, P154, DOI 10.1128/IAI.72.1.154-158.2004; Moorthy VS, 2004, LANCET, V363, P150, DOI 10.1016/S0140-6736(03)15267-1; MORAIS CG, 2005, RESPOSTA HUMORAL ISO, P102; Morais CG, 2006, AM J TROP MED HYG, V75, P582, DOI 10.4269/ajtmh.2006.75.582; Mufalo BC, 2008, MICROBES INFECT, V10, P1266, DOI 10.1016/j.micinf.2008.07.023; NARUM DL, 1994, MOL BIOCHEM PARASIT, V67, P59, DOI 10.1016/0166-6851(94)90096-5; Narum DL, 2000, INFECT IMMUN, V68, P2899, DOI 10.1128/IAI.68.5.2899-2906.2000; Ockenhouse CF, 1998, J INFECT DIS, V177, P1664, DOI 10.1086/515331; Oliveira-Ferreira J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-115; Pain A, 2009, NAT REV MICROBIOL, V7, P180, DOI 10.1038/nrmicro2096; PETERSON MG, 1989, MOL CELL BIOL, V9, P3151, DOI 10.1128/MCB.9.7.3151; Pizarro JC, 2005, SCIENCE, V308, P408, DOI 10.1126/science.1107449; Price RN, 2007, AM J TROP MED HYG, V77, P79, DOI 10.4269/ajtmh.2007.77.79; Putaporntip C, 2009, INFECT GENET EVOL, V9, P1295, DOI 10.1016/j.meegid.2009.07.005; Remarque EJ, 2008, TRENDS PARASITOL, V24, P74, DOI 10.1016/j.pt.2007.12.002; Richards JS, 2009, IMMUNOL CELL BIOL, V87, P377, DOI 10.1038/icb.2009.27; Richie TL, 2002, NATURE, V415, P694, DOI 10.1038/415694a; Rodriguesa MHC, 2005, INT J PARASITOL, V35, P185, DOI 10.1016/j.ijpara.2004.11.003; Santiago HC, 2011, J ALLERGY CLIN IMMUN, V127, P479, DOI 10.1016/j.jaci.2010.11.007; Saul A, 2005, VACCINE, V23, P3076, DOI 10.1016/j.vaccine.2004.09.040; Silvie O, 2004, J BIOL CHEM, V279, P9490, DOI 10.1074/jbc.M311331200; Stowers AW, 2002, INFECT IMMUN, V70, P6961, DOI 10.1128/IAI.70.12.6961-6967.2002; Tan LKK, 2008, LANCET INFECT DIS, V8, P449, DOI 10.1016/S1473-3099(08)70153-1; THOMAS AW, 1994, AM J TROP MED HYG, V51, P730, DOI 10.4269/ajtmh.1994.51.730; Triglia T, 2000, MOL MICROBIOL, V38, P706, DOI 10.1046/j.1365-2958.2000.02175.x; Udhayakumar V, 2001, AM J TROP MED HYG, V65, P100, DOI 10.4269/ajtmh.2001.65.100; Vekemans J, 2008, EXPERT REV VACCINES, V7, P223, DOI 10.1586/14760584.7.2.223; Wastling JM, 2009, INT J PARASITOL, V39, P135, DOI 10.1016/j.ijpara.2008.10.003; WATERS AP, 1990, J BIOL CHEM, V265, P17974; Webster D, 2003, B WORLD HEALTH ORGAN, V81, P902; Wykes M, 2007, INT J PARASITOL, V37, P705, DOI 10.1016/j.ijpara.2007.02.007	70	36	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2011	6	6							e21289	10.1371/journal.pone.0021289	http://dx.doi.org/10.1371/journal.pone.0021289			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782CL	21713006	Green Submitted, gold, Green Published			2022-12-27	WOS:000291985100027
J	Cervello, I; Mas, A; Gil-Sanchis, C; Peris, L; Faus, A; Saunders, PTK; Critchley, HOD; Simon, C				Cervello, Irene; Mas, Aymara; Gil-Sanchis, Claudia; Peris, Laura; Faus, Amparo; Saunders, Philippa T. K.; Critchley, Hilary O. D.; Simon, Carlos			Reconstruction of Endometrium from Human Endometrial Side Population Cell Lines	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; MESENCHYMAL STEM-CELLS; MENSTRUAL-CYCLE; STROMAL CELLS; PROGESTERONE-RECEPTOR; MOUSE ENDOMETRIUM; MARKERS; MICE; IDENTIFICATION; EXPRESSION	Endometrial regeneration is mediated, at least in part, by the existence of a specialized somatic stem cell (SSC) population recently identified by several groups using the side population (SP) technique. We previously demonstrated that endometrial SP displays genotypic, phenotypic and the functional capability to develop human endometrium after subcutaneous injection in NOD-SCID mice. We have now established seven human endometrial SP (hESP) cell lines (ICE 1-7): four from the epithelial and three from the stromal fraction, respectively. SP cell lines were generated under hypoxic conditions based on their cloning efficiency ability, cultured for 12-15 passages (20 weeks) and cryopreserved. Cell lines displayed normal 46XX karyotype, intermediate telomerase activity pattern and expressed mRNAs encoding proteins that are considered characteristic of undifferentiated cells (Oct-4, GDF3, DNMT3B, Nanog, GABR3) and those of mesodermal origin (WT1, Cardiac Actin, Enolase, Globin, REN). Phenotype analysis corroborated their epithelial (CD9+) or stromal (vimentin+) cell origin and mesenchymal (CD90+, CD73+ and CD45-) attributes. Markers considered characteristic of ectoderm or endoderm were not detected. Cells did not express either estrogen receptor alpha (ER alpha) or progesterone receptor (PR). The hESP cell lines were able to differentiate in vitro into adipocytes and osteocytes, which confirmed their mesenchymal origin. Finally, we demonstrated their ability to generate human endometrium when transplanted beneath the renal capsule of NOD-SCID mice. These findings confirm that SP cells exhibit key features of human endometrial SSC and open up new possibilities for the understanding of gynecological disorders such as endometriosis or Asherman syndrome. Our cell lines can be a valuable model to investigate new targets for endometrium proliferation in endometriosis.	[Cervello, Irene; Mas, Aymara; Gil-Sanchis, Claudia; Peris, Laura; Faus, Amparo; Simon, Carlos] Univ Valencia, Fdn IVI, Inst Univ IVI, INCLIVA, Valencia, Spain; [Saunders, Philippa T. K.; Critchley, Hilary O. D.] Univ Edinburgh, MRC, Ctr Reprod Hlth, Queens Med Res Inst, Edinburgh, Midlothian, Scotland; [Simon, Carlos] UVEG, Unidad Mixta CIPF, Valencian Node Spanish Stem Cell Bank, Prince Felipe Res Ctr CIPF, Valencia, Spain	University of Valencia; University of Edinburgh; Prince Felipe Research Center; University of Valencia	Cervello, I (corresponding author), Univ Valencia, Fdn IVI, Inst Univ IVI, INCLIVA, Valencia, Spain.	csimon@ivi.es	Saunders, Philippa TK/C-7489-2013; Mas, Aymara/E-4409-2018; Simon, Carlos/G-2186-2014; CRITCHLEY, HILARY OD/C-7575-2013	Saunders, Philippa TK/0000-0001-9051-9380; Simon, Carlos/0000-0003-0902-9531; Mas, Aymara/0000-0002-5866-6732; Cervello, Irene/0000-0003-4801-5538; Cervello, Irene/0000-0002-7018-4971; CRITCHLEY, HILARY/0000-0003-1913-4044	Spanish Ministry of Science and Innovation [2008-02048]; Fundacio Gent per Gent [08/09]; Regional Valencian Ministry of Education [PROMETEO/2008/163]; Medical Research Council [G0600048, U1276.00.002.00005.01]; MRC [MC_U127685844, G1100356, G1002033, G0600048] Funding Source: UKRI; Medical Research Council [G1100356, G1002033, MC_U127685844] Funding Source: researchfish	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacio Gent per Gent; Regional Valencian Ministry of Education; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work has been funded by grants SAF (Plan Nacional de Biomedicina) 2008-02048 supported by the Spanish Ministry of Science and Innovation (PI: C. S.), by Fundacio Gent per Gent 08/09 (PI: C. S.) and by PROMETEO/2008/163 (PI: C. S.) supported by the Regional Valencian Ministry of Education. Support also from Medical Research Council (G0600048 to H.O.D.C.; U1276.00.002.00005.01 to P. T. K. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Gallardo C, 2010, IN VITRO CELL DEV-AN, V46, P317, DOI 10.1007/s11626-010-9285-3; Baer PC, 2011, METHODS MOL BIOL, V702, P289, DOI 10.1007/978-1-61737-960-4_21; Cervello I, 2007, HUM REPROD, V22, P45, DOI 10.1093/humrep/del332; Cervello I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010964; Cervello I, 2009, REPROD SCI, V16, P200, DOI 10.1177/1933719108329955; Chan RWS, 2006, STEM CELLS, V24, P1529, DOI 10.1634/stemcells.2005-0411; Chan RWS, 2004, BIOL REPROD, V70, P1738, DOI 10.1095/biolreprod.103.024109; Chanda D, 2010, J CELL BIOCHEM, V111, P249, DOI 10.1002/jcb.22701; Cho NH, 2004, FERTIL STERIL, V81, P403, DOI 10.1016/j.fertnstert.2003.07.015; Choi YH, 2010, INT J BIOCHEM CELL B, V42, P662, DOI 10.1016/j.biocel.2009.12.011; Conneely OM, 2001, MOL CELL ENDOCRINOL, V179, P97, DOI 10.1016/S0303-7207(01)00465-8; Cooke PS, 1998, BIOL REPROD, V59, P470, DOI 10.1095/biolreprod59.3.470; Couse JF, 1999, ENDOCR REV, V20, P358, DOI 10.1210/er.20.3.358; Critchley HD, 2002, J CLIN ENDOCR METAB, V87, P5265, DOI 10.1210/jc.2002-020502; Das B, 2008, STEM CELLS, V26, P1818, DOI 10.1634/stemcells.2007-0724; Dimitrov R, 2008, REPRODUCTION, V135, P551, DOI 10.1530/REP-07-0428; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Du H, 2009, REPROD SCI, V16, P126, DOI 10.1177/1933719108329956; Gargett CE, 2009, BIOL REPROD, V80, P1136, DOI 10.1095/biolreprod.108.075226; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Grayson WL, 2006, J CELL PHYSIOL, V207, P331, DOI 10.1002/jcp.20571; Huang L, 2004, BONE, V34, P393, DOI 10.1016/j.bone.2003.10.013; Iohara K, 2008, STEM CELLS, V26, P2408, DOI 10.1634/stemcells.2008-0393; Kaitu'u-Lino TJ, 2007, ENDOCRINOLOGY, V148, P5105, DOI 10.1210/en.2007-0716; Kato K, 2007, HUM REPROD, V22, P1214, DOI 10.1093/humrep/del514; Larderet G, 2006, STEM CELLS, V24, P965, DOI 10.1634/stemcells.2005-0196; Martin U, 2008, METHODS, V45, P121, DOI 10.1016/j.ymeth.2008.05.009; Masuda H, 2007, P NATL ACAD SCI USA, V104, P1925, DOI 10.1073/pnas.0604310104; Masuda H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010387; Meng XL, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-57; Musina RA, 2008, B EXP BIOL MED+, V145, P539, DOI 10.1007/s10517-008-0136-0; Okulicz WC, 1998, P SOC EXP BIOL MED, V218, P316; Ono M, 2007, P NATL ACAD SCI USA, V104, P18700, DOI 10.1073/pnas.0704472104; PADYKULA AH, 1991, ANN NY ACAD SCI, V622, P47; PRIANISHNIKOV VA, 1978, CONTRACEPTION, V18, P213, DOI 10.1016/S0010-7824(78)80015-8; Schwab KE, 2008, HUM REPROD, V23, P934, DOI 10.1093/humrep/den051; Schwab KE, 2007, HUM REPROD, V22, P2903, DOI 10.1093/humrep/dem265; Schwab KE, 2005, FERTIL STERIL, V84, P1124, DOI 10.1016/j.fertnstert.2005.02.056; Sen GL, 2010, NATURE, V463, P563, DOI 10.1038/nature08683; SIMON C, 1993, J CLIN ENDOCR METAB, V77, P549, DOI 10.1210/jc.77.2.549; Smalley MJ, 2005, J MAMMARY GLAND BIOL, V10, P37, DOI 10.1007/s10911-005-2539-0; Tsuji S, 2008, FERTIL STERIL, V90, P1528, DOI 10.1016/j.fertnstert.2007.08.005; Wada-Hiraike O, 2006, P NATL ACAD SCI USA, V103, P18350, DOI 10.1073/pnas.0608861103; Winuthayanon W, 2010, P NATL ACAD SCI USA, V107, P19272, DOI 10.1073/pnas.1013226107; Wolff EF, 2007, REPROD SCI, V14, P524, DOI 10.1177/1933719107306896; Yarak S, 2010, AN BRAS DERMATOL, V85, P647, DOI 10.1590/S0365-05962010000500008; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	47	129	146	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2011	6	6							e21221	10.1371/journal.pone.0021221	http://dx.doi.org/10.1371/journal.pone.0021221			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782CL	21712999	gold, Green Published, Green Submitted			2022-12-27	WOS:000291985100018
J	Dinis, JM; Barton, DE; Ghadiri, J; Surendar, D; Reddy, K; Velasquez, F; Chaffee, CL; Lee, MCW; Gavrilova, H; Ozuna, H; Smits, SA; Ouverney, CC				Dinis, Jorge M.; Barton, David E.; Ghadiri, Jamsheed; Surendar, Deepa; Reddy, Kavitha; Velasquez, Fernando; Chaffee, Carol L.; Lee, Mei-Chong Wendy; Gavrilova, Helen; Ozuna, Hazel; Smits, Samuel A.; Ouverney, Cleber C.			In Search of an Uncultured Human-Associated TM7 Bacterium in the Environment	PLOS ONE			English	Article							MICROBIAL ECOLOGY; SEQUENCE DATA; DIVISION TM7; IN-SITU; DISEASE; ARCHAEA; IDENTIFICATION; COMMUNITIES; PHYLOGENY; DIVERSITY	We have identified an environmental bacterium in the Candidate Division TM7 with >= 98.5% 16S rDNA gene homology to a group of TM7 bacteria associated with the human oral cavity and skin. The environmental TM7 bacterium (referred to as TM7a-like) was readily detectable in wastewater with molecular techniques over two years of sampling. We present the first images of TM7a-like cells through FISH technique and the first images of any TM7 as viable cells through the STARFISH technique. In situ quantification showed TM7 concentration in wastewater up to five times greater than in human oral sites. We speculate that upon further characterization of the physiology and genetics of the TM7a-like bacterium from environmental sources and confirmation of its genomic identity to human-associated counterparts it will serve as model organisms to better understand its role in human health. The approach proposed circumvents difficulties imposed by sampling humans, provides an alternative strategy to characterizing some diseases of unknown etiology, and renders a much needed understanding of the ecophysiological role hundreds of unique Bacteria and Archaea strains play in mixed microbial communities.	[Dinis, Jorge M.; Barton, David E.; Ghadiri, Jamsheed; Surendar, Deepa; Reddy, Kavitha; Velasquez, Fernando; Gavrilova, Helen; Smits, Samuel A.; Ouverney, Cleber C.] San Jose State Univ, Dept Biol Sci, San Jose, CA 95192 USA; [Chaffee, Carol L.] Univ Florida, Dept Zool, Gainesville, FL 32611 USA; [Lee, Mei-Chong Wendy] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Ozuna, Hazel] Univ Metropolitana, Sci & Technol Dept, San Juan, PR USA	California State University System; San Jose State University; State University System of Florida; University of Florida; University of California System; University of California Santa Cruz; Universidad Metropolitana (UMET)	Dinis, JM (corresponding author), San Jose State Univ, Dept Biol Sci, San Jose, CA 95192 USA.	cleber.ouverney@sjsu.edu	Chaffee, Carol/F-8852-2011; Barton, David E/B-9460-2008	Chaffee, Carol/0000-0002-2275-4853; Lee, Mei-Chong Wendy/0000-0002-8421-0536; Ozuna, Hazel/0000-0002-8786-2089; Ouverney, Cleber/0000-0002-4135-7562	NIH [SC3GM082291]; Howard Hughes Medical Institution [52006312]; NIH Minority Access to Research Career (MARC) [5T34GM008253]; NIH RISE [1R25GM071381]; NSF [REU-RUMBA DBI-0354149]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC3GM082291, T34GM008253, R25GM071381] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institution(Howard Hughes Medical Institute); NIH Minority Access to Research Career (MARC); NIH RISE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding for this project was provided by the following agencies: NIH SC3GM082291, Howard Hughes Medical Institution 52006312, NIH Minority Access to Research Career (MARC) 5T34GM008253, NIH RISE 1R25GM071381, and NSF REU-RUMBA DBI-0354149. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amann R, 2008, NAT REV MICROBIOL, V6, P339, DOI 10.1038/nrmicro1888; Awano S, 2008, J DENT RES, V87, P334, DOI 10.1177/154405910808700418; Benson DA, 2005, NUCLEIC ACIDS RES, V33, pD34, DOI 10.1093/nar/gki063; Bik EM, ISME J; Brinig MM, 2003, APPL ENVIRON MICROB, V69, P1687, DOI 10.1128/AEM.69.3.1687-1694.2003; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; Gao Z, 2007, P NATL ACAD SCI USA, V104, P2927, DOI 10.1073/pnas.0607077104; Genco RJ, 2005, J PERIODONTOL, V76, P2075, DOI 10.1902/jop.2005.76.11-S.2075; Hugenholtz P, 2001, APPL ENVIRON MICROB, V67, P411, DOI 10.1128/AEM.67.1.411-419.2001; Klappenbach JA, 2001, NUCLEIC ACIDS RES, V29, P181, DOI 10.1093/nar/29.1.181; Konstantinidis KT, 2007, CURR OPIN MICROBIOL, V10, P504, DOI 10.1016/j.mib.2007.08.006; Kovatcheva-Datchary Petia, 2009, Therap Adv Gastroenterol, V2, P9, DOI 10.1177/1756283X09337646; Kuehbacher T, 2008, J MED MICROBIOL, V57, P1569, DOI 10.1099/jmm.0.47719-0; Lepp PW, 2004, P NATL ACAD SCI USA, V101, P6176, DOI 10.1073/pnas.0308766101; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Marcy Y, 2007, P NATL ACAD SCI USA, V104, P11889, DOI 10.1073/pnas.0704662104; McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435; Ouverney CC, 2000, APPL ENVIRON MICROB, V66, P4829, DOI 10.1128/AEM.66.11.4829-4833.2000; Ouverney CC, 2003, APPL ENVIRON MICROB, V69, P6294, DOI 10.1128/AEM.69.10.6294-6298.2003; Ouverney CC, 1999, APPL ENVIRON MICROB, V65, P1746; OUVERNEY CC, 2004, MOL MICROBIAL ECOLOG, P1689; OUVERNEY CC, 2004, MOLE MICROBIAL ECOLO, P727; Podar M, 2007, APPL ENVIRON MICROB, V73, P3205, DOI 10.1128/AEM.02985-06; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Roh C, 2006, APPL BIOCHEM BIOTECH, V134, P97, DOI 10.1385/ABAB:134:2:97; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Schloss PD, 2006, APPL ENVIRON MICROB, V72, P6773, DOI 10.1128/AEM.00474-06; Schloss PD, 2004, APPL ENVIRON MICROB, V70, P5485, DOI 10.1128/AEM.70.9.5485-5492.2004; Smith CJ, 2009, FEMS MICROBIOL ECOL, V67, P6, DOI 10.1111/j.1574-6941.2008.00629.x; Smits SA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012267; Suzuki MT, 1996, APPL ENVIRON MICROB, V62, P625, DOI 10.1128/AEM.62.2.625-630.1996; Weng L, 2006, GENOME RES, V16, P316, DOI 10.1101/gr.3676406; Wilks M, 2007, EARLY HUM DEV, V83, P165, DOI 10.1016/j.earlhumdev.2007.01.007; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; Wu DY, 2009, NATURE, V462, P1056, DOI 10.1038/nature08656; Xu J, 2007, PLOS BIOL, V5, P1574, DOI 10.1371/journal.pbio.0050156	40	41	44	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e21280	10.1371/journal.pone.0021280	http://dx.doi.org/10.1371/journal.pone.0021280			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	21701585	Green Published, gold			2022-12-27	WOS:000291983800039
J	Lee, ZW; Zhou, JB; Chen, CS; Zhao, YJ; Tan, CH; Li, L; Moore, PK; Deng, LW				Lee, Zheng Wei; Zhou, Jianbiao; Chen, Chien-Shing; Zhao, Yujun; Tan, Choon-Hong; Li, Ling; Moore, Philip Keith; Deng, Lih-Wen			The Slow-Releasing Hydrogen Sulfide Donor, GYY4137, Exhibits Novel Anti-Cancer Effects In Vitro and In Vivo	PLOS ONE			English	Article							OXIDATIVE STRESS; CELLS; INHIBITION; APOPTOSIS; CASPASE-3; P38	The slow-releasing hydrogen sulfide (H2S) donor, GYY4137, caused concentration-dependent killing of seven different human cancer cell lines (HeLa, HCT-116, Hep G2, HL-60, MCF-7, MV4-11 and U2OS) but did not affect survival of normal human lung fibroblasts (IMR90, WI-38) as determined by trypan blue exclusion. Sodium hydrosulfide (NaHS) was less potent and not active in all cell lines. A structural analogue of GYY4137 (ZYJ1122) lacking sulfur and thence not able to release H2S was inactive. Similar results were obtained using a clonogenic assay. Incubation of GYY4137 (400 mu M) in culture medium led to the generation of low (< 20 mM) concentrations of H2S sustained over 7 days. In contrast, incubation of NaHS (400 mu M) in the same way led to much higher (up to 400 mu M) concentrations of H2S which persisted for only 1 hour. Mechanistic studies revealed that GYY4137 (400 mu M) incubated for 5 days with MCF-7 but not IMR90 cells caused the generation of cleaved PARP and cleaved caspase 9, indicative of a pro-apoptotic effect. GYY4137 (but not ZYJ1122) also caused partial G(2)/M arrest of these cells. Mice xenograft studies using HL-60 and MV4-11 cells showed that GYY4137 (100-300 mg/kg/day for 14 days) significantly reduced tumor growth. We conclude that GYY4137 exhibits anti-cancer activity by releasing H2S over a period of days. We also propose that a combination of apoptosis and cell cycle arrest contributes to this effect and that H2S donors should be investigated further as potential anti-cancer agents.	[Lee, Zheng Wei; Deng, Lih-Wen] Natl Univ Singapore, Dept Biochem, Singapore 117548, Singapore; [Zhao, Yujun; Tan, Choon-Hong] Natl Univ Singapore, Dept Chem, Singapore 117548, Singapore; [Li, Ling; Moore, Philip Keith] Natl Univ Singapore, Dept Pharmacol, Singapore 117548, Singapore; [Zhou, Jianbiao] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore; [Chen, Chien-Shing] Natl Univ Singapore, Dept Med, Singapore 117548, Singapore; [Chen, Chien-Shing] Loma Linda Univ, Sch Med, Div Hematol & Oncol, Loma Linda, CA USA	National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; Loma Linda University	Lee, ZW (corresponding author), Natl Univ Singapore, Dept Biochem, Singapore 117548, Singapore.	dprmpk@nus.edu.sg; lih_wen_deng@nuhs.edu.sg	Lee, Zheng-Wei/ABI-3657-2020	Lee, Zheng-Wei/0000-0002-8062-7772; Deng, Lih-Wen/0000-0002-4985-7844	National University of Singapore [R-183-000-240-720, R183-000-240-101, R183-000-268-733]	National University of Singapore(National University of Singapore)	The work is supported by a National University of Singapore research grant to PKM, LWD and CHT (R-183-000-240-720, R183-000-240-101, R183-000-268-733). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Cai WJ, 2010, CELL BIOL INT, V34, P565, DOI 10.1042/CBI20090368; Cao QH, 2010, ANTIOXID REDOX SIGN, V12, P1101, DOI 10.1089/ars.2009.2915; Deplancke B, 2003, FASEB J, V17, P1310, DOI 10.1096/fj.02-0883fje; Fiedler N, 2008, ENVIRON HEALTH PERSP, V116, P78, DOI 10.1289/ehp.10531; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Hu LF, 2007, J NEUROCHEM, V100, P1121, DOI 10.1111/j.1471-4159.2006.04283.x; Hu LF, 2009, MOL PHARMACOL, V75, P27, DOI 10.1124/mol.108.047985; Huang SF, 2010, J MOL BIOL, V396, P708, DOI 10.1016/j.jmb.2009.11.058; Jha S, 2008, AM J PHYSIOL-HEART C, V295, pH801, DOI 10.1152/ajpheart.00377.2008; Li L, 2008, CIRCULATION, V117, P2351, DOI 10.1161/CIRCULATIONAHA.107.753467; Li L, 2011, ANNU REV PHARMACOL, V51, P169, DOI 10.1146/annurev-pharmtox-010510-100505; Rinaldi L, 2006, LAB INVEST, V86, P391, DOI 10.1038/labinvest.3700391; Rose P, 2005, WORLD J GASTROENTERO, V11, P3990, DOI 10.3748/wjg.v11.i26.3990; Shen J, 2007, EXP HEMATOL, V35, P75; Taniguchi S, 2011, BRIT J PHARMACOL, V162, P1171, DOI 10.1111/j.1476-5381.2010.01119.x; Whiteman M, 2010, ANTIOXID REDOX SIGN, V12, P1147, DOI 10.1089/ars.2009.2899; Yang GD, 2004, FASEB J, V18, P1782, DOI 10.1096/fj.04-2279fje; Yonezawa D, 2007, TOXICOLOGY, V241, P11, DOI 10.1016/j.tox.2007.07.020	18	257	268	10	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e21077	10.1371/journal.pone.0021077	http://dx.doi.org/10.1371/journal.pone.0021077			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	21701688	Green Published, gold			2022-12-27	WOS:000291983800021
J	Shi, MM; Michalski, SG; Chen, XY; Durka, W				Shi, Miao-Miao; Michalski, Stefan G.; Chen, Xiao-Yong; Durka, Walter			Isolation by Elevation: Genetic Structure at Neutral and Putatively Non-Neutral Loci in a Dominant Tree of Subtropical Forests, Castanopsis eyrei	PLOS ONE			English	Article							EFFECTIVE POPULATION-SIZE; QUERCUS-ROBUR L.; MICROSATELLITE MARKERS; ALLOZYME VARIATION; NATURAL-SELECTION; CLIMATE-CHANGE; DIVERSITY; DIFFERENTIATION; FAGACEAE; PATTERNS	Background: The distribution of genetic diversity among plant populations growing along elevational gradients can be affected by neutral as well as selective processes. Molecular markers used to study these patterns usually target neutral processes only, but may also be affected by selection. In this study, the effects of elevation and successional stage on genetic diversity of a dominant tree species were investigated controlling for neutrality of the microsatellite loci used. Methodology/Principal Findings: Diversity and differentiation among 24 populations of Castanopsis eyrei from different elevations (251-920 m) and successional stages were analysed by eight microsatellite loci. We found that one of the loci (Ccu97H18) strongly deviated from a neutral model of differentiation among populations due to either divergent selection or hitchhiking with an unknown selected locus. The analysis showed that C. eyrei populations had a high level of genetic diversity within populations (A(R) = 7.6, H-E = 0.82). Genetic variation increased with elevation for both the putatively selected locus Ccu97H18 and the neutral loci. At locus Ccu97H18 one allele was dominant at low elevations, which was replaced at higher elevations by an increasing number of other alleles. The level of genetic differentiation at neutral loci was similar to that of other Fagaceae species (F-ST = 0.032, F'(ST) = 0.15). Population differentiation followed a model of isolation by distance but additionally, strongly significant isolation by elevation was found, both for neutral loci and the putatively selected locus. Conclusions/Significance: The results indicate higher gene flow among similar elevational levels than across different elevational levels and suggest a selective influence of elevation on the distribution of genetic diversity in C. eyrei. The study underlines the importance to check the selective neutrality of marker loci in analyses of population structure.	[Shi, Miao-Miao; Michalski, Stefan G.; Durka, Walter] UFZ Helmholtz Ctr Environm Res, Dept Community Ecol BZF, Halle, Germany; [Chen, Xiao-Yong] E China Normal Univ, Sch Resources & Environm Sci, Tiantong Natl Stn Forest Ecosyst, Shanghai 200062, Peoples R China	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); East China Normal University	Shi, MM (corresponding author), UFZ Helmholtz Ctr Environm Res, Dept Community Ecol BZF, Halle, Germany.	miaomiao.shi@ufz.de	Michalski, Stefan G/O-5774-2015; Durka, Walter/E-4667-2010; Chen, Xiao-Yong/B-1467-2009	Michalski, Stefan G/0000-0002-8969-7355; Durka, Walter/0000-0002-6611-2246; Chen, Xiao-Yong/0000-0002-4795-8940	German Science Foundation (DFG) [FOR 891/1, Du 404/3]; China Scholarship Council [2008 3039]	German Science Foundation (DFG)(German Research Foundation (DFG)); China Scholarship Council(China Scholarship Council)	This work was funded by the German Science Foundation (DFG FOR 891/1, Du 404/3) and the China Scholarship Council (2008 3039). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achere V, 2005, MOL ECOL, V14, P3191, DOI 10.1111/j.1365-294X.2005.02646.x; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Blakesley D, 2004, NEW FOREST, V27, P89, DOI 10.1023/A:1025016331835; Blionis GJ, 2001, ECOGRAPHY, V24, P696, DOI 10.1034/j.1600-0587.2001.240608.x; BORCHERT R, 1983, BIOTROPICA, V15, P81, DOI 10.2307/2387949; Bruelheide H, 2011, ECOL MONOGR, V81, P25, DOI 10.1890/09-2172.1; Byars SG, 2009, ANN BOT-LONDON, V103, P885, DOI 10.1093/aob/mcp018; Caetano S, 2008, MOL ECOL, V17, P3147, DOI 10.1111/j.1365-294X.2008.03817.x; Casa AM, 2005, THEOR APPL GENET, V111, P23, DOI 10.1007/s00122-005-1952-5; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Chen XiaoYong, 1997, Acta Botanica Sinica, V39, P149; Cheng YP, 2001, J HERED, V92, P65, DOI 10.1093/jhered/92.1.65; Cheng YP, 2006, ANN BOT-LONDON, V98, P601, DOI 10.1093/aob/mcl135; Chung MY, 2002, AM J BOT, V89, P1229, DOI 10.3732/ajb.89.8.1229; Clarke LJ, 2008, J ECOL, V96, P378, DOI 10.1111/j.1365-2745.2007.01347.x; Coart E, 2002, THEOR APPL GENET, V105, P431, DOI 10.1007/s00122-002-0920-6; Cornuet JM, 1996, GENETICS, V144, P2001; Coyer JA, 2008, BIOL LETTERS, V4, P755, DOI 10.1098/rsbl.2008.0403; Edelist C, 2006, MOL ECOL, V15, P4623, DOI 10.1111/j.1365-294X.2006.03112.x; Gamperle E, 2002, FLORA, V197, P203, DOI 10.1078/0367-2530-00031; Goto S, 2009, ECOL RES, V24, P1267, DOI 10.1007/s11284-009-0611-8; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Hamrick JL, 1996, PHILOS T ROY SOC B, V351, P1291, DOI 10.1098/rstb.1996.0112; Hazler K, 1997, SILVAE GENET, V46, P229; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; Heller R, 2009, MOL ECOL, V18, P2080, DOI 10.1111/j.1365-294X.2009.04185.x; Herrera CM, 2008, HEREDITY, V100, P275, DOI 10.1038/sj.hdy.6801072; Hiraoka K, 2009, INT J PLANT SCI, V170, P748, DOI 10.1086/599072; Hiraoka K, 2009, J PLANT RES, V122, P269, DOI 10.1007/s10265-009-0217-9; Ingvarsson PK, 2010, MOL BIOL EVOL, V27, P650, DOI 10.1093/molbev/msp255; Jackson AL, 1998, P NATL ACAD SCI USA, V95, P12468, DOI 10.1073/pnas.95.21.12468; Jump AS, 2006, MOL ECOL, V15, P3469, DOI 10.1111/j.1365-294X.2006.03027.x; Kamiya K, 2002, GENES GENET SYST, V77, P177, DOI 10.1266/ggs.77.177; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; Kraj W, 2009, ANN FOREST SCI, V66, DOI 10.1051/forest/2008085; Lange R, 2010, MOL ECOL, V19, P4936, DOI 10.1111/j.1365-294X.2010.04877.x; Lazrek F, 2009, GENETICA, V135, P391, DOI 10.1007/s10709-008-9285-3; LeCorre V, 1997, MOL ECOL, V6, P519, DOI 10.1046/j.1365-294X.1997.00214.x; Lee YJ, 2006, J HERED, V97, P261, DOI 10.1093/jhered/esj030; Li Jian-hui, 2007, Shengtaixue Zazhi, V26, P509; Li JunMin, 2006, Journal of Zhejiang University (Agriculture and Life Sciences), V32, P232; Liu MH, 2008, PLANT ECOL, V197, P31, DOI 10.1007/s11258-007-9357-y; Maghuly F, 2006, FOREST ECOL MANAG, V222, P266, DOI 10.1016/j.foreco.2005.10.025; Mariette S, 2002, SILVAE GENET, V51, P72; Marsico TD, 2009, J BIOGEOGR, V36, P929, DOI 10.1111/j.1365-2699.2008.02049.x; Meirmans PG, 2006, EVOLUTION, V60, P2399, DOI 10.1111/j.0014-3820.2006.tb01874.x; Michalski SG, 2010, THEOR APPL GENET, V120, P1151, DOI 10.1007/s00122-009-1242-8; Montalvo AM, 1997, AM J BOT, V84, P1553, DOI 10.2307/2446617; Nettel A, 2009, AM J BOT, V96, P2224, DOI 10.3732/ajb.0800339; Nielsen EE, 2006, MOL ECOL, V15, P3219, DOI 10.1111/j.1365-294X.2006.03025.x; Nybom H, 2004, MOL ECOL, V13, P1143, DOI 10.1111/j.1365-294X.2004.02141.x; Ohsawa T, 2008, GLOBAL ECOL BIOGEOGR, V17, P152, DOI 10.1111/j.1466-8238.2007.00357.x; Peng SL, 2003, SILVAE GENET, V52, P60; Perez-Figueroa A, 2010, J EVOLUTION BIOL, V23, P2267, DOI 10.1111/j.1420-9101.2010.02093.x; Piotti A, 2009, HEREDITY, V103, P136, DOI 10.1038/hdy.2009.42; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Quiroga MP, 2007, J BIOGEOGR, V34, P447, DOI 10.1111/j.1365-2699.2006.01613.x; R Core Team, 2018, R LANG ENV STAT COMP; RUSCH VE, 1993, REV CHIL HIST NAT, V66, P131; Scascitelli M, 2010, MOL ECOL, V19, P521, DOI 10.1111/j.1365-294X.2009.04504.x; Stefenon VM, 2008, FOREST ECOL MANAG, V255, P2718, DOI 10.1016/j.foreco.2008.01.036; Tanaka T, 2005, BREEDING SCI, V55, P271, DOI 10.1270/jsbbs.55.271; Tomaru N, 1997, HEREDITY, V78, P241, DOI 10.1038/hdy.1997.38; Truong C, 2007, J EVOLUTION BIOL, V20, P369, DOI 10.1111/j.1420-9101.2006.01190.x; Ueno S, 2000, MOL ECOL, V9, P1188, DOI 10.1046/j.1365-294x.2000.00954-11.x; Ueno S, 2003, CONSERV GENET, V4, P813, DOI 10.1023/B:COGE.0000006120.99339.10; Ueno S, 2009, ANN FOREST SCI, V66, DOI 10.1051/forest/2009037; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vidhanaarachchi V. R. M., 2005, Japanese Journal of Tropical Agriculture, V49, P53; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wright S, 1943, GENETICS, V28, P114; Wright S, 1978, VARIABILITY NATURAL; [徐学红 Xu Xuehong], 2005, [生态学报, Acta Ecologica Sinica], V25, P645; Zhang X, 2006, NEW FOREST, V32, P347, DOI 10.1007/s11056-006-9008-5; Zhu QH, 2002, ACTA BOT SIN, V44, P1321; Zhu Y, 2010, OECOLOGIA, V162, P853, DOI 10.1007/s00442-009-1515-6	76	37	38	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e21302	10.1371/journal.pone.0021302	http://dx.doi.org/10.1371/journal.pone.0021302			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	21701584	gold, Green Published, Green Submitted			2022-12-27	WOS:000291983800040
J	Kalisvaart, JP; Rampersad, SM; Goossens, J				Kalisvaart, Joke P.; Rampersad, Sumientra M.; Goossens, Jeroen			Binocular Onset Rivalry at the Time of Saccades and Stimulus Jumps	PLOS ONE			English	Article							NASO-TEMPORAL ASYMMETRY; EYE-MOVEMENTS; AMBIGUOUS PATTERNS; EXTRASTRIATE CORTEX; VISUAL-PERCEPTION; ATTENTION; AWARENESS; REPRESENTATION; ALTERNATIONS; COMPETITION	Recent studies suggest that binocular rivalry at stimulus onset, so called onset rivalry, differs from rivalry during sustained viewing. These observations raise the interesting question whether there is a relation between onset rivalry and rivalry in the presence of eye movements. We therefore studied binocular rivalry when stimuli jumped from one visual hemifield to the other, either through a saccade or through a passive stimulus displacement, and we compared rivalry after such displacements with onset and sustained rivalry. We presented opponent motion, orthogonal gratings and face/house stimuli through a stereoscope. For all three stimulus types we found that subjects showed a strong preference for stimuli in one eye or one hemifield (Experiment 1), and that these subject-specific biases did not persist during sustained viewing (Experiment 2). These results confirm and extend previous findings obtained with gratings. The results from the main experiment (Experiment 3) showed that after a passive stimulus jump, switching probability was low when the preferred eye was dominant before a stimulus jump, but when the non-preferred eye was dominant beforehand, switching probability was comparatively high. The results thus showed that dominance after a stimulus jump was tightly related to eye dominance at stimulus onset. In the saccade condition, however, these subject-specific biases were systematically reduced, indicating that the influence of saccades can be understood from a systematic attenuation of the subjects' onset rivalry biases. Taken together, our findings demonstrate a relation between onset rivalry and rivalry after retinal shifts and involvement of extra-retinal signals in binocular rivalry.	[Kalisvaart, Joke P.; Rampersad, Sumientra M.; Goossens, Jeroen] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen	Kalisvaart, JP (corresponding author), Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands.	j.kalisvaart@donders.ru.nl	Goossens, Jeroen/D-7311-2010; Rampersad, Sumientra/Y-3536-2018	Goossens, Jeroen/0000-0001-5522-3437; Rampersad, Sumientra/0000-0001-9860-4459	NWO [864.06.005]; Radboud University Nijmegen Medical Centre	NWO(Netherlands Organization for Scientific Research (NWO)); Radboud University Nijmegen Medical Centre	This work is supported by NWO grant 864.06.005 (ALW VIDI) to JG (www.nwo.nl) and the Radboud University Nijmegen Medical Centre (www.ru.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blake R, 2002, NAT REV NEUROSCI, V3, P13, DOI 10.1038/nrn701; Blake R, 2003, NEURON, V39, P869, DOI 10.1016/S0896-6273(03)00495-1; Blake R., 2001, BRAIN MIND, V2, P5, DOI [https://doi.org/10.1023/A:1017925416289, DOI 10.1023/A:1017925416289, 10.1023/A:1017925416289]; Blake R., 2005, BINOCULAR RIVALRY, P1; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BURR DC, 1994, NATURE, V371, P511, DOI 10.1038/371511a0; Carter O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000343; Chen XC, 2004, CURR BIOL, V14, P1013, DOI 10.1016/j.cub.2004.05.042; Chen XC, 2003, VISION RES, V43, P2207, DOI 10.1016/S0042-6989(03)00359-6; Chong SC, 2006, VISION RES, V46, P1794, DOI 10.1016/j.visres.2005.10.031; COLLEWIJN H, 1975, VISION RES, V15, P447, DOI 10.1016/0042-6989(75)90098-X; CURCIO CA, 1987, SCIENCE, V236, P579, DOI 10.1126/science.3576186; Davis ET, 2004, SPATIAL VISION, V17, P249, DOI 10.1163/1568568041920168; Deubel H, 1996, VISION RES, V36, P1827, DOI 10.1016/0042-6989(95)00294-4; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; FAHLE M, 1988, VISION RES, V28, P293, DOI 10.1016/0042-6989(88)90157-5; FAHLE M, 1987, INVEST OPHTH VIS SCI, V28, P1016; Handa T, 2004, OPTOMETRY VISION SCI, V81, P377, DOI 10.1097/01.opx.0000135085.54136.65; Kanai R, 2005, PERCEPTION, V34, P803, DOI 10.1068/p5245; Kanal R, 2007, VISION RES, V47, P2675, DOI 10.1016/j.visres.2007.06.016; Klink PC, 2008, J VISION, V8, DOI 10.1167/8.5.16; KOWLER E, 1995, VISION RES, V35, P1897, DOI 10.1016/0042-6989(94)00279-U; Leopold DA, 2002, NAT NEUROSCI, V5, P605, DOI 10.1038/nn0602-851; Long GM, 2004, PSYCHOL BULL, V130, P748, DOI 10.1037/0033-2909.130.5.748; Maier A, 2003, CURR BIOL, V13, P1076, DOI 10.1016/S0960-9822(03)00414-7; Mamassian P, 2005, J VISION, V5, P361, DOI 10.1167/5.4.7; Melcher D, 2005, CURR BIOL, V15, P1745, DOI 10.1016/j.cub.2005.08.044; Nakamura K, 2002, P NATL ACAD SCI USA, V99, P4026, DOI 10.1073/pnas.052379899; Nishida S, 2003, VISION RES, V43, P639, DOI 10.1016/S0042-6989(03)00007-5; Noest AJ, 2007, J VISION, V7, DOI 10.1167/7.8.10; Ooi T L, 2001, Optometry, V72, P168; Ooi TL, 2006, PERCEPTION, V35, P581, DOI 10.1068/p5489; Pearson J, 2004, J VISION, V4, P196, DOI 10.1167/4.3.6; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; ROBBOY M W, 1990, CLAO Journal, V16, P299; Ross J, 2001, TRENDS NEUROSCI, V24, P113, DOI 10.1016/S0166-2236(00)01685-4; Ross J, 2004, NAT NEUROSCI, V7, P65, DOI 10.1038/nn1163; ROVAMO J, 1979, EXP BRAIN RES, V37, P495, DOI 10.1007/bf00236819; SCOTTO MA, 1990, PERCEPT MOTOR SKILL, V70, P1059; Tong F, 1998, NEURON, V21, P753, DOI 10.1016/S0896-6273(00)80592-9; Tong F, 2006, TRENDS COGN SCI, V10, P502, DOI 10.1016/j.tics.2006.09.003; Toppino TC, 2003, PERCEPT PSYCHOPHYS, V65, P1285, DOI 10.3758/BF03194852; Umeno MM, 1997, J NEUROPHYSIOL, V78, P1373, DOI 10.1152/jn.1997.78.3.1373; van Boxtel JJA, 2008, J VISION, V8, DOI 10.1167/8.5.17; van Dam LCJ, 2006, VISION RES, V46, P787, DOI 10.1016/j.visres.2005.10.011; van Dam LCJ, 2006, J VISION, V6, P1172, DOI 10.1167/6.11.3; Viviani P, 1990, Rev Oculomot Res, V4, P353	47	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e20017	10.1371/journal.pone.0020017	http://dx.doi.org/10.1371/journal.pone.0020017			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	778TS	21698288	gold, Green Published, Green Submitted			2022-12-27	WOS:000291730000006
J	Takeuchi, H; Iba, M; Inoue, H; Higuchi, M; Takao, K; Tsukita, K; Karatsu, Y; Iwamoto, Y; Miyakawa, T; Suhara, T; Trojanowski, JQ; Lee, VMY; Takahashi, R				Takeuchi, Hiroki; Iba, Michiyo; Inoue, Haruhisa; Higuchi, Makoto; Takao, Keizo; Tsukita, Kayoko; Karatsu, Yoshiko; Iwamoto, Yumiko; Miyakawa, Tsuyoshi; Suhara, Tetsuya; Trojanowski, John Q.; Lee, Virginia M. -Y.; Takahashi, Ryosuke			P301S Mutant Human Tau Transgenic Mice Manifest Early Symptoms of Human Tauopathies with Dementia and Altered Sensorimotor Gating	PLOS ONE			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; PREPULSE INHIBITION; VENTRAL HIPPOCAMPUS; ALZHEIMERS-DISEASE; MOUSE MODEL; MEMORY; BEHAVIOR; AGGREGATION; MECHANISMS; RECEPTOR	Tauopathies are neurodegenerative disorders characterized by the accumulation of abnormal tau protein leading to cognitive and/or motor dysfunction. To understand the relationship between tau pathology and behavioral impairments, we comprehensively assessed behavioral abnormalities in a mouse tauopathy model expressing the human P301S mutant tau protein in the early stage of disease to detect its initial neurological manifestations. Behavioral abnormalities, shown by open field test, elevated plus-maze test, hot plate test, Y-maze test, Barnes maze test, Morris water maze test, and/or contextual fear conditioning test, recapitulated the neurological deficits of human tauopathies with dementia. Furthermore, we discovered that prepulse inhibition (PPI), a marker of sensorimotor gating, was enhanced in these animals concomitantly with initial neuropathological changes in associated brain regions. This finding provides evidence that our tauopathy mouse model displays neurofunctional abnormalities in prodromal stages of disease, since enhancement of PPI is characteristic of amnestic mild cognitive impairment, a transitional stage between normal aging and dementia such as Alzheimer's disease (AD), in contrast with attenuated PPI in AD patients. Therefore, assessment of sensorimotor gating could be used to detect the earliest manifestations of tauopathies exemplified by prodromal AD, in which abnormal tau protein may play critical roles in the onset of neuronal dysfunctions.	[Takeuchi, Hiroki; Takahashi, Ryosuke] Kyoto Univ, Grad Sch Med, Dept Neurol, Sakyo Ku, Kyoto, Japan; [Takeuchi, Hiroki; Inoue, Haruhisa; Tsukita, Kayoko; Karatsu, Yoshiko; Iwamoto, Yumiko] Kyoto Univ, Ctr iPS Cell Res & Applicat CiRA, Sakyo Ku, Kyoto, Japan; [Iba, Michiyo; Trojanowski, John Q.; Lee, Virginia M. -Y.] Univ Penn, Sch Med, HUP, Ctr Neurodegenerat Dis Res,Inst Aging, Philadelphia, PA 19104 USA; [Iba, Michiyo; Trojanowski, John Q.; Lee, Virginia M. -Y.] Univ Penn, Sch Med, HUP, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Inoue, Haruhisa] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama, Japan; [Higuchi, Makoto; Suhara, Tetsuya] Natl Inst Radiol Sci, Mol Imaging Ctr, Chiba 260, Japan; [Takao, Keizo] Natl Inst Physiol Sci, Ctr Genet Anal Behav, Sect Behav Patterns, Aichi, Japan; [Miyakawa, Tsuyoshi] Fujita Hlth Univ, Inst Comprehens Med Sci, Div Syst Med Sci, Aichi, Japan	Kyoto University; Kyoto University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Japan Science & Technology Agency (JST); National Institutes for Quantum Science & Technology; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Fujita Health University	Takeuchi, H (corresponding author), Kyoto Univ, Grad Sch Med, Dept Neurol, Sakyo Ku, Kyoto, Japan.	haruhisa@cira.kyoto-u.ac.jp	; Takao, Keizo/B-9527-2008; Miyakawa, Tsuyoshi/A-7741-2008	Inoue, Haruhisa/0000-0003-4736-9537; Takao, Keizo/0000-0002-4734-3583; Miyakawa, Tsuyoshi/0000-0003-0137-8200	National Institutes of Health (NIH), USA [AG-10124, AG-17586]; Japan Science and Technology Agency (JST); NATIONAL INSTITUTE ON AGING [P30AG010124, P01AG017586] Funding Source: NIH RePORTER	National Institutes of Health (NIH), USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by grants (number AG-10124 and AG-17586) of the National Institutes of Health (NIH), USA (http://grants.nih.gov/grants/oer.htm), and by a grant for Molecular Imaging Program of the Japan Science and Technology Agency (JST) (HI) (http://www.jst.go.jp/keytech/01bunshi/index.html). No current external funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ally Brandon A, 2006, Am J Alzheimers Dis Other Demen, V21, P439; Arguello PA, 2006, NEURON, V52, P179, DOI 10.1016/j.neuron.2006.09.023; Assal F, 2002, CURR OPIN NEUROL, V15, P445, DOI 10.1097/00019052-200208000-00007; Ballard CG, 2009, NAT REV NEUROL, V5, P245, DOI 10.1038/nrneurol.2009.39; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Belleville S, 2008, PROG BRAIN RES, V169, P365, DOI 10.1016/S0079-6123(07)00023-4; Bishop SJ, 2007, TRENDS COGN SCI, V11, P307, DOI 10.1016/j.tics.2007.05.008; BRAFF DL, 1990, ARCH GEN PSYCHIAT, V47, P181; Buckner RL, 2004, NEURON, V44, P195, DOI 10.1016/j.neuron.2004.09.006; Busche MA, 2008, SCIENCE, V321, P1686, DOI 10.1126/science.1162844; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Crawley JN, 2004, MENT RETARD DEV D R, V10, P248, DOI 10.1002/mrdd.20039; de Silva R, 2006, ACTA NEUROPATHOL, V111, P329, DOI 10.1007/s00401-006-0048-x; De Vreese LP, 2001, INT J GERIATR PSYCH, V16, P794, DOI 10.1002/gps.428; Delobel P, 2008, AM J PATHOL, V172, P123, DOI 10.2353/ajpath.2008.070627; Denk F, 2009, NEUROBIOL AGING, V30, P1, DOI 10.1016/j.neurobiolaging.2007.05.010; Egashira N, 2005, BRAIN RES, V1059, P7, DOI 10.1016/j.brainres.2005.08.004; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Geyer MA, 2003, PROG NEURO-PSYCHOPH, V27, P1071, DOI 10.1016/j.pnpbp.2003.09.003; Hejl AM, 2004, NEUROBIOL AGING, V25, P1045, DOI 10.1016/j.neurobiolaging.2003.11.005; HERBERT H, 1991, J COMP NEUROL, V304, P103, DOI 10.1002/cne.903040108; Ishihara T, 1999, NEURON, V24, P751, DOI 10.1016/S0896-6273(00)81127-7; Iwatsubo T, 2006, NEUROPATHOLOGY, V26, P455, DOI 10.1111/j.1440-1789.2006.00667.x; Kaidanovich-Beilin O, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-35; Katsuno T, 2005, NEUROLOGY, V64, P687, DOI 10.1212/01.WNL.0000151958.79884.86; Kieffer BL, 1999, TRENDS PHARMACOL SCI, V20, P19, DOI 10.1016/S0165-6147(98)01279-6; Korczyn AD, 2009, J NEUROL SCI, V283, P139, DOI 10.1016/j.jns.2009.02.346; Kouzu Y, 2000, MOL BRAIN RES, V76, P142, DOI 10.1016/S0169-328X(99)00344-7; Li L, 2009, NEUROSCI BIOBEHAV R, V33, P1157, DOI 10.1016/j.neubiorev.2009.02.001; Lipska BK, 1995, PSYCHOPHARMACOLOGY, V122, P35, DOI 10.1007/BF02246439; Liu W, 2004, NEUROLOGY, V62, P742, DOI 10.1212/01.WNL.0000113729.77161.C9; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; MELONI EC, 2007, J NEUROSCI, V20, P5274; Miller EJ, 2010, NEUROSCIENCE, V165, P601, DOI 10.1016/j.neuroscience.2009.10.036; Miyasaka T, 2001, AM J PATHOL, V158, P373, DOI 10.1016/S0002-9440(10)63979-X; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; Nadler JJ, 2004, GENES BRAIN BEHAV, V3, P303, DOI 10.1111/j.1601-183X.2004.00071.x; Niemann S, 2007, EUR J NEUROSCI, V26, P1407, DOI 10.1111/j.1460-9568.2007.05774.x; Nonaka T, 2010, J BIOL CHEM, V285, P34885, DOI 10.1074/jbc.M110.148460; NUKINA N, 1987, P NATL ACAD SCI USA, V84, P3415, DOI 10.1073/pnas.84.10.3415; Pape HC, 2003, ANN NY ACAD SCI, V985, P92; Porter FL, 1996, PAIN, V68, P413, DOI 10.1016/S0304-3959(96)03210-1; Sahara N, 2008, CURR ALZHEIMER RES, V5, P591, DOI 10.2174/156720508786898442; Saint Marie RL, 2010, NEUROSCIENCE, V168, P498, DOI 10.1016/j.neuroscience.2010.03.037; Scattoni ML, 2010, BEHAV BRAIN RES, V208, P250, DOI 10.1016/j.bbr.2009.12.002; Seino Y, 2010, J NEUROSCI RES, V88, P3547, DOI 10.1002/jnr.22516; Shahani N, 2002, CELL MOL LIFE SCI, V59, P1668, DOI 10.1007/PL00012495; Shiarli AM, 2006, NEUROPATH APPL NEURO, V32, P374, DOI 10.1111/j.1365-2990.2006.00736.x; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; SUEMARU S, 1991, NEUROREPORT, V2, P337, DOI 10.1097/00001756-199106000-00009; Swerdlow NR, 2004, NEUROSCIENCE, V123, P675, DOI 10.1016/j.neuroscience.2003.08.028; Tabira T, 2009, ANN NEUROL, V65, P4, DOI 10.1002/ana.21599; Takahashi K, 2007, BIOL PSYCHIAT, V62, P148, DOI 10.1016/j.biopsych.2006.06.035; Takao K, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-11; Takao Keizo, 2006, J Vis Exp, P104, DOI 10.3791/104; Taniguchi T, 2005, FEBS LETT, V579, P5704, DOI 10.1016/j.febslet.2005.09.047; Tatebayashi Y, 2002, P NATL ACAD SCI USA, V99, P13896, DOI 10.1073/pnas.202205599; Trantham-Davidson H, 2008, BEHAV BRAIN RES, V189, P244, DOI 10.1016/j.bbr.2007.12.031; Tsuji T, 2002, NEUROCHEM RES, V27, P1245, DOI 10.1023/A:1020941929414; Ueki A, 2006, PSYCHIAT CLIN NEUROS, V60, P55, DOI 10.1111/j.1440-1819.2006.01460.x; Watanabe A, 2004, J NEUROCHEM, V90, P1302, DOI 10.1111/j.1471-4159.2004.02611.x; Yamasaki N, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-6; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Zhang MR, 2004, J MED CHEM, V47, P2228, DOI 10.1021/jm0304919	64	184	185	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e21050	10.1371/journal.pone.0021050	http://dx.doi.org/10.1371/journal.pone.0021050			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698260	Green Published, gold, Green Submitted			2022-12-27	WOS:000291730000044
J	Vural, DC				Vural, Dervis Can			When Models Interact with Their Subjects: The Dynamics of Model Aware Systems	PLOS ONE			English	Article							SOCIAL-PSYCHOLOGY; HISTORY; NOISE	A scientific model need not be a passive and static descriptor of its subject. If the subject is affected by the model, the model must be updated to explain its affected subject. In this study, two models regarding the dynamics of model aware systems are presented. The first explores the behavior of "prediction seeking" (PSP) and "prediction avoiding" (PSP) populations under the influence of a model that describes them. The second explores the publishing behavior of a group of experimentalists coupled to a model by means of confirmation bias. It is found that model aware systems can exhibit convergent random or oscillatory behavior and display universal 1/f noise. A numerical simulation of the physical experimentalists is compared with actual publications of neutron life time and L mass measurements and is in good quantitative agreement.	Univ Illinois, Dept Phys, Champaign, IL 61820 USA	University of Illinois System; University of Illinois Urbana-Champaign	Vural, DC (corresponding author), Univ Illinois, Dept Phys, Champaign, IL 61820 USA.	vural@illinois.edu		Vural, Dervis Can/0000-0002-0495-8086	National Science Foundation [NSF-DMR-03-50842, NSF-DMR09-06921]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation under grant numbers NSF-DMR-03-50842 and NSF-DMR09-06921. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakker L, 2010, PHYSICA A, V389, P1223, DOI 10.1016/j.physa.2009.11.013; BEAMAN AL, 1978, PERS SOC PSYCHOL B, V4, P406, DOI 10.1177/014616727800400309; CALLON M, 1998, LAWS MARKETS INTRO E; Chapanis A, 1995, PERCEPT MOTOR SKILL, V81, P1347, DOI 10.2466/pms.1995.81.3f.1347; EISENEGGER C, 2010, NATURE LETT, V464; FOON AE, 1986, J SOC PSYCHOL, V126, P431, DOI 10.1080/00224545.1986.9713609; Garibaldi U., 2010, FINITARY PROBABILIST, DOI DOI 10.1017/CBO9780511777585; GERGEN KJ, 1973, J PERS SOC PSYCHOL, V26, P309, DOI 10.1037/h0034436; GREENWALD GG, 1986, PSYCHOL REV, V93, P2; Hacking I., 2006, LONDON REV BOOKS, V28, P16; HONG YY, 1991, J SOC PSYCHOL, V131, P585, DOI 10.1080/00224545.1991.9713891; Jeng M, 2007, NUCL INSTRUM METH A, V571, P704, DOI 10.1016/j.nima.2006.11.024; Leech G, 2001, WORD FREQUENCIES WRI; MANDELBR.BB, 1969, WATER RESOUR RES, V5, P321, DOI 10.1029/WR005i002p00321; McKenzie D, 2006, ENGINE NOT CAMERA FI; MILLER D, 1998, VIRTUALISM NEW POLIT; Nakamura K, 2010, J PHYS G NUCL PARTIC, V37, P1, DOI 10.1088/0954-3899/37/7A/075021; Samanidou E, 2007, REP PROG PHYS, V70, P409, DOI 10.1088/0034-4885/70/3/R03; SCHICK KL, 1974, NATURE, V251, P599, DOI 10.1038/251599a0; SPROLES GB, 1981, J MARKETING, V45, P4; VOSS RF, 1976, PHYS REV B, V13, P556, DOI 10.1103/PhysRevB.13.556; Wiesenfeld K., 1988, PHYS REV A, V38	22	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e20721	10.1371/journal.pone.0020721	http://dx.doi.org/10.1371/journal.pone.0020721			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	778TS	21698284	Green Published, gold, Green Submitted			2022-12-27	WOS:000291730000021
J	Ali, S; van Mil, HGJ; Richardson, MK				Ali, Shaukat; van Mil, Harald G. J.; Richardson, Michael K.			Large-Scale Assessment of the Zebrafish Embryo as a Possible Predictive Model in Toxicity Testing	PLOS ONE			English	Article							FISH; VERTEBRATE; DECHORIONATION; NANOPARTICLES; MORPHOLOGY; ORGANISM; DISEASE; RERIO; LEAD	Background: In the drug discovery pipeline, safety pharmacology is a major issue. The zebrafish has been proposed as a model that can bridge the gap in this field between cell assays (which are cost-effective, but low in data content) and rodent assays (which are high in data content, but less cost-efficient). However, zebrafish assays are only likely to be useful if they can be shown to have high predictive power. We examined this issue by assaying 60 water-soluble compounds representing a range of chemical classes and toxicological mechanisms. Methodology/Principal Findings: Over 20,000 wild-type zebrafish embryos (including controls) were cultured individually in defined buffer in 96-well plates. Embryos were exposed for a 96 hour period starting at 24 hours post fertilization. A logarithmic concentration series was used for range-finding, followed by a narrower geometric series for LC50 determination. Zebrafish embryo LC50 (log mmol/L), and published data on rodent LD50 (log mmol/kg), were found to be strongly correlated (using Kendall's rank correlation tau and Pearson's product-moment correlation). The slope of the regression line for the full set of compounds was 0.73403. However, we found that the slope was strongly influenced by compound class. Thus, while most compounds had a similar toxicity level in both species, some compounds were markedly more toxic in zebrafish than in rodents, or vice versa. Conclusions: For the substances examined here, in aggregate, the zebrafish embryo model has good predictivity for toxicity in rodents. However, the correlation between zebrafish and rodent toxicity varies considerably between individual compounds and compound class. We discuss the strengths and limitations of the zebrafish model in light of these findings.	[Ali, Shaukat; van Mil, Harald G. J.; Richardson, Michael K.] Leiden Univ, Sylvius Lab, Inst Biol, Leiden, Netherlands; [van Mil, Harald G. J.] Leiden Univ, Math Inst, Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC	Ali, S (corresponding author), Leiden Univ, Sylvius Lab, Inst Biol, Leiden, Netherlands.	m.k.richardson@biology.leidenuniv.nl	Richardson, Michael K/E-8269-2011; Ali, Shaukat/L-2987-2019	Richardson, Michael K/0000-0003-1222-8101; Ali, Shaukat/0000-0003-2481-1978	Netherlands Ministry of Economic Affairs; Netherlands Ministry of Education, Culture and Science [SSM06010]; University of Azad Jammu and Kashmir, Pakistan [F-3/PD/Main, Mirpur/369/2007]	Netherlands Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); Netherlands Ministry of Education, Culture and Science; University of Azad Jammu and Kashmir, Pakistan	This work was supported by the Smart Mix Programme of the Netherlands Ministry of Economic Affairs and the Netherlands Ministry of Education, Culture and Science (M.K.R.) under grant number SSM06010, the University of Azad Jammu and Kashmir, Pakistan (S.A.) under project No. F-3/PD/Main & Mirpur/369/2007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali Shaukat, 2011, PLoS One, V6, pe20037, DOI 10.1371/journal.pone.0020037; Bai W, 2010, J NANOSCI NANOTECHNO, V10, P8670, DOI 10.1166/jnn.2010.2686; Braunbeck T, 2005, ALTEX-ALTERN TIEREXP, V22, P87; Brunelli E, 2008, ECOTOX ENVIRON SAFE, V71, P436, DOI 10.1016/j.ecoenv.2007.09.010; Bull J, 2000, SCIENCE, V287, P1409, DOI 10.1126/science.287.5457.1409; Dahm R, 2006, MAR BIOTECHNOL, V8, P329, DOI 10.1007/s10126-006-5139-0; Eyckmans M, 2010, COMP BIOCHEM PHYS C, V152, P270, DOI 10.1016/j.cbpc.2010.05.002; Fraysse B, 2006, ECOTOX ENVIRON SAFE, V63, P253, DOI 10.1016/j.ecoenv.2004.10.015; George S, 2011, ACS NANO, V5, P1805, DOI 10.1021/nn102734s; GORGE G, 1990, ECOTOX ENVIRON SAFE, V20, P246, DOI 10.1016/0147-6513(90)90004-O; Grunwald DJ, 2002, NAT REV GENET, V3, P717, DOI 10.1038/nrg892; Guo S, 2004, GENES BRAIN BEHAV, V3, P63, DOI 10.1046/j.1601-183X.2003.00053.x; Halle W, 2003, ATLA-ALTERN LAB ANIM, V31, P89, DOI 10.1177/026119290303100204; Henn K, 2011, COMP BIOCHEM PHYS C, V153, P91, DOI 10.1016/j.cbpc.2010.09.003; Hill AJ, 2005, TOXICOL SCI, V86, P6, DOI 10.1093/toxsci/kfi110; Hu N, 2001, ANAT REC, V264, P1, DOI 10.1002/ar.1111; Irons TD, 2010, NEUROTOXICOL TERATOL, V32, P84, DOI 10.1016/j.ntt.2009.04.066; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; KUMAR K, 1986, ECOTOX ENVIRON SAFE, V12, P199, DOI 10.1016/0147-6513(86)90011-4; Labrot F, 1999, ARCH ENVIRON CON TOX, V36, P167, DOI 10.1007/s002449900457; Lammer E, 2009, COMP BIOCHEM PHYS C, V149, P196, DOI 10.1016/j.cbpc.2008.11.006; Lanzky PF, 1997, CHEMOSPHERE, V35, P2553, DOI 10.1016/S0045-6535(97)00324-X; Lee KJ, 2007, ACS NANO, V1, P133, DOI 10.1021/nn700048y; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; MacPhail RC, 2009, NEUROTOXICOLOGY, V30, P52, DOI 10.1016/j.neuro.2008.09.011; Martins J, 2007, ENVIRON INT, V33, P414, DOI 10.1016/j.envint.2006.12.006; McGrath P, 2008, DRUG DISCOV TODAY, V13, P394, DOI 10.1016/j.drudis.2008.03.002; MCKIM JM, 1978, B ENVIRON CONTAM TOX, V19, P608, DOI 10.1007/BF01685847; Mizell M, 1997, INT J DEV BIOL, V41, P411; *ORG EC COOP DEV, 1998, 212 OECD; Parng C, 2002, ASSAY DRUG DEV TECHN, V1, P41, DOI 10.1089/154065802761001293; Peterson KJ, 2004, P NATL ACAD SCI USA, V101, P6536, DOI 10.1073/pnas.0401670101; Postlethwait JH, 2000, GENOME RES, V10, P1890, DOI 10.1101/gr.164800; Redfern William S., 2008, Journal of Pharmacological and Toxicological Methods, V58, P110, DOI 10.1016/j.vascn.2008.05.006; ROCHE H, 1994, B ENVIRON CONTAM TOX, V52, P69, DOI 10.1007/BF00197359; Rogers JT, 2003, AQUAT TOXICOL, V64, P215, DOI 10.1016/S0166-445X(03)00053-5; Rubinstein AL, 2003, CURR OPIN DRUG DI DE, V6, P218; Schaaf MJM, 2008, ENDOCRINOLOGY, V149, P1591, DOI 10.1210/en.2007-1364; Selderslaghs IWT, 2009, REPROD TOXICOL, V28, P308, DOI 10.1016/j.reprotox.2009.05.004; SHAZILI NAM, 1986, B ENVIRON CONTAM TOX, V36, P468, DOI 10.1007/BF01623536; Teraoka Hiroki, 2003, Congenital Anomalies, V43, P123, DOI 10.1111/j.1741-4520.2003.tb01036.x; Tropepe V, 2003, GENES BRAIN BEHAV, V2, P268, DOI 10.1034/j.1601-183X.2003.00038.x; Truong L, 2011, METHODS MOL BIOL, V691, P271, DOI 10.1007/978-1-60761-849-2_16; United States Environmental Protection Agency, 1996, 8260B US EPA, P1; Veldman MB, 2008, PEDIATR RES, V64, P470, DOI 10.1203/PDR.0b013e318186e609; Voelker D, 2007, AQUAT TOXICOL, V81, P355, DOI 10.1016/j.aquatox.2006.12.013; Wielhouwer EM, 2011, LAB CHIP, V11, P1815, DOI 10.1039/c0lc00443j; ZOK S, 1991, SCI TOTAL ENVIRON, V109, P411, DOI 10.1016/0048-9697(91)90196-L	48	130	138	4	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21076	10.1371/journal.pone.0021076	http://dx.doi.org/10.1371/journal.pone.0021076			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738604	gold, Green Published, Green Submitted			2022-12-27	WOS:000292142800011
J	Chen, WW; Hou, ZB; Li, CM; Xiong, S; Liu, HG				Chen, Weiwei; Hou, Zhibo; Li, Chunman; Xiong, Sheng; Liu, Henggui			Cloning and Characterization of Porcine 4Ig-B7-H3: A Potent Inhibitor of Porcine T-Cell Activation	PLOS ONE			English	Article							RESPIRATORY SYNDROME VIRUS; PROGRAMMED DEATH 1; B7 FAMILY; COSTIMULATORY MOLECULE; EXPERIMENTAL-INFECTION; ENDOTHELIAL-CELLS; TUMOR VASCULATURE; TISSUE-EXPRESSION; IMMUNE-RESPONSE; DENDRITIC CELLS	Background: Members of the B7 superfamily costimulate the proliferation of lymphocytes during the initiation and maintenance of antigen-specific humoral and cell-mediated immune responses. B7-H3 (CD276) is a newly identified member of the B7 superfamily. It has been shown that B7-H3 plays a significant role in regulating T cell response in humans and mice, but it is not known whether a counterpart of human or murine B7-H3 exists in porcine species. Methodology/Principal Findings: We cloned the porcine 4ig-b7-h3 gene using a blast search at the NCBI database with human b7-h3, RT-PCR and 39-terminus RACE. Protein sequence analysis showed that the protein encoded by this gene contained 4Ig-like domains and was 90.88% identical with human 4Ig-B7-H3. Results of Dot-blot hybridization and RT-PCR showed that B7-H3 was broadly distributed in porcine tissues mainly as two isoforms, 2Ig-B7-H3 and 4Ig-B7-H3, of which 4Ig-B7-H3 was dominant. We further demonstrated that porcine 4Ig-B7-H3 was able to inhibit the proliferation and cytokine production of porcine T cells activated through the TCR pathway, similar to human B7-H3. Conclusion: We cloned the porcine 4ig-b7-h3 gene and demonstrated that the porcine 4Ig-B7-H3 serves as a negative regulator for the T-cell immune response.	[Liu, Henggui] Chinese Acad Agr Sci, Harbin Vet Res Inst, Natl Key Lab Vet Biotechnol, Harbin, Peoples R China; [Chen, Weiwei] Beijing 302 Hosp, Treatment & Res Ctr Infect Dis, Beijing, Peoples R China; [Hou, Zhibo; Li, Chunman; Xiong, Sheng] Jinan Univ, Natl Engn Res Ctr Genet Med, Biomed R&D Ctr, Guangdong Prov Key Lab Bioengn Med, Guangzhou, Guangdong, Peoples R China	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS; Fifth Medical Center of Chinese PLA General Hospital; Jinan University	Liu, HG (corresponding author), Chinese Acad Agr Sci, Harbin Vet Res Inst, Natl Key Lab Vet Biotechnol, Harbin, Peoples R China.	Liuhenggui@gmail.com			Ministry of Science and Technology; Ministry of Health [2008ZX10004-008]; National Natural Science Foundation of China [30873082]; Ministry of Science and Technology of China [2008BAI63B05]; Program for New Century Excellent Talents in University [NCET-07-0376]; Jinan University; HOUBIO TECH CO. LTD.	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Health; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Jinan University(Jinan University); HOUBIO TECH CO. LTD.	This work was supported by the grants from the Ministry of Science and Technology and the Ministry of Health (2008ZX10004-008), the National Natural Science Foundation of China (30873082), the Ministry of Science and Technology of China (2008BAI63B05), the Program for New Century Excellent Talents in University (NCET-07-0376), the 211 Project of Jinan University to S. Xiong and grants from the donation of HOUBIO TECH CO. LTD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agata Y, 1996, INT IMMUNOL, V8, P765, DOI 10.1093/intimm/8.5.765; Alegre ML, 2001, NAT REV IMMUNOL, V1, P220, DOI 10.1038/35105024; Allende R, 2000, J VIROL, V74, P10834, DOI 10.1128/JVI.74.22.10834-10837.2000; Barach YS, 2010, TRENDS MOL MED; Batista L, 2004, CAN J VET RES, V68, P267; BOTNER A, 1994, VET MICROBIOL, V40, P351, DOI 10.1016/0378-1135(94)90122-8; Castriconi R, 2004, P NATL ACAD SCI USA, V101, P12640, DOI 10.1073/pnas.0405025101; Chapoval AI, 2001, NAT IMMUNOL, V2, P269, DOI 10.1038/85339; Crispen PL, 2008, CLIN CANCER RES, V14, P5150, DOI 10.1158/1078-0432.CCR-08-0536; Davis TA, 1996, INT IMMUNOL, V8, P1099, DOI 10.1093/intimm/8.7.1099; Dong C, 2001, NATURE, V409, P97, DOI 10.1038/35051100; Faas SJ, 2000, J IMMUNOL, V164, P6340, DOI 10.4049/jimmunol.164.12.6340; Gao Q, 2009, CLIN CANCER RES, V15, P971, DOI 10.1158/1078-0432.CCR-08-1608; Jeon DH, 2007, XENOTRANSPLANTATION, V14, P236, DOI 10.1111/j.1399-3089.2007.00403.x; Keir ME, 2006, J EXP MED, V203, P883, DOI 10.1084/jem.20051776; Krambeck AE, 2006, P NATL ACAD SCI USA, V103, P10391, DOI 10.1073/pnas.0600937103; Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330; Lee H, 2010, J CANCER RES CLIN, V136, P1445, DOI 10.1007/s00432-010-0800-4; Leitner J, 2009, EUR J IMMUNOL; Li JCB, 2005, FEBS LETT, V579, P3055, DOI 10.1016/j.febslet.2005.04.060; Ling V, 2003, GENOMICS, V82, P365, DOI 10.1016/S0888-7543(03)00126-5; LOOS M, 2008, CANC LETT; Loos M, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-463; Luo LQ, 2004, J IMMUNOL, V173, P5445, DOI 10.4049/jimmunol.173.9.5445; Maher SE, 1996, J IMMUNOL, V157, P3838; Muthumani K, 2008, J VIROL, V82, P11536, DOI 10.1128/JVI.00485-08; Peng JM, 2010, VET IMMUNOL IMMUNOP, V136, P157, DOI 10.1016/j.vetimm.2010.03.001; Plege A, 2009, TRANSPLANTATION, V87, P975, DOI 10.1097/TP.0b013e31819c85e8; Prasad DVR, 2004, J IMMUNOL, V173, P2500, DOI 10.4049/jimmunol.173.4.2500; Selenko-Gebauer N, 2003, J IMMUNOL, V170, P3637, DOI 10.4049/jimmunol.170.7.3637; Sica GL, 2003, IMMUNITY, V18, P849, DOI 10.1016/S1074-7613(03)00152-3; Steinberger P, 2004, J IMMUNOL, V172, P2352, DOI 10.4049/jimmunol.172.4.2352; Suh WK, 2003, NAT IMMUNOL, V4, P899, DOI 10.1038/ni967; Sun MY, 2002, J IMMUNOL, V168, P6294, DOI 10.4049/jimmunol.168.12.6294; Tafuri A, 2001, NATURE, V409, P105, DOI 10.1038/35051113; Terzo EA, 2005, VET IMMUNOL IMMUNOP, V103, P9, DOI 10.1016/j.vetimm.2004.08.008; Trabattoni D, 2003, BLOOD, V101, P2514, DOI 10.1182/blood-2002-10-3065; Wang SD, 2003, J EXP MED, V197, P1083, DOI 10.1084/jem.20021752; Yi KH, 2009, IMMUNOL REV, V229, P145, DOI 10.1111/j.1600-065X.2009.00768.x; Yoo J, 2008, VET IMMUNOL IMMUNOP, V121, P359, DOI 10.1016/j.vetimm.2007.10.004; Zang X, 2007, P NATL ACAD SCI USA, V104, P19458, DOI 10.1073/pnas.0709802104; Zang XX, 2007, CLIN CANCER RES, V13, P5271, DOI 10.1158/1078-0432.CCR-07-1030; Zang XX, 2010, MODERN PATHOL, V23, P1104, DOI 10.1038/modpathol.2010.95; Zhang GB, 2004, ACTA BIOCH BIOPH SIN, V36, P430, DOI 10.1093/abbs/36.6.430; Zhang GB, 2008, IMMUNOLOGY, V123, P538, DOI 10.1111/j.1365-2567.2007.02723.x; Zhang GB, 2005, CELL MOL IMMUNOL, V2, P307; Zhou YH, 2007, TISSUE ANTIGENS, V70, P96, DOI 10.1111/j.1399-0039.2007.00853.x	47	6	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21341	10.1371/journal.pone.0021341	http://dx.doi.org/10.1371/journal.pone.0021341			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738638	Green Published, Green Submitted, gold			2022-12-27	WOS:000292092600031
J	Zhang, ZH; Pugh, BF				Zhang, Zhenhai; Pugh, B. Franklin			Genomic Organization of H2Av Containing Nucleosomes in Drosophila Heterochromatin	PLOS ONE			English	Article							POSITION-EFFECT VARIEGATION; HISTONE VARIANT; MOLECULAR ASPECTS; RNA-POLYMERASE; CHROMOSOMAL MATERIAL; DNA-SEQUENCES; CHROMATIN; MELANOGASTER; ACTIVATION; PROMOTERS	H2Av is a versatile histone variant that plays both positive and negative roles in transcription, DNA repair, and chromatin structure in Drosophila. H2Av, and its broader homolog H2A.Z, tend to be enriched toward 59 ends of genes, and exist in both euchromatin and heterochromatin. Its organization around euchromatin genes and other features have been described in many eukaryotic model organisms. However, less is known about H2Av nucleosome organization in heterochromatin. Here we report the properties and organization of individual H2Av nucleosomes around genes and transposable elements located in Drosophila heterochromatic regions. We compare the similarity and differences with that found in euchromatic regions. Our analyses suggest that nucleosomes are intrinsically positioned on inverted repeats of DNA transposable elements such as those related to the "1360" element, but are not intrinsically positioned on retrotransposon-related elements.	[Zhang, Zhenhai; Pugh, B. Franklin] Penn State Univ, Dept Biochem & Mol Biol, Ctr Comparat Genom & Bioinformat, Ctr Eukaryot Gene Regulat, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Zhang, ZH (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, Ctr Comparat Genom & Bioinformat, Ctr Eukaryot Gene Regulat, University Pk, PA 16802 USA.	bfp2@psu.edu	Zhang, Zhenhai/GRX-5887-2022	Zhang, Zhenhai/0000-0002-4310-0525	NIH [HG004160]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004160, R56HG004160] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by a grant from NIH (HG004160). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; ALBERT I, 2008, BIOINFORMATICS; Albert I, 2008, BIOINFORMATICS, V24, P1305, DOI 10.1093/bioinformatics/btn119; Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; BELYAEVA ES, 1993, CHROMOSOMA, V102, P583, DOI 10.1007/BF00368351; BELYAEVA ES, 1991, CHROMOSOMA, V100, P453, DOI 10.1007/BF00364556; Bondarenko VA, 2006, MOL CELL, V24, P469, DOI 10.1016/j.molcel.2006.09.009; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; Brown SA, 1997, GENE DEV, V11, P3116, DOI 10.1101/gad.11.23.3116; Brown SA, 1996, GENE DEV, V10, P1479, DOI 10.1101/gad.10.12.1479; Carey M, 2006, MOL CELL, V24, P481, DOI 10.1016/j.molcel.2006.09.012; Dawe RK, 2006, TRENDS BIOCHEM SCI, V31, P662, DOI 10.1016/j.tibs.2006.10.004; De la Fuente R, 2006, NAT CELL BIOL, V8, P1448, DOI 10.1038/ncb1513; Dhillon N, 2006, MOL CELL BIOL, V26, P489, DOI 10.1128/MCB.26.2.489-501.2006; Eirin-Lopez JM, 2007, CURR GENOMICS, V8, P59, DOI 10.2174/138920207780076965; Elgin SCR, 1996, CURR OPIN GENET DEV, V6, P193, DOI 10.1016/S0959-437X(96)80050-5; Farris SD, 2005, J BIOL CHEM, V280, P25298, DOI 10.1074/jbc.M501784200; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Field Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000216; Hardy S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000687; Haynes KA, 2006, CURR BIOL, V16, P2222, DOI 10.1016/j.cub.2006.09.035; HOSKINS RA, 2002, GENOME BIOL, V0003; Hoskins RA, 2007, SCIENCE, V316, P1625, DOI 10.1126/science.1139816; Hughes JR, 2005, GENETICS, V171, P1183, DOI 10.1534/genetics.105.043976; Ioshikhes IP, 2006, NAT GENET, V38, P1210, DOI 10.1038/ng1878; Jin CY, 2009, NAT GENET, V41, P941, DOI 10.1038/ng.409; Jordan IK, 2003, TRENDS GENET, V19, P68, DOI 10.1016/S0168-9525(02)00006-9; Kazazian HH, 1998, NAT GENET, V19, P19, DOI 10.1038/ng0598-19; Kelly TK, 2010, MOL CELL, V39, P901, DOI 10.1016/j.molcel.2010.08.026; Larochelle M, 2003, EMBO J, V22, P4512, DOI 10.1093/emboj/cdg427; Leach TJ, 2000, J BIOL CHEM, V275, P23267, DOI 10.1074/jbc.M910206199; Li B, 2005, P NATL ACAD SCI USA, V102, P18385, DOI 10.1073/pnas.0507975102; LOHE AR, 1993, GENETICS, V134, P1149; Lu BY, 2000, GENETICS, V155, P699; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; Meneghini MD, 2003, CELL, V112, P725, DOI 10.1016/S0092-8674(03)00123-5; Miele V, 2008, NUCLEIC ACIDS RES, V36, P3746, DOI 10.1093/nar/gkn262; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Peckham HE, 2007, GENOME RES, V17, P1170, DOI 10.1101/gr.6101007; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Rakyan VK, 2002, TRENDS GENET, V18, P348, DOI 10.1016/S0168-9525(02)02709-9; Rangasamy D, 2003, EMBO J, V22, P1599, DOI 10.1093/emboj/cdg160; Romanish MT, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030010; Roy AM, 2000, J MOL BIOL, V302, P17, DOI 10.1006/jmbi.2000.4027; Santisteban MS, 2000, CELL, V103, P411, DOI 10.1016/S0092-8674(00)00133-1; Sarcinella E, 2007, MOL CELL BIOL, V27, P6457, DOI 10.1128/MCB.00241-07; SATCHWELL SC, 1986, J MOL BIOL, V191, P659, DOI 10.1016/0022-2836(86)90452-3; Schueler MG, 2006, ANNU REV GENOM HUM G, V7, P301, DOI 10.1146/annurev.genom.7.080505.115613; Schwartz BE, 2005, GENE DEV, V19, P804, DOI 10.1101/gad.1259805; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Stellwagen AE, 1998, TRENDS BIOCHEM SCI, V23, P486, DOI 10.1016/S0968-0004(98)01325-5; Swaminathan J, 2005, GENE DEV, V19, P65, DOI 10.1101/gad.1259105; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; TRIFONOV EN, 1980, NUCLEIC ACIDS RES, V8, P4041, DOI 10.1093/nar/8.17.4041; UMBETOVA GH, 1991, CHROMOSOMA, V101, P55, DOI 10.1007/BF00360687; VALOUEV A, 2008, GENOME RES; VANDAAL A, 1992, MOL BIOL CELL, V3, P593, DOI 10.1091/mbc.3.6.593; Wallberg AE, 2000, MOL CELL BIOL, V20, P2004, DOI 10.1128/MCB.20.6.2004-2013.2000; Wang JP, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000175; Wang JPZ, 2005, NUCLEIC ACIDS RES, V33, P6743, DOI 10.1093/nar/gki977; Widom J, 2001, Q REV BIOPHYS, V34, P269, DOI 10.1017/S0033583501003699; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26; Zhang HY, 2005, CELL, V123, P219, DOI 10.1016/j.cell.2005.08.036; ZHIMULEV IF, 1988, CHROMOSOMA, V96, P255, DOI 10.1007/BF00302365	68	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e20511	10.1371/journal.pone.0020511	http://dx.doi.org/10.1371/journal.pone.0020511			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738578	Green Submitted, Green Published, gold			2022-12-27	WOS:000292092600003
J	Gupta, K; Chakrabarti, A; Rana, S; Ramdeo, R; Roth, BL; Agarwal, ML; Tse, W; Agarwal, MK; Wald, DN				Gupta, Kalpana; Chakrabarti, Amitabha; Rana, Sonia; Ramdeo, Ritu; Roth, Bryan L.; Agarwal, Munna L.; Tse, William; Agarwal, Mukesh K.; Wald, David N.			Securinine, a Myeloid Differentiation Agent with Therapeutic Potential for AML	PLOS ONE			English	Article							PROMYELOCYTIC LEUKEMIA-CELLS; HL-60; APOPTOSIS; INDUCTION	As the defining feature of Acute Myeloid Leukemia (AML) is a maturation arrest, a highly desirable therapeutic strategy is to induce leukemic cell maturation. This therapeutic strategy has the potential of avoiding the significant side effects that occur with the traditional AML therapeutics. We identified a natural compound securinine, as a leukemia differentiation-inducing agent. Securinine is a plant-derived alkaloid that has previously been used clinically as a therapeutic for primarily neurological related diseases. Securinine induces monocytic differentiation of a wide range of myeloid leukemia cell lines as well as primary leukemic patient samples. Securinine's clinical potential for AML can be seen from its ability to induce significant growth arrest in cell lines and patient samples as well as its activity in significantly impairing the growth of AML tumors in nude mice. In addition, securinine can synergize with currently employed agents such as ATRA and decitabine to induce differentiation. This study has revealed securinine induces differentiation through the activation of DNA damage signaling. Securinine is a promising new monocytic differentiation inducing agent for AML that has seen previous clinical use for non-related disorders.	[Gupta, Kalpana; Ramdeo, Ritu; Wald, David N.] Case Western Reserve Sch Med, Dept Pathol, Cleveland, OH 44106 USA; [Chakrabarti, Amitabha; Rana, Sonia; Agarwal, Mukesh K.; Wald, David N.] Invenio Therapeut, Cleveland, OH USA; [Roth, Bryan L.] Univ N Carolina, Chapel Hill Med Sch, Dept Pharmacol, Chapel Hill, NC USA; [Roth, Bryan L.] Univ N Carolina, Chapel Hill Med Sch, Dept Med Chem, Chapel Hill, NC USA; [Agarwal, Munna L.] Case Western Reserve Sch Med, Dept Genet, Cleveland, OH USA; [Tse, William] W Virginia Univ, Dept Med, Morgantown, WV 26506 USA; [Wald, David N.] Univ Hosp Cleveland, Case Med Ctr, Cleveland, OH 44106 USA	Case Western Reserve University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Case Western Reserve University; West Virginia University; Case Western Reserve University; University Hospitals of Cleveland	Gupta, K (corresponding author), Case Western Reserve Sch Med, Dept Pathol, Cleveland, OH 44106 USA.	agarwamukesh@yahoo.com; dnw@case.edu	Roth, Bryan L/F-3928-2010; Roth, Bryan/ABE-7032-2020	Roth, Bryan/0000-0002-0561-6520	National Institutes of Health [R43 CA134089]; Children's Leukemia Research Foundation; NATIONAL CANCER INSTITUTE [R43CA134089] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Leukemia Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding for this work was received from National Institutes of Health grant R43 CA134089 and Children's Leukemia Research Foundation (childrensleukemia.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam S, 2006, MOL IMMUNOL, V43, P1432, DOI 10.1016/j.molimm.2005.07.025; ALESHKINA Ia A, 1956, Farmakol Toksikol, V19, P11; *AM CANC SOC, 2006, DET GUID LEUK AC MYE; Asada M, 1998, LEUKEMIA, V12, P1944, DOI 10.1038/sj.leu.2401228; BEUTLER JA, 1985, BRAIN RES, V330, P135, DOI 10.1016/0006-8993(85)90014-9; BURAVTSEVA G R, 1958, Farmakol Toksikol, V21, P7; COLLINS SJ, 1980, INT J CANCER, V25, P213, DOI 10.1002/ijc.2910250208; COLLINS SJ, 1979, J EXP MED, V149, P969, DOI 10.1084/jem.149.4.969; Copperman R, 1973, Pa Med, V76, P36; COPPERMAN R, 1974, JAMA-J AM MED ASSOC, V228, P288, DOI 10.1001/jama.1974.03230280016013; Dong NZ, 1999, ACTA PHARMACOL SIN, V20, P267; Duke J. A., 1985, REFERENCE PUBLICATIO, pS219; Estey E, 2006, LANCET, V368, P1894, DOI 10.1016/S0140-6736(06)69780-8; GUGLIELMO P, 1980, Bollettino Societa Italiana Biologia Sperimentale, V56, P183; Hill L, 1976, P N G Med J, V18, P157; Kell Jonathan, 2004, Expert Opin Emerg Drugs, V9, P55, DOI 10.1517/14728214.9.1.55; Lubick K, 2007, J LEUKOCYTE BIOL, V82, P1062, DOI 10.1189/jlb.0407255; Meyer M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007768; NEWBURGER PE, 1979, J CELL BIOL, V82, P315, DOI 10.1083/jcb.82.2.315; NEWBURGER PE, 1984, J BIOL CHEM, V259, P3771; Pu H, 2001, Zhong Yao Cai, V24, P278; Rana SV, 2010, FASEB J, V24; Rana S, 2010, FASEB J, V24, P2126, DOI 10.1096/fj.09-148999; Tallmann M. S., 2004, Annals of Hematology, V83, pS81; Wald DN, 2008, CANCER RES, V68, P4369, DOI 10.1158/0008-5472.CAN-07-6559	25	40	41	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21203	10.1371/journal.pone.0021203	http://dx.doi.org/10.1371/journal.pone.0021203			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21731671	Green Submitted, Green Published, gold			2022-12-27	WOS:000292036900015
J	Alva-Medina, J; Maya-Mendoza, A; Dent, MAR; Aranda-Anzaldo, A				Alva-Medina, Janeth; Maya-Mendoza, Apolinar; Dent, Myrna A. R.; Aranda-Anzaldo, Armando			Continued Stabilization of the Nuclear Higher-Order Structure of Post-Mitotic Neurons In Vivo	PLOS ONE			English	Article							CELL-CYCLE; DROSOPHILA-MELANOGASTER; LIVER-REGENERATION; DNA-REPLICATION; TRANSGENIC MICE; CEREBRAL-CORTEX; VISUAL-CORTEX; LOOP DOMAINS; LIFE-SPAN; MATRIX	Background: Cellular terminal differentiation (TD) correlates with a permanent exit from the cell cycle and so TD cells become stably post-mitotic. However, TD cells express the molecular machinery necessary for cell proliferation that can be reactivated by experimental manipulation, yet it has not been reported the stable proliferation of any type of reactivated TD cells. Neurons become post-mitotic after leaving the ventricular zone. When neurons are forced to reenter the cell cycle they invariably undergo cell death. Wider evidence indicates that the post-mitotic state cannot solely depend on gene products acting in trans, otherwise mutations in the corresponding genes may lead to reentry and completion of the cell cycle in TD cells, but this has not been observed. In the interphase, nuclear DNA of metazoan cells is organized in supercoiled loops anchored to a nuclear nuclear matrix (NM). The DNA-NM interactions define a higher-order structure in the cell nucleus (NHOS). We have previously compared the NHOS of aged rat hepatocytes with that of early post-mitotic rat neurons and our results indicated that a very stable NHOS is a common feature of both senescent and post-mitotic cells in vivo. Principal Findings: In the present work we compared the NHOS in rat neurons from different post-natal ages. Our results show that the trend towards further stabilization of the NHOS in neurons continues throughout post-natal life. This phenomenon occurs in absence of overt changes in the post-mitotic state and transcriptional activity of neurons, suggesting that it is independent of functional constraints. Conclusions: Apparently the continued stabilization of the NHOS as a function of time is basically determined by thermodynamic and structural constraints. We discuss how the resulting highly stable NHOS of neurons may be the structural, non-genetic basis of their permanent and irreversible post-mitotic state.	[Alva-Medina, Janeth; Maya-Mendoza, Apolinar; Dent, Myrna A. R.; Aranda-Anzaldo, Armando] Univ Autonoma Estado Mexico, Fac Med, Lab Biol Mol & Neurociencias, Toluca, Mexico		Aranda-Anzaldo, A (corresponding author), Univ Autonoma Estado Mexico, Fac Med, Lab Biol Mol & Neurociencias, Toluca, Mexico.	aaa@uaemex.mx	Aranda-Anzaldo, Armando/A-6513-2014	Aranda-Anzaldo, Armando/0000-0002-5583-5465; Maya-Mendoza, Apolinar/0000-0001-7452-9896; Dent, Myrna/0000-0003-2304-499X	CONACYT-Mexico [48447-Q-25506]; UAEMex [2212/2006]	CONACYT-Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); UAEMex	This work was funded by CONACYT-Mexico (www.conacyt.gob.mx), grant 48447-Q-25506 awarded to A. Aranda-Anzaldo, and UAEMex (www.uaemex.mx), grant 2212/2006 awarded to A. Aranda-Anzaldo and M.A.R. Dent. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	ALUBAIDI MR, 1992, P NATL ACAD SCI USA, V89, P1194, DOI 10.1073/pnas.89.4.1194; Alva-Medina J, 2010, BIOGERONTOLOGY, V11, P703, DOI 10.1007/s10522-010-9285-4; Anachkova B, 2005, J CELL BIOCHEM, V96, P951, DOI 10.1002/jcb.20610; Anisimov V. N., 2009, OPEN LONGEVITY SCI, V3, P1; Aranda-Anzaldo A, 1999, BBA-GENE STRUCT EXPR, V1446, P181, DOI 10.1016/S0167-4781(99)00086-X; Aranda-Anzaldo A, 1997, RES VIROLOGY, V148, P397, DOI 10.1016/S0923-2516(97)83629-1; Aranda-Anzaldo A, 2009, AGING-US, V1, P598, DOI 10.18632/aging.100074; Bauer JH, 2005, CURR BIOL, V15, P2063, DOI 10.1016/j.cub.2005.10.051; Beausejour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417; Benham C, 1997, J MOL BIOL, V274, P181, DOI 10.1006/jmbi.1997.1385; BEREZNEY R, 1981, EXP CELL RES, V132, P1, DOI 10.1016/0014-4827(81)90076-8; BLUE ME, 1983, J NEUROCYTOL, V12, P599, DOI 10.1007/BF01181526; BLUE ME, 1983, J NEUROCYTOL, V12, P697, DOI 10.1007/BF01181531; Boulikas T, 1995, INT REV CYTOL, V162A, P279; BRODAL P, 1992, CENTRAL NERVOUS SYST, P45; BUONGIORNONARDELLI M, 1982, NATURE, V298, P100, DOI 10.1038/298100a0; Butany J, 2005, LANCET ONCOL, V6, P219, DOI 10.1016/S1470-2045(05)70093-0; CALLADINE CR, 2004, UNDERSTANDING DNA, P94; Rivera-Mulia JC, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-3; Rivera-Mulia JC, 2010, DNA RES, V17, P23, DOI 10.1093/dnares/dsp027; Cloutier TE, 2004, MOL CELL, V14, P355, DOI 10.1016/S1097-2765(04)00210-2; Cohen-Cory S, 2002, SCIENCE, V298, P770, DOI 10.1126/science.1075510; Cook PR, 1999, SCIENCE, V284, P1790, DOI 10.1126/science.284.5421.1790; COOK PR, 1976, J CELL SCI, V22, P303; Dent MAR, 2010, FEBS LETT, V584, P2767, DOI 10.1016/j.febslet.2010.04.073; Eggan E, 2004, NATURE, V428, P44, DOI 10.1038/nature02375; Fausto N, 2000, J HEPATOL, V32, P19, DOI 10.1016/S0168-8278(00)80412-2; FEDDERSEN RM, 1992, NEURON, V9, P955, DOI 10.1016/0896-6273(92)90247-B; Forsyth NR, 2005, MECH AGEING DEV, V126, P685, DOI 10.1016/j.mad.2005.01.003; GATEFF E, 1978, SCIENCE, V200, P1448, DOI 10.1126/science.96525; Hartung EW, 1942, CANCER RES, V2, P837; HERRUP K, 1995, DEVELOPMENT, V121, P2385; Hochedlinger K, 2006, NATURE, V441, P1061, DOI 10.1038/nature04955; Hutchison CJ, 2004, NAT CELL BIOL, V6, P1062, DOI 10.1038/ncb1104-1062; Iarovaia OV, 2009, J CELL BIOCHEM, V106, P170, DOI 10.1002/jcb.21987; Iarovaia OV, 2004, NUCLEIC ACIDS RES, V32, P2079, DOI 10.1093/nar/gkh532; Ivanovic-Matic S, 2000, IUBMB LIFE, V49, P511, DOI 10.1080/15216540050167052; Kim KK, 2009, J BIOL CHEM, V284, P31052, DOI 10.1074/jbc.M109.052969; Lambert FL, 2002, J CHEM EDUC, V79, P187, DOI 10.1021/ed079p187; Lemaitre JM, 2005, CELL, V123, P787, DOI 10.1016/j.cell.2005.08.045; MARTIN GM, 1977, AM J PATHOL, V89, P484; Maya-Mendoza A, 2005, MECH AGEING DEV, V126, P767, DOI 10.1016/j.mad.2005.01.011; Maya-Mendoza A, 2004, J CELL BIOCHEM, V93, P1084, DOI 10.1002/jcb.20264; Maya-Mendoza A, 2003, NUCLEIC ACIDS RES, V31, P6168, DOI 10.1093/nar/gkg825; Maya-Mendoza A, 2003, ANAL BIOCHEM, V313, P196, DOI 10.1016/S0003-2697(02)00611-5; Meaburn KJ, 2007, NATURE, V445, P379, DOI 10.1038/445379a; Mika S, 2005, NUCLEIC ACIDS RES, V33, pD160; Mitalipov SM, 2007, HUM REPROD, V22, P2232, DOI 10.1093/humrep/dem136; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Nickerson JA, 2001, J CELL SCI, V114, P463; Ottaviani D, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-201; Pajalunga D, 2007, CELL CYCLE, V6, P1415; Pajalunga D, 2007, J CELL BIOL, V176, P807, DOI 10.1083/jcb.200608109; Pajalunga D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011559; RAKIC P, 1974, SCIENCE, V183, P425, DOI 10.1126/science.183.4123.425; Rakic P, 2006, SCIENCE, V313, P928, DOI 10.1126/science.1131713; Ramana-Murty CV, 1988, BIOCHIM BIOPHYS ACTA, V949, P23; Razin SV, 1995, INT REV CYTOL, V162B, P405; Razin SV, 2001, CELL MOL BIOL LETT, V6, P59; ROTI JLR, 1993, ADV RADIAT BIOL, V17, P227; SCHARRER B, 1950, CANCER RES, V10, P403; SMALL D, 1985, NUCLEIC ACIDS RES, V13, P2413, DOI 10.1093/nar/13.7.2413; SMITH JR, 1974, J CELL BIOL, V62, P48, DOI 10.1083/jcb.62.1.48; SZOLLOSI D, 1988, J CELL SCI, V91, P603; Takahashi A, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-10; THOMPSON RJ, 1973, J NEUROCHEM, V21, P19, DOI 10.1111/j.1471-4159.1973.tb04222.x; Thomson I, 2004, CURR BIOL, V14, P166, DOI 10.1016/j.cub.2003.12.024; Trevilla-Garcia C, 2011, J CELL BIOCHEM, V112, P531, DOI 10.1002/jcb.22943; Tsutsui KM, 2005, ACTA MED OKAYAMA, V59, P113; Wai T, 2010, BIOL REPROD, V83, P52, DOI 10.1095/biolreprod.109.080887; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wilmut I, 2002, NATURE, V419, P583, DOI 10.1038/nature01079; WUNDERLICH F, 1977, J CELL BIOL, V73, P271, DOI 10.1083/jcb.73.2.271; Yamazaki Y, 2001, P NATL ACAD SCI USA, V98, P14022, DOI 10.1073/pnas.231489398; Zhang J, 2008, CELL CYCLE, V7, P3487, DOI 10.4161/cc.7.22.7045; Zhang J, 2010, J NEUROSCI, V30, P5219, DOI 10.1523/JNEUROSCI.5628-09.2010; Zhang YL, 2004, P NATL ACAD SCI USA, V101, P8337, DOI 10.1073/pnas.0402319101	77	8	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21360	10.1371/journal.pone.0021360	http://dx.doi.org/10.1371/journal.pone.0021360			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731716	Green Published, gold, Green Submitted			2022-12-27	WOS:000292035400029
J	Bazil, JN; Dash, RK				Bazil, Jason N.; Dash, Ranjan K.			A Minimal Model for the Mitochondrial Rapid Mode of Ca2+ Uptake Mechanism	PLOS ONE			English	Article							CALCIUM OSCILLATIONS; OXIDATIVE-PHOSPHORYLATION; SARCOPLASMIC-RETICULUM; CRYSTAL-STRUCTURE; HEART; TRANSPORT; KINETICS; LIVER; CELL; PULSES	Mitochondria possess a remarkable ability to rapidly accumulate and sequester Ca2+. One of the mechanisms responsible for this ability is believed to be the rapid mode (RaM) of Ca2+ uptake. Despite the existence of many models of mitochondrial Ca2+ dynamics, very few consider RaM as a potential mechanism that regulates mitochondrial Ca2+ dynamics. To fill this gap, a novel mathematical model of the RaM mechanism is developed herein. The model is able to simulate the available experimental data of rapid Ca2+ uptake in isolated mitochondria from both chicken heart and rat liver tissues with good fidelity. The mechanism is based on Ca2+ binding to an external trigger site(s) and initiating a brief transient of high Ca2+ conductivity. It then quickly switches to an inhibited, zero-conductive state until the external Ca2+ level is dropped below a critical value (similar to 100-150 nM). RaM's Ca2+- and time-dependent properties make it a unique Ca2+ transporter that may be an important means by which mitochondria take up Ca2+ in situ and help enable mitochondria to decode cytosolic Ca2+ signals. Integrating the developed RaM model into existing models of mitochondrial Ca2+ dynamics will help elucidate the physiological role that this unique mechanism plays in mitochondrial Ca2+-homeostasis and bioenergetics.	[Bazil, Jason N.] Med Coll Wisconsin, Biotechnol & Bioengn Ctr, Milwaukee, WI 53226 USA; Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin	Bazil, JN (corresponding author), Med Coll Wisconsin, Biotechnol & Bioengn Ctr, Milwaukee, WI 53226 USA.	rdash@mcw.edu			National Institutes of Health [R01-HL095122, T32-HL094273]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095122, T32HL094273] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health grants R01-HL095122 and T32-HL094273. www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balaban RS, 2009, BBA-BIOENERGETICS, V1787, P1334, DOI 10.1016/j.bbabio.2009.05.011; Beutner G, 2001, J BIOL CHEM, V276, P21482, DOI 10.1074/jbc.M101486200; BROWN GC, 1992, BIOCHEM J, V284, P1; Buntinas L, 2001, BBA-BIOENERGETICS, V1504, P248, DOI 10.1016/S0005-2728(00)00254-1; Chacon E, 1996, FEBS LETT, V382, P31, DOI 10.1016/0014-5793(96)00138-X; COLL KE, 1982, J BIOL CHEM, V257, P8696; Cortassa S, 2003, BIOPHYS J, V84, P2734, DOI 10.1016/S0006-3495(03)75079-6; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Dash RK, 2008, J PHYSIOL-LONDON, V586, P3267, DOI 10.1113/jphysiol.2008.151977; DENTON RM, 1986, CELL CALCIUM, V7, P377, DOI 10.1016/0143-4160(86)90040-0; Di Lisa F, 2006, CARDIOVASC RES, V70, P191, DOI 10.1016/j.cardiores.2006.01.016; Duchen MR, 2000, CELL CALCIUM, V28, P339, DOI 10.1054/ceca.2000.0170; FLEISCHER S, 1967, J LIPID RES, V8, P170; GARLID KD, 1989, BIOCHIM BIOPHYS ACTA, V976, P109, DOI 10.1016/S0005-2728(89)80219-1; Ghebrehiwet B, 2002, IMMUNOBIOLOGY, V205, P421, DOI 10.1078/0171-2985-00143; GREENSTEIN JL, 2002, NATURE, V83, P2918; Griffiths EJ, 2009, BBA-BIOENERGETICS, V1787, P1324, DOI 10.1016/j.bbabio.2009.01.019; Griffiths EJ, 2009, J MOL CELL CARDIOL, V46, P789, DOI 10.1016/j.yjmcc.2009.03.001; Grima R, 2008, ESSAYS BIOCHEM, V45, P41, DOI 10.1042/BSE0450041; Gunter TE, 2004, FEBS LETT, V567, P96, DOI 10.1016/j.febslet.2004.03.071; Gunter TE, 2000, CELL CALCIUM, V28, P285, DOI 10.1054/ceca.2000.0168; Gunter TE, 1998, BBA-BIOENERGETICS, V1366, P5, DOI 10.1016/S0005-2728(98)00117-0; GUNTER TE, 1990, AM J PHYSIOL, V258, pC755, DOI 10.1152/ajpcell.1990.258.5.C755; Gunter TE, 1998, BIOFACTORS, V8, P205, DOI 10.1002/biof.5520080306; Gunter TE, 2009, BBA-BIOENERGETICS, V1787, P1291, DOI 10.1016/j.bbabio.2008.12.011; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; HAJNOCZKY G, 1999, MITOCHONDRIA, V274, P14157; Halestrap AP, 2009, J MOL CELL CARDIOL, V46, P821, DOI 10.1016/j.yjmcc.2009.02.021; Haumann J, 2010, BIOPHYS J, V99, P997, DOI 10.1016/j.bpj.2010.04.069; Hoth M, 1997, J CELL BIOL, V137, P633, DOI 10.1083/jcb.137.3.633; Jiang DW, 2009, SCIENCE, V326, P144, DOI 10.1126/science.1175145; Jiang JZ, 1999, P NATL ACAD SCI USA, V96, P3572, DOI 10.1073/pnas.96.7.3572; JOU MJ, 1996, NATURE, V497, P299; Kasparinsky FO, 1996, FEBS LETT, V389, P293, DOI 10.1016/0014-5793(96)00606-0; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Lipniacki T, 2008, J THEOR BIOL, V254, P110, DOI 10.1016/j.jtbi.2008.05.001; LUKYANENKO V, 2009, NATURE, V41, P1957; Maack C, 2006, CIRC RES, V99, P172, DOI 10.1161/01.RES.0000232546.92777.05; Magnus G, 1997, AM J PHYSIOL-CELL PH, V273, pC717, DOI 10.1152/ajpcell.1997.273.2.C717; Marhl M, 1998, BIOPHYS CHEM, V71, P125, DOI 10.1016/S0301-4622(97)00139-7; Marhl M, 2000, BIOSYSTEMS, V57, P75, DOI 10.1016/S0303-2647(00)00090-3; Marhl M, 2010, BIOPHYS CHEM, V148, P42, DOI 10.1016/j.bpc.2010.02.006; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391; MCCORMACK JG, 1981, NATURE, V196, P619; Michels G, 2009, CIRCULATION, V119, P2435, DOI 10.1161/CIRCULATIONAHA.108.835389; Moreau B, 2008, CURR BIOL, V18, P855, DOI 10.1016/j.cub.2008.05.026; Nguyen MHT, 2007, AM J PHYSIOL-CELL PH, V292, pC2004, DOI 10.1152/ajpcell.00271.2006; Ohata H, 1998, J BIOENERG BIOMEMBR, V30, P207, DOI 10.1023/A:1020588618496; PALTY R, 2010, NATURE, V107, P436; Perc M, 2003, BIOPHYS CHEM, V104, P509, DOI 10.1016/S0301-4622(03)00038-3; Perc M, 2003, CHAOS SOLITON FRACT, V18, P759, DOI 10.1016/S0960-0779(03)00027-4; Perc M, 2008, BIOPHYS CHEM, V132, P33, DOI 10.1016/j.bpc.2007.10.002; Perc M, 2007, CHEM PHYS LETT, V437, P143, DOI 10.1016/j.cplett.2007.02.003; Perc M, 2009, CHAOS, V19, DOI 10.1063/1.3160017; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; Peskoff A, 1998, BIOPHYS J, V74, P153, DOI 10.1016/S0006-3495(98)77776-8; Picard M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018317; Pradhan RK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013278; RAMESH V, 1998, NATURE, V853, P341; RIZZUTO R, 1992, NATURE, V358, P325, DOI 10.1038/358325a0; RUTTER GA, 1989, ANN NY ACAD SCI, V573, P206, DOI 10.1111/j.1749-6632.1989.tb14998.x; Sharma VK, 2000, J BIOENERG BIOMEMBR, V32, P97, DOI 10.1023/A:1005520714221; Shuai JW, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.068102; SPARAGNA GC, 1995, J BIOL CHEM, V270, P27510, DOI 10.1074/jbc.270.46.27510; SPARAGNA GC, 1994, ANAL BIOCHEM, V219, P96, DOI 10.1006/abio.1994.1236; Starkov AA, 2010, FEBS J, V277, P3652, DOI 10.1111/j.1742-4658.2010.07756.x; Straub SV, 2000, J GEN PHYSIOL, V116, P547, DOI 10.1085/jgp.116.4.547; Territo PR, 2000, AM J PHYSIOL-CELL PH, V278, pC423, DOI 10.1152/ajpcell.2000.278.2.C423; Territo PR, 2001, J BIOL CHEM, V276, P2586, DOI 10.1074/jbc.M002923200; Tinel H, 1999, EMBO J, V18, P4999, DOI 10.1093/emboj/18.18.4999; Wang SR, 1998, NAT STRUCT BIOL, V5, P476, DOI 10.1038/nsb0698-476; Wilkinson DJ, 2009, NAT REV GENET, V10, P122, DOI 10.1038/nrg2509; WINGROVE DE, 1986, J BIOL CHEM, V261, P5159; WOODS NM, 1986, NATURE, V319, P600, DOI 10.1038/319600a0; YANO K, 1994, MOL CELL BIOCHEM, V135, P61, DOI 10.1007/BF00925961	75	16	17	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21324	10.1371/journal.pone.0021324	http://dx.doi.org/10.1371/journal.pone.0021324			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731705	gold, Green Submitted, Green Published			2022-12-27	WOS:000292035400022
J	Peterburs, J; Pergola, G; Koch, B; Schwarz, M; Hoffmann, KP; Daum, I; Bellebaum, C				Peterburs, Jutta; Pergola, Giulio; Koch, Benno; Schwarz, Michael; Hoffmann, Klaus-Peter; Daum, Irene; Bellebaum, Christian			Altered Error Processing following Vascular Thalamic Damage: Evidence from an Antisaccade Task	PLOS ONE			English	Article							FRONTAL EYE FIELD; ANTERIOR CINGULATE CORTEX; BRAIN-STEM TELLS; COROLLARY DISCHARGE; CORTICAL CONTROL; PARIETAL CORTEX; ERP COMPONENTS; NEURAL SYSTEM; CEREBELLAR; MOVEMENTS	Event-related potentials (ERP) research has identified a negative deflection within about 100 to 150 ms after an erroneous response - the error-related negativity (ERN) - as a correlate of awareness-independent error processing. The short latency suggests an internal error monitoring system acting rapidly based on central information such as an efference copy signal. Studies on monkeys and humans have identified the thalamus as an important relay station for efference copy signals of ongoing saccades. The present study investigated error processing on an antisaccade task with ERPs in six patients with focal vascular damage to the thalamus and 28 control subjects. ERN amplitudes were significantly reduced in the patients, with the strongest ERN attenuation being observed in two patients with right mediodorsal and ventrolateral and bilateral ventrolateral damage, respectively. Although the number of errors was significantly higher in the thalamic lesion patients, the degree of ERN attenuation did not correlate with the error rate in the patients. The present data underline the role of the thalamus for the online monitoring of saccadic eye movements, albeit not providing unequivocal evidence in favour of an exclusive role of a particular thalamic site being involved in performance monitoring. By relaying saccade-related efference copy signals, the thalamus appears to enable fast error processing. Furthermore early error processing based on internal information may contribute to error awareness which was reduced in the patients.	[Peterburs, Jutta; Pergola, Giulio; Daum, Irene; Bellebaum, Christian] Ruhr Univ Bochum, Fac Psychol, Dept Neuropsychol, Inst Cognit Neurosci, Bochum, Germany; [Hoffmann, Klaus-Peter] Ruhr Univ Bochum, Dept Neurosci, Bochum, Germany; [Hoffmann, Klaus-Peter] Ruhr Univ Bochum, Fac Biol & Biotechnol, Bochum, Germany; [Koch, Benno; Schwarz, Michael] Klinikum Dortmund, Dept Neurol, Dortmund, Germany	Ruhr University Bochum; Ruhr University Bochum; Ruhr University Bochum; Klinikum Dortmund	Peterburs, J (corresponding author), Ruhr Univ Bochum, Fac Psychol, Dept Neuropsychol, Inst Cognit Neurosci, Bochum, Germany.	jutta.peterburs@ruhr-uni-bochum.de	Peterburs, Jutta/R-2352-2019; Pergola, Giulio/B-9754-2013	Peterburs, Jutta/0000-0003-3571-126X; Pergola, Giulio/0000-0002-9193-1841	German Research Society (Deutsche Forschungsgemeinschaft, DFG) [Be 4034/1-1]	German Research Society (Deutsche Forschungsgemeinschaft, DFG)(German Research Foundation (DFG))	This research was funded by the German Research Society (Deutsche Forschungsgemeinschaft, DFG) (Be 4034/1-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allain S, 2004, CLIN NEUROPHYSIOL, V115, P2014, DOI 10.1016/j.clinph.2004.04.013; ALLEN GI, 1974, PHYSIOL REV, V54, P957, DOI 10.1152/physrev.1974.54.4.957; Band GPH, 2000, BIOL PSYCHOL, V51, P201, DOI 10.1016/S0301-0511(99)00038-1; Barash S, 1999, J NEUROSCI, V19, P10931, DOI 10.1523/JNEUROSCI.19-24-10931.1999; Bellebaum C, 2006, BEHAV BRAIN RES, V169, P150, DOI 10.1016/j.bbr.2006.01.001; Bellebaum C, 2005, BRAIN, V128, P1139, DOI 10.1093/brain/awh474; Bellebaum C, 2006, EUR J NEUROSCI, V24, P2375, DOI 10.1111/j.1460-9568.2006.05114.x; Beste C, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000086; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Coles MGH, 2001, BIOL PSYCHOL, V56, P173, DOI 10.1016/S0301-0511(01)00076-X; Condy C, 2004, NEUROLOGY, V63, P1571, DOI 10.1212/01.WNL.0000142990.44979.5A; Crawford JR, 2005, NEUROPSYCHOLOGY, V19, P318, DOI 10.1037/0894-4105.19.3.318; Crawford JR, 2002, NEUROPSYCHOLOGIA, V40, P1196, DOI 10.1016/S0028-3932(01)00224-X; DAHL G, 1986, REDUZIERTER WECHSLER; DEHAENE S, 1994, PSYCHOL SCI, V5, P303, DOI 10.1111/j.1467-9280.1994.tb00630.x; Endrass T, 2007, EUR J NEUROSCI, V26, P1714, DOI 10.1111/j.1460-9568.2007.05785.x; Falkenstein M, 2001, NEUROREPORT, V12, P157, DOI 10.1097/00001756-200101220-00039; Falkenstein M, 2001, EXP BRAIN RES, V138, P258, DOI 10.1007/s002210100712; FALKENSTEIN M, 1991, ELECTROEN CLIN NEURO, V78, P447, DOI 10.1016/0013-4694(91)90062-9; Falkenstein M, 2000, BIOL PSYCHOL, V51, P87, DOI 10.1016/S0301-0511(99)00031-9; Fischer B, 1996, EXP BRAIN RES, V109, P507; GAYMARD B, 1994, EXP BRAIN RES, V102, P1; Gehring WJ, 2001, J NEUROSCI, V21, P9430, DOI 10.1523/JNEUROSCI.21-23-09430.2001; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Gehring WJ, 2000, NAT NEUROSCI, V3, P516, DOI 10.1038/74899; Giannetti S, 2002, BRAIN RES BULL, V58, P481, DOI 10.1016/S0361-9230(02)00815-8; Golla H, 2008, EUR J NEUROSCI, V27, P132, DOI 10.1111/j.1460-9568.2007.05996.x; GROENEWEGEN HJ, 1988, NEUROSCIENCE, V24, P379, DOI 10.1016/0306-4522(88)90339-9; H?rting, 2000, WECHSLER GED CHTNIST; Hajcak G, 2003, PSYCHOPHYSIOLOGY, V40, P895, DOI 10.1111/1469-8986.00107; HALLETT PE, 1978, VISION RES, V18, P1279, DOI 10.1016/0042-6989(78)90218-3; Holroyd CB, 1998, NEUROSCI LETT, V242, P65, DOI 10.1016/S0304-3940(98)00035-4; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Ide JS, 2011, NEUROIMAGE, V54, P455, DOI 10.1016/j.neuroimage.2010.07.042; Jenkinson N, 2010, CEREBELLUM, V9, P548, DOI 10.1007/s12311-010-0193-6; Jones E.G., 2007, THALAMUS, VVolume 1, P575; KALIL K, 1981, J COMP NEUROL, V195, P25, DOI 10.1002/cne.901950105; KAUFMAN EFS, 1985, BRAIN RES, V335, P257, DOI 10.1016/0006-8993(85)90478-0; Kiehl KA, 2000, PSYCHOPHYSIOLOGY, V37, P216, DOI 10.1111/1469-8986.3720216; Kunimatsu J, 2010, J NEUROSCI, V30, P5108, DOI 10.1523/JNEUROSCI.0406-10.2010; Lee TW, 1999, NEURAL COMPUT, V11, P417, DOI 10.1162/089976699300016719; Mokler A, 1999, EXP BRAIN RES, V125, P511, DOI 10.1007/s002210050709; Morel A., 2007, STEREOTACTIC ATLAS H, DOI 10.3109/9781420016796; Nieuwenhuis S, 2001, PSYCHOPHYSIOLOGY, V38, P752, DOI 10.1017/S0048577201001111; Nieuwenhuis S, 2002, COGN AFFECT BEHAV NE, V2, P19, DOI 10.3758/CABN.2.1.19; O'Connell RG, 2007, EUR J NEUROSCI, V25, P2571, DOI 10.1111/j.1460-9568.2007.05477.x; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Ostendorf F, 2010, P NATL ACAD SCI USA, V107, P1229, DOI 10.1073/pnas.0910742107; Pailing PE, 2004, BRAIN COGNITION, V56, P215, DOI 10.1016/j.bandc.2004.06.005; Pailing PE, 2002, PSYCHOPHYSIOLOGY, V39, P198, DOI 10.1017/S0048577201392107; Peterburs J, 2011, BEHAV BRAIN RES, V216, P496, DOI 10.1016/j.bbr.2010.08.025; PIERROTDESEILLIGNY C, 1991, BRAIN, V114, P1473, DOI 10.1093/brain/114.3.1473; PIERROTDESEILLIGNY C, 1995, ANN NEUROL, V37, P557, DOI 10.1002/ana.410370504; RABBITT PMA, 1966, J EXP PSYCHOL, V71, P264, DOI 10.1037/h0022853; Schmahmann JD, 2003, STROKE, V34, P2264, DOI 10.1161/01.STR.0000087786.38997.9E; Scudder CA, 2002, ANN NY ACAD SCI, V978, P63, DOI 10.1111/j.1749-6632.2002.tb07556.x; SEGRAVES MA, 1992, J NEUROPHYSIOL, V68, P1967, DOI 10.1152/jn.1992.68.6.1967; Seifert S, 2011, J NEUROSCI, V31, P3375, DOI 10.1523/JNEUROSCI.6242-10.2011; Sommer MA, 2002, SCIENCE, V296, P1480, DOI 10.1126/science.1069590; Sommer MA, 2004, J NEUROPHYSIOL, V91, P1381, DOI 10.1152/jn.00738.2003; Sommer MA, 2004, J NEUROPHYSIOL, V91, P1403, DOI 10.1152/jn.00740.2003; Sparks DL, 2002, NAT REV NEUROSCI, V3, P952, DOI 10.1038/nrn986; STANTON GB, 1988, J COMP NEUROL, V271, P473, DOI 10.1002/cne.902710402; Stemmer B, 2004, NEUROPSYCHOLOGIA, V42, P118, DOI 10.1016/S0028-3932(03)00121-0; Suchan B, 2007, BEHAV BRAIN RES, V183, P206, DOI 10.1016/j.bbr.2007.06.013; Swick D, 2002, P NATL ACAD SCI USA, V99, P16354, DOI 10.1073/pnas.252521499; Tehovnik EJ, 2000, BRAIN RES REV, V32, P413, DOI 10.1016/S0165-0173(99)00092-2; Turken U, 2008, NEUROSCI LETT, V441, P7, DOI 10.1016/j.neulet.2008.05.115; Ullsperger M, 2006, J COGNITIVE NEUROSCI, V18, P651, DOI 10.1162/jocn.2006.18.4.651; Ullsperger M, 2004, CORTEX, V40, P593, DOI 10.1016/S0010-9452(08)70155-2; Versino M, 2000, J NEUROL NEUROSUR PS, V68, P234, DOI 10.1136/jnnp.68.2.234; VONHOLST E, 1950, NATURWISSENSCHAFTEN, V37, P464, DOI 10.1007/BF00622503; Zimmermann P., 2002, TESTBATTERIE AUFMERK	73	45	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21517	10.1371/journal.pone.0021517	http://dx.doi.org/10.1371/journal.pone.0021517			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	782TT	21731771	Green Published, gold			2022-12-27	WOS:000292035400046
J	Cheng, L; Booker, FL; Burkey, KO; Tu, C; Shew, HD; Rufty, TW; Fiscus, EL; Deforest, JL; Hu, SJ				Cheng, Lei; Booker, Fitzgerald L.; Burkey, Kent O.; Tu, Cong; Shew, H. David; Rufty, Thomas W.; Fiscus, Edwin L.; Deforest, Jared L.; Hu, Shuijin			Soil Microbial Responses to Elevated CO2 and O-3 in a Nitrogen-Aggrading Agroecosystem	PLOS ONE			English	Article							ATMOSPHERIC CARBON-DIOXIDE; ORGANIC-MATTER; COMMUNITY COMPOSITION; TALLGRASS PRAIRIE; PINE FOREST; BIOMASS; ENRICHMENT; OZONE; METAANALYSIS; PLANT	Climate change factors such as elevated atmospheric carbon dioxide (CO2) and ozone (O-3) can exert significant impacts on soil microbes and the ecosystem level processes they mediate. However, the underlying mechanisms by which soil microbes respond to these environmental changes remain poorly understood. The prevailing hypothesis, which states that CO2- or O-3-induced changes in carbon (C) availability dominate microbial responses, is primarily based on results from nitrogen (N)-limiting forests and grasslands. It remains largely unexplored how soil microbes respond to elevated CO2 and O-3 in N-rich or N-aggrading systems, which severely hinders our ability to predict the long-term soil C dynamics in agroecosystems. Using a long-term field study conducted in a no-till wheat-soybean rotation system with open-top chambers, we showed that elevated CO2 but not O-3 had a potent influence on soil microbes. Elevated CO2 (1.5xambient) significantly increased, while O-3 (1.4xambient) reduced, aboveground (and presumably belowground) plant residue C and N inputs to soil. However, only elevated CO2 significantly affected soil microbial biomass, activities (namely heterotrophic respiration) and community composition. The enhancement of microbial biomass and activities by elevated CO2 largely occurred in the third and fourth years of the experiment and coincided with increased soil N availability, likely due to CO2-stimulation of symbiotic N-2 fixation in soybean. Fungal biomass and the fungi: bacteria ratio decreased under both ambient and elevated CO2 by the third year and also coincided with increased soil N availability; but they were significantly higher under elevated than ambient CO2. These results suggest that more attention should be directed towards assessing the impact of N availability on microbial activities and decomposition in projections of soil organic C balance in N-rich systems under future CO2 scenarios.	[Cheng, Lei; Tu, Cong; Shew, H. David; Hu, Shuijin] N Carolina State Univ, Dept Plant Pathol, Raleigh, NC 27695 USA; [Booker, Fitzgerald L.; Burkey, Kent O.; Fiscus, Edwin L.] ARS, Plant Sci Res Unit, USDA, Raleigh, NC USA; [Booker, Fitzgerald L.; Burkey, Kent O.; Rufty, Thomas W.; Fiscus, Edwin L.] N Carolina State Univ, Dept Crop Sci, Raleigh, NC 27695 USA; [Deforest, Jared L.] Ohio Univ, Dept Environm & Plant Biol, Athens, OH 45701 USA	University of North Carolina; North Carolina State University; United States Department of Agriculture (USDA); University of North Carolina; North Carolina State University; University System of Ohio; Ohio University	Cheng, L (corresponding author), Univ Oklahoma, Dept Bot & Microbiol, Inst Environm Genom, Norman, OK 73019 USA.	shuijin_hu@ncsu.edu	Cheng, lei/E-6307-2013; chen, vivi/A-1085-2012; Tu, Cong/H-9750-2013; DeForest, Jared/E-5777-2011; Cheng, Lei/G-8430-2011	DeForest, Jared/0000-0002-8390-9126; Hu, Shuijin/0000-0002-3225-5126; Cheng, Lei/0000-0002-5486-3632	USDA-ARS Plant Science Research Unit (Raleigh, NC); USDA [2009-35101-05351]	USDA-ARS Plant Science Research Unit (Raleigh, NC); USDA(United States Department of Agriculture (USDA))	Lei Cheng was supported by a fellowship from the USDA-ARS Plant Science Research Unit (Raleigh, NC) and was in part by an USDA grant to SH (2009-35101-05351). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth EA, 2002, GLOBAL CHANGE BIOL, V8, P695, DOI 10.1046/j.1365-2486.2002.00498.x; Andersen CP, 2003, NEW PHYTOL, V157, P213, DOI 10.1046/j.1469-8137.2003.00674.x; [Anonymous], 2006, SAS MIXED MODELS; Balser TC, 2005, SOIL BIOL BIOCHEM, V37, P601, DOI 10.1016/j.soilbio.2004.08.019; Barnard R, 2006, FUNCT ECOL, V20, P557, DOI 10.1111/j.1365-2435.2006.01146.x; BEARE MH, 1992, ECOL MONOGR, V62, P569, DOI 10.2307/2937317; Blagodatskaya E, 2010, GLOBAL CHANGE BIOL, V16, P836, DOI 10.1111/j.1365-2486.2009.02006.x; Booker F, 2009, J INTEGR PLANT BIOL, V51, P337, DOI 10.1111/j.1744-7909.2008.00805.x; Booker FL, 2005, J EXP BOT, V56, P2139, DOI 10.1093/jxb/eri214; Booker FL, 2005, GLOBAL CHANGE BIOL, V11, P685, DOI 10.1111/j.1365-2486.2005.00939.x; Bossio DA, 1998, MICROBIAL ECOL, V36, P1, DOI 10.1007/s002489900087; CABRERA ML, 1993, SOIL SCI SOC AM J, V57, P1007, DOI 10.2136/sssaj1993.03615995005700040021x; Carney KM, 2007, P NATL ACAD SCI USA, V104, P4990, DOI 10.1073/pnas.0610045104; Cheng L, 2010, ECOL LETT, V13, P284, DOI 10.1111/j.1461-0248.2009.01421.x; COLEMAN DC, 1978, MICROBIAL ECOL, V4, P373, DOI 10.1007/BF02013280; de Graaff MA, 2006, GLOBAL CHANGE BIOL, V12, P2077, DOI 10.1111/j.1365-2486.2006.01240.x; de Graaff MA, 2010, NEW PHYTOL, V188, P1055, DOI 10.1111/j.1469-8137.2010.03427.x; DeForest JL, 2004, SOIL SCI SOC AM J, V68, P132, DOI 10.2136/sssaj2004.1320; Dieleman WIJ, 2010, PLANT CELL ENVIRON, V33, P2001, DOI 10.1111/j.1365-3040.2010.02201.x; Drake BG, 1997, ANNU REV PLANT PHYS, V48, P609, DOI 10.1146/annurev.arplant.48.1.609; DUBOC P, 1995, J BIOTECHNOL, V43, P145, DOI 10.1016/0168-1656(95)00135-0; Feng XJ, 2010, GLOBAL CHANGE BIOL, V16, P2104, DOI 10.1111/j.1365-2486.2009.02080.x; Feng ZZ, 2008, GLOBAL CHANGE BIOL, V14, P2696, DOI 10.1111/j.1365-2486.2008.01673.x; Finzi AC, 2002, OECOLOGIA, V132, P567, DOI 10.1007/s00442-002-0996-3; Fiscus EL, 2005, PLANT CELL ENVIRON, V28, P997, DOI 10.1111/j.1365-3040.2005.01349.x; FOG K, 1988, BIOL REV, V63, P433, DOI 10.1111/j.1469-185X.1988.tb00725.x; Fontaine S, 2007, NATURE, V450, P277, DOI 10.1038/nature06275; Frostegard A, 1996, BIOL FERT SOILS, V22, P59, DOI 10.1007/BF00384433; Grantz DA, 2006, PLANT CELL ENVIRON, V29, P1193, DOI 10.1111/j.1365-3040.2006.01521.x; Hu S, 2001, NATURE, V409, P188, DOI 10.1038/35051576; Hu SJ, 2006, PLANT SOIL, V289, P47, DOI 10.1007/s11104-006-9093-4; Hu SJ, 1999, TRENDS ECOL EVOL, V14, P433, DOI 10.1016/S0169-5347(99)01682-1; Hu SJ, 2005, GLOBAL CHANGE BIOL, V11, P213, DOI 10.1111/j.1365-2486.2005.00905.x; Hungate BA, 1997, NATURE, V388, P576, DOI 10.1038/41550; Islam KR, 2000, GLOBAL CHANGE BIOL, V6, P255, DOI 10.1046/j.1365-2486.2000.00307.x; Jenkinson DS, 2004, SOIL BIOL BIOCHEM, V36, P5, DOI 10.1016/j.soilbio.2003.10.002; Jin VL, 2010, GLOBAL CHANGE BIOL, V16, P2334, DOI 10.1111/j.1365-2486.2010.02207.x; Jones TH, 1998, SCIENCE, V280, P441, DOI 10.1126/science.280.5362.441; Kaye JP, 1997, TRENDS ECOL EVOL, V12, P139, DOI 10.1016/S0169-5347(97)01001-X; Kimball BA, 1995, GLOB CHANGE BIOL, V1, P429, DOI 10.1111/j.1365-2486.1995.tb00041.x; Kimball BA, 2002, ADV AGRON, V77, P293, DOI 10.1016/S0065-2113(02)77017-X; Knorr M, 2005, ECOLOGY, V86, P3252, DOI 10.1890/05-0150; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Langley JA, 2009, SOIL BIOL BIOCHEM, V41, P54, DOI 10.1016/j.soilbio.2008.09.016; Liu LL, 2010, ECOL LETT, V13, P819, DOI 10.1111/j.1461-0248.2010.01482.x; McMaster GS, 1999, J AGRON CROP SCI, V183, P119, DOI 10.1046/j.1439-037x.1999.00325.x; Morgan PB, 2003, PLANT CELL ENVIRON, V26, P1317, DOI 10.1046/j.0016-8025.2003.01056.x; Nissen T, 2008, COMMUN SOIL SCI PLAN, V39, P1875, DOI 10.1080/00103620802073933; Oren R, 2001, NATURE, V411, P469, DOI 10.1038/35078064; Paustian K, 1997, SOIL USE MANAGE, V13, P230, DOI 10.1111/j.1475-2743.1997.tb00594.x; Pendall E, 2004, NEW PHYTOL, V162, P447, DOI 10.1111/j.1469-8137.2004.01054.x; Peralta AL, 2008, PLANT SOIL, V303, P69, DOI 10.1007/s11104-007-9474-3; Phillips RP, 2011, ECOL LETT, V14, P187, DOI 10.1111/j.1461-0248.2010.01570.x; Phillips RL, 2002, OECOLOGIA, V131, P236, DOI 10.1007/s00442-002-0868-x; Pregitzer KS, 2008, NEW PHYTOL, V180, P153, DOI 10.1111/j.1469-8137.2008.02564.x; Prior SA, 2005, GLOBAL CHANGE BIOL, V11, P657, DOI 10.1111/j.1365-2486.2005.00935.x; Reich PB, 2006, NATURE, V440, P922, DOI 10.1038/nature04486; RICE CW, 1994, PLANT SOIL, V165, P67, DOI 10.1007/BF00009963; Rillig MC, 1999, OECOLOGIA, V119, P572, DOI 10.1007/s004420050821; Rogers A, 2009, PLANT PHYSIOL, V151, P1009, DOI 10.1104/pp.109.144113; Schimel JP, 2003, SOIL BIOL BIOCHEM, V35, P549, DOI 10.1016/S0038-0717(03)00015-4; Smith JL, 1990, SOIL BIOCH, V6, P357; Talhelm AF, 2009, ECOL LETT, V12, P1219, DOI 10.1111/j.1461-0248.2009.01380.x; Tu C, 2009, CROP SCI, V49, P1827, DOI 10.2135/cropsci2008.10.0603; USEPA, 2006, AIR QUAL CRIT OZ REL, P705; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Warembourg F. R., 1993, Nitrogen isotope techniques., P127; West JB, 2006, GLOBAL CHANGE BIOL, V12, P1400, DOI 10.1111/j.1365-2486.2006.01177.x; West TO, 2002, SOIL SCI SOC AM J, V66, P1930, DOI 10.2136/sssaj2002.1930; Zak DR, 1996, ECOL APPL, V6, P257, DOI 10.2307/2269568; Zak DR, 2000, NEW PHYTOL, V147, P201, DOI 10.1046/j.1469-8137.2000.00687.x; ZAK DR, 1993, PLANT SOIL, V151, P105, DOI 10.1007/BF00010791; Zhang W, 2005, GLOBAL CHANGE BIOL, V11, P266, DOI 10.1111/j.1365-2486.2005.00902.x	73	28	29	12	119	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21377	10.1371/journal.pone.0021377	http://dx.doi.org/10.1371/journal.pone.0021377			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731722	Green Published, Green Submitted, gold			2022-12-27	WOS:000292033700070
J	Canonge, S; Deneubourg, JL; Sempo, G				Canonge, Stephane; Deneubourg, Jean-Louis; Sempo, Gregory			Group Living Enhances Individual Resources Discrimination: The Use of Public Information by Cockroaches to Assess Shelter Quality	PLOS ONE			English	Article							CONSENSUS DECISION-MAKING; COLLECTIVE BEHAVIOR; SOCIAL INFORMATION; AGGREGATION; DENSITY; INTEGRATION; SELECTION	In group-living organisms, consensual decision of site selection results from the interplay between individual responses to site characteristics and to group-members. Individuals independently gather personal information by exploring their environment. Through social interaction, the presence of others provides public information that could be used by individuals and modulates the individual probability of joining/leaving a site. The way that individual's information processing and the network of interactions influence the dynamics of public information (depending on population size) that in turn affect discrimination in site quality is a central question. Using binary choice between sheltering sites of different quality, we demonstrate that cockroaches in group dramatically outperform the problem-solving ability of single individual. Such use of public information allows animals to discriminate between alternatives whereas isolated individuals are ineffective (i.e. the personal discrimination efficiency is weak). Our theoretical results, obtained from a mathematical model based on behavioral rules derived from experiments, highlight that the collective discrimination emerges from competing amplification processes relying on the modulation of the individual sheltering time without shelters comparison and communication modulation. Finally, we well demonstrated here the adaptive value of such decision algorithm. Without any behavioral change, the system is able to shift to a more effective strategy when alternatives are present: the modification of the spatio-temporal distributions of individuals leading to the collective selection of the best resource. This collective discrimination implying such parsimonious and widespread mechanism must be shared by many group living-species.	[Canonge, Stephane; Deneubourg, Jean-Louis; Sempo, Gregory] Univ Libre Bruxelles, Unit Social Ecol, Brussels, Belgium	Universite Libre de Bruxelles	Canonge, S (corresponding author), Univ Libre Bruxelles, Unit Social Ecol, Brussels, Belgium.	scanonge@ulb.ac.be			FRS-FNRS (Belgium); Van Buuren Funds	FRS-FNRS (Belgium)(Fonds de la Recherche Scientifique - FNRS); Van Buuren Funds	The FRS-FNRS (Belgium) and the Van Buuren Funds supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ame JM, 2006, P NATL ACAD SCI USA, V103, P5835, DOI 10.1073/pnas.0507877103; Bell W. J., 1981, AM COCKROACH; Bell W. J., 2007, COCKROACHES ECOLOGY; Boulinier T, 1997, EVOL ECOL, V11, P505, DOI 10.1007/s10682-997-1507-0; Camazine S., 2001, SELF ORG BIOL SYSTEM, DOI DOI 10.1515/9780691212920; Canonge S, 2009, J INSECT PHYSIOL, V55, P976, DOI 10.1016/j.jinsphys.2009.06.011; Conradt L, 2005, TRENDS ECOL EVOL, V20, P449, DOI 10.1016/j.tree.2005.05.008; Costa J., 2006, OTHER INSECT SOC; Courchamp F, 2008, ALLEE EFFECTS IN ECOLOGY AND CONSERVATION, P1; Dall SRX, 2005, TRENDS ECOL EVOL, V20, P187, DOI 10.1016/j.tree.2005.01.010; Dambach M, 1999, J INSECT PHYSIOL, V45, P423, DOI 10.1016/S0022-1910(98)00141-3; Danchin E, 2004, SCIENCE, V305, P487, DOI 10.1126/science.1098254; Devigne C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017389; Doligez B, 2004, J ANIM ECOL, V73, P75, DOI 10.1111/j.1365-2656.2004.00782.x; Donahue MJ, 2006, OECOLOGIA, V149, P33, DOI 10.1007/s00442-006-0419-y; Dussutour A, 2008, ANIM BEHAV, V76, P5, DOI 10.1016/j.anbehav.2007.12.009; Dyer JRG, 2009, PHILOS T R SOC B, V364, P781, DOI 10.1098/rstb.2008.0233; Fletcher RJ, 2007, J ANIM ECOL, V76, P598, DOI 10.1111/j.1365-2656.2007.01230.x; GIRALDEAU LA, 2010, PHILOS T R SOC B, V357, P1559; Halloy J, 2007, SCIENCE, V318, P1155, DOI 10.1126/science.1144259; Holbrook GL, 2004, P NATL ACAD SCI USA, V101, P5595, DOI 10.1073/pnas.0400209101; Jeanson R, 2005, ANIM BEHAV, V69, P169, DOI 10.1016/j.anbehav.2004.02.009; Jeanson R, 2004, BEHAV ECOL SOCIOBIOL, V55, P388, DOI 10.1007/s00265-003-0716-y; King AJ, 2007, BIOL LETTERS, V3, P137, DOI 10.1098/rsbl.2007.0017; Krause J, 2010, TRENDS ECOL EVOL, V25, P28, DOI 10.1016/j.tree.2009.06.016; Lihoreau M, 2008, ANIM BEHAV, V75, P1965, DOI 10.1016/j.anbehav.2007.12.006; Michelena P, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016014, 10.1371/journal.pone.0018631]; Nagy M, 2010, NATURE, V464, P890, DOI 10.1038/nature08891; Nocera JJ, 2009, ECOGRAPHY, V32, P143, DOI 10.1111/j.1600-0587.2008.05614.x; Pratt SC, 2006, P NATL ACAD SCI USA, V103, P15906, DOI 10.1073/pnas.0604801103; Rands SA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011705; Rust MK, 1995, UNDERSTANDING CONTRO; SANDLER MB, 1976, ANN ENTOMOL SOC AM, V69, P889, DOI 10.1093/aesa/69.5.889; Schmickl T, 2009, AUTON AGENT MULTI-AG, V18, P133, DOI 10.1007/s10458-008-9058-5; Sempo G, 2006, LECT NOTES COMPUT SC, V4095, P703; Sempo G, 2009, ETHOLOGY, V115, P1150, DOI 10.1111/j.1439-0310.2009.01699.x; SOLOMON J, 1997, ANN ENTOMO SOC AM, V70, P409; Stroeymeyt N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013059; Sumpter D. J. T., 2009, COLLECTIVE ANIMAL BE; Sumpter DJT, 2008, CURR BIOL, V18, P1773, DOI 10.1016/j.cub.2008.09.064; Valone TJ, 2007, BEHAV ECOL SOCIOBIOL, V62, P1, DOI 10.1007/s00265-007-0439-6; Ward AJW, 2011, P NATL ACAD SCI USA, V108, P2312, DOI 10.1073/pnas.1007102108	42	40	40	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e19748	10.1371/journal.pone.0019748	http://dx.doi.org/10.1371/journal.pone.0019748			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	21701692	Green Published, Green Submitted, gold			2022-12-27	WOS:000291983800003
J	Webster, MM; Atton, N; Hart, PJB; Ward, AJW				Webster, Mike M.; Atton, Nicola; Hart, Paul J. B.; Ward, Ashley J. W.			Habitat-Specific Morphological Variation among Threespine Sticklebacks (Gasterosteus aculeatus) within a Drainage Basin	PLOS ONE			English	Article							INFLUENCE ASSOCIATION PREFERENCES; SEXUAL-DIMORPHISM; BODY SHAPE; PHENOTYPIC PLASTICITY; SOCIAL RECOGNITION; ECOLOGICAL SPECIATION; INDUCIBLE DEFENSES; GENETIC-VARIATION; TRADE-OFFS; ENOS LAKE	Habitat-specific morphological variation, often corresponding to resource specialization, is well documented in freshwater fishes. In this study we used landmark based morphometric analyses to investigate morphological variation among threespine sticklebacks (Gasterosteus aculeatus L.) from four interconnected habitat types within a single lowland drainage basin in eastern England. These included the upper and lower reaches of the river, the estuary, a connected ditch network and a coastal salt marsh. We found significant habitat-specific differences in morphology, with three axes of variation describing differences in orbit diameter, body depth, caudal peduncle shape and pectoral fin positioning as well as variation in relative dorsal and pelvic spine size. Interestingly, the ditch system, an artificial and heavily managed habitat, is populated by sticklebacks with a characteristic morphology, suggesting that human management of habitats can in some circumstances lead to morphological variation among the animals that inhabit them. We discuss the mechanisms that conceivably underlie the observed morphological variation and the further work necessary to identify them. Finally, we consider the implications of habitat-specific body shape variation for the behavioural ecology of this ecologically generalist species.	[Webster, Mike M.; Atton, Nicola; Hart, Paul J. B.; Ward, Ashley J. W.] Univ Leicester, Sch Biol, Leicester, Leics, England; [Webster, Mike M.; Atton, Nicola] Univ St Andrews, Sch Biol, St Andrews, Fife, Scotland; [Ward, Ashley J. W.] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia	University of Leicester; University of St Andrews; University of Sydney	Webster, MM (corresponding author), Univ Leicester, Sch Biol, Leicester, Leics, England.	mike.m.webster@gmail.com	Webster, Mike/C-5082-2008; Hart, Paul JB/A-1814-2008	Hart, Paul JB/0000-0002-9188-2437; Ward, Ashley/0000-0003-0842-533X; Webster, Mike/0000-0001-9597-6871	Natural Environment Research Council (NERC, UK); University of Sydney	Natural Environment Research Council (NERC, UK)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); University of Sydney(University of Sydney)	MMW was funded by a Natural Environment Research Council studentship (NERC, UK) awarded to PJBH. AJWW was supported by a DVC Grant from the University of Sydney. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre WE, 2010, J FISH BIOL, V77, P802, DOI 10.1111/j.1095-8649.2010.02705.x; Aguirre WE, 2008, BIOL J LINN SOC, V95, P465, DOI 10.1111/j.1095-8312.2008.01075.x; [Anonymous], 2017, ANIM COGN, DOI DOI 10.1007/s10071-016-1007-0; Araujo MS, 2008, ECOLOGY, V89, P1981, DOI 10.1890/07-0630.1; Bell M.A., 1994, EVOLUTIONARY BIOL TH; BENTZEN P, 1984, CAN J ZOOL, V62, P2280, DOI 10.1139/z84-331; Berner D, 2009, EVOLUTION, V63, P1740, DOI 10.1111/j.1558-5646.2009.00665.x; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; BRONMARK C, 1992, SCIENCE, V258, P1348, DOI 10.1126/science.258.5086.1348; Burns JG, 2009, J FISH BIOL, V75, P1144, DOI 10.1111/j.1095-8649.2009.02314.x; Cresko WA, 1996, ENVIRON BIOL FISH, V45, P343, DOI 10.1007/BF00002526; DARBY H.C., 1940, DRAINING FENS; Dayton GH, 2005, OIKOS, V111, P582, DOI 10.1111/j.1600-0706.2005.14340.x; DeWitt TJ, 2000, EVOL ECOL RES, V2, P129; Eklov P, 2007, J FISH BIOL, V70, P155, DOI 10.1111/j.1095-8649.2006.01283.x; FUTUYMA DJ, 1988, ANNU REV ECOL SYST, V19, P207, DOI 10.1146/annurev.es.19.110188.001231; GUSTAFSSON L, 1988, ANIM BEHAV, V36, P696, DOI 10.1016/S0003-3472(88)80152-0; Hendry AP, 2004, EVOLUTION, V58, P2319; Herbert-Read JE, 2010, BEHAV ECOL SOCIOBIOL, V64, P1107, DOI 10.1007/s00265-010-0925-0; HOOGLAND M, 1957, BEHAVIOUR, V10, P205; Januszkiewicz AJ, 2007, BIOL J LINN SOC, V90, P25, DOI 10.1111/j.1095-8312.2007.00708.x; JOHANSSON F, 1994, OECOLOGIA, V100, P74, DOI 10.1007/BF00317132; Johansson F, 2002, CAN J ZOOL, V80, P199, DOI 10.1139/Z01-225; Jones FC, 2006, J EVOLUTION BIOL, V19, P1531, DOI 10.1111/j.1420-9101.2006.01122.x; Kishida O, 2004, OECOLOGIA, V140, P414, DOI 10.1007/s00442-004-1609-0; Kishida O, 2006, J ANIM ECOL, V75, P705, DOI 10.1111/j.1365-2656.2006.01091.x; Kitano J, 2007, COPEIA, P336, DOI 10.1643/0045-8511(2007)7[336:SDITEM]2.0.CO;2; Langerhans RB, 2007, J EVOLUTION BIOL, V20, P1171, DOI 10.1111/j.1420-9101.2007.01282.x; Langerhans RB, 2008, INTEGR COMP BIOL, V48, P750, DOI 10.1093/icb/icn092; Langerhans RB, 2004, AM NAT, V164, P335, DOI 10.1086/422857; Langerhans RB, 2003, BIOL J LINN SOC, V80, P689, DOI 10.1111/j.1095-8312.2003.00266.x; Lattuca ME, 2007, J APPL ICHTHYOL, V23, P25, DOI 10.1111/j.1439-0426.2006.00789.x; Magnhagen C, 2004, J FISH BIOL, V64, P612, DOI 10.1111/j.1095-8649.2004.00325.x; MCPHAIL JD, 1984, CAN J ZOOL, V62, P1402, DOI 10.1139/z84-201; MEYER A, 1990, BIOL J LINN SOC, V39, P279, DOI 10.1111/j.1095-8312.1990.tb00517.x; Mittelbach GC, 1999, EVOL ECOL RES, V1, P111; Nilsson PA, 2000, OIKOS, V88, P539, DOI 10.1034/j.1600-0706.2000.880310.x; Pettersson LB, 1999, OECOLOGIA, V121, P12, DOI 10.1007/s004420050901; Phillips BL, 2004, P NATL ACAD SCI USA, V101, P17150, DOI 10.1073/pnas.0406440101; Portz DE, 2004, ENVIRON BIOL FISH, V71, P233, DOI 10.1007/s10641-004-0300-y; PRICE T, 1987, ECOLOGY, V68, P1015, DOI 10.2307/1938373; Quevedo M, 2006, J FISH BIOL, V69, P141, DOI 10.1111/j.1095-8649.2006.01072.x; REIMCHEN TE, 1980, CAN J ZOOL, V58, P1232, DOI 10.1139/z80-173; Reimchen TE, 2004, EVOLUTION, V58, P1274, DOI 10.1111/j.0014-3820.2004.tb01706.x; REIMCHEN TE, 1984, CAN FIELD NAT, V98, P120; Riessen HP, 2009, ECOLOGY, V90, P3455, DOI 10.1890/08-1652.1; Robinson BW, 1996, ECOLOGY, V77, P170, DOI 10.2307/2265665; Robinson BW, 1996, EVOL ECOL, V10, P631, DOI 10.1007/BF01237711; Rohlf F.J., 2005, MORPHOMETRICS SUNY S; Schluter D, 1996, PHILOS T R SOC B, V351, P807, DOI 10.1098/rstb.1996.0075; SCHLUTER D, 1995, ECOLOGY, V76, P82, DOI 10.2307/1940633; SMARTT RA, 1980, AM NAT, V116, P891, DOI 10.1086/283679; Smith TB, 1996, ANNU REV ECOL SYST, V27, P111, DOI 10.1146/annurev.ecolsys.27.1.111; Spoljaric MA, 2007, J FISH BIOL, V70, P1484, DOI 10.1111/j.1095-8649.2007.01425.x; Spoljaric MA, 2008, BIOL J LINN SOC, V95, P505, DOI 10.1111/j.1095-8312.2008.01068.x; Sumner J, 1999, BIOL CONSERV, V91, P159, DOI 10.1016/S0006-3207(99)00089-0; Svanback R, 2006, EVOL ECOL RES, V8, P37; Svanback R, 2003, OIKOS, V102, P273, DOI 10.1034/j.1600-0706.2003.12657.x; Tobler M, 2008, EVOLUTION, V62, P2643, DOI 10.1111/j.1558-5646.2008.00466.x; Walker JA, 2004, J EXP BIOL, V207, P1925, DOI 10.1242/jeb.00994; Ward AJW, 2009, BEHAV ECOL, V20, P511, DOI 10.1093/beheco/arp025; Ward AJW, 2005, BEHAV ECOL SOCIOBIOL, V57, P575, DOI 10.1007/s00265-004-0901-7; Ward AJW, 2004, BEHAV ECOL, V15, P925, DOI 10.1093/beheco/arh097; Ward AJW, 2007, P ROY SOC B-BIOL SCI, V274, P1071, DOI 10.1098/rspb.2006.0231; Webster MM, 2008, ANIM BEHAV, V76, P17, DOI 10.1016/j.anbehav.2007.12.010; Webster MM, 2008, P R SOC B, V275, P203, DOI 10.1098/rspb.2007.1178; Webster MM, 2007, BEHAVIOUR, V144, P1347, DOI 10.1163/156853907782418222; Webster MM, 2007, BEHAV ECOL SOCIOBIOL, V62, P273, DOI 10.1007/s00265-007-0462-7; [No title captured]	69	35	35	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e21060	10.1371/journal.pone.0021060	http://dx.doi.org/10.1371/journal.pone.0021060			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698269	Green Published, gold			2022-12-27	WOS:000291730000046
J	Xu, LL; Bao, LL; Zhou, JF; Wang, DY; Deng, W; Lv, Q; Ma, YL; Li, FD; Sun, HH; Zhan, LJ; Zhu, H; Ma, CM; Shu, YL; Qin, C				Xu, Lili; Bao, Linlin; Zhou, Jianfang; Wang, Dayan; Deng, Wei; Lv, Qi; Ma, Yila; Li, Fengdi; Sun, Huihui; Zhan, Lingjun; Zhu, Hua; Ma, Chunmei; Shu, Yuelong; Qin, Chuan			Genomic Polymorphism of the Pandemic A (H1N1) Influenza Viruses Correlates with Viral Replication, Virulence, and Pathogenicity In Vitro and In Vivo	PLOS ONE			English	Article							SINGLE-AMINO-ACID; A VIRUS; RESPIRATORY-FAILURE; ENHANCED VIRULENCE; MOLECULAR-BASIS; HEMAGGLUTININ; PROTEIN; ORIGIN; PATHOGENESIS; PB1-F2	The novel pandemic A (H1N1) virus was first identified in Mexico in April 2009 and quickly spread worldwide. Like all influenzas, the H1N1 strain-specific properties of replication, virulence, and pathogenicity are a result of the particular genomic sequence and concerted expression of multiple genes. Thus, specific mutations may support increased virulence and may be useful as biomarkers of potential threat to human health. We performed comparative genomic analysis of ten strains of the 2009 pandemic A (H1N1) influenza viruses to determine whether genotypes associated with clinical phenotypes, which ranged from mild to severe illness and up to lethal. Virus replication capacity was tested for each strain in vitro using cultured epithelial cells, while virulence and pathogenicity were investigated in vivo using the BALB/c mouse model. The results indicated that A/Sichuan/1/2009 strain had significantly higher replication ability and virulence than the other strains, and five unique non-synonymous mutations were identified in important gene-encoding sequences. These mutations led to amino acid substitutions in HA (L32I), PA (A343T), PB1 (K353R and T566A), and PB2 (T471M), and may be critical molecular determinants for replication, virulence, and pathogenicity. Our results suggested that the replication capacity in vitro and virulence in vivo of the 2009 pandemic A (H1N1) viruses were not associated with the clinical phenotypes. This study offers new insights into the transmission and evolution of the 2009 pandemic A (H1N1) virus.	[Xu, Lili; Bao, Linlin; Deng, Wei; Lv, Qi; Ma, Yila; Li, Fengdi; Sun, Huihui; Zhan, Lingjun; Zhu, Hua; Ma, Chunmei; Qin, Chuan] Chinese Acad Med Sci, Inst Lab Anim Sci, Beijing 100730, Peoples R China; [Xu, Lili; Bao, Linlin; Deng, Wei; Lv, Qi; Ma, Yila; Li, Fengdi; Sun, Huihui; Zhan, Lingjun; Zhu, Hua; Ma, Chunmei; Qin, Chuan] Minist Hlth, Key Lab Human Dis Comparat Med, Peking Union Med Coll, Comparat Med Ctr, Beijing, Peoples R China; [Zhou, Jianfang; Wang, Dayan; Shu, Yuelong] China CDC, Natl Inst Viral Dis Control & Prevent, Chinese Natl Influenza Ctr, State Key Lab Mol Virol & Genet Engn, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Laboratory Animal Science - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Xu, LL (corresponding author), Chinese Acad Med Sci, Inst Lab Anim Sci, Beijing 100730, Peoples R China.	qinchuan@pumc.edu.cn	Deng, Wei/GWC-9207-2022		National Science and Technology Major Projects of Infectious Disease [2009ZX10004-016, 2009ZX10004-402]; Industry Foundation of the Ministry of Health [200802036]; Key Laboratory of Human Diseases Comparative Medicine, Ministry of Health [DWS201112]	National Science and Technology Major Projects of Infectious Disease; Industry Foundation of the Ministry of Health; Key Laboratory of Human Diseases Comparative Medicine, Ministry of Health	This work was supported by the National Science and Technology Major Projects of Infectious Disease (2009ZX10004-016 and 2009ZX10004-402), the Industry Foundation of the Ministry of Health (200802036), and Open Fund of the Key Laboratory of Human Diseases Comparative Medicine, Ministry of Health (DWS201112). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auewarakul P, 2007, J VIROL, V81, P9950, DOI 10.1128/JVI.00468-07; Bao LL, 2010, VIRUS RES, V151, P60, DOI 10.1016/j.virusres.2010.03.019; Belser JA, 2010, J VIROL, V84, P4194, DOI 10.1128/JVI.02742-09; Bermejo-Martin JF, 2009, CRIT CARE, V13, DOI 10.1186/cc8208; Bussey KA, 2010, J VIROL, V84, P4395, DOI 10.1128/JVI.02642-09; Cao B, 2009, NEW ENGL J MED, V361, P2507, DOI 10.1056/NEJMoa0906612; Chen H, 2007, VIRUS RES, V128, P159, DOI 10.1016/j.virusres.2007.04.017; Cheung TKW, 2007, ANN NY ACAD SCI, V1102, P1, DOI 10.1196/annals.1408.001; Conenello GM, 2007, PLOS PATHOG, V3, P1414, DOI 10.1371/journal.ppat.0030141; Conenello GM, 2007, CELL HOST MICROBE, V2, P207, DOI 10.1016/j.chom.2007.09.010; DAVIES WL, 1964, SCIENCE, V144, P862, DOI 10.1126/science.144.3620.862; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Gabriel G, 2005, P NATL ACAD SCI USA, V102, P18590, DOI 10.1073/pnas.0507415102; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Geiss GK, 2002, P NATL ACAD SCI USA, V99, P10736, DOI 10.1073/pnas.112338099; Glaser L, 2005, J VIROL, V79, P11533, DOI 10.1128/JVI.79.17.11533-11536.2005; Glinsky GV, 2010, CELL CYCLE, V9, P958, DOI 10.4161/cc.9.5.10913; Hai R, 2010, J VIROL, V84, P4442, DOI 10.1128/JVI.02717-09; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Hatta M, 2007, PLOS PATHOG, V3, P1374, DOI 10.1371/journal.ppat.0030133; HAYDEN FG, 1980, ANTIMICROB AGENTS CH, V17, P865, DOI 10.1128/AAC.17.5.865; Herfst S, 2010, J VIROL, V84, P3752, DOI 10.1128/JVI.02634-09; Hulse-Post DJ, 2007, J VIROL, V81, P8515, DOI 10.1128/JVI.00435-07; Ikonen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013329; Jagger BW, 2010, MBIO, V1, DOI 10.1128/mBio.00067-10; Kash JC, 2006, NATURE, V443, P578, DOI 10.1038/nature05181; Kilander A, 2010, EURO SURVEILL, V15; Kobasa D, 2004, NATURE, V431, P703, DOI 10.1038/nature02951; Li ZJ, 2005, J VIROL, V79, P12058, DOI 10.1128/JVI.79.18.12058-12064.2005; Liu Y, 2010, J VIROL, V84, P12069, DOI 10.1128/JVI.01639-10; Mak GC, 2010, EURO SURVEILL, V15; McAuley JL, 2007, CELL HOST MICROBE, V2, P240, DOI 10.1016/j.chom.2007.09.001; Melidou A, 2010, VIRUS RES, V151, P192, DOI 10.1016/j.virusres.2010.05.005; Nelson M., 2009, PLOS CURR, V1, DOI [DOI 10.1371/CURRENTS.RRN1126, 10.1371/currents.RRN1126]; Pappas C, 2008, P NATL ACAD SCI USA, V105, P3064, DOI 10.1073/pnas.0711815105; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; Potdar VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009693; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rello J, 2009, CRIT CARE, V13, DOI 10.1186/cc8044; Safronetz D, 2011, J VIROL, V85, P1214, DOI 10.1128/JVI.01848-10; Salomon R, 2006, J EXP MED, V203, P689, DOI 10.1084/jem.20051938; Seo SH, 2002, NAT MED, V8, P950, DOI 10.1038/nm757; Skoner DP, 1999, J INFECT DIS, V180, P10, DOI 10.1086/314823; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Svitek N, 2008, VIROLOGY, V376, P53, DOI 10.1016/j.virol.2008.02.035; Taubenberger JK, 2006, P AM PHILOS SOC, V150, P86; Tumpey TM, 2004, P NATL ACAD SCI USA, V101, P3166, DOI 10.1073/pnas.0308391100; Tumpey TM, 2005, SCIENCE, V310, P77, DOI 10.1126/science.1119392; VAILLANT L, 2009, EURO SURVEILL, V14; Wanitchang A, 2010, VIRUS RES, V147, P145, DOI 10.1016/j.virusres.2009.10.010; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Xu LL, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-325; Zamarin D, 2006, J VIROL, V80, P7976, DOI 10.1128/JVI.00415-06; Zhou B, 2011, J VIROL, V85, P357, DOI 10.1128/JVI.01694-10; Zhu HC, 2010, VIROLOGY, V401, P1, DOI 10.1016/j.virol.2010.02.024	55	25	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e20698	10.1371/journal.pone.0020698	http://dx.doi.org/10.1371/journal.pone.0020698			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698272	Green Published, Green Submitted, gold			2022-12-27	WOS:000291730000019
J	Akachi, Y; Atun, R				Akachi, Yoko; Atun, Rifat			Effect of Investment in Malaria Control on Child Mortality in Sub-Saharan Africa in 2002-2008	PLOS ONE			English	Article							INTERVENTIONS; GOAL	Background: Around 8.8 million children under-five die each year, mostly due to infectious diseases, including malaria that accounts for 16% of deaths in Africa, but the impact of international financing of malaria control on under-five mortality in sub-Saharan Africa has not been examined. Methods and Findings: We combined multiple data sources and used panel data regression analysis to study the relationship among investment, service delivery/intervention coverage, and impact on child health by observing changes in 34 sub-Saharan African countries over 2002-2008. We used Lives Saved Tool to estimate the number of lives saved from coverage increase of insecticide-treated nets (ITNs)/indoor residual spraying (IRS). As an indicator of outcome, we also used under-five mortality rate. Global Fund investments comprised more than 70% of the Official Development Assistance (ODA) for malaria control in 34 countries. Each $1 million ODA for malaria enabled distribution of 50,478 ITNs [95%CI: 37,774-63,182] in the disbursement year. 1,000 additional ITNs distributed saved 0.625 lives [95%CI: 0.369-0.881]. Cumulatively Global Fund investments that increased ITN/IRS coverage in 2002-2008 prevented an estimated 240,000 deaths. Countries with higher malaria burden received less ODA disbursement per person-at-risk compared to lower-burden countries ($3.90 vs. $7.05). Increased ITN/IRS coverage in high-burden countries led to 3,575 lives saved per 1 million children, as compared with 914 lives in lower-burden countries. Impact of ITN/IRS coverage on under-five mortality was significant among major child health interventions such as immunisation showing that 10% increase in households with ITN/IRS would reduce 1.5 [95%CI: 0.3-2.8] child deaths per 1000 live births. Conclusions: Along with other key child survival interventions, increased ITNs/IRS coverage has significantly contributed to child mortality reduction since 2002. ITN/IRS scale-up can be more efficiently prioritized to countries where malaria is a major cause of child deaths to save greater number of lives with available resources.	[Akachi, Yoko; Atun, Rifat] Global Fund Fight AIDS TB & Malaria, Geneva, Switzerland; [Atun, Rifat] Univ London Imperial Coll Sci Technol & Med, Imperial Coll Business Sch, London, England	Imperial College London	Akachi, Y (corresponding author), Global Fund Fight AIDS TB & Malaria, Geneva, Switzerland.	r.atun@imperial.ac.uk	Atun, Rifat/AAH-5537-2021	Atun, Rifat/0000-0002-1531-5983				Baum C.F., 2006, INTRO MODERN ECONOME; Bhutta ZA, 2010, LANCET, V375, P2032, DOI 10.1016/S0140-6736(10)60678-2; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Bryce J, 2005, HEALTH POLICY PLANN, V20, pI5, DOI 10.1093/heapol/czi055; Bryce J, 2003, LANCET, V362, P159, DOI 10.1016/S0140-6736(03)13870-6; Drukker DM, 2003, STATA J, V3, P168, DOI 10.1177/1536867X0300300206; Eisele TP, 2010, INT J EPIDEMIOL, V39, P88, DOI 10.1093/ije/dyq026; Friberg IK, 2010, INT J EPIDEMIOL, V39, P11, DOI 10.1093/ije/dyq017; *GLOB FUND, GLOB FUND 2010 INN I; Greene H., 2003, ECONOMETRIC ANAL; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; Hazel E, 2010, INT J EPIDEMIOL, V39, P32, DOI 10.1093/ije/dyq019; Hedeker D., 2006, LONGITUDINAL DATA AN; Komatsu R, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-109; LENGELER C, 2010, COCHRANE DB SYST REV, V2; Mujkic Z., 2009, SPECTRUM, V3-4, P135; *OECD, OECD US GUID CRS AID; Pluess B, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006657.pub2; Rajaratnam JK, 2010, LANCET, V375, P1988, DOI 10.1016/S0140-6736(10)60703-9; *ROLL BACK MAL, 2010, PROGR IMP SER, V1; Snow RW, 2010, LANCET, V376, P1409, DOI 10.1016/S0140-6736(10)61340-2; Stover J, 2010, INT J EPIDEMIOL, V39, P7, DOI 10.1093/ije/dyq016; The Global Fund, 2022, BMJ, DOI DOI 10.1136/BMJ.O2320; Walker N, 2010, INT J EPIDEMIOL, V39, P21, DOI 10.1093/ije/dyq036; *WHO, WORLD MAL REP 2009; Wolfson LJ, 2007, LANCET, V369, P191, DOI 10.1016/S0140-6736(07)60107-X; Wooldridge J., 2002, ECONOMETRIC ANAL CRO; World Health Organization, 2004, GLOB BURD DIS 2004 U; You D, 2010, LANCET, V375, P100, DOI 10.1016/S0140-6736(09)61601-9; LIST MANUAL LIVES SA	30	31	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e21309	10.1371/journal.pone.0021309	http://dx.doi.org/10.1371/journal.pone.0021309			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738633	Green Published, Green Submitted, gold			2022-12-27	WOS:000292291800011
J	Aspinall, R; Prentice, AM; Ngom, PT				Aspinall, Richard; Prentice, Andrew M.; Ngom, Pa Tamba			Interleukin 7 from Maternal Milk Crosses the Intestinal Barrier and Modulates T-Cell Development in Offspring	PLOS ONE			English	Article							BREAST-FED INFANTS; THYMUS SIZE; PNEUMOCOCCAL VACCINE; IL-7; MORTALITY; WOMEN; BIRTH; IMMUNIZATION; LYMPHOCYTES; EXPRESSION	Background: Breastfeeding protects against illnesses and death in hazardous environments, an effect partly mediated by improved immune function. One hypothesis suggests that factors within milk supplement the inadequate immune response of the offspring, but this has not been able to account for a series of observations showing that factors within maternally derived milk may supplement the development of the immune system through a direct effect on the primary lymphoid organs. In a previous human study we reported evidence suggesting a link between IL-7 in breast milk and the thymic output of infants. Here we report evidence in mice of direct action of maternally-derived IL-7 on T cell development in the offspring. Methods and Findings: We have used recombinant IL-7 labelled with a fluorescent dye to trace the movement in live mice of IL-7 from the stomach across the gut and into the lymphoid tissues. To validate the functional ability of maternally derived IL-7 we cross fostered IL-7 knock-out mice onto normal wild type mothers. Subsets of thymocytes and populations of peripheral T cells were significantly higher than those found in knock-out mice receiving milk from IL-7 knock-out mothers. Conclusions/Significance: Our study provides direct evidence that interleukin 7, a factor which is critical in the development of T lymphocytes, when maternally derived can transfer across the intestine of the offspring, increase T cell production in the thymus and support the survival of T cells in the peripheral secondary lymphoid tissue.	[Aspinall, Richard; Ngom, Pa Tamba] Univ London Imperial Coll Sci Technol & Med, Dept Immunol, London, England; [Prentice, Andrew M.; Ngom, Pa Tamba] MRC Labs, Nutr Programme, Serrekunda, Gambia; [Prentice, Andrew M.] London Sch Hyg & Trop Med, Med Res Council Int Nutr Grp, London WC1, England; [Aspinall, Richard] Cranfield Univ, Cranfield MK43 0AL, Beds, England	Imperial College London; MRC Laboratory Molecular Biology; University of London; London School of Hygiene & Tropical Medicine; Cranfield University	Aspinall, R (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Immunol, London, England.	r.aspinall@cranfield.ac.uk	Aspinall, Richard/E-4924-2013; Prentice, Andrew/AAG-1961-2019	Aspinall, Richard/0000-0002-1648-1887	Medical Research Council International Nutrition Group; Islamic Development Bank; Westminster Medical School Research Trust	Medical Research Council International Nutrition Group; Islamic Development Bank(Islamic Development Bank); Westminster Medical School Research Trust	This work was supported by the Medical Research Council International Nutrition Group, the Islamic Development Bank and the Westminster Medical School Research Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaby P, 2002, ACTA PAEDIATR, V91, P698, DOI 10.1080/080352502760069142; Andrew D, 2001, J IMMUNOL, V166, P1524, DOI 10.4049/jimmunol.166.3.1524; Aspinall R, 2001, CELL IMMUNOL, V212, P150, DOI 10.1006/cimm.2001.1848; Bains I, 2009, J IMMUNOL, V183, P4329, DOI 10.4049/jimmunol.0900743; Bains I, 2009, BLOOD, V113, P5480, DOI 10.1182/blood-2008-10-184184; BEISEL WR, 1992, J NUTR, V122, P591, DOI 10.1093/jn/122.suppl_3.591; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Brandtzaeg P, 2003, VACCINE, V21, P3382, DOI 10.1016/S0264-410X(03)00338-4; Collinson AC, 2003, ACTA PAEDIATR, V92, P1014, DOI 10.1080/08035250310004379; Danneman PJ, 1997, LAB ANIM SCI, V47, P386; DEREN JS, 1971, AM J CLIN NUTR, V24, P144; Deubzer HE, 2004, J INFECT DIS, V190, P1758, DOI 10.1086/424597; El Kassar N, 2004, BLOOD, V104, P1419, DOI 10.1182/blood-2004-01-0201; Finn A, 2002, J INFECT DIS, V186, P1422, DOI 10.1086/344356; Fry TJ, 2005, J IMMUNOL, V174, P6571, DOI 10.4049/jimmunol.174.11.6571; Garly ML, 2008, J PEDIATR-US, V153, P683, DOI 10.1016/j.jpeds.2008.04.069; Hasselbalch H, 1996, ACTA PAEDIATR, V85, P1029, DOI 10.1111/j.1651-2227.1996.tb14211.x; Hasselbalch H, 1999, EUR J PEDIATR, V158, P964, DOI 10.1007/s004310051258; JEFFRY UV, 1995, J EXP MED, V181, P1519; Jeppesen DL, 2004, PEDIATR ALLERGY IMMU, V15, P127, DOI 10.1111/j.1399-3038.2004.00032.x; Kim K, 1998, J IMMUNOL, V160, P5735; KOLDOVSKY O, 1989, J NUTR, V119, P1543, DOI 10.1093/jn/119.11.1543; Lawrence Robert M, 2007, Curr Probl Pediatr Adolesc Health Care, V37, P7, DOI 10.1016/j.cppeds.2006.10.002; Lima K, 2010, CLIN EXP IMMUNOL, V161, P98, DOI 10.1111/j.1365-2249.2010.04152.x; LOSONSKY GA, 1982, J INFECT DIS, V145, P654, DOI 10.1093/infdis/145.2.654; MASCARTLEMONE F, 1988, SCAND J IMMUNOL, V28, P443, DOI 10.1111/j.1365-3083.1988.tb01474.x; Mazzucchelli R, 2007, NAT REV IMMUNOL, V7, P144, DOI 10.1038/nri2023; Min BK, 2003, IMMUNITY, V18, P131, DOI 10.1016/S1074-7613(02)00508-3; Moore SE, 1997, NATURE, V388, P434, DOI 10.1038/41245; Moore SE, 1999, INT J EPIDEMIOL, V28, P1088, DOI 10.1093/ije/28.6.1088; MOSINGER B, 1959, NATURE, V184, P1245, DOI 10.1038/1841245a0; Munoz FM, 2003, VACCINE, V21, P3465, DOI 10.1016/S0264-410X(03)00352-9; Ngom PT, 2004, AM J CLIN NUTR, V80, P722; Obaro SK, 2004, PEDIATR INFECT DIS J, V23, P1023, DOI 10.1097/01.inf.0000143651.54880.09; Prentice AM, 2000, ACTA PAEDIATR, V89, P8, DOI 10.1080/080352500750028979; SHAHID NS, 1995, LANCET, V346, P1252, DOI 10.1016/S0140-6736(95)91861-2; Takahata Y, 2001, PEDIATR RES, V50, P268, DOI 10.1203/00006450-200108000-00017; Vivien L, 2001, INT IMMUNOL, V13, P763, DOI 10.1093/intimm/13.6.763; Walter J, 2007, JAIDS-J ACQ IMM DEF, V46, P200, DOI 10.1097/QAI.0b013e318141f942; Wilks AB, 2010, J IMMUNOL, V185, P7097, DOI 10.4049/jimmunol.1002751; World Health Organization (WHO), 2001, GLOB STRAT INF YOUNG; Wu L, 2006, CURR OPIN IMMUNOL, V18, P121, DOI 10.1016/j.coi.2006.01.006; WU L, 1991, NATURE, V349, P71, DOI 10.1038/349071a0; Yuan X, 1998, AM J PHYSIOL-GASTR L, V274, pG342, DOI 10.1152/ajpgi.1998.274.2.G342	44	23	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e20812	10.1371/journal.pone.0020812	http://dx.doi.org/10.1371/journal.pone.0020812			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738587	Green Published, gold, Green Accepted			2022-12-27	WOS:000292291800004
J	Caswell, H				Caswell, Hal			Beyond R-0: Demographic Models for Variability of Lifetime Reproductive Output	PLOS ONE			English	Article							DYNAMIC HETEROGENEITY; POPULATION; HISTORY; VARIANCE; GROWTH; RATIO; FIRE; SIZE; SKEW	The net reproductive rate R-0 measures the expected lifetime reproductive output of an individual, and plays an important role in demography, ecology, evolution, and epidemiology. Well-established methods exist to calculate it from age- or stage-classified demographic data. As an expectation, R-0 provides no information on variability; empirical measurements of lifetime reproduction universally show high levels of variability, and often positive skewness among individuals. This is often interpreted as evidence of heterogeneity, and thus of an opportunity for natural selection. However, variability provides evidence of heterogeneity only if it exceeds the level of variability to be expected in a cohort of identical individuals all experiencing the same vital rates. Such comparisons require a way to calculate the statistics of lifetime reproduction from demographic data. Here, a new approach is presented, using the theory of Markov chains with rewards, obtaining all the moments of the distribution of lifetime reproduction. The approach applies to age- or stage-classified models, to constant, periodic, or stochastic environments, and to any kind of reproductive schedule. As examples, I analyze data from six empirical studies, of a variety of animal and plant taxa (nematodes, polychaetes, humans, and several species of perennial plants).	[Caswell, Hal] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; [Caswell, Hal] Max Planck Inst Demog Res, Rostock, Germany	Woods Hole Oceanographic Institution; Max Planck Society	Caswell, H (corresponding author), Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA.	hcaswell@whoi.edu		Caswell, Hal/0000-0003-4394-6894	National Science Foundation [DEB-0816514]; Alexander von Humboldt Foundation; Division Of Environmental Biology [0816514] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Supported by National Science Foundation Grant DEB-0816514 and by a Research Award from the Alexander von Humboldt Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; BARROWCLOUGH GF, 1993, AM NAT, V141, P281, DOI 10.1086/285473; Benito F., 1982, TRABAJOS ESTADISTICA, V33, P73, DOI DOI 10.1007/BF02888435; BRIDGES TS, 1994, J EXP MAR BIOL ECOL, V177, P99, DOI 10.1016/0022-0981(94)90146-5; Carey J. R., 2003, LONGEVITY BIOL DEMOG, DOI [10.1515/9780691224084, DOI 10.1515/9780691224084]; Caswell, 2000, MATRIX POPULATION MO; Caswell H., 2004, Animal Biodiversity and Conservation, V27, P471; Caswell H, 2001, ADV ECOL RES, V32, P1, DOI 10.1016/S0065-2504(01)32010-X; Caswell H., 2006, MAM2006, P319; Caswell H, 2009, OIKOS, V118, P1763, DOI 10.1111/j.1600-0706.2009.17620.x; Chen JJ, 2007, J GERONTOL A-BIOL, V62, P126, DOI 10.1093/gerona/62.2.126; Clutton-Brock T. H., 1988, REPROD SUCCESS; Clutton-Brock TH, 1998, TRENDS ECOL EVOL, V13, P288, DOI 10.1016/S0169-5347(98)01402-5; Clutton-Brock T, 2010, TRENDS ECOL EVOL, V25, P562, DOI 10.1016/j.tree.2010.08.002; CROW JF, 1958, AM ANTHROPOL, V60, P1; CROXALL JP, 1990, J ANIM ECOL, V59, P775, DOI 10.2307/4895; Cushing JM, 2012, J BIOL DYNAM, V6, P166, DOI 10.1080/17513758.2010.544410; Cushing J.M., 1994, Natural Resource Modeling, V8, P297; De-Camino-Beck T, 2007, B MATH BIOL, V69, P1341, DOI 10.1007/s11538-006-9162-0; DIEKMANN O, 1990, J MATH BIOL, V28, P365; Engen S, 2005, GENETICS, V170, P941, DOI 10.1534/genetics.104.028233; FEICHTINGER G, 1971, LECT NOTES OPERATION; Frigui I, 1999, TELECOMMUN SYST, V12, P51, DOI 10.1023/A:1019182325899; Fujiwara M, 2002, ECOLOGY, V83, P3257, DOI 10.2307/3072076; Gems David, 2002, P413; Grafen A., 1988, REPROD SUCCESS, P454, DOI DOI 10.1098/RSTB.2007.0011; Haydock J, 2002, P NATL ACAD SCI USA, V99, P7178, DOI 10.1073/pnas.102624199; Heesterbeek JAP, 2002, ACTA BIOTHEOR, V50, P189, DOI 10.1023/A:1016599411804; Henderson H. V., 1981, LINEAR MULTILINEAR A, V9, P271, DOI DOI 10.1080/03081088108817379; Horvitz CC, 2008, AM NAT, V172, P203, DOI 10.1086/589453; Howard R. A., 1960, DYNAMIC PROGRAMMING; Hunter CM, 2010, ECOLOGY, V91, P2883, DOI 10.1890/09-1641.1; Hunter CM, 2005, ECOL MODEL, V188, P15, DOI 10.1016/j.ecolmodel.2005.05.002; Hunter CM, 2005, J ANIM ECOL, V74, P589, DOI 10.1111/j.1365-2656.2005.00929.x; IOSIFESCU M., 1980, FINITE MARKOV PROCES; Jenouvrier S, 2010, AM NAT, V175, P739, DOI 10.1086/652436; Kaye TN, 2003, ECOLOGY, V84, P1464, DOI 10.1890/0012-9658(2003)084[1464:TEOSTO]2.0.CO;2; Kaye TN, 2001, ECOL APPL, V11, P1366, DOI 10.1890/1051-0761(2001)011[1366:TEOFOT]2.0.CO;2; Kendall M. G., 1963, ADV THEORY STAT, VI; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Knight TM, 2009, FOREST ECOL MANAG, V257, P1095, DOI 10.1016/j.foreco.2008.11.018; Knight TM, 2004, ECOL APPL, V14, P915, DOI 10.1890/03-5048; Kozlowski J, 1999, OIKOS, V86, P185, DOI 10.2307/3546437; Lawler RR, 2009, OECOLOGIA, V161, P491, DOI 10.1007/s00442-009-1382-1; Levin L, 1996, ECOL APPL, V6, P1295, DOI 10.2307/2269608; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; *M PLANCK I DEM RE, 2010, HUM FERT DAT; Mangel M., 1988, DYNAMIC MODELING BEH; Metz J., 1986, LECT NOTES BIOMATHEM, DOI DOI 10.1007/978-3-662-13159-6; Newton I, 1989, LIFETIME REPROD BIRD; OCHRAN ME, 1992, ECOL MONOGR, V62, P345; PARAMONOV Y, 2010, P 10 INT C REL STAT, P104; Partridge L., 1989, P421; Pendergrass KL, 1999, ECOL APPL, V9, P1420, DOI 10.1890/1051-0761(1999)009[1420:TROPBI]2.0.CO;2; Pico FX, 2002, ECOLOGY, V83, P1991, DOI 10.2307/3071781; Puterman ML., 2014, MARKOV DECISION PROC; Rhodes EC, 1940, J R STAT SOC, V103, P61, DOI 10.2307/2980551; ROCKWELL RF, 1995, CONSERV BIOL, V9, P1225, DOI 10.1046/j.1523-1739.1995.9051216.x-i1; Sladky K, 2005, OPERAT RES PROCEED, P319; Stearns S.C., 1992, pi; STEINER UK, 2011, NEUTRAL THEORY UNPUB; Steiner UK, 2010, J ANIM ECOL, V79, P436, DOI 10.1111/j.1365-2656.2009.01653.x; Tuljapurkar S, 2009, ECOL LETT, V12, P93, DOI 10.1111/j.1461-0248.2008.01262.x; *U CAL BERK US MAX, 2010, HUM MORT DAT; van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6; Van Dijk NM, 2006, J APPL PROBAB, V43, P1044, DOI 10.1239/jap/1165505206; [No title captured]	69	51	51	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e20809	10.1371/journal.pone.0020809	http://dx.doi.org/10.1371/journal.pone.0020809			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21738586	gold, Green Published			2022-12-27	WOS:000292290100007
J	Gao, H; Bryc, K; Bustamante, CD				Gao, Hong; Bryc, Katarzyna; Bustamante, Carlos D.			On Identifying the Optimal Number of Population Clusters via the Deviance Information Criterion	PLOS ONE			English	Article							BAYESIAN-ANALYSIS; INFERENCE; MODEL	Inferring population structure using Bayesian clustering programs often requires a priori specification of the number of subpopulations, K, from which the sample has been drawn. Here, we explore the utility of a common Bayesian model selection criterion, the Deviance Information Criterion (DIC), for estimating K. We evaluate the accuracy of DIC, as well as other popular approaches, on datasets generated by coalescent simulations under various demographic scenarios. We find that DIC outperforms competing methods in many genetic contexts, validating its application in assessing population structure.	[Gao, Hong] Stanford Univ, Stanford Genome Technol Ctr, Stanford, CA 94305 USA; [Gao, Hong] Stanford Univ, Dept Biochem, Stanford, CA 94305 USA; [Bryc, Katarzyna] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Bustamante, Carlos D.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA	Stanford University; Stanford University; Harvard University; Harvard Medical School; Stanford University	Gao, H (corresponding author), Stanford Univ, Stanford Genome Technol Ctr, Stanford, CA 94305 USA.	hgao98@stanford.edu		Bustamante, Carlos D./0000-0002-4187-7920	National Science Foundation [0606461]; National Natural Science Foundation of China [40771084]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003229] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work is funded by National Science Foundation Grant #0606461 to Susan McCouch, Carlos D. Bustamante, Georgia Eizenga and Anna McClung. The work of running the software BAPS by Dr. Yidong Lei is funded by the National Natural Science Foundation of China (Grant #40771084). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CELEUX G, 2005, BAYESIAN ANAL; Corander J, 2004, BIOINFORMATICS, V20, P2363, DOI 10.1093/bioinformatics/bth250; Corander J, 2003, GENETICS, V163, P367; Corander J, 2007, MATH BIOSCI, V205, P19, DOI 10.1016/j.mbs.2006.09.015; Corander J, 2006, MOL ECOL, V15, P2833, DOI 10.1111/j.1365-294X.2006.02994.x; Corander J, 2006, STAT COMPUT, V16, P355, DOI 10.1007/s11222-006-9391-y; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Francois O, 2006, GENETICS, V174, P805, DOI 10.1534/genetics.106.059923; Gao H, 2007, GENETICS, V176, P1635, DOI 10.1534/genetics.107.072371; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Huelsenbeck JP, 2007, GENETICS, V175, P1787, DOI 10.1534/genetics.106.061317; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pella J, 2006, CAN J FISH AQUAT SCI, V63, P576, DOI 10.1139/f05-224; Pritchard JK, 2000, GENETICS, V155, P945; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353	17	42	42	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21014	10.1371/journal.pone.0021014	http://dx.doi.org/10.1371/journal.pone.0021014			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738600	Green Submitted, gold, Green Published			2022-12-27	WOS:000292142800008
J	Kapoor, A; Hornig, M; Asokan, A; Williams, B; Henriquez, JA; Lipkin, WI				Kapoor, Amit; Hornig, Mady; Asokan, Aravind; Williams, Brent; Henriquez, Jose A.; Lipkin, W. Ian			Bocavirus Episome in Infected Human Tissue Contains Non-Identical Termini	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; ACUTE GASTROENTERITIS; HOSPITALIZED CHILDREN; PARVOVIRUS; VIRUS; SAMPLES; SEQUENCES; THAILAND; PROFILE; CLONES	Human bocaviruses (HBoV) are highly prevalent human infections whose pathogenic potential remains unknown. Recent identification of the first non-human primate bocavirus [1] in captive gorillas raised the possibility of the persistent nature of bocavirus infection. To characterize bocavirus infection in humans, we tested intestinal biopsies from 22 children with gastrointestinal disease for the presence of HBoV DNA. Four HBoV-positive tissue samples were analyzed to determine whether viral DNA was present in the linear genomic, the episomal closed circular or the host genome-integrated form. Whereas one tissue sample positive for HBoV3 contained the episomal form (HBoV3-E1), none had the genome-integrated form. The complete genome sequence of HBoV3-E1 contains 5319 nucleotides of which 513 represent the non-coding terminal sequence. The secondary structure of HBoV3-E1 termini suggests several conserved and variable features among human and animal bocaviruses. Our observation that HBoV genome exists as head-to-tail monomer in infected tissue either reflects the likely evolution of alternative replication mechanism in primate bocaviruses or a mechanism of viral persistence in their host. Moreover, we identified the HBoV genomic terminal sequences that will be helpful in developing reverse genetic systems for these widely prevalent parvoviruses. Significance: HBoV have been found in healthy human controls as well as individuals with respiratory or gastrointestinal disease. Our findings suggest that HBoV DNA can exist as episomes in infected human tissues and therefore can likely establish persistent infection in the host. Previous efforts to grow HBoV in cell culture and to develop reverse genetic systems have been unsuccessful. Complete genomic sequence of the HBoV3 episome and its genomic termini will improve our understanding of HBoV replication mechanism and its pathogenesis.	[Kapoor, Amit; Hornig, Mady; Williams, Brent; Henriquez, Jose A.; Lipkin, W. Ian] Columbia Univ, Ctr Infect & Immun, New York, NY 10027 USA; [Asokan, Aravind] Univ N Carolina, Gene Therapy Ctr, Chapel Hill, NC USA	Columbia University; University of North Carolina; University of North Carolina Chapel Hill	Kapoor, A (corresponding author), Columbia Univ, Ctr Infect & Immun, New York, NY 10027 USA.	ak3117@columbia.edu	Lipkin, W. Ian/ABE-6216-2020; Hornig, Mady/AAE-8431-2020; Grieshaber-Bouyer, Ricardo/R-7512-2016	Lipkin, W. Ian/0000-0002-8768-9386; Hornig, Mady/0000-0001-7572-3092; Grieshaber-Bouyer, Ricardo/0000-0002-2873-5135	National Institutes of Health [AI090196, AI079231, AI57158, AI070411, EY017404]; NATIONAL EYE INSTITUTE [R24EY017404] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI070411, U54AI057158, R21AI090196, R01AI079231] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant awards AI090196, AI079231, AI57158, AI070411, and EY017404. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque MCM, 2007, EMERG INFECT DIS, V13, P1756, DOI 10.3201/eid1311.070671; Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Allander T, 2008, J CLIN VIROL, V41, P29, DOI 10.1016/j.jcv.2007.10.026; Allander T, 2007, CLIN INFECT DIS, V44, P904, DOI 10.1086/512196; Anderson LJ, 2007, CLIN INFECT DIS, V44, P911, DOI 10.1086/512438; Arthur JL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000391; Bastien N, 2007, J CLIN MICROBIOL, V45, P610, DOI 10.1128/JCM.01044-06; BERNS KI, 1990, MICROBIOL REV, V54, P316, DOI 10.1128/MMBR.54.3.316-329.1990; Brown KE, 2010, REV MED VIROL, V20, P231, DOI 10.1002/rmv.648; Campe H, 2008, J CLIN VIROL, V43, P340, DOI 10.1016/j.jcv.2008.07.014; Catalano-Pons C, 2007, PEDIATR INFECT DIS J, V26, P959, DOI 10.1097/INF.0b013e3181256583; Chen AY, 2010, VIROLOGY, V403, P145, DOI 10.1016/j.virol.2010.04.014; Chen CL, 2005, J VIROL, V79, P14781, DOI 10.1128/JVI.79.23.14781-14792.2005; Cheng WX, 2008, CLIN INFECT DIS, V47, P161, DOI 10.1086/589244; Cheng WX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013583; Chieochansin T, 2008, JPN J INFECT DIS, V61, P479; Chieochansin T, 2008, J INFECTION, V56, P137, DOI 10.1016/j.jinf.2007.11.006; Chieochansin T, 2007, VIRUS RES, V129, P54, DOI 10.1016/j.virusres.2007.04.022; Chung JY, 2006, EMERG INFECT DIS, V12, P1254, DOI 10.3201/eid1708.060261; CLAUDE M, VIRUS TAXONOMY; DINA J, 2009, J PAEDIAT CHILD HLTH; Fry AM, 2007, J INFECT DIS, V195, P1038, DOI 10.1086/512163; GAGLIARDI TB, 2009, HUMAN BOCAVIRUS RESP, P1; Hornig M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003140; KAPOOR A, J INFECT DIS, V201, P1633; Kapoor A, 2009, J INFECT DIS, V199, P196, DOI 10.1086/595831; Kapoor A, 2010, J VIROL, V84, P12628, DOI 10.1128/JVI.01732-10; Kapoor A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011948; Kapoor A, 2010, J INFECT DIS, V201, P1633, DOI 10.1086/652416; Lau SKP, 2007, J INFECT DIS, V196, P986, DOI 10.1086/521310; Lindner J, 2008, INTERVIROLOGY, V51, P116, DOI 10.1159/000137411; Lusebrink J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019457; Luft F, 2001, INT J CANCER, V92, P9, DOI 10.1002/1097-0215(200102)9999:9999<::AID-IJC1144>3.0.CO;2-L; Mackay IM, 2007, J INFECT DIS, V196, P968, DOI 10.1086/521311; Manteufel J, 2008, INTERVIROLOGY, V51, P328, DOI 10.1159/000173734; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Mears JA, 2002, J MOL BIOL, V321, P215, DOI 10.1016/S0022-2836(02)00568-5; Qiu J, 2007, J VIROL, V81, P12080, DOI 10.1128/JVI.00815-07; Schnepp BC, 2005, J VIROL, V79, P14793, DOI 10.1128/JVI.79.23.14793-14803.2005; Schnepp BC, 2009, J VIROL, V83, P1456, DOI 10.1128/JVI.01686-08; Sharp CP, 2010, J VIROL, V84, P10289, DOI 10.1128/JVI.01304-10; Simmonds P, 2008, CLIN INFECT DIS, V46, P547, DOI 10.1086/526533; Sun YN, 2009, J VIROL, V83, P3956, DOI 10.1128/JVI.02569-08; Tamura K., 2011, MOL BIOL EVOLU UNPUB; XU ZQ, 2011, J CLIN MICROBIOL; Yu JM, 2008, J CLIN VIROL, V42, P280, DOI 10.1016/j.jcv.2008.03.032; Ziegler S, 2008, J CLIN VIROL, V43, P349, DOI 10.1016/j.jcv.2008.07.006; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	48	71	78	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21362	10.1371/journal.pone.0021362	http://dx.doi.org/10.1371/journal.pone.0021362			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738642	Green Published, Green Submitted, gold			2022-12-27	WOS:000292142800016
J	Agrawal, N; Leaman, DP; Rowcliffe, E; Kinkead, H; Nohria, R; Akagi, J; Bauer, K; Du, SX; Whalen, RG; Burton, DR; Zwick, MB				Agrawal, Nitish; Leaman, Daniel P.; Rowcliffe, Eric; Kinkead, Heather; Nohria, Raman; Akagi, Junya; Bauer, Katherine; Du, Sean X.; Whalen, Robert G.; Burton, Dennis R.; Zwick, Michael B.			Functional Stability of Unliganded Envelope Glycoprotein Spikes among Isolates of Human Immunodeficiency Virus Type 1 (HIV-1)	PLOS ONE			English	Article							HUMAN MONOCLONAL-ANTIBODIES; PROXIMAL EXTERNAL REGION; ENV-MEDIATED FUSION; NEUTRALIZING ANTIBODIES; ECTODOMAIN REGION; CD4-BINDING SITE; GP41 ECTODOMAIN; DISULFIDE BONDS; 2 MECHANISMS; GP120	The HIV-1 envelope glycoprotein (Env) spike is challenging to study at the molecular level, due in part to its genetic variability, structural heterogeneity and lability. However, the extent of lability in Env function, particularly for primary isolates across clades, has not been explored. Here, we probe stability of function for variant Envs of a range of isolates from chronic and acute infection, and from clades A, B and C, all on a constant virus backbone. Stability is elucidated in terms of the sensitivity of isolate infectivity to destabilizing conditions. A heat-gradient assay was used to determine T-90 values, the temperature at which HIV-1 infectivity is decreased by 90% in 1 h, which ranged between similar to 40 to 49 degrees C (n = 34). For select Envs (n = 10), the half-lives of infectivity decay at 37 degrees C were also determined and these correlated significantly with the T90 (p = 0.029), though two 'outliers' were identified. Specificity in functional Env stability was also evident. For example, Env variant HIV-1(ADA) was found to be labile to heat, 37 degrees C decay, and guanidinium hydrochloride but not to urea or extremes of pH, when compared to its thermostable counterpart, HIV-1(JR-CSF). Blue native PAGE analyses revealed that Env-dependent viral inactivation preceded complete dissociation of Env trimers. The viral membrane and membrane-proximal external region (MPER) of gp41 were also shown to be important for maintaining trimer stability at physiological temperature. Overall, our results indicate that primary HIV-1 Envs can have diverse sensitivities to functional inactivation in vitro, including at physiological temperature, and suggest that parameters of functional Env stability may be helpful in the study and optimization of native Env mimetics and vaccines.	[Agrawal, Nitish; Leaman, Daniel P.; Rowcliffe, Eric; Kinkead, Heather; Nohria, Raman; Akagi, Junya; Bauer, Katherine; Burton, Dennis R.; Zwick, Michael B.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Du, Sean X.; Whalen, Robert G.] AltraVax Inc, Sunnyvale, CA USA; [Burton, Dennis R.] Scripps Res Inst, IAVI Neutralizing Antibody Ctr, La Jolla, CA 92037 USA; [Burton, Dennis R.] Ragon Inst Massachusetts Gen Hosp Massachusetts I, Boston, MA USA	Scripps Research Institute; International AIDS Vaccine Initiative; Scripps Research Institute; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute	Agrawal, N (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.	zwick@scripps.edu	AGRAWAL, NITISH/E-3468-2013; AGRAWAL, NITISH/H-6186-2011	AGRAWAL, NITISH/0000-0003-0823-7355; Nohria, Raman/0000-0003-3313-4833	National Institutes of Health (NIH) [AI56375, AI77381, P01 AI056375, AI33292, T32 AI007606]; Summer Immunology and Virology Undergraduate Fellowship (SINAPSE); Neutralizing Antibody Consortium of the International AIDS Vaccine Initiative (IAVI NAC); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI033292, R01AI033292, R21AI077381, P01AI056375, R33AI077381, T32AI007606] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Summer Immunology and Virology Undergraduate Fellowship (SINAPSE); Neutralizing Antibody Consortium of the International AIDS Vaccine Initiative (IAVI NAC); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the National Institutes of Health (NIH) grants AI56375 (MBZ and DRB), AI77381 (MBZ), P01 AI056375 (RGW), AI33292 (DRB), T32 AI007606 (DPL), Summer Immunology and Virology Undergraduate Fellowship (SINAPSE) (RN), and the Neutralizing Antibody Consortium of the International AIDS Vaccine Initiative (IAVI NAC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez M, 2009, J MOL BIOL, V392, P872, DOI 10.1016/j.jmb.2009.07.081; Amin N, 2004, PROTEIN ENG DES SEL, V17, P787, DOI 10.1093/protein/gzh091; Barouch DH, 2008, NATURE, V455, P613, DOI 10.1038/nature07352; Beddows S, 2005, VIROLOGY, V337, P136, DOI 10.1016/j.virol.2005.03.033; Beringue V, 2003, BRAIN, V126, P2065, DOI 10.1093/brain/awg205; Binley JM, 2003, J VIROL, V77, P5678, DOI 10.1128/JVI.77.10.5678-5684.2003; Binley JM, 2000, J VIROL, V74, P627, DOI 10.1128/JVI.74.2.627-643.2000; BUCHACHER A, 1994, AIDS RES HUM RETROV, V10, P359, DOI 10.1089/aid.1994.10.359; Burrer R, 2005, VIROLOGY, V333, P102, DOI 10.1016/j.virol.2004.12.034; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; CAO J, 1993, J VIROL, V67, P2747, DOI 10.1128/JVI.67.5.2747-2755.1993; Casali M, 2008, VIROLOGY, V380, P91, DOI 10.1016/j.virol.2008.07.011; Cavacini L, 2003, AIDS, V17, P685, DOI 10.1097/00002030-200303280-00006; Chen B, 2005, NATURE, V433, P834, DOI 10.1038/nature03327; Chertova E, 2002, J VIROL, V76, P5315, DOI 10.1128/JVI.76.11.5315-5325.2002; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; Cowan DA, 1997, COMP BIOCHEM PHYS A, V118, P429, DOI 10.1016/S0300-9629(97)00004-2; Crooks ET, 2008, VIROLOGY, V377, P364, DOI 10.1016/j.virol.2008.04.045; CROOKS ET, 2011, J VIROL IN PRESS; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; Dey AK, 2008, VIROLOGY, V372, P187, DOI 10.1016/j.virol.2007.10.018; Epand RM, 2003, BIOCHEMISTRY-US, V42, P14677, DOI 10.1021/bi035587j; Finzi A, 2010, MOL CELL, V37, P656, DOI 10.1016/j.molcel.2010.02.012; Fouts TR, 1997, J VIROL, V71, P2779, DOI 10.1128/JVI.71.4.2779-2785.1997; Freed EO, 1996, J VIROL, V70, P341, DOI 10.1128/JVI.70.1.341-351.1996; FU YK, 1993, J VIROL, V67, P3818, DOI 10.1128/JVI.67.7.3818-3825.1993; GACH JS, 2011, CURR TOP ME IN PRESS; Gallo SA, 2003, BBA-BIOMEMBRANES, V1614, P36, DOI 10.1016/S0005-2736(03)00161-5; GENDELMAN HE, 1988, J EXP MED, V167, P1428, DOI 10.1084/jem.167.4.1428; Haim H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000360; Hedestam GBK, 2008, NAT REV MICROBIOL, V6, P143, DOI 10.1038/nrmicro1819; HELSETH E, 1990, J VIROL, V64, P2416, DOI 10.1128/JVI.64.5.2416-2420.1990; HELSETH E, 1991, J VIROL, V65, P2119, DOI 10.1128/JVI.65.4.2119-2123.1991; Herrera C, 2005, VIROLOGY, V338, P154, DOI 10.1016/j.virol.2005.05.002; Herrera C, 2003, J VIROL, V77, P1084, DOI 10.1128/JVI.77.2.1084-1091.2003; Huber M, 2006, PLOS MED, V3, P2078, DOI 10.1371/journal.pmed.0030441; Igarashi T, 1999, NAT MED, V5, P211, DOI 10.1038/5576; Jacobs A, 2005, J BIOL CHEM, V280, P27284, DOI 10.1074/jbc.M414411200; Kahle KM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000674; Karlsson GB, 1996, J VIROL, V70, P6136, DOI 10.1128/JVI.70.9.6136-6142.1996; Kassa A, 2009, J VIROL, V83, P8364, DOI 10.1128/JVI.00594-09; Kassa A, 2009, J VIROL, V83, P4476, DOI 10.1128/JVI.02110-08; Kirschner M, 2006, PROTEIN EXPRES PURIF, V48, P61, DOI 10.1016/j.pep.2006.02.017; KLATZMANN D, 1984, NATURE, V312, P767, DOI 10.1038/312767a0; Klein JS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000908; KOYANAGI Y, 1987, SCIENCE, V236, P819, DOI 10.1126/science.3646751; Kwong PD, 2000, J VIROL, V74, P1961, DOI 10.1128/JVI.74.4.1961-1972.2000; LAYNE SP, 1991, J VIROL, V65, P3293, DOI 10.1128/JVI.65.6.3293-3300.1991; LAYNE SP, 1992, VIROLOGY, V189, P695, DOI 10.1016/0042-6822(92)90593-E; Leaman DP, 2010, J VIROL, V84, P3382, DOI 10.1128/JVI.02363-09; Leavitt M, 2003, J VIROL, V77, P560, DOI 10.1128/JVI.77.1.560-570.2003; LEONARD CK, 1990, J BIOL CHEM, V265, P10373; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Liao ZH, 2003, AIDS RES HUM RETROV, V19, P675, DOI 10.1089/088922203322280900; Liu J, 2009, BIOCHEMISTRY-US, V48, P2915, DOI 10.1021/bi802303b; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Long EM, 2002, AIDS RES HUM RETROV, V18, P567, DOI 10.1089/088922202753747914; Lorizate M, 2006, BIOCHEMISTRY-US, V45, P14337, DOI 10.1021/bi0612521; Lusso P, 2006, EMBO J, V25, P447, DOI 10.1038/sj.emboj.7600947; Magnus C, 2009, J VIROL, V83, P1523, DOI 10.1128/JVI.01764-08; Mansy SS, 2008, P NATL ACAD SCI USA, V105, P13351, DOI 10.1073/pnas.0805086105; MCCUNE JM, 1988, CELL, V53, P55, DOI 10.1016/0092-8674(88)90487-4; MOORE JP, 1990, SCIENCE, V250, P1139, DOI 10.1126/science.2251501; MOORE JP, 1992, J VIROL, V66, P235, DOI 10.1128/JVI.66.1.235-243.1992; Moore MD, 2008, VIROLOGY, V379, P152, DOI 10.1016/j.virol.2008.06.030; Moore PL, 2006, J VIROL, V80, P2515, DOI 10.1128/JVI.80.5.2515-2528.2006; Murakami T, 2008, MICROBIOL IMMUNOL, V52, P287, DOI 10.1111/j.1348-0421.2008.00008.x; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Nelson JD, 2007, J VIROL, V81, P4033, DOI 10.1128/JVI.02588-06; Or-Guil M, 2007, IMMUNOL REV, V216, P130; ORLOFF SL, 1993, J VIROL, V67, P1461, DOI 10.1128/JVI.67.3.1461-1471.1993; Pancera M, 2005, VIROLOGY, V332, P145, DOI 10.1016/j.virol.2004.10.042; Pastore C, 2003, ANTIMICROB AGENTS CH, V47, P509, DOI 10.1128/AAC.47.2.509-517.2003; PEDEN K, 1991, VIROLOGY, V185, P661, DOI 10.1016/0042-6822(91)90537-L; Peters PJ, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-5; Poignard P, 1996, J EXP MED, V183, P473, DOI 10.1084/jem.183.2.473; Poignard P, 2003, J VIROL, V77, P353, DOI 10.1128/JVI.77.1.353-365.2003; Popovic M, 2005, P NATL ACAD SCI USA, V102, P14807, DOI 10.1073/pnas.0506857102; Poss M, 1999, J VIROL, V73, P5255, DOI 10.1128/JVI.73.7.5255-5264.1999; Poumbourios P, 2003, J BIOL CHEM, V278, P42149, DOI 10.1074/jbc.M305223200; Rainwater SMJ, 2007, CURR HIV RES, V5, P189, DOI 10.2174/157016207780076986; Reeves JD, 2002, P NATL ACAD SCI USA, V99, P16249, DOI 10.1073/pnas.252469399; Ruprecht CR, 2011, J EXP MED, V208, P439, DOI 10.1084/jem.20101907; Salzwedel K, 1999, J VIROL, V73, P2469, DOI 10.1128/JVI.73.3.2469-2480.1999; Santosuosso M, 2009, J INFECT DIS, V200, P1050, DOI 10.1086/605695; SATTENTAU QJ, 1995, J EXP MED, V182, P185, DOI 10.1084/jem.182.1.185; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; Schulke N, 2002, J VIROL, V76, P7760, DOI 10.1128/JVI.76.15.7760-7776.2002; Sharma S, 1996, P NATL ACAD SCI USA, V93, P11842, DOI 10.1073/pnas.93.21.11842; Stamatatos L, 2009, NAT MED, V15, P866, DOI 10.1038/nm.1949; Sun ZYJ, 2008, IMMUNITY, V28, P52, DOI 10.1016/j.immuni.2007.11.018; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; WESTERVELT P, 1991, P NATL ACAD SCI USA, V88, P3097, DOI 10.1073/pnas.88.8.3097; Wu SR, 2010, P NATL ACAD SCI USA, V107, P18844, DOI 10.1073/pnas.1007227107; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Wu XL, 2009, J VIROL, V83, P10892, DOI 10.1128/JVI.01142-09; Wyatt R, 1997, J VIROL, V71, P9722, DOI 10.1128/JVI.71.12.9722-9731.1997; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Yang XZ, 2003, VIROLOGY, V313, P117, DOI 10.1016/S0042-6822(03)00273-3; Yang XZ, 2001, J VIROL, V75, P1165, DOI 10.1128/JVI.75.3.1165-1171.2001; York J, 2004, J VIROL, V78, P4921, DOI 10.1128/JVI.78.9.4921-4926.2004; Yuan W, 2005, VIROLOGY, V332, P369, DOI 10.1016/j.virol.2004.11.013; Zanetti G, 2006, PLOS PATHOG, V2, DOI 10.1371/journal.ppat.0020083; Zhu P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000203; Zhu P, 2006, NATURE, V441, P847, DOI 10.1038/nature04817; Zwick MB, 2005, J VIROL, V79, P1252, DOI 10.1128/JVI.79.2.1252-1261.2005; Zwick MB, 2001, J VIROL, V75, P12198, DOI 10.1128/JVI.75.24.12198-12208.2001; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001; Zwick MB, 2007, CURR HIV RES, V5, P608, DOI 10.2174/157016207782418443	112	30	30	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21339	10.1371/journal.pone.0021339	http://dx.doi.org/10.1371/journal.pone.0021339			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738637	gold, Green Published, Green Submitted			2022-12-27	WOS:000292092600030
J	Domhan, S; Ma, LL; Tai, A; Anaya, Z; Beheshti, A; Zeier, M; Hlatky, L; Abdollahi, A				Domhan, Sophie; Ma, Lili; Tai, Albert; Anaya, Zachary; Beheshti, Afshin; Zeier, Martin; Hlatky, Lynn; Abdollahi, Amir			Intercellular Communication by Exchange of Cytoplasmic Material via Tunneling Nano-Tube Like Structures in Primary Human Renal Epithelial Cells	PLOS ONE			English	Article							FUNCTIONAL GAP-JUNCTIONS; CUTTING EDGE; NANOTUBES; MEMBRANE; EXPRESSION; MICROGLIA; MECHANISM; ALPHA; GAMMA	Transfer of cellular material via tunneling nanotubes (TNT) was recently discovered as a novel mechanism for intercellular communication. The role of intercellular exchange in communication of renal epithelium is not known. Here we report extensive spontaneous intercellular exchange of cargo vesicles and organelles between primary human proximal tubular epithelial cells (RPTEC). Cells were labeled with two different quantum dot nanocrystals (Qtracker 605 or 525) and intercellular exchange was quantified by high-throughput fluorescence imaging and FACS analysis. In co-culture, a substantial fraction of cells (67.5%) contained both dyes indicating high levels of spontaneous intercellular exchange in RPTEC. The double positive cells could be divided into three categories based on the preponderance of 605 Qtracker (46.30%), 525 Qtracker (48.3%) and approximately equal content of both Qtrackers (4.57%). The transfer of mitochondria between RPTECs was also detected using an organelle specific dye. Inhibition of TNT genesis by actin polymerization inhibitor (Latrunculin B) markedly reduced intercellular exchange (>60%) suggesting that intercellular exchange in RPTEC was in part mediated via TNT-like structures. In contrast, induction of cellular stress by Zeocin treatment increased tube-genesis in RPTEC. Our data indicates an unexpected dynamic of intercellular communication between RPTEC by exchange of cytosolic material, which may play an important role in renal physiology.	[Domhan, Sophie; Ma, Lili; Tai, Albert; Anaya, Zachary; Beheshti, Afshin; Hlatky, Lynn; Abdollahi, Amir] Tufts Univ, Dept Med, St Elizabeths Med Ctr, Ctr Canc Syst Biol, Boston, MA 02111 USA; [Domhan, Sophie; Abdollahi, Amir] Univ Heidelberg, Sch Med, Dept Radiat Oncol, Heidelberg Ion Therapy Ctr HIT, Heidelberg, Germany; [Domhan, Sophie; Abdollahi, Amir] German Canc Res Ctr, Natl Ctr Tumor Dis NCT, Heidelberg, Germany; [Domhan, Sophie; Zeier, Martin] Univ Heidelberg, Sch Med, Dept Nephrol, Heidelberg, Germany	St. Elizabeth's Medical Center; Tufts University; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Domhan, S (corresponding author), Tufts Univ, Dept Med, St Elizabeths Med Ctr, Ctr Canc Syst Biol, Boston, MA 02111 USA.	Sophie.Domhan@tufts.edu	Beheshti, Afshin/AAH-7267-2019; Beheshti, Afshin/N-2241-2014	Beheshti, Afshin/0000-0003-4643-531X	NASA Specialized Center of Research [NNJ04HJ12G]; German Krebshilfe (Deutsche Krebshilfe) [Max-Eder 108876]; DFG [SPP1190]; German Federal Ministry of Research and Technology (Bundesministerium fur Bildung und Forschung - BMBF) [03NUK004C]; University of Heidelberg	NASA Specialized Center of Research; German Krebshilfe (Deutsche Krebshilfe)(Deutsche Krebshilfe); DFG(German Research Foundation (DFG)); German Federal Ministry of Research and Technology (Bundesministerium fur Bildung und Forschung - BMBF)(Federal Ministry of Education & Research (BMBF)); University of Heidelberg	This work was supported in part by the NASA Specialized Center of Research NNJ04HJ12G, German Krebshilfe (Deutsche Krebshilfe, Max-Eder 108876), DFG National Priority Research Program: the Tumor-Vessel Interface "SPP1190", the German Federal Ministry of Research and Technology (Bundesministerium fur Bildung und Forschung - BMBF 03NUK004C) and the Olympia-Morata award of the University of Heidelberg to SD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abdollahi A, 2004, MOL CELL, V13, P649, DOI 10.1016/S1097-2765(04)00102-9; Bruno S, 2009, J AM SOC NEPHROL, V20, P1053, DOI 10.1681/ASN.2008070798; Chinnery HR, 2008, J IMMUNOL, V180, P5779, DOI 10.4049/jimmunol.180.9.5779; Duffield JS, 2005, J CLIN INVEST, V115, P1743, DOI 10.1172/JCI22593; Eugenin EA, 2009, CELL IMMUNOL, V254, P142, DOI 10.1016/j.cellimm.2008.08.005; Eugenin EA, 2003, J IMMUNOL, V170, P1320, DOI 10.4049/jimmunol.170.3.1320; Eugenin EA, 2001, P NATL ACAD SCI USA, V98, P4190, DOI 10.1073/pnas.051634298; Gerdes HH, 2008, CURR OPIN CELL BIOL, V20, P470, DOI 10.1016/j.ceb.2008.03.005; Gerdes HH, 2007, FEBS LETT, V581, P2194, DOI 10.1016/j.febslet.2007.03.071; Gerdes HH, 2009, NAT CELL BIOL, V11, P235, DOI 10.1038/ncb0309-235; Gousset K, 2009, NAT CELL BIOL, V11, P328, DOI 10.1038/ncb1841; Gurke S, 2008, EXP CELL RES, V314, P3669, DOI 10.1016/j.yexcr.2008.08.022; Koyanagi M, 2005, CIRC RES, V96, P1039, DOI 10.1161/01.RES.0000168650.23479.0c; Martinez AD, 2002, BRAIN RES, V943, P191, DOI 10.1016/S0006-8993(02)02621-5; Onfelt B, 2004, J IMMUNOL, V173, P1511, DOI 10.4049/jimmunol.173.3.1511; Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133; Zhu DH, 2005, J CELL SCI, V118, P3695, DOI 10.1242/jcs.02507; Zuba-Surma EK, 2007, FOLIA HISTOCHEM CYTO, V45, P279	18	79	83	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21283	10.1371/journal.pone.0021283	http://dx.doi.org/10.1371/journal.pone.0021283			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738629	Green Published, gold, Green Submitted			2022-12-27	WOS:000292092600025
J	Salimpour, Y; Soltanian-Zadeh, H; Salehi, S; Emadi, N; Abouzari, M				Salimpour, Yousef; Soltanian-Zadeh, Hamid; Salehi, Sina; Emadi, Nazli; Abouzari, Mehdi			Neuronal Spike Train Analysis in Likelihood Space	PLOS ONE			English	Article							RECEPTIVE-FIELD PLASTICITY; WHISKER VIBRATION; DYNAMIC-ANALYSIS; CORTEX; INFORMATION; RESPONSES; MODEL; PREDICTION; FRAMEWORK; PATTERNS	Background: Conventional methods for spike train analysis are predominantly based on the rate function. Additionally, many experiments have utilized a temporal coding mechanism. Several techniques have been used for analyzing these two sources of information separately, but using both sources in a single framework remains a challenging problem. Here, an innovative technique is proposed for spike train analysis that considers both rate and temporal information. Methodology/Principal Findings: Point process modeling approach is used to estimate the stimulus conditional distribution, based on observation of repeated trials. The extended Kalman filter is applied for estimation of the parameters in a parametric model. The marked point process strategy is used in order to extend this model from a single neuron to an entire neuronal population. Each spike train is transformed into a binary vector and then projected from the observation space onto the likelihood space. This projection generates a newly structured space that integrates temporal and rate information, thus improving performance of distribution-based classifiers. In this space, the stimulus-specific information is used as a distance metric between two stimuli. To illustrate the advantages of the proposed technique, spiking activity of inferior temporal cortex neurons in the macaque monkey are analyzed in both the observation and likelihood spaces. Based on goodness-of-fit, performance of the estimation method is demonstrated and the results are subsequently compared with the firing rate-based framework. Conclusions/Significance: From both rate and temporal information integration and improvement in the neural discrimination of stimuli, it may be concluded that the likelihood space generates a more accurate representation of stimulus space. Further, an understanding of the neuronal mechanism devoted to visual object categorization may be addressed in this framework as well.	[Salimpour, Yousef; Soltanian-Zadeh, Hamid; Salehi, Sina; Emadi, Nazli; Abouzari, Mehdi] Inst Res Fundamental Sci IPM, Sch Cognit Sci SCS, Tehran, Iran; [Salimpour, Yousef] Johns Hopkins Sch Med, Dept Biomed Engn, Baltimore, MD USA; [Soltanian-Zadeh, Hamid] Univ Tehran, Dept Elect & Comp Engn, Ctr Excellence Control & Intelligent Proc, Tehran, Iran; [Soltanian-Zadeh, Hamid] Henry Ford Hlth Syst, Dept Radiol, Image Anal Lab, Detroit, MI USA; [Salehi, Sina; Emadi, Nazli; Abouzari, Mehdi] Shahid Beheshti Univ Med Sci, Res Grp Brain & Cognit Sci, Tehran, Iran	Johns Hopkins University; Johns Hopkins Medicine; University of Tehran; Henry Ford Health System; Henry Ford Hospital; Shahid Beheshti University Medical Sciences	Salimpour, Y (corresponding author), Inst Res Fundamental Sci IPM, Sch Cognit Sci SCS, Tehran, Iran.	hamids@rad.hfh.edu	salehi, sina/F-2703-2013; Soltanian-Zadeh, Hamid/K-2903-2016; Soltanian-Zadeh, Hamid/AAD-7027-2022	salehi, sina/0000-0001-8027-6944; Soltanian-Zadeh, Hamid/0000-0002-7302-6856; Soltanian-Zadeh, Hamid/0000-0002-7302-6856; Abouzari, Mehdi/0000-0002-3585-698X	Iran National Science Foundation (INSF), Tehran, Iran	Iran National Science Foundation (INSF), Tehran, Iran(Iran National Science Foundation (INSF))	This work was supported in part by a grant from Iran National Science Foundation (INSF), Tehran, Iran. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arabzadeh E, 2005, PLOS BIOL, V3, P155, DOI 10.1371/journal.pbio.0030017; Arabzadeh E, 2004, J NEUROSCI, V24, P6011, DOI 10.1523/JNEUROSCI.1389-04.2004; Arabzadeh E, 2003, J NEUROSCI, V23, P9146; Barbieri R, 2004, NEURAL COMPUT, V16, P277, DOI 10.1162/089976604322742038; Brockwell AE, 2004, J NEUROPHYSIOL, V91, P1899, DOI 10.1152/jn.00438.2003; Brown EN, 2004, NAT NEUROSCI, V7, P456, DOI 10.1038/nn1228; Brown EN, 2004, MATH COMP BIOL SER, P253; Brown EN, 2002, NEURAL COMPUT, V14, P325, DOI 10.1162/08997660252741149; Brown EN, 2001, P NATL ACAD SCI USA, V98, P12261, DOI 10.1073/pnas.201409398; Butts DA, 2003, NETWORK-COMP NEURAL, V14, P177, DOI 10.1088/0954-898X/14/2/301; Cox T.F., 2001, MULTIDIMENSIONAL SCA, V2nd; Czanner G, 2008, J NEUROPHYSIOL, V99, P2672, DOI 10.1152/jn.00343.2007; Daley D., 2003, INTRO THEORY POINT P, V1; Dayan P, 2001, COMPUTATIONAL NEUROS; Eden UT, 2004, NEURAL COMPUT, V16, P971, DOI 10.1162/089976604773135069; Ergun A, 2007, IEEE T BIO-MED ENG, V54, P419, DOI 10.1109/TBME.2006.888821; Frank LM, 2004, J NEUROSCI, V24, P7681, DOI 10.1523/JNEUROSCI.1958-04.2004; Frank LM, 2002, J NEUROSCI, V22, P3817; Godsill SJ, 2004, J AM STAT ASSOC, V99, P156, DOI 10.1198/016214504000000151; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Hung CP, 2005, SCIENCE, V310, P863, DOI 10.1126/science.1117593; Ince RAA, 2010, NEURAL NETWORKS, V23, P713, DOI 10.1016/j.neunet.2010.05.008; Jacobsen M, 2005, POINT PROCESS THEORY; Kass RE, 2005, J NEUROPHYSIOL, V94, P8, DOI 10.1152/jn.00648.2004; Keat J, 2001, NEURON, V30, P803, DOI 10.1016/S0896-6273(01)00322-1; Kiani R, 2005, J NEUROPHYSIOL, V94, P1587, DOI 10.1152/jn.00540.2004; Kiani R, 2007, J NEUROPHYSIOL, V97, P4296, DOI 10.1152/jn.00024.2007; Musallam S, 2004, SCIENCE, V305, P258, DOI 10.1126/science.1097938; Paninski L, 2004, NETWORK-COMP NEURAL, V15, P243, DOI 10.1088/0954-898X/15/4/002; Paninski L, 2004, NEURAL COMPUT, V16, P2533, DOI 10.1162/0899766042321797; Pillow JW, 2005, J NEUROSCI, V25, P11003, DOI 10.1523/JNEUROSCI.3305-05.2005; Quiroga RQ, 2009, NAT REV NEUROSCI, V10, P173, DOI 10.1038/nrn2578; Rolls ET, 2002, COMPUTATIONAL NEUROS; Salimpour Y, 2009, I IEEE EMBS C NEUR E, P711; Serruya MD, 2002, NATURE, V416, P141, DOI 10.1038/416141a; Shoham S, 2005, IEEE T BIO-MED ENG, V52, P1312, DOI 10.1109/TBME.2005.847542; Singh R, 2004, TECHNOMETRICS, V46, P318, DOI 10.1198/004017004000000347; Smith AC, 2004, J NEUROSCI, V24, P447, DOI 10.1523/JNEUROSCI.2908-03.2004; Smith AC, 2003, NEURAL COMPUT, V15, P965, DOI 10.1162/089976603765202622; Smith AC, 2007, J NEUROPHYSIOL, V97, P2516, DOI 10.1152/jn.00946.2006; Srinivasan L, 2007, IEEE T BIO-MED ENG, V54, P526, DOI 10.1109/TBME.2006.890508; Tamura H, 2001, CEREB CORTEX, V11, P384, DOI 10.1093/cercor/11.5.384; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; Truccolo W, 2005, J NEUROPHYSIOL, V93, P1074, DOI 10.1152/jn.00697.2004; VanRullen R, 2005, TRENDS NEUROSCI, V28, P1, DOI 10.1016/j.tins.2004.10.010; Von Heimendahl M, 2007, PLOS BIOL, V5, P2696, DOI 10.1371/journal.pbio.0050305; Wessberg J, 2000, NATURE, V408, P361, DOI 10.1038/35042582; Yu BM, 2007, J NEUROPHYSIOL, V97, P3763, DOI 10.1152/jn.00482.2006	49	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21256	10.1371/journal.pone.0021256	http://dx.doi.org/10.1371/journal.pone.0021256			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738626	Green Submitted, gold, Green Published			2022-12-27	WOS:000292092600023
J	Broen, K; Greupink-Draaisma, A; Woestenenk, R; Schaap, N; Brickner, AG; Dolstra, H				Broen, Kelly; Greupink-Draaisma, Annelies; Woestenenk, Rob; Schaap, Nicolaas; Brickner, Anthony G.; Dolstra, Harry			Concurrent Detection of Circulating Minor Histocompatibility Antigen-Specific CD8(+) T Cells in SCT Recipients by Combinatorial Encoding MHC Multimers	PLOS ONE			English	Article							CLASS-I MOLECULES; MYELOID-LEUKEMIA; DIALLELIC GENE; H-Y; PEPTIDES; PRODUCTS; RESPONSES; PROTEIN; IDENTIFICATION; COMPLEXES	Allogeneic stem cell transplantation (SCT) is a potentially curative treatment for patients with hematologic malignancies. Its therapeutic effect is largely dependent on recognition of minor histocompatibility antigens (MiHA) by donor-derived CD8(+) T cells. Therefore, monitoring of multiple MiHA-specific CD8(+) T cell responses may prove to be valuable for evaluating the efficacy of allogeneic SCT. In this study, we investigated the use of the combinatorial encoding MHC multimer technique to simultaneously detect MiHA-specific CD8(+) T cells in peripheral blood of SCT recipients. Feasibility of this approach was demonstrated by applying dual-color encoding MHC multimers for a set of 10 known MiHA. Interestingly, single staining using a fluorochrome-and Qdot-based five-color combination showed comparable results to dual-color staining for most MiHA-specific CD8(+) T cell responses. In addition, we determined the potential value of combinatorial encoding MHC multimers in MiHA identification. Therefore, a set of 75 candidate MiHA peptides was predicted from polymorphic genes with a hematopoietic expression profile and further selected for high and intermediate binding affinity for HLA-A2. Screening of a large cohort of SCT recipients resulted in the detection of dual-color encoded CD8(+) T cells following MHC multimer-based T cell enrichment and short ex vivo expansion. Interestingly, candidate MiHA-specific CD8(+) T cell responses for LAG3 and TLR10 derived polymorphic peptides could be confirmed by genotyping of the respective SNPs. These findings demonstrate the potency of the combinatorial MHC multimer approach in the monitoring of CD8(+) T cell responses to known and potential MiHA in limited amounts of peripheral blood from allogeneic SCT recipients.	[Broen, Kelly; Greupink-Draaisma, Annelies; Woestenenk, Rob; Dolstra, Harry] Radboud Univ Nijmegen, Med Ctr, Dept Lab Med, Hematol Lab, Nijmegen, Netherlands; [Schaap, Nicolaas] Radboud Univ Nijmegen, Med Ctr, Dept Hematol, Nijmegen, Netherlands; [Brickner, Anthony G.] Univ Pittsburgh, Dept Med, Inst Canc, Pittsburgh, PA USA; [Brickner, Anthony G.] Univ Pittsburgh, Dept Immunol, Inst Canc, Pittsburgh, PA USA	Radboud University Nijmegen; Radboud University Nijmegen; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Broen, K (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Lab Med, Hematol Lab, Nijmegen, Netherlands.	h.dolstra@labgk.umcn.nl	Woestenenk, Rob/C-6119-2016; Brickner, Anthony/A-8088-2008; Schaap, Nicolaas/L-4625-2015; Dolstra, H./L-4276-2015	Schaap, Nicolaas/0000-0001-7696-4752; Dolstra, H./0000-0002-3998-687X	National Institutes of Health [R01CA118880]; Gabrielle's Angel Foundation for Cancer Research; NATIONAL CANCER INSTITUTE [R01CA118880] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gabrielle's Angel Foundation for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grant R01CA118880 and a grant from the Gabrielle's Angel Foundation for Cancer Research (to A.G.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akatsuka Y, 2003, J EXP MED, V197, P1489, DOI 10.1084/jem.20021925; Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Bakker AH, 2008, P NATL ACAD SCI USA, V105, P3825, DOI 10.1073/pnas.0709717105; Bleakley M, 2010, BLOOD, V115, P4923, DOI 10.1182/blood-2009-12-260539; Brickner AG, 2006, BLOOD, V107, P3779, DOI 10.1182/blood-2005-08-3501; Brickner AG, 2001, J EXP MED, V193, P195, DOI 10.1084/jem.193.2.195; den Haan JMM, 1998, SCIENCE, V279, P1054, DOI 10.1126/science.279.5353.1054; DENHAAN JMM, 1995, SCIENCE, V268, P1476, DOI 10.1126/science.7539551; Engelhard VH, 2002, MOL IMMUNOL, V39, P127, DOI 10.1016/S0161-5890(02)00096-2; GARBOCZI DN, 1992, P NATL ACAD SCI USA, V89, P3429, DOI 10.1073/pnas.89.8.3429; Hadrup SR, 2010, CANCER IMMUNOL IMMUN, V59, P1425, DOI 10.1007/s00262-010-0824-2; Hadrup SR, 2009, NAT METHODS, V6, P520, DOI 10.1038/nmeth.1345; Hambach L, 2008, BLOOD, V112, P1844, DOI 10.1182/blood-2007-11-125492; Hinrichs CS, 2011, BLOOD, V117, P808, DOI 10.1182/blood-2010-05-286286; Ho O, 2006, J IMMUNOL, V177, P8283, DOI 10.4049/jimmunol.177.12.8283; Keilholz U, 2009, BLOOD, V113, P6541, DOI 10.1182/blood-2009-02-202598; Kircher B, 2002, BRIT J HAEMATOL, V117, P935, DOI 10.1046/j.1365-2141.2002.03536.x; Marijt WAE, 2003, P NATL ACAD SCI USA, V100, P2742, DOI 10.1073/pnas.0530192100; Meadows L, 1997, IMMUNITY, V6, P273, DOI 10.1016/S1074-7613(00)80330-1; Ofran Y, 2010, CLIN CANCER RES, V16, P1642, DOI 10.1158/1078-0432.CCR-09-2701; PARKER KC, 1994, J IMMUNOL, V152, P163; Pierce RA, 2001, J IMMUNOL, V167, P3223, DOI 10.4049/jimmunol.167.6.3223; Rijke BC, 2005, J CLIN INVEST, V115, P3506, DOI 10.1172/JCI24832; Rodenko B, 2006, NAT PROTOC, V1, P1120, DOI 10.1038/nprot.2006.121; Scheibenbogen C, 2002, BLOOD, V100, P2132, DOI 10.1182/blood-2002-01-0163; Schwab SR, 2003, SCIENCE, V301, P1367, DOI 10.1126/science.1085650; van Bergen CAM, 2007, BLOOD, V109, P4089, DOI 10.1182/blood-2006-08-043935; Van Bergen CAM, 2010, CANCER RES, V70, P9073, DOI 10.1158/0008-5472.CAN-10-1832; Velthuis JH, 2010, DIABETES, V59, P1721, DOI 10.2337/db09-1486; Vigneron N, 2004, SCIENCE, V304, P587, DOI 10.1126/science.1095522; WANG W, 1995, SCIENCE, V269, P1588, DOI 10.1126/science.7667640; Wang ZD, 2010, CHINESE MED J-PEKING, V123, P912, DOI 10.3760/cma.j.issn.0366-6999.2010.07.027; Warren EH, 2006, SCIENCE, V313, P1444, DOI 10.1126/science.1130660; Yewdell JW, 1996, J IMMUNOL, V157, P1823	34	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21266	10.1371/journal.pone.0021266	http://dx.doi.org/10.1371/journal.pone.0021266			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21731686	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000292036900018
J	Smih, F; Desmoulin, F; Berry, M; Turkieh, A; Harmancey, R; Iacovoni, J; Trouillet, C; Delmas, C; Pathak, A; Lairez, O; Koukoui, F; Massabuau, P; Ferrieres, J; Galinier, M; Rouet, P				Smih, Fatima; Desmoulin, Franck; Berry, Matthieu; Turkieh, Annie; Harmancey, Romain; Iacovoni, Jason; Trouillet, Charlotte; Delmas, Clement; Pathak, Atul; Lairez, Olivier; Koukoui, Francois; Massabuau, Pierre; Ferrieres, Jean; Galinier, Michel; Rouet, Philippe			Blood Signature of Pre-Heart Failure: A Microarrays Study	PLOS ONE			English	Article							VENTRICULAR SYSTOLIC DYSFUNCTION; GENE-EXPRESSION; ECHOCARDIOGRAPHIC HEART; MONONUCLEAR-CELLS; TASK-FORCE; PREVALENCE; TRANSCRIPTOME; ASSOCIATION; POPULATION; GUIDELINES	Background: The preclinical stage of systolic heart failure (HF), known as asymptomatic left ventricular dysfunction (ALVD), is diagnosed only by echocardiography, frequent in the general population and leads to a high risk of developing severe HF. Large scale screening for ALVD is a difficult task and represents a major unmet clinical challenge that requires the determination of ALVD biomarkers. Methodology/Principal Findings: 294 individuals were screened by echocardiography. We identified 9 ALVD cases out of 128 subjects with cardiovascular risk factors. White blood cell gene expression profiling was performed using pangenomic microarrays. Data were analyzed using principal component analysis (PCA) and Significant Analysis of Microarrays (SAM). To build an ALVD classifier model, we used the nearest centroid classification method (NCCM) with the ClaNC software package. Classification performance was determined using the leave-one-out cross-validation method. Blood transcriptome analysis provided a specific molecular signature for ALVD which defined a model based on 7 genes capable of discriminating ALVD cases. Analysis of an ALVD patients validation group demonstrated that these genes are accurate diagnostic predictors for ALVD with 87% accuracy and 100% precision. Furthermore, Receiver Operating Characteristic curves of expression levels confirmed that 6 out of 7 genes discriminate for left ventricular dysfunction classification. Conclusions/Significance: These targets could serve to enhance the ability to efficiently detect ALVD by general care practitioners to facilitate preemptive initiation of medical treatment preventing the development of HF.	[Smih, Fatima; Desmoulin, Franck; Berry, Matthieu; Turkieh, Annie; Harmancey, Romain; Iacovoni, Jason; Trouillet, Charlotte; Delmas, Clement; Pathak, Atul; Lairez, Olivier; Koukoui, Francois; Massabuau, Pierre; Galinier, Michel; Rouet, Philippe] Univ Toulouse 3, INSERM, Inst Malad Metabol & Cardiovasc I2MC, UMR 1048, F-31062 Toulouse, France; [Berry, Matthieu; Trouillet, Charlotte; Delmas, Clement; Pathak, Atul; Lairez, Olivier; Massabuau, Pierre; Ferrieres, Jean; Galinier, Michel; Rouet, Philippe] Rangueil Hosp Univ, Dept Cardiol, Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse	Smih, F (corresponding author), Univ Toulouse 3, INSERM, Inst Malad Metabol & Cardiovasc I2MC, UMR 1048, F-31062 Toulouse, France.	fatima.smith-rouet@inserm.fr	DESMOULIN, Franck/O-1895-2018; Clément, DELMAS/Q-5187-2019; desmoulin, franck/AAU-4544-2020; Pathak, Atul/ABC-5223-2020; O, Lairez/B-7152-2016; Ferrieres, Jean/S-7993-2016	DESMOULIN, Franck/0000-0003-0560-6266; Clément, DELMAS/0000-0001-9180-9128; desmoulin, franck/0000-0003-0560-6266; Pathak, Atul/0000-0001-6151-0096; O, Lairez/0000-0001-8141-6582; Rouet, Philippe/0000-0001-6204-2079; Ferrieres, Jean/0000-0001-6144-1297; TURKIEH, Annie/0000-0001-6968-4517; GALINIER, Michel/0000-0003-1735-3390	National Research Agency; Fondation de France	National Research Agency(French National Research Agency (ANR)); Fondation de France(Fondation de France)	This work was supported by the National Research Agency and Fondation de France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Betti I, 2009, J CARD FAIL, V15, P377, DOI 10.1016/j.cardfail.2008.12.002; Caporali A, 2009, PHYSIOL REV, V89, P279, DOI 10.1152/physrev.00007.2008; Cappuzzello C, 2009, PHYSIOL GENOMICS, V38, P233, DOI 10.1152/physiolgenomics.90364.2008; Dabney AR, 2006, BIOINFORMATICS, V22, P122, DOI 10.1093/bioinformatics/bti756; Daniels LB, 2007, J AM COLL CARDIOL, V50, P2357, DOI 10.1016/j.jacc.2007.09.021; Davies MK, 2001, LANCET, V358, P439, DOI 10.1016/S0140-6736(01)05620-3; Dickstein K, 2008, EUR J HEART FAIL, V10, P933, DOI 10.1016/j.ejheart.2008.08.005; Fang ZY, 2005, AM HEART J, V149, P349, DOI 10.1016/j.ahj.2004.06.021; Gottdiener JS, 2002, ANN INTERN MED, V137, P631, DOI 10.7326/0003-4819-137-8-200210150-00006; Hobbs FDR, 2007, EUR HEART J, V28, P1128, DOI 10.1093/eurheartj/ehm102; Hunt SA, 2009, CIRCULATION, V119, pE391, DOI 10.1161/CIRCULATIONAHA.109.192065; Kaye DM, 2000, CIRC RES, V86, pE80, DOI 10.1161/01.RES.86.7.e80; Konig R, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh027; Liew CC, 2006, J LAB CLIN MED, V147, P126, DOI 10.1016/j.lab.2005.10.005; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Luers C, 2010, CLIN RES CARDIOL, V99, P217, DOI 10.1007/s00392-009-0108-z; Marshall OJ, 2004, BIOINFORMATICS, V20, P2471, DOI 10.1093/bioinformatics/bth254; McDonagh TA, 1997, LANCET, V350, P829, DOI 10.1016/S0140-6736(97)03033-X; McMurray JV, 1998, EUR HEART J, V19, P842, DOI 10.1093/eurheartj/19.6.842; Mosterd A, 1999, EUR HEART J, V20, P447, DOI 10.1053/euhj.1998.1239; NICKLAS JM, 1992, NEW ENGL J MED, V327, P685; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; Philip-Couderc P, 2004, FASEB J, V18, P1539, DOI 10.1096/fj.03-1242fje; Quackenbush J, 2001, NAT REV GENET, V2, P418, DOI 10.1038/35076576; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; Seiler PU, 2004, BASIC RES CARDIOL, V99, P230, DOI 10.1007/s00395-004-0467-6; SHARPE N, 1990, EUR HEART J, V11, P147, DOI 10.1093/eurheartj/11.suppl_B.147; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Varma S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-91; Verdecchia P, 2005, HYPERTENSION, V45, P412, DOI 10.1161/01.HYP.0000154822.37141.f6; Wang TJ, 2003, CIRCULATION, V108, P977, DOI 10.1161/01.CIR.0000085166.44904.79; Wang TJ, 2003, ANN INTERN MED, V138, P907, DOI 10.7326/0003-4819-138-11-200306030-00012; Whitney AR, 2003, P NATL ACAD SCI USA, V100, P1896, DOI 10.1073/pnas.252784499; Yndestad A, 2002, CARDIOVASC RES, V54, P175, DOI 10.1016/S0008-6363(02)00238-9	34	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e20414	10.1371/journal.pone.0020414	http://dx.doi.org/10.1371/journal.pone.0020414			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21731613	Green Published, gold			2022-12-27	WOS:000292036900004
J	Tati, R; Kristoffersson, AC; Stahl, AL; Morgelin, M; Motto, D; Satchell, S; Mathieson, P; Manea-Hedstrom, M; Karpman, D				Tati, Ramesh; Kristoffersson, Ann-Charlotte; Stahl, Anne-lie; Morgelin, Matthias; Motto, David; Satchell, Simon; Mathieson, Peter; Manea-Hedstrom, Minola; Karpman, Diana			Phenotypic Expression of ADAMTS13 in Glomerular Endothelial Cells	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; FACTOR-CLEAVING PROTEASE; THROMBOTIC THROMBOCYTOPENIC PURPURA; SHIGA TOXIN; VONWILLEBRAND-FACTOR; VWF; CLEAVAGE; PLASMA; SYNTHESIZE; MUTATIONS	Background: ADAMTS13 is the physiological von Willebrand factor (VWF)-cleaving protease. The aim of this study was to examine ADAMTS13 expression in kidneys from ADAMTS13 wild-type (Adamts13(+/+)) and deficient (Adamts13(-/-)) mice and to investigate the expression pattern and bioactivity in human glomerular endothelial cells. Methodology/Principal Findings: Immunohistochemistry was performed on kidney sections from ADAMTS13 wild-type and ADAMTS13-deficient mice. Phenotypic differences were examined by ultramorphology. ADAMTS13 expression in human glomerular endothelial cells and dermal microvascular endothelial cells was investigated by real-time PCR, flow cytometry, immunofluorescence and immunoblotting. VWF cleavage was demonstrated by multimer structure analysis and immunoblotting. ADAMTS13 was demonstrated in glomerular endothelial cells in Adamts13(+/+) mice but no staining was visible in tissue from Adamts13(-/-) mice. Thickening of glomerular capillaries with platelet deposition on the vessel wall was detected in Adamts13(-/-) mice. ADAMTS13 mRNA and protein were detected in both human endothelial cells and the protease was secreted. ADAMTS13 activity was demonstrated in glomerular endothelial cells as cleavage of VWF. Conclusions/Significance: Glomerular endothelial cells express and secrete ADAMTS13. The proteolytic activity could have a protective effect preventing deposition of platelets along capillary lumina under the conditions of high shear stress present in glomerular capillaries.	[Tati, Ramesh; Kristoffersson, Ann-Charlotte; Stahl, Anne-lie; Manea-Hedstrom, Minola; Karpman, Diana] Lund Univ, Dept Pediat, Lund, Sweden; [Morgelin, Matthias] Lund Univ, Div Clin & Expt Infect Med, Lund, Sweden; [Motto, David] Univ Iowa, Coll Med, Dept Internal Med & Pediat, Iowa City, IA USA; [Satchell, Simon; Mathieson, Peter] Univ Bristol, Acad Renal Unit, Southmead Hosp, Bristol, Avon, England	Lund University; Lund University; University of Iowa; Southmead Hospital; University of Bristol	Tati, R (corresponding author), Lund Univ, Dept Pediat, Lund, Sweden.	Diana.Karpman@med.lu.se		Karpman, Diana/0000-0001-7220-7658; Aradottir, Sigridur Sunna/0000-0002-6898-3256	The Swedish Research Council [K2010-65X-14008, 2008-7480]; Torsten and Ragnar Soderberg Foundation; Crown Princess Lovisa's Society for Child Care; The Konung Gustaf V:s 80-arsfond; Fanny Ekdahl's Foundation; Greta and Johan Kock Foundation; Crafoord Foundation; Royal Swedish Academy of Sciences; Medical Research Council [G0800200] Funding Source: researchfish; MRC [G0800200] Funding Source: UKRI	The Swedish Research Council(Swedish Research Council); Torsten and Ragnar Soderberg Foundation; Crown Princess Lovisa's Society for Child Care; The Konung Gustaf V:s 80-arsfond; Fanny Ekdahl's Foundation; Greta and Johan Kock Foundation; Crafoord Foundation; Royal Swedish Academy of Sciences; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by grants from The Swedish Research Council (K2010-65X-14008 to DK and 2008-7480 to MM), Torsten and Ragnar Soderberg Foundation, The Fund for Renal Research, Crown Princess Lovisa's Society for Child Care, The Konung Gustaf V:s 80-arsfond, and Fanny Ekdahl's Foundation (all to DK). Support was also provided by The Greta and Johan Kock Foundation and the Crafoord Foundation (to MM). DK is the recipient of a clinical-experimental research fellowship from the Royal Swedish Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arya M, 2002, BLOOD, V99, P3971, DOI 10.1182/blood-2001-11-0060; Chauhan AK, 2006, J EXP MED, V203, P767, DOI 10.1084/jem.20051732; Chauhan AK, 2008, BLOOD, V111, P3452, DOI 10.1182/blood-2007-08-108571; DENT JA, 1990, P NATL ACAD SCI USA, V87, P6306, DOI 10.1073/pnas.87.16.6306; Dong JF, 2002, BLOOD, V100, P4033, DOI 10.1182/blood-2002-05-1401; Furlan M, 1997, BLOOD, V89, P3097, DOI 10.1182/blood.V89.9.3097; Furlan M, 1996, BLOOD, V87, P4223, DOI 10.1182/blood.V87.10.4223.bloodjournal87104223; George JN, 2000, BLOOD, V96, P1223, DOI 10.1182/blood.V96.4.1223.h8001223_1223_1229; Herwald H, 2004, CELL, V116, P367, DOI 10.1016/S0092-8674(04)00057-1; Huang J, 2010, BLOOD, V116, P3653, DOI 10.1182/blood-2010-02-271957; JAFFE EA, 1974, P NATL ACAD SCI USA, V71, P1906, DOI 10.1073/pnas.71.5.1906; Keepers TR, 2006, J AM SOC NEPHROL, V17, P3404, DOI 10.1681/ASN.2006050419; Lanke E, 2008, THROMB HAEMOSTASIS, V100, P211, DOI 10.1160/TH08-03-0187; Lenz O, 1998, J AM SOC NEPHROL, V9, P2040; Levy GG, 2001, NATURE, V413, P488, DOI 10.1038/35097008; Liu L, 2005, J THROMB HAEMOST, V3, P2536, DOI 10.1111/j.1538-7836.2005.01561.x; Manea M, 2007, BRIT J HAEMATOL, V138, P651, DOI 10.1111/j.1365-2141.2007.06694.x; Manea M, 2007, EUR J PEDIATR, V166, P249, DOI 10.1007/s00431-006-0354-2; Manea M, 2010, PEDIATR NEPHROL, V25, P87, DOI 10.1007/s00467-009-1262-2; MOAKE JL, 1986, BLOOD, V67, P1523; Motto DG, 2005, J CLIN INVEST, V115, P2752, DOI 10.1172/JCI26007; Nitsche DP, 2006, J BIOL CHEM, V281, P1670, DOI 10.1074/jbc.M506776200; Plaimauer B, 2002, BLOOD, V100, P3626, DOI 10.1182/blood-2002-05-1397; Powazniak Y, 2011, EUR J HAEMATOL, V86, P140, DOI 10.1111/j.1600-0609.2010.01545.x; Raife TJ, 2009, BLOOD, V114, P1666, DOI 10.1182/blood-2009-01-195461; Satchell SC, 2006, KIDNEY INT, V69, P1633, DOI 10.1038/sj.ki.5000277; Shamamian P, 2001, J CELL PHYSIOL, V189, P197, DOI 10.1002/jcp.10014; Shang DZ, 2006, BLOOD, V108, P2207, DOI 10.1182/blood-2006-02-002139; SHI SR, 1991, J HISTOCHEM CYTOCHEM, V39, P741, DOI 10.1177/39.6.1709656; SPORN LA, 1985, J CLIN INVEST, V76, P1102, DOI 10.1172/JCI112064; Stahl AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006990; Suzuki M, 2004, BIOCHEM BIOPH RES CO, V313, P212, DOI 10.1016/j.bbrc.2003.11.111; TSAI HM, 1989, BLOOD, V73, P2074; Tsai HM, 1998, NEW ENGL J MED, V339, P1585, DOI 10.1056/NEJM199811263392203; Tsai HM, 1996, BLOOD, V87, P4235, DOI 10.1182/blood.V87.10.4235.bloodjournal87104235; Turner N, 2006, J THROMB HAEMOST, V4, P1396, DOI 10.1111/j.1538-7836.2006.01959.x; Turner NA, 2009, BLOOD, V114, P5102, DOI 10.1182/blood-2009-07-231597; Uemura M, 2005, BLOOD, V106, P922, DOI 10.1182/blood-2005-01-0152; Vaziri-Sani F, 2006, KIDNEY INT, V69, P981, DOI 10.1038/sj.ki.5000155; Vomund AN, 2009, J BIOL CHEM, V284, P30925, DOI 10.1074/jbc.M109.000927	40	17	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21587	10.1371/journal.pone.0021587	http://dx.doi.org/10.1371/journal.pone.0021587			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21720563	Green Published, gold, Green Submitted			2022-12-27	WOS:000292036900059
J	Stover, J; Korenromp, EL; Blakley, M; Komatsu, R; Viisainen, K; Bollinger, L; Atun, R				Stover, John; Korenromp, Eline L.; Blakley, Matthew; Komatsu, Ryuichi; Viisainen, Kirsi; Bollinger, Lori; Atun, Rifat			Long-Term Costs and Health Impact of Continued Global Fund Support for Antiretroviral Therapy	PLOS ONE			English	Article							PATIENT RETENTION; LOW-INCOME; FOLLOW-UP; HIV; MORTALITY; PROGRAMS; HIV/AIDS; ART; SERVICES; AFRICA	Background: By the end of 2011 Global Fund investments will be supporting 3.5 million people on antiretroviral therapy (ART) in 104 low-and middle-income countries. We estimated the cost and health impact of continuing treatment for these patients through 2020. Methods and Findings: Survival on first-line and second-line ART regimens is estimated based on annual retention rates reported by national AIDS programs. Costs per patient-year were calculated from country-reported ARV procurement prices, and expenditures on laboratory tests, health care utilization and end-of-life care from in-depth costing studies. Of the 3.5 million ART patients in 2011, 2.3 million will still need treatment in 2020. The annual cost of maintaining ART falls from $1.9 billion in 2011 to $1.7 billion in 2020, as a result of a declining number of surviving patients partially offset by increasing costs as more patients migrate to second-line therapy. The Global Fund is expected to continue being a major contributor to meeting this financial need, alongside other international funders and domestic resources. Costs would be $150 million less in 2020 with an annual 5% decline in first-line ARV prices and $150-370 million less with a 5%-12% annual decline in second-line prices, but $200 million higher in 2020 with phase out of stavudine (d4T), or $200 million higher with increased migration to second-line regimens expected if all countries routinely adopted viral load monitoring. Deaths postponed by ART correspond to 830,000 life-years saved in 2011, increasing to around 2.3 million life-years every year between 2015 and 2020. Conclusions: Annual patient-level direct costs of supporting a patient cohort remain fairly stable over 2011-2020, if current antiretroviral prices and delivery costs are maintained. Second-line antiretroviral prices are a major cost driver, underscoring the importance of investing in treatment quality to improve retention on first-line regimens.	[Stover, John; Bollinger, Lori] Futures Inst, Glastonbury, CT USA; [Korenromp, Eline L.; Blakley, Matthew; Komatsu, Ryuichi; Viisainen, Kirsi; Atun, Rifat] Global Fund Fight AIDS TB & Malaria, Geneva, Switzerland; [Korenromp, Eline L.; Atun, Rifat] Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Atun, Rifat] Univ London Imperial Coll Sci Technol & Med, London, England	Erasmus University Rotterdam; Erasmus MC; Imperial College London	Stover, J (corresponding author), Futures Inst, Glastonbury, CT USA.	jstover@futuresinstitute.org	Atun, Rifat/AAH-5537-2021	Atun, Rifat/0000-0002-1531-5983	The Global Fund	The Global Fund	The Global Fund commissioned this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam Taghreed, 2003, Cost Eff Resour Alloc, V1, P3, DOI 10.1186/1478-7547-1-3; *AIDS 2031 COSTS F, 2010, COSTS CHOIC FIN LONG; [Anonymous], ANT MED LOW MIDDL IN; Badri M, 2006, PLOS MED, V3, P48, DOI 10.1371/journal.pmed.0030004; BAUTISTA SA, 2003, COSTING HIV AIDS TRE; CHANDLER R, 2005, ESTIMATING RESOURCE; CHANG LW, 2010, COCHRANE DB SYST REV, V14; Cleary Susan M, 2006, Cost Eff Resour Alloc, V4, P20, DOI 10.1186/1478-7547-4-20; *EART LINC COLL, 2008, SEX TRANSM INFECT, V84, pI31; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Fox MP, 2010, TROP MED INT HEALTH, V15, P405, DOI 10.1111/j.1365-3156.2010.02473.x; GALARRAGA O, 2010, PHARMAC IN PRESS SEP; Galvao J, 2002, LANCET, V360, P1862, DOI 10.1016/S0140-6736(02)11775-2; *GLOB FUND FIGHT A, 2009, IMPR VAL MON GLOB FU; *GLOB FUND FIGHT A, 2010, KEY PERF IND 2010; *GLOB FUND FIGHT A, 2011, GLOB FUND RES REP 20; Goldie SJ, 2006, NEW ENGL J MED, V355, P1141, DOI 10.1056/NEJMsa060247; HARLING G, 2007, J ACQ IMMUN DEF SYND, V45, P3; Harries AD, 2010, TROP MED INT HEALTH, V15, P70, DOI 10.1111/j.1365-3156.2010.02506.x; Izazola-Licea JA, 2009, JAIDS-J ACQ IMM DEF, V52, pS119, DOI 10.1097/QAI.0b013e3181baeeda; Jack C, 2004, JAIDS-J ACQ IMM DEF, V36, P929, DOI 10.1097/00126334-200408010-00006; Jahn A, 2008, LANCET, V371, P1603, DOI 10.1016/S0140-6736(08)60693-5; *KAIS FAM FDN, 2009, FIN RESP AIDS LOW MI; Kitajima T, 2003, AIDS, V17, P2375, DOI 10.1097/00002030-200311070-00013; KOENIG S, 2006, AIDS 2006 16 INT AID; KOENIG S, 2006, AIDS 16 INT AIDS C 2; Komatsu R, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-109; KOMBE G, 2004, COSTS ANTIRETROVIRAL; Kombe G., 2005, HUMAN FINANCIAL RESO; Korenromp EL, 2005, EMERG INFECT DIS, V11, P1410, DOI 10.3201/eid1109.050337; Korenromp EL, 2011, AIDS, V25, P857, DOI 10.1097/QAD.0b013e3283454401; LABASTIDE W, 2002, INT C AIDS JUL 7 12, P14; LONG L, 2009, COSTING TREATMENT GU; Loubiere S, 2010, CURR OPIN HIV AIDS, V5, P225, DOI 10.1097/COH.0b013e3283384a9d; Marston M, 2007, AIDS, V21, pS65, DOI 10.1097/01.aids.0000299412.82893.62; Medecins Sans Frontieres, 2008, UNT WEB ANT PRIC RED; MEDINALARA A, 2009, 5 IAS C HIV PATH TRE; Mugyenyi P, 2010, LANCET, V375, P123, DOI 10.1016/S0140-6736(09)62067-5; Phillips AN, 2011, AIDS, V25, P843, DOI 10.1097/QAD.0b013e328344037a; *PHRPLUS, 2004, NIG RAP ASS HIV AIDS; Quentin W, 2008, TROP MED INT HEALTH, V13, P1245, DOI 10.1111/j.1365-3156.2008.02142.x; SILVESTRI A, 2009, EVALUATION ANTIRETRO; Stover J, 2008, SEX TRANSM INFECT, V84, pI24, DOI 10.1136/sti.2008.029868; Stover J, 2006, SCIENCE, V311, P1474, DOI 10.1126/science.1121176; Stover J, 2011, AIDS RES TREAT, V2011, DOI 10.1155/2011/738271; The Global Fund to Fight AIDS Tuberculosis and Malaria, 2010, GLOB FUND RES REP 20; TODD K, 2007, AIDS S, V6, pS55; Tweya H, 2010, TROP MED INT HEALTH, V15, P82, DOI 10.1111/j.1365-3156.2010.02509.x; *UK DEP INT DEV, 2008, ACH UN ACC UK STRAT; *UNAIDS, GLOB EC CRIS HIV PRE; UNAIDS, 2009, WHAT COUNTR NEED INV; WHO, 2010, ANT THER HIV INF AD; WHO, 2004, MAL HIV AIDS INT IMP; *WHO, 2009, U ACC SCAL PRIOR HIV; World Health Organization, 2006, ANT THER HIV INF AD; World Health Organization UNAIDS and UNICEF, 2010, U ACC SCAL PRIOR HIV; 2010, REPORT C COSTS TREAT	57	27	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21048	10.1371/journal.pone.0021048	http://dx.doi.org/10.1371/journal.pone.0021048			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731646	Green Published, gold, Green Submitted			2022-12-27	WOS:000292035400007
J	Zheng, CG; Feng, J; Lu, D; Wang, P; Xing, S; Coll, JL; Yang, DL; Yan, XY				Zheng, Chaogu; Feng, Jing; Lu, Di; Wang, Ping; Xing, Shu; Coll, Jean-Luc; Yang, Dongling; Yan, Xiyun			A Novel Anti-CEACAM5 Monoclonal Antibody, CC4, Suppresses Colorectal Tumor Growth and Enhances NK Cells-Mediated Tumor Immunity	PLOS ONE			English	Article							ANTIGEN CEA FAMILY; CARCINOEMBRYONIC ANTIGEN; TRANSGENIC MICE; CANCER IMMUNOSURVEILLANCE; INTERCELLULAR-ADHESION; EXPRESSION; CARCINOMA; MARKER; MEMBER; DIFFERENTIATION	Carcinoembryonic antigen (CEA, CEACAM5, and CD66e) has been found to be associated with various types of cancers, particularly colorectal carcinoma, and developed to be a molecular target for cancer diagnosis and therapy. In present study, we generated a novel anti-CEACAM5 monoclonal antibody, namely mAb CC4, by immunizing mice with living colorectal cancer LS174T cells. Immunohistochemical studies found that mAb CC4 specifically and strongly binds to tumor tissues, especially colorectal adenocarcinoma. In xenografted mice, mAb CC4 is specifically accumulated in tumor site and remarkably represses colorectal tumor growth. In vitro functional analysis showed that mAb CC4 significantly suppresses cell proliferation, migration and aggregation of colorectal cancer cells and also raises strong ADCC reaction. More interestingly, mAb CC4 is able to enhance NK cytotoxicity against MHC-I-deficient colorectal cancer cells by blocking intercellular interaction between epithelial CEACAM5 and NK inhibitory receptor CEACAM1. These data suggest that mAb CC4 has the potential to be developed as a novel tumor-targeting carrier and cancer therapeutic.	[Zheng, Chaogu; Feng, Jing; Lu, Di; Wang, Ping; Xing, Shu; Yang, Dongling; Yan, Xiyun] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China; [Coll, Jean-Luc] Inst Albert Bonniot, Grp Rech Canc Poumon, Equipe INSERM 9924, Grenoble, France	Chinese Academy of Sciences; Institute of Biophysics, CAS; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Zheng, CG (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China.	fengjing@moon.ibp.ac.cn; yanxy@sun5.ibp.ac.cn	Zheng, Chaogu/P-2753-2019; Coll, Jean-Luc/G-2520-2013; Lu, Di/D-9836-2018	Zheng, Chaogu/0000-0002-5048-4520; Coll, Jean-Luc/0000-0002-2453-3552; Lu, Di/0000-0002-4083-1656	National High-Tech R&D Program of China (863 Program) [2006AA02A245]; National Basic Research Program of China (973 Program) [2009CB521704, 2011CB915502]; National S & T Major Project [2009ZX09102-247, 2008ZX10002-017, 2008ZX10004-005]; National Natural Science Foundation of China [30801378]; Chinese Academy of Sciences [KSCX2-YW-R-121, KSCX2-YW-R-173, KSCX2-YW-G-044]; Ministry of Education, Culture, Sports, Science and Technology	National High-Tech R&D Program of China (863 Program)(National High Technology Research and Development Program of China); National Basic Research Program of China (973 Program)(National Basic Research Program of China); National S & T Major Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work is partially supported by the National High-Tech R&D Program of China (863 Program) (2006AA02A245), the National Basic Research Program of China (973 Program) (2009CB521704, 2011CB915502), National S & T Major Project (2009ZX09102-247, 2008ZX10002-017, 2008ZX10004-005), the National Natural Science Foundation of China (30801378) and the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-YW-R-121, KSCX2-YW-R-173, KSCX2-YW-G-044). This work is also supported by a contract research fund from the Ministry of Education, Culture, Sports, Science and Technology for Program of Founding Research Centers for Emerging and Reemerging Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bading JR, 2008, CANCER BIOTHER RADIO, V23, P399, DOI 10.1089/cbr.2007.0457; BENCHIMOL S, 1989, CELL, V57, P327, DOI 10.1016/0092-8674(89)90970-7; Blumenthal RD, 2005, CANCER IMMUNOL IMMUN, V54, P315, DOI 10.1007/s00262-004-0597-6; Blumenthal RD, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-2; Chan CHF, 2006, CARCINOGENESIS, V27, P1909, DOI 10.1093/carcin/bgl040; Chan CHF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001353; Chester KA, 2000, CANCER CHEMOTH PHARM, V46, pS8, DOI 10.1007/PL00014055; Duffy MJ, 2001, CLIN CHEM, V47, P624; Dunn GP, 2004, IMMUNITY, V21, P137, DOI 10.1016/j.immuni.2004.07.017; GASPARINI M, 1988, INT J CANCER, P81; Gharahdaghi F, 1999, ELECTROPHORESIS, V20, P601, DOI 10.1002/(SICI)1522-2683(19990301)20:3<601::AID-ELPS601>3.0.CO;2-6; GOLD P, 1965, J EXP MED, V122, P467, DOI 10.1084/jem.122.3.467; Gray-Owen SD, 2006, NAT REV IMMUNOL, V6, P433, DOI 10.1038/nri1864; Hammarstrom S, 1999, SEMIN CANCER BIOL, V9, P67, DOI 10.1006/scbi.1998.0119; HASHINO J, 1994, CLIN EXP METASTAS, V12, P324, DOI 10.1007/BF01753839; HOSTETTER RB, 1990, ARCH SURG-CHICAGO, V125, P300; Ilantzis C, 2002, NEOPLASIA, V4, P151, DOI 10.1038/sj.neo.7900201; Imakiire T, 2004, INT J CANCER, V108, P564, DOI 10.1002/ijc.11608; Jin ZH, 2006, MOL IMAGING, V5, P188; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Markel G, 2002, J IMMUNOL, V168, P2803, DOI 10.4049/jimmunol.168.6.2803; Mayer A, 1999, J IMMUNOL METHODS, V231, P261, DOI 10.1016/S0022-1759(99)00162-3; Ordonez C, 2000, CANCER RES, V60, P3419; Seliger B, 2008, CANCER IMMUNOL IMMUN, V57, P1719, DOI 10.1007/s00262-008-0515-4; SHARMA SK, 1994, CELL BIOPHYS, V24-5, P219, DOI 10.1007/BF02789232; Stein R, 2004, MOL CANCER THER, V3, P1559; Stern N, 2005, J IMMUNOL, V174, P6692, DOI 10.4049/jimmunol.174.11.6692; Taheri M, 2000, J BIOL CHEM, V275, P26935; Taheri M, 2003, J BIOL CHEM, V278, P14632, DOI 10.1074/jbc.M212500200; TAKEICHI M, 1977, J CELL BIOL, V75, P464, DOI 10.1083/jcb.75.2.464; THOMPSON JA, 1991, J CLIN LAB ANAL, V5, P344, DOI 10.1002/jcla.1860050510; Waldhauer I, 2008, ONCOGENE, V27, P5932, DOI 10.1038/onc.2008.267; Xu XC, 2000, CANCER RES, V60, P4475	33	32	42	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21146	10.1371/journal.pone.0021146	http://dx.doi.org/10.1371/journal.pone.0021146			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731662	gold, Green Published, Green Submitted			2022-12-27	WOS:000292033700041
J	Oak, SR; Murray, L; Herath, A; Sleeman, M; Anderson, I; Joshi, AD; Coelho, AL; Flaherty, KR; Toews, GB; Knight, D; Martinez, FJ; Hogaboam, CM				Oak, Sameer R.; Murray, Lynne; Herath, Athula; Sleeman, Matthew; Anderson, Ian; Joshi, Amrita D.; Coelho, Ana Lucia; Flaherty, Kevin R.; Toews, Galen B.; Knight, Darryl; Martinez, Fernando J.; Hogaboam, Cory M.			A Micro RNA Processing Defect in Rapidly Progressing Idiopathic Pulmonary Fibrosis	PLOS ONE			English	Article							GENE-EXPRESSION PROFILES; MESENCHYMAL TRANSITION; INTERSTITIAL PNEUMONIA; EARLY MORTALITY; DICER; ACTIVATION; PREDICTS; DIFFERENTIATION; MECHANISMS; EPITHELIUM	Background: Idiopathic pulmonary fibrosis exhibits differential progression from the time of diagnosis but the molecular basis for varying progression rates is poorly understood. The aim of the present study was to ascertain whether differential miRNA expression might provide one explanation for rapidly versus slowly progressing forms of IPF. Methodology and Principal Findings: miRNA and mRNA were isolated from surgical lung biopsies from IPF patients with a clinically documented rapid or slow course of disease over the first year after diagnosis. A quantitative PCR miRNA array containing 88 of the most abundant miRNA in the human genome was used to profile lung biopsies from 9 patients with rapidly progressing IPF, 6 patients with slowly progressing IPF, and 10 normal lung biopsies. Using this approach, 11 miRNA were significantly increased and 36 were significantly decreased in rapid biopsies compared with normal biopsies. Slowly progressive biopsies exhibited 4 significantly increased miRNA and 36 significantly decreased miRNA compared with normal lung. Among the miRNA present in IPF with validated mRNA targets were those with regulatory effects on epithelial-mesenchymal transition (EMT). Five miRNA (miR-302c, miR-423-5p, miR-210, miR-376c, and miR-185) were significantly increased in rapid compared with slow IPF lung biopsies. Additional analyses of rapid biopsies and fibroblasts grown from the same biopsies revealed that the expression of AGO1 and AGO2 (essential components of the miRNA processing RISC complex) were lower compared with either slow or normal lung biopsies and fibroblasts. Conclusion: These findings suggest that the development and/or clinical progression of IPF might be the consequence of aberrant miRNA processing.	[Oak, Sameer R.; Joshi, Amrita D.; Coelho, Ana Lucia; Hogaboam, Cory M.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Murray, Lynne; Herath, Athula; Sleeman, Matthew; Anderson, Ian] MedImmune, Cambridge, England; [Flaherty, Kevin R.; Toews, Galen B.; Martinez, Fernando J.] Univ Michigan Hlth Syst, Div Pulm & Crit Care Med, Dept Internal Med, Ann Arbor, MI USA; [Knight, Darryl] Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, UBC James Hogg Res Ctr, Heart Lung Inst, Vancouver, BC V5Z 1M9, Canada	University of Michigan System; University of Michigan; AstraZeneca; Medimmune; University of Michigan System; University of Michigan; University of British Columbia	Oak, SR (corresponding author), Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA.	hogaboam@med.umich.edu	Murray, Lynne/AAB-1793-2020; Hogaboam, Cory M./AAI-1433-2021; hogaboam, cory/M-3578-2014; Sleeman, Matthew A/E-6675-2016	Murray, Lynne/0000-0003-4879-966X; Hogaboam, Cory M./0000-0003-3366-4850; Herath, Athula/0000-0002-9465-7841	National Institutes of Health; University of Michigan Medical School	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Medical School	Funding was provided by the National Institutes of Health and the University of Michigan Medical School. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Andl T, 2006, CURR BIOL, V16, P1041, DOI 10.1016/j.cub.2006.04.005; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boon K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005134; Buckley ST, 2011, AM J PHYSIOL-LUNG C, V300, pL548, DOI 10.1152/ajplung.00230.2010; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Chilosi M, 2003, AM J PATHOL, V162, P1495, DOI 10.1016/S0002-9440(10)64282-4; Coward William R, 2010, Ther Adv Respir Dis, V4, P367, DOI 10.1177/1753465810379801; Cowland JB, 2007, APMIS, V115, P1090, DOI 10.1111/j.1600-0463.2007.apm_775.xml.x; Cushing L, 2010, AM J RESP CELL MOL B; Duisters RF, 2009, CIRC RES, V104, P170, DOI 10.1161/CIRCRESAHA.108.182535; Dutsch-Wicherek M, 2010, AM J REPROD IMMUNOL, V63, P181, DOI 10.1111/j.1600-0897.2009.00803.x; Filipowicz W, 2005, CELL, V122, P17, DOI 10.1016/j.cell.2005.06.023; Flaherty KR, 2004, AM J RESP CRIT CARE, V170, P904, DOI 10.1164/rccm.200402-147OC; Flaherty KR, 2003, THORAX, V58, P143, DOI 10.1136/thorax.58.2.143; Frankel SK, 2009, CURR OPIN PULM MED, V15, P463, DOI 10.1097/MCP.0b013e32832ea4b3; Garantziotis S, 2006, SEMIN RESP CRIT CARE, V27, P574, DOI 10.1055/s-2006-957329; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guo CJ, 2009, FEBS J, V276, P5163, DOI 10.1111/j.1742-4658.2009.07213.x; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hardie WD, 2009, AM J PATHOL, V175, P3, DOI 10.2353/ajpath.2009.081170; Harris KS, 2006, P NATL ACAD SCI USA, V103, P2208, DOI 10.1073/pnas.0510839103; Hill DA, 2009, SCIENCE, V325, P965, DOI 10.1126/science.1174334; Ji JL, 2009, FEBS LETT, V583, P759, DOI 10.1016/j.febslet.2009.01.034; Jiang X, 2010, FEBS J, V277, P2015, DOI 10.1111/j.1742-4658.2010.07632.x; Karube Y, 2005, CANCER SCI, V96, P111, DOI 10.1111/j.1349-7006.2005.00015.x; Kasper M, 1996, HISTOL HISTOPATHOL, V11, P463; Kim Dong Soon, 2006, Proc Am Thorac Soc, V3, P285, DOI 10.1513/pats.200601-005TK; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; Kinder BW, 2008, CHEST, V133, P226, DOI 10.1378/chest.07-1948; Kinder BW, 2009, CHEST, V135, P1557, DOI 10.1378/chest.08-2209; Konishi K, 2009, AM J RESP CRIT CARE, V180, P167, DOI 10.1164/rccm.200810-1596OC; KRUPA A, 2010, J AM SOC NEPHROL; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu G, 2010, J EXP MED, V207, P1589, DOI 10.1084/jem.20100035; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Maatouk DM, 2008, BIOL REPROD, V79, P696, DOI 10.1095/biolreprod.108.067827; MacRae IJ, 2008, P NATL ACAD SCI USA, V105, P512, DOI 10.1073/pnas.0710869105; Martinez FJ, 2005, ANN INTERN MED, V142, P963, DOI 10.7326/0003-4819-142-12_Part_1-200506210-00005; Milosevic J, 2010, AM J RESP CRIT CARE, V181; Muljo SA, 2005, J EXP MED, V202, P261, DOI 10.1084/jem.20050678; Oglesby IK, 2010, J IMMUNOL, V184, P1702, DOI 10.4049/jimmunol.0902669; Olson AL, 2007, AM J RESP CRIT CARE, V176, P277, DOI 10.1164/rccm.200701-044OC; Prassel A, 2009, AM J RESP CRIT CARE, V179, P717, DOI 10.1164/rccm.200808-1201OC; Pratt AJ, 2009, J BIOL CHEM, V284, P17897, DOI 10.1074/jbc.R900012200; Qian Y, 2008, DIABETES, V57, P1439, DOI 10.2337/db08-0061; Selman M, 2006, AM J RESP CRIT CARE, V173, P188, DOI 10.1164/rccm.200504-644OC; Selman M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000482; Suarez Y, 2007, CIRC RES, V100, P1164, DOI 10.1161/01.RES.0000265065.26744.17; Sumikawa H, 2008, AM J RESP CRIT CARE, V177, P433, DOI 10.1164/rccm.200611-1696OC; TSAI LM, 2009, CLIN EXP PHARM PHYSL; Tzilas V, 2009, AM J MED SCI, V338, P481, DOI 10.1097/MAJ.0b013e3181ad5984; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; van Rooij E, 2009, CIRC RES, V104, P138, DOI 10.1161/CIRCRESAHA.108.192492; Willis BC, 2007, AM J PHYSIOL-LUNG C, V293, pL525, DOI 10.1152/ajplung.00163.2007; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Yang IV, 2007, AM J RESP CRIT CARE, V175, P45, DOI 10.1164/rccm.200601-062OC; Yokoyama A, 1998, AM J RESP CRIT CARE, V158, P1680, DOI 10.1164/ajrccm.158.5.9803115	63	101	111	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2011	6	6							e21253	10.1371/journal.pone.0021253	http://dx.doi.org/10.1371/journal.pone.0021253			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782CL	21712985	gold, Green Published, Green Submitted			2022-12-27	WOS:000291985100020
J	Tapparel, C; Cordey, S; Junier, T; Farinelli, L; Van Belle, S; Soccal, PM; Aubert, JD; Zdobnov, E; Kaiser, L				Tapparel, Caroline; Cordey, Samuel; Junier, Thomas; Farinelli, Laurent; Van Belle, Sandra; Soccal, Paola M.; Aubert, John-David; Zdobnov, Evgeny; Kaiser, Laurent			Rhinovirus Genome Variation during Chronic Upper and Lower Respiratory Tract Infections	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; LUNG-TRANSPLANT RECIPIENTS; IMMUNODEFICIENT PATIENT; GENETIC DIVERSITY; VIRAL-INFECTIONS; HIGH-THROUGHPUT; SPECIES C; ASTHMA; CHILDREN; EXACERBATION	Routine screening of lung transplant recipients and hospital patients for respiratory virus infections allowed to identify human rhinovirus (HRV) in the upper and lower respiratory tracts, including immunocompromised hosts chronically infected with the same strain over weeks or months. Phylogenetic analysis of 144 HRV-positive samples showed no apparent correlation between a given viral genotype or species and their ability to invade the lower respiratory tract or lead to protracted infection. By contrast, protracted infections were found almost exclusively in immunocompromised patients, thus suggesting that host factors rather than the virus genotype modulate disease outcome, in particular the immune response. Complete genome sequencing of five chronic cases to study rhinovirus genome adaptation showed that the calculated mutation frequency was in the range observed during acute human infections. Analysis of mutation hot spot regions between specimens collected at different times or in different body sites revealed that non-synonymous changes were mostly concentrated in the viral capsid genes VP1, VP2 and VP3, independent of the HRV type. In an immunosuppressed lung transplant recipient infected with the same HRV strain for more than two years, both classical and ultra-deep sequencing of samples collected at different time points in the upper and lower respiratory tracts showed that these virus populations were phylogenetically indistinguishable over the course of infection, except for the last month. Specific signatures were found in the last two lower respiratory tract populations, including changes in the 5'UTR polypyrimidine tract and the VP2 immunogenic site 2. These results highlight for the first time the ability of a given rhinovirus to evolve in the course of a natural infection in immunocompromised patients and complement data obtained from previous experimental inoculation studies in immunocompetent volunteers.	[Tapparel, Caroline; Cordey, Samuel; Van Belle, Sandra; Kaiser, Laurent] Univ Hosp Geneva, Virol Lab, Div Infect Dis, Geneva, Switzerland; [Tapparel, Caroline; Cordey, Samuel; Van Belle, Sandra; Kaiser, Laurent] Univ Hosp Geneva, Div Lab Med, Geneva, Switzerland; [Junier, Thomas; Zdobnov, Evgeny] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Junier, Thomas; Zdobnov, Evgeny] Swiss Inst Bioinformat, Geneva, Switzerland; [Farinelli, Laurent] Fasteris SA, Plan Les Ouates, Switzerland; [Soccal, Paola M.] Univ Hosp Geneva, Div Pulm Med, Geneva, Switzerland; [Soccal, Paola M.] Univ Hosp Geneva, Clin Thorac Surg, Geneva, Switzerland; [Aubert, John-David] Univ Lausanne Hosp, Div Pulm Med, Lausanne, Switzerland	University of Geneva; University of Geneva; University of Geneva; Swiss Institute of Bioinformatics; University of Geneva; University of Geneva; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Tapparel, C (corresponding author), Univ Hosp Geneva, Virol Lab, Div Infect Dis, Geneva, Switzerland.	caroline.tapparel@hcuge.ch	Zdobnov, Evgeny M/K-1133-2012; Aubert, John-David/H-5561-2019; Zdobnov, Evgeny/AAB-2745-2022; Cordey, Samuel/C-9240-2018	Aubert, John-David/0000-0001-8856-4000; Zdobnov, Evgeny/0000-0002-5178-1498; Cordey, Samuel/0000-0002-2684-5680; Kaiser, Laurent/0000-0002-0857-2252; Tapparel Vu, Caroline/0000-0002-0411-6567	Swiss National Science Foundation [310030-127159, 32003B_127160]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The study was supported by the Swiss National Science Foundation (grant 310030-127159 to CT and grant 32003B_127160 to LK), with contributions from the Clinical Research Center, University Hospital and Faculty of Medicine, Geneva, the Louis-Jeantet Foundation and the Infectigen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EC, 2007, J GEN VIROL, V88, P3043, DOI 10.1099/vir.0.82463-0; Arden KE, 2006, J MED VIROL, V78, P1232, DOI 10.1002/jmv.20689; Bailly JL, 2000, J CLIN MICROBIOL, V38, P552, DOI 10.1128/JCM.38.2.552-557.2000; Cordey S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010588; Drake JW, 1999, ANN NY ACAD SCI, V870, P100, DOI 10.1111/j.1749-6632.1999.tb08870.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Garbino J, 2009, THORAX, V64, P399, DOI 10.1136/thx.2008.105155; Gern JE, 1999, CLIN MICROBIOL REV, V12, P9, DOI 10.1128/CMR.12.1.9; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Harvala H, 2009, J CLIN VIROL, V45, P1, DOI 10.1016/j.jcv.2009.03.009; Hovi T, 2004, J GEN VIROL, V85, P369, DOI 10.1099/vir.0.19518-0; Huang T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006355; JOHNSTON SL, 1995, BRIT MED J, V310, P1225, DOI 10.1136/bmj.310.6989.1225; Johnston SL, 1996, AM J RESP CRIT CARE, V154, P654, DOI 10.1164/ajrccm.154.3.8810601; Junier T, 2010, BIOINFORMATICS, V26, P1669, DOI 10.1093/bioinformatics/btq243; Kaiser L, 2006, AM J RESP CRIT CARE, V174, P1392, DOI 10.1164/rccm.200604-489OC; Kew OM, 1998, J CLIN MICROBIOL, V36, P2893, DOI 10.1128/JCM.36.10.2893-2899.1998; Khetsuriani N, 2008, EMERG INFECT DIS, V14, P1793, DOI 10.3201/eid1411.080386; Kistler A, 2007, J INFECT DIS, V196, P817, DOI 10.1086/520816; Kistler AL, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-40; Lamson D, 2006, J INFECT DIS, V194, P1398, DOI 10.1086/508551; Lau SKP, 2007, J CLIN MICROBIOL, V45, P3655, DOI 10.1128/JCM.01254-07; Lee WM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000966; Lewis-Rogers N, 2009, MOL BIOL EVOL, V26, P969, DOI 10.1093/molbev/msp009; Mallia P, 2011, AM J RESP CRIT CARE, V183, P734, DOI 10.1164/rccm.201006-0833OC; McErlean P, 2007, J CLIN VIROL, V39, P67, DOI 10.1016/j.jcv.2007.03.012; McIntyre CL, 2010, J VIROL, V84, P10297, DOI 10.1128/JVI.00962-10; Message SD, 2008, P NATL ACAD SCI USA, V105, P13562, DOI 10.1073/pnas.0804181105; Milano F, 2010, BLOOD, V115, P2088, DOI 10.1182/blood-2009-09-244152; Miller EK, 2009, J ALLERGY CLIN IMMUN, V123, P98, DOI 10.1016/j.jaci.2008.10.007; Odoom JK, 2008, J VIROL, V82, P9179, DOI 10.1128/JVI.00468-08; Palmenberg AC, 2009, SCIENCE, V324, P55, DOI 10.1126/science.1165557; Papadopoulos NG, 1999, J MED VIROL, V58, P100, DOI 10.1002/(SICI)1096-9071(199905)58:1&lt;100::AID-JMV16&gt;3.0.CO;2-D; Papadopoulos NG, 2000, J INFECT DIS, V181, P1875, DOI 10.1086/315513; Renwick N, 2007, J INFECT DIS, V196, P1754, DOI 10.1086/524312; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Seemungal TAR, 2000, EUR RESPIR J, V16, P677, DOI 10.1034/j.1399-3003.2000.16d19.x; SHERRY B, 1986, J VIROL, V57, P246, DOI 10.1128/JVI.57.1.246-257.1986; Simmonds P, 2010, J GEN VIROL, V91, P2409, DOI 10.1099/vir.0.023994-0; Soccal PM, 2010, CLIN INFECT DIS, V51, P163, DOI 10.1086/653529; Tapparel C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-224; Tapparel C, 2009, EMERG INFECT DIS, V15, P719, DOI 10.3201/eid1505.081286; Tapparel C, 2009, J CLIN MICROBIOL, V47, P1742, DOI 10.1128/JCM.02339-08; Tapparel C, 2009, J CLIN VIROL, V45, P157, DOI 10.1016/j.jcv.2009.03.014; Wisdom A, 2009, J CLIN MICROBIOL, V47, P3958, DOI 10.1128/JCM.00993-09	45	48	51	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2011	6	6							e21163	10.1371/journal.pone.0021163	http://dx.doi.org/10.1371/journal.pone.0021163			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782CL	21713005	gold, Green Submitted, Green Published			2022-12-27	WOS:000291985100015
J	Zhang, DY; Wang, HJ; Tan, YZ				Zhang, Da-yong; Wang, Hai-jie; Tan, Yu-zhen			Wnt/beta-Catenin Signaling Induces the Aging of Mesenchymal Stem Cells through the DNA Damage Response and the p53/p21 Pathway	PLOS ONE			English	Article							CELLULAR SENESCENCE; STROMAL CELLS; BETA; NICHES; REJUVENATION; MAINTENANCE; PROGRESSION; P16(INK4A); ACTIVATION; EXPRESSION	Recent studies have demonstrated the importance of cellular extrinsic factors in the aging of adult stem cells. However, the effects of an aged cell-extrinsic environment on mesenchymal stem cell ( MSC) aging and the factors involved remain unclear. In the current study, we examine the effects of old rat serum (ORS) on the aging of MSCs, and explore the effects and mechanisms of Wnt/beta-catenin signaling on MSC aging induced by ORS treatment. Senescence-associated changes in the cells are examined with SA-beta-galactosidase staining and ROS staining. The proliferation ability is detected by MTT assay. The surviving and apoptotic cells are determined using AO/EB staining. The results suggest that ORS promotes MSC senescence and reduces the proliferation and survival of cells. The immunofluorescence staining shows that the expression of beta-catenin increases in MSCs of old rats. To identify the effects of Wnt/beta-catenin signaling on MSC aging induced with ORS, the expression of beta-catenin, GSK-3 beta, and c-myc are detected. The results show that the Wnt/beta-catenin signaling in the cells is activated after ORS treatment. Then we examine the aging, proliferation, and survival of MSCs after modulating Wnt/beta-catenin signaling. The results indicate that the senescence and dysfunction of MSCs in the medium containing ORS is reversed by the Wnt/beta-catenin signaling inhibitor DKK1 or by beta-catenin siRNA. Moreover, the expression of gamma-H2A.X, a molecular marker of DNA damage response, p16(INK4a), p53, and p21 is increased in senescent MSCs induced with ORS, and is also reversed by DKK1 or by beta-catenin siRNA. In summary, our study indicates the Wnt/beta-catenin signaling may play a critical role in MSC aging induced by the serum of aged animals and suggests that the DNA damage response and p53/p21 pathway may be the main mediators of MSC aging induced by excessive activation of Wnt/beta-catenin signaling.	[Zhang, Da-yong; Wang, Hai-jie; Tan, Yu-zhen] Fudan Univ, Shanghai Med Coll, Dept Anat & Histol & Embryol, Shanghai 200433, Peoples R China	Fudan University	Tan, YZ (corresponding author), Fudan Univ, Shanghai Med Coll, Dept Anat & Histol & Embryol, Shanghai 200433, Peoples R China.	yztan@shmu.edu.cn	张, 大勇/AAH-4764-2020	张, 大勇/0000-0003-1537-1704	Natural Science Foundation of China [30470883, 30971674]; The Research Fund for the Doctoral Program of Higher Education of China [200802460044]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); The Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP))	This work was supported by grants from Natural Science Foundation of China (30470883 and 30971674) and The Research Fund for the Doctoral Program of Higher Education of China (200802460044). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakkenist CJ, 2004, CANCER RES, V64, P3748, DOI 10.1158/0008-5472.CAN-04-0453; Binet R, 2009, CANCER RES, V69, P9183, DOI 10.1158/0008-5472.CAN-09-1016; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Campaner S, 2010, NAT CELL BIOL, V12, P54, DOI 10.1038/ncb2004; Canepa ET, 2007, IUBMB LIFE, V59, P419, DOI 10.1080/15216540701488358; Carlson ME, 2007, AGING CELL, V6, P371, DOI 10.1111/j.1474-9726.2007.00286.x; Castilho RM, 2009, CELL STEM CELL, V5, P279, DOI 10.1016/j.stem.2009.06.017; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Collins CJ, 2003, AGING CELL, V2, P145, DOI 10.1046/j.1474-9728.2003.00048.x; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; Damalas A, 2001, EMBO J, V20, P4912, DOI 10.1093/emboj/20.17.4912; Guo HD, 2011, TISSUE ENG PT A, V17, P45, DOI [10.1089/ten.tea.2010.0124, 10.1089/ten.TEA.2010.0124]; Jaamaa S, 2010, CANCER RES, V70, P8630, DOI 10.1158/0008-5472.CAN-10-0937; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Ju ZY, 2007, ANN NY ACAD SCI, V1100, P333, DOI 10.1196/annals.1395.036; KIECHLE FL, 1993, AM J CLIN PATHOL, V100, P567, DOI 10.1093/ajcp/100.5.567; Kirstetter P, 2006, NAT IMMUNOL, V7, P1048, DOI 10.1038/ni1381; Kosar M, 2011, CELL CYCLE, V10, P457, DOI 10.4161/cc.10.3.14707; Krampera Mauro, 2007, Blood Transfus, V5, P120, DOI 10.2450/2007.0029-07; Kretlow JD, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-60; Kyriakou C, 2008, HAEMATOL-HEMATOL J, V93, P1457, DOI 10.3324/haematol.12553; Liu HJ, 2007, SCIENCE, V317, P803, DOI 10.1126/science.1143578; Luo SJ, 2010, CELL, V143, P299, DOI 10.1016/j.cell.2010.09.013; Mao CD, 2001, J BIOL CHEM, V276, P26180, DOI 10.1074/jbc.M101188200; Marchand A, 2011, AGING CELL, V10, P220, DOI 10.1111/j.1474-9726.2010.00661.x; Martinez C, 2007, BLOOD, V109, P4245, DOI 10.1182/blood-2006-08-039347; Mayack SR, 2010, NATURE, V463, P495, DOI 10.1038/nature08749; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Pan L, 2007, CELL STEM CELL, V1, P458, DOI 10.1016/j.stem.2007.09.010; Purpura KA, 2004, STEM CELLS, V22, P39, DOI 10.1634/stemcells.22-1-39; Rando TA, 2006, NATURE, V441, P1080, DOI 10.1038/nature04958; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Ryu BY, 2006, STEM CELLS, V24, P1505, DOI 10.1634/stemcells.2005-0580; Scheller M, 2006, NAT IMMUNOL, V7, P1037, DOI 10.1038/ni1387; Seoane M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003632; Sethe S, 2006, AGEING RES REV, V5, P91, DOI 10.1016/j.arr.2005.10.001; Snoeck HW, 2005, NAT BIOTECHNOL, V23, P434, DOI 10.1038/nbt0405-434; Wagner W, 2010, AGING-US, V2, P224, DOI 10.18632/aging.100136; Wallenfang MR, 2007, DEV CELL, V13, P603, DOI 10.1016/j.devcel.2007.10.011; Wang CF, 2009, AGING CELL, V8, P311, DOI 10.1111/j.1474-9726.2009.00481.x; Xu M, 2008, MOL CELL BIOL, V28, P1713, DOI 10.1128/MCB.01360-07; Zhang H, 2005, AM J PHYSIOL-HEART C, V289, pH2089, DOI 10.1152/ajpheart.00019.2005	43	180	196	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2011	6	6							e21397	10.1371/journal.pone.0021397	http://dx.doi.org/10.1371/journal.pone.0021397			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782CL	21712954	Green Published, gold, Green Submitted			2022-12-27	WOS:000291985100038
J	Bonaventure, P; Aluisio, L; Shoblock, J; Boggs, JD; Fraser, IC; Lord, B; Lovenberg, TW; Galici, R				Bonaventure, Pascal; Aluisio, Leah; Shoblock, James; Boggs, Jamin D.; Fraser, Ian C.; Lord, Brian; Lovenberg, Timothy W.; Galici, Ruggero			Pharmacological Blockade of Serotonin 5-HT7 Receptor Reverses Working Memory Deficits in Rats by Normalizing Cortical Glutamate Neurotransmission	PLOS ONE			English	Article							METHYL-D-ASPARTATE; ANTIDEPRESSANT-LIKE BEHAVIOR; ANTAGONIST SB-269970; PREFRONTAL CORTEX; LEARNING-TASK; ANIMAL-MODELS; SCHIZOPHRENIA; MODULATION; INHIBITION; KETAMINE	The role of 5-HT7 receptor has been demonstrated in various animal models of mood disorders; however its function in cognition remains largely speculative. This study evaluates the effects of SB-269970, a selective 5-HT7 antagonist, in a translational model of working memory deficit and investigates whether it modulates cortical glutamate and/or dopamine neurotransmission in rats. The effect of SB-269970 was evaluated in the delayed non-matching to position task alone or in combination with MK-801, a non-competitive NMDA receptor antagonist, and, in separate experiments, with scopolamine, a non-selective muscarinic antagonist. SB-269970 (10 mg/kg) significantly reversed the deficits induced by MK-801 (0.1 mg/kg) but augmented the deficit induced by scopolamine (0.06 mg/kg). The ability of SB-269970 to modulate MK-801-induced glutamate and dopamine extracellular levels was separately evaluated using biosensor technology and microdialysis in the prefrontal cortex of freely moving rats. SB-269970 normalized MK-801 -induced glutamate but not dopamine extracellular levels in the prefrontal cortex. Rat plasma and brain concentrations of MK-801 were not affected by co-administration of SB-269970, arguing for a pharmacodynamic rather than a pharmacokinetic mechanism. These results indicate that 5-HT7 receptor antagonists might reverse cognitive deficits associated with NMDA receptor hypofunction by selectively normalizing glutamatergic neurotransmission.	[Bonaventure, Pascal; Aluisio, Leah; Shoblock, James; Boggs, Jamin D.; Fraser, Ian C.; Lord, Brian; Lovenberg, Timothy W.; Galici, Ruggero] Johnson & Johnson Pharmaceut Res & Dev LLC, San Diego, CA 92121 USA	Johnson & Johnson; Johnson & Johnson USA	Bonaventure, P (corresponding author), Johnson & Johnson Pharmaceut Res & Dev LLC, San Diego, CA 92121 USA.	Pbonave1@its.jnj.com	Shoblock, James/J-7926-2015; Bonaventure, Pascal/K-3052-2015	Shoblock, James/0000-0002-7956-9560; Bonaventure, Pascal/0000-0003-2971-6152	Johnson & Johnson Pharmaceutical Research and Development, L.L.C.	Johnson & Johnson Pharmaceutical Research and Development, L.L.C.(Johnson & JohnsonJohnson & Johnson USA)	This work was funded by Johnson & Johnson Pharmaceutical Research and Development, L.L.C.. The funders had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter the authors' adherence to all the PLoS ONE policies.	Adams B, 1998, J NEUROSCI, V18, P5545, DOI 10.1523/JNEUROSCI.18-14-05545.1998; Ballaz SJ, 2007, NEUROSCIENCE, V149, P192, DOI 10.1016/j.neuroscience.2007.07.043; Barbier AJ, 2007, EUR J PHARMACOL, V576, P43, DOI 10.1016/j.ejphar.2007.08.009; Bonaventure P, 2007, J PHARMACOL EXP THER, V321, P690, DOI 10.1124/jpet.107.119404; Chudasama Y, 1997, PSYCHOPHARMACOLOGY, V134, P73, DOI 10.1007/s002130050427; Cifariello A, 2008, BEHAV BRAIN RES, V195, P171, DOI 10.1016/j.bbr.2007.12.012; Doyle KM, 1998, BEHAV PHARMACOL, V9, P671, DOI 10.1097/00008877-199812000-00003; DUNNETT SB, 1985, PSYCHOPHARMACOLOGY, V87, P357, DOI 10.1007/BF00432721; Galici R, 2008, BEHAV PHARMACOL, V19, P153, DOI 10.1097/FBP.0b013e3282f62d8c; Galici R, 2009, NEUROPHARMACOLOGY, V56, P1131, DOI 10.1016/j.neuropharm.2009.03.011; Gasbarri A, 2008, BEHAV BRAIN RES, V195, P164, DOI 10.1016/j.bbr.2007.12.020; Geyer MA, 2003, PROG NEURO-PSYCHOPH, V27, P1071, DOI 10.1016/j.pnpbp.2003.09.003; Hagan JJ, 2000, BRIT J PHARMACOL, V130, P539, DOI 10.1038/sj.bjp.0703357; Harsing LG, 2004, NEUROCHEM RES, V29, P1487; Hedlund PB, 2005, BIOL PSYCHIAT, V58, P831, DOI 10.1016/j.biopsych.2005.05.012; Hedlund PB, 2009, PSYCHOPHARMACOLOGY, V206, P345, DOI 10.1007/s00213-009-1626-0; HORIGUCHI M, 2010, NEUROPSYCHOPHARMACOL, V35; HORISAWA T, BEHAV BRAIN IN PRESS; Kristiansen LV, 2007, CURR OPIN PHARMACOL, V7, P48, DOI 10.1016/j.coph.2006.08.013; KRYSTAL JH, 1994, ARCH GEN PSYCHIAT, V51, P199, DOI 10.1001/archpsyc.1994.03950030035004; Krystal JH, 2003, PSYCHOPHARMACOLOGY, V169, P215, DOI 10.1007/s00213-003-1582-z; Leopoldo M, 2011, PHARMACOL THERAPEUT, V129, P120, DOI 10.1016/j.pharmthera.2010.08.013; Lopez-Gil X, 2007, NEUROPSYCHOPHARMACOL, V32, P2087, DOI 10.1038/sj.npp.1301356; Lorrain DS, 2003, NEUROSCIENCE, V117, P697, DOI 10.1016/S0306-4522(02)00652-8; LOVENBERG TW, 1993, NEURON, V11, P449, DOI 10.1016/0896-6273(93)90149-L; Meneses A, 2004, BEHAV BRAIN RES, V155, P275, DOI 10.1016/j.bbr.2004.04.026; MNIEFILALI O, 2011, NEUROPSYCHOPHARMACOL; Moghaddam B, 1997, J NEUROSCI, V17, P2921; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Perez-Garcia G, 2006, BEHAV BRAIN RES, V169, P83, DOI 10.1016/j.bbr.2005.12.013; Perez-Garcia GS, 2005, BEHAV BRAIN RES, V163, P136, DOI 10.1016/j.bbr.2005.04.014; Pouzet B, 2002, PHARMACOL BIOCHEM BE, V71, P655, DOI 10.1016/S0091-3057(01)00744-4; Roberts C, 2004, NEUROPHARMACOLOGY, V46, P935, DOI 10.1016/j.neuropharm.2004.01.010; Robinson JK, 1997, BRAIN RES, V765, P51, DOI 10.1016/S0006-8993(97)00426-5; Sarkisyan G, 2010, BEHAV BRAIN RES, V209, P99, DOI 10.1016/j.bbr.2010.01.022; Semenova S, 2008, BIOL PSYCHIAT, V63, P98, DOI 10.1016/j.biopsych.2006.12.011; SMITH SM, 2010, 13 INT C IN VIV METH; Stahl SM, 2010, J CLIN PSYCHIAT, V71, P1414, DOI 10.4088/JCP.10bs06601gry; Stefani MR, 2005, BIOL PSYCHIAT, V57, P433, DOI 10.1016/j.biopsych.2004.11.031; Thomas DR, 2004, CNS NEUROL DISORD-DR, V3, P81, DOI 10.2174/1568007043482633; USLANER JM, NEUROPHARMA IN PRESS; Vijayraghavan S, 2007, NAT NEUROSCI, V10, P376, DOI 10.1038/nn1846; Wesolowska A, 2006, NEUROPHARMACOLOGY, V51, P578, DOI 10.1016/j.neuropharm.2006.04.017; Wesolowska A, 2006, EUR J PHARMACOL, V553, P185, DOI 10.1016/j.ejphar.2006.09.064	44	44	44	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e20210	10.1371/journal.pone.0020210	http://dx.doi.org/10.1371/journal.pone.0020210			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	21701689	Green Submitted, gold, Green Published			2022-12-27	WOS:000291983800005
J	Rayes, RF; Kalai, T; Kalman, H; Geeves, MA; Fajer, PG				Rayes, Roni F.; Kalai, Tamas; Kalman Hideg; Geeves, Michael A.; Fajer, Piotr G.			Dynamics of Tropomyosin in Muscle Fibers as Monitored by Saturation Transfer EPR of Bi-Functional Probe	PLOS ONE			English	Article							RESONANCE ENERGY-TRANSFER; RABBIT SKELETAL-MUSCLE; LABELED F-ACTIN; THIN-FILAMENTS; ROTATIONAL-DYNAMICS; ALPHA-TROPOMYOSIN; COILED-COIL; TIME RANGE; MYOSIN; TROPONIN	The dynamics of four regions of tropomyosin was assessed using saturation transfer electron paramagnetic resonance in the muscle fiber. In order to fully immobilize the spin probe on the surface of tropomyosin, a bi-functional spin label was attached to i,i+4 positions via cysteine mutagenesis. The dynamics of bi-functionally labeled tropomyosin mutants decreased by three orders of magnitude when reconstituted into "ghost muscle fibers". The rates of motion varied along the length of tropomyosin with the C-terminus position 268/272 being one order of magnitude slower then N-terminal domain or the center of the molecule. Introduction of troponin decreases the dynamics of all four sites in the muscle fiber, but there was no significant effect upon addition of calcium or myosin subfragment-1.	[Rayes, Roni F.; Fajer, Piotr G.] Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA; [Rayes, Roni F.; Fajer, Piotr G.] Natl High Magnet Field Lab, Tallahassee, FL USA; [Kalai, Tamas; Kalman Hideg] Univ Pecs, Dept Organ & Med Chem, Pecs, Hungary; [Geeves, Michael A.] Univ Kent, Sch Biosci, Canterbury, Kent, England	State University System of Florida; Florida State University; State University System of Florida; Florida State University; University of Pecs; University of Kent	Rayes, RF (corresponding author), Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA.	fajer@magnet.fsu.edu	Geeves, Michael/F-7583-2011	Geeves, Michael/0000-0002-9364-8898	Hungarian Research Fund [OTKA K 81123]; NSF [MCP 0346650]	Hungarian Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); NSF(National Science Foundation (NSF))	This work was funded by the Hungarian Research Fund OTKA K 81123 to TK and KH, and the NSF MCP 0346650 grant to RR and PF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALKHAYAT HA, 1995, J MOL BIOL, V252, P611, DOI 10.1006/jmbi.1995.0524; Allen DL, 1998, PROTEIN SCI, V7, P1262, DOI 10.1002/pro.5560070524; [Anonymous], 1976, SPIN LABELING THEORY, DOI DOI 10.1016/B978-0-12-092350-2.50008-4; BOYLAN D, 1986, BIOPHYS J, V49, P76, DOI 10.1016/S0006-3495(86)83599-8; Bridges MD, 2010, APPL MAGN RESON, V37, P363, DOI 10.1007/s00723-009-0079-2; CHACKO S, 1992, BIOPHYS J, V61, P1256, DOI 10.1016/S0006-3495(92)81934-3; Chandy IK, 1999, BIOCHEMISTRY-US, V38, P9286, DOI 10.1021/bi983073s; Chen YD, 2004, BIOCHEMISTRY-US, V43, P11491, DOI 10.1021/bi049186v; Craig R, 2001, J MOL BIOL, V311, P1027, DOI 10.1006/jmbi.2001.4897; EARLEY JJ, 1991, AM J PHYSIOL, V261, pC1184; FAJER P, 1982, J MAGN RESON, V49, P212, DOI 10.1016/0022-2364(82)90185-8; Greenfield NJ, 2002, BIOPHYS J, V83, P2754, DOI 10.1016/S0006-3495(02)75285-5; Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204; Haselgrove J. C., 1972, COLD SPRING HARB SYM, V37, P341; Huxley H. E., 1972, COLD SPRING HARB SYM, V37, P361; HVIDT S, 1983, MACROMOLECULES, V16, P740, DOI 10.1021/ma00239a007; ISHII Y, 1990, BIOCHEMISTRY-US, V29, P1160, DOI 10.1021/bi00457a010; Kimura-Sakiyama C, 2008, J MOL BIOL, V376, P80, DOI 10.1016/j.jmb.2007.10.078; Lakkaraju SK, 2009, CELL MOL BIOENG, V2, P57, DOI 10.1007/s12195-009-0050-1; Li XE, J STRUCT BIOL, V170, P313; LI XE, BIOPHYS J, V100, P1005; Losel RM, 1999, BIOCONJUGATE CHEM, V10, P578, DOI 10.1021/bc980138v; LOWEY S, 1962, J MOL BIOL, V4, P293, DOI 10.1016/S0022-2836(62)80007-2; MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55; Mchaourab HS, 1996, BIOCHEMISTRY-US, V35, P7692, DOI 10.1021/bi960482k; MCKILLOP DFA, 1993, BIOPHYS J, V65, P693, DOI 10.1016/S0006-3495(93)81110-X; MIHASHI K, 1983, J BIOCHEM-TOKYO, V93, P1705, DOI 10.1093/oxfordjournals.jbchem.a134312; Miki M, 1998, J BIOCHEM-TOKYO, V123, P1104; Miki M, 2004, J BIOCHEM, V136, P39, DOI 10.1093/jb/mvh090; MIKI M, 1990, EUR J BIOCHEM, V187, P155, DOI 10.1111/j.1432-1033.1990.tb15289.x; OSTAP EM, 1991, BIOPHYS J, V59, P1235, DOI 10.1016/S0006-3495(91)82338-4; PARRY DAD, 1973, J MOL BIOL, V75, P33, DOI 10.1016/0022-2836(73)90527-5; Phillips GN, 1996, BIOPOLYMERS, V38, P89, DOI 10.1002/(SICI)1097-0282(199601)38:1<89::AID-BIP7>3.3.CO;2-X; PHILLIPS GN, 1986, J MOL BIOL, V192, P111, DOI 10.1016/0022-2836(86)90468-7; PHILLIPS GN, 1980, BIOPHYS J, V32, P485, DOI 10.1016/S0006-3495(80)84985-X; POTTER JD, 1982, METHOD ENZYMOL, V85, P241; Prochniewicz E, 1996, J MOL BIOL, V255, P446, DOI 10.1006/jmbi.1996.0037; Schoffstall B, 2006, J PHYSIOL-LONDON, V577, P935, DOI 10.1113/jphysiol.2006.120105; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; SQUIER TC, 1986, BIOPHYS J, V49, P921, DOI 10.1016/S0006-3495(86)83720-1; STEWART M, 1983, J MOL BIOL, V166, P219, DOI 10.1016/S0022-2836(83)80008-4; SWENSON CA, 1989, BIOPOLYMERS, V28, P955, DOI 10.1002/bip.360280504; SZCZESNA D, 1995, BIOCHEMISTRY-US, V34, P3614, DOI 10.1021/bi00011a016; TAO T, 1983, BIOCHEMISTRY-US, V22, P3059, DOI 10.1021/bi00282a006; THOMAS DD, 1979, J MOL BIOL, V132, P257, DOI 10.1016/0022-2836(79)90259-6; THOMAS DD, 1976, J CHEM PHYS, V65, P18; Vibert P, 1997, J MOL BIOL, V266, P8, DOI 10.1006/jmbi.1996.0800; WAHL P, 1978, EUR J BIOCHEM, V88, P421, DOI 10.1111/j.1432-1033.1978.tb12464.x; WEEDS AG, 1975, NATURE, V257, P54, DOI 10.1038/257054a0; WHITE SP, 1987, NATURE, V325, P826, DOI 10.1038/325826a0; Xu C, 1999, BIOPHYS J, V77, P985, DOI 10.1016/S0006-3495(99)76949-3	51	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e21277	10.1371/journal.pone.0021277	http://dx.doi.org/10.1371/journal.pone.0021277			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	21701580	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000291983800038
J	Liu, JJ; Kohler, JE; Blass, AL; Moncaster, JA; Mocofanescu, A; Marcus, MA; Blakely, EA; Bjornstad, KA; Amarasiriwardena, C; Casey, N; Goldstein, LE; Soybel, DI				Liu, JingJing; Kohler, Jonathan E.; Blass, Amy L.; Moncaster, Juliet A.; Mocofanescu, Anca; Marcus, Matthew A.; Blakely, Eleanor A.; Bjornstad, Kathleen A.; Amarasiriwardena, Chitra; Casey, Noel; Goldstein, Lee E.; Soybel, David I.			Demand for Zn2+ in Acid-Secreting Gastric Mucosa and Its Requirement for Intracellular Ca2+	PLOS ONE			English	Article							ZINC TRANSPORTER EXPRESSION; HELICOBACTER-PYLORI; PARIETAL-CELLS; CALCIUM; DEFICIENCY; STIMULATION; PROGRESSION; INDICATORS; MEMBRANE; TOXICITY	Background and Aims: Recent work has suggested that Zn2+ plays a critical role in regulating acidity within the secretory compartments of isolated gastric glands. Here, we investigate the content, distribution and demand for Zn2+ in gastric mucosa under baseline conditions and its regulation during secretory stimulation. Methods and Findings: Content and distribution of zinc were evaluated in sections of whole gastric mucosa using X-ray fluorescence microscopy. Significant stores of Zn2+ were identified in neural elements of the muscularis, glandular areas enriched in parietal cells, and apical regions of the surface epithelium. In in vivo studies, extraction of the low abundance isotope, Zn-70(2+), from the circulation was demonstrated in samples of mucosal tissue 24 hours or 72 hours after infusion (250 mg/kg). In in vitro studies, uptake of Zn-70(2+) from media was demonstrated in isolated rabbit gastric glands following exposure to concentrations as low as 10 nM. In additional studies, demand of individual gastric parietal cells for Zn2+ was monitored using the fluorescent zinc reporter, fluozin-3, by measuring increases in free intracellular concentrations of Zn2+ {[Zn2+](i)} during exposure to standard extracellular concentrations of Zn2+ (10 mu M) for standard intervals of time. Under resting conditions, demand for extracellular Zn2+ increased with exposure to secretagogues (forskolin, carbachol/histamine) and under conditions associated with increased intracellular Ca2+ {[Ca2+](i)}. Uptake of Zn2+ was abolished following removal of extracellular Ca2+ or depletion of intracellular Ca2+ stores, suggesting that demand for extracellular Zn2+ increases and depends on influx of extracellular Ca2+. Conclusions: This study is the first to characterize the content and distribution of Zn2+ in an organ of the gastrointestinal tract. Our findings offer the novel interpretation, that Ca2+ integrates basolateral demand for Zn2+ with stimulation of secretion of HCl into the lumen of the gastric gland. Similar connections may be detectable in other secretory cells and tissues.	[Liu, JingJing; Kohler, Jonathan E.; Blass, Amy L.; Soybel, David I.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Surg, Boston, MA 02115 USA; [Moncaster, Juliet A.; Mocofanescu, Anca; Casey, Noel; Goldstein, Lee E.] Boston Univ, Sch Med, Mol Aging & Dev Lab, Boston, MA 02118 USA; [Marcus, Matthew A.] Univ Calif Berkeley, Lawrence Berkeley Lab, Adv Light Source, Berkeley, CA 94720 USA; [Marcus, Matthew A.; Blakely, Eleanor A.; Bjornstad, Kathleen A.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; [Amarasiriwardena, Chitra] Harvard Univ, Brigham & Womens Hosp, Sch Med, Channing Labs, Boston, MA 02115 USA; [Casey, Noel; Goldstein, Lee E.] Boston Univ, Ctr Biomet & Metall, Boston, MA 02215 USA; [Amarasiriwardena, Chitra] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Boston University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Boston University; Harvard University; Harvard T.H. Chan School of Public Health	Liu, JJ (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Surg, Boston, MA 02115 USA.	dsoybel@partners.or	marcus, matthew/P-8023-2019	Moncaster, Juliet/0000-0002-7849-4325; Goldstein, Lee/0000-0001-8419-9800	American College of Surgeons [R01 T32 DK007754, R01 GM 75986, RO1 DK069929]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075986] Funding Source: NIH RePORTER	American College of Surgeons; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The study was supported by the following grants: American College of Surgeons Resident Research Fellowship (JEK), R01 T32 DK007754 (JEK, DIS), R01 GM 75986 (LEG), and RO1 DK069929 (DIS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMARASIRIWARDENA CJ, 1992, J ANAL ATOM SPECTROM, V7, P915, DOI 10.1039/ja9920700915; ARSLAN P, 1985, J BIOL CHEM, V260, P2719; Azriel-Tamir H, 2004, J BIOL CHEM, V279, P51804, DOI 10.1074/jbc.M406581200; BERGLINDH T, 1976, ACTA PHYSIOL SCAND, V96, P150, DOI 10.1111/j.1748-1716.1976.tb10184.x; BERGLINDH T, 1976, ACTA PHYSIOL SCAND, V97, P401, DOI 10.1111/j.1748-1716.1976.tb10281.x; Bertsch PM, 2001, CHEM REV, V101, P1809, DOI 10.1021/cr990070s; Caroppo R, 2001, EMBO J, V20, P6316, DOI 10.1093/emboj/20.22.6316; Carter JW, 1997, NUTR CANCER, V27, P217, DOI 10.1080/01635589709514529; CHEW CS, 1983, AM J PHYSIOL, V245, pC371, DOI 10.1152/ajpcell.1983.245.5.C371; Cima RR, 2006, AM J PHYSIOL-GASTR L, V290, pG250, DOI 10.1152/ajpgi.00501.2004; deFoneska A, 2010, CURR OPIN GASTROEN, V26, P604, DOI 10.1097/MOG.0b013e32833f1222; Devinney MJ, 2005, CELL CALCIUM, V37, P225, DOI 10.1016/j.ceca.2004.10.003; Dovhanj J, 2010, CLIN LAB, V56, P137; Finney L, 2007, P NATL ACAD SCI USA, V104, P2247, DOI 10.1073/pnas.0607238104; Fong LYY, 2003, CANCER RES, V63, P4244; Fong LYY, 2003, CANCER RES, V63, P186; FROMMER DJ, 1975, MED J AUSTRALIA, V2, P793, DOI 10.5694/j.1326-5377.1975.tb106311.x; Gee KR, 2002, J AM CHEM SOC, V124, P776, DOI 10.1021/ja011774y; Geibel JP, 2001, J BIOL CHEM, V276, P39549, DOI 10.1074/jbc.M107315200; Gerbino A, 2004, GASTROENTEROLOGY, V126, P182, DOI 10.1053/j.gastro.2003.10.068; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guerinot ML, 2000, BBA-BIOMEMBRANES, V1465, P190, DOI 10.1016/S0005-2736(00)00138-3; HAUGLAND RP, 2003, MOL PROBES PRODUCT I; HELANDER HF, 1974, GASTROENTEROLOGY, V67, P447; HERSEY SJ, 1985, AM J PHYSIOL, V248, pG561, DOI 10.1152/ajpgi.1985.248.5.G561; Hidalgo M, 2001, JNCI-J NATL CANCER I, V93, P178, DOI 10.1093/jnci/93.3.178; HOFER AM, 1993, P NATL ACAD SCI USA, V90, P2598, DOI 10.1073/pnas.90.7.2598; Hoque KM, 2006, GASTROENTEROLOGY, V130, P2201, DOI 10.1053/j.gastro.2006.02.062; ITO S, 1967, ALIMENTARY CANAL, P705; JANGHORBANI M, 1981, AM J CLIN NUTR, V34, P581, DOI 10.1093/ajcn/34.4.581; Jia YS, 2002, J PHYSIOL-LONDON, V543, P35, DOI 10.1113/jphysiol.2002.020172; JIMENEZ E, 1992, DIGESTION, V51, P18, DOI 10.1159/000200871; Joseph RM, 1999, ALIMENT PHARM THER, V13, P203; Jou MY, 2010, J PEDIATR GASTR NUTR, V50, P587, DOI 10.1097/MPG.0b013e3181d98e85; Jou MY, 2009, J NUTR, V139, P835, DOI 10.3945/jn.108.100974; KIRCHHOFF P, 2010, AM J GASTROENTE 0824; KOH JY, 1994, NEUROSCIENCE, V60, P1049, DOI 10.1016/0306-4522(94)90282-8; Kohler JE, 2010, AM J PHYSIOL-GASTR L, V299, pG170, DOI 10.1152/ajpgi.00355.2009; Kohler JE, 2009, J SURG RES, V153, P121, DOI 10.1016/j.jss.2008.05.021; Lichten LA, 2009, ANNU REV NUTR, V29, P153, DOI 10.1146/annurev-nutr-033009-083312; Lonnerdal B, 2009, ADV EXP MED BIOL, V639, P29, DOI 10.1007/978-1-4020-8749-3_3; MAGNESON GR, 1987, J BIOL CHEM, V262, P11140; Mahmood A, 2007, GUT, V56, P168, DOI 10.1136/gut.2006.099929; Marcus MA, 2004, J SYNCHROTRON RADIAT, V11, P239, DOI 10.1107/S0909049504005837; Maret W, 2001, P NATL ACAD SCI USA, V98, P12325, DOI 10.1073/pnas.231481398; Martin JL, 2006, CELL CALCIUM, V40, P393, DOI 10.1016/j.ceca.2006.04.008; MATHEW J, 2010, J SIGNAL RES, V144, P426; McCormick N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011078; MUALLEM S, 1985, AM J PHYSIOL, V248, pG216, DOI 10.1152/ajpgi.1985.248.2.G216; Naik HB, 2009, AM J PHYSIOL-CELL PH, V297, pC979, DOI 10.1152/ajpcell.00577.2008; NEGULESCU PA, 1993, AM J PHYSIOL, V264, pC843, DOI 10.1152/ajpcell.1993.264.4.C843; Ohana E, 2009, J BIOL CHEM, V284, P17677, DOI 10.1074/jbc.M109.007203; Patel A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010386; Perez-Zoghbi JF, 2008, AM J PHYSIOL-GASTR L, V295, pG671, DOI 10.1152/ajpgi.90224.2008; Scrimgeour AG, 2009, CURR OPIN CLIN NUTR, V12, P653, DOI 10.1097/MCO.0b013e3283308dd6; Sempertegui F, 2007, HELICOBACTER, V12, P43, DOI 10.1111/j.1523-5378.2007.00476.x; Sturniolo GC, 2002, J LAB CLIN MED, V139, P311, DOI 10.1067/mlc.2002.123624; Wagner D, 2005, J IMMUNOL, V174, P1491, DOI 10.4049/jimmunol.174.3.1491; Walsh BM, 2007, AM J PHYSIOL-CELL PH, V293, pC1687, DOI 10.1152/ajpcell.00189.2006; Yang LC, 2005, P NATL ACAD SCI USA, V102, P11179, DOI 10.1073/pnas.0406547102; YOKOYAMA M, 1986, NEUROSCI LETT, V71, P351, DOI 10.1016/0304-3940(86)90646-4; Yu YY, 2007, J HISTOCHEM CYTOCHEM, V55, P223, DOI 10.1369/jhc.6A7032.2006	62	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e19638	10.1371/journal.pone.0019638	http://dx.doi.org/10.1371/journal.pone.0019638			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698273	gold, Green Published, Green Submitted			2022-12-27	WOS:000291730000001
J	Vinolo, MAR; Ferguson, GJ; Kulkarni, S; Damoulakis, G; Anderson, K; Bohlooly-Y, M; Stephens, L; Hawkins, PT; Curi, R				Vinolo, Marco A. R.; Ferguson, G. John; Kulkarni, Suhasini; Damoulakis, George; Anderson, Karen; Bohlooly-Y, Mohammad; Stephens, Len; Hawkins, Phillip T.; Curi, Rui			SCFAs Induce Mouse Neutrophil Chemotaxis through the GPR43 Receptor	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; FUNCTIONAL-CHARACTERIZATION; INFLAMMATORY RESPONSES; MIGRATION; IDENTIFICATION; PI(3)K-GAMMA; GAMMA; RAC2	Short chain fatty acids (SCFAs) have recently attracted attention as potential mediators of the effects of gut microbiota on intestinal inflammation. Some of these effects have been suggested to occur through the direct actions of SCFAs on the GPR43 receptor in neutrophils, though the precise role of this receptor in neutrophil activation is still unclear. We show that mouse bone marrow derived neutrophils (BMNs) can chemotax effectively through polycarbonate filters towards a source of acetate, propionate or butyrate. Moreover, we show that BMNs move with good speed and directionality towards a source of propionate in an EZ-Taxiscan chamber coated with fibrinogen. These effects of SCFAs were mimicked by low concentrations of the synthetic GPR43 agonist phenylacetamide-1 and were abolished in GPR43(-/-) BMNs. SCFAs and phenylacetamide-1 also elicited GPR43-dependent activation of PKB, p38 and ERK and these responses were sensitive to pertussis toxin, indicating a role for Gi proteins. Phenylacetamide-1 also elicited rapid and transient activation of Rac1/2 GTPases and phosphorylation of ribosomal protein S6. Genetic and pharmacological intervention identified important roles for PI3K gamma, Rac2, p38 and ERK, but not mTOR, in GPR43-dependent chemotaxis. These results identify GPR43 as a bona fide chemotactic receptor for neutrophils in vitro and start to define important elements in its signal transduction pathways.	[Vinolo, Marco A. R.; Curi, Rui] Univ Sao Paulo, Dept Physiol & Biophys, Inst Biomed Sci, Sao Paulo, Brazil; [Ferguson, G. John; Kulkarni, Suhasini; Damoulakis, George; Anderson, Karen; Stephens, Len; Hawkins, Phillip T.] Babraham Inst, Cambridge, England; [Bohlooly-Y, Mohammad] AstraZeneca Transgen & Comparat Genom R&D Molndal, Molndal, Sweden	Universidade de Sao Paulo; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; AstraZeneca	Vinolo, MAR (corresponding author), Univ Sao Paulo, Dept Physiol & Biophys, Inst Biomed Sci, Sao Paulo, Brazil.	len.stephens@bbsrc.ac.uk; philllip.hawkins@bbsrc.ac.uk; ruicuri@icb.usp.br	Curi, Rui/C-9351-2012; Vinolo, Marco Aurélio R/K-3753-2012	stephens, len/0000-0002-2771-3487; Hawkins, Phillip/0000-0002-6979-0464; Anderson, Karen/0000-0002-7394-6660; Vinolo, Marco Aurelio/0000-0003-1335-760X	Fundacao de Apoio a Pesquisa do Estado de Sao Paulo (FAPESP); Biotechnology and Biological Sciences Research Council (BBSRC) UK; Biotechnology and Biological Sciences Research Council [BBS/E/B/0000C218] Funding Source: researchfish; BBSRC [BBS/E/B/0000C218] Funding Source: UKRI	Fundacao de Apoio a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Biotechnology and Biological Sciences Research Council (BBSRC) UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Fundacao de Apoio a Pesquisa do Estado de Sao Paulo (FAPESP) and the Biotechnology and Biological Sciences Research Council (BBSRC) UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjursell M, 2011, AM J PHYSIOL-ENDOC M, V300, pE211, DOI 10.1152/ajpendo.00229.2010; Bocker U, 2003, CLIN EXP IMMUNOL, V131, P53, DOI 10.1046/j.1365-2249.2003.02056.x; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Cavaglieri CR, 2003, LIFE SCI, V73, P1683, DOI 10.1016/S0024-3205(03)00490-9; CHRISTIANSEN NO, 1990, J LEUKOCYTE BIOL, V47, P60, DOI 10.1002/jlb.47.1.60; Condliffe AM, 1998, CLIN SCI, V94, P461, DOI 10.1042/cs0940461; CUMMINGS JH, 1987, GUT, V28, P1221, DOI 10.1136/gut.28.10.1221; Fergus GJ, 2007, NAT CELL BIOL, V9, P86, DOI 10.1038/ncb1517; Filippi MD, 2004, NAT IMMUNOL, V5, P744, DOI 10.1038/ni1081; Halili MA, 2010, J LEUKOCYTE BIOL, V87, P1103, DOI 10.1189/jlb.0509363; Heit B, 2002, J CELL BIOL, V159, P91, DOI 10.1083/jcb.200202114; Hii CS, 2004, J BIOL CHEM, V279, P49825, DOI 10.1074/jbc.M406892200; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; Kanegasaki S, 2003, J IMMUNOL METHODS, V282, P1, DOI 10.1016/j.jim.2003.07.008; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; Lee T, 2008, MOL PHARMACOL, V74, P1599, DOI 10.1124/mol.108.049536; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Mumy KL, 2009, CURR OPIN PHARMACOL, V9, P697, DOI 10.1016/j.coph.2009.10.004; Niederman R, 1997, J DENT RES, V76, P575, DOI 10.1177/00220345970760010801; Nilsson NE, 2003, BIOCHEM BIOPH RES CO, V303, P1047, DOI 10.1016/S0006-291X(03)00488-1; Ogawa H, 2004, AM J PHYSIOL-GASTR L, V287, pG1062, DOI 10.1152/ajpgi.00162.2004; Roberts AW, 1999, IMMUNITY, V10, P183, DOI 10.1016/S1074-7613(00)80019-9; Sina C, 2009, J IMMUNOL, V183, P7514, DOI 10.4049/jimmunol.0900063; STEPHENS L, 1993, EMBO J, V12, P2265, DOI 10.1002/j.1460-2075.1993.tb05880.x; Suire S, 2006, NAT CELL BIOL, V8, P1303, DOI 10.1038/ncb1494; Topping DL, 2001, PHYSIOL REV, V81, P1031, DOI 10.1152/physrev.2001.81.3.1031; Vinolo MAR, 2009, CLIN SCI, V117, P331, DOI 10.1042/CS20080642; Welch HCE, 2005, CURR BIOL, V15, P1867, DOI 10.1016/j.cub.2005.09.050; Zicha D, 1997, Methods Mol Biol, V75, P449; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	30	182	193	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e21205	10.1371/journal.pone.0021205	http://dx.doi.org/10.1371/journal.pone.0021205			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698257	gold, Green Published, Green Submitted			2022-12-27	WOS:000291730000061
J	Wu, ZY; Zhao, JM; Gao, RF; Hu, GJ; Gai, JY; Xu, GH; Xing, H				Wu, Zhaoyun; Zhao, Jinming; Gao, Ruifang; Hu, Guanjun; Gai, Junyi; Xu, Guohua; Xing, Han			Molecular Cloning, Characterization and Expression Analysis of Two Members of the Pht1 Family of Phosphate Transporters in Glycine max	PLOS ONE			English	Article							MEDICAGO-TRUNCATULA; INORGANIC-PHOSPHATE; TRANSCRIPTIONAL REGULATION; SPATIAL EXPRESSION; KINETIC-PROPERTIES; PHOSPHORUS UPTAKE; PLANT; GENE; MUTANT; IDENTIFICATION	Background: Phosphorus is one of the macronutrients essential for plant growth and development. The acquisition and translocation of phosphate are pivotal processes of plant growth. In a large number of plants, phosphate uptake by roots and translocation within the plant are presumed to occur via a phosphate/proton cotransport mechanism. Principal Findings: We cloned two cDNAs from soybean (Glycine max), GmPT1 and GmPT2, which show homology to the phosphate/proton cotransporter PHO84 from the budding yeast Saccharomyces cerevisiae. The amino acid sequence of the products predicted from GmPT1 and GmPT2 share 61% and 63% identity, respectively, with the PHO84 in amino acid sequence. The deduced structure of the encoded proteins revealed 12 membrane-spanning domains with a central hydrophilic region. The molecular mass values are similar to 58.7 kDa for GmPT1 and similar to 58.6 kDa for GmPT2. Transiently expressed GFP-protein fusions provide direct evidence that the two Pi transporters are located in the plasma membrane. Uptake of radioactive orthophosphate by the yeast mutant MB192 showed that GmPT1 and GmPT2 are dependent on pH and uptake is reduced by the addition of uncouplers of oxidative phosphorylation. The K-m for phosphate uptake by GmPT1 and GmPT2 is 6.65 mM and 6.63 mM, respectively. A quantitative real time RT-PCR assay indicated that these two genes are expressed in the roots and shoots of seedlings whether they are phosphate-deficient or not. Deficiency of phosphorus caused a slight change of the expression levels of GmPT1 and GmPT2. Conclusions: The results of our experiments show that the two phosphate transporters have low affinity and the corresponding genes are constitutively expressed. Thereby, the two phosphate transporters can perform translocation of phosphate within the plant.	[Wu, Zhaoyun; Zhao, Jinming; Gao, Ruifang; Hu, Guanjun; Gai, Junyi; Xing, Han] Nanjing Agr Univ, Natl Key Lab Crop Genet & Germplasm Enhancement, Natl Ctr Soybean Improvement, Nanjing, Jiangsu, Peoples R China; [Xu, Guohua] Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, Coll Resources & Environm Sci, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University; Nanjing Agricultural University	Wu, ZY (corresponding author), Nanjing Agr Univ, Natl Key Lab Crop Genet & Germplasm Enhancement, Natl Ctr Soybean Improvement, Nanjing, Jiangsu, Peoples R China.	hanx@njau.edu.cn	Xu, Guohua/J-1840-2012	Xu, Guohua/0000-0002-3283-2392	China transgenic Programme [2008ZX08004-002]; China 973 Programme [2009CB118400]; National public service sectors (agriculture) [nycytx-004]	China transgenic Programme; China 973 Programme(National Basic Research Program of China); National public service sectors (agriculture)	This work was supported by the China transgenic Programme (2008ZX08004-002), the China 973 Programme (2009CB118400), and National public service sectors (agriculture) special research (nycytx-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai PH, 2009, PLANT J, V57, P798, DOI 10.1111/j.1365-313X.2008.03726.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Auesukaree C, 2003, BIOCHEM BIOPH RES CO, V306, P843, DOI 10.1016/S0006-291X(03)01068-4; Bucher M, 2001, J PLANT NUTR SOIL SC, V164, P209, DOI 10.1002/1522-2624(200104)164:2<209::AID-JPLN209>3.0.CO;2-F; BUNYA M, 1991, MOL CELL BIOL, V11, P3229, DOI 10.1128/MCB.11.6.3229; BunYa M, 1996, CURR GENET, V29, P344, DOI 10.1007/s002940050055; Chiou TJ, 2001, PLANT J, V25, P281, DOI 10.1046/j.1365-313x.2001.00963.x; Daram P, 1999, PLANT CELL, V11, P2153, DOI 10.1105/tpc.11.11.2153; Daram P, 1998, PLANTA, V206, P225, DOI 10.1007/s004250050394; Deleage G, 2001, COMPUT BIOL MED, V31, P259, DOI 10.1016/S0010-4825(01)00008-7; DELHAIZE E, 1995, PLANT PHYSIOL, V107, P207, DOI 10.1104/pp.107.1.207; Dong B, 1998, PLANTA, V205, P251, DOI 10.1007/s004250050318; EPSTEIN E, 1952, PLANT PHYSIOL, V27, P457, DOI 10.1104/pp.27.3.457; EPSTEIN E, 1963, P NATL ACAD SCI USA, V49, P684, DOI 10.1073/pnas.49.5.684; FURIHATA T, 1992, PLANT CELL PHYSIOL, V33, P1151; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Gordon-Weeks R, 2003, J CELL SCI, V116, P3135, DOI 10.1242/jcs.00615; Graham PH, 2003, PLANT PHYSIOL, V131, P872, DOI 10.1104/pp.017004; Hamburger D, 2002, PLANT CELL, V14, P889, DOI 10.1105/tpc.000745; Harrison MJ, 2002, PLANT CELL, V14, P2413, DOI 10.1105/tpc.004861; Jeschke WD, 1997, J EXP BOT, V48, P75, DOI 10.1093/jxb/48.1.75; Karandashov V, 2005, TRENDS PLANT SCI, V10, P22, DOI 10.1016/j.tplants.2004.12.003; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Leggewie G, 1997, PLANT CELL, V9, P381, DOI 10.1105/tpc.9.3.381; Libault M, 2008, PLANT GENOME-US, V1, P44, DOI 10.3835/plantgenome2008.02.0091; Liu CM, 1998, PLANT PHYSIOL, V116, P91, DOI 10.1104/pp.116.1.91; Liu F, 2010, PLANT J, V62, P508, DOI 10.1111/j.1365-313X.2010.04170.x; Liu H, 1998, MOL PLANT MICROBE IN, V11, P14, DOI 10.1094/MPMI.1998.11.1.14; Liu JQ, 2001, PLANT SOIL, V237, P257, DOI 10.1023/A:1013396825577; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marschner H., 1995, MARSCHNERS MINERAL N, DOI DOI 10.1016/B978-0-12-473542-2.X5000-7; Muchhal US, 1999, P NATL ACAD SCI USA, V96, P5868, DOI 10.1073/pnas.96.10.5868; Muchhal US, 1996, P NATL ACAD SCI USA, V93, P10519, DOI 10.1073/pnas.93.19.10519; Mudge SR, 2002, PLANT J, V31, P341, DOI 10.1046/j.1365-313X.2002.01356.x; Nagy R, 2006, PLANT BIOLOGY, V8, P186, DOI 10.1055/s-2005-873052; Okumura S, 1998, DNA Res, V5, P261, DOI 10.1093/dnares/5.5.261; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Paszkowski U, 2002, P NATL ACAD SCI USA, V99, P13324, DOI 10.1073/pnas.202474599; POIRIER Y, 1991, PLANT PHYSIOL, V97, P1087, DOI 10.1104/pp.97.3.1087; Rae AL, 2003, PLANT MOL BIOL, V53, P27, DOI 10.1023/B:PLAN.0000009259.75314.15; Raghothama KG, 1999, ANNU REV PLANT PHYS, V50, P665, DOI 10.1146/annurev.arplant.50.1.665; Rashid M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-337; Rausch C, 2002, PLANTA, V216, P23, DOI 10.1007/s00425-002-0921-3; Rausch C, 2001, NATURE, V414, P462, DOI 10.1038/35106601; RIESMEIER JW, 1992, EMBO J, V11, P4705, DOI 10.1002/j.1460-2075.1992.tb05575.x; SAKANO K, 1990, PLANT PHYSIOL, V93, P479, DOI 10.1104/pp.93.2.479; Schachtman DP, 1998, PLANT PHYSIOL, V116, P447, DOI 10.1104/pp.116.2.447; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shoemaker RC, 2006, CURR OPIN PLANT BIOL, V9, P104, DOI 10.1016/j.pbi.2006.01.007; Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885; Smith FW, 2003, PLANT SOIL, V248, P71, DOI 10.1023/A:1022376332180; Smith FW, 1997, PLANT J, V11, P83, DOI 10.1046/j.1365-313X.1997.11010083.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; ULLRICHEBERIUS CI, 1984, PLANTA, V161, P46, DOI 10.1007/BF00951459; ULLRICHEBERIUS CI, 1981, PLANT PHYSIOL, V67, P797, DOI 10.1104/pp.67.4.797; Versaw WK, 2002, PLANT CELL, V14, P1751, DOI 10.1105/tpc.002220; Wykoff DD, 2001, GENETICS, V159, P1491; Yuan H, 2008, J INTEGR PLANT BIOL, V50, P849, DOI 10.1111/j.1744-7909.2008.00709.x; Zhao LM, 2003, NEW PHYTOL, V157, P291, DOI 10.1046/j.1469-8137.2003.00677.x	61	28	35	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e19752	10.1371/journal.pone.0019752	http://dx.doi.org/10.1371/journal.pone.0019752			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698287	Green Submitted, Green Published, gold			2022-12-27	WOS:000291730000002
J	Lovelock, CE; Ruess, RW; Feller, IC				Lovelock, Catherine E.; Ruess, Roger W.; Feller, Ilka C.			CO2 Efflux from Cleared Mangrove Peat	PLOS ONE			English	Article							LAND-USE; SEQUESTRATION; RESPIRATION; SEDIMENTS; COLLAPSE; FORESTS; FUTURE	Background: CO2 emissions from cleared mangrove areas may be substantial, increasing the costs of continued losses of these ecosystems, particularly in mangroves that have highly organic soils. Methodology/Principal Findings: We measured CO2 efflux from mangrove soils that had been cleared for up to 20 years on the islands of Twin Cays, Belize. We also disturbed these cleared peat soils to assess what disturbance of soils after clearing may have on CO2 efflux. CO2 efflux from soils declines from time of clearing from similar to 10 600 tonnes km 22 year 21 in the first year to 3000 tonnes km(2) year(-1) after 20 years since clearing. Disturbing peat leads to short term increases in CO2 efflux (27 umol m(-2)s(-1)), but this had returned to baseline levels within 2 days. Conclusions/Significance: Deforesting mangroves that grow on peat soils results in CO2 emissions that are comparable to rates estimated for peat collapse in other tropical ecosystems. Preventing deforestation presents an opportunity for countries to benefit from carbon payments for preservation of threatened carbon stocks.	[Lovelock, Catherine E.] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia; [Ruess, Roger W.] Univ Alaska Fairbanks, Inst Arctic Biol, Fairbanks, AK USA; [Feller, Ilka C.] Smithsonian Environm Res Ctr, Edgewater, MD 21037 USA	University of Queensland; University of Alaska System; University of Alaska Fairbanks; Smithsonian Institution; Smithsonian Environmental Research Center	Lovelock, CE (corresponding author), Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia.	c.lovelock@uq.edu.au	Lovelock, Catherine E/G-7370-2012; Lovelock, Catherine E./AAF-7294-2020	Lovelock, Catherine E/0000-0002-2219-6855; Lovelock, Catherine E./0000-0002-2219-6855; Feller, Ilka/0000-0002-6391-1608	Smithsonian Marine Science Network; National Science Foundation [DEB-9981535]	Smithsonian Marine Science Network(Smithsonian InstitutionSmithsonian Tennenbaum Marine Observatories Network); National Science Foundation(National Science Foundation (NSF))	This work was supported by the Smithsonian Marine Science Network and a National Science Foundation Biocomplexity award (DEB-9981535). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aburto-Oropeza O, 2008, P NATL ACAD SCI USA, V105, P10456, DOI 10.1073/pnas.0804601105; Alongi D.M., 2009, ENERGETICS MANGROVE, DOI [10.1007/978-1-4020-4271-3, DOI 10.1007/978-1-4020-4271-3]; Alongi DM, 2011, ENVIRON SCI POLICY, V14, P462, DOI 10.1016/j.envsci.2011.02.004; Alongi DM, 2002, ENVIRON CONSERV, V29, P331, DOI 10.1017/S0376892902000231; Anglesen A, 2009, REALISING REDD NATL; Barbier EB, 2008, SCIENCE, V319, P321, DOI 10.1126/science.1150349; Bouillon S, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003052; BOYD CE, 1992, PROCEEDINGS OF THE SPECIAL SESSION ON SHRIMP FARMING, P166; Burford MA, 2003, MAR POLLUT BULL, V46, P1456, DOI 10.1016/S0025-326X(03)00282-0; Burford MA, 2001, MAR ECOL PROG SER, V224, P187, DOI 10.3354/meps224187; Cahoon DR, 2003, J ECOL, V91, P1093, DOI 10.1046/j.1365-2745.2003.00841.x; Chimner Rodney A., 2004, Wetlands Ecology and Management, V12, P419, DOI 10.1007/s11273-004-0255-y; Chmura GL, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001917; Couwenberg J, 2010, GLOBAL CHANGE BIOL, V16, P1715, DOI 10.1111/j.1365-2486.2009.02016.x; Crow SE, 2005, ECOLOGY, V86, P1825, DOI 10.1890/04-1575; DELAUNE RD, 1994, J COASTAL RES, V10, P1021; Donato DC, 2011, NAT GEOSCI, V4, P293, DOI [10.1038/ngeo1123, 10.1038/NGEO1123]; Ellison AM, 1996, BIOTROPICA, V28, P549, DOI 10.2307/2389096; Emmett-Mattox S, 2010, NATL WETLANDS NEWSLE, V32, P6; Ewel KC, 2010, FRONT ECOL ENVIRON, V8, P20, DOI 10.1890/080090; Granek E, 2008, ESTUAR COAST SHELF S, V80, P555, DOI 10.1016/j.ecss.2008.09.012; HOUGHTON RA, 1995, GLOB CHANGE BIOL, V1, P275, DOI 10.1111/j.1365-2486.1995.tb00026.x; Kauffman JB, 2011, WETLANDS, V31, P343, DOI 10.1007/s13157-011-0148-9; Kauffman JB, 2009, ECOL APPL, V19, P1211, DOI 10.1890/08-1696.1; Lallier-Verges E, 2008, CHEM GEOL, V255, P388, DOI 10.1016/j.chemgeo.2008.07.009; Lee RY, 2008, BIOGEOCHEMISTRY, V87, P181, DOI 10.1007/s10533-008-9176-9; Lovelock CE, 2008, ECOSYSTEMS, V11, P342, DOI 10.1007/s10021-008-9125-4; McCleod E, 2011, FRONT ECOL IN PRESS; Mckee KL, 2007, GLOBAL ECOL BIOGEOGR, V16, P545, DOI 10.1111/j.1466-8238.2007.00317.x; McKee KL, 2002, ECOLOGY, V83, P1065, DOI 10.2307/3071914; Muradian R, 2009, PAYMENT ECOSYSTEM SE, P1; Rutzler K, 1996, SCI AM, V274, P94; Schuur EAG, 2009, NATURE, V459, P556, DOI 10.1038/nature08031; VALIELA I, 2001, BIOSCIENCE, V51, P807, DOI DOI 10.1641/0006-3568(2001)051[0807:MFOOTW]2.0.CO;2	34	97	99	4	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21279	10.1371/journal.pone.0021279	http://dx.doi.org/10.1371/journal.pone.0021279			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21738628	Green Published, Green Submitted, gold			2022-12-27	WOS:000292290100016
J	Schott, RK; Evans, DC; Goodwin, MB; Horner, JR; Brown, CM; Longrich, NR				Schott, Ryan K.; Evans, David C.; Goodwin, Mark B.; Horner, John R.; Brown, Caleb Marshall; Longrich, Nicholas R.			Cranial Ontogeny in Stegoceras validum (Dinosauria: Pachycephalosauria): A Quantitative Model of Pachycephalosaur Dome Growth and Variation	PLOS ONE			English	Article							BONE-HISTOLOGY; ORNITHISCHIA PACHYCEPHALOSAURIA; RELATIVE GROWTH; LONG BONES; PATTERNS; ANATOMY; SUTURES; MICROSTRUCTURE; SYSTEMATICS; ALLOMETRY	Historically, studies of pachycephalosaurs have recognized plesiomorphically flat-headed taxa and apomorphically domed taxa. More recently, it has been suggested that the expression of the frontoparietal dome is ontogenetic and derived from a flat-headed juvenile morphology. However, strong evidence to support this hypothesis has been lacking. Here we test this hypothesis in a large, stratigraphically constrained sample of specimens assigned to Stegoceras validum, the best known pachycephalosaur, using multiple independent lines of evidence including conserved morphology of ornamentation, landmark-based allometric analyses of frontoparietal shape, and cranial bone histology. New specimens show that the diagnostic ornamentation of the parietosquamosal bar is conserved throughout the size range of the sample, which links flat-headed specimens to domed S. validum. High-resolution CT scans of three frontoparietals reveal that vascularity decreases with size and document a pattern that is consistent with previously proposed histological changes during growth. Furthermore, aspects of dome shape and size are strongly correlated and indicative of ontogenetic growth. These results are complementary and strongly support the hypothesis that the sample represents a growth series of a single taxon. Cranial dome growth is positively allometric, proceeds from a flat-headed to a domed state, and confirms the synonymy of Ornatotholus browni as a juvenile Stegoceras. This dataset serves as the first detailed model of growth and variation in a pachycephalosaur. Flat-headed juveniles possess three characters (externally open cranial sutures, tuberculate dorsal surface texture, and open supratemporal fenestrae) that are reduced or eliminated during ontogeny. These characters also occur in putative flat-headed taxa, suggesting that they may also represent juveniles of domed taxa. However, open cranial sutures and supratemporal fenestrae are plesiomorphic within Ornithischia, and thus should be expected in the adult stage of a primitive pachycephalosaur. Additional lines of evidence will be needed to resolve the taxonomic validity of flat-headed pachycephalosaur taxa.	[Schott, Ryan K.; Evans, David C.; Brown, Caleb Marshall] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada; [Evans, David C.] Royal Ontario Museum, Toronto, ON M5S 2C6, Canada; [Goodwin, Mark B.] Univ Calif Berkeley, Museum Paleontol, Berkeley, CA 94720 USA; [Horner, John R.] Montana State Univ, Museum Rockies, Bozeman, MT 59717 USA; [Longrich, Nicholas R.] Yale Univ, Dept Geol, New Haven, CT USA	University of Toronto; Royal Ontario Museum; University of California System; University of California Berkeley; Montana State University System; Montana State University Bozeman; Yale University	Schott, RK (corresponding author), Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada.	ryan.schott@utoronto.ca		Longrich, Nicholas/0000-0002-9586-8907; Brown, Caleb/0000-0001-6463-8677; Schott, Ryan/0000-0002-4015-3955; Goodwin, Mark/0000-0001-7127-439X	NSERC; University of California Museum of Paleontology	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); University of California Museum of Paleontology	Funding was provided through a NSERC CGS M to RKS and an NSERC Discovery Grant to DCE. The University of California Museum of Paleontology provided funding to MBG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; BAKKER RT, 2006, NEW MEXICO MUSEUM NA, V35, P331; Botha J, 2005, PALAEONTOLOGY, V48, P385, DOI 10.1111/j.1475-4983.2005.00447.x; Botha J, 2004, ACTA PALAEONTOL POL, V49, P619; Botha J, 2000, J VERTEBR PALEONTOL, V20, P705, DOI 10.1671/0272-4634(2000)020[0705:GPDFTB]2.0.CO;2; Brown CM, 2009, J VERTEBR PALEONTOL, V29, P132, DOI 10.1671/039.029.0119; Butler RJ, 2009, ACTA PALAEONTOL POL, V54, P21, DOI 10.4202/app.2009.0104; CHAPMAN RE, 1981, J PALEONTOL, V55, P608; CHINSAMY A, 1995, J VERTEBR PALEONTOL, V15, P96, DOI 10.1080/02724634.1995.10011209; de Boef M, 2007, CAN J ZOOL, V85, P63, DOI 10.1139/Z06-195; DODSON P, 1975, J ZOOL, V175, P315; DODSON P, 1975, SYST ZOOL, V24, P37, DOI 10.2307/2412696; DONG Z, 1978, VERTEBRAT PALASIATIC, V16, P222; EBERTH DA, 1993, CAN J EARTH SCI, V30, P174, DOI 10.1139/e93-016; Eberth DA, 2005, LIFE O PAST, P54; Erickson GM, 2005, TRENDS ECOL EVOL, V20, P677, DOI 10.1016/j.tree.2005.08.012; Evans DC, 2011, J VERTEBR PALEONTOL, V31, P84, DOI 10.1080/02724634.2011.546287; Evans DC, 2010, ZOOL J LINN SOC-LOND, V159, P398, DOI 10.1111/j.1096-3642.2009.00611.x; Evans DC, 2005, LIFE O PAST, P349; Farke AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016196; GALTON P M, 1971, Journal of Paleontology, V45, P40; GALTON PM, 1983, CAN J EARTH SCI, V20, P462, DOI 10.1139/e83-043; Goodwin M.B., 1990, P189, DOI 10.1017/CBO9780511608377.017; Goodwin M, 2004, J VERTEBR PALEONTOL, V24, p65A; Goodwin MB, 2004, PALEOBIOLOGY, V30, P253, DOI 10.1666/0094-8373(2004)030<0253:CHOPOM>2.0.CO;2; Goodwin MB, 1998, J VERTEBR PALEONTOL, V18, P363, DOI 10.1080/02724634.1998.10011064; GOULD SJ, 1966, BIOL REV, V41, P587, DOI 10.1111/j.1469-185X.1966.tb01624.x; HAM AW, 1961, HISTOLOGY; Herring SW, 2000, AM J PHYS ANTHROPOL, V112, P575, DOI 10.1002/1096-8644(200008)112:4&lt;575::AID-AJPA10&gt;3.0.CO;2-0; Horner J, 2009, J VERTEBR PALEONTOL, V29, p117A; Horner JR, 2006, P ROY SOC B-BIOL SCI, V273, P2757, DOI 10.1098/rspb.2006.3643; Horner JR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007626; HUANG LK, 1995, PATTERN RECOGN, V28, P41, DOI 10.1016/0031-3203(94)E0043-K; JASINSKI SE, 2011, NEW MEXICO IN PRESS; JASLOW CR, 1990, J BIOMECH, V23, P313, DOI 10.1016/0021-9290(90)90059-C; Lambe LM., 1902, CONTRIBUTIONS CANADI, V3, P25; Legendre P., 1998, MODEL 2 REGRESSION U; Legendre P., 2012, NUMERICAL ECOLOGY; Longrich NR, 2011, CRETACEOUS RES, V32, P264, DOI 10.1016/j.cretres.2010.12.007; Longrich NR, 2010, CRETACEOUS RES, V31, P274, DOI 10.1016/j.cretres.2009.12.002; Markey MJ, 2007, J MORPHOL, V268, P89, DOI 10.1002/jmor.10504; Maryanska T., 1974, PALEONTOLOGICA POLON, V26, P133; Maryanska T, 2004, DINOSAURIA, 2ND EDITION, P464; Opperman LA, 2000, DEV DYNAM, V219, P472, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1073>3.0.CO;2-F; Owen R., 1842, REPORT BRIT ASS ADV, V9, P60; PERLE A, 1982, Acta Palaeontologica Polonica, V27, P115; Pomfret JC, 2006, ANIM BEHAV, V71, P567, DOI 10.1016/j.anbehav.2005.05.023; Rasband W., 2006, IMAGEJ; Ray S, 2004, J VERTEBR PALEONTOL, V24, P634, DOI 10.1671/0272-4634(2004)024[0634:BHAGPO]2.0.CO;2; Reid R.E.H., 1996, Brigham Young University Geology Studies, V41, P25; Ryan MJ, 2005, LIFE O PAST, P312; Sampson SD, 1997, ZOOL J LINN SOC-LOND, V121, P293, DOI 10.1111/j.1096-3642.1997.tb00340.x; Scannella JB, 2010, J VERTEBR PALEONTOL, V30, P1157, DOI 10.1080/02724634.2010.483632; Schott RK, 2009, J VERTEBR PALEONTOL, V29, P771, DOI 10.1671/039.029.0329; Seeley H.G., 1887, P R SOC LONDON, V43, P165, DOI [10.1098/rspl.1887.0117, DOI 10.1098/RSPL.1887.0117]; Sereno Paul C., 2000, P480; SERENO PC, 1986, NATL GEOGR RES, V2, P234; Sereno PC, 1999, SCIENCE, V284, P2137, DOI 10.1126/science.284.5423.2137; Sezgin M, 2004, J ELECTRON IMAGING, V13, P146, DOI 10.1117/1.1631315; Smith RJ, 2009, AM J PHYS ANTHROPOL, V140, P476, DOI 10.1002/ajpa.21090; Sokal R.R., 2012, BIOMETRY; Starck JM, 2002, J MORPHOL, V254, P232, DOI 10.1002/jmor.10029; Sternberg C. M., 1945, JOUR PALEONTOL, V19, P534; SUES H-D, 1987, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V198, P1; Sullivan R.M., 2006, NEW MEXICO MUSEUM SC, V35, P329; Sullivan RM, 2003, J VERTEBR PALEONTOL, V23, P181, DOI 10.1671/0272-4634(2003)23[181:ROTDSL]2.0.CO;2; SULLIVAN RM, 2006, NEW MEXICO MUSEUM NA, V35, P347; Sullivan R, 2007, J VERTEBR PALEONTOL, V27, p154A; Tumarkin-Deratzian AR, 2007, J HERPETOL, V41, P341, DOI 10.1670/0022-1511(2007)41[341:FBIWAA]2.0.CO;2; Tumarkin-Deratzian AR, 2007, ZOOL J LINN SOC-LOND, V150, P1, DOI 10.1111/j.1096-3642.2007.00283.x; Tumarkin-Deratzian AR, 2006, ZOOL J LINN SOC-LOND, V148, P133, DOI 10.1111/j.1096-3642.2006.00232.x; WALL WP, 1979, CAN J EARTH SCI, V16, P1176, DOI 10.1139/e79-104; Wang Q, 2002, COMPUT VIS IMAGE UND, V85, P100, DOI 10.1006/cviu.2001.0955; Warton DI, 2006, BIOL REV, V81, P259, DOI 10.1017/S1464793106007007; Williamson TE, 2002, J VERTEBR PALEONTOL, V22, P779, DOI 10.1671/0272-4634(2002)022[0779:ANGODP]2.0.CO;2; [No title captured]	76	38	38	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21092	10.1371/journal.pone.0021092	http://dx.doi.org/10.1371/journal.pone.0021092			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21738608	gold, Green Published			2022-12-27	WOS:000292290100012
J	Poustchi, H; George, J; Esmaili, S; Esna-Ashari, F; Ardalan, G; Sepanlou, SG; Alavian, SM				Poustchi, Hossein; George, Jacob; Esmaili, Saeed; Esna-Ashari, Farzaneh; Ardalan, Gelayol; Sepanlou, Sadaf Ghajarieh; Alavian, Seyed Moayed			Gender Differences in Healthy Ranges for Serum Alanine Aminotransferase Levels in Adolescence	PLOS ONE			English	Article							FATTY LIVER-DISEASE; MECHANISMS LINKING OBESITY; METABOLIC SYNDROME; RISK; PREVALENCE; OVERWEIGHT; MORTALITY; CHILDREN; ASSOCIATION; PREDICTS	Background & Aims: There is a worldwide epidemic of obesity among adolescents who subsequently are at increased risk for the development of non alcoholic fatty liver disease (NAFLD). The serum alanine aminotransferase (ALT) is the most frequently used test for screening these individuals, but no age and gender-specific upper limits of normal (ULN) based on healthy population data in children are available. The objective of the present study was to define ULN for ALT in healthy children in order to use this as a tool for case finding. Methods: A total of 975 school children (aged 7-18 years) were included in the study cohort. Highly significant correlations (all p<0.001) were noted between ALT values and measures of BMI, systolic and diastolic blood pressure, insulin levels, HOMA-IR, total cholesterol and triglyceride concentrations. In order to define the population with no risk factors, we excluded subjects having abnormal values for factors that correlated with ALT. This population comprised 186 boys and 185 girls. Results: In boys, median serum ALT levels were 16 IU/L and 9, 11, 18, and 30 IU/L for the 5th, 25th, 75th, and 95th percentiles. In girls, median serum ALT was 13, and 7, 9, 16, and 21 IU/L for the 5th, 25th, 75th, and 95th percentiles, respectively. The ULNs for ALT were 30 IU/L and 21 IU/L for boys and girls respectively. We found a linear relationship between age and ALT in females (p<0.001) but not in males. By multiple logistic regression, independent predictors of an elevated ALT included the BMI, waist hip ratio and levels of serum total cholesterol. In females, age was an additional inverse predictor. Conclusions: In children and adolescents, these normal limits for ALT should be applied. Those with persistent elevations should be investigated further.	[Poustchi, Hossein; Esmaili, Saeed; Sepanlou, Sadaf Ghajarieh] Univ Tehran Med Sci, Digest Dis Res Ctr, Tehran, Iran; [George, Jacob] Univ Sydney, Storr Liver Unit, Westmead Millennium Inst, Sydney, NSW 2006, Australia; [George, Jacob] Westmead Hosp, Sydney, NSW, Australia; [Esna-Ashari, Farzaneh] Shaheed Beheshti Univ Med Sci, Dept Community & Prevent Med, Tehran, Iran; [Ardalan, Gelayol] Minist Hlth & Med Educ, Youth & Sch Hlth Off, Tehran, Iran; [Alavian, Seyed Moayed] Baqiyatallah Univ Med Sci, Tehran Hepatitis Ctr, Baqiyatallah Res Ctr Gastroenterol & Liver Dis BR, Tehran, Iran	Tehran University of Medical Sciences; University of Sydney; Westmead Institute for Medical Research; University of Sydney; Shahid Beheshti University Medical Sciences; Ministry of Health & Medical Education (MOHME); Baqiyatallah University of Medical Sciences (BMSU)	Poustchi, H (corresponding author), Univ Tehran Med Sci, Digest Dis Res Ctr, Tehran, Iran.	editor@hepatmon.com	George, jacob/P-1496-2014; Sepanlou, Sadaf G/H-9343-2016; Esna-Ashari, Farzaneh/I-8724-2017	Sepanlou, Sadaf G/0000-0002-3669-5129; Esna-Ashari, Farzaneh/0000-0002-3151-4843; Esmaili, Saeed/0000-0002-2843-7277; Alavian., Seyed Moayed/0000-0002-4443-6602	Ministry of Health and Medical Education in Iran, the deputy of health	Ministry of Health and Medical Education in Iran, the deputy of health	The entire study was funded by The Ministry of Health and Medical Education in Iran, the deputy of health. There was no current external funding sources for this study. The funders has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014; Adams LA, 2009, AM J GASTROENTEROL, V104, P861, DOI 10.1038/ajg.2009.67; Alavian SM, 2009, LIVER INT, V29, P159, DOI 10.1111/j.1478-3231.2008.01790.x; *AM AC PED, 2004, PEDIATRICS, V101, P141; [Anonymous], 2005, DIABETES CARE, V28, pS4; Clark JM, 2002, GASTROENTEROLOGY, V122, P1649, DOI 10.1053/gast.2002.33573; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Daniel S, 1999, AM J GASTROENTEROL, V94, P3010, DOI 10.1111/j.1572-0241.1999.01451.x; de Ferranti SD, 2004, CIRCULATION, V110, P2494, DOI 10.1161/01.CIR.0000145117.40114.C7; Elinav E, 2005, AM J GASTROENTEROL, V100, P2201, DOI 10.1111/j.1572-0241.2005.41822.x; *EMRO, 2006, CLIN MAN DIAB MELL; Farrell GC, 2007, J GASTROEN HEPATOL, V22, P775, DOI 10.1111/j.1440-1746.2007.05002.x; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; George J, 2008, J PAEDIATR CHILD H, V44, P579, DOI 10.1111/j.1440-1754.2008.01386.x; Horowitz GL, DEFINING ESTABLISHIN; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Ioannou GN, 2006, HEPATOLOGY, V43, P1145, DOI 10.1002/hep.21171; Jee SH, 2006, NEW ENGL J MED, V355, P779, DOI 10.1056/NEJMoa054017; Jorgensen LGM, 2004, CLIN CHEM LAB MED, V42, P747, DOI 10.1515/CCLM.2004.126; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kariv R, 2006, LIVER INT, V26, P445, DOI 10.1111/j.1478-3231.2006.01197.x; Lazar MA, 2005, SCIENCE, V307, P373, DOI 10.1126/science.1104342; Lee TH, 2008, HEPATOLOGY, V47, P880, DOI 10.1002/hep.22090; Loomba R, 2008, GASTROENTEROLOGY, V134, P953, DOI 10.1053/j.gastro.2008.01.037; Maggio ABR, 2008, J PEDIATR-US, V152, P489, DOI 10.1016/j.jpeds.2007.10.042; Matteoni CA, 1999, GASTROENTEROLOGY, V116, P1413, DOI 10.1016/S0016-5085(99)70506-8; Mendelsohn ME, 1999, NEW ENGL J MED, V340, P1801, DOI 10.1056/NEJM199906103402306; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; Nobili V, 2008, HEPATOLOGY, V48, P119, DOI 10.1002/hep.22336; Ogden CL, 2007, GASTROENTEROLOGY, V132, P2087, DOI 10.1053/j.gastro.2007.03.052; Prati D, 2002, ANN INTERN MED, V137, P1, DOI 10.7326/0003-4819-137-1-200207020-00006; Rafeey Mandana, 2009, Ther Clin Risk Manag, V5, P371; Ritchie RF, 2004, CLIN CHEM LAB MED, V42, P702, DOI 10.1515/CCLM.2004.120; Ruhl CE, 2003, GASTROENTEROLOGY, V124, P71, DOI 10.1053/gast.2003.50004; Sattar N, 2004, DIABETES, V53, P2855, DOI 10.2337/diabetes.53.11.2855; Schwimmer JB, 2006, PEDIATRICS, V118, P1388, DOI 10.1542/peds.2006-1212; Schwinnner JB, 2005, HEPATOLOGY, V42, P641, DOI 10.1002/hep.20842; SOLBERG HE, 1987, J CLIN CHEM CLIN BIO, V25, P337; Suzuki A, 2005, HEPATOLOGY, V41, P64, DOI 10.1002/hep.20543; Suzuki D, 2005, J GASTROEN HEPATOL, V20, P327, DOI 10.1111/j.1440-1746.2005.03724.x; Uwaifo GI, 2002, DIABETES CARE, V25, P2081, DOI 10.2337/diacare.25.11.2081; Van der Poorten D, 2007, HEPATOLOGY, V46, P1750, DOI 10.1002/hep.21918; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Vozarova B, 2002, DIABETES, V51, P1889, DOI 10.2337/diabetes.51.6.1889; World Health Organization, WHO GLOB STRAT DIET; 2008, CLIN GASTROENTEROL H, V6, P799	48	45	48	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21178	10.1371/journal.pone.0021178	http://dx.doi.org/10.1371/journal.pone.0021178			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738618	Green Submitted, Green Published, gold			2022-12-27	WOS:000292092600017
J	Salt, JN; Yoshioka, K; Moeder, W; Goring, DR				Salt, Jennifer N.; Yoshioka, Keiko; Moeder, Wolfgang; Goring, Daphne R.			Altered Germination and Subcellular Localization Patterns for PUB44/SAUL1 in Response to Stress and Phytohormone Treatments	PLOS ONE			English	Article							E3 UBIQUITIN LIGASE; LESION MIMIC MUTANTS; REPEAT PROTEIN; CELL-DEATH; SELF-INCOMPATIBILITY; BIOCHEMICAL FUNCTION; RECEPTOR KINASES; ABSCISIC-ACID; ARABIDOPSIS; EXPRESSION	Background: In plants, the ubiquitin-proteasome system is emerging as a significant regulatory system throughout the plant lifecycle. The ubiquitination of a target protein requires the sequential actions of the E1, E2 and E3 enzymes, with the latter E3 enzyme conferring target selection in this process. There are a large number of predicted E3 enzymes in plant genomes, and very little is known about the functions of many of these predicted genes. Here we report here an analysis of two closely-related members of the Arabidopsis Plant U-box (PUB) family of E3 ubiquitin ligases, PUB43 and PUB44. Principal Findings: Homozygous pub44/pub44 mutant seedlings were found displayed a seedling lethal phenotype and this corresponded with widespread cell death lesions throughout the cotyledons and roots. Interestingly, heterozygous PUB44/pub44 seedlings were wild-type in appearance yet displayed intermediate levels of cell death lesions in comparison to pub44/pub44 seedlings. In contrast, homozygous pub43/pub43 mutants were viable and did not show any signs of cell death despite the PUB43 gene being more highly expressed than PUB44. The PUB44 mutants are not classical lesion mimic mutants as they did not have increased resistance to plant pathogens. We also observed increased germination rates in mutant seeds for both PUB44 and PUB43 under inhibitory concentrations of abscisic acid. Finally, the subcellular localization of PUB44 was investigated with transient expression assays in BY-2 cells. Under varying conditions, PUB44 was observed to be localized to the cytoplasm, plasma membrane, or nucleus. Conclusions: Based on mutant plant analyses, the Arabidopsis PUB43 and PUB44 genes are proposed to function during seed germination and early seedling growth. Given PUB44's ability to shuttle from the nucleus to the plasma membrane, PUB44 may be active in different subcellular compartments as part of these biological functions.	[Salt, Jennifer N.; Yoshioka, Keiko; Moeder, Wolfgang; Goring, Daphne R.] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada; [Yoshioka, Keiko; Goring, Daphne R.] Univ Toronto, Ctr Anal Genome Evolut & Funct, Toronto, ON, Canada	University of Toronto; University of Toronto	Salt, JN (corresponding author), Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada.	d.goring@utoronto.ca		Goring, Daphne/0000-0001-5295-4744; Yoshioka, Keiko/0000-0002-3797-4277; Moeder, Wolfgang/0000-0003-3889-6183	Natural Sciences and Engineering Research Council of Canada (NSERC); Canada Research Chair	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	This work was supported by grants from the Natural Sciences and Engineering Research Council of Canada (NSERC) to DRG and KY and a Canada Research Chair to DRG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Amador V, 2001, CELL, V106, P343, DOI 10.1016/S0092-8674(01)00445-7; Andersen P, 2004, J BIOL CHEM, V279, P40053, DOI 10.1074/jbc.M405057200; Azevedo C, 2001, TRENDS PLANT SCI, V6, P354, DOI 10.1016/S1360-1385(01)01960-4; Bos JIB, 2010, P NATL ACAD SCI USA, V107, P9909, DOI 10.1073/pnas.0914408107; Cho SK, 2008, PLANT CELL, V20, P1899, DOI 10.1105/tpc.108.060699; Cho SK, 2006, PLANT PHYSIOL, V142, P1664, DOI 10.1104/pp.106.087965; Clague MJ, 2010, CELL, V143, P682, DOI 10.1016/j.cell.2010.11.012; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Disch S, 2006, CURR BIOL, V16, P272, DOI 10.1016/j.cub.2005.12.026; Downes BP, 2003, PLANT J, V35, P729, DOI 10.1046/j.1365-313X.2003.01844.x; Drechsel G, 2011, J EXP BOT, V62, P775, DOI 10.1093/jxb/erq313; Durek P, 2010, NUCLEIC ACIDS RES, V38, pD828, DOI 10.1093/nar/gkp810; FINKELSTEIN RR, 1994, PLANT PHYSIOL, V105, P1203, DOI 10.1104/pp.105.4.1203; Gonzalez-Lamothe R, 2006, PLANT CELL, V18, P1067, DOI 10.1105/tpc.106.040998; Gu TS, 1998, P NATL ACAD SCI USA, V95, P382, DOI 10.1073/pnas.95.1.382; Guiboileau A, 2010, CR BIOL, V333, P382, DOI 10.1016/j.crvi.2010.01.016; Heazlewood JL, 2007, NUCLEIC ACIDS RES, V35, pD213, DOI 10.1093/nar/gkl863; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hoth S, 2002, J CELL SCI, V115, P4891, DOI 10.1242/jcs.00175; Kim M, 2003, BBA-PROTEINS PROTEOM, V1651, P50, DOI 10.1016/S1570-9639(03)00234-6; Lim PO, 2007, ANNU REV PLANT BIOL, V58, P115, DOI 10.1146/annurev.arplant.57.032905.105316; Liu F, 2010, TRENDS BIOCHEM SCI, V35, P352, DOI 10.1016/j.tibs.2010.01.002; Liu P, 2007, CURR BIOL, V17, P734, DOI 10.1016/j.cub.2007.03.022; Lorrain S, 2003, TRENDS PLANT SCI, V8, P263, DOI 10.1016/S1360-1385(03)00108-0; Marmagne A, 2007, MOL CELL PROTEOMICS, V6, P1980, DOI 10.1074/mcp.M700099-MCP200; Mbengue M, 2010, PLANT CELL, V22, P3474, DOI 10.1105/tpc.110.075861; Mudgil Y, 2004, PLANT PHYSIOL, V134, P59, DOI 10.1104/pp.103.029553; Nakabayashi K, 2005, PLANT J, V41, P697, DOI 10.1111/j.1365-313X.2005.02337.x; Ni XM, 2010, PLANT SCI, V178, P158, DOI 10.1016/j.plantsci.2009.12.002; Park JJ, 2011, PLANT J, V65, P194, DOI 10.1111/j.1365-313X.2010.04416.x; Raab S, 2009, PLANT J, V59, P39, DOI 10.1111/j.1365-313X.2009.03846.x; SAMUEL MA, 2006, INT REV CYTOL, V253, P1, DOI DOI 10.1016/S0074-7696(06)53001-3; Samuel MA, 2008, PLANT PHYSIOL, V147, P2084, DOI 10.1104/pp.108.123380; Samuel MA, 2009, PLANT CELL, V21, P2655, DOI 10.1105/tpc.109.069740; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Sessions A, 2002, PLANT CELL, V14, P2985, DOI 10.1105/tpc.004630; Stone SL, 1999, SCIENCE, V286, P1729, DOI 10.1126/science.286.5445.1729; Stone SL, 2003, PLANT CELL, V15, P885, DOI 10.1105/tpc.009845; Toufighi K, 2005, PLANT J, V43, P153, DOI 10.1111/j.1365-313X.2005.02437.x; Trujillo M, 2008, CURR BIOL, V18, P1396, DOI 10.1016/j.cub.2008.07.085; Trujillo M, 2010, CURR OPIN PLANT BIOL, V13, P402, DOI 10.1016/j.pbi.2010.04.002; Vega-Sanchez ME, 2008, PLANT CELL, V20, P1456, DOI 10.1105/tpc.108.058610; Vierstra RD, 2009, NAT REV MOL CELL BIO, V10, P385, DOI 10.1038/nrm2688; Wiborg J, 2008, BIOCHEM J, V413, P447, DOI 10.1042/BJ20071568; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Yang CW, 2006, PLANT CELL, V18, P1084, DOI 10.1105/tpc.105.039198; Yee D, 2009, J EXP BOT, V60, P1109, DOI 10.1093/jxb/ern369; Yi CL, 2005, TRENDS CELL BIOL, V15, P618, DOI 10.1016/j.tcb.2005.09.007; Yin ZC, 2000, MOL PLANT MICROBE IN, V13, P869, DOI 10.1094/MPMI.2000.13.8.869; Yoshioka K, 2006, PLANT CELL, V18, P747, DOI 10.1105/tpc.105.038786; Zeng LR, 2008, MOL PLANT, V1, P800, DOI 10.1093/mp/ssn044; Zeng LR, 2004, PLANT CELL, V16, P2795, DOI 10.1105/tpc.104.025171	53	34	37	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21321	10.1371/journal.pone.0021321	http://dx.doi.org/10.1371/journal.pone.0021321			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738636	Green Submitted, Green Published, gold			2022-12-27	WOS:000292092600029
J	Chan, CH; Yu, TH; Wong, KB				Chan, Chi-Ho; Yu, Tsz-Ha; Wong, Kam-Bo			Stabilizing Salt-Bridge Enhances Protein Thermostability by Reducing the Heat Capacity Change of Unfolding	PLOS ONE			English	Article							ELECTROSTATIC INTERACTIONS CONTRIBUTE; THERMAL-STABILITY; PHOSPHOGLYCERATE KINASE; STRUCTURE VALIDATION; SURFACE; MOLPROBITY; REMOVAL; NETWORK; STATE; L30E	Most thermophilic proteins tend to have more salt bridges, and achieve higher thermostability by up-shifting and broadening their protein stability curves. While the stabilizing effect of salt-bridge has been extensively studied, experimental data on how salt-bridge influences protein stability curves are scarce. Here, we used double mutant cycles to determine the temperature-dependency of the pair-wise interaction energy and the contribution of salt-bridges to Delta C-p in a thermophilic ribosomal protein L30e. Our results showed that the pair-wise interaction energies for the salt-bridges E6/R92 and E62/K46 were stabilizing and insensitive to temperature changes from 298 to 348 K. On the other hand, the pair-wise interaction energies between the control long-range ion-pair of E90/R92 were negligible. The Delta C-p of all single and double mutants were determined by Gibbs-Helmholtz and Kirchhoff analyses. We showed that the two stabilizing salt-bridges contributed to a reduction of Delta C-p by 0.8-1.0 kJ mol(-1) K-1. Taken together, our results suggest that the extra salt-bridges found in thermophilic proteins enhance the thermostability of proteins by reducing Delta C-p, leading to the up-shifting and broadening of the protein stability curves.	[Chan, Chi-Ho; Yu, Tsz-Ha; Wong, Kam-Bo] Chinese Univ Hong Kong, Sch Life Sci, Ctr Prot Sci & Crystallog, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong	Chan, CH (corresponding author), Chinese Univ Hong Kong, Sch Life Sci, Ctr Prot Sci & Crystallog, Shatin, Hong Kong, Peoples R China.	kbwong@cuhk.edu.hk	Wong, Kam-Bo/G-4258-2013; Wong, Kam-Bo/AAU-9364-2021	Wong, Kam-Bo/0000-0002-6984-5373; Wong, Kam-Bo/0000-0002-6984-5373	Research Grants Council of Hong Kong [476307]	Research Grants Council of Hong Kong(Hong Kong Research Grants Council)	This work was funded by the General Research Fund of Research Grants Council of Hong Kong (Project no. 476307). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BALDWIN RL, 1986, P NATL ACAD SCI USA, V83, P8069, DOI 10.1073/pnas.83.21.8069; Beadle BM, 1999, BIOCHEMISTRY-US, V38, P2570, DOI 10.1021/bi9824902; Blasie CA, 1997, BIOCHEMISTRY-US, V36, P6218, DOI 10.1021/bi962805i; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; DAOPIN S, 1991, BIOCHEMISTRY-US, V30, P7142, DOI 10.1021/bi00243a015; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Deutschman WA, 2001, BIOCHEMISTRY-US, V40, P13107, DOI 10.1021/bi010665t; Elcock AH, 1998, J MOL BIOL, V284, P489, DOI 10.1006/jmbi.1998.2159; ERWIN CR, 1990, PROTEIN ENG, V4, P87, DOI 10.1093/protein/4.1.87; FERSHT AR, 1993, CURR OPIN STRUC BIOL, V3, P75, DOI 10.1016/0959-440X(93)90205-Y; Filimonov VV, 1999, BIOPHYS CHEM, V77, P195, DOI 10.1016/S0301-4622(99)00025-3; Fukuchi S, 2001, J MOL BIOL, V309, P835, DOI 10.1006/jmbi.2001.4718; Ge M, 2008, J BIOL CHEM, V283, P31690, DOI 10.1074/jbc.M805750200; Grattinger M, 1998, J MOL BIOL, V280, P525, DOI 10.1006/jmbi.1998.1861; Gribenko AV, 2009, P NATL ACAD SCI USA, V106, P2601, DOI 10.1073/pnas.0808220106; Hendsch ZS, 1996, BIOCHEMISTRY-US, V35, P7621, DOI 10.1021/bi9605191; HENDSCH ZS, 1994, PROTEIN SCI, V3, P211; Hollien J, 1999, BIOCHEMISTRY-US, V38, P3831, DOI 10.1021/bi982684h; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; HOROVITZ A, 1990, J MOL BIOL, V216, P1031, DOI 10.1016/S0022-2836(99)80018-7; Ibarra-Molero B, 2004, J MOL BIOL, V336, P989, DOI 10.1016/j.jmb.2003.12.069; ITZHAKI LS, 1995, J MOL BIOL, V254, P260, DOI 10.1006/jmbi.1995.0616; Kumar S, 2001, BIOCHEMISTRY-US, V40, P14152, DOI 10.1021/bi0106383; Kumar S, 2000, PROTEIN ENG, V13, P179, DOI 10.1093/protein/13.3.179; Lam SY, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001027; Lassila KS, 2002, PROTEIN SCI, V11, P688, DOI 10.1110/ps.23502; Lee CF, 2005, BIOCHEMISTRY-US, V44, P16817, DOI 10.1021/bi0519654; Lee CF, 2005, J MOL BIOL, V348, P419, DOI 10.1016/j.jmb.2005.02.052; Luisi DL, 2003, BIOCHEMISTRY-US, V42, P7050, DOI 10.1021/bi027202n; Makhatadze GI, 2003, J MOL BIOL, V327, P1135, DOI 10.1016/S0022-2836(03)00233-X; MARQUSEE S, 1994, PROTEIN SCI, V3, P2217, DOI 10.1002/pro.5560031207; MATTHEWS BW, 1993, ANNU REV BIOCHEM, V62, P139, DOI 10.1146/annurev.bi.62.070193.001035; Motono C, 2001, PROTEIN ENG, V14, P961, DOI 10.1093/protein/14.12.961; MURPHY KP, 1990, SCIENCE, V247, P559, DOI 10.1126/science.2300815; MURPHY KP, 1992, ADV PROTEIN CHEM, V43, P313, DOI 10.1016/S0065-3233(08)60556-2; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; NOJIMA H, 1977, J MOL BIOL, V116, P429, DOI 10.1016/0022-2836(77)90078-X; Pace C N, 1986, Methods Enzymol, V131, P266; PERUTZ MF, 1975, NATURE, V255, P256, DOI 10.1038/255256a0; PERUTZ MF, 1978, SCIENCE, V201, P1187, DOI 10.1126/science.694508; PRIVALOV PL, 1988, ADV PROTEIN CHEM, V39, P191; Razvi A, 2006, PROTEIN SCI, V15, P1569, DOI 10.1110/ps.062130306; Robic S, 2002, PROTEIN SCI, V11, P381, DOI 10.1110/ps.38602; Robic S, 2003, P NATL ACAD SCI USA, V100, P11345, DOI 10.1073/pnas.1635051100; SALI D, 1991, J MOL BIOL, V220, P779, DOI 10.1016/0022-2836(91)90117-O; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Schweiker KL, 2007, PROTEIN SCI, V16, P2694, DOI 10.1110/ps.073091607; SERRANO L, 1990, BIOCHEMISTRY-US, V29, P9343, DOI 10.1021/bi00492a006; Spek EJ, 1998, PROTEIN SCI, V7, P2431, DOI 10.1002/pro.5560071121; SPOLAR RS, 1992, BIOCHEMISTRY-US, V31, P3947, DOI 10.1021/bi00131a009; Strop P, 2000, BIOCHEMISTRY-US, V39, P1251, DOI 10.1021/bi992257j; Szilagyi A, 2000, STRUCTURE, V8, P493, DOI 10.1016/S0969-2126(00)00133-7; Takano K, 2000, BIOCHEMISTRY-US, V39, P12375, DOI 10.1021/bi000849s; Tissot AC, 1996, BIOCHEMISTRY-US, V35, P6786, DOI 10.1021/bi952930e; Uchiyama S, 2002, PROTEIN ENG, V15, P455, DOI 10.1093/protein/15.6.455; Vetriani C, 1998, P NATL ACAD SCI USA, V95, P12300, DOI 10.1073/pnas.95.21.12300; Vogt G, 1997, FOLD DES, V2, pS40, DOI 10.1016/S1359-0278(97)00062-X; WALDBURGER CD, 1995, NAT STRUCT BIOL, V2, P122, DOI 10.1038/nsb0295-122; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; Wong KB, 2003, PROTEIN SCI, V12, P1483, DOI 10.1110/ps.0302303; Zhou HX, 2002, BIOPHYS J, V83, P3126, DOI 10.1016/S0006-3495(02)75316-2	63	70	71	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21624	10.1371/journal.pone.0021624	http://dx.doi.org/10.1371/journal.pone.0021624			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21720566	Green Published, gold, Green Submitted			2022-12-27	WOS:000292036900062
J	Sweet, MJ; Croquer, A; Bythell, JC				Sweet, Michael John; Croquer, Aldo; Bythell, John Christopher			Development of Bacterial Biofilms on Artificial Corals in Comparison to Surface-Associated Microbes of Hard Corals	PLOS ONE			English	Article							SEQUENCE-ANALYSIS; CHEMICAL WARFARE; MARINE WATERS; FRESH-WATER; SP-NOV.; REEF; COMMUNITIES; MUCUS; DIVERSITY; SUCCESSION	Numerous studies have demonstrated the differences in bacterial communities associated with corals versus those in their surrounding environment. However, these environmental samples often represent vastly different microbial micro-environments with few studies having looked at the settlement and growth of bacteria on surfaces similar to corals. As a result, it is difficult to determine which bacteria are associated specifically with coral tissue surfaces. In this study, early stages of passive settlement from the water column to artificial coral surfaces (formation of a biofilm) were assessed. Changes in bacterial diversity (16S rRNA gene), were studied on artificially created resin nubbins that were modelled from the skeleton of the reef building coral Acropora muricata. These models were dip-coated in sterile agar, mounted in situ on the reef and followed over time to monitor bacterial community succession. The bacterial community forming the biofilms remained significantly different (R = 0.864 p < 0.05) from that of the water column and from the surface mucus layer (SML) of the coral at all times from 30 min to 96 h. The water column was dominated by members of the alpha-proteobacteria, the developed community on the biofilms dominated by gamma-proteobacteria, whereas that within the SML was composed of a more diverse array of groups. Bacterial communities present within the SML do not appear to arise from passive settlement from the water column, but instead appear to have become established through a selection process. This selection process was shown to be dependent on some aspects of the physico-chemical structure of the settlement surface, since agar-coated slides showed distinct communities to coral-shaped surfaces. However, no significant differences were found between different surface coatings, including plain agar and agar enhanced with coral mucus exudates. Therefore future work should consider physico-chemical surface properties as factors governing change in microbial diversity.	[Sweet, Michael John; Croquer, Aldo; Bythell, John Christopher] Newcastle Univ, Sch Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Croquer, Aldo] Univ Simon Bolivar, Dept Estudios Ambientales, Caracas, Venezuela	Newcastle University - UK; Simon Bolivar University	Sweet, MJ (corresponding author), Newcastle Univ, Sch Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	m.j.sweet@newcastle.ac.uk	Bythell, John C/E-7962-2010; Sweet, Michael J/E-9661-2012; Croquer, Aldo/ABE-6554-2021; Bythell, John/ABE-6138-2021	Bythell, John C/0000-0003-2416-9786; Sweet, Michael J/0000-0003-4983-8333; Croquer, Aldo/0000-0001-8880-9338; Bythell, John/0000-0003-2416-9786	Natural Environmental Research Council, UK [NE/E006949]; NERC [NE/H020616/1, NE/E006949/1] Funding Source: UKRI; Natural Environment Research Council [NE/E006949/1, NE/H020616/1] Funding Source: researchfish	Natural Environmental Research Council, UK(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by the Natural Environmental Research Council, UK (NE/E006949). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakker DP, 2003, BIOFOULING, V19, P391, DOI 10.1080/08927010310001634898; Ben-Haim Y, 2003, INT J SYST EVOL MICR, V53, P309, DOI 10.1099/ijs.0.02402-0; Bengtsson MM, 2010, AQUAT MICROB ECOL, V60, P71, DOI 10.3354/ame01409; Beveridge TJ, 1997, FEMS MICROBIOL REV, V20, P291, DOI 10.1111/j.1574-6976.1997.tb00315.x; Bourne DG, 2005, CORAL REEFS, V24, P304, DOI 10.1007/s00338-005-0479-1; Bowman JP, 2007, MAR DRUGS, V5, P220, DOI 10.3390/md20070017; Brown BE, 2005, MAR ECOL PROG SER, V296, P291, DOI 10.3354/meps296291; Ceh J, 2011, FEMS MICROBIOL ECOL, V75, P134, DOI 10.1111/j.1574-6941.2010.00986.x; Cerca N, 2005, RES MICROBIOL, V156, P506, DOI 10.1016/j.resmic.2005.01.007; Charpy L, 2005, VIE MILIEU, V55, P217; Clarke KR, 2001, MAR ECOL PROG SER, V216, P265, DOI 10.3354/meps216265; Dang HY, 2008, APPL ENVIRON MICROB, V74, P52, DOI 10.1128/AEM.01400-07; Dang HY, 2002, APPL ENVIRON MICROB, V68, P496, DOI 10.1128/AEM.68.2.496-504.2002; Dang HY, 2000, APPL ENVIRON MICROB, V66, P467, DOI 10.1128/AEM.66.2.467-475.2000; Daumas R., 1982, Proceedings of the International Coral Reef Symposium, P59; Dheilly A, 2010, APPL ENVIRON MICROB, V76, P3452, DOI 10.1128/AEM.02632-09; Dobretsov SV, 1996, ZOOL ZH, V75, P499; Dunne WM, 2002, CLIN MICROBIOL REV, V15, P155, DOI 10.1128/CMR.15.2.155-166.2002; Frias-Lopez J, 2002, APPL ENVIRON MICROB, V68, P2214, DOI 10.1128/AEM.68.5.2214-2228.2002; Gourlay MR, 2005, COAST ENG, V52, P353, DOI 10.1016/j.coastaleng.2004.11.007; Guppy R, 2006, MAR ECOL PROG SER, V328, P133, DOI 10.3354/meps328133; Hayashida-Soiza G, 2008, J APPL MICROBIOL, V105, P1672, DOI 10.1111/j.1365-2672.2008.03878.x; Horn H, 1998, WATER SCI TECHNOL, V37, P139, DOI 10.2166/wst.1998.0603; Huggett MJ, 2006, OECOLOGIA, V149, P604, DOI 10.1007/s00442-006-0470-8; Jatkar AA, 2010, MAR BIOL, V157, P261, DOI 10.1007/s00227-009-1313-z; Jones PR, 2007, MICROB ECOL, V53, P153, DOI 10.1007/s00248-006-9154-5; Kelman D, 2009, PURE APPL CHEM, V81, P1113, DOI 10.1351/PAC-CON-08-10-07; Klaus JS, 2007, ENVIRON MICROBIOL, V9, P1291, DOI 10.1111/j.1462-2920.2007.01249.x; Klaus JS, 2005, CORAL REEFS, V24, P129, DOI 10.1007/s00338-004-0447-1; Koh EGL, 1997, J CHEM ECOL, V23, P379, DOI 10.1023/B:JOEC.0000006366.58633.f4; Kooperman N, 2007, FEMS MICROBIOL LETT, V276, P106, DOI 10.1111/j.1574-6968.2007.00921.x; Kushmaro A, 2001, INT J SYST EVOL MICR, V51, P1383, DOI 10.1099/00207713-51-4-1383; Kvennefors ECE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010401; Lee JW, 2008, J MICROBIOL, V46, P174, DOI 10.1007/s12275-008-0032-3; Lee YK, 2003, J MICROBIOL, V41, P183; Liu Y, 2010, WATER SCI TECHNOL, V62, P2776, DOI 10.2166/wst.2010.200; Long RA, 2001, AQUAT MICROB ECOL, V26, P103, DOI 10.3354/ame026103; Lyautey E, 2005, MICROB ECOL, V50, P589, DOI 10.1007/s00248-005-5032-9; Martiny AC, 2003, APPL ENVIRON MICROB, V69, P6899, DOI 10.1128/AEM.69.11.6899-6907.2003; MassolDeya A, 1997, APPL ENVIRON MICROB, V63, P270; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; NAIR S, 1987, APPL ENVIRON MICROB, V53, P2957, DOI 10.1128/AEM.53.12.2957-2962.1987; Nothdurft LD, 2005, GEOLOGY, V33, P169, DOI 10.1130/G20932.1; Ploug H, 1999, LIMNOL OCEANOGR, V44, P1949, DOI 10.4319/lo.1999.44.8.1949; Rao TS, 2010, AQUAT ECOL, V44, P463, DOI 10.1007/s10452-009-9304-1; RITCHIE AE, 2005, J YOUNG INVESTIGATOR; Ritchie KB, 2004, CORAL HEALTH AND DISEASE, P259; Ritchie KB, 1995, MOL MAR BIOL BIOTECH, V4, P345; Ritchie KB, 2006, MAR ECOL PROG SER, V322, P1, DOI 10.3354/meps322001; Rohwer F, 2002, MAR ECOL PROG SER, V243, P1, DOI 10.3354/meps243001; Rosenberg E, 2002, ENVIRON MICROBIOL, V4, P318, DOI 10.1046/j.1462-2920.2002.00302.x; Rosenberg E, 2007, NAT REV MICROBIOL, V5, P355, DOI 10.1038/nrmicro1635; Rypien KL, 2010, ENVIRON MICROBIOL, V12, P28, DOI 10.1111/j.1462-2920.2009.02027.x; Sanchez O, 2007, APPL ENVIRON MICROB, V73, P5962, DOI 10.1128/AEM.00817-07; Sharon G, 2008, CURR MICROBIOL, V56, P481, DOI 10.1007/s00284-008-9100-5; Siboni N, 2007, FEMS MICROBIOL LETT, V274, P24, DOI 10.1111/j.1574-6968.2007.00809.x; SLATTERY M, 1995, J EXP MAR BIOL ECOL, V190, P61, DOI 10.1016/0022-0981(95)00032-M; Stevens H, 2009, OCEAN DYNAM, V59, P291, DOI 10.1007/s10236-008-0168-z; Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705; Sunagawa S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009554; Sussman M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002393; Sweet MJ, 2011, CORAL REEFS, V30, P39, DOI 10.1007/s00338-010-0695-1; Sweet MJ, 2010, AQUAT MICROB ECOL, V61, P1, DOI 10.3354/ame01433; Thomason JC, 2002, BIOFOULING, V18, P293, DOI 10.1080/0892701021000034409; Thompson JR, 2004, APPL ENVIRON MICROB, V70, P4103, DOI 10.1128/AEM.70.7.4103-4110.2004; WHITE PA, 1991, MICROBIAL ECOL, V21, P99, DOI 10.1007/BF02539147; Wieltschnig C, 2003, MICROBIAL ECOL, V46, P62, DOI 10.1007/s00248-002-2040-x; Wild C, 2005, MAR ECOL PROG SER, V287, P87, DOI 10.3354/meps287087; Wild C, 2004, NATURE, V428, P66, DOI 10.1038/nature02344	69	32	33	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21195	10.1371/journal.pone.0021195	http://dx.doi.org/10.1371/journal.pone.0021195			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21731669	Green Published, gold, Green Submitted			2022-12-27	WOS:000292036900013
J	Tang, FC; Barbacioru, C; Nordman, E; Bao, SQ; Lee, C; Wang, XH; Tuch, BB; Heard, E; Lao, KQ; Surani, MA				Tang, Fuchou; Barbacioru, Catalin; Nordman, Ellen; Bao, Siqin; Lee, Caroline; Wang, Xiaohui; Tuch, Brian B.; Heard, Edith; Lao, Kaiqin; Surani, M. Azim			Deterministic and Stochastic Allele Specific Gene Expression in Single Mouse Blastomeres	PLOS ONE			English	Article							3' UNTRANSLATED REGIONS; RNA-SEQ; MESSENGER-RNAS; GENOME-WIDE; ALTERNATIVE POLYADENYLATION; NONCODING RNAS; STEM-CELLS; TRANSCRIPTOME; REVEALS; WIDESPREAD	Stochastic and deterministic allele specific gene expression (ASE) might influence single cell phenotype, but the extent and nature of the phenomenon at the onset of early mouse development is unknown. Here we performed single cell RNA-Seq analysis of single blastomeres of mouse embryos, which revealed significant changes in the transcriptome. Importantly, over half of the transcripts with detectable genetic polymorphisms exhibit ASE, most notably, individual blastomeres from the same two-cell embryo show similar pattern of ASE. However, about 6% of them exhibit stochastic expression, indicated by altered expression ratio between the two alleles. Thus, we demonstrate that ASE is both deterministic and stochastic in early blastomeres. Furthermore, we also found that 1,718 genes express two isoforms with different lengths of 3'UTRs, with the shorter one on average 5-6 times more abundant in early blastomeres compared to the transcripts in epiblast cells, suggesting that microRNA mediated regulation of gene expression acquires increasing importance as development progresses.	[Tang, Fuchou; Bao, Siqin; Lee, Caroline; Surani, M. Azim] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst Canc & Dev, Cambridge, England; [Barbacioru, Catalin; Nordman, Ellen; Wang, Xiaohui; Tuch, Brian B.; Lao, Kaiqin] Life Technol, Appl Biosyst, Genet Syst, Foster City, CA USA; [Tang, Fuchou] Peking Univ, Sch Life Sci, Biodynam Opt Imaging Ctr, Beijing 100871, Peoples R China; [Heard, Edith] Inst Curie, CNRS, INSERM, UMR3215,U934, F-75231 Paris, France	University of Cambridge; Thermo Fisher Scientific; Applied Biosystems; Peking University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm)	Tang, FC (corresponding author), Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst Canc & Dev, Cambridge, England.	kaiqinlao@gmail.com; a.surani@gurdon.cam.ac.uk	Heard, Edith/D-7197-2017	Heard, Edith/0000-0001-8052-7117; Surani, Azim/0000-0002-8640-4318	Wellcome Trust; Medical Research Council [G0800784, G0800784B] Funding Source: researchfish; MRC [G0800784] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The work was supported by a grant from the Wellcome Trust to M. A. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alimonti A, 2010, NAT GENET, V42, P454, DOI 10.1038/ng.556; Arias AM, 2006, NAT REV GENET, V7, P34, DOI 10.1038/nrg1750; Bell CE, 2008, MOL HUM REPROD, V14, P691, DOI 10.1093/molehr/gan063; Bjornsson HT, 2008, GENOME RES, V18, P771, DOI 10.1101/gr.073254.107; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Cheung VG, 2002, NAT GENET, V32, P522, DOI 10.1038/ng1036; Cheung VG, 2008, AM J HUM GENET, V82, P1357, DOI 10.1016/j.ajhg.2008.05.003; Chow J, 2009, CURR OPIN CELL BIOL, V21, P359, DOI 10.1016/j.ceb.2009.04.012; Cohen AA, 2008, SCIENCE, V322, P1511, DOI 10.1126/science.1160165; Daelemans C, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-25; Ferguson-Smith AC, 2001, SCIENCE, V293, P1086, DOI 10.1126/science.1064020; Fu X, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-161; Gagneur J, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.31; Gregg C, 2010, SCIENCE, V329, P682, DOI 10.1126/science.1190831; Gregg C, 2010, SCIENCE, V329, P643, DOI 10.1126/science.1190830; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hamatani T, 2004, DEV CELL, V6, P117, DOI 10.1016/S1534-5807(03)00373-3; Heap GA, 2010, HUM MOL GENET, V19, P122, DOI 10.1093/hmg/ddp473; Huang S, 2009, DEVELOPMENT, V136, P3853, DOI 10.1242/dev.035139; Ji Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008419; Ji Z, 2009, P NATL ACAD SCI USA, V106, P7028, DOI 10.1073/pnas.0900028106; Kadota M, 2007, PLOS GENET, V3, P768, DOI 10.1371/journal.pgen.0030081; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Main BJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-422; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; McDaniell R, 2010, SCIENCE, V328, P235, DOI 10.1126/science.1184655; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; NAGY A, 2003, MANIPULATING MOUSE E, P194; O'Neill MJ, 2005, HUM MOL GENET, V14, pR113, DOI 10.1093/hmg/ddi108; Palacios R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004150; Pant PVK, 2006, GENOME RES, V16, P331, DOI 10.1101/gr.4559106; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Rossant J, 2009, DEVELOPMENT, V136, P701, DOI 10.1242/dev.017178; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Schalkwyk LC, 2010, AM J HUM GENET, V86, P196, DOI 10.1016/j.ajhg.2010.01.014; Sharov AA, 2003, PLOS BIOL, V1, P410, DOI 10.1371/journal.pbio.0000074; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Tang FC, 2010, CELL STEM CELL, V6, P468, DOI 10.1016/j.stem.2010.03.015; Tang FC, 2010, NAT PROTOC, V5, P516, DOI 10.1038/nprot.2009.236; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Tuch BB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009317; Wang QT, 2004, DEV CELL, V6, P133, DOI 10.1016/S1534-5807(03)00404-0; Yan H, 2002, SCIENCE, V297, P1143, DOI 10.1126/science.1072545; Zhang K, 2009, NAT METHODS, V6, P613, DOI 10.1038/nmeth.1357	48	158	164	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21208	10.1371/journal.pone.0021208	http://dx.doi.org/10.1371/journal.pone.0021208			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731673	gold, Green Submitted, Green Published			2022-12-27	WOS:000292035400014
J	Dandoy, P; Meunier, CF; Michiels, C; Su, BL				Dandoy, Philippe; Meunier, Christophe F.; Michiels, Carine; Su, Bao-Lian			Hybrid Shell Engineering of Animal Cells for Immune Protections and Regulation of Drug Delivery: Towards the Design of "Artificial Organs"	PLOS ONE			English	Article							MICROENCAPSULATION TECHNOLOGY; THP-1 CELLS; SILICA; ENCAPSULATION; ALGINATE; GEL; CYTOTOXICITY; ACTIVATION; VIABILITY; CAPSULES	Background: With the progress in medicine, the average human life expectancy is continuously increasing. At the same time, the number of patients who require full organ transplantations is augmenting. Consequently, new strategies for cell transplantation are the subject of great interest. Methodology/Principal Findings: This work reports the design, the synthesis and the characterisation of robust and biocompatible mineralised beads composed of two layers: an alginate-silica composite core and a Ca-alginate layer. The adequate choice of materials was achieved through cytotoxicity LDH release measurement and in vitro inflammatory assay (IL-8) to meet the biocompatibility requirements for medical purpose. The results obtained following this strategy provide a direct proof of the total innocuity of silica and alginate networks for human cells as underscored by the non-activation of immune defenders (THP-1 monocytes). The accessible pore size diameter of the mineralised beads synthesized was estimated between 22 and 30 nm, as required for efficient immuno-isolation without preventing the diffusion of nutrients and metabolites. The model human cells, HepG2, entrapped within these hybrid beads display a high survival rate over more than six weeks according to the measurements of intracellular enzymatic activity, respiration rate, as well as the "de novo" biosynthesis and secretion of albumin out of the beads. Conclusions/Significance: The current study shows that active mammalian cells can be protected by a silica-alginate hybrid shell-like system. The functionality of the cell strain can be maintained. Consequently, cells coated with an artificial and a biocompatible mineral shell could respond physiologically within the human body in order to deliver therapeutic agents in a controlled fashion (i.e. insulin), substituting the declining organ functions of the patient.	[Dandoy, Philippe; Meunier, Christophe F.; Su, Bao-Lian] Univ Namur FUNDP, Dept Chem, Lab Inorgan Mat Chem, Namur, Belgium; [Michiels, Carine] Univ Namur FUNDP, Dept Biol, Lab Biochem & Cellular Biol, Namur, Belgium; [Su, Bao-Lian] Wuhan Univ Technol, State Key Lab Adv Technol Mat Synth & Proc, Wuhan 430070, Peoples R China	University of Namur; University of Namur; Wuhan University of Technology	Dandoy, P (corresponding author), Univ Namur FUNDP, Dept Chem, Lab Inorgan Mat Chem, Namur, Belgium.	christophe.meunier@fundp.ac.be; bao-lian.su@fundp.ac.be		Su, Bao-Lian/0000-0001-8474-0652	Belgian FNRS (Fonds de la Recherche Scientifique - FNRS)	Belgian FNRS (Fonds de la Recherche Scientifique - FNRS)(Fonds de la Recherche Scientifique - FNRS)	Belgian FNRS (Fonds de la Recherche Scientifique - FNRS) http://www1.frs-fnrs.be/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann AM, 2007, J MOL ENDOCRINOL, V38, P193, DOI 10.1677/JME-06-0053; Amoura M, 2007, CHEM COMMUN, P4015, DOI 10.1039/b711380c; Arcangeli G, 2001, SCI TOTAL ENVIRON, V270, P135, DOI 10.1016/S0048-9697(00)00781-6; Bartkowiak A, 1999, ANN NY ACAD SCI, V875, P135, DOI 10.1111/j.1749-6632.1999.tb08499.x; BISCEGLIE V., 1933, ZEITSCHR KREBSFORSCH, V40, P122; Boninsegna S, 2003, J SOL-GEL SCI TECHN, V26, P1151, DOI 10.1023/A:1020731429533; Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023; Carturan G, 2004, J MATER CHEM, V14, P2087, DOI 10.1039/b401450b; Carturan G, 1997, P SOC PHOTO-OPT INS, V3136, P366, DOI 10.1117/12.279168; Cirone P, 2002, HUM GENE THER, V13, P1157, DOI 10.1089/104303402320138943; Coiffier A, 2001, J MATER CHEM, V11, P2039, DOI 10.1039/b101308o; Coradin T, 2002, MATER RES SOC SYMP P, V724, P147; Coradin T, 2003, APPL MICROBIOL BIOT, V61, P429, DOI 10.1007/s00253-003-1308-5; de Vos P, 2002, DIABETOLOGIA, V45, P159, DOI 10.1007/s00125-001-0729-x; Desai TA, 1999, J MEMBRANE SCI, V159, P221, DOI 10.1016/S0376-7388(99)00062-9; DeVos P, 1997, DIABETOLOGIA, V40, P262; Di Pasqua AJ, 2008, J INORG BIOCHEM, V102, P1416, DOI 10.1016/j.jinorgbio.2007.12.028; Ferrer ML, 2002, CHEM MATER, V14, P3619, DOI 10.1021/cm025562r; Fischer D, 2003, BIOMATERIALS, V24, P1121, DOI 10.1016/S0142-9612(02)00445-3; FUKUSHIMA Y, 1988, BIOTECHNOL BIOENG, V32, P584, DOI 10.1002/bit.260320503; GOLDBERG EP, 1964, J POLYM SCI POL LETT, V2, P835, DOI 10.1002/pol.1964.110020818; Goneberg A, 1952, [No title captured], Patent No. [510419, BE 510419]; GREGORY JM, 2010, CLIN DIABETES, V28, P61; KONDORI N, 2001, INT C ANT AG CHEM 41, pJ133; Krimm H, 1962, [No title captured], Patent No. [DE 1136114, 1136114]; La Flamme Kristen E, 2005, Diabetes Technol Ther, V7, P684; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; Lee MJ, 2004, FLUID PHASE EQUILIBR, V221, P63, DOI 10.1016/j.fluid.2004.03.008; Leonard A, 2011, CHEM SOC REV, V40, P860, DOI 10.1039/c0cs00024h; LIM F, 1980, SCIENCE, V210, P908, DOI 10.1126/science.6776628; Lohr M, 2001, LANCET, V357, P1591, DOI 10.1016/S0140-6736(00)04749-8; Meunier CF, 2010, J MATER CHEM, V20, P929, DOI 10.1039/b919763j; Meunier CF, 2010, LANGMUIR, V26, P6568, DOI 10.1021/la9039286; Meunier CF, 2009, J MATER CHEM, V19, P4131, DOI 10.1039/b821769f; Mitjans M, 2010, TOXICOL IN VITRO, V24, P1803, DOI 10.1016/j.tiv.2010.06.001; Morris PJ, 1996, TRENDS BIOTECHNOL, V14, P163, DOI 10.1016/0167-7799(96)10020-2; Murua A, 2008, J CONTROL RELEASE, V132, P76, DOI 10.1016/j.jconrel.2008.08.010; NAGY JA, 1989, CANCER RES, V49, P5448; Nassif N, 2002, NAT MATER, V1, P42, DOI 10.1038/nmat709; Nieto A, 2009, ACTA BIOMATER, V5, P3478, DOI 10.1016/j.actbio.2009.05.033; Nukada Y, 2008, J TOXICOL SCI, V33, P175, DOI 10.2131/jts.33.175; Orive G, 2003, TRENDS PHARMACOL SCI, V24, P207, DOI 10.1016/S0165-6147(03)00073-7; Perullini M, 2008, CHEM MATER, V20, P3015, DOI 10.1021/cm703075b; Prakash S, 1996, NAT MED, V2, P883, DOI 10.1038/nm0896-883; Qi M, 2004, BIOMATERIALS, V25, P5885, DOI 10.1016/j.biomaterials.2004.01.050; Rooke JC, 2008, J MATER CHEM, V18, P2833, DOI 10.1039/b802705f; Sakai S, 2005, BIOMATERIALS, V26, P4786, DOI 10.1016/j.biomaterials.2004.11.043; Sakai S, 2002, BIOTECHNOL PROGR, V18, P401, DOI 10.1021/bp010147+; Sakai S, 2001, BIOMATERIALS, V22, P2827, DOI 10.1016/S0142-9612(01)00016-3; Shimizu K, 2001, CHEM BIOL, V8, P1051, DOI 10.1016/S1074-5521(01)00072-2; Strand BL, 2001, CELL TRANSPLANT, V10, P263, DOI 10.3727/000000001783986800; Vaughn HA, 1965, [No title captured], Patent No. [GB 989379, 989379]	52	19	20	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e20983	10.1371/journal.pone.0020983	http://dx.doi.org/10.1371/journal.pone.0020983			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731637	Green Submitted, gold, Green Published			2022-12-27	WOS:000292033700024
J	Chopra, M; Golden, HB; Mullapudi, S; Dowhan, W; Dostal, DE; Sharma, AC				Chopra, Mani; Golden, Honey B.; Mullapudi, Srinivas; Dowhan, William; Dostal, David E.; Sharma, Avadhesh C.			Modulation of Myocardial Mitochondrial Mechanisms during Severe Polymicrobial Sepsis in the Rat	PLOS ONE			English	Article							PERMEABILITY TRANSITION PORE; VENTRICULAR MYOCYTE CONTRACTILITY; BCL-2 FAMILY PROTEINS; K-ATP CHANNELS; CYTOCHROME-C; NITRIC-OXIDE; DYSFUNCTION; ENDOTHELIN; APOPTOSIS; RELEASE	Background: We tested the hypothesis that 5-Hydroxydecanoic acid (5HD), a putative mitoKATP channel blocker, will reverse sepsis-induced cardiodynamic and adult rat ventricular myocyte (ARVM) contractile dysfunction, restore mitochondrial membrane permeability alterations and improve survival. Methodology/Principal Findings: Male Sprague-Dawley rats (350-400 g) were made septic using 400 mg/kg cecal inoculum, ip. Sham animals received 5% dextrose water, ip. The Voltage Dependent Anion Channels (VDAC1), Bax and cytochrome C levels were determined in isolated single ARVMs obtained from sham and septic rat heart. Mitochondria and cytosolic fractions were isolated from ARVMs treated with norepinephrine (NE, 10 mu moles) in the presence/absence of 5HD (100 mmoles). A continuous infusion of 5HD using an Alzet pump reversed sepsis-induced mortality when administered at the time of induction of sepsis (-40%) and at 6 hr post-sepsis (-20%). Electrocardiography revealed that 5HD reversed sepsis-induced decrease in the average ejection fraction, Simpsons+m Mode (53.5 +/- 2.5 in sepsis and 69.2 +/- 1.2 at 24 hr in sepsis+5HD vs. 79.9 +/- 1.5 basal group) and cardiac output (63.3 +/- 1.2 mL/min sepsis and 79.3 +/- 3.9 mL/min at 24 hr in sepsis+5HD vs. 85.8 +/- 1.5 mL/min basal group). The treatment of ARVMs with 5HD also reversed sepsis-induced depressed contractility in both the vehicle and NE-treated groups. Sepsis produced a significant downregulation of VDAC1, and upregulation of Bax levels, along with mitochondrial membrane potential collapse in ARVMs. Pretreatment of septic ARVMs with 5HD blocked a NE-induced decrease in the VDAC1 and release of cytochrome C. Conclusion: The data suggest that Bax activation is an upstream event that may precede the opening of the mitoKATP channels in sepsis. We concluded that mitoKATP channel inhibition via decreased mitochondrial membrane potential and reduced release of cytochrome C provided protection against sepsis-induced ARVM and myocardial contractile dysfunction.	[Chopra, Mani; Sharma, Avadhesh C.] Texas A&M Hlth Sci Ctr, Baylor Coll Dent, Dept Biomed Sci, Dallas, TX USA; [Golden, Honey B.; Dostal, David E.] Texas A&M Hlth Sci Ctr, Dept Mol Cardiol, Cardiovasc Res Inst, Coll Med, Temple, TX USA; [Mullapudi, Srinivas; Dowhan, William] Univ Texas Med Sch Houston, Dept Biochem & Mol Biol, Houston, TX USA; [Sharma, Avadhesh C.] Philadelphia Coll Osteopath Med, Sch Pharm, Dept Pharmaceut Sci, Cardionome Lab, Suwanee, GA USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston	Chopra, M (corresponding author), Texas A&M Hlth Sci Ctr, Baylor Coll Dent, Dept Biomed Sci, Dallas, TX USA.	AvadheshSh@pcom.edu			National Institutes of Health (NHLBI) [HL 66016]; AHA [160444Z]; Texas A&M Health Science Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R15HL066016] Funding Source: NIH RePORTER	National Institutes of Health (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); AHA(American Heart Association); Texas A&M Health Science Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The present study was supported by funds obtained from the National Institutes of Health (NHLBI, HL 66016), AHA (160444Z) and in part by a grant from the Texas A&M Health Science Center Research Development and Enhancement Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardehali H, 2005, J MOL CELL CARDIOL, V39, P7, DOI 10.1016/j.yjmcc.2004.12.003; Bayrhuber M, 2008, P NATL ACAD SCI USA, V105, P15370, DOI 10.1073/pnas.0808115105; Bernardi P, 1996, BBA-BIOENERGETICS, V1275, P5, DOI 10.1016/0005-2728(96)00041-2; Bernardi P, 1996, J BIOENERG BIOMEMBR, V28, P131, DOI 10.1007/BF02110643; Bouchier-Hayes L, 2005, J CLIN INVEST, V115, P2640, DOI 10.1172/JCI26274; Brahmbhatt S, 2005, MOL CELL BIOCHEM, V271, P225, DOI 10.1007/s11010-005-6416-3; Brealey D, 2004, AM J PHYSIOL-REG I, V286, pR491, DOI 10.1152/ajpregu.00432.2003; Brealey David, 2002, Lancet (North American Edition), V360, P219, DOI 10.1016/S0140-6736(02)09459-X; Brenner C, 2006, ONCOGENE, V25, P4744, DOI 10.1038/sj.onc.1209609; Chernyak BV, 1996, EUR J BIOCHEM, V238, P623, DOI 10.1111/j.1432-1033.1996.0623w.x; Chopra M, 2007, LIFE SCI, V81, P306, DOI 10.1016/j.lfs.2007.05.021; Chopra M, 2007, FRONT BIOSCI-LANDMRK, V12, P3052, DOI 10.2741/2294; Chopra M, 2010, LIFE SCI, V87, P672, DOI 10.1016/j.lfs.2010.09.029; Chopra M, 2010, BRIT J PHARMACOL, V160, P93, DOI 10.1111/j.1476-5381.2010.00686.x; Chopra M, 2009, PHARMACOL RES, V60, P303, DOI 10.1016/j.phrs.2009.04.009; COLOMBINI M, 1979, NATURE, V279, P643, DOI 10.1038/279643a0; Cook SA, 1999, CIRC RES, V85, P940; Crouser ED, 2002, CRIT CARE MED, V30, P2722, DOI 10.1097/00003246-200212000-00017; Crouser ED, 2002, CRIT CARE MED, V30, P276, DOI 10.1097/00003246-200202000-00002; Garlid KD, 2003, BBA-BIOENERGETICS, V1606, P23, DOI 10.1016/S0005-2728(03)00108-7; Gupta A, 2005, FRONT BIOSCI-LANDMRK, V10, P3183, DOI 10.2741/1774; Gupta A, 2005, BBA-MOL BASIS DIS, V1741, P127, DOI 10.1016/j.bbadis.2005.03.006; Gupta A, 2005, J MOL CELL CARDIOL, V38, P527, DOI 10.1016/j.yjmcc.2005.01.002; Hanley PJ, 2002, J PHYSIOL-LONDON, V542, P735, DOI 10.1113/jphysiol.2002.023960; Hiller S, 2008, SCIENCE, V321, P1206, DOI 10.1126/science.1161302; Hou Q, 2005, AM J PHYSIOL-HEART C, V289, pH477, DOI 10.1152/ajpheart.00879.2004; Hou Q, 2003, APOPTOSIS, V8, P617, DOI 10.1023/A:1026187526113; INOUE I, 1991, NATURE, V352, P244, DOI 10.1038/352244a0; Krishnagopalan Sreenandh, 2002, Curr Opin Crit Care, V8, P376, DOI 10.1097/00075198-200210000-00003; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; PAUCEK P, 1992, J BIOL CHEM, V267, P26062; Peart JN, 2002, J CELL MOL MED, V6, P453, DOI 10.1111/j.1582-4934.2002.tb00449.x; Ren J, 2002, SHOCK, V18, P285, DOI 10.1097/00024382-200209000-00014; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; Seharaseyon J, 2000, J MOL CELL CARDIOL, V32, P1923, DOI 10.1006/jmcc.2000.1226; Sharma AC, 1997, J MOL CELL CARDIOL, V29, P1469, DOI 10.1006/jmcc.1997.0386; Sharma AC, 2007, SHOCK, V28, P265, DOI 10.1097/01.shk.0000235090.30550.fb; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Tsujimoto Y, 2000, CELL DEATH DIFFER, V7, P1174, DOI 10.1038/sj.cdd.4400780; Weiss JN, 2003, CIRC RES, V93, P292, DOI 10.1161/01.RES.0000087542.26971.D4; Zang Q, 2007, J APPL PHYSIOL, V102, P103, DOI 10.1152/japplphysiol.00359.2006; Zang Qun, 2007, Surg Infect (Larchmt), V8, P41, DOI 10.1089/sur.2006.033	42	27	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2011	6	6							e21285	10.1371/journal.pone.0021285	http://dx.doi.org/10.1371/journal.pone.0021285			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782CL	21712982	gold, Green Published, Green Submitted			2022-12-27	WOS:000291985100024
J	De Santis, R; Anastasi, AM; Pelliccia, A; Rosi, A; Albertoni, C; Verdoliva, A; Petronzelli, F; D'Alessio, V; Serani, S; Nuzzolo, CA				De Santis, Rita; Anastasi, Anna Maria; Pelliccia, Angela; Rosi, Antonio; Albertoni, Claudio; Verdoliva, Antonio; Petronzelli, Fiorella; D'Alessio, Valeria; Serani, Serenella; Nuzzolo, Carlo Antonio			Chemical Linkage to Injected Tissues Is a Distinctive Property of Oxidized Avidin	PLOS ONE			English	Article							PROTEIN; ANTIBODY; ACTIVATION; ACID	We recently reported that the oxidized avidin, named AvidinOX (R), resides for weeks within injected tissues as a consequence of the formation of Schiff's bases between its aldehyde groups and tissue protein amino groups. We also showed, in a mouse pre-clinical model, the usefulness of AvidinOX for the delivery of radiolabeled biotin to inoperable tumors. Taking into account that AvidinOX is the first oxidized glycoprotein known to chemically link to injected tissues, we tested in the mouse a panel of additional oxidized glycoproteins, with the aim of investigating the phenomenon. We produced oxidized ovalbumin and mannosylated streptavidin which share with avidin glycosylation pattern and tetrameric structure, respectively and found that neither of them linked significantly to cells in vitro nor to injected tissues in vivo, despite the presence of functional aldehyde groups. The study, extended to additional oxidized glycoproteins, showed that the in vivo chemical conjugation is a distinctive property of the oxidized avidin. Relevance of the high cationic charge of avidin into the stable linkage of AvidinOX to tissues is demonstrated as the oxidized acetylated avidin lost the property. Plasmon resonance on matrix proteins and cellular impedance analyses showed in vitro that avidin exhibits a peculiar interaction with proteins and cells that allows the formation of highly stable Schiff's bases, after oxidation.	[De Santis, Rita; Anastasi, Anna Maria; Pelliccia, Angela; Rosi, Antonio; Albertoni, Claudio; Petronzelli, Fiorella; D'Alessio, Valeria; Serani, Serenella; Nuzzolo, Carlo Antonio] Sigma Tau Pharmaceut Co, Dept Immunol, Rome, Italy; [Verdoliva, Antonio] Tecnogen SpA, Dept Dev, Piana Monte Verna, Caserta, Italy	Leadiant Biosciences	De Santis, R (corresponding author), Sigma Tau Pharmaceut Co, Dept Immunol, Rome, Italy.	rita.desantis@sigma-tau.it		DE SANTIS, Rita/0000-0002-5037-0611	Sigma Tau SpA	Sigma Tau SpA	The work was funded by Sigma Tau SpA. All authors are employees of Sigma-Tau SpA and Tecnogen SpA and contributed to all aspects of the study.	AVIGAD G, 1983, ANAL BIOCHEM, V134, P499, DOI 10.1016/0003-2697(83)90330-5; BRUCH RC, 1982, BIOCHEMISTRY-US, V21, P5334, DOI 10.1021/bi00264a033; CHAIET L, 1964, ARCH BIOCHEM BIOPHYS, V106, P1, DOI 10.1016/0003-9861(64)90150-X; Charbonneau J, 1999, CELL ADHES COMMUN, V7, P233, DOI 10.3109/15419069909010805; Damen CWN, 2009, J AM SOC MASS SPECTR, V20, P2021, DOI 10.1016/j.jasms.2009.07.017; De Santis R, 2003, BRIT J CANCER, V88, P996, DOI 10.1038/sj.bjc.6600818; De Santis R, 2010, CANCER BIOTHER RADIO, V25, P143, DOI 10.1089/cbr.2009.0738; De Santis R, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/921434; GREEN NM, 1965, BIOCHEM J, V94, pC23, DOI 10.1042/bj0940023C; Helppolainen SH, 2008, BBA-PROTEINS PROTEOM, V1784, P1002, DOI 10.1016/j.bbapap.2008.04.010; Helppolainen SH, 2007, BIOCHEM J, V405, P397, DOI 10.1042/BJ20070076; Hytonen VP, 2004, J BIOL CHEM, V279, P9337, DOI 10.1074/jbc.M310989200; Hytonen VP, 2003, BIOCHEM J, V372, P219, DOI 10.1042/BJ20021531; Inforzato A, 2006, BIOCHEMISTRY-US, V45, P11540, DOI 10.1021/bi0607453; Jossinet Jacques, 2010, Stud Health Technol Inform, V152, P69; Kawada K, 2009, MOL CELL BIOL, V29, P4508, DOI 10.1128/MCB.00015-09; Laitinen OH, 2006, CELL MOL LIFE SCI, V63, P2992, DOI 10.1007/s00018-006-6288-z; Ma S, 1999, ANAL CHEM, V71, P5185, DOI 10.1021/ac990376z; Maatta JAE, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-63; MUZYKANTOV VR, 1991, BIOCHEM J, V273, P393, DOI 10.1042/bj2730393; Nordlund HR, 2005, J BIOL CHEM, V280, P13250, DOI 10.1074/jbc.M414336200; OSHANNESSY DJ, 1987, J IMMUNOL METHODS, V99, P153, DOI 10.1016/0022-1759(87)90120-7; Petronzelli F, 2011, BASIC CLIN PHARMACOL, V109, P145, DOI 10.1111/j.1742-7843.2011.00701.x; Raj GV, 2004, PROSTATE, V61, P105, DOI 10.1002/pros.20083; SASHIDHAR RB, 1994, J IMMUNOL METHODS, V167, P121, DOI 10.1016/0022-1759(94)90081-7; Tankrathok A, 2009, PREP BIOCHEM BIOTECH, V39, P380, DOI 10.1080/10826060903209646; Thornalley PJ, 1999, BIOCHEM J, V344, P109, DOI 10.1042/0264-6021:3440109; Urbano N, 2007, EUR J NUCL MED MOL I, V34, P68, DOI 10.1007/s00259-006-0124-4; Verdoliva A, 2010, J BIOL CHEM, V285, P9090, DOI 10.1074/jbc.M109.080457; YAMASHITA K, 1978, J BIOL CHEM, V253, P3862; Yao ZS, 1999, J NUCL MED, V40, P479; ZABORSKY OR, 1974, BIOCHEM BIOPH RES CO, V61, P210, DOI 10.1016/0006-291X(74)90554-3	32	10	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e21075	10.1371/journal.pone.0021075	http://dx.doi.org/10.1371/journal.pone.0021075			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	21701578	Green Submitted, Green Published, gold			2022-12-27	WOS:000291983800020
J	Edwards, IP; Zak, DR; Kellner, H; Eisenlord, SD; Pregitzer, KS				Edwards, Ivan P.; Zak, Donald R.; Kellner, Harald; Eisenlord, Sarah D.; Pregitzer, Kurt S.			Simulated Atmospheric N Deposition Alters Fungal Community Composition and Suppresses Ligninolytic Gene Expression in a Northern Hardwood Forest	PLOS ONE			English	Article							MULTICOPPER OXIDASE GENES; NITROGEN DEPOSITION; NO3-DEPOSITION; TRANSCRIPTIONAL REGULATION; CARBON SEQUESTRATION; ENZYME-ACTIVITY; LEAF-LITTER; TEMPERATE; DEGRADATION; DIVERSITY	High levels of atmospheric nitrogen (N) deposition may result in greater terrestrial carbon (C) storage. In a northern hardwood ecosystem, exposure to over a decade of simulated N deposition increased C storage in soil by slowing litter decay rates, rather than increasing detrital inputs. To understand the mechanisms underlying this response, we focused on the saprotrophic fungal community residing in the forest floor and employed molecular genetic approaches to determine if the slower decomposition rates resulted from down-regulation of the transcription of key lignocellulolytic genes, by a change in fungal community composition, or by a combination of the two mechanisms. Our results indicate that across four Acer-dominated forest stands spanning a 500-km transect, community-scale expression of the cellulolytic gene cbhI under elevated N deposition did not differ significantly from that under ambient levels of N deposition. In contrast, expression of the ligninolytic gene lcc was significantly down-regulated by a factor of 2-4 fold relative to its expression under ambient N deposition. Fungal community composition was examined at the most southerly of the four sites, in which consistently lower levels of cbhI and lcc gene expression were observed over a two-year period. We recovered 19 basidiomycete and 28 ascomycete rDNA 28S operational taxonomic units; Athelia, Sistotrema, Ceratobasidium and Ceratosebacina taxa dominated the basidiomycete assemblage, and Leotiomycetes dominated the ascomycetes. Simulated N deposition increased the proportion of basidiomycete sequences recovered from forest floor, whereas the proportion of ascomycetes in the community was significantly lower under elevated N deposition. Our results suggest that chronic atmospheric N deposition may lower decomposition rates through a combination of reduced expression of ligninolytic genes such as lcc, and compositional changes in the fungal community.	[Edwards, Ivan P.; Zak, Donald R.; Kellner, Harald; Eisenlord, Sarah D.] Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA; [Zak, Donald R.] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; [Pregitzer, Kurt S.] Univ Idaho, Coll Nat Resources, Moscow, ID 83843 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Idaho; University of Idaho	Edwards, IP (corresponding author), Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA.	iedwards@umich.edu	Zak, Donald R/C-6004-2012; Kellner, Harald/B-8729-2009	Zak, Donald/0000-0002-9730-7337	National Science Foundation [DEB 061442, DEB 0814623]; Office of Science (BER) United States Department of Energy	National Science Foundation(National Science Foundation (NSF)); Office of Science (BER) United States Department of Energy(United States Department of Energy (DOE))	This work was supported by grants from the National Science Foundation (DEB 061442 and DEB 0814623) and by the Office of Science (BER) United States Department of Energy to DRZ and KSP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison SD, 2007, SOIL BIOL BIOCHEM, V39, P1878, DOI 10.1016/j.soilbio.2007.02.001; Aro N, 2005, FEMS MICROBIOL REV, V29, P719, DOI 10.1016/j.femsre.2004.11.006; Baldrian P, 2006, FEMS MICROBIOL REV, V30, P215, DOI 10.1111/j.1574-4976.2005.00010.x; Baldrian P, 2008, FEMS MICROBIOL REV, V32, P501, DOI 10.1111/j.1574-6976.2008.00106.x; Baldrian P, 2010, APPL SOIL ECOL, V46, P177, DOI 10.1016/j.apsoil.2010.08.013; Baldrian P, 2011, PLANT SOIL, V338, P111, DOI 10.1007/s11104-010-0324-3; Berg Bjorn, 1997, Environmental Reviews, V5, P1, DOI 10.1139/er-5-1-1; Binder M, 2005, SYST BIODIVERS, V3, P113, DOI 10.1017/S1477200005001623; Burton AJ, 2004, GLOBAL CHANGE BIOL, V10, P1080, DOI 10.1111/j.1365-2486.2004.00737.x; Carreiro MM, 2000, ECOLOGY, V81, P2359, DOI 10.1890/0012-9658(2000)081[2359:MESELD]2.0.CO;2; Chen DM, 2003, NEW PHYTOL, V157, P547, DOI 10.1046/j.1469-8137.2003.00687.x; De Vries W, 2006, GLOBAL CHANGE BIOL, V12, P1151, DOI 10.1111/j.1365-2486.2006.01151.x; DeForest JL, 2004, SOIL SCI SOC AM J, V68, P132, DOI 10.2136/sssaj2004.1320; Edwards IP, 2008, APPL ENVIRON MICROB, V74, P3481, DOI 10.1128/AEM.02893-07; Edwards IP, 2011, GLOBAL CHANGE BIOL, V17, P2184, DOI 10.1111/j.1365-2486.2010.02376.x; Einax E, 2003, ORG DIVERS EVOL, V3, P185, DOI 10.1078/1439-6092-00069; FOG K, 1988, BIOL REV, V63, P433, DOI 10.1111/j.1469-185X.1988.tb00725.x; Frankland JC, 1998, MYCOL RES, V102, P1, DOI 10.1017/S0953756297005364; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Hassett JE, 2009, MICROB ECOL, V57, P728, DOI 10.1007/s00248-008-9440-5; Ilmen M, 1997, APPL ENVIRON MICROB, V63, P1298; JEFFRIES TW, 1981, APPL ENVIRON MICROB, V42, P290, DOI 10.1128/AEM.42.2.290-296.1981; Katho K., 2002, NUCLEIC ACIDS RES, V30, P3059, DOI [10.1093/nar/gkf436, DOI 10.1093/NAR/GKF436]; Kellner H, 2008, SOIL BIOL BIOCHEM, V40, P638, DOI 10.1016/j.soilbio.2007.09.013; Kellner H, 2007, FEMS MICROBIOL ECOL, V61, P153, DOI 10.1111/j.1574-6941.2007.00322.x; Kellner H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010971; KIRK TK, 1987, ANNU REV MICROBIOL, V41, P465, DOI 10.1146/annurev.mi.41.100187.002341; LEATHAM GF, 1983, FEMS MICROBIOL LETT, V16, P65, DOI 10.1111/j.1574-6968.1983.tb00260.x; LI D, 1994, APPL ENVIRON MICROB, V60, P3447, DOI 10.1128/AEM.60.9.3447-3449.1994; Lindahl BD, 2007, NEW PHYTOL, V173, P611, DOI 10.1111/j.1469-8137.2006.01936.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lockington RA, 2002, FUNGAL GENET BIOL, V37, P190, DOI 10.1016/S1087-1845(02)00504-2; Luis P, 2005, GEODERMA, V128, P18, DOI 10.1016/j.geoderma.2004.12.023; Lyons JI, 2003, MICROB ECOL, V45, P270, DOI 10.1007/s00248-002-1055-7; Magnani F, 2007, NATURE, V447, P848, DOI 10.1038/nature05847; Nadelhoffer KJ, 1999, NATURE, V398, P145, DOI 10.1038/18205; Osono T, 2002, MYCOLOGIA, V94, P421, DOI 10.2307/3761776; Osono T, 2001, EUR J SOIL BIOL, V37, P17, DOI 10.1016/S1164-5563(01)01066-4; Osono T, 2007, ECOL RES, V22, P955, DOI 10.1007/s11284-007-0390-z; Pointing SB, 2005, MYCOL RES, V109, P115, DOI 10.1017/S0953756204001376; Pregitzer KS, 2008, GLOBAL CHANGE BIOL, V14, P142, DOI 10.1111/j.1365-2486.2007.01465.x; Rayner A. D. M., 1988, Fungal decomposition of wood. Its biology and ecology.; Saiya-Cork KR, 2002, SOIL BIOL BIOCHEM, V34, P1309, DOI 10.1016/S0038-0717(02)00074-3; Sinsabaugh RL, 2002, BIOGEOCHEMISTRY, V60, P1, DOI 10.1023/A:1016541114786; Soden DM, 2001, MICROBIOL-SGM, V147, P1755, DOI 10.1099/00221287-147-7-1755; Spatafora JW, 2006, MYCOLOGIA, V98, P1018, DOI 10.3852/mycologia.98.6.1018; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TERBRAAK CJF, 1986, ECOLOGY, V67, P1167; Waldrop MP, 2004, ECOL APPL, V14, P1172, DOI 10.1890/03-5120; Worrall JJ, 1997, MYCOLOGIA, V89, P199, DOI 10.2307/3761073; Zak DR, 2008, ECOL APPL, V18, P2016, DOI 10.1890/07-1743.1	51	131	141	4	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e20421	10.1371/journal.pone.0020421	http://dx.doi.org/10.1371/journal.pone.0020421			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	21701691	Green Published, gold, Green Submitted			2022-12-27	WOS:000291983800006
J	Liesz, A; Sun, L; Zhou, W; Schwarting, S; Mracsko, E; Zorn, M; Bauer, H; Sommer, C; Veltkamp, R				Liesz, Arthur; Sun, Li; Zhou, Wei; Schwarting, Soenke; Mracsko, Eva; Zorn, Markus; Bauer, Henrike; Sommer, Clemens; Veltkamp, Roland			FTY720 Reduces Post-Ischemic Brain Lymphocyte Influx but Does Not Improve Outcome in Permanent Murine Cerebral Ischemia	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; NECROSIS-FACTOR-ALPHA; MULTIPLE-SCLEROSIS; ARTERY OCCLUSION; T-LYMPHOCYTES; INFLAMMATORY MECHANISMS; QUANTITATIVE-EVALUATION; EXPERIMENTAL STROKE; FINGOLIMOD FTY720; NITRIC-OXIDE	Background: The contribution of neuroinflammation and specifically brain lymphocyte invasion is increasingly recognised as a substantial pathophysiological mechanism after stroke. FTY720 is a potent treatment for primary neuroinflammatory diseases by inhibiting lymphocyte circulation and brain immigration. Previous studies using transient focal ischemia models showed a protective effect of FTY720 but did only partially characterize the involved pathways. We tested the neuroprotective properties of FTY720 in permanent and transient cortical ischemia and analyzed the underlying neuroimmunological mechanisms. Methodology/Principal Findings: FTY720 treatment resulted in substantial reduction of circulating lymphocytes while blood monocyte counts were significantly increased. The number of histologically and flow cytometrically analyzed brain invading T-and B lymphocytes was significantly reduced in FTY720 treated mice. However, despite testing a variety of treatment protocols, infarct volume and behavioural dysfunction were not reduced 7d after permanent occlusion of the distal middle cerebral artery (MCAO). Additionally, we did not measure a significant reduction in infarct volume at 24h after 60 min filament-induced MCAO, and did not see differences in brain edema between PBS and FTY720 treatment. Analysis of brain cytokine expression revealed complex effects of FTY720 on postischemic neuroinflammation comprising a substantial reduction of delayed proinflammatory cytokine expression at 3d but an early increase of IL-1 beta and IFN-gamma at 24 h after MCAO. Also, serum cytokine levels of IL-6 and TNF-alpha were increased in FTY720 treated animals compared to controls. Conclusions/Significance: In the present study we were able to detect a reduction of lymphocyte brain invasion by FTY720 but could not achieve a significant reduction of infarct volumes and behavioural dysfunction. This lack of neuroprotection despite effective lymphopenia might be attributed to a divergent impact of FTY720 on cytokine expression and possible activation of innate immune cells after brain ischemia.	[Liesz, Arthur; Sun, Li; Zhou, Wei; Schwarting, Soenke; Mracsko, Eva; Veltkamp, Roland] Univ Heidelberg, Dept Neurol, Heidelberg, Germany; [Zorn, Markus] Univ Heidelberg, Dept Internal Med, D-6900 Heidelberg, Germany; [Bauer, Henrike; Sommer, Clemens] Univ Med Ctr Mainz, Dept Neuropathol, Mainz, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Johannes Gutenberg University of Mainz	Liesz, A (corresponding author), Univ Heidelberg, Dept Neurol, Heidelberg, Germany.	Arthur.Liesz@med.uni-heidelberg.de	Liesz, Arthur/AAT-7147-2021	Liesz, Arthur/0000-0002-9069-2594	Else-Kroner-Memorial scholarship	Else-Kroner-Memorial scholarship	This study was supported by an Else-Kroner-Memorial scholarship to RV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktas O, 2010, NAT REV NEUROL, V6, P373, DOI 10.1038/nrneurol.2010.76; Arumugam TV, 2005, NEUROMOL MED, V7, P229, DOI 10.1385/NMM:7:3:229; Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; Barone FC, 1999, J CEREBR BLOOD F MET, V19, P819, DOI 10.1097/00004647-199908000-00001; Becker K, 2001, STROKE, V32, P206, DOI 10.1161/01.STR.32.1.206; Belayev L, 1996, BRAIN RES, V739, P88, DOI 10.1016/S0006-8993(96)00815-3; Boutin H, 2001, J NEUROSCI, V21, P5528, DOI 10.1523/JNEUROSCI.21-15-05528.2001; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Brinkmann V, 2009, BRIT J PHARMACOL, V158, P1173, DOI 10.1111/j.1476-5381.2009.00451.x; Chao CC, 1995, BRAIN BEHAV IMMUN, V9, P355, DOI 10.1006/brbi.1995.1033; Czech B, 2009, BIOCHEM BIOPH RES CO, V389, P251, DOI 10.1016/j.bbrc.2009.08.142; Danton GH, 2003, J NEUROPATH EXP NEUR, V62, P127, DOI 10.1093/jnen/62.2.127; Davies CA, 1999, J CEREBR BLOOD F MET, V19, P87, DOI 10.1097/00004647-199901000-00010; del Zoppo GJ, 2001, ARCH NEUROL-CHICAGO, V58, P669, DOI 10.1001/archneur.58.4.669; Dirnagl U, 2004, E SCHERING RES FDN W, V47, P87; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Ecker RC, 2006, CYTOM PART A, V69A, P119, DOI 10.1002/cyto.a.20219; Engelhardt B, 2009, SEMIN IMMUNOPATHOL, V31, P497, DOI 10.1007/s00281-009-0177-0; Frangogiannis NG, 2002, CARDIOVASC RES, V53, P31, DOI 10.1016/S0008-6363(01)00434-5; Fujino M, 2003, J PHARMACOL EXP THER, V305, P70, DOI 10.1124/jpet.102.045658; GARCIA JH, 1994, AM J PATHOL, V144, P188; Gee JM, 2007, STROKE, V38, P783, DOI 10.1161/01.STR.0000248425.59176.7b; Gelderblom M, 2009, STROKE, V40, P1849, DOI 10.1161/STROKEAHA.108.534503; Hasegawa Y, 2010, STROKE, V41, P368, DOI 10.1161/STROKEAHA.109.568899; Hug A, 2009, STROKE, V40, P3226, DOI 10.1161/STROKEAHA.109.557967; Hughes JE, 2008, CIRC RES, V102, P950, DOI 10.1161/CIRCRESAHA.107.170779; Hurn PD, 2007, J CEREBR BLOOD F MET, V27, P1798, DOI 10.1038/sj.jcbfm.9600482; Ito D, 2001, STROKE, V32, P1208, DOI 10.1161/01.STR.32.5.1208; Jin R, 2010, J LEUKOCYTE BIOL, V87, P779, DOI 10.1189/jlb.1109766; Kappos L, 2006, NEW ENGL J MED, V355, P1124, DOI 10.1056/NEJMoa052643; Kataoka H, 2005, CELL MOL IMMUNOL, V2, P439; Kawai N, 2001, BRAIN RES, V895, P50, DOI 10.1016/S0006-8993(01)02026-1; Liesz A, 2011, BRAIN, V134, P704, DOI 10.1093/brain/awr008; Liesz A, 2009, STROKE, V40, P2849, DOI 10.1161/STROKEAHA.109.549618; Liesz A, 2009, NAT MED, V15, P192, DOI 10.1038/nm.1927; Massberg S, 2006, NEW ENGL J MED, V355, P1088, DOI 10.1056/NEJMp068159; Means CK, 2009, CARDIOVASC RES, V82, P193, DOI 10.1093/cvr/cvp086; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; Michaud J, 2010, J IMMUNOL, V184, P1475, DOI 10.4049/jimmunol.0901586; Miron VE, 2008, J NEUROL SCI, V274, P13, DOI 10.1016/j.jns.2008.06.031; PAPADOPOULOS D, J NEUROSCI RES, V88, P346; Prass K, 2003, J EXP MED, V198, P725, DOI 10.1084/jem.20021098; Rabb H, 2000, AM J PHYSIOL-RENAL, V279, pF525, DOI 10.1152/ajprenal.2000.279.3.F525; Rivera J, 2008, NAT REV IMMUNOL, V8, P753, DOI 10.1038/nri2400; Rothwell NJ, 2000, TRENDS NEUROSCI, V23, P618, DOI 10.1016/S0166-2236(00)01661-1; Salomone S, 2008, BRIT J PHARMACOL, V153, P140, DOI 10.1038/sj.bjp.0707581; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Schroeter M, 2005, NEUROMOL MED, V7, P183, DOI 10.1385/NMM:7:3:183; Shichita T, 2009, NAT MED, V15, P946, DOI 10.1038/nm.1999; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; TAMURA A, 1981, J CEREBR BLOOD F MET, V1, P53, DOI 10.1038/jcbfm.1981.6; Turrin NP, 2006, J NEUROSCI, V26, P143, DOI 10.1523/JNEUROSCI.4032-05.2006; UYAMA O, 1988, J CEREBR BLOOD F MET, V8, P282, DOI 10.1038/jcbfm.1988.59; Vogel J, 1999, STROKE, V30, P1134, DOI 10.1161/01.STR.30.5.1134; WANG Q, 2006, J NEUROIMMUNOL; Webb M, 2004, J NEUROIMMUNOL, V153, P108, DOI 10.1016/j.jneuroim.2004.04.015; WEI Y, ANN NEUROL; Weigert A, 2009, IMMUNOBIOLOGY, V214, P748, DOI 10.1016/j.imbio.2009.06.003; Yilmaz G, 2006, CIRCULATION, V113, P2105, DOI 10.1161/CIRCULATIONAHA.105.593046; Zhang L, 2002, J NEUROSCI METH, V117, P207, DOI 10.1016/S0165-0270(02)00114-0; Zwacka RM, 1997, J CLIN INVEST, V100, P279, DOI 10.1172/JCI119533	62	86	87	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e21312	10.1371/journal.pone.0021312	http://dx.doi.org/10.1371/journal.pone.0021312			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	21701599	Green Published, gold, Green Submitted			2022-12-27	WOS:000291983800041
J	Liu, XJ; Li, YY; Zhang, Y; Lu, Y; Guo, W; Liu, P; Zhou, JZ; Xiang, ZH; He, C				Liu, Xiujie; Li, Yuanyuan; Zhang, Yong; Lu, Yan; Guo, Wei; Liu, Peng; Zhou, Jiazhen; Xiang, Zhenghua; He, Cheng			SHP-2 Promotes the Maturation of Oligodendrocyte Precursor Cells Through Akt and ERK1/2 Signaling In Vitro	PLOS ONE			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; CENTRAL-NERVOUS-SYSTEM; THYROID-HORMONE; GROWTH-FACTOR; PHOSPHATIDYLINOSITOL 3-KINASE; CNS MYELINATION; KINASE; DIFFERENTIATION; MICE; ACTIVATION	Background: Oligodendrocyte precursor cells (OPCs) differentiate into oligodendrocytes (OLs), which are responsible for myelination. Myelin is essential for saltatory nerve conduction in the vertebrate nervous system. However, the molecular mechanisms of maturation and myelination by oligodendrocytes remain elusive. Methods and Findings: In the present study, we showed that maturation of oligodendrocytes was attenuated by sodium orthovanadate (a comprehensive inhibitor of tyrosine phosphatases) and PTPi IV (a specific inhibitor of SHP-2). It is also found that SHP-2 was persistently expressed during maturation process of OPCs. Down-regulation of endogenous SHP-2 led to impairment of oligodendrocytes maturation and this effect was triiodo-L-thyronine (T3) dependent. Furthermore, overexpression of SHP-2 was shown to promote maturation of oligodendrocytes. Finally, it has been identified that SHP-2 was involved in activation of Akt and extracellular-regulated kinases 1 and 2 (ERK1/2) induced by T3 in oligodendrocytes. Conclusions: SHP-2 promotes oligodendrocytes maturation via Akt and ERK1/2 signaling in vitro.	[Liu, Xiujie; Li, Yuanyuan; Zhang, Yong; Lu, Yan; Guo, Wei; Liu, Peng; Zhou, Jiazhen; Xiang, Zhenghua; He, Cheng] Second Mil Med Univ, Changzheng Hosp, Neurosci Res Ctr, Key Lab Mol Neurobiol,Inst Neurosci,Minist Educ, Shanghai, Peoples R China	Naval Medical University	Liu, XJ (corresponding author), Second Mil Med Univ, Changzheng Hosp, Neurosci Res Ctr, Key Lab Mol Neurobiol,Inst Neurosci,Minist Educ, Shanghai, Peoples R China.	chenghe@smmu.edu.cn	Messier, Claude/A-2322-2008; li, yuanyuan/GZA-4435-2022	Messier, Claude/0000-0002-4791-1763; 	National Natural Science Foundation [30970999]; National Key Basic Research Program [2007CB947100, 2011CB504401]; Ministry of Science and Technology of China [2009ZX09311-001]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program(National Basic Research Program of China); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This study was supported by the National Natural Science Foundation (30970999), National Key Basic Research Program (2007CB947100, 2011CB504401), and the Ministry of Science and Technology of China (2009ZX09311-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakura K, 1997, J NEUROCHEM, V68, P2281; Baas D, 1997, GLIA, V19, P324, DOI 10.1002/(SICI)1098-1136(199704)19:4<324::AID-GLIA5>3.0.CO;2-X; Baas D, 2002, P NATL ACAD SCI USA, V99, P2907, DOI 10.1073/pnas.052482299; Barros CS, 2009, DEVELOPMENT, V136, P2717, DOI 10.1242/dev.038679; Bibollet-Bahena O, 2009, J NEUROCHEM, V109, P1440, DOI 10.1111/j.1471-4159.2009.06071.x; Brinkmann BG, 2008, NEURON, V59, P581, DOI 10.1016/j.neuron.2008.06.028; Cao X, 2005, MOL ENDOCRINOL, V19, P102, DOI 10.1210/me.2004-0093; CARSON MJ, 1993, NEURON, V10, P729, DOI 10.1016/0896-6273(93)90173-O; Chew LJ, 2010, J NEUROSCI, V30, P11011, DOI 10.1523/JNEUROSCI.2546-10.2010; Chun SJ, 2003, J CELL BIOL, V163, P397, DOI 10.1083/jcb.200304154; Flores AI, 2008, J NEUROSCI, V28, P7174, DOI 10.1523/JNEUROSCI.0150-08.2008; Fraser MM, 2008, NEUROSCIENCE, V151, P476, DOI 10.1016/j.neuroscience.2007.10.048; Gao FB, 1998, DEV BIOL, V197, P54, DOI 10.1006/dbio.1998.8877; Gauthier AS, 2007, NEURON, V54, P245, DOI 10.1016/j.neuron.2007.03.027; Grossmann KS, 2009, P NATL ACAD SCI USA, V106, P16704, DOI 10.1073/pnas.0904336106; Kessaris N, 2006, NAT NEUROSCI, V9, P173, DOI 10.1038/nn1620; Klinghoffer RA, 1996, MOL CELL BIOL, V16, P5905; Kuo E, 2010, J NEUROCHEM, V113, P200, DOI 10.1111/j.1471-4159.2010.06596.x; Lamprianou S, 2006, J MOL NEUROSCI, V29, P241, DOI 10.1385/JMN:29:3:241; Lei JX, 2004, J BIOL CHEM, V279, P47589, DOI 10.1074/jbc.M405497200; Mannell H, 2008, J VASC RES, V45, P153, DOI 10.1159/000110081; Massa PT, 2004, J NEUROSCI RES, V77, P15, DOI 10.1002/jnr.20155; McKinnon RD, 2005, J NEUROSCI, V25, P3499, DOI 10.1523/JNEUROSCI.5049-04.2005; Mi S, 2005, NAT NEUROSCI, V8, P745, DOI 10.1038/nn1460; Miller RH, 2007, NAT NEUROSCI, V10, P1351, DOI 10.1038/nn1995; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; Peretz A, 2000, EMBO J, V19, P4036, DOI 10.1093/emboj/19.15.4036; Ranjan M, 1996, MOL CELL NEUROSCI, V7, P404, DOI 10.1006/mcne.1996.0029; Relucio J, 2009, J NEUROSCI, V29, P11794, DOI 10.1523/JNEUROSCI.0888-09.2009; Shi ZQ, 2000, MOL CELL BIOL, V20, P1526, DOI 10.1128/MCB.20.5.1526-1536.2000; Sperber BR, 2001, J NEUROSCI RES, V63, P303, DOI 10.1002/1097-4547(20010215)63:4<303::AID-JNR1024>3.0.CO;2-A; Stankoff B, 2002, J NEUROSCI, V22, P9221; Sukocheva OA, 2006, J ENDOCRINOL, V191, P447, DOI 10.1677/joe.1.07061; SWARUP G, 1982, BIOCHEM BIOPH RES CO, V107, P1104, DOI 10.1016/0006-291X(82)90635-0; Wang PS, 2009, J BIOL CHEM, V284, P33692, DOI 10.1074/jbc.M109.061770; Wu CJ, 2001, ONCOGENE, V20, P6018, DOI 10.1038/sj.onc.1204699; Younes-Rapozo V, 2009, INT J DEV NEUROSCI, V27, P757, DOI 10.1016/j.ijdevneu.2009.08.014; Zhu XQ, 2008, NEURON GLIA BIOL, V4, P19, DOI 10.1017/S1740925X09000015; Zhu Y, 2010, GLIA, V58, P1407, DOI 10.1002/glia.21016; Zito CI, 2004, J CELL PHYSIOL, V199, P227, DOI 10.1002/jcp.10446	40	15	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e21058	10.1371/journal.pone.0021058	http://dx.doi.org/10.1371/journal.pone.0021058			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	21701583	Green Submitted, Green Published, gold			2022-12-27	WOS:000291983800019
J	Chang, XF; Ravi, R; Pham, V; Bedi, A; Chatterjee, A; Sidransky, D				Chang, Xiaofei; Ravi, Rajani; Pham, Vui; Bedi, Atul; Chatterjee, Aditi; Sidransky, David			Adenylate Kinase 3 Sensitizes Cells to Cigarette Smoke Condensate Vapor Induced Cisplatin Resistance	PLOS ONE			English	Article							ALVEOLAR EPITHELIAL-CELLS; HUMAN BLADDER-CANCER; TOBACCO-SMOKE; BREAST-CANCER; NECK-CANCER; MITOCHONDRIAL-DNA; OXIDATIVE STRESS; GLOTTIC CANCER; LOCAL-CONTROL; RISK-FACTORS	Background: The major established etiologic risk factor for bladder cancer is cigarette smoking and one of the major antineoplastic agents used for the treatment of advanced bladder cancer is cisplatin. A number of reports have suggested that cancer patients who smoke while receiving treatment have lower rates of response and decreased efficacy of cancer therapies. Methodology/Principal Findings: In this study, we investigated the effect of cigarette smoke condensate (CSC) vapor on cisplatin toxicity in urothelial cell lines SV-HUC-1 and SCaBER cells. We showed that chronic exposure to CSC vapor induced cisplatin resistance in both cell lines. In addition, we found that the expression of mitochondrial-resident protein adenylate kinase-3 (AK3) is decreased by CSC vapor. We further observed that chronic CSC vapor-exposed cells displayed decreased cellular sensitivity to cisplatin, decreased mitochondrial membrane potential (Delta Psi m) and increased basal cellular ROS levels compared to unexposed cells. Re-expression of AK3 in CSC vapor-exposed cells restored cellular sensitivity to cisplatin. Finally, CSC vapor increased the growth of the tumors and also curtail the response of tumor cells to cisplatin chemotherapy in vivo. Conclusions/Significance: The current study provides evidence that chronic CSC vapor exposure affects AK3 expression and renders the cells resistant to cisplatin.	[Chang, Xiaofei; Ravi, Rajani; Pham, Vui; Bedi, Atul; Chatterjee, Aditi; Sidransky, David] Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA	Johns Hopkins University	Chang, XF (corresponding author), Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA.	chattad@jhmi.edu; dsidrans@jhmi.edu			FAMRI [072017_YCSA]	FAMRI	This research was supported by FAMRI-funded Young Clinical Scientist Award 072017_YCSA, titled "The effect of Adenylate Kinase 3 (AK3) on tobacco smoke - induced cisplatin resistance in bladder cells." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barsanti KC, 2007, MAGN RESON CHEM, V45, P167, DOI 10.1002/mrc.1939; Blaveri E, 2005, CLIN CANCER RES, V11, P7012, DOI 10.1158/1078-0432.CCR-05-0177; Boffetta P, 2004, ONCOGENE, V23, P6392, DOI 10.1038/sj.onc.1207715; BROWMAN GP, 1993, NEW ENGL J MED, V328, P159, DOI 10.1056/NEJM199301213280302; CHANG SS, INT J CANC, V126, P19; Chatterjee A, 2008, ONCOGENE, V27, P3710, DOI 10.1038/onc.2008.3; Chatterjee A, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-235; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; CherbonnelLasserre C, 1996, ONCOGENE, V13, P1489; Cho HJ, 2006, CANCER LETT, V237, P56, DOI 10.1016/j.canlet.2005.05.039; Choi MK, 2006, ARCH PHARM RES, V29, P1067, DOI 10.1007/BF02969293; Cullen KJ, 2007, J BIOENERG BIOMEMBR, V39, P43, DOI 10.1007/s10863-006-9059-5; De Flora S, 2008, MUTAT RES-REV MUTAT, V659, P137, DOI 10.1016/j.mrrev.2007.11.004; Dzeja PP, 1998, FASEB J, V12, P523, DOI 10.1096/fasebj.12.7.523; Fagerstrom K, 2002, DRUGS, V62, P1, DOI 10.2165/00003495-200262002-00001; Fanizza C, 2007, TOXICOL IN VITRO, V21, P586, DOI 10.1016/j.tiv.2006.12.002; Fleshner N, 1999, CANCER, V86, P2337, DOI 10.1002/(SICI)1097-0142(19991201)86:11<2337::AID-CNCR23>3.0.CO;2-6; Fuertes MA, 2003, CURR MED CHEM, V10, P257, DOI 10.2174/0929867033368484; GALLUZZI L, CANC RES, V70, P1793; Gonzalez VM, 2001, MOL PHARMACOL, V59, P657, DOI 10.1124/mol.59.4.657; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Hecht SS, 2002, CARCINOGENESIS, V23, P907, DOI 10.1093/carcin/23.6.907; Hecht SS, 2002, ENVIRON MOL MUTAGEN, V39, P119, DOI 10.1002/em.10071; Inouye S, 1998, J NEUROCHEM, V71, P125; Inouye S, 1999, BIOCHEM BIOPH RES CO, V254, P618, DOI 10.1006/bbrc.1998.0116; Izzotti A, 2008, MUTAT RES-FUND MOL M, V644, P38, DOI 10.1016/j.mrfmmm.2008.06.012; Jankovic S, 2007, TUMORI, V93, P4; Jiang XJ, 2007, CANCER RES, V67, P7540, DOI 10.1158/0008-5472.CAN-07-0048; Kartalou M, 2001, MUTAT RES-FUND MOL M, V478, P23, DOI 10.1016/S0027-5107(01)00141-5; Knight-Lozano CA, 2002, CIRCULATION, V105, P849, DOI 10.1161/hc0702.103977; Lu X, 2003, ANAL CHEM, V75, P4441, DOI 10.1021/ac0264224; Mambo E, 2002, CANCER RES, V62, P1349; Marshak G, 1999, INT J RADIAT ONCOL, V43, P1009, DOI 10.1016/S0360-3016(98)00547-1; MATTENHEIMER H, 1975, Z KLIN CHEM KLIN BIO, V13, P325; Miro O, 1999, CARCINOGENESIS, V20, P1331, DOI 10.1093/carcin/20.7.1331; Moodie FM, 2004, FASEB J, V18, P1897, DOI 10.1096/fj.04-1506fje; MURATA T, 1990, BIOCHEM INT, V20, P949; Nobumoto M, 1998, J BIOCHEM, V123, P128; Oh WK, 2000, UROLOGY, V55, P31, DOI 10.1016/S0090-4295(99)00408-2; Olivero OA, 1997, MUTAT RES-GEN TOX EN, V391, P79, DOI 10.1016/S0165-1218(97)00037-2; Olopade OI, 1997, CANCER J SCI AM, V3, P230; ORourke JF, 1996, EUR J BIOCHEM, V241, P403, DOI 10.1111/j.1432-1033.1996.00403.x; Rahman I, 1999, J BIOL CHEM, V274, P5088, DOI 10.1074/jbc.274.8.5088; Ravi R, 2002, CANCER RES, V62, P1583; REERS M, 1991, BIOCHEMISTRY-US, V30, P4480, DOI 10.1021/bi00232a015; Rustemeier K, 2002, FOOD CHEM TOXICOL, V40, P93, DOI 10.1016/S0278-6915(01)00085-0; Salvioli S, 1997, FEBS LETT, V411, P77, DOI 10.1016/S0014-5793(97)00669-8; Skipper PL, 2003, CANCER EPIDEM BIOMAR, V12, P503; Slebos DJ, 2007, AM J RESP CELL MOL, V36, P409, DOI 10.1165/rcmb.2006-0214OC; SMITH JA, 1993, J IMMUNOL METHODS, V162, P261, DOI 10.1016/0022-1759(93)90391-J; TANABE T, 1993, J BIOCHEM-TOKYO, V113, P200, DOI 10.1093/oxfordjournals.jbchem.a124026; TSAI YC, 1990, CANCER RES, V50, P44; van der Toorn M, 2007, AM J PHYSIOL-LUNG C, V292, pL1211, DOI 10.1152/ajplung.00291.2006; van der Voet JCM, 1998, INT J RADIAT ONCOL, V42, P247, DOI 10.1016/S0360-3016(98)00226-0; Wickenden JA, 2003, AM J RESP CELL MOL, V29, P562, DOI 10.1165/rcmb.2002-0235OC; WILLIAMSON MP, 1995, HUM MOL GENET, V4, P1569, DOI 10.1093/hmg/4.9.1569; Yang A, 2002, CELL BIOL TOXICOL, V18, P97, DOI 10.1023/A:1015328100876; Yang ZJ, 2000, CANCER CHEMOTH PHARM, V46, P255, DOI 10.1007/s002800000167	58	42	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e20806	10.1371/journal.pone.0020806	http://dx.doi.org/10.1371/journal.pone.0020806			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698293	Green Published, gold, Green Submitted			2022-12-27	WOS:000291730000025
J	Xiong, J; Wang, H; Guo, GM; Wang, SZ; He, LQ; Chen, HF; Wu, J				Xiong, Ji; Wang, Hu; Guo, Guangming; Wang, Shuzeng; He, Liqun; Chen, Haifeng; Wu, Ji			Male Germ Cell Apoptosis and Epigenetic Histone Modification Induced by Tripterygium wilfordii Hook F	PLOS ONE			English	Article							SEX-CHROMOSOME INACTIVATION; SPERMATOGONIAL STEM-CELLS; REPRESSIVE COMPLEX 2; PB-CADHERIN; FORCE-FIELD; AUTOMATED DOCKING; SELF-RENEWAL; SPERMATOGENESIS; METHYLATION; EXPRESSION	Multiglycosides of Tripterygium wilfordii Hook f (GTW), a Chinese herb-derived medicine used as a remedy for rheumatoid arthritis, are considered to be a reversible anti-fertility drug affecting the mammalian spermatids. However, the mechanism behind this effect is still unknown. To study the possible mechanism behind the impact of GTW on spermatogenesis, we administered 4 groups of 4-week-old male mice with different doses of GTW. We found a dose-dependent decrease in the number of germ cells after 40 days of GTW treatment, and an increase in apoptotic cells from the low-dose to the high-dose group. During this same period the dimethylated level of histone H3 lysine 9 (H3K9me2) in GTW-treated testes germ cells declined. Additionally, spermatogonial stem cells (SSCs) from 6-day-old mice were isolated to evaluate the possible effect of GTW or triptolide on development of SSCs. We found a significantly higher incidence of apoptosis and lower dimethylation level of H3K9me2 in the SSCs of GTW or triptolide treatment than in controls. Thus, these data suggest that the GTW-induced apoptosis might be responsible for the fertility impairment in mice. This damage could be traced back to the early stages of spermatogenesis. GTW also affected the epigenetic modification of H3K9 in spermatogenesis. Molecular dynamics simulation suggested that triptolide and dimethylated or trimethylated H3K9 might have similar interaction mechanisms with EED (embryonic ectoderm development). These candidate activation mechanisms provide the first glimpse into the pathway of GTW-induced gonad toxicity, which is crucial for further research and clinical application.	[Xiong, Ji; Wang, Hu; Guo, Guangming; Wang, Shuzeng; Wu, Ji] Shanghai Jiao Tong Univ, Key Lab Genet Dev & Neuropsychiat Disorders, Minist Educ, BioX Res Inst, Shanghai 200030, Peoples R China; [Xiong, Ji; Wang, Hu; Guo, Guangming; Wang, Shuzeng; Wu, Ji] Shanghai Jiao Tong Univ, Dept Biol Sci & Biotechnol, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China; [Chen, Haifeng] Shanghai Jiao Tong Univ, Dept Bioinformat & Biostat, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China; [He, Liqun] Shanghai Univ Tradit Chinese Med, Dept Nephrol, Key Lab Liver & Kidney Dis, Shanghai Shuguang Hosp,Minist Educ, Shanghai, Peoples R China; [He, Liqun] Shanghai Tradit Chinese Med Univ, E Inst Tradit Chinese Internal Med, Shanghai Municipal Educ Commiss, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai University of Traditional Chinese Medicine; Shanghai Municipal Education Commission (SHMEC)	Xiong, J (corresponding author), Shanghai Jiao Tong Univ, Key Lab Genet Dev & Neuropsychiat Disorders, Minist Educ, BioX Res Inst, Shanghai 200030, Peoples R China.	Heliqun59@yahoo.com.cn; haifengchen@sjtu.edu.cn; jiwu@sjtu.edu.cn	Chen, Haifeng/AAT-7444-2020	Wang, Hu/0000-0001-6132-8788	National Natural Science Foundation of China [30630012, 90919020]; National Basic Research Program of China [2010CB945001, 2011CB965104]; Ministry of Agriculture of the People's Republic of China [2009ZX08006-010B]; Program of Shanghai Subject Chief Scientist [10XD1402200]; Specialized Research Fund for the Doctoral Program of Higher Education in China [20090073110032]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Ministry of Agriculture of the People's Republic of China(Ministry of Agriculture & Rural Affairs); Program of Shanghai Subject Chief Scientist; Specialized Research Fund for the Doctoral Program of Higher Education in China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	Funding is from the Key Program and the Major Research Plan of the National Natural Science Foundation of China [no. 30630012 and 90919020], http://www.nsfc.gov.cn; the National Basic Research Program of China [no. 2010CB945001 and 2011CB965104], http://www.most.gov.cn; the Ministry of Agriculture of the People's Republic of China [no. 2009ZX08006-010B], http://www.moa.gov.cn/sjzz/jiaoyusi; the Program of Shanghai Subject Chief Scientist [no. 10XD1402200], http://www.stcsm.gov.cn/; and the Specialized Research Fund for the Doctoral Program of Higher Education in China [no. 20090073110032], http://www.moe.edu.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai JP, 2002, CONTRACEPTION, V65, P441, DOI 10.1016/S0010-7824(02)00312-8; Berger SL, 2002, CURR OPIN GENET DEV, V12, P142, DOI 10.1016/S0959-437X(02)00279-4; Bettegowda A, 2010, PHILOS T R SOC B, V365, P1637, DOI 10.1098/rstb.2009.0196; CASE DA, 2004, AMBER8; Chen HF, 2007, J AM CHEM SOC, V129, P2930, DOI 10.1021/ja0678774; CLERMONT Y, 1962, AM J ANAT, V111, P111, DOI 10.1002/aja.1001110202; Clermont Y., 1993, FRONT ENDOCRINOL, P332; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Davis TL, 1999, GENOMICS, V58, P18, DOI 10.1006/geno.1999.5813; De Rooij DG, 2000, J ANDROL, V21, P776; HUCKINS C, 1978, ANAT REC, V190, P905, DOI 10.1002/ar.1091900410; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Khalil AM, 2004, P NATL ACAD SCI USA, V101, P16583, DOI 10.1073/pnas.0406325101; Kollman PA, 1997, COMPUTER SIMULATION, P83; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Li Jie, 2009, Zhonghua Nan Ke Xue, V15, P569; Li JY, 2004, GENOMICS, V84, P952, DOI 10.1016/j.ygeno.2004.08.012; Liu ZL, 2010, J BIOL CHEM, V285, P2758, DOI 10.1074/jbc.M109.066845; LU QX, 1990, ACTA ACADEMIAE MED S, V12, P203; Morris GM, 1996, J COMPUT AID MOL DES, V10, P293, DOI 10.1007/BF00124499; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Nagano M, 1998, TISSUE CELL, V30, P389, DOI 10.1016/S0040-8166(98)80053-0; Oatley JA, 2008, ANNU REV CELL DEV BI, V24, P263, DOI 10.1146/annurev.cellbio.24.110707.175355; Okada Y, 2007, NATURE, V450, P119, DOI 10.1038/nature06236; Pasini D, 2008, COLD SH Q B, V73, P253, DOI 10.1101/sqb.2008.73.009; Payne C, 2006, DEV BIOL, V293, P461, DOI 10.1016/j.ydbio.2006.02.013; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Phillips BT, 2010, PHILOS T R SOC B, V365, P1663, DOI 10.1098/rstb.2010.0026; Qian S., 1989, CHIN J ANDROL, V3, P129; Qin F, 2010, RNA, V16, P1053, DOI 10.1261/rna.2008110; Riising EM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002704; RUSSELL LD, 1990, AM J ANAT, V188, P21, DOI 10.1002/aja.1001880104; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sharpe Richard M., 1994, P1363; STERN H, 1993, CELL MOL BIOL TESTIS, P296; Tachibana M, 2007, EMBO J, V26, P3346, DOI 10.1038/sj.emboj.7601767; TONG JS, 1988, STUD TRAD CHINESE ME, V1, P25; Turner JMA, 2007, DEVELOPMENT, V134, P1823, DOI 10.1242/dev.000018; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; WEINER SJ, 1984, J AM CHEM SOC, V106, P765, DOI 10.1021/ja00315a051; Wu J, 2005, DEV BIOL, V284, P437, DOI 10.1016/j.ydbio.2005.05.042; Wu J, 2003, J ENDOCRINOL, V176, P381, DOI 10.1677/joe.0.1760381; Wu J, 2008, CELL SIGNAL, V20, P1052, DOI 10.1016/j.cellsig.2008.01.011; Wu R, 2005, MOL BIOL CELL, V16, P2872, DOI 10.1091/mbc.e04-11-0997; Xu C, 2010, P NATL ACAD SCI USA, V107, P19266, DOI 10.1073/pnas.1008937107; YANG JY, 2008, CARCINOGENESIS TERAT, V5, P393; Yang Zhi-xia, 2008, Zhongguo Yaolixue Tongbao, V24, P838; Ye W, 1991, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V13, P235; Yuan Z, 2009, CELL PROLIFERAT, V42, P123, DOI 10.1111/j.1365-2184.2009.00589.x; Zhang CT, 2008, J REPROD MED, V17, P118; ZHANG YH, 2007, CHINESE J DERMATOVEN, V6, P138; Zhang Y, 2011, J MOL CELL BIOL, V3, P132, DOI 10.1093/jmcb/mjq043; ZHEN QS, 1995, CONTRACEPTION, V51, P121, DOI 10.1016/0010-7824(94)00018-R; Zou K, 2009, NAT CELL BIOL, V11, P631, DOI 10.1038/ncb1869; 李凡, 2008, [生殖与避孕, Reproduction and Contraception], V28, P571	56	24	31	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e20751	10.1371/journal.pone.0020751	http://dx.doi.org/10.1371/journal.pone.0020751			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698297	Green Submitted, gold, Green Published			2022-12-27	WOS:000291730000023
J	Zhou, TH; Li, SQ; Zhong, WB; Vihervaara, T; Beaslas, O; Perttila, J; Luo, W; Jiang, YL; Lehto, M; Olkkonen, VM; Yan, DG				Zhou, Tianhong; Li, Shiqian; Zhong, Wenbin; Vihervaara, Terhi; Beaslas, Olivier; Perttila, Julia; Luo, Wei; Jiang, Yingliang; Lehto, Markku; Olkkonen, Vesa M.; Yan, Daoguang			OSBP-Related Protein 8 (ORP8) Regulates Plasma and Liver Tissue Lipid Levels and Interacts with the Nucleoporin Nup62	PLOS ONE			English	Article							OXYSTEROL-BINDING-PROTEIN; NUCLEAR-PORE COMPLEX; IMPORTIN-BETA; TRANSPORT FACTOR-2; STRUCTURAL BASIS; CHOLESTEROL; NTF2; EXPRESSION; FAMILY; ORGANIZATION	We earlier identified OSBP-related protein 8 (ORP8) as an endoplasmic reticulum oxysterol-binding protein implicated in cellular lipid homeostasis. We now investigated its action in hepatic cells in vivo and in vitro. Adenoviral overexpression of ORP8 in mouse liver induced a decrease of cholesterol, phospholipids, and triglycerides in serum (-34%, -26%, -37%, respectively) and liver tissue (-40%, -12%, -24%), coinciding with reduction of nuclear (n)SREBP-1 and -2 and mRNA levels of their target genes. Consistently, excess ORP8 reduced nSREBPs in HuH7 cells, and ORP8 overexpression or silencing by RNA interference moderately suppressed or induced the expression of SREBP-1 and SREBP-2 target genes, respectively. In accordance, cholesterol biosynthesis was reduced by ORP8 overexpression and enhanced by ORP8 silencing in [ 3 H] acetate pulse-labeling experiments. ORP8, previously shown to bind 25-hydroxycholesterol, was now shown to bind also cholesterol in vitro. Yeast two-hybrid, bimolecular fluorescence complementation (BiFC), and co-immunoprecipitation analyses revealed the nuclear pore component Nup62 as an interaction partner of ORP8. Co-localization of ORP8 and Nup62 at the nuclear envelope was demonstrated by BiFC and confocal immunofluorescence microscopy. Furthermore, the impact of overexpressed ORP8 on nSREBPs and their target mRNAs was inhibited in cells depleted of Nup62. Our results reveal that ORP8 has the capacity to modulate lipid homeostasis and SREBP activity, probably through an indirect mechanism, and provide clues of an entirely new mode of ORP action.	[Zhou, Tianhong; Li, Shiqian; Zhong, Wenbin; Luo, Wei; Jiang, Yingliang; Yan, Daoguang] Jinan Univ, Dept Biol, Guangzhou, Guangdong, Peoples R China; [Vihervaara, Terhi; Beaslas, Olivier; Perttila, Julia; Olkkonen, Vesa M.] Minerva Fdn, Biomedicum, Helsinki, Finland; [Lehto, Markku] Folkhalsan Inst Genet, Folkhalsan Res Ctr, Biomedicum, Helsinki, Finland; [Olkkonen, Vesa M.] Univ Helsinki, Inst Biomed Anat, Helsinki, Finland	Jinan University; University of Helsinki; Folkhalsan Research Center; University of Helsinki; University of Helsinki	Zhou, TH (corresponding author), Jinan Univ, Dept Biol, Guangzhou, Guangdong, Peoples R China.	vesa.olkkonen@helsinki.fi; tydg@jnu.edu.cn	Yan, Daoguang/A-4146-2013; Li, Shiqian/ABH-2154-2021	Olkkonen, Vesa/0000-0001-5553-7997	Academy of Finland [121457]; NSFC, China [30971104]; Fundamental Research Funds for the Central Universities, China; Sigrid Juselius Foundation; Finnish Foundation for Cardiovascular Research; Novo Nordisk Foundation; Liv och Halsa Foundation; Magnus Ehrnrooth Foundation; European Union [202272]; Novo Nordisk Fonden [NNF11OC1014724] Funding Source: researchfish	Academy of Finland(Academy of Finland); NSFC, China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities, China(Fundamental Research Funds for the Central Universities); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Foundation for Cardiovascular Research; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Liv och Halsa Foundation; Magnus Ehrnrooth Foundation; European Union(European Commission); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by grants from the Academy of Finland (grant 121457 to V.M.O.), from NSFC, China (grant 30971104 to D.Y.), the Fundamental Research Funds for the Central Universities, China (to D.Y.), the Sigrid Juselius Foundation, the Finnish Foundation for Cardiovascular Research, The Novo Nordisk Foundation (V.M.O.), the Liv och Halsa Foundation, the Magnus Ehrnrooth Foundation (V.M.O.), and the European Union FP7 (LipidomicNet, agreement no. 202272). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barth W, 1999, BIOCHEM CELL BIOL, V77, P355, DOI 10.1139/bcb-77-4-355; Bayliss R, 1999, J MOL BIOL, V293, P579, DOI 10.1006/jmbi.1999.3166; Bayliss R, 2002, EMBO J, V21, P2843, DOI 10.1093/emboj/cdf305; Blanquart C, 2002, J BIOL CHEM, V277, P37254, DOI 10.1074/jbc.M110598200; Brunham LR, 2006, J CLIN INVEST, V116, P1052, DOI 10.1172/JCI27352; BUSS F, 1994, J CELL SCI, V107, P631; Clarkson WD, 1996, J MOL BIOL, V263, P517, DOI 10.1006/jmbi.1996.0594; D'Angelo MA, 2008, TRENDS CELL BIOL, V18, P456, DOI 10.1016/j.tcb.2008.07.009; DAWSON PA, 1989, J BIOL CHEM, V264, P16798; DAWSON PA, 1989, J BIOL CHEM, V264, P9046; Dietschy JM, 2002, J BIOL CHEM, V277, P3801, DOI 10.1074/jbc.R100057200; Du XM, 2011, J CELL BIOL, V192, P121, DOI 10.1083/jcb.201004142; Dultz E, 2008, J CELL BIOL, V180, P857, DOI 10.1083/jcb.200707026; Eberle D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018; Echeverria PC, 2009, MOL CELL BIOL, V29, P4788, DOI 10.1128/MCB.00649-09; Frey S, 2007, CELL, V130, P512, DOI 10.1016/j.cell.2007.06.024; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Isgro TA, 2007, STRUCTURE, V15, P977, DOI 10.1016/j.str.2007.06.011; Isgro TA, 2007, J MOL BIOL, V366, P330, DOI 10.1016/j.jmb.2006.11.048; Jaworski CJ, 2001, GENOMICS, V78, P185, DOI 10.1006/geno.2001.6663; Johansson M, 2005, MOL BIOL CELL, V16, P5480, DOI 10.1091/mbc.E05-03-0189; Kerppola TK, 2006, NAT PROTOC, V1, P1278, DOI 10.1038/nprot.2006.201; Lee SJ, 2003, SCIENCE, V302, P1571, DOI 10.1126/science.1088372; Lehto M, 2003, BBA-MOL CELL BIOL L, V1631, P1, DOI 10.1016/S1388-1981(02)00364-5; Lehto M, 2001, J LIPID RES, V42, P1203; Leng YM, 2007, J BIOL CHEM, V282, P19321, DOI 10.1074/jbc.M703222200; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; MACAULAY C, 1995, J BIOL CHEM, V270, P254, DOI 10.1074/jbc.270.1.254; Melcak I, 2007, SCIENCE, V315, P1729, DOI 10.1126/science.1135730; NAGELE U, 1984, J CLIN CHEM CLIN BIO, V22, P165; Nagoshi E, 1999, MOL BIOL CELL, V10, P2221, DOI 10.1091/mbc.10.7.2221; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Ngo M, 2009, MOL BIOL CELL, V20, P1388, DOI 10.1091/mbc.E08-09-0905; Otsuka S, 2008, P NATL ACAD SCI USA, V105, P16101, DOI 10.1073/pnas.0802647105; PASCHAL BM, 1995, J CELL BIOL, V129, P925, DOI 10.1083/jcb.129.4.925; Perry RJ, 2006, MOL BIOL CELL, V17, P2604, DOI 10.1091/mbc.E06-01-0060; Rabut G, 2004, NAT CELL BIOL, V6, P1114, DOI 10.1038/ncb1184; Radhakrishnan A, 2007, P NATL ACAD SCI USA, V104, P6511, DOI 10.1073/pnas.0700899104; Raychaudhuri S, 2010, ANNU REV CELL DEV BI, V26, P157, DOI 10.1146/annurev.cellbio.042308.113334; Ridgway ND, 2010, SUBCELL BIOCHEM, V51, P159, DOI 10.1007/978-90-481-8622-8_6; Schrader N, 2008, MOL CELL, V29, P46, DOI 10.1016/j.molcel.2007.10.022; SUBBAIAH PV, 2000, HDB LIPOPROTEIN TEST, P521; TAYLOR FR, 1984, J BIOL CHEM, V259, P2382; Timmins JM, 2005, J CLIN INVEST, V115, P1333, DOI 10.1172/JCI200523915; Van Impe K, 2008, TRAFFIC, V9, P695, DOI 10.1111/j.1600-0854.2008.00720.x; Walde S, 2010, TRENDS CELL BIOL, V20, P461, DOI 10.1016/j.tcb.2010.05.001; Wang PY, 2005, SCIENCE, V307, P1472, DOI 10.1126/science.1107710; Yan DG, 2008, INT REV CYTOL, V265, P253, DOI 10.1016/S0074-7696(07)65007-4; Yan D, 2008, J BIOL CHEM, V283, P332, DOI 10.1074/jbc.M705313200; Yan DG, 2007, ARTERIOSCL THROM VAS, V27, P1108, DOI 10.1161/ATVBAHA.106.138545	51	37	42	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e21078	10.1371/journal.pone.0021078	http://dx.doi.org/10.1371/journal.pone.0021078			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698267	gold, Green Submitted, Green Published			2022-12-27	WOS:000291730000049
J	Moran, A; Thacker, SA; Arikan, AA; Mastrangelo, MAA; Wu, Y; Yu, B; Tweardy, DJ				Moran, Ana; Thacker, Stephen A.; Arikan, Ayse Akcan; Mastrangelo, Mary-Ann A.; Wu, Yong; Yu, Bi; Tweardy, David J.			IL-6-Mediated Activation of Stat3 alpha Prevents Trauma/Hemorrhagic Shock-Induced Liver Inflammation	PLOS ONE			English	Article							MULTIPLE ORGAN FAILURE; ISCHEMIA-REPERFUSION INJURY; HEMORRHAGIC-SHOCK; NITRIC-OXIDE; SIGNAL TRANSDUCER; GENE-EXPRESSION; KAPPA-B; STAT3 ACTIVATION; TARGETING STAT3; PROTEIN AP2	Trauma complicated by hemorrhagic shock (T/HS) is the leading cause of morbidity and mortality in the United States for individuals under the age of 44 years. Initial survivors are susceptible to developing multiple organ failure (MOF), which is thought to be caused, at least in part, by excessive or maladaptive activation of inflammatory pathways. We previously demonstrated in rodents that T/HS results in liver injury that can be prevented by IL-6 administration at the start of resuscitation; however, the contribution of the severity of HS to the extent of liver injury, whether or not resuscitation is required, and the mechanism(s) for the IL-6 protective effect have not been reported. In the experiments described here, we demonstrated that the extent of liver inflammation induced by T/HS depends on the duration of hypotension and requires resuscitation. We established that IL-6 administration at the start of resuscitation is capable of completely reversing liver inflammation and is associated with increased Stat3 activation. Global assessment of the livers showed that the main effect of IL-6 was to normalize the T/HS-induced inflammation transcriptome. Pharmacological inhibition of Stat3 activity within the liver blocked the ability of IL-6 to prevent liver inflammation and to normalize the T/HS-induced liver inflammation transcriptome. Genetic deletion of a Stat3 beta, a naturally occurring, dominant-negative isoform of the Stat3, attenuated T/HS-induced liver inflammation, confirming a role for Stat3, especially Stat3 alpha, in preventing T/HS-mediated liver inflammation. Thus, T/HS-induced liver inflammation depends on the duration of hypotension and requires resuscitation; IL-6 administration at the start of resuscitation reverses T/HS-induced liver inflammation, through activation of Stat3 alpha, which normalized the T/HS-induced liver inflammation transcriptome.	[Moran, Ana; Mastrangelo, Mary-Ann A.; Wu, Yong; Yu, Bi; Tweardy, David J.] Baylor Coll Med, Dept Med, Infect Dis Sect, Houston, TX 77030 USA; [Arikan, Ayse Akcan] Baylor Coll Med, Dept Pediat, Crit Care Sect, Houston, TX 77030 USA; [Tweardy, David J.] Baylor Coll Med, Dept Mol, Houston, TX 77030 USA; [Thacker, Stephen A.] Baylor Coll Med, Dept Pediat, Pediat Infect Dis Sect, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Moran, A (corresponding author), Baylor Coll Med, Dept Med, Infect Dis Sect, Houston, TX 77030 USA.	dtweardy@bcm.tmc.edu	Tweardy, David/L-3929-2019	Akcan Arikan, Ayse/0000-0002-5123-6713	National Heart, Lung and Blood Institute of the National Institutes of Health [HL07619, T32-HL66991]; American Lung Association [H48839]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL066991, F32HL007619] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Lung Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported, in part, by grants HL07619 (DJT) and T32-HL66991 (AM), from the National Heart, Lung and Blood Institute of the National Institutes of Health, and H48839 (AM) from the American Lung Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldeguer X, 2002, HEPATOLOGY, V35, P40, DOI 10.1053/jhep.2002.30081; Alten JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001605; Ayuste EC, 2006, J TRAUMA, V60, P52, DOI 10.1097/01.ta.0000200156.05397.0b; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Brundage SI, 2004, J TRAUMA, V57, P970, DOI 10.1097/01.TA.0000141970.68269.AC; Chen JP, 1997, BIOCHEM BIOPH RES CO, V239, P666, DOI 10.1006/bbrc.1997.7531; Dauer DJ, 2005, ONCOGENE, V24, P3397, DOI 10.1038/sj.onc.1208469; Durant L, 2010, IMMUNITY, V32, P605, DOI 10.1016/j.immuni.2010.05.003; El Kasmi KC, 2006, J IMMUNOL, V177, P7880, DOI 10.4049/jimmunol.177.11.7880; Furukawa T, 2003, AM J PATHOL, V162, P1807, DOI 10.1016/S0002-9440(10)64315-5; Galun E, 2000, FASEB J, V14, P1979, DOI 10.1096/fj.99-0913com; Gao Q, 2004, MOL CELL PROTEOMICS, V3, P704, DOI 10.1074/mcp.M300131-MCP200; Harbrecht BG, 2001, AM SURGEON, V67, P122; Heckbert SR, 1998, J TRAUMA, V45, P545, DOI 10.1097/00005373-199809000-00022; Hierholzer C, 1998, TRANSPLANT P, V30, P2647, DOI 10.1016/S0041-1345(98)00771-4; Hierholzer C, 1998, AM J PHYSIOL-LUNG C, V275, pL611, DOI 10.1152/ajplung.1998.275.3.L611; Hierholzer C, 2003, ARCH ORTHOP TRAUM SU, V123, P55, DOI 10.1007/s00402-002-0438-z; Hierholzer C, 2002, SHOCK, V17, P98, DOI 10.1097/00024382-200202000-00003; Hierholzer C, 2001, ARCH ORTHOP TRAUM SU, V121, P219, DOI 10.1007/s004020000211; Hierholzer C, 1998, J EXP MED, V187, P917, DOI 10.1084/jem.187.6.917; Hochepied T, 2000, EUR CYTOKINE NETW, V11, P597; Hong F, 2002, J CLIN INVEST, V110, P1503, DOI 10.1172/JCI200215841; Horiguchi N, 2010, HEPATOLOGY, V51, P1724, DOI 10.1002/hep.23532; Jarrar D, 2000, J TRAUMA, V49, P879, DOI 10.1097/00005373-200011000-00015; Jing N, 2005, ANTI-CANCER DRUG, V16, P601, DOI 10.1097/00001813-200507000-00002; Jing N, 2003, DNA CELL BIOL, V22, P685, DOI 10.1089/104454903770946665; Jing NJ, 2005, CURR PHARM DESIGN, V11, P2841, DOI 10.2174/1381612054546761; Jing NJ, 2004, CANCER RES, V64, P6603, DOI 10.1158/0008-5472.CAN-03-4041; Kano A, 2003, J EXP MED, V198, P1517, DOI 10.1084/jem.20030077; Kataoka K, 2003, BIOCHEM BIOPH RES CO, V300, P656, DOI 10.1016/S0006-291X(02)02905-4; Klein C, 2003, EUR J IMMUNOL, V33, P2251, DOI 10.1002/eji.200323651; Klune JR, 2010, SURG CLIN N AM, V90, P665, DOI 10.1016/j.suc.2010.04.003; KOBELT F, 1994, SHOCK, V2, P281, DOI 10.1097/00024382-199410000-00009; Kovalovich K, 2000, HEPATOLOGY, V31, P149, DOI 10.1002/hep.510310123; Kovalovich K, 2001, J BIOL CHEM, V276, P26605, DOI 10.1074/jbc.M100740200; Kupiec-Weglinski JW, 2005, TRANSPL P, V37, P1653, DOI 10.1016/j.transproceed.2005.03.134; Lafdil F, 2009, GASTROENTEROLOGY, V137, P2125, DOI 10.1053/j.gastro.2009.08.004; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Li DY, 2003, J AM COLL CARDIOL, V41, P1048, DOI 10.1016/S0735-1097(02)02966-2; Lovato P, 2003, J BIOL CHEM, V278, P16777, DOI 10.1074/jbc.M207999200; Maier B, 2007, SHOCK, V28, P668, DOI 10.1097/shk.0b013e318123e64e; Maritano D, 2004, NAT IMMUNOL, V5, P401, DOI 10.1038/ni1052; Menezes J, 1999, AM J PHYSIOL-GASTR L, V277, pG144, DOI 10.1152/ajpgi.1999.277.1.G144; Meng ZH, 2000, SHOCK, V14, P41, DOI 10.1097/00024382-200014010-00008; Meng ZH, 2001, AM J PHYSIOL-CELL PH, V280, pC343, DOI 10.1152/ajpcell.2001.280.2.C343; Minino Arialdi M, 2006, Natl Vital Stat Rep, V54, P1; Moore FA, 1996, J TRAUMA, V40, P501, DOI 10.1097/00005373-199604000-00001; Moran A, 2009, CTS-CLIN TRANSL SCI, V2, P41, DOI 10.1111/j.1752-8062.2008.00076.x; Moran A, 2008, INT J CLIN EXP MED, V1, P213; Mudter J, 2005, AM J GASTROENTEROL, V100, P64, DOI 10.1111/j.1572-0241.2005.40615.x; Ono M, 2004, SHOCK, V21, P519, DOI 10.1097/01.shk.0000126905.75237.07; Partrick DA, 1999, AM J SURG, V178, P564, DOI 10.1016/S0002-9610(99)00240-8; Prele CM, 2008, J IMMUNOL, V181, P8018, DOI 10.4049/jimmunol.181.11.8018; Rajnik M, 2002, SHOCK, V17, P322, DOI 10.1097/00024382-200204000-00015; Rolph MS, 2006, J IMMUNOL, V177, P7794, DOI 10.4049/jimmunol.177.11.7794; Shum BOV, 2006, J CLIN INVEST, V116, P2183, DOI 10.1172/JCI24767; Sundar SV, 2005, BIOCHEM BIOPH RES CO, V332, P688, DOI 10.1016/j.bbrc.2005.05.008; Suzuki A, 2001, J EXP MED, V193, P471, DOI 10.1084/jem.193.4.471; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Wang TH, 2004, NAT MED, V10, P48, DOI 10.1038/nm976; Wu J, 2001, Chin J Traumatol, V4, P31; Xu Y, 2009, CELL PHYSIOL BIOCHEM, V23, P379, DOI 10.1159/000218184; Yarilina A, 2008, NAT IMMUNOL, V9, P378, DOI 10.1038/ni1576; Yoo JY, 2002, CELL, V108, P331, DOI 10.1016/S0092-8674(02)00636-0; Yu ZY, 2004, J AM SOC NEPHROL, V15, P585, DOI 10.1097/01.ASN.0000114556.19556.F9	66	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21449	10.1371/journal.pone.0021449	http://dx.doi.org/10.1371/journal.pone.0021449			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21738667	gold, Green Submitted, Green Published			2022-12-27	WOS:000292290100024
J	Gandolfo, MA; Hermsen, EJ; Zamaloa, MC; Nixon, KC; Gonzalez, CC; Wilf, P; Cuneo, NR; Johnson, KR				Gandolfo, Maria A.; Hermsen, Elizabeth J.; Zamaloa, Maria C.; Nixon, Kevin C.; Gonzalez, Cynthia C.; Wilf, Peter; Ruben Cuneo, N.; Johnson, Kirk R.			Oldest Known Eucalyptus Macrofossils Are from South America	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; RIBOSOMAL DNA; CORYMBIA MYRTACEAE; PLANT DIVERSITY; EOCENE; PATAGONIA; ARGENTINA; AUSTRALIA; GENUS; CLASSIFICATION	The evolutionary history of Eucalyptus and the eucalypts, the larger clade of seven genera including Eucalyptus that today have a natural distribution almost exclusively in Australasia, is poorly documented from the fossil record. Little physical evidence exists bearing on the ancient geographical distributions or morphologies of plants within the clade. Herein, we introduce fossil material of Eucalyptus from the early Eocene (ca. 51.9 Ma) Laguna del Hunco paleoflora of Chubut Province, Argentina; specimens include multiple leaves, infructescences, and dispersed capsules, several flower buds, and a single flower. Morphological similarities that relate the fossils to extant eucalypts include leaf shape, venation, and epidermal oil glands; infructescence structure; valvate capsulate fruits; and operculate flower buds. The presence of a staminophore scar on the fruits links them to Eucalyptus, and the presence of a transverse scar on the flower buds indicates a relationship to Eucalyptus subgenus Symphyomyrtus. Phylogenetic analyses of morphological data alone and combined with aligned sequence data from a prior study including 16 extant eucalypts, one outgroup, and a terminal representing the fossils indicate that the fossils are nested within Eucalyptus. These are the only illustrated Eucalyptus fossils that are definitively Eocene in age, and the only conclusively identified extant or fossil eucalypts naturally occurring outside of Australasia and adjacent Mindanao. Thus, these fossils indicate that the evolution of the eucalypt group is not constrained to a single region. Moreover, they strengthen the taxonomic connections between the Laguna del Hunco paleoflora and extant subtropical and tropical Australasia, one of the three major ecologic-geographic elements of the Laguna del Hunco paleoflora. The age and affinities of the fossils also indicate that Eucalyptus subgenus Symphyomyrtus is older than previously supposed. Paleoecological data indicate that the Patagonian Eucalyptus dominated volcanically disturbed areas adjacent to standing rainforest surrounding an Eocene caldera lake.	[Gandolfo, Maria A.; Hermsen, Elizabeth J.; Nixon, Kevin C.] Cornell Univ, Dept Plant Biol, Ithaca, NY 14850 USA; [Zamaloa, Maria C.] Univ Buenos Aires, Dept Ecol Genet & Evoluc, Buenos Aires, DF, Argentina; [Gonzalez, Cynthia C.; Ruben Cuneo, N.] Consejo Nacl Invest Cient & Tecn, Museo Paleontol Egidio Feruglio, Trelew, Chubut, Argentina; [Wilf, Peter] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; [Johnson, Kirk R.] Denver Museum Nat & Sci, Denver, CO USA	Cornell University; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Gandolfo, MA (corresponding author), Cornell Univ, Dept Plant Biol, Ithaca, NY 14850 USA.	mag4@cornell.edu		Hermsen, Elizabeth/0000-0003-2666-4385	National Science Foundation [DEB-0918932, DEB-0919071, DEB-0345750]; University of Pennsylvania Research Foundation; Andrew W. Mellon Foundation; Fulbright U.S. Scholar Program; Direct For Biological Sciences [0919071] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); University of Pennsylvania Research Foundation; Andrew W. Mellon Foundation; Fulbright U.S. Scholar Program; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by the National Science Foundation grants DEB-0918932, DEB-0919071 and DEB-0345750 (www.nsf.org) and University of Pennsylvania Research Foundation, the Andrew W. Mellon Foundation (www.mellon.org) and the Fulbright U.S. Scholar Program (www.iie.org/fulbright). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBROSE GJ, 1979, NATURE, V280, P387, DOI 10.1038/280387a0; ARAGON E., 1997, REV ASOC GEOL ARGENT, V52, P243; Basinger JF, 2007, CAN J BOT, V85, P204, DOI 10.1139/B07-001; Bayly MJ, 2008, CLADISTICS, V24, P131, DOI 10.1111/j.1096-0031.2007.00175.x; Bayly MJ, 2007, MOL PHYLOGENET EVOL, V44, P346, DOI 10.1016/j.ympev.2006.10.027; Berry E.W., 1938, GEOLOGICAL SOC AM SP, V12, P1, DOI DOI 10.1130/SPE12-P1; Berry E. W., 1925, J HOPKINS U STUDIES, V6, P182; Biffin E, 2010, ANN BOT-LONDON, V106, P79, DOI 10.1093/aob/mcq088; BLAKE S. T., 1977, AUSTROBAILEYA, V1, P43; Bohte A, 2005, PLANT SYST EVOL, V251, P53, DOI 10.1007/s00606-004-0161-z; Bohte A, 2005, PLANT SYST EVOL, V255, P17, DOI 10.1007/s00606-004-0291-3; Boland D.J., 2006, FOREST TREES AUSTR, P736; BRIGGS B. G., 1979, P LINNEAN SOC NEW S, V102, P158; Brooker MIH, 2000, AUST SYST BOT, V13, P79, DOI 10.1071/SB98008; BROOKER MIH, 1994, FIELD GUIDE EUCALYPT, V3, P383; Buechler W. K., 2004, ALTERNATIVE LEAF CLE; Carr DJ, 2002, BOT J LINN SOC, V139, P415, DOI 10.1046/j.1095-8339.2002.00062.x; CARR DJ, 1959, NATURE, V4698, P1549; Chippendale G.M., 1988, FLORA AUSTR, V19, P1; Crisp M, 2004, PHILOS T R SOC B, V359, P1551, DOI 10.1098/rstb.2004.1528; Azpelicueta MD, 2011, J VERTEBR PALEONTOL, V31, P258, DOI 10.1080/02724634.2011.550351; Zamaloa MD, 2006, INT J PLANT SCI, V167, P1279, DOI 10.1086/507873; DRINNAN A N, 1991, Australian Systematic Botany, V4, P539, DOI 10.1071/SB9910539; DRINNAN A N, 1991, Australian Systematic Botany, V4, P553, DOI 10.1071/SB9910553; DRINNAN AN, 1988, PLANT SYST EVOL, V160, P219, DOI 10.1007/BF00936049; Frenguelli J., 1953, NOTAS MUSEO LA PLATA, V16, P209; GANDOLFO MA, 1988, B TORREY BOT CLUB, V115, P83, DOI 10.2307/2996138; GOLOBOFF P. A., 1999, NONA NO NAME 2 0 WIN; Goloboff PA, 1999, CLADISTICS, V15, P415, DOI 10.1111/j.1096-0031.1999.tb00278.x; GOLOBOFF PA, 2007, TNT TREE ANAL USING; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Greenwood D. R., 2000, Proceedings of the Royal Society of Victoria, V112, P65; Greenwood DR, 1996, AUST SYST BOT, V9, P95, DOI 10.1071/SB9960095; HEATHER W. A., 1955, EMPIRE FOREST REV, V34, P255; Hill K. D., 1995, Telopea, V6, P185; HILL RS, 1999, FLORA AUSTR, V1, P251; HOLMES W B K, 1982, Proceedings of the Linnean Society of New South Wales, V106, P299; Hyland, 1993, LEAF ATLAS AUSTR TRO; JOHNSON L A S, 1972, Proceedings of the Linnean Society of New South Wales, V97, P11; JOHNSON LAS, 1984, ANN MO BOT GARD, V71, P700, DOI 10.2307/2399159; Ladiges PY, 2007, AUST SYST BOT, V20, P383, DOI 10.1071/SB07018; Ladiges PY, 2003, J BIOGEOGR, V30, P989, DOI 10.1046/j.1365-2699.2003.00881.x; LADIGES PY, 1983, BOT J LINN SOC, V87, P105, DOI 10.1111/j.1095-8339.1983.tb00986.x; LADIGES PY, 1995, AUST SYST BOT, V8, P483, DOI 10.1071/SB9950483; Lange R. T., 1982, HIST AUSTRALASIAN VE, P44; LANGE RT, 1978, AUST J BOT, V26, P221, DOI 10.1071/BT9780221; Nixon KC, 1999, CLADISTICS, V15, P407, DOI 10.1111/j.1096-0031.1999.tb00277.x; NIXON KC, 1999, WINCLADA VER 1 9 SOF; PAIJMANS K, 1973, PAC SCI, V27, P260; Parra-O C, 2006, TAXON, V55, P653, DOI 10.2307/25065641; Parra-O C, 2009, AUST SYST BOT, V22, P384, DOI 10.1071/SB09028; Pascual Rosendo, 2007, Journal of Mammalian Evolution, V14, P75, DOI 10.1007/s10914-007-9039-5; Petrulevicius JF, 2009, J PALEONTOL, V83, P994, DOI 10.1666/08-073.1; Petrulevicus JF, 2005, J PALEONTOL, V79, P658, DOI 10.1666/0022-3360(2005)079[0658:AANFOD]2.0.CO;2; POLE M, 1993, J ROY SOC NEW ZEAL, V23, P313, DOI 10.1080/03036758.1993.10721229; Pryor LD, 1971, CLASSIFICATION EUCAL; Pryor LD, 1981, ECOLOGICAL BIOGEOGRA, P499; Rozefelds A. C., 1996, Tasforests, V8, P15; Slee A.V., 2020, EUCLID EUCALYPTS AUS; Steane DA, 2002, AUST SYST BOT, V15, P49, DOI 10.1071/SB00039; Udovicic F., 2000, Kew Bulletin, V55, P633, DOI 10.2307/4118780; Whittock S, 2003, T ROY SOC SOUTH AUST, V127, P27; Wilf P, 2005, AM NAT, V165, P634, DOI 10.1086/430055; Wilf P, 2003, SCIENCE, V300, P122, DOI 10.1126/science.1080475; Wilf P, 2009, AM J BOT, V96, P2031, DOI 10.3732/ajb.0900085; Wilson PG, 2001, AM J BOT, V88, P2013, DOI 10.2307/3558428	66	104	108	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21084	10.1371/journal.pone.0021084	http://dx.doi.org/10.1371/journal.pone.0021084			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738605	Green Published, Green Submitted, gold			2022-12-27	WOS:000292142800012
J	Rocha, J; Alberich, R				Rocha, Jairo; Alberich, Ricardo			The Significance of the ProtDeform Score for Structure Prediction and Alignment	PLOS ONE			English	Article							CLASSIFICATION; SELECTIVITY; SENSITIVITY; PROTEINS; SEQUENCE; CATH	Background: When a researcher uses a program to align two proteins and gets a score, one of her main concerns is how often the program gives a similar score to pairs that are or are not in the same fold. This issue was analysed in detail recently for the program TM-align with its associated TM-score. It was shown that because the TM-score is length independent, it allows a P-value and a hit probability to be defined depending only on the score. Also, it was found that the TM-scores of gapless alignments closely follow an Extreme Value Distribution (EVD). The program ProtDeform for structural protein alignment was developed recently and is characterised by the ability to propose different transformations of different protein regions. Our goal is to analyse its associated score to allow a researcher to have objective reasons to prefer one aligner over another, and carry out a better interpretation of the output. Results: The study on the ProtDeform score reveals that it is length independent in a wider score range than TM-scores and that PD-scores of gapless (random) alignments also approximately follow an EVD. On the CASP8 predictions, PD-scores and TM-scores, with respect to native structures, are highly correlated (0.95), and show that around a fifth of the predictions have a quality as low as 99.5% of the random scores. Using the Gold Standard benchmark, ProtDeform has lower probabilities of error than TM-align both at a similar speed. The analysis is extended to homology discrimination showing that, again, ProtDeform offers higher hit probabilities than TM-align. Finally, we suggest using three different P-values according to the three different contexts: Gapless alignments, optimised alignments for fold discrimination and that for superfamily discrimination. In conclusion, PD-scores are at the very least as valuable for prediction scoring as TM-scores, and on the protein classification problem, even more reliable.	[Rocha, Jairo] Univ Balearic Isl, Dept Math & Comp Sci, Palma De Mallorca, Spain; Univ Balearic Isl, IUNICS, Palma De Mallorca, Spain	Universitat de les Illes Balears; Universitat de les Illes Balears	Rocha, J (corresponding author), Univ Balearic Isl, Dept Math & Comp Sci, Palma De Mallorca, Spain.	jairo@uib.es	Rocha, Jairo/K-9850-2014; Alberich, Ricardo/L-8763-2014	Rocha, Jairo/0000-0002-8810-7376; Alberich, Ricardo/0000-0002-0707-8607	 [MTM 2009-07165]		This research has been supported in part by the grant MTM 2009-07165. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreeva A, 2007, NUCLEIC ACIDS RES, V35, pD253, DOI 10.1093/nar/gkl746; Csaba G, 2008, BIOINFORMATICS, V24, pI98, DOI 10.1093/bioinformatics/btn271; Csaba G, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-23; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Kawabata T, 2000, PROTEINS, V41, P108, DOI 10.1002/1097-0134(20001001)41:1<108::AID-PROT130>3.3.CO;2-J; Kolodny R, 2005, J MOL BIOL, V346, P1173, DOI 10.1016/j.jmb.2004.12.032; Kouranov A, 2006, NUCLEIC ACIDS RES, V34, pD302, DOI 10.1093/nar/gkj120; Levitt M, 1998, P NATL ACAD SCI USA, V95, P5913, DOI 10.1073/pnas.95.11.5913; Menke M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040010; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Orengo CA, 1997, STRUCTURE, V5, P1093, DOI 10.1016/S0969-2126(97)00260-8; Pascual-Garcia A, 2010, PROTEINS, V78, P181, DOI 10.1002/prot.22616; Rocha J, 2009, BIOINFORMATICS, V25, P1625, DOI 10.1093/bioinformatics/btp296; Sierk ML, 2004, PROTEIN SCI, V13, P773, DOI 10.1110/ps.03328504; Standley DM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-116; TAYLOR WR, 1989, J MOL BIOL, V208, P1, DOI 10.1016/0022-2836(89)90084-3; Xu JR, 2010, BIOINFORMATICS, V26, P889, DOI 10.1093/bioinformatics/btq066; Zhang Y, 2006, P NATL ACAD SCI USA, V103, P2605, DOI 10.1073/pnas.0509379103; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264; ZHANG Y, 2005, NUCLEIC ACIDS RES, V57, P702	20	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e20889	10.1371/journal.pone.0020889	http://dx.doi.org/10.1371/journal.pone.0020889			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738592	gold, Green Published, Green Submitted			2022-12-27	WOS:000292142800005
J	Patil, SB; Hurd, TW; Ghosh, AK; Murga-Zamalloa, CA; Khanna, H				Patil, Suresh B.; Hurd, Toby W.; Ghosh, Amiya K.; Murga-Zamalloa, Carlos A.; Khanna, Hemant			Functional Analysis of Retinitis Pigmentosa 2 (RP2) Protein Reveals Variable Pathogenic Potential of Disease-Associated Missense Variants	PLOS ONE			English	Article							RETINITIS-PIGMENTOSA-2 PROTEIN; VERTEBRATE DEVELOPMENT; RETINAL DEGENERATION; CLINICAL FINDINGS; MUTATIONS; TRANSPORT; RHODOPSIN; RPGR; PHOTORECEPTORS; TRAFFICKING	Genetic mutations are frequently associated with diverse phenotypic consequences, which limits the interpretation of the consequence of a variation in patients. Mutations in the retinitis pigmentosa 2 (RP2) gene are associated with X-linked RP, which is a phenotypically heterogenic form of retinal degeneration. The purpose of this study was to assess the functional consequence of disease-associated mutations in the RP2 gene using an in vivo assay. Morpholino-mediated depletion of rp2 in zebrafish resulted in perturbations in photoreceptor development and microphthalmia (small eye). Ultrastructural and immunofluorescence analyses revealed defective photoreceptor outer segment development and lack of expression of photoreceptor-specific proteins. The retinopathy phenotype could be rescued by expressing the wild-type human RP2 protein. Notably, the tested RP2 mutants exhibited variable degrees of rescue of rod versus cone photoreceptor development as well as microphthalmia. Our results suggest that RP2 plays a key role in photoreceptor development and maintenance in zebrafish and that the clinical heterogeneity associated with RP2 mutations may, in part, result from its potentially distinct functional relevance in rod versus cone photoreceptors.	[Patil, Suresh B.; Khanna, Hemant] Univ Massachusetts, Sch Med, Dept Ophthalmol, Worcester, MA 01605 USA; [Patil, Suresh B.; Ghosh, Amiya K.; Murga-Zamalloa, Carlos A.; Khanna, Hemant] Univ Michigan, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA; [Hurd, Toby W.; Ghosh, Amiya K.] Univ Michigan, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA; [Murga-Zamalloa, Carlos A.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Patil, SB (corresponding author), Univ Massachusetts, Sch Med, Dept Ophthalmol, Worcester, MA 01605 USA.	hemant.khanna@umassmed.edu	Murga-Zamalloa, Carlos/AAX-9387-2021	Murga-Zamalloa, Carlos/0000-0002-2238-5066	Foundation Fighting Blindness [EY007961]	Foundation Fighting Blindness(European Commission)	This study was supported by the Foundation Fighting Blindness (EY007961, http://www.blindness.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartolini F, 2002, J BIOL CHEM, V277, P14629, DOI 10.1074/jbc.M200128200; Berson EL, 1996, P NATL ACAD SCI USA, V93, P4526, DOI 10.1073/pnas.93.10.4526; Bird A C, 1987, Prog Clin Biol Res, V247, P3; BIRD AC, 1975, BRIT J OPHTHALMOL, V59, P177, DOI 10.1136/bjo.59.4.177; Breuer DK, 2002, AM J HUM GENET, V70, P1545, DOI 10.1086/340848; Calvert PD, 2010, J GEN PHYSIOL, V135, P173, DOI 10.1085/jgp.200910322; Chakarova CF, 2011, HUM MOL GENET, V20, P975, DOI 10.1093/hmg/ddq543; Chapple JP, 2000, HUM MOL GENET, V9, P1919, DOI 10.1093/hmg/9.13.1919; Daiger SP, 2007, ARCH OPHTHALMOL-CHIC, V125, P151, DOI 10.1001/archopht.125.2.151; DERETIC D, 1995, J CELL SCI, V108, P215; Deretic D, 2005, P NATL ACAD SCI USA, V102, P3301, DOI 10.1073/pnas.0500095102; Deretic D, 1998, P NATL ACAD SCI USA, V95, P10620, DOI 10.1073/pnas.95.18.10620; DRYJA TP, 1995, INVEST OPHTH VIS SCI, V36, P1197; Evans RJ, 2010, HUM MOL GENET, V19, P1358, DOI 10.1093/hmg/ddq012; Evans RJ, 2006, EXP EYE RES, V82, P543, DOI 10.1016/j.exer.2005.10.023; Evans RJ, 2005, METHOD ENZYMOL, V404, P468, DOI 10.1016/S0076-6879(05)04041-3; FISHMAN GA, 1988, ARCH OPHTHALMOL-CHIC, V106, P369; Ghosh AK, 2010, HUM MOL GENET, V19, P90, DOI 10.1093/hmg/ddp469; Hardcastle AJ, 1999, AM J HUM GENET, V64, P1210, DOI 10.1086/302325; HECKENLIVELY JR, 1988, AM J OPHTHALMOL, V105, P504, DOI 10.1016/0002-9394(88)90242-5; Holopainen JM, 2010, BIOCHEMISTRY-US, V49, P7439, DOI 10.1021/bi1005249; Hurd T, 2010, HUM MOL GENET, V19, P4330, DOI 10.1093/hmg/ddq355; Ingham PW, 2009, HUM MOL GENET, V18, pR107, DOI 10.1093/hmg/ddp091; Jayasundera T, 2010, ARCH OPHTHALMOL-CHIC, V128, P915, DOI 10.1001/archophthalmol.2010.122; Khanna H, 2009, NAT GENET, V41, P739, DOI 10.1038/ng.366; Kuhnel K, 2006, STRUCTURE, V14, P367, DOI 10.1016/j.str.2005.11.008; Marszalek JR, 2000, CELL, V102, P175, DOI 10.1016/S0092-8674(00)00023-4; Nair KS, 2005, NEURON, V46, P555, DOI 10.1016/j.neuron.2005.03.023; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Otto EA, 2010, NAT GENET, V42, P840, DOI 10.1038/ng.662; Pazour GJ, 2002, J CELL BIOL, V157, P103, DOI 10.1083/jcb.200107108; Schwahn U, 1998, NAT GENET, V19, P327, DOI 10.1038/1214; Sharon D, 2003, AM J HUM GENET, V73, P1131, DOI 10.1086/379379; Sharon D, 2000, INVEST OPHTH VIS SCI, V41, P2712; Sokolov M, 2002, NEURON, V34, P95, DOI 10.1016/S0896-6273(02)00636-0; Wright AF, 2010, NAT REV GENET, V11, P273, DOI 10.1038/nrg2717; Zaghloul NA, 2010, P NATL ACAD SCI USA, V107, P10602, DOI 10.1073/pnas.1000219107	37	21	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21379	10.1371/journal.pone.0021379	http://dx.doi.org/10.1371/journal.pone.0021379			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738648	Green Published, Green Submitted, gold			2022-12-27	WOS:000292092600034
J	Chen, ZP; Resnik, E; McFarland, JM; Sakmann, B; Mehta, MR				Chen, Zhiping; Resnik, Evgeny; McFarland, James M.; Sakmann, Bert; Mehta, Mayank R.			Speed Controls the Amplitude and Timing of the Hippocampal Gamma Rhythm	PLOS ONE			English	Article							PHASE PRECESSION; UNIT-ACTIVITY; OSCILLATIONS; THETA; DYNAMICS; CA1; SYNCHRONIZATION; FREQUENCY; CORTEX; INTERNEURONS	Cortical and hippocampal gamma oscillations have been implicated in many behavioral tasks. The hippocampus is required for spatial navigation where animals run at varying speeds. Hence we tested the hypothesis that the gamma rhythm could encode the running speed of mice. We found that the amplitude of slow (20-45 Hz) and fast (45-120 Hz) gamma rhythms in the hippocampal local field potential (LFP) increased with running speed. The speed-dependence of gamma amplitude was restricted to a narrow range of theta phases where gamma amplitude was maximal, called the preferred theta phase of gamma. The preferred phase of slow gamma precessed to lower values with increasing running speed. While maximal fast and slow gamma occurred at coincident phases of theta at low speeds, they became progressively more theta-phase separated with increasing speed. These results demonstrate a novel influence of speed on the amplitude and timing of the hippocampal gamma rhythm which could contribute to learning of temporal sequences and navigation.	[Chen, Zhiping; McFarland, James M.; Mehta, Mayank R.] Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA; [Chen, Zhiping; McFarland, James M.; Mehta, Mayank R.] Univ Calif Los Angeles, Integrat Ctr Learning & Memory, Los Angeles, CA USA; [Resnik, Evgeny; Sakmann, Bert] Max Planck Inst Med Res, Dept Cell Physiol, Heidelberg, Germany; [McFarland, James M.] Brown Univ, Dept Phys, Providence, RI 02912 USA; [Sakmann, Bert] Max Plank Florida Inst, Jupiter, FL USA; [Mehta, Mayank R.] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA; [Mehta, Mayank R.] Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Max Planck Society; Brown University; Max Planck Society; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Chen, ZP (corresponding author), Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA.	MayankMehta@ucla.edu		Mehta, Mayank/0000-0003-2005-2468	NSF [0969034]; NIH/CRCNS [1-R01-MH-092925-01]; Whitehall foundation; W. M. Keck foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092925] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH/CRCNS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Whitehall foundation; W. M. Keck foundation(W.M. Keck Foundation); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grants to M. R. M. from the NSF Career #0969034 (www.nsf.gov), NIH/CRCNS #1-R01-MH-092925-01 (www.nih.gov), Whitehall foundation (www.whitehall.org) and the W. M. Keck foundation (www.wmkeck.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian ED, 1942, J PHYSIOL-LONDON, V100, P459, DOI 10.1113/jphysiol.1942.sp003955; Ang CW, 2005, J NEUROSCI, V25, P9567, DOI 10.1523/JNEUROSCI.2992-05.2005; BRAGIN A, 1995, J NEUROSCI, V15, P47; Buzsaki G, 2003, NEUROSCIENCE, V116, P201, DOI 10.1016/S0306-4522(02)00669-3; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Colgin LL, 2009, NATURE, V462, P353, DOI 10.1038/nature08573; Crone NE, 1998, BRAIN, V121, P2301, DOI 10.1093/brain/121.12.2301; Csicsvari J, 2003, NEURON, V37, P311, DOI 10.1016/S0896-6273(02)01169-8; Dudman JT, 2007, NEURON, V56, P866, DOI 10.1016/j.neuron.2007.10.020; Engel AK, 2001, TRENDS COGN SCI, V5, P16, DOI 10.1016/S1364-6613(00)01568-0; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Hafting T, 2008, NATURE, V453, P1248, DOI 10.1038/nature06957; Hahn TTG, 2007, P NATL ACAD SCI USA, V104, P5169, DOI 10.1073/pnas.0700222104; Hahn TTG, 2006, NAT NEUROSCI, V9, P1359, DOI 10.1038/nn1788; Harris KD, 2002, NATURE, V417, P738, DOI 10.1038/nature00808; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; Hentschke H, 2007, EUR J NEUROSCI, V26, P1642, DOI 10.1111/j.1460-9568.2007.05779.x; Hormuzdi SG, 2001, NEURON, V31, P487, DOI 10.1016/S0896-6273(01)00387-7; Howard MW, 2003, CEREB CORTEX, V13, P1369, DOI 10.1093/cercor/bhg084; Jarsky T, 2005, NAT NEUROSCI, V8, P1667, DOI 10.1038/nn1599; Kay Leslie M, 2003, J Integr Neurosci, V2, P31, DOI 10.1142/S0219635203000196; Korotkova T, 2010, NEURON, V68, P557, DOI 10.1016/j.neuron.2010.09.017; MCNAUGHTON BL, 1983, EXP BRAIN RES, V52, P41; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; Mehta MR, 2000, NEURON, V25, P707, DOI 10.1016/S0896-6273(00)81072-7; Mehta MR, 2001, NEUROSCIENTIST, V7, P490, DOI 10.1177/107385840100700605; Mehta MR, 2000, NEUROCOMPUTING, V32, P905, DOI 10.1016/S0925-2312(00)00259-9; MONTGOMERY SM, 2007, P NATL ACAD SCI US; Nitz D, 2004, J NEUROPHYSIOL, V91, P863, DOI 10.1152/jn.00614.2003; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Remondes M, 2002, NATURE, V416, P736, DOI 10.1038/416736a; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Sederberg PB, 2003, J NEUROSCI, V23, P10809; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; Takahashi H, 2009, NEURON, V62, P102, DOI 10.1016/j.neuron.2009.03.007; Tort ABL, 2009, P NATL ACAD SCI USA, V106, P20942, DOI 10.1073/pnas.0911331106; Tort ABL, 2008, P NATL ACAD SCI USA, V105, P20517, DOI 10.1073/pnas.0810524105; Vinck M, 2010, J NEUROSCI, V30, P1250, DOI 10.1523/JNEUROSCI.1623-09.2010; Whittington MA, 2000, INT J PSYCHOPHYSIOL, V38, P315, DOI 10.1016/S0167-8760(00)00173-2; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Womelsdorf T, 2006, NATURE, V439, P733, DOI 10.1038/nature04258; Wulff P, 2009, P NATL ACAD SCI USA, V106, P3561, DOI 10.1073/pnas.0813176106; Zhang KC, 1998, J NEUROPHYSIOL, V79, P1017, DOI 10.1152/jn.1998.79.2.1017	45	54	55	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21408	10.1371/journal.pone.0021408	http://dx.doi.org/10.1371/journal.pone.0021408			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21731735	Green Published, gold			2022-12-27	WOS:000292036900027
J	Colombo, F; Baldan, F; Mazzucchelli, S; Martin-Padura, I; Marighetti, P; Cattaneo, A; Foglieni, B; Spreafico, M; Guerneri, S; Baccarin, M; Bertolini, F; Rossi, G; Mazzaferro, V; Cadamuro, M; Maggioni, M; Agnelli, L; Rebulla, P; Prati, D; Porretti, L				Colombo, Federico; Baldan, Francesca; Mazzucchelli, Silvia; Martin-Padura, Ines; Marighetti, Paola; Cattaneo, Alessandra; Foglieni, Barbara; Spreafico, Marta; Guerneri, Silvana; Baccarin, Marco; Bertolini, Francesco; Rossi, Giorgio; Mazzaferro, Vincenzo; Cadamuro, Massimiliano; Maggioni, Marco; Agnelli, Luca; Rebulla, Paolo; Prati, Daniele; Porretti, Laura			Evidence of Distinct Tumour-Propagating Cell Populations with Different Properties in Primary Human Hepatocellular Carcinoma	PLOS ONE			English	Article							CANCER STEM-CELLS; MESENCHYMAL TRANSITION; GENE-EXPRESSION; IDENTIFICATION; PROGRESSION; LINES; ESTABLISHMENT; LEUKEMIA	Background and Aims: Increasing evidence that a number of malignancies are characterised by tumour cell heterogeneity has recently been published, but there is still a lack of data concerning liver cancers. The aim of this study was to investigate and characterise tumour-propagating cell (TPC) compartments within human hepatocellular carcinoma (HCC). Methods: After long-term culture, we identified three morphologically different tumour cell populations in a single HCC specimen, and extensively characterised them by means of flow cytometry, fluorescence microscopy, karyotyping and microarray analyses, single cell cloning, and xenotransplantation in NOD/SCID/IL2Rc gamma(-/-) mice. Results: The primary cell populations (hcc-1, -2 and -3) and two clones generated by means of limiting dilutions from hcc-1 (clone-1/7 and -1/8) differently expressed a number of tumour-associated stem cell markers, including EpCAM, CD49f, CD44, CD133, CD56, Thy-1, ALDH and CK19, and also showed different doubling times, drug resistance and tumorigenic potential. Moreover, we found that ALDH expression, in combination with CD44 or Thy-1 negativity or CD56 positivity identified subpopulations with a higher clonogenic potential within hcc-1, hcc-2 and hcc-3 primary cell populations, respectively. Karyotyping revealed the clonal evolution of the cell populations and clones within the primary tumour. Importantly, the primary tumour cell population with the greatest tumorigenic potential and drug resistance showed more chromosomal alterations than the others and contained clones with epithelial and mesenchymal features. Conclusions: Individual HCCs can harbor different self-renewing tumorigenic cell types expressing a variety of morphological and phenotypical markers, karyotypic evolution and different gene expression profiles. This suggests that the models of hepatic carcinogenesis should take into account TPC heterogeneity due to intratumour clonal evolution.	[Colombo, Federico; Baldan, Francesca; Mazzucchelli, Silvia; Cattaneo, Alessandra; Rebulla, Paolo; Prati, Daniele; Porretti, Laura] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Ctr Transfus Med Cellular Therapy & Cryobiol, Expt Hepatol Lab, Milan, Italy; [Martin-Padura, Ines; Marighetti, Paola; Bertolini, Francesco] European Inst Oncol, Lab Hematooncol, Milan, Italy; [Foglieni, Barbara; Spreafico, Marta; Prati, Daniele] Hosp A Manzoni, Dept Hematol, Lecce, Italy; [Guerneri, Silvana; Baccarin, Marco] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Med Genet Lab, Milan, Italy; [Rossi, Giorgio] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Liver & Lung Transplant Unit, Milan, Italy; [Mazzaferro, Vincenzo] Natl Canc Inst, I-20133 Milan, Italy; [Cadamuro, Massimiliano] Univ Padua, Dept Surg & Gastroenterol Sci, Padua, Italy; [Cadamuro, Massimiliano] Osped Riuniti Bergamo, Liver Res Ctr, I-24100 Bergamo, Italy; [Maggioni, Marco] AO San Paolo Milan, Dept Med Surg & Dent, Div Pathol, Milan, Italy; [Maggioni, Marco] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Med Surg & Dent, Div Pathol, Milan, Italy; [Agnelli, Luca] Univ Milan, Dept Med Sci, Milan, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS European Institute of Oncology (IEO); IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Ca Granda Ospedale Maggiore Policlinico; Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Padua; Ospedali Riuniti di Bergamo; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan	Colombo, F (corresponding author), Fdn IRCCS Ca Granda Osped Maggiore Policlin, Ctr Transfus Med Cellular Therapy & Cryobiol, Expt Hepatol Lab, Milan, Italy.	labcitofl@policlinico.mi.it	Rossi, Giorgio/M-3445-2015; Cadamuro, Massimiliano/AAC-6169-2022; bertolini, francesco/AAC-9780-2019; Agnelli, Luca/H-8238-2012; Colombo, Federico Simone/J-5586-2015; Mazzaferro, Vincenzo/AAL-4707-2020; Prati, Daniele/P-8215-2019; Maggioni, Marco/AAC-4617-2022; Mazzaferro, Vincenzo/C-2726-2017; Cattaneo, Alessandra/K-5049-2012; Porretti, Laura/J-6748-2015; Rebulla, Paolo/I-7684-2015; Spreafico, Marta/C-5945-2014	Rossi, Giorgio/0000-0002-5588-1306; Cadamuro, Massimiliano/0000-0002-0899-7613; bertolini, francesco/0000-0001-5660-3255; Colombo, Federico Simone/0000-0003-4480-3481; Prati, Daniele/0000-0002-2281-7498; Maggioni, Marco/0000-0001-8603-8998; Mazzaferro, Vincenzo/0000-0002-4013-8085; Cattaneo, Alessandra/0000-0002-4500-6540; Porretti, Laura/0000-0001-8100-4262; Rebulla, Paolo/0000-0002-3875-5754; Spreafico, Marta/0000-0003-3378-5513; Agnelli, Luca/0000-0003-0582-6170	COPEV (Comitato per la Prevenzione dell'Epatite Virale); "Progetto di Ricerca a Concorso'' IRCCS Ospedale Policlinico, Milan; Associazione Italiana Studio Fegato (AISF); Associazione Italiana Ricerca sul Cancro (AIRC); CeLiveR	COPEV (Comitato per la Prevenzione dell'Epatite Virale); "Progetto di Ricerca a Concorso'' IRCCS Ospedale Policlinico, Milan; Associazione Italiana Studio Fegato (AISF); Associazione Italiana Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); CeLiveR	This study was supported by grants from COPEV (Comitato per la Prevenzione dell'Epatite Virale); "Progetto di Ricerca a Concorso 2009/2010'' IRCCS Ospedale Policlinico, Milan; Associazione Italiana Studio Fegato (AISF); Associazione Italiana Ricerca sul Cancro (AIRC); and CeLiveR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agliano A, 2008, INT J CANCER, V123, P2222, DOI 10.1002/ijc.23772; Agnelli L, 2007, HAEMATOL-HEMATOL J, V92, P56, DOI 10.3324/haematol.10414; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; BIGNER SH, 1987, CANCER GENET CYTOGEN, V24, P163, DOI 10.1016/0165-4608(87)90094-X; Bomken S, 2010, BRIT J CANCER, V103, P439, DOI 10.1038/sj.bjc.6605821; Chen RH, 2010, CANCER CELL, V17, P362, DOI 10.1016/j.ccr.2009.12.049; Chiba T, 2006, HEPATOLOGY, V44, P240, DOI 10.1002/hep.21227; Chifenti B, 2009, PANCREAS, V38, P184, DOI 10.1097/MPA.0b013e31818c746a; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Fabris L, 2008, HEPATOLOGY, V47, P719, DOI 10.1002/hep.22015; Faivre S, 2007, NAT REV DRUG DISCOV, V6, P734, DOI 10.1038/nrd2380; Greaves M, 2010, SEMIN CANCER BIOL, V20, P65, DOI 10.1016/j.semcancer.2010.03.002; Hoshida Y, 2008, NEW ENGL J MED, V359, P1995, DOI 10.1056/NEJMoa0804525; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kim Y, 2009, CANCER RES, V69, P9271, DOI 10.1158/0008-5472.CAN-09-1605; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Lau SH, 2005, ACTA PHARMACOL SIN, V26, P659, DOI 10.1111/j.1745-7254.2005.00126.x; Liu L, 2006, CANCER RES, V66, P11851, DOI 10.1158/0008-5472.CAN-06-1377; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma S, 2007, GASTROENTEROLOGY, V132, P2542, DOI 10.1053/j.gastro.2007.04.025; Marquardt JU, 2010, J HEPATOL, V53, P568, DOI 10.1016/j.jhep.2010.05.003; Martin-Padura I, 2010, BLOOD, V116, P2616, DOI 10.1182/blood-2010-07-295584; Merlo LMF, 2006, NAT REV CANCER, V6, P924, DOI 10.1038/nrc2013; Merlo LMF, 2010, J CLIN INVEST, V120, P401, DOI 10.1172/JCI42088; Midorikawa Y, 2009, HEPATOLOGY, V49, P513, DOI 10.1002/hep.22698; Narva E, 2010, NAT BIOTECHNOL, V28, P371, DOI 10.1038/nbt.1615; Park SY, 2010, J CLIN INVEST, V120, P636, DOI 10.1172/JCI40724; Piccirillo SGM, 2009, ONCOGENE, V28, P1807, DOI 10.1038/onc.2009.27; Porretti L, 2010, CYTOM PART A, V77A, P31, DOI 10.1002/cyto.a.20834; Rebuzzini P, 2008, CYTOGENET GENOME RES, V121, P18, DOI 10.1159/000124377; Shackleton M, 2009, CELL, V138, P822, DOI 10.1016/j.cell.2009.08.017; Shi GM, 2008, J CANCER RES CLIN, V134, P1155, DOI 10.1007/s00432-008-0407-1; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Steinemann D, 2006, CLIN GASTROENTEROL H, V4, P1283, DOI 10.1016/j.cgh.2006.07.010; Suetsugi A, 2006, BIOCHEM BIOPH RES CO, V351, P820, DOI 10.1016/j.bbrc.2006.10.128; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; van Zijl F, 2009, ONCOGENE, V28, P4022, DOI 10.1038/onc.2009.253; Vergara D, 2010, CANCER LETT, V291, P59, DOI 10.1016/j.canlet.2009.09.017; Villanueva A, 2010, ANNU REV MED, V61, P317, DOI 10.1146/annurev.med.080608.100623; Visvader JE, 2011, NATURE, V469, P314, DOI 10.1038/nature09781; Wong N, 2000, HEPATOLOGY, V32, P1060, DOI 10.1053/jhep.2000.19349	42	40	50	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21369	10.1371/journal.pone.0021369	http://dx.doi.org/10.1371/journal.pone.0021369			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731718	Green Published, gold			2022-12-27	WOS:000292035400030
J	Frazer, C; Young, PG				Frazer, Corey; Young, Paul G.			Redundant Mechanisms Prevent Mitotic Entry Following Replication Arrest in the Absence of Cdc25 Hyper-Phosphorylation in Fission Yeast	PLOS ONE			English	Article							DNA-DAMAGE CHECKPOINT; S-PHASE ARREST; SCHIZOSACCHAROMYCES-POMBE; CELL-CYCLE; TYROSINE PHOSPHORYLATION; NUCLEAR EXCLUSION; KINASES CDS1; PROTEIN; PHOSPHATASE; GENE	Following replication arrest the Cdc25 phosphatase is phosphorylated and inhibited by Cds1. It has previously been reported that expressing Cdc25 where 9 putative amino-terminal Cds1 phosphorylation sites have been substituted to alanine results in bypass of the DNA replication checkpoint. However, these results were acquired by expression of the phosphorylation mutant using a multicopy expression vector in a genetic background where the DNA replication checkpoint is intact. In order to clarify these results we constructed a Cdc25(9A)-GFP native promoter integrant and examined its effect on the replication checkpoint at endogenous expression levels. In this strain the replication checkpoint operates normally, conditional on the presence of the Mik1 kinase. In response to replication arrest the Cdc25(9A)-GFP protein is degraded, suggesting the presence of a backup mechanism to eliminate the phosphatase when it cannot be inhibited through phosphorylation.	[Frazer, Corey; Young, Paul G.] Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Frazer, C (corresponding author), Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada.	Paul.Young@queensu.ca			NSERC [9335-05]	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding was provided by NSERC 9335-05 Cell Cycle Control. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfa C, 1993, EXPT FISSION YEAST L; AVES SJ, 1985, EMBO J, V4, P457, DOI 10.1002/j.1460-2075.1985.tb03651.x; Baber-Furnari BA, 2000, MOL BIOL CELL, V11, P1; Bentley NJ, 1996, EMBO J, V15, P6641, DOI 10.1002/j.1460-2075.1996.tb01054.x; Boddy MN, 2000, MOL CELL BIOL, V20, P8758, DOI 10.1128/MCB.20.23.8758-8766.2000; Boddy MN, 1998, SCIENCE, V280, P909, DOI 10.1126/science.280.5365.909; Boddy MN, 2003, MOL CELL BIOL, V23, P5939, DOI 10.1128/MCB.23.16.5939-5946.2003; Boddy MN, 2001, CELL, V107, P537, DOI 10.1016/S0092-8674(01)00536-0; Chen CT, 2008, CURR BIOL, V18, P1594, DOI 10.1016/j.cub.2008.08.067; Chen L, 1999, GENE DEV, V13, P675, DOI 10.1101/gad.13.6.675; Christensen PU, 2000, P NATL ACAD SCI USA, V97, P2579, DOI 10.1073/pnas.97.6.2579; Chu ZQ, 2009, MOL CELL BIOL, V29, P4959, DOI 10.1128/MCB.00562-09; Chua G, 2002, GENETICS, V162, P689; Collura A, 2005, MOL CELL BIOL, V25, P7889, DOI 10.1128/MCB.25.17.7889-7899.2005; Daga RR, 1999, J CELL SCI, V112, P3137; de Bruin RAM, 2008, P NATL ACAD SCI USA, V105, P11230, DOI 10.1073/pnas.0801106105; de Bruin RAM, 2006, MOL CELL, V23, P483, DOI 10.1016/j.molcel.2006.06.025; Diaz-Cuervo H, 2008, MOL BIOL CELL, V19, P2488, DOI 10.1091/mbc.E07-08-0737; DUCOMMUN B, 1990, BIOCHEM BIOPH RES CO, V167, P301, DOI 10.1016/0006-291X(90)91765-K; Dutta C, 2008, MOL CELL BIOL, V28, P5977, DOI 10.1128/MCB.00596-08; ENOCH T, 1990, CELL, V60, P665, DOI 10.1016/0092-8674(90)90669-6; Esteban V, 2004, J CELL SCI, V117, P2461, DOI 10.1242/jcs.01107; Esteban V, 2008, CELL CYCLE, V7, P1269, DOI 10.4161/cc.7.9.5947; FORD JC, 1994, SCIENCE, V265, P533, DOI 10.1126/science.8036497; FOX RM, 1985, PHARMACOL THERAPEUT, V30, P31, DOI 10.1016/0163-7258(85)90046-4; Froget B, 2008, MOL BIOL CELL, V19, P445, DOI 10.1091/mbc.E07-07-0728; Furnari B, 1999, MOL BIOL CELL, V10, P833, DOI 10.1091/mbc.10.4.833; Gardner RG, 2005, CELL, V120, P803, DOI 10.1016/j.cell.2005.01.016; GAUTIER J, 1991, CELL, V67, P197, DOI 10.1016/0092-8674(91)90583-K; GORDON CB, 1986, EMBO J, V5, P2981, DOI 10.1002/j.1460-2075.1986.tb04595.x; GOULD KL, 1989, NATURE, V342, P39, DOI 10.1038/342039a0; Gutz H., 1974, HDB GENETICS, V1, P395; Kai M, 2003, MUTAT RES-FUND MOL M, V532, P59, DOI 10.1016/j.mrfmmm.2003.08.010; Karagiannis J, 2002, GENETICS, V162, P45; Knudsen KE, 1996, P NATL ACAD SCI USA, V93, P8278, DOI 10.1073/pnas.93.16.8278; Kovelman R, 1996, MOL CELL BIOL, V16, P86; KUMAGAI A, 1991, CELL, V64, P903, DOI 10.1016/0092-8674(91)90315-P; Lambert S, 2007, DNA REPAIR, V6, P1042, DOI 10.1016/j.dnarep.2007.02.024; LEE MS, 1994, J BIOL CHEM, V269, P30530; Lindsay HD, 1998, GENE DEV, V12, P382, DOI 10.1101/gad.12.3.382; Lopez-Girona A, 1999, NATURE, V397, P172, DOI 10.1038/16488; Lopez-Girona A, 2001, CURR BIOL, V11, P50, DOI 10.1016/S0960-9822(00)00026-9; LOWNDES NF, 1992, NATURE, V355, P449, DOI 10.1038/355449a0; LUNDGREN K, 1991, CELL, V64, P1111, DOI 10.1016/0092-8674(91)90266-2; MILLAR JBA, 1992, EMBO J, V11, P4933, DOI 10.1002/j.1460-2075.1992.tb05600.x; Mishra M, 2004, J CELL SCI, V117, P3897, DOI 10.1242/jcs.01244; MIYAMOTO M, 1994, EMBO J, V13, P1873, DOI 10.1002/j.1460-2075.1994.tb06456.x; MORENO S, 1990, NATURE, V344, P549, DOI 10.1038/344549a0; MORLA AO, 1989, CELL, V58, P193, DOI 10.1016/0092-8674(89)90415-7; Moser BA, 2000, MOL CELL BIOL, V20, P4288, DOI 10.1128/MCB.20.12.4288-4294.2000; Murray JM, 1997, MOL CELL BIOL, V17, P6868, DOI 10.1128/MCB.17.12.6868; Ng SS, 2001, FEBS LETT, V503, P131, DOI 10.1016/S0014-5793(01)02720-X; NURSE P, 1975, NATURE, V256, P547, DOI 10.1038/256547a0; OConnell MJ, 1997, EMBO J, V16, P545, DOI 10.1093/emboj/16.3.545; PARKER LL, 1992, P NATL ACAD SCI USA, V89, P2917, DOI 10.1073/pnas.89.7.2917; PRENTICE HL, 1992, NUCLEIC ACIDS RES, V20, P621, DOI 10.1093/nar/20.3.621; Raleigh JM, 2000, J CELL SCI, V113, P1727; Rhind N, 2001, MOL CELL BIOL, V21, P1499, DOI 10.1128/MCB.21.5.1499-1508.2001; Rupes I, 2001, MOL BIOL CELL, V12, P3892, DOI 10.1091/mbc.12.12.3892; RUSSELL P, 1986, CELL, V45, P145, DOI 10.1016/0092-8674(86)90546-5; RUSSELL P, 1987, CELL, V49, P559, DOI 10.1016/0092-8674(87)90458-2; Saka Y, 1997, GENE DEV, V11, P3387, DOI 10.1101/gad.11.24.3387; SEATON BL, 1992, GENE, V119, P83, DOI 10.1016/0378-1119(92)90069-2; Soto T, 2002, EUR J BIOCHEM, V269, P5056, DOI 10.1046/j.1432-1033.2002.03214.x; Soto T, 2007, MICROBIOL-SGM, V153, P1519, DOI 10.1099/mic.0.2006/004283-0; Stewart E, 1997, EMBO J, V16, P2682, DOI 10.1093/emboj/16.10.2682; Tanaka K, 2004, J BIOL CHEM, V279, P32079, DOI 10.1074/jbc.M404834200; Trautmann S, 2001, CURR BIOL, V11, P931, DOI 10.1016/S0960-9822(01)00268-8; Wan SH, 1999, YEAST, V15, P821, DOI 10.1002/(SICI)1097-0061(199907)15:10A<821::AID-YEA422>3.3.CO;2-R; Wang JC, 1996, ANNU REV BIOCHEM, V65, P635, DOI 10.1146/annurev.bi.65.070196.003223; Welinder C, 2011, J PROTEOME RES, V10, P1416, DOI 10.1021/pr1011476; Willson J, 1997, NUCLEIC ACIDS RES, V25, P2138, DOI 10.1093/nar/25.11.2138; Wolfe BA, 2004, EMBO J, V23, P919, DOI 10.1038/sj.emboj.7600103; Wolfe BA, 2006, DEV CELL, V11, P423, DOI 10.1016/j.devcel.2006.07.016; Zeng Y, 1998, NATURE, V395, P507, DOI 10.1038/26766; Zeng Y, 1999, MOL CELL BIOL, V19, P7410; Zhao H, 2003, MOL CELL BIOL, V23, P8395, DOI 10.1128/MCB.23.22.8395-8403.2003; Zhu Y, 1997, EMBO J, V16, P1023, DOI 10.1093/emboj/16.5.1023	78	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21348	10.1371/journal.pone.0021348	http://dx.doi.org/10.1371/journal.pone.0021348			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731711	gold, Green Submitted, Green Published			2022-12-27	WOS:000292035400026
J	Haidari, M; Zhang, W; Ganjehei, L; Ali, M; Chen, ZP				Haidari, Mehran; Zhang, Wei; Ganjehei, Leila; Ali, Muzammil; Chen, Zhenping			Inhibition of MLC Phosphorylation Restricts Replication of Influenza Virus-A Mechanism of Action for Anti-Influenza Agents	PLOS ONE			English	Article							PHOSPHOLIPASE-C-EPSILON; LIGHT CHAIN PHOSPHORYLATION; ACTIVATED PROTEIN-KINASE; SMOOTH-MUSCLE; NITRIC-OXIDE; CA2+ SENSITIZATION; MYOSIN PHOSPHATASE; HUMAN NEUTROPHIL; NUCLEAR EXPORT; CELL MOTILITY	Influenza A viruses are a severe threat worldwide, causing large epidemics that kill thousands every year. Prevention of influenza infection is complicated by continuous viral antigenic changes. Newer anti-influenza agents include MEK/ERK and protein kinase C inhibitors; however, the downstream effectors of these pathways have not been determined. In this study, we identified a common mechanism for the inhibitory effects of a significant group of anti-influenza agents. Our studies showed that influenza infection activates a series of signaling pathways that converge to induce myosin light chain (MLC) phosphorylation and remodeling of the actin cytoskeleton. Inhibiting MLC phosphorylation by blocking RhoA/Rho kinase, phospholipase C/protein kinase C, and HRas/Raf/MEK/ERK pathways with the use of genetic or chemical manipulation leads to the inhibition of influenza proliferation. In contrast, the induction of MLC phosphorylation enhances influenza proliferation, as does activation of the HRas/Raf/MEK/ERK signaling pathway. This effect is attenuated by inhibiting MLC phosphorylation. Additionally, in intracellular trafficking studies, we found that the nuclear export of influenza ribonucleoprotein depends on MLC phosphorylation. Our studies provide evidence that modulation of MLC phosphorylation is an underlying mechanism for the inhibitory effects of many anti-influenza compounds.	[Haidari, Mehran] Univ Texas Hlth Sci Ctr Houston, Div Cardiol, Dept Internal Med, Houston, TX 77225 USA; [Haidari, Mehran; Zhang, Wei; Ganjehei, Leila; Ali, Muzammil; Chen, Zhenping] St Lukes Episcopal Hosp, Texas Heart Inst, Houston, TX USA	University of Texas System; University of Texas Health Science Center Houston; Saint Lukes Episcopal Hospital; Texas Heart Institute	Haidari, M (corresponding author), Univ Texas Hlth Sci Ctr Houston, Div Cardiol, Dept Internal Med, Houston, TX 77225 USA.	Mehran.Haidari@uth.tmc.edu			American Heart Association South Central Affiliate [0865174F]; United States Army [W81XWH-04-2-0035]	American Heart Association South Central Affiliate(American Heart Association); United States Army(United States Department of DefenseUnited States Army)	The work was supported by the American Heart Association South Central Affiliate grant (0865174F) to M. Haidari and by United States Army grant W81XWH-04-2-0035. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amerongen GPV, 1998, CIRC RES, V83, P1115, DOI 10.1161/01.RES.83.11.1115; Arora DJS, 1998, ARCH VIROL, V143, P2029, DOI 10.1007/s007050050439; Bolz SS, 2003, CIRCULATION, V107, P3081, DOI 10.1161/01.CIR.0000074202.19612.8C; Bright RA, 2006, JAMA-J AM MED ASSOC, V295, P891, DOI 10.1001/jama.295.8.joc60020; Castano E, 2010, HISTOCHEM CELL BIOL, V133, P607, DOI 10.1007/s00418-010-0701-2; Chen JC, 2003, J BIOL CHEM, V278, P2807, DOI 10.1074/jbc.M207943200; Dhanasekaran DN, 2007, ONCOGENE, V26, P3185, DOI 10.1038/sj.onc.1210411; Ding Y, 2007, J IMMUNOL, V179, P647, DOI 10.4049/jimmunol.179.1.647; DRAZNIN MB, 1986, INT J BIOCHEM, V18, P917, DOI 10.1016/0020-711X(86)90073-X; English J, 1999, EXP CELL RES, V253, P255, DOI 10.1006/excr.1999.4687; Feierbach B, 2006, PLOS PATHOG, V2, P763, DOI 10.1371/journal.ppat.0020085; Forest T, 2005, NAT CELL BIOL, V7, P429, DOI 10.1038/ncb1243; Gallagher ED, 2004, J BIOL CHEM, V279, P1872, DOI 10.1074/jbc.M309525200; Haidari M, 2010, ATHEROSCLEROSIS, V208, P90, DOI 10.1016/j.atherosclerosis.2009.07.028; Haidari M, 2009, PHYTOMEDICINE, V16, P1127, DOI 10.1016/j.phymed.2009.06.002; Hains MD, 2006, MOL PHARMACOL, V69, P2068, DOI 10.1124/mol.105.017921; HARTSHORN KL, 1990, BLOOD, V75, P218; HARTSHORN KL, 1992, BLOOD, V79, P1049; Hirano K, 2007, J PHARMACOL SCI, V104, P109, DOI 10.1254/jphs.CP0070027; Hofmann W, 2001, J CELL BIOL, V152, P895, DOI 10.1083/jcb.152.5.895; Hofmann WA, 2009, INT REV CEL MOL BIO, V273, P219, DOI 10.1016/S1937-6448(08)01806-6; Ihara E, 2007, AM J PHYSIOL-GASTR L, V293, pG699, DOI 10.1152/ajpgi.00214.2007; Ikuta S, 2008, CANCER RES, V68, P64, DOI 10.1158/0008-5472.CAN-07-3245; June CH, 2001, CURRENT PROTOCOLS CY; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; Lincoln TM, 2007, CIRC RES, V100, P10, DOI 10.1161/01.RES.0000255894.25293.82; Ludwig S, 2006, CELL MICROBIOL, V8, P375, DOI 10.1111/j.1462-5822.2005.00678.x; Ludwig S, 2004, FEBS LETT, V561, P37, DOI 10.1016/S0014-5793(04)00108-5; Ludwig S, 2007, FUTURE VIROL, V2, P91, DOI 10.2217/17460794.2.1.91; Madonna R, 2005, J BIOL CHEM, V280, P13503, DOI 10.1074/jbc.M411859200; Marjuki H, 2006, J BIOL CHEM, V281, P16707, DOI 10.1074/jbc.M510233200; Mercer J, 2009, NAT CELL BIOL, V11, P510, DOI 10.1038/ncb0509-510; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Nguyen DHD, 1999, J CELL BIOL, V146, P149, DOI 10.1083/jcb.146.1.149; NOVAK EJ, 1994, CYTOMETRY, V17, P135, DOI 10.1002/cyto.990170205; NUGENT KM, 1984, ARCH VIROL, V81, P163, DOI 10.1007/BF01309305; OCHIAI H, 1991, ANTIVIR RES, V15, P149, DOI 10.1016/0166-3542(91)90032-M; OHKAWA T, J CELL BIOL, V190, P187; Olschlager V, 2004, ONCOGENE, V23, P6639, DOI 10.1038/sj.onc.1207883; Pleschka S, 2001, NAT CELL BIOL, V3, P301, DOI 10.1038/35060098; Radtke K, 2006, CELL MICROBIOL, V8, P387, DOI 10.1111/j.1462-5822.2005.00679.x; Rimmelzwaan GF, 1999, J VIROL, V73, P8880, DOI 10.1128/JVI.73.10.8880-8883.1999; Root CN, 2000, J GEN VIROL, V81, P2697, DOI 10.1099/0022-1317-81-11-2697; SCHOLEY JM, 1980, NATURE, V287, P233, DOI 10.1038/287233a0; Seifert JP, 2008, J BIOL CHEM, V283, P29690, DOI 10.1074/jbc.M805038200; SHARON N, 1989, SCIENCE, V246, P227, DOI 10.1126/science.2552581; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Sun XJ, 2007, CELL MICROBIOL, V9, P1672, DOI 10.1111/j.1462-5822.2007.00900.x; TRYBUS KM, 1984, J BIOL CHEM, V259, P8564; Vartiainen MK, 2008, FEBS LETT, V582, P2033, DOI 10.1016/j.febslet.2008.04.010; Ward CL, 2004, J CLIN VIROL, V29, P179, DOI 10.1016/S1386-6532(03)00122-7; Wing Michele R, 2003, Mol Interv, V3, P273, DOI 10.1124/mi.3.5.273; Woods A, 2006, J BIOL CHEM, V281, P13134, DOI 10.1074/jbc.M509433200; Xia MX, 2007, NAT STRUCT MOL BIOL, V14, P215, DOI 10.1038/nsmb1208; Xiao DL, 2005, AM J PHYSIOL-HEART C, V288, pH2828, DOI 10.1152/ajpheart.01189.2004; Yeung K, 1999, NATURE, V401, P173, DOI 10.1038/43686; Zhu S, 2008, ONCOGENE, V27, P1580, DOI 10.1038/sj.onc.1210790	59	30	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21444	10.1371/journal.pone.0021444	http://dx.doi.org/10.1371/journal.pone.0021444			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731751	gold, Green Submitted, Green Published			2022-12-27	WOS:000292035400039
J	Lukasiewicz, KB; Greenwood, TM; Negron, VC; Bruzek, AK; Salisbury, JL; Lingle, WL				Lukasiewicz, Kara B.; Greenwood, Tammy M.; Negron, Vivian C.; Bruzek, Amy K.; Salisbury, Jeffrey L.; Lingle, Wilma L.			Control of Centrin Stability by Aurora A	PLOS ONE			English	Article							CENTROSOME DUPLICATION CYCLE; HUMAN BREAST-TUMORS; CELL-CYCLE; CHROMOSOMAL INSTABILITY; A OVEREXPRESSION; PROTEIN-KINASE; CANCER CELLS; AMPLIFICATION; PHOSPHORYLATION; IDENTIFICATION	Aurora A is an oncogenic serine/threonine kinase which can cause cell transformation and centrosome amplification when over-expressed. Human breast tumors show excess Aurora A and phospho-centrin in amplified centrosomes. Here, we show that Aurora A mediates the phosphorylation of and localizes with centrin at the centrosome, with both proteins reaching maximum abundance from prophase through metaphase, followed by their precipitous loss in late stages of mitosis. Overexpression of Aurora A results in excess phospho-centrin and centrosome amplification. In contrast, centrosome amplification is not seen in cells over-expressing Aurora A in the presence of a recombinant centrin mutant lacking the serine phosphorylation site at residue 170. Expression of a kinase dead Aurora A results in a decrease in mitotic index and abrogation of centrin phosphorylation. Finally, a recombinant centrin mutation that mimics centrin phosphorylation increases centrin's stability against APC/C-mediated proteasomal degradation. Taken together, these results suggest that the stability of centrin is regulated in part by Aurora A, and that excess phosphorylated centrin may promote centrosome amplification in cancer.	[Lukasiewicz, Kara B.; Greenwood, Tammy M.; Salisbury, Jeffrey L.; Lingle, Wilma L.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN USA; [Negron, Vivian C.; Bruzek, Amy K.; Lingle, Wilma L.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Lukasiewicz, KB (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Cell Cycle Regulat, Program Cell Regulat & Metab, NIH, Bethesda, MD USA.	Salisbury@mayo.edu; lingle.wilma@mayo.edu		Salisbury, Jeffrey/0000-0001-9257-4578	Mayo Clinic Breast Cancer SPORE NIH [CA116201]; NIH [R01 CA072836]; The Breast Cancer Research Foundation [FNDTBCRF-16, 17]; Mayo Foundation; NATIONAL CANCER INSTITUTE [R01CA072836, P50CA116201] Funding Source: NIH RePORTER	Mayo Clinic Breast Cancer SPORE NIH; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Breast Cancer Research Foundation; Mayo Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding for this research was through the following grants: Mayo Clinic Breast Cancer SPORE NIH CA116201 (W. L. Lingle, Core Leader and James Ingle, PI) (http://www.nih.gov/); NIH R01 CA072836 (J.L. Salisbury, PI) (http://www.nih.gov/); The Breast Cancer Research Foundation FNDTBCRF-16, 17 (W. L. Lingle, Project Leader and J.N. Ingle, PI), (http://www.bcrfcure.org/); and Predoctoral Fellowship from the Mayo Foundation (http://www.mayo.edu/), (K. B. Lukasiewicz). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acu ID, 2010, CANCER RES, V70, P3320, DOI 10.1158/0008-5472.CAN-09-3800; Buchberger A, 2010, MOL CELL, V40, P238, DOI 10.1016/j.molcel.2010.10.001; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; Clute P, 1999, NAT CELL BIOL, V1, P82, DOI 10.1038/10049; Dar AA, 2009, ONCOGENE, V28, P866, DOI 10.1038/onc.2008.434; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; DUENSING A, 2007, ONCOGENE; Ferrari S, 2005, BIOCHEM J, V390, P293, DOI 10.1042/BJ20050343; Freed E, 1999, GENE DEV, V13, P2242, DOI 10.1101/gad.13.17.2242; Fry AM, 1998, EMBO J, V17, P470, DOI 10.1093/emboj/17.2.470; Fukasawa K, 1996, SCIENCE, V271, P1744, DOI 10.1126/science.271.5256.1744; Fukasawa K, 2007, NAT REV CANCER, V7, P911, DOI 10.1038/nrc2249; Goepfert TM, 2002, CANCER RES, V62, P4115; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; HE S, 2010, CELL MOL LIFE SCI; Kasbek C, 2007, MOL BIOL CELL, V18, P4457, DOI 10.1091/mbc.E07-03-0283; Katayama H, 2004, NAT GENET, V36, P55, DOI 10.1038/ng1279; Kimura M, 1997, J BIOL CHEM, V272, P13766, DOI 10.1074/jbc.272.21.13766; Kitajima S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000944; Klein UR, 2009, J CELL SCI, V122, P3312, DOI 10.1242/jcs.050245; Li JJ, 2004, P NATL ACAD SCI USA, V101, P18123, DOI 10.1073/pnas.0408273101; Lingle WL, 1999, AM J PATHOL, V155, P1941, DOI 10.1016/S0002-9440(10)65513-7; Lingle WL, 2002, P NATL ACAD SCI USA, V99, P1978, DOI 10.1073/pnas.032479999; Lingle WL, 1998, P NATL ACAD SCI USA, V95, P2950, DOI 10.1073/pnas.95.6.2950; Littlepage LE, 2002, P NATL ACAD SCI USA, V99, P15440, DOI 10.1073/pnas.202606599; Liu Q, 2004, J BIOL CHEM, V279, P18210, DOI 10.1074/jbc.M400678200; Liu XQ, 2002, P NATL ACAD SCI USA, V99, P8672, DOI 10.1073/pnas.132269599; Lutz W, 2001, J BIOL CHEM, V276, P20774, DOI 10.1074/jbc.M101324200; Mailand N, 2005, CELL, V122, P915, DOI 10.1016/j.cell.2005.08.013; Meraldi P, 2004, CURR OPIN GENET DEV, V14, P29, DOI 10.1016/j.gde.2003.11.006; Meraldi P, 2002, EMBO J, V21, P483, DOI 10.1093/emboj/21.4.483; Miyoshi Y, 2001, INT J CANCER, V92, P370, DOI 10.1002/ijc.1200; Otto T, 2009, CANCER CELL, V15, P67, DOI 10.1016/j.ccr.2008.12.005; Paoletti A, 1996, J CELL SCI, V109, P3089; Qina L, 2009, CANCER LETT, V275, P77, DOI 10.1016/j.canlet.2008.10.011; Salisbury JL, 2002, CURR BIOL, V12, P1287, DOI 10.1016/S0960-9822(02)01019-9; Sen S, 2002, JNCI-J NATL CANCER I, V94, P1320; Swallow CJ, 2005, ONCOGENE, V24, P306, DOI 10.1038/sj.onc.1208275; Tsou MFB, 2006, NATURE, V442, P947, DOI 10.1038/nature04985; UZAWA M, 1995, DEV BIOL, V171, P51, DOI 10.1006/dbio.1995.1259; VANDRE DD, 1989, J CELL SCI, V94, P245; Venoux M, 2008, HUM MOL GENET, V17, P215, DOI 10.1093/hmg/ddm298; Vidwans SJ, 1999, J CELL BIOL, V147, P1371, DOI 10.1083/jcb.147.7.1371; Wang X, 2006, ONCOGENE, V25, P7148, DOI 10.1038/sj.onc.1209707; White RA, 2000, MICROSC RES TECHNIQ, V49, P451, DOI 10.1002/(SICI)1097-0029(20000601)49:5<451::AID-JEMT7>3.0.CO;2-9; Wigley WC, 1999, J CELL BIOL, V145, P481; Winey M, 1996, CURR BIOL, V6, P962, DOI 10.1016/S0960-9822(02)00639-5; Yang CH, 2010, MOL BIOL CELL, V21, P4361, DOI 10.1091/mbc.E10-04-0298; Zhou HY, 1998, NAT GENET, V20, P189, DOI 10.1038/2496	49	20	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21291	10.1371/journal.pone.0021291	http://dx.doi.org/10.1371/journal.pone.0021291			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731694	Green Published, Green Submitted, gold			2022-12-27	WOS:000292035400019
J	Zong, F; Fthenou, E; Mundt, F; Szatmari, T; Kovalszky, I; Szilak, L; Brodin, D; Tzanakakis, G; Hjerpe, A; Dobra, K				Zong, Fang; Fthenou, Eleni; Mundt, Filip; Szatmari, Tunde; Kovalszky, Ilona; Szilak, Laszlo; Brodin, David; Tzanakakis, George; Hjerpe, Anders; Dobra, Katalin			Specific Syndecan-1 Domains Regulate Mesenchymal Tumor Cell Adhesion, Motility and Migration	PLOS ONE			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; BREAST-CARCINOMA CELLS; SUPPRESSOR 1 MTSS1; CORE PROTEIN; CD2 FAMILY; CANCER; METASTASIS; ECTODOMAIN; RECEPTOR; ALPHA(V)BETA(3)	Background: Syndecans are proteoglycans whose core proteins have a short cytoplasmic domain, a transmembrane domain and a large N-terminal extracellular domain possessing glycosaminoglycan chains. Syndecans are involved in many important cellular processes. Our recent publications have demonstrated that syndecan-1 translocates into the nucleus and hampers tumor cell proliferation. In the present study, we aimed to investigate the role of syndecan-1 in tumor cell adhesion and migration, with special focus on the importance of its distinct protein domains, to better understand the structure-function relationship of syndecan-1 in tumor progression. Methodology/Principal Findings: We utilized two mesenchymal tumor cell lines which were transfected to stably overexpress full-length syndecan-1 or truncated variants: the 78 which lacks the extracellular domain except the DRKE sequence proposed to be essential for oligomerization, the 77 which lacks the whole extracellular domain, and the RMKKK which serves as a nuclear localization signal. The deletion of the RMKKK motif from full-length syndecan-1 abolished the nuclear translocation of this proteoglycan. Various bioassays for cell adhesion, chemotaxis, random movement and wound healing were studied. Furthermore, we performed gene microarray to analyze the global gene expression pattern influenced by syndecan-1. Both full-length and truncated syndecan-1 constructs decrease tumor cell migration and motility, and affect cell adhesion. Distinct protein domains have differential effects, the extracellular domain is more important for promoting cell adhesion, while the transmembrane and cytoplasmic domains are sufficient for inhibition of cell migration. Cell behavior seems to depend also on the nuclear translocation of syndecan-1. Many genes are differentially regulated by syndecan-1 and a number of genes are actually involved in cell adhesion and migration. Conclusions/Significance: Our results demonstrate that syndecan-1 regulates mesenchymal tumor cell adhesion and migration, and different domains have differential effects. Our study provides new insights into better understanding of the role of syndecans in tumor progression.	[Zong, Fang; Mundt, Filip; Szatmari, Tunde; Hjerpe, Anders; Dobra, Katalin] Karolinska Inst, Dept Lab Med, Div Pathol, Stockholm, Sweden; [Fthenou, Eleni; Tzanakakis, George] Univ Crete, Sch Med, Dept Histol, Div Morphol, Iraklion, Greece; [Kovalszky, Ilona] Semmelweis Univ, Inst Pathol & Expt Canc Res 1, Budapest, Hungary; [Szilak, Laszlo] Western Hungarian Univ, Savaria Univ Ctr, Inst Biol, Szombathely, Hungary; [Brodin, David] Karolinska Inst, Dept Biosci & Nutr, Bioinformat & Express Anal Core Facil, Stockholm, Sweden	Karolinska Institutet; University of Crete; Semmelweis University; University of West Hungary; Karolinska Institutet	Zong, F (corresponding author), Karolinska Inst, Dept Lab Med, Div Pathol, Stockholm, Sweden.	Fang.Zong@ki.se	Szilak, Laszlo/T-1426-2017; Tzanakakis, George/ABH-7725-2020; zong, fang/GQZ-6104-2022; Szatmári, Tünde/AAC-5808-2020; Kovalszky, Ilona/ABH-2832-2020; Tzanakakis, George N/F-6955-2010	Szilak, Laszlo/0000-0003-0334-272X; Tzanakakis, George/0000-0001-5276-4764; Szatmári, Tünde/0000-0001-7727-9589; Kovalszky, Ilona/0000-0002-0179-3378; Tzanakakis, George N/0000-0001-5276-4764; Fthenou, Eleni/0000-0002-1178-6841	Swedish Heart and Lung Fund [20080549]; Swedish AFA [56301063]	Swedish Heart and Lung Fund; Swedish AFA	This research was funded by grants from the Swedish Heart and Lung Fund (20080549, http://www.hjart-lungfonden.se) and a Swedish AFA research grant (56301063, http://www.afa.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulou AN, 2007, INT J BIOCHEM CELL B, V39, P505, DOI 10.1016/j.biocel.2006.10.014; ASUNDI VK, 1995, J BIOL CHEM, V270, P26404, DOI 10.1074/jbc.270.44.26404; Bailly M, 1998, EXP CELL RES, V241, P285, DOI 10.1006/excr.1998.4031; Bass MD, 2002, BIOCHEM J, V368, P1, DOI 10.1042/BJ20021228; Beauvais DM, 2009, J EXP MED, V206, P691, DOI 10.1084/jem.20081278; Beauvais DLM, 2004, J CELL BIOL, V167, P171, DOI 10.1083/jcb.200404171; Beauvais DM, 2003, EXP CELL RES, V286, P219, DOI 10.1016/S0014-4827(03)00126-5; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Boles KS, 2001, IMMUNOGENETICS, V52, P302, DOI 10.1007/s002510000274; Bouchon A, 2001, J IMMUNOL, V167, P5517, DOI 10.4049/jimmunol.167.10.5517; Brockstedt U, 2002, EXP CELL RES, V274, P235, DOI 10.1006/excr.2002.5477; Burbach BJ, 2004, EXP CELL RES, V300, P234, DOI 10.1016/j.yexcr.2004.07.001; Cannons JL, 2011, ANNU REV IMMUNOL, V29, P665, DOI 10.1146/annurev-immunol-030409-101302; CARTER SB, 1965, NATURE, V208, P1183, DOI 10.1038/2081183a0; Cattaruzza S, 2005, MATRIX BIOL, V24, P400, DOI 10.1016/j.matbio.2005.06.005; Chakravarti R, 2005, MOL BIOL CELL, V16, P3678, DOI 10.1091/mbc.E04-10-0907; Chakravarti R, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-83; Chalkiadaki G, 2009, INT J BIOCHEM CELL B, V41, P1323, DOI 10.1016/j.biocel.2008.11.008; Chen LG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004947; Couchman JR, 2003, NAT REV MOL CELL BIO, V4, P926, DOI 10.1038/nrm1257; Dobra K, 2000, EXP CELL RES, V258, P12, DOI 10.1006/excr.2000.4915; Endo K, 2003, J BIOL CHEM, V278, P40764, DOI 10.1074/jbc.M306736200; Harms BD, 2005, BIOPHYS J, V88, P1479, DOI 10.1529/biophysj.104.047365; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Ivanova AV, 2009, CLIN CANCER RES, V15, P2602, DOI 10.1158/1078-0432.CCR-08-2755; Izawa I, 2002, J BIOL CHEM, V277, P5345, DOI 10.1074/jbc.M110052200; JALKANEN M, 1987, J CELL BIOL, V105, P3087, DOI 10.1083/jcb.105.6.3087; Kirn-Safran C, 2009, CELL MOL LIFE SCI, V66, P3421, DOI 10.1007/s00018-009-0096-1; KLOMINEK J, 1989, CANCER RES, V49, P6118; Kumaresan PR, 2002, MOL IMMUNOL, V39, P1, DOI 10.1016/S0161-5890(02)00094-9; Langford JK, 2005, J BIOL CHEM, V280, P3467, DOI 10.1074/jbc.M412451200; Lee JK, 2007, J IMMUNOL, V179, P4672, DOI 10.4049/jimmunol.179.7.4672; Lee JH, 2009, J BIOL CHEM, V284, P27167, DOI 10.1074/jbc.M109.034678; Lee YG, 2002, NEOPLASIA, V4, P291, DOI 10.1038/sj.neo.7900231; Liu K, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-428; Liu W, 1998, J BIOL CHEM, V273, P22825, DOI 10.1074/jbc.273.35.22825; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Ma S, 2007, HUM PATHOL, V38, P1201, DOI 10.1016/j.humpath.2007.01.004; Morgan MR, 2007, NAT REV MOL CELL BIO, V8, P957, DOI 10.1038/nrm2289; Nikolova V, 2009, CARCINOGENESIS, V30, P397, DOI 10.1093/carcin/bgp001; Okina E, 2009, SCAND J MED SCI SPOR, V19, P479, DOI 10.1111/j.1600-0838.2009.00941.x; Parr C, 2009, EUR J CANCER, V45, P1673, DOI 10.1016/j.ejca.2009.02.019; Peterfia Balint, 2006, Magy Onkol, V50, P115; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; STANLEY MJ, 1995, J BIOL CHEM, V270, P5077, DOI 10.1074/jbc.270.10.5077; Subramanian SV, 1997, J BIOL CHEM, V272, P14713, DOI 10.1074/jbc.272.23.14713; THURZO V, 1976, NEOPLASMA, V23, P577; Wang ZH, 2005, BIOCHEMISTRY-US, V44, P12355, DOI 10.1021/bi050620i; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Whiteford JR, 2007, EXP CELL RES, V313, P3902, DOI 10.1016/j.yexcr.2007.08.002; Wilcox-Adelman SA, 2002, GLYCOCONJUGATE J, V19, P305, DOI 10.1023/A:1025304602057; Woods A, 2001, CURR OPIN CELL BIOL, V13, P578, DOI 10.1016/S0955-0674(00)00254-4; Xian X., 2009, CELL TISSUE RES; Zimmermann P, 2005, DEV CELL, V9, P377, DOI 10.1016/j.devcel.2005.07.011; Zong F., 2009, CELL PROLIF; Zong F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007346	56	42	42	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e14816	10.1371/journal.pone.0014816	http://dx.doi.org/10.1371/journal.pone.0014816			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731601	Green Published, Green Submitted, gold			2022-12-27	WOS:000292035400001
J	Boffetta, P; McLerran, D; Chen, Y; Inoue, M; Sinha, R; He, J; Gupta, PC; Tsugane, S; Irie, F; Tamakoshi, A; Gao, YT; Shu, XO; Wang, RW; Tsuji, I; Kuriyama, S; Matsuo, K; Satoh, H; Chen, CJ; Yuan, JM; Yoo, KY; Ahsan, H; Pan, WH; Gu, DF; Pednekar, MS; Sasazuki, S; Sairenchi, T; Yang, G; Xiang, YB; Nagai, M; Tanaka, H; Nishino, Y; You, SL; Koh, WP; Park, SK; Shen, CY; Thornquist, M; Kang, D; Rolland, B; Feng, ZD; Zheng, W; Potter, JD				Boffetta, Paolo; McLerran, Dale; Chen, Yu; Inoue, Manami; Sinha, Rashmi; He, Jiang; Gupta, Prakash Chandra; Tsugane, Shoichiro; Irie, Fujiko; Tamakoshi, Akiko; Gao, Yu-Tang; Shu, Xiao-Ou; Wang, Renwei; Tsuji, Ichiro; Kuriyama, Shinichi; Matsuo, Keitaro; Satoh, Hiroshi; Chen, Chien-Jen; Yuan, Jian-Min; Yoo, Keun-Young; Ahsan, Habibul; Pan, Wen-Harn; Gu, Dongfeng; Pednekar, Mangesh Suryakant; Sasazuki, Shizuka; Sairenchi, Toshimi; Yang, Gong; Xiang, Yong-Bing; Nagai, Masato; Tanaka, Hideo; Nishino, Yoshikazu; You, San-Lin; Koh, Woon-Puay; Park, Sue K.; Shen, Chen-Yang; Thornquist, Mark; Kang, Daehee; Rolland, Betsy; Feng, Ziding; Zheng, Wei; Potter, John D.			Body Mass Index and Diabetes in Asia: A Cross-Sectional Pooled Analysis of 900,000 Individuals in the Asia Cohort Consortium	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; INSULIN SENSITIVITY; GLUCOSE-TOLERANCE; ABDOMINAL OBESITY; FAT DISTRIBUTION; LIFE-STYLE; TYPE-2; PREVALENCE; MELLITUS; POPULATION	Background: The occurrence of diabetes has greatly increased in low- and middle-income countries, particularly in Asia, as has the prevalence of overweight and obesity; in European-derived populations, overweight and obesity are established causes of diabetes. The shape of the association of overweight and obesity with diabetes risk and its overall impact have not been adequately studied in Asia. Methods and Findings: A pooled cross-sectional analysis was conducted to evaluate the association between baseline body mass index (BMI, measured as weight in kg divided by the square of height in m) and self-reported diabetes status in over 900,000 individuals recruited in 18 cohorts from Bangladesh, China, India, Japan, Korea, Singapore and Taiwan. Logistic regression models were fitted to calculate cohort-specific odds ratios (OR) of diabetes for categories of increasing BMI, after adjustment for potential confounding factors. OR were pooled across cohorts using a random-effects meta-analysis. The sex- and age-adjusted prevalence of diabetes was 4.3% in the overall population, ranging from 0.5% to 8.2% across participating cohorts. Using the category 22.5-24.9 Kg/m(2) as reference, the OR for diabetes spanned from 0.58 (95% confidence interval [CI] 0.31, 0.76) for BMI lower than 15.0 kg/m(2) to 2.23 (95% CI 1.86, 2.67) for BMI higher than 34.9 kg/m(2). The positive association between BMI and diabetes prevalence was present in all cohorts and in all subgroups of the study population, although the association was stronger in individuals below age 50 at baseline (p-value of interaction <0.001), in cohorts from India and Bangladesh (p<0.001), in individuals with low education (p-value 0.02), and in smokers (p-value 0.03); no differences were observed by gender, urban residence, or alcohol drinking. Conclusions: This study estimated the shape and the strength of the association between BMI and prevalence of diabetes in Asian populations and identified patterns of the association by age, country, and other risk factors for diabetes.	[Boffetta, Paolo] Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USA; [Boffetta, Paolo] Int Prevent Res Inst, Lyon, France; [McLerran, Dale; Thornquist, Mark; Rolland, Betsy; Feng, Ziding; Potter, John D.] Fred Hutchinson Canc Res Ctr, Dept Publ Hlth Sci, Seattle, WA 98104 USA; [Chen, Yu] NYU, Dept Environm Med, Sch Med, New York, NY 10016 USA; [Inoue, Manami; Tsugane, Shoichiro; Sasazuki, Shizuka] Natl Canc Ctr, Res Ctr Canc Prevent & Screening, Epidemiol & Prevent Div, Tokyo 104, Japan; [Sinha, Rashmi] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [He, Jiang] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA USA; [Gupta, Prakash Chandra; Pednekar, Mangesh Suryakant] Healis Sekhsaria Inst Publ Hlth, Navi Mumbai, India; [Irie, Fujiko] Ibaraki Prefectural Govt, Dept Hlth & Social Serv, Ibaraki, Japan; [Tamakoshi, Akiko] Aichi Med Univ, Sch Med, Dept Publ Hlth, Aichi, Japan; [Gao, Yu-Tang; Xiang, Yong-Bing] Shanghai Canc Inst, Dept Epidemiol, Shanghai, Peoples R China; [Shu, Xiao-Ou; Yang, Gong; Zheng, Wei] Vanderbilt Univ, Vanderbilt Epidemiol Ctr, Dept Med, Div Epidemiol, Nashville, TN USA; [Wang, Renwei] Univ Minnesota, Mason Canc Ctr, Minneapolis, MN USA; [Tsuji, Ichiro; Kuriyama, Shinichi; Nagai, Masato] Tohoku Univ, Grad Sch Med, Dept Publ Hlth & Forens Med, Div Epidemiol, Sendai, Miyagi 980, Japan; [Matsuo, Keitaro; Tanaka, Hideo] Aichi Canc Ctr, Res Inst, Div Epidemiol & Prevent, Nagoya, Aichi 464, Japan; [Chen, Chien-Jen; You, San-Lin] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Chen, Chien-Jen; Pan, Wen-Harn] Natl Taiwan Univ, Coll Publ Hlth, Grad Inst Epidemiol, Taipei 10764, Taiwan; [Yoo, Keun-Young; Kang, Daehee] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Ahsan, Habibul] Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA; [Ahsan, Habibul] Univ Chicago, Dept Med & Human Genet, Chicago, IL 60637 USA; [Ahsan, Habibul] Univ Chicago, Canc Res Ctr, Chicago, IL 60637 USA; [Pan, Wen-Harn] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Pan, Wen-Harn] Natl Taiwan Univ, Dept Biochem Sci & Technol, Taipei 10764, Taiwan; [Gu, Dongfeng] Fuwai Hosp, Beijing, Peoples R China; [Gu, Dongfeng] Chinese Acad Med Sci, Cardiovasc Inst, Beijing 100730, Peoples R China; [Gu, Dongfeng] Peking Union Med Coll, China Natl Ctr Cardiovasc Dis, Beijing 100021, Peoples R China; [Sairenchi, Toshimi] Dokkyo Med Univ, Sch Med, Dept Publ Hlth, Mibu, Tochigi, Japan; [Nishino, Yoshikazu] Miyagi Canc Ctr, Res Inst, Div Epidemiol, Sendai, Miyagi, Japan; [Koh, Woon-Puay] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Epidemiol & Publ Hlth, Singapore 117595, Singapore; [Park, Sue K.] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Park, Sue K.] Seoul Natl Univ, Canc Res Inst, Seoul, South Korea; [Park, Sue K.] Seoul Natl Univ, Inst Hlth Policy & Management, Seoul, South Korea; [Shen, Chen-Yang] Acad Sinica, Inst Biomed Sci, Taiwan Biobank, Taipei, Taiwan; [Shen, Chen-Yang] China Med Univ, Grad Inst Environm Sci, Taichung, Taiwan	Icahn School of Medicine at Mount Sinai; Fred Hutchinson Cancer Center; New York University; National Cancer Center - Japan; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Tulane University; Aichi Medical University; Shanghai Jiao Tong University; Vanderbilt University; University of Minnesota System; University of Minnesota Twin Cities; Tohoku University; Aichi Cancer Center; Academia Sinica - Taiwan; National Taiwan University; Seoul National University (SNU); University of Chicago; University of Chicago; University of Chicago; Academia Sinica - Taiwan; National Taiwan University; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Dokkyo Medical University; Miyagi Cancer Center; National University of Singapore; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Academia Sinica - Taiwan; China Medical University Taiwan	Boffetta, P (corresponding author), Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USA.	paolo.boffetta@mssm.edu; jpotter@fhcrc.org	Matsuo, Keitaro/H-6758-2019; Park, Sue Kyung/J-2757-2012; Tsugane, Shoichiro/A-2424-2015; Yoo, Keun-Young/J-5548-2012; zhang, weihua/GXV-1334-2022; Gao, Yu/HGE-1937-2022; gao, yi/HCI-8298-2022; Kang, Dae Hee/E-8631-2012; Tanaka, Hideo/A-8145-2016; Nagai, Masato/ABC-6862-2020; Tamakoshi, Akiko/D-5105-2012; Sriwisit, Sukhumaphorn/G-1405-2011; Sinha, Rashmi/G-7446-2015; Shen, CY/F-6271-2010; Boffetta, Paolo/AAI-7767-2021; Chen, Chien-Jen/C-6976-2008; Zheng, Wei/O-3351-2013; Gao, Y./GWZ-3665-2022; He, Jiang/AAF-5303-2020; Chen, Chien-Jen/N-4723-2019	Matsuo, Keitaro/0000-0003-1761-6314; Tsugane, Shoichiro/0000-0003-4105-2774; Nagai, Masato/0000-0003-0818-3158; Sinha, Rashmi/0000-0002-2466-7462; Boffetta, Paolo/0000-0002-3811-2791; Zheng, Wei/0000-0003-1226-070X; He, Jiang/0000-0002-8286-9652; You, San-Lin/0000-0002-3192-3356; Chen, Yu/0000-0002-1519-4894; Sairenchi, Toshimi/0000-0001-8896-6501; Potter, John/0000-0001-5439-1500; Pednekar, Mangesh/0000-0001-6266-5356; Kang, Daehee/0000-0003-4031-5878; Yuan, Jian-Min/0000-0002-4620-3108	3-Prefecture Aichi, Ibaraki, Japan Collaborative Cohort Study (JACC); Japan Public Health Center-Based Study 1 (JPHC1); Japan Public Health Center-Based Study 2 (JPHC2); 3-Prefecture Miyagi, Miyagi, Ohsaki; Ministry of Health, Labour and Welfare, Japan; Ministry of Education, Culture, Sports, Science and Technology, Japan; China National Hypertension Survey Epidemiology Followup Study (CHEFS); American Heart Association [9750612N]; National Heart, Lung and Blood Institute [U01 HL072507]; National Institutes for Health [R01CA0403092, R01CA144034, RO1 CA 82729, R37CA70867, R01CA55069, R35CA53890, R01CA80205, P42ES010349, R01CA102484, R01CA107431]; National Science Council and Department of Health, Taiwan; Department of Health, Taiwan [DOH80-27, DOH81-021, DOH8202-1027, DOH83-TD-015, DOH84-TD-006]; Ministry of Education, Science and Technology, Korea [2009-0087452]; National Research Foundation of Korea [2009-0087452]; International Agency for Research on Cancer, Lyon, France; Clinical Trials Service Unit, Oxford, U.K; World Health Organisation, Geneva, Switzerland; NATIONAL CANCER INSTITUTE [R01CA144034, R01CA055069, R01CA102484, R01CA082729, R37CA070867, R01CA107431, R01CA080205, R35CA053890] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL072507] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010349] Funding Source: NIH RePORTER	3-Prefecture Aichi, Ibaraki, Japan Collaborative Cohort Study (JACC); Japan Public Health Center-Based Study 1 (JPHC1); Japan Public Health Center-Based Study 2 (JPHC2); 3-Prefecture Miyagi, Miyagi, Ohsaki; Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); China National Hypertension Survey Epidemiology Followup Study (CHEFS); American Heart Association(American Heart Association); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes for Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Council and Department of Health, Taiwan; Department of Health, Taiwan; Ministry of Education, Science and Technology, Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Foundation of Korea(National Research Foundation of Korea); International Agency for Research on Cancer, Lyon, France; Clinical Trials Service Unit, Oxford, U.K; World Health Organisation, Geneva, Switzerland(World Health Organization); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The cohorts participating in the pooled analysis were supported by the following grants: 3-Prefecture Aichi, Ibaraki, Japan Collaborative Cohort Study (JACC), Japan Public Health Center-Based Study 1 (JPHC1), Japan Public Health Center-Based Study 2 (JPHC2); 3-Prefecture Miyagi, Miyagi, Ohsaki: Grant in-aid for Cancer Research, Grant for the Third Term Comprehensive Control Research for Cancer, Grant for Health Services, Grant for Medical Services for Aged and Health Promotion, Grant for Comprehensive Research on Cardiovascular and Life-Style Related Diseases from the Ministry of Health, Labour and Welfare, Japan; Grant for the Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan; China National Hypertension Survey Epidemiology Followup Study (CHEFS): American Heart Association (9750612N); National Heart, Lung and Blood Institute (U01 HL072507); Chinese Academy of Medical Sciences Shanghai Cohort Study (SCS): National Institutes for Health (R01CA0403092, R01CA144034); Shanghai Men's Health Study (SMHS): National Institutes for Health (RO1 CA 82729) Shanghai Women's Health Study (SWHS): National Institutes for Health (R37CA70867); The Community-Based Cancer Screening Project (CBCSP): National Science Council and Department of Health, Taiwan; Disease risk FACtor Two-township Study (CVDFACTS): Department of Health, Taiwan (DOH80-27, DOH81-021, DOH8202-1027, DOH83-TD-015, and DOH84-TD-006); The Korea Multi-center Cancer Cohort (KMCC): Ministry of Education, Science and Technology, Korea (2009-0087452), National Research Foundation of Korea (2009-0087452); The Singapore Chinese Health Study (SCHS): National Institutes for Health (R01CA55069, R35CA53890, R01CA80205, R01CA144034); Health Effects of Arsenic Longitudinal Study ( HEALS): National Institutes for Health (P42ES010349, R01CA102484, R01CA107431); The Mumbai Cohort Study (MCS): International Agency for Research on Cancer, Lyon, France; Clinical Trials Service Unit, Oxford, U.K; World Health Organisation, Geneva, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABATE N, 1995, J CLIN INVEST, V96, P88, DOI 10.1172/JCI118083; Abate N, 2001, J DIABETES COMPLICAT, V15, P320, DOI 10.1016/S1056-8727(01)00161-1; Aekplakorn W, 2006, DIABETES CARE, V29, P1872, DOI 10.2337/dc05-2141; Balkau B, 2007, CIRCULATION, V116, P1942, DOI 10.1161/CIRCULATIONAHA.106.676379; BARKER DJP, 1993, DIABETOLOGIA, V36, P62, DOI 10.1007/BF00399095; Brockwell SE, 2001, STAT MED, V20, P825, DOI 10.1002/sim.650; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DESPRES JP, 1989, DIABETES, V38, P304, DOI 10.2337/diabetes.38.3.304; Ge KeYou, 1997, Asia Pacific Journal of Clinical Nutrition, V6, P175; Goodpaster BH, 1997, DIABETES, V46, P1579, DOI 10.2337/diabetes.46.10.1579; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; Hussain A, 2005, DIABETIC MED, V22, P931, DOI 10.1111/j.1464-5491.2005.01558.x; *INT DIAB FED, 2006, INT DIAB FED DIAB AT; Janus ED, 2000, DIABETIC MED, V17, P741, DOI 10.1046/j.1464-5491.2000.00376.x; Karter AJ, 1996, DIABETES, V45, P1547, DOI 10.2337/diabetes.45.11.1547; Koh-Banerjee P, 2004, AM J EPIDEMIOL, V159, P1150, DOI 10.1093/aje/kwh167; Lear SA, 2007, AM J CLIN NUTR, V86, P353, DOI 10.1093/ajcn/86.2.353; Lu FH, 1998, DIABETIC MED, V15, P564, DOI 10.1002/(SICI)1096-9136(199807)15:7<564::AID-DIA615>3.0.CO;2-H; Matsumoto K, 1997, DIABETES CARE, V20, P1562, DOI 10.2337/diacare.20.10.1562; MCKEIGUE PM, 1992, DIABETOLOGIA, V35, P785; Mohan V, 2008, DIABETES RES CLIN PR, V80, P159, DOI 10.1016/j.diabres.2007.11.018; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Nakagami T, 2003, DIABETOLOGIA, V46, P1063, DOI 10.1007/s00125-003-1158-9; Nanri A, 2008, DIABETES CARE, V31, P1568, DOI 10.2337/dc08-0297; Ramachandran A, 2005, J Assoc Physicians India, V53, P34; Ramachandran A, 2008, DIABETES CARE, V31, P893, DOI 10.2337/dc07-1207; Ramachandran A, 2010, LANCET, V375, P408, DOI 10.1016/S0140-6736(09)60937-5; Ramakrishnan U, 2004, AM J CLIN NUTR, V79, P17; Reynolds K, 2007, OBESITY, V15, P10, DOI 10.1038/oby.2007.527; Roglic G, 2005, DIABETES CARE, V28, P2130, DOI 10.2337/diacare.28.9.2130; Rosenthal AD, 2004, INT J OBESITY, V28, P594, DOI 10.1038/sj.ijo.0802597; Sadikot SM, 2004, DIABETES RES CLIN PR, V66, P293, DOI 10.1016/j.diabres.2004.04.007; SAS Institute Inc, 2008, SAS STAT 9 2 US GUID; Sasai H, 2010, MAYO CLIN PROC, V85, P36, DOI 10.4065/mcp.2009.0230; Schienkiewitz A, 2006, AM J CLIN NUTR, V84, P427; Son LENTD, 2004, DIABETIC MED, V21, P371, DOI 10.1111/j.1464-5491.2004.01159.x; Steyn NP, 2004, PUBLIC HEALTH NUTR, V7, P147, DOI 10.1079/PHN2003586; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Villegas R, 2009, NUTR METAB CARDIOVAS, V19, P190, DOI 10.1016/j.numecd.2008.06.003; Villegas R, 2007, ARCH INTERN MED, V167, P2310, DOI 10.1001/archinte.167.21.2310; Waki K, 2005, DIABETIC MED, V22, P323, DOI 10.1111/j.1464-5491.2004.01403.x; WANG J, 1994, AM J CLIN NUTR, V60, P23, DOI 10.1093/ajcn/60.1.23; *WHO, WHO AS BMI CUT POINT; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654; YAJNIK CS, 1995, DIABETIC MED, V12, P330, DOI 10.1111/j.1464-5491.1995.tb00487.x; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Yoon KH, 2006, LANCET, V368, P1681, DOI 10.1016/S0140-6736(06)69703-1	49	115	118	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e19930	10.1371/journal.pone.0019930	http://dx.doi.org/10.1371/journal.pone.0019930			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731609	Green Published, gold, Green Submitted			2022-12-27	WOS:000292033700006
J	Ferri, E; Bain, O; Barbuto, M; Martin, C; Lo, N; Uni, S; Landmann, F; Baccei, SG; Guerrero, R; Lima, SD; Bandi, C; Wanji, S; Diagne, M; Casiraghi, M				Ferri, Emanuele; Bain, Odile; Barbuto, Michela; Martin, Coralie; Lo, Nathan; Uni, Shigehiko; Landmann, Frederic; Baccei, Sara G.; Guerrero, Ricardo; Lima, Sueli de Souza; Bandi, Claudio; Wanji, Samuel; Diagne, Moustapha; Casiraghi, Maurizio			New Insights into the Evolution of Wolbachia Infections in Filarial Nematodes Inferred from a Large Range of Screened Species	PLOS ONE			English	Article							LITOMOSOIDES-SIGMODONTIS; BRUGIA-MALAYI; MOLECULAR-IDENTIFICATION; INTRACELLULAR BACTERIA; ENDOSYMBIONT-WOLBACHIA; N-SP; PHYLOGENETIC-RELATIONSHIPS; MONANEMA-MARTINI; GENE-SEQUENCES; FILARIOIDEA	Background: Wolbachia are intriguing symbiotic endobacteria with a peculiar host range that includes arthropods and a single nematode family, the Onchocercidae encompassing agents of filariases. This raises the question of the origin of infection in filariae. Wolbachia infect the female germline and the hypodermis. Some evidences lead to the theory that Wolbachia act as mutualist and coevolved with filariae from one infection event: their removal sterilizes female filariae; all the specimens of a positive species are infected; Wolbachia are vertically inherited; a few species lost the symbiont. However, most data on Wolbachia and filaria relationships derive from studies on few species of Onchocercinae and Dirofilariinae, from mammals. Methodology/Principal Findings: We investigated the Wolbachia distribution testing 35 filarial species, including 28 species and 7 genera and/or subgenera newly screened, using PCR, immunohistochemical staining, whole mount fluorescent analysis, and cocladogenesis analysis. (i) Among the newly screened Onchocercinae from mammals eight species harbour Wolbachia but for some of them, bacteria are absent in the hypodermis, or in variable density. (ii) Wolbachia are not detected in the pathological model Monanema martini and in 8, upon 9, species of Cercopithifilaria. (iii) Supergroup F Wolbachia is identified in two newly screened Mansonella species and in Cercopithifilaria japonica. (iv) Type F Wolbachia infect the intestinal cells and somatic female genital tract. (v) Among Oswaldofilariinae, Waltonellinae and Splendidofilariinae, from saurian, anuran and bird respectively, Wolbachia are not detected. Conclusions/Significance: The absence of Wolbachia in 63% of onchocercids, notably in the ancestral Oswaldofilariinae estimated 140 mya old, the diverse tissues or specimens distribution, and a recent lateral transfer in supergroup F Wolbachia, modify the current view on the role and evolution of the endosymbiont and their hosts. Further genomic analyses on some of the newly sampled species are welcomed to decipher the open questions.	[Ferri, Emanuele; Barbuto, Michela; Baccei, Sara G.; Casiraghi, Maurizio] Univ Milano Bicocca, Dipartimento Biotecnol & Biosci, Milan, Italy; [Bain, Odile; Martin, Coralie] Museum Natl Hist Nat, CNRS, Parasitol Comparee UMR 7205, Paris, France; [Bain, Odile; Martin, Coralie] Museum Natl Hist Nat, CNRS, UMR 7245, Paris, France; [Lo, Nathan] Univ Sydney, Sch Biol Sci, Sydney, Australia; [Uni, Shigehiko] Osaka City Univ, Sch Med, Dept Med Zool, Osaka 545, Japan; [Landmann, Frederic] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA; [Guerrero, Ricardo] Cent Univ Venezuela, Inst Zool Trop, Caracas, Venezuela; [Lima, Sueli de Souza] Univ Fed Juiz de Fora, Dept Zool, Juiz De Fora, MG, Brazil; [Bandi, Claudio] Univ Milan, Dipartimento Patol Anim Igiene & Sanita Pubbl Vet, Milan, Italy; [Wanji, Samuel] Res Fdn Trop Dis & Environm, Buea, Cameroon; [Diagne, Moustapha] Univ Cheikh Anta Diop Dakar, Dept Biol Anim, Dakar, Senegal	University of Milano-Bicocca; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); University of Sydney; Osaka Metropolitan University; University of California System; University of California Santa Cruz; University of Central Venezuela; Universidade Federal de Juiz de Fora; University of Milan; University Cheikh Anta Diop Dakar	Ferri, E (corresponding author), Univ Milano Bicocca, Dipartimento Biotecnol & Biosci, Milan, Italy.	maurizio.casiraghi@unimib.it	martin, coralie/O-3983-2019; Bandi, Claudio/J-7835-2018; Guerrero, Ricardo/AAC-3490-2021; uni, shigehiko/A-8940-2012; Martin, Coralie/N-6293-2018; Lo, Nathan/E-6115-2010; Casiraghi, Maurizio/E-7273-2011	martin, coralie/0000-0003-3801-2595; Bandi, Claudio/0000-0002-0181-4618; Guerrero, Ricardo/0000-0003-0925-9476; Lo, Nathan/0000-0003-2176-2840; Casiraghi, Maurizio/0000-0002-2733-2094	European Community [INCO-CT-2006-032321]; French national grant Action Transversale du Museum; Italian national grant MIUR-PRIN	European Community(European Commission); French national grant Action Transversale du Museum; Italian national grant MIUR-PRIN	This work was supported by European Community Grant INCO-CT-2006-032321, a French national grant Action Transversale du Museum "Taxonomie moleculaire: DNA Barcode et gestion durable des collections" and by Italian national grant MIUR-PRIN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agatsuma T, 2005, PARASITOL INT, V54, P195, DOI 10.1016/j.parint.2005.04.002; Anderson R. C., 2009, Keys to the nematode parasites of vertebrates: archival volume, P391, DOI 10.1079/9781845935726.0391; Attout T, 2005, PARASITOLOGY, V130, P421, DOI 10.1017/S0031182004006651; Attout T, 2008, PARASITOL INT, V57, P201, DOI 10.1016/j.parint.2008.01.001; Bain O, 2008, PARASITE, V15, P342, DOI 10.1051/parasite/2008153342; BAIN O, 1986, ANN PARASIT HUM COMP, V61, P465, DOI 10.1051/parasite/1986614465; Bain O, 2002, WORLD CL PARASITES, V5, P21; BAIN O, 1986, TROP MED PARASITOL, V37, P301; BAIN O, 1986, ANN PARASIT HUM COMP, V61, P81, DOI 10.1051/parasite/198661181; BAIN O, 1982, ANN PARASIT HUM COMP, V57, P593, DOI 10.1051/parasite/1982576593; Baldo L, 2007, CURR MICROBIOL, V55, P81, DOI 10.1007/s00284-007-0055-8; Bandi C, 1998, P ROY SOC B-BIOL SCI, V265, P2407, DOI 10.1098/rspb.1998.0591; Bandi C, 2001, TRENDS PARASITOL, V17, P88, DOI 10.1016/S1471-4922(00)01812-2; Bazzocchi C, 2000, CURR MICROBIOL, V41, P96, DOI 10.1007/s002840010100; Blaxter M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001050; Bordenstein SR, 2009, MOL BIOL EVOL, V26, P231, DOI 10.1093/molbev/msn243; Bordenstein SR, 2003, J NEMATOL, V35, P266; Brattig NW, 2004, J IMMUNOL, V173, P437, DOI 10.4049/jimmunol.173.1.437; Brattig NW, 2001, MICROBES INFECT, V3, P439, DOI 10.1016/S1286-4579(01)01399-5; Buttner Dietrich W, 2003, Filaria J, V2, P10, DOI 10.1186/1475-2883-2-10; Casiraghi M., 2003, Parassitologia (Rome), V45, P13; Casiraghi M, 2005, MICROBIOL-SGM, V151, P4015, DOI 10.1099/mic.0.28313-0; Casiraghi M, 2004, INT J PARASITOL, V34, P191, DOI 10.1016/j.ijpara.2003.10.004; Casiraghi M, 2002, INT J PARASITOL, V32, P1457, DOI 10.1016/S0020-7519(02)00158-3; Casiraghi M, 2001, PARASITOL RES, V87, P417, DOI 10.1007/s004360000368; CHABAUD A-G, 1976, Annales de Parasitologie Humaine et Comparee, V51, P365; CHABAUD AG, 1994, INT J PARASITOL, V24, P1179, DOI 10.1016/0020-7519(94)90190-2; Chirgwin SR, 2002, J PARASITOL, V88, P1248, DOI 10.1645/0022-3395(2002)088[1248:TFEWSI]2.0.CO;2; CHITWOOD BG, 1950, INTRO NEMATOLOGY 1; EBERHARD ML, 1984, ANN PARASIT HUM COMP, V59, P483, DOI 10.1051/parasite/1984595483; Fenn K, 2006, TRENDS PARASITOL, V22, P60, DOI 10.1016/j.pt.2005.12.012; Fenn K, 2006, PLOS PATHOG, V2, P887, DOI 10.1371/journal.ppat.0020094; Ferri E, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-1; Fischer P, 2002, EXP PARASITOL, V102, P201, DOI 10.1016/S0014-4894(03)00058-4; Foster J, 2005, PLOS BIOL, V3, P599, DOI 10.1371/journal.pbio.0030121; Foster JM, 2009, PARASITOL RES, V104, P1047, DOI 10.1007/s00436-008-1287-7; Gibbons L.M, 2010, KEYS NEMATODE PARASI; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Gillette-Ferguson I, 2007, INFECT IMMUN, V75, P5908, DOI 10.1128/IAI.00991-07; Guerrero R, 2003, PARASITE, V10, P219, DOI 10.1051/parasite/2003103219; GUERRERO R, 2011, FOLIA PARAS IN PRESS, P58; Haegeman A, 2009, INT J PARASITOL, V39, P1045, DOI 10.1016/j.ijpara.2009.01.006; HANSEN RD, 2010, P BIOL SCI; Heider U, 2006, INT J MED MICROBIOL, V296, P287, DOI 10.1016/j.ijmm.2005.12.019; Higazi TB, 2005, MOL BIOCHEM PARASIT, V141, P109, DOI 10.1016/j.molbiopara.2005.02.006; Hoerauf A, 1999, J CLIN INVEST, V103, P11, DOI 10.1172/JCI4768; HOERAUF A, 2008, Z B MAHYVOL, V5, P150; Hoerauf A, 2008, CURR OPIN INFECT DIS, V21, P673, DOI 10.1097/QCO.0b013e328315cde7; HOLMAL AG, 2009, BMC MICROBIOL, V28, P243; Holmes EC, 1999, MOL BIOL EVOL, V16, P405, DOI 10.1093/oxfordjournals.molbev.a026121; Hotopp JCD, 2007, SCIENCE, V317, P1753, DOI 10.1126/science.1142490; Hughes GL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001296; Johnston KL, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-99; Junker K, 2009, PARASITE, V16, P43, DOI 10.1051/parasite/2009161043; Justine Jean-Lou, 2002, P73; Kambris Z, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001143; Kambris Z, 2009, SCIENCE, V326, P134, DOI 10.1126/science.1177531; Keiser PB, 2008, MOL BIOCHEM PARASIT, V160, P123, DOI 10.1016/j.molbiopara.2008.04.012; Kramer LH, 2003, PARASITOL RES, V89, P381, DOI 10.1007/s00436-002-0765-6; Landmann F, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000758; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lo N, 2007, INT J SYST EVOL MICR, V57, P654, DOI 10.1099/ijs.0.64515-0; Lo N, 2002, MOL BIOL EVOL, V19, P341, DOI 10.1093/oxfordjournals.molbev.a004087; MANZANELL R, 1986, ANN PARASIT HUM COMP, V61, P245; Martin DP, 2009, METHODS MOL BIOL, V537, P185, DOI 10.1007/978-1-59745-251-9_9; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; McNulty SN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011029; ONEILL SL, 1993, MED VET ENTOMOL, V7, P377, DOI 10.1111/j.1365-2915.1993.tb00709.x; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Raverdy S, 2008, MOL BIOCHEM PARASIT, V160, P163, DOI 10.1016/j.molbiopara.2008.04.014; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ros VID, 2009, APPL ENVIRON MICROB, V75, P1036, DOI 10.1128/AEM.01109-08; Rowley SM, 2004, CURR MICROBIOL, V49, P208, DOI 10.1007/s00284-004-4346-z; Saint Andre AV, 2002, SCIENCE, V295, P1892, DOI 10.1126/science.1068732; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; SIMOES PM, 2011, MOL ECOL RE IN PRESS; Sironi M, 1995, MOL BIOCHEM PARASIT, V74, P223, DOI 10.1016/0166-6851(95)02494-8; SMITH JM, 1992, J MOL EVOL, V34, P126; Strubing U, 2010, INT J PARASITOL, V40, P1193, DOI 10.1016/j.ijpara.2010.03.004; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Taylor MJ, 2005, ADV PARASIT, V60, P245, DOI 10.1016/S0065-308X(05)60004-8; Taylor MJ, 1999, EXP PARASITOL, V91, P356, DOI 10.1006/expr.1998.4383; Turner JD, 2009, J BIOL CHEM, V284, P22364, DOI 10.1074/jbc.M901528200; Uni S, 2007, PARASITE, V14, P199, DOI 10.1051/parasite2007143199; Uni S, 2006, PARASITE, V13, P193, DOI 10.1051/parasite/2006133193; Uni S, 2004, PARASITE, V11, P131, DOI 10.1051/parasite/2004112131; Uni S, 2002, PARASITE, V9, P293, DOI 10.1051/parasite/2002094293; UNI S, 1983, ANN PARASIT HUM COMP, V58, P71, DOI 10.1051/parasite/1983581071; Volkmann L, 2003, TROP MED INT HEALTH, V8, P392, DOI 10.1046/j.1365-3156.2003.01040.x; VUONG PN, 1991, ANN PARASIT HUM COMP, V66, P109, DOI 10.1051/parasite/1991663109; Werren JH, 1997, ANNU REV ENTOMOL, V42, P587, DOI 10.1146/annurev.ento.42.1.587; WERREN JH, 1995, P ROY SOC B-BIOL SCI, V261, P55, DOI 10.1098/rspb.1995.0117; Werren JH, 2000, P ROY SOC B-BIOL SCI, V267, P1277, DOI 10.1098/rspb.2000.1139; WIEATANARATANAB.I, 2009, ZOO SCI, V28, P171	97	112	117	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e20843	10.1371/journal.pone.0020843	http://dx.doi.org/10.1371/journal.pone.0020843			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731626	Green Published, gold			2022-12-27	WOS:000292033700016
J	Kinoshita, S; Wang, N; Inoue, H; Maeyama, K; Okamoto, K; Nagai, K; Kondo, H; Hirono, I; Asakawa, S; Watabe, S				Kinoshita, Shigeharu; Wang, Ning; Inoue, Haruka; Maeyama, Kaoru; Okamoto, Kikuhiko; Nagai, Kiyohito; Kondo, Hidehiro; Hirono, Ikuo; Asakawa, Shuichi; Watabe, Shugo			Deep Sequencing of ESTs from Nacreous and Prismatic Layer Producing Tissues and a Screen for Novel Shell Formation-Related Genes in the Pearl Oyster	PLOS ONE			English	Article							CALCIUM-CARBONATE CRYSTALS; MATRIX PROTEIN FAMILY; PINCTADA-FUCATA-MARTENSII; MUSSEL PINNA-NOBILIS; MOLECULAR-CLONING; BIOMINERALIZATION; EVOLUTION; PERLUCIN; BIVALVE; LECTIN	Background: Despite its economic importance, we have a limited understanding of the molecular mechanisms underlying shell formation in pearl oysters, wherein the calcium carbonate crystals, nacre and prism, are formed in a highly controlled manner. We constructed comprehensive expressed gene profiles in the shell-forming tissues of the pearl oyster Pinctada fucata and identified novel shell formation-related genes candidates. Principal Findings: We employed the GS FLX 454 system and constructed transcriptome data sets from pallial mantle and pearl sac, which form the nacreous layer, and from the mantle edge, which forms the prismatic layer in P. fucata. We sequenced 260477 reads and obtained 29682 unique sequences. We also screened novel nacreous and prismatic gene candidates by a combined analysis of sequence and expression data sets, and identified various genes encoding lectin, protease, protease inhibitors, lysine-rich matrix protein, and secreting calcium-binding proteins. We also examined the expression of known nacreous and prismatic genes in our EST library and identified novel isoforms with tissue-specific expressions. Conclusions: We constructed EST data sets from the nacre-and prism-producing tissues in P. fucata and found 29682 unique sequences containing novel gene candidates for nacreous and prismatic layer formation. This is the first report of deep sequencing of ESTs in the shell-forming tissues of P. fucata and our data provide a powerful tool for a comprehensive understanding of the molecular mechanisms of molluscan biomineralization.	[Kinoshita, Shigeharu; Wang, Ning; Inoue, Haruka; Asakawa, Shuichi; Watabe, Shugo] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Aquat Biosci, Bunkyo Ku, Tokyo, Japan; [Nagai, Kiyohito] Mikimoto Co Ltd, Pearl Res Inst, Shima, Mie, Japan; [Maeyama, Kaoru; Okamoto, Kikuhiko] Mikimoto Pharmaceut CO LTD, Ise, Mie, Japan; [Kondo, Hidehiro; Hirono, Ikuo] Tokyo Univ Marine Sci & Technol, Grad Sch Marine Sci & Technol, Lab Genome Sci, Minato Ku, Tokyo, Japan	University of Tokyo; Tokyo University of Marine Science & Technology	Kinoshita, S (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Aquat Biosci, Bunkyo Ku, Tokyo, Japan.	awatabe@mail.ecc.u-tokyo.ac.jp	Kondo, Hidehiro/O-1954-2014; Kinoshita, Shigeharu/AGY-8644-2022; Hirono, Ikuo/O-1940-2014	Kondo, Hidehiro/0000-0001-5102-6831; Hirono, Ikuo/0000-0002-2355-3121				Addadi L, 2003, ADV MATER, V15, P959, DOI 10.1002/adma.200300381; Arnaud-Haond S, 2007, MAR BIOTECHNOL, V9, P113, DOI 10.1007/s10126-006-6033-5; Bedouet L, 2007, MAR BIOTECHNOL, V9, P437, DOI 10.1007/s10126-007-7120-y; Blank S, 2003, J MICROSC-OXFORD, V212, P280, DOI 10.1111/j.1365-2818.2003.01263.x; Evans JS, 2008, CHEM REV, V108, P4455, DOI 10.1021/cr078251e; Fang Z, 2008, MAR BIOL, V153, P745, DOI 10.1007/s00227-007-0851-5; Force A, 1999, GENETICS, V151, P1531; GERHKE N, 2005, CHEM MATER, V17, P6514; Huang J, 2007, BBA-GEN SUBJECTS, V1770, P1037, DOI 10.1016/j.bbagen.2007.03.006; Inoue N, 2011, MAR BIOTECHNOL, V13, P48, DOI 10.1007/s10126-010-9267-1; Inoue N, 2011, ZOOL SCI, V28, P32, DOI 10.2108/zsj.28.32; Jackson DJ, 2010, MOL BIOL EVOL, V27, P591, DOI 10.1093/molbev/msp278; Kong YW, 2009, J BIOL CHEM, V284, P10841, DOI 10.1074/jbc.M808357200; Kono M, 2000, BIOCHEM BIOPH RES CO, V269, P213, DOI 10.1006/bbrc.2000.2274; Liu HL, 2007, BIOCHEMISTRY-US, V46, P844, DOI 10.1021/bi061881a; Ma ZJ, 2007, J BIOL CHEM, V282, P23253, DOI 10.1074/jbc.M700001200; Mann S, 2001, BIOMINERALIZATION; Mao C., 2001, OCEANOL ACTA, V24, pS37; Marie B, 2010, CHEMBIOCHEM, V11, P2138, DOI 10.1002/cbic.201000276; Marin F, 2005, J BIOL CHEM, V280, P33895, DOI 10.1074/jbc.M506526200; Marin F, 2000, J BIOL CHEM, V275, P20667, DOI 10.1074/jbc.M003006200; Marin F, 2008, CURR TOP DEV BIOL, V80, P209, DOI 10.1016/S0070-2153(07)80006-8; Marxen JC, 2003, BBA-PROTEINS PROTEOM, V1650, P92, DOI 10.1016/S1570-9639(03)00203-6; Miyamoto H, 1996, P NATL ACAD SCI USA, V93, P9657, DOI 10.1073/pnas.93.18.9657; Naganuma T, 2006, MOL DIVERS, V10, P607, DOI 10.1007/s11030-006-9051-3; Samata T, 1999, FEBS LETT, V462, P225, DOI 10.1016/S0014-5793(99)01387-3; Sarashina Isao, 2006, Paleontological Research, V10, P311; Shen XY, 1997, J BIOL CHEM, V272, P32472, DOI 10.1074/jbc.272.51.32472; Sudo S, 1997, NATURE, V387, P563, DOI 10.1038/42391; Suzuki M, 2004, BIOCHEM J, V382, P205, DOI 10.1042/BJ20040319; Suzuki M, 2009, SCIENCE, V325, P1388, DOI 10.1126/science.1173793; SUZUKI T, 1990, DEV COMP IMMUNOL, V14, P161, DOI 10.1016/0145-305X(90)90088-V; SUZUKI T, 1989, COMP BIOCHEM PHYS B, V92, P455, DOI 10.1016/0305-0491(89)90116-8; Takagi R, 2010, ZOOL SCI, V27, P416, DOI 10.2108/zsj.27.416; Takakura D, 2008, MAR BIOTECHNOL, V10, P290, DOI 10.1007/s10126-007-9063-8; Takeuchi T, 2006, MAR BIOTECHNOL, V8, P52, DOI 10.1007/s10126-005-5037-x; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; TIM EC, 2010, CELL TISSUE RES, V339, P221; Treccani L, 2006, BIOPHYS J, V91, P2601, DOI 10.1529/biophysj.106.086108; Tsukamoto D, 2004, BIOCHEM BIOPH RES CO, V320, P1175, DOI 10.1016/j.bbrc.2004.06.072; Wang N, 2008, COMP BIOCHEM PHYS B, V149, P354, DOI 10.1016/j.cbpb.2007.10.007; Wang N, 2009, COMP BIOCHEM PHYS B, V154, P346, DOI 10.1016/j.cbpb.2009.07.012; Weiss IM, 2002, J EXP ZOOL, V293, P478, DOI 10.1002/jez.90004; Weiss IM, 2000, BIOCHEM BIOPH RES CO, V267, P17, DOI 10.1006/bbrc.1999.1907; Yan ZG, 2007, BBA-GEN SUBJECTS, V1770, P1338, DOI 10.1016/j.bbagen.2007.06.018; Yano M, 2007, BIOCHEM BIOPH RES CO, V362, P158, DOI 10.1016/j.bbrc.2007.07.172; Yano M, 2006, COMP BIOCHEM PHYS B, V144, P254, DOI 10.1016/j.cbpb.2006.03.004; Zhang C, 2006, BIOCHEM BIOPH RES CO, V344, P735, DOI 10.1016/j.bbrc.2006.03.179	48	101	106	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21238	10.1371/journal.pone.0021238	http://dx.doi.org/10.1371/journal.pone.0021238			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731681	gold, Green Published, Green Submitted			2022-12-27	WOS:000292033700051
J	Tourmente, M; Gomendio, M; Roldan, ERS				Tourmente, Maximiliano; Gomendio, Montserrat; Roldan, Eduardo R. S.			Mass-Specific Metabolic Rate and Sperm Competition Determine Sperm Size in Marsupial Mammals	PLOS ONE			English	Article							EJACULATE QUALITY; MALE-FERTILITY; TESTES SIZE; BODY-SIZE; EVOLUTION; VELOCITY; PHYLOGENY; MOTILITY; FERTILIZATION; TIMESCALE	Two complementary hypotheses have been proposed to explain variation in sperm size. The first proposes that post-copulatory sexual selection favors an increase in sperm size because it enhances sperm swimming speed, which is an important determinant of fertilization success in competitive contexts. The second hypothesis proposes that mass-specific metabolic rate acts as a constraint, because large animals with low mass-specific metabolic rates will not be able to process resources at the rates needed to produce large sperm. This constraint is expected to be particularly pronounced among mammals, given that this group contains some of the largest species on Earth. We tested these hypotheses among marsupials, a group in which mass-specific metabolic rates are roughly 30% lower than those of eutherian mammals of similar size, leading to the expectation that metabolic rate should be a major constraint. Our findings support both hypotheses because levels of sperm competition are associated with increases in sperm size, but low mass-specific metabolic rate constrains sperm size among large species. We also found that the relationship between sperm size and mass-specific metabolic rate is steeper among marsupials and shallower among eutherian mammals. This finding has two implications: marsupials respond to changes in mass-specific metabolic rate by modifying sperm length to a greater extent, suggesting that they are more constrained by metabolic rate. In addition, for any given mass-specific metabolic rate, marsupials produce longer sperm. We suggest that this is the consequence of marsupials diverting resources away from sperm numbers and into sperm size, due to their efficient sperm transport along the female tract and the existence of mechanisms to protect sperm.	[Tourmente, Maximiliano; Gomendio, Montserrat; Roldan, Eduardo R. S.] CSIC, Museo Nacl Ciencias Nat, Reprod Ecol & Biol Grp, E-28006 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN)	Tourmente, M (corresponding author), CSIC, Museo Nacl Ciencias Nat, Reprod Ecol & Biol Grp, E-28006 Madrid, Spain.	roldane@mncn.csic.es	Roldan, Eduardo R.S./M-7947-2014; Tourmente, Maximiliano/I-2852-2019	Roldan, Eduardo R.S./0000-0002-7545-4248; Tourmente, Maximiliano/0000-0002-5833-9117	Spanish Ministry of Science and Innovation; Spanish Ministry of Education	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministry of Education(Spanish Government)	This work was supported by the Spanish Ministry of Science and Innovation. M.T. is a postdoctoral researcher funded by the Programa Nacional de Movilidad de Recursos de investigacion of the Spanish Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2005, J ZOOL, V267, P135, DOI 10.1017/S0952836905007284; Anderson MJ, 2002, NATURE, V416, P496, DOI 10.1038/416496a; Beck RMD, 2008, J MAMMAL, V89, P175, DOI 10.1644/06-MAMM-A-437.1; BEDFORD JM, 1984, PROC R SOC SER B-BIO, V221, P221, DOI 10.1098/rspb.1984.0031; Birkhead TR, 1999, P ROY SOC B-BIOL SCI, V266, P1759, DOI 10.1098/rspb.1999.0843; Cohen J.E., 1988, STAT POWER ANAL BEHA; CUMMINS JM, 1985, J REPROD FERTIL, V75, P153, DOI 10.1530/jrf.0.0750153; DEWSBURY DA, 1982, AM NAT, V119, P601, DOI 10.1086/283938; Eddy E M, 2007, Soc Reprod Fertil Suppl, V65, P45; Eddy EM, 2003, MICROSC RES TECHNIQ, V61, P103, DOI 10.1002/jemt.10320; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Fitzpatrick JL, 2010, BIOL LETTERS, V6, P797, DOI 10.1098/rsbl.2010.0231; Fitzpatrick JL, 2009, P NATL ACAD SCI USA, V106, P1128, DOI 10.1073/pnas.0809990106; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Froman DP, 1999, BIOL REPROD, V61, P400, DOI 10.1095/biolreprod61.2.400; Gage MJG, 2004, CURR BIOL, V14, P44, DOI 10.1016/j.cub.2003.12.028; Gage MJG, 2003, P ROY SOC B-BIOL SCI, V270, P625, DOI 10.1098/rspb.2002.2258; GOMENDIO M, 1991, P ROY SOC B-BIOL SCI, V243, P181, DOI 10.1098/rspb.1991.0029; Gomendio M, 2008, INT J DEV BIOL, V52, P439, DOI 10.1387/ijdb.082595mg; Gomendio M, 2011, P ROY SOC B-BIOL SCI, V278, P3135, DOI 10.1098/rspb.2011.0275; Gomenido Montserrat, 1998, P667, DOI 10.1016/B978-012100543-6/50041-6; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Hosken DJ, 1997, P ROY SOC B-BIOL SCI, V264, P385, DOI 10.1098/rspb.1997.0055; Jones Kate E., 2009, Ecology (Washington D C), V90, P2648, DOI 10.1890/08-1494.1; KENAGY GJ, 1986, J MAMMAL, V67, P1, DOI 10.2307/1380997; Levitan DR, 2000, P ROY SOC B-BIOL SCI, V267, P531, DOI 10.1098/rspb.2000.1032; Lupold S, 2009, P R SOC B, V276, P1175, DOI 10.1098/rspb.2008.1645; Malo AF, 2005, BIOL REPROD, V72, P822, DOI 10.1095/biolreprod.104.036368; Malo AF, 2006, BIOL LETTERS, V2, P246, DOI 10.1098/rsbl.2006.0449; Meredith RW, 2008, J MAMM EVOL, V15, P1, DOI 10.1007/s10914-007-9062-6; Meredith RW, 2009, MOL PHYLOGENET EVOL, V51, P554, DOI 10.1016/j.ympev.2009.02.009; Meredith RW, 2008, AUST J ZOOL, V56, P395, DOI 10.1071/ZO08044; Miki K, 2004, P NATL ACAD SCI USA, V101, P16501, DOI 10.1073/pnas.0407708101; Miki K, 2002, DEV BIOL, V248, P331, DOI 10.1006/dbio.2002.0728; MOLLER AP, 1989, FUNCT ECOL, V3, P91, DOI 10.2307/2389679; MOLLER AP, 1988, J HUM EVOL, V17, P479, DOI 10.1016/0047-2484(88)90037-1; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; NAKATSURU K, 1982, SCIENCE, V216, P753, DOI 10.1126/science.216.4547.753; Narisawa S, 2002, MOL CELL BIOL, V22, P5554, DOI 10.1128/MCB.22.15.5554-5562.2002; Olsson M, 1997, P ROY SOC B-BIOL SCI, V264, P455, DOI 10.1098/rspb.1997.0065; Paplinska JZ, 2010, MACROPODS: THE BIOLOGY OF KANGAROOS, WALLABIES AND RAT-KANGAROOS, P65; Parker GA, 2010, J THEOR BIOL, V264, P1003, DOI 10.1016/j.jtbi.2010.03.003; Parker G.A., 1984, P1; Parker G.A., 1998, SPERM COMPETITION SE, P3, DOI DOI 10.1016/B978-012100543-6/50026-X; PARKER GA, 1982, J THEOR BIOL, V96, P281, DOI 10.1016/0022-5193(82)90225-9; Phillips MJ, 2008, MOL PHYLOGENET EVOL, V46, P594, DOI 10.1016/j.ympev.2007.09.008; PITNICK S, 1995, P NATL ACAD SCI USA, V92, P10614, DOI 10.1073/pnas.92.23.10614; Pitnick S, 2009, SPERM BIOLOGY: AN EVOLUTIONARY PERSPECTIVE, P247, DOI 10.1016/B978-0-12-372568-4.00007-0; Pizzari T, 2009, SPERM BIOLOGY: AN EVOLUTIONARY PERSPECTIVE, P207, DOI 10.1016/B978-0-12-372568-4.00006-9; Rose RW, 1997, J ZOOL, V243, P523, DOI 10.1111/j.1469-7998.1997.tb02798.x; Rosenthal R, 1991, METAANALYTIC PROCEDU; Rosenthal Robert, 1994, HDB RES SYNTHESIS, V621, P231; Rosnow RL, 2003, CAN J EXP PSYCHOL, V57, P221, DOI 10.1037/h0087427; Rowe M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015720; Savage VM, 2007, P NATL ACAD SCI USA, V104, P4718, DOI 10.1073/pnas.0611235104; Sibly RM, 2007, P NATL ACAD SCI USA, V104, P17707, DOI 10.1073/pnas.0707725104; Smithson M., 2003, CONFIDENCE INTERVALS; Soulsbury CD, 2010, PLOS ONE, V5, pA152, DOI 10.1371/journal.pone.0009581; Taggart D.A., 2003, P358; Taggart D.A., 1998, P623, DOI 10.1016/B978-012100543-6/50040-4; Tomkins JL, 2002, ANIM BEHAV, V63, P1009, DOI 10.1006/anbe.2001.1994; Tourmente M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-12; Tourmente M, 2009, EVOLUTION, V63, P2513, DOI 10.1111/j.1558-5646.2009.00739.x; Turner RM, 2006, REPROD FERT DEVELOP, V18, P25, DOI 10.1071/RD05120; Tyndale-Biscoe H, 2005, LIFE OF MARSUPIALS; Weisbecker V, 2010, P NATL ACAD SCI USA, V107, P16216, DOI 10.1073/pnas.0906486107; Westerman Michael, 2008, Australian Mammalogy, V29, P201	67	28	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21244	10.1371/journal.pone.0021244	http://dx.doi.org/10.1371/journal.pone.0021244			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731682	Green Submitted, Green Published, gold			2022-12-27	WOS:000292033700052
J	Shenkar, N; Swalla, BJ				Shenkar, Noa; Swalla, Billie J.			Global Diversity of Ascidiacea	PLOS ONE			English	Review							WESTERN PACIFIC REGION; NON-INDIGENOUS ASCIDIANS; MICROCOSMUS-SQUAMIGER ASCIDIACEA; TUNICATE CIONA-INTESTINALIS; RAPID ASSESSMENT SURVEY; STYELA-CLAVA HERDMAN; STOLIDOBRANCH ASCIDIANS; DEUTEROSTOME PHYLOGENY; BOTRYLLUS-SCHLOSSERI; MEDITERRANEAN SEA	The class Ascidiacea presents fundamental opportunities for research in the fields of development, evolution, ecology, natural products and more. This review provides a comprehensive overview of the current knowledge regarding the global biodiversity of the class Ascidiacea, focusing in their taxonomy, main regions of biodiversity, and distribution patterns. Based on analysis of the literature and the species registered in the online World Register of Marine Species, we assembled a list of 2815 described species. The highest number of species and families is found in the order Aplousobranchia. Didemnidae and Styelidae families have the highest number of species with more than 500 within each group. Sixty percent of described species are colonial. Species richness is highest in tropical regions, where colonial species predominate. In higher latitudes solitary species gradually contribute more to the total species richness. We emphasize the strong association between species richness and sampling efforts, and discuss the risks of invasive species. Our inventory is certainly incomplete as the ascidian fauna in many areas around the world is relatively poorly known, and many new species continue to be discovered and described each year.	[Shenkar, Noa; Swalla, Billie J.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Swalla, Billie J.] Univ Washington, Friday Harbor Labs, Friday Harbor, WA 98250 USA	University of Washington; University of Washington Seattle; University of Washington	Shenkar, N (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.	nshenkar@u.washington.edu			Israeli Taxonomy Initiative; Dan-David foundation	Israeli Taxonomy Initiative; Dan-David foundation	NS was funded by the Israeli Taxonomy Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We express our gratitude to G. Lambert for her advice and helpful suggestions and to C. Primo for her collaboration. N. Shenkar would like to thank the Israeli Taxonomy Initiative and the Dan-David foundation for financial support.	ABBOTT DP, 1997, BISHOP MUSEUM SPECIA, V64; Abdul JAH, 2007, J EXP MAR BIOL ECOL, V342, P189, DOI 10.1016/j.jembe.2006.10.041; Abdul Jaffar Ali H., 2009, World Journal of Fish and Marine Sciences, V1, P305; Tovar-Hernandez MA, 2010, B MAR SCI, V86, P637; Arenas F, 2006, J MAR BIOL ASSOC UK, V86, P1329, DOI 10.1017/S0025315406014354; Auker LA, 2008, ICES J MAR SCI, V65, P765, DOI 10.1093/icesjms/fsm196; Bak RPM, 1996, MAR ECOL PROG SER, V133, P303, DOI 10.3354/meps133303; Bak RPM, 1998, MAR ECOL PROG SER, V175, P285, DOI 10.3354/meps175285; Balfour F.M., 1881, TREATISE COMP EMBRYO, V2; Berrill N. J., 1950, TUNICATA ACCOUNT BRI; Berrill NJ, 1932, BIOL BULL-US, V62, P77, DOI 10.2307/1537145; Bisby FA, 2010, SPECIES 2000 ITIS CA; Boakes EH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000385; Bone Q, 2003, J MAR BIOL ASSOC UK, V83, P907, DOI 10.1017/S002531540300804Xh; Bourlat SJ, 2006, NATURE, V444, P85, DOI 10.1038/nature05241; Bourque D, 2007, J EXP MAR BIOL ECOL, V342, P78, DOI 10.1016/j.jembe.2006.10.017; Brewin B. I., 1950, Transactions of the Royal Society of New Zealand, V78, P344; Brewin B.I., 1946, T ROY SOC NZ, V76, P87; BROOKFIELD ME, 1988, MICROPALEONTOLOGY, V34, P277, DOI 10.2307/1485758; Brunel P., 1998, CAN SPEC PUBL FISH A, V126, P405; Bullard SG, 2007, J EXP MAR BIOL ECOL, V342, P99, DOI 10.1016/j.jembe.2006.10.020; Callahan AG, 2010, AQUAT INVASIONS, V5, P31, DOI 10.3391/ai.2010.5.1.5; Cameron CB, 2000, P NATL ACAD SCI USA, V97, P4469, DOI 10.1073/pnas.97.9.4469; CARLTON JT, 1993, SCIENCE, V261, P78, DOI 10.1126/science.261.5117.78; Carman MR, 2010, AQUAT INVASIONS, V5, P23, DOI 10.3391/ai.2010.5.1.4; CARVER CE, 2006, BIOL SYNOPSIS UNPUB; Casali PG, 2010, CURR OPIN ONCOL, V22, P342, DOI 10.1097/CCO.0b013e32833aaac1; Castilla Juan C., 2009, V204, P439; CHAPMAN JW, 1991, J CRUSTACEAN BIOL, V11, P386, DOI 10.2307/1548465; Chen JY, 2003, P NATL ACAD SCI USA, V100, P8314, DOI 10.1073/pnas.1431177100; Cohen AN, 2005, BIOL INVASIONS, V7, P995, DOI 10.1007/s10530-004-3121-1; Cohen AN, 2005, GUIDE EXOTIC SPECIES; Cole Linda, 2009, P1209; Coles SL, 1999, MAR BIOL, V135, P147, DOI 10.1007/s002270050612; COLL M, 2010, PLOS ONE, V5, DOI DOI 10.1371/JOURNAL.PONE.0011842; Coutts ADM, 2007, MAR POLLUT BULL, V54, P875, DOI 10.1016/j.marpolbul.2007.03.011; Davis AR, 1998, BIOFOULING, V12, P305, DOI 10.1080/08927019809378362; Davis Martin H., 2009, Aquatic Invasions, V4, P283, DOI 10.3391/ai.2009.4.1.29; DAYTON PK, 1969, SCIENCE, V163, P273, DOI 10.1126/science.163.3864.273; DeFelice RC, 2001, GUIDEBOOK INTRO MARI; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Dijkstra J, 2008, MAR BIOL, V154, P805, DOI 10.1007/s00227-008-0973-4; Dybern B. I., 1967, Sarsia, VNo. 29, P137; EDWARDS HM, 1843, ELEMENTS ZOOLOGIE, V2, P313; ESPLA AAR, 1992, B I OCEANOGR MONACO, V9, P125; Forbes E., 1853, HIST BRIT MOLLUSCA T; Gab-Alla AAFA, 2008, OCEANOLOGIA, V50, P239; Gili JM, 2001, POLAR BIOL, V24, P473, DOI 10.1007/s003000100257; Gittenberger Adriaan, 2009, Aquatic Invasions, V4, P279, DOI 10.3391/ai.2009.4.1.28; GODWIN S, 2008, MARINE INVERTEBRATE; Gollasch Stephan, 2009, V204, P507; Goodbody I, 2003, B MAR SCI, V73, P457; GOODBODY I, 1984, Uitgaven Natuurwetenschappelijke Studiekring voor Suriname en de Nederlandse Antillen, P62; Goodbody I., 2004, ATOLL RES B, V524, P1, DOI DOI 10.5479/SI.00775630.524.1; GOODBODY I, 2006, CARIBBEAN SEA SQUIRT; Griffith Kate, 2009, Aquatic Invasions, V4, P581, DOI 10.3391/ai.2009.4.4.3; HANCOCK A, 1850, ANN NAT HIST, V2, P173; HAYDAR D, 2010, WHAT IS NATURAL SCAL; Hernandez-Zanuy AC, 2001, CORAL REEFS, V20, P159, DOI 10.1007/s003380100154; HESS JE, 2009, AQUAT INV, V3, P367; Hewitt CL, 2004, MAR BIOL, V144, P183, DOI 10.1007/s00227-003-1173-x; Howes S, 2007, J EXP MAR BIOL ECOL, V342, P85, DOI 10.1016/j.jembe.2006.10.018; Iturralde Macarena, 1996, Charles Darwin Research Station Annual Report, V1988-1989, P120; Izquierdo-Munoz Andres, 2009, Aquatic Invasions, V4, P59, DOI 10.3391/ai.2009.4.1.5; JACKSON JBC, 1977, AM NAT, V111, P743, DOI 10.1086/283203; Kennedy TA, 2002, NATURE, V417, P636, DOI 10.1038/nature00776; Kott P, 2005, J NAT HIST, V39, P2409, DOI 10.1080/00222930500087077; Kott P, 1981, P LINNEAN SOC NEW S, V105, P147; KOTT P, 1982, MARINE FLORA FAUNA H, P503; Kott P, 2006, J NAT HIST, V40, P169, DOI 10.1080/00222930600621601; Kott Patricia, 2004, Beagle, V20, P37; Kott Patricia, 2001, Memoirs of the Queensland Museum, V47, P1; Koukouras A, 1995, ANN I OCEANOGR PARIS, V71, P19; Kowalevsky A., 1866, Mem. Acad. Imp. des Sciences de St. Petersbourg, tome, Vx, P1; Kumagai A, 2010, DIS AQUAT ORGAN, V90, P223, DOI 10.3354/dao02228; LAHILLE F, 1886, CR HEBD ACAD SCI, V102, P1573; LAMARCK JB, 1816, HIST NATURELLE ANIMA, V3, pC80; Lambert CC, 1998, MAR BIOL, V130, P675, DOI 10.1007/s002270050289; Lambert CC, 2005, CAN J ZOOL, V83, P1, DOI 10.1139/Z04-160; Lambert CC, 2003, MAR ECOL PROG SER, V259, P145, DOI 10.3354/meps259145; LAMBERT CC, 1987, MARINE INVERTEBRATES, V23, P467; Lambert G., 1990, P461; Lambert G, 2005, J MAR BIOL ASSOC UK, V85, P1011, DOI 10.1017/S002531540501204X; Lambert G, 2005, CAN J ZOOL, V83, P34, DOI 10.1139/Z04-156; Lambert G, 2004, J MAR BIOL ASSOC UK, V84, P239, DOI 10.1017/S0025315404009105h; Lambert G, 2003, ZOOSYSTEMA, V25, P665; Lambert G, 2001, BIOLOGY OF ASCIDIANS, P249; LAMBERT G, 2007, WASHINGTON STATE 200; Lambert G., 2003, MICRONESICA, V35, P588; Lambert Gretchen, 2009, Aquatic Invasions, V4, P5, DOI 10.3391/ai.2009.4.1.2; Lambert G, 2007, CAH BIOL MAR, V48, P95; Lambert Gretchen, 2002, Pacific Science, V56, P291, DOI 10.1353/psc.2002.0026; Lambert G, 2010, AQUAT INVASIONS, V5, P369, DOI 10.3391/ai.2010.5.4.06; Lee MR, 2008, REV CHIL HIST NAT, V81, P51; Lejeusne C, 2011, BIOL INVASIONS, V13, P635, DOI 10.1007/s10530-010-9854-0; LOYA Y, 1991, EARTH TRANSITION PAT; Marins FO, 2010, ZOOLOGIA-CURITIBA, V27, P213, DOI 10.1590/S1984-46702010000200009; Martinez-Trufero J, 2010, ANTI-CANCER DRUG, V21, P795, DOI 10.1097/CAD.0b013e32833d19f0; Mastrototaro F, 2006, J MAR BIOL ASSOC UK, V86, P181, DOI 10.1017/S0025315406013014; McClintock JB, 2004, MAR BIOL, V145, P885, DOI 10.1007/s00227-004-1388-5; MEAD A, 2011, J NAT HIST IN PRESS; Mendiola J, 2006, T ROY SOC TROP MED H, V100, P909, DOI 10.1016/j.trstmh.2005.11.013; Menna M, 2009, PHYTOCHEM REV, V8, P461, DOI 10.1007/s11101-009-9131-y; MILLAR R. H., 1956, ANN AND MAG NAT HIST, V9, P913; MILLAR R. H., 1965, ATLANTIDE REP SCI RESULTS DANISH EXP COAST TROP WEST AFR, V8, P247; MILLAR R H, 1975, Steenstrupia, V3, P205; MILLAR R. H., 1964, VIDENSKABELIGE MED DELELSER DANSK NATURHIST FOREN KOBENHAVN, V127, P159; MILLAR R. H., 1955, PROC ZOOL SOC LONDON, V125, P169; MILLAR RH, 1988, J NAT HIST, V22, P823, DOI 10.1080/00222938800770541; MILLAR RH, 1971, ADV MAR BIOL, V9, P1, DOI 10.1016/S0065-2881(08)60341-7; Millar RH., 1962, ANN S AFR MUS, V46, P113; MILLAR RH, 1966, MARINE INVERTEBRATES, V1; MONNIOT C, 1994, B MAR SCI, V54, P71; MONNIOT C, 1973, ISRAEL J ZOOL, V22, P51; Monniot C, 1997, J NAT HIST, V31, P1623, DOI 10.1080/00222939700770871; Monniot C, 2002, ZOOL J LINN SOC-LOND, V135, P65, DOI 10.1046/j.1096-3642.2002.00017.x; MONNIOT C, 1985, TETHYS, V11, P203; MONNIOT C, 1987, Memoires du Museum National d'Histoire Naturelle Serie A Zoologie, V136, P1; MONNIOT C, 1974, B MUSEUM NATL HIST N, V173, P1327; Monniot C, 1991, CORAL REEF ASCIDIANS; Monniot F, 2003, ZOOSYSTEMA, V25, P681; MONNIOT F, 1983, Bulletin du Museum National d'Histoire Naturelle Section A Zoologie Biologie et Ecologie Animales, V5, P5; MONNIOT F, 2007, DOC SCI TECH, V117, P349; Monniot Francoise, 1999, Journal of East African Natural History, V86, P1, DOI 10.2982/0012-8317(1997)86[1:ACIT]2.0.CO;2; Monniot Francoise, 2001, Zoosystema, V23, P201; Monniot F, 2009, ZOOTAXA, P13, DOI 10.11646/zootaxa.2106.1.2; NAGAR AE, 2010, AQUAT INVASIONS, V5, P169, DOI DOI 10.3391/AI.2010.5.2.06; Nguyen T. T. T., 2007, Aquaculture Asia Magazine, V12, P21; Nishida H, 2001, NATURE, V409, P724, DOI 10.1038/35055568; NISHIKAWA T, 1990, Publications of the Seto Marine Biological Laboratory, V34, P73; OLIVEIRA FRR, 2010, N BRAZ 3 IISSC WOODS; PAGE MJ, 2010, NZ 3 IISSC WOODS HOL; Peres J. M., 1962, Bulletin Sea Fisheries Research Station Israel, VNo. 30, P39; PEREZPORTELA R, 2010, 3 IISSC WOODS HOL AP; Perrier E, 1898, CR HEBD ACAD SCI, V124, P1758; PINEDA MC, 2010, 3 IISSC WOODS HOL AP; Pisut DP, 2002, J EXP MAR BIOL ECOL, V270, P203, DOI 10.1016/S0022-0981(02)00023-0; Pourquie O, 2001, NATURE, V409, P679, DOI 10.1038/35055657; Primo C, 2004, J BIOGEOGR, V31, P1987, DOI 10.1111/j.1365-2699.2004.01144.x; Primo C, 2008, NEW ZEAL J MAR FRESH, V42, P233, DOI 10.1080/00288330809509951; Primo C, 2007, ANTARCT SCI, V19, P321, DOI 10.1017/S0954102007000521; Primo C, 2009, POLAR RES-SWEDEN, V28, P403, DOI 10.1111/j.1751-8369.2009.00110.x; Raff RA, 2004, J EXP ZOOL PART B, V302B, P19, DOI 10.1002/jez.b.20004; RAYNOLDS C, 2003, ATL CAN TUN WORKSH P; Reinhardt JF, 2010, AQUAT INVASIONS, V5, P185, DOI 10.3391/ai.2010.5.2.09; Rius M, 2008, DIVERS DISTRIB, V14, P818, DOI 10.1111/j.1472-4642.2008.00485.x; Rocha RM, 2005, CARIBB J SCI, V41, P600; ROCHA RM, 2010, PAN 3 IISSC WOODS HO; ROCHA RM, 2005, REV BRAS ZOOL, V22, P1170, DOI DOI 10.1590/S0101-81752005000400052; Rocha Rosana M., 2009, Aquatic Invasions, V4, P195, DOI 10.3391/ai.2009.4.1.20; Rocha RM, 2010, BIOTA NEOTROP, V10, P209, DOI 10.1590/S1676-06032010000100021; Rodrigues S. A., 1998, GUIA ILUSTRADO IDENT; Sagular EK, 2009, GEOSCI J, V13, P121, DOI 10.1007/s12303-009-0011-7; Sanamyan K, 2000, OPHELIA, V53, P67, DOI 10.1080/00785326.2000.10409436; Sanamyan K, 1998, OPHELIA, V49, P97, DOI 10.1080/00785326.1998.10409376; SANAMYAN K, 1993, OPHELIA, V37, P163, DOI 10.1080/00785326.1993.10429915; Sanamyan K, 1999, OPHELIA, V51, P143, DOI 10.1080/00785326.1999.10409405; SANAMYAN K, 1993, OPHELIA, V38, P127, DOI 10.1080/00785326.1993.10429894; Sanamyan K, 1998, OPHELIA, V48, P103, DOI 10.1080/00785236.1998.10428680; Sanamyan K, 1996, OPHELIA, V45, P199, DOI 10.1080/00785326.1996.10432472; SAVIGNY JC, 1816, MEMOIRES ANIMOUX S 2; Scotto KW, 2002, ANTI-CANCER DRUG, V13, pS3; Seo Kyung Suk, 2009, V204, P577; Shenkar N, 2008, BIOL INVASIONS, V10, P1431, DOI 10.1007/s10530-008-9217-2; Shenkar N, 2008, MAR ECOL PROG SER, V367, P163, DOI 10.3354/meps07579; Shenkar N, 2008, AQABA EILAT IMPROBAB, P197; SHENKAR N, 2010, WORLD ASCIDIACEA DAT; Shenkar N, 2008, BIOFOULING, V24, P119, DOI 10.1080/08927010801902083; Shenkar Noa, 2009, Marine Biodiversity Records, V2, pe166, DOI 10.1017/S1755267209990753; SIMS LL, 1984, J EXP MAR BIOL ECOL, V82, P117, DOI 10.1016/0022-0981(84)90098-4; Smale DA, 2008, SCIENCE, V321, P371, DOI 10.1126/science.1158647; Smith KF, 2010, AQUAT INVASIONS, V5, P363, DOI 10.3391/ai.2010.5.4.05; Sorte CJB, 2010, ECOLOGY, V91, P2198, DOI 10.1890/10-0238.1; Stachowicz JJ, 2002, P NATL ACAD SCI USA, V99, P15497, DOI 10.1073/pnas.242437499; Stachowicz JJ, 1999, SCIENCE, V286, P1577, DOI 10.1126/science.286.5444.1577; Stefaniak Lauren, 2009, Aquatic Invasions, V4, P29, DOI 10.3391/ai.2009.4.1.3; Stoner DS, 2002, MAR ECOL PROG SER, V243, P93, DOI 10.3354/meps243093; Svane I., 1989, Oceanography and Marine Biology an Annual Review, V27, P45; Swalla BJ, 2008, PHILOS T R SOC B, V363, P1557, DOI 10.1098/rstb.2007.2246; Tatian M, 2010, SPIXIANA, V33, P111; TEO SLM, 1995, J EXP MAR BIOL ECOL, V188, P49, DOI 10.1016/0022-0981(95)99069-K; TEO SLM, 1994, MAR BIOL, V120, P297, DOI 10.1007/BF00349691; Therriault TW, 2008, ICES J MAR SCI, V65, P788, DOI 10.1093/icesjms/fsn054; THOMPSON RC, 2004, 234 PEI DEP AGR FISH, P29; Tsagkogeorga G, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-187; Turon X, 2007, J EXP MAR BIOL ECOL, V342, P185, DOI 10.1016/j.jembe.2006.10.040; VANNAME WG, 1945, B AM MUS NAT HIST, V84, P1; Vargas-Angel B, 2009, CORAL REEFS, V28, P53, DOI 10.1007/s00338-008-0428-x; Varol O, 1996, J MICROPALAEONTOL, V15, P135, DOI 10.1144/jm.15.2.135; Vazquez E, 1996, MAR ECOL PROG SER, V133, P179, DOI 10.3354/meps133179; VAZQUEZ E, 1993, OPHELIA, V37, P95, DOI 10.1080/00785326.1993.10429910; *VLIZ, 2010, MAR BOUND GEOD VERS; Wilson EO, 2003, TRENDS ECOL EVOL, V18, P77, DOI 10.1016/S0169-5347(02)00040-X; Wiltshire K., 2010, SARDI RES REPORT SER, V468; WRIGHT AE, 1990, J ORG CHEM, V55, P4508, DOI 10.1021/jo00302a006; Zenetos A, 2010, MEDITERR MAR SCI, V11, P381, DOI 10.12681/mms.87; Zeng LY, 2005, CAN J ZOOL, V83, P24, DOI 10.1139/z05-010; Zvyagintsev AY, 2007, RUSS J MAR BIOL+, V33, P133, DOI 10.1134/S1063074007020083	198	179	185	2	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e20657	10.1371/journal.pone.0020657	http://dx.doi.org/10.1371/journal.pone.0020657			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	21701684	gold, Green Published, Green Submitted			2022-12-27	WOS:000291983800009
J	Chun-Lai, T; Padyukov, L; Dhaliwal, JS; Lundstrom, E; Yahya, A; Muhamad, NA; Klareskog, L; Alfredsson, L; Larsson, PT; Murad, S				Chun-Lai, Too; Padyukov, Leonid; Dhaliwal, Jasbir Singh; Lundstrom, Emeli; Yahya, Abqariyah; Muhamad, Nor Asiah; Klareskog, Lars; Alfredsson, Lars; Larsson, Per Tobias; Murad, Shahnaz		Malaysian Epidemiological Invest	Shared Epitope Alleles Remain A Risk Factor for Anti-Citrullinated Proteins Antibody (ACPA) - Positive Rheumatoid Arthritis in Three Asian Ethnic Groups	PLOS ONE			English	Article							HLA-DRB1 ALLELES; GENETIC SUSCEPTIBILITY; JAPANESE PATIENTS; PEPTIDE ANTIBODY; HLA; ASSOCIATION; SMOKING; POPULATION; HLA-DRB1-ASTERISK-0405; AUTOANTIBODIES	Background: To investigate the associations between HLA-DRB1 shared epitope (SE) alleles and rheumatoid arthritis in subsets of rheumatoid arthritis defined by autoantibodies in three Asian populations from Malaysia. Methods: 1,079 rheumatoid arthritis patients and 1,470 healthy controls were included in the study. Levels of antibodies to citrullinated proteins (ACPA) and rheumatoid factors were assessed and the PCR-SSO method was used for HLA-DRB1 genotyping. Results: The proportion of ACPA positivity among Malay, Chinese and Indian rheumatoid arthritis patients were 62.9%, 65.2% and 68.6%, respectively. An increased frequency of SE alleles was observed in ACPA-positive rheumatoid arthritis among the three Asian ethnic groups. HLA-DRB1*10 was highly associated with rheumatoid arthritis susceptibility in these Asian populations. HLA-DRB1*0405 was significantly associated with susceptibility to rheumatoid arthritis in Malays and Chinese, but not in Indians. HLA-DRB1*01 did not show any independent effect as a risk factor for rheumatoid arthritis in this study and HLA-DRB1*1202 was protective in Malays and Chinese. There was no association between SE alleles and ACPA-negative rheumatoid arthritis in any of the three Asian ethnic groups. Conclusion: The HLA-DRB1 SE alleles increase the risk of ACPA-positive rheumatoid arthritis in all three Asian populations from Malaysia.	[Chun-Lai, Too; Padyukov, Leonid; Lundstrom, Emeli; Klareskog, Lars; Larsson, Per Tobias] Karolinska Inst, Dept Med, Rheumatol Unit, Stockholm, Sweden; [Chun-Lai, Too; Dhaliwal, Jasbir Singh] Inst Med Res, Allergy & Immunol Res Ctr, Kuala Lumpur 50588, Malaysia; [Yahya, Abqariyah; Alfredsson, Lars] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Yahya, Abqariyah; Muhamad, Nor Asiah] Inst Med Res, Epidemiol & Biostat Unit, Kuala Lumpur 50588, Malaysia	Karolinska Institutet; Kementerian Kesihatan Malaysia; Karolinska Institutet; Kementerian Kesihatan Malaysia	Chun-Lai, T (corresponding author), Karolinska Inst, Dept Med, Rheumatol Unit, Stockholm, Sweden.	leonid.padyukov@ki.se	Yahya, Abqariyah/B-5638-2017; Too, Chun Lai/AAW-8967-2021; Alfredsson, Lars/AAC-9007-2019; Chun-Lai, Too/AAI-1878-2020; Padyukov, Leonid/A-4890-2009	Yahya, Abqariyah/0000-0001-9158-415X; Too, Chun Lai/0000-0002-4079-8454; Alfredsson, Lars/0000-0003-1688-6697; Padyukov, Leonid/0000-0003-2950-5670; Klareskog, Lars/0000-0001-9601-6186	Ministry of Health (MOH), Malaysia [MRG 7/2005, JPP-IMR 08-012 (NMRR-08-820-1975)]; Swedish Medical Research Council; Swedish Combine program	Ministry of Health (MOH), Malaysia; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Combine program	This study was financially supported by the Ministry of Health (MOH), Malaysia: MRG 7/2005 and JPP-IMR 08-012 (NMRR-08-820-1975) and by the Swedish Medical Research Council and the Swedish Combine program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Balsa A, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2975; Bang SY, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3051; Bengtsson C, 2010, SCAND J RHEUMATOL, V39, P344, DOI 10.3109/03009740903501634; Bowes J, 2008, RHEUMATOLOGY, V47, P399, DOI 10.1093/rheumatology/ken005; CHAN SH, 1994, BRIT J RHEUMATOL, V33, P713; DEIGHTON CM, 1989, CLIN GENET, V36, P178; Dhaliwal JS, 2007, ASIAN PAC J ALLERGY, V25, P47; Eberhardt K, 1996, ANN RHEUM DIS, V55, P34, DOI 10.1136/ard.55.1.34; Furuya T, 2007, CLIN EXP RHEUMATOL, V25, P219; Griffiths B, 2000, RHEUMATOLOGY, V39, P857, DOI 10.1093/rheumatology/39.8.857; Hughes LB, 2008, ARTHRITIS RHEUM-US, V58, P349, DOI 10.1002/art.23166; Klareskog L, 2006, ARTHRITIS RHEUM-US, V54, P38, DOI 10.1002/art.21575; Klareskog L, 2007, CURR OPIN RHEUMATOL, V19, P49, DOI 10.1097/BOR.0b013e32801127c8; Klareskog L, 2006, NAT CLIN PRACT RHEUM, V2, P425, DOI 10.1038/ncprheum0249; Klareskog L, 2009, LANCET, V373, P659, DOI 10.1016/S0140-6736(09)60008-8; Kong KF, 2002, AUTOIMMUNITY, V35, P235, DOI 10.1080/08916930290024179; Lee HS, 2004, ARTHRITIS RHEUM-US, V50, P3468, DOI 10.1002/art.20608; Lin L, 2007, BIOCHEM CELL BIOL, V85, P227, DOI 10.1139/O06-204; Linn-Rasker SP, 2006, ANN RHEUM DIS, V65, P366, DOI 10.1136/ard.2005.041079; Liu SC, 2007, J RHEUMATOL, V34, P674; Louzada P, 2008, BRAZ J MED BIOL RES, V41, P493, DOI 10.1590/S0100-879X2008005000021; Lundstrom E, 2009, ARTHRITIS RHEUM-US, V60, P924, DOI 10.1002/art.24410; Lundstrom E, 2009, ARTHRITIS RHEUM, V60, P1597, DOI 10.1002/art.24572; Okada Y, 2009, ARTHRITIS RHEUM-US, V60, P3582, DOI 10.1002/art.24939; Pimtanothai Nattiya, 2002, Journal of the Medical Association of Thailand, V85, pS366; Poor G, 2007, ANN NY ACAD SCI, V1110, P23, DOI 10.1196/annals.1423.004; SILMAN AJ, 1993, J RHEUMATOL, V20, P1815; Stolt P, 2003, ANN RHEUM DIS, V62, P835, DOI 10.1136/ard.62.9.835; van der Woude D, 2010, ARTHRITIS RHEUM-US, V62, P1236, DOI 10.1002/art.27366; van Gaalen FA, 2004, ARTHRITIS RHEUM, V50, P2113, DOI 10.1002/art.20316; Wakitani S, 1998, SCAND J RHEUMATOL, V27, P146; Xue Y, 2008, SCAND J RHEUMATOL, V37, P183, DOI 10.1080/03009740701874444; YELAMOS J, 1993, ARTHRITIS RHEUM-US, V36, P811, DOI 10.1002/art.1780360611	34	38	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e21069	10.1371/journal.pone.0021069	http://dx.doi.org/10.1371/journal.pone.0021069			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698259	Green Submitted, Green Published, gold			2022-12-27	WOS:000291730000048
J	Wang, LF; Zhao, F; Li, M; Zhang, HM; Gao, Y; Cao, P; Pan, XW; Wang, ZH; Chang, WR				Wang, Longfei; Zhao, Fei; Li, Mei; Zhang, Hongmei; Gao, Yu; Cao, Peng; Pan, Xiaowei; Wang, Zhuanhua; Chang, Wenrui			Conformational Changes of rBTI from Buckwheat upon Binding to Trypsin: Implications for the Role of the P-8 ' Residue in the Potato Inhibitor I Family	PLOS ONE			English	Article							PROTEASE INHIBITORS; STABILITY; SITE; LOOP; ARG(50); GENE	BWI-1 (buckwheat trypsin inhibitor), a member of the potato inhibitor I family, suppresses the growth of T-acute lymphoblastic leukemia cells and induces apoptosis in human solid tumor cell lines. Here, we report the crystal structure of rBTI (recombinant buckwheat trypsin inhibitor), a recombinant protein of BWI-1, at 1.84 angstrom resolution and the structure of rBTI in complex with bovine trypsin at 2.26 angstrom resolution. A conformational change of Trp53 at the P-8' position in rBTI was observed upon its binding to trypsin, which is not seen in other members of the potato inhibitor I family reported previously. The role of the P-8' residue in the potato inhibitor I family was examined by measuring the association and dissociation rates of four rBTI mutants with different substitutions at the P-2 and P-8' positions when binding to trypsin. One of the mutants, P44T, was found to be a much stronger inhibitor than wild-type rBTI, with a picomolar (pM) dissociation constant. Our results could provide valuable insights for designing a new rBTI-based antitumor drug in the future.	[Wang, Longfei; Li, Mei; Zhang, Hongmei; Gao, Yu; Cao, Peng; Pan, Xiaowei; Chang, Wenrui] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China; [Wang, Longfei] Chinese Acad Sci, Grad Univ, Beijing 100080, Peoples R China; [Zhao, Fei; Wang, Zhuanhua] Shanxi Univ, Inst Biotechnol, Key Lab Chem Biol & Mol Engn, Minist Educ, Taiyuan, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Shanxi University	Wang, LF (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China.	zhwang@sxu.edu.cn; wrchang@sun5.ibp.ac.cn		, Peng/0000-0002-2044-3074; Li, Mei/0000-0002-1742-2360	973 Project [2011CBA00902]; National Natural Science Foundation of China [31021062]; Chinese Academy of Sciences [KSCX2-YW-R-123, KSCX2-EW-J-3]	973 Project(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the 973 Project (Grant No. 2011CBA00902), the National Natural Science Foundation of China (Grant No. 31021062) and the Knowledge Innovation Program of the Chinese Academy of Sciences (Grant No. KSCX2-YW-R-123 and KSCX2-EW-J-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BELOZERSKY MA, 1995, FEBS LETT, V371, P264, DOI 10.1016/0014-5793(95)00899-K; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cai ML, 2002, BIOCHEMISTRY-US, V41, P9572, DOI 10.1021/bi0258952; Cai ML, 1996, BIOCHEMISTRY-US, V35, P4784, DOI 10.1021/bi953038a; Cierpicki T, 2000, J MOL BIOL, V302, P1179, DOI 10.1006/jmbi.2000.4116; Dunaevsky YE, 1996, BIOCHEM MOL BIOL INT, V40, P199; Dunaevsky YE, 1997, PHYSIOL PLANTARUM, V101, P483, DOI 10.1111/j.1399-3054.1997.tb01027.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Grzesiak A, 2000, J MOL BIOL, V301, P205, DOI 10.1006/jmbi.2000.3935; JACKSON SE, 1994, BIOCHEMISTRY-US, V33, P13880, DOI 10.1021/bi00250a042; Keegan RM, 2007, ACTA CRYSTALLOGR D, V63, P447, DOI 10.1107/S0907444907002661; Khadeeva NV, 2009, BIOCHEMISTRY-MOSCOW+, V74, P260, DOI 10.1134/S0006297909030031; Krowarsch D, 2003, CELL MOL LIFE SCI, V60, P2427, DOI 10.1007/s00018-003-3120-x; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li YY, 2009, TOXICOL LETT, V189, P166, DOI 10.1016/j.toxlet.2009.05.018; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park SS, 2004, APPL BIOCHEM BIOTECH, V117, P65, DOI 10.1385/ABAB:117:2:065; Radisky ES, 2002, P NATL ACAD SCI USA, V99, P10316, DOI 10.1073/pnas.112332899; Salameh MA, 2010, J BIOL CHEM, V285, P36884, DOI 10.1074/jbc.M110.171348; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Zhang Z, 2007, ACTA BIOCH BIOPH SIN, V39, P701, DOI 10.1111/j.1745-7270.2007.00332.x	26	10	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e20950	10.1371/journal.pone.0020950	http://dx.doi.org/10.1371/journal.pone.0020950			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698291	Green Published, gold, Green Submitted			2022-12-27	WOS:000291730000030
J	Drag, L; Hauck, D; Pokluda, P; Zimmermann, K; Cizek, L				Drag, Lukas; Hauck, David; Pokluda, Pavel; Zimmermann, Kamil; Cizek, Lukas			Demography and Dispersal Ability of a Threatened Saproxylic Beetle: A Mark-Recapture Study of the Rosalia Longicorn (Rosalia alpina)	PLOS ONE			English	Article							BOLITOPHAGUS-RETICULATUS; COLEOPTERA-CERAMBYCIDAE; OSMODERMA-EREMITA; IPS-TYPOGRAPHUS; LUCANUS-CERVUS; TREE HOLLOWS; CONSERVATION; HABITAT; SIZE; METAPOPULATION	The Rosalia longicorn or Alpine longhorn (Coleoptera: Cerambycidae) is an endangered and strictly protected icon of European saproxylic biodiversity. Despite its popularity, lack of information on its demography and mobility may compromise adoption of suitable conservation strategies. The beetle experienced marked retreat from NW part of its range; its single population survives N of the Alps and W of the Carpathians. The population inhabits several small patches of old beech forest on hill-tops of the Ralska Upland, Czech Republic. We performed mark-recapture study of the population and assessed its distribution pattern. Our results demonstrate the high mobility of the beetle, including dispersal between hills (up to 1.6 km). The system is thus interconnected; it contained similar to 2000 adult beetles in 2008. Estimated population densities were high, ranging between 42 and 84 adult beetles/hectare a year. The population survives at a former military-training ground despite long-term isolation and low cover of mature beech forest (similar to 1%). Its survival could be attributed to lack of forestry activities between the 1950s and 1990s, slow succession preventing canopy closure and undergrowth expansion, and probably also to the distribution of habitat patches on conspicuous hill-tops. In order to increase chances of the population for long term survival, we propose to stop clear-cuts of old beech forests, increase semi-open beech woodlands in areas currently covered by conifer plantations and active habitat management at inhabited sites and their wider environs.	[Drag, Lukas; Pokluda, Pavel; Zimmermann, Kamil; Cizek, Lukas] Univ S Bohemia, Fac Sci, Ceske Budejovice, Czech Republic; [Drag, Lukas; Hauck, David; Pokluda, Pavel; Zimmermann, Kamil; Cizek, Lukas] Biol Ctr ASCR, Inst Entomol, Ceske Budejovice, Czech Republic	University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences	Drag, L (corresponding author), Univ S Bohemia, Fac Sci, Ceske Budejovice, Czech Republic.	lukascizek@gmail.com	Hauck, David/AAD-8289-2022; Cizek, Lukas/K-7111-2015; Cizek, Lukas/G-7905-2014; Drag, Lukas/O-6749-2017	Hauck, David/0000-0003-0517-3667; Cizek, Lukas/0000-0002-6447-2002; Cizek, Lukas/0000-0002-6447-2002; Drag, Lukas/0000-0002-6002-9214	Czech Ministry of Education [6007665801, LC06073]; Ministry of Environment [VaV/SP/2d3/153/08]; Czech Agency for Nature Conservation and Landscape Protection	Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic); Ministry of Environment(Ministry of Environment (ME), Republic of Korea); Czech Agency for Nature Conservation and Landscape Protection	This study was supported by the Czech Ministry of Education (6007665801, LC06073; http://www.msmt.cz/), Ministry of Environment (VaV/SP/2d3/153/08; http://www.mzp.cz/) and the Czech Agency for Nature Conservation and Landscape Protection (http://www.ochranaprirody.cz/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baguette M, 2003, ECOGRAPHY, V26, P153, DOI 10.1034/j.1600-0587.2003.03364.x; Baguette M, 2000, J APPL ECOL, V37, P100, DOI 10.1046/j.1365-2664.2000.00478.x; BENSE U, 2002, DGAAE NACHRICHTEN, V16, P57; BORUCKY J, 2007, OVERENI VYSKYTU EXTE; BOTTERWEG PF, 1982, Z ANGEW ENTOMOL, V94, P466; Buse J, 2007, BIOL CONSERV, V137, P372, DOI 10.1016/j.biocon.2007.02.025; Calix M., 2018, EUROPEAN RED LIST SA; *CENIA, 2010, HIST ORT MO CR PODKL; Ciach Michal, 2007, Polskie Pismo Entomologiczne, V76, P101; Cizek L, 2009, BEZDEZ, V18, P125; Cizek L, 2009, ENTOMOL FENNICA, V20, P200; COOK LM, 1967, J ANIM ECOL, V36, P57, DOI 10.2307/3014; CRAIG CC, 1953, BIOMETRIKA, V40, P170, DOI 10.2307/2333106; DOMINIK J, 1989, OCHRONA DREWNA OWADY; Dubois G., 2008, REV ECOLOGIE TERRE V, V63, P123; Dudley N., 2004, DEADWOOD LIVING FORE; Duelli P., 2005, MERKBLATT PRAXIS EID, V39, P1; EDWARDS JS, 1961, Q J MICROSC SCI, V102, P519; Ewers RM, 2006, BIOL REV, V81, P117, DOI 10.1017/S1464793105006949; Farka J., 2005, CERVENY SEZNAM OHROZ; FORSSE E, 1985, Z ANGEW ENTOMOL, V100, P47; Frankham R, 1995, ANNU REV GENET, V29, P305, DOI 10.1146/annurev.ge.29.120195.001513; Franzen M, 2007, J ANIM ECOL, V76, P1224, DOI 10.1111/j.1365-2656.2007.01285.x; Fremlin M, 2009, PENSOFT SER FAUNIST, P161; Fric Z, 2007, BASIC APPL ECOL, V8, P377, DOI 10.1016/j.baae.2006.06.005; Geiser R, 1998, SCHRIFTENREIHE LANDS, V55, P168; Gepp J, 2002, ENTOMOLOGICA AUSTRIA, V5, P3; Hedin J, 2008, BIODIVERS CONSERV, V17, P675, DOI 10.1007/s10531-007-9299-7; Heyrovsky L, 1955, FAUNA CSR, V5; Hill JK, 1996, J ANIM ECOL, V65, P725, DOI 10.2307/5671; HONCU M, 2002, BEZDEZ, V11, P219; HRDLICKA JIRI, 1964, ZIVA, V12, P145; Jendek Branislav, 2006, Folia Faunistica Slovaca, V11, P15; Jonsell M, 2003, ECOGRAPHY, V26, P421, DOI 10.1034/j.1600-0587.2003.03449.x; Jonsson M, 2003, ECOL ENTOMOL, V28, P159, DOI 10.1046/j.1365-2311.2003.00499.x; Jonsson M, 2003, J INSECT CONSERV, V7, P111, DOI 10.1023/A:1025552623766; Koenig WD, 1996, TRENDS ECOL EVOL, V11, P514, DOI 10.1016/S0169-5347(96)20074-6; Komonen Atte, 2008, Endangered Species Research, V6, P149, DOI 10.3354/esr00074; KOVACS T, 1998, FOL HIST NAT MUS MAT, V22, P247; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Lindhe A, 2005, BIODIVERS CONSERV, V14, P3033, DOI 10.1007/s10531-004-0314-y; Lopez-Pantoja G, 2008, CENT EUR J BIOL, V3, P431, DOI 10.2478/s11535-008-0044-3; MACKOVCIN P, 2002, CHRANENA UZEMI CR LI; Muller J, 2008, J INSECT CONSERV, V12, P107, DOI 10.1007/s10841-006-9065-2; Nalepa CA, 2005, ENVIRON ENTOMOL, V34, P425, DOI 10.1603/0046-225X-34.2.425; Nichols J., 2001, DISPERSAL; NILSSEN AC, 1984, ANN ENTOMOL FENN, V50, P37; Nilsson SG, 1997, ECOGRAPHY, V20, P491, DOI 10.1111/j.1600-0587.1997.tb00417.x; Okland B, 1996, BIODIVERS CONSERV, V5, P75, DOI 10.1007/BF00056293; OLEKSA A, 2011, CONSERVAT G IN PRESS; Ranius T, 2002, BIODIVERS CONSERV, V11, P931, DOI 10.1023/A:1015364020043; Ranius T, 2001, OECOLOGIA, V126, P363, DOI 10.1007/s004420000529; Ranius T, 2000, BIOL CONSERV, V95, P85, DOI 10.1016/S0006-3207(00)00007-0; Ray AM, 2009, J CHEM ECOL, V35, P96, DOI 10.1007/s10886-008-9576-2; Rink M, 2007, J ZOOL, V272, P235, DOI 10.1111/j.1469-7998.2006.00282.x; RUSSO D, 2011, J INSECT CO IN PRESS; Saccheri I, 1998, NATURE, V392, P491, DOI 10.1038/33136; Sama G., 2002, ATLAS CERAMBYCIDAE E, V1; SHAFFER ML, 1981, BIOSCIENCE, V31, P131, DOI 10.2307/1308256; Simandl Jiri, 2002, Acta Zoologica Bulgarica, V54, P59; Slama M.E.F., 1998, TESARIKOVITI CERAMBY; STARZYK J. R., 2004, POLSKA CZERWONA KSIE, P148; Thomaes A, 2008, BIOL CONSERV, V141, P1400, DOI 10.1016/j.biocon.2008.03.018; Thomas CD, 2000, P ROY SOC B-BIOL SCI, V267, P139, DOI 10.1098/rspb.2000.0978; Tikkamaki T, 2011, J INSECT CONSERV, V15, P401, DOI 10.1007/s10841-010-9313-3; Tsherepanov A. I., 1981, LONGICORN BEETLES N; Vodka S, 2009, J INSECT CONSERV, V13, P553, DOI 10.1007/s10841-008-9202-1; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Zar J. H., 1996, BIOSTATISTICAL ANAL	69	61	71	1	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e21345	10.1371/journal.pone.0021345	http://dx.doi.org/10.1371/journal.pone.0021345			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738640	Green Submitted, gold, Green Published			2022-12-27	WOS:000292291800012
J	Gonzalez, CP; Maganda, MAN; Arias-Estrada, M; del Rio, G				Polanco Gonzalez, Carlos; Nuno Maganda, Marco Aurelio; Arias-Estrada, Miguel; del Rio, Gabriel			An FPGA Implementation to Detect Selective Cationic Antibacterial Peptides	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDES; PREDICTION; PROTEINS; DESIGN	Exhaustive prediction of physicochemical properties of peptide sequences is used in different areas of biological research. One example is the identification of selective cationic antibacterial peptides (SCAPs), which may be used in the treatment of different diseases. Due to the discrete nature of peptide sequences, the physicochemical properties calculation is considered a high-performance computing problem. A competitive solution for this class of problems is to embed algorithms into dedicated hardware. In the present work we present the adaptation, design and implementation of an algorithm for SCAPs prediction into a Field Programmable Gate Array (FPGA) platform. Four physicochemical properties codes useful in the identification of peptide sequences with potential selective antibacterial activity were implemented into an FPGA board. The speed-up gained in a single-copy implementation was up to 108 times compared with a single Intel processor cycle for cycle. The inherent scalability of our design allows for replication of this code into multiple FPGA cards and consequently improvements in speed are possible. Our results show the first embedded SCAPs prediction solution described and constitutes the grounds to efficiently perform the exhaustive analysis of the sequence-physicochemical properties relationship of peptides.	[Polanco Gonzalez, Carlos; del Rio, Gabriel] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Biochem & Struct Biol, Mexico City 04510, DF, Mexico; [Nuno Maganda, Marco Aurelio] Univ Politecn Victoria, Cd Victoria, Tamaulipas, Mexico; [Arias-Estrada, Miguel] Inst Nacl Astrofis Opt & Electr, Dept Comp Sci, Puebla, Mexico	Universidad Nacional Autonoma de Mexico; Instituto Nacional de Astrofisica, Optica y Electronica	Gonzalez, CP (corresponding author), Univ Autonoma Estado Morelos, Ctr Invest Quim, Cuernavaca, Morelos, Mexico.	ariasmo@inaoep.mx; gdelrio@ifc.unam.mx	Nuno-Maganda, Marco Aurelio/AAR-7112-2020	Nuno-Maganda, Marco Aurelio/0000-0003-0102-8227; Polanco, Carlos/0000-0003-1673-2006	CONACYT [82308]; Macroproyecto Tecnologias para la Universidad de la Informacion y la computacion/UNAM	CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Macroproyecto Tecnologias para la Universidad de la Informacion y la computacion/UNAM(Universidad Nacional Autonoma de Mexico)	This work was supported in part by CONACYT project number 82308 and the Macroproyecto Tecnologias para la Universidad de la Informacion y la computacion/UNAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bogdan IA, 2008, BIOINFORMATICS, V24, P1498, DOI 10.1093/bioinformatics/btn216; del Rio G, 2001, FEBS LETT, V494, P213, DOI 10.1016/S0014-5793(01)02348-1; Du QS, 2008, CURR PROTEIN PEPT SC, V9, P248, DOI 10.2174/138920308784534005; Ellerby HM, 2008, J MED CHEM, V51, P5887, DOI 10.1021/jm800495u; Ellerby HM, 1999, NAT MED, V5, P1032, DOI 10.1038/12469; Fjell CD, 2009, J MED CHEM, V52, P2006, DOI 10.1021/jm8015365; Hilpert Kai, 2008, V494, P127, DOI 10.1007/978-1-59745-419-3_8; Juretic D, 2009, J CHEM INF MODEL, V49, P2873, DOI 10.1021/ci900327a; Kolonin MG, 2004, NAT MED, V10, P625, DOI 10.1038/nm1048; Lehnert U, 2004, Q REV BIOPHYS, V37, P121, DOI 10.1017/S003358350400397X; Polanco C, 2009, ACTA BIOCHIM POL, V56, P167; Raventos D, 2005, COMB CHEM HIGH T SCR, V8, P219, DOI 10.2174/1386207053764549; ROMERO P, 1997, NEURAL NETWORKS, V1, P90, DOI DOI 10.1109/ICNN.1997.611643; Scott MG, 2000, CRIT REV IMMUNOL, V20, P407; Uversky Vladimir N., 2007, V408, P69; Vaara M, 2009, CURR OPIN PHARMACOL, V9, P571, DOI 10.1016/j.coph.2009.08.002; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	17	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21399	10.1371/journal.pone.0021399	http://dx.doi.org/10.1371/journal.pone.0021399			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738652	Green Published, Green Submitted, gold			2022-12-27	WOS:000292142800018
J	Zhang, Y; Kang, YM; Tian, C; Zeng, Y; Jia, LX; Ma, X; Du, J; Li, HH				Zhang, Yuan; Kang, Yu-Ming; Tian, Cui; Zeng, Yong; Jia, Li-Xin; Ma, Xu; Du, Jie; Li, Hui-Hua			Overexpression of Nrdp1 in the Heart Exacerbates Doxorubicin-Induced Cardiac Dysfunction in Mice	PLOS ONE			English	Article							TRANSGENIC MICE; INDUCED CARDIOMYOPATHY; REPERFUSION INJURY; FAILURE; CARDIOTOXICITY; APOPTOSIS; DEGRADATION; EXPRESSION; PATHWAY; PARKIN	Background: Cardiac cell death and generation of oxidative stress contribute to doxorubicin (DOX)-induced cardiac dysfunction. E3 ligase Nrdp1 plays a critical role in the regulation of cell apoptosis, inflammation and production of reactive oxygen species (ROS), which may contribute to heart failure. However, the role of Nrdp1 in DOX-induced cardiac injury remains to be determined. Methods and Results: We examined the effect of Nrdp1 overexpression with DOX treatment in rat neonatal cardiomyocytes and mouse heart tissue. Cardiomyocytes were infected with adenovirus containing GFP (Ad-GFP), Nrdp1 wild-type (Ad-Nrdp1) or the dominant-negative form of Nrdp1 (Ad-Dn-Nrdp1), then treated with DOX for 24 hr. DOX treatment increased cell death and apoptosis, with Ad-Nrdp1 infection enhancing these actions but Ad-Dn-Nrdp1 infection attenuating these effects. Furthermore, 5 days after a single injection of DOX (20 mg/kg, intraperitoneally), Nrdp1 transgenic mice (TG) showed decreased cardiac function and increased apoptosis, autophagy and oxidative stress as compared with wild-type (WT) mice (P<0.01). Survival rate was significantly lower in Nrdp1 TG mice than in WT mice 10 days after DOX injection (P<0.01). Conclusions/Significance: These results were associated with decreased activation of Akt, extracellular signal-regulated kinase 1/2 (ERK1/2) and signal transducer and activator of transcription 3 (STAT3) signaling pathways. Nrdp1 may be a key mediator in the development of cardiac dysfunction after DOX treatment and associated with inhibition of Akt, ERK1/2 and STAT3. Nrdp1 may be a new therapeutic target in protecting against the cardiotoxic effects of DOX.	[Zhang, Yuan] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Pathol, Beijing 100730, Peoples R China; [Zhang, Yuan] Peking Union Med Coll, Beijing 100021, Peoples R China; [Kang, Yu-Ming] Xi An Jiao Tong Univ, Sch Med, Dept Physiol & Pathophysiol, Xian 710049, Peoples R China; [Tian, Cui; Li, Hui-Hua] Capital Med Univ, Sch Basic Med Sci, Dept Pathol, Key Lab Remodeling Related Cardiovasc Dis, Beijing, Peoples R China; [Zeng, Yong] Peking Union Med Hosp, Dept Cardiol, Beijing, Peoples R China; [Jia, Li-Xin; Du, Jie] Capital Med Univ, Key Lab Remodeling Related Cardiovasc Dis, Beijing Inst Heart Lung & Blood Vessel Dis, Beijing Anzhen Hosp,Lab Vasc Biol, Beijing, Peoples R China; [Ma, Xu] Natl Res Inst Family Planning, Dept Genet, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Xi'an Jiaotong University; Capital Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Capital Medical University; National Research Institute for Family Planning - China	Zhang, Y (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Dept Pathol, Beijing 100730, Peoples R China.	jdu@bcm.edu; hhli1935@yahoo.cn			China Natural Science Foundation [81025001, 30971097, 30888004]; Beijing High-Level Talents Program [PHR20110507]; Chinese Academy of Science [KSCX2-YW-R-129]	China Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Beijing High-Level Talents Program; Chinese Academy of Science(Chinese Academy of Sciences)	This study was supported by grants from the China Natural Science Foundation (81025001, 30971097 and 30888004), the Beijing High-Level Talents Program (PHR20110507) and the Chinese Academy of Science (KSCX2-YW-R-129). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Camenisch TD, 2002, NAT MED, V8, P850, DOI 10.1038/nm742; Christiansen S, 2006, EUR J CARDIO-THORAC, V30, P611, DOI 10.1016/j.ejcts.2006.06.024; Diamonti AJ, 2002, P NATL ACAD SCI USA, V99, P2866, DOI 10.1073/pnas.052709799; Fan GC, 2006, CIRC RES, V99, P1233, DOI 10.1161/01.RES.0000251074.19348.af; Ferreira A. L. A., 2008, Cardiovascular & Hematological Agents in Medicinal Chemistry, V6, P278, DOI 10.2174/187152508785909474; Jacoby JJ, 2003, P NATL ACAD SCI USA, V100, P12929, DOI 10.1073/pnas.2134694100; Kang YJ, 1996, J BIOL CHEM, V271, P12610, DOI 10.1074/jbc.271.21.12610; Kizaki K, 2006, PHARMACOL RES, V53, P341, DOI 10.1016/j.phrs.2006.01.001; Kobayashi S, 2010, J BIOL CHEM, V285, P793, DOI 10.1074/jbc.M109.070037; Kumarapeli ARK, 2005, FASEB J, V19, P2051, DOI 10.1096/fj.05-3973fje; Li HH, 2004, J CLIN INVEST, V114, P1058, DOI 10.1172/JCl200422220; Lim CC, 2004, J BIOL CHEM, V279, P8290, DOI 10.1074/jbc.M308033200; Martinet W, 2009, CLIN SCI, V116, P697, DOI 10.1042/CS20080508; Qiu XB, 2002, P NATL ACAD SCI USA, V99, P14843, DOI 10.1073/pnas.232580999; Qiu XB, 2004, EMBO J, V23, P800, DOI 10.1038/sj.emboj.7600075; Riad A, 2008, EUR J HEART FAIL, V10, P233, DOI 10.1016/j.ejheart.2008.01.004; Riad A, 2009, CANCER RES, V69, P695, DOI 10.1158/0008-5472.CAN-08-3076; Sawyer DB, 1999, CIRC RES, V84, P257, DOI 10.1161/01.RES.84.3.257; Singal P, 2000, MOL CELL BIOCHEM, V207, P77, DOI 10.1023/A:1007094214460; Su HF, 2006, ENDOCRINOLOGY, V147, P827, DOI 10.1210/en.2005-1098; Taniyama Y, 2002, J MOL CELL CARDIOL, V34, P1241, DOI 10.1006/jmcc.2002.2068; Teraoka K, 2000, EUR J HEART FAIL, V2, P373, DOI 10.1016/S1388-9842(00)00111-2; Wang C, 2009, NAT IMMUNOL, V10, P744, DOI 10.1038/ni.1742; Xiang P, 2009, CANCER CHEMOTH PHARM, V63, P343, DOI 10.1007/s00280-008-0744-4; Xie P, 2009, J BIOL CHEM, V284, P5488, DOI 10.1074/jbc.M806487200; Yang D, 2010, CELL PHYSIOL BIOCHEM, V25, P605, DOI 10.1159/000315079; Yen HC, 1996, J CLIN INVEST, V98, P1253, DOI 10.1172/JCI118909; Yet SF, 2001, CIRC RES, V89, P168, DOI 10.1161/hh1401.093314; Yu FR, 2008, NEUROSCI LETT, V440, P4, DOI 10.1016/j.neulet.2008.05.052; Zhang YA, 2011, BASIC RES CARDIOL, V106, P371, DOI 10.1007/s00395-011-0157-0; Zhong L, 2005, J BIOL CHEM, V280, P9425, DOI 10.1074/jbc.M408955200	31	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21104	10.1371/journal.pone.0021104	http://dx.doi.org/10.1371/journal.pone.0021104			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738612	gold, Green Published			2022-12-27	WOS:000292092600013
J	Harris, DM; Hazan-Haley, I; Coombes, K; Bueso-Ramos, C; Liu, J; Liu, ZM; Li, P; Ravoori, M; Abruzzo, L; Han, L; Singh, S; Sun, M; Kundra, V; Kurzrock, R; Estrov, Z				Harris, David M.; Hazan-Haley, Inbal; Coombes, Kevin; Bueso-Ramos, Carlos; Liu, Jie; Liu, Zhiming; Li, Ping; Ravoori, Murali; Abruzzo, Lynne; Han, Lin; Singh, Sheela; Sun, Michael; Kundra, Vikas; Kurzrock, Razelle; Estrov, Zeev			Transformation of Human Mesenchymal Cells and Skin Fibroblasts into Hematopoietic Cells	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; HUMAN BONE-MARROW; COLONY-STIMULATING FACTOR; PROGENITOR CELLS; B-CELLS; GM-CSF; DIFFERENTIAL EXPRESSION; PERIPHERAL-BLOOD; EPITHELIAL-CELLS; DNA METHYLATION	Patients with prolonged myelosuppression require frequent platelet and occasional granulocyte transfusions. Multi-donor transfusions induce alloimmunization, thereby increasing morbidity and mortality. Therefore, an autologous or HLA-matched allogeneic source of platelets and granulocytes is needed. To determine whether nonhematopoietic cells can be reprogrammed into hematopoietic cells, human mesenchymal stromal cells (MSCs) and skin fibroblasts were incubated with the demethylating agent 5-azacytidine (Aza) and the growth factors (GF) granulocyte-macrophage colony-stimulating factor and stem cell factor. This treatment transformed MSCs to round, non-adherent cells expressing T-, B-, myeloid-, or stem/progenitor-cell markers. The transformed cells engrafted as hematopoietic cells in bone marrow of immunodeficient mice. DNA methylation and mRNA array analysis suggested that Aza and GF treatment demethylated and activated HOXB genes. Indeed, transfection of MSCs or skin fibroblasts with HOXB4, HOXB5, and HOXB2 genes transformed them into hematopoietic cells. Further studies are needed to determine whether transformed MSCs or skin fibroblasts are suitable for therapy.	[Harris, David M.; Hazan-Haley, Inbal; Liu, Jie; Liu, Zhiming; Li, Ping; Estrov, Zeev] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA; [Coombes, Kevin] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Bueso-Ramos, Carlos; Abruzzo, Lynne] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA; [Ravoori, Murali; Han, Lin; Singh, Sheela; Kundra, Vikas] Univ Texas MD Anderson Canc Ctr, Dept Diagnost Radiol, Houston, TX 77030 USA; [Sun, Michael; Kurzrock, Razelle] Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Harris, DM (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA.	zestrov@mdanderson.org	Kurzrock, Razelle/AAU-9782-2020	Coombes, Kevin/0000-0002-7630-2123	M.D. Anderson Cancer Center	M.D. Anderson Cancer Center	This study was supported by a Multidisciplinary Research Program grant from M.D. Anderson Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarnas JC, 2004, ONCOLOGY-NY, V18, P867; Argiropoulos B, 2007, ONCOGENE, V26, P6766, DOI 10.1038/sj.onc.1210760; Ball LM, 2008, BONE MARROW TRANSPL, V42, pS60, DOI 10.1038/bmt.2008.286; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bjornson CRR, 1999, SCIENCE, V283, P534, DOI 10.1126/science.283.5401.534; Bleul CC, 1996, J EXP MED, V184, P1101, DOI 10.1084/jem.184.3.1101; BOYD AW, 1982, NATURE, V297, P691, DOI 10.1038/297691a0; Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775; BROXMEYER HE, 1991, CANCER CELL-MON REV, V3, P480; BROXMEYER HE, 1991, J EXP MED, V174, P447, DOI 10.1084/jem.174.2.447; Burger JA, 1999, BLOOD, V94, P3658, DOI 10.1182/blood.V94.11.3658.423k11_3658_3667; CHIU CP, 1985, CELL, V40, P417, DOI 10.1016/0092-8674(85)90155-2; CHOI J, 1990, P NATL ACAD SCI USA, V87, P7988, DOI 10.1073/pnas.87.20.7988; Choi SC, 2004, EXP MOL MED, V36, P515, DOI 10.1038/emm.2004.66; Cobaleda C, 2007, NATURE, V449, P473, DOI 10.1038/nature06159; CONNELL D, 2009, BR J SPORTS MED; CONSTANTINIDES PG, 1977, NATURE, V267, P364, DOI 10.1038/267364a0; CONSTANTINIDES PG, 1978, DEV BIOL, V66, P57, DOI 10.1016/0012-1606(78)90273-7; DARMON M, 1984, EMBO J, V3, P961, DOI 10.1002/j.1460-2075.1984.tb01914.x; Devine SM, 2003, BLOOD, V101, P2999, DOI 10.1182/blood-2002-06-1830; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Eglitis MA, 1997, P NATL ACAD SCI USA, V94, P4080, DOI 10.1073/pnas.94.8.4080; Enjoji M, 1997, HEPATOLOGY, V26, P288, DOI 10.1002/hep.510260206; FAUSER AA, 1978, BLOOD, V52, P1243; FEINBERG AP, 1983, BIOCHEM BIOPH RES CO, V111, P47, DOI 10.1016/S0006-291X(83)80115-6; Freireich EJ, 2000, BRIT J HAEMATOL, V111, P68, DOI 10.1046/j.1365-2141.2000.02144.x; Gluckman E, 2008, BONE MARROW TRANSPL, V41, P127, DOI 10.1038/sj.bmt.1705960; Gurdon JB, 2006, ANNU REV CELL DEV BI, V22, P1, DOI 10.1146/annurev.cellbio.22.090805.140144; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; Habib M, 1999, EXP CELL RES, V249, P46, DOI 10.1006/excr.1999.4434; Hai-Jiang W, 2008, AM J HEMATOL, V83, P922, DOI 10.1002/ajh.21262; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Haylock David N, 2007, Curr Stem Cell Res Ther, V2, P324, DOI 10.2174/157488807782793745; Hershko AY, 2003, GENE, V302, P65, DOI 10.1016/S0378111902010910; Hirohata S, 2002, J LEUKOCYTE BIOL, V71, P987; Hochedlinger K, 2006, NATURE, V441, P1061, DOI 10.1038/nature04955; Horwitz EM, 1999, NAT MED, V5, P309, DOI 10.1038/6529; Horwitz EM, 2002, P NATL ACAD SCI USA, V99, P8932, DOI 10.1073/pnas.132252399; Issa JPJ, 2007, CLIN CANCER RES, V13, P1634, DOI 10.1158/1078-0432.CCR-06-2076; Ivins S, 2003, ONCOGENE, V22, P3685, DOI 10.1038/sj.onc.1206328; Izumikawa M, 2005, NAT MED, V11, P271, DOI 10.1038/nm1193; Jendiroba DB, 2000, BLOOD REV, V14, P219, DOI 10.1054/blre.2000.0134; Jones EA, 2002, ARTHRITIS RHEUM-US, V46, P3349, DOI 10.1002/art.10696; JONES PA, 1985, CELL, V40, P485, DOI 10.1016/0092-8674(85)90192-8; Kaminskas E, 2005, CLIN CANCER RES, V11, P3604, DOI 10.1158/1078-0432.CCR-04-2135; Koc ON, 2002, BONE MARROW TRANSPL, V30, P215, DOI 10.1038/sj.bmt.1703650; Koc ON, 2000, J CLIN ONCOL, V18, P307, DOI 10.1200/JCO.2000.18.2.307; KONIECZNY SF, 1984, CELL, V38, P791, DOI 10.1016/0092-8674(84)90274-5; Korbling M, 2002, NEW ENGL J MED, V346, P738, DOI 10.1056/NEJMoa3461002; Korbling M, 2003, NEW ENGL J MED, V349, P570, DOI 10.1056/NEJMra022361; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; Kundra V, 2002, J NUCL MED, V43, P406; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; LASSAR AB, 1986, CELL, V47, P649, DOI 10.1016/0092-8674(86)90507-6; LAZARUS HM, 1995, BONE MARROW TRANSPL, V16, P557; Lazarus HM, 2005, BIOL BLOOD MARROW TR, V11, P389, DOI 10.1016/j.bbmt.2005.02.001; Lennartsson J, 2004, J BIOL CHEM, V279, P44544, DOI 10.1074/jbc.M404085200; Ma F, 2000, BRIT J HAEMATOL, V111, P1170, DOI 10.1046/j.1365-2141.2000.02432.x; MCNIECE IK, 1991, J IMMUNOL, V146, P3785; MCNIECE IK, 1991, EXP HEMATOL, V19, P226; Milutinovic S, 2003, J BIOL CHEM, V278, P14985, DOI 10.1074/jbc.M213219200; Murphy PM, 2000, PHARMACOL REV, V52, P145; Okamoto R, 2002, NAT MED, V8, P1011, DOI 10.1038/nm755; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pineault N, 2002, EXP HEMATOL, V30, P49, DOI 10.1016/S0301-472X(01)00757-3; Pounds S, 2003, BIOINFORMATICS, V19, P1236, DOI 10.1093/bioinformatics/btg148; Rebulla P, 2005, HAEMATOLOGICA, V90, P247; Sachan M, 2006, GENE, V380, P151, DOI 10.1016/j.gene.2006.05.029; Sachs UJH, 2007, TRANSFUS APHER SCI, V37, P273, DOI 10.1016/j.transci.2007.02.005; Sauter C, 2008, CURR OPIN HEMATOL, V15, P568, DOI 10.1097/MOH.0b013e3283136718; SAUVAGEAU G, 1994, P NATL ACAD SCI USA, V91, P12223, DOI 10.1073/pnas.91.25.12223; Schmidt AH, 2007, BONE MARROW TRANSPL, V40, P823, DOI 10.1038/sj.bmt.1705832; Shen CN, 2000, NAT CELL BIOL, V2, P879, DOI 10.1038/35046522; Slack JMW, 2007, NAT REV MOL CELL BIO, V8, P369, DOI 10.1038/nrm2146; Sonderegger I, 2008, J EXP MED, V205, P2281, DOI 10.1084/jem.20071119; SORM F, 1964, EXPERIENTIA, V20, P202, DOI 10.1007/BF02135399; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TAYLOR SM, 1979, CELL, V17, P771, DOI 10.1016/0092-8674(79)90317-9; Thirukkumaran CM, 2007, BONE MARROW TRANSPL, V40, P1, DOI 10.1038/sj.bmt.1705668; Toma JG, 2001, NAT CELL BIOL, V3, P778, DOI 10.1038/ncb0901-778; Tse W, 2008, CURR OPIN HEMATOL, V15, P279, DOI 10.1097/MOH.0b013e328304ae2c; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Wagers AJ, 2004, CELL, V116, P639, DOI 10.1016/S0092-8674(04)00208-9; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Winters JL, 2006, J CLIN APHERESIS, V21, P132, DOI 10.1002/jca.20039; Wood B, 2006, ARCH PATHOL LAB MED, V130, P680; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Yamada N, 2008, J ARTIF ORGANS, V11, P221, DOI 10.1007/s10047-008-0428-1; Yang D, 2005, RADIOLOGY, V235, P950, DOI 10.1148/radiol.2353040108; Yu BD, 2008, HUM MOL GENET, V17, pR54, DOI 10.1093/hmg/ddn086; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhou Q, 2008, CELL STEM CELL, V3, P382, DOI 10.1016/j.stem.2008.09.015; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	98	25	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21250	10.1371/journal.pone.0021250	http://dx.doi.org/10.1371/journal.pone.0021250			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731684	Green Published, Green Submitted, gold			2022-12-27	WOS:000292033700053
J	Murphy, DM; Buckley, PG; Das, S; Watters, KM; Bryan, K; Stallings, RL				Murphy, Derek M.; Buckley, Patrick G.; Das, Sudipto; Watters, Karen M.; Bryan, Kenneth; Stallings, Raymond L.			Co-Localization of the Oncogenic Transcription Factor MYCN and the DNA Methyl Binding Protein MeCP2 at Genomic Sites in Neuroblastoma	PLOS ONE			English	Article							FOCAL ADHESION KINASE; RETT-SYNDROME; HISTONE DEACETYLASE; TARGET GENES; MOUSE MODEL; EXPRESSION; PROMOTER; REPRESSION; REVEALS; PATHWAY	Background: MYCN is a transcription factor that is expressed during the development of the neural crest and its dysregulation plays a major role in the pathogenesis of pediatric cancers such as neuroblastoma, medulloblastoma and rhabdomyosarcoma. MeCP2 is a CpG methyl binding protein which has been associated with a number of cancers and developmental disorders, particularly Rett syndrome. Methods and Findings: Using an integrative global genomics approach involving chromatin immunoprecipitation applied to microarrays, we have determined that MYCN and MeCP2 co-localize to gene promoter regions, as well as inter/intragenic sites, within the neuroblastoma genome (MYCN amplified Kelly cells) at high frequency (70.2% of MYCN sites were also positive for MeCP2). Intriguingly, the frequency of co-localization was significantly less at promoter regions exhibiting substantial hypermethylation (8.7%), as determined by methylated DNA immunoprecipitation (MeDIP) applied to the same microarrays. Co-immunoprecipitation of MYCN using an anti-MeCP2 antibody indicated that a MYCN/MeCP2 interaction occurs at protein level. mRNA expression profiling revealed that the median expression of genes with promoters bound by MYCN was significantly higher than for genes bound by MeCP2, and that genes bound by both proteins had intermediate expression. Pathway analysis was carried out for genes bound by MYCN, MeCP2 or MYCN/MeCP2, revealing higher order functions. Conclusions: Our results indicate that MYCN and MeCP2 protein interact and co-localize to similar genomic sites at very high frequency, and that the patterns of binding of these proteins can be associated with significant differences in transcriptional activity. Although it is not yet known if this interaction contributes to neuroblastoma disease pathogenesis, it is intriguing that the interaction occurs at the promoter regions of several genes important for the development of neuroblastoma, including ALK, AURKA and BDNF.	[Murphy, Derek M.; Buckley, Patrick G.; Das, Sudipto; Watters, Karen M.; Bryan, Kenneth; Stallings, Raymond L.] Royal Coll Surgeons Ireland, Dept Canc Genet, Dublin 2, Ireland; [Murphy, Derek M.; Buckley, Patrick G.; Das, Sudipto; Watters, Karen M.; Bryan, Kenneth; Stallings, Raymond L.] Our Ladys Childrens Hosp, Childrens Res Ctr, Dublin, Ireland; [Buckley, Patrick G.] Royal Coll Surgeons Ireland, Dept Mol & Cellular Therapeut, Dublin 2, Ireland	Royal College of Surgeons - Ireland; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; Royal College of Surgeons - Ireland	Murphy, DM (corresponding author), Royal Coll Surgeons Ireland, Dept Canc Genet, Dublin 2, Ireland.	rstallings@rcsi.ie	Murphy, Derek/B-1285-2013; Stallings, Raymond/A-7213-2008	Bryan, Kenneth/0000-0002-9550-8354	Science Foundation Ireland [07/IN.1/B1776]; Children's Medical and Research Foundation; Cancer Research Ireland; U.S. National Institutes of Health [5R01CA127496]; NATIONAL CANCER INSTITUTE [R01CA127496] Funding Source: NIH RePORTER	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Children's Medical and Research Foundation; Cancer Research Ireland; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by Science Foundation Ireland (07/IN.1/B1776), Children's Medical and Research Foundation, Cancer Research Ireland and the U.S. National Institutes of Health (5R01CA127496). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	AMIN C, 1993, MOL CELL BIOL, V13, P383, DOI 10.1128/MCB.13.1.383; Balmer D, 2002, HUM GENET, V110, P545, DOI 10.1007/s00439-002-0724-4; Beierle EA, 2008, CLIN CANCER RES, V14, P3299, DOI 10.1158/1078-0432.CCR-07-1511; Beierle EA, 2007, J BIOL CHEM, V282, P12503, DOI 10.1074/jbc.M701450200; Beierle EA, 2010, MOL CARCINOGEN, V49, P224, DOI 10.1002/mc.20592; Berdasco M, 2009, P NATL ACAD SCI USA, V106, P21830, DOI 10.1073/pnas.0906831106; Bray I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007850; BUCKLEY PG, 2010, INT J CANC; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chen LD, 2010, CANCER RES, V70, P1377, DOI 10.1158/0008-5472.CAN-09-2598; Cotterman R, 2008, CANCER RES, V68, P9654, DOI 10.1158/0008-5472.CAN-08-1961; Fontana L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002236; Frank SR, 2003, EMBO REP, V4, P575, DOI 10.1038/sj.embor.embor861; Gartel AL, 2001, P NATL ACAD SCI USA, V98, P4510, DOI 10.1073/pnas.081074898; Gonzales ML, 2010, CURR PSYCHIAT REP, V12, P127, DOI 10.1007/s11920-010-0097-7; Gupta A, 2006, CANCER RES, V66, P8100, DOI 10.1158/0008-5472.CAN-05-4519; Horike S, 2005, NAT GENET, V37, P31, DOI 10.1038/ng1491; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Kim J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001798; Klose RJ, 2005, MOL CELL, V19, P667, DOI 10.1016/j.molcel.2005.07.021; Konduri SD, 2003, ONCOGENE, V22, P4509, DOI 10.1038/sj.onc.1206695; Koppen A, 2007, EUR J CANCER, V43, P2413, DOI 10.1016/j.ejca.2007.07.024; Krajewski WA, 1998, P NATL ACAD SCI USA, V95, P1540, DOI 10.1073/pnas.95.4.1540; LaSalle JM, 2009, EPIGENOMICS-UK, V1, P119, DOI [10.2217/epi.09.13, 10.2217/EPI.09.13]; Li QL, 2006, TRENDS GENET, V22, P197, DOI 10.1016/j.tig.2006.02.004; Lu HF, 2009, NEUROCHEM RES, V34, P1575, DOI 10.1007/s11064-009-9946-3; McMahon SB, 2000, MOL CELL BIOL, V20, P556, DOI 10.1128/MCB.20.2.556-562.2000; MESTDAGH P, 2010, ONCOGENE; MUKHERJEE B, 1992, GENE DEV, V6, P1480, DOI 10.1101/gad.6.8.1480; Muotri AR, 2010, NATURE, V468, P443, DOI 10.1038/nature09544; Murphy DM, 2011, MOL CARCINOGEN, V50, P403, DOI 10.1002/mc.20722; Murphy DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008154; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Nuber UA, 2005, HUM MOL GENET, V14, P2247, DOI 10.1093/hmg/ddi229; Ochiai H, 2010, ONCOGENE, V29, P2681, DOI 10.1038/onc.2010.22; Perini G, 2005, P NATL ACAD SCI USA, V102, P12117, DOI 10.1073/pnas.0409097102; Peukert K, 1997, EMBO J, V16, P5672, DOI 10.1093/emboj/16.18.5672; Ramachandran K, 2009, CANCER RES, V69, P1527, DOI 10.1158/0008-5472.CAN-08-3609; Schulte JH, 2008, INT J CANCER, V122, P699, DOI 10.1002/ijc.23153; SCHWAB M, 1983, NATURE, V305, P245, DOI 10.1038/305245a0; Shohet JM, 2002, CANCER RES, V62, P1123; Slack A, 2005, P NATL ACAD SCI USA, V102, P731, DOI 10.1073/pnas.0405495102; Stallings RL, 2006, CANCER RES, V66, P3673, DOI 10.1158/0008-5472.CAN-05-4154; Tudor M, 2002, P NATL ACAD SCI USA, V99, P15536, DOI 10.1073/pnas.242566899; Van Roy N, 2009, GENOME MED, V1, DOI 10.1186/gm74; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Weiss WA, 1997, EMBO J, V16, P2985, DOI 10.1093/emboj/16.11.2985; Westermann F, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r150; YANG TY, 2010, BMC CANC; Yasui DH, 2007, P NATL ACAD SCI USA, V104, P19416, DOI 10.1073/pnas.0707442104; Zeller KI, 2006, P NATL ACAD SCI USA, V103, P17834, DOI 10.1073/pnas.0604129103	53	25	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21436	10.1371/journal.pone.0021436	http://dx.doi.org/10.1371/journal.pone.0021436			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731748	gold, Green Published, Green Submitted			2022-12-27	WOS:000292033700085
J	Nierth, A; Jaschke, A				Nierth, Alexander; Jaeschke, Andres			Radioactive Phosphorylation of Alcohols to Monitor Biocatalytic Diels-Alder Reactions	PLOS ONE			English	Article							PHOSPHORIC-ACID; ACTIVE-SITE; ENERGIEREICHEN PHOSPHATE; ZUR CHEMIE; RIBOZYME; CONDENSATION; ENZYME	Nature has efficiently adopted phosphorylation for numerous biological key processes, spanning from cell signaling to energy storage and transmission. For the bioorganic chemist the number of possible ways to attach a single phosphate for radioactive labeling is surprisingly small. Here we describe a very simple and fast one-pot synthesis to phosphorylate an alcohol with phosphoric acid using trichloroacetonitrile as activating agent. Using this procedure, we efficiently attached the radioactive phosphorus isotope P-32 to an anthracene diene, which is a substrate for the Diels-Alderase ribozyme-an RNA sequence that catalyzes the eponymous reaction. We used the P-32-substrate for the measurement of RNA-catalyzed reaction kinetics of several dye-labeled ribozyme variants for which precise optical activity determination (UV/vis, fluorescence) failed due to interference of the attached dyes. The reaction kinetics were analyzed by thin-layer chromatographic separation of the P-32-labeled reaction components and densitometric analysis of the substrate and product radioactivities, thereby allowing iterative optimization of the dye positions for future single-molecule studies. The phosphorylation strategy with trichloroacetonitrile may be applicable for labeling numerous other compounds that contain alcoholic hydroxyl groups.	[Nierth, Alexander; Jaeschke, Andres] Heidelberg Univ, Inst Pharm & Mol Biotechnol, Heidelberg, Germany	Ruprecht Karls University Heidelberg	Nierth, A (corresponding author), Heidelberg Univ, Inst Pharm & Mol Biotechnol, Heidelberg, Germany.	jaeschke@uni-hd.de	Nierth, Alexander/K-9776-2015; Jäschke, Andres/F-1575-2010	Jäschke, Andres/0000-0002-4625-2655	Deutsche Forschungsgemeinschaft [Ja 794-3]; Volkswagen foundation [VW-I/82549]; Fonds der Chemischen Industrie	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Volkswagen foundation(Volkswagen); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	This work was supported by the Deutsche Forschungsgemeinschaft (Ja 794-3), the Volkswagen foundation (VW-I/82549) and the Fonds der Chemischen Industrie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berezniak T, 2010, J AM CHEM SOC, V132, P12587, DOI 10.1021/ja101370e; Bettendorff L, 2003, ANAL BIOCHEM, V322, P190, DOI 10.1016/j.ab.2003.08.013; Brun MA, 2009, J AM CHEM SOC, V131, P5873, DOI 10.1021/ja900149e; CRAMER F, 1962, CHEM BER-RECL, V95, P1657, DOI 10.1002/cber.19620950713; CRAMER F, 1962, LIEBIGS ANN CHEM, V654, P180; Cravatt BF, 2008, ANNU REV BIOCHEM, V77, P383, DOI 10.1146/annurev.biochem.75.101304.124125; DOLINNAYA NG, 1991, NUCLEIC ACIDS RES, V19, P3067, DOI 10.1093/nar/19.11.3067; Dueymes C, 2008, TETRAHEDRON LETT, V49, P5300, DOI 10.1016/j.tetlet.2008.06.083; Fiammengo R, 2005, J AM CHEM SOC, V127, P9271, DOI 10.1021/ja051179m; FONTANEL ML, 1993, ANAL BIOCHEM, V214, P338, DOI 10.1006/abio.1993.1501; GLONEK T, 1976, BIOINORG CHEM, V5, P283, DOI 10.1016/S0006-3061(00)80290-2; GLYNN IM, 1964, BIOCHEM J, V90, P147, DOI 10.1042/bj0900147; HEITZ JR, 1968, ARCH BIOCHEM BIOPHYS, V127, P627, DOI 10.1016/0003-9861(68)90271-3; Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395; HOKIN LE, 1963, BIOCHIM BIOPHYS ACTA, V67, P485; KANAYA E, 1986, BIOCHEMISTRY-US, V25, P7423, DOI 10.1021/bi00371a026; Kobitski AY, 2007, NUCLEIC ACIDS RES, V35, P2047, DOI 10.1093/nar/gkm072; Leuck M, 2004, TETRAHEDRON LETT, V45, P321, DOI 10.1016/j.tetlet.2003.10.167; Manoharan V, 2009, J AM CHEM SOC, V131, P6261, DOI 10.1021/ja900244x; Martin NI, 2007, BIOORG MED CHEM LETT, V17, P4938, DOI 10.1016/j.bmcl.2007.06.039; Melby ES, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018420; NEUFELD E, 1989, ANAL BIOCHEM, V177, P138, DOI 10.1016/0003-2697(89)90028-6; Nierth A, 2010, CHEM COMMUN, V46, P7975, DOI 10.1039/c0cc03162c; Nierth A, 2010, J AM CHEM SOC, V132, P2646, DOI 10.1021/ja9084397; PENEFSKY HS, 1967, METHOD ENZYMOL, V10, P702; SAFFHILL R, 1970, J ORG CHEM, V35, P2881, DOI 10.1021/jo00834a004; Sakakura A, 2008, HETEROCYCLES, V76, P657; Sakakura A, 2007, ANGEW CHEM INT EDIT, V46, P1423, DOI 10.1002/anie.200604333; Schmidt R. R., 2000, CARBOHYD CHEM-SPR, P5; Seelig B, 2000, ANGEW CHEM INT EDIT, V39, P4576, DOI 10.1002/1521-3773(20001215)39:24<4576::AID-ANIE4576>3.0.CO;2-J; Seelig B, 1999, CHEM BIOL, V6, P167, DOI 10.1016/S1074-5521(99)89008-5; Serganov A, 2005, NAT STRUCT MOL BIOL, V12, P218, DOI 10.1038/nsmb906; Stuhlmann F, 2002, J AM CHEM SOC, V124, P3238, DOI 10.1021/ja0167405; Tercel M, 2011, ANGEW CHEM INT EDIT, V50, P2606, DOI 10.1002/anie.201004456; Tinnefeld P, 2005, ANGEW CHEM INT EDIT, V44, P2642, DOI 10.1002/anie.200300647; van Herk T, 2005, ADV SYNTH CATAL, V347, P1155, DOI 10.1002/adsc.200505072; Vogel SR, 2005, CHEM COMMUN, P4922, DOI 10.1039/b510775j; Wiberg E., 2007, LEHRBUCH ANORGANISCH; Wombacher R, 2008, J AM CHEM SOC, V130, P8594, DOI 10.1021/ja802931q	39	2	3	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21391	10.1371/journal.pone.0021391	http://dx.doi.org/10.1371/journal.pone.0021391			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731729	Green Submitted, Green Published, gold			2022-12-27	WOS:000292033700073
J	Andress, EJ; Holic, R; Edelmann, MJ; Kessler, BM; Yu, VPCC				Andress, Edward J.; Holic, Roman; Edelmann, Mariola J.; Kessler, Benedikt M.; Yu, Veronica P. C. C.			Dia2 Controls Transcription by Mediating Assembly of the RSC Complex	PLOS ONE			English	Article							NUCLEOSOME-REMODELING COMPLEX; REGULATES DNA-REPLICATION; GENOME-WIDE LOCATION; SACCHAROMYCES-CEREVISIAE; HISTONE HOMEOSTASIS; CELL-CYCLE; S-PHASE; PROTEIN; YEAST; INTEGRITY	Background: Dia2 is an F-box protein found in the budding yeast, S. cerevisiae. Together with Skp1 and Cul1, Dia2 forms the substrate-determining part of an E3 ubiquitin ligase complex, otherwise known as the SCF. Dia2 has previously been implicated in the control of replication and genome stability via its interaction with the replisome progression complex. Principal Findings: We identified components of the RSC chromatin remodelling complex as genetic interactors with Dia2, suggesting an additional role for Dia2 in the regulation of transcription. We show that Dia2 is involved in controlling assembly of the RSC complex. RSC belongs to a group of ATP-dependent nucleosome-remodelling complexes that controls the repositioning of nucleosomes. The RSC complex is expressed abundantly and its 17 subunits are recruited to chromatin in response to both transcription activation and repression. In the absence of Dia2, RSC-mediated transcription regulation was impaired, with concomitant abnormalities in nucleosome positioning. Conclusions: Our findings imply that Dia2 is required for the correct assembly and function of the RSC complex. Dia2, by controlling the RSC chromatin remodeller, fine-tunes transcription by controlling nucleosome positioning during transcriptional activation and repression.	[Andress, Edward J.; Holic, Roman; Yu, Veronica P. C. C.] Univ London Imperial Coll Sci Technol & Med, Eukaryot Chromatin Dynam Grp, MRC Clin Sci Ctr, London, England; [Edelmann, Mariola J.; Kessler, Benedikt M.] Univ Oxford, Ctr Cellular & Mol Physiol, Nuffield Dept Clin Med, Ubiquitin Proteolysis Grp, Oxford, England; [Yu, Veronica P. C. C.] Guys Hosp, Kings Coll London, Sch Med, Dept Med & Mol Genet, London SE1 9RT, England	Imperial College London; University of Oxford; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Andress, EJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Eukaryot Chromatin Dynam Grp, MRC Clin Sci Ctr, Hammersmith Campus, London, England.	veronica.yu@kcl.ac.uk	Roman, Holic/X-7500-2018; Holic, Roman/AAC-8402-2019; Kessler, Benedikt/AAY-8614-2021	Roman, Holic/0000-0003-1347-4785; Holic, Roman/0000-0003-1347-4785; Kessler, Benedikt/0000-0002-8160-2446; Edelmann, Mariola/0000-0003-0459-7716	Medical Research Council; MRC; Wellcome Trust; Biomedical Research Centre (NIHR), Oxford, United Kingdom; Computational Biology Research Group (CBRG) at the University of Oxford; Medical Research Council [G0501068, MC_U120085813] Funding Source: researchfish; MRC [G0501068, MC_U120085813] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Biomedical Research Centre (NIHR), Oxford, United Kingdom(National Institute for Health Research (NIHR)); Computational Biology Research Group (CBRG) at the University of Oxford; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Yu and the Kessler labs are both funded by the Medical Research Council (http://www.mrc.ac.uk/index.htm). EA was funded by an MRC PhD studentship. VY was supported by a Wellcome Trust fellowship. BMK is supported by the Biomedical Research Centre (NIHR), Oxford, United Kingdom. The Mascot server is supported by the Computational Biology Research Group (CBRG) at the University of Oxford. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bairwa NK, 2011, J BIOL CHEM, V286, P2445, DOI 10.1074/jbc.M110.189456; Batycka M, 2006, RAPID COMMUN MASS SP, V20, P2074, DOI 10.1002/rcm.2563; Blake D, 2006, GENETICS, V174, P1709, DOI 10.1534/genetics.106.057836; Bryant GO, 2008, PLOS BIOL, V6, P2928, DOI 10.1371/journal.pbio.0060317; Campsteijn C, 2007, PLOS GENET, V3, P947, DOI 10.1371/journal.pgen.0030092; Floer M, 2010, CELL, V141, P407, DOI 10.1016/j.cell.2010.03.048; Ginsburg DS, 2009, MOL CELL BIOL, V29, P6473, DOI 10.1128/MCB.01033-09; HEINTZ N, 1991, BIOCHIM BIOPHYS ACTA, V1088, P327, DOI 10.1016/0167-4781(91)90122-3; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Jiang CZ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r109; Kabani M, 2005, BIOCHEM BIOPH RES CO, V332, P398, DOI 10.1016/j.bbrc.2005.04.158; Katayama S, 2002, MOL BIOL CELL, V13, P211, DOI 10.1091/mbc.01-07-0333; Kent NA, 2007, J BIOL CHEM, V282, P27693, DOI 10.1074/jbc.M704707200; Keogh Michael-Christopher, 2004, Methods Mol Biol, V257, P1, DOI 10.1385/1-59259-750-5:001; Kile AC, 2010, MOL CELL BIOL, V30, P160, DOI 10.1128/MCB.00612-09; Koepp DM, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-8; Koepp DM, 2006, MOL BIOL CELL, V17, P1540, DOI 10.1091/mbc.E05-09-0884; Lehmann A, 2004, GENES CELLS, V9, P367, DOI 10.1111/j.1356-9597.2004.00730.x; Li SS, 2002, J BIOL CHEM, V277, P44651, DOI 10.1074/jbc.M206623200; Liang B, 2007, CURR BIOL, V17, P1432, DOI 10.1016/j.cub.2007.07.035; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lorch Y, 2010, P NATL ACAD SCI USA, V107, P3458, DOI 10.1073/pnas.1000398107; Mimura S, 2009, EMBO J, V28, P3693, DOI 10.1038/emboj.2009.320; Morohashi H, 2009, CURR BIOL, V19, P1943, DOI 10.1016/j.cub.2009.09.062; Ng HH, 2002, GENE DEV, V16, P806, DOI 10.1101/gad.978902; OSLEY MA, 1991, ANNU REV BIOCHEM, V60, P827, DOI 10.1146/annurev.biochem.60.1.827; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Parnell TJ, 2008, EMBO J, V27, P100, DOI 10.1038/sj.emboj.7601946; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; RAINBOW M, 1989, BIOCHEMISTRY-US, V28, P7486, DOI 10.1021/bi00444a048; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Rose MD., 1990, METHODS YEAST GENETI; SMITH MM, 1983, J MOL BIOL, V169, P641, DOI 10.1016/S0022-2836(83)80163-6; Swaminathan S, 2007, MOL CELL BIOL, V27, P4674, DOI 10.1128/MCB.02052-06; Takayama Y, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-18; Takayama Y, 2010, DEV CELL, V18, P385, DOI 10.1016/j.devcel.2009.12.024; van Attikum H, 2005, CELL CYCLE, V4, P1011, DOI 10.4161/cc.4.8.1887; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wilson B, 2006, GENETICS, V172, P795, DOI 10.1534/genetics.105.047589; Wong MCVL, 2002, MOL CELL BIOL, V22, P4218, DOI 10.1128/MCB.22.12.4218-4229.2002; Xu DM, 2008, MOL CELL PROTEOMICS, V7, P2215, DOI 10.1074/mcp.M800095-MCP200	42	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e21172	10.1371/journal.pone.0021172	http://dx.doi.org/10.1371/journal.pone.0021172			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	21701592	Green Published, Green Submitted, gold			2022-12-27	WOS:000291983800027
J	Garcia-Gamez, E; Reverter, A; Whan, V; McWilliam, SM; Arranz, JJ; Kijas, J				Garcia-Gamez, Elsa; Reverter, Antonio; Whan, Vicki; McWilliam, Sean M.; Jose Arranz, Juan; Kijas, James		Int Sheep Genomics Consortium	Using Regulatory and Epistatic Networks to Extend the Findings of a Genome Scan: Identifying the Gene Drivers of Pigmentation in Merino Sheep	PLOS ONE			English	Article							ASSOCIATION; EXPRESSION; BIOLOGY; ENVIRONMENT; MUTATIONS; PROFILES; WHITE; SKIN; CD9	Extending genome wide association analysis by the inclusion of gene expression data may assist in the dissection of complex traits. We examined piebald, a pigmentation phenotype in both human and Merino sheep, by analysing multiple data types using a systems approach. First, a case control analysis of 49,034 ovine SNP was performed which confirmed a multigenic basis for the condition. We combined these results with gene expression data from five tissue types analysed with a skin-specific microarray. Promoter sequence analysis of differentially expressed genes allowed us to reverse-engineer a regulatory network. Likewise, by testing two-loci models derived from all pair-wise comparisons across piebald-associated SNP, we generated an epistatic network. At the intersection of both networks, we identified thirteen genes with insulin-like growth factor binding protein 7 (IGFBP7), platelet-derived growth factor alpha (PDGFRA) and the tetraspanin platelet activator CD9 at the kernel of the intersection. Further, we report a number of differentially expressed genes in regions containing highly associated SNP including ATRN, DOCK7, FGFR1OP, GLI3, SILV and TBX15. The application of network theory facilitated co-analysis of genetic variation with gene expression, recapitulated aspects of the known molecular biology of skin pigmentation and provided insights into the transcription regulation and epistatic interactions involved in piebald Merino sheep.	[Garcia-Gamez, Elsa; Reverter, Antonio; Whan, Vicki; McWilliam, Sean M.; Kijas, James] CSIRO, Livestock Ind, Brisbane, Qld, Australia; [Garcia-Gamez, Elsa; Jose Arranz, Juan] Univ Leon, Dept Anim Prod, E-24071 Leon, Spain	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Universidad de Leon	Garcia-Gamez, E (corresponding author), CSIRO, Livestock Ind, Brisbane, Qld, Australia.	James.Kijas@csiro.au	McWilliam, Sean M/H-8978-2013; Kijas, James W/A-4656-2011; Reverter, Antonio/C-9699-2013; Simianer, Henner/A-6574-2015; Arranz, Juan-Jose/H-1225-2015; Garcia-Gamez, Elsa/D-9158-2011	McWilliam, Sean M/0000-0002-3148-0428; Kijas, James W/0000-0002-1417-8278; Reverter, Antonio/0000-0002-4681-9404; Simianer, Henner/0000-0002-7551-3797; Arranz, Juan-Jose/0000-0001-9058-131X; , International Journal of Business and Applied Social Science/0000-0001-7850-0193	Spanish Ministry of Science [AGL2009-07000]; Spanish Ministry of Education [AP2008-01410]	Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministry of Education(Spanish Government)	JJA and EGG were supported by the Spanish Ministry of Science (Project AGL2009-07000), EGG was funded by the Spanish Ministry of Education (AP2008-01410, FPU programme). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archibald AL, 2010, ANIM GENET, V41, P449, DOI 10.1111/j.1365-2052.2010.02100.x; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Baudoux B, 2000, EUR J CELL BIOL, V79, P41, DOI 10.1078/S0171-9335(04)70006-0; Becker D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008689; Blasius AL, 2009, P NATL ACAD SCI USA, V106, P2706, DOI 10.1073/pnas.0813208106; Bondanza S, 2007, J INVEST DERMATOL, V127, P676, DOI 10.1038/sj.jid.5700639; BOYD AW, 2001, SCI STKE, pRE20; Boyko AR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000451; BROOKER MG, 1969, AUST J AGR RES, V20, P523, DOI 10.1071/AR9690523; Buske FA, 2010, BIOINFORMATICS, V26, P860, DOI 10.1093/bioinformatics/btq049; Candille SI, 2004, PLOS BIOL, V2, P30, DOI 10.1371/journal.pbio.0020003; Caraux G, 2005, BIOINFORMATICS, V21, P1280, DOI 10.1093/bioinformatics/bti141; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Charlier C, 2008, NAT GENET, V40, P449, DOI 10.1038/ng.96; Charrin S, 2001, J BIOL CHEM, V276, P14329, DOI 10.1074/jbc.M011297200; Diez D, 2010, MOL BIOSYST, V6, P289, DOI 10.1039/b912078e; Fitch KR, 2003, GENE DEV, V17, P214, DOI 10.1101/gad.1023703; FLEISCHMAN RA, 1991, P NATL ACAD SCI USA, V88, P10885, DOI 10.1073/pnas.88.23.10885; Flori L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006595; Fortes MRS, 2010, P NATL ACAD SCI USA, V107, P13642, DOI 10.1073/pnas.1002044107; Gunn TM, 1999, NATURE, V398, P152, DOI 10.1038/18217; Hayes BJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001139; He L, 2001, NAT GENET, V27, P40, DOI 10.1038/83741; Hecker M, 2009, BIOSYSTEMS, V96, P86, DOI 10.1016/j.biosystems.2008.12.004; Hochberg M, 2007, BRIT J DERMATOL, V156, P289, DOI 10.1111/j.1365-2133.2006.07628.x; *INT FED PIGM CELL, INT FED PIGM CELL SO; Karlsson EK, 2007, NAT GENET, V39, P1321, DOI 10.1038/ng.2007.10; Lan CCE, 2006, J INVEST DERMATOL, V126, P2119, DOI 10.1038/sj.jid.5700372; LANZA F, 1991, J BIOL CHEM, V266, P10638; Li JJ, 2009, ONCOGENE, V28, P1759, DOI 10.1038/onc.2009.15; Matera I, 2008, HUM MOL GENET, V17, P2118, DOI 10.1093/hmg/ddn110; Norris BJ, 2008, GENOME RES, V18, P1282, DOI 10.1101/gr.072090.107; Parker HG, 2010, ANNU REV GENET, V44, P309, DOI 10.1146/annurev-genet-102808-115200; Peidis P, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-14; Penas PF, 2000, J INVEST DERMATOL, V114, P1126, DOI 10.1046/j.1523-1747.2000.00998.x; Reverter A, 2005, BIOINFORMATICS, V21, P1112, DOI 10.1093/bioinformatics/bti124; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Scurr LL, 2010, CELL, V141, P717, DOI 10.1016/j.cell.2010.04.021; Seo KS, 2007, VET DERMATOL, V18, P392, DOI 10.1111/j.1365-3164.2007.00634.x; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Smith WJM, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-27; Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032; Wu CS, 2006, ACTA DERM-VENEREOL, V86, P498, DOI 10.2340/00015555-0161; Xu SX, 2010, ACTA DERM-VENEREOL, V90, P131, DOI 10.2340/00015555-0820; Yang G, 2008, MOL CELL, V32, P554, DOI 10.1016/j.molcel.2008.11.002; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608	46	27	28	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e21158	10.1371/journal.pone.0021158	http://dx.doi.org/10.1371/journal.pone.0021158			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	21701676	gold, Green Submitted, Green Published			2022-12-27	WOS:000291983800026
J	Hau, PM; Tsang, CM; Yip, YL; Huen, MSY; Tsao, SW				Hau, Pok Man; Tsang, Chi Man; Yip, Yim Ling; Huen, Michael S. Y.; Tsao, Sai Wah			Id1 Interacts and Stabilizes the Epstein-Barr Virus Latent Membrane Protein 1 (LMP1) in Nasopharyngeal Epithelial Cells	PLOS ONE			English	Article							NF-KAPPA-B; LINES HNE-1; EXPRESSION; GROWTH; MEMBRANE-PROTEIN-1; LOOP; ESTABLISHMENT; CARCINOMA; ACTIVATION; PATHWAYS	The EBV-encoded latent membrane protein 1 (LMP1) functions as a constitutive active form of tumor necrosis factor receptor (TNFR) and activates multiple downstream signaling pathways similar to CD40 signaling in a ligand-independent manner. LMP1 expression in EBV-infected cells has been postulated to play an important role in pathogenesis of nasopharyngeal carcinoma. However, variable levels of LMP1 expression were detected in nasopharyngeal carcinoma. At present, the regulation of LMP1 levels in nasopharyngeal carcinoma is poorly understood. Here we show that LMP1 mRNAs are transcribed in an EBV-positive nasopharyngeal carcinoma (NPC) cell line (C666-1) and other EBV-negative nasopharyngeal carcinoma cells stably re-infected with EBV. The protein levels of LMP1 could readily be detected after incubation with proteasome inhibitor, MG132 suggesting that LMP1 protein is rapidly degraded via proteasome-mediated proteolysis. Interestingly, we observed that Id1 overexpression could stabilize LMP1 protein in EBV-infected cells. In contrary, Id1 knockdown significantly reduced LMP1 levels in cells. Co-immunoprecipitation studies revealed that Id1 interacts with LMP1 by binding to the CTAR1 domain of LMP1. N-terminal region of Id1 is required for the interaction with LMP1. Furthermore, binding of Id1 to LMP1 suppressed polyubiquitination of LMP1 and may be involved in stabilization of LMP1 in EBV-infected nasopharyngeal epithelial cells.	[Hau, Pok Man; Tsang, Chi Man; Yip, Yim Ling; Tsao, Sai Wah] Univ Hong Kong, Dept Anat, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China; [Huen, Michael S. Y.] Univ Hong Kong, Dept Anat, Genome Stabil Res Lab, Hong Kong, Hong Kong, Peoples R China; [Huen, Michael S. Y.] Univ Hong Kong, Ctr Canc Res, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong	Hau, PM (corresponding author), Univ Hong Kong, Dept Anat, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China.	gswtsao@hkucc.hku.hk			Hong Kong General Research Fund [HKU 7770/07M]; AoE NPC [AoE/M-06/08]; University of Hong Kong; CRCG [200807176131]	Hong Kong General Research Fund; AoE NPC; University of Hong Kong(University of Hong Kong); CRCG	This work was supported by the Hong Kong General Research Fund, grant number HKU 7770/07M; the AoE NPC, grant number AoE/M-06/08; The University of Hong Kong CRCG Grant; and the CRCG Grant, grant number: 200807176131. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand G, 1997, J BIOL CHEM, V272, P19140, DOI 10.1074/jbc.272.31.19140; Aviel S, 2000, J BIOL CHEM, V275, P23491, DOI 10.1074/jbc.M002052200; BARRANCO SC, 1983, CANCER RES, V43, P1703; BENEZRA R, 1990, ANN NY ACAD SCI, V599, P1, DOI 10.1111/j.1749-6632.1990.tb42359.x; BROOKS L, 1992, J VIROL, V66, P2689, DOI 10.1128/JVI.66.5.2689-2697.1992; Chen HL, 2003, J VIROL, V77, P4139, DOI 10.1128/JVI.77.7.4139-4148.2003; Cheung ST, 1999, INT J CANCER, V83, P121, DOI 10.1002/(SICI)1097-0215(19990924)83:1<121::AID-IJC21>3.0.CO;2-F; Demetriades C, 2009, J VIROL, V83, P5269, DOI 10.1128/JVI.00097-09; EPSTEIN MA, 1964, LANCET, V1, P702, DOI 10.1016/s0140-6736(64)91524-7; Everly DN, 2008, VIROLOGY, V376, P258, DOI 10.1016/j.virol.2007.12.003; Everly DN, 2004, J VIROL, V78, P13470, DOI 10.1128/JVI.78.24.13470-13478.2004; GLASER R, 1989, P NATL ACAD SCI USA, V86, P9524, DOI 10.1073/pnas.86.23.9524; Goormachtigh G, 2006, J VIROL, V80, P7382, DOI 10.1128/JVI.02052-05; Hasskarl J, 2008, ONCOGENE, V27, P1657, DOI 10.1038/sj.onc.1210808; Hicke L, 1997, FASEB J, V11, P1215, DOI 10.1096/fasebj.11.14.9409540; Hila L, 2009, PATHOL BIOL, V57, P427, DOI 10.1016/j.patbio.2008.07.029; HU LF, 1995, EUR J CANCER, V31A, P658, DOI 10.1016/0959-8049(94)00468-K; HUANG DP, 1980, INT J CANCER, V26, P127, DOI 10.1002/ijc.2910260202; Ikeda M, 2001, J VIROL, V75, P5711, DOI 10.1128/JVI.75.12.5711-5718.2001; Johansson P, 2010, J VIROL, V84, P2787, DOI 10.1128/JVI.01052-09; Johansson P, 2009, J VIROL, V83, P1393, DOI 10.1128/JVI.01637-08; Kim AH, 2009, CELL, V136, P322, DOI 10.1016/j.cell.2008.11.050; Kwok WK, 2009, CANCER GENET CYTOGEN, V194, P58, DOI 10.1016/j.cancergencyto.2009.06.005; Lam N, 2003, EMBO J, V22, P3027, DOI 10.1093/emboj/cdg284; Lasorella A, 2006, NATURE, V442, P471, DOI 10.1038/nature04895; Li HM, 2006, INT J CANCER, V119, P1567, DOI 10.1002/ijc.22032; Li HM, 2004, ONCOGENE, V23, P4488, DOI 10.1038/sj.onc.1207580; Lo AK, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-155; Lo AKF, 2007, P NATL ACAD SCI USA, V104, P16164, DOI 10.1073/pnas.0702896104; Lo AKF, 2006, NEOPLASIA, V8, P173, DOI 10.1593/neo.05625; Lui VWY, 2009, INT J CANCER, V125, P1884, DOI 10.1002/ijc.24567; Man C, 2008, MOL BIOL CELL, V19, P2389, DOI 10.1091/mbc.E07-09-0875; Manthey C, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-2; MISKIMINS WK, 1982, J CELL PHYSIOL, V112, P327, DOI 10.1002/jcp.1041120304; Panchanathan R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010868; Perk J, 2005, NAT REV CANCER, V5, P603, DOI 10.1038/nrc1673; Rocca A, 2008, CANCER CHEMOTH PHARM, V61, P965, DOI 10.1007/s00280-007-0551-3; Rothenberger S, 2003, ONCOGENE, V22, P5614, DOI 10.1038/sj.onc.1206497; Rothenberger S, 2002, CELL MOL LIFE SCI, V59, P171, DOI 10.1007/s00018-002-8413-y; Soni V, 2007, ADV EXP MED BIOL, V597, P173; TAKADA K, 1991, VIRUS GENES, V5, P147, DOI 10.1007/BF00571929; Tang WG, 2003, J BIOL CHEM, V278, P48942, DOI 10.1074/jbc.M307962200; Tsang CM, 2010, INT J CANCER, V127, P1570, DOI 10.1002/ijc.25173; TSANG CM, 2010, INT J CANC; YAO K, 1990, INT J CANCER, V45, P83, DOI 10.1002/ijc.2910450116; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; ZHANG SH, 1983, INT J CANCER, V31, P587, DOI 10.1002/ijc.2910310509	47	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e21176	10.1371/journal.pone.0021176	http://dx.doi.org/10.1371/journal.pone.0021176			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	21701587	Green Submitted, Green Published, gold			2022-12-27	WOS:000291983800028
J	Reales, E; Sharma, N; Low, SH; Folsch, H; Weimbs, T				Reales, Elena; Sharma, Nikunj; Low, Seng Hui; Foelsch, Heike; Weimbs, Thomas			Basolateral Sorting of Syntaxin 4 Is Dependent on Its N-terminal Domain and the AP1B Clathrin Adaptor, and Required for the Epithelial Cell Polarity	PLOS ONE			English	Article							MEMBRANE-FUSION; PLASMA-MEMBRANE; SEC1/MUNC18 PROTEINS; MDCK CELLS; TRAFFICKING; SNARE; LOCALIZATION; COMPLEX; MORPHOGENESIS; ACTIVATION	Generation of epithelial cell polarity requires mechanisms to sort plasma membrane proteins to the apical and basolateral domains. Sorting involves incorporation into specific vesicular carriers and subsequent fusion to the correct target membranes mediated by specific SNARE proteins. In polarized epithelial cells, the SNARE protein syntaxin 4 localizes exclusively to the basolateral plasma membrane and plays an important role in basolateral trafficking pathways. However, the mechanism of basolateral targeting of syntaxin 4 itself has remained poorly understood. Here we show that newly synthesized syntaxin 4 is directly targeted to the basolateral plasma membrane in polarized Madin-Darby canine kidney (MDCK) cells. Basolateral targeting depends on a signal that is centered around residues 24-29 in the N-terminal domain of syntaxin 4. Furthermore, basolateral targeting of syntaxin 4 is dependent on the epithelial cell-specific clathrin adaptor AP1B. Disruption of the basolateral targeting signal of syntaxin 4 leads to non-polarized delivery to both the apical and basolateral surface, as well as partial intercellular retention in the trans-Golgi network. Importantly, disruption of the basolateral targeting signal of syntaxin 4 leads to the inability of MDCK cells to establish a polarized morphology which suggests that restriction of syntaxin 4 to the basolateral domain is required for epithelial cell polarity.	[Reales, Elena; Sharma, Nikunj; Low, Seng Hui; Weimbs, Thomas] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Reales, Elena; Sharma, Nikunj; Low, Seng Hui; Weimbs, Thomas] Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA; [Foelsch, Heike] Northwestern Univ, Dept Cell & Mol Biol, Chicago, IL 60611 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Northwestern University	Reales, E (corresponding author), Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA.	weimbs@lifesci.ucsb.edu		Folsch, Heike/0000-0003-0897-0311; REALES RODRIGUEZ, ELENA/0000-0001-6082-3306; Weimbs, Thomas/0000-0001-9423-5561	National Institutes of Health (NIH) [R01GM66785, GM070736]; American Heart Association; Spanish Ministry of Education and Science; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070736, R01GM066785] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Spanish Ministry of Education and Science(Spanish Government); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the National Institutes of Health (NIH) to TW (R01GM66785), a pre-doctoral fellowship from the American Heart Association to NS and a postdoctoral fellowship from the Spanish Ministry of Education and Science to ER. HF was supported by a grant from the NIH (GM070736). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borner GHH, 2007, TRAFFIC, V8, P893, DOI 10.1111/j.1600-0854.2007.00576.x; BOSSHART H, 1994, J CELL BIOL, V126, P1157, DOI 10.1083/jcb.126.5.1157; Doray B, 2007, MOL BIOL CELL, V18, P1887, DOI 10.1091/mbc.E07-01-0012; Fields IC, 2007, J CELL BIOL, V177, P477, DOI 10.1083/jcb.200610047; Folsch H, 1999, CELL, V99, P189, DOI 10.1016/S0092-8674(00)81650-5; Folsch H, 2005, TRENDS CELL BIOL, V15, P222, DOI 10.1016/j.tcb.2005.02.006; Folsch H, 2001, J CELL BIOL, V152, P595, DOI 10.1083/jcb.152.3.595; Folsch H, 2009, TRAFFIC, V10, P972, DOI 10.1111/j.1600-0854.2009.00927.x; Gravotta D, 2007, P NATL ACAD SCI USA, V104, P1564, DOI 10.1073/pnas.0610700104; Hu SH, 2007, P NATL ACAD SCI USA, V104, P8773, DOI 10.1073/pnas.0701124104; Jahn R, 2004, ANN NY ACAD SCI, V1014, P170, DOI 10.1196/annals.1294.018; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Kreitzer G, 2003, NAT CELL BIOL, V5, P126, DOI 10.1038/ncb917; Latham CF, 2007, ACTA CRYSTALLOGR F, V63, P524, DOI 10.1107/S1744309107022361; Latham CF, 2006, TRAFFIC, V7, P1408, DOI 10.1111/j.1600-0854.2006.00474.x; Li X, 2002, AM J PHYSIOL-RENAL, V283, pF1111, DOI 10.1152/ajprenal.00185.2002; Low SH, 1998, J CELL BIOL, V141, P1503, DOI 10.1083/jcb.141.7.1503; Low SH, 1996, MOL BIOL CELL, V7, P2007, DOI 10.1091/mbc.7.12.2007; Low SH, 2006, MOL BIOL CELL, V17, P977, DOI 10.1091/mbc.E05-05-0462; Low SH, 1998, J BIOL CHEM, V273, P3422, DOI 10.1074/jbc.273.6.3422; Martin-Belmonte F, 2008, CURR BIOL, V18, P507, DOI 10.1016/j.cub.2008.02.076; Mellman I, 2008, NAT REV MOL CELL BIO, V9, P833, DOI 10.1038/nrm2525; MOLLOY SS, 1994, EMBO J, V13, P18, DOI 10.1002/j.1460-2075.1994.tb06231.x; Mostov K, 2003, NAT CELL BIOL, V5, P287, DOI 10.1038/ncb0403-287; O'Brien LE, 2002, NAT REV MOL CELL BIO, V3, P531, DOI 10.1038/nrm859; Ohno H, 1999, FEBS LETT, V449, P215, DOI 10.1016/S0014-5793(99)00432-9; Ohno H, 2006, J CELL SCI, V119, P3719, DOI 10.1242/jcs.03085; Rizo J, 2002, NAT REV NEUROSCI, V3, P641, DOI 10.1038/nrn898; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Rodriguez-Boulan E, 2005, NAT REV MOL CELL BIO, V6, P233, DOI 10.1038/nrm1593; RODRIGUEZBOULAN E, 1989, SCIENCE, V245, P718, DOI 10.1126/science.2672330; Rowe J, 1999, J CELL SCI, V112, P1865; Sharma N, 2006, J CELL BIOL, V173, P937, DOI 10.1083/jcb.200603132; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Tellam JT, 1997, J BIOL CHEM, V272, P6179, DOI 10.1074/jbc.272.10.6179; ter Beest MBA, 2005, MOL BIOL CELL, V16, P5784, DOI 10.1091/mbc.E05-070-0661; Torres J, 2011, J BIOL CHEM, V286, P10834, DOI 10.1074/jbc.M110.186668; Weimbs T, 1997, P NATL ACAD SCI USA, V94, P3046, DOI 10.1073/pnas.94.7.3046; Zilly FE, 2006, PLOS BIOL, V4, P1789, DOI 10.1371/journal.pbio.0040330	40	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e21181	10.1371/journal.pone.0021181	http://dx.doi.org/10.1371/journal.pone.0021181			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698262	Green Published, Green Submitted, gold			2022-12-27	WOS:000291730000058
J	Sharma, K; Tripathi, S; Ranjan, P; Kumar, P; Garten, R; Deyde, V; Katz, JM; Cox, NJ; Lal, RB; Sambhara, S; Lal, SK				Sharma, Kulbhushan; Tripathi, Shashank; Ranjan, Priya; Kumar, Purnima; Garten, Rebecca; Deyde, Varough; Katz, Jacqueline M.; Cox, Nancy J.; Lal, Renu B.; Sambhara, Suryaprakash; Lal, Sunil K.			Influenza A Virus Nucleoprotein Exploits Hsp40 to Inhibit PKR Activation	PLOS ONE			English	Article							PROTEIN-KINASE PKR; KAPPA-B KINASE; NS1 PROTEIN; NUCLEAR EXPORT; RNA; INTERACTS; TRANSLATION; P58(IPK); PHOSPHORYLATION; INTERFERENCE	Background: Double-stranded RNA dependent protein kinase (PKR) is a key regulator of the anti-viral innate immune response in mammalian cells. PKR activity is regulated by a 58 kilo Dalton cellular inhibitor (P58(IPK)), which is present in inactive state as a complex with Hsp40 under normal conditions. In case of influenza A virus (IAV) infection, P58(IPK) is known to dissociate from Hsp40 and inhibit PKR activation. However the influenza virus component responsible for PKR inhibition through P58(IPK) activation was hitherto unknown. Principal Findings: Human heat shock 40 protein (Hsp40) was identified as an interacting partner of Influenza A virus nucleoprotein (IAV NP) using a yeast two-hybrid screen. This interaction was confirmed by co-immunoprecipitation studies from mammalian cells transfected with IAV NP expressing plasmid. Further, the IAV NP-Hsp40 interaction was validated in mammalian cells infected with various seasonal and pandemic strains of influenza viruses. Cellular localization studies showed that NP and Hsp40 co-localize primarily in the nucleus. During IAV infection in mammalian cells, expression of NP coincided with the dissociation of P58(IPK) from Hsp40 and decrease PKR phosphorylation. We observed that, plasmid based expression of NP in mammalian cells leads to decrease in PKR phosphorylation. Furthermore, inhibition of NP expression during influenza virus replication led to PKR activation and concomitant increase in eIF2 alpha phosphorylation. Inhibition of NP expression also led to reduced IRF3 phosphorylation, enhanced IFN beta production and concomitant reduction of virus replication. Taken together our data suggest that NP is the viral factor responsible for P58(IPK) activation and subsequent inhibition of PKR-mediated host response during IAV infection. Significance: Our findings demonstrate a novel role of IAV NP in inhibiting PKR-mediated anti-viral host response and help us understand P58(IPK) mediated inhibition of PKR activity during IAV infection.	[Sharma, Kulbhushan; Tripathi, Shashank; Kumar, Purnima; Lal, Sunil K.] Int Ctr Genet Engn & Biotechnol, Virol Grp, New Delhi, India; [Ranjan, Priya; Garten, Rebecca; Deyde, Varough; Katz, Jacqueline M.; Cox, Nancy J.; Lal, Renu B.; Sambhara, Suryaprakash] Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Centers for Disease Control & Prevention - USA	Sharma, K (corresponding author), Int Ctr Genet Engn & Biotechnol, Virol Grp, New Delhi, India.	sunillal@icgeb.res.in	SHARMA, KULBHUSHAN/AAD-7713-2019; Sambhara, Suryaprakash/AAC-4428-2021	SHARMA, KULBHUSHAN/0000-0001-5226-4209; Tripp, Ralph/0000-0002-2924-9956; Tripathi, Shashank/0000-0002-5702-9248	ICGEB (International Centre for Genetic Engineering Biotechnology); Department of Biotechnology, Government of India; Centre for Disease Control (CDC), Atlanta	ICGEB (International Centre for Genetic Engineering Biotechnology); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Centre for Disease Control (CDC), Atlanta(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported by internal funds from ICGEB (International Centre for Genetic Engineering & Biotechnology), a grant from the Department of Biotechnology, Government of India and a training grant from the Centre for Disease Control (CDC), Atlanta. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], FIELDS VIROLOGY; Bergmann M, 2000, J VIROL, V74, P6203, DOI 10.1128/JVI.74.13.6203-6206.2000; Biswas SK, 1998, J VIROL, V72, P5493, DOI 10.1128/JVI.72.7.5493-5501.1998; Bonnet MC, 2000, MOL CELL BIOL, V20, P4532, DOI 10.1128/MCB.20.13.4532-4542.2000; Cheetham ME, 1998, CELL STRESS CHAPERON, V3, P28, DOI 10.1379/1466-1268(1998)003<0028:SFAEOD>2.3.CO;2; Cheng XG, 2008, J VIROL, V82, P1229, DOI 10.1128/JVI.00540-07; Connor JH, 2005, J BIOL CHEM, V280, P13512, DOI 10.1074/jbc.M501156200; Das K, 2010, NAT STRUCT MOL BIOL, V17, P530, DOI 10.1038/nsmb.1779; Elton D, 2001, J VIROL, V75, P408, DOI 10.1128/JVI.75.1.408-419.2001; Gabriel G, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040011; Gale M, 1998, PHARMACOL THERAPEUT, V78, P29, DOI 10.1016/S0163-7258(97)00165-4; Garcia MA, 2007, BIOCHIMIE, V89, P799, DOI 10.1016/j.biochi.2007.03.001; Ge Q, 2003, P NATL ACAD SCI USA, V100, P2718, DOI 10.1073/pnas.0437841100; Goodman AG, 2007, J VIROL, V81, P2221, DOI 10.1128/JVI.02151-06; Goodman AG, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000438; Guan ZH, 2010, PROTEIN CELL, V1, P944, DOI 10.1007/s13238-010-0115-x; Guo Z, 2007, AM J RESP CELL MOL, V36, P263, DOI 10.1165/rcmb.2006-0283RC; HATTORI H, 1993, J CELL SCI, V104, P629; Haye K, 2009, J VIROL, V83, P6849, DOI 10.1128/JVI.02323-08; Hirayama E, 2004, J VIROL, V78, P1263, DOI 10.1128/JVI.78.3.1263-1270.2004; Joly AL, 2010, J INNATE IMMUN, V2, P238, DOI 10.1159/000296508; KATZE MG, 1988, J VIROL, V62, P3710, DOI 10.1128/JVI.62.10.3710-3717.1988; Kumar M, 2005, J BIOL CHEM, V280, P40041, DOI 10.1074/jbc.M508904200; Lamb R.A., 2001, FIELDS VIROLOGY, P1487; Langland JO, 2006, VIRUS RES, V119, P100, DOI 10.1016/j.virusres.2005.10.014; Lee T G, 1994, Prog Mol Subcell Biol, V14, P48; Li JZ, 2009, PROTEIN PEPTIDE LETT, V16, P606, DOI 10.2174/092986609788490159; LU Y, 1995, VIROLOGY, V214, P222, DOI 10.1006/viro.1995.9937; Melville MW, 1997, P NATL ACAD SCI USA, V94, P97, DOI 10.1073/pnas.94.1.97; MEURS E, 1990, CELL, V62, P379, DOI 10.1016/0092-8674(90)90374-N; MEURS EF, 1992, J VIROL, V66, P5805, DOI 10.1128/JVI.66.10.5805-5814.1992; Momose F, 2001, J VIROL, V75, P1899, DOI 10.1128/JVI.75.4.1899-1908.2001; Naito T, 2007, J VIROL, V81, P1339, DOI 10.1128/JVI.01917-06; Ng AKL, 2009, SCI CHINA SER C, V52, P439, DOI 10.1007/s11427-009-0064-x; Ohtsuka K, 2000, INT J HYPERTHER, V16, P231, DOI 10.1080/026567300285259; Polyak SJ, 1996, J BIOL CHEM, V271, P1702, DOI 10.1074/jbc.271.3.1702; Portela A, 2002, J GEN VIROL, V83, P723, DOI 10.1099/0022-1317-83-4-723; Qiu XB, 2006, CELL MOL LIFE SCI, V63, P2560, DOI 10.1007/s00018-006-6192-6; Ranjan P, 2009, TRENDS MOL MED, V15, P359, DOI 10.1016/j.molmed.2009.06.003; Ratra R, 2008, BIOCHEMISTRY-US, V47, P1957, DOI 10.1021/bi7016552; Sambhara S, 2010, ANNU REV MED, V61, P187, DOI 10.1146/annurev.med.050908.132031; Servant MJ, 2002, BIOCHEM PHARMACOL, V64, P985, DOI 10.1016/S0006-2952(02)01165-6; Silva AM, 2004, J BIOL CHEM, V279, P37670, DOI 10.1074/jbc.M406554200; Smith EJ, 2001, J BIOL CHEM, V276, P8951, DOI 10.1074/jbc.M008717200; Sohn SY, 2006, BIOCHEM BIOPH RES CO, V347, P764, DOI 10.1016/j.bbrc.2006.06.158; Surjit M, 2004, BIOCHEM BIOPH RES CO, V317, P1030, DOI 10.1016/j.bbrc.2004.03.154; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tan SL, 1998, MOL CELL BIOL, V18, P2431, DOI 10.1128/MCB.18.5.2431; Wang P, 2009, J VIROL, V83, P7850, DOI 10.1128/JVI.00735-09; Wang XY, 2000, J VIROL, V74, P11566, DOI 10.1128/JVI.74.24.11566-11573.2000; Watanabe T, 2010, CELL HOST MICROBE, V7, P427, DOI 10.1016/j.chom.2010.05.008; Weber F, 2004, VIRAL IMMUNOL, V17, P498, DOI 10.1089/vim.2004.17.498; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Ye QZ, 2006, NATURE, V444, P1078, DOI 10.1038/nature05379	54	57	62	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e20215	10.1371/journal.pone.0020215	http://dx.doi.org/10.1371/journal.pone.0020215			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698289	gold, Green Published, Green Submitted			2022-12-27	WOS:000291730000009
J	Zhuang, XJ; Hou, XJ; Liao, SY; Wang, XX; Cooke, HJ; Zhang, M; Han, CS				Zhuang, Xin-jie; Hou, Xiao-jun; Liao, Shang-Ying; Wang, Xiu-Xia; Cooke, Howard J.; Zhang, Ming; Han, Chunsheng			SLXL1, a Novel Acrosomal Protein, Interacts with DKKL1 and Is Involved in Fertilization in Mice	PLOS ONE			English	Article							GENE FAMILY XLR; MOUSE SPERMATOZOA; ZONA-PELLUCIDA; EXPRESSION; COMPLEX; SPERM; SYNAPSIS; SCP3; TRANSCRIPTS; DELETIONS	Background: Spermatogenesis is a complex cellular developmental process which involves diverse families of genes. The Xlr (X-linked, lymphocyte regulated) family includes multiple members, only a few of which have reported functions in meiosis, post-meiotic maturation, and fertilization of germ cells. Slx-like1 (Slxl1) is a member of the Xlr family, whose expression and function in spermatogenesis need to be elucidated. Methodology/Principal Findings: The mRNA and protein expression and localization of Slxl1 were investigated by RT-PCR, Western blotting and immunohistochemistry in different tissues and at different stages of spermatogenesis. The interacting partner of SLXL1 was examined by co-immunoprecipitation and co-localization. Assessment of the role of SLXL1 in capacitation, acrosome reaction, zona pellucida binding/penetration, and fertilization was carried out in vitro using blocking antisera. The results showed that Slxl1 mRNA and protein were specifically expressed in the testis. SLXL1 was exclusively located in the acrosome of post-meiotic germ cells and interacts with DKKL1 (Dickkopf-like1), which is an acrosome-associated protein and plays an important role in fertilization. The rates of zona pellucida binding/penetration and fertilization were significantly reduced by the anti-SLXL1 polyclonal antiserum. Conclusions/Significance: SLXL1 is the first identified member of the XLR family that is associated with acrosome and is involved in zona pellucid binding/penetration and subsequent fertilization. These results, together with previous studies, suggest that Xlr family members participate in diverse processes from meiosis to fertilization during spermatogenesis.	[Zhuang, Xin-jie; Zhang, Ming] Guangxi Univ, Anim Reprod Inst, State Key Lab Conservat & Utilizat Subtrop Agrobi, Nanning 530004, Guangxi, Peoples R China; [Zhuang, Xin-jie; Hou, Xiao-jun; Liao, Shang-Ying; Wang, Xiu-Xia; Han, Chunsheng] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China; [Cooke, Howard J.] Western Gen Hosp, Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland	Guangxi University; Chinese Academy of Sciences; Institute of Zoology, CAS; University of Edinburgh	Zhuang, XJ (corresponding author), Guangxi Univ, Anim Reprod Inst, State Key Lab Conservat & Utilizat Subtrop Agrobi, Nanning 530004, Guangxi, Peoples R China.	hancs@ioz.ac.cn			National Basic Research Program of China [2006CB944004]; National Natural Science Foundation of China [30871406]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Basic Research Program of China (2006CB944004) and the National Natural Science Foundation of China (30871406). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BABA T, 1989, J BIOL CHEM, V264, P11920; Barraud-Lange V, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-102; Bendahmane M, 2002, ARCH BIOCHEM BIOPHYS, V404, P38, DOI 10.1016/S0003-9861(02)00278-3; Bendahmane M, 2001, ARCH BIOCHEM BIOPHYS, V390, P1, DOI 10.1006/abbi.2001.2364; Benoff S, 1997, MOL HUM REPROD, V3, P599, DOI 10.1093/molehr/3.7.599; CALENDA A, 1994, EMBO J, V13, P100, DOI 10.1002/j.1460-2075.1994.tb06239.x; Cocquet J, 2010, MOL BIOL CELL, V21, P3497, DOI 10.1091/mbc.E10-07-0601; Cocquet J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000244; COHEN DI, 1985, NATURE, V314, P372, DOI 10.1038/314372a0; Dakhova O, 2009, ENDOCRINOLOGY, V150, P404, DOI 10.1210/en.2008-0673; Ellis PJI, 2005, HUM MOL GENET, V14, P2705, DOI 10.1093/hmg/ddi304; Escalier D, 1999, J IMMUNOL, V162, P292; Gob E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012072; Hu XQ, 2010, FERTIL STERIL, V93, P1482, DOI 10.1016/j.fertnstert.2009.01.067; Inoue N, 2005, NATURE, V434, P234, DOI 10.1038/nature03362; Jin M, 2011, P NATL ACAD SCI USA, V108, P4892, DOI 10.1073/pnas.1018202108; Kierszenbaum AL, 2004, ARCH HISTOL CYTOL, V67, P271, DOI 10.1679/aohc.67.271; Kohn MJ, 2010, FERTIL STERIL, V93, P1533, DOI 10.1016/j.fertnstert.2009.06.010; Kohn MJ, 2005, MOL REPROD DEV, V71, P516, DOI 10.1002/mrd.20314; Li YC, 2006, FEBS LETT, V580, P4266, DOI 10.1016/j.febslet.2006.06.010; Loeser CR, 1999, BIOL REPROD, V60, P94, DOI 10.1095/biolreprod60.1.94; Mahadevaiah SK, 2001, NAT GENET, V27, P271, DOI 10.1038/85830; Moreno RD, 2000, DEV BIOL, V219, P334, DOI 10.1006/dbio.2000.9606; Pelttari J, 2001, MOL CELL BIOL, V21, P5667, DOI 10.1128/MCB.21.16.5667-5677.2001; Primakoff P, 2002, SCIENCE, V296, P2183, DOI 10.1126/science.1072029; Reynard LN, 2007, BIOL REPROD, V77, P329, DOI 10.1095/biolreprod.107.061101; Reynard LN, 2009, BIOL REPROD, V81, P250, DOI 10.1095/biolreprod.108.075382; Scavetta RJ, 2010, MOL BIOL EVOL, V27, P1845, DOI 10.1093/molbev/msq064; Scherthan H, 1996, J CELL BIOL, V134, P1109, DOI 10.1083/jcb.134.5.1109; SIEGEL JN, 1987, J EXP MED, V166, P1702, DOI 10.1084/jem.166.6.1702; Toure A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r102; WILLIAMS RM, 1993, J EXP ZOOL, V266, P65, DOI 10.1002/jez.1402660110; Yuan L, 2002, SCIENCE, V296, P1115, DOI 10.1126/science.1070594; Yuan L, 1998, J CELL BIOL, V142, P331, DOI 10.1083/jcb.142.2.331; Yuan L, 2000, MOL CELL, V5, P73, DOI 10.1016/S1097-2765(00)80404-9	35	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e20866	10.1371/journal.pone.0020866	http://dx.doi.org/10.1371/journal.pone.0020866			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698294	Green Published, gold, Green Submitted			2022-12-27	WOS:000291730000028
J	Silady, RA; Effgen, S; Koornneef, M; Reymond, M				Silady, Rebecca A.; Effgen, Sigi; Koornneef, Maarten; Reymond, Matthieu			Variation in Seed Dormancy Quantitative Trait Loci in Arabidopsis thaliana Originating from One Site	PLOS ONE			English	Article							INBRED LINE POPULATIONS; FLOWERING-TIME; NATURAL VARIATION	A Quantitative Trait Locus (QTL) analysis was performed using two novel Recombinant Inbred Line (RIL) populations, derived from the progeny between two Arabidopsis thaliana genotypes collected at the same site in Kyoto (Japan) crossed with the reference laboratory strain Landsberg erecta (Ler). We used these two RIL populations to determine the genetic basis of seed dormancy and flowering time, which are assumed to be the main traits controlling life history variation in Arabidopsis. The analysis revealed quantitative variation for seed dormancy that is associated with allelic variation at the seed dormancy QTL DOG1 (for Delay Of Germination 1) in one population and at DOG6 in both. These DOG QTL have been previously identified using mapping populations derived from accessions collected at different sites around the world. Genetic variation within a population may enhance its ability to respond accurately to variation within and between seasons. In contrast, variation for flowering time, which also segregated within each mapping population, is mainly governed by the same QTL.	[Silady, Rebecca A.; Effgen, Sigi; Koornneef, Maarten; Reymond, Matthieu] Max Planck Inst Plant Breeding Res, Cologne, Germany; [Koornneef, Maarten] Wageningen Univ, Genet Lab, Wageningen, Netherlands	Max Planck Society; Wageningen University & Research	Silady, RA (corresponding author), So Connecticut State Univ, Dept Biol, New Haven, CT 06515 USA.	koornneef@mpipz.mpg.de		Koornneef, Maarten/0000-0002-7759-4869	Alexander von Humbolt fellowship; Max Planck Society	Alexander von Humbolt fellowship(Alexander von Humboldt Foundation); Max Planck Society(Max Planck Society)	Funding was provided by an Alexander von Humbolt fellowship to RS and by the Max Planck Society. The funders had no role in study design, data collection, decision to publish or preparation of the manuscript.	Alonso-Blanco C, 2003, GENETICS, V164, P711; Alonso-Blanco C, 2009, PLANT CELL, V21, P1877, DOI 10.1105/tpc.109.068114; Bentsink L, 2006, P NATL ACAD SCI USA, V103, P17042, DOI 10.1073/pnas.0607877103; Bentsink L, 2010, P NATL ACAD SCI USA, V107, P4264, DOI 10.1073/pnas.1000410107; Caicedo AL, 2009, MOL BIOL EVOL, V26, P699, DOI 10.1093/molbev/msn300; Donohue K, 2005, EVOLUTION, V59, P740, DOI 10.1111/j.0014-3820.2005.tb01752.x; El-Lithy ME, 2006, GENETICS, V172, P1867, DOI 10.1534/genetics.105.050617; El-Lithy ME, 2004, PLANT PHYSIOL, V135, P444, DOI 10.1104/pp.103.036822; Huang XQ, 2010, MOL ECOL, V19, P1335, DOI 10.1111/j.1365-294X.2010.04557.x; O'Neill CM, 2008, THEOR APPL GENET, V116, P623, DOI 10.1007/s00122-007-0696-9; Pico FX, 2008, GENETICS, V180, P1009, DOI 10.1534/genetics.108.089581; Platt A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000843; Shindo C, 2005, PLANT PHYSIOL, V138, P1163, DOI 10.1104/pp.105.061309; Simon M, 2008, GENETICS, V178, P2253, DOI 10.1534/genetics.107.083899; Warthmann N, 2007, BIOINFORMATICS, V23, P2784, DOI 10.1093/bioinformatics/btm428; Wilczek AM, 2009, SCIENCE, V323, P930, DOI 10.1126/science.1165826	16	13	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e20886	10.1371/journal.pone.0020886	http://dx.doi.org/10.1371/journal.pone.0020886			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738591	Green Published, Green Submitted, gold			2022-12-27	WOS:000292291800005
J	Du, SX; Xu, L; Zhang, WG; Tang, S; Boenig, RI; Chen, H; Mariano, EB; Zwick, MB; Parren, PWHI; Burton, DR; Wrin, T; Petropoulos, CJ; Ballantyne, JA; Chambers, M; Whalen, RG				Du, Sean X.; Xu, Li; Zhang, Wenge; Tang, Susan; Boenig, Rebecca I.; Chen, Helen; Mariano, Ellaine B.; Zwick, Michael B.; Parren, Paul W. H. I.; Burton, Dennis R.; Wrin, Terri; Petropoulos, Christos J.; Ballantyne, John A.; Chambers, Michael; Whalen, Robert G.			A Directed Molecular Evolution Approach to Improved Immunogenicity of the HIV-1 Envelope Glycoprotein	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; NEUTRALIZING ANTIBODY-RESPONSES; HUMAN MONOCLONAL-ANTIBODIES; CD4 BINDING-SITE; SUBTYPE-B; GP120; VACCINE; PROTEIN; COMPLEX; MACAQUES	A prophylactic vaccine is needed to slow the spread of HIV-1 infection. Optimization of the wild-type envelope glycoproteins to create immunogens that can elicit effective neutralizing antibodies is a high priority. Starting with ten genes encoding subtype B HIV-1 gp120 envelope glycoproteins and using in vitro homologous DNA recombination, we created chimeric gp120 variants that were screened for their ability to bind neutralizing monoclonal antibodies. Hundreds of variants were identified with novel antigenic phenotypes that exhibit considerable sequence diversity. Immunization of rabbits with these gp120 variants demonstrated that the majority can induce neutralizing antibodies to HIV-1. One novel variant, called ST-008, induced significantly improved neutralizing antibody responses when assayed against a large panel of primary HIV-1 isolates. Further study of various deletion constructs of ST-008 showed that the enhanced immunogenicity results from a combination of effective DNA priming, an enhanced V3-based response, and an improved response to the constant backbone sequences.	[Du, Sean X.; Xu, Li; Zhang, Wenge; Tang, Susan; Boenig, Rebecca I.; Chen, Helen; Mariano, Ellaine B.; Whalen, Robert G.] Maxygen Inc, Dept Infect Dis, Redwood City, CA USA; [Zwick, Michael B.; Parren, Paul W. H. I.; Burton, Dennis R.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Burton, Dennis R.] Scripps Res Inst, IAVI Neutralizing Antibody Ctr, La Jolla, CA 92037 USA; [Burton, Dennis R.] Ragon Inst Massachusetts Gen Hosp, MIT, Boston, MA USA; [Burton, Dennis R.] Harvard, Boston, MA USA; [Wrin, Terri; Petropoulos, Christos J.] Monogram Biosci, San Francisco, CA USA; [Ballantyne, John A.; Chambers, Michael] Aldevron LLC, Fargo, ND USA	Scripps Research Institute; International AIDS Vaccine Initiative; Scripps Research Institute; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute	Du, SX (corresponding author), Simcere Pharmaceut Grp, Nanjing, Peoples R China.	robert.whalen@altravax.com		Parren, Paul/0000-0002-4365-3859	NIH [P01 AI56375]; DOD [W9113M-05-C-0198]; Double Bottom Line Ventures; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI056375, R01AI033292] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense); Double Bottom Line Ventures; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the NIH (P01 AI56375), DOD (contract W9113M-05-C-0198), and Double Bottom Line Ventures. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apt D, 2006, VACCINE, V24, P335, DOI 10.1016/j.vaccine.2005.07.100; Baba TW, 2000, NAT MED, V6, P200, DOI 10.1038/72309; Bacher JM, 2002, GENOME BIOL, V3; BARBAS CF, 1993, J MOL BIOL, V230, P812, DOI 10.1006/jmbi.1993.1203; Barnet SW, 2001, J VIROL, V75, P5526, DOI 10.1128/JVI.75.12.5526-5540.2001; Beddows S, 2005, J VIROL, V79, P8812, DOI 10.1128/JVI.79.14.8812-8827.2005; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Binley JM, 2008, J VIROL, V82, P11651, DOI 10.1128/JVI.01762-08; Binley JM, 2000, J VIROL, V74, P627, DOI 10.1128/JVI.74.2.627-643.2000; Bojang K, 2009, HUM VACCINES, V5, P242, DOI 10.4161/hv.5.4.7050; Brideau-Andersen AD, 2007, P NATL ACAD SCI USA, V104, P8269, DOI 10.1073/pnas.0609001104; Carotenuto P, 1998, AIDS, V12, P1591, DOI 10.1097/00002030-199813000-00005; Castle LA, 2004, SCIENCE, V304, P1151, DOI 10.1126/science.1096770; Crameri A, 1998, NATURE, V391, P288, DOI 10.1038/34663; Crooks ET, 2007, VIROLOGY, V366, P245, DOI 10.1016/j.virol.2007.04.033; Derby NR, 2006, J VIROL, V80, P8745, DOI 10.1128/JVI.00956-06; Dey B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000445; Doria-Rose NA, 2005, J VIROL, V79, P11214, DOI 10.1128/JVI.79.17.11214-11224.2005; Du SX, 2008, PROTEIN EXPRES PURIF, V59, P223, DOI 10.1016/j.pep.2008.02.002; Du SX, 2009, VIROLOGY, V395, P33, DOI 10.1016/j.virol.2009.07.042; Dupuy LC, 2009, VACCINE, V27, P4152, DOI 10.1016/j.vaccine.2009.04.049; Frost SDW, 2005, P NATL ACAD SCI USA, V102, P18514, DOI 10.1073/pnas.0504658102; Frost SDW, 2005, J VIROL, V79, P6523, DOI 10.1128/JVI.79.10.6523-6527.2005; Grundner C, 2004, VIROLOGY, V330, P233, DOI 10.1016/j.virol.2004.08.037; Haas J, 1996, CURR BIOL, V6, P315, DOI 10.1016/S0960-9822(02)00482-7; Hammonds J, 2005, J VIROL, V79, P14804, DOI 10.1128/JVI.79.23.14804-14814.2005; Haynes BF, 2006, EXPERT REV VACCINES, V5, P578; Hedestam GBK, 2008, NAT REV MICROBIOL, V6, P143, DOI 10.1038/nrmicro1819; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Hofmann-Lehmann R, 2001, J VIROL, V75, P7470, DOI 10.1128/JVI.75.16.7470-7480.2001; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; Kang Y, 2009, VACCINE, V27, P5120, DOI 10.1016/j.vaccine.2009.06.037; Kothe DL, 2007, VIROLOGY, V360, P218, DOI 10.1016/j.virol.2006.10.017; Kothe DL, 2006, VIROLOGY, V352, P438, DOI 10.1016/j.virol.2006.05.011; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Kunert R, 2004, AIDS RES HUM RETROV, V20, P755, DOI 10.1089/0889222041524571; Kurtzman AL, 2001, CURR OPIN BIOTECH, V12, P361, DOI 10.1016/S0958-1669(00)00228-7; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Kwong PD, 2009, NAT IMMUNOL, V10, P573, DOI 10.1038/ni.1746; Lazetic S, 2002, J BIOL CHEM, V277, P38660, DOI 10.1074/jbc.M205808200; Leong SR, 2003, P NATL ACAD SCI USA, V100, P1163, DOI 10.1073/pnas.0237327100; Li Y, 2008, J VIROL, V82, P638, DOI 10.1128/JVI.01691-07; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; Liao HX, 2006, VIROLOGY, V353, P268, DOI 10.1016/j.virol.2006.04.043; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Mascola JR, 2003, CURR MOL MED, V3, P209, DOI 10.2174/1566524033479799; Minshull J, 2004, METHODS, V32, P416, DOI 10.1016/j.ymeth.2003.10.004; Morner A, 2009, J VIROL, V83, P540, DOI 10.1128/JVI.01102-08; Mooij P, 1998, AIDS, V12, pF15, DOI 10.1097/00002030-199805000-00002; Ness JE, 2002, NAT BIOTECHNOL, V20, P1251, DOI 10.1038/nbt754; Nishimura Y, 2002, J VIROL, V76, P2123, DOI 10.1128/jvi.76.5.2123-2130.2002; PANCERA M, 2010, J VIROL; Pantophlet R, 2004, PROTEIN ENG DES SEL, V17, P749, DOI 10.1093/protein/gzh085; Pantophlet R, 2003, J VIROL, V77, P642, DOI 10.1128/JVI.77.1.642-658.2003; Pantophlet R, 2003, J VIROL, V77, P5889, DOI 10.1128/JVI.77.10.5889-5901.2003; Pilgrim AK, 1997, J INFECT DIS, V176, P924, DOI 10.1086/516508; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; ROBEN P, 1994, J VIROL, V68, P4821, DOI 10.1128/JVI.68.8.4821-4828.1994; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Scanlan CN, 2002, J VIROL, V76, P7306, DOI 10.1128/JVI.76.14.7306-7321.2002; Selvarajah S, 2008, AIDS RES HUM RETROV, V24, P301, DOI 10.1089/aid.2007.0158; Shibata R, 1999, NAT MED, V5, P204, DOI 10.1038/5568; Srivastava IK, 2005, HUM VACCINES, V1, P45, DOI 10.4161/hv.1.2.1764; Stamatatos L, 2009, NAT MED, V15, P866, DOI 10.1038/nm.1949; STEMMER WPC, 1994, P NATL ACAD SCI USA, V91, P10747, DOI 10.1073/pnas.91.22.10747; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Walker BD, 2008, SCIENCE, V320, P760, DOI 10.1126/science.1152622; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wang S, 2008, VACCINE, V26, P1098, DOI 10.1016/j.vaccine.2007.12.024; Wang SX, 2006, VIROLOGY, V350, P34, DOI 10.1016/j.virol.2006.02.032; Weaver EA, 2006, J VIROL, V80, P6745, DOI 10.1128/JVI.02484-05; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; WU TT, 1993, PROTEINS, V16, P1, DOI 10.1002/prot.340160102; Wu XL, 2011, J VIROL, V85, P4578, DOI 10.1128/JVI.02585-10; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Xiao XD, 2009, BIOCHEM BIOPH RES CO, V390, P404, DOI 10.1016/j.bbrc.2009.09.029; Yang XZ, 2002, J VIROL, V76, P4634, DOI 10.1128/JVI.76.9.4634-4642.2002; Yang XZ, 2001, J VIROL, V75, P1165, DOI 10.1128/JVI.75.3.1165-1171.2001; Yang XZ, 2000, J VIROL, V74, P5716, DOI 10.1128/JVI.74.12.5716-5725.2000; Zanetti G, 2006, PLOS PATHOG, V2, DOI 10.1371/journal.ppat.0020083; Zhang PF, 2007, P NATL ACAD SCI USA, V104, P10193, DOI 10.1073/pnas.0608635104; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819; Zhu P, 2006, NATURE, V441, P847, DOI 10.1038/nature04817; 2003, EXPERT REV ANTI INFE, V1, P527	87	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e20927	10.1371/journal.pone.0020927	http://dx.doi.org/10.1371/journal.pone.0020927			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21738594	Green Published, Green Submitted, gold			2022-12-27	WOS:000292290100009
J	Yuan, Q; Isaacson, JS; Scanziani, M				Yuan, Qi; Isaacson, Jeffry S.; Scanziani, Massimo			Linking Neuronal Ensembles by Associative Synaptic Plasticity	PLOS ONE			English	Article							LONG-TERM POTENTIATION; PLACE CELLS; HIPPOCAMPUS; MEMORY; CORTEX; SYSTEM; CODE; CA1	Synchronized activity in ensembles of neurons recruited by excitatory afferents is thought to contribute to the coding information in the brain. However, the mechanisms by which neuronal ensembles are generated and modified are not known. Here we show that in rat hippocampal slices associative synaptic plasticity enables ensembles of neurons to change by incorporating neurons belonging to different ensembles. Associative synaptic plasticity redistributes the composition of different ensembles recruited by distinct inputs such as to specifically increase the similarity between the ensembles. These results show that in the hippocampus, the ensemble of neurons recruited by a given afferent projection is fluid and can be rapidly and persistently modified to specifically include neurons from different ensembles. This linking of ensembles may contribute to the formation of associative memories.	[Yuan, Qi; Scanziani, Massimo] Univ Calif San Diego, Dept Neurobiol, Ctr Neural Circuits & Behav, La Jolla, CA 92093 USA; [Yuan, Qi; Isaacson, Jeffry S.; Scanziani, Massimo] Univ Calif San Diego, Dept Neurosci, Ctr Neural Circuits & Behav, La Jolla, CA 92093 USA; [Scanziani, Massimo] Univ Calif San Diego, Howard Hughes Med Inst, Ctr Neural Circuits & Behav, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego	Yuan, Q (corresponding author), Univ Calif San Diego, Dept Neurobiol, Ctr Neural Circuits & Behav, La Jolla, CA 92093 USA.	massimo@ucsd.edu			NIDCD [R01 DC04682]; HHMI; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004682] Funding Source: NIH RePORTER	NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); HHMI(Howard Hughes Medical Institute); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by NIDCD R01 DC04682 (JSI) and HHMI (MS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apicella A, 2010, J NEUROSCI, V30, P14255, DOI 10.1523/JNEUROSCI.2747-10.2010; Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; BARRIONUEVO G, 1983, P NATL ACAD SCI-BIOL, V80, P7347, DOI 10.1073/pnas.80.23.7347; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Dan Y, 2006, PHYSIOL REV, V86, P1033, DOI 10.1152/physrev.00030.2005; Hebb Donald O., 1949, ORG BEHAV; Heynen AJ, 1996, NATURE, V381, P163, DOI 10.1038/381163a0; Ikegaya Y, 2004, SCIENCE, V304, P559, DOI 10.1126/science.1093173; Leutgeb S, 2005, CURR OPIN NEUROBIOL, V15, P738, DOI 10.1016/j.conb.2005.10.002; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Usrey WM, 1999, ANNU REV PHYSIOL, V61, P435, DOI 10.1146/annurev.physiol.61.1.435; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520	16	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e20486	10.1371/journal.pone.0020486	http://dx.doi.org/10.1371/journal.pone.0020486			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21738576	Green Published, gold			2022-12-27	WOS:000292290100003
J	Kaveh, DA; Bachy, VS; Hewinson, RG; Hogarth, PJ				Kaveh, Daryan A.; Bachy, Veronique S.; Hewinson, R. Glyn; Hogarth, Philip J.			Systemic BCG Immunization Induces Persistent Lung Mucosal Multifunctional CD4 T-EM Cells which Expand Following Virulent Mycobacterial Challenge	PLOS ONE			English	Article							TUBERCULOSIS INFECTION; BOVIS BCG; IFN-GAMMA; PROTECTIVE IMMUNITY; INTERFERON-GAMMA; IN-VIVO; MEMORY; MICE; RESPONSES; VACCINE	To more closely understand the mechanisms of how BCG vaccination confers immunity would help to rationally design improved tuberculosis vaccines that are urgently required. Given the established central role of CD4 T cells in BCG induced immunity, we sought to characterise the generation of memory CD4 T cell responses to BCG vaccination and M. bovis infection in a murine challenge model. We demonstrate that a single systemic BCG vaccination induces distinct systemic and mucosal populations of T effector memory (T-EM) cells in vaccinated mice. These CD4(+)CD44(hi)CD62L(lo)CD27(-) T cells concomitantly produce IFN-gamma and TNF-alpha, or IFN-gamma, IL-2 and TNF-alpha and have a higher cytokine median fluorescence intensity MFI or 'quality of response' than single cytokine producing cells. These cells are maintained for long periods (> 16 months) in BCG protected mice, maintaining a vaccine-specific functionality. Following virulent mycobacterial challenge, these cells underwent significant expansion in the lungs and are, therefore, strongly associated with protection against M. bovis challenge. Our data demonstrate that a persistent mucosal population of T-EM cells can be induced by parenteral immunization, a feature only previously associated with mucosal immunization routes; and that these multifunctional T-EM cells are strongly associated with protection. We propose that these cells mediate protective immunity, and that vaccines designed to increase the number of relevant antigen-specific T-EM in the lung may represent a new generation of TB vaccines.	[Kaveh, Daryan A.; Bachy, Veronique S.; Hewinson, R. Glyn; Hogarth, Philip J.] AHVLA, TB Res Grp, Surrey, England		Kaveh, DA (corresponding author), AHVLA, TB Res Grp, Surrey, England.	philip.hogarth@ahvla.gsi.gov.uk	Hogarth, Philip/C-6085-2011; Hewinson, Glyn/J-1902-2014; Hewinson, Glyn/F-7077-2010; Hewinson, Glyn/AAA-2364-2019	Hogarth, Philip/0000-0002-6343-7846; Kaveh, Daryan/0000-0002-1451-0082; Hewinson, Glyn/0000-0002-5517-4281	Department for Environment, Food and Rural Affairs, United Kingdom	Department for Environment, Food and Rural Affairs, United Kingdom(Department for Environment, Food & Rural Affairs (DEFRA))	This work was supported by the Department for Environment, Food and Rural Affairs, United Kingdom (www.defra.gov.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard C, 2011, NAT MED, V17, P189, DOI 10.1038/nm.2285; Abel B, 2010, AM J RESP CRIT CARE, V181, P1407, DOI 10.1164/rccm.200910-1484OC; Aldwell FE, 2006, VACCINE, V24, P2071, DOI 10.1016/j.vaccine.2005.11.017; Ashford DA, 2001, REV SCI TECH OIE, V20, P325, DOI 10.20506/rst.20.1.1266; Beamer GL, 2008, CLIN VACCINE IMMUNOL, V15, P474, DOI 10.1128/CVI.00408-07; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Beveridge NER, 2007, EUR J IMMUNOL, V37, P3089, DOI 10.1002/eji.200737504; BLOOM BR, 1994, TUBERCULOSIS PATHOGE; Caccamo N, 2010, EUR J IMMUNOL, V40, P2211, DOI 10.1002/eji.201040455; Chen LH, 2004, INFECT IMMUN, V72, P238, DOI 10.1128/IAI.72.1.238-246.2004; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; DEJONG R, 1992, EUR J IMMUNOL, V22, P993, DOI 10.1002/eji.1830220418; Elias D, 2005, T ROY SOC TROP MED H, V99, P363, DOI 10.1016/j.trstmh.2004.08.006; Forbes EK, 2008, J IMMUNOL, V181, P4955, DOI 10.4049/jimmunol.181.7.4955; Fritsch RD, 2005, J IMMUNOL, V175, P6489, DOI 10.4049/jimmunol.175.10.6489; Fuller CL, 2003, INFECT IMMUN, V71, P7023, DOI 10.1128/IAI.71.12.7023-7034.2003; GALLAGHER J, 1977, J HYG-CAMBRIDGE, V79, P155, DOI 10.1017/S0022172400052943; Ghosh S, 2006, J IMMUNOL, V176, P4914, DOI 10.4049/jimmunol.176.8.4914; Goldsack L, 2007, TUBERCULOSIS, V87, P465, DOI 10.1016/j.tube.2007.07.001; Harari A, 2005, J IMMUNOL, V174, P1037, DOI 10.4049/jimmunol.174.2.1037; Henao-Tamayo MI, 2010, CLIN VACCINE IMMUNOL, V17, P618, DOI 10.1128/CVI.00368-09; Hervas-Stubbs S, 2006, INFECT IMMUN, V74, P3396, DOI 10.1128/IAI.02086-05; Hogarth PJ, 2006, J PHARM PHARMACOL, V58, P749, DOI 10.1211/jpp.58.6.0005; Kapina MA, 2007, J IMMUNOL, V178, P976, DOI 10.4049/jimmunol.178.2.976; Kohlmeier JE, 2009, ANNU REV IMMUNOL, V27, P61, DOI 10.1146/annurev.immunol.021908.132625; Kolibab K, 2010, CLIN VACCINE IMMUNOL, V17, P793, DOI 10.1128/CVI.00006-10; Leal IS, 2001, IMMUNOLOGY, V104, P157, DOI 10.1046/j.1365-2567.2001.01305.x; Lim J, 2009, CLIN VACCINE IMMUNOL, V16, P122, DOI 10.1128/CVI.00359-08; Lindenstrom T, 2009, J IMMUNOL, V182, P8047, DOI 10.4049/jimmunol.0801592; Logan KE, 2008, TUBERCULOSIS, V88, P437, DOI 10.1016/j.tube.2008.05.005; Logan KE, 2005, VACCINE, V23, P5526, DOI 10.1016/j.vaccine.2005.07.037; Lyadova IV, 2004, CLIN EXP IMMUNOL, V138, P21, DOI 10.1111/j.1365-2249.2004.02573.x; Magalhaes I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003790; Majlessi L, 2006, INFECT IMMUN, V74, P2128, DOI 10.1128/IAI.74.4.2128-2137.2006; McShane H, 2005, MICROBES INFECT, V7, P962, DOI 10.1016/j.micinf.2005.03.009; Mikhak Z, 2006, J IMMUNOL, V176, P4959, DOI 10.4049/jimmunol.176.8.4959; Mittrucker HW, 2007, P NATL ACAD SCI USA, V104, P12434, DOI 10.1073/pnas.0703510104; Mu JY, 2010, J GENE MED, V12, P693, DOI 10.1002/jgm.1487; Olsen AW, 2004, SCAND J IMMUNOL, V60, P273, DOI 10.1111/j.0300-9475.2004.01471.x; Orme IM, 2010, TUBERCULOSIS, V90, P329, DOI 10.1016/j.tube.2010.06.002; ORME IM, 1986, TUBERCLE, V67, P133, DOI 10.1016/0041-3879(86)90007-3; Pacheco KA, 1998, AM J RESP CELL MOL, V18, P286, DOI 10.1165/ajrcmb.18.2.2687; Pepper M, 2010, NAT IMMUNOL, V11, P83, DOI 10.1038/ni.1826; Sander CR, 2009, AM J RESP CRIT CARE, V179, P724, DOI 10.1164/rccm.200809-1486OC; Santosuosso M, 2005, J IMMUNOL, V174, P7986, DOI 10.4049/jimmunol.174.12.7986; Schiott A, 2004, IMMUNOLOGY, V113, P363, DOI 10.1111/j.1365-2567.2004.01974.x; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Skinner MA, 2003, IMMUNOLOGY, V108, P548, DOI 10.1046/j.1365-2567.2003.01589.x; Sutherland JS, 2009, EUR J IMMUNOL, V39, P723, DOI 10.1002/eji.200838693; Trunz BB, 2006, LANCET, V367, P1173, DOI 10.1016/S0140-6736(06)68507-3; Vordermeier HM, 2002, INFECT IMMUN, V70, P3026, DOI 10.1128/IAI.70.6.3026-3032.2002; WALRATH JR, 2010, AM J RESP CELL MOL B; Xu BH, 2003, J EXP MED, V197, P1255, DOI 10.1084/jem.20010685; Young JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011237	55	54	54	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21566	10.1371/journal.pone.0021566	http://dx.doi.org/10.1371/journal.pone.0021566			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21720558	Green Submitted, Green Published, gold			2022-12-27	WOS:000292036900054
J	Aymanns, S; Mauerer, S; van Zandbergen, G; Wolz, C; Spellerberg, B				Aymanns, Simone; Mauerer, Stefanie; van Zandbergen, Ger; Wolz, Christiane; Spellerberg, Barbara			High-Level Fluorescence Labeling of Gram-Positive Pathogens	PLOS ONE			English	Article							CAMP-FACTOR; STREPTOCOCCUS-AGALACTIAE; PROTEIN GFP; IN-VITRO; EXPRESSION; GENE; CELLS; PHAGOCYTOSIS; BACTERIA; GORDONII	Fluorescence labeling of bacterial pathogens has a broad range of interesting applications including the observation of living bacteria within host cells. We constructed a novel vector based on the E. coli streptococcal shuttle plasmid pAT28 that can propagate in numerous bacterial species from different genera. The plasmid harbors a promoterless copy of the green fluorescent variant gene egfp under the control of the CAMP-factor gene (cfb) promoter of Streptococcus agalactiae and was designated pBSU101. Upon transfer of the plasmid into streptococci, the bacteria show a distinct and easily detectable fluorescence using a standard fluorescence microscope and quantification by FACS-analysis demonstrated values that were 10-50 times increased over the respective controls. To assess the suitability of the construct for high efficiency fluorescence labeling in different gram-positive pathogens, numerous species were transformed. We successfully labeled Streptococcus pyogenes, Streptococcus agalactiae, Streptococcus dysgalactiae subsp. equisimilis, Enterococcus faecalis, Enterococcus faecium, Streptococcus mutans, Streptococcus anginosus and Staphylococcus aureus strains utilizing the EGFP reporter plasmid pBSU101. In all of these species the presence of the cfb promoter construct resulted in high-level EGFP expression that could be further increased by growing the streptococcal and enterococcal cultures under high oxygen conditions through continuous aeration.	[Aymanns, Simone; Mauerer, Stefanie; van Zandbergen, Ger; Spellerberg, Barbara] Univ Ulm, Inst Med Microbiol & Hyg, Ulm, Germany; [Wolz, Christiane] Univ Tubingen, Interfak Inst Mikrobiol & Infekt Med, Tubingen, Germany	Ulm University; Eberhard Karls University of Tubingen	Aymanns, S (corresponding author), Univ Ulm, Inst Med Microbiol & Hyg, Ulm, Germany.	barbara.spellerberg@uniklinik-ulm.de	Spellerberg, Barbara/D-3443-2011; van Zandbergen, Ger/M-1571-2013	Spellerberg, Barbara/0000-0001-7552-8764; Wolz, Christiane/0000-0003-3909-5281	University of Ulm	University of Ulm	University of Ulm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acebo P, 2000, MICROBIOL-UK, V146, P1267, DOI 10.1099/00221287-146-6-1267; Aspiras MB, 2000, APPL ENVIRON MICROB, V66, P4074, DOI 10.1128/AEM.66.9.4074-4083.2000; AUGUSTIN J, 1990, FEMS MICROBIOL LETT, V66, P203, DOI 10.1016/0378-1097(90)90283-V; BOKMAN SH, 1981, BIOCHEM BIOPH RES CO, V101, P1372, DOI 10.1016/0006-291X(81)91599-0; Busque P, 1998, VET MICROBIOL, V63, P229, DOI 10.1016/S0378-1135(98)00216-8; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; CODY CW, 1993, BIOCHEMISTRY-US, V32, P1212, DOI 10.1021/bi00056a003; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; CUBITT AB, 1995, TRENDS BIOCHEM SCI, V20, P448, DOI 10.1016/S0968-0004(00)89099-4; Eberhardt A, 2009, MOL MICROBIOL, V74, P395, DOI 10.1111/j.1365-2958.2009.06872.x; Fortineau N, 2000, RES MICROBIOL, V151, P353, DOI 10.1016/S0923-2508(00)00158-3; FRIESENEGGER A, 1991, FEMS MICROBIOL LETT, V79, P323, DOI 10.1016/0378-1097(91)90106-K; Gase K, 1999, INFECT IMMUN, V67, P4725, DOI 10.1128/IAI.67.9.4725-4731.1999; GLEICHTHEURER U, 2009, INFECT IMMUN; Hansen MC, 2001, MICROBIOL-SGM, V147, P1383, DOI 10.1099/00221287-147-5-1383; Hazelrigg T, 1998, DEV BIOL, V199, P245, DOI 10.1006/dbio.1998.8922; Johnson MJ, 2006, J BACTERIOL, V188, P7905, DOI 10.1128/JB.00997-06; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Lang SH, 2003, J BIOL CHEM, V278, P38167, DOI 10.1074/jbc.M303544200; Lun SC, 2004, J MICROBIOL METH, V56, P401, DOI 10.1016/j.mimet.2003.11.012; PODBIELSKI A, 1994, MED MICROBIOL IMMUN, V183, P239, DOI 10.1007/BF00198458; Pron B, 1998, INFECT IMMUN, V66, P747, DOI 10.1128/IAI.66.2.747-755.1998; RICCI ML, 1994, FEMS MICROBIOL LETT, V119, P47; Rolls MM, 1999, J CELL BIOL, V146, P29, DOI 10.1083/jcb.146.1.29; ROZDZINSKI E, 1995, METHOD ENZYMOL, V253, P3; Scott KP, 2000, FEMS MICROBIOL LETT, V182, P23, DOI 10.1111/j.1574-6968.2000.tb08867.x; Smith CB, 2002, ENVIRON POLLUT, V120, P517, DOI 10.1016/S0269-7491(02)00227-0; Spellerberg B, 2002, INFECT IMMUN, V70, P2434, DOI 10.1128/IAI.70.5.2434-2440.2002; TRIEUCUOT P, 1990, NUCLEIC ACIDS RES, V18, P4296, DOI 10.1093/nar/18.14.4296; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Valdivia RH, 1996, MOL MICROBIOL, V22, P367, DOI 10.1046/j.1365-2958.1996.00120.x; Valdivia RH, 1997, SCIENCE, V277, P2007, DOI 10.1126/science.277.5334.2007; Weingart CL, 1999, INFECT IMMUN, V67, P4264, DOI 10.1128/IAI.67.8.4264-4267.1999; Yang TT, 1996, GENE, V173, P19, DOI 10.1016/0378-1119(95)00781-4; Zimmer M, 2002, CHEM REV, V102, P759, DOI 10.1021/cr010142r	35	30	30	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e19822	10.1371/journal.pone.0019822	http://dx.doi.org/10.1371/journal.pone.0019822			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731607	Green Published, gold, Green Submitted			2022-12-27	WOS:000292033700004
J	Darcy, CJ; Davis, JS; Woodberry, T; McNeil, YR; Stephens, DP; Yeo, TW; Anstey, NM				Darcy, Christabelle J.; Davis, Joshua S.; Woodberry, Tonia; McNeil, Yvette R.; Stephens, Dianne P.; Yeo, Tsin W.; Anstey, Nicholas M.			An Observational Cohort Study of the Kynurenine to Tryptophan Ratio in Sepsis: Association with Impaired Immune and Microvascular Function	PLOS ONE			English	Article							INDOLEAMINE 2,3-DIOXYGENASE ACTIVITY; COLONY-STIMULATING FACTOR; DECREASES LYMPHOCYTE APOPTOSIS; VASCULAR ENDOTHELIAL FUNCTION; T-CELL PROLIFERATION; NITRIC-OXIDE; INTERFERON-GAMMA; IMPROVES SURVIVAL; DISEASE PROGRESSION; ORGAN DYSFUNCTION	Both endothelial and immune dysfunction contribute to the high mortality rate in human sepsis, but the underlying mechanisms are unclear. In response to infection, interferon-gamma activates indoleamine 2,3-dioxygenase (IDO) which metabolizes the essential amino acid tryptophan to the toxic metabolite kynurenine. IDO can be expressed in endothelial cells, hepatocytes and mononuclear leukocytes, all of which contribute to sepsis pathophysiology. Increased IDO activity (measured by the kynurenine to tryptophan [KT] ratio in plasma) causes T-cell apoptosis, vasodilation and nitric oxide synthase inhibition. We hypothesized that IDO activity in sepsis would be related to plasma interferon-gamma, interleukin-10, T cell lymphopenia and impairment of microvascular reactivity, a measure of endothelial nitric oxide bioavailability. In an observational cohort study of 80 sepsis patients (50 severe and 30 non-severe) and 40 hospital controls, we determined the relationship between IDO activity (plasma KT ratio) and selected plasma cytokines, sepsis severity, nitric oxide-dependent microvascular reactivity and lymphocyte subsets in sepsis. Plasma amino acids were measured by high performance liquid chromatography and microvascular reactivity by peripheral arterial tonometry. The plasma KT ratio was increased in sepsis (median 141 [IQR 64-235]) compared to controls (36 [28-52]); p<0.0001), and correlated with plasma interferon-gamma and interleukin-10, and inversely with total lymphocyte count, CD8+ and CD4+ T-lymphocytes, systolic blood pressure and microvascular reactivity. In response to treatment of severe sepsis, the median KT ratio decreased from 162 [IQR 100-286] on day 0 to 89 [65-139] by day 7; p = 0.0006) and this decrease in KT ratio correlated with a decrease in the Sequential Organ Failure Assessment score (p<0.0001). IDO-mediated tryptophan catabolism is associated with dysregulated immune responses and impaired microvascular reactivity in sepsis and may link these two fundamental processes in sepsis pathophysiology.	[Darcy, Christabelle J.; Davis, Joshua S.; Woodberry, Tonia; McNeil, Yvette R.; Yeo, Tsin W.; Anstey, Nicholas M.] Menzies Sch Hlth Res, Global Hlth Div, Darwin, NT, Australia; [Darcy, Christabelle J.; Davis, Joshua S.; Woodberry, Tonia; McNeil, Yvette R.; Yeo, Tsin W.; Anstey, Nicholas M.] Charles Darwin Univ, Darwin, NT 0909, Australia; [Davis, Joshua S.; Yeo, Tsin W.; Anstey, Nicholas M.] Royal Darwin Hosp, Div Med, Darwin, NT, Australia; [Stephens, Dianne P.] Royal Darwin Hosp, Intens Care Unit, Darwin, NT, Australia	Charles Darwin University; Menzies School of Health Research; Charles Darwin University	Darcy, CJ (corresponding author), Menzies Sch Hlth Res, Global Hlth Div, Darwin, NT, Australia.	Nicholas.anstey@menzies.edu.au	Yeo, Tsin Wen/F-9505-2015; Davis, Joshua/N-2288-2013	Davis, Joshua/0000-0001-9864-5699; Stephens, Dianne/0000-0002-3785-6828	National Health and Medical Research Council of Australia [290208, 496600]; Australian Postgraduate Award	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Award(Australian Government)	The study was funded by the National Health and Medical Research Council of Australia (Program Grants 290208, 496600; Practitioner Fellowship to NMA, Scholarship to JSD) and an Australian Postgraduate Award to CJD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird WC, 2003, BLOOD, V101, P3765, DOI 10.1182/blood-2002-06-1887; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; BARTH MC, 2009, J BIOL CHEM; Blanco J, 2008, CRIT CARE, V12, DOI 10.1186/cc7157; Boasso A, 2007, BLOOD, V109, P3351, DOI 10.1182/blood-2006-07-034785; Bommhardt U, 2004, J IMMUNOL, V172, P7583, DOI 10.4049/jimmunol.172.12.7583; Bonaccorso S, 1998, AGING-CLIN EXP RES, V10, P316, DOI 10.1007/BF03339794; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Bonetti PO, 2004, J AM COLL CARDIOL, V44, P2137, DOI 10.1016/j.jacc.2004.08.062; CARLIN JM, 1989, J LEUKOCYTE BIOL, V45, P29, DOI 10.1002/jlb.45.1.29; Celermajer DS, 2008, CIRCULATION, V117, P2428, DOI 10.1161/CIRCULATIONAHA.108.775155; Chiarugi A, 2003, J LEUKOCYTE BIOL, V73, P172, DOI 10.1189/jlb.0502220; Davis JS, 2009, CRIT CARE, V13, DOI 10.1186/cc8055; DAVIS JS, 2011, MED J AUST IN PRESS; Deanfield JE, 2007, CIRCULATION, V115, P1285, DOI 10.1161/CIRCULATIONAHA.106.652859; ELLINGER P, 1947, NATURE, V160, P675, DOI 10.1038/160675b0; Fallarino F, 2002, INT IMMUNOL, V14, P65, DOI 10.1093/intimm/14.1.65; Fallarino F, 2006, J IMMUNOL, V176, P6752, DOI 10.4049/jimmunol.176.11.6752; Fallarino I, 2002, CELL DEATH DIFFER, V9, P1069, DOI 10.1038/sj.cdd.4401073; Felmet KA, 2005, J IMMUNOL, V174, P3765, DOI 10.4049/jimmunol.174.6.3765; FERNSTROM JD, 1971, SCIENCE, V173, P149, DOI 10.1126/science.173.3992.149; Finfer S, 2004, INTENS CARE MED, V30, P589, DOI 10.1007/s00134-004-2157-0; Forouzandeh F, 2008, WOUND REPAIR REGEN, V16, P379, DOI 10.1111/j.1524-475X.2008.00377.x; Gibbons J.D., 2003, NONPARAMETRIC STAT I; Hotchkiss RS, 1999, CRIT CARE MED, V27, P1230, DOI 10.1097/00003246-199907000-00002; Hotchkiss RS, 2000, NAT IMMUNOL, V1, P496, DOI 10.1038/82741; Hotchkiss RS, 1999, P NATL ACAD SCI USA, V96, P14541, DOI 10.1073/pnas.96.25.14541; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Huang A, 2002, BRIT J CANCER, V86, P1691, DOI 10.1038/sj.bjc.6600336; Huengsberg M, 1998, CLIN CHEM, V44, P858; Hunsicker A, 1997, EUR J SURG, V163, P379; HUTTUNEN R, 2009, SHOCK; Ino K, 2008, CLIN CANCER RES, V14, P2310, DOI 10.1158/1078-0432.CCR-07-4144; Iwamoto N, 2009, LIVER INT, V29, P277, DOI 10.1111/j.1478-3231.2008.01748.x; Jung ID, 2009, J IMMUNOL, V182, P3146, DOI 10.4049/jimmunol.0803104; Kao CC, 2009, CLIN SCI, V117, P23, DOI 10.1042/CS20080444; Kudo Y, 2003, AM J OBSTET GYNECOL, V188, P719, DOI 10.1067/mob.2003.156; Kuvin JT, 2007, VASC MED, V12, P13, DOI 10.1177/1358863x06076227; Kuvin JT, 2003, AM HEART J, V146, P168, DOI 10.1016/S0002-8703(03)00094-2; Larrea E, 2007, J VIROL, V81, P3662, DOI 10.1128/JVI.02248-06; Le Tulzo Y, 2002, SHOCK, V18, P487, DOI 10.1097/00024382-200212000-00001; Lee GK, 2002, IMMUNOLOGY, V107, P452, DOI 10.1046/j.1365-2567.2002.01526.x; Lob S, 2009, NAT REV CANCER, V9, P445, DOI 10.1038/nrc2639; Luiking YC, 2009, AM J CLIN NUTR, V89, P142, DOI 10.3945/ajcn.2007.25765; MacKenzie CR, 1999, ADV EXP MED BIOL, V467, P533; MacKenzie CR, 1998, J INFECT DIS, V178, P875, DOI 10.1086/515347; MAES M, 1993, PSYCHIAT RES, V49, P151, DOI 10.1016/0165-1781(93)90102-M; Maneechotesuwan K, 2008, J ALLERGY CLIN IMMUN, V121, P43, DOI 10.1016/j.jaci.2007.10.011; Merino E, 2008, CURR OPIN MICROBIOL, V11, P78, DOI 10.1016/j.mib.2008.02.005; Mohib K, 2007, AM J PHYSIOL-RENAL, V293, pF801, DOI 10.1152/ajprenal.00044.2007; Munn DH, 2002, SCIENCE, V297, P1867, DOI 10.1126/science.1073514; Munn DH, 1999, J EXP MED, V189, P1363, DOI 10.1084/jem.189.9.1363; NELSON S, 1994, CLIN INFECT DIS, V18, pS197, DOI 10.1093/clinids/18.Supplement_2.S197; Nohria A, 2006, J APPL PHYSIOL, V101, P545, DOI 10.1152/japplphysiol.01285.2005; Odemuyiwa SO, 2004, J IMMUNOL, V173, P5909, DOI 10.4049/jimmunol.173.10.5909; Orabona C, 2008, P NATL ACAD SCI USA, V105, P20828, DOI 10.1073/pnas.0810278105; Pawlak D, 2003, J PHYSIOL PHARMACOL, V54, P175; Pawlak K, 2009, THROMB RES, V124, P452, DOI 10.1016/j.thromres.2009.04.011; Pellegrin K, 2005, SHOCK, V23, P209, DOI 10.1097/01.shk.000150773.16613.d3; Samelson-Jones BJ, 2006, BIOCHEMISTRY-US, V45, P8527, DOI 10.1021/bi060143j; Schefold JC, 2010, SCAND J INFECT DIS, V42, P164, DOI 10.3109/00365540903405768; Schefold JC, 2009, NEPHROL DIAL TRANSPL, V24, P1901, DOI 10.1093/ndt/gfn739; Schwulst SJ, 2008, SHOCK, V30, P127, DOI [10.1097/SHK.0b013e318162cf17, 10.1097/shk.0b013e318162cf17]; Sekkai D, 1997, ARCH BIOCHEM BIOPHYS, V340, P117, DOI 10.1006/abbi.1997.9913; Stephens DP, 2008, CRIT CARE MED, V36, P448, DOI 10.1097/01.CCM.0B013E318161E480; Suzuki Y, 2010, LUNG CANCER, V67, P361, DOI 10.1016/j.lungcan.2009.05.001; Tattevin P, 2010, J INFECT DIS, V201, P956, DOI 10.1086/650996; Torres MI, 2007, CLIN EXP IMMUNOL, V148, P419, DOI 10.1111/j.1365-2249.2007.03365.x; Ulloa L, 2002, P NATL ACAD SCI USA, V99, P12351, DOI 10.1073/pnas.192222999; van der Sluijs KF, 2006, J INFECT DIS, V193, P214, DOI 10.1086/498911; van Wissen M, 2002, J IMMUNOL, V169, P7039, DOI 10.4049/jimmunol.169.12.7039; vanWandelen C, 1997, J CHROMATOGR A, V763, P11, DOI 10.1016/S0021-9673(96)00891-6; Vaudo G, 2008, ATHEROSCLEROSIS, V197, P747, DOI 10.1016/j.atherosclerosis.2007.07.009; Villalpando S, 2006, AM J CLIN NUTR, V84, P197, DOI 10.1093/ajcn/84.1.197; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; Wang YT, 2010, NAT MED, V16, P279, DOI 10.1038/nm.2092; Widner B, 2000, IMMUNOBIOLOGY, V201, P621, DOI 10.1016/S0171-2985(00)80079-0; Yanagawa Y, 2009, IMMUNOLOGY, V127, P345, DOI 10.1111/j.1365-2567.2008.02986.x; YANOFSKY C, 1991, J BACTERIOL, V173, P6009, DOI 10.1128/jb.173.19.6009-6017.1991; YOSHIDA R, 1981, P NATL ACAD SCI-BIOL, V78, P129, DOI 10.1073/pnas.78.1.129; Zangerle R, 2002, CLIN IMMUNOL, V104, P242, DOI 10.1006/clim.2002.5231	81	58	69	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21185	10.1371/journal.pone.0021185	http://dx.doi.org/10.1371/journal.pone.0021185			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731667	Green Published, gold, Green Submitted			2022-12-27	WOS:000292033700044
J	Sun, Z; Liu, Z; Meng, J; Meng, J; Duan, JH; Xie, SS; Lu, X; Zhu, ZH; Wang, C; Chen, SC; Xu, HY; Yang, XD				Sun, Zhao; Liu, Zhe; Meng, Jie; Meng, Jie; Duan, Jinhong; Xie, Sishen; Lu, Xin; Zhu, Zhaohui; Wang, Chen; Chen, Shuchang; Xu, Haiyan; Yang, Xian-Da			Carbon Nanotubes Enhance Cytotoxicity Mediated by Human Lymphocytes In Vitro	PLOS ONE			English	Article							NF-KAPPA-B; OXIDATIVE STRESS; PROTEIN ENHANCE; PLASMID DNA; DELIVERY; CELLS; TRANSPORTERS; TOXICITY; GENE; BIODISTRIBUTION	With the expansion of the potential applications of carbon nanotubes (CNT) in biomedical fields, the toxicity and biocompatibility of CNT have become issues of growing concern. Since the immune system often mediates tissue damage during pathogenesis, it is important to explore whether CNT can trigger cytotoxicity through affecting the immune functions. In the current study, we evaluated the influence of CNT on the cytotoxicity mediated by human lymphocytes in vitro. The results showed that while CNT at low concentrations (0.001 to 0.1 mu g/ml) did not cause obvious cell death or apoptosis directly, it enhanced lymphocyte-mediated cytotoxicity against multiple human cell lines. In addition, CNT increased the secretion of IFN-gamma and TNF-alpha by the lymphocytes. CNT also upregulated the NF-kappa B expression in lymphocytes, and the blockage of the NF-kappa B pathway reduced the lymphocyte-mediated cytotoxicity triggered by CNT. These results suggest that CNT at lower concentrations may prospectively initiate an indirect cytotoxicity through affecting the function of lymphocytes.	[Sun, Zhao; Lu, Xin; Zhu, Zhaohui; Chen, Shuchang] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China; [Sun, Zhao; Liu, Zhe; Meng, Jie; Duan, Jinhong; Lu, Xin; Zhu, Zhaohui; Chen, Shuchang; Xu, Haiyan; Yang, Xian-Da] Peking Union Med Coll, Beijing 100021, Peoples R China; [Liu, Zhe; Meng, Jie; Duan, Jinhong; Xu, Haiyan; Yang, Xian-Da] Chinese Acad Med Sci, Inst Basic Med Sci, Beijing 100730, Peoples R China; [Meng, Jie; Wang, Chen] Natl Ctr Nanosci & Technol, Beijing, Peoples R China; [Xie, Sishen] Chinese Acad Sci, Inst Phys, Beijing 100080, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Sciences; National Center for Nanoscience & Technology - China; Chinese Academy of Sciences; Institute of Physics, CAS	Sun, Z (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China.	xuhy@pumc.edu.cn; ayangmd@gmail.com	Liu, Zhe/GQH-5005-2022; Zhu, Zhaohui/CAA-1003-2022	Liu, Zhe/0000-0002-8604-2433; 	Ministry of Science and Technology of China [2011CB933504, 2011CB911003, 2011CB911004]; Natural Science Foundation of China [81071870]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by funds from the Ministry of Science and Technology of China (2011CB933504, 2011CB911003, 2011CB911004) and the Natural Science Foundation of China (81071870). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bianco A, 2005, CHEM COMMUN, P571, DOI 10.1039/b410943k; Bianco A, 2005, CURR OPIN CHEM BIOL, V9, P674, DOI 10.1016/j.cbpa.2005.10.005; Cai D, 2005, NAT METHODS, V2, P449, DOI 10.1038/NMETH761; Chou CC, 2008, NANO LETT, V8, P437, DOI 10.1021/nl0723634; CORY AH, 1991, CANCER COMMUN, V3, P207, DOI 10.3727/095535491820873191; Cui DX, 2005, TOXICOL LETT, V155, P73, DOI 10.1016/j.toxlet.2004.08.015; Davoren M, 2007, TOXICOL IN VITRO, V21, P438, DOI 10.1016/j.tiv.2006.10.007; Dumortier H, 2006, NANO LETT, V6, P1522, DOI 10.1021/nl061160x; Gao LZ, 2006, CHEMBIOCHEM, V7, P239, DOI 10.1002/cbic.200500227; Haas C, 2006, INT J CANCER, V118, P658, DOI 10.1002/ijc.21390; Heller DA, 2006, SCIENCE, V311, P508, DOI 10.1126/science.1120792; Kam NWS, 2004, J AM CHEM SOC, V126, P6850, DOI 10.1021/ja0486059; Kam NWS, 2006, ANGEW CHEM INT EDIT, V45, P577, DOI 10.1002/anie.200503389; Kam NWS, 2005, J AM CHEM SOC, V127, P6021, DOI 10.1021/ja050062v; Kam NWS, 2005, P NATL ACAD SCI USA, V102, P11600, DOI 10.1073/pnas.0502680102; Kostarelos K, 2007, NAT NANOTECHNOL, V2, P108, DOI 10.1038/nnano.2006.209; Li JG, 2009, J NANOSCI NANOTECHNO, V9, P1384, DOI 10.1166/jnn.2009.C162; Liu Y, 2005, ANGEW CHEM INT EDIT, V44, P4782, DOI 10.1002/anie.200500042; Liu Z, 2007, NAT NANOTECHNOL, V2, P47, DOI 10.1038/nnano.2006.170; Lu Q, 2004, NANO LETT, V4, P2473, DOI 10.1021/nl048326j; Mackay IR, 2008, J AUTOIMMUN, V30, P5, DOI 10.1016/j.jaut.2007.11.009; MAHOCK L, 2009, TOXICOL SCI; Manna SK, 2005, NANO LETT, V5, P1676, DOI 10.1021/nl0507966; Martin CR, 2003, NAT REV DRUG DISCOV, V2, P29, DOI 10.1038/nrd988; Meng J, 2008, SMALL, V4, P1364, DOI 10.1002/smll.200701059; Ni YC, 2005, J NANOSCI NANOTECHNO, V5, P1707, DOI 10.1166/jnn.2005.189; Pacurari M, 2008, ENVIRON HEALTH PERSP, V116, P1211, DOI 10.1289/ehp.10924; Pantarotto D, 2004, ANGEW CHEM INT EDIT, V43, P5242, DOI 10.1002/anie.200460437; Pantarotto D, 2004, CHEM COMMUN, P16, DOI 10.1039/b311254c; Raja PMV, 2007, TOXICOL LETT, V169, P51, DOI 10.1016/j.toxlet.2006.12.003; Schipper ML, 2008, NAT NANOTECHNOL, V3, P216, DOI 10.1038/nnano.2008.68; Singh R, 2005, J AM CHEM SOC, V127, P4388, DOI 10.1021/ja0441561; Singh R, 2006, P NATL ACAD SCI USA, V103, P3357, DOI 10.1073/pnas.0509009103; Sun YP, 2002, ACCOUNTS CHEM RES, V35, P1096, DOI 10.1021/ar010160v; Sun Z, 2010, CELL RES, V20, P1170, DOI 10.1038/cr.2010.133; Walker VG, 2009, TOXICOL APPL PHARM, V236, P319, DOI 10.1016/j.taap.2009.02.018; Williams KA, 2002, NATURE, V420, P761, DOI 10.1038/420761a; Wu W, 2005, ANGEW CHEM INT EDIT, V44, P6358, DOI 10.1002/anie.200501613; Yang ST, 2008, TOXICOL LETT, V181, P182, DOI 10.1016/j.toxlet.2008.07.020; Ye SF, 2009, BIOCHEM BIOPH RES CO, V379, P643, DOI 10.1016/j.bbrc.2008.12.137; Zanello LP, 2006, NANO LETT, V6, P562, DOI 10.1021/nl051861e	41	42	42	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21073	10.1371/journal.pone.0021073	http://dx.doi.org/10.1371/journal.pone.0021073			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731651	Green Submitted, Green Published, gold			2022-12-27	WOS:000292033700035
J	Takayanagi, Y; Takahashi, T; Orikabe, L; Mozue, Y; Kawasaki, Y; Nakamura, K; Sato, Y; Itokawa, M; Yamasue, H; Kasai, K; Kurachi, M; Okazaki, Y; Suzuki, M				Takayanagi, Yoichiro; Takahashi, Tsutomu; Orikabe, Lina; Mozue, Yuriko; Kawasaki, Yasuhiro; Nakamura, Kazue; Sato, Yoko; Itokawa, Masanari; Yamasue, Hidenori; Kasai, Kiyoto; Kurachi, Masayoshi; Okazaki, Yuji; Suzuki, Michio			Classification of First-Episode Schizophrenia Patients and Healthy Subjects by Automated MRI Measures of Regional Brain Volume and Cortical Thickness	PLOS ONE			English	Article							HUMAN CEREBRAL-CORTEX; 1ST EPISODE SCHIZOPHRENIA; MAGNETIC-RESONANCE IMAGES; VOXEL-BASED MORPHOMETRY; GRAY-MATTER; BIPOLAR DISORDER; SURFACE RECONSTRUCTION; GEOMETRICALLY ACCURATE; PATTERN-CLASSIFICATION; LIKELIHOOD ESTIMATION	Background: Although structural magnetic resonance imaging (MRI) studies have repeatedly demonstrated regional brain structural abnormalities in patients with schizophrenia, relatively few MRI-based studies have attempted to distinguish between patients with first-episode schizophrenia and healthy controls. Method: Three-dimensional MR images were acquired from 52 (29 males, 23 females) first-episode schizophrenia patients and 40 (22 males, 18 females) healthy subjects. Multiple brain measures (regional brain volume and cortical thickness) were calculated by a fully automated procedure and were used for group comparison and classification by linear discriminant function analysis. Results: Schizophrenia patients showed gray matter volume reductions and cortical thinning in various brain regions predominantly in prefrontal and temporal cortices compared with controls. The classifiers obtained from 66 subjects of the first group successfully assigned 26 subjects of the second group with accuracy above 80%. Conclusion: Our results showed that combinations of automated brain measures successfully differentiated first-episode schizophrenia patients from healthy controls. Such neuroimaging approaches may provide objective biological information adjunct to clinical diagnosis of early schizophrenia.	[Takayanagi, Yoichiro; Takahashi, Tsutomu; Kawasaki, Yasuhiro; Nakamura, Kazue; Kurachi, Masayoshi; Suzuki, Michio] Toyama Univ, Dept Neuropsychiat, Toyama 930, Japan; [Takayanagi, Yoichiro; Orikabe, Lina; Itokawa, Masanari; Okazaki, Yuji] Tokyo Metropolitan Matsuzawa Hosp, Dept Psychiat, Tokyo, Japan; [Orikabe, Lina; Yamasue, Hidenori; Kasai, Kiyoto] Univ Tokyo, Dept Neuropsychiat, Grad Sch Med, Tokyo, Japan; [Mozue, Yuriko] Tosa Hosp, Kochi, Japan; [Sato, Yoko] Tokyo Metropolitan Matsuzawa Hosp, Dept Radiol, Tokyo, Japan; [Takayanagi, Yoichiro; Itokawa, Masanari] Tokyo Inst Psychiat, Tokyo, Japan	University of Toyama; University of Tokyo; Tokyo Institute of Psychiatry	Takayanagi, Y (corresponding author), Toyama Univ, Dept Neuropsychiat, Toyama 930, Japan.	y-takayanagi@sky.707.to		Kasai, Kiyoto/0000-0002-4443-4535	Japanese Ministry of Health, Labour, and Welfare [21-001, 21-3]; Grants-in-Aid for Scientific Research [20591393] Funding Source: KAKEN	Japanese Ministry of Health, Labour, and Welfare(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Health and Labor Sciences Research Grant for Research on Psychiatric and Neurological Diseases and Mental Health (21-001) and a Research Grant for Nervous and Mental Disorders (21-3) from the Japanese Ministry of Health, Labour, and Welfare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Antonova E, 2004, SCHIZOPHR RES, V70, P117, DOI 10.1016/j.schres.2003.12.002; Binder JR, 2000, CEREB CORTEX, V10, P512, DOI 10.1093/cercor/10.5.512; Borgwardt SJ, 2008, SCHIZOPHR RES, V106, P108, DOI 10.1016/j.schres.2008.08.007; Buckner RL, 2004, NEUROIMAGE, V23, P724, DOI 10.1016/j.neuroimage.2004.06.018; Calhoun VD, 2008, HUM BRAIN MAPP, V29, P1265, DOI 10.1002/hbm.20463; Cosgrove KP, 2007, BIOL PSYCHIAT, V62, P847, DOI 10.1016/j.biopsych.2007.03.001; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Davatzikos C, 2005, ARCH GEN PSYCHIAT, V62, P1218, DOI 10.1001/archpsyc.62.11.1218; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Desikan RS, 2009, BRAIN, V132, P2048, DOI 10.1093/brain/awp123; Ellison-Wright I, 2008, AM J PSYCHIAT, V165, P1015, DOI 10.1176/appi.ajp.2008.07101562; Fan Y, 2007, IEEE T MED IMAGING, V26, P93, DOI 10.1109/TMI.2006.886812; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fleck DE, 2001, SCHIZOPHR RES, V52, P251, DOI 10.1016/S0920-9964(01)00170-0; Fornito A, 2009, SCHIZOPHR RES, V108, P104, DOI 10.1016/j.schres.2008.12.011; Glahn DC, 2008, BIOL PSYCHIAT, V64, P774, DOI 10.1016/j.biopsych.2008.03.031; Goldman AL, 2009, ARCH GEN PSYCHIAT, V66, P467, DOI 10.1001/archgenpsychiatry.2009.24; Goldstein JM, 2002, ARCH GEN PSYCHIAT, V59, P154, DOI 10.1001/archpsyc.59.2.154; Haahr U, 2008, PSYCHOPATHOLOGY, V41, P322, DOI 10.1159/000146070; Hollingshead A.B., 1975, 4 FACTOR INDEX SOCIA; Honea R, 2005, AM J PSYCHIAT, V162, P2233, DOI 10.1176/appi.ajp.162.12.2233; Kawasaki Y, 2007, NEUROIMAGE, V34, P235, DOI 10.1016/j.neuroimage.2006.08.018; Kim JJ, 2007, SCHIZOPHR RES, V97, P226, DOI 10.1016/j.schres.2007.09.007; Koutsouleris N, 2009, ARCH GEN PSYCHIAT, V66, P700, DOI 10.1001/archgenpsychiatry.2009.62; Krawczyk DC, 2002, NEUROSCI BIOBEHAV R, V26, P631, DOI 10.1016/S0149-7634(02)00021-0; Kuperberg GR, 2003, ARCH GEN PSYCHIAT, V60, P878, DOI 10.1001/archpsyc.60.9.878; Lieberman JA, 2005, ARCH GEN PSYCHIAT, V62, P361, DOI 10.1001/archpsyc.62.4.361; McCarley RW, 1999, BIOL PSYCHIAT, V45, P1099, DOI 10.1016/S0006-3223(99)00018-9; Molina V, 2005, SCHIZOPHR RES, V80, P61, DOI 10.1016/j.schres.2005.07.031; Nakamura K, 2004, SCHIZOPHRENIA BULL, V30, P393, DOI 10.1093/oxfordjournals.schbul.a007087; Narr KL, 2005, CEREB CORTEX, V15, P708, DOI 10.1093/cercor/bhh172; Nesvag R, 2008, SCHIZOPHR RES, V98, P16, DOI 10.1016/j.schres.2007.09.015; Onitsuka T, 2007, SCHIZOPHR RES, V92, P197, DOI 10.1016/j.schres.2007.01.027; OVERALL JE, 1962, PSYCHOL REP, V10, P799; Pantelis C, 2003, LANCET, V361, P281, DOI 10.1016/S0140-6736(03)12323-9; Pardo PJ, 2006, SCHIZOPHR RES, V87, P297, DOI 10.1016/j.schres.2006.05.007; Rimol LM, 2010, BIOL PSYCHIAT, V68, P41, DOI 10.1016/j.biopsych.2010.03.036; Rosas HD, 2002, NEUROLOGY, V58, P695, DOI 10.1212/WNL.58.5.695; Salat DH, 2004, CEREB CORTEX, V14, P721, DOI 10.1093/cercor/bhh032; Salvatore P, 2009, J CLIN PSYCHIAT, V70, P458, DOI 10.4088/JCP.08m04227; Schultz CC, 2010, SCHIZOPHR RES, V116, P204, DOI 10.1016/j.schres.2009.11.001; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Segonne F, 2007, IEEE T MED IMAGING, V26, P518, DOI 10.1109/TMI.2006.887364; Shenton ME, 2001, SCHIZOPHR RES, V49, P1, DOI 10.1016/S0920-9964(01)00163-3; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Sun DQ, 2009, BIOL PSYCHIAT, V66, P1055, DOI 10.1016/j.biopsych.2009.07.019; Takahashi T, 2002, SCHIZOPHR RES, V55, P69, DOI 10.1016/S0920-9964(01)00200-6; Takahashi T, 2009, ARCH GEN PSYCHIAT, V66, P366, DOI 10.1001/archgenpsychiatry.2009.12; Takayanagi Y, 2010, PROG NEURO-PSYCHOPH, V34, P10, DOI 10.1016/j.pnpbp.2009.09.004; Uetsuki M., 2007, SEISHIN IGAKU, V49, P17; van Haren NEM, 2007, NEUROPSYCHOPHARMACOL, V32, P2057, DOI 10.1038/sj.npp.1301347; Venkatasubramanian G, 2008, ACTA PSYCHIAT SCAND, V117, P420, DOI 10.1111/j.1600-0447.2008.01198.x; WHO, 2012, ICD 10 CLASS MENT BE; Wright IC, 2000, AM J PSYCHIAT, V157, P16, DOI 10.1176/ajp.157.1.16; Yoon U, 2007, NEUROIMAGE, V34, P1405, DOI 10.1016/j.neuroimage.2006.11.021	61	55	57	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2011	6	6							e21047	10.1371/journal.pone.0021047	http://dx.doi.org/10.1371/journal.pone.0021047			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782CL	21712987	Green Published, gold			2022-12-27	WOS:000291985100009
J	Kaufmann, A; Kenfak-Foguena, A; Andre, C; Canellini, G; Burgisser, P; Moradpour, D; Darling, KEA; Cavassini, M				Kaufmann, Annatina; Kenfak-Foguena, Alain; Andre, Cyril; Canellini, Giorgia; Buergisser, Philippe; Moradpour, Darius; Darling, Katharine E. A.; Cavassini, Matthias			Hepatitis E Virus Seroprevalence among Blood Donors in Southwest Switzerland	PLOS ONE			English	Article							IGG SEROPREVALENCE; UNITED-STATES; PREVALENCE; ANTIBODIES; ENGLAND; INFECTION	Aim: The aim of this study was to determine the seroprevalence of Hepatitis E virus (HEV) among blood donors in southwest Switzerland. Background: HEV is recognized as a food-borne disease in industrialized countries, transmitted mainly through pork meat. Cases of transmission through blood transfusion have also been reported. Recent studies have revealed seroprevalence rates of 13.5%, 16.6% and 20.6% among blood donors in England, France and Denmark, respectively. Methods: We analyzed 550 consecutive blood donor samples collected in the region of Lausanne, canton of Vaud, Switzerland, for the presence of anti-HEV IgG, using the MP Diagnostics HEV ELISA kit. For each donor, we documented age, sex and alanine aminotransferase (ALT) value. Results: The study panel was composed of 332 men (60.4%) and 218 women (39.6%). Overall, anti-HEV IgG was found in 27 of 550 samples (4.9%). The seroprevalence was 5.4% (18/332) in men and 4.1% (9/218) in women. The presence of anti-HEV IgG was not correlated with age, gender or ALT values. However, we observed a peak in seroprevalence of 5.3% in individuals aged 51 to 70 years old. Conclusions: Compared with other European countries, HEV seroprevalence among blood donors in southwest Switzerland is low. The low seroprevalence may be explained by the sensitivity of commercial tests used and/or the strict regulation of animal and meat imports. Data regarding HEV prevalence in Swiss livestock are lacking and merit exploration.	[Kaufmann, Annatina] Univ Lausanne, Fac Biol & Med, Lausanne, Switzerland; [Kenfak-Foguena, Alain; Darling, Katharine E. A.; Cavassini, Matthias] CHU Vaudois, Infect Dis Serv, Lausanne, Switzerland; [Andre, Cyril; Buergisser, Philippe] CHU Vaudois, Serv Immunol & Allergy, Lausanne, Switzerland; [Canellini, Giorgia] Serv Reg Vaudois Transfus Sanguine, Epalinges, Switzerland; [Moradpour, Darius] CHU Vaudois, Div Gastroenterol & Hepatol, Lausanne, Switzerland	University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Kaufmann, A (corresponding author), Univ Lausanne, Fac Biol & Med, Lausanne, Switzerland.		VALLET, Yannick/F-9979-2011; Moradpour, Darius/G-7918-2017; cavassini, matthias/F-8987-2017	Schnegg-Kaufmann, Annatina/0000-0001-7716-3340; Moradpour, Darius/0000-0003-1977-6792; Kenfak Foguena, Alain/0000-0002-8213-2490; cavassini, matthias/0000-0003-0933-7833; Darling, Katharine/0000-0003-1449-3873	Infectious Diseases Service, Clinique Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland	Infectious Diseases Service, Clinique Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland	All serology testing was funded by the Infectious Diseases Service, Clinique Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland. The study had no external funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendall R, 2010, J MED VIROL, V82, P799, DOI 10.1002/jmv.21656; Boutrouille A, 2007, J CLIN MICROBIOL, V45, P2009, DOI 10.1128/JCM.00235-07; Bouwknegt M, 2007, J FOOD PROTECT, V70, P2889, DOI 10.4315/0362-028X-70.12.2889; Christensen PB, 2008, CLIN INFECT DIS, V47, P1026, DOI 10.1086/591970; Dalekos GN, 1998, TRANSFUSION, V38, P589, DOI 10.1046/j.1537-2995.1998.38698326339.x; Dalton HR, 2008, EUR J CLIN MICROBIOL, V27, P579, DOI 10.1007/s10096-008-0480-z; Dalton HR, 2008, EUR J GASTROEN HEPAT, V20, P784, DOI 10.1097/MEG.0b013e3282f5195a; FOGUENA AK, 2010, EMERG INFEC IN PRESS; Herremans M, 2007, CLIN VACCINE IMMUNOL, V14, P562, DOI 10.1128/CVI.00231-06; Ijaz S, 2005, J INFECT DIS, V192, P1166, DOI 10.1086/444396; Ijaz S, 2009, J CLIN VIROL, V44, P272, DOI 10.1016/j.jcv.2009.01.005; JAMEEL S, 1999, EXPERT REV MOL MED, P1; Kamar N, 2008, NEW ENGL J MED, V358, P811, DOI 10.1056/NEJMoa0706992; Khuroo MS, 2008, CURR OPIN INFECT DIS, V21, P539, DOI 10.1097/QCO.0b013e32830ee08a; Kumar Arvind, 2004, Indian J Gastroenterol, V23, P59; Kuniholm MH, 2009, J INFECT DIS, V200, P48, DOI 10.1086/599319; LAVANCHY D, 1994, LANCET, V344, P747, DOI 10.1016/S0140-6736(94)92235-7; Lewis HC, 2010, EPIDEMIOL INFECT, V138, P145, DOI 10.1017/S0950268809990847; Mansuy JM, 2008, J MED VIROL, V80, P289, DOI 10.1002/jmv.21056; Mateos ML, 1998, VOX SANG, V75, P267; Meng XJ, 2002, J CLIN MICROBIOL, V40, P117, DOI 10.1128/JCM.40.1.117-122.2002; Okamoto H, 2007, VIRUS RES, V127, P216, DOI 10.1016/j.virusres.2007.02.002; Ollier L, 2009, ANN INTERN MED, V150, P430, DOI 10.7326/0003-4819-150-6-200903170-00026; Purcell RH, 2008, J HEPATOL, V48, P494, DOI 10.1016/j.jhep.2007.12.008; ZAAIJER HL, 1993, LANCET, V341, P826, DOI 10.1016/0140-6736(93)90599-C; ZANETTI AR, 1994, J MED VIROL, V42, P318, DOI 10.1002/jmv.1890420321	26	76	78	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e21150	10.1371/journal.pone.0021150	http://dx.doi.org/10.1371/journal.pone.0021150			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	21701586	gold, Green Published, Green Submitted			2022-12-27	WOS:000291983800025
J	Gopalakrishna-Pillai, S; Iverson, LE				Gopalakrishna-Pillai, Sailesh; Iverson, Linda E.			A DNMT3B Alternatively Spliced Exon and Encoded Peptide Are Novel Biomarkers of Human Pluripotent Stem Cells	PLOS ONE			English	Article							DNA METHYLATION; GENE; CANCER	A major obstacle in human stem cell research is the limited number of reagents capable of distinguishing pluripotent stem cells from partially differentiated or incompletely reprogrammed derivatives. Although human embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSCs) express numerous alternatively spliced transcripts, little attention has been directed at developing splice variant-encoded protein isoforms as reagents for stem cell research. In this study, several genes encoding proteins involved in important signaling pathways were screened to detect alternatively spliced transcripts that exhibited differential expression in pluripotent stem cells (PSCs) relative to spontaneously differentiated cells (SDCs). Transcripts containing the alternatively spliced exon 10 of the de novo DNA methyltransferase gene, DNMT3B, were identified that are expressed in PSCs. To demonstrate the utility and superiority of splice variant specific reagents for stem cell research, a peptide encoded by DNMT3B exon 10 was used to generate an antibody, SG1. The SG1 antibody detects a single DNMT3B protein isoform that is expressed only in PSCs but not in SDCs. The SG1 antibody is also demonstrably superior to other antibodies at distinguishing PSCs from SDCs in mixed cultures containing both pluripotent stem cells and partially differentiated derivatives. The tightly controlled down regulation of DNMT3B exon 10 containing transcripts (and exon 10 encoded peptide) upon spontaneous differentiation of PSCs suggests that this DNMT3B splice isoform is characteristic of the pluripotent state. Alternatively spliced exons, and the proteins they encode, represent a vast untapped reservoir of novel biomarkers that can be used to develop superior reagents for stem cell research and to gain further insight into mechanisms controlling stem cell pluripotency.	[Gopalakrishna-Pillai, Sailesh; Iverson, Linda E.] City Hope Natl Med Ctr, Beckman Res Inst, Stem Cell Biol, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope	Gopalakrishna-Pillai, S (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Stem Cell Biol, Duarte, CA 91010 USA.	liverson@coh.org						Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Beyrouthy MJ, 2009, CANCER RES, V69, P9360, DOI 10.1158/0008-5472.CAN-09-1490; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Chen TP, 2004, MOL CELL BIOL, V24, P9048, DOI 10.1128/MCB.24.20.9048-9058.2004; Chin MH, 2010, CELL STEM CELL, V7, P263, DOI 10.1016/j.stem.2010.06.019; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; Deng J, 2009, NAT BIOTECHNOL, V27, P353, DOI 10.1038/nbt.1530; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Gopalakrishna-Pillai S, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-12; Gopalakrishnan S, 2009, MOL CANCER RES, V7, P1622, DOI 10.1158/1541-7786.MCR-09-0018; Guenther MG, 2010, CELL STEM CELL, V7, P249, DOI 10.1016/j.stem.2010.06.015; Hansen RS, 1999, P NATL ACAD SCI USA, V96, P14412, DOI 10.1073/pnas.96.25.14412; Kellner S, 2010, HISTOL HISTOPATHOL, V25, P405, DOI 10.14670/HH-25.405; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Linhart HG, 2007, GENE DEV, V21, P3110, DOI 10.1101/gad.1594007; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; Newman AM, 2010, CELL STEM CELL, V7, P258, DOI 10.1016/j.stem.2010.06.016; Nicholas CR, 2010, NATURE, V463, P1031, DOI 10.1038/4631031a; Odorico JS, 2001, STEM CELLS, V19, P193, DOI 10.1634/stemcells.19-3-193; Orengo JP, 2007, ADV EXP MED BIOL, V623, P212, DOI 10.1007/978-0-387-77374-2_13; Pritsker M, 2005, P NATL ACAD SCI USA, V102, P14290, DOI 10.1073/pnas.0502132102; Smith JA, 2010, AGING CELL, V9, P580, DOI 10.1111/j.1474-9726.2010.00585.x; Weisenberger DJ, 2004, MOL CANCER RES, V2, P62; Yeo GW, 2007, PLOS COMPUT BIOL, V3, P1951, DOI 10.1371/journal.pcbi.0030196; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	27	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e20663	10.1371/journal.pone.0020663	http://dx.doi.org/10.1371/journal.pone.0020663			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698279	Green Published, gold, Green Submitted			2022-12-27	WOS:000291730000017
J	Walters, P; Schofield, P; Howard, L; Ashworth, M; Tylee, A				Walters, Paul; Schofield, Peter; Howard, Louise; Ashworth, Mark; Tylee, Andre			The Relationship between Asthma and Depression in Primary Care Patients: A Historical Cohort and Nested Case Control Study	PLOS ONE			English	Article							QUALITY-OF-LIFE; PRACTICE RESEARCH DATABASE; MENTAL-DISORDERS; GENERAL-PRACTICE; SYMPTOMS; EPIDEMIOLOGY; COMMUNITY; OUTCOMES; ADULTS; IMPACT	Background and Objectives: Asthma and depression are common health problems in primary care. Evidence of a relationship between asthma and depression is conflicting. Objectives: to determine 1. The incidence rate and incidence rate ratio of depression in primary care patients with asthma compared to those without asthma, and 2. The standardized mortality ratio of depressed compared to non-depressed patients with asthma. Methods: A historical cohort and nested case control study using data derived from the United Kingdom General Practice Research Database. Participants: 11,275 incident cases of asthma recorded between 1/1/95 and 31/12/96 age, sex and practice matched with non-cases from the database (ratio 1: 1) and followed up through the database for 10 years. 1,660 cases were matched by date of asthma diagnosis with 1,660 controls. Main outcome measures: number of cases diagnosed with depression, the number of deaths over the study period. Results: The rate of depression in patients with asthma was 22.4/1,000 person years and without asthma 13.8 /1,000 person years. The incident rate ratio (adjusted for age, sex, practice, diabetes, cardiovascular disease, cerebrovascular disease, smoking) was 1.59 (95% CI 1.48-1.71). The increased rate of depression was not associated with asthma severity or oral corticosteroid use. It was associated with the number of consultations (odds ratio per visit 1.09; 95% CI 1.07-1.11). The age and sex adjusted standardized mortality ratio for depressed patients with asthma was 1.87 (95% CI: 1.54-2.27). Conclusions: Asthma is associated with depression. This was not related to asthma severity or oral corticosteroid use but was related to service use. This suggests that a diagnosis of depression is related to health seeking behavior in patients with asthma. There is an increased mortality rate in depressed patients with asthma. The cause of this needs further exploration. Consideration should be given to case-finding for depression in this population.	[Walters, Paul; Howard, Louise; Tylee, Andre] Kings Coll London, Hlth Serv, Inst Psychiat, London WC2R 2LS, England; [Walters, Paul; Howard, Louise; Tylee, Andre] Kings Coll London, Populat Res Dept, Inst Psychiat, London WC2R 2LS, England; [Schofield, Peter; Ashworth, Mark] Kings Coll London, Div Hlth & Social Care Res, Dept Primary Care & Publ Hlth Sci, London WC2R 2LS, England	University of London; King's College London; University of London; King's College London; University of London; King's College London	Walters, P (corresponding author), Kings Coll London, Hlth Serv, Inst Psychiat, London WC2R 2LS, England.	p.walters@iop.kcl.ac.uk	Howard, Louise/E-3495-2010; Walters, Paul/A-6752-2011; Tylee, Andre T/D-8468-2010; Schofield, Peter/B-7821-2011	Howard, Louise/0000-0001-9942-744X; Schofield, Peter/0000-0003-1201-527X; Ashworth, Mark/0000-0001-6514-9904	Medical Research Council (ISAC) [07_051R]; NIHR Mental Health Biomedical Research Centre, Institute of Psychiatry, King's College London; South London and Maudsley Foundation Trust	Medical Research Council (ISAC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR Mental Health Biomedical Research Centre, Institute of Psychiatry, King's College London; South London and Maudsley Foundation Trust	The Medical Research Council (ISAC Protocol No. 07_051R), and the NIHR Mental Health Biomedical Research Centre, Institute of Psychiatry, King's College London and South London and Maudsley Foundation Trust jointly funded this research. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RJ, 2004, THORAX, V59, P930, DOI 10.1136/thx.2003.010256; ANDERSON HR, 1994, HLTH CARE NEEDS ASSE, P256; Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069; Chapman D. P., 2005, Preventing Chronic Disease, V2, pA14; Chapman KR, 2005, RESP MED, V99, P1350, DOI 10.1016/j.rmed.2005.03.020; Cluley S, 2001, RESP MED, V95, P37, DOI 10.1053/rmed.2000.0968; Eisner MD, 2005, ANN ALLERG ASTHMA IM, V94, P566, DOI 10.1016/S1081-1206(10)61135-0; Evans DL, 2005, BIOL PSYCHIAT, V58, P175, DOI 10.1016/j.biopsych.2005.05.001; Goldney RD, 2003, MED J AUSTRALIA, V178, P437, DOI 10.5694/j.1326-5377.2003.tb05285.x; Goodwin RD, 2004, PSYCHOL MED, V34, P1465, DOI 10.1017/S0033291704002739; Goodwin RD, 2003, ARCH GEN PSYCHIAT, V60, P1125, DOI 10.1001/archpsyc.60.11.1125; Hancox RJ, 2004, THORAX, V59, P376, DOI 10.1136/thx.2003.010363; Hansell A, 1999, THORAX, V54, P413, DOI 10.1136/thx.54.5.413; Health and Social Care Information Centre, 2005, STAT B HLTH SOC CAR; *INF CTR HLTH SOC, 2007, QOF; Mancuso CA, 2000, J GEN INTERN MED, V15, P301, DOI 10.1046/j.1525-1497.2000.07006.x; Nascimento I, 2002, PSYCHIAT RES, V110, P73, DOI 10.1016/S0165-1781(02)00029-X; NAZARETH I, 1993, BRIT MED J, V307, P910, DOI 10.1136/bmj.307.6909.910; Ng TP, 2007, INT J GERIATR PSYCH, V22, P668, DOI 10.1002/gps.1728; Opolski Melissa, 2005, Clin Pract Epidemiol Ment Health, V1, P18, DOI 10.1186/1745-0179-1-18; Perry J, 1978, OXMIS PROBLEM CODES; Rodriguez LAG, 1998, BRIT J CLIN PHARMACO, V45, P419; Rudisch B, 2003, BIOL PSYCHIAT, V54, P227, DOI 10.1016/S0006-3223(03)00587-0; Scott KM, 2007, J AFFECT DISORDERS, V103, P113, DOI 10.1016/j.jad.2007.01.015; Scott KM, 2007, GEN HOSP PSYCHIAT, V29, P123, DOI 10.1016/j.genhosppsych.2006.12.006; Strong Mark, 2006, Int J Health Geogr, V5, P29, DOI 10.1186/1476-072X-5-29; Tata LJ, 2007, AM J RESP CRIT CARE, V175, P991, DOI 10.1164/rccm.200611-1641OC; USTUN TB, 1995, MENTAL ILLNESS GEN H; Walters P, 2008, BRIT J PSYCHIAT, V193, P235, DOI 10.1192/bjp.bp.107.038299; Weich S, 1997, PSYCHOL MED, V27, P73, DOI 10.1017/S0033291796004023; Wyke Sally, 2003, Eur J Gen Pract, V9, P48	31	49	51	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e20750	10.1371/journal.pone.0020750	http://dx.doi.org/10.1371/journal.pone.0020750			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	778TS	21698276	Green Published, gold, Green Submitted			2022-12-27	WOS:000291730000022
J	Zhang, YF; Wang, XF; Zhang, WX; Yu, F; Tian, JH; Li, DR; Guo, AG				Zhang, Yanfeng; Wang, Xuefang; Zhang, Wenxue; Yu, Fei; Tian, Jianhua; Li, Dianrong; Guo, Aiguang			Functional Analysis of the Two Brassica AP3 Genes Involved in Apetalous and Stamen Carpelloid Phenotypes	PLOS ONE			English	Article							FLORAL HOMEOTIC PROTEINS; MADS-BOX GENES; FLOWER DEVELOPMENT; CONTROLLING PETAL; EVOLUTION; DIVERSIFICATION; DUPLICATION; DIVERGENCE; PISTILLATA; GENOME	The Arabidopsis homeotic genes APETALA3 (AP3) and PISTILLATA (PI) are B genes which encode MADS-box transcription factors and specify petal and stamen identities. In the current study, the stamen carpelloid (SC) mutants, HGMS and AMS, of B. rapa and B. napus were investigated and two types of AP3 genes, B.AP3.a and B.AP3.b, were functional characterized. B.AP3.a and B.AP3.b share high similarity in amino acid sequences except for 8 residues difference located at the C-terminus. Loss of this 8 residues in B.AP3.b led to the change of PI-derived motifs. Meanwhile, B.AP3.a specified petal and stamen development, whereas B.AP3.b only specified stamen development. In B. rapa, the mutations of both genes generated the SC mutant HGMS. In B. napus that contained two B.AP3.a and two B.AP3.b, loss of the two B.AP3.a functions was the key reason for the apetalous mutation, however, the loss-of-function in all four AP3 was related to the SC mutant AMS. We inferred that the 8 residues or the PI-derived motif in AP3 gene probably relates to petal formation.	[Zhang, Yanfeng; Yu, Fei; Guo, Aiguang] NW A&F Univ, Coll Life Sci, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China	Zhang, YF (corresponding author), NW A&F Univ, Coll Life Sci, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.	yczx98@126.com; guoaiguang@yahoo.com.cn			863 National High-tech Research and Development Program [2009AA101105]; Shaanxi Key Laboratory of Molecular Biology for Agriculture [200701]	863 National High-tech Research and Development Program(National High Technology Research and Development Program of China); Shaanxi Key Laboratory of Molecular Biology for Agriculture	This work was supported by a grant from 863 National High-tech Research and Development Program (2009AA101105) and the fund of Shaanxi Key Laboratory of Molecular Biology for Agriculture (200701). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOWMAN JL, 1991, DEVELOPMENT, V112, P1; Causier B, 2005, CURR BIOL, V15, P1508, DOI 10.1016/j.cub.2005.07.063; COEN ES, 1991, NATURE, V353, P31, DOI 10.1038/353031a0; de Martino G, 2006, PLANT CELL, V18, P1833, DOI 10.1105/tpc.106.042978; GOTO K, 1994, GENE DEV, V8, P1548, DOI 10.1101/gad.8.13.1548; Hernandez-Hernandez T, 2007, MOL BIOL EVOL, V24, P465, DOI 10.1093/molbev/msl182; Hileman LC, 2006, MOL BIOL EVOL, V23, P2245, DOI 10.1093/molbev/msl095; Hileman LC, 2009, AM J BOT, V96, P83, DOI 10.3732/ajb.0800066; Honma T, 2001, NATURE, V409, P525, DOI 10.1038/35054083; Howell EC, 2008, GENETICS, V180, P1849, DOI 10.1534/genetics.108.095893; Irish VF, 2005, CURR OPIN GENET DEV, V15, P454, DOI 10.1016/j.gde.2005.06.001; Irish VF, 2009, J EXP BOT, V60, P2517, DOI 10.1093/jxb/erp159; JACK T, 1992, CELL, V68, P683, DOI 10.1016/0092-8674(92)90144-2; Kim ST, 2004, AM J BOT, V91, P2102, DOI 10.3732/ajb.91.12.2102; Kramer EM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-30; Kramer EM, 1998, GENETICS, V149, P765; Kramer EM, 1999, NATURE, V399, P144, DOI 10.1038/20172; Kramer EM, 2004, GENETICS, V166, P1011, DOI 10.1534/genetics.166.2.1011; Kramer EM, 2000, INT J PLANT SCI, V161, pS29, DOI 10.1086/317576; Lamb RS, 2003, P NATL ACAD SCI USA, V100, P6558, DOI 10.1073/pnas.0631708100; Litt A, 2003, GENETICS, V165, P821; Ostergaard L, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-10; Pelaz S, 2000, NATURE, V405, P200, DOI 10.1038/35012103; Piwarzyk E, 2007, PLANT PHYSIOL, V145, P1495, DOI 10.1104/pp.107.105346; Pylatuik JD, 2003, J EXP BOT, V54, P2385, DOI 10.1093/jxb/erg254; Rasmussen DA, 2009, AM J BOT, V96, P96, DOI 10.3732/ajb.0800038; Rijpkema A, 2006, ADV BOT RES, V44, P237, DOI 10.1016/S0065-2296(06)44006-4; Rijpkema AS, 2006, PLANT CELL, V18, P1819, DOI 10.1105/tpc.106.042937; Snowdon RJ, 2002, THEOR APPL GENET, V104, P533, DOI 10.1007/s00122-001-0787-y; Stellari GM, 2004, MOL BIOL EVOL, V21, P506, DOI 10.1093/molbev/msh044; Su KM, 2008, NEW PHYTOL, V178, P544, DOI 10.1111/j.1469-8137.2008.02382.x; Theissen G, 2001, NATURE, V409, P469, DOI 10.1038/35054172; Vandenbussche M, 2004, PLANT CELL, V16, P741, DOI 10.1105/tpc.019166; Vandenbussche M, 2003, NUCLEIC ACIDS RES, V31, P4401, DOI 10.1093/nar/gkg642; WEIGEL D, 1994, CELL, V78, P203, DOI 10.1016/0092-8674(94)90291-7; Winter KU, 2002, MOL BIOL EVOL, V19, P587, DOI 10.1093/oxfordjournals.molbev.a004118; Zhang WenXue, 2005, Chinese Journal of Oil Crop Sciences, V27, P13; [张彦锋 Zhang Yanfeng], 2005, [西北农业学报, Acat Agriculturae Boreali-Occidentalis Sinica], V14, P164	38	13	14	5	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e20930	10.1371/journal.pone.0020930	http://dx.doi.org/10.1371/journal.pone.0020930			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738595	gold, Green Published, Green Submitted			2022-12-27	WOS:000292291800006
J	Deus-de-Oliveira, N; Felix, SP; Carrielo-Gama, C; Fernandes, KV; DaMatta, RA; Machado, OLT				Deus-de-Oliveira, Natalia; Felix, Shayany P.; Carrielo-Gama, Camila; Fernandes, Keysson V.; DaMatta, Renato Augusto; Machado, Olga L. T.			Identification of Critical Amino Acids in the IgE Epitopes of Ric c 1 and Ric c 3 and the Application of Glutamic Acid as an IgE Blocker	PLOS ONE			English	Article							2S ALBUMIN PRECURSOR; RICINUS-COMMUNIS; CROSS-REACTIVITY; STORAGE PROTEIN; CASTOR-OIL; ALLERGENS; POLLEN; POLLINOSIS; SEQUENCE; UPDATE	Background: The allergenicity of Ricinus communis L. (castor bean, Euphorbiaceae) is associated with components of its seeds and pollen. Castor bean allergy has been described not only in laboratory workers, but also in personnel working in oil processing mills, fertilizer retail, the upholstery industry and other industrial fields. In the present study, we describe the critical amino acids in the IgE-binding epitopes in Ric c 1 and Ric c 3, two major allergens of R. communis. In addition, we also investigate the cross-reactivity between castor bean and some air and food allergen extracts commonly used in allergy diagnosis. Methodology/Principal Findings: The IgE reactivity of human sera from atopic patients was screened by immune-dot blot against castor bean allergens. Allergenic activity was evaluated in vitro using a rat mast cell activation assay and by ELISA. Cross-reactivity was observed between castor bean allergens and extracts from shrimp, fish, gluten, wheat, soybean, peanut, corn, house dust, tobacco and airborne fungal allergens. We observed that treatment of rat and human sera (from atopic patients) with glutamic acid reduced the IgE-epitope interaction. Conclusions/Significance: The identification of glutamic acid residues with critical roles in IgE-binding to Ric c 3 and Ric c 1 support the potential use of free amino acids in allergy treatment.	[Deus-de-Oliveira, Natalia; Felix, Shayany P.; Carrielo-Gama, Camila; Fernandes, Keysson V.; Machado, Olga L. T.] Univ Estadual Norte Fluminense, Ctr Biociencias & Biotecnol, Lab Quim & Funcao Prot & Peptideos, Rio De Janeiro, Brazil; [DaMatta, Renato Augusto] Univ Estadual Norte Fluminense, Ctr Biociencias & Biotecnol, Lab Biol Celular & Tecidual, Rio De Janeiro, Brazil	Universidade Estadual do Norte Fluminense; Universidade Estadual do Norte Fluminense	Deus-de-Oliveira, N (corresponding author), Univ Estadual Norte Fluminense, Ctr Biociencias & Biotecnol, Lab Quim & Funcao Prot & Peptideos, Campos Goytacazes, Rio De Janeiro, Brazil.	olgauenf@yahoo.com.br	Machado, Olga LT/G-7461-2012; Machado, Olga/P-1944-2019; DaMatta, Renato/G-8367-2015	DaMatta, Renato/0000-0002-0108-9268; Machado, Olga/0000-0003-0647-1762	CNPq; CAPES; FAPERJ	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by grants CNPq, CAPES (graduate fellowships), and FAPERJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azam MM, 2005, BIOMASS BIOENERG, V29, P293, DOI 10.1016/j.biombioe.2005.05.001; Bashir MEH, 1998, INT ARCH ALLERGY IMM, V115, P73, DOI 10.1159/000023833; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Bousquet J., 2002, Allergy (Copenhagen), V57, P841, DOI 10.1034/j.1398-9995.2002.23625.x; Chan SL, 2008, J IMMUNOL, V181, P2586, DOI 10.4049/jimmunol.181.4.2586; Conceicao MM, 2005, ENERG FUEL, V19, P2185, DOI 10.1021/ef050016g; D'Amato G, 1998, ALLERGY, V53, P567, DOI 10.1111/j.1398-9995.1998.tb03932.x; daSilva JG, 1996, ARCH BIOCHEM BIOPHYS, V336, P10, DOI 10.1006/abbi.1996.0526; DUNN BM, 1974, J BIOL CHEM, V249, P3717; Egger M, 2006, ALLERGY, V61, P461, DOI 10.1111/j.1398-9995.2006.00994.x; Felix SP, 2008, PEPTIDES, V29, P497, DOI 10.1016/j.peptides.2007.12.013; Garcia-Gonzalez JJ, 1999, CLIN EXP ALLERGY, V29, P1265; IRWIN SD, 1990, MOL GEN GENET, V222, P400, DOI 10.1007/BF00633846; Klinglmayr E, 2009, ALLERGY, V64, P647, DOI 10.1111/j.1398-9995.2008.01844.x; MACHADO OLT, 1992, BRAZ J MED BIOL RES, V25, P567; MACHADO OLT, 2005, Patent No. 05066484; Ogunniyi DS, 2006, BIORESOURCE TECHNOL, V97, P1086, DOI 10.1016/j.biortech.2005.03.028; SHARIEF FS, 1982, J BIOL CHEM, V257, P4753; Singh A, 1997, J INVEST ALLERG CLIN, V7, P169; SINHA U, 1985, ANAL BIOCHEM, V151, P327, DOI 10.1016/0003-2697(85)90183-6; THORPE SC, 1988, J ALLERGY CLIN IMMUN, V82, P67, DOI 10.1016/0091-6749(88)90053-X; THORPE SC, 1988, J ALLERGY CLIN IMMUN, V82, P62, DOI 10.1016/0091-6749(88)90052-8; Vieths S, 2002, ANN NY ACAD SCI, V964, P47; YOST DA, 1982, J BIOL CHEM, V257, P767	24	13	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21455	10.1371/journal.pone.0021455	http://dx.doi.org/10.1371/journal.pone.0021455			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738671	gold, Green Submitted, Green Published			2022-12-27	WOS:000292092600043
J	Kitamura, E; Gribanova, YE; Farber, DB				Kitamura, Eiko; Gribanova, Yekaterina E.; Farber, Debora B.			Regulation of Retinoschisin Secretion in Weri-Rb1 Cells by the F-Actin and Microtubule Cytoskeleton	PLOS ONE			English	Article							X-LINKED RETINOSCHISIS; JUVENILE RETINOSCHISIS; MAST-CELLS; GRANULE EXOCYTOSIS; PROTEIN-KINASE; SMOOTH-MUSCLE; VESICLE TRANSPORT; GENE-THERAPY; MOUSE MODEL; CYCLIC-GMP	Retinoschisin is encoded by the gene responsible for X-linked retinoschisis (XLRS), an early onset macular degeneration that results in a splitting of the inner layers of the retina and severe loss in vision. Retinoschisin is predominantly expressed and secreted from photoreceptor cells as a homo-oligomer protein; it then associates with the surface of retinal cells and maintains the retina cellular architecture. Many missense mutations in the XLRS1 gene are known to cause intracellular retention of retinoschisin, indicating that the secretion process of the protein is a critical step for its normal function in the retina. However, the molecular mechanisms underlying retinoschisin's secretion remain to be fully elucidated. In this study, we investigated the role of the F-actin cytoskeleton in the secretion of retinoschisin by treating Weri-Rb1 cells, which are known to secrete retinoschisin, with cytochalasin D, jasplakinolide, Y-27632, and dibutyryl cGMP. Our results show that cytochalasin D and jasplakinolide inhibit retinoschisin secretion, whereas Y-27632 and dibutyryl cGMP enhance secretion causing F-actin alterations. We also demonstrate that high concentrations of taxol, which hyperpolymerizes microtubules, inhibit retinoschisin secretion. Our data suggest that retinoschisin secretion is regulated by the F-actin cytoskeleton, that cGMP or inhibition of ROCK alters F-actin structure enhancing the secretion, and that the microtubule cytoskeleton is also involved in this process.	[Kitamura, Eiko; Gribanova, Yekaterina E.; Farber, Debora B.] Univ Calif Los Angeles, David Geffen Sch Med, Jules Stein Eye Inst, Los Angeles, CA 90095 USA; [Kitamura, Eiko; Gribanova, Yekaterina E.; Farber, Debora B.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Ophthalmol, Los Angeles, CA 90095 USA; [Farber, Debora B.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [Farber, Debora B.] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Kitamura, E (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Jules Stein Eye Inst, Los Angeles, CA 90095 USA.	farber@jsei.ucla.edu		Farber, Debora/0000-0002-3207-697X	National Eye Institute [EY 08285]; NATIONAL EYE INSTITUTE [P30EY000331, R01EY008285] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Eye Institute grant EY 08285 (http://www.nei.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boran MS, 2007, J NEUROCHEM, V102, P216, DOI 10.1111/j.1471-4159.2007.04464.x; BOROVIKOV YS, 1995, J CELL SCI, V108, P657; BUBB MR, 1994, J BIOL CHEM, V269, P14869; Burgoyne RD, 2003, PHYSIOL REV, V83, P581, DOI 10.1152/physrev.00031.2002; Carbajal ME, 1997, ENDOCRINOLOGY, V138, P5374, DOI 10.1210/en.138.12.5374; da Costa SR, 1998, J CELL SCI, V111, P1267; Eitzen G, 2003, BBA-MOL CELL RES, V1641, P175, DOI 10.1016/S0167-4889(03)00087-9; Ellerbroek SM, 2003, J BIOL CHEM, V278, P19023, DOI 10.1074/jbc.M213066200; Farber DB, 1997, CURR OPIN NEUROBIOL, V7, P666, DOI 10.1016/S0959-4388(97)80087-6; Feil Robert, 2008, V184, P529; Flaumenhaft R, 2005, BLOOD, V105, P3879, DOI 10.1182/blood-2004-04-1392; Gehrig AE, 1999, MAMM GENOME, V10, P303, DOI 10.1007/s003359900991; GEORGE NDL, 1995, BRIT J OPHTHALMOL, V79, P697, DOI 10.1136/bjo.79.7.697; Giau R, 2005, J NEUROSCI, V25, P8995, DOI 10.1523/JNEUROSCI.2430-05.2005; Grayson C, 2000, HUM MOL GENET, V9, P1873, DOI 10.1093/hmg/9.12.1873; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; HAMMALVAREZ SF, 1993, J CELL SCI, V106, P955; Hammar E, 2009, ENDOCRINOLOGY, V150, P2072, DOI 10.1210/en.2008-1135; Jin J, 2008, INT J BIOCHEM CELL B, V40, P2240, DOI 10.1016/j.biocel.2008.03.004; Jog NR, 2007, AM J PHYSIOL-CELL PH, V292, pC1690, DOI 10.1152/ajpcell.00384.2006; Jordan MA, 1998, METHOD ENZYMOL, V298, P252, DOI 10.1016/S0076-6879(98)98024-7; Kapfhamer D, 2002, NAT GENET, V32, P290, DOI 10.1038/ng991; Kjellstrom S, 2007, INVEST OPHTH VIS SCI, V48, P3837, DOI 10.1167/iovs.07-0203; Ko ML, 2008, INVEST OPHTH VIS SCI, V49, P1615, DOI 10.1167/iovs.07-1189; KOFFER A, 1990, J CELL BIOL, V111, P919, DOI 10.1083/jcb.111.3.919; Kwok MCM, 2008, MOL CELL PROTEOMICS, V7, P1053, DOI 10.1074/mcp.M700571-MCP200; Lecuona E, 2003, MOL BIOL CELL, V14, P3888, DOI 10.1091/mbc.E02-12-0781; Lucas KA, 2000, PHARMACOL REV, V52, P375; Lyubchenko TA, 2003, J PHYSIOL-LONDON, V547, P835, DOI 10.1113/jphysiol.2002.033522; Malacombe M, 2006, BBA-MOL CELL RES, V1763, P1175, DOI 10.1016/j.bbamcr.2006.09.004; MCFALL RC, 1977, CANCER RES, V37, P1003; Min SH, 2005, MOL THER, V12, P644, DOI 10.1016/j.ymthe.2005.06.002; Molday LL, 2007, J BIOL CHEM, V282, P32792, DOI 10.1074/jbc.M706321200; MUALLEM S, 1995, J CELL BIOL, V128, P589, DOI 10.1083/jcb.128.4.589; ORCI L, 1972, SCIENCE, V175, P1128, DOI 10.1126/science.175.4026.1128; Pendleton A, 2001, CELL MOTIL CYTOSKEL, V48, P37; Persson PB, 2003, J PHYSIOL-LONDON, V552, P667, DOI 10.1113/jphysiol.2003.049890; Reid SNM, 1999, GENE, V227, P257, DOI 10.1016/S0378-1119(98)00578-2; Reid SNM, 2003, J NEUROSCI, V23, P6030, DOI 10.1523/JNEUROSCI.23-14-06030.2003; RIEKE F, 1994, NEURON, V13, P863, DOI 10.1016/0896-6273(94)90252-6; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Sauer CG, 1997, NAT GENET, V17, P164, DOI 10.1038/ng1097-164; Sauzeau V, 2003, J BIOL CHEM, V278, P9472, DOI 10.1074/jbc.M212776200; Shi L, 2009, J BIOL CHEM, V284, P3966, DOI 10.1074/jbc.M806333200; Steiner-Champliaud MF, 2006, MOL VIS, V12, P892; Stephen R, 2008, PHOTOCHEM PHOTOBIOL, V84, P903, DOI 10.1111/j.1751-1097.2008.00323.x; Sullivan R, 1999, J BIOL CHEM, V274, P38140, DOI 10.1074/jbc.274.53.38140; Suzuki J, 2006, CIRC RES, V98, P811, DOI 10.1161/01.RES.0000216405.85080.a6; Takada Y, 2004, INVEST OPHTH VIS SCI, V45, P3302, DOI 10.1167/iovs.04-0156; TANNENBAUM J, 1983, MOL CELL BIOL, V3, P132, DOI 10.1128/MCB.3.1.132; Tashiro K, 2003, J CELL PHYSIOL, V197, P409, DOI 10.1002/jcp.10370; Trifaro JM, 2008, ACTA PHYSIOL, V192, P165, DOI 10.1111/j.1748-1716.2007.01808.x; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Unno T, 1999, BRIT J PHARMACOL, V127, P1703, DOI 10.1038/sj.bjp.0702711; Vijayasarathy C, 2007, INVEST OPHTH VIS SCI, V48, P991, DOI 10.1167/iovs.06-0915; VITALE ML, 1995, NEURON, V14, P353, DOI 10.1016/0896-6273(95)90291-0; Wang T, 2002, HUM MOL GENET, V11, P3097, DOI 10.1093/hmg/11.24.3097; Wang ZX, 2009, J CELL SCI, V122, P893, DOI 10.1242/jcs.034355; Weber BHF, 2002, P NATL ACAD SCI USA, V99, P6222, DOI 10.1073/pnas.092528599; Wu WWH, 2005, J BIOL CHEM, V280, P10721, DOI 10.1074/jbc.M413117200; Zeng Y, 2004, INVEST OPHTH VIS SCI, V45, P3279, DOI 10.1167/iovs.04-0576; Zulauf L, 2009, BIOCHEM BIOPH RES CO, V390, P1408, DOI 10.1016/j.bbrc.2009.10.166	62	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e20707	10.1371/journal.pone.0020707	http://dx.doi.org/10.1371/journal.pone.0020707			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738583	Green Published, gold, Green Submitted			2022-12-27	WOS:000292092600007
J	LaConti, JJ; Shivapurkar, N; Preet, A; Mays, AD; Peran, I; Kim, SE; Marshall, JL; Riegel, AT; Wellstein, A				LaConti, Joseph J.; Shivapurkar, Narayan; Preet, Anju; Mays, Anne Deslattes; Peran, Ivana; Kim, Sung Eun; Marshall, John L.; Riegel, Anna T.; Wellstein, Anton			Tissue and Serum microRNAs in the Kras(G12D) Transgenic Animal Model and in Patients with Pancreatic Cancer	PLOS ONE			English	Article							CIRCULATING MICRORNAS; DUCTAL ADENOCARCINOMAS; EXPRESSION PROFILES; BIOMARKERS; TUMORS; PLASMA; SIGNATURE; COOPERATE; MECHANISM; FEATURES	microRNAs (miRs) modulate the expression levels of mRNAs and proteins and can thus contribute to cancer initiation and progression. In addition to their intracelluar function, miRs are released from cells and shed into the circulation. We postulated that circulating miRs could provide insight into pathways altered during cancer progression and may indicate responses to treatment. Here we focus on pancreatic cancer malignant progression. We report that changes in miR expression patterns during progression of normal tissues to invasive pancreatic adenocarcinoma in the p48-Cre/LSL-Kras(G12D) mouse model mirrors the miR changes observed in human pancreatic cancer tissues. miR-148a/b and miR-375 expression were found decreased whereas miR-10, miR-21, miR-100 and miR-155 were increased when comparing normal tissues, premalignant lesions and invasive carcinoma in the mouse model. Predicted target mRNAs FGFR1 (miR-10) and MLH1 (miR-155) were found downregulated. Quantitation of nine microRNAs in plasma samples from patients distinguished pancreatic cancers from other cancers as well as non-cancerous pancreatic disease. Finally, gemcitabine treatment of control animals and p48-Cre/LSL-Kras(G12D) animals with pancreatic cancer caused distinct and up to 60-fold changes in circulating miRs that indicate differential drug effects on normal and cancer tissues. These findings support the significance of detecting miRs in the circulation and suggests that circulating miRs could serve as indicators of drug response.	[LaConti, Joseph J.; Shivapurkar, Narayan; Preet, Anju; Mays, Anne Deslattes; Peran, Ivana; Kim, Sung Eun; Marshall, John L.; Riegel, Anna T.; Wellstein, Anton] Georgetown Univ, Lombardi Canc Ctr, Washington, DC 20007 USA	Georgetown University	LaConti, JJ (corresponding author), Georgetown Univ, Lombardi Canc Ctr, Washington, DC 20007 USA.	nms35@georgetown.edu; wellstea@georgetown.edu	Peran, Ivana/AAL-7480-2020	Peran, Ivana/0000-0001-7399-7452; Deslattes Mays, Anne/0000-0001-7951-3439; Wellstein, Anton/0000-0002-0570-4950	National Institutes of Health [CA108440]; US DOD CDMRP; Lombardi Cancer Center; Gordon Foundation; Lustgarten Foundation; Ruesch Center; NATIONAL CANCER INSTITUTE [R01CA108440, R01CA071508] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL068686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008386] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US DOD CDMRP(United States Department of Defense); Lombardi Cancer Center; Gordon Foundation; Lustgarten Foundation; Ruesch Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The study was supported in part by National Institutes of Health grant CA108440 (AW), US DOD CDMRP (JJL), the Lombardi Cancer Center (NS), the Gordon Foundation (AW), the Lustgarten Foundation (ATR) and the Ruesch Center (JLM and AW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre AJ, 2003, GENE DEV, V17, P3112, DOI 10.1101/gad.1158703; Ai J, 2010, BIOCHEM BIOPH RES CO, V391, P73, DOI 10.1016/j.bbrc.2009.11.005; Bardeesy N, 2006, P NATL ACAD SCI USA, V103, P5947, DOI 10.1073/pnas.0601273103; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bartels CL, 2009, CLIN CHEM, V55, P623, DOI 10.1373/clinchem.2008.112805; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Buchholz M, 2005, CLIN CANCER RES, V11, P8048, DOI 10.1158/1078-0432.CCR-05-1274; Buchholz M, 2005, ONCOGENE, V24, P6626, DOI 10.1038/sj.onc.1208804; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Carriere C, 2007, P NATL ACAD SCI USA, V104, P4437, DOI 10.1073/pnas.0701117104; Cho WCS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-1; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; D'Alessandra Y, 2010, EUR HEART J, V31, P2765, DOI 10.1093/eurheartj/ehq167; Dillhoff M, 2008, J GASTROINTEST SURG, V12, P2171, DOI 10.1007/s11605-008-0584-x; Duursma AM, 2008, RNA, V14, P872, DOI 10.1261/rna.972008; Feldmann G, 2007, CANCER RES, V67, P2187, DOI 10.1158/0008-5472.CAN-06-3281; Gibby KA, 2009, P NATL ACAD SCI USA, V106, P8585, DOI 10.1073/pnas.0810952106; Golde WT, 2005, LAB ANIMAL, V34, P39, DOI 10.1038/laban1005-39; Greither T, 2010, INT J CANCER, V126, P73, DOI 10.1002/ijc.24687; Grutzmann R, 2003, VIRCHOWS ARCH, V443, P508, DOI 10.1007/s00428-003-0884-1; Guerra C, 2007, CANCER CELL, V11, P291, DOI 10.1016/j.ccr.2007.01.012; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Habbe N, 2009, CANCER BIOL THER, V8, P340, DOI 10.4161/cbt.8.4.7338; Heneghan HM, 2010, ANN SURG, V251, P499, DOI 10.1097/SLA.0b013e3181cc939f; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Ho AS, 2010, TRANSL ONCOL, V3, P109, DOI 10.1593/tlo.09256; Huang ZH, 2010, INT J CANCER, V127, P118, DOI 10.1002/ijc.25007; Iacobuzio-Donahue CA, 2003, CANCER RES, V63, P8614; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kloosterman WP, 2007, PLOS BIOL, V5, P1738, DOI 10.1371/journal.pbio.0050203; Lee EJ, 2007, INT J CANCER, V120, P1046, DOI 10.1002/ijc.22394; Li JS, 2009, CLIN CANCER RES, V15, P3998, DOI 10.1158/1078-0432.CCR-08-3053; Lodes MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006229; Logsdon CD, 2003, CANCER RES, V63, P2649; Lowery AJ, 2008, CLIN CANCER RES, V14, P360, DOI 10.1158/1078-0432.CCR-07-0992; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Maitra A, 2008, ANNU REV PATHOL-MECH, V3, P157, DOI 10.1146/annurev.pathmechdis.3.121806.154305; MEDER B, 2010, BASIC RES C IN PRESS; Meng FY, 2006, GASTROENTEROLOGY, V130, P2113, DOI 10.1053/j.gastro.2006.02.057; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Morris JP, 2010, NAT REV CANCER, V10, P683, DOI 10.1038/nrc2899; Ng EKO, 2009, GUT, V58, P1375, DOI 10.1136/gut.2008.167817; Ohshima K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013247; Pigati L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013515; Poy MN, 2009, P NATL ACAD SCI USA, V106, P5813, DOI 10.1073/pnas.0810550106; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Roldo C, 2006, J CLIN ONCOL, V24, P4677, DOI 10.1200/JCO.2005.05.5194; Rosenfeld N, 2008, NAT BIOTECHNOL, V26, P462, DOI 10.1038/nbt1392; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Seux M, 2009, PANCREATOLOGY, V9, P66, DOI 10.1159/000178876; Shimodaira H, 2004, ANN STAT, V32, P2616, DOI 10.1214/009053604000000823; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Singh M, 2007, PANCREATOLOGY, V7, P9, DOI 10.1159/000101873; Stathis A, 2010, NAT REV CLIN ONCOL, V7, P163, DOI 10.1038/nrclinonc.2009.236; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Szafranska AE, 2007, ONCOGENE, V26, P4442, DOI 10.1038/sj.onc.1210228; Tijsen AJ, 2010, CIRC RES, V106, P1035, DOI 10.1161/CIRCRESAHA.110.218297; Tsujiura M, 2010, BRIT J CANCER, V102, P1174, DOI 10.1038/sj.bjc.6605608; UCAR A, 2010, NAT GENET; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; VALERI N, 2010, P NATL ACAD SCI US; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Visone R, 2009, AM J PATHOL, V174, P1131, DOI 10.2353/ajpath.2009.080794; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Walther A, 2009, NAT REV CANCER, V9, P489, DOI 10.1038/nrc2645; Wang GK, 2010, EUR HEART J, V31, P659, DOI 10.1093/eurheartj/ehq013; Wang J, 2009, CANCER PREV RES, V2, P807, DOI 10.1158/1940-6207.CAPR-09-0094; Yamamoto H, 2001, CANCER RES, V61, P3139; Zampetaki A, 2010, CIRC RES, V107, P810, DOI 10.1161/CIRCRESAHA.110.226357	73	70	74	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e20687	10.1371/journal.pone.0020687	http://dx.doi.org/10.1371/journal.pone.0020687			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738581	Green Submitted, Green Published, gold			2022-12-27	WOS:000292092600006
J	Plasilova, M; Chattopadhyay, C; Ghosh, A; Wenzel, F; Demougin, P; Noppen, C; Schaub, N; Szinnai, G; Terracciano, L; Heinimann, K				Plasilova, Martina; Chattopadhyay, Chandon; Ghosh, Apurba; Wenzel, Friedel; Demougin, Philippe; Noppen, Christoph; Schaub, Nathalie; Szinnai, Gabor; Terracciano, Luigi; Heinimann, Karl			Discordant Gene Expression Signatures and Related Phenotypic Differences in Lamin A- and A/C-Related Hutchinson-Gilford Progeria Syndrome (HGPS)	PLOS ONE			English	Article							MEMBRANE GLYCOPROTEIN PC-1; INSULIN-RESISTANCE; GLUCOSE-TOLERANCE; IDIOPATHIC HYPERPHOSPHATASIA; INTERMEDIATE-FILAMENTS; DIABETES-MELLITUS; NUCLEAR LAMINS; BETA-CELL; A-TYPE; OSTEOPROTEGERIN	Hutchinson-Gilford progeria syndrome (HGPS) is a genetic disorder displaying features reminiscent of premature senescence caused by germline mutations in the LMNA gene encoding lamin A and C, essential components of the nuclear lamina. By studying a family with homozygous LMNA mutation (K542N), we showed that HGPS can also be caused by mutations affecting both isoforms, lamin A and C. Here, we aimed to elucidate the molecular mechanisms underlying the pathogenesis in both, lamin A- (sporadic) and lamin A and C-related (hereditary) HGPS. For this, we performed detailed molecular studies on primary fibroblasts of hetero- and homozygous LMNA K542N mutation carriers, accompanied with clinical examinations related to the molecular findings. By assessing global gene expression we found substantial overlap in altered transcription profiles (13.7%; 90/657) in sporadic and hereditary HGPS, with 83.3% (75/90) concordant and 16.7% (15/90) discordant transcriptional changes. Among the concordant ones we observed down-regulation of TWIST2, whose inactivation in mice and humans leads to loss of subcutaneous fat and dermal appendages, and loss of expression in dermal fibroblasts and periadnexial cells from a LMNA K542N/K542N patient further confirming its pivotal role in skin development. Among the discordant transcriptional profiles we identified two key mediators of vascular calcification and bone metabolism, ENPP1 and OPG, which offer a molecular explanation for the major phenotypic differences in vascular and bone disease in sporadic and hereditary HGPS. Finally, this study correlates reduced TWIST2 and OPG expression with increased osteocalcin levels, thereby linking altered bone remodeling to energy homeostasis in hereditary HGPS.	[Plasilova, Martina; Wenzel, Friedel; Schaub, Nathalie; Heinimann, Karl] Univ Basel, Dept Biomed, Res Grp Human Genet, Basel, Switzerland; [Plasilova, Martina; Wenzel, Friedel; Schaub, Nathalie; Heinimann, Karl] Univ Childrens Hosp, Div Med Genet, Basel, Switzerland; [Chattopadhyay, Chandon; Ghosh, Apurba] Inst Child Hlth, Kolkata, India; [Chattopadhyay, Chandon] SB Devi Char Home, Kolkata, India; [Demougin, Philippe] Univ Basel, Life Sci Training Facil, Basel, Switzerland; [Demougin, Philippe] Univ Basel, Biozentrum, Div Mol Psychol, Basel, Switzerland; [Demougin, Philippe] Univ Basel, Pharmazentrum, Basel, Switzerland; [Noppen, Christoph] Viollier AG, Basel, Switzerland; [Szinnai, Gabor] Univ Childrens Hosp Basel, Div Pediat Endocrinol Diabetol, Basel, Switzerland; [Terracciano, Luigi] Univ Basel, Inst Pathol, Basel, Switzerland	University of Basel; University of Basel; University of Basel; University of Basel; University of Basel; University of Basel	Plasilova, M (corresponding author), Univ Basel, Dept Biomed, Res Grp Human Genet, Basel, Switzerland.	martina.plasilova@unibas.ch; karl.heinimann@unibas.ch	Terracciano, Luigi M./AAB-5335-2022	Terracciano, Luigi M./0000-0002-9393-9660; Szinnai, Gabor/0000-0003-0559-2597	Novartis Foundation [06B33]; University Children's Hospital of Basel	Novartis Foundation(Novartis); University Children's Hospital of Basel	This work was supported by the Novartis Foundation (Grant No. 06B33) to M.P. and K.H., and in part by the grant (Intramurale Forschungsfoerderung) from the University Children's Hospital of Basel to M.P. and K.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER PB, 1981, ARCH PATHOL LAB MED, V105, P384; Bialek P, 2004, DEV CELL, V6, P423, DOI 10.1016/S1534-5807(04)00058-9; Broers JLV, 1997, HISTOCHEM CELL BIOL, V107, P505, DOI 10.1007/s004180050138; Cao HN, 2003, J HUM GENET, V48, P271, DOI 10.1007/s10038-003-0025-3; Capell BC, 2005, P NATL ACAD SCI USA, V102, P12879, DOI 10.1073/pnas.0506001102; CEDERHOLM J, 1990, DIABETES RES CLIN PR, V10, P167, DOI 10.1016/0168-8227(90)90040-Z; Chong B, 2003, J BONE MINER RES, V18, P2095, DOI 10.1359/jbmr.2003.18.12.2095; Columbaro M, 2005, CELL MOL LIFE SCI, V62, P2669, DOI 10.1007/s00018-005-5318-6; Constantinescu D, 2006, STEM CELLS, V24, P474, DOI 10.1634/stemcells.2006-erratum.2; Csoka AB, 2004, AGING CELL, V3, P235, DOI 10.1111/j.1474-9728.2004.00105.x; Cundy T, 2002, HUM MOL GENET, V11, P2119, DOI 10.1093/hmg/11.18.2119; Cundy T, 2005, NEW ENGL J MED, V353, P918, DOI 10.1056/NEJMoa050893; De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125; Dechat T, 2008, GENE DEV, V22, P832, DOI 10.1101/gad.1652708; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Ferron M, 2008, P NATL ACAD SCI USA, V105, P5266, DOI 10.1073/pnas.0711119105; Ferron M, 2010, CELL, V142, P296, DOI 10.1016/j.cell.2010.06.003; FREIDENBERG GR, 1992, AM J DIS CHILD, V146, P93, DOI 10.1001/archpedi.1992.02160130095028; Fulzele K, 2010, CELL, V142, P309, DOI 10.1016/j.cell.2010.06.002; Gastaldelli A, 2010, DIGEST LIVER DIS, V42, P310, DOI 10.1016/j.dld.2010.01.013; Goldman RD, 2004, P NATL ACAD SCI USA, V101, P8963, DOI 10.1073/pnas.0402943101; Golledge J, 2004, STROKE, V35, P1636, DOI 10.1161/01.STR.0000129790.00318.a3; Gordon LB, 2007, PEDIATRICS, V120, P824, DOI 10.1542/peds.2007-1357; Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550; HAUSCHKA PV, 1989, PHYSIOL REV, V69, P990, DOI 10.1152/physrev.1989.69.3.990; Hennekam RCM, 2006, AM J MED GENET A, V140A, P2603, DOI 10.1002/ajmg.a.31346; Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823; Herrmann H, 2009, J CLIN INVEST, V119, P1772, DOI 10.1172/JCI38214; Hwang YC, 2009, DIABETES-METAB RES, V25, P768, DOI 10.1002/dmrr.1045; Janghorbani M, 2006, DIABETES CARE, V29, P1573, DOI 10.2337/dc06-0440; Johnson K, 2003, J BONE MINER RES, V18, P994, DOI 10.1359/jbmr.2003.18.6.994; Kanazawa I, 2009, J CLIN ENDOCR METAB, V94, P45, DOI 10.1210/jc.2008-1455; Kemink SAG, 2000, J ENDOCRINOL INVEST, V23, P295, DOI 10.1007/BF03343726; Lang C, 2003, EUR J CELL BIOL, V82, P143, DOI 10.1078/0171-9335-00305; Lee NK, 2008, TRENDS ENDOCRIN MET, V19, P161, DOI 10.1016/j.tem.2008.02.006; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Levy-Litan V, 2010, AM J HUM GENET, V86, P273, DOI 10.1016/j.ajhg.2010.01.010; Liang LL, 2009, ACTA PAEDIATR, V98, P1365, DOI 10.1111/j.1651-2227.2009.01324.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorenz-Depiereux B, 2010, AM J HUM GENET, V86, P267, DOI 10.1016/j.ajhg.2010.01.006; MADDUX BA, 1995, NATURE, V373, P448, DOI 10.1038/373448a0; Maddux BA, 2000, DIABETES, V49, P13, DOI 10.2337/diabetes.49.1.13; Marji J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011132; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Melcer S, 2007, EXP CELL RES, V313, P2157, DOI 10.1016/j.yexcr.2007.03.004; Merideth MA, 2008, NEW ENGL J MED, V358, P592, DOI 10.1056/NEJMoa0706898; Minoo P, 2009, HUM PATHOL; Motyl KJ, 2010, ARCH BIOCHEM BIOPHYS, V503, P2, DOI 10.1016/j.abb.2010.07.030; Nicodemus KK, 2001, DIABETES CARE, V24, P1192, DOI 10.2337/diacare.24.7.1192; Novelli G, 2002, AM J HUM GENET, V71, P426, DOI 10.1086/341908; Oishi I, 2003, GENES CELLS, V8, P645, DOI 10.1046/j.1365-2443.2003.00662.x; OLIVE M, 2010, ARTERIOSCLER THROMB; Paradisi M, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-27; Pereira S, 2008, MECH AGEING DEV, V129, P449, DOI 10.1016/j.mad.2008.04.003; Person AD, 2010, DEV DYNAM, V239, P327, DOI 10.1002/dvdy.22156; Piche ME, 2004, DIABETES CARE, V27, P2470, DOI 10.2337/diacare.27.10.2470; Pittas AG, 2009, J CLIN ENDOCR METAB, V94, P827, DOI 10.1210/jc.2008-1422; Plasilova M, 2004, J MED GENET, V41, P609, DOI 10.1136/jmg.2004.019661; POLLOCK NK, 2010, J BONE MINER RES; Psarros M, 2005, NUCLEIC ACIDS RES, V33, pW638, DOI 10.1093/nar/gki490; ROBER RA, 1990, J CELL SCI, V95, P587; ROBER RA, 1989, DEVELOPMENT, V105, P365; Rosen CJ, 2010, CELL, V142, P198, DOI 10.1016/j.cell.2010.07.001; ROSENBLOOM AL, 1983, J PEDIATR-US, V102, P400, DOI 10.1016/S0022-3476(83)80660-X; Rusinol AE, 2006, J CELL SCI, V119, P3265, DOI 10.1242/jcs.03156; Rutsch F, 2003, NAT GENET, V34, P379, DOI 10.1038/ng1221; Scaffidi P, 2005, NAT MED, V11, P440, DOI 10.1038/nm1204; Shackleton S, 2000, NAT GENET, V24, P153, DOI 10.1038/72807; Shumaker DK, 2006, P NATL ACAD SCI USA, V103, P8703, DOI 10.1073/pnas.0602569103; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Sosic D, 2003, CELL, V112, P169, DOI 10.1016/S0092-8674(03)00002-3; Stehbens WE, 1999, CARDIOVASC PATHOL, V8, P29, DOI 10.1016/S1054-8807(98)00023-4; Stuurman N, 1998, J STRUCT BIOL, V122, P42, DOI 10.1006/jsbi.1998.3987; Takada I, 2007, NAT CELL BIOL, V9, P1273, DOI 10.1038/ncb1647; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Terracciano LM, 2000, AM J CLIN PATHOL, V114, P754, DOI 10.1309/NR6G-T872-F090-LBRW; Tukel T, 2010, AM J HUM GENET, V87, P289, DOI 10.1016/j.ajhg.2010.07.009; Van Campenhout A, 2009, ATHEROSCLEROSIS, V204, P321, DOI 10.1016/j.atherosclerosis.2008.09.033; Verstraeten VLRM, 2006, HUM MOL GENET, V15, P2509, DOI 10.1093/hmg/ddl172; Wagner N, 2007, INT REV CYTOL, V261, P1, DOI 10.1016/S0074-7696(07)61001-8; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Wang J, 2006, J HUM GENET, V51, P934, DOI 10.1007/s10038-006-0042-0; Wang Y, 2008, HUM MOL GENET, V17, P2357, DOI 10.1093/hmg/ddn136; Whyte MP, 2002, NEW ENGL J MED, V347, P175, DOI 10.1056/NEJMoa013096; Worman HJ, 2007, EXP CELL RES, V313, P2121, DOI 10.1016/j.yexcr.2007.03.028; Yamaguchi TP, 1999, DEVELOPMENT, V126, P1211	86	11	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21433	10.1371/journal.pone.0021433	http://dx.doi.org/10.1371/journal.pone.0021433			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738662	Green Published, gold, Green Submitted			2022-12-27	WOS:000292092600041
J	Hou, R; Bao, ZM; Wang, S; Su, HL; Li, Y; Du, HX; Hu, JJ; Wang, S; Hu, XL				Hou, Rui; Bao, Zhenmin; Wang, Shan; Su, Hailin; Li, Yan; Du, Huixia; Hu, Jingjie; Wang, Shi; Hu, Xiaoli			Transcriptome Sequencing and De Novo Analysis for Yesso Scallop (Patinopecten yessoensis) Using 454 GS FLX	PLOS ONE			English	Article							GENE ONTOLOGY; SNP DISCOVERY; EST-SSRS; ANNOTATION; TOOL; BIVALVIA; BLAST2GO; HSP70; MAP	Background: Bivalves comprise 30,000 extant species, constituting the second largest group of mollusks. However, limited genetic research has focused on this group of animals so far, which is, in part, due to the lack of genomic resources. The advent of high-throughput sequencing technologies enables generation of genomic resources in a short time and at a minimal cost, and therefore provides a turning point for bivalve research. In the present study, we performed de novo transcriptome sequencing to first produce a comprehensive expressed sequence tag (EST) dataset for the Yesso scallop (Patinopecten yessoensis). Results: In a single 454 sequencing run, 805,330 reads were produced and then assembled into 32,590 contigs, with about six-fold sequencing coverage. A total of 25,237 unique protein-coding genes were identified from a variety of developmental stages and adult tissues based on sequence similarities with known proteins. As determined by GO annotation and KEGG pathway mapping, functional annotation of the unigenes recovered diverse biological functions and processes. Transcripts putatively involved in growth, reproduction and stress/immune-response were identified. More than 49,000 single nucleotide polymorphisms (SNPs) and 2,700 simple sequence repeats (SSRs) were also detected. Conclusion: Our data provide the most comprehensive transcriptomic resource currently available for P. yessoensis. Candidate genes potentially involved in growth, reproduction, and stress/immunity-response were identified, and are worthy of further investigation. A large number of SNPs and SSRs were also identified and ready for marker development. This resource should lay an important foundation for future genetic or genomic studies on this species.	[Hou, Rui; Bao, Zhenmin; Wang, Shan; Su, Hailin; Li, Yan; Du, Huixia; Hu, Jingjie; Wang, Shi; Hu, Xiaoli] Ocean Univ China, Coll Marine Life Sci, Minist Educ, Key Lab Marine Genet & Breeding MGB, Qingdao, Peoples R China	Ocean University of China	Hou, R (corresponding author), Ocean Univ China, Coll Marine Life Sci, Minist Educ, Key Lab Marine Genet & Breeding MGB, Qingdao, Peoples R China.	wangshanshine@hotmail.com; hxl707@ouc.edu.cn	Su, Hailin/D-1352-2017; xu, tao/K-6631-2016; wang, meng/GWZ-9558-2022	Su, Hailin/0000-0002-0284-2071; 	National Natural Science Foundation of China [31072190]; National Basic Research Program of China (973 Program) [2010CB126402, 2010CB126406]; Earmarked Fund for Modern Agro-industry Technology Research System	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Earmarked Fund for Modern Agro-industry Technology Research System	Financial support for this work was provided by National Natural Science Foundation of China (31072190), National Basic Research Program of China (973 Program, 2010CB126402 and 2010CB126406), and Earmarked Fund for Modern Agro-industry Technology Research System to Dr. Zhenmin Bao. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agelopoulou B, 2004, BBA-GENE STRUCT EXPR, V1676, P12, DOI 10.1016/j.bbaexp.2003.10.004; Anisimova AA, 2007, COMP CYTOGENET, V1, P63; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barakat A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-51; Barbazuk WB, 2007, PLANT J, V51, P910, DOI 10.1111/j.1365-313X.2007.03193.x; Bellin D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-555; Bieler R, 2006, ZOOL J LINN SOC-LOND, V148, P223, DOI 10.1111/j.1096-3642.2006.00255.x; Clark MS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-362; Clark MS, 2009, MAR GENOM, V2, P11, DOI 10.1016/j.margen.2009.03.003; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Conesa A., 2008, INT J PLANT GENOMICS; Craft JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008875; Emrich SJ, 2007, GENOME RES, V17, P69, DOI 10.1101/gr.5145806; Fraser KPP, 2007, J EXP BIOL, V210, P2691, DOI 10.1242/jeb.003715; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; HARTL FU, 1992, ANNU REV BIOPH BIOM, V21, P293, DOI 10.1146/annurev.bb.21.060192.001453; Hillier LW, 2009, GENOME RES, V19, P657, DOI 10.1101/gr.088112.108; Hooper SL, 2005, PHYSIOL REV, V85, P1417, DOI 10.1152/physrev.00027.2005; Hu XL, 2006, AQUAC RES, V37, P1187, DOI 10.1111/j.1365-2109.2006.01546.x; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; James P, 1997, SCIENCE, V275, P387, DOI 10.1126/science.275.5298.387; Jones-Rhoades MW, 2007, PLOS GENET, V3, P1848, DOI 10.1371/journal.pgen.0030171; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kim KS, 2008, COMP BIOCHEM PHYS B, V151, P52, DOI 10.1016/j.cbpb.2008.05.009; Kofler R, 2007, BIOINFORMATICS, V23, P1683, DOI 10.1093/bioinformatics/btm157; Liu Wei-Dong, 2009, Yichuan, V31, P629, DOI 10.3724/SP.J.1005.2009.00629; Mangone M, 2010, SCIENCE, V329, P432, DOI 10.1126/science.1191244; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Myhre S, 2006, BIOINFORMATICS, V22, P2020, DOI 10.1093/bioinformatics/btl334; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; O'Neil ST, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-310; Pyronnet S, 1999, EMBO J, V18, P270, DOI 10.1093/emboj/18.1.270; RUNNEGAR B, 1983, J PALEONTOL, V57, P73; Sarashina I, 2001, MAR BIOTECHNOL, V3, P362, DOI 10.1007/s10126-001-0013-6; Schwarz D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-633; SPIETH J, 1991, J MOL EVOL, V32, P429, DOI 10.1007/BF02101283; Sun CS, 2007, MOL ECOL NOTES, V7, P106, DOI 10.1111/j.1471-8286.2006.01545.x; Tang JF, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-438; Vega-Arreguin JC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-299; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Wang QC, 1984, FISHERIES SCI, V3, P24; WANG RC, 2008, MARINE SHELLFISH CUL; Wang XL, 2009, CONSERV GENET, V10, P1129, DOI 10.1007/s10592-008-9726-7; Xu KF, 2008, AQUAC RES, V40, P35, DOI 10.1111/j.1365-2109.2008.02058.x; Zagrobelny M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-574; Zeng SH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-94	50	191	214	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21560	10.1371/journal.pone.0021560	http://dx.doi.org/10.1371/journal.pone.0021560			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21720557	Green Published, gold, Green Submitted			2022-12-27	WOS:000292036900053
J	Rane, AA; Chuang, JS; Shah, A; Hu, DP; Dalton, ND; Gu, YS; Peterson, KL; Omens, JH; Christman, KL				Rane, Aboli A.; Chuang, Joyce S.; Shah, Amul; Hu, Diane P.; Dalton, Nancy D.; Gu, Yusu; Peterson, Kirk L.; Omens, Jeffrey H.; Christman, Karen L.			Increased Infarct Wall Thickness by a Bio-Inert Material Is Insufficient to Prevent Negative Left Ventricular Remodeling after Myocardial Infarction	PLOS ONE			English	Article							PDGF-BB; INJECTION; ALGINATE; COLLAGEN; HEART; HYDROGELS; RAT; ANGIOGENESIS; DEGRADATION; EXPANSION	Background: Several injectable materials have been shown to preserve or improve cardiac function as well as prevent or slow left ventricular (LV) remodeling post-myocardial infarction (MI). However, it is unclear as to whether it is the structural support or the bioactivity of these polymers that lead to beneficial effects. Herein, we examine how passive structural enhancement of the LV wall by an increase in wall thickness affects cardiac function post-MI using a bio-inert, non-degradable synthetic polymer in an effort to better understand the mechanisms by which injectable materials affect LV remodeling. Methods and Results: Poly(ethylene glycol) (PEG) gels of storage modulus G' = 0.5 +/- 0.1 kPa were injected and polymerized in situ one week after total occlusion of the left coronary artery in female Sprague Dawley rats. The animals were imaged using magnetic resonance imaging (MRI) at 7 +/- 1 day(s) post-MI as a baseline and again post-injection 49 +/- 4 days after MI. Infarct wall thickness was statistically increased in PEG gel injected vs. control animals (p < 0.01). However, animals in the polymer and control groups showed decreases in cardiac function in terms of end diastolic volume, end systolic volume and ejection fraction compared to baseline (p < 0.01). The cellular response to injection was also similar in both groups. Conclusion: The results of this study demonstrate that passive structural reinforcement alone was insufficient to prevent post-MI remodeling, suggesting that bioactivity and/or cell infiltration due to degradation of injectable materials are likely playing a key role in the preservation of cardiac function, thus providing a deeper understanding of the influencing properties of biomaterials necessary to prevent post-MI negative remodeling.	[Rane, Aboli A.; Chuang, Joyce S.; Shah, Amul; Hu, Diane P.; Christman, Karen L.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Dalton, Nancy D.; Gu, Yusu; Peterson, Kirk L.; Omens, Jeffrey H.] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Rane, AA (corresponding author), Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.	christman@bioeng.ucsd.edu	Rane, Anders/L-2675-2013; gu, yu/GSD-4507-2022		NIH; NIH Roadmap for Medical Research [1-DP2-OD004309-01]; National Science Foundation; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004309] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported in part by the NIH Director's New Innovator Award Program, part of the NIH Roadmap for Medical Research [1-DP2-OD004309-01]. http://commonfund.nih.gov/newinnovator/. A.A.R. would like to thank the National Science Foundation for a Graduate Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allman AJ, 2001, TRANSPLANTATION, V71, P1631, DOI 10.1097/00007890-200106150-00024; Anumolu SS, 2010, BIOMATERIALS, V31, P964, DOI 10.1016/j.biomaterials.2009.10.010; Badylak S, 2002, J SURG RES, V103, P190, DOI 10.1006/jsre.2001.6349; Badylak SF, 2008, TISSUE ENG PT A, V14, P1835, DOI 10.1089/ten.tea.2007.0264; Blom AS, 2005, CIRCULATION, V112, P1274, DOI 10.1161/CIRCULATIONAHA.104.499202; Christman KL, 2006, J AM COLL CARDIOL, V48, P907, DOI 10.1016/j.jacc.2006.06.005; Christman KL, 2004, J AM COLL CARDIOL, V44, P654, DOI 10.1016/j.jacc.2004.04.040; Christman KL, 2004, TISSUE ENG, V10, P403, DOI 10.1089/107632704323061762; Chuang JS, 2010, MAGN RESON MED, V64, P1281, DOI 10.1002/mrm.22547; CLEUTJENS JPM, 1995, J MOL CELL CARDIOL, V27, P1281, DOI 10.1016/S0022-2828(05)82390-9; Dai WD, 2005, J AM COLL CARDIOL, V46, P714, DOI 10.1016/j.jacc.2005.04.056; Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80; Dobner S, 2009, J CARD FAIL, V15, P629, DOI 10.1016/j.cardfail.2009.03.003; Draget KI, 2003, BIOMACROMOLECULES, V4, P1661, DOI 10.1021/bm034105g; Fujimoto KL, 2009, BIOMATERIALS, V30, P4357, DOI 10.1016/j.biomaterials.2009.04.055; Garbern JC, 2011, BIOMATERIALS, V32, P2407, DOI 10.1016/j.biomaterials.2010.11.075; Hao XJ, 2007, CARDIOVASC RES, V75, P178, DOI 10.1016/j.cardiores.2007.03.028; Harris J.M., 1992, POLY ETHYLENE GLYCOL; Hsieh PCH, 2006, J CLIN INVEST, V116, P237, DOI 10.1172/JCI25878; Huang NF, 2005, TISSUE ENG, V11, P1860, DOI 10.1089/ten.2005.11.1860; Ifkovits JL, 2010, P NATL ACAD SCI USA, V107, P11507, DOI 10.1073/pnas.1004097107; Iwanaga Y, 2004, J CLIN INVEST, V113, P727, DOI 10.1172/JCI200418716; Jackson BM, 2003, AM J PHYSIOL-HEART C, V284, pH475, DOI 10.1152/ajpheart.00360.2002; Jiang XJ, 2009, J BIOMED MATER RES A, V90A, P472, DOI 10.1002/jbm.a.32118; Jugdutt BI, 2003, CIRCULATION, V108, P1395, DOI 10.1161/01.CIR.0000085658.98621.49; Karamitsos TD, 2009, J AM COLL CARDIOL, V54, P1407, DOI 10.1016/j.jacc.2009.04.094; KHADEMHOSSEINI JBA, 2008, MICRO NANOENGINEERIN; Landa N, 2008, CIRCULATION, V117, P1388, DOI 10.1161/CIRCULATIONAHA.107.727420; Leor J, 2009, J AM COLL CARDIOL, V54, P1014, DOI 10.1016/j.jacc.2009.06.010; Lin-Gibson S, 2004, BIOMACROMOLECULES, V5, P1280, DOI 10.1021/bm0498777; Lloyd-Jones, 2010, CIRCULATION, V121, pE260, DOI 10.1161/CIR.0b013e3181d7cf32; Lu WN, 2009, TISSUE ENG PT A, V15, P1437, DOI 10.1089/ten.tea.2008.0143; Lutolf MP, 2003, BIOMACROMOLECULES, V4, P713, DOI 10.1021/bm025744e; Mihardja SS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010384; Nam JO, 2003, J BIOL CHEM, V278, P25902, DOI 10.1074/jbc.M300358200; Nelson DM, 2011, ACTA BIOMATER, V7, P1, DOI 10.1016/j.actbio.2010.06.039; Okada M, 2010, BIOMATERIALS, V31, P7678, DOI 10.1016/j.biomaterials.2010.06.056; PATHAK C, 2003, Patent No. 6566406; PFEFFER JM, 1991, AM J PHYSIOL, V260, pH1406, DOI 10.1152/ajpheart.1991.260.5.H1406; PFEFFER MA, 1995, ANNU REV MED, V46, P455, DOI 10.1146/annurev.med.46.1.455; Rizzi SC, 2005, BIOMACROMOLECULES, V6, P1226, DOI 10.1021/bm049614c; Ryu JH, 2005, BIOMATERIALS, V26, P319, DOI 10.1016/j.biomaterials.2004.02.058; Singelyn JM, 2010, J CARDIOVASC TRANSL, V3, P478, DOI 10.1007/s12265-010-9202-x; Singelyn JM, 2009, BIOMATERIALS, V30, P5409, DOI 10.1016/j.biomaterials.2009.06.045; Sutton MGS, 2000, CIRCULATION, V101, P2981, DOI 10.1161/01.CIR.101.25.2981; THOMPSON WD, 1992, J PATHOL, V168, P47, DOI 10.1002/path.1711680109; Uhrich KE, 1999, CHEM REV, V99, P3181, DOI 10.1021/cr940351u; Valentin JE, 2006, J BONE JOINT SURG AM, V88A, P2673, DOI 10.2106/JBJS.E.01008; Vick GW, 2009, CURR OPIN CARDIOL, V24, P567, DOI 10.1097/HCO.0b013e3283315553; Wall ST, 2006, CIRCULATION, V114, P2627, DOI 10.1161/CIRCULATIONAHA.106.657270; Wang HB, 2010, J HEART LUNG TRANSPL, V29, P881, DOI 10.1016/j.healun.2010.03.016; Wang L, 2009, AM J PHYSIOL-HEART C, V297, pH1020, DOI 10.1152/ajpheart.01082.2008; Wang T, 2009, EUR J HEART FAIL, V11, P14, DOI 10.1093/eurjhf/hfn009; WHITTAKER P, 1991, CIRCULATION, V84, P2123, DOI 10.1161/01.CIR.84.5.2123; Wu DQ, 2009, ACS APPL MATER INTER, V1, P319, DOI 10.1021/am8000456; Yu J, 2009, BIOMATERIALS, V30, P751, DOI 10.1016/j.biomaterials.2008.09.059; Zhang PC, 2006, ARTIF ORGANS, V30, P86, DOI 10.1111/j.1525-1594.2006.00186.x	57	83	84	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21571	10.1371/journal.pone.0021571	http://dx.doi.org/10.1371/journal.pone.0021571			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731777	Green Published, gold, Green Submitted			2022-12-27	WOS:000292035400050
J	Falconar, AKI; Martinez, F				Falconar, Andrew K. I.; Martinez, Fernando			The NS1 Glycoprotein Can Generate Dramatic Antibody-Enhanced Dengue Viral Replication in Normal Out-Bred Mice Resulting in Lethal Multi-Organ Disease	PLOS ONE			English	Article							NONSTRUCTURAL-1 PROTEIN NS1; FC-GAMMA RECEPTORS; ACUTE LUNG INJURY; HUMAN-IGG-FC; DEPENDENT ENHANCEMENT; YELLOW-FEVER; MONOCLONAL-ANTIBODIES; HEMORRHAGIC-FEVER; VIRUS-INFECTION; ATYPICAL MANIFESTATIONS	Antibody-enhanced replication (AER) of dengue type-2 virus (DENV-2) strains and production of antibody-enhanced disease (AED) was tested in out-bred mice. Polyclonal antibodies (PAbs) generated against the nonstructural-1 (NS1) glycoprotein candidate vaccine of the New Guinea-C (NG-C) or NSx strains reacted strongly and weakly with these antigens, respectively. These PAbs contained the IgG2a subclass, which cross-reacted with the virion-associated envelope (E) glycoprotein of the DENV-2 NSx strain, suggesting that they could generate its AER via all mouse Fc gamma-receptor classes. Indeed, when these mice were challenged with a low dose (<0.5 LD50) of the DENV-2 NSx strain, but not the NG-C strain, they all generated dramatic and lethal DENV-2 AER/AED. These AER/AED mice developed life-threatening acute respiratory distress syndrome (ARDS), displayed by diffuse alveolar damage (DAD) resulting from i) dramatic interstitial alveolar septa-thickening with mononuclear cells, ii) some hyperplasia of alveolar type-II pneumocytes, iii) copious intra-alveolar protein secretion, iv) some hyaline membrane-covered alveolar walls, and v) DENV-2 antigen-positive alveolar macrophages. These mice also developed meningo-encephalitis, with greater than 90,000-fold DENV-2 AER titers in microglial cells located throughout their brain parenchyma, some of which formed nodules around dead neurons. Their spleens contained infiltrated megakaryocytes with DENV-2 antigen-positive red-pulp macrophages, while their livers displayed extensive necrosis, apoptosis and macro-and micro-steatosis, with DENV-2 antigen-positive Kuppfer cells and hepatocytes. Their infections were confirmed by DENV-2 isolations from their lungs, spleens and livers. These findings accord with those reported in fatal human "severe dengue" cases. This DENV-2 AER/AED was blocked by high concentrations of only the NG-C NS1 glycoprotein. These results imply a potential hazard of DENV NS1 glycoprotein-based vaccines, particularly against DENV strains that contain multiple mutations or genetic recombination within or between their DENV E and NS1 glycoprotein-encoding genes. The model provides potential for assessing DENV strain pathogenicity and anti-DENV therapies in normal mice.	[Falconar, Andrew K. I.] Univ Norte, Dept Ciencias Basicas Med, Grp Invest Enfermedades Trop, Barranquilla, Colombia; [Falconar, Andrew K. I.] London Sch Hyg & Trop Med, Dept Pathogen Mol Biol, London WC1, England; [Martinez, Fernando] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA	Universidad del Norte; University of London; London School of Hygiene & Tropical Medicine; University of Texas System; UTMD Anderson Cancer Center	Falconar, AKI (corresponding author), Univ Norte, Dept Ciencias Basicas Med, Grp Invest Enfermedades Trop, Barranquilla, Colombia.	afalconar@uninorte.edu.co			European Communities; Universidad del Norte	European Communities(European Commission); Universidad del Norte	This study was supported by the European Communities and the Universidad del Norte. The funders had no role in the design of the study, data generation or analysis or the preparation of the manuscript.	Andrew S M, 2001, Curr Protoc Immunol, VChapter 2, DOI [10.1002/0471142735.im0208s21, 10.1002/0471142735.im0209s21, 10.1002/0471142735.im0207s21]; Avirutnan P, 2007, PLOS PATHOG, V3, P1798, DOI 10.1371/journal.ppat.0030183; Balsitis SJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000790; Balsitis SJ, 2009, AM J TROP MED HYG, V80, P416, DOI 10.4269/ajtmh.2009.80.416; Barth OM, 2006, MEM I OSWALDO CRUZ, V101, P905, DOI 10.1590/S0074-02762006000800014; Basílio-de-Oliveira C.A., 2005, Braz J Infect Dis, V9, P341, DOI 10.1590/S1413-86702005000400012; Baudino L, 2006, SPRINGER SEMIN IMMUN, V28, P175, DOI 10.1007/s00281-006-0037-0; Bhamarapravati Natth, 1997, P115; Bhoopat L, 1996, ASIAN PAC J ALLERGY, V14, P107; Blackley S, 2007, J VIROL, V81, P13325, DOI 10.1128/JVI.01568-07; Bosma KJ, 2007, EXPERT OPIN EMERG DR, V12, P461, DOI 10.1517/14728214.12.3.461; Bozza FA, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-86; Chau Tran Nguyen Bich, 2008, J Infect Dis, V198, P516, DOI 10.1086/590117; Chen SP, 2008, ARCH VIROL, V153, P1175, DOI 10.1007/s00705-008-0090-1; CHURDBOONCHART V, 1990, Southeast Asian Journal of Tropical Medicine and Public Health, V21, P614; Costa SM, 2006, VACCINE, V24, P4562, DOI 10.1016/j.vaccine.2005.08.022; de Macedo FC, 2006, DIAGN MOL PATHOL, V15, P223, DOI 10.1097/01.pdm.0000213462.60645.cd; Dheen ST, 2007, CURR MED CHEM, V14, P1189, DOI 10.2174/092986707780597961; Durbin AP, 2008, VIROLOGY, V376, P429, DOI 10.1016/j.virol.2008.03.028; Falconar A. K. I., 1999, Recent Research Developments in Virology, V1, P437; Falconar AKI, 1997, ARCH VIROL, V142, P897, DOI 10.1007/s007050050127; Falconar AKI, 1999, ARCH VIROL, V144, P2313, DOI 10.1007/s007050050646; Falconar AKI, 2008, CLIN VACCINE IMMUNOL, V15, P549, DOI 10.1128/CVI.00351-07; Falconar AKI, 2007, CLIN VACCINE IMMUNOL, V14, P493, DOI 10.1128/CVI.00371-06; Falconar AKI, 2006, CLIN VACCINE IMMUNOL, V13, P1044, DOI 10.1128/CVI.00105-06; FALGOUT B, 1990, J VIROL, V64, P4356, DOI 10.1128/JVI.64.9.4356-4363.1990; Flamand M, 1999, J VIROL, V73, P6104, DOI 10.1128/JVI.73.7.6104-6110.1999; Garcia-Rivera EJ, 2002, LANCET, V360, P261, DOI 10.1016/S0140-6736(02)09481-3; German AC, 2006, T ROY SOC TROP MED H, V100, P1135, DOI 10.1016/j.trstmh.2006.02.008; Gil L, 2009, INT IMMUNOL, V21, P1175, DOI 10.1093/intimm/dxp082; GOULD EA, 1989, J GEN VIROL, V70, P1605, DOI 10.1099/0022-1317-70-6-1605; GOULD EA, 1987, J GEN VIROL, V68, P3105, DOI 10.1099/0022-1317-68-12-3105; Gubler Duane J, 2006, Novartis Found Symp, V277, P3, DOI 10.1002/0470058005.ch2; Gulati S, 2007, TROP MED INT HEALTH, V12, P1087, DOI 10.1111/j.1365-3156.2007.01891.x; HALL WC, 1991, AM J TROP MED HYG, V45, P408, DOI 10.4269/ajtmh.1991.45.408; HALSTEAD SB, 1973, J INFECT DIS, V128, P15, DOI 10.1093/infdis/128.1.15; Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4; HALSTEAD SB, 2004, TXB PEDIAT INFECT DI, V2, P2200; Hathirat P, 1993, Southeast Asian J Trop Med Public Health, V24 Suppl 1, P80; Hauser W, 1999, P NATL ACAD SCI USA, V96, P8120, DOI 10.1073/pnas.96.14.8120; Hayes EB, 2005, EMERG INFECT DIS, V11, P1167, DOI 10.3201/eid1108.050289a; HENCHAL EA, 1988, J GEN VIROL, V69, P2101, DOI 10.1099/0022-1317-69-8-2101; Huang KJ, 2006, J IMMUNOL, V176, P2825, DOI 10.4049/jimmunol.176.5.2825; HUANG S, 1993, SCIENCE, V259, P1742, DOI 10.1126/science.8456301; Huerre MR, 2001, VIRCHOWS ARCH, V438, P107; Innis Bruce L., 1995, P103; Jackson ST, 2008, W INDIAN MED J, V57, P373; JACOBS SC, 1994, J GEN VIROL, V75, P2399, DOI 10.1099/0022-1317-75-9-2399; Jefferis R, 2002, IMMUNOL LETT, V82, P57, DOI 10.1016/S0165-2478(02)00019-6; Jessie K, 2004, J INFECT DIS, V189, P1411, DOI 10.1086/383043; Johnson AJ, 1999, J VIROL, V73, P783, DOI 10.1128/JVI.73.1.783-786.1999; Kamath Shrishu R., 2006, Indian Journal of Pediatrics, V73, P889, DOI 10.1007/BF02859281; KLIKS SC, 1989, AM J TROP MED HYG, V40, P444, DOI 10.4269/ajtmh.1989.40.444; KONTNY U, 1988, J VIROL, V62, P3928, DOI 10.1128/JVI.62.11.3928-3933.1988; Lazo L, 2007, VACCINE, V25, P1064, DOI 10.1016/j.vaccine.2006.09.068; Le VT, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000854; Lee YR, 2005, INTERVIROLOGY, V48, P161, DOI 10.1159/000081744; Leitmeyer KC, 1999, J VIROL, V73, P4738, DOI 10.1128/JVI.73.6.4738-4747.1999; LITTAUA R, 1990, J IMMUNOL, V144, P3183; LUM LCS, 1995, ANN TROP PAEDIATR, V15, P335, DOI 10.1080/02724936.1995.11747794; Malavige G N, 2007, Indian J Med Microbiol, V25, P143; MARIANI M, 1991, MOL IMMUNOL, V28, P69, DOI 10.1016/0161-5890(91)90088-2; Miagostovich MP, 1997, CLIN NEUROPATHOL, V16, P204; Nimmerjahn F, 2006, IMMUNITY, V24, P19, DOI 10.1016/j.immuni.2005.11.010; Ong A, 2007, INT J INFECT DIS, V11, P263, DOI 10.1016/j.ijid.2006.02.012; Pang T, 2007, IMMUNOL CELL BIOL, V85, P43, DOI 10.1038/sj.icb.7100008; Perez-Ramirez G, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-260; Prestwood TR, 2008, J VIROL, V82, P8411, DOI 10.1128/JVI.00611-08; Quan Y, 2009, NEUROSCI LETT, V464, P29, DOI 10.1016/j.neulet.2009.08.013; Quaresma JAS, 2006, VIROLOGY, V345, P22, DOI 10.1016/j.virol.2005.09.058; Raghavendran K, 2008, CURR MED CHEM, V15, P1911, DOI 10.2174/092986708785132942; Ramos C, 1998, J NEUROVIROL, V4, P465, DOI 10.3109/13550289809114548; Rothman Alan L., 1997, P245; SCHLESINGER JJ, 1993, VIROLOGY, V192, P132, DOI 10.1006/viro.1993.1015; SCHLESINGER JJ, 1987, J GEN VIROL, V68, P853, DOI 10.1099/0022-1317-68-3-853; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Schul W, 2007, J INFECT DIS, V195, P665, DOI 10.1086/511310; Shresta S, 2004, VIROLOGY, V319, P262, DOI 10.1016/j.virol.2003.09.048; Shresta S, 2006, J VIROL, V80, P10208, DOI 10.1128/JVI.00062-06; Sittisombut N, 1997, AM J TROP MED HYG, V57, P100, DOI 10.4269/ajtmh.1997.57.100; Soares CN, 2011, J NEUROL SCI, V303, P75, DOI 10.1016/j.jns.2011.01.012; Song XY, 2002, INFECT IMMUN, V70, P5177, DOI 10.1128/IAI.70.9.5177-5184.2002; Srichaikul T, 2000, BEST PRACT RES CL HA, V13, P261, DOI 10.1053/beha.2000.0073; Stephenson JR, 2005, B WORLD HEALTH ORGAN, V83, P308; Tan GK, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000672; THEIN S, 1993, J MED VIROL, V40, P102, DOI 10.1002/jmv.1890400205; Thong MK, 1998, LANCET, V352, P1712, DOI 10.1016/S0140-6736(05)61496-1; Wasay M, 2008, CLIN NEUROL NEUROSUR, V110, P635, DOI 10.1016/j.clineuro.2008.03.011; World Health Organization, 1997, DENG HAEM FEV DIAGN, P12; Worobey M, 1999, P NATL ACAD SCI USA, V96, P7352, DOI 10.1073/pnas.96.13.7352; Yamanaka A, 2008, J VIROL, V82, P927, DOI 10.1128/JVI.00992-07; [No title captured]	92	14	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21024	10.1371/journal.pone.0021024	http://dx.doi.org/10.1371/journal.pone.0021024			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731643	Green Published, Green Submitted, gold			2022-12-27	WOS:000292033700030
J	Higashi, DL; Biais, N; Weyand, NJ; Agellon, A; Sisko, JL; Brown, LM; So, M				Higashi, Dustin L.; Biais, Nicolas; Weyand, Nathan J.; Agellon, Al; Sisko, Jennifer L.; Brown, Lewis M.; So, Magdalene			N. elongata Produces Type IV Pili That Mediate Interspecies Gene Transfer with N. gonorrhoeae	PLOS ONE			English	Article							DNA UPTAKE SEQUENCE; NEISSERIA-GONORRHOEAE; ANTIGENIC VARIATION; SUBSP GLYCOLYTICA; BACTERIAL PILI; TRANSFORMATION; MENINGITIDIS; PREVALENCE; SPECIMENS; NOV	The genus Neisseria contains at least eight commensal and two pathogenic species. According to the Neisseria phylogenetic tree, commensals are basal to the pathogens. N. elongata, which is at the opposite end of the tree from N. gonorrhoeae, has been observed to be fimbriated, and these fimbriae are correlated with genetic competence in this organism. We tested the hypothesis that the fimbriae of N. elongata are Type IV pili (Tfp), and that Tfp functions in genetic competence. We provide evidence that the N. elongata fimbriae are indeed Tfp. Tfp, as well as the DNA Uptake Sequence (DUS), greatly enhance N. elongata DNA transformation. Tfp allows N. elongata to make intimate contact with N. gonorrhoeae and to mediate the transfer of antibiotic resistance markers between these two species. We conclude that Tfp functional for genetic competence is a trait of a commensal member of the Neisseria genus. Our findings provide a mechanism for the horizontal gene transfer that has been observed among Neisseria species.	[Higashi, Dustin L.; Weyand, Nathan J.; Sisko, Jennifer L.; So, Magdalene] Univ Arizona, Dept Immunobiol, Tucson, AZ 85721 USA; [Higashi, Dustin L.; Weyand, Nathan J.; Sisko, Jennifer L.; So, Magdalene] Univ Arizona, Inst BIO5, Tucson, AZ USA; [Agellon, Al] Univ Arizona, Univ Spect & Imaging Facil, Tucson, AZ USA; [Biais, Nicolas; Brown, Lewis M.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	University of Arizona; University of Arizona; University of Arizona; Columbia University	Higashi, DL (corresponding author), Univ Arizona, Dept Immunobiol, Tucson, AZ 85721 USA.	somaggie@email.arizona.edu	So, Magdalene/ABB-8918-2020	So, Magdalene/0000-0001-8301-0674	NIH [AI068033]; BIO5 Institute; College of Medicine, University of Arizona; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024728] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068033] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BIO5 Institute; College of Medicine, University of Arizona; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by NIH grant AI068033 and funds from the BIO5 Institute and the College of Medicine, University of Arizona awarded to M. So. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aho EL, 2005, FEMS MICROBIOL LETT, V249, P327, DOI 10.1016/j.femsle.2005.06.035; Ambur OH, 2007, J BACTERIOL, V189, P2077, DOI 10.1128/JB.01408-06; Ayala BP, 2001, CELL MICROBIOL, V3, P265, DOI 10.1046/j.1462-5822.2001.00112.x; Biais N, 2010, P NATL ACAD SCI USA, V107, P11358, DOI 10.1073/pnas.0911328107; BISWAS GD, 1977, J BACTERIOL, V129, P983, DOI 10.1128/JB.129.2.983-992.1977; BOVRE K, 1970, J GEN MICROBIOL, V60, P67, DOI 10.1099/00221287-60-1-67; BOVRE K, 1977, ACTA PATH MICRO IM B, V85, P18; CATLIN BW, 1960, SCIENCE, V131, P608, DOI 10.1126/science.131.3400.608-a; CAUGANT DA, 1994, J CLIN MICROBIOL, V32, P323, DOI 10.1128/JCM.32.2.323-330.1994; Chen I, 2005, SCIENCE, V310, P1456, DOI 10.1126/science.1114021; Chen I, 2004, NAT REV MICROBIOL, V2, P241, DOI 10.1038/nrmicro844; CONTRERAS M, MICROBIOLOGY, V156, P3282; COZENS AL, 1994, AM J RESP CELL MOL, V10, P38, DOI 10.1165/ajrcmb.10.1.7507342; Craig L, 2006, MOL CELL, V23, P651, DOI 10.1016/j.molcel.2006.07.004; Dillard J. P., 2006, CURR PROTOC MICROBIO, V2; Duffin PM, 2010, J BACTERIOL, V192, P4436, DOI 10.1128/JB.00442-10; ELKINS C, 1991, J BACTERIOL, V173, P3911, DOI 10.1128/JB.173.12.3911-3913.1991; FROHOLM LO, 1973, ACTA PATH MICRO IM B, VB 81, P525; Gibiansky ML, 2010, SCIENCE, V330, P197, DOI 10.1126/science.1194238; GOODMAN SD, 1988, P NATL ACAD SCI USA, V85, P6982, DOI 10.1073/pnas.85.18.6982; HENRIKSEN SD, 1976, INT J SYST BACTERIOL, V26, P478, DOI 10.1099/00207713-26-4-478; Higashi DL, 2009, MICROBIOL-SGM, V155, P4084, DOI 10.1099/mic.0.032656-0; JANDA WM, 1980, JAMA-J AM MED ASSOC, V244, P2060, DOI 10.1001/jama.244.18.2060; Kent CK, 2005, CLIN INFECT DIS, V41, P67, DOI 10.1086/430704; KNAPP J S, 1988, Clinical Microbiology Reviews, V1, P415; LENNOX ES, 1955, VIROLOGY, V1, P190, DOI 10.1016/0042-6822(55)90016-7; LUJAN R, 1991, ANTIMICROB AGENTS CH, V35, P300, DOI 10.1128/AAC.35.2.300; Marri PR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011835; Mattick JS, 2002, ANNU REV MICROBIOL, V56, P289, DOI 10.1146/annurev.micro.56.012302.160938; Merz AJ, 1996, MOL MED, V2, P745, DOI 10.1007/BF03401658; MILLER K, 1985, J INFECTION, V10, P174, DOI 10.1016/S0163-4453(85)91690-1; Nudleman E, 2006, MOL MICROBIOL, V60, P16, DOI 10.1111/j.1365-2958.2006.05095.x; OSBORNE NG, 1979, SEX TRANSM DIS, V6, P253, DOI 10.1097/00007435-197910000-00006; OTTOW JCG, 1975, ANNU REV MICROBIOL, V29, P79, DOI 10.1146/annurev.mi.29.100175.000455; PARGE HE, 1987, A VAN LEEUW J MICROB, V53, P447, DOI 10.1007/BF00415501; Qvarnstrom Y, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-11; SEGAL E, 1986, P NATL ACAD SCI USA, V83, P2177, DOI 10.1073/pnas.83.7.2177; SEIFERT HS, 1988, NATURE, V336, P392, DOI 10.1038/336392a0; SOX TE, 1979, J BACTERIOL, V138, P510, DOI 10.1128/JB.138.2.510-518.1979; SPARLING PF, 1966, J BACTERIOL, V92, P1364, DOI 10.1128/JB.92.5.1364-1371.1966; Takahashi Satoshi, 2008, Journal of Infection and Chemotherapy, V14, P442, DOI 10.1007/s10156-008-0649-5; Treangen TJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r60; Weyand NJ, 2010, J IMMUNOL, V184, P694, DOI 10.4049/jimmunol.0900522; Wolfgang M, 2000, EMBO J, V19, P6408, DOI 10.1093/emboj/19.23.6408; Wu HM, 2009, NEW ENGL J MED, V360, P886, DOI 10.1056/NEJMoa0806414; Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259; ZHANG QY, 1992, P NATL ACAD SCI USA, V89, P5366, DOI 10.1073/pnas.89.12.5366	47	26	26	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21373	10.1371/journal.pone.0021373	http://dx.doi.org/10.1371/journal.pone.0021373			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731720	Green Published, gold, Green Submitted			2022-12-27	WOS:000292033700069
J	Keeley, EC; Moorman, JR; Liu, L; Gimple, LW; Lipson, LC; Ragosta, M; Taylor, AM; Lake, DE; Burdick, MD; Mehrad, B; Strieter, RM				Keeley, Ellen C.; Moorman, J. Randall; Liu, Ling; Gimple, Lawrence W.; Lipson, Lewis C.; Ragosta, Michael; Taylor, Angela M.; Lake, Douglas E.; Burdick, Marie D.; Mehrad, Borna; Strieter, Robert M.			Plasma Chemokine Levels Are Associated with the Presence and Extent of Angiographic Coronary Collaterals in Chronic Ischemic Heart Disease	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; ARTERY-DISEASE; DIABETES-MELLITUS; PROGNOSTIC-SIGNIFICANCE; ANGINA-PECTORIS; BYPASS SURGERY; OFF-PUMP; CIRCULATION; FLOW; OCCLUSION	Background: In patients with chronic ischemic heart disease (IHD), the presence and extent of spontaneously visible coronary collaterals are powerful determinants of clinical outcome. There is marked heterogeneity in the recruitment of coronary collaterals amongst patients with similar degrees of coronary artery stenoses, but the biological basis of this heterogeneity is not known. Chemokines are potent mediators of vascular remodeling in diverse biological settings. Their role in coronary collateralization has not been investigated. We sought to determine whether plasma levels of angiogenic and angiostatic chemokines are associated with of the presence and extent of coronary collaterals in patients with chronic IHD. Methodology/Principal Findings: We measured plasma concentrations of angiogenic and angiostatic chemokine ligands in 156 consecutive subjects undergoing coronary angiography with at least one >= 90% coronary stenosis and determined the presence and extent of spontaneously visible coronary collaterals using the Rentrop scoring system. Eighty-eight subjects (56%) had evidence of coronary collaterals. In a multivariable regression model, the concentration of the angiogenic ligands CXCL5, CXCL8 and CXCL12, hyperlipidemia, and an occluded artery were associated with the presence of collaterals; conversely, the concentration of the angiostatic ligand CXCL11, interferon-gamma, hypertension and diabetes were associated with the absence of collaterals (ROC area 0.91). When analyzed according to extent of collateralization, higher Rentrop scores were significantly associated with increased concentration of the angiogenic ligand CXCL1 (p<0.0001), and decreased concentrations of angiostatic ligands CXCL9 (p<0.0001), CXCL10 (p = 0.002), and CXCL11 (p = 0.0002), and interferon-gamma (p = 0.0004). Conclusions/Significance: Plasma chemokine concentrations are associated with the presence and extent of spontaneously visible coronary artery collaterals and may be mechanistically involved in their recruitment.	[Keeley, Ellen C.; Moorman, J. Randall; Liu, Ling; Gimple, Lawrence W.; Lipson, Lewis C.; Ragosta, Michael; Taylor, Angela M.; Lake, Douglas E.] Univ Virginia, Div Cardiol, Charlottesville, VA 22903 USA; [Keeley, Ellen C.; Moorman, J. Randall; Liu, Ling; Gimple, Lawrence W.; Lipson, Lewis C.; Ragosta, Michael; Taylor, Angela M.; Lake, Douglas E.; Burdick, Marie D.; Mehrad, Borna; Strieter, Robert M.] Univ Virginia, Dept Med, Charlottesville, VA USA; [Burdick, Marie D.; Mehrad, Borna; Strieter, Robert M.] Univ Virginia, Div Pulm & Crit Care Med, Charlottesville, VA USA; [Lake, Douglas E.] Univ Virginia, Dept Stat, Charlottesville, VA USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia	Keeley, EC (corresponding author), Univ Virginia, Div Cardiol, Charlottesville, VA 22903 USA.	Keeley@Virginia.edu	Mehrad, Borna/D-9363-2015; Mehrad, Borna/AAC-9876-2019; Mehrad, Borna/G-2659-2010; Moorman, J Randall/ABG-9946-2020	Mehrad, Borna/0000-0001-5198-065X; Mehrad, Borna/0000-0001-5198-065X; Taylor, Angela/0000-0003-4927-4320	National Institutes of Health [HL97074, HL73848, CA87879, HL66027, HL98526]; NATIONAL CANCER INSTITUTE [R01CA087879] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL097074, R01HL098329, R01HL073848, R01HL098526, K23HL093118, R01HL066027] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health (HL97074 to ECK, HL73848 to BM, and CA87879, HL66027 and HL98526 to RMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaci A, 1999, CIRCULATION, V99, P2239, DOI 10.1161/01.CIR.99.17.2239; Abbott JD, 2005, AM J CARDIOL, V96, P676, DOI 10.1016/j.amjcard.2005.04.043; Ardigo D, 2007, PHYSIOL GENOMICS, V31, P402, DOI 10.1152/physiolgenomics.00104.2007; Berry C, 2007, EUR HEART J, V28, P278, DOI 10.1093/eurheartj/ehl446; Billinger M, 2002, J AM COLL CARDIOL, V40, P1545, DOI 10.1016/S0735-1097(02)02378-1; Briguori C, 2006, AM J CARDIOL, V97, P472, DOI 10.1016/j.amjcard.2005.09.076; Caputo M, 2008, ANN THORAC SURG, V85, P71, DOI 10.1016/j.athoracsur.2007.08.026; Chung NA, 2003, HEART, V89, P1411, DOI 10.1136/heart.89.12.1411; COHEN M, 1989, J AM COLL CARDIOL, V13, P297, DOI 10.1016/0735-1097(89)90502-0; Damas JK, 2000, CARDIOVASC RES, V47, P778, DOI 10.1016/S0008-6363(00)00142-5; Desch S, 2010, AM J CARDIOL, V106, P605, DOI 10.1016/j.amjcard.2010.04.010; Dincer I, 2006, CORONARY ARTERY DIS, V17, P561; Elsman P, 2004, EUR HEART J, V25, P854, DOI 10.1016/j.ehj.2004.03.005; Fleisch M, 1999, CIRCULATION, V100, P1945, DOI 10.1161/01.CIR.100.19.1945; HABIB GB, 1991, CIRCULATION, V83, P739, DOI 10.1161/01.CIR.83.3.739; HIRAI T, 1989, CIRCULATION, V79, P791, DOI 10.1161/01.CIR.79.4.791; Hughes GC, 2005, EXPERT REV CARDIOVAS, V3, P521, DOI 10.1586/14779072.3.3.521; Ishihara M, 2005, AM J CARDIOL, V95, P622, DOI 10.1016/j.amjcard.2004.11.009; Keeley EC, 2008, ARTERIOSCL THROM VAS, V28, P1928, DOI 10.1161/ATVBAHA.108.162925; Kodama K, 1996, J AM COLL CARDIOL, V27, P1133, DOI 10.1016/0735-1097(95)00596-X; Koerselman J, 2005, AM J CARDIOL, V96, P390, DOI 10.1016/j.amjcard.2005.03.083; Koerselman J, 2003, CIRCULATION, V107, P2507, DOI 10.1161/01.CIR.0000065118.99409.5F; Kornowski R, 2003, CORONARY ARTERY DIS, V14, P61, DOI 10.1097/00019501-200302000-00007; Lakshminarayanan V, 2001, AM J PATHOL, V159, P1301, DOI 10.1016/S0002-9440(10)62517-5; LEVIN DC, 1974, CIRCULATION, V50, P831, DOI 10.1161/01.CIR.50.4.831; Mason MJ, 2000, CORONARY ARTERY DIS, V11, P573, DOI 10.1097/00019501-200012000-00001; Meier P, 2007, CIRCULATION, V116, P975, DOI 10.1161/CIRCULATIONAHA.107.703959; Nathoe HM, 2006, AM J CARDIOL, V98, P31, DOI 10.1016/j.amjcard.2006.01.050; Nathoe HM, 2004, CIRCULATION, V110, P1738, DOI 10.1161/01.CIR.0000143105.42988.FD; Nisanci Yilmaz, 2002, J Invasive Cardiol, V14, P118; Nurkalem Z, 2008, ACTA CARDIOL, V63, P141, DOI 10.2143/AC.63.2.2029519; Olijhoek JK, 2005, DIABETES CARE, V28, P683, DOI 10.2337/diacare.28.3.683; Panchal VR, 2004, J AM COLL CARDIOL, V43, P1383, DOI 10.1016/j.jacc.2003.10.063; Piek JJ, 1997, J AM COLL CARDIOL, V29, P275, DOI 10.1016/S0735-1097(96)00499-8; Pohl T, 2001, J AM COLL CARDIOL, V38, P1872, DOI 10.1016/S0735-1097(01)01675-8; Pourati I, 2003, AM HEART J, V146, P876, DOI 10.1016/S0002-8703(03)00413-7; Regieli JJ, 2009, INT J CARDIOL, V132, P257, DOI 10.1016/j.ijcard.2007.11.100; RENTROP KP, 1985, J AM COLL CARDIOL, V5, P587; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Schultz A, 1999, CIRCULATION, V100, P547, DOI 10.1161/01.CIR.100.5.547; Seiler C, 2010, EUR J CLIN INVEST, V40, P465, DOI 10.1111/j.1365-2362.2010.02282.x; Sherman JA, 2006, AM J CARDIOL, V98, P1194, DOI 10.1016/j.amjcard.2006.05.046; Simonini A, 2000, CIRCULATION, V101, P1519, DOI 10.1161/01.CIR.101.13.1519; STRIETER RM, 1995, J BIOL CHEM, V270, P27348, DOI 10.1074/jbc.270.45.27348; van Liebergen RAM, 1999, J AM COLL CARDIOL, V33, P670, DOI 10.1016/S0735-1097(98)00640-8; Waltenberger J, 2001, CARDIOVASC RES, V49, P554, DOI 10.1016/S0008-6363(00)00228-5; Werner GS, 2004, CIRCULATION, V110, P1940, DOI 10.1161/01.CIR.0000143624.72027.11; Zbinden R, 2005, HEART, V91, P1289, DOI 10.1136/hrt.2004.041236	48	31	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21174	10.1371/journal.pone.0021174	http://dx.doi.org/10.1371/journal.pone.0021174			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731663	gold, Green Submitted, Green Published			2022-12-27	WOS:000292033700042
J	Caspi-Fluger, A; Inbar, M; Mozes-Daube, N; Mouton, L; Hunter, MS; Zchori-Fein, E				Caspi-Fluger, Ayelet; Inbar, Moshe; Mozes-Daube, Netta; Mouton, Laurence; Hunter, Martha S.; Zchori-Fein, Einat			Rickettsia 'In' and 'Out': Two Different Localization Patterns of a Bacterial Symbiont in the Same Insect Species	PLOS ONE			English	Article							APHID ACYRTHOSIPHON-PISUM; PEA APHID; BEMISIA-TABACI; ENDOSYMBIOTIC BACTERIUM; WOLBACHIA; FITNESS; IDENTIFICATION; EVOLUTION; BIOLOGY	Intracellular symbionts of arthropods have diverse influences on their hosts, and their functions generally appear to be associated with their localization within the host. The effect of localization pattern on the role of a particular symbiont cannot normally be tested since the localization pattern within hosts is generally invariant. However, in Israel, the secondary symbiont Rickettsia is unusual in that it presents two distinct localization patterns throughout development and adulthood in its whitefly host, Bemisia tabaci (B biotype). In the "scattered'' pattern, Rickettsia is localized throughout the whitefly hemocoel, excluding the bacteriocytes, where the obligate symbiont Portiera aleyrodidarum and some other secondary symbionts are housed. In the "confined'' pattern, Rickettsia is restricted to the bacteriocytes. We examined the effects of these patterns on Rickettsia densities, association with other symbionts (Portiera and Hamiltonella defensa inside the bacteriocytes) and on the potential for horizontal transmission to the parasitoid wasp, Eretmocerus mundus, while the wasp larvae are developing within the whitefly nymph. Sequences of four Rickettsia genes were found to be identical for both localization patterns, suggesting that they are closely related strains. However, real-time PCR analysis showed very different dynamics for the two localization types. On the first day post-adult emergence, Rickettsia densities were 21 times higher in the "confined'' pattern vs. "scattered'' pattern whiteflies. During adulthood, Rickettsia increased in density in the "scattered'' pattern whiteflies until it reached the "confined'' pattern Rickettsia density on day 21. No correlation between Rickettsia densities and Hamiltonella or Portiera densities were found for either localization pattern. Using FISH technique, we found Rickettsia in the gut of the parasitoid wasps only when they developed on whiteflies with the "scattered'' pattern. The results suggest that the localization pattern of a symbiont may influence its dynamics within the host.	[Caspi-Fluger, Ayelet; Mozes-Daube, Netta; Zchori-Fein, Einat] ARO, Dept Entomol, Newe Yaar Res Ctr, Ramat Yishay, Israel; [Caspi-Fluger, Ayelet; Inbar, Moshe] Univ Haifa, Dept Evolutionary & Environm Biol, IL-31999 Haifa, Israel; [Mouton, Laurence] Univ Lyon 1, CNRS, Lab Biometrie & Biol Evolut, UMR 5558, F-69622 Villeurbanne, France; [Hunter, Martha S.] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA	University of Haifa; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; University of Arizona	Caspi-Fluger, A (corresponding author), ARO, Dept Entomol, Newe Yaar Res Ctr, Ramat Yishay, Israel.	einat@volcani.agri.gov.il	Hunter, Martha/AAF-5288-2020; Hunter, Martha/B-7307-2012	Hunter, Martha/0000-0002-6342-675X; Hunter, Martha/0000-0002-6342-675X; Inbar, Moshe/0000-0002-4707-9508; Mouton, Laurence/0000-0002-2718-9953	BARD [US-4304-10 R]; United States-Israel Binational Agricultural Research and Development Fund; Israel Science Foundation [262/09]; STSM COST [FA0701-05091]	BARD(US-Israel Binational Science Foundation); United States-Israel Binational Agricultural Research and Development Fund(US-Israel Binational Science Foundation); Israel Science Foundation(Israel Science Foundation); STSM COST	This research was supported by Research Grant No. US-4304-10 R from BARD, the United States-Israel Binational Agricultural Research and Development Fund (http://www.bard-isus.com) E.Z.-F. and M. S. H., The Israel Science Foundation (http://www.isf.org.il/) Grant No. 262/09 to E.Z.-F., and by a STSM COST grant (http://www.cost-fa0701.com/) to N.M.-D. Grant No. FA0701-05091. The funders had no role in study design, data collection and analysis, decision to publidh, or preparation of the manuscript.	Baumann P, 2005, ANNU REV MICROBIOL, V59, P155, DOI 10.1146/annurev.micro.59.030804.121041; Braquart-Varnier C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003286; Bution ML, 2008, MICRON, V39, P1179, DOI 10.1016/j.micron.2008.05.003; Chen DQ, 1996, CURR MICROBIOL, V33, P123, DOI 10.1007/s002849900086; Chen DQ, 2000, ENTOMOL EXP APPL, V95, P315, DOI 10.1023/A:1004083324807; Chiel E, 2007, B ENTOMOL RES, V97, P407, DOI 10.1017/S0007485307005159; Chiel E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004767; Chiel E, 2009, ANN ENTOMOL SOC AM, V102, P413, DOI 10.1603/008.102.0309; Ferrari J, 2004, ECOL ENTOMOL, V29, P60, DOI 10.1111/j.1365-2311.2004.00574.x; Fournier PE, 2003, J CLIN MICROBIOL, V41, P5456, DOI 10.1128/JCM.41.12.5456-5465.2003; Frohlich DR, 1999, MOL ECOL, V8, P1683, DOI 10.1046/j.1365-294x.1999.00754.x; Fukatsu T, 2000, APPL ENVIRON MICROB, V66, P2748, DOI 10.1128/AEM.66.7.2748-2758.2000; Fukatsu T, 2001, APPL ENVIRON MICROB, V67, P1284, DOI 10.1128/AEM.67.3.1284-1291.2001; Gottlieb Y, 2008, FASEB J, V22, P2591, DOI 10.1096/fj.07-101162; Gottlieb Y, 2006, APPL ENVIRON MICROB, V72, P3646, DOI 10.1128/AEM.72.5.3646-3652.2006; Gottlieb Y, 2010, J VIROL, V84, P9310, DOI 10.1128/JVI.00423-10; Gouin E, 2004, NATURE, V427, P457, DOI 10.1038/nature02318; Gueguen G, 2010, MOL ECOL, V19, P4365, DOI 10.1111/j.1365-294X.2010.04775.x; HENDI A, 1984, B ENTOMOL SOC EGYPT, V65, P101; Koga R, 2003, P ROY SOC B-BIOL SCI, V270, P2543, DOI 10.1098/rspb.2003.2537; Macaluso KR, 2008, VECTOR-BORNE ZOONOT, V8, P391, DOI 10.1089/vbz.2007.0218; Matalon Y, 2007, J INVERTEBR PATHOL, V96, P106, DOI 10.1016/j.jip.2007.02.010; Min KT, 1997, P NATL ACAD SCI USA, V94, P10792, DOI 10.1073/pnas.94.20.10792; Montllor CB, 2002, ECOL ENTOMOL, V27, P189, DOI 10.1046/j.1365-2311.2002.00393.x; Moran NA, 2005, P NATL ACAD SCI USA, V102, P16919, DOI 10.1073/pnas.0507029102; Moran NA, 2005, APPL ENVIRON MICROB, V71, P3302, DOI 10.1128/AEM.71.6.3302-3310.2005; Mouton L, 2003, MOL ECOL, V12, P3459, DOI 10.1046/j.1365-294X.2003.02015.x; Nakabachi A, 2005, P NATL ACAD SCI USA, V102, P5477, DOI 10.1073/pnas.0409034102; Oliver KM, 2003, P NATL ACAD SCI USA, V100, P1803, DOI 10.1073/pnas.0335320100; POWELL DA, 1992, J APPL ENTOMOL, V113, P68, DOI 10.1111/j.1439-0418.1992.tb00637.x; Rosenberg E, 2010, ENV MICROBIOL REP, V2, P500, DOI 10.1111/j.1758-2229.2010.00177.x; Roux V, 1997, INT J SYST BACTERIOL, V47, P252, DOI 10.1099/00207713-47-2-252; Russell JA, 2005, APPL ENVIRON MICROB, V71, P7987, DOI 10.1128/AEM.71.12.7987-7994.2005; Sakurai M, 2005, APPL ENVIRON MICROB, V71, P4069, DOI 10.1128/AEM.71.7.4069-4075.2005; Sinisterra XH, 2005, J GEN VIROL, V86, P1525, DOI 10.1099/vir.0.80665-0; Stouthamer R, 1999, ANNU REV MICROBIOL, V53, P71, DOI 10.1146/annurev.micro.53.1.71; Tsuchida T, 2005, MICROB ECOL, V49, P126, DOI 10.1007/s00248-004-0216-2; Tsuchida T, 2004, SCIENCE, V303, P1989, DOI 10.1126/science.1094611; Vautrin E, 2009, TRENDS MICROBIOL, V17, P95, DOI 10.1016/j.tim.2008.12.002; Weintraub PG, 2006, ANNU REV ENTOMOL, V51, P91, DOI 10.1146/annurev.ento.51.110104.151039; Werren JH, 1997, ANNU REV ENTOMOL, V42, P587, DOI 10.1146/annurev.ento.42.1.587; Zchori-Fein E, 2001, P NATL ACAD SCI USA, V98, P12555, DOI 10.1073/pnas.221467498; Zchori-Fein E, 2012, FRONT MICROBIOL SER, pIX	43	51	57	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2011	6	6							e21096	10.1371/journal.pone.0021096	http://dx.doi.org/10.1371/journal.pone.0021096			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782CL	21712994	Green Published, gold, Green Submitted			2022-12-27	WOS:000291985100010
J	Dupin, M; Reynaud, P; Jarosik, V; Baker, R; Brunel, S; Eyre, D; Pergl, J; Makowski, D				Dupin, Maxime; Reynaud, Philippe; Jarosik, Vojtech; Baker, Richard; Brunel, Sarah; Eyre, Dominic; Pergl, Jan; Makowski, David			Effects of the Training Dataset Characteristics on the Performance of Nine Species Distribution Models: Application to Diabrotica virgifera virgifera	PLOS ONE			English	Article							WESTERN CORN-ROOTWORM; SAMPLE-SIZE; GEOGRAPHICAL-DISTRIBUTION; CLIMATE-CHANGE; CHRYSOMELIDAE; COLEOPTERA; INVASIONS; ACCURACY; TEMPERATURE; NORTHERN	Many distribution models developed to predict the presence/absence of invasive alien species need to be fitted to a training dataset before practical use. The training dataset is characterized by the number of recorded presences/absences and by their geographical locations. The aim of this paper is to study the effect of the training dataset characteristics on model performance and to compare the relative importance of three factors influencing model predictive capability; size of training dataset, stage of the biological invasion, and choice of input variables. Nine models were assessed for their ability to predict the distribution of the western corn rootworm, Diabrotica virgifera virgifera, a major pest of corn in North America that has recently invaded Europe. Twenty-six training datasets of various sizes (from 10 to 428 presence records) corresponding to two different stages of invasion (1955 and 1980) and three sets of input bioclimatic variables (19 variables, six variables selected using information on insect biology, and three linear combinations of 19 variables derived from Principal Component Analysis) were considered. The models were fitted to each training dataset in turn and their performance was assessed using independent data from North America and Europe. The models were ranked according to the area under the Receiver Operating Characteristic curve and the likelihood ratio. Model performance was highly sensitive to the geographical area used for calibration; most of the models performed poorly when fitted to a restricted area corresponding to an early stage of the invasion. Our results also showed that Principal Component Analysis was useful in reducing the number of model input variables for the models that performed poorly with 19 input variables. DOMAIN, Environmental Distance, MAXENT, and Envelope Score were the most accurate models but all the models tested in this study led to a substantial rate of mis-classification.	[Dupin, Maxime] INRA, UR Zool Forestiere, Orleans, France; [Dupin, Maxime] CIRAD, UMR Peuplement Vegetaux & Bio Agresseurs Milieu T, Montpellier, France; [Dupin, Maxime; Reynaud, Philippe] Anses, Lab Sante Vegetaux, Stn Angers, Angers, France; [Jarosik, Vojtech] Charles Univ Prague, Fac Sci, Dept Ecol, Prague, Czech Republic; [Baker, Richard; Eyre, Dominic] Food & Environm Res Agcy, York, N Yorkshire, England; [Brunel, Sarah] EPPO OEPP, Paris, France; [Jarosik, Vojtech; Pergl, Jan] ASCR, Inst Bot, Pruhonice, Czech Republic; [Pergl, Jan] Univ Bern, Inst Ecol & Evolut, Bern, Switzerland; [Makowski, David] INRA, UMR INRA AgroParisTech 211, Thiverval Grignon, France	INRAE; CIRAD; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Laboratoire de la Sante des Vegetaux; Charles University Prague; Food & Environment Research Agency; Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; University of Bern; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Dupin, M (corresponding author), INRA, UR Zool Forestiere, Orleans, France.	makowski@grignon.inra.fr	Makowski, David/V-4233-2019; Pergl, Jan/H-1071-2011	Makowski, David/0000-0001-6385-3703; Pergl, Jan/0000-0002-0045-1974	European Commission [212459]; Czech Science Foundation [206/09/0563]; Ministry of Education, Youth and Sports of the Czech Republic [MSM0021620828, AV0Z60050516, LC06073]	European Commission(European CommissionEuropean Commission Joint Research Centre); Czech Science Foundation(Grant Agency of the Czech Republic); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	This work was funded by the European project PRATIQUE (Framework Programme 7 of the European Commission Grant No 212459). VJ and JP acknowledge support by grant no. 206/09/0563 from the Czech Science Foundation, and long-term research plans nos. MSM0021620828, AV0Z60050516 and LC06073 from the Ministry of Education, Youth and Sports of the Czech Republic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragon P, 2010, J APPL ECOL, V47, P1026, DOI 10.1111/j.1365-2664.2010.01847.x; Barry S, 2006, J APPL ECOL, V43, P413, DOI 10.1111/j.1365-2664.2006.01136.x; Beaumont LJ, 2009, DIVERS DISTRIB, V15, P409, DOI 10.1111/j.1472-4642.2008.00547.x; Beaumont LJ, 2005, ECOL MODEL, V186, P250, DOI 10.1016/j.ecolmodel.2005.01.030; Busby JR, 1991, NATURE CONSERVATION, P64, DOI DOI 10.1046/J.1365-294X.2001.01244.X; CAITHNESS N, 1995, THESIS U WITWATERSRA; CALKINS CO, 1969, J ECON ENTOMOL, V62, P541, DOI 10.1093/jee/62.3.541; CARPENTER G, 1993, BIODIVERS CONSERV, V2, P667, DOI 10.1007/BF00051966; Carroll SS, 1998, ECOGRAPHY, V21, P401, DOI 10.1111/j.1600-0587.1998.tb00405.x; CHIANG HC, 1973, ANNU REV ENTOMOL, V18, P47, DOI 10.1146/annurev.en.18.010173.000403; Chilcott C, 2003, CLIMATE CHANGE IMPAC, P63; Ciosi M, 2008, MOL ECOL, V17, P3614, DOI 10.1111/j.1365-294X.2008.03866.x; Cumming GS, 2000, J BIOGEOGR, V27, P441, DOI 10.1046/j.1365-2699.2000.00408.x; *DAISIE, 2009, INV EC, V3; Davis PM, 1996, ENVIRON ENTOMOL, V25, P767, DOI 10.1093/ee/25.4.767; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Elith J, 2009, ECOGRAPHY, V32, P66, DOI 10.1111/j.1600-0587.2008.05505.x; Ellsbury MM, 2004, ENTOMOL EXP APPL, V111, P159, DOI 10.1111/j.0013-8703.2004.00163.x; GAVLOSKI JE, 1992, J ECON ENTOMOL, V85, P1434, DOI 10.1093/jee/85.4.1434; Giovanelli JGR, 2010, ECOL MODEL, V221, P215, DOI 10.1016/j.ecolmodel.2009.10.009; GODFREY LD, 1995, J ECON ENTOMOL, V88, P1445, DOI 10.1093/jee/88.5.1445; Hayes Keith R., 2003, P382; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hijmans RJ, 2005, DIVA GIS VERSION 5 2; Hughes G, 1999, PLANT PATHOL, V48, P147, DOI 10.1046/j.1365-3059.1999.00327.x; Jeschke JM, 2008, ANN NY ACAD SCI, V1134, P1, DOI 10.1196/annals.1439.002; Kadmon R, 2003, ECOL APPL, V13, P853, DOI 10.1890/1051-0761(2003)013[0853:ASAOFA]2.0.CO;2; Kriticos D. J., 2001, Weed risk assessment, P61; KRYSAN JL, 1978, J INSECT PHYSIOL, V24, P535, DOI 10.1016/0022-1910(78)90055-0; LEVINE E, 1992, J ECON ENTOMOL, V85, P2425, DOI 10.1093/jee/85.6.2425; Lodge DM, 2006, ECOL APPL, V16, P2035, DOI 10.1890/1051-0761(2006)016[2035:BIRFUP]2.0.CO;2; Luoto M, 2005, GLOBAL ECOL BIOGEOGR, V14, P575, DOI 10.1111/j.1466-822x.2005.00186.x; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Magarey RD, 2007, PLANT DIS, V91, P336, DOI 10.1094/PDIS-91-4-0336; Marmion M, 2009, ECOL MODEL, V220, P3512, DOI 10.1016/j.ecolmodel.2008.10.019; McPherson JM, 2004, J APPL ECOL, V41, P811, DOI 10.1111/j.0021-8901.2004.00943.x; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; Munoz MES, 2009, GEOINFORMATICA; Murtaugh PA, 1996, ECOL APPL, V6, P132, DOI 10.2307/2269559; Nix H., 1986, ATLAS ELAPID SNAKES; Norman G., 2014, BIOSTATISTICS BARE E, V4; Pearce J, 2000, ECOL MODEL, V128, P127, DOI 10.1016/S0304-3800(99)00227-6; Pearce JL, 2006, J APPL ECOL, V43, P405, DOI 10.1111/j.1365-2664.2005.01112.x; Peterson AT, 2001, BIOSCIENCE, V51, P363, DOI 10.1641/0006-3568(2001)051[0363:PSIUEN]2.0.CO;2; Peterson AT, 2003, Q REV BIOL, V78, P419, DOI 10.1086/378926; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Pimentel D., 2002, BIOL INVASIONS EC EN; Pineiro R, 2007, MOL ECOL, V16, P2155, DOI 10.1111/j.1365-294X.2007.03280.x; Quinn GP, 2003, EXPT DESIGN DATA ANA; Robertson M. P., 2001, Diversity and Distributions, V7, P15, DOI 10.1046/j.1472-4642.2001.00094.x; SCHAAFSMA AW, 1991, CAN ENTOMOL, V123, P1183, DOI 10.4039/Ent1231183-6; Segurado P, 2004, J BIOGEOGR, V31, P1555, DOI 10.1111/j.1365-2699.2004.01076.x; Spencer JL, 2005, WESTERN CORN ROOTWORM: ECOLOGY AND MANAGEMENT, P121, DOI 10.1079/9780851998176.0121; Stockwell D, 1999, INT J GEOGR INF SCI, V13, P143, DOI 10.1080/136588199241391; Stockwell DRB, 2002, ECOL MODEL, V148, P1, DOI 10.1016/S0304-3800(01)00388-X; STOCKWELL DRB, 1992, MATH COMPUT SIMULAT, V33, P385, DOI 10.1016/0378-4754(92)90126-2; Sutherst R.W., 2004, USE CLIMEX PEST RISK; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Toepfer S, 2006, J APPL ENTOMOL, V130, P193, DOI 10.1111/j.1439-0418.2006.01060.x; Tsoar A, 2007, DIVERS DISTRIB, V13, P397, DOI 10.1111/j.1472-4642.2007.00346.x; Urban MC, 2007, P ROY SOC B-BIOL SCI, V274, P1413, DOI 10.1098/rspb.2007.0114; Vaclavik T, 2009, ECOL MODEL, V220, P3248, DOI 10.1016/j.ecolmodel.2009.08.013; Vapnik V., 2013, NATURE STAT LAERNING; Vila M, 2010, FRONT ECOL ENVIRON, V8, P135, DOI 10.1890/080083; Williams SE, 2003, P ROY SOC B-BIOL SCI, V270, P1887, DOI 10.1098/rspb.2003.2464; Winter M, 2009, P NATL ACAD SCI USA, V106, P21721, DOI 10.1073/pnas.0907088106; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Yuen JE, 2002, PLANT PATHOL, V51, P407, DOI 10.1046/j.0032-0862.2002.00741.x	71	51	55	4	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e20957	10.1371/journal.pone.0020957	http://dx.doi.org/10.1371/journal.pone.0020957			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	21701579	Green Published, Green Submitted, gold			2022-12-27	WOS:000291983800015
J	Logerot, P; Krutzfeldt, NOE; Wild, JM; Kubke, MF				Logerot, Priscilla; Kruetzfeldt, Nils O. E.; Wild, J. Martin; Kubke, M. Fabiana			Subdivisions of the Auditory Midbrain (N. Mesencephalicus Lateralis, pars dorsalis) in Zebra Finches Using Calcium-Binding Protein Immunocytochemistry	PLOS ONE			English	Article							OWL TYTO-ALBA; NUCLEUS ROBUSTUS-ARCHISTRIATALIS; CALBINDIN-LIKE IMMUNOREACTIVITY; AVIAN TORUS SEMICIRCULARIS; CHRYSEMYS-SCRIPTA-ELEGANS; HUMAN INFERIOR COLLICULUS; AREA OCTAVO-LATERALIS; RED-EARED TURTLE; BARN OWL; XENOPUS-LAEVIS	The midbrain nucleus mesencephalicus lateralis pars dorsalis (MLd) is thought to be the avian homologue of the central nucleus of the mammalian inferior colliculus. As such, it is a major relay in the ascending auditory pathway of all birds and in songbirds mediates the auditory feedback necessary for the learning and maintenance of song. To clarify the organization of MLd, we applied three calcium binding protein antibodies to tissue sections from the brains of adult male and female zebra finches. The staining patterns resulting from the application of parvalbumin, calbindin and calretinin antibodies differed from each other and in different parts of the nucleus. Parvalbumin-like immunoreactivity was distributed throughout the whole nucleus, as defined by the totality of the terminations of brainstem auditory afferents; in other words parvalbumin-like immunoreactivity defines the boundaries of MLd. Staining patterns of parvalbumin, calbindin and calretinin defined two regions of MLd: inner (MLd.I) and outer (MLd.O). MLd. O largely surrounds MLd. I and is distinct from the surrounding intercollicular nucleus. Unlike the case in some non-songbirds, however, the two MLd regions do not correspond to the terminal zones of the projections of the brainstem auditory nuclei angularis and laminaris, which have been found to overlap substantially throughout the nucleus in zebra finches.	[Logerot, Priscilla] Univ Auckland, Dept Anat Radiol, Fac Med & Hlth Sci, Auckland 1, New Zealand; Univ Auckland, Ctr Brain Res, Auckland 1, New Zealand	University of Auckland; University of Auckland	Logerot, P (corresponding author), Univ Auckland, Dept Anat Radiol, Fac Med & Hlth Sci, Auckland 1, New Zealand.	f.kubke@auckland.ac.nz	Kubke, Maria Fabiana/E-2472-2011; Kubke, M Fabiana/H-3320-2012	Kubke, Maria Fabiana/0000-0002-3351-5225	Marsden Fund [UOA-306, UOA-503]	Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ))	This work was funded by the Marsden Fund, administered by the Royal Society of New Zealand (http://www.royalsociety.org.nz/programmes/funds/marsden/) (contracts UOA-306 and UOA-503). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRESSEN C, 1993, CELL TISSUE RES, V271, P181, DOI 10.1007/BF00318606; ARENDS JJ, 1981, THESIS U LEIDEN LEID; BAIMBRIDGE KG, 1992, TRENDS NEUROSCI, V15, P303, DOI 10.1016/0166-2236(92)90081-I; Bass AH, 2005, INFERIOR COLLICULUS, P459, DOI 10.1007/0-387-27083-3_16; Belekhova M G, 2004, Dokl Biol Sci, V399, P451, DOI 10.1007/s10630-005-0009-x; Belekhova MG, 2010, BRAIN RES, V1345, P84, DOI 10.1016/j.brainres.2010.05.026; BRAUN K, 1985, CELL TISSUE RES, V240, P101, DOI 10.1007/BF00217563; BRAUN K, 1991, NEUROSCIENCE, V40, P853, DOI 10.1016/0306-4522(91)90017-I; BROWNER RH, 1981, J MORPHOL, V169, P207, DOI 10.1002/jmor.1051690207; BROWNER RH, 1977, J COMP NEUROL, V176, P539, DOI 10.1002/cne.901760406; BROWNER RH, 1983, HEARING RES, V12, P139, DOI 10.1016/0378-5955(83)90122-3; BUTLER AB, 1981, NEUROSCI LETT, V25, P221, DOI 10.1016/0304-3940(81)90395-5; Cant NB, 2005, INFERIOR COLLICULUS, P115, DOI 10.1007/0-387-27083-3_3; CELIO MR, 1990, NEUROSCIENCE, V35, P375, DOI 10.1016/0306-4522(90)90091-H; COLEMAN JR, 1992, EXP NEUROL, V115, P142, DOI 10.1016/0014-4886(92)90238-L; COLES RB, 1979, J COMP PHYSIOL, V134, P241, DOI 10.1007/BF00610398; CONLEE JW, 1986, BRAIN RES, V367, P96, DOI 10.1016/0006-8993(86)91583-0; CORREIA MJ, 1982, BRAIN RES, V234, P205, DOI 10.1016/0006-8993(82)90862-9; Covey E, 2005, INFERIOR COLLICULUS, P493, DOI 10.1007/0-387-27083-3_17; Diaz C, 2000, J NEUROCYTOL, V29, P569, DOI 10.1023/A:1011067918585; DRAKONTIDES AB, 1986, J COMP NEUROL, V248, P555, DOI 10.1002/cne.902480408; DURAND SE, 1992, J COMP NEUROL, V323, P495, DOI 10.1002/cne.903230404; Edwards CJ, 2001, J COMP NEUROL, V438, P148, DOI 10.1002/cne.1306; Ehret G, 2005, INFERIOR COLLICULUS, P312, DOI 10.1007/0-387-27083-3_11; Endepols H, 2001, J COMP PHYSIOL A, V186, P1119, DOI 10.1007/s003590000159; Endepols H, 2000, BRAIN RES REV, V33, P179, DOI 10.1016/S0165-0173(00)00029-1; FENG AS, 1991, J COMP NEUROL, V306, P613, DOI 10.1002/cne.903060407; FOSTER RE, 1978, J COMP NEUROL, V178, P783, DOI 10.1002/cne.901780412; FRIAUF E, 1994, J COMP NEUROL, V349, P193, DOI 10.1002/cne.903490204; Fukushima Y, 2000, ZOOL SCI, V17, P1231, DOI 10.2108/zsj.17.1231; Glezer II, 1998, J CHEM NEUROANAT, V15, P203, DOI 10.1016/S0891-0618(98)00022-2; Grabarek Z, 2006, J MOL BIOL, V359, P509, DOI 10.1016/j.jmb.2006.03.066; HERMES DJ, 1981, HEARING RES, V5, P147, DOI 10.1016/0378-5955(81)90043-5; Hsu A, 2004, J NEUROSCI, V24, P9201, DOI 10.1523/JNEUROSCI.2449-04.2004; HUFFMAN RF, 1990, BRAIN RES REV, V15, P295, DOI 10.1016/0165-0173(90)90005-9; Idrizbegovic E, 1999, NEUROSCI LETT, V259, P49, DOI 10.1016/S0304-3940(98)00911-2; Karten H.J., 1967, STEREOTAXIC ATLAS BR; KARTEN HARVEY J., 1967, BRAIN RES, V6, P409, DOI 10.1016/0006-8993(67)90055-8; KELLEY PE, 1992, J COMP NEUROL, V320, P196, DOI 10.1002/cne.903200205; KENNEDY MC, 1981, J MORPHOL, V169, P259, DOI 10.1002/jmor.1051690302; KHACHUNTS AS, 1983, NEUROPHYSIOLOGY, V14, P191; KNUDSEN EI, 1978, J NEUROPHYSIOL, V41, P870, DOI 10.1152/jn.1978.41.4.870; KNUDSEN EI, 1983, J COMP NEUROL, V218, P174, DOI 10.1002/cne.902180205; KNUDSEN EI, 1979, J COMP PHYSIOL, V133, P1, DOI 10.1007/BF00663105; Konishi M, 2003, ANNU REV NEUROSCI, V26, P31, DOI 10.1146/annurev.neuro.26.041002.131123; Krutzfeldt NOE, 2010, J COMP NEUROL, V518, P2109, DOI 10.1002/cne.22334; Kubke MF, 1999, J COMP NEUROL, V415, P189, DOI 10.1002/(SICI)1096-9861(19991213)415:2<189::AID-CNE4>3.0.CO;2-E; KUNZLE H, 1986, BRAIN RES, V379, P307, DOI 10.1016/0006-8993(86)90785-7; KUNZLE H, 1982, J COMP NEUROL, V212, P349, DOI 10.1002/cne.902120404; LEIBLER LM, 1975, THESIS MIT CAMBRIDGE; LOGEROT P, 2009, AUSTR WINT C BRAIN R; Lohmann C, 1996, J COMP NEUROL, V367, P90, DOI 10.1002/(SICI)1096-9861(19960325)367:1<90::AID-CNE7>3.0.CO;2-E; LOWE DA, 1986, J COMP NEUROL, V245, P498, DOI 10.1002/cne.902450406; Luksch H, 1998, HEARING RES, V122, P1, DOI 10.1016/S0378-5955(98)00081-1; MANLEY JA, 1971, Z VERGL PHYSIOL, V71, P255, DOI 10.1007/BF00298138; MOHNEKE R, 1983, HEARING RES, V9, P91, DOI 10.1016/0378-5955(83)90137-5; MONTAGNESE CM, 1993, ANAT EMBRYOL, V188, P173; Nelson BS, 2004, J EXP BIOL, V207, P4121, DOI 10.1242/jeb.01230; NOTTEBOHM F, 1976, SCIENCE, V194, P211, DOI 10.1126/science.959852; NOTTEBOHM F, 1982, J COMP NEUROL, V207, P344, DOI 10.1002/cne.902070406; Oliver DL, 2005, INFERIOR COLLICULUS, P69, DOI 10.1007/0-387-27083-3_2; Paloff AM, 2004, ACTA HISTOCHEM, V106, P219, DOI 10.1016/j.acthis.2003.11.006; PARK TJ, 1991, J COMP PSYCHOL, V105, P125, DOI 10.1037/0735-7036.105.2.125; PAYNE RS, 1971, J EXP BIOL, V54, P535; PERSECHINI A, 1989, TRENDS NEUROSCI, V12, P462, DOI 10.1016/0166-2236(89)90097-0; Pinaud R, 2006, J NEUROBIOL, V66, P182, DOI 10.1002/neu.20211; Poirier C, 2009, J NEUROSCI, V29, P2252, DOI 10.1523/JNEUROSCI.4650-08.2009; POTTER HD, 1965, J NEUROPHYSIOL, V28, P1132, DOI 10.1152/jn.1965.28.6.1132; POTTER HD, 1965, J NEUROPHYSIOL, V28, P1155, DOI 10.1152/jn.1965.28.6.1155; PRITZ MB, 1974, J COMP NEUROL, V153, P179, DOI 10.1002/cne.901530204; Proctor L, 1997, P NATL ACAD SCI USA, V94, P10421, DOI 10.1073/pnas.94.19.10421; PUELLES L, 1994, J COMP NEUROL, V340, P98, DOI 10.1002/cne.903400108; Puelles L., 2007, CHICK BRAIN STEREOTA, V1st; RESIBOIS A, 1992, NEUROSCIENCE, V46, P101, DOI 10.1016/0306-4522(92)90012-Q; ROGERS JH, 1992, NEUROSCIENCE, V51, P843, DOI 10.1016/0306-4522(92)90525-7; SCHEICH H, 1977, J COMP PHYSIOL, V117, P245, DOI 10.1007/BF00612789; SETOOHSHIMA A, 1990, NEUROSCI LETT, V119, P60, DOI 10.1016/0304-3940(90)90755-X; Sharma V, 2009, J CHEM NEUROANAT, V37, P78, DOI 10.1016/j.jchemneu.2008.11.002; Simmons AM, 2000, JARO-J ASSOC RES OTO, V1, P2, DOI 10.1007/s101620010002; TAKAHASHI TT, 1988, J COMP NEUROL, V274, P212, DOI 10.1002/cne.902740207; TAKAHASHI TT, 1987, J NEUROSCI, V7, P1843; Tardif E, 2003, NEUROSCIENCE, V116, P1111, DOI 10.1016/S0306-4522(02)00774-1; VATER M, 1994, J COMP NEUROL, V341, P534, DOI 10.1002/cne.903410409; Vergne AL, 2009, BIOL REV, V84, P391, DOI 10.1111/j.1469-185X.2009.00079.x; VICARIO DS, 1991, J COMP NEUROL, V309, P486, DOI 10.1002/cne.903090405; Wagner H, 2003, J COMP NEUROL, V465, P145, DOI 10.1002/cne.10826; WAGNER H, 1987, J NEUROSCI, V7, P3105; WALKOWIAK W, 1994, AM ZOOL, V34, P685; Wang Y, 2010, J COMP NEUROL, V518, P1199, DOI 10.1002/cne.22269; WATSON JT, 1988, J COMP NEUROL, V274, P255, DOI 10.1002/cne.902740209; Wild JM, 2010, J COMP NEUROL, V518, P2149, DOI 10.1002/cne.22325; Wild JM, 1997, BRAIN RES, V759, P122, DOI 10.1016/S0006-8993(97)00253-9; WILD JM, 1987, BRAIN RES, V408, P303, DOI 10.1016/0006-8993(87)90393-3; Wild JM, 2001, BRAIN RES, V917, P235; WILD JM, 1993, J COMP NEUROL, V338, P225, DOI 10.1002/cne.903380207; WILD JM, 1995, J COMP NEUROL, V358, P465, DOI 10.1002/cne.903580402; WILL U, 1985, CELL TISSUE RES, V239, P147, DOI 10.1007/BF00214915; WILL U, 1985, CELL TISSUE RES, V239, P163, DOI 10.1007/BF00214916; Woolley SC, 2008, PLOS BIOL, V6, P525, DOI 10.1371/journal.pbio.0060062; Woolley SMN, 2009, J NEUROSCI, V29, P2780, DOI 10.1523/JNEUROSCI.2042-08.2009; Woolley SMN, 2006, J NEUROSCI, V26, P2499, DOI 10.1523/JNEUROSCI.3731-05.2006; Woolley SMN, 2005, J NEUROPHYSIOL, V94, P1143, DOI 10.1152/jn.01064.2004; Woolley SMN, 2004, J NEUROPHYSIOL, V91, P136, DOI 10.1152/jn.00633.2003; YAN K, 2008, THESIS U MARYLAND CO; Yan K, 2010, J COMP NEUROL, V518, P3409, DOI 10.1002/cne.22428; Zeng SJ, 2008, BRAIN RES, V1206, P44, DOI 10.1016/j.brainres.2008.01.101; Zeng SJ, 2009, J COMP NEUROL, V515, P600, DOI 10.1002/cne.22076; Zeng SJ, 2008, BRAIN RES, V1216, P24, DOI 10.1016/j.brainres.2008.04.012; Zeng SJ, 2007, BRAIN BEHAV EVOLUT, V70, P1, DOI 10.1159/000101066; Zeng SJ, 2004, J COMP NEUROL, V470, P192, DOI 10.1002/cne.11042; Zettel ML, 1997, J COMP NEUROL, V386, P92, DOI 10.1002/(SICI)1096-9861(19970915)386:1<92::AID-CNE9>3.0.CO;2-8; ZETTEL ML, 1991, J COMP NEUROL, V313, P1, DOI 10.1002/cne.903130102	112	18	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e20686	10.1371/journal.pone.0020686	http://dx.doi.org/10.1371/journal.pone.0020686			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	21701681	Green Submitted, Green Published, gold			2022-12-27	WOS:000291983800011
J	Li, X; Qian, J; Wang, CQ; Zheng, K; Ye, L; Fu, Y; Han, N; Bian, HW; Pan, JW; Wang, JH; Zhu, MY				Li, Xuan; Qian, Jia; Wang, Chaoqun; Zheng, Ke; Ye, Lan; Fu, Yu; Han, Ning; Bian, Hongwu; Pan, Jianwei; Wang, Junhui; Zhu, Muyuan			Regulating Cytoplasmic Calcium Homeostasis Can Reduce Aluminum Toxicity in Yeast	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; ENDOPLASMIC-RETICULUM; ABC TRANSPORTER; SACCHAROMYCES-CEREVISIAE; CA2+ HOMEOSTASIS; OXIDATIVE STRESS; BCL-2 FAMILY; APOPTOSIS; TOLERANCE; GENE	Our previous study suggested that increased cytoplasmic calcium (Ca) signals may mediate aluminum (Al) toxicity in yeast (Saccharomyces cerevisiae). In this report, we found that a yeast mutant, pmc1, lacking the vacuolar calcium ion (Ca2+) pump Ca2+-ATPase (Pmc1p), was more sensitive to Al treatment than the wild-type strain. Overexpression of either PMC1 or an anti-apoptotic factor, such as Bcl-2, Ced-9 or PpBI-1, decreased cytoplasmic Ca2+ levels and rescued yeast from Al sensitivity in both the wild-type and pmc1 mutant. Moreover, pretreatment with the Ca2+ chelator BAPTA-AM sustained cytoplasmic Ca2+ at low levels in the presence of Al, effectively making the cells more tolerant to Al exposure. Quantitative RT-PCR revealed that the expression of calmodulin (CaM) and phospholipase C (PLC), which are in the Ca2+ signaling pathway, was down-regulated under Al stress. This effect was largely counteracted when cells overexpressed anti-apoptotic Ced-9 or were pretreated with BAPTA-AM. Taken together, our results suggest that the negative regulation of Al-induced cytoplasmic Ca signaling is a novel mechanism underlying internal resistance to Al toxicity.	[Li, Xuan; Qian, Jia; Wang, Chaoqun; Zheng, Ke; Ye, Lan; Fu, Yu; Han, Ning; Bian, Hongwu; Wang, Junhui; Zhu, Muyuan] Zhejiang Univ, Coll Life Sci, State Key Lab Plant Physiol & Biochem, Key Lab Cell & Gene Engn Zhejiang Prov, Hangzhou 310003, Zhejiang, Peoples R China; [Pan, Jianwei] Zhejiang Normal Univ, Coll Chem & Life Sci, Jinhua, Peoples R China	Zhejiang University; Zhejiang Normal University	Li, X (corresponding author), Zhejiang Univ, Coll Life Sci, State Key Lab Plant Physiol & Biochem, Key Lab Cell & Gene Engn Zhejiang Prov, Hangzhou 310003, Zhejiang, Peoples R China.	hwbian@zju.edu.cn; myzhu@zju.edu.cn	Han, Ning/K-3220-2017	Han, Ning/0000-0001-9177-6792	National Science Foundation of China [30771347, 30870034]; National High Technology Research and Development Program of China (863 Program) [2007AA10Z141]; Key Program of Science and technology Department of Zhejiang Province [2009C12072, 2009C32064]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Key Program of Science and technology Department of Zhejiang Province	This work was supported by the National Science Foundation of China (Grant No. 30771347, No. 30870034), National High Technology Research and Development Program of China (863 Program) (No. 2007AA10Z141), and the Key Program of Science and technology Department of Zhejiang Province (No. 2009C12072, No. 2009C32064). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anil VS, 2008, J BIOL CHEM, V283, P3497, DOI 10.1074/jbc.M700766200; Bacus SS, 2007, J CLIN ONCOL, V25; Boursiac Y, 2010, PLANT PHYSIOL, V154, P1158, DOI 10.1104/pp.110.159038; Brini M, 2009, PHYSIOL REV, V89, P1341, DOI 10.1152/physrev.00032.2008; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Cessna SG, 1998, J BIOL CHEM, V273, P27286, DOI 10.1074/jbc.273.42.27286; CUNNINGHAM KW, 1994, J EXP BIOL, V196, P157; Cunningham KW, 1996, MOL CELL BIOL, V16, P2226; CUNNINGHAM KW, 1994, J CELL BIOL, V124, P351, DOI 10.1083/jcb.124.3.351; CUNNINGHAM KW, 2011, CELL CALCIU IN PRESS; Demaurex N, 2009, SCIENCE, V326, P57, DOI 10.1126/science.1180482; ELBLE R, 1992, BIOTECHNIQUES, V13, P18; Furukawa J, 2007, PLANT CELL PHYSIOL, V48, P1081, DOI 10.1093/pcp/pcm091; Gardarin A, 2010, MOL MICROBIOL, V76, P1034, DOI 10.1111/j.1365-2958.2010.07166.x; Geisler M, 2000, PLANT PHYSIOL, V124, P1814, DOI 10.1104/pp.124.4.1814; Ghribi O, 2002, J NEUROCHEM, V82, P137, DOI 10.1046/j.1471-4159.2002.00957.x; Gunawardena AHLAN, 2008, J EXP BOT, V59, P445, DOI 10.1093/jxb/erm189; Hirschi KD, 2000, PLANT PHYSIOL, V124, P125, DOI 10.1104/pp.124.1.125; Huang CF, 2009, PLANT CELL, V21, P655, DOI 10.1105/tpc.108.064543; Jiang L, 2010, J BIOL CHEM, V285, P30634, DOI 10.1074/jbc.M110.116681; Kakimoto M, 2005, BIOMETALS, V18, P467, DOI 10.1007/s10534-005-4663-0; Kashio Y, 2003, J IMMUNOL, V170, P3631, DOI 10.4049/jimmunol.170.7.3631; Kellermayer R, 2003, J CELL SCI, V116, P1637, DOI 10.1242/jcs.00372; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kim MC, 2009, MOL PLANT, V2, P13, DOI 10.1093/mp/ssn091; Kudla J, 2010, PLANT CELL, V22, P541, DOI 10.1105/tpc.109.072686; Kuo TH, 1998, ONCOGENE, V17, P1903, DOI 10.1038/sj.onc.1202110; Larsen PB, 2007, PLANTA, V225, P1447, DOI 10.1007/s00425-006-0452-4; Larsen PB, 2005, PLANT J, V41, P353, DOI 10.1111/j.1365-313X.2004.02306.x; Lauer CM, 2008, FEMS MICROBIOL LETT, V285, P79, DOI 10.1111/j.1574-6968.2008.01214.x; Liang QL, 2007, MOL BIOL CELL, V18, P4741, DOI 10.1091/mbc.E07-05-0431; Ma JF, 2005, SOIL SCI PLANT NUTR, V51, P609, DOI 10.1111/j.1747-0765.2005.tb00074.x; Ma JF, 2007, INT REV CYTOL, V264, P225, DOI 10.1016/S0074-7696(07)64005-4; Madeo F, 1997, J CELL BIOL, V139, P729, DOI 10.1083/jcb.139.3.729; Madeo F, 1999, J CELL BIOL, V145, P757, DOI 10.1083/jcb.145.4.757; Magalhaes JV, 2007, NAT GENET, V39, P1156, DOI 10.1038/ng2074; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; Muthukumar K, 2010, INDIAN J BIOCHEM BIO, V47, P383; Nargund AM, 2008, APOPTOSIS, V13, P811, DOI 10.1007/s10495-008-0215-8; Panda SK, 2009, PLANT SIGNAL BEHAV, V4, P592, DOI 10.4161/psb.4.7.8903; PEITER E, 2011, CELL CALCIU IN PRESS; PITTMAN JK, 2011, CELL CALCIU IN PRESS; Popa CV, 2010, FEBS J, V277, P4027, DOI 10.1111/j.1742-4658.2010.07794.x; Pottosin II, 2007, J EXP BOT, V58, P1559, DOI 10.1093/jxb/erm035; Pozos TC, 1996, MOL CELL BIOL, V16, P3730; Ramos-Diaz A, 2007, PLANTA, V225, P393, DOI 10.1007/s00425-006-0348-3; Reed JC, 2008, BLOOD, V111, P3322, DOI 10.1182/blood-2007-09-078162; Reimers K, 2008, CURR MOL MED, V8, P148, DOI 10.2174/156652408783769562; Sasaki T, 2004, PLANT J, V37, P645, DOI 10.1111/j.1365-313X.2003.01991.x; Scoltock AB, 2000, J BIOL CHEM, V275, P30586, DOI 10.1074/jbc.M004058200; Seo YW, 2009, CANCER RES, V69, P8356, DOI 10.1158/0008-5472.CAN-09-0349; Silva RD, 2005, MOL MICROBIOL, V58, P824, DOI 10.1111/j.1365-2958.2005.04868.x; Son YO, 2010, TOXICOL SCI, V113, P127, DOI 10.1093/toxsci/kfp259; Szegezdi E, 2009, AM J PHYSIOL-CELL PH, V296, pC941, DOI 10.1152/ajpcell.00612.2008; Teste MA, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-99; Ton VK, 2004, AM J PHYSIOL-CELL PH, V287, pC580, DOI 10.1152/ajpcell.00135.2004; Vanden Abeele F, 2002, CANCER CELL, V1, P169; Wang SH, 2009, CHEM-BIOL INTERACT, V181, P45, DOI 10.1016/j.cbi.2009.05.004; Wang W, 2009, WIREL COMMUN MOB COM, V9, P383, DOI 10.1002/wcm.550; Watanabe N, 2008, J BIOL CHEM, V283, P3200, DOI 10.1074/jbc.M706659200; Westphalen BC, 2005, CELL DEATH DIFFER, V12, P304, DOI 10.1038/sj.cdd.4401547; Xia JX, 2010, P NATL ACAD SCI USA, V107, P18381, DOI 10.1073/pnas.1004949107; Xu CY, 2008, J BIOL CHEM, V283, P11477, DOI 10.1074/jbc.M708385200; Yamaji N, 2009, PLANT CELL, V21, P3339, DOI 10.1105/tpc.109.070771; YOKOO T, 1993, P NATL ACAD SCI USA, V90, P1804, DOI 10.1073/pnas.90.5.1804; ZHANG B, 2007, INVEST OPHTH VIS SCI, V48, P573; Zhang YQ, 2008, CELL CYCLE, V7, P870, DOI 10.4161/cc.7.7.5616; Zhao D, 2010, INT J CARDIOL, V143, P86, DOI 10.1016/j.ijcard.2009.01.068; Zheng K, 2007, PLANT PHYSIOL, V143, P38, DOI 10.1104/pp.106.082495	69	12	14	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e21148	10.1371/journal.pone.0021148	http://dx.doi.org/10.1371/journal.pone.0021148			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698264	Green Published, Green Submitted, gold			2022-12-27	WOS:000291730000057
J	Kim, HJ; Joo, HJ; Kim, YH; Ahn, S; Chang, J; Hwang, KB; Lee, DH; Lee, KJ				Kim, Hee-Jung; Joo, Hye Joon; Kim, Yung Hee; Ahn, Soyeon; Chang, Jun; Hwang, Kyu-Baek; Lee, Dong-Hee; Lee, Kong-Joo			Systemic Analysis of Heat Shock Response Induced by Heat Shock and a Proteasome Inhibitor MG132	PLOS ONE			English	Article							UBIQUITIN-DEPENDENT DEGRADATION; INTESTINAL EPITHELIAL-CELLS; NEWLY SYNTHESIZED PROTEINS; STRESS-INDUCED APOPTOSIS; TRANSCRIPTION FACTOR; ABNORMAL PROTEINS; GENE-ONTOLOGY; C/EBP-BETA; THERMOTOLERANCE; ACTIVATION	The molecular basis of heat shock response (HSR), a cellular defense mechanism against various stresses, is not well understood. In this, the first comprehensive analysis of gene expression changes in response to heat shock and MG132 (a proteasome inhibitor), both of which are known to induce heat shock proteins (Hsps), we compared the responses of normal mouse fibrosarcoma cell line, RIF- 1, and its thermotolerant variant cell line, TR-RIF-1 (TR), to the two stresses. The cellular responses we examined included Hsp expressions, cell viability, total protein synthesis patterns, and accumulation of poly-ubiquitinated proteins. We also compared the mRNA expression profiles and kinetics, in the two cell lines exposed to the two stresses, using microarray analysis. In contrast to RIF-1 cells, TR cells resist heat shock caused changes in cell viability and whole-cell protein synthesis. The patterns of total cellular protein synthesis and accumulation of poly-ubiquitinated proteins in the two cell lines were distinct, depending on the stress and the cell line. Microarray analysis revealed that the gene expression pattern of TR cells was faster and more transient than that of RIF-1 cells, in response to heat shock, while both RIF-1 and TR cells showed similar kinetics of mRNA expression in response to MG132. We also found that 2,208 genes were up-regulated more than 2 fold and could sort them into three groups: 1) genes regulated by both heat shock and MG132, (e. g. chaperones); 2) those regulated only by heat shock (e. g. DNA binding proteins including histones); and 3) those regulated only by MG132 (e. g. innate immunity and defense related molecules). This study shows that heat shock and MG132 share some aspects of HSR signaling pathway, at the same time, inducing distinct stress response signaling pathways, triggered by distinct abnormal proteins.	[Kim, Hee-Jung; Kim, Yung Hee; Chang, Jun; Lee, Kong-Joo] Ewha Womans Univ, Coll Pharm, Ctr Cell Signaling & Drug Discovery Res, Seoul, South Korea; [Joo, Hye Joon; Lee, Dong-Hee] Ewha Womans Univ, Div Life & Pharmaceut Sci, Dept Bioinspired Sci, Dept Life Sci, Seoul, South Korea; [Hwang, Kyu-Baek] Soongsil Univ, Sch Comp Sci & Engn, Seoul, South Korea; [Ahn, Soyeon] Seoul Natl Univ, Bundang Hosp, Dept Res & Educ, Songnam, South Korea	Ewha Womans University; Ewha Womans University; Soongsil University; Seoul National University (SNU)	Kim, HJ (corresponding author), Ewha Womans Univ, Coll Pharm, Ctr Cell Signaling & Drug Discovery Res, Seoul, South Korea.	kjl@ewha.ac.kr		CHANG, JUN/0000-0002-8423-5987; Lee, Kong-Joo/0000-0001-7972-6020	Center for Cell Signaling Research and Drug Discovery Research (CCS & DDR) at Ewha Womans University [R15-2006-020]; WCU [R31-2008-000-10010-0]; Brain Korea 21 (BK21) Project	Center for Cell Signaling Research and Drug Discovery Research (CCS & DDR) at Ewha Womans University; WCU; Brain Korea 21 (BK21) Project(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This work was supported through the Center for Cell Signaling Research and Drug Discovery Research (CCS & DDR, R15-2006-020) at Ewha Womans University from the National Core Research Center (NCRC) program and by WCU project (R31-2008-000-10010-0). HJ Kim and HJ Joo were supported by Brain Korea 21 (BK21) Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Ameri K, 2004, BLOOD, V103, P1876, DOI 10.1182/blood-2003-06-1859; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bibeau-Poirier A, 2008, CYTOKINE, V43, P359, DOI 10.1016/j.cyto.2008.07.012; Bush KT, 1997, J BIOL CHEM, V272, P9086; Caraglia M, 2004, AMINO ACIDS, V26, P409, DOI 10.1007/s00726-004-0085-5; CRAIG EA, 1985, CRC CR REV BIOCH MOL, V18, P239, DOI 10.3109/10409238509085135; Daino H, 2000, BLOOD, V95, P2577; GABAI VL, 1995, FEBS LETT, V375, P21, DOI 10.1016/0014-5793(95)01152-5; Gabai VL, 1997, J BIOL CHEM, V272, P18033, DOI 10.1074/jbc.272.29.18033; Grossmann S, 2007, BIOINFORMATICS, V23, P3024, DOI 10.1093/bioinformatics/btm440; HAHN GM, 1988, CANCER RES, V48, P1803; Hahn JS, 2004, MOL CELL BIOL, V24, P5249, DOI 10.1128/MCB.24.12.5249-5256.2004; Harty RN, 2001, J VIROL, V75, P10623, DOI 10.1128/JVI.75.22.10623-10629.2001; HENDRICK JP, 1993, ANNU REV BIOCHEM, V62, P349, DOI 10.1146/annurev.bi.62.070193.002025; Hungness ES, 2002, J AM COLL SURGEONS, V195, P619, DOI 10.1016/S1072-7515(02)01342-X; Hungness ES, 2002, BIOCHEM BIOPH RES CO, V290, P469, DOI 10.1006/bbrc.2001.6168; Jain N, 2003, BIOINFORMATICS, V19, P1945, DOI 10.1093/bioinformatics/btg264; Kaspari M, 2008, FEBS LETT, V582, P666, DOI 10.1016/j.febslet.2008.01.040; Khor R, 2003, TRAFFIC, V4, P857, DOI 10.1046/j.1398-9219.2003.0140.x; Kim HJ, 2007, MOL CELLS, V23, P123; Kim HJ, 2002, MOL CELL BIOCHEM, V229, P139, DOI 10.1023/A:1017941131744; Kim HJ, 2002, J BIOL CHEM, V277, P23193, DOI 10.1074/jbc.M201007200; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Lee DH, 1996, MOL CELL BIOL, V16, P4773; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; LEE KJ, 1988, J CELL PHYSIOL, V136, P411, DOI 10.1002/jcp.1041360304; Liao W, 2006, J CELL BIOCHEM, V99, P1085, DOI 10.1002/jcb.20996; Liebermann DA, 2003, BLOOD CELL MOL DIS, V31, P213, DOI 10.1016/S1079-9796(03)00160-8; Lim CP, 1998, ONCOGENE, V16, P2915, DOI 10.1038/sj.onc.1201834; Mathew A, 2001, MOL CELL BIOL, V21, P7163, DOI 10.1128/MCB.21.21.7163-7171.2001; Medicherla B, 2008, J CELL BIOL, V182, P663, DOI 10.1083/jcb.200803022; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; MOSSER DD, 1992, J CELL PHYSIOL, V151, P561, DOI 10.1002/jcp.1041510316; Mosser DD, 1997, MOL CELL BIOL, V17, P5317, DOI 10.1128/MCB.17.9.5317; Mu TW, 2008, CELL, V134, P769, DOI 10.1016/j.cell.2008.06.037; Ott DE, 2003, J VIROL, V77, P3384, DOI 10.1128/JVI.77.6.3384-3393.2003; Park JE, 1998, ARCH PHARM RES, V21, P46, DOI 10.1007/BF03216752; Pinheiro J., 2010, NLME LINEAR NONLINEA, P1; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Robinson PN, 2004, BIOINFORMATICS, V20, P979, DOI 10.1093/bioinformatics/bth040; Rock KL, 2004, NAT IMMUNOL, V5, P670, DOI 10.1038/ni1089; Schubert U, 2000, P NATL ACAD SCI USA, V97, P13057, DOI 10.1073/pnas.97.24.13057; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; SHERMAN MY, 2006, SCI STKE, pPE16; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tacchini L, 2003, INT J BIOCHEM CELL B, V35, P316, DOI 10.1016/S1357-2725(02)00164-4; Takahashi A, 2004, CANCER RES, V64, P8839, DOI 10.1158/0008-5472.CAN-04-1876; Trinklein ND, 2004, CELL STRESS CHAPERON, V9, P21, DOI 10.1379/1466-1268(2004)009<0021:TRABOH>2.0.CO;2; Trinklein ND, 2004, MOL BIOL CELL, V15, P1254, DOI 10.1091/mbc.E03-10-0738; Woo Yong, 2004, J Biomol Tech, V15, P276	52	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e20252	10.1371/journal.pone.0020252	http://dx.doi.org/10.1371/journal.pone.0020252			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738571	Green Submitted, Green Published, gold			2022-12-27	WOS:000292291800003
J	Boualia, SK; Gaitan, Y; Murawski, I; Nadon, R; Gupta, IR; Bouchard, M				Boualia, Sami K.; Gaitan, Yaned; Murawski, Inga; Nadon, Robert; Gupta, Indra R.; Bouchard, Maxime			Vesicoureteral Reflux and Other Urinary Tract Malformations in Mice Compound Heterozygous for Pax2 and Emx2	PLOS ONE			English	Article							NEPHRIC DUCT; EXPRESSION; MORPHOGENESIS; KIDNEY; LIM1; GENE; PROTOONCOGENE; ANOMALIES; DISTINCT; DEFECTS	Congenital anomalies of the kidney and urinary tract (CAKUT) are the most common cause of chronic kidney disease in children. This disease group includes a spectrum of urinary tract defects including vesicoureteral reflux, duplex kidneys and other developmental defects that can be found alone or in combination. To identify new regulators of CAKUT, we tested the genetic cooperativity between several key regulators of urogenital system development in mice. We found a high incidence of urinary tract anomalies in Pax2;Emx2 compound heterozygous mice that are not found in single heterozygous mice. Pax2(+/-);Emx2(+/-) mice harbor duplex systems associated with urinary tract obstruction, bifid ureter and a high penetrance of vesicoureteral reflux. Remarkably, most compound heterozygous mice refluxed at low intravesical pressure. Early analysis of Pax2(+/-);Emx2(+/-) embryos point to ureter budding defects as the primary cause of urinary tract anomalies. We additionally establish Pax2 as a direct regulator of Emx2 expression in the Wolffian duct. Together, these results identify a haploinsufficient genetic combination resulting in CAKUT-like phenotype, including a high sensitivity to vesicoureteral reflux. As both genes are located on human chromosome 10q, which is lost in a proportion of VUR patients, these findings may help understand VUR and CAKUT in humans.	[Boualia, Sami K.; Gaitan, Yaned; Bouchard, Maxime] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Boualia, Sami K.; Gaitan, Yaned; Bouchard, Maxime] McGill Univ, Goodman Canc Ctr, Montreal, PQ, Canada; [Murawski, Inga; Gupta, Indra R.] McGill Univ, Dept Pediat, Montreal, PQ H3A 2T5, Canada; [Murawski, Inga; Gupta, Indra R.] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Nadon, Robert] McGill Univ, Genome Quebec Innovat Ctr, Montreal, PQ, Canada	McGill University; McGill University; McGill University; McGill University; McGill University	Boualia, SK (corresponding author), McGill Univ, Dept Biochem, Montreal, PQ, Canada.	maxime.bouchard@mcgill.ca		Bouchard, Maxime/0000-0002-7619-9680	Canadian Institutes for Health Research [MOP-84470]; Canada Research Chair in Developmental Genetics of the Urogenital System; Fonds de la Recherche en Sante du Quebec (FRSQ)	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in Developmental Genetics of the Urogenital System; Fonds de la Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec)	This work was supported by a grant from the Canadian Institutes for Health Research (MOP-84470) to MB. MB holds a Canada Research Chair in Developmental Genetics of the Urogenital System. IRG is supported by a grant from the Canadian Institutes for Health Research and is a Chercheur Boursier Clinicien Senior from the Fonds de la Recherche en Sante du Quebec (FRSQ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouchard M, 2002, GENE DEV, V16, P2958, DOI 10.1101/gad.240102; Bouchard M, 2000, DEV BIOL, V222, P135, DOI 10.1006/dbio.2000.9702; Cordell HJ, 2010, J AM SOC NEPHROL, V21, P113, DOI 10.1681/ASN.2009060624; GEORGE KM, 1994, DEVELOPMENT, V120, P2673; Grote D, 2006, DEVELOPMENT, V133, P53, DOI 10.1242/dev.02184; Grote D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000316; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; Holmes GP, 1998, MECH DEVELOP, V79, P57, DOI 10.1016/S0925-4773(98)00174-9; Hoyt PR, 1997, MECH DEVELOP, V65, P55, DOI 10.1016/S0925-4773(97)00057-9; Jain S, 2009, ORGANOGENESIS, V5, P177, DOI 10.4161/org.5.4.10048; Kelly H, 2007, J MED GENET, V44, P710, DOI 10.1136/jmg.2007.051086; Kobayashi A, 2005, DEVELOPMENT, V132, P2809, DOI 10.1242/dev.01858; MACKIE GG, 1975, J UROLOGY, V114, P274, DOI 10.1016/S0022-5347(17)67007-1; Majumdar A, 2003, DEVELOPMENT, V130, P3175, DOI 10.1242/dev.00520; Mendelsohn C, 2009, ORGANOGENESIS, V5, P306; Minowada G, 1999, DEVELOPMENT, V126, P4465; Miyamoto N, 1997, DEVELOPMENT, V124, P1653; MURAWSKI IJ, KIDNEY INT; Murawski IJ, 2008, PEDIATR NEPHROL, V23, P1021, DOI 10.1007/s00467-007-0704-y; Murawski IJ, 2007, AM J PHYSIOL-RENAL, V293, pF1736, DOI 10.1152/ajprenal.00221.2007; Nakanishi K, 2003, PEDIATR INT, V45, P610, DOI 10.1046/j.1442-200X.2003.01779.x; Narlis M, 2007, J AM SOC NEPHROL, V18, P1121, DOI 10.1681/ASN.2006070739; PACHNIS V, 1993, DEVELOPMENT, V119, P1005; Pearse RV, 2007, DEV BIOL, V310, P388, DOI 10.1016/j.ydbio.2007.08.002; Pedersen A, 2005, DEV BIOL, V288, P571, DOI 10.1016/j.ydbio.2005.09.027; Sanyanusin P, 1996, NAT GENET, V13, P129, DOI 10.1038/ng0596-129c; SANYANUSIN P, 1995, NAT GENET, V9, P358, DOI 10.1038/ng0495-358; Schedl A, 2007, NAT REV GENET, V8, P791, DOI 10.1038/nrg2205; SHAWLOT W, 1995, NATURE, V374, P425, DOI 10.1038/374425a0; Srinivas S, 1999, DEVELOPMENT, V126, P1375; Torres M, 1995, DEVELOPMENT, V121, P4057; Uetani N, 2009, CLIN GENET, V75, P307, DOI 10.1111/j.1399-0004.2009.01175.x; Waggoner DJ, 1999, AM J MED GENET, V86, P1; Yoshida M, 1997, DEVELOPMENT, V124, P101; Yu OH, 2004, AM J PHYSIOL-RENAL, V287, pF1123, DOI 10.1152/ajprenal.00444.2003	35	18	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21529	10.1371/journal.pone.0021529	http://dx.doi.org/10.1371/journal.pone.0021529			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21731775	Green Published, gold, Green Submitted			2022-12-27	WOS:000292036900049
J	Choi, HW; Kim, JS; Choi, S; Jang, HJ; Kim, MJ; Choi, Y; Scholer, HR; Chung, HM; Do, JT				Choi, Hyun Woo; Kim, Jong Soo; Choi, Sol; Jang, Hyo Jin; Kim, Min Jung; Choi, Youngsok; Schoeler, Hans R.; Chung, Hyung Min; Do, Jeong Tae			Neural Stem Cells Achieve and Maintain Pluripotency without Feeder Cells	PLOS ONE			English	Article							CONDITIONED MEDIUM; DEFINED FACTORS; SOMATIC-CELLS; MOUSE EMBRYOS; FIBROBLASTS; GENERATION; CULTURE; GROWTH; OCT-4; ESTABLISHMENT	Background: Differentiated cells can be reprogrammed into pluripotency by transduction of four defined transcription factors. Induced pluripotent stem cells (iPS cells) are expected to be useful for regenerative medicine as well as basic research. Recently, the report showed that mouse embryonic fibroblasts (MEF) cells are not essential for reprogramming. However, in using fibroblasts as donor cells for reprogramming, individual fibroblasts that had failed to reprogram could function as feeder cells. Methodology/Principal Finding: Here, we show that adult mouse neural stem cells (NSCs), which are not functional feeder cells, can be reprogrammed into iPS cells using defined four factors (Oct4, Sox2, Klf4, and c-Myc) under feeder-free conditions. The iPS cells, generated from NSCs expressing the Oct4-GFP reporter gene, could proliferate for more than two months (passage 20). Generated and maintained without feeder cells, these iPS cells expressed pluripotency markers (Oct4 and Nanog), the promoter regions of Oct4 and Nanog were hypomethylated, could differentiated into to all three germ layers in vitro, and formed a germline chimera. These data indicate that NSCs can achieve and maintain pluripotency under feeder-free conditions. Conclusion/Significance: This study suggested that factors secreted by feeder cells are not essential in the initial/early stages of reprogramming and for pluripotency maintenance. This technology might be useful for a human system, as a feeder-free reprogramming system may help generate iPS cells of a clinical grade for tissue or organ regeneration.	[Choi, Hyun Woo; Kim, Jong Soo; Choi, Sol; Jang, Hyo Jin; Kim, Min Jung; Do, Jeong Tae] CHA Univ, Dept Biomed Sci Stem Cell & Dev Biol, Seoul, South Korea; [Kim, Min Jung; Chung, Hyung Min] CHA Bio & Diotech, Seoul, South Korea; [Choi, Youngsok] CHA Univ, Dept Biomed Sci, Seoul, South Korea; [Schoeler, Hans R.] Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, Munster, Germany	Pochon Cha University; Pochon Cha University; Max Planck Society	Choi, HW (corresponding author), CHA Univ, Dept Biomed Sci Stem Cell & Dev Biol, Seoul, South Korea.	dojt@cha.ac.kr	, HS/AAB-4434-2019	, HS/0000-0003-2643-5136; Do, Jeong Tae/0000-0001-6721-1441; Choi, Youngsok/0000-0002-3862-4105	Ministry of Education, Science and Technology [20100028247]; Rural Development Administration [PJ008009]	Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Rural Development Administration(Rural Development Administration (RDA), Republic of Korea)	This work was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (Grant 20100028247) and the Next Generation Bio-Green 21 Program funded by the Rural Development Administration (Grant PJ008009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopian V, 2010, IN VITRO CELL DEV-AN, V46, P247, DOI 10.1007/s11626-010-9297-z; Baharvand H, 2010, METHODS MOL BIOL, V584, P425, DOI 10.1007/978-1-60761-369-5_23; Chen MF, 2009, CELL BIOL INT, V33, P1268, DOI 10.1016/j.cellbi.2009.06.004; Chin ACP, 2007, J BIOTECHNOL, V130, P320, DOI 10.1016/j.jbiotec.2007.04.013; Choo ABH, 2004, BIOTECHNOL BIOENG, V88, P321, DOI 10.1002/bit.20247; Do JT, 2009, STEM CELLS, V27, P2962, DOI 10.1002/stem.233; Do JT, 2004, STEM CELLS, V22, P941, DOI 10.1634/stemcells.22-6-941; Donovan PJ, 2001, NATURE, V414, P92, DOI 10.1038/35102154; Eiselleova L, 2008, INT J DEV BIOL, V52, P353, DOI 10.1387/ijdb.082590le; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Lim JWE, 2002, PROTEOMICS, V2, P1187, DOI 10.1002/1615-9861(200209)2:9<1187::AID-PROT1187>3.0.CO;2-T; MAGIN TM, 1992, NUCLEIC ACIDS RES, V20, P3795, DOI 10.1093/nar/20.14.3795; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Maherali N, 2008, CELL STEM CELL, V3, P595, DOI 10.1016/j.stem.2008.11.008; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Pakzad M, 2010, STEM CELL REV REP, V6, P96, DOI 10.1007/s12015-009-9103-z; PALMIERI SL, 1994, DEV BIOL, V166, P259, DOI 10.1006/dbio.1994.1312; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Prelle K, 2002, ANAT HISTOL EMBRYOL, V31, P169, DOI 10.1046/j.1439-0264.2002.00388.x; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; SCHOLER HR, 1991, CELL, V66, P291, DOI 10.1016/0092-8674(91)90619-A; Silva J, 2006, NATURE, V441, P997, DOI 10.1038/nature04914; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Sun N, 2009, P NATL ACAD SCI USA, V106, P15720, DOI 10.1073/pnas.0908450106; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takahashi K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008067; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Totonchi M, 2010, INT J DEV BIOL, V54, P877, DOI 10.1387/ijdb.092903mt; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Xie CQ, 2004, BIOCHEM BIOPH RES CO, V315, P581, DOI 10.1016/j.bbrc.2004.01.089; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Yeom YI, 1996, DEVELOPMENT, V122, P881; Zaehres H, 2006, METHOD ENZYMOL, V420, P49, DOI 10.1016/S0076-6879(06)20004-1; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267; Zhou D, 2009, CELL BIOL INT, V33, P796, DOI 10.1016/j.cellbi.2009.04.008	41	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21367	10.1371/journal.pone.0021367	http://dx.doi.org/10.1371/journal.pone.0021367			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21738644	Green Published, gold, Green Submitted			2022-12-27	WOS:000292036900023
J	Griffiths, UK; Clark, A; Shimanovich, V; Glinskaya, I; Tursunova, D; Kim, L; Mosina, L; Hajjeh, R; Edmond, K				Griffiths, Ulla K.; Clark, Andrew; Shimanovich, Veronika; Glinskaya, Irina; Tursunova, Dilorom; Kim, Lucia; Mosina, Liudmila; Hajjeh, Rana; Edmond, Karen			Comparative Economic Evaluation of Haemophilus influenzae Type b Vaccination in Belarus and Uzbekistan	PLOS ONE			English	Article							COST-EFFECTIVENESS; EPIDEMIOLOGY; MENINGITIS; CHILDREN; DISEASE; PNEUMONIA; CONJUGATE	Background: Hib vaccine has gradually been introduced into more and more countries during the past two decades, partly due to GAVI Alliance support to low-income countries. However, since Hib disease burden is difficult to establish in settings with limited diagnostic capacities and since the vaccine continues to be relatively expensive, some Governments remain doubtful about its value leading to concerns about financial sustainability. Similarly, several middle-income countries have not introduced the vaccine. The aim of this study is to estimate and compare the cost-effectiveness of Hib vaccination in a country relying on self-financing (Belarus) and a country eligible for GAVI Alliance support (Uzbekistan). Methods and Findings: A decision analytic model was used to estimate morbidity and mortality from Hib meningitis, Hib pneumonia and other types of Hib disease with and without the vaccine. Treatment costs were attached to each disease event. Data on disease incidence, case fatality ratios and costs were primarily determined from national sources. For the Belarus 2009 birth cohort, Hib vaccine is estimated to prevent 467 invasive disease cases, 4 cases of meningitis sequelae, and 3 deaths, while in Uzbekistan 3,069 invasive cases, 34 sequelae cases and 341 deaths are prevented. Estimated costs per discounted DALY averted are US$ 9,323 in Belarus and US$ 267 in Uzbekistan. Conclusion: The primary reason why the cost-effectiveness values are more favourable in Uzbekistan than in Belarus is that relatively more deaths are averted in Uzbekistan due to higher baseline mortality burden. Two other explanations are that the vaccine price is lower in Uzbekistan and that Uzbekistan uses a three dose schedule compared to four doses in Belarus. However, when seen in the context of the relative ability to pay for public health, the vaccine can be considered cost-effective in both countries.	[Griffiths, Ulla K.; Clark, Andrew; Edmond, Karen] London Sch Hyg & Trop Med, Hib Initiat, London WC1, England; [Shimanovich, Veronika] Republican Ctr Hyg Epidemiol & Publ Hlth, Minsk, BELARUS; [Glinskaya, Irina] Minsk City Ctr Hyg & Epidemiol, Minsk, BELARUS; [Tursunova, Dilorom; Kim, Lucia] Minist Hlth, Tashkent, Uzbekistan; [Mosina, Liudmila] WHO Reg Off Europe, Copenhagen, Denmark; [Hajjeh, Rana] Ctr Dis Control, Atlanta, GA 30333 USA	University of London; London School of Hygiene & Tropical Medicine; World Health Organization; Centers for Disease Control & Prevention - USA	Griffiths, UK (corresponding author), London Sch Hyg & Trop Med, Hib Initiat, London WC1, England.	ulla.griffiths@lshtm.ac.uk			Hib Initiative, GAVI Alliance	Hib Initiative, GAVI Alliance	This study was funded by the Hib Initiative, which was a GAVI Alliance funded project that lasted from 2005-2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akumu AO, 2007, B WORLD HEALTH ORGAN, V85, P511, DOI 10.2471/BLT.06.034686; [Anonymous], 2000, WHOVB0005; [Anonymous], 1996, GLOBAL BURDEN DIS CO; Balabanova D, 2004, HEALTH SERV RES, V39, P1927, DOI 10.1111/j.1475-6773.2004.00326.x; Bennett JV, 2002, WHOVB0218; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; BOOY R, 1993, ARCH DIS CHILD, V69, P225, DOI 10.1136/adc.69.2.225; *CDC, 2002, MMWR-MORBID MORTAL W, V51, P234; Cherian T, 2005, J HEALTH POPUL NUTR, V23, P1; Edmond K, 2010, LANCET INFECT DIS, V10, P317, DOI 10.1016/S1473-3099(10)70048-7; Garpenholt O, 1998, SCAND J INFECT DIS, V30, P5, DOI 10.1080/003655498750002222; GLINSKAYA ING, 2008, 2 RUSS C ACT PROBL M; Griffiths Ulla K, 2009, Expert Rev Pharmacoecon Outcomes Res, V9, P333, DOI 10.1586/erp.09.38; Isakbaeva ET, 2007, VACCINE, V25, P373, DOI 10.1016/j.vaccine.2006.07.029; KASIMOVA R, 2007, J DOCTOR, V2; Kim SY, 2008, PHARMACOECONOMICS, V26, P191, DOI 10.2165/00019053-200826030-00004; Kojouharova M, 2002, B WORLD HEALTH ORGAN, V80, P690; Lebedova V, 2003, Cent Eur J Public Health, V11 Suppl, pS25; Livartowski A, 1996, VACCINE, V14, P495, DOI 10.1016/0264-410X(95)00223-N; MAGER INF, 2005, EPIDEMIOLOGY INFECT, V3; MAKELA PH, 1992, J INFECT DIS, V165, pS2, DOI 10.1093/infdis/165.Supplement_1-S2; Mendsaikhan J, 2009, CLIN INFECT DIS, V48, pS141, DOI 10.1086/596493; Mulholland K, 1997, LANCET, V349, P1191, DOI 10.1016/S0140-6736(96)09267-7; Obonyo CO, 2006, EUR J CLIN MICROBIOL, V25, P90, DOI 10.1007/s10096-006-0092-4; Ojo LR, 2010, VACCINE, V28, P7117, DOI 10.1016/j.vaccine.2010.07.074; Peltola H, 2005, BMJ-BRIT MED J, V330, P18, DOI 10.1136/bmj.38301.657014.79; Platonov AE, 2006, VACCINE, V24, P2367, DOI 10.1016/j.vaccine.2005.11.054; REINERT P, 1993, VACCINE, V11, pS38, DOI 10.1016/0264-410X(93)90158-T; RICHARDSON E, 2008, BELARUS HLTH SYSTEM; Theodoratou E, 2010, INT J EPIDEMIOL, V39, P172, DOI 10.1093/ije/dyq033; Thomas K, 2002, CLIN INFECT DIS, V34, P949, DOI 10.1086/339327; TROLLFORS B, 1994, SCAND J INFECT DIS, V26, P611, DOI 10.3109/00365549409011820; *UN POP SECR, 2008, WORLD POP PROSP 2008; UNICEF, 2010, PROD MEN VACC SUPPL; UNICEF, 2007, UZB MULT IND CLUST S; Watt JP, 2009, LANCET, V374, P903, DOI 10.1016/S0140-6736(09)61203-4; *WHO, 2010, CHOOSING INT AR COST; *WHO, 2001, WHOVB0127; WOLFSON L, 2009, METHODS ESTIMATE GLO, P893; World Bank, 2011, WORLD DEVELOPMENT REPORT 2011: CONFLICT, SECURITY AND DEVELOPMENT, P1, DOI 10.1596/978-0-8213-8439-8; World Bank, 2011, GDP PER CAP CURR US; World Health Organization, 2006, Wkly Epidemiol Rec, V81, P445; World Health Organization, 2011, COST EFF THRESH; World Health Organization, 2010, WHO VACC PREV DIS MO; World Health Organization Initiative for Vaccine Research (IVR) of the Department of Immunization Vaccines and Biologicals, 2008, WHOIVB0814; Zhou FJ, 2002, PEDIATRICS, V110, P653, DOI 10.1542/peds.110.4.653	46	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21472	10.1371/journal.pone.0021472	http://dx.doi.org/10.1371/journal.pone.0021472			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21720546	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000292036900035
J	Krentsis, IM; Sela, I; Eiges, R; Blanchard, V; Berger, M; Cohen, MB; Mitrani-Rosenbaum, S				Krentsis, Irit Milman; Sela, Ilan; Eiges, Rachel; Blanchard, Veronique; Berger, Markus; Cohen, Michal Becker; Mitrani-Rosenbaum, Stella			GNE Is Involved in the Early Development of Skeletal and Cardiac Muscle	PLOS ONE			English	Article							ACETYLGLUCOSAMINE 2-EPIMERASE/N-ACETYLMANNOSAMINE KINASE; N-ACETYLNEURAMINIC ACID; BODY MYOPATHY MYOBLASTS; POLYSIALIC ACID; DISTAL MYOPATHY; KEY ENZYME; BIOSYNTHESIS; SIALYLATION; GENE; HYPOSIALYLATION	UDP-N-acetylglucosamine 2 epimerase/N-acetylmannosamime kinase (GNE) is a bifunctional enzyme which catalyzes the two key sequential steps in the biosynthetic pathway of sialic acid, the most abundant terminal monosaccharide on glycoconjugates of eukaryotic cells. GNE knock out (GNE KO) mice are embryonically lethal at day E8.5. Although the role of GNE in the sialic pathway has been well established as well as the importance of sialylation in many diverse biological pathways, less is known about the involvement of GNE in muscle development. To address this issue we have studied the role of GNE during in vitro embryogenesis by comparing the developmental profile in culture of embryonic stem cells (ES) from wild type and from GNE KO E3.5 mice embryos, during 45 days. Neuronal cells appeared rarely in GNE KO ES cultures and did not reach an advanced differentiated stage. Although primary cardiac cells appeared at the same time in both normal and GNE KO ES cultures, GNE KO cardiac cells degraded very soon and their beating capacity decayed rapidly. Furthermore very rare skeletal muscle committed cells were detected in the GNE KO ES cultures at any stage of differentiation, as assessed by analysis of the expression of either Pax7, MyoD and MyHC markers. Beyond the supporting evidence that GNE plays an important role in neuronal cell and brain development, these results show that GNE is strongly involved in cardiac tissue and skeletal muscle early survival and organization. These findings could open new avenues in the understanding of muscle function mechanisms in health and in disease.	[Krentsis, Irit Milman; Sela, Ilan; Cohen, Michal Becker; Mitrani-Rosenbaum, Stella] Hadassah Hebrew Univ, Goldyne Savad Inst Gene Therapy, Med Ctr, Jerusalem, Israel; [Eiges, Rachel] Shaare Zedek Med Ctr, Stem Cell Res Lab, Inst Med Genet, Jerusalem, Israel; [Blanchard, Veronique; Berger, Markus] Charite, Inst Lab Med Clin Chem & Pathobiochem, Berlin, Germany	Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Shaare Zedek Medical Center; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Krentsis, IM (corresponding author), Hadassah Hebrew Univ, Goldyne Savad Inst Gene Therapy, Med Ctr, Jerusalem, Israel.	stella@cc.huji.ac.il		eiges, rachel/0000-0001-8139-0933; Mitrani-Rosenbaum, Stella/0000-0001-5335-8709; Blanchard, Veronique/0000-0002-5980-6450	German-Israeli Science Foundation for Scientific Research and Development [I-9191-142.3/2006]; Israel Science Foundation [671/07]; Neuromuscular Disease Foundation; Bundesministerium fur Bildung und Forschung [03IP511]; Sonnenfeld foundation	German-Israeli Science Foundation for Scientific Research and Development(German-Israeli Foundation for Scientific Research and Development); Israel Science Foundation(Israel Science Foundation); Neuromuscular Disease Foundation; Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Sonnenfeld foundation	These studies have been supported in part by the German-Israeli Science Foundation for Scientific Research and Development (www.gif.org.il) (I-9191-142.3/2006), the Israel Science Foundation (www.isf.org.il) (671/07) and the Neuromuscular Disease Foundation (www.neuromuscdisease.org). V.B. and M.B. were financially supported by the Bundesministerium fur Bildung und Forschung [InnoProfile 03IP511] and by the Sonnenfeld foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsili S, 2007, CELL DEATH DIFFER, V14, P1916, DOI 10.1038/sj.cdd.4402208; Amsili S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002477; Angata K, 2003, BIOCHIMIE, V85, P195, DOI 10.1016/S0300-9084(03)00051-8; Bardor M, 2005, J BIOL CHEM, V280, P4228, DOI 10.1074/jbc.M412040200; Bieberich E, 2001, J BIOL CHEM, V276, P44396, DOI 10.1074/jbc.M107239200; Effertz K, 1999, J BIOL CHEM, V274, P28771, DOI 10.1074/jbc.274.40.28771; Eisenberg I, 2001, NAT GENET, V29, P83, DOI 10.1038/ng718; Gagiannis D, 2007, GLYCOCONJUGATE J, V24, P125, DOI 10.1007/s10719-006-9019-7; HARA S, 1989, ANAL BIOCHEM, V179, P162, DOI 10.1016/0003-2697(89)90218-2; Hinderlich S, 1997, J BIOL CHEM, V272, P24313, DOI 10.1074/jbc.272.39.24313; Hinderlich S, 2004, FEBS LETT, V566, P105, DOI 10.1016/j.febslet.2004.04.013; Hinderlich S, 2001, BIOL CHEM, V382, P291, DOI 10.1515/BC.2001.036; Kontou M, 2008, NEUROREPORT, V19, P1239, DOI 10.1097/WNR.0b013e32830b368a; KORNFELD S, 1964, P NATL ACAD SCI USA, V52, P371, DOI 10.1073/pnas.52.2.371; Krause S, 2005, EXP CELL RES, V304, P365, DOI 10.1016/j.yexcr.2004.11.010; Krause S, 2007, NEUROLOGY, V69, P655, DOI 10.1212/01.wnl.0000267426.97138.fd; Li YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003131; Lu JR, 1999, P NATL ACAD SCI USA, V96, P552, DOI 10.1073/pnas.96.2.552; Muhlenhoff M, 1998, CURR OPIN STRUC BIOL, V8, P558, DOI 10.1016/S0959-440X(98)80144-9; Nakamura K, 2010, PATHOBIOLOGY, V77, P191, DOI 10.1159/000292652; Noguchi S, 2004, J BIOL CHEM, V279, P11402, DOI 10.1074/jbc.M313171200; Nystedt J, 2010, STEM CELLS, V28, P258, DOI 10.1002/stem.250; Saito F, 2004, NEUROMUSCULAR DISORD, V14, P158, DOI 10.1016/j.nmd.2003.09.006; Salama I, 2005, BIOCHEM BIOPH RES CO, V328, P221, DOI 10.1016/j.bbrc.2004.12.157; Schauer R, 2004, ZOOLOGY, V107, P49, DOI 10.1016/j.zool.2003.10.002; Schwarzkopf M, 2002, P NATL ACAD SCI USA, V99, P5267, DOI 10.1073/pnas.072066199; Sela I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016334; Seppala R, 1999, AM J HUM GENET, V64, P1563, DOI 10.1086/302411; Wang ZY, 2006, J BIOL CHEM, V281, P27016, DOI 10.1074/jbc.M604903200; Weidemann W, 2006, FEBS LETT, V580, P6649, DOI 10.1016/j.febslet.2006.11.015; Weidemann W, 2010, GLYCOBIOLOGY, V20, P107, DOI 10.1093/glycob/cwp153; WOBUS AM, 1999, METHOD MOL BIOL, V184, P127	32	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21389	10.1371/journal.pone.0021389	http://dx.doi.org/10.1371/journal.pone.0021389			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21731727	Green Published			2022-12-27	WOS:000292036900025
J	Pan, JJ; Qu, HQ; Rentfro, A; McCormick, JB; Fisher-Hoch, SP; Fallon, MB				Pan, Jen-Jung; Qu, Hui-Qi; Rentfro, Anne; McCormick, Joseph B.; Fisher-Hoch, Susan P.; Fallon, Michael B.			Prevalence of Metabolic Syndrome and Risks of Abnormal Serum Alanine Aminotransferase in Hispanics: A Population-Based Study	PLOS ONE			English	Article							NONALCOHOLIC FATTY LIVER; UNITED-STATES; VIRUS-INFECTION; HEPATITIS-C; DISEASE; ASSOCIATION; DEFINITION; ETHNICITY; IMPACT	Aim: Study the prevalence of metabolic syndrome (MS) and risk factors for and association with elevated alanine aminotransferase (ALT) as markers of hepatic injury in a large Hispanic health disparity cohort with high rates of obesity. Methods: Analysis of data from a prospective cross-sectional population based study. From 2004-7, we randomly recruited 2000 community participants to the Cameron County Hispanic Cohort collecting extensive socioeconomic, clinical and laboratory data. We excluded 153 subjects due to critical missing data. Pearson chi-square tests and Student's t-tests were used for categorical and continuous variable analysis, respectively. Logistic regression analysis was performed to determine the risk factors for elevated ALT. Results: The mean age of the cohort was 45 years and 67% were females. The majority of the cohort was either overweight (32.4%) or obese (50.7%). Almost half (43.7%) had MS and nearly one-third diabetes. Elevated ALT level was more prevalent in males than females. Obesity was a strong risk for abnormal ALT in both genders. Hypertriglyceridemia, hypercholesterolemia and young age were risks for elevated ALT in males only, whereas increased fasting plasma glucose was associated with elevated ALT in females only. Conclusion: We identified high prevalence of MS and markers of liver injury in this large Mexican American cohort with gender differences in prevalence and risk factors, with younger males at greatest risk.	[Pan, Jen-Jung; Fallon, Michael B.] Univ Texas Hlth Sci Ctr Houston, Div Gastroenterol Hepatol & Nutr, Dept Internal Med, Houston, TX 77030 USA; [Qu, Hui-Qi; McCormick, Joseph B.; Fisher-Hoch, Susan P.] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Brownsville, TX 78520 USA; [Rentfro, Anne] Univ Texas Brownsville, Coll Nursing, Brownsville, TX 78520 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Rio Grande Valley	Pan, JJ (corresponding author), Univ Texas Hlth Sci Ctr Houston, Div Gastroenterol Hepatol & Nutr, Dept Internal Med, Houston, TX 77030 USA.	panjenjung@hotmail.com	Qu, Hui-Qi/B-4719-2009	Qu, Hui-Qi/0000-0001-9317-4488; McCormick, Joseph/0000-0002-5844-8102	National Center on Minority Health and Health disparities (NCMHD) [MD000170 P20]; National Center for Research Resources (NCRR) [1U54RR023417-01]; National Institute on Minority Health and Health Disparities [P20MD000170] Funding Source: NIH RePORTER	National Center on Minority Health and Health disparities (NCMHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by MD000170 P20 funded from the National Center on Minority Health and Health disparities (NCMHD), and the Centers for Translational Science Award 1U54RR023417-01 from the National Center for Research Resources (NCRR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Bedogni G, 2005, HEPATOLOGY, V42, P44, DOI 10.1002/hep.20734; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Clark JM, 2003, AM J GASTROENTEROL, V98, P960, DOI [10.1016/S0002-9270(03)00265-X, 10.1111/j.1572-0241.2003.07486.x]; de Alwis NMW, 2008, J HEPATOL, V48, pS104, DOI 10.1016/j.jhep.2008.01.009; Dong MH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014254; Fisher-Hoch SP, 2010, PREV CHRONIC DIS, V7; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Hamaguchi M, 2005, ANN INTERN MED, V143, P722, DOI 10.7326/0003-4819-143-10-200511150-00009; Kallwitz ER, 2008, DIGEST DIS SCI, V53, P1358, DOI 10.1007/s10620-008-0234-x; Kariv R, 2006, LIVER INT, V26, P445, DOI 10.1111/j.1478-3231.2006.01197.x; Kunde SS, 2005, HEPATOLOGY, V42, P650, DOI 10.1002/hep.20818; Machado M, 2006, J HEPATOL, V45, P600, DOI 10.1016/j.jhep.2006.06.013; Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161; Miyazaki Y, 2002, AM J PHYSIOL-ENDOC M, V283, pE1135, DOI 10.1152/ajpendo.0327.2001; Omagari K, 2002, J GASTROEN HEPATOL, V17, P1098, DOI 10.1046/j.1440-1746.2002.02846.x; Perez A, 2004, J GASTROEN HEPATOL, V19, P289, DOI 10.1111/j.1440-1746.2003.03277.x; Piton A, 1998, HEPATOLOGY, V27, P1213, DOI 10.1002/hep.510270505; Prati D, 2002, ANN INTERN MED, V137, P1, DOI 10.7326/0003-4819-137-1-200207020-00006; SALINAS J, 2010, AM J MENS HLTH  1007; Targher G, 2007, DIABETES CARE, V30, P1212, DOI 10.2337/dc06-2247; Wasley A, 2010, J INFECT DIS, V202, P192, DOI 10.1086/653622; Weston SR, 2005, HEPATOLOGY, V41, P372, DOI 10.1002/hep.20554; 2010, DIABETES CARE S1, V33, pS11	24	36	38	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21515	10.1371/journal.pone.0021515	http://dx.doi.org/10.1371/journal.pone.0021515			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21720553	gold, Green Submitted, Green Published			2022-12-27	WOS:000292036900047
J	Wei, YC; Multi, S; Yang, CR; Ma, JY; Zhang, QH; Wang, ZB; Li, M; Wei, L; Ge, ZJ; Zhang, CH; Ouyang, YC; Hou, Y; Schatten, H; Sun, QY				Wei, Yanchang; Multi, Saima; Yang, Cai-Rong; Ma, Junyu; Zhang, Qing-Hua; Wang, Zhen-Bo; Li, Mo; Wei, Liang; Ge, Zhao-Jia; Zhang, Chun-Hui; Ouyang, Ying-Chun; Hou, Yi; Schatten, Heide; Sun, Qing-Yuan			Spindle Assembly Checkpoint Regulates Mitotic Cell Cycle Progression during Preimplantation Embryo Development	PLOS ONE			English	Article							AGING-ASSOCIATED PHENOTYPES; MOUSE OOCYTE MEIOSIS; CHROMOSOME INSTABILITY; PREMATURE ANAPHASE; MAMMALIAN-CELLS; B DEGRADATION; BUDDING YEAST; MAD2; PROTEIN; MICE	Errors in chromosome segregation or distribution may result in aneuploid embryo formation, which causes implantation failure, spontaneous abortion, genetic diseases, or embryo death. Embryonic aneuploidy occurs when chromosome aberrations are present in gametes or early embryos. To date, it is still unclear whether the spindle assembly checkpoint ( SAC) is required for the regulation of mitotic cell cycle progression to ensure mitotic fidelity during preimplantation development. In this study, using overexpression and RNA interference (RNAi) approaches, we analyzed the role of SAC components (Bub3, BubR1 and Mad2) in mouse preimplantation embryos. Our data showed that overexpressed SAC components inhibited metaphase-anaphase transition by preventing sister chromatid segregation. Deletion of SAC components by RNAi accelerated the metaphase-anaphase transition during the first cleavage and caused micronuclei formation, chromosome misalignment and aneuploidy, which caused decreased implantation and delayed development. Furthermore, in the presence of the spindle-depolymerizing drug nocodazole, SAC depleted embryos failed to arrest at metaphase. Our results suggest that SAC is essential for the regulation of mitotic cell cycle progression in cleavage stage mouse embryos.	[Wei, Yanchang; Multi, Saima; Ma, Junyu; Zhang, Qing-Hua; Wang, Zhen-Bo; Li, Mo; Wei, Liang; Ge, Zhao-Jia; Zhang, Chun-Hui; Ouyang, Ying-Chun; Hou, Yi; Sun, Qing-Yuan] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China; [Yang, Cai-Rong; Ma, Junyu] NE Agr Univ China, Coll Life Sci, Harbin, Peoples R China; [Schatten, Heide] Univ Missouri, Dept Vet Pathobiol, Columbia, MO USA	Chinese Academy of Sciences; Institute of Zoology, CAS; Northeast Agricultural University - China; University of Missouri System; University of Missouri Columbia	Wei, YC (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China.	sunqy@ioz.ac.cn	Yang, Cairong/AAB-1440-2021; Wei, Liang/U-4349-2017	Yang, Cairong/0000-0001-9594-0529; 	National Natural Science Foundation of China [30930065]; Ministry of Science and Technology, China [2011CB944501]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology, China(Ministry of Science and Technology, China)	This study was supported by National Natural Science Foundation of China (30930065) and Major State Basic Research Program of China Ministry of Science and Technology (2011CB944501). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babu JR, 2003, J CELL BIOL, V160, P341, DOI 10.1083/jcb.200211048; Baker DJ, 2004, NAT GENET, V36, P744, DOI 10.1038/ng1382; Baker DJ, 2006, J CELL BIOL, V172, P529, DOI 10.1083/jcb.200507081; Brunet S, 2003, REPRODUCTION, V126, P443, DOI 10.1530/rep.0.1260443; Burds AA, 2005, P NATL ACAD SCI USA, V102, P11296, DOI 10.1073/pnas.0505053102; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Dai W, 2004, CANCER RES, V64, P440, DOI 10.1158/0008-5472.CAN-03-3119; Dobles M, 2000, CELL, V101, P635, DOI 10.1016/S0092-8674(00)80875-2; Gillett ES, 2004, J CELL BIOL, V164, P535, DOI 10.1083/jcb.200308100; Gorbsky GJ, 1998, J CELL BIOL, V141, P1193, DOI 10.1083/jcb.141.5.1193; Homer HA, 2005, REPRODUCTION, V130, P829, DOI 10.1530/rep.1.00856; Homer HA, 2005, GENE DEV, V19, P202, DOI 10.1101/gad.328105; Howell BJ, 2000, J CELL BIOL, V150, P1233, DOI 10.1083/jcb.150.6.1233; HOYT MA, 1991, CELL, V66, P507, DOI 10.1016/0092-8674(81)90014-3; Kalitsis P, 2000, GENE DEV, V14, P2277, DOI 10.1101/gad.827500; Kalitsis P, 2005, GENE CHROMOSOME CANC, V44, P29, DOI 10.1002/gcc.20215; Kops GJPL, 2004, P NATL ACAD SCI USA, V101, P8699, DOI 10.1073/pnas.0401142101; Lemaire-Adkins R, 1997, J CELL BIOL, V139, P1611, DOI 10.1083/jcb.139.7.1611; Li M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007701; LI R, 1991, CELL, V66, P519, DOI 10.1016/0092-8674(81)90015-5; Logarinho E, 2008, MOL BIOL CELL, V19, P1798, DOI 10.1091/mbc.E07-07-0633; May KM, 2006, J CELL SCI, V119, P4139, DOI 10.1242/jcs.03165; Meraldi P, 2004, DEV CELL, V7, P45, DOI 10.1016/j.devcel.2004.06.006; Michel L, 2004, P NATL ACAD SCI USA, V101, P4459, DOI 10.1073/pnas.0306069101; Michel LS, 2001, NATURE, V409, P355, DOI 10.1038/35053094; Morrow CJ, 2005, J CELL SCI, V118, P3639, DOI 10.1242/jcs.02487; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nasmyth K, 2005, CELL, V120, P739, DOI 10.1016/j.cell.2005.03.006; Niault T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001165; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Taylor SS, 1997, CELL, V89, P727, DOI 10.1016/S0092-8674(00)80255-X; Tsurumi C, 2004, J CELL BIOL, V167, P1037, DOI 10.1083/jcb.200405165; Wang Q, 2004, BLOOD, V103, P1278, DOI 10.1182/blood-2003-06-2158; Wang WH, 2006, FRONT BIOSCI-LANDMRK, V11, P620, DOI 10.2741/1822; Wassmann K, 2003, CURR BIOL, V13, P1596, DOI 10.1016/j.cub.2003.08.052; Weaver BAA, 2003, J CELL BIOL, V162, P551, DOI 10.1083/jcb.200303167; Wei L, 2010, CELL CYCLE, V9, P1112, DOI 10.4161/cc.9.6.10957; Yin S, 2008, CELL CYCLE, V7, P2997, DOI 10.4161/cc.7.19.6809; Yin S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003516; Zhang D, 2007, REPRODUCTION, V133, P685, DOI 10.1530/rep.1.01167	40	29	29	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21557	10.1371/journal.pone.0021557	http://dx.doi.org/10.1371/journal.pone.0021557			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21720555	gold, Green Submitted, Green Published			2022-12-27	WOS:000292036900051
J	Ali, MM; Amialchuk, A; Heiland, FW				Ali, Mir M.; Amialchuk, Aliaksandr; Heiland, Frank W.			Weight-Related Behavior among Adolescents: The Role of Peer Effects	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; SOCIAL NETWORK; US CHILDREN; NATIONAL-HEALTH; OBESITY; GAIN; PREVALENCE; NUTRITION; CONSUMPTION; OVERWEIGHT	Purpose: To investigate whether social interactions in friendship networks influence the following weight-related behaviors of adolescents: exercising regularly, playing an active sport, hours of TV/Video viewing, sleeping six or fewer hours, eating breakfast on weekdays, frequency of eating at fast food restaurants, eating five servings of fruits/vegetables daily, and consuming calorie-dense snacks. Method: Data from a nationally representative sample of adolescents are used to examine the association between peer and individual weight-related behaviors. Evidence from multivariate regression analysis controlling for an extensive list of individual-and family-level factors as well as school-level unobserved heterogeneity is obtained. Results: We find a significant positive association between individuals' and friends' behaviors in terms of sports, exercise and fast food consumption. The estimated associations are robust to controls for individual-and family-level factors, unobserved heterogeneity at the school level and our attempts to account for non-random peer selection. Conclusions: The social transmission of weight-related behaviors is a viable explanation for the spread of obesity in friendship networks documented in recent research. Traditional weight reduction interventions may be fruitfully complemented with strategies that focus on harnessing peer support to modify behaviors.	[Ali, Mir M.; Amialchuk, Aliaksandr] Univ Toledo, Dept Econ, Toledo, OH 43606 USA; [Ali, Mir M.] US FDA, Off Regulat Policy & Social Sci, College Pk, MD USA; [Heiland, Frank W.] CUNY, Baruch Coll, Grad Ctr Econ, Inst Demog Res,Sch Publ Affairs, New York, NY 10021 USA	University System of Ohio; University of Toledo; US Food & Drug Administration (FDA); City University of New York (CUNY) System; Baruch College (CUNY)	Ali, MM (corresponding author), Univ Toledo, Dept Econ, 2801 W Bancroft St, Toledo, OH 43606 USA.	mir.ali@fda.hhs.gov			National Institute of Child Health and Human Development [P01-HD31921]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD031921] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The views expressed in this study are those of the authors and do not necessarily reflect the views of the Food and Drug Administration. The authors would like to thank Andrew Stivers (FDA-ORPSS) and Chung-Tung Jordan Lin (FDA-OPRSS) for helpful comments and suggestions. This research uses data from Add Health, a program project designed by J. Richard Udry, Peter S. Bearman, and Kathleen Mullan Harris, and funded by grant P01-HD31921 from the National Institute of Child Health and Human Development, with cooperative funding from 17 other agencies. Special acknowledgment is due to Ronald R. Rindfuss and Barbara Entwisle for assistance in the original design. Persons interested in obtaining data files from Add Health should contact Add Health, Carolina Population Center, 123 W. Franklin Street, Chapel Hill, NC 27516-2524 (addhealth@unc.edu).	Adams J, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-57; Alexander C, 2001, J ADOLESCENT HEALTH, V29, P22, DOI 10.1016/S1054-139X(01)00210-5; Ali MM, 2011, SOUTH ECON J, V77, P827, DOI 10.4284/0038-4038-77.4.827; Ali MM, 2011, J ADOLESCENCE, V34, P183, DOI 10.1016/j.adolescence.2009.12.008; Ali MM, 2010, ADDICT BEHAV, V35, P337, DOI 10.1016/j.addbeh.2009.12.002; Ali MM, 2009, J ADOLESCENT HEALTH, V45, P402, DOI 10.1016/j.jadohealth.2009.02.004; Andersen RE, 1998, JAMA-J AM MED ASSOC, V279, P938, DOI 10.1001/jama.279.12.938; BARNES MG, 2010, 20102 WSU SCH EC SCI; Boone JE, 2007, INT J BEHAV NUTR PHY, V4, DOI 10.1186/1479-5868-4-26; Burke MA, 2007, ECON INQ, V45, P571, DOI 10.1111/j.1465-7295.2007.00025.x; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Clark AE, 2007, J HEALTH ECON, V26, P763, DOI 10.1016/j.jhealeco.2006.11.005; Crespo CJ, 2001, ARCH PEDIAT ADOL MED, V155, P360, DOI 10.1001/archpedi.155.3.360; Davis B, 2009, AM J PUBLIC HEALTH, V99, P505, DOI 10.2105/AJPH.2008.137638; Deri C, 2005, J HEALTH ECON, V24, P1076, DOI 10.1016/j.jhealeco.2005.03.008; Fletcher J, 2006, ARCH PEDIAT ADOL MED, V160, P383, DOI 10.1001/archpedi.160.4.383; Gordon-Larsen P, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.6.e83; Guthrie JF, 2002, J NUTR EDUC BEHAV, V34, P140, DOI 10.1016/S1499-4046(06)60083-3; Halliday TJ, 2009, ECON HUM BIOL, V7, P181, DOI 10.1016/j.ehb.2009.05.002; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; Jahns L, 2001, J PEDIATR-US, V138, P493, DOI 10.1067/mpd.2001.112162; Lieberman M, 2001, Eat Behav, V2, P215, DOI 10.1016/S1471-0153(01)00030-7; MANSKI CF, 1993, REV ECON STUD, V60, P531, DOI 10.2307/2298123; Marshall SJ, 2004, INT J OBESITY, V28, P1238, DOI 10.1038/sj.ijo.0802706; Mednick SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009775; Nelson MC, 2006, PEDIATRICS, V118, pE1627, DOI 10.1542/peds.2006-0926; Nicklas TA, 2003, AM J PREV MED, V25, P9, DOI 10.1016/S0749-3797(03)00098-9; Niemeier HM, 2006, J ADOLESCENT HEALTH, V39, P842, DOI 10.1016/j.jadohealth.2006.07.001; O'Malley AJ, 2011, STAT MED, V30, P950, DOI 10.1002/sim.4190; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Pereira MA, 2005, LANCET, V365, P36, DOI 10.1016/S0140-6736(04)17663-0; Renna F, 2008, ECON HUM BIOL, V6, P377, DOI 10.1016/j.ehb.2008.06.005; Salvy SJ, 2007, APPETITE, V49, P177, DOI 10.1016/j.appet.2007.01.011; Siega-Riz AM, 1998, AM J CLIN NUTR, V67, p748S, DOI 10.1093/ajcn/67.4.748S; Swinburn BA, 2004, PUBLIC HEALTH NUTR, V7, P123, DOI 10.1079/PHN2003585; Valente TW, 2009, J ADOLESCENT HEALTH, V45, P202, DOI 10.1016/j.jadohealth.2009.01.007; Wang SS, 2006, HEALTH PSYCHOL, V25, P658, DOI 10.1037/0278-6133.25.5.658	38	89	91	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21179	10.1371/journal.pone.0021179	http://dx.doi.org/10.1371/journal.pone.0021179			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	782TT	21731665	gold, Green Published, Green Submitted			2022-12-27	WOS:000292035400011
J	Li, YZ; Yokohama-Tamaki, T; Tanaka, TS				Li, Yanzhen; Yokohama-Tamaki, Tamaki; Tanaka, Tetsuya S.			Short-Term Serum-Free Culture Reveals that Inhibition of Gsk3 beta Induces the Tumor-Like Growth of Mouse Embryonic Stem Cells	PLOS ONE			English	Article							SELF-RENEWAL; TRANSCRIPTION FACTOR; POU-DOMAIN; PLURIPOTENCY; PROTEIN; ACTIVATION; GENE; DIFFERENTIATION; ESTABLISHMENT; DERIVATION	Here, we present evidence that the tumor-like growth of mouse embryonic stem cells (mESCs) is suppressed by short-term serum-free culture, which is reversed by pharmacological inhibition of Gsk3 beta. Mouse ESCs maintained under standard conditions using fetal bovine serum (FBS) were cultured in a uniquely formulated chemically-defined serum-free (CDSF) medium, namely ESF7, for three passages before being subcutaneously transplanted into immunocompromised mice. Surprisingly, the mESCs failed to produce teratomas for up to six months, whereas mESCs maintained under standard conditions generated well-developed teratomas in five weeks. Mouse ESCs cultured under CDSF conditions maintained the expression of Oct3/4, Nanog, Sox2 and SSEA1, and differentiated into germ cells in vivo. In addition, when mESCs were cultured under CDSF conditions supplemented with FBS, or when the cells were cultured under CDSF conditions followed by standard culture conditions, they consistently developed into teratomas. Thus, these results validate that the pluripotency of mESCs was not compromised by CDSF conditions. Mouse ESCs cultured under CDSF conditions proliferated significantly more slowly than mESCs cultured under standard conditions, and were reminiscent of Eras-null mESCs. In fact, their slower proliferation was accompanied by the downregulation of Eras and c-Myc, which regulate the tumor-like growth of mESCs. Remarkably, when mESCs were cultured under CDSF conditions supplemented with a pharmacological inhibitor of Gsk3 beta, they efficiently proliferated and developed into teratomas without upregulation of Eras and c-Myc, whereas mESCs cultured under standard conditions expressed Eras and c-Myc. Although the role of Gsk3 beta in the self-renewal of ESCs has been established, it is suggested with these data that Gsk3 beta governs the tumor-like growth of mESCs by means of a mechanism different from the one to support the pluripotency of ESCs.	[Li, Yanzhen; Yokohama-Tamaki, Tamaki; Tanaka, Tetsuya S.] Univ Illinois, Dept Anim Sci, Inst Genom Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Li, YZ (corresponding author), Univ Illinois, Dept Anim Sci, Inst Genom Biol, 328 Mumford Hall, Urbana, IL 61801 USA.	ttanaka@illinois.edu			USDA [ILLU-538-323]; University of Illinois; Illinois Regenerative Medicine Institute	USDA(United States Department of Agriculture (USDA)); University of Illinois; Illinois Regenerative Medicine Institute	This work was supported by the USDA Hatch Project (ILLU-538-323), University of Illinois and the Illinois Regenerative Medicine Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auerbach W, 2000, BIOTECHNIQUES, V29, P1024, DOI 10.2144/00295st04; Bechard M, 2009, MOL CELL BIOL, V29, P2092, DOI 10.1128/MCB.01405-08; BERNSTINE EG, 1973, P NATL ACAD SCI USA, V70, P3899, DOI 10.1073/pnas.70.12.3899; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Chambers I, 2004, ONCOGENE, V23, P7150, DOI 10.1038/sj.onc.1207930; Chen L, 2008, STEM CELLS, V26, P1858, DOI 10.1634/stemcells.2008-0050; Chen LG, 2010, STEM CELLS, V28, P57, DOI 10.1002/stem.251; Chowdhury F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015655; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Dravid G, 2005, STEM CELLS, V23, P1489, DOI 10.1634/stemcells.2005-0034; Duval D, 2000, FASEB J, V14, P1577, DOI 10.1096/fj.14.11.1577; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Furue M, 2005, IN VITRO CELL DEV-AN, V41, P19; Furue MK, 2008, P NATL ACAD SCI USA, V105, P13409, DOI 10.1073/pnas.0806136105; Goldsborough M.D, 1998, FOCUS, V20, P8; Gurdon JB, 2008, SCIENCE, V322, P1811, DOI 10.1126/science.1160810; Hayashi Y, 2007, STEM CELLS, V25, P3005, DOI 10.1634/stemcells.2007-0103; Hayashi Y, 2010, IN VITRO CELL DEV-AN, V46, P416, DOI 10.1007/s11626-009-9266-6; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; HEWLETT G, 1991, CYTOTECHNOLOGY, V5, P3, DOI 10.1007/BF00365530; Holliday MA, 1999, PEDIATR NEPHROL, V13, P989, DOI 10.1007/s004670050741; Itasaki N, 2010, DEV DYNAM, V239, P16, DOI 10.1002/dvdy.22009; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kameda T, 2005, STEM CELLS, V23, P1535, DOI 10.1634/stemcells.2005-0054; Kim WY, 2009, NAT NEUROSCI, V12, P1390, DOI 10.1038/nn.2408; Larochelle A, 1996, NAT MED, V2, P1329, DOI 10.1038/nm1296-1329; Lawrenz B, 2004, CYTOTHERAPY, V6, P212, DOI 10.1080/14653240410006031; Lindsley RC, 2006, DEVELOPMENT, V133, P3787, DOI 10.1242/dev.02551; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nakagawa M, 2010, P NATL ACAD SCI USA, V107, P14152, DOI 10.1073/pnas.1009374107; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Ohtsuka S, 2008, GENE THER, V15, P74, DOI 10.1038/sj.gt.3303065; OKAMOTO K, 1990, CELL, V60, P461, DOI 10.1016/0092-8674(90)90597-8; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Paling NRD, 2004, J BIOL CHEM, V279, P48063, DOI 10.1074/jbc.M406467200; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Raz R, 1999, P NATL ACAD SCI USA, V96, P2846, DOI 10.1073/pnas.96.6.2846; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P4505, DOI 10.1073/pnas.0504337103; ROSNER MH, 1990, NATURE, V345, P686, DOI 10.1038/345686a0; SATO GH, 1975, BIOCHEM ACTION HORM, P391; Sato GH, 2010, IN VITRO CELL DEV-AN, V46, P590, DOI 10.1007/s11626-010-9315-1; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; SCHOLER HR, 1990, NATURE, V344, P435, DOI 10.1038/344435a0; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Solter D, 2006, NAT REV GENET, V7, P319, DOI 10.1038/nrg1827; SOPRANO DR, 1994, PLASMA RETINOL BINDI, P257; Suemori H, 2001, DEV DYNAM, V222, P273, DOI 10.1002/dvdy.1191; Takahashi K, 2003, NATURE, V423, P541, DOI 10.1038/nature01646; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tanaka TS, 2008, GENESIS, V46, P347, DOI 10.1002/dvg.20404; Tanaka TS, 2006, DEV GROWTH DIFFER, V48, P381, DOI 10.1111/j.1440-169x.2006.00875.x; Tanaka TS, 2010, INT J DEV BIOL, V54, P1347, DOI 10.1387/ijdb.092862tt; Tanaka TS, 2009, REPROD FERT DEVELOP, V21, P67, DOI 10.1071/RD08219; Tanaka TS, 2002, GENOME RES, V12, P1921, DOI 10.1101/gr.670002; Tanaka Y, 2009, CELL TRANSPLANT, V18, P381, DOI 10.3727/096368909788809794; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tompers DM, 2004, STEM CELLS, V22, P243, DOI 10.1634/stemcells.22-3-243; Umehara H, 2007, STEM CELLS, V25, P2705, DOI 10.1634/stemcells.2007-0086; Viswanathan S, 2003, BIOTECHNOL BIOENG, V84, P505, DOI 10.1002/bit.10799; Voog J, 2010, CELL STEM CELL, V6, P103, DOI 10.1016/j.stem.2010.01.011; Walker E, 2007, CELL STEM CELL, V1, P71, DOI 10.1016/j.stem.2007.04.002; Wang J, 2009, SCIENCE, V325, P435, DOI 10.1126/science.1173288; Wang R, 2008, DIFFERENTIATION, V76, P931, DOI 10.1111/j.1432-0436.2008.00272.x; Watanabe S, 2006, ONCOGENE, V25, P2697, DOI 10.1038/sj.onc.1209307; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Wu DQ, 2010, TRENDS BIOCHEM SCI, V35, P161, DOI 10.1016/j.tibs.2009.10.002; Yamanaka S, 2009, CELL, V137, P13, DOI 10.1016/j.cell.2009.03.034; Yanes O, 2010, NAT CHEM BIOL, V6, P411, DOI 10.1038/nchembio.364; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, METHOD ENZYMOL, V365, P327; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yu JY, 2008, GENE DEV, V22, P1987, DOI 10.1101/gad.1689808; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang WS, 2005, DEV CELL, V8, P267, DOI 10.1016/j.devcel.2005.01.001	85	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21355	10.1371/journal.pone.0021355	http://dx.doi.org/10.1371/journal.pone.0021355			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731714	Green Published, gold, Green Submitted			2022-12-27	WOS:000292035400027
J	Hailu, M; Gebremariam, A; Alemseged, F; Deribe, K				Hailu, Mesay; Gebremariam, Abebe; Alemseged, Fissehaye; Deribe, Kebede			Birth Preparedness and Complication Readiness among Pregnant Women in Southern Ethiopia	PLOS ONE			English	Article							DISTRICT	Background: Birth preparedness and complication preparedness (BPACR) is a key component of globally accepted safe motherhood programs, which helps ensure women to reach professional delivery care when labor begins and to reduce delays that occur when mothers in labor experience obstetric complications. Objective: This study was conducted to assess practice and factors associated with BPACR among pregnant women in Aleta Wondo district in Sidama Zone, South Ethiopia. Methods: A community based cross sectional study was conducted in 2007, on a sample of 812 pregnant women. Data were collected using pre-tested and structured questionnaire. The collected data were analyzed by SPSS for windows version 12.0.1. The women were asked whether they followed the desired five steps while pregnant: identified a trained birth attendant, identified a health facility, arranged for transport, identified blood donor and saved money for emergency. Taking at least two steps was considered being well-prepared. Results: Among 743 pregnant women only a quarter (20.5%) of pregnant women identified skilled provider. Only 8.1% identified health facility for delivery and/or for obstetric emergencies. Preparedness for transportation was found to be very low (7.7%). Considerable (34.5%) number of families saved money for incurred costs of delivery and emergency if needed. Only few (2.3%) identified potential blood donor in case of emergency. Majority (87.9%) of the respondents reported that they intended to deliver at home, and only 60(8%) planned to deliver at health facilities. Overall only 17% of pregnant women were well prepared. The adjusted multivariate model showed that significant predictors for being well-prepared were maternal availing of antenatal services (OR = 1.91 95% CI; 1.21-3.01) and being pregnant for the first time (OR = 6.82, 95% CI; 1.27-36.55). Conclusion: BPACR practice in the study area was found to be low. Effort to increase BPACR should focus on availing antenatal care services.	[Hailu, Mesay] Sidam Zone Hlth Off, Hwassa, Ethiopia; [Hailu, Mesay; Gebremariam, Abebe] Coll Publ Hlth & Med Sci, Populat & Family Hlth Dept, Jimma, Ethiopia; [Alemseged, Fissehaye] Jimma Univ, Coll Publ Hlth & Med Sci, Dept Epidemiol & Biostat, Jimma, Ethiopia	Jimma University	Hailu, M (corresponding author), Sidam Zone Hlth Off, Hwassa, Ethiopia.	kebededeka@yahoo.com	Dangisso, Mesay Hailu/AAU-7743-2020; Deribe, Kebede/I-5422-2019; Deribe, Kebede/K-7055-2019	Deribe, Kebede/0000-0002-8526-6996; 	Jimma University	Jimma University	This study was financially supported by Jimma University. The funder had no role in study design, data collection and analysis, or preparation of the manuscript.	Agarwal S, 2010, J HEALTH POPUL NUTR, V28, P383; Baya B, 2004, MEASURING EFFECTS BE, P18; *CENTR STAT AG, 2006, ETH DEM HLTH SURV 20; *FED DEM REP ETH, 2006, CENTR STAT AG STAT A; Fullerton Judith T, 2005, Health Care Women Int, V26, P561, DOI 10.1080/07399330591004881; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; *J SNOW INC, 2000, ISS PROGR SAF MOTH C; JHPIEGO, 2001, MAT NEON HLTH PROGR; JHPIEGO, 2004, MON BIRTH PREP COMPL, P1; Johns Hopkins Bloomberg School of Public Health Family Care International Maternal and Neonatal Health Program., 2004, MON BIRTH PREP COMP; McPherson RA, 2006, J HEALTH POPUL NUTR, V24, P479; *MIN FIN EC DEV, 2008, ETH PROGR ACH MILL G; MOORE KM, 2000, COMMUNICATION INITIA; Moran AC, 2006, J HEALTH POPUL NUTR, V24, P489; *SID ZON FIN EC DE, 2005, SID ADM ZON SOC DEM; *SID ZON HLTH DEP, 2006, ANN REP SID ZON HLTH; *SNNPR HLTH BUR, 2004, HLTH REL IND PLANN E; Stanton CK, 2004, EVALUATION REV, V28, P179, DOI 10.1177/0193841X03262577; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; *UN CHILDR FUND, 1996, PROGR NAT; *WHIT RIBB ALL SAF, 2002, SAV MOTH LIV WHAT WO; WHO, 1989, PREV MAT DEATHS; WHO, 1994, MOTH BAB PACK IMPL S; World Health Organization, 1998, WORLD HLTH DAY SAF M; World Health Organization, 2005, WORLD HLTH DAY MAK E	25	95	96	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21432	10.1371/journal.pone.0021432	http://dx.doi.org/10.1371/journal.pone.0021432			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731747	Green Published, Green Submitted, gold			2022-12-27	WOS:000292033700084
J	Ross, AW; Helfer, G; Russell, L; Darras, VM; Morgan, PJ				Ross, Alexander W.; Helfer, Gisela; Russell, Laura; Darras, Veerle M.; Morgan, Peter J.			Thyroid Hormone Signalling Genes Are Regulated by Photoperiod in the Hypothalamus of F344 Rats	PLOS ONE			English	Article							GALANIN-LIKE PEPTIDE; TYPE-2 DEIODINASE GENE; THYROTROPIN-RELEASING-HORMONE; GROWTH-HORMONE; MEDIOBASAL HYPOTHALAMUS; SIBERIAN HAMSTER; ARCUATE NUCLEUS; NEUROPEPTIDE-Y; EXPRESSION; FISCHER-344	Seasonal animals adapt their physiology and behaviour in anticipation of climate change to optimise survival of their offspring. Intra-hypothalamic thyroid hormone signalling plays an important role in seasonal responses in mammals and birds. In the F344 rat, photoperiod stimulates profound changes in food intake, body weight and reproductive status. Previous investigations of the F344 rat have suggested a role for thyroid hormone metabolism, but have only considered Dio2 expression, which was elevated in long day photoperiods. Microarray analysis was used to identify time-dependent changes in photoperiod responsive genes, which may underlie the photoperiod-dependent phenotypes of the juvenile F344 rat. The most significant changes are those related to thyroid hormone metabolism and transport. Using photoperiod manipulations and melatonin injections into long day photoperiod (LD) rats to mimic short day (SD), we show photoinduction and photosuppression gene expression profiles and melatonin responsiveness of genes by in situ hybridization; TSH beta, CGA, Dio2 and Oatp1c1 genes were all elevated in LD whilst in SD, Dio3 and MCT-8 mRNA were increased. NPY was elevated in SD whilst GALP increased in LD. The photoinduction and photosuppression profiles for GALP were compared to that of GHRH with GALP expression following GHRH temporally. We also reveal gene sets involved in photoperiodic responses, including retinoic acid and Wnt/beta-catenin signalling. This study extends our knowledge of hypothalamic regulation by photoperiod, by revealing large temporal changes in expression of thyroid hormone signalling genes following photoperiod switch. Surprisingly, large changes in hypothalamic thyroid hormone levels or TRH expression were not detected. Expression of NPY and GALP, two genes known to regulate GHRH, were also changed by photoperiod. Whether these genes could provide links between thyroid hormone signalling and the regulation of the growth axis remains to be investigated.	[Ross, Alexander W.; Helfer, Gisela; Russell, Laura; Morgan, Peter J.] Univ Aberdeen, Rowett Inst Nutr & Hlth, Aberdeen, Scotland; [Darras, Veerle M.] Katholieke Univ Leuven, Lab Comparat Endocrinol, Div Anim Physiol & Neurobiol, Louvain, Belgium	University of Aberdeen; KU Leuven	Ross, AW (corresponding author), Univ Aberdeen, Rowett Inst Nutr & Hlth, Aberdeen, Scotland.	p.morgan@abdn.ac.uk	Helfer, Gisela/S-9189-2019	Helfer, Gisela/0000-0003-0634-4683; Ross, Alexander/0000-0002-1799-1432; Morgan, Peter/0000-0002-5071-6512	Scottish Government, RSD; BBSRC [BB/G014272/1]; Biotechnology and Biological Sciences Research Council [BB/G014272/1] Funding Source: researchfish	Scottish Government, RSD; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors acknowledge the Scottish Government, RSD (AWR, LR and PJM) and BBSRC grant number BB/G014272/1 (GH, AWR and PJM) for funding towards this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett P, 2007, ENDOCRINOLOGY, V148, P3608, DOI 10.1210/en.2007-0316; Chiamolera MI, 2009, ENDOCRINOLOGY, V150, P1091, DOI 10.1210/en.2008-1795; Cunnningham MJ, 2004, J NEUROENDOCRINOL, V16, P10, DOI 10.1111/j.1365-2826.2004.01118.x; Dardente H, 2010, CURR BIOL, V20, P2193, DOI 10.1016/j.cub.2010.10.048; DARRAS VM, 1990, GEN COMP ENDOCR, V77, P212, DOI 10.1016/0016-6480(90)90305-6; Ebling FJP, 2008, J NEUROENDOCRINOL, V20, P576, DOI 10.1111/j.1365-2826.2008.01702.x; Friesema ECH, 2008, MOL ENDOCRINOL, V22, P1357, DOI 10.1210/me.2007-0112; Gahete MD, 2009, ANN NY ACAD SCI, V1163, P137, DOI 10.1111/j.1749-6632.2008.03660.x; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hanon EA, 2008, CURR BIOL, V18, P1147, DOI 10.1016/j.cub.2008.06.076; Heideman PD, 1997, BIOL REPROD, V57, P134, DOI 10.1095/biolreprod57.1.134; Heideman PD, 2001, J NEUROENDOCRINOL, V13, P223, DOI 10.1046/j.1365-2826.2001.00617.x; Herwig A, 2009, AM J PHYSIOL-REG I, V296, pR1307, DOI 10.1152/ajpregu.90755.2008; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; Kuramochi M, 2005, REGUL PEPTIDES, V126, P85, DOI 10.1016/j.regpep.2004.08.017; Larm JA, 2000, NEUROENDOCRINOLOGY, V72, P67, DOI 10.1159/000054573; Lawrence C, 2011, FRONT NEUROENDOCRIN, V32, P1, DOI 10.1016/j.yfrne.2010.06.001; MATZUK MM, 1988, MOL ENDOCRINOL, V2, P95, DOI 10.1210/mend-2-2-95; Nakao N, 2006, ENDOCRINOLOGY, V147, P1067, DOI 10.1210/en.2005-1090; Nakao N, 2008, NATURE, V452, P317, DOI 10.1038/nature06738; Ohtaki T, 1999, J BIOL CHEM, V274, P37041, DOI 10.1074/jbc.274.52.37041; Ono H, 2008, P NATL ACAD SCI USA, V105, P18238, DOI 10.1073/pnas.0808952105; Park S, 2005, NEUROENDOCRINOLOGY, V81, P360, DOI 10.1159/000089101; Revel FG, 2006, ENDOCRINOLOGY, V147, P4680, DOI 10.1210/en.2006-0606; Reyns GE, 2002, COMP BIOCHEM PHYS B, V132, P239, DOI 10.1016/S1096-4959(01)00528-0; Rich N, 2007, PHYSIOL BEHAV, V92, P814, DOI 10.1016/j.physbeh.2007.06.003; Ross AW, 2009, J NEUROENDOCRINOL, V21, P610, DOI 10.1111/j.1365-2826.2009.01878.x; Sanchez E, 2010, ENDOCRINOLOGY, V151, P3827, DOI 10.1210/en.2010-0279; SEGERSON TP, 1987, SCIENCE, V238, P78, DOI 10.1126/science.3116669; Shahab M, 2005, NEUROENDOCRINOLOGY, V81, P254, DOI 10.1159/000087649; Shearer KD, 2010, J NEUROCHEM, V112, P246, DOI 10.1111/j.1471-4159.2009.06455.x; Sugiyama D, 2003, J BIOL CHEM, V278, P43489, DOI 10.1074/jbc.M306933200; Takatsu Y, 2001, ENDOCRINOLOGY, V142, P1626, DOI 10.1210/en.142.4.1626; van der Deure WM, 2008, ENDOCRINOLOGY, V149, P5307, DOI 10.1210/en.2008-0430; Yasuo S, 2006, ENDOCRINOLOGY, V147, P432, DOI 10.1210/en.2005-0507; Yasuo S, 2005, ENDOCRINOLOGY, V146, P2551, DOI 10.1210/en.2005-0057; Yasuo S, 2010, J NEUROENDOCRINOL, V22, P43, DOI 10.1111/j.1365-2826.2009.01936.x; Yasuo S, 2007, ENDOCRINOLOGY, V148, P4385, DOI 10.1210/en.2007-0497; Yasuo S, 2007, AM J PHYSIOL-REG I, V292, pR1315, DOI 10.1152/ajpregu.00396.2006; Yoshimura T, 2003, NATURE, V426, P178, DOI 10.1038/nature02117	40	77	79	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21351	10.1371/journal.pone.0021351	http://dx.doi.org/10.1371/journal.pone.0021351			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731713	Green Published, gold, Green Submitted			2022-12-27	WOS:000292033700066
J	Nunes, B; Viboud, C; Machado, A; Ringholz, C; Rebelo-de-Andrade, H; Nogueira, P; Miller, M				Nunes, Baltazar; Viboud, Cecile; Machado, Ausenda; Ringholz, Corinne; Rebelo-de-Andrade, Helena; Nogueira, Paulo; Miller, Mark			Excess Mortality Associated with Influenza Epidemics in Portugal, 1980 to 2004	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL-VIRUS; UNITED-STATES; HOSPITAL ADMISSIONS; IMPACT; VACCINATION; DISEASE; POPULATION; PNEUMONIA; SURVEILLANCE; CHILDREN	Background: Influenza epidemics have a substantial impact on human health, by increasing the mortality from pneumonia and influenza, respiratory and circulatory diseases, and all causes. This paper provides estimates of excess mortality rates associated with influenza virus circulation for 7 causes of death and 8 age groups in Portugal during the period of 1980-2004. Methodology/Principal Findings: We compiled monthly mortality time series data by age for all-cause mortality, cerebrovascular diseases, ischemic heart diseases, diseases of the respiratory system, chronic respiratory diseases, pneumonia and influenza. We also used a control outcome, deaths from injuries. Age-and cause-specific baseline mortality was modelled by the ARIMA approach; excess deaths attributable to influenza were calculated by subtracting expected deaths from observed deaths during influenza epidemic periods. Influenza was associated with a seasonal average of 24.7 all-cause excess deaths per 100,000 inhabitants, approximately 90% of which were among seniors over 65 yrs. Excess mortality was 3-6 fold higher during seasons dominated by the A(H3N2) subtype than seasons dominated by A(H1N1)/B. High excess mortality impact was also seen in children under the age of four years. Seasonal excess mortality rates from all the studied causes of death were highly correlated with each other (Pearson correlation range, 0.65 to 0.95, P<0.001) and with seasonal rates of influenza-like-illness (ILI) among seniors over 65 years (Pearson correlation rho >0.64, P<0.05). By contrast, there was no correlation with excess mortality from injuries. Conclusions/Significance: Our excess mortality approach is specific to influenza virus activity and produces influenza-related mortality rates for Portugal that are similar to those published for other countries. Our results indicate that all-cause excess mortality is a robust indicator of influenza burden in Portugal, and could be used to monitor the impact of influenza epidemics in this country. Additional studies are warranted to confirm these findings in other settings.	[Nunes, Baltazar; Machado, Ausenda; Nogueira, Paulo] Inst Nacl Saude Dr Ricardo Jorge, Dept Epidemiol, Lisbon, Portugal; [Viboud, Cecile; Ringholz, Corinne; Miller, Mark] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Rebelo-de-Andrade, Helena] Inst Nacl Saude Dr Ricardo Jorge, Dept Doencas Infecciosas, Lisbon, Portugal; [Rebelo-de-Andrade, Helena] Univ Lisbon, Fac Farm, Lisbon, Portugal	Instituto Nacional de Saude Dr. Ricardo Jorge; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); Instituto Nacional de Saude Dr. Ricardo Jorge; Universidade de Lisboa	Nunes, B (corresponding author), Inst Nacl Saude Dr Ricardo Jorge, Dept Epidemiol, Lisbon, Portugal.	baltazar.nunes@insa.min-saude.pt	iMed.ULisboa, HPI/B-4239-2014; Machado, Ausenda/AAE-9913-2022; Nogueira, Paulo Jorge/AAR-5605-2020; Nunes, Baltazar/V-8903-2019; Rebelo-de-Andrade, Helena/E-1871-2014; Machado, Ausenda/ABP-0781-2022; Nogueira, Paulo/HDL-7482-2022	iMed.ULisboa, HPI/0000-0001-5934-0198; Nogueira, Paulo Jorge/0000-0001-8316-5035; Nunes, Baltazar/0000-0001-6230-7209; Rebelo-de-Andrade, Helena/0000-0002-0138-0944; Machado, Ausenda/0000-0002-1849-1499	Luso-American Foundation [1-13/08]; Instituto Nacional de Saude; International Influenza Unit, Office of Global Health Affairs, Department of Health and Human Services	Luso-American Foundation; Instituto Nacional de Saude; International Influenza Unit, Office of Global Health Affairs, Department of Health and Human Services	This project was initiated during a three-month visit by B. Nunes to the Fogarty International Center, United States National Institutes of Health, and supported by the Luso-American Foundation project 1-13/08 and the Instituto Nacional de Saude Dr. Ricardo Jorge. This research was conducted in the context of the MISMS Study, an ongoing international collaborative effort to understand influenza epidemiological and evolutionary patterns, led by the Fogarty International Center, National Institutes of Health (http://www.origem.info/misms/index.php). The MISMS study is funded by the International Influenza Unit, Office of Global Health Affairs, Department of Health and Human Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baltussen RMPM, 1998, EPIDEMIOL INFECT, V121, P129, DOI 10.1017/S0950268898008966; Beigel JH, 2008, CRIT CARE MED, V36, P2660, DOI 10.1097/CCM.0b013e318180b039; BRANCO MJ, 2003, QUE MAIS SE MORRE PO; Brinkhof MWG, 2006, SWISS MED WKLY, V136, P302; CARRAT F, 1995, J EPIDEMIOL COMMUN H, V49, P419, DOI 10.1136/jech.49.4.419; CHOI K, 1982, AM J PUBLIC HEALTH, V72, P1280, DOI 10.2105/AJPH.72.11.1280; Cox NJ, 2000, ANNU REV MED, V51, P407, DOI 10.1146/annurev.med.51.1.407; FENTON LF, 1960, IRE T COMMUN, V8; Francisco PMSB, 2005, REV SAUDE PUBL, V39, P75, DOI 10.1590/S0034-89102005000100010; Hyndman R., 2008, J STAT SOFTWARE, V27; *I NAC EST, 2008, INF; *I NAC SAUD DR R J, 2009, MED SENT QUE SE FEZ; Iwane MK, 2004, PEDIATRICS, V113, P1758, DOI 10.1542/peds.113.6.1758; Jansen AGSC, 2007, EUR RESPIR J, V30, P1158, DOI 10.1183/09031936.00034407; Kyncl J, 2005, EUR J EPIDEMIOL, V20, P365, DOI 10.1007/s10654-005-1067-y; Madjid M, 2004, TEX HEART I J, V31, P4; Mazick A, 2010, EURO SURVEILL, V15; Mazick A, 2007, EURO SURVEILL, V12; Meier CR, 2000, EUR J CLIN MICROBIOL, V19, P834, DOI 10.1007/s100960000376; Nguyen-Van-Tam JS, 2001, EPIDEMIOL INFECT, V126, P71, DOI 10.1017/S0950268801005076; Nogueira PJ, 2010, EURO SURVEILL, V15; NOGUEIRA PJ, 2009, EURO SURVEILL, V14; NUNES B, 2008, VACINA ANTIGRIPAL CO; NUNES B, 2010, STAT METHODS MED RES; Oropesa S, 2004, INT CONGR SER, V1263, P355, DOI 10.1016/j.ics.2004.04.004; *R DEC COR TEAM, 2008, R LANG ENV STAT COMP; Reichert TA, 2004, AM J EPIDEMIOL, V160, P492, DOI 10.1093/aje/kwh227; Richard SA, 2009, EPIDEMIOL INFECT, V137, P1062, DOI 10.1017/S0950268809002088; Rizzo C, 2006, VACCINE, V24, P6468, DOI 10.1016/j.vaccine.2006.06.052; Schanzer DL, 2007, EPIDEMIOL INFECT, V135, P1109, DOI 10.1017/S0950268807007923; SERFLING RE, 1967, AM J EPIDEMIOL, V86, P433, DOI 10.1093/oxfordjournals.aje.a120753; Shay DK, 1999, JAMA-J AM MED ASSOC, V282, P1440, DOI 10.1001/jama.282.15.1440; Simonsen L, 1997, AM J PUBLIC HEALTH, V87, P1944, DOI 10.2105/AJPH.87.12.1944; Simonsen L, 2005, ARCH INTERN MED, V165, P265, DOI 10.1001/archinte.165.3.265; Simonsen L, 2000, J INFECT DIS, V181, P831, DOI 10.1086/315320; SPRENGER MJW, 1993, INT J EPIDEMIOL, V22, P334, DOI 10.1093/ije/22.2.334; Thompson WW, 2006, J INFECT DIS, V194, pS82, DOI 10.1086/507558; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; *UN POP DIV POP ES, 2008, WORLD POP PROSP 2008; WHO, 2006, MORT COUNTR FACT SHE; *WONCA INT CLASS C, 1999, ICPC 2 CLASS INT CUI; Yap FHY, 2004, J MED VIROL, V73, P617, DOI 10.1002/jmv.20135; Zambon MC, 2001, LANCET, V358, P1410, DOI 10.1016/S0140-6736(01)06528-X; Zucs P, 2005, EMERG THEMES EPIDEMI, V2, DOI 10.1186/1742-7622-2-6	45	56	66	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2011	6	6							e20661	10.1371/journal.pone.0020661	http://dx.doi.org/10.1371/journal.pone.0020661			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	782CL	21713040	Green Published, Green Submitted, gold			2022-12-27	WOS:000291985100003
J	Morcillo, S; Martin-Nunez, GM; Rojo-Martinez, G; Almaraz, MC; Garcia-Escobar, E; Mansego, ML; de Marco, G; Chaves, FJ; Soriguer, F				Morcillo, Sonsoles; Maria Martin-Nunez, Gracia; Rojo-Martinez, Gemma; Cruz Almaraz, Maria; Garcia-Escobar, Eva; Luisa Mansego, Maria; de Marco, Griselda; Chaves, Felipe J.; Soriguer, Federico			ELOVL6 Genetic Variation Is Related to Insulin Sensitivity: A New Candidate Gene in Energy Metabolism	PLOS ONE			English	Article							FATTY-ACID ELONGASES; OLEIC-ACID; RESISTANCE; POPULATION; PIZARRA; GLUCOSE; OBESITY	Background: The elongase of long chain fatty acids family 6 (ELOVL6) is an enzyme that specifically catalyzes the elongation of saturated and monounsaturated fatty acids with 12, 14 and 16 carbons. ELOVL6 is expressed in lipogenic tissues and it is regulated by sterol regulatory element binding protein 1 (SREBP-1). Objective: We investigated whether ELOVL6 genetic variation is associated with insulin sensitivity in a population from southern Spain. Design: We undertook a prospective, population-based study collecting phenotypic, metabolic, nutritional and genetic information. Measurements were made of weight and height and the body mass index (BMI) was calculated. Insulin resistance was measured by homeostasis model assessment. The type of dietary fat was assessed from samples of cooking oil taken from the participants' kitchens and analyzed by gas chromatography. Five SNPs of the ELOVL6 gene were analyzed by SNPlex. Results: Carriers of the minor alleles of the SNPs rs9997926 and rs6824447 had a lower risk of having high HOMA_IR, whereas carriers of the minor allele rs17041272 had a higher risk of being insulin resistant. An interaction was detected between the rs6824447 polymorphism and the intake of oil in relation with insulin resistance, such that carriers of this minor allele who consumed sunflower oil had lower HOMA_IR than those who did not have this allele (P = 0.001). Conclusions: Genetic variations in the ELOVL6 gene were associated with insulin sensitivity in this population-based study.	[Morcillo, Sonsoles; Maria Martin-Nunez, Gracia; Rojo-Martinez, Gemma; Cruz Almaraz, Maria; Garcia-Escobar, Eva; Soriguer, Federico] Hosp Carlos Haya, Endocrinol & Nutr Serv, Malaga, Spain; [Morcillo, Sonsoles; Maria Martin-Nunez, Gracia; Rojo-Martinez, Gemma; Cruz Almaraz, Maria; Garcia-Escobar, Eva; Luisa Mansego, Maria; de Marco, Griselda; Chaves, Felipe J.; Soriguer, Federico] Inst Salud Carlos III, CIBER Diabet & Enfermedades Metabol Asociadas CIB, Barcelona, Spain; [Luisa Mansego, Maria; de Marco, Griselda; Chaves, Felipe J.] Hosp Clin Res Fdn Valencia INCLIVA, Unidad Genotipado & Diagnost Genet, Valencia, Spain	Hospital Carlos Haya; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Instituto de Salud Carlos III	Morcillo, S (corresponding author), Hosp Carlos Haya, Endocrinol & Nutr Serv, Malaga, Spain.	sonsoles75@gmail.com	Rojo-martínez, Gemma/E-3351-2010; Chaves-Martinez, Felipe Javier/ABC-3294-2021; MORCILLO, SONSOLES/N-9970-2017; MANSEGO, MARIA/A-5687-2011	Rojo-martínez, Gemma/0000-0003-2179-2134; Chaves-Martinez, Felipe Javier/0000-0001-8009-3689; Almaraz, Maria Cruz/0000-0002-4470-4515; Martin Nunez, Gracia Maria/0000-0001-7069-2960; MORCILLO, SONSOLES/0000-0001-6932-5637; GARCIA-ESCOBAR, EVA/0000-0002-0134-3473; MANSEGO, MARIA/0000-0001-8914-7890; De Marco, Griselda/0000-0003-2344-9348	Fondo de Investigacion Sanitaria [PI051307, PI09/2117, PI070497]; Junta de Andalucia [PI0192/2008]; CIBERDEM [CB-02/08/2009]	Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); Junta de Andalucia(Junta de Andalucia); CIBERDEM	This study was funded by the Fondo de Investigacion Sanitaria (PI051307, PI09/2117, and PI070497), Junta de Andalucia (PI0192/2008) and CIBERDEM (INGENFRED Project CB-02/08/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartoli E, 2011, EUR J INTERN MED, V22, P8, DOI 10.1016/j.ejim.2010.07.008; BEDDINGFIELD H, 2005, IMPRINT, V52; DEFRONZO RA, 2010, DIABETOLOGIA; Gonzalez JR, 2007, BIOINFORMATICS, V23, P644, DOI 10.1093/bioinformatics/btm025; Guillou H, 2010, PROG LIPID RES, V49, P186, DOI 10.1016/j.plipres.2009.12.002; Jakobsson A, 2006, PROG LIPID RES, V45, P237, DOI 10.1016/j.plipres.2006.01.004; Jump DB, 2005, J NUTR, V135, P2503, DOI 10.1093/jn/135.11.2503; Matsuzaka T, 2002, J LIPID RES, V43, P911; Matsuzaka T, 2007, NAT MED, V13, P1193, DOI 10.1038/nm1662; Matsuzaka T, 2009, J MOL MED, V87, P379, DOI 10.1007/s00109-009-0449-0; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Moon YA, 2001, J BIOL CHEM, V276, P45358, DOI 10.1074/jbc.M108413200; MORCILLO S, 2009, J RHEUMATOL; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; Riccardi G, 2004, CLIN NUTR, V23, P447, DOI 10.1016/j.clnu.2004.02.006; Riserus U, 2009, PROG LIPID RES, V48, P44, DOI 10.1016/j.plipres.2008.10.002; Shimamura K, 2010, EUR J PHARMACOL, V630, P34, DOI 10.1016/j.ejphar.2009.12.033; Soriguer F, 2008, EUR J CLIN INVEST, V38, P126, DOI 10.1111/j.1365-2362.2007.01910.x; Soriguer F, 2004, EUR J ENDOCRINOL, V150, P33, DOI 10.1530/eje.0.1500033; SORIGUER F, 2009, EUR J CLIN NUTR; SORIGUER F, 2009, BR J NUTR, P1; Soriguer F, 2006, J NUTR, V136, P2325, DOI 10.1093/jn/136.9.2325; Sudhir Rajasekaran, 2002, Treat Endocrinol, V1, P105, DOI 10.2165/00024677-200201020-00004; Unger RH, 2003, TRENDS ENDOCRIN MET, V14, P398, DOI 10.1016/j.tem.2003.09.008; Wang Y, 2005, J LIPID RES, V46, P706, DOI 10.1194/jlr.M400335-JLR200; Wang Y, 2006, J LIPID RES, V47, P2028, DOI 10.1194/jlr.M600177-JLR200; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	27	24	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e21198	10.1371/journal.pone.0021198	http://dx.doi.org/10.1371/journal.pone.0021198			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	21701577	Green Submitted, Green Published, gold			2022-12-27	WOS:000291983800031
J	De Repentigny, Y; Ferrier, A; Ryan, SD; Sato, T; Kothary, R				De Repentigny, Yves; Ferrier, Andrew; Ryan, Scott D.; Sato, Tadasu; Kothary, Rashmi			Motor Unit Abnormalities in Dystonia musculorum Mice	PLOS ONE			English	Article							VERTEBRATE NEUROMUSCULAR-JUNCTION; BULLOUS PEMPHIGOID ANTIGEN-1; POSSIBLE CELLULAR MECHANISM; MYELINATING SCHWANN-CELLS; CROSS-LINKING FACTOR; DORSAL-ROOT GANGLIA; MUTANT MICE; DT MICE; NEUROLOGIC DEGENERATION; NEURONAL DEGENERATION	Dystonia musculorum (dt) is a mouse inherited sensory neuropathy caused by mutations in the dystonin gene. While the primary pathology lies in the sensory neurons of dt mice, the overt movement disorder suggests motor neurons may also be affected. Here, we report on the contribution of motor neurons to the pathology in dt(27J) mice. Phenotypic dt(27J) mice display reduced alpha motor neuron cell number and eccentric alpha motor nuclei in the ventral horn of the lumbar L1 spinal cord region. A dramatic reduction in the total number of motor axons in the ventral root of postnatal day 15 dt(27J) mice was also evident. Moreover, analysis of the trigeminal nerve of the brainstem showed a 2.4 fold increase in number of degenerating neurons coupled with a decrease in motor neuron number relative to wild type. Aberrant phosphorylation of neurofilaments in the perikaryon region and axonal swellings within the pre-synaptic terminal region of motor neurons were observed. Furthermore, neuromuscular junction staining of dt(27J) mouse extensor digitorum longus and tibialis anterior muscle fibers showed immature endplates and a significant decrease in axon branching compared to wild type littermates. Muscle atrophy was also observed in dt(27J) muscle. Ultrastructure analysis revealed amyelinated motor axons in the ventral root of the spinal nerve, suggesting a possible defect in Schwann cells. Finally, behavioral analysis identified defective motor function in dt(27J) mice. This study reveals neuromuscular defects that likely contribute to the dt(27J) pathology and identifies a critical role for dystonin outside of sensory neurons.	[De Repentigny, Yves; Ferrier, Andrew; Ryan, Scott D.; Sato, Tadasu; Kothary, Rashmi] Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Ferrier, Andrew; Kothary, Rashmi] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada; [Ferrier, Andrew; Kothary, Rashmi] Univ Ottawa, Dept Med, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa	De Repentigny, Y (corresponding author), Ottawa Hosp Res Inst, Ottawa, ON, Canada.	rkothary@ohri.ca		Kothary, Rashmi/0000-0002-9239-7310; Ryan, Scott/0000-0001-9829-4649	Canadian Institute of Health Research (CIHR)	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was funded by the Canadian Institute of Health Research (CIHR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antolik C, 2007, NEUROSCIENCE, V145, P56, DOI 10.1016/j.neuroscience.2006.11.047; BEKOFF A, 1977, J PHYSIOL-LONDON, V271, P25, DOI 10.1113/jphysiol.1977.sp011988; Bernier G, 1995, MOL CELL NEUROSCI, V6, P509, DOI 10.1006/mcne.1995.0003; Bernier G, 1998, DEVELOPMENT, V125, P2135; BROWN A, 1995, GENOMICS, V29, P777, DOI 10.1006/geno.1995.9936; BROWN A, 1995, NAT GENET, V10, P301, DOI 10.1038/ng0795-301; Chhabra ES, 2007, NAT CELL BIOL, V9, P1110, DOI 10.1038/ncb1007-1110; Cifuentes-Diaz C, 2002, HUM MOL GENET, V11, P1439, DOI 10.1093/hmg/11.12.1439; Dalpe G, 1998, MOL CELL NEUROSCI, V10, P243, DOI 10.1006/mcne.1997.0660; Dalpe G, 1999, DEV BIOL, V210, P367, DOI 10.1006/dbio.1999.9263; De Repentigny Y, 2003, J NEUROCHEM, V86, P564, DOI 10.1046/j.1471-4159.2003.01861.x; DEWAEGH SM, 1992, CELL, V68, P451, DOI 10.1016/0092-8674(92)90183-D; Dowling J, 1997, DEV BIOL, V187, P131, DOI 10.1006/dbio.1997.8567; Duchen L W, 1976, Adv Neurol, V14, P353; DUCHEN LW, 1964, BRAIN, V87, P367, DOI 10.1093/brain/87.2.367; Guillery RW, 2002, PROG BRAIN RES, V135, P25; GUO LF, 1995, CELL, V81, P233, DOI 10.1016/0092-8674(95)90333-X; Herrmann H, 2007, NAT REV MOL CELL BIO, V8, P562, DOI 10.1038/nrm2197; Howard J, 2003, NATURE, V422, P753, DOI 10.1038/nature01600; JANOTA I, 1972, BRAIN, V95, P529, DOI 10.1093/brain/95.3.529; Kariya S, 2008, HUM MOL GENET, V17, P2552, DOI 10.1093/hmg/ddn156; KOTHARY R, 1988, NATURE, V335, P435, DOI 10.1038/335435a0; Lalonde R, 2005, PHYSIOL BEHAV, V86, P46, DOI 10.1016/j.physbeh.2005.06.028; LALONDE R, 1993, PHYSIOL BEHAV, V54, P119, DOI 10.1016/0031-9384(93)90052-H; LANCEJONES C, 1982, DEV BRAIN RES, V4, P473, DOI 10.1016/0165-3806(82)90192-4; Leung CL, 1999, J CELL BIOL, V147, P1275, DOI 10.1083/jcb.147.6.1275; Leung CL, 2002, TRENDS CELL BIOL, V12, P37, DOI 10.1016/S0962-8924(01)02180-8; Leung CL, 2001, J CELL BIOL, V154, P691, DOI 10.1083/jcb.200012098; Martini R, 2001, MUSCLE NERVE, V24, P456, DOI 10.1002/mus.1027; MCHANWELL S, 1981, PHILOS T ROY SOC B, V293, P477, DOI 10.1098/rstb.1981.0082; MESSER A, 1980, NEUROSCIENCE, V5, P543, DOI 10.1016/0306-4522(80)90051-2; Mirsky R, 1999, BRAIN PATHOL, V9, P293; Narver HL, 2008, ANN NEUROL, V64, P465, DOI 10.1002/ana.21449; Okumura M, 2002, J BIOL CHEM, V277, P6682, DOI 10.1074/jbc.M109209200; OPPENHEIM RW, 1992, NATURE, V360, P755, DOI 10.1038/360755a0; Pool M, 2005, MAMM GENOME, V16, P909, DOI 10.1007/s00335-005-0073-4; Popko B, 2010, NAT NEUROSCI, V13, P275, DOI 10.1038/nn0310-275; Prokop A, 1998, J CELL BIOL, V143, P1283, DOI 10.1083/jcb.143.5.1283; REXED B, 1952, J COMP NEUROL, V96, P415, DOI 10.1002/cne.900960303; ROSENBLATT JD, 1995, IN VITRO CELL DEV-AN, V31, P773; Ruegg MA, 1998, TRENDS NEUROSCI, V21, P22, DOI 10.1016/S0166-2236(97)01154-5; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Schmued LC, 2000, TOXICOL PATHOL, V28, P91, DOI 10.1177/019262330002800111; Shefer Gabi, 2005, Methods Mol Biol, V290, P281; Sonnenberg A, 2007, EXP CELL RES, V313, P2189, DOI 10.1016/j.yexcr.2007.03.039; SOTELO C, 1988, NEUROSCIENCE, V27, P403, DOI 10.1016/0306-4522(88)90277-1; STANLEY JR, 1988, J CLIN INVEST, V82, P1864, DOI 10.1172/JCI113803; Tseng KW, 2008, J COMP NEUROL, V507, P1053, DOI 10.1002/cne.21606; Tseng KW, 2006, J NEUROPATH EXP NEUR, V65, P336, DOI 10.1097/01.jnen.0000218448.39944.f1; Witzemann V, 2006, CELL TISSUE RES, V326, P263, DOI 10.1007/s00441-006-0237-x; Young KG, 2008, EXP CELL RES, V314, P2750, DOI 10.1016/j.yexcr.2008.06.021; Young KG, 2007, CELL MOTIL CYTOSKEL, V64, P897, DOI 10.1002/cm.20235; Young KG, 2007, J NEUROPATH EXP NEUR, V66, P248, DOI 10.1097/01.jnen.0000248560.60703.45	55	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e21093	10.1371/journal.pone.0021093	http://dx.doi.org/10.1371/journal.pone.0021093			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698255	Green Submitted, gold, Green Published			2022-12-27	WOS:000291730000052
J	Natsoulis, G; Bell, JM; Xu, H; Buenrostro, JD; Ordonez, H; Grimes, S; Newburger, D; Jensen, M; Zahn, JM; Zhang, N; Ji, HP				Natsoulis, Georges; Bell, John M.; Xu, Hua; Buenrostro, Jason D.; Ordonez, Heather; Grimes, Susan; Newburger, Daniel; Jensen, Michael; Zahn, Jacob M.; Zhang, Nancy; Ji, Hanlee P.			A Flexible Approach for Highly Multiplexed Candidate Gene Targeted Resequencing	PLOS ONE			English	Article							COLORECTAL-CANCER; HUMAN GENOME; DNA; MUTATIONS; AMPLIFICATION; ENRICHMENT; SEQUENCES; ALIGNMENT; SYSTEM	We have developed an integrated strategy for targeted resequencing and analysis of gene subsets from the human exome for variants. Our capture technology is geared towards resequencing gene subsets substantially larger than can be done efficiently with simplex or multiplex PCR but smaller in scale than exome sequencing. We describe all the steps from the initial capture assay to single nucleotide variant (SNV) discovery. The capture methodology uses in-solution 80-mer oligonucleotides. To provide optimal flexibility in choosing human gene targets, we designed an in silico set of oligonucleotides, the Human OligoExome, that covers the gene exons annotated by the Consensus Coding Sequencing Project (CCDS). This resource is openly available as an Internet accessible database where one can download capture oligonucleotides sequences for any CCDS gene and design custom capture assays. Using this resource, we demonstrated the flexibility of this assay by custom designing capture assays ranging from 10 to over 100 gene targets with total capture sizes from over 100 Kilobases to nearly one Megabase. We established a method to reduce capture variability and incorporated indexing schemes to increase sample throughput. Our approach has multiple applications that include but are not limited to population targeted resequencing studies of specific gene subsets, validation of variants discovered in whole genome sequencing surveys and possible diagnostic analysis of disease gene subsets. We also present a cost analysis demonstrating its cost-effectiveness for large population studies.	[Natsoulis, Georges; Ji, Hanlee P.] Stanford Univ, Sch Med, Div Oncol, Dept Med, Stanford, CA 94305 USA; [Bell, John M.; Xu, Hua; Buenrostro, Jason D.; Ordonez, Heather; Grimes, Susan; Jensen, Michael; Zahn, Jacob M.; Ji, Hanlee P.] Stanford Univ, Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA; [Newburger, Daniel] Stanford Univ, Biomed Informat Program, Stanford, CA 94305 USA; [Zhang, Nancy] Stanford Univ, Dept Stat, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University	Natsoulis, G (corresponding author), Stanford Univ, Sch Med, Div Oncol, Dept Med, Stanford, CA 94305 USA.	genomics_ji@stanford.edu	Gotoh, Osamu/B-4704-2012		National Institutes of Health [5K08CA96879-6, DK56339, 2P01HG000205, R21CA12848, RC2 HG005570-01]; Doris Duke Clinical Foundation; Reddere Foundation; Liu Bie Ju Cha and Family Fellowship in Cancer; Wang Family Foundation; Howard Hughes Medical Foundation; NATIONAL CANCER INSTITUTE [R21CA128485, K08CA096879] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P01HG000205, RC2HG005570, R01HG006137] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056339] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007033] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doris Duke Clinical Foundation(Doris Duke Charitable Foundation (DDCF)); Reddere Foundation; Liu Bie Ju Cha and Family Fellowship in Cancer; Wang Family Foundation; Howard Hughes Medical Foundation(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by the following grants from the National Institutes of Health (www.nih.gov): 5K08CA96879-6 to H.P.J., DK56339 to H.P.J., 2P01HG000205 to J.M.Z., J.M.B., J.D.B. and H.P.J., R21CA12848 to J.M.B. and H.P.J. and RC2 HG005570-01 to G.N., H. X., J.M.B., S. G. and H.P.J. In addition, H.P.J. was supported by the Doris Duke Clinical Foundation (www.ddcf.org), Reddere Foundation, the Liu Bie Ju Cha and Family Fellowship in Cancer, the Wang Family Foundation and the Howard Hughes Medical Foundation (www.hhmi.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams R, 2007, EXPERT REV ANTICANC, V7, P503, DOI 10.1586/14737140.7.4.503; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; AMADO RG, 2008, J CLIN ONCOL; Bainbridge MN, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-r62; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bentley DR, 2006, CURR OPIN GENET DEV, V16, P545, DOI 10.1016/j.gde.2006.10.009; Brink M, 2003, CARCINOGENESIS, V24, P703, DOI 10.1093/carcin/bgg009; CLARK JM, 1988, NUCLEIC ACIDS RES, V16, P9677, DOI 10.1093/nar/16.20.9677; Dahl F, 2007, P NATL ACAD SCI USA, V104, P9387, DOI 10.1073/pnas.0702165104; Di Fiore F, 2007, BRIT J CANCER, V96, P1166, DOI 10.1038/sj.bjc.6603685; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Harris TD, 2008, SCIENCE, V320, P106, DOI 10.1126/science.1150427; JIANG H, 2008, BIOINFORMATICS; Jones S., 2008, SCIENCE; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Jurka J, 1998, CURR OPIN STRUC BIOL, V8, P333, DOI 10.1016/S0959-440X(98)80067-5; Kimura A, 2010, J HUM GENET, V55, P81, DOI 10.1038/jhg.2009.138; Krishnakumar S, 2008, P NATL ACAD SCI USA, V105, P9296, DOI 10.1073/pnas.0803240105; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Liu Y, 2006, P NATL ACAD SCI USA, V103, P976, DOI 10.1073/pnas.0510146103; Mamanova L, 2010, NAT METHODS, V7, P111, DOI 10.1038/nmeth.1419; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Pruitt KD, 2009, GENOME RES, V19, P1316, DOI 10.1101/gr.080531.108; Quail MA, 2008, NAT METHODS, V5, P1005, DOI 10.1038/nmeth.1270; Shendure J, 2005, SCIENCE, V309, P1728, DOI 10.1126/science.1117389; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Stenberg J, 2009, BIOINFORMATICS, V25, P666, DOI 10.1093/bioinformatics/btp001; Tewhey R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r116; Yeang CH, 2008, FASEB J, V22, P2605, DOI 10.1096/fj.08-108985	33	12	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e21088	10.1371/journal.pone.0021088	http://dx.doi.org/10.1371/journal.pone.0021088			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738606	Green Published, gold, Green Submitted			2022-12-27	WOS:000292291800008
J	Barron, EL; Sosnovtsev, SV; Bok, K; Prikhodko, V; Sandoval-Jaime, C; Rhodes, CR; Hasenkrug, K; Carmody, AB; Ward, JM; Perdue, K; Green, KY				Barron, Elyssa L.; Sosnovtsev, Stanislav V.; Bok, Karin; Prikhodko, Victor; Sandoval-Jaime, Carlos; Rhodes, Crystal R.; Hasenkrug, Kim; Carmody, Aaron B.; Ward, Jerrold M.; Perdue, Kathy; Green, Kim Y.			Diversity of Murine Norovirus Strains Isolated from Asymptomatic Mice of Different Genetic Backgrounds within a Single US Research Institute	PLOS ONE			English	Article							AMINO-ACID SUBSTITUTION; MOUSE MODEL; CAPSID PROTEIN; INFECTION; SUFFICIENT; SEQUENCE; IMMUNITY; DOMAIN; VIRUS	Antibody prevalence studies in laboratory mice indicate that murine norovirus (MNV) infections are common, but the natural history of these viruses has not been fully established. This study examined the extent of genetic diversity of murine noroviruses isolated from healthy laboratory mice housed in multiple animal facilities within a single, large research institute-the National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIAID-NIH) in Bethesda, Maryland, U. S. Ten distinct murine norovirus strains were isolated from various tissues and feces of asymptomatic wild type sentinel mice as well as asymptomatic immunodeficient (RAG 2(-/-)) mice. The NIH MNV isolates showed little cytopathic effect in permissive RAW264.7 cells in early passages, but all isolates examined could be adapted to efficient growth in cell culture by serial passage. The viruses, although closely related in genome sequence, were distinguishable from each other according to facility location, likely due to the introduction of new viruses into each facility from separate sources or vendors at different times. Our study indicates that the murine noroviruses are widespread in these animal facilities, despite rigorous guidelines for animal care and maintenance.	[Barron, Elyssa L.; Sosnovtsev, Stanislav V.; Bok, Karin; Prikhodko, Victor; Sandoval-Jaime, Carlos; Rhodes, Crystal R.; Green, Kim Y.] NIAID, Infect Dis Lab, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Hasenkrug, Kim; Carmody, Aaron B.] NIAID, Retrovirus Immunol Sect, NIH, Dept Hlth & Human Serv, Hamilton, MT USA; [Ward, Jerrold M.; Perdue, Kathy] NIAID, Comparat Med Branch, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Barron, EL (corresponding author), NIAID, Infect Dis Lab, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA.	kgreen@niaid.nih.gov	Sandoval-Jaime, Carlos/AAR-7196-2020	Sandoval-Jaime, Carlos/0000-0001-6649-9180; Prikhodko, Victor/0000-0001-6006-9454	National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001100, ZIAAI000753, ZIAAI000897] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the intramural research program of the National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard M, 2009, GASTROENTEROLOGY, V136, pA706; Ammann CG, 2009, J VIROL, V83, P13037, DOI 10.1128/JVI.01445-09; Bailey D, 2008, J VIROL, V82, P7725, DOI 10.1128/JVI.00237-08; Bok K, 2009, J VIROL, V83, P3647, DOI 10.1128/JVI.02028-08; Compton SR, 2010, J AM ASSOC LAB ANIM, V49, P11; Doom CM, 2009, VIROLOGY, V392, P153, DOI 10.1016/j.virol.2009.05.035; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Glass PJ, 2000, J VIROL, V74, P6581, DOI 10.1128/JVI.74.14.6581-6591.2000; Green K.Y, 2007, CALICIVIRIDAE NOROVI, P949; Hensley SE, 2009, J VIROL, V83, P7357, DOI 10.1128/JVI.00623-09; Hsu CC, 2005, CLIN DIAGN LAB IMMUN, V12, P1145, DOI 10.1128/CDLI.12.10.1145-1151.2005; JIANG X, 1993, VIROLOGY, V195, P51, DOI 10.1006/viro.1993.1345; Karst SM, 2003, SCIENCE, V299, P1575, DOI 10.1126/science.1077905; Kaufman SS, 2005, J PEDIATR GASTR NUTR, V40, P328, DOI 10.1097/01.MPG.0000155182.54001.48; LAMBDEN PR, SEQUENCE GENOME ORG; Lencioni KC, 2008, COMPARATIVE MED, V58, P522; Lochridge VP, 2007, J VIROL, V81, P12316, DOI 10.1128/JVI.01254-07; Muller B, 2007, ARCH VIROL, V152, P1709, DOI 10.1007/s00705-007-0989-y; Paik J, 2010, COMPARATIVE MED, V60, P189; Perdue KA, 2007, J AM ASSOC LAB ANIM, V46, P39; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sosnovtsev SV, 2006, J VIROL, V80, P7816, DOI 10.1128/JVI.00532-06; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tan M, 2004, J VIROL, V78, P6233, DOI 10.1128/JVI.78.12.6233-6242.2004; Thackray LB, 2007, J VIROL, V81, P10460, DOI 10.1128/JVI.00783-07; Ward JM, 2006, TOXICOL PATHOL, V34, P708, DOI 10.1080/01926230600918876; Wobus CE, 2004, PLOS BIOL, V2, P2076, DOI 10.1371/journal.pbio.0020432; Wobus CE, 2006, J VIROL, V80, P5104, DOI 10.1128/JVI.02346-05; Zheng DP, 2006, VIROLOGY, V346, P312, DOI 10.1016/j.virol.2005.11.015	30	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21435	10.1371/journal.pone.0021435	http://dx.doi.org/10.1371/journal.pone.0021435			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738664	Green Submitted, Green Published, gold			2022-12-27	WOS:000292142800021
J	Snively, E; Theodor, JM				Snively, Eric; Theodor, Jessica M.			Common Functional Correlates of Head-Strike Behavior in the Pachycephalosaur Stegoceras validum (Ornithischia, Dinosauria) and Combative Artiodactyls	PLOS ONE			English	Article							FRONTAL SINUSES; HELMET; MORPHOLOGY; GOATS; BONE	Background: Pachycephalosaurs were bipedal herbivorous dinosaurs with bony domes on their heads, suggestive of head-butting as seen in bighorn sheep and musk oxen. Previous biomechanical studies indicate potential for pachycephalosaur head-butting, but bone histology appears to contradict the behavior in young and old individuals. Comparing pachycephalosaurs with fighting artiodactyls tests for common correlates of head-butting in their cranial structure and mechanics. Methods/Principal Findings: Computed tomographic (CT) scans and physical sectioning revealed internal cranial structure of ten artiodactyls and pachycephalosaurs Stegoceras validum and Prenocephale prenes. Finite element analyses (FEA), incorporating bone and keratin tissue types, determined cranial stress and strain from simulated head impacts. Recursive partition analysis quantified strengths of correlation between functional morphology and actual or hypothesized behavior. Strong head-strike correlates include a dome-like cephalic morphology, neurovascular canals exiting onto the cranium surface, large neck muscle attachments, and dense cortical bone above a sparse cancellous layer in line with the force of impact. The head-butting duiker Cephalophus leucogaster is the closest morphological analog to Stegoceras, with a smaller yet similarly rounded dome. Crania of the duiker, pachycephalosaurs, and bighorn sheep Ovis canadensis share stratification of thick cortical and cancellous layers. Stegoceras, Cephalophus, and musk ox crania experience lower stress and higher safety factors for a given impact force than giraffe, pronghorn, or the non-combative llama. Conclusions/Significance: Anatomy, biomechanics, and statistical correlation suggest that some pachycephalosaurs were as competent at head-to-head impacts as extant analogs displaying such combat. Large-scale comparisons and recursive partitioning can greatly refine inference of behavioral capability for fossil animals.	[Snively, Eric] Ohio Univ, Dept Mech Engn, Athens, OH 45701 USA; [Theodor, Jessica M.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada	University System of Ohio; Ohio University; University of Calgary	Snively, E (corresponding author), Ohio Univ, Dept Mech Engn, Athens, OH 45701 USA.	es180210@ohio.edu		Theodor, Jessica/0000-0002-5159-7041	University of Calgary Alberta Ingenuity Russ College of Engineering Canada Foundation for Innovation National Science Foundation	University of Calgary Alberta Ingenuity Russ College of Engineering Canada Foundation for Innovation National Science Foundation	University of Calgary Alberta Ingenuity Russ College of Engineering Canada Foundation for Innovation National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbour VM, 2009, ANAT REC, V292, P1412, DOI 10.1002/ar.20987; BARGHUSEN H R, 1975, Paleobiology, V1, P295; BELL PR, 2009, ANAT REC, V292, P1339; BRYANT HN, 1992, PHILOS T ROY SOC B, V337, P405, DOI 10.1098/rstb.1992.0117; Bubenik A.B., 1990, P3; Carpenter Kenneth, 1997, Contributions to Geology University of Wyoming, V32, P19; Cowin S.C., 2001, BONE MECH HDB, V2nd; DAGG AI, GIRAFFE ITS BIOL BEH; Dumont ER, 2009, J THEOR BIOL, V256, P96, DOI 10.1016/j.jtbi.2008.08.017; ESTES RD, BEHAV GUIDE AFRICAN; Farke AA, 2008, J EXP BIOL, V211, P3085, DOI 10.1242/jeb.019042; Farke AA, 2010, ZOOL J LINN SOC-LOND, V159, P988, DOI 10.1111/j.1096-3642.2009.00586.x; Geist V, 1976, MOUNTAIN SHEEP STUDY; Goodwin MB, 2004, PALEOBIOLOGY, V30, P253, DOI 10.1666/0094-8373(2004)030<0253:CHOPOM>2.0.CO;2; Hellmich C, 2008, ANN BIOMED ENG, V36, P108, DOI [10.1007/s10439-007-9393-8, 10.1016/S0021-9290(08)70202-1]; Hieronymus TL, 2009, ANAT REC, V292, P1370, DOI 10.1002/ar.20985; Ivins BJ, 2008, MIL MED, V173, P1168, DOI 10.7205/MILMED.173.12.1168; Jasinoski SC, 2009, ANAT REC, V292, P862, DOI 10.1002/ar.20906; JASLOW CR, 1995, J ZOOL, V235, P193; KATZ JL, 1984, CALCIFIED TISSUE INT, V36, pS31; Kitchen D., 1974, IUCN Publs (New Series), VNo. 24, P365; KITCHENER A, 1988, J ZOOL, V214, P1, DOI 10.1111/j.1469-7998.1988.tb04983.x; KITCHENER AC, 1992, BIOMECHANICS EVOLUTI, P229; Krieg H, 1944, NATURWISSENSCHAFTEN, V32, P148, DOI 10.1007/BF01467890; KUHN JL, 1989, J BIOMECH, V22, P95, DOI 10.1016/0021-9290(89)90032-8; Maity P, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4003321; Maryanska T, 1974, Palaeontologia Polonica, VNo. 30, P45; McHenry CR, 2007, P NATL ACAD SCI USA, V104, P16010, DOI 10.1073/pnas.0706086104; Mills NJ, 2006, P I MECH ENG L-J MAT, V220, P167, DOI 10.1243/14644207JMDA100; Mills NJ, 2010, INT J CRASHWORTHINES, V15, P331, DOI 10.1080/13588260903251000; Padian K, 2011, J ZOOL, V283, P3, DOI 10.1111/j.1469-7998.2010.00719.x; Snively E, 2008, PALAEONTOL ELECTRON, V11; Snively E, 2007, ZOOL J LINN SOC-LOND, V151, P759, DOI 10.1111/j.1096-3642.2007.00334.x; Sues H.-D., 1978, Neues Jahrbuch fuer Geologie und Palaeontologie Monatshefte, V1978, P459; Tsuihiji T, 2005, J MORPHOL, V263, P151, DOI 10.1002/jmor.10294; TURNER CH, 1990, J BIOMECH, V23, P549, DOI 10.1016/0021-9290(90)90048-8; VAHEY JW, 1987, J BIOMECH, V20, P29, DOI 10.1016/0021-9290(87)90264-8; WITMER LM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P19	38	38	39	4	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21422	10.1371/journal.pone.0021422	http://dx.doi.org/10.1371/journal.pone.0021422			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738658	gold, Green Published, Green Submitted			2022-12-27	WOS:000292142800019
J	Vegliante, MC; Royo, C; Palomero, J; Salaverria, I; Balint, B; Martin-Guerrero, I; Agirre, X; Lujambio, A; Richter, J; Xargay-Torrent, S; Bea, S; Hernandez, L; Enjuanes, A; Calasanz, MJ; Rosenwald, A; Ott, G; Roman-Gomez, J; Prosper, F; Esteller, M; Jares, P; Siebert, R; Campo, E; Martin-Subero, JI; Amador, V				Carmela Vegliante, Maria; Royo, Cristina; Palomero, Jara; Salaverria, Itziar; Balint, Balazs; Martin-Guerrero, Idoia; Agirre, Xabier; Lujambio, Amaia; Richter, Julia; Xargay-Torrent, Silvia; Bea, Silvia; Hernandez, Luis; Enjuanes, Anna; Jose Calasanz, Maria; Rosenwald, Andreas; Ott, German; Roman-Gomez, Jose; Prosper, Felipe; Esteller, Manel; Jares, Pedro; Siebert, Reiner; Campo, Elias; Martin-Subero, Jose I.; Amador, Virginia			Epigenetic Activation of SOX11 in Lymphoid Neoplasms by Histone Modifications	PLOS ONE			English	Article							MANTLE CELL LYMPHOMA; DEFINED BURKITTS-LYMPHOMA; TRANSCRIPTION FACTOR; GENE-EXPRESSION; HIGH-RESOLUTION; DNA METHYLATION; NUCLEAR EXPRESSION; CANCER; MICROARRAY; SURVIVAL	Recent studies have shown aberrant expression of SOX11 in various types of aggressive B-cell neoplasms. To elucidate the molecular mechanisms leading to such deregulation, we performed a comprehensive SOX11 gene expression and epigenetic study in stem cells, normal hematopoietic cells and different lymphoid neoplasms. We observed that SOX11 expression is associated with unmethylated DNA and presence of activating histone marks (H3K9/14Ac and H3K4me3) in embryonic stem cells and some aggressive B-cell neoplasms. In contrast, adult stem cells, normal hematopoietic cells and other lymphoid neoplasms do not express SOX11. Such repression was associated with silencing histone marks H3K9me2 and H3K27me3. The SOX11 promoter of non-malignant cells was consistently unmethylated whereas lymphoid neoplasms with silenced SOX11 tended to acquire DNA hypermethylation. SOX11 silencing in cell lines was reversed by the histone deacetylase inhibitor SAHA but not by the DNA methyltransferase inhibitor AZA. These data indicate that, although DNA hypermethylation of SOX11 is frequent in lymphoid neoplasms, it seems to be functionally inert, as SOX11 is already silenced in the hematopoietic system. In contrast, the pathogenic role of SOX11 is associated with its de novo expression in some aggressive lymphoid malignancies, which is mediated by a shift from inactivating to activating histone modifications.	[Carmela Vegliante, Maria; Royo, Cristina; Palomero, Jara; Xargay-Torrent, Silvia; Bea, Silvia; Hernandez, Luis; Enjuanes, Anna; Jares, Pedro; Campo, Elias; Amador, Virginia] Univ Barcelona, Hematopathol Sect, Pathol Lab, Hosp Clin,Inst Invest Biomed August Pi & Sunyer I, Barcelona, Spain; [Salaverria, Itziar; Martin-Guerrero, Idoia; Richter, Julia; Siebert, Reiner] Univ Kiel, Inst Human Genet, Kiel, Germany; [Salaverria, Itziar; Martin-Guerrero, Idoia; Richter, Julia; Siebert, Reiner] Univ Hosp Schleswig Holstein, Kiel, Germany; [Balint, Balazs; Lujambio, Amaia; Esteller, Manel] Bellvitge Biomed Res Inst IDIBELL, Canc Epigenet & Biol Program PEBC, Barcelona, Spain; [Agirre, Xabier; Prosper, Felipe] Univ Navarra, Fdn Appl Med Res, Clin Univ Navarra, Hematol Serv, E-31080 Pamplona, Spain; [Agirre, Xabier; Prosper, Felipe] Univ Navarra, Fdn Appl Med Res, Clin Univ Navarra, Area Cell Therapy, E-31080 Pamplona, Spain; [Jose Calasanz, Maria] Univ Navarra, Dept Genet, E-31080 Pamplona, Spain; [Rosenwald, Andreas] Univ Wurzburg, Inst Pathol, D-8700 Wurzburg, Germany; [Ott, German] Robert Bosch Krankenhaus, Dept Clin Pathol, Stuttgart, Germany; [Ott, German] Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-7000 Stuttgart, Germany; [Roman-Gomez, Jose] Reina Sofia Hosp, Dept Hematol, Cordoba, Spain; [Campo, Elias; Martin-Subero, Jose I.] Univ Barcelona, Dept Anat Pathol Pharmacol & Microbiol, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Kiel; University of Kiel; Schleswig Holstein University Hospital; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Navarra; University of Navarra; University of Navarra; University of Wurzburg; Bosch; Robert Bosch Krankenhaus; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Hospital Universitario Reina Sofia - Cordoba; University of Barcelona	Vegliante, MC (corresponding author), Univ Barcelona, Hematopathol Sect, Pathol Lab, Hosp Clin,Inst Invest Biomed August Pi & Sunyer I, Barcelona, Spain.	vamador@clinic.ub.es	Esteller, Manel/L-5956-2014; Campo, Elias/AAC-5593-2019; Agirre, Xabier/ABE-4110-2020; bea, silvia/K-7699-2014; Palomero, Jara/D-7204-2018; ENJUANES, Anna/H-3245-2015; Siebert, Reiner/A-8049-2010; Prosper, Felipe/H-6859-2017; Vegliante, Maria Carmela/K-1732-2018; Vegliante, Maria Carmela/AAC-5888-2022; SALAVERRIA, ITZIAR/L-2246-2015; SALAVERRIA, ITZIAR/AAW-9019-2021; Hernandez, Luis/D-4684-2018; Martin-Guerrero, Idoia/AAF-3446-2020; Calasanz, MJ/R-5813-2016; Royo, Cristina/H-3193-2015; Jares, Pedro/T-3778-2019	Esteller, Manel/0000-0003-4490-6093; Campo, Elias/0000-0001-9850-9793; bea, silvia/0000-0001-7192-2385; Palomero, Jara/0000-0002-2092-2526; ENJUANES, Anna/0000-0002-4679-6687; Prosper, Felipe/0000-0001-6115-8790; Vegliante, Maria Carmela/0000-0002-3165-1768; Vegliante, Maria Carmela/0000-0002-3165-1768; SALAVERRIA, ITZIAR/0000-0002-2427-9822; Hernandez, Luis/0000-0002-4854-3069; Calasanz, MJ/0000-0002-0374-3008; Royo, Cristina/0000-0002-1214-4656; Lujambio, Amaia/0000-0002-2798-1481; Balint, Balazs/0000-0002-5102-0787; Martin-Subero, Jose Ignacio/0000-0001-8809-5195; Martin-Guerrero, Idoia/0000-0002-0098-1908; Xargay-Torrent, Silvia/0000-0003-3410-6674; JARES, PEDRO/0000-0002-8401-579X	Comision Ministerio de Ciencia e Innovacion [BFU2009-09235, SAF2009-08663, SAF08/3630]; Instituto de Salud Carlos III Red Tematica de Investigacion Cooperativa de Cancer [2006RET2039]; Asociacion Espanola Contra el Cancer; Deutsche Krebshilfe [70-3173-Tr3]; Kinderkrebsinitative Buchholz/Holm-Seppensen; Alexander von Humboldt Foundation; Junta de Andalucia [2009/0206]	Comision Ministerio de Ciencia e Innovacion; Instituto de Salud Carlos III Red Tematica de Investigacion Cooperativa de Cancer(Instituto de Salud Carlos III); Asociacion Espanola Contra el Cancer; Deutsche Krebshilfe(Deutsche Krebshilfe); Kinderkrebsinitative Buchholz/Holm-Seppensen; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Junta de Andalucia(Junta de Andalucia)	This study was supported by the Comision Ministerio de Ciencia e Innovacion (BFU2009-09235 to VA, SAF2009-08663 to JIM-S, SAF08/3630 to EC), Instituto de Salud Carlos III Red Tematica de Investigacion Cooperativa de Cancer (2006RET2039 to EC), the Asociacion Espanola Contra el Cancer (to ME), the Deutsche Krebshilfe through the network project "Molecular Mechanisms in Malignant Lymphomas subproject M2 (70-3173-Tr3 to RS and JIM-S), the Kinderkrebsinitative Buchholz/Holm-Seppensen (to RS), the Alexander von Humboldt Foundation (to IS) and the Junta de Andalucia (2009/0206 to JR-G). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amador V, 2007, MOL CELL, V27, P462, DOI 10.1016/j.molcel.2007.06.013; Bea S, 2009, BLOOD, V113, P3059, DOI 10.1182/blood-2008-07-170183; Bergsland M, 2006, GENE DEV, V20, P3475, DOI 10.1101/gad.403406; Bibikova M, 2009, EPIGENOMICS-UK, V1, P177, DOI [10.2217/epi.09.14, 10.2217/EPI.09.14]; Brennana DJ, 2009, EUR J CANCER, V45, P1510, DOI 10.1016/j.ejca.2009.01.028; Chaganti RSK, 2000, SEMIN HEMATOL, V37, P396; Chen YH, 2010, MODERN PATHOL, V23, P105, DOI 10.1038/modpathol.2009.140; Dictor M, 2009, HAEMATOL-HEMATOL J, V94, P1563, DOI 10.3324/haematol.2009.008474; Ek S, 2008, BLOOD, V111, P800, DOI 10.1182/blood-2007-06-093401; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Fernandez V, 2010, CANCER RES, V70, P1408, DOI 10.1158/0008-5472.CAN-09-3419; Gal-Yam EN, 2008, P NATL ACAD SCI USA, V105, P12979, DOI 10.1073/pnas.0806437105; Giorgetti A, 2009, CELL STEM CELL, V5, P353, DOI 10.1016/j.stem.2009.09.008; Gustavsson E, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-187; Hartmann EM, 2010, BLOOD, V116, P953, DOI 10.1182/blood-2010-01-263806; Haslinger A, 2009, EUR J NEUROSCI, V29, P2103, DOI 10.1111/j.1460-9568.2009.06768.x; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hong DL, 2008, SCIENCE, V319, P336, DOI 10.1126/science.1150648; Hummel M, 2006, NEW ENGL J MED, V354, P2419, DOI 10.1056/NEJMoa055351; Jankowski MP, 2006, NEUROSCIENCE, V143, P501, DOI 10.1016/j.neuroscience.2006.09.010; JAY P, 1995, GENOMICS, V29, P541, DOI 10.1006/geno.1995.9970; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kawamata N, 2008, BLOOD, V111, P776, DOI 10.1182/blood-2007-05-088310; Keshet I, 2006, NAT GENET, V38, P149, DOI 10.1038/ng1719; Lee CJ, 2002, J NEURO-ONCOL, V57, P201, DOI 10.1023/A:1015773818302; Lefebvre V, 2007, INT J BIOCHEM CELL B, V39, P2195, DOI 10.1016/j.biocel.2007.05.019; Loh YH, 2010, CELL STEM CELL, V7, P15, DOI 10.1016/j.stem.2010.06.004; Martin-Subero JI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006986; Martin-Subero JI, 2009, BLOOD, V113, P2488, DOI 10.1182/blood-2008-04-152900; Mozos A, 2009, HAEMATOL-HEMATOL J, V94, P1555, DOI 10.3324/haematol.2009.010264; Salaverria I, 2008, HAEMATOL-HEMATOL J, V93, P1327, DOI 10.3324/haematol.13071; Scholtysik R, 2010, HAEMATOL-HEMATOL J, V95, P2047, DOI 10.3324/haematol.2010.026831; Swerdlow S, 2008, WHO CLASSIFICATION T; Tong Wei-Gang, 2010, Epigenetics, V5, P499; Tost J, 2007, NAT PROTOC, V2, P2265, DOI 10.1038/nprot.2007.314; Wang X, 2008, BRIT J HAEMATOL, V143, P248, DOI 10.1111/j.1365-2141.2008.07329.x; Weigle B, 2005, ONCOL REP, V13, P139	37	37	38	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21382	10.1371/journal.pone.0021382	http://dx.doi.org/10.1371/journal.pone.0021382			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738649	Green Published, gold, Green Submitted			2022-12-27	WOS:000292092600035
J	Bukh, AR; Melchjorsen, J; Offersen, R; Jensen, JMB; Toft, L; Stovring, H; Ostergaard, L; Tolstrup, M; Sogaard, OS				Bukh, Anne Roslev; Melchjorsen, Jesper; Offersen, Rasmus; Jensen, Jens Magnus Bernth; Toft, Lars; Stovring, Henrik; Ostergaard, Lars; Tolstrup, Martin; Sogaard, Ole Schmeltz			Endotoxemia Is Associated with Altered Innate and Adaptive Immune Responses in Untreated HIV-1 Infected Individuals	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; HIV-INFECTED PATIENTS; MICROBIAL TRANSLOCATION; ANTI-GAL; BACTERIAL TRANSLOCATION; PLASMA-LEVELS; DISEASE; ALPHA; ACTIVATION; ANTIBODIES	Background: Microbial translocation may contribute to the immunopathogenesis in HIV infection. We investigated if microbial translocation and inflammation were associated with innate and adaptive immune responses in adults with HIV. Methodology/Principal Findings: This was an observational cohort study. Sera from HIV-infected and HIV-uninfected individuals were analyzed for microbial translocation (soluble CD14, lipopolysaccharides [LPS], endotoxin core antibody, and anti-a-galactosyl antibodies) and inflammatory markers (high sensitivity C-reactive protein, IL-6, IL-1 receptor antagonist, soluble tumor necrosis factor receptor II, and IL-10) with enzyme-linked immunosorbent assays. Peripheral blood mononuclear cells (PBMC) from HIV-infected persons and healthy controls (primed with single-stranded HIV-1-derived RNA) were stimulated with LPS, and cytokine production was measured. Finally, HIV-infected patients were immunized with Prevnar 7vPnC6CpG 7909 followed by Pneumo Novum PPV-23. Effects of microbial translocation and inflammation on immunization were analyzed in a predictive regression model. We included 96 HIV-infected individuals, 76 on highly active antiretroviral therapy (HAART), 20 HAART-naive, and 50 healthy controls. Microbial translocation and inflammatory markers were higher among HIV-infected persons than controls. Cytokine levels following LPS stimulation were increased in PBMCs from HAART-naive compared to HAART-treated HIV-infected persons. Further, RNA-priming of PBMCs from controls acted synergistically with LPS to augment cytokine responses. Finally, high serum LPS levels predicted poor vaccine responses among HAART-naive, but not among HAART-treated HIV-infected individuals. Conclusions/Significance: LPS acts synergistically with HIV RNA to stimulate innate immune responses in vitro and increasing serum LPS levels seem to predict poor antibody responses after vaccination among HAART-naive HIV-infected persons. Thus, our results suggest that microbial translocation may be associated with innate and adaptive immune dysfunction in untreated HIV infection.	[Bukh, Anne Roslev; Melchjorsen, Jesper; Offersen, Rasmus; Toft, Lars; Ostergaard, Lars; Tolstrup, Martin; Sogaard, Ole Schmeltz] Aarhus Univ Hosp Skejby, Dept Infect Dis, Aarhus, Denmark; [Jensen, Jens Magnus Bernth] Aarhus Univ Hosp Skejby, Dept Clin Immunol, Aarhus, Denmark; [Stovring, Henrik] Aarhus Univ, Dept Biostat, Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University	Bukh, AR (corresponding author), Aarhus Univ Hosp Skejby, Dept Infect Dis, Aarhus, Denmark.	arbukh@gmail.com	Søgaard, Ole Schmeltz/AEP-7968-2022; Ostergaard, Lars/AAA-3020-2020; Støvring, Henrik/I-4683-2012; Offersen, Rasmus/R-4579-2017; Støvring, Henrik/H-5754-2019; Søgaard, Ole S/P-6058-2016; Bernth-Jensen, Jens Magnus/H-6694-2019	Søgaard, Ole Schmeltz/0000-0001-9107-2023; Ostergaard, Lars/0000-0003-2459-0511; Støvring, Henrik/0000-0002-5821-2351; Offersen, Rasmus/0000-0002-5038-4052; Støvring, Henrik/0000-0002-5821-2351; Ostergaard, Lars/0000-0002-7619-605X; Bernth Jensen, Jens Magnus/0000-0002-5004-7822; Tolstrup, Martin/0000-0001-7020-5173	Agnethe Lovgreen's Donation; Danish AIDS foundation [F08-15, F09-14]; foundation for Advancement of Medical Science (The AP Moller Foundation); Helga and Peter Kornings Foundation; Scandinavian Society of Antimicrobial Chemotherapy [2009-22208]; Aase and Einar Danielsens Foundation [106801]; Danish Medical Research Council; University of Aarhus	Agnethe Lovgreen's Donation; Danish AIDS foundation; foundation for Advancement of Medical Science (The AP Moller Foundation); Helga and Peter Kornings Foundation; Scandinavian Society of Antimicrobial Chemotherapy; Aase and Einar Danielsens Foundation; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Aarhus	Work was funded by Agnethe Lovgreen's Donation, the Danish AIDS foundation (F08-15 and F09-14), the foundation for Advancement of Medical Science (The AP Moller Foundation), the Helga and Peter Kornings Foundation, the Scandinavian Society of Antimicrobial Chemotherapy (2009-22208), and Aase and Einar Danielsens Foundation (106801). ARB and RO were recipients of scholarships from the Danish Medical Research Council. OSS and LT were recipients of fellowships from the University of Aarhus. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancuta P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002516; Besselink MG, 2009, ANN SURG, V250, P712, DOI 10.1097/SLA.0b013e3181bce5bd; Bode C, 2003, BEST PRACT RES CL GA, V17, P575, DOI 10.1016/S1521-6918(03)00034-9; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Choudhry MA, 2004, ALCOHOL, V33, P199, DOI 10.1016/j.alcohol.2004.05.004; D'Alessandro M, 2002, CLIN IMMUNOL, V103, P63, DOI 10.1006/clim.2001.5180; Dandekar Satya, 2007, Curr HIV/AIDS Rep, V4, P10, DOI 10.1007/s11904-007-0002-0; Epple HJ, 2009, GUT, V58, P220, DOI 10.1136/gut.2008.150425; Ferri E, 2010, J INFECT DIS, V202, P176, DOI 10.1086/653215; GALILI U, 1987, J EXP MED, V165, P693, DOI 10.1084/jem.165.3.693; GALILI U, 1988, INFECT IMMUN, V56, P1730, DOI 10.1128/IAI.56.7.1730-1737.1988; GALILI U, 1993, SPRINGER SEMIN IMMUN, V15, P155; Gonzalez R, 2010, HIV MED, V11, P535, DOI 10.1111/j.1468-1293.2010.00830.x; Gringhuis SI, 2010, NAT IMMUNOL, V11, P419, DOI 10.1038/ni.1858; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Jagannathan M, 2009, J IMMUNOL, V183, P7461, DOI 10.4049/jimmunol.0901517; Jiang W, 2009, J INFECT DIS, V199, P1177, DOI 10.1086/597476; Kitchens RL, 2005, J ENDOTOXIN RES, V11, P225, DOI 10.1179/096805105X46565; Kitchens RL, 2001, J CLIN INVEST, V108, P485, DOI 10.1172/JCI200113139; KONRADSEN HB, 1993, J IMMUNOL METHODS, V164, P13, DOI 10.1016/0022-1759(93)90270-H; Lee PI, 2009, J INFECT DIS, V199, P1664, DOI 10.1086/598953; Lester RT, 2008, AIDS, V22, P685, DOI 10.1097/QAD.0b013e3282f4de35; Lester RT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005644; Macher BA, 2008, BBA-GEN SUBJECTS, V1780, P75, DOI 10.1016/j.bbagen.2007.11.003; Maes M, 2008, NEUROENDOCRINOL LETT, V29, P117; Marchetti G, 2008, AIDS, V22, P2035, DOI 10.1097/QAD.0b013e3283112d29; Mureith MW, 2010, AIDS, V24, P1841, DOI 10.1097/QAD.0b013e32833ad89a; Nazli A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000852; Nowroozalizadeh S, 2010, J INFECT DIS, V201, P1150, DOI 10.1086/651430; Nuorti JP, 2000, ANN INTERN MED, V132, P182, DOI 10.7326/0003-4819-132-3-200002010-00003; Papasavvas E, 2009, AIDS, V23, P369, DOI 10.1097/QAD.0b013e32831e9c76; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Rajasuriar R, 2010, J INFECT DIS, V202, P1254, DOI 10.1086/656369; Redd AD, 2009, P NATL ACAD SCI USA, V106, P6718, DOI 10.1073/pnas.0901983106; Saethre M, 2002, XENOTRANSPLANTATION, V9, P350, DOI 10.1034/j.1399-3089.2002.01094.x; Schnare M, 2001, NAT IMMUNOL, V2, P947, DOI 10.1038/ni712; Skovsted IC, 2007, VACCINE, V25, P6490, DOI 10.1016/j.vaccine.2007.06.034; Sogaard OS, 2008, CLIN INFECT DIS, V47, P1345, DOI 10.1086/592692; Sogaard OS, 2010, CLIN INFECT DIS, V51, P42, DOI 10.1086/653112; Sogaard OS, 2010, AIDS, V24, P1315, DOI 10.1097/QAD.0b013e328339fe0b; Subramaniam KS, 2003, J INFECT DIS, V187, P758, DOI 10.1086/368331; Wang M, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000697; Yu P, 2000, CRIT CARE MED, V28, P2573, DOI 10.1097/00003246-200007000-00065	44	27	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21275	10.1371/journal.pone.0021275	http://dx.doi.org/10.1371/journal.pone.0021275			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21731690	gold, Green Submitted, Green Published			2022-12-27	WOS:000292036900020
J	Svenson, U; Nordfjall, K; Baird, D; Roger, L; Osterman, P; Hellenius, ML; Roos, G				Svenson, Ulrika; Nordfjall, Katarina; Baird, Duncan; Roger, Laureline; Osterman, Pia; Hellenius, Mai-Lis; Roos, Goran			Blood Cell Telomere Length Is a Dynamic Feature	PLOS ONE			English	Article							CHROMOSOME-SPECIFIC VARIATIONS; OXIDATIVE STRESS; MYOCARDIAL-INFARCTION; LONGITUDINAL FINDINGS; PREDISPOSITION FACTOR; NORMAL INDIVIDUALS; PHYSICAL-ACTIVITY; T-LYMPHOCYTES; HEART-DISEASE; AGE	There is a considerable heterogeneity in blood cell telomere length (TL) for individuals of similar age and recent studies have revealed that TL changes by time are dependent on TL at baseline. TL is partly inherited, but results from several studies indicate that e. g. life style and/or environmental factors can affect TL during life. Collectively, these studies imply that blood cell TL might fluctuate during a life time and that the actual TL at a defined time point is the result of potential regulatory mechanism(s) and environmental factors. We analyzed relative TL (RTL) in subsequent blood samples taken six months apart from 50 individuals and found significant associations between RTL changes and RTL at baseline. Individual RTL changes per month were more pronounced than the changes recorded in a previously studied population analyzed after 10 years' follow up. The data argues for an oscillating TL pattern which levels out at longer follow up times. In a separate group of five blood donors, a marked telomere loss was demonstrated within a six month period for one donor where after TL was stabilized. PCR determined RTL changes were verified by Southern blotting and STELA (single telomere elongation length analysis). The STELA demonstrated that for the donor with a marked telomere loss, the heterogeneity of the telomere distribution decreased considerably, with a noteworthy loss of the largest telomeres. In summary, the collected data support the concept that individual blood cell telomere length is a dynamic feature and this will be important to recognize in future studies of human telomere biology.	[Svenson, Ulrika; Nordfjall, Katarina; Osterman, Pia; Roos, Goran] Umea Univ, Dept Med Biosci, Umea, Sweden; [Baird, Duncan; Roger, Laureline] Cardiff Univ, Sch Med, Dept Pathol, Cardiff, S Glam, Wales; [Hellenius, Mai-Lis] Karolinska Univ Hosp, Karolinska Inst, Dept Med, Cardiol Unit, Stockholm, Sweden	Umea University; Cardiff University; Karolinska Institutet; Karolinska University Hospital	Svenson, U (corresponding author), Umea Univ, Dept Med Biosci, Umea, Sweden.	goran.roos@medbio.umu.se	Baird, Duncan M/C-9671-2011	Baird, Duncan M/0000-0001-8408-5467; Osterman, Pia/0000-0001-9360-0782	Swedish Cancer Society; Lion's Cancer Research Foundation, Umea; Swedish Research Council; County Council of VAosterbotten; Cancer Research UK; Swedish National Institute of Public Health; Swedish Heart and Lung Foundation; Tornspiran Foundation; Albert and Gerda Svensson Foundation; European Community [200950]; Worldwide Cancer Research [06-0914] Funding Source: researchfish	Swedish Cancer Society(Swedish Cancer Society); Lion's Cancer Research Foundation, Umea; Swedish Research Council(Swedish Research CouncilEuropean Commission); County Council of VAosterbotten; Cancer Research UK(Cancer Research UK); Swedish National Institute of Public Health; Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Tornspiran Foundation; Albert and Gerda Svensson Foundation; European Community(European Commission); Worldwide Cancer Research	This study was supported by grants from the Swedish Cancer Society (GR), the Lion's Cancer Research Foundation, Umea (GR), the Swedish Research Council (GR), the County Council of VAosterbotten (GR), Cancer Research UK (DB), the Swedish National Institute of Public Health (M-LH), The Swedish Heart and Lung Foundation (M-LH), Tornspiran Foundation (M-LH) and The Albert and Gerda Svensson Foundation (M-LH). The research leading to these results has received funding from the European Community's Seventh Framework Program FP7/2007-2011 under grant agreement no. 200950 (GR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbar AN, 2007, J IMMUNOL, V178, P6689, DOI 10.4049/jimmunol.178.11.6689; Akiyama M, 2002, CANCER RES, V62, P3876; Aviv A, 2009, AM J EPIDEMIOL, V169, P323, DOI 10.1093/aje/kwn338; Babizhayev M.A., 2010, AM J THER; Baird DM, 2003, NAT GENET, V33, P203, DOI 10.1038/ng1084; Broberg K, 2005, CARCINOGENESIS, V26, P1263, DOI 10.1093/carcin/bgi063; Brouilette S, 2003, ARTERIOSCL THROM VAS, V23, P842, DOI 10.1161/01.ATV.0000067426.96344.32; Brouilette SW, 2007, LANCET, V369, P107, DOI 10.1016/S0140-6736(07)60071-3; Brummendorf TH, 2001, ANN NY ACAD SCI, V938, P293; Capper R, 2007, GENE DEV, V21, P2495, DOI 10.1101/gad.439107; Chen W, 2011, J GERONTOL A-BIOL, V66, P312, DOI 10.1093/gerona/glq223; Cherkas LF, 2008, ARCH INTERN MED, V168, P154, DOI 10.1001/archinternmed.2007.39; Ehrlenbach S, 2009, INT J EPIDEMIOL, V38, P1725, DOI 10.1093/ije/dyp273; Epel ES, 2009, HORM-INT J ENDOCRINO, V8, P7, DOI 10.14310/horm.2002.1217; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Farzaneh-Far R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008612; Fitzpatrick AL, 2007, AM J EPIDEMIOL, V165, P14, DOI [10.1093/aje/kw346, 10.1093/aje/kwj346]; Frenck RW, 1998, P NATL ACAD SCI USA, V95, P5607, DOI 10.1073/pnas.95.10.5607; Graakjaer J, 2006, ANN NY ACAD SCI, V1067, P311, DOI 10.1196/annals.1354.042; Graakjaer J, 2006, HUM GENET, V119, P344, DOI 10.1007/s00439-006-0137-x; Graakjaer J, 2003, MECH AGEING DEV, V124, P629, DOI 10.1016/S0047-6374(03)00081-2; Halaschek-Wiener J, 2008, MECH AGEING DEV, V129, P638, DOI 10.1016/j.mad.2008.07.004; Houben JMJ, 2008, FREE RADICAL BIO MED, V44, P235, DOI 10.1016/j.freeradbiomed.2007.10.001; Itzkovitz S, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.060902; Iwama H, 1998, HUM GENET, V102, P397, DOI 10.1007/s004390050711; Jeanclos E, 2000, HYPERTENSION, V36, P195, DOI 10.1161/01.HYP.36.2.195; Kallings LV, 2009, EUR J CARDIOV PREV R, V16, P80, DOI 10.1097/HJR.0b013e32831e953a; Kawauchi K, 2005, J IMMUNOL, V174, P5261, DOI 10.4049/jimmunol.174.9.5261; Kyo S, 1999, CANCER RES, V59, P5917; Martens UM, 2002, BRIT J HAEMATOL, V119, P810, DOI 10.1046/j.1365-2141.2002.03910.x; Njajou OT, 2007, P NATL ACAD SCI USA, V104, P12135, DOI 10.1073/pnas.0702703104; Nordfjall K, 2005, P NATL ACAD SCI USA, V102, P16374, DOI 10.1073/pnas.0501724102; Nordfjall K, 2008, OBESITY, V16, P2682, DOI 10.1038/oby.2008.413; Nordfjall K, 2010, EUR J HUM GENET, V18, P385, DOI 10.1038/ejhg.2009.178; Nordfjall K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000375; Robertson JD, 2000, BRIT J HAEMATOL, V109, P272, DOI 10.1046/j.1365-2141.2000.01970.x; Rufer N, 1999, J EXP MED, V190, P157, DOI 10.1084/jem.190.2.157; Samani NJ, 2001, LANCET, V358, P472, DOI 10.1016/S0140-6736(01)05633-1; Saretzki G, 2002, ANN NY ACAD SCI, V959, P24, DOI 10.1111/j.1749-6632.2002.tb02079.x; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shao L, 2007, J UROLOGY, V178, P1492, DOI 10.1016/j.juro.2007.05.112; Shlush LI, 2011, MECH AGEING DEV, V132, P123, DOI 10.1016/j.mad.2011.01.005; SLAGBOOM PE, 1994, AM J HUM GENET, V55, P876; Spyridopoulos I, 2008, ARTERIOSCL THROM VAS, V28, P968, DOI 10.1161/ATVBAHA.107.160846; Starr JM, 2007, EXP GERONTOL, V42, P571, DOI 10.1016/j.exger.2006.12.002; Svenson U, 2009, BBA-MOL BASIS DIS, V1792, P317, DOI 10.1016/j.bbadis.2009.01.017; Wu XF, 2003, J NATL CANCER I, V95, P1211, DOI 10.1093/jnci/djg011	47	94	95	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21485	10.1371/journal.pone.0021485	http://dx.doi.org/10.1371/journal.pone.0021485			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21720548	Green Published, Green Submitted, gold			2022-12-27	WOS:000292036900040
J	Swenson, NG				Swenson, Nathan G.			Phylogenetic Beta Diversity Metrics, Trait Evolution and Inferring the Functional Beta Diversity of Communities	PLOS ONE			English	Article							FOREST IMPLICATIONS; PATTERNS; RELATEDNESS; SIMILARITY; SIGNAL; SCALE	The beta diversity of communities along gradients has fascinated ecologists for decades. Traditionally such studies have focused on the species composition of communities, but researchers are becoming increasingly interested in analyzing the phylogenetic composition in the hope of achieving mechanistic insights into community structure. To date many metrics of phylogenetic beta diversity have been published, but few empirical studies have been published. Further inferences made from such phylogenetic studies critically rely on the pattern of trait evolution. The present work provides a study of the phylogenetic dissimilarity of 96 tree communities in India. The work compares and contrasts eight metrics of phylogenetic dissimilarity, considers the role of phylogenetic signal in trait data and shows that environmental distance rather than spatial distance is the best correlate of phylogenetic dissimilarity in the study system.	Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA	Michigan State University	Swenson, NG (corresponding author), Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA.	swensonn@msu.edu	Swenson, Nathan/A-3514-2012	Swenson, Nathan/0000-0003-3819-9767	Michigan State University	Michigan State University	This work was supported by Michigan State University. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Bryant JA, 2008, P NATL ACAD SCI USA, V105, P11505, DOI 10.1073/pnas.0801920105; Cavender-Bares J, 2004, AM NAT, V163, P823, DOI 10.1086/386375; Gillespie R, 2004, SCIENCE, V303, P356, DOI 10.1126/science.1091875; Graham CH, 2008, ECOL LETT, V11, P1265, DOI 10.1111/j.1461-0248.2008.01256.x; Hardy OJ, 2007, J ECOL, V95, P493, DOI 10.1111/j.1365-2745.2007.01222.x; Kraft NJB, 2007, AM NAT, V170, P271, DOI 10.1086/519400; Kress WJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015409; Kress WJ, 2009, P NATL ACAD SCI USA, V106, P18621, DOI 10.1073/pnas.0909820106; LOSOS JB, 1992, SYST BIOL, V41, P403, DOI 10.2307/2992583; Losos JB, 2008, ECOL LETT, V11, P995, DOI 10.1111/j.1461-0248.2008.01229.x; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Martin AP, 2002, APPL ENVIRON MICROB, V68, P3673, DOI 10.1128/AEM.68.8.3673-3682.2002; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Petchey OL, 2002, ECOL LETT, V5, P402, DOI 10.1046/j.1461-0248.2002.00339.x; Ramesh B. R., 2010, ECOLOGY, V91, P3118, DOI DOI 10.1890/10-0133.1; RAO CR, 1982, THEOR POPUL BIOL, V21, P24, DOI 10.1016/0040-5809(82)90004-1; Schreeg LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013685; Swenson NG, 2007, ECOLOGY, V88, P1770, DOI 10.1890/06-1499.1; Swenson NG, 2007, AM J BOT, V94, P451, DOI 10.3732/ajb.94.3.451; Swenson NG, 2006, ECOLOGY, V87, P2418, DOI 10.1890/0012-9658(2006)87[2418:TPAPOS]2.0.CO;2; Swenson NG, 2011, AM J BOT, V98, P472, DOI 10.3732/ajb.1000289; Swenson NG, 2011, P ROY SOC B-BIOL SCI, V278, P877, DOI 10.1098/rspb.2010.1369; Swenson NG, 2009, ECOLOGY, V90, P2161, DOI 10.1890/08-1025.1; Swenson NG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004390; Uriarte M, 2010, ECOL LETT, V13, P1503, DOI 10.1111/j.1461-0248.2010.01541.x; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Webb CO, 2000, AM NAT, V156, P145, DOI 10.1086/303378; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782	33	154	164	13	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21264	10.1371/journal.pone.0021264	http://dx.doi.org/10.1371/journal.pone.0021264			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21731685	gold, Green Submitted, Green Published			2022-12-27	WOS:000292036900017
J	Yang, W; Marr, LC				Yang, Wan; Marr, Linsey C.			Dynamics of Airborne Influenza A Viruses Indoors and Dependence on Humidity	PLOS ONE			English	Article							ABSOLUTE-HUMIDITY; SEASONAL FACTOR; SURVIVAL; PROTEIN; TRANSMISSION; INACTIVATION; DROPLETS; AEROSOL; SALIVA	There is mounting evidence that the aerosol transmission route plays a significant role in the spread of influenza in temperate regions and that the efficiency of this route depends on humidity. Nevertheless, the precise mechanisms by which humidity might influence transmissibility via the aerosol route have not been elucidated. We hypothesize that airborne concentrations of infectious influenza A viruses (IAVs) vary with humidity through its influence on virus inactivation rate and respiratory droplet size. To gain insight into the mechanisms by which humidity might influence aerosol transmission, we modeled the size distribution and dynamics of IAVs emitted from a cough in typical residential and public settings over a relative humidity (RH) range of 10-90%. The model incorporates the size transformation of virus-containing droplets due to evaporation and then removal by gravitational settling, ventilation, and virus inactivation. The predicted concentration of infectious IAVs in air is 2.4 times higher at 10% RH than at 90% RH after 10 min in a residential setting, and this ratio grows over time. Settling is important for removal of large droplets containing large amounts of IAVs, while ventilation and inactivation are relatively more important for removal of IAVs associated with droplets <5 mu m. The inactivation rate increases linearly with RH; at the highest RH, inactivation can remove up to 28% of IAVs in 10 min. Humidity is an important variable in aerosol transmission of IAVs because it both induces droplet size transformation and affects IAV inactivation rates. Our model advances a mechanistic understanding of the aerosol transmission route, and results complement recent studies on the relationship between humidity and influenza's seasonality. Maintaining a high indoor RH and ventilation rate may help reduce chances of IAV infection.			Yang, W (corresponding author), Virginia Tech, Dept Civil & Environm Engn, Blacksburg, VA 24061 USA.	lmarr@vt.edu	Lucas, Elizabeth A/E-2733-2010; Yang, Wan/K-7592-2013; Marr, Linsey/C-9698-2010	Yang, Wan/0000-0002-7555-9728; Marr, Linsey/0000-0003-3628-6891	National Science Foundation [CBET-0547107]	National Science Foundation(National Science Foundation (NSF))	This research was supported by the National Science Foundation under grant number CBET-0547107. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagger HL, 2006, EUR BIOPHYS J BIOPHY, V35, P367, DOI 10.1007/s00249-005-0035-5; Blachere FM, 2009, CLIN INFECT DIS, V48, P438, DOI 10.1086/596478; Brown JD, 2009, VET MICROBIOL, V136, P20, DOI 10.1016/j.vetmic.2008.10.027; Chao CYH, 2009, J AEROSOL SCI, V40, P122, DOI 10.1016/j.jaerosci.2008.10.003; Douglas RG, 1975, INFLUENZA VIRUSES IN, P375; DUGUID JP, 1946, J HYG-CAMBRIDGE, V44, P471, DOI 10.1017/S0022172400019288; Effros RM, 2002, AM J RESP CRIT CARE, V165, P663, DOI 10.1164/ajrccm.165.5.2101018; Enberg N, 2001, ORAL SURG ORAL MED O, V92, P292, DOI 10.1067/moe.2001.116814; Fabian P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002691; Fischer H, 2006, J MEMBRANE BIOL, V211, P139, DOI 10.1007/s00232-006-0861-0; HARPER GJ, 1961, J HYG-CAMBRIDGE, V59, P479, DOI 10.1017/S0022172400039176; HEMMES JH, 1962, ANTON VAN LEE J M S, V28, P221, DOI 10.1007/BF02538737; HEMMES JH, 1960, NATURE, V188, P430, DOI 10.1038/188430a0; HINDS WC, 1999, AEROSOL TECHNOLOGY P, P75; JENSEN MM, 1964, APPL MICROBIOL, V12, P418, DOI 10.1128/AEM.12.5.418-420.1964; Lai ACK, 2007, ATMOS ENVIRON, V41, P7473, DOI 10.1016/j.atmosenv.2007.05.045; Lindsley WG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015100; Lindsley WG, 2010, CLIN INFECT DIS, V50, P693, DOI 10.1086/650457; LOUDON RG, 1967, AM REV RESPIR DIS, V95, P435; Lowen Anice, 2009, PLoS Curr, V1, pRRN1002; Lowen AC, 2008, J VIROL, V82, P5650, DOI 10.1128/JVI.00325-08; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; McDevitt J, 2010, APPL ENVIRON MICROB, V76, P3943, DOI 10.1128/AEM.02674-09; Michishige F, 2006, J MED INVESTIG, V53, P140, DOI 10.2152/jmi.53.140; Mikhailov E, 2004, ATMOS CHEM PHYS, V4, P323, DOI 10.5194/acp-4-323-2004; Morawska L, 2009, J AEROSOL SCI, V40, P256, DOI 10.1016/j.jaerosci.2008.11.002; MURPHY BR, 1980, INFECT IMMUN, V29, P348; Myatt TA, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-55; Nicas M, 2005, J OCCUP ENVIRON HYG, V2, P143, DOI 10.1080/15459620590918466; Oberdorster G, 2005, ENVIRON HEALTH PERSP, V113, P823, DOI 10.1289/ehp.7339; Papineni R S, 1997, J Aerosol Med, V10, P105, DOI 10.1089/jam.1997.10.105; Parker ER, 1944, J LAB CLIN MED, V29, P37; Posada JA, 2010, J VIROL METHODS, V164, P88, DOI 10.1016/j.jviromet.2009.12.004; RAPHAEL GD, 1989, J CLIN INVEST, V84, P1528, DOI 10.1172/JCI114329; SCHAFFER FL, 1976, ARCH VIROL, V51, P263, DOI 10.1007/BF01317930; Seinfeld J. H., 2006, Atmospheric chemistry and physics: from air pollution to climate change; Shaman J, 2009, P NATL ACAD SCI USA, V106, P3243, DOI 10.1073/pnas.0806852106; SHECHMEISTER IL, 1950, J INFECT DIS, V87, P128, DOI 10.1093/infdis/87.2.128; Steel J, 2011, J VIROL, V85, P1400, DOI 10.1128/JVI.02186-10; TAMERIUS J, 2010, ENV HLTH PERSPECT; Tang IN, 1997, J GEOPHYS RES-ATMOS, V102, P23269, DOI 10.1029/97JD01806; Tang JWT, 2010, ARCH INTERN MED, V170, P861, DOI 10.1001/archinternmed.2010.108; Thomas Y, 2008, APPL ENVIRON MICROB, V74, P3002, DOI 10.1128/AEM.00076-08; Tompkins J. A., 2010, FACILITIES PLANNING, V4th; Ward CL, 2004, J CLIN VIROL, V29, P179, DOI 10.1016/S1386-6532(03)00122-7; Xie X, 2007, INDOOR AIR, V17, P211, DOI 10.1111/j.1600-0668.2007.00469.x; Xie XJ, 2009, J R SOC INTERFACE, V6, pS703, DOI 10.1098/rsif.2009.0388.focus; Yamamoto N, 2010, INDOOR AIR, V20, P85, DOI 10.1111/j.1600-0668.2009.00622.x; Yang SH, 2007, J AEROSOL MED, V20, P484, DOI 10.1089/jam.2007.0610; YANG W, 2011, J R SOC INT IN PRESS	50	171	175	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21481	10.1371/journal.pone.0021481	http://dx.doi.org/10.1371/journal.pone.0021481			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21731764	Green Submitted, gold, Green Published			2022-12-27	WOS:000292036900038
J	Guhr, T; Bloem, J; Derksen, NIL; Wuhrer, M; Koenderman, AHL; Aalberse, RC; Rispens, T				Guhr, Theresa; Bloem, Judith; Derksen, Ninotska I. L.; Wuhrer, Manfred; Koenderman, Anky H. L.; Aalberse, Rob C.; Rispens, Theo			Enrichment of Sialylated IgG by Lectin Fractionation Does Not Enhance the Efficacy of Immunoglobulin G in a Murine Model of Immune Thrombocytopenia	PLOS ONE			English	Article							INTRAVENOUS GAMMA-GLOBULIN; ANTIINFLAMMATORY ACTIVITY; AUTOIMMUNE-DISEASES; IVIG; MECHANISMS; PURPURA; FC; GLYCOSYLATION; SUBCLASSES; RECEPTOR	Intravenous immunoglobulin G (IVIg) is widely used against a range of clinical symptoms. For its use in immune modulating therapies such as treatment of immune thrombocytopenic purpura high doses of IVIg are required. It has been suggested that only a fraction of IVIg causes this anti immune modulating effect. Recent studies indicated that this fraction is the Fc-sialylated IgG fraction. The aim of our study was to determine the efficacy of IVIg enriched for sialylated IgG (IVIg-SA (+)) in a murine model of passive immune thrombocytopenia (PIT). We enriched IVIg for sialylated IgG by Sambucus nigra agglutinin (SNA) lectin fractionation and determined the degree of sialylation. Analysis of IVIg-SA (+) using a lectin-based ELISA revealed that we enriched predominantly for Fab-sialylated IgG, whereas we did not find an increase in Fc-sialylated IgG. Mass spectrometric analysis confirmed that Fc sialylation did not change after SNA lectin fractionation. The efficacy of sialylated IgG was measured by administering IVIg or IVIg-SA (+) 24 hours prior to an injection of a rat anti-mouse platelet mAb. We found an 85% decrease in platelet count after injection of an anti-platelet mAb, which was reduced to a 70% decrease by injecting IVIg (p<0.01). In contrast, IVIg-SA (+) had no effect on the platelet count. Serum levels of IVIg and IVIg-SA (+) were similar, ruling out enhanced IgG clearance as a possible explanation. Our results indicate that SNA lectin fractionation is not a suitable method to enrich IVIg for Fc-sialylated IgG. The use of IVIg enriched for Fab-sialylated IgG abolishes the efficacy of IVIg in the murine PIT model.	[Guhr, Theresa; Derksen, Ninotska I. L.; Aalberse, Rob C.; Rispens, Theo] Univ Amsterdam, Acad Med Ctr, Sanquin Res & Landsteiner Lab, NL-1105 AZ Amsterdam, Netherlands; [Bloem, Judith; Koenderman, Anky H. L.] Sanquin, Prod Dev Dept, Amsterdam, Netherlands; [Wuhrer, Manfred] Leiden Univ, Med Ctr, Dept Parasitol, Biomol Mass Spectrometry Unit, Leiden, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Guhr, T (corresponding author), Univ Amsterdam, Acad Med Ctr, Sanquin Res & Landsteiner Lab, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	T.Rispens@sanquin.nl	Wuhrer, Manfred/ABE-9168-2020	Wuhrer, Manfred/0000-0002-0814-4995				Anthony RM, 2008, SCIENCE, V320, P373, DOI 10.1126/science.1154315; Anthony RM, 2008, P NATL ACAD SCI USA, V105, P19571, DOI 10.1073/pnas.0810163105; Baerenwaldt A, 2010, EXPERT REV CLIN IMMU, V6, P425, DOI [10.1586/eci.10.9, 10.1586/ECI.10.9]; Ballow M, 2011, J ALLERGY CLIN IMMUN, V127, P315, DOI 10.1016/j.jaci.2010.10.030; BERCHTOLD P, 1989, BLOOD, V73, P662; Crow AR, 2001, BRIT J HAEMATOL, V115, P679, DOI 10.1046/j.1365-2141.2001.03136.x; Dalziel M, 1999, GLYCOCONJUGATE J, V16, P801, DOI 10.1023/A:1007183915921; Fernandez-Cruz E, 2009, CLIN EXP IMMUNOL, V158, P60, DOI 10.1111/j.1365-2249.2009.04028.x; FINNEY JD, 1979, STAT METHOD BIOL ASS; Flynn GC, 2010, MOL IMMUNOL, V47, P2074, DOI 10.1016/j.molimm.2010.04.006; GELFAND EW, 1992, SEMIN HEMATOL, V29, P127; Huang HS, 2010, BLOOD, V116, P5002, DOI 10.1182/blood-2010-03-275123; IMBACH P, 1981, LANCET, V1, P1228; Imbach P, 2010, VOX SANG, V98, P385, DOI 10.1111/j.1423-0410.2009.01264.x; IMBACH P, 1991, CANCER-AM CANCER SOC, V68, P1422, DOI 10.1002/1097-0142(19910915)68:6+<1422::AID-CNCR2820681403>3.0.CO;2-5; Jin F, 2005, HUM IMMUNOL, V66, P403, DOI 10.1016/j.humimm.2005.01.029; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; KAVERI SV, 1991, CLIN EXP IMMUNOL, V86, P192; Kazatchkine MD, 2001, NEW ENGL J MED, V345, P747, DOI 10.1056/NEJMra993360; Kumar A, 2006, INT ARCH ALLERGY IMM, V140, P185, DOI 10.1159/000093204; Lazarus AH, 2002, VOX SANG, V83, P53, DOI 10.1111/j.1423-0410.2002.tb05268.x; Looney RJ, 2006, BEST PRACT RES CL HA, V19, P3, DOI 10.1016/j.beha.2005.01.032; Negi VS, 2007, J CLIN IMMUNOL, V27, P233, DOI 10.1007/s10875-007-9088-9; Samuelsson A, 2001, SCIENCE, V291, P484, DOI 10.1126/science.291.5503.484; Seite JF, 2010, BLOOD, V116, P1698, DOI 10.1182/blood-2009-12-261461; Stadlmann J, 2008, PROTEOMICS, V8, P2858, DOI 10.1002/pmic.200700968; Stadlmann J, 2010, J CLIN IMMUNOL, V30, pS15, DOI 10.1007/s10875-010-9409-2; Stadlmann J, 2009, PROTEOMICS, V9, P4143, DOI 10.1002/pmic.200800931; Teeling JL, 2001, BLOOD, V98, P1095, DOI 10.1182/blood.V98.4.1095; Tha-In T, 2008, TRENDS IMMUNOL, V29, P608, DOI 10.1016/j.it.2008.08.004; VLUG A, 1994, ANN BIOL CLIN-PARIS, V52, P561; Wuhrer M, 2007, PROTEOMICS, V7, P4070, DOI 10.1002/pmic.200700289	32	88	96	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21246	10.1371/journal.pone.0021246	http://dx.doi.org/10.1371/journal.pone.0021246			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731683	Green Published, gold, Green Submitted			2022-12-27	WOS:000292035400016
J	Shimada, K; Crother, TR; Karlin, J; Chen, S; Chiba, N; Ramanujan, VK; Vergnes, L; Ojcius, DM; Arditi, M				Shimada, Kenichi; Crother, Timothy R.; Karlin, Justin; Chen, Shuang; Chiba, Norika; Ramanujan, V. Krishnan; Vergnes, Laurent; Ojcius, David M.; Arditi, Moshe			Caspase-1 Dependent IL-1 beta Secretion Is Critical for Host Defense in a Mouse Model of Chlamydia pneumoniae Lung Infection	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; IFN-GAMMA; NALP3 INFLAMMASOME; IMMUNE-RESPONSES; MICE DEFICIENT; APOPTOSIS; INNATE; INTERLEUKIN-1; ACTIVATION; INDUCTION	Chlamydia pneumoniae (CP) is an important human pathogen that causes atypical pneumonia and is associated with various chronic inflammatory disorders. Caspase-1 is a key component of the 'inflammasome', and is required to cleave pro-IL-1 beta to bioactive IL-1 beta. Here we demonstrate for the first time a critical requirement for IL-1 beta in response to CP infection. Caspase-1(-/-) mice exhibit delayed cytokine production, defective clearance of pulmonary bacteria and higher mortality in response to CP infection. Alveolar macrophages harbored increased bacterial numbers due to reduced iNOS levels in Caspase-1(-/-) mice. Pharmacological blockade of the IL-1 receptor in CP infected wild-type mice phenocopies Caspase-1-deficient mice, and administration of recombinant IL-1 beta rescues CP infected Caspase-1(-/-) mice from mortality, indicating that IL-1 beta secretion is crucial for host immune defense against CP lung infection. In vitro investigation reveals that CP-induced IL-1 beta secretion by macrophages requires TLR2/MyD88 and NLRP3/ASC/Caspase-1 signaling. Entry into the cell by CP and new protein synthesis by CP are required for inflammasome activation. Neither ROS nor cathepsin was required for CP infection induced inflammasome activation. Interestingly, Caspase-1 activation during CP infection occurs with mitochondrial dysfunction indicating a possible mechanism involving the mitochondria for CP-induced inflammasome activation.	[Shimada, Kenichi; Crother, Timothy R.; Karlin, Justin; Chen, Shuang; Chiba, Norika; Arditi, Moshe] Cedars Sinai Med Ctr, Div Pediat Infect Dis & Immunol, Los Angeles, CA 90048 USA; [Shimada, Kenichi; Crother, Timothy R.; Karlin, Justin; Chen, Shuang; Chiba, Norika; Arditi, Moshe] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Ramanujan, V. Krishnan] Cedars Sinai Med Ctr, Dept Surg, Los Angeles, CA 90048 USA; [Vergnes, Laurent] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA USA; [Ojcius, David M.] Univ Calif Merced, Hlth Sci Res Inst, Merced, CA USA; [Ojcius, David M.] Univ Calif Merced, Sch Nat Sci, Merced, CA USA	Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California System; University of California Merced; University of California System; University of California Merced	Shimada, K (corresponding author), Cedars Sinai Med Ctr, Div Pediat Infect Dis & Immunol, Los Angeles, CA 90048 USA.	arditi.moshe@cshs.org	Ojcius, David/ABE-6557-2020; Ramanujan, V Krishnan/O-2831-2014; Crother, Timothy R/E-2879-2010; Ramanujan, V Krishnan/A-6395-2011	Crother, Timothy R/0000-0001-8465-6127; Ojcius, David/0000-0003-1461-4495; vergnes, laurent/0000-0002-8804-589X	National Institutes of Health [HL-66436, AI-067995]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066436] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI067995, R01AI067995] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants HL-66436 and AI-067995 (to MA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Sater AA, 2009, J BIOL CHEM, V284, P26789, DOI 10.1074/jbc.M109.026823; Blasi F, 2009, CLIN MICROBIOL INFEC, V15, P29, DOI 10.1111/j.1469-0691.2008.02130.x; Boya P, 2003, ONCOGENE, V22, P3927, DOI 10.1038/sj.onc.1206622; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Ferri KF, 2001, NAT CELL BIOL, V3, pE255, DOI 10.1038/ncb1101-e255; Fox ES, 1998, J LEUKOCYTE BIOL, V63, P509, DOI 10.1002/jlb.63.4.509; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Frankenberg T, 2008, EUR J IMMUNOL, V38, P204, DOI 10.1002/eji.200737379; Garlid KD, 2003, BBA-BIOENERGETICS, V1606, P23, DOI 10.1016/S0005-2728(03)00108-7; Gerard HC, 2009, RHEUM DIS CLIN N AM, V35, P1, DOI 10.1016/j.rdc.2009.03.011; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Gold ES, 2004, J EXP MED, V200, P581, DOI 10.1084/jem.20040546; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; He XB, 2010, J IMMUNOL, V184, P5743, DOI 10.4049/jimmunol.0903937; HOGQUIST KA, 1991, P NATL ACAD SCI USA, V88, P8485, DOI 10.1073/pnas.88.19.8485; Joyee AG, 2008, CURR PHARM DESIGN, V14, P593, DOI 10.2174/138161208783885344; KaukorantaTolvanen SSE, 1996, MICROB PATHOGENESIS, V21, P215, DOI 10.1006/mpat.1996.0056; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; LATZ E, 2010, CURR OPIN IMMUNOL; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; MAYERBARBER KD, 2010, J IMMUNOLOGY BALTIMO, P1950; Meixenberger K, 2010, J IMMUNOL, V184, P922, DOI 10.4049/jimmunol.0901346; Miller LS, 2007, J IMMUNOL, V179, P6933, DOI 10.4049/jimmunol.179.10.6933; Moayeri M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001222; Naiki Y, 2005, J BIOL CHEM, V280, P29242, DOI 10.1074/jbc.M503225200; NAKAHIRA K, 2010, NATURE IMMUNOLOGY; Netea MG, 2000, EUR J IMMUNOL, V30, P541, DOI 10.1002/1521-4141(200002)30:2<541::AID-IMMU541>3.0.CO;2-X; Netea MG, 2004, J IMMUNOL, V173, P1477, DOI 10.4049/jimmunol.173.2.1477; Newman ZL, 2009, INFECT IMMUN, V77, P4327, DOI 10.1128/IAI.00730-09; Ott M, 2007, APOPTOSIS, V12, P913, DOI 10.1007/s10495-007-0756-2; Papaetis GS, 2009, EUR J INTERN MED, V20, P579, DOI 10.1016/j.ejim.2009.05.006; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; Rodriguez N, 2006, EUR J IMMUNOL, V36, P1145, DOI 10.1002/eji.200535152; Rottenberg ME, 2000, J IMMUNOL, V164, P4812, DOI 10.4049/jimmunol.164.9.4812; Rottenberg ME, 1999, J IMMUNOL, V162, P2829; Rottenberg ME, 2002, CURR OPIN IMMUNOL, V14, P444, DOI 10.1016/S0952-7915(02)00361-8; Rupp J, 2003, EUR RESPIR J, V22, P274, DOI 10.1183/09031936.03.00007303; Shimada K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000379; Shimada T, 2010, CELL HOST MICROBE, V7, P38, DOI 10.1016/j.chom.2009.12.008; Stutz A, 2009, J CLIN INVEST, V119, P3502, DOI 10.1172/JCI40599; Sutherland ER, 2007, CHEST, V132, P1962, DOI 10.1378/chest.06-2415; Teng XW, 2002, AM J PHYSIOL-CELL PH, V282, pC144, DOI 10.1152/ajpcell.2002.282.1.C144; Watson C, 2008, CLIN SCI, V114, P509, DOI 10.1042/CS20070298; Zhou R, 2010, NATURE	50	89	96	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21477	10.1371/journal.pone.0021477	http://dx.doi.org/10.1371/journal.pone.0021477			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731762	Green Published, Green Submitted, gold			2022-12-27	WOS:000292035400042
J	Van Bergen, NJ; Crowston, JG; Kearns, LS; Staffieri, SE; Hewitt, AW; Cohn, AC; Mackey, DA; Trounce, IA				Van Bergen, Nicole J.; Crowston, Jonathan G.; Kearns, Lisa S.; Staffieri, Sandra E.; Hewitt, Alex W.; Cohn, Amy C.; Mackey, David A.; Trounce, Ian A.			Mitochondrial Oxidative Phosphorylation Compensation May Preserve Vision in Patients with OPA1-Linked Autosomal Dominant Optic Atrophy	PLOS ONE			English	Article							DYNAMIN-RELATED PROTEIN; OPA1 MUTATIONS; HETEROZYGOUS MUTATION; NERVE HEAD; COMPLEX-I; NEUROPATHY; GENE; DYSFUNCTION; MORPHOLOGY; DEFECTS	Autosomal Dominant Optic Atrophy (ADOA) is the most common inherited optic atrophy where vision impairment results from specific loss of retinal ganglion cells of the optic nerve. Around 60% of ADOA cases are linked to mutations in the OPA1 gene. OPA1 is a fission-fusion protein involved in mitochondrial inner membrane remodelling. ADOA presents with marked variation in clinical phenotype and varying degrees of vision loss, even among siblings carrying identical mutations in OPA1. To determine whether the degree of vision loss is associated with the level of mitochondrial impairment, we examined mitochondrial function in lymphoblast cell lines obtained from six large Australian OPA1-linked ADOA pedigrees. Comparing patients with severe vision loss (visual acuity [VA]<6/36) and patients with relatively preserved vision (VA>6/9) a clear defect in mitochondrial ATP synthesis and reduced respiration rates were observed in patients with poor vision. In addition, oxidative phosphorylation (OXPHOS) enzymology in ADOA patients with normal vision revealed increased complex II+III activity and levels of complex IV protein. These data suggest that OPA1 deficiency impairs OXPHOS efficiency, but compensation through increases in the distal complexes of the respiratory chain may preserve mitochondrial ATP production in patients who maintain normal vision. Identification of genetic variants that enable this response may provide novel therapeutic insights into OXPHOS compensation for preventing vision loss in optic neuropathies.	[Van Bergen, Nicole J.; Crowston, Jonathan G.; Kearns, Lisa S.; Staffieri, Sandra E.; Hewitt, Alex W.; Cohn, Amy C.; Trounce, Ian A.] Univ Melbourne, Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, Melbourne, Vic, Australia; [Mackey, David A.] Univ Western Australia, Perth, WA 6009, Australia; [Mackey, David A.] Lions Eye Inst, Perth, WA, Australia	Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Melbourne; University of Western Australia; Lions Eye Institute; University of Western Australia	Van Bergen, NJ (corresponding author), Univ Melbourne, Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, Melbourne, Vic, Australia.	i.trounce@unimelb.edu.au	Hewitt, Alex W/D-1936-2013; Mackey, David A/H-5340-2014; Staffieri, Sandra/R-1216-2019	Hewitt, Alex W/0000-0002-5123-5999; Mackey, David A/0000-0001-7914-4709; Staffieri, Sandra/0000-0003-3131-9359; Trounce, Ian/0000-0002-1070-8892; Kearns, Lisa/0000-0001-9432-4054	National Health and Medical Research Council [590200]; Ophthalmic Research Institute of Australia; Glaucoma Australia; Henry Greenfield Research Fund; Edols Trust	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Ophthalmic Research Institute of Australia; Glaucoma Australia; Henry Greenfield Research Fund; Edols Trust	The work was supported by the National Health and Medical Research Council [grant number 590200]; Ophthalmic Research Institute of Australia; Glaucoma Australia Fund; Henry Greenfield Research Fund and Edols Trust Fund. The Centre for Eye Research Australia receives operational infrastructure support from the Victorian Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Abu-Amero KK, 2006, INVEST OPHTH VIS SCI, V47, P2533, DOI 10.1167/iovs.05-1639; Alavi MV, 2007, BRAIN, V130, P1029, DOI 10.1093/brain/awm005; Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944; Amati-Bonneau P, 2005, ANN NEUROL, V58, P958, DOI 10.1002/ana.20681; Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298; Bai RK, 2005, J MOL DIAGN, V7, P613, DOI 10.1016/S1525-1578(10)60595-8; Bonora E, 2006, CANCER RES, V66, P6087, DOI 10.1158/0008-5472.CAN-06-0171; Brown MD, 2001, AM J MED GENET, V104, P331, DOI 10.1002/1096-8628(2001)104:4<331::AID-AJMG10054>3.0.CO;2-8; Brown MD, 2000, J BIOL CHEM, V275, P39831, DOI 10.1074/jbc.M006476200; Carelli V, 2004, PROG RETIN EYE RES, V23, P53, DOI 10.1016/j.preteyeres.2003.10.003; Carelli V, 2007, BIOSCIENCE REP, V27, P173, DOI 10.1007/s10540-007-9045-0; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Chen HC, 2006, CURR OPIN CELL BIOL, V18, P453, DOI 10.1016/j.ceb.2006.06.004; CHENG S, 1994, P NATL ACAD SCI USA, V91, P5695, DOI 10.1073/pnas.91.12.5695; CHENG S, 1994, NAT GENET, V7, P350, DOI 10.1038/ng0794-350; Chevrollier A, 2008, ANN NEUROL, V63, P794, DOI 10.1002/ana.21385; Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101; Cohn AC, 2008, BRIT J OPHTHALMOL, V92, P1333, DOI 10.1136/bjo.2007.134726; Cohn AC, 2007, AM J OPHTHALMOL, V143, P656, DOI 10.1016/j.ajo.2006.12.038; Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936; Delettre C, 2001, HUM GENET, V109, P584, DOI 10.1007/s00439-001-0633-y; Duvezin-Caubet S, 2006, J BIOL CHEM, V281, P37972, DOI 10.1074/jbc.M606059200; Ferre M, 2005, HUM MUTAT, V25, P423, DOI 10.1002/humu.20161; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Fuhrmann N, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-25; Garcia-Barcelo M, 2006, CLIN CHEM, V52, P46, DOI 10.1373/clinchem.2005.056192; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; HEIDUSCHKA P, 2009, INVEST OPHTH VIS SCI, V51, P1424; Holladay JT, 2004, J CATARACT REFR SURG, V30, P287, DOI 10.1016/j.jcrs.2004.01.014; Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272; Hutter E, 2006, EXP GERONTOL, V41, P103, DOI 10.1016/j.exger.2005.09.011; Hutter E, 2004, BIOCHEM J, V380, P919, DOI 10.1042/BJ20040095; Ishihara N, 2006, EMBO J, V25, P2966, DOI 10.1038/sj.emboj.7601184; Johnston RL, 1999, OPHTHALMOLOGY, V106, P123, DOI 10.1016/S0161-6420(99)90013-1; Jun AS, 1996, MOL CELL BIOL, V16, P771; Kanazawa T, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000022; KJER P, 1959, Acta Ophthalmol Suppl, V164, P1; LEE S, 2010, EXP EYE RES     0804; Lodi R, 2004, ANN NEUROL, V56, P719, DOI 10.1002/ana.20278; Manfredi G, 2002, METHODS, V26, P317, DOI 10.1016/S1046-2023(02)00037-3; Marchbank NJ, 2002, J MED GENET, V39, DOI 10.1136/jmg.39.8.e47; Mayorov Vladimir I., 2008, BMC Biochemistry, V9, P9, DOI 10.1186/1471-2091-9-22; Meucci MA, 2005, PHARMACOGENOMICS, V6, P59, DOI 10.1517/14622416.6.1.59; Morgan JE, 2005, OPHTHALMOLOGY, V112, P855, DOI 10.1016/j.ophtha.2004.11.056; Morgan JE, 2005, BRIT J OPHTHALMOL, V89, P879, DOI 10.1136/bjo.2004.046169; O'Neill EC, 2010, NAT REV NEUROL, V6, P221, DOI 10.1038/nrneurol.2010.5; Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200; Olichon A, 2002, FEBS LETT, V523, P171, DOI 10.1016/S0014-5793(02)02985-X; Pierron D, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-70; Pottier N, 2007, HUM MOL GENET, V16, P2261, DOI 10.1093/hmg/ddm178; Sesaki H, 2003, MOL BIOL CELL, V14, P2342, DOI 10.1091/mbc.E02-12-0788; Shahrestani P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006867; Spinazzi M, 2008, HUM MOL GENET, V17, P3291, DOI 10.1093/hmg/ddn225; Stadlmann S, 2002, TRANSPLANTATION, V74, P1800, DOI 10.1097/01.TP.0000039262.25355.67; Tang S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004492; Toomes C, 2001, HUM MOL GENET, V10, P1369, DOI 10.1093/hmg/10.13.1369; Trevino LR, 2009, NAT GENET, V41, P1001, DOI 10.1038/ng.432; Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0; Votruba M, 1998, J MED GENET, V35, P793, DOI 10.1136/jmg.35.10.793; Votruba M, 2004, EYE, V18, P1126, DOI 10.1038/sj.eye.6701570; Votruba M, 2003, BRIT J OPHTHALMOL, V87, P48, DOI 10.1136/bjo.87.1.48; White KE, 2009, INVEST OPHTH VIS SCI, V50, P2567, DOI 10.1167/iovs.08-2913; Yarosh W, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040006; Yu-Wai-Man P, 2010, BRAIN, V133, P771, DOI 10.1093/brain/awq007; Yu-Wai-Man P, 2009, J MED GENET, V46, P145, DOI 10.1136/jmg.2007.054270; Yu-Wai-Man P, 2010, OPHTHALMOLOGY, V117, P1538, DOI 10.1016/j.ophtha.2009.12.038; Yu-Wai-Man P, 2009, INVEST OPHTH VIS SCI, V50, P4561, DOI 10.1167/iovs.09-3634; YUWAIMAN P, 2010, PROG RETIN EYE RES; Zanna C, 2005, APOPTOSIS, V10, P997, DOI 10.1007/s10495-005-0742-5; Zanna C, 2008, BRAIN, V131, P352, DOI 10.1093/brain/awm335	71	41	44	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21347	10.1371/journal.pone.0021347	http://dx.doi.org/10.1371/journal.pone.0021347			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731710	Green Published, gold, Green Submitted			2022-12-27	WOS:000292033700065
J	Ivanis, A; Hren, D; Marusic, M; Marusic, A				Ivanis, Ana; Hren, Darko; Marusic, Matko; Marusic, Ana			Less Work, Less Respect: Authors' Perceived Importance of Research Contributions and Their Declared Contributions to Research Articles	PLOS ONE			English	Article							DISCLOSURE; BEHAVIOR; CRITERIA; FACULTY; VIEWS; FORMS; TIME	Background: Attitudes towards authorship are connected with authors' research experience and with knowledge of authorship criteria of International Committee of Medical Journal Editors (ICMJE). The objective of this study was to assess association between authors' perceived importance of contributions for authorship qualification and their participation in manuscripts submitted to a journal. Methods: Authors (n=1181) of 265 manuscripts submitted to the Croatian Medical Journal were asked to identify and rate their contribution in the preparation of the submitted manuscript (0 - none to 4 - full for 11 listed contributions) and the importance of these contributions as authorship qualifications (0 - none to 4-full). They were randomly allocated into 3 groups: the first (n=90 manuscripts, n=404 authors) first received the contribution disclosure form and then contribution importance-rating questionnaire; the second (n=88 manuscripts, n=382 authors) first received the rating questionnaire and then the contribution disclosure form, and the third group (n=87 manuscripts, n=395 authors) received both questionnaires at the same time. We compared authors' perception of importance of contribution categories. Results: 1014 (85.9%) authors of 235 manuscripts responded. Authors who declared contribution to a specific category rated it as more important for authorship than those authors who did not contribute to the same category (P>0.005 for all contribution categories, Mann-Withney test). Authors qualifying for ICMJE authorship rated all contribution categories higher than non-qualifying authors. For all contributions, associations between perceived importance of contribution and actual author's contribution were statistically significant. Conclusions: Authorship seems to be not a normative issue subjective to categorization into criteria, but also a very personal view of the importance and value of one's contributions.	[Ivanis, Ana] Vrapce Psychiat Hosp, Zagreb, Croatia; [Hren, Darko] Univ Split, Fac Philosophy, Split, Croatia; [Marusic, Matko; Marusic, Ana] Univ Split, Sch Med, Dept Res Biomed & Hlth, Split, Croatia	University of Split; University of Split	Ivanis, A (corresponding author), Vrapce Psychiat Hosp, Zagreb, Croatia.	a.ivanis@gmail.com	Marusic, Ana/E-7683-2013; Hren, Darko/H-1819-2017; Marusic, Matko/E-1834-2017	Marusic, Ana/0000-0001-6272-0917; Hren, Darko/0000-0001-6465-6568; Marusic, Matko/0000-0001-5562-1777	Ministry of Science and Technology of the Republic of Croatia [108-1080314-0140]	Ministry of Science and Technology of the Republic of Croatia	This study was supported by the research grant from the Ministry of Science and Technology of the Republic of Croatia No. 108-1080314-0140 to MM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates T, 2004, JAMA-J AM MED ASSOC, V292, P86, DOI 10.1001/jama.292.1.86; Bhopal R, 1997, BRIT MED J, V314, P1009, DOI 10.1136/bmj.314.7086.1009; Bradburn Norman M., 2004, ASKING QUESTIONS; FESTINGER L, 1959, J ABNORM SOC PSYCH, V58, P203, DOI 10.1037/h0041593; Hoen WP, 1998, JAMA-J AM MED ASSOC, V280, P217, DOI 10.1001/jama.280.3.217; Horton R, 1996, BRIT MED J, V312, P723; Hren D, 2007, J MED ETHICS, V33, P428, DOI 10.1136/jme.2006.017160; Ilakovac V, 2007, CAN MED ASSOC J, V176, P41; Ivanis A, 2008, J GEN INTERN MED, V23, P1303, DOI 10.1007/s11606-008-0599-8; Louis KS, 2008, J HIGH EDUC, V79, P88, DOI 10.1353/jhe.2008.0002; Marusic A, 2006, CURR MED RES OPIN, V22, P1035, DOI 10.1185/030079906X104885; Pignatelli B, 2005, J MED ETHICS, V31, P578, DOI 10.1136/jme.2004.009449; REGAN DT, 1977, J EXP SOC PSYCHOL, V13, P28, DOI 10.1016/0022-1031(77)90011-7; Smith R, 1997, BRIT MED J, V314, P992, DOI 10.1136/bmj.314.7086.992; Wagena EJ, 2005, J MED ETHICS, V31, P308, DOI 10.1136/jme.2004.009308; WAGER E, 2007, MED GEN MED, V9, P16	16	13	13	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2011	6	6							e20206	10.1371/journal.pone.0020206	http://dx.doi.org/10.1371/journal.pone.0020206			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	782CL	21713036	Green Published, Green Submitted, gold			2022-12-27	WOS:000291985100001
J	Shah, A; Verma, AS; Patel, KH; Noel, R; Rivera-Amill, V; Silverstein, PS; Chaudhary, S; Bhat, HK; Stamatatos, L; Singh, DP; Buch, S; Kumar, A				Shah, Ankit; Verma, Ashish S.; Patel, Kalpeshkumar H.; Noel, Richard; Rivera-Amill, Vanessa; Silverstein, Peter S.; Chaudhary, Suman; Bhat, Hari K.; Stamatatos, Leonidas; Singh, Dhirendra P.; Buch, Shilpa; Kumar, Anil			HIV-1 gp120 Induces Expression of IL-6 through a Nuclear Factor-Kappa B-Dependent Mechanism: Suppression by gp120 Specific Small Interfering RNA	PLOS ONE			English	Article							ENVELOPE GLYCOPROTEIN GP120; NECROSIS-FACTOR-ALPHA; OXIDATIVE STRESS; GENE-EXPRESSION; PROTEIN GP120; INFLAMMATORY CYTOKINES; FUNCTIONAL EXPRESSION; ALZHEIMERS-DISEASE; RAT ASTROCYTES; CELL CULTURES	In addition to its role in virus entry, HIV-1 gp120 has also been implicated in HIV-associated neurocognitive disorders. However, the mechanism(s) responsible for gp120-mediated neuroinflammation remain undefined. In view of increased levels of IL-6 in HIV-positive individuals with neurological manifestations, we sought to address whether gp120 is involved in IL-6 over-expression in astrocytes. Transfection of a human astrocyte cell line with a plasmid encoding gp120 resulted in increased expression of IL-6 at the levels of mRNA and protein by 51.3 +/- 2.1 and 11.6 +/- 2.2 fold respectively; this effect of gp120 on IL-6 expression was also demonstrated using primary human fetal astrocytes. A similar effect on IL-6 expression was observed when primary astrocytes were treated with gp120 protein derived from different strains of X4 and R5 tropic HIV-1. The induction of IL-6 could be abrogated by use of gp120-specific siRNA. Furthermore, this study showed that the NF-kappa B pathway is involved in gp120-mediated IL-6 over-expression, as IKK-2 and IKK beta inhibitors inhibited IL-6 expression by 56.5% and 60.8%, respectively. These results were also confirmed through the use of NF-kappa B specific siRNA. We also showed that gp120 could increase the phosphorylation of I kappa B alpha. Furthermore, gp120 transfection in the SVGA cells increased translocation of NF-kappa B from cytoplasm to nucleus. These results demonstrate that HIV-1 gp120-mediated over-expression of IL-6 in astrocytes is one mechanism responsible for neuroinflammation in HIV-infected individuals and this is mediated by the NF-kappa B pathway.	[Shah, Ankit; Verma, Ashish S.; Patel, Kalpeshkumar H.; Silverstein, Peter S.; Bhat, Hari K.; Kumar, Anil] Univ Missouri, Sch Pharm, Div Pharmacol, Kansas City, MO 64110 USA; [Noel, Richard; Rivera-Amill, Vanessa; Chaudhary, Suman] Ponce Sch Med, Ponce, PR USA; [Stamatatos, Leonidas] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Singh, Dhirendra P.; Buch, Shilpa] Univ Nebraska Med Ctr, Omaha, NE USA	University of Missouri System; University of Missouri Kansas City; Center for Infectious Disease Research; University of Nebraska System; University of Nebraska Medical Center	Shah, A (corresponding author), Univ Missouri, Sch Pharm, Div Pharmacol, Kansas City, MO 64110 USA.	kumaran@umkc.edu	KUMAR, ANIL/ACD-8340-2022; Boothapati, Anil Kumar/HHS-1813-2022	Buch, Shilpa/0000-0002-3103-6685	National Institute on Drug Abuse [DA025528, DA025011]; NATIONAL EYE INSTITUTE [R01EY013394] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025528, R01DA025011] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institute on Drug Abuse grants DA025528 and DA025011 to AK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGRAWAL L, BRAIN RES, V1306, P116; AKIRA S, 1992, IMMUNOL REV, V127, P25, DOI 10.1111/j.1600-065X.1992.tb01407.x; Avdoshina V, 2010, GLIA, V58, P1630, DOI 10.1002/glia.21035; Bansal AK, 2000, BRAIN RES, V879, P42, DOI 10.1016/S0006-8993(00)02725-6; Becker C, 2004, IMMUNITY, V21, P491, DOI 10.1016/j.immuni.2004.07.020; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Bowie A, 2000, BIOCHEM PHARMACOL, V59, P13, DOI 10.1016/S0006-2952(99)00296-8; BREEN EC, 1990, J IMMUNOL, V144, P480; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Edelman DA, 2007, J TRAUMA, V62, P89, DOI 10.1097/TA.0b013e31802dd712; Eggert D, 2009, J NEUROIMMUNOL, V213, P47, DOI 10.1016/j.jneuroim.2009.06.002; Garcia MG, 2005, LEUKEMIA RES, V29, P1425, DOI 10.1016/j.leukres.2005.05.004; Grundner C, 2005, VIROLOGY, V331, P33, DOI 10.1016/j.virol.2004.09.022; Hauser KF, 2006, J NEUROIMMUNE PHARM, V1, P98, DOI 10.1007/s11481-005-9000-4; Hawkins PG, 2009, NUCLEIC ACIDS RES, V37, P2984, DOI 10.1093/nar/gkp127; Hesselgesser J, 1999, J NEUROVIROL, V5, P13, DOI 10.3109/13550289909029741; Iskander S, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-7; Kim SS, 2011, METHODS MOL BIOL, V721, P339, DOI 10.1007/978-1-61779-037-9_21; Kishore N, 2003, J BIOL CHEM, V278, P32861, DOI 10.1074/jbc.M211439200; Kong LY, 1996, CELL IMMUNOL, V172, P77, DOI 10.1006/cimm.1996.0217; Lavi E, 1998, J NEUROVIROL, V4, P301, DOI 10.3109/13550289809114531; Lazzerini PE, 2007, CLIN EXP RHEUMATOL, V25, P696; Li JL, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-31; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Louboutin JP, 2010, EXP NEUROL, V221, P231, DOI 10.1016/j.expneurol.2009.11.004; Maccioni RB, 2009, ANN NY ACAD SCI, V1153, P240, DOI 10.1111/j.1749-6632.2008.03972.x; MAJOR EO, 1985, P NATL ACAD SCI USA, V82, P1257, DOI 10.1073/pnas.82.4.1257; McLoughlin RM, 2003, J CLIN INVEST, V112, P598, DOI 10.1172/JCI200317129; Mette MF, 2000, EMBO J, V19, P5194, DOI 10.1093/emboj/19.19.5194; Minagar A, 2002, J NEUROL SCI, V202, P13, DOI 10.1016/S0022-510X(02)00207-1; MOGI M, 1994, NEUROSCI LETT, V180, P147, DOI 10.1016/0304-3940(94)90508-8; Nath A, 2000, J PSYCHOPHARMACOL, V14, P222, DOI 10.1177/026988110001400305; Nukuna A, 2004, J NEUROVIROL, V10, P82, DOI 10.1080/13550280490268188; Panickar KS, 2005, GLIA, V50, P287, DOI 10.1002/glia.20181; Ronaldson PT, 2008, J NEUROCHEM, V106, P1298, DOI 10.1111/j.1471-4159.2008.05479.x; Ronaldson PT, 2006, MOL PHARMACOL, V70, P1087, DOI 10.1124/mol.106.025973; Ronaldson PT, 2010, MOL PHARMACOL, V77, P644, DOI 10.1124/mol.109.059410; Saha RN, 2003, J NEUROCHEM, V86, P1057, DOI 10.1046/j.1471-4159.2003.01942.x; Saile B, 2001, EUR J CELL BIOL, V80, P554, DOI 10.1078/0171-9335-00182; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Schoeniger-Skinner DK, 2007, BRAIN BEHAV IMMUN, V21, P660, DOI 10.1016/j.bbi.2006.10.010; Sellhorn G, 2009, VACCINE, V28, P430, DOI 10.1016/j.vaccine.2009.10.028; SIEBENLIST U, 1994, ANNU REV CELL BIOL, V10, P405, DOI 10.1146/annurev.cb.10.110194.002201; Sinke AP, 2008, J NEUROCHEM, V106, P2302, DOI 10.1111/j.1471-4159.2008.05549.x; Thompson KA, 2004, ANN NEUROL, V56, P873, DOI 10.1002/ana.20304; Thompson WL, 2009, BRAIN RES, V1287, P47, DOI 10.1016/j.brainres.2009.06.081; Togo T, 2000, BRAIN RES, V885, P117, DOI 10.1016/S0006-8993(00)02984-X; Visalli V, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-106; Viviani B, 2006, J BIOL CHEM, V281, P30212, DOI 10.1074/jbc.M602156200; Wallace DR, 2006, SYNAPSE, V59, P51, DOI 10.1002/syn.20214; Wang AL, 2007, INT IMMUNOPHARMACOL, V7, P1552, DOI 10.1016/j.intimp.2007.07.030; Wu CX, 2009, MOL THER, V17, P2058, DOI 10.1038/mt.2009.225; YEUNG MC, 1995, AIDS, V9, P137, DOI 10.1097/00002030-199509020-00004; Younger ST, 2011, NUCL ACIDS RES; Zhang X, 2008, INFLAMM RES, V57, P524, DOI 10.1007/s00011-008-8007-8	55	56	57	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2011	6	6							e21261	10.1371/journal.pone.0021261	http://dx.doi.org/10.1371/journal.pone.0021261			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782CL	21712995	Green Published, Green Submitted, gold			2022-12-27	WOS:000291985100022
J	Belisle, SE; Yin, JM; Shedlock, DJ; Dai, AL; Yan, J; Hirao, L; Kutzler, MA; Lewis, MG; Andersen, H; Lank, SM; Karl, JA; O'Connor, DH; Khan, A; Sardesai, N; Chang, J; Aicher, L; Palermo, RE; Weiner, DB; Katze, MG; Boyer, J				Belisle, Sarah E.; Yin, Jiangmei; Shedlock, Devon J.; Dai, Anlan; Yan, Jian; Hirao, Lauren; Kutzler, Michele A.; Lewis, Mark G.; Andersen, Hanne; Lank, Simon M.; Karl, Julie A.; O'Connor, David H.; Khan, Amir; Sardesai, Niranjan; Chang, Jean; Aicher, Lauri; Palermo, Robert E.; Weiner, David B.; Katze, Michael G.; Boyer, Jean			Long-Term Programming of Antigen-Specific Immunity from Gene Expression Signatures in the PBMC of Rhesus Macaques Immunized with an SIV DNA Vaccine	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; T-CELL RESPONSES; TYPE-1 INFECTION; CHEMOKINE RECEPTORS; HIV-1 INFECTION; DISEASE PROGRESSION; CUTTING EDGE; RANTES; REPLICATION; LYMPHOCYTES	While HIV-1-specific cellular immunity is thought to be critical for the suppression of viral replication, the correlates of protection have not yet been determined. Rhesus macaques (RM) are an important animal model for the study and development of vaccines against HIV/AIDS. Our laboratory has helped to develop and study DNA-based vaccines in which recent technological advances, including genetic optimization and in vivo electroporation (EP), have helped to dramatically boost their immunogenicity. In this study, RMs were immunized with a DNA vaccine including individual plasmids encoding SIV gag, env, and pol alone, or in combination with a molecular adjuvant, plasmid DNA expressing the chemokine ligand 5 (RANTES), followed by EP. Along with standard immunological assays, flow-based activation analysis without ex vivo restimulation and high-throughput gene expression analysis was performed. Strong cellular immunity was induced by vaccination which was supported by all assays including PBMC microarray analysis that identified the up-regulation of 563 gene sequences including those involved in interferon signaling. Furthermore, 699 gene sequences were differentially regulated in these groups at peak viremia following SIVmac251 challenge. We observed that the RANTES-adjuvanted animals were significantly better at suppressing viral replication during chronic infection and exhibited a distinct pattern of gene expression which included immune cell-trafficking and cell cycle genes. Furthermore, a greater percentage of vaccine-induced central memory CD8+ T-cells capable of an activated phenotype were detected in these animals as measured by activation analysis. Thus, co-immunization with the RANTES molecular adjuvant followed by EP led to the generation of cellular immunity that was transcriptionally distinct and had a greater protective efficacy than its DNA alone counterpart. Furthermore, activation analysis and high-throughput gene expression data may provide better insight into mechanisms of viral control than may be observed using standard immunological assays.	[Belisle, Sarah E.; Chang, Jean; Aicher, Lauri; Palermo, Robert E.; Katze, Michael G.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Yin, Jiangmei; Shedlock, Devon J.; Dai, Anlan; Yan, Jian; Hirao, Lauren; Weiner, David B.; Boyer, Jean] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Kutzler, Michele A.] Drexel Univ, Dept Med, Coll Med, Philadelphia, PA 19104 USA; [Lewis, Mark G.; Andersen, Hanne] Bioqual, Res Sect, Rockville, MD USA; [Lank, Simon M.; Karl, Julie A.; O'Connor, David H.] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI USA; [Khan, Amir; Sardesai, Niranjan] Inovio Pharmaceut, Blue Bell, PA USA	University of Washington; University of Washington Seattle; University of Pennsylvania; Drexel University; BIOQUAL Inc.; University of Wisconsin System; University of Wisconsin Madison	Belisle, SE (corresponding author), Univ Washington, Dept Microbiol, Seattle, WA 98195 USA.	boyerj@mail.med.upenn.edu	Yin, Jiangmei/G-1952-2011	Shedlock, Devon/0000-0003-1018-7510; o'connor, david/0000-0003-2139-470X; Sardesai, Niranjan/0000-0001-6920-1167; Elyard, Hanne/0000-0003-1103-9608; Kutzler, Michele/0000-0001-5692-5617	National Institute of Allergy and Infectious Diseases [N01-AI-60007]; National Institutes of Health/NIAID, Maryland (Division of AIDS) [N01-A30018]; National Center for Research Resources [P51RR00166-45, R24 RR021745-06]; NCRR/NIH [P51 RR000167]; Research Facilities Improvement Program [RR15459-01, RR020141-01]; NIH/NIAID/DAIDS [HHSN272200800063C];  [R01-AI-071886];  [P01-A1-071739]; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR021745, C06RR015459, P51RR000166, P51RR000167, C06RR020141] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071886] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD010425] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health/NIAID, Maryland (Division of AIDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Research Facilities Improvement Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH/NIAID/DAIDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported in part by R01-AI-071886 to JB, P01-A1-071739 to DBW and National Institute of Allergy and Infectious Diseases Contract N01-AI-60007 to Bioqual. Funding was provided by the National Institutes of Health/NIAID Reagent Resource Support Program for AIDS Vaccine Development, Quality Biological, Gaithersburg, Maryland (Division of AIDS Contract N01-A30018). Funds were utilized from grants and National Center for Research Resources P51RR00166-45 and R24 RR021745-06 to DHO, and NCRR/NIH grant number P51 RR000167 to the Wisconsin National Primate Research Center, University of Wisconsin-Madison. This research was conducted in part at a facility constructed with support from Research Facilities Improvement Program grant numbers RR15459-01 and RR020141-01. AK and NS acknowledge funding in part from an NIH/NIAID/DAIDS - HIV Vaccine Design and Development Teams award to Inovio HHSN272200800063C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; Batten M, 2008, J IMMUNOL, V180, P2752, DOI 10.4049/jimmunol.180.5.2752; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Betts MR, 2000, J VIROL, V74, P9144, DOI 10.1128/JVI.74.19.9144-9151.2000; Bonecchi R, 1998, J EXP MED, V187, P129, DOI 10.1084/jem.187.1.129; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Bosinger SE, 2004, J IMMUNOL, V173, P6858, DOI 10.4049/jimmunol.173.11.6858; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Cecchinato V, 2008, MUCOSAL IMMUNOL, V1, P279, DOI 10.1038/mi.2008.14; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Frauenschuh A, 2004, VACCINE, V23, P546, DOI 10.1016/j.vaccine.2004.06.024; Freeman GJ, 2006, J EXP MED, V203, P2223, DOI 10.1084/jem.20061800; Giri MS, 2009, J IMMUNOL, V182, P4459, DOI 10.4049/jimmunol.0801450; Gosselin A, 2010, J IMMUNOL, V184, P1604, DOI 10.4049/jimmunol.0903058; Guadalupe M, 2003, J VIROL, V77, P11708, DOI 10.1128/JVI.77.21.11708-11717.2003; Hadida F, 1999, J IMMUNOL, V163, P1105; Hadida F, 1998, J EXP MED, V188, P609, DOI 10.1084/jem.188.3.609; Hirao LA, 2008, VACCINE, V26, P3112, DOI 10.1016/j.vaccine.2008.02.036; Imami N, 2002, J VIROL, V76, P9011, DOI 10.1128/JVI.76.18.9011-9023.2002; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; Karl JA, 2009, METHODS, V49, P11, DOI 10.1016/j.ymeth.2009.05.002; Karlsson I, 2007, J VIROL, V81, P13456, DOI 10.1128/JVI.01619-07; Kim JJ, 1998, J CLIN INVEST, V102, P1112, DOI 10.1172/JCI3986; Klenerman P, 2005, NAT IMMUNOL, V6, P873, DOI 10.1038/ni1241; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Kutzler MA, 2005, J IMMUNOL, V175, P112, DOI 10.4049/jimmunol.175.1.112; Lanzavecchia A, 2000, SCIENCE, V290, P92, DOI 10.1126/science.290.5489.92; Li QS, 2009, J IMMUNOL, V183, P1975, DOI 10.4049/jimmunol.0803222; Loetscher P, 1998, NATURE, V391, P344, DOI 10.1038/34814; Loffredo JT, 2007, J VIROL, V81, P8827, DOI 10.1128/JVI.00895-07; Loffredo JT, 2009, J IMMUNOL, V182, P7763, DOI 10.4049/jimmunol.0900111; McMichael AJ, 2001, NATURE, V410, P980, DOI 10.1038/35073658; Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845; Migueles SA, 2008, IMMUNITY, V29, P1009, DOI 10.1016/j.immuni.2008.10.010; Miller JD, 2008, IMMUNITY, V28, P710, DOI 10.1016/j.immuni.2008.02.020; Mothe BR, 2003, J VIROL, V77, P2736, DOI 10.1128/JVI.77.4.2736-2740.2003; Musey L, 1997, NEW ENGL J MED, V337, P1267, DOI 10.1056/NEJM199710303371803; Nishimura Y, 2007, J VIROL, V81, P893, DOI 10.1128/JVI.01635-06; Ockenhouse CF, 2005, J INFECT DIS, V191, P2064, DOI 10.1086/430321; Ogg GS, 1998, SCIENCE, V279, P2103, DOI 10.1126/science.279.5359.2103; Petrovas C, 2007, BLOOD, V110, P928, DOI 10.1182/blood-2007-01-069112; Petrovas C, 2006, J EXP MED, V203, P2281, DOI 10.1084/jem.20061496; Proudfoot AEI, 1999, BIOCHEM PHARMACOL, V57, P451; Prud'homme GJ, 2006, CURR GENE THER, V6, P243, DOI 10.2174/156652306776359504; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Romano JW, 2000, J VIROL METHODS, V86, P61, DOI 10.1016/S0166-0934(99)00184-6; Sallusto F, 1998, IMMUNOL TODAY, V19, P568, DOI 10.1016/S0167-5699(98)01346-2; Sauermann U, 2008, GENES IMMUN, V9, P69, DOI 10.1038/sj.gene.6364448; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Shimizu Y, 2007, VIROLOGY, V361, P68, DOI 10.1016/j.virol.2006.10.050; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Sin JI, 2000, J VIROL, V74, P11173, DOI 10.1128/JVI.74.23.11173-11180.2000; Veazey RS, 2000, J VIROL, V74, P11001, DOI 10.1128/JVI.74.23.11001-11007.2000; Velu V, 2007, J VIROL, V81, P5819, DOI 10.1128/JVI.00024-07; Waterman PM, 2004, VIRAL IMMUNOL, V17, P545, DOI 10.1089/vim.2004.17.545; Wilson JDK, 2000, AIDS, V14, P225, DOI 10.1097/00002030-200002180-00003; Wiseman RW, 2009, NAT MED, V15, P1322, DOI 10.1038/nm.2038; Xin KQ, 1999, CLIN IMMUNOL, V92, P90, DOI 10.1006/clim.1999.4730; Yant LJ, 2006, J VIROL, V80, P5074, DOI 10.1128/JVI.80.10.5074-5077.2006; YASUTOMI Y, 1993, J VIROL, V67, P1707, DOI 10.1128/JVI.67.3.1707-1711.1993; Yin JM, 2009, VIROLOGY, V393, P49, DOI 10.1016/j.virol.2009.07.017	62	25	28	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e19681	10.1371/journal.pone.0019681	http://dx.doi.org/10.1371/journal.pone.0019681			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	21701683	Green Published, Green Submitted, gold			2022-12-27	WOS:000291983800002
J	Corigliano, MG; Maglioco, A; Becher, ML; Goldman, A; Martin, V; Angel, SO; Clemente, M				Corigliano, Mariana G.; Maglioco, Andrea; Laguia Becher, Melina; Goldman, Alejandra; Martin, Valentina; Angel, Sergio O.; Clemente, Marina			Plant Hsp90 Proteins Interact with B-Cells and Stimulate Their Proliferation	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; TOLL-LIKE RECEPTORS; IN-VITRO; LEISHMANIA-INFANTUM; DENDRITIC CELLS; TOXOPLASMA-GONDII; INNATE; HSP70; HSP83; LYMPHOCYTES	Background: The molecular chaperone heat shock protein 90 (Hsp90) plays an important role in folding stabilization and activation of client proteins. Besides, Hsp90 of mammals and mammalian pathogens displays immunostimulatory properties. Here, we investigated the role of plant-derived Hsp90s as B-cell mitogens by measuring their proliferative responses in vitro. Methodology: Plant cytosolic Hsp90 isoforms from Arabidopsis thaliana (AtHsp81.2) and Nicotiana benthamiana (NbHsp90.3) were expressed in E. coli. Over-expression of recombinant plant Hsp90s (rpHsp90s) was confirmed by SDS-PAGE and western blot using and anti-AtHsp81.2 polyclonal anti-body. Both recombinant proteins were purified by Ni-NTA affinity chromatography and their identity confirmed by MALDI-TOF-TOF. Recombinant AtHsp81.2 and NbHsp90.3 proteins induced prominent proliferative responses in spleen cells form BALB/c mice. Polymyxin-B, a potent inhibitor of lipopolysaccharide (LPS), did not eliminate the rpHsp90-induced proliferation. In addition, in vitro incubation of spleen cells with rpHsp90 led to the expansion of CD19-bearing populations, suggesting a direct effect of these proteins on B lymphocytes. This effect was confirmed by immunofluorescence analysis, where a direct binding of rpHsp90 to B-but not to T-cells was observed in cells from BALB/c and C3H/HeN mice. Finally, we examined the involvement of Toll Like Receptor 4 (TLR4) molecules in the rpHsp90s induction of B-cell proliferation. Spleen cells from C3H/HeJ mice, which carry a point mutation in the cytoplasmic region of TLR4, responded poorly to prAtHsp90. However, the interaction between rpHsp90 and B-cells from C3H/HeJ mice was not altered, suggesting that the mutation on TLR4 would be affecting the signal cascade but not the rpHsp90-TLR4 receptor interaction. Conclusions: Our results show for the first time that spleen cell proliferation can be stimulated by a non-pathogen-derived Hsp90. Furthermore, our data provide a new example of a non-pathogen-derived ligand for TLRs.	[Corigliano, Mariana G.; Laguia Becher, Melina; Clemente, Marina] CONICET UNSAM, IIB INTECH, Lab Biotecnol Vegetal, Chascomus, Buenos Aires, Argentina; [Maglioco, Andrea] Acad Nacl Medicina, Inst Leucemia Expt ILEX CONICET, Buenos Aires, DF, Argentina; [Angel, Sergio O.] CONICET UNSAM, IIB INTECH, Lab Parasitol Mol, Chascomus, Buenos Aires, Argentina; [Goldman, Alejandra; Martin, Valentina] UNSAM, Escuela Ciencia & Tecnol, CESyMA, San Martin, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Buenos Aires National Academy of Medicine; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Corigliano, MG (corresponding author), CONICET UNSAM, IIB INTECH, Lab Biotecnol Vegetal, Chascomus, Buenos Aires, Argentina.	mclemente@intech.gov.ar	Angel, Sergio/AAZ-2849-2020	Laguia Becher, Melina/0000-0003-1344-4973; Angel, Sergio/0000-0003-4871-3408	Universidad General San Martin (UNSAM, Argentina) [SC 055/08]; National Agency for Scientific and Technological Promotion (ANPCyT, Argentina) [PICT 691/07]	Universidad General San Martin (UNSAM, Argentina); National Agency for Scientific and Technological Promotion (ANPCyT, Argentina)(ANPCyT)	This work was supported by SC 055/08 of the Universidad General San Martin (UNSAM, Argentina) and PICT 691/07 of the National Agency for Scientific and Technological Promotion (ANPCyT, Argentina). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2001, ADV IMMUNOL, V78, P1, DOI 10.1016/S0065-2776(01)78001-7; Aosai F, 2002, CELL STRESS CHAPERON, V7, P357, DOI 10.1379/1466-1268(2002)007<0357:TGDHSP>2.0.CO;2; Arnold-Schild D, 1999, J IMMUNOL, V162, P3757; Baba AF, 2006, GEN PHYSIOL BIOPHYS, V25, P277; Basu S, 2000, INT IMMUNOL, V12, P1539, DOI 10.1093/intimm/12.11.1539; Boshoff A, 2004, PROTEIN EXPRES PURIF, V38, P161, DOI 10.1016/j.pep.2004.06.039; BURIANI G, 2010, TRANSGENIC RES  0618; Calderwood SK, 2007, METHODS, V43, P199, DOI 10.1016/j.ymeth.2007.06.008; Callahan MK, 2006, J IMMUNOL, V177, P8393, DOI 10.4049/jimmunol.177.12.8393; Daniell H, 2009, TRENDS PLANT SCI, V14, P669, DOI 10.1016/j.tplants.2009.09.009; de Miguel N, 2009, BBA-MOL CELL RES, V1793, P1738, DOI 10.1016/j.bbamcr.2009.08.005; Echeverria P, 2001, IMMUNOL LETT, V76, P107, DOI 10.1016/S0165-2478(01)00179-1; Echeverria PC, 2006, VACCINE, V24, P4102, DOI 10.1016/j.vaccine.2006.02.039; Flohe SB, 2003, J IMMUNOL, V170, P2340, DOI 10.4049/jimmunol.170.5.2340; Gleba Y, 2005, VACCINE, V23, P2042, DOI 10.1016/j.vaccine.2005.01.006; Jackson SE, 2004, NAT STRUCT MOL BIOL, V11, P1152, DOI 10.1038/nsmb1204-1152; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Johnson JL, 2009, CELL STRESS CHAPERON, V14, P83, DOI 10.1007/s12192-008-0058-9; Kim Hanna Leah, 2008, Cancer Biol Ther, V7, P10; Krishna P, 2001, CELL STRESS CHAPERON, V6, P238, DOI 10.1379/1466-1268(2001)006<0238:THFOPI>2.0.CO;2; Laguia-Becher M, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-52; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Li ZH, 2002, FRONT BIOSCI-LANDMRK, V7, pD731; More S, 1999, IMMUNOL LETT, V69, P275, DOI 10.1016/S0165-2478(99)00100-5; Osterloh A, 2008, MED MICROBIOL IMMUN, V197, P1, DOI 10.1007/s00430-007-0055-0; Paul M, 2010, EXPERT REV VACCINES, V9, P821, DOI [10.1586/erv.10.88, 10.1586/ERV.10.88]; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Pockley AG, 2008, TRENDS BIOCHEM SCI, V33, P71, DOI 10.1016/j.tibs.2007.10.005; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Pratt WB, 2001, TRENDS PLANT SCI, V6, P54, DOI 10.1016/S1360-1385(00)01843-4; Prohaszka Z, 2004, MOL IMMUNOL, V41, P29, DOI 10.1016/j.molimm.2004.02.001; Prohaszka Z, 2007, ADV EXP MED BIOL, V594, P159; Quintana FJ, 2005, J IMMUNOL, V175, P2777, DOI 10.4049/jimmunol.175.5.2777; Rico AI, 2002, CELL STRESS CHAPERON, V7, P339, DOI 10.1379/1466-1268(2002)007<0339:THSPHA>2.0.CO;2; Rico AI, 1999, MOL IMMUNOL, V36, P1131, DOI 10.1016/S0161-5890(99)00136-4; Rowlands MG, 2004, ANAL BIOCHEM, V327, P176, DOI 10.1016/j.ab.2003.10.038; Rybicki EP, 2010, PLANT BIOTECHNOL J, V8, P620, DOI 10.1111/j.1467-7652.2010.00507.x; Scheibel T, 1999, MOL MICROBIOL, V34, P701, DOI 10.1046/j.1365-2958.1999.01632.x; Schild H, 2000, NAT IMMUNOL, V1, P100, DOI 10.1038/77770; Seki M, 1998, PLANT J, V15, P707, DOI 10.1046/j.1365-313x.1998.00237.x; Seki M, 2002, SCIENCE, V296, P141, DOI 10.1126/science.1071006; Sharma AK, 2009, BIOTECHNOL ADV, V27, P811, DOI 10.1016/j.biotechadv.2009.06.004; Srivastava P, 2002, NAT REV IMMUNOL, V2, P185, DOI 10.1038/nri749; Streatfield SJ, 2007, PLANT BIOTECHNOL J, V5, P2, DOI 10.1111/j.1467-7652.2006.00216.x; Tiwari S, 2009, BIOTECHNOL ADV, V27, P449, DOI 10.1016/j.biotechadv.2009.03.006; Tobian AAR, 2004, J IMMUNOL, V173, P5130, DOI 10.4049/jimmunol.173.8.5130; Tsan MF, 2004, CELL MOL IMMUNOL, V1, P274; Tsan MF, 2009, J LEUKOCYTE BIOL, V85, P905, DOI 10.1189/jlb.0109005; Vabulas RM, 2002, J BIOL CHEM, V277, P20847, DOI 10.1074/jbc.M200425200; Wallin RPA, 2002, TRENDS IMMUNOL, V23, P130, DOI 10.1016/S1471-4906(01)02168-8; Wang YQ, 2008, IMMUNOL LETT, V119, P57, DOI 10.1016/j.imlet.2008.04.003; Wegele H, 2004, REV PHYSIOL BIOCH P, V151, P1, DOI 10.1007/s10254-003-0021-1	53	13	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e21231	10.1371/journal.pone.0021231	http://dx.doi.org/10.1371/journal.pone.0021231			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	21701588	Green Submitted, Green Published, gold			2022-12-27	WOS:000291983800033
J	Sturm, GJ; Jin, CS; Kranzelbinder, B; Hemmer, W; Sturm, EM; Griesbacher, A; Heinemann, A; Vollmann, J; Altmann, F; Crailsheim, K; Focke, M; Aberer, W				Sturm, Gunter J.; Jin, Chunsheng; Kranzelbinder, Bettina; Hemmer, Wolfgang; Sturm, Eva M.; Griesbacher, Antonia; Heinemann, Akos; Vollmann, Jutta; Altmann, Friedrich; Crailsheim, Karl; Focke, Margarete; Aberer, Werner			Inconsistent Results of Diagnostic Tools Hamper the Differentiation between Bee and Vespid Venom Allergy	PLOS ONE			English	Article							BASOPHIL ACTIVATION TEST; REACTIVE CARBOHYDRATE DETERMINANTS; HYMENOPTERA-VENOM; IGE ANTIBODIES; CLINICAL-EVALUATION; IMMUNOGLOBULIN-E; SKIN-TESTS; BINDING; HISTAMINE; HONEYBEE	Background: Double sensitization (DS) to bee and vespid venom is frequently observed in the diagnosis of hymenoptera venom allergy, but clinically relevant DS is rare. Therefore it is sophisticated to choose the relevant venom for specific immunotherapy and overtreatment with both venoms may occur. We aimed to compare currently available routine diagnostic tests as well as experimental tests to identify the most accurate diagnostic tool. Methods: 117 patients with a history of a bee or vespid allergy were included in the study. Initially, IgE determination by the ImmunoCAP, by the Immulite, and by the ADVIA Centaur, as well as the intradermal test (IDT) and the basophil activation test (BAT) were performed. In 72 CAP double positive patients, individual IgE patterns were determined by western blot inhibition and component resolved diagnosis (CRD) with rApi m 1, nVes v 1, and nVes v 5. Results: Among 117 patients, DS was observed in 63.7% by the Immulite, in 61.5% by the CAP, in 47.9% by the IDT, in 20.5% by the ADVIA, and in 17.1% by the BAT. In CAP double positive patients, western blot inhibition revealed CCD-based DS in 50.8%, and the CRD showed 41.7% of patients with true DS. Generally, agreement between the tests was only fair and inconsistent results were common. Conclusion: BAT, CRD, and ADVIA showed a low rate of DS. However, the rate of DS is higher than expected by personal history, indicating that the matter of clinical relevance is still not solved even by novel tests. Furthermore, the lack of agreement between these tests makes it difficult to distinguish between bee and vespid venom allergy. At present, no routinely employed test can be regarded as gold standard to find the clinically relevant sensitization.	[Sturm, Gunter J.; Kranzelbinder, Bettina; Aberer, Werner] Med Univ Graz, Div Environm Dermatol & Venerol, Dept Dermatol, Graz, Austria; [Jin, Chunsheng; Altmann, Friedrich] Univ Nat Resources & Appl Life Sci, Dept Chem, Vienna, Austria; [Hemmer, Wolfgang] Floridsdorf Allergy Ctr, Vienna, Austria; [Sturm, Eva M.; Heinemann, Akos] Med Univ Graz, Inst Expt & Clin Pharmacol, Graz, Austria; [Griesbacher, Antonia] Med Univ Graz, Div Biostat, Med Res Ctr, Graz, Austria; [Vollmann, Jutta; Crailsheim, Karl] Graz Univ, Inst Zool, A-8010 Graz, Austria; [Focke, Margarete] Med Univ Vienna, Inst Pathophysiol, Vienna, Austria	Medical University of Graz; University of Natural Resources & Life Sciences, Vienna; Medical University of Graz; Medical University of Graz; University of Graz; Medical University of Vienna	Sturm, GJ (corresponding author), Med Univ Graz, Div Environm Dermatol & Venerol, Dept Dermatol, Graz, Austria.	gunter.sturm@medunigraz.at		Altmann, Friedrich/0000-0002-0112-7877; Heinemann, Akos/0000-0002-8554-2372; Sturm, Eva/0000-0003-4898-884X	Austrian Society for Dermatology and Venerology	Austrian Society for Dermatology and Venerology	The study is supported by a grant of the Austrian Society for Dermatology and Venerology (http://www.oegdv.at). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalberse RC, 2001, ALLERGY, V56, P27, DOI 10.1034/j.1398-9995.2001.00909.x; Altmann F, 2007, INT ARCH ALLERGY IMM, V142, P99, DOI 10.1159/000096114; Batanero E, 1999, J ALLERGY CLIN IMMUN, V103, P147, DOI 10.1016/S0091-6749(99)70538-5; Christensen LH, 2008, J ALLERGY CLIN IMMUN, V122, P298, DOI 10.1016/j.jaci.2008.05.026; Ebo DG, 2007, J INVEST ALLERG CLIN, V17, P357; Egner W, 1998, CLIN EXP ALLERGY, V28, P26, DOI 10.1046/j.1365-2222.1998.00176.x; Erdmann SM, 2004, ALLERGY, V59, P1102, DOI 10.1111/j.1398-9995.2004.00624.x; GEORGITIS JW, 1985, J ALLERGY CLIN IMMUN, V76, P803, DOI 10.1016/0091-6749(85)90752-3; Hemmer W, 2004, CLIN EXP ALLERGY, V34, P460, DOI 10.1111/j.1365-2222.2004.01897.x; Jin C, 2008, J ALLERGY CLIN IMMUN, V121, P185, DOI 10.1016/j.jaci.2007.07.047; Jin C, 2010, J ALLERGY CLIN IMMUN, V125, P184, DOI 10.1016/j.jaci.2009.08.037; Korosec P, 2009, CLIN EXP ALLERGY, V39, P1730, DOI 10.1111/j.1365-2222.2009.03347.x; LOCKEY RF, 1989, J ALLERGY CLIN IMMUN, V84, P967, DOI 10.1016/0091-6749(89)90396-5; Mertens M, 2010, CLIN EXP ALLERGY, V40, P1333, DOI 10.1111/j.1365-2222.2010.03535.x; Mittermann I, 2010, J ALLERGY CLIN IMMUN, V125, P1300, DOI 10.1016/j.jaci.2010.03.017; Mosbech H, 2000, ALLERGY, V55, P1005, DOI 10.1034/j.1398-9995.2000.00587.x; Muller UR, 2009, ALLERGY, V64, P543, DOI 10.1111/j.1398-9995.2008.01794.x; Paganelli R, 1998, ALLERGY, V53, P763; PASTORELLO EA, 1992, ALLERGY, V47, P463, DOI 10.1111/j.1398-9995.1992.tb00665.x; Petersen AB, 2004, CLIN BIOCHEM, V37, P882, DOI 10.1016/j.clinbiochem.2004.06.010; Pierson-Mullany LK, 2002, CLIN EXP ALLERGY, V32, P107, DOI 10.1046/j.0022-0477.2001.01244.x; Sainte-Laudy J, 2000, CLIN EXP ALLERGY, V30, P1166, DOI 10.1046/j.1365-2222.2000.00863.x; Schafer T, 1996, ALLERGY, V51, P372; Sturm GJ, 2009, ALLERGY, V64, P1319, DOI 10.1111/j.1398-9995.2009.02004.x; Sturm GJ, 2004, ALLERGY, V59, P1110, DOI 10.1111/j.1398-9995.2004.00400.x; Sturm GJ, 2009, INT ARCH ALLERGY IMM, V148, P261, DOI 10.1159/000161586; Wicklein D, 2004, BIOL CHEM, V385, P397, DOI 10.1515/BC.2004.044; Wilson IBH, 1998, GLYCOBIOLOGY, V8, P651, DOI 10.1093/glycob/8.7.651	28	60	61	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e20842	10.1371/journal.pone.0020842	http://dx.doi.org/10.1371/journal.pone.0020842			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698247	gold, Green Published, Green Submitted			2022-12-27	WOS:000291730000027
J	Kennelly, KP; Wallace, DM; Holmes, TM; Hankey, DJ; Grant, TS; O'Farrelly, C; Keegan, DJ				Kennelly, Kevin P.; Wallace, Deborah M.; Holmes, Toby M.; Hankey, Deborah J.; Grant, Timothy S.; O'Farrelly, Cliona; Keegan, David J.			Preparation of Pre-Confluent Retinal Cells Increases Graft Viability In Vitro and In Vivo: A Mouse Model	PLOS ONE			English	Article							ANTIGEN-PRESENTING CELLS; HEAT-SHOCK PROTEINS; APOPTOTIC CELLS; DENDRITIC CELLS; PIGMENT EPITHELIUM; VISUAL FUNCTION; PROINFLAMMATORY CYTOKINE; DYSTROPHIC RATS; SCHWANN-CELLS; RCS RAT	Purpose: Graft failure remains an obstacle to experimental subretinal cell transplantation. A key step is preparing a viable graft, as high levels of necrosis and apoptosis increase the risk of graft failure. Retinal grafts are commonly harvested from cell cultures. We termed the graft preparation procedure "transplant conditions" (TC). We hypothesized that culture conditions influenced graft viability, and investigated whether viability decreased following TC using a mouse retinal pigment epithelial (RPE) cell line, DH01. Methods: Cell viability was assessed by trypan blue exclusion. Levels of apoptosis and necrosis in vitro were determined by flow cytometry for annexin V and propidium iodide and Western blot analysis for the pro-and cleaved forms of caspases 3 and 7. Graft viability in vivo was established by terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) and cleaved caspase 3 immunolabeling of subretinal allografts. Results: Pre-confluent cultures had significantly less nonviable cells than post-confluent cultures (6.6%+/- 0.8% vs. 13.1%+/- 0.9%, p<0.01). Cell viability in either group was not altered significantly following TC. Caspases 3 and 7 were not altered by levels of confluence or following TC. Pre-confluent cultures had low levels of apoptosis/necrosis (5.6%+/- 1.1%) that did not increase following TC (4.8%+/- 0.5%). However, culturing beyond confluence led to progressively increasing levels of apoptosis and necrosis (up to 16.5%+/- 0.9%). Allografts prepared from post-confluent cultures had significantly more TUNEL-positive cells 3 hours post-operatively than grafts of pre-confluent cells (12.7%+/- 3.1% vs. 4.5%+/- 1.4%, p<0.001). Subretinal grafts of post-confluent cells also had significantly higher rates of cleaved caspase 3 than pre-confluent grafts (20.2%+/- 4.3% vs. 7.8%+/- 1.8%, p<0.001). Conclusion: Pre-confluent cells should be used to maximize graft cell viability.	[Kennelly, Kevin P.; Holmes, Toby M.] Univ Coll Dublin, Catherine McAuley Clin Res Ctr, Dublin 2, Ireland; [Kennelly, Kevin P.; Wallace, Deborah M.; Keegan, David J.] Mater Misericordiae Univ Hosp, Dept Ophthalmol, Dublin, Ireland; [Hankey, Deborah J.] UCL, Inst Ophthalmol, London, England; [O'Farrelly, Cliona] Trin Coll Dublin, Sch Biochem & Immunol, Dublin, Ireland; [Grant, Timothy S.] Univ Coll Dublin, Sch Publ Hlth & Populat Sci, Dublin, Ireland	University College Dublin; Mater Misericordiae University Hospital; University College Dublin; University of London; University College London; Trinity College Dublin; University College Dublin	Kennelly, KP (corresponding author), Univ Coll Dublin, Catherine McAuley Clin Res Ctr, Dublin 2, Ireland.	kpkennelly@gmail.com		Wallace, Deborah/0000-0003-2363-106X	Health Research Board, Ireland [RP/2007/202]; Irish College of Ophthalmologists	Health Research Board, Ireland; Irish College of Ophthalmologists	This work was funded by the Health Research Board, Ireland (project grant RP/2007/202), and by an Irish College of Ophthalmologists Fellowship awarded to K. Kennelly in 2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfano D, 2006, J BIOL CHEM, V281, P17758, DOI 10.1074/jbc.M601812200; ALMAZAN G, 1992, BRAIN RES, V579, P234, DOI 10.1016/0006-8993(92)90056-F; Andersson U, 2000, J EXP MED, V192, P565, DOI 10.1084/jem.192.4.565; Asea A, 2000, NAT MED, V6, P435, DOI 10.1038/74697; Basu S, 2000, INT IMMUNOL, V12, P1539, DOI 10.1093/intimm/12.11.1539; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Catanuto P, 2009, EXP EYE RES, V88, P99, DOI 10.1016/j.exer.2008.10.013; CharriautMarlangue C, 1995, NEUROREPORT, V7, P61, DOI 10.1097/00001756-199512290-00014; Chen M, 2008, INVEST OPHTH VIS SCI, V49, P3699, DOI 10.1167/iovs.07-1522; Coffey PJ, 2002, NAT NEUROSCI, V5, P53, DOI 10.1038/nn782; Croxford JL, 2000, J IMMUNOL, V164, P2776, DOI 10.4049/jimmunol.164.5.2776; Degterev A, 2003, ONCOGENE, V22, P8543, DOI 10.1038/sj.onc.1207107; Dumitriu IE, 2007, J LEUKOCYTE BIOL, V81, P84, DOI 10.1189/jlb.0306171; Dunn KC, 1996, EXP EYE RES, V62, P155, DOI 10.1006/exer.1996.0020; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; Gastpar R, 2005, CANCER RES, V65, P5238, DOI 10.1158/0008-5472.CAN-04-3804; Goldberg A, 2007, FASEB J, V21, P2840, DOI 10.1096/fj.06-7910com; GOURAS P, 1985, CURR EYE RES, V4, P253, DOI 10.3109/02713688509000857; Hill CE, 2007, EUR J NEUROSCI, V26, P1433, DOI 10.1111/j.1460-9568.2007.05771.x; Kanuga N, 2002, INVEST OPHTH VIS SCI, V43, P546; Kato K, 1996, CELL STRUCT FUNCT, V21, P459, DOI 10.1247/csf.21.459; Keegan DJ, 2003, INVEST OPHTH VIS SCI, V44, P3526, DOI 10.1167/iovs.02-0097; Kelly KJ, 2003, AM J PHYSIOL-CELL PH, V284, pC1309, DOI 10.1152/ajpcell.00353.2002; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; Kumar S, 2007, CELL DEATH DIFFER, V14, P32, DOI 10.1038/sj.cdd.4402060; LI LX, 1988, EXP EYE RES, V47, P911, DOI 10.1016/0014-4835(88)90073-5; Li MO, 2003, SCIENCE, V302, P1560, DOI 10.1126/science.1087621; Lu B, 2009, STEM CELLS, V27, P2126, DOI 10.1002/stem.149; Lund RD, 2001, P NATL ACAD SCI USA, V98, P9942, DOI 10.1073/pnas.171266298; MacLaren RE, 2006, NATURE, V444, P203, DOI 10.1038/nature05161; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; MCLAREN MJ, 1993, EXP CELL RES, V204, P311, DOI 10.1006/excr.1993.1038; NABI IR, 1993, J CELL SCI, V104, P37; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; O'Connor KA, 2003, CYTOKINE, V24, P254, DOI 10.1016/j.cyto.2003.08.001; Qin SX, 2006, J EXP MED, V203, P1637, DOI 10.1084/jem.20052203; Ronchetti A, 1999, J LEUKOCYTE BIOL, V66, P247, DOI 10.1002/jlb.66.2.247; Ronchetti A, 1999, J IMMUNOL, V163, P130; Rosenbaum DM, 2010, J NEUROSCI RES, V88, P1569, DOI 10.1002/jnr.22314; Rovere P, 1998, J IMMUNOL, V161, P4467; Saito K, 2005, EXP CELL RES, V310, P229, DOI 10.1016/j.yexcr.2005.07.014; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; SEATON AD, 1994, INVEST OPHTH VIS SCI, V35, P162; Seong SY, 2004, NAT REV IMMUNOL, V4, P469, DOI 10.1038/nri1372; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Taniguchi N, 2003, ARTHRITIS RHEUM, V48, P971, DOI 10.1002/art.10859; Trichonas G, 2010, P NATL ACAD SCI USA, V107, P21695, DOI 10.1073/pnas.1009179107; Wallace DM, 2006, INVEST OPHTH VIS SCI, V47, P2765, DOI 10.1167/iovs.05-1383; Wang Y, 2005, J IMMUNOL, V174, P3306, DOI 10.4049/jimmunol.174.6.3306; Wyburn KR, 2005, TRANSPLANTATION, V80, P1641, DOI 10.1097/01.tp.0000173903.26886.20; Yang D, 2007, J LEUKOCYTE BIOL, V81, P59, DOI 10.1189/jlb.0306180; YASUDA M, 1995, ARCH HISTOL CYTOL, V58, P185, DOI 10.1679/aohc.58.185; Young MJ, 2000, MOL CELL NEUROSCI, V16, P197, DOI 10.1006/mcne.2000.0869	53	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21365	10.1371/journal.pone.0021365	http://dx.doi.org/10.1371/journal.pone.0021365			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21738643	Green Published, gold, Green Submitted			2022-12-27	WOS:000292290100020
J	Clements, S; Chitwood, R; Schreck, CB				Clements, Shaun; Chitwood, Rob; Schreck, Carl B.			Effect of Commercially Available Egg Cures on the Survival of Juvenile Salmonids	PLOS ONE			English	Article							ACUTE TOXICITY; NADPH OXIDASE; SULFITE; TROUT; METABISULFITE; STEELHEAD; RADICALS; NITRITE; GROWTH	There is some concern that incidental consumption of eggs cured with commercially available cures for the purpose of sport fishing causes mortality in juvenile salmon. We evaluated this by feeding juvenile spring Chinook (Oncorhynchus tshawytscha) and steelhead (O. mykiss) with eggs cured with one of five commercially available cures. We observed significant levels of mortality in both pre-smolts and smolts. Depending on the experiment, 2, 3, or 4 of the cures were associated with mortality. Mortality tended to be higher in the smolts than in the parr, but there was no clear species effect. The majority of mortality occurred within the first 10 d of feeding. Removal of sodium sulfite from the cure significantly reduced the level of mortality. Soaking the eggs prior to feeding did not reduce mortality. We observed a clear relationship between the amount of cured egg consumed each day and the survival time. We conclude that consumption of eggs cured with sodium sulfite has the potential to cause mortality in juvenile steelhead and Chinook salmon in the wild.	[Clements, Shaun] Oregon Dept Fish & Wildlife, Corvallis, OR USA; [Chitwood, Rob] Oregon State Univ, Dept Fisheries & Wildlife, Corvallis, OR 97331 USA; [Schreck, Carl B.] Oregon State Univ, US Geol Survey, Oregon Cooperat Fish & Wildlife Res Unit, Corvallis, OR 97331 USA	Oregon State University; Oregon State University; United States Department of the Interior; United States Geological Survey	Clements, S (corresponding author), Oregon Dept Fish & Wildlife, Corvallis, OR USA.	Shaun.Clements@oregonstate.edu			Oregon Department of Fish and Wildlife Restoration and Enhancement Board [07-132]	Oregon Department of Fish and Wildlife Restoration and Enhancement Board	This study was partially funded by a grant (# 07-132) from the Oregon Department of Fish and Wildlife Restoration and Enhancement Board (http://www.dfw.state.or.us/fish/RE/). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT JC, 1985, BEHAVIOUR, V92, P241; AKANJI MA, 1993, TOXICOLOGY, V81, P173, DOI 10.1016/0300-483X(93)90010-P; AKOGYERAM C, 1980, FED PROC, V39, P1836; BECKSPEIER I, 1993, FREE RADICAL BIO MED, V14, P661, DOI 10.1016/0891-5849(93)90148-N; Chamulitrat W, 1999, FREE RADICAL BIO MED, V27, P411, DOI 10.1016/S0891-5849(99)00088-X; Collaco CR, 2006, ANN ALLERG ASTHMA IM, V96, P550, DOI 10.1016/S1081-1206(10)63549-1; COLT J, 1981, AQUACULTURE, V24, P111, DOI 10.1016/0044-8486(81)90048-X; COOPERSTEIN SJ, 1963, J BIOL CHEM, V238, P3606; FENDERSO.OC, 1968, J FISH RES BOARD CAN, V25, P1, DOI 10.1139/f68-001; HARKNESS DR, 1969, BIOCHEM BIOPH RES CO, V34, P849, DOI 10.1016/0006-291X(69)90258-7; HAYATSU H, 1972, BIOCHEM BIOPH RES CO, V46, P120, DOI 10.1016/0006-291X(72)90638-9; HUGOT D, 1965, ANN BIOL ANIM BIOCH, V5, P53, DOI 10.1051/rnd:19650104; INOUYE B, 1980, TOXICOL APPL PHARM, V53, P101, DOI 10.1016/0041-008X(80)90386-5; McMichael GA, 1997, T AM FISH SOC, V126, P230, DOI 10.1577/1548-8659(1997)126&lt;0230:EORHRS&gt;2.3.CO;2; OZAWA T, 1987, BIOCHEM BIOPH RES CO, V142, P410, DOI 10.1016/0006-291X(87)90289-0; PFLEIDERER G, 1956, BIOCHEM Z, V328, P287; Rankin CH, 2006, CURR BIOL, V16, pR89, DOI 10.1016/j.cub.2006.01.025; Rencuzogullari E, 2001, MUTAT RES-GEN TOX EN, V490, P107, DOI 10.1016/S1383-5718(00)00142-X; ROY AB, 1976, AUST J EXP BIOL MED, V54, P111, DOI 10.1038/icb.1976.13; SANO H, 1976, WATER RES, V10, P139, DOI 10.1016/0043-1354(76)90113-5; SMITH CE, 1974, T AM FISH SOC, V103, P389, DOI 10.1577/1548-8659(1974)103&lt;389:ENTIRT&gt;2.0.CO;2; THURSTON RV, 1978, T AM FISH SOC, V107, P361, DOI 10.1577/1548-8659(1978)107&lt;361:ATOAAN&gt;2.0.CO;2; WALLEN IE, 1957, SEWAGE IND WASTES, V29, P695; YANG SF, 1973, ENVIRON RES, V6, P395, DOI 10.1016/0013-9351(73)90055-8	24	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21406	10.1371/journal.pone.0021406	http://dx.doi.org/10.1371/journal.pone.0021406			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738653	Green Submitted, Green Published, gold			2022-12-27	WOS:000292092600037
J	Degauque, N; Boeffard, F; Foucher, Y; Ballet, C; Brouard, S; Soulillou, JP				Degauque, Nicolas; Boeffard, Francoise; Foucher, Yohann; Ballet, Caroline; Brouard, Sophie; Soulillou, Jean-Paul			The Blood of Healthy Individuals Exhibits CD8 T Cells with a Highly Altered TCR Vb Repertoire but with an Unmodified Phenotype	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; NONMALIGNANT CLONAL EXPANSIONS; LENGTH DISTRIBUTION; ELDERLY HUMANS; INFECTION; RECEPTOR; AGE; SUBSETS; TRANSCRIPTOME; LYMPHOCYTES	CD8 T cell clonal expansions (TCE) have been observed in elderly, healthy individuals as well in old mice, and have been associated with the ageing process. Both chronic latent and non-persistent viral infections have been proposed to drive the development of distinct non-functional and functional TCE respectively. Biases in TCR V beta repertoire diversity are also recurrently observed in patients that have undergone strong immune challenge, and are preferentially observed in the CD8 compartment. Healthy adults can also exhibit CD8 T cells with strong alterations of their CDR3 length distribution. Surprisingly, no specific investigations have been conducted to analyze the CD8 T cell repertoire in normal adults, to determine if such alterations in TCR V beta repertoire share the features of TCE. In this study, we characterized the phenotype and function of the CD8 population in healthy individuals of 25-52 years of age. All but one of the EBV-positive HLA-B8 healthy volunteers that were studied were CMV-negative. Using a specific unsupervised statistical method, we identified Vb families with altered CDR3 length distribution and increased TCR V beta/HPRT transcript ratios in all individuals tested. The increase in TCR V beta/HPRT transcript ratio was more frequently associated with an increase in the percentage of the corresponding V beta(+) T cells than with an absence of modification of their percentage. However, in contrast with the previously described TCE, these CD8(+) T cells were not preferentially found in the memory CD8 subset, they exhibited normal effector functions (cytokine secretion and cytotoxic molecule expression) and they were not reactive to a pool of EBV/CMV/Flu virus peptides. Taken together, the combined analysis of transcripts and proteins of the TCR V beta repertoire led to the identification of different types of CD8(+) T cell clone expansion or contraction in healthy individuals, a situation that appears more complex than previously described in aged individuals.	[Degauque, Nicolas; Boeffard, Francoise; Foucher, Yohann; Ballet, Caroline; Brouard, Sophie; Soulillou, Jean-Paul] INSERM, UMR643, Nantes, France; [Degauque, Nicolas; Boeffard, Francoise; Foucher, Yohann; Ballet, Caroline; Brouard, Sophie; Soulillou, Jean-Paul] CHU Nantes, ITUN, F-44035 Nantes 01, France; [Degauque, Nicolas; Boeffard, Francoise; Foucher, Yohann; Ballet, Caroline; Brouard, Sophie; Soulillou, Jean-Paul] Univ Nantes, Fac Med, Nantes, France; [Foucher, Yohann] INSERM, EA 4275, Nantes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Nantes Universite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Degauque, N (corresponding author), INSERM, UMR643, Nantes, France.	jean-paul.soulillou@univ-nantes.fr	Foucher, Yohann/L-8995-2015; brouard, sophie c/Q-1285-2016; Foucher, Yohann/ABB-6362-2021; Foucher, Yohann/G-2714-2013; Degauque, Nicolas/R-4944-2017	Foucher, Yohann/0000-0003-0330-7457; Foucher, Yohann/0000-0003-0330-7457; Degauque, Nicolas/0000-0003-2990-3513	TTS	TTS	Recherche translationnelle Pays de la Loire - DiRC Grand Ouest. Nicolas Degauque is a recipient of a TTS post-fellowship grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARGAET VP, 1994, J EXP MED, V180, P2335, DOI 10.1084/jem.180.6.2335; Arstila TP, 1999, SCIENCE, V286, P958, DOI 10.1126/science.286.5441.958; Baron V, 2003, IMMUNITY, V18, P193, DOI 10.1016/S1074-7613(03)00020-7; Brouard S, 2005, AM J TRANSPLANT, V5, P330, DOI 10.1111/j.1600-6143.2004.00700.x; BURROWS SR, 1994, J EXP MED, V179, P1155, DOI 10.1084/jem.179.4.1155; CALLAHAN JE, 1993, J IMMUNOL, V151, P6657; Chamberlain WD, 2000, CLIN IMMUNOL, V94, P160, DOI 10.1006/clim.1999.4832; Clambey ET, 2007, EXP GERONTOL, V42, P407, DOI 10.1016/j.exger.2006.11.008; Clambey ET, 2005, IMMUNOL REV, V205, P170, DOI 10.1111/j.0105-2896.2005.00265.x; Degauque N, 2004, INT J CANCER, V110, P721, DOI 10.1002/ijc.20149; Ely KH, 2007, J IMMUNOL, V179, P3535, DOI 10.4049/jimmunol.179.6.3535; FITZGERALD JE, 1995, J IMMUNOL, V154, P3538; Hislop AD, 2002, J EXP MED, V195, P893, DOI 10.1084/jem.20011692; Jager E, 2002, INT J CANCER, V98, P376, DOI 10.1002/ijc.10165; Khan N, 2002, J IMMUNOL, V169, P1984, DOI 10.4049/jimmunol.169.4.1984; Koch S, 2007, ANN NY ACAD SCI, V1114, P23, DOI 10.1196/annals.1396.043; Kohlmeier JE, 2010, J IMMUNOL, V185, P3456, DOI 10.4049/jimmunol.1001745; Laplaud DA, 2004, BRAIN, V127, P981, DOI 10.1093/brain/awh119; LeMaoult J, 2000, J IMMUNOL, V165, P2367, DOI 10.4049/jimmunol.165.5.2367; MORLEY JK, 1995, J IMMUNOL, V154, P6182; Obar JJ, 2010, ANN NY ACAD SCI, V1183, P251, DOI 10.1111/j.1749-6632.2009.05126.x; PANNETIER C, 1993, P NATL ACAD SCI USA, V90, P4319, DOI 10.1073/pnas.90.9.4319; POSNETT DN, 1994, J EXP MED, V179, P609, DOI 10.1084/jem.179.2.609; Ricalton NS, 1998, J GERONTOL A-BIOL, V53, pB196, DOI 10.1093/gerona/53A.3.B196; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Saurwein-Teissl M, 2002, J IMMUNOL, V168, P5893, DOI 10.4049/jimmunol.168.11.5893; Sebille F, 2001, J IMMUNOL, V167, P3082, DOI 10.4049/jimmunol.167.6.3082; Tan LC, 1999, J IMMUNOL, V162, P1827; Team RDC, 2010, R LANG ENV STAT COMP	29	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21240	10.1371/journal.pone.0021240	http://dx.doi.org/10.1371/journal.pone.0021240			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738624	Green Published, gold, Green Submitted			2022-12-27	WOS:000292092600021
J	Lu, SY; Kim, TJ; Chen, CE; Ouyang, M; Seong, J; Liao, XL; Wang, YX				Lu, Shaoying; Kim, Tae-jin; Chen, Chih-En; Ouyang, Mingxing; Seong, Jihye; Liao, Xiaoling; Wang, Yingxiao			Computational Analysis of the Spatiotemporal Coordination of Polarized PI3K and Rac1 Activities in Micro-Patterned Live Cells	PLOS ONE			English	Article							LOCALLY WEIGHTED REGRESSION; PHOSPHOINOSITIDE 3-KINASE; LIVING FIBROBLASTS; SPATIAL-ANALYSIS; ACTIN-FILAMENTS; MIGRATING CELLS; NEUTROPHIL CHEMOTAXIS; FOCAL ADHESIONS; GROWTH-FACTOR; ACTIVATION	Polarized molecular activities play important roles in guiding the cell toward persistent and directional migration. In this study, the polarized distributions of the activities of phosphatidylinositol 3-kinase (PI3K) and the Rac1 small GTPase were monitored using chimeric fluorescent proteins (FPs) in cells constrained on micro-patterned strips, with one end connecting to a neighboring cell (junction end) and the other end free of cell-cell contact (free end). The recorded spatiotemporal dynamics of the fluorescent intensity from different cells was scaled into a uniform coordinate system and applied to compute the molecular activity landscapes in space and time. The results revealed different polarization patterns of PI3K and Rac1 activity induced by the growth factor stimulation. The maximal intensity of different FPs, and the edge position and velocity at the free end were further quantified to analyze their correlation and decipher the underlying signaling sequence. The results suggest that the initiation of the edge extension occurred before the activation of PI3K, which led to a stable extension of the free end followed by the Rac1 activation. Therefore, the results support a concerted coordination of sequential signaling events and edge dynamics, underscoring the important roles played by PI3K activity at the free end in regulating the stable lamellipodia extension and cell migration. Meanwhile, the quantification methods and accompanying software developed can provide a convenient and powerful computational analysis platform for the study of spatiotemporal molecular distribution and hierarchy in live cells based on fluorescence images.	[Lu, Shaoying; Ouyang, Mingxing; Liao, Xiaoling; Wang, Yingxiao] Univ Illinois, Dept Bioengn, Champaign, IL USA; [Kim, Tae-jin; Seong, Jihye; Wang, Yingxiao] Univ Illinois, Neurosci Program, Champaign, IL USA; [Chen, Chih-En; Wang, Yingxiao] Univ Illinois, Beckman Inst Adv Sci & Technol, Champaign, IL USA; [Wang, Yingxiao] Univ Illinois, Ctr Biophys & Computat Biol, Dept Mol & Integrat Physiol, Champaign, IL USA; [Liao, Xiaoling] Chongqing Univ Sci & Technol, Inst Biomat & Living Cell Imaging Technol, Chongqing, Peoples R China	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Chongqing University of Science & Technology	Lu, SY (corresponding author), Univ Illinois, Dept Bioengn, Champaign, IL USA.	yingxiao@illinois.edu	Seong, Jihye/N-2132-2017; Ouyang, Mingxing/J-4529-2013; Ouyang, Mingxing/C-9130-2011; Ouyang, Mingxing/F-8907-2019; Ouyang, Mingxing/AAF-5896-2019	Seong, Jihye/0000-0001-8450-3315; Ouyang, Mingxing/0000-0002-2910-0713	NIH [HL098472, CA139272, NS063405]; NSF [CBET0846429, CMMI0800870]; NATIONAL CANCER INSTITUTE [R21CA139272] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098472] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063405] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is supported in part by grants NIH HL098472, CA139272, NS063405, NSF CBET0846429, and CMMI0800870. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ames W.F., 1977, NUMER METH PART D E; Beningo KA, 2001, J CELL BIOL, V153, P881, DOI 10.1083/jcb.153.4.881; Cantrell DA, 2001, J CELL SCI, V114, P1439; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; Dawes AT, 2007, BIOPHYS J, V92, P744, DOI 10.1529/biophysj.106.090514; Etienne-Manneville S, 2008, ONCOGENE, V27, P6970, DOI 10.1038/onc.2008.347; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Fok S, 2008, BIOPHYS J, V95, P1523, DOI 10.1529/biophysj.107.115246; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Giannone G, 2007, CELL, V128, P561, DOI 10.1016/j.cell.2006.12.039; Grande-Garcia A, 2007, J CELL BIOL, V177, P683, DOI 10.1083/jcb.200701006; Harris SJ, 2008, J BIOL CHEM, V283, P2465, DOI 10.1074/jbc.R700044200; Haugh JM, 2000, J CELL BIOL, V151, P1269, DOI 10.1083/jcb.151.6.1269; Haugh JM, 2004, BIOPHYS J, V86, P589, DOI 10.1016/S0006-3495(04)74137-5; HAWKINS PT, 1995, CURR BIOL, V5, P393, DOI 10.1016/S0960-9822(95)00080-7; Higashida C, 2004, SCIENCE, V303, P2007, DOI 10.1126/science.1093923; Hu K, 2007, SCIENCE, V315, P111, DOI 10.1126/science.1135085; Innocenti M, 2003, J CELL BIOL, V160, P17, DOI 10.1083/jcb.200206079; Inoue T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003068; Kim TJ, 2009, SMALL, V5, P1453, DOI 10.1002/smll.200801846; Koestler SA, 2008, NAT CELL BIOL, V10, P306, DOI 10.1038/ncb1692; Kovar DR, 2006, CURR OPIN CELL BIOL, V18, P11, DOI 10.1016/J.CEB.2005.12.011; Kurokawa K, 2005, BIOCHEM SOC T, V33, P631, DOI 10.1042/BST0330631; Lin XF, 2008, BIOPHYS J, V95, P3066, DOI 10.1529/biophysj.107.127761; Lu SY, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000127; Machacek M, 2009, NATURE, V461, P99, DOI 10.1038/nature08242; Michiels F, 1997, J CELL BIOL, V137, P387, DOI 10.1083/jcb.137.2.387; Moissoglu K, 2006, BIOL CELL, V98, P547, DOI 10.1042/BC20060025; Mouneimne G, 2006, CURR BIOL, V16, P2193, DOI 10.1016/j.cub.2006.09.016; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Ouyang MX, 2008, P NATL ACAD SCI USA, V105, P14353, DOI 10.1073/pnas.0807537105; Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765; Peng HC, 2008, BIOINFORMATICS, V24, P1827, DOI 10.1093/bioinformatics/btn346; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Sabass B, 2008, BIOPHYS J, V94, P207, DOI 10.1529/biophysj.107.113670; Sabouri-Ghomi M, 2008, CURR OPIN CELL BIOL, V20, P541, DOI 10.1016/j.ceb.2008.05.004; Schneider IC, 2005, J CELL BIOL, V171, P883, DOI 10.1083/jcb.200509028; Schneider IC, 2005, BIOPHYS J, V89, P1420, DOI 10.1529/biophysj.105.061218; Schneider IC, 2004, BIOPHYS J, V86, P599, DOI 10.1016/S0006-3495(04)74138-7; SEPPA H, 1982, J CELL BIOL, V92, P584, DOI 10.1083/jcb.92.2.584; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; Shi-wen X, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007438; Srinivasan S, 2003, J CELL BIOL, V160, P375, DOI 10.1083/jcb.200208179; Tan JL, 2003, P NATL ACAD SCI USA, V100, P1484, DOI 10.1073/pnas.0235407100; Urban E, 2010, NAT CELL BIOL, V12, P429, DOI 10.1038/ncb2044; Watanabe N, 2004, EXP CELL RES, V301, P16, DOI 10.1016/j.yexcr.2004.08.020; Weiger MC, 2010, BIOPHYS J, V98, P67, DOI 10.1016/j.bpj.2009.09.051; Weiger MC, 2009, J CELL SCI, V122, P313, DOI 10.1242/jcs.037564; Welch HCE, 2003, FEBS LETT, V546, P93, DOI 10.1016/S0014-5793(03)00454-X; Wiley HS, 2001, TRAFFIC, V2, P12, DOI 10.1034/j.1600-0854.2001.020103.x; Yamana N, 2006, MOL CELL BIOL, V26, P6844, DOI 10.1128/MCB.00283-06; Yang JM, 2009, SMALL, V5, P1984, DOI 10.1002/smll.200801559	56	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21293	10.1371/journal.pone.0021293	http://dx.doi.org/10.1371/journal.pone.0021293			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738630	Green Submitted, Green Published, gold			2022-12-27	WOS:000292092600026
J	Lucas, PJ; Cabral, C; Colford, JM				Lucas, Patricia J.; Cabral, Christie; Colford, John M., Jr.			Dissemination of Drinking Water Contamination Data to Consumers: A Systematic Review of Impact on Consumer Behaviors	PLOS ONE			English	Article							ARSENIC MITIGATION; CHANGE INTERVENTIONS; HEALTH; BANGLADESH; AWARENESS; GROUNDWATER; POPULATION; ARAIHAZAR	Background: Drinking water contaminated by chemicals or pathogens is a major public health threat in the developing world. Responses to this threat often require water consumers (households or communities) to improve their own management or treatment of water. One approach hypothesized to increase such positive behaviors is increasing knowledge of the risks of unsafe water through the dissemination of water contamination data. This paper reviews the evidence for this approach in changing behavior and subsequent health outcomes. Methods/Principal Findings: A systematic review was conducted for studies where results of tests for contaminants in drinking water were disseminated to populations whose water supply posed a known health risk. Studies of any design were included where data were available from a contemporaneous comparison or control group. Using multiple sources >14,000 documents were located. Six studies met inclusion criteria (four of arsenic contamination and two of microbiological contamination). Meta-analysis was not possible in most cases due to heterogeneity of outcomes and study designs. Outcomes included water quality, change of water source, treatment of water, knowledge of contamination, and urinary arsenic. Source switching was most frequently reported: of 5 reporting studies 4 report significantly higher rates of switching (26-72%) among those who received a positive test result and a pooled risk difference was calculate for 2 studies (RD = 0.43 [CI0.4.0-0.46] 6-12 months post intervention) suggesting 43% more of those with unsafe wells switched source compared to those with safe wells. Strength of evidence is low since the comparison is between non-equivalent groups. Two studies concerning fecal contamination reported non-significant increases in point-of-use water treatment. Conclusion: Despite the publication of some large cohort studies and some encouraging results the evidence base to support dissemination of contamination data to improve water management is currently equivocal. Rigorous studies on this topic are needed, ideally using common outcome measures.	[Lucas, Patricia J.] Univ Bristol, Sch Policy Studies, Bristol, Avon, England; [Cabral, Christie] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Colford, John M., Jr.] Univ Calif Berkeley, Sch Publ Hlth, Div Epidemiol, Berkeley, CA 94720 USA	University of Bristol; University of Bristol; University of California System; University of California Berkeley	Lucas, PJ (corresponding author), Univ Bristol, Sch Policy Studies, Bristol, Avon, England.	patricia.lucas@bristol.ac.uk	Lucas, Patricia/P-5349-2017	Colford, John/0000-0002-3288-6956; Cabral, Christie/0000-0002-9884-0555; Lucas, Patricia Jane/0000-0002-0469-8085	Bill and Melinda Gates Foundation	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was funded by the Bill and Melinda Gates Foundation (http://www.gatesfoundation.org/) with the Aquatest Project (http://www.bris.ac.uk/aquatest/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahsan H, 2006, J EXPO SCI ENV EPID, V16, P191, DOI 10.1038/sj.jea.7500449; Arnold B, 2009, INT J EPIDEMIOL, V38, P1651, DOI 10.1093/ije/dyp241; Boschi-Pinto C, 2008, B WORLD HEALTH ORGAN, V86, P710, DOI 10.2471/BLT.07.050054; BYLEVELD P, 2000, ASSESSMENT COLILERT; Chen Y, 2007, ENVIRON HEALTH PERSP, V115, P917, DOI 10.1289/ehp.9833; Craig Peter, 2008, BMJ, V337, pa1655, DOI 10.1136/bmj.a1655; Dewilde CK, 2008, HEALTH POLICY PLANN, V23, P452, DOI 10.1093/heapol/czn017; GODFREY S, 2010, SAFE ARE GLOBAL WATE; *GOV UTT, 2005, UTT RUR WAT SUPPL EN; Hadi A, 2003, HEALTH POLICY PLANN, V18, P93, DOI 10.1093/heapol/18.1.93; Hanchett S, 2002, HEALTH POLICY PLANN, V17, P393, DOI 10.1093/heapol/17.4.393; HANCHETT S, 2004, SOCIAL ASPECTS ARSEN; Hardeman W, 2002, PSYCHOL HEALTH, V17, P123, DOI 10.1080/08870440290013644a; *HLTH CAN, 2008, 1 NAT IN AB HLTH DRI; HOWARD G, 2002, EFFECTIVE APPROACHES; HOWARD G, 1999, REPORT WATERS SUPPLY; Hussam A, 2007, J ENVIRON SCI HEAL A, V42, P1869, DOI 10.1080/10934520701567122; *IDRC, 1996, PRES ABS PROGR EV RE; Jakus PM, 2009, WATER RESOUR RES, V45, DOI 10.1029/2008WR007427; Jalan J, 2008, J DEV ECON, V87, P14, DOI 10.1016/j.jdeveco.2007.10.002; Jalan J, 2009, ENVIRON DEV ECON, V14, P665, DOI 10.1017/S1355770X08005020; Johnston RB, 2007, J ENVIRON SCI HEAL A, V42, P1889, DOI 10.1080/10934520701567155; Joyce KE, 2010, J PUBLIC HEALTH-UK, V32, P283, DOI 10.1093/pubmed/fdq026; Levy K, 2009, ENVIRON SCI TECHNOL, V43, P1788, DOI 10.1021/es8022545; *LIV LEARN, 2006, INTR GUID COMM MOB M, V3; LUOTO J, 2009, INFORM PERSUASION AC; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Madajewicz M, 2007, J DEV ECON, V84, P731, DOI 10.1016/j.jdeveco.2006.12.002; Mausezahl D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000125; Michie S, 2008, J HEALTH SERV RES PO, V13, P64, DOI 10.1258/jhsrp.2008.008014; Michie S, 2008, ADDICTION, V103, P1409, DOI 10.1111/j.1360-0443.2008.02291.x; MISHRA VK, 2008, 33 WEDC INT C ACCR G; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; *NIOEH, 2007, SETT MOD COMM DRINK; Opar A, 2007, HEALTH PLACE, V13, P164, DOI 10.1016/j.healthplace.2005.11.004; *OR RDDGO, 2009, RUR WAT SUPPL HIGHL; Pang T, 2007, B WORLD HEALTH ORGAN, V85, P247, DOI 10.2471/BLT.07.040824; Parvez F, 2006, ENVIRON HEALTH PERSP, V114, P355, DOI 10.1289/ehp.7903; ROSENBOOM JW, 2004, NOT JUST RED GREEN A; RUSSELL CS, 2001, INVESTING WATER QUAL; *SAM VIK DEV SUPP, 2008, GOV ANTHR PRAD RUR W; SANCHEZ A, 1998, COMMUNITY BASED WATE; Shiell A, 2008, BMJ-BRIT MED J, V336, P1281, DOI 10.1136/bmj.39569.510521.AD; Spiegelhalter DJ, 2008, ANN FAM MED, V6, P196, DOI 10.1370/afm.848; TAROZZI A, 2010, SUBJECTIVE RISK ASSE; TAROZZI A, 2011, COMMUNICATION; Thompson T., 2007, CHEM SAFETY DRINKING; TUN TN, 2003, 29 WEDC INT C MILL D; UKOLI G, DESIGNING OPTIMAL WA; *UN, 2007, LIF SAV HYG PROGR ST; *UN, 2003, AR SEA DROUGHT UN; *UNICEF, 2008, PROM HOUS WAT TREATM; *UNICEF, WAT AL; van Geen A, 2002, B WORLD HEALTH ORGAN, V80, P732; VANDERTAK S, INNOVATIVE ACTIONS C; Waddington H., 2009, WATER SANITATION HYG; Waddington H, 2009, J DEV EFFECT, V1, P295, DOI 10.1080/19439340903141175; *WATERAID, 2002, ARS 2002 OV ARS ISS, P130; WEINSTEIN ND, 1993, HEALTH PSYCHOL, V12, P324, DOI 10.1037/0278-6133.12.4.324; *WHO, 2007, CHEM SAF DRINK WAT A; WHO, 2003, ASS MICR SAF DRINK W; *WHO, 2010, RIGHT WAT; WHO & UNICEF, 2005, WAT LIF MAK IT HAPP; Witte K, 2000, HEALTH EDUC BEHAV, V27, P591, DOI 10.1177/109019810002700506; World Health Organization, 2008, The global burden of disease: 2004 update; Zwane AP, 2007, WORLD BANK RES OBSER, V22, P1, DOI 10.1093/wbro/lkm002	67	26	26	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21098	10.1371/journal.pone.0021098	http://dx.doi.org/10.1371/journal.pone.0021098			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	783OD	21738609	Green Published, gold, Green Submitted			2022-12-27	WOS:000292092600011
J	Boeuf, P; Hasang, W; Hanssen, E; Glazier, JD; Rogerson, SJ				Boeuf, Philippe; Hasang, Wina; Hanssen, Eric; Glazier, Jocelyn D.; Rogerson, Stephen J.			Relevant Assay to Study the Adhesion of Plasmodium falciparum-Infected Erythrocytes to the Placental Epithelium	PLOS ONE			English	Article							CHONDROITIN SULFATE; GENE-EXPRESSION; MEMBRANE; PREGNANCY; ADHERENCE; TRANSPORT; BINDING; ACID	In placental malaria, Plasmodium falciparum-infected erythrocytes adhere to the apical plasma membrane of the placental epithelium, triggering an impairment of placental function detrimental to the fetus. The design of anti-adhesion intervention strategies requires a detailed understanding of the mechanisms involved. However, most adhesion assays lack in vivo relevance and are hardly quantitative. Here, we describe a flow cytometry-based adhesion assay that is fully relevant by using apical epithelial plasma membrane vesicles as the adhesion matrix, and being applicable to infected erythrocytes directly isolated from patients. Adhesion is measured both as the percentage of pathogens bound to epithelial membrane vesicles as well as the mean number of vesicles bound per infected erythrocytes. We show that adhesins alternative to those currently identified could be involved. This demonstrates the power of this assay to advance our understanding of epithelial adhesion of infected erythrocytes and in the design of intervention strategies.	[Boeuf, Philippe; Hasang, Wina; Rogerson, Stephen J.] Univ Melbourne, Royal Melbourne Hosp, Dept Med, RMH WH, Melbourne, Vic 3050, Australia; [Hanssen, Eric] Univ Melbourne, Inst Bio21, Electron Microscopy Unit, Melbourne, Vic 3050, Australia; [Hanssen, Eric] La Trobe Univ, Dept Biochem, Melbourne, Vic, Australia; [Glazier, Jocelyn D.] Univ Manchester, St Marys Hosp, Maternal & Fetal Hlth Res Ctr, Sch Med,Manchester Acad Hlth Sci Ctr, Manchester M13 0JH, Lancs, England	Royal Melbourne Hospital; University of Melbourne; University of Melbourne; La Trobe University; University of Manchester	Boeuf, P (corresponding author), Univ Melbourne, Royal Melbourne Hosp, Dept Med, RMH WH, Melbourne, Vic 3050, Australia.	pboeuf@unimelb.edu.au	Hanssen, Eric/A-7217-2013	Hanssen, Eric/0000-0002-4064-1844; Rogerson, Stephen/0000-0003-4287-1982; Hasang, Wina/0000-0001-8664-7558; Harrison, Robert/0000-0003-1186-6056; Boeuf, Philippe/0000-0002-5851-3373	Australian NHMRC [509185]; ARC/NHMRC Research Network for Parasitology; University of Melbourne	Australian NHMRC(National Health and Medical Research Council (NHMRC) of Australia); ARC/NHMRC Research Network for Parasitology(Australian Research CouncilNational Health and Medical Research Council (NHMRC) of Australia); University of Melbourne(University of Melbourne)	The Australian NHMRC (http://www.nhmrc.gov.au; project grant 509185 to SJR and JDG), the ARC/NHMRC Research Network for Parasitology (http://parasite.org.au/arcnet; Researcher Exchange Award to PB) and an Early Career Researcher Grant from The University of Melbourne (http://www.unimelb.edu.au; to PB) funded this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avril M, 2004, MICROBES INFECT, V6, P249, DOI 10.1016/j.micinf.2003.12.007; Beeson JG, 2007, J BIOL CHEM, V282, P22426, DOI 10.1074/jbc.M700231200; Beeson JG, 2004, J INFECT DIS, V189, P169, DOI 10.1086/380975; Biber J, 2007, NAT PROTOC, V2, P1356, DOI 10.1038/nprot.2007.156; Domenech P, 2009, MICROBIOL-SGM, V155, P3532, DOI 10.1099/mic.0.029199-0; Feltis BA, 2001, J SURG RES, V97, P97, DOI 10.1006/jsre.2001.6130; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; Gaynor EC, 2004, J BACTERIOL, V186, P503, DOI 10.1128/JB.186.2.503-517.2004; Glazier JD, 2006, METH MOLEC MED, V122, P241; Goyal A, 2009, EXP PARASITOL, V123, P105, DOI 10.1016/j.exppara.2009.06.001; Hommel M, 2010, INFECT IMMUN, V78, P1963, DOI 10.1128/IAI.01365-09; Joergensen L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001083; KESSLER M, 1978, BIOCHIM BIOPHYS ACTA, V506, P136, DOI 10.1016/0005-2736(78)90440-6; Kim M, 2010, CELL HOST MICROBE, V8, P20, DOI 10.1016/j.chom.2010.06.006; LOVELESS RW, 1992, INFECT IMMUN, V60, P4015, DOI 10.1128/IAI.60.10.4015-4023.1992; Madhunapantula SV, 2007, INFECT IMMUN, V75, P4409, DOI 10.1128/IAI.00478-07; Nochi T, 2007, J EXP MED, V204, P2789, DOI 10.1084/jem.20070607; PELLETIER X, 1986, BIOCHIM BIOPHYS ACTA, V856, P267, DOI 10.1016/0005-2736(86)90036-2; Pentecost M, 2006, PLOS PATHOG, V2, P29, DOI 10.1371/journal.ppat.0020003; Peters JM, 2007, J INFECT DIS, V195, P748, DOI 10.1086/511436; PEZZULO AA, 2010, AM J PHYSL LUNG CELL; Rogerson SJ, 2007, LANCET INFECT DIS, V7, P105, DOI 10.1016/S1473-3099(07)70022-1; Salanti A, 2004, J EXP MED, V200, P1197, DOI 10.1084/jem.20041579; Sidhaye VK, 2008, P NATL ACAD SCI USA, V105, P3345, DOI 10.1073/pnas.0712287105; Sood R, 2006, P NATL ACAD SCI USA, V103, P5478, DOI 10.1073/pnas.0508035103; Winter SE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001060; Wyatt SM, 2005, PLACENTA, V26, P372, DOI 10.1016/j.placenta.2004.07.003; Yeo TW, 2008, INT J PARASITOL, V38, pS35, DOI 10.1016/S0020-7519(07)00459-6; Yosaatmadja F, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-51	29	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21126	10.1371/journal.pone.0021126	http://dx.doi.org/10.1371/journal.pone.0021126			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21731654	Green Published, gold			2022-12-27	WOS:000292036900010
J	Chen, ZS; Li, J; Xiao, YN; Zhang, JJ; Zhao, YY; Liu, YX; Ma, CC; Qiu, YM; Luo, J; Huang, GW; Korteweg, C; Gu, J				Chen, Zhengshan; Li, Jing; Xiao, Yanna; Zhang, Junjun; Zhao, Yingying; Liu, Yuxuan; Ma, Changchun; Qiu, Yamei; Luo, Jin; Huang, Guowei; Korteweg, Christine; Gu, Jiang			Immunoglobulin G Locus Events in Soft Tissue Sarcoma Cell Lines	PLOS ONE			English	Article							INDUCED CYTIDINE DEAMINASE; HEAVY-CHAIN LOCUS; CLASS SWITCH RECOMBINATION; EPITHELIAL CANCER-CELLS; V(D)J RECOMBINATION; GENE REARRANGEMENTS; B-CELLS; EXPRESSION; ACTIVATION; ENHANCER	Recently immunoglobulins (Igs) have been found to be expressed by cells other than B lymphocytes, including various human carcinoma cells. Sarcomas are derived from mesenchyme, and the knowledge about the occurrence of Ig production in sarcoma cells is very limited. Here we investigated the phenomenon of immunoglobulin G (IgG) expression and its molecular basis in 3 sarcoma cell lines. The mRNA transcripts of IgG heavy chain and kappa light chain were detected by RTPCR. In addition, the expression of IgG proteins was confirmed by Western blot and immunofluorescence. Immuno-electron microscopy localized IgG to the cell membrane and rough endoplasmic reticulum. The essential enzymes required for gene rearrangement and class switch recombination, and IgG germ-line transcripts were also identified in these sarcoma cells. Chromatin immunoprecipitation results demonstrated histone H3 acetylation of both the recombination activating gene and Ig heavy chain regulatory elements. Collectively, these results confirmed IgG expression in sarcoma cells, the mechanism of which is very similar to that regulating IgG expression in B lymphocytes.	[Chen, Zhengshan; Li, Jing; Xiao, Yanna; Zhang, Junjun; Ma, Changchun; Qiu, Yamei; Luo, Jin; Huang, Guowei; Korteweg, Christine; Gu, Jiang] Shantou Univ Med Coll, Dept Pathol, Shantou, Peoples R China; [Zhao, Yingying; Liu, Yuxuan; Gu, Jiang] Peking Beijing Univ Hlth Sci Ctr, Dept Pathol, Beijing, Peoples R China	Peking University	Chen, ZS (corresponding author), Shantou Univ Med Coll, Dept Pathol, Shantou, Peoples R China.	jguemailbox@gmail.com	Chen, Zhengshan/J-7499-2014; Ma, Changchun/AAI-4282-2020; Liu, Yuxuan/F-4226-2018	Gu, Jiang/0000-0002-0706-8329; Liu, Yuxuan/0000-0003-4426-9290	National Natural Science Foundation of China [81001199, 81030033, 30971150, 30950110335]; Guangdong Colleges and Universities [LYM10079]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Colleges and Universities	This work was supported by grants (81001199 to ZC, 81030033, 30971150 to JG, 30950110335 to KC) from the National Natural Science Foundation of China, and grant LYM10079 to ZC from the Innovative Talents Program of Guangdong Colleges and Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babbage G, 2006, CANCER RES, V66, P3996, DOI 10.1158/0008-5472.CAN-05-3704; Bolland DJ, 2004, NAT IMMUNOL, V5, P630, DOI 10.1038/ni1068; Busslinger M, 2004, ANNU REV IMMUNOL, V22, P55, DOI 10.1146/annurev.immunol.22.012703.104807; CALAME KL, 1985, ANNU REV IMMUNOL, V3, P159, DOI 10.1146/annurev.iy.03.040185.001111; Chen W, 2009, AM J SURG PATHOL, V33, P863, DOI 10.1097/PAS.0b013e31819287b8; Chen ZS, 2010, CANCER-AM CANCER SOC, V116, P1953, DOI 10.1002/cncr.24892; Chen ZS, 2009, AM J PATHOL, V174, P1139, DOI 10.2353/ajpath.2009.080879; COGNE M, 1994, CELL, V77, P737, DOI 10.1016/0092-8674(94)90057-4; Henderson A, 1998, ANNU REV IMMUNOL, V16, P163, DOI 10.1146/annurev.immunol.16.1.163; Hesslein DGT, 2003, GENE DEV, V17, P37, DOI 10.1101/gad.1031403; Hsu LY, 2003, IMMUNITY, V19, P105, DOI 10.1016/S1074-7613(03)00181-X; Huang J, 2008, INT J BIOCHEM CELL B, V40, P1604, DOI 10.1016/j.biocel.2007.12.004; Huang J, 2009, J HISTOCHEM CYTOCHEM, V57, P339, DOI 10.1369/jhc.2008.951434; Jung D, 2006, ANNU REV IMMUNOL, V24, P541, DOI 10.1146/annurev.immunol.23.021704.115830; Kuo TC, 2009, CURR OPIN IMMUNOL, V21, P173, DOI 10.1016/j.coi.2009.03.008; Lansford R, 1998, INT IMMUNOL, V10, P325, DOI 10.1093/intimm/10.3.325; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Morshead KB, 2003, P NATL ACAD SCI USA, V100, P11577, DOI 10.1073/pnas.1932643100; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Niu N, 2011, INT J BIOCHEM CELL B, V43, P556, DOI 10.1016/j.biocel.2010.12.012; Perlot T, 2005, P NATL ACAD SCI USA, V102, P14362, DOI 10.1073/pnas.0507090102; Qiu XY, 2003, CANCER RES, V63, P6488; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Reynaud D, 2008, NAT IMMUNOL, V9, P927, DOI 10.1038/ni.1626; Sakai E, 1999, INT IMMUNOL, V11, P1709, DOI 10.1093/intimm/11.10.1709; SCHATZ DG, 1992, ANNU REV IMMUNOL, V10, P359, DOI 10.1146/annurev.iy.10.040192.002043; SCHLISSEL M, 1991, GENE DEV, V5, P1367, DOI 10.1101/gad.5.8.1367; SCHLISSEL MS, 1989, CELL, V58, P1001, DOI 10.1016/0092-8674(89)90951-3; SERWE M, 1993, EMBO J, V12, P2321, DOI 10.1002/j.1460-2075.1993.tb05886.x; YANCOPOULOS GD, 1985, CELL, V40, P271, DOI 10.1016/0092-8674(85)90141-2; Zhang SA, 2010, CELL MOL LIFE SCI, V67, P985, DOI 10.1007/s00018-009-0231-z; Zhao YY, 2011, J HISTOCHEM CYTOCHEM, V59, P474, DOI 10.1369/0022155411400871; Zheng H, 2007, MOL IMMUNOL, V44, P2221, DOI 10.1016/j.molimm.2006.11.010; Zheng J, 2009, J BIOL CHEM, V284, P13610, DOI 10.1074/jbc.M809524200	35	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21276	10.1371/journal.pone.0021276	http://dx.doi.org/10.1371/journal.pone.0021276			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731691	Green Published, gold, Green Submitted			2022-12-27	WOS:000292035400018
J	Holmes, AB; Hawson, A; Liu, F; Friedman, C; Khiabanian, H; Rabadan, R				holmes, Antony B.; Hawson, Alexander; Liu, Feng; Friedman, Carol; Khiabanian, Hossein; Rabadan, Raul			Discovering Disease Associations by Integrating Electronic Clinical Data and Medical Literature	PLOS ONE			English	Article							KAWASAKI-DISEASE; HEALTH RECORDS; TRAUMATIC STRESS; KAPOSIS-SARCOMA; VACCINATION; SYSTEM; AUTISM; PATHOGENESIS; CHALLENGES; INFECTION	Electronic health record (EHR) systems offer an exceptional opportunity for studying many diseases and their associated medical conditions within a population. The increasing number of clinical record entries that have become available electronically provides access to rich, large sets of patients' longitudinal medical information. By integrating and comparing relations found in the EHRs with those already reported in the literature, we are able to verify existing and to identify rare or novel associations. Of particular interest is the identification of rare disease co-morbidities, where the small numbers of diagnosed patients make robust statistical analysis difficult. Here, we introduce ADAMS, an Application for Discovering Disease Associations using Multiple Sources, which contains various statistical and language processing operations. We apply ADAMS to the New York-Presbyterian Hospital's EHR to combine the information from the relational diagnosis tables and textual discharge summaries with those from PubMed and Wikipedia in order to investigate the co-morbidities of the rare diseases Kaposi sarcoma, toxoplasmosis, and Kawasaki disease. In addition to finding well-known characteristics of diseases, ADAMS can identify rare or previously unreported associations. In particular, we report a statistically significant association between Kawasaki disease and diagnosis of autistic disorder.	[holmes, Antony B.; Liu, Feng; Friedman, Carol; Khiabanian, Hossein; Rabadan, Raul] Columbia Univ Coll Phys & Surg, Dept Biomed Informat, New York, NY 10032 USA; [holmes, Antony B.; Hawson, Alexander; Khiabanian, Hossein; Rabadan, Raul] Columbia Univ Coll Phys & Surg, Ctr Computat Biol & Bioinformat, New York, NY 10032 USA; [Hawson, Alexander] Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University	Holmes, AB (corresponding author), Columbia Univ Coll Phys & Surg, Dept Biomed Informat, 630 W 168th St, New York, NY 10032 USA.	hossein@c2b2.columbia.edu	Rabadan, Raul/AAZ-7367-2020; Khiabanian, Hossein/N-7207-2019	Khiabanian, Hossein/0000-0003-1446-4394; Rabadan, Raul/0000-0001-7946-9255	Northeast Biodefense Center [U54-AI057158]; National Library of Medicine Eureka [1R01LM010140-01]; National Library of Medicine [LM008635]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057158] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM010140, R01LM010016] Funding Source: NIH RePORTER	Northeast Biodefense Center; National Library of Medicine Eureka(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by awards from the Northeast Biodefense Center grant U54-AI057158, the National Library of Medicine Eureka grant 1R01LM010140-01 and the National Library of Medicine grant LM008635. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Association AP DSM-IV APA on, 2000, DIAGN STAT MAN MENT; Carlo Lorena, 2010, AMIA Annu Symp Proc, V2010, P91; *CDCP, 2010, INT CLASS DIS ICD 9; Centers for Disease Control and Prevention, 1993, 1993 REV CLASS SYST; Chang Huan J, 2010, JAMA, V303, P1328, DOI 10.1001/jama.303.13.1328; Chase HS, 2010, J AM MED INFORM ASSN, V17, P588, DOI 10.1136/jamia.2009.001396; Chen H, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-147; de los Reyes EC, 2010, ARCH NEUROL-CHICAGO, V67, P490, DOI 10.1001/archneurol.2010.57; ELKLIT A, 2010, BR J CLIN PSYCHOL; ENSOLI B, 1991, HEMATOL ONCOL CLIN N, V5, P281, DOI 10.1016/S0889-8588(18)30441-6; Fletcher S, 2010, AUST NZ J PSYCHIAT, V44, P1064, DOI 10.3109/00048674.2010.509858; FRIEDMAN C, 1994, J AM MED INFORM ASSN, V1, P161, DOI 10.1136/jamia.1994.95236146; Gallagher CM, 2010, J TOXICOL ENV HEAL A, V73, P1665, DOI 10.1080/15287394.2010.519317; Goldstein LB, 1998, STROKE, V29, P1602, DOI 10.1161/01.STR.29.8.1602; Hendy J, 2005, BMJ-BRIT MED J, V331, P331, DOI 10.1136/bmj.331.7512.331; Hua W, 2009, PEDIATR INFECT DIS J, V28, P943, DOI 10.1097/INF.0b013e3181a66471; Jensen LJ, 2006, NAT REV GENET, V7, P119, DOI 10.1038/nrg1768; Kaplan Jonathan E., 2009, Morbidity and Mortality Weekly Report, V58, P1; Kaposi M., 1872, ARCH DERMATOL SYPHIL, V4, P265, DOI 10.1007/BF01830024; KASPER LH, 2008, TOXOPLASMA INFECTION, pCH207; KATO H, 2007, CARDIOVASCULAR MED, P979; KAWASAKI T, 1995, JPN HEART J, V36, P1; Khiabanian H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012658; Krallinger M, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-224; LANGFORD CA, 2008, VASCULITIS SYNDROMES, pCH319; Levenshtein VI, 1966, SOV PHYS DOKL, V10, P707; Lim ST, 2005, CANCER-AM CANCER SOC, V103, P417, DOI 10.1002/cncr.20780; LINDBERG DAB, 1993, METHOD INFORM MED, V32, P281, DOI 10.1055/s-0038-1634945; Lobach DF, 2007, AM J PREV MED, V32, pS104, DOI 10.1016/j.amepre.2007.01.018; Majewska MD, 2010, ACTA NEUROBIOL EXP, V70, P196; McCarthy EP, 2000, MED CARE, V38, P868, DOI 10.1097/00005650-200008000-00010; *MEDIAWIKI, 2010, API; MORENS DM, 1980, PEDIATRICS, V65, P21; Mrozek-Budzyn D, 2010, PEDIATR INFECT DIS J, V29, P397, DOI 10.1097/INF.0b013e3181c40a8a; Navarro G, 2001, ACM COMPUT SURV, V33, P31, DOI 10.1145/375360.375365; OKOSIEME O, 2010, QJM, V103, P1; OKSENHENDLER E, 1994, AIDS, V8, P483, DOI 10.1097/00002030-199404000-00010; Robertson A, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4564; Ruiz-Casado M, 2005, LECT NOTES COMPUT SC, V3528, P380; Rzhetsky A, 2004, J BIOMED INFORM, V37, P43, DOI 10.1016/j.jbi.2003.10.001; Sam LT, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S2-S8; Schildcrout JS, 2010, J BIOMED INFORM, V43, P914, DOI 10.1016/j.jbi.2010.07.011; Shea S, 2010, NEW ENGL J MED, V362, P192, DOI 10.1056/NEJMp0910140; SIEGAL B, 1990, CANCER, V65, P492, DOI 10.1002/1097-0142(19900201)65:3<492::AID-CNCR2820650320>3.0.CO;2-C; Suri V, 2010, RHEUMATOL INT, V30, P1503, DOI 10.1007/s00296-009-1098-x; Tabarki B, 2001, PEDIATR NEUROL, V25, P239, DOI 10.1016/S0887-8994(01)00290-9; Thorp Jeremy, 2010, J AHIMA, V81, P56; Ursano RJ, 2010, ANN NY ACAD SCI, V1208, P72, DOI 10.1111/j.1749-6632.2010.05721.x; Wang XY, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S9-S13; Weyand CM, 2003, NEW ENGL J MED, V349, P160, DOI 10.1056/NEJMra022694; Yeung RSM, 2010, CURR OPIN RHEUMATOL, V22, P551, DOI 10.1097/BOR.0b013e32833cf051; Zesch Torsten, 2007, BIANN C SOC COMP LIN	52	37	37	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21132	10.1371/journal.pone.0021132	http://dx.doi.org/10.1371/journal.pone.0021132			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731656	Green Published, Green Submitted, gold			2022-12-27	WOS:000292035400009
J	Nunes, GLC; Simoes, A; Dyszy, FH; Shida, CS; Juliano, MA; Juliano, L; Gesteira, TF; Nader, HB; Murphy, G; Chaffotte, AF; Goldberg, ME; Tersariol, ILS; Almeida, PC				Nunes, Gabriel L. C.; Simoes, Alyne; Dyszy, Fabio H.; Shida, Claudio S.; Juliano, Maria A.; Juliano, Luiz; Gesteira, Tarsis F.; Nader, Helena B.; Murphy, Gillian; Chaffotte, Alain F.; Goldberg, Michel E.; Tersariol, Ivarne L. S.; Almeida, Paulo C.			Mechanism of Heparin Acceleration of Tissue Inhibitor of Metalloproteases-1 (TIMP-1) Degradation by the Human Neutrophil Elastase	PLOS ONE			English	Article							HUMAN-LEUKOCYTE ELASTASE; SECRETORY LEUKOPROTEASE INHIBITOR; PORCINE PANCREATIC ELASTASE; CATHEPSIN-G; ALPHA(1)-PROTEINASE INHIBITOR; MATRIX METALLOPROTEINASES; SUBSTRATE-SPECIFICITY; SULFATE PROTEOGLYCANS; SERINE PROTEASES; TERMINAL DOMAIN	Heparin has been shown to regulate human neutrophil elastase (HNE) activity. We have assessed the regulatory effect of heparin on Tissue Inhibitor of Metalloproteases-1 [TIMP-1] hydrolysis by HNE employing the recombinant form of TIMP-1 and correlated FRET-peptides comprising the TIMP-1 cleavage site. Heparin accelerates 2.5-fold TIMP-1 hydrolysis by HNE. The kinetic parameters of this reaction were monitored with the aid of a FRET-peptide substrate that mimics the TIMP-1 cleavage site in pre-steady-state conditionsby using a stopped-flow fluorescence system. The hydrolysis of the FRET-peptide substrate by HNE exhibits a pre-steady-state burst phase followed by a linear, steady-state pseudo-first-order reaction. The HNE acylation step (k(2)=21 +/- 1 s(-1)) was much higher than the HNE deacylation step (k(3)=0.57 +/- 0.05 s(-1)). The presence of heparin induces a dramatic effect in the pre-steady-state behavior of HNE. Heparin induces transient lag phase kinetics in HNE cleavage of the FRET-peptide substrate. The pre-steady-state analysis revealed that heparin affects all steps of the reaction through enhancing the ES complex concentration, increasing k(1) 2.4-fold and reducing k(-1) 3.1-fold. Heparin also promotes a 7.8-fold decrease in the k(2) value, whereas the k(3) value in the presence of heparin was increased 58-fold. These results clearly show that heparin binding accelerates deacylation and slows down acylation. Heparin shifts the HNE pH activity profile to the right, allowing HNE to be active at alkaline pH. Molecular docking and kinetic analysis suggest that heparin induces conformational changes in HNE structure. Here, we are showing for the first time that heparin is able to accelerate the hydrolysis of TIMP-1 by HNE. The degradation of TIMP-1is associated to important physiopathological states involving excessive activation of MMPs.	[Nunes, Gabriel L. C.; Shida, Claudio S.; Tersariol, Ivarne L. S.; Almeida, Paulo C.] Univ Mogi das Cruzes, Ctr Interdisciplinar Invest Bioquim, Mogi Das Cruzes, Brazil; [Simoes, Alyne] Univ Sao Paulo, Dept Mat Dent, Sao Paulo, Brazil; [Dyszy, Fabio H.] Univ Sao Paulo, Grp Biofis Mol, Sao Paulo, Brazil; [Nunes, Gabriel L. C.; Juliano, Maria A.; Juliano, Luiz] Univ Fed Sao Paulo, Dept Biofis, Sao Paulo, Brazil; [Gesteira, Tarsis F.; Nader, Helena B.; Tersariol, Ivarne L. S.; Almeida, Paulo C.] Univ Fed Sao Paulo, Dept Bioquim, Sao Paulo, Brazil; [Murphy, Gillian] Univ Cambridge, Dept Oncol, Cambridge, England; [Chaffotte, Alain F.] Inst Pasteur, Unite Resonance Magnet Nucl Biomol, Paris, France; [Goldberg, Michel E.] Inst Pasteur, Unite Repliement & Modelisat Prot, Paris, France	Universidade de Mogi das Cruzes; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); University of Cambridge; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Nunes, GLC (corresponding author), Univ Mogi das Cruzes, Ctr Interdisciplinar Invest Bioquim, Mogi Das Cruzes, Brazil.	ivarne@umc.br; pcezaral@gmail.com	Nader, Helena Bonciani/D-9253-2012; Dyszy, Fábio/F-6782-2012; de Almeida, Paulo C/D-8285-2014; Shida, Claudio/H-3473-2013; Juliano, Luiz/D-7204-2012; Complexos, INCT Fluidos/H-9172-2013; Dos Santos Tersariol, Ivarne Luis/G-4042-2012; Simoes, Alyne/G-2176-2012	de Almeida, Paulo C/0000-0002-5136-5152; Juliano, Luiz/0000-0002-5589-2822; Dos Santos Tersariol, Ivarne Luis/0000-0002-8399-4535; Simoes, Alyne/0000-0002-4873-1393; NADER, HELENA/0000-0002-7569-2166	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [FAPESP]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [CNPq]; Fundacao de Amparo a Pesquisa [FAEP]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [FAPESP](Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [CNPq](Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa [FAEP]	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [FAPESP], Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [CNPq] and Fundacao de Amparo a Pesquisa [FAEP]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Sabin J, 2004, STROKE, V35, P1316, DOI 10.1161/01.STR.0000126827.69286.90; BAICI A, 1980, BIOCHEM PHARMACOL, V29, P1723, DOI 10.1016/0006-2952(80)90131-8; Bekhouche M, 2010, J BIOL CHEM, V285, P15950, DOI 10.1074/jbc.M109.086447; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; BODE W, 1989, BIOCHEMISTRY-US, V28, P1951, DOI 10.1021/bi00431a001; Bord S, 1997, J ANAT, V191, P39, DOI 10.1046/j.1469-7580.1997.19110039.x; Campbell EJ, 2007, J BIOL CHEM, V282, P14645, DOI 10.1074/jbc.M608346200; Chan SCH, 2009, AM J RESP CELL MOL, V41, P620, DOI 10.1165/rcmb.2008-0185OC; Coombs GS, 1999, J BIOL CHEM, V274, P24074, DOI 10.1074/jbc.274.34.24074; CRABBE T, 1993, EUR J BIOCHEM, V218, P431, DOI 10.1111/j.1432-1033.1993.tb18393.x; FROMMHERZ KJ, 1991, J BIOL CHEM, V266, P15356; Gandhi NS, 2008, BIOCHEMISTRY-US, V47, P4851, DOI 10.1021/bi702455e; Garcia-Verdugo I, 2010, BIOCHIMIE, V92, P1608, DOI 10.1016/j.biochi.2010.05.010; GASTEIGER J, 1981, ORG MAGN RESONANCE, V15, P353, DOI 10.1002/mrc.1270150408; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Gotte M, 2003, FASEB J, V17, P575, DOI 10.1096/fj.02-0739rev; Groth I, 2008, PLANTA MED, V74, P852, DOI 10.1055/s-2008-1074549; Hedstrom L, 1996, BIOCHEMISTRY-US, V35, P4515, DOI 10.1021/bi951928k; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; HESS GP, 1970, PHILOS T ROY SOC B, V257, P89, DOI 10.1098/rstb.1970.0011; Hirata IY, 1995, LETT PEPT SCI, V1, P299, DOI DOI 10.1007/BF00119771; ITOH Y, 1995, J BIOL CHEM, V270, P16518, DOI 10.1074/jbc.270.28.16518; Jackson PL, 2010, MOL MED, V16, P159, DOI 10.2119/molmed.2009.00109; JORDAN RE, 1987, SCIENCE, V237, P777, DOI 10.1126/science.3649921; JORDAN RE, 1989, J BIOL CHEM, V264, P10493; Kainulainen V, 1998, J BIOL CHEM, V273, P11563, DOI 10.1074/jbc.273.19.11563; Koizumi M, 2008, J SYNCHROTRON RADIAT, V15, P308, DOI 10.1107/S0909049507060670; Korkmaz B, 2007, J BIOL CHEM, V282, P1989, DOI 10.1074/jbc.M608700200; KUNTZ ID, 1982, J MOL BIOL, V161, P269, DOI 10.1016/0022-2836(82)90153-X; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; MULLOY B, 1993, BIOCHEM J, V293, P849, DOI 10.1042/bj2930849; MURPHY G, 1991, BIOCHEMISTRY-US, V30, P8097, DOI 10.1021/bi00247a001; Murphy G, 2008, MOL ASPECTS MED, V29, P290, DOI 10.1016/j.mam.2008.05.002; Nagase H, 1997, BIOCHEM J, V325, P163, DOI 10.1042/bj3250163; Niemann CU, 2007, BLOOD, V109, P4478, DOI 10.1182/blood-2006-02-001719; OWEN CA, 1995, J CELL BIOL, V131, P775, DOI 10.1083/jcb.131.3.775; Owen CA, 1999, J LEUKOCYTE BIOL, V65, P137, DOI 10.1002/jlb.65.2.137; PRATT CW, 1990, J BIOL CHEM, V265, P6092; Rajgopal R, 2008, THROMB RES, V122, P293, DOI 10.1016/j.thromres.2006.10.025; Rockwell NC, 2002, J BIOL CHEM, V277, P17531, DOI 10.1074/jbc.M111909200; Rockwell NC, 2001, BIOCHEMISTRY-US, V40, P3657, DOI 10.1021/bi0020877; Sandercock P, 1997, LANCET, V349, P1569; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Schenker P, 2010, FEBS J, V277, P2486, DOI 10.1111/j.1742-4658.2010.07663.x; Schneidman-Duhovny D, 2003, PROTEINS, V52, P107, DOI 10.1002/prot.10397; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Spencer JL, 2006, BIOCHEMISTRY-US, V45, P9104, DOI 10.1021/bi060338r; STEIN RL, 1987, BIOCHEMISTRY-US, V26, P1305, DOI 10.1021/bi00379a016; STEIN RL, 1987, BIOCHEMISTRY-US, V26, P2238, DOI 10.1021/bi00382a025; STEIN RL, 1983, J AM CHEM SOC, V105, P5111, DOI 10.1021/ja00353a042; STEIN RL, 1985, J AM CHEM SOC, V107, P5767, DOI 10.1021/ja00306a026; Tang J, 2010, NEUROL RES, V32, P541, DOI 10.1179/174313209X414560; Wiernicki I, 2010, ATHEROSCLEROSIS, V212, P161, DOI 10.1016/j.atherosclerosis.2010.04.033; YASUTAKE A, 1981, BIOCHEMISTRY-US, V20, P3675, DOI 10.1021/bi00516a002; Ying QL, 1996, AM J RESP CELL MOL, V15, P283, DOI 10.1165/ajrcmb.15.2.8703486; Ying QL, 2000, AM J RESP CELL MOL, V23, P506, DOI 10.1165/ajrcmb.23.4.3939; ZHANG D, 2008, BIOCHIM BIOPHYS ACTA, V1785, P827; Zidane M, 2000, ARCH INTERN MED, V160, P2369, DOI 10.1001/archinte.160.15.2369	58	6	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21525	10.1371/journal.pone.0021525	http://dx.doi.org/10.1371/journal.pone.0021525			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731773	gold, Green Published, Green Submitted			2022-12-27	WOS:000292035400048
J	Song, C; Corry, B				Song, Chen; Corry, Ben			Testing the Applicability of Nernst-Planck Theory in Ion Channels: Comparisons with Brownian Dynamics Simulations	PLOS ONE			English	Article							FIELD MOLECULAR-DYNAMICS; MODEL CALCIUM-CHANNEL; MEMBRANE CHANNELS; ACETYLCHOLINE-RECEPTOR; POTASSIUM CHANNEL; ALPHA-HEMOLYSIN; ELECTRODIFFUSION THEORY; COMPUTATIONAL METHODS; SELECTIVITY FILTER; POISSON-BOLTZMANN	The macroscopic Nernst-Planck (NP) theory has often been used for predicting ion channel currents in recent years, but the validity of this theory at the microscopic scale has not been tested. In this study we systematically tested the ability of the NP theory to accurately predict channel currents by combining and comparing the results with those of Brownian dynamics (BD) simulations. To thoroughly test the theory in a range of situations, calculations were made in a series of simplified cylindrical channels with radii ranging from 3 to 15 angstrom, in a more complex 'catenary' channel, and in a realistic model of the mechanosensitive channel MscS. The extensive tests indicate that the NP equation is applicable in narrow ion channels provided that accurate concentrations and potentials can be input as the currents obtained from the combination of BD and NP match well with those obtained directly from BD simulations, although some discrepancies are seen when the ion concentrations are not radially uniform. This finding opens a door to utilising the results of microscopic simulations in continuum theory, something that is likely to be useful in the investigation of a range of biophysical and nano-scale applications and should stimulate further studies in this direction.	[Song, Chen; Corry, Ben] Univ Western Australia, Sch Biomed Biomol & Chem Sci, Perth, WA 6009, Australia; [Song, Chen] Max Planck Inst Biophys Chem, Dept Theoret & Computat Biophys, D-37077 Gottingen, Germany	University of Western Australia; Max Planck Society	Song, C (corresponding author), Univ Western Australia, Sch Biomed Biomol & Chem Sci, Perth, WA 6009, Australia.	ben.corry@uwa.edu.au	Corry, Ben/B-3546-2012	Corry, Ben/0000-0002-6324-442X	National Health and Medical Research Council, Australia	National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TW, 2006, BIOPHYS CHEM, V124, P251, DOI 10.1016/j.bpc.2006.04.015; Allen TW, 2004, P NATL ACAD SCI USA, V101, P117, DOI 10.1073/pnas.2635314100; ANDERSEN OS, 1989, METHOD ENZYMOL, V171, P62; Ashcroft FM, 2006, NATURE, V440, P440, DOI 10.1038/nature04707; Beckstein O, 2004, PHYS BIOL, V1, P42, DOI 10.1088/1478-3967/1/1/005; Beckstein O, 2003, FEBS LETT, V555, P85, DOI 10.1016/S0014-5793(03)01151-7; BEK S, 1994, BIOPHYS J, V66, P1028, DOI 10.1016/S0006-3495(94)80884-7; Berneche S, 2001, NATURE, V414, P73, DOI 10.1038/35102067; BERNECHE S, 2003, NATURE, V100, P8644; Boda D, 2001, J PHYS CHEM B, V105, P11574, DOI 10.1021/jp003556h; Boda D, 2002, J CHEM PHYS, V116, P7170, DOI 10.1063/1.1464826; Bolintineanu DS, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000277; Cheng MHY, 2010, J AM CHEM SOC, V132, P16442, DOI 10.1021/ja105001a; Cheng XL, 2006, J MOL BIOL, V355, P310, DOI 10.1016/j.jmb.2005.10.039; Chung SH, 1999, BIOPHYS J, V77, P2517, DOI 10.1016/S0006-3495(99)77087-6; Chung SH, 2005, SOFT MATTER, V1, P417, DOI 10.1039/b512455g; Chung SH, 2002, BIOPHYS J, V82, P628, DOI 10.1016/S0006-3495(02)75427-1; Chung SH, 2007, BIOPHYS J, V93, P44, DOI 10.1529/biophysj.106.098954; COOPER K, 1985, PROG BIOPHYS MOL BIO, V46, P51, DOI 10.1016/0079-6107(85)90012-4; Corry B, 2006, CELL MOL LIFE SCI, V63, P301, DOI 10.1007/s00018-005-5405-8; Corry B, 2006, BIOPHYS J, V90, P799, DOI 10.1529/biophysj.105.067868; Corry B, 2000, BIOPHYS J, V78, P2364, DOI 10.1016/S0006-3495(00)76781-6; Corry B, 2004, BIOPHYS J, V86, P846, DOI 10.1016/S0006-3495(04)74160-0; Corry B, 2003, BIOPHYS J, V84, P3594, DOI 10.1016/S0006-3495(03)75091-7; Corry B, 2001, BIOPHYS J, V80, P195, DOI 10.1016/S0006-3495(01)76007-9; Cozmuta I, 2005, MOL SIMULAT, V31, P79, DOI 10.1080/08927020412331308467; Crozier PS, 2001, BIOPHYS J, V81, P3077, DOI 10.1016/S0006-3495(01)75946-2; Crozier PS, 2001, PHYS REV LETT, V86, P2467, DOI 10.1103/PhysRevLett.85.2467; Eisenberg RS, 1996, J MEMBRANE BIOL, V150, P1, DOI 10.1007/s002329900026; Gillespie D, 2008, BIOPHYS J, V95, P2658, DOI 10.1529/biophysj.107.127977; Gillespie D, 2008, BIOPHYS J, V95, P609, DOI 10.1529/biophysj.107.127985; Hollerbach U, 2000, LANGMUIR, V16, P5509, DOI 10.1021/la991525b; Hoyles M, 1998, PHYS REV E, V58, P3654, DOI 10.1103/PhysRevE.58.3654; Hoyles M, 1998, COMPUT PHYS COMMUN, V115, P45, DOI 10.1016/S0010-4655(98)00090-3; Hummer G, 2005, NEW J PHYS, V7, DOI 10.1088/1367-2630/7/1/034; Hwang H, 2006, J PHYS CHEM B, V110, P6999, DOI 10.1021/jp055740e; Im W, 2002, J MOL BIOL, V322, P851, DOI 10.1016/S0022-2836(02)00778-7; JENSEN MO, 2010, NATURE, V107, P5833; Jung YW, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3268774; Koumanov A, 2003, EUR BIOPHYS J BIOPHY, V32, P689, DOI 10.1007/s00249-003-0330-y; Kurnikova MG, 1999, BIOPHYS J, V76, P642, DOI 10.1016/S0006-3495(99)77232-2; Kuyucak S, 2001, REP PROG PHYS, V64, P1427, DOI 10.1088/0034-4885/64/11/202; LEVITT DG, 1987, BIOPHYS J, V52, P455, DOI 10.1016/S0006-3495(87)83234-4; LEVITT DG, 1986, ANNU REV BIOPHYS BIO, V15, P29; LEVITT DG, 1991, BIOPHYS J, V59, P271, DOI 10.1016/S0006-3495(91)82220-2; Li SC, 1998, BIOPHYS J, V74, P37, DOI 10.1016/S0006-3495(98)77764-1; Luchinsky DG, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.021925; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mamonov AB, 2006, BIOPHYS CHEM, V124, P268, DOI 10.1016/j.bpc.2006.03.019; Ng JA, 2008, EUR BIOPHYS J BIOPHY, V37, P213, DOI [10.1007/s00249-007-0218-3, 10.1007/S00249-007-0218-3]; Noskov SY, 2004, BIOPHYS J, V87, P2299, DOI 10.1529/biophysj.104.044008; Noskov SY, 2004, NATURE, V431, P830, DOI 10.1038/nature02943; Nury H, 2010, P NATL ACAD SCI USA, V107, P6275, DOI 10.1073/pnas.1001832107; O'Keeffe J, 2007, CHEM PHYS, V342, P25, DOI 10.1016/j.chemphys.2007.09.013; O'Mara M, 2005, BIOPHYS J, V88, P3286, DOI 10.1529/biophysj.104.051664; Roux B, 2004, Q REV BIOPHYS, V37, P15, DOI 10.1017/S0033583504003968; Song C, 2010, BIOPHYS J, V98, P404, DOI 10.1016/j.bpj.2009.10.032; Song C, 2009, BBA-BIOMEMBRANES, V1788, P1466, DOI 10.1016/j.bbamem.2009.04.015; Thomas M, 2007, BIOPHYS J, V93, P2635, DOI 10.1529/biophysj.107.108167; Wang HL, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040041; Wang WJ, 2008, SCIENCE, V321, P1179, DOI 10.1126/science.1159262; Wang Z, 2007, SOFT MATTER, V3, P1041, DOI 10.1039/b700125h; Yang Y, 2003, J CHEM PHYS, V118, P4213, DOI 10.1063/1.1536957; Zhu FQ, 2010, P NATL ACAD SCI USA, V107, P19814, DOI 10.1073/pnas.1009313107	64	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21204	10.1371/journal.pone.0021204	http://dx.doi.org/10.1371/journal.pone.0021204			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731672	Green Published, Green Submitted, gold			2022-12-27	WOS:000292035400013
J	Sundberg, E; Hultdin, J; Nilsson, S; Ahlm, C				Sundberg, Erik; Hultdin, Johan; Nilsson, Sofie; Ahlm, Clas			Evidence of Disseminated Intravascular Coagulation in a Hemorrhagic Fever with Renal Syndrome-Scoring Models and Severe Illness	PLOS ONE			English	Article							PUUMALA VIRUS-INFECTION; NEPHROPATHIA-EPIDEMICA; INTERNATIONAL-SOCIETY; DIAGNOSTIC-CRITERIA; HEMOSTASIS; THROMBOSIS; SYSTEM; PATHOGENESIS; THROMBOCYTOPENIA; DYSFUNCTION	Background: Viral hemorrhagic fevers (VHF) are considered to be a serious threat to public health worldwide with up to 100 million cases annually. The general hypothesis is that disseminated intravascular coagulation (DIC) is an important part of the pathogenesis. The study objectives were to study the variability of DIC in consecutive patients with acute hemorrhagic fever with renal syndrome (HFRS), and to evaluate if different established DIC-scores can be used as a prognostic marker for a more severe illness. Method and Findings: In a prospective study 2006-2008, data from 106 patients with confirmed HFRS were analyzed and scored for the presence of DIC according to six different templates based on criteria from the International Society on Thrombosis and Haemostasis (ISTH). The DIC-scoring templates with a fibrinogen/CRP-ratio were most predictive, with predictions for moderate/severe illness (p<0.01) and bleeding of moderate/major importance (p<0.05). With these templates, 18.9-28.3% of the patients were diagnosed with DIC. Conclusions: DIC was found in about one fourth of the patients and correlated with a more severe disease. This supports that DIC is an important part of the pathogenesis in HFRS. ISTH-scores including fibrinogen/CRP-ratio outperform models without. The high negative predictive value could be a valuable tool for the clinician. We also believe that our findings could be relevant for other VHFs.	[Sundberg, Erik; Ahlm, Clas] Umea Univ, Dept Clin Microbiol Infect Dis, Umea, Sweden; [Sundberg, Erik; Hultdin, Johan; Nilsson, Sofie] Umea Univ, Dept Med Biosci Clin Chem, Umea, Sweden	Umea University; Umea University	Sundberg, E (corresponding author), Umea Univ, Dept Clin Microbiol Infect Dis, Umea, Sweden.	erik.sundberg@climi.umu.se	Hultdin, Johan/AAD-4623-2021	Hultdin, Johan/0000-0002-9599-0961	Swedish Heart and Lung Foundation; Heart Foundation of Northern Sweden; Medical Faculty of Umea University, National Board of Health and Welfare, Sweden; County Councils of Northern Sweden; County Council of Vasterbotten	Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Heart Foundation of Northern Sweden; Medical Faculty of Umea University, National Board of Health and Welfare, Sweden; County Councils of Northern Sweden; County Council of Vasterbotten	This work was supported by the Swedish Heart and Lung Foundation, the Heart Foundation of Northern Sweden, the Medical Faculty of Umea University, National Board of Health and Welfare, Sweden, the County Councils of Northern Sweden, and the County Council of Vasterbotten. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakhtiari K, 2004, CRIT CARE MED, V32, P2416, DOI 10.1097/01.CCM.0000147769.07699.E3; Bray M, 2005, CURR OPIN IMMUNOL, V17, P399, DOI 10.1016/j.coi.2005.05.001; Chen JP, 2000, BLOOD COAGUL FIBRIN, V11, P461, DOI 10.1097/00001721-200007000-00010; Cohen J, 2004, PLOS MED, V1, P188, DOI 10.1371/journal.pmed.0010059; COSGRIFF TM, 1991, T ROY SOC TROP MED H, V85, P660, DOI 10.1016/0035-9203(91)90386-D; Dempfle CE, 2004, THROMB HAEMOSTASIS, V91, P812, DOI 10.1160/TH03-09-0577; Esmon CT, 2004, MATURITAS, V47, P305, DOI 10.1016/j.maturitas.2003.10.015; Evander M, 2007, J CLIN MICROBIOL, V45, P2491, DOI 10.1128/JCM.01902-06; Feldmann H, 2011, LANCET, V377, P849, DOI 10.1016/S0140-6736(10)60667-8; FORSLUND T, 1992, J INTERN MED, V232, P87, DOI 10.1111/j.1365-2796.1992.tb00555.x; Gibbons RV, 2002, BMJ-BRIT MED J, V324, P1563, DOI 10.1136/bmj.324.7353.1563; Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X; Gowen BB, 2008, ANTIVIR RES, V78, P79, DOI 10.1016/j.antiviral.2007.10.002; Hjertqvist M, 2010, EMERG INFECT DIS, V16, P1584, DOI 10.3201/eid1610.100242; HUTTUNEN NP, 2011, SCAND J INF IN PRESS; Jonsson CB, 2010, CLIN MICROBIOL REV, V23, P412, DOI 10.1128/CMR.00062-09; Kanerva M, 1996, CLIN NEPHROL, V46, P369; Khaiboullina SF, 2002, VIRAL IMMUNOL, V15, P609, DOI 10.1089/088282402320914548; Khemani R, 2009, INTENS CARE MED, V35, P327, DOI 10.1007/s00134-008-1280-8; Kim HK, 2007, ACTA HAEMATOL-BASEL, V117, P34, DOI 10.1159/000096786; Klingstrom J, 2006, J VIROL, V80, P8279, DOI 10.1128/JVI.00742-06; LAHDEVIRTA J, 1989, REV INFECT DIS, V11, pS860; Laine O, 2010, THROMB RES, V126, P154, DOI 10.1016/j.thromres.2010.05.025; Lee M, 1983, Bibl Haematol, P181; Levi M, 2006, CRIT CARE, V10, DOI 10.1186/cc4975; LINDERHOLM M, 1991, SCAND J INFECT DIS, V23, P501, DOI 10.3109/00365549109075100; Liu ZW, 2008, VIRAL IMMUNOL, V21, P255, DOI 10.1089/vim.2007.0098; Lutteke N, 2010, VIROLOGY, V405, P70, DOI 10.1016/j.virol.2010.05.028; Mackow ER, 2009, THROMB HAEMOSTASIS, V102, P1030, DOI 10.1160/TH09-09-0640; Mahanty S, 2004, LANCET INFECT DIS, V4, P487, DOI 10.1016/S1473-3099(04)01103-X; Oh D, 2010, THROMB RES, V126, P18, DOI 10.1016/j.thromres.2009.12.008; Ong A, 2007, INT J INFECT DIS, V11, P263, DOI 10.1016/j.ijid.2006.02.012; Peters CJ, 2002, CRIT CARE MED, V30, pS268, DOI 10.1097/00003246-200205001-00016; Pettersson L, 2008, EMERG INFECT DIS, V14, P808, DOI 10.3201/eid1405.071124; Rasche FM, 2004, EMERG INFECT DIS, V10, P1420, DOI 10.3201/eid1008.031069; Schmaljohn C, 1997, EMERG INFECT DIS, V3, P95, DOI 10.3201/eid0302.970202; Semenza JC, 2009, LANCET INFECT DIS, V9, P365, DOI 10.1016/S1473-3099(09)70104-5; SETTERGREN B, 1983, LANCET, V2, P1419; Settergren B, 2000, SCAND J INFECT DIS, V32, P125, DOI 10.1080/003655400750045204; SETTERGREN B, 1989, REV INFECT DIS, V11, P921; Sironen T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003035; Takemitsu T, 2011, THROMB HAEMOSTASIS, V105, P40, DOI 10.1160/TH10-05-0293; TAKEUCHI T, 1991, KIDNEY INT, V40, pS84; Taylor FB, 2001, THROMB HAEMOSTASIS, V86, P1327, DOI 10.1055/s-0037-1616068; Toh CH, 2007, J THROMB HAEMOST, V5, P604, DOI 10.1111/j.1538-7836.2007.02313.x; Toh CH, 2005, BLOOD COAGUL FIBRIN, V16, P69, DOI 10.1097/00001721-200501000-00011; VALTONEN M, 1995, SCAND J INFECT DIS, V27, P515, DOI 10.3109/00365549509047057; Vanderschueren S, 2000, CRIT CARE MED, V28, P1871, DOI 10.1097/00003246-200006000-00031; Vapalahti O, 2003, LANCET INFECT DIS, V3, P653, DOI 10.1016/S1473-3099(03)00774-6; Voves C, 2006, BLOOD COAGUL FIBRIN, V17, P445, DOI 10.1097/01.mbc.0000240916.63521.2e; Wada H, 2010, AM J HEMATOL, V85, P691, DOI 10.1002/ajh.21783; ZAKI SR, 1995, AM J PATHOL, V146, P552	53	31	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21134	10.1371/journal.pone.0021134	http://dx.doi.org/10.1371/journal.pone.0021134			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731657	Green Published, gold, Green Submitted			2022-12-27	WOS:000292035400010
J	Gotoh, H; Cornette, R; Koshikawa, S; Okada, Y; Lavine, LC; Emlen, DJ; Miura, T				Gotoh, Hiroki; Cornette, Richard; Koshikawa, Shigeyuki; Okada, Yasukazu; Lavine, Laura Corley; Emlen, Douglas J.; Miura, Toru			Juvenile Hormone Regulates Extreme Mandible Growth in Male Stag Beetles	PLOS ONE			English	Article							TERMITE; DIFFERENTIATION; MORPHOGENESIS; EXPRESSION; ALLOMETRY; EVOLUTION; ISOPTERA	The morphological diversity of insects is one of the most striking phenomena in biology. Evolutionary modifications to the relative sizes of body parts, including the evolution of traits with exaggerated proportions, are responsible for a vast range of body forms. Remarkable examples of an insect trait with exaggerated proportions are the mandibular weapons of stag beetles. Male stag beetles possess extremely enlarged mandibles which they use in combat with rival males over females. As with other sexually selected traits, stag beetle mandibles vary widely in size among males, and this variable growth results from differential larval nutrition. However, the mechanisms responsible for coupling nutrition with growth of stag beetle mandibles (or indeed any insect structure) remain largely unknown. Here, we demonstrate that during the development of male stag beetles (Cyclommatus metallifer), juvenile hormone (JH) titers are correlated with the extreme growth of an exaggerated weapon of sexual selection. We then investigate the putative role of JH in the development of the nutritionally-dependent, phenotypically plastic mandibles, by increasing hemolymph titers of JH with application of the JH analog fenoxycarb during larval and prepupal developmental periods. Increased JH signaling during the early prepupal period increased the proportional size of body parts, and this was especially pronounced in male mandibles, enhancing the exaggerated size of this trait. The direction of this response is consistent with the measured JH titers during this same period. Combined, our results support a role for JH in the nutrition-dependent regulation of extreme mandible growth in this species. In addition, they illuminate mechanisms underlying the evolution of trait proportion, the most salient feature of the evolutionary diversification of the insects.	[Gotoh, Hiroki; Miura, Toru] Hokkaido Univ, Grad Sch Environm Sci, Lab Ecol Genet, Sapporo, Hokkaido, Japan; [Cornette, Richard] Natl Inst Agrobiol Sci, Anhydrobiosis Res Unit, Tsukuba, Ibaraki, Japan; [Koshikawa, Shigeyuki] Univ Wisconsin, Mol Biol Lab, Madison, WI 53706 USA; [Okada, Yasukazu] Okayama Univ, Grad Sch Environm Sci, Lab Evolutionary Ecol, Okayama 7008530, Japan; [Lavine, Laura Corley] Washington State Univ, Dept Entomol, Pullman, WA 99164 USA; [Emlen, Douglas J.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA	Hokkaido University; National Institute of Agrobiological Sciences - Japan; University of Wisconsin System; University of Wisconsin Madison; Okayama University; Washington State University; University of Montana System; University of Montana	Gotoh, H (corresponding author), Hokkaido Univ, Grad Sch Environm Sci, Lab Ecol Genet, Sapporo, Hokkaido, Japan.	miu@ees.hokudai.ac.jp	Miura, Toru/P-2456-2019; Gotoh, Hiroki/B-7568-2017; Koshikawa, Shigeyuki/D-3052-2012; Okada, Yasukazu/B-1590-2014	Miura, Toru/0000-0002-7456-4402; Koshikawa, Shigeyuki/0000-0003-2831-555X; Okada, Yasukazu/0000-0003-4528-2980; CORNETTE, Richard/0000-0002-0185-1443; Lavine, Laura/0000-0002-0262-359X	Ministry of Education, Culture, Sports, Science and Technology of Japan [21677001]; JSPS; Grants-in-Aid for Scientific Research [21677001, 10J04026] Funding Source: KAKEN; Direct For Biological Sciences [0919781] Funding Source: National Science Foundation; Division Of Integrative Organismal Systems [0919730] Funding Source: National Science Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by Grants-in-Aid for Young Scientists (No. 21677001) of the Ministry of Education, Culture, Sports, Science and Technology of Japan. HG, YO and SK were supported by JSPS Research Fellowships for Young Scientists. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson Malte, 1994; Cornette R, 2008, J INSECT PHYSIOL, V54, P922, DOI 10.1016/j.jinsphys.2008.04.017; Cotton S, 2004, P ROY SOC B-BIOL SCI, V271, P771, DOI 10.1098/rspb.2004.2688; Emlen DJ, 2003, INTEGR COMP BIOL, V43, P617, DOI 10.1093/icb/43.5.617; Emlen DJ, 1999, J INSECT PHYSIOL, V45, P45, DOI 10.1016/S0022-1910(98)00096-1; Emlen DJ, 2000, ANNU REV ENTOMOL, V45, P661, DOI 10.1146/annurev.ento.45.1.661; Emlen DJ, 2008, ANNU REV ECOL EVOL S, V39, P387, DOI 10.1146/annurev.ecolsys.39.110707.173502; Gu LJ, 2007, GROWTH FACTORS, V25, P264, DOI 10.1080/08977190701773187; HARTFELDER K, 2005, COMPREHENSIVE MOL IN, V3, P651; JOHNSTONE RA, 1995, BIOL REV, V70, P1, DOI 10.1111/j.1469-185X.1995.tb01439.x; Koshikawa S, 2003, NATURWISSENSCHAFTEN, V90, P180, DOI 10.1007/s00114-003-0408-5; Minakuchi C, 2008, FEBS J, V275, P2919, DOI 10.1111/j.1742-4658.2008.06428.x; Miura T, 2000, P ROY SOC B-BIOL SCI, V267, P1185, DOI 10.1098/rspb.2000.1127; Moczek AP, 2005, EVOL DEV, V7, P175, DOI 10.1111/j.1525-142X.2005.05020.x; Nijhout H.F., 1994, INSECT HORMONES; Shingleton AW, 2008, P ROY SOC B-BIOL SCI, V275, P1875, DOI 10.1098/rspb.2008.0227; Shingleton AW, 2007, BIOESSAYS, V29, P536, DOI 10.1002/bies.20584; STAAL GB, 1986, ANNU REV ENTOMOL, V31, P391, DOI 10.1146/annurev.ento.31.1.391; Stern DL, 1999, DEVELOPMENT, V126, P1091; SUTTIE JM, 1989, J ENDOCRINOL, V121, P351, DOI 10.1677/joe.0.1210351; Truman JW, 2006, SCIENCE, V312, P1385, DOI 10.1126/science.1123652; Westerlund SA, 2004, ANAL BIOANAL CHEM, V379, P540, DOI 10.1007/s00216-004-2598-x; Zera AJ, 2007, EVOL DEV, V9, P499, DOI 10.1111/j.1525-142X.2007.00181.x	23	78	79	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21139	10.1371/journal.pone.0021139	http://dx.doi.org/10.1371/journal.pone.0021139			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731659	Green Published, gold			2022-12-27	WOS:000292033700038
J	Gunn, BF; Baudouin, L; Olsen, KM				Gunn, Bee F.; Baudouin, Luc; Olsen, Kenneth M.			Independent Origins of Cultivated Coconut (Cocos nucifera L.) in the Old World Tropics	PLOS ONE			English	Article							AUSTRONESIAN MIGRATION; POPULATION-STRUCTURE; GENETIC DIVERSITY; SOUTHEAST-ASIA; ISLAND; MICROSATELLITES; LINGUISTICS; INFERENCE; MALAGASY; PROGRAM	As a portable source of food, water, fuel, and construction materials, the coconut (Cocos nucifera L.) played a fundamental role in human migrations and the development of civilization across the humid tropics. Here we investigated the coconut's domestication history and its population genetic structure as it relates to human dispersal patterns. A sample of 1,322 coconut accessions, representing the geographical and phenotypic diversity of the species, was examined using ten microsatellite loci. Bayesian analyses reveal two highly genetically differentiated subpopulations that correspond to the Pacific and Indo-Atlantic oceanic basins. This pattern suggests independent origins of coconut cultivation in these two world regions, with persistent population structure on a global scale despite long-term human cultivation and dispersal. Pacific coconuts show additional genetic substructure corresponding to phenotypic and geographical subgroups; moreover, the traits that are most clearly associated with selection under human cultivation (dwarf habit, self-pollination, and "niu vai" fruit morphology) arose only in the Pacific. Coconuts that show evidence of genetic admixture between the Pacific and Indo-Atlantic groups occur primarily in the southwestern Indian Ocean. This pattern is consistent with human introductions of Pacific coconuts along the ancient Austronesian trade route connecting Madagascar to Southeast Asia. Admixture in coastal east Africa may also reflect later historic Arab trading along the Indian Ocean coastline. We propose two geographical origins of coconut cultivation: island Southeast Asia and southern margins of the Indian subcontinent.	[Gunn, Bee F.] Australian Natl Univ, Res Sch Biol, Div Evolut Ecol & Genet, Canberra, ACT, Australia; [Baudouin, Luc] CIRAD, Montpellier, France; [Olsen, Kenneth M.] Washington Univ, Dept Biol, St Louis, MO 63130 USA	Australian National University; CIRAD; Washington University (WUSTL)	Gunn, BF (corresponding author), Australian Natl Univ, Res Sch Biol, Div Evolut Ecol & Genet, Canberra, ACT, Australia.	kolsen@wustl.edu		Gunn, Bee/0000-0002-9591-3085; Olsen, Kenneth/0000-0002-8338-3638; Baudouin, Luc/0000-0003-2620-7125	National Geographic Society [CRE 8178-07]; COGENT network; CGIAR	National Geographic Society(National Geographic Society); COGENT network; CGIAR(CGIAR)	The study was funded by a National Geographic Society (CRE 8178-07) grant to KMO and BFG, http://www.nationalgeographic.com/field/, and COGENT network and the CGIAR Generation Challenge Progamme to LB, http://www.inibap.org/cogent/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allibert C, 2008, DIOGENES, V55, P7, DOI 10.1177/0392192108090734; Battail G., 1997, THEORIE INFORM APPL; Baudouin L, 2002, DEV MICROSATELLITE K; BAUDOUIN L, 2005, COCONUT GENETIC RESO, P268; Baudouin L, 2008, EUPHYTICA, V161, P353, DOI 10.1007/s10681-007-9568-2; Baudouin L, 2009, GENET RESOUR CROP EV, V56, P257, DOI 10.1007/s10722-008-9362-6; Bourdeix Roland, 2001, P106; CHESTER KS, 1951, ORIGIN VARIATION IMM; Cooper Zarine, 2002, ARCHEOLOGY HIST EARL; Corander J, 2004, BIOINFORMATICS, V20, P2363, DOI 10.1093/bioinformatics/bth250; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fuller DQ, 2007, VERTEBR PALEOBIOL PA, P393, DOI 10.1007/1-4020-5562-5_18; Gao H, 2007, GENETICS, V176, P1635, DOI 10.1534/genetics.107.072371; Guillot G, 2005, GENETICS, V170, P1261, DOI 10.1534/genetics.104.033803; Harries H., 2004, ETHNOBOT RES APPL, V2, P37, DOI [10.17348/era.2.0.37-53, DOI 10.17348/ERA.2.0.37-53]; HARRIES HC, 1990, PLANT DIVERSITY OF MALESIA, P351; HARRIES HC, 1978, BOT REV, V44, P265, DOI 10.1007/BF02957852; HARRIES HC, 1981, ANN BOT-LONDON, V48, P873, DOI 10.1093/oxfordjournals.aob.a086195; Hurles ME, 2005, AM J HUM GENET, V76, P894, DOI 10.1086/430051; Hurles ME, 2003, TRENDS ECOL EVOL, V18, P531, DOI 10.1016/S0169-5347(03)00245-3; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Jost L, 2009, MOL ECOL, V18, P2088, DOI 10.1111/j.1365-294X.2009.04186.x; Larson G, 2005, SCIENCE, V307, P1618, DOI 10.1126/science.1106927; Lebrun P, 1998, EUPHYTICA, V101, P103, DOI 10.1023/A:1018323721803; Lebrun Patricia, 2003, P219; Martinez RT, 2010, TREE GENET GENOMES, V6, P73, DOI 10.1007/s11295-009-0229-6; Mather KA, 2010, MOL ECOL, V19, P4892, DOI 10.1111/j.1365-294X.2010.04845.x; Mauro-Herrera M, 2010, GENET RESOUR CROP EV, V57, P203, DOI 10.1007/s10722-009-9463-x; Meerow AW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007353; Menon K.P.V., 1958, COCONUT PALM MONOGRA; Oliver J, 2005, COCONUT GENETIC RESO; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Perera L, 2003, EUPHYTICA, V132, P121, DOI 10.1023/A:1024696303261; Perera L, 1999, MOL ECOL, V8, P344; Perera L., 2011, CORD, V27, P9; Pritchard JK, 2000, GENETICS, V155, P945; Rajesh MK, 2008, SCI HORTIC-AMSTERDAM, V118, P282, DOI 10.1016/j.scienta.2008.06.017; RIGBY JF, 1995, GLOBAL ENV DIVERSIFI, P379; Rivera R, 1999, GENOME, V42, P668, DOI 10.1139/gen-42-4-668; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Sauer J, 1971, MAN SEA, P309; Schuiling M., 1994, Principes, V38, P4; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Spriggs M., 1997, ISLAND MELANESIANS; Teulat B, 2000, THEOR APPL GENET, V100, P764, DOI 10.1007/s001220051350; TRIPATHI R.P., 1999, PALEOBOTANIST, V48, P251; Walshaw SC, 2010, WORLD ARCHAEOL, V42, P137, DOI 10.1080/00438240903430399; WARD RG, 1992, J BIOGEOGR, V19, P467, DOI 10.2307/2845766; Wheeler R., 1946, ANCIENT INDIA, V2, P17; WHITEHEAD RAW, 1966, SAMPLE SURVEY COLLEC; ZizumboVillarreal D, 1996, GENET RESOUR CROP EV, V43, P505, DOI 10.1007/BF00138827	53	102	111	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21143	10.1371/journal.pone.0021143	http://dx.doi.org/10.1371/journal.pone.0021143			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731660	Green Published, gold			2022-12-27	WOS:000292033700039
J	Guo, L; Yang, Q; Lu, JF; Li, HL; Ge, QY; Gu, WJ; Bai, YF; Lu, ZH				Guo, Li; Yang, Qi; Lu, Jiafeng; Li, Hailing; Ge, Qinyu; Gu, Wanjun; Bai, Yunfei; Lu, Zuhong			A Comprehensive Survey of miRNA Repertoire and 3 ' Addition Events in the Placentas of Patients with Pre-Eclampsia from High-Throughput Sequencing	PLOS ONE			English	Article							MICRORNA EXPRESSION; SMALL RNAS; ADENYLATION; CHROMOSOME-19; URIDYLATION; REGIONS; CLUSTER; SIRNAS	Background: To gain insight into potential roles of isomiR spectrum and isomiRs with 3' additions in pre-eclampsia, we performed a comprehensive survey of miRNA repertoire and 3' addition events from placental samples with different degrees of pre-eclampsia by applying SOLiD sequencing platform. Principal Findings: Over 30% isomiRs were detected with 3' non-template additional nucleotides, especially for additional nucleotide of adenosine. However, these modified isomiRs showed a lower percentage of total miRNA expression (<15%). Generally, 1-3 abundant isomiRs from a given miRNA locus were identified, but none of them was detected with 3' additions. Different miRNAs indicated various isomiR spectrums and expression patterns. The most abundant isomiR spectrum, isomiR profile and expression pattern always were stability, but herein we found several exceptions across samples, especially between normal and diseased samples. At isomiR level, we detected a distinct subset of differentially expressed modified isomiRs between normal and diseased samples or between mild and severe samples. Gene Ontology analysis of their experimentally validated target genes revealed enrichment for specific biological process categories. Conclusions: The phenomenon of multiple isomiRs, especially for isomiRs with 3' additions, is not a random event during pre-miRNA processing. Varieties of isomiRs and expression patterns reveal potential functional implication and should be taken into account. The study enriches association of miRNAs and human disease, including potential roles of various miRNA variants and 3' addition events.	[Guo, Li; Yang, Qi; Lu, Jiafeng; Li, Hailing; Bai, Yunfei; Lu, Zuhong] Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing, Peoples R China; [Ge, Qinyu; Gu, Wanjun; Lu, Zuhong] Southeast Univ, Minist Educ, Key Lab Child Dev & Learning Sci, Nanjing, Peoples R China	Southeast University - China; Southeast University - China	Guo, L (corresponding author), Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing, Peoples R China.	gl8008@163.com; zhlu@seu.edu.cn	Gu, Wanjun/P-5389-2019; Ge, Qinyu/B-5055-2012; Lu, Zuhong/A-5448-2013; Gu, Wanjun/B-3998-2010	Gu, Wanjun/0000-0003-4501-0539; Lu, Zuhong/0000-0003-3332-2615	National Natural Science Foundation of China [30871393, 30900836, 60971021]; Tsinghua National Laboratory for Information Science and Technology (TNList) Cross-Discipline Foundation; Innovation Project for Graduate Students of Jiangsu Province [CX10B_081Z]; Scientific Research Foundation of Graduate School of Southeast University [201001095]; Southeast University [KJ2010442]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tsinghua National Laboratory for Information Science and Technology (TNList) Cross-Discipline Foundation; Innovation Project for Graduate Students of Jiangsu Province; Scientific Research Foundation of Graduate School of Southeast University; Southeast University	This work was supported by projects 30871393, 30900836 and 60971021 of the National Natural Science Foundation of China and funded by Tsinghua National Laboratory for Information Science and Technology (TNList) Cross-Discipline Foundation. The work was also supported by a research grant from the Innovation Project for Graduate Students of Jiangsu Province (No. CX10B_081Z), the Scientific Research Foundation of Graduate School of Southeast University, Science and Technology Project in Nanjing (201001095) and Pre-Research Project for National Natural Science Foundation supported by Southeast University (KJ2010442). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma-Mukai A, 2008, P NATL ACAD SCI USA, V105, P7964, DOI 10.1073/pnas.0800334105; Burroughs AM, 2010, GENOME RES, V20, P1398, DOI 10.1101/gr.106054.110; Cho WCS, 2010, INT J BIOCHEM CELL B, V42, P1273, DOI 10.1016/j.biocel.2009.12.014; Czech B, 2009, MOL CELL, V36, P445, DOI 10.1016/j.molcel.2009.09.028; Ebhardt HA, 2009, NUCLEIC ACIDS RES, V37, P2461, DOI 10.1093/nar/gkp093; Enquobahrie DA, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.09.004; Fernandez-Valverde SL, 2010, RNA, V16, P1881, DOI 10.1261/rna.2379610; Fineberg SK, 2009, NEURON, V64, P303, DOI 10.1016/j.neuron.2009.10.020; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Guo L, 2010, COMPUT BIOL CHEM, V34, P165, DOI 10.1016/j.compbiolchem.2010.06.001; Guo L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011387; Hsu SD, 2011, NUCLEIC ACIDS RES, V39, pD163, DOI 10.1093/nar/gkq1107; Hu YL, 2009, CLIN CHEM LAB MED, V47, P923, DOI 10.1515/CCLM.2009.228; Ishibashi O, 2010, PLACENTA, V31, pA120; Ishibashi O, 2010, PLACENTA, V31, pA9; Jagadeeswaran G, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-52; Jones MR, 2009, NAT CELL BIOL, V11, P1157, DOI 10.1038/ncb1931; KAI ZS, NATURE STRUCTURAL MO, V17, P5; Katoh T, 2009, GENE DEV, V23, P433, DOI 10.1101/gad.1761509; Kim YK, 2010, CELL, V143, P703, DOI 10.1016/j.cell.2010.11.018; Kuchenbauer F, 2008, GENOME RES, V18, P1787, DOI 10.1101/gr.077578.108; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Langenberger D, 2009, BIOINFORMATICS, V25, P2298, DOI 10.1093/bioinformatics/btp419; Langmead B., 2009, GENOME BIOL, V10, P212, DOI DOI 10.1186/gb-2009-10-3-212; Lee LW, 2010, RNA, V16, P2170, DOI 10.1261/rna.2225110; Li JJ, 2005, CURR BIOL, V15, P1501, DOI 10.1016/j.cub.2005.07.029; Lu SF, 2009, NUCLEIC ACIDS RES, V37, P1878, DOI 10.1093/nar/gkp031; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Morlando M, 2008, NAT STRUCT MOL BIOL, V15, P902, DOI 10.1038/nsmb.1475; Mouillet JF, 2010, PLACENTA, V31, P781, DOI 10.1016/j.placenta.2010.07.001; O'Toole AS, 2006, NUCLEIC ACIDS RES, V34, P3338, DOI 10.1093/nar/gkl428; Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P354, DOI 10.1038/nsmb.1409; Okamura K, 2009, MOL CELL, V36, P431, DOI 10.1016/j.molcel.2009.09.027; Pineles BL, 2007, AM J OBSTET GYNECOL, V196, P261, DOI 10.1016/j.ajog.2007.01.008; Reid JG, 2008, GENOME RES, V18, P1571, DOI 10.1101/gr.078246.108; Ro S, 2007, NUCLEIC ACIDS RES, V35, P5944, DOI 10.1093/nar/gkm641; Roman A, 2008, AM J OBSTET GYNECOL, V199, pS78, DOI 10.1016/j.ajog.2008.09.265; Ruby JG, 2007, GENOME RES, V17, P1850, DOI 10.1101/gr.6597907; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Seitz H, 2008, CURR BIOL, V18, P147, DOI 10.1016/j.cub.2007.12.049; Shi WY, 2009, NAT STRUCT MOL BIOL, V16, P183, DOI 10.1038/nsmb.1536; Umbach JL, 2010, J VIROL, V84, P695, DOI 10.1128/JVI.02013-09; Weidhaas J, 2010, LANCET ONCOL, V11, P106, DOI 10.1016/S1470-2045(09)70386-9; Zhu XM, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.12.045	46	82	89	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21072	10.1371/journal.pone.0021072	http://dx.doi.org/10.1371/journal.pone.0021072			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731650	gold, Green Published, Green Submitted			2022-12-27	WOS:000292033700034
J	Peng, JB; Gobert, GN; Hong, Y; Jiang, WB; Han, HX; McManus, DP; Wang, XZ; Liu, JM; Fu, ZQ; Shi, YJ; Lin, JJ				Peng, Jinbiao; Gobert, Geoffrey N.; Hong, Yang; Jiang, Weibin; Han, Hongxiao; McManus, Donald P.; Wang, Xinzhi; Liu, Jinming; Fu, Zhiqiang; Shi, Yaojun; Lin, Jiaojiao			Apoptosis Governs the Elimination of Schistosoma japonicum from the Non-Permissive Host Microtus fortis	PLOS ONE			English	Article							PARASITE INTERPLAY; EXPRESSION; CLONING; CELLS	The reed vole, Microtus fortis, is the only known mammalian host in which schistosomes of Schistosoma japonicum are unable to mature and cause significant pathogenesis. However, little is known about how Schistosoma japonicum maturation (and, therefore, the development of schistosomiasis) is prevented in M. fortis. In the present study, the ultrastructure of 10 days post infection schistosomula from BALB/c mice and M. fortis were first compared using scanning electron microscopy and transmission electron microscopy. Electron microscopic investigations showed growth retardation and ultrastructural differences in the tegument and sub-tegumental tissues as well as in the parenchymal cells of schistosomula from M. fortis compared with those in BALB/c mice. Then, microarray analysis revealed significant differential expression between the schistosomula from the two rodents, with 3,293 down-regulated (by >= 2-fold) and 71 up-regulated (>= 2 fold) genes in schistosomula from the former. The up-regulated genes included a proliferation-related gene encoding granulin (Grn) and tropomyosin. Genes that were down-regulated in schistosomula from M. fortis included apoptosis-inhibited genes encoding a baculoviral IAP repeat-containing protein (SjIAP) and cytokine-induced apoptosis inhibitor (SjCIAP), genes encoding molecules involved in insulin metabolism, long-chain fatty acid metabolism, signal transduction, the transforming growth factor (TGF) pathway, the Wnt pathway and in development. TUNEL (terminal deoxynucleotidyl transferase dUTP nick end labeling) and PI/Annexin V-FITC assays, caspase 3/7 activity analysis, and flow cytometry revealed that the percentages of early apoptotic and late apoptotic and/or necrotic cells, as well as the level of caspase activity, in schistosomula from M. fortis were all significantly higher than in those from BALB/c mice.	[Peng, Jinbiao; Hong, Yang; Jiang, Weibin; Han, Hongxiao; Wang, Xinzhi; Liu, Jinming; Fu, Zhiqiang; Shi, Yaojun; Lin, Jiaojiao] Chinese Acad Agr Sci, Shanghai Vet Res Inst, Key Lab Anim Parasitol, Minist Agr, Shanghai, Peoples R China; [Gobert, Geoffrey N.; McManus, Donald P.] Queensland Inst Med Res, Herston, Qld 4006, Australia	Chinese Academy of Agricultural Sciences; Shanghai Veterinary Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; QIMR Berghofer Medical Research Institute	Peng, JB (corresponding author), Chinese Acad Agr Sci, Shanghai Vet Res Inst, Key Lab Anim Parasitol, Minist Agr, Shanghai, Peoples R China.	ebiao4215@sina.com	Gobert, Geoffrey/V-2985-2019; McManus, Donald P./G-2678-2013; McManus, Don/AAC-5394-2020	McManus, Don/0000-0001-6443-1449; Gobert, Geoffrey/0000-0001-5884-6453	National Basic Research Program of China [2007CB513108]; Special Fund for Agri-Scientific Research in the Public Interest [200903036]; National High Technology Research and Development Program of China [2006AA10A207]; NHMRC [496600]	National Basic Research Program of China(National Basic Research Program of China); Special Fund for Agri-Scientific Research in the Public Interest; National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by National Basic Research Program of China (No. 2007CB513108) (http://www.973.gov.cn/ReadItem.aspx?itemid=578), Special Fund for Agri-Scientific Research in the Public Interest (200903036) (http://www.moa.gov.cn/sjzz/jiaoyusi/), National High Technology Research and Development Program of China (No. 2006AA10A207) (http://www.863.org.cn/), NHMRC Program Grant (496600) (http://www.nhmrc.gov.au) and the Sandler Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao JP, 2002, CHINESE MED J-PEKING, V115, P1465; Chai M, 2006, CELL MOL LIFE SCI, V63, P919, DOI 10.1007/s00018-005-5578-1; Chen L, 2002, J BIOL CHEM, V277, P34329, DOI 10.1074/jbc.M201344200; Dong HF, 2002, ACTA TROP, V82, P225, DOI 10.1016/S0001-706X(02)00014-1; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Freitas TC, 2007, PLOS PATHOG, V3, P489, DOI 10.1371/journal.ppat.0030052; Gobert GN, 2006, EXP PARASITOL, V114, P160, DOI 10.1016/j.exppara.2006.03.003; Gobert GN, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000469; Gobert GN, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-128; He YX, 2001, TRENDS PARASITOL, V17, P320, DOI 10.1016/S1471-4922(01)01904-3; Hu W, 2003, NAT GENET, V35, P139, DOI 10.1038/ng1236; JIA RC, 2008, CHIN J BIOTECH, V24, P733; Jiang WB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013494; LI FK, 1965, ACTA PARASITOL SIN, V2, P103; Li H., 2000, CHIN J VET PARASITOL, V8, P12; Li HF, 2010, PARASITOL RES, V107, P795, DOI 10.1007/s00436-010-1933-8; Liu F, 2006, PLOS PATHOG, V2, P268, DOI 10.1371/journal.ppat.0020029; Liu JinMing, 2001, Acta Parasitologica et Medica Entomologica Sinica, V8, P212; Morey JS, 2006, BIOL PROCED ONLINE, V8, P175, DOI 10.1251/bpo126; Peng JB, 2010, PARASITOL RES, V106, P967, DOI 10.1007/s00436-010-1752-y; SHARON R, 2000, J BIOL CHEM, V275, P5760; Smout MJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000611; SUN H, 2008, CHIN J VET PARASIT, V16, P529; [孙军 Sun Jun], 2004, [北京大学学报. 自然科学版, Acta Scientiarum Naturalium Universitatis Pekinensis], V40, P532; Wang LD, 2008, LANCET, V372, P1793, DOI 10.1016/S0140-6736(08)61358-6; Wang XZ, 2009, MOL BIOCHEM PARASIT, V166, P62, DOI 10.1016/j.molbiopara.2009.02.016; You H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009868; You H, 2009, INT J PARASITOL, V39, P1551, DOI 10.1016/j.ijpara.2009.06.006; Yuen T, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e48; Zhou Y, 2009, NATURE, V460, P345, DOI 10.1038/nature08140	30	38	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21109	10.1371/journal.pone.0021109	http://dx.doi.org/10.1371/journal.pone.0021109			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731652	Green Published, Green Submitted, gold			2022-12-27	WOS:000292033700036
J	de Ynigo-Mojado, L; Martin-Ruiz, I; Sutherland, JD				de Ynigo-Mojado, Laura; Martin-Ruiz, Itziar; Sutherland, James D.			Efficient Allele-Specific Targeting of LRRK2 R1441 Mutations Mediated by RNAi	PLOS ONE			English	Article							DISEASE-ASSOCIATED MUTATIONS; HUNTINGTONS-DISEASE; KINASE-ACTIVITY; LEUCINE-RICH-REPEAT-KINASE-2 LRRK2; TRANSGENIC MICE; ALPHA-SYNUCLEIN; GTP-BINDING; MUTANT SOD1; RAT MODEL; GENE	Since RNA interference (RNAi) has the potential to discriminate between single nucleotide changes, there is growing interest in the use of RNAi as a promising therapeutical approach to target dominant disease-associated alleles. Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene have been linked to dominantly inherited Parkinson's disease (PD). We focused on three LRRK2 mutations (R1441G/C and the more prevalent G2109S) hoping to identify shRNAs that would both recognize and efficiently silence the mutated alleles preferentially over the wild-type alleles. Using a luciferase-based reporter system, we identified shRNAs that were able to specifically target the R1441G and R1441C alleles with 80% silencing efficiency. The same shRNAs were able to silence specifically mRNAs encoding either partial or full-length mutant LRRK2 fusion proteins, while having a minimal effect on endogenous wild-type LRRK2 expression when transfected in 293FT cells. Shifting of the mutant recognition site (MRS) from position 11 to other sites (4 and 16, within the 19-mer window of our shRNA design) reduced specificity and overall silencing efficiency. Developing an allele- specific RNAi of G2019S was problematic. Placement of the MRS at position 10 resulted in efficient silencing of reporters (75-80%), but failed to discriminate between mutant and wild-type alleles. Shifting of the MRS to positions 4, 5, 15, 16 increased the specificity of the shRNAs, but reduced the overall silencing efficiency. Consistent with previous reports, these data confirm that MRS placement influences both allele- specificity and silencing strength of shRNAs, while further modification to hairpin design or MRS position may lead to the development of effective G2019S shRNAs. In summary, the effective shRNA against LRRK2 R1441 alleles described herein suggests that RNAi-based therapy of inherited Parkinson's disease is a viable approach towards developing effective therapeutic interventions for this serious neurodegenerative disease.	[de Ynigo-Mojado, Laura; Martin-Ruiz, Itziar; Sutherland, James D.] CIC bioGUNE, Prote Unit, Derio, Bizkaia, Spain	CIC bioGUNE	Sutherland, JD (corresponding author), CIC bioGUNE, Prote Unit, Derio, Bizkaia, Spain.	jsutherland@cicbiogune.es	Sutherland, James D/K-2686-2014	Sutherland, James D/0000-0003-3229-793X	Ramon y Cajal; Spanish MICINN [RYC2005002168, PI070094]; Department of Industry of the Basque Country	Ramon y Cajal(Spanish Government); Spanish MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Department of Industry of the Basque Country	Funding for this project was provided by the Ramon y Cajal and FIS programs of the Spanish MICINN (RYC2005002168, PI070094) with core support from Bizkaia County and the Etortek Program of Department of Industry of the Basque Country. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaneya Y, 2010, METHODS MOL BIOL, V623, P313, DOI 10.1007/978-1-60761-588-0_20; Alves S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003341; Andres-Mateos E, 2009, J NEUROSCI, V29, P15846, DOI 10.1523/JNEUROSCI.4357-09.2009; Boudreau RL, 2006, CURR TOP DEV BIOL, V75, P73, DOI 10.1016/S0070-2153(06)75003-7; Boudreau RL, 2009, MOL THER, V17, P1053, DOI 10.1038/mt.2009.17; Covy JP, 2009, BIOCHEM BIOPH RES CO, V378, P473, DOI 10.1016/j.bbrc.2008.11.048; Deng JP, 2008, P NATL ACAD SCI USA, V105, P1499, DOI 10.1073/pnas.0709098105; Di Fonzo A, 2006, EUR J HUM GENET, V14, P322, DOI 10.1038/sj.ejhg.5201539; Ding HL, 2003, AGING CELL, V2, P209, DOI 10.1046/j.1474-9728.2003.00054.x; Feng XR, 2006, GENE, V371, P68, DOI 10.1016/j.gene.2005.11.006; Franich NR, 2008, MOL THER, V16, P947, DOI 10.1038/mt.2008.50; Greggio E, 2008, J BIOL CHEM, V283, P16906, DOI 10.1074/jbc.M708718200; Greggio E, 2006, NEUROBIOL DIS, V23, P329, DOI 10.1016/j.nbd.2006.04.001; Greggio E, 2009, BIOCHEM BIOPH RES CO, V389, P449, DOI 10.1016/j.bbrc.2009.08.163; Greggio E, 2009, ASN NEURO, V1, DOI 10.1042/AN20090007; Guo LX, 2007, EXP CELL RES, V313, P3658, DOI 10.1016/j.yexcr.2007.07.007; Harper SQ, 2005, P NATL ACAD SCI USA, V102, P5820, DOI 10.1073/pnas.0501507102; Hsu CH, 2010, J NEUROCHEM, V112, P1593, DOI 10.1111/j.1471-4159.2010.06568.x; Ishihara L, 2006, ARCH NEUROL-CHICAGO, V63, P1250, DOI 10.1001/archneur.63.9.1250; Ito G, 2007, BIOCHEMISTRY-US, V46, P1380, DOI 10.1021/bi061960m; Jaleel M, 2007, BIOCHEM J, V405, P307, DOI 10.1042/BJ20070209; Kamikawaji S, 2009, BIOCHEMISTRY-US, V48, P10963, DOI 10.1021/bi9011379; Kim DH, 2007, NAT REV GENET, V8, P173, DOI 10.1038/nrg2006; Klein CL, 2009, J NEUROCHEM, V111, P703, DOI 10.1111/j.1471-4159.2009.06358.x; Kubodera T, 2005, OLIGONUCLEOTIDES, V15, P298, DOI 10.1089/oli.2005.15.298; KUBODERA T, 2010, HUM GENE THER; Lewis PA, 2007, BIOCHEM BIOPH RES CO, V357, P668, DOI 10.1016/j.bbrc.2007.04.006; LI X, 2010, J BIOL CHEM; Li YP, 2009, NAT NEUROSCI, V12, P826, DOI 10.1038/nn.2349; Li YC, 2009, BBA-MOL BASIS DIS, V1792, P1194, DOI 10.1016/j.bbadis.2009.09.010; Lin X, 2009, NEURON, V64, P807, DOI 10.1016/j.neuron.2009.11.006; Lingor P, 2007, MOL BIOSYST, V3, P773, DOI 10.1039/b701169e; Lombardi MS, 2009, EXP NEUROL, V217, P312, DOI 10.1016/j.expneurol.2009.03.004; Mata IF, 2005, NEUROGENETICS, V6, P171, DOI 10.1007/s10048-005-0005-1; Miller VM, 2004, NUCLEIC ACIDS RES, V32, P661, DOI 10.1093/nar/gkh208; Miller VM, 2003, P NATL ACAD SCI USA, V100, P7195, DOI 10.1073/pnas.1231012100; NICHOLS J, 2010, BIOCH J; Nichols RJ, 2009, BIOCHEM J, V424, P47, DOI 10.1042/BJ20091035; Nuytemans K, 2010, HUM MUTAT, V31, P763, DOI 10.1002/humu.21277; Ohnishi Yusuke, 2006, J RNAi Gene Silencing, V2, P154; Ohnishi Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002248; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Paisan-Ruiz C, 2009, HUM MUTAT, V30, P1153, DOI 10.1002/humu.21038; Parisiadou L, 2009, J NEUROSCI, V29, P13971, DOI 10.1523/JNEUROSCI.3799-09.2009; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Pfister EL, 2009, CURR BIOL, V19, P774, DOI 10.1016/j.cub.2009.03.030; Qing H, 2009, BIOCHEM BIOPH RES CO, V390, P1229, DOI 10.1016/j.bbrc.2009.10.126; Ralph GS, 2005, NAT MED, V11, P429, DOI 10.1038/nm1205; Raoul C, 2005, NAT MED, V11, P423, DOI 10.1038/nm1207; Rodriguez-Lebron E, 2009, MOL THER, V17, P1563, DOI 10.1038/mt.2009.123; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Sapru MK, 2006, EXP NEUROL, V198, P382, DOI 10.1016/j.expneurol.2005.12.024; Scholefield J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007232; Schwarz DS, 2006, PLOS GENET, V2, P1307, DOI 10.1371/journal.pgen.0020140; Sen S, 2009, J BIOL CHEM, V284, P36346, DOI 10.1074/jbc.M109.025437; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Smith WLW, 2006, NAT NEUROSCI, V9, P1231, DOI 10.1038/nn1776; Smith WW, 2005, P NATL ACAD SCI USA, V102, P18676, DOI 10.1073/pnas.0508052102; Tiemann K, 2009, EMBO MOL MED, V1, P142, DOI 10.1002/emmm.200900023; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Tong YR, 2010, P NATL ACAD SCI USA, V107, P9879, DOI 10.1073/pnas.1004676107; Towne C, 2008, MOL THER, V16, P1018, DOI 10.1038/mt.2008.73; Towne C, 2009, METHODS MOL BIOL, V555, P87, DOI 10.1007/978-1-60327-295-7_7; van Bilsen PHJ, 2008, HUM GENE THER, V19, P710, DOI 10.1089/hum.2007.116; Venderova K, 2009, HUM MOL GENET, V18, P4390, DOI 10.1093/hmg/ddp394; Wang YL, 2005, NEUROSCI RES, V53, P241, DOI 10.1016/j.neures.2005.06.021; Weiss B, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.123pe27; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; West AB, 2007, HUM MOL GENET, V16, P223, DOI 10.1093/hmg/ddl471; Westerlund M, 2008, NEUROSCIENCE, V152, P429, DOI 10.1016/j.neuroscience.2007.10.062; Xia HB, 2004, NAT MED, V10, P816, DOI 10.1038/nm1076; Xia XG, 2005, J NEUROCHEM, V92, P362, DOI 10.1111/j.1471-4159.2004.02860.x; Xia XG, 2006, NEUROBIOL DIS, V23, P578, DOI 10.1016/j.nbd.2006.04.019; Zabetian CP, 2005, NEUROLOGY, V65, P741, DOI 10.1212/01.WNL.0000172630.22804.73; Zechel S, 2010, INT J DEV NEUROSCI, V28, P391, DOI 10.1016/j.ijdevneu.2010.04.002; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	76	27	32	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2011	6	6							e21352	10.1371/journal.pone.0021352	http://dx.doi.org/10.1371/journal.pone.0021352			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782CL	21712955	Green Published, gold, Green Submitted			2022-12-27	WOS:000291985100034
J	Lu, P; Zhang, GR; Song, XH; Zou, XH; Wang, LL; Ouyang, HW				Lu, Ping; Zhang, Guo Rong; Song, Xing Hui; Zou, Xiao Hui; Wang, Lin Lin; Ouyang, Hong Wei			Col V siRNA Engineered Tenocytes for Tendon Tissue Engineering	PLOS ONE			English	Article							MEDIAL COLLATERAL LIGAMENT; RAPID COLORIMETRIC ASSAY; COLLAGEN FIBRILLOGENESIS; FIBRIL MORPHOLOGY; RNA INTERFERENCE; I COLLAGEN; ACHILLES-TENDON; SKIN FRAGILITY; STEM-CELLS; MATRIX	The presence of uniformly small collagen fibrils in tendon repair is believed to play a major role in suboptimal tendon healing. Collagen V is significantly elevated in healing tendons and plays an important role in fibrillogenesis. The objective of this study was to investigate the effect of a particular chain of collagen V on the fibrillogenesis of Sprague-Dawley rat tenocytes, as well as the efficacy of Col V siRNA engineered tenocytes for tendon tissue engineering. RNA interference gene therapy and a scaffold free tissue engineered tendon model were employed. The results showed that scaffold free tissue engineered tendon had tissue-specific tendon structure. Down regulation of collagen V alpha 1 or alpha 2 chains by siRNAs (Col5 alpha 1 siRNA, Col5 alpha 2 siRNA) had different effects on collagen I and decorin gene expressions. Col5 alpha 1 siRNA treated tenocytes had smaller collagen fibrils with abnormal morphology; while those Col5 alpha 2 siRNA treated tenocytes had the same morphology as normal tenocytes. Furthermore, it was found that tendons formed by coculture of Col5 alpha 1 siRNA treated tenocytes with normal tenocytes at a proper ratio had larger collagen fibrils and relative normal contour. Conclusively, it was demonstrated that Col V siRNA engineered tenocytes improved tendon tissue regeneration. And an optimal level of collagen V is vital in regulating collagen fibrillogenesis. This may provide a basis for future development of novel cellular-and molecular biology-based therapeutics for tendon diseases.	[Lu, Ping; Zhang, Guo Rong; Song, Xing Hui; Zou, Xiao Hui; Wang, Lin Lin; Ouyang, Hong Wei] Zhejiang Univ, Sch Med, Ctr Stem Cell & Tissue Engn, Hangzhou 310003, Zhejiang, Peoples R China; [Lu, Ping; Song, Xing Hui; Wang, Lin Lin; Ouyang, Hong Wei] Zhejiang Univ, Sch Med, Inst Cell Biol, Hangzhou 310003, Zhejiang, Peoples R China; [Zou, Xiao Hui] Zhejiang Univ, Sch Med, Women Hosp, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Lu, P (corresponding author), Zhejiang Univ, Sch Med, Ctr Stem Cell & Tissue Engn, Hangzhou 310003, Zhejiang, Peoples R China.	wanglinlin2007@gmail.com; hwouyang@gmail.com		Lu, Ping/0000-0002-8953-1494	National Natural Science Foundation of China [81071461, J0830833]; Zhejiang Province grants [Z2100086, 2009C13044, Y200908872]; Program for New Century Excellent Talents in University [NCET-08-0487]; Zhejiang Provincial Program for the Cultivation of High-level Innovative Health talents	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Province grants; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Zhejiang Provincial Program for the Cultivation of High-level Innovative Health talents	This study was funded by National Natural Science Foundation of China (81071461, J0830833), URL: http://www.nsfc.gov.cn/Portal0/default124.htm; Zhejiang Province grants (Z2100086, 2009C13044, Y200908872), URL: http://www.zjnsf.net/; Program for New Century Excellent Talents in University (NCET-08-0487), URL: http://www.moe.edu.cn/; Zhejiang Provincial Program for the Cultivation of High-level Innovative Health talents, URL: http://www.zjwst.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI E, 1986, CONNECT TISSUE RES, V14, P257, DOI 10.3109/03008208609017469; Birk DE, 2001, MICRON, V32, P223, DOI 10.1016/S0968-4328(00)00043-3; BIRK DE, 1990, J CELL SCI, V95, P649; Butler DL, 2008, J ORTHOP RES, V26, P1, DOI 10.1002/jor.20456; Chakravarti S, 1998, J CELL BIOL, V141, P1277, DOI 10.1083/jcb.141.5.1277; Chanut-Delalande H, 2004, MOL CELL BIOL, V24, P6049, DOI 10.1128/MCB.24.13.6049-6057.2004; Chanut-Delalande H, 2001, J BIOL CHEM, V276, P24352, DOI 10.1074/jbc.M101182200; Chen X, 2008, BIOMATERIALS, V29, P3683, DOI 10.1016/j.biomaterials.2008.05.017; Chen X, 2009, STEM CELLS, V27, P1276, DOI 10.1002/stem.61; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; DAVID EB, 1986, J CELL BIOL, V103, P231; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; DOILLON CJ, 1985, COLLAGEN REL RES, V5, P481; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Ezura Y, 2000, J CELL BIOL, V151, P779, DOI 10.1083/jcb.151.4.779; Favata M, 2006, J ORTHOP RES, V24, P2124, DOI 10.1002/jor.20271; FESSLER LI, 1981, J BIOL CHEM, V256, P9646; Frank C, 1997, CONNECT TISSUE RES, V36, P261, DOI 10.3109/03008209709160226; Galatz LM, 2004, J BONE JOINT SURG AM, V86A, P219, DOI 10.2106/00004623-200402000-00002; Hall GW, 1999, J BIOMECH, V32, P203, DOI 10.1016/S0021-9290(98)00167-5; Iozzo RV, 1998, ANNU REV BIOCHEM, V67, P609, DOI 10.1146/annurev.biochem.67.1.609; JIMENEZ SA, 1978, BIOCHEM BIOPH RES CO, V81, P1298, DOI 10.1016/0006-291X(78)91277-9; KADLER KE, 1987, J BIOL CHEM, V262, P15696; KELLEY PM, 1980, J BIOL CHEM, V255, P3230; Lianxu C, 2006, OSTEOARTHR CARTILAGE, V14, P367, DOI 10.1016/j.joca.2005.10.009; LINSENMAYER TF, 1993, J CELL BIOL, V121, P1181, DOI 10.1083/jcb.121.5.1181; Maffulli N, 1999, CLIN J SPORT MED, V9, P157, DOI 10.1097/00042752-199907000-00007; Marchant JK, 1996, J CELL BIOL, V135, P1415, DOI 10.1083/jcb.135.5.1415; McCaffrey AP, 2002, NATURE, V418, P38, DOI 10.1038/418038a; Mizuno K, 1996, J BIOCHEM-TOKYO, V120, P934; MORRIS NP, 1990, J BIOL CHEM, V265, P10081; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Neame PJ, 2000, CELL MOL LIFE SCI, V57, P859, DOI 10.1007/s000180050048; Niyibizi C, 1995, MATRIX BIOL, V14, P743, DOI 10.1016/S0945-053X(05)80017-4; Niyibizi C, 2000, KNEE SURG SPORT TR A, V8, P281, DOI 10.1007/s001670000134; NIYIBIZI C, 1994, EUR J BIOCHEM, V224, P943, DOI 10.1111/j.1432-1033.1994.00943.x; Ouyang HW, 2006, TRANSPLANTATION, V82, P170, DOI 10.1097/01.tp.0000226232.79106.72; PARRY DAD, 1978, PROC R SOC SER B-BIO, V203, P305, DOI 10.1098/rspb.1978.0107; Ramirez F, 2003, MATRIX BIOL, V22, P101, DOI 10.1016/S0945-053X(03)00002-7; Redaelli A, 2003, J BIOMECH, V36, P1555, DOI 10.1016/S0021-9290(03)00133-7; Reed CC, 2002, GLYCOCONJUGATE J, V19, P249, DOI 10.1023/A:1025383913444; Rumian AP, 2007, J ORTHOP RES, V25, P458, DOI 10.1002/jor.20218; Scatena R, 2004, J BIOCHEM MOL BIOL, V37, P454; SCOTT JE, 1988, BIOCHEM J, V253, P607, DOI 10.1042/bj2530607; Shimomura T, 2003, CONNECT TISSUE RES, V44, P167, DOI 10.1080/03008200390215872; Svensson L, 1999, J BIOL CHEM, V274, P9636, DOI 10.1074/jbc.274.14.9636; Wenstrup RJ, 2004, J CELL BIOCHEM, V92, P113, DOI 10.1002/jcb.20024; Woo SLY, 2000, ANNU REV BIOMED ENG, V2, P83, DOI 10.1146/annurev.bioeng.2.1.83; Woo SLY, 2006, TISSUE ENG, V12, P159, DOI 10.1089/ten.2006.12.159; Zamore PD, 2001, NAT STRUCT BIOL, V8, P746, DOI 10.1038/nsb0901-746	50	10	11	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2011	6	6							e21154	10.1371/journal.pone.0021154	http://dx.doi.org/10.1371/journal.pone.0021154			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782CL	21713001	Green Submitted, Green Published, gold			2022-12-27	WOS:000291985100013
J	Dudareva, S; Schweiger, B; Thamm, M; Hoehle, M; Stark, K; Krause, G; Buda, S; Haas, W				Dudareva, Sandra; Schweiger, Brunhilde; Thamm, Michel; Hoehle, Michael; Stark, Klaus; Krause, Gerard; Buda, Silke; Haas, Walter			Prevalence of Antibodies to 2009 Pandemic Influenza A (H1N1) Virus in German Adult Population in Pre- and Post-Pandemic Period	PLOS ONE			English	Article							PREEXISTING IMMUNITY; INFECTION; EMERGENCE; RESPONSES; SERUM	Background: In order to detect levels of pre-existing cross-reactive antibodies in different age groups and to measure age-specific infection rates of the influenza A (H1N1) 2009 pandemic in Germany, we conducted a seroprevalence study based on samples from an ongoing nationwide representative health survey. Methodology/Principal Findings: We analysed 845 pre-pandemic samples collected between 25 Nov 2008 and 28 Apr 2009 and 757 post-pandemic samples collected between 12 Jan 2010 and 24 Apr 2010. Reactive antibodies against 2009 pandemic influenza A (H1N1) virus (pH1N1) were detected using a haemagglutination inhibition test (antigen A/California/7/2009). Proportions of samples with antibodies at titre >= 40 and geometric mean of the titres (GMT) were calculated and compared among 6 age groups (18-29, 30-39, 40-49, 50-59, 60-69, >= 70 years). The highest proportions of cross-reactive antibodies at titre >= 40 before the pandemic were observed among 18-29 year olds, 12.5% (95% CI 7.3-19.5%). The highest increase in seroprevalence between pre- and post-pandemic was also observed among 18-29 year olds, 29.9% (95% CI 16.7-43.2%). Effects of sampling period (pre- and post-pandemic), age, sex, and prior influenza immunization on titre were investigated with Tobit regression analysis using three birth cohorts (after 1976, between 1957 and 1976, and before 1957). The GMT increased between the pre- and post-pandemic period by a factor of 10.2 (95% CI 5.0-20.7) in the birth cohort born after 1976, 6.3 (95% CI 3.3-11.9) in those born between 1957 and 1976 and 2.4 (95% CI 1.3-4.3) in those born before 1957. Conclusions/Significance: We demonstrate that infection rates differed among age groups and that the measured pre-pandemic level of cross-reactive antibodies towards pH1N1 did not add information in relation to protection and prediction of the most affected age groups among adults in the pandemic.	[Dudareva, Sandra] European Ctr Dis Prevent & Control ECDC, EPIET, Stockholm, Sweden; [Dudareva, Sandra] Robert Koch Inst, Postgrad Training Appl Epidemiol PAE, German FETP, D-1000 Berlin, Germany; [Schweiger, Brunhilde] Robert Koch Inst, Dept Infect Dis, Natl Reference Ctr Influenza, D-1000 Berlin, Germany; [Thamm, Michel] Robert Koch Inst, Dept Epidemiol & Hlth Reporting, D-1000 Berlin, Germany; [Hoehle, Michael; Stark, Klaus; Krause, Gerard; Buda, Silke; Haas, Walter] Robert Koch Inst, Dept Infect Dis Epidemiol, D-1000 Berlin, Germany	European Centre for Disease Prevention & Control; Robert Koch Institute; Robert Koch Institute; Robert Koch Institute; Robert Koch Institute	Dudareva, S (corresponding author), European Ctr Dis Prevent & Control ECDC, EPIET, Stockholm, Sweden.	DudarevaS@rki.de	Höhle, Michael/AFM-0575-2022	Höhle, Michael/0000-0002-0423-6702; Dudareva, Sandra/0000-0003-1803-704X; Krause, Gerard/0000-0003-3328-8808				Allwinn R, 2010, MED MICROBIOL IMMUN, V199, P117, DOI 10.1007/s00430-010-0143-4; Anonymous, 2009, Morbidity and Mortality Weekly Report, V58, P453; [Anonymous], 2010, R LANG ENV STAT COMP; Bandaranayake D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013211; Boon ACM, 2004, J IMMUNOL, V172, P4435, DOI 10.4049/jimmunol.172.7.4435; Buda S, 2010, BUNDESGESUNDHEITSBLA, V53, P1223, DOI 10.1007/s00103-010-1158-0; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; Cordova J. A., 2009, Morbidity and Mortality Weekly Report, V58, P585; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Gatherer D, 2009, J CLIN VIROL, V45, P174, DOI 10.1016/j.jcv.2009.06.004; Gilbert GL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012562; Gilsdorf A, 2009, EUROSURVEILLANCE, V14, P2; Greenbaum JA, 2009, P NATL ACAD SCI USA, V106, P20365, DOI 10.1073/pnas.0911580106; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Hannoun C, 2004, VIRUS RES, V103, P133, DOI 10.1016/j.virusres.2004.02.025; Ikonen N, 2010, EUROSURVEILLANCE, V15, P16; McElhaney JE, 2006, J IMMUNOL, V176, P6333, DOI 10.4049/jimmunol.176.10.6333; Meijer A, 2006, Euro Surveill, V11, P9, DOI 10.2807/esm.11.05.00623-en; Meijer A, 2007, Euro Surveill, V12, pE11; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Paget W J, 2005, Euro Surveill, V10, P107, DOI 10.2807/esm.10.04.00529-en; Poggensee G, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-155; Pons O, 2007, ELECTRON J STAT, V1, P381, DOI 10.1214/07-EJS033; Rizzo C, 2010, VACCINE, V28, P3558, DOI 10.1016/j.vaccine.2010.03.006; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; Stephenson I, 2007, VACCINE, V25, P4056, DOI 10.1016/j.vaccine.2007.02.039; Stephenson I, 2009, EMERG INFECT DIS, V15, P1250, DOI 10.3201/eid1508.081754; TOBIN J, 1958, ECONOMETRICA, V26, P24, DOI 10.2307/1907382; WHO, 2010, WKLY EPIDEMIOL REC, V85, P229; Wu JT, 2010, CLIN INFECT DIS, V51, P1184, DOI 10.1086/656740; Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430; Zarocostas J, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b2425; Zimmer SM, 2009, NEW ENGL J MED, V361, P279, DOI 10.1056/NEJMra0904322; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	40	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e21340	10.1371/journal.pone.0021340	http://dx.doi.org/10.1371/journal.pone.0021340			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	21701598	Green Published, Green Submitted, gold			2022-12-27	WOS:000291983800043
J	Proenca-Modena, JL; Gagliardi, TB; de Paula, FE; Iwamoto, MA; Criado, MF; Camara, AA; Acrani, GO; Cintra, OAL; Cervi, MC; Arruda, LKD; Arruda, E				Proenca-Modena, Jose Luiz; Gagliardi, Talita Bianca; de Paula, Flavia Escremim; Iwamoto, Marisa Akiko; Criado, Miria Ferreira; Camara, Ataide A.; Acrani, Gustavo Olszanski; Leite Cintra, Otavio Augusto; Cervi, Maria Celia; de Paula Arruda, Luisa Karla; Arruda, Eurico			Detection of Human Bocavirus mRNA in Respiratory Secretions Correlates with High Viral Load and Concurrent Diarrhea	PLOS ONE			English	Article							REAL-TIME PCR; EPIDEMIOLOGIC PROFILE; ACUTE GASTROENTERITIS; YOUNG-CHILDREN; TRACT SAMPLES; INFECTIONS; VIRUS; PARVOVIRUS; FREQUENT; BRAZIL	Human bocavirus (HBoV) is a parvovirus recently identified in association with acute respiratory infections (ARI). Despite its worldwide occurrence, little is known on the pathogenesis of HBoV infections. In addition, few systematic studies of HBoV in ARI have been conducted in Latin America. Therefore, in order to test whether active viral replication of human bocavirus is associated with respiratory diseases and to understand the clinical impact of this virus in patients with these diseases, we performed a 3-year retrospective hospital-based study of HBoV in outpatients and inpatients with symptoms of Acute Respiratory Infections (ARI) in Brazil. Nasopharyngeal aspirates (NPAs) from 1015 patients with respiratory symptoms were tested for HBoV DNA by PCR. All samples positive for HBoV were tested by PCR for all other respiratory viruses, had HBoV viral loads determined by quantitative real time PCR and, when possible, were tested by RT-PCR for HBoV VP1 mRNA, as evidence of active viral replication. HBoV was detected in 4.8% of patients, with annual rates of 10.0%, 3.0% and 3.0% in 2005, 2006 and 2007, respectively. The range of respiratory symptoms was similar between HBoV-positive and HBoV-negative ARI patients. However, a higher rate of diarrhea was observed in HBoV-positive patients. High HBoV viral loads (> 10(8) copies/mL) and diarrhea were significantly more frequent in patients with exclusive infection by HBoV and in patients with detection of HBoV VP1 mRNA than in patients with viral co-infection, detected in 72.9% of patients with HBoV. In summary, our data demonstrated that active HBoV replication was detected in a small percentage of patients with ARI and was correlated with concurrent diarrhea and lack of other viral co-infections.	[Proenca-Modena, Jose Luiz; Gagliardi, Talita Bianca; de Paula, Flavia Escremim; Criado, Miria Ferreira; Acrani, Gustavo Olszanski; Arruda, Eurico] Univ Sao Paulo, Sch Med, Dept Cell Biol, Sao Paulo, Brazil; [de Paula Arruda, Luisa Karla] Univ Sao Paulo, Sch Med, Dept Internal Med, Sao Paulo, Brazil; [Leite Cintra, Otavio Augusto; Cervi, Maria Celia] Univ Sao Paulo, Sch Med, Dept Pediat, Sao Paulo, Brazil; [Proenca-Modena, Jose Luiz; Gagliardi, Talita Bianca; de Paula, Flavia Escremim; Iwamoto, Marisa Akiko; Criado, Miria Ferreira; Acrani, Gustavo Olszanski; Arruda, Eurico] Univ Sao Paulo, Sch Med, Virol Res Ctr, Sao Paulo, Brazil; [Camara, Ataide A.] Santa Lydia Hosp, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo	Proenca-Modena, JL (corresponding author), Univ Sao Paulo, Sch Med, Dept Cell Biol, Sao Paulo, Brazil.	jlmodena@usp.br	Gagliardi, Talita/V-1342-2019; Arruda, Eurico/E-4101-2012; Arruda, L. Karla/D-5845-2013; Cervi, Maria Celia/P-2567-2016; Proenca-Modena, Jose Luiz/C-8231-2014; Acrani, Gustavo/M-3885-2014	Gagliardi, Talita/0000-0003-4953-7135; Arruda, L. Karla/0000-0002-7505-210X; Cervi, Maria Celia/0000-0002-6563-6507; Proenca-Modena, Jose Luiz/0000-0002-4996-3153; 	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2008/50617-6, 2009/52388-7, 2009/51818-8]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [141654/2005-8]; Fundacao de Apoio ao Ensino, Pesquisa e Assistencia do Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto da Universidade de Sao Paulo	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Apoio ao Ensino, Pesquisa e Assistencia do Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto da Universidade de Sao Paulo	This work was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2008/50617-6, 2009/52388-7, 2009/51818-8], the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [141654/2005-8] and the Fundacao de Apoio ao Ensino, Pesquisa e Assistencia do Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto da Universidade de Sao Paulo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERT A, 1984, BIOMETRIKA, V71, P1; Albuquerque MCM, 2007, EMERG INFECT DIS, V13, P1756, DOI 10.3201/eid1311.070671; Albuquerque MCM, 2009, EMERG INFECT DIS, V15, P806, DOI 10.3201/eid1505.081603; Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Allander T, 2007, CLIN INFECT DIS, V44, P904, DOI 10.1086/512196; Arthur JL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000391; Bastien N, 2006, EMERG INFECT DIS, V12, P848, DOI 10.3201/eid1205.051424; Bonzel L, 2008, PEDIATR INFECT DIS J, V27, P589, DOI 10.1097/INF.0b013e3181694fb9; Camara AA, 2004, J ALLERGY CLIN IMMUN, V113, P551, DOI 10.1016/j.jaci.2003.11.027; Cheng WX, 2008, CLIN INFECT DIS, V47, P161, DOI 10.1086/589244; Chow BDW, 2009, CLIN LAB MED, V29, P695, DOI 10.1016/j.cll.2009.07.010; *CIIAGRO, 2010, MON CLIM ANT 2005 20; Dijkman R, 2009, J VIROL, V83, P7739, DOI 10.1128/JVI.00614-09; DURIGON GS, J HOSP INFECT, V76, P171; Esposito S, 2008, J CLIN MICROBIOL, V46, P1337, DOI 10.1128/JCM.02160-07; Fry AM, 2007, J INFECT DIS, V195, P1038, DOI 10.1086/512163; Gagliardi TB, 2009, EPIDEMIOL INFECT, V137, P1032, DOI 10.1017/S0950268808001842; Kapoor A, 2009, J INFECT DIS, V199, P196, DOI 10.1086/595831; Kapoor A, 2010, J INFECT DIS, V201, P1633, DOI 10.1086/652416; Kesebir D, 2006, J INFECT DIS, V194, P1276, DOI 10.1086/508213; Lee JI, 2007, J INFECT DIS, V196, P994, DOI 10.1086/521366; LONGTIN J, J INFECT DIS, V202, P1618; LONGTIN J, J INFECT DIS, V202, P1617; Longtin J, 2008, EMERG INFECT DIS, V14, P217, DOI 10.3201/eid1402.070851; Lu XY, 2008, EMERG INFECT DIS, V14, P1332, DOI 10.3201/eid1408.080300; Maggi F, 2007, J CLIN VIROL, V38, P321, DOI 10.1016/j.jcv.2007.01.008; Manning A, 2006, J INFECT DIS, V194, P1283, DOI 10.1086/508219; Manteufel J, 2008, INTERVIROLOGY, V51, P328, DOI 10.1159/000173734; Martin ET, 2010, J INFECT DIS, V201, P1625, DOI 10.1086/652405; Monteny M, 2007, EMERG INFECT DIS, V13, P180, DOI 10.3201/eid1301.060819; Neske F, 2007, J CLIN MICROBIOL, V45, P2116, DOI 10.1128/JCM.00027-07; Regamey N, 2008, PEDIATR INFECT DIS J, V27, P100, DOI 10.1097/INF.0b013e31815922c8; Regamey N, 2007, PEDIATR INFECT DIS J, V26, P177, DOI 10.1097/01.inf.0000250623.43107.bc; Russell KL, 2006, J INFECT DIS, V194, P877, DOI 10.1086/507426; Santos N, 2010, J CLIN VIROL, V48, P127, DOI 10.1016/j.jcv.2010.03.014; Schildgen O, 2008, CLIN MICROBIOL REV, V21, P291, DOI 10.1128/CMR.00030-07; Soderlund-Venermo M, 2009, EMERG INFECT DIS, V15, P1423, DOI 10.3201/eid1509.090204; Souza EL, 2009, J TROP PEDIAT; Tozer SJ, 2009, J MED VIROL, V81, P488, DOI 10.1002/jmv.21409; Vicente D, 2007, EMERG INFECT DIS, V13, P636, DOI 10.3201/eid1304.061501; Walsh EE, 1997, J INFECT DIS, V175, P814, DOI 10.1086/513976; Wong S, 2008, J MED VIROL, V80, P856, DOI 10.1002/jmv.21136	42	32	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e21083	10.1371/journal.pone.0021083	http://dx.doi.org/10.1371/journal.pone.0021083			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	21701591	Green Submitted, Green Published, gold			2022-12-27	WOS:000291983800022
J	Lehne, B; Lewis, CM; Schlitt, T				Lehne, Benjamin; Lewis, Cathryn M.; Schlitt, Thomas			From SNPs to Genes: Disease Association at the Gene Level	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ALPHA-DYSTROGLYCAN; PATHWAY ANALYSIS; COMMON DISEASES; CROHNS-DISEASE; SUSCEPTIBILITY; IDENTIFICATION; VARIANTS; MUTATION; RECEPTOR	Interpreting Genome-Wide Association Studies (GWAS) at a gene level is an important step towards understanding the molecular processes that lead to disease. In order to incorporate prior biological knowledge such as pathways and protein interactions in the analysis of GWAS data it is necessary to derive one measure of association for each gene. We compare three different methods to obtain gene-wide test statistics from Single Nucleotide Polymorphism (SNP) based association data: choosing the test statistic from the most significant SNP; the mean test statistics of all SNPs; and the mean of the top quartile of all test statistics. We demonstrate that the gene-wide test statistics can be controlled for the number of SNPs within each gene and show that all three methods perform considerably better than expected by chance at identifying genes with confirmed associations. By applying each method to GWAS data for Crohn's Disease and Type 1 Diabetes we identified new potential disease genes.	[Lehne, Benjamin; Lewis, Cathryn M.; Schlitt, Thomas] Kings Coll London, Dept Med & Mol Genet, London WC2R 2LS, England; [Lewis, Cathryn M.] Kings Coll London, Inst Psychiat, Social Genet & Dev Psychiat Ctr, London WC2R 2LS, England	University of London; King's College London; University of London; King's College London	Lehne, B (corresponding author), Kings Coll London, Dept Med & Mol Genet, London WC2R 2LS, England.	thomas.schlitt@kcl.ac.uk	Schlitt, Thomas/GWQ-8928-2022; Lewis, Cathryn/M-8766-2019; Lewis, Cathryn M/A-5225-2010; Schlitt, Thomas/F-2123-2010	Lewis, Cathryn/0000-0002-8249-8476; Lewis, Cathryn M/0000-0002-8249-8476; Schlitt, Thomas/0000-0002-0508-3971	King's College London (KCL); Wellcome Trust [076113, 085475]; Medical Research Council [G9817803B] Funding Source: researchfish	King's College London (KCL); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by King's College London (KCL) and the KCL Systems Biomedicine Graduate Program (SBGP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study makes use of data generated by the Wellcome Trust Case-Control Consortium. A full list of the investigators who contributed to the generation of the data is available from www.wtccc.org.uk. Funding for the Wellcome Trust Case-Control Consortium was provided by the Wellcome Trust under award 076113 and 085475.	[Anonymous], 1932, STAT METHODS RES WOR; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ballard David H, 2009, BMC Proc, V3 Suppl 7, pS91; Baranzini SE, 2009, HUM MOL GENET, V18, P2078, DOI 10.1093/hmg/ddp120; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Brorsson C, 2009, DIABETES OBES METAB, V11, P60, DOI 10.1111/j.1463-1326.2008.01004.x; Buil Alfonso, 2009, BMC Proc, V3 Suppl 7, pS130; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cao W, 1998, SCIENCE, V282, P2079, DOI 10.1126/science.282.5396.2079; Chapman J, 2008, GENET EPIDEMIOL, V32, P560, DOI 10.1002/gepi.20330; Cui YH, 2008, GENETICS, V179, P637, DOI 10.1534/genetics.107.082370; De la Cruz O, 2010, GENET EPIDEMIOL, V34, P222, DOI 10.1002/gepi.20452; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dudbridge F, 2008, GENET EPIDEMIOL, V32, P227, DOI 10.1002/gepi.20297; El Kasmi KC, 2007, J IMMUNOL, V179, P7215, DOI 10.4049/jimmunol.179.11.7215; Elbers CC, 2009, GENET EPIDEMIOL, V33, P419, DOI 10.1002/gepi.20395; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Franke L, 2006, AM J HUM GENET, V78, P1011, DOI 10.1086/504300; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Hampe J, 2001, LANCET, V357, P1925, DOI 10.1016/S0140-6736(00)05063-7; Holden M, 2008, BIOINFORMATICS, V24, P2784, DOI 10.1093/bioinformatics/btn516; Holmans P, 2009, AM J HUM GENET, V85, P13, DOI 10.1016/j.ajhg.2009.05.011; Hong MG, 2009, HUM GENET, V126, P289, DOI 10.1007/s00439-009-0676-z; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Lasko TA, 2005, J BIOMED INFORM, V38, P404, DOI 10.1016/j.jbi.2005.02.008; Lehne B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-92; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li MX, 2011, AM J HUM GENET, V88, P283, DOI 10.1016/j.ajhg.2011.01.019; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; MOSKVINA V, 2008, MOL PSYCHIAT; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Perry JRB, 2009, DIABETES, V58, P1463, DOI 10.2337/db08-1378; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rambukkana A, 1998, SCIENCE, V282, P2076, DOI 10.1126/science.282.5396.2076; Raychaudhuri S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000534; Segre AV, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001058; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Torkamani A, 2008, GENOMICS, V92, P265, DOI 10.1016/j.ygeno.2008.07.011; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Wang K, 2010, NAT REV GENET, V11, P843, DOI 10.1038/nrg2884; Wang K, 2009, AM J HUM GENET, V84, P399, DOI 10.1016/j.ajhg.2009.01.026; Warth A, 2008, MED HYPOTHESES, V70, P369, DOI 10.1016/j.mehy.2007.05.013; Yu K, 2009, GENET EPIDEMIOL, V33, P700, DOI 10.1002/gepi.20422	47	54	56	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e20133	10.1371/journal.pone.0020133	http://dx.doi.org/10.1371/journal.pone.0020133			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738570	gold, Green Published, Green Submitted			2022-12-27	WOS:000292291800002
J	Meeuwissen, EB; Takashima, A; Fernandez, G; Jensen, O				Meeuwissen, Esther Berendina; Takashima, Atsuko; Fernandez, Guillen; Jensen, Ole			Evidence for Human Fronto-Central Gamma Activity during Long-Term Memory Encoding of Word Sequences	PLOS ONE			English	Article							POSTERIOR PARIETAL CORTEX; BAND RESPONSES; NEURONAL SYNCHRONIZATION; ILLUSORY TRIANGLES; PREFRONTAL CORTEX; WORKING-MEMORY; OSCILLATIONS; TASK; EEG; HIPPOCAMPAL	Although human gamma activity (30-80 Hz) associated with visual processing is often reported, it is not clear to what extend gamma activity can be reliably detected non-invasively from frontal areas during complex cognitive tasks such as long term memory (LTM) formation. We conducted a memory experiment composed of 35 blocks each having three parts: LTM encoding, working memory (WM) maintenance and LTM retrieval. In the LTM encoding and WM maintenance parts, participants had to respectively encode or maintain the order of three sequentially presented words. During LTM retrieval subjects had to reproduce these sequences. Using magnetoencephalography (MEG) we identified significant differences in the gamma and beta activity. Robust gamma activity (55-65 Hz) in left BA6 (supplementary motor area (SMA)/pre-SMA) was stronger during LTM rehearsal than during WM maintenance. The gamma activity was sustained throughout the 3.4 s rehearsal period during which a fixation cross was presented. Importantly, the difference in gamma band activity correlated with memory performance over subjects. Further we observed a weak gamma power difference in left BA6 during the first half of the LTM rehearsal interval larger for successfully than unsuccessfully reproduced word triplets. In the beta band, we found a power decrease in left anterior regions during LTM rehearsal compared to WM maintenance. Also this suppression of beta power correlated with memory performance over subjects. Our findings show that an extended network of brain areas, characterized by oscillatory activity in different frequency bands, supports the encoding of word sequences in LTM. Gamma band activity in BA6 possibly reflects memory processes associated with language and timing, and suppression of beta activity at left frontal sensors is likely to reflect the release of inhibition directly associated with the engagement of language functions.	[Meeuwissen, Esther Berendina; Takashima, Atsuko; Fernandez, Guillen; Jensen, Ole] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behaviour, NL-6525 ED Nijmegen, Netherlands; [Takashima, Atsuko] Koninklijke Kentalis, St Michielsgestel, Netherlands	Radboud University Nijmegen	Meeuwissen, EB (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behaviour, NL-6525 ED Nijmegen, Netherlands.	ole.jensen@fcdonders.ru.nl	Jensenq, Ole/D-2120-2010; Fernandez, Guillen/B-3771-2009; Takashima, Atsuko/E-7880-2012	Jensenq, Ole/0000-0001-8193-8348; Fernandez, Guillen/0000-0002-5522-0604; Takashima, Atsuko/0000-0003-1114-6526	Netherlands Organization for Scientific Research [400-06-051]; VICI [453-09-002]; Netherlands Ministry of Economic Affairs; Netherlands Ministry of Education, Culture and Science the Netherlands Initiative Brain and Cognition	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); VICI(Netherlands Organization for Scientific Research (NWO)); Netherlands Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); Netherlands Ministry of Education, Culture and Science the Netherlands Initiative Brain and Cognition	This work was supported by the Netherlands Organization for Scientific Research (http://www.nwo.nl) grant number 400-06-051, VICI grant number 453-09-002 and the BrainGain Smart Mix Programme of the Netherlands Ministry of Economic Affairs and the Netherlands Ministry of Education, Culture and Science the Netherlands Initiative Brain and Cognition. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjamian P, 2004, EUR J NEUROSCI, V20, P587, DOI 10.1111/j.1460-9568.2004.03495.x; Axmacher N, 2008, CEREB CORTEX, V18, P2868, DOI 10.1093/cercor/bhn045; Axmacher N, 2006, BRAIN RES REV, V52, P170, DOI 10.1016/j.brainresrev.2006.01.007; Baker JT, 2001, NEUROREPORT, V12, P1251, DOI 10.1097/00001756-200105080-00039; Bastiaansen MCM, 2000, CLIN NEUROPHYSIOL, V111, P1300, DOI 10.1016/S1388-2457(00)00272-8; Blumenfeld RS, 2007, NEUROSCIENTIST, V13, P280, DOI 10.1177/1073858407299290; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Chaumon M, 2009, J COGNITIVE NEUROSCI, V21, P2287, DOI 10.1162/jocn.2008.21155; CRAIK FIM, 1975, J EXP PSYCHOL GEN, V104, P268, DOI 10.1037/0096-3445.104.3.268; Davachi L, 2001, J COGNITIVE NEUROSCI, V13, P1059, DOI 10.1162/089892901753294356; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; Fell J, 2001, NAT NEUROSCI, V4, P1259, DOI 10.1038/nn759; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Fries P, 2007, TRENDS NEUROSCI, V30, P309, DOI 10.1016/j.tins.2007.05.005; Gabrieli JDE, 1998, P NATL ACAD SCI USA, V95, P906, DOI 10.1073/pnas.95.3.906; Gross J, 2001, P NATL ACAD SCI USA, V98, P694, DOI 10.1073/pnas.98.2.694; Gruber T, 2008, BRAIN RES, V1196, P74, DOI 10.1016/j.brainres.2007.12.037; Gruber T, 2004, NEUROREPORT, V15, P1837, DOI 10.1097/01.wnr.0000137077.26010.12; Haegens S, 2010, HUM BRAIN MAPP, V31, P26, DOI 10.1002/hbm.20842; Hagoort P, 2008, PHILOS T R SOC B, V363, P1055, DOI 10.1098/rstb.2007.2159; HANSEN P, MEG INTRO METHODS; Hanslmayr S, 2009, CEREB CORTEX, V19, P1631, DOI 10.1093/cercor/bhn197; Hoogenboom N, 2006, NEUROIMAGE, V29, P764, DOI 10.1016/j.neuroimage.2005.08.043; Indefrey P, 2004, COGNITION, V92, P101, DOI 10.1016/j.cognition.2002.06.001; Jensen O, 2007, TRENDS NEUROSCI, V30, P317, DOI 10.1016/j.tins.2007.05.001; Jutras MJ, 2009, J NEUROSCI, V29, P12521, DOI 10.1523/JNEUROSCI.0640-09.2009; Kaiser J, 2004, NEUROIMAGE, V23, P551, DOI 10.1016/j.neuroimage.2004.06.033; Kaiser J, 2009, NEUROIMAGE, V46, P1127, DOI 10.1016/j.neuroimage.2009.03.011; Kim H, 2011, NEUROIMAGE, V54, P2446, DOI 10.1016/j.neuroimage.2010.09.045; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Majerus S, 2010, J COGNITIVE NEUROSCI, V22, P2570, DOI 10.1162/jocn.2009.21378; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Mazaheri A, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00177; MEEUWISSEN E, 2010, HUM BRAIN M IN PRESS; Montgomery SM, 2007, P NATL ACAD SCI USA, V104, P14495, DOI 10.1073/pnas.0701826104; Nachev P, 2008, NAT REV NEUROSCI, V9, P856, DOI 10.1038/nrn2478; Neuper C, 2001, INT J PSYCHOPHYSIOL, V43, P41, DOI 10.1016/S0167-8760(01)00178-7; Nieuwenhuis ILC, 2008, NEUROIMAGE, V40, P1319, DOI 10.1016/j.neuroimage.2007.12.052; Nolte G, 2003, PHYS MED BIOL, V48, P3637, DOI 10.1088/0031-9155/48/22/002; Osipova D, 2006, J NEUROSCI, V26, P7523, DOI 10.1523/JNEUROSCI.1948-06.2006; Pesaran B, 2002, NAT NEUROSCI, V5, P805, DOI 10.1038/nn890; Price CJ, 2010, ANN NY ACAD SCI, V1191, P62, DOI 10.1111/j.1749-6632.2010.05444.x; Prince SE, 2005, J NEUROSCI, V25, P1203, DOI 10.1523/JNEUROSCI.2540-04.2005; SALMELIN R, 1994, NATURE, V368, P463, DOI 10.1038/368463a0; Sederberg PB, 2007, CEREB CORTEX, V17, P1190, DOI 10.1093/cercor/bhl030; Siegel M, 2003, J NEUROSCI, V23, P4251; SINGER W, 1993, ANNU REV PHYSIOL, V55, P349, DOI 10.1146/annurev.physiol.55.1.349; Staresina BP, 2009, CEREB CORTEX, V19, P1198, DOI 10.1093/cercor/bhn165; Tallon-Baudry C, 1999, TRENDS COGN SCI, V3, P151, DOI 10.1016/S1364-6613(99)01299-1; TallonBaudry C, 1996, J NEUROSCI, V16, P4240; TallonBaudry C, 1997, J NEUROSCI, V17, P722; TallonBaudry C, 1997, NEUROREPORT, V8, P1103, DOI 10.1097/00001756-199703240-00008; Uncapher MR, 2009, NEUROBIOL LEARN MEM, V91, P139, DOI 10.1016/j.nlm.2008.10.011; Van der Werf J, 2008, J NEUROSCI, V28, P8397, DOI 10.1523/JNEUROSCI.0630-08.2008; Van der Werf J, 2010, J NEUROSCI, V30, P1402, DOI 10.1523/JNEUROSCI.3448-09.2010; Wiener M, 2010, NEUROIMAGE, V49, P1728, DOI 10.1016/j.neuroimage.2009.09.064; Wyart V, 2008, J NEUROSCI, V28, P2667, DOI 10.1523/JNEUROSCI.4748-07.2008; Yuval-Greenberg S, 2008, NEURON, V58, P429, DOI 10.1016/j.neuron.2008.03.027	58	24	25	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21356	10.1371/journal.pone.0021356	http://dx.doi.org/10.1371/journal.pone.0021356			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	786FZ	21738641	Green Submitted, Green Published, gold			2022-12-27	WOS:000292290100019
J	Aguirre, B; Costas, M; Cabrera, N; Mendoza-Hernandez, G; Helseth, DL; Fernandez, P; de Gomez-Puyou, MT; Perez-Montfort, R; Torres-Larios, A; Puyou, AG				Aguirre, Beatriz; Costas, Miguel; Cabrera, Nallely; Mendoza-Hernandez, Guillermo; Helseth, Donald L., Jr.; Fernandez, Paulette; Tuena de Gomez-Puyou, Marietta; Perez-Montfort, Ruy; Torres-Larios, Alfredo; Gomez Puyou, Armando			A Ribosomal Misincorporation of Lys for Arg in Human Triosephosphate Isomerase Expressed in Escherichia coli Gives Rise to Two Protein Populations	PLOS ONE			English	Article							GENETIC-CODE; SACCHAROMYCES-CEREVISIAE; MISSENSE ERRORS; GIARDIA-LAMBLIA; AGA CODONS; ARGININE; AMINO; MISTRANSLATION; LEVEL; TIM	We previously observed that human homodimeric triosephosphate isomerase (HsTIM) expressed in Escherichia coli and purified to apparent homogeneity exhibits two significantly different thermal transitions. A detailed exploration of the phenomenon showed that the preparations contain two proteins; one has the expected theoretical mass, while the mass of the other is 28 Da lower. The two proteins were separated by size exclusion chromatography in 3 M urea. Both proteins correspond to HsTIM as shown by Tandem Mass Spectrometry (LC/ESI-MS/MS). The two proteins were present in nearly equimolar amounts under certain growth conditions. They were catalytically active, but differed in molecular mass, thermostability, susceptibility to urea and proteinase K. An analysis of the nucleotides in the human TIM gene revealed the presence of six codons that are not commonly used in E. coli. We examined if they were related to the formation of the two proteins. We found that expression of the enzyme in a strain that contains extra copies of genes that encode for tRNAs that frequently limit translation of heterologous proteins (Arg, Ile, Leu), as well as silent mutations of two consecutive rare Arg codons (positions 98 and 99), led to the exclusive production of the more stable protein. Further analysis by LC/ESI-MS/MS showed that the 28 Da mass difference is due to the substitution of a Lys for an Arg residue at position 99. Overall, our work shows that two proteins with different biochemical and biophysical properties that coexist in the same cell environment are translated from the same nucleotide sequence frame.	[Aguirre, Beatriz; Cabrera, Nallely; Fernandez, Paulette; Tuena de Gomez-Puyou, Marietta; Perez-Montfort, Ruy; Torres-Larios, Alfredo; Gomez Puyou, Armando] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Bioquim & Biol Estruct, Mexico City 04510, DF, Mexico; [Costas, Miguel] Univ Nacl Autonoma Mexico, Fac Quim, Dept Quim Fis, Lab Biofis Quim, Mexico City 04510, DF, Mexico; [Mendoza-Hernandez, Guillermo] Univ Nacl Autonoma Mexico, Fac Med, Dept Bioquim, Mexico City 04510, DF, Mexico; [Helseth, Donald L., Jr.] Univ Illinois, CBC RRC Prote & Informat Serv, Chicago, IL USA	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Aguirre, B (corresponding author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Bioquim & Biol Estruct, Mexico City 04510, DF, Mexico.	torres@ifc.unam.mx; apuyou@ifc.unam.mx		Costas, Miguel/0000-0001-8604-6381; Torres-Larios, Alfredo/0000-0002-0702-350X; Cabrera Gonzalez, Elizabeth Nallely/0000-0001-8766-6996; Perez-Montfort, Ruy/0000-0003-0810-1159; FERNANDEZ-CARDENAS, Laura Paulette/0000-0002-4976-6467	Consejo Nacional de Ciencia y Tecnologia [60127-Q, 99844]; Universidad Nacional Autonoma de Mexico [IN202910, IN104210]; Instituto de Ciencia y Tecnologia del Distrito Federal [PIFUTP09-279, ICyTDF/304/2009]; Chicago Community Trust	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico); Instituto de Ciencia y Tecnologia del Distrito Federal; Chicago Community Trust	This work was supported by Consejo Nacional de Ciencia y Tecnologia grants 60127-Q to AT-L and 99844 to MC, Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, Universidad Nacional Autonoma de Mexico (PAPIIT) grants IN202910 to AT-L and IN104210 to MC, and Instituto de Ciencia y Tecnologia del Distrito Federal grants PIFUTP09-279 to AT-L and ICyTDF/304/2009 to RPM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; ESI services were provided by the CBC-UIC Research Resources Center Proteomics and Informatics Services Facility, which was established by a grant from The Searle Funds at the Chicago Community Trust to the Chicago Biomedical Consortium. The technical assistance of Selma Diaz Mazariegos is greatly appreciated. We gratefully acknowledge stimulating discussions with Dr. Jose Manuel Sanchez Ruiz at the early stages of this work.	Angov E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002189; BOUADLOUN F, 1983, EMBO J, V2, P1351, DOI 10.1002/j.1460-2075.1983.tb01591.x; Calderone TL, 1996, J MOL BIOL, V262, P407, DOI 10.1006/jmbi.1996.0524; Day AJ, 1996, PROTEIN EXPRES PURIF, V8, P1, DOI 10.1006/prep.1996.0068; Dittmar KA, 2005, EMBO REP, V6, P151, DOI 10.1038/sj.embor.7400341; Drummond DA, 2009, NAT REV GENET, V10, P715, DOI 10.1038/nrg2662; EDELMANN P, 1977, CELL, V10, P131, DOI 10.1016/0092-8674(77)90147-7; Forman MD, 1998, PROTEIN SCI, V7, P500; Freeland SJ, 1998, J MOL EVOL, V47, P238, DOI 10.1007/PL00006381; Gayathri P, 2007, ACTA CRYSTALLOGR D, V63, P206, DOI 10.1107/S0907444906046488; Geoghegan KF, 1999, ANAL BIOCHEM, V267, P169, DOI 10.1006/abio.1998.2990; Goldsmith M, 2009, P NATL ACAD SCI USA, V106, P6197, DOI 10.1073/pnas.0809506106; Gomes AC, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r206; Hernandez-Alcantara G, 2008, BBA-PROTEINS PROTEOM, V1784, P1493, DOI 10.1016/j.bbapap.2008.05.016; Hershberg R, 2008, ANNU REV GENET, V42, P287, DOI 10.1146/annurev.genet.42.110807.091442; KANE JF, 1995, CURR OPIN BIOTECH, V6, P494, DOI 10.1016/0958-1669(95)80082-4; Kapust RB, 1999, PROTEIN SCI, V8, P1668, DOI 10.1110/ps.8.8.1668; Kinter M., 2000, PROTEIN SEQUENCING I, DOI 10.1002/0471721980; Kramer EB, 2007, RNA, V13, P87, DOI 10.1261/rna.294907; Kramer EB, 2010, RNA, V16, P1797, DOI 10.1261/rna.2201210; Kurland C, 1996, CURR OPIN BIOTECH, V7, P489, DOI 10.1016/S0958-1669(96)80050-4; LAUGHREA M, 1987, EUR J BIOCHEM, V169, P59, DOI 10.1111/j.1432-1033.1987.tb13580.x; Ledoux S, 2009, NAT STRUCT MOL BIOL, V16, P359, DOI 10.1038/nsmb.1581; Lopez-Velazquez G, 2004, PROTEINS, V55, P824, DOI 10.1002/prot.20097; Maertens B, 2010, PROTEIN SCI, V19, P1312, DOI 10.1002/pro.408; Maes D, 1999, PROTEINS, V37, P441, DOI 10.1002/(SICI)1097-0134(19991115)37:3<441::AID-PROT11>3.3.CO;2-Z; Mainfroid V, 1996, J MOL BIOL, V257, P441, DOI 10.1006/jmbi.1996.0174; *MATR SCI, SEQ DAT SET UT; McNulty DE, 2003, PROTEIN EXPRES PURIF, V27, P365, DOI 10.1016/S1046-5928(02)00610-1; MCPHERSON DT, 1988, NUCLEIC ACIDS RES, V16, P4111, DOI 10.1093/nar/16.9.4111; Meyerovich M, 2010, P NATL ACAD SCI USA, V107, P11543, DOI 10.1073/pnas.0912989107; Mottaz A, 2010, BIOINFORMATICS, V26, P851, DOI 10.1093/bioinformatics/btq028; Moura GR, 2009, CURR OPIN MICROBIOL, V12, P631, DOI 10.1016/j.mib.2009.09.004; Murakami H, 2009, NAT STRUCT MOL BIOL, V16, P353, DOI 10.1038/nsmb.1580; Nakamura Y, 2000, NUCLEIC ACIDS RES, V28, P292, DOI 10.1093/nar/28.1.292; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; PARKER J, 1989, MICROBIOL REV, V53, P273, DOI 10.1128/MMBR.53.3.273-298.1989; Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899; Powers ET, 2008, CELL, V134, P204, DOI 10.1016/j.cell.2008.07.005; Rodriguez-Almazan C, 2008, J BIOL CHEM, V283, P23254, DOI 10.1074/jbc.M802145200; Schmeing TM, 2011, NAT STRUCT MOL BIOL, V18, P432, DOI 10.1038/nsmb.2003; SEETHARAM R, 1988, BIOCHEM BIOPH RES CO, V155, P518, DOI 10.1016/S0006-291X(88)81117-3; STARK GR, 1965, BIOCHEMISTRY-US, V4, P1030, DOI 10.1021/bi00882a008; Szaflarski W, 2008, J MOL BIOL, V380, P193, DOI 10.1016/j.jmb.2008.04.060; Wang Wenyan, 2002, Methods Mol Biol, V182, P37; Yu XC, 2009, ANAL CHEM, V81, P9282, DOI 10.1021/ac901541h; SWISSKNIFE PERL MODU; VARSPLIC UTILITY ALT	48	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21035	10.1371/journal.pone.0021035	http://dx.doi.org/10.1371/journal.pone.0021035			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738601	Green Published, gold, Green Submitted			2022-12-27	WOS:000292142800009
J	Wells, RC; Hill, RB				Wells, Robert C.; Hill, R. Blake			The Cytosolic Domain of Fis1 Binds and Reversibly Clusters Lipid Vesicles	PLOS ONE			English	Article							FISSION PROTEIN FIS1; TAIL-ANCHORED PROTEINS; DYNAMIN-RELATED GTPASE; MITOCHONDRIAL FISSION; MEMBRANE-FUSION; CYTOCHROME-C; PEROXISOMAL FISSION; DNM1P; BAX; BCL-X(L)	Every lipid membrane fission event involves the association of two apposing bilayers, mediated by proteins that can promote membrane curvature, fusion and fission. We tested the hypothesis that Fis1, a tail-anchored protein involved in mitochondrial and peroxisomal fission, promotes changes in membrane structure. We found that the cytosolic domain of Fis1 alone binds lipid vesicles, which is enhanced upon protonation and increasing concentrations of anionic phospholipids. Fluorescence and circular dichroism data indicate that the cytosolic domain undergoes a membrane-induced conformational change that buries two tryptophan side chains upon membrane binding. Light scattering and electron microscopy data show that membrane binding promotes lipid vesicle clustering. Remarkably, this vesicle clustering is reversible and vesicles largely retain their original shape and size. This raises the possibility that the Fis1 cytosolic domain might act in membrane fission by promoting a reversible membrane association, a necessary step in membrane fission.	[Wells, Robert C.; Hill, R. Blake] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Hill, R. Blake] Johns Hopkins Univ, Dept Chem, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University	Wells, RC (corresponding author), Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA.	hill@jhu.edu		Hill, Blake/0000-0001-6228-3905	National Institutes of Health (NIH) [R01GM067180, 2T32GM007231]; American Cancer Society [IRG-58-005-41]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007231, R01GM067180] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) grant R01GM067180 (RBH) and American Cancer Society award IRG-58-005-41 (RBH). RCW was supported in part by a training grant from NIH (2T32GM007231). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam G., 1968, STRUCTURAL CHEM MOL; Antonsson B, 2000, BIOCHEM J, V345, P271, DOI 10.1042/0264-6021:3450271; Arac D, 2006, NAT STRUCT MOL BIOL, V13, P209, DOI 10.1038/nsmb1056; Basanez G, 2001, J BIOL CHEM, V276, P31083, DOI 10.1074/jbc.M103879200; BenTal N, 1996, BIOPHYS J, V71, P561, DOI 10.1016/S0006-3495(96)79280-9; BERGERS JJ, 1993, BIOCHEMISTRY-US, V32, P4641, DOI 10.1021/bi00068a023; Bhar D, 2006, J BIOL CHEM, V281, P17312, DOI 10.1074/jbc.M513530200; Borgese N, 2007, CURR OPIN CELL BIOL, V19, P368, DOI 10.1016/j.ceb.2007.04.019; Branden M, 2006, P NATL ACAD SCI USA, V103, P19766, DOI 10.1073/pnas.0605909103; CALHOUN D B, 1986, Proteins Structure Function and Genetics, V1, P109, DOI 10.1002/prot.340010202; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Cerveny KL, 2001, MOL BIOL CELL, V12, P309, DOI 10.1091/mbc.12.2.309; Cevc G., 1987, PHOSPHOLIPID BILAYER; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Cheever ML, 2001, NAT CELL BIOL, V3, P613, DOI 10.1038/35083000; CHERNOMORDIK L, 1995, J MEMBRANE BIOL, V146, P1; CORNELL RB, 1991, BIOCHEMISTRY-US, V30, P5873, DOI 10.1021/bi00238a010; DECAMILLI P, 1995, CURR OPIN NEUROBIOL, V5, P559, DOI 10.1016/0959-4388(95)80059-X; Dohm JA, 2004, PROTEINS, V54, P153, DOI 10.1002/prot.10524; Fannjiang Y, 2004, GENE DEV, V18, P2785, DOI 10.1101/gad.1247904; Fekkes P, 2000, J CELL BIOL, V151, P333, DOI 10.1083/jcb.151.2.333; Frazier AA, 2002, BIOCHEMISTRY-US, V41, P6282, DOI 10.1021/bi0160821; Griffin EE, 2005, J CELL BIOL, V170, P237, DOI 10.1083/jcb.200503148; Halskau O, 2009, CURR PROTEIN PEPT SC, V10, P339, DOI 10.2174/138920309788922199; Henderson MPA, 2007, METHODS, V41, P427, DOI 10.1016/j.ymeth.2006.07.004; Hinshaw JE, 2000, ANNU REV CELL DEV BI, V16, P483, DOI 10.1146/annurev.cellbio.16.1.483; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Hurley JH, 2006, BBA-MOL CELL BIOL L, V1761, P805, DOI 10.1016/j.bbalip.2006.02.020; Jofuku A, 2005, BIOCHEM BIOPH RES CO, V333, P650, DOI 10.1016/j.bbrc.2005.05.154; Johnson JE, 1999, MOL MEMBR BIOL, V16, P217, DOI 10.1080/096876899294544; Karren MA, 2005, J CELL BIOL, V171, P291, DOI 10.1083/jcb.200506158; KIM JH, 1989, ARCH BIOCHEM BIOPHYS, V274, P100, DOI 10.1016/0003-9861(89)90420-7; Koch A, 2003, J BIOL CHEM, V278, P8597, DOI 10.1074/jbc.M211761200; Kutay Ulrike, 1993, Trends in Cell Biology, V3, P72, DOI 10.1016/0962-8924(93)90066-A; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Lackner LL, 2009, SCIENCE, V325, P874, DOI 10.1126/science.1176921; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Lee SA, 2006, J BIOL CHEM, V281, P37091, DOI 10.1074/jbc.M608610200; Leinninger GM, 2006, NAT CLIN PRACT NEURO, V2, P620, DOI 10.1038/ncpneuro0320; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Luo PZ, 1997, BIOCHEMISTRY-US, V36, P8413, DOI 10.1021/bi9707133; Martens S, 2008, NAT REV MOL CELL BIO, V9, P543, DOI 10.1038/nrm2417; MERRILL AR, 1993, BIOCHEMISTRY-US, V32, P6974, DOI 10.1021/bi00078a023; Minn AJ, 1997, NATURE, V385, P353, DOI 10.1038/385353a0; Motley AM, 2008, J CELL SCI, V121, P1633, DOI 10.1242/jcs.026344; Mozdy AD, 2000, J CELL BIOL, V151, P367, DOI 10.1083/jcb.151.2.367; Murray D, 1997, STRUCTURE, V5, P985, DOI 10.1016/S0969-2126(97)00251-7; Nagotu S, 2008, TRAFFIC, V9, P1471, DOI 10.1111/j.1600-0854.2008.00772.x; Olichon A, 2006, BBA-MOL CELL RES, V1763, P500, DOI 10.1016/j.bbamcr.2006.04.003; Osteryoung KW, 2003, SCIENCE, V302, P1698, DOI 10.1126/science.1082192; Otsuga D, 1998, J CELL BIOL, V143, P333, DOI 10.1083/jcb.143.2.333; Picton LK, 2009, BIOCHEMISTRY-US, V48, P6598, DOI 10.1021/bi802221h; Rabu C, 2009, J CELL SCI, V122, P3605, DOI 10.1242/jcs.041210; Schauss AC, 2006, J CELL SCI, V119, P3098, DOI 10.1242/jcs.03026; Schiavo G, 1996, P NATL ACAD SCI USA, V93, P13327, DOI 10.1073/pnas.93.23.13327; Serasinghe MN, 2008, EXP CELL RES, V314, P3494, DOI 10.1016/j.yexcr.2008.09.009; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Smirnova E, 1998, J CELL BIOL, V143, P351, DOI 10.1083/jcb.143.2.351; Stachowiak O, 1996, BIOCHEMISTRY-US, V35, P15522, DOI 10.1021/bi961838v; STEGMANN T, 1989, ANNU REV BIOPHYS BIO, V18, P187, DOI 10.1146/annurev.bb.18.060189.001155; Stojanovski D, 2004, J CELL SCI, V117, P1201, DOI 10.1242/jcs.01058; Suzuki M, 2005, J BIOL CHEM, V280, P21444, DOI 10.1074/jbc.M414092200; Suzuki M, 2003, J MOL BIOL, V334, P445, DOI 10.1016/j.jmb.2003.09.064; Tan FJ, 2011, PROTEIN SCI, V20, P62, DOI 10.1002/pro.536; Thuduppathy GR, 2006, BIOCHEMISTRY-US, V45, P14533, DOI 10.1021/bi0616652; Thuduppathy GR, 2006, J MOL BIOL, V359, P1045, DOI 10.1016/j.jmb.2006.03.052; Tieu Q, 2000, J CELL BIOL, V151, P353, DOI 10.1083/jcb.151.2.353; TOCANNE JF, 1990, BIOCHIM BIOPHYS ACTA, V1031, P111, DOI 10.1016/0304-4157(90)90005-W; VAZ WLC, 1978, EUR J BIOCHEM, V83, P299, DOI 10.1111/j.1432-1033.1978.tb12094.x; Waterham HR, 2007, NEW ENGL J MED, V356, P1736, DOI 10.1056/NEJMoa064436; Wells RC, 2007, J BIOL CHEM, V282, P33769, DOI 10.1074/jbc.M700807200; Wimley WC, 1998, J MOL BIOL, V277, P1091, DOI 10.1006/jmbi.1998.1640; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Wu Y, 2003, P NATL ACAD SCI USA, V100, P2082, DOI 10.1073/pnas.0435872100; Yamashita T, 2010, J PHYS CHEM B, V114, P592, DOI 10.1021/jp908768c; Yethon JA, 2003, J BIOL CHEM, V278, P48935, DOI 10.1074/jbc.M306289200; Yoon Y, 2003, MOL CELL BIOL, V23, P5409, DOI 10.1128/MCB.23.15.5409-5420.2003; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P18526, DOI 10.1073/pnas.0706441104	78	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21384	10.1371/journal.pone.0021384	http://dx.doi.org/10.1371/journal.pone.0021384			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738650	Green Published, Green Submitted, gold			2022-12-27	WOS:000292142800017
J	Chen, J; Jia, ZY; Ma, ZL; Wang, YY; Teng, GJ				Chen, Jun; Jia, Zhen-Yu; Ma, Zhan-Long; Wang, Yuan-Yuan; Teng, Gao-Jun			In Vivo Serial MR Imaging of Magnetically Labeled Endothelial Progenitor Cells Homing to the Endothelium Injured Artery in Mice	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; IRON-OXIDE NANOPARTICLES; CAROTID-ARTERY; NEOINTIMAL HYPERPLASIA; ATHEROSCLEROSIS; MOUSE; TRANSPLANTATION; ANGIOGENESIS; TRAFFICKING; MICROSCOPY	Background: Emerging evidence of histopathological analyses suggests that endothelial progenitor cells (EPCs) play an important role in vascular diseases. Neointimal hyperplasia can be reduced by intravenous transfusion of EPCs after vascular injury in mice. Therefore, it would be advantageous to develop an in vivo technique that can explore the temporal and spatial migration of EPCs homing to the damaged endothelium noninvasively. Methodology/Principal Findings: The left carotid common artery (LCCA) was injured by removal of endothelium with a flexible wire in Kunming mice. EPCs were collected by in vitro culture of spleen-derived mouse mononuclear cells (MNCs). EPCs labeling was carried out in vitro using Fe2O3-poly-L-lysine (Fe2O3-PLL). In vivo serial MR imaging was performed to follow-up the injured artery at different time points after intravenous transfusion of EPCs. Vessel wall areas of injured artery were computed on T2WI. Larger MR signal voids of vessel wall on T2WI was revealed in all 6 mice of the labeled EPC transfusion group 15 days after LCCA injury, and it was found only in 1 mouse in the unlabeled EPC transfusion group (p = 0.015). Quantitative analyses of vessel wall areas on T2WI showed that the vessel wall areas of labeled EPC transfusion group were less than those of unlabeled EPC transfusion group and control group fifteen days after artery injury (p < 0.05). Histopathological analyses confirmed accumulation and distribution of transfused EPCs at the injury site of LCCA. Conclusions/Significance: These data indicate that MR imaging might be used as an in vivo method for the tracking of EPCs homing to the endothelium injured artery.	[Chen, Jun; Jia, Zhen-Yu; Ma, Zhan-Long; Wang, Yuan-Yuan; Teng, Gao-Jun] Southeast Univ, Jiangsu Key Lab Mol Imaging & Funct Imaging, Dept Radiol, Zhongda Hosp, Nanjing, Peoples R China	Southeast University - China	Chen, J (corresponding author), Southeast Univ, Jiangsu Key Lab Mol Imaging & Funct Imaging, Dept Radiol, Zhongda Hosp, Nanjing, Peoples R China.	gjteng@vip.sina.com			National Nature Science Foundation of China [90606007, 30910103905]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by National Nature Science Foundation of China (Grant number: 90606007,30910103905). URL: http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbab AS, 2006, STEM CELLS, V24, P671, DOI 10.1634/stemcells.2005-0017; Arbab AS, 2003, RADIOLOGY, V229, P838, DOI 10.1148/radiol.2293021215; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Bergeron P, 2005, J VASC SURG, V41, P213, DOI 10.1016/j.jvs.2004.11.037; Chen J, 2011, J NEUROIMAGING, V21, P49, DOI 10.1111/j.1552-6569.2010.00490.x; Choudhury RP, 2003, J MAGN RESON IMAGING, V17, P184, DOI 10.1002/jmri.10246; FERRUCCI JT, 1990, AM J ROENTGENOL, V155, P943, DOI 10.2214/ajr.155.5.2120963; Frank JA, 2003, RADIOLOGY, V228, P480, DOI 10.1148/radiol.2281020638; Griese DP, 2003, CIRCULATION, V108, P2710, DOI 10.1161/01.CIR.0000096490.16596.A6; Groschel K, 2009, STROKE, V40, pE340, DOI 10.1161/STROKEAHA.108.532713; Jia Zhen-Yu, 2010, Zhonghua Xin Xue Guan Bing Za Zhi, V38, P166; Ju SH, 2007, RADIOLOGY, V245, P206, DOI 10.1148/radiol.2443061290; Ju SH, 2006, MAGN RESON IMAGING, V24, P611, DOI 10.1016/j.mri.2005.12.017; Kipshidze N, 2004, J AM COLL CARDIOL, V44, P733, DOI 10.1016/j.jacc.2004.04.048; Kong D, 2004, CIRCULATION, V109, P1769, DOI 10.1161/01.CIR.0000121732.85572.6F; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; LINDNER V, 1993, CIRC RES, V73, P792, DOI 10.1161/01.RES.73.5.792; Litovsky S, 2003, CIRCULATION, V107, P1545, DOI 10.1161/01.CIR.0000055323.57885.88; Liu W, 2009, EUR J RADIOL, V70, P258, DOI 10.1016/j.ejrad.2008.09.021; Ma ZL, 2008, EUR RADIOL, V18, P2174, DOI 10.1007/s00330-008-0978-x; Ma ZL, 2009, ATHEROSCLEROSIS, V205, P80, DOI 10.1016/j.atherosclerosis.2008.07.048; Mai XL, 2009, CELL TRANSPLANT, V18, P171, DOI 10.3727/096368909788341306; Manka DR, 2000, J MAGN RESON IMAGING, V12, P790, DOI 10.1002/1522-2586(200011)12:5<790::AID-JMRI19>3.0.CO;2-6; POULIQUEN D, 1991, MAGN RESON IMAGING, V9, P275, DOI 10.1016/0730-725X(91)90412-F; Qiu BS, 2007, J MAGN RESON IMAGING, V26, P339, DOI 10.1002/jmri.21016; Serruys PW, 2009, NEW ENGL J MED, V360, P961, DOI 10.1056/NEJMoa0804626; Shapiro EM, 2006, MAGN RESON MED, V55, P242, DOI 10.1002/mrm.20718; Shapiro EM, 2004, P NATL ACAD SCI USA, V101, P10901, DOI 10.1073/pnas.0403918101; Sun JH, 2008, CELL TRANSPLANT, V17, P279, DOI 10.3727/096368908784153878; Werner N, 2006, J CELL MOL MED, V10, P318, DOI 10.1111/j.1582-4934.2006.tb00402.x; Werner N, 2003, CIRC RES, V93, pE17, DOI 10.1161/01.RES.0000083812.30141.74; Werner N, 2007, ANN MED, V39, P82, DOI 10.1080/07853890601073429; Yocum GT, 2005, RADIOLOGY, V235, P547, DOI 10.1148/radiol.2352040383; Zampetaki A, 2008, CARDIOVASC RES, V78, P413, DOI 10.1093/cvr/cvn081	34	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e20790	10.1371/journal.pone.0020790	http://dx.doi.org/10.1371/journal.pone.0020790			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21731624	Green Published, Green Submitted, gold			2022-12-27	WOS:000292036900005
J	Stouffer, PC; Johnson, EI; Bierregaard, RO; Lovejoy, TE				Stouffer, Philip C.; Johnson, Erik I.; Bierregaard, Richard O., Jr.; Lovejoy, Thomas E.			Understory Bird Communities in Amazonian Rainforest Fragments: Species Turnover through 25 Years Post-Isolation in Recovering Landscapes	PLOS ONE			English	Article							HABITAT FRAGMENTATION; EXTINCTION; DEFORESTATION; RATES; COLONIZATION; DYNAMICS; ISLAND; AREA; BIOGEOGRAPHY; ASSEMBLAGES	Inferences about species loss following habitat conversion are typically drawn from short-term surveys, which cannot reconstruct long-term temporal dynamics of extinction and colonization. A long-term view can be critical, however, to determine the stability of communities within fragments. Likewise, landscape dynamics must be considered, as second growth structure and overall forest cover contribute to processes in fragments. Here we examine bird communities in 11 Amazonian rainforest fragments of 1-100 ha, beginning before the fragments were isolated in the 1980s, and continuing through 2007. Using a method that accounts for imperfect detection, we estimated extinction and colonization based on standardized mist-net surveys within discreet time intervals (1-2 preisolation samples and 4-5 post-isolation samples). Between preisolation and 2007, all fragments lost species in an area-dependent fashion, with loss of as few as,10% of preisolation species from 100-ha fragments, but up to 70% in 1-ha fragments. Analysis of individual time intervals revealed that the 2007 result was not due to gradual species loss beginning at isolation; both extinction and colonization occurred in every time interval. In the last two samples, 2000 and 2007, extinction and colonization were approximately balanced. Further, 97 of 101 species netted before isolation were detected in at least one fragment in 2007. Although a small subset of species is extremely vulnerable to fragmentation, and predictably goes extinct in fragments, developing second growth in the matrix around fragments encourages recolonization in our landscapes. Species richness in these fragments now reflects local turnover, not long-term attrition of species. We expect that similar processes could be operating in other fragmented systems that show unexpectedly low extinction.	[Stouffer, Philip C.; Johnson, Erik I.] Louisiana State Univ, Ctr Agr, Sch Renewable Nat Resources, Baton Rouge, LA 70803 USA; [Bierregaard, Richard O., Jr.] Univ N Carolina, Dept Biol, Charlotte, NC 28223 USA; [Lovejoy, Thomas E.] Heinz Ctr, Washington, DC USA; [Stouffer, Philip C.; Johnson, Erik I.; Bierregaard, Richard O., Jr.; Lovejoy, Thomas E.] Inst Nacl de Pesquisas da Amazonia, Projeto Dinam Fragmentos Florestais, Manaus, Amazonas, Brazil; [Stouffer, Philip C.; Johnson, Erik I.; Bierregaard, Richard O., Jr.; Lovejoy, Thomas E.] Smithsonian Trop Res Inst, Manaus, Amazonas, Brazil	Louisiana State University System; Louisiana State University; University of North Carolina; University of North Carolina Charlotte; Institute Nacional de Pesquisas da Amazonia; Smithsonian Institution; Smithsonian Tropical Research Institute	Stouffer, PC (corresponding author), Louisiana State Univ, Ctr Agr, Sch Renewable Nat Resources, Baton Rouge, LA 70803 USA.	pstouffer@lsu.edu	stouffer, phil/AAF-7281-2020		National Institute for Amazonian Research (INPA); World Wildlife Fund-US; Smithsonian Institution; MacArthur Foundation; U.S. National Science Foundation [DEB 0545491]; United States Agency for International Development; Mellon Foundation	National Institute for Amazonian Research (INPA); World Wildlife Fund-US; Smithsonian Institution(Smithsonian Institution); MacArthur Foundation; U.S. National Science Foundation(National Science Foundation (NSF)); United States Agency for International Development(United States Agency for International Development (USAID)); Mellon Foundation	The National Institute for Amazonian Research (INPA), World Wildlife Fund-US, Smithsonian Institution, MacArthur Foundation, U.S. National Science Foundation (DEB 0545491), United States Agency for International Development, Mellon Foundation, and other organizations generously supported this work and the Biological Dynamics of Forest Fragments Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; BIERREGAARD R O JR, 1989, Acta Amazonica, V19, P215; Blake JG, 2001, AUK, V118, P304, DOI 10.1642/0004-8038(2001)118[0304:BAISGA]2.0.CO;2; Borgella R, 2005, ECOL APPL, V15, P1062, DOI 10.1890/04-0352; Borges SH, 2007, J TROP ECOL, V23, P469, DOI 10.1017/S0266467407004105; Borges SH, 1999, CONDOR, V101, P529, DOI 10.2307/1370182; BORGES SH, 1995, THESIS INPA; Boulinier T, 1998, ECOLOGY, V79, P1018, DOI 10.2307/176597; Brook BW, 2003, NATURE, V424, P420, DOI 10.1038/nature01795; Brooks TM, 1999, CONSERV BIOL, V13, P1140, DOI 10.1046/j.1523-1739.1999.98341.x; BROWN JH, 1977, ECOLOGY, V58, P445, DOI 10.2307/1935620; BURNHAM KP, 1979, ECOLOGY, V60, P927, DOI 10.2307/1936861; Canaday C, 1996, BIOL CONSERV, V77, P63, DOI 10.1016/0006-3207(95)00115-8; Castellon TD, 2006, CONSERV BIOL, V20, P135, DOI 10.1111/j.1523-1739.2006.00332.x; Castellon TD, 2006, ECOL APPL, V16, P2223, DOI 10.1890/1051-0761(2006)016[2223:LHFAPO]2.0.CO;2; Chazdon RL, 2009, CONSERV BIOL, V23, P1406, DOI 10.1111/j.1523-1739.2009.01338.x; Cohn-Haft Mario, 1997, Ornithological Monographs, V48, P205; Collinge SK, 1998, OIKOS, V82, P66, DOI 10.2307/3546918; Ewers RM, 2006, BIOL REV, V81, P117, DOI 10.1017/S1464793105006949; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Feeley K, 2003, OECOLOGIA, V137, P104, DOI 10.1007/s00442-003-1321-5; Ferraz G, 2003, P NATL ACAD SCI USA, V100, P14069, DOI 10.1073/pnas.2336195100; Ferraz G, 2007, SCIENCE, V315, P238, DOI 10.1126/science.1133097; Gascon Claude, 2001, P31; Hagan JM, 1996, CONSERV BIOL, V10, P188, DOI 10.1046/j.1523-1739.1996.10010188.x; Haila Y, 2002, ECOL APPL, V12, P321, DOI 10.1890/1051-0761(2002)012[0321:ACGOFR]2.0.CO;2; Hanski I, 2010, THEORY OF ISLAND BIOGEOGRAPHY REVISITED, P186; He FL, 2011, NATURE, V473, P368, DOI 10.1038/nature09985; Hines JE, 1999, BIRD STUDY, V46, P209; Jaramillo A, CLASSIFICATION BIRD; Johnson DH, 1999, J WILDLIFE MANAGE, V63, P763, DOI 10.2307/3802789; Johnson EI, 2011, REV BRAS ORNITOL, V19, P1; Jullien M, 1998, J ANIM ECOL, V67, P227, DOI 10.1046/j.1365-2656.1998.00171.x; KATTAN GH, 1994, CONSERV BIOL, V8, P138, DOI 10.1046/j.1523-1739.1994.08010138.x; Kramer AM, 2008, ECOLOGY, V89, P2760, DOI 10.1890/07-1505.1; Kuussaari M, 2009, TRENDS ECOL EVOL, V24, P564, DOI 10.1016/j.tree.2009.04.011; Laurance WF, 2008, BIOL CONSERV, V141, P1731, DOI 10.1016/j.biocon.2008.05.011; Laurance WF, 2009, CONSERV BIOL, V23, P1382, DOI 10.1111/j.1523-1739.2009.01339.x; Lees AC, 2008, ANIM CONSERV, V11, P128, DOI 10.1111/j.1469-1795.2008.00162.x; Lees AC, 2006, BIOL CONSERV, V133, P198, DOI 10.1016/j.biocon.2006.06.005; Lovejoy T.E., 1986, P257; MAC ARTHUR ROBERT H., 1967; Nichols JD, 1998, CONSERV BIOL, V12, P1390, DOI 10.1046/j.1523-1739.1998.97331.x; Nichols JD, 1998, ECOL APPL, V8, P1213, DOI 10.2307/2640974; Pardini R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013666; Patten MA, 2010, BIODIVERS CONSERV, V19, P21, DOI 10.1007/s10531-009-9698-z; Prugh LR, 2008, P NATL ACAD SCI USA, V105, P20770, DOI 10.1073/pnas.0806080105; Renjifo LM, 1999, CONSERV BIOL, V13, P1124, DOI 10.1046/j.1523-1739.1999.98311.x; Robinson WD, 1999, CONSERV BIOL, V13, P85, DOI 10.1046/j.1523-1739.1999.97492.x; Ruiz-Gutierrez V, 2010, J APPL ECOL, V47, P621, DOI 10.1111/j.1365-2664.2010.01811.x; SAUER JR, 1989, J WILDLIFE MANAGE, V53, P137, DOI 10.2307/3801320; Schoener TW, 2010, THEORY OF ISLAND BIOGEOGRAPHY REVISITED, P52; Sekercioglu CH, 2007, CONSERV BIOL, V21, P482, DOI 10.1111/j.1523-1739.2007.00655.x; SIEVING KE, 1992, ECOLOGY, V73, P2310, DOI 10.2307/1941477; Sigel BJ, 2006, CONSERV BIOL, V20, P111, DOI 10.1111/j.1523-1739.2005.00293.x; SILVA JVC, 2010, THESIS INPA; SIMBERLOFF DS, 1969, ECOLOGY, V50, P278, DOI 10.2307/1934856; Sodhi NS, 2006, CONSERV BIOL, V20, P772, DOI 10.1111/j.1523-1739.2006.00363.x; Sodhi NS, 2004, ANNU REV ECOL EVOL S, V35, P323, DOI 10.1146/annurev.ecolsys.35.112202.130209; Stephens PA, 1999, TRENDS ECOL EVOL, V14, P401, DOI 10.1016/S0169-5347(99)01684-5; STOUFFER PC, 1993, CONDOR, V95, P896, DOI 10.2307/1369427; STOUFFER PC, 1995, ECOLOGY, V76, P2429, DOI 10.2307/2265818; Stouffer PC, 2007, AUK, V124, P291, DOI 10.1642/0004-8038(2007)124[291:DTSALS]2.0.CO;2; Stouffer PC, 2006, CONSERV BIOL, V20, P1212, DOI 10.1111/j.1523-1739.2006.00427.x; Stouffer PC, 2009, DIVERS DISTRIB, V15, P88, DOI 10.1111/j.1472-4642.2008.00497.x; Stratford JA, 1999, CONSERV BIOL, V13, P1416, DOI 10.1046/j.1523-1739.1999.98494.x; Terborgh J, 1997, ECOLOGY, V78, P1494, DOI 10.1890/0012-9658(1997)078[1494:BCITTL]2.0.CO;2; TILMAN D, 1994, NATURE, V371, P65, DOI 10.1038/371065a0; Wright SJ, 2006, BIOTROPICA, V38, P443, DOI 10.1111/j.1744-7429.2006.00177.x; Wright SJ, 2006, BIOTROPICA, V38, P287, DOI 10.1111/j.1744-7429.2006.00154.x; Zipkin EF, 2009, J APPL ECOL, V46, P815, DOI 10.1111/j.1365-2664.2009.01664.x	71	76	79	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e20543	10.1371/journal.pone.0020543	http://dx.doi.org/10.1371/journal.pone.0020543			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731616	Green Published, Green Submitted, gold			2022-12-27	WOS:000292033700009
J	Tang, JLW; Nicolle, ADG; Pantelic, J; Jiang, MX; Sekhr, C; Cheong, DKW; Tham, KW				Tang, Julian W.; Nicolle, Andre D. G.; Pantelic, Jovan; Jiang, Mingxiu; Sekhr, Chandra; Cheong, David K. W.; Tham, Kwok Wai			Qualitative Real-Time Schlieren and Shadowgraph Imaging of Human Exhaled Airflows: An Aid to Aerosol Infection Control	PLOS ONE			English	Article							INFLUENZA-VIRUS; CLOSTRIDIUM-DIFFICILE; OXYGEN MASKS; TRANSMISSION; VENTILATION; DISPERSION; EFFICACY; REMOVAL	Using a newly constructed airflow imaging system, airflow patterns were visualized that were associated with common, everyday respiratory activities (e. g. breathing, talking, laughing, whistling). The effectiveness of various interventions (e. g. putting hands and tissues across the mouth and nose) to reduce the potential transmission of airborne infection, whilst coughing and sneezing, were also investigated. From the digital video footage recorded, it was seen that both coughing and sneezing are relatively poorly contained by commonly used configurations of single-handed shielding maneuvers. Only some but not all of the forward momentum of the cough and sneeze puffs are curtailed with various hand techniques, and the remaining momentum is disseminated in a large puff in the immediate vicinity of the cougher, which may still act as a nearby source of infection. The use of a tissue (in this case, 4-ply, opened and ready in the hand) proved to be surprisingly effective, though the effectiveness of this depends on the tissue remaining intact and not ripping apart. Interestingly, the use of a novel 'coughcatcher' device appears to be relatively effective in containing coughs and sneezes. One aspect that became evident during the experimental procedures was that the effectiveness of all of these barrier interventions is very much dependent on the speed with which the user can put them into position to cover the mouth and nose effectively. From these qualitative schlieren and shadowgraph imaging experiments, it is clear that making some effort to contain one's cough or sneeze puffs is worthwhile. Obviously, there will be a large amount of variation between individuals in the exact hand or tissue (the most common methods) configuration used for this and other practical factors may hinder such maneuvers in daily life, for example, when carrying shopping bags or managing young children.	[Tang, Julian W.; Nicolle, Andre D. G.] Natl Univ Singapore Hosp, Dept Lab Med, Singapore, Singapore; [Pantelic, Jovan; Jiang, Mingxiu; Sekhr, Chandra; Cheong, David K. W.; Tham, Kwok Wai] Natl Univ Singapore, Dept Bldg, Sch Design & Environm, Singapore 117548, Singapore	National University of Singapore; National University of Singapore	Tang, JLW (corresponding author), Natl Univ Singapore Hosp, Dept Lab Med, Singapore, Singapore.	jwtang49@hotmail.com	THAM, Kwok Wai/B-6541-2009; Sekhar, Chandra/F-3253-2017	THAM, Kwok Wai/0000-0002-2957-1152; Sekhar, Chandra/0000-0002-0814-8662; Cheong, David/0000-0001-7680-4281; Pantelic, Jovan/0000-0001-7541-8274; Tang, Julian/0000-0002-4963-1028	Singapore National Medical Research Council [NMRC/1208/2009]	Singapore National Medical Research Council(National Medical Research Council, Singapore)	This work was funded by a grant (on which ADGN was also supported as a post-doctoral research fellow) from the Singapore National Medical Research Council (NMRC/1208/2009) to JWT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BETTIN K, 1994, INFECT CONT HOSP EP, V15, P697; Blachere FM, 2009, CLIN INFECT DIS, V48, P438, DOI 10.1086/596478; Brankston G, 2007, LANCET INFECT DIS, V7, P257, DOI 10.1016/S1473-3099(07)70029-4; Carro C, 2007, J HOSP INFECT, V67, P62, DOI 10.1016/j.jhin.2007.06.016; Eames I, 2009, J R SOC INTERFACE, V6, pS697, DOI 10.1098/rsif.2009.0407.focus; Fabian P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002691; Ferguson JK, 2009, MED J AUSTRALIA, V191, P454, DOI 10.5694/j.1326-5377.2009.tb02886.x; Hui DS, 2007, CHEST, V132, P540, DOI 10.1378/chest.07-0636; Hui DS, 2006, CHEST, V130, P822, DOI 10.1378/chest.130.3.822; Inouye S, 2003, LANCET, V362, P170, DOI 10.1016/S0140-6736(03)13874-3; Ip M, 2007, AM J INFECT CONTROL, V35, P684, DOI 10.1016/j.ajic.2007.05.007; Jabbar U, 2010, INFECT CONT HOSP EP, V31, P565, DOI 10.1086/652772; Jensen Paul A., 2005, Morbidity and Mortality Weekly Report, V54, P1; Johnson DF, 2009, CLIN INFECT DIS, V49, P275, DOI 10.1086/600041; Lemieux C, 2007, EMERG INFECT DIS, V13, P173, DOI 10.3201/eid1301.061202; Lindsley WG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015100; Lindsley WG, 2010, CLIN INFECT DIS, V50, P693, DOI 10.1086/650457; Nielsen PV, 2009, J R SOC INTERFACE, V6, pS747, DOI 10.1098/rsif.2009.0228.focus; *OCC SAF HLTH ADM, 2007, OCC SAF HLTH ADM OSH; Oughton MT, 2009, INFECT CONT HOSP EP, V30, P939, DOI 10.1086/605322; Pantelic J, 2009, J R SOC INTERFACE, V6, pS715, DOI 10.1098/rsif.2009.0311.focus; Pifferi M, 2009, PEDIAT ALLERG IMM-UK, V20, P164, DOI 10.1111/j.1399-3038.2008.00742.x; Qian H, 2006, INDOOR AIR, V16, P111, DOI 10.1111/j.1600-0668.2005.00407.x; Stelzer-Braid S, 2009, J MED VIROL, V81, P1674, DOI 10.1002/jmv.21556; Stone RE, 2003, J VOICE, V17, P283, DOI 10.1067/S0892-1997(03)00074-2; Tang JW, 2008, NEW ENGL J MED, V359, pE19, DOI 10.1056/NEJMicm072576; Tang JW, 2006, J HOSP INFECT, V64, P100, DOI 10.1016/j.jhin.2006.05.022; Tang JW, 2011, J HOSP INFECT, V77, P213, DOI 10.1016/j.jhin.2010.09.037; Tang JW, 2007, LANCET INFECT DIS, V7, P758, DOI 10.1016/S1473-3099(07)70268-2; Tang JW, 2009, J R SOC INTERFACE, V6, pS737, DOI 10.1098/rsif.2009.0227.focus; Tang JW, 2009, J R SOC INTERFACE, V6, pS727, DOI 10.1098/rsif.2009.0295.focus; Tang JWT, 2009, NEW ENGL J MED, V361, pE62, DOI 10.1056/NEJMicm0904279; Tang JW, 2005, J HOSP INFECT, V61, P283, DOI 10.1016/j.jhin.2005.05.017; Tellier R, 2007, LANCET INFECT DIS, V7, P759, DOI 10.1016/S1473-3099(07)70269-4; Tellier R, 2006, EMERG INFECT DIS, V12, P1657, DOI 10.3201/eid1211.060426; Tellier R, 2009, J R SOC INTERFACE, V6, pS783, DOI 10.1098/rsif.2009.0302.focus; *US DEP HHS, 2009, HHS PUBL, P316; Weber DJ, 2003, JAMA-J AM MED ASSOC, V289, P1274, DOI 10.1001/jama.289.10.1274; *WHO, 2007, AV INFL INCL INFL A; Xie XJ, 2009, J R SOC INTERFACE, V6, pS703, DOI 10.1098/rsif.2009.0388.focus; YANG W, 2011, J R SOC INTERFACE	41	51	52	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21392	10.1371/journal.pone.0021392	http://dx.doi.org/10.1371/journal.pone.0021392			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731730	Green Published, gold, Green Submitted			2022-12-27	WOS:000292033700074
J	Huang, NK; Lin, JH; Lin, JT; Lin, CI; Liu, EMW; Lin, CJ; Chen, WP; Shen, YC; Chen, HM; Chen, JB; Lai, HL; Yang, CW; Chiang, MC; Wu, YS; Chang, C; Chen, JF; Fang, JM; Lin, YL; Chern, YJ				Huang, Nai-Kuei; Lin, Jung-Hsin; Lin, Jiun-Tsai; Lin, Chia-I; Liu, Eric Minwei; Lin, Chun-Jung; Chen, Wan-Ping; Shen, Yuh-Chiang; Chen, Hui-Mei; Chen, Jhih-Bin; Lai, Hsing-Lin; Yang, Chieh-Wen; Chiang, Ming-Chang; Wu, Yu-Shuo; Chang, Chen; Chen, Jiang-Fan; Fang, Jim-Min; Lin, Yun-Lian; Chern, Yijuang			A New Drug Design Targeting the Adenosinergic System for Huntington's Disease	PLOS ONE			English	Article							DEPRIVATION-INDUCED APOPTOSIS; RAT PHEOCHROMOCYTOMA CELLS; SITE-DIRECTED MUTAGENESIS; TRANSGENIC MOUSE MODEL; A(2A) RECEPTOR AGONIST; CENTRAL-NERVOUS-SYSTEM; GASTRODIA-ELATA BLUME; UREA CYCLE DEFICIENCY; LIGAND RECOGNITION; SERUM DEPRIVATION	Background: Huntington's disease (HD) is a neurodegenerative disease caused by a CAG trinucleotide expansion in the Huntingtin (Htt) gene. The expanded CAG repeats are translated into polyglutamine (polyQ), causing aberrant functions as well as aggregate formation of mutant Htt. Effective treatments for HD are yet to be developed. Methodology/Principal Findings: Here, we report a novel dual-function compound, N-6-(4-hydroxybenzyl) adenine riboside (designated T1-11) which activates the A(2A)R and a major adenosine transporter (ENT1). T1-11 was originally isolated from a Chinese medicinal herb. Molecular modeling analyses showed that T1-11 binds to the adenosine pockets of the A(2A)R and ENT1. Introduction of T1-11 into the striatum significantly enhanced the level of striatal adenosine as determined by a microdialysis technique, demonstrating that T1-11 inhibited adenosine uptake in vivo. A single intraperitoneal injection of T1-11 in wildtype mice, but not in A(2A)R knockout mice, increased cAMP level in the brain. Thus, T1-11 enters the brain and elevates cAMP via activation of the A(2A)R in vivo. Most importantly, addition of T1-11 (0.05 mg/ml) to the drinking water of a transgenic mouse model of HD (R6/2) ameliorated the progressive deterioration in motor coordination, reduced the formation of striatal Htt aggregates, elevated proteasome activity, and increased the level of an important neurotrophic factor (brain derived neurotrophic factor) in the brain. These results demonstrate the therapeutic potential of T1-11 for treating HD. Conclusions/Significance: The dual functions of T1-11 enable T1-11 to effectively activate the adenosinergic system and subsequently delay the progression of HD. This is a novel therapeutic strategy for HD. Similar dual-function drugs aimed at a particular neurotransmitter system as proposed herein may be applicable to other neurotransmitter systems (e. g., the dopamine receptor/dopamine transporter and the serotonin receptor/serotonin transporter) and may facilitate the development of new drugs for other neurodegenerative diseases.	[Huang, Nai-Kuei; Chen, Wan-Ping; Shen, Yuh-Chiang; Lin, Yun-Lian] Natl Res Inst Chinese Med, Taipei, Taiwan; [Lin, Jung-Hsin] Acad Sinica, Div Mech, Res Ctr Appl Sci, Taipei 115, Taiwan; [Lin, Jung-Hsin; Lin, Jiun-Tsai; Chen, Hui-Mei; Lai, Hsing-Lin; Wu, Yu-Shuo; Chang, Chen; Chern, Yijuang] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan; [Liu, Eric Minwei; Lin, Chun-Jung] Natl Taiwan Univ, Sch Pharm, Taipei 10764, Taiwan; [Lin, Chia-I; Chen, Jhih-Bin; Yang, Chieh-Wen; Fang, Jim-Min] Natl Taiwan Univ, Dept Chem, Taipei 10764, Taiwan; [Fang, Jim-Min] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Chiang, Ming-Chang] Chinese Culture Univ, Grad Inst Biotechnol, Taipei, Taiwan; [Chen, Jiang-Fan] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA	National Research Institute of Chinese Medicine; Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Taiwan University; National Taiwan University; Academia Sinica - Taiwan; Chinese Culture University; Boston University	Huang, NK (corresponding author), Natl Res Inst Chinese Med, Taipei, Taiwan.	jmfang@ntu.edu.tw; yllin@nricm.edu.tw; bmychern@ibms.sinica.edu.tw	Chang, Chen/B-5079-2009; Lin, Jung-Hsin/B-7512-2012; Liu, Eric Minwei/V-1738-2019; Lin, Jung-Hsin/T-7390-2019; chern, yijuang/S-7013-2018	Lin, Jung-Hsin/0000-0002-6712-4994; Liu, Eric Minwei/0000-0002-3594-6678; chern, yijuang/0000-0002-5842-5429; Fang, Jim-Min/0000-0002-6070-3408; Chen, Jiang-Fan/0000-0002-0446-3956; CHUN-JUNG, LIN/0000-0001-9220-3507	National Science Council [NRICM 94-DMC-2, NRICM 95-DMC-2, NSC95-2323-B-077-002, NSC96-2323-B-077-001, NSC96-2628-M-002-003, NSC 97-2323-B-077-001]	National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by the National Science Council for financial support (NRICM 94-DMC-2, NRICM 95-DMC-2, NSC95-2323-B-077-002, NSC96-2323-B-077-001, NSC96-2628-M-002-003, and NSC 97-2323-B-077-001). The funders had no role in study design, data collection and analyses, decision to publish, or preparation of the manuscript.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; An SJ, 2003, J NEUROSCI RES, V71, P534, DOI 10.1002/jnr.10502; Assaife-Lopes N, 2010, J NEUROSCI, V30, P8468, DOI 10.1523/JNEUROSCI.5695-09.2010; Blum D, 2003, J NEUROSCI, V23, P5361; Blum D, 2002, J NEUROSCI, V22, P9122; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Brusa L, 2009, MOVEMENT DISORD, V24, P126, DOI 10.1002/mds.22376; Carter RJ, 1999, J NEUROSCI, V19, P3248; Case D, 2006, AMBER 9; Cepeda C., 2010, PLOS CURR, V2; Chen JF, 2002, J BIOL CHEM, V277, P36040, DOI 10.1074/jbc.M206830200; Chen JF, 1999, J NEUROSCI, V19, P9192, DOI 10.1523/jneurosci.19-21-09192.1999; Chiang MC, 2005, J BIOL CHEM, V280, P14331, DOI 10.1074/jbc.M413279200; Chiang MC, 2007, HUM MOL GENET, V16, P483, DOI 10.1093/hmg/ddl481; Chiang MC, 2009, HUM MOL GENET, V18, P2929, DOI 10.1093/hmg/ddp230; Chou SY, 2005, J NEUROCHEM, V93, P310, DOI 10.1111/j.1471-4159.2005.03029.x; Dai SS, 2010, J NEUROSCI, V30, P5802, DOI 10.1523/JNEUROSCI.0268-10.2010; Day JW, 2009, NAT CHEM BIOL, V5, P749, DOI 10.1038/nchembio.209; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Domenici MR, 2007, NEUROBIOL DIS, V28, P197, DOI 10.1016/j.nbd.2007.07.009; Dworak M, 2007, NEUROSCIENCE, V150, P789, DOI 10.1016/j.neuroscience.2007.09.062; Fink JS, 2004, J NEUROCHEM, V88, P538, DOI 10.1046/j.1471-4159.2003.02145.x; Flajolet M, 2008, NAT NEUROSCI, V11, P1402, DOI 10.1038/nn.2216; Fontinha BM, 2008, NEUROPHARMACOLOGY, V54, P924, DOI 10.1016/j.neuropharm.2008.01.011; FREDHOLM BB, 1992, FUNDAM CLIN PHARM, V6, P99, DOI 10.1111/j.1472-8206.1992.tb00101.x; Fredholm BB, 2005, INT REV NEUROBIOL, V63, P191, DOI 10.1016/S0074-7742(05)63007-3; Gao ZG, 2000, BIOCHEM PHARMACOL, V60, P661, DOI 10.1016/S0006-2952(00)00357-9; GASTEIGER J, 1980, TETRAHEDRON, V36, P3219, DOI 10.1016/0040-4020(80)80168-2; Gidday JM, 1996, BRAIN RES, V734, P261, DOI 10.1016/0006-8993(96)00647-6; Golder FJ, 2008, J NEUROSCI, V28, P2033, DOI 10.1523/JNEUROSCI.3570-07.2008; Gomes CARV, 2006, BRAIN RES, V1113, P129, DOI 10.1016/j.brainres.2006.07.025; Gordi T, 2006, CLIN PHARMACOKINET, V45, P1201, DOI 10.2165/00003088-200645120-00005; Hayashi J, 2002, PHYTOCHEMISTRY, V59, P513, DOI 10.1016/S0031-9422(02)00008-0; He ZX, 2000, CIRCULATION, V102, P438; Huang NK, 2007, J NAT PROD, V70, P571, DOI 10.1021/np0605182; Huang NK, 1997, PHARMACOL BIOCHEM BE, V56, P363, DOI 10.1016/S0091-3057(96)00236-5; Huang NK, 2005, FEMS MICROBIOL LETT, V244, P213, DOI 10.1016/j.femsle.2005.01.048; Huang NK, 2004, LIFE SCI, V75, P1649, DOI 10.1016/j.lfs.2004.05.008; Huang NK, 2001, J BIOL CHEM, V276, P13838, DOI 10.1074/jbc.M008589200; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jacobson KA, 1997, NEUROPHARMACOLOGY, V36, P1157, DOI 10.1016/S0028-3908(97)00104-4; Jennings LL, 2001, NEUROPHARMACOLOGY, V40, P722, DOI 10.1016/S0028-3908(00)00207-0; Jiang QL, 1996, MOL PHARMACOL, V50, P512; Jin KL, 2005, P NATL ACAD SCI USA, V102, P18189, DOI 10.1073/pnas.0506375102; Joshi PR, 2009, J NEUROSCI, V29, P2414, DOI 10.1523/JNEUROSCI.5687-08.2009; Kells AP, 2004, MOL THER, V9, P682, DOI 10.1016/j.ymthe.2004.02.016; Kim HJ, 2003, J ETHNOPHARMACOL, V84, P95, DOI 10.1016/S0378-8741(02)00290-8; Kim JH, 1996, MOL PHARMACOL, V49, P683; KIM JH, 1995, J BIOL CHEM, V270, P13987, DOI 10.1074/jbc.270.23.13987; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee FS, 2001, P NATL ACAD SCI USA, V98, P3555, DOI 10.1073/pnas.061020198; Lin JH, 1996, PHYTOCHEMISTRY, V42, P549, DOI 10.1016/0031-9422(95)00955-8; Lin JH, 2002, BIOPHYS J, V83, P1374, DOI 10.1016/S0006-3495(02)73908-8; Liu FC, 1998, FEBS LETT, V436, P92, DOI 10.1016/S0014-5793(98)01098-9; Lu MK, 2006, LIFE SCI, V79, P252, DOI 10.1016/j.lfs.2005.12.042; Luo CX, 2010, NEUROREPORT, V21, P892, DOI 10.1097/WNR.0b013e32833dbd13; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Martire A, 2007, NEUROSCI LETT, V417, P78, DOI 10.1016/j.neulet.2007.02.034; Mestre T, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006455.pub2; Mievis S, 2011, NEUROBIOL DIS, V41, P570, DOI 10.1016/j.nbd.2010.09.021; Mingote S, 2008, PHARMACOL BIOCHEM BE, V89, P345, DOI 10.1016/j.pbb.2008.01.006; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; OLAH ME, 1994, MOL PHARMACOL, V45, P978; Orru M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016088; Panov AV, 2005, MOL CELL BIOCHEM, V269, P143, DOI 10.1007/s11010-005-3454-9; Parkinson FE, 2009, J NEUROCHEM, V109, P562, DOI 10.1111/j.1471-4159.2009.05991.x; Popoli P, 2008, CURR PHARM DESIGN, V14, P1500, DOI 10.2174/138161208784480117; Ribeiro FM, 2010, J NEUROSCI, V30, P316, DOI 10.1523/JNEUROSCI.4974-09.2010; Rooseboom M, 2004, PHARMACOL REV, V56, P53, DOI 10.1124/pr.56.1.3; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SALVATORE CA, 1993, P NATL ACAD SCI USA, V90, P10365, DOI 10.1073/pnas.90.21.10365; Sathasivam K, 1999, HUM MOL GENET, V8, P813, DOI 10.1093/hmg/8.5.813; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Simmerling C, 2002, J AM CHEM SOC, V124, P11258, DOI 10.1021/ja0273851; TAGUCHI H, 1981, CHEM PHARM BULL, V29, P55; Tarditi A, 2006, NEUROBIOL DIS, V23, P44, DOI 10.1016/j.nbd.2006.01.014; Tebano MT, 2010, THESCIENTIFICWORLDJO, V10, P1768, DOI 10.1100/tsw.2010.164; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Too K, 2007, BIOORGAN MED CHEM, V15, P5551, DOI 10.1016/j.bmc.2007.05.038; Tzschentke TM, 2007, J PHARMACOL EXP THER, V323, P265, DOI 10.1124/jpet.107.126052; Varani K, 1996, BRIT J PHARMACOL, V117, P1693, DOI 10.1111/j.1476-5381.1996.tb15341.x; Varani K, 2003, FASEB J, V17, P2148, DOI 10.1096/fj.03-0079fje; VERMA A, 1985, LIFE SCI, V36, P283, DOI 10.1016/0024-3205(85)90071-2; Ward JL, 2000, J BIOL CHEM, V275, P8375, DOI 10.1074/jbc.275.12.8375; Wiese S, 2007, P NATL ACAD SCI USA, V104, P17210, DOI 10.1073/pnas.0705267104; Wu XW, 2003, CHEM PHYS LETT, V381, P512, DOI 10.1016/j.cplett.2003.10.013; Xiang ZX, 2002, P NATL ACAD SCI USA, V99, P7432, DOI 10.1073/pnas.102179699; Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793; Zhang Y, 2004, P NATL ACAD SCI USA, V101, P7594, DOI 10.1073/pnas.0305695101; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zuccato C, 2001, SCIENCE, V293, P493, DOI 10.1126/science.1059581	94	61	65	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2011	6	6							e20934	10.1371/journal.pone.0020934	http://dx.doi.org/10.1371/journal.pone.0020934			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782CL	21713039	Green Submitted, gold, Green Published			2022-12-27	WOS:000291985100007
J	Jones, GJ; Pirson, C; Gideon, HP; Wilkinson, KA; Sherman, DR; Wilkinson, RJ; Hewinson, RG; Vordermeier, HM				Jones, Gareth J.; Pirson, Chris; Gideon, Hannah P.; Wilkinson, Katalin A.; Sherman, David R.; Wilkinson, Robert J.; Hewinson, R. Glyn; Vordermeier, H. Martin			Immune Responses to the Enduring Hypoxic Response Antigen Rv0188 Are Preferentially Detected in Mycobacterium bovis Infected Cattle with Low Pathology	PLOS ONE			English	Article							ALPHA-CRYSTALLIN; BCG VACCINATION; TUBERCULOSIS; REGULON; REACTIVATION; RECOGNITION; INSIGHTS; BIOLOGY; PROTEIN; LATENCY	The DosR regulon and the Enduring Hypoxic Response (EHR) define a group of M. tuberculosis genes that are specifically induced in bacilli exposed in vitro to conditions thought to mimic the environment encountered by Mycobacteria during latent infection. Although well described in humans, latent mycobacterial infection in cattle remains poorly understood. Thus, the aim of this study was to identify antigens that may potentially disclose cattle with latent M. bovis infection. To this end, we initially screened 57 pools of overlapping peptides representing 4 DosR regulon and 29 EHR antigens for their ability to stimulate an immune response in whole blood from TB-reactor cattle using IFN-gamma and IL-2 as readouts. All 4 DosR regulon proteins were poorly recognized (maximum responder frequency of 10%). For the EHR antigens, both IFN-gamma and IL-2 revealed similar response hierarchies, with responder frequencies ranging from 54% down to 3% depending on the given EHR antigen. Furthermore, these results demonstrated that responses in the infected cattle were largely IFN-gamma biased. To support the concept for their role in latency, we evaluated if EHR antigen responses were associated with lower pathology. The EHR antigen Rv0188 was recognised predominantly in animals presenting with low pathology scores, whereas responses to ESAT-6/CFP-10 or the other EHR antigens tested were prevalent across the pathology spectrum. However, when we determined the production of additional cytokines induced by the M. bovis antigens PPD-B or ESAT-6/CFP-10, we detected significantly greater PPD-B-induced production of the pro-inflammatory cytokine IL-1 beta in animals recognizing Rv0188 (i.e. those with limited or no pathology). Thus, these results are consistent with the idea that responses to Rv0188 may identify a subset of animals at early stages of infection or in which disease progression may be limited.	[Jones, Gareth J.; Pirson, Chris; Hewinson, R. Glyn; Vordermeier, H. Martin] Anim Hlth & Vet Labs Agcy Weybridge, Dept Bacteriol, Surrey, England; [Gideon, Hannah P.; Wilkinson, Katalin A.; Wilkinson, Robert J.] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, Western Cape, South Africa; [Wilkinson, Katalin A.; Wilkinson, Robert J.] Natl Inst Med Res, MRC, London NW7 1AA, England; [Sherman, David R.] Seattle Biomed Res Inst, TB Program, Seattle, WA 98109 USA; [Wilkinson, Robert J.] Univ London Imperial Coll Sci Technol & Med, Div Med, London, England; [Wilkinson, Robert J.] Univ London Imperial Coll Sci Technol & Med, Ctr Mol Microbiol & Infect, London, England	Veterinary Laboratories Agency; University of Cape Town; MRC National Institute for Medical Research; Center for Infectious Disease Research; Imperial College London; Imperial College London	Jones, GJ (corresponding author), Anim Hlth & Vet Labs Agcy Weybridge, Dept Bacteriol, Surrey, England.	Gareth.J.Jones@ahvla.gsi.gov.uk	Vordermeier, H Martin/C-6936-2011; Hewinson, Glyn/F-7077-2010; Wilkinson, Katalin/AAF-6805-2020; Hewinson, Glyn/AAA-2364-2019; Pirson, Chris/D-8494-2011; Jones, Gareth/C-6270-2011; Hewinson, Glyn/J-1902-2014; Wilkinson, Katalin/AAQ-7713-2021	Pirson, Chris/0000-0002-5293-0221; Wilkinson, Katalin/0000-0002-9796-2040; Gideon, Hannah/0000-0002-4443-2134; Wilkinson, Robert/0000-0002-2753-1800; Hewinson, Glyn/0000-0002-5517-4281	Department for Environment, Food and Rural Affairs (DEFRA) UK; Bill and Melinda Gates Foundation [37822]; Wellcome Trust [088316]; Medical Research Council [MC_U117588499] Funding Source: researchfish; MRC [MC_U117588499] Funding Source: UKRI	Department for Environment, Food and Rural Affairs (DEFRA) UK(Department for Environment, Food & Rural Affairs (DEFRA)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by the Department for Environment, Food and Rural Affairs (DEFRA) UK and by the Bill and Melinda Gates Foundation (Ref 37822, Drugs for Latent Tuberculosis). RJW receives personal support from the Wellcome Trust (088316). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez AH, 2009, VET RES, V40, DOI 10.1051/vetres/2009005; Arend SM, 2002, J INFECT DIS, V186, P876, DOI 10.1086/342604; Arriaga AK, 2002, CLIN EXP IMMUNOL, V128, P229, DOI 10.1046/j.1365-2249.2002.01832.x; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Black GF, 2009, CLIN VACCINE IMMUNOL, V16, P1203, DOI 10.1128/CVI.00111-09; Cahn Pedro, 2003, J Int Assoc Physicians AIDS Care (Chic), V2, P106, DOI 10.1177/154510970300200303; Cassidy JP, 2006, VET MICROBIOL, V112, P151, DOI 10.1016/j.vetmic.2005.11.031; Coad M, 2010, VET RES, V41, DOI 10.1051/vetres/2009062; Demissie A, 2006, CLIN VACCINE IMMUNOL, V13, P179, DOI 10.1128/CVI.13.2.179-186.2006; Geluk A, 2007, INFECT IMMUN, V75, P2914, DOI 10.1128/IAI.01990-06; Gideon HP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001237; Goletti D, 2010, EUR RESPIR J, V36, P135, DOI 10.1183/09031936.00140009; Hinks TSC, 2009, INFECT IMMUN, V77, P5486, DOI 10.1128/IAI.01436-08; Larsen MV, 2008, EUR RESPIR J, V32, P229, DOI 10.1183/09031936.00125607; Lauzi S, 2000, VET J, V160, P17, DOI 10.1053/tvjl.1999.0444; Leyten EMS, 2006, MICROBES INFECT, V8, P2052, DOI 10.1016/j.micinf.2006.03.018; Lin MY, 2007, INFECT IMMUN, V75, P3523, DOI 10.1128/IAI.01999-06; Parrish NM, 1998, TRENDS MICROBIOL, V6, P107, DOI 10.1016/S0966-842X(98)01216-5; Pollock JM, 2002, VET J, V163, P115, DOI 10.1053/tvjl.2001.0655; Rustad TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001502; Rustad TR, 2009, CELL MICROBIOL, V11, P1151, DOI 10.1111/j.1462-5822.2009.01325.x; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Schuck SD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005590; Shi LB, 2003, P NATL ACAD SCI USA, V100, P241, DOI 10.1073/pnas.0136863100; Vordermeier HM, 2002, INFECT IMMUN, V70, P3026, DOI 10.1128/IAI.70.6.3026-3032.2002; Vordermeier HM, 1999, CLIN DIAGN LAB IMMUN, V6, P675, DOI 10.1128/CDLI.6.5.675-682.1999; Vordermeier HM, 2001, CLIN DIAGN LAB IMMUN, V8, P571, DOI 10.1128/CDLI.8.3.571-578.2001; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205; Whipple DL, 1996, J VET DIAGN INVEST, V8, P351, DOI 10.1177/104063879600800312; Wilkinson KA, 2005, J IMMUNOL, V174, P4237, DOI 10.4049/jimmunol.174.7.4237; Wilkinson RJ, 1998, SCAND J IMMUNOL, V48, P403	31	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2011	6	6							e21371	10.1371/journal.pone.0021371	http://dx.doi.org/10.1371/journal.pone.0021371			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782CL	21712953	Green Published, gold, Green Submitted			2022-12-27	WOS:000291985100036
J	Dyall-Smith, ML; Pfeiffer, F; Klee, K; Palm, P; Gross, K; Schuster, SC; Rampp, M; Oesterhelt, D				Dyall-Smith, Mike L.; Pfeiffer, Friedhelm; Klee, Kathrin; Palm, Peter; Gross, Karin; Schuster, Stephan C.; Rampp, Markus; Oesterhelt, Dieter			Haloquadratum walsbyi: Limited Diversity in a Global Pond	PLOS ONE			English	Article							MULTIPLE REPLICATION ORIGINS; SQUARE HALOARCHAEON; HALOPHILIC ARCHAEA; HALOFERAX-VOLCANII; HALOBACTERIUM-SALINARUM; TRANSPOSABLE ELEMENTS; PATHOGENICITY ISLAND; SEQUENCE-ANALYSIS; DNA-REPLICATION; GENOME SEQUENCE	Background: Haloquadratum walsbyi commonly dominates the microbial flora of hypersaline waters. Its cells are extremely fragile squares requiring > 14%(w/v) salt for growth, properties that should limit its dispersal and promote geographical isolation and divergence. To assess this, the genome sequences of two isolates recovered from sites at near maximum distance on Earth, were compared. Principal Findings: Both chromosomes are 3.1 MB in size, and 84% of each sequence was highly similar to the other (98.6% identity), comprising the core sequence. ORFs of this shared sequence were completely synteneic (conserved in genomic orientation and order), without inversion or rearrangement. Strain-specific insertions/deletions could be precisely mapped, often allowing the genetic events to be inferred. Many inferred deletions were associated with short direct repeats (4-20 bp). Deletion-coupled insertions are frequent, producing different sequences at identical positions. In cases where the inserted and deleted sequences are homologous, this leads to variant genes in a common synteneic background (as already described by others). Cas/CRISPR systems are present in C23(T) but have been lost in HBSQ001 except for a few spacer remnants. Numerous types of mobile genetic elements occur in both strains, most of which appear to be active, and with some specifically targetting others. Strain C23(T) carries two similar to 6 kb plasmids that show similarity to halovirus His1 and to sequences nearby halovirus/plasmid gene clusters commonly found in haloarchaea. Conclusions: Deletion-coupled insertions show that Hqr. walsbyi evolves by uptake and precise integration of foreign DNA, probably originating from close relatives. Change is also driven by mobile genetic elements but these do not by themselves explain the atypically low gene coding density found in this species. The remarkable genome conservation despite the presence of active systems for genome rearrangement implies both an efficient global dispersal system, and a high selective fitness for this species.	[Dyall-Smith, Mike L.; Pfeiffer, Friedhelm; Klee, Kathrin; Palm, Peter; Oesterhelt, Dieter] Max Planck Inst Biochem, Dept Membrane Biochem, D-82152 Martinsried, Germany; [Gross, Karin; Rampp, Markus] Max Planck Inst Plasma Phys, Max Planck Soc, Comp Ctr RZG, D-85748 Garching, Germany; [Schuster, Stephan C.] Penn State Univ, Ctr Comparat Genom & Bioinformat, University Pk, PA 16802 USA	Max Planck Society; Max Planck Society; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Dyall-Smith, ML (corresponding author), Charles Sturt Univ, Sch Biomed Sci, Wagga Wagga, NSW, Australia.	mdyall-smith@csu.edu.au	Pfeiffer, Friedhelm/K-1757-2019	Pfeiffer, Friedhelm/0000-0003-4691-3246; Klee, Kathrin/0000-0003-2408-1282; Rampp, Markus/0000-0001-8177-8698	Max-Planck-Society, Germany	Max-Planck-Society, Germany(Max Planck Society)	This work was funded by the Max-Planck-Society, Germany, to Dieter Oesterhelt, Director of the Department of Membrane Biochemistry, MPI for Biochemistry (http://www.biochem.mpg.de/en/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agris PF, 2007, J MOL BIOL, V366, P1, DOI 10.1016/j.jmb.2006.11.046; Anton J, 1999, ENVIRON MICROBIOL, V1, P517, DOI 10.1046/j.1462-2920.1999.00065.x; Bao TH, 2005, EMBO J, V24, P3325, DOI 10.1038/sj.emboj.7600787; Barry ER, 2006, MICROBIOL MOL BIOL R, V70, P876, DOI 10.1128/MMBR.00029-06; Bath C, 2006, VIROLOGY, V350, P228, DOI 10.1016/j.virol.2006.02.005; Berquist BR, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-31; Bolhuis H, 2004, ENVIRON MICROBIOL, V6, P1287, DOI 10.1111/j.1462-2920.2004.00692.x; Bolhuis H, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-169; Burns DG, 2007, INT J SYST EVOL MICR, V57, P387, DOI 10.1099/ijs.0.64690-0; Burns DG, 2004, FEMS MICROBIOL LETT, V238, P469, DOI 10.1016/j.femsle.2004.08.016; Casjens S, 2003, MOL MICROBIOL, V49, P277, DOI 10.1046/j.1365-2958.2003.03580.x; Chen Y, 2009, GENE, V436, P1, DOI 10.1016/j.gene.2009.01.019; Coker JA, 2009, J BACTERIOL, V191, P5253, DOI 10.1128/JB.00210-09; Cuadros-Orellana S, 2007, ISME J, V1, P235, DOI 10.1038/ismej.2007.35; Delmas S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000552; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; Ellen AF, 2010, ARCHAEA, V2010, DOI 10.1155/2010/608243; Falb M, 2005, GENOME RES, V15, P1336, DOI 10.1101/gr.3952905; Falb M, 2008, EXTREMOPHILES, V12, P177, DOI 10.1007/s00792-008-0138-x; Fu H. Y., 2010, J BACTERIOL; Gao F, 2006, NUCLEIC ACIDS RES, V34, pW686, DOI 10.1093/nar/gkl040; Gordon D., 2003, CURR PROTOC BIOINFOR, V11, P1, DOI DOI 10.1002/0471250953.BI1102S02; Greve Bo, 2005, Archaea, V1, P319, DOI 10.1155/2005/159218; Grosjean H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-470; Gudbergsdottir S, 2011, MOL MICROBIOL, V79, P35, DOI 10.1111/j.1365-2958.2010.07452.x; GuixaBoixareu N, 1996, AQUAT MICROB ECOL, V11, P215, DOI 10.3354/ame011215; Held NL, 2009, ENVIRON MICROBIOL, V11, P457, DOI 10.1111/j.1462-2920.2008.01784.x; Hickman AB, 2010, CRIT REV BIOCHEM MOL, V45, P50, DOI 10.3109/10409230903505596; HOLMES ML, 1990, J BACTERIOL, V172, P756, DOI 10.1128/jb.172.2.756-761.1990; HOLMES ML, 1995, GENE, V153, P117, DOI 10.1016/0378-1119(94)00761-G; HORVATH P, 2008, INT J FOOD MICROBIOL; Ikeuchi Y, 2010, NAT CHEM BIOL, V6, P277, DOI [10.1038/NCHEMBIO.323, 10.1038/nchembio.323]; Karginov FV, 2010, MOL CELL, V37, P7, DOI 10.1016/j.molcel.2009.12.033; Kers JA, 2005, MOL MICROBIOL, V55, P1025, DOI 10.1111/j.1365-2958.2004.04461.x; Kersulyte D, 2002, J BACTERIOL, V184, P992, DOI 10.1128/jb.184.4.992-1002.2002; KESSEL M, 1982, J BACTERIOL, V150, P851, DOI 10.1128/JB.150.2.851-860.1982; Klein C, 2007, J PROTEOME RES, V6, P1510, DOI 10.1021/pr060634q; Legault BA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-171; Lobry JR, 1996, BIOCHIMIE, V78, P323, DOI 10.1016/0300-9084(96)84764-X; Lopez P, 1999, MOL MICROBIOL, V32, P883, DOI 10.1046/j.1365-2958.1999.01370.x; Lukjancenko O, 2010, MICROB ECOL, V60, P708, DOI 10.1007/s00248-010-9717-3; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; Myllykallio H, 2000, SCIENCE, V288, P2212, DOI 10.1126/science.288.5474.2212; Norais C, 2007, PLOS GENET, V3, P729, DOI 10.1371/journal.pgen.0030077; Oesterhelt D, 1974, Methods Enzymol, V31, P667; Oh D, 2010, EXTREMOPHILES, V14, P161, DOI 10.1007/s00792-009-0295-6; Oren A, 2002, FEMS MICROBIOL ECOL, V39, P1, DOI 10.1111/j.1574-6941.2002.tb00900.x; Oren A, 1996, FEMS MICROBIOL LETT, V138, P135, DOI 10.1111/j.1574-6968.1996.tb08146.x; OREN A, 2007, PROKARYOTES; Pagaling E, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-410; Pedros-Alio C, 2000, FEMS MICROBIOL ECOL, V32, P143, DOI 10.1016/S0168-6496(00)00025-8; PFEIFER F, 1981, J BACTERIOL, V145, P375, DOI 10.1128/JB.145.1.375-381.1981; Pfeiffer F, 2008, GENOMICS, V91, P335, DOI 10.1016/j.ygeno.2008.01.001; Pfeiffer F, 2008, ARCH MICROBIOL, V190, P281, DOI 10.1007/s00203-008-0389-z; Pietila MK, 2009, MOL MICROBIOL, V72, P307, DOI 10.1111/j.1365-2958.2009.06642.x; Pritham EJ, 2007, GENE, V390, P3, DOI 10.1016/j.gene.2006.08.008; Rampp M, 2006, NUCLEIC ACIDS RES, V34, pW15, DOI 10.1093/nar/gkl254; Reno ML, 2009, P NATL ACAD SCI USA, V106, P8605, DOI 10.1073/pnas.0808945106; Robinson NP, 2007, P NATL ACAD SCI USA, V104, P5806, DOI 10.1073/pnas.0700206104; Roine E, 2010, J VIROL, V84, P3682, DOI 10.1128/JVI.01879-09; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Santos F, 2010, ENV MICROBIOL; Shimizu T, 2002, P NATL ACAD SCI USA, V99, P996, DOI 10.1073/pnas.022493799; Siguier P, 2006, NUCLEIC ACIDS RES, V34, pD32, DOI 10.1093/nar/gkj014; SOLER N, 2010, NUCL ACIDS RES; Stern A, 2010, TRENDS GENET, V26, P335, DOI 10.1016/j.tig.2010.05.008; STOECKENIUS W, 1981, J BACTERIOL, V148, P352, DOI 10.1128/JB.148.1.352-360.1981; SUMPER M, 1990, J BACTERIOL, V172, P7111, DOI 10.1128/jb.172.12.7111-7118.1990; Szabo Z, 2007, J BACTERIOL, V189, P772, DOI 10.1128/JB.01547-06; Tang SL, 2004, J BACTERIOL, V186, P2810, DOI 10.1128/JB.186.9.2810-2817.2004; Tang SL, 2002, MOL MICROBIOL, V44, P283, DOI 10.1046/j.1365-2958.2002.02890.x; Teeling H, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-163; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Touchon M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011126; van Schaik W, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-239; Vieira-Silva S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000808; WALSBY AE, 1980, NATURE, V283, P69, DOI 10.1038/283069a0; Yurist-Doutsch S, 2010, MOL MICROBIOL, V75, P1047, DOI 10.1111/j.1365-2958.2009.07045.x	79	81	90	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e20968	10.1371/journal.pone.0020968	http://dx.doi.org/10.1371/journal.pone.0020968			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	21701686	Green Published, gold, Green Submitted			2022-12-27	WOS:000291983800016
J	Bussolati, G; Annaratone, L; Medico, E; D'Armento, G; Sapino, A				Bussolati, Gianni; Annaratone, Laura; Medico, Enzo; D'Armento, Giuseppe; Sapino, Anna			Formalin Fixation at Low Temperature Better Preserves Nucleic Acid Integrity	PLOS ONE			English	Article							PARAFFIN-EMBEDDED TISSUE; GENOME GENE-EXPRESSION; RNA EXTRACTION; BREAST-CANCER; OPTIMIZATION; TIME; RECOMMENDATIONS; RECOVERY; VACUUM; ISSUES	Fixation with formalin, a widely adopted procedure to preserve tissue samples, leads to extensive degradation of nucleic acids and thereby compromises procedures like microarray-based gene expression profiling. We hypothesized that RNA fragmentation is caused by activation of RNAses during the interval between formalin penetration and tissue fixation. To prevent RNAse activation, a series of tissue samples were kept under-vacuum at 4 degrees C until fixation and then fixed at 4 degrees C, for 24 hours, in formalin followed by 4 hours in ethanol 95%. This cold-fixation (CF) procedure preserved DNA and RNA, so that RNA segments up to 660 bp were efficiently amplified. Histological and immunohistochemical features were fully comparable with those of standard fixation. Microarray-based gene expression profiles were comparable with those obtained on matched frozen samples for probes hybridizing within 700 bases from the reverse transcription start site. In conclusion, CF preserves tissues and nucleic acids, enabling reliable gene expression profiling of fixed tissues.	[Bussolati, Gianni; Annaratone, Laura; D'Armento, Giuseppe; Sapino, Anna] Univ Turin, Dept Biomed Sci & Human Oncol, I-10124 Turin, Italy; [Medico, Enzo] Univ Turin, Inst Canc Res & Treatment IRCC, Dept Oncol Sci, Candiolo, Italy	University of Turin; IRCCS Fondazione del Piemonte per l'Oncologia; University of Turin	Bussolati, G (corresponding author), Univ Turin, Dept Biomed Sci & Human Oncol, I-10124 Turin, Italy.	enzo.medico@ircc.it; anna.sapino@unito.it	Sapino, Anna/AGY-9901-2022; Medico, Enzo/AAC-3185-2021; Annaratone, Laura/J-9261-2016; Sapino, Anna/J-4113-2018	Sapino, Anna/0000-0003-3542-9571; Medico, Enzo/0000-0002-3917-2438; Annaratone, Laura/0000-0001-5750-1445; Sapino, Anna/0000-0003-3542-9571	MI.S.E.-ICE-CRUI, Uso del sottovuoto per la conservazione ed il trasferimento di biopsie [108]; AIRC [IG-9127]	MI.S.E.-ICE-CRUI, Uso del sottovuoto per la conservazione ed il trasferimento di biopsie; AIRC(Fondazione AIRC per la ricerca sul cancro)	This work was supported by MI.S.E.-ICE-CRUI Prog. n. 108 (2008) "Uso del sottovuoto per la conservazione ed il trasferimento di biopsie" research fund grants to G.B.; AIRC 2007-2009 "Micropapillary phenomenon: embolization, metastases and drug resistance" and AIRC 2010 "Tumour microenvironment and cell polarity in breast cancer: roles and implications for metastasis" research fund grants to A.S.; and AIRC (IG-9127) research fund grants to E.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovitz M, 2008, BIOTECHNIQUES, V44, P417, DOI 10.2144/000112703; April C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008162; Blum F, 1983, Z WISS MIKROSK, V10, P314; Bussolati G, 2008, VIRCHOWS ARCH, V452, P229, DOI 10.1007/s00428-007-0529-x; Chen J, 2007, DIAGN MOL PATHOL, V16, P61, DOI 10.1097/PDM.0b013e31802f0804; Chung JY, 2008, J HISTOCHEM CYTOCHEM, V56, P1033, DOI 10.1369/jhc.2008.951863; Dabbs DJ, 2008, AM J CLIN PATHOL, V129, P355, DOI 10.1309/NKF29KCHNMYEMCT3; Di Novi C, 2010, SCI TOTAL ENVIRON, V408, P3092, DOI 10.1016/j.scitotenv.2010.04.022; Dotti I, 2010, DIAGN MOL PATHOL, V19, P112, DOI 10.1097/PDM.0b013e3181b520f8; Farragher SM, 2008, HISTOCHEM CELL BIOL, V130, P435, DOI 10.1007/s00418-008-0479-7; Ferrer I, 2007, BRAIN PATHOL, V17, P297, DOI 10.1111/j.1750-3639.2007.00073.x; FOX CH, 1985, J HISTOCHEM CYTOCHEM, V33, P845, DOI 10.1177/33.8.3894502; Fu LM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-3; Goldstein NS, 2007, APPL IMMUNOHISTO M M, V15, P124, DOI 10.1097/PAI.0b013e31804c7283; Goldstein NS, 2003, AM J CLIN PATHOL, V120, P86, DOI 10.1309/QPHDRB00QXGMUQ9N; HELANDER KG, 1994, BIOTECH HISTOCHEM, V69, P177, DOI 10.3109/10520299409106282; Hewitt SM, 2008, ARCH PATHOL LAB MED, V132, P1929, DOI 10.1043/1543-2165-132.12.1929; Kibriya MG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-622; Lewis F, 2001, J PATHOL, V195, P66, DOI 10.1002/1096-9896(200109)195:1<66::AID-PATH921>3.0.CO;2-F; Marchio C, 2009, J PATHOL, V219, P16, DOI 10.1002/path.2574; Masuda N, 1999, NUCLEIC ACIDS RES, V27, P4436, DOI 10.1093/nar/27.22.4436; Medeiros F, 2007, ARCH PATHOL LAB MED, V131, P1805; Paska C, 2004, DIAGN MOL PATHOL, V13, P234, DOI 10.1097/01.pdm.0000134778.37729.9f; Pearse A. G., 1980, HISTOCHEMISTRY THEOR; Scicchitano MS, 2006, J HISTOCHEM CYTOCHEM, V54, P1229, DOI 10.1369/jhc.6A6999.2006; STANTA G, 1991, BIOTECHNIQUES, V11, P304; van Maldegem F, 2008, DIAGN MOL PATHOL, V17, P51, DOI 10.1097/PDM.0b013e31814b8866; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775	28	58	63	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e21043	10.1371/journal.pone.0021043	http://dx.doi.org/10.1371/journal.pone.0021043			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698245	Green Submitted, Green Published, gold			2022-12-27	WOS:000291730000043
J	Senum, P; Riedel, M				Senum, Phillip; Riedel, Marc			Rate-Independent Constructs for Chemical Computation	PLOS ONE			English	Article							STOCHASTIC SIMULATION; KINETICS; UNIVERSAL	This paper presents a collection of computational modules implemented with chemical reactions: an inverter, an incrementer, a decrementer, a copier, a comparator, a multiplier, an exponentiator, a raise-to-a-power operation, and a logarithm in base two. Unlike previous schemes for chemical computation, this method produces designs that are dependent only on coarse rate categories for the reactions ("fast" vs. "slow"). Given such categories, the computation is exact and independent of the specific reaction rates. The designs are validated through stochastic simulations of the chemical kinetics.	[Senum, Phillip; Riedel, Marc] Univ Minnesota, Dept Elect & Comp Engn, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Senum, P (corresponding author), Univ Minnesota, Dept Elect & Comp Engn, Minneapolis, MN 55455 USA.	senu0004@umn.edu			NSF [0845650]; University of Minnesota	NSF(National Science Foundation (NSF)); University of Minnesota(University of Minnesota System)	This research is supported by an NSF CAREER Award, #0845650 (http://www.nsf.gov/awardsearch/showAward.do?AwardNumber=0845650&WT.z_pims_id), and by a UROP Award from the University of Minnesota (http://www.research.umn.edu/undergraduate/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Epstein I.R., 1998, INTRO NONLINEAR CHEM; ERDI P., 1989, MATH MODELS CHEM REA; Gillespie DT, 2007, ANNU REV PHYS CHEM, V58, P35, DOI 10.1146/annurev.physchem.58.032806.104637; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; HORN F, 1972, ARCH RATION MECH AN, V47, P81; Jiang H, 2010, ICCAD-IEEE ACM INT, P417, DOI 10.1109/ICCAD.2010.5654189; Keasling JD, 2008, ACS CHEM BIOL, V3, P64, DOI 10.1021/cb7002434; KHARAM A, 2011, PAC S BIOC; Magnasco MO, 1997, PHYS REV LETT, V78, P1190, DOI 10.1103/PhysRevLett.78.1190; MAUCH S, 2009, IEEE ACM T COMPUTATI, V99; Qian L, 2009, LECT NOTES COMPUT SC, V5347, P70, DOI 10.1007/978-3-642-03076-5_7; Shea A, 2010, BIOCOMPUT-PAC SYM, P456; Soloveichik D., 2008, NATURAL COMPUTING, V7; Soloveichik D, 2010, P NATL ACAD SCI USA, V107, P5393, DOI 10.1073/pnas.0909380107; Strogatz S.H., 1994, NONLINEAR DYNAMICS C; VENKATARAMANA S, 2010, P NATL ACAD IN PRESS; Weiss R., 2003, THESIS MIT; WILLAMOWSKI KD, 1980, Z NATURFORSCH A, V35, P317; Win MN, 2009, CHEM BIOL, V16, P298, DOI 10.1016/j.chembiol.2009.02.011	20	21	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e21414	10.1371/journal.pone.0021414	http://dx.doi.org/10.1371/journal.pone.0021414			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738654	Green Published, gold, Green Submitted			2022-12-27	WOS:000292291800013
J	Ill-Raga, G; Palomer, E; Wozniak, MA; Ramos-Fernandez, E; Bosch-Morato, M; Tajes, M; Guix, FX; Galan, JJ; Clarimon, J; Antunez, C; Real, LM; Boada, M; Itzhaki, RF; Fandos, C; Munoz, FJ				Ill-Raga, Gerard; Palomer, Ernest; Wozniak, Matthew A.; Ramos-Fernandez, Eva; Bosch-Morato, Monica; Tajes, Marta; Guix, Francesc X.; Galan, Jose J.; Clarimon, Jordi; Antunez, Carmen; Real, Luis M.; Boada, Merce; Itzhaki, Ruth F.; Fandos, Cesar; Munoz, Francisco J.			Activation of PKR Causes Amyloid beta-Peptide Accumulation via De-Repression of BACE1 Expression	PLOS ONE			English	Article							SIMPLEX-VIRUS TYPE-1	BACE1 is a key enzyme involved in the production of amyloid beta-peptide (A beta) in Alzheimer's disease (AD) brains. Normally, its expression is constitutively inhibited due to the presence of the 5'untranslated region (5'UTR) in the BACE1 promoter. BACE1 expression is activated by phosphorylation of the eukaryotic initiation factor (eIF)2-alpha, which reverses the inhibitory effect exerted by BACE1 5'UTR. There are four kinases associated with different types of stress that could phosphorylate eIF2-alpha. Here we focus on the double-stranded (ds) RNA-activated protein kinase (PKR). PKR is activated during viral infection, including that of herpes simplex virus type 1 (HSV1), a virus suggested to be implicated in the development of AD, acting when present in brains of carriers of the type 4 allele of the apolipoprotein E gene. HSV1 is a dsDNA virus but it has genes on both strands of the genome, and from these genes complementary RNA molecules are transcribed. These could activate BACE1 expression by the PKR pathway. Here we demonstrate in HSV1-infected neuroblastoma cells, and in peripheral nervous tissue from HSV1-infected mice, that HSV1 activates PKR. Cloning BACE1 5'UTR upstream of a luciferase (luc) gene confirmed its inhibitory effect, which can be prevented by salubrinal, an inhibitor of the eIF2-alpha phosphatase PP1c. Treatment with the dsRNA analog poly (I:C) mimicked the stimulatory effect exerted by salubrinal over BACE1 translation in the 5'UTR-luc construct and increased A beta production in HEK-APPsw cells. Summarizing, our data suggest that PKR activated in brain by HSV1 could play an important role in the development of AD.	[Ill-Raga, Gerard; Palomer, Ernest; Ramos-Fernandez, Eva; Bosch-Morato, Monica; Tajes, Marta; Guix, Francesc X.; Fandos, Cesar; Munoz, Francisco J.] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Lab Mol Physiol & Channelopathies, Barcelona, Spain; [Wozniak, Matthew A.; Itzhaki, Ruth F.] Univ Manchester, Manchester, Lancs, England; [Galan, Jose J.; Real, Luis M.] NeoCodex, Seville, Spain; [Clarimon, Jordi] Hosp Santa Creu & Sant Pau, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Dept Neurol, Alzheimer Lab, Barcelona, Spain; [Antunez, Carmen] Hosp Virgen de la Arrixaca Murcia, Unidad Demencias, Fdn Alzheimur, Murcia, Spain; [Boada, Merce] Memory Clin ACE Fdn, Catalan Inst Appl Neurosci, Barcelona, Spain; [Boada, Merce] Hosp G Univ Vall dHebron, Dept Neurol, Barcelona, Spain	Pompeu Fabra University; University of Manchester; CIBERNED; Hospital of Santa Creu i Sant Pau; Hospital Clinico Universitario Virgen de la Arrixaca	Ill-Raga, G (corresponding author), Univ Pompeu Fabra, Dept Expt & Hlth Sci, Lab Mol Physiol & Channelopathies, Barcelona, Spain.	paco.munoz@upf.edu	Muñoz, F/E-6751-2014; Guix, Francesc/AAA-7462-2020; Tajes, Marta/ABG-2187-2020; Palomer, Ernest/CAI-0575-2022; Palomer, Ernest/CAF-4211-2022; ILL-Raga, Gerard/G-8864-2011; Real, Luis M/K-9646-2014	Muñoz, F/0000-0002-1343-3599; Tajes, Marta/0000-0002-9333-1794; Palomer, Ernest/0000-0001-8629-2443; Palomer, Ernest/0000-0001-8629-2443; ILL-Raga, Gerard/0000-0002-0898-5356; Clarimon, Jordi/0000-0002-6824-6942; Real, Luis M/0000-0003-4932-7429; Fandos, Cesar/0000-0001-7348-1376	Alzheimur Foundation; Spanish Ministerio de Ciencia y Tecnologia [FIS: PI07/0593, Red HERACLES RD06/0009/002]	Alzheimur Foundation; Spanish Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	Neocodex is a private research organization (more than 70 articles in indexes of international research journals in the last 8 years). Neocodex's work on this project was design, implementation, analysis and interpretation of genetic studies of the PKR gene that is included in this manuscript. Neocodex also coordinates the construction of the DNA bank employed in this draft. The work was carried out with funds from this entity and a project funded by the Alzheimur Foundation. The other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was also supported by the Spanish Ministerio de Ciencia y Tecnologia (FIS: PI07/0593; Red HERACLES RD06/0009/002).	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; BALL MJ, 1982, CAN J NEUROL SCI, V9, P303, DOI 10.1017/S0317167100044115; Barber GN, 2005, CELL DEATH DIFFER, V12, P563, DOI 10.1038/sj.cdd.4401643; Bullido MJ, 2008, NEUROBIOL AGING, V29, P1160, DOI 10.1016/j.neurobiolaging.2007.02.023; Cassady KA, 2002, J VIROL, V76, P2029, DOI 10.1128/jvi.76.5.2029-2035.2002; Chang RCC, 2002, NEUROREPORT, V13, P2429, DOI 10.1097/00001756-200212200-00011; Chang RCC, 2002, J NEUROCHEM, V83, P1215, DOI 10.1046/j.1471-4159.2002.01237.x; CHOU J, 1995, P NATL ACAD SCI USA, V92, P10516, DOI 10.1073/pnas.92.23.10516; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; Coma M, 2008, NEUROBIOL AGING, V29, P969, DOI 10.1016/j.neurobiolaging.2007.01.009; deHaro C, 1996, FASEB J, V10, P1378, DOI 10.1096/fasebj.10.12.8903508; DELTORO D, 2009, CURR MED CHEM CENTRA, P271; DEPIETRI TD, 2004, NUCLEIC ACIDS RES, V5, P1808; Der SD, 1997, P NATL ACAD SCI USA, V94, P3279, DOI 10.1073/pnas.94.7.3279; Dobson CB, 2006, J INFECT DIS, V193, P442, DOI 10.1086/499280; Garcia MA, 2007, BIOCHIMIE, V89, P799, DOI 10.1016/j.biochi.2007.03.001; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; Gatta LB, 2002, NEUROREPORT, V13, P2031, DOI 10.1097/00001756-200211150-00008; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Hinnebusch A.G., 1996, TRANSLATIONAL CONTRO, P199; Hinnebusch AG, 1997, J BIOL CHEM, V272, P21661, DOI 10.1074/jbc.272.35.21661; HINNEBUSCH AG, MECH REGULATION INIT, P184; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; Itzhaki RF, 1997, LANCET, V349, P241, DOI 10.1016/S0140-6736(96)10149-5; JAMIESON GA, 1991, J MED VIROL, V33, P224, DOI 10.1002/jmv.1890330403; Jammi NV, 2003, BIOCHEM BIOPH RES CO, V308, P50, DOI 10.1016/S0006-291X(03)01318-4; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Lammich S, 2004, EMBO REP, V5, P620, DOI 10.1038/sj.embor.7400166; LEE SB, 1994, VIROLOGY, V199, P491, DOI 10.1006/viro.1994.1151; Lin XL, 2000, P NATL ACAD SCI USA, V97, P1456, DOI 10.1073/pnas.97.4.1456; Marcinkiewicz M, 2000, J NEUROCHEM, V75, P2133, DOI 10.1046/j.1471-4159.2000.0752133.x; Matsumoto M, 2004, MICROBIOL IMMUNOL, V48, P147, DOI 10.1111/j.1348-0421.2004.tb03500.x; Mihailovich M, 2007, NUCLEIC ACIDS RES, V35, P2975, DOI 10.1093/nar/gkm191; Morris DR, 2000, MOL CELL BIOL, V20, P8635, DOI 10.1128/MCB.20.23.8635-8642.2000; O'Connor T, 2008, NEURON, V60, P988, DOI 10.1016/j.neuron.2008.10.047; Peel AL, 2004, J NEUROPATH EXP NEUR, V63, P97, DOI 10.1093/jnen/63.2.97; Peel AL, 2003, NEUROBIOL DIS, V14, P52, DOI 10.1016/S0969-9961(03)00086-X; Preece P, 2003, MOL BRAIN RES, V116, P155, DOI 10.1016/S0169-328X(03)00233-X; Scheuner D, 2006, J BIOL CHEM, V281, P21458, DOI 10.1074/jbc.M603784200; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Sun X, 2006, P NATL ACAD SCI USA, V103, P18727, DOI 10.1073/pnas.0606298103; Tamagno E, 2002, NEUROBIOL DIS, V10, P279, DOI 10.1006/nbdi.2002.0515; TAN SL, 1999, J INTERFERON CYTOKIN, V6, P543; Taylor SS, 2005, CELL, V122, P823, DOI 10.1016/j.cell.2005.09.007; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; WEK RC, 2006, BIOCH SOC T 1, P7; Williams BRG, 1999, ONCOGENE, V18, P6112, DOI 10.1038/sj.onc.1203127; Wozniak MA, 2009, J PATHOL, V217, P131, DOI 10.1002/path.2449; Wozniak MA, 2005, J MED VIROL, V75, P300, DOI 10.1002/jmv.20271; Wozniak MA, 2007, NEUROSCI LETT, V429, P95, DOI 10.1016/j.neulet.2007.09.077; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Zhang F, 2001, J BIOL CHEM, V276, P24946, DOI 10.1074/jbc.M102108200; Zhang X, 2007, J BIOL CHEM, V282, P10873, DOI 10.1074/jbc.M608856200; Zhou WH, 2006, MOL CELL BIOL, V26, P3353, DOI 10.1128/MCB.26.9.3353-3364.2006	54	49	51	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21456	10.1371/journal.pone.0021456	http://dx.doi.org/10.1371/journal.pone.0021456			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738672	Green Published, gold			2022-12-27	WOS:000292142800025
J	Pacheco-Gomez, R; Roper, DI; Dafforn, TR; Rodger, A				Pacheco-Gomez, Raul; Roper, David I.; Dafforn, Timothy R.; Rodger, Alison			The pH Dependence of Polymerization and Bundling by the Essential Bacterial Cytoskeltal Protein FtsZ	PLOS ONE			English	Article							ESCHERICHIA-COLI; GTP; DICHROISM; ORIENTATION; DYNAMICS	There is a growing body of evidence that bacterial cell division is an intricate coordinated process of comparable complexity to that seen in eukaryotic cells. The dynamic assembly of Escherichia coli FtsZ in the presence of GTP is fundamental to its activity. FtsZ polymerization is a very attractive target for novel antibiotics given its fundamental and universal function. In this study our aim was to understand further the GTP-dependent FtsZ polymerization mechanism and our main focus is on the pH dependence of its behaviour. A key feature of this work is the use of linear dichroism (LD) to follow the polymerization of FtsZ monomers into polymeric structures. LD is the differential absorption of light polarized parallel and perpendicular to an orientation direction (in this case that provided by shear flow). It thus readily distinguishes between FtsZ polymers and monomers. It also distinguishes FtsZ polymers and less well-defined aggregates, which light scattering methodologies do not. The polymerization of FtsZ over a range of pHs was studied by right-angled light scattering to probe mass of FtsZ structures, LD to probe real-time formation of linear polymeric fibres, a specially developed phosphate release assay to relate guanosine triphosphate (GTP) hydrolysis to polymer formation, and electron microscopy (EM) imaging of reaction products as a function of time and pH. We have found that lowering the pH from neutral to 6.5 does not change the nature of the FtsZ polymers in solution-it simply facilitates the polymerization so the fibres present are longer and more abundant. Conversely, lowering the pH to 6.0 has much the same effect as introducing divalent cations or the FtsZ-associated protein YgfE (a putative ZapA orthologue in E. coli)-it stablizes associations of protofilaments.	[Pacheco-Gomez, Raul; Rodger, Alison] Univ Warwick, Mol Org, Coventry CV4 7AL, W Midlands, England; [Pacheco-Gomez, Raul; Rodger, Alison] Univ Warwick, Assembly Cells Doctoral Training Ctr, Coventry CV4 7AL, W Midlands, England; [Roper, David I.] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England; [Rodger, Alison] Univ Warwick, Dept Chem, Coventry CV4 7AL, W Midlands, England; [Dafforn, Timothy R.] Univ Birmingham, Dept Biosci, Birmingham, W Midlands, England	University of Warwick; University of Warwick; University of Warwick; University of Warwick; University of Birmingham	Pacheco-Gomez, R (corresponding author), Univ Warwick, Mol Org, Coventry CV4 7AL, W Midlands, England.	a.rodger@warwick.ac.uk	Rodger, Alison/A-1063-2009; Roper, David I/A-2323-2011; Dafforn, Tim/A-9072-2015	Rodger, Alison/0000-0002-7111-3024; Roper, David I/0000-0003-0009-621X; Dafforn, Tim/0000-0003-2257-6679	Engineering and Physical Sciences Research Council [GR/S47113/01, GR/T09224/01]	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Funding from the Engineering and Physical Sciences Research Council (GR/S47113/01; GR/T09224/01) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DW, 2009, NAT REV MICROBIOL, V7, P642, DOI 10.1038/nrmicro2198; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAMHILL D, 1994, P NATL ACAD SCI USA, V91, P5813, DOI 10.1073/pnas.91.13.5813; Chen YD, 2009, BIOCHEMISTRY-US, V48, P6664, DOI 10.1021/bi8022653; ERICKSON HP, 2009, P NAT ACAD SCI, P9238; Errington J, 2003, MICROBIOL MOL BIOL R, V67, P52, DOI 10.1128/MMBR.67.1.52-65.2003; Haydon DJ, 2008, SCIENCE, V321, P1673, DOI 10.1126/science.1159961; Johnson WC, 1999, PROTEINS, V35, P307, DOI 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.0.CO;2-3; JOHNSON WC, 1988, ANNU REV BIOPHYS BIO, V17, P145, DOI 10.1146/annurev.bb.17.060188.001045; Lu CL, 2000, J BACTERIOL, V182, P164, DOI 10.1128/JB.182.1.164-170.2000; Marrington R, 2004, J BIOL CHEM, V279, P48821, DOI 10.1074/jbc.M404944200; MARRINGTON R, 2004, CALCIUM IND IN PRESS; MARRINGTON R, 2005, VALIDATION NEW MICRO, P1608; MARRINGTON R, 2004, POLARISED SPECTROSCO; Marrington R, 2006, CHIRALITY, V18, P680, DOI 10.1002/chir.20305; Mendieta J, 2009, J MOL BIOL, V390, P17, DOI 10.1016/j.jmb.2009.05.018; Mingorance J, 2001, MOL MICROBIOL, V41, P83, DOI 10.1046/j.1365-2958.2001.02498.x; Mukherjee A, 1999, J BACTERIOL, V181, P823, DOI 10.1128/JB.181.3.823-832.1999; MUKHERJEE A, 1994, J BACTERIOL, V176, P2754, DOI 10.1128/JB.176.9.2754-2758.1994; Mukherjee A, 1998, METHOD ENZYMOL, V298, P296, DOI 10.1016/S0076-6879(98)98026-0; Mukherjee A, 1998, EMBO J, V17, P462, DOI 10.1093/emboj/17.2.462; Norden B, 2010, LINEAR DICHROISM AND CIRCULAR DICHROISM: A TEXTBOOK ON POLARIZED LIGHT SPECTROSCOPY, P1; NORDH J, 1986, EUR BIOPHYS J BIOPHY, V14, P113, DOI 10.1007/BF00263068; Rodger A, 2002, PHYS CHEM CHEM PHYS, V4, P4051, DOI 10.1039/b205080n; Scheffers DJ, 2008, FEBS LETT, V582, P2601, DOI 10.1016/j.febslet.2008.06.038; SMALL E, 2003, MICROBIOLOGY, V149; Small E, 2007, J MOL BIOL, V369, P210, DOI 10.1016/j.jmb.2007.03.025; Stricker J, 2002, P NATL ACAD SCI USA, V99, P3171, DOI 10.1073/pnas.052595099; WEBB MR, 1992, P NATL ACAD SCI USA, V89, P4884, DOI 10.1073/pnas.89.11.4884; Wilks JC, 2007, J BACTERIOL, V189, P5601, DOI 10.1128/JB.00615-07	30	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e19369	10.1371/journal.pone.0019369	http://dx.doi.org/10.1371/journal.pone.0019369			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738567	Green Submitted, gold, Green Published			2022-12-27	WOS:000292142800001
J	Shin, J; Lee, HJ; Jung, DB; Jung, JH; Lee, HJ; Lee, EO; Lee, SG; Shim, BS; Choi, SH; Ko, SG; Ahn, KS; Jeong, SJ; Kim, SH				Shin, Jimin; Lee, Hyo-Jeong; Jung, Deok-Beom; Jung, Ji Hoon; Lee, Hyo-Jung; Lee, Eun-Ok; Lee, Seok Geun; Shim, Beom Sang; Choi, Seung Hoon; Ko, Seong Gyu; Ahn, Kwang Seok; Jeong, Soo-Jin; Kim, Sung-Hoon			Suppression of STAT3 and HIF-1 Alpha Mediates Anti-Angiogenic Activity of Betulinic Acid in Hypoxic PC-3 Prostate Cancer Cells	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; INDUCIBLE FACTOR 1-ALPHA; VEGF EXPRESSION; SIGNAL TRANSDUCER; HUMAN-MELANOMA; ACTIVATION; APOPTOSIS; INDUCTION; THERAPY; TRANSCRIPTION	Background: Signal transducer and activator of transcription 3 (STAT3) is a transcription factor that regulates various cellular processes such as cell survival, angiogenesis and proliferation. In the present study, we examined that betulinic acid (BA), a triterpene from the bark of white birch, had the inhibitory effects on hypoxia-mediated activation of STAT3 in androgen independent human prostate cancer PC-3 cells. Methodology/Principal Findings: BA inhibited the protein expression and the transcriptional activities of hypoxia-inducible factor-1 alpha (HIF-1 alpha) under hypoxic condition. Consistently, BA blocked hypoxia-induced phosphorylation, DNA binding activity and nuclear accumulation of STAT3. In addition, BA significantly reduced cellular and secreted levels of vascular endothelial growth factor (VEGF), a critical angiogenic factor and a target gene of STAT3 induced under hypoxia. Furthermore, BA prevented in vitro capillary tube formation in human umbilical vein endothelial cells (HUVECs) maintained in conditioned medium of hypoxic PC-3 cells, implying anti-angiogenic activity of BA under hypoxic condition. Of note, chromatin immunoprecipitation (ChiP) assay revealed that BA inhibited binding of HIF-1 alpha and STAT3 to VEGF promoter. Furthermore, silencing STAT3 using siRNA transfection effectively enhanced the reduced VEGF production induced by BA treatment under hypoxia. Conclusions/Significance: Taken together, our results suggest that BA has anti-angiogenic activity by disturbing the binding of HIF-1 alpha and STAT3 to the VEGF promoter in hypoxic PC-3 cells.	[Shin, Jimin; Lee, Hyo-Jeong; Jung, Deok-Beom; Jung, Ji Hoon; Lee, Hyo-Jung; Lee, Eun-Ok; Lee, Seok Geun; Shim, Beom Sang; Choi, Seung Hoon; Ko, Seong Gyu; Ahn, Kwang Seok; Jeong, Soo-Jin; Kim, Sung-Hoon] Kyung Hee Univ, Coll Oriental Med, Seoul, South Korea	Kyung Hee University	Shin, J (corresponding author), Kyung Hee Univ, Coll Oriental Med, Seoul, South Korea.	sungkim7@khu.ac.kr	Shim, Bum-sang/AAH-9081-2020; Lee, Eun-Ok/AAH-9116-2020; Ahn, Kwang Seok/G-4249-2013; Lee, Seok-Geun/B-3408-2011	Lee, Seok-Geun/0000-0002-0060-5777; kim, sunghoon/0000-0002-1570-3230	Korean government (MEST) [2011-0063466]	Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by the Korea Science and Engineering Foundation (KOSEF) Grant funded by the Korean government (MEST) (No. 2011-0063466). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2006, ANN NY ACAD SCI, V1091, P151, DOI 10.1196/annals.1378.063; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Chadalapaka G, 2010, MOL CANCER RES, V8, P739, DOI 10.1158/1541-7786.MCR-09-0493; Choo EJ, 2011, BIOL PHARM BULL, V34, P41, DOI 10.1248/bpb.34.41; DECLERCQ E, 1995, CLIN MICROBIOL REV, V8, P200, DOI 10.1128/CMR.8.2.200; Eichenmuller M, 2010, BRIT J CANCER, V103, P43, DOI 10.1038/sj.bjc.6605715; Ellis LM, 2008, NAT REV CANCER, V8, P579, DOI 10.1038/nrc2403; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Fulda S, 1997, CANCER RES, V57, P4956; Fulda S, 2009, MOL NUTR FOOD RES, V53, P140, DOI 10.1002/mnfr.200700491; Gariboldi MB, 2010, BIOCHEM PHARMACOL, V80, P455, DOI 10.1016/j.bcp.2010.05.011; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jung JE, 2005, FASEB J, V19, P1296, DOI 10.1096/fj.04-3099fje; Jung JE, 2008, EXP MOL MED, V40, P479, DOI 10.3858/emm.2008.40.5.479; Karna E, 2010, MOL CELL BIOCHEM, V340, P15, DOI 10.1007/s11010-010-0395-8; Kessler JH, 2007, CANCER LETT, V251, P132, DOI 10.1016/j.canlet.2006.11.003; Kim SH, 2011, EUR J PHARMACOL, V654, P10, DOI 10.1016/j.ejphar.2010.11.032; KINGSTON DGI, 1978, LLOYDIA, V41, P499; Koh MY, 2008, TRENDS BIOCHEM SCI, V33, P526, DOI 10.1016/j.tibs.2008.08.002; Lee HJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012358; Leeman-Neill RJ, 2009, CARCINOGENESIS, V30, P1848, DOI 10.1093/carcin/bgp211; MILES DH, 1974, J PHARM SCI, V63, P613, DOI 10.1002/jps.2600630427; Mukherjee PK, 1997, PLANTA MED, V63, P367, DOI 10.1055/s-2006-957705; Mullauer FB, 2010, ANTI-CANCER DRUG, V21, P215, DOI 10.1097/CAD.0b013e3283357c62; Niu GL, 2002, ONCOGENE, V21, P2000, DOI 10.1038/sj.onc.1205260; Niu GL, 2008, MOL CANCER RES, V6, P1099, DOI 10.1158/1541-7786.MCR-07-2177; Pandey MK, 2010, INT J CANCER, V127, P282, DOI 10.1002/ijc.25059; Park KY, 2010, BIOL PHARM BULL, V33, P1835, DOI 10.1248/bpb.33.1835; PISHA E, 1995, NAT MED, V1, P1046, DOI 10.1038/nm1095-1046; Pulukuri SM, 2005, J BIOL CHEM, V280, P36529, DOI 10.1074/jbc.M503111200; Rabi T, 2008, MOL CARCINOGEN, V47, P964, DOI 10.1002/mc.20447; Rieber M, 1998, DNA CELL BIOL, V17, P399, DOI 10.1089/dna.1998.17.399; Selzer E, 2000, J INVEST DERMATOL, V114, P935, DOI 10.1046/j.1523-1747.2000.00972.x; Smith TG, 2008, BRIT J HAEMATOL, V141, P325, DOI 10.1111/j.1365-2141.2008.07029.x; TRUMBULL ER, 1976, J PHARM SCI, V65, P1407, DOI 10.1002/jps.2600650938; Wei DY, 2003, ONCOGENE, V22, P319, DOI 10.1038/sj.onc.1206122; Xu Q, 2005, ONCOGENE, V24, P5552, DOI 10.1038/sj.onc.1208719; Zhang JH, 2009, PHARM RES-DORDR, V26, P2066, DOI 10.1007/s11095-009-9932-0; Zhong H, 1999, CANCER RES, V59, P5830; Zuco V, 2002, CANCER LETT, V175, P17, DOI 10.1016/S0304-3835(01)00718-2	40	61	64	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21492	10.1371/journal.pone.0021492	http://dx.doi.org/10.1371/journal.pone.0021492			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21731766	Green Published, Green Submitted, gold			2022-12-27	WOS:000292036900042
J	Zou, X; Coyle, D; Wong-Lin, K; Maguire, L				Zou, Xin; Coyle, Damien; Wong-Lin, KongFatt; Maguire, Liam			Computational Study of Hippocampal-Septal Theta Rhythm Changes Due to Beta-Amyloid-Altered Ionic Channels	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; NEURONAL-ACTIVITY; PYRAMIDAL CELLS; FREQUENCY BANDS; K+ CHANNELS; DEMENTIA; INTERNEURONS; INHIBITION; ACTIVATION; DYNAMICS	Electroencephagraphy (EEG) of many dementia patients has been characterized by an increase in low frequency field potential oscillations. One of the characteristics of early stage Alzheimer's disease (AD) is an increase in theta band power (4-7 Hz). However, the mechanism(s) underlying the changes in theta oscillations are still unclear. To address this issue, we investigate the theta band power changes associated with beta-Amyloid (Ab) peptide (one of the main markers of AD) using a computational model, and by mediating the toxicity of hippocampal pyramidal neurons. We use an established biophysical hippocampal CA1-medial septum network model to evaluate four ionic channels in pyramidal neurons, which were demonstrated to be affected by Ab. They are the L-type Ca2+ channel, delayed rectifying K+ channel, A-type fast-inactivating K+ channel and large-conductance Ca2+-activated K+ channel. Our simulation results demonstrate that only the Ab inhibited A-type fast-inactivating K+ channel can induce an increase in hippocampo-septal theta band power, while the other channels do not affect theta rhythm. We further deduce that this increased theta band power is due to enhanced synchrony of the pyramidal neurons. Our research may elucidate potential biomarkers and therapeutics for AD. Further investigation will be helpful for better understanding of AD-induced theta rhythm abnormalities and associated cognitive deficits.	[Zou, Xin; Coyle, Damien; Wong-Lin, KongFatt; Maguire, Liam] Univ Ulster, Intelligent Syst Res Ctr, Derry, North Ireland	Ulster University	Zou, X (corresponding author), Univ Ulster, Intelligent Syst Res Ctr, Magee Campus, Derry, North Ireland.	x.zou@ulster.ac.uk	Coyle, Damien H/D-1161-2013; Coyle, Damien/S-5332-2019	Coyle, Damien H/0000-0002-4739-1040; Coyle, Damien/0000-0002-4739-1040; Maguire, Liam/0000-0001-6153-3298; Wong-Lin, KongFatt/0000-0001-8724-4398	Northern Ireland Department for Employment and Learning through its "Strengthening the All-Island Research Base" initiative	Northern Ireland Department for Employment and Learning through its "Strengthening the All-Island Research Base" initiative	This study is currently supported under the CNRT award by the Northern Ireland Department for Employment and Learning through its "Strengthening the All-Island Research Base" initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeli H, 2005, J ALZHEIMERS DIS, V7, P187; Amatniek JC, 2006, EPILEPSIA, V47, P867, DOI 10.1111/j.1528-1167.2006.00554.x; ARISPE N, 1993, P NATL ACAD SCI USA, V90, P10573, DOI 10.1073/pnas.90.22.10573; BHATTACHARYA B, 2011, ADV EXPT MED BIOL, P718; BHATTACHARYA B, 2011, NEURAL NETW IN PRESS; Bonanni L, 2008, BRAIN, V131, P690, DOI 10.1093/brain/awm322; Braak H, 1998, J NEURAL TRANSM-SUPP, P97; Chen C, 2005, BIOCHEM BIOPH RES CO, V338, P1913, DOI 10.1016/j.bbrc.2005.10.169; Chi S, 2006, BRIT J PHARMACOL, V149, P1031, DOI 10.1038/sj.bjp.0706947; Chiaramonti R, 1997, NEUROPSYCHOBIOLOGY, V36, P153, DOI 10.1159/000119375; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; Dauwels J, 2010, CURR ALZHEIMER RES, V7, P487, DOI 10.2174/156720510792231720; DAVIDSON RM, 1994, BRAIN RES, V643, P324, DOI 10.1016/0006-8993(94)90041-8; DEADWYLER SA, 1995, J PHARMACOL EXP THER, V273, P734; Furukawa K, 1996, NATURE, V379, P74, DOI 10.1038/379074a0; GERSTEIN GL, 1960, BIOPHYS J, V1, P15, DOI 10.1016/S0006-3495(60)86872-5; Good TA, 1996, BIOPHYS J, V70, P296, DOI 10.1016/S0006-3495(96)79570-X; Hajos M, 2004, NEUROSCIENCE, V126, P599, DOI 10.1016/j.neuroscience.2004.03.043; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Ihl R, 1996, BIOL PSYCHIAT, V39, P319, DOI 10.1016/0006-3223(95)00174-3; Jhamandas JH, 2001, J NEUROPHYSIOL, V86, P1312, DOI 10.1152/jn.2001.86.3.1312; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; LANCASTER B, 1987, J PHYSIOL-LONDON, V389, P187, DOI 10.1113/jphysiol.1987.sp016653; Li X., 2010, NEURORADIOLOGY; Mazzoni A, 2010, NEUROIMAGE, V52, P956, DOI 10.1016/j.neuroimage.2009.12.040; Morse TM, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/fncir.2010.00016; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Ponomareva NV, 2008, NEUROBIOL AGING, V29, P819, DOI 10.1016/j.neurobiolaging.2006.12.019; Qi Jin-Shun, 2001, Shengli Xuebao, V53, P198; Qi JS, 2004, SYNAPSE, V51, P165, DOI 10.1002/syn.10299; Robbe D, 2009, J NEUROSCI, V29, P12597, DOI 10.1523/JNEUROSCI.2407-09.2009; Rotstein HG, 2005, J NEUROPHYSIOL, V94, P1509, DOI 10.1152/jn.00957.2004; Roxin A, 2011, PHYSICA D, V240, P323, DOI 10.1016/j.physd.2010.09.009; Shao LR, 1999, J PHYSIOL-LONDON, V521, P135, DOI 10.1111/j.1469-7793.1999.00135.x; Shirwany Najeeb A, 2007, Neuropsychiatr Dis Treat, V3, P597; Takahashi RH, 2010, NEUROBIOL AGING, V31, P1145, DOI 10.1016/j.neurobiolaging.2008.07.021; Tran MH, 2002, PEPTIDES, V23, P1271, DOI 10.1016/S0196-9781(02)00062-1; Villette V, 2010, J NEUROSCI, V30, P10991, DOI 10.1523/JNEUROSCI.6284-09.2010; Volicer L, 1997, INT J GERIATR PSYCH, V12, P913, DOI 10.1002/(SICI)1099-1166(199709)12:9<913::AID-GPS663>3.3.CO;2-4; Wang XJ, 1998, J NEUROPHYSIOL, V79, P1549, DOI 10.1152/jn.1998.79.3.1549; Wang XJ, 2002, J NEUROPHYSIOL, V87, P889, DOI 10.1152/jn.00135.2001; Wang XJ, 1996, J NEUROSCI, V16, P6402; WARMAN EN, 1994, J NEUROPHYSIOL, V71, P2033, DOI 10.1152/jn.1994.71.6.2033; Webster NJ, 2006, NEUROBIOL AGING, V27, P439, DOI 10.1016/j.neurobiolaging.2005.02.002; Ye H, 2010, NEUROBIOL AGING, V31, P591, DOI 10.1016/j.neurobiolaging.2008.05.012; YLINEN A, 1995, HIPPOCAMPUS, V5, P78, DOI 10.1002/hipo.450050110; Yu SP, 1998, NEUROBIOL DIS, V5, P81, DOI 10.1006/nbdi.1998.0186	48	20	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21579	10.1371/journal.pone.0021579	http://dx.doi.org/10.1371/journal.pone.0021579			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21720560	Green Published, Green Submitted, gold			2022-12-27	WOS:000292036900056
J	Mumby, PJ; Harborne, AR; Brumbaugh, DR				Mumby, Peter J.; Harborne, Alastair R.; Brumbaugh, Daniel R.			Grouper as a Natural Biocontrol of Invasive Lionfish	PLOS ONE			English	Article							CORAL-REEF FISHES; INDO-PACIFIC LIONFISH; PTEROIS-VOLITANS; FLORIDA-KEYS; RECRUITMENT; PREDATION; MANGROVES; ENHANCE	Lionfish (Pterois volitans/miles) have invaded the majority of the Caribbean region within five years. As voracious predators of native fishes with a broad habitat distribution, lionfish are poised to cause an unprecedented disruption to coral reef diversity and function. Controls of lionfish densities within its native range are poorly understood, but they have been recorded in the stomachs of large-bodied Caribbean groupers. Whether grouper predation of lionfish is sufficient to act as a biocontrol of the invasive species is unknown, but pest biocontrol by predatory fishes has been reported in other ecosystems. Groupers were surveyed along a chain of Bahamian reefs, including one of the region's most successful marine reserves which supports the top one percentile of Caribbean grouper biomass. Lionfish biomass exhibited a 7-fold and non-linear reduction in relation to the biomass of grouper. While Caribbean grouper appear to be a biocontrol of invasive lionfish, the overexploitation of their populations by fishers, means that their median biomass on Caribbean reefs is an order of magnitude less than in our study. Thus, chronic overfishing will probably prevent natural biocontrol of lionfishes in the Caribbean.	[Mumby, Peter J.; Harborne, Alastair R.] Univ Queensland, Sch Biol Sci, Marine Spatial Ecol Lab, St Lucia, Qld, Australia; [Mumby, Peter J.; Harborne, Alastair R.] Univ Exeter, Coll Life & Environm Sci, Hatherly Lab, Exeter, Devon, England; [Brumbaugh, Daniel R.] Amer Museum Nat Hist, Ctr Biodivers & Conservat, New York, NY 10024 USA; [Brumbaugh, Daniel R.] Univ Calif Santa Cruz, Inst Marine Sci, Santa Cruz, CA 95064 USA	University of Queensland; University of Exeter; American Museum of Natural History (AMNH); University of California System; University of California Santa Cruz	Mumby, PJ (corresponding author), Univ Queensland, Sch Biol Sci, Marine Spatial Ecol Lab, St Lucia, Qld, Australia.	p.j.mumby@uq.edu.au	Mumby, Peter/F-9914-2010; Harborne, Alastair R/F-6155-2013	Mumby, Peter/0000-0002-6297-9053; Harborne, Alastair R/0000-0002-6818-8615	ARC; NERC [NE/F015704/1]; EU; Pew Fellowship; Natural Environment Research Council [NE/F015704/1, NE/G017344/1] Funding Source: researchfish; NERC [NE/G017344/1] Funding Source: UKRI	ARC(Australian Research Council); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); EU(European Commission); Pew Fellowship; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This project was funded by an ARC (http://www.arc.gov.au/) Laureate Fellowship, NERC (http://www.nerc.ac.uk/) grant, EU FORCE project, and Pew Fellowship (www.pewenvironment.org) to PJM and a NERC Fellowship (NE/F015704/1) to ARH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albins MA, 2008, MAR ECOL PROG SER, V367, P233, DOI 10.3354/meps07620; [Anonymous], 1988, NMFSSEFC215 NOAA; Barbour AB, 2010, MAR ECOL PROG SER, V401, P291, DOI 10.3354/meps08373; BERNADSKY G, 1991, COPEIA, P230; Cerino C, 2010, THESIS E CAROLINA U; Coleman FC, 2000, FISHERIES, V25, P14, DOI 10.1577/1548-8446(2000)025<0014:LRF>2.0.CO;2; Cote IM, 2010, MAR ECOL PROG SER, V404, P219, DOI 10.3354/meps08458; Eggleston DB, 1998, B MAR SCI, V63, P111; Eilenberg J, 2001, BIOCONTROL, V46, P387, DOI 10.1023/A:1014193329979; Hein CL, 2006, CAN J FISH AQUAT SCI, V63, P383, DOI 10.1139/F05-229; Humann P., 2002, REEF FISH IDENTIFICA; JUD ZR, 2011, AQUATIC BIO IN PRESS; Kramer Philip A., 2003, Atoll Research Bulletin, V496, P1; Maljkovic A, 2008, CORAL REEFS, V27, P501, DOI 10.1007/s00338-008-0372-9; McClenachan L, 2009, CONSERV BIOL, V23, P636, DOI 10.1111/j.1523-1739.2008.01152.x; Morris JA, 2009, ENVIRON BIOL FISH, V86, P389, DOI 10.1007/s10641-009-9538-8; Mumby PJ, 2007, P NATL ACAD SCI USA, V104, P8362, DOI 10.1073/pnas.0702602104; Mumby PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008657; Mumby PJ, 2006, SCIENCE, V311, P98, DOI 10.1126/science.1121129; Mumby PJ, 2004, NATURE, V427, P533, DOI 10.1038/nature02286; Nagelkerken I, 2000, ESTUAR COAST SHELF S, V51, P31, DOI 10.1006/ecss.2000.0617; Sadovy Y, 2005, FISH FISH, V6, P167, DOI 10.1111/j.1467-2979.2005.00186.x; Sadovy Y, 2005, CORAL REEFS, V24, P254, DOI 10.1007/s00338-005-0474-6; SADOVY Y, 1999, FAO FISHERIES SYNOPS, V157, P65; Schofield Pamela J., 2009, Aquatic Invasions, V4, P473; Semmens BX, 2004, MAR ECOL PROG SER, V266, P239, DOI 10.3354/meps266239; Sluka R, 1998, B MAR SCI, V62, P219; Stallings CD, 2008, ECOLOGY, V89, P2090, DOI 10.1890/07-1671.1; Stallings CD, 2009, MAR ECOL PROG SER, V383, P251, DOI 10.3354/meps08004; Steneck RS, 2009, CORAL REEFS, V28, P367, DOI 10.1007/s00338-009-0470-3	30	112	121	5	196	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21510	10.1371/journal.pone.0021510	http://dx.doi.org/10.1371/journal.pone.0021510			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731769	Green Published, gold, Green Submitted			2022-12-27	WOS:000292035400044
J	Selamat, SA; Galler, JS; Joshi, AD; Fyfe, MN; Campan, M; Siegmund, KD; Kerr, KM; Laird-Offringa, IA				Selamat, Suhaida A.; Galler, Janice S.; Joshi, Amit D.; Fyfe, M. Nicky; Campan, Mihaela; Siegmund, Kimberly D.; Kerr, Keith M.; Laird-Offringa, Ite A.			DNA Methylation Changes in Atypical Adenomatous Hyperplasia, Adenocarcinoma In Situ, and Lung Adenocarcinoma	PLOS ONE			English	Article							FRIZZLED-RELATED PROTEIN-1; CPG ISLAND METHYLATION; GROUND-GLASS OPACITY; PROMOTER HYPERMETHYLATION; ABERRANT METHYLATION; CANCER INCIDENCE; EPIGENETIC INACTIVATION; POTENTIAL BIOMARKER; SOMATIC MUTATIONS; RASSF1A PROMOTER	Background: Aberrant DNA methylation is common in lung adenocarcinoma, but its timing in the phases of tumor development is largely unknown. Delineating when abnormal DNA methylation arises may provide insight into the natural history of lung adenocarcinoma and the role that DNA methylation alterations play in tumor formation. Methodology/Principal Findings: We used MethyLight, a sensitive real-time PCR-based quantitative method, to analyze DNA methylation levels at 15 CpG islands that are frequently methylated in lung adenocarcinoma and that we had flagged as potential markers for non-invasive detection. We also used two repeat probes as indicators of global DNA hypomethylation. We examined DNA methylation in 249 tissue samples from 93 subjects, spanning the putative spectrum of peripheral lung adenocarcinoma development: histologically normal adjacent non-tumor lung, atypical adenomatous hyperplasia (AAH), adenocarcinoma in situ (AIS, formerly known as bronchioloalveolar carcinoma), and invasive lung adenocarcinoma. Comparison of DNA methylation levels between the lesion types suggests that DNA hypermethylation of distinct loci occurs at different time points during the development of lung adenocarcinoma. DNA methylation at CDKN2A ex2 and PTPRN2 is already significantly elevated in AAH, while CpG islands at 2C35, EYA4, HOXA1, HOXA11, NEUROD1, NEUROD2 and TMEFF2 are significantly hypermethylated in AIS. In contrast, hypermethylation at CDH13, CDX2, OPCML, RASSF1, SFRP1 and TWIST1 and global DNA hypomethylation appear to be present predominantly in invasive cancer. Conclusions/Significance: The gradual increase in DNA methylation seen for numerous loci in progressively more transformed lesions supports the model in which AAH and AIS are sequential stages in the development of lung adenocarcinoma. The demarcation of DNA methylation changes characteristic for AAH, AIS and adenocarcinoma begins to lay out a possible roadmap for aberrant DNA methylation events in tumor development. In addition, it identifies which DNAmethylation changes might be used as molecular markers for the detection of preinvasive lesions.	[Selamat, Suhaida A.; Galler, Janice S.; Campan, Mihaela; Laird-Offringa, Ite A.] Univ So Calif, Keck Sch Med, Kenneth Norris Jr Comprehens Canc Ctr, Dept Surg, Los Angeles, CA 90033 USA; [Selamat, Suhaida A.; Galler, Janice S.; Campan, Mihaela; Laird-Offringa, Ite A.] Univ So Calif, Keck Sch Med, Kenneth Norris Jr Comprehens Canc Ctr, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA; [Joshi, Amit D.; Siegmund, Kimberly D.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Fyfe, M. Nicky; Kerr, Keith M.] Univ Aberdeen, Dept Pathol, Aberdeen Royal Infirm, Aberdeen, Scotland	University of Southern California; University of Southern California; University of Southern California; University of Aberdeen	Selamat, SA (corresponding author), Univ So Calif, Keck Sch Med, Kenneth Norris Jr Comprehens Canc Ctr, Dept Surg, Los Angeles, CA 90033 USA.	ilaird@usc.edu	Offringa, Ite/R-4101-2019	Selamat, Suhaida/0000-0002-7185-6995	Joan's Legacy (now called Uniting Against Lung Cancer); Thomas G. Labrecque Foundation; NIH/NCI [5R01CA120869]; National Cancer Institute [P30CA014089]; NATIONAL CANCER INSTITUTE [P30CA014089, R01CA097346, R01CA120869] Funding Source: NIH RePORTER	Joan's Legacy (now called Uniting Against Lung Cancer); Thomas G. Labrecque Foundation; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was funded by grants to Ite Laird-Offringa from Joan's Legacy (now called Uniting Against Lung Cancer) and the Thomas G. Labrecque Foundation, and NIH/NCI grant 5R01CA120869. The project was also supported in part by award number P30CA014089 from the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies.	Ahuja N, 1998, CANCER RES, V58, P5489; Anglim PP, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-81; Anglim PP, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-62; Anisowicz Anthony, 2008, BMC Cancer, V8, P222, DOI 10.1186/1471-2407-8-222; Au JSK, 2004, LUNG CANCER, V45, P143, DOI 10.1016/j.lungcan.2004.01.012; Baba Y, 2009, CLIN CANCER RES, V15, P4665, DOI 10.1158/1078-0432.CCR-09-0401; Belinsky SA, 2004, NAT REV CANCER, V4, P707, DOI 10.1038/nrc1432; Belinsky SA, 2005, CARCINOGENESIS, V26, P1481, DOI 10.1093/carcin/bgi020; Belinsky SA, 1998, P NATL ACAD SCI USA, V95, P11891, DOI 10.1073/pnas.95.20.11891; Benson DA, 2004, NUCLEIC ACIDS RES, V32, pD23, DOI 10.1093/nar/gkh045; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Black WC, 2000, J NATL CANCER I, V92, P1280, DOI 10.1093/jnci/92.16.1280; Blanco D, 2007, NEOPLASIA, V9, P840, DOI 10.1593/neo.07517; Brock MV, 2008, NEW ENGL J MED, V358, P1118, DOI 10.1056/NEJMoa0706550; Campan Mihhaela, 2009, V507, P325, DOI 10.1007/978-1-59745-522-0_23; Chapman AD, 2000, BRIT J CANCER, V83, P632, DOI 10.1054/bjoc.2000.1317; Chen F, 2007, CANCER EPIDEM BIOMAR, V16, P2724, DOI 10.1158/1055-9965.EPI-07-0455; Costello JF, 2000, NAT GENET, V24, P132, DOI 10.1038/72785; Dai ZY, 2001, NEOPLASIA, V3, P314, DOI 10.1038/sj.neo.7900162; Dammann R, 2000, NAT GENET, V25, P315, DOI 10.1038/77083; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Dong SM, 2005, MODERN PATHOL, V18, P170, DOI 10.1038/modpathol.3800261; Eads CA, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.8.e32; Ehrlich M, 2002, ONCOGENE, V21, P5400, DOI 10.1038/sj.onc.1205651; Ferlay J, 2010, INT J CANC; Fiegl H, 2008, CLIN CANCER RES, V14, P3494, DOI 10.1158/1078-0432.CCR-07-4557; Fukui T, 2005, ONCOGENE, V24, P6323, DOI 10.1038/sj.onc.1208777; Funama Y, 2009, J COMPUT ASSIST TOMO, V33, P49, DOI 10.1097/RCT.0b013e31815e6291; Garcia M, 2007, GLOBAL CANC FACTS FI; Guo MZ, 2004, CLIN CANCER RES, V10, P5131, DOI 10.1158/1078-0432.CCR-03-0763; Hanabata T, 2004, ONCOL REP, V12, P177; Harkness EF, 2002, INT J CANCER, V102, P179, DOI 10.1002/ijc.10661; HAYASHI N, 1994, BIOCHEM BIOPH RES CO, V202, P1426, DOI 10.1006/bbrc.1994.2090; HOBBS M, 1993, MOL MICROBIOL, V10, P233, DOI 10.1111/j.1365-2958.1993.tb01949.x; Horner MJ, 2009, SEER CANC STAT REV 1; Ikeda K, 2007, CHEST, V132, P984, DOI 10.1378/chest.07-0793; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Kaufman L., 1990, FINDING GROUPS DATA, DOI 10.1002/9780470316801; Kawai H, 2005, ONCOL REP, V13, P547; Kawasaki E, 1996, DIABETES, V45, P1344, DOI 10.2337/diabetes.45.10.1344; Kerr KM, 2007, DIS MARKERS, V23, P5, DOI 10.1155/2007/985474; Kerr KM, 2001, J CLIN PATHOL, V54, P257, DOI 10.1136/jcp.54.4.257; Kim DH, 2003, CANCER RES, V63, P3743; Kim JS, 2005, CANCER, V104, P1825, DOI 10.1002/cncr.21409; Kim YH, 2006, GENE CHROMOSOME CANC, V45, P781, DOI 10.1002/gcc.20341; Koyi H, 2002, LUNG CANCER-J IASLC, V36, P9, DOI 10.1016/S0169-5002(01)00451-2; Laird PW, 2010, NAT REV GENET, V11, P191, DOI 10.1038/nrg2732; Licchesi JDF, 2008, CARCINOGENESIS, V29, P895, DOI 10.1093/carcin/bgn017; Licchesi JDF, 2008, CLIN CANCER RES, V14, P2570, DOI 10.1158/1078-0432.CCR-07-2033; MANECKJEE R, 1990, P NATL ACAD SCI USA, V87, P3294, DOI 10.1073/pnas.87.9.3294; Maruyama R, 2004, CANCER-AM CANCER SOC, V100, P1472, DOI 10.1002/cncr.20144; Mehrotra J, 2004, CLIN CANCER RES, V10, P3104, DOI 10.1158/1078-0432.CCR-03-0118; MERLO A, 1995, NAT MED, V1, P686, DOI 10.1038/nm0795-686; Morandi L, 2007, LUNG CANCER, V56, P35, DOI 10.1016/j.lungcan.2006.11.022; Muggerud AA, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2466; *NAT LUNG SCREEN T, 2010, RAD; Navis AC, 2010, ACTA NEUROPATHOL, V119, P157, DOI 10.1007/s00401-009-0614-0; Naya FJ, 1997, GENE DEV, V11, P2323, DOI 10.1101/gad.11.18.2323; Nguyen CT, 2001, NUCLEIC ACIDS RES, V29, P4598, DOI 10.1093/nar/29.22.4598; Nguyen DX, 2009, CELL, V138, P51, DOI 10.1016/j.cell.2009.04.030; Niklinska W, 2009, FOLIA HISTOCHEM CYTO, V47, P275, DOI 10.2478/v10042-009-0091-2; Niu RF, 2007, J EXP CLIN CANC RES, V26, P385; Nuovo GJ, 1999, P NATL ACAD SCI USA, V96, P12754, DOI 10.1073/pnas.96.22.12754; PARK SY, 2010, PROMOTER CPG ISLAND; Pfeifer GP, 2002, BIOL CHEM, V383, P907, DOI 10.1515/BC.2002.097; Pike BL, 2008, LEUKEMIA, V22, P1035, DOI 10.1038/leu.2008.18; Politi K, 2006, GENE DEV, V20, P1496, DOI 10.1101/gad.1417406; Poynter JN, 2008, CANCER EPIDEM BIOMAR, V17, P3208, DOI 10.1158/1055-9965.EPI-08-0512; Rauch T, 2007, P NATL ACAD SCI USA, V104, P5527, DOI 10.1073/pnas.0701059104; Sakamoto H, 2007, J PATHOL, V212, P287, DOI 10.1002/path.2165; Sato M, 1998, HUM GENET, V103, P96, DOI 10.1007/s004390050790; Scagliotti GV, 2009, CURR OPIN ONCOL, V21, P99, DOI 10.1097/CCO.0b013e328321049e; Sellick GS, 2004, NAT GENET, V36, P1301, DOI 10.1038/ng1475; Shames DS, 2006, PLOS MED, V3, P2244, DOI 10.1371/journal.pmed.0030486; Shimada A, 2005, CANCER SCI, V96, P668, DOI 10.1111/j.1349-7006.2005.00100.x; Shiraishi M, 2002, ONCOGENE, V21, P3659, DOI 10.1038/sj.onc.1205453; Suzuki M, 2006, CANCER-AM CANCER SOC, V106, P2200, DOI 10.1002/cncr.21853; Suzuki M, 2004, CANCER RES, V64, P3137, DOI 10.1158/0008-5472.CAN-03-3046; Swensen SJ, 2003, RADIOLOGY, V226, P756, DOI 10.1148/radiol.2263020036; Takamochi K, 2001, AM J PATHOL, V159, P1941, DOI 10.1016/S0002-9440(10)63041-6; Takeyama N, 2009, LIFE SCI, V84, P678, DOI 10.1016/j.lfs.2009.02.012; Tanaka K, 2007, BIOORG MED CHEM LETT, V17, P1912, DOI 10.1016/j.bmcl.2007.01.040; Tomizawa Y, 2002, CLIN CANCER RES, V8, P2362; Toyooka KO, 2001, CANCER RES, V61, P4556; Toyooka S, 2001, MOL CANCER THER, V1, P61; Toyooka S, 2003, INT J CANCER, V103, P153, DOI 10.1002/ijc.10787; TRAVIS WD, 1999, WHO INT HISTOLOGICAL, P29; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Tse LA, 2009, LUNG CANCER, V66, P22, DOI 10.1016/j.lungcan.2008.12.023; Tsou JA, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-70; Ulivi P, 2006, J CELL PHYSIOL, V206, P611, DOI 10.1002/jcp.20503; van Iersel CA, 2007, INT J CANCER, V120, P868, DOI 10.1002/ijc.22134; Wang L, 2006, WORLD J GASTROENTERO, V12, P6949, DOI 10.3748/wjg.v12.i43.6949; Wang ZH, 2004, SCIENCE, V304, P1164, DOI 10.1126/science.1096096; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Weisenberger DJ, 2005, NUCLEIC ACIDS RES, V33, P6823, DOI 10.1093/nar/gki987; WEISENBERGER DJ, 2008, NUCL ACIDS IN PRESS; Westra W H, 2000, Respir Res, V1, P163, DOI 10.1186/rr28; Yuen HF, 2007, J CLIN PATHOL, V60, P510, DOI 10.1136/jcp.2006.039099; ZEGER SL, 1992, STAT MED, V11, P1825, DOI 10.1002/sim.4780111406; Zhang YW, 2010, NEOPLASMA, V57, P228, DOI 10.4149/neo_2010_03_228; Zhong Y, 2001, CLIN CANCER RES, V7, P1683; Zou HZ, 2005, CANCER EPIDEM BIOMAR, V14, P830, DOI 10.1158/1055-9965.EPI-04-0506	104	74	80	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21443	10.1371/journal.pone.0021443	http://dx.doi.org/10.1371/journal.pone.0021443			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731750	Green Published, Green Submitted, gold			2022-12-27	WOS:000292035400038
J	Brune, M; Schobel, A; Karau, R; Faustmann, PM; Dermietzel, R; Juckel, G; Petrasch-Parwez, E				Bruene, Martin; Schoebel, Andreas; Karau, Ramona; Faustmann, Pedro M.; Dermietzel, Rolf; Juckel, Georg; Petrasch-Parwez, Elisabeth			Neuroanatomical Correlates of Suicide in Psychosis: The Possible Role of von Economo Neurons	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; FRONTOTEMPORAL DEMENTIA; CEREBRAL-CORTEX; GREAT APES; SCHIZOPHRENIA; HUMANS; EVOLUTION; RISK; REEXAMINATION; PSYCHOLOGY	Suicide is the most important incident in psychiatric disorders. Psychological pain and empathy to pain involves a neural network that involves the anterior cingulate cortex (ACC) and the anterior insula (AI). At the neuronal level, little is known about how complex emotions such as shame, guilt, self-derogation and social isolation, all of which feature suicidal behavior, are represented in the brain. Based on the observation that the ACC and the AI contain a large spindle-shaped cell type, referred to as von Economo neuron (VEN), which has dramatically increased in density during human evolution, and on growing evidence that VENs play a role in the pathophysiology of various neuropsychiatric disorders, including autism, psychosis and dementia, we examined the density of VENs in the ACC of suicide victims. The density of VENs was determined using cresyl violet-stained sections of the ACC of 39 individuals with psychosis (20 cases with schizophrenia, 19 with bipolar disorder). Nine subjects had died from suicide. Twenty specimen were available from the right, 19 from the left ACC. The density of VENs was significantly greater in the ACC of suicide victims with psychotic disorders compared with psychotic individuals who died from other causes. This effect was restricted to the right ACC. VEN density in the ACC seems to be increased in suicide victims with psychosis. This finding may support the assumption that VEN have a special role in emotion processing and self-evaluation, including negative self-appraisal.	[Bruene, Martin] Univ Hosp Bochum, Res Dept Cognit Neuropsychiat & Psychiat Prevent, Bochum, Germany; [Bruene, Martin; Juckel, Georg] Ruhr Univ Bochum, Univ Hosp Bochum, Dept Psychiat, Bochum, Germany; [Schoebel, Andreas; Karau, Ramona; Faustmann, Pedro M.; Dermietzel, Rolf; Petrasch-Parwez, Elisabeth] Ruhr Univ Bochum, Inst Anat, Dept Neuroanat & Mol Brain Res, Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum; Ruhr University Bochum	Brune, M (corresponding author), Univ Hosp Bochum, Res Dept Cognit Neuropsychiat & Psychiat Prevent, Bochum, Germany.	martin.bruene@rub.de	Brüne, Martin/AAX-3202-2020	Brüne, Martin/0000-0002-2507-0561	Stanley Medical Research Institute [07R - 1750]	Stanley Medical Research Institute	The study was supported by a grant from the Stanley Medical Research Institute (grant number 07R - 1750). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allman J, 2002, NEUROSCIENTIST, V8, P335, DOI 10.1177/107385840200800409; Allman JM, 2005, TRENDS COGN SCI, V9, P367, DOI 10.1016/j.tics.2005.06.008; Allman JM, 2001, ANN NY ACAD SCI, V935, P107, DOI 10.1111/j.1749-6632.2001.tb03476.x; Allman JM, 2010, BRAIN STRUCT FUNCT, V214, P495, DOI 10.1007/s00429-010-0254-0; Amador XF, 1996, AM J PSYCHIAT, V153, P1185; Antypa N, 2011, NEUROSCIENCE, V172, P303, DOI 10.1016/j.neuroscience.2010.10.042; Bostwick JM, 2000, AM J PSYCHIAT, V157, P1925, DOI 10.1176/appi.ajp.157.12.1925; Brune M, 2008, NEUROPSYCHOLOGIA, V46, P1992, DOI 10.1016/j.neuropsychologia.2008.01.023; Brune M, 2010, ACTA NEUROPATHOL, V119, P771, DOI 10.1007/s00401-010-0673-2; Butti C, 2009, J COMP NEUROL, V515, P243, DOI 10.1002/cne.22055; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Economo C.v., 1926, Z GES NEUROL PSYCH, V100, P706, DOI [10.1007/BF02970950, DOI 10.1007/BF02970950]; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; Fajardo C, 2008, NEUROSCI LETT, V435, P215, DOI 10.1016/j.neulet.2008.02.048; Frith CD, 1999, SCIENCE, V286, P1692, DOI 10.1126/science.286.5445.1692; Gilbert P, 2010, BRIT J CLIN PSYCHOL, V49, P563, DOI 10.1348/014466509X479771; Hakeem AY, 2009, ANAT REC, V292, P242, DOI 10.1002/ar.20829; Hof PR, 2007, ANAT REC, V290, P1, DOI 10.1002/ar.a.20407; Joiner TE, 2005, ANNU REV PSYCHOL, V56, P287, DOI 10.1146/annurev.psych.56.091103.070320; Kaufman JA, 2008, ACTA NEUROPATHOL, V116, P479, DOI 10.1007/s00401-008-0434-7; Longe O, 2010, NEUROIMAGE, V49, P1849, DOI 10.1016/j.neuroimage.2009.09.019; Lysaker PH, 2007, SCHIZOPHRENIA BULL, V33, P192, DOI 10.1093/schbul/sbl016; Nimchinsky EA, 1999, P NATL ACAD SCI USA, V96, P5268, DOI 10.1073/pnas.96.9.5268; NIMCHINSKY EA, 1995, J COMP NEUROL, V355, P27, DOI 10.1002/cne.903550106; NORTHOFF G, 2010, CONSC C; Palmer BA, 2005, ARCH GEN PSYCHIAT, V62, P247, DOI 10.1001/archpsyc.62.3.247; Paus T, 2001, NAT REV NEUROSCI, V2, P417, DOI 10.1038/35077500; REUTERLORENZ P, 1981, NEUROPSYCHOLOGIA, V19, P609, DOI 10.1016/0028-3932(81)90030-0; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; SANTOS M, 2009, BRAIN RES IN PRESS, DOI DOI 10.1016/J.BRAINRES.2010.08.067); Schwartz RC, 2004, J PSYCHIATR RES, V38, P185, DOI 10.1016/S0022-3956(03)00088-8; Seeley WW, 2007, ALZ DIS ASSOC DIS, V21, pS50, DOI 10.1097/WAD.0b013e31815c0f14; Seeley WW, 2006, ANN NEUROL, V60, P660, DOI 10.1002/ana.21055; Simms ML, 2009, ACTA NEUROPATHOL, V118, P673, DOI 10.1007/s00401-009-0568-2; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Stimpson CD, 2011, AM J HUM BIOL, V23, P22, DOI 10.1002/ajhb.21135; VOGT BA, 1995, J COMP NEUROL, V359, P490, DOI 10.1002/cne.903590310; Vollm BA, 2006, NEUROIMAGE, V29, P90, DOI 10.1016/j.neuroimage.2005.07.022; Watson KK, 2006, NEUROSCIENCE, V141, P1107, DOI 10.1016/j.neuroscience.2006.04.084; Watson KK, 2008, ANN NY ACAD SCI, V1128, P8, DOI 10.1196/annals.1399.002	41	36	36	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e20936	10.1371/journal.pone.0020936	http://dx.doi.org/10.1371/journal.pone.0020936			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731632	Green Submitted, Green Published, gold			2022-12-27	WOS:000292033700019
J	Enjalbert, B; Jourdan, F; Portais, JC				Enjalbert, Brice; Jourdan, Fabien; Portais, Jean-Charles			Intuitive Visualization and Analysis of Multi-Omics Data and Application to Escherichia coli Carbon Metabolism	PLOS ONE			English	Article							SOFTWARE	Combinations of 'omics' investigations (i.e, transcriptomic, proteomic, metabolomic and/or fluxomic) are increasingly applied to get comprehensive understanding of biological systems. Because the latter are organized as complex networks of molecular and functional interactions, the intuitive interpretation of multi-omics datasets is difficult. Here we describe a simple strategy to visualize and analyze multi-omics data. Graphical representations of complex biological networks can be generated using Cytoscape where all molecular and functional components could be explicitly represented using a set of dedicated symbols. This representation can be used i) to compile all biologically-relevant information regarding the network through web link association, and ii) to map the network components with multi-omics data. A Cytoscape plugin was developed to increase the possibilities of both multi-omic data representation and interpretation. This plugin allowed different adjustable colour scales to be applied to the various omics data and performed the automatic extraction and visualization of the most significant changes in the datasets. For illustration purpose, the approach was applied to the central carbon metabolism of Escherichia coli. The obtained network contained 774 components and 1232 interactions, highlighting the complexity of bacterial multi-level regulations. The structured representation of this network represents a valuable resource for systemic studies of E. coli, as illustrated from the application to multi-omics data. Some current issues in network representation are discussed on the basis of this work.	[Enjalbert, Brice; Portais, Jean-Charles] Univ Toulouse, INSA, UPS, INP, Toulouse, France; [Enjalbert, Brice; Portais, Jean-Charles] INRA, Ingn Syst Biol & Procedes UMR792, F-31931 Toulouse, France; [Enjalbert, Brice; Portais, Jean-Charles] CNRS, UMR5504, Toulouse, France; [Jourdan, Fabien] INRA, UMR Xenobiot 1089, F-31931 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Institut National Polytechnique de Toulouse; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; INRAE	Enjalbert, B (corresponding author), Univ Toulouse, INSA, UPS, INP, Toulouse, France.	jean-charles.portais@insa-toulouse.fr	Jourdan, Fabien/AAW-5075-2021	Jourdan, Fabien/0000-0001-9401-2894; Enjalbert, Brice/0000-0003-1291-1373; Portais, Jean-Charles/0000-0002-3480-0933	French "Agence Nationale de la Recherche" (ANR) [ANR-06-BYOS-0003-03]	French "Agence Nationale de la Recherche" (ANR)(French National Research Agency (ANR))	This work was supported by the French "Agence Nationale de la Recherche" (ANR, Project no ANR-06-BYOS-0003-03) from which BE received a post-doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bourqui R, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-29; Frankel F, 2008, NATURE, V455, P30, DOI 10.1038/455030a; Funahashi Akira, 2003, Biosilico, V1, P159, DOI 10.1016/S1478-5382(03)02370-9; Gama-Castro S, 2008, NUCLEIC ACIDS RES, V36, pD120, DOI 10.1093/nar/gkm994; Gehlenborg N, 2010, NAT METHODS, V7, pS56, DOI [10.1038/NMETH.1436, 10.1038/nmeth.1436]; HERMAN I, 2000, DENSITY FUNCTIONS VI, P49; Ishii N, 2007, SCIENCE, V316, P593, DOI 10.1126/science.1132067; Keseler IM, 2005, NUCLEIC ACIDS RES, V33, pD334, DOI 10.1093/nar/gki108; Le Fevre F, 2007, BIOINFORMATICS, V23, P1299, DOI 10.1093/bioinformatics/btm107; Le Novere N, 2009, NAT BIOTECHNOL, V27, P735, DOI 10.1038/nbt.1558; Liebers A., 2001, Journal of Graph Algorithms and Applications, V5; MEDIGUE C, 1993, MICROBIOL REV, V57, P623; NEUWEGER H, 2010, BMC SYST BIOL, V23, P82; Noble, 2006, MUSIC LIFE BIOL GENO; Paley SM, 2006, NUCLEIC ACIDS RES, V34, P3771, DOI 10.1093/nar/gkl334; Sayers EW, 2010, NUCLEIC ACIDS RES, V38, pD5, DOI 10.1093/nar/gkp967; Schomburg I, 2002, NUCLEIC ACIDS RES, V30, P47, DOI 10.1093/nar/30.1.47; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shannon PT, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-176; Aoki Kiyoko F, 2005, Curr Protoc Bioinformatics, VChapter 1, DOI [10.1002/0471250953.bi0112s38, 10.1002/0471250953.bi0112s11]; Wegner K, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-212	21	14	14	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21318	10.1371/journal.pone.0021318	http://dx.doi.org/10.1371/journal.pone.0021318			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731702	Green Published, gold, Green Submitted			2022-12-27	WOS:000292033700063
J	Lee, JH; Voortman, J; Dingemans, AMC; Voeller, DM; Pham, T; Wang, YS; Giaccone, G				Lee, Jih-Hsiang; Voortman, Johannes; Dingemans, Anne-Marie C.; Voeller, Donna M.; Pham, Trung; Wang, Yisong; Giaccone, Giuseppe			MicroRNA Expression and Clinical Outcome of Small Cell Lung Cancer	PLOS ONE			English	Article							PREDICTS SURVIVAL; GENE-EXPRESSION; DOWN-REGULATION; MIR-34A; CARCINOMA; FAMILY; CHEMORESISTANCE; CHEMOTHERAPY; APOPTOSIS; INVASION	The role of microRNAs in small-cell lung carcinoma (SCLC) is largely unknown. miR-34a is known as a p53 regulated tumor suppressor microRNA in many cancer types. However, its therapeutic implication has never been studied in SCLC, a cancer type with frequent dysfunction of p53. We investigated the expression of a panel of 7 microRNAs (miR-21, miR-29b, miR-34a/b/c, miR-155, and let-7a) in 31 SCLC tumors, 14 SCLC cell lines, and 26 NSCLC cell lines. We observed significantly lower miR-21, miR-29b, and miR-34a expression in SCLC cell lines than in NSCLC cell lines. The expression of the 7 microRNAs was unrelated to SCLC patients' clinical characteristics and was neither prognostic in term of overall survival or progression-free survival nor predictive of treatment response. Overexpression or downregulation of miR-34a did not influence SCLC cell viability. The expression of these 7 microRNAs also did not predict in vitro sensitivity to cisplatin or etoposide in SCLC cell lines. Overexpression or downregulation of miR-34a did not influence sensitivity to cisplatin or etoposide in SCLC cell lines. In contrast to downregulation of the miR-34a target genes cMET and Axl by overexpression of miR-34a in NSCLC cell lines, the intrinsic expression of cMET and Axl was low in SCLC cell lines and was not influenced by overexpression of miR-34a. Our results suggest that the expression of the 7 selected microRNAs are not prognostic in SCLC patients, and miR-34a is unrelated to the malignant behavior of SCLC cells and is unlikely to be a therapeutic target.	[Lee, Jih-Hsiang; Voortman, Johannes; Voeller, Donna M.; Pham, Trung; Wang, Yisong; Giaccone, Giuseppe] NCI, Med Oncol Branch, NIH, Bethesda, MD 20892 USA; [Dingemans, Anne-Marie C.] Maastricht Univ Med Ctr, GROW Sch Oncol & Dev Biol, Dept Resp Med, Maastricht, Netherlands	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Maastricht University; Maastricht University Medical Centre (MUMC)	Lee, JH (corresponding author), NCI, Med Oncol Branch, NIH, Bethesda, MD 20892 USA.	giacconeg@mail.nih.gov	Voortman, J/AAO-1289-2020; Giaccone, Giuseppe/E-8297-2017	Giaccone, Giuseppe/0000-0002-5023-7562	National Institutes of Health, National Cancer Institute	National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study was funded by the National Institutes of Health, National Cancer Institute intramural program. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bader AG, 2010, CANCER RES, V70, P7027, DOI 10.1158/0008-5472.CAN-10-2010; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Cho WCS, 2010, INT J BIOCHEM CELL B, V42, P1273, DOI 10.1016/j.biocel.2009.12.014; Cho WCS, 2010, BBA-REV CANCER, V1805, P209, DOI 10.1016/j.bbcan.2009.11.003; Dingemans AMC, 1999, CLIN CANCER RES, V5, P2048; Du LQ, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-75; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Fujita Y, 2008, BIOCHEM BIOPH RES CO, V377, P114, DOI 10.1016/j.bbrc.2008.09.086; Gallardo E, 2009, CARCINOGENESIS, V30, P1903, DOI 10.1093/carcin/bgp219; Govindan R, 2006, J CLIN ONCOL, V24, P4539, DOI 10.1200/JCO.2005.04.4859; Guo LL, 2010, EUR J CANCER, V46, P1692, DOI 10.1016/j.ejca.2010.02.043; Harada T, 2011, ONCOGENE, V30, P1744, DOI 10.1038/onc.2010.545; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56; Hurwitz JL, 2009, ONCOLOGIST, V14, P986, DOI 10.1634/theoncologist.2009-0026; Hwang JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010630; Ichimura A, 2010, MOL PHARMACOL, V77, P1016, DOI 10.1124/mol.109.063321; Iorio MV, 2009, J CLIN ONCOL, V27, P5848, DOI 10.1200/JCO.2009.24.0317; Jackman DM, 2005, LANCET, V366, P1385, DOI 10.1016/S0140-6736(05)67569-1; Ji Q, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006816; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Lally BE, 2007, ONCOLOGIST, V12, P1096, DOI 10.1634/theoncologist.12-9-1096; Li N, 2009, CANCER LETT, V275, P44, DOI 10.1016/j.canlet.2008.09.035; Markou A, 2008, CLIN CHEM, V54, P1696, DOI 10.1373/clinchem.2007.101741; Miko E, 2009, EXP LUNG RES, V35, P646, DOI 10.3109/01902140902822312; Mudduluru G, 2011, ONCOGENE, V30, P2888, DOI 10.1038/onc.2011.13; Olivier M, 2002, HUM MUTAT, V19, P607, DOI 10.1002/humu.10081; Pang RTK, 2010, CARCINOGENESIS, V31, P1037, DOI 10.1093/carcin/bgq066; Ranade AR, 2010, J THORAC ONCOL, V5, P1273, DOI 10.1097/JTO.0b013e3181dea6be; Voortman J, 2010, CANCER RES, V70, P8288, DOI 10.1158/0008-5472.CAN-10-1348; Wiggins JF, 2010, CANCER RES, V70, P5923, DOI 10.1158/0008-5472.CAN-10-0655; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yu SL, 2008, CANCER CELL, V13, P48, DOI 10.1016/j.ccr.2007.12.008	34	53	58	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21300	10.1371/journal.pone.0021300	http://dx.doi.org/10.1371/journal.pone.0021300			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731696	Green Published, Green Submitted, gold			2022-12-27	WOS:000292033700058
J	Shebl, FM; Dollard, SC; Pfeiffer, RM; Biryahwaho, B; Amin, MM; Munuo, SS; Hladik, W; Parsons, R; Graubard, BI; Mbulaiteye, SM				Shebl, Fatma M.; Dollard, Sheila C.; Pfeiffer, Ruth M.; Biryahwaho, Benon; Amin, Minal M.; Munuo, Stella S.; Hladik, Wolfgang; Parsons, Ruth; Graubard, Barry I.; Mbulaiteye, Sam M.			Human Herpesvirus 8 Seropositivity Among Sexually Active Adults in Uganda	PLOS ONE			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; TO-CHILD TRANSMISSION; KAPOSIS-SARCOMA; RISK-FACTORS; INFECTION; SEROPREVALENCE; AIDS; ADOLESCENTS; PREVALENCE; PATTERNS	Introduction: Sexual transmission of human herpesvirus 8 (HHV8) has been implicated among homosexual men, but the evidence for sexual transmission among heterosexual individuals is controversial. We investigated the role of sexual transmission of HHV8 in a nationally representative sample in Uganda, where HHV8 infection is endemic and transmitted mostly during childhood. Materials and Methods: The study population was a subset of participants (n = 2681) from a population-based HIV/AIDS serobehavioral survey of adults aged 15-59 years conducted in 2004/2005. High risk for sexual transmission was assessed by questionnaire and serological testing for HIV and herpes simplex virus 2. Anti-HHV8 antibodies were measured using two enzyme immunoassays targeting synthetic peptides from the K8.1 and orf65 viral genes. The current study was restricted to 2288 sexually active adults. ORs and 95% CIs for HHV8 seropositivity were estimated by fitting logistic regression models with a random intercept using MPLUS and SAS software. Results: The weighted prevalence of HHV8 seropositivity was 56.2%, based on 1302 seropositive individuals, and it increased significantly with age (P-trend<0.0001). In analyses adjusting for age, sex, geography, education, and HIV status, HHV8 seropositivity was positively associated with reporting two versus one marital union (OR:1.52, 95% CI: 1.17-1.97) and each unit increase in the number of children born (OR: 1.04, 95% CI: 1.00-1.08), and was inversely associated with ever having used a condom (OR: 0.64, 95% CI: 0.45-0.89). HHV8 seropositivity was not associated with HIV (P = 0.660) or with herpes simplex virus 2 (P = 0.732) seropositivity. Other sexual variables, including lifetime number of sexual partners or having had at least one sexually transmitted disease, and socioeconomic variables were unrelated to HHV8 seropositivity. Conclusion: Our findings are compatible with the conclusion that sexual transmission of HHV8 in Uganda, if it occurs, is weak.	[Shebl, Fatma M.; Pfeiffer, Ruth M.; Graubard, Barry I.; Mbulaiteye, Sam M.] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Dollard, Sheila C.; Amin, Minal M.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Biryahwaho, Benon] Uganda Virus Res Inst, Entebbe, Uganda; [Munuo, Stella S.; Parsons, Ruth] Informat Management Serv Inc, Rockville, MD USA; [Hladik, Wolfgang] Ctr Dis Control & Prevent, Entebbe, Uganda	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Centers for Disease Control & Prevention - USA; Uganda Virus Research Institute; Information Management Services, Inc.	Shebl, FM (corresponding author), NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA.	mbulaits@mail.nih.gov	Pfeiffer, Ruth M/F-4748-2011; Mbulaiteye, Sam/O-3056-2019	Mbulaiteye, Sam/0000-0002-8273-9831	Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI); National Institutes of Health, Department of Health and Human Services [HHSN2612009004060P]; Support Services contract [NO2-CP-31003]; NCI [IAA Y1CP903801]; Centers for Disease Control and Prevention [IAA Y1CP903801]; NATIONAL CANCER INSTITUTE [ZIACP010176] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000732] Funding Source: NIH RePORTER	Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Support Services contract; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was supported by the Intramural Research Program of the Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI), National Institutes of Health, Department of Health and Human Services (contract HHSN2612009004060P and Support Services contract NO2-CP-31003) and with an Inter-Agency Agreement between NCI and the Centers for Disease Control and Prevention (IAA Y1CP903801). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson LA, 2008, PEDIATR INFECT DIS J, V27, P661, DOI 10.1097/INF.0b013e3181691740; Baeten JM, 2002, AIDS, V16, P2073, DOI 10.1097/00002030-200210180-00013; BERAL V, 1990, LANCET, V335, P123, DOI 10.1016/0140-6736(90)90001-L; Biryahwaho B, 2010, J INFECT DIS, V202, P1347, DOI 10.1086/656525; Bourboulia D, 1998, JAMA-J AM MED ASSOC, V280, P31, DOI 10.1001/jama.280.1.31-a; Bunnell R, 2008, AIDS, V22, P617, DOI 10.1097/QAD.0b013e3282f56b53; Butler LM, 2011, J INFECT DIS, V203, P625, DOI 10.1093/infdis/jiq092; Butler LM, 2009, J INFECT DIS, V200, P430, DOI 10.1086/600103; Casper C, 2006, SEX TRANSM INFECT, V82, P229, DOI 10.1136/sti.2005.016568; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Dedicoat M, 2003, BRIT J CANCER, V88, P1, DOI 10.1038/sj.bjc.6600745; DOLLARD SC, 2008, INT J CANCER, V127, P2395; Eltom MA, 2002, AIDS, V16, P2473, DOI 10.1097/00002030-200212060-00014; *GOV UG UG BUR STA, 2007, 2002 UG POP HOUS CEN; Hladik W, 2003, JAIDS-J ACQ IMM DEF, V33, P206, DOI 10.1097/00126334-200306010-00015; Hladik W, 2006, NEW ENGL J MED, V355, P1331, DOI 10.1056/NEJMoa055009; HOERAUF A, N ENGL J MED, V363, P1476; Lavreys L, 2003, J INFECT DIS, V187, P359, DOI 10.1086/367703; Malope BI, 2008, AIDS, V22, P519, DOI 10.1097/QAD.0b013e3282f46582; Mbulaiteye S, 2006, J INFECT DIS, V193, P1250, DOI 10.1086/503052; Mbulaiteye SM, 2008, AIDS, V22, P535, DOI 10.1097/QAD.0b013e3282f4352e; Mbulaiteye SM, 2005, JAIDS-J ACQ IMM DEF, V38, P474, DOI 10.1097/01.qai.0000132495.89162.c0; Mbulaiteye SM, 2003, J INFECT DIS, V187, P1780, DOI 10.1086/374973; Mbulaiteye SM, 2003, J NATL CANCER I, V95, P1330, DOI 10.1093/jnci/djg039; Mbulaiteye SM, 2003, HEMATOL ONCOL CLIN N, V17, P673, DOI 10.1016/S0889-8588(03)00048-0; Mermin J, 2008, JAMA-J AM MED ASSOC, V300, P540, DOI 10.1001/jama.300.5.540; Newton R, 2003, INT J CANCER, V103, P226, DOI 10.1002/ijc.10817; Olsen SJ, 1998, AIDS, V12, P1921, DOI 10.1097/00002030-199814000-00024; Parkin DM, 2008, LANCET ONCOL, V9, P683, DOI 10.1016/S1470-2045(08)70175-X; Pau CP, 1998, J CLIN MICROBIOL, V36, P1574, DOI 10.1128/JCM.36.6.1574-1577.1998; Pfeffermann D, 1998, J ROY STAT SOC B, V60, P23, DOI 10.1111/1467-9868.00106; PFEIFFER RM, 2010, ANN EPIDEMI IN PRESS; Rabkin CS, 1998, J INFECT DIS, V178, P304, DOI 10.1086/515649; RAO JNK, 1981, J AM STAT ASSOC, V76, P221, DOI 10.2307/2287815; Sitas F, 1999, NEW ENGL J MED, V340, P1863, DOI 10.1056/NEJM199906173402403; Skrondal A., 2010, MULTILEVEL MODELLING; Spira TJ, 2000, J CLIN MICROBIOL, V38, P2174; Wawer MJ, 2001, SEX TRANSM DIS, V28, P77, DOI 10.1097/00007435-200102000-00003	38	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2011	6	6							e21286	10.1371/journal.pone.0021286	http://dx.doi.org/10.1371/journal.pone.0021286			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782CL	21712983	Green Submitted, Green Published, gold			2022-12-27	WOS:000291985100025
J	Tsai, PW; Yang, CY; Chang, HT; Lan, CY				Tsai, Pei-Wen; Yang, Cheng-Yao; Chang, Hao-Teng; Lan, Chung-Yu			Characterizing the Role of Cell-Wall beta-1,3-Exoglucanase Xog1p in Candida albicans Adhesion by the Human Antimicrobial Peptide LL-37	PLOS ONE			English	Article							HUMAN CATHELICIDIN; GENE; INHIBITION; PROTEINS; IDENTIFICATION; YEAST; EXO-BETA-(1,3)-GLUCANASE; MANNOPROTEIN; DISRUPTION; DEFENSINS	Candida albicans is the major fungal pathogen of humans. Its adhesion to host-cell surfaces is the first critical step during mucosal infection. Antimicrobial peptides play important roles in the first line of mucosal immunity against C. albicans infection. LL-37 is the only member of the human cathelicidin antimicrobial peptide family and is commonly expressed in various tissues, including epithelium. We previously showed that LL-37 significantly reduced C. albicans adhesion to plastic, oral epidermoid OECM-1 cells, and urinary bladders of female BALB/c mice. The inhibitory effect of LL-37 on cell adhesion occurred via the binding of LL-37 to cell-wall carbohydrates. Here we showed that formation of LL-37-cell-wall protein complexes potentially inhibits C. albicans adhesion to polystyrene. Using phage display and ELISA, we identified 10 peptide sequences that could bind LL-37. A BLAST search revealed that four sequences in the major C. albicans cell-wall beta-1,3-exoglucanase, Xog1p, were highly similar to the consensus sequence derived from the 10 biopanned peptides. One Xog1p-derived peptide, Xog1p(90-115), and recombinant Xog1p associated with LL-37, thereby reversing the inhibitory effect of LL37 on C. albicans adhesion. LL-37 reduced Xog1p activity and thus interrupted cell-wall remodeling. Moreover, deletion of XOG1 or another beta-1,3-exoglucanase-encoding gene EXG2 showed that only when XOG1 was deleted did cellular exoglucanase activity, cell adhesion and LL-37 binding decrease. Antibodies against Xog1p also decreased cell adhesion. These data reveal that Xog1p, originally identified from LL-37 binding, has a role in C. albicans adhesion to polystyrene and, by inference, attach to host cells via direct or indirect manners. Compounds that target Xog1p might find use as drugs that prevent C. albicans infection. Additionally, LL-37 could potentially be used to screen for other cell-wall components involved in fungal cell adhesion.	[Tsai, Pei-Wen; Lan, Chung-Yu] Natl Tsing Hua Univ, Inst Mol & Cellular Biol, Hsinchu, Taiwan; [Yang, Cheng-Yao] Anim Technol Inst Taiwan, Div Anim Med, Miaoli, Taiwan; [Chang, Hao-Teng] China Med Univ, Grad Inst Mol Syst Biomed, Taichung, Taiwan; [Chang, Hao-Teng] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Chang, Hao-Teng] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Chang, Hao-Teng] China Med Univ, PhD Program Aging, Taichung, Taiwan; [Lan, Chung-Yu] Natl Tsing Hua Univ, Dept Life Sci, Hsinchu, Taiwan	National Tsing Hua University; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; National Tsing Hua University	Tsai, PW (corresponding author), Natl Tsing Hua Univ, Inst Mol & Cellular Biol, Hsinchu, Taiwan.	htchang@mail.cmu.edu.tw; cylan@life.nthu.edu.tw	Chang, Hao-Teng/O-2875-2015	Chang, Hao-Teng/0000-0001-8756-5220; Lan, Chung-Yu/0000-0002-1533-3049; Yang, Cheng-Yao/0000-0002-8694-9561	National Science Council (Taiwan) [NSC98-2311-B-007-010-MY3, NSC99-2627-B-007-007]; China Medical University (Taiwan) [CMU98-N2-13]	National Science Council (Taiwan)(Ministry of Science and Technology, Taiwan); China Medical University (Taiwan)(China Medical University)	This work was supported by grants NSC98-2311-B-007-010-MY3 and NSC99-2627-B-007-007 (to CYL) from the National Science Council (Taiwan) and in part by CMU98-N2-13 (to HTC) from China Medical University (Taiwan). The funders only supported the funding for the scientific research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DJ, 2004, MICROBIOL-SGM, V150, P2029, DOI 10.1099/mic.0.26980-0; AGERBERTH B, 1995, P NATL ACAD SCI USA, V92, P195, DOI 10.1073/pnas.92.1.195; Alloush HM, 1997, MICROBIOL-SGM, V143, P321, DOI 10.1099/00221287-143-2-321; Bals R, 2000, Respir Res, V1, P141, DOI 10.1186/rr25; Bergsson G, 2009, J IMMUNOL, V183, P543, DOI 10.4049/jimmunol.0803959; Bowman SM, 2006, BIOESSAYS, V28, P799, DOI 10.1002/bies.20441; BROWN JA, 1992, CARBOHYD RES, V227, P195, DOI 10.1016/0008-6215(92)85071-7; Burton MF, 2009, NAT PROD REP, V26, P1572, DOI 10.1039/b912533g; Calderone RA., 2002, CANDIDA CANDIDIASIS; CASANOVA M, 1992, INFECT IMMUN, V60, P4898, DOI 10.1128/IAI.60.11.4898-4906.1992; Castillo L, 2006, FUNGAL GENET BIOL, V43, P124, DOI 10.1016/j.fgb.2005.12.002; Chaffin WL, 2008, MICROBIOL MOL BIOL R, V72, P495, DOI 10.1128/MMBR.00032-07; Chaffin WL, 1998, MICROBIOL MOL BIOL R, V62, P130, DOI 10.1128/MMBR.62.1.130-180.1998; CHAMBERS RS, 1993, FEBS LETT, V327, P366, DOI 10.1016/0014-5793(93)81022-R; Chang HT, 2010, PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON COMPLEX, INTELLIGENT AND SOFTWARE INTENSIVE SYSTEMS (CISIS 2010), P672, DOI 10.1109/CISIS.2010.82; CHAPMAN T, 1992, ANTIMICROB AGENTS CH, V36, P1909, DOI 10.1128/AAC.36.9.1909; Chromek M, 2006, NAT MED, V12, P636, DOI 10.1038/nm1407; Ciornei CD, 2005, ANTIMICROB AGENTS CH, V49, P2845, DOI 10.1128/AAC.49.7.2845-2850.2005; Cutfield SM, 1999, J MOL BIOL, V294, P771, DOI 10.1006/jmbi.1999.3287; de Groot PWJ, 2004, EUKARYOT CELL, V3, P955, DOI 10.1128/EC.3.4.955-965.2004; De Smet K, 2005, BIOTECHNOL LETT, V27, P1337, DOI 10.1007/s10529-005-0936-5; den Hertog AL, 2005, BIOCHEM J, V388, P689, DOI 10.1042/BJ20042099; DENOBEL JG, 1990, YEAST, V6, P491, DOI 10.1002/yea.320060606; Dietrich DE, 2008, INFECT IMMUN, V76, P5714, DOI 10.1128/IAI.00997-08; Foschiatti M, 2009, MOL MICROBIOL, V72, P1137, DOI 10.1111/j.1365-2958.2009.06707.x; Frick IM, 2008, MOL MICROBIOL, V70, P695, DOI 10.1111/j.1365-2958.2008.06439.x; Gonzalez MD, 1997, MICROBIOL-UK, V143, P3023, DOI 10.1099/00221287-143-9-3023; Gudmundsson GH, 1996, EUR J BIOCHEM, V238, P325, DOI 10.1111/j.1432-1033.1996.0325z.x; Hoyer LL, 2001, TRENDS MICROBIOL, V9, P176, DOI 10.1016/S0966-842X(01)01984-9; Kai-Larsen Y, 2008, FRONT BIOSCI, V13, P3760, DOI 10.2741/2964; Kai-Larsen Y, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001010; Klis FM, 2001, MED MYCOL, V39, P1, DOI 10.1080/744118876; Klis FM, 2009, FEMS YEAST RES, V9, P1013, DOI 10.1111/j.1567-1364.2009.00541.x; Kohatsu L, 2006, J IMMUNOL, V177, P4718, DOI 10.4049/jimmunol.177.7.4718; KOLLAR R, 1995, J BIOL CHEM, V270, P1170, DOI 10.1074/jbc.270.3.1170; La Valle R, 2000, INFECT IMMUN, V68, P6777, DOI 10.1128/IAI.68.12.6777-6784.2000; LARRIBA G, 1995, FEMS MICROBIOL LETT, V125, P121; Latge JP, 2007, MOL MICROBIOL, V66, P279, DOI 10.1111/j.1365-2958.2007.05872.x; Lesage G, 2006, MICROBIOL MOL BIOL R, V70, P317, DOI 10.1128/MMBR.00038-05; Li XWS, 2006, J BIOL CHEM, V281, P22453, DOI 10.1074/jbc.M604064200; Li XWS, 2003, J BIOL CHEM, V278, P28553, DOI 10.1074/jbc.M300680200; LopezRibot JL, 1996, INFECT IMMUN, V64, P3333; LUNAARIAS JP, 1991, YEAST, V7, P833, DOI 10.1002/yea.320070808; McKenzie CGJ, 2010, INFECT IMMUN, V78, P1650, DOI 10.1128/IAI.00001-10; Meletiadis J, 2001, J CLIN MICROBIOL, V39, P3402, DOI 10.1128/JCM.39.9.3402-3408.2001; Mendez-Samperio P, 2010, PEPTIDES, V31, P1791, DOI 10.1016/j.peptides.2010.06.016; Mookherjee N, 2009, J IMMUNOL, V183, P2688, DOI 10.4049/jimmunol.0802586; Moura-Tamames SA, 2009, J MOL GRAPH MODEL, V27, P908, DOI 10.1016/j.jmgm.2009.01.007; Naglik J, 2004, CELL MICROBIOL, V6, P915, DOI 10.1111/j.1462-5822.2004.00439.x; Nather K, 2008, FEMS MICROBIOL LETT, V285, P137, DOI 10.1111/j.1574-6968.2008.01263.x; Nett J, 2007, ANTIMICROB AGENTS CH, V51, P510, DOI 10.1128/AAC.01056-06; Nijnik A, 2009, CURR OPIN HEMATOL, V16, P41, DOI 10.1097/MOH.0b013e32831ac517; Nimrichter L, 2005, MICROBES INFECT, V7, P789, DOI 10.1016/j.micinf.2005.03.002; ODDS FC, 1979, CANDIDA CANDIDOSIS, P382; Phan QT, 2007, PLOS BIOL, V5, P543, DOI 10.1371/journal.pbio.0050064; Pingel LC, 2008, IMMUNOL CELL BIOL, V86, P643, DOI 10.1038/icb.2008.56; Rast DM, 2003, PHYTOCHEMISTRY, V64, P339, DOI 10.1016/S0031-9422(03)00350-9; Reuss O, 2004, GENE, V341, P119, DOI 10.1016/j.gene.2004.06.021; Sambrook J., 2001, MOL CLONING LAB MANU; Sandini S, 2007, CELL MICROBIOL, V9, P1223, DOI 10.1111/j.1462-5822.2006.00862.x; SANSEGUNDO P, 1993, J BACTERIOL, V175, P3823, DOI 10.1128/JB.175.12.3823-3837.1993; Sorensen OE, 2001, BLOOD, V97, P3951, DOI 10.1182/blood.V97.12.3951; Stubbs HJ, 1999, EUR J BIOCHEM, V263, P889, DOI 10.1046/j.1432-1327.1999.00581.x; Torosantucci A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005392; Tronchin G, 2008, MED MYCOL, V46, P749, DOI 10.1080/13693780802206435; Tsai PW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017755; Zaiou M, 2002, J MOL MED, V80, P549, DOI 10.1007/s00109-002-0350-6; Zanetti M, 2005, CURR ISSUES MOL BIOL, V7, P179, DOI 10.21775/cimb.007.179; Zasloff M, 2006, NAT MED, V12, P606, DOI 10.1038/nm0606-607; Zhu WD, 2010, CELL MICROBIOL, V12, P273, DOI 10.1111/j.1462-5822.2009.01412.x	70	29	32	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2011	6	6							e21394	10.1371/journal.pone.0021394	http://dx.doi.org/10.1371/journal.pone.0021394			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782CL	21713010	gold, Green Published, Green Submitted			2022-12-27	WOS:000291985100037
J	Blumenfeld-Katzir, T; Pasternak, O; Dagan, M; Assaf, Y				Blumenfeld-Katzir, Tamar; Pasternak, Ofer; Dagan, Michael; Assaf, Yaniv			Diffusion MRI of Structural Brain Plasticity Induced by a Learning and Memory Task	PLOS ONE			English	Article							WHITE-MATTER PLASTICITY; SYNAPTIC PLASTICITY; HIPPOCAMPAL NEUROGENESIS; FUNCTIONAL PLASTICITY; ADULT BRAIN; ASTROCYTES; EXPERIENCE; POTENTIATION; ANISOTROPY; SPINES	Background: Activity-induced structural remodeling of dendritic spines and glial cells was recently proposed as an important factor in neuroplasticity and suggested to accompany the induction of long-term potentiation (LTP). Although T1 and diffusion MRI have been used to study structural changes resulting from long-term training, the cellular basis of the findings obtained and their relationship to neuroplasticity are poorly understood. Methodology/Principal Finding: Here we used diffusion tensor imaging (DTI) to examine the microstructural manifestations of neuroplasticity in rats that performed a spatial navigation task. We found that DTI can be used to define the selective localization of neuroplasticity induced by different tasks and that this process is age-dependent in cingulate cortex and corpus callosum and age-independent in the dentate gyrus. Conclusion/Significance: We relate the observed DTI changes to the structural plasticity that occurs in astrocytes and discuss the potential of MRI for probing structural neuroplasticity and hence indirectly localizing LTP.	[Blumenfeld-Katzir, Tamar; Dagan, Michael; Assaf, Yaniv] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiol, IL-69978 Tel Aviv, Israel; [Pasternak, Ofer] Harvard Univ, Sch Med, Dept Radiol, Brigham & Womens Hosp,Lab Math Imaging, Boston, MA 02115 USA	Tel Aviv University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Blumenfeld-Katzir, T (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiol, IL-69978 Tel Aviv, Israel.	assafyan@post.tau.ac.il		Assaf, Yaniv/0000-0001-6828-7595	Israel Science Foundation (ISF) [994/08]; National Institute for Psychobiology in Israel (NIPI); EU	Israel Science Foundation (ISF)(Israel Science Foundation); National Institute for Psychobiology in Israel (NIPI); EU(European Commission)	The authors wish to thank the Raymond and Beverly Sackler Insitute for Biophysics, the Israel Science Foundation and the Strauss Center for Computation Neuroimaging of Tel Aviv University for the purchase and maintenance of the MRI system. Y.A. wishes to thank the Israel Science Foundation (ISF grant no. 994/08), the National Institute for Psychobiology in Israel (NIPI) and the CONNECT consortium supported by the future and emerging technologies program of PF7 of EU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Basser PJ, 1995, NMR BIOMED, V8, P333, DOI 10.1002/nbm.1940080707; Basser PJ, 2002, NMR BIOMED, V15, P456, DOI 10.1002/nbm.783; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Becker N, 2008, NEURON, V60, P590, DOI 10.1016/j.neuron.2008.09.018; Bengtsson SL, 2005, NAT NEUROSCI, V8, P1148, DOI 10.1038/nn1516; Boyke J, 2008, J NEUROSCI, V28, P7031, DOI 10.1523/JNEUROSCI.0742-08.2008; Bruel-Jungerman E, 2007, NEUROSCIENTIST, V13, P492, DOI 10.1177/1073858407302725; Bruel-Jungerman E, 2007, REV NEUROSCIENCE, V18, P93; Butz M, 2009, BRAIN RES REV, V60, P287, DOI 10.1016/j.brainresrev.2008.12.023; Chao TC, 2009, MAGN RESON IMAGING, V27, P681, DOI 10.1016/j.mri.2008.09.004; Chumbley JR, 2009, NEUROIMAGE, V44, P62, DOI 10.1016/j.neuroimage.2008.05.021; Draganski B, 2008, BEHAV BRAIN RES, V192, P137, DOI 10.1016/j.bbr.2008.02.015; Gould E, 2000, BIOL PSYCHIAT, V48, P715, DOI 10.1016/S0006-3223(00)01021-0; Gregg C, 2007, J NEUROSCI, V27, P1812, DOI 10.1523/JNEUROSCI.4441-06.2007; Gross CG, 2000, NAT REV NEUROSCI, V1, P67, DOI 10.1038/35036235; Hickmott PW, 2006, NEUROSCIENTIST, V12, P16, DOI 10.1177/1073858405282417; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Imfeld A, 2009, NEUROIMAGE, V46, P600, DOI 10.1016/j.neuroimage.2009.02.025; Johansen-Berg H, 2007, CURR BIOL, V17, pR141, DOI 10.1016/j.cub.2006.12.022; KAPLAN MS, 1977, SCIENCE, V197, P1092, DOI 10.1126/science.887941; Lamprecht R, 2004, NAT REV NEUROSCI, V5, P45, DOI 10.1038/nrn1301; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Lushnikova I, 2009, HIPPOCAMPUS, V19, P753, DOI 10.1002/hipo.20551; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Muller Dominique, 2002, Current Molecular Medicine (Hilversum), V2, P605, DOI 10.2174/1566524023362041; Paxinos G., 2005, RAT BRAIN STEREOTAXI, Vxliii; Pekny M, 2007, INT REV NEUROBIOL, V82, P95, DOI 10.1016/S0074-7742(07)82005-8; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Rosenzweig MR, 1996, BEHAV BRAIN RES, V78, P57, DOI 10.1016/0166-4328(95)00216-2; Schlaug G, 2009, ANN NY ACAD SCI, V1169, P385, DOI 10.1111/j.1749-6632.2009.04587.x; SCHOLTZ J, 2009, P HUMAN BRAIN MAPPIN, V15, P362; SHAO YP, 1994, GLIA, V11, P147, DOI 10.1002/glia.440110209; Slezak M, 2006, J PHYSIOLOGY-PARIS, V99, P84, DOI 10.1016/j.jphysparis.2005.12.082; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Theodosis DT, 2008, PHYSIOL REV, V88, P983, DOI 10.1152/physrev.00036.2007; Theodosis DT, 1999, ADV EXP MED BIOL, V468, P175; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Voss HU, 2009, PROG BRAIN RES, V175, P483, DOI 10.1016/S0079-6123(09)17532-5; Yovel Y, 2007, NEUROIMAGE, V35, P58, DOI 10.1016/j.neuroimage.2006.08.055	43	193	194	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e20678	10.1371/journal.pone.0020678	http://dx.doi.org/10.1371/journal.pone.0020678			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	21701690	Green Published, gold			2022-12-27	WOS:000291983800010
J	Villoutreix, BO; Laconde, G; Lagorce, D; Martineau, P; Miteva, MA; Dariavach, P				Villoutreix, Bruno O.; Laconde, Guillaume; Lagorce, David; Martineau, Pierre; Miteva, Maria A.; Dariavach, Piona			Tyrosine Kinase Syk Non-Enzymatic Inhibitors and Potential Anti-Allergic Drug-Like Compounds Discovered by Virtual and In Vitro Screening	PLOS ONE			English	Article							3D CONFORMATION; SMALL MOLECULES; DOCKING; PERFORMANCE; ANTIBODIES; GENERATOR; DOMAINS; BIOLOGY; SYSTEM; TOOL	In the past decade, the spleen tyrosine kinase (Syk) has shown a high potential for the discovery of new treatments for inflammatory and autoimmune disorders. Pharmacological inhibitors of Syk catalytic site bearing therapeutic potential have been developed, with however limited specificity towards Syk. To address this topic, we opted for the design of drug-like compounds that could impede the interaction of Syk with its cellular partners while maintaining an active kinase protein. To achieve this challenging task, we used the powerful potential of intracellular antibodies for the modulation of cellular functions in vivo, combined to structure-based in silico screening. In our previous studies, we reported the anti-allergic properties of the intracellular antibody G4G11. With the aim of finding functional mimics of G4G11, we developed an Antibody Displacement Assay and we isolated the drug-like compound C-13, with promising in vivo anti-allergic activity. The likely binding cavity of this compound is located at the close vicinity of G4G11 epitope, far away from the catalytic site of Syk. Here we report the virtual screen of a collection of 500,000 molecules against this new cavity, which led to the isolation of 1000 compounds subsequently evaluated for their in vitro inhibitory effects using the Antibody Displacement Assay. Eighty five compounds were selected and evaluated for their ability to inhibit the liberation of allergic mediators from mast cells. Among them, 10 compounds inhibited degranulation with IC(50) values <= 10 mu M. The most bioactive compounds combine biological activity, significant inhibition of antibody binding and strong affinity for Syk. Moreover, these molecules show a good potential for oral bioavailability and are not kinase catalytic site inhibitors. These bioactive compounds could be used as starting points for the development of new classes of non-enzymatic inhibitors of Syk and for drug discovery endeavour in the field of inflammation related disorders.	[Villoutreix, Bruno O.; Laconde, Guillaume; Lagorce, David; Miteva, Maria A.] Univ Paris Diderot, INSERM, U973, MTi Unit, Paris, France; [Martineau, Pierre; Dariavach, Piona] Inst Rech Cancerol Montpellier, IRCM, Montpellier, France; [Martineau, Pierre; Dariavach, Piona] INSERM, U896, Montpellier, France; [Martineau, Pierre; Dariavach, Piona] Univ Montpellier 1, Montpellier, France; [Martineau, Pierre; Dariavach, Piona] Univ Montpellier 2, Montpellier, France; [Martineau, Pierre; Dariavach, Piona] CRLC Val dAurelle Paul Lamarque, Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; UNICANCER; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Universite de Montpellier; UNICANCER; Universite de Montpellier; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM)	Villoutreix, BO (corresponding author), Univ Paris Diderot, INSERM, U973, MTi Unit, Paris, France.	piona.dariavach@inserm.fr	Miteva, Maria M/N-2419-2018; Martineau, Pierre/N-4386-2017; Villoutreix, Bruno/I-4565-2015	Miteva, Maria M/0000-0001-6895-1214; Martineau, Pierre/0000-0002-7993-7183; Villoutreix, Bruno/0000-0002-6456-7730; Laconde, Guillaume/0000-0001-5577-6111				An JH, 2005, MOL CELL PROTEOMICS, V4, P752, DOI 10.1074/mcp.M400159-MCP200; Arias-Palomo E, 2007, BBA-PROTEINS PROTEOM, V1774, P1493, DOI 10.1016/j.bbapap.2007.10.008; Arkin MR, 2009, CURR OPIN CHEM BIOL, V13, P284, DOI 10.1016/j.cbpa.2009.05.125; Braselmann S, 2006, J PHARMACOL EXP THER, V319, P998, DOI 10.1124/jpet.106.109058; Dauvillier S, 2002, J IMMUNOL, V169, P2274, DOI 10.4049/jimmunol.169.5.2274; Fahy JV, 1997, AM J RESP CRIT CARE, V155, P1828, DOI 10.1164/ajrccm.155.6.9196082; Futterer K, 1998, J MOL BIOL, V281, P523, DOI 10.1006/jmbi.1998.1964; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Jain AN, 2007, J COMPUT AID MOL DES, V21, P281, DOI 10.1007/s10822-007-9114-2; Kirchmair J, 2006, J CHEM INF MODEL, V46, P1848, DOI 10.1021/ci060084g; Lagorce David, 2009, BMC Chemical Biology, V9, P6, DOI 10.1186/1472-6769-9-6; Lagorce D, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-396; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Lobato MN, 2003, TRENDS MOL MED, V9, P390, DOI 10.1016/S1471-4914(03)00163-1; Maiorov V, 2005, J CHEM INF MODEL, V45, P1017, DOI 10.1021/ci050089y; Masuda ES, 2008, PULM PHARMACOL THER, V21, P461, DOI 10.1016/j.pupt.2007.06.002; Mazuc E, 2008, J ALLERGY CLIN IMMUN, V122, P188, DOI 10.1016/j.jaci.2008.04.026; Miteva MA, 2005, J MED CHEM, V48, P6012, DOI 10.1021/jm050262h; Miteva MA, 2010, NUCLEIC ACIDS RES, V38, pW622, DOI 10.1093/nar/gkq325; Moustakas DT, 2006, J COMPUT AID MOL DES, V20, P601, DOI 10.1007/s10822-006-9060-4; Peneff C, 2000, J IMMUNOL METHODS, V236, P105, DOI 10.1016/S0022-1759(99)00228-8; Perot S, 2010, DRUG DISCOV TODAY, V15, P656, DOI 10.1016/j.drudis.2010.05.015; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Riccaboni M, 2010, DRUG DISCOV TODAY, V15, P517, DOI 10.1016/j.drudis.2010.05.001; Sauton N, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-184; Scott DL, 2006, NEW ENGL J MED, V355, P704, DOI 10.1056/NEJMct055183; Sperandio O, 2010, DRUG DISCOV TODAY, V15, P220, DOI 10.1016/j.drudis.2009.11.007; Thomsen R, 2006, J MED CHEM, V49, P3315, DOI 10.1021/jm051197e; Villoutreix BO, 2008, CURR PHARM BIOTECHNO, V9, P103, DOI 10.2174/138920108783955218; von Grotthuss M, 2003, BIOINFORMATICS, V19, P1041, DOI 10.1093/bioinformatics/btg117; Wang YL, 2009, NUCLEIC ACIDS RES, V37, pW623, DOI 10.1093/nar/gkp456; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Wong WSF, 2004, BBA-PROTEINS PROTEOM, V1697, P53, DOI 10.1016/j.bbapap.2003.11.013; Yanagi S, 2001, BIOCHEM BIOPH RES CO, V288, P495, DOI 10.1006/bbrc.2001.5788	34	19	21	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e21117	10.1371/journal.pone.0021117	http://dx.doi.org/10.1371/journal.pone.0021117			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	21701581	Green Submitted, Green Published, gold			2022-12-27	WOS:000291983800024
J	Bereswill, S; Fischer, A; Plickert, R; Haag, LM; Otto, B; Kuhl, AA; Dashti, JI; Zautner, AE; Munoz, M; Loddenkemper, C; Gross, U; Gobel, UB; Heimesaat, MM				Bereswill, Stefan; Fischer, Andre; Plickert, Rita; Haag, Lea-Maxie; Otto, Bettina; Kuehl, Anja A.; Dashti, Javid I.; Zautner, Andreas E.; Munoz, Melba; Loddenkemper, Christoph; Gross, Uwe; Goebel, Ulf B.; Heimesaat, Markus M.			Novel Murine Infection Models Provide Deep Insights into the "Menage a Trois" of Campylobacter jejuni, Microbiota and Host Innate Immunity	PLOS ONE			English	Article							GERM-FREE-MICE; TOLL-LIKE RECEPTORS; ESCHERICHIA-COLI; COLONIZATION; PATHOGENESIS; BACTERIA; IMMUNOPATHOLOGY; IDENTIFICATION; ACTIVATION; RESPONSES	Background: Although Campylobacter jejuni-infections have a high prevalence worldwide and represent a significant socioeconomic burden, it is still not well understood how C. jejuni causes intestinal inflammation. Detailed investigation of C. jejuni-mediated intestinal immunopathology is hampered by the lack of appropriate vertebrate models. In particular, mice display colonization resistance against this pathogen. Methodology/Principal Findings: To overcome these limitations we developed a novel C. jejuni-infection model using gnotobiotic mice in which the intestinal flora was eradicated by antibiotic treatment. These animals could then be permanently associated with a complete human (hfa) or murine (mfa) microbiota. After peroral infection C. jejuni colonized the gastrointestinal tract of gnotobiotic and hfa mice for six weeks, whereas mfa mice cleared the pathogen within two days. Strikingly, stable C. jejuni colonization was accompanied by a pro-inflammatory immune response indicated by increased numbers of T-and B-lymphocytes, regulatory T-cells, neutrophils and apoptotic cells, as well as increased concentrations of TNF-alpha, IL-6, and MCP-1 in the colon mucosa of hfa mice. Analysis of MyD88(-/-), TRIF-/-, TLR4(-/-), and TLR9(-/-) mice revealed that TLR4- and TLR9-signaling was essential for immunopathology following C. jejuni-infection. Interestingly, C. jejuni-mutant strains deficient in formic acid metabolism and perception induced less intestinal immunopathology compared to the parental strain infection. In summary, the murine gut flora is essential for colonization resistance against C. jejuni and can be overcome by reconstitution of gnotobiotic mice with human flora. Detection of C. jejuni-LPS and -CpG-DNA by host TLR4 and TLR9, respectively, plays a key role in immunopathology. Finally, the host immune response is tightly coupled to bacterial formic acid metabolism and invasion fitness. Conclusion/Significance: We conclude that gnotobiotic and "humanized" mice represent excellent novel C. jejuni-infection and -inflammation models and provide deep insights into the immunological and molecular interplays between C. jejuni, microbiota and innate immunity in human campylobacteriosis.	[Bereswill, Stefan; Fischer, Andre; Plickert, Rita; Haag, Lea-Maxie; Otto, Bettina; Munoz, Melba; Goebel, Ulf B.; Heimesaat, Markus M.] Charite, Dept Microbiol & Hyg, D-13353 Berlin, Germany; [Kuehl, Anja A.; Loddenkemper, Christoph] Charite, Dept Pathol, RCIS, D-13353 Berlin, Germany; [Dashti, Javid I.; Zautner, Andreas E.; Gross, Uwe] Univ Med Ctr Gottingen, Dept Med Microbiol, Gottingen, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Gottingen	Bereswill, S (corresponding author), Charite, Dept Microbiol & Hyg, D-13353 Berlin, Germany.	markus.heimesaat@charite.de	Zautner, Andreas Erich/ABA-9655-2020; Zautner, Andreas Erich/AAE-7425-2019; Haag, Lea Maxie/AAP-9001-2020	Zautner, Andreas Erich/0000-0003-0984-013X; Zautner, Andreas Erich/0000-0003-0984-013X; Kuhl, Anja/0000-0003-2293-5387; Haag, Lea-Maxie/0000-0002-3754-5317; Heimesaat, Markus/0000-0001-6399-651X	German Research Foundation (DFG) [GR906/13-1, GO363/12-1, SFB633, TP A7, TP Z1, TP B6]; German Federal Ministry of Education and Research (BMBF) [TP1.1]	German Research Foundation (DFG)(German Research Foundation (DFG)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by grants from the German Research Foundation (DFG) to UG (GR906/13-1, CampyGerm), UBG (GO363/12-1, CampyGerm; SFB633, TP A7), AK and CL (SFB633, TP Z1), MM and MMH (SFB633, TP B6), LMH and BO (SFB633, Immuco), and from the German Federal Ministry of Education and Research (BMBF) to SB (TP1.1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen-Nissen E, 2005, P NATL ACAD SCI USA, V102, P9247, DOI 10.1073/pnas.0502040102; Bacon DJ, 2000, INFECT IMMUN, V68, P4384, DOI 10.1128/IAI.68.8.4384-4390.2000; Bell JA, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-57; Bereswill S, 2003, CURR OPIN INFECT DIS, V16, P487, DOI 10.1097/00001432-200310000-00017; Chang C, 2006, INFECT IMMUN, V74, P5261, DOI 10.1128/IAI.01094-05; Dasti JI, 2010, INT J MED MICROBIOL, V300, P205, DOI 10.1016/j.ijmm.2009.07.002; de Zoete MR, 2010, INFECT IMMUN, V78, P1229, DOI 10.1128/IAI.00897-09; Dorrell N, 2007, CURR OPIN INFECT DIS, V20, P514, DOI 10.1097/QCO.0b013e3282a56b15; FRIEDMAN CR, 2000, CAMPYLOBACTER, V1, P121; Friis LM, 2009, INFECT IMMUN, V77, P1553, DOI 10.1128/IAI.00707-08; Heimesaat MM, 2007, GUT, V56, P941, DOI 10.1136/gut.2006.104497; Heimesaat MM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000662; Heimesaat MM, 2006, J IMMUNOL, V177, P8785, DOI 10.4049/jimmunol.177.12.8785; Heimesaat MM, 2010, GUT, V59, P1079, DOI 10.1136/gut.2009.197434; Hodgson AE, 1998, J MED MICROBIOL, V47, P799, DOI 10.1099/00222615-47-9-799; JESUDASON MV, 1989, INFECT IMMUN, V57, P2279, DOI 10.1128/IAI.57.8.2279-2282.1989; Ketley JM, 1997, MICROBIOL-UK, V143, P5, DOI 10.1099/00221287-143-1-5; Kist M, 2001, Contrib Microbiol, V8, P150; KORLATH JA, 1985, J INFECT DIS, V152, P592, DOI 10.1093/infdis/152.3.592; Mansfield LS, 2007, INFECT IMMUN, V75, P1099, DOI 10.1128/IAI.00833-06; Mansfield LS, 2008, MICROB PATHOGENESIS, V45, P241, DOI 10.1016/j.micpath.2008.05.010; Munoz M, 2009, J EXP MED, V206, P3047, DOI 10.1084/jem.20090900; PENNER JL, 1983, EUR J CLIN MICROBIOL, V2, P378, DOI 10.1007/BF02019474; Poly F, 2005, J CLIN MICROBIOL, V43, P2330, DOI 10.1128/JCM.43.5.2330-2338.2005; Poly F, 2004, J BACTERIOL, V186, P4781, DOI 10.1128/JB.186.14.4781-4795.2004; Rathinam VAK, 2009, INFECT IMMUN, V77, P2499, DOI 10.1128/IAI.01562-08; SAVIDGE TC, 1991, AM J PATHOL, V139, P177; SHROFF KE, 1995, ADV EXP MED BIOL, V371, P441; Singh M, 2003, INT J PARASITOL, V33, P469, DOI 10.1016/S0020-7519(03)00053-5; Tareen AM, 2010, MICROBIOL-SGM, V156, P3123, DOI 10.1099/mic.0.039438-0; Tsang RSW, 2002, CURR OPIN INFECT DIS, V15, P221, DOI 10.1097/00001432-200206000-00002; van Mourik A, 2010, J BIOL CHEM, V285, P15828, DOI 10.1074/jbc.M110.102061; VANSPREEUWEL JP, 1985, GUT, V26, P945, DOI 10.1136/gut.26.9.945; WALKER RI, 1986, MICROBIOL REV, V50, P81, DOI 10.1128/MMBR.50.1.81-94.1986; Watson RO, 2005, CELL MICROBIOL, V7, P655, DOI 10.1111/j.1462-5822.2004.00498.x; Watson RO, 2007, INFECT IMMUN, V75, P1994, DOI 10.1128/IAI.01216-06; Watters TM, 2007, IMMUNOL CELL BIOL, V85, P411, DOI 10.1038/sj.icb.7100095; YOUSSEF M, 1987, INFECT IMMUN, V55, P1019, DOI 10.1128/IAI.55.4.1019-1021.1987; YRIOS JW, 1986, INFECT IMMUN, V53, P378, DOI 10.1128/IAI.53.2.378-383.1986; YRIOS JW, 1986, INFECT IMMUN, V53, P384, DOI 10.1128/IAI.53.2.384-392.1986; YRIOS JW, 1986, INFECT IMMUN, V54, P339, DOI 10.1128/IAI.54.2.339-346.1986	41	194	196	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e20953	10.1371/journal.pone.0020953	http://dx.doi.org/10.1371/journal.pone.0020953			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698299	Green Submitted, gold, Green Published			2022-12-27	WOS:000291730000031
J	Khaidakov, M; Wang, XW; Mehta, JL				Khaidakov, Magomed; Wang, Xianwei; Mehta, Jawahar L.			Potential Involvement of LOX-1 in Functional Consequences of Endothelial Senescence	PLOS ONE			English	Article							NF-KAPPA-B; REDOX-SENSITIVE PATHWAY; CELLULAR SENESCENCE; ADHESION MOLECULES; OXIDATIVE STRESS; NITRIC-OXIDE; LECTIN-LIKE; CELLS; EXPRESSION; ATHEROSCLEROSIS	Numerous studies have described the process of senescence associated with accumulation of oxidative damage, mutations and decline in proliferative potential. Although the changes observed in senescent cells are likely to result in significant phenotypic alterations, the studies on consequences of endothelial senescence, especially in relation to aging-associated diseases, are scarce. We have analyzed effects of senescence on the functions of endothelial cells relevant to the development of atherosclerosis including angiogenesis, adhesion, apoptosis and inflammation. In the course of progressing through the passages, human umbilical vein endothelial cells (HUVECs) displayed significant increase in size (+36% passage 12 vs. passage 4, p < 0.001) and reduction in both basal and VEGF-stimulated tube formation. The analysis of a scavenger receptor LOX-1, a key molecule implicated in atherogenesis, revealed a significant decline of its message (mRNA) and protein content in senescent endothelial cells (-33%) and in aortas of 50 wk (vs. 5 wk) old mice (all p < 0.01). These effects were accompanied by a marked reduction of the basal expression of VCAM-1 and ICAM-1. Compared to early cultures, late passage HUVECs also exhibited nuclear translocation of NF-kappa B (p65) and reciprocal shifts in BAX and BCL2 protein content resulting in almost 2-fold increase in BAX/BCL2 ratio and 3-fold increase in apoptotic response to TNF alpha exposure (p < 0.04). These changes in senescent endothelial cells are suggestive of aberrant responses to physiological stimuli resulting in a less permissive environment for tissue remodeling and progression of diseases requiring angiogenesis and cell adhesion in elderly, possibly, mediated by LOX-1.	[Khaidakov, Magomed] Cent Arkansas Vet Healthcare Syst, Dept Med, Little Rock, AR USA; Univ Arkansas Med Sci, Little Rock, AR 72205 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System; University of Arkansas System; University of Arkansas Medical Sciences	Khaidakov, M (corresponding author), Cent Arkansas Vet Healthcare Syst, Dept Med, Little Rock, AR USA.	mkhaidakov@uams.edu; MehtaJL@UAMS.edu	Mehta, JL/AAG-7572-2020; Wang, Xianwei/AAN-8915-2020; Mehta, jl/AAB-8832-2019	Wang, Xianwei/0000-0002-1490-8736; Mehta, jl/0000-0003-0384-2097	Department of Veterans Affairs, Washington, D.C.; Arkansas Bioventures, Little Rock, Arkansas	Department of Veterans Affairs, Washington, D.C.(US Department of Veterans Affairs); Arkansas Bioventures, Little Rock, Arkansas	Funding was received from the Department of Veterans Affairs, Washington, D.C., and Arkansas Bioventures, Little Rock, Arkansas. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton M, 2010, PFLUG ARCH EUR J PHY, V460, P825, DOI 10.1007/s00424-010-0860-y; Beausejour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417; Chen JW, 2010, CHINESE MED J-PEKING, V123, P1553, DOI 10.3760/cma.j.issn.0366-6999.2010.12.014; Chen JW, 2004, CIRC RES, V94, P370, DOI 10.1161/01.RES.0000113782.07824.BE; COLLINS T, 1995, FASEB J, V9, P899, DOI 10.1096/fasebj.9.10.7542214; Cominacini L, 2000, J BIOL CHEM, V275, P12633, DOI 10.1074/jbc.275.17.12633; Cortes MJ, 2002, FEBS LETT, V522, P99, DOI 10.1016/S0014-5793(02)02902-2; Dandapat A, 2007, ARTERIOSCL THROM VAS, V27, P2435, DOI 10.1161/ATVBAHA.107.152272; Donato AJ, 2008, AGING CELL, V7, P805, DOI 10.1111/j.1474-9726.2008.00438.x; Farhat N, 2008, CAN J PHYSIOL PHARM, V86, P761, DOI 10.1139/Y08-082; Giorgadze S, 2009, GEORGIAN MED NEWS, V174, P88; Hoenig MR, 2008, CURR MOL MED, V8, P754, DOI 10.2174/156652408786733685; Hoffmann J, 2001, CIRC RES, V89, P709, DOI 10.1161/hh2001.097796; Holvoet P, 2008, Verh K Acad Geneeskd Belg, V70, P193; Hu CP, 2007, HYPERTENSION, V50, P952, DOI 10.1161/HYPERTENSIONAHA.107.096446; Jakob S, 2007, Z GERONTOL GERIATR, V40, P334, DOI 10.1007/s00391-007-0482-y; Kang BY, 2010, PHYSIOL GENOMICS, V42, P42, DOI 10.1152/physiolgenomics.00009.2010; Kurz DJ, 2000, J CELL SCI, V113, P3613; Li DY, 2001, CARDIOVASC RES, V52, P130, DOI 10.1016/S0008-6363(01)00371-6; Li YH, 2008, J VASC RES, V45, P205, DOI 10.1159/000112133; Madamanchi NR, 2007, CIRC RES, V100, P460, DOI 10.1161/01.RES.0000258450.44413.96; Mehta JL, 2006, CARDIOVASC RES, V69, P36, DOI 10.1016/j.cardiores.2005.09.006; Minamino T, 2010, CIRC J, V74, P2527, DOI 10.1253/circj.CJ-10-0916; Ogura S, 2009, CIRC J, V73, P1993, DOI 10.1253/circj.CJ-09-0587; Okuda K, 2000, ATHEROSCLEROSIS, V152, P391, DOI 10.1016/S0021-9150(99)00482-7; Rivard A, 1999, CIRCULATION, V99, P111, DOI 10.1161/01.CIR.99.1.111; SHEN JK, 1995, MICROVASC RES, V50, P360, DOI 10.1006/mvre.1995.1064; Tamilselvan J, 2007, FREE RADICAL BIO MED, V43, P1656, DOI 10.1016/j.freeradbiomed.2007.08.028; Terman A, 1999, EXP GERONTOL, V34, P755, DOI 10.1016/S0531-5565(99)00045-5; Vannini N, 2008, CURR PHARM DESIGN, V14, P221; Vasa M, 2000, CIRC RES, V87, P540, DOI 10.1161/01.RES.87.7.540; Voghel G, 2007, MECH AGEING DEV, V128, P662, DOI 10.1016/j.mad.2007.09.006	32	32	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e20964	10.1371/journal.pone.0020964	http://dx.doi.org/10.1371/journal.pone.0020964			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698300	gold, Green Submitted, Green Published			2022-12-27	WOS:000291730000032
J	Krzyzanowski, PM; Price, FD; Muro, EM; Rudnicki, MA; Andrade-Navarro, MA				Krzyzanowski, Paul M.; Price, Feodor D.; Muro, Enrique M.; Rudnicki, Michael A.; Andrade-Navarro, Miguel A.			Integration of Expressed Sequence Tag Data Flanking Predicted RNA Secondary Structures Facilitates Novel Non-Coding RNA Discovery	PLOS ONE			English	Article							SKELETAL-MUSCLE DIFFERENTIATION; MICRORNA PRECURSORS; GENE-EXPRESSION; DYSTROPHIN GENE; HUMAN GENOME; STEM-CELLS; MIR-206; TRANSCRIPTION; IDENTIFICATION; GROWTH	Many computational methods have been used to predict novel non-coding RNAs (ncRNAs), but none, to our knowledge, have explicitly investigated the impact of integrating existing cDNA-based Expressed Sequence Tag (EST) data that flank structural RNA predictions. To determine whether flanking EST data can assist in microRNA (miRNA) prediction, we identified genomic sites encoding putative miRNAs by combining functional RNA predictions with flanking ESTs data in a model consistent with miRNAs undergoing cleavage during maturation. In both human and mouse genomes, we observed that the inclusion of flanking ESTs adjacent to and not overlapping predicted miRNAs significantly improved the performance of various methods of miRNA prediction, including direct high-throughput sequencing of small RNA libraries. We analyzed the expression of hundreds of miRNAs predicted to be expressed during myogenic differentiation using a customized microarray and identified several known and predicted myogenic miRNA hairpins. Our results indicate that integrating ESTs flanking structural RNA predictions improves the quality of cleaved miRNA predictions and suggest that this strategy can be used to predict other non-coding RNAs undergoing cleavage during maturation.	[Krzyzanowski, Paul M.; Price, Feodor D.; Rudnicki, Michael A.] Ottawa Hosp Res Inst, Sprott Ctr Stem Cell Res, Ottawa, ON, Canada; [Krzyzanowski, Paul M.] Ontario Canc Inst, Toronto, ON M4X 1K9, Canada; [Muro, Enrique M.; Andrade-Navarro, Miguel A.] Max Delbruck Ctr Mol Med, Berlin, Germany	University of Ottawa; Ottawa Hospital Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Krzyzanowski, PM (corresponding author), Ottawa Hosp Res Inst, Sprott Ctr Stem Cell Res, Ottawa, ON, Canada.	paul.krzyzanowski@utoronto.ca	Andrade, Miguel A/B-6565-2008; Muro, Enrique M./AAX-3698-2021	Andrade, Miguel A/0000-0001-6650-1711; Rudnicki, Michael/0000-0002-3866-5249; Krzyzanowski, Paul/0000-0001-6430-5995	Ontario Government; High Performance Computing Virtual Laboratory; Canadian Institute of Health Research; Canadian Stem Cell Network; Canada Research Chair programme; Helmholtz Germany's National Genome Research Network (Bundesministerium fur Bildung und Forschung); Helmholtz Alliance on Systems Biology (Helmholtz-Gemeinschaft Deutscher Forschungszentren)	Ontario Government; High Performance Computing Virtual Laboratory; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Stem Cell Network; Canada Research Chair programme(Canada Research Chairs); Helmholtz Germany's National Genome Research Network (Bundesministerium fur Bildung und Forschung)(Federal Ministry of Education & Research (BMBF)); Helmholtz Alliance on Systems Biology (Helmholtz-Gemeinschaft Deutscher Forschungszentren)(Helmholtz Association)	The authors acknowledge support from the Ontario Government Scholarships in Science and Technology (PMK), the High Performance Computing Virtual Laboratory (PMK), the Canadian Institute of Health Research (FDP, MAR); the Canadian Stem Cell Network (PMK, EMM, MAR, MAA); the Canada Research Chair programme (MAA); the Helmholtz Germany's National Genome Research Network (Bundesministerium fur Bildung und Forschung) (EMM, MAA); and The Helmholtz Alliance on Systems Biology (Helmholtz-Gemeinschaft Deutscher Forschungszentren) (EMM, MAA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexakis C, 2007, AM J PHYSIOL-CELL PH, V293, pC661, DOI 10.1152/ajpcell.00061.2007; Anderson C, 2006, NUCLEIC ACIDS RES, V34, P5863, DOI 10.1093/nar/gkl743; Babiarz JE, 2008, GENE DEV, V22, P2773, DOI 10.1101/gad.1705308; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; BOGUSKI MS, 1993, NAT GENET, V4, P332, DOI 10.1038/ng0893-332; Bonnet E, 2004, BIOINFORMATICS, V20, P2911, DOI 10.1093/bioinformatics/bth374; Brennecke J, 2005, GENE DEV, V19, P2261, DOI 10.1101/gad.1363905; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Christodoulou F, 2010, NATURE, V463, P1084, DOI 10.1038/nature08744; Conaco C, 2006, P NATL ACAD SCI USA, V103, P2422, DOI 10.1073/pnas.0511041103; Daubas P, 2009, DEV BIOL, V327, P71, DOI 10.1016/j.ydbio.2008.11.031; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Ezhkova E, 2009, CELL, V136, P1122, DOI 10.1016/j.cell.2008.12.043; Ge XJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-285; Georgantas RW, 2007, P NATL ACAD SCI USA, V104, P2750, DOI 10.1073/pnas.0610983104; Ghosh T, 2008, NUCLEIC ACIDS RES, V36, P6318, DOI 10.1093/nar/gkn624; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Gu J, 2006, MAMM GENOME, V17, P1033, DOI 10.1007/s00335-006-0007-9; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Hofacker IL, 2004, BIOINFORMATICS, V20, P186, DOI 10.1093/bioinformatics/btg388; Houbaviy HB, 2005, RNA, V11, P1245, DOI 10.1261/rna.2890305; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Kim YK, 2007, EMBO J, V26, P775, DOI 10.1038/sj.emboj.7601512; KLAMUT HJ, 1989, BRIT MED BULL, V45, P681, DOI 10.1093/oxfordjournals.bmb.a072352; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kuhn RM, 2009, NUCLEIC ACIDS RES, V37, pD755, DOI 10.1093/nar/gkn875; Lal A, 2009, NAT STRUCT MOL BIOL, V16, P492, DOI 10.1038/nsmb.1589; Laneve P, 2007, P NATL ACAD SCI USA, V104, P7957, DOI 10.1073/pnas.0700071104; Legendre M, 2006, PLOS COMPUT BIOL, V2, P333, DOI 10.1371/journal.pcbi.0020043; Li SC, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-164; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Martick M, 2008, NATURE, V454, P899, DOI 10.1038/nature07117; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; McDaneld TG, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-77; Molnar A, 2007, NATURE, V447, P1126, DOI 10.1038/nature05903; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Nakajima N, 2006, BIOCHEM BIOPH RES CO, V350, P1006, DOI 10.1016/j.bbrc.2006.09.153; Nguyen HT, 2006, CURR OPIN GENET DEV, V16, P533, DOI 10.1016/j.gde.2006.08.010; NUDEL U, 1988, NATURE, V331, P635, DOI 10.1038/331635a0; O'Toole AS, 2006, NUCLEIC ACIDS RES, V34, P3338, DOI 10.1093/nar/gkl428; Pawlicki JM, 2009, CELL CYCLE, V8, P345, DOI 10.4161/cc.8.3.7494; Pornprasertsuk S, 2004, J BONE MINER RES, V19, P1349, DOI 10.1359/JBMR.040323; Rao PK, 2006, P NATL ACAD SCI USA, V103, P8721, DOI 10.1073/pnas.0602831103; Rogler CE, 2009, HEPATOLOGY, V50, P575, DOI 10.1002/hep.22982; Rosenberg MI, 2006, J CELL BIOL, V175, P77, DOI 10.1083/jcb.200603039; Salo AM, 2006, MATRIX BIOL, V25, P475, DOI 10.1016/j.matbio.2006.08.260; Sewer A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-267; Sironi M, 2002, FEBS LETT, V517, P163, DOI 10.1016/S0014-5793(02)02613-3; Sokol NS, 2005, GENE DEV, V19, P2343, DOI 10.1101/gad.1356105; Song L, 2007, P NATL ACAD SCI USA, V104, P5437, DOI 10.1073/pnas.0701061104; Sun Q, 2008, NUCLEIC ACIDS RES, V36, P2690, DOI 10.1093/nar/gkn032; Sweetman D, 2008, DEV BIOL, V321, P491, DOI 10.1016/j.ydbio.2008.06.019; Sweetman D, 2006, DEV DYNAM, V235, P2185, DOI 10.1002/dvdy.20881; Tanzer A, 2004, J MOL BIOL, V339, P327, DOI 10.1016/j.jmb.2004.03.065; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Washietl S, 2005, NAT BIOTECHNOL, V23, P1383, DOI 10.1038/nbt1144; Washietl S, 2005, P NATL ACAD SCI USA, V102, P2454, DOI 10.1073/pnas.0409169102; Washietl S, 2007, GENOME RES, V17, P852, DOI 10.1101/gr.5650707; Wong CF, 2008, J BIOL CHEM, V283, P9836, DOI 10.1074/jbc.M709614200; Xiong HP, 2009, BIOCHEM BIOPH RES CO, V378, P883, DOI 10.1016/j.bbrc.2008.12.010; Xu CQ, 2007, J CELL SCI, V120, P3045, DOI 10.1242/jcs.010728; Yeom KH, 2006, NUCLEIC ACIDS RES, V34, P4622, DOI 10.1093/nar/gkl458; Zhang BH, 2005, CELL RES, V15, P336, DOI 10.1038/sj.cr.7290302; Zohn IE, 2001, DEV BIOL, V239, P118, DOI 10.1006/dbio.2001.0420	69	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e20561	10.1371/journal.pone.0020561	http://dx.doi.org/10.1371/journal.pone.0020561			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698286	Green Published, Green Accepted, gold			2022-12-27	WOS:000291730000015
J	Zheng, YQ; Brady, OA; Meng, PS; Mao, YX; Hu, FH				Zheng, Yanqiu; Brady, Owen A.; Meng, Peter S.; Mao, Yuxin; Hu, Fenghua			C-Terminus of Progranulin Interacts with the Beta-Propeller Region of Sortilin to Regulate Progranulin Trafficking	PLOS ONE			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; GROWTH-FACTOR PROGRANULIN; MOTOR-NEURONS; DEMENTIA; TUMORIGENESIS; MUTATIONS; MICE	Progranulin haplo-insufficiency is a main cause of frontotemporal lobar degeneration (FTLD) with TDP-43 aggregates. Previous studies have shown that sortilin regulates progranulin trafficking and is a main determinant of progranulin level in the brain. In this study, we mapped the binding site between progranulin and sortilin. Progranulin binds to the beta-propeller region of sortilin through its C-terminal tail. The C-terminal progranulin fragment is fully sufficient for sortilin binding and progranulin C-terminal peptide displaces progranulin binding to sortilin. Deletion of the last 3 residues of progranulin (QLL) abolishes its binding to sortilin and also sortilin dependent regulation of progranulin trafficking. Since progranulin haplo-insufficiency results in FTLD, these results may provide important insights into future studies of progranulin trafficking and signaling and progranulin based therapy for FTLD.	[Zheng, Yanqiu; Brady, Owen A.; Meng, Peter S.; Mao, Yuxin; Hu, Fenghua] Cornell Univ, Weill Inst Cell & Mol Biol, Dept Mol Biol & Genet, Ithaca, NY 14850 USA	Cornell University	Zheng, YQ (corresponding author), Cornell Univ, Weill Inst Cell & Mol Biol, Dept Mol Biol & Genet, Ithaca, NY 14850 USA.	fh87@cornell.edu		Mao, Yuxin/0000-0002-5064-1397	Weill Institute for Cell and Molecular Biology; Rosalinde and Arthur Gilbert Foundation/AFAR; BMCB, NIH [5 T32 GM07273]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007273] Funding Source: NIH RePORTER	Weill Institute for Cell and Molecular Biology; Rosalinde and Arthur Gilbert Foundation/AFAR; BMCB, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funding to FH from the Weill Institute for Cell and Molecular Biology and from the Rosalinde and Arthur Gilbert Foundation/AFAR New Investigator Award in Alzheimer's Disease. OAB was supported by BMCB training grant (5 T32 GM07273 - NIH Predoctoral Training in Cellular and Molecular Biology). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen OS, 2010, J BIOL CHEM, V285, P12210, DOI 10.1074/jbc.M109.062364; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Bateman A, 1998, J ENDOCRINOL, V158, P145, DOI 10.1677/joe.0.1580145; Carrasquillo MM, 2010, AM J HUM GENET, V87, P890, DOI 10.1016/j.ajhg.2010.11.002; CASHMAN NR, 1992, DEV DYNAM, V194, P209, DOI 10.1002/aja.1001940306; Chen-Plotkin AS, 2010, ACTA NEUROPATHOL, V119, P111, DOI 10.1007/s00401-009-0576-2; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Gass J, 2006, HUM MOL GENET, V15, P2988, DOI 10.1093/hmg/ddl241; He ZH, 2003, J MOL MED-JMM, V81, P600, DOI 10.1007/s00109-003-0474-3; Hermey G, 2009, CELL MOL LIFE SCI, V66, P2677, DOI 10.1007/s00018-009-0043-1; Hu FH, 2010, NEURON, V68, P654, DOI 10.1016/j.neuron.2010.09.034; Jansen P, 2007, NAT NEUROSCI, V10, P1449, DOI 10.1038/nn2000; Laird AS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013368; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Neary D, 2005, LANCET NEUROL, V4, P771, DOI 10.1016/S1474-4422(05)70223-4; Pereson S, 2009, J PATHOL, V219, P173, DOI 10.1002/path.2580; Ratnavalli E, 2002, NEUROLOGY, V58, P1615, DOI 10.1212/WNL.58.11.1615; Ryan CL, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-130; Serrero G, 2003, BIOCHEM BIOPH RES CO, V308, P409, DOI 10.1016/S0006-291X(03)01452-9; Tang W, 2011, SCIENCE, V332, P478, DOI 10.1126/science.1199214; Vancha AR, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-23; Yin FF, 2010, FASEB J, V24, P4639, DOI 10.1096/fj.10-161471; Yin FF, 2010, J EXP MED, V207, P117, DOI 10.1084/jem.20091568	23	71	77	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e21023	10.1371/journal.pone.0021023	http://dx.doi.org/10.1371/journal.pone.0021023			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698296	gold, Green Published, Green Submitted			2022-12-27	WOS:000291730000040
J	Thorsell, AG; Lee, WH; Persson, C; Siponen, MI; Nilsson, M; Busam, RD; Kotenyova, T; Schuler, H; Lehtio, L				Thorsell, Ann-Gerd; Lee, Wen Hwa; Persson, Camilla; Siponen, Marina I.; Nilsson, Martina; Busam, Robert D.; Kotenyova, Tetyana; Schuler, Herwig; Lehtio, Lari			Comparative Structural Analysis of Lipid Binding START Domains	PLOS ONE			English	Article							ACUTE REGULATORY PROTEIN; CHOLESTEROL BINDING; GENE ENCODES; MECHANISM; MUTATIONS; ALIGNMENT; GEOMETRY; COMPLEX; TOOLS	Background: Steroidogenic acute regulatory (StAR) protein related lipid transfer (START) domains are small globular modules that form a cavity where lipids and lipid hormones bind. These domains can transport ligands to facilitate lipid exchange between biological membranes, and they have been postulated to modulate the activity of other domains of the protein in response to ligand binding. More than a dozen human genes encode START domains, and several of them are implicated in a disease. Principal Findings: We report crystal structures of the human STARD1, STARD5, STARD13 and STARD14 lipid transfer domains. These represent four of the six functional classes of START domains. Significance: Sequence alignments based on these and previously reported crystal structures define the structural determinants of human START domains, both those related to structural framework and those involved in ligand specificity.	[Thorsell, Ann-Gerd; Persson, Camilla; Siponen, Marina I.; Nilsson, Martina; Busam, Robert D.; Kotenyova, Tetyana; Schuler, Herwig; Lehtio, Lari] Karolinska Inst, Dept Med Biochem & Biophys, Struct Genom Consortium, Stockholm, Sweden; [Lee, Wen Hwa] Univ Oxford, Struct Genom Consortium, Oxford, England; [Lehtio, Lari] Abo Akad Univ, Dept Biosci, Turku, Finland	Karolinska Institutet; University of Oxford; Abo Akademi University	Thorsell, AG (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Struct Genom Consortium, Stockholm, Sweden.	herwig.schuler@ki.se; lari.lehtio@abo.fi	Lee, Wen Hwa/G-1250-2013; Schuler, Herwig/E-5751-2011; Lee, Wen Hwa/GZA-8183-2022	Lee, Wen Hwa/0000-0002-4098-5225; Schuler, Herwig/0000-0003-4059-3501; Lee, Wen Hwa/0000-0002-4098-5225; Lehtio, Lari/0000-0001-7250-832X	Canadian Institutes for Health Research; Canadian Foundation for Innovation; Genome Canada through the Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co., Inc.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust; Academy of Finland [128322]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Genome Canada through the Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co., Inc.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission); Academy of Finland(Academy of Finland)	The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research and the Wellcome Trust. LL was also supported by the Academy of Finland Grant 128322. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alpy F, 2005, J CELL SCI, V118, P2791, DOI 10.1242/jcs.02485; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barros MH, 2005, J BIOL CHEM, V280, P42627, DOI 10.1074/jbc.M510768200; Bens S, 2010, J CLIN ENDOCR METAB, V95, P1301, DOI 10.1210/jc.2009-1176; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Bose HS, 2008, BIOCHEMISTRY-US, V47, P2277, DOI 10.1021/bi701966a; Bose HS, 2000, J CLIN ENDOCR METAB, V85, P3636, DOI 10.1210/jc.85.10.3636; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Horibata Y, 2010, J BIOL CHEM, V285, P7358, DOI 10.1074/jbc.M109.056960; Ishikawa K, 1998, DNA Res, V5, P169, DOI 10.1093/dnares/5.3.169; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Keegan RM, 2008, ACTA CRYSTALLOGR D, V64, P119, DOI 10.1107/S0907444907037195; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kudo N, 2008, P NATL ACAD SCI USA, V105, P488, DOI 10.1073/pnas.0709191105; Kudo N, 2010, J MOL BIOL, V396, P245, DOI 10.1016/j.jmb.2009.12.029; Lavigne P, 2010, SUBCELL BIOCHEM, V51, P425, DOI 10.1007/978-90-481-8622-8_15; Lehtonen JV, 2004, J COMPUT AID MOL DES, V18, P401, DOI 10.1007/s10822-004-3752-4; Liang J, 1998, PROTEIN SCI, V7, P1884, DOI 10.1002/pro.5560070905; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murcia M, 2006, J LIPID RES, V47, P2614, DOI 10.1194/jlr.M600232-JLR200; Olayioye MA, 2005, J BIOL CHEM, V280, P27436, DOI 10.1074/jbc.M413330200; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Ponting CP, 1999, TRENDS BIOCHEM SCI, V24, P130, DOI 10.1016/S0968-0004(99)01362-6; Roderick SL, 2002, NAT STRUCT BIOL, V9, P507, DOI 10.1038/nsb812; Rodriguez-Agudo D, 2005, J LIPID RES, V46, P1615, DOI 10.1194/jlr.M400501-JLR200; Romanowski MJ, 2002, P NATL ACAD SCI USA, V99, P6949, DOI 10.1073/pnas.052140699; Roostaee A, 2008, BIOCHEM J, V412, P553, DOI 10.1042/BJ20071264; Roostaee A, 2009, BIOSCIENCE REP, V29, P89, DOI 10.1042/BSR20080111; Shatsky M, 2004, NUCLEIC ACIDS RES, V32, pW503, DOI 10.1093/nar/gkh413; Shatsky M, 2004, PROTEINS, V56, P143, DOI 10.1002/prot.10628; Soccio RE, 2003, J BIOL CHEM, V278, P22183, DOI 10.1074/jbc.R300003200; Soccio RE, 2002, P NATL ACAD SCI USA, V99, P6943, DOI 10.1073/pnas.052143799; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Suematsu N, 2001, EUR J BIOCHEM, V268, P2700, DOI 10.1046/j.1432-1327.2001.02162.x; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Tsujishita Y, 2000, NAT STRUCT BIOL, V7, P408; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; WIRTZ KWA, 1991, ANNU REV BIOCHEM, V60, P73, DOI 10.1146/annurev.biochem.60.1.73	43	92	96	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e19521	10.1371/journal.pone.0019521	http://dx.doi.org/10.1371/journal.pone.0019521			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738568	Green Published, Green Submitted, gold			2022-12-27	WOS:000292291800001
J	Rothe, F; Ignatiadis, M; Chaboteaux, C; Haibe-Kains, B; Kheddoumi, N; Majjaj, S; Badran, B; Fayyad-Kazan, H; Desmedt, C; Harris, AL; Piccart, M; Sotiriou, C				Rothe, Francoise; Ignatiadis, Michail; Chaboteaux, Carole; Haibe-Kains, Benjamin; Kheddoumi, Naima; Majjaj, Samira; Badran, Bassam; Fayyad-Kazan, Hussein; Desmedt, Christine; Harris, Adrian L.; Piccart, Martine; Sotiriou, Christos			Global MicroRNA Expression Profiling Identifies MiR-210 Associated with Tumor Proliferation, Invasion and Poor Clinical Outcome in Breast Cancer	PLOS ONE			English	Article							SIGNATURE; PROGNOSIS; SURVIVAL; HYPOXIA; TARGETS; MIRNA	Purpose: Aberrant microRNA (miRNA) expression is associated with cancer and has potential diagnostic and prognostic value in various malignancies. In this study, we investigated miRNA profiling as a complementary tool to improve our understanding of breast cancer (BC) biology and to assess whether miRNA expression could predict clinical outcome of BC patients. Experimental Design: Global miRNA expression profiling using microarray technology was conducted in 56 systemically untreated BC patients who had corresponding mRNA expression profiles available. Results were further confirmed using qRT-PCR in an independent dataset of 89 ER-positive BC patients homogeneously treated with tamoxifen only. MiR-210 functional analyses were performed in MCF7 and MDA-MB-231 BC cell lines using lentiviral transduction. Results: Estrogen receptor (ER) status, tumor grade and our previously developed gene expression grade index (GGI) were associated with distinct miRNA profiles. Several miRNAs were found to be clinically relevant, including miR-210, its expression being associated with tumor proliferation and differentiation. Furthermore, miR-210 was associated with poor clinical outcome in ER-positive, tamoxifen-treated BC patients. Interestingly, the prognostic performance of miR-210 was similar to several reported multi-gene signatures, highlighting its important role in BC differentiation and tumor progression. Functional analyses in BC cell lines revealed that miR-210 is involved in cell proliferation, migration and invasion. Conclusions: This integrated analysis combining miRNA and mRNA expression demonstrates that miRNA expression provides additional biological information beyond mRNA expression. Expression of miR-210 is linked to tumor proliferation and appears to be a strong potential biomarker of clinical outcome in BC.	[Rothe, Francoise; Ignatiadis, Michail; Chaboteaux, Carole; Kheddoumi, Naima; Majjaj, Samira; Desmedt, Christine; Piccart, Martine; Sotiriou, Christos] Univ Libre Bruxelles, Inst Jules Bordet, Translat Res Unit, Brussels, Belgium; [Haibe-Kains, Benjamin] Harvard Univ, Sch Publ Hlth, Dana Farber Canc Inst, Boston, MA 02115 USA; [Badran, Bassam; Fayyad-Kazan, Hussein] Univ Libre Bruxelles, Inst Jules Bordet, Lab Expt Hematol, Brussels, Belgium; [Harris, Adrian L.] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Canc Res UK Mol Oncol Labs, Oxford OX3 9DU, England	Institut Jules Bordet; Universite Libre de Bruxelles; Harvard University; Dana-Farber Cancer Institute; Harvard T.H. Chan School of Public Health; Institut Jules Bordet; Universite Libre de Bruxelles; University of Oxford	Rothe, F (corresponding author), Univ Libre Bruxelles, Inst Jules Bordet, Translat Res Unit, Brussels, Belgium.	christos.sotiriou@bordet.be	Desmedt, Christine/P-7438-2017; Harris, Adrian L/ABA-3343-2020; Haibe-Kains, Benjamin/D-3702-2011	Desmedt, Christine/0000-0002-5223-5579; Harris, Adrian L/0000-0003-1376-8409; Haibe-Kains, Benjamin/0000-0002-7684-0079; Fayyad-Kazan, Hussein/0000-0002-3465-4630	Belgian National Foundation for Cancer Research, FNRS; Breast Cancer Research Foundation; Brussels Region; MEDIC Foundation	Belgian National Foundation for Cancer Research, FNRS(Fonds de la Recherche Scientifique - FNRS); Breast Cancer Research Foundation; Brussels Region; MEDIC Foundation	This work was supported by the Belgian National Foundation for Cancer Research, FNRS (CS); by The Breast Cancer Research Foundation (FR, CS); the Brussels Region (CD) and by the MEDIC Foundation (FR, CS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; Blower PE, 2007, MOL CANCER THER, V6, P1483, DOI 10.1158/1535-7163.MCT-07-0009; Burdette JE, 2007, ENDOCR-RELAT CANCER, V14, P679, DOI 10.1677/ERC-07-0054; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Camps C, 2008, CLIN CANCER RES, V14, P1340, DOI 10.1158/1078-0432.CCR-07-1755; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; COX DR, 1972, J R STAT SOC B, V34, P187; Desmedt C, 2008, CLIN CANCER RES, V14, P5158, DOI 10.1158/1078-0432.CCR-07-4756; Giannakakis A, 2008, CANCER BIOL THER, V7, P255, DOI 10.4161/cbt.7.2.5297; Grelier G, 2009, BRIT J CANCER, V101, P673, DOI 10.1038/sj.bjc.6605193; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Heagerty PJ, 2000, BIOMETRICS, V56, P337, DOI 10.1111/j.0006-341X.2000.00337.x; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Janssen EAM, 2010, MODERN PATHOL, V23, P1567, DOI 10.1038/modpathol.2010.177; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Kumar R, 2006, MOL CANCER RES, V4, P655, DOI 10.1158/1541-7786.MCR-05-0249; Loi S, 2007, J CLIN ONCOL, V25, P1239, DOI 10.1200/JCO.2006.07.1522; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Rouas R, 2009, EUR J IMMUNOL, V39, P1608, DOI 10.1002/eji.200838509; Shell S, 2007, P NATL ACAD SCI USA, V104, P11400, DOI 10.1073/pnas.0704372104; Sotiriou C, 2003, P NATL ACAD SCI USA, V100, P10393, DOI 10.1073/pnas.1732912100; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Sotiriou C, 2007, NAT REV CANCER, V7, P545, DOI 10.1038/nrc2173; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Teschendorff AE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r157; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Van der Auwera I, 2010, BRIT J CANCER, V103, P532, DOI 10.1038/sj.bjc.6605787; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wirapati P, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2124; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025	39	179	186	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e20980	10.1371/journal.pone.0020980	http://dx.doi.org/10.1371/journal.pone.0020980			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21738599	Green Published, gold, Green Submitted			2022-12-27	WOS:000292290100011
J	Vasireddy, V; Chavali, VRM; Joseph, VT; Kadam, R; Lin, JH; Jamison, JA; Kompella, UB; Reddy, GB; Ayyagari, R				Vasireddy, Vidyullatha; Chavali, Venkata R. M.; Joseph, Victory T.; Kadam, Rajendra; Lin, Jonathan H.; Jamison, Jeffrey A.; Kompella, Uday B.; Reddy, Geereddy Bhanuprakash; Ayyagari, Radha			Rescue of Photoreceptor Degeneration by Curcumin in Transgenic Rats with P23H Rhodopsin Mutation	PLOS ONE			English	Article							DOMINANT RETINITIS-PIGMENTOSA; XENOPUS-LAEVIS MODEL; IN-VIVO; ENDOPLASMIC-RETICULUM; RETINAL DEGENERATION; MUTANT RHODOPSIN; GENE-THERAPY; CARDIOVASCULAR-DISEASE; TEMPORAL EXPRESSION; PROTEIN AGGREGATION	The P23H mutation in the rhodopsin gene causes rhodopsin misfolding, altered trafficking and formation of insoluble aggregates leading to photoreceptor degeneration and autosomal dominant retinitis pigmentosa (RP). There are no effective therapies to treat this condition. Compounds that enhance dissociation of protein aggregates may be of value in developing new treatments for such diseases. Anti-protein aggregating activity of curcumin has been reported earlier. In this study we present that treatment of COS-7 cells expressing mutant rhodopsin with curcumin results in dissociation of mutant protein aggregates and decreases endoplasmic reticulum stress. Furthermore we demonstrate that administration of curcumin to P23H-rhodopsin transgenic rats improves retinal morphology, physiology, gene expression and localization of rhodopsin. Our findings indicate that supplementation of curcumin improves retinal structure and function in P23H-rhodopsin transgenic rats. This data also suggest that curcumin may serve as a potential therapeutic agent in treating RP due to the P23H rhodopsin mutation and perhaps other degenerative diseases caused by protein trafficking defects.	[Vasireddy, Vidyullatha; Chavali, Venkata R. M.; Ayyagari, Radha] Univ Calif San Diego, Dept Ophthalmol, Jacobs Retina Ctr, La Jolla, CA 92093 USA; [Joseph, Victory T.; Lin, Jonathan H.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Kadam, Rajendra; Kompella, Uday B.] Univ Colorado Denver, Dept Pharmaceut Sci, Aurora, CO USA; [Jamison, Jeffrey A.] Opthy DS Inc, Mattawan, MI USA; [Reddy, Geereddy Bhanuprakash] Natl Inst Nutr, Hyderabad 500007, Andhra Pradesh, India	University of California System; University of California San Diego; University of California System; University of California San Diego; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Indian Council of Medical Research (ICMR); ICMR - National Institute of Nutrition (NIN)	Vasireddy, V (corresponding author), Univ Calif San Diego, Dept Ophthalmol, Jacobs Retina Ctr, La Jolla, CA 92093 USA.	rayyagari@ucsd.edu	Jamison, Jeffrey/Q-3152-2019; Reddy, G Bhanuprakash/AAJ-3494-2020	Reddy, G Bhanuprakash/0000-0003-4787-3944; Lin, Jonathan/0000-0002-7438-6941	NIH [NIH-EY018313, NIH-EY13198, NIH-EY017533, EY020361]; Research to Prevent Blindness Inc., USA; Indian Counsel of Medical Research, Department of Biotechnology and Department of Science and Technology, Government of India; NATIONAL EYE INSTITUTE [K08EY018313, R01EY017533, R01EY020846, RC1EY020361, R01EY013198] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness Inc., USA(Research to Prevent Blindness (RPB)); Indian Counsel of Medical Research, Department of Biotechnology and Department of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaDepartment of Science & Technology (India)Indian Council of Medical Research (ICMR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by grants to JHL from NIH-EY018313; RA from NIH-EY13198; Research to Prevent Blindness Inc., USA (RA), NIH-EY017533 and EY020361 (UBK), and Indian Counsel of Medical Research, Department of Biotechnology and Department of Science and Technology, Government of India (BRG). Dr. Jamison is employed by the company Ophthy-DS Inc. In the current manuscript, Dr. Jamison performed the recording of physiological changes of the retina by electroretinography (ERG). The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acland GM, 2001, NAT GENET, V28, P92, DOI 10.1038/88327; Adlerz L, 2003, MOL BRAIN RES, V119, P62, DOI 10.1016/j.molbrainres.2003.08.014; Aggarwal BB, 2003, ANTICANCER RES, V23, P363; Aggarwal BB, 2009, INT J BIOCHEM CELL B, V41, P40, DOI 10.1016/j.biocel.2008.06.010; Awasthi S, 1996, AM J CLIN NUTR, V64, P761, DOI 10.1093/ajcn/64.5.761; Bhattacharya U, 2009, CANCER SCI, V100, P1971, DOI 10.1111/j.1349-7006.2009.01251.x; Chapple JP, 2003, J BIOL CHEM, V278, P19087, DOI 10.1074/jbc.M212349200; Cheng AL, 2001, ANTICANCER RES, V21, P2895; COGAN D G, 1950, Trans Am Acad Ophthalmol Otolaryngol, V54, P629; Dejneka NS, 2001, BIOESSAYS, V23, P662, DOI 10.1002/bies.1092; Dohadwala MM, 2009, J NUTR, V139, p1788S, DOI 10.3945/jn.109.107474; DRYJA TP, 1990, NATURE, V343, P364, DOI 10.1038/343364a0; DRYJA TP, 1995, P NATL ACAD SCI USA, V92, P10177, DOI 10.1073/pnas.92.22.10177; DRYJA TP, 1990, NEW ENGL J MED, V323, P1302, DOI 10.1056/NEJM199011083231903; Egan ME, 2004, SCIENCE, V304, P600, DOI 10.1126/science.1093941; Garcia-Alloza M, 2007, J NEUROCHEM, V102, P1095, DOI 10.1111/j.1471-4159.2007.04613.x; Goel A, 2008, MOL NUTR FOOD RES, V52, P1010, DOI 10.1002/mnfr.200700354; Goel A, 2008, BIOCHEM PHARMACOL, V75, P787, DOI 10.1016/j.bcp.2007.08.016; Gorbatyuk M, 2007, VISION RES, V47, P1202, DOI 10.1016/j.visres.2006.11.026; Gorbatyuk M, 2007, EXP EYE RES, V84, P44, DOI 10.1016/j.exer.2006.08.014; GOTO Y, 1995, INVEST OPHTH VIS SCI, V36, P62; Hakimuddin F, 2008, NUTR RES, V28, P702, DOI 10.1016/j.nutres.2008.06.009; Harper CE, 2009, PROSTATE, V69, P1668, DOI 10.1002/pros.21017; Hatcher H, 2008, CELL MOL LIFE SCI, V65, P1631, DOI 10.1007/s00018-008-7452-4; Hauswirth WW, 2000, CLIN CHEM LAB MED, V38, P147, DOI 10.1515/CCLM.2000.022; Ignatova Z, 2006, P NATL ACAD SCI USA, V103, P13357, DOI 10.1073/pnas.0603772103; Jiang J, 2007, EUR J PHARMACOL, V561, P54, DOI 10.1016/j.ejphar.2006.12.028; Jurenka JS, 2009, ALTERN MED REV, V14, P141; KAUSHAL S, 1994, BIOCHEMISTRY-US, V33, P6121, DOI 10.1021/bi00186a011; Khajavi M, 2005, AM J HUM GENET, V77, P841, DOI 10.1086/497541; Khajavi M, 2007, AM J HUM GENET, V81, P438, DOI 10.1086/519926; Koenekoop RK, 2008, OPHTHALMIC GENET, V29, P89, DOI 10.1080/13816810802216480; Lal B, 1999, PHYTOTHER RES, V13, P318, DOI 10.1002/(SICI)1099-1573(199906)13:4&lt;318::AID-PTR445&gt;3.0.CO;2-7; LaVail MM, 2000, P NATL ACAD SCI USA, V97, P11488, DOI 10.1073/pnas.210319397; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; MacDonald IM, 2004, BRIT J OPHTHALMOL, V88, P305, DOI 10.1136/bjo.2003.024299; Machida S, 2000, INVEST OPHTH VIS SCI, V41, P3200; Malhotra JD, 2008, P NATL ACAD SCI USA, V105, P18525, DOI 10.1073/pnas.0809677105; Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727; Mandal MNA, 2006, INVEST OPHTH VIS SCI, V47, P5505, DOI 10.1167/iovs.06-0312; Mandal MNA, 2006, INVEST OPHTH VIS SCI, V47, P5514, DOI 10.1167/iovs.06-0449; Mandal MNA, 2009, FREE RADICAL BIO MED, V46, P672, DOI 10.1016/j.freeradbiomed.2008.12.006; Mandal MNA, 2004, GENOMICS, V83, P626, DOI 10.1016/j.ygeno.2003.09.020; Mendes HF, 2005, TRENDS MOL MED, V11, P177, DOI 10.1016/j.molmed.2005.02.007; Mendes HF, 2008, HUM MOL GENET, V17, P3043, DOI 10.1093/hmg/ddn202; Noorwez SM, 2009, J BIOL CHEM, V284, P33333, DOI 10.1074/jbc.M109.043364; OLSSON JE, 1992, NEURON, V9, P815, DOI 10.1016/0896-6273(92)90236-7; Pandya U, 2000, TOXICOL LETT, V115, P195, DOI 10.1016/S0378-4274(00)00191-0; Perez-Jimenez J, 2008, NUTR RES REV, V21, P158, DOI 10.1017/S0954422408125124; Pullakhandam R, 2009, ARCH BIOCHEM BIOPHYS, V485, P115, DOI 10.1016/j.abb.2009.02.013; Rajan RS, 2005, J BIOL CHEM, V280, P1284, DOI 10.1074/jbc.M406448200; Rajan RS, 2001, P NATL ACAD SCI USA, V98, P13060, DOI 10.1073/pnas.181479798; Reddy GB, 2009, INVEST OPHTH VIS SCI, V50, P3456, DOI 10.1167/iovs.08-2498; Rivolta C, 2002, HUM MOL GENET, V11, P1219, DOI 10.1093/hmg/11.10.1219; Rochet Jean-Christophe, 2007, Expert Reviews in Molecular Medicine, V9, DOI 10.1017/S1462399407000385; Romier B, 2009, NUTR REV, V67, P363, DOI 10.1111/j.1753-4887.2009.00210.x; ROOF DJ, 1994, INVEST OPHTH VIS SCI, V35, P4049; Rossi L, 2008, NEUROCHEM RES, V33, P2390, DOI 10.1007/s11064-008-9696-7; Roy P, 2009, CANCER BIOL THER, V8, P1281, DOI 10.4161/cbt.8.13.8728; Saliba RS, 2002, J CELL SCI, V115, P2907; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P6481, DOI 10.1073/pnas.88.15.6481; Suryanarayana P, 2005, INVEST OPHTH VIS SCI, V46, P2092, DOI 10.1167/iovs.04-1304; Tam BM, 2007, J NEUROSCI, V27, P9043, DOI 10.1523/JNEUROSCI.2245-07.2007; Tam BM, 2006, INVEST OPHTH VIS SCI, V47, P3234, DOI 10.1167/iovs.06-0213; Vasireddy V, 2006, INVEST OPHTH VIS SCI, V47, P4558, DOI 10.1167/iovs.06-0353; Vasireddy V, 2009, EXP EYE RES, V89, P905, DOI 10.1016/j.exer.2009.07.021; Verhoeff F H, 1930, Trans Am Ophthalmol Soc, V28, P176; WELEBER RG, 1991, WESTERN J MED, V155, P423; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200; Zhang R, 2008, EXP EYE RES, V86, P612, DOI 10.1016/j.exer.2008.01.005; ZHAO BL, 1989, CELL BIOPHYS, V14, P175, DOI 10.1007/BF02797132; Zunino SJ, 2009, J NUTR, V139, P1603, DOI 10.3945/jn.109.105064; RETINA INT	73	66	68	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21193	10.1371/journal.pone.0021193	http://dx.doi.org/10.1371/journal.pone.0021193			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21738619	gold, Green Published, Green Submitted			2022-12-27	WOS:000292290100015
J	Sarmady, M; Dampier, W; Tozeren, A				Sarmady, Mahdi; Dampier, William; Tozeren, Aydin			Sequence- and Interactome-Based Prediction of Viral Protein Hotspots Targeting Host Proteins: A Case Study for HIV Nef	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; LINEAR MOTIFS; INTERACTION SITES; SH3 DOMAINS; EPITOPES; DYNAMICS; STRATEGIES; DISCOVERY; INFECTION; INSIGHTS	Virus proteins alter protein pathways of the host toward the synthesis of viral particles by breaking and making edges via binding to host proteins. In this study, we developed a computational approach to predict viral sequence hotspots for binding to host proteins based on sequences of viral and host proteins and literature-curated virus-host protein interactome data. We use a motif discovery algorithm repeatedly on collections of sequences of viral proteins and immediate binding partners of their host targets and choose only those motifs that are conserved on viral sequences and highly statistically enriched among binding partners of virus protein targeted host proteins. Our results match experimental data on binding sites of Nef to host proteins such as MAPK1, VAV1, LCK, HCK, HLA-A, CD4, FYN, and GNB2L1 with high statistical significance but is a poor predictor of Nef binding sites on highly flexible, hoop-like regions. Predicted hotspots recapture CD8 cell epitopes of HIV Nef highlighting their importance in modulating virus-host interactions. Host proteins potentially targeted or outcompeted by Nef appear crowding the T cell receptor, natural killer cell mediated cytotoxicity, and neurotrophin signaling pathways. Scanning of HIV Nef motifs on multiple alignments of hepatitis C protein NS5A produces results consistent with literature, indicating the potential value of the hotspot discovery in advancing our understanding of virus-host crosstalk.	[Sarmady, Mahdi; Dampier, William; Tozeren, Aydin] Drexel Univ, Ctr Integrated Bioinformat, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA	Drexel University	Sarmady, M (corresponding author), Drexel Univ, Ctr Integrated Bioinformat, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA.	aydin.tozeren@drexel.edu	Sarmady/M-9859-2019	Sarmady/0000-0001-6069-804X	GSK; Drexel University	GSK(GlaxoSmithKline); Drexel University	The study was partially supported by the GSK-Drexel University Bioinformatics Collaboration grant funded by GSK and the Drexel University Calhoun Endowment fellowships to Mahdi Sarmady and Will N. Dampier. Neither GSK nor Calhoun endowment had any role in the design and implementation of the study.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arhel N, 2010, BBA-MOL BASIS DIS, V1802, P313, DOI 10.1016/j.bbadis.2009.12.003; Arold ST, 2001, TRENDS BIOCHEM SCI, V26, P356, DOI 10.1016/S0968-0004(01)01846-1; Balakrishnan Sivaraman, 2009, BMC Genomics, V10 Suppl 3, pS30, DOI 10.1186/1471-2164-10-S3-S30; Betzi S, 2007, P NATL ACAD SCI USA, V104, P19256, DOI 10.1073/pnas.0707130104; Bushman FD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000437; Chatr-aryamontri A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-S2-S5; Choppin J, 2001, J IMMUNOL, V166, P6164, DOI 10.4049/jimmunol.166.10.6164; CLARK JWM, 2009, HIV DRUG RESISTANCE; Coleman S H, 2001, Expert Opin Ther Targets, V5, P1, DOI 10.1517/14728222.5.1.1; Currier JR, 2006, BMC IMMUNOL, V7, DOI 10.1186/1471-2172-7-8; Davey NE, 2007, NUCLEIC ACIDS RES, V35, pW455, DOI 10.1093/nar/gkm400; Davis FP, 2007, PROTEIN SCI, V16, P2585, DOI 10.1110/ps.073228407; DAWANY NB, 2010, INT J CANC; de Chassey B, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.66; Dickerson JE, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-80; Diella F, 2008, FRONT BIOSCI-LANDMRK, V13, P6580, DOI 10.2741/3175; Dyer MD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040032; Edwards RJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000967; Evans P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008942; Evans P, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-27; Foster JL, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-84; Fu W, 2009, NUCLEIC ACIDS RES, V37, pD417, DOI 10.1093/nar/gkn708; Geyer M, 2001, FEBS LETT, V496, P91, DOI 10.1016/S0014-5793(01)02394-8; Gould CM, 2010, NUCLEIC ACIDS RES, V38, pD167, DOI 10.1093/nar/gkp1016; Greenway A, 1996, J VIROL, V70, P6701, DOI 10.1128/JVI.70.10.6701-6708.1996; Greenway AL, 2002, J VIROL, V76, P2692, DOI 10.1128/JVI.76.6.2692-2702.2002; Grzesiek S, 1997, PROTEIN SCI, V6, P1248, DOI 10.1002/pro.5560060613; Haffar O, 2005, J VIROL, V79, P13028, DOI 10.1128/JVI.79.20.13028-13036.2005; Henschel A, 2006, BIOINFORMATICS, V22, P550, DOI 10.1093/bioinformatics/bti782; Hiipakka M, 1999, J MOL BIOL, V293, P1097, DOI 10.1006/jmbi.1999.3225; HOPKINS BSJ, 1954, ANN BOT-LONDON, V18, P15; Kadaveru K, 2008, FRONT BIOSCI, V13, P6455, DOI 10.2741/3166; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Li HQ, 2006, BIOINFORMATICS, V22, P989, DOI 10.1093/bioinformatics/btl020; Li PL, 2005, VIROLOGY, V331, P367, DOI 10.1016/j.virol.2004.11.004; MacPherson JI, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000863; Mangasarian A, 1997, IMMUNITY, V6, P67, DOI 10.1016/S1074-7613(00)80243-5; MASUZAKI R, 2010, PROS DIG LIVER DI S3, V42, pS281; Matsubara M, 2005, PROTEIN SCI, V14, P494, DOI 10.1110/ps.04969605; McClune AC, 2010, CLIN LIVER DIS, V14, P461, DOI 10.1016/j.cld.2010.05.009; Mosca R, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000490; Neduva V, 2006, NUCLEIC ACIDS RES, V34, pW350, DOI 10.1093/nar/gkl159; Ofran Y, 2007, PLOS COMPUT BIOL, V3, P1169, DOI 10.1371/journal.pcbi.0030119; Ofran Y, 2007, BIOINFORMATICS, V23, pE13, DOI 10.1093/bioinformatics/btl303; Park CY, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001009; Park IW, 2009, J LEUKOCYTE BIOL, V86, P1171, DOI 10.1189/jlb.0409261; Petsalaki E, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000335; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; Racape J, 2006, P NATL ACAD SCI USA, V103, P18208, DOI 10.1073/pnas.0609029103; Richter SN, 2009, CURR MED CHEM, V16, P267, DOI 10.2174/092986709787002646; SAKSELA K, 1995, EMBO J, V14, P484, DOI 10.1002/j.1460-2075.1995.tb07024.x; Schaefer MR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000131; Schmid BV, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-184; Smith RJ, 2010, SCIENCE, V327, P697, DOI 10.1126/science.1180556; Stein A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000789; Tastan O, 2009, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2009, P516; TOZEREN A, 1987, BIOPHYS J, V52, P901, DOI 10.1016/S0006-3495(87)83284-8; Trible RP, 2006, J BIOL CHEM, V281, P27029, DOI 10.1074/jbc.M601128200; van Dijk D, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-96; Van Doorslaer K, 2010, ADV VIRUS RES, V77, P41, DOI 10.1016/S0065-3527(10)77002-0; Via A, 2000, CELL MOL LIFE SCI, V57, P1970, DOI 10.1007/PL00000677	64	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e20735	10.1371/journal.pone.0020735	http://dx.doi.org/10.1371/journal.pone.0020735			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738584	Green Published, Green Submitted, gold			2022-12-27	WOS:000292142800003
J	Benziger, A; Philip, S; Raghavan, R; Ali, PHA; Sukumaran, M; Tharian, JC; Dahanukar, N; Baby, F; Peter, R; Devi, KR; Radhakrishnan, KV; Haniffa, MA; Britz, R; Antunes, A				Benziger, Allen; Philip, Siby; Raghavan, Rajeev; Ali, Palakkaparambil Hamsa Anvar; Sukumaran, Mithun; Tharian, Josin C.; Dahanukar, Neelesh; Baby, Fibin; Peter, Reynold; Devi, Karunakaran Rema; Radhakrishnan, Kizhakke Veetil; Haniffa, Mohamed AbdulKather; Britz, Ralf; Antunes, Agostinho			Unraveling a 146 Years Old Taxonomic Puzzle: Validation of Malabar Snakehead, Species-Status and Its Relevance for Channid Systematics and Evolution	PLOS ONE			English	Article							MOLECULAR PHYLOGENETICS; SEQUENCE ALIGNMENT; FISHES; EOCENE; PERCIFORMES; PATTERN; MODEL; TREE	Background: The Malabar snakehead Channa diplogramma is one of the most enigmatic and least understood species within the family Channidae, which comprise one of the most important groups of freshwater food fish in tropical Asia. Since its description from peninsular India in 1865, it has remained a taxonomic puzzle with many researchers questioning its validity, based on its striking similarity with the South East Asian C. micropeltes. In this study, we assessed the identity of the Malabar snakehead, C. diplogramma, using morphological and molecular genetic analyses, and also evaluated its phylogenetic relationships and evolutionary biogeography. Methodology/Principal Findings: The morphometric and meristic analysis provided conclusive evidence to separate C. diplogramma and C. micropeltes as two distinct species. Number of caudal fin rays, lateral line scales, scales below lateral line; total vertebrae, pre-anal length and body depth were the most prominent characters that can be used to differentiate both the species. Channa diplogramma also shows several ontogenic color phases during its life history, which is shared with C. micropeltes. Finally, the genetic distance between both species for the partial mitochondrial 16S rRNA and COI sequences is also well above the intra-specific genetic distances of any other channid species compared in this study. Conclusions/Significance: The current distribution of C. diplogramma and C. micropeltes is best explained by vicariance. The significant variation in the key taxonomic characters and the results of the molecular marker analysis points towards an allopatric speciation event or vicariant divergence from a common ancestor, which molecular data suggests to have occurred as early as 21.76 million years ago. The resurrection of C. diplogramma from the synonymy of C. micropeltes has hence been confirmed 146 years after its initial description and 134 years after it was synonymised, establishing it is an endemic species of peninsular India and prioritizing its conservation value.	[Benziger, Allen] Fatima Mata Natl Coll, Dept Zool, Kollam, Kerala, India; [Benziger, Allen; Haniffa, Mohamed AbdulKather] St Xaviers Coll, Ctr Aquaculture Res & Extens, Palayankottai, Tamil Nadu, India; [Philip, Siby; Antunes, Agostinho] Univ Porto, CIMAR CIIMAR, Ctr Interdisciplinar Invest Marinha & Ambiental, P-4100 Oporto, Portugal; [Philip, Siby] Univ Porto, Dept Biol, Fac Ciencias, P-4100 Oporto, Portugal; [Philip, Siby; Raghavan, Rajeev; Ali, Palakkaparambil Hamsa Anvar; Tharian, Josin C.; Baby, Fibin] St Alberts Coll, Conservat Res Grp, Kochi, Kerala, India; [Raghavan, Rajeev] Univ Kent, Durrell Inst Conservat & Ecol, Sch Anthropol & Conservat, Canterbury, Kent, England; [Raghavan, Rajeev] Concert Ecol & Appl Technol, Kochi, Kerala, India; [Sukumaran, Mithun] Univ Malaysia Terengganu, Inst Trop Aquaculture, Kuala Terengganu, Malaysia; [Tharian, Josin C.] St Johns Coll, Dept Zool & Environm Sci, Anchal, Kerala, India; [Dahanukar, Neelesh] Indian Inst Sci Educ & Res, Pune, Maharashtra, India; [Peter, Reynold] Cent Marine Fisheries Res Inst, Marine Biotechnol Div, Kochi, Kerala, India; [Devi, Karunakaran Rema] So Reg Ctr, Zool Survey India, Chennai, Tamil Nadu, India; [Radhakrishnan, Kizhakke Veetil] S China Normal Univ, Sch Life Sci, Ichthyol Lab, Guangzhou, Guangdong, Peoples R China; [Britz, Ralf] Nat Hist Museum, Dept Zool, London SW7 5BD, England	Universidade do Porto; Universidade do Porto; St. Albert's College; University of Kent; Universiti Malaysia Terengganu; Indian Institute of Science Education & Research (IISER) Pune; Indian Council of Agricultural Research (ICAR); ICAR - Central Marine Fisheries Research Institute; Zoological survey of India; South China Normal University; Natural History Museum London	Benziger, A (corresponding author), Fatima Mata Natl Coll, Dept Zool, Kollam, Kerala, India.	aantunes@ciimar.up.pt	Raghavan, Rajeev/G-6430-2010; Raghavan, Rajeev P/D-4895-2011; Dahanukar, Neelesh/B-2816-2012; Raghavan, Rajeev/ABD-8719-2021	Dahanukar, Neelesh/0000-0001-7162-9023; Sukumaran, Mithun/0000-0003-1193-6931; Antunes, Agostinho/0000-0002-1328-1732	Portuguese Foundation for Science and Technology [SFRH/BD/47938/2008]; Critical Ecosystem Partnership Fund; Ashoka Trust for Research in Ecology and Environment; North of England Zoological Society-Chester Zoo (United Kingdom); Columbus Zoo-Ohio (United States of America); Endangered Species International (California, United States of America);  [PTDC/BIA-BDE/69144/2006];  [FCOMP-01-0124-FEDER-007065];  [PTDC/AAC-AMB/104983/2008]	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); Critical Ecosystem Partnership Fund; Ashoka Trust for Research in Ecology and Environment; North of England Zoological Society-Chester Zoo (United Kingdom); Columbus Zoo-Ohio (United States of America); Endangered Species International (California, United States of America); ; ; 	The Portuguese Foundation for Science and Technology is acknowledged for the funding of Siby Philip's Ph.D. grant SFRH/BD/47938/2008 and the project PTDC/BIA-BDE/69144/2006 (FCOMP-01-0124-FEDER-007065) and PTDC/AAC-AMB/104983/2008. Field work in Western Ghats was supported by grants from Critical Ecosystem Partnership Fund and Ashoka Trust for Research in Ecology and Environment; North of England Zoological Society-Chester Zoo (United Kingdom); Columbus Zoo-Ohio (United States of America) and Endangered Species International (California, United States of America) to Rajeev Raghavan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson EAS, 2010, THESIS QUEENSLAND U; Adamson EAS, 2010, MOL PHYLOGENET EVOL, V56, P707, DOI 10.1016/j.ympev.2010.03.027; [Anonymous], 2007, FRESHWATER FISH DIST; Benton MJ, 2003, SCIENCE, V300, P1698, DOI 10.1126/science.1077795; Braasch I, 2009, GENOME BIOL EVOL, V1, P479, DOI 10.1093/gbe/evp050; BRIGGS JC, 2003, BIOGEOGRAPHIC TECTON; CHAUDHRY S, 2009, IUCN 2010 IUCN RED; CHAUDHRY S, 2010, IUCN 2010 IUCN RED L; Courtenay WR, 2004, SNAKEHEADS PISCES CH; Cuvier G., 1831, HIST NATURELLE POISS, V7; Day F., 1878, P553; Day F., 1865, Proceedings of the Zoological Society, P2; DAY F, 1865, P ZOOL SOC LOND, P286; Day F., 1865, BERNARD QUARITCH, DOI DOI 10.5962/BHL.TITLE.5549; Ebanasar J., 2005, J INLAND FISHERIES S, V37, P60; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Endler JA, 2005, EVOLUTION, V59, P1795, DOI 10.1111/j.0014-3820.2005.tb01827.x; Eschmeyer W.N., CATALOG FISHES ELECT; Froese R., 2014, FISHBASE; Gam L.-H., 2006, MALAYS J BIOCH MOL B, V14, P25; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Grady JM, 1999, CONSERV BIOL, V13, P1004, DOI 10.1046/j.1523-1739.1999.98572.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Haniffa M.A., 2010, FISHING CHIMES, V30, P34; Hora S. L., 1949, P NATL I SCI INDIA, V15, P309; Jayaram K.C., 1981, P1; Jhingran A.G., 1991, INLAND FISHES INDIA, V1; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; JOHNSINGH AJT, 2006, FIELD DAYS NATURALIS; Klaus S, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-287; Kottelat Maurice, 1998, Ichthyological Exploration of Freshwaters, V9, P1; Kumazawa Y, 2000, MOL BIOL EVOL, V17, P1869, DOI 10.1093/oxfordjournals.molbev.a026288; Kumazawa Y, 1999, BIOL BIODIVERSITY, P35; Kurup B.M., 2004, P LARS2 2 LARGE RIVE, P163; Leveque C, 2008, HYDROBIOLOGIA, V595, P545, DOI 10.1007/s10750-007-9034-0; Li X, 2006, ICHTHYOL RES, V53, P148, DOI 10.1007/s10228-005-0321-3; McMillan WO, 1999, EVOLUTION, V53, P247, DOI 10.1111/j.1558-5646.1999.tb05350.x; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MOLUR S, 2001, CONSERVATION ASSESSM; Murray AM, 2008, J VERTEBR PALEONTOL, V28, P41, DOI 10.1671/0272-4634(2008)28[41:EAFFPW]2.0.CO;2; Murray AM, 2006, J PALEONTOL, V80, P1172, DOI 10.1666/0022-3360(2006)80[1172:ANCTCF]2.0.CO;2; Musikasinthorn P, 2001, ICHTHYOL RES, V48, P319, DOI 10.1007/s10228-001-8153-2; *NBFGR, 2009, THREAT FRESHW FISH I; Palumbi S, 1991, SIMPLE FOOLS GUIDE P; Pethiyagoda Rohan, 1994, Journal of South Asian Natural History, V1, P97; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; RAGHAVAN R, 2010, LEONARD SONNENSCHEIN, P169; Rainboth W.J., 1996, FAO SPECIES IDENTIFI; Randall JE, 1998, ZOOL STUD, V37, P227; Roberts T. R., 1989, MEMOIRS CALIFORNIA A, V14, P1; ROE L J, 1991, Contributions from the Museum of Paleontology University of Michigan, V28, P93; Ruber L, 2006, SYST BIOL, V55, P374, DOI 10.1080/10635150500541664; Sanderson MJ, 1997, MOL BIOL EVOL, V14, P1218, DOI 10.1093/oxfordjournals.molbev.a025731; SINH LX, 2010, FARMING SNAKEHEAD FI; Smith E. P., 2002, BIPLOT 1 1 EXCEL ADD; Smith WL, 2006, J HERED, V97, P206, DOI 10.1093/jhered/esj034; Swartz ER, 2008, S AFR J SCI, V104, P293; Tamura K, 2002, MOL BIOL EVOL, V19, P1727, DOI 10.1093/oxfordjournals.molbev.a003995; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; UNNITHAN VK, 2000, NBFGR NATP PUBLICATI, V1, P69; VANSTEENIS CGGJ, 1979, BOT J LINN SOC, V79, P97, DOI 10.1111/j.1095-8339.1979.tb01511.x; Vishwanath W., 2009, Journal of Threatened Taxa, V1, P97; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; WEBER M, 1922, FISHES INDOAUSTRLIAN, V4; Wee K.L., 1982, RECENT ADV AQUACULTU, P181; WEST RM, 1980, J PALEONTOL, V54, P508	68	34	39	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21272	10.1371/journal.pone.0021272	http://dx.doi.org/10.1371/journal.pone.0021272			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21731689	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000292036900019
J	Griener, TP; Strecker, JG; Humphries, RM; Mulvey, GL; Fuentealba, C; Hancock, REW; Armstrong, GD				Griener, Thomas P.; Strecker, Jonathan G.; Humphries, Romney M.; Mulvey, George L.; Fuentealba, Carmen; Hancock, Robert E. W.; Armstrong, Glen D.			Lipopolysaccharide Renders Transgenic Mice Expressing Human Serum Amyloid P Component Sensitive to Shiga Toxin 2	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; THROMBOTIC THROMBOCYTOPENIC PURPURA; MONOCYTE CHEMOATTRACTANT PROTEIN-1; O157-H7 HEMORRHAGIC COLITIS; NECROSIS-FACTOR-ALPHA; ESCHERICHIA-COLI; MOUSE MODEL; BINDING-PROTEIN; IN-VIVO; CIRCULATING LEVELS	Transgenic C57BL/6 mice expressing human serum amyloid P component (HuSAP) are resistant to Shiga toxin 2 (Stx2) at dosages that are lethal in HuSAP-negative wild-type mice. However, it is well established that Stx2 initiates extra-intestinal complications such as the haemolytic-uremic syndrome despite the presence of HuSAP in human sera. We now demonstrate that co-administering purified Escherichia coli O55 lipopolysaccharide (LPS), at a dosage of 300 ng/g body weight, to HuSAP-transgenic mice increases their susceptibility to the lethal effects of Stx2. The enhanced susceptibility to Stx2 correlated with an increased expression of genes encoding the pro-inflammatory cytokine TNF alpha and chemokines of the CXC and CC families in the kidneys of LPS-treated mice, 48 hours after the Stx2/LPS challenge. Co-administering the glucocorticoid dexamethasone, but not the LPS neutralizing cationic peptide LL-37, protected LPS-sensitized HuSAP-transgenic mice from lethal doses of Stx2. Dexamethasone protection was specifically associated with decreased expression of the same inflammatory mediators (CXC and CC-type chemokines and TNF alpha) linked to enhanced susceptibility caused by LPS. The studies reveal further details about the complex cascade of host-related events that are initiated by Stx2 as well as establish a new animal model system in which to investigate strategies for diminishing serious Stx2-mediated complications in humans infected with enterohemorrhagic E. coli strains.	[Griener, Thomas P.; Strecker, Jonathan G.; Humphries, Romney M.; Mulvey, George L.; Armstrong, Glen D.] Univ Calgary, Fac Med, Dept Microbiol Immunol & Infect Dis, Calgary, AB, Canada; [Fuentealba, Carmen] Univ Calgary, Fac Vet Med, Calgary, AB, Canada; [Hancock, Robert E. W.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V5Z 1M9, Canada; [Humphries, Romney M.] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90024 USA	University of Calgary; University of Calgary; University of British Columbia; University of California System; University of California Los Angeles	Griener, TP (corresponding author), Univ Calgary, Fac Med, Dept Microbiol Immunol & Infect Dis, Calgary, AB, Canada.	glen.armstrong@ucalgary.ca	Hancock, Robert E. W./E-1145-2013	Hancock, Robert E. W./0000-0001-5989-8503	Alberta Ingenuity Fund; NSERC Canada	Alberta Ingenuity Fund; NSERC Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work is supported by a grant from the Alberta Ingenuity Fund (http://www.albertaingenuity.ca/). TPG and RMH were the recipients of NSERC Canada Graduate Scholarships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong GD, 2006, J INFECT DIS, V193, P1120, DOI 10.1086/501472; ARMSTRONG GD, 2009, 7 INT S SHIG TOX VER; BARRETT TJ, 1989, INFECT IMMUN, V57, P3434, DOI 10.1128/IAI.57.11.3434-3437.1989; Bickerstaff MCM, 1999, NAT MED, V5, P694, DOI 10.1038/9544; BITZAN M, 1993, INFECTION, V21, P140, DOI 10.1007/BF01710530; Boerlin P, 1999, J CLIN MICROBIOL, V37, P497, DOI 10.1128/JCM.37.3.497-503.1999; CHART H, 1989, J CLIN MICROBIOL, V27, P285, DOI 10.1128/JCM.27.2.285-290.1989; CHART H, 1989, J CLIN PATHOL, V42, P973, DOI 10.1136/jcp.42.9.973; de Haas CJC, 1999, INFECT IMMUN, V67, P2790, DOI 10.1128/IAI.67.6.2790-2796.1999; de Haas CJC, 1998, J IMMUNOL, V161, P3607; de Haas CJC, 1999, FEMS IMMUNOL MED MIC, V26, P197, DOI 10.1016/S0928-8244(99)00148-0; EMSLEY J, 1994, NATURE, V367, P338, DOI 10.1038/367338a0; FITZPATRICK MM, 1992, KIDNEY INT, V42, P951, DOI 10.1038/ki.1992.372; Fukumoto K, 2005, PEDIATR SURG INT, V21, P20, DOI 10.1007/s00383-004-1256-x; Gomez SA, 2005, CLIN EXP IMMUNOL, V139, P65, DOI 10.1111/j.1365-2249.2005.02659.x; Gomez SA, 2003, CLIN EXP IMMUNOL, V131, P217, DOI 10.1046/j.1365-2249.2003.02057.x; Griener TP, 2007, J MED MICROBIOL, V56, P1423, DOI 10.1099/jmm.0.47282-0; HAREL Y, 1993, J CLIN INVEST, V92, P2110, DOI 10.1172/JCI116811; Ikeda M, 2004, PEDIATR NEPHROL, V19, P485, DOI 10.1007/s00467-003-1395-7; Inward CD, 1997, PEDIATR NEPHROL, V11, P556, DOI 10.1007/s004670050337; Inward CD, 1997, ARCH DIS CHILD, V77, P145, DOI 10.1136/adc.77.2.145; Kamitsuji H, 2000, CLIN NEPHROL, V53, P319; Karpman D, 1995, PEDIATR NEPHROL, V9, P694, DOI 10.1007/BF00868714; Keepers TR, 2007, INFECT IMMUN, V75, P1229, DOI 10.1128/IAI.01663-06; Keepers TR, 2006, J AM SOC NEPHROL, V17, P3404, DOI 10.1681/ASN.2006050419; Kimura T, 2001, J BIOL CHEM, V276, P41576, DOI 10.1074/jbc.M107819200; KOSTER F, 1978, NEW ENGL J MED, V298, P927, DOI 10.1056/NEJM197804272981702; Lentz EK, 2010, INFECT IMMUN, V78, P3689, DOI 10.1128/IAI.00616-10; Litalien C, 1999, PEDIATR NEPHROL, V13, P840, DOI 10.1007/s004670050712; Marcato P, 2003, INFECT IMMUN, V71, P6075, DOI 10.1128/IAI.71.10.6075-6078.2003; Mookherjee N, 2006, J IMMUNOL, V176, P2455, DOI 10.4049/jimmunol.176.4.2455; Nestoridi E, 2008, PEDIATR NEPHROL, V23, P221, DOI 10.1007/s00467-007-0636-6; Orth D, 2007, DIAGN MICR INFEC DIS, V59, P235, DOI 10.1016/j.diagmicrobio.2007.04.013; Palermo M, 2000, CLIN EXP IMMUNOL, V119, P77, DOI 10.1046/j.1365-2249.2000.01103.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Proulx F, 1999, CLIN DIAGN LAB IMMUN, V6, P773, DOI 10.1128/CDLI.6.5.773-773.1999; Proulx F, 1998, PEDIATR INFECT DIS J, V17, P899, DOI 10.1097/00006454-199810000-00010; Proulx F, 2002, PEDIATR RES, V52, P928, DOI 10.1203/01.PDR.0000034233.75228.0B; Psotka MA, 2009, INFECT IMMUN, V77, P959, DOI 10.1128/IAI.00679-08; Roche JK, 2007, AM J PATHOL, V170, P526, DOI 10.2353/ajpath.2007.060366; Rojnuckarin P, 2006, J THROMB HAEMOST, V4, P1148, DOI 10.1111/j.1538-7836.2006.01879.x; Rose Ellen, 2005, J Dtsch Dermatol Ges, V3, P200, DOI 10.1111/j.1610-0378.2005.04747.x; Sauter KAD, 2008, INFECT IMMUN, V76, P4469, DOI 10.1128/IAI.00592-08; Scott MG, 2000, J IMMUNOL, V164, P549, DOI 10.4049/jimmunol.164.2.549; Scott MG, 2002, J IMMUNOL, V169, P3883, DOI 10.4049/jimmunol.169.7.3883; Stahl AL, 2006, BLOOD, V108, P167, DOI 10.1182/blood-2005-08-3219; Stahl AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006990; Sugatani J, 2000, THROMB RES, V100, P61, DOI 10.1016/S0049-3848(00)00305-4; Suzuki K, 2000, J MED MICROBIOL, V49, P905, DOI 10.1099/0022-1317-49-10-905; Tarr PI, 2005, LANCET, V365, P1073, DOI 10.1016/S0140-6736(05)71144-2; Tsutsumi R, 2004, MICROBIOL IMMUNOL, V48, P27, DOI 10.1111/j.1348-0421.2004.tb03484.x; Valles PG, 2005, MEDICINA-BUENOS AIRE, V65, P395; Van Geet C, 1998, KIDNEY INT, V54, P1324, DOI 10.1046/j.1523-1755.1998.00103.x; Van Setten PA, 1998, PEDIATR RES, V43, P759, DOI 10.1203/00006450-199806000-00008; VANDEKAR NCAJ, 1994, PEDIATR RES, V36, P257, DOI 10.1203/00006450-199408000-00019; VANDEKAR NCAJ, 1995, BLOOD, V85, P734, DOI 10.1182/blood.V85.3.734.bloodjournal853734; vanSetten PA, 1997, KIDNEY INT, V51, P1245, DOI 10.1038/ki.1997.170; VANWIERINGEN PMV, 1976, PEDIATRICS, V58, P561; Wang XX, 2008, LIFE SCI, V83, P671, DOI 10.1016/j.lfs.2008.09.003; Weichhart T, 2010, IMMUNOL LETT, V129, P50, DOI 10.1016/j.imlet.2009.12.025; Westerholt S, 2003, CLIN DIAGN LAB IMMUN, V10, P1090, DOI 10.1128/CDLI.10.6.1090-1095.2003; ZHAO X, 1992, J BIOCHEM-TOKYO, V111, P736, DOI 10.1093/oxfordjournals.jbchem.a123828; Zhu XJ, 2009, J CLIN IMMUNOL, V29, P603, DOI 10.1007/s10875-009-9303-y	63	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21457	10.1371/journal.pone.0021457	http://dx.doi.org/10.1371/journal.pone.0021457			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21731756	Green Submitted, gold, Green Published			2022-12-27	WOS:000292036900033
J	Pennings, JLA; Schuurhof, A; Hodemaekers, HM; Buisman, A; de Rond, LCGH; Widjojoatmodjo, MN; Luytjes, W; Kimpen, JLL; Bont, L; Janssen, R				Pennings, Jeroen L. A.; Schuurhof, Annemieke; Hodemaekers, Hennie M.; Buisman, Annemarie; de Rond, Lia C. G. H.; Widjojoatmodjo, Myra N.; Luytjes, Willem; Kimpen, Jan L. L.; Bont, Louis; Janssen, Riny			Systemic Signature of the Lung Response to Respiratory Syncytial Virus Infection	PLOS ONE			English	Article							GENE-EXPRESSION; HOST-DEFENSE; RIBONUCLEASES; BRONCHIOLITIS; LEUKOCYTES; PROFILES; DISEASE; RISK; MICE	Respiratory Syncytial Virus is a frequent cause of severe bronchiolitis in children. To improve our understanding of systemic host responses to RSV, we compared BALB/c mouse gene expression responses at day 1, 2, and 5 during primary RSV infection in lung, bronchial lymph nodes, and blood. We identified a set of 53 interferon-associated and innate immunity genes that give correlated responses in all three murine tissues. Additionally, we identified blood gene signatures that are indicative of acute infection, secondary immune response, and vaccine-enhanced disease, respectively. Eosinophil-associated ribonucleases were characteristic for the vaccine-enhanced disease blood signature. These results indicate that it may be possible to distinguish protective and unfavorable patient lung responses via blood diagnostics.	[Pennings, Jeroen L. A.; Schuurhof, Annemieke; Hodemaekers, Hennie M.; Janssen, Riny] Natl Inst Publ Hlth & Environm, Lab Hlth Protect Res, NL-3720 BA Bilthoven, Netherlands; [Buisman, Annemarie; de Rond, Lia C. G. H.] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control Netherlands, NL-3720 BA Bilthoven, Netherlands; [Schuurhof, Annemieke; Kimpen, Jan L. L.; Bont, Louis] Univ Med Ctr Utrecht, Dept Pediat, Wilhelmina Childrens Hosp, Utrecht, Netherlands; [Widjojoatmodjo, Myra N.; Luytjes, Willem] Netherlands Vaccine Inst, Bilthoven, Netherlands	Netherlands National Institute for Public Health & the Environment; Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis	Pennings, JLA (corresponding author), Natl Inst Publ Hlth & Environm, Lab Hlth Protect Res, NL-3720 BA Bilthoven, Netherlands.	Jeroen.Pennings@rivm.nl		Pennings, Jeroen L.A./0000-0002-9188-6358				Allantaz F, 2007, J EXP MED, V204, P2131, DOI 10.1084/jem.20070070; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Bloemers BLP, 2007, PEDIATRICS, V120, pE1076, DOI 10.1542/peds.2007-0788; Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012; Dressman HK, 2007, PLOS MED, V4, P690, DOI 10.1371/journal.pmed.0040106; Fjaerli HO, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-175; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Janssen R, 2007, J VIROL, V81, P5958, DOI 10.1128/JVI.02220-06; Janssen R, 2007, J INFECT DIS, V196, P826, DOI 10.1086/520886; Jelier R, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-r96; Katsoulidis E, 2009, J BIOL CHEM, V284, P25051, DOI 10.1074/jbc.M109.030445; Kumar S, 2000, MOL BIOL EVOL, V17, P738, DOI 10.1093/oxfordjournals.molbev.a026352; Lattin Jane E, 2008, Immunome Res, V4, P5, DOI 10.1186/1745-7580-4-5; McNamara PS, 2002, BRIT MED BULL, V61, P13, DOI 10.1093/bmb/61.1.13; Meadows SK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001912; Meissner HC, 2003, PEDIATR INFECT DIS J, V22, pS40, DOI 10.1097/00006454-200302001-00006; Palmer C, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-115; Pennings JLA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002596; Ramilo O, 2007, BLOOD, V109, P2066, DOI 10.1182/blood-2006-02-002477; Rosenberg HF, 2008, J LEUKOCYTE BIOL, V83, P1079, DOI 10.1189/jlb.1107725; Rosenberg HF, 2001, J LEUKOCYTE BIOL, V70, P691; Rubins KH, 2004, P NATL ACAD SCI USA, V101, P15190, DOI 10.1073/pnas.0405759101; Schuurhof A, 2010, J VIROL, V84, P9584, DOI 10.1128/JVI.00302-10; Simoes EAF, 2003, PEDIATR INFECT DIS J, V22, pS13, DOI 10.1097/00006454-200302001-00003; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sui SJH, 2005, NUCLEIC ACIDS RES, V33, P3154, DOI 10.1093/nar/gki624; Thach DC, 2005, GENES IMMUN, V6, P588, DOI 10.1038/sj.gene.6364244; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Zaas AK, 2009, CELL HOST MICROBE, V6, P207, DOI 10.1016/j.chom.2009.07.006	30	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21461	10.1371/journal.pone.0021461	http://dx.doi.org/10.1371/journal.pone.0021461			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21731757	gold, Green Published, Green Submitted			2022-12-27	WOS:000292036900034
J	Shi, CW; Lu, J; Wu, W; Ma, FX; Georges, J; Huang, HJ; Balducci, J; Chang, YC; Huang, Y				Shi, Chunwei; Lu, Jia; Wu, Wen; Ma, Fanxin; Georges, Joseph; Huang, Hanju; Balducci, James; Chang, Yongchang; Huang, Yao			Endothelial Cell-Specific Molecule 2 (ECSM2) Localizes to Cell-Cell Junctions and Modulates bFGF-Directed Cell Migration via the ERK-FAK Pathway	PLOS ONE			English	Article							FOCAL ADHESION KINASE; FIBROBLAST-GROWTH-FACTOR; TYROSINE PHOSPHORYLATION; VASCULAR-PERMEABILITY; BIOLOGICAL RESPONSES; INDUCED ANGIOGENESIS; INTEGRATING SIGNALS; ADHERENS JUNCTIONS; FACTOR RECEPTOR; BETA-CATENIN	Background: Despite its first discovery by in silico cloning of novel endothelial cell-specific genes a decade ago, the biological functions of endothelial cell-specific molecule 2 (ECSM2) have only recently begun to be understood. Limited data suggest its involvement in cell migration and apoptosis. However, the underlying signaling mechanisms and novel functions of ECSM2 remain to be explored. Methodology/Principal Findings: A rabbit anti-ECSM2 monoclonal antibody (RabMAb) was generated and used to characterize the endogenous ECSM2 protein. Immunoblotting, immunoprecipitation, deglycosylation, immunostaining and confocal microscopy validated that endogenous ECSM2 is a plasma membrane glycoprotein preferentially expressed in vascular endothelial cells (ECs). Expression patterns of heterologously expressed and endogenous ECSM2 identified that ECSM2 was particularly concentrated at cell-cell contacts. Cell aggregation and transwell assays showed that ECSM2 promoted cell-cell adhesion and attenuated basic fibroblast growth factor (bFGF)-driven EC migration. Gain or loss of function assays by overexpression or knockdown of ECSM2 in ECs demonstrated that ECSM2 modulated bFGF-directed EC motility via the FGF receptor (FGFR)-extracellular regulated kinase (ERK)-focal adhesion kinase (FAK) pathway. The counterbalance between FAK tyrosine phosphorylation (activation) and ERK-dependent serine phosphorylation of FAK was critically involved. A model of how ECSM2 signals to impact bFGF/FGFR-driven EC migration was proposed. Conclusions/Significance: ECSM2 is likely a novel EC junctional protein. It can promote cell-cell adhesion and inhibit bFGF-mediated cell migration. Mechanistically, ECSM2 attenuates EC motility through the FGFR-ERK-FAK pathway. The findings suggest that ECSM2 could be a key player in coordinating receptor tyrosine kinase (RTK)-, integrin-, and EC junctional component-mediated signaling and may have important implications in disorders related to endothelial dysfunction and impaired EC junction signaling.	[Shi, Chunwei; Lu, Jia; Wu, Wen; Ma, Fanxin; Balducci, James; Huang, Yao] St Josephs Hosp, Dept Obstet & Gynecol, Phoenix, AZ 85013 USA; [Shi, Chunwei; Lu, Jia; Wu, Wen; Ma, Fanxin; Georges, Joseph; Balducci, James; Chang, Yongchang; Huang, Yao] Med Ctr, Phoenix, AZ USA; [Georges, Joseph; Chang, Yongchang] St Josephs Hosp, Barrow Neurol Inst, Phoenix, AZ 85013 USA; [Shi, Chunwei; Lu, Jia; Wu, Wen; Huang, Hanju] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Pathogen Biol, Wuhan 430074, Peoples R China; [Ma, Fanxin] Sichuan Univ, W China Hosp, State Key Lab Biotherapy, Coll Life Sci, Chengdu 610064, Peoples R China	St. Joseph's Hospital and Medical Center; Barrow Neurological Institute; St. Joseph's Hospital and Medical Center; Huazhong University of Science & Technology; Sichuan University	Shi, CW (corresponding author), St Josephs Hosp, Dept Obstet & Gynecol, Phoenix, AZ 85013 USA.	yhuang@chw.edu	Wu, Wen/V-7065-2017		St. Joseph's Foundation; Catholic Healthcare West Intellectual Innovation Network (CHWiin); American Heart Association; China Scholarship Council (CSC); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085237] Funding Source: NIH RePORTER	St. Joseph's Foundation; Catholic Healthcare West Intellectual Innovation Network (CHWiin); American Heart Association(American Heart Association); China Scholarship Council (CSC)(China Scholarship Council); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a St. Joseph's Foundation Startup Fund and a Catholic Healthcare West Intellectual Innovation Network (CHWiin) SEED Fund, and in part by an American Heart Association Award (to Y. Huang). W. Wu was partially supported by a China Scholarship Council (CSC) studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong LJ, 2008, ARTERIOSCL THROM VAS, V28, P1640, DOI 10.1161/ATVBAHA.108.162511; AYALON O, 1994, J CELL BIOL, V126, P247, DOI 10.1083/jcb.126.1.247; Bazzoni G, 2004, PHYSIOL REV, V84, P869, DOI 10.1152/physrev.00035.2003; Brizzi MF, 2001, CIRCULATION, V103, P549, DOI 10.1161/01.CIR.103.4.549; BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751; Brouillet S, 2010, MOL BIOL CELL, V21, P2832, DOI 10.1091/mbc.E10-01-0059; Bryant DM, 2005, MOL BIOL CELL, V16, P14, DOI 10.1091/mbc.E04-09-0845; CALALB MB, 1995, MOL CELL BIOL, V15, P954; Cross MJ, 2001, TRENDS PHARMACOL SCI, V22, P201, DOI 10.1016/S0165-6147(00)01676-X; Dejana E, 2004, NAT REV MOL CELL BIO, V5, P261, DOI 10.1038/nrm1357; Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897; EIDE BL, 1995, MOL CELL BIOL, V15, P2819; Eliceiri BP, 1999, MOL CELL, V4, P915, DOI 10.1016/S1097-2765(00)80221-X; Eliceiri BP, 2002, J CELL BIOL, V157, P149, DOI 10.1083/jcb.200109079; Falk MM, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-34; Folkman J, 1996, CELL, V87, P1153, DOI 10.1016/S0092-8674(00)81810-3; FRIEDLANDER M, 1995, SCIENCE, V270, P1500, DOI 10.1126/science.270.5241.1500; FRIESEL RE, 1995, FASEB J, V9, P919, DOI 10.1096/fasebj.9.10.7542215; Gan Y, 2010, ONCOGENE, V29, P4947, DOI 10.1038/onc.2010.240; Henriksen K, 2003, J BIOL CHEM, V278, P48745, DOI 10.1074/jbc.M309193200; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Huang Y, 2006, ONCOGENE, V25, P7565, DOI 10.1038/sj.onc.1209740; Huang Y, 2004, MOL ENDOCRINOL, V18, P1471, DOI 10.1210/me.2003-0418; Huang Y, 2003, J BIOL CHEM, V278, P18902, DOI 10.1074/jbc.M300939200; Huang ZY, 2003, MOL CELL BIOL, V23, P566, DOI 10.1128/MCB.23.2.566-578.2003; Huminiecki L, 2000, GENOME RES, V10, P1796, DOI 10.1101/gr.150700; Hunger-Glaser I, 2003, J BIOL CHEM, V278, P22631, DOI 10.1074/jbc.M210876200; Hunger-Glaser I, 2004, J CELL PHYSIOL, V200, P213, DOI 10.1002/jcp.20018; Ikeda K, 2009, P NATL ACAD SCI USA, V106, P8227, DOI 10.1073/pnas.0806780106; Javerzat S, 2002, TRENDS MOL MED, V8, P483, DOI 10.1016/S1471-4914(02)02394-8; Jiang XH, 2007, CELL SIGNAL, V19, P1000, DOI 10.1016/j.cellsig.2006.11.004; Joseph-Silverstein J, 1998, CANCER INVEST, V16, P176, DOI 10.3109/07357909809050034; KLINT P, 1999, FRONT BIOSCI, V4, P165; Lampugnani MG, 2006, J CELL BIOL, V174, P593, DOI 10.1083/jcb.200602080; Lampugnani MG, 2003, J CELL BIOL, V161, P793, DOI 10.1083/jcb.200209019; Ma FX, 2009, GENES CELLS, V14, P281, DOI 10.1111/j.1365-2443.2008.01267.x; McKay MM, 2007, ONCOGENE, V26, P3113, DOI 10.1038/sj.onc.1210394; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Odintsova E, 2000, CURR BIOL, V10, P1009, DOI 10.1016/S0960-9822(00)00652-7; Orian-Rousseau V, 2008, ADV CANCER RES, V101, P63, DOI 10.1016/S0065-230X(08)00404-1; Perez-Moreno M, 2006, DEV CELL, V11, P601, DOI 10.1016/j.devcel.2006.10.010; Pintucci G, 2002, FASEB J, V16, P598, DOI 10.1096/fj.01-0815fje; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Rojas AI, 1999, CRIT REV ORAL BIOL M, V10, P337, DOI 10.1177/10454411990100030601; Schaller MD, 2001, BBA-MOL CELL RES, V1540, P1, DOI 10.1016/S0167-4889(01)00123-9; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; Simons M, 2004, MOL CELL BIOCHEM, V264, P99, DOI 10.1023/B:MCBI.0000044379.25823.03; SPIEKERPOLET H, 1995, P NATL ACAD SCI USA, V92, P9348, DOI 10.1073/pnas.92.20.9348; Suyama K, 2002, CANCER CELL, V2, P301, DOI 10.1016/S1535-6108(02)00150-2; Tu YZ, 2001, J CELL BIOL, V153, P585, DOI 10.1083/jcb.153.3.585; Verissimo AR, 2009, BIOCHEM SOC T, V37, P1214, DOI 10.1042/BST0371214; Verma A, 2010, BLOOD, V115, P4614, DOI 10.1182/blood-2009-10-248856; Wallez Y, 2008, BBA-BIOMEMBRANES, V1778, P794, DOI 10.1016/j.bbamem.2007.09.003; Xu WQ, 2007, J CELL SCI, V120, P3337, DOI 10.1242/jcs.013771; Yan W, 2008, MOL BIOL CELL, V19, P2278, DOI 10.1091/mbc.E07-10-1068; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W; Zhao J, 2009, CANCER METAST REV, V28, P35, DOI 10.1007/s10555-008-9165-4; Zheng YH, 2009, MOL CELL, V35, P11, DOI 10.1016/j.molcel.2009.06.013	60	22	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21482	10.1371/journal.pone.0021482	http://dx.doi.org/10.1371/journal.pone.0021482			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21720547	Green Published, gold			2022-12-27	WOS:000292036900039
J	Barrera-Vilarmau, S; Obregon, P; de Alba, E				Barrera-Vilarmau, Susana; Obregon, Patricia; de Alba, Eva			Intrinsic Order and Disorder in the Bcl-2 Member Harakiri: Insights into Its Proapoptotic Activity	PLOS ONE			English	Article							CELL-DEATH; AMINO-ACIDS; PROTEIN; PEPTIDES; BINDING; RECOGNITION; MECHANISM; APOPTOSIS; MICELLES; CHANNEL	Harakiri is a BH3-only member of the Bcl-2 family that localizes in membranes and induces cell death by binding to prosurvival Bcl-x(L) and Bcl-2. The cytosolic domain of Harakiri is largely disorder with residual alpha-helical conformation according to previous structural studies. As these helical structures could play an important role in Harakiri's function, we have used NMR and circular dichroism to fully characterize them at the residue-atomic level. In addition, we report structural studies on a peptide fragment spanning Harakiri's C-terminal hydrophobic sequence, which potentially operates as a transmembrane domain. We initially checked by enzyme immunoassays and NMR that peptides encompassing different lengths of the cytosolic domain are functional as they bind Bcl-x(L) and Bcl-2. The structural data in water indicate that the alpha-helical conformation is restricted to a 25-residue segment comprising the BH3 domain. However, structure calculation was precluded because of insufficient NMR restraints. To bypass this problem we used alcohol-water mixture to increase structure population and confirmed by NMR that the conformation in both milieus is equivalent. The resulting three-dimensional structure closely resembles that of peptides encompassing the BH3 domain of BH3-only members in complex with their prosurvival partners, suggesting that preformed structural elements in the disordered protein are central to binding. In contrast, the transmembrane domain forms in micelles a monomeric a-helix with a population close to 100%. Its three-dimensional structure here reported reveals features that explain its function as membrane anchor. Altogether these results are used to propose a tentative structural model of how Harakiri works.	[Barrera-Vilarmau, Susana; Obregon, Patricia; de Alba, Eva] CSIC, Ctr Invest Biol, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Barrera-Vilarmau, S (corresponding author), CSIC, Ctr Invest Biol, Madrid, Spain.	dealbae@cib.csic.es	Barrera-Vilarmau, Susana/ABD-1039-2020	Barrera-Vilarmau, Susana/0000-0003-4868-6593	European Commission [IRG-046412]; Spanish Ministerio de Ciencia e Innovacion [BFU2008-03278, CSD2009-00088]; Comunidad de Madrid; Agencia CSIC IV PRICIT [CCG08-CSIC/SAL-3777]	European Commission(European CommissionEuropean Commission Joint Research Centre); Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Comunidad de Madrid(Comunidad de Madrid); Agencia CSIC IV PRICIT	This work was supported by the European Commission Marie Curie International Reintegration Grant (IRG-046412 to E.d.A.), by the Spanish Ministerio de Ciencia e Innovacion through the Programa Ramon y Cajal to E.d.A., by Plan Nacional I+D+i (grant BFU2008-03278 to E.d.A.), by Comunidad de Madrid and Agencia CSIC IV PRICIT (grant CCG08-CSIC/SAL-3777 to E.d.A.), and by the Spanish Ministerio de Ciencia e Innovacioen through theConsolider-Ingenio 2010 program (grant CSD2009-00088). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; Bernabeu A, 2007, BBA-BIOMEMBRANES, V1768, P1659, DOI 10.1016/j.bbamem.2007.02.023; Bocharov EV, 2007, J BIOL CHEM, V282, P16256, DOI 10.1074/jbc.M701745200; Bogner C, 2010, CURR OPIN CELL BIOL, V22, P845, DOI 10.1016/j.ceb.2010.08.002; Bruix M, 1997, EUR J BIOCHEM, V243, P384, DOI 10.1111/j.1432-1033.1997.0384a.x; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chou JJ, 1999, CELL, V96, P615, DOI 10.1016/S0092-8674(00)80572-3; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; DAVID CS, 2000, CELL, V103, P839; de Alba E, 2009, J BIOL CHEM, V284, P32932, DOI 10.1074/jbc.M109.024273; deAlba E, 1996, FOLD DES, V1, P133, DOI 10.1016/S1359-0278(96)00022-3; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Feller SE, 1997, BIOPHYS J, V73, P2269, DOI 10.1016/S0006-3495(97)78259-6; GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P; Goddard TD, KNELLER DG SPARKY, V3; Hinds MG, 2007, CELL DEATH DIFFER, V14, P128, DOI 10.1038/sj.cdd.4401934; Horne WS, 2008, ANGEW CHEM INT EDIT, V47, P2853, DOI 10.1002/anie.200705315; Inohara N, 1997, EMBO J, V16, P1686, DOI 10.1093/emboj/16.7.1686; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee EF, 2009, ANGEW CHEM INT EDIT, V48, P4318, DOI 10.1002/anie.200805761; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Li J, 2008, ONCOGENE, V27, P6194, DOI 10.1038/onc.2008.297; Liu Q, 2010, J BIOL CHEM, V285, P19615, DOI 10.1074/jbc.M110.105452; Lomonosova E, 2008, ONCOGENE, V27, pS2, DOI 10.1038/onc.2009.39; MASOTTI L, 1980, CELL BIOPHYS, V2, P241, DOI 10.1007/BF02790452; McDonnell JM, 1999, CELL, V96, P625, DOI 10.1016/S0092-8674(00)80573-5; Myers JK, 1997, BIOCHEMISTRY-US, V36, P10923, DOI 10.1021/bi9707180; NILGES M, 1993, PROTEINS, V17, P297, DOI 10.1002/prot.340170307; OLTVAI ZN, 1994, CELL, V79, P189, DOI 10.1016/0092-8674(94)90188-0; PERVUSHIN KV, 1994, EUR J BIOCHEM, V219, P571, DOI 10.1111/j.1432-1033.1994.tb19973.x; Petros AM, 2000, PROTEIN SCI, V9, P2528, DOI 10.1017/S096183680000331X; Pinheiro AS, 2011, J AM CHEM SOC, V133, P73, DOI 10.1021/ja107810r; Ragusa MJ, 2010, NAT STRUCT MOL BIOL, V17, P459, DOI 10.1038/nsmb.1786; Rath A, 2007, BIOPOLYMERS, V88, P217, DOI 10.1002/bip.20668; Reed JC, 2000, AM J PATHOL, V157, P1415, DOI 10.1016/S0002-9440(10)64779-7; Rohl CA, 1996, PROTEIN SCI, V5, P2623, DOI 10.1002/pro.5560051225; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Sadqi M, 2009, P NATL ACAD SCI USA, V106, P4127, DOI 10.1073/pnas.0812108106; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Sborgi L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015575; Schnell JR, 2008, NATURE, V451, P591, DOI 10.1038/nature06531; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; SPERA S, 1991, J AM CHEM SOC, V113, P5490, DOI 10.1021/ja00014a071; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Tompa P, 2008, TRENDS BIOCHEM SCI, V33, P2, DOI 10.1016/j.tibs.2007.10.003; Uversky VN, 2010, STRUCTURE, V18, P1069, DOI 10.1016/j.str.2010.08.003; Vogler M, 2009, CELL DEATH DIFFER, V16, P360, DOI 10.1038/cdd.2008.137; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Yau WM, 1998, BIOCHEMISTRY-US, V37, P14713, DOI 10.1021/bi980809c	58	16	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21413	10.1371/journal.pone.0021413	http://dx.doi.org/10.1371/journal.pone.0021413			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731739	Green Submitted, Green Published, gold			2022-12-27	WOS:000292035400035
J	Kelly, BL; Singh, G; Aiyar, A				Kelly, Ben L.; Singh, Gyanendra; Aiyar, Ashok			Molecular and Cellular Characterization of an AT-Hook Protein from Leishmania	PLOS ONE			English	Article							ORIGIN RECOGNITION COMPLEX; EPSTEIN-BARR-VIRUS; POSITION-EFFECT VARIEGATION; ARGININE-RICH PEPTIDES; MAJOR LACK ANTIGEN; HISTONE H1; NUCLEAR ANTIGEN-1; HUMAN-CELLS; TRANSCRIPTION ACTIVATION; DEPENDENT RECRUITMENT	AT-rich DNA, and the proteins that bind it (AT-hook proteins), modulate chromosome structure and function in most eukaryotes. Unlike other trypanosomatids, the genome of Leishmania species is unusually GC-rich, and the regulation of Leishmania chromosome structure, replication, partitioning is not fully understood. Because AT-hook proteins modulate these functions in other eukaryotes, we examined whether AT-hook proteins are encoded in the Leishmania genome, to test their potential functions. Several Leishmania ORFs predicted to be AT-hook proteins were identified using in silico approaches based on sequences shared between eukaryotic AT-hook proteins. We have used biochemical, molecular and cellular techniques to characterize the L. amazonensis ortholog of the L. major protein LmjF06.0720, a potential AT-hook protein that is highly conserved in Leishmania species. Using a novel fusion between the AT-hook domain encoded by LmjF06.0720 and a herpesviral protein, we have demonstrated that LmjF06.0720 functions as an AT-hook protein in mammalian cells. Further, as observed for mammalian and viral AT-hook proteins, the AT-hook domains of LmjF06.0720 bind specific regions of condensed mammalian metaphase chromosomes, and support the licensed replication of DNA in mammalian cells. LmjF06.0720 is nuclear in Leishmania, and this localization is disrupted upon exposure to drugs that displace AT-hook proteins from AT-rich DNA. Coincidentally, these drugs dramatically alter the cellular physiology of Leishmania promastigotes. Finally, we have devised a novel peptido-mimetic agent derived from the sequence of LmjF06.0720 that blocks the proliferation of Leishmania promastigotes, and lowers amastigote parasitic burden in infected macrophages. Our results indicate that AT-hook proteins are critical for the normal biology of Leishmania. In addition, we have described a simple technique to examine the function of Leishmania chromatin-binding proteins in a eukaryotic context amenable to studying chromosome structure and function. Lastly, we demonstrate the therapeutic potential of compounds directed against AT-hook proteins in Leishmania.	[Kelly, Ben L.; Aiyar, Ashok] Lousiana State Univ, Hlth Sci Ctr, Dept Microbiol Immunol & Parasitol, New Orleans, LA USA; [Singh, Gyanendra; Aiyar, Ashok] Lousiana State Univ, Hlth Sci Ctr, Stanley S Scott Canc Ctr, New Orleans, LA USA	Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University	Kelly, BL (corresponding author), Lousiana State Univ, Hlth Sci Ctr, Dept Microbiol Immunol & Parasitol, New Orleans, LA USA.	bkell2@lsuhsc.edu; aaiyar@lsuhsc.edu			NIH [AI055172, CA112564]; NATIONAL CANCER INSTITUTE [R01CA112564] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R43AI055172] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the NIH (grant numbers AI055172 and CA112564). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair JE, 2005, J BIOL CHEM, V280, P32184, DOI 10.1074/jbc.M505600200; Aiyar A, 1998, EMBO J, V17, P6394, DOI 10.1093/emboj/17.21.6394; Aiyar A, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-29; AMBINDER RF, 1991, J VIROL, V65, P1466, DOI 10.1128/JVI.65.3.1466-1478.1991; Aras S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000469; Bewley CA, 1998, ANNU REV BIOPH BIOM, V27, P105, DOI 10.1146/annurev.biophys.27.1.105; Blattes R, 2006, EMBO J, V25, P2397, DOI 10.1038/sj.emboj.7601125; Bonnefoy E, 1999, MOL CELL BIOL, V19, P2803; Chuang RY, 1999, P NATL ACAD SCI USA, V96, P2656, DOI 10.1073/pnas.96.6.2656; Cui TJ, 2007, BIOCHEMISTRY-US, V46, P13059, DOI 10.1021/bi701269s; Dement GA, 2005, EXP CELL RES, V307, P388, DOI 10.1016/j.yexcr.2005.04.004; DICKINSON LA, 1995, MOL CELL BIOL, V15, P456, DOI 10.1128/MCB.15.1.456; DISNEY JE, 1989, J CELL BIOL, V109, P1975, DOI 10.1083/jcb.109.5.1975; Dragan AI, 2008, J MOL BIOL, V384, P335, DOI 10.1016/j.jmb.2008.09.015; Duncker BP, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-214; FOSS M, 1993, SCIENCE, V262, P1838, DOI 10.1126/science.8266071; Futaki S, 2001, J BIOL CHEM, V276, P5836, DOI 10.1074/jbc.M007540200; GALLIE DR, 1991, MOL GEN GENET, V228, P258, DOI 10.1007/BF00282474; Girard F, 1998, EMBO J, V17, P2079, DOI 10.1093/emboj/17.7.2079; Giroux M, 2000, J IMMUNOL, V165, P3985, DOI 10.4049/jimmunol.165.7.3985; Hebner C, 2003, VIROLOGY, V311, P263, DOI 10.1016/S0042-6822(03)00122-3; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Huth JR, 1997, NAT STRUCT BIOL, V4, P657, DOI 10.1038/nsb0897-657; Huynh C, 2006, J EXP MED, V203, P2363, DOI 10.1084/jem.20060559; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Janssen S, 2000, MOL CELL, V6, P1013, DOI 10.1016/S1097-2765(00)00100-3; Janssen S, 2000, MOL CELL, V6, P999, DOI 10.1016/S1097-2765(00)00099-X; Joshi PB, 2002, MOL BIOCHEM PARASIT, V120, P33, DOI 10.1016/S0166-6851(01)00432-7; Kar S, 2000, J BIOL CHEM, V275, P37789, DOI 10.1074/jbc.M002149200; Kelly BL, 2004, INFECT IMMUN, V72, P6924, DOI 10.1128/IAI.72.12.6924-6931.2004; Kelly BL, 2003, J EXP MED, V198, P1689, DOI 10.1084/jem.20031162; Kelly BL, 2001, MOL BIOCHEM PARASIT, V116, P101, DOI 10.1016/S0166-6851(01)00307-3; Kim TK, 1997, MOL CELL, V1, P119, DOI 10.1016/S1097-2765(00)80013-1; KIRCHMAIER AL, 1995, J VIROL, V69, P1280, DOI 10.1128/JVI.69.2.1280-1283.1995; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; KRYSAN PJ, 1989, MOL CELL BIOL, V9, P1026, DOI 10.1128/MCB.9.3.1026; Lee JK, 2001, P NATL ACAD SCI USA, V98, P13589, DOI 10.1073/pnas.251530398; LUPTON S, 1985, MOL CELL BIOL, V5, P2533, DOI 10.1128/MCB.5.10.2533; Manabe T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008004; MAREKOV LN, 1978, BIOCHIMIE, V60, P1347; MARKY LA, 1987, P NATL ACAD SCI USA, V84, P4359, DOI 10.1073/pnas.84.13.4359; Martinez-Calvillo S, 2003, MOL CELL, V11, P1291, DOI 10.1016/S1097-2765(03)00143-6; Masina S, 2007, EXP PARASITOL, V116, P83, DOI 10.1016/j.exppara.2006.11.002; MASUKATA H, 1993, MOL BIOL CELL, V4, P1121, DOI 10.1091/mbc.4.11.1121; MICKLEM G, 1993, NATURE, V366, P87, DOI 10.1038/366087a0; Monod C, 2002, EMBO REP, V3, P747, DOI 10.1093/embo-reports/kvf155; Nagpal S, 1999, J BIOL CHEM, V274, P22563, DOI 10.1074/jbc.274.32.22563; Nanbo A, 2007, EMBO J, V26, P4252, DOI 10.1038/sj.emboj.7601853; NGUYEN VT, 1989, J BIOL CHEM, V264, P10487; Noll TM, 1997, MOL BIOCHEM PARASIT, V84, P215, DOI 10.1016/S0166-6851(96)02801-0; Norseen J, 2008, EMBO J, V27, P3024, DOI 10.1038/emboj.2008.221; PEDEN KWC, 1980, SCIENCE, V209, P1392, DOI 10.1126/science.6251547; Puechberty J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-57; Reeves R, 2005, DNA REPAIR, V4, P926, DOI 10.1016/j.dnarep.2005.04.010; Reeves R, 2001, GENE, V277, P63, DOI 10.1016/S0378-1119(01)00689-8; REEVES R, 1990, J BIOL CHEM, V265, P8573; REISMAN D, 1985, MOL CELL BIOL, V5, P1822, DOI 10.1128/MCB.5.8.1822; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; SAITOH Y, 1993, COLD SPRING HARB SYM, V58, P755, DOI 10.1101/SQB.1993.058.01.083; SAITOH Y, 1994, CELL, V76, P609, DOI 10.1016/0092-8674(94)90502-9; Schulze JM, 2010, EPIGENETICS-US, V5, P573, DOI 10.4161/epi.5.7.12856; Schulze JM, 2009, BIOCHEM CELL BIOL, V87, P65, DOI 10.1139/O08-111; Sears J, 2004, J VIROL, V78, P11487, DOI 10.1128/JVI.78.21.11487-11505.2004; Sears J, 2003, J VIROL, V77, P11767, DOI 10.1128/JVI.77.21.11767-11780.2003; Singh G, 2009, J VIROL, V83, P4227, DOI 10.1128/JVI.02578-08; Smirlis D, 2006, MOL MICROBIOL, V60, P1457, DOI 10.1111/j.1365-2958.2006.05205.x; STINCHCOMB DT, 1979, NATURE, V282, P39, DOI 10.1038/282039a0; Strick R, 1995, CELL, V83, P1137, DOI 10.1016/0092-8674(95)90140-X; SUGDEN B, 1988, MOL BIOL MED, V5, P85; Suzuki T, 2002, J BIOL CHEM, V277, P2437, DOI 10.1074/jbc.M110017200; Thomae AW, 2008, P NATL ACAD SCI USA, V105, P1692, DOI 10.1073/pnas.0707260105; Thomas S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-152; THOMPSON JF, 1991, GENE, V103, P171, DOI 10.1016/0378-1119(91)90270-L; Tosato V, 2001, CURR GENET, V40, P186, DOI 10.1007/s002940100246; WARTELL RM, 1974, J BIOL CHEM, V249, P6719; WEGNER M, 1990, BIOCHEM BIOPH RES CO, V166, P1110, DOI 10.1016/0006-291X(90)90981-R; Zhang HY, 2004, MOL CELL BIOL, V24, P9424, DOI 10.1128/MCB.24.21.9424-9436.2004; Zhao J, 2000, J BIOL CHEM, V275, P27494; ZHAO K, 1993, EMBO J, V12, P3237, DOI 10.1002/j.1460-2075.1993.tb05993.x	79	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21412	10.1371/journal.pone.0021412	http://dx.doi.org/10.1371/journal.pone.0021412			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731738	Green Published, gold, Green Submitted			2022-12-27	WOS:000292035400034
J	Zhang, YW; Li, HL; Luo, YL; Shi, X; Tian, JQ; Sun, XP				Zhang, Yingwei; Li, Hailong; Luo, Yonglan; Shi, Xu; Tian, Jingqi; Sun, Xuping			Poly(m-Phenylenediamine) Nanospheres and Nanorods: Selective Synthesis and Their Application for Multiplex Nucleic Acid Detection	PLOS ONE			English	Article							POLYANILINE NANOFIBERS; HYDROGEN-PEROXIDE; SENSING PLATFORM; CARBON NANOTUBES; DNA; REDUCTION; PROBES; POLY(ORTHO-PHENYLENEDIAMINE); ELECTROPOLYMERIZATION; PHENYLENEDIAMINE	In this paper, we demonstrate for the first time that poly(m-phenylenediamine) (PMPD) nanospheres and nanorods can be selectively synthesized via chemical oxidation polymerization of m-phenylenediamine (MPD) monomers using ammonium persulfate (APS) as an oxidant at room temperature. It suggests that the pH value plays a critical role in controlling the the morphology of the nanostructures and fast polymerization rate favors the anisotropic growth of PMPD under homogeneous nucleation condition. We further demonstrate that such PMPD nanostructures can be used as an effective fluorescent sensing platform for multiplex nucleic acid detection. A detection limit as low as 50 pM and a high selectivity down to single-base mismatch could be achieved. The fluorescence quenching is attributed to photoinduced electron transfer from nitrogen atom in PMPD to excited fluorophore. Most importantly, the successful use of this sensing platform in human blood serum system is also demonstrated.	[Zhang, Yingwei; Li, Hailong; Luo, Yonglan; Tian, Jingqi; Sun, Xuping] Changchun Inst Appl Chem, State Key Lab Electroanalyt Chem, Changchun, Jilin, Peoples R China; [Li, Hailong; Tian, Jingqi] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Shi, Xu] Jilin Univ, Affiliated Hosp 1, Inst Virol & AIDS Res, Changchun 130023, Jilin, Peoples R China	Chinese Academy of Sciences; Changchun Institute of Applied Chemistry, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Jilin University	Zhang, YW (corresponding author), Changchun Inst Appl Chem, State Key Lab Electroanalyt Chem, Changchun, Jilin, Peoples R China.	sunxp@ciac.jl.cn	Li, Hailong/H-2527-2018	Li, Hailong/0000-0002-1209-2315; TIAN, Jingqi/0000-0002-3695-7563				Bernard Valeur, 2001, MOL FLUORESCENCE PRI; Brayner R, 2008, NANO TODAY, V3, P48, DOI 10.1016/S1748-0132(08)70015-X; BURR HE, 1982, NUCLEIC ACIDS RES, V10, P719, DOI 10.1093/nar/10.2.719; Cai LT, 1999, SENSOR ACTUAT B-CHEM, V55, P14, DOI 10.1016/S0925-4005(99)00024-6; Cataldo F, 1996, EUR POLYM J, V32, P43, DOI 10.1016/0014-3057(95)00118-2; Dai HP, 1998, J ELECTROANAL CHEM, V456, P47, DOI 10.1016/S0022-0728(98)00211-3; DEMPSEY E, 1993, TALANTA, V40, P445, DOI 10.1016/0039-9140(93)80257-R; DENG Q, 1994, J ELECTROANAL CHEM, V377, P191, DOI 10.1016/0022-0728(94)03465-6; Dubertret B, 2001, NAT BIOTECHNOL, V19, P365, DOI 10.1038/86762; Fan CH, 2003, P NATL ACAD SCI USA, V100, P6297, DOI 10.1073/pnas.1132025100; Forzani ES, 2007, ANAL CHEM, V79, P5217, DOI 10.1021/ac0703202; Gao H, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/28/285203; Gornall DD, 2010, ELECTROANAL, V22, P384, DOI 10.1002/elan.200900392; Gresham D, 2006, SCIENCE, V311, P1932, DOI 10.1126/science.1123726; Han J, 2009, LANGMUIR, V25, P11054, DOI 10.1021/la901373t; He SJ, 2010, ADV FUNCT MATER, V20, P453, DOI 10.1002/adfm.200901639; Huang MR, 2006, CHEM-EUR J, V12, P4341, DOI 10.1002/chem.200501070; HUMMERS WS, 1958, J AM CHEM SOC, V80, P1339, DOI 10.1021/ja01539a017; Li D, 2009, ACCOUNTS CHEM RES, V42, P135, DOI 10.1021/ar800080n; Li D, 2010, ACCOUNTS CHEM RES, V43, P631, DOI 10.1021/ar900245u; Li HL, 2011, SMALL, V7, P1562, DOI 10.1002/smll.201100068; Li HL, 2011, MACROMOL RAPID COMM, V32, P899, DOI 10.1002/marc.201100108; Li HL, 2011, ANAL METHODS-UK, V3, P1051, DOI 10.1039/c0ay00746c; Li HL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018958; Li HL, 2011, J MATER CHEM, V21, P824, DOI 10.1039/c0jm02695f; Li HL, 2011, J MATER CHEM, V21, P4663, DOI 10.1039/c0jm04107f; Li HL, 2011, CHEM COMMUN, V47, P2625, DOI 10.1039/c0cc05394e; Li HL, 2011, CHEM COMMUN, V47, P961, DOI 10.1039/c0cc04326e; Li HX, 2004, ANAL CHEM, V76, P5414, DOI 10.1021/ac049173n; Li XG, 2002, CHEM REV, V102, P2925, DOI 10.1021/cr010423z; Li XG, 2009, LANGMUIR, V25, P1675, DOI 10.1021/la802410p; Li YJ, 1998, ELECTROANAL, V10, P671, DOI 10.1002/(SICI)1521-4109(199808)10:10<671::AID-ELAN671>3.3.CO;2-M; Liu S, 2011, NANOSCALE, V3, P967, DOI 10.1039/c0nr00873g; Liu S, 2011, J MATER CHEM, V21, P339, DOI 10.1039/c0jm03337e; Lu CH, 2009, ANGEW CHEM INT EDIT, V48, P4785, DOI 10.1002/anie.200901479; MALITESTA C, 1990, ANAL CHEM, V62, P2735, DOI 10.1021/ac00223a016; Maxwell DJ, 2002, J AM CHEM SOC, V124, P9606, DOI 10.1021/ja025814p; Ogura K, 1998, J ELECTROCHEM SOC, V145, P3351, DOI 10.1149/1.1838811; OHSAKA T, 1991, J CHEM SOC CHEM COMM, P1072, DOI 10.1039/c39910001072; PREMASIRI AH, 1995, MACROMOL CHEM PHYSIC, V196, P3655, DOI 10.1002/macp.1995.021961118; Ray PC, 2007, PLASMONICS, V2, P173, DOI 10.1007/s11468-007-9036-9; Rosi NL, 2005, CHEM REV, V105, P1547, DOI 10.1021/cr030067f; Song SP, 2009, ANGEW CHEM INT EDIT, V48, P8670, DOI 10.1002/anie.200901887; Stoeva SI, 2006, ANGEW CHEM INT EDIT, V45, P3303, DOI 10.1002/anie.200600124; Sulimenko T, 2001, J COLLOID INTERF SCI, V236, P328, DOI 10.1006/jcis.2000.7415; Sun XP, 2004, CHEM COMMUN, P1182, DOI 10.1039/b401777c; Tian JQ, 2011, ANALYST, V136, P2221, DOI 10.1039/c0an00944j; Tian JQ, 2011, LANGMUIR, V27, P874, DOI 10.1021/la103799e; Tran HD, 2008, MACROMOLECULES, V41, P7405, DOI 10.1021/ma800122d; Tran HD, 2008, ACS NANO, V2, P1841, DOI 10.1021/nn800272z; Trueba M, 2004, ELECTROCHIM ACTA, V49, P4341, DOI 10.1016/j.electacta.2004.03.043; Varghese N, 2009, CHEMPHYSCHEM, V10, P206, DOI 10.1002/cphc.200800459; WAN MX, 1995, J APPL POLYM SCI, V55, P399, DOI 10.1002/app.1995.070550304; Wang L, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1294; Yang RH, 2008, ANAL CHEM, V80, P7408, DOI 10.1021/ac801118p; Yang RH, 2008, J AM CHEM SOC, V130, P8351, DOI 10.1021/ja800604z; Zhang YW, 2011, LANGMUIR, V27, P2170, DOI 10.1021/la105092f	57	29	29	3	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e20569	10.1371/journal.pone.0020569	http://dx.doi.org/10.1371/journal.pone.0020569			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731617	gold, Green Published, Green Submitted			2022-12-27	WOS:000292035400004
J	Vaiman, D; Gascoin-Lachambre, G; Boubred, F; Mondon, F; Feuerstein, JM; Ligi, I; Grandvuillemin, I; Barbaux, S; Ghigo, E; Achard, V; Simeoni, U; Buffat, C				Vaiman, Daniel; Gascoin-Lachambre, Geraldine; Boubred, Farid; Mondon, Francoise; Feuerstein, Jean-Marc; Ligi, Isabelle; Grandvuillemin, Isabelle; Barbaux, Sandrine; Ghigo, Eric; Achard, Vincent; Simeoni, Umberto; Buffat, Christophe			The Intensity of IUGR-Induced Transcriptome Deregulations Is Inversely Correlated with the Onset of Organ Function in a Rat Model	PLOS ONE			English	Article							INTRAUTERINE GROWTH-RETARDATION; IMPRINTING CONTROL REGION; LOW-PROTEIN-DIET; GENE-EXPRESSION; BIRTH-WEIGHT; FETAL-GROWTH; METHYLATION; RESTRICTION; HYPERTENSION; PREGNANCY	A low-protein diet applied during pregnancy in the rat results in intrauterine growth restricted (IUGR) fetuses. In humans, IUGR is associated with increased perinatal morbidity, higher incidence of neuro-developmental defects and increased risk of adult metabolic anomalies, such as diabetes and cardiovascular disease. Development and function of many organs are affected by environmental conditions such as those inducing fetal and early postnatal growth restriction. This phenomenon, termed "fetal programming" has been studied unconnectedly in some organs, but very few studies (if any) have investigated at the same time several organs, on a more comparative basis. However, it is quite probable that IUGR affects differentially most organ systems, with possible persistent changes in gene expression. In this study we address transcriptional alterations induced by IUGR in a multi-organ perspective, by systematic analysis of 20-days rat fetuses. We show that (1) expressional alterations are apparently stronger in organs functioning late in foetal or postnatal life than in organs that are functioning early (2) hierarchical classification of the deregulations put together kidney and placenta in one cluster, liver, lungs and heart in another; (3) the epigenetic machinery is set up especially in the placenta, while its alterations are rather mild in other organs; (4) the genes appear deregulated in chromosome clusters; (5) the altered expression cascades varies from organ to organ, with noticeably a very significant modification of the complement and coagulation cascades in the kidney; (6) we found a significant increase in TF binding site for HNF4 proteins specifically for liver genes that are down-regulated in IUGR, suggesting that this decrease is achieved through the action of HNF transcription factors, that are themselves transcriptionnally induced in the liver by IUGR (x 1.84 fold). Altogether, our study suggests that a combination of tissue-specific mechanisms contributes to bring about tissue-driven modifications of gene cascades. The question of these cascades being activated to adapt the organ to harsh environmental condition, or as an endpoint consequence is still raised.	[Vaiman, Daniel; Gascoin-Lachambre, Geraldine; Mondon, Francoise; Barbaux, Sandrine] Inst Cochin, INSERM, Paris, France; [Vaiman, Daniel; Gascoin-Lachambre, Geraldine; Mondon, Francoise; Barbaux, Sandrine] Univ Paris 05, Paris, France; [Gascoin-Lachambre, Geraldine; Mondon, Francoise; Barbaux, Sandrine] CNRS, UMRS8104, Paris, France; [Boubred, Farid; Feuerstein, Jean-Marc; Ligi, Isabelle; Grandvuillemin, Isabelle; Simeoni, Umberto] Hop Conception, Assistance Publ Hop Marseille, Div Neonatol, Marseille, France; [Feuerstein, Jean-Marc; Ligi, Isabelle; Grandvuillemin, Isabelle; Simeoni, Umberto] Univ Mediterranee, Fac Pharm, INSERM, UMR608, Marseille, France; [Ghigo, Eric; Buffat, Christophe] Univ Mediterranee, CNRS, URMITE, UMR 6236, Marseille, France; [Achard, Vincent] Hop Conception, Assistance Publ Hop Marseille, Reprod Biol Lab, Marseille, France; [Achard, Vincent] Aix Marseille Univ, Fac Med, INSERM, UMR 626, Marseille, France; [Buffat, Christophe] Hop Conception, Assistance Publ Hop Marseille, Mol Biol Lab, Marseille, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Vaiman, D (corresponding author), Inst Cochin, INSERM, Paris, France.	daniel.vaiman@inserm.fr	Barbaux, Sandrine C/B-2878-2019; Simeoni, Umberto/GRO-6971-2022; Vaiman, Daniel/O-6030-2015; Eric, Ghigo/N-9427-2016; SIMEONI, Umberto/AAQ-1870-2021; boubred, farid/D-9831-2014	Barbaux, Sandrine C/0000-0002-8204-1855; Simeoni, Umberto/0000-0003-0730-9337; Vaiman, Daniel/0000-0002-1915-0717; SIMEONI, Umberto/0000-0003-0730-9337; Boubred, Farid/0000-0003-3039-2036	INSERM; Hopitaux de Marseille; Chiesi Farmaceuti S.p.A.	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Hopitaux de Marseille; Chiesi Farmaceuti S.p.A.(Chiesi Pharmaceuticals Inc)	Funding was granted by INSERM and Hopitaux de Marseille, and Chiesi Farmaceuti S.p.A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashworth A, 1998, EUR J CLIN NUTR, V52, pS34; Ashworth A, 1998, EUR J CLIN NUTR S1, V52, pS41; Barker DJP, 2002, TRENDS ENDOCRIN MET, V13, P364, DOI 10.1016/S1043-2760(02)00689-6; Barker DJP, 1998, CLIN SCI, V95, P115, DOI 10.1042/CS19980019; Batista F, 2007, P NATL ACAD SCI USA, V104, P3330, DOI 10.1073/pnas.0611326104; Bonasio R, 2010, SCIENCE, V330, P612, DOI 10.1126/science.1191078; Bourque DK, 2010, PLACENTA, V31, P197, DOI 10.1016/j.placenta.2009.12.003; Buffat C, 2007, J PATHOL, V213, P337, DOI 10.1002/path.2233; Buffat C, 2007, ENDOCRINOLOGY, V148, P5549, DOI 10.1210/en.2007-0765; Ceccarelli V, 2011, MOL CELL BIOCHEM, V347, P29, DOI 10.1007/s11010-010-0609-0; Chelbi ST, 2008, MOL CELL ENDOCRINOL, V282, P120, DOI 10.1016/j.mce.2007.11.022; Chelbi ST, 2007, HYPERTENSION, V49, P76, DOI 10.1161/01.HYP.0000250831.52876.cb; CHELBI ST, 2011, EPIGENETICS IN PRESS; COMBS CA, 1993, OBSTET GYNECOL, V82, P365; Cox SM, 2001, INT J GYNECOL OBSTET, V72, P85; DAHRI S, 1991, DIABETES, V40, P115, DOI 10.2337/diab.40.2.S115; De Souza CT, 2010, J PHYSIOL-LONDON, V588, P2239, DOI 10.1113/jphysiol.2009.183996; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fauque P, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-116; Fauque P, 2010, HUM MOL GENET, V19, P1779, DOI 10.1093/hmg/ddq059; Fernandez-Twinn DS, 2003, BRIT J NUTR, V90, P815, DOI 10.1079/BJN2003967; Franco MDP, 2002, CARDIOVASC RES, V56, P145, DOI 10.1016/S0008-6363(02)00508-4; Fryer AA, 2011, EPIGENETICS-US, V6, P86, DOI 10.4161/epi.6.1.13392; Galambos C, 2008, PATHOLOGY, V40, P124, DOI 10.1080/00313020701818981; Gardosi J, 2011, CLIN PERINATOL, V38, P21, DOI 10.1016/j.clp.2010.12.012; Gesta S, 2006, P NATL ACAD SCI USA, V103, P6676, DOI 10.1073/pnas.0601752103; Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928; Glaser RL, 2006, NUCLEIC ACIDS RES, V34, pD29, DOI 10.1093/nar/gkj101; Godlewski G, 1997, MICROSC RES TECHNIQ, V39, P314, DOI 10.1002/(SICI)1097-0029(19971115)39:4<314::AID-JEMT2>3.0.CO;2-H; Grantham-McGregor SM, 1998, EUR J CLIN NUTR, V52, pS59; Jansson T, 2006, PLACENTA, V27, pS91, DOI 10.1016/j.placenta.2005.11.010; Ke X, 2006, PHYSIOL GENOMICS, V25, P16, DOI 10.1152/physiolgenomics.00093.2005; Koukoura O, 2011, PLACENTA, V32, P51, DOI 10.1016/j.placenta.2010.10.017; LANGLEY SC, 1994, CLIN SCI, V86, P217, DOI 10.1042/cs0860217; Langley-Evans SC, 1999, BIOCHEM SOC T, V27, P88, DOI 10.1042/bst0270088; LangleyEvans SC, 1996, COMP BIOCHEM PHYS A, V114, P327, DOI 10.1016/0300-9629(96)00018-7; Lillycrop KA, 2007, BRIT J NUTR, V97, P1064, DOI 10.1017/S000711450769196X; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McArdle HJ, 2006, PLACENTA, V27, pS56, DOI 10.1016/j.placenta.2006.01.014; McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003; MERLETBENICHOU C, 1994, PEDIATR NEPHROL, V8, P175, DOI 10.1007/BF00865473; Nielsen PR, 2002, NATURE, V416, P103, DOI 10.1038/nature722; Nikolajev K, 2008, WORLD J PEDIATR, V4, P222, DOI 10.1007/s12519-008-0041-7; Oh-McGinnis R, 2011, DEV BIOL, V351, P277, DOI 10.1016/j.ydbio.2011.01.008; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; RESNICK O, 1979, NEUROSCI BIOBEHAV R, V3, P233, DOI 10.1016/0149-7634(79)90011-3; Richardus JH, 2003, BJOG-INT J OBSTET GY, V110, P97; Rutland CS, 2007, PLACENTA, V28, P734, DOI 10.1016/j.placenta.2006.07.001; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schwitzgebel VM, 2009, MOL CELL ENDOCRINOL, V304, P78, DOI 10.1016/j.mce.2009.02.019; Simmons RA, 2001, DIABETES, V50, P2279, DOI 10.2337/diabetes.50.10.2279; SNOECK A, 1990, BIOL NEONATE, V57, P107, DOI 10.1159/000243170; Struwe E, 2010, CLIN ENDOCRINOL, V72, P241, DOI 10.1111/j.1365-2265.2009.03659.x; THOMPSON RF, J BIOL CHEM; Torrens C, 2009, HYPERTENSION, V53, P661, DOI 10.1161/HYPERTENSIONAHA.108.122820; Tosh DN, 2010, AM J PHYSIOL-GASTR L, V299, pG1023, DOI 10.1152/ajpgi.00052.2010; Varrault A, 2006, DEV CELL, V11, P711, DOI 10.1016/j.devcel.2006.09.003; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Wolf G, 2003, NUTR REV, V61, P176, DOI 10.1301/nr.2003.may.176-179; Xie YB, 2009, NUCLEIC ACIDS RES, V37, P4100, DOI 10.1093/nar/gkp333; Zeng L, 2002, FEBS LETT, V513, P124, DOI 10.1016/S0014-5793(01)03309-9	61	34	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21222	10.1371/journal.pone.0021222	http://dx.doi.org/10.1371/journal.pone.0021222			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731679	gold, Green Published			2022-12-27	WOS:000292033700050
J	Helliwell, CA; Robertson, M; Finnegan, EJ; Buzas, DM; Dennis, ES				Helliwell, Chris A.; Robertson, Masumi; Finnegan, E. Jean; Buzas, Diana M.; Dennis, Elizabeth S.			Vernalization-Repression of Arabidopsis FLC Requires Promoter Sequences but Not Antisense Transcripts	PLOS ONE			English	Article							FLOWERING-LOCUS-C; HISTONE H3; GENE; PROTEIN; CHROMATIN; TRIMETHYLATION; RNA; THALIANA; COMPLEX	The repression of Arabidopsis FLC expression by vernalization (extended cold) has become a model for understanding polycomb-associated epigenetic regulation in plants. Antisense and sense non-coding RNAs have been respectively implicated in initiation and maintenance of FLC repression by vernalization. We show that the promoter and first exon of the FLC gene are sufficient to initiate repression during vernalization; this initial repression of FLC does not require antisense transcription. Long-term maintenance of FLC repression requires additional regions of the gene body, including those encoding sense non-coding transcripts.	[Helliwell, Chris A.; Robertson, Masumi; Finnegan, E. Jean; Buzas, Diana M.; Dennis, Elizabeth S.] CSIRO Plant Ind, Canberra, ACT, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Helliwell, CA (corresponding author), CSIRO Plant Ind, Canberra, ACT, Australia.	chris.helliwell@csiro.au	Buzas, Diana M/J-3826-2014; Finnegan, Elizabeth J/A-1183-2010; Helliwell, Chris/A-1469-2008; Buzas, Diana Mihaela/AAA-1431-2020; Dennis, Elizabeth S/A-6074-2008	Finnegan, Elizabeth J/0000-0002-2724-9311; Helliwell, Chris/0000-0001-5943-897X; Buzas, Diana Mihaela/0000-0002-8625-7872; Dennis, Elizabeth S/0000-0002-7850-591X				Buzas DM, 2011, PLANT J, V65, P872, DOI 10.1111/j.1365-313X.2010.04471.x; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; De Lucia F, 2008, P NATL ACAD SCI USA, V105, P16831, DOI 10.1073/pnas.0808687105; Deng WW, 2011, P NATL ACAD SCI USA, V108, P6680, DOI 10.1073/pnas.1103175108; Finnegan EJ, 2007, CURR BIOL, V17, P1978, DOI 10.1016/j.cub.2007.10.026; Gendall AR, 2001, CELL, V107, P525, DOI 10.1016/S0092-8674(01)00573-6; Helliwell CA, 2006, PLANT J, V46, P183, DOI 10.1111/j.1365-313X.2006.02686.x; Helliwell CA, 2002, FUNCT PLANT BIOL, V29, P1217, DOI 10.1071/FP02033; Heo JB, 2011, EPIGENETICS-US, V6, P544, DOI 10.4161/epi.6.5.15235; Heo JB, 2011, SCIENCE, V331, P76, DOI 10.1126/science.1197349; Hornyik C, 2010, DEV CELL, V18, P203, DOI 10.1016/j.devcel.2009.12.009; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; LEE I, 1994, PLANT CELL, V6, P75, DOI 10.1105/tpc.6.1.75; Liu FQ, 2007, MOL CELL, V28, P398, DOI 10.1016/j.molcel.2007.10.018; Liu FQ, 2010, SCIENCE, V327, P94, DOI 10.1126/science.1180278; Maenner S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000276; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Schubert D, 2006, EMBO J, V25, P4638, DOI 10.1038/sj.emboj.7601311; Searle I, 2006, GENE DEV, V20, P898, DOI 10.1101/gad.373506; Sheldon CC, 2002, PLANT CELL, V14, P2527, DOI 10.1105/tpc.004564; Sheldon CC, 1999, PLANT CELL, V11, P445, DOI 10.1105/tpc.11.3.445; Shirzadi R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001303; Sung SB, 2004, NATURE, V427, P159, DOI 10.1038/nature02195; Swiezewski S, 2007, P NATL ACAD SCI USA, V104, P3633, DOI 10.1073/pnas.0611459104; Swiezewski S, 2009, NATURE, V462, P799, DOI 10.1038/nature08618; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Wood CC, 2006, P NATL ACAD SCI USA, V103, P14631, DOI 10.1073/pnas.0606385103	28	92	103	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2011	6	6							e21513	10.1371/journal.pone.0021513	http://dx.doi.org/10.1371/journal.pone.0021513			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782CL	21713009	Green Submitted, gold, Green Published			2022-12-27	WOS:000291985100040
J	Lee, SKW; Teng, YF; Wong, HK; Ng, TK; Huang, L; Lei, P; Choy, KW; Liu, YP; Zhang, MZ; Lam, DSC; Yam, GHF; Pang, CP				Lee, Sharon Ka-Wai; Teng, Yufei; Wong, Hoi-Kin; Tsz-Kin Ng; Huang, Li; Lei, Peng; Choy, Kwong-Wai; Liu, Yingpeng; Zhang, Mingzhi; Lam, Dennis Shun-Chiu; Yam, Gary Hin-Fai; Pang, Chi-Pui			MicroRNA-145 Regulates Human Corneal Epithelial Differentiation	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; GROWTH-FACTOR-BETA; INTEGRIN EXPRESSION; MICROARRAY ANALYSIS; PROGENITOR CELLS; GENE-EXPRESSION; OCULAR SURFACE; PROLIFERATION; ACTIVATION; MIR-145	Background: Epigenetic factors, such as microRNAs, are important regulators in the self-renewal and differentiation of stem cells and progenies. Here we investigated the microRNAs expressed in human limbal-peripheral corneal (LPC) epithelia containing corneal epithelial progenitor cells (CEPCs) and early transit amplifying cells, and their role in corneal epithelium. Methodology/Principal Findings: Human LPC epithelia was extracted for small RNAs or dissociated for CEPC culture. By Agilent Human microRNA Microarray V2 platform and GeneSpring GX11.0 analysis, we found differential expression of 18 microRNAs against central corneal (CC) epithelia, which were devoid of CEPCs. Among them, miR-184 was up-regulated in CC epithelia, similar to reported finding. Cluster miR-143/145 was expressed strongly in LPC but weakly in CC epithelia (P = 0.0004, Mann-Whitney U-test). This was validated by quantitative polymerase chain reaction (qPCR). Locked nucleic acid-based in situ hybridization on corneal rim cryosections showed miR-143/145 presence localized to the parabasal cells of limbal epithelium but negligible in basal and superficial epithelia. With holoclone forming ability, CEPCs transfected with lentiviral plasmid containing mature miR-145 sequence gave rise to defective epithelium in organotypic culture and had increased cytokeratin-3/12 and connexin-43 expressions and decreased ABCG2 and p63 compared with cells transfected with scrambled sequences. Global gene expression was analyzed using Agilent Whole Human Genome Oligo Microarray and GeneSpring GX11.0. With a 5-fold difference compared to cells with scrambled sequences, miR-145 up-regulated 324 genes (containing genes for immune response) and down-regulated 277 genes (containing genes for epithelial development and stem cell maintenance). As validated by qPCR and luciferase reporter assay, our results showed miR-145 suppressed integrin beta 8 (ITGB8) expression in both human corneal epithelial cells and primary CEPCs. Conclusion/Significance: We found expression of miR-143/145 cluster in human corneal epithelium. Our results also showed that miR-145 regulated the corneal epithelium formation and maintenance of epithelial integrity, via ITGB8 targeting.	[Lee, Sharon Ka-Wai; Teng, Yufei; Tsz-Kin Ng; Huang, Li; Lei, Peng; Lam, Dennis Shun-Chiu; Yam, Gary Hin-Fai; Pang, Chi-Pui] Chinese Univ Hong Kong, Dept Ophthalmol & Visual Sci, Hong Kong, Hong Kong, Peoples R China; [Wong, Hoi-Kin; Choy, Kwong-Wai] Chinese Univ Hong Kong, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China; [Liu, Yingpeng; Zhang, Mingzhi] Joint Shantou Int Eye Ctr, Shantou, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong	Lee, SKW (corresponding author), Chinese Univ Hong Kong, Dept Ophthalmol & Visual Sci, Hong Kong, Hong Kong, Peoples R China.	gary_yam@cuhk.edu.hk; cppang@cuhk.edu.hk	Yam, Gary Hin-Fai/ABE-1710-2020; Choy, Richard/AAW-8230-2020; Ng, Tsz Kin/I-8061-2014; Pang, Chi P/I-5388-2014; Lam, Dennis/AAL-1211-2020	Choy, Richard/0000-0002-3616-6200; Ng, Tsz Kin/0000-0001-7863-7229; 	The Chinese University of Hong Kong [2006.1.059, 2041576]; University Grants Committee, Hong Kong	The Chinese University of Hong Kong(Chinese University of Hong Kong); University Grants Committee, Hong Kong	This study was financially supported by the Direct Grant from The Chinese University of Hong Kong (Grant Ref: 2006.1.059 and 2041576) and a block grant of the University Grants Committee, Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora A, 2007, INVEST OPHTH VIS SCI, V48, P3962, DOI 10.1167/iovs.06-1221; Ashkar S, 2004, J OCUL PHARMACOL TH, V20, P65, DOI 10.1089/108076804772745473; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bellon M, 2009, BLOOD, V113, P4914, DOI 10.1182/blood-2008-11-189845; Bhaskaran M, 2009, PHYSIOL GENOMICS, V37, P268, DOI 10.1152/physiolgenomics.90268.2008; Boettger T, 2009, J CLIN INVEST, V119, P2634, DOI 10.1172/JCI38864; Budak MT, 2005, J CELL SCI, V118, P1715, DOI 10.1242/jcs.02279; Burbach GJ, 2001, CURR EYE RES, V23, P64, DOI 10.1076/ceyr.23.1.64.5425; Cambier S, 2005, AM J PATHOL, V166, P1883, DOI 10.1016/S0002-9440(10)62497-2; Chen JM, 2010, AM J PATHOL, V176, P2520, DOI 10.2353/ajpath.2010.091061; Chen Z, 2006, STEM CELLS, V24, P1265, DOI 10.1634/stemcells.2005-0363; Cheng LC, 2005, NEURON, V46, P363, DOI 10.1016/j.neuron.2005.04.027; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; COTSARELIS G, 1989, CELL, V57, P201, DOI 10.1016/0092-8674(89)90958-6; Ella L, 2009, CELL DEATH DIFFER, V16, P1590, DOI 10.1038/cdd.2009.153; Espana EM, 2003, INVEST OPHTH VIS SCI, V44, P4275, DOI 10.1167/iovs.03-0089; Feng HC, 2008, HISTOPATHOLOGY, V52, P167, DOI 10.1111/j.1365-2559.2007.02925.x; Figueira EC, 2007, INVEST OPHTH VIS SCI, V48, P144, DOI 10.1167/iovs.06-0346; Forrest ARR, 2010, LEUKEMIA, V24, P460, DOI 10.1038/leu.2009.246; Guled M, 2009, GENE CHROMOSOME CANC, V48, P615, DOI 10.1002/gcc.20669; Hasseine LK, 2009, BIOCHEM BIOPH RES CO, V390, P1278, DOI 10.1016/j.bbrc.2009.10.135; Higa K, 2009, INVEST OPHTH VIS SCI, V50, P4640, DOI 10.1167/iovs.09-3503; Hou J, 2009, J IMMUNOL, V183, P2150, DOI 10.4049/jimmunol.0900707; Huang B, 2009, EMBO REP, V10, P180, DOI 10.1038/embor.2008.224; Huang XH, 2009, HEPATOL RES, V39, P786, DOI 10.1111/j.1872-034X.2009.00502.x; Jarad G, 2002, J BIOL CHEM, V277, P47826, DOI 10.1074/jbc.M204901200; Jukic DM, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-27; Kimura K, 2006, INVEST OPHTH VIS SCI, V47, P4323, DOI 10.1167/iovs.05-1508; Kong W, 2010, J BIOL CHEM, V285, P17869, DOI 10.1074/jbc.M110.101055; Lakhe-Reddy S, 2006, J BIOL CHEM, V281, P19688, DOI 10.1074/jbc.M601110200; Lee HJ, 2004, FASEB J, V18, P1200, DOI 10.1096/fj.03-1466com; Lehrer MS, 1998, J CELL SCI, V111, P2867; Lekhanont K, 2009, MOL VIS, V15, P1294; Li YW, 2010, CANCER RES, V70, P1486, DOI 10.1158/0008-5472.CAN-09-2792; Lin Z, 2010, J VIROL, V84, P7892, DOI 10.1128/JVI.00379-10; Liu CM, 2010, CELL STEM CELL, V6, P433, DOI 10.1016/j.stem.2010.02.017; Liu XQ, 2009, COMP FUNCT GENOM, DOI 10.1155/2009/837514; Lu Y, 2007, DEV BIOL, V310, P442, DOI 10.1016/j.ydbio.2007.08.007; Lyu J, 2006, CORNEA, V25, pS24, DOI 10.1097/01.ico.0000247209.01262.4e; Ma L, 2010, NAT BIOTECHNOL, V28, P341, DOI 10.1038/nbt.1618; Markovics JA, 2010, J BIOL CHEM, V285, P24695, DOI 10.1074/jbc.M110.113977; Merkerova M, 2008, EUR J HAEMATOL, V81, P304, DOI 10.1111/j.1600-0609.2008.01111.x; Minagawa H, 1997, ANTIVIR RES, V36, P99, DOI 10.1016/S0166-3542(97)00044-2; Minsel I, 2009, ENDOCRINOLOGY, V150, P2254, DOI 10.1210/en.2008-0577; Mu DZ, 2002, J CELL BIOL, V157, P493, DOI 10.1083/jcb.200109100; Nicoli S, 2010, NATURE, V464, P1196, DOI 10.1038/nature08889; Niederkorn JY, 1999, TRANSPLANTATION, V67, P1503, DOI 10.1097/00007890-199906270-00001; O'Brien WJ, 2001, INVEST OPHTH VIS SCI, V42, P713; Obernosterer G, 2007, NAT PROTOC, V2, P1508, DOI 10.1038/nprot.2007.153; Pellegrini G, 1999, J CELL BIOL, V145, P769, DOI 10.1083/jcb.145.4.769; Rama P, 2010, NEW ENGL J MED, V363, P147, DOI 10.1056/NEJMoa0905955; Ryan D, 2006, MOL VIS, V12, P1175; Sachdeva M, 2009, P NATL ACAD SCI USA, V106, P3207, DOI 10.1073/pnas.0808042106; SCHERMER A, 1986, J CELL BIOL, V103, P49, DOI 10.1083/jcb.103.1.49; Schlotzer-Schrehardt U, 2005, EXP EYE RES, V81, P247, DOI 10.1016/j.exer.2005.02.016; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Spivakov M, 2007, NAT REV GENET, V8, P263, DOI 10.1038/nrg2046; Stein-Streilein Joan, 2002, Int Rev Immunol, V21, P123, DOI 10.1080/08830180212066; Stepp MA, 1999, DEV DYNAM, V214, P216, DOI 10.1002/(SICI)1097-0177(199903)214:3<216::AID-AJA5>3.3.CO;2-W; SUNDERKOTTER C, 1990, AM J PATHOL, V137, P511; Tay YMS, 2008, STEM CELLS, V26, P17, DOI 10.1634/stemcells.2007-0295; Toyo-Oka K, 2005, HUM MOL GENET, V14, P3113, DOI 10.1093/hmg/ddi339; Tsai RJ, 2000, NEW ENGL J MED, V343, P86, DOI 10.1056/NEJM200007133430202; Wang Q, 2008, FASEB J, V22, P4126, DOI 10.1096/fj.08-112326; Wollensak G, 2002, CURR EYE RES, V24, P6, DOI 10.1076/ceyr.24.1.6.5431; Wong TS, 2008, CLIN CANCER RES, V14, P2588, DOI 10.1158/1078-0432.CCR-07-0666; Xin M, 2009, GENE DEV, V23, P2166, DOI 10.1101/gad.1842409; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Xu SB, 2007, J BIOL CHEM, V282, P25053, DOI 10.1074/jbc.M700501200; Yamagami H, 2003, INVEST OPHTH VIS SCI, V44, P514, DOI 10.1167/iovs.02-0498; Yi R, 2008, NATURE, V452, P225, DOI 10.1038/nature06642; Yu J, 2010, FASEB J, V24, P3950, DOI 10.1096/fj.10-157404; Zeng L, 2009, P NATL ACAD SCI USA, V106, P17793, DOI 10.1073/pnas.0903693106; Zhao XH, 2010, NEURON, V65, P612, DOI 10.1016/j.neuron.2010.02.018	74	63	69	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e21249	10.1371/journal.pone.0021249	http://dx.doi.org/10.1371/journal.pone.0021249			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	21701675	Green Published, Green Submitted, gold			2022-12-27	WOS:000291983800034
J	Tamerius, JD; Comrie, AC				Tamerius, James D.; Comrie, Andrew C.			Coccidioidomycosis Incidence in Arizona Predicted by Seasonal Precipitation	PLOS ONE			English	Article							CLIMATE; SURVEILLANCE; CALIFORNIA	The environmental mechanisms that determine the inter-annual and seasonal variability in incidence of coccidioidomycosis are unclear. In this study, we use Arizona coccidioidomycosis case data for 1995-2006 to generate a timeseries of monthly estimates of exposure rates in Maricopa County, AZ and Pima County, AZ. We reveal a seasonal autocorrelation structure for exposure rates in both Maricopa County and Pima County which indicates that exposure rates are strongly related from the fall to the spring. An abrupt end to this autocorrelation relationship occurs near the the onset of the summer precipitation season and increasing exposure rates related to the subsequent season. The identification of the autocorrelation structure enabled us to construct a "primary" exposure season that spans August-March and a "secondary" season that spans April-June which are then used in subsequent analyses. We show that October-December precipitation is positively associated with rates of exposure for the primary exposure season in both Maricopa County (R = 0.72, p = 0.012) and Pima County (R = 0.69, p = 0.019). In addition, exposure rates during the primary exposure seasons are negatively associated with concurrent precipitation in Maricopa (R = -0.79, p = 0.004) and Pima (R = -0.64, p = 0.019), possibly due to reduced spore dispersion. These associations enabled the generation of models to estimate exposure rates for the primary exposure season. The models explain 69% (p = 0.009) and 54% (p = 0.045) of the variance in the study period for Maricopa and Pima counties, respectively. We did not find any significant predictors for exposure rates during the secondary season. This study builds on previous studies examining the causes of temporal fluctuations in coccidioidomycosis, and corroborates the "grow and blow" hypothesis.	[Tamerius, James D.; Comrie, Andrew C.] Univ Arizona, Sch Geog & Dev, Tucson, AZ 85721 USA	University of Arizona	Tamerius, JD (corresponding author), Univ Arizona, Sch Geog & Dev, Tucson, AZ 85721 USA.	james.tamerius@gmail.com			United States Environmental Protection Agency [RD-83275401-0]	United States Environmental Protection Agency(United States Environmental Protection Agency)	Although the research described in this article has been funded wholly or in part by the United States Environmental Protection Agency (http://www.epa.gov/) through grant RD-83275401-0 to the University of Arizona, it has not been subjected to the Agency's required peer and policy review and therefore does not necessarily reflect the views of the agency and no official endorsement should be inferred. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Ampel NM, 2007, ANN NY ACAD SCI, V1111, P336, DOI 10.1196/annals.1406.033; Brown JH, 2002, BIOSCIENCE, V52, P979, DOI 10.1641/0006-3568(2002)052[0979:RARCDO]2.0.CO;2; CHIN J, 2000, CONTROL COMMUNICABLE; Comrie AC, 2005, ENVIRON HEALTH PERSP, V113, P688, DOI 10.1289/ehp.7786; Comrie AC, 2007, ANN NY ACAD SCI, V1111, P83, DOI 10.1196/annals.1406.024; Fisher FS, 2007, ANN NY ACAD SCI, V1111, P47, DOI 10.1196/annals.1406.031; Fisher MC, 2002, MYCOLOGIA, V94, P73, DOI 10.2307/3761847; Hugenholtz P., 1957, P S COCC, P136; Kolivras KN, 2003, INT J BIOMETEOROL, V47, P87, DOI 10.1007/s00484-002-0155-x; MOSLEY D, 1996, MMWR-MORBID MORTAL W, V45, P1069; Pappagianis D, 1988, Curr Top Med Mycol, V2, P199; Park BJ, 2005, J INFECT DIS, V191, P1981, DOI 10.1086/430092; Sharpton TJ, 2009, GENOME RES, V19, P1722, DOI 10.1101/gr.087551.108; Sunenshine RH, 2007, ANN NY ACAD SCI, V1111, P96, DOI 10.1196/annals.1406.045; Tabor JA, 2010, SCI TOTAL ENVIRON, V408, P2199, DOI 10.1016/j.scitotenv.2010.02.013; Talamantes J, 2007, ANN NY ACAD SCI, V1111, P73, DOI 10.1196/annals.1406.028; Tsang CA, 2010, EMERG INFECT DIS, V16, P1738, DOI 10.3201/eid1611.100475; Valdivia L, 2006, EMERG INFECT DIS, V12, P958; *WESTMAP W CLIM MA, 2010, CLIM AN MOD	19	49	49	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e21009	10.1371/journal.pone.0021009	http://dx.doi.org/10.1371/journal.pone.0021009			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	21701590	Green Submitted, Green Published, gold			2022-12-27	WOS:000291983800018
J	Bohnert, JA; Schuster, S; Szymaniak-Vits, M; Kern, WV				Bohnert, Juergen A.; Schuster, Sabine; Szymaniak-Vits, Magdalena; Kern, Winfried V.			Determination of Real-Time Efflux Phenotypes in Escherichia coli AcrB Binding Pocket Phenylalanine Mutants Using a 1,2 '-Dinaphthylamine Efflux Assay	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; PUMP ACRB; MULTIDRUG; MECHANISM; INHIBITORS	To evaluate the importance of phenylalanine residues for substrate transport in the Escherichia coli efflux pump protein AcrB, we subjected Phe-to-Ala binding pocket mutants to a real-time efflux assay with the novel near-infrared lipophilic membrane probe 1,2'-dinaphthylamine (1,2'-DNA). All mutations, with the exception of F617A, led to considerable retardation of efflux. F610A was the point mutation with the most pronounced impact, followed by F628A, F615A, F136A, and F178A. This is the first study to demonstrate the importance of single phenylalanine residues within the AcrB binding pocket for real-time substrate transport.	[Bohnert, Juergen A.; Schuster, Sabine; Szymaniak-Vits, Magdalena; Kern, Winfried V.] Univ Freiburg, Dept Med, Univ Hosp, Ctr Infect Dis & Travel Med, D-7800 Freiburg, Germany	University of Freiburg	Bohnert, JA (corresponding author), Univ Freiburg, Dept Med, Univ Hosp, Ctr Infect Dis & Travel Med, D-7800 Freiburg, Germany.	juergen@bohnert.name		Schuster, Sabine/0000-0002-8817-6224	University of Freiburg	University of Freiburg	The work was funded by the University of Freiburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bohnert JA, 2010, ANTIMICROB AGENTS CH, V54, P3770, DOI 10.1128/AAC.00620-10; Bohnert JA, 2007, J ANTIMICROB CHEMOTH, V59, P1216, DOI 10.1093/jac/dkl426; Bohnert JA, 2008, J BACTERIOL, V190, P8225, DOI 10.1128/JB.00912-08; Jellen-Ritter AS, 2001, ANTIMICROB AGENTS CH, V45, P1467, DOI 10.1128/AAC.45.5.1467-1472.2001; Kalchenko V, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2364903; Lomovskaya O, 2001, ANTIMICROB AGENTS CH, V45, P105, DOI 10.1128/AAC.45.1.105-116.2001; Mao WM, 2002, MOL MICROBIOL, V46, P889, DOI 10.1046/j.1365-2958.2002.03223.x; Murakami S, 2006, NATURE, V443, P173, DOI 10.1038/nature05076; Nagano K, 2009, P NATL ACAD SCI USA, V106, P5854, DOI 10.1073/pnas.0901695106; Nikaido H, 1998, CLIN INFECT DIS, V27, pS32, DOI 10.1086/514920; Piddock LJV, 2006, CLIN MICROBIOL REV, V19, P382, DOI 10.1128/CMR.19.2.382-402.2006; Seeger MA, 2006, SCIENCE, V313, P1295, DOI 10.1126/science.1131542; Sennhauser G, 2007, PLOS BIOL, V5, P106, DOI 10.1371/journal.pbio.0050007	13	31	32	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e21196	10.1371/journal.pone.0021196	http://dx.doi.org/10.1371/journal.pone.0021196			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698261	Green Published, Green Submitted, gold			2022-12-27	WOS:000291730000060
J	Verhulst, NO; Qiu, YT; Beijleveld, H; Maliepaard, C; Knights, D; Schulz, S; Berg-Lyons, D; Lauber, CL; Verduijn, W; Haasnoot, GW; Mumm, R; Bouwmeester, HJ; Claas, FHJ; Dicke, M; van Loon, JJA; Takken, W; Knight, R; Smallegange, RC				Verhulst, Niels O.; Qiu, Yu Tong; Beijleveld, Hans; Maliepaard, Chris; Knights, Dan; Schulz, Stefan; Berg-Lyons, Donna; Lauber, Christian L.; Verduijn, Willem; Haasnoot, Geert W.; Mumm, Roland; Bouwmeester, Harro J.; Claas, Frans H. J.; Dicke, Marcel; van Loon, Joop J. A.; Takken, Willem; Knight, Rob; Smallegange, Renate C.			Composition of Human Skin Microbiota Affects Attractiveness to Malaria Mosquitoes	PLOS ONE			English	Article							HUMAN AXILLARY ODOR; ANOPHELES-GAMBIAE; AEDES-AEGYPTI; PREFERENCES; SPECTROMETRY; MICROFLORA; RESPONSES; SELECTION; BEHAVIOR; ATTRACTS	The African malaria mosquito Anopheles gambiae sensu stricto continues to play an important role in malaria transmission, which is aggravated by its high degree of anthropophily, making it among the foremost vectors of this disease. In the current study we set out to unravel the strong association between this mosquito species and human beings, as it is determined by odorant cues derived from the human skin. Microbial communities on the skin play key roles in the production of human body odour. We demonstrate that the composition of the skin microbiota affects the degree of attractiveness of human beings to this mosquito species. Bacterial plate counts and 16S rRNA sequencing revealed that individuals that are highly attractive to An. gambiae s.s. have a significantly higher abundance, but lower diversity of bacteria on their skin than individuals that are poorly attractive. Bacterial genera that are correlated with the relative degree of attractiveness to mosquitoes were identified. The discovery of the connection between skin microbial populations and attractiveness to mosquitoes may lead to the development of new mosquito attractants and personalized methods for protection against vectors of malaria and other infectious diseases.	[Verhulst, Niels O.; Qiu, Yu Tong; Beijleveld, Hans; Dicke, Marcel; van Loon, Joop J. A.; Takken, Willem; Smallegange, Renate C.] Univ Wageningen & Res Ctr, Entomol Lab, Wageningen, Netherlands; [Beijleveld, Hans] Univ Wageningen & Res Ctr, Subdept Environm Technol, Wageningen, Netherlands; [Maliepaard, Chris] Univ Wageningen & Res Ctr, Wageningen UR Plant Breeding, Wageningen, Netherlands; [Knights, Dan; Knight, Rob] Univ Colorado, Dept Comp Sci, Boulder, CO 80309 USA; [Schulz, Stefan] Tech Univ Carolo Wilhelmina Braunschweig, Inst Organ Chem, Braunschweig, Germany; [Berg-Lyons, Donna; Lauber, Christian L.] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; [Verduijn, Willem; Haasnoot, Geert W.; Claas, Frans H. J.] Leiden Univ, Dept Immunohematol & Blood Transfus, Leiden, Netherlands; [Mumm, Roland] Univ Wageningen & Res Ctr, Business Unit Biosci, Wageningen, Netherlands; [Mumm, Roland] Ctr BioSyst Gen, Wageningen, Netherlands; [Bouwmeester, Harro J.] Univ Wageningen & Res Ctr, Lab Plant Physiol, Wageningen, Netherlands; [Knight, Rob] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA	Wageningen University & Research; Wageningen University & Research; Wageningen University & Research; University of Colorado System; University of Colorado Boulder; Braunschweig University of Technology; University of Colorado System; University of Colorado Boulder; Leiden University; Leiden University - Excl LUMC; Wageningen University & Research; Centre for BioSystems Genomics; Wageningen University & Research; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder	Verhulst, NO (corresponding author), Univ Wageningen & Res Ctr, Entomol Lab, Wageningen, Netherlands.	Niels.Verhulst@wur.nl	Verhulst, Simon/S-3404-2019; Pollet, Thomas V/H-3397-2012; Maliepaard, Chris/G-6041-2015; Verhulst, Niels/AAH-4288-2019; Dicke, Marcel/B-2300-2010; Pollet, Thomas/M-6346-2019; Knight, Rob/D-1299-2010; Smallegange, Renate C./L-1566-2019; Nettle, Daniel/B-2259-2008; Verhulst, Simon/B-1613-2009; Bouwmeester, Harro J/C-1414-2008; van Loon, Joop J.A./B-3744-2009	Verhulst, Simon/0000-0002-1143-6868; Pollet, Thomas V/0000-0002-4210-935X; Dicke, Marcel/0000-0001-8565-8896; Pollet, Thomas/0000-0002-4210-935X; Smallegange, Renate C./0000-0002-6946-9777; Nettle, Daniel/0000-0001-9089-2599; Verhulst, Simon/0000-0002-1143-6868; Knight, Rob/0000-0002-0975-9019; Schulz, Stefan/0000-0002-4810-324X; Verhulst, Niels/0000-0002-1106-9711; Stulp, Gert/0000-0003-0173-5554; Bouwmeester, Harro/0000-0003-0907-2732; Mumm, Roland/0000-0002-0603-1508; van Loon, Joop J.A./0000-0002-4260-0501	Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative (GCGH) [121]; Earth and Life Science Foundation of the Netherlands Organization for Scientific Research	Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative (GCGH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Earth and Life Science Foundation of the Netherlands Organization for Scientific Research	This study was funded by a grant from the Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative (GCGH# 121), and a grant from the Earth and Life Science Foundation of the Netherlands Organization for Scientific Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAN SA, 1987, ANNU REV ENTOMOL, V32, P297, DOI 10.1146/annurev.en.32.010187.001501; Ara K, 2006, CAN J MICROBIOL, V52, P357, DOI 10.1139/W05-130; Bernier UR, 1999, ANAL CHEM, V71, P1, DOI 10.1021/ac980990v; Braks MAH, 1999, PARASITOL TODAY, V15, P409, DOI 10.1016/S0169-4758(99)01514-8; Braks MAH, 1999, J CHEM ECOL, V25, P663, DOI 10.1023/A:1020970307748; Bruinsma M, 2010, OECOLOGIA, V162, P393, DOI 10.1007/s00442-009-1459-x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carde RT, 2010, ECOL CONT VECTOR-BOR, V2, P115; Costantini C, 1998, AM J TROP MED HYG, V58, P56, DOI 10.4269/ajtmh.1998.58.56; Costantini C, 1996, MED VET ENTOMOL, V10, P220, DOI 10.1111/j.1365-2915.1996.tb00734.x; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; DEJONG R, 1995, EXPERIENTIA, V51, P80, DOI 10.1007/BF01964925; Eriksson L., 2006, MULTI MEGAVARIATE DA, V2nd, DOI DOI 10.1016/j.arabjc.2013.10.006; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Gao Z, 2007, P NATL ACAD SCI USA, V104, P2927, DOI 10.1073/pnas.0607077104; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Hunt RH, 1998, T ROY SOC TROP MED H, V92, P231, DOI 10.1016/S0035-9203(98)90761-1; KHAN AA, 1968, MOSQ NEWS, V28, P462; Knols BGJ, 1995, T ROY SOC TROP MED H, V89, P604, DOI 10.1016/0035-9203(95)90406-9; Lefevre T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009546; Logan J. G., 2008, Outlooks on Pest Management, V19, P280, DOI 10.1564/19dec14; Logan JG, 2008, J CHEM ECOL, V34, P308, DOI 10.1007/s10886-008-9436-0; Okumu FO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011573; Olanga EA, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-6; Penn D, 1998, ADV IMMUNOL, V69, P411, DOI 10.1016/S0065-2776(08)60612-4; Perez-Enciso M, 2003, HUM GENET, V112, P581, DOI 10.1007/s00439-003-0921-9; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Qiu YT, 2006, MED VET ENTOMOL, V20, P280, DOI 10.1111/j.1365-2915.2006.00627.x; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; RENNIE PJ, 1991, BRIT J DERMATOL, V124, P596, DOI 10.1111/j.1365-2133.1991.tb04958.x; Savelev SU, 2008, J CHEM ECOL, V34, P1253, DOI 10.1007/s10886-008-9524-1; SHELLEY WB, 1953, AMA ARCH DERM SYPH, V68, P430, DOI 10.1001/archderm.1953.01540100070012; Smallegange RC, 2011, TRENDS PARASITOL, V27, P143, DOI 10.1016/j.pt.2010.12.009; Takken W, 1999, ANNU REV ENTOMOL, V44, P131, DOI 10.1146/annurev.ento.44.1.131; Taylor D., 2003, International Journal of Cosmetic Science, V25, P137, DOI 10.1046/j.1467-2494.2003.00181.x; Tims S, 2010, INT J LEGAL MED, V124, P477, DOI 10.1007/s00414-009-0352-9; Torr S, 2008, MED VET ENTOMOL, V22, P93, DOI 10.1111/j.1365-2915.2008.00723.x; Verhulst NO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015829; Verhulst NO, 2010, FEMS MICROBIOL ECOL, V74, P1, DOI 10.1111/j.1574-6941.2010.00908.x; Verhulst NO, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-302; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wedekind C, 1997, P ROY SOC B-BIOL SCI, V264, P1471, DOI 10.1098/rspb.1997.0204; WHITE GB, 1980, T ROY SOC TROP MED H, V74, P683; Xu Y, 2007, METABOLOMICS, V3, P427, DOI 10.1007/s11306-007-0054-6; YAMAZAKI K, 1976, J EXP MED, V144, P1324, DOI 10.1084/jem.144.5.1324	45	199	201	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e28991	10.1371/journal.pone.0028991	http://dx.doi.org/10.1371/journal.pone.0028991			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	21738577	gold, Green Published			2022-12-27	WOS:000300676300020
J	Yang, J; Liang, SY; Zhang, Y				Yang, Jing; Liang, Siyang; Zhang, Yi			Travelling Waves of a Delayed SIR Epidemic Model with Nonlinear Incidence Rate and Spatial Diffusion	PLOS ONE			English	Article							PREDATOR-PREY SYSTEM; GLOBAL STABILITY; STAGE STRUCTURE; TIME-DELAY; DEPENDENCE; FRONTS; TERMS	This paper is concerned with the existence of travlelling waves to a SIR epidemic model with nonlinear incidence rate, spatial diffusion and time delay. By analyzing the corresponding characteristic equations, the local stability of a disease-free steady state and an endemic steady state to this system under homogeneous Neumann boundary conditions is discussed. By using the cross iteration method and the Schauder's fixed point theorem, we reduce the existence of travelling waves to the existence of a pair of upper-lower solutions. By constructing a pair of upper-lower solutions, we derive the existence of a travelling wave connecting the disease-free steady state and the endemic steady state. Numerical simulations are carried out to illustrate the main results.	[Yang, Jing; Zhang, Yi] Hebei Med Univ, Dept Physiol, Shijiazhuang, Peoples R China; [Liang, Siyang] Beijing Inst Technol, Beijing 100081, Peoples R China	Hebei Medical University; Beijing Institute of Technology	Yang, J (corresponding author), Hebei Med Univ, Dept Physiol, Shijiazhuang, Peoples R China.	zhyhenry@sina.cn	Anderson, Alisha/C-1499-2008	Anderson, Alisha/0000-0001-7013-116X	National Natural Science Foundation of China [31071002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National Natural Science Foundation of China (No. 31071002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATKINSON C, 1976, MATH PROC CAMBRIDGE, V80, P315, DOI 10.1017/S0305004100052944; BERETTA E, 1995, J MATH BIOL, V33, P250, DOI 10.1007/BF00169563; Cooke K. L., 1979, ROCKY MT J MATH, V9, P31, DOI [10.1216/RMJ-1979-9-1-31, DOI 10.1216/RMJ-1979-9-1-31]; Fuentes MA, 1999, PHYSICA A, V267, P471, DOI 10.1016/S0378-4371(99)00027-8; Ge ZH, 2009, NONLINEAR ANAL-REAL, V10, P1691, DOI 10.1016/j.nonrwa.2008.02.007; Ge ZH, 2009, APPL MATH MODEL, V33, P1356, DOI 10.1016/j.apm.2007.09.037; HUANG J, 2006, ACTA MATH APPL SIN-E, V22, P243; Jianhong Wu, 2001, Journal of Dynamics and Differential Equations, V13, P651, DOI 10.1023/A:1016690424892; Kim KI, 2010, NONLINEAR ANAL-REAL, V11, P313, DOI 10.1016/j.nonrwa.2008.11.015; Kuperman MN, 1999, PHYSICA A, V272, P206, DOI 10.1016/S0378-4371(99)00284-8; Leung A.W., 1989, SYSTEMS NONLINEAR PA; Li WT, 2006, NONLINEARITY, V19, P1253, DOI 10.1088/0951-7715/19/6/003; Ma WB, 2004, APPL MATH LETT, V17, P1141, DOI 10.1016/j.aml.2003.11.005; Maidana NA, 2009, J THEOR BIOL, V258, P403, DOI 10.1016/j.jtbi.2008.12.032; Murray J. D., 1989, MATH BIOL, DOI DOI 10.1007/978-3-662-08539-4; NOBLE JV, 1974, NATURE, V250, P276; Peng R, 2009, NONLINEAR ANAL-THEOR, V71, P239, DOI 10.1016/j.na.2008.10.043; Saccomandi G, 1997, MATH COMPUT MODEL, V25, P83, DOI 10.1016/S0895-7177(97)00096-4; Sazonov I, 2011, MATH MED BIOL, V28, P165, DOI 10.1093/imammb/dqq016; Sazonov I, 2008, MATH MODEL NAT PHENO, V3, P28, DOI 10.1051/mmnp:2008069; Takeuchi Y, 2000, NONLINEAR ANAL-THEOR, V42, P931, DOI 10.1016/S0362-546X(99)00138-8; Taylor ML, 2009, J MATH BIOL, V59, P841, DOI 10.1007/s00285-009-0256-9; Wu J., 1998, CANAD APPL MATH Q, V6, P397; Xu R, 2009, NONLINEAR ANAL-REAL, V10, P3175, DOI 10.1016/j.nonrwa.2008.10.013; Zeidler E., 1986, NONLINEAR FUNCTIONAL	25	144	145	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21128	10.1371/journal.pone.0021128	http://dx.doi.org/10.1371/journal.pone.0021128			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21912618	gold, Green Published			2022-12-27	WOS:000292036900011
J	Lee, J; Romero, R; Xu, Y; Kim, JS; Topping, V; Yoo, W; Kusanovic, JP; Chaiworapongsa, T; Hassan, SS; Yoon, BH; Kim, CJ				Lee, JoonHo; Romero, Roberto; Xu, Yi; Kim, Jung-Sun; Topping, Vanessa; Yoo, Wonsuk; Pedro Kusanovic, Juan; Chaiworapongsa, Tinnakorn; Hassan, Sonia S.; Yoon, Bo Hyun; Kim, Chong Jai			A Signature of Maternal Anti-Fetal Rejection in Spontaneous Preterm Birth: Chronic Chorioamnionitis, Anti-Human Leukocyte Antigen Antibodies, and C4d	PLOS ONE			English	Article							NEONATAL ALLOIMMUNE THROMBOCYTOPENIA; CLINICAL-SIGNIFICANCE; ALLOGRAFT-REJECTION; RECURRENT ABORTION; MEDIATED REJECTION; HUMORAL IMMUNITY; UNKNOWN ETIOLOGY; HLA ANTIBODIES; PREGNANCY; MECHANISMS	Background: Chronic chorioamnionitis is found in more than one-third of spontaneous preterm births. Chronic chorioamnionitis and villitis of unknown etiology represent maternal anti-fetal cellular rejection. Antibody-mediated rejection is another type of transplantation rejection. We investigated whether there was evidence for antibody-mediated rejection against the fetus in spontaneous preterm birth. Methods and Findings: This cross-sectional study included women with (1) normal pregnancy and term delivery (n = 140) and (2) spontaneous preterm delivery (n = 140). We analyzed maternal and fetal sera for panel-reactive anti-HLA class I and class II antibodies, and determined C4d deposition on umbilical vein endothelium by immunohistochemistry. Maternal anti-HLA class I seropositivity in spontaneous preterm births was higher than in normal term births (48.6% vs. 32.1%, p = 0.005). Chronic chorioamnionitis was associated with a higher maternal anti-HLA class I seropositivity (p<0.01), significant in preterm and term birth. Villitis of unknown etiology was associated with increased maternal and fetal anti-HLA class I and II seropositivity (p<0.05, for each). Fetal anti-HLA seropositivity was closely related to maternal anti-HLA seropositivity in both groups (p<0.01, for each). C4d deposition on umbilical vein endothelium was more frequent in preterm labor than term labor (77.1% vs. 11.4%, p<0.001). Logistic regression analysis revealed that chronic chorioamnionitis (OR = 6.10, 95% CI 1.29-28.83), maternal anti-HLA class I seropositivity (OR = 5.90, 95% CI 1.60-21.83), and C4d deposition on umbilical vein endothelium (OR = 36.19, 95% CI 11.42-114.66) were associated with preterm labor and delivery. Conclusions: A major subset of spontaneous preterm births has a signature of maternal anti-fetal cellular and antibody-mediated rejections with links to fetal graft-versus-host disease and alloimmune reactions.	[Lee, JoonHo; Romero, Roberto; Xu, Yi; Topping, Vanessa; Pedro Kusanovic, Juan; Chaiworapongsa, Tinnakorn; Hassan, Sonia S.; Kim, Chong Jai] NICHHD, Perinatol Res Branch, NIH, US Dept HHS, Bethesda, MD 20892 USA; [Lee, JoonHo; Romero, Roberto; Xu, Yi; Topping, Vanessa; Pedro Kusanovic, Juan; Chaiworapongsa, Tinnakorn; Hassan, Sonia S.; Kim, Chong Jai] NICHHD, Perinatol Res Branch, NIH, US Dept HHS, Detroit, MI USA; [Romero, Roberto; Chaiworapongsa, Tinnakorn; Hassan, Sonia S.] Wayne State Univ, Sch Med, Dept Obstet & Gynecol, Detroit, MI 48201 USA; [Romero, Roberto] Wayne State Univ, Ctr Mol Med & Genet, Detroit, MI 48201 USA; [Kim, Jung-Sun] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol, Seoul, South Korea; [Yoo, Wonsuk] Wayne State Univ, Sch Med, Dept Internal Med, Detroit, MI 48201 USA; [Pedro Kusanovic, Juan] Hosp Dr Sotero del Rio, Dept Obstet & Gynecol, Santiago, Chile; [Pedro Kusanovic, Juan] Pontificia Univ Catolica Chile, Sch Med, Dept Obstet & Gynecol, Santiago, Chile; [Yoon, Bo Hyun] Seoul Natl Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea; [Kim, Chong Jai] Wayne State Univ, Sch Med, Dept Pathol, Detroit, MI 48201 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Wayne State University; Wayne State University; Sungkyunkwan University (SKKU); Samsung Medical Center; Wayne State University; Universidad de Chile; Pontificia Universidad Catolica de Chile; Seoul National University (SNU); Wayne State University	Lee, J (corresponding author), NICHHD, Perinatol Res Branch, NIH, US Dept HHS, Bethesda, MD 20892 USA.	prbchiefstaff@med.wayne.edu; cjkim@med.wayne.edu	Kusanovic, Juan Pedro/R-8616-2019; Yoon, Bo Hyun/H-6344-2011; Kusanovic, Juan Pedro/AAM-5782-2020; YOO, WONSUK/HHN-9044-2022; Romero, Roberto/A-5268-2019	Kusanovic, Juan Pedro/0000-0003-0640-2070; Lee, John Tayu/0000-0002-1551-4923; Millett, Christopher/0000-0002-0793-9884; YOO, WONSUK/0000-0003-2414-2399; Romero, Roberto/0000-0002-4448-5121	Perinatology Research Branch, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, USA; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD002400] Funding Source: NIH RePORTER	Perinatology Research Branch, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the Perinatology Research Branch, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, USA. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADENIYIJONES SCA, 1987, J IMMUNOL, V138, P1408; Agrawal Suraksha, 2002, BMC Pregnancy Childbirth, V2, P6, DOI 10.1186/1471-2393-2-6; AKSEL S, 1992, JAMA-J AM MED ASSOC, V268, P2930, DOI 10.1001/jama.268.20.2930; Althaus J, 2005, AM J OBSTET GYNECOL, V193, P1100, DOI 10.1016/j.ajog.2005.06.043; Ball B, 2000, TRANSPLANT P, V32, P353, DOI 10.1016/S0041-1345(99)00976-8; Bartel G, 2007, TRANSPLANTATION, V83, P727, DOI 10.1097/01.tp.0000256337.18347.aa; Bartel G, 2011, HUM IMMUNOL, V72, P187, DOI 10.1016/j.humimm.2010.11.005; Betkowski AS, 2002, J HEART LUNG TRANSPL, V21, P644, DOI 10.1016/S1053-2498(01)00422-3; COHEN F, 1964, BLOOD, V23, P621, DOI 10.1182/blood.V23.5.621.621; Collins AB, 1999, J AM SOC NEPHROL, V10, P2208; Colvin RB, 2005, NAT REV IMMUNOL, V5, P807, DOI 10.1038/nri1702; DUNN MJ, 1992, LANCET, V339, P1566, DOI 10.1016/0140-6736(92)91832-S; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Gu DS, 2010, HUM IMMUNOL, V71, P586, DOI 10.1016/j.humimm.2010.02.010; Guleria I, 2007, J IMMUNOL, V178, P3345, DOI 10.4049/jimmunol.178.6.3345; Howell WM, 2010, J CLIN PATHOL, V63, P387, DOI 10.1136/jcp.2009.072371; Ionescu DN, 2005, TRANSPL IMMUNOL, V15, P63, DOI 10.1016/j.trim.2005.05.001; Jacques SM, 1998, HUM PATHOL, V29, P1457, DOI 10.1016/S0046-8177(98)90016-8; KILPATRICK DC, 1987, LANCET, V2, P1460; Kim CJ, 2010, MODERN PATHOL, V23, P1000, DOI 10.1038/modpathol.2010.73; Kim IK, 2008, TRANSPLANTATION, V86, P889, DOI 10.1097/TP.0b013e318186ac4a; Kim MJ, 2009, J IMMUNOL, V182, P3919, DOI 10.4049/jimmunol.0803834; Le Moine A, 2002, TRANSPLANTATION, V73, P1373, DOI 10.1097/00007890-200205150-00001; Makrigiannakis A, 2008, AM J REPROD IMMUNOL, V60, P482, DOI 10.1111/j.1600-0897.2008.00655.x; Melamed N, 2010, J MATERN-FETAL NEO M, V23, P338, DOI 10.3109/14767050903300969; Minino Arialdi M, 2007, Natl Vital Stat Rep, V55, P1; Moncharmont P, 2004, ACTA HAEMATOL-BASEL, V111, P215, DOI 10.1159/000077569; Nielsen HS, 2007, J REPROD IMMUNOL, V75, P63, DOI 10.1016/j.jri.2007.03.003; Nielsen HS, 2010, J REPROD IMMUNOL, V87, P67, DOI 10.1016/j.jri.2010.05.006; Pandey Manoj Kumar, 2004, Archives of Gynecology and Obstetrics, V269, P161, DOI 10.1007/s00404-003-0560-3; Piper KP, 2007, BIOL REPROD, V76, P96, DOI 10.1095/biolreprod.106.055426; Porter TF, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000112.pub2; Racusen LC, 2003, AM J TRANSPLANT, V3, P708, DOI 10.1034/j.1600-6143.2003.00072.x; Raju TNK, 2006, CLIN PERINATOL, V33, P751, DOI 10.1016/j.clp.2006.09.009; Redline RW, 2005, PLACENTA, V26, pS114, DOI 10.1016/j.placenta.2005.02.009; REDLINE RW, 1993, AM J PATHOL, V143, P473; REDMAN CWG, 1983, AM J REPROD IMMUNOL, V4, P179, DOI 10.1111/j.1600-0897.1983.tb00274.x; REGAN L, 1991, HUM REPROD, V6, P294, DOI 10.1093/oxfordjournals.humrep.a137325; Romero R, 2006, BJOG-INT J OBSTET GY, V113, P17, DOI 10.1111/j.1471-0528.2006.01120.x; Rowshani AT, 2008, CLIN TRANSPLANT, V22, P689, DOI 10.1111/j.1399-0012.2008.00872.x; Russell RB, 2007, PEDIATRICS, V120, pE1, DOI 10.1542/peds.2006-2386; Saito S, 2003, TRANSFUSION, V43, P908, DOI 10.1046/j.1537-2995.2003.00429.x; SARGENT IL, 1988, LANCET, V2, P1099; Schild RL, 1999, ULTRASOUND OBST GYN, V14, P64, DOI 10.1046/j.1469-0705.1999.14010064.x; SEBRING ES, 1990, TRANSFUSION, V30, P344, DOI 10.1046/j.1537-2995.1990.30490273444.x; Simister NE, 2003, VACCINE, V21, P3365, DOI 10.1016/S0264-410X(03)00334-7; Slattery MM, 2002, LANCET, V360, P1489, DOI 10.1016/S0140-6736(02)11476-0; Sumitran-Holgersson S, 2002, TRANSPLANTATION, V74, P268, DOI 10.1097/00007890-200207270-00019; Sumitran-Holgersson S, 2008, CURR OPIN IMMUNOL, V20, P607, DOI 10.1016/j.coi.2008.07.005; Taglauer ES, 2010, INT J DEV BIOL, V54, P421, DOI 10.1387/ijdb.082800et; Takemoto SK, 2004, AM J TRANSPLANT, V4, P1033, DOI 10.1111/j.1600-6143.2004.00500.x; Thude H, 2006, TRANSFUSION MED, V16, P143, DOI 10.1111/j.1365-3148.2006.00634.x; Tilburgs T, 2010, J REPROD IMMUNOL, V85, P58, DOI 10.1016/j.jri.2010.01.005; van Halteren AGS, 2009, BLOOD, V114, P2263, DOI 10.1182/blood-2009-01-200410; von Rango U, 2008, IMMUNOL LETT, V115, P21, DOI 10.1016/j.imlet.2007.09.014; Wasowska BA, 2010, IMMUNOL RES, V47, P25, DOI 10.1007/s12026-009-8136-3; Wilczynski JR, 2006, HUM IMMUNOL, V67, P492, DOI 10.1016/j.humimm.2006.04.007; Zeevi A, 2006, IMMUNOL RES, V36, P255, DOI 10.1385/IR:36:1:255	58	175	177	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2011	6	2							e16806	10.1371/journal.pone.0016806	http://dx.doi.org/10.1371/journal.pone.0016806			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IN	21326865	gold, Green Published, Green Submitted			2022-12-27	WOS:000287037000022
J	Li, W; Zhu, S; Li, JH; Huang, Y; Zhou, RR; Fan, XG; Yang, HA; Gong, X; Eissa, NT; Jahnen-Dechent, W; Wang, P; Tracey, KJ; Sama, AE; Wang, HC				Li, Wei; Zhu, Shu; Li, Jianhua; Huang, Yan; Zhou, Rongrong; Fan, Xuegong; Yang, Huan; Gong, Xing; Eissa, N. Tony; Jahnen-Dechent, Willi; Wang, Ping; Tracey, Kevin J.; Sama, Andrew E.; Wang, Haichao			A Hepatic Protein, Fetuin-A, Occupies a Protective Role in Lethal Systemic Inflammation	PLOS ONE			English	Article							MOBILITY GROUP BOX-1; HUMAN ALPHA-2-HS GLYCOPROTEIN; ACUTE-PHASE PROTEIN; IFN-GAMMA; EXPERIMENTAL SEPSIS; BOVINE FETUIN; APOPTOTIC CELLS; TYROSINE KINASE; HMGB1 RELEASE; BACTERIAL-DNA	Background: A liver-derived protein, fetuin-A, was first purified from calf fetal serum in 1944, but its potential role in lethal systemic inflammation was previously unknown. This study aims to delineate the molecular mechanisms underlying the regulation of hepatic fetuin-A expression during lethal systemic inflammation (LSI), and investigated whether alterations of fetuin-A levels affect animal survival, and influence systemic accumulation of a late mediator, HMGB1. Methods and Findings: LSI was induced by endotoxemia or cecal ligation and puncture (CLP) in fetuin-A knock-out or wildtype mice, and animal survival rates were compared. Murine peritoneal macrophages were challenged with exogenous (endotoxin) or endogenous (IFN-gamma) stimuli in the absence or presence of fetuin-A, and HMGB1 expression and release was assessed. Circulating fetuin-A levels were decreased in a time-dependent manner, starting between 26 h, reaching a nadir around 24-48 h, and returning towards base-line approximately 72 h post onset of endotoxemia or sepsis. These dynamic changes were mirrored by an early cytokine IFN-gamma-mediated inhibition (up to 50-70%) of hepatic fetuin-A expression. Disruption of fetuin-A expression rendered animals more susceptible to LSI, whereas supplementation of fetuin-A (20100 mg/kg) dose-dependently increased animal survival rates. The protection was associated with a significant reduction in systemic HMGB1 accumulation in vivo, and parallel inhibition of IFN-gamma or LPS-induced HMGB1 release in vitro. Conclusions: These experimental data suggest that fetuin-A is protective against lethal systemic inflammation partly by inhibiting active HMGB1 release.	[Li, Wei; Zhu, Shu; Li, Jianhua; Huang, Yan; Zhou, Rongrong; Yang, Huan; Wang, Ping; Tracey, Kevin J.; Sama, Andrew E.; Wang, Haichao] Feinstein Inst Med Res, Manhasset, NY 11030 USA; [Li, Wei; Zhu, Shu; Sama, Andrew E.; Wang, Haichao] N Shore Univ Hosp, Dept Emergency Med, Manhasset, NY USA; [Huang, Yan; Zhou, Rongrong; Fan, Xuegong] Cent S Univ, Xiangya Hosp, Dept Infect Dis, Changsha, Hunan, Peoples R China; [Gong, Xing; Eissa, N. Tony] Baylor Coll Med, Pulm Crit Care & Sleep Med Sect, Houston, TX 77030 USA; [Jahnen-Dechent, Willi] RWTH Aachen Univ Hosp, Dept Biomed Engn, Biointerface Lab, Aachen, Germany	Northwell Health; Northwell Health; North Shore University Hospital; Central South University; Baylor College of Medicine; RWTH Aachen University; RWTH Aachen University Hospital	Li, W (corresponding author), Feinstein Inst Med Res, Manhasset, NY 11030 USA.	hwang@nshs.edu	Wang, Haichao/AAU-2237-2021; Jahnen-Dechent, Willi/A-7608-2011	Wang, Haichao/0000-0002-0211-9000; Wang, Ping/0000-0002-1557-0394; Jahnen-Dechent, Willi/0000-0003-1315-4407; Li, Wei/0000-0002-7941-7022; Tracey, Kevin J/0000-0003-1884-6314	National Institute of General Medical Sciences [R01GM063075, R01GM070817]; National Center for Complementary & Integrative Health [R01AT005076] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062508, R01GM070817, R01GM063075] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of General Medical Sciences (R01GM063075 and R01GM070817 to HW.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Andersson U, 2000, J EXP MED, V192, P565, DOI 10.1084/jem.192.4.565; Ao LH, 2009, AM J PHYSIOL-HEART C, V297, pH21, DOI 10.1152/ajpheart.00292.2009; Bell CW, 2006, AM J PHYSIOL-CELL PH, V291, pC1318, DOI 10.1152/ajpcell.00616.2005; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Chen GQ, 2005, J LIPID RES, V46, P623, DOI 10.1194/jlr.C400018-JLR200; Chen GQ, 2004, J LEUKOCYTE BIOL, V76, P994, DOI 10.1189/jlb.0404242; Chen GY, 2009, SCIENCE, V323, P1722, DOI 10.1126/science.1168988; Chmiela M, 1997, GUT, V40, P20, DOI 10.1136/gut.40.1.20; CHRISTIE DL, 1987, FEBS LETT, V214, P45, DOI 10.1016/0014-5793(87)80010-8; DAVEAU M, 1988, FEBS LETT, V241, P191, DOI 10.1016/0014-5793(88)81059-7; Demetriou M, 1996, J BIOL CHEM, V271, P12755, DOI 10.1074/jbc.271.22.12755; Deriy LV, 2002, SHOCK, V17, P312, DOI 10.1097/00024382-200204000-00013; DOHERTY GM, 1992, J IMMUNOL, V149, P1666; Dubreuil JD, 2002, MICROBIOL MOL BIOL R, V66, P617, DOI 10.1128/MMBR.66.4.617-629.2002; DZIEGIELEWSKA KM, 1992, J COMP PHYSIOL B, V162, P168, DOI 10.1007/BF00398343; Dziegielewska KM, 1998, IMMUNOL LETT, V60, P31, DOI 10.1016/S0165-2478(97)00126-0; Dziegielewska KM, 1995, FETUIN, P1; Fan J, 2007, J IMMUNOL, V178, P6573, DOI 10.4049/jimmunol.178.10.6573; HAASEMANN M, 1991, BIOCHEM J, V274, P899, DOI 10.1042/bj2740899; HEINZEL FP, 1990, J IMMUNOL, V145, P2920; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Ivanov S, 2007, BLOOD, V110, P1970, DOI 10.1182/blood-2006-09-044776; Jersmann HPA, 2003, CLIN SCI, V105, P273, DOI 10.1042/CS20030126; Ketteler M, 2003, LANCET, V361, P827, DOI 10.1016/S0140-6736(03)12710-9; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Li W, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001153; Li W, 2007, J IMMUNOL, V178, P3856, DOI 10.4049/jimmunol.178.6.3856; Li YH, 2009, AM J PHYSIOL-REG I, V297, pR1670, DOI 10.1152/ajpregu.00445.2009; Lord JM, 2003, CLIN SCI, V105, P267, DOI 10.1042/CS20030177; Mathews ST, 1997, LIFE SCI, V61, P1583, DOI 10.1016/S0024-3205(97)00737-6; OHNISHI T, 1993, J BONE MINER RES, V8, P367; Ombrellino M, 2001, SHOCK, V15, P181, DOI 10.1097/00024382-200115030-00004; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Rendon-Mitchell B, 2003, J IMMUNOL, V170, P3890, DOI 10.4049/jimmunol.170.7.3890; Schafer C, 2003, J CLIN INVEST, V112, P357, DOI 10.1172/JCI17202; Schinke T, 1996, J BIOL CHEM, V271, P20789, DOI 10.1074/jbc.271.34.20789; Su X, 2008, BBA-MOL CELL RES, V1783, P1623, DOI 10.1016/j.bbamcr.2008.04.009; SUZUKI M, 1994, J EXP ZOOL, V270, P501, DOI 10.1002/jez.1402700603; Szweras M, 2002, J BIOL CHEM, V277, P19991, DOI 10.1074/jbc.M112234200; Tang DL, 2009, AM J RESP CELL MOL, V41, P651, DOI 10.1165/rcmb.2008-0119OC; Tuttolomondo A, 2010, ATHEROSCLEROSIS, V208, P290, DOI 10.1016/j.atherosclerosis.2009.07.032; Ulloa L, 2002, P NATL ACAD SCI USA, V99, P12351, DOI 10.1073/pnas.192222999; Wang H, 2004, NAT MED, V10, P1216, DOI 10.1038/nm1124; Wang HC, 2010, J CEREBR BLOOD F MET, V30, P493, DOI 10.1038/jcbfm.2009.247; Wang HC, 2009, SHOCK, V32, P348, DOI 10.1097/SHK.0b013e3181a551bd; Wang Haichao, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000884; Wang HC, 2006, J NUTR, V136, P360, DOI 10.1093/jn/136.2.360; Wang HC, 1997, LANCET, V350, P861, DOI 10.1016/S0140-6736(05)62030-2; Wang HC, 2004, NAT MED, V10, P124, DOI 10.1038/nm0204-124; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Weikert C, 2008, CIRCULATION, V118, P2555, DOI 10.1161/CIRCULATIONAHA.108.814418; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022; Yang H, 2004, P NATL ACAD SCI USA, V101, P296, DOI 10.1073/pnas.2434651100; Yang SL, 2002, ANN SURG, V236, P625, DOI 10.1097/00000658-200211000-00013; Yin KS, 2005, SHOCK, V24, P396, DOI 10.1097/01.shk.0000175556.03300.c6; Zhu S, 2009, MOL MED, V15, P275, DOI 10.2119/molmed.2009.00062	57	262	275	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2011	6	2							e16945	10.1371/journal.pone.0016945	http://dx.doi.org/10.1371/journal.pone.0016945			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717WH	21347455	gold, Green Submitted, Green Published			2022-12-27	WOS:000287077600035
J	Stulp, G; Verhulst, S; Pollet, TV; Nettle, D; Buunk, AP				Stulp, Gert; Verhulst, Simon; Pollet, Thomas V.; Nettle, Daniel; Buunk, Abraham P.			Parental Height Differences Predict the Need for an Emergency Caesarean Section	PLOS ONE			English	Article							MATERNAL HEIGHT; BIRTH-WEIGHT; SHOULDER DYSTOCIA; RISK; DELIVERY; SIZE; STATURE; WOMEN; PERFORMANCE; LABOR	More than 30% of all pregnancies in the UK require some form of assistance at delivery, with one of the more severe forms of assistance being an emergency Caesarean section (ECS). Previously it has been shown that the likelihood of a delivery via ECS is positively associated with the birth weight and size of the newborn and negatively with maternal height. Paternal height affects skeletal growth and mass of the fetus, and thus might also affect pregnancy outcomes. We hypothesized that the effect of newborn birth weight on the risk of ECS would decrease with increasing maternal height. Similarly, we predicted that there would be an increase in ECS risk as a function of paternal height, but that this effect would be relative to maternal height (i.e., parental height differences). We used data from the Millennium Cohort Study: a large-scale survey (N = 18,819 births) with data on babies born and their parents from the United Kingdom surveyed 9 to 12-months after birth. We found that in primiparous women, both maternal height and parental height differences interacted with birth weight and predicted the likelihood of an ECS. When carrying a heavy newborn, the risk of ECS was more than doubled for short women (46.3%) compared to tall women (21.7%), in agreement with earlier findings. For women of average height carrying a heavy newborn while having a relatively short compared to tall partner reduced the risk by 6.7%. In conclusion, the size of the baby, the height of the mother and parental height differences affect the likelihood of an ECS in primiparous women.	[Stulp, Gert; Pollet, Thomas V.; Nettle, Daniel; Buunk, Abraham P.] Univ Groningen, Dept Psychol, NL-9712 TS Groningen, Netherlands; [Stulp, Gert; Verhulst, Simon] Univ Groningen, Dept Behav Biol, Groningen, Netherlands; [Nettle, Daniel] Newcastle Univ, Inst Neurosci, Ctr Behaviour & Evolut, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Buunk, Abraham P.] Royal Netherlands Acad Arts & Sci, Amsterdam, Netherlands	University of Groningen; University of Groningen; Newcastle University - UK	Stulp, G (corresponding author), Univ Groningen, Dept Psychol, Grote Kruisstr 2-1, NL-9712 TS Groningen, Netherlands.	g.stulp@rug.nl	Verhulst, Simon/S-3404-2019; Pollet, Thomas V/H-3397-2012; Maliepaard, Chris/G-6041-2015; Verhulst, Niels/AAH-4288-2019; Dicke, Marcel/B-2300-2010; Pollet, Thomas/M-6346-2019; Knight, Rob/D-1299-2010; Smallegange, Renate C./L-1566-2019; Nettle, Daniel/B-2259-2008; Verhulst, Simon/B-1613-2009; Bouwmeester, Harro J/C-1414-2008; van Loon, Joop J.A./B-3744-2009	Verhulst, Simon/0000-0002-1143-6868; Pollet, Thomas V/0000-0002-4210-935X; Dicke, Marcel/0000-0001-8565-8896; Pollet, Thomas/0000-0002-4210-935X; Smallegange, Renate C./0000-0002-6946-9777; Nettle, Daniel/0000-0001-9089-2599; Verhulst, Simon/0000-0002-1143-6868; Knight, Rob/0000-0002-0975-9019; Schulz, Stefan/0000-0002-4810-324X; Verhulst, Niels/0000-0002-1106-9711; Stulp, Gert/0000-0003-0173-5554; Bouwmeester, Harro/0000-0003-0907-2732; Mumm, Roland/0000-0002-0603-1508; van Loon, Joop J.A./0000-0002-4260-0501	Wellcome Trust; Royal Netherlands Academy of Arts and Sciences; NWO [451.10.032]	Wellcome Trust(Wellcome TrustEuropean Commission); Royal Netherlands Academy of Arts and Sciences; NWO(Netherlands Organization for Scientific Research (NWO))	The Millennium Cohort Study was commissioned by the Economic and Social Research Council (ESRC), whose funding has been supplemented by a consortium of government departments and the Wellcome Trust. This research was supported by grants to APB and DN from the Royal Netherlands Academy of Arts and Sciences and an NWO Veni grant to TVP (451.10.032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADADEVOH SWK, 1989, INT J GYNECOL OBSTET, V28, P243, DOI 10.1016/0020-7292(89)90725-X; Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Awonuga Awoniyi O., 2007, Archives of Gynecology and Obstetrics, V276, P523, DOI 10.1007/s00404-007-0370-0; BAIRD D, 1949, LANCET, V256, P1079; BARKEMA HW, 1992, THERIOGENOLOGY, V37, P489, DOI 10.1016/0093-691X(92)90206-7; BELLOWS RA, 1982, J ANIM SCI, V55, P18, DOI 10.2527/jas1982.55118x; Brabin L, 2002, ACTA OBSTET GYN SCAN, V81, P502, DOI 10.1034/j.1600-0412.2002.810605.x; BRESLER JB, 1962, AM J PHYS ANTHROPOL, V20, P515, DOI 10.1002/ajpa.1330200412; CAMILLERI AP, 1981, EUR J OBSTET GYN R B, V12, P347, DOI 10.1016/0028-2243(81)90080-0; CATALANO PM, 1995, AM J OBSTET GYNECOL, V172, P1459, DOI 10.1016/0002-9378(95)90478-6; Chan BCP, 2009, J OBSTET GYNAECOL RE, V35, P307, DOI 10.1111/j.1447-0756.2008.00939.x; Colburn DJ, 1997, J ANIM SCI, V75, P1452; Courtiol A, 2010, EVOLUTION, V64, P2189, DOI 10.1111/j.1558-5646.2010.00985.x; DEX S, 2004, MILLENNIUM COHORT ST, P1; Godfrey K, 2001, J BONE MINER RES, V16, P1694, DOI 10.1359/jbmr.2001.16.9.1694; Guegan JF, 2000, P ROY SOC B-BIOL SCI, V267, P2529, DOI 10.1098/rspb.2000.1316; Huber LRB, 2007, MATERN CHILD HLTH J, V11, P137, DOI 10.1007/s10995-006-0157-0; JAMES DK, 1979, BRIT MED J, V1, P10, DOI 10.1136/bmj.1.6155.10; KAPPEL B, 1987, ACTA OBSTET GYN SCAN, V66, P153, DOI 10.3109/00016348709083038; Kirchengast S., 2007, ACTA MED LITU, V14, P1; Knight B, 2005, EARLY HUM DEV, V81, P823, DOI 10.1016/j.earlhumdev.2005.06.003; LANGER O, 1991, AM J OBSTET GYNECOL, V165, P831, DOI 10.1016/0002-9378(91)90424-P; McGuinness BJ, 1999, AUST NZ J OBSTET GYN, V39, P152, DOI 10.1111/j.1479-828X.1999.tb03360.x; Mee I, 2008, VET J, V176, P93, DOI 10.1016/j.tvjl.2007.12.032; Merchant KM, 2001, BRIT J OBSTET GYNAEC, V108, P689, DOI 10.1111/j.1471-0528.2001.00181.x; Mocanu EV, 2000, EUR J OBSTET GYN R B, V92, P229, DOI 10.1016/S0301-2115(99)00280-8; *NAT HLTH STAT MAT, 2005, MAT STAT; Neilson JP, 2003, BRIT MED BULL, V67, P191, DOI 10.1093/bmb/ldg018; Nesbitt TS, 1998, AM J OBSTET GYNECOL, V179, P476, DOI 10.1016/S0002-9378(98)70382-5; PARRISH KM, 1994, JAMA-J AM MED ASSOC, V271, P443, DOI 10.1001/jama.271.6.443; Pawlowski B, 2003, P ROY SOC B-BIOL SCI, V270, P709, DOI 10.1098/rspb.2002.2294; READ AW, 1994, AM J PUBLIC HEALTH, V84, P37, DOI 10.2105/AJPH.84.1.37; SANDMIRE HF, 1988, INT J GYNECOL OBSTET, V26, P65, DOI 10.1016/0020-7292(88)90198-1; Shields Beverley M, 2006, BMC Pediatr, V6, P24, DOI 10.1186/1471-2431-6-24; Shy K, 2000, AM J OBSTET GYNECOL, V182, P1363, DOI 10.1067/mob.2000.106175; THOMSON AM, 1963, P NUTR SOC, V22, P55, DOI 10.1079/PNS19630013; Trevathan W, 2000, J HUM EVOL, V39, P583, DOI 10.1006/jhev.2000.0434; TURNER MJ, 1990, OBSTET GYNECOL, V76, P159; VANROOSMALEN J, 1992, INT J GYNECOL OBSTET, V37, P169, DOI 10.1016/0020-7292(92)90377-U; Veena SR, 2004, PAEDIATR PERINAT EP, V18, P361, DOI 10.1111/j.1365-3016.2004.00579.x; WHO, 2005, MAK EV MOTH CHILD CO; Wills AK, 2010, EARLY HUM DEV, V86, P535, DOI 10.1016/j.earlhumdev.2010.07.002; WITTER FR, 1995, OBSTET GYNECOL, V85, P947, DOI 10.1016/0029-7844(95)00082-3	43	199	201	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e20497	10.1371/journal.pone.0020497	http://dx.doi.org/10.1371/journal.pone.0020497			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	786FZ	21738577	Green Published, Green Accepted, gold			2022-12-27	WOS:000292290100004
J	Wang, QY; Chen, GR; Perc, M				Wang, Qingyun; Chen, Guanrong; Perc, Matjaz			Synchronous Bursts on Scale-Free Neuronal Networks with Attractive and Repulsive Coupling	PLOS ONE			English	Article							SYNCHRONIZATION; OSCILLATIONS; REGULARIZATION; CHAOS	This paper investigates the dependence of synchronization transitions of bursting oscillations on the information transmission delay over scale-free neuronal networks with attractive and repulsive coupling. It is shown that for both types of coupling, the delay always plays a subtle role in either promoting or impairing synchronization. In particular, depending on the inherent oscillation period of individual neurons, regions of irregular and regular propagating excitatory fronts appear intermittently as the delay increases. These delay-induced synchronization transitions are manifested as well-expressed minima in the measure for spatiotemporal synchrony. For attractive coupling, the minima appear at every integer multiple of the average oscillation period, while for the repulsive coupling, they appear at every odd multiple of the half of the average oscillation period. The obtained results are robust to the variations of the dynamics of individual neurons, the system size, and the neuronal firing type. Hence, they can be used to characterize attractively or repulsively coupled scale-free neuronal networks with delays.	[Wang, Qingyun] Beihang Univ, Dept Dynam & Control, Beijing, Peoples R China; [Chen, Guanrong] City Univ Hong Kong, Dept Elect Engn, Hong Kong, Hong Kong, Peoples R China; [Perc, Matjaz] Univ Maribor, Fac Nat Sci & Math, Dept Phys, SLO-2000 Maribor, Slovenia	Beihang University; City University of Hong Kong; University of Maribor	Wang, QY (corresponding author), Beihang Univ, Dept Dynam & Control, Beijing, Peoples R China.	drwangqy@gmail.com; matjaz.perc@uni-mb.si	wang, qinyu/GYA-0366-2022; Wang, Qingyun/G-2309-2010; Chen, Guanrong/F-6000-2011; Perc, Matjaz/A-5148-2009	Wang, Qingyun/0000-0003-2931-4663; Chen, Guanrong/0000-0003-1381-7418; Perc, Matjaz/0000-0002-3087-541X; Zhang, Min/0000-0001-5812-9518	National Science Foundation of China [10972001, 10702023, 10832006]; Slovenian Research Agency [Z1-2032]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Slovenian Research Agency(Slovenian Research Agency - Slovenia)	QW and GC acknowledge support from the National Science Foundation of China (Funds number 10972001, 10702023 and 10832006). MP acknowledges support from the Slovenian Research Agency (Grant Z1-2032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarbanel H. D. I., 1996, Physics-Uspekhi, V39, P337, DOI 10.1070/PU1996v039n04ABEH000141; Achuthan S, 2009, J NEUROSCI, V29, P5218, DOI 10.1523/JNEUROSCI.0426-09.2009; Arenas A, 2006, PHYSICA D, V224, P27, DOI 10.1016/j.physd.2006.09.029; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Batista CAS, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.016218; Bazhenov M, 2001, NEURON, V30, P553, DOI 10.1016/S0896-6273(01)00284-7; Belykh I, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.188101; DAVID G, 2001, PHYS REV LETT, V86, P4179; Drover J, 2004, SIAM J APPL MATH, V65, P69, DOI 10.1137/S0036139903431233; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; Gao Z., 2001, PHYS REV E, V65, DOI DOI 10.1103/PHYSREVE.65.016209; Gomez-Gardenes J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012313; GRAY CM, 1989, P NATL ACAD SCI USA, V86, P1698, DOI 10.1073/pnas.86.5.1698; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Huang L, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.016103; Huang L, 2008, CHAOS, V18, DOI 10.1063/1.2826289; Hunt D, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.068701; Kaiser M, 2007, EUR J NEUROSCI, V25, P3185, DOI 10.1111/j.1460-9568.2007.05574.x; Kandel E.R., 1991, PRINC NEUROSCI, V3rd ed.; Kitajo K, 2007, EPL-EUROPHYS LETT, V80, DOI 10.1209/0295-5075/80/40009; Kopell N, 2000, P NATL ACAD SCI USA, V97, P1867, DOI 10.1073/pnas.97.4.1867; Kopell N, 2004, P NATL ACAD SCI USA, V101, P15482, DOI 10.1073/pnas.0406343101; Kryukov AK, 2008, CHAOS, V18, DOI 10.1063/1.2956985; Kunichika T., 2003, INT J BIFURCAT CHAOS, V13, P653; Lai YC, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108102; Leyva I, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.056112; Li XM, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/8/083045; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; MORRIS C, 1981, BIOPHYS J, V35, P193, DOI 10.1016/S0006-3495(81)84782-0; Neiman A, 1999, PHYS REV LETT, V83, P4896, DOI 10.1103/PhysRevLett.83.4896; Nowotny T, 2008, CHAOS, V18, DOI 10.1063/1.2949925; Oh M, 2009, J COMPUT NEUROSCI, V26, P303, DOI 10.1007/s10827-008-0112-8; Osan R, 2002, PHYSICA D, V163, P217, DOI 10.1016/S0167-2789(02)00347-0; Rabinovich MI, 2006, REV MOD PHYS, V78, P1213, DOI 10.1103/RevModPhys.78.1213; Raichman N, 2008, J NEUROSCI METH, V170, P96, DOI 10.1016/j.jneumeth.2007.12.020; Rossoni E, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.061904; Roxin A, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.238103; Rulkov NF, 2004, J COMPUT NEUROSCI, V17, P203, DOI 10.1023/B:JCNS.0000037683.55688.7e; Rulkov NF, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041922; Rulkov NF, 2001, PHYS REV LETT, V86, P183, DOI 10.1103/PhysRevLett.86.183; Sainz-Trapaga M, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.031904; Shein M, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/3/036008; Shilnikov AL, 2003, INT J BIFURCAT CHAOS, V13, P3325, DOI 10.1142/S0218127403008521; Stephens GJ, 2010, P NATL ACAD SCI USA, V107, P14425, DOI 10.1073/pnas.1008662107; Suykens JAK, 2008, CHAOS, V18, DOI 10.1063/1.2985139; Martins TV, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.041103; Volman V, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/4/043013; Wang QY, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/10/383; Wang QY, 2007, EPL-EUROPHYS LETT, V77, DOI 10.1209/0295-5075/77/10004; Wang QY, 2006, PHYS LETT A, V356, P17, DOI 10.1016/j.physleta.2006.03.017; Wang QY, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/50008; Wang QY, 2005, CHINESE PHYS LETT, V22, P543, DOI 10.1088/0256-307X/22/3/007; Yanagita T, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.056218	56	311	316	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2011	6	1							e15851	10.1371/journal.pone.0015851	http://dx.doi.org/10.1371/journal.pone.0015851			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KZ	21701596	Green Published, gold, Green Submitted			2022-12-27	WOS:000286511900014
J	Zhang, YJ; Ma, PF; Li, DZ				Zhang, Yun-Jie; Ma, Peng-Fei; Li, De-Zhu			High-Throughput Sequencing of Six Bamboo Chloroplast Genomes: Phylogenetic Implications for Temperate Woody Bamboos (Poaceae: Bambusoideae)	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; GRASS FAMILY POACEAE; NATURAL HYBRIDIZATION; EVOLUTIONARY ANALYSIS; PLASTID GENOMES; GBSSI GENE; DNA; REGIONS; BAMBUSA; NUCLEAR	Background: Bambusoideae is the only subfamily that contains woody members in the grass family, Poaceae. In phylogenetic analyses, Bambusoideae, Pooideae and Ehrhartoideae formed the BEP clade, yet the internal relationships of this clade are controversial. The distinctive life history (infrequent flowering and predominance of asexual reproduction) of woody bamboos makes them an interesting but taxonomically difficult group. Phylogenetic analyses based on large DNA fragments could only provide a moderate resolution of woody bamboo relationships, although a robust phylogenetic tree is needed to elucidate their evolutionary history. Phylogenomics is an alternative choice for resolving difficult phylogenies. Methodology/Principal Findings: Here we present the complete nucleotide sequences of six woody bamboo chloroplast (cp) genomes using Illumina sequencing. These genomes are similar to those of other grasses and rather conservative in evolution. We constructed a phylogeny of Poaceae from 24 complete cp genomes including 21 grass species. Within the BEP clade, we found strong support for a sister relationship between Bambusoideae and Pooideae. In a substantial improvement over prior studies, all six nodes within Bambusoideae were supported with >= 0.95 posterior probability from Bayesian inference and 5/6 nodes resolved with 100% bootstrap support in maximum parsimony and maximum likelihood analyses. We found that repeats in the cp genome could provide phylogenetic information, while caution is needed when using indels in phylogenetic analyses based on few selected genes. We also identified relatively rapidly evolving cp genome regions that have the potential to be used for further phylogenetic study in Bambusoideae. Conclusions/Significance: The cp genome of Bambusoideae evolved slowly, and phylogenomics based on whole cp genome could be used to resolve major relationships within the subfamily. The difficulty in resolving the diversification among three clades of temperate woody bamboos, even with complete cp genome sequences, suggests that these lineages may have diverged very rapidly.	[Zhang, Yun-Jie; Ma, Peng-Fei; Li, De-Zhu] Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeog, Kunming, Yunnan, Peoples R China; [Zhang, Yun-Jie; Ma, Peng-Fei; Li, De-Zhu] Chinese Acad Sci, Kunming Inst Bot, Plant Germplasm & Genom Ctr, Germplasm Bank Wild Species, Kunming, Yunnan, Peoples R China; [Zhang, Yun-Jie; Ma, Peng-Fei] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhang, YJ (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeog, Kunming, Yunnan, Peoples R China.	dzl@mail.kib.ac.cn	Li, De-Zhu/G-8203-2011	Li, De-Zhu/0000-0002-4990-724X; Chen, Wei/0000-0002-6383-7540; Chen, Guoxun/0000-0001-6226-4050	Chinese Academy of Sciences [KSCX-YW-N-029]; National Natural Science Foundation of China [30990244]; Innovation Teams of Yunnan Province, China	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Teams of Yunnan Province, China	This project is supported by the Chinese Academy of Sciences through a project under the knowledge innovation program (KSCX-YW-N-029), National Natural Science Foundation of China (no. 30990244) and a program of Innovation Teams of Yunnan Province, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano T, 2004, DNA RES, V11, P93, DOI 10.1093/dnares/11.2.93; Bapteste E, 2002, MOL BIOL EVOL, V19, P972, DOI 10.1093/oxfordjournals.molbev.a004156; Barker NP, 2001, ANN MO BOT GARD, V88, P373, DOI 10.2307/3298585; BIRKY CW, 1995, P NATL ACAD SCI USA, V92, P11331, DOI 10.1073/pnas.92.25.11331; Bortiri Esteban, 2008, BMC Res Notes, V1, P61, DOI 10.1186/1756-0500-1-61; Bouchenak-Khelladi Y, 2008, MOL PHYLOGENET EVOL, V47, P488, DOI 10.1016/j.ympev.2008.01.035; Bystriakova N., 2003, BAMBOO BIODIVERSITY; Bystriakova N., 2004, BAMBOO BIODIVERSITY; Cahoon AB, 2010, AM J BOT, V97, P49, DOI 10.3732/ajb.0900008; Chang CC, 2006, MOL BIOL EVOL, V23, P279, DOI 10.1093/molbev/msj029; CLARK LG, 1989, NATL GEOGR RES, V5, P459; CLARK LG, 1995, SYST BOT, V20, P436, DOI 10.2307/2419803; Cronn R, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn502; CUMMINGS MP, 1994, MOL BIOL EVOL, V11, P1; Davis JI, 2010, AM J BOT, V97, P874, DOI 10.3732/ajb.0900228; Diekmann K, 2009, DNA RES, V16, P165, DOI 10.1093/dnares/dsp008; Diekmann K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002813; DOYLE JJ, 1992, P NATL ACAD SCI USA, V89, P7722, DOI 10.1073/pnas.89.16.7722; Dyall SD, 2004, SCIENCE, V304, P253, DOI 10.1126/science.1094884; Egan AN, 2008, MOL PHYLOGENET EVOL, V46, P532, DOI 10.1016/j.ympev.2007.10.006; Gaut BS, 1997, MOL BIOL EVOL, V14, P769, DOI 10.1093/oxfordjournals.molbev.a025817; GIELLY L, 1994, MOL BIOL EVOL, V11, P769; Gong X. S., 1994, J WUHAN BOT RES, V12, P277; Goremykin VV, 2005, MOL BIOL EVOL, V22, P1813, DOI 10.1093/molbev/msi173; Guisinger MM, 2010, J MOL EVOL, V70, P149, DOI 10.1007/s00239-009-9317-3; Hansen DR, 2007, MOL PHYLOGENET EVOL, V45, P547, DOI 10.1016/j.ympev.2007.06.004; HIRATSUKA J, 1989, MOL GEN GENET, V217, P185, DOI 10.1007/BF02464880; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; INBAR, 1999, SOC ISS CONSTR BAMB; Jansen RK, 2005, METHOD ENZYMOL, V395, P348, DOI 10.1016/S0076-6879(05)95020-9; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; JANZEN DH, 1976, ANNU REV ECOL SYST, V7, P347, DOI 10.1146/annurev.es.07.110176.002023; Judziewicz EJ, 1999, AM BAMBOOS; Junior TC, 2004, CURR GENET, V46, P366, DOI 10.1007/s00294-004-0542-4; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kim KJ, 2004, DNA RES, V11, P247, DOI 10.1093/dnares/11.4.247; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Leseberg CH, 2009, J MOL EVOL, V69, P311, DOI 10.1007/s00239-009-9275-9; Li D.-Z., 2006, FLORA CHINA, V22, P7; LI DZ, 1998, BAMBOO CONSERVATION; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; MAIER RM, 1995, J MOL BIOL, V251, P614, DOI 10.1006/jmbi.1995.0460; Mardanov AV, 2008, J MOL EVOL, V66, P555, DOI 10.1007/s00239-008-9091-7; Masood MS, 2004, GENE, V340, P133, DOI 10.1016/j.gene.2004.06.008; Mayor C, 2000, BIOINFORMATICS, V16, P1046, DOI 10.1093/bioinformatics/16.11.1046; Moore MJ, 2010, P NATL ACAD SCI USA, V107, P4623, DOI 10.1073/pnas.0907801107; Morris LM, 2010, AM J BOT, V97, P620, DOI 10.3732/ajb.0900226; Ogihara Y, 2002, MOL GENET GENOMICS, V266, P740, DOI 10.1007/s00438-001-0606-9; Ohrnberger D, 1999, BAMBOOS WORLD ANNOTA; Parks M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-84; Peng ZH, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-116; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; RENVOIZE SA, 1992, GRASS EVOLUTION DOME; Sanchez-Ken JG, 2007, SYST BOT, V32, P71, DOI 10.1600/036364407780360102; Saski C, 2007, THEOR APPL GENET, V115, P571, DOI 10.1007/s00122-007-0595-0; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; SHINOZAKI K, 1986, EMBO J, V5, P2043, DOI 10.1002/j.1460-2075.1986.tb04464.x; Smith SA, 2008, SCIENCE, V322, P86, DOI 10.1126/science.1163197; Soltis DE, 2004, TRENDS PLANT SCI, V9, P477, DOI 10.1016/j.tplants.2004.08.008; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Sun Y, 2005, BIOCHEM GENET, V43, P603, DOI 10.1007/s10528-005-9117-4; Sungkaew S, 2009, J PLANT RES, V122, P95, DOI 10.1007/s10265-008-0192-6; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang JB, 2004, PLANT PHYSIOL, V135, P412, DOI 10.1104/pp.103.031245; Timme RE, 2007, AM J BOT, V94, P302, DOI 10.3732/ajb.94.3.302; Triplett JK, 2010, AM J BOT, V97, P471, DOI 10.3732/ajb.0900244; Triplett JK, 2010, SYST BOT, V35, P102, DOI 10.1600/036364410790862678; Wu FH, 2009, TREE PHYSIOL, V29, P847, DOI 10.1093/treephys/tpp015; Wu FH, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-68; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Yang HQ, 2008, MOL PHYLOGENET EVOL, V48, P809, DOI 10.1016/j.ympev.2008.06.001; Yang JB, 2010, TAXON, V59, P1102, DOI 10.1002/tax.594010; Zeng CX, 2010, MOL PHYLOGENET EVOL, V56, P821, DOI 10.1016/j.ympev.2010.03.041; Zhang WP, 2000, MOL PHYLOGENET EVOL, V15, P135, DOI 10.1006/mpev.1999.0729; Zhong BJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005297	78	293	320	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20596	10.1371/journal.pone.0020596	http://dx.doi.org/10.1371/journal.pone.0020596			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21731709	Green Submitted, Green Published, gold			2022-12-27	WOS:000291097600106
J	Zhang, Y; Chen, W; Li, R; Li, Y; Ge, YB; Chen, GX				Zhang, Yan; Chen, Wei; Li, Rui; Li, Yang; Ge, Yuebin; Chen, Guoxun			Insulin-Regulated Srebp-1c and Pck1 mRNA Expression in Primary Hepatocytes from Zucker Fatty but Not Lean Rats Is Affected by Feeding Conditions	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN-1C; GENE-EXPRESSION; CALORIC RESTRICTION; SIGNALING PATHWAY; MISSENSE MUTATION; ACID SYNTHESIS; X-RECEPTOR; LIVER; OBESITY; RESISTANCE	Insulin regulates the transcription of genes for hepatic glucose and lipid metabolism. We hypothesized that this action may be impaired in hepatocytes from insulin resistant animals. Primary hepatocytes from insulin sensitive Zucker lean (ZL) and insulin resistant Zucker fatty (ZF) rats in ad libitum or after an overnight fasting were isolated, cultured and treated with insulin and other compounds for analysis of gene expression using real-time PCR. The mRNA levels of one insulin-induced (Srebp-1c) and one insulin-suppressed (Pck1) genes in response to insulin, glucagon, and compactin treatments in hepatocytes from ad libitum ZL and ZF rats were analyzed. Additionally, the effects of insulin and T1317 on their levels in hepatocytes from ad libitum or fasted ZL or ZF rats were compared. The mRNA levels of Srebp-1c, Fas, and Scd1, but not that of Insr, Gck and Pck1, were higher in freshly isolated hepatocytes from ad libitum ZF than that from ZL rats. These patterns of Srebp-1c and Pck1 mRNA levels remained in primary hepatocyte cultured in vitro. Insulin's ability to regulate Srebp-1c and Pck1 expression was diminished in hepatocytes from ad libitum ZF, but not ZL rats. Glucagon or compactin suppressed Srebp-1c mRNA expression in lean, but not fatty hepatocytes. However, glucagon induced Pck1 mRNA expression similarly in hepatocytes from ad libitum ZL and ZF rats. Insulin caused the same dose-dependent increase of Akt phosphorylation in hepatocytes from ad libitum ZL and ZF rats. It synergized with T1317 to induce Srebp-1c, and suppressed Pck1 mRNA levels in hepatocytes from fasted, but not that from ad libitum ZF rats. We demonstrated that insulin was unable to regulate its downstream genes' mRNA expression in hepatocytes from ad libitum ZF rats. This impairment can be partially restored in hepatocytes from ZF rats after an overnight fasting, a phenomenon that deserves further investigation.	[Zhang, Yan; Chen, Wei; Li, Rui; Li, Yang; Ge, Yuebin; Chen, Guoxun] Univ Tennessee, Dept Nutr, Knoxville, TN 37996 USA; [Ge, Yuebin] S Cent Univ Nationalities, Coll Pharm, Wuhan, Hubei, Peoples R China	University of Tennessee System; University of Tennessee Knoxville; South Central Minzu University	Zhang, Y (corresponding author), Univ Tennessee, Dept Nutr, Knoxville, TN 37996 USA.	gchen6@utk.edu	Li, De-Zhu/G-8203-2011	Li, De-Zhu/0000-0002-4990-724X; Chen, Wei/0000-0002-6383-7540; Chen, Guoxun/0000-0001-6226-4050	American Heart Association [09SDG2140003]; University of Tennessee at Knoxville; Allen Foundation Inc.	American Heart Association(American Heart Association); University of Tennessee at Knoxville; Allen Foundation Inc.	This work was supported by the Scientist Development Grant from American Heart Association (09SDG2140003, to G.C.), a start-up fund from the University of Tennessee at Knoxville (to G.C.), and a research grant from Allen Foundation Inc. (to G.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGIUS L, 1990, BIOCHEM J, V266, P91, DOI 10.1042/bj2660091; de Artinano AA, 2009, BRIT J NUTR, V102, P1246, DOI 10.1017/S0007114509990729; Banerjee RR, 2004, SCIENCE, V303, P1195, DOI 10.1126/science.1092341; Brown MS, 2008, CELL METAB, V7, P95, DOI 10.1016/j.cmet.2007.12.009; Buque X, 2010, J LIPID RES, V51, P500, DOI 10.1194/jlr.M001966; Chen GX, 2007, BIOCHEM BIOPH RES CO, V361, P805, DOI 10.1016/j.bbrc.2007.07.108; Chen GX, 2009, BIOCHEM J, V419, P645, DOI 10.1042/BJ20082368; Chen GX, 2004, P NATL ACAD SCI USA, V101, P11245, DOI 10.1073/pnas.0404297101; Chirieac DV, 2004, AM J PHYSIOL-ENDOC M, V287, pE42, DOI 10.1152/ajpendo.00297.2003; CLARK JB, 1983, P SOC EXP BIOL MED, V173, P68; CLARK JB, 1982, ENDOCRINOLOGY, V111, P964, DOI 10.1210/endo-111-3-964; DeBose-Boyd RA, 2001, P NATL ACAD SCI USA, V98, P1477, DOI 10.1073/pnas.98.4.1477; Flowers MI, 2009, BBA-MOL CELL BIOL L, V1791, P85, DOI 10.1016/j.bbalip.2008.12.011; Foretz M, 1999, MOL CELL BIOL, V19, P3760; Garnett KE, 2005, J MOL ENDOCRINOL, V35, P13, DOI 10.1677/jme.1.01792; Griffen SC, 2001, DIABETES, V50, P63, DOI 10.2337/diabetes.50.1.63; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; HENRY RR, 1985, J CLIN ENDOCR METAB, V61, P917, DOI 10.1210/jcem-61-5-917; Horton JD, 2008, SCIENCE, V320, P1433, DOI 10.1126/science.1159651; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Iida M, 1996, BIOCHEM BIOPH RES CO, V224, P597, DOI 10.1006/bbrc.1996.1070; IYNEDJIAN PB, 1993, BIOCHEM J, V293, P1; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Kabir M, 2005, AM J PHYSIOL-ENDOC M, V288, pE454, DOI 10.1152/ajpendo.00203.2004; Kakuma T, 2000, P NATL ACAD SCI USA, V97, P8536, DOI 10.1073/pnas.97.15.8536; Li SJ, 2010, P NATL ACAD SCI USA, V107, P3441, DOI 10.1073/pnas.0914798107; Liang GS, 2002, J BIOL CHEM, V277, P9520, DOI 10.1074/jbc.M111421200; MAGNUSON MA, 1989, P NATL ACAD SCI USA, V86, P4838, DOI 10.1073/pnas.86.13.4838; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Matsumoto M, 2003, J CLIN INVEST, V112, P935, DOI 10.1172/JCI200318816; McGarry JD, 2002, DIABETES, V51, P7, DOI 10.2337/diabetes.51.1.7; MILBURN JL, 1995, J BIOL CHEM, V270, P1295, DOI 10.1074/jbc.270.3.1295; Mokdad AH, 1999, JAMA-J AM MED ASSOC, V282, P1519, DOI 10.1001/jama.282.16.1519; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; OBrien RM, 1996, PHYSIOL REV, V76, P1109, DOI 10.1152/physrev.1996.76.4.1109; OKAUCHI N, 1995, DIABETES RES CLIN PR, V27, P97, DOI 10.1016/0168-8227(95)01029-D; Phillips MS, 1996, NAT GENET, V13, P18, DOI 10.1038/ng0596-18; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Reaven GM, 2005, ANNU REV NUTR, V25, P391, DOI 10.1146/annurev.nutr.24.012003.132155; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Sajan MP, 2009, DIABETOLOGIA, V52, P1197, DOI 10.1007/s00125-009-1336-5; Shimomura I, 2000, MOL CELL, V6, P77, DOI 10.1016/S1097-2765(00)00009-5; Shimomura L, 1999, P NATL ACAD SCI USA, V96, P13656, DOI 10.1073/pnas.96.24.13656; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; STARKE A, 1987, J CLIN INVEST, V79, P20, DOI 10.1172/JCI112784; STEVENS J, 1981, MOL CELL BIOCHEM, V37, P177, DOI 10.1007/BF02354886; Takaya K, 1996, BIOCHEM BIOPH RES CO, V225, P75, DOI 10.1006/bbrc.1996.1133; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Taniguchi CM, 2006, CELL METAB, V3, P343, DOI 10.1016/j.cmet.2006.04.005; Unger RH, 1997, TRENDS ENDOCRIN MET, V8, P276, DOI 10.1016/S1043-2760(97)00094-5; Zhou YP, 1999, METABOLISM, V48, P857, DOI 10.1016/S0026-0495(99)90219-6; ZUCKER LM, 1972, ENDOCRINOLOGY, V90, P1320, DOI 10.1210/endo-90-5-1320; ZUCKER LM, 1972, J LIPID RES, V13, P234; ZUCKER LM, 1961, J HERED, V52, P275, DOI 10.1093/oxfordjournals.jhered.a107093	55	293	320	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21342	10.1371/journal.pone.0021342	http://dx.doi.org/10.1371/journal.pone.0021342			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731709	gold, Green Published, Green Submitted			2022-12-27	WOS:000292033700064
J	Chen, YJ; Huang, WC; Wei, YL; Hsu, SC; Yuan, P; Lin, HY; Wistuba, II; Lee, JJ; Yen, CJ; Su, WC; Chang, KY; Chang, WC; Chou, TC; Chou, CK; Tsai, CH; Hung, MC				Chen, Yun-Ju; Huang, Wei-Chien; Wei, Ya-Ling; Hsu, Sheng-Chieh; Yuan, Ping; Lin, Heather Y.; Wistuba, Ignacio I.; Lee, J. Jack; Yen, Chia-Jui; Su, Wu-Chou; Chang, Kwang-Yu; Chang, Wen-Chang; Chou, Tse-Chuan; Chou, Chao-Kai; Tsai, Chang-Hai; Hung, Mien-Chie			Elevated BCRP/ABCG2 Expression Confers Acquired Resistance to Gefitinib in Wild-Type EGFR-Expressing Cells	PLOS ONE			English	Article							TYROSINE KINASE INHIBITOR; FACTOR RECEPTOR MUTATIONS; LUNG-CANCER PATIENTS; MULTIDRUG-RESISTANCE; DRUG-RESISTANCE; ANTITUMOR-ACTIVITY; GENE-MUTATIONS; PHASE-II; ERLOTINIB; PROTEIN	Background: The sensitivity of non-small cell lung cancer (NSCLC) patients to EGFR tyrosine kinase inhibitors (TKIs) is strongly associated with activating EGFR mutations. Although not as sensitive as patients harboring these mutations, some patients with wild-type EGFR (wtEGFR) remain responsive to EGFR TKIs, suggesting that the existence of unexplored mechanisms renders most of wtEGFR-expressing cancer cells insensitive. Methodology/Principal Findings: Here, we show that acquired resistance of wtEGFR-expressing cancer cells to an EGFR TKI, gefitinib, is associated with elevated expression of breast cancer resistance protein (BCRP/ABCG2), which in turn leads to gefitinib efflux from cells. In addition, BCRP/ABCG2 expression correlates with poor response to gefitinib in both cancer cell lines and lung cancer patients with wtEGFR. Co-treatment with BCRP/ABCG2 inhibitors enhanced the anti-tumor activity of gefitinib. Conclusions/Significance: Thus, BCRP/ABCG2 expression may be a predictor for poor efficacy of gefitinib treatment, and targeting BCRP/ABCG2 may broaden the use of gefitinib in patients with wtEGFR.	[Chen, Yun-Ju; Huang, Wei-Chien; Wei, Ya-Ling; Hsu, Sheng-Chieh; Hung, Mien-Chie] China Med Univ Hosp, Ctr Mol Med, Taichung, Taiwan; [Tsai, Chang-Hai] China Med Univ Hosp, Dept Pediat, Taichung, Taiwan; [Huang, Wei-Chien] China Med Univ, Grad Inst Canc Biol, Taichung, Taiwan; [Huang, Wei-Chien] China Med Univ, PhD Program Canc Biol & Drug Discovery, Taichung, Taiwan; [Tsai, Chang-Hai] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Chou, Chao-Kai; Hung, Mien-Chie] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Yuan, Ping; Wistuba, Ignacio I.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Lin, Heather Y.; Lee, J. Jack] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Chang, Wen-Chang] Natl Cheng Kung Univ, Dept Pharmacol, Tainan 70101, Taiwan; [Yen, Chia-Jui; Su, Wu-Chou] Natl Cheng Kung Univ, Inst Clin Med, Tainan 70101, Taiwan; [Chou, Tse-Chuan] Natl Cheng Kung Univ, Dept Chem Engn, Tainan, Taiwan; [Huang, Wei-Chien] Asia Univ, Dept Biotechnol, Taichung, Taiwan; [Tsai, Chang-Hai] Asia Univ, Dept Healthcare Adm, Taichung, Taiwan; [Chang, Kwang-Yu] Natl Hlth Res Inst, Natl Inst Canc Res, Tainan, Taiwan; [Chou, Tse-Chuan] Tatung Univ, Dept Chem Engn, Taipei 104, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; Asia University Taiwan; Asia University Taiwan; National Health Research Institutes - Taiwan; Tatung University	Chen, YJ (corresponding author), China Med Univ Hosp, Ctr Mol Med, Taichung, Taiwan.	whuang@mail.cmu.edu.tw; mhung@mdanderson.org	Center, Univ of Texas-M D Anderson Cancer/AAE-8182-2019; Hung, Mien-Chie/ABD-5911-2021; Huang, Wei-Chien/D-1740-2012; Chang, Kwang-Yu/G-9161-2011; Huang, Wei-Chien/H-3126-2019; Lee, Jack/P-7331-2019; Zhang, Jun/G-4598-2010	Center, Univ of Texas-M D Anderson Cancer/0000-0001-5469-9214; Hung, Mien-Chie/0000-0003-4317-4740; Huang, Wei-Chien/0000-0001-6467-8716; Huang, Wei-Chien/0000-0001-6467-8716; Lee, Jack/0000-0002-4584-929X; CHOU, CHAO-KAI/0000-0001-5231-5264; Zhang, Jun/0000-0002-6601-9180; SHENG, WANG-HUEI/0000-0002-5605-7853; Su, Wu-Chou/0000-0003-2953-4105; CHEN, YEE-CHUN/0000-0002-1816-9010; Xia, Ningshao/0000-0003-0179-5266; TSAI, KEH-SUNG/0000-0001-8528-1566; WANG, JANN-TAY/0000-0002-0924-3469; Mizuguchi, Kenji/0000-0003-3021-7078; CHANG, SHAN-CHWEN/0000-0001-6505-4139	National Science Council of Taiwan [NSC-96-2917-I-006-004, NSC-97-2320-B-039-033-MY3, NSC-98-3112-B-039-002]; National Health Research Institutes of Taiwan [NHRI-EX-98-9812BC, NSC-2632-B-001]; Cancer Center Research of Excellence [DOH-TD-C-111-005]; National Institutes of Health [NIH PO1 CA099031, NIH RO1 CA109311]; National Breast Cancer Foundation, Inc.; Kadoorie Charitable Foundation; University of Texas MD Anderson Cancer Center; CMUH Sister Institution Fund; NATIONAL CANCER INSTITUTE [P01CA099031, R01CA109311] Funding Source: NIH RePORTER	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); National Health Research Institutes of Taiwan(National Health Research Institutes - Taiwan); Cancer Center Research of Excellence; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Breast Cancer Foundation, Inc.; Kadoorie Charitable Foundation; University of Texas MD Anderson Cancer Center; CMUH Sister Institution Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Science Council of Taiwan (NSC-96-2917-I-006-004 to Y.J. Chen; NSC-97-2320-B-039-033-MY3 and NSC-98-3112-B-039-002 to W.C. Huang), the National Health Research Institutes of Taiwan (NHRI-EX-98-9812BC to W.C. Huang), NSC-2632-B-001, and Cancer Center Research of Excellence (DOH-TD-C-111-005), National Institutes of Health (NIH PO1 CA099031 and NIH RO1 CA109311), National Breast Cancer Foundation, Inc., Kadoorie Charitable Foundation, and The University of Texas MD Anderson Cancer Center and CMUH Sister Institution Fund (to M.C. Hung). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bean J, 2007, P NATL ACAD SCI USA, V104, P20932, DOI 10.1073/pnas.0710370104; Bell DW, 2005, J CLIN ONCOL, V23, P8081, DOI 10.1200/JCO.2005.02.7078; Cappuzzo F, 2005, JNCI-J NATL CANCER I, V97, P643, DOI 10.1093/jnci/dji112; Chang GC, 2006, J THORAC ONCOL, V1, P520, DOI 10.1097/01243894-200607000-00004; Coldren CD, 2006, MOL CANCER RES, V4, P521, DOI 10.1158/1541-7786.MCR-06-0095; Diestra JE, 2003, J UROLOGY, V170, P1383, DOI 10.1097/01.ju.0000074710.96154.c9; Diestra JE, 2002, J PATHOL, V198, P213, DOI 10.1002/path.1203; Fukuoka M, 2003, J CLIN ONCOL, V21, P2237, DOI 10.1200/JCO.2003.10.038; Guix M, 2008, J CLIN INVEST, V118, P2609, DOI 10.1172/JCI34588; Huang SF, 2004, CLIN CANCER RES, V10, P8195, DOI 10.1158/1078-0432.CCR-04-1245; HUANG WC, 2011, J BIOL CHEM; Kalish LH, 2004, CLIN CANCER RES, V10, P7764, DOI 10.1158/1078-0432.CCR-04-0012; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kim ES, 2008, LANCET, V372, P1809, DOI 10.1016/S0140-6736(08)61758-4; Kris MG, 2003, JAMA-J AM MED ASSOC, V290, P2149, DOI 10.1001/jama.290.16.2149; Kuo MT, 2007, ADV EXP MED BIOL, V608, P23; Lee DH, 2008, ANN ONCOL, V19, P2039, DOI 10.1093/annonc/mdn423; Lemos C, 2009, BRIT J CANCER, V100, P1120, DOI 10.1038/sj.bjc.6604980; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Marchetti S, 2008, MOL CANCER THER, V7, P2280, DOI 10.1158/1535-7163.MCT-07-2250; Nakamura Y, 2005, CANCER RES, V65, P1541, DOI 10.1158/0008-5472.CAN-03-2417; Nishimura Y, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-42; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Perez-Soler R, 2004, J CLIN ONCOL, V22, P3238, DOI 10.1200/JCO.2004.11.057; Rho JK, 2009, MOL CANCER RES, V7, P1736, DOI 10.1158/1541-7786.MCR-08-0504; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Shi Z, 2007, CANCER RES, V67, P11012, DOI 10.1158/0008-5472.CAN-07-2686; Shi Z, 2009, BIOCHEM PHARMACOL, V77, P781, DOI 10.1016/j.bcp.2008.11.007; Shi Z, 2009, ONCOL REP, V21, P483, DOI 10.3892/or_00000248; Sugimoto Y, 2005, CANCER SCI, V96, P457, DOI 10.1111/j.1349-7006.2005.00081.x; Takano T, 2005, J CLIN ONCOL, V23, P6829, DOI 10.1200/JCO.2005.01.0793; Takara K, 2006, CURR PHARM DESIGN, V12, P273, DOI 10.2174/138161206775201965; Tsao MS, 2005, NEW ENGL J MED, V353, P133, DOI 10.1056/NEJMoa050736; Usuda J, 2007, LUNG CANCER, V58, P296, DOI 10.1016/j.lungcan.2007.05.019; Vasile E, 2008, J THORAC ONCOL, V3, P912, DOI 10.1097/JTO.0b013e318180275e; Wang XD, 2007, DRUG METAB DISPOS, V35, P268, DOI 10.1124/dmd.106.011684; Wu JY, 2008, AM J RESP CRIT CARE, V178, P847, DOI 10.1164/rccm.200803-389OC; Yang CH, 2005, CANCER RES, V65, P6943, DOI 10.1158/0008-5472.CAN-05-0641; Yang CH, 2006, CANCER-AM CANCER SOC, V107, P1873, DOI 10.1002/cncr.22220; Yoh K, 2004, CLIN CANCER RES, V10, P1691, DOI 10.1158/1078-0432.CCR-0937-3; Zhang SZ, 2005, DRUG METAB DISPOS, V33, P341, DOI 10.1124/dmd.104.002501; Zhang SZ, 2004, MOL PHARMACOL, V65, P1208, DOI 10.1124/mol.65.5.1208	43	463	478	15	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21428	10.1371/journal.pone.0021428	http://dx.doi.org/10.1371/journal.pone.0021428			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21437249	Green Published, Green Submitted, gold			2022-12-27	WOS:000292035400036
J	Chen, YT; Ross, DS; Chiu, R; Zhou, XK; Chen, YY; Lee, PS; Hoda, SA; Simpson, AJ; Old, LJ; Caballero, O; Neville, AM				Chen, Yao-Tseng; Ross, Dara S.; Chiu, Rita; Zhou, Xi K.; Chen, Yunn-Yi; Lee, Peishan; Hoda, Syed A.; Simpson, Andrew J.; Old, Lloyd J.; Caballero, Otavia; Neville, A. Munro			Multiple Cancer/Testis Antigens Are Preferentially Expressed in Hormone-Receptor Negative and High-Grade Breast Cancers	PLOS ONE			English	Article							T-CELL RESPONSES; NY-ESO-1 EXPRESSION; PROTEIN EXPRESSION; ANTIBODY; IMMUNOGENICITY; IDENTIFICATION; CARCINOMA; FAMILY; GENES; CT45	Background: Cancer/testis (CT) antigens are protein antigens normally expressed only in germ cells of testis, and yet are expressed in a proportion of a wide variety of human cancers. CT antigens can elicit spontaneous immune responses in cancer patients with CT-positive cancers, and CT antigen-based therapeutic cancer vaccine trials are ongoing for "CT-rich" tumors. Although some previous studies found breast cancer to be "CT-poor", our recent analysis identified increased CT mRNA transcripts in the ER-negative subset of breast cancer. Methodology/Principal Findings: In this study, we performed a comprehensive immunohistochemical study to investigate the protein expression of eight CT genes in 454 invasive ductal carcinomas, including 225 ER/PR/HER2-negative (triple-negative) carcinomas. We found significantly more frequent expression of all eight CT antigens in ER-negative cancers, and five of them-MAGEA, CT7, NY-ESO-1, CT10 and CT45, were expressed in 12-24% of ER-negative cancers, versus 2-6% of ER-positive cancers (p < 0.001 to 0.003). In comparison, GAGE, SAGE1 and NXF2 were only expressed in 3-5% of ER-negative and 0-2% of ER-positive cancers. ER-negative cancers were also more likely to simultaneously co-express multiple CT antigens, with 27% (34/125) of ER-negative, CT-positive tumors expressing three or more CT antigens. HER2 status had no consistent effect on CT expression, and triple-negative carcinomas showed similar frequencies of MAGEA and NY-ESO-1 expression as ER-negative/HER2-positive carcinomas. More frequent CT expression was also found in tumors with higher nuclear grade (p < 0.001 to p = 0.01) and larger in size (> 2 cm). Conclusions/Significance: CT antigens are preferentially expressed in hormone receptor-negative and high-grade breast cancer. Considering the limited treatment options for ER/PR/HER2 triple-negative breast cancer, the potential of CT-based immunotherapy should be explored.	[Chen, Yao-Tseng; Ross, Dara S.; Hoda, Syed A.] Cornell Univ, Weill Med Coll, Dept Pathol & Lab Med, New York, NY 10021 USA; [Chiu, Rita; Lee, Peishan; Simpson, Andrew J.; Old, Lloyd J.; Caballero, Otavia; Neville, A. Munro] Ludwig Inst Canc Res, New York Branch, New York, NY USA; [Zhou, Xi K.] Cornell Univ, Weill Med Coll, Dept Publ Hlth, New York, NY 10021 USA; [Chen, Yunn-Yi] Univ Calif San Francisco, Dept Pathol, San Francisco, CA USA	Cornell University; Ludwig Institute for Cancer Research; Cornell University; University of California System; University of California San Francisco	Chen, YT (corresponding author), Cornell Univ, Weill Med Coll, Dept Pathol & Lab Med, New York, NY 10021 USA.	ytchen@med.cornell.edu	Center, Univ of Texas-M D Anderson Cancer/AAE-8182-2019; Hung, Mien-Chie/ABD-5911-2021; Huang, Wei-Chien/D-1740-2012; Chang, Kwang-Yu/G-9161-2011; Huang, Wei-Chien/H-3126-2019; Lee, Jack/P-7331-2019; Zhang, Jun/G-4598-2010	Center, Univ of Texas-M D Anderson Cancer/0000-0001-5469-9214; Hung, Mien-Chie/0000-0003-4317-4740; Huang, Wei-Chien/0000-0001-6467-8716; Huang, Wei-Chien/0000-0001-6467-8716; Lee, Jack/0000-0002-4584-929X; CHOU, CHAO-KAI/0000-0001-5231-5264; Zhang, Jun/0000-0002-6601-9180; SHENG, WANG-HUEI/0000-0002-5605-7853; Su, Wu-Chou/0000-0003-2953-4105; CHEN, YEE-CHUN/0000-0002-1816-9010; Xia, Ningshao/0000-0003-0179-5266; TSAI, KEH-SUNG/0000-0001-8528-1566; WANG, JANN-TAY/0000-0002-0924-3469; Mizuguchi, Kenji/0000-0003-3021-7078; CHANG, SHAN-CHWEN/0000-0001-6505-4139	Ludwig Institute for Cancer Research; NATIONAL CANCER INSTITUTE [P01CA099031, R01CA109311] Funding Source: NIH RePORTER	Ludwig Institute for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Ludwig Institute for Cancer Research < http://www.licr.org/>. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandic D, 2006, CROAT MED J, V47, P32; Boon T, 1997, IMMUNOL TODAY, V18, P267, DOI 10.1016/S0167-5699(97)80020-5; BRASSEUR F, 1995, INT J CANCER, V63, P375, DOI 10.1002/ijc.2910630313; Caballero OL, 2009, CANCER SCI, V100, P2014, DOI 10.1111/j.1349-7006.2009.01303.x; Chen YT, 2010, P NATL ACAD SCI USA, V107, P3093, DOI 10.1073/pnas.0915050107; Chen YT, 2009, INT J CANCER, V124, P2893, DOI 10.1002/ijc.24296; Chen YT, 1998, P NATL ACAD SCI USA, V95, P6919, DOI 10.1073/pnas.95.12.6919; CHEN YT, 1994, P NATL ACAD SCI USA, V91, P1004, DOI 10.1073/pnas.91.3.1004; Chen YT, 1997, P NATL ACAD SCI USA, V94, P1914, DOI 10.1073/pnas.94.5.1914; Davis ID, 2004, P NATL ACAD SCI USA, V101, P10697, DOI 10.1073/pnas.0403572101; Dunnwald LK, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1639; Grigoriadis A, 2009, P NATL ACAD SCI USA, V106, P13493, DOI 10.1073/pnas.0906840106; Gure AO, 2000, INT J CANCER, V85, P726, DOI 10.1002/(SICI)1097-0215(20000301)85:5<726::AID-IJC21>3.0.CO;2-F; Jager E, 2000, P NATL ACAD SCI USA, V97, P4760, DOI 10.1073/pnas.97.9.4760; Jager E, 1999, INT J CANCER, V84, P506, DOI 10.1002/(SICI)1097-0215(19991022)84:5<506::AID-IJC10>3.0.CO;2-6; Jungbluth AA, 2002, INT J CANCER, V99, P839, DOI 10.1002/ijc.10416; Jungbluth AA, 2001, INT J CANCER, V92, P856, DOI 10.1002/ijc.1282; Kurashige T, 2001, CANCER RES, V61, P4671; Marchand M, 1999, INT J CANCER, V80, P219, DOI 10.1002/(SICI)1097-0215(19990118)80:2<219::AID-IJC10>3.0.CO;2-S; Mischo A, 2006, INT J CANCER, V118, P696, DOI 10.1002/ijc.21352; Rimoldi D, 2000, INT J CANCER, V86, P749; Scanlan MJ, 2002, IMMUNOL REV, V188, P22, DOI 10.1034/j.1600-065X.2002.18803.x; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Stockert E, 1998, J EXP MED, V187, P1349, DOI 10.1084/jem.187.8.1349; Sugita Y, 2004, CANCER RES, V64, P2199, DOI 10.1158/0008-5472.CAN-03-3070; Theurillat JP, 2007, INT J CANCER, V120, P2411, DOI 10.1002/ijc.22376; Tinguely M, 2008, CANCER SCI, V99, P720, DOI 10.1111/j.1349-7006.2008.00738.x; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; Zhuang Ran, 2006, Cancer Immun, V6, P7	29	463	478	15	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17876	10.1371/journal.pone.0017876	http://dx.doi.org/10.1371/journal.pone.0017876			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21437249	Green Submitted, Green Published, gold			2022-12-27	WOS:000288545100041
